Activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
CD28	B-protein	NOUN	B
surface	I-protein	NOUN	I
receptor	I-protein	NOUN	I
provides	O	VERB	O
a	O	DET	O
major	O	ADJ	O
costimulatory	O	ADJ	B
signal	O	NOUN	I
for	O	ADP	O
T	O	NOUN	B
cell	O	NOUN	I
activation	O	NOUN	B
resulting	O	VERB	O
in	O	ADP	O
enhanced	O	VERB	B
production	O	NOUN	B
of	O	ADP	O
interleukin-2	B-protein	NOUN	B
(	O	PUNCT	O
IL-2	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
cell	O	NOUN	B
proliferation	O	NOUN	I
.	O	PUNCT	O


Delineation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
CD28	B-protein	NOUN	B
signaling	O	NOUN	I
cascade	O	NOUN	I
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
involve	O	VERB	O
protein	B-protein	NOUN	B
tyrosine	I-protein	NOUN	I
kinase	I-protein	NOUN	I
activity	O	NOUN	O
,	O	PUNCT	O
followed	O	VERB	O
by	O	ADP	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
phospholipase	B-protein	NOUN	B
A2	I-protein	NOUN	I
and	O	CCONJ	O
5-lipoxygenase	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
peri-kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
site	I-DNA	NOUN	I
mediates	O	VERB	O
human	B-DNA	ADJ	B
immunodeficiency	I-DNA	NOUN	I
virus	I-DNA	NOUN	I
type	I-DNA	NOUN	I
2	I-DNA	NUM	I
enhancer	I-DNA	NOUN	I
activation	O	NOUN	O
in	O	ADP	O
monocytes	B-cell_type	NOUN	B
but	O	CCONJ	O
not	O	PART	O
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Only	O	ADV	O
stably	O	ADV	B
transfected	B-cell_line	VERB	B
target	I-cell_line	NOUN	O
cells	I-cell_line	NOUN	O
exhibited	O	VERB	O
cytolytic	O	ADJ	B
susceptibility	O	NOUN	I
,	O	PUNCT	O
despite	O	SCONJ	O
expression	O	NOUN	B
of	O	ADP	O
equivalent	O	ADJ	B
levels	O	NOUN	B
of	O	ADP	O
E1A	B-protein	NOUN	B
proteins	I-protein	NOUN	I
in	O	ADP	O
Ad-infected	B-cell_line	ADJ	B
targets	I-cell_line	NOUN	B
.	O	PUNCT	O


This	O	DET	O
delay	O	NOUN	B
is	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
down-regulation	O	NOUN	B
of	O	ADP	O
many	O	ADJ	O
erythroid	B-DNA	ADJ	B
cell-specific	I-DNA	ADJ	B
genes	I-DNA	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
alpha-	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
beta-globin	I-DNA	NOUN	B
,	O	PUNCT	O
band	O	NOUN	B
3	O	NUM	I
,	O	PUNCT	O
band	O	NOUN	O
4.1	O	NUM	O
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
erythroid	B-protein	ADJ	B
cell-specific	I-protein	ADJ	B
histone	I-protein	NOUN	I
H5	B-protein	NOUN	I
.	O	PUNCT	O


To	O	PART	O
address	O	VERB	O
potential	O	ADJ	B
mechanisms	O	NOUN	B
by	O	ADP	O
which	O	DET	O
estrogens	O	NOUN	B
suppress	O	VERB	B
erythropoiesis	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
examined	O	VERB	O
their	O	PRON	O
effects	O	NOUN	B
on	O	ADP	O
GATA-1	B-protein	NOUN	B
,	O	PUNCT	O
an	O	DET	O
erythroid	B-protein	ADJ	B
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
that	O	PRON	O
participates	O	VERB	B
in	O	ADP	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
majority	O	NOUN	O
of	O	ADP	O
erythroid	B-DNA	ADJ	B
cell-specific	I-DNA	ADJ	B
genes	I-DNA	NOUN	I
and	O	CCONJ	O
is	O	AUX	O
necessary	O	ADJ	O
for	O	ADP	O
full	O	ADJ	O
maturation	O	NOUN	B
of	O	ADP	O
erythrocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


Mapping	O	NOUN	B
experiments	O	NOUN	I
indicate	O	VERB	O
that	O	SCONJ	O
GATA-1	B-protein	NOUN	B
and	O	CCONJ	O
the	O	DET	O
ER	B-protein	NOUN	B
form	O	NOUN	O
at	O	ADP	O
least	O	ADJ	O
two	O	NUM	O
contacts	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
involve	O	VERB	O
the	O	DET	O
finger	O	NOUN	B
region	O	NOUN	I
and	O	CCONJ	O
the	O	DET	O
N-terminal	B-protein	ADJ	B
activation	I-protein	NOUN	I
domain	I-protein	NOUN	I
of	O	ADP	O
GATA-1	B-protein	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
shown	O	VERB	O
that	O	SCONJ	O
interleukin-1	B-protein	NOUN	B
(	O	PUNCT	O
IL-1	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
IL-2	B-protein	NOUN	B
control	O	NOUN	O
IL-2	B-DNA	NOUN	B
receptor	I-DNA	NOUN	I
alpha	I-DNA	NOUN	I
(	I-DNA	PUNCT	O
IL-2R	I-DNA	NOUN	B
alpha	I-DNA	NOUN	I
)	I-DNA	PUNCT	O
gene	I-DNA	NOUN	B
transcription	O	NOUN	I
in	O	ADP	O
CD4-CD8-	B-cell_line	ADJ	B
murine	I-cell_line	ADJ	I
T	I-cell_line	NOUN	I
lymphocyte	I-cell_line	NOUN	I
precursors	I-cell_line	NOUN	I
.	O	PUNCT	O


Finally	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
status	O	NOUN	B
of	O	ADP	O
our	O	PRON	O
current	O	ADJ	O
knowledge	O	NOUN	B
concerning	O	VERB	O
the	O	DET	O
roles	O	NOUN	O
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
in	O	ADP	O
the	O	DET	O
commitment	O	NOUN	B
to	O	PART	O
erythroid	B-cell_type	ADJ	B
,	I-cell_type	PUNCT	O
myeloid	I-cell_type	ADJ	B
and	I-cell_type	CCONJ	O
lymphoid	I-cell_type	ADJ	B
cell	I-cell_type	NOUN	I
types	I-cell_type	NOUN	O
is	O	AUX	O
summarized	O	VERB	O
.	O	PUNCT	O


A	O	DET	O
key	O	ADJ	O
cytokine	B-protein	NOUN	B
induced	O	VERB	B
during	O	ADP	O
the	O	DET	O
immune	O	ADJ	B
response	O	NOUN	I
is	O	AUX	O
IL-2	B-protein	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
turn	O	NOUN	O
,	O	PUNCT	O
secreted	O	VERB	B
IL-2	B-protein	NOUN	B
serves	O	VERB	O
to	O	PART	O
stimulate	O	VERB	B
the	O	DET	O
proliferation	O	NOUN	B
and	O	CCONJ	O
differentiation	O	NOUN	B
of	O	ADP	O
T	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
.	O	PUNCT	O


This	O	DET	O
hypothetical	O	ADJ	B
model	O	NOUN	I
integrates	O	VERB	O
one	O	NUM	O
mechanism	O	NOUN	B
of	O	ADP	O
DNA	O	NOUN	B
repair	O	NOUN	I
with	O	ADP	O
the	O	DET	O
cell	O	NOUN	B
cycle	O	NOUN	I
control	O	NOUN	I
of	O	ADP	O
gene	O	NOUN	B
transcription	O	NOUN	I
,	O	PUNCT	O
likely	O	ADJ	O
through	O	ADP	O
E2F	B-protein	NOUN	B
.	O	PUNCT	O


Although	O	SCONJ	O
it	O	PRON	O
has	O	AUX	O
been	O	AUX	O
reported	O	VERB	O
that	O	SCONJ	O
there	O	PRON	O
are	O	AUX	O
some	O	DET	O
T	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
that	O	PRON	O
produce	O	VERB	O
IFN-gamma	B-protein	NOUN	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
IL-2	O	NOUN	B
and	O	CCONJ	O
IL-12	O	NOUN	B
stimulation	O	NOUN	B
,	O	PUNCT	O
there	O	PRON	O
has	O	AUX	O
as	O	ADP	O
yet	O	ADV	O
been	O	AUX	O
no	O	DET	O
report	O	NOUN	O
of	O	ADP	O
a	O	DET	O
natural	B-cell_line	ADJ	B
killer	I-cell_line	NOUN	I
(	I-cell_line	PUNCT	O
NK	I-cell_line	NOUN	O
)	I-cell_line	PUNCT	O
cell	I-cell_line	NOUN	O
line	I-cell_line	NOUN	O
that	O	PRON	O
responds	O	VERB	O
in	O	ADP	O
a	O	DET	O
similar	O	ADJ	O
manner	O	NOUN	O
.	O	PUNCT	O


Here	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
overexpression	O	NOUN	B
of	O	ADP	O
p95vav	B-protein	NOUN	B
alone	O	ADV	O
in	O	ADP	O
Jurkat	O	NOUN	B
T	B-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
leads	O	VERB	O
to	O	PART	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
nuclear	B-protein	ADJ	B
factors	I-protein	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
NFAT	B-protein	NOUN	B
,	O	PUNCT	O
involved	O	VERB	O
in	O	ADP	O
interleukin-2	B-protein	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


PEBP2	B-protein	NOUN	B
alpha	I-protein	NOUN	I
A1	I-protein	NOUN	I
,	O	PUNCT	O
alpha	B-protein	NOUN	B
B1	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
alpha	B-protein	NOUN	B
B2	I-protein	NOUN	I
proteins	I-protein	NOUN	I
bound	O	VERB	O
the	O	DET	O
PEBP2	B-DNA	NOUN	B
site	I-DNA	NOUN	B
within	O	ADP	O
the	O	DET	O
mouse	B-DNA	NOUN	B
GM-CSF	I-DNA	NOUN	B
promoter	I-DNA	NOUN	B
.	O	PUNCT	O


Priming	O	VERB	B
by	O	ADP	O
IFN-gamma	B-protein	NOUN	B
was	O	AUX	O
primarily	O	ADV	O
manifested	O	VERB	O
at	O	ADP	O
the	O	DET	O
level	O	NOUN	B
of	O	ADP	O
TNF	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
accumulation	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
Myc-associated	B-DNA	ADJ	B
zinc	I-DNA	NOUN	B
finger	I-DNA	NOUN	I
protein	I-DNA	NOUN	I
binding	I-DNA	NOUN	O
site	I-DNA	NOUN	O
is	O	AUX	O
one	O	NUM	O
of	O	ADP	O
four	O	NUM	O
important	O	ADJ	O
functional	B-DNA	ADJ	B
regions	I-DNA	NOUN	I
in	O	ADP	O
the	O	DET	O
CD4	B-DNA	NOUN	B
promoter	I-DNA	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
also	O	ADV	O
demonstrate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
Myc-associated	B-protein	ADJ	B
zinc	I-protein	NOUN	B
finger	I-protein	NOUN	I
protein	I-protein	NOUN	I
(	O	PUNCT	O
MAZ	B-protein	NOUN	B
)	O	PUNCT	O
appears	O	VERB	O
to	O	PART	O
be	O	AUX	O
the	O	DET	O
predominant	B-protein	ADJ	B
factor	I-protein	NOUN	B
binding	O	VERB	I
to	O	PART	O
one	O	NUM	O
of	O	ADP	O
these	O	DET	O
sites	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
last	O	ADJ	O
site	O	NOUN	B
closely	O	ADV	O
resembles	O	VERB	O
the	O	DET	O
ME1a1	B-DNA	NOUN	B
G3AG4AG3	I-DNA	NOUN	B
motif	I-DNA	NOUN	B
previously	O	ADV	O
shown	O	VERB	O
to	O	PART	O
be	O	AUX	O
a	O	DET	O
critical	O	ADJ	B
element	O	NOUN	I
in	O	ADP	O
the	O	DET	O
P2	B-DNA	NOUN	O
promoter	I-DNA	NOUN	B
of	O	ADP	O
the	O	DET	O
c-myc	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
.	O	PUNCT	O


TAL1	B-protein	NOUN	B
expression	O	NOUN	B
by	O	ADP	O
erythroid	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
in	O	X	B
vivo	O	X	I
and	O	CCONJ	O
in	O	ADP	O
chemical-induced	B-cell_line	ADJ	B
erythroleukemia	I-cell_line	NOUN	I
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
in	O	X	B
vivo	O	X	I
suggested	O	VERB	O
the	O	DET	O
gene	O	NOUN	B
might	O	AUX	O
regulate	O	VERB	B
aspects	O	NOUN	O
of	O	ADP	O
erythroid	O	ADJ	B
differentiation	O	NOUN	B
.	O	PUNCT	O


Since	O	SCONJ	O
the	O	DET	O
terminal	O	ADJ	B
events	O	NOUN	B
of	O	ADP	O
erythropoiesis	O	NOUN	B
are	O	AUX	O
controlled	O	VERB	B
by	O	ADP	O
the	O	DET	O
glycoprotein	B-protein	NOUN	B
hormone	I-protein	NOUN	I
erythropoietin	I-protein	NOUN	I
(	O	PUNCT	O
Epo	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
we	O	PRON	O
investigated	O	VERB	B
whether	O	SCONJ	O
the	O	DET	O
expression	O	NOUN	B
or	O	CCONJ	O
activity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
TAL1	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
and	O	CCONJ	O
its	O	PRON	O
protein	B-protein	NOUN	B
products	I-protein	NOUN	I
were	O	AUX	O
affected	O	VERB	B
by	O	ADP	O
Epo	B-protein	NOUN	B
in	O	ADP	O
splenic	B-cell_type	ADJ	B
erythroblasts	I-cell_type	NOUN	I
from	O	ADP	O
mice	O	NOUN	B
infected	O	VERB	B
with	O	ADP	O
an	O	DET	O
anemia-inducing	O	ADJ	B
strain	O	NOUN	I
of	O	ADP	O
Friend	O	NOUN	B
virus	O	NOUN	I
(	O	PUNCT	O
FVA	O	NOUN	B
cells	O	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
formation	O	NOUN	B
of	O	ADP	O
this	O	DET	O
complex	O	NOUN	B
would	O	AUX	O
increase	O	VERB	B
,	O	PUNCT	O
independently	O	ADV	O
of	O	ADP	O
an	O	DET	O
in	O	ADP	O
synergy	O	NOUN	B
with	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
,	O	PUNCT	O
the	O	DET	O
low	O	ADJ	B
basal	O	ADJ	B
activity	O	NOUN	I
of	O	ADP	O
the	O	DET	O
HIV	B-DNA	NOUN	B
LTR	I-DNA	NOUN	B
observed	O	VERB	O
in	O	ADP	O
normal	B-cell_type	ADJ	O
T	I-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
.	O	PUNCT	O


Control	O	NOUN	B
of	O	ADP	I
I	B-protein	NOUN	I
kappa	I-protein	NOUN	I
B-alpha	I-protein	NOUN	I
proteolysis	O	NOUN	B
by	O	ADP	O
site-specific	O	ADJ	B
,	O	PUNCT	O
signal-induced	O	ADJ	B
phosphorylation	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
liberates	O	VERB	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
to	O	PART	O
translocate	O	VERB	B
to	O	PART	O
the	O	DET	O
nucleus	O	NOUN	B
and	O	CCONJ	O
initiate	O	VERB	B
transcription	O	NOUN	B
of	O	ADP	O
genes	B-DNA	NOUN	B
important	O	ADJ	O
for	O	ADP	O
the	O	DET	O
defense	O	NOUN	B
of	O	ADP	O
the	O	DET	O
organism	O	NOUN	B
.	O	PUNCT	O


Rather	O	ADV	O
,	O	PUNCT	O
hEpoR	B-protein	NOUN	B
transcription	O	NOUN	B
activity	O	NOUN	I
depends	O	VERB	O
on	O	ADP	O
coordination	O	NOUN	B
between	O	ADP	O
Sp1	B-protein	NOUN	B
and	O	CCONJ	O
GATA-1	B-protein	NOUN	B
with	O	ADP	O
other	O	ADJ	O
cell-specific	B-protein	ADJ	B
factors	I-protein	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
possibly	O	ADV	O
other	O	ADJ	O
Sp1-like	B-protein	ADJ	B
binding	I-protein	NOUN	I
proteins	I-protein	NOUN	I
,	O	PUNCT	O
to	O	PART	O
provide	O	VERB	O
high	O	ADJ	O
level	O	NOUN	B
,	O	PUNCT	O
tissue-specific	O	ADJ	B
expression	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
identified	O	VERB	O
a	O	DET	O
cDNA	B-DNA	NOUN	B
clone	I-DNA	NOUN	O
,	O	PUNCT	O
DR-nm23	B-protein	NOUN	B
,	O	PUNCT	O
differentially	O	ADV	B
expressed	O	VERB	B
in	O	ADP	O
a	O	DET	O
blast-crisis	B-DNA	ADJ	B
cDNA	I-DNA	NOUN	B
library	I-DNA	NOUN	I
,	I-DNA	PUNCT	O
which	O	DET	O
has	O	AUX	O
approximately	O	ADV	O
70	O	NUM	O
%	O	NOUN	O
sequence	O	NOUN	B
similarity	O	NOUN	B
to	O	PART	O
the	O	DET	O
putative	B-DNA	ADJ	O
metastatic	I-DNA	ADJ	O
suppressor	I-DNA	NOUN	O
genes	I-DNA	NOUN	O
,	O	PUNCT	O
nm23-H1	B-DNA	NOUN	B
and	O	CCONJ	O
nm23-H2	B-DNA	NOUN	B
.	O	PUNCT	O


DR-nm23	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
is	O	AUX	O
preferentially	O	ADV	O
expressed	O	VERB	B
at	O	ADP	O
early	O	ADJ	B
stages	O	NOUN	I
of	O	ADP	O
myeloid	O	ADJ	B
differentiation	O	NOUN	I
of	O	ADP	O
highly	B-cell_line	ADV	O
purified	I-cell_line	VERB	B
CD34+	I-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
are	O	AUX	O
consistent	O	ADJ	B
with	O	ADP	I
a	O	DET	O
role	O	NOUN	O
for	O	ADP	O
DR-nm23	B-protein	NOUN	B
in	O	ADP	O
normal	O	ADJ	O
hematopoiesis	O	NOUN	B
and	O	CCONJ	O
raise	O	VERB	O
the	O	DET	O
possibility	O	NOUN	O
that	O	SCONJ	O
its	O	PRON	O
overexpression	O	NOUN	B
contributes	O	VERB	O
to	O	PART	O
differentiation	O	NOUN	B
arrest	O	NOUN	I
,	O	PUNCT	O
a	O	DET	O
feature	O	NOUN	O
of	O	ADP	O
blastic	O	ADJ	B
transformation	O	NOUN	I
in	O	ADP	O
chronic	O	ADJ	B
myelogenous	O	ADJ	I
leukemia	O	NOUN	I
.	O	PUNCT	O


Genomic	O	ADJ	B
sequence	O	NOUN	I
upstream	O	ADJ	I
of	O	ADP	O
the	O	DET	O
Fc	B-DNA	NOUN	B
gamma	I-DNA	NOUN	I
RIC	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
was	O	AUX	O
cloned	O	VERB	B
and	O	CCONJ	O
subjected	O	VERB	O
to	O	PART	O
primer	O	NOUN	B
extension	O	NOUN	I
analysis	O	NOUN	I
,	O	PUNCT	O
which	O	DET	O
demonstrated	O	VERB	O
a	O	DET	O
single	O	ADJ	O
transcription	B-DNA	NOUN	O
initiation	I-DNA	NOUN	O
site	I-DNA	NOUN	O
without	O	ADP	O
a	O	DET	O
TATA	B-DNA	NOUN	B
box	I-DNA	NOUN	I
.	O	PUNCT	O


Inhibition	O	NOUN	B
of	O	ADP	O
endogenous	O	ADJ	B
NO	O	NOUN	B
production	O	NOUN	B
by	O	ADP	O
L-N-monomethyl-arginine	O	NOUN	B
also	O	ADV	O
induced	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
VCAM-1	B-protein	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
did	O	AUX	O
not	O	PART	O
augment	O	VERB	O
cytokine-induced	O	ADJ	B
VCAM-1	B-protein	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
ICK-1	B-DNA	NOUN	B
binding	I-DNA	NOUN	B
site	I-DNA	NOUN	I
does	O	AUX	O
not	O	PART	O
confer	O	VERB	O
negative	O	ADJ	B
regulation	O	NOUN	B
in	O	ADP	O
U937	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
shown	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
interaction	O	NOUN	B
of	O	ADP	O
interleukin	B-protein	NOUN	B
(	I-protein	PUNCT	I
IL	I-protein	NOUN	B
)	I-protein	PUNCT	O
-5	I-protein	NUM	O
with	O	ADP	O
the	O	DET	O
receptor	O	NOUN	B
activates	O	VERB	B
Lyn	B-protein	NOUN	B
tyrosine	I-protein	NOUN	I
kinase	I-protein	NOUN	I
within	O	ADP	O
1	O	NUM	O
min	O	NOUN	B
and	O	CCONJ	O
Jak2	B-protein	NOUN	B
tyrosine	I-protein	NOUN	B
kinase	I-protein	NOUN	I
within	O	ADP	O
1-3	O	NUM	O
min	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
retinoblastoma	B-protein	NOUN	B
gene	I-protein	NOUN	I
product	I-protein	NOUN	I
negatively	O	ADV	O
regulates	O	VERB	B
transcriptional	O	ADJ	B
activation	O	NOUN	I
mediated	O	VERB	O
by	O	ADP	O
the	O	DET	O
human	B-protein	ADJ	B
cytomegalovirus	I-protein	NOUN	I
IE2	I-protein	NOUN	B
protein	I-protein	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
found	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
retinoblastoma	B-protein	NOUN	B
susceptibility	I-protein	NOUN	I
gene	I-protein	NOUN	I
product	I-protein	NOUN	I
(	O	PUNCT	O
Rb	B-protein	NOUN	B
)	O	PUNCT	O
dramatically	O	ADV	O
suppressed	O	VERB	B
this	O	DET	O
IE2	B-protein	NOUN	B
transactivation	O	NOUN	B
of	O	ADP	O
various	B-DNA	ADJ	O
promoters	I-DNA	NOUN	B
.	O	PUNCT	O


Expression	O	NOUN	B
of	O	ADP	O
nucleoside	B-protein	NOUN	B
diphosphate	I-protein	NOUN	I
(	I-protein	PUNCT	O
NDP	I-protein	NOUN	B
)	I-protein	PUNCT	O
kinase	I-protein	NOUN	B
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
homologous	O	ADJ	B
to	O	PART	O
the	O	DET	O
nm23	B-protein	NOUN	B
gene	I-protein	NOUN	I
product	I-protein	NOUN	O
in	O	ADP	O
a	O	DET	O
variety	O	NOUN	O
of	O	ADP	O
species	O	NOUN	B
,	O	PUNCT	O
has	O	AUX	O
been	O	AUX	O
found	O	VERB	O
to	O	PART	O
be	O	AUX	O
inversely	O	ADV	O
associated	O	VERB	B
with	O	ADP	I
metastatic	O	ADJ	B
potential	O	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
relationship	O	NOUN	B
remains	O	VERB	O
controversial	O	ADJ	O
according	O	VERB	O
to	O	PART	O
the	O	DET	O
tumor	B-cell_type	NOUN	B
cell	I-cell_type	NOUN	I
types	I-cell_type	NOUN	I
and	O	CCONJ	O
experimental	O	ADJ	B
system	O	NOUN	I
,	O	PUNCT	O
with	O	ADP	O
conflicting	O	VERB	O
results	O	NOUN	O
from	O	ADP	O
different	O	ADJ	O
research	O	NOUN	B
groups	O	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
difference	O	NOUN	O
of	O	ADP	O
NDP	B-protein	NOUN	B
kinase	I-protein	NOUN	B
expression	O	NOUN	B
between	O	ADP	O
KA	O	NOUN	B
and	O	CCONJ	O
SCC	O	NOUN	B
was	O	AUX	O
not	O	PART	O
statistically	O	ADV	B
significant	O	ADJ	I
.	O	PUNCT	O


The	O	DET	O
mechanism	O	NOUN	B
of	O	ADP	O
overexpression	O	NOUN	B
in	O	ADP	O
various	O	ADJ	O
tumor	B-cell_type	NOUN	B
cell	I-cell_type	NOUN	I
types	I-cell_type	NOUN	I
and	O	CCONJ	O
its	O	PRON	O
biological	O	ADJ	B
significance	O	NOUN	I
in	O	ADP	O
cutaneous	O	ADJ	B
carcinogenesis	O	NOUN	I
remain	O	VERB	O
to	O	PART	O
be	O	AUX	O
determined	O	VERB	O
.	O	PUNCT	O


CIITA	B-DNA	NOUN	B
is	O	AUX	O
a	O	DET	O
class	B-DNA	NOUN	B
II	I-DNA	NUM	I
gene	I-DNA	NOUN	I
transactivator	I-DNA	NOUN	I
known	O	VERB	O
to	O	PART	O
be	O	AUX	O
defective	O	ADJ	B
in	O	ADP	O
one	O	NUM	O
form	O	NOUN	O
of	O	ADP	O
BLS	O	NOUN	B
and	O	CCONJ	O
to	O	PART	O
be	O	AUX	O
required	O	VERB	O
for	O	ADP	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
MHC	B-protein	NOUN	B
class	I-protein	NOUN	O
II	I-protein	NUM	O
by	O	ADP	O
IFN-gamma	B-protein	NOUN	B
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
block	O	NOUN	B
in	O	ADP	O
MHC	O	NOUN	B
class	O	NOUN	I
II	O	NUM	I
inducibility	O	NOUN	B
in	O	ADP	O
RB-defective	B-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
is	O	AUX	O
not	O	PART	O
due	O	ADJ	O
to	O	PART	O
a	O	DET	O
block	O	NOUN	B
in	O	ADP	O
CIITA	B-DNA	NOUN	B
inducibility	O	NOUN	B
.	O	PUNCT	O


DESIGN	O	NOUN	O
:	O	PUNCT	O
The	O	DET	O
effects	O	NOUN	B
of	O	ADP	O
hypercortisolaemia	O	NOUN	B
,	O	PUNCT	O
hyperthermia	O	NOUN	B
and	O	CCONJ	O
cellular	O	ADJ	B
composition	O	NOUN	I
on	O	ADP	O
number	O	NOUN	O
of	O	ADP	O
glucocorticoid	B-protein	NOUN	B
receptors	I-protein	NOUN	I
per	O	ADP	O
cell	O	NOUN	O
and	O	CCONJ	O
their	O	PRON	O
affinity	O	NOUN	B
were	O	AUX	O
evaluated	O	VERB	B
,	O	PUNCT	O
both	O	CCONJ	O
in	O	X	B
vitro	O	X	I
and	O	CCONJ	O
in	O	X	B
vivo	O	X	I
,	O	PUNCT	O
in	O	ADP	O
peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
mononuclear	I-cell_type	ADJ	I
leucocytes	I-cell_type	NOUN	B
of	O	ADP	O
control	O	ADJ	B
subjects	O	NOUN	I
and	O	CCONJ	O
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
sepsis	O	NOUN	B
or	O	CCONJ	O
septic	O	ADJ	B
shock	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
possible	O	ADJ	O
signaling	O	NOUN	B
role	O	NOUN	I
for	O	ADP	O
the	O	DET	O
Syk	B-protein	NOUN	B
tyrosine	I-protein	NOUN	I
kinase	I-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
tyrosine	O	NOUN	B
kinase	O	NOUN	I
inhibitors	O	NOUN	I
genistein	O	NOUN	B
and	O	CCONJ	O
herbimycin	O	NOUN	B
A	O	NOUN	O
block	O	NOUN	B
both	O	CCONJ	O
integrin	B-protein	NOUN	B
-mediated	O	ADJ	O
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	I
and	O	CCONJ	O
increases	O	VERB	B
in	O	ADP	O
IL-1	B-protein	NOUN	B
beta	I-protein	NOUN	O
message	O	NOUN	O
levels	O	NOUN	O
,	O	PUNCT	O
indicating	O	VERB	O
a	O	DET	O
causal	O	ADJ	O
relationship	O	NOUN	B
between	O	ADP	O
the	O	DET	O
two	O	NUM	O
events	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
components	O	NOUN	B
tyrosine	O	NOUN	B
phosphorylated	O	VERB	B
subsequent	O	ADJ	O
to	O	PART	O
cell	O	NOUN	B
adhesion	O	NOUN	I
include	O	VERB	O
paxillin	B-protein	NOUN	B
,	O	PUNCT	O
pp125FAK	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
SH2	B-protein	NOUN	B
domain	I-protein	NOUN	I
containing	I-protein	VERB	O
tyrosine	I-protein	NOUN	B
kinase	I-protein	NOUN	I
Syk	I-protein	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
integrin	B-protein	NOUN	B
ligation	O	NOUN	I
with	O	ADP	O
antibodies	B-protein	NOUN	B
induces	O	VERB	O
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	I
of	O	ADP	O
Syk	B-protein	NOUN	B
but	O	CCONJ	O
not	O	PART	O
of	O	ADP	O
FAK	B-protein	NOUN	B
or	O	CCONJ	O
paxillin	B-protein	NOUN	B
.	O	PUNCT	O


This	O	DET	O
mutation	O	NOUN	B
impairs	O	VERB	B
the	O	DET	O
promoter	O	NOUN	B
activity	O	NOUN	I
in	O	ADP	O
erythroid	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
by	O	ADP	O
disrupting	O	VERB	B
a	O	DET	O
binding	B-DNA	VERB	B
site	I-DNA	NOUN	I
for	O	ADP	O
the	O	DET	O
GATA1	B-protein	NOUN	B
erythroid	I-protein	ADJ	O
transcription	I-protein	NOUN	O
factor	I-protein	NOUN	O
.	O	PUNCT	O


The	O	DET	O
results	O	NOUN	B
further	O	ADV	O
demonstrated	O	VERB	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
S6	B-protein	NOUN	B
kinase	I-protein	NOUN	I
(	O	PUNCT	O
pp90rsk	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
evidenced	O	VERB	O
by	O	ADP	O
phosphorylation	O	NOUN	B
of	O	ADP	O
S6	B-protein	NOUN	B
and	O	CCONJ	O
serum	O	NOUN	B
response	O	NOUN	I
factor	O	NOUN	I
(	O	PUNCT	O
SRF	O	NOUN	B
)	O	PUNCT	O
peptides	O	NOUN	B
,	O	PUNCT	O
in	O	ADP	O
PWM	B-cell_line	NOUN	B
treated	I-cell_line	ADJ	B
B	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
different	O	ADJ	O
genes	B-DNA	NOUN	B
,	O	PUNCT	O
the	O	DET	O
core	B-DNA	NOUN	B
sequences	I-DNA	NOUN	I
are	O	AUX	O
separated	O	VERB	O
by	O	ADP	O
integer	O	NOUN	B
numbers	O	NOUN	B
of	O	ADP	O
helical	O	ADJ	B
turns	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
TINUR	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
is	O	AUX	O
induced	O	VERB	B
within	O	ADP	O
1	O	NUM	O
h	O	NOUN	O
after	O	ADP	O
the	O	DET	O
cross-linking	O	NOUN	B
of	O	ADP	O
the	O	DET	O
T	B-protein	NOUN	B
cell	I-protein	NOUN	I
Ag	I-protein	NOUN	B
receptor	I-protein	NOUN	I
complex	I-protein	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
induction	O	NOUN	B
of	O	ADP	O
I	B-protein	NOUN	O
kappa	I-protein	NOUN	O
B	I-protein	NOUN	O
alpha	I-protein	NOUN	O
phosphorylation	O	NOUN	B
by	O	ADP	O
both	O	CCONJ	O
TNF-alpha	B-protein	NOUN	B
and	O	CCONJ	O
the	O	DET	O
phosphatase	O	NOUN	B
inhibitors	O	NOUN	I
is	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
the	O	DET	O
subsequent	O	ADJ	O
degradation	O	NOUN	B
of	O	ADP	O
I	B-protein	NOUN	O
kappa	I-protein	NOUN	O
B	I-protein	NOUN	O
alpha	I-protein	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
further	O	ADV	O
demonstrate	O	VERB	O
that	O	SCONJ	O
TNF-alpha-	O	NOUN	B
and	O	CCONJ	O
calyculin	O	NOUN	B
A-induced	O	ADJ	B
I	O	NOUN	I
kappa	O	NOUN	I
B	O	NOUN	I
alpha	O	NOUN	I
degradation	O	NOUN	I
exhibits	O	VERB	O
similar	O	ADJ	O
but	O	CCONJ	O
not	O	PART	O
identical	O	ADJ	O
sensitivities	O	NOUN	B
to	O	PART	O
a	O	DET	O
proteasome	O	NOUN	B
inhibitor	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
further	O	ADV	O
show	O	VERB	O
that	O	SCONJ	O
this	O	DET	O
G	B-DNA	NOUN	B
+	I-DNA	CCONJ	O
C-rich	I-DNA	ADJ	B
region	I-DNA	NOUN	I
is	O	AUX	O
required	O	VERB	O
for	O	ADP	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
alpha-globin	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
expression	O	NOUN	B
during	O	ADP	O
erythroid	O	ADJ	B
differentiation	O	NOUN	B
.	O	PUNCT	O


Gel-shift	O	ADJ	B
analysis	O	NOUN	I
demonstrated	O	VERB	O
that	O	SCONJ	O
stimulation	O	NOUN	B
of	O	ADP	O
CD4+	B-cell_line	ADJ	B
T	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
with	O	ADP	O
CHO-DR	B-protein	NOUN	B
and	O	CCONJ	O
staphylococcal	O	ADJ	B
enterotoxin	O	NOUN	I
A	O	NOUN	I
was	O	AUX	O
sufficient	O	ADJ	O
to	O	PART	O
induce	O	VERB	B
significant	O	ADJ	B
amounts	O	NOUN	O
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
binding	O	NOUN	I
proteins	O	NOUN	I
,	O	PUNCT	O
whereas	O	SCONJ	O
induction	O	NOUN	B
of	O	ADP	O
AP-1	B-protein	NOUN	B
binding	I-protein	NOUN	I
proteins	I-protein	NOUN	I
required	O	VERB	O
costimulation	O	NOUN	B
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	B
indicate	O	VERB	O
distinct	O	ADJ	O
effects	O	NOUN	B
of	O	ADP	I
B7	B-protein	NOUN	B
and	O	CCONJ	O
LFA-3	B-protein	NOUN	B
costimulation	O	NOUN	B
on	O	ADP	O
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
AP-1	B-protein	NOUN	B
and	O	CCONJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
endothelial	O	ADJ	B
activation	O	NOUN	I
requires	O	VERB	O
continuous	O	ADJ	B
presence	O	NOUN	B
of	O	ADP	O
LPS	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
rBPI21	B-protein	NOUN	B
acts	O	VERB	O
to	O	PART	O
reverse	O	VERB	O
LPS-mediated	O	ADJ	B
endothelial	O	ADJ	B
activation	O	NOUN	I
by	O	ADP	O
interrupting	O	VERB	B
the	O	DET	O
on-going	O	ADJ	O
LPS	O	NOUN	B
signal	O	NOUN	B
.	O	PUNCT	O


Antigen	O	NOUN	B
complexed	O	VERB	B
with	O	ADP	O
major	B-protein	ADJ	O
histocompatibility	I-protein	NOUN	O
complex	I-protein	NOUN	O
class	I-protein	NOUN	O
I	I-protein	NUM	O
or	I-protein	CCONJ	O
II	I-protein	NUM	B
molecules	I-protein	NOUN	I
on	O	ADP	O
the	O	DET	O
surface	O	NOUN	B
of	O	ADP	O
antigen	B-cell_type	NOUN	B
presenting	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
interacts	O	VERB	O
with	O	ADP	O
the	O	DET	O
T	B-protein	NOUN	B
cell	I-protein	NOUN	I
receptor	I-protein	NOUN	I
(	O	PUNCT	O
TCR	B-protein	NOUN	B
)	O	PUNCT	O
on	O	ADP	O
the	O	DET	O
surface	O	NOUN	B
of	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
initiates	O	VERB	B
an	O	DET	O
activation	O	NOUN	B
cascade	O	NOUN	I
.	O	PUNCT	O


Costimulatory	O	ADJ	B
signals	O	NOUN	B
,	O	PUNCT	O
such	O	ADJ	O
as	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
CD28	B-protein	NOUN	B
cell	I-protein	NOUN	I
surface	I-protein	NOUN	B
molecule	I-protein	NOUN	I
on	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
lead	O	VERB	O
to	O	PART	O
activation	O	NOUN	B
through	O	ADP	O
a	O	DET	O
distinct	O	ADJ	O
region	O	NOUN	O
of	O	ADP	O
the	O	DET	O
granulocyte-macrophage	B-DNA	ADJ	B
colony-stimulating	I-DNA	ADJ	I
factor	I-DNA	NOUN	I
(	I-DNA	PUNCT	O
GM-CSF	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
promoter	I-DNA	NOUN	B
.	O	PUNCT	O


Functional	O	ADJ	B
characterization	O	NOUN	B
of	O	ADP	O
novel	O	ADJ	B
IL-2	B-protein	NOUN	B
transcriptional	O	ADJ	O
inhibitors	O	NOUN	O
.	O	PUNCT	O


Formation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
NFAT-1	B-protein	NOUN	B
transcriptional	I-protein	ADJ	O
complex	I-protein	NOUN	O
on	O	ADP	O
the	O	DET	O
IL-2	B-DNA	NOUN	B
promoter	I-DNA	NOUN	O
is	O	AUX	O
essential	O	ADJ	O
for	O	ADP	O
IL-2	B-protein	NOUN	B
transcription	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
compounds	O	NOUN	B
also	O	ADV	O
inhibited	O	VERB	B
beta-galactosidase	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
levels	O	NOUN	O
.	O	PUNCT	O


Similar	O	ADJ	O
inhibition	O	NOUN	B
of	O	ADP	O
NFAT	B-protein	NOUN	B
-1-mediated	O	ADJ	O
gene	O	NOUN	B
expression	O	NOUN	I
was	O	AUX	O
observed	O	VERB	O
in	O	ADP	O
a	O	DET	O
second	O	ADJ	O
cell	B-cell_line	NOUN	B
line	I-cell_line	NOUN	I
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
stably	O	ADV	B
transfected	O	VERB	B
with	O	ADP	O
NFAT-1	B-DNA	NOUN	B
regulatory	I-DNA	ADJ	B
elements	I-DNA	NOUN	I
linked	O	VERB	O
to	O	PART	O
the	O	DET	O
reporter	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
for	I-DNA	ADP	O
sCD8	I-DNA	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
examined	O	VERB	O
the	O	DET	O
function	O	NOUN	B
of	O	ADP	O
these	O	DET	O
elements	O	NOUN	B
in	O	ADP	O
Burkitt	B-cell_line	NOUN	B
's	I-cell_line	PART	I
lymphoma	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
(	O	PUNCT	O
Ramos	B-cell_line	NOUN	B
and	O	CCONJ	O
Daudi	B-cell_line	NOUN	B
)	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
a	O	DET	O
T	B-cell_line	NOUN	B
lymphocytic	I-cell_line	ADJ	I
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
(	O	PUNCT	O
Jurkat	B-cell_line	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


By	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
cAMP	O	NOUN	B
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
calcium	O	NOUN	B
shows	O	VERB	O
no	O	DET	O
synergy	O	NOUN	O
in	O	ADP	O
c-fos	B-DNA	NOUN	B
induction	O	NOUN	B
.	O	PUNCT	O


IL-10	B-protein	NOUN	B
treatment	O	NOUN	B
of	O	ADP	O
both	O	CCONJ	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
monocytes	B-cell_type	NOUN	B
results	O	VERB	B
in	O	ADP	O
the	O	DET	O
ligand-induced	O	ADJ	B
tyrosine	O	NOUN	I
phosphorylation	O	NOUN	B
of	O	ADP	O
tyk2	B-protein	NOUN	B
and	O	CCONJ	O
Jak1	B-protein	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
Jak2	B-protein	NOUN	B
or	O	CCONJ	O
Jak3	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
inert	O	ADJ	B
quality	O	NOUN	I
of	O	ADP	O
MRL-Ipr/Ipr	B-cell_line	NOUN	B
(	I-cell_line	PUNCT	O
Ipr	I-cell_line	NOUN	B
)	I-cell_line	PUNCT	O
peripheral	I-cell_line	ADJ	B
CD4-CD8-	I-cell_line	NOUN	O
(	I-cell_line	PUNCT	O
CD4-8-	I-cell_line	ADJ	O
)	I-cell_line	PUNCT	O
T	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
manifests	O	VERB	O
primarily	O	ADV	O
as	O	ADP	O
an	O	DET	O
inability	O	NOUN	B
to	O	PART	O
proliferate	O	VERB	B
or	O	CCONJ	O
produce	O	VERB	O
IL-2	B-protein	NOUN	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
TCR	B-protein	NOUN	B
or	O	CCONJ	O
mitogenic	O	ADJ	B
stimulation	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
generation	O	NOUN	O
of	O	ADP	O
second	O	ADJ	O
messengers	O	NOUN	B
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
normally	O	ADV	O
leads	O	VERB	O
to	O	PART	O
downstream	O	ADJ	B
signaling	O	NOUN	I
that	O	PRON	O
results	O	VERB	B
in	O	ADP	O
transcriptional	O	ADJ	B
activation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
IL-2	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
.	O	PUNCT	O


This	O	DET	O
mechanism	O	NOUN	B
may	O	AUX	O
be	O	AUX	O
important	O	ADJ	O
in	O	ADP	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
HIV	O	NOUN	B
expression	O	NOUN	B
from	O	ADP	O
latently	O	ADV	B
infected	O	ADJ	I
CD4+	B-cell_line	ADJ	B
T	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
especially	O	ADV	O
in	O	ADP	O
lymphoid	O	ADJ	B
organs	O	NOUN	I
where	O	SCONJ	O
cell	O	NOUN	O
to	O	PART	O
cell	O	NOUN	B
contact	O	NOUN	I
is	O	AUX	O
conducive	O	ADJ	O
to	O	PART	O
receptor-ligand	O	ADJ	B
interactions	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
transcription	O	NOUN	B
activation	O	NOUN	I
function	O	NOUN	I
is	O	AUX	O
provided	O	VERB	O
by	O	ADP	O
the	O	DET	O
N-terminal	B-protein	ADJ	B
acidic	I-protein	ADJ	I
domain	I-protein	NOUN	I
(	O	PUNCT	O
amino	B-protein	NOUN	B
acids	I-protein	NOUN	I
26-137	I-protein	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
experimentally	O	ADV	B
exchangeable	O	ADJ	B
with	O	ADP	O
a	O	DET	O
heterologous	B-protein	ADJ	B
viral	I-protein	ADJ	B
transcription-activating	I-protein	ADJ	B
domain	I-protein	NOUN	I
.	O	PUNCT	O


Functional	O	ADJ	B
roles	O	NOUN	O
of	O	ADP	O
in	B-DNA	X	B
vivo	I-DNA	X	I
footprinted	I-DNA	ADJ	B
DNA	I-DNA	NOUN	I
motifs	I-DNA	NOUN	O
within	O	ADP	O
an	O	DET	O
alpha-globin	B-DNA	NOUN	B
enhancer	I-DNA	NOUN	I
.	O	PUNCT	O


Previous	O	ADJ	O
protein-DNA	O	ADJ	B
binding	O	NOUN	I
studies	O	NOUN	I
have	O	AUX	O
shown	O	VERB	O
that	O	SCONJ	O
HS-40	B-DNA	NOUN	B
consists	O	VERB	O
of	O	ADP	O
multiple	O	ADJ	B
nuclear	B-DNA	ADJ	O
factor	I-DNA	NOUN	O
binding	I-DNA	NOUN	O
motifs	I-DNA	NOUN	B
that	O	PRON	O
are	O	AUX	O
occupied	O	VERB	B
in	O	X	B
vivo	O	X	I
in	O	ADP	O
an	O	DET	O
erythroid	O	ADJ	B
lineage-	O	NOUN	O
and	O	CCONJ	O
developmental	O	ADJ	B
stage-specific	O	ADJ	O
manner	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
remarkable	O	ADJ	O
correlation	O	NOUN	B
between	O	ADP	O
genomic	O	ADJ	B
footprinting	O	NOUN	I
data	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
mutagenesis	O	NOUN	B
results	O	NOUN	B
also	O	ADV	O
suggests	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
erythroid	O	ADJ	B
lineage-	O	NOUN	O
and	O	CCONJ	O
developmental	O	ADJ	B
stage-specific	O	ADJ	O
regulation	O	NOUN	O
of	O	ADP	O
human	B-DNA	ADJ	B
alpha-like	I-DNA	ADJ	O
globin	I-DNA	NOUN	O
promoters	I-DNA	NOUN	O
is	O	AUX	O
indeed	O	ADV	O
modulated	O	VERB	B
by	O	ADP	O
stable	O	ADJ	B
binding	O	NOUN	B
of	O	ADP	O
specific	B-protein	ADJ	O
nuclear	I-protein	ADJ	B
factors	I-protein	NOUN	I
in	O	X	B
vivo	O	X	I
.	O	PUNCT	O


Here	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
report	O	VERB	O
that	O	SCONJ	O
nitric	O	ADJ	B
oxide	O	NOUN	I
(	O	PUNCT	O
NO	O	NOUN	B
)	O	PUNCT	O
activates	O	VERB	B
p21ras	B-DNA	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
T	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
as	O	ADP	O
evidenced	O	VERB	O
by	O	ADP	O
an	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
GTP-bound	B-protein	ADJ	B
p21ras	I-protein	NOUN	I
.	O	PUNCT	O


Interleukin-2	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
activity	O	NOUN	I
in	O	ADP	O
Epstein-Barr	B-cell_line	ADJ	B
virus-transformed	I-cell_line	ADJ	I
B	I-cell_line	NOUN	I
lymphocytes	I-cell_line	NOUN	I
is	O	AUX	O
controlled	O	VERB	B
by	O	ADP	O
nuclear	B-protein	ADJ	B
factor-chi	I-protein	NOUN	I
B	I-protein	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
can	O	AUX	O
also	O	ADV	O
synthesize	O	VERB	B
IL-2	B-protein	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
present	O	ADJ	O
study	O	NOUN	B
we	O	PRON	O
analyzed	O	VERB	B
the	O	DET	O
control	O	NOUN	B
of	O	ADP	O
IL-2	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
activity	O	NOUN	I
in	O	ADP	O
Epstein-Barr	B-cell_line	ADJ	B
virus	I-cell_line	NOUN	I
(	I-cell_line	PUNCT	O
EBV	I-cell_line	NOUN	B
)	I-cell_line	PUNCT	O
-transformed	I-cell_line	ADJ	O
B	I-cell_line	NOUN	O
cell	I-cell_line	NOUN	O
clones	I-cell_line	NOUN	O
which	O	DET	O
are	O	AUX	O
capable	O	ADJ	O
of	O	ADP	O
secreting	O	VERB	B
IL-2	B-protein	NOUN	B
at	O	ADP	O
a	O	DET	O
low	O	ADJ	B
level	O	NOUN	B
after	O	ADP	O
stimulation	O	NOUN	B
with	O	ADP	O
phorbol	O	NOUN	B
12-myristate	O	NOUN	I
13-acetate	O	NOUN	I
and	O	CCONJ	O
the	O	DET	O
Ca2+	O	NOUN	B
ionophore	O	NOUN	B
ionomycin	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
EBV-transformed	B-cell_line	ADJ	B
B	I-cell_line	NOUN	I
clones	I-cell_line	NOUN	I
,	O	PUNCT	O
the	O	DET	O
chi	B-DNA	NOUN	B
B	I-DNA	NOUN	I
site	I-DNA	NOUN	I
exerted	O	VERB	O
the	O	DET	O
strongest	O	ADJ	O
inducible	O	ADJ	B
activity	O	NOUN	O
;	O	PUNCT	O
the	O	DET	O
NF-AT	B-DNA	NOUN	B
binding	I-DNA	NOUN	O
sites	I-DNA	NOUN	O
showed	O	VERB	O
either	O	CCONJ	O
no	O	DET	O
or	O	CCONJ	O
only	O	ADV	O
weak	O	ADJ	B
activity	O	NOUN	B
compared	O	VERB	O
to	O	PART	O
Jurkat	B-cell_line	NOUN	B
T	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Does	O	AUX	O
thyroidectomy	O	NOUN	B
,	O	PUNCT	O
radioactive	O	ADJ	B
iodine	O	NOUN	I
therapy	O	NOUN	I
,	O	PUNCT	O
or	O	CCONJ	O
antithyroid	O	ADJ	B
drug	O	NOUN	I
treatment	O	NOUN	O
alter	O	VERB	O
reactivity	O	NOUN	B
of	O	ADP	O
patients	O	NOUN	B
'	O	PART	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
to	O	PART	O
epitopes	O	NOUN	B
of	O	ADP	O
thyrotropin	B-protein	NOUN	B
receptor	I-protein	NOUN	I
in	O	ADP	O
autoimmune	O	ADJ	B
thyroid	O	NOUN	I
diseases	O	NOUN	I
?	O	PUNCT	O


Expression	O	NOUN	B
studies	O	NOUN	I
on	O	ADP	O
TCF-1	B-protein	NOUN	B
protein	I-protein	NOUN	I
have	O	AUX	O
been	O	AUX	O
hampered	O	VERB	O
by	O	ADP	O
the	O	DET	O
difficulty	O	NOUN	B
to	O	PART	O
raise	O	VERB	O
antibodies	B-protein	NOUN	B
due	O	ADJ	O
to	O	PART	O
extreme	O	ADJ	O
evolutionary	O	ADJ	B
conservation	O	NOUN	B
.	O	PUNCT	O


Wild-type	O	ADJ	B
littermates	O	NOUN	B
remain	O	VERB	O
unresponsive	O	ADJ	O
to	O	PART	O
TCF-1	B-protein	NOUN	B
while	O	SCONJ	O
they	O	PRON	O
mount	O	VERB	B
a	O	DET	O
high-titer	O	ADJ	B
antibody	O	NOUN	I
response	O	NOUN	I
to	O	PART	O
the	O	DET	O
fusion	B-protein	NOUN	B
protein	I-protein	NOUN	I
,	O	PUNCT	O
Maltose	B-protein	NOUN	B
Binding	I-protein	NOUN	I
Protein	I-protein	NOUN	I
(	O	PUNCT	O
MBP	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Subsequently	O	ADV	O
,	O	PUNCT	O
TCF-1-specific	B-cell_line	ADJ	B
hybridomas	I-cell_line	NOUN	I
could	O	AUX	O
be	O	AUX	O
prepared	O	VERB	O
from	O	ADP	O
the	O	DET	O
spleens	O	NOUN	B
of	O	ADP	O
immunized	O	VERB	B
knock-out	O	ADJ	B
mice	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
prostate-specific	B-protein	ADJ	B
antigen	I-protein	NOUN	I
(	O	PUNCT	O
PSA	B-protein	NOUN	B
)	O	PUNCT	O
was	O	AUX	O
downregulated	O	VERB	B
to	O	PART	O
approximately	O	ADV	O
75	O	NUM	O
%	O	NOUN	O
during	O	ADP	O
the	O	DET	O
process	O	NOUN	B
.	O	PUNCT	O


Cell	O	NOUN	B
morphology	O	NOUN	B
showed	O	VERB	O
dendritic	O	ADJ	B
processes	O	NOUN	I
extending	O	VERB	O
from	O	ADP	O
cytoplasm	O	NOUN	B
and	O	CCONJ	O
other	O	ADJ	O
neuroendocrine	B-cell_type	ADJ	B
cell	I-cell_type	NOUN	I
characteristics	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
functions	O	NOUN	B
of	O	ADP	O
PAF	B-protein	NOUN	B
appeared	O	VERB	O
to	O	PART	O
be	O	AUX	O
mediated	O	VERB	O
through	O	ADP	O
the	O	DET	O
cell	B-protein	NOUN	B
surface	I-protein	NOUN	I
PAF	I-protein	NOUN	B
receptors	I-protein	NOUN	I
,	O	PUNCT	O
as	O	ADP	O
two	O	NUM	O
PAF	B-protein	NOUN	B
receptor	O	NOUN	I
antagonists	O	NOUN	B
,	O	PUNCT	O
WEB	O	NOUN	B
2086	O	NUM	O
and	O	CCONJ	O
L-659	O	NOUN	B
,	O	PUNCT	O
989	O	NUM	O
,	O	PUNCT	O
blocked	O	VERB	B
both	O	CCONJ	O
the	O	DET	O
up-regulation	O	NOUN	B
of	O	ADP	O
HB-EGF	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
and	O	CCONJ	O
kappa	O	NOUN	B
B	O	NOUN	I
binding	O	NOUN	I
activity	O	NOUN	I
induced	O	VERB	B
by	O	ADP	O
PAF	B-protein	NOUN	B
.	O	PUNCT	O


Mapping	O	NOUN	B
of	O	ADP	O
the	O	DET	O
interaction	B-protein	NOUN	B
site	I-protein	NOUN	B
of	O	ADP	O
the	O	DET	O
defective	B-protein	ADJ	B
transcription	I-protein	NOUN	O
factor	I-protein	NOUN	O
in	O	ADP	O
the	O	DET	O
class	B-cell_line	NOUN	B
II	I-cell_line	NUM	I
major	I-cell_line	ADJ	I
histocompatibility	I-cell_line	NOUN	I
complex	I-cell_line	NOUN	I
mutant	I-cell_line	ADJ	O
cell	I-cell_line	NOUN	O
line	I-cell_line	NOUN	O
clone-13	I-cell_line	NOUN	B
to	O	PART	O
the	O	DET	O
divergent	B-DNA	ADJ	B
X2-box	I-DNA	NOUN	B
.	O	PUNCT	O


Insertion	O	NOUN	B
of	O	ADP	O
oligonucleotides	O	NOUN	B
spanning	O	VERB	O
the	O	DET	O
DQB	B-DNA	NOUN	B
X-box	I-DNA	NOUN	I
(	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
the	O	DET	O
DQB-W	B-DNA	NOUN	B
region	I-DNA	NOUN	I
or	O	CCONJ	O
the	O	DET	O
DQB	B-DNA	NOUN	B
Y-box	I-DNA	NOUN	I
)	O	PUNCT	O
upstream	B-DNA	ADJ	B
of	I-DNA	ADP	O
-141	I-DNA	NUM	O
in	O	ADP	O
a	O	DET	O
DRA	B-DNA	NOUN	B
reporter	I-DNA	NOUN	I
plasmid	I-DNA	NOUN	I
rescued	O	VERB	B
expression	O	NOUN	B
to	O	PART	O
nearly	O	ADV	O
wild-type	O	ADJ	B
levels	O	NOUN	B
.	O	PUNCT	O


ZEBRA	B-protein	NOUN	B
is	O	AUX	O
a	O	DET	O
bZIP	B-protein	NOUN	B
transcriptional	I-protein	ADJ	O
activator	I-protein	NOUN	O
which	O	DET	O
binds	O	VERB	B
as	O	ADP	O
a	O	DET	O
dimer	O	NOUN	B
to	O	PART	O
7-bp	B-DNA	ADJ	O
response	I-DNA	NOUN	B
elements	I-DNA	NOUN	I
within	O	ADP	O
EBV	B-DNA	NOUN	B
promoters	I-DNA	NOUN	B
and	O	CCONJ	O
is	O	AUX	O
directly	O	ADV	O
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
stimulation	O	NOUN	B
of	O	ADP	O
virus	O	NOUN	B
replication	O	NOUN	B
at	O	ADP	O
the	O	DET	O
EBV	B-DNA	NOUN	B
lytic	I-DNA	ADJ	B
origin	I-DNA	NOUN	I
.	O	PUNCT	O


The	O	DET	O
ZEBRA	B-protein	NOUN	B
activation	I-protein	NOUN	B
region	I-protein	NOUN	I
was	O	AUX	O
replaced	O	VERB	O
with	O	ADP	O
the	O	DET	O
potent	O	ADJ	O
acid	B-protein	NOUN	O
activation	I-protein	NOUN	O
region	I-protein	NOUN	O
from	O	ADP	O
the	O	DET	O
herpes	B-protein	NOUN	B
simplex	I-protein	NOUN	I
virus	I-protein	NOUN	I
VP16	I-protein	NOUN	I
protein	I-protein	NOUN	I
or	O	CCONJ	O
with	O	ADP	O
the	O	DET	O
activation	B-protein	NOUN	B
region	I-protein	NOUN	I
of	O	ADP	O
the	O	DET	O
EBV	B-protein	NOUN	B
R	I-protein	NOUN	I
protein	I-protein	NOUN	I
.	O	PUNCT	O


Because	O	SCONJ	O
these	O	DET	O
are	O	AUX	O
the	O	DET	O
characteristics	O	NOUN	B
of	O	ADP	O
a	O	DET	O
signal	B-protein	NOUN	B
transducer	I-protein	NOUN	I
and	I-protein	CCONJ	O
activator	I-protein	NOUN	O
of	I-protein	ADP	O
transcription	I-protein	NOUN	O
(	I-protein	PUNCT	O
Stat	I-protein	NOUN	O
)	I-protein	PUNCT	O
protein	I-protein	NOUN	O
,	O	PUNCT	O
we	O	PRON	O
determined	O	VERB	O
whether	O	SCONJ	O
antibodies	B-protein	NOUN	B
to	I-protein	PART	O
Stat	I-protein	NOUN	B
proteins	I-protein	NOUN	I
will	O	AUX	O
interfere	O	VERB	B
with	O	ADP	I
gel	O	NOUN	B
mobility	O	NOUN	I
shift	O	NOUN	I
and	O	CCONJ	O
found	O	VERB	O
that	O	SCONJ	O
antibodies	B-protein	NOUN	B
to	I-protein	PART	O
IL-4	I-protein	NOUN	B
Stat	I-protein	NOUN	I
,	O	PUNCT	O
also	O	ADV	O
known	O	VERB	O
as	O	ADP	O
Stat6	B-protein	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
antibodies	B-protein	NOUN	B
to	O	PART	O
other	O	ADJ	O
Stat	B-protein	NOUN	B
proteins	I-protein	NOUN	I
,	O	PUNCT	O
interfere	O	VERB	B
with	O	ADP	I
the	O	DET	O
formation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IL-4	B-protein	NOUN	B
NAF	I-protein	NOUN	B
complex	I-protein	NOUN	B
.	O	PUNCT	O


HL60	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
were	O	AUX	O
induced	O	VERB	B
to	O	PART	O
differentiate	O	VERB	B
toward	O	ADP	O
monocytes-macrophages	B-cell_type	NOUN	B
by	O	ADP	O
incubation	O	NOUN	B
with	O	ADP	O
phorbol	O	NOUN	B
ester	O	NOUN	I
,	O	PUNCT	O
showing	O	VERB	O
a	O	DET	O
5-	O	NUM	O
to	O	PART	O
2-fold	O	ADJ	O
increase	O	NOUN	B
of	O	ADP	O
AhR	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
.	O	PUNCT	O


The	O	DET	O
HEL	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
also	O	ADV	O
exhibited	O	VERB	O
a	O	DET	O
similar	O	ADJ	O
elevation	O	NOUN	B
of	O	ADP	O
AhR	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
level	O	NOUN	B
,	O	PUNCT	O
when	O	SCONJ	O
they	O	PRON	O
had	O	AUX	O
differentiated	O	VERB	B
toward	O	ADP	O
monocyte-macrophage	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
by	O	ADP	O
these	O	DET	O
combined	O	ADJ	O
inducers	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
little	O	ADJ	O
change	O	NOUN	O
in	O	ADP	O
the	O	DET	O
mRNA	O	NOUN	B
level	O	NOUN	B
was	O	AUX	O
observed	O	VERB	O
when	O	SCONJ	O
the	O	DET	O
cells	O	NOUN	B
were	O	AUX	O
induced	O	VERB	B
to	O	PART	O
differentiate	O	VERB	B
into	O	ADP	O
other	O	ADJ	O
cell	O	NOUN	B
types	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
indicated	O	VERB	O
that	O	SCONJ	O
expression	O	NOUN	B
of	O	ADP	O
AhR	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
was	O	AUX	O
significantly	O	ADV	O
induced	O	VERB	B
during	O	ADP	O
monocytic	O	ADJ	B
differentiation	O	NOUN	I
and	O	CCONJ	O
that	O	SCONJ	O
the	O	DET	O
differentiated	B-cell_type	VERB	B
cells	I-cell_type	NOUN	I
were	O	AUX	O
responsive	O	ADJ	B
to	O	PART	O
xenobiotics	O	NOUN	B
.	O	PUNCT	O


p21ras	B-protein	NOUN	B
plays	O	VERB	O
an	O	DET	O
essential	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
T	O	NOUN	B
cell	O	NOUN	I
activation	O	NOUN	B
.	O	PUNCT	O


Accordingly	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	I
the	O	DET	O
constitutively	B-protein	ADV	B
active	I-protein	ADJ	O
PKCs	I-protein	NOUN	B
were	O	AUX	O
compared	O	VERB	O
to	O	PART	O
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	O
mutationally	O	ADV	B
activated	O	VERB	O
p21ras	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
data	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
PKC-epsilon	B-protein	NOUN	B
and	O	CCONJ	O
,	O	PUNCT	O
to	O	PART	O
a	O	DET	O
lesser	O	ADJ	B
extent	O	NOUN	O
PKC-alpha	B-protein	NOUN	B
but	O	CCONJ	O
not	O	PART	O
-zeta	B-protein	NOUN	O
,	O	PUNCT	O
can	O	AUX	O
regulate	O	VERB	B
the	O	DET	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
AP-1	B-protein	NOUN	B
and	O	CCONJ	O
nuclear	O	ADJ	B
factor	B-protein	NOUN	I
of	I-protein	ADP	O
activated	I-protein	VERB	B
T	I-protein	NOUN	O
cells	I-protein	NOUN	O
(	O	PUNCT	O
NF-AT-1	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
molecular	O	ADJ	B
mechanism	O	NOUN	I
for	O	ADP	O
this	O	DET	O
steroid	O	NOUN	B
resistance	O	NOUN	B
is	O	AUX	O
unclear	O	ADJ	B
.	O	PUNCT	O


Scatchard	O	NOUN	B
analysis	O	NOUN	I
of	O	ADP	O
glucocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
-	O	PUNCT	O
GRE	B-DNA	NOUN	B
binding	O	NOUN	B
showed	O	VERB	O
no	O	DET	O
change	O	NOUN	O
in	O	ADP	O
binding	O	NOUN	B
affinity	O	NOUN	B
but	O	CCONJ	O
did	O	AUX	O
show	O	VERB	O
a	O	DET	O
reduced	O	VERB	B
number	O	NOUN	O
of	O	ADP	O
receptors	B-protein	NOUN	B
available	O	ADJ	O
for	O	ADP	O
DNA	O	NOUN	B
binding	O	NOUN	I
in	O	ADP	O
the	O	DET	O
steroid-resistant	O	ADJ	B
patients	O	NOUN	B
.	O	PUNCT	O


IL-3	B-protein	NOUN	B
and	O	CCONJ	O
granulocyte-macrophage	B-protein	ADJ	B
colony-stimulating	I-protein	ADJ	I
factor	I-protein	NOUN	I
induced	O	VERB	B
,	O	PUNCT	O
similar	O	ADJ	O
to	O	PART	O
IL-5	B-protein	NOUN	B
,	O	PUNCT	O
two	O	NUM	O
DNA-binding	B-protein	ADJ	B
complexes	I-protein	NOUN	I
in	O	ADP	O
human	B-cell_type	ADJ	B
eosinophils	I-cell_type	NOUN	B
,	O	PUNCT	O
including	O	VERB	O
Stat1	B-protein	NOUN	B
alpha	I-protein	NOUN	I
.	O	PUNCT	O


To	O	PART	O
test	O	VERB	O
these	O	DET	O
hypotheses	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
studied	O	VERB	O
several	O	ADJ	O
tat	B-protein	NOUN	B
mutants	I-protein	NOUN	B
,	O	PUNCT	O
including	O	VERB	O
two	O	NUM	O
stop	B-protein	NOUN	B
codon	I-protein	NOUN	B
mutants	I-protein	NOUN	B
and	O	CCONJ	O
one	O	NUM	O
deletion	B-protein	NOUN	B
mutant	I-protein	NOUN	I
using	O	VERB	O
replication-competent	B-DNA	ADJ	B
HIV-1	I-DNA	NOUN	B
constructs	I-DNA	NOUN	B
carrying	O	VERB	O
wild-type	B-DNA	ADJ	B
or	I-DNA	CCONJ	O
mutant	I-DNA	ADJ	B
LTRs	I-DNA	NOUN	B
with	O	ADP	O
modifications	O	NOUN	B
in	O	ADP	O
the	O	DET	O
NF-kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
and/or	I-DNA	CCONJ	O
Sp1	I-DNA	NOUN	B
binding	I-DNA	NOUN	B
sites	I-DNA	NOUN	I
.	O	PUNCT	O


It	O	PRON	O
was	O	AUX	O
found	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
propagation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Tat	B-protein	NOUN	B
mutants	I-protein	NOUN	B
containing	O	VERB	O
wild-type	B-DNA	ADJ	B
LTRs	I-DNA	NOUN	B
was	O	AUX	O
less	O	ADV	O
efficient	O	ADJ	B
than	O	ADP	O
that	O	DET	O
of	O	ADP	O
the	O	DET	O
LTR-modified	B-protein	ADJ	B
Tat	I-protein	NOUN	B
mutants	I-protein	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
this	O	DET	O
efficient	O	ADJ	B
propagation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
LTR-modified	B-protein	ADJ	B
tat	I-protein	NOUN	B
mutants	I-protein	NOUN	B
was	O	AUX	O
restricted	O	ADJ	O
to	O	PART	O
some	O	DET	O
lymphoid	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
that	O	PRON	O
have	O	AUX	O
been	O	AUX	O
transformed	O	VERB	O
with	O	ADP	O
other	O	ADJ	O
viruses	O	NOUN	B
.	O	PUNCT	O


Direct	O	ADJ	B
sequencing	O	NOUN	I
of	O	ADP	O
the	O	DET	O
viral	B-DNA	ADJ	B
genomes	I-DNA	NOUN	I
and	O	CCONJ	O
reinfection	O	NOUN	B
kinetics	O	NOUN	B
showed	O	VERB	O
no	O	DET	O
evidence	O	NOUN	O
of	O	ADP	O
wild-type	O	ADJ	B
reversion	O	NOUN	B
even	O	ADV	O
after	O	ADP	O
prolonged	O	ADJ	B
infection	O	NOUN	O
with	O	ADP	O
the	O	DET	O
Tat	B-protein	NOUN	B
-virus	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
class	B-DNA	NOUN	B
II	I-DNA	NUM	I
major	I-DNA	ADJ	I
histocompatibility	I-DNA	NOUN	I
complex	I-DNA	NOUN	I
gene	I-DNA	NOUN	B
HLA-DRA	B-DNA	NOUN	I
is	O	AUX	O
expressed	O	VERB	B
in	O	ADP	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
activated	O	VERB	B
T	B-cell_type	NOUN	I
lymphocytes	I-cell_type	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
in	O	ADP	O
antigen-presenting	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Heterogeneous	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
Epstein-Barr	B-protein	ADJ	B
virus	I-protein	NOUN	I
latent	I-protein	ADJ	B
proteins	I-protein	NOUN	I
in	O	ADP	O
endemic	O	ADJ	B
Burkitt	O	NOUN	B
's	O	PART	I
lymphoma	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
lymphoblastoid	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
,	O	PUNCT	O
six	O	NUM	O
EBV-encoded	B-protein	ADJ	B
nuclear	I-protein	ADJ	O
antigens	I-protein	NOUN	O
(	O	PUNCT	O
EBNA1	B-protein	NOUN	B
,	I-protein	PUNCT	O
2	I-protein	NUM	O
,	I-protein	PUNCT	O
3A	I-protein	NOUN	B
,	I-protein	PUNCT	O
3B	I-protein	NOUN	B
,	I-protein	PUNCT	O
3C	I-protein	NOUN	B
,	I-protein	PUNCT	O
-LP	I-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
three	O	NUM	O
latent	B-protein	ADJ	B
membrane	I-protein	NOUN	I
proteins	I-protein	NOUN	I
(	O	PUNCT	O
LMP1	B-protein	NOUN	B
,	O	PUNCT	O
2A	B-protein	NOUN	B
,	O	PUNCT	O
2B	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
two	O	NUM	O
nuclear	B-RNA	ADJ	B
RNAs	I-RNA	NOUN	I
(	O	PUNCT	O
EBERs	B-RNA	NOUN	B
)	O	PUNCT	O
are	O	AUX	O
expressed	O	VERB	B
.	O	PUNCT	O


In	O	ADP	O
EBV-positive	O	ADJ	B
cases	O	NOUN	B
of	O	ADP	O
Hodgkin	O	NOUN	B
's	O	PART	I
disease	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
EBERs	B-RNA	NOUN	B
,	O	PUNCT	O
EBNA1	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
LMPs	B-protein	NOUN	B
are	O	AUX	O
expressed	O	VERB	B
(	O	PUNCT	O
latency	O	NOUN	B
II	O	NUM	I
)	O	PUNCT	O
,	O	PUNCT	O
whereas	O	SCONJ	O
in	O	ADP	O
Burkitt	O	NOUN	B
's	O	PART	I
lymphoma	O	NOUN	I
(	O	PUNCT	O
BL	O	NOUN	B
)	O	PUNCT	O
only	O	ADV	O
the	O	DET	O
EBERs	B-RNA	NOUN	B
and	O	CCONJ	O
EBNA1	B-protein	NOUN	B
have	O	AUX	O
been	O	AUX	O
detected	O	VERB	B
(	O	PUNCT	O
latency	O	NOUN	B
I	O	NUM	I
)	O	PUNCT	O
.	O	PUNCT	O


A	O	DET	O
phenotypic	O	ADJ	B
drift	O	NOUN	O
from	O	ADP	O
latency	O	NOUN	B
I	O	NUM	I
to	O	PART	O
latency	O	NOUN	B
III	O	NUM	I
has	O	AUX	O
been	O	AUX	O
observed	O	VERB	O
previously	O	ADV	O
in	O	ADP	O
some	O	DET	O
BL	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	O
suggest	O	VERB	O
that	O	SCONJ	O
a	O	DET	O
similar	O	ADJ	O
phenomenon	O	NOUN	B
may	O	AUX	O
occur	O	VERB	O
in	O	ADP	O
BL	O	NOUN	B
in	O	X	B
vivo	O	X	I
and	O	CCONJ	O
indicate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
operational	O	ADJ	B
definition	O	NOUN	B
of	O	ADP	O
EBV	O	NOUN	B
latencies	O	NOUN	B
is	O	AUX	O
not	O	PART	O
easily	O	ADV	O
applied	O	VERB	O
to	O	PART	O
human	O	ADJ	B
tumors	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
Jak	B-protein	NOUN	B
2	I-protein	NUM	I
was	O	AUX	O
studied	O	VERB	O
by	O	ADP	O
autophosphorylation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
immunoprecipitated	B-protein	VERB	B
kinase	I-protein	NOUN	I
.	O	PUNCT	O


Jak	B-protein	NOUN	B
2	I-protein	NUM	I
coprecipitated	O	VERB	B
with	O	ADP	O
the	O	DET	O
beta-subunit	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IL-5	B-protein	NOUN	B
receptor	I-protein	NOUN	I
,	O	PUNCT	O
suggesting	O	VERB	O
a	O	DET	O
physical	O	ADJ	B
association	O	NOUN	I
of	O	ADP	O
the	O	DET	O
kinase	B-protein	NOUN	B
with	O	ADP	I
the	O	DET	O
receptor	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
STAT-1	B-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
nuclear	O	ADJ	B
extract	O	NOUN	I
was	O	AUX	O
studied	O	VERB	O
by	O	ADP	O
electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assay	O	NOUN	I
.	O	PUNCT	O


Activation	O	NOUN	B
of	O	ADP	O
transcription	O	NOUN	B
by	O	ADP	O
binding	O	NOUN	B
of	O	ADP	I
NF-E1	B-protein	NOUN	I
(	O	PUNCT	O
YY1	B-protein	NOUN	B
)	O	PUNCT	O
to	O	PART	O
a	O	DET	O
newly	O	ADV	O
identified	O	VERB	O
element	O	NOUN	B
in	O	ADP	O
the	O	DET	O
first	O	ADJ	O
exon	O	NOUN	B
of	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
DR	I-DNA	NOUN	I
alpha	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
.	O	PUNCT	O


A	O	DET	O
previously	O	ADV	O
unrecognized	O	ADJ	B
element	O	NOUN	I
,	O	PUNCT	O
located	O	ADJ	O
downstream	O	ADV	B
of	O	ADP	O
the	O	DET	O
start	B-DNA	NOUN	O
site	I-DNA	NOUN	B
of	I-DNA	ADP	O
transcription	I-DNA	NOUN	B
in	O	ADP	O
the	O	DET	O
first	O	ADJ	O
exon	B-DNA	NOUN	B
of	O	ADP	O
the	O	DET	O
DR	B-DNA	NOUN	B
alpha	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
,	O	PUNCT	O
has	O	AUX	O
been	O	AUX	O
defined	O	VERB	O
that	O	PRON	O
enhances	O	VERB	O
promoter	O	NOUN	B
activity	O	NOUN	I
up	O	ADV	O
to	O	PART	O
eightfold	O	ADV	O
in	O	ADP	O
a	O	DET	O
position-dependent	O	ADJ	B
manner	O	NOUN	O
.	O	PUNCT	O


Activity	O	NOUN	B
was	O	AUX	O
mediated	O	VERB	O
through	O	ADP	O
the	O	DET	O
core	B-DNA	NOUN	B
elements	I-DNA	NOUN	I
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
IL-10	B-protein	NOUN	B
and	O	CCONJ	O
IL-4	B-protein	NOUN	B
inhibit	O	VERB	B
cytokine	B-protein	NOUN	B
production	O	NOUN	B
by	O	ADP	O
different	O	ADJ	O
mechanisms	O	NOUN	B
.	O	PUNCT	O


LMP-1	B-protein	NOUN	B
activates	O	VERB	B
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
by	O	ADP	O
targeting	O	VERB	B
the	O	DET	O
inhibitory	B-protein	ADJ	B
molecule	I-protein	NOUN	I
I	I-protein	NOUN	I
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
alpha	I-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
mechanisms	O	NOUN	B
by	O	ADP	O
which	O	DET	O
LMP-1	B-protein	NOUN	B
upregulates	O	VERB	B
these	O	DET	O
proteins	O	NOUN	B
is	O	AUX	O
unknown	O	ADJ	O
,	O	PUNCT	O
but	O	CCONJ	O
it	O	PRON	O
is	O	AUX	O
plausible	O	ADJ	O
that	O	SCONJ	O
LMP-1	B-protein	NOUN	B
modifies	O	VERB	B
signal	O	NOUN	B
transduction	O	NOUN	O
pathways	O	NOUN	O
that	O	PRON	O
result	O	VERB	O
in	O	ADP	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
one	O	NUM	O
or	O	CCONJ	O
more	O	ADJ	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
that	O	PRON	O
ultimately	O	ADV	O
regulate	O	VERB	B
transcription	O	NOUN	B
of	O	ADP	O
oncogenic	B-DNA	ADJ	B
genes	I-DNA	NOUN	I
.	O	PUNCT	O


The	O	DET	O
mechanism	O	NOUN	B
(	O	PUNCT	O
s	O	NOUN	O
)	O	PUNCT	O
regulating	O	VERB	B
this	O	DET	O
activation	O	NOUN	B
remains	O	VERB	O
unknown	O	ADJ	O
.	O	PUNCT	O


Our	O	PRON	O
data	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
increased	O	VERB	B
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
DNA	O	NOUN	B
binding	O	NOUN	I
and	O	CCONJ	O
functional	O	ADJ	B
activity	O	NOUN	I
are	O	AUX	O
present	O	ADJ	O
in	O	ADP	O
B-lymphoid	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
stably	O	ADV	B
or	O	CCONJ	O
transiently	O	ADV	O
expressing	O	VERB	B
LMP-1	B-protein	NOUN	B
.	O	PUNCT	O


I	B-protein	NOUN	O
kappa	I-protein	NOUN	O
B	I-protein	NOUN	O
alpha	I-protein	NOUN	O
is	O	AUX	O
selectively	O	ADV	O
modified	O	VERB	B
in	O	ADP	O
LMP-1-expressing	B-cell_line	ADJ	B
B	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


A	O	DET	O
phosphorylated	O	ADJ	B
form	O	NOUN	O
of	O	ADP	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
alpha	I-protein	NOUN	I
and	O	CCONJ	O
increased	O	VERB	B
protein	O	NOUN	B
turnover-degradation	O	NOUN	B
correlate	O	VERB	O
with	O	ADP	O
increased	O	VERB	B
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
nuclear	O	ADJ	O
translocation	O	NOUN	O
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
LMP-1	B-protein	NOUN	B
activates	O	VERB	B
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
in	O	ADP	O
B-cell	B-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
by	O	ADP	O
targeting	O	VERB	B
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
alpha	I-protein	NOUN	I
.	O	PUNCT	O


Together	O	ADV	O
,	O	PUNCT	O
these	O	DET	O
data	O	NOUN	B
suggest	O	VERB	O
the	O	DET	O
TR2RE-SV40	B-DNA	NOUN	B
may	O	AUX	O
represent	O	VERB	O
the	O	DET	O
first	O	ADJ	O
identified	O	VERB	B
natural	O	ADJ	B
DNA	B-DNA	NOUN	B
response	I-DNA	NOUN	I
element	I-DNA	NOUN	I
for	O	ADP	O
the	O	DET	O
TR2	B-protein	NOUN	B
orphan	I-protein	NOUN	I
receptor	I-protein	NOUN	I
that	O	PRON	O
may	O	AUX	O
function	O	VERB	B
as	O	ADP	O
a	O	DET	O
repressor	O	NOUN	B
for	O	ADP	O
the	O	DET	O
SV40	O	NOUN	B
gene	O	NOUN	B
expression	O	NOUN	I
.	O	PUNCT	O


Characterization	O	NOUN	B
of	O	ADP	O
the	O	DET	O
two	O	NUM	O
genes	O	NOUN	B
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
inv	O	NOUN	B
(	O	PUNCT	O
16	O	NUM	O
)	O	PUNCT	O
(	O	PUNCT	O
p13q22	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
CBF	B-DNA	NOUN	B
beta	I-DNA	NOUN	B
and	O	CCONJ	O
MYH11	B-DNA	NOUN	B
,	O	PUNCT	O
has	O	AUX	O
allowed	O	VERB	O
the	O	DET	O
detection	O	NOUN	B
of	O	ADP	O
fusion	B-RNA	NOUN	B
transcripts	I-RNA	NOUN	B
by	O	ADP	O
reverse-transcriptase	O	ADJ	B
polymerase	O	NOUN	I
chain	O	NOUN	I
reaction	O	NOUN	I
(	O	PUNCT	O
RT-PCR	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Taken	O	VERB	O
together	O	ADV	O
with	O	ADP	O
the	O	DET	O
detection	O	NOUN	B
of	O	ADP	O
CBF	B-DNA	NOUN	B
beta	I-DNA	NOUN	B
-	O	PUNCT	O
MYH11	B-RNA	NOUN	B
transcripts	I-RNA	NOUN	B
in	O	ADP	O
the	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
apparent	O	ADJ	B
chromosome	B-DNA	NOUN	I
16	I-DNA	NUM	O
abnormalities	O	NOUN	B
by	O	ADP	O
classical	O	ADJ	O
banding	O	NOUN	B
techniques	O	NOUN	O
,	O	PUNCT	O
these	O	DET	O
data	O	NOUN	B
show	O	VERB	O
that	O	SCONJ	O
additional	O	ADJ	O
screening	O	NOUN	B
by	O	ADP	O
either	O	CCONJ	O
RT-PCR	O	NOUN	B
or	O	CCONJ	O
FISH	O	NOUN	B
should	O	AUX	O
be	O	AUX	O
performed	O	VERB	O
in	O	ADP	O
all	O	DET	O
AML	O	NOUN	B
M4	O	NOUN	B
,	O	PUNCT	O
regardless	O	ADV	O
of	O	ADP	O
morphologic	O	ADJ	B
features	O	NOUN	I
,	O	PUNCT	O
to	O	PART	O
allow	O	VERB	O
accurate	O	ADJ	B
evaluation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
prognostic	O	ADJ	B
importance	O	NOUN	O
of	O	ADP	O
this	O	DET	O
fusion	B-RNA	NOUN	B
transcript	I-RNA	NOUN	I
.	O	PUNCT	O


This	O	DET	O
study	O	NOUN	B
demonstrates	O	VERB	O
that	O	SCONJ	O
human	B-protein	ADJ	B
immunodeficiency	I-protein	NOUN	I
virus	I-protein	NOUN	I
type	I-protein	NOUN	I
1	I-protein	NUM	I
(	I-protein	PUNCT	O
HIV-1	I-protein	NOUN	B
)	I-protein	PUNCT	O
Tat	I-protein	NOUN	B
protein	I-protein	NOUN	I
amplifies	O	VERB	O
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor	I-protein	NOUN	I
(	O	PUNCT	O
TNF	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
a	O	DET	O
cytokine	O	NOUN	B
that	O	PRON	O
stimulates	O	VERB	B
HIV-1	O	NOUN	B
replication	O	NOUN	B
through	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
.	O	PUNCT	O


A	O	DET	O
similar	O	ADJ	O
potentiation	O	NOUN	B
of	O	ADP	O
TNF	B-protein	NOUN	B
effects	O	NOUN	B
was	O	AUX	O
observed	O	VERB	O
in	O	ADP	O
Jurkat	O	NOUN	B
T	O	NOUN	I
cells	O	NOUN	I
and	O	CCONJ	O
HeLa	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
treated	O	VERB	B
with	O	ADP	I
soluble	O	ADJ	B
Tat	B-protein	NOUN	B
protein	I-protein	NOUN	I
.	O	PUNCT	O


Increasing	O	VERB	B
success	O	NOUN	B
in	O	ADP	O
the	O	DET	O
treatment	O	NOUN	B
of	O	ADP	O
childhood	O	NOUN	B
acute	O	ADJ	I
lymphoblastic	O	ADJ	I
leukemia	O	NOUN	I
has	O	AUX	O
led	O	VERB	O
to	O	PART	O
increasing	O	VERB	B
awareness	O	NOUN	B
of	O	ADP	O
avascular	O	ADJ	B
necrosis	O	NOUN	I
of	O	ADP	O
bone	O	NOUN	B
as	O	ADP	O
a	O	DET	O
potentially	O	ADV	O
disabling	O	ADJ	O
sequela	O	NOUN	B
of	O	ADP	O
glucocorticoid	O	NOUN	B
therapy	O	NOUN	I
,	O	PUNCT	O
especially	O	ADV	O
in	O	ADP	O
adolescent	O	ADJ	B
and	O	CCONJ	O
young	O	ADJ	B
adult	O	ADJ	O
patients	O	NOUN	B
.	O	PUNCT	O


Lymphocyte	B-protein	NOUN	B
glucocorticoid	I-protein	NOUN	B
receptor	I-protein	NOUN	I
:	O	PUNCT	O
predictor	O	NOUN	B
of	O	ADP	O
sertraline	O	NOUN	B
response	O	NOUN	B
in	O	ADP	O
adolescent	O	ADJ	B
major	O	ADJ	O
depressive	O	ADJ	B
disorder	O	NOUN	I
(	O	PUNCT	O
MDD	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Major	O	ADJ	B
depressive	O	ADJ	I
disorder	O	NOUN	I
(	O	PUNCT	O
MDD	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
adolescents	O	NOUN	B
demonstrates	O	VERB	O
resistance	O	NOUN	B
to	O	PART	O
tricyclic	O	ADJ	B
antidepressants	O	NOUN	I
and	O	CCONJ	O
absence	O	NOUN	B
of	O	ADP	O
hypercortisolemia	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
efficacy	O	NOUN	B
of	O	ADP	O
serotonin	O	NOUN	B
reuptake	O	NOUN	I
inhibitors	O	NOUN	I
(	O	PUNCT	O
SRIs	O	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
uncertain	O	ADJ	O
,	O	PUNCT	O
and	O	CCONJ	O
response	O	NOUN	B
predictors	O	NOUN	B
are	O	AUX	O
unavailable	O	ADJ	O
.	O	PUNCT	O


In	O	ADP	O
an	O	DET	O
open-label	O	ADJ	B
study	O	NOUN	I
,	O	PUNCT	O
adolescents	O	NOUN	B
(	O	PUNCT	O
n	O	NOUN	O
=	O	ADJ	O
20	O	NUM	O
)	O	PUNCT	O
meeting	O	NOUN	O
DSM-III-R	O	NOUN	B
criteria	O	NOUN	I
for	O	ADP	O
MDD	O	NOUN	B
showed	O	VERB	O
baseline	O	NOUN	B
lymphocyte	B-protein	NOUN	B
GCII	I-protein	NOUN	B
sites	I-protein	NOUN	O
per	O	ADP	O
cell	O	NOUN	O
(	O	PUNCT	O
sites/cell	O	NOUN	O
)	O	PUNCT	O
values	O	NOUN	B
of	O	ADP	O
793	O	NUM	O
+/-	O	CCONJ	O
106	O	NUM	O
versus	O	CCONJ	O
2	O	NUM	O
,	O	PUNCT	O
563	O	NUM	O
+/-	O	CCONJ	O
499	O	NUM	O
(	O	PUNCT	O
+/-	O	CCONJ	O
SEM	O	NOUN	B
)	O	PUNCT	O
for	O	ADP	O
matched	O	VERB	B
controls	O	NOUN	I
(	O	PUNCT	O
n	O	NOUN	O
=	O	ADJ	O
18	O	NUM	O
)	O	PUNCT	O
(	O	PUNCT	O
t	O	NOUN	O
=	O	ADJ	O
3.5	O	NUM	O
;	O	PUNCT	O
df	O	NOUN	O
=	O	ADJ	O
36	O	NUM	O
;	O	PUNCT	O
p	O	X	O
<	O	X	O
.001	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


GCII	B-protein	NOUN	B
was	O	AUX	O
bimodally	O	ADV	O
distributed	O	VERB	B
,	O	PUNCT	O
with	O	ADP	O
SRI	O	NOUN	B
responders	O	NOUN	B
differing	O	VERB	O
from	O	ADP	O
nonresponders	O	NOUN	B
(	O	PUNCT	O
t	O	NOUN	O
=	O	ADJ	O
3.9	O	NUM	O
;	O	PUNCT	O
df	O	NOUN	O
=	O	ADJ	O
14	O	NUM	O
;	O	PUNCT	O
p	O	X	O
<	O	X	O
.001	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
role	O	NOUN	O
of	O	ADP	O
NFATp	B-protein	NOUN	B
in	O	ADP	O
cyclosporin	B-DNA	NOUN	B
A-sensitive	I-DNA	ADJ	B
tumor	I-DNA	NOUN	I
necrosis	I-DNA	NOUN	I
factor-alpha	I-DNA	NOUN	O
gene	I-DNA	NOUN	O
transcription	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
tumor	B-DNA	NOUN	B
necrosis	I-DNA	NOUN	I
factor-alpha	I-DNA	NOUN	I
(	I-DNA	PUNCT	I
TNF	I-DNA	NOUN	B
alpha	I-DNA	NOUN	I
)	I-DNA	PUNCT	O
gene	I-DNA	NOUN	O
is	O	AUX	O
an	O	DET	O
immediate	O	ADJ	O
early	O	ADJ	B
gene	O	NOUN	B
in	O	ADP	O
activated	O	VERB	B
T	B-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
,	O	PUNCT	O
in	O	ADP	O
that	O	SCONJ	O
it	O	PRON	O
is	O	AUX	O
rapidly	O	ADV	O
induced	O	VERB	B
without	O	ADP	O
a	O	DET	O
requirement	O	NOUN	B
for	O	ADP	O
protein	O	NOUN	B
synthesis	O	NOUN	I
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
although	O	SCONJ	O
the	O	DET	O
kappa	B-DNA	NOUN	B
3	I-DNA	NUM	I
element	I-DNA	NOUN	B
has	O	AUX	O
little	O	ADJ	O
sequence	O	NOUN	B
similarity	O	NOUN	B
to	O	PART	O
other	O	ADJ	O
NFATp-binding	B-DNA	ADJ	B
sites	I-DNA	NOUN	I
,	O	PUNCT	O
it	O	PRON	O
appears	O	VERB	O
to	O	PART	O
function	O	VERB	B
as	O	ADP	O
a	O	DET	O
cyclosporin-sensitive	B-DNA	ADJ	O
promoter	I-DNA	NOUN	O
element	I-DNA	NOUN	O
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
by	O	ADP	O
virtue	O	NOUN	O
of	O	ADP	O
its	O	PRON	O
ability	O	NOUN	O
to	O	PART	O
bind	O	VERB	B
NFATp	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
results	O	NOUN	B
varied	O	VERB	O
with	O	ADP	O
the	O	DET	O
agent	O	NOUN	B
,	O	PUNCT	O
cell	O	NOUN	B
type	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
stage	O	NOUN	B
of	O	ADP	O
differentiation	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
complexes	O	NOUN	B
were	O	AUX	O
destroyed	O	VERB	O
by	O	ADP	O
detergent	O	NOUN	B
.	O	PUNCT	O


Coordinate	O	NOUN	B
with	O	ADP	O
temporal	O	ADJ	B
changes	O	NOUN	B
in	O	ADP	O
Ig	B-protein	NOUN	B
synthesis	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
DNA-binding	O	ADJ	B
activity	O	NOUN	O
and	O	CCONJ	O
the	O	DET	O
synthesis	O	NOUN	B
of	O	ADP	O
the	O	DET	O
B	B-protein	NOUN	B
cell-enriched	I-protein	ADJ	I
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
Oct-2	B-protein	NOUN	B
are	O	AUX	O
regulated	O	VERB	O
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
differentiation	O	NOUN	B
of	O	ADP	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
with	O	ADP	O
IL-6	B-protein	NOUN	B
in	O	X	B
vitro	O	X	I
recapitulates	O	VERB	O
the	O	DET	O
hallmarks	O	NOUN	B
of	O	ADP	O
terminal	O	ADJ	B
B	O	NOUN	O
differentiation	O	NOUN	O
in	O	X	B
vivo	O	X	I
;	O	PUNCT	O
Oct-2	B-protein	NOUN	B
may	O	AUX	O
have	O	AUX	O
a	O	DET	O
role	O	NOUN	O
in	O	ADP	O
this	O	DET	O
process	O	NOUN	B
.	O	PUNCT	O


Both	O	CCONJ	O
positive	B-DNA	ADJ	B
and	I-DNA	CCONJ	O
negative	I-DNA	ADJ	B
regulatory	I-DNA	ADJ	B
elements	I-DNA	NOUN	I
were	O	AUX	O
identified	O	VERB	B
in	O	ADP	O
the	O	DET	O
proximal	B-DNA	ADJ	B
5	I-DNA	NUM	O
'	I-DNA	PART	O
flanking	I-DNA	ADJ	B
region	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
IL-3	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
.	O	PUNCT	O


The	O	DET	O
promoter	B-DNA	NOUN	B
region	I-DNA	NOUN	I
between	O	ADP	O
-173	B-DNA	NUM	B
and	I-DNA	CCONJ	O
-60	I-DNA	NUM	B
contained	O	VERB	O
the	O	DET	O
strongest	O	ADJ	O
activating	B-DNA	VERB	B
elements	I-DNA	NOUN	O
.	O	PUNCT	O


The	O	DET	O
PEBP2	B-DNA	NOUN	B
alpha	I-DNA	NOUN	I
A	I-DNA	NOUN	I
and	I-DNA	CCONJ	O
PEBP2	I-DNA	NOUN	B
alpha	I-DNA	NOUN	I
B	I-DNA	NOUN	I
genes	I-DNA	NOUN	I
encode	O	VERB	B
the	O	DET	O
DNA-binding	B-protein	ADJ	B
subunit	I-protein	NOUN	I
of	O	ADP	O
a	O	DET	O
murine	B-protein	ADJ	B
transcription	I-protein	NOUN	B
factor	I-protein	NOUN	I
,	O	PUNCT	O
PEBP2	B-protein	NOUN	B
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
implicated	O	VERB	O
as	O	ADP	O
a	O	DET	O
T-cell-specific	B-protein	ADJ	B
transcriptional	I-protein	ADJ	I
regulator	I-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
results	O	NOUN	B
indicated	O	VERB	O
that	O	SCONJ	O
both	O	DET	O
genes	O	NOUN	B
are	O	AUX	O
expressed	O	VERB	B
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
throughout	O	ADP	O
their	O	PRON	O
development	O	NOUN	B
,	O	PUNCT	O
supporting	O	VERB	O
the	O	DET	O
notion	O	NOUN	O
that	O	SCONJ	O
PEBP2	B-protein	NOUN	B
is	O	AUX	O
a	O	DET	O
T-cell-specific	B-protein	ADJ	B
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
.	O	PUNCT	O


Glucocorticoids	O	NOUN	B
have	O	AUX	O
an	O	DET	O
inhibitory	O	ADJ	B
effect	O	NOUN	O
on	O	ADP	O
inflammatory	O	ADJ	B
and	O	CCONJ	O
immune	O	ADJ	B
responses	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
this	O	DET	O
may	O	AUX	O
be	O	AUX	O
through	O	ADP	O
the	O	DET	O
modulation	O	NOUN	B
of	O	ADP	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
binding	O	VERB	I
to	O	PART	I
DNA	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
may	O	AUX	O
be	O	AUX	O
an	O	DET	O
important	O	ADJ	O
molecular	O	ADJ	B
site	O	NOUN	I
of	O	ADP	O
steroid	O	NOUN	B
action	O	NOUN	B
.	O	PUNCT	O


During	O	ADP	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
anergy	O	NOUN	B
,	O	PUNCT	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
are	O	AUX	O
phenotypically	O	ADV	B
similar	O	ADJ	O
to	O	PART	O
cells	O	NOUN	B
responding	O	VERB	B
to	O	PART	O
an	O	DET	O
immunogenic	O	ADJ	B
stimulus	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
study	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
compared	O	VERB	B
the	O	DET	O
ability	O	NOUN	O
of	O	ADP	O
various	O	ADJ	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
to	O	PART	O
bind	O	VERB	B
to	O	PART	O
their	O	PRON	O
appropriate	O	ADJ	O
site	O	NOUN	B
on	O	ADP	O
DNA	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
inducible	B-protein	ADJ	B
factors	I-protein	NOUN	O
NK-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
,	O	PUNCT	O
beta	B-protein	NOUN	B
E2	I-protein	NOUN	I
,	O	PUNCT	O
CD28RC	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
AP-1	B-protein	NOUN	B
are	O	AUX	O
not	O	PART	O
expressed	O	VERB	B
in	O	ADP	O
resting	B-cell_type	VERB	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
are	O	AUX	O
twofold	O	ADV	O
lower	O	ADJ	O
in	O	ADP	O
anergized	O	VERB	B
as	O	ADP	O
compared	O	VERB	B
with	O	ADP	O
activated	O	VERB	B
cells	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
anergic	B-cell_type	ADJ	B
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
express	O	VERB	O
approximately	O	ADV	O
eightfold	O	ADV	O
lower	O	ADJ	O
amounts	O	NOUN	O
of	O	ADP	O
NF-AT	B-protein	NOUN	B
,	O	PUNCT	O
a	O	DET	O
member	O	NOUN	B
of	O	ADP	O
the	O	DET	O
class	O	NOUN	B
of	O	ADP	O
inducible	B-protein	ADJ	B
factors	I-protein	NOUN	I
that	O	PRON	O
regulates	O	VERB	B
IL-2	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
transcription	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
receptor	O	NOUN	B
was	O	AUX	O
tested	O	VERB	B
immunocytochemically	O	ADV	B
,	O	PUNCT	O
in	O	ADP	O
steroid	O	NOUN	B
binding	O	NOUN	I
assays	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
by	O	ADP	O
a	O	DET	O
mutation	O	NOUN	B
screening	O	NOUN	O
(	O	PUNCT	O
denaturing	O	VERB	B
gradient	O	NOUN	O
gel	O	NOUN	O
electrophoresis	O	NOUN	O
)	O	PUNCT	O
of	O	ADP	O
the	O	DET	O
receptor-cDNA	B-protein	NOUN	B
.	O	PUNCT	O


Expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
kappa	O	NOUN	O
immunoglobulin	O	NOUN	O
light	O	ADJ	O
chain	O	NOUN	O
gene	O	NOUN	O
requires	O	VERB	O
developmental-	O	ADJ	O
and	O	CCONJ	O
tissue-specific	O	ADJ	B
regulation	O	NOUN	I
by	O	ADP	O
trans-acting	B-protein	ADJ	B
factors	I-protein	NOUN	I
which	O	DET	O
interact	O	VERB	B
with	O	ADP	O
two	O	NUM	O
distinct	O	ADJ	O
enhancer	B-DNA	NOUN	B
elements	I-DNA	NOUN	I
.	O	PUNCT	O


Mutation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
AP1	B-DNA	NOUN	B
motif	I-DNA	NOUN	B
in	O	ADP	O
the	O	DET	O
context	O	NOUN	B
of	O	ADP	O
the	O	DET	O
intron	B-DNA	NOUN	B
enhancer	I-DNA	NOUN	O
was	O	AUX	O
shown	O	VERB	O
to	O	PART	O
decrease	O	VERB	B
enhancer-mediated	O	ADJ	B
activation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
promoter	O	NOUN	B
in	O	ADP	O
both	O	CCONJ	O
pre-B	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
induced	O	VERB	B
with	O	ADP	O
LPS	O	NOUN	B
and	O	CCONJ	O
constitutive	O	ADJ	B
expression	O	NOUN	B
in	O	ADP	O
mature	B-cell_type	ADJ	B
B	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Distinct	O	ADJ	O
DNase-I	B-DNA	NOUN	B
hypersensitive	I-DNA	ADJ	I
sites	I-DNA	NOUN	I
are	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
TAL-1	B-protein	NOUN	B
transcription	O	NOUN	B
in	O	ADP	O
erythroid	B-cell_line	ADJ	B
and	I-cell_line	CCONJ	O
T-cell	I-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
.	O	PUNCT	O


When	O	SCONJ	O
the	O	DET	O
supplemented	O	VERB	B
cytokine	B-protein	NOUN	B
was	O	AUX	O
switched	O	VERB	O
from	O	ADP	O
GM-CSF	B-protein	NOUN	B
to	O	PART	O
EPO	B-protein	NOUN	B
,	O	PUNCT	O
hemoglobin	B-protein	NOUN	B
synthesis	O	NOUN	I
in	O	ADP	O
M-TAT/GM-CSF	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
increased	O	VERB	B
rapidly	O	ADV	O
(	O	PUNCT	O
within	O	ADP	O
5	O	NUM	O
h	O	NOUN	O
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
level	O	NOUN	B
of	O	ADP	O
GATA-1	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
increased	O	VERB	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
support	O	VERB	O
the	O	DET	O
hypothesis	O	NOUN	B
that	O	SCONJ	O
EPO	B-protein	NOUN	B
actively	O	ADV	O
influences	O	VERB	B
the	O	DET	O
programming	O	NOUN	B
of	O	ADP	O
gene	O	NOUN	B
expression	O	NOUN	I
required	O	VERB	O
for	O	ADP	O
erythroid	B-cell_type	ADJ	B
progenitor	I-cell_type	NOUN	I
cell	I-cell_type	NOUN	B
differentiation	O	NOUN	I
.	O	PUNCT	O


Regulation	O	NOUN	B
of	O	ADP	O
I	B-protein	NOUN	O
kappa	I-protein	NOUN	O
B	I-protein	NOUN	O
alpha	I-protein	NOUN	O
and	O	CCONJ	O
p105	B-protein	NOUN	B
in	O	ADP	O
monocytes	B-cell_type	NOUN	B
and	O	CCONJ	O
macrophages	B-cell_type	NOUN	B
persistently	O	ADV	O
infected	O	VERB	B
with	O	ADP	O
human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
.	O	PUNCT	O


Another	O	DET	O
protein	O	NOUN	B
with	O	ADP	O
I	O	NOUN	O
kappa	O	NOUN	O
B	O	NOUN	O
function	O	NOUN	O
,	O	PUNCT	O
p105	B-protein	NOUN	B
,	O	PUNCT	O
is	O	AUX	O
also	O	ADV	O
modified	O	VERB	B
in	O	ADP	O
HIV-infected	O	ADJ	B
cells	O	NOUN	I
:	O	PUNCT	O
p105	B-protein	NOUN	B
and	O	CCONJ	O
p50	B-protein	NOUN	B
steady-state	O	ADJ	I
protein	O	NOUN	I
levels	O	NOUN	O
are	O	AUX	O
increased	O	VERB	B
as	O	ADP	O
a	O	DET	O
result	O	NOUN	O
of	O	ADP	O
increased	O	VERB	B
synthesis	O	NOUN	B
and	O	CCONJ	O
proteolytic	O	ADJ	B
processing	O	NOUN	I
of	O	ADP	O
p105	B-protein	NOUN	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
retinoic	O	ADJ	B
acid	O	NOUN	I
can	O	AUX	O
also	O	ADV	O
induce	O	VERB	B
apoptosis	O	NOUN	B
in	O	ADP	O
these	O	DET	O
cells	O	NOUN	B
through	O	ADP	O
the	O	DET	O
retinoic	B-protein	ADJ	B
acid	I-protein	NOUN	I
receptor	I-protein	NOUN	I
,	O	PUNCT	O
whose	O	DET	O
repressive	O	ADJ	B
functions	O	NOUN	I
but	O	CCONJ	O
not	O	PART	O
target	O	NOUN	B
site	O	NOUN	O
specificity	O	NOUN	B
,	O	PUNCT	O
are	O	AUX	O
similar	O	ADJ	O
to	O	PART	O
those	O	DET	O
of	O	ADP	O
the	O	DET	O
glucocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
.	O	PUNCT	O


HIV	O	NOUN	B
type	O	NOUN	O
1	O	NUM	O
protease	B-protein	NOUN	O
activation	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
within	O	ADP	O
T	B-cell_type	NOUN	B
lymphoid	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Deletion	O	NOUN	B
of	O	ADP	O
the	O	DET	O
NF-kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
elements	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
HIV-1	B-DNA	NOUN	B
LTR	I-DNA	NOUN	B
significantly	O	ADV	O
inhibited	O	VERB	B
Tat	B-protein	NOUN	B
-mediated	O	ADJ	O
transactivation	O	NOUN	B
in	O	ADP	O
T-cell	B-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
in	O	ADP	O
a	O	DET	O
monocyte	B-cell_line	NOUN	B
line	I-cell_line	NOUN	I
,	O	PUNCT	O
U937	B-cell_line	NOUN	B
.	O	PUNCT	O


Insertion	O	NOUN	B
of	O	ADP	O
this	O	DET	O
chimeric	B-DNA	ADJ	B
promoter	I-DNA	NOUN	O
(	O	PUNCT	O
ISG15	B-DNA	NOUN	B
LTR	I-DNA	NOUN	B
)	O	PUNCT	O
upstream	O	ADJ	B
of	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
IFNA2	I-DNA	NOUN	O
gene	I-DNA	NOUN	O
directed	O	VERB	O
high	O	ADJ	O
levels	O	NOUN	B
of	O	ADP	O
IFN	B-protein	NOUN	B
synthesis	O	NOUN	B
in	O	ADP	O
Tat-expressing	B-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
while	O	SCONJ	O
this	O	DET	O
promoter	O	NOUN	B
was	O	AUX	O
not	O	PART	O
responsive	O	ADJ	O
to	O	PART	O
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor	I-protein	NOUN	I
alpha	I-protein	NOUN	I
-mediated	O	ADJ	O
activation	O	NOUN	B
.	O	PUNCT	O


Virus	O	NOUN	B
isolated	O	VERB	B
from	O	ADP	O
IFNA-producing	B-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
was	O	AUX	O
able	O	ADJ	O
to	O	PART	O
replicate	O	VERB	B
in	O	ADP	O
the	O	DET	O
U937	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
but	O	CCONJ	O
did	O	AUX	O
not	O	PART	O
replicate	O	VERB	B
efficiently	O	ADV	B
in	O	ADP	O
U937	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
transduced	O	VERB	B
with	O	ADP	O
the	O	DET	O
IFNA	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
.	O	PUNCT	O


OBJECTIVES	O	NOUN	O
:	O	PUNCT	O
To	O	PART	O
analyze	O	VERB	O
the	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
retinoic	O	ADJ	B
acids	O	NOUN	I
(	O	PUNCT	O
RA	O	NOUN	B
)	O	PUNCT	O
on	O	ADP	O
HIV-1	O	NOUN	B
expression	O	NOUN	B
and	O	CCONJ	O
correlate	O	VERB	B
this	O	DET	O
effect	O	NOUN	B
with	O	ADP	O
expression	O	NOUN	B
levels	O	NOUN	O
of	O	ADP	O
RA	B-protein	NOUN	B
receptors	I-protein	NOUN	I
(	O	PUNCT	O
RARs	B-protein	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
T-lymphoid	B-cell_line	ADJ	B
and	I-cell_line	CCONJ	O
monocytoid	I-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
.	O	PUNCT	O


Functions	O	NOUN	B
of	O	ADP	O
glutathione	O	NOUN	B
and	O	CCONJ	O
glutathione	O	NOUN	B
disulfide	O	NOUN	I
in	O	ADP	O
immunology	O	NOUN	B
and	O	CCONJ	O
immunopathology	O	NOUN	B
.	O	PUNCT	O


As	O	ADP	O
signal	O	NOUN	B
transduction	O	NOUN	I
is	O	AUX	O
facilitated	O	VERB	O
by	O	ADP	O
prooxidant	O	ADJ	B
conditions	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
propose	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
well-known	O	ADJ	O
immunological	O	ADJ	B
consequences	O	NOUN	B
of	O	ADP	O
GSH	O	NOUN	B
depletion	O	NOUN	B
ultimately	O	ADV	O
may	O	AUX	O
be	O	AUX	O
results	O	NOUN	B
of	O	ADP	O
the	O	DET	O
accompanying	O	VERB	O
GSSG	O	NOUN	B
deficiency	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
first	O	ADJ	O
alteration	O	NOUN	B
involves	O	VERB	O
the	O	DET	O
constitutive	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
substantial	O	ADJ	B
kappa	O	NOUN	I
B-binding	O	ADJ	O
activity	O	NOUN	O
in	O	ADP	O
nuclear	O	ADJ	B
extracts	O	NOUN	I
,	O	PUNCT	O
which	O	DET	O
was	O	AUX	O
observed	O	VERB	O
in	O	ADP	O
the	O	DET	O
electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assay	O	NOUN	I
.	O	PUNCT	O


RESULTS	O	NOUN	B
:	O	PUNCT	O
The	O	DET	O
results	O	NOUN	B
showed	O	VERB	O
high	O	ADJ	O
GATA-1	B-protein	NOUN	B
binding	O	NOUN	B
activity	O	NOUN	I
and	O	CCONJ	O
very	O	ADV	O
low	O	ADJ	O
SP1	B-protein	NOUN	B
activity	O	NOUN	O
in	O	ADP	O
the	O	DET	O
fetal	B-cell_line	ADJ	B
liver	I-cell_line	NOUN	B
cultures	I-cell_line	NOUN	I
.	O	PUNCT	O


This	O	DET	O
pattern	O	NOUN	B
was	O	AUX	O
in	O	ADP	O
contrast	O	NOUN	O
to	O	PART	O
cultures	O	NOUN	B
derived	O	VERB	O
from	O	ADP	O
normal	O	ADJ	B
adult	O	ADJ	I
peripheral	O	ADJ	B
blood	O	NOUN	I
,	O	PUNCT	O
in	O	ADP	O
which	O	DET	O
both	O	CCONJ	O
GATA-1	B-protein	NOUN	B
and	O	CCONJ	O
SP1	B-protein	NOUN	B
activities	O	NOUN	O
were	O	AUX	O
high	O	ADJ	O
.	O	PUNCT	O


The	O	DET	O
demonstration	O	NOUN	O
that	O	SCONJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
can	O	AUX	O
regulate	O	VERB	O
I	B-DNA	NOUN	O
kappa	I-DNA	NOUN	O
B	I-DNA	NOUN	O
alpha/MAD-3	I-DNA	NOUN	O
gene	I-DNA	NOUN	O
transcription	O	NOUN	O
in	O	ADP	O
other	O	ADJ	O
cell	O	NOUN	B
types	O	NOUN	I
suggested	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
rapid	O	ADJ	O
increase	O	NOUN	B
in	O	ADP	O
steady-state	O	ADJ	B
I	B-RNA	NOUN	I
kappa	I-RNA	NOUN	I
B	I-RNA	NOUN	I
alpha/MAD-3	I-RNA	NOUN	I
mRNA	I-RNA	NOUN	B
levels	O	NOUN	O
we	O	PRON	O
observed	O	VERB	B
within	O	ADP	O
30	O	NUM	O
min	O	NOUN	O
of	O	ADP	O
monocyte	O	NOUN	B
adherence	O	NOUN	B
would	O	AUX	O
result	O	VERB	O
from	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
-dependent	O	ADJ	O
transcriptional	O	ADJ	B
stimulation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
I	B-DNA	NOUN	B
kappa	I-DNA	NOUN	I
B	I-DNA	NOUN	I
alpha/MAD-3	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
propose	O	VERB	O
that	O	SCONJ	O
adherent	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
regulate	O	VERB	O
nuclear	O	ADJ	B
processing	O	NOUN	I
(	O	PUNCT	O
or	O	CCONJ	O
decay	O	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
I	B-RNA	NOUN	B
kappa	I-RNA	NOUN	I
B	I-RNA	NOUN	I
alpha/MAD-3	I-RNA	NOUN	I
mRNA	I-RNA	NOUN	B
,	O	PUNCT	O
thereby	O	ADV	O
increasing	O	VERB	O
mRNA	O	NOUN	B
levels	O	NOUN	O
without	O	ADP	O
stimulating	O	VERB	O
I	B-DNA	NOUN	B
kappa	I-DNA	NOUN	I
B	I-DNA	NOUN	I
alpha/MAD-3	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
transcription	O	NOUN	I
.	O	PUNCT	O


It	O	PRON	O
contains	O	VERB	O
a	O	DET	O
basic	B-protein	ADJ	O
helix-loop-helix	I-protein	ADJ	O
(	I-protein	PUNCT	O
bHLH	I-protein	ADJ	O
)	I-protein	PUNCT	O
motif	I-protein	NOUN	O
contiguous	O	ADJ	O
with	O	ADP	O
a	O	DET	O
Per-Arnt-Sim	B-protein	NOUN	B
(	I-protein	PUNCT	O
PAS	I-protein	NOUN	B
)	I-protein	PUNCT	O
homology	I-protein	NOUN	B
region	I-protein	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
extracts	O	NOUN	B
from	O	ADP	O
nonstimulated	O	ADJ	B
cells	O	NOUN	B
the	O	DET	O
receptor	O	NOUN	B
is	O	AUX	O
recovered	O	VERB	O
in	O	ADP	O
an	O	DET	O
inducible	O	ADJ	B
cytoplasmic	O	ADJ	B
form	O	NOUN	O
associated	O	VERB	B
with	O	ADP	I
the	O	DET	O
90-kDa	B-protein	ADJ	O
heat	I-protein	NOUN	B
shock	I-protein	NOUN	I
protein	I-protein	NOUN	I
(	O	PUNCT	O
hsp90	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
a	O	DET	O
molecular	B-protein	ADJ	B
chaperone	I-protein	NOUN	I
.	O	PUNCT	O


At	O	ADP	O
least	O	ADJ	O
two	O	NUM	O
distinct	O	ADJ	O
domains	O	NOUN	B
of	O	ADP	O
the	O	DET	O
receptor	O	NOUN	B
mediated	O	ADJ	O
interaction	O	NOUN	B
with	O	ADP	O
hsp90	B-protein	NOUN	B
:	O	PUNCT	O
the	O	DET	O
ligand-binding	B-protein	ADJ	B
domain	I-protein	NOUN	I
located	O	ADJ	O
within	O	ADP	O
the	O	DET	O
PAS	B-protein	NOUN	B
region	I-protein	NOUN	B
and	O	CCONJ	O
,	O	PUNCT	O
surprisingly	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
bHLH	B-protein	ADJ	B
domain	I-protein	NOUN	I
.	O	PUNCT	O


Several	O	ADJ	O
distinct	O	ADJ	O
roles	O	NOUN	O
for	O	ADP	O
hsp90	B-protein	NOUN	B
in	O	ADP	O
modulating	O	VERB	B
dioxin	B-protein	NOUN	B
receptor	I-protein	NOUN	I
function	O	NOUN	B
are	O	AUX	O
therefore	O	ADV	O
likely	O	ADJ	O
:	O	PUNCT	O
correct	O	ADJ	O
folding	O	NOUN	B
of	O	ADP	O
the	O	DET	O
ligand-binding	O	ADJ	B
domain	O	NOUN	I
,	O	PUNCT	O
interference	O	NOUN	B
with	O	ADP	O
Arnt	B-protein	NOUN	B
heterodimerization	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
folding	O	NOUN	B
of	O	ADP	O
a	O	DET	O
DNA-binding	O	ADJ	B
conformation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
bHLH	B-protein	ADJ	B
domain	I-protein	NOUN	I
.	O	PUNCT	O


Induction	O	NOUN	B
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
in	O	ADP	O
human	B-cell_type	ADJ	B
T	I-cell_type	NOUN	O
lymphocytes	I-cell_type	NOUN	O
by	O	ADP	O
aspirin-like	O	ADJ	B
drugs	O	NOUN	I
.	O	PUNCT	O


To	O	PART	O
understand	O	VERB	O
the	O	DET	O
extent	O	NOUN	O
to	O	PART	O
which	O	DET	O
ALD	O	NOUN	B
may	O	AUX	O
mimic	O	VERB	O
mitogenic	O	ADJ	B
stimulation	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
studied	O	VERB	O
cytoplasmic	O	ADJ	B
and	O	CCONJ	O
nuclear	O	ADJ	B
signaling	O	NOUN	I
steps	O	NOUN	O
in	O	ADP	O
ALD-treated	B-cell_line	ADJ	B
T	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
found	O	VERB	O
that	O	SCONJ	O
ALD	O	NOUN	B
induce	O	VERB	B
a	O	DET	O
transient	O	ADJ	B
activation	O	NOUN	B
of	O	ADP	O
protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
(	O	PUNCT	O
PKC	B-protein	NOUN	B
)	O	PUNCT	O
but	O	CCONJ	O
have	O	AUX	O
no	O	DET	B
effect	O	NOUN	I
(	O	PUNCT	O
in	O	ADP	O
comparison	O	NOUN	B
to	O	PART	O
anti-CD3	B-protein	ADJ	B
antibodies	I-protein	NOUN	I
)	O	PUNCT	O
on	O	ADP	O
protein	O	NOUN	B
tyrosine	O	NOUN	I
phosphorylation	O	NOUN	B
nor	O	CCONJ	O
on	O	ADP	O
PCL	O	NOUN	B
gamma	O	NOUN	B
1	O	NUM	I
tyrosine	O	NOUN	I
phosphorylation	O	NOUN	B
.	O	PUNCT	O


Although	O	SCONJ	O
we	O	PRON	O
detected	O	VERB	B
no	O	DET	O
IL-2	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
in	O	ADP	O
ALD-treated	B-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
the	O	DET	O
nuclei	O	NOUN	B
of	O	ADP	O
these	O	DET	O
cells	O	NOUN	B
contain	O	VERB	O
proteins	O	NOUN	B
capable	O	ADJ	O
of	O	ADP	O
binding	O	VERB	B
to	O	PART	O
three	O	NUM	O
regulatory	B-DNA	ADJ	B
sequences	I-DNA	NOUN	I
in	O	ADP	O
the	O	DET	O
IL-2	B-DNA	NOUN	B
promoter	I-DNA	NOUN	O
region	I-DNA	NOUN	O
:	O	PUNCT	O
NFAT	B-protein	NOUN	B
,	O	PUNCT	O
NF	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
AP-1	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
signal	O	NOUN	B
is	O	AUX	O
transmitted	O	VERB	B
to	O	PART	O
the	O	DET	O
nucleus	O	NOUN	B
and	O	CCONJ	O
induces	O	VERB	B
DNA-binding	O	ADJ	B
activity	O	NOUN	O
by	O	ADP	O
several	O	ADJ	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
.	O	PUNCT	O


Reporter	O	NOUN	B
gene	O	NOUN	I
experiments	O	NOUN	I
demonstrated	O	VERB	O
that	O	SCONJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
transcriptional	O	ADJ	O
activity	O	NOUN	O
is	O	AUX	O
not	O	PART	O
affected	O	VERB	O
by	O	ADP	O
expression	O	NOUN	B
of	O	ADP	O
activated	O	VERB	B
p21ras	B-DNA	NOUN	B
.	O	PUNCT	O


Glucocorticoid-induced	O	ADJ	B
apoptosis	O	NOUN	I
of	O	ADP	O
lymphoid	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


The	O	DET	O
role	O	NOUN	O
of	O	ADP	O
chromatin	B-DNA	NOUN	B
degradation	O	NOUN	I
and	O	CCONJ	O
endonucleases	B-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
apoptotic	O	ADJ	B
process	O	NOUN	I
has	O	AUX	O
been	O	AUX	O
closely	O	ADV	O
studied	O	VERB	O
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
the	O	DET	O
involvement	O	NOUN	B
of	O	ADP	O
several	O	ADJ	O
oncogenes	B-DNA	NOUN	B
in	O	ADP	O
glucocorticoid-induced	O	ADJ	B
cell	O	NOUN	I
lysis	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
clinical	O	ADJ	B
importance	O	NOUN	O
of	O	ADP	O
glucocorticoid-induced	O	ADJ	B
apoptosis	O	NOUN	I
in	O	ADP	O
the	O	DET	O
treatment	O	NOUN	B
of	O	ADP	O
lymphoid	O	ADJ	B
neoplasms	O	NOUN	B
has	O	AUX	O
recently	O	ADV	O
received	O	VERB	O
increased	O	VERB	B
attention	O	NOUN	B
.	O	PUNCT	O


Therefore	O	ADV	O
we	O	PRON	O
investigated	O	VERB	B
the	O	DET	O
modifications	O	NOUN	B
imposed	O	VERB	O
on	O	ADP	O
NF-kappa	B-protein	NOUN	B
B/I	I-protein	NOUN	I
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
components	I-protein	NOUN	O
following	O	VERB	O
stimulation	O	NOUN	B
and	O	CCONJ	O
show	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
final	O	ADJ	O
step	O	NOUN	O
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
induction	O	NOUN	B
in	O	X	B
vivo	O	X	I
involves	O	VERB	O
phosphorylation	O	NOUN	B
of	O	ADP	O
several	O	ADJ	O
members	O	NOUN	B
of	O	ADP	O
the	O	DET	O
NF-kappa	B-protein	NOUN	B
B/I	I-protein	NOUN	I
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
protein	I-protein	NOUN	I
families	I-protein	NOUN	O
.	O	PUNCT	O


Surprisingly	O	ADV	O
,	O	PUNCT	O
even	O	ADV	O
p65	B-protein	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
c-rel	B-protein	NOUN	B
,	O	PUNCT	O
was	O	AUX	O
phosphorylated	O	VERB	B
after	O	ADP	O
induction	O	NOUN	B
in	O	X	B
vivo	O	X	I
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
TNF-alpha	B-protein	NOUN	B
selectively	O	ADV	O
activates	O	VERB	B
only	O	ADV	O
specific	O	ADJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
heteromers	O	NOUN	B
and	O	CCONJ	O
that	O	SCONJ	O
modifications	O	NOUN	B
regulate	O	VERB	B
not	O	PART	O
only	O	ADV	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
molecules	I-protein	NOUN	I
but	O	CCONJ	O
also	O	ADV	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
molecules	O	NOUN	I
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
phosphorylation	O	NOUN	B
appears	O	VERB	O
to	O	PART	O
be	O	AUX	O
a	O	DET	O
general	O	ADJ	O
mechanism	O	NOUN	B
for	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
in	O	X	B
vivo	O	X	I
.	O	PUNCT	O


Similar	O	ADJ	O
results	O	NOUN	B
were	O	AUX	O
obtained	O	VERB	O
when	O	SCONJ	O
HL60	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
were	O	AUX	O
treated	O	VERB	B
with	O	ADP	I
5	O	NUM	O
x	O	CCONJ	O
10	O	NUM	O
(	O	PUNCT	O
-7	O	NUM	O
)	O	PUNCT	O
all-trans	O	ADJ	B
RA	O	NOUN	B
together	O	ADV	O
with	O	ADP	O
a	O	DET	O
wide	O	ADJ	O
range	O	NOUN	O
of	O	ADP	O
concentrations	O	NOUN	B
of	O	ADP	O
D3	O	NOUN	B
.	O	PUNCT	O


Isolation	O	NOUN	B
of	O	ADP	O
differentially	O	ADV	B
expressed	O	VERB	B
sequence	O	NOUN	B
tags	O	NOUN	O
from	O	ADP	O
steroid-responsive	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
using	O	VERB	O
mRNA	B-RNA	NOUN	B
differential	O	ADJ	I
display	O	NOUN	I
.	O	PUNCT	O


GIG10	B-DNA	NOUN	B
is	O	AUX	O
a	O	DET	O
novel	O	ADJ	O
sequence	O	NOUN	B
and	O	CCONJ	O
GIG18	B-DNA	NOUN	B
is	O	AUX	O
the	O	DET	O
mouse	O	NOUN	B
homologue	O	NOUN	B
of	O	ADP	O
a	O	DET	O
human	B-DNA	ADJ	B
expressed	I-DNA	VERB	O
sequence	I-DNA	NOUN	O
tag	I-DNA	NOUN	O
isolated	O	VERB	B
from	O	ADP	O
activated	B-cell_type	VERB	B
B	I-cell_type	NOUN	I
lymphocytes	I-cell_type	NOUN	I
.	O	PUNCT	O


Triggering	O	VERB	B
through	O	ADP	O
CD2	B-protein	NOUN	B
is	O	AUX	O
mitogenic	O	ADJ	B
for	O	ADP	O
mature	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
immature	O	ADJ	B
,	O	PUNCT	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Serum	O	NOUN	B
cortisol	O	NOUN	I
,	O	PUNCT	O
osteocalcin	O	NOUN	B
and	O	CCONJ	O
urinary	O	ADJ	B
cortisol	O	NOUN	I
levels	O	NOUN	I
were	O	AUX	O
also	O	ADV	O
determined	O	VERB	O
.	O	PUNCT	O


These	O	DET	O
effects	O	NOUN	B
are	O	AUX	O
receptor-dependent	O	ADJ	B
,	O	PUNCT	O
reversible	O	ADJ	B
,	O	PUNCT	O
and	O	CCONJ	O
according	O	VERB	O
to	O	PART	O
serum	O	NOUN	B
and	O	CCONJ	O
urinary	O	ADJ	B
cortisol	O	NOUN	O
levels	O	NOUN	O
and	O	CCONJ	O
ITT	O	NOUN	B
,	O	PUNCT	O
leave	O	VERB	O
the	O	DET	O
hypothalamic-pituitary-adrenal	O	ADJ	B
function	O	NOUN	I
intact	O	ADJ	B
.	O	PUNCT	O


To	O	PART	O
study	O	VERB	B
this	O	DET	O
element	O	NOUN	B
and	O	CCONJ	O
its	O	PRON	O
role	O	NOUN	O
in	O	ADP	O
class	B-DNA	NOUN	B
II	I-DNA	NUM	I
gene	I-DNA	NOUN	I
regulation	O	NOUN	I
further	O	ADV	O
,	O	PUNCT	O
a	O	DET	O
cDNA	B-DNA	NOUN	B
library	I-DNA	NOUN	I
was	O	AUX	O
screened	O	VERB	B
with	O	ADP	O
oligonucleotide	O	NOUN	B
probes	O	NOUN	I
containing	O	VERB	O
both	O	CCONJ	O
the	O	DET	O
S	B-DNA	NOUN	B
element	I-DNA	NOUN	I
and	O	CCONJ	O
the	O	DET	O
nearby	O	ADJ	B
J	B-DNA	NOUN	I
element	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
DPA	I-DNA	NOUN	B
gene	I-DNA	NOUN	I
.	O	PUNCT	O


An	O	DET	O
acidic	B-protein	ADJ	B
activation	I-protein	NOUN	O
domain	I-protein	NOUN	O
is	O	AUX	O
located	O	ADJ	O
between	O	ADP	O
the	O	DET	O
N-terminal	B-protein	ADJ	B
conserved	I-protein	VERB	I
region	I-protein	NOUN	I
of	O	ADP	O
clone	B-protein	NOUN	B
18	I-protein	NUM	O
and	O	CCONJ	O
its	O	PRON	O
zinc	B-protein	NOUN	B
fingers	I-protein	NOUN	I
.	O	PUNCT	O


Antisense	O	ADJ	B
cDNA	O	NOUN	I
to	O	PART	O
clone	B-protein	NOUN	B
18	I-protein	NUM	O
inhibited	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
a	O	DET	O
reporter	O	NOUN	B
construct	O	NOUN	I
containing	O	VERB	O
the	O	DET	O
DPA	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
,	O	PUNCT	O
indicating	O	VERB	O
its	O	PRON	O
functional	O	ADJ	B
importance	O	NOUN	O
in	O	ADP	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
this	O	DET	O
class	B-DNA	NOUN	B
II	I-DNA	NUM	I
gene	I-DNA	NOUN	I
.	O	PUNCT	O


These	O	DET	O
initial	O	ADJ	O
pathways	O	NOUN	B
culminate	O	VERB	B
in	O	ADP	O
a	O	DET	O
common	O	ADJ	O
pathway	O	NOUN	B
through	O	ADP	O
which	O	DET	O
all	O	DET	O
of	O	ADP	O
the	O	DET	O
stimulating	O	NOUN	B
agents	O	NOUN	I
ultimately	O	ADV	O
signal	O	VERB	B
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activation	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
IL-2	B-DNA	NOUN	B
octamer	I-DNA	NOUN	I
motif	I-DNA	NOUN	B
is	O	AUX	O
a	O	DET	O
composite	O	ADJ	B
cis-element	B-DNA	NOUN	B
which	O	DET	O
binds	O	VERB	B
Oct-1	B-protein	NOUN	B
and	O	CCONJ	O
Oct-2	B-protein	NOUN	B
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
a	O	DET	O
TPA/Ca	B-protein	NOUN	B
(	I-protein	PUNCT	O
2+	I-protein	NUM	O
)	I-protein	PUNCT	O
-inducible	I-protein	ADJ	O
nuclear	I-protein	ADJ	B
factor	I-protein	NOUN	I
,	O	PUNCT	O
previously	O	ADV	O
termed	O	VERB	O
octamer-associated	B-protein	ADJ	O
protein	I-protein	NOUN	O
(	O	PUNCT	O
OAP40	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
an	O	DET	O
intact	B-protein	ADJ	B
COOH-terminal	I-protein	ADJ	B
domain	I-protein	NOUN	I
of	O	ADP	O
Oct-2	B-protein	NOUN	B
contributes	O	VERB	O
to	O	PART	O
both	O	DET	O
TPA/Ca	O	NOUN	B
(	O	PUNCT	O
2+	O	NUM	O
)	O	PUNCT	O
-induced	O	ADJ	O
transactivation	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
RA-mediated	O	ADJ	B
repression	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
also	O	ADV	O
show	O	VERB	O
that	O	SCONJ	O
both	O	CCONJ	O
Fos	B-protein	NOUN	B
and	O	CCONJ	O
Jun	B-protein	NOUN	B
components	O	NOUN	I
of	O	ADP	O
the	O	DET	O
AP-1	B-protein	NOUN	B
factors	O	NOUN	I
participate	O	VERB	B
in	O	ADP	O
the	O	DET	O
OAP40	B-protein	NOUN	B
complex	I-protein	NOUN	B
.	O	PUNCT	O


OAP	B-protein	NOUN	B
confers	O	VERB	O
to	O	PART	O
Oct-2	B-protein	NOUN	B
responsivity	O	NOUN	I
to	O	PART	O
both	O	CCONJ	O
TPA/Ca2+	O	NOUN	B
and	O	CCONJ	O
RA	O	NOUN	B
,	O	PUNCT	O
since	O	SCONJ	O
specific	O	ADJ	O
mutations	O	NOUN	B
of	O	ADP	O
the	O	DET	O
AP-1/OAP-binding	B-DNA	VERB	B
site	I-DNA	NOUN	I
significantly	O	ADV	O
reduce	O	VERB	O
the	O	DET	O
transactivation	O	NOUN	B
by	O	ADP	O
Oct-2	B-protein	NOUN	B
in	O	ADP	O
response	O	NOUN	O
to	O	PART	O
TPA	O	NOUN	B
and	O	CCONJ	O
Ca2+	O	NOUN	B
and	O	CCONJ	O
abolish	O	VERB	B
the	O	DET	O
inhibition	O	NOUN	B
by	O	ADP	O
RA	O	NOUN	B
.	O	PUNCT	O


Missense	O	NOUN	B
mutation	O	NOUN	I
in	O	ADP	O
exon	B-DNA	NOUN	B
7	I-DNA	NUM	I
of	O	ADP	O
the	O	DET	O
common	B-DNA	ADJ	O
gamma	I-DNA	NOUN	B
chain	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
causes	O	VERB	O
a	O	DET	O
moderate	O	ADJ	B
form	O	NOUN	O
of	O	ADP	O
X-linked	O	ADJ	B
combined	O	ADJ	I
immunodeficiency	O	NOUN	I
.	O	PUNCT	O


Posttranscriptional	O	ADJ	B
regulation	O	NOUN	I
of	O	ADP	O
macrophage	O	NOUN	B
tissue	B-protein	NOUN	I
factor	I-protein	NOUN	O
expression	O	NOUN	B
by	O	ADP	O
antioxidants	O	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
TG	O	NOUN	B
induced	O	VERB	B
increases	O	NOUN	B
in	O	ADP	O
IL-2R	B-protein	NOUN	B
alpha	I-protein	NOUN	I
protein	I-protein	NOUN	I
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
IL-2R	B-RNA	NOUN	B
alpha	I-RNA	NOUN	O
mRNA	I-RNA	NOUN	B
in	O	ADP	O
Jurkat	B-cell_line	NOUN	B
T	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
in	O	ADP	O
a	O	DET	O
dose-dependent	O	ADJ	B
manner	O	NOUN	O
.	O	PUNCT	O


Physiological	O	ADJ	B
concentration	O	NOUN	B
of	O	ADP	O
estradiol	O	NOUN	B
inhibits	O	VERB	O
polymorphonuclear	B-cell_type	ADJ	B
leukocyte	I-cell_type	NOUN	B
chemotaxis	O	NOUN	I
via	O	ADP	O
a	O	DET	O
receptor	O	NOUN	B
mediated	O	ADJ	I
system	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
receptor	O	NOUN	B
for	O	ADP	O
the	O	DET	O
macrophage	B-protein	NOUN	B
colony-stimulating	I-protein	ADJ	I
factor	I-protein	NOUN	I
(	O	PUNCT	O
or	O	CCONJ	O
colony-stimulating	B-protein	ADJ	B
factor	I-protein	NOUN	I
1	I-protein	NUM	I
[	O	PUNCT	O
CSF-1	B-protein	NOUN	B
]	O	PUNCT	O
)	O	PUNCT	O
is	O	AUX	O
expressed	O	VERB	B
from	O	ADP	O
different	O	ADJ	O
promoters	O	NOUN	B
in	O	ADP	O
monocytic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
placental	B-cell_type	ADJ	B
trophoblasts	I-cell_type	NOUN	B
.	O	PUNCT	O


Two	O	NUM	O
gel	B-protein	NOUN	B
shift	I-protein	NOUN	I
complexes	I-protein	NOUN	I
(	O	PUNCT	O
Mono	B-protein	NOUN	B
A	I-protein	NOUN	I
and	O	CCONJ	O
Mono	B-protein	NOUN	B
B	I-protein	NOUN	I
)	O	PUNCT	O
were	O	AUX	O
formed	O	VERB	O
with	O	ADP	O
separate	O	ADJ	O
sequence	O	NOUN	B
elements	O	NOUN	I
within	O	ADP	O
this	O	DET	O
region	O	NOUN	B
.	O	PUNCT	O


Pyrrolidine	O	NOUN	B
dithiocarbamate	O	NOUN	I
,	O	PUNCT	O
a	O	DET	O
potent	O	ADJ	O
inhibitor	O	NOUN	B
of	O	ADP	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
(	O	PUNCT	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
)	O	PUNCT	O
activation	O	NOUN	B
,	O	PUNCT	O
prevents	O	VERB	B
apoptosis	O	NOUN	B
in	O	ADP	O
human	O	ADJ	B
promyelocytic	B-cell_line	ADJ	I
leukemia	I-cell_line	NOUN	I
HL-60	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
and	O	CCONJ	O
thymocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


Treatment	O	NOUN	B
of	O	ADP	O
a	O	DET	O
human	B-cell_line	ADJ	B
promyelocytic	I-cell_line	ADJ	I
leukemia	I-cell_line	NOUN	I
cell	I-cell_line	NOUN	B
line	I-cell_line	NOUN	I
,	O	PUNCT	O
HL-60	B-cell_line	NOUN	B
,	O	PUNCT	O
with	O	ADP	O
10	O	NUM	O
micrograms/mL	O	X	O
etoposide	O	NOUN	B
or	O	CCONJ	O
2	O	NUM	O
microM	O	NOUN	O
1-beta-D-arabinofuranosylcytosine	O	NOUN	B
induced	O	VERB	B
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activation	O	NOUN	B
within	O	ADP	O
1	O	NUM	O
hr	O	NOUN	O
and	O	CCONJ	O
subsequently	O	ADV	O
caused	O	VERB	O
apoptosis	O	NOUN	B
within	O	ADP	O
3-4	O	NUM	O
hr	O	NOUN	O
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
PDTC	O	NOUN	B
failed	O	VERB	O
to	O	PART	O
inhibit	O	VERB	B
the	O	DET	O
endonuclease	B-protein	NOUN	B
activity	O	NOUN	I
contained	O	VERB	O
in	O	ADP	O
the	O	DET	O
whole	O	ADJ	B
cell	O	NOUN	I
lysates	O	NOUN	O
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
plays	O	VERB	O
an	O	DET	O
important	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
apoptotic	O	ADJ	B
process	O	NOUN	I
of	O	ADP	O
human	B-cell_type	ADJ	B
hematopoietic	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Two	O	NUM	O
groups	O	NOUN	B
of	O	ADP	O
U937	B-cell_line	NOUN	B
promonocytic	I-cell_line	ADJ	I
cells	I-cell_line	NOUN	I
were	O	AUX	O
obtained	O	VERB	O
by	O	ADP	O
limiting	O	VERB	O
dilution	O	NOUN	B
cloning	O	NOUN	I
which	O	DET	O
differed	O	VERB	O
strikingly	O	ADV	B
in	O	ADP	O
their	O	PRON	O
ability	O	NOUN	O
to	O	PART	O
support	O	VERB	O
human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
1	O	NUM	I
(	O	PUNCT	O
HIV-1	O	NOUN	B
)	O	PUNCT	O
replication	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
data	O	NOUN	B
also	O	ADV	O
demonstrate	O	VERB	O
that	O	SCONJ	O
special	O	ADJ	O
precautions	O	NOUN	B
must	O	AUX	O
be	O	AUX	O
taken	O	VERB	O
when	O	SCONJ	O
making	O	VERB	O
extracts	O	NOUN	B
from	O	ADP	O
myelo-monocytic	B-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Because	O	SCONJ	O
inhibition	O	NOUN	B
of	O	ADP	O
DNA-binding	O	ADJ	B
activity	O	NOUN	O
is	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
increasing	O	VERB	O
intracellular	O	ADJ	B
glutathione	O	NOUN	O
disulfide	O	NOUN	O
levels	O	NOUN	O
and	O	CCONJ	O
GSSG	B-protein	NOUN	B
can	O	AUX	O
be	O	AUX	O
shown	O	VERB	O
to	O	PART	O
inhibit	O	VERB	B
the	O	DET	O
DNA-binding	O	ADJ	B
activity	O	NOUN	O
directly	O	ADV	O
in	O	ADP	O
cell-free	O	ADJ	B
systems	O	NOUN	I
,	O	PUNCT	O
our	O	PRON	O
studies	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
GSSG	B-protein	NOUN	B
is	O	AUX	O
a	O	DET	O
physiologically	O	ADV	B
relevant	O	ADJ	B
inhibitor	O	NOUN	B
in	O	ADP	O
intact	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
also	O	ADV	O
.	O	PUNCT	O


In	O	ADP	O
August	O	PROPN	O
,	O	PUNCT	O
1992	O	NUM	O
,	O	PUNCT	O
we	O	PRON	O
established	O	VERB	O
a	O	DET	O
leukemic	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
(	O	PUNCT	O
NS-Meg	B-cell_line	NOUN	B
)	O	PUNCT	O
from	O	ADP	O
a	O	DET	O
patient	O	NOUN	B
in	O	ADP	O
megakaryoblastic	O	ADJ	B
transformation	O	NOUN	I
of	O	ADP	O
Philadelphia	O	NOUN	B
chromosome-positive	O	ADJ	I
chronic	O	ADJ	I
myeloid	O	ADJ	I
leukemia	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
NS-Meg	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
were	O	AUX	O
positive	O	ADJ	B
for	O	ADP	O
alpha-naphthyl	B-protein	ADJ	B
acetate	I-protein	NOUN	I
esterase	I-protein	NOUN	I
and	O	CCONJ	O
periodic	O	ADJ	B
acid-Schiff	O	NOUN	I
(	O	PUNCT	I
PAS	O	NOUN	B
)	O	PUNCT	O
staining	O	NOUN	B
and	O	CCONJ	O
for	O	ADP	O
surface	O	NOUN	B
CD4	B-protein	NOUN	B
,	O	PUNCT	O
CD7	B-protein	NOUN	B
,	O	PUNCT	O
CD13	B-protein	NOUN	B
,	O	PUNCT	O
CD34	B-protein	NOUN	B
,	O	PUNCT	O
CD41a	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
glycophorin	B-protein	NOUN	B
A	I-protein	NOUN	I
antigens	I-protein	NOUN	B
.	O	PUNCT	O


Ultrastructurally	O	ADV	B
,	O	PUNCT	O
the	O	DET	O
cells	O	NOUN	B
had	O	AUX	O
alpha-granules	O	NOUN	B
,	O	PUNCT	O
demarcation	O	NOUN	B
membranes	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
platelet	B-protein	NOUN	B
peroxidase	I-protein	NOUN	I
activity	O	NOUN	I
.	O	PUNCT	O


Ten-day	O	ADJ	B
exposure	O	NOUN	B
to	O	PART	I
Epo	B-protein	NOUN	B
induced	O	VERB	B
mature	B-cell_type	ADJ	B
erythroblasts	I-cell_type	NOUN	B
and	O	CCONJ	O
red	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
to	O	PART	O
activation	O	NOUN	B
of	O	ADP	O
phospholipase	B-protein	NOUN	B
C	I-protein	NOUN	I
gamma	I-protein	NOUN	I
1	I-protein	NUM	I
,	O	PUNCT	O
ligation	O	NOUN	B
of	O	ADP	O
this	O	DET	O
receptor	O	NOUN	B
also	O	ADV	O
seems	O	VERB	O
to	O	PART	O
activate	O	VERB	B
a	O	DET	O
calcium-independent	O	ADJ	B
,	O	PUNCT	O
CD28	B-protein	NOUN	B
-specific	O	ADJ	O
pathway	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
paper	O	NOUN	O
,	O	PUNCT	O
we	O	PRON	O
report	O	VERB	O
that	O	SCONJ	O
cross-linking	O	NOUN	B
of	O	ADP	O
CD28	B-protein	NOUN	B
(	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
CD2	B-protein	NOUN	B
,	O	PUNCT	O
CD5	B-protein	NOUN	B
,	O	PUNCT	O
LFA-1	B-protein	NOUN	B
,	O	PUNCT	O
or	O	CCONJ	O
CD7	B-protein	NOUN	B
)	O	PUNCT	O
leads	O	VERB	O
to	O	PART	O
an	O	DET	O
elevation	O	NOUN	B
of	O	ADP	O
c-jun	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
,	O	PUNCT	O
with	O	ADP	O
only	O	ADV	O
minimal	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
c-fos	B-DNA	NOUN	B
expression	O	NOUN	I
.	O	PUNCT	O


LTR	B-DNA	NOUN	B
-directed	O	ADJ	O
transcription	O	NOUN	B
was	O	AUX	O
measured	O	VERB	B
by	O	ADP	O
using	O	VERB	O
luciferase	B-DNA	NOUN	B
reporter	I-DNA	NOUN	I
constructs	I-DNA	NOUN	I
that	O	PRON	O
were	O	AUX	O
transiently	O	ADV	O
transfected	O	VERB	B
into	O	ADP	O
cultured	B-cell_line	VERB	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
such	O	ADJ	O
cells	O	NOUN	B
,	O	PUNCT	O
DNA	O	NOUN	B
binding	O	NOUN	I
activity	O	NOUN	I
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
can	O	AUX	O
be	O	AUX	O
detected	O	VERB	B
without	O	ADP	O
intentional	O	ADJ	B
stimulation	O	NOUN	I
.	O	PUNCT	O


Analysis	O	NOUN	B
of	O	ADP	O
primary	O	ADJ	B
cells	O	NOUN	I
revealed	O	VERB	O
substantial	O	ADJ	O
constitutive	O	ADJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
-binding	O	ADJ	O
activity	O	NOUN	B
in	O	ADP	O
blood	B-cell_type	NOUN	B
monocytes	I-cell_type	NOUN	I
,	O	PUNCT	O
pleural	B-cell_type	ADJ	B
macrophages	I-cell_type	NOUN	I
and	O	CCONJ	O
alveolar	B-cell_type	ADJ	B
macrophages	I-cell_type	NOUN	I
.	O	PUNCT	O


Constitutive	O	ADJ	B
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
was	O	AUX	O
not	O	PART	O
maintained	O	VERB	O
by	O	ADP	O
autocrine	O	ADJ	B
action	O	NOUN	O
of	O	ADP	O
cytokines	B-protein	NOUN	B
TNF	B-protein	NOUN	B
,	O	PUNCT	O
interleukin	B-protein	NOUN	B
6	I-protein	NUM	I
,	O	PUNCT	O
interleukin	B-protein	NOUN	B
10	O	NUM	I
,	O	PUNCT	O
granulocyte-macrophage	B-protein	ADJ	B
colony-stimulating	I-protein	ADJ	I
factor	I-protein	NOUN	I
or	O	CCONJ	O
macrophage	B-protein	NOUN	B
colony-stimulating	I-protein	ADJ	I
factor	I-protein	NOUN	I
,	O	PUNCT	O
since	O	SCONJ	O
neutralizing	O	VERB	B
antibodies	O	NOUN	I
did	O	AUX	O
not	O	PART	O
reduce	O	VERB	O
constitutive	O	ADJ	B
DNA-binding	O	ADJ	B
activity	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
mechanism	O	NOUN	B
(	O	PUNCT	O
s	O	NOUN	O
)	O	PUNCT	O
responsible	O	ADJ	O
for	O	ADP	O
the	O	DET	O
cell	O	NOUN	B
type-specific	O	ADJ	I
regulation	O	NOUN	I
of	O	ADP	O
TNF	B-protein	NOUN	B
alpha	I-protein	NOUN	I
is	O	AUX	O
not	O	PART	O
known	O	VERB	O
.	O	PUNCT	O


Finally	O	ADV	O
,	O	PUNCT	O
a	O	DET	O
dominant-negative	O	ADJ	B
version	O	NOUN	O
of	O	ADP	O
C/EBP	B-protein	NOUN	B
beta	I-protein	NOUN	I
blocked	O	VERB	B
TNF	B-DNA	NOUN	B
alpha	I-DNA	NOUN	I
promoter	I-DNA	NOUN	B
activation	O	NOUN	I
in	O	ADP	O
myeloid	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Increased	O	VERB	B
[	O	PUNCT	O
Ca2+	O	NOUN	B
]	O	PUNCT	O
i	O	PRON	O
activates	O	VERB	B
Ca2+/calmodulin-dependent	B-protein	ADJ	B
kinases	I-protein	NOUN	I
including	O	VERB	O
the	O	DET	O
multifunctional	O	ADJ	B
Ca2+/calmodulin-dependent	B-protein	ADJ	I
protein	I-protein	NOUN	I
kinase	I-protein	NOUN	I
II	I-protein	NUM	I
(	O	PUNCT	O
CaM-K	B-protein	NOUN	B
II	I-protein	NUM	I
)	O	PUNCT	O
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
calcineurin	B-protein	NOUN	B
,	O	PUNCT	O
a	O	DET	O
type	B-protein	NOUN	B
2B	I-protein	NOUN	I
protein	I-protein	NOUN	I
phosphatase	I-protein	NOUN	I
.	O	PUNCT	O


Recent	O	ADJ	O
studies	O	NOUN	B
have	O	AUX	O
identified	O	VERB	O
calcineurin	B-protein	NOUN	B
as	O	ADP	O
a	O	DET	O
key	O	ADJ	O
enzyme	O	NOUN	B
for	O	ADP	O
interleukin	O	NOUN	O
(	O	PUNCT	O
IL	O	NOUN	B
)	O	PUNCT	O
-2	O	NUM	O
and	O	CCONJ	O
IL-4	O	NOUN	B
promoter	O	NOUN	B
activation	O	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
CaM-K	B-protein	NOUN	B
II	I-protein	NUM	I
remains	O	VERB	O
unknown	O	ADJ	O
.	O	PUNCT	O


Cotransfection	O	NOUN	B
of	O	ADP	O
gamma	B-protein	NOUN	B
B*CaM-K	I-protein	NOUN	I
with	O	ADP	O
the	O	DET	O
IL-2	B-DNA	NOUN	B
promoter	I-DNA	NOUN	I
construct	I-DNA	NOUN	I
downregulated	O	VERB	B
its	O	PRON	O
transcription	O	NOUN	B
in	O	ADP	O
response	O	NOUN	O
to	O	PART	O
stimulation	O	NOUN	B
with	O	ADP	O
ionomycin	O	NOUN	B
and	O	CCONJ	O
phorbol	O	NOUN	B
myristate	O	NOUN	I
acetate	O	NOUN	I
(	O	PUNCT	O
PMA	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
mechanism	O	NOUN	B
of	O	ADP	O
down-regulation	O	NOUN	B
of	O	ADP	O
ICAM-I	B-protein	NOUN	B
or	O	CCONJ	O
LFA-I	B-protein	NOUN	B
in	O	ADP	O
4	B-cell_line	NUM	O
ATL	I-cell_line	NOUN	B
cell	I-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
was	O	AUX	O
next	O	ADV	O
examined	O	VERB	O
.	O	PUNCT	O


Infection	O	NOUN	B
with	O	ADP	O
Theileria	O	X	B
annulata	O	X	I
induces	O	VERB	O
expression	O	NOUN	B
of	O	ADP	O
matrix	B-protein	NOUN	B
metalloproteinase	I-protein	NOUN	I
9	I-protein	NUM	I
and	O	CCONJ	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
AP-1	B-protein	NOUN	I
in	O	ADP	O
bovine	B-cell_type	ADJ	B
leucocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


B-cell	B-cell_type	NOUN	B
proliferation	O	NOUN	I
and	O	CCONJ	O
induction	O	NOUN	B
of	O	ADP	O
early	O	ADJ	O
G1-regulating	B-protein	ADJ	B
proteins	I-protein	NOUN	I
by	O	ADP	O
Epstein-Barr	O	ADJ	B
virus	O	NOUN	I
mutants	O	NOUN	B
conditional	O	ADJ	B
for	O	ADP	O
EBNA2	B-protein	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
generated	O	VERB	O
conditional	O	ADJ	B
EBV	O	NOUN	B
mutants	O	NOUN	B
by	O	ADP	O
expressing	O	VERB	B
EBNA2	B-protein	NOUN	B
as	O	ADP	O
chimeric	B-protein	ADJ	B
fusion	I-protein	NOUN	I
protein	I-protein	NOUN	I
with	O	ADP	O
the	O	DET	O
hormone	O	NOUN	B
binding	O	NOUN	I
domain	O	NOUN	I
of	O	ADP	O
the	O	DET	O
estrogen	B-protein	NOUN	B
receptor	I-protein	NOUN	I
on	O	ADP	O
the	O	DET	O
genetic	O	ADJ	B
background	O	NOUN	I
of	O	ADP	O
the	O	DET	O
virus	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
estrogen	O	NOUN	B
about	O	ADV	O
half	O	NOUN	O
of	O	ADP	O
the	O	DET	O
cells	O	NOUN	B
enter	O	VERB	O
a	O	DET	O
quiescent	O	ADJ	B
non-proliferative	O	ADJ	B
state	O	NOUN	O
whereas	O	SCONJ	O
the	O	DET	O
others	O	NOUN	O
die	O	VERB	B
by	O	ADP	O
apoptosis	O	NOUN	B
.	O	PUNCT	O


Growth	O	NOUN	B
arrest	O	NOUN	I
occurred	O	VERB	O
at	O	ADP	O
G1	O	NOUN	B
and	O	CCONJ	O
G2	O	NOUN	B
stages	O	NOUN	I
of	O	ADP	O
the	O	DET	O
cell	O	NOUN	B
cycle	O	NOUN	I
,	O	PUNCT	O
indicating	O	VERB	O
that	O	SCONJ	O
functional	O	ADJ	B
EBNA2	B-protein	NOUN	B
is	O	AUX	O
required	O	VERB	O
at	O	ADP	O
different	O	ADJ	O
restriction	O	NOUN	B
points	O	NOUN	O
of	O	ADP	O
the	O	DET	O
cell	O	NOUN	B
cycle	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
EBV	O	NOUN	B
is	O	AUX	O
using	O	VERB	O
a	O	DET	O
common	O	ADJ	O
pathway	O	NOUN	B
for	O	ADP	O
B-cell	O	NOUN	B
activation	O	NOUN	I
bypassing	O	VERB	O
the	O	DET	O
requirement	O	NOUN	B
for	O	ADP	O
antigen	O	NOUN	B
,	O	PUNCT	O
T-cell	O	NOUN	B
signals	O	NOUN	I
and	O	CCONJ	O
growth	B-protein	NOUN	B
factors	I-protein	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
IL-1	B-protein	NOUN	B
induces	O	VERB	B
both	O	CCONJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
nuclear	O	ADJ	O
translocation	O	NOUN	O
and	O	CCONJ	O
the	O	DET	O
synthesis	O	NOUN	B
of	O	ADP	O
a	O	DET	O
protein	O	NOUN	B
(	O	PUNCT	O
s	O	NOUN	O
)	O	PUNCT	O
responsible	O	ADJ	O
for	O	ADP	O
terminating	O	VERB	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
-DNA	O	NOUN	O
interaction	O	NOUN	B
in	O	ADP	O
the	O	DET	O
nucleus	O	NOUN	B
.	O	PUNCT	O


Antigen	O	NOUN	B
receptor	O	NOUN	I
signals	O	NOUN	B
prolong	O	VERB	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
-DNA	O	NOUN	O
interaction	O	NOUN	B
,	O	PUNCT	O
probably	O	ADV	O
by	O	ADP	O
functionally	O	ADV	O
antagonizing	O	VERB	B
the	O	DET	O
IL-1	B-protein	NOUN	B
-induced	O	ADJ	O
synthesis	O	NOUN	B
of	O	ADP	O
a	O	DET	O
protein	O	NOUN	B
(	O	PUNCT	O
s	O	NOUN	O
)	O	PUNCT	O
responsible	O	ADJ	O
for	O	ADP	O
the	O	DET	O
transient	O	ADJ	B
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
-DNA	O	NOUN	O
interaction	O	NOUN	B
and	O	CCONJ	O
consequently	O	ADV	O
synergistically	O	ADV	B
enhance	O	VERB	O
IL-1	B-protein	NOUN	B
-induced	O	ADJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
-dependent	O	ADJ	O
gene	O	NOUN	B
transcription	O	NOUN	I
.	O	PUNCT	O


PCR	O	NOUN	B
studies	O	NOUN	B
revealed	O	VERB	O
that	O	SCONJ	O
CAV	O	NOUN	B
isolates	O	NOUN	B
from	O	ADP	O
across	O	ADP	O
the	O	DET	O
world	O	NOUN	B
all	O	DET	O
contained	O	VERB	O
this	O	DET	O
promoter	B-DNA	NOUN	B
sequence	I-DNA	NOUN	I
.	O	PUNCT	O


Electrophoretic	O	ADJ	B
mobility-shift	O	ADJ	I
assays	O	NOUN	I
(	O	PUNCT	O
EMSA	O	NOUN	B
)	O	PUNCT	O
showed	O	VERB	O
that	O	SCONJ	O
individual	B-DNA	ADJ	B
DR	I-DNA	NOUN	B
units	I-DNA	NOUN	B
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
the	O	DET	O
12-bp	B-DNA	ADJ	O
insert	I-DNA	NOUN	B
,	O	PUNCT	O
can	O	AUX	O
bind	O	VERB	B
to	O	PART	O
nuclear	B-protein	ADJ	B
factors	I-protein	NOUN	I
of	O	ADP	O
chicken	B-cell_type	NOUN	B
T-cells	I-cell_type	NOUN	B
.	O	PUNCT	O


A	O	DET	O
synthetic	O	ADJ	B
oligodeoxyribonucleotide	O	NOUN	I
containing	O	VERB	O
an	O	DET	O
SP1-box	B-DNA	NOUN	B
(	O	PUNCT	O
5'-GGGCGG	O	NOUN	O
)	O	PUNCT	O
could	O	AUX	O
compete	O	VERB	O
with	O	ADP	O
factors	O	NOUN	B
binding	O	VERB	B
to	O	PART	O
the	O	DET	O
12-bp	B-DNA	ADJ	O
insert	I-DNA	NOUN	B
.	O	PUNCT	O


T	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
hybridomas	I-cell_line	NOUN	B
respond	O	VERB	O
to	O	PART	O
activation	O	NOUN	B
signals	O	NOUN	B
by	O	ADP	O
undergoing	O	VERB	O
apoptotic	O	ADJ	B
cell	O	NOUN	I
death	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
this	O	DET	O
is	O	AUX	O
likely	O	ADJ	O
to	O	PART	O
represent	O	VERB	O
comparable	O	ADJ	O
events	O	NOUN	B
related	O	ADJ	O
to	O	PART	O
tolerance	O	NOUN	B
induction	O	NOUN	B
in	O	ADP	O
immature	B-cell_type	ADJ	B
and	I-cell_type	CCONJ	O
mature	I-cell_type	ADJ	B
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
in	O	X	B
vivo	O	X	I
.	O	PUNCT	O


Further	O	ADV	O
,	O	PUNCT	O
coexpression	O	NOUN	B
of	O	ADP	O
a	O	DET	O
reciprocally	B-protein	ADV	B
mutant	I-protein	ADJ	I
Myc	I-protein	NOUN	B
protein	I-protein	NOUN	I
capable	O	ADJ	O
of	O	ADP	O
forming	O	VERB	O
functional	O	ADJ	B
heterodimers	B-protein	NOUN	B
with	O	ADP	O
the	O	DET	O
mutant	O	ADJ	B
Max	B-protein	NOUN	B
can	O	AUX	O
compensate	O	VERB	O
for	O	ADP	O
the	O	DET	O
dominant	O	ADJ	B
negative	O	ADJ	B
activity	O	NOUN	B
and	O	CCONJ	O
restore	O	VERB	B
activation-induced	O	ADJ	B
apoptosis	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
protein	O	NOUN	B
that	O	PRON	O
is	O	AUX	O
phosphorylated	O	VERB	B
on	O	ADP	O
a	O	DET	O
tyrosine	O	NOUN	B
residue	O	NOUN	B
in	O	ADP	O
resting	B-cell_line	VERB	B
PBL-T	I-cell_line	NOUN	I
suppresses	O	VERB	B
binding	O	NOUN	B
of	O	ADP	O
a	O	DET	O
component	O	NOUN	B
of	O	ADP	O
Band	B-protein	NOUN	B
A	I-protein	NOUN	I
to	O	ADP	O
the	O	DET	O
SRE	B-DNA	NOUN	B
motif	I-DNA	NOUN	B
.	O	PUNCT	O


Coexpression	O	NOUN	B
of	O	ADP	O
both	O	DET	O
proteins	O	NOUN	B
activated	O	VERB	B
transcription	O	NOUN	B
of	O	ADP	O
the	O	DET	O
-137	B-DNA	NUM	O
to	I-DNA	PART	O
-64	I-DNA	NUM	O
element	I-DNA	NOUN	B
in	O	ADP	O
COS-7	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


These	O	DET	O
findings	O	NOUN	B
provide	O	VERB	O
significant	O	ADJ	O
new	O	ADJ	O
insights	O	NOUN	O
into	O	ADP	O
the	O	DET	O
protein-protein	O	ADJ	B
and	O	CCONJ	O
protein-DNA	O	ADJ	B
interactions	O	NOUN	I
that	O	PRON	O
regulate	O	VERB	B
cell-type-specific	O	ADJ	B
and	O	CCONJ	O
inducible	O	ADJ	B
IL-2R	B-protein	NOUN	O
alpha	I-protein	NOUN	O
gene	O	NOUN	B
expression	O	NOUN	I
and	O	CCONJ	O
also	O	ADV	O
have	O	AUX	O
implications	O	NOUN	O
for	O	ADP	O
other	O	ADJ	O
genes	O	NOUN	B
regulated	O	VERB	O
by	O	ADP	O
Elf-1	B-protein	NOUN	B
and	O	CCONJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
family	I-protein	NOUN	B
proteins	I-protein	NOUN	I
.	O	PUNCT	O


Isolation	O	NOUN	B
of	O	ADP	O
cDNA	B-DNA	NOUN	B
clones	I-DNA	NOUN	I
for	O	ADP	O
42	O	NUM	O
different	O	ADJ	O
Kruppel-related	B-protein	ADJ	B
zinc	I-protein	NOUN	O
finger	I-protein	NOUN	O
proteins	I-protein	NOUN	O
expressed	O	VERB	B
in	O	ADP	O
the	O	DET	O
human	B-cell_line	ADJ	B
monoblast	I-cell_line	NOUN	O
cell	I-cell_line	NOUN	O
line	I-cell_line	NOUN	O
U-937	I-cell_line	NOUN	B
.	O	PUNCT	O


By	O	ADP	O
extensive	O	ADJ	O
nucleotide	O	NOUN	B
sequence	O	NOUN	I
and	O	CCONJ	O
Northern	O	NOUN	B
blot	O	NOUN	I
analysis	O	NOUN	I
,	O	PUNCT	O
these	O	DET	O
cDNA	B-DNA	NOUN	B
clones	I-DNA	NOUN	I
were	O	AUX	O
found	O	VERB	O
to	O	PART	O
originate	O	VERB	O
from	O	ADP	O
approximately	O	ADV	B
42	O	NUM	O
different	O	ADJ	B
genes	O	NOUN	B
(	O	PUNCT	O
HZF	B-DNA	NOUN	B
1-42	I-DNA	NUM	O
)	O	PUNCT	O
of	O	ADP	O
which	O	DET	O
only	O	ADV	O
8	O	NUM	O
have	O	AUX	O
previously	O	ADV	O
been	O	AUX	O
described	O	VERB	O
.	O	PUNCT	O


68	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
the	O	DET	O
contractions	O	NOUN	B
were	O	AUX	O
also	O	ADV	O
one	O	NUM	O
or	O	CCONJ	O
two	O	NUM	O
repeats	O	NOUN	B
but	O	CCONJ	O
six	O	NUM	O
(	O	PUNCT	O
16	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
were	O	AUX	O
very	O	ADV	O
large	O	ADJ	O
(	O	PUNCT	O
12-25	O	NUM	O
repeats	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Aspirin-like	O	ADJ	B
drugs	O	NOUN	I
can	O	AUX	O
protect	O	VERB	O
human	B-cell_type	ADJ	B
T	I-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
against	O	ADP	O
benzoquinone	O	NOUN	B
cytotoxicity	O	NOUN	B
:	O	PUNCT	O
evidence	O	NOUN	B
for	O	ADP	O
a	O	DET	O
NAD	B-protein	NOUN	B
(	I-protein	PUNCT	O
P	I-protein	NOUN	O
)	I-protein	PUNCT	O
H	I-protein	NOUN	O
:	I-protein	PUNCT	O
quinone	I-protein	ADJ	B
reductase	I-protein	NOUN	I
-dependent	O	ADJ	O
mechanism	O	NOUN	B
.	O	PUNCT	O


Molt-4	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
(	O	PUNCT	O
M4	B-cell_line	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
a	O	DET	O
human	B-cell_line	ADJ	B
T	I-cell_line	NOUN	O
lymphocyte	I-cell_line	NOUN	O
cell	I-cell_line	NOUN	O
line	I-cell_line	NOUN	O
,	O	PUNCT	O
were	O	AUX	O
incubated	O	VERB	B
with	O	ADP	O
different	O	ADJ	O
concentrations	O	NOUN	B
of	O	ADP	O
two	O	NUM	O
ALD	O	NOUN	B
,	O	PUNCT	O
flurbiprofen	O	NOUN	B
and	O	CCONJ	O
sodium	O	NOUN	B
diclofenac	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
then	O	ADV	O
exposed	O	VERB	B
to	O	ADP	I
BQ	O	PROPN	B
.	O	PUNCT	O


A	O	DET	O
cDNA	B-DNA	NOUN	B
library	I-DNA	NOUN	I
was	O	AUX	O
prepared	O	VERB	O
from	O	ADP	O
peripheral	O	ADJ	B
blood	O	NOUN	I
lymphocytes	B-cell_type	NOUN	I
of	O	ADP	O
an	O	DET	O
autoimmune	O	ADJ	B
patient	O	NOUN	I
with	O	ADP	O
primary	O	ADJ	B
Sjogrens	O	NOUN	B
'	O	PART	I
syndrome	O	NOUN	I
.	O	PUNCT	O


Thereby	O	ADV	O
an	O	DET	O
alternative	O	ADJ	B
type	O	NOUN	O
of	O	ADP	O
La	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
was	O	AUX	O
identified	O	VERB	B
that	O	PRON	O
differed	O	VERB	O
from	O	ADP	O
the	O	DET	O
known	O	ADJ	O
La	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
due	O	ADJ	O
to	O	PART	O
an	O	DET	O
exchange	O	NOUN	B
of	O	ADP	O
the	O	DET	O
exon	B-DNA	NOUN	B
1	I-DNA	NUM	I
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
intron	O	NOUN	B
,	O	PUNCT	O
further	O	ADJ	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
binding	O	NOUN	I
sites	O	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
a	O	DET	O
NF-kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
element	I-DNA	NOUN	I
,	O	PUNCT	O
were	O	AUX	O
identified	O	VERB	B
leading	O	VERB	O
to	O	PART	O
the	O	DET	O
suggestion	O	NOUN	O
that	O	SCONJ	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
gene	O	NOUN	B
encoding	O	VERB	B
for	O	ADP	O
the	O	DET	O
nuclear	B-protein	ADJ	B
autoantigen	I-protein	NOUN	I
La/SS-B	I-protein	NOUN	B
alters	O	VERB	O
in	O	ADP	O
dependence	O	NOUN	O
on	O	ADP	O
disease	O	NOUN	B
conditions	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
study	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
(	I-protein	PUNCT	O
NF	I-protein	NOUN	B
)	I-protein	PUNCT	O
-kappa	I-protein	NOUN	O
B	I-protein	NOUN	O
and	O	CCONJ	O
NF-kappa	B-protein	NOUN	O
B-like	I-protein	ADJ	O
transcription	I-protein	NOUN	O
factors	I-protein	NOUN	O
are	O	AUX	O
activated	O	VERB	B
after	O	ADP	O
cross-linking	O	ADJ	B
CD40	B-protein	NOUN	B
on	O	ADP	O
resting	O	VERB	O
human	B-cell_type	ADJ	B
tonsillar	I-cell_type	NOUN	O
B	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
and	O	CCONJ	O
on	O	ADP	O
B	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
.	O	PUNCT	O


The	O	DET	O
protease	O	NOUN	B
inhibitors	O	NOUN	I
N	O	NOUN	O
alpha-tosylphenylalanyl	O	ADJ	B
chloromethyl	O	NOUN	I
ketone	O	NOUN	I
(	O	PUNCT	O
TPCK	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
N	O	NOUN	B
alpha-tosyl-L-lysine	O	NOUN	I
chloromethyl	O	NOUN	I
ketone	O	NOUN	I
(	O	PUNCT	O
TLCK	O	NOUN	B
)	O	PUNCT	O
block	O	VERB	B
activation	O	NOUN	I
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B/Rel	I-protein	NOUN	B
proteins	I-protein	NOUN	I
by	O	ADP	O
preventing	O	VERB	O
degradation	O	NOUN	B
of	O	ADP	O
I	B-protein	NOUN	O
kappa	I-protein	NOUN	O
B	I-protein	NOUN	O
alpha	I-protein	NOUN	O
.	O	PUNCT	O


Both	O	CCONJ	O
TPCK	O	NOUN	B
and	O	CCONJ	O
TLCK	O	NOUN	B
inhibited	O	VERB	B
LPS	O	NOUN	B
induction	O	NOUN	B
of	O	ADP	O
TF	B-protein	NOUN	B
protein	I-protein	NOUN	I
,	O	PUNCT	O
TF	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
and	O	CCONJ	O
TF	B-protein	NOUN	B
promoter	O	NOUN	B
activity	O	NOUN	I
in	O	ADP	O
a	O	DET	O
dose-dependent	O	ADJ	B
manner	O	NOUN	O
.	O	PUNCT	O


Taken	O	VERB	O
together	O	ADV	O
,	O	PUNCT	O
these	O	DET	O
data	O	NOUN	B
indicated	O	VERB	O
that	O	SCONJ	O
inhibiting	O	VERB	B
nuclear	O	ADJ	B
translocation	O	NOUN	I
of	O	ADP	O
c-Rel/p65	B-protein	NOUN	B
heterodimers	I-protein	NOUN	I
prevented	O	VERB	O
LPS	O	NOUN	B
induction	O	NOUN	B
of	O	ADP	O
TF	B-protein	NOUN	B
gene	O	NOUN	I
transcription	O	NOUN	O
in	O	ADP	O
monocytic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Studies	O	NOUN	B
of	O	ADP	O
these	O	DET	O
females	O	NOUN	B
show	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
XIST	B-DNA	NOUN	B
locus	I-DNA	NOUN	B
on	O	ADP	O
their	O	PRON	O
tiny	B-DNA	ADJ	O
ring	I-DNA	NOUN	O
X	I-DNA	NOUN	O
chromosomes	I-DNA	NOUN	O
is	O	AUX	O
either	O	CCONJ	O
not	O	PART	O
present	O	ADJ	O
or	O	CCONJ	O
not	O	PART	O
expressed	O	VERB	B
.	O	PUNCT	O


Stimulation	O	NOUN	B
of	O	ADP	O
T-cells	B-cell_type	NOUN	B
by	O	ADP	O
agonistic	O	ADJ	B
anti-CD28	B-protein	ADJ	O
antibodies	I-protein	NOUN	O
in	O	ADP	O
conjunction	O	NOUN	B
with	O	ADP	O
phorbol	O	NOUN	B
12-myristate	O	NOUN	I
13-acetate	O	NOUN	I
(	O	PUNCT	O
PMA	O	NOUN	B
)	O	PUNCT	O
-	O	PUNCT	O
or	O	CCONJ	O
TcR	B-protein	NOUN	B
-derived	O	ADJ	O
signals	O	NOUN	B
induces	O	VERB	B
the	O	DET	O
enhanced	O	VERB	B
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
NF-kappa	B-protein	NOUN	I
B	I-protein	NOUN	I
.	O	PUNCT	O


Nef	B-protein	NOUN	B
of	O	ADP	O
primate	O	ADJ	B
lentiviruses	O	NOUN	B
is	O	AUX	O
required	O	VERB	O
for	O	ADP	O
viremia	O	NOUN	B
and	O	CCONJ	O
progression	O	NOUN	B
to	O	PART	O
AIDS	O	NOUN	B
in	O	ADP	O
monkeys	O	NOUN	B
.	O	PUNCT	O


Expressed	O	VERB	B
in	O	ADP	O
the	O	DET	O
cytoplasm	O	NOUN	B
or	O	CCONJ	O
on	O	ADP	O
the	O	DET	O
cell	O	NOUN	B
surface	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
chimera	B-protein	NOUN	B
inhibited	O	VERB	B
or	O	CCONJ	O
activated	O	VERB	B
early	O	ADJ	O
signaling	O	NOUN	O
events	O	NOUN	O
from	O	ADP	O
the	O	DET	O
T	B-protein	NOUN	B
cell	I-protein	NOUN	I
antigen	I-protein	NOUN	I
receptor	I-protein	NOUN	I
.	O	PUNCT	O


Activated	O	VERB	B
Jurkat	B-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
died	O	VERB	B
by	O	ADP	O
apoptosis	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
only	O	ADV	O
cells	O	NOUN	B
with	O	ADP	O
mutated	O	VERB	B
nef	B-DNA	NOUN	I
genes	I-DNA	NOUN	I
expressing	O	VERB	B
truncated	O	VERB	B
Nefs	B-protein	NOUN	I
survived	O	VERB	O
,	O	PUNCT	O
which	O	DET	O
rendered	O	VERB	O
Nef	B-protein	NOUN	B
nonfunctional	O	ADJ	B
.	O	PUNCT	O


Concomitant	O	ADJ	B
with	O	ADP	I
this	O	DET	O
loss	O	NOUN	B
of	O	ADP	O
a	O	DET	O
,	O	PUNCT	O
a	O	DET	O
new	B-protein	ADJ	O
Ets-1-containing	I-protein	ADJ	O
complex	I-protein	NOUN	O
``	O	PUNCT	O
c	B-protein	NOUN	O
``	O	PUNCT	O
appeared	O	VERB	O
.	O	PUNCT	O


The	O	DET	O
TNF	B-protein	NOUN	B
alpha	I-protein	NOUN	I
-activated	O	ADJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
was	O	AUX	O
transcriptionally	O	ADV	B
functional	O	ADJ	O
.	O	PUNCT	O


Full-length	O	ADJ	B
ERP	B-protein	NOUN	B
expresses	O	VERB	B
only	O	ADV	O
negligible	O	ADJ	O
DNA-binding	O	ADJ	B
activity	O	NOUN	I
by	O	ADP	O
itself	O	PRON	O
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
within	O	ADP	O
the	O	DET	O
B-cell	B-cell_type	NOUN	B
lineage	I-cell_type	NOUN	I
,	O	PUNCT	O
ERP	B-protein	NOUN	B
is	O	AUX	O
highly	O	ADV	O
expressed	O	VERB	B
primarily	O	ADV	O
at	O	ADP	O
early	O	ADJ	B
stages	O	NOUN	I
of	O	ADP	O
B-lymphocyte	B-cell_type	NOUN	B
development	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
expression	O	NOUN	B
declines	O	VERB	B
drastically	O	ADV	B
upon	O	SCONJ	O
B-cell	O	NOUN	B
maturation	O	NOUN	B
,	O	PUNCT	O
correlating	O	VERB	B
with	O	ADP	O
the	O	DET	O
enhancer	O	NOUN	B
activity	O	NOUN	I
of	O	ADP	O
the	O	DET	O
IgH	B-DNA	NOUN	B
pi	I-DNA	NOUN	I
site	I-DNA	NOUN	I
.	O	PUNCT	O


Gene	O	NOUN	B
for	O	ADP	O
a	O	DET	O
tissue-specific	B-protein	ADJ	B
transcriptional	I-protein	ADJ	I
activator	I-protein	NOUN	I
(	O	PUNCT	O
EBF	B-protein	NOUN	B
or	O	CCONJ	O
Olf-1	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
expressed	O	VERB	B
in	O	ADP	O
early	B-cell_type	ADJ	O
B	I-cell_type	NOUN	O
lymphocytes	I-cell_type	NOUN	B
,	O	PUNCT	O
adipocytes	B-cell_type	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
olfactory	B-cell_type	ADJ	B
neurons	I-cell_type	NOUN	I
,	O	PUNCT	O
is	O	AUX	O
located	O	ADJ	O
on	O	ADP	O
human	B-DNA	ADJ	B
chromosome	I-DNA	NOUN	I
5	I-DNA	NUM	I
,	O	PUNCT	O
band	B-DNA	NOUN	B
q34	I-DNA	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
proximal	B-DNA	ADJ	B
mouse	I-DNA	NOUN	O
chromosome	I-DNA	NOUN	O
11	I-DNA	NUM	O
.	O	PUNCT	O


Murine	B-cell_type	NOUN	B
B	I-cell_type	NOUN	O
lymphocytes	I-cell_type	NOUN	O
,	O	PUNCT	O
adipocytes	B-cell_type	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
olfactory	B-cell_type	ADJ	B
neurons	I-cell_type	NOUN	B
contain	O	VERB	O
a	O	DET	O
DNA-binding	B-protein	ADJ	B
protein	I-protein	NOUN	I
that	O	PRON	O
participates	O	VERB	B
in	O	ADP	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
genes	B-DNA	NOUN	O
encoding	O	VERB	O
tissue-specific	O	ADJ	B
components	O	NOUN	I
of	O	ADP	O
signal	O	NOUN	B
transduction	O	NOUN	I
.	O	PUNCT	O


Purification	O	NOUN	B
and	O	CCONJ	O
cloning	O	NOUN	B
of	O	ADP	O
this	O	DET	O
protein	O	NOUN	B
,	O	PUNCT	O
termed	O	VERB	O
early	O	ADJ	O
B-cell	B-protein	NOUN	O
factor	I-protein	NOUN	O
(	O	PUNCT	O
EBF	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
from	O	ADP	O
murine	B-cell_type	ADJ	B
B	I-cell_type	NOUN	O
lymphocytes	I-cell_type	NOUN	O
and	O	CCONJ	O
independent	O	ADJ	O
cloning	O	NOUN	B
of	O	ADP	O
a	O	DET	O
protein	O	NOUN	B
,	O	PUNCT	O
termed	O	VERB	O
Olf-1	B-protein	NOUN	B
,	O	PUNCT	O
from	O	ADP	O
olfactory	B-cell_type	ADJ	B
neuronal	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
revealed	O	VERB	O
virtual	O	ADJ	B
complete	O	ADJ	I
amino	O	NOUN	B
acid	O	NOUN	I
sequence	O	NOUN	I
identity	O	NOUN	B
between	O	ADP	O
these	O	DET	O
proteins	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
cotransfection	O	NOUN	B
with	O	ADP	O
a	O	DET	O
combination	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
and	O	CCONJ	O
AP-1	B-protein	NOUN	B
significantly	O	ADV	O
augmented	O	VERB	B
transcription	O	NOUN	B
from	O	ADP	O
the	O	DET	O
GM-CSF	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
containing	O	VERB	O
the	O	DET	O
GM-kappa	B-DNA	NOUN	B
B/GC-box	I-DNA	NOUN	B
and	O	CCONJ	O
the	O	DET	O
CLE0	B-DNA	NOUN	B
(	O	PUNCT	O
AP-1/NF-AT	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Both	O	DET	O
constitutively	O	ADV	B
active	O	ADJ	O
forms	O	NOUN	O
of	O	ADP	O
CN	B-protein	NOUN	B
and	O	CCONJ	O
protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
C	I-protein	NOUN	I
(	O	PUNCT	O
PKC	B-protein	NOUN	B
)	O	PUNCT	O
synergistically	O	ADV	B
activated	O	VERB	B
transcription	O	NOUN	O
from	O	ADP	O
the	O	DET	O
GM-CSF	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
.	O	PUNCT	O


One	O	NUM	O
of	O	ADP	O
the	O	DET	O
nuclear	B-protein	ADJ	B
factors	I-protein	NOUN	I
(	O	PUNCT	O
NFs	B-protein	NOUN	B
)	O	PUNCT	O
that	O	PRON	O
regulates	O	VERB	B
the	O	DET	O
response	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IL-5	B-DNA	NOUN	B
promoter	I-DNA	NOUN	I
to	O	PART	O
cAMP	O	NOUN	B
and	O	CCONJ	O
PMA	O	NOUN	B
has	O	AUX	O
properties	O	NOUN	B
similar	O	ADJ	O
to	O	PART	O
NF	B-protein	NOUN	B
for	O	ADP	O
activated	B-cell_type	VERB	B
t	I-cell_type	NOUN	O
cell	I-cell_type	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
attempted	O	VERB	O
to	O	PART	O
determine	O	VERB	O
whether	O	SCONJ	O
NF	B-protein	NOUN	B
(	I-protein	PUNCT	O
P	I-protein	NOUN	O
)	I-protein	PUNCT	O
,	O	PUNCT	O
a	O	DET	O
nuclear	O	ADJ	B
factor	O	NOUN	I
specific	O	ADJ	B
for	O	ADP	O
the	O	DET	O
P	B-DNA	NOUN	O
sequence	I-DNA	NOUN	B
,	O	PUNCT	O
is	O	AUX	O
related	O	ADJ	O
to	O	PART	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
and	O	CCONJ	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
for	I-protein	ADP	O
activated	I-protein	VERB	B
T	I-protein	NOUN	O
cell	I-protein	NOUN	O
(	O	PUNCT	O
NF-AT	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


J	B-cell_line	NOUN	O
delta	I-cell_line	NOUN	O
K	I-cell_line	NOUN	O
cells	I-cell_line	NOUN	O
were	O	AUX	O
isolated	O	VERB	B
as	O	ADP	O
a	O	DET	O
chronically	B-cell_line	ADV	B
infected	I-cell_line	ADJ	B
survivor	I-cell_line	NOUN	B
cell	I-cell_line	NOUN	B
line	I-cell_line	NOUN	I
,	O	PUNCT	O
following	O	VERB	O
infection	O	NOUN	B
of	O	ADP	O
Jurkat	B-cell_line	NOUN	B
CD4+	I-cell_line	ADJ	I
T	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
with	O	ADP	O
dl-NF	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
mutated	O	VERB	B
strain	O	NOUN	I
of	O	ADP	O
human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
type	O	NOUN	I
1	O	NUM	I
(	O	PUNCT	O
HIV-1	O	NOUN	B
)	O	PUNCT	O
containing	O	VERB	O
a	O	DET	O
deletion	O	NOUN	B
of	O	ADP	O
the	O	DET	O
long	B-DNA	ADJ	B
terminal	I-DNA	ADJ	I
repeat	I-DNA	NOUN	I
(	O	PUNCT	I
LTR	B-DNA	NOUN	B
)	O	PUNCT	O
NF-kappa	B-protein	NOUN	O
B	I-protein	NOUN	O
sites	O	NOUN	O
.	O	PUNCT	O


T	B-cell_type	NOUN	B
lymphocyte	I-cell_type	NOUN	I
activation	O	NOUN	I
and	O	CCONJ	O
interleukin-2	B-protein	NOUN	B
(	O	PUNCT	O
IL-2	B-protein	NOUN	B
)	O	PUNCT	O
production	O	NOUN	B
require	O	VERB	O
at	O	ADP	O
least	O	ADJ	O
two	O	NUM	O
signals	O	NOUN	B
,	O	PUNCT	O
generated	O	VERB	O
by	O	ADP	O
phorbol	O	NOUN	B
ester	O	NOUN	I
(	O	PUNCT	O
TPA	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
Ca2+	O	NOUN	B
ionophore	O	NOUN	I
or	O	CCONJ	O
costimulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
T	B-protein	NOUN	B
cell	I-protein	NOUN	I
receptor	I-protein	NOUN	I
(	O	PUNCT	O
TCR	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
CD28	B-protein	NOUN	B
auxiliary	I-protein	NOUN	I
receptor	I-protein	NOUN	I
.	O	PUNCT	O


Hence	O	ADV	O
,	O	PUNCT	O
integration	O	NOUN	B
of	O	ADP	O
signals	O	NOUN	B
that	O	PRON	O
lead	O	VERB	O
to	O	PART	O
T	O	NOUN	B
cell	O	NOUN	I
activation	O	NOUN	B
occurs	O	VERB	O
at	O	ADP	O
the	O	DET	O
level	O	NOUN	B
of	O	ADP	O
JNK	B-protein	NOUN	B
activation	O	NOUN	B
.	O	PUNCT	O


Rat	B-cell_type	NOUN	B
splenocytes	I-cell_type	NOUN	B
were	O	AUX	O
found	O	VERB	O
to	O	PART	O
have	O	AUX	O
greater	O	ADJ	O
sensitivity	O	NOUN	B
to	O	PART	O
MPL	O	NOUN	B
(	O	PUNCT	O
EC50	O	NOUN	B
=	O	ADJ	O
7.9	O	NUM	O
nM	O	NOUN	O
)	O	PUNCT	O
than	O	ADP	O
do	O	AUX	O
human	B-cell_type	ADJ	B
peripheral	I-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
lymphocytes	I-cell_type	NOUN	I
(	O	PUNCT	O
EC50	O	NOUN	B
=	O	ADJ	O
28	O	NUM	O
nM	O	NOUN	O
)	O	PUNCT	O
.	O	PUNCT	O


Only	O	ADV	O
partial	O	ADJ	B
receptor	O	NOUN	I
occupancy	O	NOUN	B
accompanied	O	VERB	O
complete	O	ADJ	O
lymphocyte	O	NOUN	B
suppression	O	NOUN	B
.	O	PUNCT	O


Function	O	NOUN	B
of	O	ADP	O
NF-kappa	B-DNA	NOUN	B
B/Rel	I-DNA	NOUN	B
binding	I-DNA	NOUN	B
sites	I-DNA	NOUN	I
in	O	ADP	O
the	O	DET	O
major	B-DNA	ADJ	B
histocompatibility	I-DNA	NOUN	I
complex	I-DNA	NOUN	I
class	I-DNA	NOUN	I
II	I-DNA	NUM	I
invariant	I-DNA	ADJ	O
chain	I-DNA	NOUN	O
promoter	I-DNA	NOUN	O
is	O	AUX	O
dependent	O	ADJ	O
on	O	ADP	O
cell-specific	O	ADJ	B
binding	O	NOUN	I
of	O	ADP	O
different	O	ADJ	O
NF-kappa	B-protein	NOUN	B
B/Rel	I-protein	NOUN	B
subunits	I-protein	NOUN	I
.	O	PUNCT	O


Electrophoretic	O	ADJ	B
mobility	O	NOUN	I
supershift	O	NOUN	I
assays	O	NOUN	I
determine	O	VERB	O
that	O	SCONJ	O
members	O	NOUN	B
of	O	ADP	O
the	O	DET	O
NF-kappa	B-protein	NOUN	B
B/Rel	I-protein	NOUN	B
family	I-protein	NOUN	B
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
can	O	AUX	O
bind	O	VERB	B
to	O	PART	O
this	O	DET	O
site	O	NOUN	B
in	O	X	B
vitro	O	X	I
and	O	CCONJ	O
that	O	SCONJ	O
DNA-binding	B-protein	ADJ	B
complexes	I-protein	NOUN	O
that	O	PRON	O
contain	O	VERB	O
p50	B-protein	NOUN	B
,	O	PUNCT	O
p52	B-protein	NOUN	B
,	O	PUNCT	O
p65	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
cRel	B-protein	NOUN	B
correlate	O	VERB	O
with	O	ADP	O
positive	O	ADJ	B
regulation	O	NOUN	I
whereas	O	SCONJ	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
p50	B-protein	NOUN	B
correlates	O	VERB	O
with	O	ADP	O
negative	O	ADJ	B
regulation	O	NOUN	I
.	O	PUNCT	O


Demonstration	O	NOUN	B
of	O	ADP	O
replicative	O	ADJ	B
gene	O	NOUN	B
expression	O	NOUN	I
did	O	AUX	O
not	O	PART	O
correlate	O	VERB	B
with	O	ADP	O
either	O	CCONJ	O
low	O	ADJ	B
CD4+	B-protein	ADJ	B
cell	O	NOUN	I
counts	O	NOUN	I
(	O	PUNCT	O
P	O	NOUN	O
>	O	X	O
0.05	O	NUM	O
)	O	PUNCT	O
or	O	CCONJ	O
anti-EBV	O	ADJ	B
antibody	O	NOUN	I
titres	O	NOUN	B
(	O	PUNCT	O
P	O	NOUN	O
>	O	X	O
0.05	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Anti-	O	ADJ	O
ZEBRA	B-protein	NOUN	B
activity	O	NOUN	B
was	O	AUX	O
not	O	PART	O
significantly	O	ADV	O
increased	O	VERB	B
in	O	ADP	O
patients	O	NOUN	B
affected	O	VERB	O
with	O	ADP	O
ARNHL	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
cells	O	NOUN	B
of	O	ADP	O
which	O	DET	O
expressed	O	VERB	B
replicative	O	ADJ	B
gene	O	NOUN	O
products	O	NOUN	O
(	O	PUNCT	O
P	O	NOUN	O
>	O	X	O
0.05	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


CONCLUSION	O	NOUN	B
:	O	PUNCT	O
The	O	DET	O
degree	O	NOUN	B
of	O	ADP	O
immunodeficiency	O	NOUN	B
does	O	AUX	O
not	O	PART	O
clearly	O	ADV	O
enhance	O	VERB	O
replicative	O	ADJ	B
gene	O	NOUN	B
expression	O	NOUN	I
in	O	ADP	O
tumour	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
of	O	ADP	O
ARNHL	O	NOUN	B
.	O	PUNCT	O


EBV	O	NOUN	B
serology	O	NOUN	B
,	O	PUNCT	O
including	O	VERB	O
anti-	O	NOUN	O
ZEBRA	B-protein	NOUN	B
activity	O	NOUN	B
,	O	PUNCT	O
is	O	AUX	O
not	O	PART	O
a	O	DET	O
reliable	O	ADJ	O
tool	O	NOUN	O
for	O	ADP	O
predicting	O	VERB	B
the	O	DET	O
occurrence	O	NOUN	B
of	O	ADP	O
such	O	ADJ	O
proliferations	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
a	O	DET	O
mobility	O	NOUN	B
shift	O	NOUN	I
assay	O	NOUN	I
,	O	PUNCT	O
only	O	ADV	O
the	O	DET	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
(	I-protein	PUNCT	O
p50/p50	I-protein	NOUN	B
)	I-protein	PUNCT	O
homodimer	I-protein	NOUN	B
was	O	AUX	O
observed	O	VERB	O
in	O	ADP	O
a	O	DET	O
complex	O	NOUN	B
formed	O	VERB	O
with	O	ADP	O
the	O	DET	O
kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
sequence	I-DNA	NOUN	I
in	O	ADP	O
unstimulated	O	ADJ	B
SP-B21	O	NOUN	B
cells	O	NOUN	I
.	O	PUNCT	O


Since	O	SCONJ	O
these	O	DET	O
findings	O	NOUN	B
supported	O	VERB	O
the	O	DET	O
involvement	O	NOUN	B
of	O	ADP	O
serine/threonine	O	NOUN	B
protein	O	NOUN	I
phosphorylation	O	NOUN	B
in	O	ADP	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
EGR-1	B-DNA	NOUN	B
expression	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
studied	O	VERB	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
40S	B-protein	ADJ	B
ribosomal	I-protein	ADJ	I
protein	I-protein	NOUN	I
S6	I-protein	NOUN	I
serine/threonine	I-protein	NOUN	B
kinases	I-protein	NOUN	I
,	O	PUNCT	O
pp70S6K	B-protein	NOUN	B
and	O	CCONJ	O
pp90rsk	B-protein	NOUN	B
.	O	PUNCT	O


Moreover	O	ADV	O
,	O	PUNCT	O
rapamycin	O	NOUN	B
,	O	PUNCT	O
an	O	DET	O
inhibitor	O	NOUN	B
of	O	ADP	O
pp70S6K	B-protein	NOUN	B
activation	O	NOUN	B
,	O	PUNCT	O
had	O	AUX	O
no	O	DET	B
effect	O	NOUN	I
on	O	ADP	O
induction	O	NOUN	B
of	O	ADP	O
EGR-1	B-DNA	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
analysis	O	NOUN	B
of	O	ADP	O
pp90rsk	B-protein	NOUN	B
activity	O	NOUN	B
by	O	ADP	O
phosphorylation	O	NOUN	B
of	O	ADP	O
a	O	DET	O
peptide	O	NOUN	B
derived	O	VERB	O
from	O	ADP	O
S6	B-protein	NOUN	B
protein	I-protein	NOUN	I
demonstrated	O	VERB	O
stimulation	O	NOUN	B
of	O	ADP	O
this	O	DET	O
kinase	B-protein	NOUN	B
in	O	ADP	O
TPA-treated	B-cell_line	ADJ	B
U-937	I-cell_line	NOUN	B
,	I-cell_line	PUNCT	O
and	I-cell_line	CCONJ	O
not	I-cell_line	PART	O
TUR	I-cell_line	NOUN	B
,	I-cell_line	PUNCT	O
cells	I-cell_line	NOUN	B
.	O	PUNCT	O


Okadaic	O	ADJ	B
acid	O	NOUN	I
treatment	O	NOUN	B
of	O	ADP	O
both	O	DET	O
cell	O	NOUN	B
types	O	NOUN	I
was	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
activation	O	NOUN	B
of	O	ADP	O
pp90rsk	B-protein	NOUN	B
.	O	PUNCT	O


Gel-shift	O	ADJ	B
analysis	O	NOUN	I
in	O	ADP	O
HUVECs	B-cell_line	NOUN	B
demonstrated	O	VERB	O
that	O	SCONJ	O
PDTC	O	NOUN	B
prevented	O	VERB	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
mobilization	O	NOUN	B
by	O	ADP	O
TNF	B-protein	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
only	O	ADV	O
VCAM-1	B-protein	NOUN	B
induction	O	NOUN	B
was	O	AUX	O
controlled	O	VERB	B
by	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
.	O	PUNCT	O


Inhibition	O	NOUN	B
by	O	ADP	O
anti-VCAM-1	B-protein	ADJ	B
monoclonal	I-protein	ADJ	B
antibody	I-protein	NOUN	I
1G11	B-protein	NOUN	O
indicated	O	VERB	O
that	O	SCONJ	O
U937	B-cell_line	NOUN	B
adhesion	O	NOUN	I
was	O	AUX	O
VCAM-1	B-protein	NOUN	B
dependent	O	ADJ	B
and	O	CCONJ	O
suppression	O	NOUN	B
by	O	ADP	O
antioxidants	O	NOUN	B
was	O	AUX	O
due	O	ADJ	O
to	O	PART	O
reduced	O	VERB	B
VCAM-1	B-protein	NOUN	B
induction	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
inhibition	O	NOUN	B
prevented	O	VERB	B
the	O	DET	O
degradation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
inhibitor	I-protein	NOUN	I
,	O	PUNCT	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
therefore	O	ADV	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
was	O	AUX	O
retained	O	VERB	O
in	O	ADP	O
the	O	DET	O
cytosol	O	NOUN	B
.	O	PUNCT	O


Sodium	O	NOUN	B
salicylate	O	NOUN	I
and	O	CCONJ	O
aspirin	O	NOUN	B
also	O	ADV	O
inhibited	O	VERB	B
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
-dependent	O	ADJ	O
transcription	O	NOUN	B
from	O	ADP	O
the	O	DET	O
Ig	B-DNA	NOUN	B
kappa	I-DNA	NOUN	I
enhancer	I-DNA	NOUN	I
and	O	CCONJ	O
the	O	DET	O
human	B-DNA	ADJ	B
immunodeficiency	I-DNA	NOUN	I
virus	I-DNA	NOUN	I
(	I-DNA	PUNCT	O
HIV	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
long	I-DNA	ADJ	B
terminal	I-DNA	ADJ	I
repeat	I-DNA	NOUN	I
(	O	PUNCT	I
LTR	B-DNA	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
transfected	B-cell_line	VERB	B
T	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Effects	O	NOUN	B
of	O	ADP	I
the	O	DET	O
antisense	O	ADJ	B
myb	O	NOUN	I
expression	O	NOUN	B
on	O	ADP	O
hemin-	O	NOUN	B
and	O	CCONJ	O
erythropoietin-	O	NOUN	O
induced	O	VERB	B
erythroid	O	ADJ	B
differentiation	O	NOUN	O
of	O	ADP	O
K562	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


The	O	DET	O
amount	O	NOUN	B
of	O	ADP	O
c-myb	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
in	O	ADP	O
K562	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
was	O	AUX	O
reduced	O	VERB	B
during	O	ADP	O
the	O	DET	O
differentiation	O	NOUN	B
induced	O	VERB	B
by	O	ADP	O
Epo	B-protein	NOUN	B
.	O	PUNCT	O


Prenatal	O	ADJ	B
immune	O	ADJ	I
challenge	O	NOUN	O
alters	O	VERB	O
the	O	DET	O
hypothalamic-pituitary-adrenocortical	O	ADJ	B
axis	O	NOUN	B
in	O	ADP	O
adult	O	ADJ	B
rats	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
present	O	ADJ	O
paper	O	NOUN	O
studies	O	VERB	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
NM23.H1	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
in	O	ADP	O
cell	B-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
which	O	DET	O
derive	O	VERB	O
from	O	ADP	O
primary	O	ADJ	B
or	O	CCONJ	O
metastatic	O	ADJ	B
human	O	ADJ	B
malignant	O	ADJ	B
melanomas	O	NOUN	I
in	O	ADP	O
relation	O	NOUN	O
to	O	PART	O
staging	O	NOUN	B
,	O	PUNCT	O
infiltration	O	NOUN	B
degree	O	NOUN	B
,	O	PUNCT	O
lymphocytic	O	ADJ	B
infiltration	O	NOUN	I
,	O	PUNCT	O
cell	O	NOUN	B
morphology	O	NOUN	I
,	O	PUNCT	O
cell	O	NOUN	B
pigmentation	O	NOUN	I
,	O	PUNCT	O
karyotype	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
disease-free	O	ADJ	B
survival	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
gC2-	B-cell_line	NOUN	B
and	I-cell_line	CCONJ	O
gD2-specific	I-cell_line	ADJ	B
CD4+	I-cell_line	ADJ	B
clones	I-cell_line	NOUN	I
had	O	AUX	O
cytotoxic	O	ADJ	B
activity	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
approximate	O	ADJ	B
locations	O	NOUN	B
of	O	ADP	O
the	O	DET	O
HSV-2	O	NOUN	B
genes	O	NOUN	I
encoding	O	VERB	B
HSV-2	O	NOUN	B
type-specific	O	ADJ	O
CD4+	B-protein	ADJ	B
antigens	I-protein	NOUN	I
have	O	AUX	O
been	O	AUX	O
determined	O	VERB	O
by	O	ADP	O
using	O	VERB	O
HSV-1	O	NOUN	B
x	O	NOUN	O
HSV-2	O	NOUN	B
intertypic	O	ADJ	B
recombinant	O	ADJ	I
virus	O	NOUN	I
and	O	CCONJ	O
include	O	VERB	O
the	O	DET	O
approximate	O	ADJ	B
map	O	NOUN	B
regions	O	NOUN	I
0.30	O	NUM	O
to	O	PART	O
0.46	O	NUM	O
,	O	PUNCT	O
0.59	O	NUM	O
to	O	PART	O
0.67	O	NUM	O
,	O	PUNCT	O
0.67	O	NUM	O
to	O	PART	O
0.73	O	NUM	O
,	O	PUNCT	O
and	O	CCONJ	O
0.82	O	NUM	O
to	O	PART	O
1.0	O	NUM	O
units	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
antigenic	O	ADJ	B
specificity	O	NOUN	B
of	O	ADP	O
an	O	DET	O
HLA	B-cell_line	NOUN	B
DQ2-restricted	I-cell_line	ADJ	I
,	I-cell_line	PUNCT	O
HSV-2	I-cell_line	NOUN	B
type-specific	I-cell_line	ADJ	O
T-cell	I-cell_line	NOUN	O
clone	I-cell_line	NOUN	O
was	O	AUX	O
mapped	O	VERB	O
to	O	PART	O
amino	B-protein	NOUN	B
acids	I-protein	NOUN	I
425	I-protein	NUM	O
to	I-protein	PART	O
444	I-protein	NUM	O
of	O	ADP	O
VP16	B-protein	NOUN	B
of	O	ADP	O
HSV-2	O	NOUN	B
by	O	ADP	O
sequential	O	ADJ	B
use	O	NOUN	O
of	O	ADP	O
an	O	DET	O
intertypic	O	ADJ	B
recombinant	O	ADJ	I
virus	O	NOUN	I
containing	O	VERB	O
VP16	B-protein	NOUN	B
of	O	ADP	O
HSV-2	O	NOUN	B
in	O	ADP	O
an	O	DET	O
HSV-1	O	NOUN	B
background	O	NOUN	B
,	O	PUNCT	O
recombinant	B-protein	ADJ	B
VP16	I-protein	NOUN	O
fusion	I-protein	NOUN	B
proteins	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
synthetic	O	ADJ	B
peptides	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
findings	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
basophils	B-cell_type	NOUN	B
which	O	DET	O
appeared	O	VERB	O
during	O	ADP	O
the	O	DET	O
ATRA	O	NOUN	B
treatment	O	NOUN	B
are	O	AUX	O
reactive	O	ADJ	B
in	O	ADP	O
nature	O	NOUN	O
rather	O	ADV	O
than	O	ADP	O
a	O	DET	O
leukaemic	B-cell_line	ADJ	B
clone	I-cell_line	NOUN	I
.	O	PUNCT	O


The	O	DET	O
host	O	NOUN	B
response	O	NOUN	I
to	O	PART	O
Mycobacterium	O	X	B
tuberculosis	O	NOUN	I
includes	O	VERB	O
granuloma	O	NOUN	B
formation	O	NOUN	I
at	O	ADP	O
sites	O	NOUN	B
of	O	ADP	O
infection	O	NOUN	B
and	O	CCONJ	O
systemic	O	ADJ	B
symptoms	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
demonstrated	O	VERB	O
that	O	SCONJ	O
lipoarabinomannan	B-protein	NOUN	B
(	O	PUNCT	O
LAM	B-protein	NOUN	B
)	O	PUNCT	O
from	O	ADP	O
the	O	DET	O
mycobacterial	O	ADJ	B
cell	O	NOUN	B
wall	O	NOUN	I
,	O	PUNCT	O
which	O	DET	O
was	O	AUX	O
virtually	O	ADV	O
devoid	O	ADJ	O
of	O	ADP	O
lipopolysaccharide	O	NOUN	B
(	O	PUNCT	O
LPS	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
stimulated	O	VERB	B
mononuclear	B-cell_type	ADJ	B
phagocytes	I-cell_type	NOUN	B
to	O	PART	O
release	O	VERB	O
IL-6	B-protein	NOUN	B
in	O	ADP	O
a	O	DET	O
dose-response	O	ADJ	B
manner	O	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
conclude	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
NF-IL6	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
NF-kappa	I-DNA	NOUN	B
B	I-DNA	NOUN	I
sites	I-DNA	NOUN	I
mediate	O	VERB	O
IL-6	B-protein	NOUN	B
induction	O	NOUN	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
both	O	CCONJ	O
LPS	O	NOUN	B
and	O	CCONJ	O
LAM	B-protein	NOUN	B
,	O	PUNCT	O
acting	O	VERB	O
as	O	ADP	O
bacterial	B-DNA	ADJ	B
or	I-DNA	CCONJ	O
mycobacterial	I-DNA	ADJ	B
response	I-DNA	NOUN	B
elements	I-DNA	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
recently	O	ADV	O
cloned	O	VERB	B
the	O	DET	O
CD14	B-DNA	NOUN	B
5	I-DNA	NUM	I
'	I-DNA	PART	O
upstream	I-DNA	ADJ	B
sequence	I-DNA	NOUN	I
and	O	CCONJ	O
demonstrated	O	VERB	O
its	O	PRON	O
tissue-specific	B-DNA	ADJ	B
promoter	I-DNA	NOUN	O
activity	O	NOUN	O
.	O	PUNCT	O


Using	O	VERB	O
stable	O	ADJ	B
transfection	O	NOUN	B
of	O	ADP	O
the	O	DET	O
monocytoid	B-cell_line	NOUN	B
U937	I-cell_line	NOUN	I
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
with	O	ADP	O
a	O	DET	O
series	O	NOUN	O
of	O	ADP	O
deletion	O	NOUN	B
mutants	O	NOUN	I
of	O	ADP	O
the	O	DET	O
CD14	B-DNA	NOUN	B
5	I-DNA	NUM	I
'	I-DNA	PART	O
upstream	I-DNA	ADJ	B
sequence	I-DNA	NOUN	I
coupled	O	VERB	O
to	O	PART	O
a	O	DET	O
reporter	O	NOUN	B
gene	O	NOUN	I
construct	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
bp	B-DNA	NOUN	B
-128	I-DNA	NUM	O
to	I-DNA	PART	O
-70	I-DNA	NUM	O
is	O	AUX	O
the	O	DET	O
critical	O	ADJ	B
region	O	NOUN	I
for	O	ADP	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
CD14	B-protein	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


DNA-binding	O	ADJ	B
and	O	CCONJ	O
transcriptional	O	ADJ	B
regulatory	O	ADJ	O
properties	O	NOUN	O
of	O	ADP	O
hepatic	B-protein	ADJ	B
leukemia	I-protein	NOUN	I
factor	I-protein	NOUN	I
(	O	PUNCT	O
HLF	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
t	O	NOUN	O
(	O	PUNCT	O
17	O	NUM	O
;	O	PUNCT	O
19	O	NUM	O
)	O	PUNCT	O
acute	B-protein	ADJ	B
lymphoblastic	I-protein	ADJ	I
leukemia	I-protein	NOUN	I
chimera	I-protein	NOUN	B
E2A-HLF	I-protein	NOUN	B
.	O	PUNCT	O


An	O	DET	O
in	O	X	B
vitro	O	X	I
binding	O	NOUN	B
site	O	NOUN	I
selection	O	NOUN	B
procedure	O	NOUN	I
was	O	AUX	O
used	O	VERB	O
to	O	PART	O
determine	O	VERB	O
DNA	O	NOUN	B
sequences	O	NOUN	I
preferentially	O	ADV	O
bound	O	VERB	O
by	O	ADP	O
wild-type	B-protein	ADJ	B
HLF	I-protein	NOUN	B
and	O	CCONJ	O
chimeric	B-protein	ADJ	B
E2A-HLF	I-protein	NOUN	B
proteins	O	NOUN	I
isolated	O	VERB	B
from	O	ADP	O
various	O	ADJ	O
t	B-cell_line	NOUN	O
(	I-cell_line	PUNCT	O
17	I-cell_line	NUM	O
;	I-cell_line	PUNCT	O
19	I-cell_line	NUM	O
)	I-cell_line	PUNCT	O
-bearing	I-cell_line	ADJ	O
leukemias	I-cell_line	NOUN	B
.	O	PUNCT	O


All	O	DET	O
were	O	AUX	O
found	O	VERB	O
to	O	PART	O
selectively	O	ADV	O
bind	O	VERB	B
the	O	DET	O
consensus	B-DNA	NOUN	B
sequence	I-DNA	NOUN	I
5'-GTTACGTAAT-3	O	NOUN	O
'	O	PUNCT	O
with	O	ADP	O
high	O	ADJ	O
affinity	O	NOUN	B
.	O	PUNCT	O


Lipopolysaccharide	O	NOUN	B
induction	O	NOUN	B
of	O	ADP	O
tissue	B-DNA	NOUN	B
factor	I-DNA	NOUN	I
gene	I-DNA	NOUN	B
expression	O	NOUN	I
in	O	ADP	O
monocytic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
is	O	AUX	O
mediated	O	VERB	O
by	O	ADP	O
binding	O	NOUN	B
of	O	ADP	O
c-Rel/p65	B-protein	NOUN	B
heterodimers	I-protein	NOUN	B
to	O	PART	O
a	O	DET	O
kappa	B-DNA	NOUN	O
B-like	I-DNA	ADJ	B
site	I-DNA	NOUN	I
.	O	PUNCT	O


Tenascin	B-protein	NOUN	B
(	O	PUNCT	O
TN	B-protein	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
an	O	DET	O
extracellular	B-protein	ADJ	B
matrix	I-protein	NOUN	I
protein	I-protein	NOUN	I
that	O	PRON	O
is	O	AUX	O
expressed	O	VERB	B
widely	O	ADV	O
in	O	ADP	O
the	O	DET	O
fetus	O	NOUN	B
and	O	CCONJ	O
sparingly	O	ADV	B
in	O	ADP	O
the	O	DET	O
adult	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
reappears	O	VERB	O
at	O	ADP	O
high	O	ADJ	O
levels	O	NOUN	B
in	O	ADP	O
certain	O	ADJ	O
areas	O	NOUN	O
of	O	ADP	O
tissue	O	NOUN	B
insult	O	NOUN	I
such	O	ADJ	O
as	O	ADP	O
tumor	O	NOUN	B
matrices	O	NOUN	I
and	O	CCONJ	O
sites	O	NOUN	B
of	O	ADP	O
wound	O	NOUN	B
healing	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
show	O	VERB	O
here	O	ADV	O
that	O	SCONJ	O
soluble	O	ADJ	B
TN	B-protein	NOUN	B
inhibits	O	VERB	B
proliferation	O	NOUN	B
of	O	ADP	O
human	B-cell_type	ADJ	B
T	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
in	O	ADP	O
response	O	NOUN	O
to	O	PART	O
alpha	B-protein	NOUN	B
CD3	I-protein	NOUN	I
Ab	I-protein	NOUN	I
co-immobilized	O	VERB	B
with	O	ADP	O
the	O	DET	O
extracellular	B-protein	ADJ	B
matrix	I-protein	NOUN	I
protein	I-protein	NOUN	I
fibronectin	B-protein	NOUN	I
(	O	PUNCT	O
FN	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Recent	O	ADJ	O
findings	O	NOUN	B
suggest	O	VERB	O
an	O	DET	O
involvement	O	NOUN	B
of	O	ADP	O
reactive	O	ADJ	B
oxygen	O	NOUN	I
species	O	NOUN	I
in	O	ADP	O
the	O	DET	O
pathway	O	NOUN	B
of	O	ADP	O
TPA	O	NOUN	B
and	O	CCONJ	O
protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
C	I-protein	NOUN	I
leading	O	VERB	O
to	O	PART	O
expression	O	NOUN	B
of	O	ADP	O
c-fos	B-RNA	NOUN	B
and	I-RNA	CCONJ	O
c-jun	I-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
tested	O	VERB	B
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	O
BHA	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
phenolic	O	ADJ	B
,	O	PUNCT	O
lipid-soluble	O	ADJ	B
,	O	PUNCT	O
chain-breaking	O	ADJ	B
antioxidant	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
NAC	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
known	O	ADJ	O
glutathione	O	NOUN	B
precursor	O	NOUN	B
with	O	ADP	O
some	O	DET	O
direct	O	ADJ	O
free-radical	O	ADJ	B
scavenging	O	NOUN	O
properties	O	NOUN	O
as	O	ADV	O
well	O	ADV	O
,	O	PUNCT	O
on	O	ADP	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
HIV-1	O	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
latently	O	ADV	B
infected	O	ADJ	I
U1	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
and	O	CCONJ	O
in	O	ADP	O
productively	O	ADV	B
and	O	CCONJ	O
chronically	O	ADV	B
infected	O	ADJ	B
U937	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


This	O	DET	O
allows	O	VERB	O
us	O	PRON	O
to	O	PART	O
characterize	O	VERB	O
these	O	DET	O
two	O	NUM	O
granule	O	NOUN	B
populations	O	NOUN	B
with	O	ADP	O
regard	O	NOUN	O
to	O	PART	O
their	O	PRON	O
content	O	NOUN	B
of	O	ADP	O
membrane	B-protein	NOUN	B
proteins	I-protein	NOUN	I
,	O	PUNCT	O
which	O	DET	O
become	O	VERB	O
incorporated	O	VERB	O
into	O	ADP	O
the	O	DET	O
plasma	O	NOUN	B
membrane	O	NOUN	I
during	O	ADP	O
exocytosis	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
found	O	VERB	O
that	O	SCONJ	O
gelatinase	O	NOUN	B
granules	O	NOUN	I
,	O	PUNCT	O
defined	O	VERB	O
as	O	ADP	O
peroxidase-negative	O	ADJ	B
granules	O	NOUN	I
containing	O	VERB	O
gelatinase	B-protein	NOUN	B
but	O	CCONJ	O
lacking	O	VERB	O
lactoferrin	B-protein	NOUN	B
,	O	PUNCT	O
contain	O	VERB	O
50	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
total	O	ADJ	B
cell	O	NOUN	I
gelatinase	B-protein	NOUN	I
,	O	PUNCT	O
with	O	ADP	O
the	O	DET	O
remaining	O	NOUN	O
residing	O	VERB	O
in	O	ADP	O
specific	O	ADJ	O
granules	O	NOUN	B
.	O	PUNCT	O


Although	O	SCONJ	O
no	O	DET	O
qualitative	O	ADJ	B
difference	O	NOUN	O
was	O	AUX	O
observed	O	VERB	O
between	O	ADP	O
specific	O	ADJ	O
granules	O	NOUN	B
and	O	CCONJ	O
gelatinase	B-protein	NOUN	B
granules	O	NOUN	I
with	O	ADP	O
respect	O	NOUN	O
to	O	PART	O
cytochrome	B-protein	NOUN	B
b558	I-protein	NOUN	I
and	O	CCONJ	O
Mac-1	B-protein	NOUN	B
,	O	PUNCT	O
stimulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
neutrophil	B-cell_type	NOUN	B
with	O	ADP	O
FMLP	B-protein	NOUN	B
resulted	O	VERB	O
in	O	ADP	O
a	O	DET	O
selective	O	ADJ	O
mobilization	O	NOUN	B
of	O	ADP	O
the	O	DET	O
least	O	ADJ	O
dense	O	ADJ	O
peroxidase-negative	O	ADJ	B
granules	O	NOUN	I
,	O	PUNCT	O
ie	O	X	O
,	O	PUNCT	O
gelatinase	B-protein	NOUN	B
granules	O	NOUN	I
,	O	PUNCT	O
which	O	DET	O
,	O	PUNCT	O
in	O	ADP	O
concert	O	NOUN	O
with	O	ADP	O
secretory	O	ADJ	B
vesicles	O	NOUN	I
,	O	PUNCT	O
furnish	O	VERB	O
the	O	DET	O
plasma	O	NOUN	B
membrane	O	NOUN	I
with	O	ADP	O
Mac-1	B-protein	NOUN	B
and	O	CCONJ	O
cytochrome	B-protein	NOUN	B
b558	I-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
interleukin-2	B-protein	NOUN	B
receptor	I-protein	NOUN	I
alpha	I-protein	NOUN	I
chain	I-protein	NOUN	I
(	O	PUNCT	O
IL-2R	B-protein	NOUN	O
alpha	I-protein	NOUN	O
)	O	PUNCT	O
expression	O	NOUN	B
and	O	CCONJ	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
(	O	PUNCT	O
NF	O	NOUN	B
)	O	PUNCT	O
activation	O	NOUN	B
by	O	ADP	O
protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
C	I-protein	NOUN	I
(	O	PUNCT	O
PKC	B-protein	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
resting	B-cell_type	VERB	B
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
has	O	AUX	O
been	O	AUX	O
studied	O	VERB	O
.	O	PUNCT	O


Binding	O	NOUN	B
of	O	ADP	O
superantigens	O	NOUN	B
to	O	PART	O
MHC	B-protein	NOUN	B
class	I-protein	NOUN	I
II	I-protein	NUM	I
molecules	I-protein	NOUN	I
results	O	VERB	B
in	O	ADP	O
transduction	O	NOUN	B
of	O	ADP	O
biochemical	O	ADJ	B
signals	O	NOUN	B
leading	O	VERB	O
to	O	PART	O
cellular	O	ADJ	B
activation	O	NOUN	I
and	O	CCONJ	O
gene	O	NOUN	B
expression	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
staphylococcal	B-protein	ADJ	B
superantigens	I-protein	NOUN	B
toxic	B-protein	ADJ	O
shock	I-protein	NOUN	O
syndrome	I-protein	NOUN	O
toxin-1	I-protein	NOUN	B
(	O	PUNCT	O
TSST-1	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
staphylococcal	B-protein	ADJ	B
enterotoxin	I-protein	NOUN	I
A	I-protein	NOUN	I
(	O	PUNCT	O
SEA	B-protein	NOUN	B
)	O	PUNCT	O
activate	O	VERB	B
HIV-1-LTR	B-DNA	NOUN	B
-driven	O	ADJ	O
transcription	O	NOUN	B
of	O	ADP	O
chloramphenicol	B-protein	NOUN	B
acetyl	I-protein	ADJ	I
transferase	I-protein	NOUN	I
in	O	ADP	O
the	O	DET	O
human	B-cell_line	ADJ	B
monocytic	I-cell_line	ADJ	I
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
THP-1	B-cell_line	NOUN	B
.	O	PUNCT	O


Induction	O	NOUN	B
of	O	ADP	O
HIV-1-	O	ADJ	B
LTR	B-DNA	NOUN	B
-driven	O	ADJ	O
transcription	O	NOUN	B
in	O	ADP	O
THP-1	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
by	O	ADP	O
superantigens	B-protein	NOUN	B
was	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
nuclear	B-protein	ADJ	B
factor-kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
DNA-binding	O	ADJ	B
activity	O	NOUN	O
.	O	PUNCT	O


By	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
many	O	ADJ	O
studies	O	NOUN	B
have	O	AUX	O
reported	O	VERB	O
that	O	SCONJ	O
mitogen	B-protein	NOUN	B
activation	O	NOUN	B
of	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
increases	O	VERB	B
cAMP	O	NOUN	B
levels	O	NOUN	O
,	O	PUNCT	O
implying	O	VERB	O
a	O	DET	O
positive	O	ADJ	B
physiological	O	ADJ	B
role	O	NOUN	O
for	O	ADP	O
cAMP	O	NOUN	B
in	O	ADP	O
the	O	DET	O
activation	O	NOUN	B
process	O	NOUN	I
.	O	PUNCT	O


Protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
C	I-protein	NOUN	I
(	O	PUNCT	O
PKC	B-protein	NOUN	B
)	O	PUNCT	O
does	O	AUX	O
not	O	PART	O
appear	O	VERB	O
to	O	PART	O
play	O	VERB	O
a	O	DET	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
alpha-tcp	O	NOUN	B
effect	O	NOUN	B
since	O	SCONJ	O
no	O	DET	O
suppression	O	NOUN	B
of	O	ADP	O
phosphorylation	O	NOUN	B
of	O	ADP	O
PKC	B-protein	NOUN	B
substrates	O	NOUN	B
was	O	AUX	O
observed	O	VERB	O
.	O	PUNCT	O


Electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assays	O	NOUN	I
failed	O	VERB	B
to	O	PART	O
show	O	VERB	O
an	O	DET	O
alpha-tcp-induced	O	ADJ	O
decrease	O	NOUN	B
in	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
this	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
after	O	ADP	O
cytokine	B-protein	NOUN	B
stimulation	O	NOUN	I
.	O	PUNCT	O


Tat	B-protein	NOUN	B
transactivation	O	NOUN	B
mediated	O	VERB	O
by	O	ADP	O
the	O	DET	O
kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
domain	I-DNA	NOUN	I
is	O	AUX	O
sufficient	O	ADJ	O
to	O	PART	O
allow	O	VERB	O
replication	O	NOUN	B
of	O	ADP	O
TAR	B-DNA	NOUN	B
-deleted	O	ADJ	O
mutant	O	ADJ	B
HIV-1	O	NOUN	B
in	O	ADP	O
astrocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


The	O	DET	O
novel	O	ADJ	O
astrocyte-derived	O	ADJ	B
kappa	O	NOUN	I
B-binding	O	ADJ	I
activity	O	NOUN	O
is	O	AUX	O
retained	O	VERB	O
on	O	ADP	O
an	O	DET	O
HIV-1	O	NOUN	B
Tat	B-protein	NOUN	B
affinity	O	NOUN	B
column	O	NOUN	I
,	O	PUNCT	O
while	O	SCONJ	O
prototypical	O	ADJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
from	O	ADP	O
Jurkat	B-cell_line	NOUN	B
T	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
is	O	AUX	O
not	O	PART	O
.	O	PUNCT	O


Comparison	O	NOUN	B
of	O	ADP	O
retinoic	O	ADJ	B
acid	O	NOUN	I
and	O	CCONJ	O
phorbol	O	NOUN	B
myristate	O	NOUN	B
acetate	O	NOUN	I
as	O	ADP	O
inducers	O	NOUN	B
of	O	ADP	O
monocytic	O	ADJ	B
differentiation	O	NOUN	I
.	O	PUNCT	O


Expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
beta	B-DNA	NOUN	B
2-integrin	I-DNA	ADJ	I
genes	I-DNA	NOUN	I
,	O	PUNCT	O
CD11a	B-DNA	NOUN	B
and	O	CCONJ	O
CD11b	B-DNA	NOUN	B
,	O	PUNCT	O
was	O	AUX	O
clearly	O	ADV	O
increased	O	VERB	B
after	O	ADP	O
both	O	DET	O
of	O	ADP	O
these	O	DET	O
treatments	O	NOUN	B
.	O	PUNCT	O


Their	O	PRON	O
effects	O	NOUN	B
on	O	ADP	O
the	O	DET	O
src-family	B-DNA	NOUN	B
tyrosine	I-DNA	NOUN	I
kinase	I-DNA	NOUN	I
genes	I-DNA	NOUN	I
were	O	AUX	O
different	O	ADJ	O
:	O	PUNCT	O
hck	B-DNA	NOUN	B
expression	O	NOUN	B
was	O	AUX	O
similarly	O	ADV	O
induced	O	VERB	B
by	O	ADP	O
these	O	DET	O
agents	O	NOUN	B
but	O	CCONJ	O
lyn	O	NOUN	B
expression	O	NOUN	B
was	O	AUX	O
stronger	O	ADJ	B
and	O	CCONJ	O
more	O	ADV	O
rapid	O	ADJ	O
after	O	ADP	O
RA	O	NOUN	B
treatment	O	NOUN	B
.	O	PUNCT	O


As	O	ADP	O
documented	O	VERB	B
in	O	ADP	O
the	O	DET	O
accompanying	O	VERB	O
paper	O	NOUN	O
(	O	PUNCT	O
Klug	O	NOUN	O
et	O	X	O
al.	O	X	O
,	O	PUNCT	O
this	O	DET	O
issue	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
an	O	DET	O
active	O	ADJ	B
v-abl	B-protein	ADJ	B
protein	I-protein	NOUN	I
also	O	ADV	O
suppresses	O	VERB	B
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B/rel	I-protein	NOUN	I
and	O	CCONJ	O
expression	O	NOUN	B
controlled	O	VERB	I
by	O	ADP	O
the	O	DET	O
kappa	B-DNA	NOUN	B
intron	I-DNA	NOUN	I
enhancer	I-DNA	NOUN	I
.	O	PUNCT	O


The	O	DET	O
immunosuppressant	O	ADJ	B
drug	O	NOUN	O
cyclosporin	O	NOUN	B
A	O	NOUN	O
blocks	O	VERB	B
a	O	DET	O
calcium-dependent	O	ADJ	B
signal	O	NOUN	B
from	O	ADP	O
the	O	DET	O
T-cell	B-protein	NOUN	B
receptor	I-protein	NOUN	I
(	O	PUNCT	O
TCR	B-protein	NOUN	B
)	O	PUNCT	O
that	O	PRON	O
normally	O	ADV	O
leads	O	VERB	O
to	O	PART	O
T-cell	O	NOUN	B
activation	O	NOUN	I
.	O	PUNCT	O


Peripheral	O	ADJ	B
blood	O	NOUN	I
mononuclear	O	ADJ	I
cells	O	NOUN	I
from	O	ADP	O
seventeen	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
primary	O	ADJ	B
myelodysplastic	O	ADJ	I
syndromes	O	NOUN	I
(	O	PUNCT	O
MDS	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
advanced	O	ADJ	B
stage	O	NOUN	I
were	O	AUX	O
enriched	O	VERB	O
for	O	ADP	O
blasts	B-cell_type	NOUN	B
and	O	CCONJ	O
tested	O	VERB	B
for	O	ADP	O
(	O	PUNCT	O
1	O	NUM	O
)	O	PUNCT	O
karyotype	O	NOUN	B
,	O	PUNCT	O
(	O	PUNCT	O
2	O	X	O
)	O	PUNCT	O
genomic	O	ADJ	B
configuration	O	NOUN	I
and	O	CCONJ	O
(	O	PUNCT	O
3	O	X	O
)	O	PUNCT	O
expression	O	NOUN	B
of	O	ADP	O
IL-3	B-DNA	NOUN	B
,	I-DNA	PUNCT	O
GM-CSF	I-DNA	NOUN	B
,	I-DNA	PUNCT	O
FMS	I-DNA	NOUN	B
and	I-DNA	CCONJ	O
EGR-1	I-DNA	NOUN	B
genes	I-DNA	NOUN	O
which	O	DET	O
are	O	AUX	O
all	O	ADV	O
located	O	ADJ	O
on	O	ADP	O
the	O	DET	O
long	B-DNA	ADJ	B
arm	I-DNA	NOUN	I
of	I-DNA	ADP	I
chromosome	I-DNA	NOUN	I
5	I-DNA	NUM	I
.	O	PUNCT	O


A	O	DET	O
novel	O	ADJ	O
human	B-DNA	ADJ	B
homeobox	I-DNA	NOUN	O
gene	I-DNA	NOUN	O
,	O	PUNCT	O
HB9	B-DNA	NOUN	B
,	O	PUNCT	O
was	O	AUX	O
isolated	O	VERB	B
from	O	ADP	O
a	O	DET	O
cDNA	B-DNA	NOUN	B
library	I-DNA	NOUN	I
prepared	O	VERB	O
from	O	ADP	O
in	O	X	B
vitro	B-cell_type	X	I
stimulated	I-cell_type	VERB	B
human	I-cell_type	ADJ	B
tonsil	I-cell_type	NOUN	O
B	I-cell_type	NOUN	O
lymphocytes	I-cell_type	NOUN	O
and	O	CCONJ	O
from	O	ADP	O
a	O	DET	O
human	B-DNA	ADJ	B
genomic	I-DNA	ADJ	B
library	I-DNA	NOUN	I
.	O	PUNCT	O


The	O	DET	O
predicted	O	VERB	O
HB9	B-protein	NOUN	B
protein	I-protein	NOUN	I
has	O	AUX	O
a	O	DET	O
molecular	O	ADJ	B
mass	O	NOUN	I
of	O	ADP	O
41	O	NUM	O
kilodaltons	O	NOUN	B
and	O	CCONJ	O
is	O	AUX	O
enriched	O	ADJ	O
for	O	ADP	O
alanine	O	NOUN	B
,	O	PUNCT	O
glycine	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
leucine	O	NOUN	B
.	O	PUNCT	O


HB9	B-RNA	NOUN	B
RNA	I-RNA	NOUN	B
transcripts	I-RNA	NOUN	B
were	O	AUX	O
most	O	ADV	O
prevalent	O	ADJ	O
in	O	ADP	O
several	O	ADJ	O
human	B-cell_line	ADJ	B
B	I-cell_line	NOUN	O
cell	I-cell_line	NOUN	O
lines	I-cell_line	NOUN	O
and	O	CCONJ	O
K562	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Restriction	O	NOUN	B
mapping	O	NOUN	I
shows	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
transcription	B-DNA	NOUN	B
unit	I-DNA	NOUN	I
spans	O	VERB	O
approximately	O	ADV	O
35	O	NUM	O
kilobases	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
transcription	O	NOUN	B
start	O	NOUN	O
site	O	NOUN	O
is	O	AUX	O
located	O	ADJ	O
approximately	O	ADV	O
4	O	NUM	O
kilobases	O	NOUN	B
5	O	NUM	O
'	O	PUNCT	O
to	O	ADP	O
the	O	DET	O
translation	B-DNA	NOUN	B
initiation	I-DNA	NOUN	B
codon	I-DNA	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
an	O	DET	O
RNA	O	NOUN	B
splice	O	NOUN	I
of	O	ADP	O
3863	O	NUM	O
bases	O	NOUN	B
occurs	O	VERB	O
in	O	ADP	O
the	O	DET	O
5'-untranslated	B-DNA	ADJ	B
region	I-DNA	NOUN	I
to	O	PART	O
generate	O	VERB	O
mature	B-RNA	ADJ	B
HeLa	I-RNA	NOUN	B
cell	I-RNA	NOUN	O
mRNA	I-RNA	NOUN	B
.	O	PUNCT	O


CD38	B-protein	NOUN	B
is	O	AUX	O
a	O	DET	O
leukocyte	B-protein	NOUN	B
differentiation	I-protein	NOUN	I
antigen	I-protein	NOUN	I
that	O	PRON	O
has	O	AUX	O
been	O	AUX	O
thought	O	VERB	O
to	O	PART	O
be	O	AUX	O
a	O	DET	O
phenotypic	O	ADJ	B
marker	O	NOUN	I
of	O	ADP	O
different	O	ADJ	O
subpopulations	O	NOUN	B
of	O	ADP	O
T-	B-cell_type	NOUN	B
and	I-cell_type	CCONJ	O
B-	I-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
myeloid	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
CD38	B-protein	NOUN	B
is	O	AUX	O
expressed	O	VERB	B
during	O	ADP	O
early	O	ADJ	B
stages	O	NOUN	I
of	O	ADP	O
differentiation	O	NOUN	B
.	O	PUNCT	O


Much	O	ADV	O
higher	O	ADJ	B
concentrations	O	NOUN	B
of	O	ADP	O
other	O	ADJ	O
antioxidants	O	NOUN	B
--	O	PUNCT	O
including	O	VERB	B
ascorbic	O	ADJ	B
acid	O	NOUN	I
,	O	PUNCT	O
trolox	O	NOUN	B
,	O	PUNCT	O
alpha-tocopherol	O	NOUN	B
,	O	PUNCT	O
butylated	O	VERB	B
hydroxytoluene	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
5-lipoxygenase	O	ADJ	B
inhibitor	O	NOUN	I
zileuton	O	NOUN	B
--	O	PUNCT	O
did	O	AUX	O
not	O	PART	O
affect	O	VERB	O
the	O	DET	O
production	O	NOUN	B
of	O	ADP	O
these	O	DET	O
cytokines	B-protein	NOUN	B
.	O	PUNCT	O


THP	O	NOUN	B
and	O	CCONJ	O
DHA	O	NOUN	B
markedly	O	ADV	O
decreased	O	VERB	B
the	O	DET	O
levels	O	NOUN	B
of	O	ADP	O
TNF-alpha	B-protein	NOUN	B
and	O	CCONJ	O
IL-1	B-protein	NOUN	B
beta	I-protein	NOUN	I
in	O	ADP	O
the	O	DET	O
circulation	O	NOUN	B
of	O	ADP	O
mice	O	NOUN	B
following	O	VERB	O
LPS	O	NOUN	B
injection	O	NOUN	B
.	O	PUNCT	O


Coordinate	O	ADJ	B
inhibition	O	NOUN	B
of	O	ADP	O
the	O	DET	O
transcription	O	NOUN	B
of	O	ADP	O
genes	O	NOUN	B
for	O	ADP	O
inflammatory	O	ADJ	B
cytokines	B-protein	NOUN	I
could	O	AUX	O
provide	O	VERB	O
a	O	DET	O
strategy	O	NOUN	O
for	O	ADP	O
therapy	O	NOUN	B
of	O	ADP	O
diseases	O	NOUN	B
with	O	ADP	O
inflammatory	O	ADJ	B
pathogenesis	O	NOUN	B
and	O	CCONJ	O
for	O	ADP	O
septic	O	ADJ	B
shock	O	NOUN	I
.	O	PUNCT	O


It	O	PRON	O
plays	O	VERB	O
an	O	DET	O
important	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
modulating	O	VERB	B
the	O	DET	O
balance	O	NOUN	B
of	O	ADP	O
T	B-cell_type	NOUN	B
helper	I-cell_type	NOUN	I
(	I-cell_type	PUNCT	O
Th	I-cell_type	NOUN	B
)	I-cell_type	PUNCT	O
cell	I-cell_type	NOUN	B
subsets	I-cell_type	NOUN	I
,	O	PUNCT	O
favoring	O	VERB	O
expansion	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Th2	B-cell_type	NOUN	B
lineage	I-cell_type	NOUN	B
relative	O	ADJ	O
to	O	PART	O
Th1	B-cell_type	NOUN	B
.	O	PUNCT	O


This	O	DET	O
protein	O	NOUN	B
has	O	AUX	O
now	O	ADV	O
been	O	AUX	O
purified	O	VERB	B
and	O	CCONJ	O
its	O	PRON	O
encoding	O	VERB	B
gene	O	NOUN	B
cloned	O	VERB	I
.	O	PUNCT	O


Study	O	NOUN	B
of	O	ADP	O
the	O	DET	O
inhibitory	O	ADJ	B
activities	O	NOUN	O
of	O	ADP	O
phosphotyrosine-containing	O	ADJ	B
peptides	O	NOUN	I
derived	O	VERB	O
from	O	ADP	O
the	O	DET	O
intracellular	B-protein	ADJ	B
domain	I-protein	NOUN	B
of	I-protein	ADP	O
the	I-protein	DET	O
IL-4	I-protein	NOUN	B
receptor	I-protein	NOUN	I
provided	O	VERB	O
evidence	O	NOUN	B
for	O	ADP	O
direct	O	ADJ	O
coupling	O	NOUN	B
of	O	ADP	O
receptor	B-protein	NOUN	B
and	O	CCONJ	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
during	O	ADP	O
the	O	DET	O
IL-4	B-protein	NOUN	B
Stat	I-protein	NOUN	O
activation	O	NOUN	O
cycle	O	NOUN	O
.	O	PUNCT	O


Such	O	ADJ	O
observations	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
IL-4	B-protein	NOUN	B
Stat	I-protein	NOUN	I
has	O	AUX	O
the	O	DET	O
same	O	ADJ	O
functional	B-protein	ADJ	B
domain	I-protein	NOUN	I
for	O	ADP	O
both	O	CCONJ	O
receptor	O	NOUN	B
coupling	O	NOUN	I
and	O	CCONJ	O
dimerization	O	NOUN	B
.	O	PUNCT	O


For	O	ADP	O
safety	O	NOUN	B
reasons	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
Ad	O	NOUN	B
vectors	O	NOUN	I
are	O	AUX	O
rendered	O	VERB	O
replication	O	NOUN	B
deficient	O	ADJ	B
by	O	ADP	O
deletion	O	NOUN	B
of	O	ADP	O
the	O	DET	O
E1a	B-DNA	NOUN	B
region	I-DNA	NOUN	I
.	O	PUNCT	O


Because	O	SCONJ	O
there	O	PRON	O
is	O	AUX	O
the	O	DET	O
theoretical	O	ADJ	B
possibility	O	NOUN	O
of	O	ADP	O
an	O	DET	O
E1a-	O	ADJ	B
replication-deficient	O	ADJ	B
vector	O	NOUN	I
replicating	O	VERB	B
as	O	ADP	O
a	O	DET	O
result	O	NOUN	O
of	O	ADP	O
recombination	O	NOUN	B
or	O	CCONJ	O
complementation	O	NOUN	B
with	O	ADP	O
Ad	B-DNA	NOUN	B
2/5	I-DNA	NUM	O
E1a	I-DNA	NOUN	B
sequences	I-DNA	NOUN	I
present	O	ADJ	O
in	O	ADP	O
the	O	DET	O
target	O	NOUN	B
cell	O	NOUN	I
,	O	PUNCT	O
this	O	DET	O
study	O	NOUN	B
is	O	AUX	O
directed	O	VERB	O
toward	O	ADP	O
evaluating	O	VERB	B
respiratory	O	ADJ	B
epithelium	O	NOUN	I
of	O	ADP	O
normals	O	NOUN	B
and	O	CCONJ	O
individuals	O	NOUN	B
with	O	ADP	O
CF	O	NOUN	B
for	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
E1a	O	NOUN	B
sequences	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
demonstrate	O	VERB	O
that	O	SCONJ	O
there	O	PRON	O
are	O	AUX	O
detectable	O	ADJ	B
Ad	B-DNA	NOUN	B
2/5	I-DNA	NUM	O
E1a	I-DNA	NOUN	B
sequences	I-DNA	NOUN	I
in	O	ADP	O
the	O	DET	O
respiratory	O	ADJ	B
epithelium	O	NOUN	I
of	O	ADP	O
a	O	DET	O
small	O	ADJ	O
percentage	O	NOUN	B
of	O	ADP	O
normals	O	NOUN	B
and	O	CCONJ	O
individuals	O	NOUN	B
with	O	ADP	O
CF	O	NOUN	B
.	O	PUNCT	O


Because	O	SCONJ	O
of	O	ADP	O
the	O	DET	O
theoretical	O	ADJ	B
potential	O	NOUN	I
of	O	ADP	O
such	O	ADJ	O
sequences	O	NOUN	B
supporting	O	VERB	O
replication	O	NOUN	B
of	O	ADP	O
E1a-	O	ADJ	B
Ad	O	NOUN	B
vectors	O	NOUN	I
,	O	PUNCT	O
human	O	ADJ	B
gene	O	NOUN	B
therapy	O	NOUN	I
protocols	O	NOUN	B
for	O	ADP	O
CF	O	NOUN	B
utilizing	O	VERB	O
such	O	ADJ	O
vectors	O	NOUN	B
should	O	AUX	O
consider	O	VERB	O
evaluating	O	ADJ	O
study	O	NOUN	B
individuals	O	NOUN	B
for	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
Ad	B-DNA	NOUN	B
2/5	I-DNA	NUM	O
E1a	I-DNA	NOUN	B
sequences	I-DNA	NOUN	I
in	O	ADP	O
the	O	DET	O
respiratory	O	ADJ	B
epithelium	O	NOUN	I
.	O	PUNCT	O


Leiomyosarcoma	O	NOUN	B
of	O	ADP	O
the	O	DET	O
vulva	O	NOUN	B
:	O	PUNCT	O
report	O	NOUN	B
of	O	ADP	O
a	O	DET	O
case	O	NOUN	B
.	O	PUNCT	O


Pathological	O	ADJ	B
evaluation	O	NOUN	B
revealed	O	VERB	O
a	O	DET	O
high-grade	O	ADJ	B
vulvar	O	ADJ	I
leiomyosarcoma	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
an	O	DET	O
effort	O	NOUN	O
to	O	PART	O
better	O	ADV	O
understand	O	VERB	O
the	O	DET	O
biology	O	NOUN	B
of	O	ADP	O
this	O	DET	O
tumor	O	NOUN	B
additional	O	ADJ	O
immunohistochemical	O	ADJ	B
studies	O	NOUN	I
for	O	ADP	O
the	O	DET	O
protein	B-protein	NOUN	B
product	I-protein	NOUN	I
of	O	ADP	O
p53	B-DNA	NOUN	B
tumor	I-DNA	NOUN	B
suppressor	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
and	O	CCONJ	O
estrogen	B-protein	NOUN	B
receptor	I-protein	NOUN	I
expression	O	NOUN	B
by	O	ADP	O
tumor	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
the	O	DET	O
type	O	NOUN	O
of	O	ADP	O
immune	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
infiltrating	O	VERB	B
the	O	DET	O
tumor	O	NOUN	B
were	O	AUX	O
performed	O	VERB	O
.	O	PUNCT	O


The	O	DET	O
DNA	B-protein	NOUN	B
binding	I-protein	NOUN	I
protein	I-protein	NOUN	I
NF-kB	I-protein	NOUN	B
is	O	AUX	O
a	O	DET	O
central	O	ADJ	O
mediator	O	NOUN	O
in	O	ADP	O
cytokine	B-protein	NOUN	B
activation	O	NOUN	I
of	O	ADP	O
HIV	O	NOUN	B
transcription	O	NOUN	B
.	O	PUNCT	O


L227	B-protein	NOUN	B
induced	O	VERB	B
an	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
intracellular	O	ADJ	B
free	O	ADJ	O
Ca2+	O	NOUN	O
concentration	O	NOUN	B
(	O	PUNCT	O
[	O	PUNCT	O
Ca2+	O	NOUN	B
]	O	PUNCT	O
i	O	NUM	O
)	O	PUNCT	O
from	O	ADP	O
the	O	DET	O
intracellular	O	ADJ	B
pool	O	NOUN	B
and	O	CCONJ	O
little	O	ADJ	O
or	O	CCONJ	O
no	O	DET	O
protein	O	NOUN	B
tyrosine	O	NOUN	I
phosphorylation	O	NOUN	B
,	O	PUNCT	O
phosphatidyl	O	ADJ	B
inositol	O	NOUN	I
turnover	O	NOUN	B
,	O	PUNCT	O
or	O	CCONJ	O
expression	O	NOUN	B
of	O	ADP	O
Egr-1	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
,	O	PUNCT	O
whereas	O	SCONJ	O
2.06	B-protein	NUM	O
plus	O	CCONJ	O
GAM	B-protein	NOUN	B
induced	O	VERB	B
an	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
[	O	PUNCT	O
Ca2+	O	NOUN	B
]	O	PUNCT	O
i	O	NOUN	O
from	O	ADP	O
both	O	CCONJ	O
the	O	DET	O
intracellular	O	ADJ	B
and	O	CCONJ	O
,	O	PUNCT	O
in	O	ADP	O
particular	O	ADJ	O
,	O	PUNCT	O
the	O	DET	O
extracellular	O	ADJ	B
pools	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
parameters	O	NOUN	B
were	O	AUX	O
examined	O	VERB	O
in	O	ADP	O
normal	O	ADJ	B
and	O	CCONJ	O
Epstein-Barr	B-cell_line	ADJ	B
virus-immortalized	I-cell_line	ADJ	I
human	I-cell_line	ADJ	O
B	I-cell_line	NOUN	O
cells	I-cell_line	NOUN	O
and	O	CCONJ	O
compared	O	VERB	B
with	O	ADP	O
1	B-cell_line	NUM	O
alpha	I-cell_line	NOUN	B
,	I-cell_line	PUNCT	O
25-	I-cell_line	NUM	O
(	I-cell_line	PUNCT	O
OH	I-cell_line	NOUN	B
)	I-cell_line	PUNCT	O
2D3-responsive	I-cell_line	ADJ	O
cells	I-cell_line	NOUN	O
of	O	ADP	O
the	O	DET	O
T	B-cell_type	NOUN	B
and	I-cell_type	CCONJ	O
monocytic	I-cell_type	ADJ	B
lineages	I-cell_type	NOUN	I
.	O	PUNCT	O


1	O	NUM	O
alpha	O	NOUN	B
,	O	PUNCT	O
25-	O	NUM	O
(	O	PUNCT	O
OH	O	NOUN	B
)	O	PUNCT	O
2D3	O	NOUN	B
inhibited	O	VERB	B
CD23	B-protein	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
U937	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
yet	O	ADV	O
failed	O	VERB	B
to	O	PART	O
modulate	O	VERB	O
CD23	B-protein	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
1	O	NUM	O
alpha	O	NOUN	B
,	O	PUNCT	O
25-	O	NUM	O
(	O	PUNCT	O
OH	O	NOUN	B
)	O	PUNCT	O
2D3	O	NOUN	B
induced	O	VERB	B
24-hydroxylase	B-protein	NOUN	B
mRNA	O	NOUN	B
expression	O	NOUN	O
and	O	CCONJ	O
metabolic	O	ADJ	B
activity	O	NOUN	I
in	O	ADP	O
both	O	CCONJ	O
U937	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
and	O	CCONJ	O
lectin-activated	B-cell_type	ADJ	B
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
yet	O	ADV	O
failed	O	VERB	O
to	O	PART	O
induce	O	VERB	B
24-hydroxylase	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
or	O	CCONJ	O
its	O	PRON	O
metabolic	O	ADJ	B
activity	O	NOUN	I
in	O	ADP	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Positive	O	ADJ	B
and	O	CCONJ	O
negative	O	ADJ	B
regulation	O	NOUN	O
of	O	ADP	O
IL-2	B-protein	NOUN	B
gene	O	NOUN	I
expression	O	NOUN	B
:	O	PUNCT	O
role	O	NOUN	O
of	O	ADP	O
multiple	O	ADJ	B
regulatory	O	ADJ	B
sites	O	NOUN	I
.	O	PUNCT	O


Interleukin	O	NOUN	B
2	O	NUM	I
(	O	PUNCT	O
IL-2	B-protein	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
an	O	DET	O
important	O	ADJ	O
lymphokine	B-protein	NOUN	B
required	O	VERB	O
in	O	ADP	O
the	O	DET	O
process	O	NOUN	B
of	O	ADP	O
T	O	NOUN	B
cell	O	NOUN	I
activation	O	NOUN	O
,	O	PUNCT	O
proliferation	O	NOUN	B
,	O	PUNCT	O
clonal	O	ADJ	B
expansion	O	NOUN	B
and	O	CCONJ	O
differentiation	O	NOUN	B
.	O	PUNCT	O


Two	O	NUM	O
other	O	ADJ	O
sites	O	NOUN	B
display	O	VERB	O
disparate	O	ADJ	O
effects	O	NOUN	O
on	O	ADP	O
IL-2	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
expression	O	NOUN	B
in	O	ADP	O
different	O	ADJ	O
T	B-cell_line	NOUN	B
leukemia	I-cell_line	NOUN	I
cell	I-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
:	O	PUNCT	O
the	O	DET	O
distal	B-DNA	ADJ	B
purine	I-DNA	NOUN	O
box	I-DNA	NOUN	O
(	O	PUNCT	O
-291	B-DNA	NUM	O
to	I-DNA	PART	O
-277	I-DNA	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
proximal	B-DNA	ADJ	B
purine	I-DNA	NOUN	O
box	I-DNA	NOUN	O
sites	I-DNA	NOUN	O
(	O	PUNCT	O
-145	B-DNA	NUM	O
to	I-DNA	PART	O
-128	I-DNA	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
FK506	O	NOUN	B
or	O	CCONJ	O
EGTA	O	NOUN	B
(	O	PUNCT	O
Ca2+	O	NOUN	B
chelator	O	NOUN	I
)	O	PUNCT	O
similarly	O	ADV	O
affected	O	VERB	B
the	O	DET	O
formation	O	NOUN	B
of	O	ADP	O
kappa	B-protein	NOUN	O
B-like	I-protein	ADJ	B
site	I-protein	NOUN	I
binding	I-protein	NOUN	I
complexes	I-protein	NOUN	I
,	O	PUNCT	O
which	O	DET	O
were	O	AUX	O
not	O	PART	O
recognized	O	VERB	O
by	O	ADP	O
any	O	DET	O
antibodies	B-protein	NOUN	B
against	O	ADP	O
the	O	DET	O
human	B-protein	ADJ	B
Rel	I-protein	NOUN	B
family	I-protein	NOUN	I
proteins	I-protein	NOUN	I
(	O	PUNCT	O
c-Rel	B-protein	NOUN	B
,	O	PUNCT	O
p65	B-protein	NOUN	B
,	O	PUNCT	O
p50	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
p49	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
androgen	B-protein	NOUN	B
receptors	I-protein	NOUN	I
in	O	ADP	O
peripheral	B-cell_type	ADJ	B
mononuclear	I-cell_type	ADJ	I
leukocytes	I-cell_type	NOUN	B
provides	O	VERB	O
for	O	ADP	O
the	O	DET	O
first	O	ADJ	O
time	O	NOUN	O
the	O	DET	O
experimental	O	ADJ	B
basis	O	NOUN	O
for	O	ADP	O
an	O	DET	O
hypothesis	O	NOUN	B
of	O	ADP	O
direct	O	ADJ	O
,	O	PUNCT	O
receptor-mediated	O	ADJ	B
effects	O	NOUN	I
of	O	ADP	O
androgens	O	NOUN	B
on	O	ADP	O
mature	B-cell_type	ADJ	B
immunocompetent	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	O
.	O	PUNCT	O


MHC	B-protein	NOUN	B
class	I-protein	NOUN	B
II	I-protein	NUM	I
signaling	O	NOUN	B
in	O	ADP	O
B-cell	B-cell_type	NOUN	B
activation	O	NOUN	I
[	O	PUNCT	O
see	O	VERB	O
comments	O	NOUN	B
]	O	PUNCT	O


MHC	B-protein	NOUN	B
class	I-protein	NOUN	B
II	I-protein	NUM	I
molecules	O	NOUN	I
also	O	ADV	O
serve	O	VERB	O
as	O	ADP	O
receptors	O	NOUN	B
for	O	ADP	O
B-cell	B-cell_type	NOUN	B
stimulation	O	NOUN	I
by	O	ADP	O
microbial	B-protein	ADJ	B
superantigens	I-protein	NOUN	B
.	O	PUNCT	O


Lymphocytes	O	NOUN	B
of	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
rheumatoid	O	ADJ	B
arthritis	O	NOUN	I
(	O	PUNCT	O
RA	O	NOUN	B
)	O	PUNCT	O
have	O	AUX	O
diminished	O	VERB	B
receptor	O	NOUN	B
density	O	NOUN	I
;	O	PUNCT	O
thus	O	ADV	O
,	O	PUNCT	O
patients	O	NOUN	B
with	O	ADP	O
RA	O	NOUN	B
should	O	AUX	O
show	O	VERB	O
partial	O	ADJ	B
resistance	O	NOUN	B
to	O	PART	O
glucocorticoids	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
determined	O	VERB	O
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	O
glucocorticoids	O	NOUN	B
on	O	ADP	O
lymphocyte	B-cell_type	NOUN	B
proliferation	O	NOUN	I
and	O	CCONJ	O
cytokine	B-protein	NOUN	B
release	O	NOUN	I
.	O	PUNCT	O


Arrested	O	VERB	B
development	O	NOUN	B
:	O	PUNCT	O
understanding	O	VERB	O
v-abl	B-DNA	NOUN	B
.	O	PUNCT	O


A	O	DET	O
similarity	O	NOUN	B
has	O	AUX	O
recently	O	ADV	O
been	O	AUX	O
found	O	VERB	O
between	O	ADP	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
corticosteroid	B-protein	NOUN	B
receptors	I-protein	NOUN	I
in	O	ADP	O
brain	O	NOUN	B
and	O	CCONJ	O
in	O	ADP	O
lymphoid	O	ADJ	B
tissue	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
observed	O	VERB	O
that	O	SCONJ	O
RA	O	NOUN	B
did	O	AUX	O
not	O	PART	O
induced	O	VERB	B
neutrophil	O	NOUN	B
differentiation	O	NOUN	O
in	O	ADP	O
serum-free	B-cell_line	ADJ	B
grown	I-cell_line	VERB	I
HL60	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
whereas	O	SCONJ	O
50	O	NUM	O
nM	O	NOUN	O
1	O	NUM	O
alpha	O	NOUN	B
,	O	PUNCT	O
25-dihydroxyvitamin	O	NOUN	B
D3	O	NOUN	I
(	O	PUNCT	O
D3	O	NOUN	B
)	O	PUNCT	O
induced	O	VERB	B
maximal	O	ADJ	B
monocyte	O	NOUN	B
differentiation	O	NOUN	I
.	O	PUNCT	O


[	O	PUNCT	O
An	O	DET	O
overexpression	O	NOUN	B
of	O	ADP	O
retinoic	B-protein	ADJ	B
acid	I-protein	NOUN	I
receptor	I-protein	NOUN	I
alpha	I-protein	NOUN	I
blocks	O	VERB	O
myeloid	B-cell_type	ADJ	B
cell	I-cell_type	NOUN	I
differentiation	O	NOUN	O
at	O	ADP	O
the	O	DET	O
promyelocyte	O	ADJ	B
stage	O	NOUN	I
]	O	PUNCT	O


To	O	PART	O
make	O	VERB	O
clear	O	ADJ	O
the	O	DET	O
roles	O	NOUN	O
of	O	ADP	O
RA	O	NOUN	B
and	O	CCONJ	O
RAR	B-protein	NOUN	B
alpha	I-protein	NOUN	I
in	O	ADP	O
the	O	DET	O
normal	O	ADJ	B
hematopoiesis	O	NOUN	I
,	O	PUNCT	O
I	O	PRON	B
have	O	AUX	O
introduced	O	VERB	O
the	O	DET	O
construct	O	NOUN	O
of	O	ADP	O
human	B-protein	ADJ	B
RAR	I-protein	NOUN	O
alpha	I-protein	NOUN	O
(	O	PUNCT	O
hRAR	B-protein	NOUN	B
alpha	I-protein	NOUN	I
)	O	PUNCT	O
into	O	ADP	O
murine	B-cell_type	ADJ	B
bone	I-cell_type	NOUN	B
marrow	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
with	O	ADP	O
retroviral	O	ADJ	B
vector	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
selected	O	VERB	O
infected	O	ADJ	B
cells	O	NOUN	B
with	O	ADP	O
drug	B-DNA	NOUN	B
resistant	I-DNA	ADJ	I
marker	I-DNA	NOUN	I
(	O	PUNCT	O
Neo	B-DNA	NOUN	B
(	I-DNA	PUNCT	O
r	I-DNA	NOUN	O
)	I-DNA	PUNCT	O
)	O	PUNCT	O
cultured	O	VERB	B
on	O	ADP	O
the	O	DET	O
stroma	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
(	O	PUNCT	O
PA6-neo	B-cell_line	ADJ	B
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
analyzed	O	VERB	B
the	O	DET	O
behavior	O	NOUN	B
of	O	ADP	O
infected	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	B
.	O	PUNCT	O


Most	O	ADJ	O
cells	O	NOUN	B
infected	O	VERB	B
with	O	ADP	O
hRAR	B-protein	NOUN	B
alpha	I-protein	NOUN	I
exhibited	O	VERB	O
promyelocytic	B-cell_type	ADJ	B
morphology	I-cell_type	NOUN	B
and	O	CCONJ	O
were	O	AUX	O
thought	O	VERB	O
to	O	PART	O
be	O	AUX	O
blocked	O	VERB	B
at	O	ADP	O
the	O	DET	O
promyelocytic	O	ADJ	B
stage	O	NOUN	I
in	O	ADP	O
their	O	PRON	O
myeloid	O	ADJ	B
differentiation	O	NOUN	I
.	O	PUNCT	O


Northern	O	ADJ	B
analysis	O	NOUN	I
of	O	ADP	O
mRNA	O	NOUN	B
from	O	ADP	O
hypoxic	O	ADJ	B
ECs	B-cell_type	NOUN	B
also	O	ADV	O
demonstrated	O	VERB	O
increased	O	VERB	B
levels	O	NOUN	B
of	O	ADP	O
mRNA	B-RNA	NOUN	B
for	O	ADP	O
macrophage	B-protein	NOUN	B
chemotactic	I-protein	ADJ	B
protein-1	I-protein	NOUN	I
,	O	PUNCT	O
another	O	DET	O
member	O	NOUN	O
of	O	ADP	O
the	O	DET	O
chemokine	B-protein	NOUN	B
superfamily	I-protein	NOUN	I
of	O	ADP	O
proinflammatory	B-protein	ADJ	B
cytokines	I-protein	NOUN	I
.	O	PUNCT	O


IL-8	B-DNA	NOUN	B
gene	I-DNA	NOUN	O
induction	O	NOUN	B
was	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
increased	O	VERB	B
binding	O	NOUN	B
activity	O	NOUN	I
in	O	ADP	O
nuclear	O	ADJ	B
extracts	O	NOUN	I
from	O	ADP	O
hypoxic	B-cell_type	ADJ	B
ECs	I-cell_type	NOUN	B
for	O	ADP	O
the	O	DET	O
NF-kB	O	NOUN	B
site	O	NOUN	B
.	O	PUNCT	O


Taken	O	VERB	O
together	O	ADV	O
,	O	PUNCT	O
these	O	DET	O
data	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
hypoxia	O	NOUN	B
constitutes	O	VERB	O
a	O	DET	O
stimulus	O	NOUN	B
for	O	ADP	O
leukocyte	O	NOUN	B
chemotaxis	O	NOUN	I
and	O	CCONJ	O
tissue	O	NOUN	B
leukostasis	O	NOUN	I
.	O	PUNCT	O


Thrombin	B-protein	NOUN	B
and	O	CCONJ	O
TRP	O	NOUN	B
also	O	ADV	O
caused	O	VERB	O
translocation	O	NOUN	B
of	O	ADP	O
protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
C	I-protein	NOUN	I
from	O	ADP	O
the	O	DET	O
cytosol	O	NOUN	B
to	O	PART	O
the	O	DET	O
plasma	O	NOUN	B
membrane	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
magnitude	O	NOUN	B
of	O	ADP	O
the	O	DET	O
thrombin	B-protein	NOUN	B
response	O	NOUN	O
in	O	ADP	O
the	O	DET	O
different	O	ADJ	O
cell	O	NOUN	B
types	O	NOUN	I
paralleled	O	VERB	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
thrombin	B-RNA	NOUN	B
receptor	I-RNA	NOUN	I
mRNA	I-RNA	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
found	O	VERB	O
that	O	SCONJ	O
activation	O	NOUN	B
of	O	ADP	O
Jurkat	B-cell_line	NOUN	B
T	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
by	O	ADP	O
a	O	DET	O
combination	O	NOUN	B
of	O	ADP	O
phytohemagglutinin	B-protein	NOUN	B
and	O	CCONJ	O
phorbol	O	NOUN	B
12-myristate	O	NOUN	I
13-acetate	O	NOUN	I
led	O	VERB	O
to	O	PART	O
a	O	DET	O
dramatic	O	ADJ	O
inhibition	O	NOUN	B
of	O	ADP	O
thrombin	B-RNA	NOUN	B
receptor	I-RNA	NOUN	I
mRNA	I-RNA	NOUN	B
expression	O	NOUN	B
and	O	CCONJ	O
to	O	PART	O
a	O	DET	O
concomitant	O	ADJ	B
loss	O	NOUN	B
of	O	ADP	O
the	O	DET	O
thrombin	B-protein	NOUN	B
response	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
the	O	DET	O
AP-1	B-protein	NOUN	B
transcription	B-protein	NOUN	I
factor	I-protein	NOUN	I
has	O	AUX	O
been	O	AUX	O
ascribed	O	VERB	O
to	O	PART	O
the	O	DET	O
early	O	ADJ	B
events	O	NOUN	I
leading	O	VERB	O
to	O	PART	O
T	O	NOUN	B
lymphocyte	O	NOUN	I
activation	O	NOUN	B
.	O	PUNCT	O


Wortmannin	O	NOUN	B
,	O	PUNCT	O
an	O	DET	O
inhibitor	O	NOUN	B
of	O	ADP	O
receptor-coupled	O	ADJ	B
PLD	B-protein	NOUN	B
activation	O	NOUN	B
,	O	PUNCT	O
blocked	O	VERB	B
the	O	DET	O
anti-CD3	B-protein	ADJ	B
-induced	O	ADJ	O
increases	O	NOUN	B
in	O	ADP	O
both	O	CCONJ	O
PLD	B-protein	NOUN	B
activity	O	NOUN	B
and	O	CCONJ	O
AP-1	B-DNA	NOUN	B
enhancer	I-DNA	NOUN	I
activity	O	NOUN	I
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
ethanol	O	NOUN	B
,	O	PUNCT	O
an	O	DET	O
inhibitor	O	NOUN	B
of	O	ADP	O
the	O	DET	O
PLD	B-protein	NOUN	B
pathway	O	NOUN	O
,	O	PUNCT	O
blocked	O	VERB	B
the	O	DET	O
anti-CD3-stimulated	O	ADJ	B
AP-1	B-DNA	NOUN	B
enhancer	I-DNA	NOUN	I
activity	O	NOUN	O
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
PA	O	PROPN	B
-and	O	PUNCT	O
the	O	DET	O
anti-CD3	B-protein	ADJ	B
-induced	O	ADJ	O
increases	O	NOUN	B
in	O	ADP	O
AP-1	B-DNA	NOUN	B
enhancer	I-DNA	NOUN	I
activity	O	NOUN	I
were	O	AUX	O
blocked	O	VERB	B
by	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
PKC	B-protein	NOUN	B
inhibitors	O	NOUN	B
or	O	CCONJ	O
by	O	ADP	O
PKC	B-protein	NOUN	B
down-regulation	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
also	O	ADV	O
provide	O	VERB	O
evidence	O	NOUN	B
for	O	ADP	O
a	O	DET	O
role	O	NOUN	O
of	O	ADP	O
PLD	B-protein	NOUN	B
-derived	O	ADJ	O
lipids	O	NOUN	B
in	O	ADP	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
AP-1	B-DNA	NOUN	B
enhancer	I-DNA	NOUN	I
activity	O	NOUN	O
resulting	O	VERB	O
from	O	ADP	O
stimulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
TCR/CD3	B-protein	NOUN	B
complex	I-protein	NOUN	I
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
increased	O	VERB	B
PLD	B-protein	NOUN	B
activity	O	NOUN	B
can	O	AUX	O
play	O	VERB	O
an	O	DET	O
important	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
T	B-cell_type	NOUN	B
lymphocyte	I-cell_type	NOUN	I
activation	O	NOUN	I
.	O	PUNCT	O


To	O	PART	O
tie	O	VERB	O
these	O	DET	O
events	O	NOUN	B
to	O	PART	O
gene	O	NOUN	B
activation	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
measured	O	VERB	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
and	O	CCONJ	O
NF-AT	B-protein	NOUN	B
activity	O	NOUN	B
in	O	ADP	O
the	O	DET	O
nucleus	O	NOUN	B
after	O	ADP	O
anti-CD3	B-protein	ADJ	B
stimulation	O	NOUN	O
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
NF-AT	B-protein	NOUN	B
induction	O	NOUN	B
and	O	CCONJ	O
IL-2	B-protein	NOUN	B
secretion	O	NOUN	B
were	O	AUX	O
correlated	O	VERB	B
with	O	ADP	O
the	O	DET	O
levels	O	NOUN	B
of	O	ADP	O
inositol	O	NOUN	B
phosphate	O	NOUN	I
release	O	NOUN	B
but	O	CCONJ	O
not	O	PART	O
with	O	ADP	O
gross	O	ADJ	B
levels	O	NOUN	I
of	O	ADP	O
tyrosine	B-protein	NOUN	B
kinase	I-protein	NOUN	I
activity	O	NOUN	I
induced	O	VERB	B
late	O	ADV	O
following	O	VERB	O
the	O	DET	O
response	O	NOUN	B
.	O	PUNCT	O


Although	O	SCONJ	O
two	O	NUM	O
cases	O	NOUN	B
expressed	O	VERB	B
CD4	B-protein	NOUN	B
,	O	PUNCT	O
no	O	DET	O
case	O	NOUN	O
expressed	O	VERB	B
CD2	B-protein	NOUN	B
,	O	PUNCT	O
CD3	B-protein	NOUN	B
,	O	PUNCT	O
or	O	CCONJ	O
CD8	B-protein	NOUN	B
and	O	CCONJ	O
no	O	DET	O
case	O	NOUN	O
showed	O	VERB	O
clonal	O	ADJ	B
rearrangement	O	NOUN	I
of	O	ADP	I
genes	O	NOUN	O
encoding	O	VERB	B
the	O	DET	O
T-cell	B-protein	NOUN	B
receptor	I-protein	NOUN	I
(	O	PUNCT	O
TCR	B-protein	NOUN	B
beta	I-protein	NOUN	B
,	I-protein	PUNCT	O
gamma	I-protein	NOUN	B
,	I-protein	PUNCT	O
delta	I-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


IL-4	B-protein	NOUN	B
down-regulates	O	VERB	B
IL-2	B-protein	NOUN	B
-	O	PUNCT	O
,	O	PUNCT	O
IL-3	B-protein	NOUN	B
-	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
GM-CSF	B-protein	NOUN	B
-induced	O	ADJ	O
cytokine	O	NOUN	B
gene	O	NOUN	B
expression	O	NOUN	I
in	O	ADP	O
peripheral	O	ADJ	B
blood	O	NOUN	I
monocytes	O	NOUN	I
.	O	PUNCT	O


Temporal	O	ADJ	B
analysis	O	NOUN	I
of	O	ADP	O
the	O	DET	O
IL-4	B-protein	NOUN	B
down-regulatory	O	ADJ	B
effect	O	NOUN	I
on	O	ADP	O
the	O	DET	O
IL-2-	O	NOUN	B
,	O	PUNCT	O
IL-3-	O	NOUN	B
,	O	PUNCT	O
or	O	CCONJ	O
GM-CSF-induced	O	ADJ	O
proinflammatory	O	ADJ	B
cytokine	O	NOUN	I
gene	O	NOUN	B
expression	O	NOUN	I
in	O	ADP	O
monocytes	B-cell_type	NOUN	B
provided	O	VERB	O
evidence	O	NOUN	B
that	O	SCONJ	O
IL-4	B-protein	NOUN	B
acts	O	VERB	O
predominantly	O	ADV	O
on	O	ADP	O
the	O	DET	O
post-transcriptional	O	ADJ	B
level	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
primary	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
MDHM-induced	O	ADJ	B
elevation	O	NOUN	I
of	O	ADP	O
cytokine	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
levels	O	NOUN	O
was	O	AUX	O
preceded	O	VERB	O
by	O	ADP	O
a	O	DET	O
downregulation	O	NOUN	B
of	O	ADP	O
c-fos	B-DNA	NOUN	B
expression	O	NOUN	B
while	O	SCONJ	O
positive	O	ADJ	B
c-jun	B-DNA	NOUN	B
expression	O	NOUN	I
was	O	AUX	O
not	O	PART	O
modulated	O	VERB	B
.	O	PUNCT	O


This	O	DET	O
aldosterone-selectivity	O	NOUN	B
is	O	AUX	O
typical	O	ADJ	O
and	O	CCONJ	O
discriminatory	O	ADJ	B
for	O	ADP	O
the	O	DET	O
new	O	ADJ	O
aldosterone	B-protein	NOUN	B
membrane	I-protein	NOUN	I
receptor	I-protein	NOUN	I
.	O	PUNCT	O


Using	O	VERB	O
in	O	X	B
vitro	O	X	I
footprinting	O	NOUN	I
and	O	CCONJ	O
gel	O	NOUN	B
shift	O	NOUN	I
assays	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
identified	O	VERB	B
four	O	NUM	O
distinct	O	ADJ	O
binding	B-DNA	VERB	B
sites	I-DNA	NOUN	I
for	O	ADP	O
nuclear	B-protein	ADJ	B
proteins	I-protein	NOUN	I
within	O	ADP	O
this	O	DET	O
positive	B-DNA	ADJ	B
regulatory	I-DNA	ADJ	B
element	I-DNA	NOUN	I
.	O	PUNCT	O


A	O	DET	O
GC	B-DNA	NOUN	B
box	I-DNA	NOUN	B
containing	O	VERB	O
a	O	DET	O
binding	B-DNA	VERB	B
site	I-DNA	NOUN	I
for	O	ADP	O
Sp1	B-protein	NOUN	B
was	O	AUX	O
identified	O	VERB	B
(	O	PUNCT	O
nt	B-DNA	NOUN	O
4623	I-DNA	NUM	O
to	I-DNA	PART	O
4631	I-DNA	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Expression	O	NOUN	B
of	O	ADP	O
v-src	B-DNA	NOUN	B
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
correlates	O	VERB	O
with	O	ADP	O
nuclear	O	ADJ	B
expression	O	NOUN	I
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
.	O	PUNCT	O


trans-activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
HIV	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
by	O	ADP	O
a	O	DET	O
cDNA	O	NOUN	B
and	O	CCONJ	O
its	O	PRON	O
genomic	O	ADJ	B
clones	O	NOUN	I
of	O	ADP	O
human	O	ADJ	B
herpesvirus-6	O	NOUN	B
.	O	PUNCT	O


Sequence	O	NOUN	B
analyses	O	NOUN	I
of	O	ADP	O
pCD41	B-DNA	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
there	O	PRON	O
are	O	AUX	O
two	O	NUM	O
potential	O	ADJ	B
open	B-DNA	ADJ	B
reading	I-DNA	NOUN	I
frames	I-DNA	NOUN	I
(	O	PUNCT	O
ORFs	B-DNA	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
A	B-DNA	NOUN	B
and	O	CCONJ	O
B	B-DNA	NOUN	B
,	O	PUNCT	O
which	O	DET	O
are	O	AUX	O
homologous	O	ADJ	B
to	O	PART	O
the	O	DET	O
ORFs	B-DNA	NOUN	B
found	O	VERB	O
in	O	ADP	O
the	O	DET	O
genomic	O	ADJ	B
clone	O	NOUN	I
pGD41	B-DNA	NOUN	B
.	O	PUNCT	O


Protein	O	NOUN	B
synthesis	O	NOUN	I
inhibitors	O	NOUN	I
and	O	CCONJ	O
corticosteroids	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
suppress	O	VERB	B
arachidonate	O	NOUN	B
release	O	NOUN	I
and	O	CCONJ	O
the	O	DET	O
synthesis	O	NOUN	B
of	O	ADP	O
proinflammatory	B-protein	ADJ	B
cytokines	I-protein	NOUN	I
,	O	PUNCT	O
had	O	AUX	O
no	O	DET	B
effect	O	NOUN	I
on	O	ADP	O
translocation	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
in	O	ADP	O
CHO/	O	NOUN	B
CD14	B-protein	NOUN	B
or	O	CCONJ	O
RAW	B-cell_line	NOUN	B
264.7	I-cell_line	NUM	I
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
demonstrating	O	VERB	O
that	O	SCONJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
translocation	O	NOUN	B
is	O	AUX	O
an	O	DET	O
early	O	ADJ	B
event	O	NOUN	I
.	O	PUNCT	O


Although	O	SCONJ	O
TK	O	NOUN	B
activity	O	NOUN	B
was	O	AUX	O
consistently	O	ADV	O
observed	O	VERB	O
by	O	ADP	O
immunoblotting	O	VERB	B
extracts	O	NOUN	B
from	O	ADP	O
activated	O	VERB	B
RAW	B-cell_line	NOUN	B
264.7	I-cell_line	NUM	I
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
LPS-induced	O	ADJ	B
phosphotyrosine	O	NOUN	I
residues	O	NOUN	I
were	O	AUX	O
not	O	PART	O
observed	O	VERB	O
from	O	ADP	O
similarly	O	ADV	O
treated	O	VERB	B
CHO/CD14	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
TK	O	NOUN	B
inhibitors	O	NOUN	B
herbimycin	O	NOUN	B
A	O	NOUN	I
and	O	CCONJ	O
genistein	O	NOUN	B
failed	O	VERB	B
to	O	PART	O
inhibit	O	VERB	B
translocation	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
in	O	ADP	O
CHO/CD14	B-cell_line	NOUN	B
or	O	CCONJ	O
RAW	B-cell_line	NOUN	B
264.7	I-cell_line	NUM	I
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
although	O	SCONJ	O
both	O	DET	O
of	O	ADP	O
these	O	DET	O
agents	O	NOUN	B
inhibited	O	VERB	B
LPS-induced	O	ADJ	B
TK	O	NOUN	B
activity	O	NOUN	B
in	O	ADP	O
RAW	B-cell_line	NOUN	B
264.7	I-cell_line	NUM	I
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
imply	O	VERB	O
that	O	SCONJ	O
TK	O	NOUN	B
activity	O	NOUN	B
is	O	AUX	O
not	O	PART	O
obligatory	O	ADJ	O
for	O	ADP	O
CD14	B-protein	NOUN	B
-mediated	O	ADJ	O
signal	O	NOUN	B
transduction	O	NOUN	I
to	O	PART	O
occur	O	VERB	O
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
LPS	O	NOUN	B
.	O	PUNCT	O


Cytosols	O	NOUN	B
were	O	AUX	O
prepared	O	VERB	O
from	O	ADP	O
lymphocytes	O	NOUN	B
of	O	ADP	O
24	O	NUM	O
healthy	O	ADJ	B
pregnant	O	ADJ	B
women	O	NOUN	I
(	O	PUNCT	O
11	O	NUM	O
first	O	ADV	O
,	O	PUNCT	O
10	O	NUM	O
second	O	ADJ	O
and	O	CCONJ	O
three	O	NUM	O
third	O	ADJ	B
trimester	O	NOUN	I
)	O	PUNCT	O
,	O	PUNCT	O
seven	O	NUM	O
healthy	O	ADJ	B
non-pregnant	O	ADJ	B
women	O	NOUN	B
,	O	PUNCT	O
nine	O	NUM	O
women	O	NOUN	B
with	O	ADP	O
recurrent	O	ADJ	B
spontaneous	O	ADJ	O
abortion	O	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
six	O	NUM	O
healthy	O	ADJ	B
men	O	NOUN	B
.	O	PUNCT	O


Lymphocytes	B-cell_type	NOUN	B
of	O	ADP	O
non-pregnant	O	ADJ	B
women	O	NOUN	B
,	O	PUNCT	O
women	O	NOUN	B
with	O	ADP	O
threatened	O	VERB	B
pre-term	O	ADJ	B
delivery	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
men	O	NOUN	B
showed	O	VERB	O
equivalent	O	ADJ	O
levels	O	NOUN	B
:	O	PUNCT	O
3	O	NUM	O
+/-	O	CCONJ	O
1	O	NUM	O
,	O	PUNCT	O
3	O	NUM	O
+/-	O	CCONJ	O
2	O	NUM	O
and	O	CCONJ	O
5	O	NUM	O
+/-	O	CCONJ	O
4	O	NUM	O
fmol/mg	O	NOUN	O
respectively	O	ADV	O
.	O	PUNCT	O


In	O	ADP	O
nuclear	O	ADJ	B
run-on	O	ADJ	I
analysis	O	NOUN	I
,	O	PUNCT	O
such	O	ADJ	O
tolerant	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	B
show	O	VERB	O
only	O	ADV	O
a	O	DET	O
low	O	ADJ	O
degree	O	NOUN	B
of	O	ADP	O
transcription	O	NOUN	B
,	O	PUNCT	O
indicating	O	VERB	O
that	O	SCONJ	O
tolerance	O	NOUN	B
operates	O	VERB	O
at	O	ADP	O
or	O	CCONJ	O
upstream	O	ADJ	B
of	O	ADP	O
the	O	DET	O
transcription	O	NOUN	B
level	O	NOUN	B
.	O	PUNCT	O


Taken	O	VERB	O
together	O	ADV	O
,	O	PUNCT	O
these	O	DET	O
results	O	NOUN	B
demonstrate	O	VERB	O
that	O	SCONJ	O
tolerance	O	NOUN	B
to	O	PART	O
LPS	O	NOUN	B
is	O	AUX	O
determined	O	VERB	O
by	O	ADP	O
post-receptor	O	ADJ	B
mechanisms	O	NOUN	I
that	O	PRON	O
involve	O	VERB	O
an	O	DET	O
altered	O	ADJ	O
composition	O	NOUN	B
of	O	ADP	O
the	O	DET	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
complex	I-protein	NOUN	I
.	O	PUNCT	O


More	O	ADV	O
frequent	O	ADJ	B
use	O	NOUN	O
of	O	ADP	O
the	O	DET	O
classical	O	ADJ	O
Oct2a	B-protein	NOUN	B
and	O	CCONJ	O
Oct2b	B-protein	NOUN	B
isoforms	O	NOUN	I
was	O	AUX	O
observed	O	VERB	O
in	O	ADP	O
the	O	DET	O
lipopolysaccharide-stimulated	B-cell_line	ADJ	B
B	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
while	O	SCONJ	O
a	O	DET	O
preference	O	NOUN	B
for	O	ADP	O
the	O	DET	O
Oct2ab	B-protein	NOUN	B
and	O	CCONJ	O
Oct2ba	B-protein	NOUN	B
isoforms	O	NOUN	B
was	O	AUX	O
observed	O	VERB	O
in	O	ADP	O
lipopolysaccharide	B-cell_line	NOUN	B
plus	I-cell_line	CCONJ	O
phorbol-di-butyrate-treated	I-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
show	O	VERB	O
here	O	ADV	O
that	O	SCONJ	O
proerythroblasts	B-cell_type	NOUN	B
and	O	CCONJ	O
mature	B-cell_type	ADJ	B
erythroid	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
contain	O	VERB	O
a	O	DET	O
diffusible	O	ADJ	B
activity	O	NOUN	I
(	O	PUNCT	O
TAG	O	NOUN	B
)	O	PUNCT	O
capable	O	ADJ	O
of	O	ADP	O
transcriptional	O	ADJ	B
activation	O	NOUN	I
of	O	ADP	O
GATA-1	B-protein	NOUN	B
and	O	CCONJ	O
that	O	SCONJ	O
this	O	DET	O
activity	O	NOUN	B
decreases	O	VERB	B
during	O	ADP	O
the	O	DET	O
terminal	O	ADJ	B
differentiation	O	NOUN	B
of	O	ADP	O
erythroid	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Analysis	O	NOUN	B
of	O	ADP	O
truncated	O	VERB	B
LTRs	B-DNA	NOUN	B
confirmed	O	VERB	O
that	O	SCONJ	O
inhibition	O	NOUN	B
of	O	ADP	O
LTR	B-DNA	NOUN	B
activation	O	NOUN	B
was	O	AUX	O
not	O	PART	O
mediated	O	VERB	O
through	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
-binding	O	ADJ	O
activity	O	NOUN	O
but	O	CCONJ	O
through	O	ADP	O
the	O	DET	O
region	O	NOUN	B
containing	O	VERB	O
the	O	DET	O
negative	B-DNA	ADJ	B
responding	I-DNA	VERB	O
elements	I-DNA	NOUN	O
(	O	PUNCT	O
NREs	B-DNA	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Tat-binding	B-protein	ADJ	B
protein	I-protein	NOUN	I
7	I-protein	NUM	I
is	O	AUX	O
a	O	DET	O
subunit	O	NOUN	B
of	O	ADP	O
the	O	DET	O
26S	B-protein	NOUN	B
protease	I-protein	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
report	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
NFKB2	B-protein	NOUN	B
(	O	PUNCT	O
lyt-10	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
c-Rel	B-protein	NOUN	B
are	O	AUX	O
overexpressed	O	VERB	B
in	O	ADP	O
HTLV-I	O	NOUN	B
infected	O	ADJ	B
and	O	CCONJ	O
Tax-expressing	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
,	O	PUNCT	O
together	O	ADV	O
,	O	PUNCT	O
account	O	VERB	O
for	O	ADP	O
the	O	DET	O
majority	O	NOUN	O
of	O	ADP	O
the	O	DET	O
constitutive	O	ADJ	B
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
binding	O	NOUN	O
activity	O	NOUN	O
in	O	ADP	O
these	O	DET	O
cells	O	NOUN	B
before	O	ADP	O
and	O	CCONJ	O
after	O	ADP	O
PMA	O	NOUN	B
stimulation	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
difference	O	NOUN	O
in	O	ADP	O
signals	O	NOUN	B
transduced	O	VERB	B
through	O	ADP	O
sIgM	B-protein	NOUN	B
and	O	CCONJ	O
sIgD	B-protein	NOUN	B
in	O	ADP	O
B104	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
is	O	AUX	O
discussed	O	VERB	O
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
investigated	O	VERB	B
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	I
acetylsalicylic	O	ADJ	B
acid	O	NOUN	I
and	O	CCONJ	O
sodium	O	NOUN	B
salicylate	O	NOUN	I
on	O	ADP	O
the	O	DET	O
LPS-induced	O	ADJ	B
synthesis	O	NOUN	B
of	O	ADP	O
the	O	DET	O
pro-coagulant	O	ADJ	B
protein	O	NOUN	B
tissue	O	NOUN	I
factor	O	NOUN	I
(	O	PUNCT	O
TF	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
pro-inflammatory	O	ADJ	B
protein	O	NOUN	I
tumor	O	NOUN	I
necrosis	O	NOUN	I
factor-alpha	O	NOUN	I
(	O	PUNCT	O
TNF-alpha	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
the	O	DET	O
prostaglandin	B-protein	NOUN	B
PGE2	I-protein	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


Both	O	DET	O
drugs	O	NOUN	B
dose-dependently	O	ADV	O
inhibited	O	VERB	B
LPS-induced	B-protein	ADJ	B
TF	I-protein	NOUN	I
and	O	CCONJ	O
TNF-alpha	B-protein	NOUN	B
synthesis	O	NOUN	B
at	O	ADP	O
the	O	DET	O
mRNA	B-RNA	NOUN	B
and	O	CCONJ	O
the	O	DET	O
protein	O	NOUN	B
level	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
reduced	O	VERB	B
PGE2	B-protein	NOUN	B
production	O	NOUN	B
.	O	PUNCT	O


Neutral	B-protein	ADJ	B
sphingomyelinase	I-protein	NOUN	I
(	O	PUNCT	I
SMase	B-protein	NOUN	B
)	O	PUNCT	O
can	O	AUX	O
be	O	AUX	O
activated	O	VERB	B
by	O	ADP	O
extracellular	O	ADJ	B
signals	O	NOUN	O
to	O	PART	O
produce	O	VERB	O
ceramide	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
may	O	AUX	O
affect	O	VERB	O
mitogen-activated	B-protein	ADJ	B
protein	I-protein	NOUN	I
kinase	I-protein	NOUN	I
(	O	PUNCT	O
MAPK	B-protein	NOUN	B
)	O	PUNCT	O
activities	O	NOUN	B
.	O	PUNCT	O


PMA	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
Ara-C	O	NOUN	B
or	O	CCONJ	O
ceramides	O	NOUN	B
,	O	PUNCT	O
activated	O	VERB	B
ERK	B-protein	NOUN	B
MAPKS	I-protein	NOUN	B
,	O	PUNCT	O
in	O	ADP	O
Jurkat	B-cell_line	NOUN	B
and	O	CCONJ	O
EL4	B-cell_line	NOUN	B
.	O	PUNCT	O


Nonhuman	O	ADJ	B
primates	O	NOUN	I
are	O	AUX	O
naturally	O	ADV	O
infected	O	VERB	B
with	O	ADP	O
a	O	DET	O
B-lymphotropic	O	ADJ	B
herpesvirus	O	NOUN	I
closely	O	ADV	O
related	O	ADJ	O
to	O	PART	O
Epstein-Barr	O	ADJ	B
virus	O	NOUN	I
(	O	PUNCT	O
EBV	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
cloned	O	VERB	B
the	O	DET	O
latent	B-protein	ADJ	B
membrane	I-protein	NOUN	I
protein	I-protein	NOUN	I
1	I-protein	NUM	I
(	I-protein	PUNCT	O
LMP1	I-protein	NOUN	B
)	I-protein	PUNCT	O
homologs	I-protein	NOUN	B
from	O	ADP	O
the	O	DET	O
simian	O	ADJ	B
EBV	O	NOUN	B
naturally	O	ADV	O
infecting	O	VERB	B
baboons	O	NOUN	O
(	O	PUNCT	O
cercopithicine	O	NOUN	B
herpesvirus	O	NOUN	I
12	O	NUM	I
,	O	PUNCT	O
herpesvirus	O	NOUN	B
papio	O	NOUN	I
)	O	PUNCT	O
and	O	CCONJ	O
rhesus	O	NOUN	B
monkeys	O	NOUN	I
(	O	PUNCT	O
cercopithicine	O	NOUN	B
herpesvirus	O	NOUN	I
15	O	NUM	I
)	O	PUNCT	O
for	O	ADP	O
a	O	DET	O
comparative	O	ADJ	B
study	O	NOUN	I
with	O	ADP	O
the	O	DET	O
human	O	ADJ	B
EBV	O	NOUN	B
oncogene	O	NOUN	O
.	O	PUNCT	O


Nevertheless	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
simian	B-protein	ADJ	B
EBV	I-protein	NOUN	B
LMP1s	I-protein	NOUN	B
retain	O	VERB	O
most	O	ADJ	O
functions	O	NOUN	B
in	O	ADP	O
common	O	ADJ	O
with	O	ADP	O
EBV	O	NOUN	B
LMP1	B-protein	NOUN	B
,	O	PUNCT	O
including	O	VERB	O
the	O	DET	O
ability	O	NOUN	O
to	O	PART	O
induce	O	VERB	B
NF-	B-protein	NOUN	B
(	I-protein	PUNCT	O
kappa	I-protein	NOUN	O
)	I-protein	PUNCT	O
B	I-protein	NOUN	O
activity	O	NOUN	O
in	O	ADP	O
human	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
to	O	PART	O
bind	O	VERB	B
the	O	DET	O
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor-associated	I-protein	ADJ	I
factor	I-protein	NOUN	I
3	I-protein	NUM	I
(	O	PUNCT	O
TRAF3	B-protein	NOUN	B
)	O	PUNCT	O
in	O	X	B
vitro	O	X	I
,	O	PUNCT	O
and	O	CCONJ	O
to	O	PART	O
induce	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
tumor	B-DNA	NOUN	B
necrosis	I-DNA	NOUN	I
factor-responsive	I-DNA	ADJ	I
genes	I-DNA	NOUN	I
,	O	PUNCT	O
such	O	ADJ	O
as	O	ADP	O
ICAM1	B-DNA	NOUN	B
,	O	PUNCT	O
in	O	ADP	O
human	B-cell_type	ADJ	B
B	I-cell_type	NOUN	O
lymphocytes	I-cell_type	NOUN	O
.	O	PUNCT	O


Chromosome	B-DNA	NOUN	B
1	I-DNA	NUM	I
aneusomy	O	NOUN	B
with	O	ADP	O
1p36	B-DNA	NOUN	B
under-representation	O	NOUN	B
is	O	AUX	O
related	O	ADJ	O
to	O	PART	O
histologic	O	ADJ	B
grade	O	NOUN	I
,	O	PUNCT	O
DNA	O	NOUN	B
aneuploidy	O	NOUN	I
,	O	PUNCT	O
high	O	ADJ	O
c-erb	B-protein	NOUN	B
B-2	I-protein	NOUN	I
and	O	CCONJ	O
loss	O	NOUN	B
of	O	ADP	O
bcl-2	B-DNA	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
ductal	O	ADJ	B
breast	O	NOUN	I
carcinoma	O	NOUN	I
.	O	PUNCT	O


No	O	DET	O
correlation	O	NOUN	B
between	O	ADP	O
chromosome	B-DNA	NOUN	B
1	I-DNA	NUM	I
alterations	O	NOUN	B
and	O	CCONJ	O
nuclear	O	ADJ	B
grade	O	NOUN	I
,	O	PUNCT	O
age	O	NOUN	B
,	O	PUNCT	O
size	O	NOUN	B
,	O	PUNCT	O
lymph-node	O	ADJ	B
involvement	O	NOUN	B
,	O	PUNCT	O
hormonal	O	ADJ	B
receptor	O	NOUN	I
presence	O	NOUN	B
,	O	PUNCT	O
proliferation	O	NOUN	B
activity	O	NOUN	I
or	O	CCONJ	O
p53	B-protein	NOUN	B
protein	O	NOUN	I
expression	O	NOUN	B
was	O	AUX	O
detected	O	VERB	B
.	O	PUNCT	O


A	O	DET	O
study	O	NOUN	B
of	O	ADP	O
the	O	DET	O
molecular	O	ADJ	B
mechanisms	O	NOUN	I
involved	O	VERB	O
in	O	ADP	O
inflammatory	B-protein	ADJ	B
cytokine	I-protein	NOUN	O
expression	O	NOUN	O
[	O	PUNCT	O
published	O	VERB	B
erratum	O	NOUN	O
appears	O	VERB	O
in	O	ADP	O
J	O	PROPN	O
Biol	O	PROPN	O
Chem	O	PROPN	O
1994	O	NUM	O
Jun	O	NOUN	O
17	O	NUM	O
;	O	PUNCT	O
269	O	NUM	O
(	O	PUNCT	O
24	O	NUM	O
)	O	PUNCT	O
:	O	PUNCT	O
16983	O	NUM	O
]	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
maximal	O	ADJ	B
G	O	NOUN	I
(	O	PUNCT	O
Anh	O	PROPN	O
)	O	PUNCT	O
MTetra-induced	O	ADJ	B
IL-1	B-protein	NOUN	B
beta	I-protein	NOUN	O
and	O	CCONJ	O
IL-6	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
expression	O	NOUN	O
could	O	AUX	O
be	O	AUX	O
enhanced	O	VERB	B
by	O	ADP	O
co-stimulation	O	NOUN	B
with	O	ADP	O
LPS	O	NOUN	B
or	O	CCONJ	O
MDP	O	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
different	O	ADJ	O
receptors	O	NOUN	B
and/or	O	CCONJ	O
transduction	O	NOUN	B
pathways	O	NOUN	I
were	O	AUX	O
involved	O	VERB	O
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
their	O	PRON	O
specific	O	ADJ	O
function	O	NOUN	B
in	O	ADP	O
these	O	DET	O
processes	O	NOUN	B
has	O	AUX	O
not	O	PART	O
been	O	AUX	O
clearly	O	ADV	O
defined	O	VERB	O
.	O	PUNCT	O


Using	O	VERB	O
fluorescence	O	NOUN	B
in	O	X	I
situ	O	X	I
hybridization	O	NOUN	I
(	O	PUNCT	O
FISH	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
we	O	PRON	O
show	O	VERB	O
here	O	ADV	O
that	O	SCONJ	O
the	O	DET	O
genes	B-DNA	NOUN	B
encoding	O	VERB	B
the	O	DET	O
TATA-box	B-protein	NOUN	B
binding	I-protein	NOUN	I
protein	I-protein	NOUN	I
(	O	PUNCT	O
TBP	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
TFIIB	B-protein	NOUN	B
,	O	PUNCT	O
TFIIE	B-protein	NOUN	B
alpha	I-protein	NOUN	I
,	O	PUNCT	O
TFIIE	B-protein	NOUN	B
beta	I-protein	NOUN	I
,	O	PUNCT	O
RAP30	B-protein	NOUN	B
,	O	PUNCT	O
RAP74	B-protein	NOUN	B
and	O	CCONJ	O
the	O	DET	O
62	B-protein	NUM	O
kDa	I-protein	NOUN	O
subunit	I-protein	NOUN	B
,	O	PUNCT	O
of	O	ADP	O
TFIIH	B-protein	NOUN	B
are	O	AUX	O
located	O	ADJ	O
at	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
chromosomal	I-DNA	ADJ	O
bands	I-DNA	NOUN	O
6q26-27	I-DNA	NOUN	O
,	I-DNA	PUNCT	O
1p21-22	I-DNA	NOUN	O
,	I-DNA	PUNCT	O
3q21-24	I-DNA	NOUN	O
,	I-DNA	PUNCT	O
8p12	I-DNA	NOUN	B
,	I-DNA	PUNCT	O
13q14	I-DNA	NOUN	B
,	I-DNA	PUNCT	O
19p13.3	I-DNA	NOUN	B
and	I-DNA	CCONJ	O
11p14-15.1	I-DNA	NOUN	B
,	O	PUNCT	O
respectively	O	ADV	O
.	O	PUNCT	O


Although	O	SCONJ	O
no	O	DET	O
proof	O	NOUN	O
yet	O	ADV	O
exists	O	VERB	O
of	O	ADP	O
a	O	DET	O
role	O	NOUN	O
for	O	ADP	O
these	O	DET	O
lesions	O	NOUN	B
in	O	ADP	O
DLCL	O	NOUN	B
pathogenesis	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
feature	O	NOUN	O
of	O	ADP	O
the	O	DET	O
BCL-6	B-protein	NOUN	B
gene	I-protein	NOUN	I
product	I-protein	NOUN	O
,	O	PUNCT	O
its	O	PRON	O
specific	O	ADJ	O
pattern	O	NOUN	B
of	O	ADP	O
expression	O	NOUN	B
in	O	ADP	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
clustering	O	NOUN	B
of	O	ADP	O
lesions	O	NOUN	B
disrupting	O	VERB	B
its	O	PRON	O
regulatory	O	ADJ	B
domain	O	NOUN	I
strongly	O	ADV	O
suggest	O	VERB	O
that	O	SCONJ	O
deregulation	O	NOUN	B
of	O	ADP	O
BCL-6	B-protein	NOUN	B
expression	O	NOUN	B
may	O	AUX	O
contribute	O	VERB	O
to	O	PART	O
DLCL	O	NOUN	B
development	O	NOUN	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
BCL-6	B-protein	NOUN	B
rearrangements	O	NOUN	B
can	O	AUX	O
be	O	AUX	O
used	O	VERB	O
to	O	PART	O
identify	O	VERB	O
and	O	CCONJ	O
monitor	O	VERB	B
the	O	DET	O
malignant	B-cell_type	ADJ	B
clone	I-cell_type	NOUN	B
with	O	ADP	O
sensitive	O	ADJ	B
PCR-based	O	ADJ	B
techniques	O	NOUN	I
.	O	PUNCT	O


Studies	O	NOUN	B
of	O	ADP	O
pluripotent	B-cell_line	ADJ	B
islet	I-cell_line	NOUN	I
cultures	I-cell_line	NOUN	I
.	O	PUNCT	O


Generation	O	NOUN	B
of	O	ADP	O
CD1+RelB+	B-cell_type	ADJ	O
dendritic	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
tartrate-resistant	B-cell_type	ADJ	B
acid	I-cell_type	NOUN	I
phosphatase-positive	I-cell_type	ADJ	I
osteoclast-like	I-cell_type	ADJ	O
multinucleated	I-cell_type	ADJ	O
giant	I-cell_type	ADJ	O
cells	I-cell_type	NOUN	O
from	O	ADP	O
human	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
monocyte-derived	B-cell_line	ADJ	B
DC	I-cell_line	NOUN	B
were	O	AUX	O
not	O	PART	O
terminally	B-cell_line	ADV	O
differentiated	I-cell_line	VERB	O
cells	I-cell_line	NOUN	O
;	O	PUNCT	O
they	O	PRON	O
could	O	AUX	O
still	O	ADV	O
convert	O	VERB	O
to	O	PART	O
macrophages	B-cell_type	NOUN	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
M-CSF	B-protein	NOUN	B
.	O	PUNCT	O


Rather	O	ADV	O
,	O	PUNCT	O
IFN-gamma	B-protein	NOUN	B
antagonized	O	VERB	B
the	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
IL-4	B-protein	NOUN	B
and	O	CCONJ	O
suppressed	O	VERB	B
the	O	DET	O
DC	B-cell_type	NOUN	B
and	O	CCONJ	O
MGC	B-cell_type	NOUN	B
formation	O	NOUN	B
induced	O	VERB	B
by	O	ADP	O
GM-CSF	B-protein	NOUN	B
+	O	CCONJ	O
IL-4	B-protein	NOUN	B
and	O	CCONJ	O
M-CSF	B-protein	NOUN	B
+	O	CCONJ	O
IL-4	B-protein	NOUN	B
,	O	PUNCT	O
respectively	O	ADV	O
.	O	PUNCT	O


While	O	SCONJ	O
Jurkat	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
co-expressed	O	VERB	B
two	O	NUM	O
discrete	O	ADJ	O
cell-surface	B-protein	ADJ	B
isoforms	I-protein	NOUN	O
of	O	ADP	O
CD43	B-protein	NOUN	B
,	O	PUNCT	O
recognized	O	VERB	O
by	O	ADP	O
mAb	B-protein	NOUN	B
J393	I-protein	NOUN	B
and	O	CCONJ	O
mAb	B-protein	NOUN	B
G10-2	I-protein	NOUN	B
,	O	PUNCT	O
respectively	O	ADV	O
,	O	PUNCT	O
only	O	ADV	O
J393/CD43	B-protein	NOUN	B
signaled	O	VERB	O
apoptosis	O	NOUN	B
.	O	PUNCT	O


Sterol	B-DNA	NOUN	B
regulatory	I-DNA	ADJ	I
element	I-DNA	NOUN	I
(	O	PUNCT	O
SRE	B-DNA	NOUN	B
)	O	PUNCT	O
has	O	AUX	O
been	O	AUX	O
recognized	O	VERB	O
to	O	PART	O
regulate	O	VERB	B
various	O	ADJ	O
key	O	ADJ	O
genes	B-DNA	NOUN	B
coding	O	VERB	B
for	O	ADP	O
especially	O	ADV	O
low	B-protein	ADJ	B
density	I-protein	NOUN	I
lipoprotein	I-protein	NOUN	I
(	I-protein	PUNCT	I
LDL	I-protein	NOUN	B
)	I-protein	PUNCT	O
-receptor	I-protein	NOUN	O
,	O	PUNCT	O
3-hydroxy-3-methylglutaryl	B-protein	ADJ	O
coenzyme	I-protein	NOUN	O
A	I-protein	NOUN	O
(	I-protein	PUNCT	O
HMG-CoA	I-protein	NOUN	O
)	I-protein	PUNCT	O
reductase	I-protein	NOUN	O
and	O	CCONJ	O
HMG-CoA	B-protein	NOUN	B
synthase	I-protein	NOUN	I
known	O	VERB	O
to	O	PART	O
play	O	VERB	O
a	O	DET	O
crucial	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
cholesterol	O	NOUN	B
feedback	O	NOUN	I
mechanism	O	NOUN	B
.	O	PUNCT	O


Based	O	VERB	O
upon	O	SCONJ	O
these	O	DET	O
results	O	NOUN	B
we	O	PRON	O
propose	O	VERB	O
that	O	SCONJ	O
alpha-interferon	B-protein	NOUN	B
through	O	ADP	O
its	O	PRON	O
receptor	O	NOUN	B
initiates	O	VERB	B
phosphatidic	O	ADJ	B
acid	O	NOUN	I
dependent	O	ADJ	O
signalling	O	NOUN	B
which	O	DET	O
in	O	ADP	O
turn	O	NOUN	O
regulates	O	VERB	B
the	O	DET	O
affinity	O	NOUN	B
of	O	ADP	O
47	B-protein	NUM	O
kDa	I-protein	NOUN	O
sterol	I-protein	NOUN	B
regulatory	I-protein	ADJ	O
element	I-protein	NOUN	O
binding	I-protein	NOUN	O
factor	I-protein	NOUN	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
LDL-receptor	B-DNA	ADJ	B
gene	I-DNA	NOUN	B
transcription	O	NOUN	I
in	O	ADP	O
lymphocytes	B-cell_type	NOUN	B
from	O	ADP	O
CML	O	NOUN	B
patients	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
most	O	ADJ	O
cell	O	NOUN	B
lines	O	NOUN	I
,	O	PUNCT	O
proteins	O	NOUN	B
of	O	ADP	O
molecular	O	ADJ	B
weight	O	NOUN	I
49	O	NUM	O
and	O	CCONJ	O
44	O	NUM	O
kDa	O	NOUN	O
were	O	AUX	O
found	O	VERB	O
,	O	PUNCT	O
however	O	ADV	O
two	O	NUM	O
myeloid	O	ADJ	B
cell	O	NOUN	I
lines	O	NOUN	I
expressed	O	VERB	B
only	O	ADV	O
lower	O	ADJ	O
molecular	B-protein	ADJ	B
weight	I-protein	NOUN	I
species	I-protein	NOUN	O
of	I-protein	ADP	O
24	I-protein	NUM	O
and	I-protein	CCONJ	O
22	I-protein	NUM	O
kDa	I-protein	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
present	O	ADJ	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
SCL	B-protein	NOUN	B
protein	I-protein	NOUN	B
size	O	NOUN	I
was	O	AUX	O
determined	O	VERB	O
by	O	ADP	O
regulation	O	NOUN	B
of	O	ADP	O
translation	O	NOUN	B
in	O	ADP	O
a	O	DET	O
cell-specific	O	ADJ	B
manner	O	NOUN	I
.	O	PUNCT	O


Induction	O	NOUN	B
of	O	ADP	O
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	I
and	O	CCONJ	O
T-cell	B-cell_type	NOUN	B
activation	O	NOUN	I
by	O	ADP	O
vanadate	O	NOUN	B
peroxide	O	NOUN	I
,	O	PUNCT	O
an	O	DET	O
inhibitor	O	NOUN	B
of	O	ADP	O
protein	B-protein	NOUN	B
tyrosine	I-protein	NOUN	I
phosphatases	I-protein	NOUN	I
.	O	PUNCT	O


Contrary	O	ADJ	O
to	O	ADP	O
the	O	DET	O
idea	O	NOUN	O
that	O	SCONJ	O
protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
C	I-protein	NOUN	I
is	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
TCR	B-protein	NOUN	B
-mediated	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
NF-kappaB	B-protein	NOUN	B
,	O	PUNCT	O
high	O	ADJ	B
doses	O	NOUN	I
of	O	ADP	O
staurosporine	O	NOUN	B
did	O	AUX	O
not	O	PART	O
interfere	O	VERB	B
with	O	ADP	I
activation	O	NOUN	B
of	O	ADP	O
NF-kappaB	B-protein	NOUN	B
by	O	ADP	O
PHA	B-protein	NOUN	B
,	O	PUNCT	O
while	O	SCONJ	O
the	O	DET	O
same	O	ADJ	O
dose	O	NOUN	B
of	O	ADP	O
staurosporine	O	NOUN	B
completely	O	ADV	O
blocked	O	VERB	B
activation	O	NOUN	B
by	O	ADP	O
PMA	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
TCR	B-protein	NOUN	B
-mediated	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
NF-kappaB	B-protein	NOUN	B
was	O	AUX	O
also	O	ADV	O
dependent	O	ADJ	O
on	O	ADP	O
a	O	DET	O
Ca2+	O	NOUN	B
influx	O	NOUN	B
,	O	PUNCT	O
because	O	SCONJ	O
the	O	DET	O
Ca2+	O	NOUN	B
channel	O	NOUN	I
blocker	O	NOUN	I
,	O	PUNCT	O
SK	O	PROPN	B
&	O	CCONJ	O
F	O	PROPN	O
96365	O	NUM	O
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
other	O	ADJ	O
agents	O	NOUN	B
that	O	PRON	O
prevented	O	VERB	B
the	O	DET	O
Ca2+	O	NOUN	B
influx	O	NOUN	B
,	O	PUNCT	O
inhibited	O	VERB	B
NF-kappaB	B-protein	NOUN	B
activation	O	NOUN	B
.	O	PUNCT	O


Two	O	NUM	O
multicopy	B-DNA	ADJ	B
basal	I-DNA	ADJ	B
enhancer	I-DNA	NOUN	I
motifs	I-DNA	NOUN	B
within	O	ADP	O
the	O	DET	O
SCMV	O	NOUN	B
MIE	B-DNA	NOUN	O
enhancer	I-DNA	NOUN	B
,	O	PUNCT	O
namely	O	ADV	O
,	O	PUNCT	O
11	O	NUM	O
copies	O	NOUN	B
of	O	ADP	O
the	O	DET	O
16-bp	O	ADJ	O
cyclic	B-DNA	ADJ	B
AMP	I-DNA	NOUN	B
response	I-DNA	NOUN	O
element	I-DNA	NOUN	O
(	O	PUNCT	O
CRE	B-DNA	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
3	O	NUM	O
copies	O	NOUN	B
of	O	ADP	O
novel	O	ADJ	O
17-bp	O	ADJ	O
serum	B-DNA	NOUN	B
response	I-DNA	NOUN	I
factor	I-DNA	NOUN	I
(	I-DNA	PUNCT	O
SRF	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
binding	I-DNA	NOUN	B
sites	I-DNA	NOUN	I
referred	O	VERB	O
to	O	PART	O
as	O	ADP	O
the	O	DET	O
SNE	B-DNA	NOUN	B
(	O	PUNCT	O
SRF/NFkappaB-like	B-DNA	ADJ	B
element	I-DNA	NOUN	I
)	O	PUNCT	O
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
four	O	NUM	O
classical	O	ADJ	O
NFkappaB	B-DNA	NOUN	B
sites	I-DNA	NOUN	I
within	O	ADP	O
the	O	DET	O
HCMV	O	NOUN	B
version	O	NOUN	B
,	O	PUNCT	O
contribute	O	VERB	O
to	O	PART	O
TPA	O	NOUN	B
responsiveness	O	NOUN	B
in	O	ADP	O
transient	O	ADJ	B
assays	O	NOUN	I
in	O	ADP	O
monocyte	B-cell_type	NOUN	B
and	I-cell_type	CCONJ	O
T-cell	I-cell_type	NOUN	B
types	I-cell_type	NOUN	I
.	O	PUNCT	O


The	O	DET	O
TAL-1	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
specifies	O	VERB	O
for	O	ADP	O
a	O	DET	O
basic	O	ADJ	O
domain-helix-loop-helix	B-protein	ADJ	B
protein	I-protein	NOUN	I
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
control	O	NOUN	B
of	O	ADP	O
normal	O	ADJ	O
hematopoiesis	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
human	O	ADJ	B
pathology	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
TAL-1	B-protein	NOUN	B
gene	I-protein	NOUN	I
product	I-protein	NOUN	O
is	O	AUX	O
expressed	O	VERB	B
in	O	ADP	O
a	O	DET	O
high	O	ADJ	O
percentage	O	NOUN	B
of	O	ADP	O
T-cell	B-cell_type	NOUN	B
acute	O	ADJ	I
lymphoblastic	O	ADJ	I
leukemias	O	NOUN	I
in	O	ADP	O
the	O	DET	O
pediatric	O	ADJ	B
age	O	NOUN	O
range	O	NOUN	O
;	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
it	O	PRON	O
has	O	AUX	O
not	O	PART	O
been	O	AUX	O
established	O	VERB	O
whether	O	SCONJ	O
the	O	DET	O
expression	O	NOUN	B
has	O	AUX	O
a	O	DET	O
causal	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
oncogenesis	O	NOUN	B
.	O	PUNCT	O


To	O	PART	O
further	O	ADV	O
unravel	O	VERB	O
the	O	DET	O
tal-1	B-DNA	NOUN	B
oncogenic	O	ADJ	B
potential	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
strain	O	NOUN	B
of	O	ADP	O
tal-1	B-DNA	NOUN	B
transgenic	O	ADJ	B
mice	O	NOUN	I
was	O	AUX	O
crossbred	O	VERB	B
with	O	ADP	O
p53-/-	O	ADJ	B
mice	O	NOUN	I
;	O	PUNCT	O
the	O	DET	O
survival	O	NOUN	B
rate	O	NOUN	I
in	O	ADP	O
these	O	DET	O
animals	O	NOUN	B
was	O	AUX	O
reduced	O	VERB	B
by	O	ADP	O
more	O	ADJ	O
than	O	ADP	O
one-half	O	NUM	O
when	O	SCONJ	O
compared	O	VERB	B
with	O	ADP	O
that	O	DET	O
of	O	ADP	O
tal-1	B-DNA	NOUN	B
mice	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
histopathological	O	ADJ	B
analysis	O	NOUN	I
revealed	O	VERB	O
exclusively	O	ADV	O
T-cell	B-cell_type	NOUN	B
lymphomas	O	NOUN	I
.	O	PUNCT	O


TSC2	B-RNA	NOUN	B
messenger	I-RNA	NOUN	I
RNA	I-RNA	NOUN	I
was	O	AUX	O
widely	O	ADV	O
expressed	O	VERB	B
in	O	ADP	O
various	O	ADJ	O
cell	O	NOUN	B
types	O	NOUN	I
throughout	O	ADP	O
the	O	DET	O
body	O	NOUN	B
,	O	PUNCT	O
including	O	VERB	O
epithelia	O	NOUN	B
,	O	PUNCT	O
lymphocytes	B-cell_type	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
cells	O	NOUN	B
with	O	ADP	O
endocrine	O	ADJ	B
functions	O	NOUN	I
,	O	PUNCT	O
e.g.	O	X	O
,	O	PUNCT	O
adrenal	O	ADJ	B
cortex	O	NOUN	I
and	O	CCONJ	O
anterior	O	ADJ	B
pituitary	O	NOUN	B
.	O	PUNCT	O


Fas	B-protein	NOUN	B
-mediated	O	ADJ	O
apoptosis	O	NOUN	B
plays	O	VERB	O
an	O	DET	O
important	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
regulating	O	VERB	B
the	O	DET	O
immune	O	ADJ	B
response	O	NOUN	I
in	O	ADP	O
peripheral	B-cell_type	ADJ	B
T	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
.	O	PUNCT	O


To	O	PART	O
examine	O	VERB	O
the	O	DET	O
behavior	O	NOUN	B
of	O	ADP	O
Bcl-2	B-protein	NOUN	B
in	O	ADP	O
normal	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
T	B-cell_type	NOUN	B
cell	I-cell_type	NOUN	I
blasts	I-cell_type	NOUN	I
were	O	AUX	O
transiently	O	ADV	O
transfected	O	VERB	B
with	O	ADP	O
Bcl-2	B-protein	NOUN	B
and	O	CCONJ	O
related	O	ADJ	O
gene	B-protein	NOUN	B
products	I-protein	NOUN	I
to	O	PART	O
determine	O	VERB	O
the	O	DET	O
effect	O	NOUN	B
on	O	ADP	O
apoptotic	O	ADJ	B
signaling	O	NOUN	I
.	O	PUNCT	O


Expression	O	NOUN	B
of	O	ADP	O
Bcl-xL	B-protein	NOUN	B
and	O	CCONJ	O
adenovirus	B-protein	NOUN	B
E1B	I-protein	NOUN	O
19K	I-protein	NOUN	O
did	O	AUX	O
not	O	PART	O
interfere	O	VERB	B
with	O	ADP	I
anti-	O	NOUN	O
Fas	B-protein	NOUN	B
killing	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
interleukin-1beta-converting	O	ADJ	B
enzyme	O	NOUN	O
family	O	NOUN	O
protease	O	NOUN	O
inhibitors	O	NOUN	O
Ac-DEVD-CHO	O	NOUN	B
and	O	CCONJ	O
CrmA	O	NOUN	B
blocked	O	VERB	B
Fas	B-protein	NOUN	B
-mediated	O	ADJ	O
apoptosis	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
EL-4	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
incubated	O	VERB	B
with	O	ADP	O
ciprofloxacin	O	NOUN	B
showed	O	VERB	O
an	O	DET	O
early	O	ADJ	B
peak	O	NOUN	O
and	O	CCONJ	O
more	O	ADV	O
activated	O	VERB	B
nuclear	O	ADJ	O
factor	O	NOUN	O
of	O	ADP	O
activated	B-cell_type	VERB	B
T	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
(	O	PUNCT	O
NFAT-1	B-protein	NOUN	B
)	O	PUNCT	O
as	O	ADP	O
compared	O	VERB	B
to	O	PART	O
control	O	NOUN	B
cells	O	NOUN	I
without	O	ADP	O
antibiotics	O	NOUN	B
.	O	PUNCT	O


Taken	O	VERB	O
together	O	ADV	O
,	O	PUNCT	O
cipro	O	NOUN	B
inhibited	O	VERB	B
IFN-gamma	B-protein	NOUN	B
synthesis	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
enhanced	O	VERB	B
IL-2	B-protein	NOUN	B
production	O	NOUN	B
in	O	ADP	O
murine	B-cell_type	ADJ	B
lymphocytes	I-cell_type	NOUN	B
by	O	ADP	O
means	O	NOUN	O
of	O	ADP	O
influencing	O	VERB	O
NFAT-1	B-protein	NOUN	B
and	O	CCONJ	O
causing	O	VERB	O
an	O	DET	O
increased	O	VERB	B
IL-2	B-protein	NOUN	B
transcription	O	NOUN	B
.	O	PUNCT	O


Human	O	ADJ	B
T-cell	O	NOUN	I
leukemia	O	NOUN	I
virus	O	NOUN	O
type	O	NOUN	O
I	O	NUM	O
(	O	PUNCT	O
HTLV-I	O	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
the	O	DET	O
etiologic	O	ADJ	B
agent	O	NOUN	I
of	O	ADP	O
the	O	DET	O
adult	O	ADJ	B
T-cell	O	NOUN	B
leukemia	O	NOUN	I
,	O	PUNCT	O
an	O	DET	O
aggressive	O	ADJ	B
and	O	CCONJ	O
often	O	ADV	O
fatal	O	ADJ	B
malignancy	O	NOUN	B
of	O	ADP	O
activated	B-cell_line	VERB	B
human	I-cell_line	ADJ	B
CD4	I-cell_line	NOUN	O
T	I-cell_line	NOUN	O
cells	I-cell_line	NOUN	O
.	O	PUNCT	O


(	O	PUNCT	O
ABSTRACT	O	NOUN	B
TRUNCATED	O	VERB	I
AT	O	ADP	I
250	O	NUM	I
WORDS	O	NOUN	I
)	O	PUNCT	O


Skeletal	O	ADJ	B
myogenesis	O	NOUN	I
is	O	AUX	O
regulated	O	VERB	O
by	O	ADP	O
a	O	DET	O
group	O	NOUN	B
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
(	O	PUNCT	O
MyoD	B-protein	NOUN	B
,	O	PUNCT	O
myogenin	B-protein	NOUN	B
,	O	PUNCT	O
myf5	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
myf6	B-protein	NOUN	B
)	O	PUNCT	O
that	O	PRON	O
are	O	AUX	O
``	B-protein	PUNCT	O
basic	I-protein	ADJ	O
helix-loop-helix	I-protein	ADJ	O
''	I-protein	PUNCT	O
proteins	I-protein	NOUN	B
that	O	PRON	O
bind	O	VERB	B
to	O	PART	O
the	O	DET	O
promoters	B-DNA	NOUN	B
of	O	ADP	O
muscle-specific	B-DNA	ADJ	B
genes	I-DNA	NOUN	I
and	O	CCONJ	O
promote	O	VERB	B
their	O	PRON	O
expression	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
previously	O	ADV	O
shown	O	VERB	O
that	O	SCONJ	O
after	O	ADP	O
a	O	DET	O
mutation	O	NOUN	B
of	O	ADP	O
Leu122	O	NOUN	B
to	O	PART	O
Arg	O	NOUN	B
the	O	DET	O
DNA	B-protein	NOUN	B
binding	I-protein	NOUN	I
basic	I-protein	ADJ	I
domain	I-protein	NOUN	I
of	O	ADP	O
MyoD	B-protein	NOUN	B
confers	O	VERB	O
c-myc	B-DNA	NOUN	B
-like	O	ADJ	O
functional	O	ADJ	B
characteristics	O	NOUN	B
to	O	PART	O
the	O	DET	O
protein	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
study	O	NOUN	B
we	O	PRON	O
used	O	VERB	O
single-strand	O	ADJ	B
conformation	O	NOUN	I
polymorphism	O	NOUN	B
analysis	O	NOUN	B
to	O	PART	O
determine	O	VERB	O
whether	O	SCONJ	O
such	O	ADJ	O
mutations	O	NOUN	B
occur	O	VERB	O
naturally	O	ADV	O
in	O	ADP	O
rhabdomyosarcomas	O	NOUN	B
.	O	PUNCT	O


Selection	O	NOUN	B
against	O	ADP	O
such	O	ADJ	O
mutations	O	NOUN	B
may	O	AUX	O
be	O	AUX	O
the	O	DET	O
result	O	NOUN	O
of	O	ADP	O
functional	O	ADJ	B
redundancy	O	NOUN	B
of	O	ADP	O
these	O	DET	O
myogenic	B-protein	ADJ	B
transcription	I-protein	NOUN	I
factors	I-protein	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
then	O	ADV	O
generated	O	VERB	O
new	O	ADJ	O
donor	O	NOUN	B
anti-pml/RAR-alpha	B-cell_line	NOUN	O
CD4	I-cell_line	NOUN	O
(	I-cell_line	PUNCT	O
+	I-cell_line	CCONJ	O
)	I-cell_line	PUNCT	O
T-cell	I-cell_line	NOUN	O
clones	I-cell_line	NOUN	O
.	O	PUNCT	O


These	O	DET	O
clones	O	NOUN	B
were	O	AUX	O
tested	O	VERB	B
for	O	ADP	O
their	O	PRON	O
recognition	O	NOUN	B
of	O	ADP	O
BCR1/25	O	NOUN	B
.	O	PUNCT	O


Since	O	SCONJ	O
APL	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	B
do	O	AUX	O
not	O	PART	O
express	O	VERB	O
HLA	B-protein	NOUN	B
class	I-protein	NOUN	I
II	I-protein	NUM	I
molecules	I-protein	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
tested	O	VERB	B
in	O	ADP	O
two	O	NUM	O
donors	O	NOUN	B
(	O	PUNCT	O
D.E.	O	PROPN	O
and	O	CCONJ	O
C.H.R.	O	PROPN	B
)	O	PUNCT	O
and	O	CCONJ	O
in	O	ADP	O
patients	O	NOUN	B
S.R.and	O	VERB	O
P.G.whether	O	NOUN	O
the	O	DET	O
use	O	NOUN	O
of	O	ADP	O
9-mer	O	ADJ	O
peptides	O	NOUN	O
(	O	PUNCT	O
BCR1/9	O	NOUN	B
)	O	PUNCT	O
would	O	AUX	O
generate	O	VERB	O
a	O	DET	O
CD8	B-protein	NOUN	B
/HLA	B-protein	NOUN	I
class	I-protein	NOUN	I
I	I-protein	NUM	I
-restricted	O	ADJ	O
response	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
CpG	O	NOUN	B
dinucleotide	O	NOUN	I
in	O	ADP	O
this	O	DET	O
element	B-DNA	NOUN	B
is	O	AUX	O
selectively	O	ADV	O
methylated	O	VERB	B
in	O	ADP	O
Th2	B-cell_type	NOUN	B
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
other	O	ADJ	O
cells	O	NOUN	B
that	O	PRON	O
do	O	AUX	O
not	O	PART	O
express	O	VERB	O
IFN-gamma	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
methylation	O	NOUN	B
markedly	O	ADV	O
reduces	O	VERB	B
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
binding	O	NOUN	I
.	O	PUNCT	O


CD40	B-protein	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
lipopolysaccharide	O	NOUN	B
and	O	CCONJ	O
anti-IgM	B-protein	ADJ	B
stimulation	O	NOUN	B
of	O	ADP	O
primary	B-cell_type	ADJ	B
B	I-cell_type	NOUN	I
lymphocytes	I-cell_type	NOUN	I
,	O	PUNCT	O
leads	O	VERB	O
to	O	PART	O
a	O	DET	O
persistent	O	ADJ	B
nuclear	O	ADJ	B
accumulation	O	NOUN	B
of	O	ADP	O
RelB	B-protein	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
study	O	NOUN	B
we	O	PRON	O
analyzed	O	VERB	B
the	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
CD40	B-protein	NOUN	B
stimulation	O	NOUN	B
on	O	ADP	O
the	O	DET	O
activity	O	NOUN	B
and	O	CCONJ	O
nuclear	O	ADJ	B
appearance	O	NOUN	B
of	O	ADP	O
Rel/nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
kappaB	I-protein	NOUN	I
(	I-protein	PUNCT	O
NF-kappaB	I-protein	NOUN	B
)	I-protein	PUNCT	O
factors	I-protein	NOUN	B
in	O	ADP	O
primary	B-cell_type	ADJ	O
murine	I-cell_type	ADJ	O
B	I-cell_type	NOUN	O
lymphocytes	I-cell_type	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
triggering	O	NOUN	B
of	O	ADP	O
CD40	B-protein	NOUN	B
signaling	O	NOUN	B
pathway	O	NOUN	I
(	O	PUNCT	O
s	O	NOUN	O
)	O	PUNCT	O
by	O	ADP	O
CD40	B-protein	NOUN	B
ligands	I-protein	NOUN	B
expressed	O	VERB	B
on	O	ADP	O
L	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
led	O	VERB	O
to	O	PART	O
strong	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
an	O	DET	O
NF-kappaB-controlled	B-DNA	ADJ	B
beta-globin	I-DNA	NOUN	I
reporter	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
in	O	ADP	O
primary	B-cell_type	ADJ	B
B	I-cell_type	NOUN	I
lymphocytes	I-cell_type	NOUN	I
from	O	ADP	O
transgenic	O	ADJ	B
mice	O	NOUN	I
.	O	PUNCT	O


Analyses	O	NOUN	B
of	O	ADP	O
nuclear	O	ADJ	B
translocation	O	NOUN	I
of	O	ADP	O
individual	O	ADJ	B
members	O	NOUN	I
of	O	ADP	O
Rel	B-protein	NOUN	B
proteins	I-protein	NOUN	I
after	O	ADP	O
CD40	B-protein	NOUN	B
induction	O	NOUN	B
of	O	ADP	O
primary	B-cell_type	ADJ	B
B	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
showed	O	VERB	O
a	O	DET	O
strong	O	ADJ	B
and	O	CCONJ	O
long-lasting	O	ADJ	O
accumulation	O	NOUN	B
of	O	ADP	O
RelB	B-protein	NOUN	B
and	O	CCONJ	O
,	O	PUNCT	O
less	O	ADV	O
pronounced	O	ADJ	O
,	O	PUNCT	O
of	O	ADP	O
c-Rel	B-protein	NOUN	B
.	O	PUNCT	O


Identification	O	NOUN	B
and	O	CCONJ	O
characterization	O	NOUN	B
of	O	ADP	O
a	O	DET	O
leukocyte-specific	O	ADJ	B
component	O	NOUN	I
of	O	ADP	O
the	O	DET	O
nuclear	O	ADJ	B
body	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
exerting	O	VERB	O
their	O	PRON	O
antiproliferative	O	ADJ	B
effects	O	NOUN	I
,	O	PUNCT	O
GCS	O	NOUN	B
diffuse	O	NOUN	B
into	O	ADP	O
target	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
where	O	SCONJ	O
they	O	PRON	O
bind	O	VERB	B
their	O	PRON	O
cytoplasmic	B-protein	ADJ	B
receptor	I-protein	NOUN	I
,	O	PUNCT	O
which	O	DET	O
in	O	ADP	O
turn	O	NOUN	O
translocates	O	VERB	B
to	O	PART	O
the	O	DET	O
nucleus	O	NOUN	B
where	O	SCONJ	O
it	O	PRON	O
inhibits	O	VERB	B
transcription	O	NOUN	B
of	O	ADP	O
cytokine	B-DNA	NOUN	B
genes	I-DNA	NOUN	I
through	O	ADP	O
direct	O	ADJ	O
binding	O	NOUN	B
to	O	PART	O
the	O	DET	O
glucocorticoid	B-DNA	NOUN	B
response	I-DNA	NOUN	I
elements	I-DNA	NOUN	I
(	O	PUNCT	O
GRE	B-DNA	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
which	O	DET	O
are	O	AUX	O
located	O	ADJ	O
in	O	ADP	O
the	O	DET	O
promoter	O	NOUN	B
region	O	NOUN	I
of	O	ADP	O
cytokine	B-DNA	NOUN	B
genes	I-DNA	NOUN	I
or	O	CCONJ	O
,	O	PUNCT	O
alternatively	O	ADV	B
,	O	PUNCT	O
through	O	ADP	O
antagonism	O	NOUN	B
of	O	ADP	O
the	O	DET	O
action	O	NOUN	B
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
required	O	VERB	O
for	O	ADP	O
optimal	O	ADJ	B
transcriptional	O	ADJ	B
activation	O	NOUN	I
.	O	PUNCT	O


CD40	B-protein	NOUN	B
-mediated	O	ADJ	O
fra-1	B-DNA	NOUN	B
induction	O	NOUN	B
did	O	AUX	O
require	O	VERB	O
tyrosine	B-protein	NOUN	B
kinase	I-protein	NOUN	I
activity	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
demonstrate	O	VERB	O
that	O	SCONJ	O
CD40	B-protein	NOUN	B
,	O	PUNCT	O
like	O	ADP	O
sIg	B-protein	NOUN	B
,	O	PUNCT	O
may	O	AUX	O
employ	O	VERB	O
PKC	B-protein	NOUN	B
in	O	ADP	O
producing	O	VERB	O
select	O	ADJ	O
outcomes	O	NOUN	B
,	O	PUNCT	O
that	O	SCONJ	O
individual	O	ADJ	O
B	B-protein	NOUN	B
cell	I-protein	NOUN	I
receptors	I-protein	NOUN	I
may	O	AUX	O
signal	O	VERB	B
downstream	O	ADJ	I
events	O	NOUN	O
via	O	ADP	O
both	O	CCONJ	O
PKC-dependent	O	ADJ	B
and	O	CCONJ	O
PKC-independent	O	ADJ	B
pathways	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
that	O	SCONJ	O
multiple	O	ADJ	O
signal	O	NOUN	O
transduction	O	NOUN	O
pathways	O	NOUN	O
may	O	AUX	O
be	O	AUX	O
used	O	VERB	O
to	O	PART	O
activate	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
closely	O	ADV	O
related	O	ADJ	O
genes	B-DNA	NOUN	B
.	O	PUNCT	O


Activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
granulocyte-macrophage	B-DNA	ADJ	B
colony-stimulating	I-DNA	ADJ	I
factor	I-DNA	NOUN	I
promoter	I-DNA	NOUN	I
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
requires	O	VERB	O
cooperative	O	ADJ	O
binding	O	NOUN	B
of	O	ADP	O
Elf-1	B-protein	NOUN	B
and	O	CCONJ	O
AP-1	B-protein	NOUN	B
transcription	B-protein	NOUN	I
factors	I-protein	NOUN	I
.	O	PUNCT	O


(	O	PUNCT	O
ABSTRACT	O	NOUN	B
TRUNCATED	O	VERB	I
AT	O	ADP	I
250	O	NUM	I
WORDS	O	NOUN	I
)	O	PUNCT	O


Steroid-resistant	O	ADJ	B
asthma	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
prevalence	O	NOUN	B
of	O	ADP	O
DNA	O	NOUN	B
aneuploidy	O	NOUN	I
was	O	AUX	O
30	O	NUM	O
%	O	NOUN	O
,	O	PUNCT	O
overexpression	O	NOUN	B
of	O	ADP	O
ER	B-protein	NOUN	B
10	O	NUM	O
%	O	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
overexpression	O	NOUN	B
of	O	ADP	O
EGFR	B-protein	NOUN	B
35	O	NUM	O
%	O	NOUN	O
,	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
206	O	NUM	O
high	O	ADJ	B
risk	O	NOUN	I
women	O	NOUN	B
whose	O	DET	O
median	O	ADJ	B
10	O	NUM	O
year	O	NOUN	B
Gail	O	PROPN	B
risk	O	NOUN	I
(	O	PUNCT	O
projected	O	VERB	O
probability	O	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
developing	O	VERB	O
breast	O	NOUN	B
cancer	O	NOUN	I
was	O	AUX	O
4.5	O	NUM	O
%	O	NOUN	O
.	O	PUNCT	O


Nonsteroidal	O	ADJ	B
anti-inflammatory	O	ADJ	I
drugs	O	NOUN	I
such	O	ADJ	O
as	O	ADP	O
salicylates	O	NOUN	B
have	O	AUX	O
been	O	AUX	O
used	O	VERB	O
to	O	PART	O
treat	O	VERB	B
symptoms	O	NOUN	B
of	O	ADP	O
inflammation	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
new	O	ADJ	O
mechanism	O	NOUN	B
of	O	ADP	O
drug	O	NOUN	B
action	O	NOUN	I
was	O	AUX	O
suggested	O	VERB	O
recently	O	ADV	O
.	O	PUNCT	O


The	O	DET	O
chemokine	B-protein	NOUN	B
RANTES	B-protein	NOUN	B
has	O	AUX	O
been	O	AUX	O
implicated	O	VERB	O
in	O	ADP	O
the	O	DET	O
pathogenesis	O	NOUN	B
of	O	ADP	O
allergic	O	ADJ	B
inflammatory	O	ADJ	I
diseases	O	NOUN	I
including	O	VERB	O
asthma	O	NOUN	B
and	O	CCONJ	O
rhinitis	O	NOUN	B
which	O	DET	O
are	O	AUX	O
frequently	O	ADV	O
treated	O	VERB	B
with	O	ADP	I
glucocorticoids	O	NOUN	B
.	O	PUNCT	O


Association	O	NOUN	B
of	O	ADP	O
TRAF1	B-protein	NOUN	B
,	O	PUNCT	O
TRAF2	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
TRAF3	B-protein	NOUN	B
with	O	ADP	O
an	O	DET	O
Epstein-Barr	B-DNA	ADJ	B
virus	I-DNA	NOUN	I
LMP1	I-DNA	NOUN	B
domain	I-DNA	NOUN	B
important	O	ADJ	O
for	O	ADP	O
B-lymphocyte	B-cell_type	NOUN	B
transformation	O	NOUN	B
:	O	PUNCT	O
role	O	NOUN	O
in	O	ADP	O
NF-kappaB	B-protein	NOUN	B
activation	O	NOUN	B
.	O	PUNCT	O


NF-kappaB	B-protein	NOUN	B
activation	O	NOUN	B
by	O	ADP	O
LMP1	B-protein	NOUN	B
(	O	PUNCT	O
1-231	O	NUM	B
)	O	PUNCT	O
is	O	AUX	O
likely	O	ADJ	O
to	O	PART	O
be	O	AUX	O
mediated	O	VERB	O
by	O	ADP	O
TRAF1	B-protein	NOUN	B
/TRAF2	B-protein	NOUN	O
heteroaggregates	O	NOUN	B
since	O	SCONJ	O
TRAF1	B-protein	NOUN	B
is	O	AUX	O
unique	O	ADJ	B
among	O	ADP	O
the	O	DET	O
TRAFs	B-protein	NOUN	B
in	O	ADP	O
coactivating	O	VERB	B
NF-kappaB	B-protein	NOUN	I
with	O	ADP	O
LMP1	B-protein	NOUN	B
(	O	PUNCT	O
1-231	O	NUM	B
)	O	PUNCT	O
,	O	PUNCT	O
a	O	DET	O
TRAF2	B-protein	NOUN	B
dominant-negative	O	ADJ	B
mutant	O	NOUN	I
can	O	AUX	O
block	O	VERB	B
LMP1	B-protein	NOUN	B
(	O	PUNCT	O
1-231	O	NUM	B
)	O	PUNCT	O
-mediated	O	ADJ	O
NF-kappaB	B-protein	NOUN	B
activation	O	NOUN	B
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
TRAF1	B-protein	NOUN	B
coactivation	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
30	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
TRAF2	B-protein	NOUN	B
is	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
TRAF1	B-protein	NOUN	B
in	O	ADP	O
EBV-transformed	O	ADJ	B
B	O	NOUN	I
cells	O	NOUN	I
.	O	PUNCT	O


Surprisingly	O	ADV	O
,	O	PUNCT	O
TRAF1	B-protein	NOUN	B
,	I-protein	PUNCT	O
-2	I-protein	NUM	O
,	I-protein	PUNCT	O
or	I-protein	CCONJ	O
-3	I-protein	NUM	O
does	O	AUX	O
not	O	PART	O
interact	O	VERB	B
with	O	ADP	O
the	O	DET	O
terminal	B-protein	ADJ	B
LMP1	I-protein	NOUN	B
CT	I-protein	NOUN	O
aa	O	NOUN	O
333	O	NUM	O
to	O	PART	O
386	O	NUM	O
which	O	DET	O
can	O	AUX	O
independently	O	ADV	O
mediate	O	VERB	O
NF-kappaB	B-protein	NOUN	B
activation	O	NOUN	B
.	O	PUNCT	O


Lack	O	NOUN	B
of	O	ADP	O
IL-12	B-protein	NOUN	B
signaling	O	NOUN	B
in	O	ADP	O
human	B-cell_line	ADJ	B
allergen-specific	I-cell_line	ADJ	B
Th2	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
present	O	ADJ	O
study	O	NOUN	B
we	O	PRON	O
addressed	O	VERB	O
the	O	DET	O
question	O	NOUN	O
of	O	ADP	O
whether	O	SCONJ	O
IL-12	B-protein	NOUN	B
can	O	AUX	O
reverse	O	VERB	O
established	O	ADJ	O
Th2	O	NOUN	B
responses	O	NOUN	B
into	O	ADP	O
Th1/Th0	O	NOUN	B
responses	O	NOUN	B
by	O	ADP	O
inducing	O	VERB	O
IFN-gamma	B-protein	NOUN	B
production	O	NOUN	B
in	O	ADP	O
memory	B-cell_line	NOUN	B
Th2	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


To	O	ADP	O
this	O	DET	O
aim	O	NOUN	O
,	O	PUNCT	O
allergen-specific	B-cell_line	ADJ	B
CD4+	I-cell_line	ADJ	I
T	I-cell_line	NOUN	I
cell	I-cell_line	NOUN	I
clones	I-cell_line	NOUN	I
(	O	PUNCT	O
TCC	B-cell_line	NOUN	B
)	O	PUNCT	O
were	O	AUX	O
generated	O	VERB	O
from	O	ADP	O
the	O	DET	O
peripheral	O	ADJ	B
blood	O	NOUN	I
of	O	ADP	O
three	O	NUM	O
atopic	O	ADJ	B
patients	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
their	O	PRON	O
cytokine	B-protein	NOUN	B
profiles	O	NOUN	I
were	O	AUX	O
analyzed	O	VERB	B
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
human	O	ADJ	B
allergen-specific	O	ADJ	B
Th	O	NOUN	I
cells	O	NOUN	I
with	O	ADP	O
strongly	O	ADV	O
polarized	O	VERB	B
Th2	O	NOUN	B
cytokine	B-protein	NOUN	B
profiles	O	NOUN	I
do	O	AUX	O
not	O	PART	O
respond	O	VERB	O
to	O	PART	O
IL-12	B-protein	NOUN	B
and	O	CCONJ	O
,	O	PUNCT	O
therefore	O	ADV	O
,	O	PUNCT	O
can	O	AUX	O
not	O	PART	O
be	O	AUX	O
induced	O	VERB	B
to	O	PART	O
produce	O	VERB	O
IFN-gamma	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
protein	O	NOUN	B
from	O	ADP	O
E.	O	X	B
coli	O	X	I
specifically	O	ADV	O
converted	O	VERB	O
dUTP	O	NOUN	B
to	O	PART	O
dUMP	O	NOUN	B
and	O	CCONJ	O
did	O	AUX	O
not	O	PART	O
react	O	VERB	O
with	O	ADP	O
other	O	ADJ	O
dNTPs	O	NOUN	B
or	O	CCONJ	O
NTPs	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
report	O	NOUN	O
we	O	PRON	O
address	O	VERB	O
the	O	DET	O
contribution	O	NOUN	B
of	O	ADP	O
the	O	DET	O
regulatory	B-protein	ADJ	B
and	I-protein	CCONJ	O
catalytic	I-protein	ADJ	B
domains	I-protein	NOUN	I
of	O	ADP	O
pp56	B-protein	NOUN	B
(	I-protein	PUNCT	O
lck	I-protein	NOUN	B
)	I-protein	PUNCT	O
to	O	PART	O
another	O	DET	O
function	O	NOUN	B
of	O	ADP	O
this	O	DET	O
enzyme	O	NOUN	B
independent	O	ADJ	B
of	O	ADP	O
CD4	B-protein	NOUN	B
:	O	PUNCT	O
TCR-induced	O	ADJ	B
IL-2	B-protein	NOUN	B
production	O	NOUN	B
.	O	PUNCT	O


Moreover	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
catalytic	B-protein	ADJ	B
domain	I-protein	NOUN	I
of	O	ADP	O
pp56	B-protein	NOUN	B
(	I-protein	PUNCT	O
lck	I-protein	NOUN	B
)	I-protein	PUNCT	O
was	O	AUX	O
able	O	ADJ	O
to	O	PART	O
induce	O	VERB	B
IL-2	B-protein	NOUN	B
cytokine	B-protein	NOUN	B
production	O	NOUN	B
to	O	PART	O
an	O	DET	O
extent	O	NOUN	O
similar	O	ADJ	O
to	O	PART	O
that	O	DET	O
of	O	ADP	O
wild-type	O	ADJ	B
pp56	B-protein	NOUN	O
(	I-protein	PUNCT	O
lck	I-protein	NOUN	B
)	I-protein	PUNCT	O
.	O	PUNCT	O


In	O	ADP	O
fact	O	NOUN	O
,	O	PUNCT	O
while	O	SCONJ	O
the	O	DET	O
NH2	B-protein	NOUN	B
regulatory	B-protein	ADJ	B
domain	I-protein	NOUN	I
is	O	AUX	O
sufficient	O	ADJ	O
to	O	PART	O
mediate	O	VERB	O
CD4	B-protein	NOUN	B
accessory	O	ADJ	B
function	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
show	O	VERB	O
here	O	ADV	O
that	O	SCONJ	O
the	O	DET	O
catalytic	B-protein	ADJ	B
domain	I-protein	NOUN	I
of	O	ADP	O
pp56	B-protein	NOUN	B
(	I-protein	PUNCT	O
lck	I-protein	NOUN	B
)	I-protein	PUNCT	O
is	O	AUX	O
sufficient	O	ADJ	O
for	O	ADP	O
induction	O	NOUN	B
of	O	ADP	O
IL-2	B-protein	NOUN	B
production	O	NOUN	B
,	O	PUNCT	O
mimicking	O	VERB	O
TCR	B-protein	NOUN	B
ligation	O	NOUN	B
.	O	PUNCT	O


[	O	PUNCT	O
The	O	DET	O
changes	O	NOUN	B
in	O	ADP	O
glucocorticoid	O	NOUN	B
receptors	O	NOUN	I
in	O	ADP	O
peripheral	B-cell_type	ADJ	B
leukocytes	I-cell_type	NOUN	B
in	O	ADP	O
asthmatic	O	ADJ	B
subjects	O	NOUN	I
]	O	PUNCT	O


The	O	DET	O
number	O	NOUN	O
of	O	ADP	O
glucocorticoid	B-protein	NOUN	B
receptors	I-protein	NOUN	I
(	O	PUNCT	O
GCR	B-protein	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
peripheral	B-cell_type	ADJ	B
leukocytes	I-cell_type	NOUN	B
was	O	AUX	O
determined	O	VERB	O
by	O	ADP	O
radioligand-binding	O	ADJ	B
assay	O	NOUN	I
in	O	ADP	O
extrinsic	O	ADJ	B
and	O	CCONJ	O
intrinsic	O	ADJ	B
asthmatics	O	NOUN	B
.	O	PUNCT	O


Their	O	PRON	O
corresponding	O	ADJ	O
plasma	O	NOUN	B
cortisol	O	NOUN	O
levels	O	NOUN	O
were	O	AUX	O
assessed	O	VERB	B
.	O	PUNCT	O


No	O	DET	B
difference	O	NOUN	I
in	O	ADP	O
plasma	O	NOUN	B
cortisol	O	NOUN	O
level	O	NOUN	B
was	O	AUX	O
found	O	VERB	O
between	O	ADP	O
asthmatics	O	NOUN	B
and	O	CCONJ	O
healthy	O	ADJ	B
subjects	O	NOUN	I
.	O	PUNCT	O


Such	O	ADJ	O
changes	O	NOUN	B
clearly	O	ADV	O
can	O	AUX	O
not	O	PART	O
be	O	AUX	O
explained	O	VERB	O
by	O	ADP	O
genomic	O	ADJ	B
mechanisms	O	NOUN	I
,	O	PUNCT	O
which	O	DET	O
are	O	AUX	O
responsible	O	ADJ	O
for	O	ADP	O
later	O	ADJ	O
effects	O	NOUN	B
than	O	ADP	O
the	O	DET	O
membrane-related	O	ADJ	B
rapid	O	ADJ	I
responses	O	NOUN	I
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
both	O	CCONJ	O
in	O	ADP	O
vitro-translated	B-protein	ADJ	B
PU.1	I-protein	NOUN	B
and	O	CCONJ	O
PU.1	B-protein	NOUN	B
from	O	ADP	O
nuclear	O	ADJ	B
extracts	O	NOUN	I
bind	O	VERB	B
to	O	PART	O
a	O	DET	O
specific	O	ADJ	O
site	O	NOUN	B
in	O	ADP	O
the	O	DET	O
M-CSF	B-DNA	NOUN	B
receptor	I-DNA	NOUN	I
promoter	I-DNA	NOUN	B
just	O	ADV	O
upstream	O	ADV	B
from	O	ADP	O
the	O	DET	O
major	B-DNA	ADJ	O
transcription	I-DNA	NOUN	B
initiation	I-DNA	NOUN	I
site	I-DNA	NOUN	I
.	O	PUNCT	O


Mutations	O	NOUN	B
in	O	ADP	O
this	O	DET	O
site	O	NOUN	B
which	O	DET	O
eliminate	O	VERB	O
PU.1	B-protein	NOUN	B
binding	O	NOUN	B
decrease	O	VERB	B
M-CSF	B-protein	NOUN	B
receptor	I-protein	NOUN	I
promoter	O	NOUN	B
activity	O	NOUN	I
significantly	O	ADV	O
in	O	ADP	O
macrophage	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
only	O	ADV	O
.	O	PUNCT	O


BACKGROUND	O	NOUN	B
.	O	PUNCT	O


CONCLUSION	O	NOUN	O
.	O	PUNCT	O


[	O	PUNCT	O
The	O	DET	O
value	O	NOUN	O
of	O	ADP	O
the	O	DET	O
clinical	O	ADJ	B
test	O	NOUN	I
of	O	ADP	O
glucocorticoid	B-protein	NOUN	B
receptors	I-protein	NOUN	I
of	O	ADP	O
peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
leukocytes	I-cell_type	NOUN	B
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
chronic	O	ADJ	B
pulmonary	O	ADJ	I
heart	O	NOUN	I
disease	O	NOUN	I
]	O	PUNCT	O


Signaling	O	NOUN	B
via	O	ADP	O
IL-2	B-protein	NOUN	B
and	O	CCONJ	O
IL-4	B-protein	NOUN	B
in	O	ADP	O
JAK3-deficient	B-cell_line	ADJ	B
severe	I-cell_line	ADJ	B
combined	I-cell_line	ADJ	B
immunodeficiency	I-cell_line	NOUN	I
lymphocytes	I-cell_line	NOUN	I
:	O	PUNCT	O
JAK3	B-protein	NOUN	B
-dependent	O	ADJ	O
and	O	CCONJ	O
independent	O	ADJ	O
pathways	O	NOUN	B
.	O	PUNCT	O


Both	O	CCONJ	O
IL-2	B-protein	NOUN	B
and	O	CCONJ	O
IL-4	B-protein	NOUN	B
bind	O	VERB	B
to	O	PART	O
receptors	O	NOUN	B
containing	O	VERB	O
the	O	DET	O
common	B-protein	ADJ	O
gamma	I-protein	NOUN	B
chain	I-protein	NOUN	I
and	O	CCONJ	O
JAK3	B-protein	NOUN	B
.	O	PUNCT	O


Here	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
studied	O	VERB	O
IL-2	B-protein	NOUN	B
and	O	CCONJ	O
IL-4	B-protein	NOUN	B
signaling	O	NOUN	B
in	O	ADP	O
B	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
lacking	O	VERB	O
JAK3	B-protein	NOUN	B
.	O	PUNCT	O


IL-2R	B-protein	NOUN	B
alpha	I-protein	NOUN	B
transcription	O	NOUN	I
is	O	AUX	O
at	O	ADP	O
least	O	ADJ	O
in	O	ADP	O
part	O	NOUN	O
controlled	O	VERB	B
by	O	ADP	O
two	O	NUM	O
positive	B-protein	ADJ	B
regulatory	I-protein	ADJ	B
regions	I-protein	NOUN	I
,	O	PUNCT	O
PRRI	B-DNA	NOUN	B
and	O	CCONJ	O
PRRII	B-DNA	NOUN	B
.	O	PUNCT	O


Therefore	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
investigated	O	VERB	B
in	O	X	B
situ	O	X	I
the	O	DET	O
nuclear	O	ADJ	B
localization	O	NOUN	I
of	O	ADP	O
Rel/NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
proteins	I-protein	NOUN	I
in	O	ADP	O
accessory	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
of	O	ADP	O
the	O	DET	O
immune	O	ADJ	B
system	O	NOUN	I
by	O	ADP	O
immunohistochemistry	O	NOUN	B
and	O	CCONJ	O
double	O	ADJ	B
labeling	O	NOUN	I
by	O	ADP	O
immunofluorescence	O	NOUN	B
from	O	ADP	O
five	O	NUM	O
normal	O	ADJ	O
human	O	ADJ	B
tonsils	O	NOUN	B
and	O	CCONJ	O
five	O	NUM	O
lymph	O	NOUN	B
nodes	O	NOUN	I
with	O	ADP	O
follicular	O	ADJ	B
hyperplasia	O	NOUN	I
.	O	PUNCT	O


Cells	O	NOUN	B
with	O	ADP	O
nuclear	O	ADJ	B
p50	B-protein	NOUN	I
were	O	AUX	O
negative	O	ADJ	B
for	O	ADP	O
the	O	DET	O
CD38	B-protein	NOUN	B
,	O	PUNCT	O
CD20	B-protein	NOUN	B
and	O	CCONJ	O
CD2	B-protein	NOUN	B
markers	I-protein	NOUN	B
.	O	PUNCT	O


Tyrosines	O	NOUN	B
113	O	NUM	O
,	O	PUNCT	O
128	O	NUM	O
,	O	PUNCT	O
and	O	CCONJ	O
145	O	NUM	O
of	O	ADP	O
SLP-76	B-protein	NOUN	B
are	O	AUX	O
required	O	VERB	O
for	O	ADP	O
optimal	O	ADJ	B
augmentation	O	NOUN	B
of	O	ADP	O
NFAT	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
activity	O	NOUN	I
.	O	PUNCT	O


Two	O	NUM	O
tyrosines	O	NOUN	B
(	O	PUNCT	O
Y113	O	NOUN	B
and	O	CCONJ	O
Y128	O	NOUN	B
)	O	PUNCT	O
fall	O	VERB	B
within	O	ADP	O
an	O	DET	O
identical	O	ADJ	B
five	O	NUM	O
amino-acid	O	ADJ	B
motif	O	NOUN	O
and	O	CCONJ	O
are	O	AUX	O
shown	O	VERB	O
to	O	PART	O
be	O	AUX	O
phosphorylated	O	VERB	B
upon	O	SCONJ	O
TCR	B-protein	NOUN	B
ligation	O	NOUN	B
.	O	PUNCT	O


Human	B-DNA	ADJ	B
interferon	I-DNA	NOUN	B
regulatory	I-DNA	ADJ	I
factor	I-DNA	NOUN	I
2	I-DNA	NUM	I
gene	I-DNA	NOUN	I
.	O	PUNCT	O


Interferon	B-protein	NOUN	B
regulatory	I-protein	ADJ	O
factor	I-protein	NOUN	O
2	I-protein	NUM	O
(	O	PUNCT	O
IRF-2	B-protein	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
transcriptional	B-protein	ADJ	B
regulatory	I-protein	ADJ	O
protein	I-protein	NOUN	O
that	O	PRON	O
terminates	O	VERB	O
interferon	B-protein	NOUN	B
beta	I-protein	NOUN	I
expression	O	NOUN	I
initiated	O	VERB	O
by	O	ADP	O
interferon	B-protein	NOUN	B
regulatory	I-protein	ADJ	I
factor	I-protein	NOUN	I
1	I-protein	NUM	I
.	O	PUNCT	O


The	O	DET	O
IRF-2	B-protein	NOUN	B
promoter	B-DNA	NOUN	B
region	I-DNA	NOUN	I
contains	O	VERB	O
a	O	DET	O
CpG	O	NOUN	B
island	O	NOUN	I
,	O	PUNCT	O
with	O	ADP	O
several	O	ADJ	O
GC	B-DNA	NOUN	B
boxes	I-DNA	NOUN	O
,	O	PUNCT	O
a	O	DET	O
putative	O	ADJ	O
NF-kappa	B-DNA	NOUN	O
B-binding	I-DNA	ADJ	O
site	I-DNA	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
CAAT	B-DNA	NOUN	B
box	I-DNA	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
no	O	DET	O
TATA	B-DNA	NOUN	B
box	I-DNA	NOUN	O
.	O	PUNCT	O


When	O	SCONJ	O
the	O	DET	O
promoter	B-DNA	NOUN	B
region	I-DNA	NOUN	I
was	O	AUX	O
linked	O	VERB	O
with	O	ADP	O
a	O	DET	O
heterologous	B-DNA	ADJ	B
reporter	I-DNA	NOUN	B
gene	I-DNA	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
found	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
promoter	B-DNA	NOUN	B
region	I-DNA	NOUN	I
is	O	AUX	O
inducible	O	ADJ	B
by	O	ADP	O
both	O	CCONJ	O
interferons	B-protein	NOUN	B
(	O	PUNCT	O
interferon-alpha	B-protein	NOUN	B
and	I-protein	CCONJ	O
-gamma	I-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
interferon	B-protein	NOUN	B
regulatory	I-protein	ADJ	I
factor	I-protein	NOUN	I
1	I-protein	NUM	I
.	O	PUNCT	O


Interferon	B-protein	NOUN	B
alpha	I-protein	NOUN	I
selectively	O	ADV	O
affects	O	VERB	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
human	B-protein	ADJ	B
myeloid	I-protein	ADJ	O
cell	I-protein	NOUN	O
nuclear	I-protein	ADJ	B
differentiation	I-protein	NOUN	I
antigen	I-protein	NOUN	I
in	O	ADP	O
late	B-cell_type	ADJ	B
stage	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
in	O	ADP	O
the	O	DET	O
monocytic	B-cell_type	ADJ	B
but	O	CCONJ	O
not	O	PART	O
the	O	DET	O
granulocytic	B-cell_type	ADJ	B
lineage	I-cell_type	NOUN	B
.	O	PUNCT	O


The	O	DET	O
effects	O	NOUN	B
of	O	ADP	O
phorbol	O	NOUN	B
ester	O	NOUN	I
on	O	ADP	O
MNDA	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
appeared	O	VERB	O
to	O	PART	O
be	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
induced	O	VERB	B
differentiation	O	NOUN	B
since	O	SCONJ	O
inhibiting	O	VERB	B
cell	O	NOUN	B
proliferation	O	NOUN	I
did	O	AUX	O
not	O	PART	O
alter	O	VERB	O
the	O	DET	O
level	O	NOUN	B
of	O	ADP	O
MNDA	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
and	O	CCONJ	O
cell	O	NOUN	B
cycle	O	NOUN	I
variation	O	NOUN	B
in	O	ADP	O
MNDA	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
levels	O	NOUN	O
were	O	AUX	O
not	O	PART	O
observed	O	VERB	O
.	O	PUNCT	O


We	O	PRON	O
previously	O	ADV	O
identified	O	VERB	B
and	O	CCONJ	O
analyzed	O	VERB	B
a	O	DET	O
45-nucleotide	B-DNA	ADJ	B
sequence	I-DNA	NOUN	I
(	O	PUNCT	O
downstream	B-DNA	ADJ	B
regulatory	I-DNA	ADJ	I
element	I-DNA	NOUN	I
1	I-DNA	NUM	I
[	O	PUNCT	O
DRE	B-DNA	NOUN	B
1	I-DNA	NUM	O
]	O	PUNCT	O
)	O	PUNCT	O
,	O	PUNCT	O
+195	B-DNA	NUM	O
to	I-DNA	PART	O
+240	I-DNA	NUM	B
,	O	PUNCT	O
at	O	ADP	O
the	O	DET	O
boundary	O	NOUN	B
of	O	ADP	O
the	O	DET	O
R/U5	B-DNA	NOUN	B
region	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
long	B-DNA	ADJ	B
terminal	I-DNA	ADJ	I
repeat	I-DNA	NOUN	I
which	O	DET	O
is	O	AUX	O
required	O	VERB	O
for	O	ADP	O
HTLV-I	O	NOUN	B
basal	O	ADJ	B
transcription	O	NOUN	I
.	O	PUNCT	O


An	O	DET	O
affinity	O	NOUN	B
column	O	NOUN	I
fraction	O	NOUN	B
,	O	PUNCT	O
containing	O	VERB	O
p37	B-protein	NOUN	B
,	O	PUNCT	O
stimulated	O	VERB	B
HTLV-I	O	NOUN	B
transcription	O	NOUN	I
approximately	O	ADV	O
12-fold	O	ADV	O
in	O	X	B
vitro	O	X	I
.	O	PUNCT	O


The	O	DET	O
subjects	O	NOUN	B
were	O	AUX	O
exposed	O	VERB	B
to	O	ADP	I
cold	O	ADJ	B
air	O	NOUN	I
(	O	PUNCT	O
4	O	NUM	O
degrees	O	NOUN	O
C	O	NOUN	O
)	O	PUNCT	O
twice/d	O	ADV	O
,	O	PUNCT	O
30	O	NUM	O
min/exposure	O	NOUN	B
,	O	PUNCT	O
for	O	ADP	O
a	O	DET	O
total	O	NOUN	O
of	O	ADP	O
80	O	NUM	O
exposures	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
these	O	DET	O
cells	O	NOUN	B
,	O	PUNCT	O
nuclear	B-protein	ADJ	B
factors	I-protein	NOUN	I
involved	O	VERB	O
in	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
HIV-1	B-DNA	NOUN	B
LTR	I-DNA	NOUN	B
,	O	PUNCT	O
which	O	DET	O
contains	O	VERB	O
the	O	DET	O
transcriptional	B-DNA	ADJ	B
control	I-DNA	NOUN	I
elements	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
virus	O	NOUN	B
,	O	PUNCT	O
are	O	AUX	O
unknown	O	ADJ	O
.	O	PUNCT	O


Sequence	O	NOUN	B
analysis	O	NOUN	I
and	O	CCONJ	O
expression	O	NOUN	B
in	O	ADP	O
cultured	B-cell_type	VERB	B
lymphocytes	I-cell_type	NOUN	I
of	O	ADP	O
the	O	DET	O
human	O	ADJ	B
FOSB	B-DNA	NOUN	O
gene	I-DNA	NOUN	O
(	O	PUNCT	O
G0S3	B-DNA	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
kinetics	O	NOUN	B
of	O	ADP	O
expression	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
high	O	ADJ	O
initial	O	ADJ	B
levels	O	NOUN	B
are	O	AUX	O
caused	O	VERB	O
by	O	ADP	O
the	O	DET	O
isolation	O	NOUN	B
procedure	O	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
do	O	AUX	O
not	O	PART	O
reflect	O	VERB	O
constitutive	O	ADJ	B
expression	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
cells	O	NOUN	B
preincubated	O	VERB	B
for	O	ADP	O
a	O	DET	O
day	O	NOUN	B
,	O	PUNCT	O
levels	O	NOUN	B
of	O	ADP	O
FOS	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
reach	O	VERB	O
a	O	DET	O
maximum	O	NOUN	B
20	O	NUM	O
min	O	NOUN	O
after	O	ADP	O
the	O	DET	O
addition	O	NOUN	O
of	O	ADP	O
lectin	B-protein	NOUN	B
and	O	CCONJ	O
decline	O	NOUN	B
to	O	PART	O
control	O	NOUN	B
levels	O	NOUN	I
over	O	ADP	O
the	O	DET	O
next	O	ADJ	O
3	O	NUM	O
hr	O	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
preincubated	O	VERB	B
cells	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
cycloheximide	O	NOUN	B
response	O	NOUN	B
is	O	AUX	O
decreased	O	VERB	B
,	O	PUNCT	O
especially	O	ADV	O
in	O	ADP	O
the	O	DET	O
case	O	NOUN	B
of	O	ADP	O
FOSB	B-DNA	NOUN	B
.	O	PUNCT	O


All	O	DET	O
human	O	ADJ	B
adenoviruses	O	NOUN	B
transform	O	VERB	I
rodent	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
in	O	X	B
vitro	O	X	I
,	O	PUNCT	O
but	O	CCONJ	O
only	O	ADV	O
cells	O	NOUN	B
transformed	O	VERB	B
by	O	ADP	O
serotypes	O	NOUN	B
belonging	O	VERB	O
to	O	PART	O
subgroups	O	NOUN	B
A	O	DET	O
(	O	PUNCT	O
Ad12	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
B	O	NOUN	B
(	O	PUNCT	O
Ad3	O	NOUN	B
)	O	PUNCT	O
are	O	AUX	O
tumorigenic	O	ADJ	B
for	O	ADP	O
immunocompetent	O	ADJ	B
animals	O	NOUN	B
.	O	PUNCT	O


Susceptibility	O	NOUN	B
of	O	ADP	O
these	O	DET	O
transformed	O	VERB	B
cell	B-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
to	O	PART	O
NK	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
was	O	AUX	O
determined	O	VERB	O
by	O	ADP	O
cytolytic	O	ADJ	B
assays	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
results	O	NOUN	B
obtained	O	VERB	O
suggest	O	VERB	O
that	O	SCONJ	O
two	O	NUM	O
Ad12	B-DNA	NOUN	B
E1A	I-DNA	NOUN	I
domains	I-DNA	NOUN	I
are	O	AUX	O
required	O	VERB	O
to	O	PART	O
induce	O	VERB	B
resistance	O	NOUN	B
of	O	ADP	O
the	O	DET	O
cell	B-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
to	O	PART	O
NK	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


For	O	ADP	O
this	O	DET	O
expression	O	NOUN	B
pattern	O	NOUN	O
the	O	DET	O
first	O	ADJ	O
280	B-DNA	NUM	O
bp	I-DNA	NOUN	O
upstream	I-DNA	ADJ	B
of	O	ADP	O
the	O	DET	O
major	B-DNA	ADJ	O
transcriptional	I-DNA	ADJ	B
start	I-DNA	NOUN	O
site	I-DNA	NOUN	O
seems	O	VERB	O
to	O	PART	O
be	O	AUX	O
sufficient	O	ADJ	B
.	O	PUNCT	O


Lipopolysaccharide	O	NOUN	B
(	O	PUNCT	O
LPS	O	NOUN	B
)	O	PUNCT	O
induces	O	VERB	O
expression	O	NOUN	B
of	O	ADP	O
inflammatory	B-protein	ADJ	B
cytokines	I-protein	NOUN	O
in	O	ADP	O
monocytes/macrophages	B-cell_type	NOUN	B
via	O	ADP	O
CD14	B-protein	NOUN	B
,	O	PUNCT	O
one	O	NUM	O
of	O	ADP	O
the	O	DET	O
LPS	B-protein	NOUN	B
receptors	I-protein	NOUN	I
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
expressed	O	VERB	B
predominantly	O	ADV	O
in	O	ADP	O
these	O	DET	O
cells	O	NOUN	B
.	O	PUNCT	O


Gel	O	NOUN	B
shift	O	NOUN	I
mobility	O	NOUN	I
assay	O	NOUN	I
showed	O	VERB	O
stimulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
AP-1	B-protein	NOUN	B
and	O	CCONJ	O
NF-kappaB	B-protein	NOUN	B
contents	O	NOUN	B
in	O	ADP	O
P-LPS-treated	O	ADJ	B
cells	O	NOUN	I
.	O	PUNCT	O


Antiphosphotyrosine	O	ADJ	B
immunoblots	O	NOUN	B
of	O	ADP	O
whole	O	ADJ	B
cell	O	NOUN	I
lysates	O	NOUN	O
prepared	O	VERB	O
from	O	ADP	O
neutrophils	B-cell_type	NOUN	B
show	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
G-CSF	B-protein	NOUN	B
rapidly	O	ADV	O
induces	O	VERB	B
prominent	O	ADJ	O
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	B
of	O	ADP	O
a	O	DET	O
protein	O	NOUN	B
of	O	ADP	O
a	O	DET	O
relative	O	ADJ	O
molecular	O	ADJ	B
mass	O	NOUN	I
of	O	ADP	O
80	O	NUM	O
kDa	O	NOUN	O
.	O	PUNCT	O


IEF-1	B-protein	NOUN	B
,	O	PUNCT	O
a	O	DET	O
pancreatic	O	ADJ	B
beta-cell	O	NOUN	I
type-specific	O	ADJ	I
complex	O	NOUN	I
believed	O	VERB	O
to	O	PART	O
regulate	O	VERB	B
insulin	O	NOUN	B
expression	O	NOUN	B
,	O	PUNCT	O
is	O	AUX	O
demonstrated	O	VERB	O
to	O	PART	O
consist	O	VERB	O
of	O	ADP	O
at	O	ADP	O
least	O	ADJ	O
two	O	NUM	O
distinct	O	ADJ	O
species	O	NOUN	B
,	O	PUNCT	O
one	O	NUM	O
of	O	ADP	O
which	O	DET	O
does	O	AUX	O
not	O	PART	O
contain	O	VERB	O
Pan	B-protein	NOUN	B
molecules	I-protein	NOUN	I
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
p50	B-protein	NOUN	B
protein	O	NOUN	I
was	O	AUX	O
detected	O	VERB	B
in	O	ADP	O
the	O	DET	O
cytoplasm	O	NOUN	B
of	O	ADP	O
all	O	DET	O
lymphocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


The	O	DET	O
elevation	O	NOUN	B
in	O	ADP	O
intracellular	O	ADJ	B
calcium	O	NOUN	B
that	O	PRON	O
is	O	AUX	O
induced	O	VERB	B
by	O	ADP	O
interactions	O	NOUN	B
at	O	ADP	O
the	O	DET	O
antigen	B-protein	NOUN	B
receptor	I-protein	NOUN	I
leads	O	VERB	O
to	O	PART	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
calcium-dependent	B-protein	ADJ	B
phosphatase	I-protein	NOUN	I
calcineurin	B-protein	NOUN	I
.	O	PUNCT	O


Induction	O	NOUN	B
of	O	ADP	O
vascular	B-protein	ADJ	B
cell	I-protein	NOUN	I
adhesion	I-protein	NOUN	I
molecule-1	I-protein	NOUN	I
by	O	ADP	O
low-density	B-protein	ADJ	B
lipoprotein	I-protein	NOUN	I
.	O	PUNCT	O


Among	O	ADP	O
the	O	DET	O
documented	O	VERB	B
cellular	O	ADJ	B
responses	O	NOUN	I
to	O	PART	O
LDL	B-protein	NOUN	B
is	O	AUX	O
increased	O	VERB	B
recruitment	O	NOUN	B
of	O	ADP	O
monocytes	B-cell_type	NOUN	B
,	O	PUNCT	O
which	O	DET	O
are	O	AUX	O
believed	O	VERB	O
to	O	PART	O
play	O	VERB	O
a	O	DET	O
major	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
promoting	O	VERB	O
intimal	O	ADJ	B
plaque	O	NOUN	B
formation	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
findings	O	NOUN	B
presented	O	VERB	O
here	O	ADV	O
link	O	VERB	O
an	O	DET	O
atheogenic	B-protein	ADJ	B
lipoprotein	I-protein	NOUN	I
,	O	PUNCT	O
LDL	B-protein	NOUN	B
,	O	PUNCT	O
with	O	ADP	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
an	O	DET	O
adhesion	O	NOUN	B
molecule	O	NOUN	I
important	O	ADJ	O
in	O	ADP	O
atherogenesis	O	NOUN	B
Human	O	ADJ	B
LDL	B-protein	NOUN	B
induces	O	VERB	O
the	O	DET	O
vascular	B-protein	ADJ	B
cell	I-protein	NOUN	I
adhesion	I-protein	NOUN	I
molecule-1	I-protein	NOUN	I
(	O	PUNCT	O
VCAM-1	B-protein	NOUN	B
)	O	PUNCT	O
transcriptionally	O	ADV	B
with	O	ADP	O
an	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
mRNA	O	NOUN	B
levels	O	NOUN	O
through	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
VCAM	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
.	O	PUNCT	O


After	O	ADP	O
a	O	DET	O
2-day	O	ADJ	O
incubation	O	NOUN	B
in	O	ADP	O
LDL	B-protein	NOUN	B
,	O	PUNCT	O
the	O	DET	O
binding	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
believed	O	VERB	O
to	O	PART	O
be	O	AUX	O
a	O	DET	O
key	O	ADJ	O
oxidative-stress	O	ADJ	B
sensor	O	NOUN	B
for	O	ADP	O
VCAM	B-protein	NOUN	B
regulation	O	NOUN	I
,	O	PUNCT	O
remains	O	VERB	O
at	O	ADP	O
basal	O	ADJ	B
level	O	NOUN	I
.	O	PUNCT	O


Therefore	O	ADV	O
we	O	PRON	O
first	O	ADV	O
examined	O	VERB	O
the	O	DET	O
participation	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
in	O	ADP	O
germline	B-cell_line	NOUN	B
C	I-cell_line	NOUN	I
epsilon	I-cell_line	NOUN	I
transcription	O	NOUN	I
in	O	ADP	O
a	O	DET	O
human	B-cell_line	ADJ	B
Burkitt	I-cell_line	NOUN	O
lymphoma	I-cell_line	NOUN	O
B	I-cell_line	NOUN	O
cell	I-cell_line	NOUN	O
line	I-cell_line	NOUN	O
,	O	PUNCT	O
DND39	B-cell_line	NOUN	B
.	O	PUNCT	O


Second	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
studied	O	VERB	O
the	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
NAC	O	NOUN	B
on	O	ADP	O
IgE	B-protein	NOUN	B
synthesis	O	NOUN	B
in	O	ADP	O
human	O	ADJ	B
normal	O	ADJ	O
B	O	NOUN	O
cells	O	NOUN	O
costimulated	O	VERB	B
with	O	ADP	O
IL-4	B-protein	NOUN	B
and	O	CCONJ	O
anti-CD40	B-protein	ADJ	B
mAb	I-protein	NOUN	B
.	O	PUNCT	O


Prostaglandin	O	NOUN	B
E2	O	NOUN	I
induction	O	NOUN	B
of	O	ADP	O
binding	O	NOUN	B
activity	O	NOUN	I
to	O	PART	O
CRE	B-DNA	NOUN	B
and	O	CCONJ	O
AP-2	B-DNA	NOUN	B
elements	I-DNA	NOUN	I
in	O	ADP	O
human	B-cell_type	ADJ	B
T	I-cell_type	NOUN	O
lymphocytes	I-cell_type	NOUN	O
.	O	PUNCT	O


Since	O	SCONJ	O
the	O	DET	O
okadaic	O	ADJ	B
acid	O	NOUN	I
,	O	PUNCT	O
a	O	DET	O
potent	O	ADJ	O
protein	O	NOUN	B
phosphatase	O	NOUN	I
inhibitor	O	NOUN	I
,	O	PUNCT	O
prolongs	O	VERB	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
the	O	DET	O
binding	O	NOUN	B
activity	O	NOUN	I
,	O	PUNCT	O
phosphorylation	O	NOUN	B
events	O	NOUN	O
are	O	AUX	O
likely	O	ADJ	O
to	O	PART	O
occur	O	VERB	O
.	O	PUNCT	O


ISH	O	NOUN	B
for	O	ADP	O
EBV-encoded	B-RNA	ADJ	B
small	I-RNA	ADJ	O
non-polyadenylated	I-RNA	ADJ	B
RNAs	I-RNA	NOUN	I
showed	O	VERB	O
that	O	SCONJ	O
all	O	DET	O
cases	O	NOUN	B
,	O	PUNCT	O
whether	O	SCONJ	O
NK	O	NOUN	B
or	O	CCONJ	O
T	O	NOUN	B
,	O	PUNCT	O
harboured	O	VERB	B
EBV	O	NOUN	B
in	O	ADP	O
virtually	O	ADV	O
all	O	DET	O
tumour	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


The	O	DET	O
process	O	NOUN	B
of	O	ADP	O
activation	O	NOUN	B
involves	O	VERB	O
calcium	O	NOUN	B
mobilization	O	NOUN	I
,	O	PUNCT	O
activation	O	NOUN	B
of	O	ADP	O
protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
C	I-protein	NOUN	I
(	O	PUNCT	O
PKC	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
phosphorylation	O	NOUN	B
of	O	ADP	O
tyrosine	B-protein	NOUN	B
kinases	I-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
involvement	O	NOUN	B
of	O	ADP	O
p21	B-protein	NOUN	B
(	I-protein	PUNCT	O
ras	I-protein	NOUN	B
)	I-protein	PUNCT	O
in	O	ADP	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
calcium-dependent	O	ADJ	B
signals	O	NOUN	B
has	O	AUX	O
been	O	AUX	O
suggested	O	VERB	O
through	O	ADP	O
analysis	O	NOUN	B
of	O	ADP	O
its	O	PRON	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
NF-AT	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
promoters	B-DNA	NOUN	B
dependent	O	ADJ	B
on	O	ADP	O
these	O	DET	O
elements	O	NOUN	B
is	O	AUX	O
inhibitable	O	ADJ	B
by	O	ADP	O
the	O	DET	O
immunosuppressants	O	NOUN	B
cyclosporin	O	NOUN	B
A	O	NOUN	I
(	O	PUNCT	O
CsA	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
tacrolimus	O	NOUN	B
(	O	PUNCT	O
FK-506	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
show	O	VERB	O
that	O	SCONJ	O
this	O	DET	O
technique	O	NOUN	B
is	O	AUX	O
useful	O	ADJ	O
for	O	ADP	O
the	O	DET	O
identification	O	NOUN	B
of	O	ADP	O
minimal	O	ADJ	O
residual	O	ADJ	O
disease	O	NOUN	O
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
APL	O	NOUN	B
and	O	CCONJ	O
that	O	SCONJ	O
cytotoxic	O	ADJ	B
chemotherapy	O	NOUN	I
following	O	VERB	O
ATRA	O	NOUN	B
therapy	O	NOUN	B
is	O	AUX	O
required	O	VERB	O
for	O	ADP	O
the	O	DET	O
elimination	O	NOUN	B
of	O	ADP	O
APL	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
present	O	ADJ	O
in-vitro	O	X	B
experiments	O	NOUN	B
the	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
dexamethasone	O	NOUN	B
,	O	PUNCT	O
of	O	ADP	O
further	O	ADJ	O
glucocorticoids	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
of	O	ADP	O
the	O	DET	O
glucocorticoid	O	NOUN	B
receptor	O	NOUN	I
antagonist	O	NOUN	B
RU	O	NOUN	B
486	O	NUM	O
,	O	PUNCT	O
on	O	ADP	O
structural	O	ADJ	B
order	O	NOUN	O
of	O	ADP	O
human	O	ADJ	B
erythrocyte	O	NOUN	B
ghost	O	NOUN	O
membranes	O	NOUN	O
was	O	AUX	O
investigated	O	VERB	B
by	O	ADP	O
determining	O	VERB	O
the	O	DET	O
steady-state	O	ADJ	B
fluorescence	O	NOUN	B
anisotropy	O	NOUN	I
of	O	ADP	I
diphenylhexatriene	O	NOUN	I
(	O	PUNCT	O
DPH	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Dexamethasone	O	NOUN	B
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
induce	O	VERB	B
a	O	DET	O
significant	O	ADJ	O
decrease	O	NOUN	B
in	O	ADP	O
membrane	O	NOUN	B
structural	O	ADJ	B
order	O	NOUN	O
at	O	ADP	O
concentrations	O	NOUN	B
of	O	ADP	O
about	O	ADV	O
10	O	NUM	O
(	O	PUNCT	O
-6	O	NUM	O
)	O	PUNCT	O
M	O	NOUN	O
in	O	ADP	O
a	O	DET	O
concentration-dependent	O	ADJ	B
manner	O	NOUN	O
.	O	PUNCT	O


Moreover	O	ADV	O
,	O	PUNCT	O
TCR	B-protein	NOUN	B
-induced	O	ADJ	O
phosphorylation	O	NOUN	B
of	O	ADP	O
pp36-38	B-protein	NOUN	B
,	O	PUNCT	O
thought	O	VERB	O
to	O	PART	O
play	O	VERB	O
a	O	DET	O
role	O	NOUN	O
upstream	O	ADJ	B
of	O	ADP	O
these	O	DET	O
pathways	O	NOUN	B
,	O	PUNCT	O
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
be	O	AUX	O
reduced	O	VERB	B
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
overexpression	O	NOUN	B
of	O	ADP	O
wild-type	B-protein	ADJ	B
ZAP-70	I-protein	NOUN	B
induced	O	VERB	B
constitutive	O	ADJ	B
activation	O	NOUN	B
of	O	ADP	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
of	I-protein	ADP	O
activated	I-protein	VERB	B
T	I-protein	NOUN	O
cells	I-protein	NOUN	O
.	O	PUNCT	O


This	O	DET	O
result	O	NOUN	O
demonstrates	O	VERB	O
that	O	SCONJ	O
Tyr-492	O	NOUN	B
and	O	CCONJ	O
Tyr-493	O	NOUN	B
are	O	AUX	O
not	O	PART	O
responsible	O	ADJ	O
for	O	ADP	O
the	O	DET	O
Src	O	NOUN	B
homology	O	NOUN	B
domain	O	NOUN	I
2-mediated	O	ADJ	O
association	O	NOUN	B
of	O	ADP	O
p56	B-protein	NOUN	B
(	I-protein	PUNCT	O
lck	I-protein	NOUN	B
)	I-protein	PUNCT	O
with	O	ADP	O
ZAP-70	B-protein	NOUN	B
.	O	PUNCT	O


Primer	O	NOUN	B
extension	O	NOUN	B
and	O	CCONJ	O
nuclease	O	NOUN	B
S1	O	NOUN	I
protection	O	NOUN	I
analysis	O	NOUN	I
revealed	O	VERB	O
two	O	NUM	O
major	O	ADJ	O
transcription	B-DNA	NOUN	B
initiation	I-DNA	NOUN	I
sites	I-DNA	NOUN	I
.	O	PUNCT	O


The	O	DET	O
promoter	B-DNA	NOUN	B
region	I-DNA	NOUN	I
lacked	O	VERB	O
a	O	DET	O
TATA	B-DNA	NOUN	B
box	I-DNA	NOUN	O
but	O	CCONJ	O
contained	O	VERB	O
potential	O	ADJ	O
binding	O	NOUN	B
sites	O	NOUN	I
for	O	ADP	O
the	O	DET	O
transcriptional	B-protein	ADJ	B
factors	I-protein	NOUN	I
including	O	VERB	O
two	O	NUM	O
Sp1	B-protein	NOUN	B
,	O	PUNCT	O
CRE	B-protein	NOUN	B
,	O	PUNCT	O
Myb	B-protein	NOUN	B
and	O	CCONJ	O
NFkB	B-protein	NOUN	B
located	O	ADJ	O
at	O	ADP	O
positions	B-DNA	NOUN	B
-153	I-DNA	NUM	O
,	I-DNA	PUNCT	O
-178	I-DNA	NUM	O
,	I-DNA	PUNCT	O
-286	I-DNA	NUM	O
,	I-DNA	PUNCT	O
-875	I-DNA	NUM	O
,	I-DNA	PUNCT	O
and	I-DNA	CCONJ	O
-1011	I-DNA	NUM	O
,	O	PUNCT	O
respectively	O	ADV	O
.	O	PUNCT	O


Constitutive	O	ADJ	B
nuclear	O	ADJ	B
appearance	O	NOUN	B
was	O	AUX	O
also	O	ADV	O
observed	O	VERB	O
for	O	ADP	O
NF-kB2/p52	O	NOUN	B
.	O	PUNCT	O


It	O	PRON	O
remains	O	VERB	O
to	O	PART	O
be	O	AUX	O
shown	O	VERB	O
which	O	DET	O
molecular	O	ADJ	B
events	O	NOUN	I
lead	O	VERB	O
to	O	PART	O
the	O	DET	O
specific	O	ADJ	O
'pre-activation	O	NOUN	B
'	O	PUNCT	O
,	O	PUNCT	O
i.e	O	ADV	O
.	O	PUNCT	O


These	O	DET	O
ROI-induced	O	ADJ	B
effects	O	NOUN	B
can	O	AUX	O
,	O	PUNCT	O
to	O	ADP	O
a	O	DET	O
large	O	ADJ	O
extent	O	NOUN	O
,	O	PUNCT	O
be	O	AUX	O
attributed	O	VERB	O
to	O	PART	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
NF-kappaB	B-protein	NOUN	I
.	O	PUNCT	O


When	O	SCONJ	O
CD45RA+	B-cell_type	ADJ	B
(	I-cell_type	PUNCT	O
naive	I-cell_type	ADJ	B
)	I-cell_type	PUNCT	O
and	O	CCONJ	O
CD45RO+	B-cell_type	ADJ	B
(	I-cell_type	PUNCT	O
memory	I-cell_type	NOUN	B
)	I-cell_type	PUNCT	O
T	I-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
were	O	AUX	O
directly	O	ADV	O
stimulated	O	VERB	B
with	O	ADP	O
H2O2	O	NOUN	B
,	O	PUNCT	O
NF-kappaB	B-protein	NOUN	B
nuclear	O	ADJ	O
translocation	O	NOUN	B
was	O	AUX	O
stronger	O	ADJ	O
in	O	ADP	O
naive	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
than	O	ADP	O
in	O	ADP	O
memory	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
it	O	PRON	O
could	O	AUX	O
be	O	AUX	O
induced	O	VERB	B
with	O	ADP	O
lower	O	ADJ	B
doses	O	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
anti-	O	NOUN	O
CD45	B-protein	NOUN	B
antibodies	O	NOUN	I
inhibit	O	VERB	B
these	O	DET	O
effects	O	NOUN	B
in	O	ADP	I
cells	O	NOUN	B
from	O	ADP	O
infected	O	ADJ	B
individuals	O	NOUN	B
.	O	PUNCT	O


Second	O	ADV	O
,	O	PUNCT	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
which	O	DET	O
lack	O	VERB	O
CD45	B-protein	NOUN	B
and	O	CCONJ	O
can	O	AUX	O
not	O	PART	O
signal	O	VERB	B
via	O	ADP	O
the	O	DET	O
TCR	B-protein	NOUN	B
,	O	PUNCT	O
supported	O	VERB	O
higher	O	ADJ	O
levels	O	NOUN	B
of	O	ADP	O
viral	O	ADJ	B
replication	O	NOUN	I
and	O	CCONJ	O
gene	O	NOUN	B
expression	O	NOUN	I
.	O	PUNCT	O


This	O	DET	O
was	O	AUX	O
due	O	ADJ	O
to	O	PART	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
active	O	ADJ	B
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
complexes	I-protein	NOUN	I
in	O	ADP	O
the	O	DET	O
nucleus	O	NOUN	B
of	O	ADP	O
CD45	B-protein	NOUN	B
-T	O	NOUN	O
cells	O	NOUN	B
.	O	PUNCT	O


Calcineurin	B-protein	NOUN	B
potentiates	O	VERB	B
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
granulocyte-macrophage	B-DNA	ADJ	B
colony-stimulating	I-DNA	ADJ	I
factor	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
:	O	PUNCT	O
involvement	O	NOUN	B
of	O	ADP	O
the	O	DET	O
conserved	B-DNA	VERB	O
lymphokine	I-DNA	NOUN	B
element	I-DNA	NOUN	O
0	I-DNA	NUM	O
.	O	PUNCT	O


Alternate	O	ADJ	B
immune	O	ADJ	I
system	O	NOUN	I
targets	O	VERB	O
for	O	ADP	O
TCDD	O	NOUN	B
:	O	PUNCT	O
lymphocyte	B-cell_type	NOUN	B
stem	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
extrathymic	B-cell_type	ADJ	B
T-cell	I-cell_type	NOUN	I
development	O	NOUN	B
.	O	PUNCT	O


Both	O	CCONJ	O
TCDD	O	NOUN	B
and	O	CCONJ	O
estradiol	O	NOUN	B
induce	O	VERB	O
extrathymic	O	ADJ	B
T-cell	O	NOUN	I
differentiation	O	NOUN	O
in	O	ADP	O
the	O	DET	O
liver	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
Bcd	B-DNA	NOUN	B
proto-oncogene	B-DNA	NOUN	I
was	O	AUX	O
activated	O	VERB	B
by	O	ADP	O
a	O	DET	O
truncation	O	NOUN	B
in	O	ADP	O
the	O	DET	O
5	B-DNA	NUM	O
'	I-DNA	PART	O
UTR	I-DNA	NOUN	B
.	O	PUNCT	O


Within	O	ADP	O
the	O	DET	O
PBL	B-cell_type	NOUN	B
,	O	PUNCT	O
Bcd	B-DNA	NOUN	B
gene	O	NOUN	O
expression	O	NOUN	B
was	O	AUX	O
restricted	O	ADJ	O
to	O	PART	O
CD19+	B-cell_type	ADJ	B
B-cells	I-cell_type	NOUN	I
and	O	CCONJ	O
absent	O	ADJ	B
from	O	ADP	O
CD14+	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
and	O	CCONJ	O
T-cells	B-cell_type	NOUN	B
.	O	PUNCT	O


Bcd	B-DNA	NOUN	B
transcripts	O	NOUN	B
were	O	AUX	O
detected	O	VERB	B
in	O	ADP	O
all	O	DET	O
normal	O	ADJ	O
PBL	B-cell_type	NOUN	B
samples	O	NOUN	B
tested	O	VERB	B
but	O	CCONJ	O
not	O	PART	O
in	O	ADP	O
several	O	ADJ	O
malignant	B-cell_line	ADJ	B
human	I-cell_line	ADJ	O
B-cell	I-cell_line	NOUN	O
lines	I-cell_line	NOUN	O
and	O	CCONJ	O
not	O	PART	O
in	O	ADP	O
50	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
B-cells	B-cell_type	NOUN	B
from	O	ADP	O
B-CLL	O	NOUN	B
patients	O	NOUN	B
.	O	PUNCT	O


Electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assays	O	NOUN	I
(	O	PUNCT	O
EMSA	O	NOUN	B
)	O	PUNCT	O
with	O	ADP	O
a	O	DET	O
43-mer	B-DNA	ADJ	O
oligonucleotide	I-DNA	NOUN	B
derived	O	VERB	O
from	O	ADP	O
the	O	DET	O
functionally	O	ADV	O
identified	O	VERB	O
cis-acting	B-DNA	ADJ	B
element	I-DNA	NOUN	I
revealed	O	VERB	O
specific	O	ADJ	O
complexes	O	NOUN	B
.	O	PUNCT	O


Expression	O	NOUN	B
of	O	ADP	O
Egr-1	B-protein	NOUN	B
correlates	O	VERB	B
with	O	ADP	O
the	O	DET	O
transformed	O	VERB	B
phenotype	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
type	O	NOUN	O
of	O	ADP	O
viral	O	ADJ	B
latency	O	NOUN	I
in	O	ADP	O
EBV	B-cell_line	NOUN	B
genome	I-cell_line	NOUN	B
positive	I-cell_line	ADJ	O
lymphoid	I-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
.	O	PUNCT	O


Recent	O	ADJ	O
work	O	NOUN	O
has	O	AUX	O
shown	O	VERB	O
that	O	SCONJ	O
IL-10	B-protein	NOUN	B
induces	O	VERB	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
JAK	B-protein	NOUN	B
-STAT	B-protein	ADJ	O
signaling	O	NOUN	B
pathway	O	NOUN	I
.	O	PUNCT	O


This	O	DET	O
study	O	NOUN	B
thus	O	ADV	O
supports	O	VERB	O
the	O	DET	O
concept	O	NOUN	B
that	O	SCONJ	O
utilization	O	NOUN	B
of	O	ADP	O
distinct	O	ADJ	O
STAT	B-protein	NOUN	B
proteins	I-protein	NOUN	I
by	O	ADP	O
different	O	ADJ	O
cytokine	B-protein	NOUN	B
receptors	I-protein	NOUN	I
is	O	AUX	O
dependent	O	ADJ	B
on	O	ADP	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
particular	O	ADJ	O
ligand-activatable	O	ADJ	B
,	O	PUNCT	O
tyrosine-containing	B-protein	ADJ	B
STAT	I-protein	NOUN	I
docking	I-protein	NOUN	I
sites	I-protein	NOUN	I
in	O	ADP	O
receptor	B-protein	NOUN	B
intracellular	I-protein	ADJ	I
domains	I-protein	NOUN	B
.	O	PUNCT	O


Impaired	O	ADJ	B
silencing	O	NOUN	B
of	O	ADP	O
gamma-globin	B-protein	NOUN	B
expression	O	NOUN	B
identifies	O	VERB	O
EKLF	B-protein	NOUN	B
as	O	ADP	O
the	O	DET	O
first	O	ADJ	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
participating	O	VERB	O
quantitatively	O	ADV	B
in	O	ADP	O
the	O	DET	O
gamma-globin	B-protein	NOUN	B
to	O	PART	O
beta-globin	B-protein	NOUN	B
switch	O	NOUN	B
.	O	PUNCT	O


Zinc	O	NOUN	B
is	O	AUX	O
an	O	DET	O
important	O	ADJ	O
trace	O	NOUN	B
element	O	NOUN	I
for	O	ADP	O
immune	O	ADJ	B
function	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
E3	B-protein	NOUN	B
is	O	AUX	O
a	O	DET	O
hematopoietic-specific	B-DNA	ADJ	B
gene	I-DNA	NOUN	I
that	O	PRON	O
is	O	AUX	O
an	O	DET	O
immediate	O	ADJ	B
target	O	NOUN	B
for	O	ADP	O
the	O	DET	O
activated	O	VERB	B
RAR	B-protein	NOUN	B
alpha	I-protein	NOUN	I
during	O	ADP	O
myelopoiesis	O	NOUN	B
.	O	PUNCT	O


Because	O	SCONJ	O
the	O	DET	O
-180	B-DNA	NUM	O
site	I-DNA	NOUN	B
is	O	AUX	O
not	O	PART	O
required	O	VERB	O
for	O	ADP	O
trans-activation	O	NOUN	B
,	O	PUNCT	O
it	O	PRON	O
was	O	AUX	O
possible	O	ADJ	O
to	O	PART	O
confirm	O	VERB	O
by	O	ADP	O
mutation	O	NOUN	B
in	O	ADP	O
the	O	DET	O
normal	O	ADJ	B
mouse	B-DNA	NOUN	B
IL-2	I-DNA	NOUN	B
enhancer	I-DNA	NOUN	O
that	O	SCONJ	O
this	O	DET	O
site	O	NOUN	B
is	O	AUX	O
absolutely	O	ADV	O
essential	O	ADJ	O
for	O	ADP	O
anergy	O	NOUN	B
induction	O	NOUN	B
.	O	PUNCT	O


Deletion	O	NOUN	B
of	O	ADP	O
the	O	DET	O
glucocorticoid	O	NOUN	B
response	O	NOUN	I
elements	O	NOUN	I
located	O	ADJ	O
at	O	ADP	O
ca.	B-DNA	X	O
bp	I-DNA	NOUN	O
-850	I-DNA	NUM	O
upstream	O	ADJ	B
of	O	ADP	O
Cp	B-DNA	NOUN	B
did	O	AUX	O
not	O	PART	O
result	O	VERB	O
in	O	ADP	O
a	O	DET	O
significant	O	ADJ	O
loss	O	NOUN	B
in	O	ADP	O
activity	O	NOUN	B
.	O	PUNCT	O


Protein-tyrosine	O	ADJ	B
kinase	O	NOUN	I
activation	O	NOUN	B
is	O	AUX	O
required	O	VERB	O
for	O	ADP	O
lipopolysaccharide	O	NOUN	B
induction	O	NOUN	B
of	O	ADP	O
interleukin	B-protein	NOUN	B
1beta	I-protein	NOUN	I
and	O	CCONJ	O
NFkappaB	B-protein	NOUN	B
activation	O	NOUN	O
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
NFkappaB	B-protein	NOUN	B
nuclear	O	ADJ	B
translocation	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
human	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
,	O	PUNCT	O
interleukin	B-protein	NOUN	B
1beta	I-protein	NOUN	I
protein	O	NOUN	I
production	O	NOUN	B
and	O	CCONJ	O
steady	O	ADJ	B
state	O	NOUN	I
mRNA	O	NOUN	B
levels	O	NOUN	O
are	O	AUX	O
increased	O	VERB	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
lipopolysaccharide	O	NOUN	B
,	O	PUNCT	O
predominantly	O	ADV	O
as	O	ADP	O
a	O	DET	O
result	O	NOUN	O
of	O	ADP	O
increased	O	VERB	B
transcription	O	NOUN	B
of	O	ADP	O
the	O	DET	O
interleukin	B-protein	NOUN	B
1beta	I-protein	NOUN	I
gene	O	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
tyrosine	B-protein	NOUN	B
kinase	I-protein	NOUN	I
activity	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
ability	O	NOUN	O
of	O	ADP	O
NFkappaB	B-protein	NOUN	B
to	O	PART	O
stimulate	O	VERB	B
transcription	O	NOUN	B
is	O	AUX	O
impaired	O	ADJ	B
.	O	PUNCT	O


ATRA	O	NOUN	B
induces	O	VERB	O
both	O	CCONJ	O
in	O	X	B
vitro	O	X	I
and	O	CCONJ	O
in	O	X	B
vivo	O	X	I
differentiation	O	NOUN	B
of	O	ADP	O
APL	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	B
into	O	ADP	O
mature	B-cell_type	ADJ	B
granulocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


Because	O	SCONJ	O
interferon	B-protein	NOUN	B
(	I-protein	PUNCT	O
IFN	I-protein	NOUN	B
)	I-protein	PUNCT	O
regulatory	I-protein	ADJ	B
factors	I-protein	NOUN	I
(	O	PUNCT	O
IRF-1	B-protein	NOUN	B
and	O	CCONJ	O
IRF-2	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
other	O	ADJ	O
IFN-inducible	B-protein	ADJ	B
gene	I-protein	NOUN	O
products	I-protein	NOUN	O
regulate	O	VERB	B
cell	O	NOUN	B
growth	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
analyzed	O	VERB	B
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	O
ATRA	O	NOUN	B
on	O	ADP	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
these	O	DET	O
genes	O	NOUN	B
.	O	PUNCT	O


Loss	O	NOUN	B
of	O	ADP	O
heterozygosity	O	NOUN	B
in	O	ADP	O
PB	B-cell_type	NOUN	B
granulocytes	I-cell_type	NOUN	B
would	O	AUX	O
be	O	AUX	O
masked	O	VERB	O
by	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
significant	O	ADJ	B
numbers	O	NOUN	O
of	O	ADP	O
normal	B-cell_type	ADJ	B
granulocytes	I-cell_type	NOUN	I
not	O	PART	O
derived	O	VERB	O
from	O	ADP	O
the	O	DET	O
malignant	B-cell_line	ADJ	B
clone	I-cell_line	NOUN	B
.	O	PUNCT	O


Therefore	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
human	B-protein	ADJ	B
androgen	I-protein	NOUN	O
receptor	I-protein	NOUN	O
assay	O	NOUN	O
(	O	PUNCT	O
HUMARA	O	NOUN	B
)	O	PUNCT	O
was	O	AUX	O
used	O	VERB	O
to	O	PART	O
determine	O	VERB	O
granulocyte	O	NOUN	B
clonality	O	NOUN	B
.	O	PUNCT	O


Soluble	B-protein	ADJ	B
factors	I-protein	NOUN	O
secreted	O	VERB	B
by	O	ADP	O
activated	B-cell_type	VERB	B
T-lymphocytes	I-cell_type	NOUN	B
modulate	O	VERB	B
the	O	DET	O
transcription	O	NOUN	B
of	O	ADP	O
the	O	DET	O
immunosuppressive	B-protein	ADJ	B
cytokine	I-protein	NOUN	B
TGF-beta	B-protein	NOUN	B
2	I-protein	NUM	O
in	O	ADP	O
glial	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
conclusion	O	NOUN	O
,	O	PUNCT	O
E	B-DNA	NOUN	B
(	I-DNA	PUNCT	O
gre	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
motifs	O	NOUN	B
and	O	CCONJ	O
interacting	O	VERB	B
basic	B-protein	ADJ	O
helix-loop-helix	I-protein	ADJ	B
proteins	I-protein	NOUN	I
are	O	AUX	O
important	O	ADJ	O
determinants	O	NOUN	B
for	O	ADP	O
MLV	O	NOUN	B
transcriptional	O	ADJ	B
activity	O	NOUN	I
in	O	ADP	O
lymphocytic	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
report	O	VERB	O
that	O	SCONJ	O
human	B-cell_type	ADJ	B
leukaemia	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	B
carrying	O	VERB	O
the	O	DET	O
translocation	O	NOUN	B
t	B-DNA	NOUN	O
(	I-DNA	PUNCT	O
17	I-DNA	NUM	O
;	I-DNA	PUNCT	O
19	I-DNA	NUM	O
)	I-DNA	PUNCT	O
rapidly	O	ADV	O
died	O	VERB	B
by	O	ADP	O
apoptosis	O	NOUN	B
when	O	SCONJ	O
programmed	O	VERB	B
to	O	PART	O
express	O	VERB	O
a	O	DET	O
dominant-negative	O	ADJ	B
suppressor	O	NOUN	I
of	O	ADP	I
the	O	DET	I
fusion	O	NOUN	I
protein	O	NOUN	I
E2A-HLF	B-protein	NOUN	B
,	O	PUNCT	O
indicating	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
chimaeric	B-protein	ADJ	B
oncoprotein	I-protein	NOUN	I
probably	O	ADV	O
affects	O	VERB	O
cell	O	NOUN	B
survival	O	NOUN	I
rather	O	ADV	O
than	O	ADP	O
cell	O	NOUN	B
growth	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
close	O	ADJ	O
homology	O	NOUN	B
of	O	ADP	O
the	O	DET	O
basic	B-protein	ADJ	O
region/leucine	I-protein	NOUN	O
zipper	I-protein	NOUN	O
(	O	PUNCT	O
bZIP	B-protein	NOUN	B
)	O	PUNCT	O
DNA-binding	O	ADJ	B
and	O	CCONJ	O
dimerization	B-protein	NOUN	B
domain	I-protein	NOUN	I
of	O	ADP	O
HLF	B-protein	NOUN	B
to	O	PART	O
that	O	DET	O
of	O	ADP	O
the	O	DET	O
CES-2	B-protein	NOUN	B
cell-death	I-protein	NOUN	O
specification	I-protein	NOUN	O
protein	I-protein	NOUN	B
of	O	ADP	O
Caenorhabditis	O	NOUN	B
elegans	O	NOUN	I
suggests	O	VERB	O
a	O	DET	O
model	O	NOUN	B
of	O	ADP	O
leukaemogenesis	O	NOUN	B
in	O	ADP	O
which	O	DET	O
E2A-HLF	B-protein	NOUN	B
blocks	O	VERB	I
an	O	DET	O
early	O	ADJ	O
step	O	NOUN	O
within	O	ADP	O
an	O	DET	O
evolutionarily	O	ADV	O
conserved	O	VERB	O
cell-death	O	NOUN	B
pathway	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
show	O	VERB	O
that	O	SCONJ	O
immunization	O	NOUN	B
with	O	ADP	O
synthetic	O	ADJ	B
peptides	O	NOUN	I
can	O	AUX	O
lead	O	VERB	O
to	O	PART	O
the	O	DET	O
elimination	O	NOUN	B
of	O	ADP	O
anti-tumor	O	ADJ	B
CTL	O	NOUN	B
responses	O	NOUN	B
.	O	PUNCT	O


As	O	ADP	O
a	O	DET	O
consequence	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
immune	O	ADJ	B
response	O	NOUN	I
developed	O	VERB	O
in	O	ADP	O
senescent	O	ADJ	B
organisms	O	NOUN	O
is	O	AUX	O
usually	O	ADV	O
inappropriate	O	ADJ	B
,	O	PUNCT	O
often	O	ADV	O
inefficient	O	ADJ	B
,	O	PUNCT	O
sometimes	O	ADV	O
aberrant	O	ADJ	B
,	O	PUNCT	O
and	O	CCONJ	O
potentially	O	ADV	O
detrimental	O	ADJ	B
.	O	PUNCT	O


The	O	DET	O
purpose	O	NOUN	O
of	O	ADP	O
this	O	DET	O
review	O	NOUN	B
is	O	AUX	O
to	O	PART	O
show	O	VERB	O
how	O	SCONJ	O
the	O	DET	O
accumulation	O	NOUN	B
of	O	ADP	O
various	O	ADJ	O
biochemical	O	ADJ	B
lesions	O	NOUN	B
with	O	ADP	O
advancing	O	VERB	O
age	O	NOUN	B
leads	O	VERB	O
to	O	PART	O
the	O	DET	O
failure	O	NOUN	B
of	O	ADP	O
a	O	DET	O
critical	O	ADJ	B
cell	O	NOUN	I
function	O	NOUN	I
,	O	PUNCT	O
namely	O	ADV	O
the	O	DET	O
activation-induced	O	ADJ	B
lymphocyte	O	NOUN	I
proliferation	O	NOUN	I
.	O	PUNCT	O


Levels	O	NOUN	B
of	O	ADP	O
bcl-2	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
and	O	CCONJ	O
protein	O	NOUN	B
increase	O	NOUN	B
with	O	ADP	O
cross-linking	O	NOUN	B
of	O	ADP	O
surface	B-protein	NOUN	B
immunoglobulin	I-protein	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
show	O	VERB	O
by	O	ADP	O
antibody	O	NOUN	B
supershift	O	NOUN	I
experiments	O	NOUN	I
and	O	CCONJ	O
UV	O	NOUN	B
cross-linking	O	NOUN	B
followed	O	VERB	O
by	O	ADP	O
denaturing	O	VERB	B
polyacrylamide	O	NOUN	I
gel	O	NOUN	I
electrophoresis	O	NOUN	I
that	O	SCONJ	O
both	O	CCONJ	O
CREB	O	NOUN	B
and	O	CCONJ	O
ATF	O	NOUN	B
family	O	NOUN	B
members	O	NOUN	I
bind	O	VERB	B
to	O	PART	O
this	O	DET	O
region	O	NOUN	B
in	O	X	B
vitro	O	X	I
.	O	PUNCT	O


bcl-2	B-protein	NOUN	B
expression	O	NOUN	B
is	O	AUX	O
increased	O	VERB	B
following	O	VERB	O
phorbol	O	NOUN	B
ester	O	NOUN	I
treatment	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
increased	O	VERB	B
expression	O	NOUN	B
is	O	AUX	O
dependent	O	ADJ	B
on	O	ADP	O
the	O	DET	O
CRE	B-DNA	NOUN	B
site	I-DNA	NOUN	O
.	O	PUNCT	O


These	O	DET	O
stimuli	O	NOUN	B
result	O	VERB	O
in	O	ADP	O
phosphorylation	O	NOUN	B
of	O	ADP	O
CREB	B-protein	NOUN	B
at	O	ADP	O
serine	O	NOUN	B
133	O	NUM	I
.	O	PUNCT	O


Moreover	O	ADV	O
,	O	PUNCT	O
defective	O	ADJ	B
DNA	O	NOUN	B
binding	O	NOUN	I
was	O	AUX	O
corrected	O	VERB	O
by	O	ADP	O
treatment	O	NOUN	B
with	O	ADP	O
acid	O	NOUN	B
phosphatase	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
cyclosporin	B-protein	NOUN	B
A	I-protein	NOUN	I
(	I-protein	PUNCT	O
CsA	I-protein	NOUN	B
)	I-protein	PUNCT	O
/FK506-sensitive	I-protein	ADJ	O
nuclear	I-protein	ADJ	B
factor	I-protein	NOUN	I
of	I-protein	ADP	O
activated	I-protein	VERB	B
T	I-protein	NOUN	O
cells	I-protein	NOUN	O
(	O	PUNCT	O
NFAT	B-protein	NOUN	B
)	O	PUNCT	O
plays	O	VERB	O
a	O	DET	O
key	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
inducible	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
cytokine	B-DNA	NOUN	B
genes	I-DNA	NOUN	I
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


The	O	DET	O
amino	B-protein	NOUN	B
acid	I-protein	NOUN	I
sequence	I-protein	NOUN	I
of	O	ADP	O
NFATc.beta	B-protein	NOUN	B
differs	O	VERB	O
from	O	ADP	O
that	O	DET	O
of	O	ADP	O
NFATc	B-protein	NOUN	B
.	O	PUNCT	O


Transient	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
NFATc.beta	B-protein	NOUN	B
was	O	AUX	O
capable	O	ADJ	O
of	O	ADP	O
activating	O	VERB	B
an	O	DET	O
interleukin-2	B-DNA	NOUN	B
NFAT-driven	I-DNA	ADJ	O
reporter	I-DNA	NOUN	O
gene	I-DNA	NOUN	O
in	O	ADP	O
stimulated	B-cell_line	VERB	B
Jurkat	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
in	O	ADP	O
a	O	DET	O
CsA-sensitive	O	ADJ	B
manner	O	NOUN	O
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
NFATc.beta	B-protein	NOUN	B
neither	O	CCONJ	O
bound	O	VERB	O
to	O	PART	O
the	O	DET	O
kappa3	B-DNA	NOUN	B
element	I-DNA	NOUN	I
(	O	PUNCT	O
an	O	DET	O
NFAT-binding	B-DNA	ADJ	B
site	I-DNA	NOUN	I
)	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
tumor	B-DNA	NOUN	B
necrosis	I-DNA	NOUN	I
factor-alpha	I-DNA	NOUN	I
promoter	I-DNA	NOUN	I
nor	O	CCONJ	O
activated	O	VERB	B
the	O	DET	O
tumor	B-DNA	NOUN	B
necrosis	I-DNA	NOUN	I
factor-alpha	I-DNA	NOUN	I
promoter	I-DNA	NOUN	I
in	O	ADP	O
cotransfection	O	NOUN	B
assays	O	NOUN	I
.	O	PUNCT	O


Regulation	O	NOUN	B
of	O	ADP	O
interferon-gamma	B-protein	NOUN	O
gene	O	NOUN	B
expression	O	NOUN	I
.	O	PUNCT	O


IFN-gamma	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
and	O	CCONJ	O
protein	O	NOUN	B
are	O	AUX	O
expressed	O	VERB	B
predominantly	O	ADV	O
by	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
large	B-cell_type	ADJ	O
granular	I-cell_type	ADJ	B
lymphocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


The	O	DET	O
IFN-gamma	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
is	O	AUX	O
induced/inhibited	O	VERB	B
in	O	ADP	O
these	O	DET	O
cell	O	NOUN	B
types	O	NOUN	I
by	O	ADP	O
a	O	DET	O
wide	O	ADJ	O
variety	O	NOUN	O
of	O	ADP	O
extracellular	O	ADJ	B
signals	O	NOUN	O
,	O	PUNCT	O
thus	O	ADV	O
implicating	O	VERB	O
a	O	DET	O
number	O	NOUN	O
of	O	ADP	O
diverse	O	ADJ	B
,	O	PUNCT	O
yet	O	ADV	O
convergent	O	ADJ	B
signal	O	NOUN	I
transduction	O	NOUN	I
pathways	O	NOUN	I
in	O	ADP	O
its	O	PRON	O
transcriptional	O	ADJ	B
control	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
study	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
examined	O	VERB	O
seven	O	NUM	O
EBV-positive	O	ADJ	B
gastric	O	ADJ	B
carcinoma	O	NOUN	I
tissues	O	NOUN	B
for	O	ADP	O
viral	O	ADJ	B
gene	O	NOUN	I
expression	O	NOUN	B
at	O	ADP	O
the	O	DET	O
mRNA	O	NOUN	B
level	O	NOUN	B
,	O	PUNCT	O
from	O	ADP	O
which	O	DET	O
studies	O	NOUN	B
on	O	ADP	O
the	O	DET	O
EBV	O	NOUN	B
oncogenicity	O	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
epithelial	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
will	O	AUX	O
benefit	O	VERB	B
.	O	PUNCT	O


Reverse	O	VERB	B
transcription-PCR	O	NOUN	I
analysis	O	NOUN	I
showed	O	VERB	O
that	O	SCONJ	O
all	O	DET	O
seven	O	NUM	O
EBV-positive	O	ADJ	B
tumour	O	NOUN	O
tissues	O	NOUN	B
constitutively	O	ADV	B
expressed	O	VERB	O
EBV	B-RNA	NOUN	B
nuclear	I-RNA	ADJ	O
antigen	I-RNA	NOUN	O
(	I-RNA	PUNCT	O
EBNA	I-RNA	NOUN	B
)	I-RNA	PUNCT	O
1	I-RNA	NUM	O
mRNA	I-RNA	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
EBNA2	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
.	O	PUNCT	O


Both	O	DET	O
are	O	AUX	O
located	O	ADJ	O
in	O	ADP	O
the	O	DET	O
particulate	O	ADJ	B
fraction	O	NOUN	I
following	O	VERB	O
platelet	B-cell_type	NOUN	B
activation	O	NOUN	I
and	O	CCONJ	O
are	O	AUX	O
also	O	ADV	O
able	O	ADJ	O
to	O	PART	O
bind	O	VERB	B
to	O	PART	O
a	O	DET	O
GST-construct	B-protein	NOUN	B
containing	O	VERB	O
the	O	DET	O
SH2	B-protein	NOUN	B
and	I-protein	CCONJ	O
SH3	I-protein	NOUN	B
domains	I-protein	NOUN	I
of	O	ADP	O
phospholipase	B-protein	NOUN	B
C	I-protein	NOUN	I
gamma	I-protein	NOUN	I
1	I-protein	NUM	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
IFN-alpha5	B-protein	NOUN	B
and	O	CCONJ	O
IFN-beta	B-protein	NOUN	B
are	O	AUX	O
produced	O	VERB	O
at	O	ADP	O
low	O	ADJ	B
levels	O	NOUN	B
in	O	ADP	O
normal	O	ADJ	B
tissues	O	NOUN	I
and	O	CCONJ	O
play	O	VERB	O
an	O	DET	O
important	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
cell	O	NOUN	B
function	O	NOUN	I
and	O	CCONJ	O
in	O	ADP	O
the	O	DET	O
maintenance	O	NOUN	B
of	O	ADP	O
homeostasis	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
although	O	SCONJ	O
the	O	DET	O
individual	O	ADJ	B
components	O	NOUN	B
of	O	ADP	O
this	O	DET	O
element	O	NOUN	B
do	O	AUX	O
not	O	PART	O
respond	O	VERB	O
to	O	PART	O
IL-2	B-protein	NOUN	B
,	O	PUNCT	O
together	O	ADV	O
they	O	PRON	O
form	O	VERB	O
a	O	DET	O
composite	O	ADJ	B
element	O	NOUN	B
capable	O	ADJ	O
of	O	ADP	O
conferring	O	VERB	O
IL-2	B-protein	NOUN	B
responsiveness	O	NOUN	B
to	O	PART	O
a	O	DET	O
heterologous	B-DNA	ADJ	B
promoter	I-DNA	NOUN	B
.	O	PUNCT	O


Multiple	O	ADJ	B
factors	O	NOUN	I
including	O	VERB	O
Stat5	B-protein	NOUN	B
,	O	PUNCT	O
Elf-1	B-protein	NOUN	B
,	O	PUNCT	O
HMG-I	B-protein	NOUN	B
(	I-protein	PUNCT	O
Y	I-protein	NOUN	B
)	I-protein	PUNCT	O
and	O	CCONJ	O
GATA	B-protein	NOUN	B
family	I-protein	NOUN	B
proteins	I-protein	NOUN	I
bind	O	VERB	B
to	O	PART	O
the	O	DET	O
IL-2	B-DNA	NOUN	B
response	I-DNA	NOUN	I
element	I-DNA	NOUN	I
and	O	CCONJ	O
mutation	O	NOUN	B
of	O	ADP	O
any	O	DET	O
one	O	NUM	O
of	O	ADP	O
these	O	DET	O
binding	O	VERB	B
sites	O	NOUN	I
diminishes	O	VERB	O
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
this	O	DET	O
element	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
proximal	B-protein	ADJ	B
sequence	I-protein	NOUN	I
element	I-protein	NOUN	I
(	I-protein	PUNCT	O
PSE	I-protein	NOUN	B
)	I-protein	PUNCT	O
-binding	I-protein	ADJ	O
transcription	I-protein	NOUN	B
factor	I-protein	NOUN	I
(	O	PUNCT	O
PTF	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
which	O	DET	O
binds	O	VERB	B
the	O	DET	O
PSE	B-DNA	NOUN	B
of	O	ADP	O
both	O	CCONJ	O
RNA	B-DNA	NOUN	B
polymerase	I-DNA	NOUN	I
II	I-DNA	NUM	I
-and	I-DNA	NOUN	O
RNA	I-DNA	NOUN	B
polymerase	I-DNA	NOUN	I
III-transcribed	I-DNA	ADJ	I
mammalian	I-DNA	ADJ	B
small	I-DNA	ADJ	B
nuclear	I-DNA	ADJ	I
RNA	I-DNA	NOUN	I
(	I-DNA	PUNCT	O
snRNA	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
genes	I-DNA	NOUN	O
,	O	PUNCT	O
is	O	AUX	O
essential	O	ADJ	O
for	O	ADP	O
their	O	PRON	O
transcription	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
previously	O	ADV	O
reported	O	VERB	O
the	O	DET	O
purification	O	NOUN	B
of	O	ADP	O
human	B-protein	ADJ	B
PTF	I-protein	NOUN	B
,	O	PUNCT	O
a	O	DET	O
complex	O	NOUN	B
of	O	ADP	O
four	B-protein	NUM	O
subunits	I-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
molecular	O	ADJ	B
cloning	O	NOUN	I
and	O	CCONJ	O
characterization	O	NOUN	B
of	O	ADP	O
PTF	B-protein	NOUN	B
gamma	I-protein	NOUN	O
and	I-protein	CCONJ	O
delta	I-protein	NOUN	O
subunits	I-protein	NOUN	O
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
describe	O	VERB	O
the	O	DET	O
isolation	O	NOUN	B
and	O	CCONJ	O
expression	O	NOUN	B
of	O	ADP	O
a	O	DET	O
cDNA	B-DNA	NOUN	B
encoding	O	VERB	O
PTF	B-protein	NOUN	B
beta	I-protein	NOUN	B
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
functional	O	ADJ	B
studies	O	NOUN	I
using	O	VERB	O
anti-PTF	B-protein	ADJ	B
beta	I-protein	NOUN	I
antibodies	I-protein	NOUN	I
.	O	PUNCT	O


Along	O	ADP	O
with	O	ADP	O
our	O	PRON	O
previous	O	ADJ	O
demonstration	O	NOUN	O
of	O	ADP	O
both	O	DET	O
physical	O	ADJ	B
interactions	O	NOUN	I
between	O	ADP	O
PTF	B-protein	NOUN	B
gamma/PTF	I-protein	NOUN	B
delta	I-protein	NOUN	B
and	O	CCONJ	O
TBP	B-protein	NOUN	B
and	O	CCONJ	O
the	O	DET	O
involvement	O	NOUN	B
of	O	ADP	O
TFIIIB90	B-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
transcription	O	NOUN	B
of	O	ADP	O
class	B-DNA	NOUN	B
III	I-DNA	NUM	I
snRNA	I-DNA	NOUN	B
genes	I-DNA	NOUN	I
,	O	PUNCT	O
these	O	DET	O
results	O	NOUN	B
are	O	AUX	O
consistent	O	ADJ	B
with	O	ADP	I
the	O	DET	O
notion	O	NOUN	O
that	O	SCONJ	O
a	O	DET	O
TBP-containing	B-protein	ADJ	B
complex	I-protein	NOUN	B
related	O	ADJ	O
to	O	PART	O
TFIIIB	B-protein	NOUN	B
is	O	AUX	O
required	O	VERB	O
for	O	ADP	O
the	O	DET	O
transcription	O	NOUN	B
of	O	ADP	O
class	B-DNA	NOUN	B
III	I-DNA	NUM	I
snRNA	I-DNA	NOUN	B
genes	I-DNA	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
acts	O	VERB	O
through	O	ADP	O
weak	O	ADJ	B
interaction	O	NOUN	B
with	O	ADP	O
the	O	DET	O
four-subunit	B-protein	ADJ	B
PTF	I-protein	NOUN	B
.	O	PUNCT	O


Attenuated	O	VERB	B
function	O	NOUN	I
of	O	ADP	O
a	O	DET	O
variant	O	ADJ	B
form	O	NOUN	O
of	O	ADP	O
the	O	DET	O
helix-loop-helix	B-protein	ADJ	B
protein	I-protein	NOUN	I
,	O	PUNCT	O
Id-3	B-protein	NOUN	B
,	O	PUNCT	O
generated	O	VERB	O
by	O	ADP	O
an	O	DET	O
alternative	O	ADJ	B
splicing	O	NOUN	B
mechanism	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
report	O	VERB	O
here	O	ADV	O
on	O	ADP	O
the	O	DET	O
identification	O	NOUN	B
of	O	ADP	O
a	O	DET	O
17	B-protein	NUM	O
kDa	I-protein	NOUN	O
variant	I-protein	NOUN	B
of	O	ADP	O
the	O	DET	O
14	B-protein	NUM	O
kDa	I-protein	NOUN	O
Id-3	I-protein	NOUN	B
protein	O	NOUN	I
termed	O	VERB	O
Id-3L	B-protein	NOUN	B
(	O	PUNCT	O
long	O	ADJ	B
version	O	NOUN	I
)	O	PUNCT	O
which	O	DET	O
possesses	O	VERB	O
a	O	DET	O
unique	O	ADJ	O
60	B-protein	NUM	O
amino	I-protein	NOUN	B
acid	I-protein	NOUN	I
carboxy-terminus	I-protein	NOUN	B
generated	O	VERB	O
by	O	ADP	O
read	O	VERB	B
through	O	ADP	O
of	O	ADP	O
a	O	DET	O
'	O	PUNCT	O
coding	B-DNA	VERB	B
intron	I-DNA	NOUN	I
'	O	PUNCT	O
and	O	CCONJ	O
alternative	O	ADJ	B
splicing	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
previously	O	ADV	O
shown	O	VERB	O
that	O	SCONJ	O
tyloxapol	O	NOUN	B
is	O	AUX	O
a	O	DET	O
potent	O	ADJ	O
antioxidant	O	NOUN	B
for	O	ADP	O
hydroxyl	O	NOUN	B
radicals	O	NOUN	I
(	O	PUNCT	O
OH	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Tyloxapol	O	NOUN	B
also	O	ADV	O
reduces	O	VERB	B
the	O	DET	O
viscosity	O	NOUN	B
of	O	ADP	O
CF	O	NOUN	B
sputum	O	NOUN	B
(	O	PUNCT	O
from	O	ADP	O
463	O	NUM	O
+/-	O	CCONJ	O
133	O	NUM	O
to	O	PART	O
128	O	NUM	O
+/-	O	CCONJ	O
52	O	NUM	O
centipoise	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
NF-kappaB/Rel	B-protein	NOUN	B
family	I-protein	NOUN	O
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
regulates	O	VERB	B
the	O	DET	O
inducible	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
many	O	ADJ	O
genes	O	NOUN	B
in	O	ADP	O
activated	B-cell_type	VERB	B
human	I-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
and	O	CCONJ	O
endothelial	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
study	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
examined	O	VERB	O
the	O	DET	O
molecular	O	ADJ	B
mechanism	O	NOUN	O
by	O	ADP	O
which	O	DET	O
agents	O	NOUN	B
that	O	PRON	O
elevate	O	VERB	O
intracellular	O	ADJ	B
cAMP	O	NOUN	B
inhibit	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor	I-protein	NOUN	I
alpha	I-protein	NOUN	I
(	O	PUNCT	O
TNFalpha	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
tissue	B-protein	NOUN	B
factor	I-protein	NOUN	I
,	O	PUNCT	O
endothelial	B-protein	ADJ	B
leukocyte	I-protein	NOUN	I
adhesion	I-protein	NOUN	I
molecule-1	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
vascular	B-DNA	ADJ	B
cell	I-DNA	NOUN	I
adhesion	I-DNA	NOUN	I
molecule-1	I-DNA	NOUN	I
genes	I-DNA	NOUN	I
.	O	PUNCT	O


Elevated	O	ADJ	B
cAMP	O	NOUN	B
did	O	AUX	O
not	O	PART	O
prevent	O	VERB	O
nuclear	O	ADJ	B
translocation	O	NOUN	I
of	O	ADP	O
p50/p65	B-protein	NOUN	B
and	O	CCONJ	O
c-Rel/p65	B-protein	NOUN	B
heterodimers	I-protein	NOUN	I
,	O	PUNCT	O
decrease	O	VERB	B
nuclear	O	ADJ	B
translocation	O	NOUN	I
of	O	ADP	O
p65	B-protein	NOUN	B
,	O	PUNCT	O
or	O	CCONJ	O
significantly	O	ADV	O
modify	O	VERB	O
TNFalpha	B-protein	NOUN	B
-induced	O	ADJ	O
phosphorylation	O	NOUN	B
of	O	ADP	O
p65	B-protein	NOUN	B
.	O	PUNCT	O


Despite	O	SCONJ	O
the	O	DET	O
widespread	O	ADJ	B
use	O	NOUN	O
of	O	ADP	O
glucocorticoids	O	NOUN	B
in	O	ADP	O
the	O	DET	O
treatment	O	NOUN	B
of	O	ADP	O
diseases	O	NOUN	B
characterized	O	VERB	B
by	O	ADP	O
inflammation	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
molecular	O	ADJ	B
mechanism	O	NOUN	I
(	O	PUNCT	O
s	O	NOUN	O
)	O	PUNCT	O
by	O	ADP	O
which	O	DET	O
these	O	DET	O
hormones	O	NOUN	B
exert	O	VERB	O
this	O	DET	O
beneficial	O	ADJ	O
effect	O	NOUN	B
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
asthma	O	NOUN	B
remains	O	VERB	O
to	O	PART	O
be	O	AUX	O
elucidated	O	VERB	O
.	O	PUNCT	O


No	O	DET	O
glucocorticoid	B-DNA	NOUN	B
recognition	I-DNA	NOUN	I
sequences	I-DNA	NOUN	I
are	O	AUX	O
present	O	ADJ	O
in	O	ADP	O
this	O	DET	O
promoter	B-DNA	NOUN	B
region	I-DNA	NOUN	I
and	O	CCONJ	O
dexamethasone	O	NOUN	B
is	O	AUX	O
still	O	ADV	O
able	O	ADJ	O
to	O	PART	O
repress	O	VERB	B
transcription	O	NOUN	B
when	O	SCONJ	O
the	O	DET	O
multimerized	B-DNA	ADJ	B
NF-kappa	I-DNA	NOUN	B
B	I-DNA	NOUN	I
sequence	I-DNA	NOUN	I
is	O	AUX	O
transactivated	O	VERB	B
by	O	ADP	O
TNF-alpha	B-protein	NOUN	B
upon	O	SCONJ	O
transfection	O	NOUN	B
in	O	ADP	O
293	B-cell_line	NUM	O
cells	I-cell_line	NOUN	B
.	O	PUNCT	O


Abnormalities	O	NOUN	B
of	O	ADP	O
p16	B-DNA	NOUN	B
,	I-DNA	PUNCT	O
p15	I-DNA	NOUN	B
and	I-DNA	CCONJ	O
CDK4	I-DNA	NOUN	B
genes	I-DNA	NOUN	I
in	O	ADP	O
recurrent	O	ADJ	B
malignant	O	ADJ	B
astrocytomas	O	NOUN	I
.	O	PUNCT	O


Abnormalities	O	NOUN	B
in	O	ADP	O
the	O	DET	O
p16	B-DNA	NOUN	B
,	I-DNA	PUNCT	O
p15	I-DNA	NOUN	B
and	I-DNA	CCONJ	O
CDK4	I-DNA	NOUN	B
genes	I-DNA	NOUN	I
that	O	PRON	O
regulate	O	VERB	B
transition	O	NOUN	B
through	O	ADP	O
the	O	DET	O
G1	O	NOUN	B
phase	O	NOUN	I
of	O	ADP	O
the	O	DET	O
cell	O	NOUN	B
cycle	O	NOUN	I
have	O	AUX	O
been	O	AUX	O
implicated	O	VERB	O
in	O	ADP	O
the	O	DET	O
malignant	O	ADJ	B
progression	O	NOUN	B
of	O	ADP	O
astrocytomas	O	NOUN	B
.	O	PUNCT	O


BCL-6	B-protein	NOUN	B
,	O	PUNCT	O
a	O	DET	O
POZ/zinc-finger	B-protein	NOUN	B
protein	I-protein	NOUN	I
,	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
sequence-specific	B-protein	ADJ	B
transcriptional	I-protein	ADJ	I
repressor	I-protein	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
BCL-6	B-protein	NOUN	B
protein	I-protein	NOUN	I
can	O	AUX	O
function	O	VERB	B
as	O	ADP	O
a	O	DET	O
sequence-specific	B-protein	ADJ	B
transcriptional	I-protein	ADJ	I
repressor	I-protein	NOUN	I
and	O	CCONJ	O
have	O	AUX	O
implications	O	NOUN	O
for	O	ADP	O
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
BCL6	B-protein	NOUN	B
in	O	ADP	O
normal	O	ADJ	O
lymphoid	O	ADJ	B
development	O	NOUN	O
and	O	CCONJ	O
lymphomagenesis	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
data	O	NOUN	B
obtained	O	VERB	O
demonstrate	O	VERB	O
that	O	SCONJ	O
phorbol	O	NOUN	B
dibutyrate/calcium	O	NOUN	I
ionophore	O	NOUN	I
A23187	O	NOUN	I
(	O	PUNCT	O
PDBu/iono	O	NOUN	O
)	O	PUNCT	O
combination	O	NOUN	B
induced	O	VERB	B
a	O	DET	O
clearly	O	ADV	O
higher	O	ADJ	O
nuclear	O	ADJ	B
translocation	O	NOUN	I
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
in	O	ADP	O
neonatal	B-cell_type	ADJ	B
than	I-cell_type	ADP	O
adult	I-cell_type	ADJ	B
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Analysis	O	NOUN	B
of	O	ADP	O
the	O	DET	O
nuclear	O	ADJ	B
extracts	O	NOUN	I
with	O	ADP	O
antibodies	B-protein	NOUN	B
directed	O	VERB	O
against	O	ADP	O
the	O	DET	O
major	O	ADJ	O
components	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
the	O	DET	O
p50	B-protein	NOUN	B
and	I-protein	CCONJ	O
RelA	I-protein	NOUN	B
(	I-protein	PUNCT	O
p65	I-protein	NOUN	O
)	I-protein	PUNCT	O
proteins	I-protein	NOUN	O
,	O	PUNCT	O
indicated	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
composition	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
was	O	AUX	O
similar	O	ADJ	O
in	O	ADP	O
neonatal	B-cell_type	ADJ	B
and	I-cell_type	CCONJ	O
adult	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	B
.	O	PUNCT	O


The	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
the	O	DET	O
steroid	O	NOUN	B
is	O	AUX	O
mediated	O	VERB	O
by	O	ADP	O
its	O	PRON	O
binding	O	NOUN	B
to	O	PART	O
corticosteroid	B-protein	NOUN	B
receptors	I-protein	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
present	O	ADJ	O
study	O	NOUN	B
,	O	PUNCT	O
corticosteroid	B-protein	NOUN	B
Type	I-protein	NOUN	I
I	I-protein	NUM	I
and	I-protein	CCONJ	O
Type	I-protein	NOUN	B
II	I-protein	NUM	I
receptors	I-protein	NOUN	I
in	O	ADP	O
mononuclear	B-cell_type	ADJ	B
leukocytes	I-cell_type	NOUN	B
were	O	AUX	O
measured	O	VERB	B
in	O	ADP	O
10	O	NUM	O
elderly	O	ADJ	B
subjects	O	NOUN	I
and	O	CCONJ	O
in	O	ADP	O
9	O	NUM	O
young	O	ADJ	B
adults	O	NOUN	I
,	O	PUNCT	O
before	O	ADP	O
and	O	CCONJ	O
after	O	ADP	O
overnight	O	ADJ	B
DST	O	NOUN	B
(	O	PUNCT	O
1	O	NUM	O
mg	O	NOUN	O
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
number	O	NOUN	O
of	O	ADP	O
Type	B-protein	NOUN	B
I	I-protein	NUM	I
and	I-protein	CCONJ	O
Type	I-protein	NOUN	B
II	I-protein	NUM	I
receptors	I-protein	NOUN	I
before	O	ADP	O
the	O	DET	O
test	O	NOUN	B
was	O	AUX	O
lower	O	ADJ	O
in	O	ADP	O
elderly	O	ADJ	B
subjects	O	NOUN	I
than	O	ADP	O
in	O	ADP	O
adults	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
suggest	O	VERB	O
that	O	SCONJ	O
in	O	ADP	O
young	O	ADJ	B
subjects	O	NOUN	I
Type	B-protein	NOUN	B
II	I-protein	NUM	I
receptors	I-protein	NOUN	I
are	O	AUX	O
initially	O	ADV	O
up-regulated	O	VERB	B
by	O	ADP	O
dexamethasone	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
then	O	ADV	O
down-regulated	O	VERB	B
,	O	PUNCT	O
while	O	SCONJ	O
in	O	ADP	O
aged	O	ADJ	B
subjects	O	NOUN	I
an	O	DET	O
up-regulation	O	NOUN	B
can	O	AUX	O
not	O	PART	O
be	O	AUX	O
achieved	O	VERB	O
,	O	PUNCT	O
as	O	ADP	O
suggested	O	VERB	O
by	O	ADP	O
the	O	DET	O
higher	O	ADJ	B
values	O	NOUN	B
of	O	ADP	O
plasma	O	NOUN	B
cortisol	O	NOUN	B
usually	O	ADV	O
found	O	VERB	O
in	O	ADP	O
aging	O	NOUN	B
subjects	O	NOUN	I
.	O	PUNCT	O


Three	O	NUM	O
subtypes	O	NOUN	B
of	O	ADP	O
retinoic	B-protein	ADJ	B
acid	I-protein	NOUN	I
receptors	I-protein	NOUN	I
(	O	PUNCT	O
RAR	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
termed	O	VERB	O
RAR	B-protein	NOUN	B
alpha	I-protein	NOUN	I
,	O	PUNCT	O
RAR	B-protein	NOUN	B
beta	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
RAR	B-protein	NOUN	B
gamma	I-protein	NOUN	O
,	O	PUNCT	O
have	O	AUX	O
been	O	AUX	O
described	O	VERB	O
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
antagonists	O	NOUN	B
show	O	VERB	O
distinctly	O	ADV	O
different	O	ADJ	O
requirements	O	NOUN	B
for	O	ADP	O
efficient	O	ADJ	B
binding	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
may	O	AUX	O
contribute	O	VERB	O
to	O	PART	O
their	O	PRON	O
interference	O	NOUN	B
in	O	ADP	O
the	O	DET	O
ligand-inducible	O	ADJ	B
transactivation	O	NOUN	I
function	O	NOUN	I
of	O	ADP	O
RAR	B-protein	NOUN	B
alpha	I-protein	NOUN	I
.	O	PUNCT	O


Calcineurin	B-protein	NOUN	B
mutants	I-protein	NOUN	B
render	O	VERB	O
T	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
resistant	O	ADJ	B
to	O	PART	O
cyclosporin	O	NOUN	B
A	O	NOUN	I
.	O	PUNCT	O


CsA	O	NOUN	B
and	O	CCONJ	O
FK506	O	NOUN	B
associate	O	VERB	B
with	O	ADP	I
intracellular	B-protein	ADJ	B
binding	I-protein	NOUN	O
proteins	I-protein	NOUN	O
(	O	PUNCT	O
i.e.	O	X	O
,	O	PUNCT	O
CsA	O	NOUN	B
with	O	ADP	O
cyclophilin	B-protein	NOUN	B
A	I-protein	NOUN	I
and	O	CCONJ	O
FK506	O	NOUN	B
with	O	ADP	O
FKBP12	B-protein	NOUN	B
)	O	PUNCT	O
to	O	PART	O
form	O	VERB	O
protein/drug	O	NOUN	B
complexes	O	NOUN	I
that	O	PRON	O
suppress	O	VERB	B
the	O	DET	O
immune	O	ADJ	B
system	O	NOUN	I
by	O	ADP	O
preventing	O	VERB	O
activation	O	NOUN	B
of	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
in	O	ADP	O
response	O	NOUN	O
to	O	PART	O
antigen	O	NOUN	B
presentation	O	NOUN	B
.	O	PUNCT	O


Epstein-Barr	O	ADJ	B
viral	O	ADJ	B
latency	O	NOUN	I
is	O	AUX	O
disrupted	O	VERB	B
by	O	ADP	O
the	O	DET	O
immediate-early	B-protein	ADJ	B
BRLF1	I-protein	NOUN	B
protein	I-protein	NOUN	I
through	O	ADP	O
a	O	DET	O
cell-specific	O	ADJ	B
mechanism	O	NOUN	I
.	O	PUNCT	O


Understanding	O	VERB	O
how	O	SCONJ	O
viral	O	ADJ	B
latency	O	NOUN	I
is	O	AUX	O
disrupted	O	VERB	B
is	O	AUX	O
a	O	DET	O
central	O	ADJ	O
issue	O	NOUN	O
in	O	ADP	O
herpesvirus	O	NOUN	B
biology	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
extent	O	NOUN	O
to	O	PART	O
which	O	DET	O
peptides	O	NOUN	B
containing	O	VERB	O
chemically	O	ADV	B
and	O	CCONJ	O
post-translationally	O	ADV	B
modified	O	VERB	B
amino	B-protein	NOUN	B
acid	I-protein	NOUN	I
side	I-protein	NOUN	B
chains	I-protein	NOUN	I
are	O	AUX	O
recognized	O	VERB	O
by	O	ADP	O
primed	B-cell_line	VERB	B
CTL	I-cell_line	NOUN	B
has	O	AUX	O
not	O	PART	O
been	O	AUX	O
clearly	O	ADV	O
defined	O	VERB	O
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
unwanted	O	ADJ	B
and	O	CCONJ	O
potentially	O	ADV	O
hazardous	O	ADJ	B
specificities	O	NOUN	I
may	O	AUX	O
be	O	AUX	O
elicited	O	VERB	O
when	O	SCONJ	O
using	O	VERB	O
synthetic	O	ADJ	B
peptides	O	NOUN	I
in	O	ADP	O
subunit	O	NOUN	B
vaccines	O	NOUN	I
in	O	ADP	O
which	O	DET	O
succinimide	O	NOUN	B
residues	O	NOUN	I
may	O	AUX	O
form	O	VERB	O
spontaneously	O	ADV	B
during	O	ADP	O
storage	O	NOUN	B
or	O	CCONJ	O
chemical	O	NOUN	B
synthesis	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
we	O	PRON	O
provide	O	VERB	O
evidence	O	NOUN	B
for	O	ADP	O
a	O	DET	O
decrease	O	NOUN	B
in	O	ADP	O
basal	O	ADJ	B
transcription	O	NOUN	I
activity	O	NOUN	I
in	O	X	B
vitro	O	X	I
.	O	PUNCT	O


In	O	X	B
situ	O	X	I
hybridization	O	NOUN	I
and	O	CCONJ	O
Northern	O	NOUN	B
blot	O	NOUN	I
analysis	O	NOUN	I
suggest	O	VERB	O
that	O	SCONJ	O
Spi-B	B-protein	NOUN	B
gene	O	NOUN	O
expression	O	NOUN	B
increases	O	VERB	B
during	O	ADP	O
B	O	NOUN	B
cell	O	NOUN	I
maturation	O	NOUN	B
and	O	CCONJ	O
decreases	O	VERB	B
during	O	ADP	O
T	O	NOUN	B
cell	O	NOUN	I
maturation	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
critical	O	ADJ	O
role	O	NOUN	O
of	O	ADP	O
Sp1-	B-protein	NOUN	B
and	I-protein	CCONJ	O
Ets-related	I-protein	ADJ	B
transcription	I-protein	NOUN	I
factors	I-protein	NOUN	I
in	O	ADP	O
maintaining	O	VERB	O
CTL-specific	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
mouse	B-DNA	NOUN	B
perforin	I-DNA	NOUN	B
gene	I-DNA	NOUN	I
.	O	PUNCT	O


To	O	PART	O
confirm	O	VERB	O
the	O	DET	O
importance	O	NOUN	O
of	O	ADP	O
the	O	DET	O
three	O	NUM	O
cis-acting	B-DNA	ADJ	B
elements	I-DNA	NOUN	I
in	O	ADP	O
the	O	DET	O
perforin	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
expression	O	NOUN	B
,	O	PUNCT	O
point	O	NOUN	B
mutation	O	NOUN	I
was	O	AUX	O
introduced	O	VERB	O
again	O	ADV	O
to	O	ADP	O
each	O	DET	O
proximal	B-DNA	ADJ	B
GC	I-DNA	NOUN	B
box	I-DNA	NOUN	B
,	O	PUNCT	O
EBS	B-DNA	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
GT	B-DNA	NOUN	B
box	I-DNA	NOUN	I
of	O	ADP	O
PFP5a	B-DNA	NOUN	B
.	O	PUNCT	O


The	O	DET	O
point	O	NOUN	B
mutations	O	NOUN	I
resulted	O	VERB	O
in	O	ADP	O
a	O	DET	O
2.5-	O	NUM	O
to	O	PART	O
3-fold	O	ADJ	O
reduction	O	NOUN	B
of	O	ADP	O
CAT	B-protein	NOUN	B
activity	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
primary	B-RNA	ADJ	O
RNA	I-RNA	NOUN	B
transcript	I-RNA	NOUN	I
of	O	ADP	O
the	O	DET	O
gene	O	NOUN	B
is	O	AUX	O
subject	O	ADJ	O
to	O	PART	O
alternative	O	ADJ	B
splicing	O	NOUN	B
to	O	PART	O
yield	O	VERB	O
different	O	ADJ	O
variants	O	NOUN	B
which	O	DET	O
can	O	AUX	O
either	O	CCONJ	O
activate	O	VERB	B
or	O	CCONJ	O
repress	O	VERB	B
gene	O	NOUN	B
expression	O	NOUN	I
.	O	PUNCT	O


Consistent	O	ADJ	B
with	O	ADP	I
these	O	DET	O
results	O	NOUN	B
,	O	PUNCT	O
quantitative	O	ADJ	B
DNase	B-protein	NOUN	I
footprinting	O	NOUN	I
of	O	ADP	O
the	O	DET	O
TNF-alpha	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
using	O	VERB	O
increasing	O	VERB	B
amounts	O	NOUN	O
of	O	ADP	O
recombinant	O	ADJ	B
NFATp	B-protein	NOUN	B
demonstrated	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
-76	B-DNA	NUM	O
site	I-DNA	NOUN	B
binds	O	VERB	B
to	O	PART	O
NFATp	B-protein	NOUN	B
with	O	ADP	O
a	O	DET	O
higher	O	ADJ	O
affinity	O	NOUN	B
than	O	ADP	O
the	O	DET	O
kappa	B-DNA	NOUN	B
3	I-DNA	NUM	I
site	I-DNA	NOUN	I
.	O	PUNCT	O


Anergic	B-cell_line	ADJ	B
CD4+	I-cell_line	ADJ	O
Th	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
do	O	AUX	O
not	O	PART	O
produce	O	VERB	O
IL-2	B-protein	NOUN	B
when	O	SCONJ	O
challenged	O	VERB	O
with	O	ADP	O
Ag-pulsed	B-cell_line	ADJ	B
accessory	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
because	O	SCONJ	O
of	O	ADP	O
a	O	DET	O
transcriptional	O	ADJ	B
defect	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
work	O	NOUN	O
,	O	PUNCT	O
we	O	PRON	O
report	O	VERB	O
that	O	SCONJ	O
these	O	DET	O
anergic	B-cell_line	ADJ	B
T	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
are	O	AUX	O
defective	O	ADJ	B
in	O	ADP	O
their	O	PRON	O
ability	O	NOUN	O
to	O	PART	O
up-regulate	O	VERB	B
protein	O	NOUN	B
binding	O	NOUN	I
and	O	CCONJ	O
transactivation	O	NOUN	B
at	O	ADP	O
two	O	NUM	O
critical	O	ADJ	O
IL-2	B-DNA	NOUN	B
DNA	I-DNA	NOUN	O
enhancer	I-DNA	NOUN	O
elements	I-DNA	NOUN	O
:	O	PUNCT	O
NF-AT	B-protein	NOUN	B
(	O	PUNCT	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
of	I-protein	ADP	O
activated	I-protein	VERB	B
T	I-protein	NOUN	O
cells	I-protein	NOUN	O
;	O	PUNCT	O
a	O	DET	O
sequence	O	NOUN	B
that	O	PRON	O
binds	O	VERB	B
a	O	DET	O
heterotrimeric	B-protein	ADJ	B
NFATp	I-protein	NOUN	I
,	I-protein	PUNCT	O
Fos	I-protein	NOUN	B
,	I-protein	PUNCT	O
and	I-protein	CCONJ	O
Jun	I-protein	NOUN	B
protein	I-protein	NOUN	I
complex	I-protein	NOUN	I
)	O	PUNCT	O
and	O	CCONJ	O
Activator	B-protein	NOUN	B
Protein-1	I-protein	NOUN	I
(	O	PUNCT	O
AP-1	B-protein	NOUN	B
)	O	PUNCT	O
(	O	PUNCT	O
that	O	PRON	O
binds	O	VERB	B
Fos	B-protein	NOUN	B
and	I-protein	CCONJ	O
Jun	I-protein	NOUN	B
heterodimers	I-protein	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


B-cell-specific	O	ADJ	B
transcription	O	NOUN	I
of	O	ADP	O
immunoglobulin	B-DNA	NOUN	B
genes	I-DNA	NOUN	I
is	O	AUX	O
mediated	O	VERB	O
by	O	ADP	O
the	O	DET	O
interaction	O	NOUN	B
of	O	ADP	O
a	O	DET	O
POU	B-DNA	NOUN	B
domain	I-DNA	NOUN	I
containing	O	VERB	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
Oct-1	B-protein	NOUN	I
or	O	CCONJ	O
Oct-2	B-protein	NOUN	B
,	O	PUNCT	O
with	O	ADP	O
the	O	DET	O
B-cell-specific	B-protein	ADJ	B
coactivator	I-protein	NOUN	I
OCA-B	B-protein	NOUN	I
(	O	PUNCT	O
Bob-1	B-protein	NOUN	B
,	O	PUNCT	O
OBF-1	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
prototype	B-DNA	NOUN	B
octamer	I-DNA	NOUN	B
element	I-DNA	NOUN	I
.	O	PUNCT	O


Enzymatic	O	ADJ	B
assay	O	NOUN	I
of	O	ADP	O
alpha-galactosidase	B-protein	NOUN	B
in	O	ADP	O
blood	B-cell_type	NOUN	B
leucocytes	I-cell_type	NOUN	I
,	O	PUNCT	O
skin	B-cell_type	NOUN	B
fibroblasts	I-cell_type	NOUN	I
,	O	PUNCT	O
Epstein-Barr	B-cell_line	ADJ	B
virus	I-cell_line	NOUN	I
transformed	I-cell_line	VERB	B
lymphoid	I-cell_line	ADJ	O
cell	I-cell_line	NOUN	O
lines	I-cell_line	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
hair	O	NOUN	B
follicles	O	NOUN	I
of	O	ADP	O
the	O	DET	O
twins	O	NOUN	B
and	O	CCONJ	O
their	O	PRON	O
parents	O	NOUN	B
confirmed	O	VERB	O
the	O	DET	O
heterozygous	O	ADJ	B
status	O	NOUN	O
of	O	ADP	O
the	O	DET	O
twins	O	NOUN	B
and	O	CCONJ	O
indicated	O	VERB	O
that	O	SCONJ	O
Fabry	O	NOUN	B
disease	O	NOUN	I
had	O	AUX	O
occurred	O	VERB	O
as	O	ADP	O
a	O	DET	O
result	O	NOUN	O
of	O	ADP	O
a	O	DET	O
de	O	X	B
novo	O	X	I
mutation	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
son	O	NOUN	O
of	O	ADP	O
the	O	DET	O
unaffected	O	ADJ	O
twin	O	NOUN	B
sister	O	NOUN	I
was	O	AUX	O
shown	O	VERB	O
to	O	PART	O
be	O	AUX	O
hemizygous	O	ADJ	B
.	O	PUNCT	O


Analysis	O	NOUN	B
of	O	ADP	O
the	O	DET	O
inactive	B-DNA	ADJ	B
X	I-DNA	NOUN	O
specific	O	ADJ	O
methylation	O	NOUN	B
at	O	ADP	O
the	O	DET	O
androgen	B-DNA	NOUN	B
receptor	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
showed	O	VERB	O
unbalanced	O	ADJ	O
inactivation	O	NOUN	B
in	O	ADP	O
the	O	DET	O
twins	O	NOUN	B
'	O	PART	O
fibroblasts	O	NOUN	B
and	O	CCONJ	O
in	O	ADP	O
opposite	O	ADJ	O
directions	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
core	O	NOUN	O
GGAAs	O	NOUN	B
of	O	ADP	O
the	O	DET	O
muA	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
muB	I-DNA	NOUN	B
sites	I-DNA	NOUN	I
are	O	AUX	O
separated	O	VERB	O
by	O	ADP	O
30	O	NUM	O
nucleotides	O	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
ETS	B-protein	NOUN	B
proteins	I-protein	NOUN	I
bind	O	VERB	B
to	O	PART	O
these	O	DET	O
sites	O	NOUN	B
from	O	ADP	O
these	O	DET	O
same	O	ADJ	O
side	O	NOUN	O
of	O	ADP	O
the	O	DET	O
DNA	O	NOUN	B
helix	O	NOUN	I
.	O	PUNCT	O


Circular	O	ADJ	B
permutation	O	NOUN	I
and	O	CCONJ	O
phasing	O	NOUN	B
analyses	O	NOUN	I
demonstrated	O	VERB	O
that	O	SCONJ	O
PU.1	B-protein	NOUN	B
binding	O	NOUN	B
but	O	CCONJ	O
not	O	PART	O
TFE3	B-protein	NOUN	B
or	O	CCONJ	O
Ets-1	B-protein	NOUN	B
bends	O	VERB	O
mu	B-DNA	NOUN	O
enhancer	I-DNA	NOUN	O
DNA	I-DNA	NOUN	O
toward	O	ADP	O
the	O	DET	O
major	O	ADJ	O
groove	O	NOUN	O
.	O	PUNCT	O


Although	O	SCONJ	O
corticosteroids	O	NOUN	B
are	O	AUX	O
the	O	DET	O
most	O	ADV	O
potent	O	ADJ	O
therapeutic	O	ADJ	B
agents	O	NOUN	I
used	O	VERB	O
for	O	ADP	O
this	O	DET	O
disease	O	NOUN	B
,	O	PUNCT	O
their	O	PRON	O
anti-inflammatory	O	ADJ	B
effect	O	NOUN	O
differs	O	VERB	O
from	O	ADP	O
patient	O	NOUN	B
to	O	PART	O
patient	O	NOUN	B
.	O	PUNCT	O


Induction	O	NOUN	B
of	O	ADP	O
activator	B-protein	NOUN	O
protein	I-protein	NOUN	O
(	I-protein	PUNCT	O
AP	I-protein	NOUN	B
)	I-protein	PUNCT	O
-1	I-protein	NUM	O
and	O	CCONJ	O
nuclear	B-protein	ADJ	B
factor-kappaB	I-protein	NOUN	I
by	O	ADP	O
CD28	B-protein	NOUN	B
stimulation	O	NOUN	I
involves	O	VERB	O
both	O	CCONJ	O
phosphatidylinositol	B-protein	NOUN	B
3-kinase	I-protein	NOUN	I
and	O	CCONJ	O
acidic	B-protein	ADJ	B
sphingomyelinase	I-protein	NOUN	O
signals	O	NOUN	B
.	O	PUNCT	O


To	O	PART	O
overcome	O	VERB	O
this	O	DET	O
problem	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
exploited	O	VERB	O
the	O	DET	O
observation	O	NOUN	B
that	O	SCONJ	O
activated	O	VERB	B
human	B-cell_type	ADJ	B
T	I-cell_type	NOUN	B
cell	I-cell_type	NOUN	I
blasts	I-cell_type	NOUN	O
can	O	AUX	O
be	O	AUX	O
stimulated	O	VERB	B
via	O	ADP	O
the	O	DET	O
CD28	B-protein	NOUN	B
surface	I-protein	NOUN	O
molecule	I-protein	NOUN	O
in	O	ADP	O
the	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
antigenic	O	ADJ	B
challenge	O	NOUN	O
;	O	PUNCT	O
thus	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
been	O	AUX	O
able	O	ADJ	O
to	O	PART	O
observe	O	VERB	O
the	O	DET	O
response	O	NOUN	B
of	O	ADP	O
normal	B-cell_type	ADJ	O
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
to	O	PART	O
CD28	B-protein	NOUN	B
activation	O	NOUN	B
in	O	ADP	O
isolation	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
engagement	O	NOUN	B
of	O	ADP	O
the	O	DET	O
TCR	B-protein	NOUN	B
by	O	ADP	O
class	B-protein	NOUN	B
II	I-protein	NUM	I
MHC/superantigen	I-protein	NOUN	B
,	O	PUNCT	O
either	O	CCONJ	O
with	O	ADP	O
or	O	CCONJ	O
without	O	ADP	O
CD28	B-protein	NOUN	B
ligation	O	NOUN	I
,	O	PUNCT	O
resulted	O	VERB	O
in	O	ADP	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
NF-AT	B-protein	NOUN	B
,	O	PUNCT	O
AP-1	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
NF-kappaB	B-protein	NOUN	B
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
IL-2	B-protein	NOUN	B
production	O	NOUN	B
.	O	PUNCT	O


Induction	O	NOUN	B
by	O	ADP	O
glucocorticoids	O	NOUN	B
and	O	CCONJ	O
enhancement	O	NOUN	B
by	O	ADP	O
IFN-beta	B-protein	NOUN	B
,	O	PUNCT	O
IFN-gamma	B-protein	NOUN	B
,	O	PUNCT	O
IL-4	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
lipopolysaccharide	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
cytokines	B-protein	NOUN	B
IFN-beta	B-protein	NOUN	B
,	O	PUNCT	O
IFN-gamma	B-protein	NOUN	B
,	O	PUNCT	O
IL-4	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
LPS	O	NOUN	B
,	O	PUNCT	O
although	O	SCONJ	O
unable	O	ADJ	O
to	O	PART	O
induce	O	VERB	B
sialoadhesin	B-protein	NOUN	B
expression	O	NOUN	B
by	O	ADP	O
themselves	O	PRON	O
,	O	PUNCT	O
were	O	AUX	O
able	O	ADJ	O
to	O	PART	O
enhance	O	VERB	O
GC-mediated	O	ADJ	B
induction	O	NOUN	B
of	O	ADP	O
sialoadhesin	B-protein	NOUN	B
.	O	PUNCT	O


Finally	O	ADV	O
,	O	PUNCT	O
it	O	PRON	O
is	O	AUX	O
demonstrated	O	VERB	O
that	O	SCONJ	O
macrophages	B-cell_type	NOUN	B
in	O	ADP	O
the	O	DET	O
adrenal	O	ADJ	B
gland	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
major	O	ADJ	O
site	O	NOUN	B
of	O	ADP	O
endogenous	O	ADJ	B
GC	O	NOUN	B
production	O	NOUN	B
,	O	PUNCT	O
express	O	VERB	O
sialoadhesin	B-protein	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
present	O	VERB	O
a	O	DET	O
model	O	NOUN	B
for	O	ADP	O
HIV	O	NOUN	B
replication	O	NOUN	B
in	O	ADP	O
which	O	DET	O
the	O	DET	O
viral	B-protein	ADJ	B
protease	I-protein	NOUN	I
depletes	O	VERB	B
the	O	DET	O
infected	O	ADJ	B
cells	O	NOUN	B
of	O	ADP	O
bcl-2	B-protein	NOUN	B
,	O	PUNCT	O
leading	O	VERB	O
to	O	PART	O
oxidative	O	ADJ	B
stress-dependent	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
NF	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
,	O	PUNCT	O
a	O	DET	O
cellular	B-protein	ADJ	B
factor	I-protein	NOUN	I
required	O	VERB	O
for	O	ADP	O
HIV	O	NOUN	B
transcription	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
ultimately	O	ADV	O
to	O	PART	O
cell	O	NOUN	B
death	O	NOUN	I
.	O	PUNCT	O


Nevertheless	O	ADV	O
,	O	PUNCT	O
forskolin	O	NOUN	B
also	O	ADV	O
inhibits	O	VERB	B
PKC	B-protein	NOUN	B
downstream	O	ADJ	O
events	O	NOUN	O
,	O	PUNCT	O
such	O	ADJ	O
as	O	ADP	O
c-jun	B-DNA	NOUN	B
expression	O	NOUN	I
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
critical	O	ADJ	O
for	O	ADP	O
the	O	DET	O
activation	O	NOUN	B
process	O	NOUN	I
of	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Transcriptional	O	ADJ	B
and	O	CCONJ	O
posttranscriptional	O	ADJ	B
regulation	O	NOUN	I
of	O	ADP	O
erythroid	B-DNA	ADJ	B
gene	I-DNA	NOUN	B
expression	O	NOUN	I
in	O	ADP	O
anthracycline-induced	O	ADJ	B
differentiation	O	NOUN	I
of	O	ADP	O
human	B-cell_type	ADJ	B
erythroleukemic	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Cell	O	NOUN	B
hemoglobinization	O	NOUN	I
was	O	AUX	O
accompanied	O	VERB	O
by	O	ADP	O
the	O	DET	O
increased	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
genes	B-DNA	NOUN	B
encoding	O	VERB	B
gamma-globin	B-protein	NOUN	B
and	I-protein	CCONJ	O
porphobilinogen	I-protein	NOUN	B
deaminase	I-protein	NOUN	I
(	O	PUNCT	O
PBGD	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
an	O	DET	O
enzyme	O	NOUN	B
of	O	ADP	O
heme	O	NOUN	B
synthesis	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
inhibition	O	NOUN	B
of	O	ADP	O
mRNA	B-RNA	NOUN	B
synthesis	O	NOUN	I
with	O	ADP	O
actinomycin	O	NOUN	B
D	O	NOUN	I
indicated	O	VERB	O
that	O	SCONJ	O
DOX	O	NOUN	B
induced	O	VERB	B
an	O	DET	O
increased	O	VERB	B
stability	O	NOUN	B
of	O	ADP	O
PBGD	B-RNA	NOUN	B
and	I-RNA	CCONJ	O
GATA-1	I-RNA	NOUN	B
mRNAs	I-RNA	NOUN	B
,	O	PUNCT	O
whereas	O	SCONJ	O
ACLA	O	NOUN	B
did	O	AUX	O
not	O	PART	O
affect	O	VERB	O
the	O	DET	O
half-lives	O	NOUN	B
of	O	ADP	O
these	O	DET	O
mRNAs	B-RNA	NOUN	B
.	O	PUNCT	O


Indeed	O	ADV	O
,	O	PUNCT	O
erythroid	B-DNA	ADJ	B
gene	I-DNA	NOUN	B
expression	O	NOUN	I
was	O	AUX	O
demonstrated	O	VERB	O
to	O	PART	O
be	O	AUX	O
regulated	O	VERB	O
transcriptionally	O	ADV	B
by	O	ADP	O
ACLA	O	NOUN	B
and	O	CCONJ	O
mainly	O	ADV	O
posttranscriptionally	O	ADV	B
by	O	ADP	O
DOX	O	NOUN	B
.	O	PUNCT	O


Interleukin-7	B-protein	NOUN	B
signaling	O	NOUN	B
in	O	ADP	O
human	B-cell_line	ADJ	B
B	I-cell_line	NOUN	O
cell	I-cell_line	NOUN	O
precursor	I-cell_line	NOUN	O
acute	I-cell_line	ADJ	O
lymphoblastic	I-cell_line	ADJ	O
leukemia	I-cell_line	NOUN	O
cells	I-cell_line	NOUN	B
and	O	CCONJ	O
murine	B-cell_line	ADJ	B
BAF3	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
involves	O	VERB	O
activation	O	NOUN	B
of	O	ADP	O
STAT1	B-protein	NOUN	B
and	O	CCONJ	O
STAT5	B-protein	NOUN	B
mediated	O	VERB	O
via	O	ADP	O
the	O	DET	O
interleukin-7	B-protein	NOUN	B
receptor	I-protein	NOUN	I
alpha	I-protein	NOUN	I
chain	I-protein	NOUN	I
.	O	PUNCT	O


Supershifts	O	NOUN	B
with	O	ADP	O
anti-STAT	O	NOUN	B
antibodies	O	NOUN	I
identified	O	VERB	B
these	O	DET	O
as	O	ADP	O
STAT1	B-protein	NOUN	B
and	O	CCONJ	O
STAT5	B-protein	NOUN	B
complexes	I-protein	NOUN	O
.	O	PUNCT	O


The	O	DET	O
percentage	O	NOUN	B
of	O	ADP	O
cells	O	NOUN	B
expressing	O	VERB	B
CD40	B-protein	NOUN	B
in	O	ADP	O
T	B-cell_line	NOUN	B
and	I-cell_line	CCONJ	O
B	I-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
co-cultures	I-cell_line	NOUN	B
increased	O	VERB	B
from	O	ADP	O
4.2	O	NUM	O
%	O	NOUN	O
to	O	PART	O
13.8	O	NUM	O
%	O	NOUN	O
after	O	ADP	O
oligo	O	ADJ	B
stimulation	O	NOUN	O
in	O	ADP	O
patients	O	NOUN	B
,	O	PUNCT	O
while	O	SCONJ	O
it	O	PRON	O
increased	O	VERB	B
form	O	NOUN	O
4.7	O	NUM	O
%	O	NOUN	O
to	O	PART	O
48.6	O	NUM	O
%	O	NOUN	O
in	O	ADP	O
healthy	O	ADJ	B
controls	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
proportion	O	NOUN	B
of	O	ADP	O
CD40	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	B
(	O	PUNCT	O
26	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
in	O	ADP	O
a	O	DET	O
resting	B-cell_line	VERB	B
B-cell	I-cell_line	NOUN	I
preparation	I-cell_line	NOUN	I
from	O	ADP	O
hepatitis	O	NOUN	B
B	O	NOUN	I
patients	O	NOUN	B
decreased	O	VERB	B
to	O	PART	O
zero	O	NUM	O
after	O	ADP	O
a	O	DET	O
5-day	O	ADJ	O
culture	O	NOUN	B
with	O	ADP	O
sequence	O	NOUN	B
I	O	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
IgG	O	NOUN	B
levels	O	NOUN	B
in	O	ADP	O
the	O	DET	O
culture	O	NOUN	B
supernatant	O	NOUN	I
increased	O	VERB	B
.	O	PUNCT	O


Activation	B-protein	NOUN	B
protein	I-protein	NOUN	I
1	I-protein	NUM	I
-dependent	O	ADJ	O
transcriptional	O	ADJ	B
activation	O	NOUN	I
of	O	ADP	O
interleukin	B-DNA	NOUN	B
2	I-DNA	NUM	I
gene	I-DNA	NOUN	I
by	O	ADP	O
Ca2+/calmodulin	B-protein	NOUN	B
kinase	I-protein	NOUN	I
type	I-protein	NOUN	I
IV/Gr	I-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
Ca2+/calmodulin-dependent	B-protein	ADJ	B
protein	I-protein	NOUN	I
kinase	I-protein	NOUN	I
(	I-protein	PUNCT	O
CaMK	I-protein	NOUN	B
)	I-protein	PUNCT	O
type	I-protein	NOUN	O
IV/Gr	I-protein	NOUN	B
is	O	AUX	O
selectively	O	ADV	O
expressed	O	VERB	B
in	O	ADP	O
T	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
and	O	CCONJ	O
is	O	AUX	O
activated	O	VERB	B
after	O	ADP	O
signaling	O	VERB	B
via	O	ADP	O
the	O	DET	O
T	B-protein	NOUN	B
cell	I-protein	NOUN	I
antigen	I-protein	NOUN	I
receptor	I-protein	NOUN	I
(	O	PUNCT	O
TCR	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
indicating	O	VERB	O
that	O	SCONJ	O
it	O	PRON	O
mediates	O	VERB	O
some	O	DET	O
of	O	ADP	O
the	O	DET	O
Ca	O	NOUN	B
(	O	PUNCT	O
2+	O	NUM	O
)	O	PUNCT	O
-dependent	O	ADJ	O
transcriptional	O	ADJ	B
events	O	NOUN	I
that	O	PRON	O
follow	O	VERB	O
TCR	B-protein	NOUN	B
engagement	O	NOUN	B
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
CaMKIV/Gr	B-protein	NOUN	B
induces	O	VERB	B
the	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
activation	I-protein	NOUN	I
protein	I-protein	NOUN	I
1	I-protein	NUM	I
(	O	PUNCT	O
AP-1	B-protein	NOUN	B
)	O	PUNCT	O
alone	O	ADV	O
or	O	CCONJ	O
in	O	ADP	O
synergy	O	NOUN	B
with	O	ADP	O
T	B-protein	NOUN	B
cell	I-protein	NOUN	I
mitogens	I-protein	NOUN	O
and	O	CCONJ	O
with	O	ADP	O
the	O	DET	O
p21ras	B-protein	NOUN	B
oncoprotein	I-protein	NOUN	I
.	O	PUNCT	O


AP-1	B-protein	NOUN	B
is	O	AUX	O
an	O	DET	O
integral	O	ADJ	B
component	O	NOUN	O
of	O	ADP	O
the	O	DET	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
of	I-protein	ADP	O
activated	I-protein	VERB	B
T	I-protein	NOUN	O
cells	I-protein	NOUN	O
(	I-protein	PUNCT	O
NFAT	I-protein	NOUN	B
)	I-protein	PUNCT	O
transcriptional	I-protein	ADJ	O
complex	I-protein	NOUN	O
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
required	O	VERB	O
for	O	ADP	O
interleukin	B-DNA	NOUN	B
2	I-DNA	NUM	I
gene	I-DNA	NOUN	B
expression	O	NOUN	I
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
CaMKIV/Gr	B-protein	NOUN	B
reconstitutes	O	VERB	B
the	O	DET	O
capacity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
cytosolic	O	ADJ	B
component	O	NOUN	O
of	O	ADP	O
NFAT	B-protein	NOUN	B
to	O	PART	O
direct	O	VERB	O
transcription	O	NOUN	B
from	O	ADP	O
NFAT	B-DNA	NOUN	B
sites	I-DNA	NOUN	I
in	O	ADP	O
non-	O	ADJ	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Our	O	PRON	O
data	O	NOUN	B
provide	O	VERB	O
the	O	DET	O
first	O	ADJ	O
demonstration	O	NOUN	O
that	O	SCONJ	O
IL-12	B-protein	NOUN	B
-mediated	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
T	B-cell_type	NOUN	B
and	I-cell_type	CCONJ	O
NK	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
does	O	AUX	O
not	O	PART	O
involve	O	VERB	O
expression	O	NOUN	B
of	O	ADP	O
members	O	NOUN	B
of	O	ADP	O
the	O	DET	O
immediate-early	B-DNA	ADJ	B
activation	I-DNA	NOUN	O
genes	I-DNA	NOUN	O
family	I-DNA	NOUN	O
(	O	PUNCT	O
egr-1	B-DNA	NOUN	B
,	O	PUNCT	O
c-fos	B-DNA	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
junB	B-DNA	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
AP-1	B-protein	NOUN	B
transcriptional	O	ADJ	I
activity	O	NOUN	I
,	O	PUNCT	O
or	O	CCONJ	O
bcl-2	B-DNA	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
indicates	O	VERB	O
that	O	SCONJ	O
functional	O	ADJ	B
differences	O	NOUN	O
observed	O	VERB	O
in	O	ADP	O
IL-2-	B-cell_line	NOUN	B
and	I-cell_line	CCONJ	O
IL-12-stimulated	I-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
may	O	AUX	O
depend	O	VERB	O
,	O	PUNCT	O
at	O	ADP	O
least	O	ADJ	O
in	O	ADP	O
part	O	NOUN	O
,	O	PUNCT	O
on	O	ADP	O
differential	O	ADJ	O
gene	O	NOUN	B
regulation	O	NOUN	I
.	O	PUNCT	O


Treatment	O	NOUN	B
of	O	ADP	O
B	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
with	O	ADP	O
the	O	DET	O
cytokine	B-protein	NOUN	B
IL-4	B-protein	NOUN	B
(	O	PUNCT	O
IL-4	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
prior	O	ADJ	O
activation	O	NOUN	B
,	O	PUNCT	O
induces	O	VERB	B
a	O	DET	O
weak	O	ADJ	B
up-regulation	O	NOUN	B
of	O	ADP	O
VDR	B-protein	NOUN	B
expression	O	NOUN	B
but	O	CCONJ	O
fails	O	VERB	O
to	O	PART	O
generate	O	VERB	O
vitamin	B-protein	NOUN	B
D-responsive	I-protein	ADJ	I
element	I-protein	NOUN	I
(	I-protein	PUNCT	O
VDRE	I-protein	NOUN	B
)	I-protein	PUNCT	O
-reactive	I-protein	ADJ	O
nuclear	I-protein	ADJ	B
protein	I-protein	NOUN	I
complexes	I-protein	NOUN	I
or	O	CCONJ	O
to	O	PART	O
initiate	O	VERB	B
the	O	DET	O
genomic	O	ADJ	B
transcription	O	NOUN	I
of	O	ADP	O
25-hydroxyvitamin	B-protein	NOUN	B
D3	I-protein	NOUN	I
24-hydroxylase	I-protein	NOUN	I
.	O	PUNCT	O


Stimulation	O	NOUN	B
of	O	ADP	O
B	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
by	O	ADP	O
either	O	CCONJ	O
ligation	O	NOUN	B
of	O	ADP	O
CD40	B-protein	NOUN	B
Ag	I-protein	NOUN	B
or	O	CCONJ	O
cross-linking	O	VERB	B
the	O	DET	O
Ig	B-protein	NOUN	B
receptor	I-protein	NOUN	I
is	O	AUX	O
also	O	ADV	O
insufficient	O	ADJ	O
to	O	PART	O
render	O	VERB	O
B	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
responsive	O	ADJ	B
to	O	PART	O
1	O	NUM	O
alpha	O	NOUN	B
,	O	PUNCT	O
25	O	NUM	O
(	O	PUNCT	O
OH	O	NOUN	B
)	O	PUNCT	O
2D3	O	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
this	O	DET	O
apparent	O	ADJ	B
lack	O	NOUN	O
of	O	ADP	O
response	O	NOUN	B
to	O	PART	O
the	O	DET	O
secosterol	O	NOUN	B
can	O	AUX	O
be	O	AUX	O
overcome	O	VERB	B
by	O	ADP	O
stimulation	O	NOUN	B
of	O	ADP	O
B	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
with	O	ADP	O
a	O	DET	O
combination	O	NOUN	B
of	O	ADP	O
these	O	DET	O
cellular	O	ADJ	B
activation	O	NOUN	I
signals	O	NOUN	O
,	O	PUNCT	O
which	O	DET	O
are	O	AUX	O
sufficient	O	ADJ	O
to	O	PART	O
lead	O	VERB	O
to	O	PART	O
G1	O	NOUN	B
cell	O	NOUN	I
cycle	O	NOUN	I
progression	O	NOUN	B
.	O	PUNCT	O


Third	O	ADV	O
,	O	PUNCT	O
a	O	DET	O
coimmunoprecipitation	O	NOUN	B
assay	O	NOUN	I
showed	O	VERB	O
that	O	SCONJ	O
in	O	ADP	O
HTLV-1-infected	B-cell_line	ADJ	B
human	I-cell_line	ADJ	B
T	I-cell_line	NOUN	O
lymphocytes	I-cell_line	NOUN	O
,	O	PUNCT	O
Tax	B-protein	NOUN	B
and	O	CCONJ	O
TFIIA	B-protein	NOUN	B
were	O	AUX	O
associated	O	VERB	O
.	O	PUNCT	O


Finally	O	ADV	O
,	O	PUNCT	O
TFIIA	B-protein	NOUN	B
facilitates	O	VERB	O
Tax	B-protein	NOUN	B
transactivation	O	NOUN	B
in	O	X	B
vitro	O	X	I
and	O	CCONJ	O
in	O	X	B
vivo	O	X	I
.	O	PUNCT	O


The	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
belonging	O	VERB	O
to	O	PART	O
the	O	DET	O
signal	B-protein	NOUN	B
transducer	I-protein	NOUN	I
and	I-protein	CCONJ	O
activator	I-protein	NOUN	O
of	I-protein	ADP	O
transcription	I-protein	NOUN	O
(	I-protein	PUNCT	O
STAT	I-protein	NOUN	O
)	I-protein	PUNCT	O
family	I-protein	NOUN	B
was	O	AUX	O
analyzed	O	VERB	B
in	O	ADP	O
PHA-activated	B-cell_line	ADJ	B
mononuclear	I-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
and	O	CCONJ	O
in	O	ADP	O
purified	B-cell_line	VERB	B
T	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
activated	O	VERB	B
by	O	ADP	O
cross-linking	O	ADJ	B
cell	B-protein	NOUN	I
surface	I-protein	NOUN	I
CD3	I-protein	NOUN	B
.	O	PUNCT	O


Among	O	ADP	O
the	O	DET	O
20	O	NUM	O
selected	O	VERB	O
oligonucleotides	O	NOUN	B
,	O	PUNCT	O
two	O	NUM	O
potent	O	ADJ	O
15-mer	O	ADJ	O
AS	O	ADJ	B
oligonucleotides	O	NOUN	B
(	O	PUNCT	O
C-JUN	O	NOUN	B
AS	O	ADJ	I
oligonucleotides	O	NOUN	B
)	O	PUNCT	O
exhibited	O	VERB	O
significant	O	ADJ	O
inhibition	O	NOUN	B
of	O	ADP	O
cell	O	NOUN	B
growth	O	NOUN	I
in	O	ADP	O
a	O	DET	O
dose-dependent	O	ADJ	B
manner	O	NOUN	O
between	O	ADP	O
2	O	NUM	O
and	O	CCONJ	O
10	O	NUM	O
microM	O	NOUN	O
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
a	O	DET	O
critical	O	ADJ	O
role	O	NOUN	O
of	O	ADP	O
c-jun	B-DNA	NOUN	B
in	O	ADP	O
both	O	DET	O
cell	O	NOUN	B
proliferation	O	NOUN	I
and	O	CCONJ	O
PMA-induced	O	ADJ	B
cell	O	NOUN	O
adhesion	O	NOUN	O
but	O	CCONJ	O
not	O	PART	O
in	O	ADP	O
PMA-induced	O	ADJ	B
respiratory	O	ADJ	B
burst	O	NOUN	I
in	O	ADP	O
U937	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assays	O	NOUN	I
(	O	PUNCT	O
EMSAs	O	NOUN	B
)	O	PUNCT	O
we	O	PRON	O
showed	O	VERB	O
that	O	SCONJ	O
IL-10	B-protein	NOUN	B
and	O	CCONJ	O
IL-4	B-protein	NOUN	B
inhibited	O	VERB	B
LPS-induced	O	ADJ	B
AP-1	B-protein	NOUN	B
binding	O	NOUN	I
activity	O	NOUN	I
.	O	PUNCT	O


Significantly	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
CBF	B-DNA	NOUN	B
sites	I-DNA	NOUN	B
are	O	AUX	O
in	O	ADP	O
each	O	DET	O
case	O	NOUN	B
contained	O	VERB	O
within	O	ADP	O
the	O	DET	O
minimum	O	ADJ	O
essential	B-DNA	ADJ	O
core	I-DNA	NOUN	O
regions	I-DNA	NOUN	O
required	O	VERB	O
for	O	ADP	O
inducible	O	ADJ	B
activation	O	NOUN	B
of	O	ADP	O
transcription	O	NOUN	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
these	O	DET	O
core	O	NOUN	B
regions	O	NOUN	I
of	O	ADP	O
the	O	DET	O
enhancer	O	NOUN	B
and	O	CCONJ	O
promoter	O	NOUN	B
each	O	DET	O
encompass	O	VERB	O
closely	B-DNA	ADV	O
linked	I-DNA	VERB	O
binding	I-DNA	VERB	B
sites	I-DNA	NOUN	I
for	O	ADP	O
CBF	B-protein	NOUN	B
,	O	PUNCT	O
AP-1	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
NFATp	B-protein	NOUN	B
.	O	PUNCT	O


This	O	DET	O
study	O	NOUN	B
adds	O	VERB	O
GM-CSF	B-protein	NOUN	B
to	O	PART	O
a	O	DET	O
growing	O	VERB	O
list	O	NOUN	O
of	O	ADP	O
cytokines	B-protein	NOUN	B
and	O	CCONJ	O
receptors	O	NOUN	B
that	O	PRON	O
are	O	AUX	O
regulated	O	VERB	O
by	O	ADP	O
CBF	B-protein	NOUN	B
and	O	CCONJ	O
which	O	DET	O
control	O	VERB	B
the	O	DET	O
growth	O	NOUN	B
,	O	PUNCT	O
differentiation	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
activation	O	NOUN	B
of	O	ADP	O
hemopoietic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


The	O	DET	O
preferential	O	ADJ	O
induction	O	NOUN	B
of	O	ADP	O
c-jun	B-DNA	NOUN	B
by	O	ADP	O
H2O2	O	NOUN	B
did	O	AUX	O
not	O	PART	O
represent	O	VERB	O
redox	O	NOUN	B
stabilization	O	NOUN	B
of	O	ADP	O
mRNA	B-RNA	NOUN	B
transcripts	I-RNA	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
oxidative	O	ADJ	B
signals	O	NOUN	I
closely	O	ADV	O
resembled	O	VERB	O
PHA/PMA	O	NOUN	B
stimulation	O	NOUN	I
by	O	ADP	O
effectively	O	ADV	O
transactivating	O	VERB	B
the	O	DET	O
full	O	ADJ	O
length	O	NOUN	O
c-jun	B-DNA	NOUN	O
promoter	O	NOUN	O
via	O	ADP	O
the	O	DET	O
proximal	B-DNA	ADJ	B
jun1	I-DNA	NOUN	O
tumor	I-DNA	NOUN	O
promoter-responsive	I-DNA	ADJ	O
element	I-DNA	NOUN	O
(	I-DNA	PUNCT	O
TRE	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
-like	I-DNA	ADJ	O
promoter	I-DNA	NOUN	B
element	I-DNA	NOUN	I
.	O	PUNCT	O


Functional	O	ADJ	B
activation	O	NOUN	O
of	O	ADP	O
gene	O	NOUN	B
expression	O	NOUN	I
by	O	ADP	O
Pb	O	NOUN	B
was	O	AUX	O
confirmed	O	VERB	O
using	O	VERB	O
primary	B-cell_line	ADJ	B
CD4+	I-cell_line	ADJ	B
T	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
transfected	O	VERB	B
with	O	ADP	O
an	O	DET	O
NF-kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
dependent	I-DNA	ADJ	O
reporter	I-DNA	NOUN	O
gene	I-DNA	NOUN	O
construct	I-DNA	NOUN	O
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
may	O	AUX	O
be	O	AUX	O
an	O	DET	O
important	O	ADJ	O
molecular	O	ADJ	B
mediator	O	NOUN	I
of	O	ADP	O
Pb-induced	O	ADJ	B
immunotoxicity	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
use	O	NOUN	O
of	O	ADP	O
the	O	DET	O
protein	B-protein	NOUN	B
tyrosine	I-protein	NOUN	I
kinase	I-protein	NOUN	I
(	O	PUNCT	O
PTK	B-protein	NOUN	B
)	O	PUNCT	O
-specific	O	ADJ	O
inhibitor	O	NOUN	B
herbimycin	O	NOUN	B
A	O	NOUN	O
dramatically	O	ADV	O
decreased	O	VERB	B
cellular	O	ADJ	B
proliferation	O	NOUN	I
without	O	ADP	O
altering	O	VERB	B
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
immunodeficiency	I-DNA	NOUN	I
virus-1	I-DNA	NOUN	I
long	I-DNA	ADJ	I
terminal	I-DNA	ADJ	I
repeat	I-DNA	NOUN	I
(	O	PUNCT	O
HIV-1	B-DNA	NOUN	B
LTR	I-DNA	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
a	O	DET	O
promoter	B-DNA	NOUN	B
largely	O	ADV	O
dependent	O	ADJ	O
on	O	ADP	O
the	O	DET	O
binding	O	NOUN	B
of	O	ADP	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
(	O	PUNCT	O
NF-	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


While	O	SCONJ	O
PKC	B-protein	NOUN	B
depletion	O	NOUN	B
did	O	AUX	O
not	O	PART	O
alter	O	VERB	O
the	O	DET	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
level	O	NOUN	B
,	O	PUNCT	O
treatment	O	NOUN	B
of	O	ADP	O
B	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
with	O	ADP	O
H-89	O	NOUN	B
or	O	CCONJ	O
herbimycin	O	NOUN	B
A	O	NOUN	O
provoked	O	VERB	O
a	O	DET	O
decrease	O	NOUN	B
in	O	ADP	O
the	O	DET	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
level	O	NOUN	B
.	O	PUNCT	O


Norepinephrine	O	NOUN	B
and	O	CCONJ	O
epinephrine	O	NOUN	B
also	O	ADV	O
suppressed	O	VERB	B
IL-12	B-protein	NOUN	B
production	O	NOUN	B
in	O	ADP	O
a	O	DET	O
dose-dependent	O	ADJ	B
fashion	O	NOUN	B
and	O	CCONJ	O
at	O	ADP	O
physiological	O	ADJ	B
concentrations	O	NOUN	B
;	O	PUNCT	O
both	O	DET	O
catecholamines	O	NOUN	B
,	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
dose-dependently	O	ADV	O
increased	O	VERB	B
the	O	DET	O
production	O	NOUN	B
of	O	ADP	O
IL-10	B-protein	NOUN	B
.	O	PUNCT	O


These	O	DET	O
findings	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
central	O	ADJ	B
nervous	O	ADJ	I
system	O	NOUN	I
may	O	AUX	O
regulate	O	VERB	B
IL-12	O	NOUN	B
and	O	CCONJ	O
IL-10	O	NOUN	B
secretion	O	NOUN	B
and	O	CCONJ	O
,	O	PUNCT	O
hence	O	ADV	O
,	O	PUNCT	O
TH1/TH2	O	NOUN	B
balance	O	NOUN	B
via	O	ADP	O
the	O	DET	O
peripheral	O	ADJ	B
end-effectors	O	NOUN	B
of	O	ADP	O
the	O	DET	O
stress	O	NOUN	B
system	O	NOUN	I
.	O	PUNCT	O


Like	O	ADP	O
LPS	O	NOUN	B
,	O	PUNCT	O
purified	B-protein	VERB	B
native	I-protein	ADJ	B
B.	I-protein	X	B
burgdorferi	I-protein	X	I
OspA	I-protein	NOUN	B
and	O	CCONJ	O
synthetic	O	ADJ	B
analogs	O	NOUN	B
of	O	ADP	O
OspA	B-protein	NOUN	B
,	O	PUNCT	O
OspB	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
two	O	NUM	O
T.	B-protein	X	B
pallidum	I-protein	X	I
lipoproteins	I-protein	NOUN	I
(	O	PUNCT	O
Tpp47	B-protein	NOUN	B
and	O	CCONJ	O
Tpp17	B-protein	NOUN	B
)	O	PUNCT	O
all	O	DET	O
induced	O	VERB	B
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
translocation	O	NOUN	B
in	O	ADP	O
THP-1	B-cell_type	NOUN	B
human	I-cell_type	ADJ	B
monocytoid	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


By	O	ADP	O
using	O	VERB	O
70Z/3-derived	B-cell_line	ADJ	O
pre-B-cell	I-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
either	O	CCONJ	O
lacking	O	VERB	B
or	O	CCONJ	O
expressing	O	VERB	B
human	B-protein	ADJ	B
CD14	I-protein	NOUN	B
(	O	PUNCT	O
the	O	DET	O
LPS	B-protein	NOUN	B
receptor	I-protein	NOUN	I
)	O	PUNCT	O
,	O	PUNCT	O
it	O	PRON	O
was	O	AUX	O
observed	O	VERB	O
that	O	SCONJ	O
expression	O	NOUN	B
of	O	ADP	O
human	B-protein	ADJ	B
CD14	I-protein	NOUN	B
imparted	O	VERB	O
responsiveness	O	NOUN	B
to	O	PART	O
LPS	O	NOUN	B
but	O	CCONJ	O
not	O	PART	O
to	O	PART	O
OspA	B-protein	NOUN	B
or	O	CCONJ	O
spirochetal	B-protein	ADJ	B
lipopeptides	I-protein	NOUN	I
(	O	PUNCT	O
assessed	O	VERB	B
by	O	ADP	O
induction	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
and	O	CCONJ	O
expression	O	NOUN	B
of	O	ADP	O
surface	B-protein	NOUN	B
immunoglobulin	I-protein	NOUN	O
M	I-protein	NOUN	O
)	O	PUNCT	O
.	O	PUNCT	O


Transcriptional	O	ADJ	B
control	O	NOUN	I
of	O	ADP	O
steroid-regulated	O	ADJ	B
apoptosis	O	NOUN	B
in	O	ADP	O
murine	B-cell_type	ADJ	B
thymoma	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


GR	B-protein	NOUN	B
expression	O	NOUN	B
levels	O	NOUN	O
were	O	AUX	O
shown	O	VERB	O
to	O	PART	O
be	O	AUX	O
rate-limiting	O	ADJ	O
for	O	ADP	O
initiating	O	VERB	O
the	O	DET	O
apoptotic	O	ADJ	B
pathway	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
positive	O	ADJ	B
correlation	O	NOUN	B
between	O	ADP	O
steroid	O	NOUN	B
sensitivity	O	NOUN	B
and	O	CCONJ	O
GR	B-protein	NOUN	B
-mediated	O	ADJ	O
induction	O	NOUN	B
of	O	ADP	O
an	O	DET	O
integrated	O	ADJ	B
mouse	B-DNA	NOUN	I
mammary	I-DNA	ADJ	O
tumor	I-DNA	NOUN	O
virus	I-DNA	NOUN	O
(	I-DNA	PUNCT	O
MMTV	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
LTR	I-DNA	NOUN	B
reporter	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
was	O	AUX	O
observed	O	VERB	O
.	O	PUNCT	O


Analysis	O	NOUN	B
of	O	ADP	O
GR	B-protein	NOUN	B
chimeric	I-protein	ADJ	B
receptors	I-protein	NOUN	I
containing	O	VERB	O
the	O	DET	O
potent	O	ADJ	O
VP16	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
E1A	I-DNA	NOUN	B
viral	I-DNA	ADJ	B
transactivation	I-DNA	NOUN	I
domains	I-DNA	NOUN	O
in	O	ADP	O
place	O	NOUN	O
of	O	ADP	O
the	O	DET	O
GR	B-protein	NOUN	B
N	I-protein	NOUN	O
terminus	I-protein	NOUN	B
revealed	O	VERB	O
that	O	SCONJ	O
even	O	ADV	O
low	O	ADJ	B
level	O	NOUN	B
expression	O	NOUN	B
of	O	ADP	O
these	O	DET	O
receptors	O	NOUN	B
resulted	O	VERB	O
in	O	ADP	O
both	O	CCONJ	O
enhanced	O	VERB	B
steroid	O	NOUN	B
sensitivity	O	NOUN	O
and	O	CCONJ	O
MMTV	O	NOUN	B
induction	O	NOUN	B
,	O	PUNCT	O
thus	O	ADV	O
supporting	O	VERB	O
a	O	DET	O
role	O	NOUN	O
for	O	ADP	O
transactivation	O	NOUN	B
in	O	ADP	O
apoptosis	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
found	O	VERB	O
that	O	SCONJ	O
GIG18	B-DNA	NOUN	B
was	O	AUX	O
rapidly	O	ADV	O
induced	O	VERB	B
to	O	PART	O
comparable	O	ADJ	O
levels	O	NOUN	B
by	O	ADP	O
both	O	CCONJ	O
AR	B-protein	NOUN	B
and	O	CCONJ	O
GR	B-protein	NOUN	B
,	O	PUNCT	O
demonstrating	O	VERB	O
that	O	SCONJ	O
AR	B-protein	NOUN	B
can	O	AUX	O
indeed	O	ADV	O
function	O	VERB	B
as	O	ADP	O
a	O	DET	O
transcriptional	O	ADJ	B
activator	O	NOUN	I
in	O	ADP	O
S49	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
and	O	CCONJ	O
,	O	PUNCT	O
moreover	O	ADV	O
,	O	PUNCT	O
that	O	SCONJ	O
GIG18	B-DNA	NOUN	B
induction	O	NOUN	B
may	O	AUX	O
be	O	AUX	O
a	O	DET	O
marker	O	NOUN	B
of	O	ADP	O
early	O	ADJ	O
apoptotic	O	ADJ	B
events	O	NOUN	O
in	O	ADP	O
steroid-treated	O	ADJ	B
cells	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
transcriptional	O	ADJ	B
activity	O	NOUN	I
of	O	ADP	O
the	O	DET	O
NFAT	B-DNA	NOUN	B
binding	I-DNA	NOUN	I
site	I-DNA	NOUN	I
is	O	AUX	O
mediated	O	VERB	O
by	O	ADP	O
a	O	DET	O
complex	O	NOUN	B
comprising	O	VERB	O
a	O	DET	O
member	O	NOUN	B
of	O	ADP	O
the	O	DET	O
NFAT	B-protein	NOUN	B
group	O	NOUN	B
and	O	CCONJ	O
AP-1	B-protein	NOUN	B
family	I-protein	NOUN	I
proteins	I-protein	NOUN	I
.	O	PUNCT	O


Retinoid	O	NOUN	B
differentiation	O	NOUN	I
therapy	O	NOUN	I
in	O	ADP	O
promyelocytic	O	ADJ	B
leukemia	O	NOUN	I
.	O	PUNCT	O


Acute	O	ADJ	B
promyelocytic	O	ADJ	I
leukemia	O	NOUN	I
(	O	PUNCT	O
APL	O	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
specific	O	ADJ	O
type	O	NOUN	O
of	O	ADP	O
acute	O	ADJ	B
myeloid	O	ADJ	I
leukemia	O	NOUN	I
characterized	O	VERB	B
by	O	ADP	O
the	O	DET	O
morphology	O	NOUN	B
of	O	ADP	O
the	O	DET	O
blast	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
a	O	DET	O
specific	O	ADJ	O
t	O	NOUN	O
(	O	PUNCT	O
15	O	NUM	O
;	O	PUNCT	O
17	O	NUM	O
)	O	PUNCT	O
translocation	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
risks	O	NOUN	B
of	O	ADP	O
definite	O	ADJ	O
coagulopathy	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
discovery	O	NOUN	B
of	O	ADP	O
these	O	DET	O
signaling	O	NOUN	B
pathways	O	NOUN	I
has	O	AUX	O
led	O	VERB	O
to	O	PART	O
important	O	ADJ	O
new	O	ADJ	O
insights	O	NOUN	O
into	O	ADP	O
their	O	PRON	O
role	O	NOUN	O
in	O	ADP	O
lymphocyte	O	NOUN	B
maturation	O	NOUN	B
,	O	PUNCT	O
as	O	ADP	O
it	O	PRON	O
has	O	AUX	O
emerged	O	VERB	O
that	O	SCONJ	O
mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
genes	O	NOUN	B
encoding	O	VERB	B
both	O	CCONJ	O
gamma	B-protein	NOUN	B
c	I-protein	NOUN	I
and	O	CCONJ	O
JAK3	B-protein	NOUN	B
result	O	VERB	B
in	O	ADP	O
similar	O	ADJ	O
forms	O	NOUN	O
of	O	ADP	O
severe	O	ADJ	B
combined	O	ADJ	B
immunodeficiency	O	NOUN	I
(	O	PUNCT	O
SCID	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
IL-6	B-protein	NOUN	B
may	O	AUX	O
play	O	VERB	O
a	O	DET	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
development	O	NOUN	B
of	O	ADP	O
bronchiolitis	O	NOUN	B
obliterans	O	NOUN	I
after	O	ADP	O
transplantation	O	NOUN	B
.	O	PUNCT	O


Stimulation	O	NOUN	B
by	O	ADP	O
RA	O	NOUN	B
resulted	O	VERB	O
in	O	ADP	O
increased	O	VERB	B
RAR	B-protein	NOUN	B
beta	I-protein	NOUN	B
/RXR	B-protein	NOUN	I
DNA	O	NOUN	B
binding	O	NOUN	I
,	O	PUNCT	O
activated	O	VERB	B
RARE	B-DNA	NOUN	B
-dependent	O	ADJ	O
transcription	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
increased	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
RAR-beta	B-protein	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
neither	O	CCONJ	O
the	O	DET	O
RA-stimulated	O	ADJ	B
,	O	PUNCT	O
RARE	B-DNA	NOUN	B
-mediated	O	ADJ	O
transcription	O	NOUN	B
nor	O	CCONJ	O
the	O	DET	O
induced	O	VERB	B
RAR-beta	B-protein	NOUN	B
expression	O	NOUN	B
was	O	AUX	O
suppressed	O	VERB	B
by	O	ADP	O
VitD3	O	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
VitD3	O	NOUN	B
selectively	O	ADV	O
inhibited	O	VERB	B
the	O	DET	O
retinoid-induced	O	ADJ	B
differentiation	O	NOUN	I
program	O	NOUN	I
but	O	CCONJ	O
not	O	PART	O
the	O	DET	O
RARE	B-DNA	NOUN	B
-mediated	O	ADJ	O
signal	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
human	B-protein	ADJ	B
T-cell	I-protein	NOUN	I
leukemia	I-protein	NOUN	I
virus	I-protein	NOUN	O
type	I-protein	NOUN	O
1	I-protein	NUM	O
posttranscriptional	I-protein	ADJ	B
trans-activator	I-protein	NOUN	O
Rex	B-protein	NOUN	B
contains	O	VERB	O
a	O	DET	O
nuclear	B-protein	ADJ	B
export	I-protein	NOUN	I
signal	I-protein	NOUN	I
.	O	PUNCT	O


Translocation	B-DNA	NOUN	B
(	I-DNA	PUNCT	O
3	I-DNA	NUM	O
;	I-DNA	PUNCT	O
14	I-DNA	NUM	O
)	I-DNA	PUNCT	O
(	I-DNA	PUNCT	O
q27	I-DNA	NOUN	B
;	I-DNA	PUNCT	O
q11	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
:	O	PUNCT	O
a	O	DET	O
new	O	ADJ	O
variant	O	ADJ	B
translocation	O	NOUN	B
in	O	ADP	O
a	O	DET	O
patient	O	NOUN	B
with	O	ADP	O
non-Hodgkin	O	ADJ	B
's	O	PART	I
lymphoma	O	NOUN	I
of	O	ADP	O
B-cell	O	NOUN	B
type	O	NOUN	I
with	O	ADP	O
BCL6	B-DNA	NOUN	B
rearrangement	O	NOUN	B
.	O	PUNCT	O


Histological	O	ADJ	B
diagnosis	O	NOUN	B
was	O	AUX	O
``	O	PUNCT	O
malignant	O	ADJ	B
lymphoma	O	NOUN	I
,	O	PUNCT	O
diffuse	O	NOUN	B
,	O	PUNCT	O
large	O	ADJ	O
cell	O	NOUN	O
''	O	PUNCT	O
type	O	NOUN	O
according	O	VERB	O
to	O	ADP	O
an	O	DET	O
International	O	PROPN	B
Working	O	PROPN	I
Formulation	O	PROPN	I
.	O	PUNCT	O


This	O	DET	O
yields	O	VERB	O
a	O	DET	O
fusion	O	NOUN	B
transcript	O	NOUN	I
,	O	PUNCT	O
PML/RARalpha	B-protein	NOUN	B
,	O	PUNCT	O
a	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
with	O	ADP	O
reported	O	VERB	O
dominant	O	ADJ	O
negative	O	ADJ	B
functions	O	NOUN	B
in	O	ADP	O
the	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
hormone	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
full-length	O	ADJ	O
PML/RARalpha	B-DNA	NOUN	B
cDNA	I-DNA	NOUN	B
driven	O	VERB	O
by	O	ADP	O
the	O	DET	O
CD11b	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
was	O	AUX	O
expressed	O	VERB	B
in	O	ADP	O
transgenic	O	ADJ	B
mice	O	NOUN	I
.	O	PUNCT	O


Impaired	O	ADJ	B
myelopoiesis	O	NOUN	B
in	O	X	B
vivo	O	X	I
was	O	AUX	O
shown	O	VERB	O
by	O	ADP	O
stressing	O	VERB	O
these	O	DET	O
mice	O	NOUN	B
with	O	ADP	O
sublethal	O	ADJ	B
irradiation	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
studies	O	NOUN	B
initiated	O	VERB	O
to	O	PART	O
evaluate	O	VERB	B
relationships	O	NOUN	B
between	O	ADP	O
EBV	B-DNA	NOUN	B
latent	I-DNA	ADJ	B
genes	I-DNA	NOUN	I
and	O	CCONJ	O
p53	B-protein	NOUN	B
,	O	PUNCT	O
p53	B-protein	NOUN	B
levels	O	NOUN	B
were	O	AUX	O
found	O	VERB	O
to	O	PART	O
increase	O	VERB	B
approximately	O	ADV	O
10-fold	O	ADV	O
4	O	NUM	O
to	O	PART	O
5	O	NUM	O
days	O	NOUN	B
after	O	ADP	O
EBV	O	NOUN	B
infection	O	NOUN	B
of	O	ADP	O
purified	O	VERB	B
resting	B-cell_type	VERB	I
human	I-cell_type	ADJ	O
B	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
;	O	PUNCT	O
the	O	DET	O
induced	O	VERB	B
p53	B-protein	NOUN	B
was	O	AUX	O
transcriptionally	O	ADV	B
active	O	ADJ	O
.	O	PUNCT	O


Together	O	ADV	O
the	O	DET	O
Act-1	B-DNA	NUM	B
and	O	CCONJ	O
CBF	B-DNA	NOUN	B
sites	I-DNA	NOUN	B
form	O	VERB	O
a	O	DET	O
functional	B-DNA	ADJ	B
unit	I-DNA	NOUN	I
(	O	PUNCT	O
AC	B-DNA	NOUN	B
unit	I-DNA	NOUN	I
)	O	PUNCT	O
with	O	ADP	O
dual	O	ADJ	B
activity	O	NOUN	I
.	O	PUNCT	O


This	O	DET	O
activity	O	NOUN	B
is	O	AUX	O
further	O	ADV	O
inducible	O	ADJ	B
in	O	ADP	O
activated	O	VERB	B
T	B-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
in	O	ADP	O
fibroblasts	B-cell_type	NOUN	B
.	O	PUNCT	O


Modulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IFN-gamma	B-protein	NOUN	B
receptor	I-protein	NOUN	I
beta-chain	I-protein	NOUN	I
controls	O	VERB	I
responsiveness	O	NOUN	B
to	O	PART	O
IFN-gamma	B-protein	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
peripheral	I-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
work	O	NOUN	O
,	O	PUNCT	O
we	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
human	B-cell_type	ADJ	B
peripheral	I-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
that	O	PRON	O
are	O	AUX	O
stimulated	O	VERB	B
through	O	ADP	O
the	O	DET	O
TCR	B-protein	NOUN	B
and	O	CCONJ	O
expanded	O	VERB	O
with	O	ADP	O
IL-2	B-protein	NOUN	B
are	O	AUX	O
unresponsive	O	ADJ	O
to	O	PART	O
IFN-gamma	B-protein	NOUN	B
,	O	PUNCT	O
as	O	ADP	O
determined	O	VERB	O
by	O	ADP	O
a	O	DET	O
lack	O	NOUN	B
of	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
jak	B-protein	NOUN	B
kinases	I-protein	NOUN	I
and	O	CCONJ	O
the	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
,	O	PUNCT	O
STAT1	B-protein	NOUN	B
(	I-protein	PUNCT	O
alpha	I-protein	NOUN	B
)	I-protein	PUNCT	O
,	O	PUNCT	O
a	O	DET	O
signal	O	NOUN	B
transducer	O	NOUN	I
and	O	CCONJ	O
activator	O	NOUN	O
of	O	ADP	O
transcription	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
nonresponsiveness	O	NOUN	B
occurs	O	VERB	O
because	O	SCONJ	O
of	O	ADP	O
a	O	DET	O
lack	O	NOUN	B
of	O	ADP	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
beta-	B-protein	NOUN	B
chain	I-protein	NOUN	I
(	O	PUNCT	O
accessory	O	ADJ	B
factor	O	NOUN	I
)	O	PUNCT	O
of	O	ADP	O
the	O	DET	O
IFN-gamma	B-protein	NOUN	B
receptor	I-protein	NOUN	I
,	O	PUNCT	O
while	O	SCONJ	O
at	O	ADP	O
the	O	DET	O
same	O	ADJ	O
time	O	NOUN	O
maintaining	O	VERB	O
IFN-gamma	B-protein	NOUN	B
receptor	I-protein	NOUN	I
alpha-chain	I-protein	NOUN	O
expression	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
results	O	NOUN	B
of	O	ADP	O
competition	O	NOUN	B
experiments	O	NOUN	B
analyzing	O	VERB	O
the	O	DET	O
normal	O	ADJ	B
components	O	NOUN	I
of	O	ADP	O
NF-AT	B-protein	NOUN	B
showed	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
age-related	O	ADJ	B
reductions	O	NOUN	B
in	O	ADP	O
stimulus-dependent	O	ADJ	B
NF-AT	B-protein	NOUN	B
complexes	I-protein	NOUN	B
corresponded	O	VERB	O
to	O	PART	O
the	O	DET	O
slow	O	ADJ	B
migrating	O	VERB	I
complexes	O	NOUN	B
that	O	PRON	O
were	O	AUX	O
composed	O	VERB	O
of	O	ADP	O
c-Fos/c-Jun	B-protein	NOUN	B
AP-1	B-protein	NOUN	I
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
JAK2	B-protein	NOUN	B
associated	O	VERB	B
with	O	ADP	I
the	O	DET	O
IL-4R	B-protein	NOUN	B
p140	I-protein	NOUN	B
before	O	ADP	O
and	O	CCONJ	O
after	O	ADP	O
stimulation	O	NOUN	B
with	O	ADP	O
IL-13	B-protein	NOUN	B
.	O	PUNCT	O


Differential	O	ADJ	B
regulation	O	NOUN	I
of	O	ADP	O
IL-6	B-DNA	NOUN	B
gene	I-DNA	NOUN	B
transcription	O	NOUN	I
and	O	CCONJ	O
expression	O	NOUN	B
by	O	ADP	O
IL-4	B-protein	NOUN	B
and	O	CCONJ	O
IL-10	B-protein	NOUN	B
in	O	ADP	O
human	B-cell_line	ADJ	B
monocytic	I-cell_line	ADJ	O
cell	I-cell_line	NOUN	O
lines	I-cell_line	NOUN	O
.	O	PUNCT	O


IL-4	B-protein	NOUN	B
and	O	CCONJ	O
IL-10	B-protein	NOUN	B
inhibit	O	VERB	B
the	O	DET	O
cytokine	B-protein	NOUN	B
production	O	NOUN	I
and	O	CCONJ	O
mRNA	O	NOUN	B
expression	O	NOUN	O
by	O	ADP	O
monocytes/macrophages	B-cell_type	NOUN	B
.	O	PUNCT	O


Activation	O	NOUN	B
of	O	ADP	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
of	I-protein	ADP	O
activated	I-protein	VERB	B
T	I-protein	NOUN	O
cells	I-protein	NOUN	O
in	O	ADP	O
a	O	DET	O
cyclosporin	O	NOUN	B
A-resistant	O	ADJ	O
pathway	O	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
transient	O	ADJ	B
transfection	O	NOUN	B
assays	O	NOUN	I
,	O	PUNCT	O
both	O	CCONJ	O
multicopy	O	ADJ	B
NFAT	B-protein	NOUN	I
-and	O	NOUN	O
IL-2	B-DNA	NOUN	B
promoter-beta-galactosidase	I-DNA	NOUN	I
reporter	I-DNA	NOUN	I
gene	I-DNA	NOUN	B
constructs	I-DNA	NOUN	I
could	O	AUX	O
be	O	AUX	O
activated	O	VERB	B
by	O	ADP	O
phorbol	O	NOUN	B
12-myristate	O	NOUN	I
13-acetate	O	NOUN	I
(	O	PUNCT	O
PMA	O	NOUN	B
)	O	PUNCT	O
/alpha-	O	NOUN	O
CD28	B-protein	NOUN	B
stimulation	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
this	O	DET	O
activation	O	NOUN	B
was	O	AUX	O
resistant	O	ADJ	B
to	O	PART	O
CsA	O	NOUN	B
.	O	PUNCT	O


Electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assay	O	NOUN	I
showed	O	VERB	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
a	O	DET	O
CsA-resistant	B-protein	ADJ	B
NFAT	I-protein	NOUN	I
complex	I-protein	NOUN	I
in	O	ADP	O
the	O	DET	O
nuclear	O	ADJ	B
extracts	O	NOUN	I
of	O	ADP	O
peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
stimulated	O	VERB	B
with	O	ADP	O
PMA	O	NOUN	B
plus	O	CCONJ	O
alphaCD28	B-protein	NOUN	B
.	O	PUNCT	O


Collectively	O	ADV	O
,	O	PUNCT	O
these	O	DET	O
data	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
NFAT	B-protein	NOUN	B
can	O	AUX	O
be	O	AUX	O
activated	O	VERB	B
and	O	CCONJ	O
IL-2	B-protein	NOUN	B
can	O	AUX	O
be	O	AUX	O
produced	O	VERB	O
in	O	ADP	O
a	O	DET	O
calcineurin	B-protein	NOUN	B
independent	O	ADJ	O
manner	O	NOUN	O
.	O	PUNCT	O


IL-10	B-protein	NOUN	B
effected	O	VERB	O
dose-dependent	O	ADJ	B
inhibition	O	NOUN	B
of	O	ADP	O
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor	I-protein	NOUN	I
alpha	I-protein	NOUN	I
(	O	PUNCT	O
TNF-alpha	B-protein	NOUN	B
)	O	PUNCT	O
release	O	NOUN	B
in	O	ADP	O
PBMC	B-cell_type	NOUN	B
stimulated	O	VERB	B
by	O	ADP	O
LPS	O	NOUN	B
and	O	CCONJ	O
C.	O	X	B
neoformans	O	X	I
,	O	PUNCT	O
with	O	ADP	O
significant	O	ADJ	B
inhibition	O	NOUN	B
seen	O	VERB	O
with	O	ADP	O
0.1	O	NUM	O
U/ml	O	NOUN	O
and	O	CCONJ	O
greater	O	ADJ	O
than	O	ADP	O
90	O	NUM	O
%	O	NOUN	O
inhibition	O	NOUN	B
noted	O	VERB	O
with	O	ADP	O
10	O	NUM	O
U/ml	O	NOUN	O
.	O	PUNCT	O


IL-10	B-protein	NOUN	B
profoundly	O	ADV	O
inhibited	O	VERB	B
release	O	NOUN	B
of	O	ADP	O
IL-1beta	B-protein	NOUN	B
from	O	ADP	O
PBMC	B-cell_type	NOUN	B
stimulated	O	VERB	B
by	O	ADP	O
all	O	DET	O
three	O	NUM	O
stimuli	O	NOUN	B
.	O	PUNCT	O


Much	O	ADJ	O
attention	O	NOUN	B
has	O	AUX	O
recently	O	ADV	O
focused	O	VERB	O
on	O	ADP	O
the	O	DET	O
observation	O	NOUN	B
that	O	SCONJ	O
UV	O	NOUN	B
light	O	NOUN	I
can	O	AUX	O
activate	O	VERB	B
the	O	DET	O
long	B-DNA	ADJ	B
terminal	I-DNA	ADJ	I
repeat	I-DNA	NOUN	I
(	O	PUNCT	I
LTR	B-DNA	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
the	O	DET	O
human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
(	O	PUNCT	O
HIV	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
report	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
present	O	VERB	O
data	O	NOUN	B
demonstrating	O	NOUN	O
that	O	SCONJ	O
HIV	O	NOUN	B
LTR	B-DNA	NOUN	B
activation	O	NOUN	B
is	O	AUX	O
not	O	PART	O
a	O	DET	O
general	O	ADJ	O
consequence	O	NOUN	B
of	O	ADP	I
cellular	B-DNA	ADJ	B
DNA	I-DNA	NOUN	I
damage	O	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
rather	O	ADV	O
a	O	DET	O
process	O	NOUN	O
unique	O	ADJ	B
to	O	PART	O
specific	O	ADJ	O
genotoxic	O	ADJ	B
stimuli	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
that	O	SCONJ	O
it	O	PRON	O
does	O	AUX	O
not	O	PART	O
necessarily	O	ADV	O
depend	O	VERB	O
on	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
.	O	PUNCT	O


COS-1	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
co-expressing	O	VERB	B
the	O	DET	O
human	O	ADJ	B
IL-10R	B-protein	NOUN	B
and	O	CCONJ	O
individual	O	ADJ	O
STAT	B-protein	NOUN	B
proteins	I-protein	NOUN	I
,	O	PUNCT	O
confirmed	O	VERB	O
a	O	DET	O
preference	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IL-10R	B-protein	NOUN	B
for	O	ADP	O
STAT3	B-protein	NOUN	B
and	O	CCONJ	O
STAT1	B-protein	NOUN	B
.	O	PUNCT	O


(	O	PUNCT	O
2E	O	NOUN	B
)	O	PUNCT	O
-3-	O	NOUN	O
[	O	PUNCT	O
5-	O	NUM	O
(	O	PUNCT	O
2	O	NUM	O
,	O	PUNCT	O
3-Dimethoxy-6-methyl-1	O	NUM	O
,	O	PUNCT	O
4-benzoquinoyl	O	ADJ	O
)	O	PUNCT	O
]	O	PUNCT	O
-2-nonyl-2-	O	NOUN	O
propenoic	O	ADJ	B
acid	O	NOUN	I
(	O	PUNCT	O
E3330	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
novel	O	ADJ	O
agent	O	NOUN	B
with	O	ADP	O
hepatoprotective	O	ADJ	B
activity	O	NOUN	I
.	O	PUNCT	O


Nuclear	O	ADJ	B
run-on	O	ADJ	I
experiments	O	NOUN	I
showed	O	VERB	O
that	O	SCONJ	O
E3330	O	NOUN	B
decreases	O	VERB	B
transcriptional	O	ADJ	B
activation	O	NOUN	I
of	O	ADP	O
TNF-alpha	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
induced	O	VERB	B
by	O	ADP	O
lipopolysaccharide	O	NOUN	B
(	O	PUNCT	O
LPS	O	NOUN	B
)	O	PUNCT	O
stimulation	O	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
peripheral	I-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	I
.	O	PUNCT	O


To	O	PART	O
investigate	O	VERB	B
the	O	DET	O
inhibitory	O	ADJ	B
mechanisms	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
constructed	O	VERB	O
a	O	DET	O
secreted-type	B-DNA	ADJ	B
placental	I-DNA	ADJ	I
alkaline	I-DNA	NOUN	B
phosphatase	I-DNA	NOUN	I
(	I-DNA	PUNCT	O
PLAP	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
reporter	I-DNA	NOUN	B
gene	I-DNA	NOUN	I
whose	O	DET	O
transcription	O	NOUN	B
is	O	AUX	O
controlled	O	VERB	B
by	O	ADP	O
a	O	DET	O
1.4-kb	B-DNA	ADJ	O
human	I-DNA	ADJ	B
TNF-alpha	I-DNA	NOUN	B
promoter	I-DNA	NOUN	B
.	O	PUNCT	O


E3330	O	NOUN	B
inhibited	O	VERB	B
this	O	DET	O
induced	O	VERB	B
promoter	O	NOUN	B
activity	O	NOUN	I
in	O	ADP	O
a	O	DET	O
dose-dependent	O	ADJ	B
manner	O	NOUN	O
.	O	PUNCT	O


In	O	X	B
vitro	O	X	I
mutagenesis	O	NOUN	B
and	O	CCONJ	O
transient	O	ADJ	B
transfection	O	NOUN	O
experiments	O	NOUN	O
indicate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
C-terminal	B-protein	ADJ	B
serine/threonine/proline-rich	I-protein	ADJ	I
region	I-protein	NOUN	I
of	O	ADP	O
BSAP	B-protein	NOUN	B
contains	O	VERB	O
a	O	DET	O
potent	O	ADJ	O
transactivation	B-protein	NOUN	B
domain	I-protein	NOUN	O
of	O	ADP	O
55	O	NUM	O
amino	O	NOUN	B
acids	O	NOUN	I
which	O	DET	O
is	O	AUX	O
active	O	ADJ	B
from	O	ADP	O
promoter	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
enhancer	I-DNA	NOUN	B
positions	I-DNA	NOUN	B
.	O	PUNCT	O


Structural	O	ADJ	B
and	O	CCONJ	O
functional	O	ADJ	B
characterization	O	NOUN	B
of	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
CD36	I-DNA	NOUN	O
gene	I-DNA	NOUN	O
promoter	I-DNA	NOUN	B
:	O	PUNCT	O
identification	O	NOUN	B
of	O	ADP	O
a	O	DET	O
proximal	O	ADJ	B
PEBP2/CBF	B-DNA	NOUN	B
site	I-DNA	NOUN	I
.	O	PUNCT	O


Its	O	PRON	O
expression	O	NOUN	B
is	O	AUX	O
restricted	O	ADJ	O
to	O	PART	O
a	O	DET	O
few	O	ADJ	O
cell	O	NOUN	B
types	O	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
monocyte/macrophages	B-cell_type	NOUN	B
.	O	PUNCT	O


Within	O	ADP	O
the	O	DET	O
above	O	ADJ	O
region	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
fragment	O	NOUN	B
spanning	O	NOUN	O
nucleotides	B-DNA	NOUN	B
-158	I-DNA	NUM	O
to	I-DNA	PART	O
-90	I-DNA	NUM	O
was	O	AUX	O
required	O	VERB	O
for	O	ADP	O
optimal	O	ADJ	B
transcription	O	NOUN	B
in	O	ADP	O
monocytic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


The	O	DET	O
association	O	NOUN	B
of	O	ADP	O
specific	O	ADJ	O
HLA-DQ	B-DNA	NOUN	B
alleles	I-DNA	NOUN	B
with	O	ADP	O
autoimmunity	O	NOUN	B
is	O	AUX	O
correlated	O	VERB	B
with	O	ADP	O
discrete	O	ADJ	O
polymorphisms	O	NOUN	B
in	O	ADP	O
the	O	DET	O
HLA-DQ	B-DNA	NOUN	B
sequence	I-DNA	NOUN	B
that	O	PRON	O
are	O	AUX	O
localized	O	ADJ	B
within	O	ADP	O
sites	O	NOUN	B
suitable	O	ADJ	O
for	O	ADP	O
peptide	O	NOUN	B
recognition	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
complementary	O	ADJ	O
single-residue	O	NOUN	B
substitution	O	NOUN	B
in	O	ADP	O
the	O	DET	O
peptide	O	NOUN	B
abolished	O	VERB	O
its	O	PRON	O
binding	O	NOUN	B
to	O	PART	O
DQ3.2	O	NOUN	B
and	O	CCONJ	O
converted	O	VERB	O
it	O	PRON	O
to	O	PART	O
a	O	DET	O
peptide	O	NOUN	B
that	O	PRON	O
can	O	AUX	O
bind	O	VERB	B
to	O	PART	O
DQ3.1	O	NOUN	B
and	O	CCONJ	O
DQ3.3	B-protein	NOUN	O
Asp-57-positive	I-protein	ADJ	B
MHC	I-protein	NOUN	I
molecules	I-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
requires	O	VERB	O
engagement	O	NOUN	B
of	O	ADP	O
the	O	DET	O
T	B-protein	NOUN	B
cell	I-protein	NOUN	I
receptor/CD3	I-protein	NOUN	O
complex	I-protein	NOUN	O
and	O	CCONJ	O
co-stimulatory	B-protein	ADJ	B
molecules	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
results	O	VERB	B
in	O	ADP	O
the	O	DET	O
triggering	O	NOUN	B
of	O	ADP	O
several	O	ADJ	O
signaling	O	NOUN	B
pathways	O	NOUN	I
which	O	DET	O
lead	O	VERB	O
rapidly	O	ADV	O
to	O	PART	O
the	O	DET	O
nuclear	O	ADJ	B
translocation	O	NOUN	I
of	O	ADP	O
several	O	ADJ	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
,	O	PUNCT	O
such	O	ADJ	O
as	O	ADP	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
(	I-protein	PUNCT	O
NF	I-protein	NOUN	B
)	I-protein	PUNCT	O
-kappa	I-protein	NOUN	O
B	I-protein	NOUN	B
and	O	CCONJ	O
NF-AT	B-protein	NOUN	B
.	O	PUNCT	O


While	O	SCONJ	O
Jurkat	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
both	O	CCONJ	O
secrete	O	VERB	B
and	O	CCONJ	O
respond	O	VERB	O
to	O	PART	O
IFN-gamma	B-protein	NOUN	B
in	O	ADP	O
an	O	DET	O
autocrine	O	NOUN	B
loop	O	NOUN	O
,	O	PUNCT	O
it	O	PRON	O
seems	O	VERB	O
likely	O	ADJ	O
that	O	SCONJ	O
the	O	DET	O
responding	O	VERB	B
cells	O	NOUN	B
may	O	AUX	O
differ	O	VERB	O
from	O	ADP	O
those	O	DET	O
synthesizing	O	VERB	O
this	O	DET	O
cytokine	B-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
mononuclear	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
cultures	I-cell_line	NOUN	O
in	O	ADP	O
the	O	DET	O
light	O	NOUN	O
of	O	ADP	O
the	O	DET	O
recent	O	ADJ	O
report	O	NOUN	O
that	O	SCONJ	O
Th1	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
lack	O	VERB	O
the	O	DET	O
IFN-gamma	B-protein	NOUN	B
receptor	O	NOUN	I
chain	O	NOUN	I
necessary	O	ADJ	O
for	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
STAT1	B-protein	NOUN	B
(	O	PUNCT	O
Pernis	O	PROPN	O
,	O	PUNCT	O
A.	O	PROPN	B
,	O	PUNCT	O
Gupta	O	PROPN	B
,	O	PUNCT	O
S.	O	PROPN	B
,	O	PUNCT	O
Gollob	O	PROPN	B
,	O	PUNCT	O
K.J.	O	PROPN	B
,	O	PUNCT	O
Garfein	O	PROPN	B
,	O	PUNCT	O
E.	O	PROPN	B
,	O	PUNCT	O
Coffman	O	PROPN	B
,	O	PUNCT	O
R.L.	O	PROPN	B
,	O	PUNCT	O
Schindler	O	PROPN	B
,	O	PUNCT	O
C.	O	PROPN	B
,	O	PUNCT	O
and	O	CCONJ	O
Rothman	O	PROPN	B
,	O	PUNCT	O
P.	O	PROPN	B
,	O	PUNCT	O
Science	O	PROPN	O
1995.	O	PROPN	O
269	O	NUM	O
:	O	PUNCT	O
245	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Active	O	ADJ	B
Raf-1	B-protein	NOUN	B
phosphorylates	O	VERB	B
and	O	CCONJ	O
activates	O	VERB	B
the	O	DET	O
mitogen-activated	B-protein	ADJ	B
protein	I-protein	NOUN	I
(	I-protein	PUNCT	O
MAP	I-protein	NOUN	B
)	I-protein	PUNCT	O
kinase/extracellular	I-protein	NOUN	O
signal-regulated	I-protein	ADJ	O
kinase	I-protein	NOUN	O
kinase	I-protein	NOUN	O
1	I-protein	NUM	O
(	O	PUNCT	O
MEK1	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
which	O	DET	O
in	O	ADP	O
turn	O	NOUN	O
phosphorylates	O	VERB	B
and	O	CCONJ	O
activates	O	VERB	B
the	O	DET	O
MAP	B-protein	NOUN	B
kinases/extracellular	I-protein	ADJ	B
signal	I-protein	NOUN	I
regulated	I-protein	VERB	I
kinases	I-protein	NOUN	I
,	O	PUNCT	O
ERK1	B-protein	NOUN	B
and	O	CCONJ	O
ERK2	B-protein	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
demonstrated	O	VERB	O
that	O	SCONJ	O
IL-9	B-DNA	NOUN	B
gene	I-DNA	NOUN	B
expression	O	NOUN	I
is	O	AUX	O
controlled	O	VERB	B
,	O	PUNCT	O
at	O	ADP	O
least	O	ADJ	O
in	O	ADP	O
part	O	NOUN	O
,	O	PUNCT	O
by	O	ADP	O
transcriptional	O	ADJ	B
activation	O	NOUN	I
.	O	PUNCT	O


Transient	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
luciferase	B-DNA	NOUN	B
reporter	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
linked	O	VERB	O
to	O	PART	O
serially	O	ADV	B
deleted	O	VERB	I
sequences	O	NOUN	I
of	O	ADP	O
the	O	DET	O
5'-flanking	B-DNA	ADJ	B
region	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
IL-9	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
has	O	AUX	O
revealed	O	VERB	O
several	O	ADJ	O
positive	O	ADJ	B
and	O	CCONJ	O
negative	B-DNA	ADJ	B
regulatory	I-DNA	ADJ	B
elements	I-DNA	NOUN	I
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
basal	O	ADJ	B
and	O	CCONJ	O
inducible	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IL-9	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
in	O	ADP	O
C5MJ2	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Mutations	O	NOUN	B
at	O	ADP	O
different	O	ADJ	O
sites	O	NOUN	B
within	O	ADP	O
this	O	DET	O
proximal	B-DNA	ADJ	B
promoter	I-DNA	NOUN	B
region	I-DNA	NOUN	I
abolished	O	VERB	O
the	O	DET	O
promoter	O	NOUN	B
activity	O	NOUN	I
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
the	O	DET	O
DNA	O	NOUN	B
binding	O	NOUN	I
.	O	PUNCT	O


Although	O	SCONJ	O
GM-CSF	B-protein	NOUN	B
does	O	AUX	O
not	O	PART	O
appear	O	VERB	O
to	O	PART	O
be	O	AUX	O
essential	O	ADJ	B
for	O	ADP	O
normal	O	ADJ	B
hemopoiesis	O	NOUN	B
,	O	PUNCT	O
overexpression	O	NOUN	B
of	O	ADP	O
GM-CSF	O	NOUN	B
has	O	AUX	O
been	O	AUX	O
implicated	O	VERB	O
in	O	ADP	O
the	O	DET	O
pathogenesis	O	NOUN	B
of	O	ADP	O
some	O	DET	O
diseases	O	NOUN	B
such	O	ADJ	O
as	O	ADP	O
myeloid	O	ADJ	B
leukemia	O	NOUN	I
and	O	CCONJ	O
chronic	O	ADJ	B
inflammation	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
investigated	O	VERB	B
oligonucleotide-directed	O	ADJ	B
triple	O	ADJ	I
helix	O	NOUN	I
formation	O	NOUN	I
across	O	ADP	O
this	O	DET	O
regulatory	B-DNA	ADJ	B
sequence	I-DNA	NOUN	I
as	O	ADP	O
a	O	DET	O
potential	O	ADJ	O
tool	O	NOUN	O
to	O	PART	O
inhibit	O	VERB	B
GM-CSF	B-protein	NOUN	B
gene	O	NOUN	B
transcription	O	NOUN	I
.	O	PUNCT	O


Reversible	O	ADJ	B
differentiation	O	NOUN	B
of	O	ADP	O
human	B-cell_line	ADJ	B
monoblastic	I-cell_line	ADJ	I
leukemia	I-cell_line	NOUN	I
U937	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
by	O	ADP	O
ML-9	O	NOUN	B
,	O	PUNCT	O
an	O	DET	O
inhibitor	O	NOUN	B
of	O	ADP	O
myosin	B-protein	ADJ	B
light	I-protein	ADJ	I
chain	I-protein	NOUN	I
kinase	I-protein	NOUN	I
.	O	PUNCT	O


ML-9-induced	O	ADJ	B
differentiation	O	NOUN	I
was	O	AUX	O
also	O	ADV	O
reversible	O	ADJ	O
when	O	SCONJ	O
the	O	DET	O
cells	O	NOUN	B
were	O	AUX	O
cultured	O	VERB	B
with	O	ADP	O
cultured	O	VERB	B
with	O	ADP	O
ML-9	O	NOUN	B
plus	O	CCONJ	O
an	O	DET	O
anti-cancer	O	ADJ	B
drug	O	NOUN	I
such	O	ADJ	O
as	O	ADP	O
1-beta-D-arabino-furanosylcytosine	O	NOUN	B
or	O	CCONJ	O
daunomycin	O	NOUN	B
.	O	PUNCT	O


Modulation	O	NOUN	B
of	O	ADP	O
endogenous	O	ADJ	B
IL-1	B-protein	NOUN	B
beta	I-protein	NOUN	O
and	O	CCONJ	O
IL-1	B-protein	NOUN	B
receptor	I-protein	NOUN	I
antagonist	O	NOUN	B
results	O	VERB	B
in	O	ADP	O
opposing	O	VERB	O
effects	O	NOUN	O
on	O	ADP	O
HIV	O	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
chronically	B-cell_line	ADV	B
infected	I-cell_line	ADJ	B
monocytic	I-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
regard	O	NOUN	O
,	O	PUNCT	O
anti-inflammatory	B-protein	ADJ	B
cytokines	I-protein	NOUN	O
inhibited	O	VERB	B
LPS	O	NOUN	B
plus	O	CCONJ	O
GM-CSF	B-protein	NOUN	B
-stimulated	O	ADJ	O
HIV	O	NOUN	B
expression	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
this	O	DET	O
effect	O	NOUN	B
closely	O	ADV	O
correlated	O	VERB	B
with	O	ADP	O
inhibition	O	NOUN	B
of	O	ADP	O
IL-1	B-protein	NOUN	B
beta	I-protein	NOUN	O
release	O	NOUN	O
and	O	CCONJ	O
,	O	PUNCT	O
in	O	ADP	O
particular	O	ADJ	O
,	O	PUNCT	O
with	O	ADP	O
up-regulation	O	NOUN	B
of	O	ADP	O
endogenous	O	ADJ	B
IL-1ra	O	NOUN	B
production	O	NOUN	B
.	O	PUNCT	O


Like	O	ADP	O
other	O	ADJ	O
cytokines	O	NOUN	B
,	O	PUNCT	O
IL-12	B-protein	NOUN	B
mediates	O	VERB	O
its	O	PRON	O
biologic	O	ADJ	B
activity	O	NOUN	I
through	O	ADP	O
high-affinity	O	ADJ	B
receptors	O	NOUN	I
expressed	O	VERB	B
on	O	ADP	O
responsive	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


To	O	ADP	O
date	O	NOUN	O
,	O	PUNCT	O
a	O	DET	O
large	O	ADJ	O
number	O	NOUN	O
of	O	ADP	O
receptors	O	NOUN	B
for	O	ADP	O
IL-12	B-protein	NOUN	B
have	O	AUX	O
been	O	AUX	O
found	O	VERB	O
only	O	ADV	O
on	O	ADP	O
PBMC	B-cell_type	NOUN	B
following	O	VERB	O
activation	O	NOUN	B
with	O	ADP	O
PHA	B-protein	NOUN	B
or	O	CCONJ	O
IL-2	B-protein	NOUN	B
.	O	PUNCT	O


A	O	DET	O
number	O	NOUN	O
of	O	ADP	O
recent	O	ADJ	O
studies	O	NOUN	B
have	O	AUX	O
described	O	VERB	O
interactions	O	NOUN	B
between	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
in	O	ADP	O
lymphocytes	O	NOUN	B
that	O	PRON	O
provide	O	VERB	O
new	O	ADJ	O
insights	O	NOUN	O
into	O	ADP	O
mechanisms	O	NOUN	B
regulating	O	VERB	B
gene	O	NOUN	B
expression	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
role	O	NOUN	O
of	O	ADP	O
hLH-2	B-DNA	NOUN	B
in	O	ADP	O
the	O	DET	O
development	O	NOUN	B
or	O	CCONJ	O
progression	O	NOUN	B
of	O	ADP	O
leukaemia	O	NOUN	B
is	O	AUX	O
not	O	PART	O
known	O	VERB	O
.	O	PUNCT	O


Lymphoid	O	ADJ	B
cell	O	NOUN	I
resistance	O	NOUN	O
to	O	PART	O
glucocorticoids	O	NOUN	B
in	O	ADP	O
HIV	O	NOUN	B
infection	O	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
chronically	B-cell_type	ADV	B
HIV-infected	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	O
appear	O	VERB	O
to	O	PART	O
be	O	AUX	O
resistant	O	ADJ	B
to	O	PART	O
glucocorticoid-evoked	O	ADJ	B
cell	O	NOUN	I
death	O	NOUN	I
.	O	PUNCT	O


Glucocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
-ligand	O	NOUN	O
binding	O	NOUN	B
studies	O	NOUN	I
on	O	ADP	O
patients	O	NOUN	B
'	O	PART	O
cells	O	NOUN	B
have	O	AUX	O
shown	O	VERB	O
reduced	O	VERB	B
affinity	O	NOUN	B
between	O	ADP	O
the	O	DET	O
receptor	B-protein	NOUN	B
binding	I-protein	NOUN	I
sites	I-protein	NOUN	I
and	O	CCONJ	O
test	O	NOUN	B
steroids	O	NOUN	I
.	O	PUNCT	O


In	O	X	B
vitro	O	X	I
,	O	PUNCT	O
chronically	B-cell_line	ADV	B
HIV-infected	I-cell_line	ADJ	B
cells	I-cell_line	NOUN	B
of	O	ADP	O
the	O	DET	O
lymphoid	B-cell_line	ADJ	B
CEM	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
displayed	O	VERB	O
resistance	O	NOUN	B
to	O	PART	O
glucocorticoid-induced	O	ADJ	B
apoptosis	O	NOUN	I
.	O	PUNCT	O


As	O	ADP	O
neutrophils	B-cell_type	NOUN	B
occupy	O	VERB	O
approximately	O	ADV	O
92	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
the	O	DET	O
cells	O	NOUN	B
in	O	ADP	O
this	O	DET	O
fraction	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
cells	O	NOUN	B
expressing	O	VERB	B
p45	B-protein	NOUN	B
is	O	AUX	O
most	O	ADV	O
likely	O	ADJ	O
to	O	PART	O
be	O	AUX	O
neutrophils	B-cell_type	NOUN	B
.	O	PUNCT	O


HL-60	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
were	O	AUX	O
found	O	VERB	O
to	O	PART	O
express	O	VERB	O
mafK	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
,	O	PUNCT	O
indicating	O	VERB	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
genuine	O	ADJ	O
NF-E2	B-protein	NOUN	B
complex	I-protein	NOUN	I
in	O	ADP	O
the	O	DET	O
cells	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
found	O	VERB	O
nuclear	O	ADJ	B
p62c-fos	B-protein	NOUN	I
,	O	PUNCT	O
p39c-jun	B-protein	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
AP-1	B-protein	NOUN	B
binding	O	NOUN	I
activity	O	NOUN	I
throughout	O	ADP	O
the	O	DET	O
cell	O	NOUN	B
cycle	O	NOUN	I
both	O	CCONJ	O
in	O	ADP	O
HL60	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
and	O	CCONJ	O
in	O	ADP	O
PHA-stimulated	B-cell_line	ADJ	B
PBL	I-cell_line	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
we	O	PRON	O
postulate	O	VERB	O
that	O	SCONJ	O
these	O	DET	O
proteins	O	NOUN	B
are	O	AUX	O
required	O	VERB	O
throughout	O	ADP	O
the	O	DET	O
cell	O	NOUN	B
cycle	O	NOUN	I
and	O	CCONJ	O
not	O	PART	O
transiently	O	ADV	O
in	O	ADP	O
the	O	DET	O
G0	O	NOUN	B
to	O	PART	O
G1	O	NOUN	B
transition	O	NOUN	B
as	O	ADP	O
previous	O	ADJ	O
mRNA	O	NOUN	B
studies	O	NOUN	I
have	O	AUX	O
indicated	O	VERB	O
.	O	PUNCT	O


Following	O	VERB	O
PHA	B-protein	NOUN	B
stimulation	O	NOUN	B
of	O	ADP	O
PBL	B-cell_type	NOUN	B
,	O	PUNCT	O
the	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
AP-1	B-protein	NOUN	B
activity	O	NOUN	I
was	O	AUX	O
delayed	O	VERB	B
with	O	ADP	O
respect	O	NOUN	O
to	O	PART	O
the	O	DET	O
augmentation	O	NOUN	B
of	O	ADP	O
p39c-jun	B-protein	NOUN	O
expression	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
B	B-protein	NOUN	B
cell	I-protein	NOUN	I
restricted	I-protein	ADJ	O
coactivator	I-protein	NOUN	B
may	O	AUX	O
be	O	AUX	O
responsible	O	ADJ	O
for	O	ADP	O
the	O	DET	O
B	O	NOUN	B
cell	O	NOUN	I
specific	O	ADJ	O
expression	O	NOUN	B
of	O	ADP	O
PU.1	B-protein	NOUN	B
mediated	O	VERB	O
by	O	ADP	O
the	O	DET	O
octamer	B-DNA	NOUN	B
site	I-DNA	NOUN	I
.	O	PUNCT	O


During	O	ADP	O
T-cell	O	NOUN	B
activation	O	NOUN	I
,	O	PUNCT	O
c-myb	B-DNA	NOUN	B
expression	O	NOUN	B
is	O	AUX	O
induced	O	VERB	B
and	O	CCONJ	O
much	O	ADJ	O
of	O	ADP	O
the	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
expression	O	NOUN	B
occurs	O	VERB	O
at	O	ADP	O
the	O	DET	O
transcriptional	O	ADJ	B
level	O	NOUN	B
.	O	PUNCT	O


An	O	DET	O
electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assay	O	NOUN	I
(	O	PUNCT	O
EMSA	O	NOUN	B
)	O	PUNCT	O
with	O	ADP	O
nuclear	O	ADJ	B
extract	O	NOUN	I
from	O	ADP	O
activated	B-cell_type	VERB	B
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
an	O	DET	O
oligonucleotide	O	NOUN	B
of	O	ADP	O
this	O	DET	O
binding	O	VERB	B
site	O	NOUN	I
demonstrated	O	VERB	O
a	O	DET	O
new	O	ADJ	O
protein-DNA	B-protein	ADJ	B
complex	I-protein	NOUN	I
,	O	PUNCT	O
referred	O	VERB	O
to	O	PART	O
as	O	ADP	O
CMAT	B-protein	NOUN	B
for	O	ADP	O
c-myb	B-protein	NOUN	B
in	I-protein	ADP	O
activated	I-protein	VERB	B
T	I-protein	NOUN	O
cells	I-protein	NOUN	O
;	O	PUNCT	O
this	O	DET	O
complex	O	NOUN	B
was	O	AUX	O
not	O	PART	O
present	O	ADJ	O
in	O	ADP	O
unactivated	B-cell_type	ADJ	B
T	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
.	O	PUNCT	O


U1	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
stimulated	O	VERB	B
with	O	ADP	O
10	O	NUM	O
(	O	PUNCT	O
-7	O	NUM	O
)	O	PUNCT	O
M	O	NOUN	O
PMA	O	NOUN	B
released	O	VERB	O
approximately	O	ADV	O
1	O	NUM	O
ng/ml	O	NOUN	O
endogenous	B-protein	ADJ	B
TBP-1	I-protein	NOUN	B
with	O	ADP	O
an	O	DET	O
initial	O	ADJ	B
peak	O	NOUN	O
observed	O	VERB	O
at	O	ADP	O
1	O	NUM	O
h	O	NOUN	O
and	O	CCONJ	O
a	O	DET	O
second	O	ADJ	O
peak	O	NOUN	O
at	O	ADP	O
24	O	NUM	O
h	O	NOUN	O
after	O	ADP	O
PMA	O	NOUN	B
stimulation	O	NOUN	B
.	O	PUNCT	O


r-hTBP-1	B-protein	NOUN	B
also	O	ADV	O
partially	O	ADV	O
reversed	O	VERB	O
inhibition	O	NOUN	B
of	O	ADP	O
U1	O	NOUN	B
cellular	O	ADJ	B
proliferation	O	NOUN	I
caused	O	VERB	O
by	O	ADP	O
PMA	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
conclude	O	VERB	O
that	O	SCONJ	O
soluble	O	ADJ	B
TNF	O	NOUN	B
receptors	O	NOUN	I
can	O	AUX	O
inhibit	O	VERB	B
stimuli-induced	O	ADJ	O
HIV-1	O	NOUN	B
expression	O	NOUN	B
and	O	CCONJ	O
NK-	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
DNA-binding	O	ADJ	B
activity	O	NOUN	O
in	O	ADP	O
chronically	O	ADV	B
infected	B-cell_type	ADJ	B
U1	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Transcriptional	O	ADJ	B
activation	O	NOUN	I
of	O	ADP	O
RNA	B-DNA	NOUN	B
polymerase	I-DNA	NOUN	I
III-dependent	I-DNA	ADJ	I
genes	I-DNA	NOUN	I
by	O	ADP	O
the	O	DET	O
human	B-protein	ADJ	B
T-cell	I-protein	NOUN	I
leukemia	I-protein	NOUN	I
virus	I-protein	NOUN	O
type	I-protein	NOUN	O
1	I-protein	NUM	O
tax	I-protein	NOUN	O
protein	I-protein	NOUN	O
.	O	PUNCT	O


The	O	DET	O
viral	B-protein	ADJ	B
protein	I-protein	NOUN	I
Tax	I-protein	NOUN	B
was	O	AUX	O
likely	O	ADV	O
responsible	O	ADJ	O
for	O	ADP	O
this	O	DET	O
higher	O	ADJ	B
level	O	NOUN	B
of	O	ADP	O
class	B-DNA	NOUN	B
II	I-DNA	NUM	I
gene	I-DNA	NOUN	B
transcription	O	NOUN	I
,	O	PUNCT	O
as	O	ADP	O
purified	B-protein	VERB	O
Tax	I-protein	NOUN	B
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
stimulate	O	VERB	B
both	O	DET	O
genes	O	NOUN	B
when	O	SCONJ	O
added	O	VERB	O
to	O	PART	O
the	O	DET	O
uninfected	O	ADJ	B
cell	O	NOUN	B
extract	O	NOUN	I
or	O	CCONJ	O
in	O	ADP	O
reconstituted	O	VERB	B
systems	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
recently	O	ADV	O
cloned	O	VERB	B
TCL1	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
,	O	PUNCT	O
also	O	ADV	O
involved	O	VERB	O
in	O	ADP	O
translocations	O	NOUN	B
and	O	CCONJ	O
inversions	O	NOUN	B
associated	O	VERB	B
with	O	ADP	I
T-cell	O	NOUN	B
proliferations	O	NOUN	I
,	O	PUNCT	O
codes	O	VERB	B
for	O	ADP	O
a	O	DET	O
14-kD	B-protein	ADJ	O
protein	I-protein	NOUN	B
that	O	PRON	O
displays	O	VERB	O
significant	O	ADJ	O
homology	O	NOUN	B
with	O	ADP	O
p13MTCP1	B-protein	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
generated	O	VERB	O
rabbit	O	NOUN	B
antisera	O	NOUN	B
against	O	ADP	O
this	O	DET	O
putative	O	ADJ	O
p13MTCP1	B-protein	NOUN	B
protein	I-protein	NOUN	I
and	O	CCONJ	O
screened	O	VERB	B
for	O	ADP	O
expression	O	NOUN	B
of	O	ADP	O
p13MTCP1	B-protein	NOUN	B
normal	O	ADJ	O
lymphoid	O	ADJ	B
tissues	O	NOUN	B
and	O	CCONJ	O
33	O	NUM	O
cases	O	NOUN	B
of	O	ADP	O
immature	B-cell_type	ADJ	B
and	I-cell_type	CCONJ	O
mature	I-cell_type	ADJ	B
lymphoid	I-cell_type	ADJ	B
T-cell	I-cell_type	NOUN	O
proliferations	I-cell_type	NOUN	O
using	O	VERB	O
a	O	DET	O
sensitive	O	ADJ	B
Western	O	NOUN	B
blot	O	NOUN	I
assay	O	NOUN	I
.	O	PUNCT	O


Newly	O	ADV	B
translated	O	VERB	O
STAT1	B-protein	NOUN	B
binds	O	VERB	B
in	O	ADP	O
equilibrium	O	X	B
fashion	O	NOUN	O
to	O	PART	O
STAT2	B-protein	NOUN	B
and	O	CCONJ	O
STAT3	B-protein	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
we	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
STAT2	B-protein	NOUN	B
and	O	CCONJ	O
STAT3	B-protein	NOUN	B
exist	O	VERB	O
in	O	ADP	O
separate	O	ADJ	O
heterocomplexes	B-protein	NOUN	B
with	O	ADP	O
STAT1	B-protein	NOUN	B
,	O	PUNCT	O
consistent	O	ADJ	B
with	O	ADP	I
a	O	DET	O
model	O	NOUN	B
in	O	ADP	O
which	O	DET	O
STAT1	B-protein	NOUN	B
contains	O	VERB	O
a	O	DET	O
common	O	ADJ	O
binding	O	VERB	B
site	O	NOUN	I
for	O	ADP	O
other	O	ADJ	O
STAT	B-protein	NOUN	B
proteins	I-protein	NOUN	I
.	O	PUNCT	O


Not	O	PART	O
only	O	ADV	O
was	O	AUX	O
this	O	DET	O
effect	O	NOUN	B
observed	O	VERB	B
at	O	ADP	O
the	O	DET	O
mRNA	O	NOUN	B
level	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
activator	B-protein	NOUN	B
protein-1	I-protein	NOUN	I
(	O	PUNCT	O
AP-1	B-protein	NOUN	B
)	O	PUNCT	O
DNA	O	NOUN	B
binding	O	NOUN	I
capacity	O	NOUN	I
was	O	AUX	O
affected	O	VERB	B
as	O	ADV	O
well	O	ADV	O
,	O	PUNCT	O
A	O	DET	O
strong	O	ADJ	O
reduction	O	NOUN	B
was	O	AUX	O
observed	O	VERB	O
in	O	ADP	O
the	O	DET	O
LPS-induced	O	ADJ	B
DNA-binding	O	ADJ	B
activity	O	NOUN	O
of	O	ADP	O
AP-1	B-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
IFN-gamma	B-protein	NOUN	B
.	O	PUNCT	O


MIP-1	B-protein	NOUN	B
alpha	I-protein	NOUN	B
is	O	AUX	O
a	O	DET	O
secreted	O	VERB	B
chemokine	B-protein	NOUN	B
which	O	DET	O
can	O	AUX	O
inhibit	O	VERB	B
hematopoietic	B-cell_type	ADJ	B
stem	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
modulate	O	VERB	B
inflammatory	O	ADJ	B
responses	O	NOUN	I
.	O	PUNCT	O


Although	O	SCONJ	O
Stat	O	NOUN	B
binding	O	NOUN	I
to	O	PART	O
the	O	DET	O
intracellular	B-protein	ADJ	B
domain	I-protein	NOUN	B
of	O	ADP	O
the	O	DET	O
cytokine	B-protein	NOUN	B
receptor	I-protein	NOUN	I
strongly	O	ADV	O
depends	O	VERB	O
on	O	ADP	O
the	O	DET	O
phosphotyrosine	O	NOUN	B
residue	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
recruitment	O	NOUN	B
of	O	ADP	O
a	O	DET	O
specific	O	ADJ	O
Stat	B-protein	NOUN	B
protein	I-protein	NOUN	I
is	O	AUX	O
dictated	O	VERB	O
by	O	ADP	O
amino	O	NOUN	B
acid	O	NOUN	I
residues	O	NOUN	I
C-terminal	O	ADJ	B
to	O	PART	O
the	O	DET	O
phosphotyrosine	O	NOUN	B
.	O	PUNCT	O


Specific	O	ADJ	O
docking	B-protein	NOUN	B
sites	I-protein	NOUN	I
within	O	ADP	O
individual	O	ADJ	O
cytokine	B-protein	NOUN	B
receptors	I-protein	NOUN	I
have	O	AUX	O
been	O	AUX	O
identified	O	VERB	B
for	O	ADP	O
almost	O	ADV	O
all	O	DET	O
Stat	B-protein	NOUN	B
proteins	I-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
direct	O	ADJ	O
coupling	O	NOUN	B
between	O	ADP	O
cytokine	B-protein	NOUN	B
receptor	I-protein	NOUN	I
and	O	CCONJ	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
helps	O	VERB	O
to	O	PART	O
explain	O	VERB	O
how	O	SCONJ	O
different	O	ADJ	O
cytokines	B-protein	NOUN	B
elicit	O	VERB	O
distinct	O	ADJ	O
patterns	O	NOUN	B
of	O	ADP	O
gene	O	NOUN	B
expression	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
immediate-early	B-DNA	ADJ	B
gene	I-DNA	NOUN	O
egr-1	B-DNA	NOUN	B
encodes	O	VERB	O
a	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
(	O	PUNCT	O
EGR1	B-protein	NOUN	B
)	O	PUNCT	O
that	O	PRON	O
links	O	VERB	O
B-cell	B-protein	NOUN	B
antigen	I-protein	NOUN	I
receptor	I-protein	NOUN	I
(	O	PUNCT	O
BCR	B-protein	NOUN	B
)	O	PUNCT	O
signals	O	NOUN	O
to	O	PART	O
downstream	O	ADJ	B
activation	O	NOUN	O
events	O	NOUN	O
through	O	ADP	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
previously	O	ADV	O
unidentified	O	ADJ	O
target	B-DNA	NOUN	B
genes	I-DNA	NOUN	I
.	O	PUNCT	O


Cotransfection	O	NOUN	B
of	O	ADP	O
a	O	DET	O
CD44	B-DNA	NOUN	B
promoter-chloramphenicol	I-DNA	ADJ	B
acetyltransferase	I-DNA	NOUN	I
reporter	I-DNA	NOUN	I
construct	I-DNA	NOUN	I
with	O	ADP	O
an	O	DET	O
egr-1	B-DNA	NOUN	B
expression	I-DNA	NOUN	B
vector	I-DNA	NOUN	I
resulted	O	VERB	O
in	O	ADP	O
a	O	DET	O
6.5-	O	NUM	O
to	O	PART	O
8.5-fold	O	ADJ	O
induction	O	NOUN	B
of	O	ADP	O
transcriptional	O	ADJ	B
activity	O	NOUN	I
relative	O	ADJ	O
to	O	PART	O
an	O	DET	O
empty	B-DNA	ADJ	B
expression	I-DNA	NOUN	B
vector	I-DNA	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
human	B-cell_line	ADJ	B
Jurkat	I-cell_line	NOUN	O
T	I-cell_line	NOUN	O
cells	I-cell_line	NOUN	O
and	O	CCONJ	O
its	O	PRON	O
subclone	O	NOUN	B
Wurzburg	B-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
oxidant	O	ADJ	B
challenge	O	NOUN	O
elevated	O	ADJ	O
[	O	PUNCT	O
Ca2+	O	NOUN	B
]	O	PUNCT	O
i	O	NUM	O
by	O	ADP	O
mobilizing	O	VERB	B
Ca2+	O	NOUN	B
from	O	ADP	O
intracellular	O	ADJ	B
stores	O	NOUN	B
.	O	PUNCT	O


Transactivation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
interleukin-1alpha	B-DNA	NOUN	B
promoter	I-DNA	NOUN	O
by	O	ADP	O
human	B-protein	ADJ	B
T-cell	I-protein	NOUN	O
leukemia	I-protein	NOUN	O
virus	I-protein	NOUN	O
type	I-protein	NOUN	O
I	I-protein	NUM	O
and	I-protein	CCONJ	O
type	I-protein	NOUN	B
II	I-protein	NUM	I
Tax	I-protein	NOUN	I
proteins	I-protein	NOUN	I
.	O	PUNCT	O


IL-1alpha	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
constructs	I-DNA	NOUN	I
drive	O	VERB	O
transcription	O	NOUN	B
of	O	ADP	O
the	O	DET	O
chloramphenicol	B-DNA	NOUN	B
acetyltransferase	I-DNA	NOUN	I
(	I-DNA	PUNCT	O
CAT	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
reporter	I-DNA	NOUN	B
gene	I-DNA	NOUN	I
in	O	ADP	O
HTLV-I-positive	B-cell_line	ADJ	B
MT-2	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
which	O	DET	O
constitutively	O	ADV	B
produce	O	VERB	O
IL-1alpha	B-protein	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
a	O	DET	O
cotransfection	O	NOUN	B
assay	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
Tax	B-protein	NOUN	B
protein	I-protein	NOUN	I
of	O	ADP	O
both	O	CCONJ	O
HTLV-I	O	NOUN	B
and	O	CCONJ	O
HTLV-II	O	NOUN	B
specifically	O	ADV	O
activated	O	VERB	B
transcription	O	NOUN	O
from	O	ADP	O
the	O	DET	O
IL-1alpha	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
in	O	ADP	O
an	O	DET	O
uninfected	B-cell_line	ADJ	B
Jurkat	I-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
.	O	PUNCT	O


The	O	DET	O
myeloid-cell-specific	B-DNA	ADJ	B
c-fes	I-DNA	NOUN	I
promoter	I-DNA	NOUN	B
is	O	AUX	O
regulated	O	VERB	O
by	O	ADP	O
Sp1	B-protein	NOUN	B
,	O	PUNCT	O
PU.1	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
novel	O	ADJ	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
.	O	PUNCT	O


DNase	O	NOUN	B
I	O	NUM	I
footprinting	O	NOUN	I
assays	O	NOUN	I
revealed	O	VERB	O
four	O	NUM	O
distinct	O	ADJ	O
sites	O	NOUN	B
that	O	PRON	O
bind	O	VERB	B
myeloid	B-protein	ADJ	B
nuclear	I-protein	ADJ	I
proteins	I-protein	NOUN	I
(	O	PUNCT	O
-408	B-DNA	NUM	O
to	I-DNA	PART	O
-386	I-DNA	NUM	O
,	O	PUNCT	O
-293	B-DNA	NUM	O
to	I-DNA	PART	O
-254	I-DNA	NUM	O
,	O	PUNCT	O
-76	B-DNA	NUM	O
to	I-DNA	PART	O
-65	I-DNA	NUM	O
,	O	PUNCT	O
and	O	CCONJ	O
-34	B-DNA	NUM	O
to	I-DNA	PART	O
+3	I-DNA	NUM	B
)	O	PUNCT	O
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
transient-cotransfection	O	ADJ	B
assay	O	NOUN	I
demonstrated	O	VERB	O
that	O	SCONJ	O
PU.1	B-protein	NOUN	B
(	O	PUNCT	O
and	O	CCONJ	O
not	O	PART	O
Elf-1	B-protein	NOUN	B
)	O	PUNCT	O
can	O	AUX	O
transactivate	O	VERB	B
the	O	DET	O
c-fes	B-DNA	NOUN	B
promoter	I-DNA	NOUN	I
in	O	ADP	O
nonmyeloid	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
.	O	PUNCT	O


IL-10	B-protein	NOUN	B
inhibits	O	VERB	B
nuclear	B-protein	ADJ	B
factor-kappa	I-protein	NOUN	I
B/Rel	I-protein	NOUN	B
nuclear	O	ADJ	O
activity	O	NOUN	O
in	O	ADP	O
CD3-stimulated	B-cell_line	ADJ	B
human	I-cell_line	ADJ	B
peripheral	I-cell_line	ADJ	O
T	I-cell_line	NOUN	O
lymphocytes	I-cell_line	NOUN	O
.	O	PUNCT	O


Indeed	O	ADV	O
,	O	PUNCT	O
monocytes	B-cell_type	NOUN	B
pretreated	O	VERB	O
with	O	ADP	O
IL-10	B-protein	NOUN	B
are	O	AUX	O
able	O	ADJ	O
so	O	ADV	O
inhibit	O	VERB	B
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
nuclear	O	ADJ	O
activity	O	NOUN	O
in	O	ADP	O
purified	O	VERB	B
T	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
stimulated	O	VERB	O
with	O	ADP	O
OKT3	B-protein	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
a	O	DET	O
panel	O	NOUN	O
of	O	ADP	O
32	O	NUM	O
B-cell	B-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
,	O	PUNCT	O
A-myb	B-DNA	NOUN	B
was	O	AUX	O
very	O	ADV	O
strongly	O	ADV	O
expressed	O	VERB	B
in	O	ADP	O
most	O	ADJ	O
Burkitt	O	NOUN	B
's	O	PART	I
lymphoma	O	NOUN	I
(	O	PUNCT	O
BL	O	NOUN	B
)	O	PUNCT	O
cell	O	NOUN	B
lines	O	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
weak	O	ADJ	B
or	O	CCONJ	O
negative	O	ADJ	B
in	O	ADP	O
2	O	NUM	O
pre-B	O	ADJ	O
acute	O	ADJ	B
lymphoblastic	O	ADJ	I
leukemia	O	NOUN	I
(	O	PUNCT	O
ALL	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
4	O	NUM	O
non-Hodgkin	O	ADJ	B
's	O	PART	I
lymphoma	O	NOUN	I
(	O	PUNCT	O
NHL	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
6	O	NUM	O
Epstein-Barr	B-cell_line	ADJ	B
virus-immortalized	I-cell_line	ADJ	I
lymphoblastoid	I-cell_line	ADJ	I
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
6	O	NUM	O
myeloma	B-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
.	O	PUNCT	O


Protein	O	NOUN	B
expression	O	NOUN	I
paralleled	O	VERB	O
that	O	DET	O
of	O	ADP	O
the	O	DET	O
RNA	O	NOUN	B
.	O	PUNCT	O


Unexpectedly	O	ADV	O
,	O	PUNCT	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
same	O	ADJ	O
EBNA2	B-protein	NOUN	B
-oestrogen	O	NOUN	O
receptor	O	NOUN	B
fusion	O	NOUN	I
protein	O	NOUN	I
in	O	ADP	O
established	B-cell_line	ADJ	O
human	I-cell_line	ADJ	B
B	I-cell_line	NOUN	O
cell	I-cell_line	NOUN	O
lymphoma	I-cell_line	NOUN	O
lines	I-cell_line	NOUN	O
resulted	O	VERB	O
in	O	ADP	O
growth	O	NOUN	B
retardation	O	NOUN	I
or	O	CCONJ	O
growth	O	NOUN	B
arrest	O	NOUN	I
upon	O	SCONJ	O
the	O	DET	O
addition	O	NOUN	O
of	O	ADP	O
oestrogen	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
functional	O	ADJ	B
Ets	B-DNA	NOUN	B
binding	I-DNA	NOUN	I
site	I-DNA	NOUN	I
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
bind	O	VERB	B
Ets	B-protein	NOUN	B
family	I-protein	NOUN	I
proteins	I-protein	NOUN	I
,	O	PUNCT	O
principally	O	ADV	O
GA-binding	B-protein	ADJ	B
protein	I-protein	NOUN	I
and	O	CCONJ	O
Elf-1	B-protein	NOUN	B
and	O	CCONJ	O
could	O	AUX	O
be	O	AUX	O
transactivated	O	VERB	B
by	O	ADP	O
GABPalpha	B-protein	NOUN	B
and	O	CCONJ	O
-beta	B-protein	NOUN	O
synergistically	O	ADV	B
.	O	PUNCT	O


One	O	NUM	O
of	O	ADP	O
the	O	DET	O
manifestations	O	NOUN	B
of	O	ADP	O
human	O	ADJ	B
HIV-1	O	NOUN	B
and	O	CCONJ	O
nonhuman	O	ADJ	B
primate	O	ADJ	I
SIV	O	NOUN	B
infection	O	NOUN	O
that	O	PRON	O
lead	O	VERB	O
to	O	PART	O
disease	O	NOUN	B
is	O	AUX	O
reasoned	O	VERB	O
to	O	PART	O
be	O	AUX	O
secondary	O	ADJ	B
to	O	PART	I
generalized	O	VERB	B
T-cell	O	NOUN	I
dysfunction	O	NOUN	I
.	O	PUNCT	O


To	O	PART	O
address	O	VERB	O
this	O	DET	O
issue	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
sought	O	VERB	O
to	O	PART	O
utilize	O	VERB	O
the	O	DET	O
nonhuman	O	ADJ	B
primate	O	ADJ	I
model	O	NOUN	I
to	O	PART	O
study	O	VERB	B
intracellular	O	ADJ	B
signaling	O	NOUN	O
events	O	NOUN	O
in	O	ADP	O
cells	O	NOUN	B
from	O	ADP	O
disease-susceptible	O	ADJ	B
rhesus	O	NOUN	I
macaques	O	NOUN	I
and	O	CCONJ	O
disease-resistant	O	ADJ	B
sooty	O	ADJ	B
mangabeys	O	NOUN	I
.	O	PUNCT	O


Of	O	ADP	O
five	O	NUM	O
positive	O	ADJ	B
clones	O	NOUN	B
isolated	O	VERB	B
from	O	ADP	O
0.75	O	NUM	O
x	O	NOUN	O
10	O	NUM	O
(	O	PUNCT	O
6	O	NUM	O
)	O	PUNCT	O
yeast	O	NOUN	B
colonies	O	NOUN	B
,	O	PUNCT	O
four	O	NUM	O
were	O	AUX	O
members	O	NOUN	B
of	O	ADP	O
the	O	DET	O
CREB/activating	B-protein	ADJ	B
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
(	I-protein	PUNCT	O
ATF	I-protein	NOUN	B
)	I-protein	PUNCT	O
family	I-protein	NOUN	B
:	O	PUNCT	O
CREB	B-protein	NOUN	B
,	O	PUNCT	O
two	B-protein	NUM	O
isoforms	I-protein	NOUN	B
of	I-protein	ADP	O
the	I-protein	DET	O
cyclic	I-protein	ADJ	B
AMP-responsive	I-protein	ADJ	B
element	I-protein	NOUN	I
modulator	I-protein	NOUN	I
(	O	PUNCT	O
CREM	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
ATF-1	B-protein	NOUN	B
.	O	PUNCT	O


This	O	DET	O
shows	O	VERB	O
that	O	SCONJ	O
in	O	ADP	O
a	O	DET	O
eukaryotic	O	ADJ	B
nucleus	O	NOUN	I
,	O	PUNCT	O
Tax	B-protein	NOUN	B
specifically	O	ADV	O
interacts	O	VERB	O
with	O	ADP	O
the	O	DET	O
basic	B-protein	ADJ	O
domain-leucine	I-protein	ADJ	O
zipper	I-protein	NOUN	O
region	I-protein	NOUN	O
of	O	ADP	O
ATF-1	B-protein	NOUN	B
,	O	PUNCT	O
CREB	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
CREM	B-protein	NOUN	B
.	O	PUNCT	O


Interleukin-13	B-protein	NOUN	B
(	O	PUNCT	O
IL-13	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
IL-4	B-protein	NOUN	B
are	O	AUX	O
cytokines	O	NOUN	B
produced	O	VERB	O
by	O	ADP	O
T	O	NOUN	B
cells	O	NOUN	I
that	O	PRON	O
are	O	AUX	O
encoded	O	VERB	B
by	O	ADP	O
the	O	DET	O
q23-31	O	NOUN	B
region	O	NOUN	I
of	O	ADP	O
human	O	ADJ	B
chromosome	O	NOUN	I
5	O	NUM	I
.	O	PUNCT	O


As	O	ADP	O
assessed	O	VERB	B
with	O	ADP	O
mutagenized	B-DNA	ADJ	B
promoters	I-DNA	NOUN	I
,	O	PUNCT	O
the	O	DET	O
most	O	ADV	O
important	O	ADJ	O
IL-2	B-DNA	NOUN	B
cis-regulatory	I-DNA	ADJ	B
elements	I-DNA	NOUN	I
in	O	ADP	O
normal	B-cell_type	ADJ	O
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
are	O	AUX	O
the	O	DET	O
proximal	B-DNA	ADJ	B
AP-1	I-DNA	NOUN	B
site	I-DNA	NOUN	I
and	O	CCONJ	O
the	O	DET	O
NF-	B-DNA	NOUN	B
kappaB	I-DNA	NOUN	I
site	I-DNA	NOUN	I
.	O	PUNCT	O


Previous	O	ADJ	O
studies	O	NOUN	B
have	O	AUX	O
shown	O	VERB	O
that	O	SCONJ	O
retinoic	O	ADJ	B
acid	O	NOUN	I
(	O	PUNCT	O
RA	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
similar	O	ADJ	O
to	O	PART	O
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor-alpha	I-protein	NOUN	I
(	O	PUNCT	O
TNF-alpha	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
can	O	AUX	O
act	O	VERB	O
as	O	ADP	O
a	O	DET	O
bifunctional	O	ADJ	B
regulator	O	NOUN	I
of	O	ADP	O
the	O	DET	O
growth	O	NOUN	B
of	O	ADP	O
bone	B-cell_type	NOUN	B
marrow	I-cell_type	NOUN	I
progenitors	I-cell_type	NOUN	I
,	O	PUNCT	O
in	O	ADP	O
that	O	SCONJ	O
it	O	PRON	O
can	O	AUX	O
stimulate	O	VERB	B
granulocyte-macrophage	O	ADJ	B
colony-stimulating	O	ADJ	I
factor	O	NOUN	I
(	O	PUNCT	O
GM-CSF	O	NOUN	B
)	O	PUNCT	O
-	O	PUNCT	O
or	O	CCONJ	O
interleukin-3	O	NOUN	B
(	O	PUNCT	O
IL-3	O	NOUN	B
)	O	PUNCT	O
-induced	O	ADJ	O
GM	O	NOUN	B
colony	O	NOUN	B
formation	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
potently	O	ADV	O
inhibit	O	VERB	B
G-CSF	B-protein	NOUN	B
-induced	O	ADJ	O
growth	O	NOUN	B
.	O	PUNCT	O


Transactivation	O	NOUN	B
studies	O	NOUN	O
showed	O	VERB	O
that	O	SCONJ	O
both	O	CCONJ	O
the	O	DET	O
RAR	B-protein	NOUN	B
(	O	PUNCT	O
Ro	O	NOUN	B
13-7410	O	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
RXR	B-protein	NOUN	B
(	O	PUNCT	O
Ro	O	NOUN	B
25-6603	O	NUM	I
and	O	CCONJ	O
Ro	O	NOUN	B
25-7386	O	NUM	I
)	O	PUNCT	O
ligands	O	NOUN	B
were	O	AUX	O
highly	O	ADV	O
selective	O	ADJ	O
at	O	ADP	O
100	O	NUM	O
nmol/L	O	NOUN	O
.	O	PUNCT	O


By	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
AM580	O	NOUN	B
is	O	AUX	O
not	O	PART	O
effective	O	ADJ	O
as	O	ADP	O
ATRA	O	NOUN	B
in	O	ADP	O
modulating	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
these	O	DET	O
differentiation	B-protein	NOUN	B
markers	I-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
HL-60	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
and	O	CCONJ	O
in	O	ADP	O
freshly	B-cell_type	ADV	O
isolated	I-cell_type	VERB	B
granulocytes	I-cell_type	NOUN	O
obtained	O	VERB	O
from	O	ADP	O
the	O	DET	O
peripheral	O	ADJ	B
blood	O	NOUN	I
of	O	ADP	O
chronic	O	ADJ	B
myelogenous	O	ADJ	I
leukemia	O	NOUN	I
patients	O	NOUN	B
during	O	ADP	O
the	O	DET	O
stable	O	ADJ	B
phase	O	NOUN	B
of	O	ADP	O
the	O	DET	O
disease	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
show	O	VERB	O
that	O	SCONJ	O
AM580	O	NOUN	B
is	O	AUX	O
more	O	ADV	O
powerful	O	ADJ	O
than	O	ADP	O
ATRA	O	NOUN	B
in	O	ADP	O
modulating	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
differentiation	O	NOUN	B
antigens	O	NOUN	B
only	O	ADV	O
in	O	ADP	O
cells	O	NOUN	B
in	O	ADP	O
which	O	DET	O
PML-RAR	B-protein	NOUN	B
is	O	AUX	O
present	O	ADJ	O
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
PML-RAR	B-protein	NOUN	B
,	O	PUNCT	O
the	O	DET	O
synthetic	O	ADJ	B
retinoid	O	NOUN	B
is	O	AUX	O
a	O	DET	O
much	O	ADV	O
better	O	ADJ	O
transactivator	O	NOUN	B
of	O	ADP	O
retinoic	B-DNA	ADJ	B
acid-responsive	I-DNA	ADJ	I
element-containing	I-DNA	ADJ	I
promoters	I-DNA	NOUN	I
than	O	ADP	O
the	O	DET	O
natural	O	ADJ	B
retinoid	O	NOUN	B
,	O	PUNCT	O
whereas	O	SCONJ	O
,	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
RAR	B-protein	NOUN	B
alpha	I-protein	NOUN	I
,	O	PUNCT	O
AM580	O	NOUN	B
and	O	CCONJ	O
ATRA	O	NOUN	B
have	O	AUX	O
similar	O	ADJ	O
activity	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
hypothesized	O	VERB	O
that	O	SCONJ	O
an	O	DET	O
intracellular	B-protein	ADJ	B
vitamin	I-protein	NOUN	B
D	I-protein	NOUN	I
binding	I-protein	NOUN	I
protein	I-protein	NOUN	I
(	O	PUNCT	O
IDBP	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
present	O	ADJ	O
in	O	ADP	O
both	O	CCONJ	O
nuclear	O	ADJ	B
and	O	CCONJ	O
cytoplasmic	O	ADJ	B
fractions	O	NOUN	B
of	O	ADP	O
NWP	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	B
,	O	PUNCT	O
or	O	CCONJ	O
another	O	DET	O
protein	O	NOUN	B
(	O	PUNCT	O
s	O	NOUN	O
)	O	PUNCT	O
may	O	AUX	O
cause	O	VERB	B
or	O	CCONJ	O
contribute	O	VERB	O
to	O	PART	O
the	O	DET	O
steroid	O	NOUN	B
hormone-resistant	O	ADJ	B
state	O	NOUN	I
in	O	ADP	O
NWP	B-cell_line	NOUN	B
by	O	ADP	O
disruption	O	NOUN	B
of	O	ADP	O
the	O	DET	O
receptor	O	NOUN	B
dimerization	O	NOUN	I
process	O	NOUN	I
and/or	O	CCONJ	O
by	O	ADP	O
interference	O	NOUN	B
of	O	ADP	O
receptor	B-protein	NOUN	B
complex	I-protein	NOUN	I
binding	O	VERB	B
to	O	PART	O
the	O	DET	O
consensus	B-DNA	NOUN	B
response	I-DNA	NOUN	I
elements	I-DNA	NOUN	I
present	O	ADJ	O
in	O	ADP	O
the	O	DET	O
enhancer	B-DNA	NOUN	B
regions	I-DNA	NOUN	I
of	O	ADP	O
steroid-responsive	B-DNA	ADJ	B
genes	I-DNA	NOUN	I
.	O	PUNCT	O


The	O	DET	O
extracts	O	NOUN	B
were	O	AUX	O
compared	O	VERB	B
for	O	ADP	O
their	O	PRON	O
ability	O	NOUN	O
to	O	PART	O
retard	O	VERB	B
the	O	DET	O
migration	O	NOUN	B
of	O	ADP	O
radiolabeled	O	VERB	B
double	O	ADJ	B
stranded	O	ADJ	I
oligomers	O	NOUN	I
representative	O	NOUN	O
of	O	ADP	O
the	O	DET	O
VDREs	B-DNA	NOUN	B
of	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
osteocalcin	I-DNA	NOUN	B
and	I-DNA	CCONJ	O
the	I-DNA	DET	O
mouse	I-DNA	NOUN	B
osteopontin	I-DNA	NOUN	B
gene	I-DNA	NOUN	B
promoters	I-DNA	NOUN	I
.	O	PUNCT	O


The	O	DET	O
present	O	ADJ	O
study	O	NOUN	B
shows	O	VERB	O
that	O	SCONJ	O
BCL-6	B-protein	NOUN	B
expression	O	NOUN	B
is	O	AUX	O
regulated	O	VERB	O
in	O	ADP	O
lymphocytes	B-cell_type	NOUN	B
during	O	ADP	O
mitogenic	O	ADJ	B
stimulation	O	NOUN	I
.	O	PUNCT	O


Of	O	ADP	O
these	O	DET	O
,	O	PUNCT	O
11	O	NUM	O
were	O	AUX	O
found	O	VERB	O
to	O	PART	O
possess	O	VERB	O
DNA-binding	O	ADJ	B
properties	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
resting	B-cell_type	VERB	B
T	I-cell_type	NOUN	I
lymphocytes	I-cell_type	NOUN	I
,	O	PUNCT	O
the	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
NF-kappaB	B-protein	NOUN	I
is	O	AUX	O
sequestered	O	VERB	B
in	O	ADP	O
the	O	DET	O
cytoplasm	O	NOUN	B
via	O	ADP	O
interactions	O	NOUN	B
with	O	ADP	O
members	O	NOUN	B
of	O	ADP	O
the	O	DET	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
family	I-protein	NOUN	O
of	O	ADP	O
inhibitors	O	NOUN	B
,	O	PUNCT	O
including	O	VERB	O
IkappaBalpha	B-protein	NOUN	B
and	O	CCONJ	O
IkappaBbeta	B-protein	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
to	O	PART	O
its	O	PRON	O
transient	O	ADJ	B
pattern	O	NOUN	B
of	O	ADP	O
nuclear	O	ADJ	B
induction	O	NOUN	I
during	O	ADP	O
an	O	DET	O
immune	O	ADJ	B
response	O	NOUN	I
,	O	PUNCT	O
NF-kappaB	B-protein	NOUN	B
is	O	AUX	O
constitutively	O	ADV	B
activated	O	VERB	B
in	O	ADP	O
cells	O	NOUN	B
expressing	O	VERB	B
the	O	DET	O
Tax	B-protein	NOUN	B
transforming	I-protein	NOUN	O
protein	I-protein	NOUN	O
of	O	ADP	O
human	O	ADJ	B
T-cell	O	NOUN	O
leukemia	O	NOUN	O
virus	O	NOUN	O
type	O	NOUN	O
I	O	NUM	O
(	O	PUNCT	O
HTLV-1	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
it	O	PRON	O
remains	O	VERB	O
unclear	O	ADJ	B
how	O	SCONJ	O
this	O	DET	O
viral	B-protein	ADJ	B
protein	I-protein	NOUN	I
induces	O	VERB	B
a	O	DET	O
persistent	O	ADJ	B
rather	O	ADV	O
than	O	ADP	O
transient	O	ADJ	B
NF-kappaB	B-protein	NOUN	B
response	O	NOUN	O
.	O	PUNCT	O


These	O	DET	O
findings	O	NOUN	B
with	O	ADP	O
IkappaBbeta	B-protein	NOUN	B
provide	O	VERB	O
a	O	DET	O
potential	O	ADJ	B
mechanism	O	NOUN	B
for	O	ADP	O
the	O	DET	O
constitutive	O	ADJ	B
activation	O	NOUN	B
of	O	ADP	O
NF-kappaB	B-protein	NOUN	B
in	O	ADP	O
Tax-expressing	B-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Although	O	SCONJ	O
a	O	DET	O
role	O	NOUN	O
of	O	ADP	O
p16	B-protein	NOUN	B
in	O	ADP	O
this	O	DET	O
regulation	O	NOUN	B
has	O	AUX	O
been	O	AUX	O
presumed	O	VERB	O
,	O	PUNCT	O
there	O	PRON	O
is	O	AUX	O
no	O	DET	O
proof	O	NOUN	O
so	O	ADV	O
far	O	ADV	O
that	O	SCONJ	O
loss	O	NOUN	B
of	O	ADP	O
this	O	DET	O
tumor	B-DNA	NOUN	B
suppressor	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
really	O	ADV	O
affects	O	VERB	O
E2F	B-protein	NOUN	B
-mediated	O	ADJ	O
regulations	O	NOUN	B
.	O	PUNCT	O


Transient	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
p16	B-protein	NOUN	B
in	O	ADP	O
normal	O	ADJ	O
human	O	ADJ	B
lymphocytes	O	NOUN	B
caused	O	VERB	O
arrest	O	NOUN	B
in	O	ADP	O
G1	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
was	O	AUX	O
without	O	ADP	O
effect	O	NOUN	B
on	O	ADP	O
the	O	DET	O
cell	O	NOUN	B
growth	O	NOUN	I
of	O	ADP	O
MOLT-4	B-cell_line	NOUN	B
and	I-cell_line	CCONJ	O
CEM	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
although	O	SCONJ	O
all	O	DET	O
of	O	ADP	O
them	O	PRON	O
express	O	VERB	O
functional	O	ADJ	B
retinoblastoma	B-protein	NOUN	I
protein	I-protein	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
found	O	VERB	O
that	O	SCONJ	O
ICSAT	B-protein	NOUN	B
has	O	AUX	O
a	O	DET	O
different	O	ADJ	O
repressive	O	ADJ	B
effect	O	NOUN	O
from	O	ADP	O
that	O	DET	O
of	O	ADP	O
IRF-2	B-protein	NOUN	B
or	O	CCONJ	O
ICSBP	B-protein	NOUN	B
in	O	ADP	O
some	O	DET	O
IFN-responsive	B-DNA	ADJ	B
reporter	I-DNA	NOUN	O
constructs	I-DNA	NOUN	O
.	O	PUNCT	O


H1-agonists	O	NOUN	B
(	O	PUNCT	O
histamine	O	NOUN	B
and	O	CCONJ	O
2-methylhistamine	O	NOUN	B
)	O	PUNCT	O
caused	O	VERB	O
a	O	DET	O
transient	O	ADJ	B
rise	O	NOUN	O
of	O	ADP	O
[	O	PUNCT	O
Ca2+	O	NOUN	B
]	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
H1-antagonists	O	NOUN	B
(	O	PUNCT	O
pyrilamine	O	NOUN	B
and	O	CCONJ	O
doxepin	O	NOUN	B
)	O	PUNCT	O
inhibited	O	VERB	B
the	O	DET	O
histamine-induced	O	ADJ	B
[	O	PUNCT	O
Ca2+	O	NOUN	B
]	O	PUNCT	O
i	O	PRON	O
rise	O	VERB	O
more	O	ADV	O
potently	O	ADV	B
than	O	ADP	O
the	O	DET	O
H2-antagonist	O	ADJ	B
(	O	PUNCT	O
cimetidine	O	NOUN	B
)	O	PUNCT	O
on	O	ADP	O
the	O	DET	O
H3-antagonist	O	ADJ	B
(	O	PUNCT	O
impromidine	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Binding	O	NOUN	B
parameters	O	NOUN	B
of	O	ADP	O
[	O	PUNCT	O
3H	O	NOUN	B
]	O	PUNCT	O
pyrilamine	O	NOUN	B
binding	O	NOUN	O
were	O	AUX	O
Kd	O	NOUN	O
=	O	ADJ	O
5.53	O	NUM	O
nM	O	NOUN	O
and	O	CCONJ	O
Bmax	O	NOUN	B
=	O	ADJ	O
2	O	NUM	O
,	O	PUNCT	O
647	O	NUM	O
sites/cell	O	NOUN	O
.	O	PUNCT	O


Pretreatment	O	NOUN	B
with	O	ADP	O
B.pertussis	O	NOUN	B
,	O	PUNCT	O
V.cholera.	O	NOUN	B
or	O	CCONJ	O
C.botulinum	O	NOUN	B
toxin	O	NOUN	I
did	O	AUX	O
not	O	PART	O
influence	O	VERB	B
histamine-induced	O	ADJ	B
[	O	PUNCT	O
Ca2+	O	NOUN	B
]	O	PUNCT	O
i	O	PRON	O
rise	O	VERB	O
.	O	PUNCT	O


A	O	DET	O
signal	O	NOUN	B
transduction	O	NOUN	I
pathway	O	NOUN	O
activated	O	VERB	B
by	O	ADP	O
many	O	ADJ	O
cytokines	B-protein	NOUN	B
has	O	AUX	O
recently	O	ADV	O
been	O	AUX	O
elaborated	O	VERB	O
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
report	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
describe	O	VERB	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
constitutively	O	ADV	B
activated	O	VERB	O
STAT	B-protein	NOUN	B
factors	I-protein	NOUN	I
in	O	ADP	O
peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
from	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
acute	O	ADJ	B
leukemia	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
used	O	VERB	O
oligonucleotide	O	NOUN	B
probes	O	NOUN	I
from	O	ADP	O
the	O	DET	O
beta-casein	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
IRF-1	I-DNA	NOUN	B
gene	I-DNA	NOUN	B
promoters	I-DNA	NOUN	I
and	O	CCONJ	O
the	O	DET	O
ISRE	O	NOUN	B
probe	O	NOUN	I
to	O	PART	O
detect	O	VERB	B
STAT	B-protein	NOUN	B
proteins	I-protein	NOUN	I
in	O	ADP	O
nuclear	O	ADJ	B
extracts	O	NOUN	I
from	O	ADP	O
acute	B-cell_type	ADJ	B
leukemia	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	B
in	O	ADP	O
bandshift	O	NOUN	B
assays	O	NOUN	I
.	O	PUNCT	O


It	O	PRON	O
is	O	AUX	O
likely	O	ADJ	O
that	O	SCONJ	O
the	O	DET	O
constitutive	O	ADJ	B
activation	O	NOUN	B
of	O	ADP	O
STAT	B-protein	NOUN	B
proteins	I-protein	NOUN	I
is	O	AUX	O
a	O	DET	O
part	O	NOUN	O
of	O	ADP	O
the	O	DET	O
events	O	NOUN	B
of	O	ADP	O
leukemogenesis	O	NOUN	B
.	O	PUNCT	O


An	O	DET	O
element	B-DNA	NOUN	B
upstream	O	ADJ	B
from	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
delta-globin-encoding	I-DNA	ADJ	I
gene	I-DNA	NOUN	I
specifically	O	ADV	O
enhances	O	VERB	O
beta-globin	B-DNA	NOUN	B
reporter	I-DNA	NOUN	I
gene	I-DNA	NOUN	B
expression	O	NOUN	I
in	O	ADP	O
murine	B-cell_type	ADJ	B
erythroleukemia	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
previously	O	ADV	O
shown	O	VERB	O
that	O	SCONJ	O
a	O	DET	O
DNA-binding	B-protein	ADJ	B
factor	I-protein	NOUN	I
specific	O	ADJ	O
to	O	PART	O
adult	B-cell_type	ADJ	B
hematopoietic	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
(	O	PUNCT	O
polypryrimidine-binding	B-protein	ADJ	B
factor	I-protein	NOUN	I
,	O	PUNCT	O
PYBF	B-protein	NOUN	B
)	O	PUNCT	O
binds	O	VERB	B
to	O	PART	O
a	O	DET	O
pyrimidine-rich	B-DNA	ADJ	B
region	I-DNA	NOUN	I
1	B-DNA	NUM	I
kb	I-DNA	NOUN	I
upstream	I-DNA	ADJ	I
from	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
delta-globin-encoding	I-DNA	ADJ	I
gene	I-DNA	NOUN	I
(	O	PUNCT	O
HBD	B-DNA	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Here	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
describe	O	VERB	O
the	O	DET	O
characterization	O	NOUN	B
of	O	ADP	O
an	O	DET	O
alternatively	O	ADV	O
spliced	O	VERB	B
variant	O	NOUN	O
of	O	ADP	O
Spi-B	B-protein	NOUN	B
,	O	PUNCT	O
named	O	VERB	O
deltaSpi-B	B-protein	NOUN	B
,	O	PUNCT	O
which	O	DET	O
has	O	AUX	O
lost	O	VERB	O
the	O	DET	O
Ets	B-protein	NOUN	B
domain	I-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
class	B-protein	NOUN	B
II	I-protein	NUM	I
transactivator	I-protein	NOUN	I
(	O	PUNCT	O
CIITA	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
B	B-protein	NOUN	B
cell	I-protein	NOUN	I
octamer-binding	I-protein	ADJ	I
protein	I-protein	NOUN	I
1/octamer-binding	I-protein	ADJ	O
factor	I-protein	NOUN	O
1/Oct	I-protein	NUM	O
coactivator	I-protein	NOUN	B
from	O	ADP	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
(	O	PUNCT	O
Bob1/OBF-1/OCA-B	B-protein	NOUN	B
)	O	PUNCT	O
represent	O	VERB	O
two	O	NUM	O
B	B-protein	NOUN	O
cell-specific	I-protein	ADJ	O
transcriptional	I-protein	ADJ	O
coactivators	I-protein	NOUN	O
.	O	PUNCT	O


Ten	O	NUM	O
mutants	O	NOUN	B
of	O	ADP	O
the	O	DET	O
simian	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
(	O	PUNCT	O
SIV	O	NOUN	B
)	O	PUNCT	O
SIVmac239	O	NOUN	B
bearing	O	VERB	O
deletions	O	NOUN	B
(	O	PUNCT	O
delta	O	NOUN	B
)	O	PUNCT	O
or	O	CCONJ	O
substitutions	O	NOUN	B
(	O	PUNCT	O
subst	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
NF-kappaB	B-DNA	NOUN	B
and/or	O	CCONJ	O
Sp1	B-DNA	NOUN	B
binding	I-DNA	NOUN	B
elements	I-DNA	NOUN	I
were	O	AUX	O
created	O	VERB	O
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
replicative	O	ADJ	B
capacities	O	NOUN	B
of	O	ADP	O
the	O	DET	O
mutants	O	NOUN	B
were	O	AUX	O
analyzed	O	VERB	B
.	O	PUNCT	O


One	O	NUM	O
group	O	NOUN	B
of	O	ADP	O
mutants	O	NOUN	B
replicated	O	VERB	B
very	O	ADV	O
similarly	O	ADV	O
to	O	PART	O
SIVmac239	O	NOUN	B
in	O	ADP	O
kinetics	O	NOUN	B
and	O	CCONJ	O
yield	O	NOUN	B
in	O	ADP	O
CEMxl74	B-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
(	O	PUNCT	O
2x	O	NOUN	O
NFKappaB	B-protein	NOUN	B
>	O	X	O
or	O	CCONJ	O
=	O	ADJ	O
SlVmac239	B-protein	NOUN	B
approximately	O	ADV	O
deltaNFkappaB	B-protein	VERB	O
approximately	O	ADV	O
deltaSpl234	B-protein	NOUN	O
approximately	O	ADV	O
substNFkappaB	B-protein	VERB	O
approximately	O	ADV	O
substSpl2	B-protein	VERB	O
approximately	O	ADV	B
substSp23	B-protein	X	B
)	O	PUNCT	O
,	O	PUNCT	O
while	O	SCONJ	O
a	O	DET	O
second	O	ADJ	O
group	O	NOUN	B
replicated	O	VERB	B
with	O	ADP	O
delayed	O	VERB	B
or	O	CCONJ	O
slightly	O	ADV	O
delayed	O	VERB	B
kinetics	O	NOUN	B
in	O	ADP	O
CEMxl74	B-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
(	O	PUNCT	O
SIVmac239	O	NOUN	B
>	O	X	O
substSp34	B-protein	X	B
>	O	X	O
deltaNFkappaBdeltaSpl234	B-protein	VERB	O
approximately	O	ADV	O
deltaNFkappaBdeltaSp1	B-protein	VERB	B
>	O	X	O
substSpl234	B-protein	PROPN	B
)	O	PUNCT	O
.	O	PUNCT	O


This	O	DET	O
region	O	NOUN	B
is	O	AUX	O
responsive	O	ADJ	O
to	O	PART	O
transactivation	O	NOUN	B
by	O	ADP	O
Tat	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
Epstein-Barr	B-protein	ADJ	B
virus-encoded	I-protein	ADJ	I
nuclear	I-protein	ADJ	I
antigen	I-protein	NOUN	I
EBNA-5	I-protein	NOUN	B
accumulates	O	VERB	B
in	O	ADP	O
PML-containing	O	ADJ	B
bodies	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
nuclei	O	NOUN	B
of	O	ADP	O
EBV-transformed	B-cell_line	ADJ	B
lymphoblastoid	I-cell_line	ADJ	I
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
EBNA-5	B-protein	NOUN	B
is	O	AUX	O
preferentially	O	ADV	O
targetted	O	VERB	O
to	O	PART	O
distinct	O	ADJ	O
nuclear	O	ADJ	B
foci	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
model	O	NOUN	B
of	O	ADP	O
latent	O	ADJ	B
adenovirus	O	NOUN	I
5	O	NUM	I
infection	O	NOUN	B
in	O	ADP	O
the	O	DET	O
guinea	O	NOUN	B
pig	O	NOUN	B
(	O	PUNCT	O
Cavia	O	NOUN	B
porcellus	O	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


These	O	DET	O
stable	O	ADJ	O
Jurkat	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
clones	I-cell_line	NOUN	O
provide	O	VERB	O
a	O	DET	O
convenient	O	ADJ	B
and	O	CCONJ	O
sensitive	O	ADJ	B
tool	O	NOUN	O
to	O	PART	O
study	O	VERB	B
NFAT	B-protein	NOUN	B
regulation	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
possibility	O	NOUN	O
that	O	SCONJ	O
Oct-2a	B-protein	NOUN	B
can	O	AUX	O
act	O	VERB	O
as	O	ADP	O
an	O	DET	O
activator	O	NOUN	B
and/or	O	CCONJ	O
a	O	DET	O
repressor	O	NOUN	B
may	O	AUX	O
have	O	AUX	O
important	O	ADJ	O
consequences	O	NOUN	B
for	O	ADP	O
the	O	DET	O
function	O	NOUN	B
of	O	ADP	O
Oct-2a	B-protein	NOUN	B
in	O	ADP	O
B	O	NOUN	B
cell	O	NOUN	I
differentiation	O	NOUN	I
and	O	CCONJ	O
other	O	ADJ	O
developmental	O	ADJ	B
processes	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
first	O	ADJ	O
was	O	AUX	O
to	O	PART	O
abruptly	O	ADV	O
terminate	O	VERB	B
tumor	O	NOUN	B
necrosis	O	NOUN	I
factor-induced	O	ADJ	O
NF-kappaB	B-protein	NOUN	B
binding	O	NOUN	I
to	O	PART	O
the	O	DET	O
enhancer	O	NOUN	B
sequences	O	NOUN	I
in	O	ADP	O
U1	O	NOUN	B
monocytic	O	ADJ	I
cells	O	NOUN	I
,	O	PUNCT	O
using	O	VERB	O
a	O	DET	O
short	O	ADJ	B
pulse	O	NOUN	I
of	O	ADP	O
exogenous	B-protein	ADJ	B
tumor	I-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor	I-protein	NOUN	I
.	O	PUNCT	O


Exogenous	O	ADJ	B
IL-2	B-protein	NOUN	B
,	O	PUNCT	O
which	O	DET	O
restitutes	O	VERB	B
the	O	DET	O
proliferative	O	ADJ	B
response	O	NOUN	I
of	O	ADP	O
the	O	DET	O
anti-CD3-	B-cell_line	NOUN	B
and	I-cell_line	CCONJ	O
anti-CD28-treated	I-cell_line	ADJ	B
Rel-/-	I-cell_line	ADJ	B
T	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
restores	O	VERB	B
production	O	NOUN	B
of	O	ADP	O
IL-5	O	NOUN	B
,	O	PUNCT	O
TNF-alpha	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
IFN-gamma	B-protein	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
IL-3	B-protein	NOUN	B
and	O	CCONJ	O
GM-CSF	B-protein	NOUN	B
expression	O	NOUN	B
to	O	PART	O
approximately	O	ADV	O
normal	O	ADJ	O
levels	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
IL-2	B-protein	NOUN	B
enhancer	O	NOUN	I
contains	O	VERB	O
a	O	DET	O
functional	O	ADJ	B
motif	O	NOUN	B
named	O	VERB	O
CD28	B-DNA	NOUN	B
response	I-DNA	NOUN	I
element	I-DNA	NOUN	I
(	O	PUNCT	O
CD28RE	B-DNA	NOUN	B
)	O	PUNCT	O
that	O	PRON	O
serves	O	VERB	O
a	O	DET	O
role	O	NOUN	O
as	O	ADP	O
a	O	DET	O
target	O	NOUN	B
for	O	ADP	O
mitogenic	O	ADJ	B
T	O	NOUN	I
cell	O	NOUN	I
activation	O	NOUN	B
signals	O	NOUN	O
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
CD28RE	B-DNA	NOUN	B
binds	O	VERB	B
an	O	DET	O
inducible	O	ADJ	B
protein	O	NOUN	I
with	O	ADP	O
a	O	DET	O
molecular	O	ADJ	B
mass	O	NOUN	I
of	O	ADP	O
approximately	O	ADV	O
35	O	NUM	O
kDa	O	NOUN	O
called	O	VERB	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
of	I-protein	ADP	O
mitogenic-activated	I-protein	ADJ	B
T	I-protein	NOUN	I
cells	I-protein	NOUN	I
(	O	PUNCT	O
NF-MATp35	B-protein	NOUN	B
)	O	PUNCT	O
that	O	PRON	O
is	O	AUX	O
clearly	O	ADV	O
different	O	ADJ	O
from	O	ADP	O
the	O	DET	O
known	O	ADJ	O
NF-	B-protein	NOUN	B
kappaB/Rel	I-protein	NOUN	O
family	I-protein	NOUN	B
members	I-protein	NOUN	I
.	O	PUNCT	O


Studies	O	NOUN	B
included	O	VERB	O
structural	O	ADJ	B
comparison	O	NOUN	B
of	O	ADP	O
the	O	DET	O
promoters	O	NOUN	B
for	O	ADP	O
human	O	ADJ	B
and	O	CCONJ	O
mouse	O	NOUN	B
inducible	B-DNA	ADJ	O
NO	I-DNA	NOUN	O
synthase	I-DNA	NOUN	O
(	I-DNA	PUNCT	O
iNOS	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
genes	I-DNA	NOUN	O
,	O	PUNCT	O
transfection	O	NOUN	B
and	O	CCONJ	O
assay	O	NOUN	B
of	O	ADP	O
human	O	ADJ	B
and	O	CCONJ	O
mouse	O	NOUN	B
iNOS	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
regions	I-DNA	NOUN	I
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
LPS	O	NOUN	B
+/-	O	CCONJ	O
IFN-gamma	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assays	O	NOUN	I
of	O	ADP	O
kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
response	I-DNA	NOUN	I
elements	I-DNA	NOUN	I
.	O	PUNCT	O


Viral	B-DNA	ADJ	B
DNA	I-DNA	NOUN	I
fragments	I-DNA	NOUN	I
that	O	PRON	O
potentially	O	ADV	O
contain	O	VERB	O
oriP	B-DNA	NOUN	B
were	O	AUX	O
cloned	O	VERB	B
into	O	ADP	O
a	O	DET	O
plasmid	B-DNA	NOUN	B
that	O	PRON	O
contains	O	VERB	O
the	O	DET	O
hygromycin	B-DNA	NOUN	B
resistance	I-DNA	NOUN	B
gene	I-DNA	NOUN	I
.	O	PUNCT	O


In	O	X	B
vivo	O	X	I
,	O	PUNCT	O
anergy	O	NOUN	B
has	O	AUX	O
mainly	O	ADV	O
been	O	AUX	O
studied	O	VERB	O
at	O	ADP	O
the	O	DET	O
cellular	O	ADJ	B
level	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
repeated	O	ADJ	O
injections	O	NOUN	B
of	O	ADP	O
SEA	B-protein	NOUN	B
cause	O	VERB	O
CD4+	B-cell_type	ADJ	B
T-cell	I-cell_type	NOUN	I
deletion	O	NOUN	B
and	O	CCONJ	O
anergy	O	NOUN	B
in	O	ADP	O
the	O	DET	O
remaining	O	VERB	O
CD4+	O	ADJ	B
T	B-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
characterized	O	VERB	B
by	O	ADP	O
reduced	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
IL-2	B-protein	NOUN	B
at	O	ADP	O
mRNA	O	NOUN	B
and	O	CCONJ	O
protein	O	NOUN	B
levels	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
anergic	B-cell_type	ADJ	B
CD4+	I-cell_type	ADJ	O
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
contained	O	VERB	O
severely	O	ADV	O
reduced	O	VERB	B
levels	O	NOUN	B
of	O	ADP	O
AP-1	B-protein	NOUN	B
and	O	CCONJ	O
Fos/Jun-containing	B-protein	ADJ	B
NF-AT	I-protein	NOUN	B
complexes	I-protein	NOUN	O
but	O	CCONJ	O
expressed	O	VERB	B
significant	O	ADJ	O
amounts	O	NOUN	O
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
and	O	CCONJ	O
Oct	B-protein	NOUN	B
binding	I-protein	NOUN	I
proteins	I-protein	NOUN	I
after	O	ADP	O
SEA	B-protein	NOUN	B
stimulation	O	NOUN	B
.	O	PUNCT	O


Resolution	O	NOUN	B
of	O	ADP	O
the	O	DET	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
complex	I-protein	NOUN	I
demonstrated	O	VERB	O
predominant	O	ADJ	O
expression	O	NOUN	B
of	O	ADP	O
p50-p65	B-protein	NOUN	B
heterodimers	I-protein	NOUN	I
in	O	ADP	O
activated	B-cell_type	VERB	B
CD4+	I-cell_type	ADJ	B
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
while	O	SCONJ	O
anergic	O	ADJ	B
cells	O	NOUN	I
mainly	O	ADV	O
expressed	O	VERB	B
the	O	DET	O
transcriptionally	O	ADV	B
inactive	O	ADJ	B
p50	B-protein	NOUN	B
homodimer	I-protein	NOUN	I
.	O	PUNCT	O


Fas	B-protein	NOUN	B
ligation	O	NOUN	I
induces	O	VERB	B
apoptosis	O	NOUN	B
and	O	CCONJ	O
Jun	B-protein	NOUN	B
kinase	I-protein	NOUN	I
activation	O	NOUN	B
independently	O	ADV	O
of	O	ADP	O
CD45	B-protein	NOUN	B
and	O	CCONJ	O
Lck	B-protein	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


More	O	ADJ	O
is	O	AUX	O
known	O	VERB	O
regarding	O	VERB	O
signal	O	NOUN	B
transduction	O	NOUN	I
events	O	NOUN	O
that	O	PRON	O
occur	O	VERB	O
after	O	ADP	O
ligation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
T-cell	B-protein	NOUN	B
antigen	I-protein	NOUN	I
receptor	I-protein	NOUN	I
(	O	PUNCT	O
TCR	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


It	O	PRON	O
has	O	AUX	O
been	O	AUX	O
shown	O	VERB	O
that	O	SCONJ	O
TCR	B-protein	NOUN	B
stimulation	O	NOUN	B
requires	O	VERB	O
both	O	CCONJ	O
the	O	DET	O
membrane	B-protein	NOUN	B
tyrosine	I-protein	NOUN	I
phosphatase	I-protein	NOUN	I
,	O	PUNCT	O
CD45	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
Src-family	B-protein	NOUN	B
kinase	I-protein	NOUN	I
,	O	PUNCT	O
Lck	B-protein	NOUN	B
,	O	PUNCT	O
to	O	PART	O
result	O	VERB	O
in	O	ADP	O
cellular	O	ADJ	B
activation	O	NOUN	I
.	O	PUNCT	O


Our	O	PRON	O
data	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
although	O	SCONJ	O
CD45	B-protein	NOUN	B
and	O	CCONJ	O
Lck	B-protein	NOUN	B
are	O	AUX	O
not	O	PART	O
required	O	VERB	O
for	O	ADP	O
Fas	B-protein	NOUN	B
signaling	O	NOUN	I
,	O	PUNCT	O
JNK	B-protein	NOUN	B
activation	O	NOUN	B
may	O	AUX	O
play	O	VERB	O
an	O	DET	O
important	O	ADJ	O
role	O	NOUN	O
transducing	O	VERB	O
distal	O	ADJ	O
signals	O	NOUN	B
that	O	PRON	O
lead	O	VERB	O
to	O	PART	O
apoptosis	O	NOUN	B
after	O	ADP	O
Fas	B-protein	NOUN	B
ligation	O	NOUN	I
.	O	PUNCT	O


Globin	O	NOUN	B
gene	O	NOUN	I
switching	O	NOUN	O
.	O	PUNCT	O


In	O	X	B
vivo	O	X	I
protein-DNA	O	ADJ	B
interactions	O	NOUN	B
of	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
beta-globin	I-DNA	NOUN	B
locus	I-DNA	NOUN	I
in	O	ADP	O
erythroid	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
expressing	O	VERB	B
the	O	DET	O
fetal	O	ADJ	B
or	O	CCONJ	O
the	O	DET	O
adult	O	ADJ	B
globin	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
program	O	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
in	O	X	B
vivo	O	X	I
footprints	O	NOUN	B
on	O	ADP	O
GT	B-DNA	NOUN	B
(	I-DNA	PUNCT	O
CACCC	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
motifs	I-DNA	NOUN	B
differed	O	VERB	O
between	O	ADP	O
the	O	DET	O
cells	O	NOUN	B
expressing	O	VERB	B
the	O	DET	O
fetal	O	ADJ	B
or	O	CCONJ	O
the	O	DET	O
adult	O	ADJ	B
globin	O	NOUN	B
program	O	NOUN	I
.	O	PUNCT	O


Antisense	O	ADJ	B
inhibition	O	NOUN	I
of	O	ADP	O
vitamin	B-protein	NOUN	B
D	I-protein	NOUN	I
receptor	I-protein	NOUN	I
expression	O	NOUN	B
induces	O	VERB	O
apoptosis	O	NOUN	B
in	O	ADP	O
monoblastoid	B-cell_line	ADJ	B
U937	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


A	O	DET	O
considerable	O	ADJ	O
proportion	O	NOUN	B
of	O	ADP	O
cells	O	NOUN	B
were	O	AUX	O
outside	O	ADP	O
the	O	DET	O
cycle	O	NOUN	B
and	O	CCONJ	O
DNA	O	NOUN	B
fragmentation	O	NOUN	I
confirmed	O	VERB	O
apoptosis	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
now	O	ADV	O
report	O	VERB	O
that	O	SCONJ	O
galectin-3	B-protein	NOUN	B
is	O	AUX	O
abundantly	O	ADV	O
expressed	O	VERB	B
in	O	ADP	O
a	O	DET	O
number	O	NOUN	O
of	O	ADP	O
human	B-cell_line	ADJ	B
T	I-cell_line	NOUN	O
lymphotropic	I-cell_line	ADJ	O
virus	I-cell_line	NOUN	O
(	I-cell_line	PUNCT	O
HTLV	I-cell_line	NOUN	B
)	I-cell_line	PUNCT	O
-I-infected	I-cell_line	ADJ	O
human	I-cell_line	ADJ	B
T	I-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
F6T	B-cell_line	NOUN	B
,	O	PUNCT	O
HUT	B-cell_line	NOUN	B
102	I-cell_line	NUM	O
,	O	PUNCT	O
K3T	B-cell_line	NOUN	B
,	O	PUNCT	O
MT-2	B-cell_line	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
SLB-I	B-cell_line	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
is	O	AUX	O
not	O	PART	O
expressed	O	VERB	B
in	O	ADP	O
non-HTLV-I-infected	B-cell_line	ADJ	B
T	I-cell_line	NOUN	I
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
such	O	ADJ	O
as	O	ADP	O
Jurkat	B-cell_line	NOUN	B
,	O	PUNCT	O
CEM	B-cell_line	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
MOLT-4	B-cell_line	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
co-transfection	O	NOUN	B
experiments	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
galectin-3	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
was	O	AUX	O
significantly	O	ADV	O
up-regulated	O	VERB	B
by	O	ADP	O
expression	B-DNA	NOUN	B
vectors	I-DNA	NOUN	I
encoding	O	VERB	B
the	O	DET	O
40-kd	B-protein	ADJ	O
Tax	I-protein	NOUN	B
protein	I-protein	NOUN	I
,	O	PUNCT	O
a	O	DET	O
potent	O	ADJ	O
transactivator	O	NOUN	B
in	O	ADP	O
HTLV-I	O	NOUN	B
.	O	PUNCT	O


Nuclear	O	ADJ	B
extracts	O	NOUN	I
from	O	ADP	O
LPS	O	NOUN	B
-and	O	NOUN	O
zymosan-treated	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
showed	O	VERB	O
strong	O	ADJ	O
AP-1	B-protein	NOUN	B
activity	O	NOUN	I
by	O	ADP	O
gel-shift	O	ADJ	B
analysis	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
supershift	O	NOUN	B
analysis	O	NOUN	I
showed	O	VERB	O
the	O	DET	O
AP-1	B-protein	NOUN	B
complexes	I-protein	NOUN	I
contained	O	VERB	O
specific	O	ADJ	O
members	O	NOUN	B
of	O	ADP	O
both	O	CCONJ	O
the	O	DET	O
jun	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
fos	I-DNA	NOUN	B
gene	I-DNA	NOUN	I
families	I-DNA	NOUN	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
as	O	ADP	O
compared	O	VERB	O
to	O	PART	O
regulation	O	NOUN	B
by	O	ADP	O
phorbol	O	NOUN	B
ester	O	NOUN	I
,	O	PUNCT	O
collagenase	B-protein	NOUN	B
induction	O	NOUN	B
in	O	ADP	O
monocytic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
by	O	ADP	O
cell	O	NOUN	B
wall	O	NOUN	I
derivatives	O	NOUN	I
of	O	ADP	O
bacteria	O	NOUN	B
or	O	CCONJ	O
yeast	O	NOUN	B
is	O	AUX	O
largely	O	ADV	O
independent	O	ADJ	B
of	O	ADP	O
upstream	B-DNA	ADJ	B
promoter	I-DNA	NOUN	B
sequences	I-DNA	NOUN	I
.	O	PUNCT	O


As	O	ADP	O
AP-1	B-protein	NOUN	B
activity	O	NOUN	I
is	O	AUX	O
regulated	O	VERB	O
in	O	ADP	O
part	O	NOUN	O
by	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
c-Jun	B-protein	NOUN	B
N-terminal	I-protein	ADJ	I
kinase	I-protein	NOUN	I
(	O	PUNCT	O
JNK	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
which	O	DET	O
phosphorylates	O	VERB	B
and	O	CCONJ	O
subsequently	O	ADV	O
increases	O	VERB	B
the	O	DET	O
transcriptional	O	ADJ	B
activity	O	NOUN	I
of	O	ADP	O
c-Jun	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
examined	O	VERB	O
whether	O	SCONJ	O
LPS	O	NOUN	B
treatment	O	NOUN	B
of	O	ADP	O
macrophages	B-cell_type	NOUN	B
resulted	O	VERB	O
in	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
this	O	DET	O
kinase	B-protein	NOUN	B
.	O	PUNCT	O


Further	O	ADJ	O
addition	O	NOUN	O
of	O	ADP	O
E220K	B-protein	NOUN	B
significantly	O	ADV	O
enhanced	O	VERB	B
ubiquitinylation	O	NOUN	B
of	O	ADP	O
c-Jun	B-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
heterodimer	O	NOUN	B
suggesting	O	VERB	O
a	O	DET	O
regulatory	O	ADJ	O
role	O	NOUN	O
of	O	ADP	O
E220K	B-protein	NOUN	B
.	O	PUNCT	O


From	O	ADP	O
a	O	DET	O
murine	B-DNA	ADJ	B
B-cell	I-DNA	NOUN	O
cDNA-library	I-DNA	NOUN	O
we	O	PRON	O
have	O	AUX	O
cloned	O	VERB	B
a	O	DET	O
cDNA	B-DNA	NOUN	B
encoding	O	VERB	B
the	O	DET	O
murine	B-protein	ADJ	B
B-cell	I-protein	NOUN	O
specific	I-protein	ADJ	O
coactivator	I-protein	NOUN	O
mBob1	B-protein	NOUN	O
.	O	PUNCT	O


mBob1	B-protein	NOUN	B
interacts	O	VERB	O
with	O	ADP	O
the	O	DET	O
octamer	B-protein	NOUN	B
transcription	I-protein	NOUN	O
factors	I-protein	NOUN	O
Oct-1	B-protein	NOUN	B
and	O	CCONJ	O
Oct-2	B-protein	NOUN	B
and	O	CCONJ	O
stimulates	O	VERB	B
transcription	O	NOUN	B
mediated	O	VERB	O
by	O	ADP	O
these	O	DET	O
factors	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
provide	O	VERB	O
new	O	ADJ	O
insights	O	NOUN	O
into	O	ADP	O
how	O	SCONJ	O
gp120	B-protein	NOUN	B
can	O	AUX	O
influence	O	VERB	B
the	O	DET	O
involvement	O	NOUN	B
of	O	ADP	O
glial	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
in	O	ADP	O
the	O	DET	O
pathogenesis	O	NOUN	B
of	O	ADP	O
AIDS	O	NOUN	B
dementia	O	NOUN	B
complex	O	NOUN	O
.	O	PUNCT	O


IL-10	B-protein	NOUN	B
is	O	AUX	O
elevated	O	ADJ	B
in	O	ADP	O
HIV-1-infected	O	ADJ	B
individuals	O	NOUN	B
and	O	CCONJ	O
has	O	AUX	O
been	O	AUX	O
implicated	O	VERB	O
in	O	ADP	O
disease	O	NOUN	B
progression	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
combination	O	NOUN	B
with	O	ADP	O
TNF-alpha	B-protein	NOUN	B
,	O	PUNCT	O
IL-10	B-protein	NOUN	B
stimulated	O	VERB	O
activating	B-protein	NOUN	O
protein-1	I-protein	NOUN	O
(	O	PUNCT	O
AP-1	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
(	I-protein	PUNCT	O
NF	I-protein	NOUN	B
)	I-protein	PUNCT	O
-kappa	I-protein	NOUN	O
B	I-protein	NOUN	B
binding	O	NOUN	I
activities	O	NOUN	I
and	O	CCONJ	O
cooperated	O	VERB	O
to	O	PART	O
increase	O	VERB	B
HIV-1	O	NOUN	B
steady-state	O	ADJ	B
mRNA	O	NOUN	B
levels	O	NOUN	O
and	O	CCONJ	O
enhance	O	VERB	B
long	B-DNA	ADJ	B
terminal	I-DNA	ADJ	I
repeat	I-DNA	NOUN	I
-directed	O	ADJ	O
transcription	O	NOUN	B
through	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
NF-kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
binding	I-DNA	NOUN	I
sites	I-DNA	NOUN	I
,	O	PUNCT	O
suggesting	O	VERB	O
the	O	DET	O
IL-10	B-protein	NOUN	B
effect	O	NOUN	B
occurs	O	VERB	O
at	O	ADP	O
least	O	ADJ	O
in	O	ADP	O
part	O	NOUN	O
at	O	ADP	O
the	O	DET	O
transcriptional	O	ADJ	B
level	O	NOUN	B
.	O	PUNCT	O


One	O	NUM	O
family	O	NOUN	B
of	O	ADP	O
host	B-protein	NOUN	B
transcription	I-protein	NOUN	B
factors	I-protein	NOUN	I
whose	O	DET	O
activity	O	NOUN	B
is	O	AUX	O
altered	O	VERB	O
by	O	ADP	O
Tax	B-protein	NOUN	B
includes	O	VERB	O
NF-kappa	B-protein	NOUN	B
B/Rel	I-protein	NOUN	B
.	O	PUNCT	O


Inhibition	O	NOUN	B
of	O	ADP	O
protein	B-protein	NOUN	B
phosphatase	I-protein	NOUN	I
2A	I-protein	NOUN	I
induces	O	VERB	O
serine/threonine	O	NOUN	B
phosphorylation	O	NOUN	B
,	O	PUNCT	O
subcellular	O	ADJ	B
redistribution	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
functional	O	ADJ	B
inhibition	O	NOUN	B
of	O	ADP	O
STAT3	B-protein	NOUN	B
.	O	PUNCT	O


Signal	B-protein	NOUN	B
transducers	I-protein	NOUN	I
and	I-protein	CCONJ	O
activators	I-protein	NOUN	B
of	I-protein	ADP	O
transcription	I-protein	NOUN	O
(	O	PUNCT	O
STATs	B-protein	NOUN	B
)	O	PUNCT	O
are	O	AUX	O
rapidly	O	ADV	O
phosphorylated	O	VERB	B
on	O	ADP	O
tyrosine	O	NOUN	B
residues	O	NOUN	I
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
cytokine	B-protein	NOUN	B
and	O	CCONJ	O
growth	B-protein	NOUN	B
factor	I-protein	NOUN	I
stimulation	O	NOUN	I
of	O	ADP	O
cell	B-protein	NOUN	B
surface	I-protein	NOUN	I
receptors	I-protein	NOUN	I
.	O	PUNCT	O


Similar	O	ADJ	O
results	O	NOUN	B
were	O	AUX	O
obtained	O	VERB	O
with	O	ADP	O
other	O	ADJ	O
PP2A	O	NOUN	B
inhibitors	O	NOUN	B
(	O	PUNCT	O
okadaic	O	ADJ	B
acid	O	NOUN	I
,	O	PUNCT	O
endothall	O	NOUN	B
thioanhydride	O	NOUN	I
)	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
with	O	ADP	O
inhibitors	O	NOUN	B
of	O	ADP	O
PP1	B-protein	NOUN	B
(	O	PUNCT	O
tautomycin	O	NOUN	B
)	O	PUNCT	O
or	O	CCONJ	O
PP2B	B-protein	NOUN	B
(	O	PUNCT	O
cyclosporine	O	NOUN	B
A	O	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


Polyamines	O	NOUN	B
in	O	ADP	O
human	O	ADJ	B
breast	O	NOUN	O
cancer	O	NOUN	O
and	O	CCONJ	O
its	O	PRON	O
relations	O	NOUN	B
to	O	PART	O
classical	O	ADJ	O
prognostic	O	ADJ	B
features	O	NOUN	O
:	O	PUNCT	O
clinical	O	ADJ	B
implications	O	NOUN	O
.	O	PUNCT	O


Nevertheless	O	ADV	O
how	O	SCONJ	O
the	O	DET	O
protective	O	ADJ	B
response	O	NOUN	I
is	O	AUX	O
exerted	O	VERB	O
by	O	ADP	O
flavonoids	O	NOUN	B
is	O	AUX	O
not	O	PART	O
well	O	ADV	O
characterized	O	VERB	B
.	O	PUNCT	O


Of	O	ADP	O
six	O	NUM	O
flavonoids	O	NOUN	B
tested	O	VERB	B
,	O	PUNCT	O
myricetin	O	NOUN	B
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
strongly	O	ADV	O
inhibit	O	VERB	B
IKK	B-protein	NOUN	B
kinase	O	NOUN	I
activity	O	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
prevent	O	VERB	B
the	O	DET	O
degradation	O	NOUN	B
of	O	ADP	O
IkappaBalpha	B-protein	NOUN	B
and	O	CCONJ	O
IkappaBbeta	B-protein	NOUN	B
in	O	ADP	O
activated	O	VERB	B
endothelial	O	ADJ	O
cells	O	NOUN	O
.	O	PUNCT	O


Phosphorylated	O	VERB	B
Bcl-2	B-protein	NOUN	I
can	O	AUX	O
not	O	PART	O
bind	O	VERB	B
calcineurin	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
NFAT	B-protein	NOUN	B
activation	O	NOUN	B
,	O	PUNCT	O
FasL	B-protein	NOUN	B
expression	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
apoptosis	O	NOUN	B
can	O	AUX	O
occur	O	VERB	O
after	O	ADP	O
Bcl-2	B-protein	NOUN	B
phosphorylation	O	NOUN	B
.	O	PUNCT	O


MHC	B-protein	NOUN	B
class	I-protein	NOUN	O
II	I-protein	NUM	O
density	O	NOUN	B
on	O	ADP	O
the	O	DET	O
APC	B-cell_type	NOUN	B
was	O	AUX	O
modified	O	VERB	B
using	O	VERB	O
DQ2	B-cell_line	NOUN	B
homo	I-cell_line	NOUN	I
-and	I-cell_line	NOUN	O
heterozygous	I-cell_line	ADJ	B
B-LCLs	I-cell_line	NOUN	B
as	O	ADP	O
APCs	B-cell_type	NOUN	B
,	O	PUNCT	O
however	O	ADV	O
this	O	DET	O
variation	O	NOUN	B
of	O	ADP	O
MHC	O	NOUN	B
concentration	O	NOUN	B
had	O	AUX	O
no	O	DET	B
effect	O	NOUN	I
on	O	ADP	O
T	B-cell_type	NOUN	B
cell	I-cell_type	NOUN	I
proliferation	O	NOUN	I
.	O	PUNCT	O


It	O	PRON	O
is	O	AUX	O
interesting	O	ADJ	O
that	O	SCONJ	O
IL-11	B-protein	NOUN	B
did	O	AUX	O
not	O	PART	O
affect	O	VERB	O
BAL	O	NOUN	B
fluid	O	ADJ	B
content	O	NOUN	B
of	O	ADP	O
the	O	DET	O
CXC	B-protein	NOUN	B
chemokines	I-protein	NOUN	B
,	O	PUNCT	O
macrophage	B-protein	NOUN	B
inflammatory	I-protein	ADJ	I
protein-2	I-protein	NOUN	I
(	O	PUNCT	O
MIP-2	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
cytokine-inducible	B-protein	ADJ	B
neutrophil	I-protein	NOUN	O
chemoattractant	I-protein	NOUN	O
(	O	PUNCT	O
CINC	B-protein	NOUN	B
)	O	PUNCT	O
;	O	PUNCT	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
IL-11	B-protein	NOUN	B
did	O	AUX	O
not	O	PART	O
affect	O	VERB	O
these	O	DET	O
chemokines	B-protein	NOUN	B
.	O	PUNCT	O


Hence	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
investigated	O	VERB	B
whether	O	SCONJ	O
Stat	B-protein	NOUN	B
proteins	I-protein	NOUN	I
are	O	AUX	O
present	O	ADJ	O
in	O	ADP	O
platelets	B-cell_type	NOUN	B
and	O	CCONJ	O
,	O	PUNCT	O
if	O	SCONJ	O
so	O	ADV	O
,	O	PUNCT	O
whether	O	SCONJ	O
they	O	PRON	O
become	O	VERB	O
tyrosine	O	NOUN	B
phosphorylated	O	VERB	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
thrombopoietin	B-protein	NOUN	B
.	O	PUNCT	O


Thrombopoietin	B-protein	NOUN	B
induced	O	VERB	B
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	I
of	O	ADP	O
Stat3	B-protein	NOUN	B
and	O	CCONJ	O
Stat5	B-protein	NOUN	B
in	O	ADP	O
these	O	DET	O
cells	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
review	O	NOUN	B
suggests	O	VERB	O
roles	O	NOUN	O
for	O	ADP	O
these	O	DET	O
alterations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
development	O	NOUN	B
of	O	ADP	O
lymphoid	O	ADJ	B
neoplasms	O	NOUN	B
.	O	PUNCT	O


An	O	DET	O
understanding	O	NOUN	O
of	O	ADP	O
the	O	DET	O
mechanistic	O	ADJ	B
consequences	O	NOUN	B
following	O	VERB	O
such	O	ADJ	O
genetic	O	ADJ	B
alterations	O	NOUN	I
is	O	AUX	O
essential	O	ADJ	O
to	O	PART	O
an	O	DET	O
understanding	O	NOUN	O
of	O	ADP	O
the	O	DET	O
development	O	NOUN	B
of	O	ADP	O
these	O	DET	O
lymphoid	O	ADJ	B
neoplasms	O	NOUN	B
.	O	PUNCT	O


Taken	O	VERB	O
together	O	ADV	O
,	O	PUNCT	O
this	O	DET	O
review	O	NOUN	B
supports	O	VERB	O
the	O	DET	O
notion	O	NOUN	O
that	O	SCONJ	O
the	O	DET	O
development	O	NOUN	B
of	O	ADP	O
lymphoid	O	ADJ	B
malignancies	O	NOUN	I
is	O	AUX	O
multifactorial	O	ADJ	B
,	O	PUNCT	O
involving	O	VERB	O
genetic	O	ADJ	B
alterations	O	NOUN	I
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
dysregulated	O	VERB	B
cytokine	B-protein	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
to	O	PART	O
its	O	PRON	O
role	O	NOUN	O
as	O	ADP	O
a	O	DET	O
precursor	O	NOUN	B
for	O	ADP	O
other	O	ADJ	O
steroid	O	NOUN	B
hormones	O	NOUN	I
,	O	PUNCT	O
DHEA	O	NOUN	B
has	O	AUX	O
been	O	AUX	O
proposed	O	VERB	O
to	O	PART	O
play	O	VERB	O
an	O	DET	O
important	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
immunity	O	NOUN	B
.	O	PUNCT	O


Cytotoxicity	B-protein	NOUN	B
markers	I-protein	NOUN	B
assessed	O	VERB	B
include	O	VERB	O
tumor	O	NOUN	B
cell	O	NOUN	I
killing	O	NOUN	O
,	O	PUNCT	O
IL-1	B-protein	NOUN	B
secretion	O	NOUN	B
,	O	PUNCT	O
reactive	O	ADJ	B
oxygen	O	NOUN	I
intermediate	O	NOUN	I
release	O	NOUN	I
,	O	PUNCT	O
nitric	B-protein	ADJ	B
oxide	I-protein	NOUN	I
synthetase	I-protein	NOUN	I
activity	O	NOUN	O
as	O	ADP	O
measured	O	VERB	B
by	O	ADP	O
the	O	DET	O
release	O	NOUN	B
of	O	ADP	O
reactive	O	ADJ	B
nitrogen	O	NOUN	I
intermediates	O	NOUN	I
,	O	PUNCT	O
complement	B-protein	NOUN	B
receptor-1	I-protein	NOUN	I
cell	I-protein	NOUN	I
surface	I-protein	NOUN	I
protein	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
TNF-alpha	B-protein	NOUN	B
protein	I-protein	NOUN	I
presence	O	NOUN	B
.	O	PUNCT	O


Finally	O	ADV	O
,	O	PUNCT	O
Scatchard	O	NOUN	B
plot	O	NOUN	I
analysis	O	NOUN	I
demonstrated	O	VERB	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
a	O	DET	O
DHEA	O	NOUN	B
receptor	O	NOUN	I
in	O	ADP	O
monocytes	B-cell_type	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
DHEA	O	NOUN	B
effects	O	NOUN	B
on	O	ADP	O
LPS-stimulated	B-cell_line	ADJ	B
monocytes	I-cell_line	NOUN	B
are	O	AUX	O
mediated	O	VERB	O
through	O	ADP	O
a	O	DET	O
receptor-dependent	O	ADJ	B
process	O	NOUN	I
.	O	PUNCT	O


IL-4	B-protein	NOUN	B
activates	O	VERB	B
gene	O	NOUN	B
expression	O	NOUN	I
by	O	ADP	O
inducing	O	VERB	O
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	B
,	O	PUNCT	O
homodimerization	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
nuclear	O	ADJ	B
translocation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
latent	B-protein	ADJ	B
transcription	I-protein	NOUN	O
factor	I-protein	NOUN	O
,	O	PUNCT	O
STAT6	B-protein	NOUN	B
(	O	PUNCT	O
signal	B-protein	NOUN	B
transducer	I-protein	NOUN	I
and	I-protein	CCONJ	I
activator	I-protein	NOUN	O
of	I-protein	ADP	O
transcription-6	I-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


This	O	DET	O
inhibition	O	NOUN	B
was	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
decreased	O	VERB	B
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	B
and	O	CCONJ	O
nuclear	O	ADJ	B
translocation	O	NOUN	I
of	O	ADP	O
STAT6	B-protein	NOUN	B
and	O	CCONJ	O
was	O	AUX	O
not	O	PART	O
evident	O	ADJ	O
unless	O	SCONJ	O
the	O	DET	O
cells	O	NOUN	B
were	O	AUX	O
preincubated	O	VERB	B
with	O	ADP	O
IFN	B-protein	NOUN	B
for	O	ADP	O
at	O	ADP	O
least	O	ADJ	O
1	O	NUM	O
hr	O	NOUN	O
before	O	ADP	O
IL-4	B-protein	NOUN	B
stimulation	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
further	O	ADV	O
explored	O	VERB	O
the	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
dopamine	O	NOUN	B
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
phorbol	O	NOUN	B
esters	O	NOUN	I
or	O	CCONJ	O
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor-alpha	I-protein	NOUN	I
(	O	PUNCT	O
TNF-alpha	B-protein	NOUN	B
)	O	PUNCT	O
known	O	VERB	O
to	O	PART	O
activate	O	VERB	B
NF-kappaB	B-protein	NOUN	B
.	O	PUNCT	O


Selective	O	ADJ	O
DNA-binding	O	ADJ	B
activity	O	NOUN	O
of	O	ADP	O
interleukin-10-stimulated	B-protein	ADJ	O
STAT	I-protein	NOUN	B
molecules	I-protein	NOUN	I
in	O	ADP	O
human	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


Peptides	O	NOUN	B
derived	O	VERB	O
from	O	ADP	O
the	O	DET	O
HSV-2	B-protein	NOUN	B
VP16	I-protein	NOUN	B
protein	I-protein	NOUN	I
were	O	AUX	O
utilized	O	VERB	O
for	O	ADP	O
studies	O	NOUN	B
of	O	ADP	O
peptide	O	NOUN	B
binding	O	VERB	I
to	O	PART	O
DQ0302	O	NOUN	B
molecules	O	NOUN	B
and	O	CCONJ	O
T	O	NOUN	B
cell	O	NOUN	I
activation	O	NOUN	B
at	O	ADP	O
both	O	CCONJ	O
neutral	O	ADJ	B
and	O	CCONJ	O
acidic	O	ADJ	B
pH	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
homologous	O	ADJ	B
peptide	O	NOUN	I
430-444	O	NUM	O
,	O	PUNCT	O
442A	O	NOUN	B
has	O	AUX	O
an	O	DET	O
Asp	O	NOUN	B
to	O	PART	O
Ala	O	NOUN	B
substitution	O	NOUN	I
at	O	ADP	O
position	O	NOUN	B
442	O	NUM	O
and	O	CCONJ	O
binds	O	VERB	B
to	O	PART	O
DQ0302	O	NOUN	B
with	O	ADP	O
a	O	DET	O
Kd	O	NOUN	O
similar	O	ADJ	O
to	O	PART	O
433-442	O	NUM	O
.	O	PUNCT	O


While	O	SCONJ	O
the	O	DET	O
MHC-peptide	B-protein	NOUN	B
complexes	I-protein	NOUN	B
formed	O	VERB	O
with	O	ADP	O
the	O	DET	O
native	O	ADJ	B
peptide	O	NOUN	B
are	O	AUX	O
stable	O	ADJ	B
,	O	PUNCT	O
complexes	O	NOUN	B
formed	O	VERB	O
with	O	ADP	O
the	O	DET	O
Ala-substituted	O	ADJ	B
peptide	O	NOUN	I
had	O	AUX	O
a	O	DET	O
functional	O	ADJ	B
t1/2	O	NOUN	B
of	O	ADP	O
less	O	ADJ	O
than	O	ADP	O
4	O	NUM	O
hr	O	NOUN	O
at	O	ADP	O
neutral	O	ADJ	B
pH	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
RAW264.7	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
the	O	DET	O
binding	O	NOUN	B
was	O	AUX	O
constitutive	O	ADJ	B
,	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
in	O	ADP	O
bone	B-cell_line	NOUN	B
marrow-derived	I-cell_line	ADJ	O
macrophages	I-cell_line	NOUN	B
binding	O	NOUN	B
activity	O	NOUN	I
was	O	AUX	O
shown	O	VERB	O
to	O	PART	O
be	O	AUX	O
interferon-gamma	B-protein	NOUN	B
inducible	O	ADJ	B
.	O	PUNCT	O


This	O	DET	O
may	O	AUX	O
imply	O	VERB	O
a	O	DET	O
role	O	NOUN	O
for	O	ADP	O
ets	B-protein	NOUN	B
transcription	I-protein	NOUN	I
factors	I-protein	NOUN	I
in	O	ADP	O
the	O	DET	O
production	O	NOUN	B
of	O	ADP	O
TNF-alpha	B-protein	NOUN	B
.	O	PUNCT	O


Due	O	ADP	O
to	O	ADP	O
its	O	PRON	O
location	O	NOUN	B
within	O	ADP	O
this	O	DET	O
cluster	O	NOUN	B
and	O	CCONJ	O
its	O	PRON	O
biologic	O	ADJ	B
role	O	NOUN	O
in	O	ADP	O
Ig	O	NOUN	B
class	O	NOUN	I
switching	O	NOUN	I
and	O	CCONJ	O
Th2	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	B
differentiation	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
IL-4	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
has	O	AUX	O
emerged	O	VERB	O
as	O	ADP	O
one	O	NUM	O
major	O	ADJ	O
candidate	O	NOUN	O
for	O	ADP	O
the	O	DET	O
atopy	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
support	O	NOUN	O
of	O	ADP	O
this	O	DET	O
model	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
report	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
human	B-DNA	ADJ	B
IL-4	I-DNA	NOUN	B
promoter	I-DNA	NOUN	B
exists	O	VERB	O
in	O	ADP	O
multiple	O	ADJ	B
allelic	O	ADJ	B
forms	O	NOUN	O
that	O	PRON	O
exhibit	O	VERB	O
distinct	O	ADJ	O
transcriptional	O	ADJ	B
activities	O	NOUN	I
in	O	ADP	O
IL-4-positive	B-cell_type	ADJ	B
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
EMSAs	O	NOUN	B
,	O	PUNCT	O
this	O	DET	O
substitution	O	NOUN	B
results	O	VERB	B
in	O	ADP	O
a	O	DET	O
markedly	O	ADV	O
enhanced	O	VERB	B
affinity	O	NOUN	B
for	O	ADP	O
sequence-specific	O	ADJ	B
complexes	O	NOUN	I
exhibiting	O	VERB	O
an	O	DET	O
AP-1	B-protein	NOUN	B
specificity	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
activated	O	VERB	B
T	B-cell_type	NOUN	O
lymphocytes	I-cell_type	NOUN	O
from	O	ADP	O
older	O	ADJ	B
individuals	O	NOUN	B
show	O	VERB	O
a	O	DET	O
significant	O	ADJ	O
reduction	O	NOUN	B
in	O	ADP	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
NF	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
in	O	ADP	O
response	O	NOUN	O
to	O	PART	O
the	O	DET	O
same	O	ADJ	O
stimuli	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
now	O	ADV	O
further	O	ADV	O
studied	O	VERB	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
IL-1ra	B-protein	NOUN	B
by	O	ADP	O
the	O	DET	O
major	O	ADJ	O
physiological	O	ADJ	B
human	O	ADJ	B
glucocorticoid	O	NOUN	B
,	O	PUNCT	O
cortisol	O	NOUN	B
.	O	PUNCT	O


Cell-mediated	O	ADJ	B
immunity	O	NOUN	I
plays	O	VERB	O
an	O	DET	O
essential	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
control	O	NOUN	B
of	O	ADP	I
infection	O	NOUN	O
with	O	ADP	O
the	O	DET	O
human	O	ADJ	B
cytomegalovirus	O	NOUN	I
(	O	PUNCT	O
HCMV	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
only	O	ADV	O
a	O	DET	O
few	O	ADJ	O
CD8	B-protein	NOUN	B
(	I-protein	PUNCT	O
+	I-protein	CCONJ	O
)	I-protein	PUNCT	O
-T-cell	I-protein	NOUN	O
epitopes	I-protein	NOUN	B
are	O	AUX	O
known	O	VERB	O
,	O	PUNCT	O
with	O	ADP	O
the	O	DET	O
majority	O	NOUN	O
being	O	AUX	O
contained	O	VERB	O
in	O	ADP	O
the	O	DET	O
pp65	B-protein	NOUN	B
phosphoprotein	I-protein	NOUN	I
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
believed	O	VERB	O
to	O	PART	O
dominate	O	VERB	O
the	O	DET	O
CD8	O	NOUN	B
(	O	PUNCT	O
+	O	CCONJ	O
)	O	PUNCT	O
-T-cell	O	ADJ	O
response	O	NOUN	O
to	O	PART	O
HCMV	O	NOUN	B
.	O	PUNCT	O


Here	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
readdressed	O	VERB	O
the	O	DET	O
issue	O	NOUN	B
of	O	ADP	O
CD8	B-cell_type	NOUN	B
(	I-cell_type	PUNCT	O
+	I-cell_type	CCONJ	O
)	I-cell_type	PUNCT	O
T	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
specific	O	ADJ	O
for	O	ADP	O
the	O	DET	O
72-kDa	B-protein	ADJ	O
major	I-protein	ADJ	O
immediate-early	I-protein	ADJ	B
protein	I-protein	NOUN	I
(	O	PUNCT	O
IE-1	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
nonstructural	O	ADJ	B
but	O	CCONJ	O
is	O	AUX	O
found	O	VERB	O
very	O	ADV	O
early	O	ADV	B
and	O	CCONJ	O
throughout	O	ADP	O
the	O	DET	O
replicative	O	ADJ	B
cycle	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
frequencies	O	NOUN	B
of	O	ADP	O
CD8	B-cell_type	NOUN	B
(	I-cell_type	PUNCT	O
+	I-cell_type	CCONJ	O
)	I-cell_type	PUNCT	O
T	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
directed	O	VERB	O
against	O	ADP	O
IE-1	B-protein	NOUN	B
were	O	AUX	O
similar	O	ADJ	O
to	O	PART	O
those	O	DET	O
directed	O	VERB	O
against	O	ADP	O
pp65	B-protein	NOUN	B
in	O	ADP	O
donors	O	NOUN	B
tested	O	VERB	B
with	O	ADP	O
known	O	VERB	O
pp65	B-protein	NOUN	B
-derived	O	ADJ	O
peptides	O	NOUN	B
.	O	PUNCT	O


E1A	B-DNA	NOUN	B
oncogene	I-DNA	NOUN	O
induction	O	NOUN	B
of	O	ADP	O
cellular	O	ADJ	B
susceptibility	O	NOUN	I
to	O	PART	O
killing	O	NOUN	B
by	O	ADP	O
cytolytic	B-cell_type	ADJ	B
lymphocytes	I-cell_type	NOUN	I
through	O	ADP	O
target	O	NOUN	B
cell	O	NOUN	O
sensitization	O	NOUN	O
to	O	PART	O
apoptotic	O	ADJ	B
injury	O	NOUN	I
.	O	PUNCT	O


Loss	O	NOUN	B
of	O	ADP	O
both	O	CCONJ	O
cytolytic	O	ADJ	B
susceptibility	O	NOUN	I
and	O	CCONJ	O
sensitization	O	NOUN	B
to	O	PART	O
chemically	O	ADV	B
induced	O	VERB	B
apoptosis	O	NOUN	B
was	O	AUX	O
coselected	O	VERB	B
during	O	ADP	O
in	O	X	B
vivo	O	X	I
selection	O	NOUN	B
of	O	ADP	O
E1A-positive	B-cell_type	ADJ	B
sarcoma	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
for	O	ADP	O
increased	O	VERB	B
tumorigenicity	O	NOUN	B
.	O	PUNCT	O


Copyright	O	NOUN	O
1999	O	NUM	O
Academic	O	PROPN	B
Press	O	PROPN	I
.	O	PUNCT	O


In	O	ADP	O
transient-transfection	O	ADJ	B
assays	O	NOUN	I
,	O	PUNCT	O
a	O	DET	O
Qp-CAT	B-DNA	NOUN	B
reporter	I-DNA	NOUN	I
was	O	AUX	O
activated	O	VERB	B
by	O	ADP	O
cotransfected	O	VERB	B
JAK-1	B-protein	NOUN	B
and	O	CCONJ	O
by	O	ADP	O
treatment	O	NOUN	B
of	O	ADP	O
cells	O	NOUN	B
with	O	ADP	O
the	O	DET	O
cytokine	B-protein	NOUN	B
IL-6	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
ability	O	NOUN	O
of	O	ADP	O
Qp	B-DNA	NOUN	B
to	O	PART	O
bind	O	VERB	B
signal	B-protein	NOUN	B
transducer	I-protein	NOUN	I
and	I-protein	CCONJ	O
activator	I-protein	NOUN	O
of	I-protein	ADP	O
transcription	I-protein	NOUN	O
(	I-protein	PUNCT	O
STAT	I-protein	NOUN	O
)	I-protein	PUNCT	O
proteins	I-protein	NOUN	O
was	O	AUX	O
directly	O	ADV	O
demonstrated	O	VERB	O
by	O	ADP	O
electrophoretic	O	ADJ	B
mobility-shift	O	ADJ	I
assay	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
mutation	O	NOUN	B
of	O	ADP	O
potential	O	ADJ	O
STAT-binding	B-DNA	ADJ	B
sites	I-DNA	NOUN	I
reduced	O	VERB	B
Qp	B-DNA	NOUN	B
responsiveness	O	NOUN	B
to	O	PART	O
Janus	B-protein	NOUN	B
kinase	I-protein	NOUN	I
(	I-protein	PUNCT	I
JAK	I-protein	NOUN	B
)	I-protein	PUNCT	O
-1	I-protein	NUM	O
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
previously	O	ADV	O
shown	O	VERB	O
that	O	SCONJ	O
gene	O	NOUN	B
expression	O	NOUN	I
directed	O	VERB	O
by	O	ADP	O
the	O	DET	O
HIV-1	O	NOUN	B
NF	B-DNA	NOUN	I
kappa	I-DNA	NOUN	I
B	I-DNA	NOUN	I
elements	I-DNA	NOUN	I
is	O	AUX	O
inhibited	O	VERB	B
by	O	ADP	O
CD8	B-protein	NOUN	B
+	O	CCONJ	O
cell-derived	O	ADJ	O
supernatants	O	NOUN	O
(	O	PUNCT	O
Copeland	O	PROPN	O
et	O	X	O
al.	O	X	O
,	O	PUNCT	O
AIDS	O	PROPN	B
Res	O	PROPN	I
Hum	O	PROPN	I
Retroviruses	O	PROPN	I
,	O	PUNCT	O
1995	O	NUM	O
;	O	PUNCT	O
11	O	NUM	O
:	O	PUNCT	O
1321-1326	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Inhibition	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activation	O	NOUN	B
in	O	ADP	O
human	B-cell_line	ADJ	B
T-cell	I-cell_line	NOUN	O
lines	I-cell_line	NOUN	O
by	O	ADP	O
anetholdithiolthione	O	NOUN	B
.	O	PUNCT	O


Induction	O	NOUN	B
of	O	ADP	O
endothelial	B-protein	ADJ	B
adhesion	I-protein	NOUN	I
molecules	I-protein	NOUN	I
by	O	ADP	O
the	O	DET	O
cytokine	B-protein	NOUN	B
tumor	B-protein	NOUN	O
necrosis	I-protein	NOUN	O
factor-alpha	I-protein	NOUN	O
(	O	PUNCT	O
TNF	B-protein	NOUN	B
)	O	PUNCT	O
can	O	AUX	O
occur	O	VERB	O
independently	O	ADV	O
of	O	ADP	O
protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
C	I-protein	NOUN	I
and	O	CCONJ	O
activation	O	NOUN	B
of	O	ADP	O
a	O	DET	O
protein	B-protein	NOUN	B
tyrosine	I-protein	NOUN	I
kinase	I-protein	NOUN	I
(	O	PUNCT	O
PTK	B-protein	NOUN	B
)	O	PUNCT	O
has	O	AUX	O
recently	O	ADV	O
been	O	AUX	O
implicated	O	VERB	O
in	O	ADP	O
the	O	DET	O
upregulation	O	NOUN	B
of	O	ADP	O
vascular	B-protein	ADJ	B
cell	I-protein	NOUN	I
adhesion	I-protein	NOUN	I
molecule	I-protein	NOUN	I
1	I-protein	NUM	I
(	O	PUNCT	O
VCAM-1	B-protein	NOUN	B
)	O	PUNCT	O
by	O	ADP	O
interleukin-4	B-protein	NOUN	B
(	O	PUNCT	O
IL-4	B-protein	NOUN	B
)	O	PUNCT	O
on	O	ADP	O
endothelial	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
PTK	B-protein	NOUN	B
inhibitors	O	NOUN	B
herbimycin	O	NOUN	B
A	O	NOUN	I
or	O	CCONJ	O
genistein	O	NOUN	B
suppress	O	VERB	B
induction	O	NOUN	B
of	O	ADP	O
endothelial	O	ADJ	B
VCAM-1	B-protein	NOUN	B
and	O	CCONJ	O
E-selectin	B-protein	NOUN	B
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
subsequent	O	ADJ	O
monocytic	O	ADJ	B
cell	O	NOUN	I
adhesion	O	NOUN	O
to	O	PART	O
endothelial	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
stimulated	O	VERB	B
by	O	ADP	O
TNF	B-protein	NOUN	B
.	O	PUNCT	O


Protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
C-zeta	I-protein	NOUN	B
mediates	O	VERB	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activation	O	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
immunodeficiency	I-cell_type	NOUN	I
virus-infected	I-cell_type	ADJ	I
monocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


Although	O	SCONJ	O
little	O	ADJ	O
information	O	NOUN	B
as	O	ADP	O
to	O	ADP	O
what	O	DET	O
signal	O	NOUN	B
transduction	O	NOUN	O
pathways	O	NOUN	O
mediate	O	VERB	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activation	O	NOUN	B
in	O	ADP	O
monocytes-macrophages	B-cell_type	NOUN	B
is	O	AUX	O
available	O	ADJ	O
,	O	PUNCT	O
our	O	PRON	O
previous	O	ADJ	O
work	O	NOUN	O
indicated	O	VERB	O
that	O	SCONJ	O
classical	O	ADJ	O
protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
C	I-protein	NOUN	I
(	I-protein	PUNCT	O
PKC	I-protein	NOUN	B
)	I-protein	PUNCT	O
isoenzymes	I-protein	NOUN	B
were	O	AUX	O
not	O	PART	O
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
HIV-mediated	O	ADJ	B
NF-kappa	B-protein	NOUN	I
B	I-protein	NOUN	I
activation	O	NOUN	I
.	O	PUNCT	O


Immunoblotting	O	NOUN	B
experiments	O	NOUN	B
with	O	ADP	O
U937	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
demonstrate	O	VERB	O
that	O	SCONJ	O
PKC-zeta	B-protein	NOUN	B
is	O	AUX	O
present	O	ADJ	O
in	O	ADP	O
these	O	DET	O
cells	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
its	O	PRON	O
expression	O	NOUN	B
can	O	AUX	O
be	O	AUX	O
downmodulated	O	VERB	B
by	O	ADP	O
antisense	O	ADJ	B
oligonucleotides	O	NOUN	I
(	O	PUNCT	O
AO	O	PROPN	B
)	O	PUNCT	O
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
cotransfection	O	NOUN	B
of	O	ADP	O
a	O	DET	O
negative	O	ADJ	B
dominant	O	ADJ	O
molecule	O	NOUN	O
of	O	ADP	O
PKC-zeta	B-protein	NOUN	B
(	O	PUNCT	O
PKC-zeta	B-protein	NOUN	B
mut	I-protein	NOUN	I
)	O	PUNCT	O
with	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
-dependent	O	ADJ	O
reporter	O	NOUN	B
genes	O	NOUN	I
selectively	O	ADV	O
inhibits	O	VERB	B
the	O	DET	O
HIV	O	NOUN	B
-but	O	X	O
not	O	PART	O
phorbol	O	NOUN	B
myristate	O	NOUN	I
acetate-	O	NOUN	O
or	O	CCONJ	O
lipopolysaccharide-mediated	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
.	O	PUNCT	O


Induction	O	NOUN	B
of	O	ADP	O
Bcl-x	B-protein	NOUN	B
(	I-protein	PUNCT	O
L	I-protein	NOUN	B
)	I-protein	PUNCT	O
expression	O	NOUN	B
by	O	ADP	O
human	B-protein	ADJ	B
T-cell	I-protein	NOUN	O
leukemia	I-protein	NOUN	O
virus	I-protein	NOUN	O
type	I-protein	NOUN	O
1	I-protein	NUM	O
Tax	I-protein	NOUN	B
through	O	ADP	O
NF-kappaB	B-protein	NOUN	B
in	O	ADP	O
apoptosis-resistant	B-cell_line	ADJ	B
T-cell	I-cell_line	NOUN	I
transfectants	I-cell_line	NOUN	B
with	O	ADP	O
Tax	B-protein	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
found	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
recruitment	O	NOUN	B
of	O	ADP	O
EKLF	B-protein	NOUN	B
to	O	PART	O
5'HS3	B-DNA	NOUN	B
depends	O	VERB	O
on	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
5'HS2	B-DNA	NOUN	B
in	O	ADP	O
cis	O	NOUN	O
,	O	PUNCT	O
but	O	CCONJ	O
the	O	DET	O
recruitment	O	NOUN	B
to	O	ADP	O
5'HS2	B-DNA	NOUN	B
does	O	AUX	O
not	O	PART	O
depend	O	VERB	O
on	O	ADP	O
5'HS3	B-DNA	NOUN	B
.	O	PUNCT	O


The	O	DET	O
resulting	O	VERB	O
diminished	O	VERB	B
phosphorylation	O	NOUN	B
of	O	ADP	O
c-Jun	B-protein	NOUN	B
and	O	CCONJ	O
JunD	B-protein	NOUN	B
at	O	ADP	O
their	O	PRON	O
NH	B-protein	NOUN	B
(	I-protein	PUNCT	O
2	I-protein	NUM	O
)	I-protein	PUNCT	O
-termini	I-protein	NOUN	O
decreases	O	VERB	B
the	O	DET	O
ability	O	NOUN	O
of	O	ADP	O
these	O	DET	O
nuclear	O	ADJ	B
proteins	O	NOUN	I
to	O	PART	O
autostimulate	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
c-Jun	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
JunD	I-DNA	NOUN	B
genes	I-DNA	NOUN	I
,	O	PUNCT	O
thus	O	ADV	O
leading	O	VERB	O
to	O	PART	O
lower	O	ADJ	O
production	O	NOUN	B
of	O	ADP	O
c-Jun	B-protein	NOUN	B
and	O	CCONJ	O
JunD	B-protein	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
conclusion	O	NOUN	O
,	O	PUNCT	O
we	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
CD3	B-protein	NOUN	B
ligation	O	NOUN	I
by	O	ADP	O
mAb	B-protein	NOUN	B
and	O	CCONJ	O
SE	O	NOUN	B
triggers	O	VERB	B
a	O	DET	O
rapid	O	ADJ	B
,	O	PUNCT	O
PP1	B-protein	NOUN	B
-sensitive	O	ADJ	O
tyrosine	O	NOUN	B
and	O	CCONJ	O
serine	O	NOUN	B
phosphorylation	O	NOUN	B
of	O	ADP	O
Stat3	B-protein	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
CD4+	I-cell_type	ADJ	B
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


cDNA	B-DNA	NOUN	B
microarrays	I-DNA	NOUN	I
and	O	CCONJ	O
a	O	DET	O
clustering	O	NOUN	B
algorithm	O	NOUN	I
were	O	AUX	O
used	O	VERB	O
to	O	PART	O
identify	O	VERB	O
patterns	O	NOUN	B
of	O	ADP	O
gene	O	NOUN	B
expression	O	NOUN	I
in	O	ADP	O
human	B-cell_type	ADJ	B
mammary	I-cell_type	ADJ	B
epithelial	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
growing	O	VERB	O
in	O	ADP	O
culture	O	NOUN	B
and	O	CCONJ	O
in	O	ADP	O
primary	O	ADJ	B
human	O	ADJ	B
breast	O	NOUN	B
tumors	O	NOUN	I
.	O	PUNCT	O


PPARgamma	B-protein	NOUN	B
activation	O	NOUN	B
induces	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
adipocyte	B-DNA	NOUN	B
fatty	I-DNA	ADJ	B
acid	I-DNA	NOUN	I
binding	I-DNA	NOUN	I
protein	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
in	O	ADP	O
human	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


PPARgamma	B-protein	NOUN	B
induces	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
many	O	ADJ	O
genes	B-DNA	NOUN	B
involved	O	VERB	O
in	O	ADP	O
lipid	O	NOUN	B
anabolism	O	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
the	O	DET	O
adipocyte	B-protein	NOUN	B
fatty	I-protein	ADJ	B
acid	I-protein	NOUN	I
binding	I-protein	NOUN	I
protein	I-protein	NOUN	I
(	O	PUNCT	O
aP2	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
is	O	AUX	O
a	O	DET	O
key	O	ADJ	O
regulator	O	NOUN	B
of	O	ADP	O
adipocyte	B-cell_type	NOUN	B
differentiation	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
dephosphorylation	O	NOUN	B
was	O	AUX	O
inhibited	O	VERB	B
by	O	ADP	O
treatment	O	NOUN	B
of	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
with	O	ADP	O
cyclosporin	O	NOUN	B
A	O	NOUN	I
or	O	CCONJ	O
FK506	O	NOUN	B
prior	O	ADV	O
to	O	PART	O
stimulation	O	NOUN	B
.	O	PUNCT	O


CD40	B-protein	NOUN	B
signaling	O	NOUN	B
activates	O	VERB	B
downstream	B-protein	ADJ	B
effectors	I-protein	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
the	O	DET	O
tyrosine	B-protein	NOUN	B
protein	I-protein	NOUN	I
kinase	I-protein	NOUN	I
,	O	PUNCT	O
Lyn	B-protein	NOUN	B
,	O	PUNCT	O
the	O	DET	O
phosphatidylinositol-3-kinase	B-protein	NOUN	B
(	O	PUNCT	O
PI-3	B-protein	NOUN	B
kinase	I-protein	NOUN	I
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
transcription	O	NOUN	B
factor	O	NOUN	I
,	O	PUNCT	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
activation	O	NOUN	B
is	O	AUX	O
rapid	O	ADJ	B
and	O	CCONJ	O
transient	O	ADJ	B
and	O	CCONJ	O
is	O	AUX	O
mediated	O	VERB	O
through	O	ADP	O
a	O	DET	O
cyclosporin	O	NOUN	B
A-insensitive	O	ADJ	B
pathway	O	NOUN	I
.	O	PUNCT	O


Consistent	O	ADJ	B
with	O	ADP	I
these	O	DET	O
data	O	NOUN	B
,	O	PUNCT	O
CD40	B-protein	NOUN	B
signals	O	NOUN	B
up-regulate	O	VERB	B
c-jun	B-RNA	NOUN	B
but	I-RNA	CCONJ	O
not	I-RNA	PART	O
c-fos	I-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
and	O	CCONJ	O
alter	O	VERB	O
the	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
ATF2	B-protein	NOUN	B
but	O	CCONJ	O
not	O	PART	O
the	O	DET	O
Raf-1	B-protein	NOUN	B
protein	I-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
tyrosine	B-protein	NOUN	B
phosphatase	I-protein	NOUN	I
specific	O	ADJ	O
inhibitor	O	NOUN	B
pervanadate	O	NOUN	B
is	O	AUX	O
a	O	DET	O
potent	O	ADJ	O
activator	O	NOUN	B
of	O	ADP	O
T	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
through	O	ADP	O
induction	O	NOUN	B
of	O	ADP	O
tyrosine	B-protein	NOUN	B
phosphorylation	I-protein	NOUN	I
and	O	CCONJ	O
downstream	O	ADJ	B
events	O	NOUN	O
of	O	ADP	O
the	O	DET	O
activation	O	NOUN	B
cascade	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
variety	O	NOUN	O
of	O	ADP	O
factors	O	NOUN	B
are	O	AUX	O
known	O	VERB	O
to	O	PART	O
play	O	VERB	O
a	O	DET	O
role	O	NOUN	O
in	O	ADP	O
terminal	O	ADJ	O
neutrophil	B-cell_type	NOUN	B
maturation	O	NOUN	B
,	O	PUNCT	O
including	O	VERB	O
the	O	DET	O
vitamin	O	NOUN	B
A	O	NOUN	I
derivative	O	NOUN	I
,	O	PUNCT	O
retinoic	O	ADJ	B
acid	O	NOUN	I
.	O	PUNCT	O


Rheumatoid	O	ADJ	B
arthritis	O	NOUN	I
(	O	PUNCT	O
RA	O	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
chronic	O	ADJ	B
autoimmune	O	ADJ	I
inflammatory	O	ADJ	I
disease	O	NOUN	I
in	O	ADP	O
which	O	DET	O
unknown	O	ADJ	O
arthrogenic	B-protein	ADJ	B
autoantigen	I-protein	NOUN	I
is	O	AUX	O
presented	O	VERB	O
to	O	PART	O
CD4+	B-cell_type	ADJ	B
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


The	O	DET	O
strong	O	ADJ	O
association	O	NOUN	B
of	O	ADP	O
the	O	DET	O
disease	O	NOUN	B
with	O	ADP	O
an	O	DET	O
epitope	B-protein	NOUN	B
within	O	ADP	O
the	O	DET	O
HLA-DR	B-protein	NOUN	B
chain	I-protein	NOUN	B
shared	O	VERB	O
between	O	ADP	O
various	O	ADJ	O
alleles	O	NOUN	B
of	O	ADP	O
HLA-DR4	B-protein	NOUN	B
and	O	CCONJ	O
DR1	B-protein	NOUN	B
emphasizes	O	VERB	O
the	O	DET	O
importance	O	NOUN	O
of	O	ADP	O
antigen	O	NOUN	B
presentation	O	NOUN	B
.	O	PUNCT	O


It	O	PRON	O
is	O	AUX	O
important	O	ADJ	O
to	O	PART	O
note	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
effector	O	NOUN	B
response	O	NOUN	I
is	O	AUX	O
not	O	PART	O
self-limiting	O	ADJ	B
in	O	ADP	O
RA	O	NOUN	B
autoimmune	O	ADJ	B
inflammation	O	NOUN	I
.	O	PUNCT	O


Tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor	I-protein	NOUN	I
(	O	PUNCT	O
TNF	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
interleukin-7	B-protein	NOUN	B
(	O	PUNCT	O
IL-7	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
secreted	O	VERB	B
during	O	ADP	O
this	O	DET	O
interaction	O	NOUN	B
,	O	PUNCT	O
are	O	AUX	O
critical	O	ADJ	O
cytokines	O	NOUN	B
for	O	ADP	O
HIV	B-DNA	NOUN	B
long	I-DNA	ADJ	B
terminal	I-DNA	ADJ	I
repeat	I-DNA	NOUN	I
transactivation	O	NOUN	I
through	O	ADP	O
NF-kappaB	B-protein	NOUN	B
-dependent	O	ADJ	O
activation	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
requirement	O	NOUN	B
for	O	ADP	O
TNF	B-protein	NOUN	B
is	O	AUX	O
further	O	ADV	O
confirmed	O	VERB	O
by	O	ADP	O
the	O	DET	O
observation	O	NOUN	B
that	O	SCONJ	O
the	O	DET	O
inability	O	NOUN	B
of	O	ADP	O
the	O	DET	O
intermediate	B-cell_type	ADJ	B
CD4	I-cell_type	NOUN	O
(	I-cell_type	PUNCT	O
+	I-cell_type	CCONJ	O
)	I-cell_type	PUNCT	O
CD8	I-cell_type	NOUN	B
(	I-cell_type	PUNCT	O
-	I-cell_type	PUNCT	O
)	I-cell_type	PUNCT	O
CD3	I-cell_type	NOUN	B
(	I-cell_type	PUNCT	O
-	I-cell_type	PUNCT	O
)	I-cell_type	PUNCT	O
thymocytes	I-cell_type	NOUN	B
to	O	PART	O
replicate	O	VERB	B
the	O	DET	O
virus	O	NOUN	B
is	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
a	O	DET	O
defect	O	NOUN	B
in	O	ADP	O
TNF	B-protein	NOUN	B
production	O	NOUN	B
during	O	ADP	O
their	O	PRON	O
interaction	O	NOUN	B
with	O	ADP	O
TEC	B-cell_type	NOUN	B
and	O	CCONJ	O
correlates	O	VERB	B
with	O	ADP	O
the	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
nuclear	O	ADJ	B
NF-kappaB	B-protein	NOUN	I
activity	O	NOUN	O
in	O	ADP	O
these	O	DET	O
freshly	B-cell_type	ADV	O
isolated	I-cell_type	VERB	B
thymocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


The	O	DET	O
other	O	ADJ	O
major	O	ADJ	O
subpopulation	O	NOUN	B
expressing	O	VERB	B
the	O	DET	O
CD4	B-protein	NOUN	B
receptor	I-protein	NOUN	I
,	O	PUNCT	O
namely	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
double-positive	B-cell_type	ADJ	B
(	I-cell_type	PUNCT	I
DP	I-cell_type	NOUN	I
)	I-cell_type	PUNCT	I
CD4	I-cell_type	NOUN	B
(	I-cell_type	PUNCT	O
+	I-cell_type	CCONJ	O
)	I-cell_type	PUNCT	O
CD8	I-cell_type	NOUN	B
(	I-cell_type	PUNCT	O
+	I-cell_type	CCONJ	O
)	I-cell_type	PUNCT	O
CD3	I-cell_type	NOUN	O
(	I-cell_type	PUNCT	O
+/-	I-cell_type	CCONJ	O
)	I-cell_type	PUNCT	O
thymocytes	I-cell_type	NOUN	B
,	O	PUNCT	O
despite	O	SCONJ	O
the	O	DET	O
entry	O	NOUN	B
of	O	ADP	O
the	O	DET	O
virus	O	NOUN	B
,	O	PUNCT	O
do	O	AUX	O
not	O	PART	O
produce	O	VERB	O
a	O	DET	O
significant	O	ADJ	O
level	O	NOUN	B
of	O	ADP	O
virus	O	NOUN	B
,	O	PUNCT	O
presumably	O	ADV	O
because	O	SCONJ	O
they	O	PRON	O
are	O	AUX	O
unresponsive	O	ADJ	O
to	O	PART	O
TNF	B-protein	NOUN	B
and	O	CCONJ	O
IL-7	B-protein	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
under	O	ADP	O
conditions	O	NOUN	B
of	O	ADP	O
inflammatory	O	ADJ	B
response	O	NOUN	I
after	O	ADP	O
infection	O	NOUN	B
,	O	PUNCT	O
TNF	B-protein	NOUN	B
might	O	AUX	O
also	O	ADV	O
be	O	AUX	O
present	O	ADJ	O
in	O	ADP	O
the	O	DET	O
intermediate	B-cell_type	ADJ	B
thymocyte	I-cell_type	NOUN	B
compartment	I-cell_type	NOUN	B
,	O	PUNCT	O
leading	O	VERB	O
to	O	PART	O
efficient	O	ADJ	B
HIV	O	NOUN	B
replication	O	NOUN	B
in	O	ADP	O
these	O	DET	O
cells	O	NOUN	B
.	O	PUNCT	O


Inhibition	O	NOUN	B
of	O	ADP	O
the	O	DET	O
NF-kappaB	B-protein	NOUN	B
pathway	O	NOUN	I
by	O	ADP	O
overexpression	O	NOUN	B
of	O	ADP	O
a	O	DET	O
dominant-active	O	ADJ	B
inhibitor	O	NOUN	I
of	O	ADP	O
NF-kappaB	B-protein	NOUN	B
abolished	O	VERB	O
CD40	B-protein	NOUN	B
-induced	O	ADJ	O
up-regulation	O	NOUN	B
of	O	ADP	O
both	O	CCONJ	O
the	O	DET	O
Bfl-1	B-protein	NOUN	B
and	O	CCONJ	O
Bcl-x	B-protein	NOUN	B
genes	O	NOUN	I
and	O	CCONJ	O
also	O	ADV	O
eliminated	O	VERB	O
the	O	DET	O
ability	O	NOUN	O
of	O	ADP	O
CD40	B-protein	NOUN	B
to	O	PART	O
rescue	O	VERB	O
Fas	B-protein	NOUN	B
-induced	O	ADJ	O
cell	O	NOUN	B
death	O	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
stimulation	O	NOUN	B
with	O	ADP	O
MBP	B-protein	NOUN	B
did	O	AUX	O
not	O	PART	O
produce	O	VERB	O
an	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
the	O	DET	O
binding	O	NOUN	B
activity	O	NOUN	I
of	O	ADP	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
(	I-protein	PUNCT	O
NF	I-protein	NOUN	B
)	I-protein	PUNCT	O
-kappaB	I-protein	NOUN	O
or	O	CCONJ	O
activator	B-protein	NOUN	B
protein-1	I-protein	NOUN	I
.	O	PUNCT	O


MBP	B-protein	NOUN	B
also	O	ADV	O
induced	O	VERB	B
transient	O	ADJ	B
increases	O	NOUN	B
in	O	ADP	O
mRNA	B-RNA	NOUN	B
for	O	ADP	O
macrophage	B-protein	NOUN	B
inflammatory	I-protein	ADJ	I
protein	I-protein	NOUN	I
(	I-protein	PUNCT	O
MIP	I-protein	NOUN	B
)	I-protein	PUNCT	O
-1alpha	I-protein	NOUN	B
and	O	CCONJ	O
MIP-1beta	B-protein	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
did	O	AUX	O
not	O	PART	O
stimulate	O	VERB	O
the	O	DET	O
release	O	NOUN	B
of	O	ADP	O
either	O	DET	O
chemokine	B-protein	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
show	O	VERB	O
here	O	ADV	O
,	O	PUNCT	O
that	O	SCONJ	O
expression	O	NOUN	B
of	O	ADP	O
TCL1	B-protein	NOUN	B
occurs	O	VERB	O
in	O	ADP	O
leukaemic	B-cell_type	ADJ	B
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
from	O	ADP	O
A-T	O	NOUN	B
patients	O	NOUN	B
with	O	ADP	O
chromosome	B-DNA	NOUN	B
14	I-DNA	NUM	I
rearrangements	O	NOUN	I
.	O	PUNCT	O


Expression	O	NOUN	B
of	O	ADP	O
TCL1	B-protein	NOUN	B
also	O	ADV	O
occurs	O	VERB	O
in	O	ADP	O
the	O	DET	O
preleukaemic	B-cell_type	ADJ	B
clone	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
of	O	ADP	O
A-T	O	NOUN	B
patients	O	NOUN	B
containing	O	VERB	O
the	O	DET	O
primary	O	ADJ	B
translocation	O	NOUN	B
alone	O	ADV	O
.	O	PUNCT	O


A	O	DET	O
high-affinity	O	ADJ	B
calcineurin	B-protein	NOUN	I
-binding	O	ADJ	O
peptide	O	NOUN	B
was	O	AUX	O
selected	O	VERB	O
from	O	ADP	O
combinatorial	O	ADJ	O
peptide	O	NOUN	B
libraries	O	NOUN	I
based	O	VERB	O
on	O	ADP	O
the	O	DET	O
calcineurin	B-protein	NOUN	B
docking	I-protein	NOUN	I
motif	I-protein	NOUN	I
of	O	ADP	O
NFAT	B-protein	NOUN	B
.	O	PUNCT	O


Other	O	ADJ	O
peroxisome	B-protein	NOUN	B
proliferator	I-protein	NOUN	I
activated	I-protein	ADJ	I
receptor	I-protein	NOUN	I
(	O	PUNCT	O
PPAR	B-protein	NOUN	B
)	O	PUNCT	O
ligands	O	NOUN	B
,	O	PUNCT	O
15d-PGJ	O	NOUN	B
(	O	PUNCT	O
2	O	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
troglitazone	O	NOUN	B
(	O	PUNCT	O
PPARgamma	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
Wy14	O	NOUN	B
,	O	PUNCT	O
643	O	NUM	O
(	O	PUNCT	O
PPARalpha	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
PD195599	O	NOUN	B
(	O	PUNCT	O
PPARbeta	B-protein	NOUN	B
)	O	PUNCT	O
inhibited	O	VERB	B
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
MCP-1	B-protein	NOUN	B
by	O	ADP	O
RA	O	NOUN	B
.	O	PUNCT	O


RA	O	NOUN	B
's	O	PART	O
effect	O	NOUN	B
on	O	ADP	O
MCP-1	B-protein	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
human	O	ADJ	B
elutriated	O	ADJ	B
monocytes	O	NOUN	B
were	O	AUX	O
similar	O	ADJ	O
to	O	PART	O
that	O	DET	O
observed	O	VERB	B
in	O	ADP	O
the	O	DET	O
THP-1	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


IVS1-10T	O	NOUN	B
--	O	PUNCT	O
>	O	X	O
C	O	NOUN	B
is	O	AUX	O
a	O	DET	O
unique	O	ADJ	O
BRCA1	B-DNA	NOUN	B
change	O	NOUN	B
that	O	PRON	O
occurs	O	VERB	O
in	O	ADP	O
the	O	DET	O
last	O	ADJ	O
nucleotide	O	NOUN	B
of	O	ADP	O
a	O	DET	O
consensus	B-DNA	NOUN	B
sequence	I-DNA	NOUN	I
for	O	ADP	O
a	O	DET	O
branch	B-DNA	NOUN	B
site	I-DNA	NOUN	I
critical	O	ADJ	O
for	O	ADP	O
RNA	O	NOUN	B
splicing	O	NOUN	I
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
IVS1-10T	O	NOUN	B
--	O	PUNCT	O
>	O	X	O
C	O	NOUN	B
is	O	AUX	O
not	O	PART	O
harmful	O	ADJ	O
to	O	PART	O
BRCA1	B-DNA	NOUN	B
function	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
is	O	AUX	O
classified	O	VERB	O
a	O	DET	O
benign	O	ADJ	B
polymorphism	O	NOUN	B
.	O	PUNCT	O


For	O	ADP	O
example	O	ADJ	O
dendritic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
(	O	PUNCT	O
DC	B-cell_type	NOUN	B
)	O	PUNCT	O
can	O	AUX	O
be	O	AUX	O
found	O	VERB	O
in	O	ADP	O
colonies	O	NOUN	B
of	O	ADP	O
GM-CSF-responsive	B-cell_type	ADJ	B
bone	I-cell_type	NOUN	I
marrow	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
under	O	ADP	O
experimental	O	ADJ	B
conditions	O	NOUN	I
are	O	AUX	O
routinely	O	ADV	O
expanded	O	VERB	O
as	O	ADP	O
a	O	DET	O
population	O	NOUN	B
in	O	X	B
vitro	O	X	I
from	O	ADP	O
GM-CSF-responsive	B-cell_type	ADJ	B
progenitor	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


The	O	DET	O
differentiated	O	VERB	O
DC	B-cell_type	NOUN	B
are	O	AUX	O
potent	O	ADJ	O
presenters	O	NOUN	B
of	O	ADP	O
antigen	O	NOUN	B
in	O	ADP	O
mixed	O	ADJ	O
lymphocyte	O	NOUN	B
reactions	O	NOUN	I
and	O	CCONJ	O
of	O	ADP	O
soluble	O	ADJ	B
antigen	O	NOUN	O
to	O	PART	O
specific	O	ADJ	O
T	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
.	O	PUNCT	O


A	O	DET	O
distinctive	O	ADJ	O
pattern	O	NOUN	O
of	O	ADP	O
differentially	O	ADV	B
expressed	O	VERB	B
cDNAs	B-DNA	NOUN	B
is	O	AUX	O
evident	O	ADJ	O
where	O	SCONJ	O
macrophage-specific	B-DNA	ADJ	B
cDNAs	I-DNA	NOUN	I
are	O	AUX	O
homologous	O	ADJ	B
to	O	PART	O
genes	O	NOUN	B
encoding	O	VERB	B
cytoskeletal	B-protein	ADJ	B
and	I-protein	CCONJ	O
cell-surface	I-protein	ADJ	B
proteins	I-protein	NOUN	I
,	O	PUNCT	O
whereas	O	SCONJ	O
the	O	DET	O
DC	B-cell_type	NOUN	B
-specific	O	ADJ	O
cDNAs	B-DNA	NOUN	B
are	O	AUX	O
homologous	O	ADJ	B
to	O	PART	O
signaling	B-DNA	NOUN	B
,	I-DNA	PUNCT	O
chemokine	I-DNA	NOUN	B
,	I-DNA	PUNCT	O
and	I-DNA	CCONJ	O
IFN-gamma-inducible	I-DNA	ADJ	B
genes	I-DNA	NOUN	I
.	O	PUNCT	O


Western	O	NOUN	B
blot	O	NOUN	I
analysis	O	NOUN	I
showed	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
level	O	NOUN	B
of	O	ADP	O
L.	O	X	B
pneumophila	O	X	I
RpoS	B-protein	NOUN	B
increased	O	VERB	B
in	O	ADP	O
stationary	O	ADJ	B
phase	O	NOUN	I
.	O	PUNCT	O


Monoallelic	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
Pax5	B-protein	NOUN	B
:	O	PUNCT	O
a	O	DET	O
paradigm	O	NOUN	B
for	O	ADP	O
the	O	DET	O
haploinsufficiency	O	NOUN	B
of	O	ADP	O
mammalian	B-DNA	ADJ	B
Pax	I-DNA	NOUN	B
genes	I-DNA	NOUN	I
?	O	PUNCT	O


Hence	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
diploid	O	ADJ	B
state	O	NOUN	O
of	O	ADP	O
the	O	DET	O
genome	O	NOUN	B
offers	O	VERB	O
the	O	DET	O
advantage	O	NOUN	O
that	O	SCONJ	O
a	O	DET	O
loss-of-function	O	ADJ	B
mutation	O	NOUN	O
in	O	ADP	O
one	O	NUM	O
allele	B-DNA	NOUN	B
can	O	AUX	O
be	O	AUX	O
compensated	O	VERB	B
for	O	ADP	O
by	O	ADP	O
the	O	DET	O
remaining	O	VERB	O
wild-type	B-DNA	ADJ	B
allele	I-DNA	NOUN	O
of	O	ADP	O
the	O	DET	O
same	O	ADJ	O
gene	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
allele	B-DNA	NOUN	B
-specific	O	ADJ	O
regulation	O	NOUN	B
of	O	ADP	O
Pax5	B-protein	NOUN	B
raises	O	VERB	O
the	O	DET	O
intriguing	O	ADJ	O
possibility	O	NOUN	O
that	O	SCONJ	O
monoallelic	O	ADJ	B
expression	O	NOUN	B
may	O	AUX	O
also	O	ADV	O
be	O	AUX	O
the	O	DET	O
mechanism	O	NOUN	B
causing	O	VERB	O
the	O	DET	O
haploinsufficiency	O	NOUN	B
of	O	ADP	O
other	O	ADJ	O
Pax	B-DNA	NOUN	B
genes	I-DNA	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
signal	O	NOUN	B
transduction	O	NOUN	I
of	O	ADP	O
IL-10	B-protein	NOUN	B
in	O	ADP	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
is	O	AUX	O
poorly	O	ADV	O
understood	O	VERB	O
.	O	PUNCT	O


An	O	DET	O
extensive	O	ADJ	O
immunocytochemical	O	ADJ	B
evaluation	O	NOUN	B
of	O	ADP	O
fixed	O	ADJ	B
tissues	O	NOUN	I
confirmed	O	VERB	O
MNDA	B-protein	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
normal	B-cell_type	ADJ	O
maturing	I-cell_type	VERB	B
granulocytes	I-cell_type	NOUN	B
and	O	CCONJ	O
monocytes	B-cell_type	NOUN	B
and	O	CCONJ	O
in	O	ADP	O
acute	O	ADJ	B
nonlymphocytic	O	ADJ	I
leukemias	O	NOUN	I
and	O	CCONJ	O
chronic	O	ADJ	B
myelogenous	O	ADJ	I
leukemia	O	NOUN	I
.	O	PUNCT	O


Both	O	CCONJ	O
PPAR-alpha	B-RNA	NOUN	B
and	I-RNA	CCONJ	O
PPAR-gamma	I-RNA	NOUN	B
mRNAs	I-RNA	NOUN	B
were	O	AUX	O
detected	O	VERB	B
in	O	ADP	O
HAECs	B-cell_type	NOUN	B
by	O	ADP	O
using	O	VERB	O
reverse	O	ADJ	B
transcription-polymerase	O	ADJ	I
chain	O	NOUN	I
reaction	O	NOUN	I
and	O	CCONJ	O
a	O	DET	O
ribonuclease	B-protein	NOUN	B
protection	O	NOUN	I
assay	O	NOUN	I
;	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
yet	O	ADV	O
to	O	PART	O
determine	O	VERB	O
which	O	DET	O
,	O	PUNCT	O
if	O	SCONJ	O
any	O	DET	O
,	O	PUNCT	O
of	O	ADP	O
the	O	DET	O
PPARs	B-protein	NOUN	B
are	O	AUX	O
mediating	O	VERB	O
this	O	DET	O
process	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
physiological	O	ADJ	B
substrates	O	NOUN	O
for	O	ADP	O
SHP1	B-protein	NOUN	B
in	O	ADP	O
T	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
,	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
have	O	AUX	O
remained	O	VERB	O
unclear	O	ADJ	B
or	O	CCONJ	O
controversial	O	ADJ	O
.	O	PUNCT	O


Expression	O	NOUN	B
of	O	ADP	O
wild-type	B-protein	ADJ	B
SHP1	I-protein	NOUN	B
had	O	AUX	O
a	O	DET	O
very	O	ADV	O
small	O	ADJ	O
effect	O	NOUN	B
on	O	ADP	O
the	O	DET	O
TCR-induced	O	ADJ	B
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	B
of	O	ADP	O
ZAP-70	B-protein	NOUN	B
and	O	CCONJ	O
Syk	B-protein	NOUN	B
,	O	PUNCT	O
even	O	ADV	O
when	O	SCONJ	O
SHP1	B-protein	NOUN	B
was	O	AUX	O
overexpressed	O	VERB	B
20	O	NUM	O
-	O	PUNCT	O
100-fold	O	ADV	O
over	O	ADP	O
endogenous	B-protein	ADJ	B
SHP1	I-protein	NOUN	B
.	O	PUNCT	O


Inactive	B-protein	ADJ	B
SHP1-D421A	I-protein	NOUN	B
and	O	CCONJ	O
wild-type	B-protein	ADJ	B
SHP2	I-protein	NOUN	B
were	O	AUX	O
without	O	ADP	O
effects	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
a	O	DET	O
constitutively	O	ADV	B
active	O	ADJ	B
SHP2-DeltaSH2	B-protein	NOUN	O
had	O	AUX	O
no	O	DET	O
statistically	O	ADV	B
significant	O	ADJ	I
effect	O	NOUN	O
(	O	PUNCT	O
although	O	SCONJ	O
it	O	PRON	O
caused	O	VERB	O
a	O	DET	O
slight	O	ADJ	O
augmentation	O	NOUN	B
in	O	ADP	O
some	O	DET	O
individual	O	ADJ	O
experiments	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Taken	O	VERB	O
together	O	ADV	O
,	O	PUNCT	O
our	O	PRON	O
findings	O	NOUN	B
support	O	VERB	O
the	O	DET	O
notion	O	NOUN	O
that	O	SCONJ	O
ZAP-70	B-protein	NOUN	B
and	O	CCONJ	O
Syk	B-protein	NOUN	B
can	O	AUX	O
be	O	AUX	O
direct	O	ADJ	O
substrates	O	NOUN	B
for	O	ADP	O
SHP1	B-protein	NOUN	B
in	O	ADP	O
intact	O	ADJ	B
cells	O	NOUN	I
.	O	PUNCT	O


Electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assays	O	NOUN	I
(	O	PUNCT	O
EMSAs	O	NOUN	B
)	O	PUNCT	O
showed	O	VERB	O
that	O	SCONJ	O
recombinant	O	ADJ	B
C/EBPbeta	B-protein	NOUN	B
protein	O	NOUN	I
could	O	AUX	O
bind	O	VERB	B
to	O	PART	O
the	O	DET	O
potential	O	ADJ	B
C/EBP-binding	B-DNA	ADJ	B
site	I-DNA	NOUN	I
(	O	PUNCT	O
bp	B-DNA	NOUN	B
-90	I-DNA	NUM	O
to	I-DNA	PART	O
-82	I-DNA	NUM	O
)	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
MBP	B-protein	NOUN	B
promoter	O	NOUN	B
.	O	PUNCT	O


STAT3	B-protein	NOUN	B
(	O	PUNCT	O
signal	B-protein	NOUN	B
transducer	I-protein	NOUN	I
and	I-protein	CCONJ	I
activator	I-protein	NOUN	O
of	I-protein	ADP	O
transcription	I-protein	NOUN	O
3	I-protein	NUM	O
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
latent	O	ADJ	B
transcription	O	NOUN	B
factor	O	NOUN	I
that	O	PRON	O
is	O	AUX	O
activated	O	VERB	B
by	O	ADP	O
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	I
(	O	PUNCT	O
Tyr-705	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
cells	O	NOUN	B
stimulated	O	VERB	B
with	O	ADP	O
cytokines	B-protein	NOUN	B
or	O	CCONJ	O
growth	B-protein	NOUN	B
factors	I-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
drug	O	NOUN	B
was	O	AUX	O
less	O	ADV	O
effective	O	ADJ	B
on	O	ADP	O
cytokines	B-protein	NOUN	B
:	O	PUNCT	O
it	O	PRON	O
virtually	O	ADV	O
abolished	O	VERB	O
the	O	DET	O
response	O	NOUN	B
to	O	PART	O
GM-CSF	B-protein	NOUN	B
that	O	PRON	O
occurred	O	VERB	O
5	O	NUM	O
min	O	NOUN	O
after	O	ADP	O
stimulation	O	NOUN	B
but	O	CCONJ	O
only	O	ADV	O
partly	O	ADV	O
decreased	O	VERB	B
those	O	DET	O
at	O	ADP	O
15-30	O	NUM	O
min	O	NOUN	O
and	O	CCONJ	O
did	O	AUX	O
not	O	PART	O
appreciably	O	ADV	O
alter	O	VERB	O
responses	O	NOUN	B
to	O	PART	O
G-CSF	B-protein	NOUN	B
regardless	O	ADV	O
of	O	ADP	O
incubation	O	NOUN	B
time	O	NOUN	I
.	O	PUNCT	O


Renal	O	ADJ	B
cell	O	NOUN	I
carcinoma-derived	O	ADJ	B
gangliosides	O	NOUN	B
suppress	O	VERB	B
nuclear	B-protein	ADJ	B
factor-kappaB	I-protein	NOUN	I
activation	O	NOUN	I
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


This	O	DET	O
phenomenon	O	NOUN	B
is	O	AUX	O
mediated	O	VERB	O
,	O	PUNCT	O
in	O	ADP	O
part	O	NOUN	O
,	O	PUNCT	O
through	O	ADP	O
inducible	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
CXC	B-protein	NOUN	B
chemokine	I-protein	NOUN	I
,	O	PUNCT	O
interleukin-8	B-protein	NOUN	B
(	O	PUNCT	O
IL-8	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Surprisingly	O	ADV	O
,	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
DMSO	O	NOUN	B
has	O	AUX	O
no	O	DET	O
effect	O	NOUN	O
on	O	ADP	O
inducible	O	ADJ	B
Rel	B-protein	NOUN	B
A	I-protein	NOUN	I
binding	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
TNFalpha	B-protein	NOUN	B
induces	O	VERB	O
a	O	DET	O
delayed	O	VERB	O
ROS-dependent	O	ADJ	B
signalling	O	NOUN	O
pathway	O	NOUN	O
that	O	PRON	O
is	O	AUX	O
required	O	VERB	O
for	O	ADP	O
NF-kappaB	B-protein	NOUN	B
transcriptional	O	ADJ	O
activation	O	NOUN	O
and	O	CCONJ	O
is	O	AUX	O
separable	O	ADJ	O
from	O	ADP	O
that	O	DET	O
required	O	VERB	O
for	O	ADP	O
its	O	PRON	O
nuclear	O	ADJ	B
translocation	O	NOUN	I
.	O	PUNCT	O


Estrogen	B-protein	NOUN	B
receptors	I-protein	NOUN	I
influence	O	VERB	B
non-genomic	O	ADJ	B
events	O	NOUN	I
,	O	PUNCT	O
which	O	DET	O
are	O	AUX	O
rapid	O	ADJ	O
in	O	ADP	O
onset	O	NOUN	B
and	O	CCONJ	O
genomic	O	ADJ	B
events	O	NOUN	I
,	O	PUNCT	O
which	O	DET	O
are	O	AUX	O
longer	O	ADV	O
acting	O	NOUN	O
responses	O	NOUN	B
.	O	PUNCT	O


Although	O	SCONJ	O
estrogens	O	NOUN	B
initiate	O	VERB	O
vascular	O	ADJ	B
responses	O	NOUN	I
,	O	PUNCT	O
genomic	O	ADJ	B
sex	O	NOUN	I
may	O	AUX	O
influence	O	VERB	B
and/or	O	CCONJ	O
limit	O	VERB	O
expression	O	NOUN	B
of	O	ADP	O
estrogen	O	NOUN	B
receptors	O	NOUN	I
and	O	CCONJ	O
therefore	O	ADV	O
actions	O	NOUN	B
of	O	ADP	O
sex	O	NOUN	B
steroid	O	NOUN	B
hormones	O	NOUN	I
throughout	O	ADP	O
the	O	DET	O
vasculature	O	NOUN	B
.	O	PUNCT	O


mRNA	B-RNA	NOUN	B
levels	O	NOUN	O
for	O	ADP	O
IL-13R	B-protein	NOUN	B
alpha1	I-protein	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
IL-4R	B-protein	NOUN	B
alpha	I-protein	NOUN	B
,	O	PUNCT	O
were	O	AUX	O
markedly	O	ADV	O
decreased	O	VERB	B
in	O	ADP	O
in	B-cell_line	X	B
vitro	I-cell_line	X	I
monocyte-derived	I-cell_line	ADJ	B
macrophages	I-cell_line	NOUN	I
(	O	PUNCT	O
MDMac	B-cell_line	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
with	O	ADP	O
increasing	O	VERB	B
time	O	NOUN	B
of	O	ADP	O
monocytes	B-cell_type	NOUN	B
in	O	ADP	O
culture	O	NOUN	B
correlated	O	VERB	B
with	O	ADP	O
the	O	DET	O
loss	O	NOUN	B
of	O	ADP	O
IL-13	B-protein	NOUN	B
regulation	O	NOUN	B
of	O	ADP	O
lipopolysaccharide-induced	O	ADJ	O
TNF-alpha	B-protein	NOUN	B
production	O	NOUN	B
.	O	PUNCT	O


Analysis	O	NOUN	B
of	O	ADP	O
cell	B-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
Daudi	B-cell_line	NOUN	B
and	O	CCONJ	O
THP-1	B-cell_line	NOUN	B
that	O	PRON	O
differentially	O	ADV	O
express	O	VERB	B
gamma	B-protein	NOUN	B
(	I-protein	PUNCT	I
c	I-protein	NOUN	I
)	I-protein	PUNCT	O
and	O	CCONJ	O
IL-13R	B-protein	NOUN	B
alpha1	I-protein	NOUN	I
showed	O	VERB	O
that	O	SCONJ	O
IL-13	B-protein	NOUN	B
can	O	AUX	O
activate	O	VERB	B
STAT6	B-protein	NOUN	B
in	O	ADP	O
IL-13R	B-cell_line	NOUN	B
alpha1-positive	I-cell_line	ADJ	B
THP-1	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
but	O	CCONJ	O
not	O	PART	O
in	O	ADP	O
gamma	B-cell_line	NOUN	B
(	I-cell_line	PUNCT	I
c	I-cell_line	NOUN	I
)	I-cell_line	PUNCT	O
-positive	I-cell_line	ADJ	O
,	I-cell_line	PUNCT	O
IL-13R	I-cell_line	NOUN	B
alpha1-negative	I-cell_line	ADJ	O
Daudi	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
with	O	ADP	O
reduced	O	VERB	B
IL-13R	B-protein	NOUN	B
alpha1	I-protein	NOUN	I
expression	O	NOUN	B
and	O	CCONJ	O
low	O	ADJ	B
nuclear	O	ADJ	B
STAT6	B-protein	NOUN	I
activity	O	NOUN	B
,	O	PUNCT	O
some	O	DET	O
IL-13	B-protein	NOUN	B
-induced	O	ADJ	O
responses	O	NOUN	B
were	O	AUX	O
unaltered	O	ADJ	B
in	O	ADP	O
magnitude	O	NOUN	B
in	O	ADP	O
MDMac	B-cell_line	NOUN	B
.	O	PUNCT	O


The	O	DET	O
promoter	B-DNA	NOUN	B
and	O	CCONJ	O
5	B-DNA	NUM	O
'	I-DNA	PART	O
flanking	I-DNA	ADJ	B
sequences	I-DNA	NOUN	I
controlling	O	VERB	O
human	O	ADJ	B
B29	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
expression	O	NOUN	O
.	O	PUNCT	O


All	O	DET	O
these	O	DET	O
motifs	O	NOUN	B
are	O	AUX	O
strikingly	O	ADV	O
conserved	O	VERB	O
in	O	ADP	O
sequence	O	NOUN	B
and	O	CCONJ	O
placement	O	NOUN	B
relative	O	ADJ	O
to	O	PART	O
the	O	DET	O
previously	O	ADV	O
characterized	O	VERB	B
murine	B-DNA	ADJ	B
B29	I-DNA	NOUN	B
promoter	I-DNA	NOUN	I
.	O	PUNCT	O


A	O	DET	O
newly	O	ADV	O
identified	O	VERB	O
motif	O	NOUN	B
called	O	VERB	O
the	O	DET	O
B29	B-DNA	NOUN	B
conserved	I-DNA	ADJ	I
sequence	I-DNA	NOUN	I
(	O	PUNCT	O
BCS	B-DNA	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
found	O	VERB	O
upstream	O	ADV	B
of	O	ADP	O
both	O	CCONJ	O
human	B-DNA	ADJ	B
and	I-DNA	CCONJ	O
murine	I-DNA	ADJ	B
B29	I-DNA	NOUN	B
promoters	I-DNA	NOUN	I
,	O	PUNCT	O
appears	O	VERB	O
to	O	PART	O
stimulate	O	VERB	B
B29	B-protein	NOUN	B
transcription	O	NOUN	I
through	O	ADP	O
a	O	DET	O
novel	O	ADJ	O
mechanism	O	NOUN	B
.	O	PUNCT	O


Instead	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
BCS	B-DNA	NOUN	B
stimulated	O	VERB	B
transcription	O	NOUN	B
by	O	ADP	O
counteracting	O	VERB	O
5	B-DNA	NUM	O
'	I-DNA	PART	O
negative	I-DNA	ADJ	B
regulatory	I-DNA	ADJ	O
DNA	I-DNA	NOUN	O
sequences	I-DNA	NOUN	O
that	O	PRON	O
block	O	VERB	B
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
B29	B-protein	NOUN	B
minimal	B-DNA	ADJ	I
promoter	I-DNA	NOUN	B
in	O	ADP	O
its	O	PRON	O
absence	O	NOUN	B
.	O	PUNCT	O


Expression	O	NOUN	B
of	O	ADP	O
luciferase	B-protein	NOUN	B
in	O	ADP	O
these	O	DET	O
cells	O	NOUN	B
was	O	AUX	O
induced	O	VERB	B
by	O	ADP	O
phorbol	O	NOUN	B
myristate	O	NOUN	B
acetate	O	NOUN	I
plus	O	CCONJ	O
a	O	DET	O
calcium	O	NOUN	B
ionophore	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
NFAT-controlled	B-DNA	ADJ	B
luciferase	I-DNA	NOUN	I
gene	I-DNA	NOUN	O
system	I-DNA	NOUN	O
distinguishes	O	VERB	O
CIF	B-protein	NOUN	B
from	O	ADP	O
other	O	ADJ	O
T	O	NOUN	B
cell	O	NOUN	I
inhibitory	O	ADJ	B
activities	O	NOUN	O
present	O	ADJ	O
in	O	ADP	O
colostrum	O	NOUN	B
,	O	PUNCT	O
in	O	ADP	O
particular	O	ADJ	O
,	O	PUNCT	O
TGF	B-protein	NOUN	B
beta	I-protein	NOUN	I
1	I-protein	NUM	I
and	O	CCONJ	O
TGF	B-protein	NOUN	B
beta	I-protein	NOUN	I
2	I-protein	NUM	I
and	O	CCONJ	O
the	O	DET	O
glucocorticoids	O	NOUN	B
.	O	PUNCT	O


Stably	O	ADV	B
transfected	O	VERB	B
Jurkat	O	NOUN	B
cells	O	NOUN	I
behaved	O	VERB	O
similarly	O	ADV	O
to	O	PART	O
the	O	DET	O
transiently	O	ADV	O
transfected	O	VERB	B
ones	O	NOUN	O
with	O	ADP	O
respect	O	NOUN	O
to	O	PART	O
inhibition	O	NOUN	B
by	O	ADP	O
CIF	B-protein	NOUN	B
and	O	CCONJ	O
cyclosporine	O	NOUN	B
.	O	PUNCT	O


Staurosporine	O	NOUN	B
(	O	PUNCT	O
PKC	O	NOUN	B
inhibitor	O	NOUN	I
)	O	PUNCT	O
,	O	PUNCT	O
pentoxifylline	O	NOUN	B
(	O	PUNCT	O
NF-kappa	O	NOUN	B
B	O	NOUN	I
inhibitor	O	NOUN	I
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
Ro5-3335	O	NOUN	B
(	O	PUNCT	O
HIV-1	O	NOUN	B
Tat	B-protein	NOUN	B
inhibitor	O	NOUN	B
)	O	PUNCT	O
also	O	ADV	O
inhibited	O	VERB	B
significantly	O	ADV	O
the	O	DET	O
heat	O	NOUN	B
shock	O	NOUN	I
induced	O	VERB	B
virus	O	NOUN	B
activation	O	NOUN	B
.	O	PUNCT	O


Using	O	VERB	O
a	O	DET	O
combination	O	NOUN	B
of	O	ADP	O
bacterial	O	ADJ	B
motility	O	NOUN	I
assays	O	NOUN	O
in	O	ADP	O
platelet	O	NOUN	B
extracts	O	NOUN	I
with	O	ADP	O
Escherichia	O	X	B
coli	O	X	I
expressing	O	VERB	B
the	O	DET	O
Shigella	B-protein	NOUN	B
IcsA	I-protein	NOUN	I
protein	I-protein	NOUN	I
and	O	CCONJ	O
in	O	X	B
vitro	O	X	I
analysis	O	NOUN	B
of	O	ADP	O
reconstituted	O	VERB	B
systems	O	NOUN	I
from	O	ADP	O
purified	B-protein	VERB	B
proteins	I-protein	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
show	O	VERB	O
here	O	ADV	O
that	O	SCONJ	O
the	O	DET	O
bacterial	B-protein	ADJ	B
protein	I-protein	NOUN	I
IcsA	I-protein	NOUN	B
binds	O	VERB	B
N-WASP	B-protein	NOUN	B
and	O	CCONJ	O
activates	O	VERB	B
it	O	PRON	O
in	O	ADP	O
a	O	DET	O
Cdc42	B-protein	NOUN	B
-like	O	ADJ	O
fashion	O	NOUN	B
.	O	PUNCT	O


c-Maf	B-protein	NOUN	B
induces	O	VERB	O
monocytic	O	ADJ	B
differentiation	O	NOUN	I
and	O	CCONJ	O
apoptosis	O	NOUN	B
in	O	ADP	O
bipotent	B-cell_type	ADJ	B
myeloid	I-cell_type	ADJ	I
progenitors	I-cell_type	NOUN	I
.	O	PUNCT	O


Because	O	SCONJ	O
the	O	DET	O
elevated	O	ADJ	B
Myb	B-protein	NOUN	B
:	I-protein	PUNCT	O
Maf	I-protein	NOUN	B
status	O	NOUN	O
seen	O	VERB	O
in	O	ADP	O
differentiating	B-cell_type	VERB	O
cells	I-cell_type	NOUN	B
can	O	AUX	O
be	O	AUX	O
recapitulated	O	VERB	O
by	O	ADP	O
overexpression	O	NOUN	B
of	O	ADP	O
c-Maf	B-protein	NOUN	B
in	O	ADP	O
myeloid	O	ADJ	B
cell	O	NOUN	I
lines	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
inducibly	O	ADV	B
expressed	O	VERB	B
the	O	DET	O
c-Maf	B-DNA	NOUN	B
cDNA	I-DNA	NOUN	B
in	O	ADP	O
2	O	NUM	O
bipotent	O	ADJ	B
human	B-cell_type	ADJ	B
myeloid	I-cell_type	ADJ	O
progenitor	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
.	O	PUNCT	O


Analysis	O	NOUN	B
of	O	ADP	O
targets	O	NOUN	B
that	O	PRON	O
could	O	AUX	O
mediate	O	VERB	O
these	O	DET	O
phenotypic	O	ADJ	B
changes	O	NOUN	B
indicated	O	VERB	O
that	O	SCONJ	O
c-Maf	B-protein	NOUN	B
likely	O	ADV	O
plays	O	VERB	O
a	O	DET	O
key	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
myeloid	O	ADJ	B
cell	O	NOUN	I
development	O	NOUN	B
through	O	ADP	O
dual	O	ADJ	O
mechanisms	O	NOUN	B
;	O	PUNCT	O
inhibition	O	NOUN	B
of	O	ADP	O
a	O	DET	O
select	O	ADJ	O
set	O	NOUN	O
of	O	ADP	O
c-Myb	B-protein	NOUN	B
regulated	O	ADJ	O
targets	O	NOUN	B
,	O	PUNCT	O
such	O	ADJ	O
as	O	ADP	O
Bcl-2	B-protein	NOUN	B
and	O	CCONJ	O
CD13/APN	B-protein	NOUN	B
,	O	PUNCT	O
coupled	O	VERB	B
with	O	ADP	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
as	O	ADV	O
yet	O	ADV	O
undefined	O	ADJ	O
differentiation-promoting	B-DNA	ADJ	B
genes	I-DNA	NOUN	I
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
in	O	X	B
vitro	O	X	I
binding	O	NOUN	B
analysis	O	NOUN	I
revealed	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
AML1	B-DNA	NOUN	B
runt	I-DNA	NOUN	I
DNA-binding	I-DNA	ADJ	B
domain	I-DNA	NOUN	I
physically	O	ADV	O
interacts	O	VERB	O
with	O	ADP	O
the	O	DET	O
paired	B-DNA	ADJ	O
DNA-binding	I-DNA	ADJ	B
domain	I-DNA	NOUN	I
of	O	ADP	O
BSAP	B-protein	NOUN	B
,	O	PUNCT	O
a	O	DET	O
B	B-protein	NOUN	O
cell-specific	I-protein	ADJ	O
transcription	I-protein	NOUN	O
factor	I-protein	NOUN	O
.	O	PUNCT	O


BSAP	B-protein	NOUN	B
has	O	AUX	O
been	O	AUX	O
shown	O	VERB	O
previously	O	ADV	O
to	O	PART	O
be	O	AUX	O
important	O	ADJ	O
for	O	ADP	O
B	O	NOUN	B
cell-specific	O	ADJ	O
regulation	O	NOUN	O
of	O	ADP	O
the	O	DET	O
blk	B-DNA	NOUN	B
gene	O	NOUN	I
.	O	PUNCT	O


Physical	O	ADJ	B
interaction	O	NOUN	I
of	O	ADP	O
AML1	B-protein	NOUN	B
with	O	ADP	O
BSAP	B-protein	NOUN	B
correlates	O	VERB	O
with	O	ADP	O
functional	O	ADJ	B
cooperativity	O	NOUN	B
in	O	ADP	O
transfection	O	NOUN	B
studies	O	NOUN	I
where	O	SCONJ	O
AML1	B-protein	NOUN	B
and	O	CCONJ	O
BSAP	B-protein	NOUN	B
synergistically	O	ADV	B
activate	O	VERB	B
blk	B-DNA	NOUN	B
promoter	O	NOUN	B
transcription	O	NOUN	I
by	O	ADP	O
more	O	ADJ	O
than	O	ADP	O
50-fold	O	ADV	O
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
demonstrate	O	VERB	O
physical	O	ADJ	B
and	O	CCONJ	O
functional	O	ADJ	B
interactions	O	NOUN	B
between	O	ADP	O
AML1	B-protein	NOUN	B
and	O	CCONJ	O
BSAP	B-protein	NOUN	B
and	O	CCONJ	O
suggest	O	VERB	O
that	O	SCONJ	O
AML1	B-protein	NOUN	B
is	O	AUX	O
an	O	DET	O
important	O	ADJ	O
factor	O	NOUN	B
for	O	ADP	O
regulating	O	VERB	B
a	O	DET	O
critical	O	ADJ	O
B	B-DNA	NOUN	O
cell-specific	I-DNA	ADJ	O
gene	I-DNA	NOUN	O
,	O	PUNCT	O
blk	B-DNA	NOUN	B
.	O	PUNCT	O


Expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
class	B-protein	NOUN	B
A	I-protein	NOUN	O
macrophage	I-protein	NOUN	B
scavenger	I-protein	NOUN	I
receptor	I-protein	NOUN	I
(	I-protein	PUNCT	O
MSR	I-protein	NOUN	B
)	I-protein	PUNCT	O
contributes	O	VERB	O
to	O	PART	O
the	O	DET	O
uptake	O	NOUN	B
of	O	ADP	O
modified	B-protein	VERB	B
low	I-protein	ADJ	O
density	I-protein	NOUN	O
lipoproteins	I-protein	NOUN	O
(	I-protein	PUNCT	O
LDL	I-protein	NOUN	B
)	I-protein	PUNCT	O
by	O	ADP	O
macrophages	B-cell_type	NOUN	B
and	O	CCONJ	O
transformation	O	NOUN	B
of	O	ADP	O
these	O	DET	O
cells	O	NOUN	B
into	O	ADP	O
lipid-laden	B-cell_type	ADJ	B
foam	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
which	O	DET	O
characterize	O	VERB	O
atherosclerosis	O	NOUN	B
.	O	PUNCT	O


When	O	SCONJ	O
treated	O	VERB	B
with	O	ADP	I
IL-6	B-protein	NOUN	B
,	O	PUNCT	O
macrophages	B-cell_type	NOUN	B
derived	O	VERB	O
from	O	ADP	O
peripheral	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
and	O	CCONJ	O
phorbol	B-cell_line	NOUN	B
12-myristate	I-cell_line	NOUN	I
13-acetate	I-cell_line	NOUN	I
(	I-cell_line	PUNCT	O
PMA	I-cell_line	NOUN	B
)	I-cell_line	PUNCT	O
-differentiated	I-cell_line	ADJ	O
THP-1	I-cell_line	NOUN	B
monocytic	I-cell_line	ADJ	I
cells	I-cell_line	NOUN	I
showed	O	VERB	O
significantly	O	ADV	O
reduced	O	VERB	B
uptake	O	NOUN	B
and/or	O	CCONJ	O
binding	O	NOUN	B
of	O	ADP	O
the	O	DET	O
MSR	B-protein	NOUN	B
ligand	O	NOUN	B
,	O	PUNCT	O
acetylated	B-protein	VERB	B
LDL	I-protein	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
molecular	O	ADJ	B
mechanism	O	NOUN	O
of	O	ADP	O
Rb	B-protein	NOUN	B
rescue	O	NOUN	B
of	O	ADP	O
the	O	DET	O
class	B-DNA	NOUN	B
II	I-DNA	NUM	I
genes	I-DNA	NOUN	I
is	O	AUX	O
unknown	O	ADJ	O
.	O	PUNCT	O


BLPs	B-protein	NOUN	B
were	O	AUX	O
found	O	VERB	O
to	O	PART	O
induce	O	VERB	B
apoptosis	O	NOUN	B
in	O	ADP	O
THP-1	B-cell_line	NOUN	B
monocytic	I-cell_line	ADJ	I
cells	I-cell_line	NOUN	I
through	O	ADP	O
human	B-protein	ADJ	B
Toll-like	I-protein	ADJ	B
receptor-2	I-protein	NOUN	I
(	I-protein	PUNCT	O
hTLR2	I-protein	NOUN	B
)	I-protein	PUNCT	O
.	O	PUNCT	O


Different	O	ADJ	O
glucocorticoid	O	NOUN	B
hormones	O	NOUN	I
(	O	PUNCT	O
GCH	O	NOUN	B
)	O	PUNCT	O
show	O	VERB	O
differences	O	NOUN	B
in	O	ADP	O
the	O	DET	O
intensity	O	NOUN	B
and	O	CCONJ	O
in	O	ADP	O
the	O	DET	O
kinetics	O	NOUN	B
of	O	ADP	O
their	O	PRON	O
immunomodulating	O	ADJ	B
activity	O	NOUN	I
.	O	PUNCT	O


This	O	DET	O
staining	O	NOUN	B
pattern	O	NOUN	O
clearly	O	ADV	O
differed	O	VERB	O
from	O	ADP	O
that	O	DET	O
of	O	ADP	O
classical	O	ADJ	O
HD	O	NOUN	B
,	O	PUNCT	O
whose	O	DET	O
cellular	O	ADJ	B
background	O	NOUN	I
was	O	AUX	O
made	O	VERB	O
up	O	ADP	O
of	O	ADP	O
CD3+/CD4+	B-cell_type	ADJ	B
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
showing	O	VERB	O
the	O	DET	O
BCL-6	B-protein	NOUN	B
-/	O	NOUN	O
CD40L	B-protein	NOUN	B
+	O	CCONJ	O
phenotype	O	NOUN	B
.	O	PUNCT	O


Selenium-mediated	O	ADJ	B
inhibition	O	NOUN	B
of	O	ADP	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
NF-kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
and	O	CCONJ	O
HIV-1	B-DNA	NOUN	B
LTR	I-DNA	NOUN	B
promoter	I-DNA	NOUN	B
activity	O	NOUN	I
.	O	PUNCT	O


IkappaB	B-protein	NOUN	B
levels	O	NOUN	B
in	O	ADP	O
MNC	B-cell_type	NOUN	B
homogenates	O	NOUN	B
increased	O	VERB	B
at	O	ADP	O
1	O	NUM	O
hr	O	NOUN	O
,	O	PUNCT	O
peaked	O	VERB	O
at	O	ADP	O
2-4	O	NUM	O
hr	O	NOUN	O
,	O	PUNCT	O
started	O	VERB	O
to	O	PART	O
decrease	O	VERB	B
at	O	ADP	O
8	O	NUM	O
hr	O	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
returned	O	VERB	O
to	O	PART	O
baseline	O	NOUN	B
levels	O	NOUN	B
at	O	ADP	O
24	O	NUM	O
hr	O	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
our	O	PRON	O
study	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
determined	O	VERB	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
apoptosis	O	NOUN	B
by	O	ADP	O
GC	O	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


Stimulation	O	NOUN	B
with	O	ADP	O
different	O	ADJ	O
GC	O	NOUN	B
at	O	ADP	O
therapeutic	O	ADJ	B
concentrations	O	NOUN	B
resulted	O	VERB	O
in	O	ADP	O
monocyte	O	NOUN	B
apoptosis	O	NOUN	B
in	O	ADP	O
a	O	DET	O
time-	O	NOUN	O
and	O	CCONJ	O
dose-dependent	O	ADJ	B
manner	O	NOUN	O
.	O	PUNCT	O


Differential	O	ADJ	B
effects	O	NOUN	I
of	O	ADP	O
lipopolysaccharide	O	NOUN	B
and	O	CCONJ	O
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor	I-protein	NOUN	I
on	O	ADP	O
monocytic	B-protein	ADJ	B
IkappaB	I-protein	NOUN	I
kinase	I-protein	NOUN	I
signalsome	O	ADJ	O
activation	O	NOUN	O
and	O	CCONJ	O
IkappaB	B-protein	NOUN	B
proteolysis	O	NOUN	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
our	O	PRON	O
studies	O	NOUN	B
showed	O	VERB	O
association	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IKK-alpha/beta	B-protein	NOUN	B
heterodimer	I-protein	NOUN	I
with	O	ADP	O
NIK	B-protein	NOUN	B
,	O	PUNCT	O
IkappaB-alpha	B-protein	NOUN	B
and	O	CCONJ	O
-epsilon	B-protein	NOUN	B
in	O	ADP	O
unstimulated	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


On	O	ADP	O
the	O	DET	O
contrary	O	NOUN	O
,	O	PUNCT	O
32Dcl3	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
stably	O	ADV	O
expressing	O	VERB	B
AML1/ETO	B-DNA	NOUN	B
were	O	AUX	O
completely	O	ADV	O
resistant	O	ADJ	B
to	O	PART	O
differentiation	O	NOUN	B
and	O	CCONJ	O
continued	O	VERB	O
to	O	PART	O
grow	O	VERB	B
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
G-CSF	B-protein	NOUN	B
.	O	PUNCT	O


Host	O	NOUN	B
defense	O	NOUN	B
mechanisms	O	NOUN	I
triggered	O	VERB	O
by	O	ADP	O
microbial	B-protein	ADJ	B
lipoproteins	I-protein	NOUN	I
through	O	ADP	O
toll-like	B-protein	ADJ	B
receptors	I-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
generation	O	NOUN	B
of	O	ADP	O
cell-mediated	O	ADJ	B
immunity	O	NOUN	I
against	O	ADP	O
many	O	ADJ	O
infectious	O	ADJ	B
pathogens	O	NOUN	B
involves	O	VERB	O
the	O	DET	O
production	O	NOUN	B
of	O	ADP	O
interleukin-12	B-protein	NOUN	B
(	O	PUNCT	O
IL-12	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
a	O	DET	O
key	O	ADJ	O
signal	O	NOUN	B
of	O	ADP	O
the	O	DET	O
innate	O	ADJ	B
immune	O	ADJ	I
system	O	NOUN	I
.	O	PUNCT	O


Yet	O	ADV	O
,	O	PUNCT	O
for	O	ADP	O
many	O	ADJ	O
pathogens	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
molecules	O	NOUN	B
that	O	PRON	O
induce	O	VERB	B
IL-12	B-protein	NOUN	B
production	O	NOUN	B
by	O	ADP	O
macrophages	B-cell_type	NOUN	B
and	O	CCONJ	O
the	O	DET	O
mechanisms	O	NOUN	B
by	O	ADP	O
which	O	DET	O
they	O	PRON	O
do	O	AUX	O
so	O	ADV	O
remain	O	VERB	O
undefined	O	ADJ	B
.	O	PUNCT	O


Here	O	ADV	O
it	O	PRON	O
is	O	AUX	O
shown	O	VERB	O
that	O	SCONJ	O
microbial	B-protein	ADJ	B
lipoproteins	I-protein	NOUN	I
are	O	AUX	O
potent	O	ADJ	O
stimulators	O	NOUN	B
of	O	ADP	O
IL-12	B-protein	NOUN	B
production	O	NOUN	B
by	O	ADP	O
human	O	ADJ	B
macrophages	B-cell_type	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
that	O	SCONJ	O
induction	O	NOUN	B
is	O	AUX	O
mediated	O	VERB	O
by	O	ADP	O
Toll-like	B-protein	ADJ	B
receptors	I-protein	NOUN	I
(	O	PUNCT	O
TLRs	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Freshly	O	ADV	B
isolated	O	VERB	B
T	B-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
from	O	ADP	O
lupus	O	NOUN	B
patients	O	NOUN	B
,	O	PUNCT	O
rheumatoid	O	ADJ	B
arthritis	O	NOUN	I
(	O	PUNCT	O
RA	O	NOUN	B
)	O	PUNCT	O
patients	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
normal	O	ADJ	O
individuals	O	NOUN	B
were	O	AUX	O
activated	O	VERB	B
physiologically	O	ADV	B
via	O	ADP	O
the	O	DET	O
TCR	B-protein	NOUN	B
with	O	ADP	O
anti-CD3	B-protein	NOUN	B
and	O	CCONJ	O
anti-CD28	B-protein	ADJ	B
Abs	I-protein	NOUN	B
to	O	PART	O
assess	O	VERB	O
proximal	O	ADJ	B
membrane	O	NOUN	I
signaling	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
with	O	ADP	O
PMA	O	NOUN	B
and	O	CCONJ	O
a	O	DET	O
calcium	O	NOUN	B
ionophore	O	NOUN	I
(	O	PUNCT	O
A23187	O	NOUN	B
)	O	PUNCT	O
to	O	PART	O
bypass	O	VERB	B
membrane-mediated	O	ADJ	I
signaling	O	NOUN	I
events	O	NOUN	I
.	O	PUNCT	O


When	O	SCONJ	O
compared	O	VERB	B
with	O	ADP	O
normal	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activity	O	NOUN	O
in	O	ADP	O
SLE	O	NOUN	B
patients	O	NOUN	B
was	O	AUX	O
significantly	O	ADV	O
decreased	O	VERB	B
in	O	ADP	O
SLE	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
in	O	ADP	O
RA	O	NOUN	B
,	O	PUNCT	O
patients	O	NOUN	B
.	O	PUNCT	O


Finally	O	ADV	O
,	O	PUNCT	O
immunoblot	O	NOUN	B
analysis	O	NOUN	I
of	O	ADP	O
nuclear	O	ADJ	B
extracts	O	NOUN	I
showed	O	VERB	O
decreased	O	VERB	B
or	O	CCONJ	O
absent	O	ADJ	O
p65	B-protein	NOUN	O
protein	I-protein	NOUN	O
levels	O	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
TLR2	B-protein	NOUN	B
associates	O	VERB	B
with	O	ADP	I
the	O	DET	O
high-affinity	B-protein	ADJ	B
LPS	I-protein	NOUN	B
binding	I-protein	NOUN	O
protein	I-protein	NOUN	B
membrane	O	NOUN	I
CD14	B-protein	NOUN	B
to	O	PART	O
serve	O	VERB	O
as	O	ADP	O
an	O	DET	O
LPS	B-protein	NOUN	B
receptor	I-protein	NOUN	I
complex	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
that	O	SCONJ	O
LPS	O	NOUN	B
treatment	O	NOUN	B
enhances	O	VERB	B
the	O	DET	O
oligomerization	O	NOUN	B
of	O	ADP	O
TLR2	B-protein	NOUN	B
.	O	PUNCT	O


Tyrphostin	O	NOUN	B
AG-490	O	NOUN	B
inhibits	O	VERB	B
cytokine-mediated	O	ADJ	B
JAK3	B-protein	NOUN	I
/STAT5a/b	B-protein	ADJ	O
signal	O	NOUN	B
transduction	O	NOUN	I
and	O	CCONJ	O
cellular	O	ADJ	B
proliferation	O	NOUN	I
of	O	ADP	O
antigen-activated	O	ADJ	B
human	O	ADJ	I
T	B-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


AG-490	O	NOUN	B
also	O	ADV	O
inhibited	O	VERB	B
IL-2	B-protein	NOUN	B
-mediated	O	ADJ	O
proliferative	O	ADJ	B
growth	O	NOUN	I
in	O	ADP	O
human	O	ADJ	B
T	B-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
with	O	ADP	O
an	O	DET	O
IC50	O	NOUN	B
)	O	PUNCT	O
=	O	ADJ	O
25	O	NUM	O
microM	O	NOUN	O
that	O	PRON	O
was	O	AUX	O
partially	O	ADV	O
recoverable	O	ADJ	B
.	O	PUNCT	O


The	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
C/EBP	B-protein	NOUN	B
beta	I-protein	NOUN	I
was	O	AUX	O
confirmed	O	VERB	O
by	O	ADP	O
immunohistochemistry	O	NOUN	B
and	O	CCONJ	O
Western	O	NOUN	B
blot	O	NOUN	I
analysis	O	NOUN	I
with	O	ADP	O
isolated	O	VERB	B
synovial	B-cell_type	ADJ	B
fibroblasts	I-cell_type	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
conclusion	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
enhanced	O	VERB	B
nuclear	O	ADJ	B
staining	O	NOUN	I
for	O	ADP	O
C/EBP	B-protein	NOUN	B
beta	I-protein	NOUN	I
in	O	ADP	O
the	O	DET	O
synovial	O	ADJ	B
lining	O	NOUN	I
,	O	PUNCT	O
compared	O	VERB	B
to	O	PART	O
the	O	DET	O
sublining	O	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
activation	O	NOUN	B
in	O	ADP	O
the	O	DET	O
lining	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
positive	O	ADJ	B
correlation	O	NOUN	B
of	O	ADP	O
lining	O	VERB	B
layer	O	NOUN	I
depth	O	NOUN	B
with	O	ADP	O
the	O	DET	O
percentage	O	NOUN	B
of	O	ADP	O
cells	O	NOUN	B
in	O	ADP	O
the	O	DET	O
lining	O	ADJ	B
positive	O	ADJ	B
for	O	ADP	O
nuclear	O	ADJ	B
C/EBP	B-protein	NOUN	I
beta	I-protein	NOUN	I
,	O	PUNCT	O
suggest	O	VERB	O
a	O	DET	O
potential	O	ADJ	O
role	O	NOUN	O
for	O	ADP	O
C/EBP	B-protein	NOUN	B
beta	I-protein	NOUN	I
in	O	ADP	O
chronic	O	ADJ	B
inflammation	O	NOUN	I
.	O	PUNCT	O


IRF-1	B-protein	NOUN	B
is	O	AUX	O
a	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
regulated	O	VERB	O
by	O	ADP	O
IFNs	B-protein	NOUN	B
that	O	PRON	O
is	O	AUX	O
also	O	ADV	O
essential	O	ADJ	O
for	O	ADP	O
Th1	B-cell_type	NOUN	B
responses	O	NOUN	B
.	O	PUNCT	O


First	O	ADV	O
,	O	PUNCT	O
STAT4	B-protein	NOUN	B
was	O	AUX	O
required	O	VERB	O
for	O	ADP	O
the	O	DET	O
IL-12	B-protein	NOUN	B
-dependent	O	ADJ	O
transactivation	O	NOUN	B
of	O	ADP	O
an	O	DET	O
IRF-1	B-DNA	NOUN	B
reporter	I-DNA	NOUN	I
construct	I-DNA	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
second	O	ADV	O
,	O	PUNCT	O
STAT4	B-protein	NOUN	B
binding	O	VERB	B
to	O	PART	O
the	O	DET	O
IRF-1	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
was	O	AUX	O
shown	O	VERB	O
using	O	VERB	O
EMSA	O	NOUN	B
.	O	PUNCT	O


Therefore	O	ADV	O
,	O	PUNCT	O
IRF-1	B-protein	NOUN	B
may	O	AUX	O
be	O	AUX	O
an	O	DET	O
important	O	ADJ	O
contributor	O	NOUN	O
to	O	PART	O
IL-12	B-protein	NOUN	B
signaling	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
we	O	PRON	O
speculate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
defective	O	ADJ	B
IL-12	B-protein	NOUN	B
responses	O	NOUN	B
seen	O	VERB	O
in	O	ADP	O
IRF	B-protein	NOUN	B
-1-/-	O	ADJ	O
mice	O	NOUN	B
might	O	AUX	O
be	O	AUX	O
attributable	O	ADJ	O
,	O	PUNCT	O
in	O	ADP	O
part	O	NOUN	O
,	O	PUNCT	O
to	O	PART	O
the	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
this	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
.	O	PUNCT	O


One	O	NUM	O
feature	O	NOUN	O
of	O	ADP	O
this	O	DET	O
chromatin	O	NOUN	B
reorganization	O	NOUN	I
is	O	AUX	O
the	O	DET	O
formation	O	NOUN	B
of	O	ADP	O
DNase	B-DNA	NOUN	B
1	I-DNA	NUM	I
hypersensitive	I-DNA	ADJ	B
sites	I-DNA	NOUN	I
in	O	ADP	O
the	O	DET	O
regions	O	NOUN	B
of	O	ADP	O
active	B-DNA	ADJ	O
globin	I-DNA	NOUN	O
gene	I-DNA	NOUN	B
promoters	I-DNA	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
recently	O	ADV	O
reported	O	VERB	O
that	O	SCONJ	O
prolonged	O	ADJ	B
exposure	O	NOUN	B
of	O	ADP	I
human	B-cell_type	ADJ	B
aortic	I-cell_type	ADJ	O
endothelial	I-cell_type	ADJ	O
cells	I-cell_type	NOUN	O
(	O	PUNCT	O
HAEC	B-cell_line	NOUN	B
)	O	PUNCT	O
to	O	PART	O
low	O	ADJ	B
shear	O	NOUN	B
stress	O	NOUN	I
flow	O	NOUN	I
patterns	O	NOUN	O
is	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
a	O	DET	O
sustained	O	ADJ	O
increase	O	NOUN	B
in	O	ADP	O
the	O	DET	O
activated	O	VERB	B
form	O	NOUN	O
of	O	ADP	O
the	O	DET	O
transcriptional	O	ADJ	B
regulator	O	NOUN	I
nuclear	B-protein	ADJ	O
factor-kappaB	I-protein	NOUN	O
(	O	PUNCT	O
NF-kappaB	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


NFAT	O	NOUN	B
transcription	O	NOUN	B
factors	O	NOUN	I
bind	O	VERB	B
to	O	PART	O
a	O	DET	O
sequence	O	NOUN	B
in	O	ADP	O
the	O	DET	O
IL-2	B-DNA	NOUN	B
enhancer	I-DNA	NOUN	I
known	O	VERB	O
as	O	ADP	O
the	O	DET	O
antigen	B-DNA	NOUN	B
receptor	I-DNA	NOUN	I
response	I-DNA	NOUN	I
element	I-DNA	NOUN	I
2	I-DNA	NUM	I
(	O	PUNCT	O
ARRE-2	B-DNA	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Using	O	VERB	O
in	O	X	B
vitro	O	X	I
translated	O	VERB	B
polypeptides	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
demonstrated	O	VERB	O
that	O	SCONJ	O
NF90	B-protein	NOUN	B
specifically	O	ADV	O
binds	O	VERB	B
to	O	PART	O
double-stranded	B-RNA	ADJ	B
RNA	I-RNA	NOUN	I
.	O	PUNCT	O


The	O	DET	O
correlation	O	NOUN	B
between	O	ADP	O
C5a-induced	O	ADJ	O
kappaB	B-protein	NOUN	B
binding	O	NOUN	I
activity	O	NOUN	I
and	O	CCONJ	O
IL-8	B-protein	NOUN	B
gene	O	NOUN	O
expression	O	NOUN	B
was	O	AUX	O
examined	O	VERB	O
in	O	ADP	O
the	O	DET	O
RAW264.7	B-cell_line	NOUN	B
macrophage	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
using	O	VERB	O
reporter	O	NOUN	B
genes	O	NOUN	I
directed	O	VERB	O
by	O	ADP	O
the	O	DET	O
kappaB	B-DNA	NOUN	B
sequence	I-DNA	NOUN	I
from	O	ADP	O
IkappaBalpha	B-protein	NOUN	B
and	O	CCONJ	O
IL-8	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
regions	I-DNA	NOUN	I
.	O	PUNCT	O


Alternative	O	ADJ	B
splicing	O	NOUN	I
of	O	ADP	O
the	O	DET	O
GC	B-RNA	NOUN	B
receptor	I-RNA	NOUN	I
(	I-RNA	PUNCT	O
GCR	I-RNA	NOUN	B
)	I-RNA	PUNCT	O
pre-mRNA	I-RNA	NOUN	B
generates	O	VERB	O
a	O	DET	O
second	O	ADJ	O
GCR	B-protein	NOUN	B
,	O	PUNCT	O
termed	O	VERB	O
GCRbeta	B-protein	NOUN	B
,	O	PUNCT	O
which	O	DET	O
does	O	AUX	O
not	O	PART	O
bind	O	VERB	B
GC	O	NOUN	B
but	O	CCONJ	O
antagonizes	O	VERB	B
the	O	DET	O
transactivating	O	NOUN	B
activity	O	NOUN	O
of	O	ADP	O
the	O	DET	O
classic	O	ADJ	B
GCR	B-protein	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
also	O	ADV	O
examined	O	VERB	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
GCRbeta	B-protein	NOUN	B
in	O	ADP	O
specimens	O	NOUN	B
from	O	ADP	O
the	O	DET	O
airways	O	NOUN	B
of	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
chronic	O	ADJ	B
bronchitis	O	NOUN	I
.	O	PUNCT	O


Novel	O	ADJ	B
therapies	O	NOUN	B
for	O	ADP	O
inflammatory	O	ADJ	B
bowel	O	NOUN	I
disease	O	NOUN	I
.	O	PUNCT	O


When	O	SCONJ	O
a	O	DET	O
drug	O	NOUN	B
appears	O	VERB	O
to	O	PART	O
be	O	AUX	O
less	O	ADV	O
effective	O	ADJ	B
than	O	ADP	O
preclinical	O	ADJ	B
models	O	NOUN	I
suggest	O	VERB	O
,	O	PUNCT	O
can	O	AUX	O
failures	O	NOUN	B
in	O	ADP	O
effectiveness	O	NOUN	B
from	O	ADP	O
delivery	O	NOUN	B
or	O	CCONJ	O
dosing	O	NOUN	B
be	O	AUX	O
differentiated	O	VERB	B
?	O	PUNCT	O
The	O	DET	O
disappointing	O	ADJ	O
results	O	NOUN	B
of	O	ADP	O
clinical	O	ADJ	B
trials	O	NOUN	I
with	O	ADP	O
IL-10	B-protein	NOUN	B
--	O	PUNCT	O
so	O	SCONJ	O
at	O	ADP	O
odds	O	NOUN	B
with	O	ADP	O
the	O	DET	O
prediction	O	NOUN	B
of	O	ADP	O
benefit	O	NOUN	B
from	O	ADP	O
animal	O	NOUN	B
models	O	NOUN	I
--	O	PUNCT	O
bring	O	VERB	O
into	O	ADP	O
question	O	NOUN	O
the	O	DET	O
validity	O	NOUN	B
of	O	ADP	O
those	O	DET	O
models	O	NOUN	B
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
the	O	DET	O
soundness	O	NOUN	B
of	O	ADP	O
design	O	NOUN	B
of	O	ADP	O
the	O	DET	O
clinical	O	ADJ	B
trials	O	NOUN	I
on	O	ADP	O
which	O	DET	O
efficacy	O	NOUN	B
of	O	ADP	O
IL-10	B-protein	NOUN	B
is	O	AUX	O
judged	O	VERB	O
.	O	PUNCT	O


The	O	DET	O
variability	O	NOUN	B
of	O	ADP	O
response	O	NOUN	B
even	O	ADV	O
to	O	PART	O
the	O	DET	O
most	O	ADV	O
narrowly	O	ADV	O
targeted	O	VERB	B
agents	O	NOUN	I
suggests	O	VERB	O
that	O	SCONJ	O
these	O	DET	O
diseases	O	NOUN	B
are	O	AUX	O
far	O	ADV	O
more	O	ADV	O
heterogeneous	O	ADJ	B
in	O	ADP	O
humans	O	NOUN	B
than	O	ADP	O
in	O	ADP	O
their	O	PRON	O
murine	O	ADJ	B
counterparts	O	NOUN	B
.	O	PUNCT	O


HIV-1	O	NOUN	B
expressing	O	VERB	B
IkappaB-alphaS32/36A	B-protein	NOUN	B
down-regulates	O	VERB	B
viral	O	ADJ	B
expression	O	NOUN	I
and	O	CCONJ	O
is	O	AUX	O
highly	O	ADV	O
attenuated	O	VERB	B
in	O	ADP	O
both	O	CCONJ	O
Jurkat	B-cell_line	NOUN	B
and	O	CCONJ	O
peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
mononuclear	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
IkappaB-alphaS32/36A	B-protein	NOUN	B
offers	O	VERB	O
proof-of-principle	O	NOUN	O
that	O	SCONJ	O
artifactually	O	ADV	B
gained	O	VERB	O
functions	O	NOUN	O
,	O	PUNCT	O
when	O	SCONJ	O
used	O	VERB	O
to	O	PART	O
attenuate	O	VERB	B
the	O	DET	O
replication	O	NOUN	B
of	O	ADP	O
live	O	ADJ	B
HIV-1	O	NOUN	B
,	O	PUNCT	O
can	O	AUX	O
be	O	AUX	O
stable	O	ADJ	B
.	O	PUNCT	O


TCR	B-protein	NOUN	B
affinities	O	NOUN	B
were	O	AUX	O
then	O	ADV	O
indirectly	O	ADV	O
estimated	O	VERB	O
by	O	ADP	O
blocking	O	VERB	B
CD8	B-protein	NOUN	B
interaction	O	NOUN	B
with	O	ADP	O
an	O	DET	O
anti-CD8	B-protein	ADJ	B
mAb	I-protein	NOUN	B
.	O	PUNCT	O


During	O	ADP	O
studies	O	NOUN	B
of	O	ADP	O
apoptosis	O	NOUN	B
induced	O	VERB	B
by	O	ADP	O
T	O	NOUN	B
cell-receptor	O	NOUN	I
engagement	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
identified	O	VERB	O
ALG-4F	B-protein	NOUN	B
,	O	PUNCT	O
a	O	DET	O
truncated	B-protein	VERB	B
transcript	I-protein	NOUN	O
that	O	PRON	O
prevents	O	VERB	B
T	O	NOUN	B
cell-receptor-induced	O	ADJ	O
FasL	B-protein	NOUN	B
upregulation	O	NOUN	B
and	O	CCONJ	O
cell	O	NOUN	B
death	O	NOUN	I
.	O	PUNCT	O


Overexpression	O	NOUN	B
of	O	ADP	O
full-length	B-protein	ADJ	B
ALG-4	I-protein	NOUN	B
induced	O	VERB	B
transcription	O	NOUN	B
of	O	ADP	O
FasL	B-protein	NOUN	B
and	O	CCONJ	O
,	O	PUNCT	O
consequently	O	ADV	O
,	O	PUNCT	O
apoptosis	O	NOUN	B
.	O	PUNCT	O


Further	O	ADV	O
,	O	PUNCT	O
LMP1	B-protein	NOUN	B
does	O	AUX	O
not	O	PART	O
require	O	VERB	O
TRADD	B-protein	NOUN	B
residues	O	NOUN	B
294	O	NUM	O
to	O	PART	O
312	O	NUM	O
for	O	ADP	O
NF-kappaB	B-protein	NOUN	B
activation	O	NOUN	B
,	O	PUNCT	O
while	O	SCONJ	O
TNFR1	B-protein	NOUN	B
requires	O	VERB	O
TRADD	B-protein	NOUN	B
residues	O	NOUN	B
296	O	NUM	O
to	O	PART	O
302	O	NUM	O
.	O	PUNCT	O


Inhibition	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
resulted	O	VERB	O
in	O	ADP	O
the	O	DET	O
externalization	O	NOUN	B
of	O	ADP	O
phosphatidylserine	O	NOUN	B
,	O	PUNCT	O
induction	O	NOUN	B
of	O	ADP	O
DNA	O	NOUN	B
breaks	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
morphological	O	ADJ	B
changes	O	NOUN	B
consistent	O	ADJ	B
with	O	ADP	I
apoptosis	O	NOUN	B
.	O	PUNCT	O


Preactivation	O	NOUN	B
of	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
resulting	O	VERB	O
in	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
nuclear	O	ADJ	O
translocation	O	NOUN	O
protected	O	VERB	O
cells	O	NOUN	B
from	O	ADP	O
SN50-induced	O	ADJ	B
apoptosis	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
Ras	B-protein	NOUN	B
-Aiolos	B-protein	NOUN	O
interaction	O	NOUN	B
was	O	AUX	O
confirmed	O	VERB	O
in	O	X	B
vitro	O	X	I
and	O	CCONJ	O
in	O	X	B
vivo	O	X	I
by	O	ADP	O
co-immunoprecipitation	O	NOUN	B
.	O	PUNCT	O


Co-transfection	O	NOUN	B
experiments	O	NOUN	B
confirm	O	VERB	B
that	O	SCONJ	O
Aiolos	B-protein	NOUN	B
induces	O	VERB	O
Bcl-2	B-protein	NOUN	B
expression	O	NOUN	B
and	O	CCONJ	O
prevents	O	VERB	B
apoptosis	O	NOUN	B
in	O	ADP	O
IL-2-deprived	B-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Binding	O	NOUN	B
of	O	ADP	O
YY1	B-protein	NOUN	B
and	O	CCONJ	O
Oct1	B-protein	NOUN	B
to	O	PART	O
a	O	DET	O
novel	O	ADJ	B
element	O	NOUN	B
that	O	PRON	O
downregulates	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
IL-5	B-protein	NOUN	B
in	O	ADP	O
human	O	ADJ	B
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
both	O	CCONJ	O
atopic	O	ADJ	B
and	O	CCONJ	O
nonatopic	O	ADJ	B
asthma	O	NOUN	I
,	O	PUNCT	O
elevated	O	ADJ	B
IL-5	B-protein	NOUN	B
has	O	AUX	O
been	O	AUX	O
detected	O	VERB	B
in	O	ADP	O
peripheral	O	ADJ	B
blood	O	NOUN	I
and	O	CCONJ	O
the	O	DET	O
airways	O	NOUN	B
.	O	PUNCT	O


RESULTS	O	NOUN	B
:	O	PUNCT	O
We	O	PRON	O
identified	O	VERB	B
5	O	NUM	O
protein	B-DNA	NOUN	B
binding	I-DNA	NOUN	I
regions	I-DNA	NOUN	I
(	O	PUNCT	O
BRs	B-DNA	NOUN	B
)	O	PUNCT	O
located	O	ADJ	O
within	O	ADP	O
the	O	DET	O
proximal	B-DNA	ADJ	B
hIL-5	I-DNA	NOUN	B
promoter	I-DNA	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
BR3	B-DNA	NOUN	B
sequence	O	NOUN	B
contains	O	VERB	O
a	O	DET	O
novel	O	ADJ	O
negative	B-DNA	ADJ	B
regulatory	I-DNA	ADJ	B
element	I-DNA	NOUN	I
located	O	ADJ	O
at	O	ADP	O
positions	O	NOUN	B
-90	O	NUM	O
to	O	PART	O
-79	O	NUM	O
of	O	ADP	O
the	O	DET	O
hIL-5	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
,	O	PUNCT	O
which	O	DET	O
binds	O	VERB	B
Oct1	B-protein	NOUN	B
,	O	PUNCT	O
octamer-like	B-protein	ADJ	B
,	O	PUNCT	O
and	O	CCONJ	O
YY1	B-protein	NOUN	B
nuclear	I-protein	ADJ	B
factors	I-protein	NOUN	I
.	O	PUNCT	O


Human	B-protein	ADJ	B
T-cell	I-protein	NOUN	I
leukemia	I-protein	NOUN	I
virus	I-protein	NOUN	O
type	I-protein	NOUN	O
1	I-protein	NUM	O
(	I-protein	PUNCT	O
HTLV-1	I-protein	NOUN	B
)	I-protein	PUNCT	O
Tax	I-protein	NOUN	B
transforms	O	VERB	O
normal	O	ADJ	O
T-cells	B-cell_type	NOUN	B
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
interleukin	B-protein	NOUN	B
(	I-protein	PUNCT	I
IL	I-protein	NOUN	B
)	I-protein	PUNCT	O
-2	I-protein	NUM	O
in	O	X	B
vitro	O	X	I
.	O	PUNCT	O


STAT	B-protein	NOUN	B
is	O	AUX	O
a	O	DET	O
family	O	NOUN	B
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
that	O	PRON	O
play	O	VERB	O
a	O	DET	O
pivotal	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
cytokine-induced	O	ADJ	B
functions	O	NOUN	I
of	O	ADP	O
a	O	DET	O
various	O	ADJ	O
type	O	NOUN	O
of	O	ADP	O
cells	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
STAT1	B-protein	NOUN	B
and	O	CCONJ	O
STAT5	B-protein	NOUN	B
in	O	ADP	O
a	O	DET	O
human	B-cell_line	ADJ	B
T-cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
was	O	AUX	O
induced	O	VERB	B
by	O	ADP	O
Tax	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
role	O	NOUN	O
of	O	ADP	O
the	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
NF-kappaB	B-protein	NOUN	I
in	O	ADP	O
the	O	DET	O
pathogenesis	O	NOUN	B
of	O	ADP	O
rheumatoid	O	ADJ	B
arthritis	O	NOUN	I
has	O	AUX	O
long	O	ADV	O
been	O	AUX	O
a	O	DET	O
subject	O	NOUN	B
of	O	ADP	O
controversy	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
found	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
spontaneous	O	ADJ	B
production	O	NOUN	B
of	O	ADP	O
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor	I-protein	NOUN	I
alpha	I-protein	NOUN	I
and	O	CCONJ	O
other	O	ADJ	O
pro-inflammatory	B-protein	ADJ	B
cytokines	I-protein	NOUN	O
is	O	AUX	O
NF-kappaB	B-protein	NOUN	B
-dependent	O	ADJ	O
in	O	ADP	O
rheumatoid	O	ADJ	B
synovial	O	ADJ	O
tissue	O	NOUN	O
,	O	PUNCT	O
in	O	ADP	O
contrast	O	NOUN	O
to	O	PART	O
the	O	DET	O
main	O	ADJ	O
anti-inflammatory	B-protein	ADJ	B
mediators	I-protein	NOUN	O
,	O	PUNCT	O
like	O	ADP	O
IL-10	B-protein	NOUN	B
and	I-protein	CCONJ	O
-11	I-protein	NUM	B
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
IL-1	B-protein	NOUN	B
receptor	I-protein	NOUN	I
antagonist	I-protein	NOUN	B
.	O	PUNCT	O


Of	O	ADP	O
even	O	ADV	O
more	O	ADJ	O
interest	O	NOUN	O
,	O	PUNCT	O
IkappaBalpha	B-protein	NOUN	B
overexpression	O	NOUN	B
inhibited	O	VERB	B
the	O	DET	O
production	O	NOUN	B
of	O	ADP	O
matrix	B-protein	NOUN	B
metalloproteinases	I-protein	NOUN	I
1	I-protein	NUM	I
and	I-protein	CCONJ	O
3	I-protein	NUM	O
while	O	SCONJ	O
not	O	PART	O
affecting	O	VERB	O
their	O	PRON	O
tissue	O	NOUN	B
inhibitor	O	NOUN	I
.	O	PUNCT	O


Blocking	O	VERB	B
NF-kappaB	B-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
rheumatoid	O	ADJ	B
joint	O	NOUN	I
thus	O	ADV	O
has	O	AUX	O
a	O	DET	O
very	O	ADV	O
beneficial	O	ADJ	O
profile	O	NOUN	O
,	O	PUNCT	O
reducing	O	VERB	B
both	O	CCONJ	O
the	O	DET	O
inflammatory	O	ADJ	B
response	O	NOUN	I
and	O	CCONJ	O
the	O	DET	O
tissue	O	NOUN	B
destruction	O	NOUN	B
.	O	PUNCT	O


Our	O	PRON	O
data	O	NOUN	B
demonstrate	O	VERB	O
that	O	SCONJ	O
those	O	DET	O
cell	B-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
lacking	O	VERB	O
capability	O	NOUN	B
to	O	PART	O
form	O	VERB	O
metastatic	O	ADJ	B
tumors	O	NOUN	I
in	O	X	B
vivo	O	X	I
are	O	AUX	O
susceptible	O	ADJ	B
to	O	PART	O
TNF	B-protein	NOUN	B
induced	O	ADJ	B
apoptosis	O	NOUN	B
in	O	X	B
vitro	O	X	I
.	O	PUNCT	O


To	O	PART	O
ascertain	O	VERB	O
this	O	DET	O
possibility	O	NOUN	O
,	O	PUNCT	O
we	O	PRON	O
examined	O	VERB	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
markers	O	NOUN	B
for	O	ADP	O
B-cell	O	NOUN	B
activation	O	NOUN	I
,	O	PUNCT	O
differentiation	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
proliferation	O	NOUN	B
in	O	ADP	O
ILFs	O	NOUN	B
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
chronic	O	ADJ	B
hepatitis	O	NOUN	I
C	O	NOUN	I
using	O	VERB	O
surgically	O	ADV	B
resected	O	ADJ	I
specimens	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
compared	O	VERB	B
them	O	PRON	O
with	O	ADP	O
specimens	O	NOUN	B
of	O	ADP	O
perihepatic	O	ADJ	B
lymph	O	NOUN	I
nodes	O	NOUN	I
by	O	ADP	O
an	O	DET	O
immunohistochemical	O	ADJ	B
technique	O	NOUN	I
.	O	PUNCT	O


K562	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
express	O	VERB	O
endogenous	O	ADJ	B
WT1	B-DNA	NOUN	B
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
downregulated	O	VERB	B
as	O	ADP	O
a	O	DET	O
response	O	NOUN	B
to	O	PART	O
induced	O	VERB	B
differentiation	O	NOUN	B
along	O	ADP	O
the	O	DET	O
erythroid	O	ADJ	B
and	O	CCONJ	O
megakaryocytic	O	ADJ	B
pathways	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
previously	O	ADV	O
shown	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
membrane-proximal	B-protein	ADJ	B
portion	I-protein	NOUN	I
in	O	ADP	O
the	O	DET	O
cytoplasmic	B-protein	ADJ	B
domain	I-protein	NOUN	I
of	O	ADP	O
the	O	DET	O
human	B-protein	ADJ	B
IL-4R	I-protein	NOUN	O
alpha	I-protein	NOUN	O
(	O	PUNCT	O
hIL-4R	B-protein	NOUN	B
alpha	I-protein	NOUN	I
)	O	PUNCT	O
is	O	AUX	O
critical	O	ADJ	O
for	O	ADP	O
proliferation	O	NOUN	B
,	O	PUNCT	O
generation	O	NOUN	B
of	O	ADP	O
germline	O	NOUN	B
epsilon	O	NOUN	I
transcript	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
activation	O	NOUN	B
of	O	ADP	O
STAT6	B-protein	NOUN	B
,	O	PUNCT	O
based	O	VERB	O
on	O	ADP	O
analyses	O	NOUN	B
of	O	ADP	O
truncated	B-protein	VERB	O
hIL-4R	I-protein	NOUN	B
alphas	I-protein	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
study	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
found	O	VERB	O
that	O	SCONJ	O
p47phox	O	NOUN	B
,	O	PUNCT	O
an	O	DET	O
activator	O	NOUN	B
of	O	ADP	O
the	O	DET	O
phagocyte	B-protein	NOUN	B
NADPH	I-protein	NOUN	B
oxidase	I-protein	NOUN	I
,	O	PUNCT	O
binds	O	VERB	B
to	O	PART	O
this	O	DET	O
portion	O	NOUN	B
by	O	ADP	O
the	O	DET	O
two-hybrid	O	ADJ	B
system	O	NOUN	I
.	O	PUNCT	O


METHODS	O	NOUN	O
:	O	PUNCT	O
Protein	O	NOUN	B
production	O	NOUN	I
in	O	ADP	O
supernatants	O	NOUN	B
was	O	AUX	O
assessed	O	VERB	B
by	O	ADP	O
ELISA	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
mRNA	B-RNA	NOUN	B
expression	O	NOUN	B
was	O	AUX	O
evaluated	O	VERB	B
by	O	ADP	O
semiquantitative	O	ADJ	B
RT-PCR	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
provide	O	VERB	O
compelling	O	ADJ	O
links	O	NOUN	O
between	O	ADP	O
the	O	DET	O
efficiency	O	NOUN	B
of	O	ADP	O
the	O	DET	O
20-epi	O	NOUN	O
analogue	O	NOUN	B
in	O	ADP	O
inducing	O	VERB	O
VDR	B-protein	NOUN	B
/DRIP	O	NOUN	O
interactions	O	NOUN	B
,	O	PUNCT	O
transactivation	O	NOUN	B
in	O	X	B
vitro	O	X	I
,	O	PUNCT	O
and	O	CCONJ	O
its	O	PRON	O
enhanced	O	VERB	O
ability	O	NOUN	O
to	O	PART	O
induce	O	VERB	B
cellular	O	ADJ	B
differentiation	O	NOUN	I
.	O	PUNCT	O


Following	O	VERB	O
T	B-protein	NOUN	B
cell	I-protein	NOUN	I
antigen	I-protein	NOUN	I
receptor	I-protein	NOUN	I
stimulation	O	NOUN	I
,	O	PUNCT	O
SLP-76	B-protein	NOUN	B
and	O	CCONJ	O
Vav	B-protein	NOUN	B
both	O	DET	O
undergo	O	VERB	O
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	I
and	O	CCONJ	O
associate	O	VERB	B
with	O	ADP	I
each	O	DET	O
other	O	ADJ	O
via	O	ADP	O
the	O	DET	O
SH2	O	NOUN	B
domain	O	NOUN	I
of	O	ADP	O
Vav	B-protein	NOUN	B
and	O	CCONJ	O
phosphorylated	O	ADJ	B
tyrosines	O	NOUN	I
of	O	ADP	O
SLP-76	B-protein	NOUN	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
SLP-76	B-protein	NOUN	B
and	O	CCONJ	O
Vav	B-protein	NOUN	B
have	O	AUX	O
a	O	DET	O
synergistic	O	ADJ	B
effect	O	NOUN	O
on	O	ADP	O
interleukin	B-DNA	NOUN	B
(	I-DNA	PUNCT	I
IL	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
-2	I-DNA	NUM	O
promoter	I-DNA	NOUN	B
activity	O	NOUN	I
in	O	ADP	O
T	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Rel/NF-kappaB	B-protein	NOUN	B
can	O	AUX	O
trigger	O	VERB	O
the	O	DET	O
Notch	O	NOUN	B
signaling	O	NOUN	I
pathway	O	NOUN	I
by	O	ADP	O
inducing	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
Jagged1	B-protein	NOUN	B
,	O	PUNCT	O
a	O	DET	O
ligand	O	NOUN	B
for	O	ADP	O
Notch	B-protein	NOUN	B
receptors	I-protein	NOUN	I
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	B
demonstrated	O	VERB	O
that	O	SCONJ	O
:	O	PUNCT	O
(	O	PUNCT	O
i	O	X	O
)	O	PUNCT	O
PGN	O	NOUN	B
induced	O	VERB	B
phosphorylation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
ATF-1	B-protein	NOUN	B
and	O	CCONJ	O
CREB	B-protein	NOUN	B
;	O	PUNCT	O
(	O	PUNCT	O
ii	O	X	O
)	O	PUNCT	O
ATF-1	B-protein	NOUN	B
and	O	CCONJ	O
CREB	B-protein	NOUN	B
bound	O	VERB	O
DNA	O	NOUN	O
as	O	ADP	O
a	O	DET	O
dimer	O	NOUN	B
and	O	CCONJ	O
induced	O	VERB	B
transcriptional	O	ADJ	B
activation	O	NOUN	I
of	O	ADP	O
a	O	DET	O
CRE	B-DNA	NOUN	B
reporter	I-DNA	NOUN	I
plasmid	I-DNA	NOUN	I
,	O	PUNCT	O
which	O	DET	O
was	O	AUX	O
inhibited	O	VERB	B
by	O	ADP	O
dominant	O	ADJ	B
negative	O	ADJ	B
CREB	B-protein	NOUN	B
and	O	CCONJ	O
ATF-1	B-protein	NOUN	B
;	O	PUNCT	O
(	O	PUNCT	O
iii	O	X	O
)	O	PUNCT	O
PGN	O	NOUN	B
induced	O	VERB	B
phosphorylation	O	NOUN	B
of	O	ADP	O
c-Jun	B-protein	NOUN	B
,	O	PUNCT	O
protein	O	NOUN	B
synthesis	O	NOUN	I
of	O	ADP	O
JunB	B-protein	NOUN	B
and	O	CCONJ	O
c-Fos	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
transcriptional	O	ADJ	B
activation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
AP-1	B-DNA	NOUN	B
reporter	I-DNA	NOUN	I
plasmid	I-DNA	NOUN	I
,	O	PUNCT	O
which	O	DET	O
was	O	AUX	O
inhibited	O	VERB	B
by	O	ADP	O
dominant	O	ADJ	B
negative	O	ADJ	B
c-Fos	B-protein	NOUN	B
;	O	PUNCT	O
and	O	CCONJ	O
(	O	PUNCT	O
iv	O	X	O
)	O	PUNCT	O
PGN-induced	O	ADJ	B
activation	O	NOUN	B
of	O	ADP	O
CREB/ATF	B-protein	NOUN	B
and	O	CCONJ	O
AP-1	B-protein	NOUN	B
was	O	AUX	O
mediated	O	VERB	O
through	O	ADP	O
CD14	B-protein	NOUN	B
.	O	PUNCT	O


BACKGROUND	O	NOUN	B
:	O	PUNCT	O
Growing	O	VERB	O
evidence	O	NOUN	B
indicates	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
immune	O	ADJ	B
system	O	NOUN	I
and	O	CCONJ	O
the	O	DET	O
hypothalamic-pituitary-adrenal	O	ADJ	B
system	O	NOUN	I
are	O	AUX	O
linked	O	VERB	O
by	O	ADP	O
several	O	ADJ	O
mechanisms	O	NOUN	B
,	O	PUNCT	O
for	O	ADP	O
example	O	ADJ	O
intracellular	O	ADJ	B
glucocorticoid	B-protein	NOUN	B
receptors	I-protein	NOUN	I
(	O	PUNCT	O
hGR	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


PATIENTS	O	NOUN	B
AND	O	CCONJ	O
METHODS	O	NOUN	O
:	O	PUNCT	O
IBD	O	NOUN	B
patients	O	NOUN	B
were	O	AUX	O
either	O	ADV	O
treated	O	VERB	B
with	O	ADP	I
5-60	O	NUM	O
mg	O	NOUN	O
of	O	ADP	O
prednisolone	O	NOUN	B
for	O	ADP	O
more	O	ADJ	O
than	O	ADP	O
1	O	NUM	O
week	O	NOUN	B
or	O	CCONJ	O
were	O	AUX	O
without	O	ADP	O
glucocorticoid	O	NOUN	B
treatment	O	NOUN	B
for	O	ADP	O
more	O	ADJ	O
than	O	ADP	O
4	O	NUM	O
weeks	O	NOUN	B
.	O	PUNCT	O


ICSAT	B-protein	NOUN	B
(	O	PUNCT	O
Interferon	B-protein	NOUN	B
Consensus	I-protein	NOUN	I
Sequence	I-protein	NOUN	I
binding	I-protein	NOUN	I
protein	I-protein	NOUN	I
for	I-protein	ADP	O
Activated	I-protein	VERB	B
T	I-protein	NOUN	I
cells	I-protein	NOUN	I
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
lymphocyte-specific	O	ADJ	B
member	O	NOUN	I
of	O	ADP	O
the	O	DET	O
interferon	B-protein	NOUN	B
regulatory	I-protein	ADJ	I
factor	I-protein	NOUN	I
(	I-protein	PUNCT	O
IRF	I-protein	NOUN	B
)	I-protein	PUNCT	O
family	I-protein	NOUN	B
of	O	ADP	O
transcription	O	NOUN	B
factors	O	NOUN	I
,	O	PUNCT	O
originally	O	ADV	O
identified	O	VERB	B
through	O	ADP	O
Southwestern	O	NOUN	B
screening	O	NOUN	I
of	O	ADP	O
the	O	DET	O
ATL	B-DNA	NOUN	B
(	I-DNA	PUNCT	O
Adult	I-DNA	ADJ	B
T-cell	I-DNA	NOUN	I
leukemia	I-DNA	NOUN	I
)	I-DNA	PUNCT	O
-16T	I-DNA	ADJ	O
expression	I-DNA	NOUN	B
library	I-DNA	NOUN	I
.	O	PUNCT	O


No	O	DET	B
difference	O	NOUN	I
in	O	ADP	O
cytokine	B-protein	NOUN	B
secretion	O	NOUN	I
profiles	O	NOUN	B
of	O	ADP	O
freshly	B-cell_type	ADV	B
isolated	I-cell_type	VERB	B
memory	I-cell_type	NOUN	O
T	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
was	O	AUX	O
detected	O	VERB	B
between	O	ADP	O
patients	O	NOUN	B
and	O	CCONJ	O
controls	O	NOUN	B
.	O	PUNCT	O


By	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
priming	O	NOUN	B
under	O	ADP	O
those	O	DET	O
conditions	O	NOUN	B
resulted	O	VERB	O
in	O	ADP	O
Th2	O	NOUN	B
differentiation	O	NOUN	B
in	O	ADP	O
only	O	ADV	O
9	O	NUM	O
of	O	ADP	O
24	O	NUM	O
RA	O	NOUN	B
patients	O	NOUN	B
.	O	PUNCT	O


Our	O	PRON	O
findings	O	NOUN	B
offer	O	VERB	O
important	O	ADJ	O
insights	O	NOUN	O
into	O	ADP	O
parasite	O	ADJ	B
survival	O	NOUN	B
strategies	O	NOUN	O
and	O	CCONJ	O
demonstrate	O	VERB	O
that	O	SCONJ	O
parasite-induced	O	ADJ	B
constitutive	O	ADJ	O
NF-kappaB	B-protein	NOUN	B
activation	O	NOUN	O
is	O	AUX	O
an	O	DET	O
essential	O	ADJ	O
step	O	NOUN	O
in	O	ADP	O
maintaining	O	VERB	O
the	O	DET	O
transformed	O	VERB	O
phenotype	O	NOUN	B
of	O	ADP	O
the	O	DET	O
infected	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	B
.	O	PUNCT	O


To	O	PART	O
find	O	VERB	O
out	O	ADP	O
if	O	SCONJ	O
the	O	DET	O
induction	O	NOUN	B
by	O	ADP	O
UV	O	NOUN	B
light	O	NOUN	I
is	O	AUX	O
caused	O	VERB	O
by	O	ADP	O
the	O	DET	O
formation	O	NOUN	B
of	O	ADP	O
an	O	DET	O
Ah	O	NOUN	B
receptor	O	NOUN	I
ligand	O	NOUN	B
,	O	PUNCT	O
Hepa-1	B-cell_line	NOUN	B
wild-type	I-cell_line	ADJ	B
and	I-cell_line	CCONJ	O
Ah	I-cell_line	NOUN	B
receptor	I-cell_line	NOUN	I
deficient	I-cell_line	ADJ	O
c12	I-cell_line	NOUN	O
cell	I-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
were	O	AUX	O
applied	O	VERB	O
.	O	PUNCT	O


Consistent	O	ADJ	B
with	O	ADP	I
these	O	DET	O
findings	O	NOUN	B
,	O	PUNCT	O
Ikaros	B-protein	NOUN	B
and	O	CCONJ	O
its	O	PRON	O
repression	B-protein	NOUN	B
domains	I-protein	NOUN	I
can	O	AUX	O
interact	O	VERB	B
in	O	X	B
vivo	O	X	I
and	O	CCONJ	O
in	O	X	B
vitro	O	X	I
with	O	ADP	O
the	O	DET	O
mSin3	B-protein	NOUN	B
family	I-protein	NOUN	I
of	O	ADP	O
co-repressors	O	NOUN	B
which	O	DET	O
bind	O	VERB	B
to	O	PART	O
histone	B-protein	NOUN	B
deacetylases	I-protein	NOUN	I
.	O	PUNCT	O


Protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
B	I-protein	NOUN	I
(	O	PUNCT	O
c-Akt	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
phosphatidylinositol	B-protein	NOUN	B
3-kinase	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
STAT5	B-protein	NOUN	B
are	O	AUX	O
activated	O	VERB	B
by	O	ADP	O
erythropoietin	B-protein	NOUN	B
(	O	PUNCT	O
EPO	B-protein	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
HCD57	B-cell_line	NOUN	B
erythroid	I-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
but	O	CCONJ	O
are	O	AUX	O
constitutively	O	ADV	B
active	O	ADJ	B
in	O	ADP	O
an	O	DET	O
EPO-independent	B-cell_line	ADJ	B
,	I-cell_line	PUNCT	O
apoptosis-resistant	I-cell_line	ADJ	B
subclone	I-cell_line	NOUN	I
(	O	PUNCT	O
HCD57-SREI	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


We	O	PRON	O
found	O	VERB	O
that	O	SCONJ	O
erythropoietin	B-protein	NOUN	B
(	O	PUNCT	O
EPO	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
stem	B-protein	NOUN	B
cell	I-protein	NOUN	I
factor	I-protein	NOUN	I
(	O	PUNCT	O
SCF	B-protein	NOUN	B
)	O	PUNCT	O
activated	B-protein	VERB	B
protein	I-protein	NOUN	I
kinase	I-protein	NOUN	I
B	I-protein	NOUN	I
(	O	PUNCT	O
PKB/Akt	B-protein	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
EPO-dependent	B-cell_line	ADJ	B
HCD57	I-cell_line	NOUN	B
erythroid	I-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


These	O	DET	O
observations	O	NOUN	B
suggest	O	VERB	O
possible	O	ADJ	O
mechanisms	O	NOUN	B
by	O	ADP	O
which	O	DET	O
Id3	B-protein	NOUN	B
overexpression	O	NOUN	B
can	O	AUX	O
differentially	O	ADV	O
affect	O	VERB	O
development	O	NOUN	B
of	O	ADP	O
pre-T	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
into	O	ADP	O
TCRalpha	B-cell_line	NOUN	B
beta	I-cell_line	NOUN	I
and	I-cell_line	CCONJ	I
gamma	I-cell_line	NOUN	B
delta	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
also	O	ADV	O
observed	O	VERB	O
that	O	SCONJ	O
cell	B-cell_type	NOUN	B
surface	I-cell_type	NOUN	I
CD4	I-cell_type	NOUN	I
(	I-cell_type	PUNCT	O
-	I-cell_type	PUNCT	O
)	I-cell_type	PUNCT	O
CD8	I-cell_type	NOUN	B
(	I-cell_type	PUNCT	O
-	I-cell_type	PUNCT	O
)	I-cell_type	PUNCT	O
CD3	I-cell_type	NOUN	B
(	I-cell_type	PUNCT	O
-	I-cell_type	PUNCT	O
)	I-cell_type	PUNCT	O
cells	I-cell_type	NOUN	B
with	O	ADP	O
rearranged	B-DNA	ADJ	O
TCR	I-DNA	NOUN	B
genes	I-DNA	NOUN	B
developed	O	VERB	O
from	O	ADP	O
Id3-transduced	B-cell_line	ADJ	B
but	O	CCONJ	O
not	O	PART	O
from	O	ADP	O
control-transduced	B-cell_line	ADJ	B
pre-T	I-cell_line	ADJ	I
cells	I-cell_line	NOUN	I
in	O	ADP	O
an	O	DET	O
FTOC	B-cell_line	NOUN	B
.	O	PUNCT	O


When	O	SCONJ	O
submitted	O	VERB	O
to	O	PART	O
an	O	DET	O
in	O	X	B
vitro	O	X	I
CD4	B-protein	NOUN	B
cross-linking	O	NOUN	B
by	O	ADP	O
iHIV-1	O	NOUN	B
,	O	PUNCT	O
PBMCs	B-cell_type	NOUN	B
from	O	ADP	O
HIV-1-infected	O	ADJ	B
patients	O	NOUN	B
were	O	AUX	O
found	O	VERB	O
to	O	PART	O
produce	O	VERB	O
virus	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
virus	O	NOUN	B
reactivation	O	NOUN	I
was	O	AUX	O
not	O	PART	O
observed	O	VERB	O
following	O	VERB	O
CD4	B-protein	NOUN	B
oligomerization	O	NOUN	I
by	O	ADP	O
antibodies	B-protein	NOUN	B
that	O	PRON	O
bind	O	VERB	B
other	O	ADJ	O
epitopes	O	NOUN	B
in	O	ADP	O
D1	B-protein	NOUN	B
,	O	PUNCT	O
including	O	VERB	O
the	O	DET	O
D1/CDR3-loop	B-protein	NOUN	B
.	O	PUNCT	O


Signaling	O	NOUN	B
through	O	ADP	O
the	O	DET	O
lymphotoxin-beta	B-protein	NOUN	B
receptor	I-protein	NOUN	I
stimulates	O	VERB	B
HIV-1	O	NOUN	B
replication	O	NOUN	B
alone	O	ADV	O
and	O	CCONJ	O
in	O	ADP	O
cooperation	O	NOUN	B
with	O	ADP	O
soluble	O	ADJ	B
or	O	CCONJ	O
membrane-bound	B-protein	ADJ	B
TNF-alpha	I-protein	NOUN	B
.	O	PUNCT	O


OBJECTIVE	O	NOUN	B
:	O	PUNCT	O
To	O	PART	O
create	O	VERB	O
monoclonal	B-protein	ADJ	B
anti-endothelial	I-protein	ADJ	I
cell	I-protein	NOUN	I
antibodies	I-protein	NOUN	I
(	O	PUNCT	O
mAECA	B-protein	NOUN	B
)	O	PUNCT	O
from	O	ADP	O
a	O	DET	O
patient	O	NOUN	B
with	O	ADP	O
Takayasu	O	NOUN	B
arteritis	O	NOUN	I
to	O	PART	O
evaluate	O	VERB	B
their	O	PRON	O
ability	O	NOUN	O
to	O	PART	O
activate	O	VERB	B
human	B-cell_line	ADJ	B
umbilical	I-cell_line	ADJ	I
vein	I-cell_line	NOUN	I
endothelial	I-cell_line	ADJ	O
cells	I-cell_line	NOUN	O
(	O	PUNCT	O
HUVEC	B-cell_line	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
to	O	PART	O
characterize	O	VERB	O
the	O	DET	O
mechanism	O	NOUN	B
of	O	ADP	O
EC	O	NOUN	B
activation	O	NOUN	B
.	O	PUNCT	O


Cutting	O	ADJ	B
edge	O	NOUN	I
:	O	PUNCT	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
NF	B-protein	NOUN	B
of	I-protein	ADP	O
activated	I-protein	VERB	B
T	I-protein	NOUN	O
cells	I-protein	NOUN	O
in	O	ADP	O
eosinophils	B-cell_type	NOUN	B
:	O	PUNCT	O
regulation	O	NOUN	B
by	O	ADP	O
IL-4	B-protein	NOUN	B
and	O	CCONJ	O
IL-5	B-protein	NOUN	B
.	O	PUNCT	O


Only	O	ADV	O
NF-AT1	B-protein	NOUN	B
and	O	CCONJ	O
NF-AT4	B-protein	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
NF-AT2	B-protein	NOUN	B
and	O	CCONJ	O
NF-AT3	B-protein	NOUN	B
,	O	PUNCT	O
have	O	AUX	O
translocated	O	VERB	B
into	O	ADP	O
the	O	DET	O
nuclei	O	NOUN	B
in	O	ADP	O
IL-4-	B-cell_line	NOUN	B
or	I-cell_line	CCONJ	O
IL-5-stimulated	I-cell_line	ADJ	B
eosinophils	I-cell_line	NOUN	I
.	O	PUNCT	O


These	O	DET	O
findings	O	NOUN	B
delineate	O	VERB	O
a	O	DET	O
novel	O	ADJ	O
pathway	O	NOUN	B
in	O	ADP	O
the	O	DET	O
cytokine	O	NOUN	B
network	O	NOUN	B
in	O	ADP	O
which	O	DET	O
Th2	B-cell_line	NOUN	B
lymphocytes	I-cell_line	NOUN	B
``	O	PUNCT	O
control	O	NOUN	B
''	O	PUNCT	I
eosinophils	B-cell_type	NOUN	B
via	O	ADP	O
the	O	DET	O
release	O	NOUN	B
of	O	ADP	O
IL-4	B-protein	NOUN	B
and	O	CCONJ	O
IL-5	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
activation	O	NOUN	B
of	O	ADP	O
NF-AT	B-protein	NOUN	B
in	O	ADP	O
eosinophils	B-cell_type	NOUN	B
.	O	PUNCT	O


Better	O	ADJ	O
understanding	O	NOUN	O
of	O	ADP	O
transcriptional	O	ADJ	B
regulation	O	NOUN	I
of	O	ADP	O
adhesion	B-protein	NOUN	B
molecules	I-protein	NOUN	O
in	O	ADP	O
ECs	B-cell_type	NOUN	B
may	O	AUX	O
provide	O	VERB	O
important	O	ADJ	O
insight	O	NOUN	O
into	O	ADP	O
plaque	O	NOUN	B
formation	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
show	O	VERB	O
here	O	ADV	O
that	O	SCONJ	O
the	O	DET	O
transcriptional	B-protein	ADJ	B
co-activators	I-protein	NOUN	B
CBP/p300	B-protein	NOUN	B
bind	O	VERB	B
to	O	PART	O
and	O	CCONJ	O
control	O	VERB	B
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
inducible	B-protein	ADJ	B
N-terminal	I-protein	ADJ	B
transactivation	I-protein	NOUN	I
domain	I-protein	NOUN	I
of	O	ADP	O
NF-ATc	B-protein	NOUN	B
,	O	PUNCT	O
TAD-A	B-protein	NOUN	B
.	O	PUNCT	O


Similar	O	ADJ	O
to	O	PART	O
the	O	DET	O
N	B-protein	NOUN	B
terminal	I-protein	ADJ	I
transactivation	I-protein	NOUN	I
domain	I-protein	NOUN	I
of	O	ADP	O
c-Jun	B-protein	NOUN	B
,	O	PUNCT	O
TAD-A	B-protein	NOUN	B
is	O	AUX	O
inducibly	O	ADV	B
phosphorylated	O	VERB	B
,	O	PUNCT	O
but	O	CCONJ	O
this	O	DET	O
phosphorylation	O	NOUN	B
is	O	AUX	O
dispensable	O	ADJ	O
for	O	ADP	O
the	O	DET	O
interaction	O	NOUN	B
with	O	ADP	O
CBP/p300	B-protein	NOUN	B
.	O	PUNCT	O


Considerably	O	ADV	O
higher	O	ADJ	O
proportions	O	NOUN	B
of	O	ADP	O
low	O	ADJ	B
responders	O	NOUN	I
were	O	AUX	O
found	O	VERB	O
among	O	ADP	O
the	O	DET	O
patient	O	NOUN	B
population	O	NOUN	I
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
our	O	PRON	O
data	O	NOUN	B
provide	O	VERB	O
novel	O	ADJ	O
evidence	O	NOUN	B
that	O	SCONJ	O
selective	O	ADJ	O
modulation	O	NOUN	B
of	O	ADP	O
NF-kappaB	B-protein	NOUN	B
by	O	ADP	O
adenoviral	O	ADJ	B
transfer	O	NOUN	I
of	O	ADP	O
IkappaB-alpha	B-protein	NOUN	B
impairs	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
multiple	O	ADJ	B
endothelial	B-protein	ADJ	O
gene	I-protein	NOUN	O
products	I-protein	NOUN	O
required	O	VERB	O
for	O	ADP	O
subsequent	O	ADJ	O
monocyte	O	NOUN	B
arrest	O	NOUN	I
and	O	CCONJ	O
emigration	O	NOUN	B
in	O	ADP	O
shear	O	NOUN	B
flow	O	NOUN	I
and	O	CCONJ	O
thus	O	ADV	O
for	O	ADP	O
monocyte	O	NOUN	B
infiltration	O	NOUN	I
in	O	ADP	O
atherosclerotic	O	ADJ	B
plaques	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
silent	O	ADJ	B
mutation	O	NOUN	B
in	O	ADP	O
codon	B-DNA	NOUN	B
10	I-DNA	NUM	I
of	O	ADP	I
exon	B-DNA	NOUN	I
1	I-DNA	NUM	I
,	O	PUNCT	O
detected	O	VERB	B
in	O	ADP	O
ER-negative	B-cell_line	ADJ	B
and	I-cell_line	CCONJ	O
ER-positive	I-cell_line	ADJ	B
human	I-cell_line	ADJ	B
breast	I-cell_line	NOUN	B
cancer	I-cell_line	NOUN	I
cell	I-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
,	O	PUNCT	O
in	O	ADP	O
breast	O	NOUN	B
tumors	O	NOUN	I
and	O	CCONJ	O
blood	B-DNA	NOUN	B
DNA	I-DNA	NOUN	I
from	O	ADP	O
breast	O	NOUN	B
cancer	O	NOUN	I
patients	O	NOUN	B
,	O	PUNCT	O
has	O	AUX	O
been	O	AUX	O
recognized	O	VERB	O
as	O	ADP	O
a	O	DET	O
polymorphic	B-DNA	ADJ	B
site	I-DNA	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
detected	O	VERB	O
ER	B-DNA	NOUN	B
codon	I-DNA	NOUN	O
10	I-DNA	NUM	O
polymorphism	O	NOUN	B
in	O	ADP	O
these	O	DET	O
samples	O	NOUN	B
and	O	CCONJ	O
have	O	AUX	O
compared	O	VERB	B
them	O	PRON	O
to	O	PART	O
those	O	DET	O
observed	O	VERB	O
in	O	ADP	O
breast	O	NOUN	B
cancer	O	NOUN	I
samples	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
two	O	NUM	O
proteins	O	NOUN	B
physically	O	ADV	B
interact	O	VERB	B
with	O	ADP	O
each	O	DET	O
other	O	ADJ	O
and	O	CCONJ	O
mutually	O	ADV	O
inhibit	O	VERB	B
their	O	PRON	O
respective	O	ADJ	O
biological	O	ADJ	B
functions	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
some	O	DET	O
patients	O	NOUN	B
,	O	PUNCT	O
no	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
RelA/NFkappaB1	B-protein	NOUN	B
-binding	O	ADJ	O
activity	O	NOUN	B
was	O	AUX	O
detectable	O	ADJ	B
,	O	PUNCT	O
while	O	SCONJ	O
in	O	ADP	O
others	O	NOUN	O
kappaB	B-protein	NOUN	B
-binding	O	ADJ	O
activity	O	NOUN	B
was	O	AUX	O
modestly	O	ADV	O
induced	O	VERB	B
but	O	CCONJ	O
the	O	DET	O
duration	O	NOUN	B
was	O	AUX	O
reduced	O	VERB	B
.	O	PUNCT	O


While	O	SCONJ	O
controls	O	NOUN	B
showed	O	VERB	O
a	O	DET	O
moderate	O	ADJ	B
correlation	O	NOUN	B
between	O	ADP	O
binding	O	NOUN	B
affinity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
GR	B-protein	NOUN	B
in	O	ADP	O
lymphocytes	O	NOUN	B
and	O	CCONJ	O
regulatory	O	ADJ	B
function	O	NOUN	I
at	O	ADP	O
the	O	DET	O
hypothalamic	O	ADJ	B
level	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
patients	O	NOUN	B
did	O	AUX	O
not	O	PART	O
.	O	PUNCT	O


The	O	DET	O
purpose	O	NOUN	O
of	O	ADP	O
this	O	DET	O
study	O	NOUN	B
was	O	AUX	O
to	O	PART	O
evaluate	O	VERB	B
whether	O	SCONJ	O
the	O	DET	O
mitogen-activated	B-protein	ADJ	B
protein	I-protein	NOUN	I
kinase	I-protein	NOUN	I
(	O	PUNCT	O
MAPK	B-protein	NOUN	B
)	O	PUNCT	O
signaling	O	NOUN	B
pathway	O	NOUN	I
contributes	O	VERB	O
to	O	PART	O
12-O-tetradecanoylphorbol-13-acetate	O	NOUN	B
(	O	PUNCT	O
TPA	O	NOUN	B
)	O	PUNCT	O
-induced	O	ADJ	O
mononuclear	O	ADJ	B
differentiation	O	NOUN	I
in	O	ADP	O
the	O	DET	O
human	B-cell_line	ADJ	B
myeloblastic	I-cell_line	ADJ	I
leukemia	I-cell_line	NOUN	I
ML-1	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
anorexia	O	NOUN	B
nervosa	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
incorporation	O	NOUN	B
of	O	ADP	O
[	O	PUNCT	O
3H	O	NOUN	B
]	O	PUNCT	O
thymidine	O	NOUN	B
into	O	ADP	O
the	O	DET	O
MNL	B-cell_type	NOUN	B
was	O	AUX	O
inversely	O	ADV	O
correlated	O	VERB	B
with	O	ADP	O
urinary	O	ADJ	B
free	O	ADJ	I
cortisol	O	NOUN	I
levels	O	NOUN	O
.	O	PUNCT	O


This	O	DET	O
core	O	NOUN	B
contains	O	VERB	O
a	O	DET	O
GATA	B-DNA	NOUN	B
site	I-DNA	NOUN	I
separated	O	VERB	O
by	O	ADP	O
10	O	NUM	O
base	O	NOUN	B
pairs	O	NOUN	I
from	O	ADP	O
an	O	DET	O
E-box	B-DNA	NOUN	B
motif	I-DNA	NOUN	B
.	O	PUNCT	O


Recent	O	ADJ	O
studies	O	NOUN	B
have	O	AUX	O
shown	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
non-steroidal	O	ADJ	B
anti-inflammatory	O	ADJ	I
drugs	O	NOUN	I
(	O	PUNCT	O
NSAIDs	O	NOUN	B
)	O	PUNCT	O
activate	O	VERB	B
heat	B-protein	NOUN	B
shock	I-protein	NOUN	I
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
(	O	PUNCT	O
HSF1	B-protein	NOUN	B
)	O	PUNCT	O
from	O	ADP	O
a	O	DET	O
latent	B-protein	ADJ	B
cytoplasmic	I-protein	ADJ	B
form	I-protein	NOUN	O
to	O	PART	O
a	O	DET	O
nuclear	B-protein	ADJ	B
,	I-protein	PUNCT	O
DNA	I-protein	NOUN	B
binding	I-protein	NOUN	I
state	I-protein	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
only	O	ADV	O
a	O	DET	O
subset	O	NOUN	O
of	O	ADP	O
the	O	DET	O
NSAIDs	O	NOUN	B
induced	O	VERB	B
HSP70	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
species	I-RNA	NOUN	I
.	O	PUNCT	O


These	O	DET	O
mutations	O	NOUN	B
were	O	AUX	O
introduced	O	VERB	O
in	O	ADP	O
the	O	DET	O
tax	B-DNA	NOUN	O
gene	I-DNA	NOUN	O
of	O	ADP	O
the	O	DET	O
ACH	B-DNA	NOUN	B
functional	I-DNA	ADJ	B
molecular	I-DNA	ADJ	B
clone	I-DNA	NOUN	I
of	O	ADP	O
HTLV-1	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
virus	O	NOUN	B
produced	O	VERB	O
from	O	ADP	O
the	O	DET	O
mutant	B-DNA	ADJ	B
ACH	I-DNA	NOUN	B
clones	I-DNA	NOUN	B
was	O	AUX	O
examined	O	VERB	O
for	O	ADP	O
the	O	DET	O
ability	O	NOUN	O
to	O	PART	O
replicate	O	VERB	B
and	O	CCONJ	O
immortalize	O	VERB	B
primary	B-cell_type	ADJ	O
human	I-cell_type	ADJ	B
lymphocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


Analogous	O	ADJ	O
to	O	PART	O
costimulation	O	NOUN	B
via	O	ADP	O
CD28	B-protein	NOUN	B
,	O	PUNCT	O
this	O	DET	O
activity	O	NOUN	B
is	O	AUX	O
mediated	O	VERB	O
through	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
Rel/kappaB	B-protein	NOUN	B
,	O	PUNCT	O
a	O	DET	O
family	O	NOUN	B
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
known	O	VERB	O
to	O	PART	O
regulate	O	VERB	B
IL-2	B-protein	NOUN	B
and	O	CCONJ	O
other	O	ADJ	O
activation-inducible	B-protein	ADJ	B
proteins	I-protein	NOUN	I
.	O	PUNCT	O


This	O	DET	O
NF-kappaB	B-protein	NOUN	B
binding	I-protein	NOUN	I
complex	I-protein	NOUN	I
is	O	AUX	O
composed	O	VERB	O
of	O	ADP	O
transcriptionally	B-protein	ADV	B
active	I-protein	ADJ	O
p65	I-protein	NOUN	O
(	I-protein	PUNCT	O
RelA	I-protein	NOUN	B
)	I-protein	PUNCT	O
/p50	I-protein	NOUN	O
heterodimers	I-protein	NOUN	B
and	O	CCONJ	O
results	O	VERB	B
primarily	O	ADV	O
from	O	ADP	O
the	O	DET	O
targeted	O	VERB	B
degradation	O	NOUN	B
of	O	ADP	O
IkappaB-alpha	B-protein	NOUN	B
,	O	PUNCT	O
an	O	DET	O
inhibitor	O	NOUN	B
that	O	PRON	O
sequesters	O	VERB	B
Rel/kappaB	B-protein	VERB	O
in	O	ADP	O
the	O	DET	O
cytoplasm	O	NOUN	B
.	O	PUNCT	O


Escape	O	NOUN	B
of	O	ADP	O
human	O	ADJ	B
cytomegalovirus	O	NOUN	O
from	O	ADP	O
HLA-DR	B-protein	NOUN	B
-restricted	O	ADJ	O
CD4	O	NOUN	B
(	O	PUNCT	O
+	O	CCONJ	O
)	O	PUNCT	O
T-cell	O	NOUN	O
response	O	NOUN	O
is	O	AUX	O
mediated	O	VERB	O
by	O	ADP	O
repression	O	NOUN	B
of	O	ADP	O
gamma	B-protein	NOUN	B
interferon	I-protein	NOUN	I
-induced	O	ADJ	O
class	B-protein	NOUN	B
II	I-protein	NUM	I
transactivator	I-protein	NOUN	I
expression	O	NOUN	B
.	O	PUNCT	O


Altogether	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
data	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
defect	O	NOUN	B
induced	O	VERB	B
by	O	ADP	O
HCMV	O	NOUN	B
resides	O	VERB	B
in	O	ADP	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IFN-gamma-responsive	B-DNA	ADJ	B
promoter	I-DNA	NOUN	I
of	O	ADP	O
CIITA	B-DNA	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
study	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
demonstrate	O	VERB	O
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	O
DZA	O	NOUN	B
on	O	ADP	O
nuclear	B-protein	ADJ	B
factor-kappaB	I-protein	NOUN	I
(	O	PUNCT	I
NF-kappaB	B-protein	NOUN	B
)	O	PUNCT	O
regulation	O	NOUN	B
.	O	PUNCT	O


C3	O	NOUN	B
transferase	O	NOUN	I
and	O	CCONJ	O
cytochalasin	O	NOUN	B
D	O	NOUN	I
did	O	AUX	O
not	O	PART	O
alter	O	VERB	O
the	O	DET	O
expression	O	NOUN	B
levels	O	NOUN	B
of	O	ADP	O
monocyte-binding	B-protein	ADJ	B
receptors	I-protein	NOUN	I
on	O	ADP	O
endothelial	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
did	O	AUX	O
inhibit	O	VERB	B
clustering	O	NOUN	B
of	O	ADP	O
E-selectin	B-protein	NOUN	B
,	O	PUNCT	O
ICAM-1	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
VCAM-1	B-protein	NOUN	B
on	O	ADP	O
the	O	DET	O
cell	O	NOUN	B
surface	O	NOUN	I
induced	O	VERB	B
by	O	ADP	O
monocyte	O	NOUN	B
adhesion	O	NOUN	I
or	O	CCONJ	O
cross-linking	B-protein	ADJ	B
antibodies	I-protein	NOUN	I
.	O	PUNCT	O


Finally	O	ADV	O
,	O	PUNCT	O
receptor	O	NOUN	B
clusters	O	NOUN	I
colocalized	O	VERB	B
with	O	ADP	O
ezrin/moesin/radixin	B-protein	NOUN	B
proteins	I-protein	NOUN	I
.	O	PUNCT	O


Advances	O	NOUN	B
in	O	ADP	O
gene	O	NOUN	B
technology	O	NOUN	I
have	O	AUX	O
allowed	O	VERB	O
the	O	DET	O
manipulation	O	NOUN	B
of	O	ADP	O
molecular	O	ADJ	B
interactions	O	NOUN	I
that	O	PRON	O
shape	O	VERB	B
the	O	DET	O
T	O	NOUN	B
cell	O	NOUN	I
repertoire	O	NOUN	O
.	O	PUNCT	O


Previous	O	ADJ	O
studies	O	NOUN	B
have	O	AUX	O
characterized	O	VERB	B
the	O	DET	O
CD28	B-protein	NOUN	B
augmentation	O	NOUN	B
of	O	ADP	O
TCR	B-protein	NOUN	B
-mediated	O	ADJ	O
signaling	O	NOUN	B
in	O	ADP	O
peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
through	O	ADP	O
transcriptional	O	ADJ	B
activation	O	NOUN	I
of	O	ADP	O
an	O	DET	O
IL-2	B-protein	NOUN	B
promoter	O	NOUN	B
CD28	B-DNA	NOUN	B
response	I-DNA	NOUN	I
element	I-DNA	NOUN	I
(	O	PUNCT	O
CD28RE	B-DNA	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
along	O	ADP	O
with	O	ADP	O
enhanced	O	VERB	O
mRNA	O	NOUN	B
stability	O	NOUN	I
.	O	PUNCT	O


DTT	O	NOUN	B
antagonized	O	VERB	B
and	O	CCONJ	O
BSO	O	NOUN	B
enhanced	O	VERB	B
As2O3-induced	O	ADJ	B
ATP	O	NOUN	B
depletion	O	NOUN	B
,	O	PUNCT	O
delta	O	NOUN	B
psi	O	NOUN	I
(	O	PUNCT	I
m	O	NOUN	I
)	O	PUNCT	O
collapse	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
apoptosis	O	NOUN	B
.	O	PUNCT	O


To	O	PART	O
interpret	O	VERB	O
the	O	DET	O
mechanisms	O	NOUN	B
by	O	ADP	O
which	O	DET	O
EBV	O	NOUN	B
activates	O	VERB	B
the	O	DET	O
cell	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
assayed	O	VERB	B
many	O	ADJ	O
proteins	O	NOUN	B
involved	O	VERB	O
in	O	ADP	O
control	O	NOUN	B
of	O	ADP	O
the	O	DET	O
G0	O	NOUN	B
and	O	CCONJ	O
G1	O	NOUN	B
phases	O	NOUN	I
of	O	ADP	O
the	O	DET	O
cell	O	NOUN	B
cycle	O	NOUN	I
and	O	CCONJ	O
regulation	O	NOUN	B
of	O	ADP	O
apoptosis	O	NOUN	B
.	O	PUNCT	O


Here	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
analyzed	O	VERB	B
the	O	DET	O
mechanisms	O	NOUN	B
involved	O	VERB	O
in	O	ADP	O
CTLA-4	B-protein	NOUN	B
-mediated	O	ADJ	O
inhibition	O	NOUN	B
of	O	ADP	O
T	O	NOUN	B
cell	O	NOUN	I
activation	O	NOUN	B
of	O	ADP	O
naive	O	ADJ	B
CD4+	B-cell_type	ADJ	B
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
using	O	VERB	O
Ab	O	NOUN	B
cross-linking	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
T	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
hybridomas	I-cell_line	NOUN	B
,	O	PUNCT	O
both	O	CCONJ	O
T	O	NOUN	B
cell	O	NOUN	I
activators	O	NOUN	B
and	O	CCONJ	O
glucocorticoids	O	NOUN	B
induce	O	VERB	B
apoptosis	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
conclude	O	VERB	O
that	O	SCONJ	O
NF-kappaB	B-protein	NOUN	B
is	O	AUX	O
a	O	DET	O
context-dependent	O	ADJ	O
apoptosis	O	NOUN	B
regulator	O	NOUN	O
.	O	PUNCT	O


SOCS-3	B-protein	NOUN	B
protein	O	NOUN	I
was	O	AUX	O
detectable	O	ADJ	B
as	O	ADV	O
early	O	ADV	O
as	O	ADP	O
30	O	NUM	O
min	O	NOUN	O
following	O	VERB	O
IL-2	B-protein	NOUN	B
stimulation	O	NOUN	B
,	O	PUNCT	O
while	O	SCONJ	O
CIS	B-protein	NOUN	B
was	O	AUX	O
seen	O	VERB	O
only	O	ADV	O
at	O	ADP	O
low	O	ADJ	B
levels	O	NOUN	B
after	O	ADP	O
2	O	NUM	O
h	O	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
recently	O	ADV	O
reported	O	VERB	O
that	O	SCONJ	O
human	B-cell_type	ADJ	B
alveolar	I-cell_type	ADJ	B
macrophages	I-cell_type	NOUN	I
do	O	AUX	O
not	O	PART	O
express	O	VERB	O
AP-1	B-protein	NOUN	B
DNA	O	NOUN	O
binding	O	NOUN	O
activity	O	NOUN	O
(	O	PUNCT	O
Monick	O	PROPN	B
,	O	PUNCT	O
M.	O	PROPN	B
M.	O	PROPN	I
,	O	PUNCT	O
Carter	O	PROPN	O
,	O	PUNCT	O
A.	O	PROPN	B
B.	O	PROPN	I
,	O	PUNCT	O
Gudmundsson	O	PROPN	B
,	O	PUNCT	O
G.	O	PROPN	O
,	O	PUNCT	O
Geist	O	PROPN	B
,	O	PUNCT	O
L.	O	PROPN	O
J.	O	PROPN	O
,	O	PUNCT	O
and	O	CCONJ	O
Hunninghake	O	PROPN	B
,	O	PUNCT	O
G.	O	PROPN	O
W.	O	PROPN	O
(	O	PUNCT	O
1998	O	NUM	O
)	O	PUNCT	O
Am.	O	PROPN	O
J.	O	PROPN	O
Physiol.	O	PROPN	O
275	O	NUM	O
,	O	PUNCT	O
L389-L397	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Development	O	NOUN	B
and	O	CCONJ	O
maturation	O	NOUN	B
of	O	ADP	O
secondary	O	ADJ	B
lymphoid	O	ADJ	B
tissues	O	NOUN	B
.	O	PUNCT	O


Studies	O	NOUN	B
over	O	ADP	O
the	O	DET	O
past	O	ADJ	O
few	O	ADJ	O
years	O	NOUN	B
have	O	AUX	O
identified	O	VERB	B
lymphotoxin	O	NOUN	B
as	O	ADP	O
a	O	DET	O
critical	O	ADJ	O
signaling	O	NOUN	B
molecule	O	NOUN	I
not	O	PART	O
only	O	ADV	O
for	O	ADP	O
the	O	DET	O
organogenesis	O	NOUN	B
of	O	ADP	O
secondary	O	ADJ	B
lymphoid	O	ADJ	B
tissues	O	NOUN	B
but	O	CCONJ	O
for	O	ADP	O
the	O	DET	O
maintenance	O	NOUN	B
of	O	ADP	O
aspects	O	NOUN	O
of	O	ADP	O
their	O	PRON	O
microarchitecture	O	NOUN	B
as	O	ADV	O
well	O	ADV	O
.	O	PUNCT	O


Modulation	O	NOUN	B
of	O	ADP	O
CD28	B-protein	NOUN	B
expression	O	NOUN	B
:	O	PUNCT	O
distinct	O	ADJ	O
regulatory	O	ADJ	B
pathways	O	NOUN	I
during	O	ADP	O
activation	O	NOUN	B
and	O	CCONJ	O
replicative	O	ADJ	B
senescence	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
a	O	DET	O
model	O	NOUN	B
where	O	SCONJ	O
foreign	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
(	O	PUNCT	O
rat	B-cell_type	NOUN	B
fibroblasts	I-cell_type	NOUN	B
)	O	PUNCT	O
were	O	AUX	O
cocultured	O	VERB	B
with	O	ADP	O
human	B-cell_type	ADJ	B
IL-2	I-cell_type	NOUN	B
activated	I-cell_type	ADJ	B
NK	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
observed	O	VERB	O
that	O	SCONJ	O
NK	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
were	O	AUX	O
capable	O	ADJ	O
of	O	ADP	O
efficiently	O	ADV	O
killing	O	VERB	B
their	O	PRON	O
targets	O	NOUN	B
only	O	ADV	O
if	O	SCONJ	O
the	O	DET	O
cells	O	NOUN	B
overexpressed	O	VERB	B
the	O	DET	O
oncogene	O	NOUN	B
c-Myc	B-protein	NOUN	I
or	O	CCONJ	O
E1A	B-protein	NOUN	B
.	O	PUNCT	O


Differences	O	NOUN	B
in	O	ADP	O
phosphorylation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IL-2R	B-protein	NOUN	B
associated	I-protein	ADJ	O
JAK/STAT	I-protein	NOUN	B
proteins	I-protein	NOUN	I
between	O	ADP	O
HTLV-I	B-cell_line	NOUN	B
(	I-cell_line	PUNCT	O
+	I-cell_line	ADV	O
)	I-cell_line	PUNCT	O
,	I-cell_line	PUNCT	O
IL-2-independent	I-cell_line	ADJ	B
and	I-cell_line	CCONJ	O
IL-2-dependent	I-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
and	O	CCONJ	O
uncultured	B-cell_type	ADJ	B
leukemic	I-cell_type	ADJ	O
cells	I-cell_type	NOUN	O
from	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
adult	O	ADJ	B
T-cell	O	NOUN	B
lymphoma/leukemia	O	NOUN	I
.	O	PUNCT	O


To	O	PART	O
determine	O	VERB	O
activation	O	NOUN	B
status	O	NOUN	I
of	O	ADP	O
the	O	DET	O
IL-2R	B-protein	NOUN	B
-associated	O	ADJ	O
(	O	PUNCT	O
Jak/STAT	B-protein	NOUN	O
)	O	PUNCT	O
pathway	O	NOUN	O
in	O	ADP	O
the	O	DET	O
HTLV-I	B-cell_line	NOUN	B
infected	I-cell_line	ADJ	B
cells	I-cell_line	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
examined	O	VERB	O
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	B
of	O	ADP	O
Jak3	B-protein	NOUN	B
,	O	PUNCT	O
STAT3	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
STAT5	B-protein	NOUN	B
in	O	ADP	O
several	O	ADJ	O
HTLV-I	B-cell_line	NOUN	B
(	I-cell_line	PUNCT	O
+	I-cell_line	CCONJ	O
)	I-cell_line	PUNCT	O
T-cell	I-cell_line	NOUN	O
lines	I-cell_line	NOUN	O
and	O	CCONJ	O
in	O	ADP	O
uncultured	B-cell_type	ADJ	B
leukemic	I-cell_type	ADJ	O
T	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
isolated	O	VERB	B
from	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
adult	O	ADJ	B
T-cell	O	NOUN	O
lymphoma/leukemia	O	NOUN	O
(	O	PUNCT	O
ATLL	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
stimulation	O	NOUN	B
with	O	ADP	O
IL-2	B-protein	NOUN	B
resulted	O	VERB	O
in	O	ADP	O
Jak3	B-protein	NOUN	B
and	O	CCONJ	O
STAT5	B-protein	NOUN	B
phosphorylation	O	NOUN	B
in	O	ADP	O
both	O	CCONJ	O
leukemic	B-cell_type	ADJ	B
ATLL	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	O
and	O	CCONJ	O
IL-2-dependent	B-cell_line	ADJ	B
lines	I-cell_line	NOUN	I
.	O	PUNCT	O


Of	O	ADP	O
86	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
a	O	DET	O
chronic	O	ADJ	B
MPD	O	NOUN	B
,	O	PUNCT	O
71	O	NUM	O
(	O	PUNCT	O
82	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
exhibited	O	VERB	O
an	O	DET	O
allele	B-DNA	NOUN	B
ratio	O	NOUN	I
greater	O	ADJ	O
than	O	ADP	O
3	O	NUM	O
:	O	PUNCT	O
1	O	NUM	O
,	O	PUNCT	O
whereas	O	SCONJ	O
only	O	ADV	O
10	O	NUM	O
(	O	PUNCT	O
12	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
of	O	ADP	O
86	O	NUM	O
age-matched	O	ADJ	O
control	O	ADJ	B
subjects	O	NOUN	I
showed	O	VERB	O
a	O	DET	O
skewed	O	ADJ	O
XCI	O	NOUN	B
pattern	O	NOUN	B
.	O	PUNCT	O


GATA-1	B-protein	NOUN	B
and	O	CCONJ	O
erythropoietin	B-protein	NOUN	B
cooperate	O	VERB	O
to	O	PART	O
promote	O	VERB	B
erythroid	O	ADJ	B
cell	O	NOUN	O
survival	O	NOUN	B
by	O	ADP	O
regulating	O	VERB	O
bcl-xL	B-protein	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
GATA-1	B-protein	NOUN	B
is	O	AUX	O
essential	O	ADJ	O
for	O	ADP	O
normal	O	ADJ	B
erythropoiesis	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
mechanisms	O	NOUN	B
by	O	ADP	O
which	O	DET	O
GATA-1	B-protein	NOUN	B
controls	O	VERB	B
cell	O	NOUN	B
survival	O	NOUN	I
are	O	AUX	O
unknown	O	ADJ	O
.	O	PUNCT	O


Moreover	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	I
rapamycin	O	NOUN	B
on	O	ADP	O
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
p70	B-protein	NOUN	B
(	I-protein	PUNCT	O
s6k	I-protein	NOUN	B
)	I-protein	PUNCT	O
in	O	ADP	O
,	O	PUNCT	O
IL-2	B-protein	NOUN	B
and	O	CCONJ	O
PI	B-protein	NOUN	B
3-kinase	I-protein	NOUN	O
activation	O	NOUN	B
of	O	ADP	O
E2Fs	B-protein	NOUN	B
have	O	AUX	O
not	O	PART	O
been	O	AUX	O
characterized	O	VERB	B
.	O	PUNCT	O


Our	O	PRON	O
present	O	ADJ	O
results	O	NOUN	B
show	O	VERB	O
that	O	SCONJ	O
IL-2	B-protein	NOUN	B
-and	O	NOUN	O
PI	B-protein	NOUN	B
3-kinase	I-protein	NOUN	I
-induced	O	ADJ	O
pathways	O	NOUN	B
for	O	ADP	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
E2F	B-protein	NOUN	B
transcriptional	O	ADJ	I
activity	O	NOUN	I
include	O	VERB	O
both	O	CCONJ	O
rapamycin-resistant	O	ADJ	B
and	O	CCONJ	O
rapamycin-sensitive	O	ADJ	B
components	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
to	O	ADP	O
increasing	O	VERB	B
our	O	PRON	O
understanding	O	NOUN	O
of	O	ADP	O
the	O	DET	O
molecular	O	ADJ	B
pathways	O	NOUN	I
that	O	PRON	O
regulate	O	VERB	B
T	O	NOUN	B
cell	O	NOUN	I
development	O	NOUN	B
and	O	CCONJ	O
function	O	NOUN	B
,	O	PUNCT	O
these	O	DET	O
results	O	NOUN	B
have	O	AUX	O
suggested	O	VERB	O
novel	O	ADJ	O
targets	O	NOUN	B
for	O	ADP	O
genetic	O	ADJ	B
and	O	CCONJ	O
pharmacological	O	ADJ	B
manipulation	O	NOUN	B
of	O	ADP	O
T	O	NOUN	B
cell	O	NOUN	I
immunity	O	NOUN	B
.	O	PUNCT	O


To	O	PART	O
understand	O	VERB	O
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
complexes	O	NOUN	I
in	O	ADP	O
T	O	NOUN	B
cell	O	NOUN	I
development	O	NOUN	B
and	O	CCONJ	O
activation	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
generated	O	VERB	O
transgenic	O	ADJ	B
mice	O	NOUN	I
in	O	ADP	O
which	O	DET	O
RelA	B-protein	NOUN	B
and	O	CCONJ	O
c-Rel	B-protein	NOUN	B
complexes	I-protein	NOUN	O
were	O	AUX	O
selectively	O	ADV	O
inhibited	O	VERB	B
in	O	ADP	O
the	O	DET	O
T-lineage	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
by	O	ADP	O
specific	O	ADJ	O
expression	O	NOUN	B
of	O	ADP	O
a	O	DET	O
trans-dominant	O	ADJ	B
form	O	NOUN	I
of	O	ADP	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
alpha	I-protein	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
to	O	PART	O
TNF	B-protein	NOUN	B
,	O	PUNCT	O
LPS-induced	O	ADJ	B
IL-6	O	NOUN	B
and	O	CCONJ	O
spontaneous	O	ADJ	B
IL-1ra	O	NOUN	B
production	O	NOUN	B
were	O	AUX	O
also	O	ADV	O
enhanced	O	VERB	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
NFkappaB	O	NOUN	B
translocation	O	NOUN	B
following	O	VERB	O
LPS	O	NOUN	B
activation	O	NOUN	B
was	O	AUX	O
higher	O	ADJ	O
after	O	ADP	O
IL-10	B-protein	NOUN	B
pre-treatment	O	NOUN	B
on	O	ADP	O
Teflon	O	NOUN	B
than	O	ADP	O
on	O	ADP	O
plastic	O	NOUN	B
.	O	PUNCT	O


Interestingly	O	ADV	O
,	O	PUNCT	O
an	O	DET	O
enhanced	O	VERB	B
frequency	O	NOUN	B
of	O	ADP	O
CD16	B-protein	NOUN	B
and	O	CCONJ	O
CD68	O	NOUN	B
(	O	PUNCT	O
+	O	CCONJ	O
)	O	PUNCT	O
cells	O	NOUN	O
among	O	ADP	O
the	O	DET	O
CD14	O	NOUN	B
(	O	PUNCT	O
+	O	CCONJ	O
)	O	PUNCT	O
cells	O	NOUN	O
was	O	AUX	O
observed	O	VERB	O
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
IL-10	B-protein	NOUN	B
,	O	PUNCT	O
independently	O	ADV	O
of	O	ADP	O
the	O	DET	O
pre-culture	O	ADJ	B
conditions	O	NOUN	B
of	O	ADP	O
the	O	DET	O
PBMC	B-cell_type	NOUN	B
.	O	PUNCT	O


Altogether	O	ADV	O
,	O	PUNCT	O
these	O	DET	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
IL-10	B-protein	NOUN	B
-induced	O	ADJ	O
up-regulation	O	NOUN	B
of	O	ADP	O
cytokine	B-protein	NOUN	B
production	O	NOUN	I
depends	O	VERB	O
on	O	ADP	O
the	O	DET	O
prevention	O	NOUN	B
of	O	ADP	O
monocyte	O	NOUN	B
adherence	O	NOUN	B
by	O	ADP	O
red	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
in	O	ADP	O
the	O	DET	O
whole	O	ADJ	B
blood	O	NOUN	I
assays	O	NOUN	I
or	O	CCONJ	O
by	O	ADP	O
cultures	O	NOUN	B
of	O	ADP	O
PBMC	B-cell_type	NOUN	B
on	O	ADP	O
Teflon	O	NOUN	B
.	O	PUNCT	O


Cell	O	NOUN	O
growth-regulated	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
mammalian	B-DNA	ADJ	B
MCM5	I-DNA	NOUN	B
and	I-DNA	CCONJ	O
MCM6	I-DNA	NOUN	B
genes	I-DNA	NOUN	I
mediated	O	VERB	O
by	O	ADP	O
the	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
E2F	B-protein	NOUN	I
.	O	PUNCT	O


Expression	O	NOUN	B
of	O	ADP	O
all	O	DET	O
mammalian	B-DNA	ADJ	B
genes	I-DNA	NOUN	B
of	O	ADP	O
the	O	DET	O
MCM	B-DNA	NOUN	B
family	I-DNA	NOUN	B
is	O	AUX	O
induced	O	VERB	B
by	O	ADP	O
growth	O	NOUN	B
stimulation	O	NOUN	I
,	O	PUNCT	O
unlike	O	ADP	O
yeast	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
mRNA	O	NOUN	B
levels	O	NOUN	O
peak	O	VERB	O
at	O	ADP	O
G1/S	O	NOUN	B
boundary	O	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
a	O	DET	O
role	O	NOUN	O
for	O	ADP	O
NF-kappaB	B-protein	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
CD34	I-cell_type	NOUN	B
(	I-cell_type	PUNCT	O
+	I-cell_type	CCONJ	O
)	I-cell_type	PUNCT	O
bone	I-cell_type	NOUN	B
marrow	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
has	O	AUX	O
not	O	PART	O
been	O	AUX	O
described	O	VERB	O
.	O	PUNCT	O


We	O	PRON	O
demonstrate	O	VERB	O
here	O	ADV	O
that	O	SCONJ	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
lysosomal	B-protein	ADJ	B
enzyme	I-protein	NOUN	O
acid	B-protein	NOUN	O
sphingomyelinase	I-protein	NOUN	O
(	O	PUNCT	O
ASM	O	NOUN	B
;	O	PUNCT	O
E.C.3.1.4.12	O	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
induced	O	VERB	B
during	O	ADP	O
this	O	DET	O
process	O	NOUN	B
and	O	CCONJ	O
is	O	AUX	O
strongly	O	ADV	O
elevated	O	ADJ	B
in	O	ADP	O
differentiated	O	VERB	O
THP-1	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
in	O	ADP	O
differentiated	O	VERB	O
human	B-cell_type	ADJ	B
mononuclear	I-cell_type	ADJ	B
phagocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


This	O	DET	O
cell-type	O	ADJ	B
specific	O	ADJ	O
induction	O	NOUN	B
by	O	ADP	O
PMA	O	NOUN	B
treatment	O	NOUN	B
was	O	AUX	O
further	O	ADV	O
investigated	O	VERB	B
with	O	ADP	O
respect	O	NOUN	O
to	O	PART	O
transcriptional	O	ADJ	B
control	O	NOUN	I
.	O	PUNCT	O


Nonspecific	O	ADJ	B
protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
inhibition	O	NOUN	B
inhibited	O	VERB	B
NF-kappaB	B-protein	NOUN	B
activation	O	NOUN	I
and	O	CCONJ	O
TNF-alpha	B-protein	NOUN	B
release	O	NOUN	B
,	O	PUNCT	O
while	O	SCONJ	O
specific	O	ADJ	O
PKC	B-protein	NOUN	B
inhibition	O	NOUN	B
with	O	ADP	O
Bis	O	NOUN	B
had	O	AUX	O
no	O	DET	B
effect	O	NOUN	I
on	O	ADP	O
LPS-induced	O	ADJ	B
NF-kappaB	B-protein	NOUN	I
DNA	O	NOUN	B
binding	O	NOUN	I
or	O	CCONJ	O
TNF-alpha	B-protein	NOUN	B
release	O	NOUN	B
.	O	PUNCT	O


Increased	O	VERB	B
activity	O	NOUN	B
of	O	ADP	O
various	O	ADJ	O
proteases	B-protein	NOUN	B
is	O	AUX	O
observed	O	VERB	O
in	O	ADP	O
both	O	CCONJ	O
human	O	ADJ	B
and	O	CCONJ	O
experimental	O	ADJ	B
pancreatitis	O	NOUN	I
;	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
information	O	NOUN	B
on	O	ADP	O
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	I
specific	O	ADJ	O
protease	O	NOUN	B
inhibitors	O	NOUN	I
on	O	ADP	O
the	O	DET	O
disease	O	NOUN	B
is	O	AUX	O
limited	O	VERB	O
.	O	PUNCT	O


Elastatinal	O	NOUN	B
had	O	AUX	O
some	O	DET	O
of	O	ADP	O
the	O	DET	O
same	O	ADJ	O
effects	O	NOUN	B
as	O	ADP	O
GDSP	O	NOUN	B
but	O	CCONJ	O
was	O	AUX	O
less	O	ADV	O
potent	O	ADJ	O
and	O	CCONJ	O
effective	O	ADJ	B
.	O	PUNCT	O


Given	O	VERB	O
the	O	DET	O
deleterious	O	ADJ	B
effects	O	NOUN	I
to	O	PART	O
the	O	DET	O
host	O	NOUN	B
of	O	ADP	O
TNF-alpha	B-protein	NOUN	B
,	O	PUNCT	O
it	O	PRON	O
has	O	AUX	O
been	O	AUX	O
postulated	O	VERB	O
that	O	SCONJ	O
TNF-alpha	B-protein	NOUN	B
gene	O	NOUN	O
expression	O	NOUN	B
must	O	AUX	O
be	O	AUX	O
tightly	O	ADV	O
regulated	O	VERB	O
.	O	PUNCT	O


Finally	O	ADV	O
,	O	PUNCT	O
chromosomal	O	ADJ	B
localization	O	NOUN	I
using	O	VERB	O
fluorescence	O	NOUN	B
in	O	X	I
situ	O	X	I
hybridization	O	NOUN	I
revealed	O	VERB	O
that	O	SCONJ	O
LITAF	B-protein	NOUN	B
mapped	O	VERB	B
to	O	PART	O
chromosome	B-DNA	NOUN	O
16p12-16p13.3	I-DNA	NOUN	O
.	O	PUNCT	O


There	O	PRON	O
were	O	AUX	O
12	O	NUM	O
independent	O	ADJ	O
mutation	O	NOUN	B
events	O	NOUN	O
at	O	ADP	O
a	O	DET	O
single	B-DNA	ADJ	O
mutation	I-DNA	NOUN	B
site	I-DNA	NOUN	I
,	O	PUNCT	O
defining	O	VERB	O
a	O	DET	O
small	B-DNA	ADJ	O
deletion	I-DNA	NOUN	O
hotspot	I-DNA	NOUN	O
.	O	PUNCT	O


Neighbouring	O	VERB	B
sequence	O	NOUN	O
analysis	O	NOUN	O
favours	O	VERB	O
a	O	DET	O
small	O	ADJ	O
deletion	O	NOUN	O
model	O	NOUN	O
of	O	ADP	O
slipped	O	ADJ	B
mispairing	O	NOUN	I
events	O	NOUN	I
during	O	ADP	O
replication	O	NOUN	B
.	O	PUNCT	O


In	O	X	B
vitro	O	X	I
transcription	O	NOUN	B
and	O	CCONJ	O
translation	O	NOUN	B
analysis	O	NOUN	I
showed	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
longer	O	ADV	O
5	B-DNA	NUM	O
'	I-DNA	PART	O
UTR	I-DNA	NOUN	B
resulted	O	VERB	O
in	O	ADP	O
about	O	ADV	O
a	O	DET	O
35	O	NUM	O
%	O	NOUN	O
decrease	O	NOUN	B
in	O	ADP	O
translation	O	NOUN	B
efficiency	O	NOUN	B
.	O	PUNCT	O


Its	O	PRON	O
differential	O	ADJ	B
expression	O	NOUN	B
in	O	ADP	O
different	O	ADJ	O
tissues	O	NOUN	B
and	O	CCONJ	O
cells	O	NOUN	B
is	O	AUX	O
regulated	O	VERB	O
not	O	PART	O
only	O	ADV	O
at	O	ADP	O
the	O	DET	O
transcriptional	O	ADJ	B
level	O	NOUN	O
but	O	CCONJ	O
also	O	ADV	O
at	O	ADP	O
the	O	DET	O
translational	O	ADJ	B
level	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
summary	O	NOUN	O
,	O	PUNCT	O
our	O	PRON	O
results	O	NOUN	B
provide	O	VERB	O
compelling	O	ADJ	O
evidence	O	NOUN	B
that	O	SCONJ	O
NF-kappaB	B-protein	NOUN	B
protects	O	VERB	B
against	O	ADP	O
Fas	B-protein	NOUN	B
-mediated	O	ADJ	O
death	O	NOUN	B
and	O	CCONJ	O
is	O	AUX	O
likely	O	ADJ	O
to	O	PART	O
be	O	AUX	O
an	O	DET	O
important	O	ADJ	O
regulator	O	NOUN	B
of	O	ADP	O
T	O	NOUN	B
cell	O	NOUN	I
homeostasis	O	NOUN	B
and	O	CCONJ	O
tolerance	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
,	O	PUNCT	O
in	O	ADP	O
addition	O	NOUN	O
to	O	PART	O
STAT1alpha	B-protein	NOUN	B
,	O	PUNCT	O
STAT3	B-protein	NOUN	B
is	O	AUX	O
also	O	ADV	O
activated	O	VERB	B
by	O	ADP	O
IFN-gamma	B-protein	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
neutrophils	I-cell_type	NOUN	B
.	O	PUNCT	O


Induction	O	NOUN	B
of	O	ADP	O
apoptosis	O	NOUN	B
of	O	ADP	O
mononucleated	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
is	O	AUX	O
a	O	DET	O
physiological	O	ADJ	B
process	O	NOUN	I
for	O	ADP	O
regulating	O	VERB	B
the	O	DET	O
intensity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
immune	O	ADJ	B
response	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
data	O	NOUN	B
presented	O	VERB	O
here	O	ADV	O
suggest	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
female	B-protein	ADJ	B
steroid	I-protein	NOUN	B
receptors	I-protein	NOUN	I
play	O	VERB	O
a	O	DET	O
role	O	NOUN	O
in	O	ADP	O
regulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
immune	O	ADJ	B
response	O	NOUN	I
by	O	ADP	O
preventing	O	VERB	B
apoptosis	O	NOUN	B
of	O	ADP	O
monoblastoid	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
;	O	PUNCT	O
this	O	DET	O
effect	O	NOUN	B
might	O	AUX	O
have	O	AUX	O
important	O	ADJ	O
consequences	O	NOUN	B
in	O	ADP	O
the	O	DET	O
clinical	O	ADJ	B
use	O	NOUN	O
of	O	ADP	O
steroid	O	NOUN	B
receptor	O	NOUN	I
drugs	O	NOUN	O
.	O	PUNCT	O


--	O	PUNCT	O
Vegeto	O	PROPN	B
,	O	PUNCT	O
E.	O	PROPN	B
,	O	PUNCT	O
Pollio	O	PROPN	B
,	O	PUNCT	O
G.	O	PROPN	O
,	O	PUNCT	O
Pellicciari	O	PROPN	B
,	O	PUNCT	O
C.	O	PROPN	B
,	O	PUNCT	O
Maggi	O	PROPN	B
,	O	PUNCT	O
A	O	PROPN	O
.	O	PUNCT	O


Inhibition	O	NOUN	B
of	O	ADP	O
T	O	NOUN	B
cell	O	NOUN	I
signaling	O	NOUN	O
by	O	ADP	O
mitogen-activated	B-protein	ADJ	B
protein	I-protein	NOUN	I
kinase-targeted	I-protein	ADJ	O
hematopoietic	I-protein	ADJ	B
tyrosine	I-protein	NOUN	I
phosphatase	I-protein	NOUN	I
(	O	PUNCT	O
HePTP	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Our	O	PRON	O
findings	O	NOUN	B
demonstrate	O	VERB	O
that	O	SCONJ	O
p38	B-protein	NOUN	B
MAPK	I-protein	NOUN	I
1	O	NUM	I
)	O	PUNCT	O
plays	O	VERB	O
an	O	DET	O
important	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
signal	O	NOUN	B
integration	O	NOUN	B
during	O	ADP	O
costimulation	O	NOUN	B
of	O	ADP	O
primary	B-cell_type	ADJ	B
mouse	I-cell_type	NOUN	I
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
2	O	NUM	O
)	O	PUNCT	O
may	O	AUX	O
be	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
c-Jun	B-protein	NOUN	B
activation	O	NOUN	I
and	O	CCONJ	O
augmentation	O	NOUN	B
of	O	ADP	O
AP-1	B-protein	NOUN	B
transcriptional	O	ADJ	I
activity	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
3	O	X	O
)	O	PUNCT	O
regulates	O	VERB	B
whether	O	SCONJ	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
enter	O	VERB	O
a	O	DET	O
state	O	NOUN	B
of	O	ADP	O
functional	O	ADJ	B
unresponsiveness	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
procedures	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
greatly	O	ADV	O
reduced	O	VERB	B
the	O	DET	O
number	O	NOUN	O
of	O	ADP	O
retrievable	O	ADJ	O
alveolar	B-cell_type	ADJ	B
macrophages	I-cell_type	NOUN	I
,	O	PUNCT	O
suppressed	O	VERB	B
activation	O	NOUN	B
of	O	ADP	O
lung	B-protein	NOUN	B
NF-kappaB	I-protein	NOUN	I
in	O	ADP	O
the	O	DET	O
inflammatory	O	ADJ	B
model	O	NOUN	I
.	O	PUNCT	O


Cytokines	B-protein	NOUN	B
that	O	PRON	O
bind	O	VERB	B
to	O	PART	O
the	O	DET	O
common	O	ADJ	O
gamma	B-protein	NOUN	B
chain	I-protein	NOUN	I
of	O	ADP	I
the	O	DET	O
IL-2	B-protein	NOUN	B
receptor	O	NOUN	I
promote	O	VERB	B
the	O	DET	O
survival	O	NOUN	B
of	O	ADP	O
T	B-cell_type	NOUN	B
cell	I-cell_type	NOUN	I
blasts	I-cell_type	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
also	O	ADV	O
induce	O	VERB	B
proliferation	O	NOUN	B
.	O	PUNCT	O


Copyright	O	NOUN	O
1999	O	NUM	O
Academic	O	PROPN	B
Press	O	PROPN	I
.	O	PUNCT	O


Altogether	O	ADV	O
,	O	PUNCT	O
our	O	PRON	O
results	O	NOUN	O
suggest	O	VERB	O
that	O	SCONJ	O
NAC	O	NOUN	B
might	O	AUX	O
impair	O	VERB	B
the	O	DET	O
generation	O	NOUN	B
of	O	ADP	O
primary	O	ADJ	B
immune	O	ADJ	B
responses	O	NOUN	I
in	O	ADP	O
humans	O	NOUN	B
through	O	ADP	O
its	O	PRON	O
inhibitory	O	ADJ	B
action	O	NOUN	I
on	O	ADP	O
DC	B-cell_type	NOUN	B
.	O	PUNCT	O


Retinoids	O	NOUN	B
are	O	AUX	O
bifunctional	O	ADJ	B
regulators	O	NOUN	I
of	O	ADP	O
growth	O	NOUN	B
and	O	CCONJ	O
differentiation	O	NOUN	B
of	O	ADP	O
hematopoietic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


RA	O	NOUN	B
(	O	PUNCT	O
100	O	NUM	O
nM	O	NOUN	O
)	O	PUNCT	O
induced	O	VERB	B
an	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
the	O	DET	O
percentage	O	NOUN	B
of	O	ADP	O
dead	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
from	O	ADP	O
24	O	NUM	O
%	O	NOUN	O
to	O	PART	O
44	O	NUM	O
%	O	NOUN	O
at	O	ADP	O
day	O	NOUN	B
6	O	NUM	O
(	O	PUNCT	O
p	O	NOUN	O
<	O	X	O
0.05	O	NUM	O
,	O	PUNCT	O
n	O	NOUN	O
=	O	ADJ	O
6	O	NUM	O
)	O	PUNCT	O
as	O	ADP	O
compared	O	VERB	B
to	O	PART	O
control	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
cultured	O	VERB	B
in	O	ADP	O
medium	O	NOUN	B
alone	O	ADV	O
.	O	PUNCT	O


Apoptosis	O	NOUN	B
,	O	PUNCT	O
or	O	CCONJ	O
programmed	O	VERB	B
cell	O	NOUN	I
death	O	NOUN	I
,	O	PUNCT	O
was	O	AUX	O
demonstrated	O	VERB	O
as	O	ADP	O
the	O	DET	O
mode	O	NOUN	B
of	O	ADP	O
cell	O	NOUN	B
death	O	NOUN	I
by	O	ADP	O
using	O	VERB	O
the	O	DET	O
TUNEL	O	NOUN	B
assay	O	NOUN	O
,	O	PUNCT	O
which	O	DET	O
detects	O	VERB	O
single	O	ADJ	O
strand	O	NOUN	O
nicks	O	NOUN	B
in	O	ADP	O
DNA	O	NOUN	B
,	O	PUNCT	O
or	O	CCONJ	O
by	O	ADP	O
the	O	DET	O
Nicoletti	O	NOUN	B
technique	O	NOUN	I
demonstrating	O	VERB	O
a	O	DET	O
subdiploid	O	ADJ	B
population	O	NOUN	I
by	O	ADP	O
DNA	O	NOUN	B
staining	O	NOUN	I
.	O	PUNCT	O


Suppressive	O	ADJ	B
effects	O	NOUN	B
of	O	ADP	O
anti-inflammatory	O	ADJ	B
agents	O	NOUN	I
on	O	ADP	O
human	B-cell_type	ADJ	B
endothelial	I-cell_type	ADJ	O
cell	I-cell_type	NOUN	O
activation	O	NOUN	B
and	O	CCONJ	O
induction	O	NOUN	B
of	O	ADP	O
heat	B-protein	NOUN	B
shock	I-protein	NOUN	I
proteins	I-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
interactions	O	NOUN	B
of	O	ADP	O
Hsp60-specific	B-cell_line	ADJ	B
T	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
with	O	ADP	O
arterial	O	ADJ	B
endothelial	B-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
(	O	PUNCT	O
EC	B-cell_type	NOUN	B
)	O	PUNCT	O
require	O	VERB	O
expression	O	NOUN	B
of	O	ADP	O
both	O	CCONJ	O
Hsp60	B-protein	NOUN	B
and	O	CCONJ	O
certain	O	ADJ	O
adhesion	B-protein	NOUN	B
molecules	I-protein	NOUN	B
shown	O	VERB	O
to	O	PART	O
be	O	AUX	O
induced	O	VERB	B
simultaneously	O	ADV	B
in	O	ADP	O
EC	B-cell_type	NOUN	B
by	O	ADP	O
mechanical	O	ADJ	B
and	O	CCONJ	O
other	O	ADJ	O
types	O	NOUN	O
of	O	ADP	O
stress	O	NOUN	B
.	O	PUNCT	O


MATERIAL	O	NOUN	B
AND	O	CCONJ	O
METHODS	O	NOUN	O
:	O	PUNCT	O
In	O	ADP	O
the	O	DET	O
present	O	ADJ	O
study	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
analyzed	O	VERB	B
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	O
CyA	O	NOUN	B
,	O	PUNCT	O
aspirin	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
indomethacin	O	NOUN	B
on	O	ADP	O
T	O	NOUN	B
cell	O	NOUN	I
proliferation	O	NOUN	I
using	O	VERB	O
a	O	DET	O
proliferation	O	NOUN	B
assay	O	NOUN	I
.	O	PUNCT	O


Before	O	ADP	O
and	O	CCONJ	O
after	O	ADP	O
treatment	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
patients	O	NOUN	B
underwent	O	VERB	O
fiberoptic	O	ADJ	B
bronchoscopy	O	NOUN	I
with	O	ADP	O
endobronchial	O	ADJ	B
biopsy	O	NOUN	I
and	O	CCONJ	O
sampling	O	NOUN	B
of	O	ADP	O
venous	O	ADJ	B
blood	O	NOUN	I
for	O	ADP	O
measurements	O	NOUN	B
of	O	ADP	O
GR	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
levels	O	NOUN	O
.	O	PUNCT	O


Jeg-3	O	NOUN	B
human	O	ADJ	B
choriocarcinoma-induced	O	ADJ	B
immunosuppression	O	NOUN	I
:	O	PUNCT	O
downregulation	O	NOUN	B
of	O	ADP	O
interleukin-2	B-protein	NOUN	B
,	O	PUNCT	O
interleukin-2	B-protein	NOUN	B
receptor	I-protein	NOUN	I
alpha-chain	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
its	O	PRON	O
Jak/Stat	B-protein	NOUN	B
signaling	O	NOUN	I
pathway	O	NOUN	I
.	O	PUNCT	O


Jak1	O	NOUN	B
,	O	PUNCT	O
Jak3	O	NOUN	B
,	O	PUNCT	O
Stat1	O	NOUN	B
,	O	PUNCT	O
Stat3	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
Stat5	O	NOUN	B
expression	O	NOUN	B
is	O	AUX	O
suppressed	O	VERB	B
approximately	O	ADV	O
to	O	PART	O
,	O	PUNCT	O
or	O	CCONJ	O
below	O	ADP	O
the	O	DET	O
level	O	NOUN	B
of	O	ADP	O
unstimulated	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


The	O	DET	O
Th2-type	B-protein	ADJ	B
cytokines	I-protein	NOUN	B
,	O	PUNCT	O
interleukin-4	B-protein	NOUN	B
(	O	PUNCT	O
IL-4	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
interleukin-13	B-protein	NOUN	B
(	O	PUNCT	O
IL-13	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
induce	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
a	O	DET	O
distinct	O	ADJ	O
subset	O	NOUN	O
of	O	ADP	O
genes	O	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
,	O	PUNCT	O
including	O	VERB	O
FcepsilonRIIb	B-protein	NOUN	B
(	O	PUNCT	O
CD23	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
15-lipoxygenase	B-protein	NOUN	B
,	O	PUNCT	O
IL-1	B-protein	NOUN	B
receptor	I-protein	NOUN	I
antagonist	I-protein	NOUN	I
(	O	PUNCT	O
IL-1ra	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
type	B-protein	NOUN	B
I	I-protein	NUM	I
and	I-protein	CCONJ	O
type	I-protein	NOUN	B
II	I-protein	NUM	I
IL-1	I-protein	NOUN	I
receptors	I-protein	NOUN	I
(	O	PUNCT	O
IL-1R	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Type	B-protein	NOUN	B
I	I-protein	NUM	I
interferons	I-protein	NOUN	I
(	O	PUNCT	O
IFN-alpha	B-protein	NOUN	B
and	O	CCONJ	O
IFN-beta	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
type	B-protein	NOUN	B
II	I-protein	NUM	I
interferon	I-protein	NOUN	I
(	O	PUNCT	O
IFN-gamma	B-protein	NOUN	B
)	O	PUNCT	O
inhibit	O	VERB	B
induction	O	NOUN	B
of	O	ADP	O
these	O	DET	O
genes	O	NOUN	B
by	O	ADP	O
IL-4	B-protein	NOUN	B
and	O	CCONJ	O
IL-13	B-protein	NOUN	B
.	O	PUNCT	O


Inhibition	O	NOUN	B
of	O	ADP	O
STAT6	B-protein	NOUN	B
activity	O	NOUN	B
is	O	AUX	O
not	O	PART	O
evident	O	ADJ	O
unless	O	SCONJ	O
cells	O	NOUN	B
are	O	AUX	O
preincubated	O	VERB	B
with	O	ADP	O
IFN	B-protein	NOUN	B
for	O	ADP	O
at	O	ADP	O
least	O	ADJ	O
1	O	NUM	O
h	O	NOUN	O
before	O	ADP	O
IL-4	B-protein	NOUN	B
stimulation	O	NOUN	B
.	O	PUNCT	O


HLA	B-protein	NOUN	B
class	I-protein	NOUN	I
I	I-protein	NUM	I
-mediated	O	ADJ	O
inactivation	O	NOUN	B
of	O	ADP	O
Rb	B-protein	NOUN	B
can	O	AUX	O
be	O	AUX	O
inhibited	O	VERB	B
specifically	O	ADV	O
by	O	ADP	O
neutralizing	B-protein	VERB	O
Abs	I-protein	NOUN	B
to	O	PART	O
basic	B-protein	ADJ	O
fibroblast	I-protein	NOUN	B
growth	I-protein	NOUN	I
factor	I-protein	NOUN	I
(	O	PUNCT	O
bFGF	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
suggesting	O	VERB	O
a	O	DET	O
role	O	NOUN	O
for	O	ADP	O
FGF	B-protein	NOUN	B
receptors	I-protein	NOUN	I
in	O	ADP	O
the	O	DET	O
signaling	O	NOUN	B
process	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
cdk2	O	NOUN	B
inhibitor	O	NOUN	B
,	O	PUNCT	O
Olomoucine	O	NOUN	B
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
a	O	DET	O
dominant-negative	B-DNA	ADJ	B
cdk2	I-DNA	NOUN	B
construct	I-DNA	NOUN	O
prevented	O	VERB	B
HLA	B-protein	NOUN	B
class	I-protein	NOUN	I
I	I-protein	NUM	I
-mediated	O	ADJ	O
inactivation	O	NOUN	B
of	O	ADP	O
Rb	B-protein	NOUN	B
;	O	PUNCT	O
in	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
dominant-negative	B-DNA	ADJ	B
cdk4	I-DNA	NOUN	B
and	I-DNA	CCONJ	O
cdk6	I-DNA	NOUN	B
constructs	I-DNA	NOUN	B
had	O	AUX	O
no	O	DET	B
effect	O	NOUN	I
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
there	O	PRON	O
was	O	AUX	O
no	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
cyclin	B-protein	NOUN	B
D-associated	I-protein	ADJ	I
kinase	I-protein	NOUN	I
activity	O	NOUN	I
upon	O	SCONJ	O
HLA	B-protein	NOUN	B
class	I-protein	NOUN	I
I	I-protein	NUM	I
ligation	O	NOUN	I
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
cyclin	B-protein	NOUN	B
E-dependent	I-protein	ADJ	I
kinase	I-protein	NOUN	I
activity	O	NOUN	I
mediates	O	VERB	O
Rb	B-protein	NOUN	B
inactivation	O	NOUN	B
,	O	PUNCT	O
leading	O	VERB	O
to	O	PART	O
E2F	B-protein	NOUN	B
activation	O	NOUN	I
and	O	CCONJ	O
cell	O	NOUN	B
proliferation	O	NOUN	I
.	O	PUNCT	O


Most	O	ADJ	O
erythroleukemic	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
established	O	VERB	O
in	O	X	B
vitro	O	X	I
coexpress	O	VERB	B
erythrocytic	B-protein	ADJ	B
and	I-protein	CCONJ	O
megakaryocytic	I-protein	ADJ	B
markers	I-protein	NOUN	B
that	O	PRON	O
often	O	ADV	O
are	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
expression	O	NOUN	B
of	O	ADP	O
Spi-1	B-protein	NOUN	B
and/or	O	CCONJ	O
Fli-1	B-protein	NOUN	B
transcription	I-protein	NOUN	I
factors	I-protein	NOUN	I
known	O	VERB	O
as	O	ADP	O
transactivators	B-protein	NOUN	B
of	I-protein	ADP	O
megakaryocyte-specific	I-protein	ADJ	B
promoters	I-protein	NOUN	I
.	O	PUNCT	O


Switching	O	VERB	B
the	O	DET	O
cells	O	NOUN	B
to	O	PART	O
the	O	DET	O
nonpermissive	O	ADJ	B
temperature	O	NOUN	B
led	O	VERB	O
to	O	PART	O
a	O	DET	O
marked	O	ADJ	O
increase	O	NOUN	B
in	O	ADP	O
globin	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
expression	O	NOUN	B
and	O	CCONJ	O
concomitant	O	ADJ	B
decrease	O	NOUN	B
in	O	ADP	O
expression	O	NOUN	B
of	O	ADP	O
Spi-1	B-protein	NOUN	B
,	O	PUNCT	O
Fli-1	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
megakaryocytic	B-DNA	ADJ	B
genes	I-DNA	NOUN	I
in	O	ADP	O
an	O	DET	O
erythropoietin	B-protein	NOUN	B
-dependent	O	ADJ	O
manner	O	NOUN	O
.	O	PUNCT	O


Interestingly	O	ADV	O
,	O	PUNCT	O
enhanced	O	VERB	O
expression	O	NOUN	B
of	O	ADP	O
Spi-1	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
Fli-1	I-DNA	NOUN	B
genes	I-DNA	NOUN	I
already	O	ADV	O
was	O	AUX	O
detected	O	VERB	B
in	O	ADP	O
the	O	DET	O
Ter	B-cell_line	NOUN	B
119	I-cell_line	NUM	O
positive	I-cell_line	ADJ	B
cell	I-cell_line	NOUN	B
population	I-cell_line	NOUN	I
of	O	ADP	O
transgenic	O	ADJ	B
mice	O	NOUN	I
spleen	O	NOUN	B
in	O	X	B
vivo	O	X	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
like	O	ADP	O
normal	B-cell_line	ADJ	O
Ter	I-cell_line	NOUN	B
119	I-cell_line	NUM	O
erythroid	I-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
these	O	DET	O
Ter	B-cell_line	NOUN	B
119	I-cell_line	NUM	O
positive	I-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
from	O	ADP	O
transgenic	O	ADJ	B
mice	O	NOUN	I
still	O	ADV	O
expressed	O	VERB	B
high	O	ADJ	O
levels	O	NOUN	B
of	O	ADP	O
beta-globin	B-protein	NOUN	B
and	O	CCONJ	O
very	O	ADV	O
low	O	ADJ	O
or	O	CCONJ	O
undetectable	O	ADJ	B
glycoprotein	B-protein	NOUN	B
IIb	I-protein	NOUN	I
and	O	CCONJ	O
platelet	B-protein	NOUN	B
factor	I-protein	NOUN	I
4	I-protein	NUM	I
megakaryocytic	I-protein	ADJ	B
transcripts	I-protein	NOUN	B
.	O	PUNCT	O


Although	O	SCONJ	O
it	O	PRON	O
can	O	AUX	O
be	O	AUX	O
incorporated	O	VERB	O
into	O	ADP	O
the	O	DET	O
DNA	O	NOUN	B
of	O	ADP	O
dividing	O	VERB	B
cells	O	NOUN	I
,	O	PUNCT	O
fludarabine	O	NOUN	B
is	O	AUX	O
also	O	ADV	O
a	O	DET	O
potent	O	ADJ	O
inhibitor	O	NOUN	B
of	O	ADP	O
cells	O	NOUN	B
with	O	ADP	O
a	O	DET	O
low	O	ADJ	B
growth	O	NOUN	B
fraction	O	NOUN	I
,	O	PUNCT	O
thus	O	ADV	O
it	O	PRON	O
must	O	AUX	O
have	O	AUX	O
other	O	ADJ	O
mechanisms	O	NOUN	B
of	O	ADP	O
action	O	NOUN	B
.	O	PUNCT	O


Whereas	O	SCONJ	O
the	O	DET	O
NF-kappaB	B-protein	NOUN	B
binding	O	NOUN	I
activity	O	NOUN	I
in	O	ADP	O
Tax-expressing	B-cell_line	ADJ	B
T-cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
consisted	O	VERB	O
mostly	O	ADV	O
of	O	ADP	O
p50/c-Rel	B-protein	NOUN	B
,	O	PUNCT	O
fresh	O	ADJ	B
ATL	O	NOUN	B
samples	O	NOUN	B
contained	O	VERB	O
p50/p50	B-protein	NOUN	B
and	I-protein	CCONJ	O
p50/p65	I-protein	NOUN	B
heterodimers	I-protein	NOUN	I
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	O
suggest	O	VERB	O
that	O	SCONJ	O
activation	O	NOUN	B
of	O	ADP	O
NF-kappaB	B-protein	NOUN	B
occurs	O	VERB	O
through	O	ADP	O
a	O	DET	O
Tax	B-protein	NOUN	B
-independent	O	ADJ	O
mechanism	O	NOUN	B
in	O	ADP	O
leukemic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
of	O	ADP	O
ATL	O	NOUN	B
patients	O	NOUN	B
,	O	PUNCT	O
possibly	O	ADV	O
due	O	ADJ	O
to	O	PART	O
differential	O	ADJ	O
NF-kappaB	B-protein	NOUN	B
subunit	O	NOUN	I
activation	O	NOUN	B
.	O	PUNCT	O


Therefore	O	ADV	O
,	O	PUNCT	O
this	O	DET	O
study	O	NOUN	B
was	O	AUX	O
designed	O	VERB	O
to	O	PART	O
analyze	O	VERB	B
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
Lck	B-protein	NOUN	B
in	O	ADP	O
IFN-alpha	B-protein	NOUN	B
signaling	O	NOUN	B
by	O	ADP	O
using	O	VERB	O
the	O	DET	O
Jurkat	O	NOUN	B
,	O	PUNCT	O
JCam	O	NOUN	B
(	O	PUNCT	O
an	O	DET	O
Lck-defective	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
derived	O	VERB	O
from	O	ADP	O
Jurkat	B-cell_line	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
JCam/Lck	B-cell_line	NOUN	B
(	O	PUNCT	O
JCam	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
with	O	ADP	O
Lck	B-protein	NOUN	B
restored	O	VERB	B
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
results	O	NOUN	B
show	O	VERB	O
that	O	SCONJ	O
IFN-alpha	B-protein	NOUN	B
can	O	AUX	O
induce	O	VERB	B
MAPK	B-protein	NOUN	B
activity	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
only	O	ADV	O
in	O	ADP	O
cells	O	NOUN	B
containing	O	VERB	O
Lck	B-protein	NOUN	B
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
Lck	B-protein	NOUN	B
and	O	CCONJ	O
active	O	ADJ	B
MAPK	B-protein	NOUN	B
do	O	AUX	O
not	O	PART	O
affect	O	VERB	O
IFN-alpha	B-protein	NOUN	B
-induced	O	ADJ	O
growth	O	NOUN	B
arrest	O	NOUN	I
or	O	CCONJ	O
induction	O	NOUN	B
of	O	ADP	O
STAT1s1	O	NOUN	B
and	O	CCONJ	O
-3	O	NUM	O
DNA	O	NOUN	B
binding	O	NOUN	I
ability	O	NOUN	O
.	O	PUNCT	O


Copyright	O	NOUN	O
1999	O	NUM	O
Academic	O	PROPN	B
Press	O	PROPN	I
.	O	PUNCT	O


Of	O	ADP	O
p38	B-protein	NOUN	B
MAPk	I-protein	NOUN	B
isoforms	I-protein	NOUN	B
studied	O	VERB	O
,	O	PUNCT	O
only	O	ADV	O
p38alpha	B-protein	NOUN	B
and	O	CCONJ	O
p38delta	B-protein	NOUN	B
were	O	AUX	O
detected	O	VERB	B
in	O	ADP	O
neutrophils	B-cell_type	NOUN	B
.	O	PUNCT	O


LPS	O	NOUN	B
stimulation	O	NOUN	B
selectively	O	ADV	O
activated	O	VERB	B
p38alpha	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
evolutionarily	B-DNA	ADV	O
conserved	I-DNA	VERB	O
sequence	I-DNA	NOUN	O
upstream	O	ADJ	O
of	O	ADP	O
the	O	DET	O
human	B-protein	ADJ	B
Ig	I-protein	NOUN	O
heavy	I-protein	ADJ	O
chain	I-protein	NOUN	O
S	I-protein	NOUN	O
gamma	I-protein	NOUN	O
3	I-protein	NUM	O
region	I-protein	NOUN	O
is	O	AUX	O
an	O	DET	O
inducible	B-DNA	ADJ	B
promoter	I-DNA	NOUN	B
:	O	PUNCT	O
synergistic	O	ADJ	B
activation	O	NOUN	B
by	O	ADP	O
CD40	B-protein	NOUN	B
ligand	I-protein	NOUN	B
and	O	CCONJ	O
IL-4	B-protein	NOUN	B
via	O	ADP	O
cooperative	O	ADJ	O
NF-kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
and	I-DNA	CCONJ	O
STAT-6	I-DNA	NOUN	B
binding	I-DNA	NOUN	B
sites	I-DNA	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
these	O	DET	O
transfected	O	VERB	B
CL-01	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
CD40	O	NOUN	B
:	O	PUNCT	O
CD40L	B-protein	NOUN	B
engagement	O	NOUN	B
and	O	CCONJ	O
exposure	O	NOUN	B
to	O	PART	I
IL-4	B-protein	NOUN	B
synergistically	O	ADV	B
induced	O	VERB	B
gamma	O	NOUN	B
3	O	NUM	I
ECS-dependent	O	ADJ	B
luciferase	B-DNA	NOUN	B
reporter	I-DNA	NOUN	I
gene	I-DNA	NOUN	O
activation	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
transactivator	B-protein	NOUN	B
CIITA	B-protein	NOUN	B
behaves	O	VERB	O
as	O	ADP	O
a	O	DET	O
master	O	NOUN	O
controller	O	NOUN	O
of	O	ADP	O
constitutive	O	ADJ	B
and	O	CCONJ	O
inducible	O	ADJ	B
MHC	B-DNA	NOUN	O
class	I-DNA	NOUN	O
II	I-DNA	NUM	O
gene	I-DNA	NOUN	B
activation	O	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
its	O	PRON	O
exact	O	ADJ	O
mechanism	O	NOUN	B
of	O	ADP	O
action	O	NOUN	B
is	O	AUX	O
not	O	PART	O
known	O	VERB	O
.	O	PUNCT	O


Expression	O	NOUN	B
of	O	ADP	O
GrpL	B-protein	NOUN	B
is	O	AUX	O
restricted	O	ADJ	O
to	O	PART	O
hematopoietic	O	ADJ	B
tissues	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
it	O	PRON	O
is	O	AUX	O
distinguished	O	VERB	O
from	O	ADP	O
Grb2	B-protein	NOUN	B
by	O	ADP	O
having	O	VERB	O
a	O	DET	O
proline-rich	B-protein	ADJ	B
region	I-protein	NOUN	I
.	O	PUNCT	O


GrpL	B-protein	NOUN	B
can	O	AUX	O
be	O	AUX	O
coimmunoprecipitated	O	VERB	B
with	O	ADP	O
SLP-76	B-protein	NOUN	B
but	O	CCONJ	O
not	O	PART	O
with	O	ADP	O
Sos1	B-protein	NOUN	B
or	O	CCONJ	O
Sos2	B-protein	NOUN	B
from	O	ADP	O
Jurkat	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
lysates	O	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
another	O	DET	O
inducible	O	ADJ	B
gene	O	NOUN	B
expression	O	NOUN	I
of	O	ADP	O
monocyte	B-protein	NOUN	B
chemotactic	I-protein	ADJ	I
protein-1	I-protein	NOUN	I
(	O	PUNCT	O
a	O	DET	O
CC	B-protein	NOUN	B
chemokine	I-protein	NOUN	I
)	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
transcriptional	B-protein	ADJ	B
factor	I-protein	NOUN	I
(	O	PUNCT	O
FcRFgamma	B-protein	NOUN	B
)	O	PUNCT	O
bound	O	VERB	O
to	O	PART	O
the	O	DET	O
gamma	B-DNA	NOUN	B
response	I-DNA	NOUN	I
region	I-DNA	NOUN	I
were	O	AUX	O
similarly	O	ADV	O
or	O	CCONJ	O
less	O	ADV	O
abundantly	O	ADV	B
induced	O	VERB	B
by	O	ADP	O
IFNgamma	B-protein	NOUN	B
treatment	O	NOUN	B
in	O	ADP	O
PMA	O	NOUN	B
-or	O	PART	O
RA-differentiated	O	ADJ	B
U937	B-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
indicating	O	VERB	O
that	O	SCONJ	O
increased	O	VERB	B
IP-10	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
induction	O	NOUN	B
was	O	AUX	O
not	O	PART	O
due	O	ADJ	O
to	O	PART	O
the	O	DET	O
augmented	O	ADJ	B
ability	O	NOUN	B
of	O	ADP	O
the	O	DET	O
cells	O	NOUN	B
to	O	PART	O
respond	O	VERB	O
to	O	PART	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
IFNgamma	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
STP	B-protein	NOUN	B
oncoproteins	I-protein	NOUN	B
of	O	ADP	O
the	O	DET	O
herpesvirus	O	NOUN	B
saimiri	O	NOUN	I
(	O	PUNCT	O
HVS	O	NOUN	B
)	O	PUNCT	O
subgroup	O	NOUN	B
A	O	NOUN	O
strain	O	NOUN	B
11	O	NUM	I
and	O	CCONJ	O
subgroup	O	NOUN	B
C	O	NOUN	O
strain	O	NOUN	O
488	O	NUM	O
are	O	AUX	O
now	O	ADV	O
found	O	VERB	O
to	O	PART	O
be	O	AUX	O
stably	O	ADV	B
associated	O	VERB	B
with	O	ADP	I
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor	I-protein	NOUN	I
receptor-associated	I-protein	ADJ	I
factor	I-protein	NOUN	I
(	I-protein	PUNCT	I
TRAF	I-protein	NOUN	B
)	I-protein	PUNCT	O
1	I-protein	NUM	O
,	I-protein	PUNCT	O
2	I-protein	NUM	O
,	I-protein	PUNCT	O
or	I-protein	CCONJ	O
3	I-protein	NUM	O
.	O	PUNCT	O


The	O	DET	O
HVS	O	NOUN	B
STP-C488	B-protein	NOUN	I
P10	O	NOUN	I
--	O	PUNCT	O
>	O	X	O
R	O	NOUN	B
mutant	O	NOUN	I
was	O	AUX	O
deficient	O	ADJ	B
in	O	ADP	O
human	O	ADJ	B
T-lymphocyte	O	NOUN	B
transformation	O	NOUN	I
to	O	PART	O
interleukin-2-independent	O	ADJ	B
growth	O	NOUN	O
but	O	CCONJ	O
showed	O	VERB	O
wild-type	O	ADJ	B
phenotype	O	NOUN	B
for	O	ADP	O
marmoset	O	NOUN	B
T-lymphocyte	O	NOUN	B
transformation	O	NOUN	O
in	O	X	B
vitro	O	X	I
and	O	CCONJ	O
in	O	X	B
vivo	O	X	I
.	O	PUNCT	O


Cleavage	O	NOUN	B
of	O	ADP	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
SP1	B-protein	NOUN	B
by	O	ADP	O
caspases	B-protein	NOUN	B
during	O	ADP	O
anti-IgM-induced	O	ADJ	B
B-cell	B-cell_type	NOUN	I
apoptosis	O	NOUN	B
.	O	PUNCT	O


Cleavage	O	NOUN	B
could	O	AUX	O
be	O	AUX	O
completely	O	ADV	O
inhibited	O	VERB	B
by	O	ADP	O
zDEVD-fmk	O	NOUN	B
,	O	PUNCT	O
an	O	DET	O
inhibitor	O	NOUN	B
specific	O	ADJ	B
for	O	ADP	O
caspase	B-protein	NOUN	B
3-like	I-protein	ADJ	I
proteases	I-protein	NOUN	I
.	O	PUNCT	O


CD40	B-protein	NOUN	B
expression	O	NOUN	B
was	O	AUX	O
confirmed	O	VERB	O
in	O	ADP	O
7	O	NUM	O
human	B-cell_line	ADJ	B
MM	I-cell_line	NOUN	O
cell	I-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
established	O	VERB	O
from	O	ADP	O
immunogenic	O	ADJ	B
primary	O	ADJ	B
tumors	O	NOUN	I
or	O	CCONJ	O
metastases	O	NOUN	B
,	O	PUNCT	O
whereas	O	SCONJ	O
11	O	NUM	O
cell	B-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
established	O	VERB	O
from	O	ADP	O
advanced	O	ADJ	B
stages	O	NOUN	I
were	O	AUX	O
CD40	B-protein	NOUN	B
negative	O	ADJ	B
.	O	PUNCT	O


CD40	B-protein	NOUN	B
expression	O	NOUN	B
could	O	AUX	O
be	O	AUX	O
enhanced	O	VERB	B
in	O	ADP	O
CD40	B-protein	NOUN	B
-positive	O	ADJ	O
MM	O	NOUN	B
by	O	ADP	O
stimulation	O	NOUN	B
with	O	ADP	O
IFN-gamma	B-protein	NOUN	B
and	O	CCONJ	O
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor-alpha	I-protein	NOUN	I
but	O	CCONJ	O
not	O	PART	O
by	O	ADP	O
interleukin	B-protein	NOUN	B
(	I-protein	PUNCT	O
IL	I-protein	NOUN	B
)	I-protein	PUNCT	O
-1beta	I-protein	NOUN	B
or	O	CCONJ	O
CD40	B-protein	NOUN	B
triggering	O	NOUN	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
CD40	B-protein	NOUN	B
ligation	O	NOUN	B
of	O	ADP	O
a	O	DET	O
HLA-A2+	B-cell_line	ADJ	B
,	I-cell_line	PUNCT	O
MelanA/MART1+	I-cell_line	ADJ	B
MM	I-cell_line	NOUN	I
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
enhanced	O	VERB	B
its	O	PRON	O
susceptibility	O	NOUN	B
to	O	PART	O
specific	O	ADJ	O
lysis	O	NOUN	B
by	O	ADP	O
a	O	DET	O
HLA-A2-restricted	B-cell_line	ADJ	B
,	I-cell_line	PUNCT	O
MelanA/MART-1-specific	I-cell_line	ADJ	B
CTL	I-cell_line	NOUN	B
clone	I-cell_line	NOUN	B
.	O	PUNCT	O


Finally	O	ADV	O
,	O	PUNCT	O
CD40	B-protein	NOUN	B
ligation	O	NOUN	B
induced	O	VERB	B
growth	O	NOUN	B
inhibition	O	NOUN	I
and	O	CCONJ	O
apoptosis	O	NOUN	B
in	O	ADP	O
MM	O	NOUN	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
whereas	O	SCONJ	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
fusion	O	NOUN	B
protein	O	NOUN	I
AML1/MDS1/EVI1	B-protein	NOUN	B
completely	O	ADV	O
abrogates	O	VERB	B
the	O	DET	O
growth-inhibitory	O	ADJ	B
effect	O	NOUN	I
of	O	ADP	O
TGF-beta1	B-protein	NOUN	B
and	O	CCONJ	O
allows	O	VERB	O
32Dcl3	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
to	O	PART	O
proliferate	O	VERB	B
,	O	PUNCT	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
normal	O	ADJ	B
protein	O	NOUN	I
MDS1/EVI1	B-DNA	NOUN	B
has	O	AUX	O
the	O	DET	O
opposite	O	ADJ	O
effect	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
it	O	PRON	O
strengthens	O	VERB	O
the	O	DET	O
response	O	NOUN	B
of	O	ADP	I
cells	O	NOUN	O
to	O	PART	O
the	O	DET	O
growth-inhibitory	O	ADJ	B
effect	O	NOUN	I
of	O	ADP	O
TGF-beta1	B-protein	NOUN	B
.	O	PUNCT	O


METHODS	O	NOUN	O
:	O	PUNCT	O
Platelets	B-cell_type	NOUN	B
were	O	AUX	O
collected	O	VERB	O
from	O	ADP	O
112	O	NUM	O
drug-free	O	ADJ	O
patients	O	NOUN	B
with	O	ADP	O
bipolar	O	ADJ	B
disorder	O	NOUN	I
(	O	PUNCT	O
52	O	NUM	O
euthymic	O	ADJ	B
,	O	PUNCT	O
29	O	NUM	O
depressed	O	ADJ	B
,	O	PUNCT	O
and	O	CCONJ	O
31	O	NUM	O
manic	O	ADJ	B
)	O	PUNCT	O
and	O	CCONJ	O
62	O	NUM	O
healthy	O	ADJ	B
subjects	O	NOUN	I
.	O	PUNCT	O


Two	O	NUM	O
types	O	NOUN	O
of	O	ADP	O
effector	O	NOUN	B
cells	O	NOUN	I
characterized	O	VERB	B
by	O	ADP	O
their	O	PRON	O
distinct	O	ADJ	O
expression	O	NOUN	B
of	O	ADP	O
cytokine	B-protein	NOUN	B
profiles	O	NOUN	I
have	O	AUX	O
been	O	AUX	O
described	O	VERB	O
.	O	PUNCT	O


Th1	O	NOUN	B
cells	O	NOUN	I
produce	O	VERB	O
IL-2	B-protein	NOUN	B
and	O	CCONJ	O
IFN-gamma	B-protein	NOUN	B
,	O	PUNCT	O
whereas	O	SCONJ	O
Th2	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
produce	O	VERB	O
IL-4	B-protein	NOUN	B
,	O	PUNCT	O
IL-5	B-protein	NOUN	B
,	O	PUNCT	O
IL-6	B-protein	NOUN	B
,	O	PUNCT	O
IL-10	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
IL-13	B-protein	NOUN	B
.	O	PUNCT	O


Beta-catenin	O	NOUN	B
is	O	AUX	O
the	O	DET	O
vertebrate	O	ADJ	B
homolog	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Drosophila	B-DNA	X	B
segment	I-DNA	NOUN	O
polarity	I-DNA	NOUN	O
gene	I-DNA	NOUN	B
Armadillo	B-DNA	NOUN	I
and	O	CCONJ	O
plays	O	VERB	O
roles	O	NOUN	O
in	O	ADP	O
both	O	CCONJ	O
cell-cell	O	ADJ	B
adhesion	O	NOUN	I
and	O	CCONJ	O
transduction	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Wnt	O	NOUN	B
signaling	O	NOUN	I
cascade	O	NOUN	I
.	O	PUNCT	O


Recently	O	ADV	O
,	O	PUNCT	O
members	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Lef/Tcf	B-protein	NOUN	B
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
family	I-protein	NOUN	I
have	O	AUX	O
been	O	AUX	O
identified	O	VERB	B
as	O	ADP	O
protein	O	NOUN	B
partners	O	NOUN	I
of	O	ADP	O
beta-catenin	B-protein	NOUN	B
,	O	PUNCT	O
explaining	O	VERB	O
how	O	SCONJ	O
beta-catenin	B-protein	NOUN	B
alters	O	VERB	O
gene	O	NOUN	B
expression	O	NOUN	I
.	O	PUNCT	O


EBNA2	B-protein	NOUN	B
-dependent	O	ADJ	O
transcriptional	O	ADJ	B
induction	O	NOUN	I
of	O	ADP	O
the	O	DET	O
IFN-beta	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
occurred	O	VERB	O
in	O	ADP	O
EBV-negative	B-cell_line	ADJ	B
Burkitt	I-cell_line	NOUN	I
's	I-cell_line	PART	I
lymphoma	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
indicating	O	VERB	O
that	O	SCONJ	O
other	O	ADJ	O
EBV	B-DNA	NOUN	B
genes	I-DNA	NOUN	I
were	O	AUX	O
not	O	PART	O
required	O	VERB	O
for	O	ADP	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
IFN-beta	B-protein	NOUN	B
synthesis	O	NOUN	B
.	O	PUNCT	O


Incubation	O	NOUN	B
of	O	ADP	O
human	O	ADJ	B
whole	O	ADJ	O
blood	O	NOUN	O
with	O	ADP	O
PGG-Glucan	O	NOUN	B
significantly	O	ADV	O
enhanced	O	VERB	B
the	O	DET	O
oxidative	O	ADJ	B
burst	O	NOUN	I
response	O	NOUN	I
of	O	ADP	O
subsequently	B-cell_type	ADV	O
isolated	I-cell_type	VERB	B
blood	I-cell_type	NOUN	O
leukocytes	I-cell_type	NOUN	O
to	O	PART	O
both	O	CCONJ	O
soluble	O	ADJ	B
and	O	CCONJ	O
particulate	O	ADJ	B
activators	O	NOUN	B
in	O	ADP	O
a	O	DET	O
dose-dependent	O	ADJ	B
manner	O	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
increased	O	VERB	B
leukocyte	O	NOUN	B
microbicidal	O	ADJ	O
activity	O	NOUN	O
.	O	PUNCT	O


Electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assays	O	NOUN	I
demonstrated	O	VERB	O
that	O	SCONJ	O
PGG-Glucan	O	NOUN	B
induced	O	VERB	B
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
an	O	DET	O
NF-kappaB-like	B-protein	ADJ	B
nuclear	I-protein	ADJ	I
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
in	O	ADP	O
purified	B-cell_type	VERB	O
human	I-cell_type	ADJ	B
neutrophils	I-cell_type	NOUN	B
.	O	PUNCT	O


Glucocorticoids	O	NOUN	B
promote	O	VERB	O
nonphlogistic	O	ADJ	B
phagocytosis	O	NOUN	I
of	O	ADP	O
apoptotic	B-cell_type	ADJ	B
leukocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


These	O	DET	O
effects	O	NOUN	B
were	O	AUX	O
specific	O	ADJ	O
in	O	ADP	O
that	O	SCONJ	O
the	O	DET	O
potentiated	O	VERB	B
phagocytosis	O	NOUN	B
of	O	ADP	O
apoptotic	B-cell_type	ADJ	B
neutrophils	I-cell_type	NOUN	B
was	O	AUX	O
completely	O	ADV	O
blocked	O	VERB	B
by	O	ADP	O
the	O	DET	O
glucocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
antagonist	O	NOUN	B
RU38486	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
glucocorticoids	O	NOUN	B
did	O	AUX	O
not	O	PART	O
promote	O	VERB	O
5-day	O	ADJ	O
M	O	NOUN	B
phi	O	NOUN	I
ingestion	O	NOUN	B
of	O	ADP	O
opsonized	B-cell_type	ADJ	B
erythrocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


1	O	NUM	O
,	O	PUNCT	O
25-Dihydroxyvitamin	O	NOUN	B
D3	O	NOUN	I
induces	O	VERB	O
differentiation	O	NOUN	B
of	O	ADP	O
a	O	DET	O
retinoic	B-cell_line	ADJ	B
acid-resistant	I-cell_line	ADJ	O
acute	I-cell_line	ADJ	B
promyelocytic	I-cell_line	ADJ	I
leukemia	I-cell_line	NOUN	I
cell	I-cell_line	NOUN	O
line	I-cell_line	NOUN	O
(	O	PUNCT	O
UF-1	B-cell_line	NOUN	B
)	O	PUNCT	O
associated	O	VERB	B
with	O	ADP	I
expression	O	NOUN	B
of	O	ADP	O
p21	B-protein	NOUN	B
(	I-protein	PUNCT	O
WAF1/CIP1	I-protein	NOUN	B
)	I-protein	PUNCT	O
and	O	CCONJ	O
p27	B-protein	NOUN	B
(	I-protein	PUNCT	O
KIP1	I-protein	NOUN	B
)	I-protein	PUNCT	O
.	O	PUNCT	O


Retinoic	O	ADJ	B
acid	O	NOUN	I
(	O	PUNCT	O
RA	O	NOUN	B
)	O	PUNCT	O
resistance	O	NOUN	B
is	O	AUX	O
a	O	DET	O
serious	O	ADJ	O
problem	O	NOUN	B
for	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
acute	O	ADJ	B
promyelocytic	O	ADJ	I
leukemia	O	NOUN	I
(	O	PUNCT	O
APL	O	NOUN	B
)	O	PUNCT	O
who	O	PRON	O
are	O	AUX	O
receiving	O	VERB	O
all-trans	O	ADJ	B
RA	O	NOUN	B
.	O	PUNCT	O


RXRs	B-protein	NOUN	B
heterodimerize	O	VERB	B
with	O	ADP	O
1	B-protein	NUM	O
,	I-protein	PUNCT	O
25-dihydroxyvitamin	I-protein	NOUN	B
D3	I-protein	NOUN	I
[	I-protein	PUNCT	O
1	I-protein	NUM	O
,	I-protein	PUNCT	O
25	I-protein	NUM	O
(	I-protein	PUNCT	O
OH	I-protein	NOUN	B
)	I-protein	PUNCT	O
2D3	I-protein	NOUN	O
]	I-protein	PUNCT	O
receptor	I-protein	NOUN	O
(	O	PUNCT	O
VDR	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
enabling	O	VERB	O
their	O	PRON	O
efficient	O	ADJ	B
transcriptional	O	ADJ	B
activation	O	NOUN	I
.	O	PUNCT	O


This	O	DET	O
1	O	NUM	O
,	O	PUNCT	O
25	O	NUM	O
(	O	PUNCT	O
OH	O	NOUN	B
)	O	PUNCT	O
2D3-induced	O	ADJ	O
G1	O	NOUN	B
arrest	O	NOUN	I
is	O	AUX	O
enhanced	O	VERB	O
by	O	ADP	O
all-trans	O	ADJ	B
RA	O	NOUN	B
.	O	PUNCT	O


Northern	O	NOUN	B
blot	O	NOUN	I
analysis	O	NOUN	I
showed	O	VERB	O
that	O	SCONJ	O
p21	B-protein	NOUN	B
(	I-protein	PUNCT	O
WAF1/CIP1	I-protein	NOUN	B
)	I-protein	PUNCT	O
and	O	CCONJ	O
p27	B-protein	NOUN	B
(	I-protein	PUNCT	O
KIP1	I-protein	NOUN	B
)	I-protein	PUNCT	O
transcripts	O	NOUN	B
were	O	AUX	O
induced	O	VERB	B
after	O	ADP	O
6	O	NUM	O
hours	O	NOUN	B
'	O	PART	O
exposure	O	NOUN	B
to	O	PART	I
1	O	NUM	O
,	O	PUNCT	O
25	O	NUM	O
(	O	PUNCT	O
OH	O	NOUN	B
)	O	PUNCT	O
2D3	O	NOUN	B
and	O	CCONJ	O
then	O	ADV	O
decreased	O	VERB	B
to	O	PART	O
basal	O	ADJ	B
levels	O	NOUN	I
over	O	ADP	O
48	O	NUM	O
hours	O	NOUN	B
.	O	PUNCT	O


Interestingly	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
combination	O	NOUN	B
of	O	ADP	O
1	O	NUM	O
,	O	PUNCT	O
25	O	NUM	O
(	O	PUNCT	O
OH	O	NOUN	B
)	O	PUNCT	O
2D3	O	NOUN	B
and	O	CCONJ	O
RA	O	NOUN	B
markedly	O	ADV	O
enhanced	O	VERB	B
the	O	DET	O
levels	O	NOUN	B
of	O	ADP	O
p27	B-protein	NOUN	B
(	I-protein	PUNCT	O
KIP1	I-protein	NOUN	B
)	I-protein	PUNCT	O
transcript	O	NOUN	B
and	O	CCONJ	O
protein	O	NOUN	B
as	O	ADP	O
compared	O	VERB	B
with	O	ADP	O
levels	O	NOUN	B
induced	O	VERB	B
by	O	ADP	O
1	O	NUM	O
,	O	PUNCT	O
25	O	NUM	O
(	O	PUNCT	O
OH	O	NOUN	B
)	O	PUNCT	O
2D3	O	NOUN	B
alone	O	ADV	O
.	O	PUNCT	O


Molecular	O	ADJ	B
mechanisms	O	NOUN	I
of	O	ADP	O
neutrophil-endothelial	O	ADJ	B
cell	O	NOUN	I
adhesion	O	NOUN	I
induced	O	VERB	B
by	O	ADP	O
redox	O	NOUN	B
imbalance	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
redox	O	NOUN	B
changes	O	NOUN	I
are	O	AUX	O
similar	O	ADJ	O
to	O	PART	O
those	O	DET	O
observed	O	VERB	O
with	O	ADP	O
anoxia/reoxygenation	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
study	O	NOUN	B
demonstrates	O	VERB	O
that	O	SCONJ	O
changes	O	NOUN	B
in	O	ADP	O
endothelial	O	ADJ	B
cell	O	NOUN	I
GSSG/GSH	O	NOUN	B
cause	O	VERB	O
transcription-independent	O	ADJ	B
and	O	CCONJ	O
transcription-dependent	O	ADJ	B
surface	O	NOUN	O
expression	O	NOUN	B
of	O	ADP	O
different	O	ADJ	O
endothelial	B-protein	ADJ	B
cell	I-protein	NOUN	I
adhesion	I-protein	NOUN	O
molecules	I-protein	NOUN	O
,	O	PUNCT	O
which	O	DET	O
leads	O	VERB	O
to	O	PART	O
a	O	DET	O
2-phase	O	ADJ	O
neutrophil	B-cell_type	NOUN	B
-endothelial	O	ADJ	O
adhesion	O	NOUN	B
response	O	NOUN	B
.	O	PUNCT	O


Fewer	O	ADJ	O
apoptotic	B-cell_type	ADJ	B
cell	I-cell_type	NOUN	I
bodies	I-cell_type	NOUN	O
were	O	AUX	O
present	O	ADJ	O
in	O	ADP	O
ectopic	O	ADJ	B
pregnancy	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
use	O	NOUN	O
of	O	ADP	O
tissue	O	NOUN	B
obtained	O	VERB	O
from	O	ADP	O
ectopic	O	ADJ	B
pregnancy	O	NOUN	I
may	O	AUX	O
become	O	VERB	O
an	O	DET	O
excellent	O	ADJ	B
model	O	NOUN	B
to	O	PART	O
identify	O	VERB	O
the	O	DET	O
mechanism	O	NOUN	B
of	O	ADP	O
trophoblast	O	NOUN	B
invasion	O	NOUN	B
in	O	ADP	O
eutopic	O	ADJ	B
pregnancies	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
renin	B-protein	NOUN	B
-angiotensin	O	NOUN	O
system	O	NOUN	O
may	O	AUX	O
contribute	O	VERB	O
to	O	PART	O
the	O	DET	O
pathogenesis	O	NOUN	B
of	O	ADP	O
atherosclerosis	O	NOUN	B
.	O	PUNCT	O


Moreover	O	ADV	O
,	O	PUNCT	O
ANG	B-protein	NOUN	B
II	I-protein	NUM	I
stimulated	O	VERB	B
NF-kappaB	B-protein	NOUN	B
activation	O	NOUN	I
in	O	ADP	O
human	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
in	O	ADP	O
lymphocytes	B-cell_type	NOUN	B
from	O	ADP	O
the	O	DET	O
same	O	ADJ	O
preparation	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
effects	O	NOUN	B
were	O	AUX	O
blocked	O	VERB	B
by	O	ADP	O
mAbs	B-protein	NOUN	B
against	O	ADP	O
endothelial	B-protein	ADJ	B
and/or	I-protein	CCONJ	O
leukocyte	I-protein	NOUN	B
adhesion	I-protein	NOUN	I
molecules	I-protein	NOUN	I
(	O	PUNCT	O
beta1	B-protein	NOUN	B
and	I-protein	CCONJ	O
beta2	I-protein	NOUN	B
integrins	I-protein	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


She	O	PRON	O
was	O	AUX	O
treated	O	VERB	B
with	O	ADP	I
6	O	NUM	O
g	O	NOUN	O
of	O	ADP	O
salt	O	NOUN	B
daily	O	ADV	B
to	O	PART	O
prevent	O	VERB	B
dehydration	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
she	O	PRON	O
stopped	O	VERB	B
herself	O	PRON	B
because	O	SCONJ	O
of	O	ADP	O
reduced	O	VERB	B
fecal	O	ADJ	B
losses	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
urinary	O	ADJ	B
steroidogram	O	NOUN	I
resulted	O	VERB	O
in	O	ADP	O
highly	O	ADV	O
elevated	O	ADJ	O
tetrahydrocortisol	O	NOUN	O
(	O	PUNCT	O
THF	O	NOUN	B
:	O	PUNCT	O
13.3	O	NUM	O
mg/24h	O	NOUN	O
;	O	PUNCT	O
N	O	NOUN	O
:	O	PUNCT	O
1.4+/-0.8	O	NUM	O
)	O	PUNCT	O
with	O	ADP	O
no	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
tetrahydrocortisone	O	NOUN	B
(	O	PUNCT	O
THE	O	PROPN	O
:	O	PUNCT	O
3.16	O	NUM	O
mg/24h	O	NOUN	O
;	O	PUNCT	O
N	O	NOUN	O
:	O	PUNCT	O
2.7+/-2.0	O	NUM	O
)	O	PUNCT	O
excretion	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
with	O	ADP	O
low	O	ADJ	B
THE/THF	O	NOUN	B
(	O	PUNCT	O
0.24	O	NUM	O
;	O	PUNCT	O
N	O	NOUN	O
:	O	PUNCT	O
1.87+/-0.36	O	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
alpha	O	NOUN	B
THF/THF	O	NOUN	I
(	O	PUNCT	O
0.35	O	NUM	O
;	O	PUNCT	O
N	O	NOUN	O
:	O	PUNCT	O
0.92+/-0.42	O	NUM	O
)	O	PUNCT	O
ratios	O	NOUN	B
.	O	PUNCT	O


Nevertheless	O	ADV	O
,	O	PUNCT	O
this	O	DET	O
hyperaldosteronism	O	NOUN	B
may	O	AUX	O
be	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
hyponatremia	O	NOUN	B
and	O	CCONJ	O
hyperkalemia	O	NOUN	B
suggesting	O	VERB	O
PHA	O	NOUN	B
related	O	ADJ	O
to	O	PART	O
the	O	DET	O
major	O	ADJ	O
importance	O	NOUN	O
of	O	ADP	O
the	O	DET	O
colon	O	NOUN	B
for	O	ADP	O
the	O	DET	O
absorption	O	NOUN	B
of	O	ADP	O
sodium	O	NOUN	B
.	O	PUNCT	O


Differential	O	ADJ	B
regulation	O	NOUN	I
of	O	ADP	O
4E-BP1	B-protein	NOUN	B
and	O	CCONJ	O
4E-BP2	B-protein	NOUN	B
,	O	PUNCT	O
two	O	NUM	O
repressors	O	NOUN	B
of	O	ADP	O
translation	O	NOUN	B
initiation	O	NOUN	I
,	O	PUNCT	O
during	O	ADP	O
human	B-cell_type	ADJ	B
myeloid	I-cell_type	ADJ	O
cell	I-cell_type	NOUN	O
differentiation	O	NOUN	O
.	O	PUNCT	O


Human	O	ADJ	B
myeloid	O	ADJ	B
differentiation	O	NOUN	I
is	O	AUX	O
accompanied	O	VERB	O
by	O	ADP	O
a	O	DET	O
decrease	O	NOUN	B
in	O	ADP	O
cell	O	NOUN	B
proliferation	O	NOUN	I
.	O	PUNCT	O


Dephosphorylation	O	NOUN	B
of	O	ADP	O
4E-BP1	B-protein	NOUN	B
was	O	AUX	O
also	O	ADV	O
observed	O	VERB	O
when	O	SCONJ	O
U-937	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
were	O	AUX	O
induced	O	VERB	B
to	O	PART	O
differentiate	O	VERB	B
into	O	ADP	O
monocytes/macrophages	B-cell_type	NOUN	B
following	O	VERB	O
treatment	O	NOUN	B
with	O	ADP	O
retinoic	O	ADJ	B
acid	O	NOUN	I
or	O	CCONJ	O
DMSO	O	NOUN	B
.	O	PUNCT	O


Taken	O	VERB	O
together	O	ADV	O
,	O	PUNCT	O
these	O	DET	O
data	O	NOUN	B
provide	O	VERB	O
evidence	O	NOUN	B
for	O	ADP	O
differential	O	ADJ	B
regulation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
translational	O	ADJ	B
machinery	O	NOUN	B
during	O	ADP	O
human	O	ADJ	B
myeloid	O	ADJ	B
differentiation	O	NOUN	I
,	O	PUNCT	O
specific	O	ADJ	O
to	O	PART	O
the	O	DET	O
monocytic/macrophage	O	NOUN	B
pathway	O	NOUN	I
or	O	CCONJ	O
to	O	PART	O
the	O	DET	O
granulocytic	O	ADJ	B
pathway	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
studied	O	VERB	O
mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
5	B-DNA	NUM	O
'	I-DNA	PART	O
noncoding	I-DNA	ADJ	B
region	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
Bcl6	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
in	O	ADP	O
different	O	ADJ	O
subtypes	O	NOUN	B
of	O	ADP	O
lymphomas	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
frequency	O	NOUN	B
,	O	PUNCT	O
distribution	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
nature	O	NOUN	B
of	O	ADP	O
these	O	DET	O
mutations	O	NOUN	B
were	O	AUX	O
similar	O	ADJ	O
to	O	PART	O
those	O	DET	O
resulting	O	VERB	O
from	O	ADP	O
the	O	DET	O
Ig	O	NOUN	B
hypermutation	O	NOUN	I
process	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
FL	O	NOUN	B
,	O	PUNCT	O
follicles	O	NOUN	B
were	O	AUX	O
densely	O	ADV	O
populated	O	ADJ	B
,	O	PUNCT	O
and	O	CCONJ	O
their	O	PRON	O
borders	O	NOUN	B
were	O	AUX	O
irregular	O	ADJ	B
,	O	PUNCT	O
with	O	ADP	O
some	O	DET	O
Bcl-6+	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
in	O	ADP	O
the	O	DET	O
interfollicular	O	ADJ	B
zones	O	NOUN	B
.	O	PUNCT	O


(	O	PUNCT	O
2	O	X	O
)	O	PUNCT	O
Intrafollicular	B-cell_type	ADJ	B
CD3+	I-cell_type	ADJ	B
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
many	O	ADJ	O
of	O	ADP	O
which	O	DET	O
were	O	AUX	O
also	O	ADV	O
positive	O	ADJ	B
for	O	ADP	O
Bcl-6	B-protein	NOUN	B
,	O	PUNCT	O
were	O	AUX	O
markedly	O	ADV	O
depleted	O	VERB	B
in	O	ADP	O
AITL/GC	O	NOUN	B
,	O	PUNCT	O
with	O	ADP	O
increased	O	VERB	B
interfollicular	O	ADJ	B
Bcl-6+/CD3+	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
suggesting	O	VERB	O
an	O	DET	O
outward	O	ADJ	B
migration	O	NOUN	I
of	O	ADP	O
intrafollicular	B-cell_type	ADJ	B
T	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
in	O	ADP	O
this	O	DET	O
condition	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
experiments	O	NOUN	B
showed	O	VERB	O
that	O	SCONJ	O
,	O	PUNCT	O
in	O	ADP	O
fact	O	NOUN	O
,	O	PUNCT	O
NF-kappaB	B-protein	NOUN	B
was	O	AUX	O
translocated	O	VERB	B
to	O	PART	O
the	O	DET	O
nucleus	O	NOUN	B
following	O	VERB	O
viral	O	ADJ	B
binding	O	NOUN	I
or	O	CCONJ	O
purified	O	VERB	B
viral	O	ADJ	B
ligand	O	NOUN	O
binding	O	NOUN	O
.	O	PUNCT	O


Regulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
megakaryocytic	B-DNA	ADJ	B
glycoprotein	I-DNA	NOUN	I
IX	I-DNA	NUM	I
promoter	I-DNA	NOUN	B
by	O	ADP	O
the	O	DET	O
oncogenic	B-protein	ADJ	B
Ets	I-protein	NOUN	B
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
Fli-1	B-protein	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
Ets	B-protein	NOUN	B
protein	I-protein	NOUN	I
(	O	PUNCT	O
s	O	NOUN	O
)	O	PUNCT	O
that	O	PRON	O
regulated	O	VERB	O
GPIX	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
expression	O	NOUN	I
was	O	AUX	O
unknown	O	ADJ	O
.	O	PUNCT	O


According	O	VERB	O
to	O	ADP	O
current	O	ADJ	B
models	O	NOUN	B
the	O	DET	O
inhibitory	O	ADJ	B
capacity	O	NOUN	O
of	O	ADP	O
I	B-protein	NOUN	O
(	I-protein	PUNCT	O
kappa	I-protein	NOUN	O
)	I-protein	PUNCT	O
B	I-protein	NOUN	O
(	I-protein	PUNCT	O
alpha	I-protein	NOUN	B
)	I-protein	PUNCT	O
would	O	AUX	O
be	O	AUX	O
mediated	O	VERB	O
through	O	ADP	O
the	O	DET	O
retention	O	NOUN	B
of	O	ADP	O
Rel/NF-kappaB	B-protein	NOUN	B
proteins	I-protein	NOUN	I
in	O	ADP	O
the	O	DET	O
cytosol	B-cell_type	NOUN	B
.	O	PUNCT	O


Unexpectedly	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
nuclear	B-protein	ADJ	B
I	I-protein	NOUN	I
(	I-protein	PUNCT	O
kappa	I-protein	NOUN	O
)	I-protein	PUNCT	O
B	I-protein	NOUN	O
(	I-protein	PUNCT	O
alpha	I-protein	NOUN	B
)	I-protein	PUNCT	O
did	O	AUX	O
not	O	PART	O
inhibit	O	VERB	B
NF-kappaB	B-protein	NOUN	B
binding	O	NOUN	I
to	O	PART	O
DNA	O	NOUN	B
and	O	CCONJ	O
this	O	DET	O
phenomenon	O	NOUN	B
was	O	AUX	O
not	O	PART	O
due	O	ADJ	O
to	O	PART	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
IkappaBbeta	B-protein	NOUN	B
at	O	ADP	O
the	O	DET	O
nuclear	O	ADJ	B
level	O	NOUN	O
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	B
demonstrate	O	VERB	O
that	O	SCONJ	O
in	O	ADP	O
resting	O	VERB	B
and	O	CCONJ	O
PMA-activated	B-cell_type	ADJ	B
human	I-cell_type	ADJ	B
PBL	I-cell_type	NOUN	B
,	O	PUNCT	O
I	B-protein	NOUN	B
(	I-protein	PUNCT	O
kappa	I-protein	NOUN	O
)	I-protein	PUNCT	O
B	I-protein	NOUN	O
(	I-protein	PUNCT	O
alpha	I-protein	NOUN	B
)	I-protein	PUNCT	O
is	O	AUX	O
present	O	ADJ	O
in	O	ADP	O
the	O	DET	O
nucleus	O	NOUN	B
in	O	ADP	O
an	O	DET	O
apparently	O	ADV	O
inactive	O	ADJ	B
form	O	NOUN	O
unable	O	ADJ	O
to	O	PART	O
disrupt	O	VERB	B
NF-kappaB	B-protein	NOUN	B
binding	O	NOUN	I
from	O	ADP	O
DNA	O	NOUN	B
.	O	PUNCT	O


Impaired	O	ADJ	B
fetal	B-cell_type	ADJ	O
thymocyte	I-cell_type	NOUN	O
development	O	NOUN	B
after	O	ADP	O
efficient	O	ADJ	B
adenovirus-mediated	O	ADJ	B
inhibition	O	NOUN	I
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activation	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
introduce	O	VERB	O
a	O	DET	O
new	O	ADJ	O
experimental	O	ADJ	B
system	O	NOUN	I
combining	O	VERB	O
adenovirus-mediated	O	ADJ	B
gene	O	NOUN	I
transfer	O	NOUN	I
and	O	CCONJ	O
fetal	O	ADJ	B
thymic	O	ADJ	O
organ	O	NOUN	O
culture	O	NOUN	O
(	O	PUNCT	O
FTOC	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Fetal	B-cell_type	ADJ	B
thymocytes	I-cell_type	NOUN	B
infected	O	VERB	B
with	O	ADP	O
adenovirus	O	NOUN	B
containing	O	VERB	O
mut-I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
were	O	AUX	O
found	O	VERB	O
to	O	PART	O
develop	O	VERB	O
normally	O	ADV	O
until	O	ADP	O
the	O	DET	O
CD44	B-protein	NOUN	B
-CD25+	O	NOUN	O
,	O	PUNCT	O
CD4	B-protein	NOUN	B
-	O	PUNCT	O
CD8	B-protein	NOUN	B
-	O	PUNCT	O
double-negative	O	ADJ	B
stage	O	NOUN	I
,	O	PUNCT	O
while	O	SCONJ	O
production	O	NOUN	B
of	O	ADP	O
more	O	ADV	O
mature	O	ADJ	B
double-positive	O	ADJ	B
and	O	CCONJ	O
single-positive	O	ADJ	B
populations	O	NOUN	I
was	O	AUX	O
strongly	O	ADV	O
decreased	O	VERB	B
.	O	PUNCT	O


Taken	O	VERB	O
together	O	ADV	O
,	O	PUNCT	O
these	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
plays	O	VERB	O
a	O	DET	O
crucial	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
ensuring	O	VERB	O
the	O	DET	O
differentiation	O	NOUN	B
and	O	CCONJ	O
survival	O	NOUN	B
of	O	ADP	O
thymocytes	B-cell_type	NOUN	B
in	O	ADP	O
the	O	DET	O
early	O	ADJ	B
stages	O	NOUN	I
of	O	ADP	O
their	O	PRON	O
development	O	NOUN	B
.	O	PUNCT	O


No	O	DET	O
correlations	O	NOUN	B
were	O	AUX	O
observed	O	VERB	O
for	O	ADP	O
these	O	DET	O
variables	O	NOUN	B
with	O	ADP	O
blood	O	NOUN	B
pressure	O	NOUN	I
or	O	CCONJ	O
serum	B-protein	NOUN	B
lipoproteins	I-protein	NOUN	I
.	O	PUNCT	O


Cobalt	O	NOUN	B
chloride-induced	O	ADJ	B
signaling	O	NOUN	I
in	O	ADP	O
endothelium	O	NOUN	B
leading	O	VERB	O
to	O	PART	O
the	O	DET	O
augmented	O	ADJ	B
adherence	O	NOUN	B
of	O	ADP	O
sickle	B-cell_type	ADJ	B
red	I-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
transendothelial	O	ADJ	B
migration	O	NOUN	I
of	O	ADP	O
monocyte-like	B-cell_line	ADJ	B
HL-60	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
is	O	AUX	O
blocked	O	VERB	B
by	O	ADP	O
PAF-receptor	O	NOUN	B
antagonist	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
utilized	O	VERB	O
CoCl2	O	NOUN	B
as	O	ADP	O
a	O	DET	O
mimetic	O	ADJ	B
molecule	O	NOUN	I
for	O	ADP	O
hypoxia	O	NOUN	B
to	O	PART	O
study	O	VERB	B
cellular	O	ADJ	B
signaling	O	NOUN	I
pathways	O	NOUN	I
.	O	PUNCT	O


Inhibitors	O	NOUN	B
of	O	ADP	O
MAP	B-protein	NOUN	B
kinase	I-protein	NOUN	I
(	O	PUNCT	O
PD98059	O	NOUN	B
)	O	PUNCT	O
or	O	CCONJ	O
platelet-activating	O	ADJ	B
factor	O	NOUN	I
(	O	PUNCT	O
PAF	O	NOUN	B
)	O	PUNCT	O
-	O	PUNCT	O
receptor	O	NOUN	B
antagonist	O	NOUN	I
(	O	PUNCT	O
CV3988	O	NOUN	B
)	O	PUNCT	O
inhibited	O	VERB	B
the	O	DET	O
CoCl2-induced	O	ADJ	B
NF-kappaB	B-protein	NOUN	I
activation	O	NOUN	B
and	O	CCONJ	O
VCAM-1	B-protein	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


Our	O	PRON	O
data	O	NOUN	B
suggests	O	VERB	O
that	O	SCONJ	O
CoCl2-induced	O	ADJ	B
cellular	O	ADJ	B
signals	O	NOUN	I
directing	O	VERB	O
increased	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
VCAM-1	B-protein	NOUN	B
in	O	ADP	O
HUVEC	B-cell_type	NOUN	B
involve	O	VERB	O
downstream	O	ADJ	B
activation	O	NOUN	B
of	O	ADP	O
MAP	B-protein	NOUN	B
kinase	I-protein	NOUN	I
and	O	CCONJ	O
NF-kappaB	B-protein	NOUN	B
,	O	PUNCT	O
while	O	SCONJ	O
the	O	DET	O
phosphorylation	O	NOUN	B
of	O	ADP	O
PECAM-1	B-protein	NOUN	B
occurs	O	VERB	O
as	O	ADP	O
a	O	DET	O
result	O	NOUN	O
of	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
PKC	B-protein	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
conclude	O	VERB	O
that	O	SCONJ	O
PAF-receptor	O	NOUN	B
antagonist	O	NOUN	B
inhibits	O	VERB	B
the	O	DET	O
CoCl2	O	NOUN	B
-or	O	PART	O
hypoxia-induced	O	ADJ	B
increase	O	NOUN	B
in	O	ADP	O
the	O	DET	O
adhesion	O	NOUN	B
of	O	ADP	O
SS	B-cell_type	NOUN	B
RBC	I-cell_type	NOUN	B
,	O	PUNCT	O
PECAM-1	B-protein	NOUN	B
phosphorylation	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
concomitant	O	ADJ	B
transendothelial	O	ADJ	B
migration	O	NOUN	I
of	O	ADP	O
monocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


LPS-induced	O	ADJ	B
NF-kappaB	B-protein	NOUN	B
activation	O	NOUN	B
was	O	AUX	O
not	O	PART	O
inhibited	O	VERB	B
by	O	ADP	O
a	O	DET	O
dominant	O	ADJ	B
negative	O	ADJ	B
mutant	O	NOUN	B
of	O	ADP	O
TRAF2	B-protein	NOUN	B
that	O	PRON	O
is	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
TNF	B-protein	NOUN	B
signaling	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
E2A-HLF	B-DNA	NOUN	B
fusion	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
,	O	PUNCT	O
generated	O	VERB	O
by	O	ADP	O
t	B-DNA	NOUN	O
(	I-DNA	PUNCT	O
17	I-DNA	NUM	O
;	I-DNA	PUNCT	O
19	I-DNA	NUM	O
)	I-DNA	PUNCT	O
(	I-DNA	PUNCT	O
q22	I-DNA	NOUN	B
;	I-DNA	PUNCT	O
p13	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
in	O	ADP	O
acute	O	ADJ	B
lymphoblastic	O	ADJ	I
leukemia	O	NOUN	I
(	O	PUNCT	O
ALL	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
encodes	O	VERB	B
a	O	DET	O
chimeric	B-protein	ADJ	B
transcription	I-protein	NOUN	O
factor	I-protein	NOUN	O
in	O	ADP	O
which	O	DET	O
the	O	DET	O
trans-activating	B-protein	ADJ	B
domains	I-protein	NOUN	I
of	O	ADP	O
E2A	B-protein	NOUN	B
are	O	AUX	O
fused	O	VERB	B
to	O	PART	O
the	O	DET	O
DNA-	B-protein	NOUN	B
binding	I-protein	NOUN	I
and	I-protein	CCONJ	O
dimerization	I-protein	NOUN	B
domains	I-protein	NOUN	I
of	O	ADP	O
hepatic	B-protein	ADJ	B
leukemic	I-protein	ADJ	I
factor	I-protein	NOUN	I
(	O	PUNCT	O
HLF	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


These	O	DET	O
findings	O	NOUN	B
indicated	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
E2A-HLF	B-protein	NOUN	B
induced	O	VERB	B
T-cell	O	NOUN	B
apoptosis	O	NOUN	I
and	O	CCONJ	O
B-cell	O	NOUN	B
maturation	O	NOUN	I
arrest	O	NOUN	O
in	O	X	B
vivo	O	X	I
and	O	CCONJ	O
that	O	SCONJ	O
the	O	DET	O
susceptibility	O	NOUN	B
of	O	ADP	O
the	O	DET	O
transgenic	O	ADJ	B
mice	O	NOUN	I
to	O	PART	O
infection	O	NOUN	B
was	O	AUX	O
due	O	ADJ	O
to	O	PART	O
immunodeficiency	O	NOUN	B
.	O	PUNCT	O


Moreover	O	ADV	O
,	O	PUNCT	O
several	O	ADJ	O
transgenic	O	ADJ	B
mice	O	NOUN	I
developed	O	VERB	O
acute	O	ADJ	B
leukemia	O	NOUN	I
,	O	PUNCT	O
classified	O	VERB	O
as	O	ADP	O
T-ALL	O	NOUN	B
based	O	VERB	O
on	O	ADP	O
the	O	DET	O
surface	O	NOUN	B
marker	O	NOUN	O
analysis	O	NOUN	O
and	O	CCONJ	O
DNA	O	NOUN	B
rearrangements	O	NOUN	I
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
an	O	DET	O
additional	O	ADJ	O
event	O	NOUN	B
is	O	AUX	O
required	O	VERB	O
for	O	ADP	O
malignant	O	ADJ	B
transformation	O	NOUN	I
of	O	ADP	O
lymphoid	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
expressing	O	VERB	B
E2A-HLF	B-protein	NOUN	B
.	O	PUNCT	O


Nevertheless	O	ADV	O
,	O	PUNCT	O
relatively	O	ADV	O
high	O	ADJ	O
,	O	PUNCT	O
pharmacological	O	ADJ	B
concentrations	O	NOUN	B
of	O	ADP	O
RA	O	NOUN	B
(	O	PUNCT	O
1	O	NUM	O
to	O	PART	O
10	O	NUM	O
&	O	CCONJ	O
mgr	O	NOUN	B
;	O	PUNCT	O
M	O	NOUN	B
)	O	PUNCT	O
overcome	O	VERB	O
these	O	DET	O
differentiation	O	NOUN	B
blocks	O	NOUN	I
and	O	CCONJ	O
induce	O	VERB	B
terminal	O	ADJ	O
granulocytic	O	ADJ	B
differentiation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
MPRO	B-cell_type	NOUN	B
promyelocytes	I-cell_type	NOUN	B
while	O	SCONJ	O
potentiating	O	VERB	O
interleukin-3	B-protein	NOUN	B
(	O	PUNCT	O
IL-3	B-protein	NOUN	B
)	O	PUNCT	O
-induced	O	ADJ	O
commitment	O	NOUN	B
of	O	ADP	O
EML	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	B
to	O	PART	O
the	O	DET	O
granulocyte/monocyte	O	NOUN	B
lineage	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
present	O	ADJ	O
study	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
utilized	O	VERB	O
RXR	B-protein	NOUN	B
-and	O	NOUN	O
RAR	B-protein	NOUN	B
-specific	O	ADJ	O
agonists	O	NOUN	B
and	O	CCONJ	O
antagonists	O	NOUN	B
to	O	PART	O
determine	O	VERB	O
how	O	SCONJ	O
RA	O	NOUN	B
overcomes	O	VERB	O
the	O	DET	O
dominant-negative	O	ADJ	B
activity	O	NOUN	I
of	O	ADP	O
the	O	DET	O
truncated	B-protein	VERB	B
RARalpha	I-protein	NOUN	B
in	O	ADP	O
these	O	DET	O
different	O	ADJ	O
myeloid	O	ADJ	B
developmental	O	ADJ	I
stages	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
more	O	ADV	O
immature	O	ADJ	B
,	O	PUNCT	O
multipotent	O	ADJ	B
EML	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	B
we	O	PRON	O
observed	O	VERB	O
that	O	SCONJ	O
this	O	DET	O
RXR	B-protein	NOUN	B
-specific	O	ADJ	O
agonist	O	NOUN	B
is	O	AUX	O
inactive	O	ADJ	B
either	O	CCONJ	O
in	O	ADP	O
potentiating	O	VERB	O
IL-3	B-protein	NOUN	B
-mediated	O	ADJ	O
commitment	O	NOUN	B
of	O	ADP	O
EML	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	B
to	O	PART	O
the	O	DET	O
granulocyte	B-cell_type	NOUN	B
lineage	I-cell_type	NOUN	I
or	O	CCONJ	O
in	O	ADP	O
transactivating	O	VERB	B
RAR-RXR	B-DNA	NOUN	I
response	I-DNA	NOUN	I
elements	I-DNA	NOUN	I
.	O	PUNCT	O


The	O	DET	O
magnitude	O	NOUN	B
of	O	ADP	O
these	O	DET	O
functional	O	ADJ	B
responses	O	NOUN	I
is	O	AUX	O
greatly	O	ADV	O
augmented	O	VERB	B
when	O	SCONJ	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
are	O	AUX	O
activated	O	VERB	B
by	O	ADP	O
the	O	DET	O
combination	O	NOUN	B
of	O	ADP	O
IL-12	B-protein	NOUN	B
and	O	CCONJ	O
IL-2	B-protein	NOUN	B
.	O	PUNCT	O


Using	O	VERB	O
antibodies	O	NOUN	B
against	O	ADP	O
the	O	DET	O
p50	B-protein	NOUN	B
and	O	CCONJ	O
p65	B-protein	NOUN	B
subunits	I-protein	NOUN	I
of	O	ADP	O
NF-kappaB	B-protein	NOUN	B
in	O	ADP	O
EMSAs	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
involvement	O	NOUN	B
of	O	ADP	O
both	O	CCONJ	O
p50	B-protein	NOUN	B
and	O	CCONJ	O
p65	B-protein	NOUN	B
proteins	I-protein	NOUN	I
was	O	AUX	O
further	O	ADV	O
demonstrated	O	VERB	O
.	O	PUNCT	O


The	O	DET	O
work	O	NOUN	O
reported	O	VERB	O
here	O	ADV	O
was	O	AUX	O
instigated	O	VERB	O
to	O	PART	O
identify	O	VERB	O
additional	O	ADJ	O
VDR	B-protein	NOUN	B
3'-UTR	B-DNA	NOUN	I
polymorphisms	O	NOUN	B
that	O	PRON	O
may	O	AUX	O
have	O	AUX	O
functional	O	ADJ	B
significance	O	NOUN	I
and	O	CCONJ	O
to	O	PART	O
then	O	ADV	O
test	O	VERB	B
whether	O	SCONJ	O
these	O	DET	O
genetic	O	ADJ	B
variants	O	NOUN	I
alter	O	VERB	O
message	O	NOUN	B
stability	O	NOUN	I
.	O	PUNCT	O


IL-2	B-protein	NOUN	B
-mediated	O	ADJ	O
cell	O	NOUN	B
cycle	O	NOUN	I
progression	O	NOUN	I
and	O	CCONJ	O
inhibition	O	NOUN	B
of	O	ADP	O
apoptosis	O	NOUN	B
does	O	AUX	O
not	O	PART	O
require	O	VERB	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
or	O	CCONJ	O
activating	O	VERB	B
protein-1	O	NOUN	B
activation	O	NOUN	I
in	O	ADP	O
primary	O	ADJ	O
human	O	ADJ	B
T	O	NOUN	B
cells	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
current	O	ADJ	O
study	O	NOUN	B
clearly	O	ADV	O
demonstrates	O	VERB	O
that	O	SCONJ	O
IL-2	B-protein	NOUN	B
does	O	AUX	O
not	O	PART	O
induce	O	VERB	B
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
alpha	O	NOUN	I
degradation	O	NOUN	I
or	O	CCONJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activation	O	NOUN	B
in	O	ADP	O
primary	B-cell_type	ADJ	O
human	I-cell_type	ADJ	B
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
that	O	PRON	O
respond	O	VERB	O
to	O	PART	O
IL-2	B-protein	NOUN	B
by	O	ADP	O
entering	O	VERB	O
the	O	DET	O
cell	O	NOUN	B
cycle	O	NOUN	I
and	O	CCONJ	O
avoiding	O	VERB	O
apoptosis	O	NOUN	B
.	O	PUNCT	O


Quantitative	O	ADJ	B
thin-layer	O	ADJ	I
chromatography	O	NOUN	I
(	O	PUNCT	O
TLC	O	NOUN	B
)	O	PUNCT	O
analyses	O	NOUN	O
showed	O	VERB	O
that	O	SCONJ	O
HL60	B-cell_line	NOUN	B
and	O	CCONJ	O
normal	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
are	O	AUX	O
able	O	ADJ	O
to	O	PART	O
generate	O	VERB	O
estrone	O	NOUN	B
(	O	PUNCT	O
E1	O	NOUN	B
)	O	PUNCT	O
from	O	ADP	O
estradiol	O	NOUN	B
(	O	PUNCT	O
E2	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Reverse	O	ADJ	B
transcriptase	O	NOUN	I
polymerase	O	NOUN	I
chain	O	NOUN	I
reaction	O	NOUN	I
and	O	CCONJ	O
Northern	O	NOUN	B
analyses	O	NOUN	I
confirmed	O	VERB	O
that	O	SCONJ	O
normal	O	ADJ	B
and	O	CCONJ	O
leukemic	O	ADJ	B
myeloid	B-cell_type	ADJ	I
progenitor	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
expressed	O	VERB	B
mRNA	B-RNA	NOUN	B
for	O	ADP	O
the	O	DET	O
type	O	NOUN	B
I	O	NUM	I
and	O	CCONJ	O
IV	O	NUM	O
isoforms	O	NOUN	B
of	O	ADP	O
17	B-protein	NUM	O
beta-hydroxysteroid	I-protein	NOUN	B
dehydrogenase	I-protein	NOUN	I
.	O	PUNCT	O


When	O	SCONJ	O
HL60	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
or	O	CCONJ	O
normal	O	ADJ	O
myeloid	B-cell_type	ADJ	B
progenitor	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
were	O	AUX	O
exposed	O	VERB	O
to	O	PART	O
exogenous	O	ADJ	B
E1	O	NOUN	B
they	O	PRON	O
became	O	VERB	O
more	O	ADV	O
sensitive	O	ADJ	B
to	O	PART	O
the	O	DET	O
differentiation-inducing	O	ADJ	B
effects	O	NOUN	I
of	O	ADP	I
D3	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
found	O	VERB	O
that	O	SCONJ	O
it	O	PRON	O
is	O	AUX	O
phosphorylated	O	VERB	B
,	O	PUNCT	O
predominantly	O	ADV	O
on	O	ADP	O
serine	O	NOUN	B
residues	O	NOUN	I
,	O	PUNCT	O
when	O	SCONJ	O
transiently	O	ADV	O
overexpressed	O	VERB	B
in	O	ADP	O
293	B-cell_line	NUM	O
cells	I-cell_line	NOUN	B
.	O	PUNCT	O


Cbl-b	B-protein	NOUN	B
,	O	PUNCT	O
a	O	DET	O
homologue	O	NOUN	B
of	O	ADP	O
Cbl	B-protein	NOUN	B
,	O	PUNCT	O
is	O	AUX	O
widely	O	ADV	O
expressed	O	VERB	B
in	O	ADP	O
many	O	ADJ	O
tissues	O	NOUN	B
and	O	CCONJ	O
cells	O	NOUN	B
including	O	VERB	O
hematopoietic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
[	O	PUNCT	O
6	O	NUM	O
]	O	PUNCT	O
[	O	PUNCT	O
7	O	NUM	O
]	O	PUNCT	O
.	O	PUNCT	O


Incidentally	O	ADV	O
,	O	PUNCT	O
Grf40	B-protein	NOUN	B
binds	O	VERB	B
to	O	PART	O
linker	B-protein	NOUN	B
for	I-protein	ADP	O
activation	I-protein	NOUN	B
of	I-protein	ADP	O
T	I-protein	NOUN	B
cells	I-protein	NOUN	I
(	O	PUNCT	O
LAT	B-protein	NOUN	B
)	O	PUNCT	O
possibly	O	ADV	O
via	O	ADP	O
its	O	PRON	O
SH2	B-protein	NOUN	B
domain	I-protein	NOUN	I
.	O	PUNCT	O


Overexpression	O	NOUN	B
of	O	ADP	O
wild-type	B-protein	ADJ	B
Grf40	I-protein	NOUN	B
in	O	ADP	O
Jurkat	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
induced	O	VERB	B
a	O	DET	O
significant	O	ADJ	O
increase	O	NOUN	B
of	O	ADP	O
SLP-76-dependent	B-DNA	ADJ	B
interleukin	I-DNA	NOUN	O
(	I-DNA	PUNCT	O
IL	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
-2	I-DNA	NUM	O
promoter	I-DNA	NOUN	B
and	O	CCONJ	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
of	I-protein	ADP	O
activated	I-protein	VERB	B
T	I-protein	NOUN	O
cell	I-protein	NOUN	O
(	O	PUNCT	O
NF-AT	B-protein	NOUN	B
)	O	PUNCT	O
activation	O	NOUN	B
upon	O	SCONJ	O
T	B-protein	NOUN	B
cell	I-protein	NOUN	I
receptor	I-protein	NOUN	I
(	O	PUNCT	O
TCR	B-protein	NOUN	B
)	O	PUNCT	O
stimulation	O	NOUN	B
,	O	PUNCT	O
whereas	O	SCONJ	O
the	O	DET	O
COOH-terminal	B-protein	ADJ	B
SH3-deleted	I-protein	ADJ	I
Grf40	I-protein	NOUN	B
mutant	I-protein	NOUN	I
lacked	O	VERB	O
any	O	DET	O
recognizable	O	ADJ	O
increase	O	NOUN	B
in	O	ADP	O
IL-2	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
activity	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
present	O	ADJ	O
report	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
identified	O	VERB	B
and	O	CCONJ	O
monitored	O	VERB	B
the	O	DET	O
pocket	B-protein	NOUN	B
protein-E2F	I-protein	ADJ	I
complexes	I-protein	NOUN	I
in	O	ADP	O
human	B-cell_type	ADJ	B
primary	I-cell_type	ADJ	O
B-lymphocytes	I-cell_type	NOUN	B
after	O	ADP	O
activation	O	NOUN	B
by	O	ADP	O
phorbol	O	NOUN	B
12-myristate	O	NOUN	I
13-acetate	O	NOUN	I
.	O	PUNCT	O


Engagement	O	NOUN	B
of	O	ADP	O
natural	O	ADJ	B
cytotoxicity	O	NOUN	O
programs	O	NOUN	O
regulates	O	VERB	B
AP-1	B-protein	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
the	O	DET	O
NKL	B-cell_line	NOUN	B
human	I-cell_line	ADJ	B
NK	I-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
.	O	PUNCT	O


To	O	PART	O
test	O	VERB	O
this	O	DET	O
apparent	O	ADJ	B
discrepancy	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
realized	O	VERB	O
that	O	SCONJ	O
HTB	O	NOUN	B
and	O	CCONJ	O
triflusal	O	NOUN	B
(	O	PUNCT	O
but	O	CCONJ	O
neither	O	CCONJ	O
aspirin	O	NOUN	B
nor	O	CCONJ	O
salicylate	O	NOUN	B
)	O	PUNCT	O
produced	O	VERB	O
a	O	DET	O
concentration-dependent	O	ADJ	B
inhibition	O	NOUN	B
of	O	ADP	O
COX-2	B-protein	NOUN	B
protein	O	NOUN	I
expression	O	NOUN	B
in	O	ADP	O
peripheral	B-cell_type	ADJ	B
human	I-cell_type	ADJ	B
mononuclear	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Involvement	O	NOUN	B
of	O	ADP	O
adenylate	B-protein	ADJ	B
cyclase	I-protein	NOUN	I
and	O	CCONJ	O
p70	B-protein	NOUN	B
(	I-protein	PUNCT	O
S6	I-protein	NOUN	B
)	I-protein	PUNCT	O
-kinase	I-protein	NOUN	O
activation	O	NOUN	B
in	O	ADP	O
IL-10	B-protein	NOUN	B
up-regulation	O	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
by	O	ADP	O
gp41	B-protein	NOUN	B
envelope	I-protein	NOUN	I
protein	I-protein	NOUN	I
of	O	ADP	O
human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
type	O	NOUN	I
1	O	NUM	I
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
study	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
examined	O	VERB	O
whether	O	SCONJ	O
gp41	B-protein	NOUN	B
-induced	O	ADJ	O
IL-10	B-protein	NOUN	B
up-regulation	O	NOUN	B
is	O	AUX	O
mediated	O	VERB	O
by	O	ADP	O
the	O	DET	O
previously	O	ADV	O
described	O	VERB	O
synergistic	O	ADJ	B
activation	O	NOUN	B
of	O	ADP	O
cAMP	O	NOUN	B
and	O	CCONJ	O
NF-kappaB	B-protein	NOUN	B
pathways	O	NOUN	I
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
describe	O	VERB	O
methods	O	NOUN	B
to	O	PART	O
investigate	O	VERB	B
whether	O	SCONJ	O
and	O	CCONJ	O
how	O	SCONJ	O
signaling	O	NOUN	B
agonists	O	NOUN	I
induce	O	VERB	O
myeloid	O	ADJ	B
differentiation	O	NOUN	I
and	O	CCONJ	O
how	O	SCONJ	O
oncoproteins	B-protein	NOUN	B
might	O	AUX	O
cause	O	VERB	O
AML	O	NOUN	B
by	O	ADP	O
modulating	O	VERB	B
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
that	O	PRON	O
are	O	AUX	O
pivotal	O	ADJ	O
for	O	ADP	O
normal	O	ADJ	O
myeloid	O	ADJ	B
development	O	NOUN	O
.	O	PUNCT	O


Interestingly	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
self	O	NOUN	B
and	O	CCONJ	O
bacterial	O	ADJ	B
peptides	O	NOUN	O
equally	O	ADV	O
were	O	AUX	O
substantially	O	ADV	O
less	O	ADV	O
effective	O	ADJ	B
than	O	ADP	O
the	O	DET	O
cognate	O	ADJ	B
viral	O	ADJ	O
peptide	O	NOUN	O
in	O	ADP	O
sensitizing	O	VERB	B
target	O	NOUN	B
cell	O	NOUN	B
lysis	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
also	O	ADV	O
resulted	O	VERB	O
only	O	ADV	O
in	O	ADP	O
a	O	DET	O
weak	O	ADJ	B
reactivation	O	NOUN	B
of	O	ADP	O
memory	B-cell_type	NOUN	B
CTLs	I-cell_type	NOUN	I
in	O	ADP	O
limiting	O	VERB	O
dilution	O	NOUN	B
assays	O	NOUN	I
,	O	PUNCT	O
whereas	O	SCONJ	O
the	O	DET	O
cognate	O	ADJ	B
peptide	O	NOUN	I
was	O	AUX	O
highly	O	ADV	O
immunogenic	O	ADJ	B
.	O	PUNCT	O


RANTES	B-protein	NOUN	B
is	O	AUX	O
expressed	O	VERB	B
late	O	ADV	O
(	O	PUNCT	O
3-5	O	NUM	O
days	O	NOUN	B
)	O	PUNCT	O
after	O	ADP	O
activation	O	NOUN	B
in	O	ADP	O
T	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
.	O	PUNCT	O


Using	O	VERB	O
expression	O	NOUN	B
cloning	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
identified	O	VERB	B
the	O	DET	O
first	O	ADJ	O
``	O	PUNCT	O
late	O	ADJ	O
''	O	PUNCT	O
T	B-protein	NOUN	B
lymphocyte	I-protein	NOUN	I
associated	I-protein	VERB	O
transcription	I-protein	NOUN	O
factor	I-protein	NOUN	O
and	O	CCONJ	O
named	O	VERB	O
it	O	PRON	O
``	O	PUNCT	O
RANTES	B-protein	NOUN	B
Factor	I-protein	NOUN	O
of	I-protein	ADP	O
Late	I-protein	ADJ	B
Activated	I-protein	VERB	I
T	I-protein	NOUN	I
Lymphocytes-1	I-protein	NOUN	I
``	O	PUNCT	I
(	O	PUNCT	O
RFLAT-1	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Here	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
report	O	VERB	O
that	O	SCONJ	O
expression	O	NOUN	B
of	O	ADP	O
FasL	B-protein	NOUN	B
protein	I-protein	NOUN	I
and	O	CCONJ	O
mRNA	B-RNA	NOUN	B
in	O	ADP	O
activated	B-cell_type	VERB	B
NK	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
is	O	AUX	O
also	O	ADV	O
regulated	O	VERB	O
by	O	ADP	O
redox	O	NOUN	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
these	O	DET	O
oxidative	O	ADJ	B
stresses	O	NOUN	I
inhibited	O	VERB	B
activity	O	NOUN	B
of	O	ADP	O
calcineurin	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
serine/	O	NOUN	B
threonine	B-protein	NOUN	I
phosphatase	I-protein	NOUN	I
that	O	PRON	O
regulates	O	VERB	B
NFAT	B-protein	NOUN	B
activation	O	NOUN	B
.	O	PUNCT	O


Purified	B-cell_line	VERB	B
human	I-cell_line	ADJ	B
peripheral	I-cell_line	ADJ	O
T	I-cell_line	NOUN	O
cells	I-cell_line	NOUN	O
or	O	CCONJ	O
Jurkat	B-cell_line	NOUN	B
T	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
were	O	AUX	O
stimulated	O	VERB	B
with	O	ADP	O
Chinese	O	ADJ	B
hamster	O	NOUN	I
ovary	O	NOUN	I
(	O	PUNCT	O
CHO	O	NOUN	B
)	O	PUNCT	O
cells	O	NOUN	B
expressing	O	VERB	B
either	O	CCONJ	O
human	B-protein	ADJ	B
CD80	I-protein	NOUN	B
(	O	PUNCT	O
CHO-CD80	B-protein	NOUN	B
)	O	PUNCT	O
or	O	CCONJ	O
human	B-protein	ADJ	B
CD86	I-protein	NOUN	B
(	O	PUNCT	O
CHO-CD86	B-protein	NOUN	B
)	O	PUNCT	O
or	O	CCONJ	O
with	O	ADP	O
anti-CD28	B-protein	ADJ	B
monoclonal	I-protein	ADJ	I
antibody	I-protein	NOUN	I
(	O	PUNCT	O
mAb	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
association	O	NOUN	B
of	O	ADP	O
phosphoinositide	B-protein	NOUN	B
3-kinase	I-protein	NOUN	I
with	O	ADP	O
CD28	B-protein	NOUN	B
and	O	CCONJ	O
enhanced	O	VERB	B
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	I
of	O	ADP	O
phospholipase	O	NOUN	B
Cgamma	O	NOUN	I
were	O	AUX	O
seen	O	VERB	O
after	O	ADP	O
anti-CD28	O	ADJ	B
mAb	O	NOUN	B
and	O	CCONJ	O
CHO-CD80	O	NOUN	B
stimulation	O	NOUN	I
but	O	CCONJ	O
to	O	ADP	O
a	O	DET	O
much	O	ADV	O
lesser	O	ADJ	B
extent	O	NOUN	O
after	O	ADP	O
CHO-CD86	B-protein	NOUN	B
stimulation	O	NOUN	I
.	O	PUNCT	O


Binding	O	NOUN	B
of	O	ADP	O
HMG-I	B-protein	NOUN	B
(	I-protein	PUNCT	O
Y	I-protein	NOUN	O
)	I-protein	PUNCT	O
elicits	O	VERB	O
structural	O	ADJ	B
changes	O	NOUN	O
in	O	ADP	O
a	O	DET	O
silencer	O	NOUN	B
of	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
beta-globin	I-DNA	NOUN	O
gene	I-DNA	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
previously	O	ADV	O
showed	O	VERB	O
that	O	SCONJ	O
repression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
beta-globin	O	NOUN	B
gene	O	NOUN	I
appears	O	VERB	O
to	O	PART	O
be	O	AUX	O
mediated	O	VERB	O
through	O	ADP	O
two	O	NUM	O
DNA	B-DNA	NOUN	B
sequences	I-DNA	NOUN	I
,	O	PUNCT	O
silencers	B-DNA	NOUN	B
I	I-DNA	NUM	I
and	I-DNA	CCONJ	I
II	I-DNA	NUM	B
,	O	PUNCT	O
and	O	CCONJ	O
identified	O	VERB	B
a	O	DET	O
protein	O	NOUN	B
termed	O	VERB	O
BP1	B-protein	NOUN	B
which	O	DET	O
binds	O	VERB	B
to	O	PART	O
both	O	CCONJ	O
silencer	O	NOUN	B
sequences	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
study	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
cloned	O	VERB	B
two	O	NUM	O
cDNAs	B-DNA	NOUN	B
encoding	O	NOUN	B
proteins	O	NOUN	B
which	O	DET	O
bind	O	VERB	B
to	O	PART	O
an	O	DET	O
oligonucleotide	O	NOUN	B
in	O	ADP	O
silencer	B-DNA	NOUN	B
I	I-DNA	NUM	I
containing	O	VERB	O
a	O	DET	O
BP1	B-protein	NOUN	B
binding	O	NOUN	B
site	O	NOUN	I
.	O	PUNCT	O


Expression	O	NOUN	B
studies	O	NOUN	I
revealed	O	VERB	O
that	O	SCONJ	O
HMG-I	B-protein	NOUN	B
(	I-protein	PUNCT	O
Y	I-protein	NOUN	B
)	I-protein	PUNCT	O
is	O	AUX	O
ubiquitously	O	ADV	O
expressed	O	VERB	B
in	O	ADP	O
human	O	ADJ	B
tissues	O	NOUN	B
that	O	PRON	O
do	O	AUX	O
not	O	PART	O
express	O	VERB	O
beta-globin	B-protein	NOUN	B
,	O	PUNCT	O
being	O	AUX	O
present	O	ADJ	O
in	O	ADP	O
48	O	NUM	O
of	O	ADP	O
50	O	NUM	O
tissues	O	NOUN	B
and	O	CCONJ	O
six	O	NUM	O
hematopoietic	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
examined	O	VERB	B
.	O	PUNCT	O


Class	B-DNA	NOUN	B
II	I-DNA	NUM	I
major	I-DNA	ADJ	I
histocompatibility	I-DNA	NOUN	I
(	I-DNA	PUNCT	O
class	I-DNA	NOUN	B
II	I-DNA	NUM	I
)	I-DNA	PUNCT	O
genes	I-DNA	NOUN	O
are	O	AUX	O
regulated	O	VERB	O
in	O	ADP	O
a	O	DET	O
B-cell-specific	O	ADJ	B
and	O	CCONJ	O
gamma	O	NOUN	O
interferon-inducible	O	ADJ	O
fashion	O	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
measured	O	VERB	B
the	O	DET	O
number	O	NOUN	O
of	O	ADP	O
glucocorticoid	B-protein	NOUN	B
receptors	I-protein	NOUN	I
(	O	PUNCT	O
GR	B-protein	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
cord	B-cell_type	NOUN	B
blood	I-cell_type	NOUN	I
lymphocytes	I-cell_type	NOUN	I
and	O	CCONJ	O
the	O	DET	O
binding	O	NOUN	B
affinity	O	NOUN	O
(	O	PUNCT	O
Kd	O	NOUN	O
)	O	PUNCT	O
in	O	ADP	O
15	O	NUM	O
term	O	NOUN	B
and	O	CCONJ	O
in	O	ADP	O
20	O	NUM	O
preterm	O	NOUN	B
babies	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
study	O	NOUN	B
on	O	ADP	O
the	O	DET	O
number	O	NOUN	B
and	O	CCONJ	O
function	O	NOUN	B
of	O	ADP	O
GR	B-protein	NOUN	B
in	O	ADP	O
lymphocytes	B-cell_type	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
were	O	AUX	O
unable	O	ADJ	O
to	O	PART	O
find	O	VERB	O
a	O	DET	O
relation	O	NOUN	O
between	O	ADP	O
the	O	DET	O
functionality	O	NOUN	B
of	O	ADP	O
the	O	DET	O
GR	B-protein	NOUN	B
and	O	CCONJ	O
the	O	DET	O
development	O	NOUN	B
of	O	ADP	O
NRDS	O	PROPN	B
.	O	PUNCT	O


Our	O	PRON	O
data	O	NOUN	B
constitute	O	VERB	O
a	O	DET	O
starting	O	NOUN	O
point	O	NOUN	O
for	O	ADP	O
studies	O	NOUN	B
to	O	PART	O
elucidate	O	VERB	O
the	O	DET	O
molecular	O	ADJ	B
mechanism	O	NOUN	O
by	O	ADP	O
which	O	DET	O
TGF-beta	B-protein	NOUN	B
regulates	O	VERB	B
IgA	B-protein	NOUN	B
production	O	NOUN	B
.	O	PUNCT	O


CD44	O	NOUN	B
is	O	AUX	O
a	O	DET	O
ubiquitous	O	ADJ	B
molecule	O	NOUN	I
also	O	ADV	O
known	O	VERB	O
as	O	ADP	O
hyaluronic	O	ADJ	B
acid	O	NOUN	I
or	O	CCONJ	O
homing	O	VERB	B
receptor	O	NOUN	I
.	O	PUNCT	O


Using	O	VERB	O
synovial	O	ADJ	B
cells	O	NOUN	I
from	O	ADP	O
rheumatoid	O	ADJ	B
arthritis	O	NOUN	I
(	O	PUNCT	O
RA	O	NOUN	B
)	O	PUNCT	O
patients	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
demonstrated	O	VERB	O
that	O	SCONJ	O
CD44	O	NOUN	B
cross-linking	O	NOUN	I
and	O	CCONJ	O
binding	O	NOUN	B
to	O	PART	O
hyaluronan	O	NOUN	B
augmented	O	VERB	B
VCAM-1	B-protein	NOUN	B
expression	O	NOUN	B
and	O	CCONJ	O
subsequently	O	ADV	O
VCAM-1	B-protein	NOUN	B
-mediated	O	ADJ	O
cell	O	NOUN	B
adhesion	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
adhesion	O	NOUN	B
of	O	ADP	O
RA	B-cell_type	NOUN	B
synovial	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
to	O	PART	O
matrices	O	NOUN	B
such	O	ADJ	O
as	O	ADP	O
hyaluronic	O	ADJ	B
acid	O	NOUN	I
through	O	ADP	O
CD44	B-protein	NOUN	B
could	O	AUX	O
up-regulate	O	VERB	B
VCAM-1	B-protein	NOUN	B
expression	O	NOUN	B
and	O	CCONJ	O
VCAM-1	B-protein	NOUN	B
-mediated	O	ADJ	O
adhesion	O	NOUN	B
to	O	PART	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
which	O	DET	O
might	O	AUX	O
in	O	ADP	O
turn	O	NOUN	O
cause	O	VERB	O
activation	O	NOUN	B
of	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
synovial	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
in	O	ADP	O
RA	O	NOUN	B
synovitis	O	NOUN	B
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
rate	O	NOUN	B
of	O	ADP	O
constitutive	O	ADJ	B
apoptosis	O	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
neutrophils	I-cell_type	NOUN	B
and	O	CCONJ	O
eosinophils	B-cell_type	NOUN	B
is	O	AUX	O
greatly	O	ADV	O
accelerated	O	VERB	B
in	O	ADP	O
both	O	CCONJ	O
a	O	DET	O
rapid	O	ADJ	B
and	O	CCONJ	O
concentration-dependent	O	ADJ	B
manner	O	NOUN	O
by	O	ADP	O
the	O	DET	O
fungal	O	ADJ	B
metabolite	O	NOUN	B
gliotoxin	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
by	O	ADP	O
its	O	PRON	O
inactive	O	ADJ	B
analog	O	NOUN	B
methylthiogliotoxin	O	NOUN	O
.	O	PUNCT	O


Gliotoxin	O	NOUN	B
also	O	ADV	O
augmented	O	VERB	B
dramatically	O	ADV	O
the	O	DET	O
early	O	ADJ	B
(	O	PUNCT	O
2-6	O	NUM	O
h	O	NOUN	O
)	O	PUNCT	O
pro-apoptotic	O	ADJ	B
effects	O	NOUN	B
of	O	ADP	O
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor-alpha	I-protein	NOUN	I
(	O	PUNCT	O
TNF-alpha	B-protein	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
neutrophils	B-cell_type	NOUN	B
and	O	CCONJ	O
unmasked	O	VERB	O
the	O	DET	O
ability	O	NOUN	O
of	O	ADP	O
TNF-alpha	B-protein	NOUN	B
to	O	PART	O
induce	O	VERB	B
eosinophil	B-cell_type	NOUN	B
apoptosis	O	NOUN	B
.	O	PUNCT	O


FasL-dependent	B-DNA	ADJ	B
reporter	I-DNA	NOUN	I
constructs	I-DNA	NOUN	I
in	O	ADP	O
MRL-lpr/lpr	B-cell_line	NOUN	B
and	I-cell_line	CCONJ	O
C3H-gld/gld	I-cell_line	ADJ	B
CD4	I-cell_line	NOUN	B
(	I-cell_line	PUNCT	O
-	I-cell_line	PUNCT	O
)	I-cell_line	PUNCT	O
CD8	I-cell_line	NOUN	B
(	I-cell_line	PUNCT	O
-	I-cell_line	PUNCT	O
)	I-cell_line	PUNCT	O
T	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
were	O	AUX	O
constitutively	O	ADV	B
active	O	ADJ	O
,	O	PUNCT	O
and	O	CCONJ	O
this	O	DET	O
activity	O	NOUN	B
was	O	AUX	O
largely	O	ADV	O
prevented	O	VERB	B
by	O	ADP	O
mutation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
critical	O	ADJ	O
Egr	B-DNA	NOUN	B
family	I-DNA	NOUN	O
binding	I-DNA	NOUN	O
element	I-DNA	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
lack	O	NOUN	B
of	O	ADP	O
NF-YA	B-protein	NOUN	B
protein	I-protein	NOUN	I
is	O	AUX	O
due	O	ADJ	O
to	O	PART	O
posttranscriptional	O	ADJ	B
regulation	O	NOUN	I
and	O	CCONJ	O
not	O	PART	O
to	O	PART	O
a	O	DET	O
specific	O	ADJ	O
proteolytic	O	ADJ	B
activity	O	NOUN	I
.	O	PUNCT	O


After	O	ADP	O
T-cell	B-protein	NOUN	B
receptor	I-protein	NOUN	I
stimulation	O	NOUN	I
,	O	PUNCT	O
ZAP-70	B-protein	NOUN	B
associates	O	VERB	B
with	O	ADP	I
the	O	DET	O
receptor	O	NOUN	B
and	O	CCONJ	O
is	O	AUX	O
phosphorylated	O	VERB	B
on	O	ADP	O
many	O	ADJ	O
tyrosines	O	NOUN	B
,	O	PUNCT	O
including	O	VERB	O
Y292	O	NOUN	B
,	O	PUNCT	O
Y315	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
Y319	O	NOUN	B
within	O	ADP	O
interdomain	O	NOUN	B
B	O	NOUN	I
.	O	PUNCT	O


This	O	DET	O
is	O	AUX	O
manifested	O	VERB	O
by	O	ADP	O
the	O	DET	O
ability	O	NOUN	B
of	O	ADP	O
Delta	B-protein	NOUN	B
to	O	PART	O
restore	O	VERB	O
induction	O	NOUN	B
of	O	ADP	O
calcium	O	NOUN	B
fluxes	O	NOUN	I
and	O	CCONJ	O
mitogen-activated	B-protein	ADJ	B
protein	I-protein	NOUN	I
kinase	I-protein	NOUN	I
activation	O	NOUN	B
and	O	CCONJ	O
by	O	ADP	O
the	O	DET	O
ability	O	NOUN	O
of	O	ADP	O
dominant	O	ADJ	B
negative	O	ADJ	B
Ras	B-protein	NOUN	B
and	O	CCONJ	O
FK506	B-protein	NOUN	B
to	O	PART	O
block	O	VERB	B
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
NF-AT	B-protein	NOUN	B
activity	O	NOUN	B
mediated	O	VERB	O
by	O	ADP	O
Delta	B-protein	NOUN	B
.	O	PUNCT	O


Differential	O	ADJ	B
induction	O	NOUN	B
of	O	ADP	O
DNA-binding	B-protein	ADJ	B
activities	I-protein	NOUN	I
following	O	VERB	O
CD19	B-protein	NOUN	B
cross-linking	O	NOUN	I
in	O	ADP	O
human	B-cell_type	ADJ	B
B	I-cell_type	NOUN	O
lineage	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
.	O	PUNCT	O


The	O	DET	O
cells	O	NOUN	B
used	O	VERB	O
were	O	AUX	O
the	O	DET	O
BLIN-1	B-cell_line	NOUN	B
pre-B	I-cell_line	ADJ	O
cell	I-cell_line	NOUN	O
line	I-cell_line	NOUN	O
expressing	O	VERB	B
low	O	ADJ	O
levels	O	NOUN	O
of	O	ADP	O
cell	B-protein	NOUN	B
surface	I-protein	NOUN	I
mu	I-protein	NOUN	O
heavy	I-protein	ADJ	O
chain	I-protein	NOUN	O
associated	O	VERB	B
with	O	ADP	I
surrogate	B-protein	ADJ	B
light	I-protein	ADJ	I
chain	I-protein	NOUN	I
and	O	CCONJ	O
the	O	DET	O
1E8	O	NOUN	B
immature	O	ADJ	B
B	O	NOUN	O
cell	O	NOUN	O
line	O	NOUN	O
expressing	O	NOUN	B
cell	B-protein	NOUN	B
surface	I-protein	NOUN	I
mu/kappa	I-protein	NOUN	B
.	O	PUNCT	O


Oxidants	O	NOUN	B
,	O	PUNCT	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
intestinal	O	ADJ	B
inflammation	O	NOUN	B
.	O	PUNCT	O


Oxidants	O	NOUN	B
are	O	AUX	O
also	O	ADV	O
known	O	VERB	O
to	O	PART	O
activate	O	VERB	B
another	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
,	O	PUNCT	O
activator	B-protein	NOUN	B
protein-1	I-protein	NOUN	I
.	O	PUNCT	O


Identification	O	NOUN	B
of	O	ADP	O
target	B-DNA	NOUN	B
genes	I-DNA	NOUN	O
of	O	ADP	O
the	O	DET	O
lymphoid-specific	B-protein	ADJ	B
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
Oct2	I-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
Oct2	B-protein	NOUN	B
transcription	B-protein	NOUN	O
factor	I-protein	NOUN	O
is	O	AUX	O
expressed	O	VERB	B
predominantly	O	ADV	O
in	O	ADP	O
B	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
and	O	CCONJ	O
plays	O	VERB	O
an	O	DET	O
essential	O	ADJ	O
role	O	NOUN	O
during	O	ADP	O
the	O	DET	O
terminal	O	ADJ	B
phase	O	NOUN	B
of	O	ADP	O
B	O	NOUN	B
cell	O	NOUN	I
differentiation	O	NOUN	O
.	O	PUNCT	O


RFX-B	B-DNA	NOUN	B
is	O	AUX	O
the	O	DET	O
gene	O	NOUN	B
responsible	O	ADJ	O
for	O	ADP	O
the	O	DET	O
most	O	ADV	O
common	O	ADJ	O
cause	O	NOUN	B
of	O	ADP	O
the	O	DET	O
bare	O	ADJ	B
lymphocyte	O	NOUN	I
syndrome	O	NOUN	I
,	O	PUNCT	O
an	O	DET	O
MHC	B-protein	NOUN	B
class	I-protein	NOUN	I
II	I-protein	NUM	I
immunodeficiency	O	NOUN	I
[	O	PUNCT	O
published	O	VERB	O
erratum	O	NOUN	O
appears	O	VERB	O
in	O	ADP	O
Immunity	O	NOUN	B
1999	O	NUM	O
Mar	O	PROPN	B
;	O	PUNCT	O
10	O	NUM	O
(	O	PUNCT	O
3	O	NUM	O
)	O	PUNCT	O
:	O	PUNCT	O
399	O	NUM	O
]	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
purified	O	VERB	B
the	O	DET	O
RFX	B-protein	NOUN	B
complex	I-protein	NOUN	B
and	O	CCONJ	O
sequenced	O	VERB	B
its	O	PRON	O
three	O	NUM	O
subunits	O	NOUN	B
.	O	PUNCT	O


Although	O	SCONJ	O
NF-kappaB/Rel	B-protein	NOUN	B
factors	I-protein	NOUN	O
are	O	AUX	O
known	O	VERB	O
to	O	PART	O
induce	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
T-cell	B-protein	NOUN	B
growth	I-protein	NOUN	I
factor	I-protein	NOUN	I
interleukin	I-protein	NOUN	I
(	I-protein	PUNCT	O
IL	I-protein	NOUN	B
)	I-protein	PUNCT	O
-2	I-protein	NUM	O
,	O	PUNCT	O
it	O	PRON	O
is	O	AUX	O
unclear	O	ADJ	O
how	O	SCONJ	O
they	O	PRON	O
participate	O	VERB	B
in	O	ADP	O
the	O	DET	O
IL-2	B-protein	NOUN	B
-independent	O	ADJ	O
growth	O	NOUN	B
of	O	ADP	O
HTLV-I-transformed	B-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


To	O	PART	O
investigate	O	VERB	B
the	O	DET	O
events	O	NOUN	B
involved	O	VERB	O
in	O	ADP	O
activation-induced	O	ADJ	B
Fas	B-protein	NOUN	B
upregulation	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
examined	O	VERB	O
mRNA	O	NOUN	B
accumulation	O	NOUN	B
,	O	PUNCT	O
fas	O	NOUN	B
promoter	O	NOUN	B
activity	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
protein	O	NOUN	B
expression	O	NOUN	I
in	O	ADP	O
the	O	DET	O
Jurkat	B-cell_line	NOUN	B
T-cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
treated	O	VERB	B
with	O	ADP	I
phorbol	O	NOUN	B
myristate	O	NOUN	B
acetate	O	NOUN	I
and	O	CCONJ	O
ionomycin	O	NOUN	B
(	O	PUNCT	O
P/I	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
pharmacological	O	ADJ	B
mimics	O	NOUN	B
of	O	ADP	O
T-cell	B-protein	NOUN	B
receptor	I-protein	NOUN	I
activation	O	NOUN	B
.	O	PUNCT	O


Using	O	VERB	O
sequential	B-DNA	ADJ	B
deletion	I-DNA	NOUN	B
mutants	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
fas	I-DNA	NOUN	O
promoter	I-DNA	NOUN	B
in	O	ADP	O
transient	O	ADJ	B
transfection	O	NOUN	B
assays	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
identified	O	VERB	B
a	O	DET	O
47-bp	B-DNA	ADJ	O
sequence	I-DNA	NOUN	B
(	O	PUNCT	O
positions	B-DNA	NOUN	B
-306	I-DNA	NUM	O
to	I-DNA	PART	O
-260	I-DNA	NUM	O
relative	O	ADJ	O
to	O	PART	O
the	O	DET	O
ATG	O	NOUN	B
)	O	PUNCT	O
required	O	VERB	O
for	O	ADP	O
activation-driven	O	ADJ	O
fas	O	NOUN	B
upregulation	O	NOUN	B
.	O	PUNCT	O


Sequence	O	NOUN	B
analysis	O	NOUN	I
revealed	O	VERB	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
a	O	DET	O
previously	O	ADV	O
unrecognized	B-DNA	ADJ	O
composite	I-DNA	ADJ	B
binding	I-DNA	NOUN	B
site	I-DNA	NOUN	I
for	O	ADP	O
both	O	CCONJ	O
the	O	DET	O
Sp1	B-protein	NOUN	B
and	O	CCONJ	O
NF-kappaB	B-protein	NOUN	B
transcription	B-protein	NOUN	I
factors	I-protein	NOUN	I
at	O	ADP	O
positions	B-DNA	NOUN	B
-295	I-DNA	NUM	O
to	I-DNA	PART	O
-286	I-DNA	NUM	O
.	O	PUNCT	O


Electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assay	O	NOUN	I
(	O	PUNCT	O
EMSA	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
supershift	O	NOUN	B
analyses	O	NOUN	I
of	O	ADP	O
this	O	DET	O
region	O	NOUN	B
documented	O	VERB	O
constitutive	O	ADJ	B
binding	O	NOUN	O
of	O	ADP	O
Sp1	B-protein	NOUN	B
in	O	ADP	O
unactivated	O	ADJ	B
nuclear	O	ADJ	I
extracts	O	NOUN	I
and	O	CCONJ	O
inducible	O	ADJ	B
binding	O	NOUN	O
of	O	ADP	O
p50-p65	B-protein	NOUN	B
NF-kappaB	I-protein	NOUN	I
heterodimers	I-protein	NOUN	B
after	O	ADP	O
P/I	O	NOUN	B
activation	O	NOUN	B
.	O	PUNCT	O


Instead	O	ADV	O
,	O	PUNCT	O
signal	O	NOUN	B
transduction	O	NOUN	I
to	O	PART	O
the	O	DET	O
human	O	ADJ	B
IL-2	B-DNA	NOUN	O
gene	I-DNA	NOUN	O
became	O	VERB	O
disrupted	O	VERB	B
.	O	PUNCT	O


Following	O	VERB	O
integration	O	NOUN	B
into	O	ADP	O
the	O	DET	O
host	O	NOUN	B
cell	O	NOUN	O
genome	O	NOUN	O
,	O	PUNCT	O
HTLV-I	O	NOUN	B
replication	O	NOUN	B
is	O	AUX	O
regulated	O	VERB	O
by	O	ADP	O
both	O	CCONJ	O
host	O	NOUN	B
and	O	CCONJ	O
viral	O	ADJ	B
mechanisms	O	NOUN	I
that	O	PRON	O
control	O	VERB	B
transcription	O	NOUN	I
.	O	PUNCT	O


Further	O	ADJ	O
studies	O	NOUN	B
indicated	O	VERB	O
that	O	SCONJ	O
inhibition	O	NOUN	B
of	O	ADP	O
GTP-cyclohydrolase	B-protein	NOUN	B
I	I-protein	NUM	I
(	O	PUNCT	O
an	O	DET	O
enzyme	O	NOUN	B
involved	O	VERB	O
in	O	ADP	O
de	O	X	O
novo	O	X	O
synthesis	O	NOUN	B
of	O	ADP	O
an	O	DET	O
important	O	ADJ	O
cofactor	O	NOUN	B
for	O	ADP	O
NOS	B-protein	NOUN	B
activity	O	NOUN	B
,	O	PUNCT	O
tetrahydrobiopterin	O	NOUN	B
)	O	PUNCT	O
prevented	O	VERB	B
the	O	DET	O
generation	O	NOUN	B
of	O	ADP	O
NO	O	NOUN	B
in	O	ADP	O
A/R-tolerant	B-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Mildly	O	ADV	B
oxidized	O	VERB	O
low-density	B-protein	ADJ	B
lipoproteins	I-protein	NOUN	I
decrease	O	VERB	B
early	O	ADJ	O
production	O	NOUN	B
of	O	ADP	O
interleukin	B-protein	NOUN	B
2	I-protein	NUM	I
and	O	CCONJ	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
kappaB	I-protein	NOUN	I
binding	O	NOUN	I
to	O	PART	O
DNA	O	NOUN	B
in	O	ADP	O
activated	B-cell_type	VERB	B
T-lymphocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


Taken	O	VERB	O
together	O	ADV	O
,	O	PUNCT	O
these	O	DET	O
observations	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
immunosuppressive	O	ADJ	B
effect	O	NOUN	I
of	O	ADP	O
oxLDLs	B-protein	NOUN	B
might	O	AUX	O
operate	O	VERB	O
via	O	ADP	O
a	O	DET	O
dysregulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
T-lymphocyte	B-cell_type	NOUN	B
activation	O	NOUN	B
mechanisms	O	NOUN	B
.	O	PUNCT	O


Early	B-protein	ADJ	B
B-cell	I-protein	NOUN	O
factor	I-protein	NOUN	O
(	O	PUNCT	O
EBF	B-protein	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
suggested	O	VERB	O
as	O	ADP	O
essential	O	ADJ	B
for	O	ADP	O
early	O	ADJ	O
B-lymphocyte	B-cell_type	NOUN	B
development	O	NOUN	B
by	O	ADP	O
findings	O	NOUN	B
in	O	ADP	O
mice	O	NOUN	B
where	O	SCONJ	O
the	O	DET	O
coding	O	VERB	B
gene	O	NOUN	I
has	O	AUX	O
been	O	AUX	O
inactivated	O	VERB	B
by	O	ADP	O
homologous	O	ADJ	B
disruption	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
makes	O	VERB	O
the	O	DET	O
identification	O	NOUN	B
of	O	ADP	O
genetic	O	ADJ	B
targets	O	NOUN	I
for	O	ADP	O
this	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
pertinent	O	ADJ	O
for	O	ADP	O
the	O	DET	O
understanding	O	NOUN	O
of	O	ADP	O
early	O	ADJ	B
B-cell	O	NOUN	B
development	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
lack	O	NOUN	B
of	O	ADP	O
B29	B-RNA	NOUN	B
transcripts	I-RNA	NOUN	I
,	O	PUNCT	O
coding	O	VERB	B
for	O	ADP	O
the	O	DET	O
beta	B-protein	NOUN	B
subunit	I-protein	NOUN	I
of	O	ADP	I
the	O	DET	I
B-cell	O	NOUN	I
receptor	O	NOUN	I
complex	O	NOUN	I
,	O	PUNCT	O
in	O	ADP	O
pro-B	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
from	O	ADP	O
EBF	B-protein	NOUN	B
-deficient	O	ADJ	O
mice	O	NOUN	B
suggested	O	VERB	O
that	O	SCONJ	O
B29	O	NOUN	B
might	O	AUX	O
be	O	AUX	O
a	O	DET	O
genetic	O	ADJ	B
target	O	NOUN	I
for	O	ADP	O
EBF	B-protein	NOUN	B
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
B29	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
is	O	AUX	O
a	O	DET	O
genetic	O	ADJ	B
target	O	NOUN	I
for	O	ADP	O
EBF	B-protein	NOUN	B
in	O	ADP	O
early	O	ADJ	B
B-cell	O	NOUN	B
development	O	NOUN	B
.	O	PUNCT	O


Although	O	SCONJ	O
DOR1	B-protein	NOUN	B
signaling	O	NOUN	B
increased	O	VERB	B
[	O	PUNCT	O
Ca2+	O	NOUN	B
]	O	PUNCT	O
i	O	NUM	O
,	O	PUNCT	O
deltorphin	O	NOUN	B
enhanced	O	VERB	O
transcriptional	O	ADJ	B
activity	O	NOUN	I
of	O	ADP	O
the	O	DET	O
NF-AT/AP-1-binding	B-DNA	VERB	B
site	I-DNA	NOUN	I
via	O	ADP	O
a	O	DET	O
mechanism	O	NOUN	B
independent	O	ADJ	B
of	O	ADP	O
calcineurin	B-protein	NOUN	B
and	O	CCONJ	O
distinct	O	ADJ	O
from	O	ADP	O
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	I
elevated	O	ADJ	B
[	O	PUNCT	O
Ca2+	O	NOUN	B
]	O	PUNCT	O
i	O	NUM	O
.	O	PUNCT	O


Moreover	O	ADV	O
,	O	PUNCT	O
transfection	O	NOUN	B
of	O	ADP	O
Daudi	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
with	O	ADP	O
the	O	DET	O
polymerized	O	ADJ	B
NF-kappaB	B-DNA	NOUN	B
binding	I-DNA	NOUN	I
sequence	I-DNA	NOUN	I
ligated	O	VERB	O
to	O	PART	O
a	O	DET	O
thymidine	B-DNA	NOUN	B
kinase/chloramphenicol	I-DNA	NOUN	I
acetyltransferase	I-DNA	NOUN	I
(	I-DNA	PUNCT	O
CAT	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
reporter	I-DNA	NOUN	O
plasmid	I-DNA	NOUN	O
greatly	O	ADV	O
induced	O	VERB	B
CAT	B-protein	NOUN	B
activity	O	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
transfection	O	NOUN	B
with	O	ADP	O
the	O	DET	O
polymerized	B-DNA	ADJ	B
mutated	I-DNA	VERB	B
NF-kappaB	I-DNA	NOUN	B
binding	I-DNA	NOUN	I
sequence	I-DNA	NOUN	I
did	O	AUX	O
not	O	PART	O
.	O	PUNCT	O


T-cell	O	NOUN	B
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
GATA-3	I-DNA	NOUN	B
gene	I-DNA	NOUN	I
is	O	AUX	O
regulated	O	VERB	O
by	O	ADP	O
a	O	DET	O
non-lineage-specific	B-DNA	ADJ	B
silencer	I-DNA	NOUN	I
.	O	PUNCT	O


The	O	DET	O
first	B-DNA	ADJ	O
intron	I-DNA	NOUN	B
acted	O	VERB	O
as	O	ADP	O
a	O	DET	O
strong	O	ADJ	O
transcriptional	O	ADJ	B
activator	O	NOUN	I
in	O	ADP	O
a	O	DET	O
position-dependent	O	ADJ	B
manner	O	NOUN	O
and	O	CCONJ	O
with	O	ADP	O
no	O	DET	O
cell-type	O	ADJ	B
specificity	O	NOUN	B
.	O	PUNCT	O


Two	O	NUM	O
CAGGTG	O	NOUN	B
E-boxes	O	NOUN	B
,	O	PUNCT	O
located	O	ADJ	O
at	O	ADP	O
the	O	DET	O
5'-	B-DNA	ADJ	B
and	I-DNA	CCONJ	O
3'-ends	I-DNA	NOUN	B
of	O	ADP	O
the	O	DET	O
silencer	O	NOUN	B
,	O	PUNCT	O
were	O	AUX	O
necessary	O	ADJ	O
for	O	ADP	O
this	O	DET	O
silencer	O	NOUN	B
activity	O	NOUN	I
.	O	PUNCT	O


To	O	PART	O
clarify	O	VERB	O
the	O	DET	O
etiological	O	ADJ	B
relationship	O	NOUN	B
between	O	ADP	O
the	O	DET	O
two	O	NUM	O
variants	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
analyzed	O	VERB	B
responsiveness	O	NOUN	B
to	O	PART	O
IL-4	B-protein	NOUN	B
of	O	ADP	O
transfectants	O	NOUN	B
with	O	ADP	O
four	O	NUM	O
kinds	O	NOUN	O
of	O	ADP	O
IL-4Ralpha	B-protein	NOUN	B
carrying	O	VERB	B
either	O	CCONJ	O
Val	O	NOUN	B
or	O	CCONJ	O
Ile	O	NOUN	B
at	O	ADP	O
50	B-protein	NUM	O
and	O	CCONJ	O
either	O	CCONJ	O
Gln	O	NOUN	B
or	O	CCONJ	O
Arg	O	NOUN	B
at	O	ADP	O
551	B-protein	NUM	O
.	O	PUNCT	O


We	O	PRON	O
developed	O	VERB	O
mice	O	NOUN	B
transgenic	O	ADJ	B
for	O	ADP	O
human	O	ADJ	B
CSF-1R	B-protein	NOUN	B
because	O	SCONJ	O
mouse	O	NOUN	B
CSF-1	B-protein	NOUN	B
can	O	AUX	O
not	O	PART	O
activate	O	VERB	O
human	O	ADJ	B
CSF-1R	B-protein	NOUN	B
.	O	PUNCT	O


Then	O	ADV	O
bone	B-cell_type	NOUN	B
marrow	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
from	O	ADP	O
transgenic	O	ADJ	B
mice	O	NOUN	I
were	O	AUX	O
plated	O	VERB	O
onto	O	ADP	O
MS-5	O	NOUN	B
stromal	O	ADJ	B
cells	O	NOUN	I
expressing	O	VERB	B
the	O	DET	O
membrane	B-protein	NOUN	B
form	I-protein	NOUN	O
of	O	ADP	O
human	B-protein	ADJ	B
CSF-1	I-protein	NOUN	B
(	O	PUNCT	O
2M-1	B-cell_line	NOUN	O
cells	I-cell_line	NOUN	O
)	O	PUNCT	O
in	O	ADP	O
order	O	NOUN	O
to	O	PART	O
combine	O	VERB	O
the	O	DET	O
hematopoietic	O	ADJ	B
supporting	O	NOUN	O
properties	O	NOUN	B
of	O	ADP	O
stromal	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
the	O	DET	O
proliferative	O	ADJ	B
effects	O	NOUN	O
of	O	ADP	O
CSF-1	B-protein	NOUN	B
.	O	PUNCT	O


Under	O	ADP	O
these	O	DET	O
conditions	O	NOUN	B
,	O	PUNCT	O
about	O	ADV	O
0.5	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
47.10	B-cell_line	NUM	O
cells	I-cell_line	NOUN	B
formed	O	VERB	O
large	O	ADJ	O
14-day	O	ADJ	O
colonies	O	NOUN	B
(	O	PUNCT	O
>	O	NOUN	O
1	O	NUM	O
mm	O	NOUN	O
)	O	PUNCT	O
composed	O	VERB	O
of	O	ADP	O
mature	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
and	O	CCONJ	O
granulocytes	B-cell_type	NOUN	B
,	O	PUNCT	O
reflecting	O	VERB	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
progenitors	O	NOUN	B
endowed	O	VERB	O
with	O	ADP	O
high	O	ADJ	O
proliferative	O	ADJ	B
potential	O	NOUN	O
(	O	PUNCT	O
HPP-47.10	B-cell_line	NUM	B
cells	I-cell_line	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


Previous	O	ADJ	O
studies	O	NOUN	B
found	O	VERB	O
that	O	SCONJ	O
P1	B-DNA	NOUN	B
,	O	PUNCT	O
an	O	DET	O
element	O	NOUN	B
of	O	ADP	O
the	O	DET	O
interleukin	B-DNA	NOUN	B
4	I-DNA	NUM	I
(	I-DNA	PUNCT	O
IL-4	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
promoter	I-DNA	NOUN	B
that	O	PRON	O
binds	O	VERB	B
AP-1	O	NOUN	B
,	O	PUNCT	O
is	O	AUX	O
important	O	ADJ	O
for	O	ADP	O
Th2-restricted	O	ADJ	B
IL-4	B-protein	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


JunB	B-protein	NOUN	B
has	O	AUX	O
previously	O	ADV	O
been	O	AUX	O
considered	O	VERB	O
to	O	PART	O
be	O	AUX	O
a	O	DET	O
negative	O	ADJ	B
regulator	O	NOUN	O
of	O	ADP	O
transcription	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
conclude	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
transrepressive	O	ADJ	B
effect	O	NOUN	I
of	O	ADP	O
glucocorticoids	O	NOUN	B
on	O	ADP	O
IL-2	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
transcription	O	NOUN	O
is	O	AUX	O
exclusively	O	ADV	O
mediated	O	VERB	O
by	O	ADP	O
GRalpha	B-protein	NOUN	B
.	O	PUNCT	O


When	O	SCONJ	O
immunoglobulin	B-cell_type	NOUN	B
(	I-cell_type	PUNCT	I
Ig	I-cell_type	NOUN	I
)	I-cell_type	PUNCT	I
expressing	I-cell_type	VERB	B
B	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
are	O	AUX	O
fused	O	VERB	B
with	O	ADP	O
non-B	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
Ig	O	NOUN	B
expression	O	NOUN	I
is	O	AUX	O
rapidly	O	ADV	O
suppressed	O	VERB	B
at	O	ADP	O
the	O	DET	O
level	O	NOUN	B
of	O	ADP	O
transcription	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
phenomenon	O	NOUN	B
termed	O	VERB	O
extinction	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
immunophilin	B-protein	NOUN	B
FKBP51	I-protein	NOUN	I
was	O	AUX	O
13-fold	O	ADV	O
higher	O	ADJ	O
in	O	ADP	O
SML	B-cell_type	NOUN	B
than	O	ADP	O
in	O	ADP	O
HL	O	NOUN	B
cytosol	O	NOUN	B
;	O	PUNCT	O
FKBP52	B-protein	NOUN	B
in	O	ADP	O
SML	B-cell_type	NOUN	B
was	O	AUX	O
42	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
that	O	DET	O
in	O	ADP	O
HL	O	NOUN	B
cytosol	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
cotransfection	O	NOUN	B
of	O	ADP	O
this	O	DET	O
LTR	B-DNA	NOUN	B
with	O	ADP	O
a	O	DET	O
mutated	O	VERB	B
IkappaBalpha	B-protein	NOUN	B
molecule	I-protein	NOUN	I
formally	O	ADV	O
demonstrates	O	VERB	O
that	O	SCONJ	O
LTR	B-DNA	NOUN	B
transactivation	O	NOUN	B
is	O	AUX	O
regulated	O	VERB	O
by	O	ADP	O
members	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Rel/NF-kappaB	B-protein	NOUN	B
family	I-protein	NOUN	I
in	O	ADP	O
thymocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
IL-7	B-protein	NOUN	B
,	O	PUNCT	O
a	O	DET	O
crucial	O	ADJ	O
factor	O	NOUN	B
for	O	ADP	O
thymopoiesis	O	NOUN	B
that	O	PRON	O
is	O	AUX	O
secreted	O	VERB	B
mainly	O	ADV	O
by	O	ADP	O
TEC	B-cell_type	NOUN	B
,	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
necessary	O	ADJ	O
cofactor	O	NOUN	B
for	O	ADP	O
NF-kappaB	B-protein	NOUN	B
activation	O	NOUN	B
elicited	O	VERB	O
by	O	ADP	O
TNF	B-protein	NOUN	B
or	O	CCONJ	O
IL-1	B-protein	NOUN	B
.	O	PUNCT	O


In	O	X	B
vitro	O	X	I
apoptosis	O	NOUN	B
induction	O	NOUN	B
in	O	ADP	O
CLL	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	B
was	O	AUX	O
delayed	O	VERB	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
GCs	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
to	O	PART	O
other	O	ADJ	O
apoptosis	O	NOUN	B
inducers	O	NOUN	B
.	O	PUNCT	O


Western	O	NOUN	B
blot	O	NOUN	I
with	O	ADP	O
an	O	DET	O
N-terminal	O	ADJ	B
antibody	O	NOUN	I
showed	O	VERB	O
normal	O	ADJ	O
levels	O	NOUN	O
of	O	ADP	O
immunoreactive	B-protein	ADJ	B
GR	I-protein	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
quantitative	O	ADJ	B
analysis	O	NOUN	I
with	O	ADP	O
isoform-specific	O	ADJ	B
C-terminal	B-protein	ADJ	I
antibodies	I-protein	NOUN	I
revealed	O	VERB	O
a	O	DET	O
markedly	O	ADV	O
reduced	O	VERB	B
GRalpha	B-protein	NOUN	B
expression	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
high	O	ADJ	O
GRbeta	B-protein	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


Sequences	O	NOUN	B
upstream	O	ADJ	B
and	O	CCONJ	O
downstream	O	ADJ	B
from	O	ADP	O
the	O	DET	O
TATA	B-DNA	NOUN	B
box	I-DNA	NOUN	I
were	O	AUX	O
found	O	VERB	O
to	O	PART	O
contribute	O	VERB	O
to	O	PART	O
elk-1	B-DNA	NOUN	B
promoter	O	NOUN	B
activity	O	NOUN	I
.	O	PUNCT	O


Because	O	SCONJ	O
Egr-1	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
and	O	CCONJ	O
protein	O	NOUN	B
levels	O	NOUN	I
were	O	AUX	O
observed	O	VERB	O
to	O	PART	O
increase	O	VERB	B
significantly	O	ADV	O
before	O	ADP	O
induction	O	NOUN	B
of	O	ADP	O
elk-1	B-DNA	NOUN	B
expression	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
propose	O	VERB	O
that	O	SCONJ	O
Egr-1	B-protein	NOUN	B
is	O	AUX	O
important	O	ADJ	O
for	O	ADP	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
elk-1	B-DNA	NOUN	B
transcription	O	NOUN	B
in	O	ADP	O
differentiating	O	VERB	O
monocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


Three	O	NUM	O
of	O	ADP	O
the	O	DET	O
27	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
squamous	O	ADJ	B
cell	O	NOUN	I
carcinoma	O	NOUN	I
showed	O	VERB	O
slight	O	ADJ	O
expression	O	NOUN	B
of	O	ADP	O
c-fos	O	NOUN	B
in	O	ADP	O
their	O	PRON	O
tumor	O	NOUN	B
cells	O	NOUN	I
before	O	ADP	O
and/or	O	CCONJ	O
at	O	ADP	O
4	O	NUM	O
or	O	CCONJ	O
10	O	NUM	O
Gy	O	NOUN	O
of	O	ADP	O
radiotherapy	O	NOUN	B
.	O	PUNCT	O


Paternal	O	ADJ	B
expression	O	NOUN	I
of	O	ADP	O
WT1	B-protein	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
fibroblasts	I-cell_type	NOUN	B
and	O	CCONJ	O
lymphocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


Our	O	PRON	O
unexpected	O	ADJ	O
observations	O	NOUN	B
of	O	ADP	O
paternal	O	ADJ	B
or	O	CCONJ	O
biallelic	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
WT1	B-protein	NOUN	B
in	O	ADP	O
fibroblasts	B-cell_type	NOUN	B
and	O	CCONJ	O
lymphocytes	B-cell_type	NOUN	B
,	O	PUNCT	O
together	O	ADV	O
with	O	ADP	O
the	O	DET	O
previous	O	ADJ	O
findings	O	NOUN	B
of	O	ADP	O
maternal	O	ADJ	B
or	O	CCONJ	O
biallelic	O	ADJ	B
expression	O	NOUN	B
in	O	ADP	O
placentae	O	NOUN	B
and	O	CCONJ	O
brains	O	NOUN	B
,	O	PUNCT	O
suggest	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
allele-specific	O	ADJ	B
regulatory	O	ADJ	I
system	O	NOUN	I
of	O	ADP	O
WT1	B-protein	NOUN	B
is	O	AUX	O
unique	O	ADJ	B
and	O	CCONJ	O
may	O	AUX	O
be	O	AUX	O
controlled	O	VERB	B
by	O	ADP	O
a	O	DET	O
putative	O	ADJ	O
tissue-	O	NOUN	O
and	O	CCONJ	O
individual-specific	O	ADJ	B
modifier	O	NOUN	I
.	O	PUNCT	O


CONCLUSION	O	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
previously	O	ADV	O
reported	O	VERB	O
that	O	SCONJ	O
gold	O	ADJ	B
compounds	O	NOUN	I
,	O	PUNCT	O
especially	O	ADV	O
aurothioglucose	O	NOUN	B
(	O	PUNCT	O
AuTG	O	NOUN	B
)	O	PUNCT	O
containing	O	VERB	O
monovalent	O	ADJ	B
gold	O	NOUN	I
ion	O	NOUN	I
,	O	PUNCT	O
inhibited	O	VERB	B
the	O	DET	O
DNA-binding	O	NOUN	B
of	O	ADP	O
NF-kappaB	B-protein	NOUN	B
in	O	X	B
vitro	O	X	I
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
report	O	NOUN	O
we	O	PRON	O
have	O	AUX	O
examined	O	VERB	O
the	O	DET	O
efficacy	O	NOUN	B
of	O	ADP	O
the	O	DET	O
gold	O	ADJ	B
compound	O	NOUN	O
AuTG	O	NOUN	B
as	O	ADP	O
an	O	DET	O
inhibitor	O	NOUN	B
of	O	ADP	O
HIV	O	NOUN	B
replication	O	NOUN	B
in	O	ADP	O
latently	O	ADV	B
infected	O	ADJ	B
OM10.1	B-cell_line	NOUN	B
and	I-cell_line	CCONJ	O
Ach2	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor	I-protein	NOUN	I
(	I-protein	PUNCT	O
TNF	I-protein	NOUN	B
)	I-protein	PUNCT	O
-alpha	I-protein	NOUN	B
-induced	O	ADJ	O
HIV-1	O	NOUN	B
replication	O	NOUN	B
in	O	ADP	O
OM10.1	B-cell_line	NOUN	B
or	O	CCONJ	O
Ach2	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
was	O	AUX	O
significantly	O	ADV	O
inhibited	O	VERB	B
by	O	ADP	O
non-cytotoxic	O	ADJ	B
doses	O	NOUN	I
of	O	ADP	O
AuTG	O	NOUN	B
(	O	PUNCT	O
>	O	NOUN	O
10	O	NUM	O
microM	O	NOUN	O
in	O	ADP	O
OM10.1	O	NOUN	B
cells	O	NOUN	I
and	O	CCONJ	O
>	O	X	O
25	O	NUM	O
F.M	O	NOUN	B
in	O	ADP	O
Ach2	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
)	O	PUNCT	O
,	O	PUNCT	O
while	O	SCONJ	O
25	O	NUM	O
microM	O	NOUN	O
of	O	ADP	O
the	O	DET	O
counter-anion	B-protein	ADJ	B
thioglucose	I-protein	NOUN	O
(	O	PUNCT	O
TG	B-protein	NOUN	B
)	O	PUNCT	O
or	O	CCONJ	O
gold	O	NOUN	B
compound	O	NOUN	I
containing	O	VERB	O
divalent	O	ADJ	B
gold	O	NOUN	O
ion	O	NOUN	O
,	O	PUNCT	O
HAuCl3	O	NOUN	B
,	O	PUNCT	O
had	O	AUX	O
no	O	DET	B
effect	O	NOUN	I
.	O	PUNCT	O


Specific	O	ADJ	O
staining	O	NOUN	B
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
electron	O	NOUN	B
microscopic	O	ADJ	I
examinations	O	NOUN	B
revealed	O	VERB	O
the	O	DET	O
accumulation	O	NOUN	B
of	O	ADP	O
metal	O	NOUN	B
gold	O	NOUN	B
in	O	ADP	O
the	O	DET	O
cells	O	NOUN	B
,	O	PUNCT	O
supporting	O	VERB	O
our	O	PRON	O
previous	O	ADJ	O
hypothesis	O	NOUN	B
that	O	SCONJ	O
gold	O	NOUN	B
ions	O	NOUN	B
could	O	AUX	O
block	O	VERB	B
NF-kappaB	B-protein	NOUN	B
-DNA	O	NOUN	O
binding	O	NOUN	B
by	O	ADP	O
a	O	DET	O
redox	O	NOUN	B
mechanism	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
observations	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
monovalent	O	ADJ	B
gold	O	NOUN	O
compound	O	NOUN	O
AuTG	O	NOUN	B
is	O	AUX	O
a	O	DET	O
potentially	O	ADV	O
useful	O	ADJ	O
drug	O	NOUN	B
for	O	ADP	O
the	O	DET	O
treatment	O	NOUN	B
of	O	ADP	O
patients	O	NOUN	B
infected	O	VERB	B
with	O	ADP	O
HIV	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
idiopathic	O	ADJ	B
hypereosinophilic	O	ADJ	I
syndrome	O	NOUN	I
(	O	PUNCT	O
IHES	O	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
rare	O	ADJ	O
disorder	O	NOUN	B
characterized	O	VERB	B
by	O	ADP	O
unexplained	O	ADJ	B
,	O	PUNCT	O
persistent	O	ADJ	B
eosinophilia	O	NOUN	O
associated	O	VERB	B
with	O	ADP	I
multiple	O	ADJ	B
organ	O	NOUN	I
dysfunction	O	NOUN	I
due	O	ADJ	O
to	O	PART	O
eosinophilic	O	ADJ	B
tissue	O	NOUN	B
infiltration	O	NOUN	B
.	O	PUNCT	O


Peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
eosinophils	I-cell_type	NOUN	I
were	O	AUX	O
isolated	O	VERB	B
by	O	ADP	O
their	O	PRON	O
autofluoresence	O	NOUN	B
using	O	VERB	O
flow	O	NOUN	B
cytometric	O	ADJ	I
sorting	O	NOUN	I
.	O	PUNCT	O


Eosinophils	B-cell_type	NOUN	B
purified	O	VERB	B
from	O	ADP	O
a	O	DET	O
female	O	ADJ	B
patient	O	NOUN	B
presenting	O	VERB	O
with	O	ADP	O
IHES	O	NOUN	B
were	O	AUX	O
found	O	VERB	O
to	O	PART	O
show	O	VERB	O
a	O	DET	O
clonal	O	ADJ	B
pattern	O	NOUN	I
of	O	ADP	O
X-inactivation	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
concert	O	NOUN	O
with	O	ADP	O
the	O	DET	O
coactivator	B-protein	NOUN	B
CREB	I-protein	NOUN	I
binding	I-protein	NOUN	I
protein/p300	I-protein	NOUN	I
,	O	PUNCT	O
which	O	DET	O
interacts	O	VERB	O
with	O	ADP	O
GABPalpha	B-protein	NOUN	B
,	O	PUNCT	O
the	O	DET	O
binding	O	NOUN	B
of	O	ADP	O
GABPalpha	B-protein	NOUN	B
and	O	CCONJ	O
-beta	B-protein	NOUN	O
to	O	PART	O
the	O	DET	O
dyad	B-DNA	NOUN	B
symmetry	I-DNA	NOUN	I
element	I-DNA	NOUN	O
controls	O	VERB	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
IL-16	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


The	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
tissue	B-protein	NOUN	B
factor	I-protein	NOUN	I
(	O	PUNCT	O
TF	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
the	O	DET	O
principal	O	ADJ	B
initiator	O	NOUN	I
of	O	ADP	O
coagulation	O	NOUN	B
,	O	PUNCT	O
is	O	AUX	O
increased	O	VERB	B
during	O	ADP	O
inflammation	O	NOUN	B
and	O	CCONJ	O
atherosclerosis	O	NOUN	B
.	O	PUNCT	O


Regulation	O	NOUN	B
of	O	ADP	O
fas-ligand	O	NOUN	B
expression	O	NOUN	B
during	O	ADP	O
activation-induced	O	ADJ	B
cell	O	NOUN	I
death	O	NOUN	I
in	O	ADP	O
T	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
via	O	ADP	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
kappaB	I-protein	NOUN	I
.	O	PUNCT	O


A	O	DET	O
number	O	NOUN	O
of	O	ADP	O
potential	B-DNA	ADJ	B
regulatory	I-DNA	ADJ	B
sequences	I-DNA	NOUN	I
similar	O	ADJ	O
to	O	PART	O
those	O	DET	O
found	O	VERB	O
in	O	ADP	O
mammals	O	NOUN	B
have	O	AUX	O
been	O	AUX	O
identified	O	VERB	B
in	O	ADP	O
the	O	DET	O
promoter	B-DNA	NOUN	B
.	O	PUNCT	O


Sequence	O	NOUN	B
comparisons	O	NOUN	B
also	O	ADV	O
predict	O	VERB	O
other	O	ADJ	O
potential	O	ADJ	B
transcription	O	NOUN	B
factor	O	NOUN	I
binding	O	NOUN	I
sites	O	NOUN	I
as	O	ADP	O
yet	O	ADV	O
undescribed	O	ADJ	O
in	O	ADP	O
mammalian	B-DNA	ADJ	B
IL2	I-DNA	NOUN	B
promoters	I-DNA	NOUN	B
.	O	PUNCT	O


A	O	DET	O
Taq	B-DNA	NOUN	B
I	I-DNA	NUM	I
polymorphism	I-DNA	NOUN	B
was	O	AUX	O
identified	O	VERB	B
which	O	DET	O
enabled	O	VERB	O
chicken	O	NOUN	B
IL2	B-protein	NOUN	B
to	O	PART	O
be	O	AUX	O
mapped	O	VERB	B
to	O	PART	O
chromosome	B-DNA	NOUN	B
4	I-DNA	NUM	I
,	O	PUNCT	O
linked	O	VERB	O
to	O	PART	O
ANX5	B-DNA	NOUN	B
,	O	PUNCT	O
with	O	ADP	O
synteny	O	NOUN	B
with	O	ADP	O
mouse	B-DNA	NOUN	B
chromosome	I-DNA	NOUN	I
3	I-DNA	NUM	I
and	O	CCONJ	O
human	B-DNA	ADJ	B
chromosome	I-DNA	NOUN	I
4	I-DNA	NUM	I
.	O	PUNCT	O


An	O	DET	O
inhibition	O	NOUN	B
of	O	ADP	O
MCP-1	B-protein	NOUN	B
production	O	NOUN	B
was	O	AUX	O
observed	O	VERB	O
that	O	PRON	O
was	O	AUX	O
specifically	O	ADV	O
caused	O	VERB	O
by	O	ADP	O
mixture	O	NOUN	O
of	O	ADP	O
IFN-gamma	B-protein	NOUN	B
with	O	ADP	O
heparin-like	O	ADJ	B
,	O	PUNCT	O
and	O	CCONJ	O
therefore	O	ADV	O
cytokine-binding	O	ADJ	B
,	O	PUNCT	O
GAGs	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
activities	O	NOUN	B
may	O	AUX	O
contribute	O	VERB	O
to	O	PART	O
the	O	DET	O
immunomodulatory	O	ADJ	B
properties	O	NOUN	O
of	O	ADP	O
heparin	O	NOUN	B
.	O	PUNCT	O


Therefore	O	ADV	O
,	O	PUNCT	O
our	O	PRON	O
data	O	NOUN	B
not	O	PART	O
only	O	ADV	O
reveal	O	VERB	O
that	O	SCONJ	O
Nmi	B-protein	NOUN	B
can	O	AUX	O
potentiate	O	VERB	O
STAT	B-protein	NOUN	B
-dependent	O	ADJ	O
transcription	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
also	O	ADV	O
suggest	O	VERB	O
that	O	SCONJ	O
it	O	PRON	O
can	O	AUX	O
augment	O	VERB	O
coactivator	O	NOUN	B
protein	O	NOUN	I
recruitment	O	NOUN	B
to	O	PART	O
at	O	ADP	O
least	O	ADJ	O
some	O	DET	O
members	O	NOUN	B
of	O	ADP	O
a	O	DET	O
group	O	NOUN	B
of	O	ADP	O
sequence-specific	B-protein	ADJ	B
transcription	I-protein	NOUN	I
factors	I-protein	NOUN	I
.	O	PUNCT	O


Activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
LTR	B-DNA	NOUN	B
in	O	ADP	O
Jurkat	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
was	O	AUX	O
strongly	O	ADV	O
enhanced	O	VERB	B
by	O	ADP	O
vanadate	O	NOUN	B
and	O	CCONJ	O
inhibited	O	VERB	B
by	O	ADP	O
catalase	B-protein	NOUN	B
,	O	PUNCT	O
implicating	O	VERB	O
H2O2	O	NOUN	B
.	O	PUNCT	O


Activated	O	VERB	B
primed	O	VERB	O
CD4	B-cell_type	NOUN	O
T	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
contain	O	VERB	O
more	O	ADJ	O
NFAT1	B-protein	NOUN	B
and	O	CCONJ	O
support	O	VERB	O
greater	O	ADJ	O
NFAT	B-protein	NOUN	B
-directed	O	ADJ	O
transcription	O	NOUN	B
than	O	ADP	O
unprimed	O	ADJ	B
CD4	B-cell_type	NOUN	B
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
while	O	SCONJ	O
activator	B-protein	NOUN	B
protein	I-protein	NOUN	I
1	I-protein	NUM	I
binding	O	NOUN	O
and	O	CCONJ	O
activator	B-protein	NOUN	O
protein	I-protein	NOUN	O
1	I-protein	NUM	O
-mediated	O	ADJ	O
transcription	O	NOUN	B
by	O	ADP	O
both	O	DET	O
cell	O	NOUN	B
types	O	NOUN	I
is	O	AUX	O
similar	O	ADJ	O
.	O	PUNCT	O


Here	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
demonstrate	O	VERB	O
the	O	DET	O
testosterone	O	NOUN	B
responsiveness	O	NOUN	B
of	O	ADP	O
murine	B-cell_type	ADJ	B
splenic	I-cell_type	ADJ	B
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
in	O	X	B
vitro	O	X	I
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
unconventional	B-protein	ADJ	B
cell	I-protein	NOUN	I
surface	I-protein	NOUN	O
receptors	I-protein	NOUN	O
for	O	ADP	O
testosterone	O	NOUN	B
and	O	CCONJ	O
classical	B-protein	ADJ	O
intracellular	I-protein	ADJ	B
AR	I-protein	NOUN	B
.	O	PUNCT	O


Binding	O	NOUN	B
of	O	ADP	O
the	O	DET	O
plasma	O	NOUN	B
membrane	O	NOUN	I
impermeable	O	ADJ	B
testosterone-BSA	B-protein	NOUN	B
conjugate	I-protein	NOUN	I
induces	O	VERB	B
a	O	DET	O
rapid	O	ADJ	O
rise	O	NOUN	O
(	O	PUNCT	O
<	O	X	O
5	O	NUM	O
s	O	NOUN	O
)	O	PUNCT	O
in	O	ADP	O
[	O	PUNCT	O
Ca2+	O	NOUN	B
]	O	PUNCT	O
i	O	NOUN	O
of	O	ADP	O
Fura-2-loaded	B-cell_type	ADJ	B
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Limited	O	ADJ	B
proteolysis	O	NOUN	B
for	O	ADP	O
assaying	O	VERB	B
ligand	O	NOUN	B
binding	O	NOUN	B
affinities	O	NOUN	B
of	O	ADP	O
nuclear	B-protein	ADJ	B
receptors	I-protein	NOUN	I
.	O	PUNCT	O


Significant	O	ADJ	B
progress	O	NOUN	B
has	O	AUX	O
been	O	AUX	O
made	O	VERB	O
in	O	ADP	O
gaining	O	VERB	O
a	O	DET	O
detailed	O	ADJ	O
understanding	O	NOUN	O
of	O	ADP	O
the	O	DET	O
transcriptional	O	ADJ	B
regulation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
interleukin-4	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
.	O	PUNCT	O


Serine	O	NOUN	B
phosphorylation	O	NOUN	B
of	O	ADP	O
STAT1	B-protein	NOUN	B
and	O	CCONJ	O
STAT3	B-protein	NOUN	B
was	O	AUX	O
seen	O	VERB	O
occasionally	O	ADV	O
in	O	ADP	O
other	O	ADJ	O
leukemias	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
it	O	PRON	O
was	O	AUX	O
a	O	DET	O
universal	O	ADJ	O
finding	O	NOUN	O
only	O	ADV	O
in	O	ADP	O
CLL	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
serine	O	NOUN	B
phosphorylation	O	NOUN	B
of	O	ADP	O
these	O	DET	O
STATs	B-protein	NOUN	B
was	O	AUX	O
a	O	DET	O
continuous	O	ADJ	B
process	O	NOUN	I
,	O	PUNCT	O
as	O	ADP	O
incubation	O	NOUN	B
of	O	ADP	O
CLL	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	B
with	O	ADP	O
the	O	DET	O
kinase	B-protein	NOUN	B
inhibitor	I-protein	NOUN	I
H7	I-protein	NOUN	B
led	O	VERB	O
to	O	PART	O
the	O	DET	O
dephosphorylation	O	NOUN	B
of	O	ADP	O
these	O	DET	O
serine	O	NOUN	B
residues	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
X-inactivation	O	NOUN	B
patterns	O	NOUN	B
of	O	ADP	O
circulating	O	VERB	B
PMNCs	B-cell_type	NOUN	B
and	O	CCONJ	O
T	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
individual	O	ADJ	O
granulocyte	B-cell_line	NOUN	B
colonies	I-cell_line	NOUN	B
grown	O	VERB	O
in	O	X	B
vitro	O	X	I
from	O	ADP	O
bone	O	NOUN	B
marrow	O	NOUN	I
cells	O	NOUN	I
were	O	AUX	O
analyzed	O	VERB	B
.	O	PUNCT	O


Immunohistochemical	O	ADJ	B
evidence	O	NOUN	B
of	O	ADP	O
low	O	ADJ	B
proliferative	O	ADJ	B
activity	O	NOUN	O
and	O	CCONJ	O
virtual	O	ADJ	B
absence	O	NOUN	B
of	O	ADP	O
mutation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
p53	B-DNA	NOUN	B
tumor-suppressor	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
.	O	PUNCT	O


All	O	DET	O
of	O	ADP	O
the	O	DET	O
tumors	O	NOUN	B
exhibited	O	VERB	O
typical	O	ADJ	O
morphology	O	NOUN	B
,	O	PUNCT	O
were	O	AUX	O
limited	O	ADJ	O
to	O	PART	O
the	O	DET	O
ovary	O	NOUN	B
(	O	PUNCT	O
stage	O	NOUN	B
I	O	NUM	I
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
7	O	NUM	O
cases	O	NOUN	B
followed	O	VERB	O
a	O	DET	O
benign	O	ADJ	B
clinical	O	ADJ	B
course	O	NOUN	I
.	O	PUNCT	O


Members	O	NOUN	O
of	O	ADP	O
this	O	DET	O
family	O	NOUN	B
have	O	AUX	O
been	O	AUX	O
isolated	O	VERB	B
from	O	ADP	O
invertebrates	O	NOUN	B
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
vertebrates	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
data	O	NOUN	B
presented	O	VERB	O
below	O	ADP	O
indicate	O	VERB	O
that	O	SCONJ	O
Notch-1	B-protein	NOUN	B
expression	O	NOUN	B
provides	O	VERB	O
significant	O	ADJ	O
protection	O	NOUN	B
to	O	PART	O
T	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
from	O	ADP	O
TCR	B-protein	NOUN	B
-mediated	O	ADJ	O
apoptosis	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
CD4+	B-protein	ADJ	B
T	O	NOUN	I
cell	O	NOUN	I
proliferative	O	ADJ	B
responses	O	NOUN	O
to	O	PART	O
eight	O	NUM	O
synthetic	O	ADJ	B
peptides	O	NOUN	I
representing	O	VERB	O
amino	O	NOUN	B
acid	O	NOUN	I
sequences	O	NOUN	I
of	O	ADP	O
the	O	DET	O
VZV	B-protein	NOUN	B
IE62	I-protein	NOUN	B
protein	I-protein	NOUN	I
was	O	AUX	O
assessed	O	VERB	B
using	O	VERB	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
DC	B-cell_type	NOUN	B
from	O	ADP	O
VZV-susceptible	O	ADJ	B
donors	O	NOUN	B
.	O	PUNCT	O


Monocytes	B-cell_type	NOUN	B
were	O	AUX	O
effective	O	ADJ	B
APC	B-cell_type	NOUN	B
for	O	ADP	O
VZV	O	NOUN	B
peptides	O	NOUN	B
only	O	ADV	O
after	O	ADP	O
immunization	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
include	O	VERB	O
Fc	B-protein	NOUN	B
epsilonRII	I-protein	NOUN	I
(	O	PUNCT	O
CD23	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
15-lipoxygenase	B-protein	NOUN	B
,	O	PUNCT	O
IL-1	B-protein	NOUN	B
receptor	I-protein	NOUN	I
antagonist	I-protein	NOUN	I
(	O	PUNCT	O
IL-1ra	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
type	B-protein	NOUN	B
I	I-protein	NUM	I
and	I-protein	CCONJ	O
type	I-protein	NOUN	B
II	I-protein	NUM	I
IL-1	I-protein	NOUN	I
receptors	I-protein	NOUN	I
(	O	PUNCT	O
IL-1R	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


These	O	DET	O
findings	O	NOUN	B
demonstrate	O	VERB	O
that	O	SCONJ	O
certain	O	ADJ	O
cytokines	O	NOUN	B
,	O	PUNCT	O
including	O	VERB	O
IFN-gamma	B-protein	NOUN	B
and	O	CCONJ	O
IL-10	B-protein	NOUN	B
,	O	PUNCT	O
antagonize	O	VERB	B
the	O	DET	O
ability	O	NOUN	O
of	O	ADP	O
IL-4	B-protein	NOUN	B
and	O	CCONJ	O
IL-13	B-protein	NOUN	B
to	O	PART	O
induce	O	VERB	B
increased	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IL-1RI	O	NOUN	B
and	O	CCONJ	O
IL-1RII	B-DNA	NOUN	B
genes	I-DNA	NOUN	I
in	O	ADP	O
monocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


To	O	PART	O
explore	O	VERB	O
long-term	O	ADJ	B
regulatory	O	ADJ	B
mechanisms	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
investigated	O	VERB	B
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
on	O	ADP	O
the	O	DET	O
gene	O	NOUN	B
expression	O	NOUN	I
level	O	NOUN	B
which	O	DET	O
may	O	AUX	O
be	O	AUX	O
important	O	ADJ	O
to	O	PART	O
substitute	O	VERB	O
for	O	ADP	O
metabolized	B-protein	VERB	B
transcription	I-protein	NOUN	B
factor	I-protein	NOUN	I
proteins	I-protein	NOUN	I
after	O	ADP	O
their	O	PRON	O
activation	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
identified	O	VERB	B
a	O	DET	O
cell-type-specific	O	ADJ	B
differential	O	ADJ	O
response	O	NOUN	O
:	O	PUNCT	O
CREB	B-DNA	NOUN	B
,	I-DNA	PUNCT	O
CTF	I-DNA	NOUN	B
,	I-DNA	PUNCT	O
OTF-1	I-DNA	NOUN	B
,	I-DNA	PUNCT	O
OFT-2	I-DNA	NOUN	B
,	I-DNA	PUNCT	O
and	I-DNA	CCONJ	O
NF-kappa	I-DNA	NOUN	B
B	I-DNA	NOUN	I
genes	I-DNA	NOUN	I
were	O	AUX	O
strongly	O	ADV	O
induced	O	VERB	B
1	O	NUM	O
to	O	PART	O
4	O	NUM	O
hours	O	NOUN	B
after	O	ADP	O
influenza	O	NOUN	B
A	O	NOUN	I
virus	O	NOUN	I
infection	O	NOUN	O
in	O	ADP	O
the	O	DET	O
monocytic	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
Mono	B-cell_line	NOUN	I
Mac	I-cell_line	NOUN	I
6	I-cell_line	NUM	I
,	O	PUNCT	O
while	O	SCONJ	O
in	O	ADP	O
freshly	O	ADV	B
prepared	O	VERB	O
human	O	ADJ	B
monocytes	B-cell_type	NOUN	B
no	O	DET	B
significant	O	ADJ	I
changes	O	NOUN	B
were	O	AUX	O
detected	O	VERB	B
.	O	PUNCT	O


In	O	ADP	O
infected	O	ADJ	B
monocytes	B-cell_type	NOUN	B
,	O	PUNCT	O
which	O	DET	O
die	O	VERB	O
by	O	ADP	O
apoptosis	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
CREB	B-protein	NOUN	B
,	O	PUNCT	O
CTF	B-protein	PROPN	B
,	O	PUNCT	O
and	O	CCONJ	O
OTF-2	B-protein	NOUN	B
was	O	AUX	O
rather	O	ADV	O
suppressed	O	VERB	B
8	O	NUM	O
hours	O	NOUN	O
after	O	ADP	O
infection	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
conclusion	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
long-term	O	ADJ	B
regulation	O	NOUN	B
of	O	ADP	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
gene	O	NOUN	B
expression	O	NOUN	I
in	O	ADP	O
non-proliferating	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
seems	O	VERB	O
to	O	PART	O
be	O	AUX	O
of	O	ADP	O
minor	O	ADJ	O
importance	O	NOUN	O
after	O	ADP	O
influenza	O	NOUN	B
infection	O	NOUN	I
since	O	SCONJ	O
in	O	ADP	O
apoptosisprone	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
an	O	DET	O
immediate	O	ADJ	O
availability	O	NOUN	B
of	O	ADP	I
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
proteins	I-protein	NOUN	I
is	O	AUX	O
required	O	VERB	O
.	O	PUNCT	O


NF-kappaB	B-protein	NOUN	B
binding	O	NOUN	I
activity	O	NOUN	I
correlated	O	VERB	B
with	O	ADP	O
the	O	DET	O
degree	O	NOUN	B
of	O	ADP	O
albuminuria	O	NOUN	B
(	O	PUNCT	O
r	O	NOUN	O
=	O	ADJ	O
0.316	O	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
with	O	ADP	O
thrombomodulin	B-protein	NOUN	B
plasma	O	NOUN	I
concentrations	O	NOUN	I
(	O	PUNCT	O
r	O	NOUN	O
=	O	ADJ	O
0.33	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
indicative	O	ADJ	B
for	O	ADP	O
albuminuria	O	NOUN	B
associated	O	VERB	O
endothelial	O	ADJ	B
dysfunction	O	NOUN	I
.	O	PUNCT	O


Transcripts	O	NOUN	B
for	O	ADP	O
osteoprotegerin	B-protein	NOUN	B
ligand	I-protein	NOUN	I
(	O	PUNCT	O
OPGL	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
an	O	DET	O
osteoclast	B-protein	NOUN	B
differentiation	I-protein	NOUN	I
factor	I-protein	NOUN	I
(	O	PUNCT	O
also	O	ADV	O
known	O	VERB	O
as	O	ADP	O
RANKL	B-protein	NOUN	B
and	O	CCONJ	O
TRANCE	B-protein	NOUN	B
)	O	PUNCT	O
are	O	AUX	O
expressed	O	VERB	B
,	O	PUNCT	O
likely	O	ADV	O
by	O	ADP	O
adherent	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


At	O	ADP	O
10	O	NUM	O
to	O	PART	O
100	O	NUM	O
micromol/L	O	NOUN	O
for	O	ADP	O
>	O	NOUN	O
24	O	NUM	O
hours	O	NOUN	B
,	O	PUNCT	O
oleate	O	NOUN	B
inhibited	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
all	O	DET	O
adhesion	B-protein	NOUN	B
molecules	I-protein	NOUN	B
tested	O	VERB	B
.	O	PUNCT	O


Adhesion	O	NOUN	B
of	O	ADP	O
monocytoid	B-cell_line	ADJ	B
U937	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
to	O	PART	O
LPS-treated	O	ADJ	B
endothelial	O	ADJ	B
cells	O	NOUN	I
was	O	AUX	O
reduced	O	VERB	B
concomitantly	O	ADV	O
.	O	PUNCT	O


Oleate	O	NOUN	B
also	O	ADV	O
produced	O	VERB	O
a	O	DET	O
quantitatively	O	ADV	B
similar	O	ADJ	O
reduction	O	NOUN	B
of	O	ADP	O
VCAM-1	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
levels	O	NOUN	O
on	O	ADP	O
Northern	O	NOUN	B
blot	O	NOUN	I
analysis	O	NOUN	I
and	O	CCONJ	O
inhibited	O	VERB	B
nuclear	B-protein	ADJ	B
factor-kappaB	I-protein	NOUN	I
activation	O	NOUN	I
on	O	ADP	O
electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assays	O	NOUN	I
.	O	PUNCT	O


Moreover	O	ADV	O
,	O	PUNCT	O
IL-6	B-protein	NOUN	B
induced	O	VERB	B
macrophage-differentiation	O	NOUN	B
and	O	CCONJ	O
apoptosis	O	NOUN	B
of	O	ADP	O
1A9-M	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Whereas	O	SCONJ	O
the	O	DET	O
signal	B-protein	NOUN	B
transducer	I-protein	NOUN	I
and	I-protein	CCONJ	O
activator	I-protein	NOUN	O
of	I-protein	ADP	O
transcription	I-protein	NOUN	O
3	I-protein	NUM	O
(	O	PUNCT	O
Stat3	B-protein	NOUN	B
)	O	PUNCT	O
was	O	AUX	O
phosphorylated	O	VERB	B
and	O	CCONJ	O
activated	O	VERB	B
,	O	PUNCT	O
there	O	PRON	O
was	O	AUX	O
no	O	DET	O
effect	O	NOUN	O
on	O	ADP	O
either	O	CCONJ	O
Stat1	B-protein	NOUN	B
or	O	CCONJ	O
Stat5	B-protein	NOUN	B
.	O	PUNCT	O


Interleukin-8	B-protein	NOUN	B
(	O	PUNCT	O
IL-8	B-protein	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
chemokine	B-protein	NOUN	B
that	O	PRON	O
belongs	O	VERB	O
to	O	PART	O
the	O	DET	O
alpha-chemokine	B-protein	NOUN	B
or	O	CCONJ	O
CXC	B-protein	NOUN	B
subfamily	I-protein	NOUN	I
and	O	CCONJ	O
is	O	AUX	O
produced	O	VERB	O
by	O	ADP	O
a	O	DET	O
wide	O	ADJ	O
variety	O	NOUN	O
of	O	ADP	O
human	O	ADJ	B
cells	O	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
monocytes	B-cell_type	NOUN	B
and	O	CCONJ	O
polymorphonuclear	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
(	O	PUNCT	O
PMN	B-cell_type	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Since	O	SCONJ	O
C3a	B-protein	NOUN	B
has	O	AUX	O
been	O	AUX	O
shown	O	VERB	O
to	O	PART	O
induce	O	VERB	B
PGE2	O	NOUN	B
production	O	NOUN	B
by	O	ADP	O
monocytes	B-cell_type	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
PGE2	O	NOUN	B
has	O	AUX	O
been	O	AUX	O
shown	O	VERB	O
to	O	PART	O
influence	O	VERB	B
cytokine	O	NOUN	B
production	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
investigated	O	VERB	B
the	O	DET	O
potential	O	ADJ	O
role	O	NOUN	O
of	O	ADP	O
PGE2	O	NOUN	B
in	O	ADP	O
C3a	B-protein	NOUN	B
-mediated	O	ADJ	O
enhancement	O	NOUN	B
of	O	ADP	O
LPS-	O	NOUN	B
and	O	CCONJ	O
IL-1beta-induced	O	ADJ	B
IL-6	O	NOUN	B
production	O	NOUN	B
.	O	PUNCT	O


Indomethacin	O	NOUN	B
blocked	O	VERB	B
PGE2	O	NOUN	B
release	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
had	O	AUX	O
no	O	DET	O
influence	O	NOUN	B
on	O	ADP	O
the	O	DET	O
observed	O	VERB	O
effects	O	NOUN	B
of	O	ADP	I
C3a	B-protein	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	I
C3a	B-protein	NOUN	B
on	O	ADP	O
IL-6	B-protein	NOUN	B
production	O	NOUN	B
are	O	AUX	O
independent	O	ADJ	B
of	O	ADP	O
PGE2	O	NOUN	B
formation	O	NOUN	B
by	O	ADP	O
monocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
demonstrate	O	VERB	O
the	O	DET	O
capacity	O	NOUN	B
of	O	ADP	O
intact	O	ADJ	B
C3a	B-protein	NOUN	B
and	O	CCONJ	O
its	O	PRON	O
circulating	O	VERB	B
des-Arg	B-protein	ADJ	B
form	I-protein	NOUN	O
to	O	PART	O
exert	O	VERB	O
immunmodulatory	O	ADJ	B
effects	O	NOUN	I
in	O	X	B
vitro	O	X	I
.	O	PUNCT	O


Phenylarsine	O	NOUN	B
oxide	O	NOUN	I
inhibits	O	VERB	B
ex	O	X	B
vivo	O	X	I
HIV-1	O	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


Since	O	SCONJ	O
human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
type	O	NOUN	I
1	O	NUM	I
(	O	PUNCT	O
HIV-1	O	NOUN	B
)	O	PUNCT	O
replication	O	NOUN	B
is	O	AUX	O
known	O	VERB	O
to	O	PART	O
be	O	AUX	O
favored	O	VERB	O
under	O	ADP	O
oxidative	O	ADJ	B
stress	O	NOUN	I
conditions	O	NOUN	I
,	O	PUNCT	O
ex	O	X	B
vivo	O	X	I
experiments	O	NOUN	B
using	O	VERB	O
uninfected	O	ADJ	B
PBMCs	B-cell_type	NOUN	B
,	O	PUNCT	O
primary	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
or	O	CCONJ	O
a	O	DET	O
latently	O	ADV	B
infected	O	ADJ	I
promonocytic	B-cell_line	ADJ	B
U1	I-cell_line	NOUN	I
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
show	O	VERB	O
that	O	SCONJ	O
HIV-1	O	NOUN	B
replication	O	NOUN	B
and	O	CCONJ	O
reactivation	O	NOUN	B
,	O	PUNCT	O
monitored	O	VERB	O
by	O	ADP	O
p24	B-protein	NOUN	B
antigen	I-protein	NOUN	I
measurement	O	NOUN	B
,	O	PUNCT	O
are	O	AUX	O
inhibited	O	VERB	B
by	O	ADP	O
PAO	O	NOUN	B
in	O	ADP	O
a	O	DET	O
time-	O	NOUN	O
and	O	CCONJ	O
concentration-dependent	O	ADJ	B
manner	O	NOUN	O
.	O	PUNCT	O


Recently	O	ADV	O
,	O	PUNCT	O
fibromyalgia	O	NOUN	B
(	O	PUNCT	O
FMS	O	NOUN	B
)	O	PUNCT	O
was	O	AUX	O
shown	O	VERB	O
to	O	PART	O
be	O	AUX	O
a	O	DET	O
disorder	O	NOUN	B
associated	O	VERB	B
with	O	ADP	I
an	O	DET	O
altered	O	ADJ	O
functioning	O	NOUN	B
of	O	ADP	O
the	O	DET	O
stress	O	NOUN	B
response	O	NOUN	I
system	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
suggested	O	VERB	O
that	O	SCONJ	O
negative	O	ADJ	B
feedback	O	NOUN	B
of	O	ADP	O
cortisol	O	NOUN	B
could	O	AUX	O
be	O	AUX	O
deranged	O	VERB	B
.	O	PUNCT	O


Urinary	O	ADJ	B
free	O	ADJ	I
cortisol	O	NOUN	I
excretion	O	NOUN	B
in	O	ADP	O
FMS	O	NOUN	B
and	O	CCONJ	O
LBP	O	NOUN	B
patients	O	NOUN	B
was	O	AUX	O
lower	O	ADJ	O
compared	O	VERB	B
to	O	PART	O
controls	O	NOUN	B
.	O	PUNCT	O


Only	O	ADV	O
FMS	O	NOUN	B
patients	O	NOUN	B
displayed	O	VERB	O
lower	O	ADJ	O
CBG	O	NOUN	B
and	O	CCONJ	O
basal	O	ADJ	B
serum	O	NOUN	I
cortisol	O	NOUN	B
concentrations	O	NOUN	I
when	O	SCONJ	O
compared	O	VERB	B
to	O	PART	O
controls	O	NOUN	B
.	O	PUNCT	O


There	O	PRON	O
was	O	AUX	O
no	O	DET	O
difference	O	NOUN	O
in	O	ADP	O
the	O	DET	O
number	O	NOUN	O
of	O	ADP	O
GR	B-protein	NOUN	B
per	O	ADP	O
cell	O	NOUN	O
among	O	ADP	O
the	O	DET	O
three	O	NUM	O
groups	O	NOUN	B
(	O	PUNCT	O
FMS	O	NOUN	B
:	O	PUNCT	O
6498	O	NUM	O
+/-	O	CCONJ	O
252	O	NUM	O
,	O	PUNCT	O
LBP	O	NOUN	B
:	O	PUNCT	O
6625	O	NUM	O
+/-	O	CCONJ	O
284	O	NUM	O
,	O	PUNCT	O
controls	O	NOUN	B
:	O	PUNCT	O
6576	O	NUM	O
+/-	O	CCONJ	O
304	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
but	O	CCONJ	O
the	O	DET	O
dissociation	O	NOUN	B
constant	O	NOUN	I
(	O	PUNCT	O
Kd	O	NOUN	O
)	O	PUNCT	O
of	O	ADP	O
the	O	DET	O
FMS	O	NOUN	B
(	O	PUNCT	O
14.5	O	NUM	O
+/-	O	CCONJ	O
0.9	O	NUM	O
nmol/l	O	NOUN	O
)	O	PUNCT	O
and	O	CCONJ	O
LBP	O	NOUN	B
(	O	PUNCT	O
14.7	O	NUM	O
+/-	O	CCONJ	O
1.3	O	NUM	O
nmol/l	O	NOUN	O
)	O	PUNCT	O
subjects	O	NOUN	B
was	O	AUX	O
significantly	O	ADV	O
higher	O	ADJ	O
than	O	ADP	O
that	O	DET	O
of	O	ADP	O
the	O	DET	O
controls	O	NOUN	B
(	O	PUNCT	O
10.9	O	NUM	O
+/-	O	CCONJ	O
0.8	O	NUM	O
nmol/l	O	NOUN	O
)	O	PUNCT	O
(	O	PUNCT	O
p	O	NOUN	O
<	O	X	O
.05	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
actual	O	ADJ	O
binding	O	NOUN	B
of	O	ADP	O
these	O	DET	O
peptides	O	NOUN	B
was	O	AUX	O
analysed	O	VERB	B
in	O	ADP	O
a	O	DET	O
stabilization	O	NOUN	B
assay	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
stability	O	NOUN	B
of	O	ADP	O
already	O	ADV	O
formed	O	VERB	O
complexed	O	NOUN	B
was	O	AUX	O
somewhat	O	ADV	O
different	O	ADJ	O
in	O	ADP	O
the	O	DET	O
HLA-A3	B-protein	NOUN	B
and	O	CCONJ	O
HLA-Cw*0702	B-protein	NOUN	B
system	O	NOUN	I
:	O	PUNCT	O
both	O	DET	O
were	O	AUX	O
more	O	ADV	O
stable	O	ADJ	B
at	O	ADP	O
26	O	NUM	O
degrees	O	NOUN	B
C	O	NOUN	O
than	O	ADP	O
at	O	ADP	O
37	O	NUM	O
degrees	O	NOUN	B
C	O	NOUN	I
but	O	CCONJ	O
while	O	SCONJ	O
the	O	DET	O
beta	B-protein	NOUN	B
2-m	I-protein	NOUN	I
and	O	CCONJ	O
FCS	O	NOUN	B
did	O	AUX	O
not	O	PART	O
influence	O	VERB	B
the	O	DET	O
stability	O	NOUN	B
of	O	ADP	O
the	O	DET	O
HLA-A3/peptide	B-protein	NOUN	B
complex	I-protein	NOUN	I
,	O	PUNCT	O
they	O	PRON	O
seemed	O	VERB	O
to	O	PART	O
cause	O	VERB	O
opposite	O	ADJ	O
effects	O	NOUN	B
in	O	ADP	O
the	O	DET	O
HLA-Cw*0702	B-protein	NOUN	B
system	O	NOUN	I
(	O	PUNCT	O
beta	B-protein	NOUN	B
2-m	I-protein	NOUN	I
stabilized	O	VERB	B
and	O	CCONJ	O
FCS	O	NOUN	B
destabilized	O	VERB	B
the	O	DET	O
complex	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Further	O	ADJ	O
optimization	O	NOUN	B
of	O	ADP	O
culture	O	NOUN	B
conditions	O	NOUN	I
,	O	PUNCT	O
type	O	NOUN	O
of	O	ADP	O
Antigen	B-cell_type	NOUN	B
Presenting	I-cell_type	NOUN	I
Cells	I-cell_type	NOUN	I
(	O	PUNCT	O
APC	B-cell_type	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
peptides	O	NOUN	B
,	O	PUNCT	O
use	O	NOUN	O
of	O	ADP	O
stabilizers	O	NOUN	B
like	O	ADP	O
beta	B-protein	NOUN	B
2-m	I-protein	NOUN	I
are	O	AUX	O
still	O	ADV	O
needed	O	VERB	O
.	O	PUNCT	O


Phosphatidylinositol	B-protein	NOUN	B
3-kinase	I-protein	NOUN	I
couples	O	VERB	B
the	O	DET	O
interleukin-2	B-protein	NOUN	B
receptor	I-protein	NOUN	I
to	O	PART	O
the	O	DET	O
cell	B-protein	NOUN	B
cycle	I-protein	NOUN	I
regulator	I-protein	NOUN	I
E2F	B-protein	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
eliminate	O	VERB	O
both	O	CCONJ	O
Stat5	B-protein	NOUN	B
and	O	CCONJ	O
Raf	B-protein	NOUN	B
/MEK	B-protein	NOUN	I
pathways	O	NOUN	I
from	O	ADP	O
E2F	B-protein	NOUN	B
regulation	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
Epstein-Barr	O	ADJ	B
virus	O	NOUN	I
latent	B-protein	ADJ	B
membrane	I-protein	NOUN	I
protein	I-protein	NOUN	I
1	I-protein	NUM	I
(	O	PUNCT	O
LMP1	B-protein	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
essential	O	ADJ	O
for	O	ADP	O
the	O	DET	O
transformation	O	NOUN	B
of	O	ADP	O
B	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
into	O	ADP	O
lymphoblastoid	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
transfection	O	NOUN	B
assays	O	NOUN	I
,	O	PUNCT	O
TRADD	B-protein	NOUN	B
and	O	CCONJ	O
TES2	B-protein	NOUN	B
synergistically	O	ADV	B
mediated	O	VERB	O
high-level	O	ADJ	O
NF-kappaB	B-protein	NOUN	B
activation	O	NOUN	I
.	O	PUNCT	O


Inhibition	O	NOUN	B
of	O	ADP	O
T	B-cell_type	NOUN	B
cell	I-cell_type	NOUN	I
and	O	CCONJ	O
promotion	O	NOUN	B
of	O	ADP	O
natural	O	ADJ	B
killer	O	NOUN	I
cell	O	NOUN	I
development	O	NOUN	B
by	O	ADP	O
the	O	DET	O
dominant	B-protein	ADJ	B
negative	I-protein	ADJ	B
helix	I-protein	NOUN	O
loop	I-protein	NOUN	O
helix	I-protein	NOUN	O
factor	I-protein	NOUN	O
Id3	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
mechanisms	O	NOUN	B
controlling	O	VERB	O
this	O	DET	O
developmental	O	ADJ	B
choice	O	NOUN	O
are	O	AUX	O
unknown	O	ADJ	O
.	O	PUNCT	O


The	O	DET	O
natural	O	ADJ	B
dominant	B-protein	ADJ	I
negative	I-protein	ADJ	I
HLH	I-protein	ADJ	B
factor	I-protein	NOUN	I
Id3	B-protein	NOUN	B
,	O	PUNCT	O
which	O	DET	O
blocks	O	VERB	B
transcriptional	O	ADJ	B
activity	O	NOUN	I
of	O	ADP	O
a	O	DET	O
number	O	NOUN	O
of	O	ADP	O
known	O	VERB	O
bHLH	B-protein	ADJ	B
factors	I-protein	NOUN	I
,	O	PUNCT	O
was	O	AUX	O
expressed	O	VERB	B
in	O	ADP	O
CD34+	B-cell_type	ADJ	B
progenitor	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
by	O	ADP	O
retrovirus-mediated	O	ADJ	B
gene	O	NOUN	I
transfer	O	NOUN	I
.	O	PUNCT	O


NB4	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
pulse-exposed	O	ADJ	B
(	O	PUNCT	O
30	O	NUM	O
minutes	O	NOUN	B
)	O	PUNCT	O
to	O	PART	O
all-trans	O	ADJ	B
retinoic	O	ADJ	I
acid	O	NOUN	I
(	O	PUNCT	O
ATRA	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
washed	O	VERB	B
,	O	PUNCT	O
and	O	CCONJ	O
cultured	O	VERB	B
(	O	PUNCT	O
3	O	NUM	O
days	O	NOUN	B
)	O	PUNCT	O
with	O	ADP	O
either	O	CCONJ	O
dimethylsulfoxide	O	NOUN	B
(	O	PUNCT	O
DMSO	O	NOUN	B
)	O	PUNCT	O
or	O	CCONJ	O
hexamethylene	O	NOUN	B
bisacetamide	O	NOUN	I
(	O	PUNCT	O
HMBA	O	NOUN	B
)	O	PUNCT	O
had	O	AUX	O
a	O	DET	O
prominent	O	ADJ	O
increase	O	NOUN	B
in	O	ADP	O
levels	O	NOUN	B
of	O	ADP	O
C/EBP	B-RNA	NOUN	B
epsilon	I-RNA	NOUN	I
mRNA	I-RNA	NOUN	B
and	O	CCONJ	O
an	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
granulocytic	O	ADJ	B
differentiation	O	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
exposure	O	NOUN	B
to	O	PART	I
either	O	CCONJ	O
DMSO	O	NOUN	B
or	O	CCONJ	O
HMBA	O	NOUN	B
alone	O	ADV	O
had	O	AUX	O
no	O	DET	B
effect	O	NOUN	I
on	O	ADP	O
base	O	NOUN	B
levels	O	NOUN	I
of	O	ADP	O
C/EBP	O	NOUN	B
epsilon	O	NOUN	I
and	O	CCONJ	O
did	O	AUX	O
not	O	PART	O
induce	O	VERB	B
differentiation	O	NOUN	B
.	O	PUNCT	O


ATRA	O	NOUN	B
also	O	ADV	O
induced	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
C/EBP	B-protein	NOUN	B
epsilon	I-protein	NOUN	I
protein	I-protein	NOUN	I
in	O	ADP	O
NB4	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
as	O	ADP	O
shown	O	VERB	O
by	O	ADP	O
Western	O	NOUN	B
blotting	O	NOUN	I
.	O	PUNCT	O


Dual	O	ADJ	B
effects	O	NOUN	I
of	O	ADP	O
LPS	B-protein	NOUN	B
antibodies	I-protein	NOUN	B
on	O	ADP	O
cellular	O	ADJ	B
uptake	O	NOUN	I
of	O	ADP	O
LPS	O	NOUN	B
and	O	CCONJ	O
LPS-induced	O	ADJ	B
proinflammatory	O	ADJ	B
functions	O	NOUN	I
.	O	PUNCT	O


Ab-associated	O	ADJ	B
changes	O	NOUN	B
in	O	ADP	O
the	O	DET	O
uptake	O	NOUN	B
and	O	CCONJ	O
cellular	O	ADJ	B
distribution	O	NOUN	I
of	O	ADP	O
FITC-LPS	O	NOUN	B
were	O	AUX	O
assessed	O	VERB	B
by	O	ADP	O
flow	O	NOUN	B
cytometry	O	NOUN	I
and	O	CCONJ	O
laser	O	NOUN	B
scanning	O	NOUN	I
confocal	O	ADJ	I
microscopy	O	NOUN	I
in	O	ADP	O
human	B-cell_line	ADJ	B
CD14-transfected	I-cell_line	ADJ	B
Chinese	I-cell_line	ADJ	I
hamster	I-cell_line	NOUN	O
ovary	I-cell_line	NOUN	O
fibroblasts	I-cell_line	NOUN	O
(	O	PUNCT	O
CHO-CD14	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
)	O	PUNCT	O
and	O	CCONJ	O
human	B-cell_type	ADJ	B
peripheral	I-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
monocytes	I-cell_type	NOUN	O
.	O	PUNCT	O


LPS-specific	B-protein	ADJ	B
Abs	I-protein	NOUN	B
thus	O	ADV	O
mediate	O	VERB	O
anti-inflammatory	O	ADJ	B
and	O	CCONJ	O
proinflammatory	O	ADJ	B
functions	O	NOUN	I
,	O	PUNCT	O
respectively	O	ADV	O
,	O	PUNCT	O
by	O	ADP	O
preventing	O	VERB	B
target	O	NOUN	B
cell	O	NOUN	O
uptake	O	NOUN	O
of	O	ADP	O
LPS	O	NOUN	B
through	O	ADP	O
mCD14	B-protein	NOUN	B
and	O	CCONJ	O
augmenting	O	VERB	B
uptake	O	NOUN	B
through	O	ADP	O
CR1	B-protein	NOUN	B
or	O	CCONJ	O
other	O	ADJ	O
cell	B-protein	NOUN	B
receptors	I-protein	NOUN	I
.	O	PUNCT	O


Activator	B-protein	NOUN	B
protein	I-protein	NOUN	I
(	I-protein	PUNCT	O
AP	I-protein	NOUN	B
)	I-protein	PUNCT	O
-1	I-protein	NUM	O
family	I-protein	NOUN	B
proteins	I-protein	NOUN	I
interacted	O	VERB	O
with	O	ADP	O
CLE0	B-DNA	NOUN	B
,	O	PUNCT	O
P	O	NOUN	O
,	O	PUNCT	O
P2	B-DNA	NOUN	B
and	O	CCONJ	O
P4	B-DNA	NOUN	B
.	O	PUNCT	O


The	O	DET	O
described	O	VERB	O
conditions	O	NOUN	B
which	O	DET	O
inhibited	O	VERB	B
or	O	CCONJ	O
prevented	O	VERB	B
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IL-1RI-associated	B-protein	ADJ	B
kinase	I-protein	NOUN	I
similarly	O	ADV	O
impaired	O	VERB	B
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
in	O	ADP	O
EL4	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Involvement	O	NOUN	B
of	O	ADP	O
different	O	ADJ	O
transduction	O	NOUN	B
pathways	O	NOUN	O
in	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activation	O	NOUN	B
by	O	ADP	O
several	O	ADJ	O
inducers	B-DNA	NOUN	B
.	O	PUNCT	O


Double-stimulation	O	NOUN	B
was	O	AUX	O
used	O	VERB	O
to	O	PART	O
demonstrate	O	VERB	O
that	O	SCONJ	O
,	O	PUNCT	O
in	O	ADP	O
a	O	DET	O
T	B-cell_line	NOUN	B
lymphocytic	I-cell_line	ADJ	I
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
(	O	PUNCT	O
CEM	B-cell_line	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
phorbol	O	NOUN	B
myristate	O	NOUN	I
acetate	O	NOUN	I
(	O	PUNCT	O
PMA	O	NOUN	B
)	O	PUNCT	O
rapidly	O	ADV	O
induced	O	VERB	B
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
through	O	ADP	O
a	O	DET	O
signaling	O	NOUN	B
pathway	O	NOUN	I
which	O	DET	O
did	O	AUX	O
not	O	PART	O
involve	O	VERB	O
reactive	O	ADJ	B
oxygen	O	NOUN	I
species	O	NOUN	I
(	O	PUNCT	O
ROS	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
was	O	AUX	O
different	O	ADJ	O
from	O	ADP	O
the	O	DET	O
activation	O	NOUN	B
triggered	O	VERB	B
by	O	ADP	I
either	O	CCONJ	O
H2O2	O	NOUN	B
or	O	CCONJ	O
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor-alpha	I-protein	NOUN	I
(	O	PUNCT	O
TNF-alpha	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


In	O	ADP	O
UCSD-AML1	B-cell_line	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
also	O	ADV	O
identified	O	VERB	O
fusion	B-RNA	NOUN	B
transcripts	I-RNA	NOUN	O
between	O	ADP	O
the	O	DET	O
ecotropic	B-DNA	ADJ	B
viral	I-DNA	ADJ	O
insertion	I-DNA	NOUN	O
site	I-DNA	NOUN	O
I	I-DNA	NUM	O
(	I-DNA	PUNCT	O
EVI1	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
gene	I-DNA	NOUN	B
in	O	ADP	O
3q26	B-DNA	NOUN	B
and	O	CCONJ	O
GR6	B-DNA	NOUN	B
and	O	CCONJ	O
between	O	ADP	O
EVI1	B-DNA	NOUN	B
and	O	CCONJ	O
Ribophorin	B-DNA	NOUN	B
I	I-DNA	NUM	I
that	O	PRON	O
maps	O	VERB	B
30	O	NUM	O
kb	O	NOUN	O
telomeric	O	ADJ	O
to	O	PART	O
GR6	B-DNA	NOUN	B
in	O	ADP	O
3q21	B-DNA	NOUN	B
.	O	PUNCT	O


The	O	DET	O
v-myb	B-DNA	NOUN	B
oncogene	I-DNA	NOUN	I
,	O	PUNCT	O
carried	O	VERB	O
by	O	ADP	O
avian	O	ADJ	B
defective	O	ADJ	B
retroviruses	O	NOUN	O
,	O	PUNCT	O
causes	O	VERB	O
leukaemias	O	NOUN	B
in	O	ADP	O
the	O	DET	O
chicken	O	NOUN	B
and	O	CCONJ	O
transforms	O	VERB	O
haematopoietic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
in	O	X	B
vitro	O	X	I
.	O	PUNCT	O


The	O	DET	O
third	O	ADJ	O
member	O	NOUN	B
of	O	ADP	O
the	O	DET	O
family	B-protein	NOUN	B
,	O	PUNCT	O
A-myb	B-protein	NOUN	B
,	O	PUNCT	O
shows	O	VERB	O
the	O	DET	O
most	O	ADV	O
restricted	O	ADJ	B
pattern	O	NOUN	B
of	O	ADP	O
expression	O	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
a	O	DET	O
very	O	ADV	O
specific	O	ADJ	O
role	O	NOUN	O
for	O	ADP	O
this	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
.	O	PUNCT	O


It	O	PRON	O
was	O	AUX	O
recently	O	ADV	O
shown	O	VERB	O
by	O	ADP	O
us	O	PRON	O
that	O	SCONJ	O
the	O	DET	O
protein	O	NOUN	B
is	O	AUX	O
located	O	ADJ	O
in	O	ADP	O
germinal	B-cell_type	ADJ	B
center	I-cell_type	NOUN	I
B	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
their	O	PRON	O
neoplastic	B-cell_type	ADJ	B
counterparts	I-cell_type	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
present	O	ADJ	O
study	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
bcl-6	B-protein	NOUN	B
protein	I-protein	NOUN	I
on	O	ADP	O
normal	O	ADJ	B
epidermis	O	NOUN	I
,	O	PUNCT	O
benign	O	ADJ	B
,	O	PUNCT	O
and	O	CCONJ	O
malignant	O	ADJ	B
tumors	O	NOUN	I
originating	O	VERB	O
from	O	ADP	O
epidermal	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
squamous	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
carcinoma	I-cell_line	NOUN	I
(	I-cell_line	PUNCT	O
SCC	I-cell_line	NOUN	B
)	I-cell_line	PUNCT	O
cell	I-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
are	O	AUX	O
investigated	O	VERB	B
.	O	PUNCT	O


Papillomas	O	NOUN	B
and	O	CCONJ	O
keratoacanthomas	O	NOUN	B
copied	O	VERB	O
their	O	PRON	O
normal	O	ADJ	O
counterparts	O	NOUN	O
in	O	ADP	O
the	O	DET	O
mode	O	NOUN	B
of	O	ADP	O
expression	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
previous	O	ADJ	O
experiments	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
-70	B-DNA	NUM	O
to	I-DNA	PART	O
-65	I-DNA	NUM	O
and	I-DNA	CCONJ	O
-121	I-DNA	NUM	O
to	I-DNA	PART	O
-103	I-DNA	NUM	O
regions	I-DNA	NOUN	B
of	O	ADP	O
the	O	DET	O
CD11c	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
and	O	CCONJ	O
the	O	DET	O
-66	B-DNA	NUM	O
to	I-DNA	PART	O
-59	I-DNA	NUM	O
region	I-DNA	NOUN	O
of	O	ADP	O
the	O	DET	O
CD11b	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
were	O	AUX	O
shown	O	VERB	O
to	O	PART	O
be	O	AUX	O
essential	O	ADJ	B
for	O	ADP	O
Sp1-	B-protein	ADJ	B
mediated	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
these	O	DET	O
genes	O	NOUN	B
.	O	PUNCT	O


Cotransfection	O	NOUN	B
of	O	ADP	O
Sp3	B-protein	NOUN	B
along	O	ADP	O
with	O	ADP	O
CD11c	B-DNA	NOUN	B
promoter-luciferase	I-DNA	ADJ	B
constructs	I-DNA	NOUN	O
into	O	ADP	O
Sp-deficient	B-cell_line	ADJ	B
Drosophila	I-cell_line	X	B
Schneider	I-cell_line	NOUN	B
2	I-cell_line	NUM	I
cells	I-cell_line	NOUN	I
showed	O	VERB	O
that	O	SCONJ	O
Sp3	B-protein	NOUN	B
could	O	AUX	O
activate	O	VERB	B
the	O	DET	O
CD11c	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
.	O	PUNCT	O


Deletion	O	NOUN	B
of	O	ADP	O
both	O	CCONJ	O
the	O	DET	O
-70	B-DNA	NUM	O
to	I-DNA	PART	O
-65	I-DNA	NUM	O
and	I-DNA	CCONJ	O
-121	I-DNA	NUM	O
to	I-DNA	PART	O
-103	I-DNA	NUM	O
regions	I-DNA	NOUN	B
of	O	ADP	O
the	O	DET	O
CD11c	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
resulted	O	VERB	O
in	O	ADP	O
the	O	DET	O
loss	O	NOUN	B
of	O	ADP	O
activation	O	NOUN	B
by	O	ADP	O
Sp3	B-protein	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
recently	O	ADV	O
identified	O	VERB	B
the	O	DET	O
winged-helix	B-protein	ADJ	B
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
Trident	B-protein	PROPN	I
and	O	CCONJ	O
described	O	VERB	O
its	O	PRON	O
expression	O	NOUN	B
pattern	O	NOUN	I
in	O	ADP	O
synchronized	B-cell_type	ADJ	B
fibroblasts	I-cell_type	NOUN	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
additional	O	ADJ	O
factor	O	NOUN	B
(	O	PUNCT	O
s	O	NOUN	O
)	O	PUNCT	O
are	O	AUX	O
necessary	O	ADJ	O
for	O	ADP	O
full	O	ADJ	O
ER	B-protein	NOUN	B
function	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
functions	O	NOUN	B
of	O	ADP	O
basic	B-protein	ADJ	O
helix-loop-helix	I-protein	ADJ	O
(	I-protein	PUNCT	O
bHLH	I-protein	ADJ	O
)	I-protein	PUNCT	O
transcription	I-protein	NOUN	B
factors	I-protein	NOUN	I
in	O	ADP	O
activating	O	VERB	B
differentiation-linked	O	ADJ	B
gene	O	NOUN	B
expression	O	NOUN	I
and	O	CCONJ	O
in	O	ADP	O
inducing	O	VERB	B
G1	O	NOUN	B
cell	O	NOUN	I
cycle	O	NOUN	I
arrest	O	NOUN	I
are	O	AUX	O
negatively	O	ADV	O
regulated	O	VERB	O
by	O	ADP	O
members	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Id	B-protein	NOUN	B
family	I-protein	NOUN	I
of	I-protein	ADP	O
HLH	I-protein	ADJ	B
proteins	I-protein	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
mouse	O	NOUN	B
embryo	O	NOUN	I
,	O	PUNCT	O
mNFATc	B-RNA	NOUN	B
transcript	I-RNA	NOUN	B
was	O	AUX	O
strongly	O	ADV	O
expressed	O	VERB	B
in	O	ADP	O
thymus	O	NOUN	B
,	O	PUNCT	O
lung	O	NOUN	B
and	O	CCONJ	O
submandibular	O	ADJ	B
gland	O	NOUN	I
and	O	CCONJ	O
weakly	O	ADV	O
in	O	ADP	O
skeletal	O	ADJ	B
muscle	O	NOUN	I
and	O	CCONJ	O
heart	O	NOUN	B
suggesting	O	VERB	O
that	O	SCONJ	O
mNFATc	B-protein	NOUN	B
may	O	AUX	O
have	O	AUX	O
a	O	DET	O
role	O	NOUN	O
both	O	CCONJ	O
in	O	ADP	O
embryogenesis	O	NOUN	B
and	O	CCONJ	O
in	O	ADP	O
mature	B-cell_type	ADJ	B
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


TNFalpha	B-protein	NOUN	B
cooperates	O	VERB	B
with	O	ADP	O
the	O	DET	O
protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
A	I-protein	NOUN	I
pathway	O	NOUN	B
to	O	PART	O
synergistically	O	ADV	B
increase	O	VERB	B
HIV-1	B-DNA	NOUN	B
LTR	I-DNA	NOUN	B
transcription	O	NOUN	B
via	O	ADP	O
downstream	O	ADJ	B
TRE-like	B-DNA	ADJ	B
cAMP	I-DNA	NOUN	I
response	I-DNA	NOUN	I
elements	I-DNA	NOUN	I
.	O	PUNCT	O


These	O	DET	O
downstream	B-DNA	ADJ	B
sequence	I-DNA	NOUN	I
elements	I-DNA	NOUN	I
,	O	PUNCT	O
termed	O	VERB	O
DSE	B-DNA	NOUN	B
,	O	PUNCT	O
can	O	AUX	O
bind	O	VERB	B
both	O	CCONJ	O
AP-1	B-protein	NOUN	B
and	O	CCONJ	O
CREB/ATF	B-protein	NOUN	B
transcription	B-protein	NOUN	I
factors	I-protein	NOUN	I
.	O	PUNCT	O


Recently	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
demonstrated	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
DSE	B-DNA	NOUN	B
are	O	AUX	O
also	O	ADV	O
cAMP-responsive	B-DNA	ADJ	B
elements	I-DNA	NOUN	I
(	O	PUNCT	O
CRE	B-DNA	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
since	O	SCONJ	O
they	O	PRON	O
mediated	O	VERB	O
activation	O	NOUN	B
signals	O	NOUN	B
elicited	O	VERB	O
by	O	ADP	O
cholera	B-protein	NOUN	B
toxin	I-protein	NOUN	I
(	O	PUNCT	O
Ctx	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
a	O	DET	O
potent	O	ADJ	O
activator	O	NOUN	B
of	O	ADP	O
the	O	DET	O
cAMP-dependent	O	ADJ	B
protein	B-protein	NOUN	I
kinase	I-protein	NOUN	I
A	I-protein	NOUN	I
(	O	PUNCT	O
PKA	B-protein	NOUN	B
)	O	PUNCT	O
signal	O	NOUN	B
transduction	O	NOUN	I
pathway	O	NOUN	O
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
are	O	AUX	O
consistent	O	ADJ	B
with	O	ADP	I
EBNA3C	B-protein	NOUN	B
contributing	O	VERB	O
to	O	PART	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
EBNA	B-protein	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
latently	B-cell_type	ADV	B
infected	I-cell_type	ADJ	I
B	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
through	O	ADP	O
CBF1/RBP-Jkappa	B-protein	NOUN	B
and	O	CCONJ	O
another	O	DET	O
factor	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
this	O	DET	O
need	O	AUX	O
not	O	PART	O
directly	O	ADV	O
involve	O	VERB	O
EBNA2	B-protein	NOUN	B
.	O	PUNCT	O


Finally	O	ADV	O
,	O	PUNCT	O
although	O	SCONJ	O
it	O	PRON	O
has	O	AUX	O
been	O	AUX	O
reported	O	VERB	O
that	O	SCONJ	O
EBNA3C	B-protein	NOUN	B
can	O	AUX	O
upregulate	O	VERB	B
CD21	B-protein	NOUN	B
in	O	ADP	O
some	O	DET	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
were	O	AUX	O
unable	O	ADJ	O
to	O	PART	O
demonstrate	O	VERB	O
any	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
EBNA3C	B-protein	NOUN	B
on	O	ADP	O
reporter	B-DNA	NOUN	B
plasmids	I-DNA	NOUN	I
which	O	DET	O
contain	O	VERB	O
the	O	DET	O
CD21	B-DNA	NOUN	B
promoter	I-DNA	NOUN	I
.	O	PUNCT	O


Relationship	O	NOUN	B
between	O	ADP	O
glucocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
and	O	CCONJ	O
response	O	NOUN	B
to	O	PART	O
glucocorticoid	O	NOUN	B
therapy	O	NOUN	I
in	O	ADP	O
ulcerative	O	ADJ	B
colitis	O	NOUN	I
.	O	PUNCT	O


IgE	B-DNA	NOUN	B
germline	I-DNA	NOUN	B
promoter	I-DNA	NOUN	B
reporter	I-DNA	NOUN	I
gene	I-DNA	NOUN	O
constructs	I-DNA	NOUN	O
carrying	O	VERB	O
point	O	NOUN	O
mutations	O	NOUN	O
in	O	ADP	O
the	O	DET	O
NF	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B2	I-protein	NOUN	I
site	O	NOUN	O
were	O	AUX	O
largely	O	ADV	O
unresponsive	O	ADJ	O
to	O	PART	O
IL-4	B-protein	NOUN	B
stimulation	O	NOUN	B
in	O	ADP	O
transient	O	ADJ	B
transfection	O	NOUN	O
experiments	O	NOUN	O
,	O	PUNCT	O
while	O	SCONJ	O
plasmids	O	NOUN	B
with	O	ADP	O
similar	O	ADJ	O
mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
NF	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B1	I-protein	NOUN	I
site	O	NOUN	B
responded	O	VERB	O
to	O	PART	O
cytokine	B-protein	NOUN	B
stimulation	O	NOUN	I
better	O	ADV	O
than	O	ADP	O
the	O	DET	O
wild-type	B-DNA	ADJ	B
promoter	I-DNA	NOUN	O
.	O	PUNCT	O


Considering	O	VERB	O
that	O	SCONJ	O
nuclear	B-protein	ADJ	B
regulatory	I-protein	ADJ	I
factor-kappa	I-protein	NOUN	I
beta	I-protein	NOUN	I
(	B-protein	PUNCT	I
NF-kappa	I-protein	NOUN	B
B	I-protein	NOUN	I
)	I-protein	PUNCT	O
/Rel	I-protein	NOUN	B
is	O	AUX	O
a	O	DET	O
common	O	ADJ	O
regulatory	B-protein	ADJ	B
element	I-protein	NOUN	I
of	O	ADP	O
the	O	DET	O
promoter	B-DNA	NOUN	B
region	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
inflammatory	B-DNA	ADJ	B
cytokine	I-DNA	NOUN	O
genes	I-DNA	NOUN	O
,	O	PUNCT	O
herein	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
tested	O	VERB	B
the	O	DET	O
hypothesis	O	NOUN	B
that	O	SCONJ	O
acute	O	ADJ	B
ethanol	O	NOUN	B
affects	O	VERB	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activation	O	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


Adherence-isolated	B-cell_line	ADJ	B
monocytes	I-cell_line	NOUN	I
showed	O	VERB	O
constitutive	O	ADJ	B
DNA	O	NOUN	B
binding	O	NOUN	I
activity	O	NOUN	I
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
.	O	PUNCT	O


Tolerant	O	ADJ	B
cells	O	NOUN	I
still	O	ADV	O
express	O	VERB	O
the	O	DET	O
CD14	B-protein	NOUN	B
receptor	I-protein	NOUN	I
and	O	CCONJ	O
they	O	PRON	O
can	O	AUX	O
still	O	ADV	O
be	O	AUX	O
activated	O	VERB	B
to	O	PART	O
mobilize	O	VERB	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
into	O	ADP	O
nucleus	O	NOUN	B
.	O	PUNCT	O


Cyclosporin	O	NOUN	B
A	O	NOUN	I
(	O	PUNCT	O
CsA	O	NOUN	B
)	O	PUNCT	O
may	O	AUX	O
achieve	O	VERB	O
its	O	PRON	O
immunosuppressive	O	ADJ	B
effects	O	NOUN	I
by	O	ADP	O
inhibiting	O	VERB	B
the	O	DET	O
calcium-	B-protein	NOUN	B
and	I-protein	CCONJ	O
calmodulin-dependent	I-protein	ADJ	B
phosphatase	I-protein	NOUN	I
calcineurin	B-protein	NOUN	I
which	O	DET	O
is	O	AUX	O
required	O	VERB	O
for	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
target	B-DNA	NOUN	B
genes	I-DNA	NOUN	I
by	O	ADP	O
members	O	NOUN	B
of	O	ADP	O
the	O	DET	O
NFAT	B-protein	NOUN	B
(	I-protein	PUNCT	O
nuclear	I-protein	ADJ	B
factor	I-protein	NOUN	I
of	I-protein	ADP	O
activated	I-protein	VERB	B
T	I-protein	NOUN	O
cells	I-protein	NOUN	O
)	I-protein	PUNCT	O
transcription	I-protein	NOUN	O
factor	I-protein	NOUN	O
family	I-protein	NOUN	O
.	O	PUNCT	O


Among	O	ADP	O
these	O	DET	O
target	B-DNA	NOUN	B
genes	I-DNA	NOUN	I
is	O	AUX	O
the	O	DET	O
gene	O	NOUN	B
encoding	O	VERB	O
interleukin-2	B-protein	NOUN	B
(	O	PUNCT	O
IL2	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
a	O	DET	O
cytokine	B-protein	NOUN	B
facilitating	O	VERB	O
progression	O	NOUN	B
through	O	ADP	O
the	O	DET	O
G1	O	NOUN	B
phase	O	NOUN	I
of	O	ADP	O
the	O	DET	O
cell	O	NOUN	B
cycle	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
cells	O	NOUN	B
that	O	PRON	O
have	O	AUX	O
been	O	AUX	O
preincubated	O	VERB	B
to	O	PART	O
lower	O	VERB	O
mRNA	O	NOUN	B
levels	O	NOUN	O
,	O	PUNCT	O
there	O	PRON	O
is	O	AUX	O
a	O	DET	O
transient	O	ADJ	B
increase	O	NOUN	B
in	O	ADP	O
G0S2	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
,	O	PUNCT	O
peaking	O	VERB	O
between	O	ADP	O
1-2	O	NUM	O
h	O	NOUN	O
,	O	PUNCT	O
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
Concanavalin-A	O	NOUN	B
(	O	PUNCT	O
ConA	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
or	O	CCONJ	O
to	O	PART	O
the	O	DET	O
combination	O	NOUN	B
of	O	ADP	O
phorbol	O	NOUN	B
ester	O	NOUN	I
(	O	PUNCT	O
TPA	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
calcium	O	NOUN	B
ionophore	O	NOUN	I
,	O	PUNCT	O
ionomycin	O	NOUN	B
.	O	PUNCT	O


To	O	PART	O
further	O	ADV	O
clarify	O	VERB	O
the	O	DET	O
complex	O	ADJ	B
transcriptional	O	ADJ	B
regulation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
GM-CSF	I-DNA	NOUN	B
gene	I-DNA	NOUN	O
,	O	PUNCT	O
which	O	DET	O
was	O	AUX	O
extensively	O	ADV	O
investigated	O	VERB	B
in	O	ADP	O
activated	B-cell_type	VERB	B
T	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
studied	O	VERB	O
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
an	O	DET	O
upstream	O	ADJ	B
NF-kappaB	B-DNA	NOUN	I
like	I-DNA	ADP	O
site	I-DNA	NOUN	B
in	O	ADP	O
the	O	DET	O
5637	B-cell_line	NOUN	O
non-lymphoid	I-cell_line	ADJ	O
cell	I-cell_line	NOUN	O
line	I-cell_line	NOUN	O
,	O	PUNCT	O
which	O	DET	O
derives	O	VERB	O
from	O	ADP	O
a	O	DET	O
bladder	O	NOUN	B
carcinoma	O	NOUN	I
and	O	CCONJ	O
constitutively	O	ADV	B
produces	O	VERB	O
GM-CSF	B-protein	NOUN	B
.	O	PUNCT	O


Repression	O	NOUN	B
of	O	ADP	O
human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
type	O	NOUN	I
1	O	NUM	I
through	O	ADP	O
the	O	DET	O
novel	O	ADJ	B
cooperation	O	NOUN	B
of	O	ADP	O
human	B-protein	ADJ	B
factors	I-protein	NOUN	O
YY1	B-protein	NOUN	B
and	O	CCONJ	O
LSF	B-protein	NOUN	B
[	O	PUNCT	O
published	O	VERB	O
erratum	O	NOUN	O
appears	O	VERB	O
in	O	ADP	O
J	O	PROPN	O
Virol	O	PROPN	O
1998	O	NUM	O
Feb	O	PROPN	O
;	O	PUNCT	O
72	O	NUM	O
(	O	PUNCT	O
2	O	NUM	O
)	O	PUNCT	O
:	O	PUNCT	O
1709	O	NUM	O
]	O	PUNCT	O


Few	O	ADJ	O
host	O	NOUN	B
factors	O	NOUN	I
that	O	PRON	O
directly	O	ADV	O
limit	O	VERB	O
HIV-1	O	NOUN	B
transcription	O	NOUN	B
and	O	CCONJ	O
could	O	AUX	O
support	O	VERB	O
this	O	DET	O
state	O	NOUN	O
of	O	ADP	O
nonproductive	O	ADJ	O
HIV-1	O	NOUN	B
infection	O	NOUN	O
have	O	AUX	O
been	O	AUX	O
described	O	VERB	O
.	O	PUNCT	O


This	O	DET	O
cooperative	O	ADJ	B
function	O	NOUN	I
may	O	AUX	O
account	O	VERB	O
for	O	ADP	O
the	O	DET	O
divergent	O	ADJ	B
effects	O	NOUN	B
of	O	ADP	O
LSF	B-protein	NOUN	B
previously	O	ADV	O
observed	O	VERB	O
in	O	X	B
vitro	O	X	I
and	O	CCONJ	O
in	O	X	B
vivo	O	X	I
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
report	O	VERB	O
a	O	DET	O
real-time	O	ADJ	B
study	O	NOUN	I
of	O	ADP	O
factor/DNA	O	NOUN	B
interactions	O	NOUN	O
using	O	VERB	O
a	O	DET	O
surface	O	NOUN	B
plasmon	O	NOUN	I
resonance	O	NOUN	I
approach	O	NOUN	I
and	O	CCONJ	O
further	O	ADJ	O
characterization	O	NOUN	B
of	O	ADP	O
recovered	B-protein	ADJ	B
proteins	I-protein	NOUN	I
involved	O	VERB	O
in	O	ADP	O
this	O	DET	O
interaction	O	NOUN	B
.	O	PUNCT	O


Finally	O	ADV	O
,	O	PUNCT	O
recovered	O	ADJ	O
protein	O	NOUN	B
was	O	AUX	O
identified	O	VERB	O
as	O	ADP	O
genuine	O	ADJ	O
huGATA-3	B-protein	NOUN	B
by	O	ADP	O
SDS-PAGE	O	NOUN	B
,	O	PUNCT	O
Western	O	NOUN	B
blotting	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
bandshift	O	NOUN	B
assays	O	NOUN	I
.	O	PUNCT	O


Recruitment	O	NOUN	B
and	O	CCONJ	O
extravasation	O	NOUN	B
of	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
through	O	ADP	O
the	O	DET	O
blood-brain	O	ADJ	B
barrier	O	NOUN	I
are	O	AUX	O
favored	O	VERB	O
by	O	ADP	O
adhesion	B-protein	NOUN	B
molecule	I-protein	NOUN	I
-mediated	O	ADJ	O
interactions	O	NOUN	B
of	O	ADP	O
circulating	B-cell_type	VERB	B
T	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
with	O	ADP	O
endothelial	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
also	O	ADV	O
found	O	VERB	O
that	O	SCONJ	O
Vpr	B-protein	NOUN	B
modulates	O	VERB	B
T-cell	O	NOUN	B
receptor	O	NOUN	I
(	O	PUNCT	O
TCR	B-protein	NOUN	B
)	O	PUNCT	O
-triggered	O	ADJ	O
apoptosis	O	NOUN	B
in	O	ADP	O
a	O	DET	O
manner	O	NOUN	O
similar	O	ADJ	O
to	O	PART	O
that	O	DET	O
of	O	ADP	O
glucocorticoids	O	NOUN	B
.	O	PUNCT	O


Tissue	O	NOUN	B
transglutaminase-dependent	O	ADJ	B
posttranslational	O	ADJ	B
modification	O	NOUN	I
of	O	ADP	O
the	O	DET	O
retinoblastoma	B-protein	NOUN	B
gene	I-protein	NOUN	I
product	I-protein	NOUN	O
in	O	ADP	O
promonocytic	B-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
undergoing	O	VERB	O
apoptosis	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
shift	O	NOUN	B
in	O	ADP	O
pRB	B-protein	NOUN	B
molecular	O	ADJ	B
weight	O	NOUN	I
was	O	AUX	O
reproduced	O	VERB	O
by	O	ADP	O
adding	O	VERB	O
exogenous	O	ADJ	B
purified	O	VERB	B
tTG	O	NOUN	B
to	O	PART	O
extracts	O	NOUN	B
obtained	O	VERB	O
from	O	ADP	O
viable	O	ADJ	O
U937	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
and	O	CCONJ	O
was	O	AUX	O
prevented	O	VERB	B
by	O	ADP	O
dansylcadaverine	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
potent	O	ADJ	O
enzyme	O	NOUN	B
inhibitor	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
phosphorylation	O	NOUN	B
of	O	ADP	O
STAT	B-protein	NOUN	B
proteins	I-protein	NOUN	I
on	O	ADP	O
serine	O	NOUN	B
residues	O	NOUN	I
is	O	AUX	O
also	O	ADV	O
required	O	VERB	O
for	O	ADP	O
competent	O	ADJ	B
STAT	B-protein	NOUN	B
transcription	O	NOUN	I
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	B
show	O	VERB	O
that	O	SCONJ	O
phosphorylation	O	NOUN	B
of	O	ADP	O
STAT3alpha	B-protein	NOUN	B
on	O	ADP	O
serine	O	NOUN	B
727	O	NUM	I
is	O	AUX	O
not	O	PART	O
constitutive	O	ADJ	B
in	O	ADP	O
quiescent	B-cell_type	ADJ	B
T	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
but	O	CCONJ	O
can	O	AUX	O
be	O	AUX	O
induced	O	VERB	B
by	O	ADP	O
the	O	DET	O
cytokine	B-protein	NOUN	B
IL-2	I-protein	NOUN	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
thus	O	ADV	O
show	O	VERB	O
that	O	SCONJ	O
STAT3	B-protein	NOUN	B
proteins	I-protein	NOUN	B
are	O	AUX	O
targets	O	NOUN	B
for	O	ADP	O
multiple	O	ADJ	B
kinase	O	NOUN	O
pathways	O	NOUN	O
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
can	O	AUX	O
integrate	O	VERB	O
signals	O	NOUN	B
from	O	ADP	O
both	O	CCONJ	O
cytokine	B-protein	NOUN	B
receptors	I-protein	NOUN	I
and	O	CCONJ	O
antigen	B-protein	NOUN	B
receptors	I-protein	NOUN	I
.	O	PUNCT	O


NF-kappa	B-protein	NOUN	B
B/Rel	I-protein	NOUN	B
family	I-protein	NOUN	B
members	I-protein	NOUN	I
regulating	O	VERB	B
the	O	DET	O
ICAM-1	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
in	O	ADP	O
monocytic	B-cell_line	ADJ	B
THP-1	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


The	O	DET	O
second	O	ADJ	O
complex	O	NOUN	B
contained	O	VERB	O
RelA	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
exhibited	O	VERB	O
higher	O	ADJ	B
affinity	O	NOUN	B
towards	O	ADP	O
the	O	DET	O
ICAM-1	B-DNA	NOUN	B
kappa	I-DNA	NOUN	I
B	I-DNA	NOUN	I
than	O	ADP	O
to	O	PART	O
the	O	DET	O
HIV	B-DNA	NOUN	B
kappa	I-DNA	NOUN	I
B	I-DNA	NOUN	I
site	I-DNA	NOUN	I
.	O	PUNCT	O


The	O	DET	O
distinct	O	ADJ	O
N-terminal	B-protein	ADJ	B
half	I-protein	NOUN	O
of	O	ADP	O
MZF-2	B-protein	NOUN	B
carries	O	VERB	O
two	O	NUM	O
characteristic	O	ADJ	O
domains	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
leucine-rich	B-protein	ADJ	B
domain	I-protein	NOUN	I
called	O	VERB	O
LeR	B-protein	NOUN	B
and	O	CCONJ	O
an	O	DET	O
acidic	B-protein	ADJ	B
domain	I-protein	NOUN	I
,	O	PUNCT	O
which	O	DET	O
suggests	O	VERB	O
a	O	DET	O
unique	O	ADJ	O
function	O	NOUN	B
of	O	ADP	O
MZF-2	B-protein	NOUN	B
in	O	ADP	O
neutrophil	O	NOUN	B
development	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
calculated	O	VERB	B
binding	O	NOUN	B
affinity	O	NOUN	B
(	O	PUNCT	O
Kd	O	NOUN	O
;	O	PUNCT	O
nmol/L	O	NOUN	O
)	O	PUNCT	O
and	O	CCONJ	O
capacity	O	NOUN	B
(	O	PUNCT	O
Bmax	O	NOUN	B
;	O	PUNCT	O
sites/cell	O	NOUN	O
)	O	PUNCT	O
for	O	ADP	O
dexamethasone	O	NOUN	B
and	O	CCONJ	O
cortisol	O	NOUN	B
from	O	ADP	O
homologous	O	ADJ	B
and	O	CCONJ	O
heterologous	O	ADJ	B
competition	O	NOUN	B
curves	O	NOUN	I
for	O	ADP	O
specific	O	ADJ	O
[	O	PUNCT	O
3H	O	NOUN	B
]	O	PUNCT	O
dexamethasone	O	NOUN	B
binding	O	NOUN	B
sites	O	NOUN	I
on	O	ADP	O
HML	B-cell_type	NOUN	B
isolated	O	VERB	B
from	O	ADP	O
the	O	DET	O
blood	O	NOUN	B
of	O	ADP	O
normotensive	O	ADJ	B
volunteers	O	NOUN	B
and	O	CCONJ	O
subjects	O	NOUN	B
with	O	ADP	O
essential	O	ADJ	B
hypertension	O	NOUN	I
.	O	PUNCT	O


Kd	O	NOUN	B
values	O	NOUN	I
(	O	PUNCT	O
mean+/-SE	O	NOUN	O
)	O	PUNCT	O
for	O	ADP	O
cortisol	O	NOUN	B
in	O	ADP	O
HML	B-cell_type	NOUN	B
of	O	ADP	O
hypertensive	O	ADJ	B
patients	O	NOUN	B
were	O	AUX	O
higher	O	ADJ	O
than	O	ADP	O
in	O	ADP	O
control	O	ADJ	B
subjects	O	NOUN	I
(	O	PUNCT	O
24.6+/-2.4	O	NUM	O
versus	O	CCONJ	O
17.5+/-1.7	O	NUM	O
nmol/L	O	NOUN	O
,	O	PUNCT	O
P	O	NOUN	O
<	O	X	O
.04	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Binding	O	NOUN	B
capacity	O	NOUN	O
(	O	PUNCT	O
4978+/-391	O	ADJ	O
versus	O	CCONJ	O
4131+/-321	O	NUM	O
sites/cell	O	NOUN	O
)	O	PUNCT	O
,	O	PUNCT	O
Kd	O	NOUN	B
values	O	NOUN	I
for	O	ADP	O
dexamethasone	O	NOUN	B
(	O	PUNCT	O
6.7+/-0.5	O	NUM	O
versus	O	CCONJ	O
5.7+/-0.3	O	NUM	O
nmol/L	O	NOUN	O
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
IC50	O	NOUN	B
values	O	NOUN	B
for	O	ADP	O
dexamethasone	O	NOUN	B
(	O	PUNCT	O
3.4+/-0.3	O	NUM	O
versus	O	CCONJ	O
3.1+/-0.2	O	NUM	O
nmol/L	O	NOUN	O
)	O	PUNCT	O
and	O	CCONJ	O
cortisol	O	NOUN	B
(	O	PUNCT	O
12.2+/-1.6	O	NUM	O
versus	O	CCONJ	O
9.5+/-0.3	O	NUM	O
nmol/L	O	NOUN	O
)	O	PUNCT	O
were	O	AUX	O
not	O	PART	O
significantly	O	ADV	O
different	O	ADJ	O
.	O	PUNCT	O


Both	O	CCONJ	O
Kd	O	NOUN	B
(	O	PUNCT	O
30.3+/-2.5	O	NUM	O
versus	O	CCONJ	O
19.2+/-2.4	O	NUM	O
nmol/L	O	NOUN	O
)	O	PUNCT	O
and	O	CCONJ	O
IC50	O	NOUN	B
values	O	NOUN	B
(	O	PUNCT	O
15.5+/-1.8	O	NUM	O
versus	O	CCONJ	O
8.9+/-1.2	O	NUM	O
nmol/L	O	NOUN	O
)	O	PUNCT	O
for	O	ADP	O
cortisol	O	NOUN	B
were	O	AUX	O
significantly	O	ADV	O
higher	O	ADJ	O
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
lower	O	ADJ	O
renin	B-protein	NOUN	B
values	O	NOUN	B
(	O	PUNCT	O
P	O	NOUN	O
<	O	X	O
.03	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Other	O	ADJ	O
variables	O	NOUN	B
,	O	PUNCT	O
including	O	VERB	O
plasma	O	NOUN	B
hormone	O	NOUN	I
and	O	CCONJ	O
electrolyte	O	NOUN	B
values	O	NOUN	I
and	O	CCONJ	O
binding	O	NOUN	B
characteristics	O	NOUN	B
for	O	ADP	O
dexamethasone	O	NOUN	B
,	O	PUNCT	O
were	O	AUX	O
not	O	PART	O
different	O	ADJ	O
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
cortisol	O	NOUN	B
binding	O	NOUN	I
to	O	PART	O
glucocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
is	O	AUX	O
slightly	O	ADV	O
impaired	O	ADJ	B
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
essential	O	ADJ	B
hypertension	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
-45	B-DNA	NUM	O
site	I-DNA	NOUN	B
is	O	AUX	O
an	O	DET	O
E	B-DNA	NOUN	B
box	I-DNA	NOUN	I
that	O	PRON	O
binds	O	VERB	B
basic	B-protein	ADJ	O
helix-loop-helix-zipper	I-protein	ADJ	B
proteins	I-protein	NOUN	I
whereas	O	SCONJ	O
the	O	DET	O
-160	B-DNA	NUM	O
site	I-DNA	NOUN	B
is	O	AUX	O
a	O	DET	O
composite	B-DNA	ADJ	B
PU.1	I-DNA	NOUN	B
and	I-DNA	CCONJ	O
Pip	I-DNA	NOUN	B
binding	I-DNA	NOUN	I
site	I-DNA	NOUN	I
.	O	PUNCT	O


Ten	O	NUM	O
HIV-infected	O	ADJ	B
patients	O	NOUN	B
with	O	ADP	O
normal	O	ADJ	B
receptor	O	NOUN	I
affinity	O	NOUN	B
to	O	PART	O
glucocorticoids	O	NOUN	B
(	O	PUNCT	O
AIDS-C	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
10	O	NUM	O
HIV-infected	O	ADJ	B
patients	O	NOUN	B
with	O	ADP	O
low	O	ADJ	B
receptor	O	NOUN	I
affinity	O	NOUN	B
to	O	PART	O
glucocorticoids	O	NOUN	B
(	O	PUNCT	O
AIDS-GR	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
20	O	NUM	O
healthy	O	ADJ	B
subjects	O	NOUN	I
were	O	AUX	O
studied	O	VERB	O
.	O	PUNCT	O


Monochloramine	O	NOUN	B
derivatives	O	NOUN	O
are	O	AUX	O
long	O	ADV	O
lived	O	VERB	O
physiological	O	ADJ	B
oxidants	O	NOUN	B
produced	O	VERB	O
by	O	ADP	O
neutrophils	B-cell_type	NOUN	B
during	O	ADP	O
the	O	DET	O
respiratory	O	ADJ	B
burst	O	NOUN	I
.	O	PUNCT	O


Neutrophils	O	NOUN	B
pretreated	O	VERB	B
with	O	ADP	O
NH2Cl	O	NOUN	B
(	O	PUNCT	O
30-50	O	NUM	O
microM	O	NOUN	O
)	O	PUNCT	O
showed	O	VERB	O
a	O	DET	O
marked	O	ADJ	O
decrease	O	NOUN	B
in	O	ADP	O
the	O	DET	O
respiratory	O	ADJ	B
burst	O	NOUN	I
activity	O	NOUN	I
induced	O	VERB	B
by	O	ADP	O
phorbol	O	NOUN	B
12-myristate	O	NOUN	I
13-acetate	O	NOUN	I
(	O	PUNCT	O
PMA	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
a	O	DET	O
potent	O	ADJ	O
PKC	B-protein	NOUN	B
activator	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
NH2Cl-treated	B-cell_line	ADJ	B
neutrophils	I-cell_line	NOUN	I
showed	O	VERB	O
a	O	DET	O
decrease	O	NOUN	B
in	O	ADP	O
both	O	CCONJ	O
PKC	B-protein	NOUN	B
activity	O	NOUN	B
and	O	CCONJ	O
PMA-induced	O	ADJ	B
phosphorylation	O	NOUN	B
of	O	ADP	O
a	O	DET	O
47-kDa	B-protein	ADJ	B
protein	I-protein	NOUN	I
,	O	PUNCT	O
which	O	DET	O
corresponds	O	VERB	O
to	O	PART	O
the	O	DET	O
cytosolic	B-protein	ADJ	B
factor	I-protein	NOUN	I
of	O	ADP	O
NADPH	B-protein	NOUN	B
oxidase	I-protein	NOUN	I
,	O	PUNCT	O
p47	B-protein	NOUN	B
(	I-protein	PUNCT	O
phox	I-protein	NOUN	B
)	I-protein	PUNCT	O
.	O	PUNCT	O


This	O	DET	O
was	O	AUX	O
also	O	ADV	O
accompanied	O	VERB	O
by	O	ADP	O
a	O	DET	O
decrease	O	NOUN	B
in	O	ADP	O
both	O	CCONJ	O
PKC	B-protein	NOUN	B
activity	O	NOUN	B
and	O	CCONJ	O
nuclear	O	ADJ	B
transcription	O	NOUN	I
factor-	O	NOUN	I
kappaB	B-protein	NOUN	I
activation	O	NOUN	I
,	O	PUNCT	O
also	O	ADV	O
without	O	ADP	O
loss	O	NOUN	B
of	O	ADP	O
cell	O	NOUN	B
viability	O	NOUN	I
.	O	PUNCT	O


Evidence	O	NOUN	B
that	O	SCONJ	O
calcineurin	O	NOUN	B
is	O	AUX	O
rate-limiting	O	ADJ	O
for	O	ADP	O
primary	O	ADJ	B
human	O	ADJ	B
lymphocyte	O	NOUN	O
activation	O	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
clinical	O	ADJ	B
use	O	NOUN	I
,	O	PUNCT	O
CsA	O	NOUN	B
treatment	O	NOUN	B
inhibits	O	VERB	B
50-75	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
CN	B-protein	NOUN	B
activity	O	NOUN	I
in	O	ADP	O
circulating	B-cell_type	VERB	B
leukocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
in	O	ADP	O
E29.1	B-cell_line	NOUN	B
T	I-cell_line	NOUN	I
cell	I-cell_line	NOUN	I
hybridoma	I-cell_line	NOUN	I
I	B-protein	NOUN	I
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
alpha	I-protein	NOUN	I
and	O	CCONJ	O
I	B-protein	NOUN	O
kappa	I-protein	NOUN	O
B	I-protein	NOUN	O
beta	I-protein	NOUN	O
are	O	AUX	O
equally	O	ADV	O
associated	O	VERB	B
with	O	ADP	I
p65	B-protein	NOUN	B
and	O	CCONJ	O
that	O	SCONJ	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
beta	I-protein	NOUN	I
is	O	AUX	O
degraded	O	VERB	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
TNF	B-protein	NOUN	B
alpha	I-protein	NOUN	I
in	O	ADP	O
contrast	O	NOUN	O
to	O	PART	O
what	O	PRON	O
has	O	AUX	O
been	O	AUX	O
originally	O	ADV	O
published	O	VERB	B
.	O	PUNCT	O


Our	O	PRON	O
data	O	NOUN	B
also	O	ADV	O
suggest	O	VERB	O
that	O	SCONJ	O
,	O	PUNCT	O
unlike	O	ADP	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
alpha	I-protein	NOUN	I
,	O	PUNCT	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
beta	I-protein	NOUN	I
is	O	AUX	O
constitutively	O	ADV	B
phosphorylated	O	VERB	B
and	O	CCONJ	O
resynthesized	O	VERB	B
as	O	ADP	O
a	O	DET	O
hypophosphorylated	B-protein	ADJ	B
form	I-protein	NOUN	O
.	O	PUNCT	O


The	O	DET	O
molecule	O	NOUN	B
bound	O	VERB	O
CD40	B-protein	NOUN	B
with	O	ADP	O
a	O	DET	O
high	O	ADJ	O
affinity	O	NOUN	B
(	O	PUNCT	O
2.2	O	NUM	O
nM	O	NOUN	O
)	O	PUNCT	O
and	O	CCONJ	O
was	O	AUX	O
a	O	DET	O
monomer	O	NOUN	B
in	O	ADP	O
solution	O	NOUN	B
.	O	PUNCT	O


Basal	O	ADJ	B
activity	O	NOUN	I
of	O	ADP	O
a	O	DET	O
3070	B-DNA	NUM	O
bp	I-DNA	NOUN	O
CRH	I-DNA	NOUN	B
promoter	I-DNA	NOUN	B
fragment	I-DNA	NOUN	I
was	O	AUX	O
only	O	ADV	O
seen	O	VERB	O
in	O	ADP	O
neuronal	O	ADJ	B
and	O	CCONJ	O
lymphoblastoid	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
.	O	PUNCT	O


A	O	DET	O
similar	O	ADJ	O
spectrum	O	NOUN	B
of	O	ADP	O
transcript	O	NOUN	B
deletions	O	NOUN	B
has	O	AUX	O
previously	O	ADV	O
been	O	AUX	O
described	O	VERB	O
in	O	ADP	O
the	O	DET	O
putative	B-DNA	ADJ	B
tumour	I-DNA	NOUN	I
suppressor	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
FHIT	B-DNA	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
transcripts	O	NOUN	B
from	O	ADP	O
TSG101	B-DNA	NOUN	B
,	O	PUNCT	O
FHIT	B-DNA	NOUN	B
and	O	CCONJ	O
seven	O	NUM	O
other	O	ADJ	O
genes	O	NOUN	B
were	O	AUX	O
analysed	O	VERB	B
in	O	ADP	O
RNA	O	NOUN	B
isolated	O	VERB	B
from	O	ADP	O
normal	B-cell_type	ADJ	O
peripheral	I-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
lymphocytes	I-cell_type	NOUN	I
.	O	PUNCT	O


Our	O	PRON	O
findings	O	NOUN	B
demonstrate	O	VERB	O
that	O	SCONJ	O
truncated	B-RNA	VERB	B
TSG101	I-RNA	NOUN	B
and	I-RNA	CCONJ	O
FHIT	I-RNA	NOUN	B
transcripts	I-RNA	NOUN	B
are	O	AUX	O
commonly	O	ADV	O
detected	O	VERB	B
in	O	ADP	O
both	O	CCONJ	O
normal	O	ADJ	B
and	O	CCONJ	O
malignant	O	ADJ	B
tissues	O	NOUN	I
and	O	CCONJ	O
that	O	SCONJ	O
a	O	DET	O
significant	O	ADJ	O
fraction	O	NOUN	B
of	O	ADP	O
these	O	DET	O
are	O	AUX	O
likely	O	ADJ	O
to	O	PART	O
be	O	AUX	O
the	O	DET	O
result	O	NOUN	O
of	O	ADP	O
aberrant	O	ADJ	B
splicing	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
study	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
observed	O	VERB	O
that	O	SCONJ	O
curcumin	O	NOUN	B
(	O	PUNCT	O
50	O	NUM	O
microM	O	NOUN	O
)	O	PUNCT	O
inhibited	O	VERB	B
proliferation	O	NOUN	B
of	O	ADP	O
rat	B-cell_type	NOUN	B
thymocytes	I-cell_type	NOUN	B
stimulated	O	VERB	B
with	O	ADP	O
concanavalin	O	NOUN	B
A	O	NOUN	I
(	O	PUNCT	O
Con	O	NOUN	B
A	O	NOUN	I
)	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
that	O	DET	O
of	O	ADP	O
human	B-cell_type	ADJ	B
Jurkat	I-cell_type	NOUN	O
lymphoblastoid	I-cell_type	ADJ	O
cells	I-cell_type	NOUN	O
in	O	ADP	O
the	O	DET	O
logarithmic	O	ADJ	B
growth	O	NOUN	I
phase	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
pigment	O	NOUN	B
also	O	ADV	O
inhibited	O	VERB	B
apoptosis	O	NOUN	B
in	O	ADP	O
dexamethasone-treated	B-cell_line	ADJ	B
rat	I-cell_line	NOUN	B
thymocytes	I-cell_line	NOUN	B
and	O	CCONJ	O
in	O	ADP	O
UV-irradiated	B-cell_line	ADJ	B
Jurkat	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
as	O	ADP	O
judged	O	VERB	O
by	O	ADP	O
DNA	O	NOUN	B
ladder	O	NOUN	I
formation	O	NOUN	I
,	O	PUNCT	O
cellular	O	ADJ	B
morphological	O	ADJ	B
changes	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
flow	O	NOUN	B
cytometry	O	NOUN	I
analysis	O	NOUN	I
.	O	PUNCT	O


T-cell	B-protein	NOUN	B
receptor	I-protein	NOUN	I
(	B-protein	PUNCT	O
TCR	I-protein	NOUN	B
)	I-protein	PUNCT	O
/CD3	I-protein	NOUN	O
engagement	O	NOUN	B
results	O	VERB	B
in	O	ADP	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
nuclear	O	ADJ	B
factor	O	NOUN	I
of	O	ADP	O
activated	B-cell_type	VERB	B
T	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
(	O	PUNCT	O
NFAT	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
activator	B-protein	NOUN	B
protein-1	I-protein	NOUN	I
(	O	PUNCT	O
AP-1	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
kappaB	I-protein	NOUN	I
(	O	PUNCT	O
NFkappaB	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
whereas	O	SCONJ	O
the	O	DET	O
CD28	B-protein	NOUN	B
responsive	I-protein	ADJ	I
complex	I-protein	NOUN	I
(	O	PUNCT	O
CD28RC	B-protein	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
activated	O	VERB	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
the	O	DET	O
CD28	B-protein	NOUN	B
signal	O	NOUN	B
.	O	PUNCT	O


Finally	O	ADV	O
,	O	PUNCT	O
a	O	DET	O
110-kDa	B-protein	ADJ	O
protein	I-protein	NOUN	B
has	O	AUX	O
been	O	AUX	O
identified	O	VERB	B
in	O	ADP	O
the	O	DET	O
nuclei	O	NOUN	B
of	O	ADP	O
all	O	DET	O
the	O	DET	O
B	B-cell_line	NOUN	B
,	I-cell_line	PUNCT	O
but	I-cell_line	CCONJ	O
not	I-cell_line	PART	O
T	I-cell_line	NOUN	B
,	I-cell_line	PUNCT	O
cell	I-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
that	O	PRON	O
specifically	O	ADV	O
binds	O	VERB	B
to	O	PART	O
this	O	DET	O
A-MYB	B-protein	NOUN	B
N-terminal	I-protein	ADJ	B
domain	I-protein	NOUN	I
.	O	PUNCT	O


Most	O	ADV	O
interestingly	O	ADV	O
,	O	PUNCT	O
expression	O	NOUN	B
of	O	ADP	O
CD95	B-protein	NOUN	B
(	O	PUNCT	O
Fas/Apo-1	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
of	O	ADP	O
CD23	B-protein	NOUN	B
was	O	AUX	O
down-regulated	O	VERB	B
in	O	ADP	O
all	O	DET	O
K46	B-cell_line	NOUN	B
transfectants	I-cell_line	NOUN	B
.	O	PUNCT	O


As	O	ADP	O
a	O	DET	O
consequence	O	NOUN	B
,	O	PUNCT	O
they	O	PRON	O
became	O	VERB	O
resistant	O	ADJ	B
to	O	PART	O
apoptosis	O	NOUN	B
induced	O	VERB	B
by	O	ADP	O
anti-CD95	B-protein	ADJ	B
Ab	I-protein	NOUN	I
treatment	O	NOUN	B
.	O	PUNCT	O


Similarly	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
Egr-1-expressing	B-cell_line	ADJ	B
Ramos	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
showed	O	VERB	O
reduced	O	VERB	B
levels	O	NOUN	B
of	O	ADP	O
CD95	B-protein	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


TCR	B-protein	NOUN	B
-contact	O	ADJ	O
site	O	NOUN	B
heterogeneity	O	NOUN	B
was	O	AUX	O
excluded	O	VERB	O
as	O	ADP	O
the	O	DET	O
selective	O	ADJ	O
force	O	NOUN	O
in	O	ADP	O
diversity	O	NOUN	B
generation	O	NOUN	B
since	O	SCONJ	O
the	O	DET	O
epitope-encoded	O	ADJ	B
sequences	O	NOUN	I
were	O	AUX	O
found	O	VERB	O
to	O	PART	O
be	O	AUX	O
identical	O	ADJ	B
within	O	ADP	O
endogenous	O	ADJ	B
virus	O	NOUN	B
isolates	O	NOUN	B
.	O	PUNCT	O


Collectively	O	ADV	O
,	O	PUNCT	O
these	O	DET	O
findings	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
A/R	O	NOUN	B
elicits	O	VERB	O
a	O	DET	O
two-phase	O	ADJ	O
neutrophil-endothelial	O	ADJ	O
cell	O	NOUN	O
adhesion	O	NOUN	O
response	O	NOUN	B
that	O	PRON	O
involves	O	VERB	O
transcription-independent	O	ADJ	B
and	O	CCONJ	O
transcription-dependent	O	ADJ	B
surface	O	NOUN	O
expression	O	NOUN	B
of	O	ADP	O
different	O	ADJ	O
endothelial	B-protein	ADJ	B
cell	I-protein	NOUN	I
adhesion	I-protein	NOUN	O
molecules	I-protein	NOUN	O
.	O	PUNCT	O


CD40	B-protein	NOUN	B
ligation	O	NOUN	B
leads	O	VERB	O
to	O	PART	O
B	O	NOUN	B
cell	O	NOUN	I
activation	O	NOUN	O
events	O	NOUN	O
such	O	ADJ	O
as	O	ADP	O
proliferation	O	NOUN	B
,	O	PUNCT	O
Ig	O	NOUN	B
secretion	O	NOUN	I
,	O	PUNCT	O
isotype	O	NOUN	B
switching	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
up-regulation	O	NOUN	B
of	O	ADP	O
cell	B-protein	NOUN	B
surface	I-protein	NOUN	I
molecules	I-protein	NOUN	I
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
the	O	DET	O
generation	O	NOUN	B
of	O	ADP	O
memory	B-cell_type	NOUN	B
B	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activation	O	NOUN	B
was	O	AUX	O
insufficient	O	ADJ	B
for	O	ADP	O
CD40	B-protein	NOUN	B
-mediated	O	ADJ	O
up-regulation	O	NOUN	B
of	O	ADP	O
B7-1	B-protein	NOUN	B
,	O	PUNCT	O
Fas	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
CD23	B-protein	NOUN	B
.	O	PUNCT	O


CD30	B-protein	NOUN	B
,	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
has	O	AUX	O
also	O	ADV	O
been	O	AUX	O
implicated	O	VERB	O
in	O	ADP	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
apoptotic	O	ADJ	B
cell	O	NOUN	I
death	O	NOUN	O
of	O	ADP	O
lymphocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


Consistent	O	ADJ	B
with	O	ADP	I
this	O	DET	O
hypothesis	O	NOUN	B
,	O	PUNCT	O
expression	O	NOUN	B
of	O	ADP	O
a	O	DET	O
dominant-negative	B-protein	ADJ	B
form	I-protein	NOUN	I
of	O	ADP	O
TRAF2	B-protein	NOUN	B
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
potentiate	O	VERB	O
TNFR1	B-protein	NOUN	B
-mediated	O	ADJ	O
death	O	NOUN	B
.	O	PUNCT	O


By	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
monocyte-macrophage	B-protein	ADJ	B
colony	I-protein	NOUN	O
stimulating	I-protein	NOUN	O
factor	I-protein	NOUN	O
(	I-protein	PUNCT	O
M-CSF	I-protein	NOUN	B
)	I-protein	PUNCT	O
receptor	I-protein	NOUN	O
was	O	AUX	O
largely	O	ADV	O
absent	O	ADJ	B
at	O	ADP	O
this	O	DET	O
stage	O	NOUN	B
and	O	CCONJ	O
in	O	ADP	O
the	O	DET	O
CD34+Thy-1-CD45RA-	B-cell_line	ADJ	B
subsets	I-cell_line	NOUN	I
.	O	PUNCT	O


Addition	O	NOUN	B
of	O	ADP	O
GM-CSF	B-protein	NOUN	B
to	O	PART	O
this	O	DET	O
basic	O	ADJ	O
cocktail	O	NOUN	B
consistently	O	ADV	O
increased	O	VERB	B
the	O	DET	O
clonogenic	O	ADJ	B
capacity	O	NOUN	B
of	O	ADP	O
single	B-cell_line	ADJ	O
CD34+Thy-1+	I-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
this	O	DET	O
effect	O	NOUN	B
was	O	AUX	O
further	O	ADV	O
enhanced	O	VERB	B
(	O	PUNCT	O
up	O	ADV	O
to	O	PART	O
72.3	O	NUM	O
+/-	O	CCONJ	O
4.3	O	NUM	O
%	O	NOUN	O
on	O	ADP	O
day	O	NOUN	B
7	O	NUM	O
)	O	PUNCT	O
by	O	ADP	O
the	O	DET	O
inclusion	O	NOUN	B
of	O	ADP	O
TNF-alpha	B-protein	NOUN	B
.	O	PUNCT	O


Recent	O	ADJ	O
studies	O	NOUN	B
from	O	ADP	O
our	O	PRON	O
laboratory	O	NOUN	B
have	O	AUX	O
indicated	O	VERB	O
that	O	SCONJ	O
protein	B-protein	NOUN	B
tyrosine	I-protein	NOUN	I
phosphatase	I-protein	NOUN	I
(	O	PUNCT	O
PTPase	B-protein	NOUN	B
)	O	PUNCT	O
inhibitors	O	NOUN	B
can	O	AUX	O
down-modulate	O	VERB	B
the	O	DET	O
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor	I-protein	NOUN	I
(	O	PUNCT	O
TNF	B-protein	NOUN	B
)	O	PUNCT	O
-mediated	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
nuclear	B-protein	ADJ	B
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
NF-kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
in	O	ADP	O
ML-1a	B-cell_line	NOUN	B
,	O	PUNCT	O
a	O	DET	O
monocytic	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
(	O	PUNCT	O
Singh	O	PROPN	B
and	O	CCONJ	O
Aggarwal	O	PROPN	O
,	O	PUNCT	O
J.	O	PROPN	O
Biol.	O	PROPN	O
Chem.	O	PROPN	O
1995	O	NUM	O
:	O	PUNCT	O
270	O	NUM	O
:	O	PUNCT	O
10631	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Like	O	ADP	O
ML-1a	B-cell_line	NOUN	B
,	O	PUNCT	O
human	B-cell_line	ADJ	B
dermal	I-cell_line	ADJ	O
microvessel	I-cell_line	NOUN	O
endothelial	I-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
(	O	PUNCT	O
MVEC	B-cell_line	NOUN	B
)	O	PUNCT	O
treated	O	VERB	B
with	O	ADP	I
TNF	B-protein	NOUN	B
rapidly	O	ADV	O
activated	O	VERB	B
(	O	PUNCT	O
within	O	ADP	O
30	O	NUM	O
min	O	NOUN	O
)	O	PUNCT	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
;	O	PUNCT	O
this	O	DET	O
effect	O	NOUN	B
was	O	AUX	O
completely	O	ADV	O
abolished	O	VERB	O
by	O	ADP	O
co-treatment	O	NOUN	B
with	O	ADP	O
phenylarsine	O	NOUN	B
oxide	O	NOUN	I
(	O	PUNCT	O
PAO	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
a	O	DET	O
specific	O	ADJ	O
inhibitor	O	NOUN	B
of	O	ADP	O
PTPase	B-protein	NOUN	B
.	O	PUNCT	O


Consistent	O	ADJ	B
with	O	ADP	I
these	O	DET	O
results	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
attachment	O	NOUN	B
of	O	ADP	O
monocytes	O	NOUN	B
to	O	PART	O
MVEC	B-cell_line	NOUN	B
was	O	AUX	O
also	O	ADV	O
blocked	O	VERB	B
by	O	ADP	O
the	O	DET	O
PTPase	B-protein	NOUN	B
inhibitors	O	NOUN	I
.	O	PUNCT	O


Spi-1/PU.1	B-protein	NOUN	B
is	O	AUX	O
a	O	DET	O
myeloid-	B-protein	NOUN	B
and	I-protein	CCONJ	O
B-cell	I-protein	NOUN	O
specific	I-protein	ADJ	O
transcription	I-protein	NOUN	O
factor	I-protein	NOUN	O
which	O	DET	O
is	O	AUX	O
also	O	ADV	O
involved	O	VERB	O
in	O	ADP	O
Friend	O	NOUN	B
virus-induced	O	ADJ	I
murine	O	ADJ	I
erythroleukemia	O	NOUN	I
.	O	PUNCT	O


Analysis	O	NOUN	B
of	O	ADP	O
erythroblasts	O	NOUN	B
co-expressing	O	VERB	O
Spi-1	B-protein	NOUN	B
and	O	CCONJ	O
the	O	DET	O
wild-type	B-protein	ADJ	B
mouse	I-protein	NOUN	B
EpoR	I-protein	NOUN	B
showed	O	VERB	O
that	O	SCONJ	O
differentiation	O	NOUN	B
arrest	O	NOUN	I
and	O	CCONJ	O
inhibition	O	NOUN	B
of	O	ADP	O
apoptosis	O	NOUN	B
depended	O	VERB	O
on	O	ADP	O
specific	O	ADJ	O
cooperation	O	NOUN	B
between	O	ADP	O
Spi-1	B-protein	NOUN	B
and	O	CCONJ	O
EpoR	B-protein	NOUN	B
(	I-protein	PUNCT	O
R129C	I-protein	NOUN	B
)	I-protein	PUNCT	O
.	O	PUNCT	O


Cellular	O	ADJ	B
and	O	CCONJ	O
molecular	O	ADJ	B
mechanisms	O	NOUN	I
of	O	ADP	O
IL-5	B-protein	NOUN	B
synthesis	O	NOUN	I
in	O	ADP	O
atopic	O	ADJ	B
diseases	O	NOUN	I
:	O	PUNCT	O
a	O	DET	O
study	O	NOUN	B
with	O	ADP	O
allergen-specific	B-cell_line	ADJ	B
human	I-cell_line	ADJ	I
helper	I-cell_line	NOUN	I
T	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Elucidation	O	NOUN	B
of	O	ADP	O
IL-5	B-protein	NOUN	B
-specific	O	ADJ	O
regulatory	O	ADJ	B
mechanisms	O	NOUN	I
may	O	AUX	O
facilitate	O	VERB	O
the	O	DET	O
development	O	NOUN	B
of	O	ADP	O
novel	O	ADJ	B
treatments	O	NOUN	B
for	O	ADP	O
allergic	O	ADJ	B
diseases	O	NOUN	I
associated	O	VERB	B
with	O	ADP	I
eosinophilic	O	ADJ	B
inflammation	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
finding	O	NOUN	B
that	O	SCONJ	O
Oct-2	B-protein	NOUN	B
is	O	AUX	O
under	O	ADP	O
NF-kappaB	B-protein	NOUN	B
control	O	NOUN	B
highlights	O	VERB	O
an	O	DET	O
important	O	ADJ	O
cross-talk	O	NOUN	B
mechanism	O	NOUN	B
involving	O	VERB	O
two	O	NUM	O
distinct	O	ADJ	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
families	I-protein	NOUN	I
that	O	PRON	O
regulate	O	VERB	B
B	B-cell_type	NOUN	O
lymphocyte	I-cell_type	NOUN	O
function	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
active	O	ADJ	B
ingredients	O	NOUN	I
mediating	O	VERB	O
the	O	DET	O
pharmacological	O	ADJ	B
effect	O	NOUN	I
are	O	AUX	O
mainly	O	ADV	O
sesquiterpene	O	NOUN	B
lactones	O	NOUN	I
,	O	PUNCT	O
such	O	ADJ	O
as	O	ADP	O
helenalin	O	NOUN	B
,	O	PUNCT	O
11alpha	O	NOUN	B
,	O	PUNCT	O
13-dihydrohelenalin	O	NOUN	B
,	O	PUNCT	O
chamissonolid	O	NOUN	B
and	O	CCONJ	O
their	O	PRON	O
ester	O	NOUN	B
derivatives	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
suggest	O	VERB	O
a	O	DET	O
molecular	O	ADJ	B
mechanism	O	NOUN	I
for	O	ADP	O
the	O	DET	O
anti-inflammatory	O	ADJ	B
effect	O	NOUN	O
of	O	ADP	O
sesquiterpene	O	NOUN	B
lactones	O	NOUN	I
,	O	PUNCT	O
which	O	DET	O
differs	O	VERB	O
from	O	ADP	O
that	O	DET	O
of	O	ADP	O
other	O	ADJ	O
nonsteroidal	O	ADJ	B
anti-inflammatory	O	ADJ	I
drugs	O	NOUN	I
(	O	PUNCT	O
NSAIDs	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
indomethacin	O	NOUN	B
and	O	CCONJ	O
acetyl	O	ADJ	B
salicylic	O	ADJ	I
acid	O	NOUN	I
.	O	PUNCT	O


Electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assay	O	NOUN	I
analysis	O	NOUN	I
showed	O	VERB	O
that	O	SCONJ	O
Tax	B-protein	NOUN	B
increased	O	VERB	B
the	O	DET	O
DNA	O	NOUN	B
binding	O	NOUN	I
activity	O	NOUN	I
of	O	ADP	O
both	O	CCONJ	O
Sp1	B-protein	NOUN	B
and	O	CCONJ	O
NGFI-A/Egr-1	B-protein	NOUN	B
using	O	VERB	O
a	O	DET	O
TRE1	B-DNA	NOUN	B
probe	I-DNA	NOUN	I
.	O	PUNCT	O


Analysis	O	NOUN	B
of	O	ADP	O
Tax	B-protein	NOUN	B
mutants	I-protein	NOUN	B
showed	O	VERB	O
that	O	SCONJ	O
two	O	NUM	O
mutants	O	NOUN	B
,	O	PUNCT	O
IEXC29S	B-protein	NOUN	B
and	O	CCONJ	O
IEXL320G	B-protein	NOUN	B
,	O	PUNCT	O
were	O	AUX	O
unable	O	ADJ	O
to	O	PART	O
significantly	O	ADV	O
transactivate	O	VERB	B
the	O	DET	O
c-sis/PDGF-B	B-DNA	NOUN	B
promoter	I-DNA	NOUN	I
.	O	PUNCT	O


The	O	DET	O
phenotype	O	NOUN	B
of	O	ADP	O
RelB	B-protein	NOUN	B
knockout	O	NOUN	B
mice	O	NOUN	I
implicates	O	VERB	O
this	O	DET	O
member	O	NOUN	B
of	O	ADP	O
the	O	DET	O
NF	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B/Rel	I-protein	NOUN	B
family	I-protein	NOUN	O
in	O	ADP	O
DC	B-cell_type	NOUN	B
differentiation	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
member	O	NOUN	O
of	O	ADP	O
the	O	DET	O
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor	I-protein	NOUN	I
receptor	I-protein	NOUN	I
superfamily	I-protein	NOUN	B
was	O	AUX	O
isolated	O	VERB	B
by	O	ADP	O
virtue	O	NOUN	O
of	O	ADP	O
its	O	PRON	O
affinity	O	NOUN	B
for	O	ADP	O
CAML	B-protein	NOUN	B
.	O	PUNCT	O


Although	O	SCONJ	O
IL-4	B-protein	NOUN	B
activated	O	VERB	B
signal	B-protein	NOUN	O
transducers	I-protein	NOUN	O
and	I-protein	CCONJ	O
activators	I-protein	NOUN	B
of	I-protein	ADP	O
transcription	I-protein	NOUN	O
(	I-protein	PUNCT	O
STAT	I-protein	NOUN	B
)	I-protein	PUNCT	O
6	I-protein	NUM	O
in	O	ADP	O
addition	O	NOUN	O
to	O	PART	O
NF-kappaB	B-protein	NOUN	B
,	O	PUNCT	O
NAC	O	NOUN	B
treatment	O	NOUN	B
or	O	CCONJ	O
the	O	DET	O
transfection	O	NOUN	B
of	O	ADP	O
decoy	O	NOUN	B
oligodeoxynucleotides	O	NOUN	I
for	O	ADP	O
NF-kappaB	B-protein	NOUN	B
or	O	CCONJ	O
STAT6	B-protein	NOUN	B
only	O	ADV	O
partly	O	ADV	O
blocked	O	VERB	B
IL-4	B-protein	NOUN	B
-induced	O	ADJ	O
germline	B-DNA	NOUN	B
Cepsilon	O	NOUN	I
transcription	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
coordination	O	NOUN	B
of	O	ADP	O
NF-kappaB	B-protein	NOUN	B
and	O	CCONJ	O
STAT6	B-protein	NOUN	B
may	O	AUX	O
be	O	AUX	O
required	O	VERB	O
for	O	ADP	O
induction	O	NOUN	B
of	O	ADP	O
germline	B-DNA	NOUN	B
Cepsilon	O	NOUN	I
transcription	O	NOUN	I
by	O	ADP	O
IL-4	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
that	O	SCONJ	O
CD40	B-protein	NOUN	B
-mediated	O	ADJ	O
NF-kappaB	B-protein	NOUN	B
activation	O	NOUN	B
may	O	AUX	O
be	O	AUX	O
important	O	ADJ	O
in	O	ADP	O
regulating	O	VERB	B
both	O	CCONJ	O
enhancement	O	NOUN	B
of	O	ADP	O
germline	B-DNA	NOUN	B
Cepsilon	O	NOUN	I
transcription	O	NOUN	I
and	O	CCONJ	O
class	O	NOUN	B
switching	O	NOUN	I
to	O	PART	O
IgE	B-protein	NOUN	B
.	O	PUNCT	O


There	O	PRON	O
are	O	AUX	O
many	O	ADJ	O
hypotheses	O	NOUN	B
concerning	O	VERB	O
the	O	DET	O
pathogenesis	O	NOUN	B
of	O	ADP	O
endometriosis	O	NOUN	B
,	O	PUNCT	O
though	O	SCONJ	O
no	O	DET	O
single	O	ADJ	O
theory	O	NOUN	O
can	O	AUX	O
explain	O	VERB	O
all	O	DET	O
cases	O	NOUN	B
.	O	PUNCT	O


Recent	O	ADJ	O
evidence	O	NOUN	B
has	O	AUX	O
implicated	O	VERB	O
components	O	NOUN	B
of	O	ADP	O
the	O	DET	O
immune	O	ADJ	B
system	O	NOUN	I
in	O	ADP	O
the	O	DET	O
pathogenesis	O	NOUN	B
of	O	ADP	O
endometriosis	O	NOUN	B
.	O	PUNCT	O


One	O	NUM	O
ATF/CRE	B-DNA	NOUN	B
motif	I-DNA	NOUN	B
is	O	AUX	O
located	O	ADJ	O
in	O	ADP	O
the	O	DET	O
distal	B-DNA	ADJ	B
promoter	I-DNA	NOUN	B
at	O	ADP	O
the	O	DET	O
nuclear	B-DNA	ADJ	B
matrix-associated	I-DNA	ADJ	I
Site	I-DNA	NOUN	I
IV	I-DNA	NUM	I
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
second	O	ADJ	O
motif	O	NOUN	B
is	O	AUX	O
present	O	ADJ	O
in	O	ADP	O
the	O	DET	O
proximal	B-DNA	ADJ	B
promoter	I-DNA	NOUN	B
at	O	ADP	O
Site	B-DNA	NOUN	B
I	I-DNA	NUM	I
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
our	O	PRON	O
data	O	NOUN	B
establish	O	VERB	O
that	O	SCONJ	O
ATF/CREB	B-protein	NOUN	B
factors	I-protein	NOUN	B
functionally	O	ADV	O
modulate	O	VERB	O
histone	B-DNA	NOUN	B
H4	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
transcription	O	NOUN	O
at	O	ADP	O
distal	B-DNA	ADJ	B
and	I-DNA	CCONJ	O
proximal	I-DNA	ADJ	B
promoter	I-DNA	NOUN	B
elements	I-DNA	NOUN	I
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
propose	O	VERB	O
that	O	SCONJ	O
these	O	DET	O
putative	O	ADJ	O
CD	O	NOUN	B
peptides	O	NOUN	I
bind	O	VERB	B
to	O	PART	O
oligosaccharide	O	NOUN	B
residues	O	NOUN	I
on	O	ADP	O
HLA	B-protein	NOUN	B
class	I-protein	NOUN	I
II	I-protein	NUM	I
molecules	I-protein	NOUN	I
distal	O	ADJ	B
to	O	PART	O
the	O	DET	O
peptide-binding	B-protein	ADJ	B
groove	I-protein	NOUN	I
invoking	O	VERB	O
recognition	O	NOUN	B
and	O	CCONJ	O
binding	O	NOUN	B
by	O	ADP	O
specialized	O	ADJ	O
subsets	O	NOUN	B
of	O	ADP	O
gamma	B-cell_type	NOUN	B
delta	I-cell_type	NOUN	I
T	I-cell_type	NOUN	I
cell	I-cell_type	NOUN	I
receptor-bearing	I-cell_type	ADJ	I
lymphocytes	I-cell_type	NOUN	I
.	O	PUNCT	O


Finally	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
speculate	O	VERB	O
that	O	SCONJ	O
molecular	O	ADJ	B
mimicry	O	NOUN	I
between	O	ADP	O
one	O	NUM	O
or	O	CCONJ	O
more	O	ADJ	O
gliadin	O	NOUN	B
peptides	O	NOUN	O
and	O	CCONJ	O
some	O	DET	O
,	O	PUNCT	O
as	O	ADP	O
yet	O	ADV	O
unidentified	O	ADJ	O
,	O	PUNCT	O
bacterial	B-protein	ADJ	B
or	I-protein	CCONJ	O
viral	I-protein	ADJ	B
superantigen	I-protein	NOUN	I
plays	O	VERB	O
a	O	DET	O
role	O	NOUN	O
in	O	ADP	O
disease	O	NOUN	B
pathogenesis	O	NOUN	B
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
LMP-1	B-protein	NOUN	B
induces	O	VERB	B
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
AP-1	B-protein	NOUN	B
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
,	O	PUNCT	O
a	O	DET	O
dimer	O	NOUN	B
of	O	ADP	O
Jun/Jun	B-protein	NOUN	B
or	I-protein	CCONJ	O
Jun/Fos	I-protein	NOUN	B
proteins	I-protein	NOUN	I
.	O	PUNCT	O


JNK	B-protein	NOUN	B
-mediated	O	ADJ	O
transcriptional	O	ADJ	B
activation	O	NOUN	I
of	O	ADP	O
AP-1	B-protein	NOUN	B
is	O	AUX	O
the	O	DET	O
direct	O	ADJ	O
output	O	NOUN	B
of	O	ADP	O
LMP	B-protein	NOUN	B
-1-triggered	O	ADJ	O
signaling	O	NOUN	B
,	O	PUNCT	O
as	O	ADP	O
shown	O	VERB	O
by	O	ADP	O
an	O	DET	O
inducible	O	ADJ	B
LMP-1	B-protein	NOUN	B
mutant	I-protein	NOUN	I
.	O	PUNCT	O


4.	O	X	O
When	O	SCONJ	O
apoptotic	B-cell_type	ADJ	B
lymphocytes	I-cell_type	NOUN	O
from	O	ADP	O
exposed	O	VERB	B
individuals	O	NOUN	B
were	O	AUX	O
compared	O	VERB	O
to	O	PART	O
apoptotic	B-cell_type	ADJ	B
lymphocytes	I-cell_type	NOUN	I
from	O	ADP	O
the	O	DET	O
control	O	NOUN	B
group	O	NOUN	I
,	O	PUNCT	O
statistically-significant	O	ADJ	O
differences	O	NOUN	O
between	O	ADP	O
each	O	DET	O
mean	O	ADJ	B
group	O	NOUN	I
were	O	AUX	O
detected	O	VERB	B
(	O	PUNCT	O
26.4	O	NUM	O
+/-	O	CCONJ	O
1.8	O	NUM	O
and	O	CCONJ	O
12.1	O	NUM	O
+/-	O	CCONJ	O
1.3	O	NUM	O
,	O	PUNCT	O
respectively	O	ADV	O
)	O	PUNCT	O
,	O	PUNCT	O
indicating	O	VERB	O
an	O	DET	O
increased	O	VERB	B
rate	O	NOUN	B
of	O	ADP	O
apoptosis	O	NOUN	B
in	O	ADP	O
80.5	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
exposed	O	VERB	B
individuals	O	NOUN	B
(	O	PUNCT	O
P	O	NOUN	O
<	O	X	O
0.0001	O	NUM	O
,	O	PUNCT	O
Mann-Whitney	O	NOUN	B
U-Test	O	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


Subcellular	O	ADJ	B
localization	O	NOUN	O
analysis	O	NOUN	O
in	O	ADP	O
various	O	ADJ	O
cells	O	NOUN	B
,	O	PUNCT	O
using	O	VERB	O
a	O	DET	O
specific	B-protein	ADJ	O
monoclonal	I-protein	ADJ	B
antibody	I-protein	NOUN	I
raised	O	VERB	O
against	O	ADP	O
SR-BP	B-protein	NOUN	B
,	O	PUNCT	O
demonstrated	O	VERB	O
that	O	SCONJ	O
this	O	DET	O
protein	O	NOUN	B
was	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
the	O	DET	O
nuclear	O	ADJ	B
envelope	O	NOUN	I
.	O	PUNCT	O


Such	O	ADJ	O
genes	O	NOUN	B
disclose	O	VERB	O
a	O	DET	O
common	O	ADJ	O
element	O	NOUN	B
within	O	ADP	O
their	O	PRON	O
promoters	B-DNA	NOUN	B
,	O	PUNCT	O
defined	O	VERB	O
Interferon	B-DNA	NOUN	B
Stimulated	I-DNA	ADJ	B
Response	I-DNA	NOUN	I
Element	I-DNA	NOUN	I
(	O	PUNCT	O
ISRE	B-DNA	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
which	O	DET	O
binds	O	VERB	B
a	O	DET	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
(	O	PUNCT	O
s	O	NOUN	O
)	O	PUNCT	O
translocated	O	VERB	B
from	O	ADP	O
the	O	DET	O
cytoplasm	O	NOUN	B
to	O	PART	O
the	O	DET	O
nucleus	O	NOUN	B
(	O	PUNCT	O
ISGF3	B-protein	NOUN	B
)	O	PUNCT	O
after	O	ADP	O
the	O	DET	O
binding	O	NOUN	B
of	O	ADP	O
interferon	B-protein	NOUN	B
(	O	PUNCT	O
IFN	B-protein	NOUN	B
)	O	PUNCT	O
to	O	PART	O
the	O	DET	O
specific	O	ADJ	O
receptor	O	NOUN	B
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
report	O	VERB	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
the	O	DET	O
synthesis	O	NOUN	B
and	O	CCONJ	O
of	O	ADP	O
the	O	DET	O
hydrolytic	O	ADJ	B
activity	O	NOUN	B
of	O	ADP	O
phospholipase	B-protein	NOUN	B
C	I-protein	NOUN	I
gamma	I-protein	NOUN	I
1	I-protein	NUM	I
(	O	PUNCT	O
PLC	B-protein	NOUN	B
gamma	I-protein	NOUN	O
1	I-protein	NUM	O
)	O	PUNCT	O
in	O	ADP	O
human	B-cell_type	ADJ	B
T	I-cell_type	NOUN	O
lymphocytes	I-cell_type	NOUN	O
by	O	ADP	O
IFN-beta	B-protein	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
ability	O	NOUN	O
of	O	ADP	O
this	O	DET	O
enzyme	B-protein	NOUN	B
to	O	PART	O
hydrolyse	O	VERB	B
PIP2	O	NOUN	B
,	O	PUNCT	O
also	O	ADV	O
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
genistein	O	NOUN	B
,	O	PUNCT	O
implies	O	VERB	O
the	O	DET	O
possibility	O	NOUN	O
that	O	SCONJ	O
this	O	DET	O
enzyme	O	NOUN	B
can	O	AUX	O
exert	O	VERB	O
its	O	PRON	O
hydrolytic	O	ADJ	B
activity	O	NOUN	O
independently	O	ADV	O
of	O	ADP	O
protein	B-protein	NOUN	B
tyrosine	I-protein	NOUN	I
kinase	I-protein	NOUN	I
activation	O	NOUN	B
.	O	PUNCT	O


Hypoxia	O	NOUN	B
enhances	O	VERB	O
induction	O	NOUN	B
of	O	ADP	O
endothelial	B-protein	ADJ	B
ICAM-1	I-protein	NOUN	B
:	O	PUNCT	O
role	O	NOUN	O
for	O	ADP	O
metabolic	O	ADJ	B
acidosis	O	NOUN	I
and	O	CCONJ	O
proteasomes	B-protein	NOUN	B
.	O	PUNCT	O


Immunoprecipitation	O	NOUN	B
and	O	CCONJ	O
electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
analysis	O	NOUN	I
revealed	O	VERB	O
that	O	SCONJ	O
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	B
of	O	ADP	O
JAK2	B-protein	NOUN	B
and	O	CCONJ	O
activation	O	NOUN	B
of	O	ADP	O
STAT5	B-protein	NOUN	B
were	O	AUX	O
induced	O	VERB	B
upon	O	SCONJ	O
stimulation	O	NOUN	B
with	O	ADP	O
hIL-5	B-protein	NOUN	B
in	O	ADP	O
all	O	DET	O
three	O	NUM	O
cell	O	NOUN	B
types	O	NOUN	I
,	O	PUNCT	O
while	O	SCONJ	O
STAT1	B-protein	NOUN	B
activation	O	NOUN	B
was	O	AUX	O
only	O	ADV	O
observed	O	VERB	B
in	O	ADP	O
eosinophils	B-cell_type	NOUN	B
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	B
demonstrate	O	VERB	O
that	O	SCONJ	O
short-term	O	ADJ	B
incubation	O	NOUN	B
of	O	ADP	O
these	O	DET	O
cells	O	NOUN	B
with	O	ADP	O
oxLDL	B-protein	NOUN	B
activated	I-protein	VERB	B
p50/p65	I-protein	NOUN	B
containing	O	VERB	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
dimers	I-protein	NOUN	I
and	O	CCONJ	O
induced	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
target	B-DNA	NOUN	B
gene	I-DNA	NOUN	O
IL-8	I-DNA	NOUN	B
.	O	PUNCT	O


This	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
was	O	AUX	O
inhibited	O	VERB	B
by	O	ADP	O
the	O	DET	O
antioxidant	O	NOUN	B
and	O	CCONJ	O
H2O2	O	NOUN	B
scavenger	O	NOUN	B
pyrrolidine	O	NOUN	I
dithiocarbamate	O	NOUN	I
and	O	CCONJ	O
the	O	DET	O
proteasome	B-protein	NOUN	B
inhibitor	O	NOUN	I
PSI	O	NOUN	B
.	O	PUNCT	O


After	O	ADP	O
stimulation	O	NOUN	B
,	O	PUNCT	O
neutrophils	O	NOUN	B
separated	O	VERB	O
from	O	ADP	O
a	O	DET	O
healthy	O	ADJ	B
human	O	ADJ	B
volunteer	O	NOUN	B
were	O	AUX	O
added	O	VERB	O
with	O	ADP	O
or	O	CCONJ	O
without	O	ADP	O
anti-CD18	B-protein	ADJ	B
antibody	I-protein	NOUN	I
.	O	PUNCT	O


Pretreatment	O	NOUN	B
with	O	ADP	O
dexamethasone	O	NOUN	B
tapered	O	VERB	O
NFkappaB	B-protein	NOUN	B
translocation	O	NOUN	B
into	O	ADP	O
the	O	DET	O
nucleus	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
transcriptional	B-DNA	ADJ	B
start	I-DNA	NOUN	O
sites	I-DNA	NOUN	O
were	O	AUX	O
identified	O	VERB	B
by	O	ADP	O
an	O	DET	O
RNase	B-protein	NOUN	B
protection	O	NOUN	B
assay	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
ability	O	NOUN	O
of	O	ADP	O
BHRF1	B-protein	NOUN	B
to	O	PART	O
inhibit	O	VERB	B
apoptosis	O	NOUN	B
is	O	AUX	O
dependent	O	ADJ	O
on	O	ADP	O
stimulus	O	NOUN	B
and	O	CCONJ	O
cell	O	NOUN	B
type	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
BHRF1	B-protein	NOUN	B
protected	O	VERB	O
these	O	DET	O
cells	O	NOUN	B
from	O	ADP	O
monocyte-mediated	O	ADJ	B
killing	O	NOUN	B
but	O	CCONJ	O
failed	O	VERB	B
to	O	PART	O
protect	O	VERB	B
them	O	PRON	O
from	O	ADP	O
killing	O	VERB	B
mediated	O	VERB	O
by	O	ADP	O
lymphokine-activated	B-cell_type	ADJ	B
killer	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Among	O	ADP	O
the	O	DET	O
regulatory	B-DNA	ADJ	B
promoter	I-DNA	NOUN	O
elements	I-DNA	NOUN	O
potentially	O	ADV	O
regulating	O	VERB	B
eotaxin	B-DNA	NOUN	B
gene	I-DNA	NOUN	O
expression	O	NOUN	B
and/or	O	CCONJ	O
mediating	O	VERB	O
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	O
anti-inflammatory	O	ADJ	B
drugs	O	NOUN	I
we	O	PRON	O
identified	O	VERB	O
consensus	B-DNA	NOUN	B
sequences	I-DNA	NOUN	I
known	O	VERB	O
to	O	PART	O
interact	O	VERB	B
with	O	ADP	O
nuclear	B-protein	ADJ	B
factors	I-protein	NOUN	I
like	O	ADP	O
NF-IL6	B-protein	NOUN	B
,	O	PUNCT	O
AP-1	B-protein	NOUN	B
,	O	PUNCT	O
a	O	DET	O
NF-kappa-B	B-DNA	NOUN	B
like	I-DNA	ADP	O
consensus	I-DNA	NOUN	B
sequence	I-DNA	NOUN	I
and	O	CCONJ	O
gamma-interferon-	B-DNA	NOUN	B
as	I-DNA	ADV	O
well	I-DNA	ADV	O
as	I-DNA	ADP	O
glucocorticoid	I-DNA	NOUN	B
response	I-DNA	NOUN	I
elements	I-DNA	NOUN	I
.	O	PUNCT	O


Mutations	O	NOUN	B
that	O	PRON	O
abolish	O	VERB	B
the	O	DET	O
binding	O	NOUN	B
of	O	ADP	O
each	O	DET	O
factor	O	NOUN	B
to	O	PART	O
its	O	PRON	O
cognate	O	ADJ	B
site	O	NOUN	I
are	O	AUX	O
introduced	O	VERB	O
in	O	ADP	O
an	O	DET	O
infectious	O	ADJ	B
HIV-1	O	NOUN	B
molecular	O	ADJ	B
clone	O	NOUN	I
to	O	PART	O
study	O	VERB	B
their	O	PRON	O
effect	O	NOUN	B
on	O	ADP	O
HIV-1	O	NOUN	B
transcription	O	NOUN	B
and	O	CCONJ	O
replication	O	NOUN	B
.	O	PUNCT	O


Dexamethasone	O	NOUN	B
,	O	PUNCT	O
up	O	ADV	O
to	O	PART	O
a	O	DET	O
concentration	O	NOUN	B
of	O	ADP	O
1	O	NUM	O
mumol/L	O	NOUN	O
,	O	PUNCT	O
neither	O	CCONJ	O
affected	O	VERB	B
significantly	O	ADV	O
the	O	DET	O
release	O	NOUN	B
of	O	ADP	O
granule	B-protein	NOUN	B
enzymes	I-protein	NOUN	B
nor	O	CCONJ	O
interfered	O	VERB	B
with	O	ADP	O
PAF	B-protein	NOUN	B
binding	O	VERB	O
to	O	PART	O
its	O	PRON	O
membrane	B-protein	NOUN	B
receptors	I-protein	NOUN	I
.	O	PUNCT	O


Although	O	SCONJ	O
IL-2Rbeta	B-protein	NOUN	B
is	O	AUX	O
constitutively	O	ADV	B
expressed	O	VERB	B
by	O	ADP	O
lymphocytes	O	NOUN	B
,	O	PUNCT	O
its	O	PRON	O
expression	O	NOUN	B
can	O	AUX	O
be	O	AUX	O
further	O	ADV	O
induced	O	VERB	B
by	O	ADP	O
a	O	DET	O
number	O	NOUN	O
of	O	ADP	O
stimuli	O	NOUN	B
,	O	PUNCT	O
including	O	VERB	O
phorbol	O	NOUN	B
12-myristate	O	NOUN	I
13-acetate	O	NOUN	I
(	O	PUNCT	O
PMA	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


In	O	ADP	O
Jurkat	B-cell_line	NOUN	B
T	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
induction	O	NOUN	B
of	O	ADP	O
PIF	B-protein	NOUN	B
DNA	O	NOUN	B
binding	O	NOUN	I
activity	O	NOUN	I
was	O	AUX	O
rapidly	O	ADV	O
induced	O	VERB	B
,	O	PUNCT	O
required	O	VERB	O
de	O	X	O
novo	O	X	O
protein	O	NOUN	B
synthesis	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
was	O	AUX	O
sustained	O	ADJ	B
at	O	ADP	O
a	O	DET	O
high	O	ADJ	O
level	O	NOUN	B
for	O	ADP	O
at	O	ADP	O
least	O	ADJ	O
23	O	NUM	O
h	O	NOUN	O
.	O	PUNCT	O


Interestingly	O	ADV	O
,	O	PUNCT	O
PIF	B-protein	NOUN	B
was	O	AUX	O
constitutively	O	ADV	B
activated	O	VERB	B
in	O	ADP	O
human	B-cell_line	ADJ	B
T-cell	I-cell_line	NOUN	O
leukemia	I-cell_line	NOUN	O
virus	I-cell_line	NOUN	O
type	I-cell_line	NOUN	O
1-transformed	I-cell_line	ADJ	O
MT-2	I-cell_line	NOUN	O
cells	I-cell_line	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
Jurkat	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
both	O	DET	O
sites	O	NOUN	B
were	O	AUX	O
required	O	VERB	O
for	O	ADP	O
maximal	O	ADJ	B
IL-2Rbeta	B-protein	NOUN	B
promoter	O	NOUN	B
activity	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
in	O	ADP	O
HeLaS3	O	NOUN	B
cells	O	NOUN	I
,	O	PUNCT	O
transfection	O	NOUN	B
of	O	ADP	O
Egr-1	B-protein	NOUN	B
could	O	AUX	O
drive	O	VERB	O
activity	O	NOUN	B
of	O	ADP	O
a	O	DET	O
reporter	O	NOUN	B
construct	O	NOUN	I
containing	O	VERB	O
both	O	DET	O
sites	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
MHC	B-protein	NOUN	B
class	I-protein	NOUN	O
II	I-protein	NUM	O
homologous	I-protein	ADJ	O
proteins	I-protein	NOUN	O
HLA-DMA	B-protein	NOUN	B
and	O	CCONJ	O
HLA-DMB	B-protein	ADJ	B
function	O	NOUN	I
in	O	ADP	O
the	O	DET	O
loading	O	NOUN	B
of	O	ADP	O
peptides	O	NOUN	B
onto	O	ADP	O
class	B-protein	NOUN	B
II	I-protein	NUM	I
molecules	I-protein	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
monocytes	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
virus	O	NOUN	B
was	O	AUX	O
bound	O	VERB	O
to	O	PART	O
the	O	DET	O
surface	O	NOUN	B
without	O	ADP	O
being	O	AUX	O
internalized	O	VERB	B
.	O	PUNCT	O


The	O	DET	O
human	B-protein	ADJ	B
myeloid	I-protein	ADJ	O
nuclear	I-protein	ADJ	O
differentiation	I-protein	NOUN	O
antigen	I-protein	NOUN	O
(	O	PUNCT	O
MNDA	B-protein	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
expressed	O	VERB	B
specifically	O	ADV	O
in	O	ADP	O
maturing	B-cell_type	VERB	B
cells	I-cell_type	NOUN	I
of	O	ADP	O
the	O	DET	O
myelomonocytic	O	ADJ	B
lineage	O	NOUN	I
and	O	CCONJ	O
in	O	ADP	O
monocytes	B-cell_type	NOUN	B
and	O	CCONJ	O
granulocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
analysis	O	NOUN	B
of	O	ADP	O
deletion	B-DNA	NOUN	B
mutants	I-DNA	NOUN	I
localized	O	VERB	B
nearly	O	ADV	O
all	O	DET	O
of	O	ADP	O
the	O	DET	O
promoter	O	NOUN	B
activity	O	NOUN	I
to	O	PART	O
a	O	DET	O
short	O	ADJ	B
region	O	NOUN	I
(	O	PUNCT	O
-73	B-DNA	NUM	O
to	I-DNA	PART	O
-16	I-DNA	NUM	O
)	O	PUNCT	O
that	O	PRON	O
did	O	AUX	O
not	O	PART	O
include	O	VERB	O
the	O	DET	O
cluster	O	NOUN	B
of	O	ADP	O
c-Myb	B-DNA	NOUN	B
sites	I-DNA	NOUN	B
.	O	PUNCT	O


A	O	DET	O
4-bp	O	ADJ	O
mutation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
core	B-DNA	NOUN	B
Sp1	I-DNA	NOUN	B
consensus	I-DNA	NOUN	B
element	I-DNA	NOUN	I
(	O	PUNCT	O
GC	B-DNA	NOUN	B
box	I-DNA	NOUN	I
)	O	PUNCT	I
(	O	PUNCT	O
-20	O	NUM	O
)	O	PUNCT	O
reduced	O	VERB	B
overall	O	ADJ	O
promoter	O	NOUN	B
activity	O	NOUN	I
of	O	ADP	O
the	O	DET	O
1-kb	B-DNA	ADJ	O
fragment	I-DNA	NOUN	B
.	O	PUNCT	O


Critical	O	ADJ	B
cytoplasmic	B-protein	ADJ	I
domains	I-protein	NOUN	I
of	O	ADP	O
human	B-protein	ADJ	B
interleukin-9	I-protein	NOUN	O
receptor	I-protein	NOUN	O
alpha	I-protein	NOUN	O
chain	I-protein	NOUN	O
in	O	ADP	O
interleukin	B-protein	NOUN	B
-9-mediated	O	ADJ	O
cell	O	NOUN	B
proliferation	O	NOUN	I
and	O	CCONJ	O
signal	O	NOUN	B
transduction	O	NOUN	I
.	O	PUNCT	O


Deletion	O	NOUN	B
of	O	ADP	O
this	O	DET	O
region	O	NOUN	B
or	O	CCONJ	O
internal	O	ADJ	B
deletion	O	NOUN	I
of	O	ADP	O
the	O	DET	O
BOX1	B-protein	NOUN	B
motif	I-protein	NOUN	B
abrogated	O	VERB	O
IL-9	B-protein	NOUN	B
-induced	O	ADJ	O
cell	O	NOUN	B
proliferation	O	NOUN	I
and	O	CCONJ	O
signal	O	NOUN	B
transduction	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
cooperation	O	NOUN	B
or	O	CCONJ	O
cross-talk	O	NOUN	B
of	O	ADP	O
signaling	O	VERB	B
molecules	O	NOUN	I
associated	O	VERB	B
with	O	ADP	I
different	O	ADJ	O
domains	O	NOUN	B
of	O	ADP	O
IL-9Ralpha	B-protein	NOUN	B
other	O	ADJ	O
than	O	ADP	O
STAT3	B-protein	NOUN	B
is	O	AUX	O
essential	O	ADJ	O
for	O	ADP	O
IL-9	B-protein	NOUN	B
-mediated	O	ADJ	O
cell	O	NOUN	B
growth	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
results	O	NOUN	B
indicated	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
apoptosis	O	NOUN	B
induced	O	VERB	B
by	O	ADP	O
bufalin	O	NOUN	B
in	O	ADP	O
U937	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
was	O	AUX	O
significantly	O	ADV	O
inhibited	O	VERB	B
by	O	ADP	O
overexpression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Bcl-2	B-protein	NOUN	B
protein	I-protein	NOUN	I
.	O	PUNCT	O


Mutations	O	NOUN	B
in	O	ADP	O
these	O	DET	O
liver-enriched	B-protein	ADJ	B
transcription	I-protein	NOUN	I
factors	I-protein	NOUN	I
result	O	VERB	O
in	O	ADP	O
two	O	NUM	O
forms	O	NOUN	O
of	O	ADP	O
early-onset	O	ADJ	B
type	O	NOUN	B
2	O	NUM	I
diabetes	O	NOUN	I
(	O	PUNCT	O
maturity-onset	O	ADJ	B
diabetes	O	NOUN	I
of	O	ADP	O
the	O	DET	O
young	O	ADJ	B
[	O	PUNCT	O
MODY	O	NOUN	B
]	O	PUNCT	O
)	O	PUNCT	O
,	O	PUNCT	O
MODY3	O	NOUN	B
and	O	CCONJ	O
MODY1	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
are	O	AUX	O
characterized	O	VERB	B
by	O	ADP	O
impaired	O	ADJ	B
glucose-stimulated	O	ADJ	B
insulin	O	NOUN	B
secretion	O	NOUN	I
,	O	PUNCT	O
early	O	ADJ	B
disease	O	NOUN	I
onset	O	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
autosomal	O	ADJ	B
dominant	O	ADJ	O
inheritance	O	NOUN	B
.	O	PUNCT	O


Together	O	ADV	O
,	O	PUNCT	O
these	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
class	O	NOUN	B
I	O	NOUN	I
triggering	O	NOUN	B
can	O	AUX	O
induce	O	VERB	B
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B/Rel	I-protein	NOUN	B
nuclear	O	ADJ	B
activity	O	NOUN	I
in	O	ADP	O
peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
T	I-cell_type	NOUN	I
lymphocytes	I-cell_type	NOUN	I
,	O	PUNCT	O
thereby	O	ADV	O
modulating	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
genes	O	NOUN	B
regulated	O	VERB	B
by	O	ADP	O
these	O	DET	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
conclude	O	VERB	O
that	O	SCONJ	O
interactions	O	NOUN	B
between	O	ADP	O
TAFII32	B-protein	NOUN	B
and	O	CCONJ	O
CIITA	B-protein	NOUN	B
are	O	AUX	O
responsible	O	ADJ	O
for	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
class	B-DNA	NOUN	B
II	I-DNA	NUM	I
genes	I-DNA	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
cellular	O	ADJ	B
or	O	CCONJ	O
molecular	B-protein	ADJ	B
factors	I-protein	NOUN	I
responsible	O	ADJ	O
for	O	ADP	O
a	O	DET	O
delay	O	NOUN	B
in	O	ADP	O
B-CLL	O	NOUN	B
cell	O	NOUN	O
death	O	NOUN	O
are	O	AUX	O
unknown	O	ADJ	O
.	O	PUNCT	O


Further	O	ADV	O
,	O	PUNCT	O
in	O	ADP	O
consecutive	O	ADJ	B
samples	O	NOUN	B
of	O	ADP	O
fresh	O	ADJ	B
blood	O	NOUN	B
obtained	O	VERB	O
from	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
B-CLL	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	O
,	O	PUNCT	O
the	O	DET	O
addition	O	NOUN	O
of	O	ADP	O
IL-10	B-protein	NOUN	B
inhibited	O	VERB	B
B-CLL	B-cell_line	NOUN	B
proliferation	O	NOUN	B
,	O	PUNCT	O
enhanced	O	VERB	O
B-CLL	B-cell_line	NOUN	B
differentiation	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
did	O	AUX	O
not	O	PART	O
induce	O	VERB	B
apoptosis	O	NOUN	B
.	O	PUNCT	O


For	O	ADP	O
this	O	DET	O
purpose	O	NOUN	O
,	O	PUNCT	O
mice	O	NOUN	B
were	O	AUX	O
immunized	O	VERB	B
with	O	ADP	O
a	O	DET	O
fusion	B-protein	NOUN	B
protein	I-protein	NOUN	I
including	O	VERB	O
the	O	DET	O
sequence	O	NOUN	B
Thr729-Lys984	B-protein	NOUN	B
of	O	ADP	O
hMR	B-protein	NOUN	B
.	O	PUNCT	O


By	O	ADP	O
using	O	VERB	O
several	O	ADJ	O
HBD	B-protein	NOUN	B
subfragments	I-protein	NOUN	B
,	O	PUNCT	O
the	O	DET	O
mAb	B-protein	NOUN	B
18C7	I-protein	NOUN	B
epitope	I-protein	NOUN	I
was	O	AUX	O
located	O	ADJ	O
in	O	ADP	O
the	O	DET	O
N-terminal	B-protein	ADJ	B
region	I-protein	NOUN	I
of	O	ADP	O
the	O	DET	O
HBD	B-protein	NOUN	B
from	O	ADP	O
Thr729	B-protein	NOUN	B
to	I-protein	PART	O
Leu765	I-protein	NOUN	B
.	O	PUNCT	O


Previous	O	ADJ	O
work	O	NOUN	O
has	O	AUX	O
demonstrated	O	VERB	O
that	O	SCONJ	O
SLP-76	B-protein	NOUN	B
,	O	PUNCT	O
a	O	DET	O
Grb2-associated	B-protein	ADJ	B
tyrosine-phosphorylated	I-protein	ADJ	I
protein	I-protein	NOUN	I
,	O	PUNCT	O
augments	O	VERB	O
Interleukin-2	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
activity	O	NOUN	I
when	O	SCONJ	O
overexpressed	O	VERB	B
in	O	ADP	O
the	O	DET	O
Jurkat	B-cell_line	NOUN	B
T	I-cell_line	NOUN	I
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
.	O	PUNCT	O


This	O	DET	O
review	O	NOUN	B
focuses	O	VERB	O
on	O	ADP	O
the	O	DET	O
molecular	O	ADJ	B
actions	O	NOUN	I
of	O	ADP	O
prolactin	O	NOUN	B
in	O	ADP	O
the	O	DET	O
immune	O	ADJ	B
system	O	NOUN	I
.	O	PUNCT	O


Emphasis	O	NOUN	B
is	O	AUX	O
given	O	VERB	O
to	O	ADP	O
recent	O	ADJ	O
information	O	NOUN	B
about	O	ADP	O
the	O	DET	O
molecular	O	ADJ	B
mechanisms	O	NOUN	I
of	O	ADP	O
prolactin	O	NOUN	B
receptor	O	NOUN	I
signal	O	NOUN	I
transduction	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
signaling	B-protein	NOUN	B
molecules	I-protein	NOUN	I
and	O	CCONJ	O
prolactin-inducible	B-DNA	ADJ	B
target	I-DNA	NOUN	I
genes	I-DNA	NOUN	I
that	O	PRON	O
participate	O	VERB	B
in	O	ADP	O
these	O	DET	O
responses	O	NOUN	B
.	O	PUNCT	O


Activation	O	NOUN	B
of	O	ADP	O
transcription	O	NOUN	B
factor	O	NOUN	I
NF-kappa	B-protein	NOUN	I
B	I-protein	NOUN	I
by	O	ADP	O
phagocytic	O	ADJ	B
stimuli	O	NOUN	B
in	O	ADP	O
human	O	ADJ	B
neutrophils	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
conclude	O	VERB	O
that	O	SCONJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activation	O	NOUN	B
could	O	AUX	O
constitute	O	VERB	O
one	O	NUM	O
of	O	ADP	O
the	O	DET	O
mechanisms	O	NOUN	B
whereby	O	SCONJ	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
kappa	B-DNA	NOUN	O
B-responsive	I-DNA	ADJ	O
genes	I-DNA	NOUN	O
is	O	AUX	O
enhanced	O	VERB	B
in	O	ADP	O
phagocytosing	B-cell_type	VERB	B
neutrophils	I-cell_type	NOUN	B
.	O	PUNCT	O


Because	O	SCONJ	O
candidiasis	O	NOUN	B
and	O	CCONJ	O
cryptococcosis	O	NOUN	B
are	O	AUX	O
common	O	ADJ	O
in	O	ADP	O
human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
(	O	PUNCT	O
HIV	O	NOUN	B
)	O	PUNCT	O
-infected	O	ADJ	O
persons	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
Cryptococcus	O	NOUN	B
neoformans	O	NOUN	I
and	O	CCONJ	O
Candida	O	NOUN	B
albicans	O	NOUN	I
on	O	ADP	O
HIV	O	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
monocytic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
was	O	AUX	O
examined	O	VERB	O
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
C.	O	X	B
neoformans	O	NOUN	I
and	O	CCONJ	O
C.	O	X	B
albicans	O	NOUN	I
enhance	O	VERB	O
HIV	O	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
monocytic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
through	O	ADP	O
a	O	DET	O
TNF-alpha-	O	NOUN	B
and	O	CCONJ	O
NF-kappaB-dependent	O	ADJ	B
mechanism	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
double	B-DNA	ADJ	O
NF-kappaB	I-DNA	NOUN	B
site	I-DNA	NOUN	I
identified	O	VERB	B
in	O	ADP	O
the	O	DET	O
LTR	B-DNA	NOUN	B
of	O	ADP	O
the	O	DET	O
human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus-1	O	NOUN	I
(	O	PUNCT	O
HIV-1	O	NOUN	B
)	O	PUNCT	O
has	O	AUX	O
been	O	AUX	O
demonstrated	O	VERB	O
to	O	PART	O
be	O	AUX	O
necessary	O	ADJ	O
for	O	ADP	O
efficient	O	ADJ	B
viral	O	ADJ	B
transcription	O	NOUN	I
.	O	PUNCT	O


At	O	ADP	O
least	O	ADJ	O
four	O	NUM	O
different	O	ADJ	O
specific	O	ADJ	O
NF-kappaB	B-protein	NOUN	B
complexes	I-protein	NOUN	B
are	O	AUX	O
present	O	ADJ	O
in	O	ADP	O
the	O	DET	O
nucleus	O	NOUN	B
of	O	ADP	O
these	O	DET	O
cells	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
correlation	O	NOUN	B
is	O	AUX	O
specific	O	ADJ	O
as	O	ADP	O
the	O	DET	O
level	O	NOUN	B
of	O	ADP	O
at	O	ADP	O
least	O	ADJ	O
three	O	NUM	O
other	O	ADJ	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
did	O	AUX	O
not	O	PART	O
change	O	VERB	O
.	O	PUNCT	O


c-Myb	B-DNA	NOUN	B
and	O	CCONJ	O
Ets	B-protein	NOUN	B
proteins	I-protein	NOUN	I
synergize	O	VERB	B
to	O	PART	O
overcome	O	VERB	O
transcriptional	O	ADJ	B
repression	O	NOUN	I
by	O	ADP	O
ZEB	B-protein	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
one	O	NUM	O
target	O	NOUN	B
of	O	ADP	O
this	O	DET	O
positive/negative	O	ADJ	O
regulation	O	NOUN	O
in	O	X	B
vivo	O	X	I
is	O	AUX	O
the	O	DET	O
alpha4	B-protein	NOUN	B
integrin	I-protein	NOUN	I
,	O	PUNCT	O
which	O	DET	O
play	O	VERB	O
a	O	DET	O
key	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
normal	O	ADJ	O
hematopoiesis	O	NOUN	B
and	O	CCONJ	O
function	O	NOUN	B
of	O	ADP	O
mature	B-cell_type	ADJ	B
leukocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


Stat	B-protein	NOUN	B
(	O	PUNCT	O
signal	B-protein	NOUN	B
transducers	I-protein	NOUN	I
and	I-protein	CCONJ	O
activators	I-protein	NOUN	B
of	I-protein	ADP	O
transcription	I-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
Jak	B-protein	NOUN	B
(	O	PUNCT	O
Janus	B-protein	NOUN	B
kinases	I-protein	NOUN	I
)	O	PUNCT	O
proteins	O	NOUN	O
are	O	AUX	O
central	O	ADJ	B
components	O	NOUN	I
in	O	ADP	O
the	O	DET	O
signal	O	NOUN	B
transduction	O	NOUN	I
events	O	NOUN	O
in	O	ADP	O
hematopoietic	B-cell_type	ADJ	B
and	I-cell_type	CCONJ	O
epithelial	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


They	O	PRON	O
are	O	AUX	O
rapidly	O	ADV	O
activated	O	VERB	B
by	O	ADP	O
various	O	ADJ	O
cytokines	B-protein	NOUN	B
,	O	PUNCT	O
hormones	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
growth	O	NOUN	B
factors	O	NOUN	I
.	O	PUNCT	O


Upon	O	SCONJ	O
ligand	O	NOUN	B
binding	O	NOUN	I
and	O	CCONJ	O
cytokine	B-protein	NOUN	B
receptor	I-protein	NOUN	I
dimerization	O	NOUN	I
,	O	PUNCT	O
Stat	B-protein	NOUN	B
proteins	I-protein	NOUN	I
are	O	AUX	O
phosphorylated	O	VERB	B
on	O	ADP	O
tyrosine	O	NOUN	B
residues	O	NOUN	I
by	O	ADP	O
Jak	B-protein	NOUN	B
kinases	I-protein	NOUN	I
.	O	PUNCT	O


IL-4	B-protein	NOUN	B
-dependent	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
Stat6	B-protein	NOUN	B
was	O	AUX	O
also	O	ADV	O
observed	O	VERB	O
in	O	ADP	O
HC11	B-cell_line	NOUN	B
mammary	I-cell_line	ADJ	B
epithelial	I-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


The	O	DET	O
glucocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
was	O	AUX	O
able	O	ADJ	O
to	O	PART	O
further	O	ADV	O
enhance	O	VERB	O
IL-4	B-protein	NOUN	B
-induced	O	ADJ	O
gene	O	NOUN	B
transcription	O	NOUN	I
through	O	ADP	O
the	O	DET	O
action	O	NOUN	B
of	O	ADP	O
Stat6	B-protein	NOUN	B
.	O	PUNCT	O


Deletion	O	NOUN	B
analysis	O	NOUN	I
of	O	ADP	O
the	O	DET	O
carboxyl-terminal	B-protein	ADJ	B
region	I-protein	NOUN	I
of	O	ADP	O
Stat6	B-protein	NOUN	B
and	O	CCONJ	O
recombination	O	NOUN	B
of	O	ADP	O
this	O	DET	O
region	O	NOUN	B
with	O	ADP	O
a	O	DET	O
heterologous	B-protein	ADJ	B
DNA	I-protein	NOUN	B
binding	I-protein	NOUN	I
domain	I-protein	NOUN	I
allowed	O	VERB	O
the	O	DET	O
delimitation	O	NOUN	B
and	O	CCONJ	O
characterization	O	NOUN	B
of	O	ADP	O
the	O	DET	O
transactivation	O	NOUN	B
domain	O	NOUN	I
of	O	ADP	O
Stat6	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
potencies	O	NOUN	B
of	O	ADP	O
the	O	DET	O
transactivation	B-protein	NOUN	B
domains	I-protein	NOUN	O
of	O	ADP	O
Stat5	B-protein	NOUN	B
,	O	PUNCT	O
Stat6	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
viral	B-protein	ADJ	B
protein	I-protein	NOUN	I
VP16	I-protein	NOUN	B
were	O	AUX	O
compared	O	VERB	B
.	O	PUNCT	O


ETS1	B-protein	NOUN	B
,	O	PUNCT	O
NFkappaB	B-protein	NOUN	B
and	O	CCONJ	O
AP1	B-protein	NOUN	B
synergistically	O	ADV	B
transactivate	O	VERB	B
the	O	DET	O
human	B-DNA	ADJ	B
GM-CSF	I-DNA	NOUN	B
promoter	I-DNA	NOUN	B
.	O	PUNCT	O


This	O	DET	O
defect	O	NOUN	B
in	O	ADP	O
maturation	O	NOUN	B
resulted	O	VERB	O
in	O	ADP	O
a	O	DET	O
transgene	O	NOUN	B
dose-dependent	O	ADJ	B
reduction	O	NOUN	B
in	O	ADP	O
peripheral	B-cell_type	ADJ	B
T	I-cell_type	NOUN	I
lymphocytes	I-cell_type	NOUN	I
,	O	PUNCT	O
with	O	ADP	O
the	O	DET	O
CD8	B-cell_type	NOUN	B
lineage	I-cell_type	NOUN	B
being	O	AUX	O
more	O	ADV	O
severely	O	ADV	B
affected	O	VERB	B
.	O	PUNCT	O


The	O	DET	O
current	O	ADJ	O
study	O	NOUN	B
investigates	O	VERB	B
the	O	DET	O
hypothesis	O	NOUN	B
that	O	SCONJ	O
CD40	B-protein	NOUN	B
expressed	O	VERB	B
on	O	ADP	O
lung	B-cell_type	NOUN	B
fibroblasts	I-cell_type	NOUN	B
is	O	AUX	O
an	O	DET	O
activation	O	NOUN	B
structure	O	NOUN	I
and	O	CCONJ	O
mechanism	O	NOUN	B
for	O	ADP	O
interaction	O	NOUN	B
with	O	ADP	O
hemopoietic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Communication	O	NOUN	B
between	O	ADP	O
resident	O	ADJ	B
tissue	O	NOUN	B
fibroblasts	B-cell_type	NOUN	B
and	O	CCONJ	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
is	O	AUX	O
necessary	O	ADJ	O
for	O	ADP	O
normal	O	ADJ	O
wound	O	NOUN	B
healing	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
can	O	AUX	O
be	O	AUX	O
pathologic	O	ADJ	B
,	O	PUNCT	O
resulting	O	VERB	O
in	O	ADP	O
tissue	O	NOUN	B
fibrosis	O	NOUN	I
.	O	PUNCT	O


Signaling	O	NOUN	B
through	O	ADP	O
CD40	B-protein	NOUN	B
with	O	ADP	O
soluble	O	ADJ	B
CD40	B-protein	NOUN	B
ligand	O	NOUN	B
stimulated	O	VERB	B
fibroblast	O	NOUN	B
activation	O	NOUN	I
,	O	PUNCT	O
as	O	ADP	O
evidenced	O	VERB	O
by	O	ADP	O
mobilization	O	NOUN	B
of	O	ADP	O
nuclear	O	ADJ	B
factor-kappaB	O	NOUN	I
and	O	CCONJ	O
by	O	ADP	O
induction	O	NOUN	B
of	O	ADP	O
the	O	DET	O
proinflammatory	O	ADJ	B
and	O	CCONJ	O
chemoattractant	O	NOUN	B
cytokines	B-protein	NOUN	I
IL-6	B-protein	NOUN	B
and	O	CCONJ	O
IL-8	B-protein	NOUN	B
.	O	PUNCT	O


Fine	O	ADJ	B
mapping	O	NOUN	I
by	O	ADP	O
in	O	X	B
vivo	O	X	I
footprinting	O	NOUN	I
demonstrated	O	VERB	O
five	O	NUM	O
transcription	O	NOUN	B
factor	O	NOUN	I
binding	O	NOUN	I
sites	O	NOUN	I
that	O	PRON	O
are	O	AUX	O
occupied	O	VERB	B
in	O	ADP	O
both	O	CCONJ	O
resting	O	VERB	B
and	O	CCONJ	O
activated	B-cell_type	VERB	B
peripheral	I-cell_type	ADJ	O
blood	I-cell_type	NOUN	O
T	I-cell_type	NOUN	O
lymphocytes	I-cell_type	NOUN	O
;	O	PUNCT	O
these	O	DET	O
are	O	AUX	O
tandem	B-DNA	ADJ	B
CRE	I-DNA	NOUN	B
motifs	I-DNA	NOUN	B
,	O	PUNCT	O
a	O	DET	O
Sp1	B-DNA	NOUN	B
site	I-DNA	NOUN	B
,	O	PUNCT	O
an	O	DET	O
overlapping	O	VERB	O
Egr-1/Sp1	B-DNA	NOUN	B
site	I-DNA	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
novel	O	ADJ	O
palindromic	B-DNA	ADJ	B
octamer	I-DNA	NOUN	I
sequence	I-DNA	NOUN	I
(	O	PUNCT	O
POS	B-DNA	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Distinct	O	ADJ	O
mechanisms	O	NOUN	B
for	O	ADP	O
N-acetylcysteine	O	NOUN	B
inhibition	O	NOUN	B
of	O	ADP	O
cytokine-induced	B-protein	ADJ	B
E-selectin	I-protein	NOUN	I
and	O	CCONJ	O
VCAM-1	B-protein	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


Although	O	SCONJ	O
NAC	O	NOUN	B
reduced	O	VERB	B
nuclear	B-protein	ADJ	B
factor-kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
(	O	PUNCT	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
)	O	PUNCT	O
activation	O	NOUN	B
in	O	ADP	O
EC	B-cell_type	NOUN	B
as	O	ADP	O
measured	O	VERB	B
by	O	ADP	O
gel-shift	O	ADJ	B
assays	O	NOUN	I
using	O	VERB	O
an	O	DET	O
oligonucleotide	B-DNA	NOUN	B
probe	I-DNA	NOUN	I
corresponding	O	VERB	O
to	O	PART	O
the	O	DET	O
consensus	O	NOUN	B
NF-kappa	B-DNA	NOUN	I
B	I-DNA	NOUN	I
binding	I-DNA	NOUN	O
sites	I-DNA	NOUN	O
of	O	ADP	O
the	O	DET	O
VCAM-1	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
(	O	PUNCT	O
VCAM-NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
)	O	PUNCT	O
,	O	PUNCT	O
the	O	DET	O
antioxidant	O	NOUN	B
had	O	AUX	O
no	O	DET	O
appreciable	O	ADJ	O
effect	O	NOUN	B
when	O	SCONJ	O
an	O	DET	O
oligomer	O	NOUN	B
corresponding	O	VERB	O
to	O	PART	O
the	O	DET	O
consensus	B-DNA	NOUN	B
NF-kappa	I-DNA	NOUN	I
B	I-DNA	NOUN	I
binding	I-DNA	NOUN	I
site	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
E-selectin	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
(	O	PUNCT	O
E-selectin	B-protein	NOUN	B
-NF-kappa	B-protein	NOUN	O
B	I-protein	NOUN	O
)	O	PUNCT	O
was	O	AUX	O
used	O	VERB	O
.	O	PUNCT	O


We	O	PRON	O
here	O	ADV	O
report	O	VERB	O
that	O	SCONJ	O
(	O	PUNCT	O
i	O	X	O
)	O	PUNCT	O
like	O	ADP	O
PML-RAR	B-protein	NOUN	B
alpha	I-protein	NOUN	I
expression	O	NOUN	B
,	O	PUNCT	O
PLZF-RAR	B-protein	NOUN	B
alpha	I-protein	NOUN	I
expression	O	NOUN	B
blocks	O	VERB	I
terminal	O	ADJ	B
differentiation	O	NOUN	B
of	O	ADP	O
hematopoietic	O	ADJ	B
precursor	O	NOUN	I
cell	O	NOUN	I
lines	O	NOUN	I
(	O	PUNCT	O
U937	B-cell_line	NOUN	B
and	O	CCONJ	O
HL-60	B-cell_line	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
different	O	ADJ	O
stimuli	O	NOUN	B
(	O	PUNCT	O
vitamin	O	NOUN	B
D3	O	NOUN	I
,	O	PUNCT	O
transforming	O	VERB	B
growth	O	NOUN	I
factor	O	NOUN	I
beta1	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
dimethyl	O	ADJ	B
sulfoxide	O	NOUN	I
)	O	PUNCT	O
;	O	PUNCT	O
(	O	PUNCT	O
ii	O	X	O
)	O	PUNCT	O
PML-RAR	B-protein	NOUN	B
alpha	I-protein	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
PLZF-RAR	B-protein	NOUN	B
alpha	I-protein	NOUN	I
,	O	PUNCT	O
increases	O	VERB	B
RA	O	NOUN	B
sensitivity	O	NOUN	B
of	O	ADP	O
hematopoietic	B-cell_type	ADJ	B
precursor	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
restores	O	VERB	B
RA	O	NOUN	B
sensitivity	O	NOUN	B
of	O	ADP	O
RA-resistant	B-cell_type	ADJ	B
hematopoietic	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
;	O	PUNCT	O
(	O	PUNCT	O
iii	O	X	O
)	O	PUNCT	O
PML-RAR	B-protein	NOUN	B
alpha	I-protein	NOUN	I
and	O	CCONJ	O
PLZF-RAR	B-protein	NOUN	B
alpha	I-protein	NOUN	I
have	O	AUX	O
similar	O	ADJ	O
RA	O	NOUN	B
binding	O	NOUN	B
affinities	O	NOUN	B
;	O	PUNCT	O
and	O	CCONJ	O
(	O	PUNCT	O
iv	O	X	O
)	O	PUNCT	O
PML-RAR	B-protein	NOUN	B
alpha	I-protein	NOUN	I
enhances	O	VERB	B
the	O	DET	O
RA	O	NOUN	B
response	O	NOUN	B
of	O	ADP	O
RA	B-DNA	NOUN	B
target	I-DNA	NOUN	B
genes	I-DNA	NOUN	O
(	O	PUNCT	O
those	O	DET	O
for	O	ADP	O
RAR	B-protein	NOUN	B
beta	I-protein	NOUN	B
,	O	PUNCT	O
RAR	B-protein	NOUN	B
gamma	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
transglutaminase	B-protein	NOUN	B
type	I-protein	NOUN	I
II	I-protein	NUM	I
[	O	PUNCT	I
TGase	B-protein	NOUN	B
]	O	PUNCT	O
)	O	PUNCT	O
in	O	X	B
vivo	O	X	I
,	O	PUNCT	O
while	O	SCONJ	O
PLZF-RAR	B-protein	NOUN	B
alpha	I-protein	NOUN	I
expression	O	NOUN	B
has	O	AUX	O
either	O	CCONJ	O
no	O	DET	B
effect	O	NOUN	I
(	O	PUNCT	O
RAR	B-protein	NOUN	B
beta	I-protein	NOUN	I
)	O	PUNCT	O
or	O	CCONJ	O
an	O	DET	O
inhibitory	O	ADJ	B
activity	O	NOUN	I
(	O	PUNCT	O
RAR	B-protein	NOUN	B
gamma	I-protein	NOUN	I
and	O	CCONJ	I
type	B-protein	NOUN	I
II	I-protein	NUM	I
TGase	I-protein	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
show	O	VERB	O
,	O	PUNCT	O
by	O	ADP	O
electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assays	O	NOUN	I
,	O	PUNCT	O
that	O	SCONJ	O
ascorbate	O	NOUN	B
increases	O	VERB	B
the	O	DET	O
binding	O	NOUN	B
of	O	ADP	O
NF-kappaB	B-protein	NOUN	B
to	O	PART	O
DNA	O	NOUN	B
in	O	ADP	O
TNF-alpha-stimulated	B-cell_line	ADJ	B
Jurkat	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Construction	O	NOUN	B
and	O	CCONJ	O
biological	O	ADJ	B
characterization	O	NOUN	B
of	O	ADP	O
an	O	DET	O
interleukin-12	B-protein	NOUN	B
fusion	I-protein	NOUN	I
protein	I-protein	NOUN	I
(	O	PUNCT	O
Flexi-12	B-protein	NOUN	B
)	O	PUNCT	O
:	O	PUNCT	O
delivery	O	NOUN	B
to	O	PART	O
acute	B-cell_type	ADJ	B
myeloid	I-cell_type	ADJ	I
leukemic	I-cell_type	ADJ	I
blasts	I-cell_type	NOUN	I
using	O	VERB	O
adeno-associated	O	ADJ	B
virus	O	NOUN	I
.	O	PUNCT	O


Production	O	NOUN	B
of	O	ADP	O
functional	B-protein	ADJ	B
IL-12	I-protein	NOUN	B
requires	O	VERB	O
the	O	DET	O
coordinated	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
both	O	DET	O
genes	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
studies	O	NOUN	B
also	O	ADV	O
confirm	O	VERB	O
that	O	SCONJ	O
AAV	O	PROPN	B
is	O	AUX	O
an	O	DET	O
efficient	O	ADJ	B
delivery	O	NOUN	B
vehicle	O	NOUN	I
for	O	ADP	O
cytokines	B-protein	NOUN	B
to	O	PART	O
leukemic	O	ADJ	B
cells	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
experiments	O	NOUN	B
reported	O	VERB	O
in	O	ADP	O
this	O	DET	O
study	O	NOUN	B
were	O	AUX	O
designed	O	VERB	O
to	O	PART	O
address	O	VERB	O
the	O	DET	O
signaling	O	NOUN	B
events	O	NOUN	O
triggered	O	VERB	B
by	O	ADP	I
TCR	B-protein	NOUN	B
engagement	O	NOUN	B
that	O	PRON	O
are	O	AUX	O
important	O	ADJ	O
for	O	ADP	O
regulating	O	VERB	B
CD95	B-protein	NOUN	B
ligand	I-protein	NOUN	O
gene	O	NOUN	B
expression	O	NOUN	I
.	O	PUNCT	O


This	O	DET	O
paper	O	NOUN	O
reviews	O	VERB	B
the	O	DET	O
considerable	O	ADJ	O
data	O	NOUN	B
available	O	ADJ	O
relating	O	VERB	O
ROS	O	NOUN	B
activity	O	NOUN	B
and	O	CCONJ	O
antioxidant	O	ADJ	B
defence	O	NOUN	I
to	O	PART	O
inflammatory	O	ADJ	B
diseases	O	NOUN	I
and	O	CCONJ	O
attempts	O	VERB	B
to	O	PART	O
draw	O	VERB	O
parallels	O	NOUN	O
with	O	ADP	O
periodontitis	O	NOUN	B
,	O	PUNCT	O
in	O	ADP	O
an	O	DET	O
effort	O	NOUN	O
to	O	PART	O
stimulate	O	VERB	B
more	O	ADV	O
periodontal	O	ADJ	B
research	O	NOUN	O
in	O	ADP	O
this	O	DET	O
important	O	ADJ	O
area	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
one	O	NUM	O
case	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
PTT	O	PROPN	B
shift	O	NOUN	B
was	O	AUX	O
explained	O	VERB	O
by	O	ADP	O
in-frame	O	ADJ	B
splicing	O	NOUN	I
out	O	ADP	O
of	O	ADP	O
exon	B-RNA	NOUN	B
10	I-RNA	NUM	O
,	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
a	O	DET	O
normal	B-DNA	ADJ	O
exon	I-DNA	NOUN	O
10	I-DNA	NUM	O
genomic	I-DNA	ADJ	B
sequence	I-DNA	NOUN	I
.	O	PUNCT	O


Confirmed	O	ADJ	B
mutations	O	NOUN	B
were	O	AUX	O
identified	O	VERB	B
in	O	ADP	O
28	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
the	O	DET	O
families	O	NOUN	B
studied	O	VERB	B
and	O	CCONJ	O
on	O	ADP	O
the	O	DET	O
assumption	O	NOUN	O
that	O	SCONJ	O
half	O	NOUN	O
of	O	ADP	O
the	O	DET	O
sporadic	O	ADJ	B
cases	O	NOUN	B
should	O	AUX	O
have	O	AUX	O
TSC2	B-DNA	NOUN	B
mutations	I-DNA	NOUN	B
,	O	PUNCT	O
a	O	DET	O
crude	O	ADJ	B
estimate	O	NOUN	B
of	O	ADP	O
the	O	DET	O
detection	O	NOUN	B
rate	O	NOUN	B
would	O	AUX	O
be	O	AUX	O
60	O	NUM	O
%	O	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
conclusion	O	NOUN	O
,	O	PUNCT	O
we	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
vitamin	O	NOUN	B
E	O	NOUN	I
derivative	O	ADJ	I
TCP	O	NOUN	B
succinate	O	NOUN	B
prevents	O	VERB	O
monocytic	O	ADJ	B
cell	O	NOUN	I
adhesion	O	NOUN	O
to	O	PART	O
cytokine-stimulated	O	ADJ	B
endothelial	B-cell_type	ADJ	O
cells	I-cell_type	NOUN	O
by	O	ADP	O
inhibiting	O	VERB	B
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
,	O	PUNCT	O
further	O	ADV	O
emphasizing	O	VERB	O
the	O	DET	O
antiatherosclerotic	O	ADJ	B
potential	O	NOUN	B
of	O	ADP	O
lipid	O	NOUN	B
soluble	O	ADJ	O
antioxidants	O	NOUN	B
.	O	PUNCT	O


Using	O	VERB	O
a	O	DET	O
fragment	O	NOUN	B
of	O	ADP	I
K	B-protein	NOUN	I
protein	I-protein	NOUN	I
as	O	ADP	O
bait	O	NOUN	B
in	O	ADP	O
the	O	DET	O
yeast	O	NOUN	B
two-hybrid	O	ADJ	B
screen	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
isolated	O	VERB	B
a	O	DET	O
cDNA	B-DNA	NOUN	B
that	O	PRON	O
encodes	O	VERB	B
a	O	DET	O
protein	O	NOUN	B
whose	O	DET	O
primary	O	ADJ	B
structure	O	NOUN	I
has	O	AUX	O
extensive	O	ADJ	O
similarity	O	NOUN	B
to	O	PART	O
the	O	DET	O
Drosophila	B-protein	X	B
melanogaster	I-protein	X	O
extra	I-protein	X	B
sex	I-protein	NOUN	I
combs	I-protein	NOUN	I
(	I-protein	PUNCT	O
esc	I-protein	NOUN	B
)	I-protein	PUNCT	O
gene	I-protein	NOUN	O
product	I-protein	NOUN	O
,	O	PUNCT	O
Esc	B-protein	NOUN	B
,	O	PUNCT	O
a	O	DET	O
putative	O	ADJ	O
silencer	O	NOUN	O
of	O	ADP	O
homeotic	B-DNA	ADJ	B
genes	I-DNA	NOUN	I
.	O	PUNCT	O


Eed	B-protein	NOUN	B
also	O	ADV	O
represses	O	VERB	B
transcription	O	NOUN	B
when	O	SCONJ	O
recruited	O	VERB	O
to	O	PART	O
a	O	DET	O
target	O	NOUN	B
promoter	O	NOUN	B
by	O	ADP	O
Gal4-K	B-protein	NOUN	B
protein	I-protein	NOUN	I
.	O	PUNCT	O


Interferons	B-protein	NOUN	B
up-regulate	O	VERB	B
STAT1	B-protein	NOUN	B
,	O	PUNCT	O
STAT2	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
IRF	B-protein	NOUN	B
family	O	NOUN	I
transcription	O	NOUN	I
factor	O	NOUN	I
gene	O	NOUN	I
expression	O	NOUN	O
in	O	ADP	O
human	B-cell_type	ADJ	B
peripheral	I-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
mononuclear	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
macrophages	B-cell_type	NOUN	B
.	O	PUNCT	O


IRF-2	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
was	O	AUX	O
apparently	O	ADV	O
only	O	ADV	O
weakly	O	ADV	O
responsive	O	ADJ	B
to	O	PART	O
IFNs	B-protein	NOUN	B
in	O	ADP	O
these	O	DET	O
cells	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
studies	O	NOUN	B
demonstrate	O	VERB	O
that	O	SCONJ	O
E2a-Pbx1	B-protein	NOUN	B
initiates	O	VERB	B
programmed	O	VERB	B
cell	O	NOUN	I
death	O	NOUN	I
of	O	ADP	O
hematopoietic	B-cell_type	ADJ	B
precursers	I-cell_type	NOUN	I
by	O	ADP	O
a	O	DET	O
mechanism	O	NOUN	B
that	O	PRON	O
requires	O	VERB	O
its	O	PRON	O
chimeric	O	ADJ	B
transcriptional	O	ADJ	B
properties	O	NOUN	O
,	O	PUNCT	O
but	O	CCONJ	O
,	O	PUNCT	O
unlike	O	ADP	O
other	O	ADJ	O
nuclear	B-protein	ADJ	B
oncoproteins	I-protein	NOUN	I
,	O	PUNCT	O
is	O	AUX	O
independent	O	ADJ	O
of	O	ADP	O
p53	B-protein	NOUN	B
.	O	PUNCT	O


These	O	DET	O
transcripts	O	NOUN	B
can	O	AUX	O
encode	O	VERB	B
three	O	NUM	O
proteins	O	NOUN	B
of	O	ADP	O
calculated	O	VERB	B
molecular	O	ADJ	B
mass	O	NOUN	I
32.2	B-RNA	NUM	O
kDa	I-RNA	NOUN	O
,	O	PUNCT	O
27.8	B-RNA	NUM	O
kDa	I-RNA	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
14.3	B-RNA	NUM	O
kDa	I-RNA	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
previously	O	ADV	O
showed	O	VERB	O
that	O	SCONJ	O
PO-B	B-protein	NOUN	B
DNA-binding	O	NOUN	B
is	O	AUX	O
progressively	O	ADV	O
induced	O	VERB	B
during	O	ADP	O
differentiation	O	NOUN	B
of	O	ADP	O
promyelomonocytic	B-cell_line	ADJ	B
leukemic	I-cell_line	ADJ	O
HL-60	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
to	O	PART	O
the	O	DET	O
macrophage-like	B-cell_type	ADJ	B
lineage	I-cell_type	NOUN	I
(	O	PUNCT	O
with	O	ADP	O
phorbol	O	NOUN	B
esters	O	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


In	O	ADP	O
gel	O	NOUN	B
mobility	O	NOUN	O
shift	O	NOUN	O
assays	O	NOUN	O
,	O	PUNCT	O
hT86	O	NOUN	O
attenuated	O	VERB	B
the	O	DET	O
intensity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
retarded	O	VERB	B
band	O	NOUN	B
composed	O	VERB	O
of	O	ADP	O
the	O	DET	O
octamer	B-DNA	NOUN	B
probe	I-DNA	NOUN	I
and	O	CCONJ	O
Oct-2	B-protein	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
a	O	DET	O
dominant	O	ADJ	B
negative	O	ADJ	B
effect	O	NOUN	O
on	O	ADP	O
the	O	DET	O
DNA-binding	O	ADJ	B
activity	O	NOUN	O
of	O	ADP	O
Oct-2	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
strategy	O	NOUN	O
described	O	VERB	O
here	O	ADV	O
provides	O	VERB	O
a	O	DET	O
new	O	ADJ	O
approach	O	NOUN	O
for	O	ADP	O
studying	O	VERB	O
protein-protein	O	ADJ	B
interactions	O	NOUN	I
that	O	PRON	O
govern	O	VERB	O
the	O	DET	O
complex	O	ADJ	B
regulation	O	NOUN	B
of	O	ADP	O
gene	O	NOUN	B
expression	O	NOUN	I
.	O	PUNCT	O


Leukocyte	B-protein	NOUN	B
integrins	I-protein	NOUN	I
are	O	AUX	O
fundamentally	O	ADV	O
important	O	ADJ	O
in	O	ADP	O
modulating	O	VERB	B
adhesion	O	NOUN	B
to	O	PART	O
extracellular	O	ADJ	B
matrix	O	NOUN	I
components	O	NOUN	B
and	O	CCONJ	O
to	O	PART	O
other	O	ADJ	O
cells	O	NOUN	B
.	O	PUNCT	O


Moreover	O	ADV	O
,	O	PUNCT	O
integrin	B-protein	NOUN	B
-ligand	O	NOUN	O
interactions	O	NOUN	B
trigger	O	VERB	O
signaling	O	NOUN	B
pathways	O	NOUN	I
that	O	PRON	O
may	O	AUX	O
influence	O	VERB	B
leukocyte	O	NOUN	B
phenotype	O	NOUN	B
and	O	CCONJ	O
function	O	NOUN	B
at	O	ADP	O
sites	O	NOUN	B
of	O	ADP	O
inflammation	O	NOUN	B
.	O	PUNCT	O


By	O	ADP	O
electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assays	O	NOUN	I
,	O	PUNCT	O
this	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
mRNA	B-RNA	NOUN	B
was	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
a	O	DET	O
5-	O	NUM	O
to	O	PART	O
10-fold	O	ADJ	O
increase	O	NOUN	B
in	O	ADP	O
the	O	DET	O
STAT1-containing	B-protein	ADJ	B
DNA-binding	I-protein	ADJ	I
complex	I-protein	NOUN	I
that	O	PRON	O
binds	O	VERB	B
to	O	PART	O
Fc	B-DNA	NOUN	B
gammaRI	I-DNA	NOUN	I
promoter	I-DNA	NOUN	B
elements	I-DNA	NOUN	I
.	O	PUNCT	O


The	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
many	O	ADJ	O
genes	O	NOUN	B
for	O	ADP	O
which	O	DET	O
products	O	NOUN	B
are	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
inflammation	O	NOUN	B
is	O	AUX	O
controlled	O	VERB	B
by	O	ADP	O
the	O	DET	O
transcriptional	B-protein	ADJ	B
regulator	I-protein	NOUN	I
nuclear	I-protein	ADJ	O
factor	I-protein	NOUN	O
(	I-protein	PUNCT	O
NF	I-protein	NOUN	B
)	I-protein	PUNCT	O
-kappa	I-protein	NOUN	O
B	I-protein	NOUN	O
.	O	PUNCT	O


Activation	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
in	O	ADP	O
THP-1	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
by	O	ADP	O
SP-A	B-protein	NOUN	B
doses	O	NOUN	B
as	O	ADV	O
low	O	ADJ	O
as	O	ADP	O
1	O	NUM	O
microgram/ml	O	NOUN	O
occurred	O	VERB	O
within	O	ADP	O
30	O	NUM	O
min	O	NOUN	O
of	O	ADP	O
SP-A	B-protein	NOUN	B
treatment	O	NOUN	B
,	O	PUNCT	O
peaked	O	VERB	O
at	O	ADP	O
60	O	NUM	O
min	O	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
then	O	ADV	O
declined	O	VERB	B
.	O	PUNCT	O


GABP	B-protein	NOUN	B
factors	I-protein	NOUN	I
bind	O	VERB	B
to	O	PART	O
a	O	DET	O
distal	B-DNA	ADJ	B
interleukin	I-DNA	NOUN	I
2	I-DNA	NUM	I
(	I-DNA	PUNCT	O
IL-2	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
enhancer	I-DNA	NOUN	B
and	O	CCONJ	O
contribute	O	VERB	O
to	O	PART	O
c-Raf	B-protein	NOUN	B
-mediated	O	ADJ	O
increase	O	NOUN	B
in	O	ADP	O
IL-2	B-protein	NOUN	B
induction	O	NOUN	B
.	O	PUNCT	O


Overexpression	O	NOUN	B
of	O	ADP	O
BXB	B-protein	NOUN	B
,	O	PUNCT	O
a	O	DET	O
constitutive	O	ADJ	B
active	O	ADJ	O
version	O	NOUN	O
of	O	ADP	O
c-Raf	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
of	O	ADP	O
further	O	ADJ	O
members	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Ras	B-protein	NOUN	B
-	O	PUNCT	O
Raf	B-protein	PROPN	B
-	O	PUNCT	O
Erk	B-protein	NOUN	B
signal	O	NOUN	B
cascade	O	NOUN	I
exerted	O	VERB	O
an	O	DET	O
increase	O	NOUN	B
of	O	ADP	O
GABP	B-protein	NOUN	B
-mediated	O	ADJ	O
promoter-enhancer	O	ADJ	B
induction	O	NOUN	I
.	O	PUNCT	O


Regulation	O	NOUN	B
by	O	ADP	O
Egr-1	B-protein	NOUN	B
,	O	PUNCT	O
c-Jun	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
NF-kappaB	B-protein	NOUN	B
transcription	B-protein	NOUN	I
factors	I-protein	NOUN	I
.	O	PUNCT	O


Rescue	O	NOUN	B
by	O	ADP	O
cytokines	B-protein	NOUN	B
of	O	ADP	O
apoptotic	O	ADJ	B
cell	O	NOUN	I
death	O	NOUN	I
induced	O	VERB	B
by	O	ADP	O
IL-2	B-protein	NOUN	B
deprivation	O	NOUN	B
of	O	ADP	O
human	B-cell_line	ADJ	B
antigen-specific	I-cell_line	ADJ	O
T	I-cell_line	NOUN	O
cell	I-cell_line	NOUN	O
clones	I-cell_line	NOUN	O
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
IL-10	B-protein	NOUN	B
did	O	AUX	O
not	O	PART	O
affect	O	VERB	O
IFN-gamma	B-protein	NOUN	B
-induced	O	ADJ	O
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	B
of	O	ADP	O
STAT-1alpha	B-protein	NOUN	B
or	O	CCONJ	O
alter	O	VERB	O
STAT-1alpha	B-protein	NOUN	B
binding	O	NOUN	I
to	O	PART	O
the	O	DET	O
IFN-gamma	B-DNA	NOUN	B
response	I-DNA	NOUN	O
element	I-DNA	NOUN	O
(	O	PUNCT	O
IRE	B-DNA	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
ICAM-1	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
IL-10	B-protein	NOUN	B
inhibits	O	VERB	B
IFN-gamma	B-protein	NOUN	B
-induced	O	ADJ	O
transcription	O	NOUN	B
of	O	ADP	O
the	O	DET	O
ICAM-1	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
by	O	ADP	O
a	O	DET	O
regulatory	O	ADJ	B
mechanism	O	NOUN	B
that	O	PRON	O
may	O	AUX	O
involve	O	VERB	O
NF-kappaB	B-protein	NOUN	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
these	O	DET	O
plasmids	B-DNA	NOUN	B
were	O	AUX	O
not	O	PART	O
active	O	ADJ	O
in	O	ADP	O
RJ2.2.5	B-cell_line	NOUN	B
,	O	PUNCT	O
an	O	DET	O
in	O	X	B
vitro	O	X	I
mutagenized	O	VERB	B
derivative	O	NOUN	B
of	O	ADP	O
Raji	B-cell_line	NOUN	B
in	O	ADP	O
which	O	DET	O
both	O	DET	O
copies	O	NOUN	B
of	O	ADP	O
CIITA	B-protein	NOUN	B
are	O	AUX	O
defective	O	ADJ	B
.	O	PUNCT	O


Following	O	VERB	O
TcR	B-protein	NOUN	B
stimulation	O	NOUN	B
,	O	PUNCT	O
activation	O	NOUN	B
of	O	ADP	O
Erk2	B-protein	NOUN	B
was	O	AUX	O
only	O	ADV	O
inhibited	O	VERB	B
by	O	ADP	O
a	O	DET	O
previously	O	ADV	O
described	O	VERB	O
truncated	B-protein	VERB	B
form	I-protein	NOUN	O
of	I-protein	ADP	O
p85	I-protein	NOUN	B
that	O	PRON	O
can	O	AUX	O
not	O	PART	O
bind	O	VERB	B
the	O	DET	O
catalytic	B-protein	ADJ	B
subunit	I-protein	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
by	O	ADP	O
other	O	ADJ	O
constructs	O	NOUN	B
of	O	ADP	O
p85	B-protein	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
several	O	ADJ	O
mutant	O	ADJ	B
p85	B-protein	NOUN	O
alleles	O	NOUN	O
had	O	AUX	O
dramatic	O	ADJ	O
effects	O	NOUN	O
on	O	ADP	O
NFAT	B-protein	NOUN	B
activation	O	NOUN	B
.	O	PUNCT	O


Analysis	O	NOUN	B
of	O	ADP	O
phosphotyrosine-containing	B-protein	ADJ	B
proteins	I-protein	NOUN	I
bound	O	VERB	O
to	O	PART	O
truncated	O	VERB	B
p85	B-protein	NOUN	O
constructs	I-protein	NOUN	O
revealed	O	VERB	O
cooperative	O	ADJ	B
binding	O	NOUN	I
of	O	ADP	O
the	O	DET	O
two	B-protein	NUM	O
SH2	I-protein	NOUN	B
domains	I-protein	NOUN	I
but	O	CCONJ	O
no	O	DET	O
apparent	O	ADJ	O
differences	O	NOUN	O
between	O	ADP	O
the	O	DET	O
N-	B-protein	NOUN	B
and	I-protein	CCONJ	O
C-	I-protein	NOUN	O
terminal	I-protein	ADJ	O
SH2	I-protein	NOUN	B
domains	I-protein	NOUN	I
.	O	PUNCT	O


Wortmannin	O	NOUN	B
did	O	AUX	O
not	O	PART	O
interfere	O	VERB	B
with	O	ADP	I
NFAT	B-protein	NOUN	B
activation	O	NOUN	B
,	O	PUNCT	O
although	O	SCONJ	O
it	O	PRON	O
inhibited	O	VERB	B
PI3-K	B-protein	NOUN	B
and	O	CCONJ	O
Erk2	B-protein	NOUN	B
activation	O	NOUN	B
in	O	ADP	O
the	O	DET	O
same	O	ADJ	O
experiment	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
generated	O	VERB	O
transgenic	O	ADJ	B
mice	O	NOUN	I
in	O	ADP	O
which	O	DET	O
the	O	DET	O
PML/RARalpha	B-protein	NOUN	B
fusion	I-protein	NOUN	I
protein	I-protein	NOUN	I
is	O	AUX	O
specifically	O	ADV	O
expressed	O	VERB	B
in	O	ADP	O
the	O	DET	O
myeloid-promyelocytic	B-cell_type	ADJ	B
lineage	I-cell_type	NOUN	I
.	O	PUNCT	O


During	O	ADP	O
their	O	PRON	O
first	O	ADJ	O
year	O	NOUN	B
of	O	ADP	O
life	O	NOUN	O
,	O	PUNCT	O
all	O	DET	O
the	O	DET	O
PML/	O	NOUN	B
RARalpha	B-protein	NOUN	B
transgenic	O	ADJ	B
mice	O	NOUN	I
have	O	AUX	O
an	O	DET	O
abnormal	O	ADJ	B
hematopoiesis	O	NOUN	B
that	O	PRON	O
can	O	AUX	O
best	O	ADV	O
be	O	AUX	O
described	O	VERB	O
as	O	ADP	O
a	O	DET	O
myeloproliferative	O	ADJ	B
disorder	O	NOUN	I
.	O	PUNCT	O


Constitutive	O	ADJ	B
and	O	CCONJ	O
inducible	O	ADJ	B
protein/DNA	O	NOUN	B
interactions	O	NOUN	I
of	O	ADP	O
the	O	DET	O
IFN-gamma	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
in	O	X	B
vivo	O	X	I
were	O	AUX	O
detected	O	VERB	B
in	O	ADP	O
all	O	DET	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
tested	O	VERB	B
.	O	PUNCT	O


Interestingly	O	ADV	O
,	O	PUNCT	O
an	O	DET	O
inducible	O	ADJ	B
footprint	O	NOUN	O
between	O	ADP	O
-183	B-DNA	NUM	O
and	I-DNA	CCONJ	O
-196	I-DNA	NUM	O
was	O	AUX	O
consistently	O	ADV	O
observed	O	VERB	B
in	O	ADP	O
Jurkat	B-cell_line	NOUN	B
T	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
and	O	CCONJ	O
CD45RA	B-cell_type	NOUN	B
and	I-cell_type	CCONJ	O
CD45R0	I-cell_type	NOUN	B
T	I-cell_type	NOUN	I
helper	I-cell_type	NOUN	I
subsets	I-cell_type	NOUN	I
upon	O	SCONJ	O
stimulation	O	NOUN	B
with	O	ADP	O
phorbol	O	NOUN	B
12-myristate	O	NOUN	I
13-acetate+	O	NUM	I
phytohemagglutinin	B-protein	NOUN	I
(	O	PUNCT	O
PMA+	O	ADJ	B
PHA	B-protein	NOUN	I
)	O	PUNCT	O
that	O	PRON	O
was	O	AUX	O
highly	O	ADV	O
sensitive	O	ADJ	B
to	O	PART	O
treatment	O	NOUN	B
with	O	ADP	O
corticosteroids	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
propose	O	VERB	O
a	O	DET	O
model	O	NOUN	B
where	O	SCONJ	O
basal	O	ADJ	B
transcription	O	NOUN	I
is	O	AUX	O
maintained	O	VERB	O
by	O	ADP	O
binding	O	NOUN	B
of	O	ADP	O
various	O	ADJ	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
to	O	PART	O
the	O	DET	O
IFN-gamma	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
,	O	PUNCT	O
whereas	O	SCONJ	O
PMA+	O	ADJ	B
PHA	B-protein	NOUN	B
-inducible	O	ADJ	O
IFN-gamma	B-protein	NOUN	B
transcription	O	NOUN	B
in	O	ADP	O
CD45R0	B-cell_type	NOUN	B
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
is	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
binding	O	NOUN	B
of	O	ADP	O
AP-1	B-protein	NOUN	B
to	O	PART	O
the	O	DET	O
C-site	B-DNA	NOUN	B
.	O	PUNCT	O


ZEBRA	B-protein	NOUN	B
is	O	AUX	O
also	O	ADV	O
indispensable	O	ADJ	O
for	O	ADP	O
viral	O	ADJ	B
replication	O	NOUN	I
and	O	CCONJ	O
binds	O	VERB	B
directly	O	ADV	O
to	O	PART	O
the	O	DET	O
EBV	O	NOUN	B
lytic	O	ADJ	B
origin	O	NOUN	I
of	O	ADP	O
replication	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
tissue-specific	B-DNA	ADJ	B
core	I-DNA	NOUN	I
promoter	I-DNA	NOUN	B
structure	I-DNA	NOUN	I
is	O	AUX	O
apparently	O	ADV	O
conserved	O	VERB	O
in	O	ADP	O
other	O	ADJ	O
T-cell-specifically	B-DNA	ADV	B
expressed	I-DNA	VERB	O
genes	I-DNA	NOUN	O
such	O	ADJ	O
as	O	ADP	O
the	O	DET	O
CD4	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
.	O	PUNCT	O


The	O	DET	O
human	B-cell_line	ADJ	B
monocytic	I-cell_line	ADJ	O
cell	I-cell_line	NOUN	O
line	I-cell_line	NOUN	O
THP-1	B-cell_line	NOUN	B
mimics	O	VERB	O
PAM	B-cell_type	NOUN	B
in	O	ADP	O
1	O	NUM	O
,	O	PUNCT	O
25	O	NUM	O
(	O	PUNCT	O
OH	O	NOUN	B
)	O	PUNCT	O
2D3	O	NOUN	B
synthesis	O	NOUN	I
and	O	CCONJ	O
sensitivity	O	NOUN	B
to	O	PART	O
exogenous	O	ADJ	B
1	O	NUM	O
,	O	PUNCT	O
25	O	NUM	O
(	O	PUNCT	O
OH	O	NOUN	B
)	O	PUNCT	O
2D3	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
utilized	O	VERB	O
THP-1	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
to	O	PART	O
examine	O	VERB	O
the	O	DET	O
response	O	NOUN	B
to	O	PART	O
1	O	NUM	O
,	O	PUNCT	O
25	O	NUM	O
(	O	PUNCT	O
OH	O	NOUN	B
)	O	PUNCT	O
2D3	O	NOUN	O
with	O	ADP	O
macrophage	O	NOUN	B
activation	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
antagonistic	O	ADJ	B
effects	O	NOUN	I
of	O	ADP	O
gamma-IFN	B-protein	NOUN	B
are	O	AUX	O
not	O	PART	O
merely	O	ADV	O
restricted	O	ADJ	O
to	O	PART	O
enzymatic	O	ADJ	B
activities	O	NOUN	I
.	O	PUNCT	O


CIITA	B-protein	NOUN	B
is	O	AUX	O
a	O	DET	O
positive	O	ADJ	O
regulator	O	NOUN	B
of	O	ADP	O
class	B-DNA	NOUN	B
II	I-DNA	NUM	I
major	I-DNA	ADJ	I
histocompatibility	I-DNA	NOUN	I
complex	I-DNA	NOUN	I
gene	I-DNA	NOUN	B
transcription	O	NOUN	I
that	O	PRON	O
has	O	AUX	O
been	O	AUX	O
found	O	VERB	O
to	O	PART	O
be	O	AUX	O
defective	O	ADJ	B
in	O	ADP	O
one	O	NUM	O
of	O	ADP	O
the	O	DET	O
five	O	NUM	O
complementation	O	NOUN	B
groups	O	NOUN	O
of	O	ADP	O
class	B-cell_line	NOUN	B
II	I-cell_line	NUM	I
major	I-cell_line	ADJ	I
histocompatibility	I-cell_line	NOUN	I
complex-negative	I-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
.	O	PUNCT	O


Cyclin	B-protein	NOUN	B
A	I-protein	NOUN	I
was	O	AUX	O
observed	O	VERB	O
after	O	ADP	O
4	O	NUM	O
days	O	NOUN	B
of	O	ADP	O
costimulation	O	NOUN	B
with	O	ADP	O
anti	B-protein	ADJ	B
CD2	I-protein	NOUN	I
+	O	CCONJ	O
CD28	B-protein	NOUN	B
whereas	O	SCONJ	O
stimulation	O	NOUN	B
by	O	ADP	O
anti	B-protein	ADJ	B
CD2	I-protein	NOUN	I
or	O	CCONJ	O
anti	B-protein	ADJ	B
CD28	I-protein	NOUN	B
alone	O	ADV	O
was	O	AUX	O
not	O	PART	O
effective	O	ADJ	B
.	O	PUNCT	O


They	O	PRON	O
bind	O	VERB	B
in	O	X	B
vitro	O	X	I
respectively	O	ADV	O
ATF-1	B-protein	NOUN	B
and	O	CCONJ	O
NF-Y	B-protein	NOUN	B
proteins	I-protein	NOUN	I
.	O	PUNCT	O


Consistent	O	ADJ	B
with	O	ADP	I
theses	O	DET	O
results	O	NOUN	B
,	O	PUNCT	O
nuclear	O	ADJ	B
extracts	O	NOUN	I
prepared	O	VERB	O
from	O	ADP	O
quiescent	O	ADJ	B
cells	O	NOUN	I
formed	O	VERB	O
a	O	DET	O
specific	O	ADJ	O
complex	O	NOUN	B
with	O	ADP	O
this	O	DET	O
element	O	NOUN	B
,	O	PUNCT	O
whereas	O	SCONJ	O
extracts	O	NOUN	B
prepared	O	VERB	O
from	O	ADP	O
cells	O	NOUN	B
treated	O	VERB	B
with	O	ADP	I
anti	B-protein	ADJ	B
CD2	I-protein	NOUN	I
+	O	CCONJ	O
anti	B-protein	ADJ	B
CD28	I-protein	NOUN	B
failed	O	VERB	B
to	O	PART	O
do	O	AUX	O
so	O	ADV	O
after	O	ADP	O
cells	O	NOUN	B
entered	O	VERB	O
a	O	DET	O
proliferative	O	ADJ	B
state	O	NOUN	I
.	O	PUNCT	O


T	B-protein	NOUN	B
cell	I-protein	NOUN	I
receptor	I-protein	NOUN	I
(	I-protein	PUNCT	O
TCR	I-protein	NOUN	O
)	I-protein	PUNCT	O
alpha	I-protein	NOUN	O
and	O	CCONJ	O
delta	O	NOUN	B
gene	O	NOUN	I
segments	O	NOUN	O
are	O	AUX	O
organized	O	VERB	B
within	O	ADP	O
a	O	DET	O
single	O	ADJ	O
genetic	O	ADJ	B
locus	O	NOUN	I
but	O	CCONJ	O
are	O	AUX	O
differentially	O	ADV	O
regulated	O	VERB	O
during	O	ADP	O
T	O	NOUN	B
cell	O	NOUN	I
development	O	NOUN	B
.	O	PUNCT	O


Cells	O	NOUN	B
in	O	ADP	O
the	O	DET	O
B	O	NOUN	B
series	O	NOUN	B
with	O	ADP	O
4C	O	NOUN	B
DNA	O	NOUN	I
content	O	NOUN	I
(	O	PUNCT	O
100B	O	NOUN	O
and	O	CCONJ	O
200B	O	NOUN	B
)	O	PUNCT	O
also	O	ADV	O
differed	O	VERB	O
from	O	ADP	O
the	O	DET	O
A	B-cell_line	NOUN	O
series	I-cell_line	NOUN	B
4C	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	O
by	O	ADP	O
the	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
DNA	O	NOUN	B
binding	O	NOUN	I
by	O	ADP	O
the	O	DET	O
full-length	O	ADJ	B
Sp1	B-protein	NOUN	B
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
show	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
initial	O	ADJ	O
steps	O	NOUN	B
in	O	ADP	O
the	O	DET	O
1	O	NUM	O
,	O	PUNCT	O
25D3	O	NOUN	B
signaling	O	NOUN	I
pathway	O	NOUN	I
are	O	AUX	O
intact	O	ADJ	B
in	O	ADP	O
B	O	NOUN	B
series	O	NOUN	I
resistant	O	ADJ	I
cells	O	NOUN	I
and	O	CCONJ	O
lead	O	VERB	O
to	O	PART	O
the	O	DET	O
appearance	O	NOUN	B
of	O	ADP	O
early	O	ADJ	B
markers	O	NOUN	B
of	O	ADP	O
monocytic	O	ADJ	B
differentiation	O	NOUN	I
.	O	PUNCT	O


Tat	O	NOUN	B
also	O	ADV	O
superactivates	O	VERB	B
the	O	DET	O
HIV-1	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
through	O	ADP	O
a	O	DET	O
TAR	B-DNA	NOUN	B
-independent	O	ADJ	O
mechanism	O	NOUN	B
,	O	PUNCT	O
including	O	VERB	O
tumor	O	NOUN	B
necrosis	O	NOUN	I
factor	O	NOUN	I
alpha-induced	O	ADJ	I
and	O	CCONJ	I
protein	O	NOUN	B
kinase	O	NOUN	I
C	O	NOUN	I
(	O	PUNCT	O
PKC	B-protein	NOUN	B
)	O	PUNCT	O
-dependent	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
inhibitors	O	NOUN	B
of	O	ADP	O
Tat	B-protein	NOUN	B
and	O	CCONJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
cooperatively	O	ADV	O
down-regulate	O	VERB	B
this	O	DET	O
Tat	B-protein	NOUN	B
-mediated	O	ADJ	O
LTR	B-DNA	NOUN	B
superactivation	O	NOUN	B
.	O	PUNCT	O


There	O	PRON	O
are	O	AUX	O
other	O	ADJ	O
elements	O	NOUN	O
regulating	O	VERB	B
IL-4	B-DNA	NOUN	B
gene	I-DNA	NOUN	B
expression	O	NOUN	I
,	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
relative	O	ADJ	O
importance	O	NOUN	O
of	O	ADP	O
these	O	DET	O
recently	O	ADV	O
identified	O	VERB	B
proteins	O	NOUN	B
has	O	AUX	O
yet	O	ADV	O
to	O	PART	O
be	O	AUX	O
determined	O	VERB	O
.	O	PUNCT	O


Previous	O	ADJ	O
reports	O	NOUN	B
have	O	AUX	O
suggested	O	VERB	O
the	O	DET	O
CD28	B-protein	NOUN	B
stimulation	O	NOUN	B
contributes	O	VERB	O
to	O	PART	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IL-2	B-DNA	NOUN	B
promoter	I-DNA	NOUN	O
by	O	ADP	O
up-regulating	O	VERB	B
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
several	O	ADJ	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
AP-1	B-protein	NOUN	B
and	O	CCONJ	O
nuclear	B-protein	ADJ	B
factor-kappaB	I-protein	NOUN	I
(	I-protein	PUNCT	I
NF-kappaB	I-protein	NOUN	B
)	I-protein	PUNCT	O
/Rel	I-protein	NOUN	B
family	I-protein	NOUN	B
members	I-protein	NOUN	I
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
an	O	DET	O
uncharacterized	B-protein	ADJ	B
transcription	I-protein	NOUN	B
factor	I-protein	NOUN	I
called	O	VERB	O
CD28	B-protein	NOUN	B
response	O	NOUN	I
complex	O	NOUN	I
.	O	PUNCT	O


Recent	O	ADJ	O
studies	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
CD28	B-DNA	NOUN	B
response	I-DNA	NOUN	I
element	I-DNA	NOUN	I
(	O	PUNCT	O
CD28RE	B-DNA	NOUN	B
)	O	PUNCT	O
does	O	AUX	O
not	O	PART	O
function	O	VERB	B
independently	O	ADV	O
but	O	CCONJ	O
works	O	VERB	O
instead	O	ADV	O
in	O	ADP	O
conjunction	O	NOUN	B
with	O	ADP	O
the	O	DET	O
adjacent	B-DNA	ADJ	B
promoter	I-DNA	NOUN	B
proximal	I-DNA	ADJ	I
AP-1-binding	I-DNA	ADJ	B
site	I-DNA	NOUN	I
and	O	CCONJ	O
this	O	DET	O
hypothesis	O	NOUN	B
is	O	AUX	O
confirmed	O	VERB	O
here	O	ADV	O
.	O	PUNCT	O


BOB.1/OBF.1	B-protein	NOUN	B
is	O	AUX	O
a	O	DET	O
transcriptional	B-protein	ADJ	B
coactivator	I-protein	NOUN	I
that	O	PRON	O
is	O	AUX	O
constitutively	O	ADV	B
expressed	O	VERB	B
in	O	ADP	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
interacts	O	VERB	O
with	O	ADP	O
the	O	DET	O
Oct1	O	NOUN	B
and	O	CCONJ	O
Oct2	O	NOUN	B
transcription	B-protein	NOUN	O
factors	I-protein	NOUN	O
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
BOB.1/OBF.1	B-protein	NOUN	B
is	O	AUX	O
a	O	DET	O
transcriptional	B-protein	ADJ	B
coactivator	I-protein	NOUN	I
that	O	PRON	O
is	O	AUX	O
critically	O	ADV	O
regulated	O	VERB	O
by	O	ADP	O
posttranslational	O	ADJ	B
modifications	O	NOUN	B
to	O	PART	O
mediate	O	VERB	O
cell	O	NOUN	B
type-specific	O	ADJ	I
gene	O	NOUN	I
expression	O	NOUN	I
.	O	PUNCT	O


It	O	PRON	O
is	O	AUX	O
hypothesized	O	VERB	O
that	O	SCONJ	O
individuals	O	NOUN	B
who	O	PRON	O
differ	O	VERB	O
in	O	ADP	O
G	B-protein	NOUN	B
(	I-protein	PUNCT	I
S	I-protein	NOUN	I
)	I-protein	PUNCT	I
alpha	I-protein	NOUN	B
expression	O	NOUN	I
may	O	AUX	O
also	O	ADV	O
differ	O	VERB	O
in	O	ADP	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
certain	O	ADJ	O
cAMP-dependent	B-DNA	ADJ	B
genes	I-DNA	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
study	O	NOUN	B
,	O	PUNCT	O
using	O	VERB	O
a	O	DET	O
chromogenic	O	ADJ	B
assay	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
shown	O	VERB	O
thrombin	B-protein	NOUN	B
generation	O	NOUN	O
by	O	ADP	O
apoptotic	B-cell_type	ADJ	B
VSMCs	I-cell_type	NOUN	B
expressing	O	VERB	O
c-myc	B-protein	NOUN	O
(	O	PUNCT	O
VSMC-myc	B-cell_line	NOUN	B
)	O	PUNCT	O
with	O	ADP	O
an	O	DET	O
area	O	NOUN	B
under	O	ADP	O
the	O	DET	O
thrombin	B-protein	NOUN	B
-generation	O	NOUN	O
curve	O	NOUN	O
(	O	PUNCT	O
AUC	O	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
305	O	NUM	O
+/-	O	CCONJ	O
17	O	NUM	O
nmol	O	NOUN	O
x	O	NOUN	O
min/L	O	NOUN	O
and	O	CCONJ	O
a	O	DET	O
peak	O	NOUN	B
thrombin	B-protein	NOUN	I
(	O	PUNCT	O
PT	O	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
154	O	NUM	O
+/-	O	CCONJ	O
9	O	NUM	O
nmol/L	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
thrombin	B-protein	NOUN	B
-generating	O	ADJ	O
potential	O	NOUN	B
of	O	ADP	O
the	O	DET	O
apoptotic	B-cell_line	ADJ	B
VSMC-myc	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
was	O	AUX	O
greater	O	ADJ	O
than	O	ADP	O
that	O	DET	O
of	O	ADP	O
unactivated	B-cell_type	ADJ	B
platelets	I-cell_type	NOUN	I
(	O	PUNCT	O
P	O	NOUN	O
=	O	ADJ	O
.003	O	NUM	O
for	O	ADP	O
AUC	O	NOUN	B
;	O	PUNCT	O
P	O	NOUN	O
=	O	ADJ	O
.0002	O	NUM	O
for	O	ADP	O
PT	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
similar	O	ADJ	O
to	O	PART	O
calcium-ionophore	O	ADJ	B
activated	B-cell_type	VERB	O
platelets	I-cell_type	NOUN	O
(	O	PUNCT	O
AUC	O	NOUN	B
of	O	ADP	O
332	O	NUM	O
+/-	O	CCONJ	O
15	O	NUM	O
nmol	O	NOUN	O
x	O	NOUN	O
min/L	O	NOUN	O
,	O	PUNCT	O
P	O	NOUN	O
=	O	ADJ	O
.3	O	NOUN	O
;	O	PUNCT	O
PT	O	NOUN	B
of	O	ADP	O
172	O	NUM	O
+/-	O	CCONJ	O
8	O	NUM	O
nmol/L	O	NOUN	O
,	O	PUNCT	O
P	O	NOUN	O
=	O	ADJ	O
.2	O	NOUN	O
)	O	PUNCT	O
.	O	PUNCT	O


IL-4	B-protein	NOUN	B
induces	O	VERB	O
Cepsilon	B-RNA	NOUN	B
germline	I-RNA	NOUN	B
transcripts	I-RNA	NOUN	I
and	O	CCONJ	O
IgE	B-protein	NOUN	B
isotype	I-protein	NOUN	B
switching	O	NOUN	B
in	O	ADP	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
from	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
gammac	B-protein	NOUN	B
chain	I-protein	NOUN	I
deficiency	O	NOUN	I
.	O	PUNCT	O


Elf-1	B-protein	NOUN	B
is	O	AUX	O
a	O	DET	O
lymphoid-specific	B-protein	ADJ	B
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
that	O	PRON	O
belongs	O	VERB	O
to	O	PART	O
the	O	DET	O
ETS	B-protein	NOUN	B
protein	I-protein	NOUN	I
family	I-protein	NOUN	O
.	O	PUNCT	O


It	O	PRON	O
can	O	AUX	O
bind	O	VERB	B
to	O	PART	O
DNA	O	NOUN	B
target	O	NOUN	I
sequences	O	NOUN	I
within	O	ADP	O
a	O	DET	O
variety	O	NOUN	O
of	O	ADP	O
cytokine	B-DNA	NOUN	B
genes	I-DNA	NOUN	I
.	O	PUNCT	O


This	O	DET	O
Tax1	B-protein	NOUN	B
-induced	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
cellular	B-DNA	ADJ	B
genes	I-DNA	NOUN	I
is	O	AUX	O
considered	O	VERB	O
to	O	PART	O
be	O	AUX	O
a	O	DET	O
critical	O	ADJ	O
event	O	NOUN	O
in	O	ADP	O
T-cell	O	NOUN	B
transformation	O	NOUN	I
by	O	ADP	O
HTLV-I	O	NOUN	B
.	O	PUNCT	O


To	O	PART	O
elucidate	O	VERB	O
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
each	O	DET	O
Tax1	B-protein	NOUN	B
-inducible	O	ADJ	O
transcriptional	O	ADJ	B
pathway	O	NOUN	I
in	O	ADP	O
T-cell	O	NOUN	B
transformation	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
introduced	O	VERB	O
Tax1	B-protein	NOUN	B
mutants	I-protein	NOUN	B
with	O	ADP	O
different	O	ADJ	O
trans-activating	O	ADJ	B
phenotypes	O	NOUN	B
into	O	ADP	O
peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
lymphocytes	I-cell_type	NOUN	I
(	O	PUNCT	O
PBL	B-cell_type	NOUN	B
)	O	PUNCT	O
by	O	ADP	O
retroviral	O	ADJ	B
vectors	O	NOUN	I
.	O	PUNCT	O


Importantly	O	ADV	O
,	O	PUNCT	O
despite	O	SCONJ	O
high	O	ADJ	O
ligand	O	NOUN	B
binding	O	NOUN	O
affinity	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
prototypic	O	ADJ	B
dissociated	O	ADJ	I
compound	O	NOUN	I
,	O	PUNCT	O
RU24858	O	NOUN	B
,	O	PUNCT	O
acted	O	VERB	O
as	O	ADP	O
a	O	DET	O
weak	O	ADJ	B
agonist	O	NOUN	B
and	O	CCONJ	O
did	O	AUX	O
not	O	PART	O
efficiently	O	ADV	O
antagonize	O	VERB	B
dexamethasone-induced	O	ADJ	B
transcription	O	NOUN	I
in	O	ADP	O
transfected	B-cell_type	VERB	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Phorbol	O	NOUN	B
ester	O	NOUN	I
treatment	O	NOUN	B
of	O	ADP	O
a	O	DET	O
pre-B	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
up-regulated	O	VERB	B
CD19	B-protein	NOUN	B
expression	O	NOUN	B
,	O	PUNCT	O
induced	O	VERB	B
Egr-1	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
enhanced	O	VERB	B
the	O	DET	O
footprint	O	NOUN	B
over	O	ADP	O
the	O	DET	O
GC	O	NOUN	B
box	O	NOUN	B
.	O	PUNCT	O


Early	B-protein	ADJ	B
B	I-protein	NOUN	O
cell	I-protein	NOUN	O
factor	I-protein	NOUN	O
(	O	PUNCT	O
EBF	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
E47	B-protein	NOUN	B
participate	O	VERB	B
in	O	ADP	O
the	O	DET	O
transcriptional	O	ADJ	B
control	O	NOUN	I
of	O	ADP	O
early	O	ADJ	B
B	O	NOUN	O
lymphocyte	O	NOUN	O
differentiation	O	NOUN	O
.	O	PUNCT	O


Multiple	O	ADJ	B
functionally	O	ADV	O
important	O	ADJ	O
EBF	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
E47	I-DNA	NOUN	B
binding	I-DNA	NOUN	I
sites	I-DNA	NOUN	I
were	O	AUX	O
identified	O	VERB	B
in	O	ADP	O
the	O	DET	O
lambda5	B-DNA	NOUN	B
promoter/enhancer	I-DNA	NOUN	I
region	I-DNA	NOUN	I
,	O	PUNCT	O
indicating	O	VERB	O
that	O	SCONJ	O
lambda5	B-DNA	NOUN	B
is	O	AUX	O
a	O	DET	O
direct	O	ADJ	O
genetic	O	ADJ	B
target	O	NOUN	B
for	O	ADP	O
these	O	DET	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
common	B-protein	ADJ	O
gamma-chain	I-protein	NOUN	B
(	O	PUNCT	O
gamma	B-protein	NOUN	O
(	I-protein	PUNCT	O
c	I-protein	NOUN	O
)	I-protein	PUNCT	O
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
functional	O	ADJ	B
component	O	NOUN	O
of	O	ADP	O
the	O	DET	O
IL-4R	B-protein	NOUN	B
,	O	PUNCT	O
yet	O	ADV	O
cells	O	NOUN	B
lacking	O	VERB	O
gamma	B-protein	NOUN	O
(	I-protein	PUNCT	O
c	I-protein	NOUN	O
)	I-protein	PUNCT	O
are	O	AUX	O
able	O	ADJ	O
to	O	PART	O
respond	O	VERB	O
to	O	PART	O
IL-4	B-protein	NOUN	B
.	O	PUNCT	O


An	O	DET	O
alternative	O	ADJ	B
possibility	O	NOUN	O
is	O	AUX	O
that	O	SCONJ	O
in	O	ADP	O
the	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
gamma	B-protein	NOUN	B
(	I-protein	PUNCT	I
c	I-protein	NOUN	I
)	I-protein	PUNCT	O
,	O	PUNCT	O
the	O	DET	O
IL-4R	B-protein	NOUN	B
alpha	I-protein	NOUN	B
chain	I-protein	NOUN	I
is	O	AUX	O
able	O	ADJ	O
to	O	PART	O
transduce	O	VERB	B
signals	O	NOUN	B
by	O	ADP	O
homodimerization	O	NOUN	B
.	O	PUNCT	O


To	O	PART	O
test	O	VERB	O
this	O	DET	O
latter	O	ADJ	O
possibility	O	NOUN	O
,	O	PUNCT	O
a	O	DET	O
chimeric	B-protein	ADJ	B
receptor	I-protein	NOUN	I
containing	O	VERB	O
the	O	DET	O
extracellular	B-protein	ADJ	B
domain	I-protein	NOUN	I
of	O	ADP	O
c-kit	B-protein	NOUN	B
(	O	PUNCT	O
the	O	DET	O
stem	B-protein	NOUN	B
cell	I-protein	NOUN	I
factor	I-protein	NOUN	I
(	I-protein	PUNCT	O
SCF	I-protein	NOUN	B
)	I-protein	PUNCT	O
receptor	I-protein	NOUN	O
)	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
cytoplasmic	B-protein	ADJ	B
and	I-protein	CCONJ	O
transmembrane	I-protein	ADJ	B
domains	I-protein	NOUN	I
of	O	ADP	O
the	O	DET	O
IL-4R	B-protein	NOUN	B
alpha	I-protein	NOUN	B
chain	I-protein	NOUN	I
was	O	AUX	O
generated	O	VERB	O
.	O	PUNCT	O


Together	O	ADV	O
,	O	PUNCT	O
these	O	DET	O
data	O	NOUN	B
demonstrate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
IL-4R	B-protein	NOUN	B
alpha	I-protein	NOUN	O
cytoplasmic	I-protein	ADJ	O
domain	I-protein	NOUN	O
is	O	AUX	O
sufficient	O	ADJ	O
to	O	PART	O
activate	O	VERB	B
JAK-1	B-protein	NOUN	B
and	O	CCONJ	O
STAT6	B-protein	NOUN	B
and	O	CCONJ	O
to	O	PART	O
induce	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
IL-4	B-DNA	NOUN	B
target	I-DNA	NOUN	B
genes	I-DNA	NOUN	O
,	O	PUNCT	O
thus	O	ADV	O
identifying	O	VERB	O
a	O	DET	O
mechanism	O	NOUN	B
by	O	ADP	O
which	O	DET	O
IL-4	B-protein	NOUN	B
signaling	O	NOUN	B
can	O	AUX	O
proceed	O	VERB	O
in	O	ADP	O
the	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
JAK-3	B-protein	NOUN	B
and	O	CCONJ	O
gamma	B-protein	NOUN	B
(	I-protein	PUNCT	I
c	I-protein	NOUN	I
)	I-protein	PUNCT	O
.	O	PUNCT	O


Dibutyryl	O	NOUN	B
cAMP	O	NOUN	B
also	O	ADV	O
increased	O	VERB	B
c-fos	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
and	O	CCONJ	O
protein	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
levels	O	NOUN	B
remained	O	VERB	O
elevated	O	ADJ	B
even	O	ADV	O
after	O	ADP	O
12	O	NUM	O
hr	O	NOUN	O
of	O	ADP	O
treatment	O	NOUN	B
.	O	PUNCT	O


Inhibition	O	NOUN	B
of	O	ADP	O
binding	O	NOUN	B
by	O	ADP	O
anti-P	B-protein	ADJ	B
selectin	I-protein	NOUN	I
antibodies	I-protein	NOUN	I
reduced	O	VERB	B
the	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
activated	B-cell_type	VERB	B
platelets	I-cell_type	NOUN	O
on	O	ADP	O
cytokine	B-protein	NOUN	B
production	O	NOUN	I
.	O	PUNCT	O


Triggering	O	NOUN	B
of	O	ADP	O
HLA	B-protein	NOUN	B
class	I-protein	NOUN	I
II	I-protein	NUM	I
antigens	I-protein	NOUN	B
by	O	ADP	O
the	O	DET	O
anti-HLA-DR	B-protein	ADJ	B
monoclonal	I-protein	ADJ	I
antibody	I-protein	NOUN	I
(	I-protein	PUNCT	I
mAb	I-protein	NOUN	B
)	I-protein	PUNCT	O
L243	I-protein	NOUN	O
significantly	O	ADV	O
(	O	PUNCT	O
P	O	NOUN	O
<	O	X	O
0.05	O	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
differentially	O	ADV	B
enhanced	O	VERB	B
the	O	DET	O
release	O	NOUN	B
of	O	ADP	O
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor	I-protein	NOUN	I
alpha	I-protein	NOUN	I
(	O	PUNCT	O
TNF-alpha	B-protein	NOUN	B
)	O	PUNCT	O
by	O	ADP	O
the	O	DET	O
non-Hodgkin	B-cell_type	ADJ	B
's	I-cell_type	PART	I
lymphoma	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
Ri-I	B-cell_line	NOUN	O
,	O	PUNCT	O
Ci-I	B-cell_line	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
Sc-I	B-cell_line	PROPN	B
,	O	PUNCT	O
which	O	DET	O
are	O	AUX	O
at	O	ADP	O
a	O	DET	O
distinct	O	ADJ	O
stage	O	NOUN	B
of	O	ADP	O
B-cell	O	NOUN	B
differentiation	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
by	O	ADP	O
the	O	DET	O
more	O	ADV	O
mature	O	ADJ	B
Burkitt	B-cell_line	NOUN	B
lymphoma	I-cell_line	NOUN	I
cell	I-cell_line	NOUN	I
Raji	I-cell_line	NOUN	I
;	O	PUNCT	O
in	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
it	O	PRON	O
did	O	AUX	O
not	O	PART	O
induce	O	VERB	O
TNF-alpha	B-protein	NOUN	B
release	O	NOUN	B
by	O	ADP	O
the	O	DET	O
pre-B	B-cell_type	ADJ	B
leukemia	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	B
Nalm-6	B-cell_line	NOUN	B
and	O	CCONJ	O
BV173	B-cell_line	NOUN	B
.	O	PUNCT	O


Transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
GATA-3	I-protein	NOUN	B
is	O	AUX	O
differentially	O	ADV	O
expressed	O	VERB	B
in	O	ADP	O
murine	B-cell_line	ADJ	B
Th1	I-cell_line	NOUN	B
and	I-cell_line	CCONJ	O
Th2	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
and	O	CCONJ	O
controls	O	VERB	B
Th2-specific	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
interleukin-5	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
.	O	PUNCT	O


Using	O	VERB	O
homologous	O	ADJ	B
recombination	O	NOUN	I
,	O	PUNCT	O
both	O	CCONJ	O
EKLF	B-DNA	NOUN	B
alleles	I-DNA	NOUN	I
in	O	ADP	O
murine	B-cell_line	ADJ	B
embryonic	I-cell_line	ADJ	O
stem	I-cell_line	NOUN	O
(	I-cell_line	PUNCT	O
ES	I-cell_line	NOUN	O
)	I-cell_line	PUNCT	O
cells	I-cell_line	NOUN	O
were	O	AUX	O
inactivated	O	VERB	B
.	O	PUNCT	O


The	O	DET	O
ratio	O	NOUN	B
of	O	ADP	O
adult	B-RNA	ADJ	B
beta-globin/alpha-globin	I-RNA	NOUN	O
mRNA	I-RNA	NOUN	B
in	O	ADP	O
the	O	DET	O
mutant	B-cell_line	ADJ	B
ES	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
was	O	AUX	O
1/15	O	NUM	O
of	O	ADP	O
that	O	DET	O
in	O	ADP	O
wild-type	B-cell_type	ADJ	B
ES	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
show	O	VERB	O
for	O	ADP	O
human	B-cell_line	ADJ	B
Jurkat	I-cell_line	NOUN	O
T	I-cell_line	NOUN	O
leukemia	I-cell_line	NOUN	O
cells	I-cell_line	NOUN	B
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
human	B-cell_type	ADJ	B
and	I-cell_type	CCONJ	O
mouse	I-cell_type	NOUN	B
primary	I-cell_type	ADJ	O
T	I-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
,	O	PUNCT	O
that	O	SCONJ	O
this	O	DET	O
inhibitory	O	ADJ	B
effect	O	NOUN	O
is	O	AUX	O
accompanied	O	VERB	O
by	O	ADP	O
an	O	DET	O
impaired	O	ADJ	B
nuclear	O	ADJ	B
translocation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
Rel	B-protein	NOUN	B
proteins	I-protein	NOUN	I
c-Rel	B-protein	NOUN	B
,	O	PUNCT	O
RelA/p65	B-protein	NOUN	B
and	O	CCONJ	O
NF-kappa	B-protein	NOUN	B
B1/p50	I-protein	NOUN	I
,	O	PUNCT	O
whereas	O	SCONJ	O
the	O	DET	O
nuclear	O	ADJ	B
appearance	O	NOUN	B
of	O	ADP	O
RelB	B-protein	NOUN	B
remains	O	VERB	O
unaffected	O	ADJ	O
.	O	PUNCT	O


For	O	ADP	O
purposes	O	NOUN	O
of	O	ADP	O
comparison	O	NOUN	B
,	O	PUNCT	O
microglia	B-cell_type	NOUN	B
were	O	AUX	O
also	O	ADV	O
stimulated	O	VERB	B
with	O	ADP	O
bacterial	O	ADJ	B
LPS	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
known	O	ADJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
inducer	O	NOUN	B
.	O	PUNCT	O


Glucocorticoid-mediated	O	ADJ	B
repression	O	NOUN	B
of	O	ADP	O
cytokine	B-DNA	NOUN	B
gene	I-DNA	NOUN	B
transcription	O	NOUN	I
in	O	ADP	O
human	O	ADJ	B
arteritis-SCID	B-protein	NOUN	B
chimeras	I-protein	NOUN	I
.	O	PUNCT	O


Giant	O	ADJ	B
cell	O	NOUN	I
arteritis	O	NOUN	I
(	O	PUNCT	O
GCA	O	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
vasculitic	O	ADJ	B
syndrome	O	NOUN	I
that	O	PRON	O
preferentially	O	ADV	O
affects	O	VERB	O
medium	O	NOUN	B
and	O	CCONJ	O
large-sized	O	ADJ	O
arteries	O	NOUN	B
.	O	PUNCT	O


Defective	O	ADJ	B
survival	O	NOUN	I
and	O	CCONJ	O
activation	O	NOUN	B
of	O	ADP	O
thymocytes	B-cell_type	NOUN	B
in	O	ADP	O
transgenic	O	ADJ	B
mice	O	NOUN	I
expressing	O	VERB	B
a	O	DET	O
catalytically	B-protein	ADV	B
inactive	I-protein	ADJ	I
form	I-protein	NOUN	O
of	O	ADP	O
Ca2+/calmodulin-dependent	B-protein	ADJ	B
protein	I-protein	NOUN	I
kinase	I-protein	NOUN	I
IV	I-protein	NUM	I
.	O	PUNCT	O


Because	O	SCONJ	O
transgene	O	NOUN	B
expression	O	NOUN	B
was	O	AUX	O
regulated	O	VERB	O
by	O	ADP	O
the	O	DET	O
proximal	B-DNA	ADJ	B
promoter	I-DNA	NOUN	B
of	O	ADP	O
the	O	DET	O
murine	B-DNA	NOUN	B
lck	I-DNA	NOUN	B
gene	I-DNA	NOUN	I
and	O	CCONJ	O
this	O	DET	O
promoter	O	NOUN	B
is	O	AUX	O
inactivated	O	VERB	B
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
that	O	PRON	O
exit	O	VERB	B
the	O	DET	O
thymus	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
mutant	B-protein	ADJ	B
hCaMKIV	I-protein	NOUN	O
is	O	AUX	O
not	O	PART	O
present	O	ADJ	O
in	O	ADP	O
peripheral	B-cell_type	ADJ	B
T	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
.	O	PUNCT	O


Whereas	O	SCONJ	O
the	O	DET	O
pathway	O	NOUN	B
responsible	O	ADJ	O
for	O	ADP	O
this	O	DET	O
latter	O	ADJ	O
role	O	NOUN	O
is	O	AUX	O
yet	O	ADV	O
to	O	PART	O
be	O	AUX	O
elucidated	O	VERB	O
,	O	PUNCT	O
it	O	PRON	O
is	O	AUX	O
unlikely	O	ADJ	O
to	O	PART	O
include	O	VERB	O
CREB	B-protein	NOUN	B
phosphorylation	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
gene	O	NOUN	B
,	O	PUNCT	O
SRG3	B-DNA	NOUN	B
,	O	PUNCT	O
showed	O	VERB	O
a	O	DET	O
significant	O	ADJ	O
sequence	O	NOUN	O
homology	O	NOUN	B
to	O	PART	O
SWI3	B-DNA	NOUN	B
,	O	PUNCT	O
a	O	DET	O
yeast	B-DNA	NOUN	B
transcriptional	I-DNA	ADJ	O
activator	I-DNA	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
its	O	PRON	O
human	B-DNA	ADJ	B
homolog	I-DNA	NOUN	B
BAF155	I-DNA	NOUN	B
.	O	PUNCT	O


The	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
anti-sense	B-protein	ADJ	B
RNA	I-protein	NOUN	I
to	O	PART	O
SRG3	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
in	O	ADP	O
a	O	DET	O
thymoma	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
,	O	PUNCT	O
S49.1	B-cell_line	NOUN	B
,	O	PUNCT	O
reduced	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
level	O	NOUN	B
of	O	ADP	O
the	O	DET	O
SRG3	B-protein	NOUN	B
protein	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
decreased	O	VERB	B
the	O	DET	O
apoptotic	O	ADJ	B
cell	O	NOUN	I
death	O	NOUN	O
induced	O	VERB	B
by	O	ADP	O
glucocorticoids	O	NOUN	B
.	O	PUNCT	O


Rapid	O	NOUN	B
and	O	CCONJ	O
strong	O	ADJ	O
induction	O	NOUN	B
of	O	ADP	O
promoter	O	NOUN	B
activity	O	NOUN	I
was	O	AUX	O
lost	O	VERB	O
in	O	ADP	O
constructs	O	NOUN	B
with	O	ADP	O
a	O	DET	O
mutant	B-DNA	ADJ	B
AP-1	I-DNA	NOUN	B
element	I-DNA	NOUN	I
;	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
at	O	ADP	O
16-96	O	NUM	O
h	O	NOUN	O
post-PMA	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
mutant	B-DNA	ADJ	B
collagenase-1	I-DNA	NOUN	I
promoter	I-DNA	NOUN	B
displayed	O	VERB	O
AP-1	B-protein	NOUN	B
independent	O	ADJ	O
PMA-mediated	O	ADJ	B
transactivation	O	NOUN	B
.	O	PUNCT	O


Our	O	PRON	O
findings	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
distinct	O	ADJ	O
regulatory	B-DNA	ADJ	B
elements	I-DNA	NOUN	I
,	O	PUNCT	O
acting	O	VERB	O
somewhat	O	ADV	O
independently	O	ADV	O
of	O	ADP	O
each	O	DET	O
other	O	ADJ	O
,	O	PUNCT	O
control	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
collagenase-1	B-protein	NOUN	B
.	O	PUNCT	O


It	O	PRON	O
has	O	AUX	O
been	O	AUX	O
recently	O	ADV	O
claimed	O	VERB	O
that	O	SCONJ	O
polymorphism	O	NOUN	B
for	O	ADP	O
the	O	DET	O
vitamin	B-protein	NOUN	B
D	I-protein	NOUN	I
receptor	I-protein	NOUN	I
(	O	PUNCT	O
VDR	B-protein	NOUN	B
)	O	PUNCT	O
influences	O	VERB	B
several	O	ADJ	O
aspects	O	NOUN	O
of	O	ADP	O
calcium	O	NOUN	B
and	O	CCONJ	O
bone	O	NOUN	B
metabolism	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
concentration	O	NOUN	B
of	O	ADP	O
the	O	DET	O
VDR	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
was	O	AUX	O
10	O	NUM	O
(	O	PUNCT	O
-8	O	NUM	O
)	O	PUNCT	O
to	O	PART	O
10	O	NUM	O
(	O	PUNCT	O
-7	O	NUM	O
)	O	PUNCT	O
g/g	O	NOUN	O
of	O	ADP	O
total	O	ADJ	O
RNA	O	NOUN	B
in	O	ADP	O
cell-sorted	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
and	O	CCONJ	O
in	O	ADP	O
in	B-cell_type	X	B
vitro	I-cell_type	X	I
activated	I-cell_type	VERB	B
lymphocytes	I-cell_type	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
only	O	ADV	O
10	O	NUM	O
(	O	PUNCT	O
-12	O	NUM	B
)	O	PUNCT	O
g/g	O	NOUN	O
of	O	ADP	O
total	O	ADJ	O
mRNA	O	NOUN	B
in	O	ADP	O
resting	O	VERB	B
lymphocytes	B-cell_type	NOUN	I
,	O	PUNCT	O
establishing	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
VDR	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
determined	O	VERB	O
by	O	ADP	O
our	O	PRON	O
method	O	NOUN	B
in	O	ADP	O
PBMCs	B-cell_type	NOUN	B
is	O	AUX	O
due	O	ADJ	O
to	O	PART	O
constitutive	O	ADJ	B
expression	O	NOUN	B
in	O	ADP	O
monocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


Following	O	VERB	O
an	O	DET	O
initial	O	ADJ	O
genotype	O	NOUN	B
screening	O	NOUN	B
of	O	ADP	O
85	O	NUM	O
normal	O	ADJ	B
volunteers	O	NOUN	I
by	O	ADP	O
polymerase	O	NOUN	B
chain	O	NOUN	I
reaction	O	NOUN	I
or	O	CCONJ	O
restriction	B-DNA	NOUN	B
fragment	I-DNA	NOUN	I
length	I-DNA	NOUN	I
polymorphism	I-DNA	NOUN	I
analysis	O	NOUN	I
,	O	PUNCT	O
14	O	NUM	O
individuals	O	NOUN	B
with	O	ADP	O
the	O	DET	O
Bb	O	NOUN	B
genotype	O	NOUN	B
,	O	PUNCT	O
12	O	NUM	O
with	O	ADP	O
the	O	DET	O
bb	O	NOUN	B
genotype	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
12	O	NUM	O
with	O	ADP	O
the	O	DET	O
BB	O	NOUN	B
genotype	O	NOUN	B
were	O	AUX	O
selected	O	VERB	O
.	O	PUNCT	O


This	O	DET	O
gene	O	NOUN	B
,	O	PUNCT	O
originally	O	ADV	O
named	O	VERB	O
AML1	B-DNA	NOUN	B
,	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
human	O	ADJ	B
homologue	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Drosophila	B-DNA	NOUN	B
gene	I-DNA	NOUN	B
runt	I-DNA	NOUN	I
that	O	PRON	O
controls	O	VERB	B
early	O	ADJ	O
events	O	NOUN	O
in	O	ADP	O
fly	O	NOUN	B
embryogenesis	O	NOUN	B
.	O	PUNCT	O


Biochemical	O	ADJ	B
analysis	O	NOUN	I
by	O	ADP	O
Western	O	NOUN	B
blotting	O	NOUN	I
of	O	ADP	O
fetal	B-cell_type	ADJ	B
and	I-cell_type	CCONJ	O
adult	I-cell_type	ADJ	B
hematopoietic	I-cell_type	ADJ	B
populations	I-cell_type	NOUN	I
shows	O	VERB	O
several	O	ADJ	O
runt	B-protein	NOUN	B
isoforms	I-protein	NOUN	I
.	O	PUNCT	O


Our	O	PRON	O
data	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
although	O	SCONJ	O
PBSC	B-cell_type	NOUN	B
harvests	O	NOUN	B
collected	O	VERB	O
after	O	ADP	O
consolidation	O	NOUN	B
chemotherapy	O	NOUN	I
are	O	AUX	O
contaminated	O	VERB	B
by	O	ADP	O
leukemic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
the	O	DET	O
degree	O	NOUN	B
of	O	ADP	O
leukemic	O	ADJ	B
cell	O	NOUN	I
contamination	O	NOUN	B
decreases	O	VERB	B
with	O	ADP	O
repeated	O	VERB	O
cycles	O	NOUN	B
of	O	ADP	O
chemotherapy	O	NOUN	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
MRD	O	NOUN	B
in	O	ADP	O
PBSC	B-cell_type	NOUN	B
harvests	O	NOUN	B
is	O	AUX	O
less	O	ADJ	O
than	O	ADP	O
in	O	ADP	O
the	O	DET	O
corresponding	O	ADJ	O
bone	O	NOUN	B
marrow	O	NOUN	I
obtained	O	VERB	O
on	O	ADP	O
the	O	DET	O
day	O	NOUN	B
of	O	ADP	O
the	O	DET	O
PBSC	B-cell_type	NOUN	B
collection	O	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
a	O	DET	O
substantial	O	ADJ	O
decrease	O	NOUN	B
of	O	ADP	O
AML1/ETO	B-RNA	NOUN	B
transcripts	I-RNA	NOUN	B
was	O	AUX	O
seen	O	VERB	O
following	O	VERB	O
autologous	O	ADJ	B
PBSCT	O	NOUN	I
.	O	PUNCT	O


Exogenous	O	ADJ	B
recombinant	B-protein	ADJ	O
Tat	I-protein	NOUN	B
protein	I-protein	NOUN	I
was	O	AUX	O
also	O	ADV	O
able	O	ADJ	O
to	O	PART	O
upregulate	O	VERB	B
c-fos	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
activity	O	NOUN	I
in	O	ADP	O
serum-activated	O	ADJ	B
Jurkat	O	NOUN	I
and	O	CCONJ	O
U937	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
endogenous	O	ADJ	B
c-fos	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
expression	O	NOUN	B
and	O	CCONJ	O
c-Fos	B-protein	NOUN	B
protein	O	NOUN	O
synthesis	O	NOUN	O
in	O	ADP	O
both	O	CCONJ	O
serum-activated	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
and	O	CCONJ	O
primary	B-cell_type	ADJ	B
PBMC	I-cell_type	NOUN	B
.	O	PUNCT	O


Cytokines	B-protein	NOUN	B
control	O	VERB	O
growth	O	NOUN	O
,	O	PUNCT	O
differentiation	O	NOUN	B
,	O	PUNCT	O
death	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
function	O	NOUN	B
of	O	ADP	O
cells	O	NOUN	B
of	O	ADP	O
lymphocytic	B-cell_type	ADJ	B
,	I-cell_type	PUNCT	O
hemopoietic	I-cell_type	ADJ	B
systems	I-cell_type	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
together	O	ADV	O
with	O	ADP	O
nerve	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
provide	O	VERB	O
a	O	DET	O
pertinent	O	ADJ	O
model	O	NOUN	B
to	O	PART	O
study	O	VERB	B
intercellular	O	ADJ	B
communications	O	NOUN	I
and	O	CCONJ	O
intercellular	O	ADJ	B
signal	O	NOUN	I
networks	O	NOUN	I
.	O	PUNCT	O


Tissue	B-protein	NOUN	B
factor	I-protein	NOUN	I
(	O	PUNCT	O
TF	O	NOUN	B
)	O	PUNCT	O
expression	O	NOUN	B
by	O	ADP	O
peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
monocytes	I-cell_type	NOUN	I
during	O	ADP	O
sepsis	O	NOUN	B
initiates	O	VERB	O
intravascular	O	ADJ	B
thrombosis	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
two	O	NUM	O
AP-1	B-DNA	NOUN	B
sites	I-DNA	NOUN	I
bound	O	VERB	B
c-Fos/c-Jun	B-protein	NOUN	B
heterodimers	I-protein	NOUN	I
in	O	ADP	O
both	O	CCONJ	O
unstimulated	B-cell_type	ADJ	B
and	I-cell_type	CCONJ	O
LPS-stimulated	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Synergistic	O	ADJ	B
transactivation	O	NOUN	O
of	O	ADP	O
the	O	DET	O
LPS	B-DNA	NOUN	B
response	I-DNA	NOUN	B
element	I-DNA	NOUN	I
in	O	ADP	O
Drosophila	B-cell_line	X	B
Schneider	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
by	O	ADP	O
coexpression	O	NOUN	B
of	O	ADP	O
c-Fos	B-protein	NOUN	B
,	O	PUNCT	O
c-Jun	B-protein	NOUN	B
,	O	PUNCT	O
c-Rel	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
p65	B-protein	NOUN	B
or	O	CCONJ	O
c-Jun	B-protein	NOUN	B
and	O	CCONJ	O
p65	B-protein	NOUN	B
required	O	VERB	O
the	O	DET	O
transactivation	B-protein	NOUN	B
domains	I-protein	NOUN	O
of	O	ADP	O
c-Jun	B-protein	NOUN	B
and	O	CCONJ	O
p65	B-protein	NOUN	B
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
indicated	O	VERB	O
that	O	SCONJ	O
c-Fos	B-protein	NOUN	B
/c-Jun	B-protein	NOUN	B
,	O	PUNCT	O
c-Rel	B-protein	NOUN	B
/p65	B-protein	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
Sp1	B-protein	NOUN	B
regulate	O	VERB	B
TF	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
expression	O	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
monocytic	I-cell_type	ADJ	O
cells	I-cell_type	NOUN	O
.	O	PUNCT	O


The	O	DET	O
GH-induced	O	ADJ	B
inhibitory	O	ADJ	B
effect	O	NOUN	O
was	O	AUX	O
also	O	ADV	O
observed	O	VERB	O
using	O	VERB	O
normal	B-cell_type	ADJ	O
human	I-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
and	O	CCONJ	O
monocyte-derived	B-cell_type	ADJ	B
macrophages	I-cell_type	NOUN	I
.	O	PUNCT	O


The	O	DET	O
capacity	O	NOUN	B
of	O	ADP	O
GH	O	NOUN	B
to	O	PART	O
inhibit	O	VERB	B
LPS-induced	O	ADJ	B
TNF-alpha	B-protein	NOUN	B
production	O	NOUN	B
by	O	ADP	O
monocytes	B-cell_type	NOUN	B
without	O	ADP	O
altering	O	VERB	B
other	O	ADJ	O
pathways	O	NOUN	B
leading	O	VERB	O
to	O	PART	O
TNF-alpha	B-protein	NOUN	B
production	O	NOUN	B
may	O	AUX	O
be	O	AUX	O
of	O	ADP	O
potential	O	ADJ	B
relevance	O	NOUN	B
in	O	ADP	O
septic	O	ADJ	B
shock	O	NOUN	I
,	O	PUNCT	O
since	O	SCONJ	O
GH	O	NOUN	B
is	O	AUX	O
available	O	ADJ	O
for	O	ADP	O
clinical	O	ADJ	B
use	O	NOUN	I
.	O	PUNCT	O


Nuclear	B-protein	ADJ	B
factor-kappaB	I-protein	NOUN	I
activation	O	NOUN	I
in	O	ADP	O
human	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
stimulated	O	VERB	O
with	O	ADP	O
lipopolysaccharide	O	NOUN	B
is	O	AUX	O
inhibited	O	VERB	B
by	O	ADP	O
fibroblast	O	NOUN	B
conditioned	O	ADJ	I
medium	O	NOUN	I
and	O	CCONJ	O
exogenous	O	ADJ	B
PGE2	O	NOUN	B
.	O	PUNCT	O


On	O	ADP	O
the	O	DET	O
other	O	ADJ	O
hand	O	NOUN	B
,	O	PUNCT	O
FCM	O	NOUN	B
produced	O	VERB	O
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
indomethacin	O	NOUN	B
does	O	AUX	O
not	O	PART	O
inhibit	O	VERB	B
NF-kappaB	B-protein	NOUN	B
activation	O	NOUN	B
by	O	ADP	O
LPS	O	NOUN	B
.	O	PUNCT	O


Immunoblot	O	NOUN	B
and	O	CCONJ	O
flow	O	NOUN	B
cytometry	O	NOUN	I
analysis	O	NOUN	I
revealed	O	VERB	O
a	O	DET	O
limited	O	ADJ	O
proteolysis	O	NOUN	B
of	O	ADP	O
the	O	DET	O
carboxyl	B-protein	NOUN	B
terminus	I-protein	NOUN	B
of	O	ADP	O
the	O	DET	O
alphaIIb	B-protein	NOUN	B
subunit	I-protein	NOUN	I
heavy	I-protein	ADJ	I
chain	I-protein	NOUN	I
(	O	PUNCT	I
alphaIIbH	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
as	O	ADP	O
judged	O	VERB	O
by	O	ADP	O
the	O	DET	O
disappearance	O	NOUN	B
of	O	ADP	O
the	O	DET	O
epitope	O	NOUN	B
for	O	ADP	O
the	O	DET	O
monoclonal	B-protein	ADJ	B
antibody	I-protein	NOUN	I
PMI-1	I-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
malignant	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
of	O	ADP	O
acute	O	ADJ	B
promyelocytic	O	ADJ	I
leukemia	O	NOUN	I
(	O	PUNCT	O
APL	O	NOUN	B
)	O	PUNCT	O
contain	O	VERB	O
a	O	DET	O
reciprocal	O	ADJ	O
chromosomal	O	ADJ	B
translocation	O	NOUN	I
that	O	PRON	O
fuses	O	VERB	O
the	O	DET	O
promyelocytic	B-DNA	ADJ	B
leukemia	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
(	O	PUNCT	O
PML	O	NOUN	B
)	O	PUNCT	O
with	O	ADP	O
the	O	DET	O
retinoic	B-DNA	ADJ	B
acid	I-DNA	NOUN	I
receptor	I-DNA	NOUN	I
alpha	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
(	O	PUNCT	O
RAR	B-protein	NOUN	B
alpha	I-protein	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


PMLRAR	O	NOUN	B
alpha	O	NOUN	I
transgenic	O	ADJ	B
mice	O	NOUN	I
exhibited	O	VERB	O
impaired	O	ADJ	B
neutrophil	O	NOUN	B
maturation	O	NOUN	B
early	O	ADV	B
in	O	ADP	O
life	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
progressed	O	VERB	O
at	O	ADP	O
a	O	DET	O
low	O	ADJ	B
frequency	O	NOUN	I
over	O	ADP	O
the	O	DET	O
course	O	NOUN	B
of	O	ADP	O
several	O	ADJ	O
months	O	NOUN	B
to	O	PART	O
overt	O	ADJ	B
APL	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
APL	O	NOUN	B
recapitulated	O	VERB	O
features	O	NOUN	B
of	O	ADP	O
the	O	DET	O
human	O	ADJ	B
disease	O	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
a	O	DET	O
response	O	NOUN	B
to	O	PART	O
retinoic	O	ADJ	B
acid	O	NOUN	I
.	O	PUNCT	O


Hypermethylation	O	NOUN	B
within	O	ADP	O
the	O	DET	O
promoters	B-DNA	NOUN	B
of	O	ADP	O
some	O	DET	O
genes	O	NOUN	B
appear	O	VERB	O
to	O	PART	O
be	O	AUX	O
an	O	DET	O
early	O	ADJ	B
event	O	NOUN	O
in	O	ADP	O
the	O	DET	O
pathogenesis	O	NOUN	B
of	O	ADP	O
neoplasia	O	NOUN	B
(	O	PUNCT	O
ER	B-DNA	NOUN	B
,	O	PUNCT	O
P15	B-DNA	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
while	O	SCONJ	O
other	O	ADJ	O
genes	O	NOUN	B
seem	O	VERB	O
to	O	PART	O
become	O	VERB	O
methylated	O	VERB	B
during	O	ADP	O
the	O	DET	O
progression	O	NOUN	B
of	O	ADP	O
leukemias	O	NOUN	B
(	O	PUNCT	O
HIC1	O	NOUN	B
,	O	PUNCT	O
c-abl	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Using	O	VERB	O
the	O	DET	O
yeast	O	NOUN	B
two-hybrid	O	ADJ	B
system	O	NOUN	I
to	O	PART	O
screen	O	VERB	B
for	O	ADP	O
proteins	O	NOUN	B
which	O	DET	O
interact	O	VERB	B
with	O	ADP	O
Tax1	B-protein	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
isolated	O	VERB	B
the	O	DET	O
B	B-protein	NOUN	B
subunit	I-protein	NOUN	I
of	O	ADP	O
the	O	DET	O
CCAAT	B-protein	NOUN	B
binding	I-protein	NOUN	I
protein	I-protein	NOUN	I
NF-Y	B-protein	NOUN	B
from	O	ADP	O
a	O	DET	O
HeLa	B-DNA	NOUN	B
cDNA	I-DNA	NOUN	B
library	I-DNA	NOUN	I
.	O	PUNCT	O


Further	O	ADV	O
,	O	PUNCT	O
Tax1	B-protein	NOUN	B
coimmunoprecipitated	O	VERB	B
with	O	ADP	O
NF-Y	B-protein	NOUN	B
from	O	ADP	O
nuclear	O	ADJ	B
extracts	O	NOUN	I
of	O	ADP	O
HTLV-1-transformed	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
providing	O	VERB	O
evidence	O	NOUN	B
for	O	ADP	O
in	O	X	B
vivo	O	X	I
interaction	O	NOUN	B
of	O	ADP	O
Tax1	B-protein	NOUN	B
and	O	CCONJ	O
NF-YB	B-protein	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
mutation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Y-box	B-DNA	NOUN	B
element	I-DNA	NOUN	O
alone	O	ADV	O
abrogated	O	VERB	B
Tax1	B-protein	NOUN	B
-mediated	O	ADJ	O
activation	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
murine	B-cell_line	ADJ	B
Ba/F3	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
transfected	O	VERB	B
with	O	ADP	O
the	O	DET	O
human	B-protein	ADJ	B
G-CSFR	I-protein	NOUN	B
and	O	CCONJ	O
NFS-60	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
constitutively	O	ADV	B
expressing	O	VERB	B
the	O	DET	O
murine	B-protein	ADJ	B
G-CSFR	I-protein	NOUN	B
,	O	PUNCT	O
G-CSF	B-protein	NOUN	B
induced	O	VERB	B
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	I
and	O	CCONJ	O
activation	O	NOUN	B
of	O	ADP	O
Jak1	B-protein	NOUN	B
,	O	PUNCT	O
Jak2	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
Tyk2	B-protein	NOUN	B
.	O	PUNCT	O


Activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Jak	B-protein	NOUN	B
-Stat	B-protein	NOUN	O
pathway	O	NOUN	B
correlates	O	VERB	O
with	O	ADP	O
proliferative	O	ADJ	B
signaling	O	NOUN	I
by	O	ADP	O
the	O	DET	O
G-CSFR	B-protein	NOUN	B
and	O	CCONJ	O
requires	O	VERB	O
the	O	DET	O
membrane-proximal	B-protein	ADJ	B
box	I-protein	NOUN	I
1	I-protein	NUM	I
PXP	I-protein	NOUN	B
motif	I-protein	NOUN	B
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
conserved	O	VERB	O
in	O	ADP	O
members	O	NOUN	B
of	O	ADP	O
the	O	DET	O
cytokine	B-protein	NOUN	B
receptor	I-protein	NOUN	I
superfamily	I-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
transcriptional	B-protein	ADJ	B
factor	I-protein	NOUN	I
c-Fos/c-Jun	O	NOUN	I
AP-1	B-protein	NOUN	I
is	O	AUX	O
essential	O	ADJ	O
for	O	ADP	O
normal	O	ADJ	O
T	B-cell_type	NOUN	B
cell	I-cell_type	NOUN	I
responsiveness	O	NOUN	B
and	O	CCONJ	O
is	O	AUX	O
often	O	ADV	O
impaired	O	ADJ	B
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
during	O	ADP	O
aging	O	NOUN	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
nuclear	B-protein	ADJ	B
protein	I-protein	NOUN	I
complexes	I-protein	NOUN	I
binding	O	VERB	B
the	O	DET	O
SRE	B-DNA	NOUN	B
motif	I-DNA	NOUN	B
induced	O	VERB	B
in	O	ADP	O
activated	B-cell_type	VERB	B
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
of	O	ADP	O
young	O	ADJ	B
and	O	CCONJ	O
elderly	O	ADJ	B
subjects	O	NOUN	I
contained	O	VERB	O
serum	B-protein	NOUN	B
response	I-protein	NOUN	I
factor	I-protein	NOUN	I
and	O	CCONJ	O
Elk-1	B-protein	NOUN	B
pointing	O	NOUN	O
toward	O	ADP	O
age-related	O	ADJ	B
defects	O	NOUN	B
in	O	ADP	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
transcriptional	B-protein	ADJ	B
regulatory	I-protein	ADJ	O
proteins	I-protein	NOUN	O
distinct	O	ADJ	O
from	O	ADP	O
c-jun/AP-1	B-protein	NOUN	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
underlying	O	VERB	O
aberrancies	O	NOUN	B
in	O	ADP	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
c-fos/c-jun	B-DNA	NOUN	B
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
their	O	PRON	O
nuclear	B-protein	ADJ	B
regulatory	I-protein	ADJ	I
proteins	I-protein	NOUN	I
may	O	AUX	O
contribute	O	VERB	O
to	O	PART	O
the	O	DET	O
age-related	O	ADJ	B
impairments	O	NOUN	I
of	O	ADP	O
AP-1	B-protein	NOUN	B
activation	O	NOUN	I
in	O	ADP	O
human	B-cell_type	ADJ	B
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Investigating	O	VERB	B
cytokines	B-protein	NOUN	B
known	O	VERB	O
to	O	PART	O
affect	O	VERB	O
B	O	NOUN	B
cell	O	NOUN	I
differentiation	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
recently	O	ADV	O
shown	O	VERB	O
that	O	SCONJ	O
IL-6	B-protein	NOUN	B
production	O	NOUN	B
is	O	AUX	O
augmented	O	VERB	B
by	O	ADP	O
RA	O	NOUN	B
.	O	PUNCT	O


Total	O	ADJ	O
mRNA	B-RNA	NOUN	B
was	O	AUX	O
extracted	O	VERB	O
from	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
using	O	VERB	O
RT-PCR	O	NOUN	B
,	O	PUNCT	O
changes	O	NOUN	B
in	O	ADP	O
the	O	DET	O
production	O	NOUN	B
of	O	ADP	O
IL-2	B-protein	NOUN	B
and	O	CCONJ	O
RA	B-protein	NOUN	B
receptors	I-protein	NOUN	I
(	O	PUNCT	O
RAR	B-protein	NOUN	B
)	O	PUNCT	O
-	O	PUNCT	O
alpha	B-RNA	NOUN	B
,	O	PUNCT	O
beta	B-RNA	NOUN	B
,	O	PUNCT	O
gamma	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	I
were	O	AUX	O
determined	O	VERB	O
.	O	PUNCT	O


We	O	PRON	O
and	O	CCONJ	O
others	O	NOUN	O
have	O	AUX	O
shown	O	VERB	O
that	O	SCONJ	O
SAA	B-protein	NOUN	B
gene	O	NOUN	I
is	O	AUX	O
induced	O	VERB	B
in	O	ADP	O
monocyte/macrophage	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
by	O	ADP	O
lipopolysaccharide	O	NOUN	B
(	O	PUNCT	O
LPS	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Cytomegalovirus	B-DNA	NOUN	B
immediate	I-DNA	ADJ	B
early	I-DNA	ADJ	O
genes	I-DNA	NOUN	O
upregulate	O	VERB	B
interleukin-6	B-protein	NOUN	B
gene	O	NOUN	B
expression	O	NOUN	I
.	O	PUNCT	O


METHODS	O	NOUN	O
:	O	PUNCT	O
THP-1	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
a	O	DET	O
monocytic	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
,	O	PUNCT	O
were	O	AUX	O
transfected	O	VERB	B
with	O	ADP	O
the	O	DET	O
CMV	B-DNA	NOUN	B
IE	I-DNA	NOUN	I
genes	I-DNA	NOUN	B
.	O	PUNCT	O


RESULTS	O	NOUN	B
:	O	PUNCT	O
Interleukin-6	B-protein	NOUN	B
protein	I-protein	NOUN	I
and	O	CCONJ	O
mRNA	O	NOUN	B
production	O	NOUN	I
were	O	AUX	O
significantly	O	ADV	O
increased	O	VERB	B
in	O	ADP	O
cells	O	NOUN	B
transfected	O	VERB	B
with	O	ADP	O
the	O	DET	O
CMV	B-DNA	NOUN	B
IE	I-DNA	NOUN	I
genes	I-DNA	NOUN	O
and	O	CCONJ	O
stimulated	O	VERB	B
with	O	ADP	O
LPS	O	NOUN	B
compared	O	VERB	O
to	O	PART	O
LPS-stimulated	B-cell_line	ADJ	B
control	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


An	O	DET	O
additional	O	ADJ	O
complex	O	NOUN	B
composed	O	VERB	O
of	O	ADP	O
p50/RelA	B-protein	NOUN	B
(	I-protein	PUNCT	O
p65	I-protein	NOUN	B
)	I-protein	PUNCT	O
heterodimers	I-protein	NOUN	B
appeared	O	VERB	O
only	O	ADV	O
in	O	ADP	O
nuclear	O	ADJ	B
extracts	O	NOUN	I
from	O	ADP	O
7-day	O	ADJ	O
MDMs	B-cell_type	NOUN	B
.	O	PUNCT	O


Immunoblot	O	NOUN	B
analysis	O	NOUN	I
showed	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
p50	O	NOUN	B
subunit	O	NOUN	I
was	O	AUX	O
constitutively	O	ADV	B
expressed	O	VERB	B
in	O	ADP	O
monocytes	B-cell_type	NOUN	B
and	O	CCONJ	O
MDMs	B-cell_type	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
intensity	O	NOUN	B
of	O	ADP	O
p65	B-protein	NOUN	B
labeling	O	NOUN	B
was	O	AUX	O
much	O	ADV	O
higher	O	ADJ	O
in	O	ADP	O
several	O	ADJ	O
thymocytes	B-cell_type	NOUN	B
from	O	ADP	O
the	O	DET	O
medulla	O	NOUN	B
.	O	PUNCT	O


With	O	ADP	O
the	O	DET	O
aim	O	NOUN	O
of	O	ADP	O
gaining	O	VERB	O
insight	O	NOUN	O
into	O	ADP	O
the	O	DET	O
function	O	NOUN	B
of	O	ADP	O
context-dependent	B-protein	ADJ	O
activation	I-protein	NOUN	O
domains	I-protein	NOUN	O
,	O	PUNCT	O
we	O	PRON	O
cloned	O	VERB	B
ALY	B-protein	NOUN	B
,	O	PUNCT	O
a	O	DET	O
novel	O	ADJ	O
LEF-1-interacting	B-protein	ADJ	B
protein	I-protein	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
overexpressed	O	VERB	B
AML1a	B-protein	NOUN	B
(	O	PUNCT	O
without	O	ADP	O
the	O	DET	O
transcription-activating	B-protein	ADJ	B
domain	I-protein	NOUN	I
)	O	PUNCT	O
and	O	CCONJ	O
AML1b	B-protein	NOUN	B
(	O	PUNCT	O
with	O	ADP	O
the	O	DET	O
domain	O	NOUN	B
)	O	PUNCT	O
proteins	O	NOUN	O
in	O	ADP	O
K562	B-cell_type	NOUN	B
leukemia	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	B
,	O	PUNCT	O
which	O	DET	O
can	O	AUX	O
be	O	AUX	O
induced	O	VERB	B
to	O	PART	O
differentiate	O	VERB	B
into	O	ADP	O
hemoglobin-producing	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
megakaryocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


The	O	DET	O
AML1a-transfected	B-cell_line	ADJ	B
K562	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
had	O	AUX	O
a	O	DET	O
reduced	O	VERB	B
capacity	O	NOUN	B
to	O	PART	O
differentiate	O	VERB	B
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
sodium	O	NOUN	B
n-butyrate	O	NOUN	I
but	O	CCONJ	O
not	O	PART	O
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
other	O	ADJ	O
inducers	O	NOUN	B
,	O	PUNCT	O
such	O	ADJ	O
as	O	ADP	O
hemin	O	NOUN	B
,	O	PUNCT	O
1-beta-D-arabinofuranosylcytosine	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
herbimycin	O	NOUN	B
A	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
cloned	O	VERB	B
and	O	CCONJ	O
sequenced	O	VERB	B
a	O	DET	O
portion	O	NOUN	B
of	O	ADP	O
the	O	DET	O
ER	B-protein	NOUN	B
upstream	B-DNA	ADJ	O
regulatory	I-DNA	ADJ	B
region	I-DNA	NOUN	I
from	O	ADP	O
the	O	DET	O
ER-positive	B-cell_line	ADJ	B
MCF-7	I-cell_line	NOUN	B
and	O	CCONJ	O
the	O	DET	O
ER-negative	B-cell_line	ADJ	B
MDA-MB-231	I-cell_line	NOUN	B
breast	I-cell_line	NOUN	B
cancer	I-cell_line	NOUN	I
cell	I-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
to	O	PART	O
determine	O	VERB	O
if	O	SCONJ	O
sequence	O	NOUN	B
alterations	O	NOUN	B
in	O	ADP	O
this	O	DET	O
region	O	NOUN	B
account	O	VERB	O
for	O	ADP	O
the	O	DET	O
ER	B-protein	NOUN	B
-negative	O	ADJ	O
phenotype	O	NOUN	B
of	O	ADP	O
some	O	DET	O
tumors	O	NOUN	B
.	O	PUNCT	O


IL-4	B-protein	NOUN	B
is	O	AUX	O
secreted	O	VERB	B
by	O	ADP	O
activated	O	VERB	B
Th2	B-cell_type	NOUN	B
but	O	CCONJ	O
not	O	PART	O
Th1	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
plays	O	VERB	O
a	O	DET	O
major	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
immune	O	ADJ	B
response	O	NOUN	I
by	O	ADP	O
modulating	O	VERB	B
the	O	DET	O
differentiation	O	NOUN	B
of	O	ADP	O
naive	B-cell_type	ADJ	B
Th	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
toward	O	ADP	O
the	O	DET	O
Th2	B-cell_type	NOUN	B
phenotype	I-cell_type	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
mouse	B-cell_line	NOUN	B
Th2	I-cell_line	NOUN	B
D10	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
and	O	CCONJ	O
in	O	ADP	O
the	O	DET	O
human	B-cell_line	ADJ	B
Th2	I-cell_line	NOUN	B
clones	I-cell_line	NOUN	O
,	O	PUNCT	O
POS-1	B-protein	NOUN	B
(	O	PUNCT	O
designated	O	VERB	O
POS-1b	B-protein	NOUN	B
)	O	PUNCT	O
contains	O	VERB	O
NF-IL6beta	B-protein	NOUN	B
,	O	PUNCT	O
Jun	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
NF-ATc/p	B-protein	NOUN	B
.	O	PUNCT	O


Germline	B-protein	NOUN	B
transcripts	I-protein	NOUN	I
initiate	O	VERB	B
from	O	ADP	O
promoters	B-DNA	NOUN	B
upstream	O	ADV	B
of	O	ADP	O
the	O	DET	O
immunoglobulin	B-DNA	NOUN	B
switch	I-DNA	NOUN	I
region	I-DNA	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
are	O	AUX	O
necessary	O	ADJ	O
to	O	PART	O
target	O	VERB	B
the	O	DET	O
appropriate	O	ADJ	O
switch	O	NOUN	B
region	O	NOUN	I
for	O	ADP	O
recombination	O	NOUN	B
and	O	CCONJ	O
switching	O	NOUN	B
.	O	PUNCT	O


BSAP	B-protein	NOUN	B
is	O	AUX	O
unique	O	ADJ	B
among	O	ADP	O
the	O	DET	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
that	O	PRON	O
regulate	O	VERB	B
epsilon	O	NOUN	O
germline	B-DNA	NOUN	B
expression	O	NOUN	B
,	O	PUNCT	O
because	O	SCONJ	O
it	O	PRON	O
is	O	AUX	O
B	O	NOUN	B
cell	O	NOUN	I
specific	O	ADJ	B
,	O	PUNCT	O
and	O	CCONJ	O
is	O	AUX	O
at	O	ADP	O
the	O	DET	O
merging	O	ADJ	O
point	O	NOUN	O
of	O	ADP	O
two	O	NUM	O
signalling	O	NOUN	B
pathways	O	NOUN	I
that	O	PRON	O
are	O	AUX	O
critical	O	ADJ	O
for	O	ADP	O
IgE	B-protein	NOUN	B
switching	O	NOUN	B
.	O	PUNCT	O


Two	O	NUM	O
sets	O	NOUN	O
of	O	ADP	O
independent	O	ADJ	O
evidences	O	NOUN	B
are	O	AUX	O
presented	O	VERB	O
here	O	ADV	O
that	O	PRON	O
demonstrate	O	VERB	O
a	O	DET	O
biological	O	ADJ	B
relevance	O	NOUN	B
for	O	ADP	O
this	O	DET	O
model	O	NOUN	B
.	O	PUNCT	O


Antibodies	O	NOUN	B
recognizing	O	VERB	O
double-stranded	O	ADJ	B
DNA	O	NOUN	I
were	O	AUX	O
confined	O	VERB	O
to	O	PART	O
patients	O	NOUN	B
with	O	ADP	O
frequent	O	ADJ	B
polyomavirus	O	NOUN	B
reactivations	O	NOUN	B
.	O	PUNCT	O


Transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
required	O	VERB	O
for	O	ADP	O
lymphoid	O	ADJ	B
lineage	O	NOUN	B
commitment	O	NOUN	B
.	O	PUNCT	O


Using	O	VERB	O
various	O	ADJ	O
constructs	O	NOUN	B
expressing	O	VERB	B
a	O	DET	O
lacZ	B-DNA	NOUN	B
reporter	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
under	O	ADP	O
the	O	DET	O
control	O	NOUN	B
of	O	ADP	O
the	O	DET	O
intact	O	ADJ	B
or	O	CCONJ	O
three	O	NUM	O
deleted	O	ADJ	O
forms	O	NOUN	O
of	O	ADP	O
HIV-1	B-DNA	NOUN	B
LTR	I-DNA	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
obtained	O	VERB	O
evidence	O	NOUN	B
that	O	SCONJ	O
the	O	DET	O
kappaB	B-DNA	NOUN	B
regulatory	I-DNA	ADJ	I
elements	I-DNA	NOUN	I
located	O	ADJ	O
in	O	ADP	O
the	O	DET	O
U3	B-DNA	NOUN	B
region	I-DNA	NOUN	I
are	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
cell-to-cell	O	ADJ	B
activation	O	NOUN	I
of	O	ADP	O
HIV-1	B-DNA	NOUN	B
LTR	I-DNA	NOUN	B
.	O	PUNCT	O


Cell-to-cell	O	ADJ	B
contact	O	NOUN	B
activation	O	NOUN	B
of	O	ADP	O
NF-kappaB	B-protein	NOUN	B
was	O	AUX	O
only	O	ADV	O
partially	O	ADV	O
inhibited	O	VERB	B
by	O	ADP	O
100	O	NUM	O
microM	O	NOUN	O
pyrrolidine	O	NOUN	B
dithiocarbamate	O	NOUN	I
and	O	CCONJ	O
was	O	AUX	O
not	O	PART	O
correlated	O	VERB	B
with	O	ADP	O
a	O	DET	O
significant	O	ADJ	O
decrease	O	NOUN	B
of	O	ADP	O
cellular	B-protein	ADJ	B
inhibitor	I-protein	NOUN	I
kappaB	I-protein	NOUN	I
alpha	I-protein	NOUN	I
.	O	PUNCT	O


NAC	O	NOUN	B
was	O	AUX	O
also	O	ADV	O
effective	O	ADJ	B
in	O	ADP	O
diminishing	O	VERB	O
germline	B-DNA	NOUN	B
C	O	NOUN	I
epsilon	O	NOUN	I
transcription	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
its	O	PRON	O
potency	O	NOUN	B
was	O	AUX	O
higher	O	ADJ	O
in	O	ADP	O
cultures	O	NOUN	B
costimulated	O	VERB	B
with	O	ADP	O
IL-4	B-protein	NOUN	B
and	O	CCONJ	O
anti-CD40	B-protein	ADJ	B
mAb	I-protein	NOUN	B
than	O	ADP	O
in	O	ADP	O
those	O	DET	O
stimulated	O	VERB	B
with	O	ADP	O
IL-4	B-protein	NOUN	B
alone	O	ADV	O
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
compared	O	VERB	B
the	O	DET	O
action	O	NOUN	B
on	O	ADP	O
U-937	B-cell_line	NOUN	B
human	I-cell_line	ADJ	O
promonocytic	I-cell_line	ADJ	O
leukemia	I-cell_line	NOUN	O
cells	I-cell_line	NOUN	B
of	O	ADP	O
two	O	NUM	O
DNA	B-protein	NOUN	B
topoisomerase	I-protein	NOUN	I
II	I-protein	NUM	I
inhibitors	O	NOUN	I
,	O	PUNCT	O
namely	O	ADV	O
the	O	DET	O
epipodophyllotoxin	O	NOUN	B
etoposide	O	NOUN	I
and	O	CCONJ	O
the	O	DET	O
bisdioxopiperazine	O	NOUN	B
ICRF-193	O	NOUN	B
.	O	PUNCT	O


By	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
these	O	DET	O
effects	O	NOUN	B
were	O	AUX	O
not	O	PART	O
observed	O	VERB	O
upon	O	SCONJ	O
pulse-treatment	O	ADJ	B
with	O	ADP	O
6	O	NUM	O
microM	O	NOUN	O
ICRF-193	O	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
continuous	O	ADJ	B
treatments	O	NOUN	B
with	O	ADP	O
subcytotoxic	O	ADJ	B
concentrations	O	NOUN	B
of	O	ADP	O
etoposide	O	NOUN	B
(	O	PUNCT	O
0.15	O	NUM	O
microM	O	NOUN	O
)	O	PUNCT	O
and	O	CCONJ	O
ICRF-193	O	NOUN	B
(	O	PUNCT	O
0.3	O	NUM	O
microM	O	NOUN	O
)	O	PUNCT	O
produced	O	VERB	O
several	O	ADJ	O
similar	O	ADJ	O
effects	O	NOUN	B
,	O	PUNCT	O
namely	O	ADV	O
decreased	O	VERB	B
cell	O	NOUN	B
proliferation	O	NOUN	I
,	O	PUNCT	O
accumulation	O	NOUN	B
of	O	ADP	O
cells	O	NOUN	B
at	O	ADP	O
G2	O	NOUN	B
,	O	PUNCT	O
increase	O	NOUN	B
in	O	ADP	O
cell	O	NOUN	B
mass	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
induction	O	NOUN	B
of	O	ADP	O
differentiation	O	NOUN	B
.	O	PUNCT	O


By	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
ICRF-193	O	NOUN	B
only	O	ADV	O
provoked	O	VERB	O
a	O	DET	O
late	O	ADJ	O
activation	O	NOUN	B
(	O	PUNCT	O
from	O	ADP	O
hours	O	NOUN	O
72	O	NUM	O
to	O	PART	O
96	O	NUM	O
)	O	PUNCT	O
of	O	ADP	O
the	O	DET	O
total	O	ADJ	O
enzyme	O	NOUN	B
.	O	PUNCT	O


When	O	SCONJ	O
used	O	VERB	O
at	O	ADP	O
differentiation-inducing	O	ADJ	B
concentrations	O	NOUN	B
,	O	PUNCT	O
both	O	CCONJ	O
topoisomerase	B-protein	NOUN	B
inhibitors	O	NOUN	I
caused	O	VERB	O
a	O	DET	O
great	O	ADJ	O
stimulation	O	NOUN	B
of	O	ADP	O
AP-1	B-protein	NOUN	B
binding	O	NOUN	I
activity	O	NOUN	I
,	O	PUNCT	O
with	O	ADP	O
maximum	O	ADJ	B
value	O	NOUN	I
at	O	ADP	O
hour	O	NOUN	B
12	O	NUM	O
in	O	ADP	O
etoposide-treated	O	ADJ	B
cells	O	NOUN	I
and	O	CCONJ	O
at	O	ADP	O
hour	O	NOUN	B
48	O	NUM	O
in	O	ADP	O
ICRF-193-treated	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


It	O	PRON	O
is	O	AUX	O
concluded	O	VERB	O
that	O	SCONJ	O
topoisomerase	O	NOUN	B
II	O	NUM	I
inhibitors	O	NOUN	I
may	O	AUX	O
induce	O	VERB	B
the	O	DET	O
differentiation	O	NOUN	B
of	O	ADP	O
promonocytic	O	ADJ	B
cells	O	NOUN	I
,	O	PUNCT	O
independently	O	ADV	O
of	O	ADP	O
their	O	PRON	O
capacity	O	NOUN	B
to	O	PART	O
cause	O	VERB	O
DNA	O	NOUN	B
strand	O	NOUN	I
breaks	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
onset	O	NOUN	O
of	O	ADP	O
both	O	DET	O
processes	O	NOUN	B
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
be	O	AUX	O
closely	O	ADV	O
paralleled	O	VERB	O
by	O	ADP	O
,	O	PUNCT	O
and	O	CCONJ	O
dependent	O	ADJ	B
on	O	ADP	O
,	O	PUNCT	O
IkappaB-alpha	B-protein	NOUN	B
degradation	O	NOUN	I
.	O	PUNCT	O


Therefore	O	ADV	O
we	O	PRON	O
studied	O	VERB	O
the	O	DET	O
expression	O	NOUN	B
pattern	O	NOUN	O
of	O	ADP	O
LAZ3/BCL6	B-protein	NOUN	B
by	O	ADP	O
in	O	X	B
situ	O	X	I
hybridization	O	NOUN	I
with	O	ADP	O
synthetic	O	ADJ	B
oligonucleotide	O	NOUN	I
probes	O	NOUN	I
in	O	ADP	O
frozen	O	ADJ	B
tissue	O	NOUN	I
sections	O	NOUN	I
from	O	ADP	O
five	O	NUM	O
reactive	O	ADJ	B
lymph	O	NOUN	I
nodes	O	NOUN	I
and	O	CCONJ	O
38	O	NUM	O
B	O	NOUN	B
cell	O	NOUN	I
and	O	CCONJ	O
non-B	O	ADJ	B
NHL	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
we	O	PRON	O
investigated	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
LAZ3/BCL6	B-protein	NOUN	B
by	O	ADP	O
Northern	O	NOUN	B
blot	O	NOUN	I
analysis	O	NOUN	I
on	O	ADP	O
multiple	O	ADJ	O
human	O	ADJ	B
tissues	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
LAZ3/BCL6	B-RNA	NOUN	B
transcript	I-RNA	NOUN	I
was	O	AUX	O
found	O	VERB	O
in	O	ADP	O
a	O	DET	O
variety	O	NOUN	O
of	O	ADP	O
tissues	O	NOUN	B
,	O	PUNCT	O
including	O	VERB	O
skeletal	O	ADJ	B
muscle	O	NOUN	I
,	O	PUNCT	O
peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
leukocytes	I-cell_type	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
weakly	O	ADV	O
in	O	ADP	O
normal	O	ADJ	O
lymph	O	NOUN	B
nodes	O	NOUN	I
.	O	PUNCT	O


Hence	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
LAZ3/BCL6	B-protein	NOUN	B
does	O	AUX	O
not	O	PART	O
correlate	O	VERB	O
to	O	PART	O
malignancy	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
reflects	O	VERB	O
the	O	DET	O
origin	O	NOUN	B
of	O	ADP	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
from	O	ADP	O
the	O	DET	O
germinal	O	ADJ	B
centers	O	NOUN	I
.	O	PUNCT	O


Based	O	VERB	O
upon	O	SCONJ	O
work	O	NOUN	O
from	O	ADP	O
our	O	PRON	O
laboratory	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
propose	O	VERB	O
that	O	SCONJ	O
inhibition	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activation	O	NOUN	B
produces	O	VERB	O
significant	O	ADJ	O
anti	O	ADJ	B
inflammatory	O	ADJ	I
activity	O	NOUN	I
which	O	DET	O
may	O	AUX	O
be	O	AUX	O
mediated	O	VERB	O
by	O	ADP	O
the	O	DET	O
inhibition	O	NOUN	B
of	O	ADP	O
transcription	O	NOUN	B
of	O	ADP	O
certain	O	ADJ	O
pro-inflammatory	B-protein	ADJ	B
mediators	I-protein	NOUN	O
and	O	CCONJ	O
adhesion	B-protein	NOUN	B
molecules	I-protein	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
cytotoxic	B-cell_type	ADJ	B
T	I-cell_type	NOUN	I
lymphocyte	I-cell_type	NOUN	I
(	O	PUNCT	O
CTL	B-cell_type	NOUN	B
)	O	PUNCT	O
response	O	NOUN	B
to	O	PART	O
Ad	O	NOUN	B
could	O	AUX	O
limit	O	VERB	O
the	O	DET	O
effectiveness	O	NOUN	B
of	O	ADP	O
such	O	ADJ	O
approaches	O	NOUN	B
.	O	PUNCT	O


When	O	SCONJ	O
B10	O	NOUN	B
mice	O	NOUN	I
were	O	AUX	O
inoculated	O	VERB	O
multiple	O	ADJ	O
times	O	NOUN	O
either	O	CCONJ	O
i.p	O	NOUN	B
.	O	PUNCT	O


Platelet/endothelial	B-protein	NOUN	B
cell	I-protein	NOUN	I
adhesion	I-protein	NOUN	I
molecule-1	I-protein	NOUN	I
(	O	PUNCT	O
PECAM-1	B-protein	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
130-kD	B-protein	ADJ	O
member	I-protein	NOUN	B
of	O	ADP	O
the	O	DET	O
Ig	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
superfamily	I-DNA	NOUN	O
that	O	PRON	O
is	O	AUX	O
expressed	O	VERB	B
on	O	ADP	O
platelets	B-cell_type	NOUN	B
,	O	PUNCT	O
endothelial	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
certain	O	ADJ	O
leukocyte	B-cell_type	NOUN	B
subsets	I-cell_type	NOUN	I
.	O	PUNCT	O


Within	O	ADP	O
this	O	DET	O
region	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
19-bp	B-DNA	ADJ	O
nuclear	I-DNA	ADJ	B
factor	I-DNA	NOUN	I
binding	I-DNA	NOUN	I
site	I-DNA	NOUN	I
(	O	PUNCT	O
-570	B-DNA	NUM	O
to	I-DNA	PART	O
-552	I-DNA	NUM	O
)	O	PUNCT	O
was	O	AUX	O
characterized	O	VERB	B
by	O	ADP	O
DNase	B-protein	NOUN	B
I	I-protein	NUM	I
footprinting	O	NOUN	I
and	O	CCONJ	O
electromobility	O	NOUN	B
shift	O	NOUN	I
assay	O	NOUN	I
.	O	PUNCT	O


This	O	DET	O
is	O	AUX	O
the	O	DET	O
first	O	ADJ	O
description	O	NOUN	B
of	O	ADP	O
a	O	DET	O
negative	B-DNA	ADJ	B
regulatory	I-DNA	ADJ	B
region	I-DNA	NOUN	I
responsive	O	ADJ	O
to	O	PART	O
glucocorticoids	O	NOUN	B
in	O	ADP	O
a	O	DET	O
cytokine	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
.	O	PUNCT	O


Mutations	O	NOUN	B
which	O	DET	O
abrogated	O	VERB	B
the	O	DET	O
gene-suppressive	O	ADJ	B
activity	O	NOUN	I
of	O	ADP	O
NRE	B-DNA	NOUN	B
gamma	I-DNA	NOUN	O
prevented	O	VERB	B
RFX1	B-protein	NOUN	B
from	O	ADP	O
binding	O	VERB	B
to	O	PART	O
NRE	B-DNA	NOUN	B
gamma	I-DNA	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
CRF	O	NOUN	B
patients	O	NOUN	B
,	O	PUNCT	O
Bmax	O	NOUN	B
and	O	CCONJ	O
Kd	O	NOUN	B
in	O	ADP	O
quiescent	O	ADJ	B
PBMC	B-cell_type	NOUN	B
of	O	ADP	O
the	O	DET	O
GC-sensitive	O	ADJ	B
group	O	NOUN	B
were	O	AUX	O
6.04	O	NUM	O
+/-	O	CCONJ	O
2.35	O	NUM	O
fmol/10	O	NOUN	O
(	O	PUNCT	O
6	O	NUM	O
)	O	PUNCT	O
cells	O	NOUN	B
and	O	CCONJ	O
3.49	O	NUM	O
+/-	O	CCONJ	O
1.72	O	NUM	O
nM	O	NOUN	O
,	O	PUNCT	O
respectively	O	ADV	O
,	O	PUNCT	O
while	O	SCONJ	O
those	O	DET	O
in	O	ADP	O
PBMC	B-cell_type	NOUN	B
of	O	ADP	O
the	O	DET	O
GC-resistant	O	ADJ	B
group	O	NOUN	B
were	O	AUX	O
5.13	O	NUM	O
+/-	O	CCONJ	O
2.31	O	NUM	O
fmol/10	O	NOUN	O
(	O	PUNCT	O
6	O	NUM	O
)	O	PUNCT	O
cells	O	NOUN	B
and	O	CCONJ	O
4.04	O	NUM	O
+/-	O	CCONJ	O
1.62	O	NUM	O
nM	O	NOUN	O
,	O	PUNCT	O
respectively	O	ADV	O
.	O	PUNCT	O


IL-2	B-protein	NOUN	B
superinduction	O	NOUN	B
by	O	ADP	O
Tat	B-protein	NOUN	B
occurred	O	VERB	O
at	O	ADP	O
the	O	DET	O
transcriptional	O	ADJ	B
level	O	NOUN	B
,	O	PUNCT	O
was	O	AUX	O
mediated	O	VERB	O
by	O	ADP	O
the	O	DET	O
CD28-responsive	B-DNA	ADJ	B
element	I-DNA	NOUN	I
in	O	ADP	O
the	O	DET	O
IL-2	B-DNA	NOUN	B
promoter	I-DNA	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
was	O	AUX	O
exclusively	O	ADV	O
dependent	O	ADJ	B
on	O	ADP	O
the	O	DET	O
29	B-protein	NUM	O
amino	I-protein	NOUN	B
acids	I-protein	NOUN	I
encoded	O	VERB	B
by	O	ADP	O
the	O	DET	O
second	B-DNA	ADJ	O
exon	I-DNA	NOUN	B
of	I-DNA	ADP	O
Tat	I-DNA	NOUN	B
.	O	PUNCT	O


Most	O	ADJ	O
patients	O	NOUN	B
will	O	AUX	O
respond	O	VERB	O
but	O	CCONJ	O
a	O	DET	O
few	O	ADJ	O
patients	O	NOUN	B
respond	O	VERB	O
less	O	ADV	O
to	O	ADP	O
these	O	DET	O
drugs	O	NOUN	B
.	O	PUNCT	O


CONCLUSIONS	O	NOUN	O
:	O	PUNCT	O
The	O	DET	O
reduction	O	NOUN	B
of	O	ADP	O
symptoms	O	NOUN	B
due	O	ADJ	O
to	O	PART	O
topical	O	ADJ	B
fluticasone	O	NOUN	B
propionate	O	NOUN	B
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
rhinitis	O	NOUN	B
and	O	CCONJ	O
allergy	O	NOUN	B
to	O	PART	O
house	O	NOUN	B
dust	O	NOUN	I
mite	O	NOUN	I
is	O	AUX	O
not	O	PART	O
correlated	O	VERB	B
with	O	ADP	O
the	O	DET	O
characteristics	O	NOUN	B
of	O	ADP	O
the	O	DET	O
glucocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
replacement	O	NOUN	B
of	O	ADP	O
p50	B-protein	NOUN	B
homodimers	I-protein	NOUN	I
with	O	ADP	O
transcriptionally	O	ADV	B
active	O	ADJ	O
heterodimers	O	NOUN	B
following	O	VERB	O
time	O	NOUN	O
in	O	ADP	O
culture	O	NOUN	B
may	O	AUX	O
partially	O	ADV	O
explain	O	VERB	O
the	O	DET	O
progressive	O	ADJ	B
increase	O	NOUN	B
in	O	ADP	O
susceptibility	O	NOUN	B
of	O	ADP	O
monocytes	B-cell_type	NOUN	B
to	O	PART	O
HIV	O	NOUN	B
infection	O	NOUN	I
during	O	ADP	O
in	O	X	B
vitro	O	X	I
culture	O	NOUN	B
.	O	PUNCT	O


Ascorbic	O	NOUN	B
acid	O	NOUN	I
(	O	PUNCT	O
ascorbate	O	NOUN	B
or	O	CCONJ	O
vitamin	O	NOUN	B
C	O	NOUN	I
)	O	PUNCT	O
has	O	AUX	O
been	O	AUX	O
shown	O	VERB	O
to	O	PART	O
suppress	O	VERB	B
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
HIV	O	NOUN	B
in	O	ADP	O
latently	B-cell_type	ADV	B
infected	I-cell_type	ADJ	I
T	I-cell_type	NOUN	B
lymphocytic	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
following	O	VERB	O
stimulation	O	NOUN	B
with	O	ADP	O
a	O	DET	O
tumor	O	NOUN	B
promoter	O	NOUN	I
(	O	PUNCT	O
PMA	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
inflammatory	B-protein	ADJ	B
cytokine	I-protein	NOUN	I
(	O	PUNCT	O
TNF-alpha	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Interleukin-3	B-protein	NOUN	B
(	O	PUNCT	O
IL-3	B-protein	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
cytokine	B-protein	NOUN	B
that	O	PRON	O
is	O	AUX	O
expressed	O	VERB	B
primarily	O	ADV	O
in	O	ADP	O
activated	B-cell_type	VERB	B
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
identified	O	VERB	B
an	O	DET	O
inducible	O	ADJ	B
T	B-DNA	NOUN	O
cell-specific	I-DNA	ADJ	O
enhancer	I-DNA	NOUN	O
14	O	NUM	O
kb	O	NOUN	O
upstream	O	ADJ	O
of	O	ADP	O
the	O	DET	O
IL-3	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
that	O	PRON	O
responded	O	VERB	O
to	O	PART	O
activation	O	NOUN	B
of	O	ADP	O
T	B-protein	NOUN	B
cell	I-protein	NOUN	I
receptor	I-protein	NOUN	I
signaling	O	NOUN	O
pathways	O	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
suggest	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
T	O	NOUN	B
cell-specific	O	ADJ	O
expression	O	NOUN	O
of	O	ADP	O
the	O	DET	O
IL-3	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
is	O	AUX	O
partly	O	ADV	O
controlled	O	VERB	B
through	O	ADP	O
the	O	DET	O
enhancer	O	NOUN	B
by	O	ADP	O
cooperation	O	NOUN	B
between	O	ADP	O
Oct	B-protein	NOUN	B
and	I-protein	CCONJ	O
NFAT	I-protein	NOUN	B
family	I-protein	NOUN	O
proteins	I-protein	NOUN	O
.	O	PUNCT	O


Inefficient	O	ADJ	B
DNA	O	NOUN	O
replication	O	NOUN	O
is	O	AUX	O
also	O	ADV	O
found	O	VERB	O
in	O	ADP	O
another	O	DET	O
monocyte	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
,	O	PUNCT	O
THP-1	B-cell_line	NOUN	B


Activation	O	NOUN	B
of	O	ADP	O
Ras	O	NOUN	B
and	O	CCONJ	O
mitogen-activated	B-protein	ADJ	B
protein	I-protein	NOUN	I
kinase	I-protein	NOUN	I
pathway	O	NOUN	I
by	O	ADP	O
terminal	B-protein	ADJ	B
complement	I-protein	NOUN	B
complexes	I-protein	NOUN	I
is	O	AUX	O
G	B-protein	NOUN	B
protein	I-protein	NOUN	I
dependent	O	ADJ	O
.	O	PUNCT	O


Both	O	CCONJ	O
C5b-9	B-protein	NOUN	B
and	O	CCONJ	O
C5b-7	B-protein	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
C5b6	B-protein	NOUN	B
,	O	PUNCT	O
increased	O	VERB	B
Raf-1	B-protein	NOUN	B
kinase	O	NOUN	O
activity	O	NOUN	O
maximum	O	VERB	B
3.3-fold	O	ADV	O
at	O	ADP	O
2	O	NUM	O
min	O	NOUN	O
and	O	CCONJ	O
2.8-fold	O	ADV	O
at	O	ADP	O
5	O	NUM	O
min	O	NOUN	B
,	O	PUNCT	O
respectively	O	ADV	O
.	O	PUNCT	O


ERK1	B-protein	NOUN	B
activity	O	NOUN	B
was	O	AUX	O
2-fold	O	ADV	O
increased	O	VERB	B
by	O	ADP	O
C5b-9	B-protein	NOUN	B
at	O	ADP	O
2	O	NUM	O
min	O	NOUN	O
and	O	CCONJ	O
by	O	ADP	O
C5b-7	B-protein	NOUN	B
at	O	ADP	O
10	O	NUM	O
min	O	NOUN	O
,	O	PUNCT	O
over	O	ADP	O
the	O	DET	O
C5b6	B-protein	NOUN	B
level	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
role	O	NOUN	O
of	O	ADP	O
mitogen-activated	B-protein	ADJ	B
protein	I-protein	NOUN	I
kinase	I-protein	NOUN	I
(	O	PUNCT	O
MAPK	B-protein	NOUN	O
)	O	PUNCT	O
pathway	O	NOUN	O
on	O	ADP	O
TCC	B-protein	NOUN	B
-inducible	O	ADJ	O
mitotic	O	ADJ	B
signaling	O	NOUN	I
was	O	AUX	O
evaluated	O	VERB	B
by	O	ADP	O
assessing	O	VERB	O
DNA	O	NOUN	B
synthesis	O	NOUN	I
and	O	CCONJ	O
activator	B-protein	NOUN	B
protein	I-protein	NOUN	I
1	I-protein	NUM	I
(	O	PUNCT	O
AP-1	B-protein	NOUN	B
)	O	PUNCT	O
DNA-binding	O	ADJ	B
activity	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
MAPK/ERK-specific	O	ADJ	B
inhibitor	O	NOUN	B
PD	O	NOUN	B
098	O	NUM	O
,	O	PUNCT	O
059	O	NUM	O
abolished	O	VERB	O
the	O	DET	O
C5b-9	B-protein	NOUN	B
-induced	O	ADJ	O
DNA	O	NOUN	B
synthesis	O	NOUN	I
.	O	PUNCT	O


Overexpression	O	NOUN	B
of	O	ADP	O
beta-adrenergic	O	ADJ	B
receptor	O	NOUN	I
kinase	O	NOUN	I
1	O	NUM	I
carboxyl-terminal	O	ADJ	B
peptide	O	NOUN	I
in	O	ADP	O
JY25	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
also	O	ADV	O
inhibited	O	VERB	B
Raf-1	B-protein	NOUN	B
and	O	CCONJ	O
ERK1	B-protein	NOUN	B
activity	O	NOUN	B
,	O	PUNCT	O
indicating	O	VERB	O
a	O	DET	O
direct	O	ADJ	O
involvement	O	NOUN	B
of	O	ADP	O
G	O	NOUN	B
betagamma	O	NOUN	I
subunits	O	NOUN	I
in	O	ADP	O
the	O	DET	O
signal	O	NOUN	B
transduction	O	NOUN	I
generated	O	VERB	O
through	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
MAPK	B-protein	NOUN	B
pathway	O	NOUN	I
by	O	ADP	O
TCC	B-protein	NOUN	B
assembly	O	NOUN	B
in	O	ADP	O
the	O	DET	O
plasma	O	NOUN	B
membrane	O	NOUN	I
.	O	PUNCT	O


Spontaneous	O	ADJ	B
occurrence	O	NOUN	B
of	O	ADP	O
early	O	ADJ	B
region	O	NOUN	I
1A	O	NOUN	O
reiteration	O	NOUN	B
mutants	O	NOUN	B
of	O	ADP	O
type	O	NOUN	B
5	O	NUM	I
adenovirus	O	NOUN	I
in	O	ADP	O
persistently	B-cell_type	ADV	O
infected	I-cell_type	ADJ	B
human	I-cell_type	ADJ	B
T-lymphocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
report	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
demonstrate	O	VERB	O
a	O	DET	O
functional	O	ADJ	B
correlate	O	NOUN	B
of	O	ADP	O
DQA1	O	NOUN	B
polymorphism	O	NOUN	B
.	O	PUNCT	O


T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
infiltrating	O	VERB	B
a	O	DET	O
herpes	O	NOUN	B
simplex	O	NOUN	I
virus	O	NOUN	I
(	O	PUNCT	O
HSV	O	NOUN	B
)	O	PUNCT	O
lesion	O	NOUN	B
from	O	ADP	O
a	O	DET	O
HLA	O	NOUN	B
DQ	O	NOUN	I
2	O	NUM	I
,	O	PUNCT	O
7	O	NUM	O
individual	O	NOUN	B
yielded	O	VERB	O
a	O	DET	O
virus-specific	B-cell_line	ADJ	B
CD4+	I-cell_line	ADJ	B
clone	I-cell_line	NOUN	I
restricted	O	VERB	O
by	O	ADP	O
DQ2	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
major	B-protein	ADJ	B
histocompatibility	I-protein	NOUN	I
complex	I-protein	NOUN	I
(	I-protein	PUNCT	O
MHC	I-protein	NOUN	B
)	I-protein	PUNCT	O
class	I-protein	NOUN	B
II	I-protein	NUM	I
antigens	I-protein	NOUN	O
is	O	AUX	O
constitutive	O	ADJ	B
in	O	ADP	O
professional	B-cell_type	ADJ	B
antigen	I-cell_type	NOUN	I
presenting	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
(	O	PUNCT	O
APCs	B-cell_type	NOUN	B
)	O	PUNCT	O
but	O	CCONJ	O
can	O	AUX	O
also	O	ADV	O
be	O	AUX	O
induced	O	VERB	B
by	O	ADP	O
interferon-gamma	B-protein	NOUN	B
(	O	PUNCT	O
IFN-gamma	B-protein	NOUN	B
)	O	PUNCT	O
on	O	ADP	O
the	O	DET	O
majority	O	NOUN	O
of	O	ADP	O
the	O	DET	O
non	O	ADJ	B
professional	B-cell_type	ADJ	I
APCs	I-cell_type	NOUN	B
(	O	PUNCT	O
e.g	O	ADV	O
.	O	PUNCT	O
fibroblasts	B-cell_type	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Here	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
demonstrate	O	VERB	O
a	O	DET	O
novel	O	ADJ	O
role	O	NOUN	O
for	O	ADP	O
IK	B-protein	NOUN	B
in	O	ADP	O
MHC	B-protein	NOUN	B
class	I-protein	NOUN	I
II	I-protein	NUM	I
expression	O	NOUN	B
since	O	SCONJ	O
over-expression	O	NOUN	B
of	O	ADP	O
this	O	DET	O
protein	O	NOUN	B
by	O	ADP	O
stable	O	ADJ	O
transfection	O	NOUN	B
into	O	ADP	O
human	O	ADJ	B
B	O	NOUN	O
cells	O	NOUN	O
led	O	VERB	O
to	O	PART	O
a	O	DET	O
total	O	ADJ	O
disappearance	O	NOUN	B
of	O	ADP	O
constitutive	O	ADJ	B
MHC	B-RNA	NOUN	B
class	I-RNA	NOUN	I
II	I-RNA	NUM	I
mRNA	I-RNA	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


Upon	O	SCONJ	O
antigen	O	NOUN	B
stimulation	O	NOUN	I
,	O	PUNCT	O
precursor	O	NOUN	B
CD4+	B-cell_type	ADJ	B
T	I-cell_type	NOUN	I
helper	I-cell_type	NOUN	I
(	I-cell_type	PUNCT	I
pTh	I-cell_type	NOUN	O
)	I-cell_type	PUNCT	O
cells	I-cell_type	NOUN	B
proliferate	O	VERB	I
and	O	CCONJ	O
differentiate	O	VERB	B
into	O	ADP	O
two	O	NUM	O
populations	O	NOUN	B
of	O	ADP	O
effector	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
(	O	PUNCT	O
eTh1	B-cell_type	NOUN	B
and	O	CCONJ	O
eTh2	B-cell_type	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
each	O	DET	O
one	O	NUM	O
expressing	O	VERB	B
a	O	DET	O
specific	O	ADJ	O
pattern	O	NOUN	B
of	O	ADP	O
cytokines	B-protein	NOUN	B
that	O	PRON	O
distinguishes	O	VERB	O
them	O	PRON	O
from	O	ADP	O
their	O	PRON	O
precursors	O	NOUN	B
.	O	PUNCT	O


Regulation	O	NOUN	B
of	O	ADP	O
NFAT	B-protein	NOUN	B
could	O	AUX	O
be	O	AUX	O
therefore	O	ADV	O
a	O	DET	O
critical	O	ADJ	B
element	O	NOUN	I
in	O	ADP	O
the	O	DET	O
polarization	O	NOUN	B
to	O	PART	O
eTh1	B-cell_type	NOUN	B
or	O	CCONJ	O
eTh2	B-cell_type	NOUN	B
.	O	PUNCT	O


c-Rel	B-protein	NOUN	B
is	O	AUX	O
a	O	DET	O
target	O	NOUN	B
of	O	ADP	O
pentoxifylline-mediated	O	ADJ	B
inhibition	O	NOUN	I
of	O	ADP	O
T	O	NOUN	B
lymphocyte	O	NOUN	I
activation	O	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
induction	O	NOUN	B
of	O	ADP	O
NF-AT	B-protein	NOUN	B
,	O	PUNCT	O
which	O	DET	O
has	O	AUX	O
the	O	DET	O
same	O	ADJ	O
signaling	O	NOUN	B
requirements	O	NOUN	O
as	O	ADP	O
c-Rel	B-protein	NOUN	B
induction	O	NOUN	B
,	O	PUNCT	O
was	O	AUX	O
not	O	PART	O
inhibited	O	VERB	B
by	O	ADP	O
PF	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
tested	O	VERB	B
the	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
three	O	NUM	O
linear	O	ADJ	B
or	O	CCONJ	O
two	O	NUM	O
loop	O	NOUN	B
peptides	O	NOUN	I
derived	O	VERB	O
from	O	ADP	O
the	O	DET	O
V3	B-protein	NOUN	B
region	I-protein	NOUN	I
of	O	ADP	O
the	O	DET	O
HTLV-III	O	NOUN	B
BH10	O	NOUN	I
clone	O	NOUN	I
or	O	CCONJ	O
the	O	DET	O
SF2	O	NOUN	B
strain	O	NOUN	I
of	O	ADP	O
human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
type	O	NOUN	I
1	O	NUM	O
on	O	ADP	O
IL-2	B-protein	NOUN	B
-driven	O	ADJ	O
T	O	NOUN	B
cell	O	NOUN	I
proliferation	O	NOUN	I
.	O	PUNCT	O


BACKGROUND	O	NOUN	B
:	O	PUNCT	O
A	O	DET	O
delicate	O	ADJ	B
balance	O	NOUN	B
between	O	ADP	O
positive	O	ADJ	B
and	O	CCONJ	O
negative	O	ADJ	B
regulatory	O	ADJ	B
mechanisms	O	NOUN	I
during	O	ADP	O
T-cell	O	NOUN	B
activation	O	NOUN	I
determines	O	VERB	O
the	O	DET	O
specificity	O	NOUN	B
and	O	CCONJ	O
magnitude	O	NOUN	B
of	O	ADP	O
an	O	DET	O
immune	O	ADJ	B
response	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
Pax-5	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
is	O	AUX	O
alternatively	O	ADV	O
spliced	O	VERB	B
during	O	ADP	O
B-cell	O	NOUN	B
development	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
Syk	B-protein	NOUN	B
-mediated	O	ADJ	O
T	B-protein	NOUN	B
cell	I-protein	NOUN	I
antigen	I-protein	NOUN	I
receptor	I-protein	NOUN	I
-induced	O	ADJ	O
MAPK	B-protein	NOUN	B
activation	O	NOUN	B
was	O	AUX	O
detectable	O	ADJ	B
within	O	ADP	O
1	O	NUM	O
min	O	NOUN	O
of	O	ADP	O
receptor	O	NOUN	B
stimulation	O	NOUN	I
and	O	CCONJ	O
peaked	O	VERB	B
at	O	ADP	O
3-5	O	NUM	O
min	O	NOUN	O
.	O	PUNCT	O


For	O	ADP	O
cells	O	NOUN	B
of	O	ADP	O
the	O	DET	O
innate	O	ADJ	B
immune	O	ADJ	I
system	O	NOUN	I
to	O	PART	O
mount	O	VERB	B
a	O	DET	O
host	O	NOUN	B
defence	O	NOUN	B
response	O	NOUN	I
to	O	PART	O
infection	O	NOUN	B
,	O	PUNCT	O
they	O	PRON	O
must	O	AUX	O
recognize	O	VERB	O
products	O	NOUN	B
of	O	ADP	O
microbial	O	ADJ	B
pathogens	O	NOUN	B
such	O	ADJ	O
as	O	ADP	O
lipopolysaccharide	O	NOUN	B
(	O	PUNCT	O
LPS	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
the	O	DET	O
endotoxin	O	NOUN	B
secreted	O	VERB	B
by	O	ADP	O
Gram-negative	O	ADJ	B
bacteria	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
stimulation	O	NOUN	B
of	O	ADP	O
NK	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
either	O	CCONJ	O
freshly	O	ADV	B
isolated	O	VERB	B
from	O	ADP	O
peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
lymphocytes	I-cell_type	NOUN	I
(	O	PUNCT	O
PBL	B-cell_type	NOUN	B
)	O	PUNCT	O
or	O	CCONJ	O
long-term	B-cell_line	ADJ	B
cultured	I-cell_line	VERB	O
NK	I-cell_line	NOUN	O
clones	I-cell_line	NOUN	O
,	O	PUNCT	O
with	O	ADP	O
specific	O	ADJ	O
cell	O	NOUN	B
targets	O	NOUN	O
results	O	VERB	B
in	O	ADP	O
an	O	DET	O
increased	O	VERB	B
binding	O	NOUN	B
activity	O	NOUN	I
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
and	O	CCONJ	O
AP-1	B-protein	NOUN	B
transcription	B-protein	NOUN	I
factors	I-protein	NOUN	I
measured	O	VERB	B
by	O	ADP	O
gel	O	NOUN	B
retardation	O	NOUN	I
.	O	PUNCT	O


On	O	ADP	O
electromobility	O	NOUN	B
shift	O	NOUN	I
assays	O	NOUN	I
(	O	PUNCT	O
EMSA	O	NOUN	B
)	O	PUNCT	O
a	O	DET	O
single	O	ADJ	O
E2F-DNA	B-protein	NOUN	B
binding	I-protein	NOUN	I
complex	I-protein	NOUN	I
was	O	AUX	O
detected	O	VERB	B
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
monocytes	B-cell_type	NOUN	B
which	O	DET	O
was	O	AUX	O
shown	O	VERB	O
to	O	PART	O
contain	O	VERB	O
E2F-4	B-protein	NOUN	B
,	O	PUNCT	O
DP-1	B-protein	NOUN	B
and	O	CCONJ	O
p130	B-protein	NOUN	B
,	O	PUNCT	O
indicating	O	VERB	O
that	O	SCONJ	O
all	O	DET	O
quiescent	B-cell_type	ADJ	B
haemopoietic	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
have	O	AUX	O
the	O	DET	O
same	O	ADJ	O
complex	O	NOUN	B
.	O	PUNCT	O


Examination	O	NOUN	B
of	O	ADP	O
18	O	NUM	O
AML	O	NOUN	B
samples	O	NOUN	B
by	O	ADP	O
EMSA	O	NOUN	B
revealed	O	VERB	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
E2F	B-protein	NOUN	B
binding	O	NOUN	I
and	O	CCONJ	O
no	O	DET	O
gross	O	ADJ	B
abnormalities	O	NOUN	I
were	O	AUX	O
detected	O	VERB	B
.	O	PUNCT	O


Associated	O	VERB	B
with	O	ADP	I
its	O	PRON	O
inhibitor	O	NOUN	B
,	O	PUNCT	O
I	B-protein	NOUN	B
kappaB	I-protein	NOUN	I
,	O	PUNCT	O
NF-kappaB	B-protein	NOUN	B
resides	O	VERB	B
as	O	ADP	O
an	O	DET	O
inactive	O	ADJ	B
form	O	NOUN	O
in	O	ADP	O
the	O	DET	O
cytoplasm	O	NOUN	B
.	O	PUNCT	O


Upon	O	SCONJ	O
stimulation	O	NOUN	B
by	O	ADP	O
various	O	ADJ	O
agents	O	NOUN	B
,	O	PUNCT	O
I	B-protein	PRON	B
kappaB	I-protein	NOUN	I
is	O	AUX	O
proteolyzed	O	VERB	B
and	O	CCONJ	O
NF-kappaB	B-protein	NOUN	B
translocates	O	VERB	I
to	O	PART	O
the	O	DET	O
nucleus	O	NOUN	B
,	O	PUNCT	O
where	O	SCONJ	O
it	O	PRON	O
activates	O	VERB	B
its	O	PRON	O
target	O	NOUN	B
genes	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
transduction	O	NOUN	B
pathways	O	NOUN	I
that	O	PRON	O
lead	O	VERB	O
to	O	PART	O
I	B-protein	NOUN	O
kappaB	I-protein	NOUN	O
inactivation	O	NOUN	B
remain	O	VERB	O
poorly	O	ADV	O
understood	O	VERB	O
.	O	PUNCT	O


Analysis	O	NOUN	B
of	O	ADP	O
the	O	DET	O
redox	O	NOUN	B
status	O	NOUN	I
of	O	ADP	O
1.3E2	B-cell_line	NOUN	B
does	O	AUX	O
not	O	PART	O
reveal	O	VERB	O
any	O	DET	O
difference	O	NOUN	O
from	O	ADP	O
wild-type	B-cell_line	ADJ	B
70Z/3	I-cell_line	NOUN	O
.	O	PUNCT	O


Finally	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
two	O	NUM	O
other	O	ADJ	O
I	B-protein	NOUN	B
kappaB	I-protein	NOUN	I
molecules	I-protein	NOUN	I
,	O	PUNCT	O
I	B-protein	NOUN	B
kappaB	I-protein	NOUN	I
beta	I-protein	NOUN	I
and	O	CCONJ	O
the	O	DET	O
recently	O	ADV	O
identified	O	VERB	O
I	B-protein	NOUN	O
kappaB	I-protein	NOUN	O
epsilon	I-protein	NOUN	O
,	O	PUNCT	O
are	O	AUX	O
not	O	PART	O
degraded	O	VERB	B
in	O	ADP	O
the	O	DET	O
1.3E2	B-cell_line	NOUN	B
cell	O	NOUN	I
line	O	NOUN	I
following	O	VERB	O
stimulation	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
this	O	DET	O
analysis	O	NOUN	B
suggests	O	VERB	O
a	O	DET	O
common	O	ADJ	O
step	O	NOUN	O
in	O	ADP	O
the	O	DET	O
signaling	O	NOUN	B
pathways	O	NOUN	I
that	O	PRON	O
trigger	O	VERB	O
I	B-protein	NOUN	B
kappaB	I-protein	NOUN	I
alpha	I-protein	NOUN	I
,	O	PUNCT	O
I	B-protein	NOUN	B
kappaB	I-protein	NOUN	I
beta	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
I	B-protein	NOUN	B
kappaB	I-protein	NOUN	I
epsilon	I-protein	NOUN	I
degradation	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
order	O	NOUN	O
to	O	PART	O
evaluate	O	VERB	B
the	O	DET	O
conditions	O	NOUN	B
for	O	ADP	O
optimal	O	ADJ	B
expression	O	NOUN	B
and	O	CCONJ	O
immunogenicity	O	NOUN	B
of	O	ADP	O
varicella-zoster	B-protein	NOUN	B
virus	I-protein	NOUN	I
(	I-protein	PUNCT	O
VZV	I-protein	NOUN	B
)	I-protein	PUNCT	O
proteins	I-protein	NOUN	B
in	O	ADP	O
a	O	DET	O
herpes	O	NOUN	B
simplex	O	NOUN	I
virus-1	O	NOUN	I
(	O	PUNCT	O
HSV-1	O	NOUN	B
)	O	PUNCT	O
vector	O	NOUN	O
,	O	PUNCT	O
we	O	PRON	O
selected	O	VERB	O
the	O	DET	O
VZV	B-protein	NOUN	B
glycoprotein	I-protein	NOUN	I
E	I-protein	NOUN	I
(	O	PUNCT	O
gE	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
encoded	O	VERB	B
by	O	ADP	O
ORF	B-DNA	NOUN	B
68	I-DNA	NUM	O
and	O	CCONJ	O
the	O	DET	O
VZV	B-protein	NOUN	B
product	I-protein	NOUN	B
of	O	ADP	O
ORF	B-DNA	NOUN	B
62	I-DNA	NUM	O
,	O	PUNCT	O
an	O	DET	O
immediate-early	B-protein	ADJ	B
major	I-protein	ADJ	O
tegument	I-protein	ADJ	B
protein	I-protein	NOUN	I
(	O	PUNCT	O
IE62	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
report	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
active	O	ADJ	B
form	O	NOUN	I
of	O	ADP	O
NF-AT1	B-protein	NOUN	B
is	O	AUX	O
also	O	ADV	O
present	O	ADJ	O
in	O	ADP	O
the	O	DET	O
nuclei	O	NOUN	B
of	O	ADP	O
HTLV-I-transformed	B-cell_type	ADJ	B
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
that	O	PRON	O
express	O	VERB	O
the	O	DET	O
Tax	B-protein	NOUN	B
protein	I-protein	NOUN	I
.	O	PUNCT	O


NFAT4/x	B-protein	NOUN	B
was	O	AUX	O
very	O	ADV	O
weakly	O	ADV	O
expressed	O	VERB	B
in	O	ADP	O
unstimulated	O	ADJ	B
cells	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
its	O	PRON	O
level	O	NOUN	B
did	O	AUX	O
not	O	PART	O
increase	O	VERB	B
upon	O	SCONJ	O
treatment	O	NOUN	B
with	O	ADP	O
activating	O	VERB	B
agents	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
demonstrate	O	VERB	O
the	O	DET	O
selective	O	ADJ	O
role	O	NOUN	O
of	O	ADP	O
GATA-4	B-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
transcriptional	O	ADJ	B
regulation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
IL-5	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
in	O	ADP	O
a	O	DET	O
circumstance	O	NOUN	B
where	O	SCONJ	O
multiple	O	ADJ	O
members	O	NOUN	B
of	O	ADP	O
the	O	DET	O
GATA-binding	B-protein	ADJ	B
proteins	I-protein	NOUN	I
are	O	AUX	O
expressed	O	VERB	B
.	O	PUNCT	O


The	O	DET	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
of	I-protein	ADP	O
activated	I-protein	VERB	B
T	I-protein	NOUN	O
cells	I-protein	NOUN	O
(	O	PUNCT	O
NFAT	B-protein	NOUN	B
)	O	PUNCT	O
regulates	O	VERB	B
cytokine	B-DNA	NOUN	B
gene	I-DNA	NOUN	B
expression	O	NOUN	I
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
through	O	ADP	O
cis-acting	B-DNA	ADJ	B
elements	I-DNA	NOUN	I
located	O	ADJ	O
in	O	ADP	O
the	O	DET	O
promoters	B-DNA	NOUN	B
of	O	ADP	O
several	O	ADJ	O
cytokine	B-DNA	NOUN	B
genes	I-DNA	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
also	O	ADV	O
show	O	VERB	O
that	O	SCONJ	O
calcineurin	B-protein	NOUN	B
associated	O	VERB	B
with	O	ADP	I
the	O	DET	O
N-terminal	B-protein	ADJ	B
domain	I-protein	NOUN	I
of	O	ADP	O
NFATx1	B-protein	NOUN	B
at	O	ADP	O
multiple	B-protein	ADJ	B
docking	I-protein	NOUN	B
sites	I-protein	NOUN	I
and	O	CCONJ	O
caused	O	VERB	O
a	O	DET	O
reduction	O	NOUN	B
of	O	ADP	O
size	O	NOUN	B
,	O	PUNCT	O
indicative	O	ADJ	B
of	O	ADP	O
dephosphorylation	O	NOUN	B
,	O	PUNCT	O
in	O	ADP	O
NFATx1	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
transcriptional	O	ADJ	B
activity	O	NOUN	I
of	O	ADP	O
the	O	DET	O
IgH-luciferase	B-DNA	ADJ	B
construct	I-DNA	NOUN	I
was	O	AUX	O
induced	O	VERB	B
upon	O	SCONJ	O
ligation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
full-length	B-protein	ADJ	B
chimeric	I-protein	ADJ	B
receptor	I-protein	NOUN	I
but	O	CCONJ	O
not	O	PART	O
by	O	ADP	O
truncated	B-protein	VERB	B
gp130	I-protein	NOUN	B
receptors	I-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
in	O	X	B
vitro	O	X	I
transendothelial	O	ADJ	B
migration	O	NOUN	B
of	O	ADP	O
circulating	B-cell_type	VERB	B
filarial	I-cell_type	ADJ	O
antigen-specific	I-cell_type	ADJ	B
T-cells	I-cell_type	NOUN	I
was	O	AUX	O
examined	O	VERB	O
in	O	ADP	O
Wuchereria	O	X	B
banerofti	O	X	I
infection	O	NOUN	O
.	O	PUNCT	O


Cotransfection	O	NOUN	B
with	O	ADP	O
a	O	DET	O
transdominant	B-protein	ADJ	B
negative	I-protein	ADJ	O
mutant	I-protein	NOUN	B
of	O	ADP	O
the	O	DET	O
NF-YA	B-protein	NOUN	B
subunit	I-protein	NOUN	I
abolishes	O	VERB	O
the	O	DET	O
transcriptional	O	ADJ	B
activation	O	NOUN	I
by	O	ADP	O
heme	B-protein	NOUN	B
,	O	PUNCT	O
indicating	O	VERB	O
that	O	SCONJ	O
NF-Y	B-protein	NOUN	B
plays	O	VERB	O
an	O	DET	O
essential	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
this	O	DET	O
activation	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
also	O	ADV	O
observed	O	VERB	O
a	O	DET	O
differential	O	ADJ	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
NF-YA	B-protein	NOUN	B
subunit	I-protein	NOUN	I
in	O	ADP	O
heme-treated	O	ADJ	B
and	O	CCONJ	O
control	O	NOUN	B
FLCs	B-cell_line	NOUN	B
and	O	CCONJ	O
during	O	ADP	O
monocyte-to-macrophage	O	ADJ	B
differentiation	O	NOUN	O
.	O	PUNCT	O


Concomitant	O	ADJ	B
downregulation	O	NOUN	B
of	O	ADP	O
IgH	B-DNA	NOUN	B
3	I-DNA	NUM	I
'	I-DNA	PART	I
enhancer	I-DNA	NOUN	B
activity	O	NOUN	I
and	O	CCONJ	O
c-myc	B-DNA	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
a	O	DET	O
plasmacytoma	O	NOUN	B
x	O	NOUN	O
fibroblast	O	NOUN	B
environment	O	NOUN	I
:	O	PUNCT	O
implications	O	NOUN	O
for	O	ADP	O
dysregulation	O	NOUN	B
of	O	ADP	O
translocated	O	VERB	B
c-myc	B-DNA	NOUN	I
.	O	PUNCT	O


Western	O	NOUN	B
blot	O	NOUN	I
analysis	O	NOUN	I
of	O	ADP	O
the	O	DET	O
NF-kappaB	B-protein	NOUN	B
inhibitory	I-protein	ADJ	O
subunits	I-protein	NOUN	O
(	O	PUNCT	O
IkappaB	B-protein	NOUN	B
)	O	PUNCT	O
demonstrated	O	VERB	O
that	O	SCONJ	O
both	O	CCONJ	O
IkappaB	B-protein	NOUN	B
-alpha	O	NOUN	O
proteolysis	O	NOUN	B
and	O	CCONJ	O
p105	B-protein	NOUN	B
processing	O	NOUN	I
were	O	AUX	O
induced	O	VERB	B
by	O	ADP	O
the	O	DET	O
treatment	O	NOUN	B
.	O	PUNCT	O


NF-kappaB	B-protein	NOUN	B
activation	O	NOUN	B
was	O	AUX	O
very	O	ADV	O
effective	O	ADJ	B
when	O	SCONJ	O
cells	O	NOUN	B
were	O	AUX	O
subjected	O	VERB	O
to	O	PART	O
hyperthermia	O	NOUN	B
before	O	ADP	O
being	O	AUX	O
treated	O	VERB	B
with	O	ADP	I
HOCl	O	NOUN	B
.	O	PUNCT	O


Various	O	ADJ	O
antioxidants	O	NOUN	B
,	O	PUNCT	O
such	O	ADJ	O
as	O	ADP	O
pyrrolidine	O	NOUN	B
dithiocarbamate	O	NOUN	I
,	O	PUNCT	O
p-bromophenacyl-bromide	O	NOUN	B
and	O	CCONJ	O
nordihydroguaiaretic	O	ADJ	B
acid	O	NOUN	I
could	O	AUX	O
strongly	O	ADV	O
reduce	O	VERB	O
NF-kappaB	B-protein	NOUN	B
translocation	O	NOUN	B
,	O	PUNCT	O
demonstrating	O	VERB	O
the	O	DET	O
importance	O	NOUN	O
of	O	ADP	O
oxidative	O	ADJ	B
species	O	NOUN	I
in	O	ADP	O
the	O	DET	O
transduction	O	NOUN	B
mechanism	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
importance	O	NOUN	O
of	O	ADP	O
TNF-alpha	B-protein	NOUN	B
release	O	NOUN	B
in	O	ADP	O
NF-kappaB	B-protein	NOUN	B
induction	O	NOUN	B
by	O	ADP	O
HOCl	O	NOUN	B
or	O	CCONJ	O
H2O2	O	NOUN	B
was	O	AUX	O
demonstrated	O	VERB	O
by	O	ADP	O
the	O	DET	O
fact	O	NOUN	O
that	O	SCONJ	O
:	O	PUNCT	O
(	O	PUNCT	O
1	O	X	O
)	O	PUNCT	O
the	O	DET	O
nuclear	O	ADJ	B
appearance	O	NOUN	B
of	O	ADP	O
NF-kappaB	B-protein	NOUN	B
was	O	AUX	O
promoted	O	VERB	O
in	O	ADP	O
untreated	B-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
;	O	PUNCT	O
and	O	CCONJ	O
(	O	PUNCT	O
2	O	X	O
)	O	PUNCT	O
synergism	O	NOUN	B
between	O	ADP	O
TNF-alpha	B-protein	NOUN	B
and	O	CCONJ	O
HOCl	O	NOUN	B
was	O	AUX	O
detected	O	VERB	B
.	O	PUNCT	O


Binding	O	VERB	B
to	O	PART	O
RBD	B-protein	NOUN	B
increased	O	VERB	B
from	O	ADP	O
undetectable	O	ADJ	B
levels	O	NOUN	B
in	O	ADP	O
resting	B-cell_type	VERB	B
platelets	I-cell_type	NOUN	I
to	O	PART	O
>	O	X	O
50	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
total	O	ADJ	O
Rap1	B-protein	NOUN	B
within	O	ADP	O
30	O	NUM	O
s	O	NOUN	O
after	O	ADP	O
stimulation	O	NOUN	B
.	O	PUNCT	O


Physical	O	ADJ	B
interactions	O	NOUN	I
between	O	ADP	O
Ets	B-protein	NOUN	B
and	I-protein	CCONJ	O
NF-kappaB/NFAT	I-protein	NOUN	B
proteins	I-protein	NOUN	I
play	O	VERB	O
an	O	DET	O
important	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
their	O	PRON	O
cooperative	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
immunodeficiency	I-DNA	NOUN	I
virus	I-DNA	NOUN	I
enhancer	I-DNA	NOUN	I
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


This	O	DET	O
interaction	O	NOUN	B
is	O	AUX	O
mediated	O	VERB	O
by	O	ADP	O
the	O	DET	O
Ets	B-DNA	NOUN	B
domain	I-DNA	NOUN	I
of	O	ADP	O
Ets	B-protein	NOUN	B
proteins	I-protein	NOUN	I
and	O	CCONJ	O
the	O	DET	O
C-terminal	O	ADJ	B
region	O	NOUN	I
of	O	ADP	O
the	O	DET	O
Rel	O	NOUN	B
homology	O	NOUN	I
domains	O	NOUN	I
of	O	ADP	O
NF-kappaB/NFAT	B-protein	NOUN	B
proteins	I-protein	NOUN	I
.	O	PUNCT	O


A	O	DET	O
dominant-negative	O	ADJ	B
mutant	O	NOUN	I
of	O	ADP	O
NF-kappaB	B-protein	NOUN	B
p50	I-protein	NOUN	I
that	O	PRON	O
binds	O	VERB	B
DNA	O	NOUN	B
but	O	CCONJ	O
fails	O	VERB	O
to	O	PART	O
interact	O	VERB	B
with	O	ADP	O
Ets	B-protein	NOUN	B
proteins	I-protein	NOUN	I
inhibits	O	VERB	B
the	O	DET	O
synergistic	O	ADJ	B
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
HIV-1	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
HIV-2	I-DNA	NOUN	B
enhancers	I-DNA	NOUN	B
by	O	ADP	O
NF-kappaB	B-protein	NOUN	B
(	O	PUNCT	O
p50	B-protein	NOUN	B
+	O	CCONJ	O
p65	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
Ets-1	B-protein	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
physical	O	ADJ	B
interaction	O	NOUN	I
between	O	ADP	O
Ets	B-protein	NOUN	B
and	O	CCONJ	O
NF-kappaB	B-protein	NOUN	B
proteins	I-protein	NOUN	I
is	O	AUX	O
required	O	VERB	O
for	O	ADP	O
the	O	DET	O
transcriptional	O	ADJ	B
activity	O	NOUN	I
of	O	ADP	O
the	O	DET	O
HIV-1	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
HIV-2	I-DNA	NOUN	B
enhancers	I-DNA	NOUN	B
.	O	PUNCT	O


From	O	ADP	O
AML1	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
,	O	PUNCT	O
two	O	NUM	O
representative	O	ADJ	O
forms	O	NOUN	O
of	O	ADP	O
proteins	O	NOUN	B
,	O	PUNCT	O
AML1a	B-protein	NOUN	B
and	O	CCONJ	O
AML1b	B-protein	NOUN	B
,	O	PUNCT	O
are	O	AUX	O
produced	O	VERB	O
by	O	ADP	O
an	O	DET	O
alternative	O	ADJ	B
splicing	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
considered	O	VERB	O
four	O	NUM	O
bZIP	B-protein	NOUN	B
transcription	I-protein	NOUN	O
factors	I-protein	NOUN	O
as	O	ADP	O
candidates	O	NOUN	O
for	O	ADP	O
this	O	DET	O
putative	O	ADJ	O
IL-3-regulated	B-protein	ADJ	B
factor	I-protein	NOUN	I
,	O	PUNCT	O
each	O	DET	O
of	O	ADP	O
which	O	DET	O
binds	O	VERB	B
avidly	O	ADV	O
to	O	PART	O
the	O	DET	O
DNA	B-DNA	NOUN	B
consensus	I-DNA	NOUN	I
sequence	I-DNA	NOUN	I
recognized	O	VERB	O
by	O	ADP	O
E2A-HLF	B-protein	NOUN	B
and	O	CCONJ	O
is	O	AUX	O
related	O	ADJ	O
to	O	PART	O
the	O	DET	O
Caenorhabditis	B-protein	NOUN	B
elegans	I-protein	X	I
CES-2	I-protein	NOUN	B
(	O	PUNCT	O
cell	B-protein	NOUN	B
death	I-protein	NOUN	I
specification	I-protein	NOUN	I
protein	I-protein	NOUN	I
)	O	PUNCT	O
neuron-specific	B-protein	ADJ	O
mediator	I-protein	NOUN	O
of	I-protein	ADP	O
cell	I-protein	NOUN	B
death	I-protein	NOUN	I
.	O	PUNCT	O


Adenovirus	O	NOUN	B
can	O	AUX	O
establish	O	VERB	O
persistent	O	ADJ	B
infections	O	NOUN	I
which	O	DET	O
may	O	AUX	O
reactivate	O	VERB	B
and	O	CCONJ	O
cause	O	VERB	O
disease	O	NOUN	B
in	O	ADP	O
immunocompromised	O	ADJ	B
hosts	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
assay	O	NOUN	B
of	O	ADP	O
PBMC	B-cell_type	NOUN	B
by	O	ADP	O
the	O	DET	O
adenovirus-specific	O	ADJ	B
PCR	O	NOUN	I
may	O	AUX	O
help	O	VERB	O
detect	O	VERB	B
early	O	ADJ	O
invasive	O	ADJ	B
disease	O	NOUN	I
and	O	CCONJ	O
warrants	O	VERB	O
further	O	ADJ	O
evaluation	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
specific	O	ADJ	O
p38	B-protein	NOUN	B
MAPk	I-protein	NOUN	B
inhibitor	O	NOUN	I
(	O	PUNCT	O
SK	O	PROPN	B
&	O	CCONJ	O
F	O	PROPN	O
86002	O	NUM	O
)	O	PUNCT	O
blocked	O	VERB	B
superoxide	O	NOUN	B
anion	O	NOUN	I
production	O	NOUN	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
FMLP	B-protein	NOUN	B
and	O	CCONJ	O
reduced	O	VERB	B
adhesion	O	NOUN	B
and	O	CCONJ	O
chemotaxis	O	NOUN	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
PAF	B-protein	NOUN	B
or	O	CCONJ	O
FMLP	B-protein	NOUN	B
.	O	PUNCT	O


Northern	O	NOUN	B
blot	O	NOUN	I
analyses	O	NOUN	I
indicated	O	VERB	O
a	O	DET	O
highly	O	ADV	O
restricted	O	ADJ	O
mRNA	O	NOUN	B
expression	O	NOUN	O
pattern	O	NOUN	O
,	O	PUNCT	O
with	O	ADP	O
the	O	DET	O
strongest	O	ADJ	O
expression	O	NOUN	B
occurring	O	VERB	O
in	O	ADP	O
promyelocyte	B-cell_line	NOUN	B
and	I-cell_line	CCONJ	O
late-myeloblast-like	I-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
.	O	PUNCT	O


The	O	DET	O
tumour	B-protein	NOUN	B
associated	I-protein	VERB	O
cell	I-protein	NOUN	O
surface	I-protein	NOUN	O
antigen	I-protein	NOUN	O
A6H	B-protein	NOUN	B
is	O	AUX	O
costimulatory	O	ADJ	B
for	O	ADP	O
human	B-cell_type	ADJ	B
CD4+	I-cell_type	ADJ	B
but	I-cell_type	CCONJ	O
not	I-cell_type	PART	O
CD8+	I-cell_type	ADJ	B
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


As	O	ADP	O
a	O	DET	O
first	O	ADJ	O
step	O	NOUN	O
in	O	ADP	O
understanding	O	VERB	O
the	O	DET	O
mechanism	O	NOUN	B
of	O	ADP	O
decreased	O	VERB	B
binding	O	NOUN	B
affinity	O	NOUN	B
in	O	ADP	O
New	O	ADJ	B
World	O	NOUN	I
primates	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
used	O	VERB	O
reverse	O	ADJ	B
transcription-PCR	O	NOUN	I
to	O	PART	O
clone	O	NOUN	B
the	O	DET	O
glucocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
from	O	ADP	O
squirrel	O	NOUN	B
monkey	O	NOUN	I
liver	O	NOUN	B
and	O	CCONJ	O
have	O	AUX	O
compared	O	VERB	B
the	O	DET	O
sequence	O	NOUN	B
to	O	PART	O
receptor	O	NOUN	B
sequences	O	NOUN	I
obtained	O	VERB	O
from	O	ADP	O
owl	O	ADJ	B
monkey	O	NOUN	I
liver	O	NOUN	B
,	O	PUNCT	O
cotton-top	B-cell_line	ADJ	B
tamarin	I-cell_line	NOUN	I
B95-8	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
human	B-cell_type	ADJ	B
lymphocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


None	O	NOUN	O
of	O	ADP	O
the	O	DET	O
substitutions	O	NOUN	B
in	O	ADP	O
the	O	DET	O
ligand-binding	B-protein	ADJ	B
domain	I-protein	NOUN	I
matched	O	ADJ	O
mutations	O	NOUN	B
known	O	VERB	O
to	O	PART	O
influence	O	VERB	B
binding	O	NOUN	B
affinity	O	NOUN	B
in	O	ADP	O
other	O	ADJ	O
species	O	NOUN	B
.	O	PUNCT	O


Shared	O	VERB	B
gamma	B-protein	NOUN	I
(	I-protein	PUNCT	I
c	I-protein	NOUN	I
)	I-protein	PUNCT	I
subunit	I-protein	NOUN	B
within	O	ADP	O
the	O	DET	O
human	B-protein	ADJ	B
interleukin-7	I-protein	NOUN	B
receptor	I-protein	NOUN	I
complex	I-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
gamma	B-protein	NOUN	B
(	I-protein	PUNCT	I
c	I-protein	NOUN	I
)	I-protein	PUNCT	I
subunit	I-protein	NOUN	I
can	O	AUX	O
be	O	AUX	O
employed	O	VERB	O
in	O	ADP	O
receptor	B-protein	NOUN	B
complexes	I-protein	NOUN	I
for	O	ADP	O
IL-2	B-protein	NOUN	B
,	I-protein	PUNCT	O
-4	I-protein	NUM	B
,	I-protein	PUNCT	O
-7	I-protein	NUM	B
,	I-protein	PUNCT	O
-9	I-protein	NUM	B
,	I-protein	PUNCT	O
and	I-protein	CCONJ	O
-15	I-protein	NUM	B
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
multiple	O	ADJ	B
signaling	O	NOUN	B
defects	O	NOUN	O
that	O	PRON	O
would	O	AUX	O
result	O	VERB	O
from	O	ADP	O
a	O	DET	O
defective	O	ADJ	B
gamma	B-protein	NOUN	I
(	I-protein	PUNCT	I
c	I-protein	NOUN	I
)	I-protein	PUNCT	I
chain	I-protein	NOUN	I
in	O	ADP	O
these	O	DET	O
receptors	O	NOUN	B
are	O	AUX	O
proposed	O	VERB	O
to	O	PART	O
cause	O	VERB	O
the	O	DET	O
severe	O	ADJ	B
phenotype	O	NOUN	B
of	O	ADP	O
X-SCID	O	NOUN	B
patients	O	NOUN	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
replacement	O	NOUN	B
of	O	ADP	O
the	O	DET	O
gamma	B-protein	NOUN	O
(	I-protein	PUNCT	O
c	I-protein	NOUN	O
)	I-protein	PUNCT	O
cytoplasmic	B-protein	ADJ	B
domain	I-protein	NOUN	I
by	O	ADP	O
a	O	DET	O
severely	B-protein	ADV	B
truncated	I-protein	VERB	I
erythropoeitin	I-protein	NOUN	I
receptor	I-protein	NOUN	I
does	O	AUX	O
not	O	PART	O
affect	O	VERB	O
measured	O	VERB	B
IL-7R	B-protein	NOUN	B
signaling	O	NOUN	B
events	O	NOUN	I
.	O	PUNCT	O


Activated	O	VERB	B
NF-kappa	B-protein	NOUN	I
B	I-protein	NOUN	I
in	O	ADP	O
nuclear	O	ADJ	B
extracts	O	NOUN	I
was	O	AUX	O
measured	O	VERB	B
by	O	ADP	O
an	O	DET	O
electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assay	O	NOUN	I
using	O	VERB	O
32P-labeled	B-DNA	ADJ	B
probe	I-DNA	NOUN	I
.	O	PUNCT	O


Northern	O	NOUN	B
analyses	O	NOUN	I
showed	O	VERB	O
similar	O	ADJ	O
levels	O	NOUN	B
of	O	ADP	O
two	O	NUM	O
elf-2	B-RNA	NOUN	B
transcripts	I-RNA	NOUN	B
(	O	PUNCT	O
3.5	O	NUM	O
kb	O	NOUN	O
and	O	CCONJ	O
3.8	O	NUM	O
kb	O	NOUN	O
)	O	PUNCT	O
in	O	ADP	O
all	O	DET	O
tissues	O	NOUN	B
except	O	SCONJ	O
thymus	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
expression	O	NOUN	B
patterns	O	NOUN	I
suggest	O	VERB	O
that	O	SCONJ	O
RBTN-2	B-protein	NOUN	B
normally	O	ADV	O
interacts	O	VERB	O
equally	O	ADV	O
with	O	ADP	O
elf-2a	B-protein	NOUN	O
and	O	CCONJ	O
elf-2b	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
low	O	ADJ	B
frequency	O	NOUN	B
with	O	ADP	O
which	O	DET	O
these	O	DET	O
Ig-expressing	B-cell_line	ADJ	B
hybrids	I-cell_line	NOUN	I
are	O	AUX	O
recovered	O	VERB	B
,	O	PUNCT	O
along	O	ADP	O
with	O	ADP	O
the	O	DET	O
fact	O	NOUN	O
that	O	SCONJ	O
cell	O	NOUN	B
fusions	O	NOUN	I
can	O	AUX	O
lead	O	VERB	O
to	O	PART	O
chromosome	O	NOUN	B
loss	O	NOUN	I
,	O	PUNCT	O
led	O	VERB	O
us	O	PRON	O
to	O	PART	O
propose	O	VERB	O
that	O	SCONJ	O
this	O	DET	O
rare	O	ADJ	B
phenotype	O	NOUN	B
was	O	AUX	O
due	O	ADJ	O
to	O	PART	O
loss	O	NOUN	B
of	O	ADP	O
a	O	DET	O
T-cell-derived	B-protein	ADJ	B
chromosome	I-protein	NOUN	I
encoding	I-protein	VERB	B
a	I-protein	DET	O
factor	I-protein	NOUN	B
or	O	CCONJ	O
factors	O	NOUN	B
with	O	ADP	O
gene	O	NOUN	B
silencing	O	NOUN	I
activity	O	NOUN	B
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
deregulated	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
a	O	DET	O
single	O	ADJ	O
viral	B-DNA	ADJ	B
gene	I-DNA	NOUN	I
,	O	PUNCT	O
ORF	B-DNA	NOUN	B
50	I-DNA	NUM	O
,	O	PUNCT	O
which	O	DET	O
encodes	O	VERB	B
a	O	DET	O
transactivator	O	NOUN	B
able	O	ADJ	O
to	O	PART	O
selectively	O	ADV	O
upregulate	O	VERB	B
delayed-early	B-DNA	ADJ	B
viral	I-DNA	ADJ	B
genes	I-DNA	NOUN	I
,	O	PUNCT	O
suffices	O	VERB	O
to	O	PART	O
disrupt	O	VERB	B
latency	O	NOUN	B
and	O	CCONJ	O
induce	O	VERB	B
the	O	DET	O
lytic	O	ADJ	B
gene	O	NOUN	I
cascade	O	NOUN	I
in	O	ADP	O
latently	B-cell_type	ADV	B
infected	I-cell_type	ADJ	B
B	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


The	O	DET	O
identification	O	NOUN	B
of	O	ADP	O
this	O	DET	O
gene	O	NOUN	B
opens	O	VERB	O
the	O	DET	O
way	O	NOUN	O
to	O	PART	O
studies	O	NOUN	B
of	O	ADP	O
the	O	DET	O
physiologic	O	ADJ	B
mechanisms	O	NOUN	B
controlling	O	VERB	O
reactvation	O	NOUN	B
of	O	ADP	O
KSHV	O	NOUN	B
from	O	ADP	O
latency	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
addition	O	NOUN	O
of	O	ADP	O
rCTLA4Ig	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
blocks	O	VERB	B
CD28	B-protein	NOUN	B
binding	O	NOUN	I
to	O	PART	O
its	O	PRON	O
ligand	O	NOUN	B
,	O	PUNCT	O
to	O	PART	O
the	O	DET	O
cultures	O	NOUN	B
decreased	O	VERB	B
IL-2	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
activation	O	NOUN	I
by	O	ADP	O
>	O	X	O
80	O	NUM	O
%	O	NOUN	O
.	O	PUNCT	O


B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
epithelial	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
have	O	AUX	O
a	O	DET	O
pivotal	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
life	O	NOUN	B
cycle	O	NOUN	I
of	O	ADP	O
the	O	DET	O
virus	O	NOUN	B
.	O	PUNCT	O


Using	O	VERB	O
a	O	DET	O
yeast	O	NOUN	B
two-hybrid	O	ADJ	B
screen	O	NOUN	I
to	O	PART	O
identify	O	VERB	O
Syk	B-protein	NOUN	B
kinases-interacting	I-protein	ADJ	I
proteins	I-protein	NOUN	I
(	O	PUNCT	O
SKIPs	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
we	O	PRON	O
isolated	O	VERB	B
3BP2	B-protein	NOUN	B
,	O	PUNCT	O
an	O	DET	O
Abl	B-protein	NOUN	B
SH3-interacting	I-protein	ADJ	I
protein	I-protein	NOUN	I
of	O	ADP	O
unknown	O	ADJ	O
function	O	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
to	O	PART	O
Zap-70	B-protein	NOUN	B
,	O	PUNCT	O
the	O	DET	O
3BP2	B-protein	NOUN	O
SH2	I-protein	NOUN	B
domain	I-protein	NOUN	I
associated	O	VERB	O
in	O	X	B
vitro	O	X	I
with	O	ADP	O
LAT	B-protein	NOUN	B
,	O	PUNCT	O
Grb2	B-protein	NOUN	B
,	O	PUNCT	O
PLCgamma1	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
Cbl	B-protein	NOUN	B
from	O	ADP	O
activated	O	VERB	B
T	O	NOUN	B
cell	O	NOUN	I
lysates	O	NOUN	O
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
3BP2	B-protein	NOUN	B
is	O	AUX	O
an	O	DET	O
important	O	ADJ	O
adaptor	O	NOUN	B
that	O	PRON	O
may	O	AUX	O
couple	O	VERB	O
activated	O	VERB	B
Zap-70/Syk	B-protein	NOUN	O
to	O	PART	O
a	O	DET	O
LAT-containing	B-protein	ADJ	B
signaling	I-protein	NOUN	B
complex	I-protein	NOUN	I
involved	O	VERB	O
in	O	ADP	O
TCR-mediated	O	ADJ	B
gene	O	NOUN	I
transcription	O	NOUN	I
.	O	PUNCT	O


In	O	X	B
vitro	O	X	I
suppression	O	NOUN	B
of	O	ADP	O
programmed	O	VERB	B
cell	O	NOUN	I
death	O	NOUN	I
of	O	ADP	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
by	O	ADP	O
tissue	O	NOUN	B
inhibitor	O	NOUN	I
of	O	ADP	O
metalloproteinases-1	B-protein	NOUN	B
.	O	PUNCT	O


Results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
TIMP-1-positive	B-cell_line	ADJ	B
BL	I-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
show	O	VERB	O
resistance	O	NOUN	B
to	O	PART	O
cold-shock-induced	O	ADJ	B
apoptosis	O	NOUN	I
.	O	PUNCT	O


Carboxylesterases	B-protein	NOUN	B
play	O	VERB	O
an	O	DET	O
important	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
defense	O	NOUN	B
and	O	CCONJ	O
clearance	O	NOUN	B
mechanisms	O	NOUN	B
of	O	ADP	O
the	O	DET	O
monocyte/macrophage	O	NOUN	B
system	O	NOUN	I
.	O	PUNCT	O


Taken	O	VERB	O
together	O	ADV	O
these	O	DET	O
data	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
carboxylesterase	O	NOUN	B
gene	O	NOUN	B
transcription	O	NOUN	I
in	O	ADP	O
THP-1	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
starts	O	VERB	O
at	O	ADP	O
multiple	O	ADJ	B
initiation	O	NOUN	B
sites	O	NOUN	I
and	O	CCONJ	O
that	O	SCONJ	O
Sp1	B-protein	NOUN	B
and	O	CCONJ	O
IRBP	B-protein	NOUN	B
may	O	AUX	O
be	O	AUX	O
critical	O	ADJ	B
factors	O	NOUN	I
for	O	ADP	O
modulating	O	VERB	B
the	O	DET	O
differentiation-dependent	O	ADJ	B
transcription	O	NOUN	B
of	O	ADP	O
this	O	DET	O
human	B-DNA	ADJ	B
carboxylesterase	I-DNA	NOUN	B
gene	I-DNA	NOUN	I
.	O	PUNCT	O


During	O	ADP	O
fetal	O	ADJ	B
development	O	NOUN	I
,	O	PUNCT	O
it	O	PRON	O
is	O	AUX	O
required	O	VERB	O
at	O	ADP	O
the	O	DET	O
earliest	O	ADJ	O
stage	O	NOUN	B
of	O	ADP	O
T	O	NOUN	B
cell	O	NOUN	I
and	O	CCONJ	O
B	O	NOUN	B
cell	O	NOUN	I
specification	O	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
adult	O	NOUN	B
,	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
lymphoid	B-cell_type	ADJ	B
lineages	I-cell_type	NOUN	B
rely	O	VERB	O
on	O	ADP	O
Ikaros	B-DNA	NOUN	B
at	O	ADP	O
distinct	O	ADJ	O
phases	O	NOUN	B
of	O	ADP	O
their	O	PRON	O
development	O	NOUN	B
.	O	PUNCT	O


Its	O	PRON	O
activity	O	NOUN	B
is	O	AUX	O
essential	O	ADJ	O
for	O	ADP	O
the	O	DET	O
generation	O	NOUN	B
of	O	ADP	O
B	B-cell_type	NOUN	B
cell	I-cell_type	NOUN	I
but	O	CCONJ	O
not	O	PART	O
of	O	ADP	O
T	B-cell_type	NOUN	B
cell	I-cell_type	NOUN	I
precursors	I-cell_type	NOUN	O
,	O	PUNCT	O
although	O	SCONJ	O
the	O	DET	O
differentiation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
latter	O	ADJ	O
is	O	AUX	O
not	O	PART	O
normal	O	ADJ	O
.	O	PUNCT	O


Changes	O	NOUN	B
in	O	ADP	O
this	O	DET	O
regulatory	O	ADJ	B
network	O	NOUN	I
may	O	AUX	O
reflect	O	VERB	O
differentiation	O	NOUN	B
and	O	CCONJ	O
proliferation	O	NOUN	B
adjustments	O	NOUN	B
made	O	VERB	O
in	O	ADP	O
hemo-lymphoid	B-cell_type	ADJ	B
progenitors	I-cell_type	NOUN	I
and	O	CCONJ	O
precursors	B-cell_type	NOUN	B
as	O	ADP	O
they	O	PRON	O
give	O	VERB	O
rise	O	NOUN	O
to	O	PART	O
the	O	DET	O
cells	O	NOUN	B
of	O	ADP	O
our	O	PRON	O
immune	O	ADJ	B
system	O	NOUN	I
.	O	PUNCT	O


STAT1	B-protein	NOUN	B
pathway	O	NOUN	I
is	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
caprine	O	NOUN	B
arthritis-encephalitis	B-DNA	NOUN	B
virus	I-DNA	NOUN	I
long	I-DNA	ADJ	B
terminal	I-DNA	ADJ	I
repeat	I-DNA	NOUN	I
in	O	ADP	O
monocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


At	O	ADP	O
the	O	DET	O
5	B-DNA	NUM	O
'	I-DNA	PART	O
end	I-DNA	NOUN	O
,	O	PUNCT	O
this	O	DET	O
70-bp	B-DNA	ADJ	O
IFN-gamma	I-DNA	NOUN	B
response	I-DNA	NOUN	B
element	I-DNA	NOUN	I
contains	O	VERB	O
sequence	O	NOUN	B
similarity	O	NOUN	B
to	O	PART	O
the	O	DET	O
gamma	B-DNA	NOUN	B
activated	I-DNA	ADJ	I
site	I-DNA	NOUN	I
(	O	PUNCT	O
GAS	B-DNA	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Consistent	O	ADJ	B
with	O	ADP	I
the	O	DET	O
binding	O	NOUN	B
data	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
same	O	ADJ	O
mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
GAS	B-DNA	NOUN	B
element	I-DNA	NOUN	B
eliminate	O	VERB	O
responsiveness	O	NOUN	B
to	O	PART	O
IFN-gamma	B-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
context	O	NOUN	B
of	O	ADP	O
both	O	CCONJ	O
a	O	DET	O
functional	O	ADJ	B
CAEV	B-DNA	NOUN	B
LTR	I-DNA	NOUN	B
and	O	CCONJ	O
a	O	DET	O
heterologous	B-DNA	ADJ	B
promoter	I-DNA	NOUN	B
.	O	PUNCT	O


The	O	DET	O
cellular	O	ADJ	B
factor	O	NOUN	I
that	O	PRON	O
binds	O	VERB	B
to	O	PART	O
the	O	DET	O
GAS	B-DNA	NOUN	B
element	I-DNA	NOUN	O
is	O	AUX	O
present	O	ADJ	O
from	O	ADP	O
5	O	NUM	O
min	O	NOUN	O
to	O	PART	O
14	O	NUM	O
h	O	NOUN	O
after	O	ADP	O
stimulation	O	NOUN	B
with	O	ADP	O
IFN-gamma	B-protein	NOUN	B
.	O	PUNCT	O


Transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
binding	O	VERB	I
to	O	PART	O
the	O	DET	O
core	B-DNA	NOUN	O
promoter	I-DNA	NOUN	B
of	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
monoamine	I-DNA	NOUN	B
oxidase	I-DNA	NOUN	I
B	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
in	O	ADP	O
the	O	DET	O
cerebral	O	ADJ	B
cortex	O	NOUN	I
and	O	CCONJ	O
in	O	ADP	O
blood	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Many	O	ADJ	O
studies	O	NOUN	B
show	O	VERB	O
that	O	SCONJ	O
monoamine	B-protein	NOUN	B
oxidase	I-protein	NOUN	I
B	I-protein	NOUN	I
in	O	ADP	O
blood	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
is	O	AUX	O
a	O	DET	O
biological	O	ADJ	B
marker	O	NOUN	I
for	O	ADP	O
personality	O	NOUN	B
characteristics	O	NOUN	I
such	O	ADJ	O
as	O	ADP	O
sensation	O	NOUN	B
seeking	O	NOUN	O
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
are	O	AUX	O
well	O	ADV	O
in	O	ADP	O
line	O	NOUN	O
with	O	ADP	O
the	O	DET	O
long-standing	O	ADJ	O
notion	O	NOUN	O
that	O	SCONJ	O
interindividual	O	ADJ	B
differences	O	NOUN	B
in	O	ADP	O
platelet	B-protein	NOUN	B
monoamine	I-protein	NOUN	I
oxidase	I-protein	NOUN	I
may	O	AUX	O
represent	O	VERB	O
differences	O	NOUN	B
in	O	ADP	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
enzyme	O	NOUN	B
rather	O	ADV	O
than	O	ADP	O
genotypic	O	ADJ	B
variation	O	NOUN	B
.	O	PUNCT	O


Enhanced	O	VERB	B
differentiation	O	NOUN	B
of	O	ADP	O
HL-60	B-cell_line	NOUN	B
leukemia	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	B
to	O	PART	O
macrophages	B-cell_type	NOUN	B
induced	O	VERB	B
by	O	ADP	O
ciprofibrate	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
particular	O	ADJ	O
,	O	PUNCT	O
TRAF6	B-protein	NOUN	B
interacted	O	VERB	O
with	O	ADP	O
membrane-proximal	B-protein	ADJ	B
determinants	I-protein	NOUN	B
distinct	O	ADJ	O
from	O	ADP	O
those	O	DET	O
binding	O	NOUN	B
TRAFs	B-protein	NOUN	I
1	I-protein	NUM	I
,	I-protein	PUNCT	O
2	I-protein	NUM	O
,	I-protein	PUNCT	O
3	I-protein	NUM	O
,	I-protein	PUNCT	O
and	I-protein	CCONJ	O
5	I-protein	NUM	O
.	O	PUNCT	O


When	O	SCONJ	O
this	O	DET	O
membrane-proximal	B-protein	ADJ	B
TRAF6	I-protein	NOUN	B
interaction	I-protein	NOUN	B
domain	I-protein	NOUN	O
was	O	AUX	O
deleted	O	VERB	B
,	O	PUNCT	O
RANK	B-protein	NOUN	B
-mediated	O	ADJ	O
NF-kappaB	B-protein	NOUN	B
signaling	O	NOUN	O
was	O	AUX	O
completely	O	ADV	O
inhibited	O	VERB	B
while	O	SCONJ	O
c-Jun	B-protein	NOUN	B
NH2-terminal	I-protein	ADJ	I
kinase	I-protein	NOUN	I
activation	O	NOUN	B
was	O	AUX	O
partially	O	ADV	O
inhibited	O	VERB	B
.	O	PUNCT	O


In	O	ADP	O
Th2	O	NOUN	B
cells	O	NOUN	I
,	O	PUNCT	O
IL-4	B-protein	NOUN	B
gene	O	NOUN	B
expression	O	NOUN	I
is	O	AUX	O
tightly	O	ADV	O
controlled	O	VERB	B
at	O	ADP	O
the	O	DET	O
level	O	NOUN	B
of	O	ADP	O
transcription	O	NOUN	B
by	O	ADP	O
the	O	DET	O
coordinated	O	VERB	B
binding	O	NOUN	B
of	O	ADP	O
multiple	O	ADJ	B
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
to	O	PART	O
regulatory	O	ADJ	B
elements	O	NOUN	I
in	O	ADP	O
the	O	DET	O
proximal	O	ADJ	B
promoter	B-DNA	NOUN	B
region	I-DNA	NOUN	I
.	O	PUNCT	O


Nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
of	I-protein	ADP	O
activated	I-protein	VERB	B
T	I-protein	NOUN	O
cell	I-protein	NOUN	O
(	I-protein	PUNCT	O
NFAT	I-protein	NOUN	B
)	I-protein	PUNCT	O
family	I-protein	NOUN	B
members	I-protein	NOUN	I
play	O	VERB	O
a	O	DET	O
critical	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
regulating	O	VERB	B
IL-4	B-protein	NOUN	B
transcription	O	NOUN	O
and	O	CCONJ	O
interact	O	VERB	B
with	O	ADP	O
up	O	ADV	O
to	O	PART	O
five	O	NUM	O
sequences	O	NOUN	B
(	O	PUNCT	O
termed	O	VERB	O
P0	O	NOUN	B
through	O	ADP	O
P4	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
IL-4	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
.	O	PUNCT	O


The	O	DET	O
molecular	O	ADJ	B
mechanisms	O	NOUN	I
by	O	ADP	O
which	O	DET	O
IL-4	B-protein	NOUN	B
induces	O	VERB	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IL-4	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
are	O	AUX	O
not	O	PART	O
known	O	VERB	O
,	O	PUNCT	O
although	O	SCONJ	O
the	O	DET	O
IL-4-activated	B-protein	ADJ	B
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
signal	I-protein	NOUN	I
transducer	I-protein	NOUN	I
and	I-protein	CCONJ	O
activator	I-protein	NOUN	O
of	I-protein	ADP	O
transcription	I-protein	NOUN	O
6	I-protein	NUM	O
(	O	PUNCT	O
Stat6	B-protein	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
required	O	VERB	O
for	O	ADP	O
this	O	DET	O
effect	O	NOUN	B
.	O	PUNCT	O


BACKGROUND	O	NOUN	O
&	O	CCONJ	O
AIMS	O	NOUN	B
:	O	PUNCT	O
Entamoeba	O	X	B
histolytica	O	NOUN	I
infection	O	NOUN	I
of	O	ADP	O
the	O	DET	O
intestine	O	NOUN	B
can	O	AUX	O
induce	O	VERB	B
severe	O	ADJ	B
gut	O	NOUN	B
inflammation	O	NOUN	I
.	O	PUNCT	O


During	O	ADP	O
monocyte-to-macrophage	O	ADJ	B
differentiation	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
cellular	O	ADJ	B
content	O	NOUN	I
of	O	ADP	O
vacuolar	B-protein	ADJ	B
H+-ATPase	I-protein	NOUN	I
(	O	PUNCT	O
V-ATPase	B-protein	NOUN	B
)	O	PUNCT	O
increases	O	VERB	B
more	O	ADJ	O
than	O	ADP	O
4-fold	O	ADV	O
.	O	PUNCT	O


c-Jun	O	NOUN	B
and	O	CCONJ	O
GST-pi	O	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
plasma	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


The	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
these	O	DET	O
two	O	NUM	O
proteins	O	NOUN	B
was	O	AUX	O
not	O	PART	O
related	O	ADJ	O
to	O	PART	O
clinical	O	ADJ	B
or	O	CCONJ	O
laboratory	O	ADJ	B
data	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
IL-3	B-protein	NOUN	B
,	O	PUNCT	O
IL-5	B-protein	NOUN	B
and	O	CCONJ	O
GM-CSF	B-protein	NOUN	B
receptors	I-protein	NOUN	I
share	O	VERB	O
a	O	DET	O
common	B-protein	ADJ	O
signal	I-protein	NOUN	B
transducer	I-protein	NOUN	I
that	O	PRON	O
possesses	O	VERB	O
no	O	DET	O
intrinsic	B-protein	ADJ	O
kinase	I-protein	NOUN	O
domain	I-protein	NOUN	O
.	O	PUNCT	O


Requirement	O	NOUN	B
of	O	ADP	O
GATA-1	B-protein	NOUN	B
and	O	CCONJ	O
p45	B-protein	NOUN	B
NF-E2	I-protein	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
butyric	O	ADJ	B
acid-induced	O	ADJ	O
erythroid	O	ADJ	O
differentiation	O	NOUN	O
.	O	PUNCT	O


Epstein-Barr	O	ADJ	B
virus	O	NOUN	I
,	O	PUNCT	O
a	O	DET	O
human	O	ADJ	B
gammaherpesvirus	O	NOUN	I
,	O	PUNCT	O
possesses	O	VERB	O
a	O	DET	O
unique	O	ADJ	O
set	O	NOUN	O
of	O	ADP	O
latent	B-DNA	ADJ	B
genes	I-DNA	NOUN	I
whose	O	DET	O
constitutive	O	ADJ	B
expression	O	NOUN	B
in	O	ADP	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
leads	O	VERB	O
to	O	PART	O
cell	O	NOUN	B
growth	O	NOUN	I
transformation	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
upstream	O	ADJ	B
regions	O	NOUN	I
UAS3	B-DNA	NOUN	B
(	O	PUNCT	O
-1168	B-DNA	NUM	O
to	I-DNA	PART	O
-440	I-DNA	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
UAS2	B-DNA	NOUN	B
(	O	PUNCT	O
-352	B-DNA	NUM	O
to	I-DNA	PART	O
-264	I-DNA	NUM	O
)	O	PUNCT	O
both	O	DET	O
functioned	O	VERB	O
in	O	ADP	O
a	O	DET	O
cell	O	NOUN	B
lineage-independent	O	ADJ	I
manner	O	NOUN	I
and	O	CCONJ	O
were	O	AUX	O
together	O	ADV	O
responsible	O	ADJ	O
for	O	ADP	O
the	O	DET	O
bulk	O	NOUN	O
of	O	ADP	O
Wp	O	NOUN	B
activity	O	NOUN	O
in	O	ADP	O
non-B	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
;	O	PUNCT	O
mutational	O	ADJ	B
analysis	O	NOUN	I
indicated	O	VERB	O
the	O	DET	O
importance	O	NOUN	O
of	O	ADP	O
a	O	DET	O
YY1	B-DNA	NOUN	B
binding	I-DNA	NOUN	B
site	I-DNA	NOUN	I
in	O	ADP	O
UAS2	B-DNA	NOUN	B
in	O	ADP	O
that	O	DET	O
context	O	NOUN	B
.	O	PUNCT	O


By	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
UAS1	B-DNA	NOUN	B
(	O	PUNCT	O
-140	B-DNA	NUM	O
to	I-DNA	PART	O
-87	I-DNA	NUM	O
)	O	PUNCT	O
was	O	AUX	O
B	O	NOUN	B
cell	O	NOUN	I
specific	O	ADJ	B
and	O	CCONJ	O
was	O	AUX	O
the	O	DET	O
key	O	ADJ	O
determinant	O	NOUN	O
of	O	ADP	O
the	O	DET	O
promoter	O	NOUN	B
's	O	PART	I
increased	O	VERB	B
activity	O	NOUN	B
in	O	ADP	O
B	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
.	O	PUNCT	O


AIDS-related	O	ADJ	B
Epstein-Barr	O	ADJ	I
virus	O	NOUN	I
(	O	PUNCT	O
EBV	O	NOUN	B
)	O	PUNCT	O
-associated	O	ADJ	O
T	O	NOUN	B
cell	O	NOUN	I
lymphomas	O	NOUN	I
are	O	AUX	O
emerging	O	VERB	O
as	O	ADP	O
a	O	DET	O
new	O	ADJ	O
,	O	PUNCT	O
distinct	O	ADJ	O
histopathological	O	ADJ	B
entity	O	NOUN	B
.	O	PUNCT	O


Demonstration	O	NOUN	B
of	O	ADP	O
EBV	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
transcripts	I-RNA	NOUN	I
encoding	O	VERB	O
immediate-early	B-protein	ADJ	B
transcriptional	I-protein	ADJ	O
transactivators	I-protein	NOUN	O
in	O	ADP	O
EBV-infected	B-cell_type	ADJ	B
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
provides	O	VERB	O
the	O	DET	O
first	O	ADJ	O
evidence	O	NOUN	B
for	O	ADP	O
a	O	DET	O
possible	O	ADJ	O
mechanism	O	NOUN	B
whereby	O	SCONJ	O
EBV	O	NOUN	B
could	O	AUX	O
contribute	O	VERB	O
to	O	PART	O
T	O	NOUN	B
cell	O	NOUN	I
proliferation	O	NOUN	I
and	O	CCONJ	O
EBV-associated	O	ADJ	B
T	O	NOUN	I
cell	O	NOUN	I
malignancies	O	NOUN	I
.	O	PUNCT	O


T-lineage	O	NOUN	B
precursor	O	NOUN	O
populations	O	NOUN	O
from	O	ADP	O
the	O	DET	O
adult	O	ADJ	B
mouse	O	NOUN	B
thymus	O	NOUN	B
,	O	PUNCT	O
prior	O	ADJ	O
to	O	PART	O
T-cell	O	NOUN	B
receptor	O	NOUN	I
gene	O	NOUN	I
rearrangement	O	NOUN	O
,	O	PUNCT	O
display	O	VERB	B
a	O	DET	O
capacity	O	NOUN	B
to	O	PART	O
produce	O	VERB	O
DC	B-cell_type	NOUN	B
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
in	O	ADP	O
the	O	DET	O
thymus	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
are	O	AUX	O
very	O	ADV	O
efficient	O	ADJ	B
precursors	O	NOUN	B
of	O	ADP	O
DC	B-cell_type	NOUN	B
in	O	ADP	O
culture	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
lymphoid/DC	B-cell_type	ADJ	O
precursors	I-cell_type	NOUN	B
have	O	AUX	O
little	O	ADJ	O
capacity	O	NOUN	B
to	O	PART	O
form	O	VERB	O
myeloid	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
indicating	O	VERB	O
that	O	SCONJ	O
thymic	B-cell_type	ADJ	B
DC	I-cell_type	NOUN	B
are	O	AUX	O
a	O	DET	O
lymphoid-related	O	ADJ	O
rather	O	ADV	O
than	O	ADP	O
myeloid-related	B-cell_type	ADJ	B
lineage	I-cell_type	NOUN	B
.	O	PUNCT	O


DC	B-cell_type	NOUN	B
can	O	AUX	O
develop	O	VERB	O
in	O	ADP	O
mutant	O	ADJ	B
mice	O	NOUN	O
lacking	O	VERB	O
mature	B-cell_type	ADJ	B
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
provided	O	VERB	O
the	O	DET	O
common	O	ADJ	O
precursors	O	NOUN	B
are	O	AUX	O
present	O	ADJ	O
.	O	PUNCT	O


The	O	DET	O
discrepancy	O	NOUN	B
in	O	ADP	O
the	O	DET	O
degree	O	NOUN	B
of	O	ADP	O
inhibition	O	NOUN	B
by	O	ADP	O
membrane	O	NOUN	B
extracts	O	NOUN	I
and	O	CCONJ	O
NK	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
with	O	ADP	O
mutant	B-protein	ADJ	B
TNFRI	I-protein	NOUN	B
suggests	O	VERB	O
that	O	SCONJ	O
additional	O	ADJ	O
pathways	O	NOUN	B
are	O	AUX	O
utilized	O	VERB	O
by	O	ADP	O
NK	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
to	O	PART	O
activate	O	VERB	B
EC	B-cell_type	NOUN	B


Ras	B-protein	NOUN	B
-dependent	O	ADJ	O
,	O	PUNCT	O
Ca2+-stimulated	O	ADJ	B
activation	O	NOUN	B
of	O	ADP	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
of	I-protein	ADP	O
activated	I-protein	VERB	B
T	I-protein	NOUN	O
cells	I-protein	NOUN	O
by	O	ADP	O
a	O	DET	O
constitutively	O	ADV	B
active	O	ADJ	O
Cbl	B-protein	NOUN	B
mutant	I-protein	NOUN	I
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


As	O	ADP	O
a	O	DET	O
first	O	ADJ	O
step	O	NOUN	O
toward	O	ADP	O
elucidating	O	VERB	O
the	O	DET	O
function	O	NOUN	B
of	O	ADP	O
Cbl	B-protein	NOUN	B
in	O	ADP	O
TCR	B-protein	NOUN	B
-initiated	O	ADJ	O
signaling	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
evaluated	O	VERB	B
the	O	DET	O
ability	O	NOUN	O
of	O	ADP	O
wild-type	B-protein	ADJ	B
Cbl	I-protein	NOUN	B
or	O	CCONJ	O
a	O	DET	O
transforming	O	VERB	B
Cbl	B-protein	NOUN	I
mutant	I-protein	NOUN	I
(	O	PUNCT	O
70Z/3	O	NOUN	B
)	O	PUNCT	O
to	O	PART	O
induce	O	VERB	B
transcriptional	O	ADJ	B
activation	O	NOUN	I
of	O	ADP	O
a	O	DET	O
nuclear	B-DNA	ADJ	B
factor	I-DNA	NOUN	I
of	I-DNA	ADP	O
activated	I-DNA	VERB	B
T	I-DNA	NOUN	O
cells	I-DNA	NOUN	O
(	I-DNA	PUNCT	O
NFAT	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
element	I-DNA	NOUN	O
derived	O	VERB	O
from	O	ADP	O
the	O	DET	O
interleukin	B-DNA	NOUN	B
2	I-DNA	NUM	I
(	I-DNA	PUNCT	O
IL2	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
promoter	I-DNA	NOUN	B
in	O	ADP	O
transiently	O	ADV	O
cotransfected	O	VERB	B
Jurkat-TAg	B-cell_line	NOUN	O
T	I-cell_line	NOUN	O
cells	I-cell_line	NOUN	O
.	O	PUNCT	O


Additional	O	ADJ	O
mapping	O	NOUN	B
studies	O	NOUN	I
indicated	O	VERB	O
that	O	SCONJ	O
defined	O	VERB	O
deletions	O	NOUN	B
of	O	ADP	O
C-terminal	O	ADJ	B
70Z/3	B-protein	NOUN	I
sequences	O	NOUN	I
affected	O	VERB	B
to	O	PART	O
a	O	DET	O
variable	O	ADJ	B
degree	O	NOUN	B
its	O	PRON	O
ability	O	NOUN	O
to	O	PART	O
stimulate	O	VERB	B
NFAT	B-protein	NOUN	B
activity	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	O
implicate	O	VERB	O
Cbl	B-protein	NOUN	B
in	O	ADP	O
Ras	B-protein	NOUN	B
-dependent	O	ADJ	O
signaling	O	NOUN	B
pathways	O	NOUN	I
which	O	DET	O
lead	O	VERB	O
to	O	PART	O
NFAT	B-protein	NOUN	B
activation	O	NOUN	B
.	O	PUNCT	O


Lipopolysaccharide	O	NOUN	B
(	O	PUNCT	O
LPS	O	NOUN	B
)	O	PUNCT	O
-prestimulated	O	ADJ	O
and	O	CCONJ	O
untreated	O	ADJ	B
THP-1	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
were	O	AUX	O
cocultured	O	VERB	B
with	O	ADP	O
resting	B-cell_type	VERB	B
human	I-cell_type	ADJ	I
umbilical	I-cell_type	ADJ	I
vein	I-cell_type	NOUN	I
endothelial	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
(	O	PUNCT	O
HUVEC	B-cell_type	NOUN	B
)	O	PUNCT	O
for	O	ADP	O
3	O	NUM	O
and	O	CCONJ	O
24	O	NUM	O
h	O	NOUN	O
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
colimycin	O	NOUN	B
to	O	PART	O
neutralize	O	VERB	B
LPS	O	NOUN	B
traces	O	NOUN	B
.	O	PUNCT	O


Addition	O	NOUN	B
of	O	ADP	O
untreated	O	ADJ	B
THP-1	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
had	O	AUX	O
little	O	ADJ	O
effect	O	NOUN	O
on	O	ADP	O
HUVEC	B-cell_type	NOUN	B
adhesiveness	O	NOUN	B
.	O	PUNCT	O


Under	O	ADP	O
these	O	DET	O
conditions	O	NOUN	O
HUVEC	B-protein	NOUN	B
adhesion	I-protein	NOUN	B
molecules	I-protein	NOUN	O
,	O	PUNCT	O
E-selectin	B-protein	NOUN	B
,	O	PUNCT	O
VCAM-1	B-protein	NOUN	B
and	O	CCONJ	O
ICAM-1	B-protein	NOUN	B
,	O	PUNCT	O
were	O	AUX	O
increased	O	VERB	B
at	O	ADP	O
3	O	NUM	O
h	O	NOUN	O
with	O	ADP	O
only	O	ADJ	O
ICAM-1	B-protein	NOUN	B
remaining	O	VERB	O
overexpressed	O	VERB	B
at	O	ADP	O
24	O	NUM	O
h	O	NOUN	O
.	O	PUNCT	O


CD15	O	NOUN	B
cross-linking	O	NOUN	B
also	O	ADV	O
concomitantly	O	ADV	O
increased	O	VERB	B
interleukin-1	B-RNA	NOUN	B
beta	I-RNA	NOUN	I
(	I-RNA	PUNCT	O
IL-1	I-RNA	NOUN	B
beta	I-RNA	NOUN	I
)	I-RNA	PUNCT	O
mRNA	I-RNA	NOUN	B
,	O	PUNCT	O
while	O	SCONJ	O
no	O	DET	O
apparent	O	ADJ	B
change	O	NOUN	I
was	O	AUX	O
observed	O	VERB	O
in	O	ADP	O
the	O	DET	O
levels	O	NOUN	B
of	O	ADP	O
beta-actin	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
,	O	PUNCT	O
indicating	O	VERB	O
specificity	O	NOUN	B
.	O	PUNCT	O


To	O	PART	O
examine	O	VERB	O
transcriptional	O	ADJ	B
regulation	O	NOUN	I
of	O	ADP	O
cytokine	B-DNA	NOUN	B
genes	I-DNA	NOUN	I
by	O	ADP	O
CD15	O	NOUN	B
engagement	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
CAT	O	NOUN	B
plasmid	O	NOUN	I
reporter	O	NOUN	B
construct	O	NOUN	I
containing	O	VERB	O
IL-1	B-DNA	NOUN	B
beta	I-DNA	NOUN	O
promoter/enhancer	I-DNA	NOUN	O
sequences	I-DNA	NOUN	O
was	O	AUX	O
introduced	O	VERB	O
into	O	ADP	O
MM6	B-cell_line	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
conclude	O	VERB	O
that	O	SCONJ	O
engagement	O	NOUN	B
of	O	ADP	O
CD15	O	NOUN	B
on	O	ADP	O
monocytes	O	NOUN	B
results	O	VERB	B
in	O	ADP	O
monocyte	O	NOUN	B
activation	O	NOUN	I
.	O	PUNCT	O


CD2	B-protein	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
CD3	B-protein	NOUN	B
,	O	PUNCT	O
cross-linking	O	NOUN	B
increased	O	VERB	B
cAMP	O	NOUN	B
detected	O	VERB	B
by	O	ADP	O
competitive	O	ADJ	B
enzyme-linked	O	ADJ	B
immunosorbent	O	ADJ	I
assay	O	NOUN	I
(	O	PUNCT	O
ELISA	O	NOUN	B
)	O	PUNCT	O
approximately	O	ADV	O
fourfold	O	ADV	O
.	O	PUNCT	O


Both	O	CCONJ	O
CD2	B-protein	NOUN	B
and	O	CCONJ	O
CD3	B-protein	NOUN	B
cross-linking	O	NOUN	I
increased	O	VERB	B
binding	O	NOUN	B
of	O	ADP	O
nuclear	B-protein	ADJ	B
proteins	I-protein	NOUN	I
to	O	PART	O
a	O	DET	O
radiolabelled	O	ADJ	B
CRE	O	NOUN	O
oligonucleotide	O	NOUN	B
probe	O	NOUN	I
in	O	ADP	O
electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assays	O	NOUN	I
suggesting	O	VERB	O
that	O	SCONJ	O
lymphocyte	O	NOUN	B
activation	O	NOUN	O
enhances	O	VERB	O
binding	O	NOUN	B
independently	O	ADV	O
of	O	ADP	O
phosphorylation	O	NOUN	B
of	O	ADP	O
CREB	B-protein	NOUN	B
at	O	ADP	O
serine	O	NOUN	B
133	O	NUM	I
.	O	PUNCT	O


The	O	DET	O
importance	O	NOUN	O
of	O	ADP	O
these	O	DET	O
observations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
pathophysiology	O	NOUN	B
of	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
AIDS-related	O	ADJ	B
cancers	O	NOUN	I
treated	O	VERB	B
by	O	ADP	I
radiotherapy	O	NOUN	B
remains	O	VERB	O
to	O	PART	O
be	O	AUX	O
established	O	VERB	O
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	B
demonstrate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
altered	O	ADJ	O
CCAAT	B-DNA	NOUN	B
box	I-DNA	NOUN	I
(	O	PUNCT	O
CCAAC	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
lack	O	NOUN	B
of	O	ADP	O
an	O	DET	O
EKLF	B-DNA	NOUN	B
binding	I-DNA	NOUN	I
site	I-DNA	NOUN	I
in	O	ADP	O
delta-globin	B-protein	NOUN	B
contribute	O	VERB	O
to	O	PART	O
its	O	PRON	O
low	O	ADJ	B
level	O	NOUN	B
of	O	ADP	O
expression	O	NOUN	B
in	O	ADP	O
the	O	DET	O
hAEC	B-cell_line	NOUN	B
model	I-cell_line	NOUN	B
as	O	ADV	O
well	O	ADV	O
.	O	PUNCT	O


The	O	DET	O
lung	B-cell_type	NOUN	B
macrophage	I-cell_type	NOUN	I
was	O	AUX	O
identified	O	VERB	O
as	O	ADP	O
the	O	DET	O
main	O	ADJ	O
cellular	O	ADJ	B
source	O	NOUN	I
for	O	ADP	O
critical	O	ADJ	O
inflammatory	B-protein	ADJ	B
mediators	I-protein	NOUN	I
such	O	ADJ	O
as	O	ADP	O
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor-alpha	I-protein	NOUN	I
,	O	PUNCT	O
the	O	DET	O
chemokines	B-protein	NOUN	B
interleukin	B-protein	NOUN	I
(	I-protein	PUNCT	O
IL	I-protein	NOUN	B
)	I-protein	PUNCT	O
-8	I-protein	NUM	O
and	I-protein	CCONJ	O
-6	I-protein	NUM	B
,	O	PUNCT	O
and	O	CCONJ	O
matrix	B-protein	NOUN	B
metalloproteinase-9	I-protein	NOUN	I
in	O	ADP	O
this	O	DET	O
model	O	NOUN	B
system	O	NOUN	I
of	O	ADP	O
mechanical	O	ADJ	B
ventilation	O	NOUN	I
.	O	PUNCT	O


This	O	DET	O
model	O	NOUN	B
is	O	AUX	O
of	O	ADP	O
particular	O	ADJ	O
value	O	NOUN	O
for	O	ADP	O
exploring	O	VERB	O
physical	O	ADJ	B
stress-induced	O	ADJ	I
signaling	O	NOUN	I
pathways	O	NOUN	I
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
for	O	ADP	O
testing	O	VERB	B
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	O
novel	O	ADJ	B
ventilatory	O	ADJ	B
strategies	O	NOUN	I
or	O	CCONJ	O
adjunctive	O	ADJ	B
substances	O	NOUN	I
aimed	O	VERB	O
at	O	ADP	O
modulating	O	VERB	B
cell	O	NOUN	B
activation	O	NOUN	I
induced	O	VERB	B
by	O	ADP	O
mechanical	O	ADJ	B
ventilation	O	NOUN	I
.	O	PUNCT	O


Signaling	O	NOUN	B
pathways	O	NOUN	I
mediated	O	VERB	O
by	O	ADP	O
the	O	DET	O
TNF-	B-protein	NOUN	B
and	I-protein	CCONJ	O
cytokine-receptor	I-protein	ADJ	B
families	O	NOUN	B
target	O	VERB	B
a	O	DET	O
common	O	ADJ	O
cis-element	B-DNA	NOUN	B
of	O	ADP	O
the	O	DET	O
IFN	B-DNA	NOUN	B
regulatory	I-DNA	ADJ	O
factor	I-DNA	NOUN	O
1	I-DNA	NUM	O
promoter	I-DNA	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
performed	O	VERB	O
an	O	DET	O
analysis	O	NOUN	B
of	O	ADP	O
the	O	DET	O
mechanisms	O	NOUN	B
by	O	ADP	O
which	O	DET	O
two	O	NUM	O
PKC	B-protein	NOUN	B
inhibitors	O	NOUN	B
,	O	PUNCT	O
Calphostin	O	NOUN	B
C	O	NOUN	I
and	O	CCONJ	O
Staurosporine	O	NOUN	B
,	O	PUNCT	O
prevent	O	VERB	B
the	O	DET	O
FN	B-protein	NOUN	B
-induced	O	ADJ	O
IL-1beta	B-protein	NOUN	B
response	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
integral	O	ADJ	B
membrane	O	NOUN	I
glycoprotein	B-protein	NOUN	I
CD36	I-protein	NOUN	B
appears	O	VERB	O
to	O	PART	O
play	O	VERB	O
a	O	DET	O
physiological	O	ADJ	B
role	O	NOUN	O
in	O	ADP	O
binding	O	NOUN	B
and	O	CCONJ	O
uptake	O	NOUN	B
of	O	ADP	O
Ox	O	NOUN	B
LDL	O	NOUN	I
by	O	ADP	O
monocyte-macrophages	B-cell_type	NOUN	B
,	O	PUNCT	O
although	O	SCONJ	O
the	O	DET	O
molecular	O	ADJ	B
events	O	NOUN	I
associated	O	VERB	B
with	O	ADP	I
CD36	B-protein	NOUN	B
-Ox	O	NUM	O
LDL	O	NOUN	B
interaction	O	NOUN	B
are	O	AUX	O
unknown	O	ADJ	O
.	O	PUNCT	O


We	O	PRON	O
report	O	VERB	O
here	O	ADV	O
that	O	SCONJ	O
Ox	O	NOUN	B
LDL	O	NOUN	I
enhanced	O	VERB	O
DNA	O	NOUN	B
binding	O	NOUN	I
activity	O	NOUN	I
of	O	ADP	O
nuclear	O	ADJ	B
extracts	O	NOUN	I
to	O	PART	O
an	O	DET	O
NF-kappaB	B-DNA	NOUN	B
sequence	I-DNA	NOUN	O
following	O	VERB	O
activation	O	NOUN	B
of	O	ADP	O
CD36-producing	B-cell_line	ADJ	B
CHO	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	B
with	O	ADP	O
the	O	DET	O
proinflammatory	B-protein	ADJ	B
cytokine	I-protein	NOUN	O
tumor	B-protein	NOUN	O
necrosis	I-protein	NOUN	O
factor-alpha	I-protein	NOUN	O
(	O	PUNCT	O
TNF-alpha	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
structural	O	ADJ	B
organization	O	NOUN	I
of	O	ADP	O
the	O	DET	O
393	B-protein	NUM	O
amino	I-protein	NOUN	B
acid	I-protein	NOUN	I
long	I-protein	ADJ	O
human	I-protein	ADJ	B
TRAMP	I-protein	NOUN	B
is	O	AUX	O
most	O	ADV	O
homologous	O	ADJ	B
to	O	PART	O
TNF	B-protein	NOUN	B
receptor	I-protein	NOUN	I
1	I-protein	NUM	I
.	O	PUNCT	O


IL-4	B-protein	NOUN	B
and	O	CCONJ	O
IL-13	B-protein	NOUN	B
up-regulated	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
both	O	CCONJ	O
genomic	O	ADJ	B
and	O	CCONJ	O
spliced	O	VERB	B
HIV	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
in	O	ADP	O
monocytes	B-cell_type	NOUN	B
cultured	O	VERB	B
on	O	ADP	O
Teflon	O	NOUN	B
,	O	PUNCT	O
as	O	ADP	O
determined	O	VERB	O
by	O	ADP	O
Northern	O	NOUN	B
analysis	O	NOUN	I
and	O	CCONJ	O
p24	B-protein	NOUN	B
Ag	I-protein	NOUN	B
assay	O	NOUN	B
.	O	PUNCT	O


Conversely	O	ADV	O
,	O	PUNCT	O
IL-4	B-protein	NOUN	B
and	O	CCONJ	O
IL-13	B-protein	NOUN	B
markedly	O	ADV	O
and	O	CCONJ	O
significantly	O	ADV	O
inhibited	O	VERB	B
HIV	O	NOUN	B
replication	O	NOUN	B
at	O	ADP	O
the	O	DET	O
transcriptional	O	ADJ	B
level	O	NOUN	O
in	O	ADP	O
monocyte-derived	B-cell_type	ADJ	B
macrophages	I-cell_type	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
this	O	DET	O
occurred	O	VERB	O
whether	O	SCONJ	O
these	O	DET	O
cytokines	B-protein	NOUN	B
were	O	AUX	O
added	O	VERB	O
before	O	ADP	O
or	O	CCONJ	O
after	O	ADP	O
HIV	O	NOUN	B
infection	O	NOUN	I
.	O	PUNCT	O


IL-4	B-protein	NOUN	B
enhanced	O	VERB	O
CD11b	B-protein	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
inhibited	O	VERB	B
CD26	B-protein	NOUN	B
expression	O	NOUN	B
and	O	CCONJ	O
delayed	O	VERB	B
CD13	B-protein	NOUN	B
loss	O	NOUN	I
.	O	PUNCT	O


IL-10	B-protein	NOUN	B
attenuated	O	VERB	B
LPS-stimulated	O	ADJ	B
TNF-alpha	B-protein	NOUN	B
production	O	NOUN	B
(	O	PUNCT	O
297+/-54	O	NUM	O
;	O	PUNCT	O
p	O	X	O
<	O	X	O
.001	O	NUM	O
versus	O	CCONJ	O
LPS	O	NOUN	B
alone	O	ADV	O
)	O	PUNCT	O
.	O	PUNCT	O


Therefore	O	ADV	O
in	O	ADP	O
this	O	DET	O
study	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
examined	O	VERB	O
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
glucocorticoid	B-protein	NOUN	B
receptor/s	I-protein	NOUN	I
(	O	PUNCT	O
GR	B-protein	NOUN	B
)	O	PUNCT	O
characteristics	O	NOUN	B
in	O	ADP	O
the	O	DET	O
developing	O	NOUN	O
of	O	ADP	O
these	O	DET	O
abnormalities	O	NOUN	B
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
PCOS	O	NOUN	B
.	O	PUNCT	O


Heterogeneous	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
lipocalin	B-protein	NOUN	B
NGAL	I-protein	NOUN	B
in	O	ADP	O
primary	O	ADJ	B
breast	O	NOUN	B
cancers	O	NOUN	I
.	O	PUNCT	O


When	O	SCONJ	O
breast	O	NOUN	B
cancers	O	NOUN	I
were	O	AUX	O
examined	O	VERB	O
for	O	ADP	O
NGAL	O	NOUN	B
mRNA	O	NOUN	B
and	O	CCONJ	O
protein	O	NOUN	B
levels	O	NOUN	I
,	O	PUNCT	O
they	O	PRON	O
were	O	AUX	O
found	O	VERB	O
to	O	PART	O
exhibit	O	VERB	O
heterogeneous	O	ADJ	B
expression	O	NOUN	B
.	O	PUNCT	O


Interestingly	O	ADV	O
,	O	PUNCT	O
unlike	O	ADP	O
NRL	B-protein	NOUN	B
in	O	ADP	O
rat	O	NOUN	B
mammary	O	ADJ	B
carcinomas	O	NOUN	I
,	O	PUNCT	O
no	O	DET	O
significant	O	ADJ	O
association	O	NOUN	B
between	O	ADP	O
NGAL	B-protein	NOUN	B
expression	O	NOUN	B
and	O	CCONJ	O
HER-2/neu	B-protein	NOUN	B
activation	O	NOUN	B
was	O	AUX	O
found	O	VERB	O
in	O	ADP	O
human	O	ADJ	B
breast	O	NOUN	B
tumors	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
a	O	DET	O
significant	O	ADJ	O
correlation	O	NOUN	B
between	O	ADP	O
NGAL	B-protein	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
breast	O	NOUN	B
cancer	O	NOUN	I
was	O	AUX	O
found	O	VERB	O
with	O	ADP	O
several	O	ADJ	O
other	O	ADJ	O
markers	O	NOUN	B
of	O	ADP	O
poor	O	ADJ	B
prognosis	O	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
estrogen	O	NOUN	B
and	O	CCONJ	O
progesterone	B-protein	NOUN	B
receptor	I-protein	NOUN	I
-negative	O	ADJ	O
status	O	NOUN	B
and	O	CCONJ	O
high	O	ADJ	B
proliferation	O	NOUN	I
(	O	PUNCT	O
S-phase	O	NOUN	B
fraction	O	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


Overexpression	O	NOUN	B
of	O	ADP	O
BASH	B-protein	NOUN	B
results	O	VERB	B
in	O	ADP	O
suppression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
NF-AT	B-protein	NOUN	B
activation	O	NOUN	B
induced	O	VERB	B
by	O	ADP	O
BCR	B-protein	NOUN	B
-cross-linking	O	ADJ	I
.	O	PUNCT	O


StatG	B-protein	NOUN	B
in	O	ADP	O
normal	B-cell_type	ADJ	O
immature	I-cell_type	ADJ	B
human	I-cell_type	ADJ	B
myeloid	I-cell_type	ADJ	O
cells	I-cell_type	NOUN	O
,	O	PUNCT	O
i.e	O	ADV	O
.	O	PUNCT	O
adult	B-cell_type	ADJ	B
CD34+	I-cell_type	ADJ	B
bone	I-cell_type	NOUN	I
marrow	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
was	O	AUX	O
composed	O	VERB	O
of	O	ADP	O
Stat3beta	B-protein	NOUN	B
.	O	PUNCT	O


Because	O	SCONJ	O
this	O	DET	O
region	O	NOUN	B
of	O	ADP	O
Stat3alpha	B-protein	NOUN	B
is	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
transcriptional	O	ADJ	B
activation	O	NOUN	I
,	O	PUNCT	O
our	O	PRON	O
findings	O	NOUN	B
suggest	O	VERB	O
the	O	DET	O
possibility	O	NOUN	O
that	O	SCONJ	O
Stat3gamma	B-protein	NOUN	B
may	O	AUX	O
be	O	AUX	O
transcriptionally	O	ADV	B
inactive	O	ADJ	B
and	O	CCONJ	O
may	O	AUX	O
compete	O	VERB	O
with	O	ADP	O
Stat3alpha	B-protein	NOUN	B
for	O	ADP	O
Stat3	B-DNA	NOUN	B
binding	I-DNA	NOUN	B
sites	I-DNA	NOUN	I
in	O	ADP	O
these	O	DET	O
terminally	B-cell_type	ADV	O
differentiated	I-cell_type	VERB	O
myeloid	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
monoclonal	O	ADJ	B
integration	O	NOUN	B
of	O	ADP	O
HTLV-1	O	NOUN	B
provirus	O	NOUN	B
to	O	PART	O
the	O	DET	O
genome	O	NOUN	B
of	O	ADP	O
T	B-cell_type	NOUN	B
cell	I-cell_type	NOUN	I
,	O	PUNCT	O
especially	O	ADV	O
the	O	DET	O
number	O	NOUN	O
of	O	ADP	O
integration	O	NOUN	B
sites	O	NOUN	I
,	O	PUNCT	O
is	O	AUX	O
one	O	NUM	O
of	O	ADP	O
the	O	DET	O
factors	O	NOUN	B
for	O	ADP	O
induction	O	NOUN	B
of	O	ADP	O
ICAM-1	B-protein	NOUN	B
molecules	I-protein	NOUN	I
.	O	PUNCT	O


Finally	O	ADV	O
,	O	PUNCT	O
it	O	PRON	O
was	O	AUX	O
observed	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
rate	O	NOUN	B
of	O	ADP	O
decay	O	NOUN	B
of	O	ADP	O
vimentin	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
upon	O	SCONJ	O
actinomycin	O	NOUN	B
D	O	NOUN	O
administration	O	NOUN	B
was	O	AUX	O
decreased	O	VERB	B
in	O	ADP	O
heat-	B-cell_line	ADJ	O
and	I-cell_line	CCONJ	O
cadmium-pretreated	I-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
in	O	ADP	O
comparison	O	NOUN	B
to	O	PART	O
untreated	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Since	O	SCONJ	O
the	O	DET	O
AES	B-protein	NOUN	B
proteins	I-protein	NOUN	B
are	O	AUX	O
part	O	NOUN	O
of	O	ADP	O
a	O	DET	O
set	O	NOUN	O
of	O	ADP	O
transcriptional	O	ADJ	B
repressors	O	NOUN	O
encoded	O	VERB	B
by	O	ADP	O
the	O	DET	O
Enhancer	B-DNA	NOUN	B
of	I-DNA	ADP	I
split	I-DNA	NOUN	I
[	I-DNA	PUNCT	I
E	I-DNA	PROPN	I
(	I-DNA	PUNCT	I
spl	I-DNA	NOUN	O
)	I-DNA	PUNCT	O
]	I-DNA	PUNCT	O
genes	I-DNA	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
since	O	SCONJ	O
these	O	DET	O
repressors	O	NOUN	B
are	O	AUX	O
activated	O	VERB	B
to	O	PART	O
suppress	O	VERB	B
cell	O	NOUN	B
differentiation	O	NOUN	I
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
Notch	B-protein	NOUN	B
receptors	I-protein	NOUN	I
signalling	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
AES	O	NOUN	B
peptides	O	NOUN	B
may	O	AUX	O
represent	O	VERB	O
a	O	DET	O
novel	O	ADJ	B
class	O	NOUN	O
of	O	ADP	O
self-antigens	B-protein	NOUN	B
that	O	PRON	O
deserve	O	VERB	O
further	O	ADJ	O
consideration	O	NOUN	O
as	O	ADP	O
tumor	B-protein	NOUN	B
Ag	I-protein	NOUN	I
in	O	ADP	O
epithelial	O	ADJ	B
cancers	O	NOUN	I
.	O	PUNCT	O


Our	O	PRON	O
data	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
stimulation	O	NOUN	B
of	O	ADP	O
PML	B-DNA	NOUN	B
expression	O	NOUN	B
by	O	ADP	O
interferons	B-protein	NOUN	B
and	O	CCONJ	O
IL-1	B-protein	NOUN	B
may	O	AUX	O
account	O	VERB	O
for	O	ADP	O
upregulation	O	NOUN	B
of	O	ADP	O
PML	B-protein	NOUN	B
proteins	I-protein	NOUN	I
observed	O	VERB	O
in	O	ADP	O
inflammatory	O	ADJ	B
tissues	O	NOUN	I
and	O	CCONJ	O
in	O	ADP	O
proliferative	O	ADJ	B
states	O	NOUN	O
.	O	PUNCT	O


Previously	O	ADV	O
we	O	PRON	O
demonstrated	O	VERB	O
that	O	SCONJ	O
heterologous	B-protein	ADJ	B
activation	I-protein	NOUN	B
domains	I-protein	NOUN	I
can	O	AUX	O
fully	O	ADV	O
substitute	O	VERB	O
for	O	ADP	O
the	O	DET	O
ZEBRA	B-protein	NOUN	B
activation	I-protein	NOUN	O
domain	I-protein	NOUN	O
.	O	PUNCT	O


Their	O	PRON	O
mean	O	ADJ	O
Kd	O	NOUN	B
(	O	PUNCT	I
affinity	O	NOUN	B
)	O	PUNCT	O
was	O	AUX	O
also	O	ADV	O
significantly	O	ADV	O
lower	O	ADJ	O
than	O	ADP	O
that	O	DET	O
found	O	VERB	O
in	O	ADP	O
the	O	DET	O
healthy	O	ADJ	B
controls	O	NOUN	I
(	O	PUNCT	O
obese	O	ADJ	B
Kd	O	NOUN	O
:	O	PUNCT	O
2.92	O	NUM	O
+/-	O	CCONJ	O
0.84	O	NUM	O
nmol/l	O	NOUN	O
,	O	PUNCT	O
control	O	ADJ	B
Kd	O	NOUN	O
:	O	PUNCT	O
4.55	O	NUM	O
+/-	O	CCONJ	O
0.67	O	NUM	O
nM	O	NOUN	O
,	O	PUNCT	O
p	O	X	O
<	O	X	O
0.05	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


At	O	ADP	O
the	O	DET	O
same	O	ADJ	O
time	O	NOUN	B
,	O	PUNCT	O
3-O-MG	O	NOUN	B
transport	O	NOUN	B
was	O	AUX	O
determined	O	VERB	O
in	O	ADP	O
the	O	DET	O
same	O	ADJ	O
subjects	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
indicated	O	VERB	O
that	O	SCONJ	O
,	O	PUNCT	O
in	O	ADP	O
abdominal	O	ADJ	B
obesity	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
GR	B-protein	NOUN	B
binding	O	NOUN	O
capacity	O	NOUN	O
in	O	ADP	O
MNL	B-cell_type	NOUN	B
is	O	AUX	O
influenced	O	VERB	B
by	O	ADP	O
the	O	DET	O
changes	O	NOUN	B
in	O	ADP	O
glucose	O	NOUN	B
transport	O	NOUN	I
.	O	PUNCT	O


DNA	O	NOUN	B
taken	O	VERB	O
from	O	ADP	O
families	O	NOUN	B
with	O	ADP	O
an	O	DET	O
asthmatic	O	ADJ	B
proband	O	NOUN	B
was	O	AUX	O
examined	O	VERB	O
for	O	ADP	O
base	O	NOUN	B
exchanges	O	NOUN	B
by	O	ADP	O
single-stranded	O	ADJ	B
conformational	O	ADJ	I
polymorphism	O	NOUN	I
(	O	PUNCT	O
SSCP	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
Tpl-2	B-protein	NOUN	B
kinase	I-protein	NOUN	I
activates	O	VERB	B
the	O	DET	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
of	I-protein	ADP	O
activated	I-protein	VERB	B
T	I-protein	NOUN	O
cells	I-protein	NOUN	O
(	O	PUNCT	O
NFAT	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
induces	O	VERB	B
IL-2	B-protein	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
T-cell	B-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IL-2	B-DNA	NOUN	B
promoter	I-DNA	NOUN	O
by	O	ADP	O
Tpl-2	B-protein	NOUN	B
is	O	AUX	O
inhibited	O	VERB	B
by	O	ADP	O
mutant	B-protein	ADJ	B
signaling	I-protein	NOUN	I
molecules	I-protein	NOUN	I
that	O	PRON	O
inhibit	O	VERB	B
the	O	DET	O
mitogen-activated	B-protein	ADJ	B
protein	I-protein	NOUN	I
kinase	I-protein	NOUN	I
(	O	PUNCT	O
MAPK	B-protein	NOUN	B
)	O	PUNCT	O
or	O	CCONJ	O
the	O	DET	O
calcineurin	B-protein	NOUN	B
/NFAT	B-protein	NOUN	O
pathways	O	NOUN	O
and	O	CCONJ	O
is	O	AUX	O
promoted	O	VERB	O
by	O	ADP	O
combinations	O	NOUN	B
of	O	ADP	O
signaling	B-protein	VERB	B
molecules	I-protein	NOUN	I
that	O	PRON	O
activate	O	VERB	B
these	O	DET	O
pathways	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
,	O	PUNCT	O
therefore	O	ADV	O
,	O	PUNCT	O
conclude	O	VERB	O
that	O	SCONJ	O
signals	O	NOUN	B
generated	O	VERB	O
by	O	ADP	O
the	O	DET	O
convergence	O	NOUN	B
of	O	ADP	O
the	O	DET	O
MAPK	B-protein	NOUN	B
and	O	CCONJ	O
the	O	DET	O
calcineurin	B-protein	NOUN	B
/NFAT	B-protein	NOUN	O
pathway	O	NOUN	O
are	O	AUX	O
necessary	O	ADJ	O
and	O	CCONJ	O
sufficient	O	ADJ	B
for	O	ADP	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IL-2	B-DNA	NOUN	B
promoter	I-DNA	NOUN	O
by	O	ADP	O
Tpl-2	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
both	O	CCONJ	O
the	O	DET	O
IL-2	B-DNA	NOUN	B
promoter	I-DNA	NOUN	I
and	O	CCONJ	O
an	O	DET	O
NFAT-driven	B-DNA	ADJ	B
minimal	I-DNA	ADJ	B
promoter	I-DNA	NOUN	B
were	O	AUX	O
shown	O	VERB	O
to	O	PART	O
depend	O	VERB	O
on	O	ADP	O
signals	O	NOUN	B
transduced	O	VERB	B
by	O	ADP	O
Raf1	B-protein	NOUN	B
.	O	PUNCT	O


Since	O	SCONJ	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
NFAT	B-protein	NOUN	B
is	O	AUX	O
MAPK	B-protein	NOUN	B
-dependent	O	ADJ	O
these	O	DET	O
findings	O	NOUN	B
suggested	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
MAPK	B-protein	NOUN	B
by	O	ADP	O
Tpl-2	B-protein	NOUN	B
is	O	AUX	O
either	O	CCONJ	O
independent	O	ADJ	B
or	O	CCONJ	O
only	O	ADV	O
partially	O	ADV	B
dependent	O	ADJ	I
on	O	ADP	O
MEK1	B-protein	NOUN	B
and	O	CCONJ	O
MEK2	B-protein	NOUN	B
.	O	PUNCT	O


Experiments	O	NOUN	B
in	O	ADP	O
COS-1	B-cell_line	NOUN	B
and	O	CCONJ	O
EL-4	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
confirmed	O	VERB	O
both	O	DET	O
hypotheses	O	NOUN	B
and	O	CCONJ	O
revealed	O	VERB	B
that	O	SCONJ	O
the	O	DET	O
second	O	ADJ	O
factor	O	NOUN	B
activated	O	VERB	B
by	O	ADP	O
Tpl-2	B-protein	NOUN	B
is	O	AUX	O
NF-kappaB	B-protein	NOUN	B
.	O	PUNCT	O


While	O	SCONJ	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IL-2	B-DNA	NOUN	B
promoter	I-DNA	NOUN	I
and	O	CCONJ	O
an	O	DET	O
NFAT-driven	B-DNA	ADJ	B
minimal	I-DNA	ADJ	B
promoter	I-DNA	NOUN	B
by	O	ADP	O
Tpl-2	B-protein	NOUN	B
was	O	AUX	O
fully	O	ADV	O
blocked	O	VERB	B
by	O	ADP	O
the	O	DET	O
dominant	B-protein	ADJ	B
negative	I-protein	ADJ	B
mutant	I-protein	ADJ	B
NFAT	B-protein	NOUN	O
delta418	I-protein	NOUN	O
,	O	PUNCT	O
it	O	PRON	O
was	O	AUX	O
only	O	ADV	O
partially	O	ADV	O
blocked	O	VERB	B
by	O	ADP	O
the	O	DET	O
calcineurin	B-protein	NOUN	B
inhibitor	O	NOUN	O
cyclosporin	O	NOUN	B
A	O	NOUN	O
suggesting	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
Tpl-2	B-protein	NOUN	B
-mediated	O	ADJ	O
NFAT	B-protein	NOUN	B
activation	O	NOUN	B
is	O	AUX	O
under	O	ADP	O
the	O	DET	O
control	O	NOUN	B
of	O	ADP	O
a	O	DET	O
combination	O	NOUN	B
of	O	ADP	O
calcineurin-dependent	O	ADJ	B
and	O	CCONJ	O
independent	O	ADJ	O
pathways	O	NOUN	B
.	O	PUNCT	O


Both	O	DET	O
pathways	O	NOUN	B
were	O	AUX	O
fully	O	ADV	O
blocked	O	VERB	B
by	O	ADP	O
Bcl-2	B-protein	NOUN	B
or	O	CCONJ	O
Bcl-X	B-protein	NOUN	B
(	I-protein	PUNCT	O
L	I-protein	NOUN	B
)	I-protein	PUNCT	O
.	O	PUNCT	O


Representational	O	ADJ	B
difference	O	NOUN	I
analysis	O	NOUN	I
has	O	AUX	O
been	O	AUX	O
used	O	VERB	O
to	O	PART	O
isolate	O	VERB	B
cDNA	B-DNA	NOUN	B
clones	I-DNA	NOUN	I
corresponding	O	VERB	O
to	O	PART	O
mRNA	B-RNA	NOUN	B
species	I-RNA	NOUN	I
activated	O	VERB	B
following	O	VERB	O
stable	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
HOX11	B-protein	NOUN	B
in	O	ADP	O
NIH	B-cell_line	NOUN	B
3T3	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


NF-X2	B-DNA	NOUN	B
,	O	PUNCT	O
which	O	DET	O
contains	O	VERB	O
members	O	NOUN	B
of	O	ADP	O
the	O	DET	O
AP-1/ATF/CREB	B-protein	ADJ	B
families	I-protein	NOUN	B
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
,	O	PUNCT	O
interacts	O	VERB	O
with	O	ADP	O
the	O	DET	O
X2	B-DNA	NOUN	B
box	I-DNA	NOUN	I
(	O	PUNCT	O
5'-TGCGTCA-3	O	NOUN	O
'	O	PUNCT	O
)	O	PUNCT	O
from	O	ADP	O
positions	O	NOUN	B
-97	O	NUM	O
to	O	PART	O
-91	O	NUM	O
in	O	ADP	O
the	O	DET	O
DRA	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
sharp	O	ADJ	O
contrast	O	NOUN	O
,	O	PUNCT	O
in	O	ADP	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
treated	O	VERB	B
with	O	ADP	I
the	O	DET	O
phorbol	O	NOUN	B
ester	O	NOUN	I
12-O-tetradecanoylphorbol-13-acetate	O	NOUN	I
(	O	PUNCT	O
TPA	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
strong	O	ADJ	O
interactions	O	NOUN	B
between	O	ADP	O
the	O	DET	O
X2	B-DNA	NOUN	B
box	I-DNA	NOUN	I
and	O	CCONJ	I
NF-X2	B-DNA	NOUN	I
containing	O	VERB	O
c-Fos	B-protein	NOUN	B
were	O	AUX	O
observed	O	VERB	B
.	O	PUNCT	O


Immunofluorescence	O	NOUN	B
studies	O	NOUN	I
on	O	ADP	O
thymic	B-cell_type	ADJ	B
populations	I-cell_type	NOUN	I
of	O	ADP	O
mice	O	NOUN	B
carrying	O	VERB	O
transgenes	O	NOUN	B
in	O	ADP	O
various	O	ADJ	O
combinations	O	NOUN	B
of	O	ADP	O
these	O	DET	O
regulatory	B-DNA	ADJ	B
DNA	I-DNA	NOUN	I
elements	I-DNA	NOUN	I
revealed	O	VERB	O
that	O	SCONJ	O
thymocytes	B-cell_type	NOUN	B
control	O	VERB	B
the	O	DET	O
CD4	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
in	O	ADP	O
a	O	DET	O
different	O	ADJ	O
manner	O	NOUN	O
than	O	ADP	O
mature	O	ADJ	B
peripheral	B-cell_type	ADJ	B
T	I-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
.	O	PUNCT	O


Direct	O	ADJ	B
suppression	O	NOUN	I
of	O	ADP	O
Stat1	B-protein	NOUN	B
function	O	NOUN	O
during	O	ADP	O
adenoviral	O	ADJ	B
infection	O	NOUN	I
.	O	PUNCT	O


Similar	O	ADJ	O
to	O	PART	O
the	O	DET	O
E2	O	NOUN	B
response	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
slope	O	NOUN	B
factors	O	NOUN	I
for	O	ADP	O
alpha-zearalenol	O	NOUN	B
,	O	PUNCT	O
zearalenone	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
genistein	O	NOUN	B
were	O	AUX	O
close	O	ADJ	O
to	O	PART	O
3.0	O	NUM	O
,	O	PUNCT	O
suggesting	O	VERB	O
positive	O	ADJ	B
cooperativity	O	NOUN	B
in	O	ADP	O
the	O	DET	O
estrogenic	O	ADJ	B
response	O	NOUN	I
.	O	PUNCT	O


Dendritic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
autologous	B-cell_type	ADJ	B
CD4+	I-cell_type	ADJ	B
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
were	O	AUX	O
isolated	O	VERB	B
from	O	ADP	O
peripheral	O	ADJ	B
blood	O	NOUN	I
by	O	ADP	O
a	O	DET	O
series	O	NOUN	O
of	O	ADP	O
density-gradient	O	ADJ	B
centrifugations	O	NOUN	I
or	O	CCONJ	O
magnetic	O	ADJ	B
bead	O	NOUN	I
separations	O	NOUN	I
(	O	PUNCT	O
or	O	CCONJ	O
both	O	DET	O
)	O	PUNCT	O
.	O	PUNCT	O


Three	O	NUM	O
VZV-susceptible	O	ADJ	B
donors	O	NOUN	B
were	O	AUX	O
tested	O	VERB	B
,	O	PUNCT	O
and	O	CCONJ	O
all	O	DET	O
demonstrated	O	VERB	O
an	O	DET	O
in	O	X	B
vitro	O	X	I
response	O	NOUN	I
to	O	PART	O
multiple	O	ADJ	O
VZV	O	NOUN	B
peptides	O	NOUN	B
.	O	PUNCT	O


Xenogeneic	O	ADJ	B
human	O	ADJ	B
serum	O	NOUN	B
promotes	O	VERB	O
leukocyte	O	NOUN	B
adhesion	O	NOUN	I
to	O	PART	O
porcine	O	NOUN	B
endothelium	O	NOUN	B
under	O	ADP	O
flow	O	NOUN	B
conditions	O	NOUN	I
,	O	PUNCT	O
possibly	O	ADV	O
through	O	ADP	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
NF-kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
evaluated	O	VERB	B
whether	O	SCONJ	O
xenogeneic	O	ADJ	B
serum	O	NOUN	I
,	O	PUNCT	O
as	O	ADP	O
a	O	DET	O
source	O	NOUN	B
of	O	ADP	O
xenoreactive	B-protein	ADJ	B
natural	I-protein	ADJ	O
antibodies	I-protein	NOUN	O
and	O	CCONJ	O
complement	O	NOUN	B
,	O	PUNCT	O
induced	O	VERB	B
endothelial	O	ADJ	B
cell	O	NOUN	I
activation	O	NOUN	B
with	O	ADP	O
consequent	O	ADJ	O
leukocyte	O	NOUN	B
adhesion	O	NOUN	I
under	O	ADP	O
flow	O	NOUN	B
conditions	O	NOUN	I
.	O	PUNCT	O


At	O	ADP	O
variance	O	NOUN	B
,	O	PUNCT	O
in	O	ADP	O
PAEC	B-cell_line	NOUN	B
incubated	O	VERB	B
with	O	ADP	O
the	O	DET	O
homologous	O	ADJ	B
serum	O	NOUN	B
,	O	PUNCT	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
was	O	AUX	O
strictly	O	ADV	O
localized	O	ADJ	B
in	O	ADP	O
the	O	DET	O
cell	O	NOUN	B
cytoplasm	O	NOUN	I
.	O	PUNCT	O


C5a	B-protein	NOUN	B
and	O	CCONJ	O
C3a	B-protein	NOUN	B
stimulation	O	NOUN	I
of	O	ADP	O
human	B-cell_type	ADJ	B
peripheral	I-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
monocytes	I-cell_type	NOUN	O
resulted	O	VERB	O
in	O	ADP	O
nuclear	O	ADJ	B
expression	O	NOUN	I
of	O	ADP	O
a	O	DET	O
DNA	O	NOUN	B
binding	O	NOUN	I
activity	O	NOUN	I
with	O	ADP	O
specificity	O	NOUN	B
to	O	PART	O
the	O	DET	O
kappaB	B-DNA	NOUN	B
sequence	I-DNA	NOUN	I
.	O	PUNCT	O


Thrombopoietin	B-protein	NOUN	B
(	O	PUNCT	O
TPO	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
the	O	DET	O
primary	O	ADJ	O
physiological	O	ADJ	O
regulator	O	NOUN	O
of	O	ADP	O
platelet	O	NOUN	B
production	O	NOUN	I
,	O	PUNCT	O
was	O	AUX	O
initially	O	ADV	O
thought	O	VERB	O
to	O	PART	O
be	O	AUX	O
a	O	DET	O
lineage-specific	O	ADJ	B
factor	O	NOUN	I
acting	O	VERB	O
predominantly	O	ADV	O
on	O	ADP	O
megakaryocytopoiesis	O	NOUN	B
.	O	PUNCT	O


Preclinical	O	ADJ	B
and	O	CCONJ	O
clinical	O	ADJ	B
studies	O	NOUN	I
demonstrate	O	VERB	O
the	O	DET	O
potential	O	ADJ	B
use	O	NOUN	O
of	O	ADP	O
TPO	B-protein	NOUN	B
in	O	ADP	O
a	O	DET	O
variety	O	NOUN	O
of	O	ADP	O
contexts	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
it	O	PRON	O
is	O	AUX	O
too	O	ADV	O
early	O	ADJ	O
to	O	PART	O
evaluate	O	VERB	B
its	O	PRON	O
benefit	O	NOUN	B
in	O	ADP	O
reducing	O	VERB	B
platelet	O	NOUN	B
transfusion	O	NOUN	I
.	O	PUNCT	O


Previously	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
shown	O	VERB	O
that	O	SCONJ	O
TAL1	B-protein	NOUN	B
and	O	CCONJ	O
the	O	DET	O
LIM-only	B-DNA	ADJ	B
protein	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
(	O	PUNCT	O
LMO	B-DNA	NOUN	B
)	O	PUNCT	O
are	O	AUX	O
regularly	O	ADV	O
coactivated	O	VERB	O
in	O	ADP	O
T-cell	O	NOUN	B
acute	O	ADJ	I
lymphoblastic	O	ADJ	I
leukemia	O	NOUN	I
(	O	PUNCT	O
T-ALL	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


As	O	ADP	O
a	O	DET	O
step	O	NOUN	O
toward	O	ADP	O
elucidating	O	VERB	O
the	O	DET	O
pathophysiological	O	ADJ	B
background	O	NOUN	B
of	O	ADP	O
the	O	DET	O
so-called	O	ADJ	O
glucose	O	NOUN	B
toxicity	O	NOUN	B
to	O	PART	O
pancreatic	B-cell_type	ADJ	B
beta	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
induced	O	VERB	B
glycation	O	NOUN	B
in	O	ADP	O
HIT-T15	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
using	O	VERB	O
a	O	DET	O
sugar	O	NOUN	B
with	O	ADP	O
strong	O	ADJ	O
deoxidizing	O	NOUN	B
activity	O	NOUN	I
,	O	PUNCT	O
D-ribose	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
examined	O	VERB	B
the	O	DET	O
effects	O	NOUN	B
on	O	ADP	O
insulin	O	NOUN	B
gene	O	NOUN	I
transcription	O	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
agreement	O	NOUN	O
with	O	ADP	O
this	O	DET	O
,	O	PUNCT	O
decrease	O	NOUN	B
in	O	ADP	O
the	O	DET	O
insulin	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
and	O	CCONJ	O
insulin	O	NOUN	B
content	O	NOUN	B
was	O	AUX	O
observed	O	VERB	O
in	O	ADP	O
the	O	DET	O
glycation-induced	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


OBJECTIVE	O	NOUN	B
:	O	PUNCT	O
The	O	DET	O
NF-kappa	B-protein	NOUN	B
B/Rel	I-protein	NOUN	B
family	I-protein	NOUN	B
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
regulates	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
many	O	ADJ	O
genes	O	NOUN	B
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
immune	O	ADJ	B
or	O	CCONJ	O
inflammatory	O	ADJ	B
response	O	NOUN	I
at	O	ADP	O
the	O	DET	O
transcriptional	O	ADJ	B
level	O	NOUN	B
.	O	PUNCT	O


CONCLUSION	O	NOUN	O
:	O	PUNCT	O
Overall	O	ADV	B
,	O	PUNCT	O
the	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
may	O	AUX	O
play	O	VERB	O
a	O	DET	O
central	O	ADJ	O
part	O	NOUN	O
in	O	ADP	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
infiltrating	B-cell_type	VERB	B
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
in	O	ADP	O
chronic	O	ADJ	B
rheumatoid	O	ADJ	I
arthritis	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
rapid	O	ADJ	O
expansion	O	NOUN	B
of	O	ADP	O
the	O	DET	O
number	O	NOUN	O
of	O	ADP	O
women	O	NOUN	B
now	O	ADV	O
suitable	O	ADJ	O
for	O	ADP	O
X	O	NOUN	B
inactivation	O	NOUN	I
analysis	O	NOUN	I
has	O	AUX	O
however	O	ADV	O
given	O	VERB	O
rise	O	NOUN	O
to	O	ADP	O
new	O	ADJ	O
controversies	O	NOUN	B
,	O	PUNCT	O
one	O	NUM	O
of	O	ADP	O
the	O	DET	O
more	O	ADV	O
troublesome	O	ADJ	O
being	O	AUX	O
the	O	DET	O
possibility	O	NOUN	O
of	O	ADP	O
a	O	DET	O
modification	O	NOUN	B
of	O	ADP	O
the	O	DET	O
pattern	O	NOUN	B
of	O	ADP	O
X-	B-DNA	NOUN	B
chromosome	I-DNA	NOUN	I
inactivation	O	NOUN	I
pattern	O	NOUN	B
in	O	ADP	O
blood	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
of	O	ADP	O
elderly	O	ADJ	B
women	O	NOUN	I
.	O	PUNCT	O


Type	B-protein	NOUN	B
I	I-protein	NUM	I
IFNs	I-protein	NOUN	I
(	O	PUNCT	O
IFN-alpha/beta	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
in	O	ADP	O
addition	O	NOUN	O
to	O	PART	O
IL-12	B-protein	NOUN	B
,	O	PUNCT	O
have	O	AUX	O
been	O	AUX	O
shown	O	VERB	O
to	O	PART	O
play	O	VERB	O
an	O	DET	O
important	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
differentiation	O	NOUN	B
of	O	ADP	O
human	O	ADJ	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
mouse	O	NOUN	B
,	O	PUNCT	O
Th	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
restimulation	O	NOUN	B
of	O	ADP	O
human	B-cell_line	ADJ	B
Th2	I-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
and	O	CCONJ	O
clones	O	NOUN	B
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
IFN-alpha	B-protein	NOUN	B
does	O	AUX	O
not	O	PART	O
induce	O	VERB	B
the	O	DET	O
production	O	NOUN	B
of	O	ADP	O
IFN-gamma	B-protein	NOUN	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
activation	O	NOUN	B
of	O	ADP	O
Stat4	B-protein	NOUN	B
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
necessary	O	ADJ	O
for	O	ADP	O
the	O	DET	O
differentiation	O	NOUN	B
of	O	ADP	O
naive	B-cell_type	ADJ	B
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
into	O	ADP	O
polarized	O	VERB	B
Th1	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
is	O	AUX	O
not	O	PART	O
sufficient	O	ADJ	O
to	O	PART	O
induce	O	VERB	B
phenotype	O	NOUN	B
reversal	O	NOUN	B
of	O	ADP	O
human	B-cell_type	ADJ	B
Th2	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
.	O	PUNCT	O


Molecular	O	ADJ	B
cloning	O	NOUN	I
of	O	ADP	O
FKHRL1P2	B-protein	NOUN	B
,	O	PUNCT	O
a	O	DET	O
member	O	NOUN	O
of	O	ADP	O
the	O	DET	O
developmentally	O	ADV	B
regulated	O	VERB	I
fork	B-protein	NOUN	I
head	I-protein	NOUN	I
domain	I-protein	NOUN	I
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
family	I-protein	NOUN	I
.	O	PUNCT	O


Inhibition	O	NOUN	B
of	O	ADP	O
Th1	O	NOUN	B
development	O	NOUN	B
mediated	O	VERB	O
by	O	ADP	O
GATA-3	B-protein	NOUN	B
through	O	ADP	O
an	O	DET	O
IL-4-independent	O	ADJ	B
mechanism	O	NOUN	B
.	O	PUNCT	O


Recently	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
GATA-3	B-protein	NOUN	B
was	O	AUX	O
shown	O	VERB	O
to	O	PART	O
be	O	AUX	O
selectively	O	ADV	O
expressed	O	VERB	B
in	O	ADP	O
Th2	O	NOUN	B
but	O	CCONJ	O
not	O	PART	O
Th1	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
to	O	PART	O
augment	O	VERB	O
Th2-specific	B-protein	ADJ	B
cytokines	I-protein	NOUN	B
.	O	PUNCT	O


GATA-3	B-protein	NOUN	B
inhibits	O	VERB	B
Th1	B-protein	NOUN	B
cytokines	I-protein	NOUN	B
by	O	ADP	O
a	O	DET	O
cell-intrinsic	O	ADJ	B
mechanism	O	NOUN	B
that	O	PRON	O
is	O	AUX	O
not	O	PART	O
dependent	O	ADJ	O
on	O	ADP	O
IL-4	B-protein	NOUN	B
and	O	CCONJ	O
that	O	DET	O
may	O	AUX	O
involve	O	VERB	O
repression	O	NOUN	B
of	O	ADP	O
IL-12	B-protein	NOUN	B
signaling	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
domains	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
have	O	AUX	O
been	O	AUX	O
characterized	O	VERB	B
as	O	ADP	O
DNase	B-DNA	NOUN	B
I	I-DNA	NUM	I
hypersensitive	I-DNA	ADJ	O
sites	I-DNA	NOUN	O
(	O	PUNCT	O
HSs	B-DNA	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
comprise	O	VERB	O
the	O	DET	O
active	O	ADJ	B
elements	O	NOUN	I
of	O	ADP	O
the	O	DET	O
LCR	B-DNA	NOUN	B
.	O	PUNCT	O


Cloning	O	NOUN	B
of	O	ADP	O
ARE-containing	B-DNA	ADJ	B
genes	I-DNA	NOUN	I
by	O	ADP	O
AU-motif-directed	O	ADJ	B
display	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
motifs	O	NOUN	B
are	O	AUX	O
regulatory	B-DNA	ADJ	B
sequences	I-DNA	NOUN	I
within	O	ADP	O
the	O	DET	O
so-called	O	ADJ	O
AU-rich	B-DNA	ADJ	O
elements	I-DNA	NOUN	O
(	O	PUNCT	O
AREs	B-DNA	NOUN	B
)	O	PUNCT	O
often	O	ADV	O
found	O	VERB	O
in	O	ADP	O
3	B-DNA	NUM	O
'	I-DNA	PART	O
untranslated	I-DNA	ADJ	B
regions	I-DNA	NOUN	I
of	O	ADP	O
genes	O	NOUN	B
such	O	ADJ	O
as	O	ADP	O
cytokines	B-protein	NOUN	B
,	O	PUNCT	O
proto-oncogenes	B-DNA	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
.	O	PUNCT	O


It	O	PRON	O
has	O	AUX	O
been	O	AUX	O
applied	O	VERB	O
to	O	PART	O
peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
monocytes	I-cell_type	NOUN	O
and	O	CCONJ	O
a	O	DET	O
T	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
clone	I-cell_line	NOUN	O
to	O	PART	O
isolate	O	VERB	B
59	B-DNA	NUM	O
cDNA	I-DNA	NOUN	B
fragments	I-DNA	NOUN	B
associated	O	VERB	B
to	O	PART	I
activation	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
tissular	O	ADJ	B
patterns	O	NOUN	B
of	O	ADP	O
CIITA	O	NOUN	B
and	O	CCONJ	O
MHC	O	NOUN	B
class	O	NOUN	I
II	O	NUM	I
gene	O	NOUN	B
expression	O	NOUN	I
are	O	AUX	O
tightly	O	ADV	O
correlated	O	VERB	B
:	O	PUNCT	O
CIITA	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
is	O	AUX	O
highly	O	ADV	O
expressed	O	VERB	B
in	O	ADP	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
is	O	AUX	O
induced	O	VERB	B
by	O	ADP	O
interferon	B-protein	NOUN	B
gamma	I-protein	NOUN	I
(	O	PUNCT	I
IFN-gamma	B-protein	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
macrophage	B-cell_line	NOUN	B
and	I-cell_line	CCONJ	O
epithelial	I-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
.	O	PUNCT	O


eGLs	B-cell_type	NOUN	B
are	O	AUX	O
evidently	O	ADV	O
functionally	O	ADV	O
important	O	ADJ	O
in	O	ADP	O
the	O	DET	O
eutopic	O	ADJ	B
endometrium	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
group	B-cell_line	NOUN	B
I	I-cell_line	NUM	I
BL	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
containing	O	VERB	O
low	O	ADJ	B
levels	O	NOUN	B
of	O	ADP	O
NF-kappaB	B-protein	NOUN	B
,	O	PUNCT	O
only	O	ADV	O
RBP	B-protein	NOUN	B
binding	O	NOUN	B
was	O	AUX	O
observed	O	VERB	O
in	O	ADP	O
EMSAs	O	NOUN	B
,	O	PUNCT	O
whereas	O	SCONJ	O
NF-kappaB	B-protein	NOUN	B
binding	O	NOUN	O
could	O	AUX	O
be	O	AUX	O
demonstrated	O	VERB	O
in	O	ADP	O
EBV-transformed	B-cell_line	ADJ	B
B	I-cell_line	NOUN	I
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
containing	O	VERB	O
high	O	ADJ	O
levels	O	NOUN	B
of	O	ADP	O
activated	O	VERB	B
NF-kappaB	B-protein	NOUN	B
.	O	PUNCT	O


Flow	O	NOUN	B
cytometric	O	ADJ	I
and	O	CCONJ	O
morphological	O	ADJ	B
analyses	O	NOUN	I
demonstrated	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
addition	O	NOUN	O
of	O	ADP	O
CD70	O	NOUN	B
transfectants	O	NOUN	B
to	O	PART	O
B	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
cultures	I-cell_line	NOUN	O
remarkably	O	ADV	O
promoted	O	VERB	O
differentiation	O	NOUN	B
into	O	ADP	O
plasma	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
IL-4	B-protein	NOUN	B
and	O	CCONJ	O
CD40	B-protein	NOUN	B
signaling	O	NOUN	B
.	O	PUNCT	O


Much	O	ADJ	O
attention	O	NOUN	B
has	O	AUX	O
focused	O	VERB	O
on	O	ADP	O
the	O	DET	O
series	O	NOUN	B
of	O	ADP	O
sequence	O	NOUN	B
elements	O	NOUN	I
upstream	O	ADJ	B
of	O	ADP	O
the	O	DET	O
transcriptional	B-DNA	ADJ	B
initiation	I-DNA	NOUN	O
site	I-DNA	NOUN	O
in	O	ADP	O
the	O	DET	O
U3	B-DNA	NOUN	B
region	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
LTR	B-DNA	NOUN	B
including	O	VERB	O
the	O	DET	O
Sp1	B-protein	NOUN	B
and	O	CCONJ	O
NF-kappaB	B-protein	NOUN	B
binding	B-DNA	NOUN	I
sites	I-DNA	NOUN	I
.	O	PUNCT	O


Recent	O	ADJ	O
studies	O	NOUN	B
,	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
demonstrate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
transcribed	O	VERB	B
5'-untranslated	B-DNA	ADJ	B
leader	I-DNA	NOUN	I
region	I-DNA	NOUN	I
(	O	PUNCT	O
5'-UTR	B-DNA	NOUN	B
)	O	PUNCT	O
also	O	ADV	O
contains	O	VERB	O
important	O	ADJ	O
transcriptional	B-DNA	ADJ	B
elements	I-DNA	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
propose	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
inducible	B-DNA	ADJ	B
transcription	I-DNA	NOUN	O
factor	I-DNA	NOUN	O
binding	I-DNA	NOUN	O
sites	I-DNA	NOUN	O
in	O	ADP	O
the	O	DET	O
5'-UTR	B-DNA	NOUN	B
comprise	O	VERB	O
a	O	DET	O
downstream	B-DNA	ADJ	B
enhancer	I-DNA	NOUN	O
domain	I-DNA	NOUN	O
that	O	PRON	O
can	O	AUX	O
function	O	VERB	B
independent	O	ADJ	B
of	O	ADP	O
,	O	PUNCT	O
or	O	CCONJ	O
in	O	ADP	O
concert	O	NOUN	O
with	O	ADP	O
,	O	PUNCT	O
the	O	DET	O
LTR	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
to	O	PART	O
rapidly	O	ADV	O
increase	O	VERB	B
latent	O	ADJ	B
proviral	O	ADJ	B
transcription	O	NOUN	I
in	O	ADP	O
response	O	NOUN	O
to	O	PART	O
cell	O	NOUN	B
activation	O	NOUN	I
signals	O	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
review	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
describe	O	VERB	O
the	O	DET	O
host-cell	B-protein	ADJ	B
transcription	I-protein	NOUN	I
factors	I-protein	NOUN	I
that	O	PRON	O
interact	O	VERB	B
with	O	ADP	O
the	O	DET	O
5'-UTR	B-DNA	NOUN	B
and	O	CCONJ	O
discuss	O	VERB	O
their	O	PRON	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
transcriptional	O	ADJ	B
regulation	O	NOUN	I
of	O	ADP	O
HIV-1	O	NOUN	B
gene	O	NOUN	B
expression	O	NOUN	I
.	O	PUNCT	O


LOX-1	B-protein	NOUN	B
is	O	AUX	O
an	O	DET	O
endothelial	B-protein	ADJ	B
receptor	I-protein	NOUN	I
for	O	ADP	O
oxidized	B-protein	VERB	B
low-density	I-protein	ADJ	I
lipoprotein	I-protein	NOUN	I
that	O	PRON	O
plays	O	VERB	O
essential	O	ADJ	O
roles	O	NOUN	O
in	O	ADP	O
atherogenesis	O	NOUN	B
.	O	PUNCT	O


Fluorescence	O	NOUN	B
in	O	X	B
situ	O	X	I
hybridization	O	NOUN	I
and	O	CCONJ	O
analyses	O	NOUN	B
of	O	ADP	O
a	O	DET	O
yeast	O	NOUN	B
artificial	O	ADJ	B
chromosome	O	NOUN	I
contig	O	NOUN	I
revealed	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
human	B-DNA	ADJ	B
LOX-1	I-DNA	NOUN	B
gene	I-DNA	NOUN	I
is	O	AUX	O
located	O	ADJ	O
in	O	ADP	O
the	O	DET	O
natural	B-protein	ADJ	B
killer	I-protein	NOUN	I
gene	I-protein	NOUN	I
complex	I-protein	NOUN	I
on	O	ADP	O
chromosome	B-DNA	NOUN	B
12p12-p13	I-DNA	NOUN	I
,	O	PUNCT	O
where	O	SCONJ	O
the	O	DET	O
genes	O	NOUN	B
of	O	ADP	O
the	O	DET	O
natural	B-protein	ADJ	B
killer	I-protein	NOUN	I
cell	I-protein	NOUN	I
receptors	I-protein	NOUN	I
cluster	O	VERB	O
.	O	PUNCT	O


A	O	DET	O
1753-bp	B-DNA	ADJ	O
fragment	I-DNA	NOUN	O
of	O	ADP	O
the	O	DET	O
5	B-DNA	NUM	O
'	I-DNA	PART	O
flanking	I-DNA	ADJ	B
region	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
LOX-1	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
had	O	AUX	O
a	O	DET	O
functional	O	ADJ	B
promoter	O	NOUN	B
activity	O	NOUN	I
.	O	PUNCT	O


This	O	DET	O
region	O	NOUN	B
contains	O	VERB	O
binding	B-DNA	VERB	B
sites	I-DNA	NOUN	I
for	O	ADP	O
several	O	ADJ	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
the	O	DET	O
STAT	B-protein	NOUN	B
family	I-protein	NOUN	I
and	O	CCONJ	O
NF-IL6	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
LOX-1	B-protein	NOUN	B
was	O	AUX	O
upregulated	O	VERB	B
by	O	ADP	O
several	O	ADJ	O
cytokines	B-protein	NOUN	B
.	O	PUNCT	O


Copyright	O	NOUN	O
1998	O	NUM	O
Academic	O	PROPN	B
Press	O	PROPN	I
.	O	PUNCT	O


The	O	DET	O
beta-casein	B-DNA	NOUN	B
promoter	I-DNA	NOUN	O
has	O	AUX	O
been	O	AUX	O
widely	O	ADV	O
used	O	VERB	O
to	O	PART	O
monitor	O	VERB	B
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
STAT	B-protein	NOUN	B
(	I-protein	PUNCT	O
signal	I-protein	NOUN	B
transducer	I-protein	NOUN	I
and	I-protein	CCONJ	O
activator	I-protein	NOUN	O
of	I-protein	ADP	O
transcription	I-protein	NOUN	O
)	I-protein	PUNCT	O
5	I-protein	NUM	O
since	O	SCONJ	O
STAT5	B-protein	NOUN	B
was	O	AUX	O
originally	O	ADV	O
found	O	VERB	O
as	O	ADP	O
a	O	DET	O
mediator	O	NOUN	O
of	O	ADP	O
PRL-inducible	O	ADJ	B
beta-casein	B-protein	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


IL-2	B-protein	NOUN	B
-induced	O	ADJ	O
beta-casein	B-protein	NOUN	B
expression	O	NOUN	B
was	O	AUX	O
enhanced	O	VERB	O
by	O	ADP	O
dexamethasone	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
this	O	DET	O
synergistic	O	ADJ	B
effect	O	NOUN	O
of	O	ADP	O
Dexamethasone	O	NOUN	B
requires	O	VERB	O
the	O	DET	O
sequence	O	NOUN	B
between	O	ADP	O
-155	B-DNA	NUM	O
and	I-DNA	CCONJ	O
-193	I-DNA	NUM	O
in	O	ADP	O
the	O	DET	O
beta-casein	B-DNA	NOUN	B
promoter	I-DNA	NOUN	O
.	O	PUNCT	O


Coincidentally	O	ADV	B
,	O	PUNCT	O
a	O	DET	O
deletion	O	NOUN	B
of	O	ADP	O
this	O	DET	O
region	O	NOUN	B
enhanced	O	VERB	B
the	O	DET	O
IL-2	B-protein	NOUN	B
-induced	O	ADJ	O
expression	O	NOUN	B
of	O	ADP	O
beta-casein	B-protein	NOUN	B
.	O	PUNCT	O


Expression	O	NOUN	B
of	O	ADP	O
an	O	DET	O
active	O	ADJ	B
form	O	NOUN	I
of	O	ADP	O
Ras	B-protein	NOUN	B
,	O	PUNCT	O
Ras	B-protein	NOUN	B
(	I-protein	PUNCT	O
G12V	I-protein	NOUN	B
)	I-protein	PUNCT	O
,	O	PUNCT	O
suppressed	O	VERB	B
the	O	DET	O
IL-2	B-protein	NOUN	B
-induced	O	ADJ	O
beta-casein	B-protein	NOUN	B
and	O	CCONJ	O
OSM	B-protein	NOUN	B
gene	O	NOUN	O
expression	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
negative	O	ADJ	B
effect	O	NOUN	B
of	O	ADP	O
Ras	B-protein	NOUN	B
is	O	AUX	O
mediated	O	VERB	O
by	O	ADP	O
the	O	DET	O
region	O	NOUN	B
between	O	ADP	O
-105	B-DNA	NUM	O
and	I-DNA	CCONJ	O
-193	I-DNA	NUM	O
in	O	ADP	O
the	O	DET	O
beta-casein	B-DNA	NOUN	B
promoter	I-DNA	NOUN	O
.	O	PUNCT	O


Engagement	O	NOUN	B
of	O	ADP	O
any	O	DET	O
of	O	ADP	O
these	O	DET	O
receptors	O	NOUN	B
induces	O	VERB	B
the	O	DET	O
rapid	O	ADJ	O
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	B
of	O	ADP	O
a	O	DET	O
shared	O	VERB	O
group	O	NOUN	B
of	O	ADP	O
intracellular	B-protein	ADJ	B
signaling	I-protein	NOUN	B
proteins	I-protein	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
Vav	B-protein	NOUN	B
,	O	PUNCT	O
Cbl	B-protein	NOUN	B
,	O	PUNCT	O
p85	B-protein	NOUN	B
phosphoinositide	I-protein	NOUN	I
3-kinase	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
Src	B-protein	NOUN	B
family	I-protein	NOUN	B
kinases	I-protein	NOUN	I
Lck	B-protein	NOUN	I
and	O	CCONJ	O
Fyn	B-protein	NOUN	B
.	O	PUNCT	O


Costimulation	O	NOUN	B
through	O	ADP	O
CD28	B-protein	NOUN	B
and/or	O	CCONJ	O
CD2	B-protein	NOUN	B
did	O	AUX	O
not	O	PART	O
modulate	O	VERB	O
the	O	DET	O
CD3	B-protein	NOUN	B
-dependent	O	ADJ	O
phosphorylation	O	NOUN	B
of	O	ADP	O
HS1	B-protein	NOUN	B
.	O	PUNCT	O


RESULTS	O	NOUN	B
:	O	PUNCT	O
Cord	O	NOUN	B
lymphocytes	O	NOUN	I
revealed	O	VERB	O
a	O	DET	O
greater	O	ADJ	O
proliferation	O	NOUN	B
rate	O	NOUN	B
with	O	ADP	O
PHA	B-protein	NOUN	B
and	O	CCONJ	O
alphaCD3	B-protein	NOUN	B
than	O	ADP	O
adult	O	ADJ	B
lymphocytes	O	NOUN	B
(	O	PUNCT	O
p	O	NOUN	O
=	O	ADJ	O
0.0081	O	NUM	O
and	O	CCONJ	O
0.0023	O	NUM	O
,	O	PUNCT	O
respectively	O	ADV	O
)	O	PUNCT	O
.	O	PUNCT	O


CONCLUSION	O	NOUN	O
:	O	PUNCT	O
Although	O	SCONJ	O
cord	B-cell_type	NOUN	B
lymphocyte	I-cell_type	NOUN	B
proliferation	O	NOUN	I
rates	O	NOUN	B
were	O	AUX	O
significantly	O	ADV	O
greater	O	ADJ	O
than	O	ADP	O
those	O	DET	O
of	O	ADP	O
adult	O	ADJ	B
lymphocytes	O	NOUN	B
following	O	VERB	O
stimulation	O	NOUN	B
,	O	PUNCT	O
lymphocyte	O	NOUN	B
activation	O	NOUN	I
,	O	PUNCT	O
as	O	ADP	O
analyzed	O	VERB	B
by	O	ADP	O
c-fos	O	NOUN	B
and	O	CCONJ	O
c-jun	O	NOUN	B
mRNA	O	NOUN	B
expression	O	NOUN	B
,	O	PUNCT	O
appears	O	VERB	O
similar	O	ADJ	O
in	O	ADP	O
both	O	CCONJ	O
cord	O	NOUN	B
and	O	CCONJ	O
adult	O	ADJ	B
samples	O	NOUN	B
.	O	PUNCT	O


Using	O	VERB	O
the	O	DET	O
specific	O	ADJ	O
MAPK	B-protein	NOUN	B
/extracellular	O	ADJ	O
signal-regulated	O	ADJ	B
kinase	O	NOUN	I
kinase	O	NOUN	I
(	O	PUNCT	O
MAPK	O	NOUN	B
kinase	O	NOUN	I
)	O	PUNCT	O
inhibitor	O	NOUN	B
PD98059	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
found	O	VERB	O
that	O	SCONJ	O
MAPK	B-protein	NOUN	B
activation	O	NOUN	B
is	O	AUX	O
necessary	O	ADJ	O
for	O	ADP	O
FcR	B-protein	NOUN	B
-dependent	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
NF-kappaB	B-protein	NOUN	I
.	O	PUNCT	O


Accordingly	O	ADV	O
,	O	PUNCT	O
an	O	DET	O
expanded	O	VERB	O
survey	O	NOUN	B
in	O	ADP	O
lymphoid	O	ADJ	B
malignancies	O	NOUN	I
showed	O	VERB	O
that	O	SCONJ	O
BCL-6	B-protein	NOUN	B
mutations	O	NOUN	B
are	O	AUX	O
restricted	O	ADJ	O
to	O	PART	O
B	O	NOUN	B
cell	O	NOUN	I
tumors	O	NOUN	I
displaying	O	VERB	O
GC	O	NOUN	B
or	O	CCONJ	O
post-GC	O	ADJ	B
phenotype	O	NOUN	B
and	O	CCONJ	O
carrying	O	VERB	O
mutated	B-DNA	VERB	B
Ig	I-DNA	NOUN	O
variable	I-DNA	ADJ	O
heavy	I-DNA	ADJ	O
chain	I-DNA	NOUN	O
sequences	I-DNA	NOUN	O
.	O	PUNCT	O


Since	O	SCONJ	O
neither	O	CCONJ	O
DNA	O	NOUN	B
binding	O	NOUN	I
nor	O	CCONJ	O
protein	O	NOUN	B
dimerization	O	NOUN	I
through	O	ADP	O
the	O	DET	O
bZIP	B-protein	NOUN	B
domain	I-protein	NOUN	O
of	O	ADP	O
HLF	B-protein	NOUN	B
is	O	AUX	O
required	O	VERB	O
for	O	ADP	O
this	O	DET	O
effect	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
propose	O	VERB	O
mechanisms	O	NOUN	B
whereby	O	SCONJ	O
protein-protein	O	ADJ	B
interactions	O	NOUN	I
with	O	ADP	O
the	O	DET	O
amino-terminal	O	ADJ	B
region	O	NOUN	I
of	O	ADP	O
E2A	B-protein	NOUN	B
allow	O	VERB	O
the	O	DET	O
chimera	B-protein	NOUN	B
to	O	PART	O
act	O	VERB	O
as	O	ADP	O
a	O	DET	O
transcriptional	O	ADJ	B
cofactor	O	NOUN	I
to	O	PART	O
alter	O	VERB	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
genes	O	NOUN	B
regulating	O	VERB	B
the	O	DET	O
apoptotic	O	ADJ	B
machinery	O	NOUN	I
in	O	ADP	O
pro-B	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Hepatocytes	O	NOUN	B
achieve	O	VERB	O
an	O	DET	O
efficient	O	ADJ	B
hormonal	O	ADJ	B
control	O	NOUN	I
of	O	ADP	O
this	O	DET	O
promoter	O	NOUN	B
through	O	ADP	O
a	O	DET	O
functional	O	ADJ	B
interaction	O	NOUN	B
between	O	ADP	O
the	O	DET	O
estrogen	B-DNA	NOUN	B
responsive	I-DNA	ADJ	I
elements	I-DNA	NOUN	I
and	O	CCONJ	O
a	O	DET	O
promoter	B-DNA	NOUN	B
proximal	I-DNA	ADJ	I
region	I-DNA	NOUN	I
upstream	O	ADJ	O
of	O	ADP	O
the	O	DET	O
TATA	B-DNA	NOUN	B
box	I-DNA	NOUN	O
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
characterized	O	VERB	B
by	O	ADP	O
a	O	DET	O
high	O	ADJ	B
density	O	NOUN	I
of	O	ADP	O
binding	O	VERB	B
sites	O	NOUN	I
for	O	ADP	O
the	O	DET	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
CTF/NF-1	B-protein	NOUN	B
,	O	PUNCT	O
C/EBP	B-protein	NOUN	B
and	O	CCONJ	O
HNF3	B-protein	NOUN	B
.	O	PUNCT	O


Finally	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
observed	O	VERB	O
that	O	SCONJ	O
activated	O	VERB	B
STAT5a	B-protein	NOUN	B
and	O	CCONJ	O
STAT5b	B-protein	NOUN	B
proteins	O	NOUN	I
form	O	VERB	O
distinct	O	ADJ	O
Fc	O	NOUN	B
gamma	O	NOUN	I
RI	O	NOUN	I
GAS	O	NOUN	B
binding	O	NOUN	I
patterns	O	NOUN	O
in	O	ADP	O
T	B-cell_type	NOUN	B
and	I-cell_type	CCONJ	O
NK	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
they	O	PRON	O
might	O	AUX	O
have	O	AUX	O
different	O	ADJ	O
roles	O	NOUN	O
in	O	ADP	O
gene	O	NOUN	B
regulation	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
regulatory	B-DNA	ADJ	B
element	I-DNA	NOUN	I
in	O	ADP	O
the	O	DET	O
CD95	B-DNA	NOUN	B
(	I-DNA	PUNCT	O
APO-1/Fas	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
ligand	I-DNA	NOUN	B
promoter	I-DNA	NOUN	B
is	O	AUX	O
essential	O	ADJ	O
for	O	ADP	O
responsiveness	O	NOUN	B
to	O	PART	O
TCR	B-protein	NOUN	B
-mediated	O	ADJ	O
activation	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
mechanism	O	NOUN	B
by	O	ADP	O
which	O	DET	O
progesterone	O	NOUN	B
causes	O	VERB	O
localized	O	ADJ	B
suppression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
immune	O	ADJ	B
response	O	NOUN	I
during	O	ADP	O
pregnancy	O	NOUN	B
has	O	AUX	O
remained	O	VERB	O
elusive	O	ADJ	O
.	O	PUNCT	O


We	O	PRON	O
propose	O	VERB	O
that	O	SCONJ	O
direct	O	ADJ	O
inhibition	O	NOUN	B
of	O	ADP	O
K+	B-protein	NOUN	B
channels	I-protein	NOUN	I
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
by	O	ADP	O
progesterone	O	NOUN	B
contributes	O	VERB	O
to	O	PART	O
progesterone-induced	O	ADJ	B
immunosuppression	O	NOUN	I
.	O	PUNCT	O


Transgenic	O	ADJ	B
mice	O	NOUN	I
with	O	ADP	O
human	B-DNA	ADJ	B
CD3epsilon	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
have	O	AUX	O
been	O	AUX	O
shown	O	VERB	O
to	O	PART	O
exhibit	O	VERB	O
early	O	ADJ	O
arrest	O	NOUN	B
of	O	ADP	O
T	O	NOUN	B
cell	O	NOUN	I
development	O	NOUN	B
in	O	ADP	O
the	O	DET	O
thymus	O	NOUN	B
.	O	PUNCT	O


In	O	X	B
vitro	O	X	I
studies	O	NOUN	B
identify	O	VERB	O
three	O	NUM	O
essential	O	ADJ	B
elements	O	NOUN	I
of	O	ADP	O
the	O	DET	O
TATA-less	B-DNA	ADJ	B
blr1	I-DNA	NOUN	B
core	I-DNA	NOUN	B
promoter	I-DNA	NOUN	I
that	O	PRON	O
confer	O	VERB	O
cell	O	NOUN	B
type-	O	NOUN	I
and	O	CCONJ	O
differentiation-specific	O	ADJ	O
expression	O	NOUN	O
in	O	ADP	O
the	O	DET	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
of	O	ADP	O
both	O	CCONJ	O
humans	O	NOUN	B
and	O	CCONJ	O
mice	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
functional	B-DNA	ADJ	B
promoter	I-DNA	NOUN	B
region	I-DNA	NOUN	I
(	O	PUNCT	O
-36	O	NUM	O
with	O	ADP	O
respect	O	NOUN	O
to	O	PART	O
the	O	DET	O
transcription	B-DNA	NOUN	B
start	I-DNA	NOUN	O
site	I-DNA	NOUN	O
)	O	PUNCT	O
,	O	PUNCT	O
a	O	DET	O
NF-kappaB	B-DNA	NOUN	B
motif	I-DNA	NOUN	I
(	O	PUNCT	O
+44	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
noncanonical	B-DNA	ADJ	B
octamer	I-DNA	NOUN	I
motif	I-DNA	NOUN	I
(	O	PUNCT	O
+157	O	NUM	B
)	O	PUNCT	O
.	O	PUNCT	O


CD4	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
transactivation	O	NOUN	I
by	O	ADP	O
human	O	ADJ	B
herpesvirus	O	NOUN	I
6	O	NUM	I
.	O	PUNCT	O


Our	O	PRON	O
objective	O	NOUN	B
was	O	AUX	O
to	O	PART	O
identify	O	VERB	O
the	O	DET	O
mechanisms	O	NOUN	B
underlying	O	VERB	O
such	O	ADJ	O
phenomena	O	NOUN	B
.	O	PUNCT	O


Neutrophil	O	NOUN	B
maturation	O	NOUN	B
was	O	AUX	O
impaired	O	ADJ	B
in	O	ADP	O
PEBP2betaMYH11	B-protein	NOUN	B
transgenic	O	ADJ	B
mice	O	NOUN	I
.	O	PUNCT	O


Human	O	ADJ	B
T	O	NOUN	O
cell	O	NOUN	O
leukemia	O	NOUN	O
virus-I	O	NOUN	B
(	O	PUNCT	O
HTLV-I	O	NOUN	B
)	O	PUNCT	O
Tax	B-protein	NOUN	B
-mediated	O	ADJ	O
apoptosis	O	NOUN	B
in	O	ADP	O
activated	B-cell_type	VERB	B
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
requires	O	VERB	O
an	O	DET	O
enhanced	O	VERB	O
intracellular	O	ADJ	B
prooxidant	O	ADJ	B
state	O	NOUN	I
.	O	PUNCT	O


Additional	O	ADJ	O
stimulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
CD3	B-protein	NOUN	B
/TCR	B-protein	NOUN	I
pathway	O	NOUN	B
enhances	O	VERB	B
the	O	DET	O
oxidative	O	ADJ	B
and	O	CCONJ	O
apoptotic	O	ADJ	B
effects	O	NOUN	O
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
inhibition	O	NOUN	B
of	O	ADP	O
protein	O	NOUN	B
synthesis	O	NOUN	I
with	O	ADP	O
cycloheximide	O	NOUN	B
anytime	O	ADV	B
during	O	ADP	O
the	O	DET	O
first	O	ADJ	O
18	O	NUM	O
h	O	NOUN	O
of	O	ADP	O
steroid	O	NOUN	B
treatment	O	NOUN	B
was	O	AUX	O
as	O	ADP	O
effective	O	ADJ	B
in	O	ADP	O
blocking	O	VERB	B
chromatin	O	NOUN	B
fragmentation	O	NOUN	I
as	O	ADP	O
inhibition	O	NOUN	B
for	O	ADP	O
the	O	DET	O
entire	O	ADJ	O
period	O	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
synthesis	O	NOUN	B
of	O	ADP	O
a	O	DET	O
component	O	NOUN	B
with	O	ADP	O
a	O	DET	O
rapid	O	ADJ	O
turnover	O	NOUN	B
rate	O	NOUN	O
is	O	AUX	O
required	O	VERB	O
.	O	PUNCT	O


It	O	PRON	O
was	O	AUX	O
proposed	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
mechanism	O	NOUN	B
of	O	ADP	O
antiviral	O	ADJ	B
action	O	NOUN	I
of	O	ADP	O
S9a	O	NOUN	B
was	O	AUX	O
on	O	ADP	O
the	O	DET	O
host	O	NOUN	B
cell	O	NOUN	I
,	O	PUNCT	O
by	O	ADP	O
blocking	O	VERB	B
TNF-alpha	B-protein	NOUN	B
transcription	O	NOUN	B
via	O	ADP	O
a	O	DET	O
Tat	B-protein	NOUN	B
-induced	O	ADJ	O
tar-independent	O	ADJ	B
loop	O	NOUN	O
,	O	PUNCT	O
which	O	DET	O
decreases	O	VERB	B
downstream	O	ADJ	B
NF-kappaB	B-protein	NOUN	B
activation	O	NOUN	B
of	O	ADP	O
HIV-1	B-DNA	NOUN	B
long	I-DNA	ADJ	B
terminal	I-DNA	ADJ	I
repeat	I-DNA	NOUN	I
(	O	PUNCT	I
LTR	B-DNA	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


We	O	PRON	O
determined	O	VERB	O
whether	O	SCONJ	O
Hsp70	B-protein	NOUN	B
induction	O	NOUN	B
by	O	ADP	O
TS	O	NOUN	B
was	O	AUX	O
mediated	O	VERB	O
by	O	ADP	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
HS	B-protein	NOUN	B
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
,	O	PUNCT	O
HSF	B-protein	NOUN	B
.	O	PUNCT	O


Th1	O	NOUN	B
and	O	CCONJ	O
Th2	O	NOUN	B
effector	O	NOUN	O
functions	O	NOUN	O
and	O	CCONJ	O
their	O	PRON	O
development	O	NOUN	B
are	O	AUX	O
attributable	O	ADJ	O
to	O	PART	O
their	O	PRON	O
distinct	O	ADJ	O
cytokine	B-protein	NOUN	B
expression	O	NOUN	O
patterns	O	NOUN	O
.	O	PUNCT	O


It	O	PRON	O
is	O	AUX	O
,	O	PUNCT	O
therefore	O	ADV	O
,	O	PUNCT	O
suggested	O	VERB	O
that	O	SCONJ	O
clarification	O	NOUN	B
of	O	ADP	O
the	O	DET	O
mechanisms	O	NOUN	B
of	O	ADP	O
differential	O	ADJ	O
gene	O	NOUN	B
expression	O	NOUN	I
in	O	ADP	O
Th1/Th2	B-cell_line	NOUN	B
should	O	AUX	O
lead	O	VERB	O
to	O	ADP	O
rational	O	ADJ	O
strategies	O	NOUN	O
for	O	ADP	O
manipulating	O	VERB	O
pathological	O	ADJ	B
immune	O	ADJ	B
responses	O	NOUN	I
.	O	PUNCT	O


Activation	O	NOUN	B
of	O	ADP	O
helper	B-cell_type	NOUN	B
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
mediated	O	VERB	O
by	O	ADP	O
the	O	DET	O
T	O	NOUN	B
cell	O	NOUN	I
receptor	O	NOUN	I
induces	O	VERB	B
a	O	DET	O
series	O	NOUN	O
of	O	ADP	O
biochemical	O	ADJ	B
events	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
molecular	O	ADJ	B
cloning	O	NOUN	I
of	O	ADP	O
the	O	DET	O
NFAT	B-protein	NOUN	B
family	I-protein	NOUN	O
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
has	O	AUX	O
facilitated	O	VERB	O
rapid	O	ADJ	O
progress	O	NOUN	B
in	O	ADP	O
the	O	DET	O
understanding	O	NOUN	O
of	O	ADP	O
the	O	DET	O
signalling	O	NOUN	B
mechanisms	O	NOUN	B
that	O	PRON	O
control	O	VERB	B
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
NFAT	B-protein	NOUN	B
.	O	PUNCT	O


Northern	O	ADJ	B
analysis	O	NOUN	I
confirmed	O	VERB	O
that	O	SCONJ	O
expression	O	NOUN	B
of	O	ADP	O
both	O	DET	O
mRNAs	B-RNA	NOUN	B
was	O	AUX	O
reduced	O	VERB	B
in	O	ADP	O
cells	O	NOUN	B
with	O	ADP	O
decreased	O	VERB	B
numbers	O	NOUN	O
of	O	ADP	O
VDR	B-protein	NOUN	B
.	O	PUNCT	O


Further	O	ADJ	O
Northern	O	ADJ	B
analyses	O	NOUN	I
indicated	O	VERB	O
that	O	SCONJ	O
there	O	PRON	O
was	O	AUX	O
no	O	DET	O
significant	O	ADJ	O
change	O	NOUN	O
in	O	ADP	O
17beta-HSD	B-protein	NOUN	B
IV	I-protein	NUM	I
or	O	CCONJ	O
DNA-PK	B-RNA	NOUN	B
(	I-RNA	PUNCT	O
CS	I-RNA	ADJ	B
)	I-RNA	PUNCT	O
mRNA	I-RNA	NOUN	B
levels	O	NOUN	O
following	O	VERB	O
treatment	O	NOUN	B
with	O	ADP	O
1	O	NUM	O
,	O	PUNCT	O
25	O	NUM	O
(	O	PUNCT	O
OH	O	NOUN	B
)	O	PUNCT	O
2D3	O	NOUN	B
,	O	PUNCT	O
although	O	SCONJ	O
expression	O	NOUN	B
of	O	ADP	O
both	O	DET	O
genes	O	NOUN	B
varied	O	VERB	O
with	O	ADP	O
changes	O	NOUN	B
in	O	ADP	O
cell	O	NOUN	B
proliferation	O	NOUN	I
.	O	PUNCT	O


Prostaglandin	O	NOUN	B
E2	O	NOUN	I
Up-regulates	O	VERB	B
HIV-1	B-DNA	NOUN	B
long	I-DNA	ADJ	B
terminal	I-DNA	ADJ	I
repeat	I-DNA	NOUN	I
-driven	O	ADJ	O
gene	O	NOUN	B
activity	O	NOUN	I
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
via	O	ADP	O
NF-kappaB-dependent	O	ADJ	B
and	O	CCONJ	O
-independent	O	ADJ	O
signaling	O	NOUN	B
pathways	O	NOUN	I
.	O	PUNCT	O


Unexpectedly	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
found	O	VERB	O
that	O	SCONJ	O
conventional	O	ADJ	B
procedures	O	NOUN	B
employed	O	VERB	O
to	O	PART	O
prepare	O	VERB	O
cellular	O	ADJ	B
extracts	O	NOUN	I
cause	O	VERB	O
the	O	DET	O
release	O	NOUN	B
of	O	ADP	O
proteolytic	O	ADJ	B
activities	O	NOUN	I
that	O	PRON	O
are	O	AUX	O
normally	O	ADV	O
stored	O	VERB	B
in	O	ADP	O
intracellular	O	ADJ	B
granules	O	NOUN	I
,	O	PUNCT	O
resulting	O	VERB	O
in	O	ADP	O
the	O	DET	O
degradation	O	NOUN	B
of	O	ADP	O
various	O	ADJ	O
NF-kappaB/Rel	B-protein	NOUN	B
and	O	CCONJ	O
STAT	B-protein	NOUN	B
proteins	I-protein	NOUN	I
.	O	PUNCT	O


Low	O	ADJ	B
CD3+CD28-induced	O	ADJ	B
interleukin-2	B-protein	NOUN	I
production	O	NOUN	B
correlates	O	VERB	B
with	O	ADP	O
decreased	O	VERB	B
reactive	O	ADJ	B
oxygen	O	NOUN	I
intermediate	O	NOUN	I
formation	O	NOUN	I
in	O	ADP	O
neonatal	B-cell_type	ADJ	B
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


PDBu	O	NOUN	B
+	O	CCONJ	O
iono	O	NOUN	B
induced	O	VERB	B
equally	O	ADV	O
high	O	ADJ	O
IL-2	B-protein	NOUN	B
levels	O	NOUN	B
in	O	ADP	O
both	O	DET	O
groups	O	NOUN	B
and	O	CCONJ	O
,	O	PUNCT	O
when	O	SCONJ	O
stimulated	O	VERB	B
with	O	ADP	O
plate-bound	O	ADJ	B
anti-CD3	B-protein	ADJ	B
monoclonal	I-protein	ADJ	I
antibody	I-protein	NOUN	I
(	O	PUNCT	O
mAb	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
the	O	DET	O
IL-2	B-protein	NOUN	B
secretion	O	NOUN	B
by	O	ADP	O
neonatal	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	O
was	O	AUX	O
undetectable	O	ADJ	B
and	O	CCONJ	O
adult	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	B
produced	O	VERB	O
low	O	ADJ	B
amounts	O	NOUN	O
of	O	ADP	O
IL-2	B-protein	NOUN	B
(	O	PUNCT	O
mean	O	NOUN	O
331	O	NUM	O
+/-	O	CCONJ	O
86	O	NUM	O
pg/ml	O	NOUN	O
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
addition	O	NOUN	O
of	O	ADP	O
anti-CD28	B-protein	ADJ	B
mAb	I-protein	NOUN	B
to	O	PART	O
anti-CD3-stimulated	B-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
markedly	O	ADV	O
increased	O	VERB	B
IL-2	B-protein	NOUN	B
production	O	NOUN	B
in	O	ADP	O
both	O	DET	O
cell	O	NOUN	B
types	O	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
levels	O	NOUN	B
of	O	ADP	O
IL-2	B-protein	NOUN	B
in	O	ADP	O
neonatal	B-cell_type	ADJ	B
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
remained	O	VERB	O
clearly	O	ADV	O
lower	O	ADJ	O
than	O	ADP	O
those	O	DET	O
of	O	ADP	O
adult	B-cell_type	ADJ	B
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
(	O	PUNCT	O
respective	O	ADJ	O
mean	O	ADJ	O
values	O	NOUN	O
:	O	PUNCT	O
385	O	NUM	O
+/-	O	CCONJ	O
109	O	NUM	O
pg/ml	O	NOUN	O
and	O	CCONJ	O
4494	O	NUM	O
+/-	O	CCONJ	O
1199	O	NUM	O
pg/ml	O	NOUN	O
)	O	PUNCT	O
.	O	PUNCT	O


As	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
is	O	AUX	O
a	O	DET	O
critical	O	ADJ	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
in	O	ADP	O
the	O	DET	O
control	O	NOUN	B
of	O	ADP	O
IL-2	B-protein	NOUN	B
expression	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
next	O	ADV	O
analysed	O	VERB	B
its	O	PRON	O
nuclear	O	ADJ	B
translocation	O	NOUN	I
in	O	ADP	O
neonatal	B-cell_type	ADJ	B
and	I-cell_type	CCONJ	O
adult	I-cell_type	ADJ	B
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
using	O	VERB	O
the	O	DET	O
electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assay	O	NOUN	I
and	O	CCONJ	O
,	O	PUNCT	O
because	O	SCONJ	O
induction	O	NOUN	B
of	O	ADP	O
reactive	O	ADJ	B
oxygen	O	NOUN	I
intermediates	O	NOUN	I
(	O	PUNCT	O
ROI	O	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
required	O	VERB	O
for	O	ADP	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
also	O	ADV	O
analysed	O	VERB	B
levels	O	NOUN	B
of	O	ADP	O
intracellular	O	ADJ	B
ROI	O	NOUN	B
in	O	ADP	O
these	O	DET	O
cells	O	NOUN	B
using	O	VERB	O
the	O	DET	O
ROI-reactive	O	ADJ	B
fluorochrome	O	NOUN	I
DCFH-DA	O	NOUN	I
and	O	CCONJ	O
flow	O	NOUN	B
cytometry	O	NOUN	I
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	O
suggest	O	VERB	O
that	O	SCONJ	O
reduced	O	VERB	B
IL-2	B-protein	NOUN	B
production	O	NOUN	B
by	O	ADP	O
neonatal	B-cell_type	ADJ	B
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
is	O	AUX	O
specific	O	ADJ	O
for	O	ADP	O
anti-CD3	B-protein	ADJ	B
and	O	CCONJ	O
anti-CD3	B-protein	ADJ	B
+	O	CCONJ	O
anti-CD28	B-protein	ADJ	B
-mediated	O	ADJ	O
stimulation	O	NOUN	B
and	O	CCONJ	O
that	O	SCONJ	O
these	O	DET	O
activators	O	NOUN	B
can	O	AUX	O
not	O	PART	O
effectively	O	ADV	O
activate	O	VERB	B
the	O	DET	O
ROI	O	NOUN	B
-NF-kappa	B-protein	NOUN	O
B	I-protein	NOUN	B
signalling	O	NOUN	I
pathway	O	NOUN	I
in	O	ADP	O
neonatal	B-cell_type	ADJ	B
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


CD30	B-protein	NOUN	B
is	O	AUX	O
a	O	DET	O
CD40-inducible	B-protein	ADJ	B
molecule	I-protein	NOUN	I
that	O	PRON	O
negatively	O	ADV	O
regulates	O	VERB	B
CD40-mediated	B-protein	ADJ	B
immunoglobulin	I-protein	NOUN	O
class	O	NOUN	O
switching	O	NOUN	O
in	O	ADP	O
non-antigen-selected	B-cell_line	ADJ	B
human	I-cell_line	ADJ	B
B	I-cell_line	NOUN	O
cells	I-cell_line	NOUN	O
.	O	PUNCT	O


Switching	O	NOUN	B
is	O	AUX	O
hampered	O	VERB	O
by	O	ADP	O
CD30	B-protein	NOUN	B
coengagement	O	NOUN	I
,	O	PUNCT	O
possibly	O	ADV	O
through	O	ADP	O
interference	O	NOUN	B
with	O	ADP	O
the	O	DET	O
CD40	B-protein	NOUN	B
-mediated	O	ADJ	O
NF-kappaB	B-protein	NOUN	B
-dependent	O	ADJ	O
transcriptional	O	ADJ	B
activation	O	NOUN	I
of	O	ADP	O
downstream	B-DNA	ADJ	B
C	I-DNA	NOUN	I
(	I-DNA	PUNCT	O
H	I-DNA	NOUN	O
)	I-DNA	PUNCT	O
genes	I-DNA	NOUN	O
.	O	PUNCT	O


But	O	CCONJ	O
many	O	ADJ	O
puzzles	O	NOUN	O
of	O	ADP	O
the	O	DET	O
drugs	O	NOUN	B
remain	O	VERB	O
.	O	PUNCT	O


What	O	PRON	O
is	O	AUX	O
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
CyA	O	NOUN	B
in	O	ADP	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
transforming	B-protein	VERB	B
growth	I-protein	NOUN	I
factor-beta	I-protein	NOUN	I
(	O	PUNCT	O
TGF-beta	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
particularly	O	ADV	O
in	O	ADP	O
relationship	O	NOUN	B
to	O	PART	O
nephrotoxicity	O	NOUN	B
and	O	CCONJ	O
fibrogenesis	O	NOUN	B
?	O	PUNCT	O


Interleukin	B-protein	NOUN	B
2	I-protein	NUM	I
and	I-protein	CCONJ	O
15	I-protein	NUM	O
activate	O	VERB	B
Stat3alpha	B-protein	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
T	I-cell_type	NOUN	O
lymphocytes	I-cell_type	NOUN	O
.	O	PUNCT	O


Copyright	O	NOUN	O
1998	O	NUM	O
Academic	O	PROPN	B
Press	O	PROPN	I
.	O	PUNCT	O


Transcriptional	O	ADJ	B
regulation	O	NOUN	I
of	O	ADP	O
lysosomal	B-protein	ADJ	B
acid	I-protein	NOUN	I
lipase	I-protein	NOUN	I
in	O	ADP	O
differentiating	O	VERB	O
monocytes	O	NOUN	B
is	O	AUX	O
mediated	O	VERB	O
by	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
Sp1	B-protein	NOUN	B
and	O	CCONJ	O
AP-2	B-protein	NOUN	B
.	O	PUNCT	O


Cepharanthine	O	NOUN	B
is	O	AUX	O
a	O	DET	O
biscoclaurine	O	NOUN	B
alkaloid	O	NOUN	I
isolated	O	VERB	B
from	O	ADP	O
Stephania	O	X	B
cepharantha	O	X	I
Hayata	O	X	I
and	O	CCONJ	O
has	O	AUX	O
been	O	AUX	O
shown	O	VERB	O
to	O	PART	O
have	O	AUX	O
antiinflammatory	O	ADJ	B
,	O	PUNCT	O
antiallergic	O	ADJ	B
,	O	PUNCT	O
and	O	CCONJ	O
immunomodulatory	O	ADJ	B
activities	O	NOUN	I
in	O	X	B
vivo	O	X	I
.	O	PUNCT	O


LMP1	B-protein	NOUN	B
contains	O	VERB	O
two	O	NUM	O
domains	O	NOUN	B
that	O	PRON	O
activate	O	VERB	B
the	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
NF-kappaB	B-protein	NOUN	I
,	O	PUNCT	O
one	O	NUM	O
through	O	ADP	O
interactions	O	NOUN	B
with	O	ADP	O
TRAF	B-protein	NOUN	B
proteins	I-protein	NOUN	I
and	O	CCONJ	O
the	O	DET	O
other	O	ADJ	O
with	O	ADP	O
the	O	DET	O
TRADD	B-protein	NOUN	B
protein	I-protein	NOUN	I
.	O	PUNCT	O


Hemorrhagic	O	ADJ	B
shock	O	NOUN	I
(	O	PUNCT	O
HS	O	NOUN	B
)	O	PUNCT	O
initiates	O	VERB	B
an	O	DET	O
inflammatory	O	ADJ	B
cascade	O	NOUN	I
that	O	PRON	O
includes	O	VERB	O
the	O	DET	O
production	O	NOUN	B
of	O	ADP	O
cytokines	B-protein	NOUN	B
and	O	CCONJ	O
recruitment	O	NOUN	B
of	O	ADP	O
neutrophils	B-cell_type	NOUN	B
(	O	PUNCT	O
PMN	B-cell_type	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
may	O	AUX	O
progress	O	VERB	B
to	O	PART	O
organ	O	VERB	B
failure	O	NOUN	I
,	O	PUNCT	O
inducing	O	VERB	O
acute	O	ADJ	B
respiratory	O	ADJ	I
distress	O	NOUN	I
syndrome	O	NOUN	I
(	O	PUNCT	O
ARDS	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Intratracheal	O	ADJ	B
instillation	O	NOUN	I
of	O	ADP	O
IL-6	B-protein	NOUN	B
alone	O	ADV	O
into	O	ADP	O
normal	O	ADJ	O
rats	O	NOUN	B
resulted	O	VERB	O
in	O	ADP	O
PMN	O	NOUN	B
infiltration	O	NOUN	B
into	O	ADP	O
lung	O	NOUN	B
interstitium	O	NOUN	I
and	O	CCONJ	O
alveoli	O	NOUN	B
,	O	PUNCT	O
marked	O	ADJ	O
elevation	O	NOUN	B
of	O	ADP	O
bronchoalveolar	O	ADJ	B
lavage	O	NOUN	I
cellularity	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
increased	O	VERB	B
wet-to-dry	O	ADJ	B
ratio	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
peroxisome	B-protein	NOUN	B
proliferator-activated	I-protein	ADJ	I
receptor	I-protein	NOUN	I
alpha	I-protein	NOUN	I
(	O	PUNCT	O
PPARalpha	B-protein	NOUN	B
)	O	PUNCT	O
ligand	O	NOUN	B
WY	O	NOUN	B
14	O	NUM	O
,	O	PUNCT	O
643	O	NUM	O
does	O	AUX	O
not	O	PART	O
interfere	O	VERB	B
with	O	ADP	I
leukotriene	O	NOUN	B
B4	O	NOUN	I
induced	O	ADJ	B
adhesion	O	NOUN	B
of	O	ADP	O
neutrophils	B-cell_type	NOUN	B
to	O	PART	O
endothelial	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


When	O	SCONJ	O
endothelial	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
were	O	AUX	O
treated	O	VERB	B
with	O	ADP	I
WY	O	NOUN	B
14	O	NUM	O
,	O	PUNCT	O
643	O	NUM	O
prior	O	ADJ	O
to	O	PART	O
activation	O	NOUN	B
with	O	ADP	O
LTB4	O	NOUN	B
(	O	PUNCT	O
or	O	CCONJ	O
fMLP	B-protein	NOUN	B
,	O	PUNCT	O
IL-1beta	B-protein	NOUN	B
or	O	CCONJ	O
TNFalpha	B-protein	NOUN	B
,	O	PUNCT	O
as	O	ADP	O
controls	O	NOUN	B
)	O	PUNCT	O
we	O	PRON	O
could	O	AUX	O
not	O	PART	O
document	O	VERB	B
any	O	DET	O
effect	O	NOUN	B
on	O	ADP	O
the	O	DET	O
number	O	NOUN	O
of	O	ADP	O
adhering	B-cell_type	VERB	O
PMN	I-cell_type	NOUN	B
or	O	CCONJ	O
duration	O	NOUN	B
of	O	ADP	O
the	O	DET	O
response	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
determined	O	VERB	O
whether	O	SCONJ	O
the	O	DET	O
interaction	O	NOUN	B
of	O	ADP	O
SS	B-cell_type	NOUN	B
RBC	I-cell_type	NOUN	B
with	O	ADP	O
cultured	O	VERB	B
endothelial	B-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
induced	O	VERB	B
cellular	O	ADJ	B
oxidant	O	ADJ	I
stress	O	NOUN	I
that	O	PRON	O
would	O	AUX	O
culminate	O	VERB	O
in	O	ADP	O
expression	O	NOUN	B
of	O	ADP	O
cell	B-protein	NOUN	B
adhesion	I-protein	NOUN	I
molecules	I-protein	NOUN	I
(	O	PUNCT	O
CAMs	B-protein	NOUN	B
)	O	PUNCT	O
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
adhesion	O	NOUN	B
and	O	CCONJ	O
diapedesis	O	NOUN	B
of	O	ADP	O
monocytes	B-cell_type	NOUN	B
and	O	CCONJ	O
the	O	DET	O
adherence	O	NOUN	B
of	O	ADP	O
SS	B-cell_type	NOUN	B
reticulocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
showed	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
interaction	O	NOUN	B
of	O	ADP	O
SS	B-cell_type	NOUN	B
RBC	I-cell_type	NOUN	B
at	O	ADP	O
2	O	NUM	O
%	O	NOUN	O
concentration	O	NOUN	B
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
multimers	O	NOUN	B
of	O	ADP	O
von	B-protein	NOUN	B
Willebrand	I-protein	NOUN	I
factor	I-protein	NOUN	I
(	O	PUNCT	O
vWf	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
derived	O	VERB	O
from	O	ADP	O
endothelial	O	ADJ	B
cell-derived	O	ADJ	O
conditioned	O	ADJ	O
medium	O	NOUN	O
(	O	PUNCT	O
E-CM	O	NOUN	B
)	O	PUNCT	O
with	O	ADP	O
cultured	B-cell_line	VERB	B
human	I-cell_line	ADJ	I
umbilical	I-cell_line	ADJ	I
vein	I-cell_line	NOUN	I
endothelial	I-cell_line	ADJ	I
cells	I-cell_line	NOUN	I
(	O	PUNCT	O
HUVEC	B-cell_line	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
resulted	O	VERB	O
in	O	ADP	O
a	O	DET	O
fivefold	O	ADV	O
increased	O	VERB	B
formation	O	NOUN	B
of	O	ADP	O
thiobarbituric	O	ADJ	B
acid-reactive	O	ADJ	O
substances	O	NOUN	O
(	O	PUNCT	O
TBARS	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
NF-kB	B-protein	NOUN	I
,	O	PUNCT	O
both	O	DET	O
indicators	O	NOUN	B
of	O	ADP	O
cellular	O	ADJ	B
oxidant	O	ADJ	O
stress	O	NOUN	O
.	O	PUNCT	O


Additionally	O	ADV	O
,	O	PUNCT	O
preincubation	O	NOUN	B
of	O	ADP	O
HUVEC	B-cell_line	NOUN	B
with	O	ADP	O
a	O	DET	O
synthetic	O	ADJ	B
peptide	O	NOUN	I
Arg-Gly-Asp	O	NOUN	I
(	O	PUNCT	O
RGD	O	NOUN	B
)	O	PUNCT	O
that	O	PRON	O
prevents	O	VERB	B
vWf	B-protein	NOUN	B
-mediated	O	ADJ	O
adhesion	O	NOUN	B
of	O	ADP	O
SS	B-cell_type	NOUN	B
RBC	I-cell_type	NOUN	B
reduced	O	VERB	B
the	O	DET	O
surface	O	NOUN	B
expression	O	NOUN	B
of	O	ADP	O
VCAM-1	B-protein	NOUN	B
and	O	CCONJ	O
NF-kB	B-protein	NOUN	B
activation	O	NOUN	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
SS	B-cell_type	NOUN	B
RBC	I-cell_type	NOUN	B
-induced	O	ADJ	O
oxidant	O	ADJ	B
stress	O	NOUN	I
resulted	O	VERB	O
in	O	ADP	O
a	O	DET	O
twofold	O	ADJ	O
increase	O	NOUN	B
in	O	ADP	O
the	O	DET	O
transendothelial	O	ADJ	B
migration	O	NOUN	I
of	O	ADP	O
both	O	CCONJ	O
monocyte-like	B-cell_line	ADJ	B
HL-60	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
and	O	CCONJ	O
human	B-cell_type	ADJ	B
peripheral	I-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
monocytes	I-cell_type	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
approximately	O	ADV	O
a	O	DET	O
sixfold	O	ADJ	B
increase	O	NOUN	B
in	O	ADP	O
platelet-endothelial	B-protein	ADJ	B
cell	I-protein	NOUN	I
adhesion	I-protein	NOUN	I
molecule-1	I-protein	NOUN	I
(	O	PUNCT	O
PECAM-1	B-protein	NOUN	B
)	O	PUNCT	O
phosphorylation	O	NOUN	B
,	O	PUNCT	O
each	O	DET	O
of	O	ADP	O
which	O	DET	O
was	O	AUX	O
blocked	O	VERB	B
by	O	ADP	O
protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
C	I-protein	NOUN	I
inhibitor	O	NOUN	I
and	O	CCONJ	O
antioxidants	O	NOUN	B
.	O	PUNCT	O


Relative	O	ADJ	O
levels	O	NOUN	O
were	O	AUX	O
then	O	ADV	O
correlated	O	VERB	B
with	O	ADP	O
a	O	DET	O
series	O	NOUN	O
of	O	ADP	O
clinical	O	ADJ	B
variables	O	NOUN	I
including	O	VERB	O
response	O	NOUN	B
to	O	PART	O
therapy	O	NOUN	B
,	O	PUNCT	O
performance	O	NOUN	B
status	O	NOUN	I
,	O	PUNCT	O
survival	O	NOUN	B
,	O	PUNCT	O
disease	O	NOUN	B
sites	O	NOUN	I
,	O	PUNCT	O
age	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
others	O	NOUN	O
.	O	PUNCT	O


TCRzeta	B-protein	NOUN	B
and	O	CCONJ	O
p56	B-protein	NOUN	B
(	I-protein	PUNCT	O
lck	I-protein	NOUN	B
)	I-protein	PUNCT	O
were	O	AUX	O
detected	O	VERB	B
in	O	ADP	O
the	O	DET	O
peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
in	O	ADP	O
27	O	NUM	O
of	O	ADP	O
29	O	NUM	O
patients	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
overall	O	ADV	B
,	O	PUNCT	O
reduced	O	VERB	B
levels	O	NOUN	B
were	O	AUX	O
noted	O	VERB	O
visually	O	ADV	B
in	O	ADP	O
12	O	NUM	O
of	O	ADP	O
29	O	NUM	O
(	O	PUNCT	O
41	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
and	O	CCONJ	O
13	O	NUM	O
of	O	ADP	O
29	O	NUM	O
(	O	PUNCT	O
45	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
individuals	O	NOUN	B
,	O	PUNCT	O
respectively	O	ADV	O
.	O	PUNCT	O


Activation	O	NOUN	B
of	O	ADP	O
NFkappaB	B-protein	NOUN	B
in	O	ADP	O
peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
was	O	AUX	O
inducible	O	ADJ	B
during	O	ADP	O
cytokine	B-protein	NOUN	B
therapy	O	NOUN	I
in	O	ADP	O
four	O	NUM	O
of	O	ADP	O
six	O	NUM	O
individuals	O	NOUN	B
who	O	PRON	O
displayed	O	VERB	O
impaired	O	ADJ	B
NFkappaB	B-protein	NOUN	B
activity	O	NOUN	I
prior	O	ADJ	O
to	O	PART	O
therapy	O	NOUN	B
.	O	PUNCT	O


Moreover	O	ADV	O
,	O	PUNCT	O
impaired	O	ADJ	B
activation	O	NOUN	B
of	O	ADP	O
NFkappaB	B-protein	NOUN	B
does	O	AUX	O
not	O	PART	O
appear	O	VERB	O
linked	O	VERB	O
to	O	PART	O
a	O	DET	O
reduction	O	NOUN	B
of	O	ADP	O
TCRzeta	B-protein	NOUN	B
expression	O	NOUN	B
,	O	PUNCT	O
because	O	SCONJ	O
in	O	ADP	O
five	O	NUM	O
patients	O	NOUN	B
,	O	PUNCT	O
normal	O	ADJ	O
TCRzeta	B-protein	NOUN	B
levels	O	NOUN	B
were	O	AUX	O
present	O	ADJ	O
although	O	SCONJ	O
kappaB	B-protein	NOUN	B
binding	O	NOUN	I
was	O	AUX	O
not	O	PART	O
inducible	O	ADJ	B
.	O	PUNCT	O


Degenerate	O	NOUN	B
primers	O	NOUN	I
corresponding	O	VERB	O
to	O	PART	O
the	O	DET	O
TFIIIA	B-DNA	NOUN	B
zinc-finger	I-DNA	ADJ	I
consensus	I-DNA	NOUN	I
amino	I-DNA	NOUN	I
acid	I-DNA	NOUN	I
sequences	I-DNA	NOUN	I
and	O	CCONJ	O
to	O	PART	O
the	O	DET	O
POU-homeodomain	B-protein	NOUN	B
and	O	CCONJ	O
POU-specific	B-protein	ADJ	B
domain	I-protein	NOUN	I
were	O	AUX	O
used	O	VERB	O
to	O	PART	O
amplify	O	VERB	B
genes	O	NOUN	B
on	O	ADP	O
the	O	DET	O
basis	O	NOUN	O
that	O	SCONJ	O
they	O	PRON	O
contained	O	VERB	O
similarities	O	NOUN	B
in	O	ADP	O
structural	O	ADJ	B
motifs	O	NOUN	B
shared	O	VERB	O
within	O	ADP	O
these	O	DET	O
families	O	NOUN	B
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
.	O	PUNCT	O


PCR	B-DNA	NOUN	B
fragments	I-DNA	NOUN	B
were	O	AUX	O
cloned	O	VERB	B
,	O	PUNCT	O
sequenced	O	VERB	B
,	O	PUNCT	O
clustered	O	VERB	B
into	O	ADP	O
homologous	O	ADJ	B
groups	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
group	O	NOUN	B
sequences	O	NOUN	I
searched	O	VERB	O
on	O	ADP	O
the	O	DET	O
GenBank	O	NOUN	B
database	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
Oct	O	NOUN	O
1	O	NUM	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
very	O	ADV	O
close	O	ADJ	O
homologue	O	NOUN	B
,	O	PUNCT	O
KIAA0144	B-DNA	NOUN	B
,	O	PUNCT	O
was	O	AUX	O
identified	O	VERB	B
using	O	VERB	O
the	O	DET	O
POU	O	NOUN	B
family	O	NOUN	I
primers	O	NOUN	I
.	O	PUNCT	O


Position	O	NOUN	B
effect	O	NOUN	I
of	O	ADP	O
translocations	O	NOUN	B
involving	O	VERB	O
the	O	DET	O
inactive	B-DNA	ADJ	B
X	I-DNA	NOUN	B
chromosome	I-DNA	NOUN	I
:	O	PUNCT	O
physical	O	ADJ	B
linkage	O	NOUN	I
to	O	PART	O
XIC/XIST	B-DNA	NOUN	B
does	O	AUX	O
not	O	PART	O
lead	O	VERB	O
to	O	PART	O
long-range	O	ADJ	O
de	O	X	O
novo	O	X	O
inactivation	O	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
differentiated	I-cell_type	VERB	O
cells	I-cell_type	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
analyzed	O	VERB	B
de	O	X	O
novo	O	X	O
radiation-induced	O	ADJ	B
translocations	O	NOUN	I
between	O	ADP	O
the	O	DET	O
Xi	B-DNA	NOUN	B
and	O	CCONJ	O
autosomes	B-DNA	NOUN	B
to	O	PART	O
study	O	VERB	B
the	O	DET	O
maintenance	O	NOUN	B
and	O	CCONJ	O
spreading	O	NOUN	B
of	O	ADP	O
X-chromosome	B-DNA	NOUN	B
inactivation	O	NOUN	B
(	O	PUNCT	O
X	O	NOUN	O
inactivation	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
relation	O	NOUN	O
to	O	PART	O
the	O	DET	O
position	O	NOUN	B
of	O	ADP	O
the	O	DET	O
X-inactivation	O	NOUN	B
center	O	NOUN	I
(	B-DNA	PUNCT	O
XIC	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
/XIST	I-DNA	NOUN	O
in	O	ADP	O
differentiated	B-cell_type	VERB	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Interleukin-4	B-protein	NOUN	B
and	I-protein	CCONJ	O
-13	I-protein	NUM	B
induce	O	VERB	B
upregulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
murine	O	ADJ	B
macrophage	O	NOUN	B
12/15-lipoxygenase	B-protein	NOUN	B
activity	I-protein	NOUN	I
:	O	PUNCT	O
evidence	O	NOUN	B
for	O	ADP	O
the	O	DET	O
involvement	O	NOUN	B
of	O	ADP	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
STAT6	B-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
IL-4-induced	B-protein	ADJ	B
complex	I-protein	NOUN	I
reacted	O	VERB	O
with	O	ADP	O
anti-STAT	B-protein	NOUN	B
(	I-protein	PUNCT	O
signal	I-protein	NOUN	B
transducers	I-protein	NOUN	I
and	I-protein	CCONJ	O
activators	I-protein	NOUN	B
of	I-protein	ADP	O
transcription	I-protein	NOUN	B
)	I-protein	PUNCT	O
6	I-protein	NUM	O
,	O	PUNCT	O
resulting	O	VERB	O
in	O	ADP	O
a	O	DET	O
supershift	O	NOUN	B
whereas	O	SCONJ	O
the	O	DET	O
formation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IFN-gamma-induced	B-protein	ADJ	B
complex	I-protein	NOUN	O
was	O	AUX	O
inhibited	O	VERB	B
by	O	ADP	O
anti-STAT	B-protein	NOUN	B
1	I-protein	NUM	I
.	O	PUNCT	O


The	O	DET	O
intermediate	O	ADJ	B
complex	O	NOUN	I
appeared	O	VERB	O
to	O	PART	O
react	O	VERB	O
with	O	ADP	O
both	O	CCONJ	O
anti-STAT	B-protein	NOUN	B
6	I-protein	NUM	O
and	O	CCONJ	O
anti-STAT	B-protein	NOUN	B
1	I-protein	NUM	I
.	O	PUNCT	O


Hence	O	ADV	O
in	O	ADP	O
the	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
p56	B-protein	NOUN	B
,	O	PUNCT	O
T	B-protein	NOUN	B
cell	I-protein	NOUN	I
receptor	I-protein	NOUN	I
triggered	O	VERB	O
activation	O	NOUN	B
does	O	AUX	O
not	O	PART	O
occur	O	VERB	O
.	O	PUNCT	O


These	O	DET	O
studies	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
iNO	O	NOUN	B
attenuates	O	VERB	B
iNOS	B-protein	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
macrophages	B-cell_type	NOUN	B
and	O	CCONJ	O
inhibits	O	VERB	B
monocyte	O	NOUN	B
adhesion	O	NOUN	I
to	O	PART	O
endothelial	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
suggest	O	VERB	O
that	O	SCONJ	O
endogenously	O	ADV	B
derived	O	VERB	O
iNO	O	NOUN	B
may	O	AUX	O
be	O	AUX	O
an	O	DET	O
important	O	ADJ	O
autoregulatory	O	ADJ	B
inhibitor	O	NOUN	I
of	O	ADP	O
vascular	O	ADJ	B
inflammation	O	NOUN	I


Detection	O	NOUN	B
of	O	ADP	O
oestrogen	B-protein	NOUN	B
receptor	I-protein	NOUN	I
variants	I-protein	NOUN	B
in	O	ADP	O
endometrium	O	NOUN	B
,	O	PUNCT	O
myometrium	O	NOUN	B
,	O	PUNCT	O
leiomyoma	O	NOUN	B
and	O	CCONJ	O
peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
mononuclear	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
:	O	PUNCT	O
comparison	O	NOUN	B
to	O	PART	O
variants	O	NOUN	B
present	O	ADJ	O
in	O	ADP	O
breast	O	NOUN	B
cancer	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
aberrant	O	ADJ	B
ER	B-protein	NOUN	B
forms	O	NOUN	O
in	O	ADP	O
Oestrogen-dependent	O	ADJ	B
tumours	O	NOUN	I
has	O	AUX	O
been	O	AUX	O
discussed	O	VERB	O
in	O	ADP	O
correlation	O	NOUN	B
with	O	ADP	O
tumour	O	NOUN	B
progression	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
detected	O	VERB	B
variant	O	ADJ	B
ER	B-protein	NOUN	B
in	O	ADP	O
these	O	DET	O
samples	O	NOUN	B
and	O	CCONJ	O
have	O	AUX	O
compared	O	VERB	B
the	O	DET	O
variant	O	ADJ	B
profile	O	NOUN	B
to	O	PART	O
that	O	DET	O
observed	O	VERB	B
in	O	ADP	O
breast	O	NOUN	B
cancer	O	NOUN	I
.	O	PUNCT	O


Variants	O	NOUN	B
with	O	ADP	O
exon	B-DNA	NOUN	B
5	I-DNA	NUM	I
deleted	O	VERB	B
were	O	AUX	O
detected	O	VERB	B
only	O	ADV	O
in	O	ADP	O
peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
mononuclear	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
in	O	ADP	O
breast	O	NOUN	B
cancer	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
physiological	O	ADJ	B
significance	O	NOUN	I
and	O	CCONJ	O
possible	O	ADJ	O
clinical	O	ADJ	B
relevance	O	NOUN	B
of	O	ADP	O
the	O	DET	O
variant	O	ADJ	B
ER	B-protein	NOUN	B
forms	O	NOUN	O
remain	O	VERB	O
to	O	PART	O
be	O	AUX	O
elucidated	O	VERB	O
.	O	PUNCT	O


p21ras	B-protein	NOUN	B
is	O	AUX	O
activated	O	VERB	B
by	O	ADP	O
the	O	DET	O
T	B-protein	NOUN	B
cell	I-protein	NOUN	I
antigen	I-protein	NOUN	I
receptor	I-protein	NOUN	I
(	O	PUNCT	O
TCR	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
then	O	ADV	O
co-ordinates	O	VERB	B
important	O	ADJ	O
signaling	O	NOUN	B
pathways	O	NOUN	I
for	O	ADP	O
T	B-protein	NOUN	B
lymphocyte	I-protein	NOUN	I
activation	O	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
also	O	ADV	O
examined	O	VERB	O
the	O	DET	O
possibility	O	NOUN	O
that	O	SCONJ	O
Akt/PKB	B-protein	NOUN	B
is	O	AUX	O
regulated	O	VERB	O
by	O	ADP	O
Ras	O	NOUN	B
signaling	O	NOUN	I
pathways	O	NOUN	I
in	O	ADP	O
T	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
p21ras	B-protein	NOUN	B
signals	O	NOUN	I
are	O	AUX	O
unable	O	ADJ	O
to	O	PART	O
induce	O	VERB	B
Akt/PKB	B-protein	NOUN	B
activity	O	NOUN	I
in	O	ADP	O
T	B-cell_type	NOUN	B
cell	I-cell_type	NOUN	I
nor	O	CCONJ	O
is	O	AUX	O
Ras	B-protein	NOUN	B
function	O	NOUN	B
required	O	VERB	O
for	O	ADP	O
Akt/PKB	B-protein	NOUN	B
activation	O	NOUN	I
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
the	O	DET	O
TCR	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
effects	O	NOUN	B
of	O	ADP	O
MCM	O	NOUN	B
on	O	ADP	O
cellular	O	ADJ	B
proliferation	O	NOUN	I
,	O	PUNCT	O
AR	B-protein	NOUN	B
protein	I-protein	NOUN	I
and	O	CCONJ	O
PSA	B-protein	NOUN	B
secretion	O	NOUN	B
were	O	AUX	O
abolished	O	VERB	O
by	O	ADP	O
pretreatment	O	NOUN	B
of	O	ADP	O
MCM	O	NOUN	B
with	O	ADP	O
a	O	DET	O
neutralizing	O	VERB	O
anti-IL-1beta	B-protein	NOUN	O
antibody	I-protein	NOUN	O
.	O	PUNCT	O


Our	O	PRON	O
findings	O	NOUN	B
reveal	O	VERB	O
that	O	SCONJ	O
monocyte-derived	B-protein	ADJ	B
IL-1beta	I-protein	NOUN	B
inhibits	O	VERB	B
the	O	DET	O
proliferation	O	NOUN	B
of	O	ADP	O
androgen-responsive	B-cell_type	ADJ	B
prostate	I-cell_type	NOUN	I
tumour	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
reduces	O	VERB	B
AR	B-protein	NOUN	B
and	O	CCONJ	O
PSA	B-protein	NOUN	B
levels	O	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
it	O	PRON	O
is	O	AUX	O
unclear	O	ADJ	O
whether	O	SCONJ	O
similar	O	ADJ	O
molecular	O	ADJ	B
mechanisms	O	NOUN	I
underlie	O	VERB	O
transcription	O	NOUN	B
of	O	ADP	O
the	O	DET	O
two	O	NUM	O
genes	B-DNA	NOUN	B
.	O	PUNCT	O


The	O	DET	O
interleukin	B-DNA	NOUN	B
2	I-DNA	NUM	I
receptor	I-DNA	NOUN	I
alpha	I-DNA	NOUN	I
chain/CD25	I-DNA	NOUN	O
promoter	I-DNA	NOUN	B
is	O	AUX	O
a	O	DET	O
target	O	NOUN	B
for	O	ADP	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
of	I-protein	ADP	O
activated	I-protein	VERB	B
T	I-protein	NOUN	O
cells	I-protein	NOUN	O
.	O	PUNCT	O


Our	O	PRON	O
data	O	NOUN	B
indicate	O	VERB	O
an	O	DET	O
important	O	ADJ	O
role	O	NOUN	O
for	O	ADP	O
NF-AT	B-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
faithful	O	ADJ	O
expression	O	NOUN	B
of	O	ADP	O
high	B-protein	ADJ	O
affinity	I-protein	NOUN	B
IL-2	I-protein	NOUN	O
receptors	I-protein	NOUN	O
and	O	CCONJ	O
a	O	DET	O
close	O	ADJ	O
link	O	NOUN	O
between	O	ADP	O
the	O	DET	O
TCR	B-protein	NOUN	B
-mediated	O	ADJ	O
induction	O	NOUN	B
of	O	ADP	O
IL-2	B-protein	NOUN	B
and	O	CCONJ	O
IL-2	B-DNA	NOUN	B
receptor	I-DNA	NOUN	I
alpha	I-DNA	NOUN	I
chain	I-DNA	NOUN	I
promoters	I-DNA	NOUN	I
,	O	PUNCT	O
both	O	DET	O
of	O	ADP	O
which	O	DET	O
are	O	AUX	O
regulated	O	VERB	O
by	O	ADP	O
NF-AT	B-protein	NOUN	B
factors	I-protein	NOUN	O
.	O	PUNCT	O


A	O	DET	O
novel	O	ADJ	B
mutation	O	NOUN	B
in	O	ADP	O
the	O	DET	O
coding	O	VERB	B
sequence	O	NOUN	I
of	O	ADP	O
the	O	DET	O
FY*B	B-DNA	NOUN	B
allele	I-DNA	NOUN	I
of	O	ADP	I
the	O	DET	I
Duffy	B-DNA	NOUN	B
chemokine	I-DNA	NOUN	I
receptor	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
is	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
an	O	DET	O
altered	O	ADJ	O
erythrocyte	O	NOUN	B
phenotype	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
Duffy	O	NOUN	B
blood	O	NOUN	I
group	O	NOUN	I
system	O	NOUN	I
is	O	AUX	O
of	O	ADP	O
clinical	O	ADJ	B
and	O	CCONJ	O
biological	O	ADJ	B
significance	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
particular	O	ADJ	O
,	O	PUNCT	O
these	O	DET	O
cell	B-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
may	O	AUX	O
help	O	VERB	O
understand	O	VERB	O
the	O	DET	O
relative	O	ADJ	O
contribution	O	NOUN	B
of	O	ADP	O
HHV-8	O	NOUN	B
and	O	CCONJ	O
EBV	O	NOUN	B
to	O	PART	O
PEL	O	NOUN	B
growth	O	NOUN	O
and	O	CCONJ	O
development	O	NOUN	B
and	O	CCONJ	O
may	O	AUX	O
facilitate	O	VERB	O
the	O	DET	O
identification	O	NOUN	B
of	O	ADP	O
recurrent	O	ADJ	B
cytogenetic	O	ADJ	B
abnormalities	O	NOUN	I
highlighting	O	VERB	O
putative	O	ADJ	O
novel	O	ADJ	O
cancer	O	NOUN	O
related	O	ADJ	O
loci	O	NOUN	B
relevant	O	ADJ	B
to	O	PART	O
PEL	B-cell_line	NOUN	B
.	O	PUNCT	O


Two-site	O	ADJ	B
interaction	O	NOUN	B
of	O	ADP	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
of	I-protein	ADP	O
activated	I-protein	VERB	B
T	I-protein	NOUN	O
cells	I-protein	NOUN	O
with	O	ADP	O
activated	O	VERB	B
calcineurin	B-protein	NOUN	I
.	O	PUNCT	O


Upon	O	SCONJ	O
cell	O	NOUN	B
activation	O	NOUN	I
,	O	PUNCT	O
displacement	O	NOUN	B
of	O	ADP	O
the	O	DET	O
autoinhibitory	B-protein	ADJ	B
domain	I-protein	NOUN	I
by	O	ADP	O
calmodulin	B-protein	NOUN	B
binding	O	NOUN	I
allows	O	VERB	O
NFAT	B-protein	NOUN	B
to	O	PART	O
bind	O	VERB	B
additionally	O	ADV	O
to	O	PART	O
the	O	DET	O
calcineurin	B-protein	NOUN	B
active	I-protein	ADJ	B
site	I-protein	NOUN	I
,	O	PUNCT	O
thus	O	ADV	O
positioning	O	VERB	O
NFAT	B-protein	NOUN	B
for	O	ADP	O
immediate	O	ADJ	O
dephosphorylation	O	NOUN	B
at	O	ADP	O
functional	O	ADJ	B
phosphoserine	O	NOUN	B
residues	O	NOUN	I
.	O	PUNCT	O


Nuclear	B-protein	ADJ	B
factor-kappaB	I-protein	NOUN	I
induction	O	NOUN	I
in	O	ADP	O
CD45RO+	B-cell_type	ADJ	B
and	I-cell_type	CCONJ	O
CD45RA+	I-cell_type	ADJ	B
T	I-cell_type	NOUN	I
cell	I-cell_type	NOUN	I
subsets	I-cell_type	NOUN	O
during	O	ADP	O
aging	O	NOUN	B
.	O	PUNCT	O


Expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IL-2	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
requires	O	VERB	O
activation	O	NOUN	B
of	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
through	O	ADP	O
stimulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
TCR	B-protein	NOUN	B
and	O	CCONJ	O
costimulation	O	NOUN	B
through	O	ADP	O
accessory	B-protein	ADJ	B
receptors	I-protein	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
found	O	VERB	O
recently	O	ADV	O
that	O	SCONJ	O
okadaic	B-protein	ADJ	B
acid-sensitive	I-protein	ADJ	O
Ser/Thr	I-protein	NOUN	O
phosphatases	I-protein	NOUN	O
are	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
a	O	DET	O
cyclosporin	O	NOUN	B
A-insensitive	O	ADJ	B
pathway	O	NOUN	I
that	O	PRON	O
selectively	O	ADV	O
transmits	O	VERB	O
costimulatory	O	ADJ	B
signals	O	NOUN	B
.	O	PUNCT	O


Insulin	O	NOUN	B
dose-dependently	O	ADV	O
increased	O	VERB	B
the	O	DET	O
PI-3	O	NOUN	B
,	O	PUNCT	O
4	O	NUM	O
,	O	PUNCT	O
5-P3	O	NOUN	B
production	O	NOUN	B
but	O	CCONJ	O
YM268	O	NOUN	B
had	O	AUX	O
no	O	DET	O
significant	O	ADJ	O
effect	O	NOUN	O
on	O	ADP	O
the	O	DET	O
insulin-dependent	O	ADJ	B
and	O	CCONJ	O
-independent	O	ADJ	O
PI	O	NOUN	B
3-kinase	O	NOUN	O
activation	O	NOUN	B
.	O	PUNCT	O


BCL-6	B-cell_line	NOUN	B
(	I-cell_line	PUNCT	O
-	I-cell_line	PUNCT	O
)	I-cell_line	PUNCT	O
/syn-1	I-cell_line	NOUN	B
(	I-cell_line	PUNCT	O
+	I-cell_line	CCONJ	O
)	I-cell_line	PUNCT	O
tumor	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
of	O	ADP	O
CHD	O	NOUN	B
are	O	AUX	O
mostly	O	ADV	O
found	O	VERB	O
surrounded	O	VERB	B
by	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
expressing	O	VERB	B
CD40L	B-protein	NOUN	B
,	O	PUNCT	O
consistent	O	ADJ	B
with	O	ADP	I
the	O	DET	O
observation	O	NOUN	B
that	O	SCONJ	O
CD40	B-protein	NOUN	B
signaling	O	NOUN	B
downregulates	O	VERB	B
BCL-6	B-protein	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
observations	O	NOUN	B
demonstrate	O	VERB	O
that	O	SCONJ	O
CD4	B-protein	NOUN	B
signaling	O	NOUN	I
mediates	O	VERB	O
HIV-induced	O	ADJ	B
apoptosis	O	NOUN	B
by	O	ADP	O
a	O	DET	O
mechanism	O	NOUN	B
independent	O	ADJ	B
of	O	ADP	O
Fas	B-protein	NOUN	B
-Fas	B-protein	ADJ	O
ligand	I-protein	NOUN	B
interaction	O	NOUN	B
,	O	PUNCT	O
does	O	AUX	O
not	O	PART	O
require	O	VERB	O
p56	B-protein	NOUN	B
(	I-protein	PUNCT	O
lck	I-protein	NOUN	B
)	I-protein	PUNCT	O
signaling	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
may	O	AUX	O
involve	O	VERB	O
a	O	DET	O
critical	O	ADJ	B
region	O	NOUN	I
for	O	ADP	O
CD4	B-protein	NOUN	B
dimerization	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
determined	O	VERB	O
how	O	SCONJ	O
the	O	DET	O
phosphorylation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
retinoblastoma	B-protein	NOUN	B
family	I-protein	NOUN	I
(	O	PUNCT	O
pRb	B-protein	NOUN	B
,	O	PUNCT	O
p107	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
p130	B-protein	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
governed	O	VERB	O
in	O	ADP	O
individual	O	ADJ	B
cell	O	NOUN	B
cycle	O	NOUN	I
phases	O	NOUN	I
of	O	ADP	O
Daudi	B-cell_line	NOUN	B
B-cells	I-cell_line	NOUN	I
during	O	ADP	O
cell	O	NOUN	B
cycle	O	NOUN	I
exit	O	NOUN	B
triggered	O	VERB	B
by	O	ADP	I
alpha-interferon	B-protein	NOUN	B
(	O	PUNCT	O
alpha-IFN	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
entry	O	NOUN	B
of	O	ADP	O
microorganisms	O	NOUN	B
into	O	ADP	O
the	O	DET	O
body	O	NOUN	B
induces	O	VERB	O
inflammatory	O	ADJ	B
processes	O	NOUN	I
.	O	PUNCT	O


Addition	O	NOUN	B
of	O	ADP	O
ASA	O	NOUN	B
to	O	PART	O
an	O	DET	O
in	O	X	B
vitro	O	X	I
T	O	NOUN	B
helper	O	NOUN	I
cell	O	NOUN	I
differentiation	O	NOUN	I
system	O	NOUN	I
,	O	PUNCT	O
at	O	ADP	O
concentrations	O	NOUN	B
compatible	O	ADJ	O
with	O	ADP	O
plasma	O	NOUN	B
levels	O	NOUN	O
reached	O	VERB	O
during	O	ADP	O
anti-inflammatory	O	ADJ	B
therapy	O	NOUN	I
,	O	PUNCT	O
resulted	O	VERB	O
in	O	ADP	O
reduced	O	VERB	B
development	O	NOUN	B
of	O	ADP	O
Th1	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


MHC	B-protein	NOUN	B
class	I-protein	NOUN	B
II	I-protein	NUM	I
expression	O	NOUN	B
was	O	AUX	O
examined	O	VERB	O
in	O	ADP	O
macrophages	B-cell_type	NOUN	B
infected	O	VERB	B
with	O	ADP	O
Mycobacterium	O	NOUN	B
tuberculosis	O	NOUN	I
.	O	PUNCT	O


Despite	O	SCONJ	O
this	O	DET	O
effect	O	NOUN	B
,	O	PUNCT	O
steady	O	ADJ	B
state	O	NOUN	I
levels	O	NOUN	O
of	O	ADP	O
HLA-DRalpha	B-protein	NOUN	B
,	O	PUNCT	O
HLA-DRbeta	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
invariant	B-protein	ADJ	B
(	I-protein	PUNCT	O
Ii	I-protein	NOUN	O
)	I-protein	PUNCT	O
chains	I-protein	NOUN	O
were	O	AUX	O
equivalent	O	ADJ	O
in	O	ADP	O
control	B-cell_type	NOUN	B
and	I-cell_type	CCONJ	O
infected	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
results	O	NOUN	B
of	O	ADP	O
intracellular	O	ADJ	B
staining	O	NOUN	B
and	O	CCONJ	O
dual	O	ADJ	B
color	O	NOUN	I
confocal	O	ADJ	I
microscopy	O	NOUN	I
revealed	O	VERB	O
a	O	DET	O
significant	O	ADJ	O
defect	O	NOUN	B
in	O	ADP	O
transport	O	NOUN	B
of	O	ADP	O
newly	O	ADV	B
synthesized	O	VERB	I
class	B-protein	NOUN	B
II	I-protein	NUM	I
molecules	I-protein	NOUN	I
through	O	ADP	O
the	O	DET	O
endocytic	O	ADJ	B
compartment	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
CAT	B-DNA	NOUN	B
reporter	I-DNA	NOUN	I
constructions	I-DNA	NOUN	O
no	O	DET	O
appreciable	O	ADJ	O
level	O	NOUN	B
of	O	ADP	O
CAT	B-protein	NOUN	B
activity	O	NOUN	I
was	O	AUX	O
supported	O	VERB	O
by	O	ADP	O
the	O	DET	O
beta	B-DNA	NOUN	B
globin	I-DNA	NOUN	I
promoter	I-DNA	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
only	O	ADV	O
low	O	ADJ	B
level	O	NOUN	O
activity	O	NOUN	B
by	O	ADP	O
the	O	DET	O
delta	B-DNA	NOUN	B
promoter	I-DNA	NOUN	I
.	O	PUNCT	O


BACKGROUND	O	NOUN	B
:	O	PUNCT	O
Recent	O	ADJ	O
data	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
class	O	NOUN	B
switching	O	NOUN	I
to	O	PART	O
IgE	B-protein	NOUN	B
by	O	ADP	O
cytokines	B-protein	NOUN	B
is	O	AUX	O
mediated	O	VERB	O
by	O	ADP	O
STAT	B-protein	NOUN	B
transcription	I-protein	NOUN	I
factors	I-protein	NOUN	I
.	O	PUNCT	O


This	O	DET	O
transactivation	O	NOUN	B
sequence	O	NOUN	I
is	O	AUX	O
altered	O	VERB	O
by	O	ADP	O
tissue-specific	O	ADJ	B
alternative	O	ADJ	O
splicing	O	NOUN	O
in	O	ADP	O
newly	O	ADV	O
isolated	O	VERB	B
NFATx	B-protein	NOUN	B
isoforms	I-protein	NOUN	B
,	O	PUNCT	O
resulting	O	VERB	O
in	O	ADP	O
lower	O	ADJ	O
transactivation	O	NOUN	B
activity	O	NOUN	O
in	O	ADP	O
Jurkat	B-cell_line	NOUN	B
T	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


NFATx1	B-protein	NOUN	B
is	O	AUX	O
expressed	O	VERB	B
predominantly	O	ADV	O
in	O	ADP	O
the	O	DET	O
thymus	O	NOUN	B
and	O	CCONJ	O
peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
leukocyte	I-cell_type	NOUN	I
,	O	PUNCT	O
while	O	SCONJ	O
the	O	DET	O
skeletal	O	ADJ	B
muscle	O	NOUN	I
expressed	O	VERB	B
primarily	O	ADV	O
NFATx2	B-protein	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
Jurkat	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
transcription	O	NOUN	B
from	O	ADP	O
the	O	DET	O
NFAT	B-DNA	NOUN	B
site	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
IL-2	B-DNA	NOUN	B
promoter	I-DNA	NOUN	I
is	O	AUX	O
activated	O	VERB	B
strongly	O	ADV	O
by	O	ADP	O
NFATx1	B-protein	NOUN	B
but	O	CCONJ	O
only	O	ADV	O
weakly	O	ADV	O
by	O	ADP	O
NFATx2	B-protein	NOUN	B
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
demonstrate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
15-amino	B-protein	ADJ	B
acid	I-protein	NOUN	I
sequence	I-protein	NOUN	I
of	O	ADP	O
NFATx1	B-protein	NOUN	B
is	O	AUX	O
a	O	DET	O
major	B-protein	ADJ	O
transactivation	I-protein	NOUN	B
sequence	I-protein	NOUN	O
required	O	VERB	O
for	O	ADP	O
induction	O	NOUN	B
of	O	ADP	O
genes	O	NOUN	B
by	O	ADP	O
NFATx1	B-protein	NOUN	B
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
possibly	O	ADV	O
regulates	O	VERB	B
NFAT	B-protein	NOUN	B
activity	O	NOUN	O
through	O	ADP	O
tissue-specific	O	ADJ	B
alternative	O	ADJ	O
splicing	O	NOUN	O
.	O	PUNCT	O


CIITA	B-protein	NOUN	B
B-cell-specific	B-DNA	ADJ	B
promoter	I-DNA	NOUN	I
suppression	O	NOUN	B
in	O	ADP	O
MHC	B-cell_line	NOUN	B
class	I-cell_line	NOUN	O
II-silenced	I-cell_line	ADJ	O
cell	I-cell_line	NOUN	O
hybrids	I-cell_line	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
first	O	ADV	O
demonstrate	O	VERB	O
,	O	PUNCT	O
in	O	ADP	O
human	B-cell_line	ADJ	B
and	I-cell_line	CCONJ	O
mouse	I-cell_line	NOUN	B
intraspecies	I-cell_line	NOUN	B
hybrids	I-cell_line	NOUN	B
,	O	PUNCT	O
the	O	DET	O
coordinate	O	NOUN	B
suppression	O	NOUN	B
of	O	ADP	O
MHC	B-protein	NOUN	B
class	I-protein	NOUN	I
II	I-protein	NUM	I
,	O	PUNCT	O
Ii	B-protein	NOUN	B
(	O	PUNCT	O
invariant	B-protein	ADJ	O
chain	I-protein	NOUN	O
)	O	PUNCT	O
and	O	CCONJ	O
HLA-DM	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
transcription	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
release	O	NOUN	B
of	O	ADP	O
the	O	DET	O
silencing	O	NOUN	B
by	O	ADP	O
the	O	DET	O
addition	O	NOUN	O
of	O	ADP	O
interferon	B-protein	NOUN	B
gamma	I-protein	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
report	O	NOUN	O
expression	O	NOUN	B
profiles	O	NOUN	I
and	O	CCONJ	O
activation	O	NOUN	B
of	O	ADP	O
PKC	B-protein	NOUN	B
were	O	AUX	O
analyzed	O	VERB	B
in	O	ADP	O
human	B-cell_line	ADJ	B
Raji	I-cell_line	NOUN	O
B	I-cell_line	NOUN	O
lymphoblastoid	I-cell_line	ADJ	O
cells	I-cell_line	NOUN	O
.	O	PUNCT	O


Finally	O	ADV	O
,	O	PUNCT	O
functional	O	ADJ	B
activation	O	NOUN	I
and	O	CCONJ	O
translocation	O	NOUN	B
of	O	ADP	O
PKC	B-protein	NOUN	B
were	O	AUX	O
investigated	O	VERB	B
with	O	ADP	O
a	O	DET	O
selective	O	ADJ	O
in	O	X	B
vitro	O	X	I
kinase	O	NOUN	B
assay	O	NOUN	I
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
translocation	O	NOUN	B
event	O	NOUN	B
per	O	X	O
se	O	X	O
occurs	O	VERB	O
independently	O	ADV	O
of	O	ADP	O
PKC	B-protein	NOUN	B
activation	O	NOUN	B
in	O	ADP	O
these	O	DET	O
cells	O	NOUN	B
.	O	PUNCT	O


Sequence-specific	O	ADJ	B
DNA-binding	O	ADJ	I
small	O	ADJ	I
molecules	O	NOUN	I
that	O	PRON	O
can	O	AUX	O
permeate	O	VERB	B
human	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	O
potentially	O	ADV	O
could	O	AUX	O
regulate	O	VERB	B
transcription	O	NOUN	B
of	O	ADP	O
specific	O	ADJ	O
genes	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
ability	O	NOUN	O
of	O	ADP	O
small	O	ADJ	B
molecules	O	NOUN	I
to	O	PART	O
target	O	VERB	B
predetermined	O	ADJ	O
DNA	B-DNA	NOUN	B
sequences	I-DNA	NOUN	I
located	O	ADJ	O
within	O	ADP	O
RNA	B-DNA	NOUN	B
polymerase	I-DNA	NOUN	I
II	I-DNA	NUM	I
promoters	I-DNA	NOUN	I
suggests	O	VERB	O
a	O	DET	O
general	O	ADJ	O
approach	O	NOUN	O
for	O	ADP	O
regulation	O	NOUN	B
of	O	ADP	O
gene	O	NOUN	B
expression	O	NOUN	I
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
a	O	DET	O
mechanism	O	NOUN	B
for	O	ADP	O
the	O	DET	O
inhibition	O	NOUN	B
of	O	ADP	O
viral	O	ADJ	B
replication	O	NOUN	I
.	O	PUNCT	O


Musculin	O	NOUN	B
protein	O	NOUN	I
is	O	AUX	O
closely	O	ADV	O
related	O	ADJ	O
to	O	PART	O
human	B-protein	ADJ	B
ABF-1	I-protein	NOUN	B
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
expressed	O	VERB	B
in	O	ADP	O
activated	O	VERB	B
B	B-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
to	O	PART	O
epicardin/capsulin/Pod-1	B-protein	NOUN	B
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
expressed	O	VERB	B
in	O	ADP	O
branchial	B-cell_type	ADJ	B
myoblasts	I-cell_type	NOUN	B
,	O	PUNCT	O
visceral	O	ADJ	B
and	O	CCONJ	O
urogenital	O	ADJ	B
mesoderm	O	NOUN	I
and	O	CCONJ	O
epicardium	O	NOUN	B
.	O	PUNCT	O


Previously	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
demonstrated	O	VERB	O
that	O	SCONJ	O
granulocyte	B-RNA	NOUN	B
colony-stimulating	I-RNA	ADJ	I
factor	I-RNA	NOUN	I
(	I-RNA	PUNCT	O
G-CSF	I-RNA	NOUN	B
)	I-RNA	PUNCT	O
receptor	I-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
was	O	AUX	O
undetectable	O	ADJ	B
and	O	CCONJ	O
granulocyte	O	NOUN	B
maturation	O	NOUN	O
blocked	O	VERB	B
in	O	ADP	O
CCAAT	B-protein	NOUN	B
enhancer	I-protein	NOUN	I
binding	I-protein	NOUN	I
protein	I-protein	NOUN	I
alpha	I-protein	NOUN	I
(	O	PUNCT	O
C/EBPalpha	B-protein	NOUN	B
)	O	PUNCT	O
-deficient	O	ADJ	O
mice	O	NOUN	B
.	O	PUNCT	O


Although	O	SCONJ	O
bacterial	O	ADJ	B
lipopolysaccharides	O	NOUN	O
(	O	PUNCT	O
LPS	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
several	O	ADJ	O
other	O	ADJ	O
microbial	O	ADJ	B
agonists	O	NOUN	B
can	O	AUX	O
bind	O	VERB	B
to	O	PART	O
mCD14	B-protein	NOUN	B
(	O	PUNCT	O
membrane	B-protein	NOUN	B
CD14	I-protein	NOUN	I
)	O	PUNCT	O
,	O	PUNCT	O
a	O	DET	O
cell-surface	O	ADJ	B
receptor	O	NOUN	I
found	O	VERB	O
principally	O	ADV	O
on	O	ADP	O
monocytes	B-cell_type	NOUN	B
and	O	CCONJ	O
neutrophils	B-cell_type	NOUN	B
,	O	PUNCT	O
host-derived	O	ADJ	B
mCD14	B-protein	NOUN	B
ligands	O	NOUN	B
are	O	AUX	O
poorly	O	ADV	O
defined	O	VERB	O
.	O	PUNCT	O


To	O	PART	O
elucidate	O	VERB	O
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
retinoic	O	ADJ	B
acid	O	NOUN	I
(	O	PUNCT	O
RA	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
anti-CD40	B-protein	NOUN	B
+	O	CCONJ	I
interleukin-4	B-protein	NOUN	B
(	O	PUNCT	O
IL-4	B-protein	NOUN	B
)	O	PUNCT	O
-mediated	O	ADJ	O
B-cell	O	NOUN	B
activation	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
10	O	NUM	O
(	O	PUNCT	O
-12	O	NUM	B
)	O	PUNCT	O
to	O	PART	O
10	O	NUM	O
(	O	PUNCT	O
-6	O	NUM	O
)	O	PUNCT	O
mol/L	O	NOUN	O
RA	O	NOUN	B
was	O	AUX	O
studied	O	VERB	O
in	O	ADP	O
anti-CD40	B-protein	NOUN	B
(	O	PUNCT	O
1	O	NUM	O
microgram/mL	O	NOUN	O
)	O	PUNCT	O
+	O	CCONJ	O
IL-4	B-protein	NOUN	B
(	O	PUNCT	O
5	O	NUM	O
ng/mL	O	NOUN	O
)	O	PUNCT	O
-mediated	O	ADJ	O
proliferation	O	NOUN	B
and	O	CCONJ	O
Ig	O	NOUN	B
synthesis	O	NOUN	I
by	O	ADP	O
human	B-cell_type	ADJ	B
peripheral	I-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
mononuclear	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
(	O	PUNCT	O
PBMC	B-cell_type	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
in	O	ADP	O
healthy	O	ADJ	B
donors	O	NOUN	I
.	O	PUNCT	O


Tax	B-protein	NOUN	B
expression	O	NOUN	B
promotes	O	VERB	B
N-terminal	O	ADJ	B
phosphorylation	O	NOUN	B
and	O	CCONJ	O
degradation	O	NOUN	B
of	O	ADP	O
IkappaB	B-protein	NOUN	B
alpha	I-protein	NOUN	I
,	O	PUNCT	O
a	O	DET	O
principal	O	ADJ	B
cytoplasmic	O	ADJ	I
inhibitor	O	NOUN	I
of	O	ADP	O
NF-kappaB	B-protein	NOUN	B
.	O	PUNCT	O


Here	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
report	O	VERB	O
that	O	SCONJ	O
LPS	O	NOUN	B
induces	O	VERB	O
IKK	B-protein	NOUN	B
activity	O	NOUN	O
in	O	ADP	O
human	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
and	O	CCONJ	O
THP-1	B-cell_line	NOUN	B
monocytic	I-cell_line	ADJ	I
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


The	O	DET	O
kinetics	O	NOUN	B
of	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
kinase	O	NOUN	B
activity	O	NOUN	I
in	O	ADP	O
monocytic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
are	O	AUX	O
relatively	O	ADV	O
slow	O	ADJ	B
with	O	ADP	O
maximal	O	ADJ	B
activity	O	NOUN	O
observed	O	VERB	O
at	O	ADP	O
60	O	NUM	O
min	O	NOUN	O
,	O	PUNCT	O
which	O	DET	O
coincides	O	VERB	O
with	O	ADP	O
the	O	DET	O
degradation	O	NOUN	B
of	O	ADP	O
IkappaBs	B-protein	NOUN	B
and	O	CCONJ	O
the	O	DET	O
nuclear	O	ADJ	B
translocation	O	NOUN	I
of	O	ADP	O
NF-kappaB	B-protein	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
transfection	O	NOUN	B
experiments	O	NOUN	O
,	O	PUNCT	O
overexpression	O	NOUN	B
of	O	ADP	O
wild	O	ADJ	B
type	O	NOUN	I
IKK1	B-protein	NOUN	B
,	O	PUNCT	O
a	O	DET	O
dominant	B-protein	ADJ	B
negative	I-protein	ADJ	B
mutant	I-protein	ADJ	O
IKK1	I-protein	NOUN	O
(	O	PUNCT	O
K44M	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
or	O	CCONJ	O
wild	B-protein	ADJ	B
type	I-protein	NOUN	I
IKK2	I-protein	NOUN	I
did	O	AUX	O
not	O	PART	O
affect	O	VERB	O
LPS-induced	O	ADJ	B
kappaB	B-protein	NOUN	B
-dependent	O	ADJ	O
transcription	O	NOUN	B
in	O	ADP	O
monocytic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
a	O	DET	O
dominant	O	ADJ	B
negative	O	ADJ	B
mutant	O	NOUN	B
of	O	ADP	O
IKK2	B-protein	NOUN	B
inhibited	O	VERB	B
LPS	O	NOUN	B
induction	O	NOUN	B
of	O	ADP	O
kappaB	B-protein	NOUN	B
-dependent	O	ADJ	O
transcription	O	NOUN	B
in	O	ADP	O
a	O	DET	O
dose-dependent	O	ADJ	B
manner	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
mechanism	O	NOUN	B
by	O	ADP	O
which	O	DET	O
early	B-cell_type	ADJ	O
lymphoid	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
are	O	AUX	O
selectively	O	ADV	O
transformed	O	VERB	O
by	O	ADP	O
v-Abl	B-protein	NOUN	B
is	O	AUX	O
currently	O	ADV	O
unknown	O	ADJ	O
.	O	PUNCT	O


Previous	O	ADJ	O
studies	O	NOUN	B
have	O	AUX	O
shown	O	VERB	O
constitutive	O	ADJ	B
activation	O	NOUN	B
of	O	ADP	O
IL-4	B-protein	NOUN	B
and	O	CCONJ	O
IL-7	B-protein	NOUN	B
signaling	O	NOUN	O
pathways	O	NOUN	O
,	O	PUNCT	O
as	O	ADP	O
measured	O	VERB	B
by	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
Janus	B-protein	NOUN	B
protein	I-protein	NOUN	I
kinase	I-protein	NOUN	I
(	I-protein	PUNCT	O
JAK	I-protein	NOUN	B
)	I-protein	PUNCT	O
1	I-protein	NUM	O
,	O	PUNCT	O
JAK3	B-protein	NOUN	B
,	O	PUNCT	O
STAT5	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
STAT6	B-protein	NOUN	B
,	O	PUNCT	O
in	O	ADP	O
pre-B	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
transformed	O	VERB	B
by	O	ADP	O
v-Abl	B-protein	NOUN	B
.	O	PUNCT	O


To	O	PART	O
determine	O	VERB	O
whether	O	SCONJ	O
activation	O	NOUN	B
of	O	ADP	O
these	O	DET	O
cytokine	O	NOUN	B
signaling	O	NOUN	I
pathways	O	NOUN	I
by	O	ADP	O
v-Abl	B-protein	NOUN	B
is	O	AUX	O
important	O	ADJ	O
in	O	ADP	O
the	O	DET	O
cellular	O	ADJ	B
events	O	NOUN	I
induced	O	VERB	B
by	O	ADP	O
the	O	DET	O
Abelson	O	NOUN	B
murine	O	ADJ	I
leukemia	O	NOUN	I
virus	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	O
IL-4	B-protein	NOUN	B
and	O	CCONJ	O
IL-7	B-protein	NOUN	B
on	O	ADP	O
pre-B	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
transformed	O	VERB	O
with	O	ADP	O
a	O	DET	O
temperature-sensitive	B-protein	ADJ	B
v-Abl	I-protein	NOUN	B
mutant	I-protein	NOUN	O
were	O	AUX	O
examined	O	VERB	O
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
induction	O	NOUN	B
of	O	ADP	O
differentiation	O	NOUN	B
but	O	CCONJ	O
not	O	PART	O
of	O	ADP	O
proliferation	O	NOUN	B
was	O	AUX	O
followed	O	VERB	O
by	O	ADP	O
a	O	DET	O
25-	O	NUM	O
to	O	PART	O
30-fold	O	ADJ	O
increase	O	NOUN	B
in	O	ADP	O
the	O	DET	O
nuclear	O	ADJ	B
level	O	NOUN	O
of	O	ADP	O
the	O	DET	O
tumor	B-protein	NOUN	B
suppressor	I-protein	NOUN	I
proteins	I-protein	NOUN	I
p53	I-protein	NOUN	I
(	O	PUNCT	O
wild	O	ADJ	B
type	O	NOUN	I
)	O	PUNCT	O
,	O	PUNCT	O
pRb	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
p130/Rb2	B-protein	NOUN	B
and	O	CCONJ	O
of	O	ADP	O
the	O	DET	O
p53-dependent	B-protein	ADJ	B
cyclin	I-protein	NOUN	B
kinase	I-protein	NOUN	I
inhibitor	I-protein	NOUN	I
p21/Cip1	B-protein	NOUN	B
.	O	PUNCT	O


As	O	ADP	O
a	O	DET	O
result	O	NOUN	B
,	O	PUNCT	O
G1-S-associated	B-DNA	ADJ	B
DNA	I-DNA	NOUN	I
and	O	CCONJ	O
mRNA	O	NOUN	B
synthesis	O	NOUN	I
is	O	AUX	O
inhibited	O	VERB	B
,	O	PUNCT	O
growth	O	NOUN	B
uncoupled	O	VERB	B
from	O	ADP	O
differentiation	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
maturation	O	NOUN	B
enabled	O	VERB	O
to	O	PART	O
proceed	O	VERB	O
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
cells	O	NOUN	B
obtained	O	VERB	O
from	O	ADP	O
IL-2	B-protein	NOUN	B
-treated	O	ADJ	O
patients	O	NOUN	B
did	O	AUX	O
not	O	PART	O
have	O	AUX	O
low-level	O	ADJ	B
constitutive	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
STAT	B-protein	NOUN	B
binding	I-protein	NOUN	I
factors	I-protein	NOUN	I
as	O	ADP	O
did	O	AUX	O
LAK	B-protein	NOUN	B
cells	I-protein	NOUN	I
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
provide	O	VERB	O
further	O	ADJ	O
information	O	NOUN	B
on	O	ADP	O
the	O	DET	O
molecular	O	ADJ	B
events	O	NOUN	I
occurring	O	VERB	O
in	O	ADP	O
immune	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
generated	O	VERB	O
through	O	ADP	O
in	O	X	B
vivo	O	X	I
and	O	CCONJ	O
in	O	X	B
vitro	O	X	I
administration	O	NOUN	B
of	O	ADP	O
IL-2	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
further	O	ADV	O
document	O	VERB	B
that	O	SCONJ	O
there	O	PRON	O
is	O	AUX	O
not	O	PART	O
a	O	DET	O
precise	O	ADJ	O
congruence	O	NOUN	B
between	O	ADP	O
PBMC	B-cell_type	NOUN	B
activated	O	VERB	B
in	O	X	B
vivo	O	X	I
and	O	CCONJ	O
in	O	X	B
vitro	O	X	I
by	O	ADP	O
IL-2	B-protein	NOUN	B
.	O	PUNCT	O


Activated	B-cell_type	VERB	B
platelets	I-cell_type	NOUN	I
induce	O	VERB	B
monocyte	B-protein	NOUN	B
chemotactic	I-protein	ADJ	I
protein-1	I-protein	NOUN	I
secretion	O	NOUN	I
and	O	CCONJ	O
surface	O	NOUN	B
expression	O	NOUN	B
of	O	ADP	O
intercellular	B-cell_type	ADJ	B
adhesion	I-cell_type	NOUN	I
molecule-1	I-cell_type	NOUN	I
on	O	ADP	O
endothelial	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
[	O	PUNCT	O
see	O	VERB	O
comments	O	NOUN	B
]	O	PUNCT	O


The	O	DET	O
role	O	NOUN	O
of	O	ADP	O
platelets	O	NOUN	B
for	O	ADP	O
monocyte	B-protein	NOUN	B
chemotactic	I-protein	ADJ	I
protein-1	I-protein	NOUN	I
(	O	PUNCT	O
MCP-1	B-protein	NOUN	B
)	O	PUNCT	O
secretion	O	NOUN	B
and	O	CCONJ	O
surface	O	NOUN	B
expression	O	NOUN	B
of	O	ADP	O
intercellular	B-cell_type	ADJ	B
adhesion	I-cell_type	NOUN	I
molecule-1	I-cell_type	NOUN	I
(	O	PUNCT	O
ICAM-1	B-protein	NOUN	B
)	O	PUNCT	O
on	O	ADP	O
endothelial	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
has	O	AUX	O
been	O	AUX	O
assessed	O	VERB	B
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
ADP-activated	B-cell_type	ADJ	B
platelets	I-cell_type	NOUN	B
,	O	PUNCT	O
both	O	CCONJ	O
MCP-1	B-protein	NOUN	B
secretion	O	NOUN	B
and	O	CCONJ	O
ICAM-1	B-protein	NOUN	B
surface	O	NOUN	B
expression	O	NOUN	B
were	O	AUX	O
significantly	O	ADV	O
increased	O	VERB	B
compared	O	VERB	B
with	O	ADP	O
nonstimulated	B-cell_type	ADJ	B
platelets	I-cell_type	NOUN	B
(	O	PUNCT	O
P	O	NOUN	O
<	O	X	O
0.02	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
nuclear	I-protein	ADJ	I
factor-kappaB	I-protein	NOUN	I
(	O	PUNCT	I
NF-kappaB	B-protein	NOUN	B
)	O	PUNCT	O
determined	O	VERB	O
by	O	ADP	O
electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assay	O	NOUN	I
and	O	CCONJ	O
kappaB	B-protein	NOUN	B
-dependent	O	ADJ	O
transcriptional	O	ADJ	B
activity	O	NOUN	I
was	O	AUX	O
enhanced	O	VERB	B
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
activated	B-cell_type	VERB	B
platelets	I-cell_type	NOUN	B
.	O	PUNCT	O


Additionally	O	ADV	O
,	O	PUNCT	O
to	O	PART	O
determine	O	VERB	O
the	O	DET	O
impact	O	NOUN	B
of	O	ADP	O
RXR	B-protein	NOUN	B
for	O	ADP	O
erythroid	O	ADJ	B
cell	O	NOUN	I
development	O	NOUN	B
,	O	PUNCT	O
dominant	O	ADJ	B
interfering	O	VERB	O
mutant	B-protein	ADJ	O
RXRs	I-protein	NOUN	O
,	O	PUNCT	O
lacking	O	VERB	O
the	O	DET	O
transcriptional	O	ADJ	B
activator	O	NOUN	I
functions	O	NOUN	O
AF-1	B-protein	NOUN	B
and	O	CCONJ	O
AF-2	B-protein	NOUN	B
,	O	PUNCT	O
or	O	CCONJ	O
AF-2	B-protein	NOUN	B
only	O	ADV	O
,	O	PUNCT	O
or	O	CCONJ	O
the	O	DET	O
entire	B-DNA	ADJ	O
DNA-binding	I-DNA	ADJ	B
domain	I-DNA	NOUN	I
,	O	PUNCT	O
were	O	AUX	O
introduced	O	VERB	O
into	O	ADP	O
erythroid	B-cell_type	ADJ	B
progenitor	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
via	O	ADP	O
recombinant	O	ADJ	B
retrovirus	O	NOUN	I
vectors	O	NOUN	I
and	O	CCONJ	O
analyzed	O	VERB	B
for	O	ADP	O
RXR	B-protein	NOUN	B
-specific	O	ADJ	O
effects	O	NOUN	B
.	O	PUNCT	O


T	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
from	O	ADP	O
6	O	NUM	O
of	O	ADP	O
the	O	DET	O
14	O	NUM	O
patients	O	NOUN	B
also	O	ADV	O
exhibited	O	VERB	O
an	O	DET	O
increased	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
dual	O	ADJ	B
specificity	B-protein	NOUN	I
phosphatase	I-protein	NOUN	I
,	O	PUNCT	O
map	B-protein	NOUN	B
kinase	I-protein	NOUN	I
phosphatase-1	I-protein	NOUN	I
(	O	PUNCT	O
MKP-1	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Abnormalities	O	NOUN	B
of	O	ADP	O
I	O	NUM	O
or	O	CCONJ	O
more	O	ADJ	O
signaling	B-protein	VERB	B
molecules	I-protein	NOUN	I
were	O	AUX	O
found	O	VERB	O
in	O	ADP	O
9	O	NUM	O
of	O	ADP	O
14	O	NUM	O
patients	O	NOUN	B
;	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
only	O	ADV	O
3	O	NUM	O
patients	O	NOUN	B
had	O	AUX	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
that	O	PRON	O
exhibited	O	VERB	O
all	O	DET	O
5	O	NUM	O
defects	O	NOUN	B
.	O	PUNCT	O


For	O	ADP	O
example	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
analysis	O	NOUN	B
of	O	ADP	O
only	O	ADV	O
1	O	NUM	O
signaling	B-protein	NOUN	B
molecule	I-protein	NOUN	I
may	O	AUX	O
allow	O	VERB	O
patients	O	NOUN	B
with	O	ADP	O
significant	O	ADJ	O
defects	O	NOUN	B
in	O	ADP	O
T-cell	O	NOUN	B
signaling	O	NOUN	I
to	O	PART	O
go	O	VERB	O
unnoticed	O	ADJ	O
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
first	O	ADJ	O
series	O	NOUN	O
we	O	PRON	O
found	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
number	O	NOUN	O
of	O	ADP	O
glucocorticoid	B-protein	NOUN	B
receptors	I-protein	NOUN	I
and	O	CCONJ	O
dissociation	O	NOUN	B
constant	O	NOUN	O
did	O	AUX	O
not	O	PART	O
depend	O	VERB	O
on	O	ADP	O
the	O	DET	O
season	O	NOUN	B
,	O	PUNCT	O
on	O	ADP	O
the	O	DET	O
age	O	NOUN	B
of	O	ADP	O
subjects	O	NOUN	B
nor	O	CCONJ	O
on	O	ADP	O
cortisol	O	NOUN	B
concentrations	O	NOUN	B
in	O	ADP	O
blood	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
Rho	B-protein	NOUN	B
family	O	NOUN	B
of	O	ADP	O
small	B-protein	ADJ	O
GTP-binding	I-protein	ADJ	B
proteins	I-protein	NOUN	I
is	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
cytoskeletal	O	ADJ	B
structure	O	NOUN	I
,	O	PUNCT	O
gene	O	NOUN	B
transcription	O	NOUN	I
,	O	PUNCT	O
specific	O	ADJ	O
cell	O	NOUN	B
fate	O	NOUN	I
development	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
transformation	O	NOUN	B
.	O	PUNCT	O


Overexpression	O	NOUN	B
of	O	ADP	O
a	O	DET	O
V14Rho	B-DNA	NOUN	B
construct	I-DNA	NOUN	O
incapable	O	ADJ	O
of	O	ADP	O
membrane	O	NOUN	B
localization	O	NOUN	I
(	O	PUNCT	O
CAAX	B-DNA	NOUN	B
deleted	I-DNA	VERB	B
)	O	PUNCT	O
abolishes	O	VERB	O
PMA-induced	O	ADJ	B
AP-1	B-protein	NOUN	B
transcriptional	O	ADJ	O
activation	O	NOUN	O
.	O	PUNCT	O


One	O	NUM	O
consequence	O	NOUN	B
of	O	ADP	I
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
PKC	B-protein	NOUN	B
can	O	AUX	O
be	O	AUX	O
increased	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
mitogen-activated	B-protein	ADJ	B
protein	I-protein	NOUN	I
(	I-protein	PUNCT	O
MAP	I-protein	NOUN	B
)	I-protein	PUNCT	O
kinase	I-protein	NOUN	O
pathways	O	NOUN	O
.	O	PUNCT	O


Therefore	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
also	O	ADV	O
evaluated	O	VERB	B
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
MAP	B-protein	NOUN	B
kinase	I-protein	NOUN	I
extracellular	I-protein	ADJ	O
signal-regulated	I-protein	ADJ	O
kinase	I-protein	NOUN	O
(	I-protein	PUNCT	O
ERK	I-protein	NOUN	B
)	I-protein	PUNCT	O
2	I-protein	NUM	O
by	O	ADP	O
the	O	DET	O
phorbol	O	NOUN	B
ester	O	NOUN	I
phorbol	O	NOUN	B
12-myristate	O	NOUN	I
13-acetate	O	NOUN	I
(	O	PUNCT	O
PMA	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


These	O	DET	O
studies	O	NOUN	B
show	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
differential	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
PKC	B-protein	NOUN	B
isoforms	I-protein	NOUN	B
in	O	ADP	O
alveolar	B-cell_type	ADJ	B
macrophages	I-cell_type	NOUN	I
and	O	CCONJ	O
blood	B-cell_type	NOUN	B
monocytes	I-cell_type	NOUN	I
is	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
important	O	ADJ	O
functional	O	ADJ	B
alterations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
cells	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
recently	O	ADV	O
described	O	VERB	O
an	O	DET	O
inherited	O	VERB	B
over-expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
macrophage	B-protein	NOUN	B
scavenger	I-protein	NOUN	I
receptor	I-protein	NOUN	I
(	O	PUNCT	O
SR	B-protein	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
blood	B-cell_type	NOUN	B
monocytes	I-cell_type	NOUN	I
from	O	ADP	O
members	O	NOUN	B
of	O	ADP	O
a	O	DET	O
kindred	O	NOUN	B
,	O	PUNCT	O
only	O	ADV	O
two	O	NUM	O
of	O	ADP	O
whom	O	PRON	O
displayed	O	VERB	O
extensive	O	ADJ	O
xanthomatosis	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
role	O	NOUN	O
of	O	ADP	O
H2O2	O	NOUN	B
and	O	CCONJ	O
other	O	ADJ	O
reactive	O	ADJ	B
oxygen	O	NOUN	I
species	O	NOUN	I
(	O	PUNCT	O
ROS	O	NOUN	B
)	O	PUNCT	O
as	O	ADP	O
an	O	DET	O
integratory	O	ADJ	B
secondary	O	ADJ	O
messenger	O	NOUN	O
for	O	ADP	O
divergent	O	ADJ	B
T	O	NOUN	B
cell	O	NOUN	I
signals	O	NOUN	O
has	O	AUX	O
been	O	AUX	O
complicated	O	ADJ	O
by	O	ADP	O
the	O	DET	O
fact	O	NOUN	O
that	O	SCONJ	O
various	O	ADJ	O
T	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
and	O	CCONJ	O
peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
differ	O	VERB	O
markedly	O	ADV	B
in	O	ADP	O
the	O	DET	O
levels	O	NOUN	B
of	O	ADP	O
NF-kappaB	B-protein	NOUN	B
activation	O	NOUN	B
induced	O	VERB	B
by	O	ADP	O
oxidant	O	ADJ	B
stress	O	NOUN	I
.	O	PUNCT	O


Data	O	NOUN	B
are	O	AUX	O
also	O	ADV	O
presented	O	VERB	O
to	O	PART	O
suggest	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
redox	O	NOUN	B
regulation	O	NOUN	I
in	O	ADP	O
NF-kappaB	B-protein	NOUN	B
activation	O	NOUN	B
may	O	AUX	O
be	O	AUX	O
relevant	O	ADJ	O
to	O	PART	O
immune-related	O	ADJ	B
diseases	O	NOUN	I
and	O	CCONJ	O
to	O	PART	O
aging	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
found	O	VERB	O
that	O	SCONJ	O
EPO	B-protein	NOUN	B
did	O	AUX	O
not	O	PART	O
activate	O	VERB	B
Stat1alpha	B-protein	NOUN	B
or	O	CCONJ	O
Stat3	B-protein	NOUN	B
in	O	ADP	O
UT-7/GM	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Indeed	O	ADV	O
,	O	PUNCT	O
USA-derived	B-protein	ADJ	B
PC2	I-protein	NOUN	B
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
act	O	VERB	O
synergistically	O	ADV	B
with	O	ADP	O
PC4	B-protein	NOUN	B
in	O	ADP	O
reproducing	O	VERB	B
the	O	DET	O
function	O	NOUN	B
of	O	ADP	O
intact	O	ADJ	B
USA	O	NOUN	B
in	O	ADP	O
the	O	DET	O
assay	O	NOUN	B
system	O	NOUN	I
.	O	PUNCT	O


Data	O	NOUN	B
obtained	O	VERB	O
by	O	ADP	O
electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assay	O	NOUN	I
suggested	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
activated	B-protein	VERB	B
Stat-3	I-protein	NOUN	B
protein	I-protein	NOUN	I
associates	O	VERB	B
with	O	ADP	I
the	O	DET	O
human	B-DNA	ADJ	B
serum-inducible	I-DNA	ADJ	O
element	I-DNA	NOUN	O
(	I-DNA	PUNCT	O
hSIE	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
DNA-probe	I-DNA	NOUN	B
derived	O	VERB	O
from	O	ADP	O
the	O	DET	O
interferon-gamma	B-DNA	NOUN	B
activated	I-DNA	ADJ	O
site	I-DNA	NOUN	O
(	O	PUNCT	O
GAS	B-DNA	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
c-fos	B-DNA	NOUN	B
promoter	I-DNA	NOUN	I
,	O	PUNCT	O
a	O	DET	O
common	O	ADJ	O
DNA	O	NOUN	B
sequence	O	NOUN	I
for	O	ADP	O
Stat	B-protein	NOUN	B
protein	I-protein	NOUN	I
binding	O	NOUN	I
.	O	PUNCT	O


This	O	DET	O
dominant-negative	B-protein	ADJ	B
acting	I-protein	VERB	O
Stat-3	I-protein	NOUN	B
isoform	I-protein	NOUN	B
significantly	O	ADV	O
inhibited	O	VERB	B
apoptosis	O	NOUN	B
induced	O	VERB	B
by	O	ADP	O
ligation	O	NOUN	B
of	O	ADP	O
MHC-I	B-protein	NOUN	B
.	O	PUNCT	O


This	O	DET	O
inhibition	O	NOUN	B
is	O	AUX	O
not	O	PART	O
accompanied	O	VERB	O
by	O	ADP	O
a	O	DET	O
loss	O	NOUN	B
in	O	ADP	O
viability	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
DMDTC-treated	B-cell_type	ADJ	B
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
retain	O	VERB	O
other	O	ADJ	O
active	O	ADJ	B
signaling	O	NOUN	B
pathways	O	NOUN	I
throughout	O	ADP	O
the	O	DET	O
exposure	O	NOUN	B
duration	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
15-LO	B-protein	NOUN	B
promoter	O	NOUN	B
is	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
a	O	DET	O
CpG	O	NOUN	B
island	O	NOUN	I
at	O	ADP	O
the	O	DET	O
5'-end	B-DNA	NOUN	B
of	O	ADP	O
the	O	DET	O
gene	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
sequence	O	NOUN	B
analysis	O	NOUN	I
reveals	O	VERB	O
putative	O	ADJ	O
Sp1	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
Ap2	I-DNA	NOUN	B
binding	I-DNA	NOUN	O
site/s	I-DNA	NOUN	B
and	O	CCONJ	O
absence	O	NOUN	B
of	O	ADP	O
TATA	B-DNA	NOUN	B
or	I-DNA	CCONJ	O
CAAT	I-DNA	NOUN	B
motifs	I-DNA	NOUN	I
.	O	PUNCT	O


Using	O	VERB	O
deletion	B-DNA	NOUN	B
constructs	I-DNA	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
defined	O	VERB	O
an	O	DET	O
active	B-DNA	ADJ	O
promoter	I-DNA	NOUN	B
region	I-DNA	NOUN	I
of	O	ADP	O
1056	O	NUM	O
bp	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
efficacy	O	NOUN	B
of	O	ADP	O
the	O	DET	O
activated	B-cell_type	VERB	B
LN	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
is	O	AUX	O
augmented	O	VERB	B
when	O	SCONJ	O
the	O	DET	O
sensitizing	O	VERB	B
tumor	O	NOUN	O
is	O	AUX	O
a	O	DET	O
genetically	B-cell_line	ADV	B
modified	I-cell_line	VERB	I
variant	I-cell_line	NOUN	I
(	O	PUNCT	O
designated	O	VERB	O
D5G6	B-cell_line	NOUN	B
)	O	PUNCT	O
that	O	PRON	O
secretes	O	VERB	B
granulocyte/macrophage-colony-stimulating	B-protein	ADJ	B
factor	I-protein	NOUN	I
.	O	PUNCT	O


After	O	ADP	O
5-day	O	ADJ	O
anti-CD3	B-protein	ADJ	B
/IL-2	B-protein	NOUN	O
activation	O	NOUN	B
,	O	PUNCT	O
levels	O	NOUN	B
of	O	ADP	O
p56lck	B-protein	NOUN	B
and	O	CCONJ	O
p59fyn	B-protein	NOUN	B
and	O	CCONJ	O
protein	O	NOUN	B
tyrosine	O	NOUN	I
kinase	O	NOUN	I
activity	O	NOUN	I
increased	O	VERB	B
.	O	PUNCT	O


Transient	O	ADJ	B
transfectants	O	NOUN	B
of	O	ADP	O
the	O	DET	O
porcine	B-cell_line	NOUN	B
B-cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
L23	I-cell_line	NOUN	I
with	O	ADP	O
the	O	DET	O
mutated	O	VERB	B
CIITA	B-DNA	NOUN	B
constructs	I-DNA	NOUN	B
were	O	AUX	O
tested	O	VERB	B
for	O	ADP	O
the	O	DET	O
suppression	O	NOUN	B
of	O	ADP	O
constitutive	O	ADJ	B
SLA-DR	O	NOUN	B
and	O	CCONJ	O
SLA-DQ	O	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


T-cell	O	NOUN	B
proliferation	O	NOUN	I
studies	O	NOUN	I
were	O	AUX	O
performed	O	VERB	O
using	O	VERB	O
highly	O	ADV	O
purified	O	VERB	B
human	B-cell_type	ADJ	B
CD4+	I-cell_type	ADJ	B
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Normal	O	ADJ	B
artery	O	NOUN	I
specimens	O	NOUN	I
(	O	PUNCT	O
n	O	NOUN	O
=	O	ADJ	O
6	O	NUM	O
)	O	PUNCT	O
reveal	O	VERB	O
minimal	B-protein	ADJ	O
immunoreactive	I-protein	ADJ	B
PPARgamma	I-protein	NOUN	B
.	O	PUNCT	O


Crkl	B-protein	NOUN	B
,	O	PUNCT	O
an	O	DET	O
SH2/SH3	B-protein	NOUN	B
adapter	I-protein	NOUN	I
protein	I-protein	NOUN	I
,	O	PUNCT	O
becomes	O	VERB	O
coimmunoprecipitated	O	VERB	B
specifically	O	ADV	O
with	O	ADP	O
STAT5	B-protein	NOUN	B
from	O	ADP	O
erythropoietin-stimulated	B-cell_type	ADJ	B
erythroid	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
;	O	PUNCT	O
although	O	SCONJ	O
it	O	PRON	O
was	O	AUX	O
shown	O	VERB	O
to	O	PART	O
become	O	VERB	O
associated	O	VERB	B
with	O	ADP	I
c-Cbl	B-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
studies	O	NOUN	B
using	O	VERB	O
cell	B-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
.	O	PUNCT	O


This	O	DET	O
report	O	NOUN	B
sets	O	VERB	I
a	O	DET	O
basis	O	NOUN	O
for	O	ADP	O
further	O	ADJ	O
studies	O	NOUN	B
on	O	ADP	O
signaling	O	NOUN	B
in	O	ADP	O
primary	B-cell_type	ADJ	B
cultured	I-cell_type	VERB	I
human	I-cell_type	ADJ	B
erythroid	I-cell_type	ADJ	O
precursors	I-cell_type	NOUN	O
,	O	PUNCT	O
which	O	DET	O
in	O	ADP	O
turn	O	NOUN	O
contribute	O	VERB	O
to	O	ADP	O
our	O	PRON	O
better	O	ADJ	O
understanding	O	NOUN	O
in	O	ADP	O
the	O	DET	O
differentiation	O	NOUN	B
processes	O	NOUN	O
of	O	ADP	O
erythrocytes	B-cell_type	NOUN	B
and	O	CCONJ	O
their	O	PRON	O
precursors	O	NOUN	B
.	O	PUNCT	O


DNA-binding	O	ADJ	B
activities	O	NOUN	O
(	O	PUNCT	O
determined	O	VERB	O
by	O	ADP	O
the	O	DET	O
electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assay	O	NOUN	I
)	O	PUNCT	O
of	O	ADP	O
three	O	NUM	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
:	O	PUNCT	O
NFkappaB	B-protein	NOUN	B
,	O	PUNCT	O
AP-1	B-protein	NOUN	B
and	O	CCONJ	O
NFAT	B-protein	NOUN	B
,	O	PUNCT	O
were	O	AUX	O
abolished	O	VERB	O
in	O	ADP	O
the	O	DET	O
lymphocytes	B-cell_type	NOUN	B
by	O	ADP	O
all	O	DET	O
three	O	NUM	O
modes	O	NOUN	B
of	O	ADP	O
oxidative	O	ADJ	B
stress	O	NOUN	I
.	O	PUNCT	O


TGFs	B-protein	NOUN	B
play	O	VERB	O
important	O	ADJ	O
roles	O	NOUN	O
in	O	ADP	O
wound	O	NOUN	B
healing	O	NOUN	I
and	O	CCONJ	O
carcinogenesis	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
previously	O	ADV	O
demonstrated	O	VERB	O
that	O	SCONJ	O
eosinophils	B-cell_type	NOUN	B
infiltrating	O	VERB	I
into	O	ADP	O
different	O	ADJ	O
pathologic	O	ADJ	B
processes	O	NOUN	I
elaborate	O	VERB	O
TGF-alpha	B-protein	NOUN	B
and	O	CCONJ	O
TGF-beta1	B-protein	NOUN	B
.	O	PUNCT	O


Supernatants	O	NOUN	B
from	O	ADP	O
these	O	DET	O
cultures	O	NOUN	B
were	O	AUX	O
assayed	O	VERB	B
for	O	ADP	O
secreted	O	VERB	B
TGF-alpha	B-protein	NOUN	B
and	O	CCONJ	O
TGF-beta1	B-protein	NOUN	B
using	O	VERB	O
TGF	B-protein	NOUN	B
-specific	O	ADJ	O
ELISAs	O	NOUN	B
.	O	PUNCT	O


Consistent	O	ADJ	B
with	O	ADP	I
the	O	DET	O
ability	O	NOUN	O
of	O	ADP	O
IL-4	B-protein	NOUN	B
to	O	PART	O
regulate	O	VERB	B
eosinophil	O	NOUN	B
responses	O	NOUN	O
,	O	PUNCT	O
IL-4	B-protein	NOUN	B
signaling	I-protein	NOUN	I
molecules	I-protein	NOUN	I
are	O	AUX	O
present	O	ADJ	O
in	O	ADP	O
human	B-cell_type	ADJ	B
eosinophils	I-cell_type	NOUN	B
.	O	PUNCT	O


The	O	DET	O
translocation	B-DNA	NOUN	B
t	I-DNA	NOUN	O
(	I-DNA	PUNCT	O
10	I-DNA	NUM	O
;	I-DNA	PUNCT	O
11	I-DNA	NUM	O
)	I-DNA	PUNCT	O
(	I-DNA	PUNCT	O
p13	I-DNA	NOUN	B
;	I-DNA	PUNCT	O
q14	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
has	O	AUX	O
been	O	AUX	O
observed	O	VERB	O
in	O	ADP	O
acute	O	ADJ	B
lymphoblastic	O	ADJ	I
leukemia	O	NOUN	I
(	O	PUNCT	O
ALL	O	NOUN	B
)	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
acute	O	ADJ	B
myeloid	O	ADJ	I
leukemia	O	NOUN	I
(	O	PUNCT	O
AML	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


In	O	ADP	O
all	O	DET	O
3	O	NUM	O
cases	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
characteristic	O	ADJ	O
immunophenotype	O	NOUN	B
was	O	AUX	O
identified	O	VERB	O
(	O	PUNCT	O
CD4+	B-protein	ADJ	B
,	O	PUNCT	O
CD13	B-protein	NOUN	B
-	O	PUNCT	O
,	O	PUNCT	O
CD33+	O	ADJ	B
,	O	PUNCT	O
CD65s+	O	ADJ	B
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
role	O	NOUN	O
of	O	ADP	O
E-proteins	B-protein	NOUN	B
in	O	ADP	O
B-	O	NOUN	B
and	O	CCONJ	O
T-lymphocyte	O	NOUN	B
development	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
review	O	NOUN	B
we	O	PRON	O
describe	O	VERB	O
the	O	DET	O
defects	O	NOUN	B
in	O	ADP	O
B-	O	NOUN	B
and	O	CCONJ	O
T-	O	NOUN	B
lymphocyte	O	NOUN	I
development	O	NOUN	I
in	O	ADP	O
mice	O	NOUN	B
carrying	O	VERB	O
targeted	O	VERB	O
mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
E-protein	B-DNA	NOUN	B
genes	I-DNA	NOUN	I
and	O	CCONJ	O
discuss	O	VERB	O
our	O	PRON	O
current	O	ADJ	O
understanding	O	NOUN	O
of	O	ADP	O
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
these	O	DET	O
proteins	O	NOUN	B
in	O	ADP	O
lymphoid	O	ADJ	B
development	O	NOUN	B


One	O	NUM	O
site	O	NOUN	B
is	O	AUX	O
similar	O	ADJ	O
to	O	PART	O
activated	O	VERB	B
TNFRII	B-protein	NOUN	B
in	O	ADP	O
associating	O	VERB	O
with	O	ADP	O
TNFR-associated	B-protein	ADJ	B
factors	I-protein	NOUN	I
TRAF1	B-protein	NOUN	B
and	O	CCONJ	O
TRAF2	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
second	O	ADJ	O
site	O	NOUN	B
is	O	AUX	O
similar	O	ADJ	O
to	O	PART	O
TNFRI	B-protein	NOUN	B
in	O	ADP	O
associating	O	VERB	O
with	O	ADP	O
the	O	DET	O
TNFRI	B-protein	NOUN	B
death	I-protein	NOUN	O
domain	I-protein	NOUN	B
interacting	I-protein	NOUN	I
protein	I-protein	NOUN	I
TRADD	B-protein	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
report	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
NF-kappaB	B-protein	NOUN	B
activation	O	NOUN	B
by	O	ADP	O
LMP1	B-protein	NOUN	B
or	O	CCONJ	O
by	O	ADP	O
each	O	DET	O
of	O	ADP	O
its	O	PRON	O
effector	B-protein	NOUN	B
sites	I-protein	NOUN	I
is	O	AUX	O
mediated	O	VERB	O
by	O	ADP	O
a	O	DET	O
pathway	O	NOUN	B
that	O	PRON	O
includes	O	VERB	O
NIK	B-protein	NOUN	B
,	O	PUNCT	O
IKKalpha	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
IKKbeta	B-protein	NOUN	B
.	O	PUNCT	O


Exposure	O	NOUN	B
of	O	ADP	I
cells	O	NOUN	O
to	O	PART	O
adverse	O	VERB	B
environmental	O	ADJ	B
conditions	O	NOUN	I
invokes	O	VERB	O
a	O	DET	O
genetically	O	ADV	B
programmed	O	VERB	O
series	O	NOUN	O
of	O	ADP	O
events	O	NOUN	B
resulting	O	VERB	O
in	O	ADP	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
specific	B-DNA	ADJ	O
genes	I-DNA	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
present	O	ADJ	O
investigation	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
ciprofloxacin	O	NOUN	B
at	O	ADP	O
supratherapeutic	O	ADJ	B
concentrations	O	NOUN	B
on	O	ADP	O
immediate-early	O	ADJ	B
(	O	PUNCT	O
<	O	X	O
2	O	NUM	O
h	O	NOUN	O
)	O	PUNCT	O
gene	O	NOUN	B
expression	O	NOUN	I
in	O	ADP	O
primary	B-cell_type	ADJ	B
human	I-cell_type	ADJ	B
peripheral	I-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
lymphocytes	I-cell_type	NOUN	I
was	O	AUX	O
studied	O	VERB	O
with	O	ADP	O
Northern	O	NOUN	B
blots	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
recently	O	ADV	O
developed	O	VERB	O
a	O	DET	O
novel	O	ADJ	O
RAR	B-protein	NOUN	B
-selective	O	ADJ	O
antagonist	O	NOUN	B
(	O	PUNCT	O
ER27191	O	NOUN	B
)	O	PUNCT	O
which	O	DET	O
prevents	O	VERB	B
RAR	B-protein	NOUN	B
activation	O	NOUN	B
by	O	ADP	O
retinoids	O	NOUN	B
.	O	PUNCT	O


Additional	O	ADJ	O
experiments	O	NOUN	B
showed	O	VERB	O
that	O	SCONJ	O
levels	O	NOUN	B
of	O	ADP	O
BCL-2	B-protein	NOUN	B
protein	I-protein	NOUN	I
decreased	O	VERB	B
during	O	ADP	O
differentiation	O	NOUN	B
of	O	ADP	O
myeloid	B-cell_type	ADJ	B
leukemic	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
HL-60	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
transduced	O	VERB	B
with	O	ADP	O
a	O	DET	O
bcl-2	B-DNA	NOUN	B
expression	I-DNA	NOUN	B
vector	I-DNA	NOUN	I
showed	O	VERB	O
the	O	DET	O
same	O	ADJ	O
differentiation	O	NOUN	B
response	O	NOUN	O
to	O	PART	O
retinoids	O	NOUN	B
as	O	ADP	O
did	O	AUX	O
parental	B-cell_line	ADJ	B
HL-60	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
even	O	ADV	O
though	O	SCONJ	O
apoptosis	O	NOUN	B
was	O	AUX	O
inhibited	O	VERB	B
in	O	ADP	O
these	O	DET	O
bcl-2-transduced	B-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
differentiation	O	NOUN	B
and	O	CCONJ	O
apoptosis	O	NOUN	B
are	O	AUX	O
regulated	O	VERB	O
independently	O	ADV	O
in	O	ADP	O
myeloid	B-cell_type	ADJ	B
leukemic	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


More	O	ADJ	O
than	O	ADP	O
50	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
TPO-treated	B-cell_line	ADJ	B
UT-7/GMT	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
positively	O	ADV	O
stained	O	VERB	O
for	O	ADP	O
Hb	B-protein	NOUN	B
.	O	PUNCT	O


Biologic	O	ADJ	B
effects	O	NOUN	B
of	O	ADP	O
IL-13	B-protein	NOUN	B
on	O	ADP	O
primary	B-cell_type	ADJ	O
human	I-cell_type	ADJ	B
NK	I-cell_type	NOUN	B
and	I-cell_type	CCONJ	O
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
have	O	AUX	O
not	O	PART	O
been	O	AUX	O
well	O	ADV	O
defined	O	VERB	O
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
IL-13	B-protein	NOUN	B
,	O	PUNCT	O
like	O	ADP	O
IL-4	B-protein	NOUN	B
,	O	PUNCT	O
induces	O	VERB	B
distinct	O	ADJ	O
STAT6-DNA	B-protein	NOUN	B
binding	I-protein	NOUN	I
complexes	I-protein	NOUN	I
and	O	CCONJ	O
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	I
of	O	ADP	O
STAT6	B-protein	NOUN	B
and	O	CCONJ	O
Janus	B-protein	NOUN	B
kinase	I-protein	NOUN	I
3	I-protein	NUM	I
(	O	PUNCT	O
JAK3	B-protein	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
NK	O	NOUN	B
and	O	CCONJ	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


These	O	DET	O
findings	O	NOUN	B
show	O	VERB	O
that	O	SCONJ	O
IL-13	B-protein	NOUN	B
and	O	CCONJ	O
IL-4	B-protein	NOUN	B
have	O	AUX	O
the	O	DET	O
ability	O	NOUN	O
to	O	PART	O
regulate	O	VERB	B
NK	O	NOUN	B
and	O	CCONJ	O
T	O	NOUN	B
cell	O	NOUN	I
activation	O	NOUN	B
and	O	CCONJ	O
that	O	SCONJ	O
IL-13	B-protein	NOUN	B
is	O	AUX	O
a	O	DET	O
potent	O	ADJ	O
regulator	O	NOUN	B
of	O	ADP	O
STAT6	B-protein	NOUN	B
and	O	CCONJ	O
JAK3	B-protein	NOUN	B
in	O	ADP	O
these	O	DET	O
cell	O	NOUN	B
types	O	NOUN	I
.	O	PUNCT	O


Inhibition	O	NOUN	B
of	O	ADP	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
kappaB	I-protein	NOUN	I
activation	O	NOUN	I
attenuates	O	VERB	B
apoptosis	O	NOUN	B
resistance	O	NOUN	B
in	O	ADP	O
lymphoid	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


NFkappaB	B-protein	NOUN	B
activity	O	NOUN	O
is	O	AUX	O
independent	O	ADJ	O
from	O	ADP	O
FADD	B-protein	NOUN	B
,	O	PUNCT	O
caspases	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
apoptosis	O	NOUN	B
induction	O	NOUN	B
.	O	PUNCT	O


Pax-5	B-protein	NOUN	B
codes	O	VERB	I
for	O	ADP	O
the	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
BSAP	B-protein	NOUN	I
which	O	DET	O
is	O	AUX	O
expressed	O	VERB	B
throughout	O	ADP	O
B	O	NOUN	B
cell	O	NOUN	I
development	O	NOUN	O
except	O	SCONJ	O
in	O	ADP	O
terminally	B-cell_type	ADV	O
differentiated	I-cell_type	VERB	O
plasma	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Gene	O	NOUN	B
targeting	O	NOUN	I
experiments	O	NOUN	B
in	O	ADP	O
the	O	DET	O
mouse	O	NOUN	B
revealed	O	VERB	O
a	O	DET	O
differential	O	ADJ	O
dependency	O	NOUN	O
of	O	ADP	O
fetal	O	ADJ	B
and	O	CCONJ	O
adult	O	ADJ	B
B-lymphopoiesis	O	NOUN	B
on	O	ADP	O
this	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
functional	O	ADJ	B
effects	O	NOUN	O
of	O	ADP	O
these	O	DET	O
interactions	O	NOUN	B
are	O	AUX	O
that	O	SCONJ	O
CBP	B-protein	NOUN	B
and	O	CCONJ	O
p300	B-protein	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
P/CAF	B-protein	NOUN	B
,	O	PUNCT	O
enhance	O	VERB	O
EKLF	B-protein	NOUN	B
's	O	PART	I
transcriptional	O	ADJ	B
activation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
beta-globin	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
in	O	ADP	O
erythroid	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Adhesion	O	NOUN	B
to	O	PART	O
extracellular	O	ADJ	B
matrices	O	NOUN	I
is	O	AUX	O
known	O	VERB	O
to	O	PART	O
modulate	O	VERB	B
leukocyte	O	NOUN	B
activation	O	NOUN	I
,	O	PUNCT	O
although	O	SCONJ	O
the	O	DET	O
mechanisms	O	NOUN	B
are	O	AUX	O
not	O	PART	O
fully	O	ADV	O
understood	O	VERB	O
.	O	PUNCT	O


NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activation	O	NOUN	B
,	O	PUNCT	O
minimal	O	ADJ	B
in	O	ADP	O
unstimulated	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
was	O	AUX	O
substantially	O	ADV	O
up-regulated	O	VERB	B
by	O	ADP	O
fibrinogen	B-protein	NOUN	B
.	O	PUNCT	O


Peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
monocytes	B-cell_type	NOUN	B
and	O	CCONJ	O
B	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
derived	O	VERB	O
from	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
lupus	O	NOUN	B
express	O	VERB	O
estrogen	O	NOUN	B
receptor	O	NOUN	I
transcripts	O	NOUN	B
similar	O	ADJ	O
to	O	PART	O
those	O	DET	O
of	O	ADP	O
normal	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Some	O	DET	O
monocytes	B-cell_type	NOUN	B
and	O	CCONJ	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
were	O	AUX	O
stimulated	O	VERB	B
with	O	ADP	O
estradiol	O	NOUN	B
,	O	PUNCT	O
PMA	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
ionomycin	O	NOUN	B
.	O	PUNCT	O


There	O	PRON	O
were	O	AUX	O
no	O	DET	O
notable	O	ADJ	O
differences	O	NOUN	O
in	O	ADP	O
the	O	DET	O
ER	B-RNA	NOUN	B
transcripts	I-RNA	NOUN	B
between	O	ADP	O
patients	O	NOUN	B
and	O	CCONJ	O
healthy	O	ADJ	B
controls	O	NOUN	I
.	O	PUNCT	O


Precise	O	ADJ	O
deletion	O	NOUN	B
of	O	ADP	O
the	O	DET	O
exons	O	NOUN	B
suggests	O	VERB	O
that	O	SCONJ	O
they	O	PRON	O
are	O	AUX	O
alternatively	O	ADV	O
spliced	O	VERB	B
transcripts	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
1.2	O	NUM	O
kb	O	NOUN	O
FasL	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
responded	O	VERB	O
to	O	PART	O
DNA	O	NOUN	B
damage	O	NOUN	I
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
coexpression	O	NOUN	B
with	O	ADP	O
p65	B-protein	NOUN	B
Rel	I-protein	NOUN	I
or	O	CCONJ	O
Fos/Jun	B-protein	NOUN	B
.	O	PUNCT	O


Although	O	SCONJ	O
all	O	DET	O
MRD-positive	O	ADJ	B
patients	O	NOUN	B
in	O	ADP	O
LT	O	ADJ	B
remission	O	NOUN	B
are	O	AUX	O
still	O	ADV	O
until	O	ADP	O
now	O	ADV	O
event-free	O	ADJ	B
,	O	PUNCT	O
3	O	NUM	O
of	O	ADP	O
the	O	DET	O
7	O	NUM	O
MRD-positive	O	ADJ	B
(	O	PUNCT	O
MRD+	O	ADJ	B
)	O	PUNCT	O
patients	O	NOUN	B
in	O	ADP	O
ST	O	ADJ	B
remission	O	NOUN	B
soon	O	ADV	O
relapsed	O	ADJ	B
.	O	PUNCT	O


The	O	DET	O
CD8	B-protein	NOUN	B
+	O	CCONJ	O
CD28	B-protein	NOUN	B
+	O	CCONJ	O
population	O	NOUN	B
showed	O	VERB	O
the	O	DET	O
same	O	ADJ	O
tendency	O	NOUN	O
(	O	PUNCT	O
p	O	NOUN	O
<	O	X	O
.01-.02	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
major	O	ADJ	O
goal	O	NOUN	B
of	O	ADP	O
this	O	DET	O
study	O	NOUN	B
was	O	AUX	O
to	O	PART	O
determine	O	VERB	O
whether	O	SCONJ	O
the	O	DET	O
mycobacterial	B-cell_type	ADJ	B
cell	I-cell_type	NOUN	B
wall	O	NOUN	I
component	O	NOUN	O
mannose-capped	O	ADJ	O
lipoarabinomannan	O	NOUN	O
(	O	PUNCT	O
ManLAM	O	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
Mycobacterium	O	X	B
tuberculosis	O	X	I
(	O	PUNCT	O
M.	O	X	B
tuberculosis	O	X	I
)	O	PUNCT	O
could	O	AUX	O
activate	O	VERB	B
transcription	O	NOUN	B
of	O	ADP	O
HIV-1	O	NOUN	B
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
with	O	ADP	O
the	O	DET	O
use	O	NOUN	O
of	O	ADP	O
an	O	DET	O
in	O	X	B
vitro	O	X	I
cell	O	NOUN	B
culture	O	NOUN	I
system	O	NOUN	I
.	O	PUNCT	O


Differences	O	NOUN	B
in	O	ADP	O
LTR	B-DNA	NOUN	B
sequence	I-DNA	NOUN	O
also	O	ADV	O
resulted	O	VERB	O
in	O	ADP	O
differences	O	NOUN	O
in	O	ADP	O
transcription	O	NOUN	B
factor	O	NOUN	I
recruitment	O	NOUN	B
to	O	PART	O
cis-acting	B-DNA	ADJ	B
sites	I-DNA	NOUN	I
within	O	ADP	O
the	O	DET	O
U3	B-DNA	NOUN	B
region	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
LTR	B-DNA	NOUN	B
,	O	PUNCT	O
as	O	ADP	O
demonstrated	O	VERB	O
by	O	ADP	O
electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assays	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
findings	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
LTR	B-DNA	NOUN	B
sequence	I-DNA	NOUN	O
changes	O	NOUN	B
can	O	AUX	O
significantly	O	ADV	O
affect	O	VERB	O
basal	O	ADJ	B
LTR	B-DNA	NOUN	O
function	O	NOUN	O
and	O	CCONJ	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
recruitment	O	NOUN	I
,	O	PUNCT	O
which	O	DET	O
may	O	AUX	O
,	O	PUNCT	O
in	O	ADP	O
turn	O	NOUN	O
,	O	PUNCT	O
alter	O	VERB	O
the	O	DET	O
course	O	NOUN	B
of	O	ADP	O
viral	O	ADJ	B
replication	O	NOUN	I
in	O	ADP	O
cells	O	NOUN	B
of	O	ADP	O
CNS	O	NOUN	B
and	O	CCONJ	O
immune	O	ADJ	B
system	O	NOUN	I
origin	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
lymphocyte	B-cell_type	NOUN	B
differentiation	O	NOUN	I
,	O	PUNCT	O
several	O	ADJ	O
HMG	B-protein	NOUN	B
box	I-protein	NOUN	I
proteins	I-protein	NOUN	I
play	O	VERB	O
a	O	DET	O
decisive	O	ADJ	O
role	O	NOUN	O
.	O	PUNCT	O


Proliferation	O	NOUN	B
index	O	NOUN	I
as	O	ADP	O
a	O	DET	O
prognostic	O	ADJ	B
marker	O	NOUN	I
in	O	ADP	O
breast	O	NOUN	B
cancer	O	NOUN	I
.	O	PUNCT	O


Life-table	O	ADJ	B
analysis	O	NOUN	I
(	O	PUNCT	O
Mantel-Cox	O	NOUN	B
)	O	PUNCT	O
was	O	AUX	O
used	O	VERB	O
to	O	PART	O
assess	O	VERB	B
the	O	DET	O
probability	O	NOUN	B
of	O	ADP	O
disease-free	O	ADJ	B
survival	O	NOUN	I
(	O	PUNCT	O
DFS	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
overall	O	ADJ	B
survival	O	NOUN	I
(	O	PUNCT	O
OS	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
this	O	DET	O
proliferative	O	ADJ	B
parameter	O	NOUN	O
maintained	O	VERB	O
its	O	PRON	O
prognostic	O	ADJ	B
significance	O	NOUN	O
when	O	SCONJ	O
the	O	DET	O
patients	O	NOUN	B
were	O	AUX	O
stratified	O	VERB	B
according	O	VERB	O
to	O	PART	O
lymph	O	NOUN	B
node	O	NOUN	I
involvement	O	NOUN	B
,	O	PUNCT	O
menopausal	O	ADJ	B
status	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
nuclear	B-protein	ADJ	B
estrogen	I-protein	NOUN	I
receptor	I-protein	NOUN	I
content	O	NOUN	B
.	O	PUNCT	O


Tumor	O	NOUN	B
proliferative	O	ADJ	I
activity	O	NOUN	I
as	O	ADP	O
evaluated	O	VERB	B
by	O	ADP	O
the	O	DET	O
monoclonal	B-protein	ADJ	B
antibody	I-protein	NOUN	I
Ki-67	I-protein	NOUN	B
seems	O	VERB	O
to	O	PART	O
be	O	AUX	O
an	O	DET	O
effective	O	ADJ	B
indicator	O	NOUN	B
of	O	ADP	O
prognosis	O	NOUN	B
in	O	ADP	O
breast	O	NOUN	B
cancer	O	NOUN	I
for	O	ADP	O
DFS	O	NOUN	B
and	O	CCONJ	O
OS	O	NOUN	B
.	O	PUNCT	O


Co-immunoprecipitation	O	NOUN	B
experiments	O	NOUN	B
demonstrated	O	VERB	O
an	O	DET	O
association	O	NOUN	B
between	O	ADP	O
Elf-1	B-protein	NOUN	B
and	O	CCONJ	O
Rb	B-protein	NOUN	B
in	O	ADP	O
resting	B-cell_type	VERB	B
normal	I-cell_type	ADJ	I
human	I-cell_type	ADJ	I
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
demonstrate	O	VERB	O
that	O	SCONJ	O
Rb	B-protein	NOUN	B
interacts	O	VERB	B
specifically	O	ADV	O
with	O	ADP	O
a	O	DET	O
lineage-restricted	B-protein	ADJ	O
Ets	I-protein	NOUN	O
transcription	I-protein	NOUN	O
factor	I-protein	NOUN	O
.	O	PUNCT	O


Human	B-cell_line	ADJ	B
CD3-CD16+	I-cell_line	ADJ	B
natural	I-cell_line	ADJ	B
killer	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
express	O	VERB	O
the	O	DET	O
hGATA-3	B-protein	NOUN	O
T	I-protein	NOUN	B
cell	I-protein	NOUN	I
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
and	O	CCONJ	O
an	O	DET	O
unrearranged	O	ADJ	B
2.3-kb	B-protein	ADJ	B
TcR	I-protein	NOUN	I
delta	I-protein	NOUN	I
transcript	I-protein	NOUN	I
.	O	PUNCT	O


Multiple	O	ADJ	B
TcR	B-protein	NOUN	I
delta	I-protein	NOUN	I
transcripts	I-protein	NOUN	B
deriving	O	VERB	O
from	O	ADP	O
an	O	DET	O
unrearranged	O	ADJ	B
TcR	B-DNA	NOUN	I
delta	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
were	O	AUX	O
detected	O	VERB	B
in	O	ADP	O
both	O	CCONJ	O
polyclonal	B-cell_line	ADJ	B
and	I-cell_line	CCONJ	O
clonal	I-cell_line	ADJ	B
CD3-CD16+	I-cell_line	ADJ	B
natural	I-cell_line	ADJ	O
killer	I-cell_line	NOUN	O
(	I-cell_line	PUNCT	O
NK	I-cell_line	NOUN	O
)	I-cell_line	PUNCT	O
cell	I-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
.	O	PUNCT	O


All	O	DET	O
NK	B-cell_line	NOUN	B
clones	I-cell_line	NOUN	I
and	O	CCONJ	O
cell	O	NOUN	B
lines	O	NOUN	I
studied	O	VERB	O
were	O	AUX	O
found	O	VERB	O
to	O	PART	O
express	O	VERB	O
hGATA-3-specific	B-RNA	ADJ	O
mRNA	I-RNA	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
hGATA-3	B-protein	NOUN	B
may	O	AUX	O
be	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
unrearranged	O	ADJ	B
TcR	B-DNA	NOUN	I
delta	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
expression	O	NOUN	O
in	O	ADP	O
NK	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


The	O	DET	O
activated	O	VERB	B
form	O	NOUN	O
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
rapidly	O	ADV	O
taken	O	VERB	O
up	O	ADP	O
into	O	ADP	O
nuclei	O	NOUN	B
,	O	PUNCT	O
initiates	O	VERB	B
transcription	O	NOUN	B
from	O	ADP	O
immediate	O	ADJ	O
early	O	ADJ	O
genes	O	NOUN	O
in	O	ADP	O
a	O	DET	O
wide	O	ADJ	O
variety	O	NOUN	O
of	O	ADP	O
cell	O	NOUN	B
types	O	NOUN	I
.	O	PUNCT	O


Most	O	ADJ	O
of	O	ADP	O
the	O	DET	O
target	O	NOUN	B
genes	O	NOUN	O
for	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
are	O	AUX	O
of	O	ADP	O
relevance	O	NOUN	B
for	O	ADP	O
the	O	DET	O
immune	O	ADJ	B
response	O	NOUN	I
and	O	CCONJ	O
can	O	AUX	O
be	O	AUX	O
grouped	O	VERB	B
into	O	ADP	O
those	O	DET	O
encoding	O	VERB	B
cytokines	B-protein	NOUN	B
,	O	PUNCT	O
cell	B-protein	NOUN	B
surface	I-protein	NOUN	I
receptors	I-protein	NOUN	I
,	O	PUNCT	O
acute	B-protein	ADJ	B
phase	I-protein	NOUN	I
proteins	I-protein	NOUN	I
and	O	CCONJ	O
viral	B-DNA	ADJ	B
genomes	I-DNA	NOUN	I
,	O	PUNCT	O
such	O	ADJ	O
as	O	ADP	O
that	O	DET	O
of	O	ADP	O
human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
type	O	NOUN	I
1	O	NUM	I
(	O	PUNCT	O
HIV-1	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Differential	O	ADJ	B
contribution	O	NOUN	I
of	O	ADP	O
herpes	B-protein	NOUN	B
simplex	I-protein	NOUN	I
virus	I-protein	NOUN	I
type	I-protein	NOUN	I
1	I-protein	NUM	I
gene	I-protein	NOUN	I
products	I-protein	NOUN	I
and	O	CCONJ	O
cellular	B-protein	ADJ	B
factors	I-protein	NOUN	I
to	O	PART	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
type	O	NOUN	I
1	O	NUM	I
provirus	O	NOUN	I
.	O	PUNCT	O


Transcriptional	O	ADJ	B
activation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
macrophage	B-DNA	NOUN	B
colony-stimulating	I-DNA	ADJ	O
factor	I-DNA	NOUN	O
gene	I-DNA	NOUN	O
by	O	ADP	O
IL-2	B-protein	NOUN	B
is	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
secretion	O	NOUN	B
of	O	ADP	O
bioactive	O	ADJ	B
macrophage	B-protein	NOUN	I
colony-stimulating	I-protein	ADJ	B
factor	I-protein	NOUN	I
protein	I-protein	NOUN	I
by	O	ADP	O
monocytes	B-cell_type	NOUN	B
and	O	CCONJ	O
involves	O	VERB	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
NF-kappa	B-protein	NOUN	I
B	I-protein	NOUN	I
.	O	PUNCT	O


Human	B-cell_type	ADJ	B
peripheral	I-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
monocytes	I-cell_type	NOUN	I
(	O	PUNCT	O
Mo	B-cell_type	NOUN	B
)	O	PUNCT	O
constitutively	O	ADV	B
display	O	VERB	I
the	O	DET	O
beta-chain	O	NOUN	B
of	O	ADP	O
the	O	DET	O
receptor	O	NOUN	B
for	O	ADP	O
IL-2	B-protein	NOUN	B
,	O	PUNCT	O
whereas	O	SCONJ	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IL-2R	B-protein	NOUN	B
alpha-chain	I-protein	NOUN	I
is	O	AUX	O
not	O	PART	O
constitutive	O	ADJ	B
but	O	CCONJ	O
inducible	O	ADJ	B
with	O	ADP	O
IL-2	B-protein	NOUN	B
.	O	PUNCT	O


Transcriptional	O	ADJ	B
activation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
M-CSF	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
by	O	ADP	O
IL-2	B-protein	NOUN	B
is	O	AUX	O
preceded	O	VERB	O
by	O	ADP	O
enhanced	O	VERB	B
binding	O	NOUN	B
activity	O	NOUN	I
of	O	ADP	O
the	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
NF-kappa	B-protein	NOUN	I
B	I-protein	NOUN	I
to	O	PART	O
its	O	PRON	O
recognition	O	NOUN	B
sequence	O	NOUN	I
in	O	ADP	O
the	O	DET	O
5	O	NUM	O
'	O	PART	O
regulatory	O	ADJ	B
enhancer	O	NOUN	I
region	O	NOUN	I
of	O	ADP	O
the	O	DET	O
M-CSF	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
.	O	PUNCT	O


Regulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
interleukin-1	B-DNA	NOUN	B
beta	I-DNA	NOUN	I
(	I-DNA	PUNCT	O
IL-1	I-DNA	NOUN	B
beta	I-DNA	NOUN	I
)	I-DNA	PUNCT	I
gene	I-DNA	NOUN	I
by	O	ADP	O
mycobacterial	B-protein	ADJ	B
components	I-protein	NOUN	B
and	O	CCONJ	O
lipopolysaccharide	O	NOUN	B
is	O	AUX	O
mediated	O	VERB	O
by	O	ADP	O
two	O	NUM	O
nuclear	B-DNA	ADJ	B
factor-IL6	I-DNA	ADJ	I
motifs	I-DNA	NOUN	I
.	O	PUNCT	O


Within	O	ADP	O
this	O	DET	O
DNA	O	NOUN	B
fragment	O	NOUN	I
,	O	PUNCT	O
there	O	PRON	O
were	O	AUX	O
two	O	NUM	O
novel	O	ADJ	O
9-bp	O	ADJ	O
motifs	O	NOUN	B
(	O	PUNCT	O
-90/-82	O	NUM	O
and	O	CCONJ	O
-40/-32	O	NUM	O
)	O	PUNCT	O
with	O	ADP	O
high	O	ADJ	O
homology	O	NOUN	B
to	O	PART	O
the	O	DET	O
nuclear	B-DNA	ADJ	B
factor-IL6	I-DNA	NOUN	I
(	I-DNA	PUNCT	I
NF-IL6	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
binding	I-DNA	NOUN	B
site	I-DNA	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
found	O	VERB	O
that	O	SCONJ	O
Nef	B-protein	NOUN	B
inhibited	O	VERB	B
the	O	DET	O
recruitment	O	NOUN	B
of	O	ADP	O
AP-1	B-protein	NOUN	B
DNA-binding	O	ADJ	I
activity	O	NOUN	I
in	O	ADP	O
mitogen-stimulated	O	ADJ	B
human	B-cell_type	ADJ	O
T-cells	I-cell_type	NOUN	O
.	O	PUNCT	O


Recent	O	ADJ	O
studies	O	NOUN	B
have	O	AUX	O
provided	O	VERB	O
new	O	ADJ	O
insights	O	NOUN	O
into	O	ADP	O
how	O	SCONJ	O
the	O	DET	O
individual	O	ADJ	B
genes	O	NOUN	B
of	O	ADP	O
the	O	DET	O
cluster	O	NOUN	B
are	O	AUX	O
regulated	O	VERB	B
through	O	ADP	O
development	O	NOUN	B
.	O	PUNCT	O


Two	O	NUM	O
transcriptional	O	ADJ	B
elements	O	NOUN	I
in	O	ADP	O
the	O	DET	O
TSP	B-protein	NOUN	B
1	I-protein	NUM	O
promoter	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
distal	O	ADJ	B
element	O	NOUN	I
at	O	ADP	O
-1280	O	NUM	O
and	O	CCONJ	O
a	O	DET	O
proximal	O	ADJ	B
element	O	NOUN	O
at	O	ADP	O
-65	O	NUM	B
,	O	PUNCT	O
were	O	AUX	O
required	O	VERB	O
for	O	ADP	O
the	O	DET	O
response	O	NOUN	B
of	O	ADP	O
the	O	DET	O
human	O	ADJ	B
TSP	O	NOUN	O
1	O	NUM	O
gene	O	NOUN	B
to	O	PART	O
serum	O	NOUN	B
.	O	PUNCT	O


Deletions	O	NOUN	B
or	O	CCONJ	O
mutations	O	NOUN	B
in	O	ADP	O
this	O	DET	O
element	O	NOUN	B
reduced	O	VERB	B
the	O	DET	O
serum	O	NOUN	B
response	O	NOUN	I
of	O	ADP	O
the	O	DET	O
TSP	B-DNA	NOUN	B
1	I-DNA	NUM	O
gene	I-DNA	NOUN	B
by	O	ADP	O
80-90	O	NUM	O
%	O	NOUN	O
.	O	PUNCT	O


Cell-type-specific	O	ADJ	B
transactivation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
parathyroid	B-DNA	ADJ	B
hormone-related	I-DNA	ADJ	I
protein	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
promoter	I-DNA	NOUN	B
by	O	ADP	O
the	O	DET	O
human	B-protein	ADJ	B
T-cell	I-protein	NOUN	I
leukemia	I-protein	NOUN	I
virus	I-protein	NOUN	O
type	I-protein	NOUN	O
I	I-protein	NUM	O
(	I-protein	PUNCT	O
HTLV-I	I-protein	NOUN	B
)	I-protein	PUNCT	O
tax	I-protein	NOUN	O
and	O	CCONJ	O
HTLV-II	B-protein	NOUN	B
tax	I-protein	NOUN	I
proteins	I-protein	NOUN	I
.	O	PUNCT	O


They	O	PRON	O
are	O	AUX	O
part	O	NOUN	O
of	O	ADP	O
the	O	DET	O
high	B-protein	ADJ	O
affinity	I-protein	NOUN	O
IgE	I-protein	NOUN	O
receptor	I-protein	NOUN	O
in	O	ADP	O
mast	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
basophils	B-cell_type	NOUN	B
,	O	PUNCT	O
Langerhans	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
possibly	O	ADV	O
other	O	ADJ	O
cells	O	NOUN	B
;	O	PUNCT	O
a	O	DET	O
component	O	NOUN	B
of	O	ADP	O
the	O	DET	O
low	O	ADJ	B
affinity	O	NOUN	B
receptor	O	NOUN	I
for	O	ADP	O
IgG	B-protein	NOUN	B
(	O	PUNCT	O
Fc	B-protein	NOUN	B
gamma	I-protein	NOUN	I
RIIIA	I-protein	NOUN	I
or	O	CCONJ	O
CD16	B-protein	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
natural	O	ADJ	B
killer	B-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
macrophages	B-cell_type	NOUN	B
;	O	PUNCT	O
and	O	CCONJ	O
part	O	NOUN	O
of	O	ADP	O
the	O	DET	O
T	B-protein	NOUN	B
cell	I-protein	NOUN	I
antigen	I-protein	NOUN	I
receptor	I-protein	NOUN	I
in	O	ADP	O
subsets	O	NOUN	B
of	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Chlorinated	O	VERB	B
dibenzo-p-dioxins	O	NOUN	B
and	O	CCONJ	O
dibenzofurans	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
human	O	ADJ	B
immune	O	ADJ	B
system	O	NOUN	I
.	O	PUNCT	O


With	O	ADP	O
one	O	NUM	O
exception	O	NOUN	O
,	O	PUNCT	O
these	O	DET	O
were	O	AUX	O
all	O	DET	O
increases	O	NOUN	B
.	O	PUNCT	O


None	O	NOUN	O
of	O	ADP	O
the	O	DET	O
alterations	O	NOUN	B
observed	O	VERB	B
are	O	AUX	O
of	O	ADP	O
medical	O	ADJ	B
relevance	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
initial	O	ADJ	O
infection	O	NOUN	B
with	O	ADP	O
human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
type	O	NOUN	I
1	O	NUM	I
(	O	PUNCT	O
HIV-1	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
most	O	ADJ	O
individuals	O	NOUN	B
usually	O	ADV	O
results	O	VERB	B
in	O	ADP	O
the	O	DET	O
establishment	O	NOUN	O
of	O	ADP	O
a	O	DET	O
latent	O	ADJ	B
or	O	CCONJ	O
chronic	O	ADJ	B
infection	O	NOUN	I
before	O	ADP	O
eventual	O	ADJ	B
progression	O	NOUN	B
toward	O	ADP	O
acquired	O	VERB	B
immunodeficiency	O	NOUN	I
syndrome	O	NOUN	I
.	O	PUNCT	O


Expression	O	NOUN	B
of	O	ADP	O
mRNA	B-RNA	NOUN	B
for	O	ADP	O
the	O	DET	O
GATA-binding	B-protein	ADJ	B
proteins	I-protein	NOUN	I
in	O	ADP	O
human	B-cell_type	ADJ	B
eosinophils	I-cell_type	NOUN	I
and	O	CCONJ	O
basophils	B-cell_type	NOUN	B
:	O	PUNCT	O
potential	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
gene	O	NOUN	B
transcription	O	NOUN	I
.	O	PUNCT	O


Oxidoreductive	O	ADJ	B
regulation	O	NOUN	I
of	O	ADP	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
investigated	O	VERB	B
an	O	DET	O
oxidoreductive	O	ADJ	B
regulatory	O	ADJ	O
pathway	O	NOUN	O
for	O	ADP	O
the	O	DET	O
DNA	O	NOUN	B
binding	O	NOUN	I
activity	O	NOUN	I
of	O	ADP	O
a	O	DET	O
pleiotropic	B-protein	ADJ	B
cellular	I-protein	ADJ	O
transcription	I-protein	NOUN	O
factor	I-protein	NOUN	O
,	O	PUNCT	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
(	O	PUNCT	O
NF	B-protein	NOUN	O
kappa	I-protein	NOUN	O
B	I-protein	NOUN	O
)	O	PUNCT	O
,	O	PUNCT	O
has	O	AUX	O
been	O	AUX	O
investigated	O	VERB	B
by	O	ADP	O
using	O	VERB	O
NF	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
prepared	O	VERB	O
from	O	ADP	O
the	O	DET	O
nucleus	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
cytosol	O	NOUN	B
of	O	ADP	O
the	O	DET	O
primary	B-cell_type	ADJ	B
human	I-cell_type	ADJ	B
T	I-cell_type	NOUN	O
lymphocytes	I-cell_type	NOUN	O
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
hexamethylene	O	NOUN	B
bisacetamide	O	NOUN	I
(	O	PUNCT	O
HMBA	O	NOUN	B
)	O	PUNCT	O
induced	O	VERB	B
K562	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
to	O	PART	O
differentiate	O	VERB	B
along	O	ADP	O
a	O	DET	O
third	O	ADJ	O
pathway	O	NOUN	B
.	O	PUNCT	O


Stimulation	O	NOUN	B
of	O	ADP	O
highly	B-cell_type	ADV	O
purified	I-cell_type	VERB	B
human	I-cell_type	ADJ	B
T-cells	I-cell_type	NOUN	O
via	O	ADP	O
CD2	B-protein	NOUN	B
and	I-protein	CCONJ	O
CD28	I-protein	NOUN	B
adhesion	I-protein	NOUN	I
molecules	I-protein	NOUN	O
induces	O	VERB	B
and	O	CCONJ	O
maintains	O	VERB	B
proliferation	O	NOUN	B
for	O	ADP	O
more	O	ADJ	O
than	O	ADP	O
3	O	NUM	O
weeks	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
potent	O	ADJ	O
interleukin	B-protein	NOUN	B
2	I-protein	NUM	I
(	O	PUNCT	O
IL-2	B-protein	NOUN	B
)	O	PUNCT	O
-dependent	O	ADJ	O
activation	O	NOUN	B
does	O	AUX	O
not	O	PART	O
require	O	VERB	O
monocytes	B-cell_type	NOUN	B
or	O	CCONJ	O
accessory	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Increase	O	NOUN	B
of	O	ADP	O
IL-2R	B-DNA	NOUN	B
alpha	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
transcription	O	NOUN	O
involves	O	VERB	O
the	O	DET	O
enhanced	O	VERB	B
binding	O	NOUN	B
of	O	ADP	O
the	O	DET	O
transcription	O	NOUN	B
factor	O	NOUN	I
NF-kappa	B-protein	NOUN	I
B	I-protein	NOUN	I
to	O	PART	O
its	O	PRON	O
consensus	B-DNA	NOUN	B
sequence	I-DNA	NOUN	I
in	O	ADP	O
the	O	DET	O
5'-regulatory	B-DNA	ADJ	B
region	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
IL-2R	B-DNA	NOUN	B
alpha	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
.	O	PUNCT	O


Resting	O	VERB	B
T-cell	O	NOUN	I
nuclear	O	ADJ	I
extracts	O	NOUN	I
contained	O	VERB	O
KBF1/p50	B-protein	NOUN	B
homodimer	I-protein	NOUN	I
.	O	PUNCT	O


After	O	ADP	O
stimulation	O	NOUN	B
,	O	PUNCT	O
two	O	NUM	O
new	O	ADJ	O
kappa	B-protein	NOUN	B
B-specific	I-protein	ADJ	I
complexes	I-protein	NOUN	I
were	O	AUX	O
identified	O	VERB	O
as	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
p50-p65	B-protein	NOUN	I
heterodimer	I-protein	NOUN	I
and	O	CCONJ	O
putative	O	ADJ	O
c-Rel	B-protein	NOUN	O
homodimer	I-protein	NOUN	O
or	O	CCONJ	O
c-Rel-p65	B-protein	NOUN	B
heterodimer	I-protein	NOUN	I
.	O	PUNCT	O


A	O	DET	O
new	O	ADJ	O
approach	O	NOUN	O
to	O	PART	O
facilitate	O	VERB	O
immobilization	O	NOUN	B
and	O	CCONJ	O
affinity	O	NOUN	B
purification	O	NOUN	I
of	O	ADP	O
recombinant	B-protein	ADJ	B
proteins	I-protein	NOUN	I
and	O	CCONJ	O
selected	O	VERB	O
human	B-cell_type	ADJ	B
B	I-cell_type	NOUN	O
lymphocytes	I-cell_type	NOUN	O
has	O	AUX	O
been	O	AUX	O
developed	O	VERB	O
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
an	O	DET	O
inhibitor	O	NOUN	B
of	O	ADP	O
PKC	B-protein	NOUN	B
blocked	O	VERB	B
both	O	CCONJ	O
activated	O	VERB	B
ras	B-protein	NOUN	B
and	O	CCONJ	O
phorbol	O	NOUN	B
ester	O	NOUN	I
stimulation	O	NOUN	I
,	O	PUNCT	O
suggesting	O	VERB	O
a	O	DET	O
role	O	NOUN	O
for	O	ADP	O
ras	B-protein	NOUN	B
upstream	O	ADJ	I
of	O	ADP	O
PKC	B-protein	NOUN	B
.	O	PUNCT	O


NF-AT	B-protein	NOUN	B
is	O	AUX	O
thought	O	VERB	O
to	O	PART	O
consist	O	VERB	O
of	O	ADP	O
two	O	NUM	O
components	O	NOUN	B
:	O	PUNCT	O
a	O	DET	O
ubiquitous	B-protein	ADJ	O
,	I-protein	PUNCT	O
inducible	I-protein	ADJ	B
nuclear	I-protein	ADJ	O
component	I-protein	NOUN	O
that	O	PRON	O
we	O	PRON	O
have	O	AUX	O
identified	O	VERB	B
as	O	ADP	O
Fos	B-protein	NOUN	B
and	O	CCONJ	O
Jun	B-protein	NOUN	B
proteins	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
preexisting	O	ADJ	B
,	O	PUNCT	O
T	B-protein	NOUN	B
cell-specific	I-protein	ADJ	I
component	I-protein	NOUN	I
(	O	PUNCT	O
NF-ATp	B-protein	NOUN	B
)	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
the	O	DET	O
target	O	NOUN	B
for	O	ADP	O
the	O	DET	O
immunosuppressive	O	ADJ	B
agents	O	NOUN	I
cyclosporin	O	NOUN	B
A	O	NOUN	I
(	O	PUNCT	O
CsA	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
FK506	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
E2F	B-protein	NOUN	B
activates	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
multiple	O	ADJ	B
genes	B-DNA	NOUN	I
involved	O	VERB	O
in	O	ADP	O
cell	O	NOUN	B
proliferation	O	NOUN	I
,	O	PUNCT	O
such	O	ADJ	O
as	O	ADP	O
c-myc	B-DNA	NOUN	B
and	O	CCONJ	O
the	O	DET	O
dihydrofolate	B-DNA	ADJ	B
reductase	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
.	O	PUNCT	O


Regulation	O	NOUN	B
of	O	ADP	O
E2F	B-protein	NOUN	B
involves	O	VERB	O
its	O	PRON	O
interactions	O	NOUN	B
with	O	ADP	O
other	O	ADJ	O
cellular	B-protein	ADJ	B
proteins	I-protein	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
the	O	DET	O
retinoblastoma	B-protein	NOUN	B
protein	I-protein	NOUN	I
(	O	PUNCT	O
Rb	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
the	O	DET	O
Rb-related	B-protein	ADJ	B
protein	I-protein	NOUN	I
p107	B-protein	NOUN	I
,	O	PUNCT	O
cyclin	B-protein	NOUN	B
A	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
cdk2	B-protein	NOUN	B
.	O	PUNCT	O


Three	O	NUM	O
E2F	B-protein	NOUN	B
DNA-binding	O	ADJ	B
activities	O	NOUN	I
were	O	AUX	O
identified	O	VERB	B
in	O	ADP	O
resting	O	VERB	O
(	O	PUNCT	O
G0	O	NOUN	O
)	O	PUNCT	O
T	B-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
with	O	ADP	O
mobilities	O	NOUN	B
in	O	ADP	O
gel	O	NOUN	B
shift	O	NOUN	I
assays	O	NOUN	I
distinct	O	ADJ	O
from	O	ADP	O
those	O	DET	O
of	O	ADP	O
previously	O	ADV	O
defined	O	VERB	O
E2F	B-protein	NOUN	B
complexes	O	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
X	B-protein	NOUN	O
failed	O	VERB	B
to	O	PART	O
react	O	VERB	O
with	O	ADP	O
a	O	DET	O
variety	O	NOUN	O
of	O	ADP	O
antibodies	O	NOUN	B
against	O	ADP	O
Rb	B-protein	NOUN	B
or	O	CCONJ	O
p107	B-protein	NOUN	B
,	O	PUNCT	O
implicating	O	VERB	O
the	O	DET	O
involvement	O	NOUN	B
of	O	ADP	O
an	O	DET	O
E1A-binding	B-protein	ADJ	B
protein	I-protein	NOUN	I
other	O	ADJ	O
than	O	ADP	O
Rb	B-protein	NOUN	B
or	O	CCONJ	O
p107	B-protein	NOUN	B
.	O	PUNCT	O


These	O	DET	O
species	O	NOUN	B
showed	O	VERB	O
different	O	ADJ	O
cell	O	NOUN	B
cycle	O	NOUN	I
kinetics	O	NOUN	B
.	O	PUNCT	O


Together	O	ADV	O
,	O	PUNCT	O
these	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
E2F	B-protein	NOUN	B
consists	O	VERB	O
of	O	ADP	O
multiple	O	ADJ	B
,	O	PUNCT	O
biochemically	O	ADV	B
distinct	O	ADJ	O
DNA-binding	B-protein	ADJ	B
proteins	I-protein	NOUN	I
which	O	DET	O
function	O	VERB	B
at	O	ADP	O
different	O	ADJ	O
points	O	NOUN	O
in	O	ADP	O
the	O	DET	O
cell	O	NOUN	B
cycle	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
finding	O	NOUN	B
that	O	SCONJ	O
HL-60/vinc/R	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
respond	O	VERB	O
to	O	PART	O
TPA	O	NOUN	B
with	O	ADP	O
induction	O	NOUN	B
of	O	ADP	O
a	O	DET	O
monocytic	O	ADJ	B
phenotype	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
c-jun	B-DNA	NOUN	B
expression	O	NOUN	I
,	O	PUNCT	O
suggests	O	VERB	O
that	O	SCONJ	O
c-jun	B-DNA	NOUN	B
induction	O	NOUN	I
is	O	AUX	O
not	O	PART	O
obligatory	O	ADJ	O
for	O	ADP	O
monocytic	O	ADJ	B
differentiation	O	NOUN	I
.	O	PUNCT	O


Other	O	ADJ	O
studies	O	NOUN	B
further	O	ADV	O
demonstrate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
jun-B	B-DNA	NOUN	B
and	O	CCONJ	O
fra-1	B-DNA	NOUN	B
genes	B-DNA	NOUN	I
are	O	AUX	O
induced	O	VERB	B
by	O	ADP	O
TPA	O	NOUN	B
in	O	ADP	O
both	O	CCONJ	O
HL-60/vinc	B-cell_line	NOUN	B
and	O	CCONJ	O
HL-60/vinc/R	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
whereas	O	SCONJ	O
c-fos	B-DNA	NOUN	B
expression	O	NOUN	B
is	O	AUX	O
attenuated	O	VERB	B
in	O	ADP	O
the	O	DET	O
HL-60/vinc	O	NOUN	B
line	O	NOUN	I
.	O	PUNCT	O


FK506	O	NOUN	B
and	O	CCONJ	O
ciclosporin	O	NOUN	B
:	O	PUNCT	O
molecular	O	ADJ	B
probes	O	NOUN	I
for	O	ADP	O
studying	O	VERB	O
intracellular	O	ADJ	B
signal	O	NOUN	B
transduction	O	NOUN	I
.	O	PUNCT	O


p105	B-protein	NOUN	B
and	O	CCONJ	O
p98	B-protein	NOUN	B
precursor	B-protein	NOUN	I
proteins	I-protein	NOUN	I
play	O	VERB	O
an	O	DET	O
active	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
-mediated	O	ADJ	O
signal	O	NOUN	B
transduction	O	NOUN	I
.	O	PUNCT	O


Association	O	NOUN	B
with	O	ADP	O
the	O	DET	O
precursors	O	NOUN	B
is	O	AUX	O
sufficient	O	ADJ	O
for	O	ADP	O
cytoplasmic	O	ADJ	B
retention	O	NOUN	O
of	O	ADP	O
either	O	CCONJ	O
p65	B-protein	NOUN	B
or	O	CCONJ	O
c-Rel	B-protein	NOUN	B
,	O	PUNCT	O
both	O	DET	O
of	O	ADP	O
which	O	DET	O
are	O	AUX	O
otherwise	O	ADV	O
nuclear	O	ADJ	B
.	O	PUNCT	O


Together	O	ADV	O
,	O	PUNCT	O
these	O	DET	O
results	O	NOUN	B
show	O	VERB	O
that	O	SCONJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
controls	O	VERB	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
alpha	O	NOUN	I
by	O	ADP	O
means	O	NOUN	O
of	O	ADP	O
an	O	DET	O
inducible	O	ADJ	B
autoregulatory	O	ADJ	B
pathway	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
cell-type-independent	B-DNA	ADJ	B
lipopolysaccharide	I-DNA	NOUN	B
(	I-DNA	PUNCT	O
LPS	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
-responsive	I-DNA	ADJ	O
enhancer	I-DNA	NOUN	B
element	I-DNA	NOUN	I
located	O	ADJ	O
between	O	ADP	O
-3757	B-DNA	NUM	O
and	I-DNA	CCONJ	O
-2729	I-DNA	NUM	O
bp	I-DNA	NOUN	O
upstream	I-DNA	ADJ	O
from	O	ADP	O
the	O	DET	O
transcription	B-DNA	NOUN	B
start	I-DNA	NOUN	O
site	I-DNA	NOUN	O
(	O	PUNCT	O
cap	B-DNA	NOUN	B
site	I-DNA	NOUN	I
)	O	PUNCT	O
consisted	O	VERB	O
of	O	ADP	O
at	O	ADP	O
least	O	ADJ	O
six	O	NUM	O
discrete	O	ADJ	O
subregions	O	NOUN	B
which	O	DET	O
were	O	AUX	O
essential	O	ADJ	O
to	O	PART	O
the	O	DET	O
maximal	O	ADJ	B
induction	O	NOUN	B
by	O	ADP	O
LPS	O	NOUN	B
in	O	ADP	O
transfected	B-cell_line	VERB	B
monocytes	I-cell_line	NOUN	B
.	O	PUNCT	O


Deletion	O	NOUN	B
and	O	CCONJ	O
base	O	NOUN	B
substitution	O	NOUN	I
mutations	O	NOUN	I
along	O	ADP	O
with	O	ADP	O
DNA	O	NOUN	B
binding	O	NOUN	I
studies	O	NOUN	I
demonstrated	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
enhancer	O	NOUN	B
contained	O	VERB	O
a	O	DET	O
minimum	O	NOUN	B
of	O	ADP	O
three	O	NUM	O
functional	O	ADJ	B
protein	B-DNA	NOUN	B
binding	I-DNA	NOUN	I
sequences	I-DNA	NOUN	I
,	O	PUNCT	O
two	O	NUM	O
of	O	ADP	O
which	O	DET	O
appeared	O	VERB	O
to	O	PART	O
be	O	AUX	O
important	O	ADJ	O
for	O	ADP	O
gene	O	NOUN	B
induction	O	NOUN	I
.	O	PUNCT	O


When	O	SCONJ	O
ligated	O	VERB	B
to	O	PART	O
the	O	DET	O
proIL-1	B-DNA	NOUN	B
beta	I-DNA	NOUN	B
cap	I-DNA	NOUN	I
site	I-DNA	NOUN	I
-proximal	B-DNA	ADJ	I
region	I-DNA	NOUN	I
(	O	PUNCT	O
located	O	ADJ	O
between	O	ADP	O
-131	O	NUM	O
to	O	PART	O
+12	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
both	O	CCONJ	O
the	O	DET	O
proIL-1	B-DNA	NOUN	B
beta	I-DNA	NOUN	B
and	I-DNA	CCONJ	O
the	I-DNA	DET	O
simian	I-DNA	ADJ	B
virus	I-DNA	NOUN	I
40	I-DNA	NUM	O
enhancer	I-DNA	NOUN	B
elements	I-DNA	NOUN	I
functioned	O	VERB	O
more	O	ADV	O
efficiently	O	ADV	B
in	O	ADP	O
monocytes	B-cell_type	NOUN	B
than	O	ADP	O
in	O	ADP	O
HeLa	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
which	O	DET	O
are	O	AUX	O
not	O	PART	O
normally	O	ADV	O
competent	O	ADJ	B
for	O	ADP	O
IL-1	B-protein	NOUN	B
beta	I-protein	NOUN	B
expression	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
PILOT	B-protein	NOUN	B
protein	O	NOUN	I
has	O	AUX	O
a	O	DET	O
calculated	O	VERB	B
M	O	NOUN	B
(	O	PUNCT	O
r	O	NOUN	O
)	O	PUNCT	O
of	O	ADP	O
42.6	O	NUM	O
kDa	O	NOUN	O
and	O	CCONJ	O
contains	O	VERB	O
three	O	NUM	O
zinc	B-protein	NOUN	B
fingers	I-protein	NOUN	I
of	O	ADP	O
the	O	DET	O
C2H2-type	B-protein	NOUN	B
at	O	ADP	O
the	O	DET	O
carboxyl-terminus	B-protein	NOUN	B
which	O	DET	O
are	O	AUX	O
highly	O	ADV	O
homologous	O	ADJ	B
to	O	PART	O
the	O	DET	O
zinc	B-protein	NOUN	B
finger	I-protein	NOUN	I
regions	I-protein	NOUN	I
of	O	ADP	O
the	O	DET	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
EGR1	B-protein	NOUN	B
,	O	PUNCT	O
EGR2	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
pAT	B-protein	NOUN	B
133	I-protein	NUM	O
.	O	PUNCT	O


This	O	DET	O
function	O	NOUN	B
has	O	AUX	O
been	O	AUX	O
attributed	O	VERB	O
to	O	PART	O
the	O	DET	O
coordinated	O	VERB	B
binding	O	NOUN	B
of	O	ADP	O
subunits	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
to	O	PART	O
distinct	O	ADJ	O
regions	O	NOUN	B
of	O	ADP	O
the	O	DET	O
promoter	B-DNA	NOUN	B
elements	I-DNA	NOUN	I
of	O	ADP	O
numerous	O	ADJ	O
genes	O	NOUN	B
,	O	PUNCT	O
including	O	VERB	O
cytokines	B-protein	NOUN	B
,	O	PUNCT	O
growth	B-protein	NOUN	B
factor	I-protein	NOUN	I
receptors	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
adhesion	B-protein	NOUN	B
molecules	I-protein	NOUN	O
.	O	PUNCT	O


A	O	DET	O
reduction	O	NOUN	B
in	O	ADP	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
p65	B-protein	NOUN	B
was	O	AUX	O
produced	O	VERB	O
by	O	ADP	O
treatment	O	NOUN	B
with	O	ADP	O
the	O	DET	O
phosphorothioate	O	ADJ	B
antisense	O	ADJ	I
oligodeoxynucleotide	O	NOUN	I
.	O	PUNCT	O


This	O	DET	O
reduction	O	NOUN	B
was	O	AUX	O
accompanied	O	VERB	O
by	O	ADP	O
rapid	O	ADJ	O
changes	O	NOUN	B
in	O	ADP	O
the	O	DET	O
cellular	O	ADJ	B
adhesion	O	NOUN	I
of	O	ADP	O
dimethyl	B-cell_line	ADJ	B
sulfoxide-differentiated	I-cell_line	ADJ	I
HL-60	I-cell_line	NOUN	I
leukemia	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	B
stimulated	O	VERB	B
by	O	ADP	O
12-O-tetradecanoylphorbol	O	NOUN	B
13-acetate	O	NOUN	I
(	O	PUNCT	O
TPA	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Both	O	CCONJ	O
overexpressed	O	VERB	B
p65	B-protein	NOUN	B
and	O	CCONJ	O
coexpressed	O	VERB	B
p50	B-protein	NOUN	B
are	O	AUX	O
cytoplasmic	O	ADJ	B
,	O	PUNCT	O
whereas	O	SCONJ	O
p65	B-protein	NOUN	B
delta	I-protein	NOUN	I
is	O	AUX	O
partly	O	ADV	O
nuclear	O	ADJ	B
,	O	PUNCT	O
indicating	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
induced	O	VERB	B
by	O	ADP	O
p65	B-protein	NOUN	B
can	O	AUX	O
maintain	O	VERB	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
in	O	ADP	O
the	O	DET	O
cytoplasm	O	NOUN	B
.	O	PUNCT	O


Within	O	ADP	O
24	O	NUM	O
h	O	NOUN	O
following	O	VERB	O
LPS	O	NOUN	B
stimulation	O	NOUN	B
there	O	PRON	O
was	O	AUX	O
a	O	DET	O
striking	O	ADJ	O
increase	O	NOUN	B
in	O	ADP	O
the	O	DET	O
levels	O	NOUN	B
of	O	ADP	O
c-Rel	B-protein	NOUN	B
,	O	PUNCT	O
p105	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
p50	B-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
cytosol	O	NOUN	B
.	O	PUNCT	O


LPS	O	NOUN	B
activation	O	NOUN	B
of	O	ADP	O
THP-1	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
resulted	O	VERB	O
in	O	ADP	O
phosphorylation	O	NOUN	B
of	O	ADP	O
MAD3	B-protein	NOUN	B
(	O	PUNCT	O
an	O	DET	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
-like	O	ADJ	I
protein	O	NOUN	I
)	O	PUNCT	O
,	O	PUNCT	O
a	O	DET	O
rapid	O	ADJ	O
increase	O	NOUN	B
in	O	ADP	O
MAD3	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
an	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
MAD3	B-protein	NOUN	B
protein	O	NOUN	I
by	O	ADP	O
2	O	NUM	O
h	O	NOUN	O
.	O	PUNCT	O


At	O	ADP	O
nucleotide	O	NOUN	B
2	O	NUM	I
,	O	PUNCT	O
317	O	NUM	O
we	O	PRON	O
identified	O	VERB	B
a	O	DET	O
homozygous	O	ADJ	B
A	O	NOUN	O
for	O	ADP	O
G	O	NOUN	B
point	O	NOUN	I
mutation	O	NOUN	O
that	O	PRON	O
predicts	O	VERB	O
an	O	DET	O
isoleucine	O	NOUN	B
(	O	PUNCT	O
ATT	O	NOUN	B
)	O	PUNCT	O
for	O	ADP	O
valine	O	NOUN	B
(	O	PUNCT	O
GTT	O	NOUN	B
)	O	PUNCT	O
substitution	O	NOUN	B
at	O	ADP	O
amino	O	NOUN	B
acid	O	NOUN	I
729	O	NUM	O
.	O	PUNCT	O


The	O	DET	O
transactivator	O	NOUN	B
HTLV-I	B-protein	NOUN	I
Tax	I-protein	NOUN	B
activates	O	VERB	B
the	O	DET	O
promoter	B-DNA	NOUN	B
of	O	ADP	O
the	O	DET	O
gene	O	NOUN	B
coding	O	VERB	I
for	O	ADP	O
the	O	DET	O
interleukin	B-protein	NOUN	B
2	I-protein	NUM	I
alpha-chain	I-protein	NOUN	I
receptor	I-protein	NOUN	I
(	O	PUNCT	O
IL-2R	B-protein	NOUN	B
alpha	I-protein	NOUN	I
)	O	PUNCT	O
via	O	ADP	O
a	O	DET	O
kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
site	I-DNA	NOUN	I
that	O	PRON	O
can	O	AUX	O
bind	O	VERB	B
several	O	ADJ	O
protein	O	NOUN	B
species	O	NOUN	I
of	O	ADP	O
the	O	DET	O
rel	B-protein	NOUN	B
family	I-protein	NOUN	I
.	O	PUNCT	O


Overexpression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
p50	B-protein	NOUN	B
,	O	PUNCT	O
p65	B-protein	NOUN	B
and	O	CCONJ	O
Rel	B-protein	NOUN	B
proteins	I-protein	NOUN	I
in	O	ADP	O
these	O	DET	O
cells	O	NOUN	B
showed	O	VERB	O
that	O	SCONJ	O
significant	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IL-2R	B-protein	NOUN	B
alpha	I-protein	NOUN	I
kappa	B-DNA	NOUN	I
B	I-DNA	NOUN	I
site	I-DNA	NOUN	I
was	O	AUX	O
observed	O	VERB	O
only	O	ADV	O
with	O	ADP	O
Rel	B-protein	NOUN	B
and	O	CCONJ	O
Rel	B-protein	NOUN	B
plus	O	CCONJ	I
p65	B-protein	NOUN	I
.	O	PUNCT	O


Moreover	O	ADV	O
,	O	PUNCT	O
whereas	O	SCONJ	O
both	O	CCONJ	O
Tax	B-protein	NOUN	B
and	O	CCONJ	O
phorbol	O	NOUN	B
12-myristate	O	NOUN	I
13-acetate	O	NOUN	I
(	O	PUNCT	O
PMA	O	NOUN	B
)	O	PUNCT	O
are	O	AUX	O
able	O	ADJ	O
to	O	PART	O
efficiently	O	ADV	O
induce	O	VERB	B
the	O	DET	O
binding	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
to	O	PART	O
the	O	DET	O
IL-2R	B-DNA	NOUN	B
alpha	I-DNA	NOUN	I
kappa	I-DNA	NOUN	I
B	I-DNA	NOUN	I
site	I-DNA	NOUN	I
,	O	PUNCT	O
PMA	O	NOUN	B
is	O	AUX	O
functionally	O	ADV	O
inactive	O	ADJ	B
.	O	PUNCT	O


Using	O	VERB	O
the	O	DET	O
DNA	O	NOUN	B
affinity	O	NOUN	I
precipitation	O	NOUN	I
assay	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
observed	O	VERB	O
that	O	SCONJ	O
Tax1	B-protein	NOUN	B
is	O	AUX	O
able	O	ADJ	O
to	O	PART	O
efficiently	O	ADV	O
induce	O	VERB	B
the	O	DET	O
binding	O	NOUN	B
of	O	ADP	O
Rel	O	NOUN	B
,	O	PUNCT	O
whereas	O	SCONJ	O
PMA	O	NOUN	B
is	O	AUX	O
not	O	PART	O
.	O	PUNCT	O


The	O	DET	O
data	O	NOUN	B
also	O	ADV	O
indicate	O	VERB	O
that	O	SCONJ	O
CD2	B-protein	NOUN	B
receptor	O	NOUN	I
activation	O	NOUN	B
and	O	CCONJ	O
phytohemagglutinin	B-protein	NOUN	B
plus	O	CCONJ	O
phorbol	O	NOUN	B
12-myristate	O	NOUN	I
13-acetate	O	NOUN	I
stimulation	O	NOUN	I
augment	O	VERB	O
T	O	NOUN	B
cell	O	NOUN	I
IL3	B-protein	NOUN	B
gene	O	NOUN	B
expression	O	NOUN	I
through	O	ADP	O
the	O	DET	O
same	O	ADJ	O
cis-	O	ADJ	B
and	O	CCONJ	O
trans-activating	O	ADJ	B
signals	O	NOUN	I
.	O	PUNCT	O


Inducible	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
(	O	PUNCT	O
HIV	O	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
regulated	O	VERB	O
by	O	ADP	O
a	O	DET	O
cellular	O	ADJ	B
transcription	B-protein	NOUN	I
factor	I-protein	NOUN	I
,	O	PUNCT	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
(	O	PUNCT	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
long	B-DNA	ADJ	B
terminal	I-DNA	ADJ	I
repeat	I-DNA	NOUN	I
(	O	PUNCT	I
LTR	B-DNA	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
the	O	DET	O
type	O	NOUN	B
1	O	NUM	I
human	O	ADJ	I
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
(	O	PUNCT	O
HIV-1	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
5	B-DNA	NUM	O
'	I-DNA	PART	O
regulatory	I-DNA	ADJ	B
region	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
gene	O	NOUN	B
encoding	O	VERB	B
the	O	DET	O
interleukin	B-protein	NOUN	B
2	I-protein	NUM	I
receptor	I-protein	NOUN	I
alpha	I-protein	NOUN	I
subunit	I-protein	NOUN	I
(	O	PUNCT	O
IL-2R	B-protein	NOUN	B
alpha	I-protein	NOUN	I
)	O	PUNCT	O
share	O	VERB	O
functional	O	ADJ	B
kappa	B-DNA	NOUN	I
B	I-DNA	NOUN	I
enhancer	I-DNA	NOUN	I
elements	I-DNA	NOUN	I
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
these	O	DET	O
inducible	O	ADJ	B
transcription	O	NOUN	B
units	O	NOUN	I
during	O	ADP	O
T-cell	O	NOUN	B
activation	O	NOUN	I
.	O	PUNCT	O


Together	O	ADV	O
,	O	PUNCT	O
these	O	DET	O
findings	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
one	O	NUM	O
function	O	NOUN	B
of	O	ADP	O
c-Rel	B-protein	NOUN	B
is	O	AUX	O
as	O	ADP	O
a	O	DET	O
physiologic	O	ADJ	B
repressor	O	NOUN	B
of	O	ADP	O
the	O	DET	O
HIV-1	B-DNA	NOUN	B
LTR	I-DNA	NOUN	B
and	O	CCONJ	O
IL-2R	B-protein	NOUN	B
alpha	I-protein	NOUN	O
promoters	O	NOUN	O
,	O	PUNCT	O
serving	O	VERB	O
to	O	PART	O
efficiently	O	ADV	B
counter	O	VERB	O
the	O	DET	O
strong	O	ADJ	O
transcriptional	O	ADJ	B
activating	O	NOUN	I
effects	O	NOUN	B
of	O	ADP	I
p65	B-protein	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
therefore	O	ADV	O
propose	O	VERB	O
a	O	DET	O
model	O	NOUN	B
whereby	O	SCONJ	O
a	O	DET	O
core	O	NOUN	B
NFAT	B-protein	NOUN	I
complex	I-protein	NOUN	O
consisting	O	VERB	O
of	O	ADP	O
Jun	B-protein	NOUN	B
,	O	PUNCT	O
Fos	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
constitutive	B-protein	ADJ	B
nuclear	I-protein	ADJ	O
factor	I-protein	NOUN	O
is	O	AUX	O
formed	O	VERB	O
in	O	ADP	O
both	O	CCONJ	O
T	B-cell_type	NOUN	B
and	I-cell_type	CCONJ	O
B	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
an	O	DET	O
additional	O	ADJ	O
factor	O	NOUN	B
and/or	O	CCONJ	O
post-translational	O	ADJ	B
modification	O	NOUN	I
of	O	ADP	O
a	O	DET	O
factor	O	NOUN	B
,	O	PUNCT	O
missing	O	VERB	O
in	O	ADP	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
might	O	AUX	O
be	O	AUX	O
required	O	VERB	O
for	O	ADP	O
transactivation	O	NOUN	B
by	O	ADP	O
NFAT	B-protein	NOUN	B
.	O	PUNCT	O


Positive	O	ADJ	B
autoregulation	O	NOUN	B
of	O	ADP	O
GR	B-protein	NOUN	B
expression	O	NOUN	B
was	O	AUX	O
also	O	ADV	O
observed	O	VERB	O
in	O	ADP	O
glucocorticoid-resistant	B-cell_line	ADJ	B
CEM-C1	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
which	O	DET	O
contain	O	VERB	O
functional	O	ADJ	B
GR	B-protein	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
whose	O	DET	O
growth	O	NOUN	B
is	O	AUX	O
unaffected	O	ADJ	O
by	O	ADP	O
glucocorticoids	O	NOUN	B
.	O	PUNCT	O


Measurement	O	NOUN	B
of	O	ADP	O
GR	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
turnover	O	NOUN	B
in	O	ADP	O
6TG1.1	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
treated	O	VERB	B
with	O	ADP	I
actinomycin-D	O	NOUN	B
revealed	O	VERB	O
a	O	DET	O
half-life	O	NOUN	B
of	O	ADP	O
2.5	O	NUM	O
h	O	NOUN	O
,	O	PUNCT	O
which	O	DET	O
was	O	AUX	O
unaffected	O	ADJ	O
by	O	ADP	O
dexamethasone	O	NOUN	B
treatment	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
are	O	AUX	O
consistent	O	ADJ	B
with	O	ADP	I
the	O	DET	O
interpretation	O	NOUN	B
that	O	SCONJ	O
glucocorticoid-mediated	O	ADJ	B
autoregulation	O	NOUN	B
of	O	ADP	O
GR	O	NOUN	B
expression	O	NOUN	B
is	O	AUX	O
a	O	DET	O
tissue-specific	O	ADJ	B
primary	O	ADJ	O
transcriptional	O	ADJ	O
response	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
relationship	O	NOUN	B
between	O	ADP	O
glucocorticoid	O	NOUN	B
effect	O	NOUN	I
and	O	CCONJ	O
regulation	O	NOUN	B
of	O	ADP	O
cell	B-protein	NOUN	B
surface	I-protein	NOUN	I
antigens	I-protein	NOUN	O
was	O	AUX	O
investigated	O	VERB	B
in	O	ADP	O
two	O	NUM	O
models	O	NOUN	B
of	O	ADP	O
leukemic	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
,	O	PUNCT	O
CEM	B-cell_line	NOUN	B
C7	I-cell_line	NOUN	I
denoted	O	VERB	I
(	O	PUNCT	O
r+	O	ADJ	O
,	O	PUNCT	O
ly+	O	ADJ	B
)	O	PUNCT	O
and	O	CCONJ	O
CEM	B-cell_line	NOUN	B
C1	I-cell_line	NOUN	I
(	O	PUNCT	O
r+	O	ADJ	B
,	O	PUNCT	O
ly-	O	ADJ	O
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
reactivity	O	NOUN	B
of	O	ADP	O
murine	B-protein	ADJ	B
monoclonal	I-protein	ADJ	B
antibodies	I-protein	NOUN	I
,	O	PUNCT	O
anti-CD4-FITC	B-protein	NOUN	B
,	O	PUNCT	O
anti-CD8-FITC	B-protein	NOUN	B
,	O	PUNCT	O
anti-CD2-FITC	B-protein	NOUN	B
and	O	CCONJ	O
anti-calla-FITC	B-protein	NOUN	B
,	O	PUNCT	O
were	O	AUX	O
analyzed	O	VERB	B
using	O	VERB	O
flow	O	NOUN	B
cytometry	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
human	O	ADJ	B
leukemic	O	ADJ	O
cells	O	NOUN	O
studied	O	VERB	O
here	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
ability	O	NOUN	O
to	O	PART	O
induce	O	VERB	B
CD8	B-protein	NOUN	B
antigen	I-protein	NOUN	I
expression	O	NOUN	B
in	O	ADP	O
a	O	DET	O
CD4+	B-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
correlates	O	VERB	B
with	O	ADP	O
the	O	DET	O
ability	O	NOUN	O
to	O	PART	O
induce	O	VERB	B
cell	O	NOUN	B
lysis	O	NOUN	I
in	O	ADP	O
a	O	DET	O
glucocorticoid	B-cell_line	NOUN	B
receptor	I-cell_line	NOUN	I
positive	I-cell_line	ADJ	B
cell	I-cell_line	NOUN	B
population	I-cell_line	NOUN	I
.	O	PUNCT	O


Adenovirus	O	NOUN	B
E1A	O	NOUN	B
inhibits	O	VERB	B
IFN	B-protein	NOUN	B
-induced	O	ADJ	O
resistance	O	NOUN	B
to	O	PART	O
cytolysis	O	NOUN	B
by	O	ADP	O
natural	B-cell_type	ADJ	B
killer	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


To	O	PART	O
test	O	VERB	O
this	O	DET	O
hypothesis	O	NOUN	B
,	O	PUNCT	O
4-h	O	ADJ	O
NK	O	NOUN	B
cytolysis	O	NOUN	O
assays	O	NOUN	O
were	O	AUX	O
performed	O	VERB	O
on	O	ADP	O
IFN-gamma-treated	B-cell_line	ADJ	B
human	I-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
infected	O	VERB	B
with	O	ADP	O
an	O	DET	O
Ad5	O	NOUN	B
E1A	B-DNA	NOUN	I
deletion	O	NOUN	B
mutant	O	NOUN	I
,	O	PUNCT	O
dl343	O	NOUN	B
,	O	PUNCT	O
or	O	CCONJ	O
transfected	O	VERB	B
with	O	ADP	O
the	O	DET	O
Ad5	B-DNA	NOUN	B
E1A	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
.	O	PUNCT	O


IFN	B-protein	NOUN	B
-MCP	O	NOUN	O
was	O	AUX	O
not	O	PART	O
inhibited	O	VERB	B
by	O	ADP	O
infection	O	NOUN	B
with	O	ADP	O
dl343	O	NOUN	B
,	O	PUNCT	O
despite	O	SCONJ	O
the	O	DET	O
production	O	NOUN	B
of	O	ADP	O
large	O	ADJ	O
amounts	O	NOUN	O
of	O	ADP	O
both	O	CCONJ	O
early	O	ADJ	B
(	O	PUNCT	O
E1B	B-protein	NOUN	B
,	O	PUNCT	O
p55	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
late	O	ADJ	B
(	O	PUNCT	O
hexon	B-protein	NOUN	B
)	O	PUNCT	O
Ad	B-protein	NOUN	B
proteins	I-protein	NOUN	I
.	O	PUNCT	O


Nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
of	I-protein	ADP	O
activated	I-protein	VERB	B
T	I-protein	NOUN	O
cells	I-protein	NOUN	O
(	O	PUNCT	O
NF-AT	B-protein	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
transcriptional	B-protein	ADJ	B
activator	I-protein	NOUN	I
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
IL-2	B-protein	NOUN	B
gene	O	NOUN	I
expression	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
,	O	PUNCT	O
in	O	ADP	O
normal	O	ADJ	O
human	O	ADJ	B
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
an	O	DET	O
AP-1	B-protein	NOUN	B
protein	I-protein	NOUN	I
is	O	AUX	O
a	O	DET	O
component	O	NOUN	B
of	O	ADP	O
the	O	DET	O
NF-AT	B-protein	NOUN	B
protein	I-protein	NOUN	I
complex	I-protein	NOUN	I
.	O	PUNCT	O


This	O	DET	O
was	O	AUX	O
evidenced	O	VERB	O
by	O	ADP	O
the	O	DET	O
ability	O	NOUN	O
of	O	ADP	O
the	O	DET	O
AP-1	B-DNA	NOUN	B
site	I-DNA	NOUN	I
to	O	PART	O
compete	O	VERB	B
with	O	ADP	O
the	O	DET	O
NF-AT	B-protein	NOUN	B
site	O	NOUN	B
for	O	ADP	O
binding	O	VERB	B
to	O	PART	O
NF-AT	B-protein	NOUN	B
and	O	CCONJ	O
by	O	ADP	O
the	O	DET	O
capacity	O	NOUN	B
of	O	ADP	O
immobilized	B-protein	VERB	B
anti-Jun	I-protein	ADJ	B
and	O	CCONJ	O
anti-Fos	B-protein	ADJ	B
antibodies	O	NOUN	I
to	O	PART	O
deplete	O	VERB	O
NF-AT	B-protein	NOUN	B
-binding	O	ADJ	O
activity	O	NOUN	B
from	O	ADP	O
nuclear	O	ADJ	B
extracts	O	NOUN	I
of	O	ADP	O
activated	B-cell_type	VERB	B
T	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
.	O	PUNCT	O


The	O	DET	O
IL-2R	B-protein	NOUN	B
alpha	I-protein	NOUN	O
enhancer	O	NOUN	O
binds	O	VERB	B
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
poorly	O	ADV	B
and	O	CCONJ	O
is	O	AUX	O
only	O	ADV	O
weakly	O	ADV	O
activated	O	VERB	B
by	O	ADP	O
the	O	DET	O
NF-kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
site	I-DNA	NOUN	I
alone	O	ADV	O
.	O	PUNCT	O


Surprisingly	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
levels	O	NOUN	B
of	O	ADP	O
SRF	B-protein	NOUN	B
constitutively	O	ADV	B
expressed	O	VERB	B
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
are	O	AUX	O
consistently	O	ADV	O
higher	O	ADJ	O
than	O	ADP	O
in	O	ADP	O
other	O	ADJ	O
cell	O	NOUN	B
types	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
NK-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
complex	I-protein	NOUN	I
is	O	AUX	O
sequestered	O	VERB	B
in	O	ADP	O
the	O	DET	O
cytoplasm	O	NOUN	B
by	O	ADP	O
the	O	DET	O
inhibitory	O	ADJ	B
protein	O	NOUN	I
I	B-protein	NOUN	I
kappa	I-protein	NOUN	I
B-alpha	I-protein	NOUN	I
(	O	PUNCT	O
MAD-3	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Various	O	ADJ	O
cellular	O	ADJ	B
stimuli	O	NOUN	I
relieve	O	VERB	O
this	O	DET	O
inhibition	O	NOUN	B
by	O	ADP	O
mechanisms	O	NOUN	B
largely	O	ADV	O
unknown	O	ADJ	O
,	O	PUNCT	O
leading	O	VERB	O
to	O	PART	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
nuclear	O	ADJ	O
localization	O	NOUN	O
and	O	CCONJ	O
transactivation	O	NOUN	B
of	O	ADP	O
its	O	PRON	O
target	O	NOUN	B
genes	O	NOUN	I
.	O	PUNCT	O


Replication	O	NOUN	B
of	O	ADP	O
type	O	NOUN	O
1	O	NUM	O
human	O	ADJ	B
immunodeficiency	O	NOUN	I
viruses	O	NOUN	I
containing	O	VERB	O
linker	O	NOUN	B
substitution	O	NOUN	I
mutations	O	NOUN	I
in	O	ADP	O
the	O	DET	O
-201	B-DNA	NUM	O
to	I-DNA	PART	O
-130	I-DNA	NUM	O
region	I-DNA	NOUN	O
of	O	ADP	O
the	O	DET	O
long	B-DNA	ADJ	B
terminal	I-DNA	ADJ	I
repeat	I-DNA	NOUN	I
.	O	PUNCT	O


By	O	ADP	O
ablating	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
endogenous	O	ADJ	B
GATA-1	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
are	O	AUX	O
in	O	ADP	O
a	O	DET	O
position	O	NOUN	B
to	O	PART	O
introduce	O	VERB	O
a	O	DET	O
variety	O	NOUN	O
of	O	ADP	O
constructs	O	NOUN	B
that	O	PRON	O
harbor	O	VERB	O
subtle	O	ADJ	O
modifications	O	NOUN	B
in	O	ADP	O
flanking	O	NOUN	B
or	O	CCONJ	O
protein-coding	B-DNA	ADJ	B
sequences	I-DNA	NOUN	I
.	O	PUNCT	O


Although	O	SCONJ	O
the	O	DET	O
assay	O	NOUN	B
involves	O	VERB	O
the	O	DET	O
dramatic	O	ADJ	O
loss	O	NOUN	B
of	O	ADP	O
red	O	ADJ	B
cell	O	NOUN	I
production	O	NOUN	O
,	O	PUNCT	O
it	O	PRON	O
should	O	AUX	O
be	O	AUX	O
possible	O	ADJ	O
to	O	PART	O
define	O	VERB	O
important	O	ADJ	O
regulatory	O	ADJ	B
domains	O	NOUN	I
that	O	PRON	O
can	O	AUX	O
then	O	ADV	O
be	O	AUX	O
assayed	O	VERB	B
using	O	VERB	O
less	O	ADV	O
stringent	O	ADJ	O
systems	O	NOUN	O
,	O	PUNCT	O
such	O	ADJ	O
as	O	ADP	O
cell-free	O	ADJ	B
extracts	O	NOUN	I
for	O	ADP	O
in	O	X	B
vitro	O	X	I
transcription	O	NOUN	B
.	O	PUNCT	O


Structure-function	O	ADJ	B
studies	O	NOUN	I
of	O	ADP	O
the	O	DET	O
GATA-1	B-protein	NOUN	B
protein	O	NOUN	I
could	O	AUX	O
be	O	AUX	O
greatly	O	ADV	O
simplified	O	VERB	O
and	O	CCONJ	O
a	O	DET	O
larger	O	ADJ	O
number	O	NOUN	O
of	O	ADP	O
mutants	O	NOUN	B
studied	O	VERB	O
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
ES	O	NOUN	B
cell	O	NOUN	I
system	O	NOUN	I
can	O	AUX	O
be	O	AUX	O
used	O	VERB	O
as	O	ADP	O
an	O	DET	O
alternative	O	NOUN	B
until	O	ADP	O
targeted	B-cell_line	VERB	B
erythroleukemia	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
become	O	VERB	O
available	O	ADJ	O
.	O	PUNCT	O


If	O	SCONJ	O
they	O	PRON	O
can	O	AUX	O
not	O	PART	O
,	O	PUNCT	O
chimeric	B-protein	ADJ	B
proteins	I-protein	NOUN	I
can	O	AUX	O
be	O	AUX	O
tested	O	VERB	B
to	O	PART	O
identify	O	VERB	O
which	O	DET	O
amino	O	NOUN	B
acids	O	NOUN	I
distinguish	O	VERB	O
the	O	DET	O
different	O	ADJ	O
family	O	NOUN	B
members	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
feel	O	VERB	O
that	O	SCONJ	O
these	O	DET	O
experiments	O	NOUN	B
are	O	AUX	O
vital	O	ADJ	O
to	O	PART	O
understanding	O	VERB	O
the	O	DET	O
function	O	NOUN	B
of	O	ADP	O
GATA-1	B-protein	NOUN	B
during	O	ADP	O
erythroid	O	ADJ	B
ontogeny	O	NOUN	B
.	O	PUNCT	O


Comparison	O	NOUN	B
of	O	ADP	O
a	O	DET	O
full-length	B-DNA	ADJ	O
cDNA	I-DNA	NOUN	B
sequence	I-DNA	NOUN	I
with	O	ADP	O
the	O	DET	O
corresponding	O	ADJ	O
genomic	O	ADJ	B
sequence	O	NOUN	I
reveals	O	VERB	O
an	O	DET	O
open	B-DNA	ADJ	B
reading	I-DNA	NOUN	I
frame	I-DNA	NOUN	I
of	O	ADP	O
326	O	NUM	O
amino	O	NOUN	B
acids	O	NOUN	I
,	O	PUNCT	O
distributed	O	VERB	O
across	O	ADP	O
two	O	NUM	O
exons	B-DNA	NOUN	B
.	O	PUNCT	O


Groups	O	NOUN	B
1	O	NUM	O
and	O	CCONJ	O
2	O	NUM	O
have	O	AUX	O
a	O	DET	O
serine-rich	B-protein	ADJ	B
region	I-protein	NOUN	I
and	O	CCONJ	O
an	O	DET	O
``	O	PUNCT	O
arginine	B-protein	NOUN	B
element	I-protein	NOUN	O
``	O	PUNCT	O
(	O	PUNCT	O
RRLPIF	B-protein	NOUN	B
)	O	PUNCT	O
at	O	ADP	O
the	O	DET	O
carboxyl	B-protein	NOUN	B
terminus	I-protein	NOUN	I
.	O	PUNCT	O


A	O	DET	O
CpG	O	NOUN	B
island	O	NOUN	O
suggests	O	VERB	O
expression	O	NOUN	B
in	O	ADP	O
the	O	DET	O
germ	O	NOUN	B
line	O	NOUN	I
.	O	PUNCT	O


Regulation	O	NOUN	B
of	O	ADP	O
lymphoid-specific	B-DNA	ADJ	B
immunoglobulin	I-DNA	NOUN	I
mu	I-DNA	NOUN	I
heavy	I-DNA	ADJ	I
chain	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
enhancer	I-DNA	NOUN	I
by	O	ADP	O
ETS-domain	O	ADJ	B
proteins	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
enhancer	B-DNA	NOUN	B
for	O	ADP	O
the	O	DET	O
immunoglobulin	B-DNA	NOUN	B
mu	I-DNA	NOUN	I
heavy	I-DNA	ADJ	I
chain	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
(	O	PUNCT	O
IgH	B-protein	NOUN	B
)	O	PUNCT	O
activates	O	VERB	B
a	O	DET	O
heterologous	B-DNA	ADJ	B
gene	I-DNA	NOUN	O
at	O	ADP	O
the	O	DET	O
pre-B	O	ADJ	B
cell	O	NOUN	I
stage	O	NOUN	I
of	O	ADP	O
B	B-cell_type	NOUN	B
lymphocyte	I-cell_type	NOUN	I
differentiation	O	NOUN	I
.	O	PUNCT	O


1	O	NUM	O
,	O	PUNCT	O
25-Dihydroxy	O	NUM	O
vitamin	O	NOUN	B
D3	O	NOUN	I
and	O	CCONJ	O
12-O-tetradecanoyl	O	NOUN	B
phorbol-13-acetate	O	NOUN	I
synergistically	O	ADV	B
induce	O	VERB	B
monocytic	B-cell_type	ADJ	B
cell	I-cell_type	NOUN	I
differentiation	O	NOUN	I
:	O	PUNCT	O
FOS	B-protein	NOUN	B
and	O	CCONJ	O
RB	B-protein	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


Mice	O	NOUN	B
deficient	O	ADJ	B
for	O	ADP	O
the	O	DET	O
55	B-protein	NUM	O
kd	I-protein	NOUN	O
tumor	I-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor	I-protein	NOUN	I
receptor	I-protein	NOUN	I
are	O	AUX	O
resistant	O	ADJ	B
to	O	PART	O
endotoxic	O	ADJ	B
shock	O	NOUN	I
,	O	PUNCT	O
yet	O	ADV	O
succumb	O	VERB	O
to	O	PART	O
L.	O	X	B
monocytogenes	O	X	I
infection	O	NOUN	I
.	O	PUNCT	O


Using	O	VERB	O
gene	O	NOUN	B
targeting	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
generated	O	VERB	O
a	O	DET	O
TNFRp55	B-protein	NOUN	B
-deficient	O	ADJ	O
mouse	O	NOUN	B
strain	O	NOUN	I
.	O	PUNCT	O


Cells	O	NOUN	B
from	O	ADP	O
TNFRp55-/-mutant	O	ADJ	B
mice	O	NOUN	B
lack	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
TNFRp55	B-protein	NOUN	B
but	O	CCONJ	O
display	O	VERB	O
normal	O	ADJ	O
numbers	O	NOUN	O
of	O	ADP	O
high	B-protein	ADJ	O
affinity	I-protein	NOUN	B
TNFRp75	I-protein	NOUN	B
molecules	I-protein	NOUN	I
.	O	PUNCT	O


Enhanced	O	VERB	B
IL-2	B-protein	NOUN	B
transcription	O	NOUN	O
correlates	O	VERB	O
with	O	ADP	O
increased	O	VERB	B
c-fos	B-protein	NOUN	B
synthesis	O	NOUN	I
and	O	CCONJ	O
increased	O	VERB	B
Fos	B-protein	NOUN	B
content	O	NOUN	B
of	O	ADP	O
AP-1	B-protein	NOUN	B
.	O	PUNCT	O


This	O	DET	O
effect	O	NOUN	B
is	O	AUX	O
largely	O	ADV	O
independent	O	ADJ	B
of	O	ADP	O
the	O	DET	O
CD2	O	NOUN	B
:	O	PUNCT	O
lymphocyte	O	NOUN	B
function-associated	O	ADJ	I
Ag-3	O	NOUN	I
pathway	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
studied	O	VERB	O
the	O	DET	O
functional	O	ADJ	B
interaction	O	NOUN	B
between	O	ADP	O
human	B-DNA	ADJ	B
embryonic	I-DNA	ADJ	O
zeta	I-DNA	NOUN	O
2	I-DNA	NUM	O
globin	I-DNA	NOUN	B
promoter	I-DNA	NOUN	I
and	O	CCONJ	O
the	O	DET	O
alpha	B-DNA	NOUN	B
globin	I-DNA	NOUN	I
regulatory	I-DNA	ADJ	B
element	I-DNA	NOUN	I
(	O	PUNCT	O
HS-40	B-DNA	NOUN	B
)	O	PUNCT	O
located	O	ADJ	O
40	B-DNA	NUM	O
kb	I-DNA	NOUN	O
upstream	I-DNA	ADV	O
of	O	ADP	O
the	O	DET	O
zeta	B-DNA	NOUN	B
2	I-DNA	NUM	I
globin	I-DNA	NOUN	B
gene	I-DNA	NOUN	I
.	O	PUNCT	O


Although	O	SCONJ	O
sequences	O	NOUN	B
located	O	ADJ	O
between	O	ADP	O
-559	O	NUM	O
and	O	CCONJ	O
-88	O	NUM	B
of	O	ADP	O
the	O	DET	O
zeta	B-DNA	NOUN	B
2	I-DNA	NUM	I
globin	I-DNA	NOUN	B
gene	I-DNA	NOUN	I
were	O	AUX	O
dispensable	O	ADJ	O
for	O	ADP	O
its	O	PRON	O
expression	O	NOUN	B
on	O	ADP	O
enhancerless	B-DNA	NOUN	B
plasmids	I-DNA	NOUN	I
,	O	PUNCT	O
they	O	PRON	O
were	O	AUX	O
required	O	VERB	O
for	O	ADP	O
the	O	DET	O
HS-40	B-DNA	NOUN	B
enhancer	I-DNA	NOUN	I
-mediated	O	ADJ	O
activity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
zeta	B-DNA	NOUN	B
2	I-DNA	NUM	I
globin	I-DNA	NOUN	B
promoter	I-DNA	NOUN	I
.	O	PUNCT	O


Finally	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
did	O	AUX	O
genomic	O	ADJ	B
footprinting	O	NOUN	I
of	O	ADP	O
the	O	DET	O
HS-40	B-DNA	NOUN	B
enhancer	I-DNA	NOUN	I
region	I-DNA	NOUN	I
in	O	ADP	O
K562	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
adult	B-cell_line	ADJ	B
nucleated	I-cell_line	ADJ	B
erythroblasts	I-cell_line	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
different	O	ADJ	O
nonerythroid	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


To	O	PART	O
further	O	ADV	O
evaluate	O	VERB	B
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
X	B-protein	NOUN	B
box	I-protein	NOUN	I
DNA-binding	I-protein	ADJ	I
proteins	I-protein	NOUN	I
in	O	ADP	O
class	B-DNA	NOUN	B
II	I-DNA	NUM	I
gene	I-DNA	NOUN	B
expression	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
the	O	DET	O
X	B-DNA	NOUN	B
box	I-DNA	NOUN	I
region	I-DNA	NOUN	I
was	O	AUX	O
examined	O	VERB	O
in	O	ADP	O
both	O	CCONJ	O
class	B-cell_line	NOUN	B
II-positive	I-cell_line	ADJ	I
and	O	CCONJ	O
-negative	B-cell_line	ADJ	O
lymphoid	I-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


The	O	DET	O
effects	O	NOUN	B
of	O	ADP	O
these	O	DET	O
substitutions	O	NOUN	B
on	O	ADP	O
viral	O	ADJ	B
replication	O	NOUN	I
in	O	ADP	O
transfected	O	VERB	B
HeLa	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
and	O	CCONJ	O
on	O	ADP	O
HIV	O	NOUN	B
infection	O	NOUN	O
of	O	ADP	O
human	B-cell_type	ADJ	B
peripheral	I-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
lymphocytes	I-cell_type	NOUN	I
or	O	CCONJ	O
continuous	B-cell_line	ADJ	B
T-leukemia	I-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
were	O	AUX	O
evaluated	O	VERB	B
.	O	PUNCT	O


Ionizing	O	VERB	B
radiation	O	NOUN	I
triggers	O	VERB	B
a	O	DET	O
signal	O	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
B-lymphocyte	I-cell_type	NOUN	B
precursors	I-cell_type	NOUN	I
that	O	PRON	O
is	O	AUX	O
intimately	O	ADV	O
linked	O	VERB	O
to	O	PART	O
an	O	DET	O
active	O	ADJ	B
protein-tyrosine	B-protein	ADJ	B
kinase	I-protein	NOUN	I
regulatory	O	ADJ	O
pathway	O	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
in	O	ADP	O
B-lymphocyte	B-cell_type	NOUN	B
precursors	I-cell_type	NOUN	B
,	O	PUNCT	O
irradiation	O	NOUN	B
with	O	ADP	O
gamma-rays	O	NOUN	B
leads	O	VERB	O
to	O	PART	O
(	O	PUNCT	O
i	O	X	O
)	O	PUNCT	O
stimulation	O	NOUN	B
of	O	ADP	O
phosphatidylinositol	O	NOUN	B
turnover	O	NOUN	B
;	O	PUNCT	O
(	O	PUNCT	O
ii	O	X	O
)	O	PUNCT	O
downstream	O	ADJ	B
activation	O	NOUN	B
by	O	ADP	O
covalent	O	ADJ	B
modification	O	NOUN	I
of	O	ADP	O
multiple	O	ADJ	B
serine-specific	B-protein	ADJ	B
protein	I-protein	NOUN	I
kinases	I-protein	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
C	I-protein	NOUN	I
;	O	PUNCT	O
and	O	CCONJ	O
(	O	PUNCT	O
iii	O	X	O
)	O	PUNCT	O
activation	O	NOUN	B
of	O	ADP	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
.	O	PUNCT	O


Our	O	PRON	O
report	O	NOUN	O
expands	O	VERB	O
current	O	ADJ	B
knowledge	O	NOUN	B
of	O	ADP	O
the	O	DET	O
radiation-induced	O	ADJ	B
signaling	O	NOUN	I
cascade	O	NOUN	I
by	O	ADP	O
clarifying	O	VERB	O
the	O	DET	O
chronological	O	ADJ	B
sequence	O	NOUN	I
of	O	ADP	O
biochemical	O	ADJ	B
events	O	NOUN	O
that	O	PRON	O
follow	O	VERB	O
irradiation	O	NOUN	B
.	O	PUNCT	O


Adenovirus	O	NOUN	B
can	O	AUX	O
establish	O	VERB	O
persistent	O	ADJ	B
infections	O	NOUN	I
which	O	DET	O
may	O	AUX	O
reactivate	O	VERB	B
and	O	CCONJ	O
cause	O	VERB	O
disease	O	NOUN	B
in	O	ADP	O
immunocompromised	O	ADJ	B
hosts	O	NOUN	I
.	O	PUNCT	O


Both	O	DET	O
primers	O	NOUN	B
detected	O	VERB	B
a	O	DET	O
single	O	ADJ	O
copy	O	NOUN	B
of	O	ADP	I
the	O	DET	I
adenovirus	B-DNA	NOUN	B
type	I-DNA	NOUN	I
2	I-DNA	NUM	I
genome	I-DNA	NOUN	I
but	O	CCONJ	O
were	O	AUX	O
less	O	ADV	O
sensitive	O	ADJ	B
for	O	ADP	O
the	O	DET	O
group	O	NOUN	B
B	O	NOUN	O
type	O	NOUN	O
35	O	NUM	O
.	O	PUNCT	O


OBJECTIVE	O	NOUN	B
:	O	PUNCT	O
To	O	PART	O
examine	O	VERB	O
the	O	DET	O
inter-relationship	O	NOUN	B
between	O	ADP	O
HIV-1	O	NOUN	B
infection	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
cell	O	NOUN	B
surface	O	NOUN	I
receptors	O	NOUN	I
for	O	ADP	O
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor	I-protein	NOUN	I
(	I-protein	PUNCT	O
TNF	I-protein	NOUN	B
)	I-protein	PUNCT	O
-alpha	I-protein	NOUN	O
,	O	PUNCT	O
an	O	DET	O
immunoregulatory	O	ADJ	B
cytokine	O	NOUN	I
that	O	PRON	O
can	O	AUX	O
enhance	O	VERB	O
HIV-1	O	NOUN	B
replication	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
series	O	NOUN	B
of	O	ADP	O
uninfected	B-cell_line	ADJ	B
parental	I-cell_line	ADJ	B
HL-60	I-cell_line	NOUN	B
subclones	I-cell_line	NOUN	I
all	O	DET	O
reduced	O	VERB	B
TR75	B-protein	NOUN	B
surface	O	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
TNF-alpha	B-protein	NOUN	B
treatment	O	NOUN	B
.	O	PUNCT	O


Both	O	CCONJ	O
these	O	DET	O
signals	O	NOUN	B
were	O	AUX	O
necessary	O	ADJ	O
for	O	ADP	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
reporter	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
.	O	PUNCT	O


When	O	SCONJ	O
co-transfected	O	VERB	B
with	O	ADP	O
a	O	DET	O
construct	O	NOUN	O
capable	O	ADJ	O
of	O	ADP	O
overexpressing	O	VERB	B
the	O	DET	O
tyrosine	B-protein	NOUN	B
kinase	I-protein	NOUN	I
p59fyn	B-protein	NOUN	I
,	O	PUNCT	O
the	O	DET	O
reporter	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
was	O	AUX	O
activated	O	VERB	B
by	O	ADP	O
PMA	B-protein	NOUN	B
alone	O	ADV	O
.	O	PUNCT	O


Dependence	O	NOUN	B
for	O	ADP	O
the	O	DET	O
proliferative	O	ADJ	B
response	O	NOUN	I
to	O	PART	O
erythropoietin	B-protein	NOUN	B
on	O	ADP	O
an	O	DET	O
established	O	ADJ	O
erythroid	O	ADJ	B
differentiation	O	NOUN	I
program	O	NOUN	O
in	O	ADP	O
a	O	DET	O
human	B-cell_line	ADJ	B
hematopoietic	I-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
,	O	PUNCT	O
UT-7	B-cell_line	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
comparison	O	NOUN	B
,	O	PUNCT	O
UT-7	B-cell_line	NOUN	B
Epo	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
expressed	O	VERB	B
alpha-globin	O	NOUN	B
and	O	CCONJ	O
higher	O	ADJ	B
levels	O	NOUN	B
of	O	ADP	O
gamma-globin	B-protein	NOUN	B
(	O	PUNCT	O
5-fold	O	ADV	O
)	O	PUNCT	O
and	O	CCONJ	O
beta-globin	B-protein	NOUN	B
(	O	PUNCT	O
from	O	ADP	O
barely	O	ADV	O
to	O	PART	O
clearly	O	ADV	O
detectable	O	ADJ	B
)	O	PUNCT	O
.	O	PUNCT	O


Globin	B-protein	NOUN	B
chains	I-protein	NOUN	I
(	O	PUNCT	O
alpha	B-protein	NOUN	B
,	O	PUNCT	O
beta	B-protein	NOUN	B
and	O	CCONJ	O
gamma	B-protein	NOUN	B
)	O	PUNCT	O
were	O	AUX	O
clearly	O	ADV	O
detectable	O	ADJ	B
by	O	ADP	O
affinity	O	NOUN	B
chromatography	O	NOUN	I
in	O	ADP	O
UT-7	B-protein	NOUN	B
Epo	I-protein	NOUN	B
but	O	CCONJ	O
not	O	PART	O
in	O	ADP	O
UT-7	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


The	O	DET	O
number	O	NOUN	O
of	O	ADP	O
gamma-positive	B-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
and	O	CCONJ	O
their	O	PRON	O
fluorescence	O	NOUN	B
intensity	O	NOUN	I
were	O	AUX	O
higher	O	ADJ	O
in	O	ADP	O
UT-7	B-protein	NOUN	B
Epo	I-protein	NOUN	B
than	O	ADP	O
in	O	ADP	O
UT-7	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
(	O	PUNCT	O
0	O	NUM	O
to	O	PART	O
17	O	NUM	O
%	O	NOUN	O
barely	O	ADV	O
positive	O	ADJ	O
cells	O	NOUN	O
and	O	CCONJ	O
23	O	NUM	O
to	O	PART	O
40	O	NUM	O
%	O	NOUN	O
clearly	O	ADV	O
positive	O	ADJ	B
cells	O	NOUN	I
,	O	PUNCT	O
respectively	O	ADV	O
)	O	PUNCT	O
,	O	PUNCT	O
indicating	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
globin	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
observed	O	VERB	O
in	O	ADP	O
UT-7	B-protein	NOUN	B
Epo	I-protein	NOUN	B
is	O	AUX	O
due	O	ADJ	O
to	O	PART	O
both	O	CCONJ	O
an	O	DET	O
increase	O	NOUN	B
of	O	ADP	O
gene	O	NOUN	B
expression	O	NOUN	I
per	O	ADP	O
cell	O	NOUN	O
and	O	CCONJ	O
an	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
numbers	O	NOUN	O
of	O	ADP	O
cells	O	NOUN	B
containing	O	VERB	O
gamma-globin	B-protein	NOUN	B
.	O	PUNCT	O


Recent	O	ADJ	O
isolation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
CD11b	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
shows	O	VERB	O
that	O	SCONJ	O
92	O	NUM	O
base	O	NOUN	B
pairs	O	NOUN	I
(	O	PUNCT	O
bp	O	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
5'-flanking	B-DNA	ADJ	B
DNA	I-DNA	NOUN	I
are	O	AUX	O
sufficient	O	ADJ	O
to	O	PART	O
direct	O	VERB	O
myeloid-specific	O	ADJ	B
expression	O	NOUN	O
of	O	ADP	O
a	O	DET	O
reporter	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
propose	O	VERB	O
a	O	DET	O
model	O	NOUN	B
in	O	ADP	O
which	O	DET	O
binding	O	NOUN	B
of	O	ADP	O
a	O	DET	O
myeloid-specific	B-protein	ADJ	B
factor	I-protein	NOUN	I
(	O	PUNCT	O
PU.1	B-protein	NOUN	B
)	O	PUNCT	O
allows	O	VERB	O
a	O	DET	O
general	O	ADJ	B
factor	O	NOUN	I
(	O	PUNCT	O
Sp1	B-protein	NOUN	B
)	O	PUNCT	O
to	O	PART	O
bind	O	VERB	B
in	O	ADP	O
a	O	DET	O
tissue-specific	O	ADJ	B
fashion	O	NOUN	I
thereby	O	ADV	O
contributing	O	VERB	O
to	O	PART	O
the	O	DET	O
myeloid-specific	O	ADJ	B
expression	O	NOUN	I
of	O	ADP	O
CD11b	B-cell_line	NOUN	B
.	O	PUNCT	O


Stimulation	O	NOUN	B
of	O	ADP	O
interleukin-1	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
transcription	O	NOUN	I
may	O	AUX	O
be	O	AUX	O
caused	O	VERB	O
by	O	ADP	O
the	O	DET	O
stimulation	O	NOUN	B
of	O	ADP	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
activities	O	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
those	O	DET	O
of	O	ADP	O
AP-1	B-protein	NOUN	B
,	O	PUNCT	O
by	O	ADP	O
these	O	DET	O
protein	B-protein	NOUN	B
phosphatase	I-protein	NOUN	I
inhibitors	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
functional	O	ADJ	B
significance	O	NOUN	I
of	O	ADP	O
c-Rel	B-protein	NOUN	B
involvement	O	NOUN	B
in	O	ADP	O
the	O	DET	O
CD28-responsive	B-protein	ADJ	B
complex	I-protein	NOUN	I
is	O	AUX	O
demonstrated	O	VERB	O
by	O	ADP	O
transient	O	ADJ	B
transfection	O	NOUN	B
analysis	O	NOUN	I
,	O	PUNCT	O
where	O	SCONJ	O
cotransfection	O	NOUN	B
of	O	ADP	O
c-Rel	B-protein	NOUN	B
augments	O	VERB	O
the	O	DET	O
level	O	NOUN	B
of	O	ADP	O
expression	O	NOUN	B
of	O	ADP	O
a	O	DET	O
chloramphenicol	B-DNA	NOUN	B
acetyltransferase	I-DNA	NOUN	I
reporter	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
linked	O	VERB	O
to	O	PART	O
the	O	DET	O
CD28-responsive	B-DNA	ADJ	B
element	I-DNA	NOUN	I
.	O	PUNCT	O


Two	O	NUM	O
stable	O	ADJ	B
B	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
were	O	AUX	O
established	O	VERB	O
:	O	PUNCT	O
R59Z	B-cell_line	NOUN	B
activator	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
were	O	AUX	O
used	O	VERB	O
to	O	PART	O
induce	O	VERB	B
lytic	O	ADJ	B
EBV	O	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
a	O	DET	O
constitutive	O	ADJ	B
manner	O	NOUN	O
by	O	ADP	O
the	O	DET	O
production	O	NOUN	B
of	O	ADP	O
the	O	DET	O
BZLF	B-protein	NOUN	B
1	I-protein	NUM	I
trans-activator	I-protein	NOUN	I
(	O	PUNCT	O
Zta	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


R7-57	B-cell_line	NOUN	B
reporter	I-cell_line	NOUN	O
cells	I-cell_line	NOUN	O
,	O	PUNCT	O
on	O	ADP	O
the	O	DET	O
other	O	ADJ	O
hand	O	NOUN	B
,	O	PUNCT	O
signaled	O	VERB	B
induced	O	VERB	B
activity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
lytic	B-DNA	ADJ	B
origin	I-DNA	NOUN	B
of	I-DNA	ADP	O
EBV	I-DNA	NOUN	B
replication	I-DNA	NOUN	B
(	O	PUNCT	O
ori	B-DNA	NOUN	B
Lyt	I-DNA	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


No	O	DET	O
lytic	O	ADJ	B
effect	O	NOUN	I
on	O	ADP	O
the	O	DET	O
reporter	O	NOUN	B
cells	O	NOUN	I
could	O	AUX	O
be	O	AUX	O
measured	O	VERB	B
,	O	PUNCT	O
neither	O	CCONJ	O
by	O	ADP	O
cocultivation	O	NOUN	B
of	O	ADP	O
activator	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
nor	O	CCONJ	O
by	O	ADP	O
coincubation	O	NOUN	B
of	O	ADP	O
BZLF	B-protein	NOUN	B
1	I-protein	NUM	O
-containing	O	ADJ	O
cell	O	NOUN	B
lysates	O	NOUN	I
.	O	PUNCT	O


Neither	O	CCONJ	O
Bt2cAMP	O	NOUN	B
nor	O	CCONJ	O
PMA	O	NOUN	B
individually	O	ADV	O
mediated	O	VERB	O
these	O	DET	O
sustained	O	ADJ	B
effects	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
therefore	O	ADV	O
appear	O	VERB	O
as	O	ADP	O
a	O	DET	O
consequence	O	NOUN	O
of	O	ADP	O
the	O	DET	O
interplay	O	NOUN	O
between	O	ADP	O
both	O	CCONJ	O
metabolic	O	ADJ	B
stimuli	O	NOUN	O
.	O	PUNCT	O


Tax	B-protein	NOUN	B
was	O	AUX	O
transfected	O	VERB	B
into	O	ADP	O
HTLV-I-negative	B-cell_line	ADJ	B
human	I-cell_line	ADJ	B
T-cell	I-cell_line	NOUN	O
lines	I-cell_line	NOUN	O
.	O	PUNCT	O


PMA	O	NOUN	B
induced	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
both	O	CCONJ	O
CD14	B-protein	NOUN	B
and	O	CCONJ	O
CD23	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
and	O	CCONJ	O
protein	O	NOUN	B
.	O	PUNCT	O


Southwestern	O	NOUN	B
blotting	O	NOUN	I
and	O	CCONJ	O
UV	O	NOUN	B
cross-linking	O	NOUN	I
studies	O	NOUN	I
confirmed	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
BAT	B-protein	NOUN	B
box	I-protein	NOUN	B
binding	I-protein	NOUN	I
proteins	I-protein	NOUN	I
were	O	AUX	O
Oct-1	B-protein	NOUN	B
and	O	CCONJ	O
Oct-2	B-protein	NOUN	B
.	O	PUNCT	O


One	O	NUM	O
cDNA	B-DNA	NOUN	B
clone	I-DNA	NOUN	B
of	O	ADP	O
a	O	DET	O
primary	O	ADJ	B
response	O	NOUN	I
gene	O	NOUN	I
,	O	PUNCT	O
expressed	O	VERB	B
upon	O	SCONJ	O
macrophage	O	NOUN	B
differentiation	O	NOUN	I
,	O	PUNCT	O
encoded	O	VERB	B
for	O	ADP	O
Egr-1	B-protein	NOUN	B
,	O	PUNCT	O
a	O	DET	O
zinc	B-protein	NOUN	B
finger	I-protein	NOUN	I
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
.	O	PUNCT	O


HL-60	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
constitutively	O	ADV	B
expressing	O	VERB	B
an	O	DET	O
Egr-1	B-DNA	NOUN	B
transgene	I-DNA	NOUN	I
(	O	PUNCT	O
HL-60Egr-1	B-DNA	NOUN	B
)	O	PUNCT	O
could	O	AUX	O
be	O	AUX	O
induced	O	VERB	B
for	O	ADP	O
macrophage	B-cell_type	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
granulocyte	B-cell_type	NOUN	B
,	O	PUNCT	O
differentiation	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
present	O	ADJ	O
studies	O	NOUN	B
we	O	PRON	O
have	O	AUX	O
examined	O	VERB	O
the	O	DET	O
signaling	O	NOUN	B
pathways	O	NOUN	I
by	O	ADP	O
which	O	DET	O
this	O	DET	O
monocyte-specific	O	ADJ	B
response	O	NOUN	I
is	O	AUX	O
induced	O	VERB	B
.	O	PUNCT	O


Agents	O	NOUN	B
which	O	DET	O
increased	O	VERB	B
cAMP	O	NOUN	B
levels	O	NOUN	O
,	O	PUNCT	O
including	O	VERB	O
cholera	O	NOUN	B
toxin	O	NOUN	I
,	O	PUNCT	O
pertussis	O	NOUN	B
toxin	O	NOUN	I
,	O	PUNCT	O
dibutyryl	O	NOUN	B
cAMP	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
isoproterenol	O	NOUN	B
mimicked	O	VERB	B
the	O	DET	O
actions	O	NOUN	B
of	O	ADP	O
MM-LDL	B-protein	NOUN	B
.	O	PUNCT	O


Agents	O	NOUN	B
which	O	DET	O
elevated	O	VERB	B
cAMP	O	NOUN	B
were	O	AUX	O
also	O	ADV	O
shown	O	VERB	O
to	O	PART	O
activate	O	VERB	B
NF	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
,	O	PUNCT	O
suggesting	O	VERB	O
a	O	DET	O
role	O	NOUN	O
for	O	ADP	O
this	O	DET	O
transcription	O	NOUN	B
factor	O	NOUN	I
in	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
monocyte-endothelial	O	ADJ	B
interactions	O	NOUN	O
.	O	PUNCT	O


Further	O	ADV	O
,	O	PUNCT	O
deletion	O	NOUN	B
of	O	ADP	O
the	O	DET	O
hGATA-3	B-DNA	NOUN	O
transcriptional	I-DNA	ADJ	B
activation	I-DNA	NOUN	O
domain	I-DNA	NOUN	O
abolished	O	VERB	O
GATA-dependent	O	ADJ	B
HIV-1	O	NOUN	B
trans-activation	O	NOUN	B
,	O	PUNCT	O
showing	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
stimulation	O	NOUN	B
of	O	ADP	O
viral	O	ADJ	B
transcription	O	NOUN	I
observed	O	VERB	B
is	O	AUX	O
a	O	DET	O
direct	O	ADJ	O
effect	O	NOUN	B
of	O	ADP	O
cotransfected	B-protein	VERB	B
hGATA-3	I-protein	NOUN	B
.	O	PUNCT	O


Cytokine	O	NOUN	B
modulation	O	NOUN	I
of	O	ADP	O
HIV	O	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


Infection	O	NOUN	B
with	O	ADP	O
the	O	DET	O
human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
(	O	PUNCT	O
HIV	O	NOUN	B
)	O	PUNCT	O
has	O	AUX	O
been	O	AUX	O
shown	O	VERB	O
to	O	PART	O
induce	O	VERB	B
production	O	NOUN	B
of	O	ADP	O
several	O	ADJ	O
cytokines	B-protein	NOUN	B
both	O	CCONJ	O
in	O	X	B
vitro	O	X	I
and	O	CCONJ	O
in	O	X	B
vivo	O	X	I
.	O	PUNCT	O


Conversely	O	ADV	O
,	O	PUNCT	O
several	O	ADJ	O
cytokines	B-protein	NOUN	B
modulate	O	VERB	B
the	O	DET	O
levels	O	NOUN	B
of	O	ADP	O
HIV	O	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
infected	O	ADJ	B
cells	O	NOUN	B
of	O	ADP	O
both	O	CCONJ	O
T	B-cell_type	NOUN	B
lymphocytic	I-cell_type	ADJ	I
and	I-cell_type	CCONJ	O
mononuclear	I-cell_type	ADJ	B
phagocytic	I-cell_type	ADJ	B
lineage	I-cell_type	NOUN	B
.	O	PUNCT	O


Cell-specific	O	ADJ	B
expression	O	NOUN	O
of	O	ADP	O
helix-loop-helix	B-protein	ADJ	B
transcription	I-protein	NOUN	I
factors	I-protein	NOUN	I
encoded	O	VERB	B
by	O	ADP	O
the	O	DET	O
E2A	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
.	O	PUNCT	O


Transfection	O	NOUN	B
of	O	ADP	O
cells	O	NOUN	B
with	O	ADP	O
full	O	ADJ	O
length	O	NOUN	O
E2A	B-DNA	NOUN	B
cDNA	I-DNA	NOUN	B
leads	O	VERB	O
to	O	PART	O
appearance	O	NOUN	B
of	O	ADP	O
protein	O	NOUN	B
co-migrating	O	VERB	I
with	O	ADP	O
the	O	DET	O
73	B-protein	NUM	O
kDa	I-protein	NOUN	O
protein	I-protein	NOUN	O
on	O	ADP	O
SDS	O	NOUN	B
gel	O	NOUN	I
electrophoresis	O	NOUN	I
and	O	CCONJ	O
co-migrating	O	VERB	B
with	O	ADP	O
LEF1/BCF1	B-protein	NOUN	O
on	O	ADP	O
mobility	O	NOUN	B
shift	O	NOUN	I
analysis	O	NOUN	I
.	O	PUNCT	O


Hypertension	O	NOUN	B
in	O	ADP	O
pregnancy	O	NOUN	B
.	O	PUNCT	O


Problems	O	NOUN	B
of	O	ADP	O
antihypertensive	O	ADJ	B
therapy	O	NOUN	I
are	O	AUX	O
discussed	O	VERB	O
and	O	CCONJ	O
the	O	DET	O
first	O	ADJ	O
results	O	NOUN	B
of	O	ADP	O
a	O	DET	O
pilot	O	NOUN	B
study	O	NOUN	I
with	O	ADP	O
Urapidil	O	NOUN	B
are	O	AUX	O
presented	O	VERB	O
.	O	PUNCT	O


The	O	DET	O
data	O	NOUN	B
show	O	VERB	O
that	O	SCONJ	O
hypertension	O	NOUN	B
in	O	ADP	O
preeclamptic	O	ADJ	B
women	O	NOUN	B
can	O	AUX	O
be	O	AUX	O
treated	O	VERB	B
by	O	ADP	O
Urapidil	O	NOUN	B
without	O	ADP	O
side	O	NOUN	B
effects	O	NOUN	I
or	O	CCONJ	O
reflex-tachycardia	O	NOUN	B
.	O	PUNCT	O


Hemin	O	NOUN	B
induction	O	NOUN	B
appears	O	VERB	O
to	O	PART	O
nonspecifically	O	ADV	B
increase	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
transiently	O	ADV	O
transfected	O	VERB	O
genes	O	NOUN	O
in	O	ADP	O
K562	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Beyond	O	ADP	O
this	O	DET	O
nonspecific	O	ADJ	B
increase	O	NOUN	B
in	O	ADP	O
gene	O	NOUN	B
expression	O	NOUN	I
,	O	PUNCT	O
hemin	B-protein	NOUN	B
induction	O	NOUN	B
acts	O	VERB	O
to	O	PART	O
increase	O	VERB	B
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
lineage	B-protein	NOUN	B
limited	I-protein	ADJ	O
transcription	I-protein	NOUN	B
factor	I-protein	NOUN	I
NF-E2	O	NOUN	I
.	O	PUNCT	O


Over	O	ADP	O
its	O	PRON	O
3	B-DNA	NUM	O
'	I-DNA	PART	O
end	I-DNA	NOUN	O
,	O	PUNCT	O
it	O	PRON	O
binds	O	VERB	B
a	O	DET	O
factor	O	NOUN	B
that	O	PRON	O
is	O	AUX	O
ubiquitously	O	ADV	B
and	O	CCONJ	O
constitutively	O	ADV	B
expressed	O	VERB	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
and	O	CCONJ	O
despite	O	SCONJ	O
a	O	DET	O
lack	O	NOUN	B
of	O	ADP	O
sequence	O	NOUN	O
homology	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
promoters	O	NOUN	B
of	O	ADP	O
IL-3	B-protein	NOUN	B
and	O	CCONJ	O
IL-2	B-protein	NOUN	B
share	O	VERB	O
an	O	DET	O
organizational	O	ADJ	B
pattern	O	NOUN	I
of	O	ADP	O
regulatory	O	ADJ	B
elements	O	NOUN	I
that	O	PRON	O
is	O	AUX	O
likely	O	ADJ	O
to	O	PART	O
be	O	AUX	O
important	O	ADJ	O
for	O	ADP	O
the	O	DET	O
T-cell-specific	O	ADJ	B
expression	O	NOUN	O
of	O	ADP	O
these	O	DET	O
genes	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
genes	O	NOUN	B
encode	O	VERB	O
proteins	O	NOUN	B
that	O	PRON	O
form	O	VERB	O
the	O	DET	O
dimeric	B-protein	ADJ	B
complex	I-protein	ADJ	I
activator	B-protein	NOUN	I
protein-1	I-protein	NOUN	I
(	O	PUNCT	O
AP-1	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
active	O	ADJ	B
as	O	ADP	O
a	O	DET	O
transcriptional	B-protein	ADJ	B
factor	I-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
inhibition	O	NOUN	B
of	O	ADP	O
c-fos	B-DNA	NOUN	B
and	O	CCONJ	O
c-jun	O	NOUN	B
expression	O	NOUN	I
by	O	ADP	O
IL-4	B-protein	NOUN	B
in	O	ADP	O
LPS-treated	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	O
was	O	AUX	O
shown	O	VERB	O
to	O	PART	O
be	O	AUX	O
due	O	ADJ	O
to	O	PART	O
a	O	DET	O
lower	O	ADJ	B
transcription	O	NOUN	B
rate	O	NOUN	I
of	O	ADP	O
the	O	DET	O
c-fos	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
c-jun	I-DNA	NOUN	B
genes	I-DNA	NOUN	I
.	O	PUNCT	O


These	O	DET	O
involve	O	VERB	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
sodium/proton	B-protein	ADJ	B
exchanger	I-protein	NOUN	I
of	O	ADP	I
the	O	DET	I
cell	O	NOUN	I
membrane	O	NOUN	I
at	O	ADP	O
very	O	ADV	O
low	O	ADJ	O
,	O	PUNCT	O
physiological	O	ADJ	B
concentrations	O	NOUN	B
of	O	ADP	O
aldosterone	O	NOUN	B
with	O	ADP	O
an	O	DET	O
acute	O	ADJ	B
onset	O	NOUN	O
within	O	ADP	O
1-2	O	NUM	O
min	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
unique	O	ADJ	B
characteristics	O	NOUN	B
of	O	ADP	O
this	O	DET	O
new	O	ADJ	O
pathway	O	NOUN	B
for	O	ADP	O
steroid	O	NOUN	B
action	O	NOUN	O
include	O	VERB	O
its	O	PRON	O
rapid	O	ADJ	O
time	O	NOUN	O
course	O	NOUN	O
,	O	PUNCT	O
10	O	NUM	O
,	O	PUNCT	O
000-fold	O	ADJ	O
selectivity	O	NOUN	B
for	O	ADP	O
aldosterone	O	NOUN	B
over	O	ADP	O
cortisol	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
ineffectiveness	O	NOUN	B
of	O	ADP	O
spironolactones	O	NOUN	B
,	O	PUNCT	O
classical	O	ADJ	O
mineralocorticoid	O	NOUN	B
antagonists	O	NOUN	B
,	O	PUNCT	O
as	O	ADP	O
antagonists	O	NOUN	B
of	O	ADP	O
the	O	DET	O
response	O	NOUN	B
.	O	PUNCT	O


Production	O	NOUN	B
of	O	ADP	O
HIV-1	O	NOUN	B
from	O	ADP	O
latently	O	ADV	B
infected	O	ADJ	I
cells	O	NOUN	B
requires	O	VERB	O
host	O	NOUN	B
cell	O	NOUN	B
activation	O	NOUN	I
by	O	ADP	O
T-cell	B-protein	NOUN	B
mitogens	I-protein	NOUN	I
(	O	PUNCT	O
T.Folks	O	PROPN	B
,	O	PUNCT	O
D.M.Powell	O	PROPN	B
,	O	PUNCT	O
M.M.Lightfoote	O	PROPN	B
,	O	PUNCT	O
S.Benn	O	PROPN	B
,	O	PUNCT	O
M.A.	O	PROPN	O
Martin	O	PROPN	O
,	O	PUNCT	O
and	O	CCONJ	O
A.S.Fauci	O	PROPN	B
,	O	PUNCT	O
Science	O	PROPN	B
231	O	NUM	O
:	O	PUNCT	O
600-602	O	NUM	O
,	O	PUNCT	O
1986	O	NUM	O
;	O	PUNCT	O
D.Zagury	O	PROPN	B
,	O	PUNCT	O
J.	O	PROPN	O
Bernard	O	PROPN	B
,	O	PUNCT	O
R.Leonard	O	PROPN	B
,	O	PUNCT	O
R.Cheynier	O	PROPN	B
,	O	PUNCT	O
M.Feldman	O	PROPN	B
,	O	PUNCT	O
P.S.Sarin	O	PROPN	B
,	O	PUNCT	O
and	O	CCONJ	O
R.C.	O	PROPN	O
Gallo	O	PROPN	O
,	O	PUNCT	O
Science	O	PROPN	O
231	O	NUM	O
:	O	PUNCT	O
850-853	O	NUM	O
,	O	PUNCT	O
1986	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Further	O	ADJ	O
evidence	O	NOUN	B
suggests	O	VERB	O
that	O	SCONJ	O
Nef	B-protein	NOUN	B
inhibits	O	VERB	B
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
induction	O	NOUN	B
by	O	ADP	O
interfering	O	VERB	B
with	O	ADP	O
a	O	DET	O
signal	O	NOUN	B
derived	O	VERB	O
from	O	ADP	O
the	O	DET	O
T-cell	B-protein	NOUN	B
receptor	I-protein	NOUN	I
complex	I-protein	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
PHA-activated	B-cell_line	ADJ	B
PBL	I-cell_line	NOUN	B
,	O	PUNCT	O
no	O	DET	O
age-related	O	ADJ	O
differences	O	NOUN	O
were	O	AUX	O
observed	O	VERB	O
in	O	ADP	O
c-fos	O	NOUN	B
or	O	CCONJ	O
jun	O	NOUN	B
B	O	NOUN	I
mRNA	O	NOUN	B
expression	O	NOUN	O
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
c-jun	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
levels	O	NOUN	O
decreased	O	VERB	B
significantly	O	ADV	O
(	O	PUNCT	O
1.73	O	NUM	O
+/-	O	CCONJ	O
0.08	O	NUM	O
vs.	O	CCONJ	O
1.16	O	NUM	O
+/-	O	CCONJ	O
0.09	O	NUM	O
arbitrary	O	ADJ	B
units	O	NOUN	I
,	O	PUNCT	O
P	O	NOUN	O
<	O	X	O
0.01	O	NUM	O
,	O	PUNCT	O
young	O	ADJ	B
vs.	O	CCONJ	O
old	O	ADJ	B
)	O	PUNCT	O
in	O	ADP	O
PBL	B-cell_type	NOUN	B
from	O	ADP	O
elderly	O	ADJ	B
individuals	O	NOUN	B
activated	O	VERB	B
with	O	ADP	O
PHA	B-protein	NOUN	B
.	O	PUNCT	O


Oct2	B-protein	NOUN	B
expression	O	NOUN	B
was	O	AUX	O
unable	O	ADJ	O
to	O	PART	O
stimulate	O	VERB	B
a	O	DET	O
multimerized	B-DNA	ADJ	B
octamer	I-DNA	NOUN	O
enhancer	I-DNA	NOUN	O
element	I-DNA	NOUN	O
in	O	ADP	O
HeLa	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
however	O	ADV	O
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
tested	O	VERB	B
a	O	DET	O
variety	O	NOUN	O
of	O	ADP	O
Oct2	B-protein	NOUN	B
isoforms	I-protein	NOUN	B
generated	O	VERB	O
by	O	ADP	O
alternative	O	ADJ	B
splicing	O	NOUN	B
for	O	ADP	O
the	O	DET	O
capability	O	NOUN	B
to	O	PART	O
activate	O	VERB	B
an	O	DET	O
octamer	B-DNA	NOUN	B
enhancer	I-DNA	NOUN	I
in	O	ADP	O
nonlymphoid	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
a	O	DET	O
B-cell	B-cell_line	NOUN	B
line	I-cell_line	NOUN	I
.	O	PUNCT	O


The	O	DET	O
glutamine-rich	B-protein	ADJ	B
activation	I-protein	NOUN	B
domain	I-protein	NOUN	O
present	O	ADJ	O
in	O	ADP	O
the	O	DET	O
amino-terminal	B-protein	ADJ	B
portion	I-protein	NOUN	I
of	I-protein	ADP	O
Oct2	I-protein	NOUN	B
and	O	CCONJ	O
the	O	DET	O
POU	B-protein	NOUN	B
domain	I-protein	NOUN	I
contribute	O	VERB	O
only	O	ADV	O
marginally	O	ADV	O
to	O	PART	O
the	O	DET	O
transactivation	O	NOUN	B
function	O	NOUN	O
from	O	ADP	O
a	O	DET	O
distal	O	ADJ	B
position	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
promoter	B-DNA	NOUN	B
of	O	ADP	O
the	O	DET	O
CD19	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
is	O	AUX	O
a	O	DET	O
target	O	NOUN	B
for	O	ADP	O
the	O	DET	O
B-cell-specific	B-protein	ADJ	B
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
BSAP	B-protein	NOUN	I
.	O	PUNCT	O


Postoperatively	O	ADV	B
,	O	PUNCT	O
blood	O	NOUN	B
was	O	AUX	O
taken	O	VERB	O
as	O	ADV	O
well	O	ADV	O
in	O	ADP	O
order	O	NOUN	O
to	O	PART	O
compare	O	VERB	B
pre-	O	ADJ	B
and	O	CCONJ	O
postoperative	O	ADJ	B
values	O	NOUN	O
.	O	PUNCT	O


Except	O	SCONJ	O
for	O	ADP	O
PGF2	O	NOUN	B
alpha	O	NOUN	I
,	O	PUNCT	O
HHT	O	NOUN	B
and	O	CCONJ	O
15-HETE	O	NOUN	O
no	O	DET	O
detectable	O	ADJ	B
quantities	O	NOUN	B
of	O	ADP	O
eicosanoids	O	NOUN	B
were	O	AUX	O
found	O	VERB	O
in	O	ADP	O
the	O	DET	O
non-tumor	O	ADJ	B
material	O	NOUN	I
,	O	PUNCT	O
whereas	O	SCONJ	O
in	O	ADP	O
the	O	DET	O
malignant	O	ADJ	B
tumor	O	NOUN	I
material	O	NOUN	I
substantial	O	ADJ	O
quantities	O	NOUN	B
of	O	ADP	O
a	O	DET	O
number	O	NOUN	O
of	O	ADP	O
eicosanoid	O	NOUN	B
metabolites	O	NOUN	B
were	O	AUX	O
present	O	ADJ	O
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
evaluated	O	VERB	B
the	O	DET	O
mineralocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
(	O	PUNCT	O
MR	B-protein	NOUN	O
)	O	PUNCT	O
status	O	NOUN	O
in	O	ADP	O
mononuclear	B-cell_type	ADJ	B
leukocytes	I-cell_type	NOUN	B
in	O	ADP	O
the	O	DET	O
2	O	NUM	O
groups	O	NOUN	B
.	O	PUNCT	O


Small	O	ADJ	B
apolar	O	ADJ	B
substitutions	O	NOUN	I
(	O	PUNCT	O
11	O	NUM	O
alpha-methyl	O	NOUN	B
,	O	PUNCT	O
11	O	NUM	O
alpha-fluoromethyl	O	NOUN	O
)	O	PUNCT	O
did	O	AUX	O
not	O	PART	O
markedly	O	ADV	O
decrease	O	VERB	B
the	O	DET	O
affinity	O	NOUN	B
for	O	ADP	O
the	O	DET	O
vitamin	B-protein	NOUN	B
D	I-protein	NOUN	I
receptor	I-protein	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
larger	O	ADJ	O
(	O	PUNCT	O
11	O	NUM	O
alpha-chloromethyl	O	NOUN	B
or	O	CCONJ	O
11	O	NUM	O
alpha-	O	NOUN	O
or	O	CCONJ	O
11	O	NUM	O
beta-phenyl	O	NOUN	B
)	O	PUNCT	O
or	O	CCONJ	O
more	O	ADV	O
polar	O	ADJ	B
substitutions	O	NOUN	I
(	O	PUNCT	O
11	O	NUM	O
alpha-hydroxymethyl	O	NOUN	O
,	O	PUNCT	O
11	O	NUM	O
alpha-	O	NOUN	O
(	O	PUNCT	O
2-hydroxyethyl	O	NOUN	O
]	O	PUNCT	O
decreased	O	VERB	B
the	O	DET	O
affinity	O	NOUN	B
to	O	PART	O
less	O	ADJ	O
than	O	ADP	O
5	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
that	O	DET	O
of	O	ADP	O
1	O	NUM	O
alpha	O	NOUN	B
,	O	PUNCT	O
25-OH	O	NOUN	B
)	O	PUNCT	O
2D3	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
11	O	NUM	O
beta-methyl	O	NOUN	B
analog	O	NOUN	I
had	O	AUX	O
a	O	DET	O
greater	O	ADJ	O
than	O	ADP	O
10-fold	O	ADV	O
lower	O	ADJ	O
activity	O	NOUN	B
.	O	PUNCT	O


Large	O	ADJ	O
or	O	CCONJ	O
polar	O	ADJ	B
substitutions	O	NOUN	I
on	O	ADP	O
C-11	O	NOUN	B
of	O	ADP	I
1	O	NUM	I
alpha	O	NOUN	I
,	O	PUNCT	O
25-	O	NUM	O
(	O	PUNCT	O
OH	O	NOUN	B
)	O	PUNCT	O
2D3	O	NOUN	B
thus	O	ADV	O
impair	O	VERB	B
the	O	DET	O
binding	O	NOUN	B
of	O	ADP	O
the	O	DET	O
vitamin	B-protein	NOUN	B
D	I-protein	NOUN	I
receptor	I-protein	NOUN	I
but	O	CCONJ	O
increase	O	VERB	B
the	O	DET	O
affinity	O	NOUN	B
to	O	PART	O
vitamin	B-protein	NOUN	B
D-binding	I-protein	ADJ	I
protein	I-protein	NOUN	I
.	O	PUNCT	O


1	O	X	O
.	O	PUNCT	O


2	O	X	O
.	O	PUNCT	O


Initial	O	ADJ	B
and	O	CCONJ	O
post-dexamethasone	O	ADJ	B
in	O	X	B
vitro	O	X	I
fibroblast	O	NOUN	B
binding	O	NOUN	I
to	O	PART	O
glucocorticoid	O	NOUN	B
was	O	AUX	O
not	O	PART	O
different	O	ADJ	O
between	O	ADP	O
major	O	ADJ	O
depressive	O	ADJ	B
disorder	O	NOUN	I
and	O	CCONJ	O
non-depressed	O	ADJ	B
control	O	ADJ	I
subjects	O	NOUN	I
.	O	PUNCT	O


High	O	ADJ	O
affinity	O	NOUN	O
aldosterone	O	NOUN	O
binding	O	VERB	O
to	O	PART	O
plasma	O	NOUN	B
membrane	O	NOUN	I
rich	O	ADJ	O
fractions	O	NOUN	B
from	O	ADP	O
mononuclear	B-cell_type	ADJ	B
leukocytes	I-cell_type	NOUN	B
:	O	PUNCT	O
is	O	AUX	O
there	O	PRON	O
a	O	DET	O
membrane	B-protein	NOUN	B
receptor	I-protein	NOUN	I
for	O	ADP	O
mineralocorticoids	O	NOUN	B
?	O	PUNCT	O


The	O	DET	O
findings	O	NOUN	B
are	O	AUX	O
the	O	DET	O
first	O	ADJ	O
to	O	PART	O
demonstrate	O	VERB	O
membrane	O	NOUN	B
binding	O	NOUN	I
sites	O	NOUN	I
with	O	ADP	O
a	O	DET	O
high	O	ADJ	O
affinity	O	NOUN	B
for	O	ADP	O
aldosterone	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
for	O	ADP	O
cortisol	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
variation	O	NOUN	B
was	O	AUX	O
the	O	DET	O
result	O	NOUN	O
of	O	ADP	O
a	O	DET	O
duplication	O	NOUN	B
of	O	ADP	O
a	O	DET	O
short	B-DNA	ADJ	B
DNA	I-DNA	NOUN	I
sequence	I-DNA	NOUN	I
(	O	PUNCT	O
CTG-motif	B-DNA	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
virus	O	NOUN	B
with	O	ADP	O
four	O	NUM	O
Sp1	O	NOUN	B
sites	O	NOUN	B
did	O	AUX	O
outgrow	O	VERB	O
the	O	DET	O
three	O	NUM	O
Sp1	O	NOUN	B
virus	O	NOUN	O
in	O	ADP	O
35	O	NUM	O
days	O	NOUN	B
of	O	ADP	O
culture	O	NOUN	B
and	O	CCONJ	O
CTG-monomer	O	NOUN	B
virus	O	NOUN	I
outcompeted	O	VERB	O
the	O	DET	O
CTG-dimer	O	NOUN	B
virus	O	NOUN	I
in	O	ADP	O
42	O	NUM	O
days	O	NOUN	B
.	O	PUNCT	O


To	O	PART	O
address	O	VERB	O
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
Oct-2	B-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
T-cell	B-cell_type	NOUN	B
lineage	I-cell_type	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
studied	O	VERB	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
Oct-2	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
and	O	CCONJ	O
protein	O	NOUN	B
in	O	ADP	O
nontransformed	B-cell_line	ADJ	B
human	I-cell_line	ADJ	B
and	I-cell_line	CCONJ	O
mouse	I-cell_line	NOUN	B
T	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Possible	O	ADJ	O
relationship	O	NOUN	B
between	O	ADP	O
the	O	DET	O
changes	O	NOUN	B
in	O	ADP	O
IL-1	B-protein	NOUN	B
and	O	CCONJ	O
GR	B-protein	NOUN	B
in	O	ADP	O
aged	O	ADJ	B
long-distance	O	ADJ	B
runner	O	NOUN	B
and	O	CCONJ	O
its	O	PRON	O
physiological	O	ADJ	B
significance	O	NOUN	I
are	O	AUX	O
discussed	O	VERB	O
.	O	PUNCT	O


Mineralocorticoid	O	NOUN	B
effector	O	NOUN	I
mechanisms	O	NOUN	B
were	O	AUX	O
evaluated	O	VERB	B
in	O	ADP	O
29	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
preeclampsia	O	NOUN	B
and	O	CCONJ	O
in	O	ADP	O
25	O	NUM	O
uncomplicated	O	ADJ	B
pregnancies	O	NOUN	I
by	O	ADP	O
measurement	O	NOUN	B
of	O	ADP	O
plasma	O	NOUN	B
aldosterone	O	NOUN	O
,	O	PUNCT	O
levels	O	NOUN	B
of	O	ADP	O
mineralocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
(	O	PUNCT	O
MR	B-protein	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
mononuclear	B-cell_type	ADJ	B
leucocytes	I-cell_type	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
subtraction	O	NOUN	B
potential	O	ADJ	I
difference	O	NOUN	I
(	O	PUNCT	O
SPD	O	NOUN	B
;	O	PUNCT	O
rectal	O	ADJ	B
minus	O	CCONJ	I
oral	O	ADJ	B
values	O	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


Specific	O	ADJ	O
nuclear	O	ADJ	B
translocation	O	NOUN	B
of	O	ADP	O
[	B-protein	PUNCT	O
3H	I-protein	NOUN	B
]	I-protein	PUNCT	O
calcitriol/VDR	I-protein	NOUN	O
was	O	AUX	O
examined	O	VERB	O
after	O	ADP	O
exposure	O	NOUN	B
of	O	ADP	I
whole	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
to	O	PART	O
10	O	NUM	O
(	O	PUNCT	O
-9	O	NUM	O
)	O	PUNCT	O
M/l	O	NOUN	B
calcitriol	O	NOUN	I
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
and	O	CCONJ	O
absence	O	NOUN	B
of	O	ADP	O
a	O	DET	O
500-fold	O	ADJ	O
excess	O	NOUN	B
of	O	ADP	O
unlabeled	O	ADJ	B
ligand	O	NOUN	B
and	O	CCONJ	O
subsequent	O	ADJ	O
isolation	O	NOUN	B
of	O	ADP	O
nuclei	O	NOUN	B
.	O	PUNCT	O


Pulse	O	NOUN	B
exposure	O	NOUN	I
of	O	ADP	O
HL60	B-cell_line	NOUN	B
to	O	PART	O
radiolabeled	O	VERB	B
hormone	O	NOUN	O
for	O	ADP	O
3	O	NUM	O
h	O	NOUN	O
followed	O	VERB	O
by	O	ADP	O
culture	O	NOUN	B
in	O	ADP	O
medium	O	NOUN	B
without	O	ADP	O
serum	O	NOUN	B
and	O	CCONJ	O
calcitriol	O	NOUN	B
lead	O	VERB	O
to	O	PART	O
nuclear	O	ADJ	B
retention	O	NOUN	I
of	O	ADP	O
approximately	O	ADV	O
1600	B-protein	NUM	O
radiolabeled	I-protein	VERB	B
VDR	I-protein	NOUN	B
by	O	ADP	O
8	O	NUM	O
h	O	NOUN	O
and	O	CCONJ	O
approximately	O	ADV	O
1000	O	NUM	O
VDR	B-protein	NOUN	B
by	O	ADP	O
24	O	NUM	O
h	O	NOUN	O
.	O	PUNCT	O


No	O	DET	B
effect	O	NOUN	I
was	O	AUX	O
seen	O	VERB	O
in	O	ADP	O
ethanol	B-cell_line	NOUN	B
treated	I-cell_line	ADJ	B
controls	I-cell_line	NOUN	B
.	O	PUNCT	O


Enhanced	O	VERB	B
activity	O	NOUN	B
of	O	ADP	O
topoisomerases	B-protein	NOUN	B
in	O	ADP	O
nuclear	O	ADJ	B
extracts	O	NOUN	I
upon	O	SCONJ	O
translocation	O	NOUN	B
of	O	ADP	O
VDR	B-protein	NOUN	B
might	O	AUX	O
reflect	O	VERB	O
interaction	O	NOUN	B
of	O	ADP	O
both	O	DET	O
within	O	ADP	O
the	O	DET	O
nuclear	O	ADJ	B
compartment	O	NOUN	I
,	O	PUNCT	O
thus	O	ADV	O
initiating	O	VERB	O
DNA-unwinding	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
prerequisite	O	NOUN	O
of	O	ADP	O
transcription	O	NOUN	B
initiation	O	NOUN	B
.	O	PUNCT	O


Influence	O	NOUN	B
of	O	ADP	O
estradiol	O	NOUN	B
and	O	CCONJ	O
tamoxifen	O	NOUN	B
on	O	ADP	O
susceptibility	O	NOUN	B
of	O	ADP	O
human	B-cell_line	ADJ	B
breast	I-cell_line	NOUN	O
cancer	I-cell_line	NOUN	O
cell	I-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
to	O	PART	O
lysis	O	NOUN	B
by	O	ADP	O
lymphokine-activated	B-cell_type	ADJ	B
killer	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


E2-stimulated	B-cell_line	ADJ	B
ER+	I-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
were	O	AUX	O
more	O	ADV	O
susceptible	O	ADJ	B
to	O	PART	O
lysis	O	NOUN	B
by	O	ADP	O
LAK	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
than	O	ADP	O
corresponding	O	VERB	O
TAM-treated	B-cell_line	ADJ	B
or	O	CCONJ	O
control	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
while	O	SCONJ	O
treatment	O	NOUN	B
of	O	ADP	O
ER-	B-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
with	O	ADP	O
either	O	CCONJ	O
E2	O	NOUN	B
or	O	CCONJ	O
TAM	O	NOUN	B
alone	O	ADV	O
did	O	AUX	O
not	O	PART	O
alter	O	VERB	O
from	O	ADP	O
control	O	NOUN	B
their	O	PRON	O
susceptibility	O	NOUN	B
to	O	PART	O
this	O	DET	O
immune-mediated	O	ADJ	B
lysis	O	NOUN	I
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
c-myb	B-protein	NOUN	B
proto-oncogene	I-protein	NOUN	I
product	I-protein	NOUN	O
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
itself	O	PRON	O
a	O	DET	O
DNA-binding	B-protein	ADJ	B
protein	I-protein	NOUN	I
and	O	CCONJ	O
transcriptional	B-protein	ADJ	B
transactivator	I-protein	NOUN	I
,	O	PUNCT	O
can	O	AUX	O
interact	O	VERB	B
synergistically	O	ADV	B
with	O	ADP	I
Z	B-protein	NOUN	B
in	O	ADP	O
activating	O	VERB	B
the	O	DET	O
BMRF1	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
in	O	ADP	O
Jurkat	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
(	O	PUNCT	O
a	O	DET	O
T-cell	B-cell_line	NOUN	B
line	I-cell_line	NOUN	I
)	O	PUNCT	O
or	O	CCONJ	O
Raji	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
(	O	PUNCT	O
an	O	DET	O
EBV-positive	B-cell_line	ADJ	B
B-cell	I-cell_line	NOUN	I
)	O	PUNCT	O
,	O	PUNCT	O
whereas	O	SCONJ	O
the	O	DET	O
c-myb	B-protein	NOUN	B
gene	I-protein	NOUN	I
product	I-protein	NOUN	O
by	O	ADP	O
itself	O	PRON	O
has	O	AUX	O
little	O	ADJ	O
effect	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
simian	B-DNA	ADJ	B
virus	I-DNA	NOUN	I
40	I-DNA	NUM	O
early	I-DNA	ADJ	O
promoter	I-DNA	NOUN	B
is	O	AUX	O
also	O	ADV	O
synergistically	O	ADV	B
activated	O	VERB	B
by	O	ADP	O
the	O	DET	O
Z/c-myb	B-protein	NOUN	B
combination	I-protein	NOUN	B
.	O	PUNCT	O


That	O	SCONJ	O
the	O	DET	O
c-myb	B-protein	NOUN	B
oncogene	I-protein	NOUN	I
product	I-protein	NOUN	I
can	O	AUX	O
interact	O	VERB	B
synergistically	O	ADV	B
with	O	ADP	O
an	O	DET	O
EBV-encoded	B-protein	ADJ	B
member	I-protein	NOUN	I
of	O	ADP	O
the	O	DET	O
leucine	B-protein	NOUN	B
zipper	I-protein	NOUN	I
protein	I-protein	NOUN	I
family	I-protein	NOUN	O
suggests	O	VERB	O
c-myb	B-DNA	NOUN	B
is	O	AUX	O
likely	O	ADJ	O
to	O	PART	O
engage	O	VERB	O
in	O	ADP	O
similar	O	ADJ	O
interactions	O	NOUN	B
with	O	ADP	O
cellularly	B-protein	ADV	B
encoded	I-protein	VERB	O
transcription	I-protein	NOUN	B
factors	I-protein	NOUN	I
.	O	PUNCT	O


Acquired	O	VERB	B
immunodeficiency	O	NOUN	I
syndrome	O	NOUN	I
(	O	PUNCT	O
AIDS	O	NOUN	B
)	O	PUNCT	O
results	O	VERB	B
from	O	ADP	O
infection	O	NOUN	B
with	O	ADP	O
a	O	DET	O
human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
(	O	PUNCT	O
HIV	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Reticuloendotheliosis	B-DNA	NOUN	B
virus	I-DNA	NOUN	I
long	I-DNA	ADJ	B
terminal	I-DNA	ADJ	I
repeat	I-DNA	NOUN	I
elements	I-DNA	NOUN	I
are	O	AUX	O
efficient	O	ADJ	B
promoters	B-DNA	NOUN	B
in	O	ADP	O
cells	O	NOUN	B
of	O	ADP	O
various	O	ADJ	O
species	O	NOUN	B
and	O	CCONJ	O
tissue	O	NOUN	B
origin	O	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
human	B-cell_type	ADJ	B
lymphoid	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


REVs	O	NOUN	B
do	O	AUX	O
not	O	PART	O
encode	O	VERB	B
a	O	DET	O
transactivator	O	NOUN	B
targeted	O	VERB	B
to	O	PART	O
the	O	DET	O
viral	B-DNA	ADJ	B
LTR	I-DNA	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
cells	O	NOUN	B
infected	O	VERB	B
with	O	ADP	O
Marek	O	NOUN	B
's	O	PART	I
disease	O	NOUN	I
virus	O	NOUN	I
,	O	PUNCT	O
a	O	DET	O
herpesvirus	O	NOUN	B
with	O	ADP	O
an	O	DET	O
overlapping	O	VERB	O
host	O	NOUN	B
range	O	NOUN	O
,	O	PUNCT	O
do	O	AUX	O
not	O	PART	O
express	O	VERB	O
factors	O	NOUN	B
that	O	PRON	O
preferentially	O	ADV	O
enhance	O	VERB	B
expression	O	NOUN	B
from	O	ADP	O
REV	O	NOUN	B
or	O	CCONJ	O
avian	B-DNA	ADJ	B
sarcoma/leukemia	I-DNA	NOUN	B
virus	I-DNA	NOUN	I
LTRs	I-DNA	NOUN	B
.	O	PUNCT	O


REV	B-DNA	NOUN	B
LTRs	I-DNA	NOUN	B
work	O	VERB	O
efficiently	O	ADV	B
in	O	ADP	O
human	B-cell_type	ADJ	B
lymphoid	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
are	O	AUX	O
viable	O	ADJ	O
alternatives	O	NOUN	O
to	O	PART	O
promoters	B-DNA	NOUN	B
commonly	O	ADV	O
used	O	VERB	O
for	O	ADP	O
expression	O	NOUN	B
of	O	ADP	O
cloned	B-DNA	VERB	B
genes	I-DNA	NOUN	I
.	O	PUNCT	O


Human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
type	O	NOUN	I
1	O	NUM	I
(	O	PUNCT	O
HIV-1	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
HIV-2	O	NOUN	B
are	O	AUX	O
structurally	O	ADV	B
related	O	ADJ	O
retroviruses	O	NOUN	B
which	O	DET	O
both	O	DET	O
cause	O	VERB	O
AIDS	O	NOUN	B
in	O	ADP	O
humans	O	NOUN	B
.	O	PUNCT	O


Heterodimerization	O	NOUN	B
and	O	CCONJ	O
transcriptional	O	ADJ	B
activation	O	NOUN	I
in	O	X	B
vitro	O	X	I
by	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
proteins	I-protein	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
all	O	DET	O
subjects	O	NOUN	B
,	O	PUNCT	O
in	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
lymphocyte	B-cell_type	NOUN	B
subsets	I-cell_type	NOUN	I
were	O	AUX	O
determined	O	VERB	O
as	O	ADP	O
an	O	DET	O
index	O	NOUN	O
of	O	ADP	O
corticosteroid	O	NOUN	B
action	O	NOUN	B
.	O	PUNCT	O


All	O	DET	O
of	O	ADP	O
the	O	DET	O
parameters	O	NOUN	B
were	O	AUX	O
also	O	ADV	O
tested	O	VERB	B
for	O	ADP	O
correlation	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
significant	O	ADJ	O
inverse	O	ADJ	B
correlation	O	NOUN	B
was	O	AUX	O
found	O	VERB	O
between	O	ADP	O
age	O	NOUN	B
and	O	CCONJ	O
type	B-protein	NOUN	B
I	I-protein	NUM	I
and	O	CCONJ	O
type	B-protein	NOUN	B
II	I-protein	NUM	I
receptors	I-protein	NOUN	I
when	O	SCONJ	O
all	O	DET	O
subjects	O	NOUN	B
were	O	AUX	O
plotted	O	VERB	B
and	O	CCONJ	O
between	O	ADP	O
aged	O	ADJ	B
and	O	CCONJ	O
CD4	B-cell_type	NOUN	B
and	O	CCONJ	O
age	O	NOUN	B
and	O	CCONJ	O
CD4/CD8	B-cell_type	NOUN	B
in	O	ADP	O
the	O	DET	O
aged	O	ADJ	B
group	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
show	O	VERB	O
that	O	SCONJ	O
aged	O	ADJ	B
subjects	O	NOUN	B
have	O	AUX	O
reductions	O	NOUN	B
of	O	ADP	O
corticosteroid	B-protein	NOUN	B
receptors	I-protein	NOUN	I
that	O	PRON	O
are	O	AUX	O
not	O	PART	O
associated	O	VERB	B
with	O	ADP	I
increase	O	NOUN	B
of	O	ADP	O
related	O	ADJ	O
steroids	O	NOUN	B
and	O	CCONJ	O
that	O	SCONJ	O
this	O	DET	O
situation	O	NOUN	O
probably	O	ADV	O
represents	O	VERB	O
a	O	DET	O
concomitant	O	NOUN	B
of	O	ADP	O
the	O	DET	O
normal	O	ADJ	B
aging	O	NOUN	B
process	O	NOUN	O
.	O	PUNCT	O


T	O	NOUN	B
cell-specific	O	ADJ	O
negative	O	ADJ	O
regulation	O	NOUN	O
of	O	ADP	O
transcription	O	NOUN	B
of	O	ADP	O
the	O	DET	O
human	B-protein	ADJ	B
cytokine	I-protein	NOUN	B
IL-4	I-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
gene	O	NOUN	B
expression	O	NOUN	I
during	O	ADP	O
lymphocyte	B-cell_type	NOUN	B
differentiation	O	NOUN	I
is	O	AUX	O
a	O	DET	O
complex	O	ADJ	B
process	O	NOUN	B
involving	O	VERB	O
interactions	O	NOUN	B
between	O	ADP	O
multiple	B-DNA	ADJ	O
positive	I-DNA	ADJ	B
and	I-DNA	CCONJ	O
negative	I-DNA	ADJ	B
transcriptional	I-DNA	ADJ	B
regulatory	I-DNA	ADJ	O
elements	I-DNA	NOUN	O
.	O	PUNCT	O


Photoaffinity	O	NOUN	B
labeling	O	NOUN	I
of	O	ADP	O
plasma	B-protein	NOUN	B
membrane	I-protein	NOUN	I
receptors	I-protein	NOUN	I
for	O	ADP	O
aldosterone	O	NOUN	B
from	O	ADP	O
human	B-cell_type	ADJ	B
mononuclear	I-cell_type	ADJ	B
leukocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


Sodium	O	NOUN	B
dodecyl	O	NOUN	I
sulfate-polyacrylamide	O	ADJ	I
gel	O	NOUN	I
electrophoresis	O	NOUN	I
showed	O	VERB	O
significant	O	ADJ	O
aldosterone	O	NOUN	B
binding	O	NOUN	I
at	O	ADP	O
a	O	DET	O
molecular	O	ADJ	B
weight	O	NOUN	I
of	O	ADP	O
approximately	O	ADV	O
50000	O	NUM	O
Dalton	O	NOUN	B
which	O	DET	O
was	O	AUX	O
absent	O	ADJ	B
with	O	ADP	O
1	O	NUM	O
microM	O	NOUN	O
cold	O	ADJ	B
aldosterone	O	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
cortisol	O	NOUN	B
in	O	ADP	O
the	O	DET	O
binding	O	VERB	B
media	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
tested	O	VERB	B
the	O	DET	O
hypothesis	O	NOUN	B
that	O	SCONJ	O
cellular	O	ADJ	B
activation	O	NOUN	I
events	O	NOUN	O
occurring	O	VERB	O
in	O	ADP	O
T	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
and	O	CCONJ	O
monocytes	B-cell_type	NOUN	B
and	O	CCONJ	O
mediated	O	VERB	O
through	O	ADP	O
translocation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
NF-kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
are	O	AUX	O
dependent	O	ADJ	O
upon	O	SCONJ	O
the	O	DET	O
constitutive	O	ADJ	B
redox	O	NOUN	B
status	O	NOUN	I
of	O	ADP	O
these	O	DET	O
cells	O	NOUN	B
.	O	PUNCT	O


BHA	O	NOUN	B
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
suppress	O	VERB	B
not	O	PART	O
only	O	ADV	O
PMA-	O	NOUN	B
or	O	CCONJ	O
TNF-induced	O	ADJ	B
,	O	PUNCT	O
but	O	CCONJ	O
also	O	ADV	O
constitutive	O	ADJ	B
,	O	PUNCT	O
HIV-enhancer	O	NOUN	B
activity	O	NOUN	B
concomitant	O	ADJ	B
to	O	PART	O
an	O	DET	O
inhibition	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
binding	O	NOUN	I
activity	O	NOUN	I
in	O	ADP	O
both	O	CCONJ	O
lymphoblastoid	B-cell_line	ADJ	B
T	I-cell_line	NOUN	I
(	O	PUNCT	O
J.Jhan	B-cell_line	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
monocytic	B-cell_line	ADJ	B
(	I-cell_line	PUNCT	O
U937	I-cell_line	NOUN	B
)	I-cell_line	PUNCT	O
cell	I-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
product	O	NOUN	B
of	O	ADP	O
the	O	DET	O
proto-oncogene	B-DNA	NOUN	B
c-rel	I-DNA	NOUN	I
can	O	AUX	O
bind	O	VERB	B
to	O	PART	O
similar	O	ADJ	O
DNA	O	NOUN	B
motifs	O	NOUN	I
by	O	ADP	O
itself	O	PRON	O
or	O	CCONJ	O
as	O	ADP	O
a	O	DET	O
heterodimer	O	NOUN	B
with	O	ADP	O
p50	B-protein	NOUN	B
or	O	CCONJ	O
p65	B-protein	NOUN	B
.	O	PUNCT	O


Similarly	O	ADV	O
,	O	PUNCT	O
in	O	ADP	O
transfection	O	NOUN	B
experiments	O	NOUN	O
in	O	ADP	O
which	O	DET	O
the	O	DET	O
selective	B-DNA	ADJ	B
kappa	I-DNA	NOUN	I
B	I-DNA	NOUN	I
binding	I-DNA	NOUN	I
sites	I-DNA	NOUN	I
were	O	AUX	O
used	O	VERB	O
to	O	PART	O
drive	O	VERB	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
a	O	DET	O
chloramphenicol	B-DNA	NOUN	B
acetyltransferase	I-DNA	NOUN	I
reporter	I-DNA	NOUN	I
construct	I-DNA	NOUN	I
,	O	PUNCT	O
the	O	DET	O
p65	B-DNA	NOUN	B
-and	I-DNA	NOUN	O
p50-selected	I-DNA	ADJ	O
motifs	I-DNA	NOUN	B
were	O	AUX	O
activated	O	VERB	B
only	O	ADV	O
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
p65	B-protein	NOUN	B
and	O	CCONJ	O
p50/65	B-protein	NOUN	B
(	O	PUNCT	O
a	O	DET	O
chimeric	B-protein	ADJ	B
protein	I-protein	NOUN	I
with	O	ADP	O
the	O	DET	O
p50	B-protein	NOUN	B
DNA	I-protein	NOUN	I
binding	I-protein	NOUN	I
domain	I-protein	NOUN	I
and	O	CCONJ	O
p65	B-protein	NOUN	B
activation	I-protein	NOUN	I
domain	I-protein	NOUN	I
)	O	PUNCT	O
expression	O	NOUN	B
vectors	O	NOUN	I
,	O	PUNCT	O
respectively	O	ADV	O
,	O	PUNCT	O
and	O	CCONJ	O
neither	O	DET	O
demonstrated	O	VERB	O
a	O	DET	O
significant	O	ADJ	O
response	O	NOUN	B
to	O	PART	O
stimuli	O	NOUN	B
that	O	PRON	O
induce	O	VERB	B
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activity	O	NOUN	O
.	O	PUNCT	O


Deletions	O	NOUN	B
in	O	ADP	O
this	O	DET	O
promoter	B-DNA	NOUN	B
indicated	O	VERB	O
that	O	SCONJ	O
this	O	DET	O
upregulation	O	NOUN	B
was	O	AUX	O
mediated	O	VERB	O
through	O	ADP	O
the	O	DET	O
NF-kappa	O	NOUN	B
B-	O	NOUN	B
but	O	CCONJ	O
not	O	PART	O
the	O	DET	O
AP-1-binding	B-DNA	ADJ	B
motif	I-DNA	NOUN	I
,	O	PUNCT	O
by	O	ADP	O
bona	O	X	O
fide	O	X	O
p50/p65	B-protein	NOUN	B
heterodimers	I-protein	NOUN	I
.	O	PUNCT	O


T3SO4	O	NOUN	B
had	O	AUX	O
no	O	DET	O
thyromimetic	O	ADJ	B
effect	O	NOUN	I
on	O	ADP	O
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
Ca	B-protein	NOUN	B
(	I-protein	PUNCT	O
2+	I-protein	NUM	O
)	I-protein	PUNCT	O
-ATPase	I-protein	NOUN	O
in	O	ADP	O
human	O	ADJ	B
erythrocyte	O	NOUN	B
membranes	O	NOUN	I
at	O	ADP	O
doses	O	NOUN	B
up	O	ADV	O
to	O	PART	O
10	O	NUM	O
,	O	PUNCT	O
000	O	NUM	O
times	O	NOUN	O
the	O	DET	O
maximally	O	ADV	O
effective	O	ADJ	B
dose	O	NOUN	B
of	O	ADP	O
T3	O	NOUN	B
(	O	PUNCT	O
10	O	NUM	O
(	O	PUNCT	O
-10	O	NUM	B
)	O	PUNCT	O
mol/L	O	NOUN	O
)	O	PUNCT	O
.	O	PUNCT	O


Propylthiouracil	O	NOUN	B
(	O	PUNCT	O
50	O	NUM	O
mumol/L	O	NOUN	O
)	O	PUNCT	O
did	O	AUX	O
not	O	PART	O
affect	O	VERB	O
the	O	DET	O
action	O	NOUN	B
of	O	ADP	O
T3SO4	O	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
deiodination	O	NOUN	B
was	O	AUX	O
not	O	PART	O
important	O	ADJ	O
for	O	ADP	O
this	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
T3SO4	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
studied	O	VERB	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
AP-1	B-protein	NOUN	B
activity	O	NOUN	I
in	O	ADP	O
human	B-cell_type	ADJ	B
peripheral	I-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
T	I-cell_type	NOUN	I
lymphocytes	I-cell_type	NOUN	I
stimulated	O	VERB	B
through	O	ADP	O
the	O	DET	O
activation	O	NOUN	B
inducer	O	NOUN	O
molecule	O	NOUN	O
(	O	PUNCT	O
AIM	O	NOUN	B
)	O	PUNCT	O
/	O	SYM	O
CD69	B-protein	NOUN	B
activation	O	NOUN	B
pathway	O	NOUN	I
.	O	PUNCT	O


Phorbol	O	NOUN	B
esters	O	NOUN	I
are	O	AUX	O
required	O	VERB	O
to	O	PART	O
induce	O	VERB	B
AIM/CD69	B-protein	NOUN	O
cell-surface	O	ADJ	B
expression	O	NOUN	B
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
for	O	ADP	O
triggering	O	VERB	B
the	O	DET	O
proliferation	O	NOUN	B
of	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
in	O	ADP	O
conjunction	O	NOUN	B
with	O	ADP	O
anti-AIM	B-protein	ADJ	B
mAb	I-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
AP-1	B-protein	NOUN	B
-binding	O	ADJ	O
activity	O	NOUN	B
was	O	AUX	O
accompanied	O	VERB	O
by	O	ADP	O
the	O	DET	O
marked	O	ADJ	O
stimulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
transcription	O	NOUN	B
of	O	ADP	O
c-fos	B-protein	NOUN	B
but	O	CCONJ	O
not	O	PART	O
that	O	DET	O
of	O	ADP	O
c-jun	B-protein	NOUN	B
.	O	PUNCT	O


Blockade	O	NOUN	B
of	O	ADP	O
the	O	DET	O
DNA-binding	B-protein	ADJ	B
complexes	I-protein	NOUN	O
with	O	ADP	O
an	O	DET	O
anti-Fos	B-protein	ADJ	B
mAb	I-protein	NOUN	B
demonstrated	O	VERB	O
a	O	DET	O
direct	O	ADJ	O
participation	O	NOUN	B
of	O	ADP	O
c-Fos	B-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
AP-1	B-protein	NOUN	B
complexes	I-protein	NOUN	I
induced	O	VERB	B
by	O	ADP	O
anti-AIM	B-protein	ADJ	B
mAb	I-protein	NOUN	I
.	O	PUNCT	O


On	O	ADP	O
the	O	DET	O
other	O	ADJ	O
hand	O	NOUN	B
,	O	PUNCT	O
phorbol	O	NOUN	B
ester-induced	O	ADJ	B
production	O	NOUN	B
of	O	ADP	O
O2-	O	NOUN	B
was	O	AUX	O
similar	O	ADJ	O
in	O	ADP	O
cells	O	NOUN	B
treated	O	VERB	B
with	O	ADP	I
and	O	CCONJ	O
without	O	ADP	O
gangliosides	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
cDNA	B-DNA	NOUN	B
has	O	AUX	O
an	O	DET	O
open	B-DNA	ADJ	B
reading	I-DNA	NOUN	I
frame	I-DNA	NOUN	I
of	O	ADP	O
900	B-DNA	NUM	O
amino	I-DNA	NOUN	B
acids	I-DNA	NOUN	I
capable	O	ADJ	O
of	O	ADP	O
encoding	O	VERB	B
a	O	DET	O
97-kDa	B-protein	ADJ	O
protein	I-protein	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
vitro-translated	B-protein	ADJ	B
proteins	I-protein	NOUN	I
,	O	PUNCT	O
truncated	O	VERB	B
downstream	O	ADV	I
of	O	ADP	O
the	O	DET	O
Rel	B-DNA	NOUN	B
domain	I-DNA	NOUN	I
and	O	CCONJ	O
excluding	O	VERB	O
the	O	DET	O
repeats	O	NOUN	B
,	O	PUNCT	O
bind	O	VERB	B
kappa	B-DNA	NOUN	I
B	I-DNA	NOUN	I
sites	I-DNA	NOUN	O
.	O	PUNCT	O


The	O	DET	O
data	O	NOUN	B
imply	O	VERB	O
the	O	DET	O
existence	O	NOUN	O
of	O	ADP	O
a	O	DET	O
complex	O	ADJ	B
family	O	NOUN	O
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B-like	I-protein	ADJ	O
transcription	I-protein	NOUN	O
factors	I-protein	NOUN	O
.	O	PUNCT	O


Proliferation	O	NOUN	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
TG	B-protein	NOUN	B
was	O	AUX	O
observed	O	VERB	O
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
from	O	ADP	O
only	O	ADV	O
1	O	NUM	O
of	O	ADP	O
5	O	NUM	O
Hashimoto	O	NOUN	B
patients	O	NOUN	B
.	O	PUNCT	O


Stable	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
transdominant	B-protein	ADJ	B
Rev	I-protein	NOUN	I
protein	I-protein	NOUN	I
in	O	ADP	O
human	B-cell_type	ADJ	B
T	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
inhibits	O	VERB	B
human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
replication	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
(	O	PUNCT	O
HIV	O	NOUN	B
)	O	PUNCT	O
Rev	B-protein	NOUN	B
protein	I-protein	NOUN	I
is	O	AUX	O
essential	O	ADJ	O
for	O	ADP	O
viral	O	ADJ	B
structural	O	ADJ	I
protein	O	NOUN	I
expression	O	NOUN	I
(	O	PUNCT	O
Gag	B-protein	NOUN	B
,	O	PUNCT	O
Pol	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
Env	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
,	O	PUNCT	O
hence	O	ADV	O
,	O	PUNCT	O
for	O	ADP	O
viral	O	ADJ	B
replication	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
transient	O	ADJ	B
transfection	O	NOUN	B
assays	O	NOUN	I
,	O	PUNCT	O
mutant	O	ADJ	B
forms	O	NOUN	O
of	O	ADP	O
Rev	B-protein	NOUN	B
have	O	AUX	O
been	O	AUX	O
identified	O	VERB	O
that	O	PRON	O
inhibit	O	VERB	B
wild-type	O	ADJ	B
Rev	B-protein	NOUN	B
activity	O	NOUN	B
and	O	CCONJ	O
therefore	O	ADV	O
suppress	O	VERB	B
viral	O	ADJ	B
replication	O	NOUN	I
.	O	PUNCT	O


While	O	SCONJ	O
all	O	DET	O
the	O	DET	O
M10-expressing	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
remained	O	VERB	O
infectable	O	ADJ	B
by	O	ADP	O
HIV-1	O	NOUN	B
,	O	PUNCT	O
these	O	DET	O
same	O	ADJ	O
cells	O	NOUN	B
failed	O	VERB	B
to	O	PART	O
support	O	VERB	O
a	O	DET	O
productive	O	ADJ	O
replication	O	NOUN	B
cycle	O	NOUN	I
when	O	SCONJ	O
infected	O	VERB	B
with	O	ADP	O
a	O	DET	O
cloned	O	VERB	B
isolate	O	NOUN	B
of	O	ADP	O
HIV-1	O	NOUN	B
.	O	PUNCT	O


Mitogen	O	NOUN	B
stimulation	O	NOUN	I
of	O	ADP	O
T-cells	O	NOUN	B
increases	O	VERB	B
c-Fos	B-protein	NOUN	B
and	O	CCONJ	O
c-Jun	B-protein	NOUN	B
protein	O	NOUN	I
levels	O	NOUN	O
,	O	PUNCT	O
AP-1	O	NOUN	B
binding	O	NOUN	I
and	O	CCONJ	O
AP-1	O	NOUN	B
transcriptional	O	ADJ	I
activity	O	NOUN	I
.	O	PUNCT	O


PMA	O	NOUN	B
was	O	AUX	O
also	O	ADV	O
found	O	VERB	O
to	O	PART	O
increase	O	VERB	B
the	O	DET	O
AP-1	O	NOUN	B
enhancer	O	NOUN	I
activity	O	NOUN	I
,	O	PUNCT	O
whereas	O	SCONJ	O
elevation	O	NOUN	B
of	O	ADP	O
Ca2+	O	NOUN	B
or	O	CCONJ	O
cAMP	O	NOUN	B
had	O	AUX	O
only	O	ADV	O
minor	O	ADJ	B
effects	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
binding	B-protein	VERB	B
protein	I-protein	NOUN	I
(	O	PUNCT	O
s	O	NOUN	O
)	O	PUNCT	O
that	O	PRON	O
recognize	O	VERB	O
the	O	DET	O
P	B-DNA	NOUN	O
sequence	I-DNA	NOUN	B
of	O	ADP	O
the	O	DET	O
IL-4	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
were	O	AUX	O
identified	O	VERB	B
by	O	ADP	O
DNA-mobility-shift	O	ADJ	B
assays	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
we	O	PRON	O
looked	O	VERB	O
at	O	ADP	O
the	O	DET	O
modulation	O	NOUN	B
of	O	ADP	O
nuclear	B-protein	ADJ	B
factors	I-protein	NOUN	I
binding	O	VERB	B
specifically	O	ADV	O
to	O	PART	O
the	O	DET	O
AP-1	B-DNA	NOUN	B
element	I-DNA	NOUN	I
after	O	ADP	O
LTB4	O	NOUN	B
stimulation	O	NOUN	B
.	O	PUNCT	O


Further	O	ADJ	O
analysis	O	NOUN	B
identified	O	VERB	B
three	O	NUM	O
elements	O	NOUN	B
required	O	VERB	O
for	O	ADP	O
efficient	O	ADJ	B
induction	O	NOUN	B
,	O	PUNCT	O
referred	O	VERB	O
to	O	PART	O
as	O	ADP	O
GM2	B-DNA	NOUN	B
,	O	PUNCT	O
GC-box	B-DNA	NOUN	B
and	O	CCONJ	O
conserved	B-DNA	VERB	O
lymphokine	I-DNA	NOUN	O
element	I-DNA	NOUN	O
(	O	PUNCT	O
CLE0	B-DNA	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Viral	B-protein	ADJ	B
trans-activators	I-protein	NOUN	I
such	O	ADJ	O
as	O	ADP	O
Tax	B-protein	NOUN	B
(	O	PUNCT	O
human	O	ADJ	B
T	O	NOUN	O
cell	O	NOUN	O
leukemia	O	NOUN	O
virus-1	O	NOUN	B
,	O	PUNCT	O
HTLV-1	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
E2	B-protein	NOUN	B
(	O	PUNCT	O
bovine	O	ADJ	B
papilloma	O	NOUN	I
virus	O	NOUN	I
,	O	PUNCT	O
BPV	O	NOUN	B
)	O	PUNCT	O
proteins	O	NOUN	O
are	O	AUX	O
other	O	ADJ	O
agents	O	NOUN	B
which	O	DET	O
activate	O	VERB	B
lymphokine	B-DNA	NOUN	B
gene	I-DNA	NOUN	O
expression	O	NOUN	B
by	O	ADP	O
bypassing	O	VERB	O
T	B-protein	NOUN	B
cell	I-protein	NOUN	I
receptor	I-protein	NOUN	I
(	O	PUNCT	O
TCR	B-protein	NOUN	B
)	O	PUNCT	O
mediated	O	ADJ	O
signaling	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
trans-activation	O	NOUN	B
domain	O	NOUN	I
of	O	ADP	O
E2	B-protein	NOUN	B
and	O	CCONJ	O
Tax	B-protein	NOUN	B
is	O	AUX	O
interchangeable	O	ADJ	O
although	O	SCONJ	O
they	O	PRON	O
have	O	AUX	O
no	O	DET	O
obvious	O	ADJ	O
sequence	O	NOUN	B
homology	O	NOUN	B
between	O	ADP	O
them	O	PRON	O
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
have	O	AUX	O
therefore	O	ADV	O
examined	O	VERB	B
the	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
the	O	DET	O
phorbol	O	NOUN	B
ester	O	NOUN	I
PMA	O	NOUN	I
(	O	PUNCT	O
phorbol	O	NOUN	B
12-myristate	O	NOUN	I
13-acetate	O	NOUN	I
)	O	PUNCT	O
which	O	DET	O
stimulates	O	VERB	B
PKC	B-protein	NOUN	B
and	O	CCONJ	O
a	O	DET	O
combination	O	NOUN	B
of	O	ADP	O
the	O	DET	O
adenosine	B-protein	NOUN	B
receptor	I-protein	NOUN	I
agonist	O	NOUN	B
NECA	O	NOUN	B
(	O	PUNCT	O
5'-	O	ADJ	O
(	O	PUNCT	O
N-ethyl	O	NOUN	B
)	O	PUNCT	O
-carboxamido	O	NOUN	O
adenosine	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
forskolin	O	NOUN	B
to	O	PART	O
raise	O	VERB	O
cAMP	O	NOUN	B
,	O	PUNCT	O
on	O	ADP	O
the	O	DET	O
levels	O	NOUN	B
of	O	ADP	O
c-Fos	B-protein	NOUN	B
and	O	CCONJ	O
Jun	B-protein	NOUN	B
and	O	CCONJ	O
on	O	ADP	O
the	O	DET	O
binding	O	NOUN	B
and	O	CCONJ	O
transcriptional	O	ADJ	B
activity	O	NOUN	I
of	O	ADP	O
the	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
,	O	PUNCT	O
activator	B-protein	NOUN	B
protein-1	I-protein	NOUN	I
(	O	PUNCT	O
AP-1	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


During	O	ADP	O
the	O	DET	O
inflammatory	O	ADJ	B
response	O	NOUN	I
increased	O	VERB	B
levels	O	NOUN	B
of	O	ADP	O
PGE2	O	NOUN	B
bind	O	VERB	B
to	O	PART	O
their	O	PRON	O
receptors	O	NOUN	B
on	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
thus	O	ADV	O
alter	O	VERB	O
responsiveness	O	NOUN	B
.	O	PUNCT	O


2	O	X	O
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
DRA	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
discriminates	O	VERB	O
against	O	ADP	O
OTF-1	B-protein	NOUN	B
activation	O	NOUN	I
at	O	ADP	O
the	O	DET	O
level	O	NOUN	B
of	O	ADP	O
DNA	O	NOUN	B
binding	O	NOUN	I
in	O	ADP	O
the	O	DET	O
glioblastoma	B-cell_line	NOUN	B
line	I-cell_line	NOUN	I
.	O	PUNCT	O


Therefore	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
describe	O	VERB	O
a	O	DET	O
microtitre	O	NOUN	B
assay	O	NOUN	I
system	O	NOUN	O
for	O	ADP	O
glucocorticoid	B-protein	NOUN	B
receptors	I-protein	NOUN	I
which	O	DET	O
is	O	AUX	O
a	O	DET	O
whole-cell	O	ADJ	O
competitive	O	ADJ	B
binding	O	NOUN	B
radioassay	O	NOUN	I
using	O	VERB	O
[	O	PUNCT	O
3H	O	NOUN	B
]	O	PUNCT	O
-dexamethasone	O	NOUN	O
as	O	ADP	O
radioligand	O	NOUN	B
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
AP-1	B-DNA	NOUN	B
site	I-DNA	NOUN	I
at	O	ADP	O
-150	B-DNA	NUM	O
bp	I-DNA	NOUN	O
represents	O	VERB	O
a	O	DET	O
major	O	ADJ	O
,	O	PUNCT	O
if	O	SCONJ	O
not	O	PART	O
the	O	DET	O
only	O	ADJ	O
,	O	PUNCT	O
site	O	NOUN	B
of	O	ADP	O
PKC	B-protein	NOUN	B
responsiveness	O	NOUN	B
in	O	ADP	O
the	O	DET	O
IL-2	B-DNA	NOUN	B
promoter	I-DNA	NOUN	I
.	O	PUNCT	O


The	O	DET	O
number	O	NOUN	O
of	O	ADP	O
glucocorticoid	B-protein	NOUN	B
and	I-protein	CCONJ	O
mineralocorticoid	I-protein	NOUN	B
binding	I-protein	NOUN	I
sites	I-protein	NOUN	I
was	O	AUX	O
increased	O	VERB	B
in	O	ADP	O
hypertensives	O	NOUN	B
vs	O	CCONJ	O
normotensives	O	NOUN	B
.	O	PUNCT	O


Leukotriene	O	NOUN	B
B4	O	NOUN	I
(	O	PUNCT	O
LTB4	O	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
notable	O	ADJ	O
participant	O	NOUN	B
in	O	ADP	O
inflammation	O	NOUN	B
and	O	CCONJ	O
chemotaxis	O	NOUN	B
.	O	PUNCT	O


Here	O	ADV	O
,	O	PUNCT	O
Stanley	O	PROPN	O
Korsmeyer	O	PROPN	B
provides	O	VERB	O
a	O	DET	O
brief	O	ADJ	O
overview	O	NOUN	O
of	O	ADP	O
bcl-2	B-protein	NOUN	B
,	O	PUNCT	O
concentrating	O	VERB	O
on	O	ADP	O
its	O	PRON	O
roles	O	NOUN	O
in	O	ADP	O
B-	O	NOUN	B
and	O	CCONJ	O
T-cell	O	NOUN	B
development	O	NOUN	B
and	O	CCONJ	O
in	O	ADP	O
oncogenesis	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
insertion	O	NOUN	B
was	O	AUX	O
not	O	PART	O
required	O	VERB	O
for	O	ADP	O
Fc	B-protein	NOUN	B
gamma	I-protein	NOUN	I
RII	I-protein	NOUN	I
to	O	PART	O
modulate	O	VERB	B
surface	B-protein	NOUN	B
immunoglobulin	I-protein	NOUN	B
-triggered	O	ADJ	I
B-cell	O	NOUN	I
activation	O	NOUN	B
.	O	PUNCT	O


Instead	O	ADV	O
,	O	PUNCT	O
regulation	O	NOUN	B
of	O	ADP	O
activation	O	NOUN	B
involved	O	VERB	O
a	O	DET	O
region	O	NOUN	B
of	O	ADP	O
the	O	DET	O
cytoplasmic	B-protein	ADJ	B
domain	I-protein	NOUN	I
common	O	ADJ	O
to	O	PART	O
both	O	CCONJ	O
the	O	DET	O
lymphocyte	B-protein	NOUN	B
and	I-protein	CCONJ	O
macrophage	I-protein	NOUN	B
receptor	I-protein	NOUN	I
isoforms	I-protein	NOUN	B
.	O	PUNCT	O


[	O	PUNCT	O
Age-related	O	ADJ	B
changes	O	NOUN	B
in	O	ADP	O
glucocorticoid	B-protein	NOUN	B
and	I-protein	CCONJ	O
mineralocorticoid	I-protein	NOUN	B
receptors	I-protein	NOUN	I
in	O	ADP	O
lymphocytes	B-cell_type	NOUN	B
of	O	ADP	O
healthy	O	ADJ	B
persons	O	NOUN	B
and	O	CCONJ	O
patients	O	NOUN	B
with	O	ADP	O
hypertension	O	NOUN	B
]	O	PUNCT	O


The	O	DET	O
mechanisms	O	NOUN	B
of	O	ADP	O
hormone-receptor	O	NOUN	B
interactions	O	NOUN	B
in	O	ADP	O
hypertension	O	NOUN	B
are	O	AUX	O
activated	O	VERB	B
:	O	PUNCT	O
the	O	DET	O
number	O	NOUN	O
of	O	ADP	O
glucocorticoid	B-protein	NOUN	B
and	I-protein	CCONJ	O
mineralocorticoid	I-protein	NOUN	B
binding	I-protein	NOUN	I
sites	I-protein	NOUN	I
grows	O	VERB	O
in	O	ADP	O
hypertensive	O	ADJ	B
patients	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
mechanism	O	NOUN	B
of	O	ADP	O
action	O	NOUN	B
of	O	ADP	O
cyclosporin	O	NOUN	B
A	O	NOUN	I
and	O	CCONJ	O
FK506	O	NOUN	B
.	O	PUNCT	O


PLB-IIIB	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	B
clearly	O	ADV	O
possessed	O	VERB	O
a	O	DET	O
more	O	ADV	O
monocytic	O	ADJ	B
phenotype	O	NOUN	B
than	O	ADP	O
the	O	DET	O
parental	B-cell_type	ADJ	B
myeloblasts	I-cell_type	NOUN	B
,	O	PUNCT	O
as	O	ADP	O
determined	O	VERB	O
by	O	ADP	O
differential	O	ADJ	B
staining	O	NOUN	I
,	O	PUNCT	O
increased	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
myeloid-specific	B-protein	ADJ	B
surface	I-protein	NOUN	I
markers	I-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
transcription	O	NOUN	B
of	O	ADP	O
the	O	DET	O
c-fms	B-DNA	NOUN	B
proto-oncogene	I-DNA	NOUN	I
.	O	PUNCT	O


All	O	DET	O
four	O	NUM	O
female	O	ADJ	B
patients	O	NOUN	B
presented	O	VERB	O
between	O	ADP	O
the	O	DET	O
age	O	NOUN	B
of	O	ADP	O
20-30	O	NUM	O
yr	O	NOUN	O
with	O	ADP	O
acne	O	NOUN	B
,	O	PUNCT	O
hirsutism	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
irregular	O	ADJ	B
menstruations	O	NOUN	B
.	O	PUNCT	O


All	O	DET	O
patients	O	NOUN	B
showed	O	VERB	O
insufficient	O	ADJ	B
suppression	O	NOUN	B
of	O	ADP	O
serum	O	NOUN	B
cortisol	O	NOUN	O
concentrations	O	NOUN	O
in	O	ADP	O
the	O	DET	O
overnight	O	ADJ	B
1-mg	O	ADJ	O
dexamethasone	O	NOUN	B
test	O	NOUN	O
.	O	PUNCT	O


There	O	PRON	O
was	O	AUX	O
a	O	DET	O
normal	O	ADJ	O
increase	O	NOUN	B
in	O	ADP	O
ACTH	O	NOUN	B
,	O	PUNCT	O
cortisol	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
GH	O	NOUN	B
(	O	PUNCT	O
except	O	SCONJ	O
in	O	ADP	O
one	O	NUM	O
obese	O	ADJ	B
patient	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
insulin-induced	O	ADJ	B
hypoglycemia	O	NOUN	B
,	O	PUNCT	O
while	O	SCONJ	O
cortisol	O	NOUN	B
production	O	NOUN	O
was	O	AUX	O
elevated	O	ADJ	B
in	O	ADP	O
three	O	NUM	O
patients	O	NOUN	B
.	O	PUNCT	O


Therapy	O	NOUN	B
with	O	ADP	O
dexamethasone	O	NOUN	B
was	O	AUX	O
successful	O	ADJ	O
in	O	ADP	O
female	O	ADJ	B
patients	O	NOUN	B
with	O	ADP	O
acne	O	NOUN	B
and	O	CCONJ	O
hirsutism	O	NOUN	B
,	O	PUNCT	O
as	O	ADP	O
the	O	DET	O
secondary	O	ADJ	B
increase	O	NOUN	B
in	O	ADP	O
the	O	DET	O
production	O	NOUN	B
of	O	ADP	O
adrenal	O	ADJ	B
androgens	O	NOUN	B
was	O	AUX	O
effectively	O	ADV	O
controlled	O	VERB	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
profound	O	ADJ	O
T	O	NOUN	B
cell	O	NOUN	I
deficit	O	NOUN	O
of	O	ADP	O
nude	O	ADJ	B
mice	O	NOUN	I
indicates	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
thymus	O	NOUN	B
is	O	AUX	O
by	O	ADP	O
far	O	ADV	O
the	O	DET	O
most	O	ADV	O
potent	O	ADJ	O
site	O	NOUN	B
for	O	ADP	O
inducing	O	VERB	B
the	O	DET	O
expansion	O	NOUN	B
per	O	X	O
se	O	X	O
,	O	PUNCT	O
even	O	ADV	O
if	O	SCONJ	O
other	O	ADJ	O
sites	O	NOUN	B
can	O	AUX	O
induce	O	VERB	B
some	O	DET	O
response	O	NOUN	B
acquisition	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
details	O	NOUN	O
of	O	ADP	O
the	O	DET	O
regulatory	O	ADJ	B
mechanism	O	NOUN	B
that	O	PRON	O
selects	O	VERB	O
particular	O	ADJ	O
loci	B-DNA	NOUN	B
for	O	ADP	O
rearrangement	O	NOUN	B
are	O	AUX	O
still	O	ADV	O
not	O	PART	O
known	O	VERB	O
.	O	PUNCT	O


Third	O	ADJ	B
is	O	AUX	O
the	O	DET	O
complex	O	ADJ	B
process	O	NOUN	B
of	O	ADP	O
selection	O	NOUN	B
.	O	PUNCT	O


Whereas	O	SCONJ	O
peripheral	B-cell_type	ADJ	B
T	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
can	O	AUX	O
undergo	O	VERB	O
forms	O	NOUN	O
of	O	ADP	O
positive	O	ADJ	B
selection	O	NOUN	B
(	O	PUNCT	O
by	O	ADP	O
antigen-driven	O	ADJ	B
clonal	O	ADJ	I
expansion	O	NOUN	I
)	O	PUNCT	O
and	O	CCONJ	O
negative	O	ADJ	B
selection	O	NOUN	B
(	O	PUNCT	O
by	O	ADP	O
abortive	O	ADJ	B
stimulation	O	NOUN	I
leading	O	VERB	O
to	O	PART	O
anergy	O	NOUN	B
or	O	CCONJ	O
death	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
neither	O	CCONJ	O
is	O	AUX	O
exactly	O	ADV	O
the	O	DET	O
same	O	ADJ	O
phenomenon	O	NOUN	B
that	O	PRON	O
occurs	O	VERB	O
in	O	ADP	O
the	O	DET	O
thymic	O	ADJ	B
cortex	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
active	O	ADJ	B
nuclear	O	ADJ	O
form	O	NOUN	O
of	O	ADP	O
the	O	DET	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
complex	I-protein	NOUN	I
is	O	AUX	O
composed	O	VERB	O
of	O	ADP	O
two	O	NUM	O
DNA	B-protein	NOUN	B
binding	I-protein	NOUN	I
subunits	I-protein	NOUN	I
,	O	PUNCT	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
p65	I-protein	NOUN	I
and	O	CCONJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
p50	I-protein	NOUN	B
,	O	PUNCT	O
both	O	DET	O
of	O	ADP	O
which	O	DET	O
share	O	VERB	O
extensive	O	ADJ	O
N-terminal	O	ADJ	B
sequence	O	NOUN	I
homology	O	NOUN	O
with	O	ADP	O
the	O	DET	O
v-rel	B-protein	NOUN	B
oncogene	I-protein	NOUN	I
product	I-protein	NOUN	I
.	O	PUNCT	O


To	O	PART	O
investigate	O	VERB	B
the	O	DET	O
molecular	O	ADJ	B
basis	O	NOUN	I
for	O	ADP	O
the	O	DET	O
critical	O	ADJ	O
regulatory	O	ADJ	O
interaction	O	NOUN	O
between	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
and	O	CCONJ	O
I	B-protein	NOUN	O
kappa	I-protein	NOUN	O
B/MAD-3	I-protein	NOUN	B
,	O	PUNCT	O
a	O	DET	O
series	O	NOUN	O
of	O	ADP	O
human	B-protein	ADJ	B
NF-kappa	I-protein	NOUN	O
B	I-protein	NOUN	O
p65	I-protein	NOUN	O
mutants	I-protein	NOUN	B
was	O	AUX	O
identified	O	VERB	B
that	O	PRON	O
functionally	O	ADV	O
segregated	O	VERB	O
DNA	O	NOUN	B
binding	O	NOUN	I
,	O	PUNCT	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
-mediated	O	ADJ	O
inhibition	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
-induced	O	ADJ	O
nuclear	O	ADJ	B
exclusion	O	NOUN	I
of	O	ADP	O
this	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
.	O	PUNCT	O


This	O	DET	O
factor	O	NOUN	B
has	O	AUX	O
a	O	DET	O
DNA-binding	O	ADJ	B
specificity	O	NOUN	B
similar	O	ADJ	O
to	O	PART	O
that	O	DET	O
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
but	O	CCONJ	O
is	O	AUX	O
unrelated	O	ADJ	O
to	O	PART	O
this	O	DET	O
or	O	CCONJ	O
other	O	ADJ	O
Rel	B-protein	NOUN	B
proteins	I-protein	NOUN	I
by	O	ADP	O
functional	O	ADJ	B
and	O	CCONJ	O
biochemical	O	ADJ	B
criteria	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
candidate	B-protein	NOUN	O
oncoprotein	I-protein	NOUN	B
Bcl-3	I-protein	NOUN	I
is	O	AUX	O
an	O	DET	O
antagonist	O	NOUN	B
of	O	ADP	O
p50/NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
-mediated	O	ADJ	O
inhibition	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
activation	O	NOUN	B
of	O	ADP	O
c-raf	B-protein	NOUN	B
kinase	I-protein	NOUN	I
was	O	AUX	O
normal	O	ADJ	O
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
report	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
newly	O	ADV	O
synthesized	O	VERB	B
nuclear	B-protein	ADJ	B
component	I-protein	NOUN	I
of	O	ADP	O
NF-AT	B-protein	NOUN	B
is	O	AUX	O
the	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
AP-1	B-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
affinity	O	NOUN	B
of	O	ADP	O
glucocorticoid	B-protein	NOUN	B
receptors	I-protein	NOUN	I
(	O	PUNCT	O
Kd	O	NOUN	O
)	O	PUNCT	O
was	O	AUX	O
strikingly	O	ADV	O
decreased	O	VERB	B
(	O	PUNCT	O
9.36	O	NUM	O
+/-	O	CCONJ	O
3.44	O	NUM	O
nM	O	NOUN	O
in	O	ADP	O
group	O	NOUN	B
1	O	NUM	O
;	O	PUNCT	O
3.2	O	NUM	O
+/-	O	CCONJ	O
1.5	O	NUM	O
nM	O	NOUN	O
in	O	ADP	O
group	O	NOUN	B
2	O	NUM	I
;	O	PUNCT	O
2.0	O	NUM	O
+/-	O	CCONJ	O
0.8	O	NUM	O
nM	O	NOUN	O
in	O	ADP	O
controls	O	NOUN	B
;	O	PUNCT	O
P	O	NOUN	O
less	O	ADJ	O
than	O	ADP	O
0.01	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


[	O	PUNCT	O
3H	O	NOUN	B
]	O	PUNCT	O
Thymidine	O	NOUN	B
incorporation	O	NOUN	B
was	O	AUX	O
decreased	O	VERB	B
dose-dependently	O	ADV	O
by	O	ADP	O
dexamethasone	O	NOUN	B
in	O	ADP	O
controls	O	NOUN	B
and	O	CCONJ	O
patients	O	NOUN	B
;	O	PUNCT	O
the	O	DET	O
effect	O	NOUN	B
was	O	AUX	O
significantly	O	ADV	O
blunted	O	VERB	B
(	O	PUNCT	O
P	O	NOUN	O
less	O	ADJ	O
than	O	ADP	O
0.05	O	NUM	O
)	O	PUNCT	O
in	O	ADP	O
group	O	NOUN	B
1	O	NUM	O
patients	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
suggests	O	VERB	O
that	O	SCONJ	O
activation	O	NOUN	B
of	O	ADP	O
glucocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
is	O	AUX	O
impaired	O	ADJ	B
as	O	ADP	O
a	O	DET	O
result	O	NOUN	O
of	O	ADP	O
the	O	DET	O
glucocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
abnormality	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
resultant	O	ADJ	O
primer	B-DNA	NOUN	B
products	I-DNA	NOUN	I
are	O	AUX	O
analysed	O	VERB	B
by	O	ADP	O
denaturing	O	VERB	B
polyacrylamide	O	NOUN	I
gel	O	NOUN	I
electrophoresis	O	NOUN	I
and	O	CCONJ	O
autoradiography	O	NOUN	B
.	O	PUNCT	O


It	O	PRON	O
is	O	AUX	O
evident	O	ADJ	O
that	O	SCONJ	O
assembly	O	NOUN	B
of	O	ADP	O
the	O	DET	O
surface	B-protein	NOUN	B
domain	I-protein	NOUN	I
of	O	ADP	O
TF	B-protein	NOUN	B
with	O	ADP	O
VIIa	B-protein	NOUN	B
to	O	PART	O
form	O	VERB	O
the	O	DET	O
binary	O	ADJ	B
TF.VIIa	B-protein	NOUN	O
complex	I-protein	NOUN	B
induces	O	VERB	B
a	O	DET	O
significant	O	ADJ	O
increase	O	NOUN	B
in	O	ADP	O
the	O	DET	O
Kcat	O	NOUN	B
of	O	ADP	O
the	O	DET	O
catalytic	B-protein	ADJ	B
domain	I-protein	NOUN	I
of	O	ADP	O
VIIa	B-protein	NOUN	B
for	O	ADP	O
small	O	ADJ	B
peptidyl	O	ADJ	B
substrates	O	NOUN	I
and	O	CCONJ	O
more	O	ADV	O
profoundly	O	ADV	O
for	O	ADP	O
protein	B-protein	NOUN	B
substrate	I-protein	NOUN	I
.	O	PUNCT	O


This	O	DET	O
provides	O	VERB	O
substantial	O	ADJ	O
evidence	O	NOUN	B
for	O	ADP	O
an	O	DET	O
allosteric	O	ADJ	B
effect	O	NOUN	I
on	O	ADP	O
the	O	DET	O
catalytic	O	ADJ	B
cleft	O	NOUN	I
of	O	ADP	O
VIIa	B-protein	NOUN	B
that	O	PRON	O
is	O	AUX	O
imparted	O	VERB	O
by	O	ADP	O
binding	O	VERB	B
to	O	PART	O
TF	B-protein	NOUN	B
,	O	PUNCT	O
its	O	PRON	O
cognate	O	ADJ	B
catalytic	O	ADJ	O
cofactor	B-protein	NOUN	O
.	O	PUNCT	O


Treatment	O	NOUN	B
of	O	ADP	O
endothelial	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
with	O	ADP	O
LPS	O	NOUN	B
(	O	PUNCT	O
1	O	NUM	O
microgram/ml	O	NOUN	O
)	O	PUNCT	O
stimulated	O	VERB	B
transcription	O	NOUN	B
of	O	ADP	O
ELAM-1	B-protein	NOUN	B
,	O	PUNCT	O
as	O	ADP	O
shown	O	VERB	O
by	O	ADP	O
Northern	O	NOUN	B
blot	O	NOUN	I
analysis	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
expression	O	NOUN	B
of	O	ADP	O
membrane-associated	B-protein	ADJ	O
ELAM-1	I-protein	NOUN	B
and	O	CCONJ	O
ICAM-1	B-protein	NOUN	B
,	O	PUNCT	O
as	O	ADP	O
shown	O	VERB	O
by	O	ADP	O
quantitative	O	ADJ	B
immunofluorescence	O	NOUN	I
(	O	PUNCT	O
both	O	DET	O
P	O	NOUN	O
<	O	X	O
0.001	O	NUM	O
,	O	PUNCT	O
n	O	NOUN	O
=	O	ADJ	O
9	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Dexamethasone	O	NOUN	B
markedly	O	ADV	O
inhibited	O	VERB	B
LPS-stimulated	O	ADJ	B
accumulation	O	NOUN	B
of	O	ADP	O
mRNA	O	NOUN	B
for	O	ADP	O
ELAM-1	B-protein	NOUN	B
and	O	CCONJ	O
expression	O	NOUN	B
of	O	ADP	O
ELAM-1	B-protein	NOUN	B
and	O	CCONJ	O
ICAM-1	B-protein	NOUN	B
(	O	PUNCT	O
IC50	O	NOUN	B
<	O	NOUN	O
10	O	NUM	O
nM	O	NOUN	O
,	O	PUNCT	O
both	O	CCONJ	O
P	O	NOUN	O
<	O	X	O
0.001	O	NUM	O
,	O	PUNCT	O
n	O	NOUN	O
=	O	ADJ	O
4-9	O	NUM	O
)	O	PUNCT	O
;	O	PUNCT	O
inhibition	O	NOUN	B
of	O	ADP	O
expression	O	NOUN	B
by	O	ADP	O
dexamethasone	O	NOUN	B
was	O	AUX	O
reversed	O	VERB	O
by	O	ADP	O
RU-486	O	NOUN	B
(	O	PUNCT	O
both	O	DET	O
P	O	NOUN	O
<	O	X	O
0.005	O	NUM	O
,	O	PUNCT	O
n	O	NOUN	O
=	O	ADJ	O
4-6	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
a	O	DET	O
microenvironment-directed	O	ADJ	B
,	O	PUNCT	O
two-step	O	ADJ	O
model	O	NOUN	B
for	O	ADP	O
GATA-1	B-protein	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
differentiating	B-cell_type	VERB	O
hematopoietic	I-cell_type	ADJ	B
progenitors	I-cell_type	NOUN	I
that	O	PRON	O
involves	O	VERB	O
(	O	PUNCT	O
i	O	X	O
)	O	PUNCT	O
cycle-dependent	O	ADJ	B
initiation	O	NOUN	B
and	O	CCONJ	O
(	O	PUNCT	O
ii	O	X	O
)	O	PUNCT	O
lineage-dependent	O	ADJ	B
maintenance	O	NOUN	B
or	O	CCONJ	O
suppression	O	NOUN	B
.	O	PUNCT	O


Specific	O	ADJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
subunits	I-protein	NOUN	O
act	O	VERB	O
in	O	ADP	O
concert	O	NOUN	O
with	O	ADP	O
Tat	B-protein	NOUN	B
to	O	PART	O
stimulate	O	VERB	B
human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
type	O	NOUN	I
1	O	NUM	I
transcription	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
found	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
p49	B-protein	NOUN	B
(	I-protein	PUNCT	O
100	I-protein	NUM	O
)	I-protein	PUNCT	O
DNA	I-protein	NOUN	B
binding	I-protein	NOUN	I
subunit	I-protein	NOUN	I
,	O	PUNCT	O
together	O	ADV	O
with	O	ADP	O
p65	B-protein	NOUN	B
,	O	PUNCT	O
can	O	AUX	O
act	O	VERB	O
in	O	ADP	O
concert	O	NOUN	O
with	O	ADP	O
Tat-I	B-protein	NOUN	B
to	O	PART	O
stimulate	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
HIV-CAT	B-DNA	NOUN	B
plasmid	I-DNA	NOUN	I
.	O	PUNCT	O


It	O	PRON	O
therefore	O	ADV	O
appears	O	VERB	O
that	O	SCONJ	O
an	O	DET	O
indirect	O	ADJ	B
interaction	O	NOUN	B
occurs	O	VERB	O
between	O	ADP	O
these	O	DET	O
two	O	NUM	O
sites	O	NOUN	B
and	O	CCONJ	O
that	O	SCONJ	O
this	O	DET	O
interaction	O	NOUN	B
is	O	AUX	O
crucial	O	ADJ	O
for	O	ADP	O
v-erb	B-protein	NOUN	B
A	I-protein	NOUN	I
function	O	NOUN	B
.	O	PUNCT	O


Within	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
enhancer	I-DNA	NOUN	O
,	O	PUNCT	O
these	O	DET	O
two	O	NUM	O
sites	O	NOUN	B
are	O	AUX	O
located	O	ADJ	O
within	O	ADP	O
the	O	DET	O
previously	O	ADV	O
defined	O	VERB	O
DNase	B-protein	NOUN	B
I	I-protein	NUM	I
footprints	O	NOUN	B
,	O	PUNCT	O
NFAT-1	B-DNA	NOUN	B
and	O	CCONJ	O
NFIL-2B	B-DNA	NOUN	B
,	O	PUNCT	O
respectively	O	ADV	O
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
in	O	X	B
vitro	O	X	I
mutagenesis	O	NOUN	B
experiments	O	NOUN	B
demonstrated	O	VERB	O
that	O	SCONJ	O
inducible	O	ADJ	B
interleukin-2	B-DNA	NOUN	B
enhancer	I-DNA	NOUN	I
function	O	NOUN	O
requires	O	VERB	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
either	O	CCONJ	O
EBS1	O	NOUN	B
or	O	CCONJ	O
EBS2	B-DNA	NOUN	B
.	O	PUNCT	O


Transcription	O	NOUN	B
of	O	ADP	O
the	O	DET	O
hypersensitive	B-DNA	ADJ	B
site	I-DNA	NOUN	I
HS2	I-DNA	NOUN	B
enhancer	I-DNA	NOUN	I
in	O	ADP	O
erythroid	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


The	O	DET	O
palindromic	B-DNA	ADJ	B
site	I-DNA	NOUN	I
(	O	PUNCT	O
site	B-DNA	NOUN	B
B	I-DNA	NOUN	I
)	O	PUNCT	O
recognized	O	VERB	O
by	O	ADP	O
this	O	DET	O
protein	O	NOUN	B
is	O	AUX	O
related	O	ADJ	O
to	O	PART	O
the	O	DET	O
palindromic	B-DNA	ADJ	B
binding	I-DNA	VERB	I
sites	I-DNA	NOUN	I
of	O	ADP	O
members	O	NOUN	B
of	O	ADP	O
the	O	DET	O
steroid/thyroid	B-protein	NOUN	B
hormone	I-protein	NOUN	I
receptor	I-protein	NOUN	I
family	I-protein	NOUN	O
.	O	PUNCT	O


This	O	DET	O
protein	O	NOUN	B
is	O	AUX	O
distinct	O	ADJ	O
from	O	ADP	O
other	O	ADJ	O
members	O	NOUN	B
of	O	ADP	O
the	O	DET	O
steroid/thyroid	B-protein	NOUN	B
hormone	I-protein	NOUN	I
receptor	I-protein	NOUN	I
family	I-protein	NOUN	B
including	O	VERB	O
the	O	DET	O
COUP	B-protein	NOUN	B
protein	I-protein	NOUN	I
which	O	DET	O
has	O	AUX	O
a	O	DET	O
closely	O	ADV	O
related	O	ADJ	O
DNA	O	NOUN	B
binding	O	NOUN	I
specificity	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
interaction	O	NOUN	B
is	O	AUX	O
believed	O	VERB	O
to	O	PART	O
be	O	AUX	O
an	O	DET	O
important	O	ADJ	O
component	O	NOUN	B
of	O	ADP	O
the	O	DET	O
mechanism	O	NOUN	B
of	O	ADP	O
transactivation	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
report	O	NOUN	O
we	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
in	O	ADP	O
certain	O	ADJ	O
CNS-derived	B-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
Tat	B-protein	NOUN	B
is	O	AUX	O
capable	O	ADJ	O
of	O	ADP	O
activating	O	VERB	B
HIV-1	O	NOUN	B
through	O	ADP	O
a	O	DET	O
TAR	B-DNA	NOUN	B
-independent	O	ADJ	O
pathway	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
Tat-responsive	B-DNA	ADJ	B
element	I-DNA	NOUN	B
is	O	AUX	O
found	O	VERB	O
upstream	O	ADV	B
within	O	ADP	O
the	O	DET	O
viral	B-DNA	ADJ	B
promoter	I-DNA	NOUN	I
that	O	PRON	O
in	O	ADP	O
glial-derived	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
allows	O	VERB	O
transactivation	O	NOUN	B
in	O	ADP	O
the	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
TAR	B-RNA	NOUN	B
.	O	PUNCT	O


Transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
AP-2	I-protein	NOUN	I
activates	O	VERB	B
gene	O	NOUN	B
expression	O	NOUN	I
of	O	ADP	O
HTLV-I	O	NOUN	B
.	O	PUNCT	O


Gel	O	NOUN	B
retardation	O	NOUN	I
and	O	CCONJ	O
methylation	O	NOUN	B
interference	O	NOUN	O
studies	O	NOUN	O
revealed	O	VERB	O
that	O	SCONJ	O
bacterially	B-protein	ADV	B
produced	I-protein	VERB	O
AP-2	I-protein	NOUN	B
bound	O	VERB	O
specifically	O	ADV	O
and	O	CCONJ	O
with	O	ADP	O
high	O	ADJ	O
affinity	O	NOUN	B
to	O	PART	O
all	O	DET	O
three	O	NUM	O
21	B-DNA	NUM	O
bp	I-DNA	NOUN	O
repeats	I-DNA	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
that	O	SCONJ	O
it	O	PRON	O
required	O	VERB	O
the	O	DET	O
core	B-DNA	NOUN	B
sequence	I-DNA	NOUN	I
AGGC	O	NOUN	B
for	O	ADP	O
specific	O	ADJ	O
binding	O	NOUN	B
.	O	PUNCT	O


(	O	PUNCT	O
ABSTRACT	O	NOUN	B
TRUNCATED	O	VERB	I
AT	O	ADP	I
250	O	NUM	I
WORDS	O	NOUN	I
)	O	PUNCT	O


Recombinant	B-protein	ADJ	B
OTF-2	I-protein	NOUN	B
protein	I-protein	NOUN	I
produced	O	VERB	O
by	O	ADP	O
in	O	X	B
vitro	O	X	I
transcription/translation	O	NOUN	B
could	O	AUX	O
also	O	ADV	O
enhance	O	VERB	O
DRA	B-DNA	NOUN	B
gene	I-DNA	NOUN	B
transcription	O	NOUN	I
in	O	X	B
vitro	O	X	I
.	O	PUNCT	O


Although	O	SCONJ	O
IFN-gamma	B-protein	NOUN	B
alone	O	ADV	O
does	O	AUX	O
not	O	PART	O
induce	O	VERB	O
ISG	O	NOUN	B
expression	O	NOUN	B
,	O	PUNCT	O
IFN-gamma	B-protein	NOUN	B
pretreatment	O	NOUN	B
markedly	O	ADV	O
increases	O	VERB	B
and	O	CCONJ	O
hastens	O	VERB	B
ISG	O	NOUN	B
expression	O	NOUN	B
and	O	CCONJ	O
transcriptional	O	ADJ	B
induction	O	NOUN	I
.	O	PUNCT	O


(	O	PUNCT	O
ABSTRACT	O	NOUN	B
TRUNCATED	O	VERB	I
AT	O	ADP	I
250	O	NUM	I
WORDS	O	NOUN	I
)	O	PUNCT	O


cells/tube	O	NOUN	B
in	O	ADP	O
the	O	DET	O
assay	O	NOUN	B
volume	O	NOUN	B
0.25	O	NUM	O
ml	O	NOUN	O
were	O	AUX	O
found	O	VERB	O
to	O	PART	O
be	O	AUX	O
optimal	O	ADJ	B
.	O	PUNCT	O


We	O	PRON	O
conclude	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
cellular	O	ADJ	B
glucocorticoid	B-protein	NOUN	I
receptor	I-protein	NOUN	I
levels	O	NOUN	B
in	O	ADP	O
peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
leukocytes	I-cell_type	NOUN	B
reflect	O	VERB	O
in	O	X	B
vitro	O	X	I
responsiveness	O	NOUN	B
to	O	PART	O
glucocorticoids	O	NOUN	B
in	O	ADP	O
mononuclear	B-cell_type	ADJ	B
leukocytes	I-cell_type	NOUN	B
from	O	ADP	O
healthy	O	ADJ	B
males	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
that	O	SCONJ	O
the	O	DET	O
individual	O	ADJ	B
responsiveness	O	NOUN	B
may	O	AUX	O
alter	O	VERB	O
upon	O	SCONJ	O
changes	O	NOUN	B
in	O	ADP	O
the	O	DET	O
cellular	O	ADJ	B
levels	O	NOUN	I
of	O	ADP	O
glucocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
.	O	PUNCT	O


Activation	O	NOUN	B
of	O	ADP	O
expression	O	NOUN	B
of	O	ADP	O
genes	B-DNA	NOUN	B
encoding	O	VERB	B
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
:	O	PUNCT	O
c-fos	B-DNA	NOUN	B
and	O	CCONJ	O
c-jun	B-DNA	NOUN	B
and	O	CCONJ	O
formation	O	NOUN	B
of	O	ADP	O
AP1	B-protein	NOUN	B
transcriptional	I-protein	ADJ	O
complex	I-protein	NOUN	O
in	O	ADP	O
human	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
was	O	AUX	O
investigated	O	VERB	B
.	O	PUNCT	O


It	O	PRON	O
was	O	AUX	O
found	O	VERB	O
that	O	SCONJ	O
lipopolysaccharide	O	NOUN	B
induced	O	VERB	B
strongly	O	ADV	O
both	O	CCONJ	O
c-fos	B-DNA	NOUN	B
and	O	CCONJ	O
c-jun	B-DNA	NOUN	B
expression	O	NOUN	I
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
AP1	B-protein	NOUN	B
formation	O	NOUN	B
.	O	PUNCT	O


When	O	SCONJ	O
dexamethasone	O	NOUN	B
was	O	AUX	O
added	O	VERB	O
to	O	PART	O
the	O	DET	O
cultures	O	NOUN	B
3	O	NUM	O
hours	O	NOUN	B
after	O	ADP	O
the	O	DET	O
stimulators	O	NOUN	B
,	O	PUNCT	O
it	O	PRON	O
clearly	O	ADV	O
decreased	O	VERB	B
the	O	DET	O
interleukin-1	B-RNA	NOUN	B
beta	I-RNA	NOUN	I
mRNA	I-RNA	NOUN	B
levels	O	NOUN	O
regardless	O	ADV	O
of	O	ADP	O
the	O	DET	O
stimulator	O	NOUN	B
used	O	VERB	O
(	O	PUNCT	O
although	O	SCONJ	O
the	O	DET	O
effect	O	NOUN	B
was	O	AUX	O
clearly	O	ADV	O
weaker	O	ADJ	O
on	O	ADP	O
the	O	DET	O
PMA-induced	B-RNA	ADJ	B
mRNA	I-RNA	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Our	O	PRON	O
data	O	NOUN	B
correlate	O	VERB	O
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
NF-AT	B-protein	NOUN	B
and	O	CCONJ	O
AP-1	B-protein	NOUN	B
in	O	ADP	O
gel	O	NOUN	B
shift	O	NOUN	I
assays	O	NOUN	I
with	O	ADP	O
the	O	DET	O
two	O	NUM	O
signals	O	NOUN	O
requirements	O	NOUN	B
for	O	ADP	O
IL-2	B-DNA	NOUN	B
gene	I-DNA	NOUN	O
expression	O	NOUN	B
.	O	PUNCT	O


Expression	O	NOUN	B
of	O	ADP	O
Tax	B-protein	NOUN	B
protein	I-protein	NOUN	I
in	O	ADP	O
19D	B-cell_line	NOUN	B
and	O	CCONJ	O
9J	B-cell_line	NOUN	B
resulted	O	VERB	O
in	O	ADP	O
transcription	O	NOUN	B
of	O	ADP	O
the	O	DET	O
endogenous	B-DNA	ADJ	B
NF-kappa	I-DNA	NOUN	B
B-dependent	I-DNA	ADJ	I
granulocyte-macrophage	I-DNA	ADJ	O
colony	I-DNA	NOUN	O
stimulating	I-DNA	NOUN	O
factor	I-DNA	NOUN	O
gene	I-DNA	NOUN	O
and	O	CCONJ	O
increased	O	VERB	B
basal	O	ADJ	B
level	O	NOUN	O
expression	O	NOUN	B
of	O	ADP	O
transfected	O	VERB	B
NF-kappa	B-DNA	NOUN	O
B-regulated	I-DNA	ADJ	B
promoters	I-DNA	NOUN	I
.	O	PUNCT	O


Activation	O	NOUN	B
of	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
by	O	ADP	O
antigen	O	NOUN	B
,	O	PUNCT	O
lectin	B-protein	NOUN	B
,	O	PUNCT	O
or	O	CCONJ	O
a	O	DET	O
combination	O	NOUN	B
of	O	ADP	O
phorbol-12-myristate	O	NOUN	B
acetate	O	NOUN	I
(	O	PUNCT	O
PMA	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
calcium	O	NOUN	B
ionophore	O	NOUN	I
(	O	PUNCT	O
A23187	O	NOUN	B
)	O	PUNCT	O
leads	O	VERB	O
to	O	PART	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
genes	O	NOUN	B
for	O	ADP	O
a	O	DET	O
set	O	NOUN	O
of	O	ADP	O
lymphokines	B-protein	NOUN	B
,	O	PUNCT	O
including	O	VERB	O
granulocyte-macrophage	B-protein	ADJ	B
colony-stimulating	I-protein	ADJ	I
factor	I-protein	NOUN	I
(	O	PUNCT	O
GM-CSF	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
GM2	B-DNA	NOUN	B
sequence	I-DNA	NOUN	I
(	O	PUNCT	O
GGTAGTTCCC	O	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
recognized	O	VERB	O
by	O	ADP	O
an	O	DET	O
inducible	B-protein	ADJ	B
factor	I-protein	NOUN	I
NF-GM2	I-protein	NOUN	I
;	O	PUNCT	O
the	O	DET	O
other	O	ADJ	O
(	O	PUNCT	O
CCGCCC	O	NOUN	B
)	O	PUNCT	O
by	O	ADP	O
constitutive	B-protein	ADJ	B
factors	I-protein	NOUN	I
A1	B-protein	NOUN	I
,	O	PUNCT	O
A2	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
B	B-protein	NOUN	B
.	O	PUNCT	O


Preincubation	O	NOUN	B
of	O	ADP	O
cells	O	NOUN	B
with	O	ADP	O
1	O	NUM	O
,	O	PUNCT	O
25-	O	NUM	O
(	O	PUNCT	O
OH	O	NOUN	B
)	O	PUNCT	O
2D3	O	NOUN	B
had	O	AUX	O
no	O	DET	B
effect	O	NOUN	I
on	O	ADP	O
the	O	DET	O
time	O	NOUN	B
course	O	NOUN	I
of	O	ADP	O
IL-1	B-RNA	NOUN	B
beta	I-RNA	NOUN	O
mRNA	I-RNA	NOUN	B
appearance	O	NOUN	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
LPS	O	NOUN	B
.	O	PUNCT	O


Clone	B-DNA	NOUN	B
pAT	I-DNA	NOUN	B
133	I-DNA	NUM	O
identifies	O	VERB	O
a	O	DET	O
gene	O	NOUN	B
that	O	PRON	O
encodes	O	VERB	B
another	O	DET	O
human	O	ADJ	B
member	O	NOUN	O
of	O	ADP	O
a	O	DET	O
class	O	NOUN	B
of	O	ADP	O
growth	B-DNA	NOUN	B
factor-induced	I-DNA	ADJ	I
genes	I-DNA	NOUN	I
with	O	ADP	O
almost	O	ADV	O
identical	O	ADJ	O
zinc-finger	B-protein	ADJ	B
domains	I-protein	NOUN	I
.	O	PUNCT	O


Except	O	SCONJ	O
for	O	ADP	O
the	O	DET	O
conserved	O	VERB	O
zinc-finger	B-protein	ADJ	B
domains	I-protein	NOUN	I
,	O	PUNCT	O
the	O	DET	O
amino	B-protein	NOUN	B
acid	I-protein	NOUN	I
sequences	I-protein	NOUN	I
of	O	ADP	O
the	O	DET	O
three	O	NUM	O
proteins	O	NOUN	B
are	O	AUX	O
distinct	O	ADJ	O
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
upon	O	SCONJ	O
transition	O	NOUN	B
from	O	ADP	O
a	O	DET	O
proliferating	O	NOUN	B
(	O	PUNCT	O
G1	O	NOUN	B
)	O	PUNCT	O
to	O	PART	O
a	O	DET	O
resting	O	VERB	B
state	O	NOUN	I
of	O	ADP	O
the	O	DET	O
cell	O	NOUN	B
cycle	O	NOUN	I
the	O	DET	O
three	O	NUM	O
genes	O	NOUN	B
were	O	AUX	O
differently	O	ADV	O
regulated	O	VERB	O
.	O	PUNCT	O


Here	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
v-erbA	B-protein	NOUN	B
and	O	CCONJ	O
c-erbA	B-protein	NOUN	B
bind	O	VERB	B
directly	O	ADV	O
to	O	PART	O
sequences	O	NOUN	B
within	O	ADP	O
the	O	DET	O
promoter	B-DNA	NOUN	B
of	O	ADP	O
the	O	DET	O
erythrocyte-specific	B-protein	ADJ	B
carbonic	I-protein	ADJ	I
anhydrase	I-protein	NOUN	I
II	I-protein	NUM	I
(	O	PUNCT	O
CAII	B-DNA	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
a	O	DET	O
gene	O	NOUN	B
whose	O	DET	O
transcription	O	NOUN	B
is	O	AUX	O
efficiently	O	ADV	O
suppressed	O	VERB	B
by	O	ADP	O
v-erbA	B-protein	NOUN	B
.	O	PUNCT	O


These	O	DET	O
studies	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
interaction	O	NOUN	B
of	O	ADP	O
CD2	B-protein	NOUN	B
with	O	ADP	O
its	O	PRON	O
natural	O	ADJ	B
ligand	O	NOUN	O
,	O	PUNCT	O
LFA-3	B-protein	NOUN	B
,	O	PUNCT	O
may	O	AUX	O
play	O	VERB	O
a	O	DET	O
role	O	NOUN	O
in	O	ADP	O
regulation	O	NOUN	B
of	O	ADP	O
HIV	O	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


Hydrogen	O	NOUN	B
peroxide	O	NOUN	I
and	O	CCONJ	O
oxygen	O	NOUN	B
radicals	O	NOUN	I
are	O	AUX	O
agents	O	NOUN	B
commonly	O	ADV	O
produced	O	VERB	O
during	O	ADP	O
inflammatory	O	ADJ	B
processes	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
dimerization	B-protein	NOUN	B
domain	I-protein	NOUN	I
of	O	ADP	O
KBF1/p50	B-protein	NOUN	B
is	O	AUX	O
contained	O	VERB	O
between	B-protein	ADP	O
amino	I-protein	NOUN	B
acids	I-protein	NOUN	I
201	I-protein	NUM	I
and	I-protein	CCONJ	O
367	I-protein	NUM	O
.	O	PUNCT	O


Tissue-specific	O	ADJ	B
expression	O	NOUN	I
of	O	ADP	O
the	O	DET	O
platelet	B-DNA	NOUN	B
GPIIb	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
.	O	PUNCT	O


For	O	ADP	O
these	O	DET	O
reasons	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
5'-flanking	B-DNA	ADJ	B
region	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
GPIIb	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
was	O	AUX	O
used	O	VERB	O
to	O	PART	O
identify	O	VERB	O
the	O	DET	O
regions	O	NOUN	B
that	O	PRON	O
interact	O	VERB	B
with	O	ADP	O
DNA-binding	B-protein	ADJ	B
nuclear	I-protein	ADJ	I
factors	I-protein	NOUN	I
.	O	PUNCT	O


A	O	DET	O
fragment	O	NOUN	B
extending	O	VERB	O
from	O	ADP	O
-643	B-DNA	NUM	O
to	I-DNA	PART	O
+33	I-DNA	NUM	O
is	O	AUX	O
capable	O	ADJ	O
of	O	ADP	O
controlling	O	VERB	B
the	O	DET	O
tissue-specific	O	ADJ	B
expression	O	NOUN	I
of	O	ADP	O
the	O	DET	O
CAT	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
in	O	ADP	O
transfection	O	NOUN	B
experiments	O	NOUN	O
.	O	PUNCT	O


Notably	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
do	O	AUX	O
not	O	PART	O
see	O	VERB	O
particularly	O	ADV	O
strong	O	ADJ	O
transcription	O	NOUN	B
when	O	SCONJ	O
the	O	DET	O
immunoglobulin	B-DNA	NOUN	B
kappa	I-DNA	NOUN	I
enhancer	I-DNA	NOUN	I
(	O	PUNCT	O
or	O	CCONJ	O
the	O	DET	O
immunoglobulin	B-DNA	NOUN	B
heavy	I-DNA	ADJ	I
chain	I-DNA	NOUN	I
enhancer	I-DNA	NOUN	I
)	O	PUNCT	O
is	O	AUX	O
used	O	VERB	O
to	O	PART	O
activate	O	VERB	B
a	O	DET	O
kappa	O	NOUN	B
gene	O	NOUN	I
promoter	B-DNA	NOUN	O
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
postulated	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
circadian	O	ADJ	B
modification	O	NOUN	B
of	O	ADP	O
GR	B-protein	NOUN	B
was	O	AUX	O
independent	O	ADJ	O
of	O	ADP	O
the	O	DET	O
diurnal	O	ADJ	B
fluctuations	O	NOUN	B
in	O	ADP	O
plasma	O	NOUN	B
cortisol	O	NOUN	O
level	O	NOUN	O
or	O	CCONJ	O
the	O	DET	O
circadian	O	ADJ	B
variations	O	NOUN	B
in	O	ADP	O
environmental	O	ADJ	B
lighting	O	NOUN	I
and	O	CCONJ	O
that	O	SCONJ	O
the	O	DET	O
rhythmicity	O	NOUN	B
might	O	AUX	O
be	O	AUX	O
regulated	O	VERB	O
by	O	ADP	O
the	O	DET	O
'circadian	O	ADJ	B
pacemaker	O	NOUN	I
'	O	PUNCT	O
located	O	ADJ	O
in	O	ADP	O
the	O	DET	O
human	O	ADJ	B
basal	O	ADJ	B
brain	O	NOUN	I
.	O	PUNCT	O


Transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
requirements	O	NOUN	I
for	O	ADP	O
U2	B-RNA	NOUN	B
snRNA	I-RNA	NOUN	I
-encoding	O	ADJ	O
gene	O	NOUN	B
activation	O	NOUN	I
in	O	ADP	O
B	B-cell_type	NOUN	B
lymphoid	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


When	O	SCONJ	O
cloned	O	VERB	B
in	O	ADP	O
multiple	O	ADJ	B
copies	O	NOUN	B
this	O	DET	O
so-called	O	ADJ	O
TCEd	B-DNA	NOUN	B
(	O	PUNCT	O
distal	B-DNA	ADJ	B
T	I-DNA	NOUN	I
cell	I-DNA	NOUN	I
element	I-DNA	NOUN	I
)	O	PUNCT	O
acts	O	VERB	O
as	O	ADP	O
an	O	DET	O
inducible	O	ADJ	B
proto-enhancer	B-DNA	NOUN	B
element	I-DNA	NOUN	I
in	O	ADP	O
E14	B-cell_line	NOUN	B
T	I-cell_line	NOUN	I
lymphoma	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
in	O	ADP	O
HeLa	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


The	O	DET	O
conversion	O	NOUN	B
of	O	ADP	O
the	O	DET	O
TCEd	B-DNA	NOUN	B
to	O	PART	O
a	O	DET	O
'perfect	B-DNA	NOUN	B
'	I-DNA	PUNCT	I
NF-kB	I-DNA	NOUN	B
binding	I-DNA	NOUN	O
site	I-DNA	NOUN	O
leads	O	VERB	O
to	O	PART	O
a	O	DET	O
tighter	O	ADJ	O
binding	O	NOUN	B
of	O	ADP	O
NF-kB	B-protein	NOUN	B
to	O	PART	O
TCEd	B-DNA	NOUN	B
DNA	I-DNA	NOUN	B
and	O	CCONJ	O
,	O	PUNCT	O
as	O	ADP	O
a	O	DET	O
functional	O	ADJ	B
consequence	O	NOUN	B
,	O	PUNCT	O
to	O	PART	O
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
'converted	B-DNA	ADJ	B
'	I-DNA	PUNCT	I
TCEd	I-DNA	NOUN	B
motifs	I-DNA	NOUN	B
in	O	ADP	O
HeLa	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


A	O	DET	B
region	O	NOUN	I
upstream	O	ADJ	O
to	O	PART	O
the	O	DET	O
first	O	ADJ	O
exon	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
highly	O	ADV	O
conserved	O	VERB	O
between	O	ADP	O
mouse	O	NOUN	B
and	O	CCONJ	O
man	O	NOUN	B
,	O	PUNCT	O
acts	O	VERB	O
as	O	ADP	O
an	O	DET	O
erythroid	O	ADJ	B
specific	O	ADJ	O
enhancer	O	NOUN	B
in	O	ADP	O
transient	O	ADJ	B
assays	O	NOUN	I
,	O	PUNCT	O
if	O	SCONJ	O
linked	O	VERB	O
to	O	PART	O
the	O	DET	O
GATA-1	B-protein	NOUN	B
or	O	CCONJ	O
to	O	PART	O
the	O	DET	O
SV40	O	NOUN	B
promoter	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
enhancer	O	NOUN	B
is	O	AUX	O
almost	O	ADV	O
completely	O	ADV	O
dependent	O	ADJ	B
on	O	ADP	O
the	O	DET	O
integrity	O	NOUN	B
of	O	ADP	O
a	O	DET	O
dimeric	B-DNA	ADJ	B
GATA-1	I-DNA	NOUN	B
binding	I-DNA	NOUN	B
site	I-DNA	NOUN	I
.	O	PUNCT	O


Glucocorticoid	B-protein	NOUN	B
receptors	I-protein	NOUN	I
(	O	PUNCT	O
GcR	B-protein	NOUN	B
)	O	PUNCT	O
were	O	AUX	O
determined	O	VERB	O
by	O	ADP	O
a	O	DET	O
whole	O	ADJ	B
cell	O	NOUN	I
assay	O	NOUN	O
in	O	ADP	O
human	B-cell_type	ADJ	B
mononulear	I-cell_type	ADJ	O
leukocytes	I-cell_type	NOUN	B
(	O	PUNCT	O
hMNL	B-cell_type	NOUN	B
)	O	PUNCT	O
from	O	ADP	O
control	O	ADJ	B
subjects	O	NOUN	I
,	O	PUNCT	O
patients	O	NOUN	B
receiving	O	VERB	O
glucocorticoid	O	NOUN	B
therapy	O	NOUN	I
for	O	ADP	O
systemic	O	ADJ	B
diseases	O	NOUN	I
and	O	CCONJ	O
Cushing	O	NOUN	B
's	O	PART	I
disease	O	NOUN	I
patients	O	NOUN	B
with	O	ADP	O
or	O	CCONJ	O
without	O	ADP	O
ketoconazole	O	NOUN	B
therapy	O	NOUN	I
.	O	PUNCT	O


Human	O	ADJ	B
T-cell	O	NOUN	I
leukemia	O	NOUN	I
virus	O	NOUN	O
type	O	NOUN	O
1	O	NUM	O
(	O	PUNCT	O
HTLV-1	O	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
an	O	DET	O
etiological	O	ADJ	B
agent	O	NOUN	I
of	O	ADP	O
adult	O	ADJ	B
T-cell	O	NOUN	O
leukemia	O	NOUN	O
(	O	PUNCT	O
ATL	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


We	O	PRON	O
showed	O	VERB	O
here	O	ADV	O
by	O	ADP	O
mobility-shift	O	ADJ	B
assay	O	NOUN	I
that	O	SCONJ	O
T-cell	B-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
transformed	O	VERB	B
with	O	ADP	I
the	O	DET	O
virus	O	NOUN	B
contained	O	VERB	O
high	O	ADJ	O
levels	O	NOUN	B
of	O	ADP	O
AP-1	B-protein	NOUN	B
activities	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
Tax1-inducible	B-protein	ADJ	B
transcription	I-protein	NOUN	B
factors	I-protein	NOUN	I
identified	O	VERB	B
here	O	ADV	O
are	O	AUX	O
encoded	O	VERB	B
by	O	ADP	O
the	O	DET	O
members	O	NOUN	B
of	O	ADP	O
immediate	B-DNA	ADJ	O
early	I-DNA	ADJ	O
genes	I-DNA	NOUN	B
under	O	ADP	O
the	O	DET	O
control	O	NOUN	B
of	O	ADP	O
growth	O	NOUN	B
signals	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
concentration	O	NOUN	B
of	O	ADP	O
corticosteroid	O	NOUN	B
producing	O	VERB	O
50	O	NUM	O
%	O	NOUN	O
inhibition	O	NOUN	B
(	O	PUNCT	O
IC50	O	NOUN	B
)	O	PUNCT	O
was	O	AUX	O
600	O	NUM	O
nM	O	NOUN	O
,	O	PUNCT	O
70	O	NUM	O
nM	O	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
0.5	O	NUM	O
nM	O	NOUN	O
for	O	ADP	O
hydrocortisone	O	NOUN	B
,	O	PUNCT	O
methylprednisolone	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
dexamethasone	O	NOUN	B
,	O	PUNCT	O
respectively	O	ADV	O
,	O	PUNCT	O
in	O	ADP	O
monocytes	B-cell_type	NOUN	B
from	O	ADP	O
CS	O	ADJ	B
individuals	O	NOUN	B
.	O	PUNCT	O


There	O	PRON	O
was	O	AUX	O
only	O	ADV	O
weak	O	ADJ	B
inhibition	O	NOUN	B
of	O	ADP	O
the	O	DET	O
generation	O	NOUN	B
of	O	ADP	O
enhancing	O	NOUN	B
activity	O	NOUN	B
by	O	ADP	O
the	O	DET	O
corticosteroids	O	NOUN	B
in	O	ADP	O
the	O	DET	O
CR	O	ADJ	B
asthmatic	O	ADJ	B
individuals	O	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
in	O	ADP	O
either	O	CCONJ	O
EL-4	B-cell_line	NOUN	B
(	I-cell_line	PUNCT	O
T	I-cell_line	NOUN	O
)	I-cell_line	PUNCT	O
cells	I-cell_line	NOUN	O
or	O	CCONJ	O
S194	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
both	O	DET	O
lower-affinity	O	ADJ	B
sites	O	NOUN	I
can	O	AUX	O
be	O	AUX	O
significantly	O	ADV	O
induced	O	VERB	B
by	O	ADP	O
the	O	DET	O
tax	B-protein	NOUN	O
gene	I-protein	NOUN	B
product	I-protein	NOUN	I
of	O	ADP	O
human	O	ADJ	B
T-cell	O	NOUN	O
leukemia	O	NOUN	O
virus	O	NOUN	O
type	O	NOUN	O
I	O	NUM	O
,	O	PUNCT	O
showing	O	VERB	O
that	O	SCONJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activity	O	NOUN	O
can	O	AUX	O
be	O	AUX	O
modulated	O	VERB	B
even	O	ADV	O
in	O	ADP	O
a	O	DET	O
B-cell	B-cell_line	NOUN	B
line	I-cell_line	NOUN	I
that	O	PRON	O
constitutively	O	ADV	B
expresses	O	VERB	B
this	O	DET	O
factor	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
study	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
generated	O	VERB	O
transgenic	O	ADJ	B
mice	O	NOUN	I
carrying	O	VERB	O
the	O	DET	O
human	B-DNA	ADJ	B
IRF-1	I-DNA	NOUN	B
gene	I-DNA	NOUN	I
linked	O	VERB	O
to	O	PART	O
the	O	DET	O
human	B-DNA	ADJ	B
immunoglobulin	I-DNA	NOUN	O
heavy-chain	I-DNA	ADJ	O
enhancer	I-DNA	NOUN	O
.	O	PUNCT	O


Glucocorticoid	O	NOUN	B
pharmacokinetics	O	NOUN	B
,	O	PUNCT	O
glucocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
characteristics	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
inhibition	O	NOUN	B
of	O	ADP	O
peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
T	I-cell_type	NOUN	I
cell	I-cell_type	NOUN	I
proliferation	O	NOUN	I
by	O	ADP	O
glucocorticoids	O	NOUN	B
in	O	X	B
vitro	O	X	I
.	O	PUNCT	O


The	O	DET	O
present	O	ADJ	O
work	O	NOUN	O
demonstrates	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
glucocorticoid	O	NOUN	B
dexamethasone	O	NOUN	B
inhibits	O	VERB	B
TPA-induced	O	ADJ	B
increases	O	NOUN	B
in	O	ADP	O
c-jun	O	NOUN	B
and	O	CCONJ	O
c-fos	O	NOUN	B
mRNA	O	NOUN	B
levels	O	NOUN	O
in	O	ADP	O
U-937	B-cell_line	NOUN	B
leukemia	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	B
.	O	PUNCT	O


Other	O	ADJ	O
studies	O	NOUN	B
have	O	AUX	O
demonstrated	O	VERB	O
that	O	SCONJ	O
TPA-induced	O	ADJ	B
monocytic	O	ADJ	B
differentiation	O	NOUN	I
and	O	CCONJ	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
c-jun	B-DNA	NOUN	B
and	O	CCONJ	O
c-fos	B-DNA	NOUN	B
genes	I-DNA	NOUN	I
in	O	ADP	O
myeloid	B-cell_type	ADJ	B
leukemia	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	B
are	O	AUX	O
regulated	O	VERB	O
by	O	ADP	O
protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
C	I-protein	NOUN	I
(	O	PUNCT	O
PKC	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


This	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
CAT	B-protein	NOUN	B
activity	O	NOUN	I
was	O	AUX	O
sensitive	O	ADJ	B
to	O	PART	O
dexamethasone	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
findings	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
dexamethasone	O	NOUN	B
down-regulates	O	VERB	B
TPA-induced	O	ADJ	B
transcription	O	NOUN	B
of	O	ADP	O
the	O	DET	O
c-jun	B-DNA	NOUN	B
gene	O	NOUN	I
during	O	ADP	O
monocytic	O	ADJ	B
differentiation	O	NOUN	I
by	O	ADP	O
inhibiting	O	VERB	B
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
AP-1	B-DNA	NOUN	B
site	I-DNA	NOUN	I
.	O	PUNCT	O


Human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
(	O	PUNCT	O
HIV	O	NOUN	B
)	O	PUNCT	O
expression	O	NOUN	B
and	O	CCONJ	O
replication	O	NOUN	B
are	O	AUX	O
under	O	ADP	O
tight	O	ADJ	B
regulatory	O	ADJ	I
control	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
family	O	NOUN	B
of	O	ADP	O
transcriptional	B-protein	ADJ	B
activators	I-protein	NOUN	I
has	O	AUX	O
recently	O	ADV	O
been	O	AUX	O
identified	O	VERB	B
in	O	ADP	O
chickens	O	NOUN	B
;	O	PUNCT	O
these	O	DET	O
transcriptional	B-protein	ADJ	B
activators	I-protein	NOUN	I
recognize	O	VERB	O
a	O	DET	O
common	O	ADJ	O
consensus	B-DNA	NOUN	B
motif	I-DNA	NOUN	I
(	O	PUNCT	O
WGATAR	B-DNA	NOUN	B
)	O	PUNCT	O
through	O	ADP	O
a	O	DET	O
conserved	O	VERB	O
C4	B-protein	NOUN	B
zinc	I-protein	NOUN	B
finger	I-protein	NOUN	I
DNA-binding	I-protein	ADJ	B
domain	I-protein	NOUN	I
.	O	PUNCT	O


T-cell	O	NOUN	B
activation	O	NOUN	O
also	O	ADV	O
correlates	O	VERB	O
with	O	ADP	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
the	O	DET	O
factor	O	NOUN	B
NF-kappa	B-protein	NOUN	I
B	I-protein	NOUN	I
which	O	DET	O
binds	O	VERB	B
to	O	PART	O
two	O	NUM	O
adjacent	O	ADJ	B
sites	O	NOUN	O
in	O	ADP	O
the	O	DET	O
HIV-1	B-DNA	NOUN	B
long	I-DNA	ADJ	B
terminal	I-DNA	ADJ	I
repeat	I-DNA	NOUN	I
.	O	PUNCT	O


Most	O	ADJ	O
B	B-cell_line	NOUN	B
lymphocyte	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
expressed	O	VERB	B
negligible	O	ADJ	O
levels	O	NOUN	B
of	O	ADP	O
1	B-RNA	NUM	O
,	I-RNA	PUNCT	O
25	I-RNA	NUM	O
(	I-RNA	PUNCT	O
OH	I-RNA	NOUN	B
)	I-RNA	PUNCT	O
2D3	I-RNA	NOUN	B
receptor	I-RNA	NOUN	I
RNA	I-RNA	NOUN	I
and	O	CCONJ	O
protein	O	NOUN	B
;	O	PUNCT	O
however	O	ADV	O
;	O	PUNCT	O
analysis	O	NOUN	B
of	O	ADP	O
a	O	DET	O
lymphoid/myeloid	B-cell_line	ADJ	B
somatic	I-cell_line	ADJ	I
hybrid	I-cell_line	NOUN	I
suggested	O	VERB	O
that	O	SCONJ	O
suppression	O	NOUN	B
of	O	ADP	O
expression	O	NOUN	B
of	O	ADP	O
1	B-RNA	NUM	O
,	I-RNA	PUNCT	O
25	I-RNA	NUM	O
(	I-RNA	PUNCT	O
OH	I-RNA	NOUN	B
)	I-RNA	PUNCT	O
2D3	I-RNA	NOUN	B
receptor	I-RNA	NOUN	I
RNA	I-RNA	NOUN	I
in	O	ADP	O
B	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
may	O	AUX	O
be	O	AUX	O
a	O	DET	O
dominant	O	ADJ	B
characteristic	O	NOUN	O
.	O	PUNCT	O


Levels	O	NOUN	B
of	O	ADP	O
occupied	O	VERB	B
1	B-protein	NUM	O
,	I-protein	PUNCT	O
25	I-protein	NUM	O
(	I-protein	PUNCT	O
OH	I-protein	NOUN	B
)	I-protein	PUNCT	O
2D3	I-protein	NOUN	B
receptor	I-protein	NOUN	I
protein	I-protein	NOUN	I
increased	O	VERB	B
in	O	ADP	O
these	O	DET	O
HL-60	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
;	O	PUNCT	O
but	O	CCONJ	O
the	O	DET	O
total	O	ADJ	O
number	O	NOUN	O
of	O	ADP	O
1	B-protein	NUM	O
,	I-protein	PUNCT	O
25	I-protein	NUM	O
(	I-protein	PUNCT	O
OH	I-protein	NOUN	B
)	I-protein	PUNCT	O
2D3	I-protein	NOUN	B
receptors	I-protein	NOUN	I
decreased	O	VERB	B
about	O	ADV	O
50	O	NUM	O
%	O	NOUN	O
at	O	ADP	O
24	O	NUM	O
hours	O	NOUN	B
and	O	CCONJ	O
returned	O	VERB	O
toward	O	ADP	O
normal	O	ADJ	B
at	O	ADP	O
72	O	NUM	O
hours	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
nondividing	B-cell_type	ADJ	B
peripheral	I-cell_type	ADJ	I
blood	I-cell_type	NOUN	I
lymphocytes	I-cell_type	NOUN	I
from	O	ADP	O
normal	O	ADJ	O
individuals	O	NOUN	B
did	O	AUX	O
not	O	PART	O
express	O	VERB	O
1	B-RNA	NUM	O
,	I-RNA	PUNCT	O
25	I-RNA	NUM	O
(	I-RNA	PUNCT	O
OH	I-RNA	NOUN	B
)	I-RNA	PUNCT	O
2D3	I-RNA	NOUN	B
receptor	I-RNA	NOUN	I
RNA	I-RNA	NOUN	I
;	O	PUNCT	O
with	O	ADP	O
stimulation	O	NOUN	B
of	O	ADP	O
proliferation	O	NOUN	B
of	O	ADP	O
these	O	DET	O
cells	O	NOUN	B
,	O	PUNCT	O
accumulation	O	NOUN	B
of	O	ADP	O
1	B-RNA	NUM	O
,	I-RNA	PUNCT	O
25	I-RNA	NUM	O
(	I-RNA	PUNCT	O
OH	I-RNA	NOUN	B
)	I-RNA	PUNCT	O
2D3	I-RNA	NOUN	B
receptor	I-RNA	NOUN	I
RNA	I-RNA	NOUN	I
increased	O	VERB	B
markedly	O	ADV	B
.	O	PUNCT	O


The	O	DET	O
three	O	NUM	O
jun	B-DNA	NOUN	B
genes	I-DNA	NOUN	I
showed	O	VERB	O
a	O	DET	O
similar	O	ADJ	O
time	O	NOUN	B
course	O	NOUN	I
in	O	ADP	O
their	O	PRON	O
induction	O	NOUN	B
by	O	ADP	O
PMA	O	NOUN	B
,	O	PUNCT	O
maximal	O	ADJ	B
mRNA	O	NOUN	B
levels	O	NOUN	O
being	O	AUX	O
reached	O	VERB	O
after	O	ADP	O
60	O	NUM	O
min	O	NOUN	O
of	O	ADP	O
induction	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
29-kDa	B-protein	ADJ	O
proteins	I-protein	NOUN	B
phosphorylated	O	VERB	B
in	O	ADP	O
thrombin-activated	B-cell_line	ADJ	B
human	I-cell_line	ADJ	B
platelets	I-cell_line	NOUN	B
are	O	AUX	O
forms	O	NOUN	O
of	O	ADP	O
the	O	DET	O
estrogen	B-protein	NOUN	B
receptor-related	I-protein	ADJ	I
27-kDa	I-protein	ADJ	I
heat	I-protein	NOUN	B
shock	I-protein	NOUN	I
protein	I-protein	NOUN	I
.	O	PUNCT	O


A	O	DET	O
murine	B-protein	ADJ	B
monoclonal	I-protein	ADJ	B
antibody	I-protein	NOUN	I
raised	O	VERB	O
to	O	PART	O
an	O	DET	O
unidentified	B-protein	ADJ	O
estrogen	I-protein	NOUN	B
receptor-related	I-protein	ADJ	I
29-kDa	I-protein	ADJ	I
protein	I-protein	NOUN	I
selectively	O	ADV	O
recognized	O	VERB	O
these	O	DET	O
proteins	O	NOUN	B
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
a	O	DET	O
more	O	ADV	O
basic	O	ADJ	O
,	O	PUNCT	O
unphosphorylated	B-protein	ADJ	B
27-kDa	I-protein	ADJ	O
protein	I-protein	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
a	O	DET	O
central	O	ADJ	B
core	O	NOUN	I
in	O	ADP	O
the	O	DET	O
kappa	B-DNA	NOUN	B
E3	I-DNA	NOUN	I
'	I-DNA	PART	I
enhancer	I-DNA	NOUN	I
is	O	AUX	O
active	O	ADJ	B
at	O	ADP	O
the	O	DET	O
pre-B-cell	O	ADJ	B
stage	O	NOUN	I
but	O	CCONJ	O
is	O	AUX	O
repressed	O	VERB	B
by	O	ADP	O
flanking	B-DNA	VERB	O
negative-acting	I-DNA	ADJ	B
elements	I-DNA	NOUN	I
.	O	PUNCT	O


The	O	DET	O
predicted	O	VERB	O
amino	O	NOUN	B
acid	O	NOUN	I
sequence	O	NOUN	I
of	O	ADP	O
this	O	DET	O
protein	O	NOUN	B
contains	O	VERB	O
features	O	NOUN	B
characteristic	O	ADJ	O
of	O	ADP	O
transcriptional	B-protein	ADJ	B
activators	I-protein	NOUN	I
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
transcriptional	B-protein	ADJ	B
repressors	I-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
derived	O	VERB	O
103-amino-acid	B-protein	ADJ	O
basic	I-protein	ADJ	O
protein	I-protein	NOUN	B
has	O	AUX	O
two	O	NUM	O
potential	O	ADJ	O
alpha-helical	B-protein	ADJ	B
domains	I-protein	NOUN	I
separated	O	VERB	O
by	O	ADP	O
a	O	DET	O
hydrophobic	B-protein	ADJ	B
region	I-protein	NOUN	I
with	O	ADP	O
the	O	DET	O
potential	O	NOUN	B
to	O	PART	O
generate	O	VERB	O
turns	O	NOUN	B
and	O	CCONJ	O
assume	O	VERB	O
a	O	DET	O
beta-sheet	O	ADJ	B
conformation	O	NOUN	I
.	O	PUNCT	O


Consistent	O	ADJ	B
with	O	ADP	I
involvement	O	NOUN	B
in	O	ADP	O
the	O	DET	O
G0/G1	B-DNA	NOUN	B
switch	I-DNA	NOUN	B
,	O	PUNCT	O
the	O	DET	O
protein	O	NOUN	B
contains	O	VERB	O
potential	O	ADJ	B
sites	O	NOUN	O
for	O	ADP	O
phosphorylation	O	NOUN	B
by	O	ADP	O
protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
C	I-protein	NOUN	I
and	O	CCONJ	O
casein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
II	I-protein	NUM	I
.	O	PUNCT	O


Potential	O	ADJ	B
sites	O	NOUN	O
for	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
AP1	B-protein	NOUN	B
,	O	PUNCT	O
AP2	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
AP3	B-protein	NOUN	B
are	O	AUX	O
consistent	O	ADJ	B
with	O	ADP	I
rapid	O	ADJ	O
transcriptional	O	ADJ	B
activation	O	NOUN	O
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
inducing	O	VERB	O
agents	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
HIV-TF1	B-protein	NOUN	I
,	O	PUNCT	O
which	O	DET	O
binds	O	VERB	B
to	O	PART	O
a	O	DET	O
region	O	NOUN	B
about	O	ADV	O
60	B-DNA	NUM	O
bp	I-DNA	NOUN	O
upstream	I-DNA	ADJ	O
from	O	ADP	O
the	O	DET	O
enhancer	O	NOUN	B
of	O	ADP	O
the	O	DET	O
human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus-1	O	NOUN	I
(	O	PUNCT	O
HIV-1	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
was	O	AUX	O
purified	O	VERB	O
from	O	ADP	O
human	B-cell_type	ADJ	B
B	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
HIV-TF1	B-protein	NOUN	B
is	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
transcriptional	O	ADJ	B
regulation	O	NOUN	I
of	O	ADP	O
HIV-1	O	NOUN	B
.	O	PUNCT	O


Severe	O	ADJ	B
5-fluorouracil	O	NOUN	B
toxicity	O	NOUN	B
secondary	O	ADJ	B
to	O	PART	I
dihydropyrimidine	B-protein	NOUN	B
dehydrogenase	I-protein	NOUN	I
deficiency	O	NOUN	I
.	O	PUNCT	O


Monitoring	O	VERB	B
DPD	B-protein	NOUN	B
activity	O	NOUN	O
may	O	AUX	O
be	O	AUX	O
important	O	ADJ	O
in	O	ADP	O
the	O	DET	O
management	O	NOUN	B
of	O	ADP	O
patients	O	NOUN	B
experiencing	O	VERB	O
severe	O	ADJ	B
toxicity	O	NOUN	B
secondary	O	ADJ	B
to	O	PART	O
FUra	O	NOUN	B
chemotherapy	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
thymus-specific	B-protein	ADJ	B
member	I-protein	NOUN	I
of	O	ADP	O
the	O	DET	O
HMG	B-protein	NOUN	B
protein	I-protein	NOUN	I
family	I-protein	NOUN	O
regulates	O	VERB	B
the	O	DET	O
human	B-DNA	ADJ	B
T	I-DNA	NOUN	O
cell	I-DNA	NOUN	O
receptor	I-DNA	NOUN	O
C	I-DNA	NOUN	O
alpha	I-DNA	NOUN	O
enhancer	I-DNA	NOUN	O
.	O	PUNCT	O


The	O	DET	O
interaction	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Oct2	B-protein	NOUN	B
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
with	O	ADP	O
the	O	DET	O
cognate	B-DNA	ADJ	B
octamer	I-DNA	NOUN	O
motif	I-DNA	NOUN	O
ATGCAAAT	O	NOUN	O
is	O	AUX	O
a	O	DET	O
critical	O	ADJ	O
determinant	O	NOUN	B
of	O	ADP	O
the	O	DET	O
lymphoid-specific	O	ADJ	B
expression	O	NOUN	I
of	O	ADP	O
immunoglobulin	B-DNA	NOUN	B
genes	I-DNA	NOUN	I
.	O	PUNCT	O


Ectopic	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
cloned	B-DNA	VERB	B
Oct2	I-DNA	NOUN	B
cDNA	I-DNA	NOUN	B
was	O	AUX	O
shown	O	VERB	O
to	O	PART	O
be	O	AUX	O
sufficient	O	ADJ	B
to	O	PART	O
reconstitute	O	VERB	B
at	O	ADP	O
least	O	ADJ	O
some	O	DET	O
aspects	O	NOUN	O
of	O	ADP	O
this	O	DET	O
regulation	O	NOUN	B
in	O	ADP	O
non-lymphoid	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Different	O	ADJ	O
amounts	O	NOUN	O
of	O	ADP	O
the	O	DET	O
various	O	ADJ	O
isoforms	B-protein	NOUN	B
are	O	AUX	O
present	O	ADJ	O
within	O	ADP	O
the	O	DET	O
same	O	ADJ	O
B-cell	B-cell_type	NOUN	B
regardless	O	ADV	O
of	O	ADP	O
the	O	DET	O
developmental	O	ADJ	B
stage	O	NOUN	I
of	O	ADP	O
B-cell	B-cell_type	NOUN	B
differentiation	O	NOUN	I
and	O	CCONJ	O
at	O	ADP	O
least	O	ADJ	O
some	O	DET	O
of	O	ADP	O
the	O	DET	O
isoforms	B-protein	NOUN	B
are	O	AUX	O
conserved	O	VERB	O
between	O	ADP	O
mouse	O	NOUN	B
and	O	CCONJ	O
humans	O	NOUN	B
.	O	PUNCT	O


[	O	PUNCT	O
Regulation	O	NOUN	B
of	O	ADP	O
intracellular	O	ADJ	B
cholesterol	O	NOUN	B
synthesis	O	NOUN	I
in	O	ADP	O
hypercholesterolemia	O	NOUN	B
by	O	ADP	O
glucocorticoids	O	NOUN	B
]	O	PUNCT	O


The	O	DET	O
rate	O	NOUN	B
of	O	ADP	O
endogenous	O	ADJ	B
cholesterol	O	NOUN	B
synthesis	O	NOUN	I
in	O	ADP	O
blood	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
and	O	CCONJ	O
skin	B-cell_type	NOUN	B
fibroblasts	I-cell_type	NOUN	O
from	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
type	O	NOUN	B
IIa	O	NOUN	I
hyperlipidemia	O	NOUN	I
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
be	O	AUX	O
increased	O	VERB	B
in	O	ADP	O
comparison	O	NOUN	B
with	O	ADP	O
healthy	O	ADJ	B
donors	O	NOUN	I
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
both	O	CCONJ	O
NF-kappa	B-protein	NOUN	B
B-binding	I-protein	ADJ	I
complexes	I-protein	NOUN	I
are	O	AUX	O
needed	O	VERB	O
for	O	ADP	O
optimal	O	ADJ	B
viral	O	ADJ	B
transcription	O	NOUN	I
.	O	PUNCT	O


An	O	DET	O
age-related	O	ADJ	B
decrease	O	NOUN	B
in	O	ADP	O
the	O	DET	O
number	O	NOUN	O
of	O	ADP	O
GR	B-protein	NOUN	B
was	O	AUX	O
suggested	O	VERB	O
between	O	ADP	O
subjects	O	NOUN	B
younger	O	ADJ	B
than	O	ADP	O
20	O	NUM	O
years	O	NOUN	B
and	O	CCONJ	O
elderly	O	ADJ	B
subjects	O	NOUN	I
;	O	PUNCT	O
there	O	PRON	O
was	O	AUX	O
no	O	DET	O
apparent	O	ADJ	O
seasonal	O	ADJ	B
variation	O	NOUN	I
in	O	ADP	O
GR	B-protein	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
in	O	ADP	O
normal	O	ADJ	B
subjects	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
GR	B-protein	NOUN	B
in	O	ADP	O
MNL	B-cell_type	NOUN	B
did	O	AUX	O
not	O	PART	O
demonstrate	O	VERB	O
circadian	O	ADJ	B
variation	O	NOUN	B
,	O	PUNCT	O
in	O	ADP	O
contrast	O	NOUN	O
to	O	PART	O
concentrations	O	NOUN	B
of	O	ADP	O
plasma	O	NOUN	B
cortisol	O	NOUN	O
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
C26	B-DNA	NOUN	B
element	I-DNA	NOUN	B
alone	O	ADV	O
,	O	PUNCT	O
even	O	ADV	O
when	O	SCONJ	O
repeated	O	VERB	O
,	O	PUNCT	O
could	O	AUX	O
not	O	PART	O
be	O	AUX	O
activated	O	VERB	B
by	O	ADP	O
p40tax	B-protein	NOUN	B
,	O	PUNCT	O
unlike	O	ADP	O
other	O	ADJ	O
NF-kappa	B-DNA	NOUN	B
B-binding	I-DNA	ADJ	I
elements	I-DNA	NOUN	I
.	O	PUNCT	O


These	O	DET	O
findings	O	NOUN	B
therefore	O	ADV	O
suggest	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
HTLV-I	B-DNA	NOUN	B
enhancer	I-DNA	NOUN	I
contains	O	VERB	O
multiple	B-DNA	ADJ	O
functional	I-DNA	ADJ	O
elements	I-DNA	NOUN	O
,	O	PUNCT	O
including	O	VERB	O
binding	O	VERB	B
sites	O	NOUN	I
for	O	ADP	O
at	O	ADP	O
least	O	ADJ	O
CREB-	B-protein	NOUN	B
and	I-protein	CCONJ	O
NF-kappa	I-protein	NOUN	O
B-like	I-protein	ADJ	O
factors	I-protein	NOUN	O
,	O	PUNCT	O
which	O	DET	O
synergistically	O	ADV	B
cooperate	O	VERB	O
in	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
HTLV-I	B-DNA	NOUN	B
enhancer	I-DNA	NOUN	I
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
p40tax	B-protein	NOUN	B
.	O	PUNCT	O


Although	O	SCONJ	O
three	O	NUM	O
sites	O	NOUN	B
in	O	ADP	O
the	O	DET	O
TNF-alpha	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
(	O	PUNCT	O
kappa	O	NOUN	O
1	O	NUM	O
,	O	PUNCT	O
kappa	O	NOUN	B
2	O	NUM	I
,	O	PUNCT	O
and	O	CCONJ	O
kappa	O	NOUN	B
3	O	NUM	I
)	O	PUNCT	O
specifically	O	ADV	O
bind	O	VERB	B
the	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
NF-kappa	B-protein	NOUN	I
B	I-protein	NOUN	I
in	O	ADP	O
lymphoid	O	ADJ	B
nuclear	O	ADJ	O
extracts	O	NOUN	O
,	O	PUNCT	O
TNF-alpha	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
induction	O	NOUN	B
by	O	ADP	O
PMA	O	NOUN	B
does	O	AUX	O
not	O	PART	O
correlate	O	VERB	O
with	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
binding	O	NOUN	I
activities	O	NOUN	I
displayed	O	VERB	O
by	O	ADP	O
different	O	ADJ	O
T	B-cell_line	NOUN	B
and	I-cell_line	CCONJ	O
B	I-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
.	O	PUNCT	O


The	O	DET	O
BZLF1	B-protein	NOUN	B
protein	I-protein	NOUN	I
of	O	ADP	O
Epstein-Barr	O	ADJ	B
virus	O	NOUN	I
(	O	PUNCT	O
EBV	O	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
key	O	ADJ	O
immediate-early	B-protein	ADJ	B
protein	I-protein	NOUN	I
which	O	DET	O
has	O	AUX	O
been	O	AUX	O
shown	O	VERB	O
to	O	PART	O
disrupt	O	VERB	B
virus	O	NOUN	B
latency	O	NOUN	B
in	O	ADP	O
EBV-infected	B-cell_type	ADJ	B
B	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
generated	O	VERB	O
a	O	DET	O
monoclonal	B-protein	ADJ	B
antibody	I-protein	NOUN	I
,	O	PUNCT	O
BZ1	B-protein	NOUN	B
,	O	PUNCT	O
to	O	PART	O
BZLF1	B-protein	NOUN	B
which	O	DET	O
reacts	O	VERB	O
in	O	ADP	O
immunohistology	O	NOUN	B
,	O	PUNCT	O
immunoblotting	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
immunoprecipitation	O	NOUN	B
and	O	CCONJ	O
which	O	DET	O
recognizes	O	VERB	O
both	O	CCONJ	O
the	O	DET	O
active	B-protein	ADJ	B
,	I-protein	PUNCT	O
dimeric	I-protein	ADJ	B
form	I-protein	NOUN	I
and	O	CCONJ	O
the	O	DET	O
inactive	B-protein	ADJ	B
,	I-protein	PUNCT	O
monomeric	I-protein	ADJ	B
form	I-protein	NOUN	I
of	O	ADP	O
the	O	DET	O
protein	O	NOUN	B
.	O	PUNCT	O


Biopsies	O	NOUN	B
of	O	ADP	O
oral	O	ADJ	B
hairy	O	ADJ	I
leukoplakia	O	NOUN	I
,	O	PUNCT	O
an	O	DET	O
AIDS-associated	O	ADJ	B
lesion	O	NOUN	I
characterized	O	VERB	B
by	O	ADP	O
high-level	O	ADJ	O
EBV	O	NOUN	B
replication	O	NOUN	B
,	O	PUNCT	O
were	O	AUX	O
examined	O	VERB	O
by	O	ADP	O
immunohistochemistry	O	NOUN	B
using	O	VERB	O
the	O	DET	O
BZ1	B-protein	NOUN	B
monoclonal	B-protein	ADJ	I
antibody	I-protein	NOUN	I
.	O	PUNCT	O


Induction	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
during	O	ADP	O
monocyte	O	NOUN	B
differentiation	O	NOUN	I
is	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
activation	O	NOUN	B
of	O	ADP	O
HIV-gene	O	ADJ	B
expression	O	NOUN	B
.	O	PUNCT	O


Cells	O	NOUN	B
of	O	ADP	O
the	O	DET	O
monocyte-macrophage	B-cell_type	ADJ	B
lineage	I-cell_type	NOUN	I
are	O	AUX	O
important	O	ADJ	O
targets	O	NOUN	B
of	O	ADP	O
HIV	O	NOUN	B
infection	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
demonstration	O	NOUN	B
of	O	ADP	O
hormone	B-protein	NOUN	B
receptor	I-protein	NOUN	I
proteins	I-protein	NOUN	I
in	O	ADP	O
cells	O	NOUN	B
from	O	ADP	O
malignant	O	ADJ	B
effusions	O	NOUN	I
is	O	AUX	O
possible	O	ADJ	O
and	O	CCONJ	O
that	O	SCONJ	O
there	O	PRON	O
is	O	AUX	O
a	O	DET	O
correlation	O	NOUN	B
with	O	ADP	O
the	O	DET	O
status	O	NOUN	B
of	O	ADP	O
the	O	DET	O
primary	O	ADJ	B
site	O	NOUN	I
of	O	ADP	O
cancer	O	NOUN	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
our	O	PRON	O
results	O	NOUN	B
indicated	O	VERB	O
that	O	SCONJ	O
thymocytes	B-cell_type	NOUN	B
have	O	AUX	O
a	O	DET	O
constitutively	B-protein	ADV	B
active	I-protein	ADJ	O
form	I-protein	NOUN	O
of	O	ADP	O
NF-kB	B-protein	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
they	O	PRON	O
are	O	AUX	O
activated	O	VERB	B
in	O	X	B
vivo	O	X	I
.	O	PUNCT	O


The	O	DET	O
regulatory	O	ADJ	B
effect	O	NOUN	I
of	O	ADP	O
insulin	B-protein	NOUN	B
on	O	ADP	O
the	O	DET	O
specific	O	ADJ	O
binding	O	NOUN	B
power	O	NOUN	O
of	O	ADP	O
glucocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
(	O	PUNCT	O
GR	B-protein	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
human	B-cell_type	ADJ	B
leukocytes	I-cell_type	NOUN	B
was	O	AUX	O
assessed	O	VERB	B
by	O	ADP	O
the	O	DET	O
unoccupied	B-protein	ADJ	B
receptor	I-protein	NOUN	I
sites	I-protein	NOUN	O
capable	O	ADJ	O
of	O	ADP	O
combining	O	VERB	O
with	O	ADP	O
[	O	PUNCT	O
3H	O	NOUN	B
]	O	PUNCT	O
labelled	O	VERB	B
dexamethasone	O	NOUN	B
measured	O	VERB	B
at	O	ADP	O
3	O	NUM	O
and	O	CCONJ	O
24	O	NUM	O
h	O	NOUN	O
after	O	ADP	O
incubation	O	NOUN	B
with	O	ADP	O
various	O	ADJ	O
concentrations	O	NOUN	B
of	O	ADP	O
insulin	B-protein	NOUN	B
added	O	VERB	O
to	O	PART	O
the	O	DET	O
medium	O	NOUN	B
.	O	PUNCT	O


Thus	O	ADV	O
the	O	DET	O
inhibitory	O	ADJ	B
effect	O	NOUN	O
of	O	ADP	O
insulin	B-protein	NOUN	B
on	O	ADP	O
the	O	DET	O
GR	B-protein	NOUN	B
binding	O	NOUN	O
power	O	NOUN	O
is	O	AUX	O
both	O	CCONJ	O
dose-	O	NOUN	O
and	O	CCONJ	O
time-dependent	O	ADJ	B
,	O	PUNCT	O
which	O	DET	O
strongly	O	ADV	O
suggests	O	VERB	O
that	O	SCONJ	O
GR	B-protein	NOUN	B
is	O	AUX	O
tonically	O	ADV	O
controlled	O	VERB	O
by	O	ADP	O
insulin	B-protein	NOUN	B
concentration	O	NOUN	B
change	O	NOUN	O
under	O	ADP	O
physiological	O	ADJ	B
conditions	O	NOUN	O
.	O	PUNCT	O


An	O	DET	O
unexpected	O	ADJ	O
finding	O	NOUN	B
was	O	AUX	O
that	O	SCONJ	O
the	O	DET	O
Ig	O	NOUN	B
levels	O	NOUN	I
decreased	O	VERB	B
during	O	ADP	O
the	O	DET	O
follow-up	O	ADJ	B
period	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
decrease	O	NOUN	B
was	O	AUX	O
seen	O	VERB	O
in	O	ADP	O
patients	O	NOUN	B
who	O	PRON	O
responded	O	VERB	O
to	O	PART	O
the	O	DET	O
therapy	O	NOUN	B
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
in	O	ADP	O
those	O	DET	O
who	O	PRON	O
did	O	AUX	O
not	O	PART	O
.	O	PUNCT	O


5-Aminolevulinate	B-protein	NOUN	B
synthase	I-protein	NOUN	I
(	O	PUNCT	O
ALAS	B-protein	NOUN	B
)	O	PUNCT	O
catalyzes	O	VERB	B
the	O	DET	O
first	O	ADJ	O
step	O	NOUN	O
of	O	ADP	O
the	O	DET	O
heme	B-protein	NOUN	B
biosynthetic	O	ADJ	I
pathway	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
mature	O	ADJ	B
mitochondrial	O	ADJ	B
forms	O	NOUN	I
of	O	ADP	O
the	O	DET	O
erythroid	O	ADJ	B
and	O	CCONJ	O
housekeeping	B-protein	ADJ	B
ALAS	I-protein	NOUN	I
isozymes	I-protein	NOUN	I
are	O	AUX	O
predicted	O	VERB	O
to	O	PART	O
have	O	AUX	O
molecular	O	ADJ	B
weights	O	NOUN	I
of	O	ADP	O
59.5	O	NUM	O
kd	O	NOUN	O
and	O	CCONJ	O
64.6	O	NUM	O
kd	O	NOUN	O
,	O	PUNCT	O
respectively	O	ADV	O
.	O	PUNCT	O


The	O	DET	O
two	O	NUM	O
isozymes	B-protein	NOUN	B
show	O	VERB	O
little	O	ADJ	O
amino	O	NOUN	B
acid	O	NOUN	I
identity	O	NOUN	B
in	O	ADP	O
their	O	PRON	O
N-terminal	B-protein	ADJ	B
signal	I-protein	NOUN	I
sequences	I-protein	NOUN	I
but	O	CCONJ	O
have	O	AUX	O
considerable	O	ADJ	O
sequence	O	NOUN	O
identity	O	NOUN	B
in	O	ADP	O
the	O	DET	O
C-terminal	B-protein	ADJ	B
two-thirds	I-protein	NUM	B
of	O	ADP	O
their	O	PRON	O
proteins	O	NOUN	B
.	O	PUNCT	O


Over	O	ADP	O
the	O	DET	O
past	O	ADJ	O
decade	O	NOUN	O
it	O	PRON	O
has	O	AUX	O
become	O	VERB	O
clear	O	ADJ	O
that	O	SCONJ	O
glucocorticosteroid	B-protein	NOUN	B
receptors	I-protein	NOUN	I
play	O	VERB	O
a	O	DET	O
significant	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
mechanism	O	NOUN	B
of	O	ADP	O
glucocorticosteroid	O	NOUN	B
action	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
binding	O	NOUN	B
affinity	O	NOUN	B
was	O	AUX	O
not	O	PART	O
different	O	ADJ	O
between	O	ADP	O
patients	O	NOUN	B
and	O	CCONJ	O
controls	O	NOUN	B
.	O	PUNCT	O


Upon	O	SCONJ	O
cotransfection	O	NOUN	B
into	O	ADP	O
non-T	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
TCF-1	B-protein	NOUN	B
could	O	AUX	O
transactivate	O	VERB	B
through	O	ADP	O
its	O	PRON	O
cognate	O	ADJ	B
motif	O	NOUN	O
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
longer	O	ADJ	O
periods	O	NOUN	B
of	O	ADP	O
incubation	O	NOUN	B
were	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
a	O	DET	O
return	O	NOUN	B
to	O	ADP	I
the	O	DET	O
distribution	O	NOUN	B
of	O	ADP	O
PKC	B-protein	NOUN	B
in	O	ADP	O
control	O	NOUN	B
cells	O	NOUN	I
.	O	PUNCT	O


(	O	PUNCT	O
ABSTRACT	O	NOUN	B
TRUNCATED	O	VERB	I
AT	O	ADP	I
250	O	NUM	I
WORDS	O	NOUN	I
)	O	PUNCT	O


Similarly	O	ADV	O
,	O	PUNCT	O
covalent	O	ADJ	B
modification	O	NOUN	I
of	O	ADP	O
free	O	ADJ	B
sulfhydryl	O	NOUN	O
groups	O	NOUN	O
with	O	ADP	O
diamide	O	NOUN	B
(	O	PUNCT	O
reversible	O	ADJ	B
)	O	PUNCT	O
or	O	CCONJ	O
N-ethylmaleimide	O	NOUN	B
(	O	PUNCT	O
irreversible	O	ADJ	B
)	O	PUNCT	O
results	O	VERB	B
in	O	ADP	O
a	O	DET	O
complete	O	ADJ	O
loss	O	NOUN	B
of	O	ADP	O
DNA	O	NOUN	B
binding	O	NOUN	I
activity	O	NOUN	I
.	O	PUNCT	O


In	B-protein	X	B
vitro	I-protein	X	I
translated	I-protein	VERB	B
hGR	I-protein	NOUN	B
was	O	AUX	O
capable	O	ADJ	O
of	O	ADP	O
selective	O	ADJ	O
DNA	O	NOUN	B
binding	O	NOUN	I
even	O	ADV	O
in	O	ADP	O
the	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
glucocorticoid	O	NOUN	B
.	O	PUNCT	O


Oligonucleotides	O	NOUN	B
containing	O	VERB	O
the	O	DET	O
consensus	B-DNA	NOUN	B
GRE	I-DNA	NOUN	I
were	O	AUX	O
the	O	DET	O
most	O	ADV	O
efficient	O	ADJ	B
competitors	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
fragments	O	NOUN	B
containing	O	VERB	O
regulatory	B-DNA	ADJ	B
sequences	I-DNA	NOUN	I
from	O	ADP	O
glucocorticoid-repressible	B-DNA	ADJ	B
genes	I-DNA	NOUN	I
were	O	AUX	O
somewhat	O	ADV	O
competitive	O	ADJ	B
,	O	PUNCT	O
whereas	O	SCONJ	O
single	O	ADJ	O
stranded	O	ADJ	B
oligonucleotides	O	NOUN	B
were	O	AUX	O
unable	O	ADJ	O
to	O	PART	O
compete	O	VERB	B
for	O	ADP	O
mouse	B-DNA	NOUN	B
mammary	I-DNA	ADJ	O
tumor	I-DNA	NOUN	O
virus-long	I-DNA	ADJ	O
terminal	I-DNA	ADJ	O
repeat	I-DNA	NOUN	O
DNA	O	NOUN	B
binding	O	NOUN	I
,	O	PUNCT	O
except	O	SCONJ	O
when	O	SCONJ	O
competitor	O	NOUN	B
was	O	AUX	O
present	O	ADJ	O
at	O	ADP	O
extremely	O	ADV	O
high	O	ADJ	O
concentrations	O	NOUN	B
.	O	PUNCT	O


Similarities	O	NOUN	B
between	O	ADP	O
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	I
dexamethasone	O	NOUN	B
and	O	CCONJ	O
RU486	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
antiglucocorticoid	O	ADJ	B
properties	O	NOUN	B
of	O	ADP	O
RU486	O	NOUN	B
do	O	AUX	O
not	O	PART	O
occur	O	VERB	O
at	O	ADP	O
the	O	DET	O
level	O	NOUN	B
of	O	ADP	O
specific	O	ADJ	O
DNA	O	NOUN	B
binding	O	NOUN	I
.	O	PUNCT	O


1	O	NUM	O
,	O	PUNCT	O
25	O	NUM	O
(	O	PUNCT	O
OH	O	NOUN	B
)	O	PUNCT	O
2D3	O	NOUN	B
is	O	AUX	O
known	O	VERB	O
to	O	PART	O
be	O	AUX	O
produced	O	VERB	O
at	O	ADP	O
sites	O	NOUN	B
of	O	ADP	O
granulomatous	O	ADJ	B
reactions	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
percentage	O	NOUN	B
of	O	ADP	O
lavage	B-cell_type	NOUN	B
T-lymphocytes	I-cell_type	NOUN	I
expressing	O	VERB	O
1	B-protein	NUM	O
,	I-protein	PUNCT	O
25	I-protein	NUM	O
(	I-protein	PUNCT	O
OH	I-protein	NOUN	B
)	I-protein	PUNCT	O
2D3	I-protein	NOUN	B
receptors	I-protein	NOUN	I
was	O	AUX	O
significantly	O	ADV	O
greater	O	ADJ	O
for	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
tuberculosis	O	NOUN	B
presenting	O	VERB	O
with	O	ADP	O
isolated	O	VERB	B
hilar	O	ADJ	B
adenopathy	O	NOUN	I
than	O	ADP	O
for	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
pulmonary	O	ADJ	B
infiltrates	O	NOUN	I
and/or	O	CCONJ	O
cavities	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
studies	O	NOUN	B
have	O	AUX	O
been	O	AUX	O
extended	O	VERB	O
to	O	PART	O
show	O	VERB	O
that	O	SCONJ	O
(	O	PUNCT	O
i	O	X	O
)	O	PUNCT	O
a	O	DET	O
mutant	O	ADJ	B
EBV	O	NOUN	B
strain	O	NOUN	B
lacking	O	VERB	O
the	O	DET	O
gene	O	NOUN	B
encoding	O	NOUN	O
EBNA	B-protein	NOUN	B
2	I-protein	NUM	I
fails	O	VERB	O
to	O	PART	O
switch	O	VERB	B
from	O	ADP	O
Wp	O	NOUN	B
to	O	PART	O
Cp	B-DNA	NOUN	B
usage	O	NOUN	B
in	O	ADP	O
primary	B-cell_type	ADJ	B
B	I-cell_type	NOUN	I
lymphocytes	I-cell_type	NOUN	I
,	O	PUNCT	O
although	O	SCONJ	O
the	O	DET	O
virus	O	NOUN	B
contains	O	VERB	O
a	O	DET	O
functional	O	ADJ	B
Cp	B-DNA	NOUN	B
;	O	PUNCT	O
(	O	PUNCT	O
ii	O	X	O
)	O	PUNCT	O
a	O	DET	O
region	O	NOUN	B
from	O	ADP	O
-429	B-DNA	NUM	O
to	I-DNA	PART	O
-245	I-DNA	NUM	O
base	I-DNA	NOUN	B
pairs	I-DNA	NOUN	I
upstream	O	ADJ	I
of	O	ADP	O
Cp	B-DNA	NOUN	B
is	O	AUX	O
essential	O	ADJ	O
for	O	ADP	O
Cp	B-DNA	NOUN	B
activity	O	NOUN	B
in	O	ADP	O
B	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
only	O	ADV	O
in	O	ADP	O
the	O	DET	O
context	O	NOUN	B
of	O	ADP	O
upstream	B-DNA	ADJ	B
and	I-DNA	CCONJ	O
downstream	I-DNA	ADJ	B
sequences	I-DNA	NOUN	I
;	O	PUNCT	O
(	O	PUNCT	O
iii	O	X	O
)	O	PUNCT	O
this	O	DET	O
region	O	NOUN	B
contains	O	VERB	O
an	O	DET	O
EBNA	B-DNA	NOUN	B
2-dependent	I-DNA	ADJ	I
enhancer	I-DNA	NOUN	I
;	O	PUNCT	O
and	O	CCONJ	O
(	O	PUNCT	O
iv	O	X	O
)	O	PUNCT	O
DNase	B-protein	NOUN	B
I	I-protein	NUM	I
protection	O	NOUN	B
employing	O	VERB	O
nuclear	O	ADJ	B
extracts	O	NOUN	I
from	O	ADP	O
B	B-cell_type	NOUN	B
and	I-cell_type	CCONJ	O
T	I-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
revealed	O	VERB	O
a	O	DET	O
B-cell-specific	B-DNA	ADJ	B
footprint	I-DNA	NOUN	I
in	O	ADP	O
the	O	DET	O
region	O	NOUN	B
of	O	ADP	O
the	O	DET	O
EBNA	B-DNA	NOUN	B
2-dependent	I-DNA	ADJ	I
enhancer	I-DNA	NOUN	I
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
establish	O	VERB	O
for	O	ADP	O
the	O	DET	O
first	O	ADJ	O
time	O	NOUN	O
HBxAg	B-protein	NOUN	B
as	O	ADP	O
an	O	DET	O
antigen	O	NOUN	B
in	O	ADP	O
the	O	DET	O
cellular	O	ADJ	B
immune	O	ADJ	I
response	O	NOUN	I
.	O	PUNCT	O


[	O	PUNCT	O
Changes	O	NOUN	B
in	O	ADP	O
leucocytic	B-protein	ADJ	B
estrogen	I-protein	NOUN	I
receptor	I-protein	NOUN	I
levels	O	NOUN	B
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
gynecomastia	O	NOUN	B
]	O	PUNCT	O


The	O	DET	O
HIV-1	O	NOUN	B
mutant	O	ADJ	B
virus	O	NOUN	I
containing	O	VERB	O
both	O	CCONJ	O
NF	B-DNA	NOUN	B
kappa	I-DNA	NOUN	I
B	I-DNA	NOUN	I
and	I-DNA	CCONJ	O
NFAT-1	I-DNA	NOUN	B
deletion	I-DNA	NOUN	B
was	O	AUX	O
able	O	ADJ	O
to	O	PART	O
replicate	O	VERB	B
although	O	SCONJ	O
at	O	ADP	O
a	O	DET	O
much	O	ADJ	O
decreased	O	VERB	B
growth	O	NOUN	B
rate	O	NOUN	I
,	O	PUNCT	O
while	O	SCONJ	O
the	O	DET	O
deletion	O	NOUN	B
of	O	ADP	O
NFAT-1	B-protein	NOUN	B
alone	O	ADV	O
increased	O	VERB	B
the	O	DET	O
viral	O	ADJ	B
growth	O	NOUN	I
rate	O	NOUN	O
in	O	ADP	O
Jurkat	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


As	O	ADP	O
a	O	DET	O
homodimer	O	NOUN	B
JunB	B-protein	NOUN	B
is	O	AUX	O
unable	O	ADJ	O
to	O	PART	O
bind	O	VERB	B
the	O	DET	O
enhancer	O	NOUN	B
;	O	PUNCT	O
however	O	ADV	O
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
c-Fos	B-protein	NOUN	B
,	O	PUNCT	O
high-affinity	O	ADJ	B
binding	O	NOUN	I
is	O	AUX	O
observed	O	VERB	O
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
demonstrate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
transcriptional	O	ADJ	B
activity	O	NOUN	I
of	O	ADP	O
an	O	DET	O
AP-1-related	B-protein	ADJ	B
protein	I-protein	NOUN	I
is	O	AUX	O
regulated	O	VERB	O
by	O	ADP	O
the	O	DET	O
cAMP-dependent	O	ADJ	B
second-messenger	O	NOUN	I
pathway	O	NOUN	I
and	O	CCONJ	O
suggest	O	VERB	O
that	O	SCONJ	O
JunD	B-protein	NOUN	B
and	O	CCONJ	O
other	O	ADJ	O
AP-1-related	B-protein	ADJ	B
proteins	I-protein	NOUN	I
may	O	AUX	O
play	O	VERB	O
an	O	DET	O
important	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
gene	O	NOUN	B
expression	O	NOUN	I
by	O	ADP	O
cAMP-dependent	O	ADJ	B
intracellular	O	ADJ	B
signaling	O	NOUN	O
pathways	O	NOUN	O
.	O	PUNCT	O


PATIENTS	O	NOUN	B
:	O	PUNCT	O
Sixteen	O	NUM	O
anorexic	O	ADJ	B
patients	O	NOUN	B
,	O	PUNCT	O
aged	O	ADJ	B
16-27	O	NUM	O
years	O	NOUN	B
,	O	PUNCT	O
with	O	ADP	O
a	O	DET	O
mean	O	NOUN	O
+/-	O	CCONJ	O
SEM	O	NOUN	B
body	O	NOUN	B
mass	O	NOUN	I
index	O	NOUN	I
of	O	ADP	O
14.2	O	NUM	O
+/-	O	CCONJ	O
2.0	O	NUM	O
(	O	PUNCT	O
ranging	O	VERB	O
from	O	ADP	O
11.1	O	NUM	O
to	O	PART	O
17.4	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
15	O	NUM	O
normal	O	ADJ	O
women	O	NOUN	B
were	O	AUX	O
studied	O	VERB	O
.	O	PUNCT	O


RESULTS	O	NOUN	B
:	O	PUNCT	O
In	O	ADP	O
patients	O	NOUN	B
,	O	PUNCT	O
both	O	DET	O
total	O	NOUN	O
and	O	CCONJ	O
free	O	ADJ	B
plasma	O	NOUN	B
cortisol	O	NOUN	O
concentrations	O	NOUN	B
were	O	AUX	O
higher	O	ADJ	O
than	O	ADP	O
in	O	ADP	O
the	O	DET	O
normal	O	ADJ	O
women	O	NOUN	B
,	O	PUNCT	O
as	O	ADP	O
was	O	AUX	O
their	O	PRON	O
urinary	O	ADJ	B
free	O	ADJ	I
cortisol	O	NOUN	I
;	O	PUNCT	O
the	O	DET	O
number	O	NOUN	O
of	O	ADP	O
glucocorticoid	B-protein	NOUN	B
receptors	I-protein	NOUN	I
per	O	ADP	O
cell	O	NOUN	O
(	O	PUNCT	O
Ro	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
binding	O	NOUN	B
affinity	O	NOUN	O
(	O	PUNCT	O
Kd	O	NOUN	O
)	O	PUNCT	O
for	O	ADP	O
dexamethasone	O	NOUN	B
were	O	AUX	O
,	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
not	O	PART	O
significantly	O	ADV	O
different	O	ADJ	O
(	O	PUNCT	O
Ro	O	NOUN	B
:	O	PUNCT	O
7687	O	NUM	O
+/-	O	CCONJ	O
1750	O	NUM	O
vs	O	CCONJ	O
7347	O	NUM	O
+/-	O	CCONJ	O
1285	O	NUM	O
sites/cell	O	NOUN	O
;	O	PUNCT	O
Kd	O	NOUN	O
:	O	PUNCT	O
7.7	O	NUM	O
+/-	O	CCONJ	O
2.4	O	NUM	O
vs	O	CCONJ	O
7.4	O	NUM	O
+/-	O	CCONJ	O
1.7	O	NUM	O
nM	O	NOUN	O
at	O	ADP	O
24	O	NUM	O
degrees	O	NOUN	B
C	O	NOUN	O
)	O	PUNCT	O
.	O	PUNCT	O


Inhibition	O	NOUN	B
of	O	ADP	O
protein	B-protein	NOUN	B
phosphatases	I-protein	NOUN	I
by	O	ADP	O
okadaic	O	ADJ	B
acid	O	NOUN	I
induces	O	VERB	O
AP1	B-protein	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Similar	O	ADJ	O
to	O	PART	O
its	O	PRON	O
effect	O	NOUN	B
on	O	ADP	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
AP1	B-protein	NOUN	B
by	O	ADP	O
okadaic	O	ADJ	B
acid	O	NOUN	I
,	O	PUNCT	O
PMA	O	NOUN	B
inhibits	O	VERB	B
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
c-jun	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
by	O	ADP	O
okadaic	O	ADJ	B
acid	O	NOUN	I
.	O	PUNCT	O


Second	O	ADV	O
,	O	PUNCT	O
by	O	ADP	O
high	O	ADJ	O
stringency	O	NOUN	O
Northern	O	NOUN	O
blotting	O	NOUN	O
and	O	CCONJ	O
in	O	X	B
situ	O	X	I
hybridization	O	NOUN	I
,	O	PUNCT	O
TCF-1	B-protein	NOUN	B
expression	O	NOUN	B
was	O	AUX	O
shown	O	VERB	O
to	O	PART	O
be	O	AUX	O
confined	O	VERB	O
to	O	PART	O
the	O	DET	O
thymus	O	NOUN	B
and	O	CCONJ	O
to	O	PART	O
the	O	DET	O
T	O	NOUN	B
cell	O	NOUN	I
areas	O	NOUN	O
of	O	ADP	O
the	O	DET	O
spleen	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
new	O	ADJ	O
homeobox	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
,	O	PUNCT	O
HB24	B-DNA	NOUN	B
,	O	PUNCT	O
has	O	AUX	O
been	O	AUX	O
isolated	O	VERB	B
from	O	ADP	O
a	O	DET	O
human	O	ADJ	B
B-lymphocyte	O	NOUN	B
cDNA	O	NOUN	O
library	O	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
report	O	NOUN	O
we	O	PRON	O
begin	O	VERB	O
to	O	PART	O
uncover	O	VERB	O
the	O	DET	O
influence	O	NOUN	B
of	O	ADP	O
platelet-activating	B-protein	ADJ	B
factor	I-protein	NOUN	I
on	O	ADP	O
B	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
.	O	PUNCT	O


Moreover	O	ADV	O
,	O	PUNCT	O
platelet-activating	B-protein	ADJ	B
factor	I-protein	NOUN	I
was	O	AUX	O
capable	O	ADJ	O
of	O	ADP	O
inducing	O	VERB	B
transcription	O	NOUN	B
of	O	ADP	O
the	O	DET	O
nuclear	B-DNA	ADJ	B
proto-oncogenes	I-DNA	NOUN	I
c-fos	B-DNA	NOUN	I
and	O	CCONJ	O
c-jun	B-DNA	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
summary	O	NOUN	O
,	O	PUNCT	O
platelet-activating	B-protein	ADJ	B
factor	I-protein	NOUN	I
is	O	AUX	O
shown	O	VERB	O
here	O	ADV	O
to	O	PART	O
have	O	AUX	O
a	O	DET	O
direct	O	ADJ	O
and	O	CCONJ	O
profound	O	ADJ	O
effect	O	NOUN	O
on	O	ADP	O
a	O	DET	O
pure	B-cell_line	ADJ	O
B	I-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
.	O	PUNCT	O


Tandem	O	ADJ	B
copies	O	NOUN	B
of	O	ADP	O
this	O	DET	O
67-bp	B-DNA	ADJ	O
MnlI-AluI	I-DNA	NOUN	B
fragment	I-DNA	NOUN	I
,	O	PUNCT	O
when	O	SCONJ	O
fused	O	VERB	B
to	O	PART	O
the	O	DET	O
chloramphenicol	B-DNA	NOUN	B
acetyltransferase	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
driven	O	VERB	O
by	O	ADP	O
the	O	DET	O
conalbumin	B-DNA	ADJ	B
promoter	I-DNA	NOUN	B
,	O	PUNCT	O
stimulated	O	VERB	B
transcription	O	NOUN	B
in	O	ADP	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
but	O	CCONJ	O
not	O	PART	O
in	O	ADP	O
Jurkat	B-cell_line	NOUN	B
T	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
or	O	CCONJ	O
HeLa	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
agreement	O	NOUN	O
with	O	ADP	O
the	O	DET	O
results	O	NOUN	B
of	O	ADP	O
gel	O	NOUN	B
retardation	O	NOUN	I
assays	O	NOUN	I
,	O	PUNCT	O
tandem	O	ADJ	B
copies	O	NOUN	B
of	O	ADP	O
the	O	DET	O
E6	B-DNA	NOUN	B
motif	I-DNA	NOUN	I
stimulated	O	VERB	O
transcription	O	NOUN	B
in	O	ADP	O
ARH77	B-cell_line	NOUN	B
and	O	CCONJ	O
Raji	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
but	O	CCONJ	O
not	O	PART	O
in	O	ADP	O
Jurkat	B-cell_line	NOUN	B
or	O	CCONJ	O
HeLa	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
blockade	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Ca	B-protein	NOUN	B
(	I-protein	PUNCT	O
2+	I-protein	NUM	O
)	I-protein	PUNCT	O
-activated	I-protein	ADJ	O
K+	I-protein	NOUN	B
channel	I-protein	NOUN	I
is	O	AUX	O
not	O	PART	O
associated	O	VERB	B
with	O	ADP	I
changes	O	NOUN	B
in	O	ADP	O
cell-cycle	O	ADJ	B
gene	O	NOUN	B
activation	O	NOUN	I
,	O	PUNCT	O
IL-2	B-protein	NOUN	B
production	O	NOUN	B
,	O	PUNCT	O
IL-2R	B-protein	NOUN	B
expression	O	NOUN	B
or	O	CCONJ	O
B	O	NOUN	B
and	O	CCONJ	O
T	O	NOUN	B
cell	O	NOUN	I
mitogenesis	O	NOUN	O
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
human	B-DNA	ADJ	B
immunodeficiency	I-DNA	NOUN	I
virus	I-DNA	NOUN	I
type	I-DNA	NOUN	I
1	I-DNA	NUM	I
LTR	I-DNA	NOUN	I
possesses	O	VERB	O
functional	O	ADJ	B
redundancy	O	NOUN	B
which	O	DET	O
ensures	O	VERB	O
virus	O	NOUN	B
replication	O	NOUN	B
in	O	ADP	O
different	O	ADJ	O
T-cell	B-cell_type	NOUN	B
types	I-cell_type	NOUN	I
and	O	CCONJ	O
is	O	AUX	O
capable	O	ADJ	O
of	O	ADP	O
changing	O	VERB	B
depending	O	VERB	O
on	O	ADP	O
the	O	DET	O
particular	O	ADJ	O
combination	O	NOUN	B
of	O	ADP	O
transcriptional	B-protein	ADJ	B
factors	I-protein	NOUN	I
present	O	ADJ	O
.	O	PUNCT	O


This	O	DET	O
protein	O	NOUN	B
is	O	AUX	O
immunologically	O	ADV	B
distinct	O	ADJ	O
from	O	ADP	O
IRF-1/ISGF2	B-protein	NOUN	B
.	O	PUNCT	O


TNF	B-protein	NOUN	B
alpha	I-protein	NOUN	I
did	O	AUX	O
not	O	PART	O
activate	O	VERB	B
cAMP	O	NOUN	B
production	O	NOUN	O
and	O	CCONJ	O
its	O	PRON	O
signal	O	NOUN	B
was	O	AUX	O
not	O	PART	O
modulated	O	VERB	B
by	O	ADP	O
cAMP	O	NOUN	B
activators	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
functional	O	ADJ	B
domains	O	NOUN	I
of	O	ADP	O
the	O	DET	O
murine	B-DNA	ADJ	B
Thy-1	I-DNA	NOUN	B
gene	I-DNA	NOUN	I
promoter	I-DNA	NOUN	B
.	O	PUNCT	O


It	O	PRON	O
can	O	AUX	O
only	O	ADV	O
be	O	AUX	O
activated	O	VERB	B
in	O	ADP	O
a	O	DET	O
tissue-specific	O	ADJ	B
manner	O	NOUN	O
by	O	ADP	O
elements	O	NOUN	B
that	O	PRON	O
lie	O	VERB	O
downstream	O	ADJ	B
of	O	ADP	O
the	O	DET	O
initiation	B-DNA	NOUN	B
site	I-DNA	NOUN	I
.	O	PUNCT	O


DNase	O	NOUN	B
I	O	NUM	I
and	O	CCONJ	O
gel	O	NOUN	B
mobility	O	NOUN	O
shift	O	NOUN	O
assays	O	NOUN	O
show	O	VERB	O
the	O	DET	O
binding	O	NOUN	B
of	O	ADP	O
a	O	DET	O
number	O	NOUN	O
of	O	ADP	O
nuclear	B-protein	ADJ	B
factors	I-protein	NOUN	I
to	O	PART	O
these	O	DET	O
elements	B-DNA	NOUN	B
,	O	PUNCT	O
including	O	VERB	O
Sp1	B-protein	NOUN	B
and	O	CCONJ	O
CP1	B-protein	NOUN	B
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	B
show	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
structure	O	NOUN	B
of	O	ADP	O
this	O	DET	O
promoter	B-DNA	NOUN	B
only	O	ADV	O
permits	O	VERB	O
productive	O	ADJ	O
interactions	O	NOUN	B
of	O	ADP	O
the	O	DET	O
two	O	NUM	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
Sp1	B-protein	NOUN	B
and	O	CCONJ	O
CP1	B-protein	NOUN	B
with	O	ADP	O
the	O	DET	O
basal	O	ADJ	B
transcription	O	NOUN	I
machinery	O	NOUN	I
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
enhancer	B-DNA	NOUN	B
sequences	I-DNA	NOUN	I
.	O	PUNCT	O


The	O	DET	O
purified	O	VERB	O
homodimer	B-protein	NOUN	B
(	O	PUNCT	O
two	O	NUM	O
p50s	B-protein	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
the	O	DET	O
DNA-binding	B-protein	ADJ	B
subunit	I-protein	NOUN	I
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
binds	O	VERB	B
the	O	DET	O
B2	B-DNA	NOUN	B
site	O	NOUN	I
of	O	ADP	O
proenkephalin	O	NOUN	B
relatively	O	ADV	O
better	O	ADJ	O
than	O	ADP	O
does	O	AUX	O
the	O	DET	O
heterotetramer	B-protein	NOUN	B
(	O	PUNCT	O
two	O	NUM	O
p65s	B-protein	NOUN	O
plus	O	CCONJ	O
two	O	NUM	O
p50s	B-protein	NOUN	B
)	O	PUNCT	O
form	O	NOUN	O
of	O	ADP	O
the	O	DET	O
factor	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
nuclear	O	ADJ	B
extracts	O	NOUN	I
from	O	ADP	O
monocytes	B-cell_type	NOUN	B
or	O	CCONJ	O
macrophages	B-cell_type	NOUN	B
,	O	PUNCT	O
induction	O	NOUN	B
of	O	ADP	O
NF-KB	B-protein	NOUN	B
occurred	O	VERB	O
only	O	ADV	O
if	O	SCONJ	O
the	O	DET	O
cells	O	NOUN	B
were	O	AUX	O
previously	O	ADV	O
infected	O	VERB	B
with	O	ADP	O
HIV-1	O	NOUN	B
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
in	O	ADP	O
lymphocytes	B-cell_type	NOUN	B
,	O	PUNCT	O
growth-affecting	B-DNA	ADJ	B
genes	I-DNA	NOUN	I
other	O	ADJ	O
than	O	ADP	O
immune	B-protein	ADJ	B
receptors	I-protein	NOUN	I
risk	O	VERB	B
rearrangements	O	NOUN	I
.	O	PUNCT	O


TR	B-protein	NOUN	B
alpha	I-protein	NOUN	I
1	I-protein	NUM	I
and	O	CCONJ	O
TR	B-protein	NOUN	B
beta	I-protein	NOUN	I
2	I-protein	NUM	I
each	O	DET	O
formed	O	VERB	O
a	O	DET	O
single	O	ADJ	O
major	O	ADJ	O
TR	B-protein	NOUN	B
:	I-protein	PUNCT	O
TREp	I-protein	NOUN	B
complex	I-protein	NOUN	O
which	O	DET	O
comigrated	O	VERB	B
with	O	ADP	O
the	O	DET	O
least	O	ADV	O
retarded	O	VERB	B
complex	O	NOUN	B
formed	O	VERB	O
by	O	ADP	O
GH3	O	NOUN	B
NE	O	NOUN	B
,	O	PUNCT	O
while	O	SCONJ	O
TR	B-protein	NOUN	B
beta	I-protein	NOUN	I
1	I-protein	NUM	I
formed	O	VERB	O
multiple	O	ADJ	B
complexes	O	NOUN	B
suggesting	O	VERB	O
that	O	SCONJ	O
it	O	PRON	O
can	O	AUX	O
bind	O	VERB	B
to	O	PART	O
TREp	B-DNA	NOUN	B
as	O	ADP	O
an	O	DET	O
oligomer	B-protein	NOUN	B
.	O	PUNCT	O


A	O	DET	O
similar	O	ADJ	O
,	O	PUNCT	O
heat	O	NOUN	B
labile	O	ADJ	I
activity	O	NOUN	I
which	O	DET	O
altered	O	VERB	O
mobility	O	NOUN	B
of	O	ADP	O
the	O	DET	O
TR	B-protein	NOUN	B
:	I-protein	PUNCT	O
TRE	I-protein	NOUN	B
complex	I-protein	NOUN	I
was	O	AUX	O
also	O	ADV	O
present	O	ADJ	O
in	O	ADP	O
NE	O	NOUN	B
from	O	ADP	O
T3-unresponsive	B-cell_line	ADJ	O
JEG-3	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Cell-specific	O	ADJ	B
differences	O	NOUN	I
in	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
NF-kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
regulatory	I-DNA	ADJ	B
elements	I-DNA	NOUN	I
of	O	ADP	O
human	B-DNA	ADJ	B
immunodeficiency	I-DNA	NOUN	I
virus	I-DNA	NOUN	I
and	I-DNA	CCONJ	O
beta	I-DNA	NOUN	B
interferon	I-DNA	NOUN	I
promoters	I-DNA	NOUN	I
by	O	ADP	O
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor	I-protein	NOUN	I
.	O	PUNCT	O


Paramyxovirus	O	NOUN	B
infection	O	NOUN	I
induced	O	VERB	B
a	O	DET	O
5-	O	NUM	O
to	O	PART	O
10-fold	O	ADJ	O
increase	O	NOUN	B
in	O	ADP	O
the	O	DET	O
steady-state	O	ADJ	B
level	O	NOUN	B
of	O	ADP	O
TNF-alpha	B-RNA	NOUN	B
RNA	I-RNA	NOUN	I
in	O	ADP	O
U9-IIIB	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
compared	O	VERB	B
with	O	ADP	O
U937	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
HIV-infected	B-cell_line	ADJ	B
monocytic	I-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
produced	O	VERB	O
higher	O	ADJ	O
levels	O	NOUN	B
of	O	ADP	O
TNF-alpha	B-protein	NOUN	B
than	O	ADP	O
did	O	AUX	O
normal	O	ADJ	B
cells	O	NOUN	I
after	O	ADP	O
a	O	DET	O
secondary	O	ADJ	B
virus	O	NOUN	B
infection	O	NOUN	I
.	O	PUNCT	O


TNF-alpha	B-protein	NOUN	B
was	O	AUX	O
able	O	ADJ	O
to	O	PART	O
increase	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
HIV	B-DNA	NOUN	B
LTR	I-DNA	NOUN	B
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
in	O	ADP	O
monocytic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
TNF-alpha	B-protein	NOUN	B
did	O	AUX	O
not	O	PART	O
induce	O	VERB	B
the	O	DET	O
HIV	B-DNA	NOUN	B
LTR	I-DNA	NOUN	B
above	O	ADP	O
a	O	DET	O
constitutive	O	ADJ	B
level	O	NOUN	B
of	O	ADP	O
activity	O	NOUN	B
.	O	PUNCT	O


Electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assays	O	NOUN	I
demonstrate	O	VERB	O
that	O	SCONJ	O
LPS	O	NOUN	B
induces	O	VERB	B
a	O	DET	O
DNA	O	NOUN	B
binding	O	NOUN	I
activity	O	NOUN	I
indistinguishable	O	ADJ	O
from	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
in	O	ADP	O
U937	B-cell_line	NOUN	B
and	O	CCONJ	O
THP-1	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


The	O	DET	O
stimulation	O	NOUN	B
of	O	ADP	O
viral	O	ADJ	B
production	O	NOUN	I
from	O	ADP	O
this	O	DET	O
cell	O	NOUN	B
line	O	NOUN	I
occurs	O	VERB	O
only	O	ADV	O
if	O	SCONJ	O
these	O	DET	O
cells	O	NOUN	B
are	O	AUX	O
treated	O	VERB	B
with	O	ADP	I
granulocyte/macrophage	B-protein	ADJ	B
colony-stimulating	I-protein	ADJ	I
factor	I-protein	NOUN	I
(	O	PUNCT	O
GM-CSF	B-protein	NOUN	B
)	O	PUNCT	O
before	O	ADP	O
treatment	O	NOUN	B
with	O	ADP	O
LPS	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
stimulation	O	NOUN	B
of	O	ADP	O
HIV-1	O	NOUN	B
production	O	NOUN	B
is	O	AUX	O
correlated	O	VERB	B
with	O	ADP	O
an	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
the	O	DET	O
level	O	NOUN	B
of	O	ADP	O
HIV-1	B-RNA	NOUN	B
RNA	I-RNA	NOUN	B
and	O	CCONJ	O
and	O	CCONJ	O
activation	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
.	O	PUNCT	O


LPS	O	NOUN	B
is	O	AUX	O
not	O	PART	O
able	O	ADJ	O
to	O	PART	O
induce	O	VERB	B
HIV-1	O	NOUN	B
production	O	NOUN	B
in	O	ADP	O
a	O	DET	O
cloned	O	VERB	B
T	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
.	O	PUNCT	O


The	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
LPS	O	NOUN	B
on	O	ADP	O
HIV-1	O	NOUN	B
replication	O	NOUN	B
occurs	O	VERB	O
at	O	ADP	O
picogram	O	NOUN	B
per	O	ADP	O
milliliter	O	NOUN	O
concentrations	O	NOUN	B
and	O	CCONJ	O
may	O	AUX	O
be	O	AUX	O
clinically	O	ADV	B
significant	O	ADJ	I
in	O	ADP	O
understanding	O	VERB	O
the	O	DET	O
variability	O	NOUN	B
of	O	ADP	O
the	O	DET	O
natural	O	ADJ	B
history	O	NOUN	I
of	O	ADP	O
HIV-1	O	NOUN	B
infection	O	NOUN	O
.	O	PUNCT	O


Inhibitory	O	ADJ	B
drug	O	NOUN	B
interactions	O	NOUN	I
affecting	O	VERB	B
the	O	DET	O
metabolism	O	NOUN	B
of	O	ADP	O
methylprednisolone	O	NOUN	B
(	O	PUNCT	O
MP	O	NOUN	B
)	O	PUNCT	O
may	O	AUX	O
produce	O	VERB	O
either	O	CCONJ	O
steroid	O	NOUN	B
sparing	O	NOUN	O
or	O	CCONJ	O
adverse	O	ADJ	B
effects	O	NOUN	I
partly	O	ADV	O
by	O	ADP	O
increasing	O	VERB	B
the	O	DET	O
exposure	O	NOUN	B
time	O	NOUN	I
to	O	ADP	O
the	O	DET	O
steroid	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
pharmacodynamic	O	ADJ	B
model	O	NOUN	I
for	O	ADP	O
basophil	O	NOUN	B
cell	O	NOUN	I
distribution	O	NOUN	B
to	O	PART	O
and	O	CCONJ	O
from	O	ADP	O
an	O	DET	O
extravascular	O	ADJ	B
compartment	O	NOUN	I
describes	O	VERB	O
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	I
MP	O	NOUN	B
after	O	ADP	O
both	O	DET	O
regimens	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
decline	O	NOUN	B
and	O	CCONJ	O
return	O	NOUN	B
of	O	ADP	I
cortisol	O	NOUN	B
concentrations	O	NOUN	B
were	O	AUX	O
similar	O	ADJ	O
between	O	ADP	O
MP	O	NOUN	B
treatments	O	NOUN	B
with	O	ADP	O
suppression	O	NOUN	B
continuing	O	VERB	B
for	O	ADP	O
24	O	NUM	O
hours	O	NOUN	B
.	O	PUNCT	O


Erythroid-specific	B-DNA	ADJ	B
genes	I-DNA	NOUN	I
contain	O	VERB	O
binding	O	VERB	B
sites	O	NOUN	I
for	O	ADP	O
NF-E1	B-protein	NOUN	B
(	O	PUNCT	O
also	O	ADV	O
called	O	VERB	O
GF-1	B-protein	NOUN	B
and	O	CCONJ	O
Eryf-1	B-protein	NOUN	B
;	O	PUNCT	O
refs	O	NOUN	O
1-3	O	NUM	O
respectively	O	ADV	O
)	O	PUNCT	O
,	O	PUNCT	O
the	O	DET	O
principal	O	ADJ	B
DNA-binding	B-protein	ADJ	B
protein	I-protein	NOUN	I
of	O	ADP	O
the	O	DET	O
erythrocytic	B-cell_type	ADJ	B
lineage	I-cell_type	NOUN	I
.	O	PUNCT	O


Transcriptional	O	ADJ	B
down-regulation	O	NOUN	B
of	O	ADP	O
c-myc	B-DNA	NOUN	B
expression	O	NOUN	B
by	O	ADP	O
protein	O	NOUN	B
synthesis-dependent	O	ADJ	I
and	O	CCONJ	O
-independent	O	ADJ	O
pathways	O	NOUN	B
in	O	ADP	O
a	O	DET	O
human	B-cell_line	ADJ	B
T	I-cell_line	NOUN	B
lymphoblastic	I-cell_line	ADJ	I
tumor	I-cell_line	NOUN	I
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
.	O	PUNCT	O


A	O	DET	O
block	O	NOUN	B
to	O	PART	O
RNA	O	NOUN	B
elongation	O	NOUN	I
is	O	AUX	O
largely	O	ADV	O
responsible	O	ADJ	O
for	O	ADP	O
decreased	O	VERB	B
c-myc	B-DNA	NOUN	B
transcription	O	NOUN	I
.	O	PUNCT	O


Although	O	SCONJ	O
negative	O	ADJ	B
regulation	O	NOUN	B
by	O	ADP	O
dimethyl	O	ADJ	B
sulfoxide	O	NOUN	I
takes	O	VERB	O
place	O	NOUN	O
even	O	ADV	O
when	O	SCONJ	O
protein	O	NOUN	B
synthesis	O	NOUN	I
is	O	AUX	O
inhibited	O	VERB	B
by	O	ADP	O
cycloheximide	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
phorbol	O	NOUN	B
myristate	O	NOUN	I
acetate	O	NOUN	B
effect	O	NOUN	I
is	O	AUX	O
blocked	O	VERB	B
to	O	PART	O
some	O	DET	O
extent	O	NOUN	O
only	O	ADV	O
by	O	ADP	O
cycloheximide	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
calcium	O	NOUN	B
ionophore-induced	O	ADJ	I
c-myc	B-DNA	NOUN	I
suppression	O	NOUN	B
,	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
strictly	O	ADV	O
requires	O	VERB	O
de	O	X	O
novo	O	X	O
protein	O	NOUN	B
synthesis	O	NOUN	I
.	O	PUNCT	O


Therefore	O	ADV	O
,	O	PUNCT	O
two	O	NUM	O
different	O	ADJ	O
negative	O	ADJ	B
regulatory	O	ADJ	B
pathways	O	NOUN	I
are	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
c-myc	B-DNA	NOUN	B
regulation	O	NOUN	I
:	O	PUNCT	O
one	O	NUM	O
which	O	DET	O
is	O	AUX	O
independent	O	ADJ	B
and	O	CCONJ	O
one	O	NUM	O
which	O	DET	O
depends	O	VERB	O
on	O	ADP	O
de	O	X	O
novo	O	X	O
protein	O	NOUN	B
synthesis	O	NOUN	I
.	O	PUNCT	O


Oestrogen	B-protein	NOUN	B
receptors	I-protein	NOUN	I
(	O	PUNCT	O
ER	B-protein	NOUN	B
)	O	PUNCT	O
are	O	AUX	O
present	O	ADJ	O
in	O	ADP	O
neoplastic	B-cell_type	ADJ	B
lymphoid	I-cell_type	ADJ	O
cells	I-cell_type	NOUN	O
and	O	CCONJ	O
have	O	AUX	O
been	O	AUX	O
considered	O	VERB	O
a	O	DET	O
physiological	O	ADJ	B
marker	O	NOUN	I
of	O	ADP	O
growth	O	NOUN	B
rate	O	NOUN	I
or	O	CCONJ	O
differentiation	O	NOUN	B
.	O	PUNCT	O


It	O	PRON	O
is	O	AUX	O
of	O	ADP	O
interest	O	NOUN	O
that	O	SCONJ	O
one	O	NUM	O
of	O	ADP	O
the	O	DET	O
positive	O	ADJ	B
cases	O	NOUN	B
was	O	AUX	O
diagnosed	O	VERB	B
as	O	ADP	O
CLL	O	NOUN	B
with	O	ADP	O
Richter	O	NOUN	B
's	O	PART	I
transformation	O	NOUN	I
confirming	O	VERB	O
earlier	O	ADJ	O
findings	O	NOUN	B
.	O	PUNCT	O


Competition	O	NOUN	B
analysis	O	NOUN	I
showed	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
anti-estrogen	O	ADJ	B
tamoxifen	O	NOUN	I
and	O	CCONJ	O
the	O	DET	O
flavonoids	O	NOUN	B
quercetin	O	NOUN	I
and	O	CCONJ	O
rutin	O	NOUN	B
competed	O	VERB	O
for	O	ADP	O
(	O	PUNCT	O
3H	O	NOUN	B
)	O	PUNCT	O
-E2	O	NOUN	O
binding	O	VERB	B
to	O	PART	O
type-II	B-protein	ADJ	B
EBS	I-protein	NOUN	B
.	O	PUNCT	O


Growth	O	NOUN	B
experiments	O	NOUN	I
demonstrated	O	VERB	O
that	O	SCONJ	O
diethylstilbestrol	O	NOUN	B
(	O	PUNCT	O
DES	O	NOUN	B
)	O	PUNCT	O
tamoxifen	O	NOUN	B
(	O	PUNCT	O
TAM	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
quercetin	O	NOUN	B
and	O	CCONJ	O
rutin	O	NOUN	B
exerted	O	VERB	O
a	O	DET	O
reversible	O	ADJ	O
dose-dependent	O	ADJ	B
inhibition	O	NOUN	B
of	O	ADP	O
cell	O	NOUN	B
proliferation	O	NOUN	I
in	O	ADP	O
the	O	DET	O
range	O	NOUN	B
of	O	ADP	O
concentrations	O	NOUN	B
between	O	ADP	O
10	O	NUM	O
nM	O	NOUN	O
and	O	CCONJ	O
10	O	NUM	O
microM	O	NOUN	O
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	O
suggest	O	VERB	O
that	O	SCONJ	O
high	O	ADJ	O
estrogen	O	NOUN	B
and	O	CCONJ	O
anti-estrogen	O	NOUN	B
concentrations	O	NOUN	I
and	O	CCONJ	O
flavonoids	O	NOUN	B
may	O	AUX	O
regulate	O	VERB	B
IM-9	B-cell_line	NOUN	B
cell	O	NOUN	I
growth	O	NOUN	O
through	O	ADP	O
a	O	DET	O
common	O	ADJ	O
mechanism	O	NOUN	B
involving	O	VERB	O
a	O	DET	O
binding	O	NOUN	B
interaction	O	NOUN	B
with	O	ADP	O
type-II	B-protein	ADJ	B
EBS	I-protein	NOUN	B
.	O	PUNCT	O


Lymphocytic	O	ADJ	B
levels	O	NOUN	O
of	O	ADP	O
glucocorticoid	B-protein	NOUN	B
receptors	I-protein	NOUN	I
were	O	AUX	O
evaluated	O	VERB	B
in	O	ADP	O
114	O	NUM	O
patients	O	NOUN	B
suffering	O	VERB	B
from	O	ADP	O
Icenko-Cushing	O	NOUN	B
's	O	PART	I
syndrome	O	NOUN	I
.	O	PUNCT	O


Effects	O	NOUN	B
of	O	ADP	I
1	O	NUM	O
alpha	O	NOUN	B
,	O	PUNCT	O
25-dihydroxyvitamin	O	NOUN	B
D3	O	NOUN	I
on	O	ADP	O
the	O	DET	O
human	B-cell_line	ADJ	B
chronic	I-cell_line	ADJ	B
myelogenous	I-cell_line	ADJ	I
leukemia	I-cell_line	NOUN	I
cell	I-cell_line	NOUN	B
line	I-cell_line	NOUN	I
RWLeu-4	B-cell_line	NOUN	B
.	O	PUNCT	O


The	O	DET	O
effects	O	NOUN	B
of	O	ADP	I
1	O	NUM	O
alpha	O	NOUN	B
,	O	PUNCT	O
25-dihydroxyvitamin	O	NOUN	B
D3	O	NOUN	I
(	O	PUNCT	O
VD3	O	NOUN	B
)	O	PUNCT	O
on	O	ADP	O
proliferation	O	NOUN	B
,	O	PUNCT	O
differentiation	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
macromolecular	O	ADJ	B
synthesis	O	NOUN	I
in	O	ADP	O
the	O	DET	O
new	O	ADJ	O
Philadelphia	B-cell_line	NOUN	B
chromosome-positive	I-cell_line	ADJ	I
chronic	I-cell_line	ADJ	I
myelogenous	I-cell_line	ADJ	I
leukemia	I-cell_line	NOUN	I
cell	I-cell_line	NOUN	B
line	I-cell_line	NOUN	I
,	O	PUNCT	O
RWLeu-4	B-cell_line	NOUN	B
,	O	PUNCT	O
were	O	AUX	O
investigated	O	VERB	B
.	O	PUNCT	O


c-myc	B-RNA	NOUN	B
RNA	I-RNA	NOUN	I
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
constitutively	O	ADV	B
expressed	O	VERB	B
in	O	ADP	O
RWLeu-4	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
increased	O	VERB	B
after	O	ADP	O
0.5	O	NUM	O
h	O	NOUN	O
of	O	ADP	O
treatment	O	NOUN	B
with	O	ADP	O
50	O	NUM	O
nM	O	NOUN	O
VD3	O	NOUN	B
and	O	CCONJ	O
then	O	ADV	O
rapidly	O	ADV	O
decreased	O	VERB	B
to	O	PART	O
barely	O	ADV	O
detectable	O	ADJ	B
levels	O	NOUN	B
after	O	ADP	O
4	O	NUM	O
h	O	NOUN	O
of	O	ADP	O
treatment	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
complementary	B-DNA	ADJ	O
DNA	I-DNA	NOUN	O
encoding	O	VERB	B
a	O	DET	O
DNA-binding	B-protein	ADJ	B
protein	I-protein	NOUN	I
(	O	PUNCT	O
human	B-protein	ADJ	B
X	I-protein	NOUN	I
box	I-protein	NOUN	I
binding	I-protein	NOUN	I
protein	I-protein	NOUN	I
,	O	PUNCT	O
hXBP-1	B-protein	NOUN	B
)	O	PUNCT	O
whose	O	DET	O
target	O	NOUN	B
is	O	AUX	O
the	O	DET	O
human	B-DNA	ADJ	B
DR	I-DNA	NOUN	I
alpha	I-DNA	NOUN	I
X	I-DNA	NOUN	I
box	I-DNA	NOUN	I
and	O	CCONJ	O
the	O	DET	O
3	B-DNA	NUM	O
'	I-DNA	PART	O
flanking	I-DNA	ADJ	B
region	I-DNA	NOUN	I
has	O	AUX	O
now	O	ADV	O
been	O	AUX	O
cloned	O	VERB	B
.	O	PUNCT	O


Higher	O	ADJ	B
NK	O	NOUN	B
activity	O	NOUN	O
could	O	AUX	O
be	O	AUX	O
predicted	O	VERB	B
by	O	ADP	O
the	O	DET	O
perception	O	NOUN	B
of	O	ADP	O
high	O	ADJ	B
quality	O	NOUN	B
emotional	O	ADJ	B
support	O	NOUN	O
from	O	ADP	O
a	O	DET	O
spouse	O	NOUN	B
or	O	CCONJ	O
intimate	O	ADJ	B
other	O	ADJ	O
,	O	PUNCT	O
perceived	O	VERB	B
social	O	ADJ	B
support	O	NOUN	I
from	O	ADP	O
the	O	DET	O
patient	O	NOUN	B
's	O	PART	I
physician	O	NOUN	B
,	O	PUNCT	O
estrogen	B-protein	NOUN	B
receptor	I-protein	NOUN	I
-negative	O	ADJ	O
tumor	O	NOUN	B
status	O	NOUN	I
,	O	PUNCT	O
having	O	VERB	O
an	O	DET	O
excisional	O	ADJ	B
biopsy	O	NOUN	I
as	O	ADP	O
surgical	O	ADJ	B
treatment	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
actively	O	ADV	O
seeking	O	VERB	O
social	O	ADJ	B
support	O	NOUN	I
as	O	ADP	O
a	O	DET	O
major	O	ADJ	O
coping	O	NOUN	B
strategy	O	NOUN	O
(	O	PUNCT	O
R2	O	NOUN	O
=	O	ADJ	O
0.33	O	NUM	O
,	O	PUNCT	O
F	O	NOUN	B
(	O	PUNCT	O
5	O	NUM	O
,	O	PUNCT	O
55	O	NUM	O
)	O	PUNCT	O
=	O	ADJ	O
5.5	O	NUM	O
,	O	PUNCT	O
p	O	NOUN	O
less	O	ADJ	O
than	O	ADP	O
0.0004	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Findings	O	NOUN	B
are	O	AUX	O
discussed	O	VERB	O
in	O	ADP	O
terms	O	NOUN	O
of	O	ADP	O
host	O	NOUN	B
interaction	O	NOUN	B
with	O	ADP	O
tumor	O	NOUN	B
endocrine	O	ADJ	I
status	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
role	O	NOUN	O
that	O	SCONJ	O
social	O	ADJ	B
support	O	NOUN	I
might	O	AUX	O
play	O	VERB	O
in	O	ADP	O
modulating	O	VERB	B
such	O	ADJ	O
activity	O	NOUN	B
.	O	PUNCT	O


An	O	DET	O
in	O	X	B
vitro	O	X	I
globin	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
switching	O	NOUN	I
model	O	NOUN	I
based	O	VERB	O
on	O	ADP	O
differentiated	B-cell_type	VERB	O
embryonic	I-cell_type	ADJ	B
stem	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
ES-derived	B-cell_type	ADJ	B
embryoid	I-cell_type	ADJ	B
bodies	I-cell_type	NOUN	I
express	O	VERB	B
the	O	DET	O
full	O	ADJ	O
complement	O	NOUN	O
of	O	ADP	O
mouse	B-DNA	NOUN	B
embryonic	I-DNA	ADJ	I
globin	I-DNA	NOUN	O
genes	I-DNA	NOUN	O
in	O	ADP	O
the	O	DET	O
correct	O	ADJ	O
temporal	O	ADJ	B
order	O	NOUN	O
and	O	CCONJ	O
that	O	SCONJ	O
on	O	ADP	O
further	O	ADJ	O
differentiation	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
switch	O	NOUN	B
occurs	O	VERB	O
to	O	PART	O
the	O	DET	O
fetal/adult	B-DNA	ADJ	B
genes	I-DNA	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
tested	O	VERB	O
several	O	ADJ	O
subregions	O	NOUN	B
of	O	ADP	O
the	O	DET	O
DR	B-DNA	NOUN	B
enhancer	I-DNA	NOUN	O
B	B-DNA	NOUN	O
domain	I-DNA	NOUN	O
,	O	PUNCT	O
either	O	CCONJ	O
alone	O	ADV	O
or	O	CCONJ	O
in	O	ADP	O
combination	O	NOUN	B
,	O	PUNCT	O
for	O	ADP	O
their	O	PRON	O
capacity	O	NOUN	B
to	O	PART	O
transmit	O	VERB	B
the	O	DET	O
R-activating	O	ADJ	B
signal	O	NOUN	I
to	O	PART	O
the	O	DET	O
rabbit	B-DNA	NOUN	B
beta-globin	I-DNA	NOUN	B
promoter	I-DNA	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
patients	O	NOUN	B
with	O	ADP	O
diabetes	O	NOUN	B
mellitus	O	NOUN	I
,	O	PUNCT	O
chronic	O	ADJ	B
renal	O	ADJ	I
failure	O	NOUN	I
and	O	CCONJ	O
hepatic	O	ADJ	B
cirrhosis	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
nuclear	B-protein	ADJ	B
T3R	I-protein	NOUN	I
MBC	O	NOUN	I
of	O	ADP	O
lymphocytes	B-cell_type	NOUN	B
was	O	AUX	O
about	O	ADV	O
1.5-1.6	O	NUM	O
times	O	NOUN	O
of	O	ADP	O
the	O	DET	O
normal	O	ADJ	B
controls	O	NOUN	I
.	O	PUNCT	O


Three	O	NUM	O
cell	B-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
established	O	VERB	O
from	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
VDDR-II	O	NOUN	B
(	O	PUNCT	O
Rh-	O	ADJ	B
VDR	B-protein	NOUN	B
,	O	PUNCT	O
Sh-	O	ADJ	B
VDR	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
Ab-	O	ADJ	B
VDR	B-protein	NOUN	B
)	O	PUNCT	O
showed	O	VERB	O
no	O	DET	O
specific	O	ADJ	O
binding	O	NOUN	B
of	O	ADP	O
1	O	NUM	O
,	O	PUNCT	O
25	O	NUM	O
(	O	PUNCT	O
OH	O	NOUN	B
)	O	PUNCT	O
2D3	O	NOUN	O
to	O	PART	O
a	O	DET	O
receptor	B-protein	NOUN	B
and	O	CCONJ	O
treatment	O	NOUN	B
of	O	ADP	O
the	O	DET	O
cultured	B-cell_line	VERB	B
cells	I-cell_line	NOUN	I
with	O	ADP	O
1	O	NUM	O
,	O	PUNCT	O
25	O	NUM	O
(	O	PUNCT	O
OH	O	NOUN	B
)	O	PUNCT	O
2D3	O	NOUN	B
did	O	AUX	O
not	O	PART	O
stimulate	O	VERB	O
production	O	NOUN	B
of	O	ADP	O
24	O	NUM	O
,	O	PUNCT	O
25-dihydroxy-vitamin	O	ADJ	B
D3	O	NOUN	I
(	O	PUNCT	O
24	O	NUM	O
,	O	PUNCT	O
25	O	NUM	O
(	O	PUNCT	O
OH	O	NOUN	B
)	O	PUNCT	O
2D3	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
a	O	DET	O
response	O	NOUN	B
which	O	DET	O
is	O	AUX	O
diagnostic	O	ADJ	B
of	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
a	O	DET	O
functional	B-protein	ADJ	B
1	I-protein	NUM	O
,	I-protein	PUNCT	O
25	I-protein	NUM	O
(	I-protein	PUNCT	O
OH	I-protein	NOUN	B
)	I-protein	PUNCT	O
2D3	I-protein	NOUN	B
receptor	I-protein	NOUN	I
.	O	PUNCT	O


Transcriptional	O	ADJ	B
and	O	CCONJ	O
post-transcriptional	O	ADJ	B
regulation	O	NOUN	I
of	O	ADP	O
c-jun	B-DNA	NOUN	B
expression	O	NOUN	I
during	O	ADP	O
monocytic	O	ADJ	B
differentiation	O	NOUN	I
of	O	ADP	O
human	B-cell_line	ADJ	B
myeloid	I-cell_line	ADJ	O
leukemic	I-cell_line	ADJ	O
cells	I-cell_line	NOUN	O
.	O	PUNCT	O


Treatment	O	NOUN	B
of	O	ADP	O
HL-60	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
with	O	ADP	O
both	O	CCONJ	O
TPA	O	NOUN	B
and	O	CCONJ	O
cycloheximide	O	NOUN	B
had	O	AUX	O
no	O	DET	B
effect	O	NOUN	I
on	O	ADP	O
the	O	DET	O
rates	O	NOUN	B
of	O	ADP	O
c-jun	B-DNA	NOUN	B
transcription	O	NOUN	I
.	O	PUNCT	O


[	O	PUNCT	O
Hormonal	O	ADJ	B
interactions	O	NOUN	I
and	O	CCONJ	O
glucocorticoid	B-protein	NOUN	B
receptors	I-protein	NOUN	I
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
the	O	DET	O
nephrotic	O	ADJ	B
syndrome	O	NOUN	I
]	O	PUNCT	O


Transfections	O	NOUN	B
of	O	ADP	O
E3	B-DNA	NOUN	B
constructs	I-DNA	NOUN	I
linked	O	VERB	O
to	O	PART	O
the	O	DET	O
chloramphenicol	B-DNA	NOUN	B
acetyltransferase	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
revealed	O	VERB	O
that	O	SCONJ	O
mutagenesis	O	NOUN	B
of	O	ADP	O
the	O	DET	O
distal	B-DNA	ADJ	B
NF-kappa	I-DNA	NOUN	I
B	I-DNA	NOUN	I
motif	I-DNA	NOUN	I
(	O	PUNCT	O
L2	B-DNA	NOUN	B
)	O	PUNCT	O
had	O	AUX	O
minimal	O	ADJ	B
effects	O	NOUN	B
on	O	ADP	O
promoter	O	NOUN	B
expression	O	NOUN	I
in	O	ADP	O
HeLa	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
resulted	O	VERB	O
in	O	ADP	O
dramatic	O	ADJ	O
decreases	O	NOUN	B
in	O	ADP	O
expression	O	NOUN	B
by	O	ADP	O
lymphoid	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Characterization	O	NOUN	B
of	O	ADP	O
defensin	B-protein	NOUN	B
resistance	O	NOUN	I
phenotypes	O	NOUN	B
associated	O	VERB	B
with	O	ADP	I
mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
phoP	B-DNA	NOUN	B
virulence	I-DNA	NOUN	B
regulon	I-DNA	NOUN	B
of	O	ADP	O
Salmonella	O	X	B
typhimurium	O	X	I
.	O	PUNCT	O


The	O	DET	O
defensin	B-protein	NOUN	B
sensitivities	O	NOUN	O
of	O	ADP	O
Salmonella	O	X	B
typhimurium	O	X	I
strains	O	NOUN	B
with	O	ADP	O
mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
phoP/phoQ	B-DNA	NOUN	B
two-component	I-DNA	ADJ	B
virulence	I-DNA	NOUN	I
regulon	I-DNA	NOUN	I
were	O	AUX	O
tested	O	VERB	B
by	O	ADP	O
using	O	VERB	O
purified	B-protein	VERB	B
defensins	I-protein	NOUN	B
NP-1	B-protein	NOUN	B
and	O	CCONJ	O
NP-2	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
virulence	O	NOUN	B
defect	O	NOUN	B
conferred	O	VERB	O
by	O	ADP	O
mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
phoP	B-DNA	NOUN	B
-phoQ	B-DNA	NOUN	O
two-component	O	ADJ	B
regulatory	O	ADJ	I
system	O	NOUN	I
is	O	AUX	O
not	O	PART	O
completely	O	ADV	O
explained	O	VERB	O
by	O	ADP	O
alterations	O	NOUN	B
in	O	ADP	O
resistance	O	NOUN	B
to	O	PART	O
cationic	B-protein	ADJ	B
proteins	I-protein	NOUN	I
and	O	CCONJ	O
involves	O	VERB	O
the	O	DET	O
control	O	NOUN	B
of	O	ADP	O
other	O	ADJ	O
proteins	O	NOUN	B
necessary	O	ADJ	O
for	O	ADP	O
S.	O	X	B
typhimurium	O	X	I
survival	O	NOUN	B
within	O	ADP	O
macrophages	B-cell_type	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
found	O	VERB	O
a	O	DET	O
dissociation	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
translocation	O	NOUN	B
from	O	ADP	O
transactivation	O	NOUN	B
of	O	ADP	O
either	O	CCONJ	O
the	O	DET	O
HIV	B-DNA	NOUN	B
LTR	I-DNA	NOUN	B
or	O	CCONJ	O
the	O	DET	O
HIV	B-DNA	NOUN	B
enhancer	I-DNA	NOUN	I
.	O	PUNCT	O


Interleukin	B-protein	NOUN	B
2	I-protein	NUM	I
induced	O	VERB	B
proliferation	O	NOUN	B
but	O	CCONJ	O
not	O	PART	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
translocation	O	NOUN	B
or	O	CCONJ	O
LTR	B-DNA	NOUN	B
transactivation	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
two	O	NUM	O
latter	O	ADJ	O
signals	O	NOUN	B
were	O	AUX	O
nevertheless	O	ADV	O
able	O	ADJ	O
to	O	PART	O
induce	O	VERB	B
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
translocation	O	NOUN	B
with	O	ADP	O
a	O	DET	O
pattern	O	NOUN	B
in	O	ADP	O
the	O	DET	O
band-shift	O	ADJ	B
assay	O	NOUN	I
indistinguishable	O	ADJ	B
from	O	ADP	O
that	O	DET	O
observed	O	VERB	O
using	O	VERB	O
phorbol	O	NOUN	B
ester	O	NOUN	I
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
our	O	PRON	O
results	O	NOUN	O
suggest	O	VERB	O
that	O	SCONJ	O
events	O	NOUN	B
linked	O	VERB	O
to	O	PART	O
T-cell	O	NOUN	B
activation	O	NOUN	I
,	O	PUNCT	O
in	O	ADP	O
addition	O	NOUN	O
to	O	PART	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
translocation	O	NOUN	B
per	O	X	O
se	O	X	O
,	O	PUNCT	O
induce	O	VERB	B
functional	O	ADJ	B
interactions	O	NOUN	B
of	O	ADP	O
the	O	DET	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
complex	I-protein	NOUN	I
with	O	ADP	O
the	O	DET	O
HIV	B-DNA	NOUN	B
enhancer	I-DNA	NOUN	I
.	O	PUNCT	O


On	O	ADP	O
the	O	DET	O
contrary	O	NOUN	O
,	O	PUNCT	O
there	O	PRON	O
was	O	AUX	O
no	O	DET	B
significant	O	ADJ	I
difference	O	NOUN	O
between	O	ADP	O
the	O	DET	O
phosphate-supplemented	O	ADJ	B
patients	O	NOUN	B
(	O	PUNCT	O
58.3	O	NUM	O
+/-	O	CCONJ	O
2.7	O	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
controls	O	NOUN	B
.	O	PUNCT	O


There	O	PRON	O
was	O	AUX	O
a	O	DET	O
significant	O	ADJ	O
positive	O	ADJ	B
correlation	O	NOUN	B
between	O	ADP	O
VDR	B-protein	NOUN	B
concentration	O	NOUN	B
and	O	CCONJ	O
serum	O	NOUN	B
phosphate	O	NOUN	I
(	O	PUNCT	O
P	O	NOUN	O
less	O	ADJ	O
than	O	ADP	O
0.05	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Two	O	NUM	O
distinct	O	ADJ	O
forms	O	NOUN	O
of	O	ADP	O
active	B-protein	ADJ	B
transcription	I-protein	NOUN	O
factor	I-protein	NOUN	O
CREB	I-protein	NOUN	O
(	O	PUNCT	O
cAMP	B-protein	NOUN	B
response	I-protein	NOUN	I
element	I-protein	NOUN	I
binding	I-protein	NOUN	I
protein	I-protein	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


As	O	ADP	O
expected	O	VERB	O
for	O	ADP	O
proteins	O	NOUN	B
of	O	ADP	O
this	O	DET	O
class	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
CREB	B-protein	NOUN	B
proteins	I-protein	NOUN	I
bind	O	VERB	B
DNA	O	NOUN	B
as	O	ADP	O
dimers	O	NOUN	B
.	O	PUNCT	O


BSAP	B-protein	NOUN	B
is	O	AUX	O
exclusively	O	ADV	O
restricted	O	ADJ	O
to	O	PART	O
the	O	DET	O
B-cell	O	NOUN	B
lineage	O	NOUN	I
of	O	ADP	O
lymphoid	O	ADJ	B
differentiation	O	NOUN	O
.	O	PUNCT	O


Its	O	PRON	O
expression	O	NOUN	B
appears	O	VERB	O
to	O	PART	O
be	O	AUX	O
activated	O	VERB	B
during	O	ADP	O
pro-B-cell	O	ADJ	B
development	O	NOUN	I
,	O	PUNCT	O
is	O	AUX	O
abundant	O	ADJ	B
at	O	ADP	O
the	O	DET	O
pre-B-	O	ADJ	B
and	O	CCONJ	O
mature	O	ADJ	B
B-cell	O	NOUN	B
stages	O	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
is	O	AUX	O
absent	O	ADJ	B
in	O	ADP	O
terminally	B-cell_type	ADV	O
differentiated	I-cell_type	VERB	O
plasma	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Octamer	B-protein	NOUN	B
transcription	I-protein	NOUN	I
factors	I-protein	NOUN	I
and	O	CCONJ	O
the	O	DET	O
cell	B-DNA	NOUN	B
type-specificity	I-DNA	NOUN	I
of	I-DNA	ADP	O
immunoglobulin	I-DNA	NOUN	B
gene	I-DNA	NOUN	I
expression	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
octamer	B-DNA	NOUN	B
sequence	I-DNA	NOUN	I
ATGCAAAT	O	NOUN	I
is	O	AUX	O
present	O	ADJ	O
in	O	ADP	O
the	O	DET	O
promoter	B-DNA	NOUN	B
and	O	CCONJ	O
the	O	DET	O
enhancer	B-DNA	NOUN	B
of	O	ADP	O
Ig	B-DNA	NOUN	B
genes	I-DNA	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
plays	O	VERB	O
an	O	DET	O
important	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
its	O	PRON	O
tissue-specific	O	ADJ	B
expression	O	NOUN	I
.	O	PUNCT	O


It	O	PRON	O
appears	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
B	O	NOUN	B
cell-specific	O	ADJ	B
expression	O	NOUN	I
of	O	ADP	O
Ig	B-DNA	NOUN	B
genes	I-DNA	NOUN	I
is	O	AUX	O
mediated	O	VERB	O
at	O	ADP	O
least	O	ADJ	O
in	O	ADP	O
part	O	NOUN	O
by	O	ADP	O
cell	O	NOUN	B
type-specific	B-protein	ADJ	I
Oct	I-protein	NOUN	I
factors	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
that	O	SCONJ	O
there	O	PRON	O
are	O	AUX	O
both	O	CCONJ	O
quantitative	O	ADJ	B
and	O	CCONJ	O
qualitative	O	ADJ	B
differences	O	NOUN	O
between	O	ADP	O
Oct-1	B-protein	NOUN	B
and	O	CCONJ	O
Oct-2	B-protein	NOUN	B
factors	I-protein	NOUN	I
.	O	PUNCT	O


Many	O	ADJ	O
of	O	ADP	O
these	O	DET	O
may	O	AUX	O
be	O	AUX	O
created	O	VERB	O
by	O	ADP	O
alternative	O	ADJ	B
splicing	O	NOUN	B
of	O	ADP	O
a	O	DET	O
primary	B-RNA	ADJ	B
transcript	I-RNA	NOUN	I
of	O	ADP	O
one	O	NUM	O
Oct	O	NOUN	O
factor	O	NOUN	O
gene	O	NOUN	O
and	O	CCONJ	O
may	O	AUX	O
serve	O	VERB	O
a	O	DET	O
specific	O	ADJ	O
function	O	NOUN	B
in	O	ADP	O
the	O	DET	O
fine	O	ADJ	O
tuning	O	NOUN	B
of	O	ADP	O
gene	O	NOUN	B
expression	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
transcriptional	B-DNA	ADJ	B
enhancer	I-DNA	NOUN	I
located	O	ADJ	O
in	O	ADP	O
the	O	DET	O
first	O	ADJ	O
intron	O	NOUN	B
of	O	ADP	O
the	O	DET	O
immunoglobulin	B-DNA	NOUN	B
heavy	I-DNA	ADJ	I
chain	I-DNA	NOUN	I
constant	I-DNA	ADJ	I
region	I-DNA	NOUN	I
is	O	AUX	O
a	O	DET	O
major	O	ADJ	O
determinant	O	NOUN	O
of	O	ADP	O
B-cell-specific	O	ADJ	B
expression	O	NOUN	I
of	O	ADP	O
immunoglobulin	B-DNA	NOUN	B
genes	I-DNA	NOUN	I
.	O	PUNCT	O


It	O	PRON	O
is	O	AUX	O
present	O	ADJ	O
in	O	ADP	O
an	O	DET	O
active	O	ADJ	B
form	O	NOUN	I
in	O	ADP	O
both	O	CCONJ	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
non-B	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
where	O	SCONJ	O
it	O	PRON	O
can	O	AUX	O
mediate	O	VERB	O
transcriptional	O	ADJ	B
activation	O	NOUN	I
in	O	X	B
vitro	O	X	I
and	O	CCONJ	O
in	O	X	B
vivo	O	X	I
.	O	PUNCT	O


Viral	O	ADJ	B
gene	O	NOUN	I
expression	O	NOUN	B
was	O	AUX	O
assayed	O	VERB	B
by	O	ADP	O
the	O	DET	O
level	O	NOUN	B
of	O	ADP	O
p24	B-protein	NOUN	B
gag	I-protein	NOUN	I
protein	I-protein	NOUN	I
released	O	VERB	B
from	O	ADP	O
cultures	O	NOUN	B
transfected	O	VERB	B
with	O	ADP	O
the	O	DET	O
proviral	O	ADJ	B
constructs	O	NOUN	I
.	O	PUNCT	O


High	O	ADJ	B
level	O	NOUN	B
gene	O	NOUN	B
expression	O	NOUN	I
of	O	ADP	O
these	O	DET	O
TAR	B-DNA	NOUN	B
mutant	I-DNA	ADJ	I
constructs	I-DNA	NOUN	B
in	O	ADP	O
phorbol	B-cell_line	NOUN	B
ester-treated	I-cell_line	ADJ	O
Jurkat	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
was	O	AUX	O
eliminated	O	VERB	O
by	O	ADP	O
second	O	ADJ	O
site	O	NOUN	B
mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
enhancer	B-DNA	NOUN	B
region	I-DNA	NOUN	I
or	O	CCONJ	O
by	O	ADP	O
disruption	O	NOUN	B
of	O	ADP	O
the	O	DET	O
tat	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
.	O	PUNCT	O


Under	O	ADP	O
carbimazole	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
plasma	O	NOUN	B
T4	O	NOUN	O
markedly	O	ADV	O
decreased	O	VERB	B
(	O	PUNCT	O
27.7	O	NUM	O
+/-	O	CCONJ	O
3.6	O	NUM	O
nmol/l	O	NOUN	O
)	O	PUNCT	O
but	O	CCONJ	O
the	O	DET	O
patient	O	NOUN	B
remained	O	VERB	O
euthyroid	O	ADJ	B
.	O	PUNCT	O


Inducible	O	ADJ	B
nuclear	B-protein	ADJ	O
factor	I-protein	NOUN	O
binding	O	VERB	O
to	O	PART	O
the	O	DET	O
kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
elements	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
immunodeficiency	I-DNA	NOUN	I
virus	I-DNA	NOUN	I
enhancer	I-DNA	NOUN	I
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
can	O	AUX	O
be	O	AUX	O
blocked	O	VERB	B
by	O	ADP	O
cyclosporin	O	NOUN	B
A	O	NOUN	O
in	O	ADP	O
a	O	DET	O
signal-dependent	O	ADJ	B
manner	O	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
(	O	PUNCT	O
HIV	O	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
partially	O	ADV	O
suppressed	O	VERB	B
.	O	PUNCT	O


The	O	DET	O
kappa	O	NOUN	O
B-binding	O	ADJ	O
activity	O	NOUN	O
with	O	ADP	O
the	O	DET	O
HIV	B-DNA	NOUN	B
enhancer	I-DNA	NOUN	I
is	O	AUX	O
inhibited	O	VERB	B
only	O	ADV	O
if	O	SCONJ	O
it	O	PRON	O
is	O	AUX	O
activated	O	VERB	B
via	O	ADP	O
the	O	DET	O
mitogen	B-protein	NOUN	B
phytohemagglutinin	B-protein	NOUN	I
whereas	O	SCONJ	O
phorbol	O	NOUN	B
myristate	O	NOUN	I
acetate-mediated	O	ADJ	B
activation	O	NOUN	I
is	O	AUX	O
completely	O	ADV	O
insensitive	O	ADJ	O
to	O	PART	O
the	O	DET	O
drug	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
differentiation	O	NOUN	B
of	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
into	O	ADP	O
functionally	O	ADV	O
diverse	O	ADJ	B
subpopulations	O	NOUN	B
is	O	AUX	O
controlled	O	VERB	B
in	O	ADP	O
part	O	NOUN	O
,	O	PUNCT	O
by	O	ADP	O
transcriptional	O	ADJ	B
activation	O	NOUN	I
and	O	CCONJ	O
silencing	O	NOUN	B
;	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
little	O	ADJ	O
is	O	AUX	O
known	O	VERB	O
in	O	ADP	O
detail	O	NOUN	O
about	O	ADP	O
the	O	DET	O
proteins	O	NOUN	B
that	O	PRON	O
influence	O	VERB	B
this	O	DET	O
developmental	O	ADJ	B
process	O	NOUN	I
.	O	PUNCT	O


DNA-protein	O	ADJ	B
binding	O	NOUN	I
assays	O	NOUN	I
with	O	ADP	O
nuclear	O	ADJ	B
extracts	O	NOUN	I
from	O	ADP	O
induced	O	VERB	B
cells	O	NOUN	B
demonstrate	O	VERB	O
a	O	DET	O
high	B-protein	ADJ	O
molecular	I-protein	ADJ	B
weight	I-protein	NOUN	I
complex	I-protein	NOUN	I
on	O	ADP	O
the	O	DET	O
enhancer	B-DNA	NOUN	B
.	O	PUNCT	O


The	O	DET	O
formation	O	NOUN	B
of	O	ADP	O
this	O	DET	O
complex	O	NOUN	B
also	O	ADV	O
requires	O	VERB	O
both	O	CCONJ	O
AP-1	B-DNA	NOUN	B
sites	I-DNA	NOUN	I
and	O	CCONJ	O
correlates	O	VERB	O
with	O	ADP	O
maximal	O	ADJ	B
enhancer	B-DNA	NOUN	I
activity	O	NOUN	I
.	O	PUNCT	O


Identification	O	NOUN	B
of	O	ADP	O
a	O	DET	O
novel	B-protein	ADJ	O
factor	I-protein	NOUN	B
that	O	PRON	O
interacts	O	VERB	O
with	O	ADP	O
an	O	DET	O
immunoglobulin	B-DNA	NOUN	B
heavy-chain	I-DNA	ADJ	I
promoter	I-DNA	NOUN	B
and	O	CCONJ	O
stimulates	O	VERB	B
transcription	O	NOUN	B
in	O	ADP	O
conjunction	O	NOUN	B
with	O	ADP	O
the	O	DET	O
lymphoid	B-protein	ADJ	B
cell-specific	I-protein	ADJ	B
factor	I-protein	NOUN	I
OTF2	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
OTF	O	NOUN	B
interactions	O	NOUN	B
we	O	PRON	O
observed	O	VERB	O
extended	O	VERB	B
over	O	ADP	O
the	O	DET	O
heptamer	B-DNA	NOUN	B
element	I-DNA	NOUN	O
5'-CTCAGGA-3	O	NOUN	O
'	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
it	O	PRON	O
seems	O	VERB	O
likely	O	ADJ	O
that	O	SCONJ	O
the	O	DET	O
binding	O	NOUN	B
of	O	ADP	O
the	O	DET	O
purified	B-protein	VERB	B
factors	I-protein	NOUN	I
involves	O	VERB	O
cooperation	O	NOUN	B
between	O	ADP	O
octamer	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
heptamer	I-DNA	NOUN	B
sites	I-DNA	NOUN	I
in	O	ADP	O
this	O	DET	O
promoter	B-DNA	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
to	O	PART	O
these	O	DET	O
elements	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
identified	O	VERB	B
a	O	DET	O
second	O	ADJ	O
regulatory	B-DNA	ADJ	B
element	I-DNA	NOUN	I
,	O	PUNCT	O
the	O	DET	O
N	B-DNA	NOUN	B
element	I-DNA	NOUN	I
with	O	ADP	O
the	O	DET	O
sequence	O	NOUN	B
5'-GGAACCTCCCCC-3'	O	NOUN	O
.	O	PUNCT	O


As	O	ADP	O
shown	O	VERB	O
by	O	ADP	O
a	O	DET	O
methylation	O	NOUN	B
interference	O	NOUN	O
analysis	O	NOUN	O
and	O	CCONJ	O
oligonucleotide	O	NOUN	B
competition	O	NOUN	I
experiments	O	NOUN	B
,	O	PUNCT	O
purified	O	VERB	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
binds	O	VERB	B
at	O	ADP	O
positions	B-DNA	NOUN	B
-82	I-DNA	NUM	O
to	I-DNA	PART	O
-91	I-DNA	NUM	O
(	O	PUNCT	O
GGGAACTACC	O	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
the	O	DET	O
GM-CSF	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
sequence	O	NOUN	I
with	O	ADP	O
an	O	DET	O
affinity	O	NOUN	B
similar	O	ADJ	O
to	O	PART	O
that	O	DET	O
with	O	ADP	O
which	O	DET	O
it	O	PRON	O
binds	O	VERB	B
to	O	PART	O
the	O	DET	O
biologically	B-DNA	ADV	B
functional	I-DNA	ADJ	I
kappa	I-DNA	NOUN	I
B	I-DNA	NOUN	I
motif	I-DNA	NOUN	B
in	O	ADP	O
the	O	DET	O
beta	B-DNA	NOUN	B
interferon	I-DNA	NOUN	I
promoter	I-DNA	NOUN	I
(	O	PUNCT	O
GGGAAATTCC	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Alone	O	ADV	B
,	O	PUNCT	O
PMA	O	NOUN	B
and	O	CCONJ	O
calcium	O	NOUN	B
ionophore	O	NOUN	I
A23187	O	NOUN	B
did	O	AUX	O
not	O	PART	O
affect	O	VERB	O
,	O	PUNCT	O
but	O	CCONJ	O
together	O	ADV	O
stimulated	O	VERB	B
,	O	PUNCT	O
like	O	ADP	O
phytohaemagglutinin	B-protein	NOUN	B
(	O	PUNCT	O
PHA	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
leucine	O	NOUN	B
and	O	CCONJ	O
,	O	PUNCT	O
in	O	ADP	O
particular	O	ADJ	O
,	O	PUNCT	O
thymidine	O	NOUN	B
incorporation	O	NOUN	B
.	O	PUNCT	O


Amino	O	NOUN	B
acid	O	NOUN	I
sequences	O	NOUN	I
of	O	ADP	O
all	O	DET	O
proteins	O	NOUN	B
are	O	AUX	O
essays	O	NOUN	O
written	O	VERB	B
in	O	ADP	O
the	O	DET	O
same	O	ADJ	O
language	O	NOUN	B
.	O	PUNCT	O


On	O	ADP	O
the	O	DET	O
other	O	ADJ	O
hand	O	NOUN	B
,	O	PUNCT	O
interleukin	B-protein	NOUN	B
2	I-protein	NUM	I
(	O	PUNCT	O
IL-2	B-protein	NOUN	B
)	O	PUNCT	O
-induced	O	ADJ	O
signals	O	NOUN	B
are	O	AUX	O
blocked	O	VERB	B
by	O	ADP	O
rapamycin	O	NOUN	B
but	O	CCONJ	O
not	O	PART	O
by	O	ADP	O
FK506	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
increased	O	VERB	B
PDGF	B-RNA	NOUN	B
(	I-RNA	PUNCT	O
B	I-RNA	NOUN	B
)	I-RNA	PUNCT	O
mRNA	I-RNA	NOUN	B
observed	O	VERB	B
in	O	ADP	O
adherent	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
was	O	AUX	O
accompanied	O	VERB	O
by	O	ADP	O
increases	O	NOUN	B
in	O	ADP	O
mRNAs	B-RNA	NOUN	B
of	O	ADP	O
the	O	DET	O
early	B-DNA	ADJ	B
growth	I-DNA	NOUN	B
response	I-DNA	NOUN	I
genes	I-DNA	NOUN	I
c-fos	B-DNA	NOUN	O
(	O	PUNCT	O
maximal	O	ADJ	B
at	O	ADP	O
20	O	NUM	O
min	O	NOUN	O
)	O	PUNCT	O
,	O	PUNCT	O
c-jun	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
EGR2	O	NOUN	B
(	O	PUNCT	O
maximal	O	ADJ	B
at	O	ADP	O
6-24	O	NUM	O
h	O	NOUN	O
)	O	PUNCT	O
.	O	PUNCT	O


Modulation	O	NOUN	B
of	O	ADP	O
these	O	DET	O
events	O	NOUN	B
at	O	ADP	O
the	O	DET	O
time	O	NOUN	B
of	O	ADP	O
adherence	O	NOUN	B
offers	O	VERB	O
a	O	DET	O
mechanism	O	NOUN	B
by	O	ADP	O
which	O	DET	O
differential	O	ADJ	O
priming	O	NOUN	B
of	O	ADP	O
the	O	DET	O
cells	O	NOUN	B
may	O	AUX	O
be	O	AUX	O
accomplished	O	VERB	O
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
analyzed	O	VERB	B
the	O	DET	O
distribution	O	NOUN	B
of	O	ADP	O
NF-AT	B-protein	NOUN	B
transcriptional	O	ADJ	B
activity	O	NOUN	I
among	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
undergoing	O	VERB	O
activation	O	NOUN	B
by	O	ADP	O
using	O	VERB	O
a	O	DET	O
construct	O	NOUN	O
in	O	ADP	O
which	O	DET	O
three	O	NUM	O
tandem	O	ADJ	B
copies	O	NOUN	B
of	O	ADP	O
the	O	DET	O
NF-AT-binding	B-DNA	ADJ	B
site	I-DNA	NOUN	B
directs	O	VERB	O
transcription	O	NOUN	B
of	O	ADP	O
the	O	DET	O
lacZ	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
.	O	PUNCT	O


Further	O	ADJ	O
results	O	NOUN	B
,	O	PUNCT	O
in	O	ADP	O
which	O	DET	O
beta-gal	B-protein	NOUN	B
activity	O	NOUN	I
is	O	AUX	O
correlated	O	VERB	B
with	O	ADP	O
NF-AT	B-protein	NOUN	B
-binding	O	ADJ	O
activity	O	NOUN	B
,	O	PUNCT	O
indicate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
concentration	O	NOUN	B
of	O	ADP	O
NF-AT	B-protein	NOUN	B
must	O	AUX	O
exceed	O	VERB	O
a	O	DET	O
critical	O	ADJ	O
threshold	O	NOUN	B
before	O	ADP	O
transcription	O	NOUN	B
initiates	O	VERB	B
.	O	PUNCT	O


Similar	O	ADJ	O
constructs	O	NOUN	B
controlled	O	VERB	B
by	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
or	O	CCONJ	O
the	O	DET	O
entire	O	ADJ	O
interleukin-2	B-DNA	NOUN	B
enhancer	I-DNA	NOUN	O
show	O	VERB	O
bimodal	O	ADJ	B
expression	O	NOUN	B
patterns	O	NOUN	O
during	O	ADP	O
induction	O	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
thresholds	O	NOUN	B
set	O	VERB	O
by	O	ADP	O
the	O	DET	O
concentration	O	NOUN	B
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
may	O	AUX	O
be	O	AUX	O
a	O	DET	O
common	O	ADJ	O
property	O	NOUN	B
of	O	ADP	O
inducible	B-DNA	ADJ	B
genes	I-DNA	NOUN	I
.	O	PUNCT	O


Complementary	B-DNA	ADJ	B
DNA	I-DNA	NOUN	I
encoding	O	VERB	B
the	O	DET	O
human	B-protein	ADJ	B
T-cell	I-protein	NOUN	I
FK506-binding	I-protein	ADJ	I
protein	I-protein	NOUN	I
,	O	PUNCT	O
a	O	DET	O
peptidylprolyl	B-protein	ADJ	B
cis-trans	I-protein	ADJ	I
isomerase	I-protein	NOUN	I
distinct	O	ADJ	O
from	O	ADP	O
cyclophilin	B-protein	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
study	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
isolated	O	VERB	B
a	O	DET	O
cDNA	B-DNA	NOUN	B
coding	O	NOUN	O
for	O	ADP	O
FK506-binding	O	ADJ	B
protein	O	NOUN	I
(	O	PUNCT	O
FKBP	B-protein	NOUN	B
)	O	PUNCT	O
from	O	ADP	O
human	O	ADJ	B
peripheral	O	ADJ	B
blood	O	NOUN	I
T	B-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
by	O	ADP	O
using	O	VERB	O
mixed	O	ADJ	O
20-mer	O	ADJ	O
oligonucleotide	O	NOUN	B
probes	O	NOUN	I
synthesized	O	VERB	B
on	O	ADP	O
the	O	DET	O
basis	O	NOUN	O
of	O	ADP	O
the	O	DET	O
sequence	O	NOUN	B
,	O	PUNCT	O
Glu-Asp-Gly-Lys-Lys-Phe-Asp	O	NOUN	B
,	O	PUNCT	O
reported	O	VERB	O
for	O	ADP	O
bovine	B-protein	ADJ	B
FKBP	I-protein	NOUN	B
.	O	PUNCT	O


Computer-assisted	O	ADJ	B
analysis	O	NOUN	I
of	O	ADP	O
the	O	DET	O
deduced	O	VERB	B
amino	O	NOUN	B
acid	O	NOUN	I
sequence	O	NOUN	I
indicates	O	VERB	O
that	O	SCONJ	O
FKBP	B-protein	NOUN	B
exhibits	O	VERB	O
no	O	DET	O
internal	O	ADJ	O
homology	O	NOUN	O
and	O	CCONJ	O
does	O	AUX	O
not	O	PART	O
have	O	AUX	O
significant	O	ADJ	B
sequence	O	NOUN	B
similarity	O	NOUN	O
to	O	PART	O
any	O	DET	O
other	O	ADJ	O
amino	O	NOUN	B
acid	O	NOUN	I
sequences	O	NOUN	I
of	O	ADP	O
known	O	ADJ	O
proteins	O	NOUN	B
,	O	PUNCT	O
including	O	VERB	O
cyclophilin	B-protein	NOUN	B
.	O	PUNCT	O


Involvement	O	NOUN	B
of	O	ADP	O
a	O	DET	O
second	O	ADJ	O
lymphoid-specific	B-DNA	ADJ	B
enhancer	I-DNA	NOUN	I
element	I-DNA	NOUN	O
in	O	ADP	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
immunoglobulin	B-DNA	NOUN	B
heavy-chain	I-DNA	ADJ	I
gene	I-DNA	NOUN	I
expression	O	NOUN	O
.	O	PUNCT	O


This	O	DET	O
effect	O	NOUN	B
was	O	AUX	O
comparable	O	ADJ	O
to	O	PART	O
or	O	CCONJ	O
even	O	ADV	O
stronger	O	ADJ	O
than	O	ADP	O
the	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
a	O	DET	O
mutation	O	NOUN	B
in	O	ADP	O
the	O	DET	O
OCTA	B-DNA	NOUN	B
site	I-DNA	NOUN	B
.	O	PUNCT	O


Nevertheless	O	ADV	O
,	O	PUNCT	O
a	O	DET	O
multimer	O	NOUN	B
of	O	ADP	O
the	O	DET	O
microB	B-DNA	NOUN	B
motif	I-DNA	NOUN	I
alone	O	ADV	O
showed	O	VERB	O
no	O	DET	O
enhancer	O	NOUN	B
activity	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
transactivator	B-DNA	NOUN	B
(	I-DNA	PUNCT	O
IE-2	I-DNA	NOUN	O
)	I-DNA	PUNCT	O
gene	I-DNA	NOUN	O
of	O	ADP	O
the	O	DET	O
human	O	ADJ	B
cytomegalovirus	O	NOUN	I
(	O	PUNCT	O
CMV	O	NOUN	B
)	O	PUNCT	O
can	O	AUX	O
enhance	O	VERB	O
HIV-2	O	NOUN	B
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
HIV-1	O	NOUN	B
gene	O	NOUN	O
expression	O	NOUN	B
in	O	X	B
vitro	O	X	I
.	O	PUNCT	O


Both	O	CCONJ	O
HIV-2	O	NOUN	B
and	O	CCONJ	O
CMV	B-DNA	NOUN	B
transactivators	I-DNA	NOUN	O
enhance	O	VERB	O
HIV-2	O	NOUN	B
gene	O	NOUN	B
expression	O	NOUN	I
by	O	ADP	O
transcriptional	O	ADJ	B
activation	O	NOUN	I
involving	O	VERB	O
transcript	O	NOUN	B
initiation	O	NOUN	B
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
elongation	O	NOUN	B
,	O	PUNCT	O
with	O	ADP	O
CMV	B-DNA	NOUN	B
transactivator	I-DNA	NOUN	I
affecting	O	VERB	O
elongation	O	NOUN	B
more	O	ADJ	O
than	O	ADP	O
the	O	DET	O
initiation	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
parameters	O	NOUN	B
were	O	AUX	O
correlated	O	VERB	B
with	O	ADP	O
nuclear	O	ADJ	B
grade	O	NOUN	I
and	O	CCONJ	O
biochemically	O	ADV	B
determined	O	VERB	O
hormone	O	NOUN	B
receptor	O	NOUN	I
status	O	NOUN	O
,	O	PUNCT	O
known	O	ADJ	O
markers	O	NOUN	B
of	O	ADP	O
tumour	O	NOUN	B
differentiation	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
diameter	O	NOUN	B
of	O	ADP	O
the	O	DET	O
PCVs	O	NOUN	B
also	O	ADV	O
increased	O	VERB	B
with	O	ADP	O
increasing	O	VERB	O
inflammatory	O	ADJ	B
infiltrate	O	NOUN	I
(	O	PUNCT	O
P	O	NOUN	O
less	O	ADJ	O
than	O	ADP	O
0.02	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Reactivity	O	NOUN	B
of	O	ADP	O
lymphocytes	B-cell_line	NOUN	B
to	O	PART	O
a	O	DET	O
progesterone	B-protein	NOUN	B
receptor-specific	I-protein	ADJ	O
monoclonal	I-protein	ADJ	O
antibody	I-protein	NOUN	O
.	O	PUNCT	O


Using	O	VERB	O
an	O	DET	O
avidin	B-protein	NOUN	B
-biotin	B-protein	NOUN	O
peroxidase	I-protein	NOUN	B
detection	O	NOUN	I
system	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
found	O	VERB	O
a	O	DET	O
nuclear	O	ADJ	B
staining	O	NOUN	I
in	O	ADP	O
14.6	O	NUM	O
+/-	O	CCONJ	O
3.7	O	NUM	O
%	O	NOUN	O
(	O	PUNCT	O
mean	O	NOUN	O
+/-	O	CCONJ	O
SEM	O	NOUN	B
,	O	PUNCT	O
N	O	NOUN	O
=	O	ADJ	O
27	O	NUM	O
)	O	PUNCT	O
of	O	ADP	O
pregnancy	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
,	O	PUNCT	O
while	O	SCONJ	O
only	O	ADV	O
0.47	O	NUM	O
+/-	O	CCONJ	O
0.33	O	NUM	O
%	O	NOUN	O
(	O	PUNCT	O
mean	O	NOUN	O
+/-	O	CCONJ	O
SEM	O	NOUN	B
,	O	PUNCT	O
N	O	NOUN	O
=	O	ADJ	O
15	O	NUM	O
)	O	PUNCT	O
of	O	ADP	O
nonpregnancy	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	B
reacted	O	VERB	O
with	O	ADP	O
the	O	DET	O
antibody	O	NOUN	B
.	O	PUNCT	O


To	O	PART	O
characterize	O	VERB	O
the	O	DET	O
receptor-bearing	O	ADJ	B
subset	O	NOUN	I
,	O	PUNCT	O
CD8+	B-cell_line	ADJ	B
and	I-cell_line	CCONJ	O
CD4+	I-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
were	O	AUX	O
depleted	O	VERB	B
by	O	ADP	O
complement-dependent	O	ADJ	B
lysis	O	NOUN	I
.	O	PUNCT	O


Fibronectin	B-protein	NOUN	B
synergized	O	VERB	B
with	O	ADP	O
anti-CD3	B-protein	ADJ	B
antibody	I-protein	NOUN	I
to	O	PART	O
promote	O	VERB	B
CD4	B-protein	NOUN	B
cell	O	NOUN	I
proliferation	O	NOUN	O
in	O	ADP	O
a	O	DET	O
serum-free	O	ADJ	B
culture	O	NOUN	I
system	O	NOUN	I
whereas	O	SCONJ	O
no	O	DET	O
proliferation	O	NOUN	B
was	O	AUX	O
observed	O	VERB	O
when	O	SCONJ	O
CD4	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
were	O	AUX	O
cultured	O	VERB	B
with	O	ADP	O
anti-CD3	B-protein	NOUN	B
alone	O	ADV	O
or	O	CCONJ	O
fibronectin	B-protein	NOUN	B
alone	O	ADV	O
.	O	PUNCT	O


In	O	ADP	O
an	O	DET	O
analysis	O	NOUN	B
of	O	ADP	O
the	O	DET	O
molecular	O	ADJ	B
mechanism	O	NOUN	I
by	O	ADP	O
which	O	DET	O
IL-2	B-protein	NOUN	B
message	O	NOUN	B
was	O	AUX	O
generated	O	VERB	O
,	O	PUNCT	O
we	O	PRON	O
showed	O	VERB	O
that	O	SCONJ	O
a	O	DET	O
fibronectin	B-protein	NOUN	B
-VLA-5	O	NOUN	O
fibronectin	B-protein	NOUN	B
receptor	I-protein	NOUN	I
interaction	O	NOUN	B
may	O	AUX	O
contribute	O	VERB	O
an	O	DET	O
independent	O	ADJ	B
signal	O	NOUN	B
distinct	O	ADJ	O
from	O	ADP	O
the	O	DET	O
CD3	B-protein	NOUN	B
pathway	O	NOUN	I
of	O	ADP	O
activation	O	NOUN	B
by	O	ADP	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
an	O	DET	O
AP-1	B-protein	NOUN	B
transcriptional	I-protein	ADJ	I
factor	I-protein	NOUN	I
.	O	PUNCT	O


No	O	DET	O
correlations	O	NOUN	B
were	O	AUX	O
found	O	VERB	O
between	O	ADP	O
all	O	DET	O
or	O	CCONJ	O
high	O	ADJ	O
levels	O	NOUN	B
of	O	ADP	O
amplification	O	NOUN	B
of	O	ADP	O
each	O	DET	O
oncogene	O	NOUN	B
separately	O	ADV	B
or	O	CCONJ	O
combined	O	VERB	O
with	O	ADP	O
T	O	NOUN	B
,	O	PUNCT	O
N	O	NOUN	B
,	O	PUNCT	O
grade	O	NOUN	B
,	O	PUNCT	O
multifocality	O	NOUN	B
of	O	ADP	O
tumor	O	NOUN	B
,	O	PUNCT	O
or	O	CCONJ	O
associated	O	VERB	O
carcinoma	O	NOUN	O
in	O	X	B
situ	O	X	I
.	O	PUNCT	O


We	O	PRON	O
propose	O	VERB	O
that	O	SCONJ	O
malignant	O	ADJ	B
cell	O	NOUN	I
cytokine	B-protein	NOUN	B
production	O	NOUN	I
may	O	AUX	O
help	O	VERB	O
explain	O	VERB	O
this	O	DET	O
observation	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
cells	O	NOUN	B
lines	O	NOUN	I
described	O	VERB	O
here	O	ADV	O
should	O	AUX	O
be	O	AUX	O
useful	O	ADJ	O
for	O	ADP	O
the	O	DET	O
delineation	O	NOUN	B
of	O	ADP	O
signaling	O	NOUN	B
pathways	O	NOUN	I
utilized	O	VERB	O
in	O	ADP	O
the	O	DET	O
selective	O	ADJ	O
regulation	O	NOUN	B
of	O	ADP	O
gene	O	NOUN	B
expression	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
sexual	O	ADJ	B
difference	O	NOUN	I
in	O	ADP	O
the	O	DET	O
incidence	O	NOUN	B
of	O	ADP	O
autoimmune	O	ADJ	B
diseases	O	NOUN	I
has	O	AUX	O
remained	O	VERB	O
an	O	DET	O
enigma	O	NOUN	O
for	O	ADP	O
many	O	ADJ	O
years	O	NOUN	B
.	O	PUNCT	O


Sex	O	NOUN	B
steroid	O	NOUN	B
regulation	O	NOUN	O
of	O	ADP	O
the	O	DET	O
production	O	NOUN	B
of	O	ADP	O
this	O	DET	O
molecule	O	NOUN	B
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
other	O	ADJ	O
cytokines	B-protein	NOUN	B
,	O	PUNCT	O
may	O	AUX	O
help	O	VERB	O
explain	O	VERB	O
the	O	DET	O
gender-specific	O	ADJ	O
differences	O	NOUN	O
in	O	ADP	O
the	O	DET	O
immune	O	ADJ	B
system	O	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
autoimmunity	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
novel	O	ADJ	B
T-cell	B-protein	NOUN	B
trans-activator	I-protein	NOUN	I
that	O	PRON	O
recognizes	O	VERB	O
a	O	DET	O
phorbol	B-DNA	NOUN	B
ester-inducible	I-DNA	ADJ	I
element	I-DNA	NOUN	O
of	O	ADP	O
the	O	DET	O
interleukin-2	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
.	O	PUNCT	O


These	O	DET	O
risk	O	NOUN	B
factors	O	NOUN	I
were	O	AUX	O
highly	O	ADV	O
age	O	NOUN	B
dependent	O	ADJ	O
,	O	PUNCT	O
with	O	ADP	O
EIC	O	NOUN	B
markedly	O	ADV	O
more	O	ADV	O
prevalent	O	ADJ	O
in	O	ADP	O
women	O	NOUN	B
younger	O	ADJ	B
than	O	ADP	O
50	O	NUM	O
,	O	PUNCT	O
MCR	O	NOUN	B
and	O	CCONJ	O
G	O	NOUN	B
in	O	ADP	O
women	O	NOUN	B
younger	O	ADJ	B
than	O	ADP	O
40	O	NUM	O
.	O	PUNCT	O


The	O	DET	O
human	B-DNA	ADJ	B
T-cell	I-DNA	NOUN	I
leukemia	I-DNA	NOUN	I
virus	I-DNA	NOUN	O
type	I-DNA	NOUN	O
I	I-DNA	NUM	O
(	I-DNA	PUNCT	O
HTLV-I	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
promoter	I-DNA	NOUN	B
contains	O	VERB	O
three	O	NUM	O
copies	O	NOUN	B
of	O	ADP	O
imperfect	O	ADJ	B
repeats	O	NOUN	B
of	O	ADP	O
a	O	DET	O
21-base	O	ADJ	B
pair	O	NOUN	I
sequence	O	NOUN	I
designated	O	VERB	O
here	O	ADV	O
as	O	ADP	O
TRE	B-DNA	NOUN	B
(	O	PUNCT	O
Tax-response	B-DNA	ADJ	B
element	I-DNA	NOUN	I
)	O	PUNCT	O
that	O	PRON	O
is	O	AUX	O
responsive	O	ADJ	B
to	O	PART	O
the	O	DET	O
virally	B-protein	ADV	B
encoded	I-protein	VERB	O
transactivator	I-protein	NOUN	B
protein	I-protein	NOUN	I
Tax	B-protein	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
identified	O	VERB	B
and	O	CCONJ	O
separated	O	VERB	O
four	O	NUM	O
nuclear	B-protein	ADJ	B
proteins	I-protein	NOUN	I
from	O	ADP	O
C81-66-45	O	NOUN	B
cells	O	NOUN	I
,	O	PUNCT	O
an	O	DET	O
HTLV-I	B-cell_line	NOUN	B
immortalized	I-cell_line	ADJ	B
Tax-expressing	I-cell_line	ADJ	B
human	I-cell_line	ADJ	B
T-lymphocyte	I-cell_line	NOUN	O
line	I-cell_line	NOUN	O
(	O	PUNCT	O
Salahuddin	O	PROPN	O
et	O	X	O
al.	O	X	O
,	O	PUNCT	O
1983	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
that	O	PRON	O
interact	O	VERB	B
with	O	ADP	O
the	O	DET	O
TRE-DNA	B-DNA	NOUN	B
,	O	PUNCT	O
none	O	NOUN	O
of	O	ADP	O
which	O	DET	O
are	O	AUX	O
identical	O	ADJ	B
with	O	ADP	O
the	O	DET	O
Tax-protein	B-protein	NOUN	B
.	O	PUNCT	O


Two	O	NUM	O
complementary	B-DNA	ADJ	O
DNAs	I-DNA	NOUN	B
were	O	AUX	O
isolated	O	VERB	B
that	O	PRON	O
encode	O	VERB	B
proteins	O	NOUN	B
,	O	PUNCT	O
denoted	O	VERB	O
ITF-1	B-protein	NOUN	B
and	O	CCONJ	O
ITF-2	B-protein	NOUN	B
,	O	PUNCT	O
that	O	PRON	O
are	O	AUX	O
expressed	O	VERB	B
in	O	ADP	O
a	O	DET	O
variety	O	NOUN	O
of	O	ADP	O
cell	O	NOUN	B
types	O	NOUN	I
and	O	CCONJ	O
bind	O	VERB	B
the	O	DET	O
microE5/kappa	B-DNA	NOUN	B
2	I-DNA	NUM	O
motif	I-DNA	NOUN	B
found	O	VERB	O
in	O	ADP	O
both	O	CCONJ	O
heavy	B-DNA	ADJ	B
and	I-DNA	CCONJ	I
kappa	I-DNA	NOUN	I
light	I-DNA	ADJ	I
chain	I-DNA	NOUN	I
enhancers	I-DNA	NOUN	I
.	O	PUNCT	O


The	O	DET	O
actions	O	NOUN	B
of	O	ADP	O
cyclosporin	O	NOUN	B
A	O	NOUN	I
and	O	CCONJ	O
FK506	O	NOUN	B
suggest	O	VERB	O
a	O	DET	O
novel	O	ADJ	O
step	O	NOUN	O
in	O	ADP	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
T	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
.	O	PUNCT	O


The	O	DET	O
internal	O	ADJ	B
methionine	O	NOUN	I
codons	O	NOUN	I
of	O	ADP	O
human	B-DNA	ADJ	B
T-cell	I-DNA	NOUN	O
leukemia	I-DNA	NOUN	O
virus	I-DNA	NOUN	O
type	I-DNA	NOUN	O
II	I-DNA	NUM	O
rex	I-DNA	NOUN	O
gene	I-DNA	NOUN	O
are	O	AUX	O
not	O	PART	O
required	O	VERB	O
for	O	ADP	O
p24rex	B-protein	NOUN	B
production	O	NOUN	B
or	O	CCONJ	O
virus	O	NOUN	B
replication	O	NOUN	B
and	O	CCONJ	O
transformation	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
proteins	O	NOUN	B
are	O	AUX	O
differentially	O	ADV	O
expressed	O	VERB	B
in	O	ADP	O
human	B-cell_line	ADJ	B
glioblastoma	I-cell_line	NOUN	B
and	I-cell_line	CCONJ	O
neuroblastoma	I-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
.	O	PUNCT	O


Rex	B-protein	NOUN	B
is	O	AUX	O
a	O	DET	O
phosphoprotein	B-protein	NOUN	B
found	O	VERB	O
in	O	ADP	O
the	O	DET	O
cell	O	NOUN	B
nucleolus	O	NOUN	I
,	O	PUNCT	O
whose	O	DET	O
function	O	NOUN	B
may	O	AUX	O
be	O	AUX	O
regulated	O	VERB	O
by	O	ADP	O
its	O	PRON	O
localization	O	NOUN	B
and	O	CCONJ	O
phosphorylation	O	NOUN	B
.	O	PUNCT	O


Cell	O	NOUN	B
proliferation	O	NOUN	I
of	O	ADP	O
CEM-C7	B-cell_line	NOUN	B
cells	O	NOUN	I
cultured	O	VERB	B
in	O	ADP	O
both	O	CCONJ	O
serum-free	O	ADJ	B
media	O	NOUN	I
has	O	AUX	O
been	O	AUX	O
sustained	O	ADJ	B
for	O	ADP	O
3	O	NUM	O
mo	O	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
work	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
mixed	B-cell_type	ADJ	O
leucocytes	I-cell_type	NOUN	B
were	O	AUX	O
further	O	ADV	O
separated	O	VERB	O
into	O	ADP	O
mononuclear	B-cell_type	ADJ	B
(	I-cell_type	PUNCT	O
MNL	I-cell_type	NOUN	B
)	I-cell_type	PUNCT	O
and	I-cell_type	CCONJ	O
polymorphonuclear	I-cell_type	ADJ	B
(	I-cell_type	PUNCT	O
PML	I-cell_type	NOUN	B
)	I-cell_type	PUNCT	O
leucocytes	I-cell_type	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
GCR	B-protein	NOUN	B
were	O	AUX	O
determined	O	VERB	O
in	O	ADP	O
each	O	DET	O
part	O	NOUN	O
of	O	ADP	O
leucocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


GCR	B-protein	NOUN	B
on	O	ADP	O
MNL	B-cell_type	NOUN	B
,	O	PUNCT	O
PML	B-cell_type	NOUN	B
and	O	CCONJ	O
mixed	B-cell_type	ADJ	O
leucocytes	I-cell_type	NOUN	B
in	O	ADP	O
5	O	NUM	O
patients	O	NOUN	B
were	O	AUX	O
determined	O	VERB	O
simultaneously	O	ADV	B
,	O	PUNCT	O
and	O	CCONJ	O
all	O	DET	O
lowered	O	VERB	B
from	O	ADP	O
the	O	DET	O
control	O	NOUN	B
group	O	NOUN	I
.	O	PUNCT	O


All	O	DET	O
immunoglobulin	B-DNA	NOUN	B
genes	I-DNA	NOUN	I
contain	O	VERB	O
a	O	DET	O
conserved	O	VERB	O
octanucleotide	B-DNA	NOUN	B
promoter	I-DNA	NOUN	O
element	I-DNA	NOUN	O
,	O	PUNCT	O
ATGCAAAT	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
has	O	AUX	O
been	O	AUX	O
shown	O	VERB	O
to	O	PART	O
be	O	AUX	O
required	O	VERB	O
for	O	ADP	O
their	O	PRON	O
normal	O	ADJ	O
B-cell-specific	O	ADJ	B
transcription	O	NOUN	I
.	O	PUNCT	O


Some	O	DET	O
of	O	ADP	O
these	O	DET	O
proteins	O	NOUN	B
(	O	PUNCT	O
referred	O	VERB	O
to	O	PART	O
as	O	ADP	O
OTF-2	B-protein	NOUN	B
)	O	PUNCT	O
are	O	AUX	O
lymphoid	O	ADJ	B
specific	O	ADJ	B
,	O	PUNCT	O
whereas	O	SCONJ	O
at	O	ADP	O
least	O	ADJ	O
one	O	NUM	O
other	O	ADJ	O
,	O	PUNCT	O
and	O	CCONJ	O
possibly	O	ADV	O
more	O	ADJ	O
(	O	PUNCT	O
referred	O	VERB	O
to	O	PART	O
as	O	ADP	O
OTF-1	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
is	O	AUX	O
found	O	VERB	O
ubiquitously	O	ADV	B
in	O	ADP	O
all	O	DET	O
cell	O	NOUN	B
types	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
OTF-1	B-protein	NOUN	B
,	O	PUNCT	O
without	O	ADP	O
OTF-2	B-protein	NOUN	B
,	O	PUNCT	O
is	O	AUX	O
sufficient	O	ADJ	O
for	O	ADP	O
transcription	O	NOUN	B
of	O	ADP	O
immunoglobulin	B-DNA	NOUN	B
genes	I-DNA	NOUN	I
and	O	CCONJ	O
that	O	SCONJ	O
OTF-2	B-protein	NOUN	B
alone	O	ADV	O
is	O	AUX	O
not	O	PART	O
responsible	O	ADJ	O
for	O	ADP	O
the	O	DET	O
B-cell-specific	O	ADJ	B
regulation	O	NOUN	I
of	O	ADP	O
immunoglobulin	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
expression	O	NOUN	B
.	O	PUNCT	O


Effects	O	NOUN	B
of	O	ADP	I
aldosterone	O	NOUN	B
on	O	ADP	O
intralymphocytic	O	ADJ	B
sodium	O	NOUN	O
and	O	CCONJ	O
potassium	O	NOUN	B
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
essential	O	ADJ	B
hypertension	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
decrease	O	NOUN	B
of	O	ADP	O
intracellular	O	ADJ	B
sodium	O	NOUN	B
or	O	CCONJ	O
potassium	O	NOUN	B
occurred	O	VERB	O
during	O	ADP	O
incubation	O	NOUN	B
without	O	ADP	O
aldosterone	O	NOUN	B
(	O	PUNCT	O
P	O	NOUN	O
less	O	ADJ	O
than	O	ADP	O
0.02	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Octamer-dependent	O	ADJ	B
activation	O	NOUN	B
of	O	ADP	O
a	O	DET	O
reporter	B-DNA	NOUN	B
plasmid	I-DNA	NOUN	I
or	O	CCONJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
-dependent	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
immunodeficiency	I-DNA	NOUN	I
virus	I-DNA	NOUN	I
(	I-DNA	PUNCT	O
HIV	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
enhancer	I-DNA	NOUN	O
was	O	AUX	O
inhibited	O	VERB	B
when	O	SCONJ	O
the	O	DET	O
appropriate	O	ADJ	O
phosphorothioate	O	NOUN	B
oligonucleotide	O	NOUN	I
was	O	AUX	O
added	O	VERB	O
to	O	PART	O
a	O	DET	O
transiently	B-cell_line	ADV	O
transfected	I-cell_line	VERB	B
B	I-cell_line	NOUN	O
cell	I-cell_line	NOUN	O
line	I-cell_line	NOUN	O
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
action	O	NOUN	B
of	O	ADP	O
IFN-alpha	B-protein	NOUN	B
in	O	ADP	O
CML	O	NOUN	B
may	O	AUX	O
be	O	AUX	O
linked	O	VERB	O
to	O	PART	O
a	O	DET	O
pathway	O	NOUN	B
that	O	PRON	O
can	O	AUX	O
result	O	VERB	O
in	O	ADP	O
posttranslational	O	ADJ	B
modification	O	NOUN	I
of	O	ADP	O
nuclear	B-protein	ADJ	B
proteins	I-protein	NOUN	I
.	O	PUNCT	O


Secondarily	O	ADV	B
,	O	PUNCT	O
heat	O	NOUN	B
shock	O	NOUN	I
of	O	ADP	O
Hyon	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
stabilized	O	VERB	B
the	O	DET	O
c-myc	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
level	O	NOUN	B
by	O	ADP	O
increasing	O	VERB	B
its	O	PRON	O
half-life	O	NOUN	B
from	O	ADP	O
24	O	NUM	O
to	O	PART	O
45	O	NUM	O
min	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
immune	O	ADJ	B
response	O	NOUN	I
to	O	PART	O
the	O	DET	O
X	B-protein	NOUN	B
protein	I-protein	NOUN	I
of	O	ADP	O
human	O	ADJ	B
hepatitis	O	NOUN	O
B	O	NOUN	O
virus	O	NOUN	O
(	O	PUNCT	O
HBV	O	NOUN	B
)	O	PUNCT	O
was	O	AUX	O
studied	O	VERB	O
by	O	ADP	O
epitope	O	NOUN	B
mapping	O	NOUN	I
by	O	ADP	O
using	O	VERB	O
a	O	DET	O
set	O	NOUN	O
of	O	ADP	O
MS2-HBx	B-protein	NOUN	B
fusion	I-protein	NOUN	B
proteins	I-protein	NOUN	I
and	O	CCONJ	O
synthetic	O	ADJ	B
peptides	O	NOUN	I
.	O	PUNCT	O


Antibodies	O	NOUN	B
in	O	ADP	O
sera	O	NOUN	B
of	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
acute	O	ADJ	B
and	O	CCONJ	O
chronic	O	ADJ	B
HBV	O	NOUN	O
infection	O	NOUN	O
showed	O	VERB	O
a	O	DET	O
multispecific	O	ADJ	B
immune	O	ADJ	I
response	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
carboxy-terminal	B-protein	ADJ	B
half	I-protein	NOUN	I
of	O	ADP	O
the	O	DET	O
HBx	B-protein	NOUN	B
protein	I-protein	NOUN	I
was	O	AUX	O
preferentially	O	ADV	O
recognized	O	VERB	O
by	O	ADP	O
antibodies	B-protein	NOUN	B
from	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
chronic	O	ADJ	B
hepatitis	O	NOUN	I
and	O	CCONJ	O
contained	O	VERB	O
a	O	DET	O
short	O	ADJ	O
immunodominant	B-protein	ADJ	B
antigenic	I-protein	ADJ	O
region	I-protein	NOUN	O
with	O	ADP	O
at	O	ADP	O
least	O	ADJ	O
two	O	NUM	O
major	O	ADJ	O
nonoverlapping	B-protein	ADJ	O
epitopes	I-protein	NOUN	B
.	O	PUNCT	O


Heterogeneity	O	NOUN	B
of	O	ADP	O
antigen	B-protein	NOUN	B
molecules	I-protein	NOUN	I
recognized	O	VERB	O
by	O	ADP	O
anti-tax1	B-protein	ADJ	B
monoclonal	I-protein	ADJ	B
antibody	I-protein	NOUN	I
Lt-4	B-protein	NOUN	B
in	O	ADP	O
cell	O	NOUN	B
lines	O	NOUN	I
bearing	O	VERB	O
human	O	ADJ	B
T	O	NOUN	O
cell	O	NOUN	O
leukemia	O	NOUN	O
virus	O	NOUN	O
type	O	NOUN	O
I	O	NUM	O
and	O	CCONJ	O
related	O	ADJ	O
retroviruses	O	NOUN	B
.	O	PUNCT	O


Using	O	VERB	O
a	O	DET	O
monoclonal	B-protein	ADJ	B
antibody	I-protein	NOUN	I
,	O	PUNCT	O
Lt-4	B-protein	NOUN	B
,	O	PUNCT	O
directed	O	VERB	O
against	O	ADP	O
human	B-protein	ADJ	B
T	I-protein	NOUN	B
cell	I-protein	NOUN	I
leukemia	I-protein	NOUN	I
virus	I-protein	NOUN	O
type	I-protein	NOUN	O
I	I-protein	NUM	O
(	I-protein	PUNCT	O
HTLV-I	I-protein	NOUN	O
)	I-protein	PUNCT	O
trans-activator	I-protein	NOUN	O
(	I-protein	PUNCT	O
tax1	I-protein	NOUN	O
)	I-protein	PUNCT	O
antigen	I-protein	NOUN	O
,	O	PUNCT	O
we	O	PRON	O
examined	O	VERB	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
tax1	B-protein	NOUN	B
and	O	CCONJ	O
related	O	ADJ	O
antigens	B-protein	NOUN	B
in	O	ADP	O
a	O	DET	O
variety	O	NOUN	O
of	O	ADP	O
T	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
bearing	O	VERB	O
HTLV-I	O	NOUN	B
and	O	CCONJ	O
related	O	ADJ	O
retroviruses	O	NOUN	B
,	O	PUNCT	O
simian	O	ADJ	B
T	O	NOUN	I
cell	O	NOUN	I
leukemia	O	NOUN	I
virus	O	NOUN	O
type	O	NOUN	O
I	O	NUM	O
(	O	PUNCT	O
STLV-I	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
HTLV-II	O	NOUN	B
,	O	PUNCT	O
by	O	ADP	O
immunofluorescence	O	NOUN	B
and	O	CCONJ	O
immunoblot	O	NOUN	B
assays	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
STLV-I-bearing	B-cell_line	ADJ	B
T	I-cell_line	NOUN	I
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
,	O	PUNCT	O
tax1-related	B-protein	ADJ	B
antigen	I-protein	NOUN	I
molecules	I-protein	NOUN	I
detected	O	VERB	B
by	O	ADP	O
Lt-4	B-protein	NOUN	B
were	O	AUX	O
heterogeneous	O	ADJ	B
,	O	PUNCT	O
having	O	VERB	O
molecular	O	ADJ	B
weights	O	NOUN	I
in	O	ADP	O
the	O	DET	O
range	O	NOUN	B
of	O	ADP	O
36-41	O	NUM	O
kd	O	NOUN	O
.	O	PUNCT	O


Both	O	CCONJ	O
C1	B-protein	NOUN	B
and	O	CCONJ	O
C2	B-protein	NOUN	B
proteins	I-protein	NOUN	I
also	O	ADV	O
bind	O	VERB	B
to	O	PART	O
a	O	DET	O
similar	O	ADJ	O
sequence	O	NOUN	B
found	O	VERB	O
in	O	ADP	O
the	O	DET	O
interleukin-2-receptor	B-DNA	NOUN	B
alpha-subunit	I-DNA	NOUN	I
enhancer	I-DNA	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
conclusion	O	NOUN	O
,	O	PUNCT	O
HIV-1	O	NOUN	B
and	O	CCONJ	O
HIV-2	O	NOUN	B
are	O	AUX	O
differentially	O	ADV	O
regulated	O	VERB	O
by	O	ADP	O
T	O	NOUN	B
cell	O	NOUN	I
activation	O	NOUN	B
signals	O	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
this	O	DET	O
difference	O	NOUN	O
may	O	AUX	O
account	O	VERB	O
for	O	ADP	O
the	O	DET	O
longer	O	ADJ	O
period	O	NOUN	B
of	O	ADP	O
viral	O	ADJ	B
latency	O	NOUN	I
observed	O	VERB	O
with	O	ADP	O
HIV-2	O	NOUN	B
than	O	ADP	O
with	O	ADP	O
HIV-1	O	NOUN	B
infection	O	NOUN	O
.	O	PUNCT	O


Several	O	ADJ	O
new	O	ADJ	O
4	O	NUM	O
,	O	PUNCT	O
19-substituted	O	ADJ	B
steroids	O	NOUN	I
and	O	CCONJ	O
previously	O	ADV	O
synthesized	O	VERB	B
corticosteroids	O	NOUN	B
were	O	AUX	O
assayed	O	VERB	B
for	O	ADP	O
affinity	O	NOUN	B
to	O	PART	O
type	B-protein	NOUN	B
1	I-protein	NUM	I
receptors	I-protein	NOUN	I
in	O	ADP	O
human	B-cell_type	ADJ	B
mononuclear	I-cell_type	ADJ	B
leukocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


11	O	NUM	O
beta	O	NOUN	B
,	O	PUNCT	O
19-epoxy-4	O	NOUN	O
,	O	PUNCT	O
21-dihydroxypregn-4-ene-3	O	NUM	O
,	O	PUNCT	O
20-dione	O	NOUN	B
(	O	PUNCT	O
2	O	NUM	O
)	O	PUNCT	O
was	O	AUX	O
hydrogenated	O	VERB	B
with	O	ADP	O
Pd-C	O	NOUN	B
to	O	PART	O
yield	O	VERB	O
a	O	DET	O
mixture	O	NOUN	O
of	O	ADP	O
all	O	DET	O
four	O	NUM	O
dihydro	O	NOUN	B
derivatives	O	NOUN	I
5	O	NUM	I
,	O	PUNCT	O
accompanied	O	VERB	O
by	O	ADP	O
4	O	NUM	O
,	O	PUNCT	O
21-diacetoxy-11	O	NOUN	O
beta	O	NOUN	B
,	O	PUNCT	O
19-epoxy-3-hydroxypregnan-20-one	O	NUM	O
(	O	PUNCT	O
6	O	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
21-acetoxy-11	O	NOUN	O
beta	O	NOUN	B
,	O	PUNCT	O
19-epoxy-4-hydroxypregnane-3	O	NOUN	O
,	O	PUNCT	O
20-dione	O	NOUN	B
(	O	PUNCT	O
7	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


This	O	DET	O
report	O	NOUN	B
represents	O	VERB	O
the	O	DET	O
first	O	ADJ	O
demonstration	O	NOUN	B
that	O	SCONJ	O
a	O	DET	O
multimerized	O	ADJ	B
short	O	ADJ	B
binding	O	NOUN	I
motif	O	NOUN	I
can	O	AUX	O
function	O	VERB	B
appropriately	O	ADV	O
in	O	ADP	O
transgenic	O	ADJ	B
mice	O	NOUN	I
.	O	PUNCT	O


NFAT-1	B-protein	NOUN	B
activity	O	NOUN	B
had	O	AUX	O
previously	O	ADV	O
been	O	AUX	O
thought	O	VERB	O
to	O	PART	O
be	O	AUX	O
confined	O	VERB	O
to	O	PART	O
activated	B-cell_type	VERB	B
T-lymphocytes	I-cell_type	NOUN	B
upon	O	SCONJ	O
release	O	NOUN	O
of	O	ADP	O
intracellular	B-cell_type	ADJ	B
calcium	I-cell_type	NOUN	B
.	O	PUNCT	O


By	O	ADP	O
targeting	O	VERB	B
NFAT-1	B-protein	NOUN	B
-dependent	O	ADJ	O
gene	O	NOUN	B
expression	O	NOUN	I
in	O	ADP	O
transgenic	O	ADJ	B
mice	O	NOUN	I
we	O	PRON	O
discovered	O	VERB	O
new	O	ADJ	O
sites	O	NOUN	B
of	O	ADP	O
NFAT-1	B-protein	NOUN	B
activity	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
novel	O	ADJ	B
T-cell	B-protein	NOUN	B
protein	I-protein	NOUN	I
which	O	DET	O
recognizes	O	VERB	O
a	O	DET	O
palindromic	B-DNA	ADJ	B
sequence	I-DNA	NOUN	I
in	O	ADP	O
the	O	DET	O
negative	B-DNA	ADJ	B
regulatory	I-DNA	ADJ	B
element	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
immunodeficiency	I-DNA	NOUN	I
virus	I-DNA	NOUN	I
long	I-DNA	ADJ	B
terminal	I-DNA	ADJ	I
repeat	I-DNA	NOUN	I
.	O	PUNCT	O


This	O	DET	O
study	O	NOUN	B
investigated	O	VERB	B
whether	O	SCONJ	O
the	O	DET	O
suppressive	O	ADJ	B
effect	O	NOUN	O
of	O	ADP	O
progesterone	O	NOUN	B
on	O	ADP	O
pregnancy	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
is	O	AUX	O
mediated	O	VERB	O
by	O	ADP	O
specific	O	ADJ	O
progesterone	B-protein	NOUN	B
receptors	I-protein	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
a	O	DET	O
study	O	NOUN	B
of	O	ADP	O
cellular	B-protein	ADJ	B
proteins	I-protein	NOUN	I
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
transcriptional	O	ADJ	B
regulation	O	NOUN	I
of	O	ADP	O
murine	O	ADJ	B
retroviruses	O	NOUN	B
in	O	ADP	O
T	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
discovered	O	VERB	O
that	O	SCONJ	O
a	O	DET	O
member	O	NOUN	B
of	O	ADP	O
the	O	DET	O
ets	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
family	I-DNA	NOUN	O
encodes	O	VERB	O
a	O	DET	O
sequence-specific	B-protein	ADJ	B
DNA-binding	I-protein	ADJ	I
protein	I-protein	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
study	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
fluctuations	O	NOUN	B
of	O	ADP	O
type	B-protein	NOUN	B
II	I-protein	NUM	I
EBS	I-protein	NOUN	I
during	O	ADP	O
the	O	DET	O
menstrual	O	ADJ	B
cycle	O	NOUN	I
were	O	AUX	O
analyzed	O	VERB	B
in	O	ADP	O
6	O	NUM	O
normally	O	ADV	O
menstruating	O	VERB	B
women	O	NOUN	B
.	O	PUNCT	O


Ras-related	B-protein	ADJ	B
GTP-binding	I-protein	ADJ	B
proteins	I-protein	NOUN	I
and	O	CCONJ	O
leukocyte	B-cell_type	NOUN	B
signal	O	NOUN	I
transduction	O	NOUN	I
.	O	PUNCT	O


B-cell-specific	B-protein	ADJ	B
activator	I-protein	NOUN	I
protein	I-protein	NOUN	I
(	O	PUNCT	O
BSAP	B-protein	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
recently	O	ADV	O
identified	O	VERB	O
member	O	NOUN	O
of	O	ADP	O
the	O	DET	O
Pax-gene	B-DNA	NOUN	B
family	I-DNA	NOUN	I
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
;	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
lymphoid	O	ADJ	B
system	O	NOUN	I
,	O	PUNCT	O
BSAP	B-protein	NOUN	B
is	O	AUX	O
produced	O	VERB	O
only	O	ADV	O
in	O	ADP	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


When	O	SCONJ	O
cells	O	NOUN	B
were	O	AUX	O
activated	O	VERB	B
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
1	O	NUM	O
,	O	PUNCT	O
25	O	NUM	O
(	O	PUNCT	O
OH	O	NOUN	B
)	O	PUNCT	O
2D3	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
levels	O	NOUN	B
of	O	ADP	O
the	O	DET	O
mature	O	ADJ	B
protein	O	NOUN	I
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
its	O	PRON	O
precursor	O	NOUN	B
were	O	AUX	O
decreased	O	VERB	B
.	O	PUNCT	O


MZF-1	B-DNA	NOUN	B
represses	O	VERB	B
CAT	B-DNA	NOUN	B
reporter	I-DNA	NOUN	I
gene	I-DNA	NOUN	B
expression	O	NOUN	I
via	O	ADP	O
GAL4	B-protein	NOUN	B
binding	O	NOUN	B
sites	O	NOUN	I
in	O	ADP	O
the	O	DET	O
nonhematopoietic	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
NIH	B-cell_line	NOUN	B
3T3	I-cell_line	NOUN	I
and	O	CCONJ	O
293	B-cell_line	NUM	O
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
MZF-1	B-DNA	NOUN	B
activates	O	VERB	B
CAT	B-DNA	NOUN	B
reporter	I-DNA	NOUN	I
gene	I-DNA	NOUN	B
expression	O	NOUN	I
in	O	ADP	O
the	O	DET	O
hematopoietic	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
K562	B-cell_line	NOUN	B
and	O	CCONJ	O
Jurkat	B-cell_line	NOUN	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
BCL6	B-protein	NOUN	B
plays	O	VERB	O
a	O	DET	O
role	O	NOUN	O
in	O	ADP	O
activated	B-cell_type	VERB	B
lymphocytes	I-cell_type	NOUN	B
as	O	ADP	O
an	O	DET	O
immediate	O	ADJ	O
early	O	ADJ	B
gene	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
DNA-binding	O	ADJ	B
properties	O	NOUN	B
of	O	ADP	O
two	B-protein	NUM	O
heat	I-protein	NOUN	B
shock	I-protein	NOUN	I
factors	I-protein	NOUN	I
,	O	PUNCT	O
HSF1	B-protein	NOUN	B
and	O	CCONJ	O
HSF3	B-protein	NOUN	B
,	O	PUNCT	O
are	O	AUX	O
induced	O	VERB	B
in	O	ADP	O
the	O	DET	O
avian	B-cell_line	ADJ	B
erythroblast	I-cell_line	NOUN	O
cell	I-cell_line	NOUN	O
line	I-cell_line	NOUN	O
HD6	B-cell_line	NOUN	B
.	O	PUNCT	O


As	O	ADP	O
occurs	O	VERB	O
for	O	ADP	O
HSF1	B-protein	NOUN	B
,	O	PUNCT	O
heat	O	NOUN	B
shock	O	NOUN	I
leads	O	VERB	O
to	O	PART	O
the	O	DET	O
translocation	O	NOUN	B
of	O	ADP	O
HSF3	B-protein	NOUN	B
to	O	PART	O
the	O	DET	O
nucleus	O	NOUN	B
.	O	PUNCT	O


Treatment	O	NOUN	B
of	O	ADP	O
the	O	DET	O
cells	O	NOUN	B
with	O	ADP	O
ionomycin	O	NOUN	B
resulted	O	VERB	O
in	O	ADP	O
a	O	DET	O
decrease	O	NOUN	B
in	O	ADP	O
the	O	DET	O
molecular	O	ADJ	B
weight	O	NOUN	I
of	O	ADP	O
NFATp	B-protein	NOUN	B
and	O	CCONJ	O
a	O	DET	O
loss	O	NOUN	B
of	O	ADP	O
32P	O	NOUN	B
,	O	PUNCT	O
consistent	O	ADJ	B
with	O	ADP	I
NFATp	B-protein	NOUN	B
dephosphorylation	O	NOUN	O
.	O	PUNCT	O


Activation	O	NOUN	B
and	O	CCONJ	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
nuclear	B-protein	ADJ	B
factors	I-protein	NOUN	I
of	O	ADP	O
activated	B-cell_type	VERB	B
T	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
,	O	PUNCT	O
NFATp	B-protein	NOUN	B
and	O	CCONJ	O
NFATc	B-protein	NOUN	B
,	O	PUNCT	O
in	O	ADP	O
human	B-cell_type	ADJ	B
natural	I-cell_type	ADJ	O
killer	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
:	O	PUNCT	O
regulation	O	NOUN	B
upon	O	SCONJ	O
CD16	B-protein	NOUN	B
ligand	O	NOUN	I
binding	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
putative	O	ADJ	B
factors	O	NOUN	I
that	O	PRON	O
couple	O	VERB	O
the	O	DET	O
signal	O	NOUN	B
transduction	O	NOUN	I
from	O	ADP	O
surface	O	NOUN	B
receptors	O	NOUN	I
to	O	PART	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
cytokine	B-protein	NOUN	B
synthesis	O	NOUN	I
in	O	ADP	O
natural	B-cell_type	ADJ	B
killer	I-cell_type	NOUN	I
(	I-cell_type	PUNCT	O
NK	I-cell_type	NOUN	O
)	I-cell_type	PUNCT	O
cells	I-cell_type	NOUN	O
have	O	AUX	O
not	O	PART	O
been	O	AUX	O
elucidated	O	VERB	O
.	O	PUNCT	O


NK	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
do	O	AUX	O
not	O	PART	O
express	O	VERB	O
NFATc	B-protein	NOUN	B
constitutively	O	ADV	B
,	O	PUNCT	O
but	O	CCONJ	O
NFATc	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
accumulation	O	NOUN	B
is	O	AUX	O
induced	O	VERB	B
in	O	ADP	O
these	O	DET	O
cells	O	NOUN	B
within	O	ADP	O
2	O	NUM	O
h	O	NOUN	O
of	O	ADP	O
stimulation	O	NOUN	B
with	O	ADP	O
CD16	O	NOUN	B
ligands	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
mechanisms	O	NOUN	B
by	O	ADP	O
which	O	DET	O
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	I
IL-2	B-protein	NOUN	B
are	O	AUX	O
propagated	O	VERB	O
within	O	ADP	O
cells	O	NOUN	B
are	O	AUX	O
not	O	PART	O
understood	O	VERB	O
.	O	PUNCT	O


While	O	SCONJ	O
the	O	DET	O
binding	O	NOUN	B
of	O	ADP	O
IL-2	B-protein	NOUN	B
to	O	PART	O
its	O	PRON	O
receptor	O	NOUN	B
was	O	AUX	O
recently	O	ADV	O
shown	O	VERB	O
to	O	PART	O
lead	O	VERB	O
to	O	PART	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
two	O	NUM	O
kinases	B-protein	NOUN	B
,	O	PUNCT	O
Jak-1	B-protein	NOUN	B
and	O	CCONJ	O
Jak-3	B-protein	NOUN	B
,	O	PUNCT	O
subsequent	O	ADJ	O
steps	O	NOUN	O
in	O	ADP	O
the	O	DET	O
signaling	O	NOUN	B
pathway	O	NOUN	I
to	O	PART	O
the	O	DET	O
nucleus	O	NOUN	B
that	O	PRON	O
lead	O	VERB	O
to	O	PART	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
specific	O	ADJ	O
genes	O	NOUN	B
had	O	AUX	O
not	O	PART	O
been	O	AUX	O
characterized	O	VERB	B
.	O	PUNCT	O


Menopause	O	NOUN	B
is	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
a	O	DET	O
significant	O	ADJ	O
increase	O	NOUN	B
in	O	ADP	O
blood	O	NOUN	B
monocyte	O	NOUN	I
number	O	NOUN	I
and	O	CCONJ	O
a	O	DET	O
relative	O	ADJ	O
decrease	O	NOUN	B
in	O	ADP	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
estrogen	B-protein	NOUN	B
receptors	I-protein	NOUN	I
in	O	ADP	O
human	B-cell_type	ADJ	B
peripheral	I-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	I
.	O	PUNCT	O


RESULTS	O	NOUN	B
:	O	PUNCT	O
During	O	ADP	O
menopause	O	NOUN	B
there	O	PRON	O
is	O	AUX	O
a	O	DET	O
significant	O	ADJ	O
decrease	O	NOUN	B
in	O	ADP	O
the	O	DET	O
percentage	O	NOUN	B
of	O	ADP	O
ER	B-cell_type	NOUN	B
positive	I-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
an	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
blood	B-cell_type	NOUN	B
monocyte	I-cell_type	NOUN	I
number	O	NOUN	I
,	O	PUNCT	O
which	O	DET	O
declines	O	VERB	O
following	O	VERB	O
estrogen	O	NOUN	B
replacement	O	NOUN	I
therapy	O	NOUN	I
to	O	PART	O
values	O	NOUN	B
of	O	ADP	O
the	O	DET	O
young	O	NOUN	B
.	O	PUNCT	O


Staphylococcal	B-protein	ADJ	B
enterotoxins	I-protein	NOUN	I
(	O	PUNCT	O
SE	B-protein	NOUN	B
)	O	PUNCT	O
stimulate	O	VERB	B
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
expressing	O	VERB	B
the	O	DET	O
appropriate	O	ADJ	O
variable	B-protein	ADJ	B
region	I-protein	NOUN	I
beta	I-protein	NOUN	B
chain	I-protein	NOUN	I
of	I-protein	ADP	I
(	I-protein	PUNCT	I
V	I-protein	NOUN	I
beta	I-protein	NOUN	I
)	I-protein	PUNCT	I
T-cell	I-protein	NOUN	I
receptors	I-protein	NOUN	I
and	O	CCONJ	O
have	O	AUX	O
been	O	AUX	O
implicated	O	VERB	O
in	O	ADP	O
the	O	DET	O
pathogenesis	O	NOUN	B
of	O	ADP	O
several	O	ADJ	O
autoimmune	O	ADJ	B
diseases	O	NOUN	I
.	O	PUNCT	O


Here	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
SE	B-protein	NOUN	B
induce	O	VERB	B
dynamic	O	ADJ	B
changes	O	NOUN	O
in	O	ADP	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
and	O	CCONJ	O
signal	O	NOUN	B
transduction	O	NOUN	I
through	O	ADP	O
the	O	DET	O
IL-2	B-protein	NOUN	B
receptor	I-protein	NOUN	I
(	I-protein	PUNCT	O
IL-2R	I-protein	NOUN	B
)	I-protein	PUNCT	O
beta	I-protein	NOUN	B
and	I-protein	CCONJ	O
gamma	I-protein	NOUN	B
chains	I-protein	NOUN	I
(	O	PUNCT	O
IL-2R	B-protein	NOUN	B
beta	I-protein	NOUN	O
and	O	CCONJ	O
IL-2R	B-protein	NOUN	B
gamma	I-protein	NOUN	O
)	O	PUNCT	O
in	O	ADP	O
human	B-cell_line	ADJ	B
antigen-specific	I-cell_line	ADJ	B
CD4+	I-cell_line	ADJ	O
T-cell	I-cell_line	NOUN	O
lines	I-cell_line	NOUN	O
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
after	O	ADP	O
4	O	NUM	O
hr	O	NOUN	O
of	O	ADP	O
exposure	O	NOUN	B
to	O	PART	I
SEA	B-protein	NOUN	B
and	O	CCONJ	O
SEB	B-protein	NOUN	B
,	O	PUNCT	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
IL-2R	B-protein	NOUN	B
beta	I-protein	NOUN	B
was	O	AUX	O
down-regulated	O	VERB	B
,	O	PUNCT	O
IL-2R	B-protein	NOUN	B
gamma	I-protein	NOUN	O
was	O	AUX	O
slightly	O	ADV	O
up-regulated	O	VERB	B
,	O	PUNCT	O
while	O	SCONJ	O
IL-2R	B-protein	NOUN	B
alpha	I-protein	NOUN	O
remained	O	VERB	O
largely	O	ADV	O
unaffected	O	ADJ	B
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
I	O	NOUN	B
kappa	O	NOUN	I
b	O	NOUN	I
beta	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
I	B-protein	NOUN	O
kappa	I-protein	NOUN	O
B	I-protein	NOUN	O
alpha	I-protein	NOUN	O
,	O	PUNCT	O
is	O	AUX	O
required	O	VERB	O
for	O	ADP	O
the	O	DET	O
signal-dependent	O	ADJ	B
activation	O	NOUN	I
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
in	O	ADP	O
fibroblasts	B-cell_type	NOUN	B
.	O	PUNCT	O


IL-7	B-protein	NOUN	B
was	O	AUX	O
observed	O	VERB	O
to	O	PART	O
induce	O	VERB	B
a	O	DET	O
rapid	O	ADJ	B
and	O	CCONJ	O
dose-dependent	O	ADJ	B
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	I
of	O	ADP	O
Jak	B-protein	NOUN	B
1	I-protein	NUM	I
and	O	CCONJ	O
Jak	B-protein	NOUN	B
3	I-protein	NUM	I
and	O	CCONJ	O
concomitantly	O	ADV	B
,	O	PUNCT	O
the	O	DET	O
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	I
and	O	CCONJ	O
DNA	O	NOUN	B
binding	O	NOUN	I
activity	O	NOUN	I
of	O	ADP	O
multiple	O	ADJ	B
STAT	B-protein	NOUN	B
proteins	I-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
current	O	ADJ	O
study	O	NOUN	B
was	O	AUX	O
conducted	O	VERB	O
to	O	PART	O
evaluate	O	VERB	B
the	O	DET	O
cytokine	B-protein	NOUN	B
modulating	O	NOUN	O
activity	O	NOUN	B
of	O	ADP	O
tepoxalin	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
iron	O	NOUN	B
in	O	ADP	O
these	O	DET	O
effects	O	NOUN	B
.	O	PUNCT	O


Although	O	SCONJ	O
the	O	DET	O
interrelationship	O	NOUN	B
between	O	ADP	O
the	O	DET	O
two	O	NUM	O
messengers	O	NOUN	B
Ca2+	O	NOUN	B
and	O	CCONJ	O
cyclic	O	ADJ	B
AMP	O	NOUN	I
in	O	ADP	O
platelet	O	NOUN	B
function	O	NOUN	I
is	O	AUX	O
well	O	ADV	O
documented	O	VERB	B
,	O	PUNCT	O
its	O	PRON	O
mechanism	O	NOUN	B
of	O	ADP	O
action	O	NOUN	B
still	O	ADV	O
remains	O	VERB	O
to	O	PART	O
be	O	AUX	O
established	O	VERB	O
.	O	PUNCT	O


We	O	PRON	O
could	O	AUX	O
show	O	VERB	O
a	O	DET	O
decrease	O	NOUN	B
in	O	ADP	O
the	O	DET	O
expression	O	NOUN	B
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
in	O	ADP	O
the	O	DET	O
phosphorylation	O	NOUN	B
of	O	ADP	O
Rap1	B-protein	NOUN	B
protein	I-protein	NOUN	I
and	O	CCONJ	O
demonstrate	O	VERB	O
a	O	DET	O
lower	O	ADJ	O
effect	O	NOUN	B
of	O	ADP	O
C.	B-protein	NOUN	B
Sub	I-protein	NOUN	I
.	I-protein	PUNCT	O
on	O	ADP	O
Ca2+	O	NOUN	B
transport	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
tumour	B-protein	NOUN	B
suppressor	I-protein	NOUN	I
p53	I-protein	NOUN	I
has	O	AUX	O
been	O	AUX	O
shown	O	VERB	O
to	O	PART	O
regulate	O	VERB	B
this	O	DET	O
type	O	NOUN	O
of	O	ADP	O
apoptosis	O	NOUN	B
in	O	ADP	O
thymocytes	B-cell_type	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
an	O	DET	O
as	O	ADP	O
yet	O	ADV	O
unknown	O	ADJ	O
,	O	PUNCT	O
p53	B-protein	NOUN	B
-independent	O	ADJ	O
pathway	O	NOUN	B
(	O	PUNCT	O
s	O	NOUN	O
)	O	PUNCT	O
appears	O	VERB	O
to	O	PART	O
mediate	O	VERB	O
the	O	DET	O
same	O	ADJ	O
event	O	NOUN	B
in	O	ADP	O
mitogen-activated	B-cell_line	ADJ	B
mature	I-cell_line	ADJ	I
T	I-cell_line	NOUN	B
lymphocytes	I-cell_line	NOUN	I
.	O	PUNCT	O


Ectopic	O	ADJ	B
overexpression	O	NOUN	B
of	O	ADP	O
IRF-1	B-protein	NOUN	B
results	O	VERB	B
in	O	ADP	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
endogenous	B-DNA	ADJ	B
gene	I-DNA	NOUN	B
for	O	ADP	O
ICE	B-protein	NOUN	B
and	O	CCONJ	O
enhances	O	VERB	B
the	O	DET	O
sensitivity	O	NOUN	B
of	O	ADP	O
cells	O	NOUN	B
to	O	PART	O
radiation-induced	O	ADJ	B
apoptosis	O	NOUN	I
.	O	PUNCT	O


2	O	X	O
)	O	PUNCT	O
The	O	DET	O
FI	O	NOUN	B
of	O	ADP	O
the	O	DET	O
chemotactic	O	ADJ	B
migration	O	NOUN	I
rate	O	NOUN	B
of	O	ADP	O
PMN	B-cell_type	NOUN	B
by	O	ADP	O
cortisol	O	NOUN	B
also	O	ADV	O
showed	O	VERB	O
diurnal	O	ADJ	B
changes	O	NOUN	B
which	O	DET	O
were	O	AUX	O
synchronous	O	ADJ	B
with	O	ADP	O
that	O	DET	O
of	O	ADP	O
GR	B-protein	NOUN	B
.	O	PUNCT	O


Identification	O	NOUN	B
of	O	ADP	O
an	O	DET	O
ionomycin/cyclosporin	B-DNA	NOUN	B
A-responsive	I-DNA	ADJ	I
element	I-DNA	NOUN	O
within	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
T	I-DNA	NOUN	O
cell	I-DNA	NOUN	O
receptor	I-DNA	NOUN	O
gamma	I-DNA	NOUN	O
enhancer	I-DNA	NOUN	O
.	O	PUNCT	O


Coexpression	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B/Rel	I-protein	NOUN	B
and	O	CCONJ	O
Sp1	B-protein	NOUN	B
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
in	O	ADP	O
human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
1-induced	O	ADJ	O
,	O	PUNCT	O
dendritic	O	ADJ	B
cell-T-cell	O	NOUN	O
syncytia	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
Cu2+	O	NOUN	B
inhibits	O	VERB	B
the	O	DET	O
release	O	NOUN	B
of	O	ADP	O
NF	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
by	O	ADP	O
blockade	O	NOUN	B
of	O	ADP	O
a	O	DET	O
signal	O	NOUN	B
leading	O	VERB	O
to	O	PART	O
the	O	DET	O
phosphorylation	O	NOUN	B
of	O	ADP	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
alpha	I-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
B4-2	B-DNA	NOUN	B
clone	O	NOUN	B
coded	O	VERB	B
for	O	ADP	O
an	O	DET	O
mRNA	B-RNA	NOUN	B
of	O	ADP	O
2061	O	NUM	O
bp	O	NOUN	O
in	O	ADP	O
length	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
polyclonal	O	ADJ	B
antiserum	O	NOUN	I
raised	O	VERB	O
against	O	ADP	O
recombinant	B-protein	ADJ	B
B4-2	I-protein	NOUN	B
recognizes	O	VERB	O
a	O	DET	O
32-34	B-protein	NUM	O
kDa	I-protein	NOUN	O
protein	I-protein	NOUN	O
in	O	ADP	O
lymphocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


Activation	O	NOUN	B
of	O	ADP	O
JAK3	B-protein	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
JAK1	B-protein	NOUN	B
,	O	PUNCT	O
is	O	AUX	O
critical	O	ADJ	O
for	O	ADP	O
IL-2	B-protein	NOUN	B
-induced	O	ADJ	O
proliferation	O	NOUN	B
and	O	CCONJ	O
STAT5	B-protein	NOUN	B
recruitment	O	NOUN	B
by	O	ADP	O
a	O	DET	O
COOH-terminal	B-protein	ADJ	B
region	I-protein	NOUN	I
of	O	ADP	O
the	O	DET	O
IL-2	B-protein	NOUN	B
receptor	I-protein	NOUN	I
beta-chain	I-protein	NOUN	I
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
when	O	SCONJ	O
human	B-protein	ADJ	B
IL-2R	I-protein	NOUN	B
beta	I-protein	NOUN	O
was	O	AUX	O
stably	O	ADV	B
expressed	O	VERB	B
in	O	ADP	O
murine	B-cell_line	ADJ	B
BA/F3	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
robust	O	ADJ	O
IL-2	B-protein	NOUN	B
-induced	O	ADJ	O
proliferation	O	NOUN	B
and	O	CCONJ	O
JAK3	B-protein	NOUN	B
activation	O	NOUN	B
occurred	O	VERB	O
without	O	ADP	O
detectable	O	ADJ	B
involvement	O	NOUN	B
of	O	ADP	O
either	O	CCONJ	O
JAK1	B-protein	NOUN	B
,	O	PUNCT	O
JAK2	B-protein	NOUN	B
or	O	CCONJ	O
TYK2	B-protein	NOUN	B
.	O	PUNCT	O


It	O	PRON	O
has	O	AUX	O
been	O	AUX	O
suggested	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
ubiquitin	B-protein	NOUN	B
-proteasome	B-protein	ADJ	O
system	O	NOUN	O
is	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
process	O	NOUN	B
;	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
specific	O	ADJ	O
enzymes	B-protein	NOUN	B
involved	O	VERB	O
and	O	CCONJ	O
the	O	DET	O
mechanism	O	NOUN	B
of	O	ADP	O
limited	O	ADJ	B
proteolysis	O	NOUN	B
,	O	PUNCT	O
in	O	ADP	O
which	O	DET	O
half	O	NOUN	O
of	O	ADP	O
the	O	DET	O
molecule	O	NOUN	B
is	O	AUX	O
spared	O	VERB	O
,	O	PUNCT	O
have	O	AUX	O
been	O	AUX	O
obscure	O	ADJ	B
.	O	PUNCT	O


OBJECTIVE	O	NOUN	B
:	O	PUNCT	O
To	O	PART	O
investigate	O	VERB	B
the	O	DET	O
long-term	O	ADJ	B
effects	O	NOUN	B
of	O	ADP	O
treatment	O	NOUN	B
with	O	ADP	O
low	O	ADJ	B
doses	O	NOUN	I
of	O	ADP	O
flutamide	O	NOUN	B
on	O	ADP	O
clinical	O	ADJ	B
and	O	CCONJ	O
hormonal	O	ADJ	B
parameters	O	NOUN	B
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
on	O	ADP	O
the	O	DET	O
androgen	B-protein	NOUN	B
receptor	I-protein	NOUN	I
status	O	NOUN	I
,	O	PUNCT	O
in	O	ADP	O
hirsute	O	ADJ	B
women	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
reduction	O	NOUN	B
of	O	ADP	O
serum	O	NOUN	B
androgens	O	NOUN	B
was	O	AUX	O
found	O	VERB	O
,	O	PUNCT	O
whereas	O	SCONJ	O
no	O	DET	O
change	O	NOUN	O
was	O	AUX	O
observed	O	VERB	O
in	O	ADP	O
either	O	CCONJ	O
basal	O	ADJ	B
or	O	CCONJ	O
GnRH-stimulated	O	ADJ	B
gonadotropins	O	NOUN	I
or	O	CCONJ	O
in	O	ADP	O
the	O	DET	O
cortisol	O	NOUN	B
and	O	CCONJ	O
17	O	NUM	O
alpha-hydroxyprogesterone	O	NOUN	B
response	O	NOUN	O
to	O	PART	O
ACTH	O	NOUN	B
.	O	PUNCT	O


An	O	DET	O
increased	O	VERB	B
growth	O	NOUN	B
rate	O	NOUN	I
of	O	ADP	O
these	O	DET	O
Jurkat-tat	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
as	O	ADP	O
compared	O	VERB	B
with	O	ADP	O
control	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
was	O	AUX	O
observed	O	VERB	B
.	O	PUNCT	O


Lastly	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
different	O	ADJ	O
mobilities	O	NOUN	B
of	O	ADP	O
osteoblast	B-protein	NOUN	B
nuclear	I-protein	ADJ	I
extract-DNA	I-protein	ADJ	I
complexes	I-protein	NOUN	I
compared	O	VERB	B
with	O	ADP	O
T-cell	B-protein	NOUN	B
nuclear	I-protein	ADJ	I
extract-DNA	I-protein	ADJ	I
complexes	I-protein	NOUN	I
,	O	PUNCT	O
along	O	ADP	O
with	O	ADP	O
the	O	DET	O
inability	O	NOUN	B
of	O	ADP	O
OSF2	B-protein	NOUN	B
to	O	PART	O
be	O	AUX	O
upregulated	O	VERB	B
by	O	ADP	O
retinoic	O	ADJ	B
acid	O	NOUN	I
,	O	PUNCT	O
unlike	O	ADP	O
the	O	DET	O
other	O	ADJ	O
PEBP2	B-protein	NOUN	B
alpha	I-protein	NOUN	O
factors	I-protein	NOUN	O
,	O	PUNCT	O
suggest	O	VERB	O
that	O	SCONJ	O
OSF2	B-protein	NOUN	B
is	O	AUX	O
a	O	DET	O
new	O	ADJ	O
member	O	NOUN	O
of	O	ADP	O
this	O	DET	O
family	O	NOUN	B
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
analyzed	O	VERB	B
several	O	ADJ	O
molecular	O	ADJ	B
aspects	O	NOUN	I
of	O	ADP	O
IBR/F	B-protein	NOUN	B
and	O	CCONJ	O
shown	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
factor	O	NOUN	B
associates	O	VERB	B
as	O	ADP	O
stable	O	ADJ	B
homodimers	B-protein	NOUN	B
and	O	CCONJ	O
that	O	SCONJ	O
the	O	DET	O
dimer	B-protein	NOUN	B
is	O	AUX	O
the	O	DET	O
relevant	B-protein	ADJ	O
DNA-binding	I-protein	ADJ	B
species	I-protein	NOUN	O
.	O	PUNCT	O


The	O	DET	O
evolutionarily	O	ADV	O
conserved	O	VERB	O
N-terminal	B-protein	ADJ	B
half	I-protein	NOUN	O
of	O	ADP	O
IBR/F	B-protein	NOUN	O
harbors	O	VERB	O
the	O	DET	O
DNA-binding/dimerization	B-protein	ADJ	B
domain	I-protein	NOUN	I
(	O	PUNCT	O
outer	O	ADJ	O
limits	O	NOUN	O
,	O	PUNCT	O
127	O	NUM	O
to	O	PART	O
283	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
one	O	NUM	O
or	O	CCONJ	O
several	O	ADJ	O
casein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
II	I-protein	NUM	I
sites	I-protein	NOUN	O
(	O	PUNCT	O
37	O	NUM	O
to	O	PART	O
67	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
bipartite	B-protein	ADJ	B
nuclear	I-protein	ADJ	I
localization	I-protein	NOUN	I
signal	I-protein	NOUN	I
(	O	PUNCT	O
89	O	NUM	O
to	O	PART	O
106	O	NUM	O
)	O	PUNCT	O
which	O	DET	O
appears	O	VERB	O
to	O	PART	O
be	O	AUX	O
necessary	O	ADJ	O
for	O	ADP	O
nuclear	O	ADJ	B
targeting	O	NOUN	B
.	O	PUNCT	O


Triggering	O	NOUN	B
of	O	ADP	O
the	O	DET	O
human	O	ADJ	B
interleukin-6	O	NOUN	O
gene	O	NOUN	O
by	O	ADP	O
interferon-gamma	O	NOUN	B
and	O	CCONJ	O
tumor	O	NOUN	B
necrosis	O	NOUN	I
factor-alpha	O	NOUN	I
in	O	ADP	O
monocytic	O	ADJ	B
cells	O	NOUN	I
involves	O	VERB	O
cooperation	O	NOUN	B
between	O	ADP	O
interferon	B-protein	NOUN	B
regulatory	I-protein	ADJ	I
factor-1	I-protein	NOUN	I
,	O	PUNCT	O
NF	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
Sp1	B-protein	NOUN	B
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
.	O	PUNCT	O


An	O	DET	O
Epstein-Barr	B-cell_line	ADJ	B
virus	I-cell_line	NOUN	I
(	I-cell_line	PUNCT	O
EBV	I-cell_line	NOUN	B
)	I-cell_line	PUNCT	O
-transformed	I-cell_line	ADJ	O
cell	I-cell_line	NOUN	B
line	I-cell_line	NOUN	I
derived	O	VERB	O
from	O	ADP	O
her	O	PRON	O
lymphocytes	B-cell_type	NOUN	B
had	O	AUX	O
normal	O	ADJ	B
gamma	B-protein	NOUN	I
c	I-protein	NOUN	I
expression	O	NOUN	B
but	O	CCONJ	O
lacked	O	VERB	O
Jak3	B-protein	NOUN	B
protein	I-protein	NOUN	I
and	O	CCONJ	O
had	O	AUX	O
greatly	O	ADV	O
diminished	O	VERB	O
Jak3	B-RNA	NOUN	B
messenger	I-RNA	NOUN	O
RNA	I-RNA	NOUN	O
.	O	PUNCT	O


The	O	DET	O
lack	O	NOUN	B
of	O	ADP	O
Jak3	B-protein	NOUN	B
expression	O	NOUN	B
correlated	O	VERB	B
with	O	ADP	O
impaired	O	ADJ	B
B	O	NOUN	O
cell	O	NOUN	O
signaling	O	NOUN	O
,	O	PUNCT	O
as	O	ADP	O
demonstrated	O	VERB	O
by	O	ADP	O
the	O	DET	O
inability	O	NOUN	B
of	O	ADP	O
IL-4	B-protein	NOUN	B
to	O	PART	O
activate	O	VERB	B
Stat6	B-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
EBV-transformed	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
from	O	ADP	O
the	O	DET	O
patient.	O	NOUN	B
These	O	DET	O
observations	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
functions	O	NOUN	B
of	O	ADP	O
gamma	B-protein	NOUN	B
c	I-protein	NOUN	I
are	O	AUX	O
dependent	O	ADJ	B
on	O	ADP	O
Jak3	B-protein	NOUN	B
and	O	CCONJ	O
that	O	SCONJ	O
Jak3	B-protein	NOUN	B
is	O	AUX	O
essential	O	ADJ	O
for	O	ADP	O
lymphoid	O	ADJ	B
development	O	NOUN	B
and	O	CCONJ	O
signaling	O	NOUN	B
.	O	PUNCT	O


Constitutive	O	ADJ	B
overexpression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
L-selectin	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
in	O	ADP	O
fresh	O	ADJ	B
leukemic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
of	O	ADP	O
adult	O	ADJ	B
T-cell	O	NOUN	B
leukemia	O	NOUN	I
that	O	PRON	O
can	O	AUX	O
be	O	AUX	O
transactivated	O	VERB	B
by	O	ADP	O
human	B-protein	ADJ	B
T-cell	I-protein	NOUN	O
lymphotropic	I-protein	ADJ	O
virus	I-protein	NOUN	O
type	I-protein	NOUN	O
1	I-protein	NUM	O
Tax	I-protein	NOUN	B
.	O	PUNCT	O


Upon	O	SCONJ	O
cellular	O	ADJ	B
activation	O	NOUN	I
,	O	PUNCT	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
L-selectin	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
is	O	AUX	O
downregulated	O	VERB	B
at	O	ADP	O
both	O	CCONJ	O
the	O	DET	O
protein	O	NOUN	B
and	O	CCONJ	O
mRNA	O	NOUN	B
levels	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
serum	O	NOUN	B
level	O	NOUN	B
of	O	ADP	O
the	O	DET	O
shed	O	NOUN	O
form	O	NOUN	O
of	O	ADP	O
L-selectin	B-protein	NOUN	B
was	O	AUX	O
significantly	O	ADV	O
increased	O	VERB	B
in	O	ADP	O
ATL	O	NOUN	B
patients	O	NOUN	B
(	O	PUNCT	O
mean	O	NOUN	O
+/-	O	CCONJ	O
SD	O	NOUN	B
,	O	PUNCT	O
4	O	NUM	O
,	O	PUNCT	O
215.4	O	NUM	O
+/-	O	CCONJ	O
4	O	NUM	O
,	O	PUNCT	O
111	O	NUM	O
ng/mL	O	NOUN	O
)	O	PUNCT	O
compared	O	VERB	B
with	O	ADP	O
those	O	DET	O
of	O	ADP	O
asymptomatic	O	ADJ	B
carriers	O	NOUN	B
and	O	CCONJ	O
healthy	O	ADJ	B
blood	O	NOUN	I
donors	O	NOUN	I
(	O	PUNCT	O
mean	O	NOUN	O
+/-	O	CCONJ	O
SD	O	NOUN	B
,	O	PUNCT	O
1	O	NUM	O
,	O	PUNCT	O
148.0	O	NUM	O
+/-	O	CCONJ	O
269.0	O	NUM	O
ng/mL	O	NOUN	O
and	O	CCONJ	O
991.9	O	NUM	O
+/-	O	CCONJ	O
224	O	NUM	O
ng/mL	O	NOUN	O
,	O	PUNCT	O
respectively	O	ADV	O
)	O	PUNCT	O
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
compared	O	VERB	B
the	O	DET	O
frequency	O	NOUN	B
of	O	ADP	O
a	O	DET	O
restriction	B-DNA	NOUN	B
fragment	I-DNA	NOUN	I
length	I-DNA	NOUN	I
polymorphism	I-DNA	NOUN	I
(	O	PUNCT	O
Bsm	O	NOUN	B
I	O	NUM	I
)	O	PUNCT	O
associated	O	VERB	B
with	O	ADP	I
different	O	ADJ	O
alleles	O	NOUN	B
of	O	ADP	O
the	O	DET	O
VDR	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
in	O	ADP	O
a	O	DET	O
group	O	NOUN	B
of	O	ADP	O
33	O	NUM	O
well	O	ADV	O
characterized	O	VERB	O
absorptive	O	ADJ	B
hypercalciuric	O	NOUN	B
patients	O	NOUN	B
and	O	CCONJ	O
a	O	DET	O
group	O	NOUN	B
of	O	ADP	O
36	O	NUM	O
normal	O	ADJ	B
race-	O	NOUN	O
and	O	CCONJ	O
age-matched	O	ADJ	O
control	O	ADJ	B
subjects	O	NOUN	I
.	O	PUNCT	O


Platelet	B-protein	NOUN	B
thromboxane	I-protein	NOUN	I
receptors	I-protein	NOUN	I
are	O	AUX	O
acutely	O	ADV	B
and	O	CCONJ	O
reversibly	O	ADV	O
upregulated	O	VERB	B
after	O	ADP	O
acute	O	ADJ	B
myocardial	O	ADJ	I
infarction	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
findings	O	NOUN	B
strongly	O	ADV	O
suggest	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
mechanism	O	NOUN	B
for	O	ADP	O
previously	O	ADV	O
described	O	VERB	O
upregulation	O	NOUN	B
of	O	ADP	O
platelet	B-protein	NOUN	B
thromboxane	I-protein	NOUN	I
receptors	I-protein	NOUN	I
after	O	ADP	O
acute	O	ADJ	B
myocardial	O	ADJ	I
infarction	O	NOUN	I
is	O	AUX	O
increased	O	VERB	B
thromboxane	B-DNA	NOUN	B
receptor	I-DNA	NOUN	I
gene	I-DNA	NOUN	B
transcription	O	NOUN	I
in	O	ADP	O
platelet-progenitor	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


As	O	ADP	O
considerable	O	ADJ	O
evidence	O	NOUN	B
has	O	AUX	O
accumulated	O	VERB	O
that	O	SCONJ	O
social	O	ADJ	B
support	O	NOUN	I
in	O	ADP	O
both	O	CCONJ	O
animal	O	NOUN	B
and	O	CCONJ	O
human	O	ADJ	B
populations	O	NOUN	B
may	O	AUX	O
have	O	AUX	O
survival	O	NOUN	B
value	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
sought	O	VERB	O
to	O	PART	O
test	O	VERB	B
the	O	DET	O
reliability	O	NOUN	B
of	O	ADP	O
this	O	DET	O
regression	O	NOUN	B
model	O	NOUN	I
,	O	PUNCT	O
using	O	VERB	O
coping	O	NOUN	B
and	O	CCONJ	O
perceived	O	VERB	B
support	O	NOUN	O
factor	O	NOUN	B
values	O	NOUN	I
obtained	O	VERB	O
at	O	ADP	O
3	O	NUM	O
months	O	NOUN	B
after	O	ADP	O
surgery	O	NOUN	B
to	O	PART	O
account	O	VERB	O
for	O	ADP	O
concurrent	O	ADJ	B
follow-up	O	ADJ	B
NK	O	NOUN	B
activity	O	NOUN	B
in	O	ADP	O
this	O	DET	O
serially	O	ADV	O
assessed	O	VERB	B
group	O	NOUN	B
of	O	ADP	O
patients	O	NOUN	B
.	O	PUNCT	O


Our	O	PRON	O
findings	O	NOUN	B
also	O	ADV	O
suggest	O	VERB	O
one	O	NUM	O
possible	O	ADJ	O
immunological	O	ADJ	B
variable	O	NOUN	B
involved	O	VERB	O
,	O	PUNCT	O
with	O	ADP	O
potential	O	ADJ	O
clinical	O	ADJ	B
significance	O	NOUN	I
,	O	PUNCT	O
for	O	ADP	O
this	O	DET	O
patient	O	NOUN	B
population	O	NOUN	I
.	O	PUNCT	O


Now	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
report	O	VERB	O
the	O	DET	O
solution	O	NOUN	B
structure	O	NOUN	B
of	O	ADP	O
the	O	DET	O
sequence-specific	B-protein	ADJ	B
HMG-box	I-protein	NOUN	I
of	O	ADP	O
the	O	DET	O
SRY-related	B-protein	ADJ	B
protein	I-protein	NOUN	I
Sox-4	B-protein	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggested	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
bound	B-protein	VERB	B
kinase	I-protein	NOUN	I
is	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
signaling	O	NOUN	B
pathway	O	NOUN	I
of	O	ADP	O
LPS	O	NOUN	B
by	O	ADP	O
inducing	O	VERB	B
the	O	DET	O
phosphorylation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
C-terminal	B-protein	ADJ	B
region	I-protein	NOUN	I
of	O	ADP	O
I	B-protein	NOUN	O
kappa	I-protein	NOUN	O
B	I-protein	NOUN	O
alpha	I-protein	NOUN	O
and	O	CCONJ	O
subsequent	O	ADJ	O
dissociation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
.	O	PUNCT	O
I	B-protein	NOUN	O
kappa	I-protein	NOUN	O
B	I-protein	NOUN	O
alpha	I-protein	NOUN	O
complex	I-protein	NOUN	O
.	O	PUNCT	O


The	O	DET	O
TCF-1	B-DNA	NOUN	B
gene	I-DNA	NOUN	O
encodes	O	VERB	B
a	O	DET	O
putative	B-protein	ADJ	B
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
with	O	ADP	O
affinity	O	NOUN	B
for	O	ADP	O
a	O	DET	O
sequence	O	NOUN	B
motif	O	NOUN	B
occurring	O	VERB	O
in	O	ADP	O
a	O	DET	O
number	O	NOUN	O
of	O	ADP	O
T-cell	B-DNA	NOUN	B
enhancers	I-DNA	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
expression	O	NOUN	B
reportedly	O	ADV	O
occurs	O	VERB	O
in	O	ADP	O
multiple	O	ADJ	B
nonlymphoid	O	ADJ	B
tissues	O	NOUN	B
during	O	ADP	O
murine	O	ADJ	B
embryogenesis	O	NOUN	B
.	O	PUNCT	O


Immunohistochemistry	O	NOUN	B
on	O	ADP	O
a	O	DET	O
panel	O	NOUN	O
of	O	ADP	O
human	O	ADJ	B
tissues	O	NOUN	B
revealed	O	VERB	B
that	O	SCONJ	O
the	O	DET	O
TCF-1	B-protein	NOUN	B
protein	I-protein	NOUN	I
was	O	AUX	O
found	O	VERB	O
exclusively	O	ADV	O
in	O	ADP	O
thymocytes	O	NOUN	B
and	O	CCONJ	O
in	O	ADP	O
CD3+	B-cell_line	ADJ	B
T	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
in	O	ADP	O
peripheral	O	ADJ	B
lymphoid	O	ADJ	B
tissues	O	NOUN	B
.	O	PUNCT	O


Elevation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
levels	O	NOUN	B
of	O	ADP	O
circulating	B-protein	VERB	B
immune	I-protein	ADJ	B
complexes	I-protein	NOUN	I
frequently	O	ADV	O
accompanies	O	VERB	O
HIV-1	O	NOUN	B
infection	O	NOUN	B
and	O	CCONJ	O
is	O	AUX	O
a	O	DET	O
prognostic	O	ADJ	B
indicator	O	NOUN	B
of	O	ADP	O
clinical	O	ADJ	B
progression	O	NOUN	I
from	O	ADP	O
asymptomatic	O	ADJ	B
infection	O	NOUN	I
to	O	ADP	O
AIDS	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
THP-1	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
Fc	B-protein	NOUN	B
gamma	I-protein	NOUN	I
R	I-protein	NOUN	I
cross-linking	O	NOUN	I
induced	O	VERB	B
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
known	O	VERB	O
to	O	PART	O
bind	O	VERB	B
to	O	PART	O
the	O	DET	O
regulatory	B-DNA	ADJ	B
region	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
long	B-DNA	ADJ	B
terminal	I-DNA	ADJ	I
repeat	I-DNA	NOUN	I
(	O	PUNCT	I
LTR	B-DNA	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
HIV-1	O	NOUN	B
and	O	CCONJ	O
to	O	PART	O
activate	O	VERB	B
HIV-1	O	NOUN	B
transcription	O	NOUN	B
.	O	PUNCT	O
Anti-TNF-alpha	B-protein	ADJ	B
antibody	I-protein	NOUN	I
but	O	CCONJ	O
not	O	PART	O
anti-IL-1	B-protein	ADJ	B
beta	I-protein	NOUN	I
antibody	I-protein	NOUN	I
strongly	O	ADV	O
inhibited	O	VERB	B
both	O	CCONJ	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
HIV-1-	O	ADJ	B
LTR	B-DNA	NOUN	B
-driven	O	ADJ	O
transcription	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
by	O	ADP	O
Fc	B-protein	NOUN	B
gamma	I-protein	NOUN	I
R	I-protein	NOUN	I
cross-linking	O	NOUN	B
.	O	PUNCT	O


Anti-	O	ADJ	O
CD28	B-protein	NOUN	B
MoAb	I-protein	NOUN	B
costimulation	O	NOUN	B
increased	O	VERB	B
NF	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
levels	O	NOUN	B
in	O	ADP	O
neonates	O	NOUN	B
,	O	PUNCT	O
albeit	O	SCONJ	O
to	O	PART	O
levels	O	NOUN	B
lower	O	ADJ	O
than	O	ADP	O
that	O	DET	O
of	O	ADP	O
adults	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
determined	O	VERB	O
the	O	DET	O
functional	O	ADJ	B
role	O	NOUN	O
of	O	ADP	O
C/EBP	B-protein	NOUN	B
proteins	I-protein	NOUN	I
and	O	CCONJ	O
C/EBP	B-DNA	NOUN	B
sites	I-DNA	NOUN	I
in	O	ADP	O
regulating	O	VERB	B
transcription	O	NOUN	I
from	O	ADP	O
the	O	DET	O
HIV-	B-DNA	ADJ	B
1	I-DNA	NUM	O
LTR	I-DNA	NOUN	B
in	O	ADP	O
monocytes/macrophages	B-cell_type	NOUN	B
.	O	PUNCT	O


Observations	O	NOUN	B
such	O	ADJ	O
as	O	ADP	O
these	O	DET	O
encourage	O	VERB	O
the	O	DET	O
speculation	O	NOUN	B
that	O	SCONJ	O
there	O	PRON	O
may	O	AUX	O
be	O	AUX	O
subtle	O	ADJ	O
differences	O	NOUN	O
in	O	ADP	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
HIV-1	O	NOUN	B
and	O	CCONJ	O
HIV-2	O	NOUN	B
expression	O	NOUN	B
that	O	PRON	O
may	O	AUX	O
be	O	AUX	O
relevant	O	ADJ	B
to	O	PART	O
the	O	DET	O
possible	O	ADJ	O
longer	O	ADJ	B
latency	O	NOUN	I
and	O	CCONJ	O
reduced	O	VERB	B
pathogenicity	O	NOUN	B
of	O	ADP	O
HIV-2	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
report	O	VERB	O
here	O	ADV	O
that	O	SCONJ	O
both	O	CCONJ	O
NF-M-dependent	B-DNA	ADJ	B
promoter	I-DNA	NOUN	B
constructs	I-DNA	NOUN	I
and	O	CCONJ	O
resident	O	ADJ	B
genes	O	NOUN	O
could	O	AUX	O
be	O	AUX	O
activated	O	VERB	B
by	O	ADP	O
addition	O	NOUN	O
of	O	ADP	O
beta-estradiol	O	NOUN	B
to	O	PART	O
the	O	DET	O
NF-M-estrogen	B-cell_line	NOUN	B
receptor	I-cell_line	NOUN	I
expressing	I-cell_line	NOUN	B
progenitors	I-cell_line	NOUN	B
.	O	PUNCT	O


PRL	B-protein	NOUN	B
and	O	CCONJ	O
IL-2	B-protein	NOUN	B
receptor	O	NOUN	I
activation	O	NOUN	B
are	O	AUX	O
both	O	DET	O
linked	O	VERB	O
to	O	PART	O
the	O	DET	O
Jak/Stat	B-protein	NOUN	B
(	O	PUNCT	O
signal	B-protein	NOUN	B
transducer	I-protein	NOUN	I
and	I-protein	CCONJ	O
activator	I-protein	NOUN	O
of	I-protein	ADP	O
transcription	I-protein	NOUN	O
)	O	PUNCT	O
pathway	O	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
investigated	O	VERB	B
the	O	DET	O
ability	O	NOUN	O
of	O	ADP	O
PRL	B-protein	NOUN	B
and	O	CCONJ	O
IL-2	B-protein	NOUN	B
to	O	PART	O
activate	O	VERB	B
Stat	B-protein	NOUN	B
proteins	I-protein	NOUN	I
in	O	ADP	O
different	O	ADJ	O
T	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	B
emphasize	O	VERB	O
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
PRL	B-protein	NOUN	B
as	O	ADP	O
a	O	DET	O
regulator	O	NOUN	B
of	O	ADP	O
the	O	DET	O
immune	O	ADJ	B
response	O	NOUN	I
and	O	CCONJ	O
indicate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
Stat	B-protein	NOUN	B
factors	I-protein	NOUN	I
mammary	B-protein	ADJ	B
gland	I-protein	NOUN	I
factor-Stat5	I-protein	NOUN	B
and	O	CCONJ	O
Stat1	B-protein	NOUN	B
play	O	VERB	O
a	O	DET	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
gene	O	NOUN	B
expression	O	NOUN	I
during	O	ADP	O
T	O	NOUN	B
cell	O	NOUN	I
development	O	NOUN	B
.	O	PUNCT	O


Cis-acting	B-DNA	ADJ	B
elements	I-DNA	NOUN	I
with	O	ADP	O
NF	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
,	O	PUNCT	O
AP-1	B-protein	NOUN	B
and	O	CCONJ	O
ETS-like	B-DNA	ADJ	B
motifs	I-DNA	NOUN	B
have	O	AUX	O
been	O	AUX	O
identified	O	VERB	B
in	O	ADP	O
the	O	DET	O
promoter	O	NOUN	B
region	O	NOUN	I
of	O	ADP	O
the	O	DET	O
GM-CSF	B-DNA	NOUN	B
gene	I-DNA	NOUN	O
,	O	PUNCT	O
which	O	DET	O
are	O	AUX	O
important	O	ADJ	O
for	O	ADP	O
transcriptional	O	ADJ	B
activity	O	NOUN	I
following	O	VERB	O
PMA	O	NOUN	B
and	O	CCONJ	O
ionomycin	O	NOUN	B
stimulation	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
GM-CSF	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
,	O	PUNCT	O
modified	O	VERB	B
in	O	ADP	O
this	O	DET	O
way	O	NOUN	O
to	O	PART	O
be	O	AUX	O
ETS1	B-protein	NOUN	B
specific	O	ADJ	B
,	O	PUNCT	O
is	O	AUX	O
fully	O	ADV	O
responsive	O	ADJ	O
to	O	PART	O
PMA/ionomycin	O	NOUN	B
induction	O	NOUN	B
,	O	PUNCT	O
in	O	ADP	O
addition	O	NOUN	O
to	O	PART	O
ETS1	B-protein	NOUN	B
transactivation	O	NOUN	B
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
PMA	O	NOUN	B
and	O	CCONJ	O
ionomycin	O	NOUN	B
.	O	PUNCT	O


Data	O	NOUN	B
from	O	ADP	O
cell	O	NOUN	B
culture	O	NOUN	I
and	O	CCONJ	O
animal	O	NOUN	B
studies	O	NOUN	I
indicate	O	VERB	O
that	O	SCONJ	O
TR	B-protein	NOUN	B
expression	O	NOUN	B
may	O	AUX	O
be	O	AUX	O
regulated	O	VERB	O
to	O	PART	O
modulate	O	VERB	B
target	O	NOUN	B
organ	O	NOUN	B
responsiveness	O	NOUN	O
to	O	PART	O
thyroid	O	NOUN	B
hormone	O	NOUN	I
.	O	PUNCT	O


Human	B-RNA	ADJ	B
TR	I-RNA	NOUN	O
beta	I-RNA	NOUN	O
1	I-RNA	NUM	O
mRNA	I-RNA	NOUN	B
levels	O	NOUN	O
in	O	ADP	O
lymphocytes	B-cell_type	NOUN	B
were	O	AUX	O
1.8	O	NUM	O
+/-	O	CCONJ	O
0.4	O	NUM	O
,	O	PUNCT	O
1.9	O	NUM	O
+/-	O	CCONJ	O
0.5	O	NUM	O
,	O	PUNCT	O
1.1	O	NUM	O
+/-	O	CCONJ	O
0.4	O	NUM	O
10	O	NUM	O
(	O	PUNCT	O
-18	O	NUM	O
)	O	PUNCT	O
mol/microgram	O	NOUN	B
RNA	O	NOUN	B
in	O	ADP	O
hypo-	O	ADJ	O
,	O	PUNCT	O
eu	O	X	O
-and	O	NOUN	O
hyperthyroid	O	ADJ	B
patients	O	NOUN	B
,	O	PUNCT	O
respectively	O	ADV	O
,	O	PUNCT	O
corresponding	O	VERB	O
to	O	PART	O
an	O	DET	O
estimated	O	VERB	B
0.5	O	NUM	O
-2	O	NUM	O
molecules	O	NOUN	B
per	O	ADP	O
cell	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
strong	O	ADJ	O
repressor	B-protein	NOUN	B
element	I-protein	NOUN	B
,	O	PUNCT	O
termed	O	VERB	O
nuclear	B-protein	ADJ	B
inhibitory	I-protein	ADJ	I
protein	I-protein	NOUN	I
(	O	PUNCT	O
NIP	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
was	O	AUX	O
previously	O	ADV	O
mapped	O	VERB	B
to	O	PART	O
a	O	DET	O
segment	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IL-3	B-DNA	NOUN	B
promoter	I-DNA	NOUN	I
between	O	ADP	O
nucleotides	B-DNA	NOUN	B
-271	I-DNA	NUM	O
and	I-DNA	CCONJ	O
-250	I-DNA	NUM	O
.	O	PUNCT	O


DNA	O	NOUN	B
binding	O	NOUN	I
experiments	O	NOUN	I
were	O	AUX	O
carried	O	VERB	O
out	O	ADP	O
to	O	PART	O
characterize	O	VERB	O
the	O	DET	O
repressor	O	NOUN	B
activity	O	NOUN	B
.	O	PUNCT	O


Complex	B-protein	NOUN	B
1	I-protein	NUM	O
results	O	NOUN	B
from	O	ADP	O
binding	O	NOUN	B
of	O	ADP	O
a	O	DET	O
ubiquitous	O	ADJ	O
polypeptide	O	NOUN	B
that	O	PRON	O
recognizes	O	VERB	O
the	O	DET	O
3	B-DNA	NUM	O
'	I-DNA	PART	O
portion	I-DNA	NOUN	B
of	O	ADP	O
this	O	DET	O
sequence	O	NOUN	B
and	O	CCONJ	O
is	O	AUX	O
not	O	PART	O
required	O	VERB	O
for	O	ADP	O
repression	O	NOUN	B
.	O	PUNCT	O


B	O	NOUN	O
cell-specific	O	ADJ	B
transcriptional	O	ADJ	I
promoter	O	NOUN	O
activity	O	NOUN	O
mediated	O	VERB	O
by	O	ADP	O
the	O	DET	O
octamer	B-DNA	NOUN	B
motif	I-DNA	NOUN	B
requires	O	VERB	O
the	O	DET	O
Oct1	B-protein	NOUN	B
or	O	CCONJ	O
Oct2	B-protein	NOUN	B
protein	I-protein	NOUN	I
and	O	CCONJ	O
additional	O	ADJ	O
B	B-protein	NOUN	O
cell-restricted	I-protein	ADJ	O
cofactors	I-protein	NOUN	O
.	O	PUNCT	O


Stimulation	O	NOUN	B
of	O	ADP	O
cells	O	NOUN	B
with	O	ADP	O
anti-IgM	B-protein	NOUN	B
led	O	VERB	O
to	O	PART	O
increased	O	VERB	B
activity	O	NOUN	B
of	O	ADP	O
a	O	DET	O
nuclear	B-protein	ADJ	B
kinase	I-protein	NOUN	I
that	O	PRON	O
could	O	AUX	O
phosphorylate	O	VERB	B
the	O	DET	O
peptide	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
this	O	DET	O
activity	O	NOUN	B
was	O	AUX	O
reduced	O	VERB	B
by	O	ADP	O
10	O	NUM	O
microM	O	NOUN	O
KN-62	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
lymphoid	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
higher	O	ADJ	O
activation	O	NOUN	B
levels	O	NOUN	O
were	O	AUX	O
observed	O	VERB	B
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
distinct	O	ADJ	O
B-cell-specific	B-protein	ADJ	B
cofactors	I-protein	NOUN	I
in	O	ADP	O
concert	O	NOUN	O
with	O	ADP	O
the	O	DET	O
effector	B-protein	NOUN	B
domains	I-protein	NOUN	I
of	O	ADP	O
Oct-2a	B-protein	NOUN	B
might	O	AUX	O
be	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
mediating	O	VERB	O
transcription	O	NOUN	B
from	O	ADP	O
proximal	O	ADJ	B
and	O	CCONJ	O
remote	O	ADJ	B
positions	O	NOUN	B
.	O	PUNCT	O


Whereas	O	SCONJ	O
the	O	DET	O
mechanism	O	NOUN	B
of	O	ADP	O
nonopsonic	O	ADJ	B
phagocytosis	O	NOUN	I
of	O	ADP	O
Pseudomonas	O	X	B
aeruginosa	O	X	I
has	O	AUX	O
been	O	AUX	O
described	O	VERB	O
,	O	PUNCT	O
the	O	DET	O
bacterial	O	ADJ	B
ligands	O	NOUN	O
required	O	VERB	O
are	O	AUX	O
poorly	O	ADV	O
understood	O	VERB	O
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
report	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
following	O	VERB	O
incubation	O	NOUN	B
of	O	ADP	O
L540	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
(	O	PUNCT	O
Hodgkin	B-cell_line	NOUN	B
's	I-cell_line	PART	I
disease-derived	I-cell_line	ADJ	I
,	I-cell_line	PUNCT	O
T	I-cell_line	NOUN	B
cell-like	I-cell_line	ADJ	I
,	I-cell_line	PUNCT	O
CD30+	I-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
)	O	PUNCT	O
with	O	ADP	O
the	O	DET	O
agonistic	B-protein	ADJ	B
anti-CD30	I-protein	ADJ	O
monoclonal	I-protein	ADJ	O
antibodies	I-protein	NOUN	O
(	O	PUNCT	O
mAb	B-protein	NOUN	B
)	O	PUNCT	O
M44	B-protein	NOUN	B
and	O	CCONJ	O
M67	B-protein	NOUN	B
,	O	PUNCT	O
two	O	NUM	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
(	I-protein	PUNCT	O
NF	I-protein	NOUN	B
)	I-protein	PUNCT	O
-kappa	I-protein	NOUN	O
B	I-protein	NOUN	O
DNA	O	NOUN	B
binding	O	NOUN	I
activities	O	NOUN	I
were	O	AUX	O
induced	O	VERB	B
in	O	ADP	O
nuclear	O	ADJ	B
extracts	O	NOUN	I
,	O	PUNCT	O
as	O	ADP	O
determined	O	VERB	O
in	O	ADP	O
gel	O	NOUN	B
retardation	O	NOUN	I
assays	O	NOUN	I
.	O	PUNCT	O


Moreover	O	ADV	O
,	O	PUNCT	O
in	O	ADP	O
human	B-cell_line	ADJ	B
T	I-cell_line	NOUN	O
helper	I-cell_line	NOUN	O
(	I-cell_line	PUNCT	O
Th	I-cell_line	NOUN	B
)	I-cell_line	PUNCT	O
clones	I-cell_line	NOUN	B
functionally	O	ADV	O
characterized	O	VERB	B
as	O	ADP	O
being	O	AUX	O
of	O	ADP	O
the	O	DET	O
type	O	NOUN	O
0	O	NUM	O
,	O	PUNCT	O
type	O	NOUN	O
1	O	NUM	O
and	O	CCONJ	O
type	O	NOUN	B
2	O	NUM	I
(	O	PUNCT	O
28	O	NUM	O
%	O	NOUN	O
,	O	PUNCT	O
<	O	X	O
1	O	NUM	O
%	O	NOUN	O
und	O	ADV	O
93	O	NUM	O
%	O	NOUN	O
CD30+	O	NOUN	B
,	O	PUNCT	O
respectively	O	ADV	O
)	O	PUNCT	O
,	O	PUNCT	O
the	O	DET	O
extent	O	NOUN	O
of	O	ADP	O
CD30	B-protein	NOUN	B
-mediated	O	ADJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activation	O	NOUN	B
correlated	O	VERB	B
with	O	ADP	O
the	O	DET	O
proportion	O	NOUN	B
of	O	ADP	O
CD30+	B-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Pathogenesis	O	NOUN	B
of	O	ADP	O
atherosclerosis	O	NOUN	B
.	O	PUNCT	O


RESULTS	O	NOUN	B
:	O	PUNCT	O
Both	O	CCONJ	O
the	O	DET	O
epithelium	O	NOUN	B
and	O	CCONJ	O
subepithelium	O	NOUN	B
of	O	ADP	O
the	O	DET	O
tarsal	O	ADJ	B
and	O	CCONJ	O
bulbar	O	ADJ	B
conjunctiva	O	NOUN	I
of	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
VKC	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
those	O	DET	O
of	O	ADP	O
four	O	NUM	O
nonatopic	O	ADJ	B
control	O	ADJ	O
subjects	O	NOUN	O
,	O	PUNCT	O
showed	O	VERB	O
intense	O	ADJ	O
positive	O	ADJ	B
staining	O	NOUN	B
for	O	ADP	O
estrogen	O	NOUN	B
and	O	CCONJ	O
progesterone	B-protein	NOUN	B
receptors	I-protein	NOUN	I
.	O	PUNCT	O


Associations	O	NOUN	B
between	O	ADP	O
HLA	B-protein	NOUN	B
class	I-protein	NOUN	I
II	I-protein	NUM	I
antigens	I-protein	NOUN	B
and	O	CCONJ	O
autoantibodies	B-protein	NOUN	B
to	O	PART	O
the	O	DET	O
ribonucleoproteins	B-protein	NOUN	B
Ro	B-protein	NOUN	B
(	I-protein	PUNCT	O
SSA	I-protein	PROPN	B
)	I-protein	PUNCT	O
and	O	CCONJ	O
La	B-protein	NOUN	B
(	I-protein	PUNCT	O
SSB	I-protein	NOUN	B
)	I-protein	PUNCT	O
have	O	AUX	O
been	O	AUX	O
reported	O	VERB	O
in	O	ADP	O
these	O	DET	O
patients	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
majority	O	NOUN	O
of	O	ADP	O
patients	O	NOUN	B
who	O	PRON	O
have	O	AUX	O
these	O	DET	O
RFLPs	B-DNA	NOUN	B
and	O	CCONJ	O
HLA	B-protein	NOUN	B
class	I-protein	NOUN	I
II	I-protein	NUM	I
antigens	I-protein	NOUN	B
previously	O	ADV	O
associated	O	VERB	B
with	O	ADP	I
the	O	DET	O
anti-	O	NOUN	B
Ro	B-protein	NOUN	I
(	I-protein	PUNCT	O
SSA	I-protein	ADJ	B
)	I-protein	PUNCT	O
response	O	NOUN	B
make	O	VERB	O
this	O	DET	O
antibody	O	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
interactions	O	NOUN	B
between	O	ADP	O
products	O	NOUN	B
of	O	ADP	O
these	O	DET	O
loci	B-DNA	NOUN	B
occur	I-DNA	VERB	O
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
Ro	B-protein	NOUN	B
(	I-protein	PUNCT	O
SSA	I-protein	PROPN	B
)	I-protein	PUNCT	O
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
C	I-protein	NOUN	I
stimulation	O	NOUN	B
or	O	CCONJ	O
RelA	B-protein	NOUN	B
overexpression	O	NOUN	B
does	O	AUX	O
not	O	PART	O
affect	O	VERB	O
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
a	O	DET	O
human	B-DNA	ADJ	B
IL4	I-DNA	NOUN	B
promoter	I-DNA	NOUN	B
containing	O	VERB	O
a	O	DET	O
mouse	B-DNA	NOUN	B
P	I-DNA	NOUN	O
sequence	I-DNA	NOUN	O
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
a	O	DET	O
higher-affinity	B-DNA	ADJ	B
site	I-DNA	NOUN	I
for	O	ADP	O
NF-ATp	B-protein	NOUN	B
and	O	CCONJ	O
a	O	DET	O
lower-affinity	B-DNA	ADJ	B
site	I-DNA	NOUN	I
for	O	ADP	O
RelA	B-protein	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
used	O	VERB	O
mononuclear	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
priming	I-cell_line	NOUN	B
cultures	I-cell_line	NOUN	B
and	O	CCONJ	O
inflammatory	B-cell_type	ADJ	B
synovial	I-cell_type	ADJ	I
fluids	I-cell_type	NOUN	I
(	O	PUNCT	O
SFs	B-cell_type	NOUN	B
)	O	PUNCT	O
derived	O	VERB	O
from	O	ADP	O
arthritis	O	NOUN	B
patients	O	NOUN	B
to	O	PART	O
examine	O	VERB	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
cytokine	B-protein	NOUN	B
production	O	NOUN	I
and	O	CCONJ	O
STAT	B-protein	NOUN	B
activity	O	NOUN	I
by	O	ADP	O
an	O	DET	O
inflammatory	O	ADJ	B
synovial	O	ADJ	B
microenvironment	O	NOUN	B
.	O	PUNCT	O


Monocyte/macrophages	B-cell_type	NOUN	B
may	O	AUX	O
harbor	O	VERB	O
HIV	O	NOUN	B
in	O	ADP	O
a	O	DET	O
nonproductive	O	ADJ	O
fashion	O	NOUN	O
for	O	ADP	O
prolonged	O	ADJ	B
periods	O	NOUN	B
of	O	ADP	O
time	O	NOUN	B
.	O	PUNCT	O


Taken	O	VERB	O
together	O	ADV	O
,	O	PUNCT	O
these	O	DET	O
observations	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
HIV	O	NOUN	B
gene	O	NOUN	B
expression	O	NOUN	I
may	O	AUX	O
be	O	AUX	O
activated	O	VERB	B
in	O	ADP	O
infected	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
through	O	ADP	O
interaction	O	NOUN	B
of	O	ADP	O
the	O	DET	O
cells	O	NOUN	B
with	O	ADP	O
complement-opsonized	B-protein	ADJ	B
particles	I-protein	NOUN	I
and	O	CCONJ	O
that	O	SCONJ	O
enhanced	O	VERB	B
viral	O	ADJ	B
replication	O	NOUN	I
is	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
C3	B-protein	NOUN	B
receptor	I-protein	NOUN	I
-mediated	O	ADJ	O
nuclear	O	ADJ	B
translocation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
complex	I-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
changes	O	NOUN	B
in	O	ADP	O
gene	O	NOUN	B
expression	O	NOUN	I
brought	O	VERB	O
about	O	ADP	O
by	O	ADP	O
gamma	B-protein	NOUN	B
interferon	I-protein	NOUN	I
are	O	AUX	O
thought	O	VERB	O
to	O	PART	O
involve	O	VERB	O
transient	O	ADJ	B
increases	O	NOUN	B
in	O	ADP	O
the	O	DET	O
activities	O	NOUN	B
of	O	ADP	O
cellular	B-protein	ADJ	B
protein	I-protein	NOUN	I
tyrosine	I-protein	NOUN	I
kinases	I-protein	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
the	O	DET	O
Janus	B-protein	NOUN	B
kinases	I-protein	NOUN	I
Jak1	B-protein	NOUN	I
and	O	CCONJ	O
Jak2	B-protein	NOUN	B
,	O	PUNCT	O
leading	O	VERB	O
to	O	PART	O
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
Stat1	I-protein	NOUN	B
.	O	PUNCT	O


Jak1	B-protein	NOUN	B
,	O	PUNCT	O
Jak2	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
Stat1	B-protein	NOUN	B
were	O	AUX	O
immunoprecipitated	O	VERB	B
from	O	ADP	O
control	O	NOUN	B
and	O	CCONJ	O
interferon-treated	B-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	I
of	O	ADP	O
these	O	DET	O
proteins	O	NOUN	B
,	O	PUNCT	O
detected	O	VERB	B
by	O	ADP	O
antiphosphotyrosine	O	ADJ	B
immunoblotting	O	NOUN	I
was	O	AUX	O
used	O	VERB	O
to	O	PART	O
measured	O	VERB	B
their	O	PRON	O
activation	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
observation	O	NOUN	B
that	O	SCONJ	O
binding	O	VERB	B
sites	O	NOUN	I
for	O	ADP	O
the	O	DET	O
nuclear	B-protein	ADJ	B
factor-mu	I-protein	ADJ	I
negative	I-protein	ADJ	I
regulator	I-protein	NOUN	I
(	I-protein	PUNCT	O
NF-muNR	I-protein	NOUN	B
)	I-protein	PUNCT	O
enhancer	I-protein	NOUN	O
repressor	I-protein	NOUN	O
overlap	I-protein	NOUN	B
nuclear	I-protein	ADJ	B
matrix	I-protein	NOUN	I
attachment	I-protein	NOUN	I
regions	I-protein	NOUN	I
(	O	PUNCT	O
MARs	B-protein	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
this	O	DET	O
enhancer	B-DNA	NOUN	B
has	O	AUX	O
lead	O	VERB	O
to	O	PART	O
the	O	DET	O
hypothesis	O	NOUN	B
that	O	SCONJ	O
the	O	DET	O
cell	O	NOUN	B
type	O	NOUN	I
specificity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
enhancer	B-DNA	NOUN	B
might	O	AUX	O
be	O	AUX	O
controlled	O	VERB	B
by	O	ADP	O
regulating	O	VERB	B
nuclear	O	ADJ	B
matrix	O	NOUN	I
attachment	O	NOUN	B
(	O	PUNCT	O
Scheuermann	O	PROPN	B
,	O	PUNCT	O
R.	O	PROPN	O
H.	O	PROPN	O
,	O	PUNCT	O
and	O	CCONJ	O
Chen	O	PROPN	O
,	O	PUNCT	O
U.	O	PROPN	O
(	O	PUNCT	O
1989	O	NUM	O
)	O	PUNCT	O
Genes	O	NOUN	O
&	O	CCONJ	O
Dev.	O	NOUN	O
3	O	NUM	O
,	O	PUNCT	O
1255-1266	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


PU.1	B-protein	NOUN	B
(	O	PUNCT	O
Spi-1	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
C/EBP	B-protein	NOUN	B
alpha	I-protein	NOUN	I
regulate	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
granulocyte-macrophage	B-DNA	ADJ	B
colony-stimulating	I-DNA	ADJ	I
factor	I-DNA	NOUN	I
receptor	I-DNA	NOUN	I
alpha	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
.	O	PUNCT	O


C/EBP	B-protein	NOUN	B
alpha	I-protein	NOUN	I
is	O	AUX	O
the	O	DET	O
major	O	ADJ	O
CCAAT/enhancer-binding	B-protein	ADJ	B
protein	I-protein	NOUN	I
(	O	PUNCT	O
C/EBP	B-protein	NOUN	B
)	O	PUNCT	O
form	O	NOUN	O
binding	O	VERB	B
to	O	PART	O
this	O	DET	O
site	O	NOUN	B
in	O	ADP	O
nuclear	O	ADJ	B
extracts	O	NOUN	I
of	O	ADP	O
U937	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Point	O	NOUN	B
mutations	O	NOUN	I
of	O	ADP	O
either	O	CCONJ	O
the	O	DET	O
PU.1	B-DNA	NOUN	B
site	I-DNA	NOUN	I
or	O	CCONJ	O
the	O	DET	O
C/EBP	B-DNA	NOUN	B
site	I-DNA	NOUN	I
that	O	PRON	O
abolish	O	VERB	B
the	O	DET	O
binding	O	NOUN	B
of	O	ADP	O
the	O	DET	O
respective	O	ADJ	O
factors	O	NOUN	B
result	O	VERB	B
in	O	ADP	O
a	O	DET	O
significant	O	ADJ	O
decrease	O	NOUN	B
of	O	ADP	O
GM-CSF	B-DNA	NOUN	B
receptor	I-DNA	NOUN	I
alpha	I-DNA	NOUN	I
promoter	I-DNA	NOUN	B
activity	O	NOUN	I
in	O	ADP	O
myelomonocytic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
only	O	ADV	O
.	O	PUNCT	O


Constitutive	O	ADJ	B
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	B
of	O	ADP	O
a	O	DET	O
130-kD	B-protein	ADJ	O
protein	I-protein	NOUN	B
(	O	PUNCT	O
s	O	NOUN	O
)	O	PUNCT	O
was	O	AUX	O
observed	O	VERB	O
in	O	ADP	O
the	O	DET	O
tax	B-protein	NOUN	O
transformed	B-cell_line	VERB	O
fibroblast	I-cell_line	NOUN	O
B	I-cell_line	NOUN	O
line	I-cell_line	NOUN	O
and	O	CCONJ	O
in	O	ADP	O
HTLV-1	B-cell_line	NOUN	B
transformed	I-cell_line	ADJ	O
human	I-cell_line	ADJ	B
lymphoid	I-cell_line	ADJ	O
lines	I-cell_line	NOUN	O
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
in	O	ADP	O
thymocytes	B-cell_type	NOUN	B
from	O	ADP	O
Thy-tax	O	NOUN	B
transgenic	O	ADJ	B
mice	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
strongly	O	ADV	O
suggest	O	VERB	O
that	O	SCONJ	O
HU	O	NOUN	B
induces	O	VERB	B
both	O	CCONJ	O
transcriptional	O	ADJ	B
and	O	CCONJ	O
post-transcription	O	ADJ	B
regulation	O	NOUN	I
of	O	ADP	O
c-jun	B-DNA	NOUN	B
during	O	ADP	O
erythroid	O	ADJ	B
differentiation	O	NOUN	B
.	O	PUNCT	O


Glucocorticoid	O	NOUN	B
effects	O	NOUN	I
were	O	AUX	O
assessed	O	VERB	B
in	O	X	B
vivo	O	X	I
by	O	ADP	O
depletion	O	NOUN	B
of	O	ADP	O
endogenous	O	ADJ	B
glucocorticoids	O	NOUN	B
after	O	ADP	O
oral	O	ADJ	B
administration	O	NOUN	I
of	O	ADP	O
1.5	O	NUM	O
g	O	NOUN	O
metyrapone	O	NOUN	B
(	O	PUNCT	O
MET	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
subsequent	O	ADJ	O
glucocorticoid	O	NOUN	B
replacement	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
in	O	X	B
vitro	O	X	I
by	O	ADP	O
incubation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
cells	O	NOUN	B
with	O	ADP	O
different	O	ADJ	O
doses	O	NOUN	B
of	O	ADP	O
dexamethasone	O	NOUN	B
(	O	PUNCT	O
DEX	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Transcription	O	NOUN	B
specific	O	ADJ	O
differences	O	NOUN	O
visualized	O	VERB	O
by	O	ADP	O
fluorescence	O	NOUN	B
in	O	X	I
situ	O	X	I
hybridization	O	NOUN	I
pattern	O	NOUN	B
on	O	ADP	O
interphase	O	NOUN	B
nuclei	O	NOUN	I
of	O	ADP	O
different	O	ADJ	O
cell	O	NOUN	B
types	O	NOUN	I
.	O	PUNCT	O


Correspondingly	O	ADV	O
,	O	PUNCT	O
RNase	B-protein	NOUN	B
treatment	O	NOUN	B
had	O	AUX	O
no	O	DET	B
effect	O	NOUN	I
on	O	ADP	O
hybridization	O	NOUN	B
pattern	O	NOUN	B
at	O	ADP	O
all	O	ADV	O
.	O	PUNCT	O


In	O	ADP	O
conclusion	O	NOUN	O
an	O	DET	O
increased	O	VERB	B
transcription	O	NOUN	B
efficiency	O	NOUN	B
of	O	ADP	O
a	O	DET	O
cell	O	NOUN	B
type	O	NOUN	I
specific	O	ADJ	I
gene	O	NOUN	I
is	O	AUX	O
accompanied	O	VERB	O
by	O	ADP	O
a	O	DET	O
higher	O	ADJ	B
hybridization	O	NOUN	B
accessibility	O	NOUN	B
in	O	ADP	O
the	O	DET	O
corresponding	O	ADJ	O
cell	O	NOUN	B
nuclei	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
reasons	O	NOUN	B
for	O	ADP	O
the	O	DET	O
dissimilar	O	ADJ	O
oncogenicities	O	NOUN	B
of	O	ADP	O
human	O	ADJ	B
adenoviruses	O	NOUN	B
and	O	CCONJ	O
human	O	ADJ	B
papillomaviruses	O	NOUN	I
(	O	PUNCT	O
HPV	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
humans	O	NOUN	B
are	O	AUX	O
unknown	O	ADJ	O
but	O	CCONJ	O
may	O	AUX	O
relate	O	VERB	O
to	O	PART	O
differences	O	NOUN	B
in	O	ADP	O
the	O	DET	O
capacities	O	NOUN	B
of	O	ADP	O
the	O	DET	O
E1A	B-protein	NOUN	B
and	O	CCONJ	O
E7	B-protein	NOUN	B
proteins	I-protein	NOUN	I
to	O	PART	O
target	B-cell_type	VERB	B
cells	I-cell_type	NOUN	I
for	O	ADP	O
rejection	O	NOUN	B
by	O	ADP	O
the	O	DET	O
host	B-cell_type	NOUN	B
natural	I-cell_type	ADJ	O
killer	I-cell_type	NOUN	O
(	I-cell_type	PUNCT	O
NK	I-cell_type	NOUN	O
)	I-cell_type	PUNCT	O
cell	I-cell_type	NOUN	B
response	O	NOUN	I
.	O	PUNCT	O


Cells	O	NOUN	B
expressing	O	VERB	B
the	O	DET	O
E1A	B-protein	NOUN	B
oncoprotein	I-protein	NOUN	I
were	O	AUX	O
selectively	O	ADV	O
killed	O	VERB	B
by	O	ADP	O
unstimulated	B-cell_line	ADJ	B
NK	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
while	O	SCONJ	O
the	O	DET	O
same	O	ADJ	O
parental	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
but	O	CCONJ	O
expressing	O	VERB	B
the	O	DET	O
HPV	O	NOUN	B
type	O	NOUN	I
16	O	NUM	I
(	O	PUNCT	O
HPV-16	O	NOUN	B
)	O	PUNCT	O
or	O	CCONJ	O
HPV-18	O	NOUN	B
E7	B-protein	NOUN	I
oncoprotein	I-protein	NOUN	I
were	O	AUX	O
resistant	O	ADJ	B
to	O	PART	O
NK	O	NOUN	B
cell	O	NOUN	I
lysis	O	NOUN	O
.	O	PUNCT	O


Oxidative	O	ADJ	B
stress	O	NOUN	I
enhances	O	VERB	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
(	O	PUNCT	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
)	O	PUNCT	O
activity	O	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activity	O	NOUN	O
has	O	AUX	O
been	O	AUX	O
shown	O	VERB	O
to	O	PART	O
enhance	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
cytotoxic	B-protein	ADJ	B
cytokines	I-protein	NOUN	B
.	O	PUNCT	O


In	O	X	B
vitro	O	X	I
treatment	O	NOUN	B
of	O	ADP	O
a	O	DET	O
monocyte/macrophage	O	NOUN	B
cell	O	NOUN	I
line	O	NOUN	I
with	O	ADP	O
CCl4	O	NOUN	B
led	O	VERB	O
to	O	PART	O
enhanced	O	VERB	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
binding	O	NOUN	O
and	O	CCONJ	O
an	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
tumor	B-RNA	NOUN	B
necrosis	I-RNA	NOUN	I
factor-alpha	I-RNA	NOUN	I
(	I-RNA	PUNCT	O
TNF-alpha	I-RNA	NOUN	B
)	I-RNA	PUNCT	O
messenger	I-RNA	NOUN	O
RNA	I-RNA	NOUN	O
levels	O	NOUN	O
.	O	PUNCT	O


By	O	ADP	O
combining	O	VERB	O
partially	B-protein	ADV	O
purified	I-protein	VERB	B
proteins	I-protein	NOUN	I
in	O	X	B
vitro	O	X	I
,	O	PUNCT	O
we	O	PRON	O
observed	O	VERB	O
the	O	DET	O
loss	O	NOUN	B
of	O	ADP	O
the	O	DET	O
bound	O	VERB	B
NFATp/AP-1-DNA	B-protein	NOUN	B
complex	I-protein	NOUN	I
upon	O	SCONJ	O
inclusion	O	NOUN	B
of	O	ADP	O
VDR	B-protein	NOUN	B
or	O	CCONJ	O
VDR-retinoid	B-protein	NOUN	B
X	I-protein	NOUN	I
receptor	I-protein	NOUN	I
.	O	PUNCT	O


Order	O	NOUN	B
of	O	ADP	O
addition	O	NOUN	O
and	O	CCONJ	O
off-rate	O	ADJ	B
experiments	O	NOUN	I
indicate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
VDR-retinoid	B-protein	NOUN	B
X	I-protein	NOUN	I
receptor	I-protein	NOUN	I
heterodimer	I-protein	NOUN	I
blocks	O	VERB	O
NFATp/AP-1	B-protein	NOUN	B
complex	I-protein	NOUN	I
formation	O	NOUN	B
and	O	CCONJ	O
then	O	ADV	O
stably	O	ADV	B
associates	O	VERB	B
with	O	ADP	I
the	O	DET	O
NF-AT-1	B-DNA	NOUN	B
element	I-DNA	NOUN	B
.	O	PUNCT	O


These	O	DET	O
binding	O	VERB	B
sites	O	NOUN	I
have	O	AUX	O
similar	O	ADJ	O
sequences	O	NOUN	B
and	O	CCONJ	O
multiple	O	ADJ	B
copies	O	NOUN	B
of	O	ADP	O
the	O	DET	O
binding	B-DNA	VERB	B
sites	I-DNA	NOUN	I
confer	O	VERB	O
tissue-specific	O	ADJ	B
down-regulation	O	NOUN	I
when	O	SCONJ	O
attached	O	VERB	O
to	O	PART	O
a	O	DET	O
minimal	B-DNA	ADJ	B
lox	I-DNA	NOUN	B
promoter	I-DNA	NOUN	I
fragment	I-DNA	NOUN	I
.	O	PUNCT	O


Transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
as	O	ADP	O
targets	O	NOUN	B
for	O	ADP	O
oxidative	O	ADJ	B
signalling	O	NOUN	I
during	O	ADP	O
lymphocyte	O	NOUN	B
activation	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
current	O	ADJ	O
study	O	NOUN	B
,	O	PUNCT	O
cysteamine	O	NOUN	B
,	O	PUNCT	O
an	O	DET	O
aminothiol	O	NOUN	B
compound	O	NOUN	I
with	O	ADP	O
antioxidant	O	ADJ	B
activity	O	NOUN	I
,	O	PUNCT	O
has	O	AUX	O
been	O	AUX	O
used	O	VERB	O
to	O	PART	O
further	O	ADV	O
investigate	O	VERB	B
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
oxidative	O	ADJ	B
signalling	O	NOUN	I
during	O	ADP	O
lymphocyte	O	NOUN	B
activation	O	NOUN	I
.	O	PUNCT	O


It	O	PRON	O
therefore	O	ADV	O
was	O	AUX	O
of	O	ADP	O
interest	O	NOUN	O
to	O	PART	O
establish	O	VERB	O
which	O	DET	O
,	O	PUNCT	O
if	O	SCONJ	O
any	O	DET	O
,	O	PUNCT	O
commitment	O	NOUN	B
events	O	NOUN	I
were	O	AUX	O
affected	O	VERB	B
by	O	ADP	O
oxidative	O	ADJ	B
signalling	O	NOUN	I
during	O	ADP	O
cell	O	NOUN	B
cycle	O	NOUN	I
entry	O	NOUN	I
.	O	PUNCT	O


Taking	O	VERB	O
the	O	DET	O
IL-2	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
as	O	ADP	O
a	O	DET	O
candidate	O	NOUN	O
,	O	PUNCT	O
we	O	PRON	O
examined	O	VERB	O
the	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
cysteamine	O	NOUN	B
treatment	O	NOUN	B
on	O	ADP	O
early	B-DNA	ADJ	O
gene	I-DNA	NOUN	B
expression	O	NOUN	I
during	O	ADP	O
lymphocyte	O	NOUN	B
activation	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
on	O	ADP	O
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
AP-1	B-protein	NOUN	B
,	O	PUNCT	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
,	O	PUNCT	O
NF-AT	B-protein	NOUN	B
and	O	CCONJ	O
Oct1	B-protein	NOUN	B
,	O	PUNCT	O
whose	O	DET	O
functions	O	NOUN	B
are	O	AUX	O
required	O	VERB	O
for	O	ADP	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IL-2	B-protein	NOUN	B
mRNA	O	NOUN	B
.	O	PUNCT	O


Twenty	O	NUM	O
two	O	NUM	O
healthy	O	ADJ	B
men	O	NOUN	B
aged	O	ADJ	B
21-66	O	NUM	O
yr	O	NOUN	O
(	O	PUNCT	O
mean	O	NOUN	O
+/-	O	CCONJ	O
SD	O	NOUN	B
41.0	O	NUM	O
+/-	O	CCONJ	O
13.6	O	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
nineteen	O	NUM	O
healthy	O	ADJ	B
women	O	NOUN	B
aged	O	ADJ	B
22-60	O	NUM	O
yr	O	NOUN	O
(	O	PUNCT	O
38.9	O	NUM	O
+/-	O	CCONJ	O
13.9	O	NUM	O
)	O	PUNCT	O
have	O	AUX	O
been	O	AUX	O
studied	O	VERB	O
.	O	PUNCT	O


Further	O	ADJ	O
studies	O	NOUN	B
are	O	AUX	O
needed	O	VERB	O
to	O	PART	O
elucidate	O	VERB	O
if	O	SCONJ	O
this	O	DET	O
sex	O	NOUN	B
difference	O	NOUN	O
in	O	ADP	O
PBMC	B-protein	NOUN	B
receptors	I-protein	NOUN	B
for	O	ADP	O
1.25	O	NUM	O
Dihydroxyvitamin	O	NOUN	B
D3	O	NOUN	I
is	O	AUX	O
of	O	ADP	O
any	O	DET	O
pathophysiological	O	ADJ	B
relevance	O	NOUN	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
sodium	O	NOUN	B
salicylate	O	NOUN	I
blocked	O	VERB	B
the	O	DET	O
LPS-induced	O	ADJ	B
proteolytic	O	ADJ	B
degradation	O	NOUN	I
of	O	ADP	O
I	B-protein	NOUN	O
kappa	I-protein	NOUN	O
B	I-protein	NOUN	O
alpha	I-protein	NOUN	O
,	O	PUNCT	O
which	O	DET	O
prevented	O	VERB	B
the	O	DET	O
nuclear	O	ADJ	B
translocation	O	NOUN	I
of	O	ADP	O
c-Rel/p65	B-protein	NOUN	B
heterodimers	I-protein	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
two	O	NUM	O
other	O	ADJ	O
nonsteroidal	O	ADJ	B
anti-inflammatory	O	ADJ	I
drugs	O	NOUN	I
,	O	PUNCT	O
ibuprofen	O	NOUN	B
and	O	CCONJ	O
indomethacin	O	NOUN	B
,	O	PUNCT	O
did	O	AUX	O
not	O	PART	O
inhibit	O	VERB	B
LPS	O	NOUN	B
induction	O	NOUN	B
of	O	ADP	O
the	O	DET	O
TF	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
.	O	PUNCT	O


Critical	O	ADJ	B
role	O	NOUN	I
for	O	ADP	O
IL-6	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
T	O	NOUN	B
cell	O	NOUN	I
activation	O	NOUN	B
is	O	AUX	O
initiated	O	VERB	O
by	O	ADP	O
interaction	O	NOUN	B
of	O	ADP	O
specific	O	ADJ	O
Ags	B-protein	NOUN	B
with	O	ADP	O
TCR	B-protein	NOUN	B
,	O	PUNCT	O
followed	O	VERB	O
by	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
intracellular	O	ADJ	B
biochemical	O	ADJ	B
events	O	NOUN	O
leading	O	VERB	O
to	O	PART	O
activation	O	NOUN	B
of	O	ADP	O
several	O	ADJ	O
genes	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
purified	B-cell_type	VERB	B
human	I-cell_type	ADJ	B
peripheral	I-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
nuclear	B-protein	ADJ	B
STAT	I-protein	NOUN	I
proteins	I-protein	NOUN	I
were	O	AUX	O
activated	O	VERB	B
approximately	O	ADV	O
3	O	NUM	O
h	O	NOUN	O
after	O	ADP	O
activation	O	NOUN	B
by	O	ADP	O
cross-linked	O	ADJ	B
anti-CD3	B-protein	ADJ	B
Abs	I-protein	NOUN	B
.	O	PUNCT	O


Northern	O	NOUN	B
blot	O	NOUN	I
analysis	O	NOUN	I
revealed	O	VERB	O
that	O	SCONJ	O
BLR2	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
could	O	AUX	O
be	O	AUX	O
highly	O	ADV	O
stimulated	O	VERB	B
in	O	ADP	O
mitogen-	B-cell_line	NOUN	B
and	I-cell_line	CCONJ	O
anti-CD3-treated	I-cell_line	ADJ	B
peripheral	I-cell_line	ADJ	B
blood	I-cell_line	NOUN	I
lymphocytes	I-cell_line	NOUN	I
.	O	PUNCT	O


BLR2-specific	B-RNA	ADJ	B
mRNA	I-RNA	NOUN	B
could	O	AUX	O
be	O	AUX	O
detected	O	VERB	B
in	O	ADP	O
all	O	DET	O
Epstein-Barr	B-cell_line	ADJ	B
virus	I-cell_line	NOUN	I
positive	I-cell_line	ADJ	B
B	I-cell_line	NOUN	I
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
.	O	PUNCT	O


Activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
interleukin	B-DNA	NOUN	B
2	I-DNA	NUM	I
(	I-DNA	PUNCT	O
IL-2	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
gene	I-DNA	NOUN	O
after	O	ADP	O
antigen	O	NOUN	B
recognition	O	NOUN	I
is	O	AUX	O
a	O	DET	O
critical	O	ADJ	O
event	O	NOUN	O
for	O	ADP	O
T	O	NOUN	B
cell	O	NOUN	I
proliferation	O	NOUN	I
and	O	CCONJ	O
effector	O	NOUN	B
function	O	NOUN	I
.	O	PUNCT	O


Addition	O	NOUN	B
of	O	ADP	O
TFE-3	B-protein	NOUN	B
,	O	PUNCT	O
which	O	DET	O
binds	O	VERB	B
to	O	PART	O
an	O	DET	O
E-box	B-DNA	NOUN	B
motif	I-DNA	NOUN	B
upstream	O	ADJ	I
of	O	ADP	O
the	O	DET	O
LEF-1	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
Ets-1	I-DNA	NOUN	B
sites	I-DNA	NOUN	O
,	O	PUNCT	O
further	O	ADV	O
augments	O	VERB	O
transcription	O	NOUN	B
in	O	ADP	O
this	O	DET	O
system	O	NOUN	B
.	O	PUNCT	O


Immunoprecipitation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
gp	B-protein	NOUN	B
160	I-protein	NUM	O
-induced	O	ADJ	O
nuclear	O	ADJ	B
extracts	O	NOUN	I
with	O	ADP	O
polyclonal	B-protein	ADJ	B
antibodies	I-protein	NOUN	I
to	O	PART	O
Fos	B-protein	NOUN	B
and	O	CCONJ	O
Jun	B-protein	NOUN	B
proteins	I-protein	NOUN	I
indicates	O	VERB	O
that	O	SCONJ	O
AP-1	B-protein	NOUN	B
complex	I-protein	NOUN	I
is	O	AUX	O
comprised	O	VERB	O
of	O	ADP	O
members	O	NOUN	B
of	O	ADP	O
these	O	DET	O
family	O	NOUN	B
of	O	ADP	I
proteins	O	NOUN	I
.	O	PUNCT	O


Activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
CD28	B-protein	NOUN	B
surface	I-protein	NOUN	I
receptor	I-protein	NOUN	I
provides	O	VERB	O
a	O	DET	O
major	O	ADJ	O
costimulatory	O	ADJ	B
signal	O	NOUN	I
for	O	ADP	O
T	O	NOUN	B
cell	O	NOUN	I
activation	O	NOUN	B
resulting	O	VERB	O
in	O	ADP	O
enhanced	O	VERB	B
production	O	NOUN	B
of	O	ADP	O
interleukin-2	B-protein	NOUN	B
(	O	PUNCT	O
IL-2	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
cell	O	NOUN	B
proliferation	O	NOUN	I
.	O	PUNCT	O


Further	O	ADV	O
,	O	PUNCT	O
while	O	SCONJ	O
specific	O	ADJ	O
constitutive	O	ADJ	B
binding	O	NOUN	B
to	O	PART	O
the	O	DET	O
peri-kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
site	I-DNA	NOUN	I
is	O	AUX	O
seen	O	VERB	O
in	O	ADP	O
monocytes	B-cell_type	NOUN	B
,	O	PUNCT	O
stimulation	O	NOUN	B
with	O	ADP	O
phorbol	O	NOUN	B
esters	O	NOUN	I
induces	O	VERB	O
additional	O	ADJ	O
,	O	PUNCT	O
specific	O	ADJ	O
binding	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
inability	O	NOUN	B
of	O	ADP	O
E1A	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
products	O	NOUN	I
to	O	PART	O
induce	O	VERB	B
cytolytic	O	ADJ	B
susceptibility	O	NOUN	I
during	O	ADP	O
infection	O	NOUN	B
was	O	AUX	O
not	O	PART	O
explained	O	VERB	O
by	O	ADP	O
an	O	DET	O
inhibitory	O	ADJ	B
effect	O	NOUN	O
of	O	ADP	O
viral	O	ADJ	B
infection	O	NOUN	I
on	O	ADP	O
otherwise	O	ADV	O
susceptible	O	ADJ	B
target	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
or	O	CCONJ	O
by	O	ADP	O
viral	B-DNA	ADJ	B
gene	I-DNA	NOUN	I
effects	O	NOUN	O
on	O	ADP	O
class	B-protein	NOUN	B
I	I-protein	NUM	I
MHC	I-protein	NOUN	I
antigen	I-protein	NOUN	I
expression	O	NOUN	B
on	O	ADP	O
target	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Distinct	O	ADJ	O
signaling	O	NOUN	B
properties	O	NOUN	B
identify	O	VERB	O
functionally	O	ADV	O
different	O	ADJ	O
CD4	B-protein	NOUN	B
epitopes	I-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
CD4	B-protein	NOUN	B
coreceptor	I-protein	NOUN	I
interacts	O	VERB	O
with	O	ADP	O
non-polymorphic	B-protein	ADJ	B
regions	I-protein	NOUN	I
of	O	ADP	O
major	B-protein	ADJ	O
histocompatibility	I-protein	NOUN	O
complex	I-protein	NOUN	O
class	I-protein	NOUN	O
II	I-protein	NUM	O
molecules	I-protein	NOUN	O
on	O	ADP	O
antigen-presenting	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
contributes	O	VERB	O
to	O	PART	O
T	O	NOUN	B
cell	O	NOUN	I
activation	O	NOUN	B
.	O	PUNCT	O


Whereas	O	SCONJ	O
different	O	ADJ	O
anti-CD4	B-protein	ADJ	B
mAb	I-protein	NOUN	B
or	O	CCONJ	O
HIV-1	B-protein	NOUN	B
gp120	I-protein	NOUN	B
could	O	AUX	O
all	O	DET	O
trigger	O	VERB	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
protein	B-protein	NOUN	B
tyrosine	I-protein	NOUN	I
kinases	I-protein	NOUN	I
p56lck	B-protein	NOUN	I
and	O	CCONJ	O
p59fyn	B-protein	NOUN	B
and	O	CCONJ	O
phosphorylation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Shc	B-protein	NOUN	B
adaptor	I-protein	NOUN	I
protein	I-protein	NOUN	I
,	O	PUNCT	O
which	O	DET	O
mediates	O	VERB	O
signals	O	NOUN	B
to	O	PART	O
Ras	B-protein	NOUN	B
,	O	PUNCT	O
they	O	PRON	O
differed	O	VERB	O
significantly	O	ADV	O
in	O	ADP	O
their	O	PRON	O
ability	O	NOUN	O
to	O	PART	O
activate	O	VERB	B
NF-AT	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
results	O	NOUN	B
identify	O	VERB	O
functionally	O	ADV	O
distinct	O	ADJ	O
epitopes	B-protein	NOUN	B
on	O	ADP	O
the	O	DET	O
CD4	B-protein	NOUN	B
coreceptor	I-protein	NOUN	I
involved	O	VERB	O
in	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Ras/protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
C	I-protein	NOUN	I
and	O	CCONJ	O
calcium	O	NOUN	B
pathways	O	NOUN	I
.	O	PUNCT	O


To	O	PART	O
address	O	VERB	O
potential	O	ADJ	B
mechanisms	O	NOUN	B
by	O	ADP	O
which	O	DET	O
estrogens	O	NOUN	B
suppress	O	VERB	B
erythropoiesis	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
examined	O	VERB	O
their	O	PRON	O
effects	O	NOUN	B
on	O	ADP	O
GATA-1	B-protein	NOUN	B
,	O	PUNCT	O
an	O	DET	O
erythroid	B-protein	ADJ	B
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
that	O	PRON	O
participates	O	VERB	B
in	O	ADP	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
majority	O	NOUN	O
of	O	ADP	O
erythroid	B-DNA	ADJ	B
cell-specific	I-DNA	ADJ	B
genes	I-DNA	NOUN	I
and	O	CCONJ	O
is	O	AUX	O
necessary	O	ADJ	O
for	O	ADP	O
full	O	ADJ	O
maturation	O	NOUN	B
of	O	ADP	O
erythrocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
transcriptional	O	ADJ	B
activity	O	NOUN	I
of	O	ADP	O
GATA-1	B-protein	NOUN	B
is	O	AUX	O
strongly	O	ADV	O
repressed	O	VERB	B
by	O	ADP	O
the	O	DET	O
estrogen	B-protein	NOUN	B
receptor	I-protein	NOUN	I
(	O	PUNCT	O
ER	B-protein	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
a	O	DET	O
ligand-dependent	O	ADJ	B
manner	O	NOUN	O
and	O	CCONJ	O
that	O	SCONJ	O
this	O	DET	O
repression	O	NOUN	B
is	O	AUX	O
reversible	O	ADJ	O
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
4-hydroxytamoxifen	O	NOUN	B
.	O	PUNCT	O


(	O	PUNCT	O
ABSTRACT	O	NOUN	B
TRUNCATED	O	VERB	I
AT	O	ADP	I
250	O	NUM	I
WORDS	O	NOUN	I
)	O	PUNCT	O


This	O	DET	O
segment	O	NOUN	B
functions	O	VERB	B
as	O	ADP	O
an	O	DET	O
IL-2-inducible	B-DNA	ADJ	B
enhancer	I-DNA	NOUN	I
and	O	CCONJ	O
lies	O	VERB	O
within	O	ADP	O
a	O	DET	O
region	O	NOUN	B
that	O	PRON	O
becomes	O	VERB	O
DNase	B-protein	NOUN	B
I	I-protein	NUM	I
hypersensitive	O	ADJ	B
in	O	ADP	O
normal	O	ADJ	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
in	O	ADP	O
which	O	DET	O
IL-2R	B-protein	NOUN	B
alpha	I-protein	NOUN	O
expression	O	NOUN	B
has	O	AUX	O
been	O	AUX	O
induced	O	VERB	B
.	O	PUNCT	O


We	O	PRON	O
and	O	CCONJ	O
others	O	NOUN	O
have	O	AUX	O
shown	O	VERB	O
that	O	SCONJ	O
EBV	O	NOUN	B
can	O	AUX	O
also	O	ADV	O
infect	O	VERB	B
a	O	DET	O
subset	O	NOUN	O
of	O	ADP	O
thymocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


This	O	DET	O
is	O	AUX	O
in	O	ADP	O
contrast	O	NOUN	O
to	O	PART	O
the	O	DET	O
infection	O	NOUN	B
in	O	ADP	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
where	O	SCONJ	O
the	O	DET	O
genome	O	NOUN	B
can	O	AUX	O
circularize	O	VERB	B
within	O	ADP	O
24	O	NUM	O
hr	O	NOUN	O
of	O	ADP	O
infection	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
appearance	O	NOUN	B
of	O	ADP	O
the	O	DET	O
BamHI	B-protein	NOUN	B
ZLF-1	I-protein	NOUN	B
gene	I-protein	NOUN	B
product	I-protein	NOUN	I
,	O	PUNCT	O
ZEBRA	B-protein	NOUN	B
,	O	PUNCT	O
by	O	ADP	O
RT-PCR	O	NOUN	B
,	O	PUNCT	O
was	O	AUX	O
observed	O	VERB	O
within	O	ADP	O
8	O	NUM	O
hr	O	NOUN	O
of	O	ADP	O
infection	O	NOUN	B
.	O	PUNCT	O


Transcripts	O	NOUN	B
encoding	O	VERB	B
gp350/220	B-protein	NOUN	B
,	O	PUNCT	O
the	O	DET	O
major	B-protein	ADJ	O
coat	I-protein	NOUN	B
protein	I-protein	NOUN	I
of	O	ADP	O
EBV	O	NOUN	B
,	O	PUNCT	O
were	O	AUX	O
identified	O	VERB	B
,	O	PUNCT	O
but	O	CCONJ	O
we	O	PRON	O
did	O	AUX	O
not	O	PART	O
find	O	VERB	O
any	O	DET	O
evidence	O	NOUN	B
of	O	ADP	O
transcription	O	NOUN	B
from	O	ADP	O
the	O	DET	O
LMP-2A	B-DNA	NOUN	B
or	O	CCONJ	O
EBER-1	B-DNA	NOUN	B
loci	I-DNA	NOUN	I
in	O	ADP	O
infected	O	ADJ	B
thymocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


Human	B-cell_type	ADJ	B
peripheral	I-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
lymphocytes	I-cell_type	NOUN	I
were	O	AUX	O
observed	O	VERB	O
to	O	PART	O
contain	O	VERB	O
several	O	ADJ	O
IL-2	B-protein	NOUN	B
-inducible	O	ADJ	O
DNA	O	NOUN	B
binding	O	NOUN	I
activities	O	NOUN	I
.	O	PUNCT	O


Similar	O	ADJ	O
activities	O	NOUN	B
were	O	AUX	O
also	O	ADV	O
observed	O	VERB	O
in	O	ADP	O
a	O	DET	O
transformed	B-cell_line	VERB	O
human	I-cell_line	ADJ	B
lymphocyte	I-cell_line	NOUN	O
line	I-cell_line	NOUN	O
,	O	PUNCT	O
termed	O	VERB	O
YT	B-cell_line	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
purified	O	VERB	O
these	O	DET	O
activities	O	NOUN	B
and	O	CCONJ	O
found	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
principal	O	ADJ	B
IL-2-inducible	B-protein	ADJ	O
component	I-protein	NOUN	O
bears	O	VERB	O
significant	O	ADJ	O
relatedness	O	NOUN	B
to	O	PART	O
a	O	DET	O
prolactin-induced	B-protein	ADJ	B
transcription	I-protein	NOUN	O
factor	I-protein	NOUN	O
first	O	ADV	O
identified	O	VERB	B
in	O	ADP	O
sheep	B-cell_type	NOUN	B
mammary	I-cell_type	ADJ	B
gland	I-cell_type	NOUN	I
tissue	I-cell_type	NOUN	B
.	O	PUNCT	O


E2F-1	B-protein	NOUN	B
and	O	CCONJ	O
a	O	DET	O
cyclin-like	B-protein	ADJ	B
DNA	I-protein	NOUN	I
repair	I-protein	NOUN	I
enzyme	I-protein	NOUN	I
,	O	PUNCT	O
uracil-DNA	B-protein	ADJ	B
glycosylase	I-protein	NOUN	I
,	O	PUNCT	O
provide	O	VERB	O
evidence	O	NOUN	B
for	O	ADP	O
an	O	DET	O
autoregulatory	O	ADJ	B
mechanism	O	NOUN	B
for	O	ADP	O
transcription	O	NOUN	B
.	O	PUNCT	O


Overexpression	O	NOUN	B
of	O	ADP	O
UDG	B-protein	NOUN	B
in	O	ADP	O
Saos	B-cell_line	NOUN	B
2	I-cell_line	NUM	I
cells	I-cell_line	NOUN	I
was	O	AUX	O
observed	O	VERB	O
to	O	PART	O
delay	O	VERB	B
growth	O	NOUN	I
late	O	ADJ	O
in	O	ADP	O
G1	O	NOUN	B
phase	O	NOUN	I
and	O	CCONJ	O
transiently	O	ADV	B
arrest	O	VERB	I
these	O	DET	O
cells	O	NOUN	B
from	O	ADP	O
progressing	O	VERB	B
into	O	ADP	O
the	O	DET	O
S	O	NOUN	B
phase	O	NOUN	I
.	O	PUNCT	O


This	O	DET	O
hypothetical	O	ADJ	B
model	O	NOUN	I
integrates	O	VERB	O
one	O	NUM	O
mechanism	O	NOUN	B
of	O	ADP	O
DNA	O	NOUN	B
repair	O	NOUN	I
with	O	ADP	O
the	O	DET	O
cell	O	NOUN	B
cycle	O	NOUN	I
control	O	NOUN	I
of	O	ADP	O
gene	O	NOUN	B
transcription	O	NOUN	I
,	O	PUNCT	O
likely	O	ADJ	O
through	O	ADP	O
E2F	B-protein	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
NFAT	B-protein	NOUN	B
activation	O	NOUN	B
by	O	ADP	O
a	O	DET	O
G-protein-coupled	B-protein	ADJ	B
receptor	I-protein	NOUN	I
is	O	AUX	O
not	O	PART	O
modulated	O	VERB	B
by	O	ADP	O
p95vav	B-protein	NOUN	B
overexpression	O	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
effect	O	NOUN	B
is	O	AUX	O
specific	O	ADJ	O
to	O	PART	O
the	O	DET	O
TCR	B-protein	NOUN	B
signaling	O	NOUN	B
pathways	O	NOUN	I
.	O	PUNCT	O


There	O	PRON	O
are	O	AUX	O
at	O	ADP	O
least	O	ADJ	O
two	O	NUM	O
genes	O	NOUN	B
,	O	PUNCT	O
alpha	B-DNA	NOUN	B
A	I-DNA	NOUN	I
and	O	CCONJ	O
alpha	B-DNA	NOUN	B
B	I-DNA	NOUN	I
,	O	PUNCT	O
encoding	O	VERB	B
the	O	DET	O
alpha	B-protein	NOUN	B
subunit	I-protein	NOUN	I
.	O	PUNCT	O


Coexpression	O	NOUN	B
of	O	ADP	O
alpha	B-protein	NOUN	B
B1	I-protein	NOUN	I
and	O	CCONJ	O
alpha	B-protein	NOUN	B
B2	I-protein	NOUN	I
showed	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
promoter	O	NOUN	B
activity	O	NOUN	I
could	O	AUX	O
be	O	AUX	O
determined	O	VERB	O
by	O	ADP	O
the	O	DET	O
alpha	B-protein	NOUN	B
B1	I-protein	NOUN	I
/alpha	B-protein	NOUN	I
B2	I-protein	NOUN	I
ratio	O	NOUN	B
.	O	PUNCT	O


Priming	O	VERB	B
by	O	ADP	O
IFN-gamma	B-protein	NOUN	B
was	O	AUX	O
primarily	O	ADV	O
manifested	O	VERB	O
at	O	ADP	O
the	O	DET	O
level	O	NOUN	B
of	O	ADP	O
TNF	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
accumulation	O	NOUN	B
.	O	PUNCT	O


Priming	O	NOUN	B
occurred	O	VERB	O
after	O	ADP	O
several	O	ADJ	O
hours	O	NOUN	O
of	O	ADP	O
treatment	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
primed	O	VERB	B
state	O	NOUN	I
was	O	AUX	O
induced	O	VERB	B
by	O	ADP	O
either	O	CCONJ	O
IFN-gamma	B-protein	NOUN	B
or	O	CCONJ	O
GM-CSF	B-protein	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
M-CSF	B-protein	NOUN	B
.	O	PUNCT	O


(	O	PUNCT	O
ABSTRACT	O	NOUN	B
TRUNCATED	O	VERB	I
AT	O	ADP	I
250	O	NUM	I
WORDS	O	NOUN	I
)	O	PUNCT	O


We	O	PRON	O
determined	O	VERB	O
that	O	SCONJ	O
an	O	DET	O
initiator-like	B-DNA	ADJ	B
sequence	I-DNA	NOUN	I
present	O	ADJ	O
at	O	ADP	O
the	O	DET	O
cap	B-DNA	NOUN	B
site	I-DNA	NOUN	I
and	O	CCONJ	O
an	O	DET	O
Ets	B-DNA	NOUN	B
consensus	I-DNA	NOUN	I
sequence	I-DNA	NOUN	I
are	O	AUX	O
required	O	VERB	O
for	O	ADP	O
full	O	ADJ	O
promoter	B-DNA	NOUN	B
function	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
protein	B-protein	NOUN	B
products	I-protein	NOUN	I
of	O	ADP	O
this	O	DET	O
gene	O	NOUN	B
contain	O	VERB	O
the	O	DET	O
basic-helix-loop-helix	B-protein	ADJ	B
motif	I-protein	NOUN	I
characteristic	O	ADJ	I
of	O	ADP	O
a	O	DET	O
large	O	ADJ	O
family	O	NOUN	O
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
that	O	PRON	O
bind	O	VERB	B
to	O	PART	O
the	O	DET	O
canonical	B-DNA	ADJ	B
DNA	I-DNA	NOUN	I
sequence	I-DNA	NOUN	I
CANNTG	I-DNA	NOUN	I
as	O	ADP	O
protein	B-protein	NOUN	B
heterodimers	I-protein	NOUN	I
.	O	PUNCT	O


An	O	DET	O
Epo	B-protein	NOUN	B
-inducible	O	ADJ	O
TAL1	B-protein	NOUN	B
DNA	O	NOUN	B
binding	O	NOUN	I
activity	O	NOUN	I
was	O	AUX	O
identified	O	VERB	O
in	O	ADP	O
FVA	O	NOUN	B
cell	O	NOUN	O
nuclear	O	ADJ	O
extracts	O	NOUN	O
that	O	PRON	O
subsequently	O	ADV	O
decayed	O	VERB	B
despite	O	SCONJ	O
accumulating	O	VERB	O
mRNA	B-RNA	NOUN	B
and	O	CCONJ	O
protein	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
formation	O	NOUN	B
of	O	ADP	O
this	O	DET	O
complex	O	NOUN	B
would	O	AUX	O
increase	O	VERB	B
,	O	PUNCT	O
independently	O	ADV	O
of	O	ADP	O
an	O	DET	O
in	O	ADP	O
synergy	O	NOUN	B
with	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
,	O	PUNCT	O
the	O	DET	O
low	O	ADJ	B
basal	O	ADJ	B
activity	O	NOUN	I
of	O	ADP	O
the	O	DET	O
HIV	B-DNA	NOUN	B
LTR	I-DNA	NOUN	B
observed	O	VERB	O
in	O	ADP	O
normal	B-cell_type	ADJ	O
T	I-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
.	O	PUNCT	O


Activation	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
correlates	O	VERB	O
with	O	ADP	O
phosphorylation	O	NOUN	B
of	O	ADP	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B-alpha	I-protein	NOUN	I
and	O	CCONJ	O
requires	O	VERB	O
the	O	DET	O
proteolysis	O	NOUN	B
of	O	ADP	O
this	O	DET	O
inhibitor	O	NOUN	B
.	O	PUNCT	O


Regulation	O	NOUN	B
of	O	ADP	O
transcription	O	NOUN	B
of	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
erythropoietin	I-DNA	NOUN	I
receptor	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
by	O	ADP	O
proteins	O	NOUN	B
binding	O	VERB	I
to	O	PART	O
GATA-1	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
Sp1	I-DNA	NOUN	B
motifs	I-DNA	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
used	O	VERB	O
deletion	O	NOUN	B
analysis	O	NOUN	I
and	O	CCONJ	O
transfection	O	NOUN	B
assays	O	NOUN	I
with	O	ADP	O
reporter	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
constructs	I-DNA	NOUN	O
to	O	PART	O
examine	O	VERB	O
the	O	DET	O
transcription	B-DNA	NOUN	B
control	I-DNA	NOUN	I
elements	I-DNA	NOUN	I
in	O	ADP	O
the	O	DET	O
5	B-DNA	NUM	O
'	I-DNA	PART	O
flanking	I-DNA	ADJ	B
region	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
EpoR	I-DNA	NOUN	B
gene	I-DNA	NOUN	I
.	O	PUNCT	O


The	O	DET	O
molecular	O	ADJ	B
changes	O	NOUN	I
associated	O	VERB	B
with	O	ADP	I
chronic	O	ADJ	B
phase	O	NOUN	I
to	O	PART	O
blast	O	NOUN	B
crisis	O	NOUN	I
transition	O	NOUN	B
are	O	AUX	O
largely	O	ADV	O
unknown	O	ADJ	O
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
identified	O	VERB	O
a	O	DET	O
cDNA	B-DNA	NOUN	B
clone	I-DNA	NOUN	O
,	O	PUNCT	O
DR-nm23	B-protein	NOUN	B
,	O	PUNCT	O
differentially	O	ADV	B
expressed	O	VERB	B
in	O	ADP	O
a	O	DET	O
blast-crisis	B-DNA	ADJ	B
cDNA	I-DNA	NOUN	B
library	I-DNA	NOUN	I
,	I-DNA	PUNCT	O
which	O	DET	O
has	O	AUX	O
approximately	O	ADV	O
70	O	NUM	O
%	O	NOUN	O
sequence	O	NOUN	B
similarity	O	NOUN	B
to	O	PART	O
the	O	DET	O
putative	B-DNA	ADJ	O
metastatic	I-DNA	ADJ	O
suppressor	I-DNA	NOUN	O
genes	I-DNA	NOUN	O
,	O	PUNCT	O
nm23-H1	B-DNA	NOUN	B
and	O	CCONJ	O
nm23-H2	B-DNA	NOUN	B
.	O	PUNCT	O


DR-nm23	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
is	O	AUX	O
preferentially	O	ADV	O
expressed	O	VERB	B
at	O	ADP	O
early	O	ADJ	B
stages	O	NOUN	I
of	O	ADP	O
myeloid	O	ADJ	B
differentiation	O	NOUN	I
of	O	ADP	O
highly	B-cell_line	ADV	O
purified	I-cell_line	VERB	B
CD34+	I-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Genomic	O	ADJ	B
sequence	O	NOUN	I
upstream	O	ADJ	I
of	O	ADP	O
the	O	DET	O
Fc	B-DNA	NOUN	B
gamma	I-DNA	NOUN	I
RIC	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
was	O	AUX	O
cloned	O	VERB	B
and	O	CCONJ	O
subjected	O	VERB	O
to	O	PART	O
primer	O	NOUN	B
extension	O	NOUN	I
analysis	O	NOUN	I
,	O	PUNCT	O
which	O	DET	O
demonstrated	O	VERB	O
a	O	DET	O
single	O	ADJ	O
transcription	B-DNA	NOUN	O
initiation	I-DNA	NOUN	O
site	I-DNA	NOUN	O
without	O	ADP	O
a	O	DET	O
TATA	B-DNA	NOUN	B
box	I-DNA	NOUN	I
.	O	PUNCT	O


A	O	DET	O
17-bp	B-DNA	ADJ	O
sequence	I-DNA	NOUN	B
between	O	ADP	O
positions	O	NOUN	B
-51	O	NUM	O
and	O	CCONJ	O
-35	O	NUM	B
conferred	O	VERB	O
IFN-gamma	B-protein	NOUN	B
responsiveness	O	NOUN	B
on	O	ADP	O
a	O	DET	O
heterologous	B-DNA	ADJ	B
promoter	I-DNA	NOUN	B
.	O	PUNCT	O


Gel	O	NOUN	B
shift	O	NOUN	I
experiments	O	NOUN	I
further	O	ADV	O
showed	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
STAT1	B-protein	NOUN	B
alpha	I-protein	NOUN	I
protein	I-protein	NOUN	I
bound	O	VERB	O
to	O	PART	O
the	O	DET	O
Fc	B-DNA	NOUN	B
gamma	I-DNA	NOUN	I
RIC	I-DNA	NOUN	I
GIRE	I-DNA	NOUN	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
IFN-gamma	B-protein	NOUN	B
treatment	O	NOUN	B
of	O	ADP	O
U937	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Human	O	ADJ	B
T	O	NOUN	O
cell	O	NOUN	O
lymphotropic	O	ADJ	O
virus	O	NOUN	O
I	O	NOUN	O
(	O	PUNCT	O
HTLV-I	O	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
the	O	DET	O
etiological	O	ADJ	B
agent	O	NOUN	I
for	O	ADP	O
adult	O	ADJ	B
T	O	NOUN	B
cell	O	NOUN	I
leukemia	O	NOUN	I
and	O	CCONJ	O
tropical	O	ADJ	B
spastic	O	ADJ	I
paraparesis	O	NOUN	I
(	O	PUNCT	O
also	O	ADV	O
termed	O	VERB	O
HTLV-I-associated	O	ADJ	B
myelopathy	O	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


Nitric	O	ADJ	B
oxide	O	NOUN	I
selectively	O	ADV	O
reduces	O	VERB	O
endothelial	O	ADJ	B
expression	O	NOUN	O
of	O	ADP	O
adhesion	B-protein	NOUN	B
molecules	I-protein	NOUN	I
and	O	CCONJ	O
proinflammatory	B-protein	ADJ	B
cytokines	I-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
Toremifene	O	NOUN	B
on	O	ADP	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
some	O	DET	O
genes	O	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
mononuclear	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
found	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
retinoblastoma	B-protein	NOUN	B
susceptibility	I-protein	NOUN	I
gene	I-protein	NOUN	I
product	I-protein	NOUN	I
(	O	PUNCT	O
Rb	B-protein	NOUN	B
)	O	PUNCT	O
dramatically	O	ADV	O
suppressed	O	VERB	B
this	O	DET	O
IE2	B-protein	NOUN	B
transactivation	O	NOUN	B
of	O	ADP	O
various	B-DNA	ADJ	O
promoters	I-DNA	NOUN	B
.	O	PUNCT	O


Expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
nucleoside	B-protein	NOUN	B
diphosphate	I-protein	NOUN	I
kinase	I-protein	NOUN	I
in	O	ADP	O
human	O	ADJ	B
skin	O	NOUN	O
cancers	O	NOUN	O
:	O	PUNCT	O
an	O	DET	O
immunohistochemical	O	ADJ	B
study	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
order	O	NOUN	O
to	O	PART	O
determine	O	VERB	O
whether	O	SCONJ	O
NDP	B-protein	NOUN	B
kinase	I-protein	NOUN	B
expression	O	NOUN	B
serves	O	VERB	O
as	O	ADP	O
a	O	DET	O
marker	O	NOUN	B
for	O	ADP	O
metastatic	O	ADJ	B
potential	O	NOUN	B
in	O	ADP	O
human	O	ADJ	B
skin	O	NOUN	O
cancer	O	NOUN	O
,	O	PUNCT	O
we	O	PRON	O
assessed	O	VERB	B
the	O	DET	O
levels	O	NOUN	B
of	O	ADP	O
NDP	B-protein	NOUN	B
kinase	I-protein	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
9	O	NUM	O
keratoacanthomas	O	NOUN	B
(	O	PUNCT	O
KAs	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
26	O	NUM	O
squamous	O	ADJ	B
cell	O	NOUN	I
carcinomas	O	NOUN	I
(	O	PUNCT	O
SCCs	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
25	O	NUM	O
basal	O	ADJ	B
cell	O	NOUN	I
carcinomas	O	NOUN	I
(	O	PUNCT	O
BCCs	O	NOUN	B
)	O	PUNCT	O
using	O	VERB	O
immunohistochemistry	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
NDP	B-protein	NOUN	B
kinase	I-protein	NOUN	B
was	O	AUX	O
intense	O	ADJ	O
in	O	ADP	O
KA	O	NOUN	B
and	O	CCONJ	O
SCC	O	NOUN	B
compared	O	VERB	B
with	O	ADP	O
BCC	O	NOUN	B
.	O	PUNCT	O


RB-defective	B-cell_line	ADJ	B
tumor	I-cell_line	NOUN	O
lines	I-cell_line	NOUN	O
are	O	AUX	O
non-inducible	O	ADJ	B
for	O	ADP	O
MHC	B-protein	NOUN	B
class	I-protein	NOUN	O
II	I-protein	NUM	O
by	O	ADP	O
IFN-gamma	B-protein	NOUN	B
,	O	PUNCT	O
or	O	CCONJ	O
very	O	ADV	O
weakly	O	ADV	O
inducible	O	ADJ	B
,	O	PUNCT	O
but	O	CCONJ	O
transfection	O	NOUN	B
of	O	ADP	O
2	O	NUM	O
different	O	ADJ	O
lines	O	NOUN	B
with	O	ADP	O
RB	B-DNA	NOUN	B
expression	I-DNA	NOUN	O
vectors	I-DNA	NOUN	O
re-establishes	O	VERB	B
or	O	CCONJ	O
substantially	O	ADV	O
enhances	O	VERB	B
class	O	NOUN	B
II	O	NUM	I
inducibility	O	NOUN	B
.	O	PUNCT	O


Therefore	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
examined	O	VERB	O
the	O	DET	O
RB	B-protein	NOUN	B
status	O	NOUN	B
of	O	ADP	O
a	O	DET	O
series	O	NOUN	O
of	O	ADP	O
B-cell	O	NOUN	B
mutants	O	NOUN	I
that	O	PRON	O
are	O	AUX	O
defective	O	ADJ	B
in	O	ADP	O
class	O	NOUN	B
II	O	NUM	I
expression	O	NOUN	B
,	O	PUNCT	O
generated	O	VERB	O
either	O	CCONJ	O
in	O	X	B
vitro	O	X	I
or	O	CCONJ	O
derived	O	VERB	O
from	O	ADP	O
Bare	O	PROPN	B
Lymphocyte	O	NOUN	I
Syndrome	O	NOUN	I
(	O	PUNCT	O
BLS	O	NOUN	B
)	O	PUNCT	O
patients	O	NOUN	B
.	O	PUNCT	O


CIITA	B-DNA	NOUN	B
is	O	AUX	O
a	O	DET	O
class	B-DNA	NOUN	B
II	I-DNA	NUM	I
gene	I-DNA	NOUN	I
transactivator	I-DNA	NOUN	I
known	O	VERB	O
to	O	PART	O
be	O	AUX	O
defective	O	ADJ	B
in	O	ADP	O
one	O	NUM	O
form	O	NOUN	O
of	O	ADP	O
BLS	O	NOUN	B
and	O	CCONJ	O
to	O	PART	O
be	O	AUX	O
required	O	VERB	O
for	O	ADP	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
MHC	B-protein	NOUN	B
class	I-protein	NOUN	O
II	I-protein	NUM	O
by	O	ADP	O
IFN-gamma	B-protein	NOUN	B
.	O	PUNCT	O


Interleukin	B-protein	NOUN	B
12	I-protein	NUM	I
induces	O	VERB	B
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	B
and	O	CCONJ	O
activation	O	NOUN	B
of	O	ADP	O
STAT4	B-protein	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
lymphocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


Interleukin	B-protein	NOUN	B
12	I-protein	NUM	I
(	O	PUNCT	O
IL-12	B-protein	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
an	O	DET	O
important	O	ADJ	O
immunoregulatory	B-protein	ADJ	B
cytokine	I-protein	NOUN	I
whose	O	DET	O
receptor	O	NOUN	B
is	O	AUX	O
a	O	DET	O
member	O	NOUN	B
of	O	ADP	O
the	O	DET	O
hematopoietin	B-protein	NOUN	B
receptor	I-protein	NOUN	I
superfamily	I-protein	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
recently	O	ADV	O
demonstrated	O	VERB	O
that	O	SCONJ	O
stimulation	O	NOUN	B
of	O	ADP	O
human	B-cell_type	ADJ	B
T	I-cell_type	NOUN	B
and	I-cell_type	CCONJ	O
natural	I-cell_type	ADJ	B
killer	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
with	O	ADP	O
IL-12	B-protein	NOUN	B
induces	O	VERB	O
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Janus	B-protein	NOUN	B
family	I-protein	NOUN	I
tyrosine	I-protein	NOUN	I
kinase	I-protein	NOUN	I
JAK2	B-protein	NOUN	I
and	O	CCONJ	O
Tyk2	B-protein	NOUN	B
,	O	PUNCT	O
implicating	O	VERB	O
these	O	DET	O
kinases	B-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
immediate	O	ADJ	B
biochemical	O	ADJ	B
response	O	NOUN	O
to	O	PART	O
IL-12	B-protein	NOUN	B
.	O	PUNCT	O


OBJECTIVE	O	NOUN	O
:	O	PUNCT	O
Activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
hypothalamic-pituitary-adrenal	O	ADJ	B
axis	O	NOUN	I
is	O	AUX	O
of	O	ADP	O
vital	O	ADJ	O
importance	O	NOUN	O
during	O	ADP	O
critical	O	ADJ	B
illness	O	NOUN	I
.	O	PUNCT	O


DESIGN	O	NOUN	O
:	O	PUNCT	O
The	O	DET	O
effects	O	NOUN	B
of	O	ADP	O
hypercortisolaemia	O	NOUN	B
,	O	PUNCT	O
hyperthermia	O	NOUN	B
and	O	CCONJ	O
cellular	O	ADJ	B
composition	O	NOUN	I
on	O	ADP	O
number	O	NOUN	O
of	O	ADP	O
glucocorticoid	B-protein	NOUN	B
receptors	I-protein	NOUN	I
per	O	ADP	O
cell	O	NOUN	O
and	O	CCONJ	O
their	O	PRON	O
affinity	O	NOUN	B
were	O	AUX	O
evaluated	O	VERB	B
,	O	PUNCT	O
both	O	CCONJ	O
in	O	X	B
vitro	O	X	I
and	O	CCONJ	O
in	O	X	B
vivo	O	X	I
,	O	PUNCT	O
in	O	ADP	O
peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
mononuclear	I-cell_type	ADJ	I
leucocytes	I-cell_type	NOUN	B
of	O	ADP	O
control	O	ADJ	B
subjects	O	NOUN	I
and	O	CCONJ	O
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
sepsis	O	NOUN	B
or	O	CCONJ	O
septic	O	ADJ	B
shock	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
decreased	O	VERB	B
affinity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
glucocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
together	O	ADV	O
with	O	ADP	O
the	O	DET	O
negative	O	ADJ	B
correlation	O	NOUN	B
between	O	ADP	O
hyperthermia	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
number	O	NOUN	O
of	O	ADP	O
glucocorticoid	B-protein	NOUN	B
receptors	I-protein	NOUN	I
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
sepsis	O	NOUN	B
or	O	CCONJ	O
septic	O	ADJ	B
shock	O	NOUN	I
suggest	O	VERB	O
that	O	SCONJ	O
hypothalamic-pituitary-adrenal	O	ADJ	B
axis	O	NOUN	I
activation	O	NOUN	I
during	O	ADP	O
critical	O	ADJ	B
illness	O	NOUN	I
is	O	AUX	O
accompanied	O	VERB	O
by	O	ADP	O
peripheral	O	ADJ	B
adaptation	O	NOUN	B
in	O	ADP	O
glucocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
number	O	NOUN	I
and	O	CCONJ	O
affinity	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
possible	O	ADJ	O
signaling	O	NOUN	B
role	O	NOUN	I
for	O	ADP	O
the	O	DET	O
Syk	B-protein	NOUN	B
tyrosine	I-protein	NOUN	I
kinase	I-protein	NOUN	I
.	O	PUNCT	O


Activation	O	NOUN	B
of	O	ADP	O
cytoplasmic	B-protein	ADJ	B
tyrosine	I-protein	NOUN	B
kinases	I-protein	NOUN	I
is	O	AUX	O
an	O	DET	O
important	O	ADJ	O
aspect	O	NOUN	O
of	O	ADP	O
signal	O	NOUN	B
transduction	O	NOUN	I
mediated	O	VERB	O
by	O	ADP	O
integrins	B-protein	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
integrin	B-protein	NOUN	B
ligation	O	NOUN	I
leads	O	VERB	O
to	O	PART	O
nuclear	O	ADJ	B
translocation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
p50	B-protein	NOUN	B
and	O	CCONJ	O
p65	B-protein	NOUN	B
subunits	I-protein	NOUN	I
of	O	ADP	O
the	O	DET	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
,	O	PUNCT	O
to	O	PART	O
activation	O	NOUN	B
of	O	ADP	O
a	O	DET	O
reporter	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
driven	O	VERB	O
by	O	ADP	O
a	O	DET	O
promoter	B-DNA	NOUN	B
containing	O	VERB	O
NF-kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
sites	I-DNA	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
to	O	PART	O
increased	O	VERB	B
levels	O	NOUN	B
of	O	ADP	O
mRNAs	B-RNA	NOUN	B
for	O	ADP	O
immediate-early	B-DNA	ADJ	B
genes	I-DNA	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
the	O	DET	O
cytokine	B-protein	NOUN	B
interleukin	I-protein	NOUN	I
(	I-protein	PUNCT	O
IL	I-protein	NOUN	B
)	I-protein	PUNCT	O
-1	I-protein	NUM	O
beta	I-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
inhibitory	O	ADJ	B
activity	O	NOUN	O
was	O	AUX	O
heat	O	NOUN	B
labile	O	ADJ	I
and	O	CCONJ	O
trypsin	B-protein	NOUN	B
sensitive	O	ADJ	B
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
demonstrate	O	VERB	O
that	O	SCONJ	O
B95-8	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
contain	O	VERB	O
a	O	DET	O
competitive	O	ADJ	B
inhibitor	O	NOUN	B
that	O	PRON	O
prevents	O	VERB	B
binding	O	NOUN	B
of	O	ADP	O
dexamethasone	O	NOUN	B
to	O	PART	O
its	O	PRON	O
cognate	B-protein	ADJ	B
receptor	I-protein	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
DNA	O	NOUN	B
mobility	O	NOUN	I
shift	O	NOUN	I
assays	O	NOUN	I
,	O	PUNCT	O
this	O	DET	O
sequence	O	NOUN	B
can	O	AUX	O
give	O	VERB	O
either	O	CCONJ	O
six	O	NUM	O
different	O	ADJ	O
specific	O	ADJ	O
bands	O	NOUN	B
which	O	DET	O
are	O	AUX	O
competed	O	VERB	O
out	O	ADP	O
by	O	ADP	O
different	O	ADJ	O
parts	O	NOUN	B
of	O	ADP	O
the	O	DET	O
sequence	O	NOUN	B
or	O	CCONJ	O
one	O	NUM	O
specific	O	ADJ	O
band	O	NOUN	B
which	O	DET	O
is	O	AUX	O
competed	O	VERB	O
out	O	ADP	O
by	O	ADP	O
each	O	DET	O
of	O	ADP	O
the	O	DET	O
inverted	O	ADJ	B
repeats	O	NOUN	I
,	O	PUNCT	O
depending	O	VERB	O
on	O	ADP	O
the	O	DET	O
reconstitution	O	NOUN	B
conditions	O	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
also	O	ADV	O
propose	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
NGFI-B/nur77	B-protein	NOUN	B
family	I-protein	NOUN	B
can	O	AUX	O
be	O	AUX	O
classified	O	VERB	O
into	O	ADP	O
two	O	NUM	O
subtypes	O	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
upon	O	SCONJ	O
stable	O	ADJ	B
integration	O	NOUN	B
into	O	ADP	O
chromatin	B-DNA	NOUN	B
,	O	PUNCT	O
deletion	O	NOUN	B
of	O	ADP	O
this	O	DET	O
region	O	NOUN	B
causes	O	VERB	O
a	O	DET	O
nearly	O	ADV	O
90	O	NUM	O
%	O	NOUN	O
decrease	O	NOUN	B
in	O	ADP	O
promoter	O	NOUN	B
activity	O	NOUN	I
compared	O	VERB	B
with	O	ADP	O
expression	O	NOUN	B
from	O	ADP	O
an	O	DET	O
alpha-globin	B-DNA	NOUN	B
promoter	I-DNA	NOUN	I
retaining	O	VERB	O
this	O	DET	O
region	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
Ah	B-protein	NOUN	B
receptor	I-protein	NOUN	I
recognizes	O	VERB	O
DNA	B-DNA	NOUN	B
binding	I-DNA	NOUN	I
sites	I-DNA	NOUN	I
for	O	ADP	O
the	O	DET	O
B	B-protein	NOUN	B
cell	I-protein	NOUN	I
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
,	O	PUNCT	O
BSAP	B-protein	NOUN	B
:	O	PUNCT	O
a	O	DET	O
possible	O	ADJ	O
mechanism	O	NOUN	B
for	O	ADP	O
dioxin-mediated	O	ADJ	O
alteration	O	NOUN	B
of	O	ADP	O
CD19	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
expression	O	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
B	I-cell_type	NOUN	O
lymphocytes	I-cell_type	NOUN	O
.	O	PUNCT	O


Northern	O	NOUN	B
blot	O	NOUN	I
analysis	O	NOUN	I
showed	O	VERB	O
that	O	SCONJ	O
TCDD	O	NOUN	B
treatment	O	NOUN	B
decreased	O	VERB	B
steady	O	ADJ	B
state	O	NOUN	I
levels	O	NOUN	O
of	O	ADP	O
CD19	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
by	O	ADP	O
67	O	NUM	O
%	O	NOUN	O
in	O	ADP	O
the	O	DET	O
IM-9	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
Ah	B-protein	NOUN	B
receptor	I-protein	NOUN	I
complex	I-protein	NOUN	I
recognized	O	VERB	O
a	O	DET	O
DNA	B-DNA	NOUN	B
binding	I-DNA	NOUN	I
site	I-DNA	NOUN	I
for	O	ADP	O
B	B-protein	NOUN	B
cell	I-protein	NOUN	I
lineage-specific	I-protein	ADJ	I
activator	I-protein	NOUN	I
protein	I-protein	NOUN	I
(	O	PUNCT	O
BSAP	B-protein	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
promoter	B-DNA	NOUN	B
region	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
human	O	ADJ	B
CD19	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
which	O	DET	O
is	O	AUX	O
similar	O	ADJ	O
to	O	PART	O
the	O	DET	O
consensus	B-DNA	NOUN	B
Ah	I-DNA	NOUN	I
receptor	I-DNA	NOUN	I
DNA	I-DNA	NOUN	B
binding	I-DNA	NOUN	I
site	I-DNA	NOUN	I
.	O	PUNCT	O


Moreover	O	ADV	O
,	O	PUNCT	O
both	O	CCONJ	O
the	O	DET	O
mutant	B-protein	ADJ	B
nm23-H2His	I-protein	NOUN	O
protein	I-protein	NOUN	B
and	O	CCONJ	O
truncated	B-protein	VERB	B
nm23-H2	I-protein	NOUN	B
protein	I-protein	NOUN	I
containing	O	VERB	O
N-terminal	B-protein	ADJ	B
(	I-protein	PUNCT	O
1-60	I-protein	NUM	O
)	I-protein	PUNCT	O
peptide	I-protein	NOUN	B
,	O	PUNCT	O
which	O	DET	O
do	O	AUX	O
not	O	PART	O
have	O	AUX	O
NDP	B-protein	NOUN	B
kinase	I-protein	NOUN	B
activity	O	NOUN	I
,	O	PUNCT	O
also	O	ADV	O
inhibited	O	VERB	B
erythroid	O	ADJ	B
differentiation	O	NOUN	O
of	O	ADP	O
HEL	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Endothelial	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
stimulated	O	VERB	B
by	O	ADP	O
LPS	O	NOUN	B
express	O	VERB	O
E-selectin	B-protein	NOUN	B
,	O	PUNCT	O
which	O	DET	O
plays	O	VERB	O
an	O	DET	O
important	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
mediating	O	VERB	O
neutrophil	B-cell_type	NOUN	B
adhesion	O	NOUN	B
during	O	ADP	O
inflammation	O	NOUN	B
.	O	PUNCT	O


GM-CSF	B-protein	NOUN	B
and	O	CCONJ	O
IL-2	B-protein	NOUN	B
share	O	VERB	O
common	O	ADJ	O
control	O	NOUN	B
mechanisms	O	NOUN	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
costimulatory	O	ADJ	B
signals	O	NOUN	O
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


So	O	ADV	O
called	O	VERB	O
costimulatory	O	ADJ	B
signals	O	NOUN	B
,	O	PUNCT	O
mediated	O	VERB	O
by	O	ADP	O
other	O	ADJ	O
cell	O	NOUN	B
surface	O	NOUN	I
interactions	O	NOUN	B
or	O	CCONJ	O
soluble	B-protein	ADJ	B
cytokines	I-protein	NOUN	B
produced	O	VERB	O
by	O	ADP	O
antigen	B-cell_type	NOUN	B
presenting	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
,	O	PUNCT	O
are	O	AUX	O
also	O	ADV	O
required	O	VERB	O
for	O	ADP	O
complete	O	ADJ	B
T	O	NOUN	B
cell	O	NOUN	I
activation	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
NFAT	B-protein	NOUN	B
by	O	ADP	O
TCR	B-protein	NOUN	B
signals	O	NOUN	B
has	O	AUX	O
been	O	AUX	O
well	O	ADV	O
described	O	VERB	O
for	O	ADP	O
interleukin-2	O	NOUN	B
(	O	PUNCT	O
IL-2	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
IL-4	O	NOUN	B
gene	O	NOUN	I
transcription	O	NOUN	I
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Costimulatory	O	ADJ	B
signals	O	NOUN	B
,	O	PUNCT	O
such	O	ADJ	O
as	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
CD28	B-protein	NOUN	B
cell	I-protein	NOUN	I
surface	I-protein	NOUN	B
molecule	I-protein	NOUN	I
on	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
lead	O	VERB	O
to	O	PART	O
activation	O	NOUN	B
through	O	ADP	O
a	O	DET	O
distinct	O	ADJ	O
region	O	NOUN	O
of	O	ADP	O
the	O	DET	O
granulocyte-macrophage	B-DNA	ADJ	B
colony-stimulating	I-DNA	ADJ	I
factor	I-DNA	NOUN	I
(	I-DNA	PUNCT	O
GM-CSF	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
promoter	I-DNA	NOUN	B
.	O	PUNCT	O


This	O	DET	O
observation	O	NOUN	B
,	O	PUNCT	O
together	O	ADV	O
with	O	ADP	O
the	O	DET	O
fact	O	NOUN	O
that	O	SCONJ	O
both	O	CCONJ	O
GM-CSF	B-protein	NOUN	B
and	O	CCONJ	O
IL-2	B-protein	NOUN	B
respond	O	VERB	O
to	O	PART	O
TCR	B-protein	NOUN	B
signals	O	NOUN	B
via	O	ADP	O
NFAT	B-protein	NOUN	B
,	O	PUNCT	O
implies	O	VERB	O
a	O	DET	O
high	O	ADJ	O
degree	O	NOUN	B
of	O	ADP	O
conservation	O	NOUN	B
in	O	ADP	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
cytokine	B-protein	NOUN	B
gene	O	NOUN	B
expression	O	NOUN	I
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Using	O	VERB	O
a	O	DET	O
cell	O	NOUN	B
line	O	NOUN	I
that	O	PRON	O
is	O	AUX	O
stably	O	ADV	B
transfected	O	VERB	B
with	O	ADP	O
a	O	DET	O
trimer	O	NOUN	B
of	O	ADP	O
the	O	DET	O
NFAT-1	B-DNA	NOUN	B
regulatory	I-DNA	ADJ	B
element	I-DNA	NOUN	I
linked	O	VERB	O
to	O	PART	O
a	O	DET	O
lac-Z	B-DNA	NOUN	B
reporter	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
screened	O	VERB	B
for	O	ADP	O
inhibitors	O	NOUN	B
of	O	ADP	O
NFAT	B-protein	NOUN	B
-1-mediated	O	ADJ	O
beta-galactosidase	B-protein	NOUN	B
activity	O	NOUN	O
.	O	PUNCT	O


WIN	O	NOUN	B
53071	O	NUM	O
inhibited	O	VERB	B
IL-2	B-protein	NOUN	B
production	O	NOUN	B
induced	O	VERB	B
in	O	ADP	O
the	O	DET	O
calcium-dependent	O	ADJ	B
PMA	O	NOUN	B
and	O	CCONJ	O
ionomycin	O	NOUN	B
pathway	O	NOUN	B
.	O	PUNCT	O


Conversely	O	ADV	O
,	O	PUNCT	O
calcium-independent	B-protein	ADJ	B
anti-CD28	I-protein	ADJ	B
Ab	I-protein	NOUN	I
and	O	CCONJ	O
PMA-induced	O	ADJ	B
IL-2	B-protein	NOUN	B
production	O	NOUN	B
was	O	AUX	O
resistant	O	ADJ	B
.	O	PUNCT	O


Monocyte-macrophage	O	ADJ	B
differentiation	O	NOUN	I
was	O	AUX	O
used	O	VERB	O
as	O	ADP	O
a	O	DET	O
model	O	NOUN	B
system	O	NOUN	I
for	O	ADP	O
studying	O	VERB	O
gene	O	NOUN	B
regulation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
human	B-protein	ADJ	B
vacuolar	I-protein	NOUN	I
H	I-protein	NOUN	I
(	I-protein	PUNCT	O
+	I-protein	CCONJ	O
)	I-protein	PUNCT	O
-ATPase	I-protein	NOUN	O
(	O	PUNCT	O
V-ATPase	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Synergy	O	NOUN	B
between	O	ADP	O
signal	O	NOUN	B
transduction	O	NOUN	O
pathways	O	NOUN	O
is	O	AUX	O
obligatory	O	ADJ	O
for	O	ADP	O
expression	O	NOUN	B
of	O	ADP	O
c-fos	B-DNA	NOUN	B
in	O	ADP	O
B	B-cell_line	NOUN	B
and	I-cell_line	CCONJ	O
T	I-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
:	O	PUNCT	O
implication	O	NOUN	B
for	O	ADP	O
c-fos	B-DNA	NOUN	B
control	O	NOUN	I
via	O	ADP	O
surface	B-protein	NOUN	B
immunoglobulin	I-protein	NOUN	B
and	O	CCONJ	O
T	B-protein	NOUN	B
cell	I-protein	NOUN	I
antigen	I-protein	NOUN	I
receptors	I-protein	NOUN	I
.	O	PUNCT	O


Expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
protooncogene	B-DNA	NOUN	B
c-fos	I-DNA	NOUN	I
is	O	AUX	O
controlled	O	VERB	B
by	O	ADP	O
three	O	NUM	O
main	O	ADJ	O
regulatory	O	ADJ	B
pathways	O	NOUN	I
involving	O	VERB	O
kinase	B-protein	NOUN	B
C	I-protein	NOUN	I
,	O	PUNCT	O
cAMP	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
calcium	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
main	O	ADJ	O
difference	O	NOUN	O
between	O	ADP	O
Ramos	B-cell_line	NOUN	B
(	O	PUNCT	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
)	O	PUNCT	O
and	O	CCONJ	O
Jurkat	B-cell_line	NOUN	B
(	O	PUNCT	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
)	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
c-fos	B-DNA	NOUN	B
is	O	AUX	O
that	O	SCONJ	O
cAMP	O	NOUN	B
plus	O	CCONJ	O
calcium	O	NOUN	B
is	O	AUX	O
strongly	O	ADV	O
synergistic	O	ADJ	B
in	O	ADP	O
Jurkat	B-cell_line	NOUN	B
and	O	CCONJ	O
is	O	AUX	O
without	O	ADP	O
effect	O	NOUN	B
in	O	ADP	O
Ramos	B-cell_line	NOUN	B
.	O	PUNCT	O


Use	O	PROPN	O
of	O	ADP	O
new	O	ADJ	O
biologic	O	ADJ	B
markers	O	NOUN	B
in	O	ADP	O
the	O	DET	O
ovulation	O	NOUN	B
induction	O	NOUN	B
.	O	PUNCT	O


Abnormal	O	ADJ	B
regulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IL-2	B-DNA	NOUN	B
promoter	I-DNA	NOUN	O
in	O	ADP	O
lpr	O	NOUN	B
CD4-CD8-	B-cell_line	ADJ	I
T	I-cell_line	NOUN	I
lymphocytes	I-cell_line	NOUN	I
results	O	VERB	B
in	O	ADP	O
constitutive	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
a	O	DET	O
novel	B-protein	ADJ	O
nuclear	I-protein	ADJ	B
factor	I-protein	NOUN	I
of	I-protein	ADP	O
activated	I-protein	VERB	B
T	I-protein	NOUN	O
cells-binding	I-protein	ADJ	O
factor	I-protein	NOUN	O
.	O	PUNCT	O


Yet	O	CCONJ	O
these	O	DET	O
same	O	ADJ	O
cells	O	NOUN	B
do	O	AUX	O
initiate	O	VERB	O
early	O	ADJ	O
TCR	B-protein	NOUN	B
-mediated	O	ADJ	O
signaling	O	NOUN	B
events	O	NOUN	I
,	O	PUNCT	O
such	O	ADJ	O
as	O	ADP	O
generation	O	NOUN	O
of	O	ADP	O
inositol	O	NOUN	B
phosphates	O	NOUN	B
and	O	CCONJ	O
increased	O	VERB	B
intracellular	O	ADJ	B
calcium	O	NOUN	B
.	O	PUNCT	O


Upon	O	SCONJ	O
stimulation	O	NOUN	B
with	O	ADP	O
mitogens	O	NOUN	B
,	O	PUNCT	O
formation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
transactivating	O	VERB	B
complex	O	NOUN	I
,	O	PUNCT	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
of	I-protein	ADP	O
activated	I-protein	VERB	B
T	I-protein	NOUN	O
cells	I-protein	NOUN	O
(	O	PUNCT	O
NF-AT	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
occurs	O	VERB	O
with	O	ADP	O
normal	O	ADJ	O
kinetics	O	NOUN	B
in	O	ADP	O
Ipr	B-cell_line	NOUN	B
CD4-8-	I-cell_line	ADJ	O
T	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Upon	O	SCONJ	O
mitogenic	O	ADJ	B
stimulation	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
binding	O	NOUN	B
activity	O	NOUN	I
of	O	ADP	O
the	O	DET	O
novel	O	ADJ	O
NF-AT-binding	B-protein	NOUN	B
factor	I-protein	NOUN	I
is	O	AUX	O
rapidly	O	ADV	O
down-regulated	O	VERB	B
in	O	ADP	O
normal	O	ADJ	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
persists	O	VERB	O
at	O	ADP	O
high	O	ADJ	O
levels	O	NOUN	B
in	O	ADP	O
Ipr	B-cell_line	NOUN	B
CD4-8-	I-cell_line	ADJ	O
T	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
CD30	B-protein	NOUN	B
-CD30L	B-protein	ADJ	O
interactions	O	NOUN	B
mediate	O	VERB	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
HIV	O	NOUN	B
expression	O	NOUN	B
by	O	ADP	O
a	O	DET	O
kappa	O	NOUN	O
B-dependent	O	ADJ	B
pathway	O	NOUN	I
that	O	PRON	O
is	O	AUX	O
independent	O	ADJ	O
of	O	ADP	O
TNF	B-protein	NOUN	B
.	O	PUNCT	O


Four	O	NUM	O
distinct	O	ADJ	O
complementation	O	NOUN	B
groups	O	NOUN	O
have	O	AUX	O
been	O	AUX	O
identified	O	VERB	B
.	O	PUNCT	O


The	O	DET	O
transactivation	O	NOUN	B
of	O	ADP	O
multiple	B-DNA	ADJ	B
cis	I-DNA	ADJ	I
elements	I-DNA	NOUN	I
,	O	PUNCT	O
especially	O	ADV	O
S	B-DNA	NOUN	B
and	O	CCONJ	O
X2	B-DNA	NOUN	B
,	O	PUNCT	O
of	O	ADP	O
the	O	DET	O
DR	B-DNA	NOUN	B
alpha	I-DNA	NOUN	I
proximal	I-DNA	ADJ	I
promoter	I-DNA	NOUN	B
in	O	ADP	O
group	B-cell_line	NOUN	B
II	I-cell_line	NUM	I
CID	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
is	O	AUX	O
CIITA	B-protein	NOUN	B
dependent	O	ADJ	B
.	O	PUNCT	O


Since	O	SCONJ	O
CIITA	B-protein	NOUN	B
overexpression	O	NOUN	B
in	O	ADP	O
normal	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
did	O	AUX	O
not	O	PART	O
increase	O	VERB	B
class	O	NOUN	B
II	O	NUM	I
expression	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
propose	O	VERB	O
that	O	SCONJ	O
initiation	O	NOUN	B
of	O	ADP	O
CIITA	B-protein	NOUN	B
expression	O	NOUN	B
serves	O	VERB	O
as	O	ADP	O
the	O	DET	O
on-off	O	ADJ	B
switch	O	NOUN	I
,	O	PUNCT	O
while	O	SCONJ	O
availability	O	NOUN	B
of	O	ADP	I
downstream	O	ADJ	B
interactor	O	NOUN	I
(	O	PUNCT	O
s	O	NOUN	O
)	O	PUNCT	O
limits	O	VERB	B
transcription	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
demonstrate	O	VERB	O
that	O	SCONJ	O
P-selectin	B-protein	NOUN	B
,	O	PUNCT	O
through	O	ADP	O
its	O	PRON	O
ligands	O	NOUN	B
on	O	ADP	O
monocytes	B-cell_type	NOUN	B
,	O	PUNCT	O
may	O	AUX	O
locally	O	ADV	O
regulate	O	VERB	B
cytokine	B-protein	NOUN	B
secretion	O	NOUN	I
in	O	ADP	O
inflamed	O	ADJ	B
tissues	O	NOUN	B
.	O	PUNCT	O


In	O	X	B
vitro	O	X	I
studies	O	NOUN	B
using	O	VERB	O
pure	B-protein	ADJ	O
recombinant	I-protein	ADJ	B
p21ras	I-protein	NOUN	O
demonstrate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
activation	O	NOUN	B
is	O	AUX	O
direct	O	ADJ	O
and	O	CCONJ	O
reversible	O	ADJ	B
.	O	PUNCT	O


Circular	O	ADJ	B
dichroism	O	NOUN	I
analysis	O	NOUN	I
reveals	O	VERB	O
that	O	SCONJ	O
NO	O	NOUN	B
induces	O	VERB	B
a	O	DET	O
profound	O	ADJ	O
conformational	O	ADJ	B
change	O	NOUN	I
in	O	ADP	O
p21ras	B-DNA	NOUN	B
in	O	ADP	O
association	O	NOUN	B
with	O	ADP	O
GDP/GTP	O	NOUN	B
exchange	O	NOUN	I
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
p21ras	B-protein	NOUN	B
is	O	AUX	O
essential	O	ADJ	O
for	O	ADP	O
NO-induced	O	ADJ	B
downstream	O	ADJ	O
signaling	O	NOUN	O
,	O	PUNCT	O
such	O	ADJ	O
as	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activation	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
that	O	SCONJ	O
endogenous	O	ADJ	B
NO	O	NOUN	B
can	O	AUX	O
activate	O	VERB	B
p21ras	B-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
same	O	ADJ	O
cell	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
studies	O	NOUN	B
identify	O	VERB	O
p21ras	B-DNA	NOUN	B
as	O	ADP	O
a	O	DET	O
target	O	NOUN	B
of	O	ADP	O
NO	O	NOUN	B
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
suggest	O	VERB	O
that	O	SCONJ	O
NO	O	NOUN	B
activates	O	VERB	B
p21ras	B-DNA	NOUN	B
by	O	ADP	O
an	O	DET	O
action	O	NOUN	B
which	O	DET	O
mimics	O	VERB	B
that	O	DET	O
of	O	ADP	O
guanine	B-protein	NOUN	B
nucleotide	I-protein	NOUN	I
exchange	I-protein	NOUN	I
factors	I-protein	NOUN	I
.	O	PUNCT	O


Interleukin-2	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
activity	O	NOUN	I
in	O	ADP	O
Epstein-Barr	B-cell_line	ADJ	B
virus-transformed	I-cell_line	ADJ	I
B	I-cell_line	NOUN	I
lymphocytes	I-cell_line	NOUN	I
is	O	AUX	O
controlled	O	VERB	B
by	O	ADP	O
nuclear	B-protein	ADJ	B
factor-chi	I-protein	NOUN	I
B	I-protein	NOUN	I
.	O	PUNCT	O


An	O	DET	O
IL-2	B-DNA	NOUN	B
promoter	I-DNA	NOUN	O
bearing	O	VERB	O
a	O	DET	O
defective	O	ADJ	B
NF-chi	B-DNA	NOUN	B
B	I-DNA	NOUN	I
site	I-DNA	NOUN	O
was	O	AUX	O
completely	O	ADV	O
inactive	O	ADJ	B
in	O	ADP	O
EBV-transformed	B-cell_line	ADJ	B
B	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
while	O	SCONJ	O
it	O	PRON	O
still	O	ADV	O
had	O	AUX	O
activity	O	NOUN	B
in	O	ADP	O
Jurkat	B-cell_line	NOUN	B
T	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Similarly	O	ADV	O
,	O	PUNCT	O
a	O	DET	O
human	B-DNA	ADJ	B
immunodeficiency	I-DNA	NOUN	I
virus	I-DNA	NOUN	I
promoter	I-DNA	NOUN	B
,	O	PUNCT	O
whose	O	DET	O
activity	O	NOUN	B
is	O	AUX	O
controlled	O	VERB	B
through	O	ADP	O
chi	B-protein	NOUN	B
B	I-protein	NOUN	I
factors	I-protein	NOUN	I
,	O	PUNCT	O
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
be	O	AUX	O
active	O	ADJ	B
in	O	ADP	O
the	O	DET	O
IL-2	B-cell_line	NOUN	B
producing	I-cell_line	NOUN	O
EBV-B	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
inactive	O	ADJ	B
in	O	ADP	O
the	O	DET	O
non-IL-2-producing	B-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Three	O	NUM	O
to	O	PART	O
6	O	NUM	O
months	O	NOUN	B
after	O	ADP	O
RAI	O	NOUN	B
,	O	PUNCT	O
T	O	NOUN	B
cell	O	NOUN	I
responses	O	NOUN	O
to	O	PART	O
TSHR	B-protein	NOUN	B
peptides	O	NOUN	B
were	O	AUX	O
less	O	ADJ	O
than	O	ADP	O
those	O	DET	O
6-8	O	NUM	O
weeks	O	NOUN	B
after	O	ADP	O
RAI	O	NOUN	B
therapy	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
still	O	ADV	O
higher	O	ADJ	O
than	O	ADP	O
the	O	DET	O
values	O	NOUN	B
on	O	ADP	O
day	O	NOUN	B
0	O	NUM	O
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
used	O	VERB	O
these	O	DET	O
mice	O	NOUN	B
to	O	PART	O
generate	O	VERB	O
anti-TCF-1	B-protein	NOUN	B
antibodies	I-protein	NOUN	I
.	O	PUNCT	O


Wild-type	O	ADJ	B
littermates	O	NOUN	B
remain	O	VERB	O
unresponsive	O	ADJ	O
to	O	PART	O
TCF-1	B-protein	NOUN	B
while	O	SCONJ	O
they	O	PRON	O
mount	O	VERB	B
a	O	DET	O
high-titer	O	ADJ	B
antibody	O	NOUN	I
response	O	NOUN	I
to	O	PART	O
the	O	DET	O
fusion	B-protein	NOUN	B
protein	I-protein	NOUN	I
,	O	PUNCT	O
Maltose	B-protein	NOUN	B
Binding	I-protein	NOUN	I
Protein	I-protein	NOUN	I
(	O	PUNCT	O
MBP	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
PuF	B-DNA	NOUN	B
site	I-DNA	NOUN	I
on	O	ADP	O
the	O	DET	O
silent	B-DNA	ADJ	B
normal	I-DNA	ADJ	O
c-myc	I-DNA	NOUN	O
allele	I-DNA	NOUN	O
was	O	AUX	O
unoccupied	O	ADJ	B
.	O	PUNCT	O


These	O	DET	O
cells	O	NOUN	B
showed	O	VERB	O
G1	O	NOUN	B
phase	O	NOUN	I
arrest	O	NOUN	I
and	O	CCONJ	O
the	O	DET	O
clonogenicity	O	NOUN	B
was	O	AUX	O
reduced	O	VERB	B
.	O	PUNCT	O


These	O	DET	O
included	O	VERB	O
vimentin	B-protein	NOUN	B
,	O	PUNCT	O
correlating	O	VERB	B
to	O	PART	O
cell	O	NOUN	B
shape	O	NOUN	O
changes	O	NOUN	B
,	O	PUNCT	O
cytokeratins	B-protein	NOUN	B
8	I-protein	NUM	O
and	I-protein	CCONJ	O
18	I-protein	NUM	O
,	O	PUNCT	O
associated	O	VERB	B
with	O	ADP	I
differentiated	B-cell_type	VERB	O
cell	I-cell_type	NOUN	B
types	I-cell_type	NOUN	I
of	O	ADP	O
prostate	O	NOUN	B
epithelia	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
neuron-specific	B-protein	ADJ	B
enolase	I-protein	NOUN	I
and	O	CCONJ	O
serotonin	O	NOUN	B
,	O	PUNCT	O
associated	O	VERB	B
with	O	ADP	I
neuroendocrine	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


This	O	DET	O
growth	B-protein	NOUN	B
modulator	I-protein	NOUN	I
was	O	AUX	O
semipurified	O	VERB	B
and	O	CCONJ	O
had	O	AUX	O
an	O	DET	O
estimated	O	VERB	O
molecular	O	ADJ	B
weight	O	NOUN	I
13	O	NUM	O
,	O	PUNCT	O
000	O	NUM	O
to	O	PART	O
24	O	NUM	O
,	O	PUNCT	O
000	O	NUM	O
Da	O	NOUN	O
.	O	PUNCT	O


Platelet-activating	B-protein	ADJ	B
factor	I-protein	NOUN	I
stimulates	O	VERB	B
transcription	O	NOUN	B
of	O	ADP	O
the	O	DET	O
heparin-binding	B-protein	ADJ	B
epidermal	I-protein	ADJ	I
growth	I-protein	NOUN	I
factor-like	I-protein	ADJ	B
growth	I-protein	NOUN	I
factor	I-protein	NOUN	I
in	O	ADP	O
monocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


Pretreatment	O	NOUN	B
of	O	ADP	O
monocytes	B-cell_type	NOUN	B
with	O	ADP	O
pertussis	O	NOUN	B
toxin	O	NOUN	I
inhibited	O	VERB	B
these	O	DET	O
functions	O	NOUN	B
of	O	ADP	O
PAF	B-protein	NOUN	B
,	O	PUNCT	O
whereas	O	SCONJ	O
cholera	O	NOUN	B
toxin	O	NOUN	I
had	O	AUX	O
no	O	DET	O
inhibitory	O	ADJ	B
effect	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
a	O	DET	O
potential	O	ADJ	O
role	O	NOUN	O
of	O	ADP	O
PAF	B-protein	NOUN	B
in	O	ADP	O
HB-EGF	B-protein	NOUN	B
expression	O	NOUN	B
and	O	CCONJ	O
provide	O	VERB	O
evidence	O	NOUN	B
that	O	SCONJ	O
this	O	DET	O
stimulation	O	NOUN	B
may	O	AUX	O
occur	O	VERB	O
through	O	ADP	O
increased	O	VERB	B
kappa	O	NOUN	O
B	O	NOUN	O
binding	O	NOUN	O
activity	O	NOUN	O
.	O	PUNCT	O


Mapping	O	NOUN	B
of	O	ADP	O
the	O	DET	O
interaction	B-protein	NOUN	B
site	I-protein	NOUN	B
of	O	ADP	O
the	O	DET	O
defective	B-protein	ADJ	B
transcription	I-protein	NOUN	O
factor	I-protein	NOUN	O
in	O	ADP	O
the	O	DET	O
class	B-cell_line	NOUN	B
II	I-cell_line	NUM	I
major	I-cell_line	ADJ	I
histocompatibility	I-cell_line	NOUN	I
complex	I-cell_line	NOUN	I
mutant	I-cell_line	ADJ	O
cell	I-cell_line	NOUN	O
line	I-cell_line	NOUN	O
clone-13	I-cell_line	NOUN	B
to	O	PART	O
the	O	DET	O
divergent	B-DNA	ADJ	B
X2-box	I-DNA	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
employed	O	VERB	O
the	O	DET	O
ZEBRA	B-protein	NOUN	B
/EBV	O	NOUN	O
biological	O	ADJ	B
system	O	NOUN	I
to	O	PART	O
test	O	VERB	B
whether	O	SCONJ	O
a	O	DET	O
heterologous	B-protein	ADJ	B
activation	I-protein	NOUN	B
domain	I-protein	NOUN	I
can	O	AUX	O
substitute	O	VERB	O
for	O	ADP	O
another	O	DET	O
activation	O	NOUN	B
domain	O	NOUN	I
(	O	PUNCT	O
the	O	DET	O
ZEBRA	B-protein	NOUN	B
domain	I-protein	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


These	O	DET	O
studies	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
specificities	O	NOUN	B
of	O	ADP	O
some	O	DET	O
of	O	ADP	O
the	O	DET	O
known	O	ADJ	O
biological	O	ADJ	B
functions	O	NOUN	I
of	O	ADP	O
ZEBRA	B-protein	NOUN	B
are	O	AUX	O
not	O	PART	O
dependent	O	ADJ	O
upon	O	SCONJ	O
the	O	DET	O
nature	O	NOUN	O
of	O	ADP	O
the	O	DET	O
activation	B-protein	NOUN	B
domain	I-protein	NOUN	I
present	I-protein	ADJ	O
within	O	ADP	O
ZEBRA	B-protein	NOUN	B
.	O	PUNCT	O


Evidence	O	NOUN	B
for	O	ADP	O
the	O	DET	O
involvement	O	NOUN	B
of	O	ADP	O
Janus	B-protein	NOUN	B
kinase	I-protein	NOUN	I
3	I-protein	NUM	I
and	O	CCONJ	O
interleukin-4	B-protein	NOUN	B
Stat	I-protein	NOUN	I
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
a	O	DET	O
specific	O	ADJ	O
induction	O	NOUN	B
of	O	ADP	O
AhR	B-protein	NOUN	B
during	O	ADP	O
monocytic	O	ADJ	B
differentiation	O	NOUN	I
was	O	AUX	O
investigated	O	VERB	B
in	O	ADP	O
HL60	B-cell_line	NOUN	B
and	O	CCONJ	O
HEL	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


The	O	DET	O
HEL	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
also	O	ADV	O
exhibited	O	VERB	O
a	O	DET	O
similar	O	ADJ	O
elevation	O	NOUN	B
of	O	ADP	O
AhR	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
level	O	NOUN	B
,	O	PUNCT	O
when	O	SCONJ	O
they	O	PRON	O
had	O	AUX	O
differentiated	O	VERB	B
toward	O	ADP	O
monocyte-macrophage	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
by	O	ADP	O
these	O	DET	O
combined	O	ADJ	O
inducers	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
little	O	ADJ	O
change	O	NOUN	O
in	O	ADP	O
the	O	DET	O
mRNA	O	NOUN	B
level	O	NOUN	B
was	O	AUX	O
observed	O	VERB	O
when	O	SCONJ	O
the	O	DET	O
cells	O	NOUN	B
were	O	AUX	O
induced	O	VERB	B
to	O	PART	O
differentiate	O	VERB	B
into	O	ADP	O
other	O	ADJ	O
cell	O	NOUN	B
types	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
promoters	B-DNA	NOUN	B
were	O	AUX	O
used	O	VERB	O
without	O	ADP	O
enhancers	B-DNA	NOUN	B
,	O	PUNCT	O
or	O	CCONJ	O
with	O	ADP	O
enhancers	B-DNA	NOUN	B
derived	O	VERB	O
from	O	ADP	O
the	O	DET	O
beta-globin	B-DNA	NOUN	B
locus	I-DNA	NOUN	O
control	I-DNA	NOUN	O
region	I-DNA	NOUN	O
and	O	CCONJ	O
the	O	DET	O
alpha-globin	B-DNA	NOUN	B
HS-40	I-DNA	NOUN	I
enhancer	I-DNA	NOUN	I
.	O	PUNCT	O


Point	O	NOUN	B
mutation	O	NOUN	I
of	O	ADP	O
a	O	DET	O
CCACC	B-DNA	NOUN	B
site	I-DNA	NOUN	I
at	O	ADP	O
-240	O	NUM	O
had	O	AUX	O
no	O	DET	B
effect	O	NOUN	I
.	O	PUNCT	O


Moreover	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
data	O	NOUN	B
comparing	O	VERB	O
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	I
activated	B-protein	VERB	B
Ras	I-protein	NOUN	B
and	O	CCONJ	O
PKC	B-protein	NOUN	B
mutants	I-protein	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
PKC-alpha	B-protein	NOUN	B
,	O	PUNCT	O
p21ras	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
PKC-epsilon	B-protein	NOUN	B
are	O	AUX	O
not	O	PART	O
positioned	O	ADJ	O
linearly	O	ADV	O
on	O	ADP	O
a	O	DET	O
single	O	ADJ	O
signal	O	NOUN	O
transduction	O	NOUN	O
pathway	O	NOUN	O
.	O	PUNCT	O


Moreover	O	ADV	O
,	O	PUNCT	O
IL-5	B-protein	NOUN	B
induced	O	VERB	B
at	O	ADP	O
least	O	ADJ	O
two	O	NUM	O
DNA-binding	B-protein	ADJ	B
complexes	I-protein	NOUN	O
,	O	PUNCT	O
using	O	VERB	O
nuclear	O	ADJ	B
extracts	O	NOUN	I
from	O	ADP	O
normal	O	ADJ	O
human	B-cell_type	ADJ	B
eosinophils	I-cell_type	NOUN	B
and	O	CCONJ	O
the	O	DET	O
IL-6/interferon-gamma	B-DNA	NOUN	B
response	I-DNA	NOUN	I
element	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
ICAM-1	B-DNA	NOUN	B
promoter	I-DNA	NOUN	I
(	O	PUNCT	O
ICAM-1	B-DNA	NOUN	B
pIRE	I-DNA	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
an	O	DET	O
electromobility	O	NOUN	B
shift	O	NOUN	I
assay	O	NOUN	I
.	O	PUNCT	O


Infection	O	NOUN	B
and	O	CCONJ	O
replication	O	NOUN	B
of	O	ADP	O
Tat-	O	NOUN	B
human	O	ADJ	B
immunodeficiency	O	NOUN	I
viruses	O	NOUN	I
:	O	PUNCT	O
genetic	O	ADJ	B
analyses	O	NOUN	I
of	O	ADP	O
LTR	B-DNA	NOUN	B
and	O	CCONJ	O
tat	B-protein	NOUN	B
mutations	I-protein	NOUN	I
in	O	ADP	O
primary	B-cell_type	ADJ	B
and	I-cell_type	CCONJ	O
long-term	I-cell_type	ADJ	B
human	I-cell_type	ADJ	B
lymphoid	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
this	O	DET	O
efficient	O	ADJ	B
propagation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
LTR-modified	B-protein	ADJ	B
tat	I-protein	NOUN	B
mutants	I-protein	NOUN	B
was	O	AUX	O
restricted	O	ADJ	O
to	O	PART	O
some	O	DET	O
lymphoid	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
that	O	PRON	O
have	O	AUX	O
been	O	AUX	O
transformed	O	VERB	O
with	O	ADP	O
other	O	ADJ	O
viruses	O	NOUN	B
.	O	PUNCT	O


Functional	O	ADJ	B
roles	O	NOUN	O
of	O	ADP	O
the	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
Oct-2A	I-protein	NOUN	I
and	O	CCONJ	O
the	O	DET	O
high	B-protein	ADJ	O
mobility	I-protein	NOUN	B
group	I-protein	NOUN	I
protein	I-protein	NOUN	O
I/Y	B-protein	NOUN	O
in	O	ADP	O
HLA-DRA	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
expression	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
HLA-DRA	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
expression	O	NOUN	B
is	O	AUX	O
inducible	O	ADJ	B
in	O	ADP	O
a	O	DET	O
variety	O	NOUN	O
of	O	ADP	O
cell	O	NOUN	B
types	O	NOUN	I
by	O	ADP	O
interferon-gamma	B-protein	NOUN	B
(	O	PUNCT	O
IFN-gamma	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Coexpression	O	NOUN	B
of	O	ADP	O
HMG	B-protein	NOUN	B
I/Y	I-protein	NOUN	I
and	O	CCONJ	O
Oct-2	B-protein	NOUN	B
in	O	ADP	O
cell	B-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
lacking	O	VERB	O
Oct-2	B-protein	NOUN	B
results	O	VERB	I
in	O	ADP	O
high	O	ADJ	O
levels	O	NOUN	B
of	O	ADP	O
HLA-DRA	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
expression	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
in	O	X	B
vitro	O	X	I
DNA-binding	O	ADJ	B
studies	O	NOUN	B
reveal	O	VERB	O
that	O	SCONJ	O
HMG	O	NOUN	B
I/Y	B-protein	NOUN	B
stimulates	O	VERB	B
Oct-2A	B-protein	NOUN	B
binding	O	NOUN	I
to	O	PART	O
the	O	DET	O
HLA-DRA	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
.	O	PUNCT	O


By	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
Oct-2A	B-protein	NOUN	B
is	O	AUX	O
not	O	PART	O
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
IFN-gamma	B-protein	NOUN	B
induction	O	NOUN	B
of	O	ADP	O
the	O	DET	O
HLA-DRA	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
in	O	ADP	O
HeLa	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
antisense	B-DNA	ADJ	B
HMG	I-DNA	NOUN	I
I/Y	I-DNA	NOUN	I
dramatically	O	ADV	O
decreases	O	VERB	B
the	O	DET	O
level	O	NOUN	B
of	O	ADP	O
induction	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
lymphoblastoid	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
,	O	PUNCT	O
six	O	NUM	O
EBV-encoded	B-protein	ADJ	B
nuclear	I-protein	ADJ	O
antigens	I-protein	NOUN	O
(	O	PUNCT	O
EBNA1	B-protein	NOUN	B
,	I-protein	PUNCT	O
2	I-protein	NUM	O
,	I-protein	PUNCT	O
3A	I-protein	NOUN	B
,	I-protein	PUNCT	O
3B	I-protein	NOUN	B
,	I-protein	PUNCT	O
3C	I-protein	NOUN	B
,	I-protein	PUNCT	O
-LP	I-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
three	O	NUM	O
latent	B-protein	ADJ	B
membrane	I-protein	NOUN	I
proteins	I-protein	NOUN	I
(	O	PUNCT	O
LMP1	B-protein	NOUN	B
,	O	PUNCT	O
2A	B-protein	NOUN	B
,	O	PUNCT	O
2B	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
two	O	NUM	O
nuclear	B-RNA	ADJ	B
RNAs	I-RNA	NOUN	I
(	O	PUNCT	O
EBERs	B-RNA	NOUN	B
)	O	PUNCT	O
are	O	AUX	O
expressed	O	VERB	B
.	O	PUNCT	O


Reduced	O	VERB	B
mitogenic	O	ADJ	B
stimulation	O	NOUN	I
of	O	ADP	O
peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
mononuclear	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
as	O	ADP	O
a	O	DET	O
prognostic	O	ADJ	B
parameter	O	NOUN	O
for	O	ADP	O
the	O	DET	O
course	O	NOUN	B
of	O	ADP	O
breast	O	NOUN	B
cancer	O	NOUN	I
:	O	PUNCT	O
a	O	DET	O
prospective	O	ADJ	B
longitudinal	O	ADJ	I
study	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
core	B-DNA	NOUN	B
elements	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
SL3	O	NOUN	B
virus	O	NOUN	I
are	O	AUX	O
important	O	ADJ	O
genetic	O	ADJ	B
determinants	O	NOUN	I
of	O	ADP	O
the	O	DET	O
ability	O	NOUN	B
of	O	ADP	O
this	O	DET	O
virus	O	NOUN	B
to	O	PART	O
induce	O	VERB	B
T-cell	O	NOUN	B
lymphomas	O	NOUN	I
and	O	CCONJ	O
the	O	DET	O
transcriptional	O	ADJ	B
activity	O	NOUN	I
of	O	ADP	O
the	O	DET	O
viral	B-DNA	ADJ	B
long	I-DNA	ADJ	I
terminal	I-DNA	ADJ	I
repeat	I-DNA	NOUN	I
in	O	ADP	O
T	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
.	O	PUNCT	O


An	O	DET	O
exogenously	O	ADV	B
expressed	O	VERB	B
Cbf	B-protein	NOUN	B
alpha	I-protein	NOUN	I
2-encoded	I-protein	ADJ	I
subunit	I-protein	NOUN	I
(	O	PUNCT	O
CBF	B-protein	NOUN	B
alpha	I-protein	NOUN	O
2-451	I-protein	NUM	O
)	O	PUNCT	O
stimulated	O	VERB	B
transcription	O	NOUN	B
from	O	ADP	O
the	O	DET	O
SL3	B-DNA	NOUN	B
enhancer	I-DNA	NOUN	O
in	O	ADP	O
P19	B-protein	NOUN	B
and	O	CCONJ	O
HeLa	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Using	O	VERB	O
electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assays	O	NOUN	I
(	O	PUNCT	O
EMSA	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
we	O	PRON	O
now	O	ADV	O
show	O	VERB	O
that	O	SCONJ	O
,	O	PUNCT	O
in	O	ADP	O
monocytes	O	NOUN	B
stimulated	O	VERB	B
with	O	ADP	O
LPS	O	NOUN	B
or	O	CCONJ	O
TNF	B-protein	NOUN	B
alpha	I-protein	NOUN	I
,	O	PUNCT	O
IL-10	B-protein	NOUN	B
inhibits	O	VERB	B
nuclear	O	ADJ	B
stimulation	O	NOUN	I
of	O	ADP	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
(	O	PUNCT	O
NF	B-protein	NOUN	O
kappa	I-protein	NOUN	O
B	I-protein	NOUN	O
)	O	PUNCT	O
,	O	PUNCT	O
a	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
inflammatory	B-DNA	ADJ	B
cytokine	I-DNA	NOUN	O
genes	I-DNA	NOUN	O
.	O	PUNCT	O
Several	O	ADJ	O
other	O	ADJ	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
including	O	VERB	O
NF-	O	NOUN	B
IL-6	B-protein	NOUN	B
,	O	PUNCT	O
AP-1	B-protein	NOUN	B
,	O	PUNCT	O
AP-2	B-protein	NOUN	B
,	O	PUNCT	O
GR	B-protein	NOUN	B
,	O	PUNCT	O
CREB	B-protein	NOUN	B
,	O	PUNCT	O
Oct-1	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
Sp-1	B-protein	NOUN	B
are	O	AUX	O
not	O	PART	O
affected	O	VERB	O
by	O	ADP	O
IL-10	B-protein	NOUN	B
.	O	PUNCT	O


Taken	O	VERB	O
together	O	ADV	O
,	O	PUNCT	O
these	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
inhibition	O	NOUN	B
of	O	ADP	O
NF	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
activation	O	NOUN	B
may	O	AUX	O
be	O	AUX	O
an	O	DET	O
important	O	ADJ	O
mechanism	O	NOUN	B
for	O	ADP	O
IL-10	B-protein	NOUN	B
suppression	O	NOUN	B
of	O	ADP	O
cytokine	O	NOUN	B
gene	O	NOUN	B
transcription	O	NOUN	I
in	O	ADP	O
human	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


LMP-1	B-protein	NOUN	B
,	O	PUNCT	O
an	O	DET	O
Epstein-Barr	B-protein	ADJ	B
virus	I-protein	NOUN	I
membrane	I-protein	NOUN	I
protein	I-protein	NOUN	I
expressed	O	VERB	B
during	O	ADP	O
latent	O	ADJ	B
infection	O	NOUN	I
,	O	PUNCT	O
has	O	AUX	O
oncogenic	O	ADJ	B
properties	O	NOUN	B
,	O	PUNCT	O
as	O	ADP	O
judged	O	VERB	O
from	O	ADP	O
its	O	PRON	O
ability	O	NOUN	O
to	O	PART	O
transform	O	VERB	B
B	O	NOUN	I
lymphocytes	B-cell_type	NOUN	I
and	O	CCONJ	O
rodent	B-cell_type	ADJ	B
fibroblasts	I-cell_type	NOUN	B
.	O	PUNCT	O


The	O	DET	O
mechanism	O	NOUN	B
(	O	PUNCT	O
s	O	NOUN	O
)	O	PUNCT	O
regulating	O	VERB	B
this	O	DET	O
activation	O	NOUN	B
remains	O	VERB	O
unknown	O	ADJ	O
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
show	O	VERB	O
that	O	SCONJ	O
CBF	B-RNA	NOUN	B
beta-MYH11	I-RNA	NOUN	B
fusion	I-RNA	NOUN	B
transcripts	I-RNA	NOUN	I
occur	O	VERB	O
not	O	PART	O
only	O	ADV	O
in	O	ADP	O
the	O	DET	O
vast	O	ADJ	O
majority	O	NOUN	O
of	O	ADP	O
typical	O	ADJ	O
AML	O	NOUN	B
M4Eo	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
also	O	ADV	O
in	O	ADP	O
approximately	O	ADV	O
10	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
AML	O	NOUN	B
M4	O	NOUN	B
without	O	ADP	O
eosinophilic	O	ADJ	B
abnormalities	O	NOUN	I
,	O	PUNCT	O
a	O	DET	O
much	O	ADV	O
higher	O	ADJ	B
incidence	O	NOUN	B
than	O	ADP	O
the	O	DET	O
sporadic	O	ADJ	B
reports	O	NOUN	I
of	O	ADP	O
chromosome	B-DNA	NOUN	O
16	I-DNA	NUM	O
abnormalities	O	NOUN	B
in	O	ADP	O
AML	O	NOUN	B
M4	O	NOUN	B
would	O	AUX	O
suggest	O	VERB	O
.	O	PUNCT	O


Therefore	O	ADV	O
,	O	PUNCT	O
Tat	B-protein	NOUN	B
-mediated	O	ADJ	O
effects	O	NOUN	B
on	O	ADP	O
the	O	DET	O
cellular	O	ADJ	B
redox	O	NOUN	I
state	O	NOUN	I
were	O	AUX	O
analyzed	O	VERB	B
.	O	PUNCT	O


In	O	ADP	O
both	O	CCONJ	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
HeLa	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
HIV-1	B-protein	NOUN	B
Tat	I-protein	NOUN	B
suppressed	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
Mn-dependent	B-protein	ADJ	B
superoxide	I-protein	NOUN	I
dismutase	I-protein	NOUN	I
(	O	PUNCT	O
Mn-SOD	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
a	O	DET	O
mitochondrial	B-protein	ADJ	B
enzyme	I-protein	NOUN	B
that	O	PRON	O
is	O	AUX	O
part	O	NOUN	O
of	O	ADP	O
the	O	DET	O
cellular	O	ADJ	B
defense	O	NOUN	I
system	O	NOUN	I
against	O	ADP	O
oxidative	O	ADJ	B
stress	O	NOUN	I
.	O	PUNCT	O


(	O	PUNCT	O
ABSTRACT	O	NOUN	B
TRUNCATED	O	VERB	I
AT	O	ADP	I
250	O	NUM	I
WORDS	O	NOUN	I
)	O	PUNCT	O


Binding	O	VERB	B
sites	O	NOUN	I
were	O	AUX	O
mapped	O	VERB	B
for	O	ADP	O
each	O	DET	O
factor	O	NOUN	B
.	O	PUNCT	O


Major	O	ADJ	B
depressive	O	ADJ	I
disorder	O	NOUN	I
(	O	PUNCT	O
MDD	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
adolescents	O	NOUN	B
demonstrates	O	VERB	O
resistance	O	NOUN	B
to	O	PART	O
tricyclic	O	ADJ	B
antidepressants	O	NOUN	I
and	O	CCONJ	O
absence	O	NOUN	B
of	O	ADP	O
hypercortisolemia	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
an	O	DET	O
open-label	O	ADJ	B
study	O	NOUN	I
,	O	PUNCT	O
adolescents	O	NOUN	B
(	O	PUNCT	O
n	O	NOUN	O
=	O	ADJ	O
20	O	NUM	O
)	O	PUNCT	O
meeting	O	NOUN	O
DSM-III-R	O	NOUN	B
criteria	O	NOUN	I
for	O	ADP	O
MDD	O	NOUN	B
showed	O	VERB	O
baseline	O	NOUN	B
lymphocyte	B-protein	NOUN	B
GCII	I-protein	NOUN	B
sites	I-protein	NOUN	O
per	O	ADP	O
cell	O	NOUN	O
(	O	PUNCT	O
sites/cell	O	NOUN	O
)	O	PUNCT	O
values	O	NOUN	B
of	O	ADP	O
793	O	NUM	O
+/-	O	CCONJ	O
106	O	NUM	O
versus	O	CCONJ	O
2	O	NUM	O
,	O	PUNCT	O
563	O	NUM	O
+/-	O	CCONJ	O
499	O	NUM	O
(	O	PUNCT	O
+/-	O	CCONJ	O
SEM	O	NOUN	B
)	O	PUNCT	O
for	O	ADP	O
matched	O	VERB	B
controls	O	NOUN	I
(	O	PUNCT	O
n	O	NOUN	O
=	O	ADJ	O
18	O	NUM	O
)	O	PUNCT	O
(	O	PUNCT	O
t	O	NOUN	O
=	O	ADJ	O
3.5	O	NUM	O
;	O	PUNCT	O
df	O	NOUN	O
=	O	ADJ	O
36	O	NUM	O
;	O	PUNCT	O
p	O	X	O
<	O	X	O
.001	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


NFATp	B-protein	NOUN	B
binds	O	VERB	B
to	O	PART	O
two	O	NUM	O
sites	O	NOUN	B
within	O	ADP	O
the	O	DET	O
kappa	B-DNA	NOUN	B
3	I-DNA	NUM	I
element	I-DNA	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
occupancy	O	NOUN	B
of	O	ADP	O
both	O	DET	O
sites	O	NOUN	B
is	O	AUX	O
required	O	VERB	O
for	O	ADP	O
TNF	B-protein	NOUN	B
alpha	O	NOUN	I
gene	O	NOUN	I
induction	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
results	O	NOUN	B
varied	O	VERB	O
with	O	ADP	O
the	O	DET	O
agent	O	NOUN	B
,	O	PUNCT	O
cell	O	NOUN	B
type	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
stage	O	NOUN	B
of	O	ADP	O
differentiation	O	NOUN	B
.	O	PUNCT	O


None	O	NOUN	O
of	O	ADP	O
the	O	DET	O
DNA	O	NOUN	B
fragments	O	NOUN	I
investigated	O	VERB	B
indicated	O	VERB	O
interaction	O	NOUN	B
of	O	ADP	O
EBNA-2	B-protein	NOUN	B
with	O	ADP	O
the	O	DET	O
DNA	O	NOUN	B
via	O	ADP	O
protein-protein	O	ADJ	B
interactions	O	NOUN	I
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
differentiation	O	NOUN	B
of	O	ADP	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
with	O	ADP	O
IL-6	B-protein	NOUN	B
in	O	X	B
vitro	O	X	I
recapitulates	O	VERB	O
the	O	DET	O
hallmarks	O	NOUN	B
of	O	ADP	O
terminal	O	ADJ	B
B	O	NOUN	O
differentiation	O	NOUN	O
in	O	X	B
vivo	O	X	I
;	O	PUNCT	O
Oct-2	B-protein	NOUN	B
may	O	AUX	O
have	O	AUX	O
a	O	DET	O
role	O	NOUN	O
in	O	ADP	O
this	O	DET	O
process	O	NOUN	B
.	O	PUNCT	O


Northern	O	NOUN	B
(	O	PUNCT	O
RNA	O	NOUN	B
)	O	PUNCT	O
blots	O	NOUN	B
of	O	ADP	O
various	O	ADJ	O
adult	O	ADJ	B
mouse	O	NOUN	B
tissues	O	NOUN	I
revealed	O	VERB	B
that	O	SCONJ	O
the	O	DET	O
levels	O	NOUN	B
of	O	ADP	O
expression	O	NOUN	B
of	O	ADP	O
both	O	DET	O
genes	O	NOUN	B
were	O	AUX	O
most	O	ADV	O
prominent	O	ADJ	O
in	O	ADP	O
the	O	DET	O
thymus	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
results	O	NOUN	B
indicated	O	VERB	O
that	O	SCONJ	O
both	O	DET	O
genes	O	NOUN	B
are	O	AUX	O
expressed	O	VERB	B
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
throughout	O	ADP	O
their	O	PRON	O
development	O	NOUN	B
,	O	PUNCT	O
supporting	O	VERB	O
the	O	DET	O
notion	O	NOUN	O
that	O	SCONJ	O
PEBP2	B-protein	NOUN	B
is	O	AUX	O
a	O	DET	O
T-cell-specific	B-protein	ADJ	B
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
.	O	PUNCT	O


TNF-alpha	O	NOUN	B
,	O	PUNCT	O
IL-1	O	NOUN	B
beta	O	NOUN	I
and	O	CCONJ	O
phorbol	O	NOUN	B
myristate	O	NOUN	B
acetate	O	NOUN	I
(	O	PUNCT	O
PMA	O	NOUN	B
)	O	PUNCT	O
treatment	O	NOUN	B
increased	O	VERB	B
AP-1	B-protein	NOUN	B
and	O	CCONJ	O
NF	O	NOUN	B
kappa	O	NOUN	I
B	O	NOUN	I
DNA	O	NOUN	B
binding	O	NOUN	I
by	O	ADP	O
up	O	ADV	O
to	O	PART	O
200	O	NUM	O
%	O	NOUN	O
but	O	CCONJ	O
decreased	O	VERB	B
CREB	B-protein	NOUN	B
binding	O	NOUN	B
(	O	PUNCT	O
38	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
over	O	ADP	O
a	O	DET	O
60-min	O	ADJ	O
time	O	NOUN	B
course	O	NOUN	I
.	O	PUNCT	O


This	O	DET	O
enhancement	O	NOUN	B
by	O	ADP	O
BDP	O	NOUN	B
was	O	AUX	O
found	O	VERB	O
either	O	CCONJ	O
for	O	ADP	O
constitutive	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
gcRs	B-protein	NOUN	B
or	O	CCONJ	O
in	O	ADP	O
experiments	O	NOUN	B
when	O	SCONJ	O
the	O	DET	O
lymphocytes	B-cell_type	NOUN	B
were	O	AUX	O
stimulated	O	VERB	B
by	O	ADP	O
interleukin	B-protein	NOUN	B
(	I-protein	PUNCT	I
IL	I-protein	NOUN	B
)	I-protein	PUNCT	O
-6	I-protein	NUM	O
.	O	PUNCT	O


HS	B-DNA	NOUN	B
I	I-DNA	NUM	I
,	I-DNA	PUNCT	O
IV	I-DNA	NUM	B
,	I-DNA	PUNCT	O
and	I-DNA	CCONJ	O
V	I-DNA	NOUN	B
were	O	AUX	O
exclusively	O	ADV	O
observed	O	VERB	B
in	O	ADP	O
the	O	DET	O
erythroid/megakaryocytic	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
that	O	PRON	O
express	O	VERB	O
tal-1	B-DNA	NOUN	B
from	O	ADP	O
the	O	DET	O
promoters	B-DNA	NOUN	B
1a	I-DNA	NOUN	I
and	I-DNA	CCONJ	O
1b	I-DNA	NOUN	B
.	O	PUNCT	O


cdc2	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
transcripts	I-RNA	NOUN	I
were	O	AUX	O
detected	O	VERB	B
in	O	ADP	O
immature	B-cell_type	ADJ	B
bone	I-cell_type	NOUN	B
marrow	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
became	O	VERB	O
undetectable	O	ADJ	B
along	O	ADP	O
with	O	ADP	O
differentiation	O	NOUN	B
.	O	PUNCT	O


Transient	O	ADJ	B
chloramphenicol	B-protein	NOUN	B
acetyltransferase	I-protein	NOUN	O
assay	O	NOUN	O
revealed	O	VERB	B
that	O	SCONJ	O
the	O	DET	O
region	O	NOUN	B
containing	O	VERB	O
E2F	B-DNA	NOUN	B
binding	I-DNA	NOUN	I
site	I-DNA	NOUN	I
had	O	AUX	O
a	O	DET	O
strong	O	ADJ	O
promoter	O	NOUN	B
activity	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
introduction	O	NOUN	B
of	O	ADP	O
the	O	DET	O
mutation	O	NOUN	B
at	O	ADP	O
the	O	DET	O
E2F	B-DNA	NOUN	B
binding	I-DNA	NOUN	I
site	I-DNA	NOUN	I
resulted	O	VERB	O
in	O	ADP	O
a	O	DET	O
significant	O	ADJ	O
loss	O	NOUN	B
of	O	ADP	O
the	O	DET	O
activity	O	NOUN	B
.	O	PUNCT	O


Whether	O	SCONJ	O
virus-induced	O	ADJ	B
NF-kappa	B-protein	NOUN	I
B	I-protein	NOUN	I
activation	O	NOUN	B
is	O	AUX	O
a	O	DET	O
mechanism	O	NOUN	B
that	O	PRON	O
favors	O	VERB	O
continuous	O	ADJ	B
viral	O	ADJ	B
replication	O	NOUN	O
in	O	ADP	O
macrophages	B-cell_type	NOUN	B
remains	O	VERB	O
unknown	O	ADJ	O
.	O	PUNCT	O


First	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
persistent	O	ADJ	B
HIV	O	NOUN	B
infection	O	NOUN	I
results	O	VERB	B
in	O	ADP	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
NF-kappa	O	NOUN	B
B	O	NOUN	I
not	O	PART	O
only	O	ADV	O
in	O	ADP	O
monocytic	O	ADJ	B
cells	O	NOUN	I
but	O	CCONJ	O
also	O	ADV	O
in	O	ADP	O
macrophages	B-cell_type	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
HIV-infected	O	ADJ	B
cells	O	NOUN	I
,	O	PUNCT	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
alpha	I-protein	NOUN	I
protein	O	NOUN	I
levels	O	NOUN	O
are	O	AUX	O
decreased	O	VERB	B
secondary	O	ADJ	B
to	O	PART	I
enhanced	O	VERB	O
protein	O	NOUN	B
degradation	O	NOUN	I
.	O	PUNCT	O


Glucocorticoid-induced	O	ADJ	B
apoptosis	O	NOUN	I
of	O	ADP	O
human	B-cell_type	ADJ	B
leukemic	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
is	O	AUX	O
caused	O	VERB	O
by	O	ADP	O
the	O	DET	O
repressive	O	ADJ	B
function	O	NOUN	I
of	O	ADP	O
the	O	DET	O
glucocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
.	O	PUNCT	O


NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
is	O	AUX	O
a	O	DET	O
nuclear	B-protein	ADJ	B
protein	I-protein	NOUN	I
of	O	ADP	O
the	O	DET	O
rel	B-protein	NOUN	B
oncogene	I-protein	NOUN	I
family	I-protein	NOUN	O
capable	O	ADJ	O
of	O	ADP	O
enhancing	O	VERB	B
transcription	O	NOUN	B
of	O	ADP	O
several	B-DNA	ADJ	O
cellular	I-DNA	ADJ	B
genes	I-DNA	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
IL-2	B-protein	NOUN	B
and	O	CCONJ	O
the	O	DET	O
IL-2	B-protein	NOUN	B
receptor	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
viral	B-DNA	ADJ	B
genes	I-DNA	NOUN	I
transcribed	O	VERB	B
from	O	ADP	O
the	O	DET	O
HIV-1	B-DNA	NOUN	B
LTR	I-DNA	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
study	O	NOUN	B
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	O
HIV	O	NOUN	B
protease	O	NOUN	I
on	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
precursor	O	NOUN	O
activation	O	NOUN	O
were	O	AUX	O
examined	O	VERB	O
in	O	ADP	O
Jurkat	O	NOUN	B
T	B-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
by	O	ADP	O
introducing	O	VERB	O
a	O	DET	O
protease	B-DNA	NOUN	B
expression	I-DNA	NOUN	O
vector	I-DNA	NOUN	O
into	O	ADP	O
the	O	DET	O
cells	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
examined	O	VERB	O
the	O	DET	O
feasibility	O	NOUN	B
of	O	ADP	O
using	O	VERB	O
interferon	B-protein	NOUN	B
(	O	PUNCT	O
IFN	B-protein	NOUN	B
)	O	PUNCT	O
gene	O	NOUN	B
transfer	O	NOUN	I
as	O	ADP	O
a	O	DET	O
novel	O	ADJ	O
approach	O	NOUN	O
to	O	PART	O
anti-human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
type	O	NOUN	I
1	O	NUM	I
(	O	PUNCT	O
HIV-1	O	NOUN	B
)	O	PUNCT	O
therapy	O	NOUN	B
in	O	ADP	O
this	O	DET	O
study	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
genes	O	NOUN	B
KOX	B-DNA	NOUN	B
4	I-DNA	NUM	I
and	O	CCONJ	O
KOX	B-DNA	NOUN	B
9	I-DNA	NUM	O
,	O	PUNCT	O
mapped	O	VERB	B
on	O	ADP	O
chromosome	B-DNA	NOUN	B
8q24	I-DNA	NOUN	I
,	O	PUNCT	O
were	O	AUX	O
found	O	VERB	O
to	O	PART	O
be	O	AUX	O
located	O	ADJ	O
within	O	ADP	O
a	O	DET	O
DNA	B-DNA	NOUN	B
fragment	I-DNA	NOUN	I
of	O	ADP	O
450	O	NUM	O
kb	O	NOUN	O
.	O	PUNCT	O


Mononuclear	B-cell_type	ADJ	B
leukocytes	I-cell_type	NOUN	B
from	O	ADP	O
young	O	ADJ	B
or	O	CCONJ	O
elderly	O	ADJ	B
persons	O	NOUN	I
were	O	AUX	O
sham-exposed	O	VERB	B
or	O	CCONJ	O
exposed	O	VERB	B
to	O	PART	I
influenza	O	NOUN	B
virus	O	NOUN	I
for	O	ADP	O
1	O	NUM	O
,	O	PUNCT	O
24	O	NUM	O
,	O	PUNCT	O
and	O	CCONJ	O
72	O	NUM	O
h	O	NOUN	O
.	O	PUNCT	O


Fewer	O	ADJ	O
virus-exposed	O	ADJ	B
cells	O	NOUN	I
from	O	ADP	O
elderly	O	ADJ	B
donors	O	NOUN	I
stained	O	VERB	B
for	O	ADP	O
Fos	B-protein	NOUN	B
and	O	CCONJ	O
Jun	B-protein	NOUN	B
at	O	ADP	O
each	O	DET	O
data	O	NOUN	B
point	O	NOUN	I
compared	O	VERB	B
with	O	ADP	O
cells	O	NOUN	B
from	O	ADP	O
young	O	ADJ	B
donors	O	NOUN	I
.	O	PUNCT	O


OBJECTIVES	O	NOUN	O
:	O	PUNCT	O
To	O	PART	O
analyze	O	VERB	O
the	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
retinoic	O	ADJ	B
acids	O	NOUN	I
(	O	PUNCT	O
RA	O	NOUN	B
)	O	PUNCT	O
on	O	ADP	O
HIV-1	O	NOUN	B
expression	O	NOUN	B
and	O	CCONJ	O
correlate	O	VERB	B
this	O	DET	O
effect	O	NOUN	B
with	O	ADP	O
expression	O	NOUN	B
levels	O	NOUN	O
of	O	ADP	O
RA	B-protein	NOUN	B
receptors	I-protein	NOUN	I
(	O	PUNCT	O
RARs	B-protein	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
T-lymphoid	B-cell_line	ADJ	B
and	I-cell_line	CCONJ	O
monocytoid	I-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
.	O	PUNCT	O


The	O	DET	O
expression	O	NOUN	B
levels	O	NOUN	B
of	O	ADP	O
human	B-protein	ADJ	B
RAR	I-protein	NOUN	O
alpha	I-protein	NOUN	O
(	O	PUNCT	O
hRAR	B-protein	NOUN	B
alpha	I-protein	NOUN	I
,	I-protein	PUNCT	O
receptor	I-protein	NOUN	B
for	O	ADP	O
all-trans	O	ADJ	B
RA	O	NOUN	I
)	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
human	B-protein	ADJ	B
retinoid-X	I-protein	NOUN	I
receptor	I-protein	NOUN	I
alpha	I-protein	NOUN	I
(	O	PUNCT	O
hRXR	B-protein	NOUN	B
alpha	I-protein	NOUN	I
receptor	I-protein	NOUN	I
for	O	ADP	O
9-cis	O	ADJ	O
RA	O	NOUN	B
)	O	PUNCT	O
were	O	AUX	O
determined	O	VERB	O
by	O	ADP	O
Northern	O	NOUN	B
blot	O	NOUN	I
analysis	O	NOUN	I
.	O	PUNCT	O


RESULTS	O	NOUN	B
:	O	PUNCT	O
Both	O	CCONJ	O
all-trans	O	ADJ	B
and	O	CCONJ	O
9-cis	O	ADJ	B
RA	O	NOUN	I
inhibited	O	VERB	B
virus	O	NOUN	B
replication	O	NOUN	B
in	O	ADP	O
HIV-1	B-cell_line	NOUN	B
IIIB-infected	I-cell_line	ADJ	B
monocytoid	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
and	O	CCONJ	O
absence	O	NOUN	B
of	O	ADP	O
the	O	DET	O
co-stimulatory	O	ADJ	B
agent	O	NOUN	I
phorbol	O	NOUN	B
myristate	O	NOUN	I
acetate	O	NOUN	I
(	O	PUNCT	O
PMA	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Human	B-protein	ADJ	B
RAR	I-protein	NOUN	O
alpha	I-protein	NOUN	O
was	O	AUX	O
expressed	O	VERB	B
in	O	ADP	O
H9	B-cell_line	NOUN	B
,	O	PUNCT	O
U937	B-cell_line	NOUN	B
and	O	CCONJ	O
THP-1	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
almost	O	ADV	O
undetectable	O	ADJ	B
in	O	ADP	O
CEM	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Human	B-protein	ADJ	B
RXR	I-protein	NOUN	B
alpha	I-protein	NOUN	I
was	O	AUX	O
significantly	O	ADV	O
expressed	O	VERB	B
in	O	ADP	O
U937	B-cell_line	NOUN	B
and	I-cell_line	CCONJ	O
THP-1	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
weakly	O	ADV	O
expressed	O	VERB	B
in	O	ADP	O
H9	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
and	O	CCONJ	O
not	O	PART	O
detectable	O	ADJ	B
in	O	ADP	O
CEM	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Human	O	ADJ	B
RAR	O	NOUN	O
alpha	O	NOUN	O
expression	O	NOUN	B
was	O	AUX	O
unchanged	O	ADJ	B
in	O	ADP	O
H9	B-cell_line	NOUN	B
and	O	CCONJ	O
CEM	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
elevated	O	ADJ	B
in	O	ADP	O
U937	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
after	O	ADP	O
PMA	O	NOUN	B
stimulation	O	NOUN	B
.	O	PUNCT	O


At	O	ADP	O
low	O	ADJ	O
GSSG	O	NOUN	B
levels	O	NOUN	B
,	O	PUNCT	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
can	O	AUX	O
not	O	PART	O
optimally	O	ADV	O
activate	O	VERB	B
the	O	DET	O
immunologically	O	ADV	B
important	O	ADJ	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
NF	B-protein	NOUN	I
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
,	O	PUNCT	O
whereas	O	SCONJ	O
high	O	ADJ	O
GSSG	O	NOUN	B
levels	O	NOUN	B
inhibit	O	VERB	B
the	O	DET	O
DNA	O	NOUN	B
binding	O	NOUN	I
activity	O	NOUN	I
of	O	ADP	O
NF	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
effects	O	NOUN	B
of	O	ADP	O
GSSG	O	NOUN	B
are	O	AUX	O
antagonized	O	VERB	B
by	O	ADP	O
reduced	O	VERB	B
thioredoxin	B-protein	NOUN	B
(	O	PUNCT	O
TRX	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


As	O	ADP	O
signal	O	NOUN	B
transduction	O	NOUN	I
is	O	AUX	O
facilitated	O	VERB	O
by	O	ADP	O
prooxidant	O	ADJ	B
conditions	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
propose	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
well-known	O	ADJ	O
immunological	O	ADJ	B
consequences	O	NOUN	B
of	O	ADP	O
GSH	O	NOUN	B
depletion	O	NOUN	B
ultimately	O	ADV	O
may	O	AUX	O
be	O	AUX	O
results	O	NOUN	B
of	O	ADP	O
the	O	DET	O
accompanying	O	VERB	O
GSSG	O	NOUN	B
deficiency	O	NOUN	B
.	O	PUNCT	O


As	O	ADP	O
HIV-infected	O	ADJ	B
patients	O	NOUN	B
and	O	CCONJ	O
SIV-infected	O	ADJ	B
rhesus	O	NOUN	O
macaques	O	NOUN	O
have	O	AUX	O
,	O	PUNCT	O
on	O	ADP	O
the	O	DET	O
average	O	NOUN	B
,	O	PUNCT	O
significantly	O	ADV	O
decreased	O	VERB	B
plasma	O	NOUN	B
cyst	O	NOUN	I
(	O	PUNCT	O
e	O	X	O
)	O	PUNCT	O
ine	O	NOUN	B
and	O	CCONJ	O
intracellular	O	ADJ	B
GSH	O	NOUN	B
levels	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
also	O	ADV	O
hypothesize	O	VERB	O
that	O	SCONJ	O
AIDS	O	NOUN	B
may	O	AUX	O
be	O	AUX	O
the	O	DET	O
consequence	O	NOUN	B
of	O	ADP	I
a	O	DET	O
GSSG	O	NOUN	B
deficiency	O	NOUN	I
as	O	ADV	O
well	O	ADV	O
.	O	PUNCT	O


Recent	O	ADJ	O
data	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
poor	O	ADJ	O
induction	O	NOUN	B
of	O	ADP	O
a	O	DET	O
T-cell	O	NOUN	B
response	O	NOUN	I
to	O	PART	O
human	O	ADJ	B
renal	O	ADJ	O
cell	O	NOUN	O
carcinoma	O	NOUN	O
(	O	PUNCT	O
RCC	O	NOUN	B
)	O	PUNCT	O
may	O	AUX	O
be	O	AUX	O
related	O	ADJ	O
to	O	PART	O
alterations	O	NOUN	B
in	O	ADP	O
signal	O	NOUN	B
transduction	O	NOUN	I
pathways	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
report	O	VERB	O
that	O	SCONJ	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
from	O	ADP	O
RCC	O	NOUN	B
patients	O	NOUN	B
have	O	AUX	O
two	O	NUM	O
alterations	O	NOUN	B
in	O	ADP	O
kappa	O	NOUN	B
B	O	NOUN	I
motif-specific	O	ADJ	I
DNA-binding	O	ADJ	I
activity	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
magnitude	O	NOUN	B
of	O	ADP	O
kappa	O	NOUN	B
B	O	NOUN	I
activity	O	NOUN	O
in	O	ADP	O
unstimulated	B-cell_type	ADJ	B
patient	I-cell_type	NOUN	B
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
was	O	AUX	O
similar	O	ADJ	O
to	O	PART	O
that	O	DET	O
observed	O	VERB	B
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
from	O	ADP	O
normal	O	ADJ	O
individuals	O	NOUN	B
that	O	PRON	O
had	O	AUX	O
been	O	AUX	O
activated	O	VERB	B
in	O	X	B
vitro	O	X	I
.	O	PUNCT	O


The	O	DET	O
altered	O	ADJ	O
kappa	O	NOUN	O
B-binding	O	ADJ	O
activity	O	NOUN	O
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
from	O	ADP	O
RCC	O	NOUN	B
patients	O	NOUN	B
may	O	AUX	O
impair	O	VERB	B
their	O	PRON	O
capacity	O	NOUN	B
to	O	PART	O
respond	O	VERB	O
normally	O	ADV	O
to	O	ADP	O
various	O	ADJ	O
stimuli	O	NOUN	B
.	O	PUNCT	O


MATERIALS	O	NOUN	O
AND	O	CCONJ	O
METHODS	O	NOUN	O
:	O	PUNCT	O
In	O	ADP	O
the	O	DET	O
present	O	ADJ	O
work	O	NOUN	O
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
studied	O	VERB	O
,	O	PUNCT	O
the	O	DET	O
activities	O	NOUN	B
of	O	ADP	O
GATA-1	B-protein	NOUN	B
and	O	CCONJ	O
SP1	B-protein	NOUN	B
during	O	ADP	O
differentiation	O	NOUN	B
of	O	ADP	O
cultured	O	VERB	B
erythroid	B-cell_type	ADJ	I
progenitors	I-cell_type	NOUN	I
derived	O	VERB	O
from	O	ADP	O
cord	O	NOUN	B
blood	O	NOUN	I
and	O	CCONJ	O
from	O	ADP	O
fetal	O	ADJ	B
livers	O	NOUN	I
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
from	O	ADP	O
beta	O	NOUN	B
zero-thalassemia	O	ADJ	I
patients	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
demonstration	O	NOUN	O
that	O	SCONJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
can	O	AUX	O
regulate	O	VERB	O
I	B-DNA	NOUN	O
kappa	I-DNA	NOUN	O
B	I-DNA	NOUN	O
alpha/MAD-3	I-DNA	NOUN	O
gene	I-DNA	NOUN	O
transcription	O	NOUN	O
in	O	ADP	O
other	O	ADJ	O
cell	O	NOUN	B
types	O	NOUN	I
suggested	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
rapid	O	ADJ	O
increase	O	NOUN	B
in	O	ADP	O
steady-state	O	ADJ	B
I	B-RNA	NOUN	I
kappa	I-RNA	NOUN	I
B	I-RNA	NOUN	I
alpha/MAD-3	I-RNA	NOUN	I
mRNA	I-RNA	NOUN	B
levels	O	NOUN	O
we	O	PRON	O
observed	O	VERB	B
within	O	ADP	O
30	O	NUM	O
min	O	NOUN	O
of	O	ADP	O
monocyte	O	NOUN	B
adherence	O	NOUN	B
would	O	AUX	O
result	O	VERB	O
from	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
-dependent	O	ADJ	O
transcriptional	O	ADJ	B
stimulation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
I	B-DNA	NOUN	B
kappa	I-DNA	NOUN	I
B	I-DNA	NOUN	I
alpha/MAD-3	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
.	O	PUNCT	O


The	O	DET	O
adherence-dependent	O	ADJ	B
increase	O	NOUN	B
in	O	ADP	O
I	B-RNA	NOUN	B
kappa	I-RNA	NOUN	I
B	I-RNA	NOUN	I
alpha/MAD-3	I-RNA	NOUN	I
mRNA	I-RNA	NOUN	B
levels	O	NOUN	O
was	O	AUX	O
also	O	ADV	O
not	O	PART	O
a	O	DET	O
consequence	O	NOUN	O
of	O	ADP	O
mRNA	B-RNA	NOUN	B
stabilization	O	NOUN	O
events	O	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
extracts	O	NOUN	B
from	O	ADP	O
nonstimulated	O	ADJ	B
cells	O	NOUN	B
the	O	DET	O
receptor	O	NOUN	B
is	O	AUX	O
recovered	O	VERB	O
in	O	ADP	O
an	O	DET	O
inducible	O	ADJ	B
cytoplasmic	O	ADJ	B
form	O	NOUN	O
associated	O	VERB	B
with	O	ADP	I
the	O	DET	O
90-kDa	B-protein	ADJ	O
heat	I-protein	NOUN	B
shock	I-protein	NOUN	I
protein	I-protein	NOUN	I
(	O	PUNCT	O
hsp90	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
a	O	DET	O
molecular	B-protein	ADJ	B
chaperone	I-protein	NOUN	I
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
dioxin	B-protein	NOUN	B
receptor	I-protein	NOUN	I
system	O	NOUN	I
provides	O	VERB	O
a	O	DET	O
complex	O	NOUN	B
and	O	CCONJ	O
interesting	O	ADJ	O
model	O	NOUN	B
of	O	ADP	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
by	O	ADP	O
hsp90	B-protein	NOUN	B
.	O	PUNCT	O


To	O	PART	O
understand	O	VERB	O
the	O	DET	O
extent	O	NOUN	O
to	O	PART	O
which	O	DET	O
ALD	O	NOUN	B
may	O	AUX	O
mimic	O	VERB	O
mitogenic	O	ADJ	B
stimulation	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
studied	O	VERB	O
cytoplasmic	O	ADJ	B
and	O	CCONJ	O
nuclear	O	ADJ	B
signaling	O	NOUN	I
steps	O	NOUN	O
in	O	ADP	O
ALD-treated	B-cell_line	ADJ	B
T	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Although	O	SCONJ	O
we	O	PRON	O
detected	O	VERB	B
no	O	DET	O
IL-2	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
in	O	ADP	O
ALD-treated	B-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
the	O	DET	O
nuclei	O	NOUN	B
of	O	ADP	O
these	O	DET	O
cells	O	NOUN	B
contain	O	VERB	O
proteins	O	NOUN	B
capable	O	ADJ	O
of	O	ADP	O
binding	O	VERB	B
to	O	PART	O
three	O	NUM	O
regulatory	B-DNA	ADJ	B
sequences	I-DNA	NOUN	I
in	O	ADP	O
the	O	DET	O
IL-2	B-DNA	NOUN	B
promoter	I-DNA	NOUN	O
region	I-DNA	NOUN	O
:	O	PUNCT	O
NFAT	B-protein	NOUN	B
,	O	PUNCT	O
NF	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
AP-1	B-protein	NOUN	B
.	O	PUNCT	O


Protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
C	I-protein	NOUN	I
is	O	AUX	O
not	O	PART	O
a	O	DET	O
downstream	O	ADJ	B
effector	O	NOUN	O
of	O	ADP	O
p21ras	B-DNA	NOUN	B
in	O	ADP	O
activated	B-cell_type	VERB	B
T	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
.	O	PUNCT	O


Oct-1	B-protein	NOUN	B
and	O	CCONJ	O
Oct-2	B-protein	NOUN	B
are	O	AUX	O
human	O	ADJ	B
transcriptional	B-protein	ADJ	B
activators	I-protein	NOUN	O
that	O	PRON	O
bind	O	VERB	B
to	O	PART	O
the	O	DET	O
same	O	ADJ	O
DNA	O	NOUN	B
element	O	NOUN	I
but	O	CCONJ	O
activate	O	VERB	B
distinct	O	ADJ	O
sets	O	NOUN	O
of	O	ADP	O
genes	O	NOUN	B
.	O	PUNCT	O


Transfer	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Oct-2	B-protein	NOUN	B
C-terminal	I-protein	ADJ	I
domain	I-protein	NOUN	I
onto	O	ADP	O
either	O	CCONJ	O
Oct-1	B-protein	NOUN	B
(	O	PUNCT	O
Oct1.2	B-protein	NOUN	O
)	O	PUNCT	O
or	O	CCONJ	O
a	O	DET	O
nonactivating	B-protein	ADJ	B
DNA-binding	I-protein	ADJ	I
domain	I-protein	NOUN	I
from	O	ADP	O
GAL4	B-protein	NOUN	B
created	O	VERB	O
activators	O	NOUN	B
capable	O	ADJ	O
of	O	ADP	O
greater	O	ADJ	O
than	O	ADP	O
15	O	NUM	O
and	O	CCONJ	O
10-fold	O	ADJ	O
stimulation	O	NOUN	B
of	O	ADP	O
activity	O	NOUN	B
,	O	PUNCT	O
respectively	O	ADV	O
.	O	PUNCT	O


Glucocorticoid-induced	O	ADJ	B
apoptosis	O	NOUN	I
of	O	ADP	O
lymphoid	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Taken	O	VERB	O
together	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
report	O	VERB	O
that	O	SCONJ	O
IL-2	B-protein	NOUN	B
induces	O	VERB	O
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	B
and	O	CCONJ	O
subsequent	O	ADJ	O
nuclear	O	ADJ	B
translocation	O	NOUN	I
of	O	ADP	O
stat3	B-protein	NOUN	B
and	O	CCONJ	O
an	O	DET	O
as	O	ADP	O
yet	O	ADV	O
undefined	O	ADJ	O
84-kDa	B-protein	ADJ	O
protein	I-protein	NOUN	B
in	O	ADP	O
antigen-specific	B-cell_line	ADJ	B
human	I-cell_line	ADJ	I
T	I-cell_line	NOUN	I
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
study	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
Tax	B-protein	NOUN	B
-stimulated	O	ADJ	O
nuclear	O	ADJ	B
expression	O	NOUN	I
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
in	O	ADP	O
both	O	CCONJ	O
HTLV-I-infected	B-cell_line	ADJ	B
and	I-cell_line	CCONJ	O
Tax-transfected	I-cell_line	ADJ	B
human	I-cell_line	ADJ	O
T	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
is	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
the	O	DET	O
phosphorylation	O	NOUN	B
and	O	CCONJ	O
rapid	O	ADJ	B
proteolytic	O	ADJ	B
degradation	O	NOUN	I
of	O	ADP	O
I	B-protein	NOUN	O
kappa	I-protein	NOUN	O
B	I-protein	NOUN	O
alpha	I-protein	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
to	O	PART	O
prior	O	ADJ	O
in	O	X	B
vitro	O	X	I
studies	O	NOUN	I
,	O	PUNCT	O
at	O	ADP	O
least	O	ADJ	O
a	O	DET	O
fraction	O	NOUN	B
of	O	ADP	O
the	O	DET	O
phosphorylated	O	ADJ	B
form	O	NOUN	O
of	O	ADP	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
alpha	I-protein	NOUN	I
remains	O	VERB	O
physically	O	ADV	B
associated	O	VERB	B
with	O	ADP	I
the	O	DET	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
complex	I-protein	NOUN	I
in	O	X	B
vivo	O	X	I
but	O	CCONJ	O
is	O	AUX	O
subject	O	ADJ	O
to	O	PART	O
rapid	O	ADJ	O
degradation	O	NOUN	B
,	O	PUNCT	O
thereby	O	ADV	O
promoting	O	VERB	B
the	O	DET	O
nuclear	O	ADJ	B
translocation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
active	O	ADJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
complex	I-protein	NOUN	I
.	O	PUNCT	O


Transcriptional	O	ADJ	B
control	O	NOUN	I
of	O	ADP	O
steroid-regulated	B-DNA	ADJ	B
gene	I-DNA	NOUN	I
networks	I-DNA	NOUN	O
by	O	ADP	O
nuclear	B-protein	ADJ	B
receptor	I-protein	NOUN	I
proteins	I-protein	NOUN	I
results	O	VERB	B
in	O	ADP	O
the	O	DET	O
coordinate	O	NOUN	B
expression	O	NOUN	B
of	O	ADP	O
a	O	DET	O
limited	O	ADJ	O
number	O	NOUN	O
of	O	ADP	O
target	B-DNA	NOUN	B
genes	I-DNA	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
also	O	ADV	O
used	O	VERB	O
DDPCR	O	NOUN	B
to	O	PART	O
isolate	O	VERB	B
DESTs	B-DNA	NOUN	B
from	O	ADP	O
androgen-modulated	O	ADJ	B
rat	O	NOUN	I
ventral	O	ADJ	B
prostate	O	NOUN	I
tissue	O	NOUN	I
,	O	PUNCT	O
one	O	NUM	O
of	O	ADP	O
which	O	DET	O
we	O	PRON	O
characterized	O	VERB	B
and	O	CCONJ	O
found	O	VERB	O
to	O	PART	O
correspond	O	VERB	O
to	O	ADP	O
the	O	DET	O
3	B-RNA	NUM	O
'	I-RNA	PART	O
end	I-RNA	NOUN	O
of	O	ADP	O
prostatic	B-RNA	ADJ	B
spermine	I-RNA	NOUN	B
binding	I-RNA	NOUN	I
protein	I-RNA	NOUN	I
mRNA	I-RNA	NOUN	B
,	O	PUNCT	O
a	O	DET	O
known	O	ADJ	O
androgen-regulated	B-DNA	ADJ	B
gene	I-DNA	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
shown	O	VERB	O
that	O	SCONJ	O
,	O	PUNCT	O
within	O	ADP	O
the	O	DET	O
thymus	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
population	O	NOUN	B
of	O	ADP	O
large	B-cell_type	ADJ	O
,	I-cell_type	PUNCT	O
immature	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
expresses	O	VERB	B
CD21	B-protein	NOUN	B
.	O	PUNCT	O


These	O	DET	O
components	O	NOUN	B
included	O	VERB	O
transcription	O	NOUN	B
of	O	ADP	O
BZLF-1	B-DNA	NOUN	B
,	O	PUNCT	O
an	O	DET	O
early	B-DNA	ADJ	B
gene	I-DNA	NOUN	I
that	O	PRON	O
characterizes	O	VERB	O
EBV-infected	B-cell_type	ADJ	B
B	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
after	O	ADP	O
disruption	O	NOUN	B
of	O	ADP	O
latency	O	NOUN	B
.	O	PUNCT	O


Glucocorticoids	O	NOUN	B
are	O	AUX	O
among	O	ADP	O
the	O	DET	O
most	O	ADV	O
potent	O	ADJ	O
antiinflammatory	O	ADJ	B
agents	O	NOUN	I
that	O	PRON	O
can	O	AUX	O
be	O	AUX	O
used	O	VERB	O
in	O	ADP	O
the	O	DET	O
treatment	O	NOUN	B
of	O	ADP	O
rhinitis	O	NOUN	B
.	O	PUNCT	O


Serum	O	NOUN	B
osteocalcin	B-protein	NOUN	B
decreased	O	VERB	B
significantly	O	ADV	O
during	O	ADP	O
treatment	O	NOUN	B
with	O	ADP	O
both	O	CCONJ	O
BUD	O	NOUN	B
and	O	CCONJ	O
FP	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activation	O	NOUN	B
during	O	ADP	O
T	O	NOUN	B
cell	O	NOUN	I
activation	O	NOUN	B
by	O	ADP	O
TcR/CD3	B-protein	NOUN	B
signals	O	NOUN	B
is	O	AUX	O
biphasic	O	ADJ	B
:	O	PUNCT	O
TcR/CD3	B-protein	NOUN	B
triggers	O	VERB	B
its	O	PRON	O
immediate	O	ADJ	O
translocation	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
transient	O	ADJ	B
if	O	SCONJ	O
no	O	DET	O
TNF-alpha	B-protein	NOUN	B
is	O	AUX	O
present	O	ADJ	O
.	O	PUNCT	O


The	O	DET	O
cis-acting	B-DNA	ADJ	B
region	I-DNA	NOUN	I
,	O	PUNCT	O
GM-kappa	B-DNA	NOUN	B
B/GC-box	I-DNA	NOUN	B
(	O	PUNCT	O
positions	B-DNA	NOUN	B
-95	I-DNA	NUM	O
and	O	CCONJ	O
-73	B-DNA	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
within	O	ADP	O
the	O	DET	O
murine	B-DNA	ADJ	B
GM-CSF	I-DNA	NOUN	B
gene	I-DNA	NOUN	B
promoter	I-DNA	NOUN	I
is	O	AUX	O
required	O	VERB	O
for	O	ADP	O
maximal	O	ADJ	B
induction	O	NOUN	B
by	O	ADP	O
stimulation	O	NOUN	B
with	O	ADP	O
phorbol-12-myristate	O	NOUN	B
acetate	O	NOUN	I
(	O	PUNCT	O
PMA	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
calcium	O	NOUN	B
ionophore	O	NOUN	I
(	O	PUNCT	O
A23187	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


A	O	DET	O
factor	O	NOUN	O
that	O	PRON	O
regulates	O	VERB	B
the	O	DET	O
class	B-DNA	NOUN	B
II	I-DNA	NUM	I
major	I-DNA	ADJ	I
histocompatibility	I-DNA	NOUN	I
complex	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
DPA	B-DNA	NOUN	O
is	O	AUX	O
a	O	DET	O
member	O	NOUN	O
of	O	ADP	O
a	O	DET	O
subfamily	O	NOUN	B
of	O	ADP	O
zinc	B-protein	NOUN	B
finger	I-protein	NOUN	I
proteins	I-protein	NOUN	I
that	O	PRON	O
includes	O	VERB	O
a	O	DET	O
Drosophila	B-protein	X	B
developmental	I-protein	ADJ	B
control	I-protein	NOUN	I
protein	I-protein	NOUN	I
.	O	PUNCT	O


One	O	NUM	O
of	O	ADP	O
the	O	DET	O
Drosophila	B-DNA	NOUN	B
sequences	I-DNA	NOUN	B
,	O	PUNCT	O
ttk	B-DNA	NOUN	B
,	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
developmental	B-DNA	ADJ	B
control	I-DNA	NOUN	O
gene	I-DNA	NOUN	O
,	O	PUNCT	O
while	O	SCONJ	O
a	O	DET	O
second	O	NOUN	O
does	O	AUX	O
not	O	PART	O
contain	O	VERB	O
a	O	DET	O
zinc	B-protein	NOUN	B
finger	I-protein	NOUN	I
region	I-protein	NOUN	I
but	O	CCONJ	O
encodes	O	VERB	B
a	O	DET	O
structure	O	NOUN	B
important	O	ADJ	O
in	O	ADP	O
oocyte	O	NOUN	B
development	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
include	O	VERB	O
a	O	DET	O
redox-regulatory	O	ADJ	B
mechanism	O	NOUN	B
(	O	PUNCT	O
s	O	NOUN	O
)	O	PUNCT	O
in	O	ADP	O
this	O	DET	O
common	O	ADJ	O
pathway	O	NOUN	B
to	O	PART	O
account	O	VERB	O
for	O	ADP	O
the	O	DET	O
previously	O	ADV	O
demonstrated	O	VERB	O
redox	O	NOUN	B
regulation	O	NOUN	I
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activation	O	NOUN	B
in	O	ADP	O
Jurkat	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
(	O	PUNCT	O
in	O	ADP	O
which	O	DET	O
oxidants	O	NOUN	B
do	O	AUX	O
n't	O	PART	O
activate	O	VERB	B
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
)	O	PUNCT	O
;	O	PUNCT	O
we	O	PRON	O
put	O	VERB	O
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	B
in	O	ADP	O
the	O	DET	O
common	O	ADJ	O
pathway	O	NOUN	B
by	O	ADP	O
showing	O	VERB	O
that	O	SCONJ	O
kinase	O	NOUN	B
activity	O	NOUN	I
(	O	PUNCT	O
inhibitable	O	ADJ	B
by	O	ADP	O
herbimycin	O	NOUN	B
A	O	NOUN	I
and	O	CCONJ	O
tyrphostin	O	NOUN	B
47	O	NUM	O
)	O	PUNCT	O
is	O	AUX	O
required	O	VERB	O
for	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activation	O	NOUN	B
by	O	ADP	O
all	O	DET	O
stimuli	O	NOUN	B
tested	O	VERB	B
in	O	ADP	O
both	O	DET	O
cell	O	NOUN	B
lines	O	NOUN	I
.	O	PUNCT	O


Deleted	O	VERB	B
chromosome	B-DNA	NOUN	I
20	I-DNA	NUM	I
from	O	ADP	O
a	O	DET	O
patient	O	NOUN	B
with	O	ADP	O
Alagille	O	NOUN	B
syndrome	O	NOUN	I
isolated	O	VERB	B
in	O	ADP	O
a	O	DET	O
cell	O	NOUN	B
hybrid	O	NOUN	I
through	O	ADP	O
leucine	O	NOUN	B
transport	O	NOUN	I
selection	O	NOUN	B
:	O	PUNCT	O
study	O	NOUN	B
of	O	ADP	O
three	O	NUM	O
candidate	O	NOUN	O
genes	O	NOUN	O
.	O	PUNCT	O


Alagille	O	NOUN	B
syndrome	O	NOUN	I
(	O	PUNCT	O
AGS	O	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
well-defined	O	ADJ	O
genetic	O	ADJ	B
entity	O	NOUN	I
assigned	O	VERB	B
to	O	PART	O
the	O	DET	O
short	B-DNA	ADJ	B
arm	I-DNA	NOUN	I
of	O	ADP	I
Chromosome	B-DNA	NOUN	I
(	I-DNA	PUNCT	I
Chr	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
20	I-DNA	NUM	O
by	O	ADP	O
a	O	DET	O
series	O	NOUN	O
of	O	ADP	O
observations	O	NOUN	B
of	O	ADP	O
AGS	O	NOUN	B
patients	O	NOUN	B
associated	O	VERB	B
with	O	ADP	I
microdeletions	O	NOUN	B
in	O	ADP	O
this	O	DET	O
region	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
hybrid	O	NOUN	O
clone	O	NOUN	B
,	O	PUNCT	O
designated	O	VERB	O
NR2	B-cell_line	NOUN	B
,	O	PUNCT	O
was	O	AUX	O
characterized	O	VERB	B
by	O	ADP	O
several	O	ADJ	O
methods	O	NOUN	B
,	O	PUNCT	O
including	O	VERB	O
PCR	O	NOUN	B
,	O	PUNCT	O
with	O	ADP	O
eight	O	NUM	O
pairs	O	NOUN	B
of	O	ADP	O
oligonucleotides	O	NOUN	B
mapped	O	VERB	B
to	O	PART	O
Chr	B-DNA	NOUN	O
20	I-DNA	NUM	O
:	O	PUNCT	O
D20S5	B-DNA	NOUN	B
,	O	PUNCT	O
D20S41	B-DNA	NOUN	B
,	O	PUNCT	O
D20S42	B-DNA	NOUN	B
,	O	PUNCT	O
D20S56	B-DNA	NOUN	B
,	O	PUNCT	O
D20S57	B-DNA	NOUN	B
,	O	PUNCT	O
D20S58	B-DNA	NOUN	B
,	O	PUNCT	O
adenosine	B-DNA	NOUN	B
deaminase	I-DNA	NOUN	I
(	O	PUNCT	O
ADA	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
Prion	B-DNA	NOUN	B
protein	I-DNA	NOUN	I
(	O	PUNCT	O
PRIP	B-protein	NOUN	B
)	O	PUNCT	O
;	O	PUNCT	O
Restriction	O	NOUN	B
Fragment	O	NOUN	I
Length	O	NOUN	I
Polymorphism	O	NOUN	I
(	O	PUNCT	O
RFLP	B-DNA	NOUN	B
)	O	PUNCT	O
analyses	O	NOUN	B
with	O	ADP	O
four	O	NUM	O
genomic	B-DNA	ADJ	B
anonymous	I-DNA	ADJ	I
probes	I-DNA	NOUN	I
(	O	PUNCT	O
D20S5	B-DNA	NOUN	B
,	O	PUNCT	O
cD3H12	B-DNA	NOUN	B
,	O	PUNCT	O
D20S17	B-DNA	NOUN	B
,	O	PUNCT	O
D20S18	B-DNA	NOUN	B
)	O	PUNCT	O
;	O	PUNCT	O
and	O	CCONJ	O
fluorescent	O	ADJ	B
in	O	X	I
situ	O	X	I
hybridization	O	NOUN	I
(	O	PUNCT	O
FISH	O	NOUN	B
)	O	PUNCT	O
with	O	ADP	O
total	B-DNA	ADJ	O
human	I-DNA	ADJ	B
DNA	I-DNA	NOUN	B
and	O	CCONJ	O
D20Z1	B-DNA	NOUN	B
,	O	PUNCT	O
a	O	DET	O
sequence	O	NOUN	B
specific	O	ADJ	B
to	O	PART	O
the	O	DET	O
human	B-DNA	ADJ	B
Chr	I-DNA	NOUN	O
20	I-DNA	NUM	O
centromere	I-DNA	NOUN	B
,	O	PUNCT	O
as	O	ADP	O
probes	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
NR2	B-cell_line	NOUN	B
hybrid	I-cell_line	NOUN	B
allowed	O	VERB	O
us	O	PRON	O
to	O	PART	O
exclude	O	VERB	O
three	O	NUM	O
candidate	B-DNA	NOUN	O
genes	I-DNA	NOUN	B
for	O	ADP	O
AGS	O	NOUN	B
:	O	PUNCT	O
hepatic	B-DNA	ADJ	B
nuclear	I-DNA	ADJ	I
factor	I-DNA	NOUN	I
3	I-DNA	NUM	I
beta	I-DNA	NOUN	I
(	O	PUNCT	O
HNF3	B-DNA	NOUN	B
beta	I-DNA	NOUN	I
)	O	PUNCT	O
,	O	PUNCT	O
paired	B-DNA	ADJ	B
box	I-DNA	NOUN	I
1	I-DNA	NUM	I
(	O	PUNCT	O
PAX1	B-DNA	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
cystatin	B-DNA	NOUN	B
C	I-DNA	NOUN	I
(	O	PUNCT	O
CST3	B-DNA	NOUN	B
)	O	PUNCT	O
as	O	ADP	O
shown	O	VERB	O
by	O	ADP	O
their	O	PRON	O
localization	O	NOUN	B
outside	O	ADP	O
of	O	ADP	O
the	O	DET	O
deletion	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
differentiating	O	VERB	O
agent	O	NOUN	B
retinoic	O	ADJ	B
acid	O	NOUN	I
(	O	PUNCT	O
RA	O	NOUN	B
)	O	PUNCT	O
has	O	AUX	O
been	O	AUX	O
previously	O	ADV	O
reported	O	VERB	O
to	O	PART	O
interfere	O	VERB	B
with	O	ADP	I
12-O-tetradecanoyl-phorbol-13-acetate	O	NOUN	B
(	O	PUNCT	O
TPA	O	NOUN	B
)	O	PUNCT	O
/Ca	O	NOUN	O
(	O	PUNCT	O
2+	O	NUM	O
)	O	PUNCT	O
-induced	O	ADJ	O
signals	O	NOUN	B
for	O	ADP	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
-96	B-DNA	NUM	O
to	I-DNA	PART	O
-66-bp	I-DNA	ADJ	O
octamer	I-DNA	NOUN	B
motif	I-DNA	NOUN	B
found	O	VERB	O
in	O	ADP	O
the	O	DET	O
enhancer	O	NOUN	B
for	O	ADP	O
the	O	DET	O
interleukin	B-DNA	NOUN	B
(	I-DNA	PUNCT	I
IL	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
-2	I-DNA	NUM	O
gene	I-DNA	NOUN	B
,	O	PUNCT	O
which	O	DET	O
encodes	O	VERB	B
a	O	DET	O
major	O	ADJ	O
T	B-protein	NOUN	B
lymphocyte	I-protein	NOUN	I
growth	I-protein	NOUN	I
factor	I-protein	NOUN	I
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
transfected	O	VERB	B
c-jun	B-DNA	NOUN	B
,	I-DNA	PUNCT	O
jun-B	I-DNA	NOUN	B
,	I-DNA	PUNCT	O
jun-D	I-DNA	NOUN	B
,	I-DNA	PUNCT	O
c-fos	I-DNA	NOUN	B
,	I-DNA	PUNCT	O
or	I-DNA	CCONJ	O
Fos-B	I-DNA	NOUN	B
expression	I-DNA	NOUN	O
vectors	I-DNA	NOUN	O
partially	O	ADV	O
substitute	O	VERB	O
for	O	ADP	O
TPA	O	NOUN	B
and	O	CCONJ	O
Ca2+	O	NOUN	B
and	O	CCONJ	O
cooperate	O	VERB	B
with	O	ADP	O
Oct-2	B-protein	NOUN	B
for	O	ADP	O
the	O	DET	O
transactivation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
combined	O	ADJ	O
OAP/octamer	B-DNA	NOUN	B
cis-element	I-DNA	NOUN	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
retinoic	B-protein	ADJ	B
acid	I-protein	NOUN	I
receptor	I-protein	NOUN	I
(	O	PUNCT	O
RAR	B-protein	NOUN	B
)	O	PUNCT	O
alpha	O	NOUN	O
is	O	AUX	O
able	O	ADJ	O
to	O	PART	O
inhibit	O	VERB	B
in	O	X	B
vitro	O	X	I
the	O	DET	O
formation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
complex	O	NOUN	B
between	O	ADP	O
the	O	DET	O
nuclear	O	ADJ	B
AP-1	B-protein	NOUN	I
/OAP	B-protein	NOUN	I
and	O	CCONJ	O
its	O	PRON	O
specific	O	ADJ	O
binding	O	NOUN	B
site	O	NOUN	I
,	O	PUNCT	O
resulting	O	VERB	O
in	O	ADP	O
the	O	DET	O
interference	O	NOUN	B
with	O	ADP	O
Oct-2	B-protein	NOUN	B
-dependent	O	ADJ	O
cis-regulatory	O	ADJ	B
function	O	NOUN	I
of	O	ADP	O
this	O	DET	O
AP-1	B-protein	NOUN	B
element	O	NOUN	I
.	O	PUNCT	O


As	O	ADP	O
in	O	ADP	O
XSCID	O	NOUN	B
,	O	PUNCT	O
X-chromosome	O	NOUN	B
inactivation	O	NOUN	B
in	O	ADP	O
obligate	O	ADJ	B
carriers	O	NOUN	B
of	O	ADP	O
XCID	O	NOUN	B
was	O	AUX	O
nonrandom	O	ADJ	B
in	O	ADP	O
T	B-cell_type	NOUN	B
and	I-cell_type	CCONJ	O
B	I-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
X	B-DNA	NOUN	B
chromosome	I-DNA	NOUN	I
inactivation	O	NOUN	I
in	O	ADP	O
PMNs	O	NOUN	B
was	O	AUX	O
variable	O	ADJ	B
.	O	PUNCT	O


Tissue	B-protein	NOUN	B
factor	I-protein	NOUN	I
(	O	PUNCT	O
TF	B-protein	NOUN	B
)	O	PUNCT	O
expression	O	NOUN	B
by	O	ADP	O
cells	O	NOUN	B
of	O	ADP	O
monocyte/macrophage	B-cell_type	NOUN	B
lineage	I-cell_type	NOUN	B
represents	O	VERB	O
an	O	DET	O
important	O	ADJ	O
mechanism	O	NOUN	B
underlying	O	VERB	O
the	O	DET	O
initiation	O	NOUN	B
of	O	ADP	O
fibrin	B-protein	NOUN	B
deposition	O	NOUN	I
at	O	ADP	O
sites	O	NOUN	B
of	O	ADP	O
extravascular	O	ADJ	B
inflammation	O	NOUN	I
.	O	PUNCT	O


Both	O	DET	O
pyrrolidine	O	NOUN	B
dithiocarbamate	O	NOUN	I
,	O	PUNCT	O
an	O	DET	O
oxidant	O	ADJ	B
scavenger	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
N-acetyl-cysteine	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
precursor	O	NOUN	B
of	O	ADP	O
the	O	DET	O
endogenous	O	ADJ	B
antioxidant	O	ADJ	B
glutathione	O	NOUN	I
,	O	PUNCT	O
inhibited	O	VERB	B
stimulation	O	NOUN	B
of	O	ADP	O
macrophage	O	NOUN	B
procoagulant	O	ADJ	B
activity	O	NOUN	I
by	O	ADP	O
LPS	O	NOUN	B
.	O	PUNCT	O


Characterization	O	NOUN	B
of	O	ADP	O
the	O	DET	O
CD48	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
demonstrates	O	VERB	O
a	O	DET	O
positive	O	ADJ	B
element	O	NOUN	B
that	O	PRON	O
is	O	AUX	O
specific	O	ADJ	O
to	O	PART	O
Epstein-Barr	B-cell_type	ADJ	B
virus-immortalized	I-cell_type	ADJ	I
B-cell	I-cell_type	NOUN	I
lines	I-cell_type	NOUN	I
and	O	CCONJ	O
contains	O	VERB	O
an	O	DET	O
essential	O	ADJ	O
NF-kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
site	I-DNA	NOUN	I
.	O	PUNCT	O


Here	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
report	O	VERB	O
on	O	ADP	O
the	O	DET	O
identification	O	NOUN	B
of	O	ADP	O
an	O	DET	O
enhancer	B-DNA	NOUN	B
element	I-DNA	NOUN	I
in	O	ADP	O
the	O	DET	O
CD48	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
which	O	DET	O
reproducibly	O	ADV	O
confers	O	VERB	O
strong	O	ADJ	O
transcriptional	O	ADJ	B
activity	O	NOUN	I
only	O	ADV	O
in	O	ADP	O
EBV-positive	B-cell_line	ADJ	B
B-lymphoblastoid	I-cell_line	ADJ	O
cell	I-cell_line	NOUN	O
lines	I-cell_line	NOUN	O
.	O	PUNCT	O


TG	O	NOUN	B
plus	O	CCONJ	O
phorbol	O	NOUN	B
myristate	O	NOUN	I
acetate	O	NOUN	I
(	O	PUNCT	O
PMA	O	NOUN	B
)	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
TG	O	NOUN	B
alone	O	ADV	O
induced	O	VERB	B
IL-2	B-protein	NOUN	B
in	O	ADP	O
Jurkat	B-cell_line	NOUN	B
T	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
TG	O	NOUN	B
had	O	AUX	O
no	O	DET	B
effect	O	NOUN	I
on	O	ADP	O
protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
C	I-protein	NOUN	I
(	O	PUNCT	O
PKC	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
TG	O	NOUN	B
induced	O	VERB	B
increases	O	NOUN	B
in	O	ADP	O
IL-2R	B-protein	NOUN	B
alpha	I-protein	NOUN	I
protein	I-protein	NOUN	I
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
IL-2R	B-RNA	NOUN	B
alpha	I-RNA	NOUN	O
mRNA	I-RNA	NOUN	B
in	O	ADP	O
Jurkat	B-cell_line	NOUN	B
T	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
in	O	ADP	O
a	O	DET	O
dose-dependent	O	ADJ	B
manner	O	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
toto	O	NOUN	B
,	O	PUNCT	O
these	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
TG	O	NOUN	B
induces	O	VERB	O
IL-2R	B-protein	NOUN	B
alpha	I-protein	NOUN	I
in	O	ADP	O
human	B-cell_type	ADJ	B
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
through	O	ADP	O
a	O	DET	O
PKC	B-protein	NOUN	B
-independent	O	ADJ	O
pathway	O	NOUN	B
.	O	PUNCT	O


Since	O	SCONJ	O
PDTC	O	NOUN	B
has	O	AUX	O
both	O	CCONJ	O
antioxidant	O	ADJ	B
and	O	CCONJ	O
metal-ion	O	NOUN	B
chelating	O	NOUN	I
activities	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
tested	O	VERB	B
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	O
N-acetyl-L-cysteine	O	NOUN	B
(	O	PUNCT	O
NAC	O	NOUN	B
)	O	PUNCT	O
(	O	PUNCT	O
antioxidant	O	NOUN	B
)	O	PUNCT	O
or	O	CCONJ	O
o-phenanthroline	O	NOUN	B
(	O	PUNCT	O
OP	O	NOUN	B
)	O	PUNCT	O
(	O	PUNCT	O
metal-ion	O	NOUN	B
chelator	O	NOUN	I
)	O	PUNCT	O
on	O	ADP	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
apoptosis	O	NOUN	B
.	O	PUNCT	O


PKC-zeta	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
expressed	O	VERB	B
a	O	DET	O
more	O	ADV	O
differentiated	O	VERB	B
phenotype	O	NOUN	B
as	O	ADP	O
assessed	O	VERB	B
by	O	ADP	O
changes	O	NOUN	B
in	O	ADP	O
morphology	O	NOUN	B
,	O	PUNCT	O
surface	O	NOUN	B
antigen	O	NOUN	I
expression	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
lysosomal	B-protein	ADJ	B
enzyme	I-protein	NOUN	O
activities	O	NOUN	O
and	O	CCONJ	O
were	O	AUX	O
distinct	O	ADJ	O
from	O	ADP	O
parental	B-cell_line	ADJ	B
U937	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
stimulated	O	VERB	B
to	O	PART	O
differentiate	O	VERB	B
by	O	ADP	O
exposure	O	NOUN	B
to	O	PART	I
phorbol	O	NOUN	B
esters	O	NOUN	I
.	O	PUNCT	O


Increased	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
c-jun	B-DNA	NOUN	B
protooncogene	O	NOUN	I
and	O	CCONJ	O
an	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
AP-1	B-protein	NOUN	B
binding	O	NOUN	I
activity	O	NOUN	I
in	O	ADP	O
PKC-zeta	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
provides	O	VERB	O
a	O	DET	O
potential	O	ADJ	B
mechanism	O	NOUN	B
for	O	ADP	O
explaining	O	VERB	O
the	O	DET	O
altered	O	ADJ	O
differentiation	O	NOUN	B
status	O	NOUN	B
of	O	ADP	O
this	O	DET	O
cell	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
family	O	NOUN	B
of	O	ADP	O
serine	B-protein	NOUN	B
proteases	I-protein	NOUN	I
expressed	O	VERB	B
exclusively	O	ADV	O
in	O	ADP	O
myelo-	O	ADJ	O
monocytic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
specifically	O	ADV	O
processes	O	VERB	B
the	O	DET	O
nuclear	B-protein	ADJ	B
factor-kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
subunit	I-protein	NOUN	I
p65	I-protein	NOUN	I
in	O	X	B
vitro	O	X	I
and	O	CCONJ	O
may	O	AUX	O
impair	O	VERB	B
human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
replication	O	NOUN	B
in	O	ADP	O
these	O	DET	O
cells	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
specific	O	ADJ	O
proteases	O	NOUN	B
are	O	AUX	O
coordinately	O	ADV	O
expressed	O	VERB	B
and	O	CCONJ	O
were	O	AUX	O
present	O	ADJ	O
exclusively	O	ADV	O
in	O	ADP	O
the	O	DET	O
minus	B-cell_line	CCONJ	B
U937	I-cell_line	NOUN	B
clones	I-cell_line	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
in	O	ADP	O
the	O	DET	O
plus	B-cell_line	CCONJ	B
clones	I-cell_line	NOUN	I
,	O	PUNCT	O
as	O	ADP	O
demonstrated	O	VERB	O
in	O	ADP	O
the	O	DET	O
case	O	NOUN	B
of	O	ADP	O
cathepsin	B-protein	NOUN	B
G	I-protein	NOUN	I
.	O	PUNCT	O


Peripheral	B-DNA	ADJ	B
leucocyte	I-DNA	NOUN	I
genomic	I-DNA	ADJ	B
DNAs	I-DNA	NOUN	I
were	O	AUX	O
obtained	O	VERB	O
from	O	ADP	O
41	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
primary	O	ADJ	B
ovarian	O	ADJ	I
carcinoma	O	NOUN	I
and	O	CCONJ	O
83	O	NUM	O
controls	O	NOUN	B
from	O	ADP	O
Ireland	O	PROPN	B
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
from	O	ADP	O
26	O	NUM	O
primary	O	ADJ	B
ovarian	O	ADJ	B
carcinoma	O	NOUN	I
patients	O	NOUN	B
and	O	CCONJ	O
101	O	NUM	O
controls	O	NOUN	B
in	O	ADP	O
Germany	O	PROPN	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
expression	O	NOUN	B
of	O	ADP	O
OBF-1	B-protein	NOUN	B
in	O	ADP	O
HeLa	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
selectively	O	ADV	O
stimulates	O	VERB	B
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
a	O	DET	O
natural	O	ADJ	B
immunoglobulin	B-DNA	NOUN	O
promoter	I-DNA	NOUN	O
in	O	ADP	O
an	O	DET	O
octamer	B-DNA	NOUN	B
site	I-DNA	NOUN	I
-dependent	O	ADJ	O
manner	O	NOUN	O
.	O	PUNCT	O


Modulation	O	NOUN	B
of	O	ADP	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
NF	I-protein	NOUN	I
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
activity	O	NOUN	B
by	O	ADP	O
intracellular	O	ADJ	B
glutathione	O	NOUN	B
levels	O	NOUN	O
and	O	CCONJ	O
by	O	ADP	O
variations	O	NOUN	B
of	O	ADP	O
the	O	DET	O
extracellular	O	ADJ	B
cysteine	O	NOUN	B
supply	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
first	O	ADJ	O
early-induced	O	ADJ	B
peak	O	NOUN	O
was	O	AUX	O
transient	O	ADJ	B
and	O	CCONJ	O
likely	O	ADV	O
corresponds	O	VERB	O
to	O	ADP	O
the	O	DET	O
well	O	ADV	O
documented	O	VERB	B
typical	O	ADJ	O
junB	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
,	O	PUNCT	O
stimulated	O	VERB	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
numerous	O	ADJ	O
growth	B-protein	NOUN	B
factors	I-protein	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
IL-6	B-protein	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
August	O	PROPN	O
,	O	PUNCT	O
1992	O	NUM	O
,	O	PUNCT	O
we	O	PRON	O
established	O	VERB	O
a	O	DET	O
leukemic	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
(	O	PUNCT	O
NS-Meg	B-cell_line	NOUN	B
)	O	PUNCT	O
from	O	ADP	O
a	O	DET	O
patient	O	NOUN	B
in	O	ADP	O
megakaryoblastic	O	ADJ	B
transformation	O	NOUN	I
of	O	ADP	O
Philadelphia	O	NOUN	B
chromosome-positive	O	ADJ	I
chronic	O	ADJ	I
myeloid	O	ADJ	I
leukemia	O	NOUN	I
.	O	PUNCT	O


Erythropoietin	B-protein	NOUN	B
(	O	PUNCT	O
Epo	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
granulocyte/macrophage	B-protein	ADJ	B
colony	I-protein	NOUN	I
stimulating	I-protein	NOUN	I
factor	I-protein	NOUN	I
(	O	PUNCT	O
GM-CSF	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
interleukin	B-protein	NOUN	B
3	I-protein	NUM	I
(	O	PUNCT	O
IL-3	B-protein	NOUN	B
)	O	PUNCT	O
promoted	O	VERB	B
the	O	DET	O
growth	O	NOUN	B
of	O	ADP	O
NS-Meg	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


These	O	DET	O
benzidine-positive	B-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
were	O	AUX	O
positive	O	ADJ	B
for	O	ADP	O
hemoglobin	B-protein	NOUN	B
F	O	NOUN	I
staining	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
to	O	PART	O
activation	O	NOUN	B
of	O	ADP	O
phospholipase	B-protein	NOUN	B
C	I-protein	NOUN	I
gamma	I-protein	NOUN	I
1	I-protein	NUM	I
,	O	PUNCT	O
ligation	O	NOUN	B
of	O	ADP	O
this	O	DET	O
receptor	O	NOUN	B
also	O	ADV	O
seems	O	VERB	O
to	O	PART	O
activate	O	VERB	B
a	O	DET	O
calcium-independent	O	ADJ	B
,	O	PUNCT	O
CD28	B-protein	NOUN	B
-specific	O	ADJ	O
pathway	O	NOUN	B
.	O	PUNCT	O


Enhanced	O	VERB	B
responsiveness	O	NOUN	B
to	O	PART	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
contributes	O	VERB	O
to	O	PART	O
the	O	DET	O
unique	O	ADJ	B
phenotype	O	NOUN	B
of	O	ADP	O
simian	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
variant	O	ADJ	B
SIVsmmPBj14	O	NOUN	B
.	O	PUNCT	O


Inclusion	O	NOUN	B
of	O	ADP	O
this	O	DET	O
LTR	B-DNA	NOUN	B
in	O	ADP	O
recombinant	O	ADJ	B
SIVs	O	NOUN	B
also	O	ADV	O
resulted	O	VERB	O
in	O	ADP	O
a	O	DET	O
two-	O	NUM	O
to	O	PART	O
threefold	O	ADV	O
rise	O	VERB	O
in	O	ADP	O
the	O	DET	O
extent	O	NOUN	O
of	O	ADP	O
cellular	O	ADJ	B
proliferation	O	NOUN	I
that	O	PRON	O
was	O	AUX	O
induced	O	VERB	B
in	O	ADP	O
quiescent	B-cell_line	ADJ	B
simian	I-cell_line	ADJ	I
peripheral	I-cell_line	ADJ	B
blood	I-cell_line	NOUN	I
mononuclear	I-cell_line	ADJ	I
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


The	O	DET	O
level	O	NOUN	B
of	O	ADP	O
constitutive	O	ADJ	B
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
in	O	ADP	O
these	O	DET	O
cells	O	NOUN	B
is	O	AUX	O
variable	O	ADJ	B
and	O	CCONJ	O
is	O	AUX	O
frequently	O	ADV	O
found	O	VERB	O
to	O	PART	O
be	O	AUX	O
lower	O	ADJ	O
in	O	ADP	O
the	O	DET	O
more	O	ADV	O
mature	B-cell_type	ADJ	B
macrophages	I-cell_type	NOUN	B
.	O	PUNCT	O


BFU-E-derived	B-cell_line	ADJ	B
colonies	I-cell_line	NOUN	B
increase	O	VERB	B
progressively	O	ADV	O
in	O	ADP	O
size	O	NOUN	B
,	O	PUNCT	O
as	O	ADP	O
determined	O	VERB	O
by	O	ADP	O
cell	O	NOUN	B
number	O	NOUN	I
,	O	PUNCT	O
from	O	ADP	O
day	O	NOUN	B
7	O	NUM	O
to	O	PART	O
day	O	NOUN	B
14	O	NUM	O
of	O	ADP	O
culture	O	NOUN	B
,	O	PUNCT	O
with	O	ADP	O
the	O	DET	O
greatest	O	ADJ	O
increase	O	NOUN	B
in	O	ADP	O
colony	O	NOUN	B
size	O	NOUN	I
(	O	PUNCT	O
10-fold	O	ADJ	O
expansion	O	NOUN	B
)	O	PUNCT	O
occurring	O	VERB	O
between	O	ADP	O
day	O	NOUN	B
7	O	NUM	O
and	O	CCONJ	O
day	O	NOUN	B
10	O	NUM	O
.	O	PUNCT	O


In	O	ADP	O
BFU-E-derived	B-cell_line	ADJ	B
colonies	I-cell_line	NOUN	B
cultured	O	VERB	B
with	O	ADP	O
Steel	B-protein	NOUN	B
factor	I-protein	NOUN	I
,	O	PUNCT	O
colony	O	NOUN	B
size	O	NOUN	I
was	O	AUX	O
significantly	O	ADV	O
increased	O	VERB	B
compared	O	VERB	O
to	O	PART	O
control	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
response	O	NOUN	B
of	O	ADP	O
LFA-3	B-protein	NOUN	B
to	O	PART	O
TaxI	B-protein	NOUN	B
induction	O	NOUN	B
was	O	AUX	O
,	O	PUNCT	O
on	O	ADP	O
the	O	DET	O
other	O	ADJ	O
hand	O	NOUN	B
,	O	PUNCT	O
relatively	O	ADV	O
slow	O	ADJ	B
and	O	CCONJ	O
weak	O	ADJ	B
,	O	PUNCT	O
and	O	CCONJ	O
might	O	AUX	O
be	O	AUX	O
indirect	O	ADJ	B
.	O	PUNCT	O


Transactivation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
ICAM-I	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
by	O	ADP	O
TaxI	B-protein	NOUN	B
was	O	AUX	O
further	O	ADV	O
shown	O	VERB	O
by	O	ADP	O
co-transfection	O	NOUN	B
of	O	ADP	O
a	O	DET	O
CAT	B-DNA	NOUN	B
reporter	I-DNA	NOUN	I
construct	I-DNA	NOUN	I
with	O	ADP	O
the	O	DET	O
ICAM-I	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
and	O	CCONJ	O
a	O	DET	O
plasmid	B-DNA	NOUN	B
expressing	O	VERB	B
TaxI	B-protein	NOUN	B
.	O	PUNCT	O


No	O	DET	O
genomic	O	ADJ	B
changes	O	NOUN	I
were	O	AUX	O
found	O	VERB	O
,	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
CAT	B-DNA	NOUN	B
reporter	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
with	O	ADP	O
the	O	DET	O
CD18	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
was	O	AUX	O
inactive	O	ADJ	B
in	O	ADP	O
the	O	DET	O
3	O	NUM	O
of	O	ADP	O
them	O	PRON	O
,	O	PUNCT	O
again	O	ADV	O
suggesting	O	VERB	O
lack	O	NOUN	B
of	O	ADP	O
(	O	PUNCT	O
a	O	X	O
)	O	PUNCT	O
transcriptional	B-protein	ADJ	B
factor	I-protein	NOUN	I
(	O	PUNCT	O
s	O	NOUN	O
)	O	PUNCT	O
necessary	O	ADJ	O
for	O	ADP	O
CD18	B-protein	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


Infection	O	NOUN	B
with	O	ADP	O
Theileria	O	X	B
annulata	O	X	I
induces	O	VERB	O
expression	O	NOUN	B
of	O	ADP	O
matrix	B-protein	NOUN	B
metalloproteinase	I-protein	NOUN	I
9	I-protein	NUM	I
and	O	CCONJ	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
AP-1	B-protein	NOUN	I
in	O	ADP	O
bovine	B-cell_type	ADJ	B
leucocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


Theileria	O	X	B
annulata	O	X	I
infects	O	VERB	B
bovine	B-cell_type	ADJ	B
leucocytes	I-cell_type	NOUN	B
and	O	CCONJ	O
results	O	VERB	B
in	O	ADP	O
their	O	PRON	O
reversible	O	ADJ	B
transformation	O	NOUN	B
such	O	ADJ	O
that	O	SCONJ	O
they	O	PRON	O
become	O	VERB	O
immortalised	O	ADJ	B
and	O	CCONJ	O
metastatic	O	ADJ	B
.	O	PUNCT	O


T.	B-cell_type	X	B
annulata-infected	I-cell_type	X	I
leucocytes	I-cell_type	NOUN	B
produce	O	VERB	O
a	O	DET	O
number	O	NOUN	O
of	O	ADP	O
novel	O	ADJ	B
metalloproteinase	B-protein	NOUN	B
activities	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
predicted	O	VERB	O
protein	O	NOUN	B
sequence	O	NOUN	I
of	O	ADP	O
B1	B-protein	NOUN	B
is	O	AUX	O
81	O	NUM	O
%	O	NOUN	O
identical	O	ADJ	B
to	O	PART	O
human	O	ADJ	B
matrix	B-protein	NOUN	O
metalloproteinase	I-protein	NOUN	O
9	I-protein	NUM	O
(	O	PUNCT	O
MMP9	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
demonstrating	O	VERB	O
that	O	SCONJ	O
it	O	PRON	O
is	O	AUX	O
the	O	DET	O
bovine	O	ADJ	B
homologue	O	NOUN	B
of	O	ADP	O
this	O	DET	O
enzyme	O	NOUN	B
.	O	PUNCT	O


Growth	O	NOUN	B
transformation	O	NOUN	I
of	O	ADP	O
primary	B-cell_type	ADJ	B
normal	I-cell_type	ADJ	I
B-cells	I-cell_type	NOUN	B
by	O	ADP	O
mutant	O	ADJ	B
virus	O	NOUN	I
resulted	O	VERB	O
in	O	ADP	O
estrogen-dependent	B-cell_line	ADJ	B
lymphoblastoid	I-cell_line	ADJ	O
cell	I-cell_line	NOUN	O
lines	I-cell_line	NOUN	O
expressing	O	VERB	B
the	O	DET	O
chimeric	O	ADJ	B
EBNA2	B-protein	NOUN	I
protein	I-protein	NOUN	I
.	O	PUNCT	O


EBV	O	NOUN	B
induces	O	VERB	B
the	O	DET	O
same	O	ADJ	O
cell	O	NOUN	B
cycle	O	NOUN	I
regulating	O	NOUN	I
proteins	O	NOUN	I
as	O	ADP	O
polyclonal	O	ADJ	B
stimuli	O	NOUN	I
in	O	ADP	O
primary	O	ADJ	B
B-cells	B-cell_type	NOUN	I
.	O	PUNCT	O


Western	O	NOUN	B
blot	O	NOUN	I
and	O	CCONJ	O
phosphorylation	O	NOUN	B
analyses	O	NOUN	B
demonstrate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
synergistic	O	ADJ	B
effect	O	NOUN	O
on	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
functional	O	ADJ	O
activity	O	NOUN	O
is	O	AUX	O
independent	O	ADJ	O
of	O	ADP	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
alpha	I-protein	NOUN	I
(	O	PUNCT	O
MAD3	B-protein	NOUN	B
)	O	PUNCT	O
-	O	PUNCT	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
dissociation	O	NOUN	B
in	O	ADP	O
the	O	DET	O
cytosol	O	NOUN	B
and	O	CCONJ	O
is	O	AUX	O
not	O	PART	O
associated	O	VERB	B
with	O	ADP	I
I	B-protein	NOUN	O
kappa	I-protein	NOUN	O
B	I-protein	NOUN	O
nuclear	O	ADJ	O
translocation	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
single	O	ADJ	O
promoter	B-DNA	NOUN	B
region	I-DNA	NOUN	I
in	O	ADP	O
the	O	DET	O
cloned	O	VERB	B
genome	O	NOUN	B
[	O	PUNCT	O
Noteborn	O	PROPN	B
et	O	X	O
al.	O	X	O
,	O	PUNCT	O
J.	O	PROPN	O
Virol.	O	PROPN	O
65	O	NUM	O
(	O	PUNCT	O
1991	O	NUM	O
)	O	PUNCT	O
3131-3139	O	NUM	O
]	O	PUNCT	O
of	O	ADP	O
chicken	O	NOUN	B
anemia	O	NOUN	B
virus	O	NOUN	I
(	O	PUNCT	O
CAV	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
chicken	B-cell_type	NOUN	B
T-cells	I-cell_type	NOUN	B
was	O	AUX	O
analysed	O	VERB	B
via	O	ADP	O
CAT	B-protein	NOUN	B
assays	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
unique	O	ADJ	B
region	O	NOUN	O
containing	O	VERB	O
four	O	NUM	O
or	O	CCONJ	O
five	O	NUM	O
near-perfect	O	ADJ	O
direct	O	ADJ	O
repeats	O	NOUN	O
(	O	PUNCT	O
DR	O	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
21	O	NUM	O
bp	O	NOUN	O
with	O	ADP	O
one	O	NUM	O
12-bp	B-DNA	ADJ	O
insert	I-DNA	NOUN	B
was	O	AUX	O
proven	O	VERB	O
to	O	PART	O
be	O	AUX	O
the	O	DET	O
main	O	ADJ	O
transcription-activation	B-DNA	ADJ	B
element	I-DNA	NOUN	I
,	O	PUNCT	O
with	O	ADP	O
enhancer-like	O	ADJ	B
characteristics	O	NOUN	I
.	O	PUNCT	O


Functional	O	ADJ	B
Myc-Max	B-protein	NOUN	B
heterodimer	I-protein	NOUN	I
is	O	AUX	O
required	O	VERB	O
for	O	ADP	O
activation-induced	O	ADJ	B
apoptosis	O	NOUN	I
in	O	ADP	O
T	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
hybridomas	I-cell_line	NOUN	B
.	O	PUNCT	O


Previous	O	ADJ	O
studies	O	NOUN	B
using	O	VERB	O
antisense	O	ADJ	B
oligonucleotides	O	NOUN	I
implicated	O	VERB	O
the	O	DET	O
c-Myc	B-protein	NOUN	B
protein	I-protein	NOUN	I
in	O	ADP	O
the	O	DET	O
phenomenon	O	NOUN	B
of	O	ADP	O
activation-induced	O	ADJ	B
apoptosis	O	NOUN	B
.	O	PUNCT	O


Epstein-Barr	B-protein	ADJ	B
virus	I-protein	NOUN	I
SM	I-protein	NOUN	O
protein	I-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
serum	B-DNA	NOUN	B
response	I-DNA	NOUN	I
element	I-DNA	NOUN	I
(	O	PUNCT	O
SRE	B-DNA	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
c-fos	B-DNA	NOUN	B
regulatory	I-DNA	ADJ	I
region	I-DNA	NOUN	I
participates	O	VERB	O
in	O	ADP	O
induction	O	NOUN	B
of	O	ADP	O
transcription	O	NOUN	B
by	O	ADP	O
various	O	ADJ	O
growth	B-protein	NOUN	B
factors	I-protein	NOUN	I
and	O	CCONJ	O
by	O	ADP	O
phorbol	O	NOUN	B
esters	O	NOUN	I
and	O	CCONJ	O
subsequent	O	ADJ	O
squelching	O	NOUN	B
of	O	ADP	O
transcription	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
an	O	DET	O
inducible	O	ADJ	B
protein	B-protein	NOUN	I
complex	I-protein	NOUN	I
(	O	PUNCT	O
Band	B-protein	NOUN	B
A	I-protein	NOUN	I
)	O	PUNCT	O
binds	O	VERB	B
to	O	PART	O
SRE	B-DNA	NOUN	B
DNA	I-DNA	NOUN	B
within	O	ADP	O
10	O	NUM	O
min	O	NOUN	O
after	O	ADP	O
mitogenic	O	ADJ	B
stimulation	O	NOUN	I
of	O	ADP	O
human	B-cell_line	ADJ	B
PBL-T	I-cell_line	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
becomes	O	VERB	O
nondetectable	O	ADJ	B
by	O	ADP	O
60	O	NUM	O
min	O	NOUN	O
.	O	PUNCT	O


Regulation	O	NOUN	B
of	O	ADP	O
cell-type-specific	O	ADJ	B
interleukin-2	B-protein	NOUN	I
receptor	I-protein	NOUN	I
alpha-chain	I-protein	NOUN	I
gene	O	NOUN	O
expression	O	NOUN	B
:	O	PUNCT	O
potential	O	ADJ	O
role	O	NOUN	O
of	O	ADP	O
physical	O	ADJ	B
interactions	O	NOUN	I
between	O	ADP	O
Elf-1	B-protein	NOUN	B
,	O	PUNCT	O
HMG-I	B-protein	NOUN	B
(	I-protein	PUNCT	O
Y	I-protein	NOUN	B
)	I-protein	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
family	I-protein	NOUN	B
proteins	I-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
interleukin	B-DNA	NOUN	B
2	I-DNA	NUM	I
receptor	I-DNA	NOUN	I
alpha-chain	I-DNA	NOUN	I
(	I-DNA	PUNCT	O
IL-2R	I-DNA	NOUN	B
alpha	I-DNA	NOUN	I
)	I-DNA	PUNCT	O
gene	I-DNA	NOUN	O
is	O	AUX	O
rapidly	O	ADV	O
and	O	CCONJ	O
potently	O	ADV	O
induced	O	VERB	B
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
in	O	ADP	O
response	O	NOUN	O
to	O	PART	O
mitogenic	O	ADJ	B
stimuli	O	NOUN	I
.	O	PUNCT	O


This	O	DET	O
is	O	AUX	O
the	O	DET	O
first	O	ADJ	O
report	O	NOUN	O
of	O	ADP	O
a	O	DET	O
physical	O	ADJ	B
interaction	O	NOUN	I
between	O	ADP	O
an	O	DET	O
Ets	O	NOUN	B
family	O	NOUN	I
member	O	NOUN	I
and	O	CCONJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
family	I-protein	NOUN	B
proteins	I-protein	NOUN	I
.	O	PUNCT	O


By	O	ADP	O
extensive	O	ADJ	O
nucleotide	O	NOUN	B
sequence	O	NOUN	I
and	O	CCONJ	O
Northern	O	NOUN	B
blot	O	NOUN	I
analysis	O	NOUN	I
,	O	PUNCT	O
these	O	DET	O
cDNA	B-DNA	NOUN	B
clones	I-DNA	NOUN	I
were	O	AUX	O
found	O	VERB	O
to	O	PART	O
originate	O	VERB	O
from	O	ADP	O
approximately	O	ADV	B
42	O	NUM	O
different	O	ADJ	B
genes	O	NOUN	B
(	O	PUNCT	O
HZF	B-DNA	NOUN	B
1-42	I-DNA	NUM	O
)	O	PUNCT	O
of	O	ADP	O
which	O	DET	O
only	O	ADV	O
8	O	NUM	O
have	O	AUX	O
previously	O	ADV	O
been	O	AUX	O
described	O	VERB	O
.	O	PUNCT	O


CAG	O	NOUN	B
repeat	O	NOUN	I
length	O	NOUN	I
variation	O	NOUN	I
in	O	ADP	O
sperm	B-cell_type	NOUN	B
from	O	ADP	O
a	O	DET	O
patient	O	NOUN	B
with	O	ADP	O
Kennedy	O	PROPN	B
's	O	PART	I
disease	O	NOUN	I
.	O	PUNCT	O


ALDs	O	NOUN	B
induced	O	VERB	B
QR	B-protein	NOUN	B
activity	O	NOUN	I
in	O	ADP	O
the	O	DET	O
M4	O	NOUN	B
cells	O	NOUN	I
in	O	ADP	O
the	O	DET	O
same	O	ADJ	O
range	O	NOUN	O
of	O	ADP	O
concentrations	O	NOUN	B
that	O	PRON	O
protected	O	VERB	O
the	O	DET	O
cells	O	NOUN	B
against	O	ADP	O
BQ	O	NOUN	B
toxicity	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
good	O	ADJ	O
linear	O	ADJ	O
correlation	O	NOUN	B
,	O	PUNCT	O
with	O	ADP	O
an	O	DET	O
r	O	NOUN	O
value	O	NOUN	O
of	O	ADP	O
0.91	O	NUM	O
,	O	PUNCT	O
between	O	ADP	O
the	O	DET	O
ED50	O	NOUN	B
values	O	NOUN	B
for	O	ADP	O
the	O	DET	O
differentiation-inducing	O	ADJ	B
activity	O	NOUN	I
towards	O	ADP	O
HL-60	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
and	O	CCONJ	O
that	O	DET	O
towards	O	ADP	O
NB4	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
was	O	AUX	O
found	O	VERB	O
.	O	PUNCT	O


Platelet-activating	B-protein	ADJ	B
factor	I-protein	NOUN	I
(	O	PUNCT	O
PAF	B-protein	NOUN	B
)	O	PUNCT	O
positively	O	ADV	O
auto-regulates	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
human	B-protein	ADJ	B
PAF	I-protein	NOUN	B
receptor	I-protein	NOUN	I
transcript	I-protein	NOUN	O
1	I-protein	NUM	O
(	O	PUNCT	O
leukocyte-type	O	NOUN	B
)	O	PUNCT	O
through	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
.	O	PUNCT	O


By	O	ADP	O
primer	O	NOUN	B
extension	O	NOUN	I
analysis	O	NOUN	I
to	O	PART	O
discriminate	O	VERB	O
two	O	NUM	O
transcripts	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
found	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
levels	O	NOUN	B
of	O	ADP	O
PAFR	B-RNA	NOUN	B
transcript	I-RNA	NOUN	O
1	I-RNA	NUM	O
(	O	PUNCT	O
leukocyte-type	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
PAFR	B-RNA	NOUN	B
transcript	I-RNA	NOUN	O
2	I-RNA	NUM	O
(	O	PUNCT	O
tissue-type	O	ADJ	B
)	O	PUNCT	O
,	O	PUNCT	O
are	O	AUX	O
upregulated	O	VERB	B
by	O	ADP	O
PAF	B-protein	NOUN	B
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
by	O	ADP	O
12-O-tetradecanoylphorbol-13-acetate	O	NOUN	B
(	O	PUNCT	O
TPA	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
human	B-cell_line	ADJ	B
stomach	I-cell_line	NOUN	O
cancer	I-cell_line	NOUN	O
cell	I-cell_line	NOUN	O
line	I-cell_line	NOUN	O
(	O	PUNCT	O
JR-St	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
)	O	PUNCT	O
which	O	DET	O
expresses	O	VERB	B
both	O	CCONJ	O
functional	O	ADJ	B
PAFR	B-RNA	NOUN	B
transcript	I-RNA	NOUN	O
1	I-RNA	NUM	O
and	O	CCONJ	O
PAFR	B-RNA	NOUN	B
transcript	I-RNA	NOUN	B
2	I-RNA	NUM	O
endogenously	O	ADV	B
.	O	PUNCT	O


Tyrosine	O	NOUN	B
kinase	O	NOUN	I
activity	O	NOUN	O
is	O	AUX	O
increased	O	VERB	B
shortly	O	ADV	O
after	O	ADP	O
engagement	O	NOUN	B
of	O	ADP	O
this	O	DET	O
receptor	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
activation	O	NOUN	B
is	O	AUX	O
rapid	O	ADJ	B
and	O	CCONJ	O
is	O	AUX	O
mediated	O	VERB	O
through	O	ADP	O
a	O	DET	O
tyrosine	O	NOUN	B
kinase-dependent	O	ADJ	I
pathway	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
complexes	O	NOUN	B
detected	O	VERB	B
in	O	ADP	O
electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assays	O	NOUN	I
contain	O	VERB	O
p50	B-protein	NOUN	B
,	O	PUNCT	O
p65	B-protein	NOUN	B
(	O	PUNCT	O
RelA	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
c-Rel	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
most	O	ADV	O
likely	O	ADJ	O
other	O	ADJ	O
components	O	NOUN	B
.	O	PUNCT	O


Tissue	B-protein	NOUN	B
factor	I-protein	NOUN	I
(	O	PUNCT	O
TF	B-protein	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
expressed	O	VERB	B
rapidly	O	ADV	O
by	O	ADP	O
human	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
exposed	O	VERB	B
to	O	PART	I
bacterial	B-protein	ADJ	B
endotoxin	I-protein	NOUN	O
(	O	PUNCT	O
lipopolysaccharide	O	NOUN	B
,	O	PUNCT	O
or	O	CCONJ	O
LPS	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
protease	O	NOUN	B
inhibitors	O	NOUN	I
N	O	NOUN	O
alpha-tosylphenylalanyl	O	ADJ	B
chloromethyl	O	NOUN	I
ketone	O	NOUN	I
(	O	PUNCT	O
TPCK	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
N	O	NOUN	B
alpha-tosyl-L-lysine	O	NOUN	I
chloromethyl	O	NOUN	I
ketone	O	NOUN	I
(	O	PUNCT	O
TLCK	O	NOUN	B
)	O	PUNCT	O
block	O	VERB	B
activation	O	NOUN	I
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B/Rel	I-protein	NOUN	B
proteins	I-protein	NOUN	I
by	O	ADP	O
preventing	O	VERB	O
degradation	O	NOUN	B
of	O	ADP	O
I	B-protein	NOUN	O
kappa	I-protein	NOUN	O
B	I-protein	NOUN	O
alpha	I-protein	NOUN	O
.	O	PUNCT	O


A	O	DET	O
decreased	O	VERB	B
number	O	NOUN	O
of	O	ADP	O
calcitriol	B-protein	NOUN	B
(	I-protein	PUNCT	O
1	I-protein	NUM	O
,	I-protein	PUNCT	O
25	I-protein	NUM	O
(	I-protein	PUNCT	O
OH	I-protein	NOUN	B
)	I-protein	PUNCT	O
2D3	I-protein	NOUN	O
)	I-protein	PUNCT	O
receptors	I-protein	NOUN	O
has	O	AUX	O
been	O	AUX	O
observed	O	VERB	O
in	O	ADP	O
parathyroid	O	ADJ	B
glands	O	NOUN	I
of	O	ADP	O
uremic	O	ADJ	B
animals	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
two	O	NUM	O
tiny	O	ADJ	O
ring	O	NOUN	O
X	B-DNA	NOUN	O
chromosomes	I-DNA	NOUN	O
studied	O	VERB	O
with	O	ADP	O
an	O	DET	O
antibody	B-protein	NOUN	B
specific	O	ADJ	B
for	O	ADP	O
the	O	DET	O
acetylated	O	VERB	B
isoforms	O	NOUN	B
of	O	ADP	O
histone	B-protein	NOUN	B
H4	I-protein	NOUN	I
marking	O	VERB	O
transcribed	B-DNA	VERB	B
chromatin	I-DNA	NOUN	I
domains	I-DNA	NOUN	I
were	O	AUX	O
labeled	O	VERB	B
at	O	ADP	O
a	O	DET	O
level	O	NOUN	B
consistent	O	ADJ	B
with	O	ADP	I
their	O	PRON	O
being	O	AUX	O
active	O	ADJ	B
.	O	PUNCT	O


Expressed	O	VERB	B
in	O	ADP	O
the	O	DET	O
cytoplasm	O	NOUN	B
or	O	CCONJ	O
on	O	ADP	O
the	O	DET	O
cell	O	NOUN	B
surface	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
chimera	B-protein	NOUN	B
inhibited	O	VERB	B
or	O	CCONJ	O
activated	O	VERB	B
early	O	ADJ	O
signaling	O	NOUN	O
events	O	NOUN	O
from	O	ADP	O
the	O	DET	O
T	B-protein	NOUN	B
cell	I-protein	NOUN	I
antigen	I-protein	NOUN	I
receptor	I-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
constructs	O	NOUN	B
containing	O	VERB	O
5	B-DNA	NUM	O
'	I-DNA	PART	O
deletion	I-DNA	NOUN	B
mutants	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
alpha	B-DNA	NOUN	B
4	I-DNA	NUM	I
gene	I-DNA	NOUN	I
promoter	I-DNA	NOUN	O
was	O	AUX	O
compared	O	VERB	O
in	O	ADP	O
transfection	O	NOUN	B
assays	O	NOUN	I
into	O	ADP	O
cell	B-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
that	O	PRON	O
express	O	VERB	O
alpha	B-protein	NOUN	B
4	I-protein	NUM	I
and	O	CCONJ	O
cell	B-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
that	O	PRON	O
do	O	AUX	O
not	O	PART	O
.	O	PUNCT	O


The	O	DET	O
sequence	O	NOUN	B
between	O	ADP	O
position	O	NOUN	B
-42	B-DNA	NUM	O
and	I-DNA	CCONJ	O
-76	I-DNA	NUM	B
base	I-DNA	NOUN	I
pairs	I-DNA	NOUN	I
(	O	PUNCT	O
bp	O	NOUN	B
)	O	PUNCT	O
was	O	AUX	O
required	O	VERB	O
for	O	ADP	O
efficient	O	ADJ	B
transcription	O	NOUN	B
in	O	ADP	O
cells	O	NOUN	B
that	O	PRON	O
express	O	VERB	B
alpha	B-protein	NOUN	B
4	I-protein	NUM	I
,	O	PUNCT	O
but	O	CCONJ	O
it	O	PRON	O
showed	O	VERB	O
no	O	DET	O
activity	O	NOUN	O
in	O	ADP	O
HeLa	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
which	O	DET	O
do	O	AUX	O
not	O	PART	O
express	O	VERB	O
alpha	B-protein	NOUN	B
4	I-protein	NUM	I
.	O	PUNCT	O


Full-length	O	ADJ	B
ERP	B-protein	NOUN	B
expresses	O	VERB	B
only	O	ADV	O
negligible	O	ADJ	O
DNA-binding	O	ADJ	B
activity	O	NOUN	I
by	O	ADP	O
itself	O	PRON	O
.	O	PUNCT	O


At	O	ADP	O
least	O	ADJ	O
three	O	NUM	O
ERP-related	B-protein	ADJ	B
transcripts	I-protein	NOUN	B
are	O	AUX	O
expressed	O	VERB	B
in	O	ADP	O
a	O	DET	O
variety	O	NOUN	O
of	O	ADP	O
tissues	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
ERP	B-protein	NOUN	B
might	O	AUX	O
play	O	VERB	O
a	O	DET	O
role	O	NOUN	O
in	O	ADP	O
B-cell	B-cell_type	NOUN	B
development	O	NOUN	B
and	O	CCONJ	O
in	O	ADP	O
IgH	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
regulation	O	NOUN	I
.	O	PUNCT	O


Murine	B-cell_type	NOUN	B
B	I-cell_type	NOUN	O
lymphocytes	I-cell_type	NOUN	O
,	O	PUNCT	O
adipocytes	B-cell_type	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
olfactory	B-cell_type	ADJ	B
neurons	I-cell_type	NOUN	B
contain	O	VERB	O
a	O	DET	O
DNA-binding	B-protein	ADJ	B
protein	I-protein	NOUN	I
that	O	PRON	O
participates	O	VERB	B
in	O	ADP	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
genes	B-DNA	NOUN	O
encoding	O	VERB	O
tissue-specific	O	ADJ	B
components	O	NOUN	I
of	O	ADP	O
signal	O	NOUN	B
transduction	O	NOUN	I
.	O	PUNCT	O


Purification	O	NOUN	B
and	O	CCONJ	O
cloning	O	NOUN	B
of	O	ADP	O
this	O	DET	O
protein	O	NOUN	B
,	O	PUNCT	O
termed	O	VERB	O
early	O	ADJ	O
B-cell	B-protein	NOUN	O
factor	I-protein	NOUN	O
(	O	PUNCT	O
EBF	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
from	O	ADP	O
murine	B-cell_type	ADJ	B
B	I-cell_type	NOUN	O
lymphocytes	I-cell_type	NOUN	O
and	O	CCONJ	O
independent	O	ADJ	O
cloning	O	NOUN	B
of	O	ADP	O
a	O	DET	O
protein	O	NOUN	B
,	O	PUNCT	O
termed	O	VERB	O
Olf-1	B-protein	NOUN	B
,	O	PUNCT	O
from	O	ADP	O
olfactory	B-cell_type	ADJ	B
neuronal	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
revealed	O	VERB	O
virtual	O	ADJ	B
complete	O	ADJ	I
amino	O	NOUN	B
acid	O	NOUN	I
sequence	O	NOUN	I
identity	O	NOUN	B
between	O	ADP	O
these	O	DET	O
proteins	O	NOUN	B
.	O	PUNCT	O


By	O	ADP	O
Southern	O	NOUN	B
hybridization	O	NOUN	I
analyses	O	NOUN	I
of	O	ADP	O
somatic	O	ADJ	B
cell	O	NOUN	I
hybrid	O	NOUN	I
panels	O	NOUN	I
with	O	ADP	O
murine	B-DNA	ADJ	B
cDNA	I-DNA	NOUN	B
probe	I-DNA	NOUN	I
,	O	PUNCT	O
fluorescence	O	NOUN	B
chromosomal	O	NOUN	I
in	O	X	B
situ	O	X	I
hybridization	O	NOUN	I
(	O	PUNCT	O
FISH	O	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
human	B-DNA	ADJ	B
genomic	I-DNA	ADJ	B
clones	I-DNA	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
analysis	O	NOUN	B
of	O	ADP	O
recombinant	B-cell_line	ADJ	B
inbred	I-cell_line	ADJ	O
mouse	I-cell_line	NOUN	O
strains	I-cell_line	NOUN	O
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
found	O	VERB	O
single	O	ADJ	O
sites	O	NOUN	O
for	O	ADP	O
EBF	B-DNA	NOUN	B
homologous	I-DNA	ADJ	B
sequences	I-DNA	NOUN	I
on	O	ADP	O
human	O	ADJ	B
Chromosome	O	NOUN	I
(	O	PUNCT	I
Chr	O	NOUN	B
)	O	PUNCT	O
5	O	NUM	O
,	O	PUNCT	O
band	B-DNA	NOUN	B
q34	I-DNA	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
on	O	ADP	O
proximal	B-DNA	ADJ	B
mouse	I-DNA	NOUN	B
Chr	I-DNA	NOUN	O
11	I-DNA	NUM	O
,	O	PUNCT	O
in	O	ADP	O
an	O	DET	O
evolutionarily	B-DNA	ADV	O
conserved	I-DNA	VERB	O
region	I-DNA	NOUN	O
.	O	PUNCT	O


Calcineurin	B-protein	NOUN	B
activates	O	VERB	B
transcription	O	NOUN	B
from	O	ADP	O
the	O	DET	O
GM-CSF	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
in	O	ADP	O
synergy	O	NOUN	B
with	O	ADP	O
either	O	CCONJ	O
protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
C	I-protein	NOUN	I
or	O	CCONJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
/AP-1	B-protein	NOUN	B
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Expression	O	NOUN	B
of	O	ADP	O
a	O	DET	O
constitutively	O	ADV	B
active	O	ADJ	O
calcineurin	B-protein	NOUN	O
(	O	PUNCT	O
CN	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
a	O	DET	O
Ca2+/calmodulin-dependent	B-protein	ADJ	B
protein	I-protein	NOUN	I
phosphatase	I-protein	NOUN	I
,	O	PUNCT	O
potentiated	O	VERB	B
by	O	ADP	O
two	O	NUM	O
fold	O	NOUN	O
the	O	DET	O
transcriptional	O	ADJ	B
activation	O	NOUN	I
by	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
/AP-1	B-protein	NOUN	B
.	O	PUNCT	O


One	O	NUM	O
of	O	ADP	O
the	O	DET	O
nuclear	B-protein	ADJ	B
factors	I-protein	NOUN	I
(	O	PUNCT	O
NFs	B-protein	NOUN	B
)	O	PUNCT	O
that	O	PRON	O
regulates	O	VERB	B
the	O	DET	O
response	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IL-5	B-DNA	NOUN	B
promoter	I-DNA	NOUN	I
to	O	PART	O
cAMP	O	NOUN	B
and	O	CCONJ	O
PMA	O	NOUN	B
has	O	AUX	O
properties	O	NOUN	B
similar	O	ADJ	O
to	O	PART	O
NF	B-protein	NOUN	B
for	O	ADP	O
activated	B-cell_type	VERB	B
t	I-cell_type	NOUN	O
cell	I-cell_type	NOUN	O
.	O	PUNCT	O


The	O	DET	O
P	B-DNA	NOUN	O
sequence	I-DNA	NOUN	B
of	O	ADP	O
the	O	DET	O
IL-4	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
,	O	PUNCT	O
defined	O	VERB	O
as	O	ADP	O
a	O	DET	O
responsive	B-DNA	ADJ	B
element	I-DNA	NOUN	O
for	O	ADP	O
PMA	O	NOUN	B
and	O	CCONJ	O
calcium	O	NOUN	B
ionophore	O	NOUN	I
(	O	PUNCT	O
A23187	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
shares	O	VERB	O
sequence	O	NOUN	B
similarity	O	NOUN	B
with	O	ADP	O
the	O	DET	O
NF	B-DNA	NOUN	B
kappa	I-DNA	NOUN	I
B	I-DNA	NOUN	I
and	I-DNA	CCONJ	O
the	I-DNA	DET	O
NF-activated	I-DNA	ADJ	B
T	I-DNA	NOUN	O
cell	I-DNA	NOUN	O
binding	I-DNA	NOUN	O
sites	I-DNA	NOUN	O
.	O	PUNCT	O


Because	O	SCONJ	O
this	O	DET	O
segment	O	NOUN	B
presumably	O	ADV	O
folds	O	VERB	B
upon	O	SCONJ	O
specific	O	ADJ	O
DNA	O	NOUN	B
binding	O	NOUN	I
,	O	PUNCT	O
its	O	PRON	O
flexibility	O	NOUN	B
in	O	ADP	O
solution	O	NOUN	B
may	O	AUX	O
reduce	O	VERB	B
the	O	DET	O
intrinsic	O	ADJ	B
DNA	O	NOUN	O
affinity	O	NOUN	O
of	O	ADP	O
POUHD	B-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
POUs	B-protein	NOUN	B
.	O	PUNCT	O


HIV-1	O	NOUN	B
expression	O	NOUN	B
was	O	AUX	O
activated	O	VERB	B
from	O	ADP	O
J	B-cell_line	NOUN	B
delta	I-cell_line	NOUN	I
K	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
by	O	ADP	O
treatment	O	NOUN	B
with	O	ADP	O
phorbol	O	NOUN	B
myristate	O	NOUN	I
acetate	O	NOUN	I
(	O	PUNCT	O
PMA	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
sodium	O	NOUN	B
butyrate	O	NOUN	I
(	O	PUNCT	O
NaB	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
or	O	CCONJ	O
hexamethylene	O	NOUN	B
bisacetamide	O	NOUN	I
(	O	PUNCT	O
HMBA	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor	I-protein	NOUN	I
alpha	I-protein	NOUN	I
(	O	PUNCT	O
TNF-alpha	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
confirming	O	VERB	O
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
in	O	ADP	O
mediating	O	VERB	O
TNF-alpha	B-protein	NOUN	B
induction	O	NOUN	B
of	O	ADP	O
HIV	O	NOUN	B
transcription	O	NOUN	B
.	O	PUNCT	O


JNK	B-protein	NOUN	B
is	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
signal	O	NOUN	B
integration	O	NOUN	B
during	O	ADP	O
costimulation	O	NOUN	B
of	O	ADP	O
T	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
.	O	PUNCT	O


Full	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
MAP	B-protein	NOUN	B
kinases	I-protein	NOUN	I
that	O	PRON	O
phosphorylate	O	VERB	B
the	O	DET	O
Jun	B-protein	NOUN	B
activation	I-protein	NOUN	I
domain	I-protein	NOUN	I
,	O	PUNCT	O
JNK1	B-protein	NOUN	B
and	O	CCONJ	O
JNK2	B-protein	NOUN	B
,	O	PUNCT	O
required	O	VERB	O
costimulation	O	NOUN	B
of	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
with	O	ADP	O
either	O	CCONJ	O
TPA	O	NOUN	B
and	O	CCONJ	O
Ca2+	O	NOUN	B
ionophore	O	NOUN	I
or	O	CCONJ	O
antibodies	O	NOUN	B
to	O	PART	O
TCR	B-protein	NOUN	B
and	O	CCONJ	O
CD28	B-protein	NOUN	B
.	O	PUNCT	O


By	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
MAP	B-protein	NOUN	B
kinases	I-protein	NOUN	I
ERK1	B-protein	NOUN	B
and	O	CCONJ	O
ERK2	B-protein	NOUN	B
were	O	AUX	O
fully	O	ADV	O
activated	O	VERB	B
by	O	ADP	O
TPA	O	NOUN	B
or	O	CCONJ	O
TCR	B-protein	NOUN	B
stimulation	O	NOUN	B
and	O	CCONJ	O
were	O	AUX	O
not	O	PART	O
affected	O	VERB	O
by	O	ADP	O
Ca2+	O	NOUN	B
,	O	PUNCT	O
CD28	O	NOUN	B
,	O	PUNCT	O
or	O	CCONJ	O
CsA	O	NOUN	B
.	O	PUNCT	O


In	O	X	B
vivo	O	X	I
studies	O	NOUN	B
in	O	ADP	O
rats	O	NOUN	B
utilized	O	VERB	O
2	O	NUM	O
mg/kg	O	NOUN	O
IV	O	NUM	O
bolus	O	NOUN	B
doses	O	NOUN	I
of	O	ADP	O
liposomal	O	ADJ	B
MPL	O	NOUN	B
compared	O	VERB	O
to	O	PART	O
drug	O	NOUN	B
in	O	ADP	O
solution	O	NOUN	B
.	O	PUNCT	O


Ii	B-DNA	NOUN	B
kappa	I-DNA	NOUN	I
B-2	I-DNA	NOUN	I
is	O	AUX	O
a	O	DET	O
site	O	NOUN	B
of	O	ADP	O
positive	O	ADJ	B
regulation	O	NOUN	O
in	O	ADP	O
B-cell	B-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
and	O	CCONJ	O
a	O	DET	O
site	O	NOUN	B
of	O	ADP	O
negative	O	ADJ	B
regulation	O	NOUN	O
in	O	ADP	O
H9	B-cell_line	NOUN	B
T	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
myelomonocytic	B-cell_line	ADJ	B
,	I-cell_line	PUNCT	O
and	I-cell_line	CCONJ	O
glial	I-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
.	O	PUNCT	O


Demonstration	O	NOUN	B
of	O	ADP	O
replicative	O	ADJ	B
gene	O	NOUN	B
expression	O	NOUN	I
did	O	AUX	O
not	O	PART	O
correlate	O	VERB	B
with	O	ADP	O
either	O	CCONJ	O
low	O	ADJ	B
CD4+	B-protein	ADJ	B
cell	O	NOUN	I
counts	O	NOUN	I
(	O	PUNCT	O
P	O	NOUN	O
>	O	X	O
0.05	O	NUM	O
)	O	PUNCT	O
or	O	CCONJ	O
anti-EBV	O	ADJ	B
antibody	O	NOUN	I
titres	O	NOUN	B
(	O	PUNCT	O
P	O	NOUN	O
>	O	X	O
0.05	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


CONCLUSION	O	NOUN	B
:	O	PUNCT	O
The	O	DET	O
degree	O	NOUN	B
of	O	ADP	O
immunodeficiency	O	NOUN	B
does	O	AUX	O
not	O	PART	O
clearly	O	ADV	O
enhance	O	VERB	O
replicative	O	ADJ	B
gene	O	NOUN	B
expression	O	NOUN	I
in	O	ADP	O
tumour	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
of	O	ADP	O
ARNHL	O	NOUN	B
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	O
suggest	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
target	O	NOUN	B
of	O	ADP	O
PGE2	B-protein	NOUN	B
action	O	NOUN	B
is	O	AUX	O
a	O	DET	O
component	O	NOUN	B
in	O	ADP	O
the	O	DET	O
signal	O	NOUN	B
transduction	O	NOUN	I
pathway	O	NOUN	O
leading	O	VERB	O
to	O	PART	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
C	I-protein	NOUN	I
.	O	PUNCT	O


NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
(	O	PUNCT	O
P65	B-protein	NOUN	B
or	O	CCONJ	O
P65/P50	B-protein	NOUN	B
heterodimer	I-protein	NOUN	I
)	O	PUNCT	O
bound	O	VERB	O
to	O	PART	O
the	O	DET	O
P	B-DNA	NOUN	O
sequence	I-DNA	NOUN	B
in	O	ADP	O
electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assays	O	NOUN	I
(	O	PUNCT	O
EMSA	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
activated	O	VERB	B
transcription	O	NOUN	I
through	O	ADP	O
the	O	DET	O
P	B-DNA	NOUN	O
sequence	I-DNA	NOUN	B
when	O	SCONJ	O
expression	B-DNA	NOUN	B
plasmids	I-DNA	NOUN	I
were	O	AUX	O
cotransfected	O	VERB	B
with	O	ADP	O
P	B-DNA	NOUN	O
sequence-driven	I-DNA	ADJ	B
reporter	I-DNA	NOUN	I
plasmids	I-DNA	NOUN	O
in	O	ADP	O
Jurkat	B-cell_line	NOUN	B
T	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Cell	O	NOUN	B
adhesion	O	NOUN	I
to	O	PART	O
endothelial	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
stimulated	B-protein	VERB	B
by	I-protein	ADP	O
tumor	I-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor-alpha	I-protein	NOUN	I
(	O	PUNCT	I
TNF	B-protein	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
due	O	ADJ	O
to	O	PART	O
induction	O	NOUN	B
of	O	ADP	O
surface	B-protein	NOUN	B
receptors	I-protein	NOUN	I
,	O	PUNCT	O
such	O	ADJ	O
as	O	ADP	O
vascular	B-protein	ADJ	B
cell	I-protein	NOUN	I
adhesion	I-protein	NOUN	I
molecule-1	I-protein	NOUN	I
(	O	PUNCT	O
VCAM-1	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Since	O	SCONJ	O
kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
motifs	I-DNA	NOUN	B
are	O	AUX	O
present	O	ADJ	O
in	O	ADP	O
VCAM-1	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
intercellular	I-DNA	ADJ	B
adhesion	I-DNA	NOUN	I
molecule-1	I-DNA	NOUN	I
(	I-DNA	PUNCT	O
ICAM-1	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
promoters	I-DNA	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
used	O	VERB	O
PDTC	O	NOUN	B
to	O	PART	O
study	O	VERB	B
the	O	DET	O
regulatory	O	ADJ	B
mechanisms	O	NOUN	I
of	O	ADP	O
VCAM-1	B-protein	NOUN	B
and	O	CCONJ	O
ICAM-1	B-protein	NOUN	B
induction	O	NOUN	B
and	O	CCONJ	O
subsequent	O	ADJ	O
monocyte	B-cell_type	NOUN	B
adhesion	O	NOUN	I
in	O	ADP	O
TNF-treated	B-cell_line	ADJ	B
human	I-cell_line	ADJ	B
umbilical	I-cell_line	ADJ	O
vein	I-cell_line	NOUN	O
endothelial	I-cell_line	ADJ	O
cells	I-cell_line	NOUN	O
(	O	PUNCT	O
HUVECs	B-cell_line	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Although	O	SCONJ	O
ICAM-1	B-protein	NOUN	B
induction	O	NOUN	B
was	O	AUX	O
unaffected	O	ADJ	O
,	O	PUNCT	O
inhibitors	O	NOUN	B
of	O	ADP	O
NADPH	B-protein	NOUN	B
oxidase	I-protein	NOUN	I
(	O	PUNCT	O
apocynin	O	NOUN	B
)	O	PUNCT	O
or	O	CCONJ	O
cytochrome	B-protein	NOUN	B
P-450	I-protein	NOUN	I
(	O	PUNCT	O
SKF525a	O	NOUN	B
)	O	PUNCT	O
suppressed	O	VERB	B
VCAM-1	B-protein	NOUN	B
induction	O	NOUN	B
by	O	ADP	O
TNF	O	NOUN	B
,	O	PUNCT	O
revealing	O	VERB	O
that	O	SCONJ	O
several	O	ADJ	O
radical-generating	O	ADJ	B
systems	O	NOUN	I
are	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
its	O	PRON	O
regulation	O	NOUN	B
.	O	PUNCT	O


Displacement	O	NOUN	B
of	O	ADP	O
an	O	DET	O
E-box-binding	B-protein	ADJ	B
repressor	I-protein	NOUN	I
by	O	ADP	O
basic	B-protein	ADJ	O
helix-loop-helix	I-protein	ADJ	B
proteins	I-protein	NOUN	I
:	O	PUNCT	O
implications	O	NOUN	O
for	O	ADP	O
B-cell	O	NOUN	B
specificity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
immunoglobulin	B-DNA	NOUN	B
heavy-chain	I-DNA	ADJ	I
enhancer	I-DNA	NOUN	I
.	O	PUNCT	O


This	O	DET	O
inhibition	O	NOUN	B
prevented	O	VERB	B
the	O	DET	O
degradation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
inhibitor	I-protein	NOUN	I
,	O	PUNCT	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
therefore	O	ADV	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
was	O	AUX	O
retained	O	VERB	O
in	O	ADP	O
the	O	DET	O
cytosol	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
order	O	NOUN	O
to	O	PART	O
elucidate	O	VERB	O
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
c-myb	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
in	O	ADP	O
erythroid	O	ADJ	B
differentiation	O	NOUN	I
of	O	ADP	O
K562	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
induced	O	VERB	B
by	O	ADP	O
hemin	B-protein	NOUN	B
(	O	PUNCT	O
Hm	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
erythropoietin	B-protein	NOUN	B
(	O	PUNCT	O
Epo	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
we	O	PRON	O
constructed	O	VERB	O
recombinant	B-DNA	ADJ	B
plasmid	I-DNA	NOUN	I
that	O	PRON	O
could	O	AUX	O
produce	O	VERB	O
antisense	B-RNA	ADJ	B
myb	I-RNA	NOUN	I
RNA	I-RNA	NOUN	I
after	O	ADP	O
induction	O	NOUN	B
with	O	ADP	O
dexamethasone	O	NOUN	B
.	O	PUNCT	O


Fos	B-protein	NOUN	B
kinase	I-protein	NOUN	I
may	O	AUX	O
play	O	VERB	O
a	O	DET	O
role	O	NOUN	O
in	O	ADP	O
transcriptional	O	ADJ	B
regulation	O	NOUN	I
through	O	ADP	O
its	O	PRON	O
capacity	O	NOUN	B
to	O	PART	O
phosphorylate	O	VERB	B
c-Fos	B-protein	NOUN	B
at	O	ADP	O
a	O	DET	O
site	O	NOUN	B
required	O	VERB	O
for	O	ADP	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
transcriptional	O	ADJ	B
transrepressive	O	ADJ	O
activity	O	NOUN	O
of	O	ADP	O
this	O	DET	O
molecule	O	NOUN	B
.	O	PUNCT	O


Moreover	O	ADV	O
,	O	PUNCT	O
its	O	PRON	O
rapid	O	ADJ	O
activation	O	NOUN	B
suggests	O	VERB	O
it	O	PRON	O
may	O	AUX	O
have	O	AUX	O
a	O	DET	O
wider	O	ADJ	O
role	O	NOUN	O
within	O	ADP	O
signal	O	NOUN	B
transduction	O	NOUN	I
cascades	O	NOUN	O
in	O	ADP	O
lymphocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
investigated	O	VERB	B
the	O	DET	O
antigenic	O	ADJ	B
specificity	O	NOUN	O
of	O	ADP	O
47	O	NUM	O
HSV-specific	B-cell_line	ADJ	B
CD4+	I-cell_line	ADJ	B
T-cell	I-cell_line	NOUN	I
clones	I-cell_line	NOUN	O
recovered	O	VERB	O
from	O	ADP	O
the	O	DET	O
HSV-2	O	NOUN	B
buttock	O	NOUN	I
and	O	CCONJ	O
thigh	O	NOUN	B
lesions	O	NOUN	I
of	O	ADP	O
five	O	NUM	O
patients	O	NOUN	B
.	O	PUNCT	O


Clones	O	NOUN	B
with	O	ADP	O
proliferative	O	ADJ	B
responses	O	NOUN	I
to	O	PART	O
recombinant	B-protein	ADJ	B
truncated	I-protein	VERB	I
glycoprotein	I-protein	NOUN	I
B	I-protein	NOUN	I
(	O	PUNCT	O
gB	B-protein	NOUN	B
)	O	PUNCT	O
or	O	CCONJ	O
gD	B-protein	NOUN	B
of	O	ADP	O
HSV-2	O	NOUN	B
or	O	CCONJ	O
purified	O	VERB	B
natural	O	ADJ	B
gC	O	NOUN	B
of	O	ADP	O
HSV-2	O	NOUN	B
comprised	O	VERB	O
a	O	DET	O
minority	O	NOUN	B
of	O	ADP	O
the	O	DET	O
total	O	ADJ	O
number	O	NOUN	O
of	O	ADP	O
HSV-specific	B-cell_line	ADJ	B
clones	I-cell_line	NOUN	I
isolated	O	VERB	B
from	O	ADP	O
lesions	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
gC2-	B-cell_line	NOUN	B
and	I-cell_line	CCONJ	O
gD2-specific	I-cell_line	ADJ	B
CD4+	I-cell_line	ADJ	B
clones	I-cell_line	NOUN	I
had	O	AUX	O
cytotoxic	O	ADJ	B
activity	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
antigenic	O	ADJ	B
specificity	O	NOUN	B
of	O	ADP	O
an	O	DET	O
HLA	B-cell_line	NOUN	B
DQ2-restricted	I-cell_line	ADJ	I
,	I-cell_line	PUNCT	O
HSV-2	I-cell_line	NOUN	B
type-specific	I-cell_line	ADJ	O
T-cell	I-cell_line	NOUN	O
clone	I-cell_line	NOUN	O
was	O	AUX	O
mapped	O	VERB	O
to	O	PART	O
amino	B-protein	NOUN	B
acids	I-protein	NOUN	I
425	I-protein	NUM	O
to	I-protein	PART	O
444	I-protein	NUM	O
of	O	ADP	O
VP16	B-protein	NOUN	B
of	O	ADP	O
HSV-2	O	NOUN	B
by	O	ADP	O
sequential	O	ADJ	B
use	O	NOUN	O
of	O	ADP	O
an	O	DET	O
intertypic	O	ADJ	B
recombinant	O	ADJ	I
virus	O	NOUN	I
containing	O	VERB	O
VP16	B-protein	NOUN	B
of	O	ADP	O
HSV-2	O	NOUN	B
in	O	ADP	O
an	O	DET	O
HSV-1	O	NOUN	B
background	O	NOUN	B
,	O	PUNCT	O
recombinant	B-protein	ADJ	B
VP16	I-protein	NOUN	O
fusion	I-protein	NOUN	B
proteins	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
synthetic	O	ADJ	B
peptides	O	NOUN	I
.	O	PUNCT	O


Each	O	DET	O
of	O	ADP	O
the	O	DET	O
remaining	O	VERB	O
four	O	NUM	O
patients	O	NOUN	B
also	O	ADV	O
yielded	O	VERB	O
at	O	ADP	O
least	O	ADJ	O
one	O	NUM	O
type-specific	B-cell_line	ADJ	B
T-cell	I-cell_line	NOUN	I
clone	I-cell_line	NOUN	I
reactive	O	ADJ	B
with	O	ADP	O
an	O	DET	O
HSV-2	O	NOUN	B
epitope	O	NOUN	B
mapping	O	VERB	I
to	O	PART	O
approximately	O	ADV	O
0.67	O	NUM	O
to	O	PART	O
0.73	O	NUM	O
map	O	NOUN	B
units	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
antigenic	O	ADJ	B
specificities	O	NOUN	B
of	O	ADP	O
lesion-derived	B-cell_line	ADJ	B
CD4+	I-cell_line	ADJ	B
T-cell	I-cell_line	NOUN	I
clones	I-cell_line	NOUN	O
are	O	AUX	O
quite	O	ADV	O
diverse	O	ADJ	B
and	O	CCONJ	O
include	O	VERB	O
at	O	ADP	O
least	O	ADJ	O
10	O	NUM	O
epitopes	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
host	O	NOUN	B
response	O	NOUN	I
to	O	PART	O
Mycobacterium	O	X	B
tuberculosis	O	NOUN	I
includes	O	VERB	O
granuloma	O	NOUN	B
formation	O	NOUN	I
at	O	ADP	O
sites	O	NOUN	B
of	O	ADP	O
infection	O	NOUN	B
and	O	CCONJ	O
systemic	O	ADJ	B
symptoms	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
conclude	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
NF-IL6	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
NF-kappa	I-DNA	NOUN	B
B	I-DNA	NOUN	I
sites	I-DNA	NOUN	I
mediate	O	VERB	O
IL-6	B-protein	NOUN	B
induction	O	NOUN	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
both	O	CCONJ	O
LPS	O	NOUN	B
and	O	CCONJ	O
LAM	B-protein	NOUN	B
,	O	PUNCT	O
acting	O	VERB	O
as	O	ADP	O
bacterial	B-DNA	ADJ	B
or	I-DNA	CCONJ	O
mycobacterial	I-DNA	ADJ	B
response	I-DNA	NOUN	B
elements	I-DNA	NOUN	I
.	O	PUNCT	O


CD14	B-protein	NOUN	B
,	O	PUNCT	O
a	O	DET	O
monocyte/macrophage	B-protein	NOUN	B
receptor	I-protein	NOUN	I
for	O	ADP	O
the	O	DET	O
complex	O	NOUN	B
of	O	ADP	O
LPS	O	NOUN	B
and	O	CCONJ	O
LPS	B-protein	NOUN	B
binding	I-protein	NOUN	O
protein	I-protein	NOUN	O
,	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
differentiation	O	NOUN	B
marker	O	NOUN	B
for	O	ADP	O
the	O	DET	O
monocyte/macrophage	B-cell_type	NOUN	B
lineage	I-cell_type	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
recently	O	ADV	O
cloned	O	VERB	B
the	O	DET	O
CD14	B-DNA	NOUN	B
5	I-DNA	NUM	I
'	I-DNA	PART	O
upstream	I-DNA	ADJ	B
sequence	I-DNA	NOUN	I
and	O	CCONJ	O
demonstrated	O	VERB	O
its	O	PRON	O
tissue-specific	B-DNA	ADJ	B
promoter	I-DNA	NOUN	O
activity	O	NOUN	O
.	O	PUNCT	O


All	O	DET	O
were	O	AUX	O
found	O	VERB	O
to	O	PART	O
selectively	O	ADV	O
bind	O	VERB	B
the	O	DET	O
consensus	B-DNA	NOUN	B
sequence	I-DNA	NOUN	I
5'-GTTACGTAAT-3	O	NOUN	O
'	O	PUNCT	O
with	O	ADP	O
high	O	ADJ	O
affinity	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
findings	O	NOUN	B
establish	O	VERB	O
a	O	DET	O
spectrum	O	NOUN	B
of	O	ADP	O
binding	O	VERB	B
site-specific	O	ADJ	O
transcriptional	O	ADJ	O
properties	O	NOUN	O
for	O	ADP	O
E2A-HLF	B-protein	NOUN	B
which	O	DET	O
may	O	AUX	O
preferentially	O	ADV	O
activate	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
select	O	ADJ	O
subordinate	O	ADJ	B
genes	O	NOUN	I
as	O	ADP	O
a	O	DET	O
homodimer	O	NOUN	B
and	O	CCONJ	O
potentially	O	ADV	O
antagonize	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
others	O	NOUN	O
through	O	ADP	O
heteromeric	O	ADJ	B
interactions	O	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
all	O	DET	O
these	O	DET	O
cell	O	NOUN	B
types	O	NOUN	I
still	O	ADV	O
gave	O	VERB	O
strong	O	ADJ	O
Ca2+	O	NOUN	B
and	O	CCONJ	O
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	I
responses	O	NOUN	B
to	O	PART	O
H2O2	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
investigated	O	VERB	B
the	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
redox	O	NOUN	B
changes	O	NOUN	O
in	O	X	B
vivo	O	X	I
on	O	ADP	O
the	O	DET	O
differentiation	O	NOUN	B
of	O	ADP	O
two	O	NUM	O
human	B-cell_line	ADJ	B
myeloid	I-cell_line	ADJ	O
cell	I-cell_line	NOUN	O
lines	I-cell_line	NOUN	O
,	O	PUNCT	O
HL-60	B-cell_line	NOUN	B
and	O	CCONJ	O
KG-1	B-cell_line	NOUN	B
.	O	PUNCT	O


In	O	X	B
vitro	O	X	I
binding	O	NOUN	B
studies	O	NOUN	I
demonstrated	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
TF	B-DNA	NOUN	B
site	I-DNA	NOUN	I
bound	O	VERB	O
translated	O	VERB	O
c-Rel	B-protein	NOUN	B
and	I-protein	CCONJ	O
p65	I-protein	NOUN	B
homodimers	I-protein	NOUN	I
but	O	CCONJ	O
not	O	PART	O
p50/p65	B-protein	NOUN	B
heterodimers	I-protein	NOUN	I
or	O	CCONJ	O
p50	B-protein	NOUN	B
homodimers	I-protein	NOUN	I
.	O	PUNCT	O


TN	B-protein	NOUN	B
also	O	ADV	O
inhibits	O	VERB	B
proliferation	O	NOUN	B
driven	O	VERB	O
by	O	ADP	O
alpha	B-protein	NOUN	B
CD3/IL-2	I-protein	NOUN	B
or	O	CCONJ	O
by	O	ADP	O
phorbol	B-protein	NOUN	B
ester/IL-2	I-protein	NOUN	I
,	I-protein	PUNCT	O
and	O	CCONJ	O
it	O	PRON	O
prevents	O	VERB	B
high	O	ADJ	O
level	O	NOUN	B
induction	O	NOUN	B
of	O	ADP	O
IL-2R	B-protein	NOUN	B
.	O	PUNCT	O


To	O	PART	O
define	O	VERB	O
the	O	DET	O
mechanism	O	NOUN	B
of	O	ADP	O
action	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Nef	B-protein	NOUN	B
protein	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
signal	O	NOUN	B
transduction	O	NOUN	I
pathways	O	NOUN	I
which	O	DET	O
may	O	AUX	O
be	O	AUX	O
affected	O	VERB	B
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
by	O	ADP	O
constitutive	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
nef	O	NOUN	B
gene	O	NOUN	I
were	O	AUX	O
examined	O	VERB	O
.	O	PUNCT	O


Further	O	ADJ	O
characterization	O	NOUN	B
of	O	ADP	O
gelatinase	O	NOUN	B
granules	O	NOUN	I
has	O	AUX	O
been	O	AUX	O
hampered	O	VERB	O
by	O	ADP	O
poor	O	ADJ	B
separation	O	NOUN	I
of	O	ADP	O
specific	O	ADJ	B
and	O	CCONJ	O
gelatinase	O	NOUN	B
granules	O	NOUN	I
on	O	ADP	O
both	O	CCONJ	O
two-layer	O	ADJ	B
Percoll	O	NOUN	B
gradients	O	NOUN	I
and	O	CCONJ	O
sucrose	O	NOUN	B
gradients	O	NOUN	I
.	O	PUNCT	O


Treatment	O	NOUN	B
of	O	ADP	O
human	O	ADJ	B
resting	B-cell_type	VERB	O
T	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
with	O	ADP	O
phorbol	O	NOUN	B
esters	O	NOUN	I
strongly	O	ADV	O
induced	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
IL-2R	B-protein	NOUN	B
alpha	I-protein	NOUN	I
and	O	CCONJ	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
NF.kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
.	O	PUNCT	O


Interestingly	O	ADV	O
,	O	PUNCT	O
all	O	DET	O
of	O	ADP	O
those	O	DET	O
events	O	NOUN	B
were	O	AUX	O
largely	O	ADV	O
indirect	O	ADJ	B
and	O	CCONJ	O
mediated	O	VERB	O
by	O	ADP	O
endogenously	O	ADV	B
secreted	O	VERB	B
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor	I-protein	NOUN	I
alpha	I-protein	NOUN	I
(	O	PUNCT	O
TNF	B-protein	NOUN	B
alpha	I-protein	NOUN	I
)	O	PUNCT	O
,	O	PUNCT	O
as	O	ADP	O
they	O	PRON	O
were	O	AUX	O
strongly	O	ADV	O
inhibited	O	VERB	B
by	O	ADP	O
a	O	DET	O
neutralizing	B-protein	VERB	O
anti-TNF	I-protein	ADJ	O
alpha	I-protein	NOUN	O
monoclonal	I-protein	ADJ	B
antibody	I-protein	NOUN	I
.	O	PUNCT	O


Induction	O	NOUN	B
of	O	ADP	O
HIV-1-	O	ADJ	B
LTR	B-DNA	NOUN	B
-driven	O	ADJ	O
transcription	O	NOUN	B
in	O	ADP	O
THP-1	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
by	O	ADP	O
superantigens	B-protein	NOUN	B
was	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
nuclear	B-protein	ADJ	B
factor-kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
DNA-binding	O	ADJ	B
activity	O	NOUN	O
.	O	PUNCT	O


A	O	DET	O
large	O	ADJ	O
body	O	NOUN	O
of	O	ADP	O
evidence	O	NOUN	B
indicates	O	VERB	O
that	O	SCONJ	O
experimental	O	ADJ	B
agents	O	NOUN	I
which	O	DET	O
raise	O	VERB	O
cellular	O	ADJ	B
cAMP	O	NOUN	O
levels	O	NOUN	O
inhibit	O	VERB	B
T	O	NOUN	B
cell	O	NOUN	I
growth	O	NOUN	O
and	O	CCONJ	O
division	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
present	O	ADJ	O
study	O	NOUN	B
we	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
mitogen	B-protein	NOUN	B
activation	O	NOUN	B
of	O	ADP	O
human	B-cell_type	ADJ	B
peripheral	I-cell_type	ADJ	O
T	I-cell_type	NOUN	O
lymphocytes	I-cell_type	NOUN	O
induces	O	VERB	O
nuclear	O	ADJ	B
factors	O	NOUN	I
that	O	PRON	O
form	O	VERB	O
complexes	O	NOUN	B
with	O	ADP	O
cyclic	B-protein	ADJ	B
AMP	I-protein	NOUN	I
response	I-protein	NOUN	I
element-binding	I-protein	ADJ	O
protein	I-protein	NOUN	O
(	O	PUNCT	O
CREB	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Human	O	ADJ	B
umbilical	O	ADJ	I
vein	O	NOUN	I
ECs	B-cell_type	NOUN	B
were	O	AUX	O
pretreated	O	VERB	B
with	O	ADP	O
alpha-tcp	O	NOUN	B
before	O	ADP	O
stimulation	O	NOUN	B
with	O	ADP	O
known	O	ADJ	O
agonists	O	NOUN	B
of	O	ADP	O
monocyte	O	NOUN	B
adhesion	O	NOUN	I
:	O	PUNCT	O
IL-1	B-protein	NOUN	B
(	O	PUNCT	O
10	O	NUM	O
ng/ml	O	NOUN	O
)	O	PUNCT	O
,	O	PUNCT	O
LPS	O	NOUN	B
(	O	PUNCT	O
10	O	NUM	O
ng/ml	O	NOUN	O
)	O	PUNCT	O
,	O	PUNCT	O
thrombin	B-protein	NOUN	B
(	O	PUNCT	O
30	O	NUM	O
U/ml	O	NOUN	O
)	O	PUNCT	O
,	O	PUNCT	O
or	O	CCONJ	O
PMA	O	NOUN	B
(	O	PUNCT	O
10	O	NUM	O
nM	O	NOUN	O
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
IC50	O	NOUN	B
of	O	ADP	O
alpha-tcp	O	NOUN	B
on	O	ADP	O
an	O	DET	O
IL-1	B-protein	NOUN	B
-induced	O	ADJ	O
response	O	NOUN	B
was	O	AUX	O
45	O	NUM	O
microM	O	NOUN	B
.	O	PUNCT	O


Tat	B-protein	NOUN	B
transactivation	O	NOUN	B
mediated	O	VERB	O
by	O	ADP	O
the	O	DET	O
kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
domain	I-DNA	NOUN	I
is	O	AUX	O
sufficient	O	ADJ	O
to	O	PART	O
allow	O	VERB	O
replication	O	NOUN	B
of	O	ADP	O
TAR	B-DNA	NOUN	B
-deleted	O	ADJ	O
mutant	O	ADJ	B
HIV-1	O	NOUN	B
in	O	ADP	O
astrocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


Hence	O	ADV	O
,	O	PUNCT	O
PPAR	B-protein	NOUN	B
can	O	AUX	O
positively	O	ADV	B
or	O	CCONJ	O
negatively	O	ADV	B
influence	O	VERB	B
TH	O	NOUN	B
action	O	NOUN	B
depending	O	VERB	O
on	O	ADP	O
TRE	B-DNA	NOUN	B
structure	O	NOUN	O
and	O	CCONJ	O
THR	B-protein	NOUN	B
isotype	I-protein	NOUN	B
.	O	PUNCT	O


To	O	PART	O
test	O	VERB	O
this	O	DET	O
hypothesis	O	NOUN	B
,	O	PUNCT	O
light-chain	B-DNA	ADJ	B
gene	I-DNA	NOUN	I
structure	I-DNA	NOUN	O
was	O	AUX	O
examined	O	VERB	O
in	O	ADP	O
pre-B	B-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
transformed	O	VERB	O
by	O	ADP	O
temperature-sensitive	O	ADJ	B
mutants	O	NOUN	I
of	O	ADP	O
the	O	DET	O
Abelson	O	NOUN	B
virus	O	NOUN	I
and	O	CCONJ	O
in	O	ADP	O
derivatives	O	NOUN	O
that	O	PRON	O
survive	O	VERB	B
at	O	ADP	O
the	O	DET	O
nonpermissive	O	ADJ	B
temperature	O	NOUN	B
because	O	SCONJ	O
they	O	PRON	O
express	O	VERB	B
a	O	DET	O
human	B-DNA	ADJ	B
BCL-2	I-DNA	NOUN	B
gene	I-DNA	NOUN	I
.	O	PUNCT	O


To	O	PART	O
identify	O	VERB	O
potential	O	ADJ	O
cellular	O	ADJ	B
homologues	O	NOUN	I
of	O	ADP	O
cyclosporin	O	NOUN	B
A	O	NOUN	I
that	O	PRON	O
might	O	AUX	O
regulate	O	VERB	B
calcium	O	NOUN	B
signalling	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
cloned	O	VERB	B
human	O	ADJ	B
genes	O	NOUN	I
encoding	O	VERB	O
cyclophilin	B-protein	NOUN	B
B-binding-proteins	I-protein	NOUN	I
using	O	VERB	O
the	O	DET	O
yeast	O	NOUN	B
two-hybrid	O	ADJ	O
system	O	NOUN	O
.	O	PUNCT	O


CAML	B-protein	NOUN	B
appears	O	VERB	O
to	O	PART	O
be	O	AUX	O
a	O	DET	O
new	O	ADJ	O
participant	O	NOUN	B
in	O	ADP	O
the	O	DET	O
calcium-signal	O	ADJ	B
transduction	O	NOUN	O
pathway	O	NOUN	O
,	O	PUNCT	O
implicating	O	VERB	O
cyclophilin	B-protein	NOUN	B
B	I-protein	NOUN	I
in	O	ADP	O
calcium	O	NOUN	B
signalling	O	NOUN	I
,	O	PUNCT	O
even	O	ADV	O
in	O	ADP	O
the	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
cyclosporin	O	NOUN	B
.	O	PUNCT	O


Eleven	O	NOUN	O
of	O	ADP	O
the	O	DET	O
17	O	NUM	O
patients	O	NOUN	B
had	O	AUX	O
abnormal	O	ADJ	B
karyotypes	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
M-CSF	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
was	O	AUX	O
expressed	O	VERB	B
in	O	ADP	O
6	O	NUM	O
cases	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
FMS	B-DNA	NOUN	B
and	O	CCONJ	O
the	O	DET	O
EGR-1	B-DNA	NOUN	B
genes	I-DNA	NOUN	B
were	O	AUX	O
expressed	O	VERB	B
in	O	ADP	O
2	O	NUM	O
of	O	ADP	O
the	O	DET	O
latter	O	ADJ	O
cases	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
novel	O	ADJ	O
human	B-DNA	ADJ	B
homeobox	I-DNA	NOUN	O
gene	I-DNA	NOUN	O
,	O	PUNCT	O
HB9	B-DNA	NOUN	B
,	O	PUNCT	O
was	O	AUX	O
isolated	O	VERB	B
from	O	ADP	O
a	O	DET	O
cDNA	B-DNA	NOUN	B
library	I-DNA	NOUN	I
prepared	O	VERB	O
from	O	ADP	O
in	O	X	B
vitro	B-cell_type	X	I
stimulated	I-cell_type	VERB	B
human	I-cell_type	ADJ	B
tonsil	I-cell_type	NOUN	O
B	I-cell_type	NOUN	O
lymphocytes	I-cell_type	NOUN	O
and	O	CCONJ	O
from	O	ADP	O
a	O	DET	O
human	B-DNA	ADJ	B
genomic	I-DNA	ADJ	B
library	I-DNA	NOUN	I
.	O	PUNCT	O


Transient	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
HIV-1	B-protein	NOUN	B
Tat	I-protein	NOUN	B
induced	O	VERB	B
a	O	DET	O
five-	O	NUM	O
to	O	PART	O
eightfold	O	ADJ	O
increase	O	NOUN	B
in	O	ADP	O
IL-2	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
activity	O	NOUN	I
in	O	ADP	O
Jurkat	B-cell_line	NOUN	B
T	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
stimulated	O	VERB	B
with	O	ADP	O
phytohemagglutinin	B-protein	NOUN	B
and	O	CCONJ	O
phorbol	O	NOUN	B
myristate	O	NOUN	B
acetate	O	NOUN	I
.	O	PUNCT	O


Alternative	O	ADJ	B
splicing	O	NOUN	I
of	O	ADP	O
RNA	B-RNA	NOUN	B
transcripts	I-RNA	NOUN	I
encoded	O	VERB	B
by	O	ADP	O
the	O	DET	O
murine	B-DNA	NOUN	B
p105	I-DNA	NOUN	B
NF-kappa	I-DNA	NOUN	I
B	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
generates	O	VERB	O
I	B-protein	NOUN	O
kappa	I-protein	NOUN	O
B	I-protein	NOUN	O
gamma	I-protein	NOUN	O
isoforms	I-protein	NOUN	O
with	O	ADP	O
different	O	ADJ	O
inhibitory	O	ADJ	B
activities	O	NOUN	I
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
alternative	O	ADJ	O
RNA	O	NOUN	B
splicing	O	NOUN	I
generates	O	VERB	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
gamma	I-protein	NOUN	I
isoforms	I-protein	NOUN	I
with	O	ADP	O
properties	O	NOUN	B
different	O	ADJ	O
from	O	ADP	O
those	O	DET	O
of	O	ADP	O
p70	B-protein	NOUN	B
.	O	PUNCT	O


There	O	PRON	O
are	O	AUX	O
13	O	NUM	O
protein	O	NOUN	B
coding	O	NOUN	I
exons	B-DNA	NOUN	I
in	O	ADP	O
the	O	DET	O
LBR	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
CD38	B-protein	NOUN	B
expression	O	NOUN	B
was	O	AUX	O
not	O	PART	O
inducible	O	ADJ	B
by	O	ADP	O
ATRA	O	NOUN	B
in	O	ADP	O
HL-60R	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
transfected	O	VERB	B
with	O	ADP	O
a	O	DET	O
functional	O	ADJ	B
RAR	B-protein	NOUN	B
beta	I-protein	NOUN	I
,	O	PUNCT	O
RAR	B-protein	NOUN	B
gamma	I-protein	NOUN	I
,	O	PUNCT	O
or	O	CCONJ	O
RXR	B-protein	NOUN	B
alpha	I-protein	NOUN	I
receptor	I-protein	NOUN	I
.	O	PUNCT	O


Following	O	VERB	O
culture	O	NOUN	B
with	O	ADP	O
ATRA	O	NOUN	B
,	O	PUNCT	O
increased	O	VERB	B
CD38	B-protein	NOUN	B
protein	O	NOUN	I
levels	O	NOUN	O
were	O	AUX	O
also	O	ADV	O
observed	O	VERB	O
in	O	ADP	O
normal	B-cell_type	ADJ	O
CD34+	I-cell_type	ADJ	B
bone	I-cell_type	NOUN	I
marrow	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
on	O	ADP	O
normal	B-cell_type	ADJ	O
circulating	I-cell_type	VERB	O
granulocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


Some	O	DET	O
antioxidants	O	NOUN	B
,	O	PUNCT	O
including	O	VERB	O
butylated	O	VERB	B
hydroxyanisole	O	NOUN	I
(	O	PUNCT	O
BHA	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
tetrahydropapaveroline	O	NOUN	B
(	O	PUNCT	O
THP	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
nordihydroguiauretic	O	ADJ	B
acid	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
10	O	NUM	O
,	O	PUNCT	O
11-dihydroxyaporphine	O	NOUN	B
(	O	PUNCT	O
DHA	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
were	O	AUX	O
found	O	VERB	O
to	O	PART	O
be	O	AUX	O
potent	O	ADJ	O
inhibitors	O	NOUN	B
of	O	ADP	O
the	O	DET	O
production	O	NOUN	B
of	O	ADP	O
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor	I-protein	NOUN	I
(	I-protein	PUNCT	O
TNF	I-protein	NOUN	B
)	I-protein	PUNCT	O
-alpha	I-protein	NOUN	O
,	O	PUNCT	O
IL-1	B-protein	NOUN	B
beta	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
IL-6	B-protein	NOUN	B
by	O	ADP	O
human	B-cell_type	ADJ	B
peripheral	I-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
mononuclear	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
(	O	PUNCT	O
PBMC	B-cell_type	NOUN	B
)	O	PUNCT	O
stimulated	O	VERB	B
by	O	ADP	O
lipopolysaccharide	O	NOUN	B
(	O	PUNCT	O
LPS	O	NOUN	B
)	O	PUNCT	O
(	O	PUNCT	O
IC50s	O	NOUN	B
in	O	ADP	O
the	O	DET	O
low	O	ADJ	B
micromolar	O	ADJ	B
range	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Thus	O	ADV	O
antioxidants	O	NOUN	B
vary	O	VERB	O
widely	O	ADV	O
in	O	ADP	O
potency	O	NOUN	B
as	O	ADP	O
inhibitors	O	NOUN	B
of	O	ADP	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
and	O	CCONJ	O
of	O	ADP	O
the	O	DET	O
transcription	O	NOUN	B
of	O	ADP	O
genes	B-DNA	NOUN	B
for	O	ADP	O
pro-inflammatory	B-protein	ADJ	B
cytokines	I-protein	NOUN	B
.	O	PUNCT	O


Interleukin-4	B-protein	NOUN	B
(	O	PUNCT	O
IL-4	B-protein	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
an	O	DET	O
immunomodulatory	O	ADJ	B
cytokine	O	NOUN	O
secreted	O	VERB	B
by	O	ADP	O
activated	O	VERB	B
T	B-cell_type	NOUN	O
lymphocytes	I-cell_type	NOUN	O
,	O	PUNCT	O
basophils	B-cell_type	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
mast	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
CF	O	NOUN	B
individuals	O	NOUN	B
,	O	PUNCT	O
7	O	NUM	O
of	O	ADP	O
52	O	NUM	O
(	O	PUNCT	O
13	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
had	O	AUX	O
detectable	O	ADJ	B
E1a	B-DNA	NOUN	B
sequences	I-DNA	NOUN	I
in	O	ADP	O
the	O	DET	O
respiratory	O	ADJ	B
epithelium	O	NOUN	I
,	O	PUNCT	O
with	O	ADP	O
E1a	O	NOUN	B
copy	O	NOUN	B
number	O	NOUN	I
in	O	ADP	O
the	O	DET	O
positive	O	ADJ	B
samples	O	NOUN	B
of	O	ADP	O
80	O	NUM	O
+/-	O	CCONJ	O
21/10	O	NUM	O
(	O	PUNCT	O
3	O	NUM	O
)	O	PUNCT	O
recovered	O	ADJ	B
cells	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
52-year-old	O	ADJ	O
female	O	NOUN	B
presented	O	VERB	O
with	O	ADP	O
a	O	DET	O
progressively	O	ADV	O
enlarging	O	VERB	O
vulvar	O	ADJ	B
mass	O	NOUN	I
.	O	PUNCT	O


Immunohistochemical	O	ADJ	B
and	O	CCONJ	O
ultrastructural	O	ADJ	B
studies	O	NOUN	I
were	O	AUX	O
performed	O	VERB	O
to	O	PART	O
support	O	VERB	O
the	O	DET	O
diagnosis	O	NOUN	B
.	O	PUNCT	O


Macrophages	B-cell_type	NOUN	B
and	O	CCONJ	O
T	B-cell_type	NOUN	B
and	I-cell_type	CCONJ	O
B	I-cell_type	NOUN	O
lymphocytes	I-cell_type	NOUN	O
infiltrated	O	VERB	B
the	O	DET	O
tumor	O	NOUN	B
in	O	ADP	O
moderate	O	ADJ	B
numbers	O	NOUN	O
with	O	ADP	O
occasional	O	ADJ	O
lymphoid	O	ADJ	B
aggregate	O	NOUN	O
formation	O	NOUN	O
.	O	PUNCT	O


LIF	B-protein	NOUN	B
induced	O	VERB	B
a	O	DET	O
dose-dependent	O	ADJ	B
increase	O	NOUN	B
in	O	ADP	O
p24	B-protein	NOUN	B
antigen	I-protein	NOUN	I
production	O	NOUN	B
in	O	ADP	O
the	O	DET	O
chronically	B-cell_line	ADV	B
infected	I-cell_line	ADJ	B
promonocytic	I-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
U1	I-cell_line	NOUN	O
.	O	PUNCT	O


LIF	B-protein	NOUN	B
increased	O	VERB	B
steady-state	O	ADJ	B
levels	O	NOUN	O
of	O	ADP	O
HIV	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
at	O	ADP	O
2.0	O	NUM	O
,	O	PUNCT	O
4.3	O	NUM	O
,	O	PUNCT	O
and	O	CCONJ	O
9.2	O	NUM	O
kB	O	NOUN	O
.	O	PUNCT	O


Two	O	NUM	O
anti-MHC	B-protein	ADJ	B
class	I-protein	NOUN	I
II	I-protein	NUM	I
Ab	I-protein	NOUN	I
,	O	PUNCT	O
L227	B-protein	NOUN	B
and	O	CCONJ	O
2.06	B-protein	NUM	O
,	O	PUNCT	O
inhibited	O	VERB	B
the	O	DET	O
growth	O	NOUN	B
of	O	ADP	O
B104	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
although	O	SCONJ	O
2.06	B-protein	NUM	O
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
L227	B-protein	NOUN	B
,	O	PUNCT	O
needed	O	VERB	O
to	O	PART	O
be	O	AUX	O
further	O	ADV	O
cross-linked	O	VERB	B
with	O	ADP	O
a	O	DET	O
goat	B-protein	NOUN	B
anti-mouse	I-protein	ADJ	O
IgG	I-protein	NOUN	O
Ab	I-protein	NOUN	O
(	O	PUNCT	O
GAM	B-protein	NOUN	B
)	O	PUNCT	O
to	O	PART	O
show	O	VERB	O
the	O	DET	O
effect	O	NOUN	B
.	O	PUNCT	O


Although	O	SCONJ	O
resting	O	VERB	B
tonsillar	O	ADJ	I
B	O	NOUN	I
cells	O	NOUN	I
did	O	AUX	O
not	O	PART	O
express	O	VERB	O
VDR	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
,	O	PUNCT	O
activation	O	NOUN	B
of	O	ADP	O
these	O	DET	O
cells	O	NOUN	B
with	O	ADP	O
interleukin-4	B-protein	NOUN	B
induced	O	VERB	B
VDR	B-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
exogenously	O	ADV	B
supplemented	O	VERB	O
1	O	NUM	O
alpha	O	NOUN	B
,	O	PUNCT	O
25-	O	NUM	O
(	O	PUNCT	O
OH	O	NOUN	B
)	O	PUNCT	O
2D3	O	NOUN	B
.	O	PUNCT	O


1	O	NUM	O
alpha	O	NOUN	B
,	O	PUNCT	O
25-	O	NUM	O
(	O	PUNCT	O
OH	O	NOUN	B
)	O	PUNCT	O
2D3	O	NOUN	B
inhibited	O	VERB	B
CD23	B-protein	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
U937	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
yet	O	ADV	O
failed	O	VERB	B
to	O	PART	O
modulate	O	VERB	O
CD23	B-protein	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Positive	O	ADJ	B
and	O	CCONJ	O
negative	O	ADJ	B
regulation	O	NOUN	O
of	O	ADP	O
IL-2	B-protein	NOUN	B
gene	O	NOUN	I
expression	O	NOUN	B
:	O	PUNCT	O
role	O	NOUN	O
of	O	ADP	O
multiple	O	ADJ	B
regulatory	O	ADJ	B
sites	O	NOUN	I
.	O	PUNCT	O


One	O	NUM	O
major	B-DNA	ADJ	O
and	I-DNA	CCONJ	O
one	I-DNA	NUM	O
minor	I-DNA	ADJ	B
transcription	I-DNA	NOUN	B
start	I-DNA	NOUN	O
site	I-DNA	NOUN	O
were	O	AUX	O
identified	O	VERB	B
101	B-DNA	NUM	O
and	I-DNA	CCONJ	O
130	I-DNA	NUM	O
base	I-DNA	NOUN	B
pairs	I-DNA	NOUN	I
(	I-DNA	PUNCT	O
bp	I-DNA	NOUN	O
)	I-DNA	PUNCT	O
upstream	I-DNA	ADJ	O
,	O	PUNCT	O
respectively	O	ADV	O
,	O	PUNCT	O
from	O	ADP	O
the	O	DET	O
protein	B-DNA	NOUN	B
translation	I-DNA	NOUN	B
start	I-DNA	NOUN	O
ATG	I-DNA	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
observed	O	VERB	O
that	O	SCONJ	O
FK506	O	NOUN	B
suppressed	O	VERB	B
the	O	DET	O
transcription	O	NOUN	B
of	O	ADP	O
a	O	DET	O
chemotactic	B-protein	ADJ	B
cytokine	I-protein	NOUN	I
,	O	PUNCT	O
interleukin-8	B-protein	NOUN	B
(	O	PUNCT	O
IL-8	B-protein	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
a	O	DET	O
human	B-cell_line	ADJ	B
T	I-cell_line	NOUN	O
cell	I-cell_line	NOUN	O
line	I-cell_line	NOUN	O
,	O	PUNCT	O
Jurkat	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
activated	O	VERB	B
by	O	ADP	O
phorbol	O	NOUN	B
12-myristate	O	NOUN	I
13-acetate	O	NOUN	I
(	O	PUNCT	O
PMA	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
calcium	O	NOUN	B
(	O	PUNCT	O
Ca2+	O	NOUN	O
)	O	PUNCT	O
ionophore	O	NOUN	O
(	O	PUNCT	O
ionomycin	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


By	O	ADP	O
deleted	O	VERB	B
and	O	CCONJ	O
mutated	O	VERB	B
analysis	O	NOUN	I
of	O	ADP	O
the	O	DET	O
IL-8	B-DNA	NOUN	B
promoters	I-DNA	NOUN	B
,	O	PUNCT	O
the	O	DET	O
AP-1	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
kappa	I-DNA	NOUN	O
B-like	I-DNA	ADJ	B
sites	I-DNA	NOUN	I
were	O	AUX	O
identified	O	VERB	B
as	O	ADP	O
the	O	DET	O
responsive	O	ADJ	B
elements	O	NOUN	I
for	O	ADP	O
PMA	O	NOUN	B
and	O	CCONJ	O
ionomycin	O	NOUN	B
.	O	PUNCT	O


Cells	O	NOUN	B
were	O	AUX	O
separated	O	VERB	O
from	O	ADP	O
blood	O	NOUN	B
samples	O	NOUN	I
on	O	ADP	O
a	O	DET	O
Ficoll	O	NOUN	B
gradient	O	NOUN	I
and	O	CCONJ	O
incubated	O	VERB	B
with	O	ADP	O
different	O	ADJ	O
concentrations	O	NOUN	B
of	O	ADP	O
[	O	PUNCT	O
3H	O	NOUN	O
]	O	PUNCT	O
testosterone	O	NOUN	B
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
or	O	CCONJ	O
absence	O	NOUN	B
of	O	ADP	O
a	O	DET	O
400-fold	O	ADJ	O
excess	O	NOUN	B
of	O	ADP	O
unlabelled	O	ADJ	B
testosterone	O	NOUN	B
.	O	PUNCT	O


OBJECTIVE	O	NOUN	O
.	O	PUNCT	O


Arrested	O	VERB	B
development	O	NOUN	B
:	O	PUNCT	O
understanding	O	VERB	O
v-abl	B-DNA	NOUN	B
.	O	PUNCT	O


Corticosteroid	B-protein	NOUN	B
receptors	I-protein	NOUN	I
in	O	ADP	O
lymphocytes	B-cell_type	NOUN	B
:	O	PUNCT	O
a	O	DET	O
possible	O	ADJ	O
marker	O	NOUN	B
of	O	ADP	O
brain	O	NOUN	B
involution	O	NOUN	I
?	O	PUNCT	O


That	O	DET	O
RA	O	NOUN	B
promotes	O	VERB	B
both	O	CCONJ	O
neutrophil	O	NOUN	B
and	O	CCONJ	O
monocyte	O	NOUN	B
differentiation	O	NOUN	I
has	O	AUX	O
implications	O	NOUN	O
for	O	ADP	O
the	O	DET	O
use	O	NOUN	O
of	O	ADP	O
RA	O	NOUN	B
and	O	CCONJ	O
D3	O	NOUN	B
in	O	ADP	O
treatment	O	NOUN	B
of	O	ADP	O
leukemias	O	NOUN	B
and	O	CCONJ	O
provides	O	VERB	O
insight	O	NOUN	O
into	O	ADP	O
mechanisms	O	NOUN	B
whereby	O	SCONJ	O
RAR	O	NOUN	B
,	O	PUNCT	O
VDR	B-protein	NOUN	B
and	O	CCONJ	O
RXR	B-protein	NOUN	B
facilitate	O	VERB	O
monocyte	O	NOUN	B
differentiation	O	NOUN	I
.	O	PUNCT	O


RARs	B-protein	NOUN	B
are	O	AUX	O
members	O	NOUN	B
of	O	ADP	O
the	O	DET	O
steroid/thyroid	B-protein	NOUN	B
hormone	I-protein	NOUN	I
receptor	I-protein	NOUN	I
superfamily	I-protein	NOUN	B
and	O	CCONJ	O
exhibit	O	VERB	O
a	O	DET	O
molecular	O	ADJ	B
structure	O	NOUN	I
that	O	PRON	O
possess	O	VERB	O
discrete	O	ADJ	O
DNA-binding	O	ADJ	B
and	O	CCONJ	O
RA	B-protein	NOUN	B
(	I-protein	PUNCT	O
ligand	I-protein	NOUN	B
)	I-protein	PUNCT	O
-binding	I-protein	ADJ	O
domains	I-protein	NOUN	B
.	O	PUNCT	O


Most	O	ADJ	O
cells	O	NOUN	B
infected	O	VERB	B
with	O	ADP	O
hRAR	B-protein	NOUN	B
alpha	I-protein	NOUN	I
exhibited	O	VERB	O
promyelocytic	B-cell_type	ADJ	B
morphology	I-cell_type	NOUN	B
and	O	CCONJ	O
were	O	AUX	O
thought	O	VERB	O
to	O	PART	O
be	O	AUX	O
blocked	O	VERB	B
at	O	ADP	O
the	O	DET	O
promyelocytic	O	ADJ	B
stage	O	NOUN	I
in	O	ADP	O
their	O	PRON	O
myeloid	O	ADJ	B
differentiation	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
observations	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
an	O	DET	O
overexpression	O	NOUN	B
of	O	ADP	O
RAR	B-protein	NOUN	B
alpha	I-protein	NOUN	I
alone	O	ADV	O
is	O	AUX	O
effective	O	ADJ	B
to	O	PART	O
suppress	O	VERB	B
myeloid	B-cell_type	ADJ	B
cell	I-cell_type	NOUN	I
differentiation	O	NOUN	O
and	O	CCONJ	O
RAR	B-protein	NOUN	B
alpha	I-protein	NOUN	I
plays	O	VERB	O
a	O	DET	O
crucial	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
terminal	O	ADJ	B
differentiation	O	NOUN	B
of	O	ADP	O
myeloid	O	ADJ	B
precursors	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
system	O	NOUN	B
described	O	VERB	O
here	O	ADV	O
may	O	AUX	O
serve	O	VERB	O
as	O	ADP	O
a	O	DET	O
model	O	NOUN	B
for	O	ADP	O
studying	O	VERB	O
the	O	DET	O
the	O	DET	O
essential	B-DNA	ADJ	B
genes	I-DNA	NOUN	I
for	O	ADP	O
differentiation	O	NOUN	B
of	O	ADP	O
normal	B-cell_type	ADJ	B
bone	I-cell_type	NOUN	I
marrow	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
mice	O	NOUN	B
exposed	O	VERB	B
to	O	PART	I
hypoxia	O	NOUN	B
(	O	PUNCT	O
PO2	O	NOUN	B
approximately	O	ADV	O
30-40	O	NUM	O
Torr	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
there	O	PRON	O
was	O	AUX	O
increased	O	VERB	B
pulmonary	O	ADJ	B
leukostasis	O	NOUN	I
,	O	PUNCT	O
as	O	ADP	O
evidenced	O	VERB	O
by	O	ADP	O
increased	O	VERB	B
myeloperoxidase	B-protein	NOUN	B
activity	O	NOUN	I
in	O	ADP	O
tissue	O	NOUN	B
homogenates	O	NOUN	B
.	O	PUNCT	O


Thrombin	B-protein	NOUN	B
and	O	CCONJ	O
thrombin	B-protein	NOUN	B
receptor	I-protein	NOUN	I
agonist	O	NOUN	I
peptide	O	NOUN	B
induce	O	VERB	O
early	O	ADJ	O
events	O	NOUN	O
of	O	ADP	O
T	O	NOUN	B
cell	O	NOUN	I
activation	O	NOUN	B
and	O	CCONJ	O
synergize	O	VERB	B
with	O	ADP	O
TCR	B-protein	NOUN	B
cross-linking	O	NOUN	B
for	O	ADP	O
CD69	B-protein	NOUN	B
expression	O	NOUN	B
and	O	CCONJ	O
interleukin	O	NOUN	B
2	O	NUM	I
production	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
synthetic	O	ADJ	B
thrombin	B-protein	NOUN	I
receptor	I-protein	NOUN	I
agonist	O	NOUN	I
peptide	O	NOUN	I
(	O	PUNCT	O
TRP	O	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
7	O	NUM	O
residues	O	NOUN	B
(	O	PUNCT	O
SFLLRNP	O	NOUN	B
)	O	PUNCT	O
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
be	O	AUX	O
as	O	ADV	O
effective	O	ADJ	B
as	O	ADP	O
thrombin	B-protein	NOUN	B
for	O	ADP	O
[	O	PUNCT	O
Ca2+	O	NOUN	B
]	O	PUNCT	O
i	O	NOUN	O
mobilization	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
both	O	DET	O
agonists	O	NOUN	B
induced	O	VERB	B
Ca2+	O	NOUN	B
release	O	NOUN	B
exclusively	O	ADV	O
from	O	ADP	O
internal	O	ADJ	B
stores	O	NOUN	I
.	O	PUNCT	O


Thrombin	B-protein	NOUN	B
and	O	CCONJ	O
TRP	O	NOUN	B
also	O	ADV	O
caused	O	VERB	O
translocation	O	NOUN	B
of	O	ADP	O
protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
C	I-protein	NOUN	I
from	O	ADP	O
the	O	DET	O
cytosol	O	NOUN	B
to	O	PART	O
the	O	DET	O
plasma	O	NOUN	B
membrane	O	NOUN	I
.	O	PUNCT	O


As	O	ADP	O
a	O	DET	O
likely	O	ADJ	O
consequence	O	NOUN	O
of	O	ADP	O
these	O	DET	O
events	O	NOUN	B
,	O	PUNCT	O
thrombin	B-protein	NOUN	B
activated	O	VERB	B
the	O	DET	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
NF-kB	I-protein	NOUN	I
.	O	PUNCT	O


Several	O	ADJ	O
cell	O	NOUN	B
lines	O	NOUN	I
of	O	ADP	O
hematopoietic	O	ADJ	B
origin	O	NOUN	I
including	O	VERB	O
the	O	DET	O
leukemic	B-cell_line	ADJ	B
T	I-cell_line	NOUN	I
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
HPB.ALL	I-cell_line	NOUN	B
and	O	CCONJ	O
the	O	DET	O
erythroleukemic	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
K562	I-cell_line	NOUN	I
were	O	AUX	O
responsive	O	ADJ	O
to	O	PART	O
thrombin	B-protein	NOUN	B
,	O	PUNCT	O
whereas	O	SCONJ	O
others	O	NOUN	O
such	O	ADJ	O
as	O	ADP	O
THP1	B-cell_line	NOUN	B
,	O	PUNCT	O
a	O	DET	O
myelomonocytic	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
BL2	B-cell_line	NOUN	B
,	I-cell_line	PUNCT	O
a	O	DET	O
Burkitt	B-cell_line	NOUN	B
lymphoma	I-cell_line	NOUN	I
were	O	AUX	O
refractory	O	ADJ	B
to	O	PART	O
thrombin	B-protein	NOUN	B
or	O	CCONJ	O
TRP	O	NOUN	B
stimulation	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
found	O	VERB	O
that	O	SCONJ	O
activation	O	NOUN	B
of	O	ADP	O
Jurkat	B-cell_line	NOUN	B
T	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
by	O	ADP	O
a	O	DET	O
combination	O	NOUN	B
of	O	ADP	O
phytohemagglutinin	B-protein	NOUN	B
and	O	CCONJ	O
phorbol	O	NOUN	B
12-myristate	O	NOUN	I
13-acetate	O	NOUN	I
led	O	VERB	O
to	O	PART	O
a	O	DET	O
dramatic	O	ADJ	O
inhibition	O	NOUN	B
of	O	ADP	O
thrombin	B-RNA	NOUN	B
receptor	I-RNA	NOUN	I
mRNA	I-RNA	NOUN	B
expression	O	NOUN	B
and	O	CCONJ	O
to	O	PART	O
a	O	DET	O
concomitant	O	ADJ	B
loss	O	NOUN	B
of	O	ADP	O
the	O	DET	O
thrombin	B-protein	NOUN	B
response	O	NOUN	O
.	O	PUNCT	O


Senescent	B-cell_line	ADJ	B
human	I-cell_line	ADJ	B
T	I-cell_line	NOUN	B
lymphocyte	I-cell_line	NOUN	I
cultures	I-cell_line	NOUN	I
are	O	AUX	O
unable	O	ADJ	O
to	O	PART	O
undergo	O	VERB	O
proliferation	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
show	O	VERB	O
no	O	DET	O
difference	O	NOUN	O
from	O	ADP	O
early	B-cell_line	ADJ	B
passage	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
in	O	ADP	O
cytotoxic	O	ADJ	B
function	O	NOUN	I
or	O	CCONJ	O
surface	O	NOUN	B
antigenic	O	ADJ	O
profile	O	NOUN	O
.	O	PUNCT	O


This	O	DET	O
decline	O	NOUN	B
is	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
a	O	DET	O
decrease	O	NOUN	B
in	O	ADP	O
binding	O	NOUN	B
of	O	ADP	O
nuclear	O	ADJ	B
extracts	O	NOUN	I
to	O	PART	O
the	O	DET	O
consensus	B-DNA	NOUN	B
heat	I-DNA	NOUN	I
shock	I-DNA	NOUN	I
element	I-DNA	NOUN	I
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
ethanol	O	NOUN	B
,	O	PUNCT	O
an	O	DET	O
inhibitor	O	NOUN	B
of	O	ADP	O
the	O	DET	O
PLD	B-protein	NOUN	B
pathway	O	NOUN	O
,	O	PUNCT	O
blocked	O	VERB	B
the	O	DET	O
anti-CD3-stimulated	O	ADJ	B
AP-1	B-DNA	NOUN	B
enhancer	I-DNA	NOUN	I
activity	O	NOUN	O
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
this	O	DET	O
anti-CD3	B-protein	ADJ	B
-mediated	O	ADJ	O
response	O	NOUN	B
was	O	AUX	O
not	O	PART	O
inhibited	O	VERB	B
by	O	ADP	O
neomycin	O	NOUN	B
,	O	PUNCT	O
an	O	DET	O
inhibitor	O	NOUN	B
of	O	ADP	O
phosphoinositide	O	ADJ	B
hydrolysis	O	NOUN	B
.	O	PUNCT	O


Upregulation	O	NOUN	B
of	O	ADP	O
bcl-2	B-DNA	NOUN	B
by	O	ADP	O
the	O	DET	O
Epstein-Barr	B-protein	ADJ	B
virus	I-protein	NOUN	I
latent	I-protein	ADJ	B
membrane	I-protein	NOUN	I
protein	I-protein	NOUN	I
LMP1	B-protein	NOUN	B
:	O	PUNCT	O
a	O	DET	O
B-cell-specific	O	ADJ	B
response	O	NOUN	I
that	O	PRON	O
is	O	AUX	O
delayed	O	VERB	B
relative	O	ADJ	O
to	O	PART	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activation	O	NOUN	B
and	O	CCONJ	O
to	O	PART	O
induction	O	NOUN	B
of	O	ADP	O
cell	B-protein	NOUN	B
surface	I-protein	NOUN	I
markers	I-protein	NOUN	B
.	O	PUNCT	O


Our	O	PRON	O
data	O	NOUN	B
also	O	ADV	O
suggest	O	VERB	O
that	O	SCONJ	O
whilst	O	SCONJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
may	O	AUX	O
be	O	AUX	O
an	O	DET	O
essential	O	ADJ	O
component	O	NOUN	O
of	O	ADP	O
LMP1	B-protein	NOUN	B
signal	O	NOUN	O
transduction	O	NOUN	O
,	O	PUNCT	O
other	O	ADJ	O
cell-specific	B-protein	ADJ	B
factors	I-protein	NOUN	I
may	O	AUX	O
be	O	AUX	O
required	O	VERB	O
to	O	PART	O
effect	O	VERB	B
some	O	DET	O
functions	O	NOUN	B
of	O	ADP	O
the	O	DET	O
viral	B-protein	ADJ	B
protein	I-protein	NOUN	I
.	O	PUNCT	O


To	O	PART	O
tie	O	VERB	O
these	O	DET	O
events	O	NOUN	B
to	O	PART	O
gene	O	NOUN	B
activation	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
measured	O	VERB	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
and	O	CCONJ	O
NF-AT	B-protein	NOUN	B
activity	O	NOUN	B
in	O	ADP	O
the	O	DET	O
nucleus	O	NOUN	B
after	O	ADP	O
anti-CD3	B-protein	ADJ	B
stimulation	O	NOUN	O
.	O	PUNCT	O


On	O	ADP	O
the	O	DET	O
other	O	ADJ	O
hand	O	NOUN	B
,	O	PUNCT	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
induction	O	NOUN	B
and	O	CCONJ	O
IL-2	B-protein	NOUN	B
receptor	O	NOUN	I
expression	O	NOUN	B
occurred	O	VERB	O
even	O	ADV	O
with	O	ADP	O
the	O	DET	O
smaller	O	ADJ	O
second	O	ADJ	O
messenger	O	NOUN	B
response	O	NOUN	I
generated	O	VERB	O
by	O	ADP	O
OKT3	B-protein	NOUN	B
.	O	PUNCT	O


Using	O	VERB	O
a	O	DET	O
combination	O	NOUN	B
of	O	ADP	O
panning	O	NOUN	B
and	O	CCONJ	O
multiparameter	O	NOUN	B
flow	O	NOUN	B
cytometric	O	ADJ	I
sorting	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
identified	O	VERB	B
a	O	DET	O
normal	B-cell_type	ADJ	O
CD56+	I-cell_type	NOUN	B
,	I-cell_type	PUNCT	O
CD33+	I-cell_type	ADJ	B
,	I-cell_type	PUNCT	O
CD16-	I-cell_type	ADJ	B
counterpart	I-cell_type	NOUN	I
cell	I-cell_type	NOUN	I
at	O	ADP	O
a	O	DET	O
frequency	O	NOUN	B
of	O	ADP	O
1	O	NUM	O
%	O	NOUN	O
to	O	PART	O
2	O	NUM	O
%	O	NOUN	O
in	O	ADP	O
the	O	DET	O
peripheral	O	ADJ	B
blood	O	NOUN	I
of	O	ADP	O
healthy	O	ADJ	B
individuals	O	NOUN	B
.	O	PUNCT	O


IL-4	B-protein	NOUN	B
also	O	ADV	O
suppressed	O	VERB	B
the	O	DET	O
IL-2	B-protein	NOUN	B
-induced	O	ADJ	O
IL-6	B-protein	NOUN	B
mRNA	O	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
study	O	NOUN	B
shows	O	VERB	O
that	O	SCONJ	O
human	O	ADJ	B
peripheral	O	ADJ	B
blood	O	NOUN	I
monocytes	B-cell_type	NOUN	I
(	O	PUNCT	O
PBMo	B-cell_type	NOUN	B
)	O	PUNCT	O
also	O	ADV	O
respond	O	VERB	O
to	O	PART	O
MDHM	O	NOUN	B
with	O	ADP	O
increases	O	NOUN	B
in	O	ADP	O
IL-1	B-protein	NOUN	B
beta	I-protein	NOUN	B
,	O	PUNCT	O
IL-6	B-protein	NOUN	B
and	O	CCONJ	O
TNF	B-protein	NOUN	B
alpha	I-protein	NOUN	O
expression	O	NOUN	B
,	O	PUNCT	O
both	O	CCONJ	O
at	O	ADP	O
the	O	DET	O
mRNA	O	NOUN	B
and	O	CCONJ	O
protein	O	NOUN	B
level	O	NOUN	O
.	O	PUNCT	O


It	O	PRON	O
,	O	PUNCT	O
thus	O	ADV	O
,	O	PUNCT	O
appears	O	VERB	O
as	O	ADP	O
an	O	DET	O
integral	B-protein	ADJ	B
membrane	I-protein	NOUN	I
protein	I-protein	NOUN	I
.	O	PUNCT	O


Using	O	VERB	O
in	O	X	B
vitro	O	X	I
footprinting	O	NOUN	I
and	O	CCONJ	O
gel	O	NOUN	B
shift	O	NOUN	I
assays	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
identified	O	VERB	B
four	O	NUM	O
distinct	O	ADJ	O
binding	B-DNA	VERB	B
sites	I-DNA	NOUN	I
for	O	ADP	O
nuclear	B-protein	ADJ	B
proteins	I-protein	NOUN	I
within	O	ADP	O
this	O	DET	O
positive	B-DNA	ADJ	B
regulatory	I-DNA	ADJ	B
element	I-DNA	NOUN	I
.	O	PUNCT	O


trans-activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
HIV	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
by	O	ADP	O
a	O	DET	O
cDNA	O	NOUN	B
and	O	CCONJ	O
its	O	PRON	O
genomic	O	ADJ	B
clones	O	NOUN	I
of	O	ADP	O
human	O	ADJ	B
herpesvirus-6	O	NOUN	B
.	O	PUNCT	O


Human	O	ADJ	B
herpesvirus	O	NOUN	I
6	O	NUM	I
(	O	PUNCT	O
HHV-6	O	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
lymphotropic	O	ADJ	B
herpesvirus	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
in	O	X	B
vitro	O	X	I
,	O	PUNCT	O
it	O	PRON	O
can	O	AUX	O
productively	O	ADV	B
infect	O	VERB	B
human	O	ADJ	B
CD4+	B-cell_line	ADJ	B
T	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
as	O	ADP	O
HIV-1	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
sought	O	VERB	O
to	O	PART	O
determine	O	VERB	O
if	O	SCONJ	O
this	O	DET	O
pathway	O	NOUN	B
were	O	AUX	O
present	O	ADJ	O
in	O	ADP	O
CHO/CD14	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
and	O	CCONJ	O
to	O	PART	O
elucidate	O	VERB	O
the	O	DET	O
relationship	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activation	O	NOUN	B
to	O	PART	O
the	O	DET	O
CD14	B-protein	NOUN	B
receptor	O	NOUN	I
system	O	NOUN	I
.	O	PUNCT	O


Protein	O	NOUN	B
synthesis	O	NOUN	I
inhibitors	O	NOUN	I
and	O	CCONJ	O
corticosteroids	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
suppress	O	VERB	B
arachidonate	O	NOUN	B
release	O	NOUN	I
and	O	CCONJ	O
the	O	DET	O
synthesis	O	NOUN	B
of	O	ADP	O
proinflammatory	B-protein	ADJ	B
cytokines	I-protein	NOUN	I
,	O	PUNCT	O
had	O	AUX	O
no	O	DET	B
effect	O	NOUN	I
on	O	ADP	O
translocation	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
in	O	ADP	O
CHO/	O	NOUN	B
CD14	B-protein	NOUN	B
or	O	CCONJ	O
RAW	B-cell_line	NOUN	B
264.7	I-cell_line	NUM	I
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
demonstrating	O	VERB	O
that	O	SCONJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
translocation	O	NOUN	B
is	O	AUX	O
an	O	DET	O
early	O	ADJ	B
event	O	NOUN	I
.	O	PUNCT	O


Signals	O	NOUN	B
transduced	O	VERB	B
through	O	ADP	O
the	O	DET	O
CD4	B-protein	NOUN	B
molecule	I-protein	NOUN	I
on	O	ADP	O
T	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
activate	O	VERB	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
.	O	PUNCT	O


Stimulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
human	B-cell_line	ADJ	B
monocytic	I-cell_line	ADJ	I
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
Mono	B-cell_line	NOUN	I
Mac	I-cell_line	NOUN	I
6	I-cell_line	NUM	I
with	O	ADP	O
lipopolysaccharide	O	NOUN	B
(	O	PUNCT	O
LPS	O	NOUN	B
)	O	PUNCT	O
leads	O	VERB	O
to	O	PART	O
rapid	O	ADJ	B
and	O	CCONJ	O
transient	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
cytokines	B-protein	NOUN	B
like	O	ADP	O
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor	I-protein	NOUN	I
(	O	PUNCT	O
TNF	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


This	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
p50	B-protein	NOUN	B
homodimers	I-protein	NOUN	I
coincides	O	VERB	O
with	O	ADP	O
an	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
p105	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
,	O	PUNCT	O
suggestive	O	ADJ	O
of	O	ADP	O
a	O	DET	O
transcriptional	O	ADJ	B
up-regulation	O	NOUN	B
of	O	ADP	O
p50	B-protein	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
a	O	DET	O
new	O	ADJ	O
combination	O	NOUN	B
isoform	O	NOUN	B
containing	O	VERB	O
Oct2a	B-protein	NOUN	B
's	I-protein	PART	I
amino	I-protein	NOUN	B
terminal	I-protein	ADJ	I
insert	I-protein	NOUN	I
(	O	PUNCT	O
exon	B-DNA	NOUN	B
7a	I-DNA	NOUN	I
)	O	PUNCT	O
and	O	CCONJ	O
Oct2b	B-protein	NOUN	B
's	I-protein	PART	I
carboxy	I-protein	NOUN	B
terminal	I-protein	ADJ	I
insert	I-protein	NOUN	I
(	O	PUNCT	O
exon	B-DNA	NOUN	O
13	I-DNA	NUM	O
)	O	PUNCT	O
was	O	AUX	O
found	O	VERB	O
that	O	PRON	O
created	O	VERB	O
a	O	DET	O
novel	O	ADJ	O
large	O	ADJ	O
isoform	O	NOUN	B
,	O	PUNCT	O
Oct2ab	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
zinc	B-protein	NOUN	B
finger	I-protein	NOUN	I
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
GATA-1	B-protein	NOUN	B
is	O	AUX	O
a	O	DET	O
major	O	ADJ	O
regulator	O	NOUN	B
of	O	ADP	O
gene	O	NOUN	B
expression	O	NOUN	I
in	O	ADP	O
erythroid	B-cell_type	ADJ	B
,	I-cell_type	PUNCT	O
megakaryocyte	I-cell_type	NOUN	B
,	I-cell_type	PUNCT	O
and	I-cell_type	CCONJ	O
mast	I-cell_type	NOUN	B
cell	I-cell_type	NOUN	I
lineages	I-cell_type	NOUN	O
.	O	PUNCT	O


Efficient	O	ADJ	B
rescue	O	NOUN	B
of	O	ADP	O
the	O	DET	O
defect	O	NOUN	B
requires	O	VERB	O
an	O	DET	O
intact	O	ADJ	B
GATA	B-DNA	NOUN	B
element	I-DNA	NOUN	I
in	O	ADP	O
the	O	DET	O
distal	B-DNA	ADJ	B
promoter	I-DNA	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
autoregulatory	O	ADJ	B
control	O	NOUN	I
of	O	ADP	O
GATA-1	B-protein	NOUN	B
transcription	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
report	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
exposure	O	NOUN	B
of	O	ADP	I
cells	O	NOUN	B
to	O	PART	O
hypoxia	O	NOUN	B
(	O	PUNCT	O
0.02	O	NUM	O
%	O	NOUN	O
O2	O	NOUN	B
)	O	PUNCT	O
results	O	VERB	B
in	O	ADP	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
alpha	I-protein	NOUN	I
degradation	O	NOUN	I
,	O	PUNCT	O
increased	O	VERB	B
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
DNA	O	NOUN	B
binding	O	NOUN	I
activity	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
transactivation	O	NOUN	B
of	O	ADP	O
a	O	DET	O
reporter	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
construct	I-DNA	NOUN	I
containing	O	VERB	O
two	O	NUM	O
NF-kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
DNA	I-DNA	NOUN	B
binding	I-DNA	NOUN	I
sites	I-DNA	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
comparison	O	NOUN	B
to	O	PART	O
other	O	ADJ	O
activators	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
such	O	ADJ	O
as	O	ADP	O
phorbol	O	NOUN	B
myristate	O	NOUN	B
acetate	O	NOUN	I
or	O	CCONJ	O
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor	I-protein	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
did	O	AUX	O
not	O	PART	O
detect	O	VERB	B
changes	O	NOUN	B
in	O	ADP	O
the	O	DET	O
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	I
status	O	NOUN	O
of	O	ADP	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
alpha	I-protein	NOUN	I
following	O	VERB	O
treatment	O	NOUN	B
with	O	ADP	O
either	O	DET	O
of	O	ADP	O
these	O	DET	O
agents	O	NOUN	B
.	O	PUNCT	O


Overproduction	O	NOUN	B
of	O	ADP	O
NFKB2	B-protein	NOUN	B
(	O	PUNCT	O
lyt-10	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
c-Rel	B-protein	NOUN	B
:	O	PUNCT	O
a	O	DET	O
mechanism	O	NOUN	B
for	O	ADP	O
HTLV-I	B-protein	NOUN	B
Tax	I-protein	NOUN	B
-mediated	O	ADJ	O
trans-activation	O	NOUN	B
via	O	ADP	O
the	O	DET	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
signalling	O	NOUN	I
pathway	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
Tax	B-protein	NOUN	B
protein	I-protein	NOUN	I
of	O	ADP	O
HTLV-I	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
positive	B-protein	ADJ	B
transcriptional	I-protein	ADJ	B
activator	I-protein	NOUN	I
of	O	ADP	O
HTLV-I	O	NOUN	B
gene	O	NOUN	O
expression	O	NOUN	O
,	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
viral	O	ADJ	B
oncogene	O	NOUN	I
that	O	PRON	O
also	O	ADV	O
increases	O	VERB	B
transcription	O	NOUN	B
of	O	ADP	O
cellular	B-DNA	ADJ	B
genes	I-DNA	NOUN	I
including	O	VERB	O
GM-CSF	B-protein	NOUN	B
,	O	PUNCT	O
IL-2R	B-protein	NOUN	B
alpha	I-protein	NOUN	I
and	O	CCONJ	O
IL-2	B-protein	NOUN	B
.	O	PUNCT	O


One	O	NUM	O
of	O	ADP	O
the	O	DET	O
cellular	O	ADJ	B
targets	O	NOUN	I
of	O	ADP	O
the	O	DET	O
trans-activating	O	ADJ	B
effects	O	NOUN	O
of	O	ADP	O
Tax	O	NOUN	B
is	O	AUX	O
the	O	DET	O
NF-kappa	B-protein	NOUN	B
B/Rel	I-protein	NOUN	B
family	I-protein	NOUN	B
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
,	O	PUNCT	O
pleiotropic	B-protein	ADJ	B
regulators	I-protein	NOUN	I
of	O	ADP	O
immunoregulatory	O	ADJ	B
,	O	PUNCT	O
cytokine	O	NOUN	B
and	O	CCONJ	O
viral	O	ADJ	B
gene	O	NOUN	I
expression	O	NOUN	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
NFKB2	B-protein	NOUN	B
precursor	O	NOUN	B
is	O	AUX	O
physically	O	ADV	B
associated	O	VERB	B
with	O	ADP	I
c-Rel	B-protein	NOUN	B
and	O	CCONJ	O
with	O	ADP	O
Tax	B-protein	NOUN	B
in	O	ADP	O
HTLV-I	B-cell_type	NOUN	B
infected	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
clonogenetic	B-cell_line	ADJ	B
fetal	I-cell_line	ADJ	I
calf	I-cell_line	NOUN	I
serum-supplemented	I-cell_line	ADJ	B
(	I-cell_line	PUNCT	O
FCS+	I-cell_line	NOUN	B
)	I-cell_line	PUNCT	O
or	I-cell_line	CCONJ	O
-nonsupplemented	I-cell_line	ADJ	O
(	I-cell_line	PUNCT	O
FCS-	I-cell_line	ADJ	B
)	I-cell_line	PUNCT	O
culture	I-cell_line	NOUN	B
treated	O	VERB	B
with	O	ADP	I
saturating	O	ADJ	B
levels	O	NOUN	O
of	O	ADP	O
interleukin-3	B-protein	NOUN	B
(	O	PUNCT	O
IL-3	B-protein	NOUN	B
)	O	PUNCT	O
granulocyte-macrophage	B-protein	ADJ	O
colony-stimulating	I-protein	ADJ	O
factor	I-protein	NOUN	O
(	O	PUNCT	O
GM-CSF	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
erythropoietin	B-protein	NOUN	B
(	O	PUNCT	O
Ep	B-protein	NOUN	B
)	O	PUNCT	O
(	O	PUNCT	O
combined	O	VERB	O
with	O	ADP	O
c-kit	B-protein	NOUN	B
ligand	O	NOUN	O
in	O	ADP	O
FCS	O	NOUN	B
(	O	PUNCT	O
-	O	PUNCT	O
)	O	PUNCT	O
-culture	O	ADJ	O
conditions	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
RA	O	NOUN	B
induces	O	VERB	B
a	O	DET	O
dramatic	O	ADJ	O
dose-dependent	O	ADJ	B
shift	O	NOUN	B
from	O	ADP	O
erythroid	O	ADJ	B
to	O	PART	O
granulomonocytic	O	ADJ	B
colony	O	NOUN	B
formation	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
latter	O	ADJ	O
colonies	O	NOUN	B
being	O	AUX	O
essentially	O	ADV	O
represented	O	VERB	O
by	O	ADP	O
granulocytic	B-cell_line	ADJ	B
clones	I-cell_line	NOUN	I
.	O	PUNCT	O


The	O	DET	O
difference	O	NOUN	O
in	O	ADP	O
signals	O	NOUN	B
transduced	O	VERB	B
through	O	ADP	O
sIgM	B-protein	NOUN	B
and	O	CCONJ	O
sIgD	B-protein	NOUN	B
in	O	ADP	O
B104	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
is	O	AUX	O
discussed	O	VERB	O
.	O	PUNCT	O


Co-treatment	O	NOUN	B
of	O	ADP	O
RBCs	B-cell_type	NOUN	B
with	O	ADP	O
TCDD	O	NOUN	B
and	O	CCONJ	O
NaOV	O	NOUN	B
completely	O	ADV	O
blocked	O	VERB	B
the	O	DET	O
TCDD-induced	O	ADJ	B
increase	O	NOUN	B
in	O	ADP	O
parasitemia	O	NOUN	B
.	O	PUNCT	O


Analysis	O	NOUN	B
at	O	ADP	O
the	O	DET	O
phenotype	O	NOUN	B
and	O	CCONJ	O
genetic	O	ADJ	B
level	O	NOUN	I
showed	O	VERB	O
that	O	SCONJ	O
lack	O	NOUN	B
of	O	ADP	O
CD5	B-protein	NOUN	B
expression	O	NOUN	B
was	O	AUX	O
due	O	ADJ	O
neither	O	CCONJ	O
to	O	PART	O
segregation	O	NOUN	B
of	O	ADP	O
human	B-DNA	ADJ	B
autosome	I-DNA	NOUN	O
11	I-DNA	NUM	O
,	O	PUNCT	O
on	O	ADP	O
which	O	DET	O
the	O	DET	O
CD5	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
has	O	AUX	O
been	O	AUX	O
mapped	O	VERB	B
,	O	PUNCT	O
nor	O	CCONJ	O
to	O	PART	O
deletion	O	NOUN	B
of	O	ADP	O
the	O	DET	O
CD5	B-DNA	NOUN	B
structural	I-DNA	ADJ	O
gene	I-DNA	NOUN	O
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
loss	O	NOUN	B
of	O	ADP	O
CD5	B-protein	NOUN	B
surface	O	NOUN	B
expression	O	NOUN	B
correlated	O	VERB	B
with	O	ADP	O
the	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
specific	O	ADJ	O
mRNA	B-RNA	NOUN	B
.	O	PUNCT	O


Since	O	SCONJ	O
these	O	DET	O
hybrids	O	NOUN	B
preferentially	O	ADV	O
segregate	O	VERB	O
human	O	ADJ	B
chromosomes	O	NOUN	O
,	O	PUNCT	O
these	O	DET	O
results	O	NOUN	B
indicate	O	VERB	O
the	O	DET	O
existence	O	NOUN	O
of	O	ADP	O
a	O	DET	O
non-syntenic	B-DNA	ADJ	B
trans-active	I-DNA	ADJ	B
locus	I-DNA	NOUN	I
,	O	PUNCT	O
or	O	CCONJ	O
loci	O	NOUN	B
,	O	PUNCT	O
positively	O	ADV	O
controlling	O	VERB	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
CD5	I-DNA	NOUN	B
gene	I-DNA	NOUN	I
.	O	PUNCT	O


These	O	DET	O
factors	O	NOUN	B
are	O	AUX	O
detected	O	VERB	B
at	O	ADP	O
the	O	DET	O
time	O	NOUN	B
the	O	DET	O
CD11b	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
is	O	AUX	O
activated	O	VERB	B
.	O	PUNCT	O


Interferon	O	NOUN	B
augments	O	VERB	O
PML	B-protein	NOUN	B
and	O	CCONJ	O
PML/RAR	B-protein	NOUN	B
alpha	I-protein	NOUN	I
expression	O	NOUN	B
in	O	ADP	O
normal	O	ADJ	B
myeloid	B-cell_type	ADJ	I
and	O	CCONJ	O
acute	B-cell_type	ADJ	B
promyelocytic	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
cooperates	O	VERB	B
with	O	ADP	O
all-trans	O	ADJ	B
retinoic	O	ADJ	I
acid	O	NOUN	I
to	O	PART	O
induce	O	VERB	B
maturation	O	NOUN	B
of	O	ADP	O
a	O	DET	O
retinoid-resistant	B-cell_line	ADJ	B
promyelocytic	I-cell_line	ADJ	I
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
.	O	PUNCT	O


Effects	O	NOUN	B
of	O	ADP	I
Ara-C	O	NOUN	B
on	O	ADP	O
neutral	B-protein	ADJ	B
sphingomyelinase	I-protein	NOUN	I
and	O	CCONJ	O
mitogen-	B-protein	NOUN	B
and	I-protein	CCONJ	O
stress-	I-protein	NOUN	O
activated	I-protein	VERB	O
protein	I-protein	NOUN	O
kinases	I-protein	NOUN	O
in	O	ADP	O
T-lymphocyte	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
latent	O	ADJ	B
,	O	PUNCT	O
transformation-associated	O	ADJ	B
viral	O	ADJ	O
genes	O	NOUN	O
demonstrate	O	VERB	O
marked	O	ADJ	O
sequence	O	NOUN	B
divergence	O	NOUN	B
among	O	ADP	O
species	O	NOUN	B
despite	O	SCONJ	O
the	O	DET	O
conserved	O	VERB	B
functions	O	NOUN	I
.	O	PUNCT	O


Chromosome	B-DNA	NOUN	B
1	I-DNA	NUM	I
aneusomy	O	NOUN	B
with	O	ADP	O
1p36	B-DNA	NOUN	B
under-representation	O	NOUN	B
is	O	AUX	O
related	O	ADJ	O
to	O	PART	O
histologic	O	ADJ	B
grade	O	NOUN	I
,	O	PUNCT	O
DNA	O	NOUN	B
aneuploidy	O	NOUN	I
,	O	PUNCT	O
high	O	ADJ	O
c-erb	B-protein	NOUN	B
B-2	I-protein	NOUN	I
and	O	CCONJ	O
loss	O	NOUN	B
of	O	ADP	O
bcl-2	B-DNA	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
ductal	O	ADJ	B
breast	O	NOUN	I
carcinoma	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
ductal	O	ADJ	B
carcinomas	O	NOUN	I
,	O	PUNCT	O
chromosome	B-DNA	NOUN	B
1	I-DNA	NUM	I
alterations	O	NOUN	B
increased	O	VERB	B
with	O	ADP	O
histologic	O	ADJ	B
grade	O	NOUN	I
,	O	PUNCT	O
DNA	O	NOUN	B
aneuploidy	O	NOUN	I
,	O	PUNCT	O
loss	O	NOUN	B
of	O	ADP	O
bcl-2	O	NOUN	B
and	O	CCONJ	O
high	O	ADJ	O
c-erb	B-protein	NOUN	B
B-2	I-protein	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
study	O	NOUN	B
of	O	ADP	O
the	O	DET	O
molecular	O	ADJ	B
mechanisms	O	NOUN	I
involved	O	VERB	O
in	O	ADP	O
inflammatory	B-protein	ADJ	B
cytokine	I-protein	NOUN	O
expression	O	NOUN	O
[	O	PUNCT	O
published	O	VERB	B
erratum	O	NOUN	O
appears	O	VERB	O
in	O	ADP	O
J	O	PROPN	O
Biol	O	PROPN	O
Chem	O	PROPN	O
1994	O	NUM	O
Jun	O	NOUN	O
17	O	NUM	O
;	O	PUNCT	O
269	O	NUM	O
(	O	PUNCT	O
24	O	NUM	O
)	O	PUNCT	O
:	O	PUNCT	O
16983	O	NUM	O
]	O	PUNCT	O


The	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
mRNA	O	NOUN	B
accumulation	O	NOUN	B
was	O	AUX	O
at	O	ADP	O
least	O	ADJ	O
partly	O	ADV	O
due	O	ADJ	O
to	O	PART	O
an	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
the	O	DET	O
transcription	O	NOUN	B
rates	O	NOUN	I
of	O	ADP	O
the	O	DET	O
respective	O	ADJ	O
genes	B-DNA	NOUN	B
and	O	CCONJ	O
was	O	AUX	O
accompanied	O	VERB	O
by	O	ADP	O
a	O	DET	O
strong	O	ADJ	O
induction	O	NOUN	B
of	O	ADP	O
nuclear	O	ADJ	B
factor-kappa	O	NOUN	I
B	O	NOUN	I
and	O	CCONJ	O
activator	O	NOUN	O
protein-1	O	NOUN	O
transcription	O	NOUN	O
factor	O	NOUN	O
expression	O	NOUN	O
.	O	PUNCT	O


Experiments	O	NOUN	B
using	O	VERB	O
inhibitors	O	NOUN	B
of	O	ADP	O
protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
C	I-protein	NOUN	I
,	O	PUNCT	O
protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
A	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
tyrosine	O	NOUN	B
kinase-dependent	O	ADJ	I
pathways	O	NOUN	I
revealed	O	VERB	O
that	O	SCONJ	O
G	O	NOUN	B
(	O	PUNCT	O
Anh	O	PROPN	O
)	O	PUNCT	O
MTetra-induced	O	ADJ	B
IL-1	B-protein	NOUN	B
beta	I-protein	NOUN	O
and	O	CCONJ	O
IL-6	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
expression	O	NOUN	B
involves	O	VERB	O
activation	O	NOUN	B
of	O	ADP	O
an	O	DET	O
H7-inhibitable	O	ADJ	B
pathway	O	NOUN	I
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
maximal	O	ADJ	B
G	O	NOUN	I
(	O	PUNCT	O
Anh	O	PROPN	O
)	O	PUNCT	O
MTetra-induced	O	ADJ	B
IL-1	B-protein	NOUN	B
beta	I-protein	NOUN	O
and	O	CCONJ	O
IL-6	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
expression	O	NOUN	O
could	O	AUX	O
be	O	AUX	O
enhanced	O	VERB	B
by	O	ADP	O
co-stimulation	O	NOUN	B
with	O	ADP	O
LPS	O	NOUN	B
or	O	CCONJ	O
MDP	O	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
different	O	ADJ	O
receptors	O	NOUN	B
and/or	O	CCONJ	O
transduction	O	NOUN	B
pathways	O	NOUN	I
were	O	AUX	O
involved	O	VERB	O
.	O	PUNCT	O


Previous	O	ADJ	O
studies	O	NOUN	B
have	O	AUX	O
suggested	O	VERB	O
that	O	SCONJ	O
gangliosides	O	NOUN	B
have	O	AUX	O
an	O	DET	O
important	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
cell	O	NOUN	B
signaling	O	NOUN	I
and	O	CCONJ	O
recognition	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
treatment	O	NOUN	B
also	O	ADV	O
caused	O	VERB	O
increased	O	VERB	B
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	B
of	O	ADP	O
specific	O	ADJ	O
protein	O	NOUN	B
substrates	O	NOUN	I
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
BCL-6	B-protein	NOUN	B
rearrangements	O	NOUN	B
can	O	AUX	O
be	O	AUX	O
used	O	VERB	O
to	O	PART	O
identify	O	VERB	O
and	O	CCONJ	O
monitor	O	VERB	B
the	O	DET	O
malignant	B-cell_type	ADJ	B
clone	I-cell_type	NOUN	B
with	O	ADP	O
sensitive	O	ADJ	B
PCR-based	O	ADJ	B
techniques	O	NOUN	I
.	O	PUNCT	O


Studies	O	NOUN	B
of	O	ADP	O
pluripotent	B-cell_line	ADJ	B
islet	I-cell_line	NOUN	I
cultures	I-cell_line	NOUN	I
.	O	PUNCT	O


Generation	O	NOUN	B
of	O	ADP	O
CD1+RelB+	B-cell_type	ADJ	O
dendritic	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
tartrate-resistant	B-cell_type	ADJ	B
acid	I-cell_type	NOUN	I
phosphatase-positive	I-cell_type	ADJ	I
osteoclast-like	I-cell_type	ADJ	O
multinucleated	I-cell_type	ADJ	O
giant	I-cell_type	ADJ	O
cells	I-cell_type	NOUN	O
from	O	ADP	O
human	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
monocyte-derived	B-cell_line	ADJ	B
DC	I-cell_line	NOUN	B
were	O	AUX	O
not	O	PART	O
terminally	B-cell_line	ADV	O
differentiated	I-cell_line	VERB	O
cells	I-cell_line	NOUN	O
;	O	PUNCT	O
they	O	PRON	O
could	O	AUX	O
still	O	ADV	O
convert	O	VERB	O
to	O	PART	O
macrophages	B-cell_type	NOUN	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
M-CSF	B-protein	NOUN	B
.	O	PUNCT	O


Tepoxalin	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
dual	O	ADJ	O
enzyme	O	NOUN	B
inhibitor	O	NOUN	I
of	O	ADP	O
cyclooxygenase	B-protein	NOUN	B
and	O	CCONJ	O
5-lipoxygenase	B-protein	NOUN	B
has	O	AUX	O
been	O	AUX	O
shown	O	VERB	O
to	O	PART	O
inhibit	O	VERB	B
T-cell	O	NOUN	B
activation	O	NOUN	I
.	O	PUNCT	O


Its	O	PRON	O
immunosuppressive	O	ADJ	B
property	O	NOUN	I
is	O	AUX	O
distinct	O	ADJ	O
from	O	ADP	O
cyclosporin	O	NOUN	B
because	O	SCONJ	O
only	O	ADV	O
tepoxalin	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
cyclosporin	O	NOUN	B
,	O	PUNCT	O
suppresses	O	VERB	B
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activation	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
mechanism	O	NOUN	B
of	O	ADP	O
inhibition	O	NOUN	B
is	O	AUX	O
related	O	ADJ	O
to	O	PART	O
the	O	DET	O
surface	O	NOUN	B
expression	O	NOUN	B
of	O	ADP	O
several	O	ADJ	O
cell	O	NOUN	B
adhesion	B-protein	NOUN	I
molecules	I-protein	NOUN	I
.	O	PUNCT	O


Characterization	O	NOUN	B
of	O	ADP	O
a	O	DET	O
CD43/leukosialin	B-protein	NOUN	B
-mediated	O	ADJ	O
pathway	O	NOUN	B
for	O	ADP	O
inducing	O	VERB	B
apoptosis	O	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
T-lymphoblastoid	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Sterol	B-DNA	NOUN	B
regulatory	I-DNA	ADJ	I
element	I-DNA	NOUN	I
(	O	PUNCT	O
SRE	B-DNA	NOUN	B
)	O	PUNCT	O
has	O	AUX	O
been	O	AUX	O
recognized	O	VERB	O
to	O	PART	O
regulate	O	VERB	B
various	O	ADJ	O
key	O	ADJ	O
genes	B-DNA	NOUN	B
coding	O	VERB	B
for	O	ADP	O
especially	O	ADV	O
low	B-protein	ADJ	B
density	I-protein	NOUN	I
lipoprotein	I-protein	NOUN	I
(	I-protein	PUNCT	I
LDL	I-protein	NOUN	B
)	I-protein	PUNCT	O
-receptor	I-protein	NOUN	O
,	O	PUNCT	O
3-hydroxy-3-methylglutaryl	B-protein	ADJ	O
coenzyme	I-protein	NOUN	O
A	I-protein	NOUN	O
(	I-protein	PUNCT	O
HMG-CoA	I-protein	NOUN	O
)	I-protein	PUNCT	O
reductase	I-protein	NOUN	O
and	O	CCONJ	O
HMG-CoA	B-protein	NOUN	B
synthase	I-protein	NOUN	I
known	O	VERB	O
to	O	PART	O
play	O	VERB	O
a	O	DET	O
crucial	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
cholesterol	O	NOUN	B
feedback	O	NOUN	I
mechanism	O	NOUN	B
.	O	PUNCT	O


Overexpression	O	NOUN	B
of	O	ADP	O
full-length	O	ADJ	B
SCL	B-protein	NOUN	O
protein	I-protein	NOUN	O
in	O	ADP	O
the	O	DET	O
lymphoid	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
,	O	PUNCT	O
SupT1	O	NOUN	B
and	O	CCONJ	O
Raji	O	NOUN	B
,	O	PUNCT	O
did	O	AUX	O
not	O	PART	O
alter	O	VERB	O
cell	O	NOUN	B
phenotype	O	NOUN	B
and	O	CCONJ	O
there	O	PRON	O
was	O	AUX	O
no	O	DET	O
evidence	O	NOUN	O
for	O	ADP	O
autoregulation	O	NOUN	B
of	O	ADP	O
SCL	B-protein	NOUN	B
transcription	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
restricted	O	ADJ	B
pattern	O	NOUN	B
of	O	ADP	O
SCL	B-protein	NOUN	B
protein	I-protein	NOUN	O
synthesis	O	NOUN	O
is	O	AUX	O
consistent	O	ADJ	B
with	O	ADP	I
the	O	DET	O
restricted	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
SCL	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
documented	O	VERB	B
previously	O	ADV	O
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
present	O	ADJ	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
SCL	B-protein	NOUN	B
protein	I-protein	NOUN	B
size	O	NOUN	I
was	O	AUX	O
determined	O	VERB	O
by	O	ADP	O
regulation	O	NOUN	B
of	O	ADP	O
translation	O	NOUN	B
in	O	ADP	O
a	O	DET	O
cell-specific	O	ADJ	B
manner	O	NOUN	I
.	O	PUNCT	O


Induction	O	NOUN	B
of	O	ADP	O
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	I
and	O	CCONJ	O
T-cell	B-cell_type	NOUN	B
activation	O	NOUN	I
by	O	ADP	O
vanadate	O	NOUN	B
peroxide	O	NOUN	I
,	O	PUNCT	O
an	O	DET	O
inhibitor	O	NOUN	B
of	O	ADP	O
protein	B-protein	NOUN	B
tyrosine	I-protein	NOUN	I
phosphatases	I-protein	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
thus	O	ADV	O
conclude	O	VERB	O
that	O	SCONJ	O
PTPases	B-protein	NOUN	B
play	O	VERB	O
a	O	DET	O
crucial	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
negative	O	ADJ	B
regulation	O	NOUN	B
of	O	ADP	O
signal	O	NOUN	B
transduction	O	NOUN	I
culminating	O	VERB	O
in	O	ADP	O
T-lymphocyte	B-cell_type	NOUN	B
activation	O	NOUN	I
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
identify	O	VERB	O
intracellular	O	ADJ	B
signaling	O	NOUN	B
components	O	NOUN	I
involved	O	VERB	O
in	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
NF-kappaB	B-protein	NOUN	B
following	O	VERB	O
TCR	B-protein	NOUN	B
stimulation	O	NOUN	B
.	O	PUNCT	O


Contrary	O	ADJ	O
to	O	ADP	O
the	O	DET	O
idea	O	NOUN	O
that	O	SCONJ	O
protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
C	I-protein	NOUN	I
is	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
TCR	B-protein	NOUN	B
-mediated	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
NF-kappaB	B-protein	NOUN	B
,	O	PUNCT	O
high	O	ADJ	B
doses	O	NOUN	I
of	O	ADP	O
staurosporine	O	NOUN	B
did	O	AUX	O
not	O	PART	O
interfere	O	VERB	B
with	O	ADP	I
activation	O	NOUN	B
of	O	ADP	O
NF-kappaB	B-protein	NOUN	B
by	O	ADP	O
PHA	B-protein	NOUN	B
,	O	PUNCT	O
while	O	SCONJ	O
the	O	DET	O
same	O	ADJ	O
dose	O	NOUN	B
of	O	ADP	O
staurosporine	O	NOUN	B
completely	O	ADV	O
blocked	O	VERB	B
activation	O	NOUN	B
by	O	ADP	O
PMA	O	NOUN	B
.	O	PUNCT	O


Two	O	NUM	O
multicopy	B-DNA	ADJ	B
basal	I-DNA	ADJ	B
enhancer	I-DNA	NOUN	I
motifs	I-DNA	NOUN	B
within	O	ADP	O
the	O	DET	O
SCMV	O	NOUN	B
MIE	B-DNA	NOUN	O
enhancer	I-DNA	NOUN	B
,	O	PUNCT	O
namely	O	ADV	O
,	O	PUNCT	O
11	O	NUM	O
copies	O	NOUN	B
of	O	ADP	O
the	O	DET	O
16-bp	O	ADJ	O
cyclic	B-DNA	ADJ	B
AMP	I-DNA	NOUN	B
response	I-DNA	NOUN	O
element	I-DNA	NOUN	O
(	O	PUNCT	O
CRE	B-DNA	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
3	O	NUM	O
copies	O	NOUN	B
of	O	ADP	O
novel	O	ADJ	O
17-bp	O	ADJ	O
serum	B-DNA	NOUN	B
response	I-DNA	NOUN	I
factor	I-DNA	NOUN	I
(	I-DNA	PUNCT	O
SRF	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
binding	I-DNA	NOUN	B
sites	I-DNA	NOUN	I
referred	O	VERB	O
to	O	PART	O
as	O	ADP	O
the	O	DET	O
SNE	B-DNA	NOUN	B
(	O	PUNCT	O
SRF/NFkappaB-like	B-DNA	ADJ	B
element	I-DNA	NOUN	I
)	O	PUNCT	O
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
four	O	NUM	O
classical	O	ADJ	O
NFkappaB	B-DNA	NOUN	B
sites	I-DNA	NOUN	I
within	O	ADP	O
the	O	DET	O
HCMV	O	NOUN	B
version	O	NOUN	B
,	O	PUNCT	O
contribute	O	VERB	O
to	O	PART	O
TPA	O	NOUN	B
responsiveness	O	NOUN	B
in	O	ADP	O
transient	O	ADJ	B
assays	O	NOUN	I
in	O	ADP	O
monocyte	B-cell_type	NOUN	B
and	I-cell_type	CCONJ	O
T-cell	I-cell_type	NOUN	B
types	I-cell_type	NOUN	I
.	O	PUNCT	O


The	O	DET	O
survival	O	NOUN	B
rate	O	NOUN	I
of	O	ADP	O
tal-1	B-DNA	NOUN	B
transgenic	O	ADJ	B
animals	O	NOUN	I
was	O	AUX	O
much	O	ADV	O
lower	O	ADJ	O
as	O	ADP	O
compared	O	VERB	B
with	O	ADP	O
control	O	ADJ	B
mice	O	NOUN	B
.	O	PUNCT	O


Primary	B-cell_line	ADJ	B
lymphocyte	I-cell_line	NOUN	I
cultures	I-cell_line	NOUN	I
showed	O	VERB	O
partial	O	ADJ	B
independence	O	NOUN	B
from	O	ADP	O
exogenous	O	ADJ	B
growth	O	NOUN	B
stimuli	O	NOUN	I
and	O	CCONJ	O
increased	O	VERB	B
resistance	O	NOUN	B
to	O	PART	O
low-serum	O	ADJ	B
apoptosis	O	NOUN	B
.	O	PUNCT	O


TSC2	B-DNA	NOUN	B
is	O	AUX	O
a	O	DET	O
gene	O	NOUN	B
on	O	ADP	O
chromosome	B-DNA	NOUN	B
16p13.3	I-DNA	NOUN	I
associated	O	VERB	B
with	O	ADP	I
the	O	DET	O
autosomal	O	ADJ	B
dominant	O	ADJ	O
neurocutaneous	O	ADJ	B
disorder	O	NOUN	I
,	O	PUNCT	O
tuberous	O	ADJ	B
sclerosis	O	NOUN	I
complex	O	NOUN	I
(	O	PUNCT	O
TSC	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


By	O	ADP	O
using	O	VERB	O
a	O	DET	O
partial	O	ADJ	B
nucleotide	O	NOUN	B
sequence	O	NOUN	I
from	O	ADP	O
the	O	DET	O
cloned	O	VERB	B
TSC2	B-DNA	NOUN	B
and	O	CCONJ	O
polymerase	O	NOUN	B
chain	O	NOUN	I
reaction	O	NOUN	I
methodology	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
constructed	O	VERB	O
a	O	DET	O
digoxigenin-labeled	B-DNA	ADJ	B
complementary	I-DNA	ADJ	I
DNA	I-DNA	NOUN	I
probe	I-DNA	NOUN	I
to	O	PART	O
examine	O	VERB	O
TSC2	B-DNA	NOUN	B
gene	O	NOUN	I
expression	O	NOUN	B
in	O	ADP	O
autopsy-	O	NOUN	O
or	O	CCONJ	O
biopsy-derived	O	ADJ	B
human	O	ADJ	B
tissues	O	NOUN	B
by	O	ADP	O
in	O	X	B
situ	O	X	I
hybridization	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
peripheral	B-cell_type	ADJ	B
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
use	O	VERB	O
distinct	O	ADJ	O
apoptosis	O	NOUN	B
signaling	O	NOUN	O
pathways	O	NOUN	O
with	O	ADP	O
differential	O	ADJ	O
sensitivity	O	NOUN	O
to	O	PART	O
Bcl-2	B-protein	NOUN	B
and	O	CCONJ	O
interleukin-1beta-converting	O	ADJ	B
enzyme	O	NOUN	O
family	O	NOUN	O
protease	O	NOUN	O
inhibitors	O	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
EL-4	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
incubated	O	VERB	B
with	O	ADP	O
ciprofloxacin	O	NOUN	B
showed	O	VERB	O
an	O	DET	O
early	O	ADJ	B
peak	O	NOUN	O
and	O	CCONJ	O
more	O	ADV	O
activated	O	VERB	B
nuclear	O	ADJ	O
factor	O	NOUN	O
of	O	ADP	O
activated	B-cell_type	VERB	B
T	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
(	O	PUNCT	O
NFAT-1	B-protein	NOUN	B
)	O	PUNCT	O
as	O	ADP	O
compared	O	VERB	B
to	O	PART	O
control	O	NOUN	B
cells	O	NOUN	I
without	O	ADP	O
antibiotics	O	NOUN	B
.	O	PUNCT	O


Human	O	ADJ	B
T-cell	O	NOUN	I
leukemia	O	NOUN	I
virus	O	NOUN	O
type	O	NOUN	O
I	O	NUM	O
(	O	PUNCT	O
HTLV-I	O	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
the	O	DET	O
etiologic	O	ADJ	B
agent	O	NOUN	I
of	O	ADP	O
the	O	DET	O
adult	O	ADJ	B
T-cell	O	NOUN	B
leukemia	O	NOUN	I
,	O	PUNCT	O
an	O	DET	O
aggressive	O	ADJ	B
and	O	CCONJ	O
often	O	ADV	O
fatal	O	ADJ	B
malignancy	O	NOUN	B
of	O	ADP	O
activated	B-cell_line	VERB	B
human	I-cell_line	ADJ	B
CD4	I-cell_line	NOUN	O
T	I-cell_line	NOUN	O
cells	I-cell_line	NOUN	O
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
physical	O	ADJ	B
interaction	O	NOUN	I
of	O	ADP	O
Tax	B-protein	NOUN	B
with	O	ADP	O
p100	B-protein	NOUN	B
leads	O	VERB	O
to	O	PART	O
the	O	DET	O
inhibition	O	NOUN	B
of	O	ADP	O
Tax	B-protein	NOUN	B
-induced	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
HTLV-I	O	NOUN	B
and	O	CCONJ	O
human	B-DNA	ADJ	B
immunodeficiency	I-DNA	NOUN	I
virus	I-DNA	NOUN	I
type	I-DNA	NOUN	I
1	I-DNA	NUM	I
long	I-DNA	ADJ	I
terminal	I-DNA	ADJ	I
repeats	I-DNA	NOUN	I
,	O	PUNCT	O
reflecting	O	VERB	O
p100	B-protein	NOUN	B
-mediated	O	ADJ	O
cytoplasmic	O	ADJ	B
sequestration	O	NOUN	B
of	O	ADP	O
the	O	DET	O
normally	O	ADV	O
nuclearly	O	ADV	B
expressed	O	VERB	B
Tax	B-protein	NOUN	B
protein	I-protein	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
a	O	DET	O
mutant	O	NOUN	B
of	O	ADP	O
Tax	B-protein	NOUN	B
that	O	PRON	O
selectively	O	ADV	O
fails	O	VERB	O
to	O	PART	O
activate	O	VERB	B
nuclear	O	ADJ	B
NF-kappa	B-protein	NOUN	I
B	I-protein	NOUN	I
expression	O	NOUN	B
does	O	AUX	O
not	O	PART	O
associate	O	VERB	B
with	O	ADP	I
p100	B-protein	NOUN	B
.	O	PUNCT	O


Function	O	NOUN	B
and	O	CCONJ	O
activation	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
in	O	ADP	O
the	O	DET	O
immune	O	ADJ	B
system	O	NOUN	I
.	O	PUNCT	O


An	O	DET	O
exception	O	NOUN	B
is	O	AUX	O
the	O	DET	O
Bcl-3	B-protein	NOUN	B
protein	I-protein	NOUN	I
which	O	DET	O
in	O	ADP	O
addition	O	NOUN	O
can	O	AUX	O
function	O	VERB	B
as	O	ADP	O
a	O	DET	O
transcription	B-protein	NOUN	B
activating	I-protein	NOUN	I
subunit	I-protein	NOUN	I
in	O	ADP	O
th	O	DET	O
nucleus	O	NOUN	B
.	O	PUNCT	O


As	O	ADP	O
a	O	DET	O
target	O	NOUN	B
for	O	ADP	O
DNA	O	NOUN	B
methylation	O	NOUN	I
and	O	CCONJ	O
for	O	ADP	O
binding	O	NOUN	B
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
that	O	PRON	O
mediate	O	VERB	O
or	O	CCONJ	O
impede	O	VERB	O
transcription	O	NOUN	B
,	O	PUNCT	O
this	O	DET	O
element	O	NOUN	B
appears	O	VERB	O
to	O	PART	O
play	O	VERB	O
a	O	DET	O
central	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
controlling	O	VERB	O
IFN-gamma	B-protein	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


CD40	B-protein	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
lipopolysaccharide	O	NOUN	B
and	O	CCONJ	O
anti-IgM	B-protein	ADJ	B
stimulation	O	NOUN	B
of	O	ADP	O
primary	B-cell_type	ADJ	B
B	I-cell_type	NOUN	I
lymphocytes	I-cell_type	NOUN	I
,	O	PUNCT	O
leads	O	VERB	O
to	O	PART	O
a	O	DET	O
persistent	O	ADJ	B
nuclear	O	ADJ	B
accumulation	O	NOUN	B
of	O	ADP	O
RelB	B-protein	NOUN	B
.	O	PUNCT	O


High	O	ADJ	O
levels	O	NOUN	B
of	O	ADP	O
Sp140	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
were	O	AUX	O
detected	O	VERB	B
in	O	ADP	O
human	O	ADJ	B
spleen	O	NOUN	B
and	O	CCONJ	O
peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
leukocytes	I-cell_type	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
other	O	ADJ	O
human	O	ADJ	B
tissues	O	NOUN	B
.	O	PUNCT	O


Regulation	O	NOUN	B
of	O	ADP	O
cytokine	B-protein	NOUN	B
and	O	CCONJ	O
cytokine	B-protein	NOUN	B
receptor	I-protein	NOUN	I
expression	O	NOUN	B
by	O	ADP	O
glucocorticoids	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
to	O	PART	O
their	O	PRON	O
inhibitory	O	ADJ	B
effects	O	NOUN	O
on	O	ADP	O
cytokine	B-protein	NOUN	B
expression	O	NOUN	B
,	O	PUNCT	O
GCS	O	NOUN	B
up-regulate	O	VERB	B
cytokine	B-protein	NOUN	B
receptor	I-protein	NOUN	I
expression	O	NOUN	B
that	O	PRON	O
correlates	O	VERB	O
with	O	ADP	O
enhanced	O	VERB	B
cytokine	B-protein	NOUN	B
effects	O	NOUN	I
on	O	ADP	O
target	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Murine	B-DNA	ADJ	B
fra-1	I-DNA	NOUN	B
was	O	AUX	O
highly	O	ADV	O
homologous	O	ADJ	B
to	O	PART	O
rat	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
human	I-DNA	ADJ	B
fra-1	I-DNA	NOUN	B
.	O	PUNCT	O


Pharmacological	O	ADJ	B
modification	O	NOUN	B
of	O	ADP	O
cytokine	B-protein	NOUN	B
dysregulation	O	NOUN	I
,	O	PUNCT	O
therefore	O	ADV	O
,	O	PUNCT	O
has	O	AUX	O
been	O	AUX	O
suggested	O	VERB	O
as	O	ADP	O
a	O	DET	O
therapeutic	O	ADJ	B
modality	O	NOUN	I
for	O	ADP	O
HIV-1	O	NOUN	B
infection	O	NOUN	B
.	O	PUNCT	O


Pentoxifylline	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
trisubstituted	O	ADJ	B
xanthine	O	NOUN	I
derivative	O	NOUN	I
,	O	PUNCT	O
has	O	AUX	O
been	O	AUX	O
used	O	VERB	O
to	O	PART	O
decrease	O	VERB	B
blood	O	NOUN	B
viscosity	O	NOUN	I
and	O	CCONJ	O
is	O	AUX	O
reasonably	O	ADV	O
well	O	ADV	O
tolerated	O	VERB	B
by	O	ADP	O
most	O	ADJ	O
recipients	O	NOUN	B
of	O	ADP	O
the	O	DET	O
drug	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
report	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
PB1	B-DNA	NOUN	B
element	I-DNA	NOUN	B
alone	O	ADV	O
confers	O	VERB	O
inducibility	O	NOUN	B
on	O	ADP	O
a	O	DET	O
heterologous	O	ADJ	B
promoter	O	NOUN	B
following	O	VERB	O
transfection	O	NOUN	B
into	O	ADP	O
human	B-cell_line	ADJ	B
Jurkat	I-cell_line	NOUN	O
T	I-cell_line	NOUN	O
cells	I-cell_line	NOUN	O
.	O	PUNCT	O


These	O	DET	O
findings	O	NOUN	B
may	O	AUX	O
have	O	AUX	O
important	O	ADJ	O
implications	O	NOUN	O
for	O	ADP	O
the	O	DET	O
design	O	NOUN	B
of	O	ADP	O
alternative	O	ADJ	B
treatment	O	NOUN	O
approaches	O	NOUN	O
for	O	ADP	O
recalcitrant	O	ADJ	B
asthma	O	NOUN	B
.	O	PUNCT	O


Low	O	ADJ	B
risk	O	NOUN	B
women	O	NOUN	B
were	O	AUX	O
those	O	DET	O
without	O	ADP	O
these	O	DET	O
or	O	CCONJ	O
other	O	ADJ	O
major	O	ADJ	O
identifiable	O	ADJ	O
risk	O	NOUN	B
factors	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
prevalence	O	NOUN	B
of	O	ADP	O
aneuploidy	O	NOUN	B
and	O	CCONJ	O
overexpressed	O	VERB	B
EGFR	B-protein	NOUN	B
was	O	AUX	O
significantly	O	ADV	O
higher	O	ADJ	O
in	O	ADP	O
the	O	DET	O
high	O	ADJ	B
risk	O	NOUN	I
women	O	NOUN	B
than	O	ADP	O
in	O	ADP	O
the	O	DET	O
25	O	NUM	O
low	O	ADJ	B
risk	O	NOUN	I
controls	O	NOUN	I
(	O	PUNCT	O
p	O	NOUN	O
<	O	X	O
0.002	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
whose	O	DET	O
median	O	ADJ	B
10	O	NUM	O
year	O	NOUN	B
Gail	O	PROPN	B
risk	O	NOUN	I
was	O	AUX	O
0.7	O	NUM	O
%	O	NOUN	O
.	O	PUNCT	O


This	O	DET	O
may	O	AUX	O
be	O	AUX	O
due	O	ADJ	O
to	O	PART	O
the	O	DET	O
low	O	ADJ	B
prevalence	O	NOUN	B
of	O	ADP	O
overexpressed	O	VERB	B
ER	B-protein	NOUN	B
and	O	CCONJ	O
the	O	DET	O
small	O	ADJ	O
number	O	NOUN	O
of	O	ADP	O
controls	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
significant	O	ADJ	O
difference	O	NOUN	O
was	O	AUX	O
noted	O	VERB	O
in	O	ADP	O
the	O	DET	O
prevalence	O	NOUN	B
of	O	ADP	O
one	O	NUM	O
or	O	CCONJ	O
more	O	ADV	O
abnormal	O	ADJ	B
biomarkers	O	NOUN	B
between	O	ADP	O
the	O	DET	O
high	O	ADJ	B
risk	O	NOUN	I
and	O	CCONJ	O
low	O	ADJ	B
risk	O	NOUN	I
women	O	NOUN	B
(	O	PUNCT	O
p	O	NOUN	O
<	O	X	O
0.001	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Inhibition	O	NOUN	B
of	O	ADP	O
nuclear	B-RNA	ADJ	B
factor	I-RNA	NOUN	I
kappa	I-RNA	NOUN	I
B	I-RNA	NOUN	I
subunit	I-RNA	NOUN	I
p65	I-RNA	NOUN	I
mRNA	I-RNA	NOUN	B
accumulation	O	NOUN	B
in	O	ADP	O
lipopolysaccharide-stimulated	B-cell_line	ADJ	B
human	I-cell_line	ADJ	O
monocytic	I-cell_line	ADJ	O
cells	I-cell_line	NOUN	O
treated	O	VERB	B
with	O	ADP	I
sodium	O	NOUN	B
salicylate	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
observed	O	VERB	O
that	O	SCONJ	O
dexamethasone	O	NOUN	B
dramatically	O	ADV	O
inhibited	O	VERB	B
RANTES	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
expression	O	NOUN	B
dose	O	NOUN	I
dependently	O	ADV	O
in	O	ADP	O
anti-CD3	B-cell_line	ADJ	B
activated	I-cell_line	VERB	B
Hut-78	I-cell_line	NOUN	O
T	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
and	O	CCONJ	O
human	B-cell_type	ADJ	B
PBMCs	I-cell_type	NOUN	B
.	O	PUNCT	O


Inhibition	O	NOUN	B
of	O	ADP	O
RANTES	B-protein	NOUN	B
expression	O	NOUN	B
did	O	AUX	O
not	O	PART	O
appear	O	VERB	O
to	O	PART	O
be	O	AUX	O
secondary	O	ADJ	B
to	O	PART	I
IL-2	B-protein	NOUN	B
inhibition	O	NOUN	B
and	O	CCONJ	O
required	O	VERB	O
binding	O	NOUN	B
to	O	PART	O
the	O	DET	O
intracellular	O	ADJ	B
glucocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
.	O	PUNCT	O


Association	O	NOUN	B
of	O	ADP	O
TRAF1	B-protein	NOUN	B
,	O	PUNCT	O
TRAF2	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
TRAF3	B-protein	NOUN	B
with	O	ADP	O
an	O	DET	O
Epstein-Barr	B-DNA	ADJ	B
virus	I-DNA	NOUN	I
LMP1	I-DNA	NOUN	B
domain	I-DNA	NOUN	B
important	O	ADJ	O
for	O	ADP	O
B-lymphocyte	B-cell_type	NOUN	B
transformation	O	NOUN	B
:	O	PUNCT	O
role	O	NOUN	O
in	O	ADP	O
NF-kappaB	B-protein	NOUN	B
activation	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
demonstrated	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
virus	B-protein	NOUN	B
dUTPase	I-protein	NOUN	B
isolated	O	VERB	B
from	O	ADP	O
EBV-infected	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
is	O	AUX	O
a	O	DET	O
phosphoprotein	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
protein	O	NOUN	B
expressed	O	VERB	B
in	O	ADP	O
insect	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
was	O	AUX	O
used	O	VERB	O
to	O	PART	O
test	O	VERB	B
for	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
specific	B-protein	ADJ	O
antibodies	I-protein	NOUN	B
in	O	ADP	O
sera	O	NOUN	B
from	O	ADP	O
normal	O	ADJ	B
,	O	PUNCT	O
healthy	O	ADJ	B
carriers	O	NOUN	I
and	O	CCONJ	O
from	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
various	O	ADJ	O
diseases	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
indicated	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
dUTPase	O	NOUN	B
is	O	AUX	O
expressed	O	VERB	B
during	O	ADP	O
EBV	O	NOUN	B
replication	O	NOUN	B
and	O	CCONJ	O
reactivation	O	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
it	O	PRON	O
has	O	AUX	O
been	O	AUX	O
recently	O	ADV	O
reported	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
NH2	B-protein	NOUN	B
regulatory	B-protein	ADJ	B
domain	I-protein	NOUN	I
is	O	AUX	O
sufficient	O	ADJ	O
to	O	PART	O
mediate	O	VERB	O
CD4	B-protein	NOUN	B
accessory	O	ADJ	B
function	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
findings	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
there	O	PRON	O
is	O	AUX	O
no	O	DET	O
primary	O	ADJ	O
and	O	CCONJ	O
general	O	ADJ	B
impairment	O	NOUN	I
of	O	ADP	O
glucocorticoid	O	NOUN	B
metabolism	O	NOUN	I
in	O	ADP	O
the	O	DET	O
asthmatics	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
the	O	DET	O
number	O	NOUN	O
of	O	ADP	O
GCR	B-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
asthmatics	O	NOUN	B
is	O	AUX	O
lower	O	ADJ	O
than	O	ADP	O
that	O	DET	O
in	O	ADP	O
healthy	O	ADJ	B
controls	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
involve	O	VERB	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
sodium/proton-exchanger	B-protein	NOUN	B
of	O	ADP	O
the	O	DET	O
cell	O	NOUN	B
membrane	O	NOUN	I
at	O	ADP	O
very	O	ADV	O
low	O	ADJ	O
,	O	PUNCT	O
physiological	O	ADJ	B
concentrations	O	NOUN	B
of	O	ADP	O
aldosterone	O	NOUN	B
with	O	ADP	O
an	O	DET	O
acute	O	ADJ	B
onset	O	NOUN	O
within	O	ADP	O
1-2	O	NUM	O
minutes	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
present	O	ADJ	O
paper	O	NOUN	O
reviews	O	VERB	B
the	O	DET	O
data	O	NOUN	B
supporting	O	VERB	O
a	O	DET	O
new	O	ADJ	O
,	O	PUNCT	O
two-step	O	ADJ	O
model	O	NOUN	B
for	O	ADP	O
non-genomic	O	ADJ	B
and	O	CCONJ	O
genomic	O	ADJ	B
aldosterone	O	NOUN	I
effects	O	NOUN	B
.	O	PUNCT	O


Mutations	O	NOUN	B
in	O	ADP	O
this	O	DET	O
site	O	NOUN	B
which	O	DET	O
eliminate	O	VERB	O
PU.1	B-protein	NOUN	B
binding	O	NOUN	B
decrease	O	VERB	B
M-CSF	B-protein	NOUN	B
receptor	I-protein	NOUN	I
promoter	O	NOUN	B
activity	O	NOUN	I
significantly	O	ADV	O
in	O	ADP	O
macrophage	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
only	O	ADV	O
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
PU.1	B-protein	NOUN	B
transactivates	O	VERB	B
the	O	DET	O
M-CSF	B-DNA	NOUN	B
receptor	I-DNA	NOUN	I
promoter	I-DNA	NOUN	B
in	O	ADP	O
nonmacrophage	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


The	O	DET	O
authors	O	NOUN	B
investigated	O	VERB	B
whether	O	SCONJ	O
there	O	PRON	O
is	O	AUX	O
a	O	DET	O
correlation	O	NOUN	B
between	O	ADP	O
HER-2/neu	B-protein	NOUN	B
expression	O	NOUN	B
and	O	CCONJ	O
immunologic	O	ADJ	B
parameters	O	NOUN	B
representing	O	VERB	O
tumor	O	NOUN	B
defense	O	NOUN	I
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
breast	O	NOUN	B
cancer	O	NOUN	I
.	O	PUNCT	O


Within	O	ADP	O
this	O	DET	O
group	O	NOUN	B
of	O	ADP	O
patients	O	NOUN	B
,	O	PUNCT	O
NK	B-cell_type	NOUN	B
cell	I-cell_type	NOUN	I
activity	O	NOUN	B
was	O	AUX	O
significantly	O	ADV	O
lower	O	ADJ	O
(	O	PUNCT	O
45.6	O	NUM	O
+/-	O	CCONJ	O
16.1	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
compared	O	VERB	B
with	O	ADP	O
the	O	DET	O
group	O	NOUN	B
with	O	ADP	O
no	O	DET	O
HER-2/neu	B-protein	NOUN	B
overexpression	O	NOUN	B
(	O	PUNCT	O
57.3	O	NUM	O
+/-	O	CCONJ	O
11.0	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
.	O	PUNCT	O


CONCLUSION	O	NOUN	O
.	O	PUNCT	O


No	O	DET	B
difference	O	NOUN	I
in	O	ADP	O
plasma	O	NOUN	B
cortisol	O	NOUN	O
was	O	AUX	O
found	O	VERB	O
between	O	ADP	O
the	O	DET	O
patients	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
healthy	O	ADJ	B
subjects	O	NOUN	I
(	O	PUNCT	O
P	O	NOUN	O
>	O	X	O
0.05	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
IL-4	B-protein	NOUN	B
signaling	O	NOUN	B
occurs	O	VERB	O
in	O	ADP	O
the	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
of	O	ADP	O
JAK3	B-protein	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
is	O	AUX	O
comparatively	O	ADV	O
inefficient	O	ADJ	B
.	O	PUNCT	O


IL-2R	B-protein	NOUN	B
alpha	I-protein	NOUN	B
transcription	O	NOUN	I
is	O	AUX	O
at	O	ADP	O
least	O	ADJ	O
in	O	ADP	O
part	O	NOUN	O
controlled	O	VERB	B
by	O	ADP	O
two	O	NUM	O
positive	B-protein	ADJ	B
regulatory	I-protein	ADJ	B
regions	I-protein	NOUN	I
,	O	PUNCT	O
PRRI	B-DNA	NOUN	B
and	O	CCONJ	O
PRRII	B-DNA	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
none	O	NOUN	O
of	O	ADP	O
these	O	DET	O
proximal	O	ADJ	B
regions	O	NOUN	I
account	O	VERB	O
for	O	ADP	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
IL-2R	O	NOUN	B
alpha	O	NOUN	O
transcription	O	NOUN	O
by	O	ADP	O
IL-2	B-protein	NOUN	B
.	O	PUNCT	O


To	O	PART	O
confirm	O	VERB	O
the	O	DET	O
physiological	O	ADJ	B
relevance	O	NOUN	B
of	O	ADP	O
these	O	DET	O
findings	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
carried	O	VERB	O
out	O	ADP	O
in	O	X	B
vivo	O	X	I
footprinting	O	NOUN	O
experiments	O	NOUN	B
which	O	DET	O
showed	O	VERB	O
that	O	SCONJ	O
stimulation	O	NOUN	B
of	O	ADP	O
IL-2R	B-protein	NOUN	B
alpha	I-protein	NOUN	O
expression	O	NOUN	B
correlated	O	VERB	B
with	O	ADP	O
occupancy	O	NOUN	B
of	O	ADP	O
the	O	DET	O
GASd	B-DNA	NOUN	B
element	I-DNA	NOUN	B
.	O	PUNCT	O


An	O	DET	O
overexpression	O	NOUN	B
of	O	ADP	O
p50	B-protein	NOUN	B
has	O	AUX	O
been	O	AUX	O
described	O	VERB	O
in	O	ADP	O
follicular	B-cell_type	ADJ	B
dendritic	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
(	O	PUNCT	O
FDC	B-cell_type	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


In	O	ADP	O
T	O	NOUN	B
cell	O	NOUN	I
areas	O	NOUN	O
,	O	PUNCT	O
p50	B-protein	NOUN	B
,	O	PUNCT	O
p52	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
RelB	B-protein	NOUN	B
were	O	AUX	O
found	O	VERB	O
in	O	ADP	O
the	O	DET	O
nuclei	O	NOUN	B
of	O	ADP	O
HLA-DR+	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
with	O	ADP	O
an	O	DET	O
antigen-presenting	O	ADJ	B
cell	O	NOUN	I
(	O	PUNCT	O
APC	O	NOUN	B
)	O	PUNCT	O
morphology	O	NOUN	B
.	O	PUNCT	O


Cells	O	NOUN	B
with	O	ADP	O
nuclear	O	ADJ	B
p50	B-protein	NOUN	I
were	O	AUX	O
negative	O	ADJ	B
for	O	ADP	O
the	O	DET	O
CD38	B-protein	NOUN	B
,	O	PUNCT	O
CD20	B-protein	NOUN	B
and	O	CCONJ	O
CD2	B-protein	NOUN	B
markers	I-protein	NOUN	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
show	O	VERB	O
that	O	SCONJ	O
,	O	PUNCT	O
physiologically	O	ADV	B
,	O	PUNCT	O
high	O	ADJ	O
levels	O	NOUN	B
of	O	ADP	O
nuclear	O	ADJ	B
of	O	ADP	O
p50	B-protein	NOUN	B
,	O	PUNCT	O
p52	B-protein	NOUN	B
and	O	CCONJ	O
RelB	B-protein	NOUN	B
are	O	AUX	O
restricted	O	ADJ	O
to	O	PART	O
accessory	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
of	O	ADP	O
the	O	DET	O
immune	O	ADJ	B
system	O	NOUN	I
,	O	PUNCT	O
which	O	DET	O
include	O	VERB	O
FDC	B-cell_type	NOUN	B
in	O	ADP	O
GC	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
DC	B-cell_type	NOUN	B
and	O	CCONJ	O
macrophages	O	NOUN	B
in	O	ADP	O
the	O	DET	O
T	O	NOUN	B
cell	O	NOUN	I
zone	O	NOUN	I
,	O	PUNCT	O
that	O	SCONJ	O
specialized	O	ADJ	O
scavenger	B-cell_type	NOUN	B
macrophages	I-cell_type	NOUN	I
from	O	ADP	O
GC	B-cell_type	NOUN	B
do	O	AUX	O
not	O	PART	O
have	O	AUX	O
detectable	O	ADJ	B
levels	O	NOUN	B
of	O	ADP	O
p52	B-protein	NOUN	B
and	O	CCONJ	O
RelB	B-protein	NOUN	B
,	O	PUNCT	O
whereas	O	SCONJ	O
macrophages	B-cell_type	NOUN	B
from	O	ADP	O
the	O	DET	O
T	O	NOUN	B
cell	O	NOUN	I
area	O	NOUN	O
,	O	PUNCT	O
known	O	VERB	O
to	O	PART	O
present	O	VERB	O
the	O	DET	O
antigen	O	NOUN	B
to	O	PART	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
do	O	AUX	O
have	O	AUX	O
both	O	CCONJ	O
nuclear	O	ADJ	B
p52	B-protein	NOUN	I
and	O	CCONJ	O
RelB	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
that	O	SCONJ	O
in	O	ADP	O
the	O	DET	O
T	O	NOUN	B
cell	O	NOUN	I
zone	O	NOUN	I
,	O	PUNCT	O
p52	B-protein	NOUN	B
and	O	CCONJ	O
RelB	B-protein	NOUN	B
are	O	AUX	O
located	O	ADJ	O
in	O	ADP	O
nuclei	O	NOUN	B
of	O	ADP	O
both	O	CCONJ	O
CD1a+	B-cell_line	NOUN	B
,	O	PUNCT	O
CD68+	B-cell_line	ADJ	B
or	O	CCONJ	O
both	O	DET	O
,	O	PUNCT	O
cells	O	NOUN	B
APC	B-cell_type	NOUN	B
,	O	PUNCT	O
whereas	O	SCONJ	O
p50	B-protein	NOUN	B
is	O	AUX	O
restricted	O	ADJ	O
to	O	PART	O
CD1a-	B-cell_type	NOUN	B
and	O	CCONJ	O
CD68-	B-cell_type	NOUN	B
APC	I-cell_type	NOUN	B
.	O	PUNCT	O


Intron-exon	O	ADJ	B
organization	O	NOUN	I
and	O	CCONJ	O
functional	O	ADJ	B
analysis	O	NOUN	I
of	O	ADP	O
5'-flanking	B-DNA	ADJ	B
region	I-DNA	NOUN	I
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
interferon	B-protein	NOUN	B
regulatory	I-protein	ADJ	I
factor	I-protein	NOUN	I
1	I-protein	NUM	I
not	O	PART	O
only	O	ADV	O
triggers	O	VERB	B
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
interferon	B-protein	NOUN	B
signal	O	NOUN	I
transduction	O	NOUN	I
pathway	O	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
also	O	ADV	O
may	O	AUX	O
play	O	VERB	O
a	O	DET	O
role	O	NOUN	O
in	O	ADP	O
limiting	O	VERB	O
the	O	DET	O
duration	O	NOUN	B
of	O	ADP	O
this	O	DET	O
response	O	NOUN	B
by	O	ADP	O
activating	O	VERB	B
the	O	DET	O
transcription	O	NOUN	B
of	O	ADP	O
IRF-2	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
human	B-protein	ADJ	B
myeloid	I-protein	ADJ	O
cell	I-protein	NOUN	O
nuclear	I-protein	ADJ	B
differentiation	I-protein	NOUN	I
antigen	I-protein	NOUN	I
(	O	PUNCT	O
MNDA	B-protein	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
expressed	O	VERB	B
constitutively	O	ADV	B
in	O	ADP	O
cells	O	NOUN	B
of	O	ADP	O
the	O	DET	O
myeloid	B-cell_type	ADJ	B
lineage	I-cell_type	NOUN	I
,	O	PUNCT	O
appearing	O	VERB	O
in	O	ADP	O
myeloblast	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
in	O	ADP	O
some	O	DET	O
cases	O	NOUN	B
of	O	ADP	O
acute	O	ADJ	B
myeloid	O	ADJ	I
leukemia	O	NOUN	I
and	O	CCONJ	O
consistently	O	ADV	O
being	O	AUX	O
detected	O	VERB	B
in	O	ADP	O
promyelocyte	B-cell_type	ADJ	B
stage	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
in	O	ADP	O
all	O	DET	O
later	B-cell_type	ADJ	O
stage	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
including	O	VERB	O
peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
monocytes	I-cell_type	NOUN	I
and	O	CCONJ	O
granulocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


The	O	DET	O
human	B-cell_line	ADJ	B
myeloid	I-cell_line	ADJ	I
leukemia	I-cell_line	NOUN	I
cell	I-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
,	O	PUNCT	O
HL-60	B-cell_line	NOUN	B
,	O	PUNCT	O
U937	B-cell_line	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
THP-1	B-cell_line	NOUN	B
,	O	PUNCT	O
express	O	VERB	O
similar	O	ADJ	O
levels	O	NOUN	B
of	O	ADP	O
immunochemically	O	ADV	B
detectable	O	ADJ	B
MNDA	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
MNDA	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
level	O	NOUN	B
in	O	ADP	O
the	O	DET	O
myeloid	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
was	O	AUX	O
also	O	ADV	O
unaffected	O	ADJ	O
by	O	ADP	O
the	O	DET	O
latter	O	ADJ	O
four	O	NUM	O
agents	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
effects	O	NOUN	B
of	O	ADP	O
phorbol	O	NOUN	B
ester	O	NOUN	I
on	O	ADP	O
MNDA	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
appeared	O	VERB	O
to	O	PART	O
be	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
induced	O	VERB	B
differentiation	O	NOUN	B
since	O	SCONJ	O
inhibiting	O	VERB	B
cell	O	NOUN	B
proliferation	O	NOUN	I
did	O	AUX	O
not	O	PART	O
alter	O	VERB	O
the	O	DET	O
level	O	NOUN	B
of	O	ADP	O
MNDA	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
and	O	CCONJ	O
cell	O	NOUN	B
cycle	O	NOUN	I
variation	O	NOUN	B
in	O	ADP	O
MNDA	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
levels	O	NOUN	O
were	O	AUX	O
not	O	PART	O
observed	O	VERB	O
.	O	PUNCT	O


An	O	DET	O
affinity	O	NOUN	B
column	O	NOUN	I
fraction	O	NOUN	B
,	O	PUNCT	O
containing	O	VERB	O
p37	B-protein	NOUN	B
,	O	PUNCT	O
stimulated	O	VERB	B
HTLV-I	O	NOUN	B
transcription	O	NOUN	I
approximately	O	ADV	O
12-fold	O	ADV	O
in	O	X	B
vitro	O	X	I
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
we	O	PRON	O
supplemented	O	VERB	O
one	O	NUM	O
group	O	NOUN	B
of	O	ADP	O
individuals	O	NOUN	B
with	O	ADP	O
a	O	DET	O
daily	O	ADV	B
oral	O	ADJ	B
replacement	O	NOUN	I
dose	O	NOUN	I
of	O	ADP	O
T3	O	NOUN	B
to	O	PART	O
isolate	O	VERB	B
the	O	DET	O
influence	O	NOUN	B
of	O	ADP	O
serum	O	NOUN	B
thyroxine	O	NOUN	I
(	O	PUNCT	O
T4	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
thyrotropin	O	NOUN	B
(	O	PUNCT	I
TSH	O	NOUN	I
)	O	PUNCT	I
levels	O	NOUN	B
on	O	ADP	O
receptor	O	NOUN	B
kinetics	O	NOUN	B
.	O	PUNCT	O


Mononuclear	B-cell_type	ADJ	B
leukocytes	I-cell_type	NOUN	B
were	O	AUX	O
isolated	O	VERB	B
from	O	ADP	O
peripheral	O	ADJ	B
blood	O	NOUN	I
before	O	ADP	O
the	O	DET	O
cold	O	ADJ	B
exposure	O	NOUN	I
and	O	CCONJ	O
drug	O	NOUN	B
regimen	O	NOUN	I
began	O	VERB	O
,	O	PUNCT	O
and	O	CCONJ	O
then	O	ADV	O
after	O	ADP	O
every	O	DET	O
20	O	NUM	O
exposures	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
dissociation	O	NOUN	B
constant	O	NOUN	I
(	O	PUNCT	O
Kd	O	NOUN	O
)	O	PUNCT	O
and	O	CCONJ	O
maximum	O	ADJ	B
binding	O	NOUN	I
capacity	O	NOUN	I
(	O	PUNCT	O
MBC	O	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
the	O	DET	O
NT3R	B-protein	NOUN	B
values	O	NOUN	B
were	O	AUX	O
log	O	NOUN	B
transformed	O	VERB	I
to	O	PART	O
minimize	O	VERB	O
between-subject	O	ADJ	B
variability	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
cells	O	NOUN	B
preincubated	O	VERB	B
for	O	ADP	O
a	O	DET	O
day	O	NOUN	B
,	O	PUNCT	O
levels	O	NOUN	B
of	O	ADP	O
FOS	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
reach	O	VERB	O
a	O	DET	O
maximum	O	NOUN	B
20	O	NUM	O
min	O	NOUN	O
after	O	ADP	O
the	O	DET	O
addition	O	NOUN	O
of	O	ADP	O
lectin	B-protein	NOUN	B
and	O	CCONJ	O
decline	O	NOUN	B
to	O	PART	O
control	O	NOUN	B
levels	O	NOUN	I
over	O	ADP	O
the	O	DET	O
next	O	ADJ	O
3	O	NUM	O
hr	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
results	O	NOUN	B
obtained	O	VERB	O
suggest	O	VERB	O
that	O	SCONJ	O
two	O	NUM	O
Ad12	B-DNA	NOUN	B
E1A	I-DNA	NOUN	I
domains	I-DNA	NOUN	I
are	O	AUX	O
required	O	VERB	O
to	O	PART	O
induce	O	VERB	B
resistance	O	NOUN	B
of	O	ADP	O
the	O	DET	O
cell	B-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
to	O	PART	O
NK	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


For	O	ADP	O
this	O	DET	O
expression	O	NOUN	B
pattern	O	NOUN	O
the	O	DET	O
first	O	ADJ	O
280	B-DNA	NUM	O
bp	I-DNA	NOUN	O
upstream	I-DNA	ADJ	B
of	O	ADP	O
the	O	DET	O
major	B-DNA	ADJ	O
transcriptional	I-DNA	ADJ	B
start	I-DNA	NOUN	O
site	I-DNA	NOUN	O
seems	O	VERB	O
to	O	PART	O
be	O	AUX	O
sufficient	O	ADJ	B
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
erythroleukemia	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
K562	I-cell_line	NOUN	I
,	O	PUNCT	O
due	O	ADP	O
to	O	PART	O
the	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
Spi-B	B-protein	NOUN	B
,	O	PUNCT	O
only	O	ADV	O
PU.1	B-protein	NOUN	B
bound	O	VERB	O
to	O	PART	O
the	O	DET	O
Btk	B-DNA	NOUN	B
promoter	I-DNA	NOUN	I
.	O	PUNCT	O


Implication	O	NOUN	B
of	O	ADP	O
viruses	O	NOUN	B
such	O	ADJ	O
as	O	ADP	O
Epstein-Barr	O	ADJ	B
virus	O	NOUN	I
(	O	PUNCT	O
EBV	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
rheumatoid	O	ADJ	B
arthritis	O	NOUN	I
pathogenesis	O	NOUN	B
has	O	AUX	O
been	O	AUX	O
suspected	O	VERB	B
on	O	ADP	O
the	O	DET	O
basis	O	NOUN	O
of	O	ADP	O
several	O	ADJ	O
indirect	O	ADJ	B
observations	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
thus	O	ADV	O
far	O	ADV	O
,	O	PUNCT	O
a	O	DET	O
direct	O	ADJ	O
link	O	NOUN	O
between	O	ADP	O
EBV	O	NOUN	B
and	O	CCONJ	O
rheumatoid	O	ADJ	B
arthritis	O	NOUN	I
has	O	AUX	O
not	O	PART	O
been	O	AUX	O
provided	O	VERB	O
.	O	PUNCT	O


G-CSF	B-protein	NOUN	B
receptors	I-protein	NOUN	O
lack	O	VERB	B
intrinsic	O	ADJ	O
tyrosine	B-protein	NOUN	O
kinase	I-protein	NOUN	O
activity	O	NOUN	O
,	O	PUNCT	O
but	O	CCONJ	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
receptor	O	NOUN	B
results	O	VERB	B
in	O	ADP	O
the	O	DET	O
rapid	O	ADJ	O
induction	O	NOUN	B
of	O	ADP	O
tyrosine	O	NOUN	B
kinase	O	NOUN	I
activity	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	I
of	O	ADP	O
p80c-rel	B-protein	NOUN	B
was	O	AUX	O
unique	O	ADJ	O
to	O	PART	O
G-CSF	B-protein	NOUN	B
in	O	ADP	O
that	O	SCONJ	O
granulocyte-macrophage	B-protein	ADJ	B
colony	I-protein	NOUN	B
stimulating	I-protein	NOUN	I
factor	I-protein	NOUN	I
which	O	DET	O
also	O	ADV	O
stimulates	O	VERB	B
neutrophils	B-cell_type	NOUN	B
and	O	CCONJ	O
induces	O	VERB	B
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	B
does	O	AUX	O
not	O	PART	O
result	O	VERB	O
in	O	ADP	O
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	I
of	O	ADP	O
p80c-rel	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
consequences	O	NOUN	B
of	O	ADP	I
p80c-rel	B-protein	NOUN	B
tyrosine	O	NOUN	I
phosphorylation	O	NOUN	B
are	O	AUX	O
not	O	PART	O
yet	O	ADV	O
known	O	VERB	O
;	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
tyrosine-phosphorylated	O	ADJ	B
p80c-rel	B-protein	NOUN	B
is	O	AUX	O
capable	O	ADJ	O
of	O	ADP	O
binding	O	VERB	B
to	O	PART	I
DNA	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
G-CSF	B-protein	NOUN	B
stimulation	O	NOUN	B
results	O	VERB	B
in	O	ADP	O
an	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
the	O	DET	O
amount	O	NOUN	B
of	O	ADP	O
p80c-rel	B-protein	NOUN	B
which	O	DET	O
binds	O	VERB	B
to	O	PART	O
DNA	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
demonstrate	O	VERB	O
that	O	SCONJ	O
one	O	NUM	O
of	O	ADP	O
the	O	DET	O
first	O	ADJ	O
biochemical	O	ADJ	B
events	O	NOUN	O
which	O	DET	O
occurs	O	VERB	O
in	O	ADP	O
neutrophils	B-cell_type	NOUN	B
following	O	VERB	O
G-CSF	B-protein	NOUN	B
stimulation	O	NOUN	B
,	O	PUNCT	O
activation	O	NOUN	B
of	O	ADP	O
a	O	DET	O
tyrosine	B-protein	NOUN	B
kinase	I-protein	NOUN	I
,	O	PUNCT	O
leads	O	VERB	O
directly	O	ADV	O
to	O	PART	O
the	O	DET	O
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	B
of	O	ADP	O
p80c-rel	B-protein	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
to	O	PART	O
previous	O	ADJ	O
results	O	NOUN	B
obtained	O	VERB	O
using	O	VERB	O
polyclonal	O	ADJ	B
antiseras	O	NOUN	O
to	O	PART	O
detect	O	VERB	B
Pan/	O	NOUN	B
E2A	B-protein	NOUN	B
proteins	I-protein	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
report	O	VERB	O
comparable	O	ADJ	O
levels	O	NOUN	B
of	O	ADP	O
Pan	B-protein	NOUN	B
proteins	I-protein	NOUN	I
in	O	ADP	O
GH/PRL-	B-cell_line	NOUN	B
and	I-cell_line	CCONJ	O
insulin-producing	I-cell_line	ADJ	B
,	I-cell_line	PUNCT	O
B-	I-cell_line	NOUN	B
and	I-cell_line	CCONJ	O
T-lymphocyte	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Visualization	O	NOUN	B
of	O	ADP	O
the	O	DET	O
endogenous	B-protein	ADJ	B
NF-kappa	I-protein	NOUN	B
B	I-protein	NOUN	I
p50	I-protein	NOUN	I
subunit	I-protein	NOUN	I
in	O	ADP	O
the	O	DET	O
nucleus	O	NOUN	B
of	O	ADP	O
follicular	B-cell_type	ADJ	B
dendritic	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
in	O	ADP	O
germinal	O	ADJ	B
centers	O	NOUN	I
.	O	PUNCT	O


NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
,	O	PUNCT	O
a	O	DET	O
50	B-protein	NUM	O
kDa/65	I-protein	NUM	O
kDa	I-protein	NOUN	O
(	I-protein	PUNCT	O
p50/p65	I-protein	NOUN	B
)	I-protein	PUNCT	O
heterodimer	I-protein	NOUN	B
,	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
ubiquitous	B-protein	ADJ	O
transcription	I-protein	NOUN	B
factor	I-protein	NOUN	I
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
positive	O	ADJ	B
regulation	O	NOUN	B
of	O	ADP	O
various	O	ADJ	O
immune	B-DNA	ADJ	B
genes	I-DNA	NOUN	I
.	O	PUNCT	O


The	O	DET	O
elevation	O	NOUN	B
in	O	ADP	O
intracellular	O	ADJ	B
calcium	O	NOUN	B
that	O	PRON	O
is	O	AUX	O
induced	O	VERB	B
by	O	ADP	O
interactions	O	NOUN	B
at	O	ADP	O
the	O	DET	O
antigen	B-protein	NOUN	B
receptor	I-protein	NOUN	I
leads	O	VERB	O
to	O	PART	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
calcium-dependent	B-protein	ADJ	B
phosphatase	I-protein	NOUN	I
calcineurin	B-protein	NOUN	I
.	O	PUNCT	O


NF-ATn	B-protein	NOUN	B
is	O	AUX	O
a	O	DET	O
ubiquitous	O	ADJ	O
protein	O	NOUN	O
,	O	PUNCT	O
can	O	AUX	O
be	O	AUX	O
synthesized	O	VERB	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
PMA	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
has	O	AUX	O
many	O	ADJ	O
similarities	O	NOUN	B
to	O	PART	O
AP-1	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
findings	O	NOUN	B
presented	O	VERB	O
here	O	ADV	O
link	O	VERB	O
an	O	DET	O
atheogenic	B-protein	ADJ	B
lipoprotein	I-protein	NOUN	I
,	O	PUNCT	O
LDL	B-protein	NOUN	B
,	O	PUNCT	O
with	O	ADP	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
an	O	DET	O
adhesion	O	NOUN	B
molecule	O	NOUN	I
important	O	ADJ	O
in	O	ADP	O
atherogenesis	O	NOUN	B
Human	O	ADJ	B
LDL	B-protein	NOUN	B
induces	O	VERB	O
the	O	DET	O
vascular	B-protein	ADJ	B
cell	I-protein	NOUN	I
adhesion	I-protein	NOUN	I
molecule-1	I-protein	NOUN	I
(	O	PUNCT	O
VCAM-1	B-protein	NOUN	B
)	O	PUNCT	O
transcriptionally	O	ADV	B
with	O	ADP	O
an	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
mRNA	O	NOUN	B
levels	O	NOUN	O
through	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
VCAM	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
a	O	DET	O
component	O	NOUN	B
of	O	ADP	O
LDL	B-protein	NOUN	B
-enhanced	O	ADJ	O
endothelial	O	ADJ	B
recruitment	O	NOUN	B
of	O	ADP	O
monocytes	B-cell_type	NOUN	B
is	O	AUX	O
attributed	O	VERB	O
to	O	PART	O
VCAM-1	B-protein	NOUN	B
expression	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
appears	O	VERB	O
to	O	PART	O
be	O	AUX	O
mediated	O	VERB	O
through	O	ADP	O
AP-1	B-protein	NOUN	B
and	O	CCONJ	O
GATA	B-protein	NOUN	B
.	O	PUNCT	O


n-Acetyl-L-cysteine	O	NOUN	B
(	O	PUNCT	O
NAC	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
a	O	DET	O
potent	O	ADJ	O
antioxidant	O	NOUN	B
,	O	PUNCT	O
blocked	O	VERB	B
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activation	O	NOUN	B
caused	O	VERB	O
by	O	ADP	O
IL-4	B-protein	NOUN	B
and	O	CCONJ	O
by	O	ADP	O
anti-CD40	B-protein	ADJ	B
mAb	I-protein	NOUN	B
.	O	PUNCT	O


Prostaglandin	O	NOUN	B
E2	O	NOUN	I
induction	O	NOUN	B
of	O	ADP	O
binding	O	NOUN	B
activity	O	NOUN	I
to	O	PART	O
CRE	B-DNA	NOUN	B
and	O	CCONJ	O
AP-2	B-DNA	NOUN	B
elements	I-DNA	NOUN	I
in	O	ADP	O
human	B-cell_type	ADJ	B
T	I-cell_type	NOUN	O
lymphocytes	I-cell_type	NOUN	O
.	O	PUNCT	O


Both	O	CCONJ	O
NK-	B-cell_type	NOUN	B
and	I-cell_type	CCONJ	O
T-cell	I-cell_type	NOUN	B
subtypes	I-cell_type	NOUN	B
are	O	AUX	O
closely	O	ADV	O
associated	O	VERB	B
with	O	ADP	I
Epstein-Barr	O	ADJ	B
virus	O	NOUN	I
(	O	PUNCT	O
EBV	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
analysis	O	NOUN	B
of	O	ADP	O
EBV	O	NOUN	B
protein	O	NOUN	O
expression	O	NOUN	B
by	O	ADP	O
IH	O	NOUN	B
revealed	O	VERB	O
a	O	DET	O
heterogeneous	O	ADJ	B
pattern	O	NOUN	B
of	O	ADP	O
EBV	B-DNA	NOUN	B
gene	I-DNA	NOUN	B
expression	O	NOUN	I
at	O	ADP	O
the	O	DET	O
single-cell	O	ADJ	B
level	O	NOUN	I
consisting	O	VERB	O
of	O	ADP	O
both	O	CCONJ	O
LMP1+	B-cell_type	ADJ	B
and	I-cell_type	CCONJ	O
LMP1-	I-cell_type	ADJ	B
tumour	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
suggesting	O	VERB	O
a	O	DET	O
mixture	O	NOUN	O
of	O	ADP	O
latency	O	NOUN	B
I	O	NUM	I
and	O	CCONJ	O
II	O	NUM	B
.	O	PUNCT	O


Down-regulation	O	NOUN	B
of	O	ADP	O
immunogenic	B-protein	ADJ	B
proteins	I-protein	NOUN	I
(	O	PUNCT	O
EBNA2-EBNA6	B-protein	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
nasal	O	ADJ	B
lymphoma	O	NOUN	I
may	O	AUX	O
enable	O	VERB	O
tumour	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
to	O	PART	O
evade	O	VERB	O
host	O	NOUN	B
cytotoxic	O	ADJ	B
T-cell	O	NOUN	O
surveillance	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
provides	O	VERB	O
the	O	DET	O
hormone	O	NOUN	B
with	O	ADP	O
an	O	DET	O
interesting	O	ADJ	O
therapeutic	O	ADJ	B
potential	O	NOUN	B
.	O	PUNCT	O


Studies	O	NOUN	B
with	O	ADP	O
20-epi	O	NOUN	O
analogues	O	NOUN	B
pointed	O	VERB	O
out	O	ADP	O
the	O	DET	O
importance	O	NOUN	O
of	O	ADP	O
the	O	DET	O
carbon-20	O	NOUN	B
position	O	NOUN	I
and	O	CCONJ	O
led	O	VERB	O
to	O	PART	O
the	O	DET	O
development	O	NOUN	B
of	O	ADP	O
20-methyl	O	ADJ	O
derivatives	O	NOUN	O
of	O	ADP	O
VD	O	NOUN	B
.	O	PUNCT	O


Both	O	DET	O
compounds	O	NOUN	B
show	O	VERB	O
about	O	ADP	O
2-fold	O	ADV	O
lower	O	ADJ	O
affinity	O	NOUN	B
to	O	PART	O
the	O	DET	O
VD	O	NOUN	B
receptor	O	NOUN	I
(	O	PUNCT	O
VDR	O	NOUN	B
)	O	PUNCT	O
than	O	ADP	O
VD	O	NOUN	B
.	O	PUNCT	O


Whereas	O	SCONJ	O
the	O	DET	O
hypercalcemic	O	ADJ	B
effect	O	NOUN	B
for	O	ADP	O
ZK157202	O	NOUN	B
is	O	AUX	O
also	O	ADV	O
increased	O	VERB	B
10-fold	O	ADV	O
,	O	PUNCT	O
ZK161422	O	NOUN	B
has	O	AUX	O
the	O	DET	O
same	O	ADJ	O
calcium-mobilizing	O	ADJ	B
potency	O	NOUN	O
as	O	ADP	O
VD	O	NOUN	B
.	O	PUNCT	O


Calcium-dependent	O	ADJ	B
immediate-early	B-DNA	ADJ	I
gene	I-DNA	NOUN	B
induction	O	NOUN	I
in	O	ADP	O
lymphocytes	B-cell_type	NOUN	B
is	O	AUX	O
negatively	O	ADV	O
regulated	O	VERB	O
by	O	ADP	O
p21Ha-ras	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
activated	O	VERB	B
p21	B-protein	NOUN	I
(	I-protein	PUNCT	O
ras	I-protein	NOUN	B
)	I-protein	PUNCT	O
negatively	O	ADV	O
regulated	O	VERB	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
IE	B-DNA	ADJ	B
genes	I-DNA	NOUN	B
by	O	ADP	O
calcium	O	NOUN	B
ionophore	O	NOUN	I
.	O	PUNCT	O


This	O	DET	O
inhibition	O	NOUN	B
of	O	ADP	O
calcium-activated	O	ADJ	B
IE	B-DNA	NOUN	I
gene	I-DNA	NOUN	B
induction	O	NOUN	I
was	O	AUX	O
reversed	O	VERB	O
by	O	ADP	O
treatment	O	NOUN	B
with	O	ADP	O
cyclosporin	O	NOUN	B
A	O	NOUN	I
,	O	PUNCT	O
suggesting	O	VERB	O
the	O	DET	O
involvement	O	NOUN	B
of	O	ADP	O
calcineurin	B-protein	NOUN	B
in	O	ADP	O
this	O	DET	O
regulation	O	NOUN	B
.	O	PUNCT	O


Calcineurin	B-protein	NOUN	B
,	O	PUNCT	O
a	O	DET	O
Ca2+/calmodulin-dependent	B-protein	ADJ	B
protein	I-protein	NOUN	I
phosphatase	I-protein	NOUN	I
,	O	PUNCT	O
is	O	AUX	O
the	O	DET	O
FK-506	O	NOUN	B
-and	O	NOUN	O
CsA-sensitive	O	ADJ	B
enzyme	O	NOUN	B
required	O	VERB	O
for	O	ADP	O
TcR	O	NOUN	B
mediated	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IL-2	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
.	O	PUNCT	O


By	O	ADP	O
Northern	O	NOUN	B
blot	O	NOUN	I
analysis	O	NOUN	I
,	O	PUNCT	O
DM	O	NOUN	B
caused	O	VERB	O
a	O	DET	O
comparable	O	ADJ	O
decrease	O	NOUN	B
in	O	ADP	O
IL-2R	B-protein	NOUN	B
alpha	I-protein	NOUN	I
and	O	CCONJ	O
in	O	ADP	O
IL-2R	B-protein	NOUN	B
beta	I-protein	NOUN	O
mRNA	O	NOUN	O
levels	O	NOUN	O
to	O	PART	O
membrane	O	NOUN	B
receptor	O	NOUN	I
expression	O	NOUN	B
in	O	ADP	O
mitogen-stimulated	B-cell_type	ADJ	B
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
present	O	ADJ	O
in-vitro	O	X	B
experiments	O	NOUN	B
the	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
dexamethasone	O	NOUN	B
,	O	PUNCT	O
of	O	ADP	O
further	O	ADJ	O
glucocorticoids	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
of	O	ADP	O
the	O	DET	O
glucocorticoid	O	NOUN	B
receptor	O	NOUN	I
antagonist	O	NOUN	B
RU	O	NOUN	B
486	O	NUM	O
,	O	PUNCT	O
on	O	ADP	O
structural	O	ADJ	B
order	O	NOUN	O
of	O	ADP	O
human	O	ADJ	B
erythrocyte	O	NOUN	B
ghost	O	NOUN	O
membranes	O	NOUN	O
was	O	AUX	O
investigated	O	VERB	B
by	O	ADP	O
determining	O	VERB	O
the	O	DET	O
steady-state	O	ADJ	B
fluorescence	O	NOUN	B
anisotropy	O	NOUN	I
of	O	ADP	I
diphenylhexatriene	O	NOUN	I
(	O	PUNCT	O
DPH	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


This	O	DET	O
mutant	O	NOUN	B
inhibited	O	VERB	B
TCR	B-protein	NOUN	B
-induced	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
of	I-protein	ADP	O
activated	I-protein	VERB	B
T	I-protein	NOUN	O
cells	I-protein	NOUN	O
by	O	ADP	O
interfering	O	VERB	B
with	O	ADP	O
both	O	CCONJ	O
intracellular	O	ADJ	B
calcium	O	NOUN	B
increase	O	NOUN	B
and	O	CCONJ	O
Ras	B-protein	NOUN	B
-regulated	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
extracellular	B-protein	ADJ	B
signal-regulated	I-protein	ADJ	I
kinases	I-protein	NOUN	I
.	O	PUNCT	O


ZAP-70	B-protein	NOUN	B
will	O	AUX	O
then	O	ADV	O
be	O	AUX	O
able	O	ADJ	O
to	O	PART	O
effectively	O	ADV	O
control	O	VERB	B
phosphorylation	O	NOUN	B
of	O	ADP	O
its	O	PRON	O
substrates	O	NOUN	B
and	O	CCONJ	O
lead	O	VERB	O
to	O	PART	O
gene	O	NOUN	B
activation	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
a	O	DET	O
significant	O	ADJ	O
correlation	O	NOUN	B
was	O	AUX	O
noted	O	VERB	O
between	O	ADP	O
the	O	DET	O
degree	O	NOUN	B
of	O	ADP	O
inhibition	O	NOUN	B
of	O	ADP	O
lymphocyte	O	NOUN	B
proliferation	O	NOUN	I
(	O	PUNCT	O
IC50	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
binding	O	NOUN	B
affinity	O	NOUN	B
of	O	ADP	O
dexamethasone	O	NOUN	B
to	O	PART	O
the	O	DET	O
GCR	B-protein	NOUN	B
.	O	PUNCT	O


Primer	O	NOUN	B
extension	O	NOUN	B
and	O	CCONJ	O
nuclease	O	NOUN	B
S1	O	NOUN	I
protection	O	NOUN	I
analysis	O	NOUN	I
revealed	O	VERB	O
two	O	NUM	O
major	O	ADJ	O
transcription	B-DNA	NOUN	B
initiation	I-DNA	NOUN	I
sites	I-DNA	NOUN	I
.	O	PUNCT	O


B	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
from	O	ADP	O
the	O	DET	O
peripheral	O	ADJ	B
blood	O	NOUN	I
of	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
chronic	O	ADJ	B
lymphocytic	O	ADJ	I
leukaemia	O	NOUN	I
(	O	PUNCT	O
CLL	O	NOUN	B
)	O	PUNCT	O
were	O	AUX	O
analysed	O	VERB	B
for	O	ADP	O
the	O	DET	O
nuclear	O	ADJ	B
presence	O	NOUN	B
and	O	CCONJ	O
DNA	O	NOUN	B
binding	O	NOUN	I
of	O	ADP	O
a	O	DET	O
panel	O	NOUN	O
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
which	O	DET	O
are	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
gene	O	NOUN	B
control	O	NOUN	I
of	O	ADP	O
lymphoid	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


The	O	DET	O
following	O	VERB	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
were	O	AUX	O
studied	O	VERB	O
:	O	PUNCT	O
the	O	DET	O
Octamer	B-protein	NOUN	B
factors	I-protein	NOUN	I
Oct-1	B-protein	NOUN	B
and	O	CCONJ	O
Oct-2	B-protein	NOUN	B
,	O	PUNCT	O
members	O	NOUN	B
of	O	ADP	O
the	O	DET	O
AP-1	B-protein	NOUN	B
factor	I-protein	NOUN	I
family	I-protein	NOUN	I
,	O	PUNCT	O
NF-AT	B-protein	NOUN	B
factors	I-protein	NOUN	B
,	O	PUNCT	O
in	O	ADP	O
particular	O	ADJ	O
NF-ATp	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
members	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Rel/NF-kB	B-protein	NOUN	B
family	I-protein	NOUN	I
.	O	PUNCT	O


Constitutive	O	ADJ	B
binding	O	NOUN	O
of	O	ADP	O
further	O	ADJ	O
factor	B-protein	NOUN	B
proteins	I-protein	NOUN	I
to	O	PART	O
DNA	O	NOUN	B
,	O	PUNCT	O
such	O	ADJ	O
as	O	ADP	O
JunD	B-protein	NOUN	B
,	O	PUNCT	O
c-Fos	B-protein	NOUN	B
and	O	CCONJ	O
FosB	B-protein	NOUN	B
,	O	PUNCT	O
was	O	AUX	O
detected	O	VERB	B
in	O	ADP	O
several	O	ADJ	O
patients	O	NOUN	B
whereas	O	SCONJ	O
the	O	DET	O
localisation	O	NOUN	B
and	O	CCONJ	O
DNA	O	NOUN	B
binding	O	NOUN	I
of	O	ADP	O
other	O	ADJ	O
factors	O	NOUN	B
such	O	ADJ	O
as	O	ADP	O
c-Jun	B-protein	NOUN	B
,	O	PUNCT	O
RelA/p65	B-protein	NOUN	B
and	O	CCONJ	O
c-Rel	B-protein	NOUN	B
was	O	AUX	O
unaltered	O	ADJ	B
.	O	PUNCT	O


The	O	DET	O
magnitude	O	NOUN	B
and	O	CCONJ	O
kinetics	O	NOUN	B
of	O	ADP	O
intracellular	O	ADJ	B
ROI	O	NOUN	B
were	O	AUX	O
similar	O	ADJ	O
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
there	O	PRON	O
were	O	AUX	O
no	O	DET	O
differences	O	NOUN	O
in	O	ADP	O
ROI-forming	O	ADJ	B
mechanisms	O	NOUN	B
or	O	CCONJ	O
antioxidative	O	ADJ	B
capacities	O	NOUN	B
.	O	PUNCT	O


Cells	O	NOUN	B
need	O	VERB	O
to	O	PART	O
distinguish	O	VERB	O
between	O	ADP	O
transient	O	ADJ	B
Ca2+	O	NOUN	B
signals	O	NOUN	B
that	O	PRON	O
induce	O	VERB	B
events	O	NOUN	B
such	O	ADJ	O
as	O	ADP	O
muscle	O	NOUN	B
contraction	O	NOUN	I
,	O	PUNCT	O
secretion	O	NOUN	B
,	O	PUNCT	O
adhesion	O	NOUN	B
and	O	CCONJ	O
synaptic	O	ADJ	B
transmission	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
sustained	O	ADJ	B
Ca2+	O	NOUN	B
signals	O	NOUN	B
that	O	PRON	O
are	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
cell	O	NOUN	B
proliferation	O	NOUN	I
and	O	CCONJ	O
differentiation	O	NOUN	B
.	O	PUNCT	O


Subsequent	O	ADJ	O
studies	O	NOUN	B
have	O	AUX	O
revealed	O	VERB	O
that	O	SCONJ	O
(	O	PUNCT	O
i	O	X	O
)	O	PUNCT	O
cytoplasmic	B-protein	ADJ	B
RelA	I-protein	NOUN	B
is	O	AUX	O
stably	O	ADV	B
associated	O	VERB	B
not	O	PART	I
only	O	ADV	O
with	O	ADP	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
alpha	I-protein	NOUN	I
but	O	CCONJ	O
also	O	ADV	O
with	O	ADP	O
other	O	ADJ	O
ankyrin	B-protein	NOUN	B
motif-rich	I-protein	ADJ	I
proteins	I-protein	NOUN	I
including	O	VERB	O
the	O	DET	O
products	O	NOUN	B
of	O	ADP	O
the	O	DET	O
NF-kappa	B-DNA	NOUN	B
B2	I-DNA	NOUN	I
(	I-DNA	PUNCT	O
p100	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
and	I-DNA	CCONJ	O
NF-kappa	I-DNA	NOUN	B
B1	I-DNA	NOUN	I
(	I-DNA	PUNCT	O
p105	I-DNA	NOUN	O
)	I-DNA	PUNCT	O
genes	I-DNA	NOUN	O
;	O	PUNCT	O
(	O	PUNCT	O
ii	O	X	O
)	O	PUNCT	O
in	O	ADP	O
contrast	O	NOUN	O
to	O	PART	O
RelA	B-protein	NOUN	B
-I	B-protein	NOUN	I
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
alpha	I-protein	NOUN	I
,	O	PUNCT	O
RelA-p100	B-protein	NOUN	B
cytoplasmic	I-protein	ADJ	I
complexes	I-protein	NOUN	I
are	O	AUX	O
not	O	PART	O
dissociated	O	VERB	O
following	O	VERB	O
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor	I-protein	NOUN	I
alpha	I-protein	NOUN	I
activation	O	NOUN	I
;	O	PUNCT	O
(	O	PUNCT	O
iii	O	X	O
)	O	PUNCT	O
p100	B-protein	NOUN	B
functions	O	VERB	B
as	O	ADP	O
a	O	DET	O
potent	O	ADJ	O
inhibitor	O	NOUN	B
of	O	ADP	O
RelA	B-protein	NOUN	B
-mediated	O	ADJ	O
transcription	O	NOUN	B
in	O	X	B
vivo	O	X	I
;	O	PUNCT	O
(	O	PUNCT	O
iv	O	X	O
)	O	PUNCT	O
the	O	DET	O
interaction	O	NOUN	B
of	O	ADP	O
RelA	B-protein	NOUN	B
and	O	CCONJ	O
p100	B-protein	NOUN	B
involves	O	VERB	O
the	O	DET	O
conserved	B-protein	VERB	O
Rel	I-protein	NOUN	B
homology	I-protein	NOUN	I
domain	I-protein	NOUN	I
of	O	ADP	O
both	O	DET	O
proteins	O	NOUN	B
but	O	CCONJ	O
not	O	PART	O
the	O	DET	O
nuclear	B-protein	ADJ	B
localization	I-protein	NOUN	I
signal	I-protein	NOUN	I
of	O	ADP	O
RelA	B-protein	NOUN	B
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
required	O	VERB	O
for	O	ADP	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
alpha	I-protein	NOUN	I
binding	O	NOUN	I
;	O	PUNCT	O
(	O	PUNCT	O
v	O	X	O
)	O	PUNCT	O
p100	B-protein	NOUN	B
inhibition	O	NOUN	B
of	O	ADP	O
RelA	B-protein	NOUN	B
function	O	NOUN	I
requires	O	VERB	O
the	O	DET	O
C-terminal	B-protein	ADJ	B
ankyrin	I-protein	NOUN	I
motif	I-protein	NOUN	I
domain	I-protein	NOUN	I
,	O	PUNCT	O
which	O	DET	O
mediates	O	VERB	O
cytoplasmic	O	ADJ	B
retention	O	NOUN	O
of	O	ADP	O
RelA	B-protein	NOUN	B
;	O	PUNCT	O
and	O	CCONJ	O
(	O	PUNCT	O
vi	O	X	O
)	O	PUNCT	O
as	O	ADP	O
observed	O	VERB	O
with	O	ADP	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
alpha	I-protein	NOUN	I
,	O	PUNCT	O
nuclear	O	ADJ	B
RelA	B-protein	NOUN	I
stimulates	O	VERB	O
p100	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
and	O	CCONJ	O
protein	O	NOUN	B
expression	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
GM-CSF	B-protein	NOUN	B
and	O	CCONJ	O
IL-2	B-protein	NOUN	B
is	O	AUX	O
inhibited	O	VERB	B
by	O	ADP	O
immunosuppressive	O	ADJ	B
drugs	O	NOUN	I
such	O	ADJ	O
as	O	ADP	O
cyclosporin	O	NOUN	B
A	O	NOUN	I
(	O	PUNCT	O
CsA	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
FK506	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
constitutively	O	ADV	B
active	O	ADJ	O
type	O	NOUN	O
of	O	ADP	O
the	O	DET	O
CN	B-protein	NOUN	B
A	I-protein	NOUN	I
subunit	I-protein	NOUN	B
,	O	PUNCT	O
which	O	DET	O
lacks	O	VERB	O
the	O	DET	O
auto-inhibitory	B-protein	ADJ	B
and	O	CCONJ	O
calmodulin-binding	B-protein	ADJ	O
domains	I-protein	NOUN	O
,	O	PUNCT	O
acts	O	VERB	O
in	O	ADP	O
synergy	O	NOUN	B
with	O	ADP	O
PMA	O	NOUN	B
to	O	PART	O
activate	O	VERB	B
transcription	O	NOUN	B
from	O	ADP	O
the	O	DET	O
GM-CSF	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
.	O	PUNCT	O


NF-	O	NOUN	B
CLE0	B-DNA	NOUN	B
gamma	O	NOUN	B
binding	O	NOUN	I
is	O	AUX	O
induced	O	VERB	B
by	O	ADP	O
PMA/A23187	O	NOUN	B
and	O	CCONJ	O
is	O	AUX	O
inhibited	O	VERB	B
by	O	ADP	O
treatment	O	NOUN	B
with	O	ADP	O
CsA	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
atrophy	O	NOUN	B
induction	O	NOUN	B
does	O	AUX	O
not	O	PART	O
involve	O	VERB	O
apoptotic	O	ADJ	B
mechanisms	O	NOUN	B
in	O	ADP	O
thymocytes	B-cell_type	NOUN	B
affected	O	VERB	B
by	O	ADP	O
the	O	DET	O
bcl-2	B-DNA	NOUN	B
proto-oncogene	I-DNA	NOUN	I
.	O	PUNCT	O


The	O	DET	O
Bcd	B-DNA	NOUN	B
proto-oncogene	B-DNA	NOUN	I
was	O	AUX	O
activated	O	VERB	B
by	O	ADP	O
a	O	DET	O
truncation	O	NOUN	B
in	O	ADP	O
the	O	DET	O
5	B-DNA	NUM	O
'	I-DNA	PART	O
UTR	I-DNA	NOUN	B
.	O	PUNCT	O


ORF1	B-DNA	NOUN	B
consists	O	VERB	O
of	O	ADP	O
240	O	NUM	O
bp	O	NOUN	O
that	O	PRON	O
would	O	AUX	O
encode	O	VERB	B
80	O	NUM	O
amino	O	NOUN	B
acids	O	NOUN	I
,	O	PUNCT	O
while	O	SCONJ	O
the	O	DET	O
major	B-DNA	ADJ	O
ORF2	I-DNA	NOUN	B
consists	O	VERB	O
of	O	ADP	O
648	O	NUM	O
bp	O	NOUN	O
capable	O	ADJ	O
of	O	ADP	O
coding	O	VERB	B
for	O	ADP	O
216	O	NUM	O
amino	O	NOUN	B
acids	O	NOUN	I
.	O	PUNCT	O


Transfection	O	NOUN	B
of	O	ADP	O
an	O	DET	O
expression	B-DNA	NOUN	B
vector	I-DNA	NOUN	I
containing	O	VERB	O
ORF2	B-DNA	NOUN	B
but	O	CCONJ	O
not	O	PART	O
full	B-DNA	ADJ	O
length	I-DNA	NOUN	B
cDNA	I-DNA	NOUN	B
was	O	AUX	O
able	O	ADJ	O
to	O	PART	O
transform	O	VERB	B
NIH3T3	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
and	O	CCONJ	O
induce	O	VERB	B
tumors	O	NOUN	B
in	O	ADP	O
nude	O	ADJ	B
mice	O	NOUN	I
.	O	PUNCT	O


Within	O	ADP	O
the	O	DET	O
PBL	B-cell_type	NOUN	B
,	O	PUNCT	O
Bcd	B-DNA	NOUN	B
gene	O	NOUN	O
expression	O	NOUN	B
was	O	AUX	O
restricted	O	ADJ	O
to	O	PART	O
CD19+	B-cell_type	ADJ	B
B-cells	I-cell_type	NOUN	I
and	O	CCONJ	O
absent	O	ADJ	B
from	O	ADP	O
CD14+	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
and	O	CCONJ	O
T-cells	B-cell_type	NOUN	B
.	O	PUNCT	O


These	O	DET	O
observations	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
a	O	DET	O
so-far-unrecognized	O	ADJ	O
SP-1	B-DNA	NOUN	B
site	I-DNA	NOUN	O
in	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
IL-1beta	I-DNA	NOUN	B
promoter	I-DNA	NOUN	B
may	O	AUX	O
participate	O	VERB	B
in	O	ADP	O
the	O	DET	O
transcriptional	O	ADJ	B
regulation	O	NOUN	I
of	O	ADP	O
this	O	DET	O
gene	O	NOUN	B
in	O	ADP	O
keratinocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


Stat3	B-protein	NOUN	B
recruitment	O	NOUN	B
by	O	ADP	O
two	O	NUM	O
distinct	O	ADJ	O
ligand-induced	B-protein	ADJ	B
,	I-protein	PUNCT	O
tyrosine-phosphorylated	I-protein	ADJ	B
docking	I-protein	NOUN	I
sites	I-protein	NOUN	I
in	O	ADP	O
the	O	DET	O
interleukin-10	B-protein	NOUN	B
receptor	I-protein	NOUN	I
intracellular	I-protein	ADJ	B
domain	I-protein	NOUN	B
.	O	PUNCT	O


To	O	PART	O
define	O	VERB	O
the	O	DET	O
mechanism	O	NOUN	B
underlying	O	VERB	O
signal	B-protein	NOUN	B
transducer	I-protein	NOUN	I
and	I-protein	CCONJ	O
activator	I-protein	NOUN	O
of	I-protein	ADP	O
transcription	I-protein	NOUN	O
(	I-protein	PUNCT	O
STAT	I-protein	NOUN	O
)	I-protein	PUNCT	O
protein	I-protein	NOUN	B
recruitment	O	NOUN	B
to	O	PART	O
the	O	DET	O
interleukin	B-protein	NOUN	B
10	I-protein	NUM	I
(	I-protein	PUNCT	O
IL-10	I-protein	NOUN	B
)	I-protein	PUNCT	O
receptor	I-protein	NOUN	O
,	O	PUNCT	O
the	O	DET	O
STAT	B-protein	NOUN	B
proteins	I-protein	NOUN	I
activated	O	VERB	B
by	O	ADP	O
IL-10	B-protein	NOUN	B
in	O	ADP	O
different	O	ADJ	O
cell	O	NOUN	B
populations	O	NOUN	I
were	O	AUX	O
first	O	ADV	O
defined	O	VERB	O
using	O	VERB	O
electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assays	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
find	O	VERB	O
that	O	SCONJ	O
in	O	ADP	O
the	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
EKLF	B-protein	NOUN	B
,	O	PUNCT	O
while	O	SCONJ	O
human	B-protein	ADJ	B
beta-globin	I-protein	NOUN	B
expression	O	NOUN	B
is	O	AUX	O
dramatically	O	ADV	O
reduced	O	VERB	B
,	O	PUNCT	O
gamma-globin	B-RNA	NOUN	B
transcripts	I-RNA	NOUN	B
are	O	AUX	O
elevated	O	VERB	B
approximately	O	ADV	O
5-fold	O	ADV	O
.	O	PUNCT	O


Impaired	O	ADJ	B
silencing	O	NOUN	B
of	O	ADP	O
gamma-globin	B-protein	NOUN	B
expression	O	NOUN	B
identifies	O	VERB	O
EKLF	B-protein	NOUN	B
as	O	ADP	O
the	O	DET	O
first	O	ADJ	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
participating	O	VERB	O
quantitatively	O	ADV	B
in	O	ADP	O
the	O	DET	O
gamma-globin	B-protein	NOUN	B
to	O	PART	O
beta-globin	B-protein	NOUN	B
switch	O	NOUN	B
.	O	PUNCT	O


Here	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
zinc	O	NOUN	B
addition	O	NOUN	O
in	O	ADP	O
a	O	DET	O
serum-	O	NOUN	B
and	O	CCONJ	O
lipopolysaccharide-free	O	ADJ	B
cell	O	NOUN	O
culture	O	NOUN	O
system	O	NOUN	O
leads	O	VERB	O
to	O	PART	O
significantly	O	ADV	O
enhanced	O	VERB	B
levels	O	NOUN	B
of	O	ADP	O
interleukin	B-protein	NOUN	B
1	I-protein	NUM	I
beta	I-protein	NOUN	I
(	O	PUNCT	O
IL-1	B-protein	NOUN	B
beta	I-protein	NOUN	I
)	O	PUNCT	O
and	O	CCONJ	O
tumour	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor	I-protein	NOUN	I
alpha	I-protein	NOUN	I
(	O	PUNCT	O
TNF-alpha	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
to	O	PART	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
corresponding	O	ADJ	O
mRNA	B-RNA	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
peripheral	I-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
mononuclear	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
(	O	PUNCT	O
PBMC	B-cell_type	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Therefore	O	ADV	O
,	O	PUNCT	O
monokine	O	NOUN	B
induction	O	NOUN	B
is	O	AUX	O
a	O	DET	O
zinc-specific	O	ADJ	B
effect	O	NOUN	O
influenced	O	VERB	B
by	O	ADP	O
the	O	DET	O
physicochemical	O	ADJ	B
properties	O	NOUN	I
of	O	ADP	O
the	O	DET	O
ion	O	NOUN	B
.	O	PUNCT	O


E3	B-protein	NOUN	B
,	O	PUNCT	O
one	O	NUM	O
of	O	ADP	O
nine	O	NUM	O
sequences	O	NOUN	B
identified	O	VERB	B
,	O	PUNCT	O
was	O	AUX	O
upregulated	O	VERB	B
in	O	ADP	O
an	O	DET	O
immediate-early	O	ADJ	B
manner	O	NOUN	O
,	O	PUNCT	O
with	O	ADP	O
transcript	O	NOUN	B
levels	O	NOUN	B
peaking	O	VERB	O
after	O	ADP	O
60	O	NUM	O
minutes	O	NOUN	B
exposure	O	NOUN	B
to	O	PART	O
RA	O	NOUN	B
.	O	PUNCT	O


Multifactor	O	ADJ	B
cis-dominant	O	ADJ	O
negative	O	ADJ	O
regulation	O	NOUN	O
of	O	ADP	O
IL-2	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
expression	O	NOUN	B
in	O	ADP	O
anergized	B-cell_type	VERB	B
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Because	O	SCONJ	O
the	O	DET	O
-180	B-DNA	NUM	O
site	I-DNA	NOUN	B
is	O	AUX	O
not	O	PART	O
required	O	VERB	O
for	O	ADP	O
trans-activation	O	NOUN	B
,	O	PUNCT	O
it	O	PRON	O
was	O	AUX	O
possible	O	ADJ	O
to	O	PART	O
confirm	O	VERB	O
by	O	ADP	O
mutation	O	NOUN	B
in	O	ADP	O
the	O	DET	O
normal	O	ADJ	B
mouse	B-DNA	NOUN	B
IL-2	I-DNA	NOUN	B
enhancer	I-DNA	NOUN	O
that	O	SCONJ	O
this	O	DET	O
site	O	NOUN	B
is	O	AUX	O
absolutely	O	ADV	O
essential	O	ADJ	O
for	O	ADP	O
anergy	O	NOUN	B
induction	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
multiple	O	ADJ	B
cytokine	B-protein	NOUN	B
production	O	NOUN	I
deficiency	O	NOUN	O
could	O	AUX	O
not	O	PART	O
be	O	AUX	O
restored	O	VERB	B
by	O	ADP	O
IL-2	B-protein	NOUN	B
or	O	CCONJ	O
co-stimulatory	O	ADJ	B
signals	O	NOUN	B
provided	O	VERB	O
by	O	ADP	O
antigen-presenting	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
(	O	PUNCT	O
APC	B-cell_type	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Whereas	O	SCONJ	O
AP-1	B-protein	NOUN	B
,	O	PUNCT	O
NF-kappa	O	NOUN	B
B	O	NOUN	I
,	O	PUNCT	O
Oct	B-protein	NOUN	O
,	O	PUNCT	O
CREB	B-protein	NOUN	B
and	O	CCONJ	O
SP1	B-protein	NOUN	B
displayed	O	VERB	O
normal	O	ADJ	O
binding	O	NOUN	B
activities	O	NOUN	I
in	O	ADP	O
nuclear	O	ADJ	B
extracts	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
binding	O	NOUN	B
of	O	ADP	O
NF-AT	B-protein	NOUN	B
to	O	PART	O
its	O	PRON	O
IL-2	B-protein	NOUN	B
promoter	O	NOUN	B
response	O	NOUN	I
element	O	NOUN	I
was	O	AUX	O
barely	O	ADV	O
detectable	O	ADJ	B
both	O	CCONJ	O
before	O	ADP	O
and	O	CCONJ	O
after	O	ADP	O
T	O	NOUN	B
cell	O	NOUN	I
stimulation	O	NOUN	O
.	O	PUNCT	O


Deletion	O	NOUN	B
of	O	ADP	O
the	O	DET	O
EBNA2-dependent	B-DNA	ADJ	B
enhancer	I-DNA	NOUN	I
located	O	ADJ	O
upstream	O	ADV	B
of	O	ADP	O
Cp	B-DNA	NOUN	B
resulted	O	VERB	O
in	O	ADP	O
a	O	DET	O
ca.	O	X	O
two-	O	NUM	O
to	O	PART	O
fivefold	O	ADJ	O
reduction	O	NOUN	B
in	O	ADP	O
Cp	B-DNA	NOUN	B
activity	O	NOUN	B
in	O	ADP	O
the	O	DET	O
LCLs	B-cell_line	NOUN	B
assayed	O	VERB	B
.	O	PUNCT	O


Since	O	SCONJ	O
recent	O	ADJ	O
studies	O	NOUN	B
have	O	AUX	O
shown	O	VERB	O
that	O	SCONJ	O
lipopolysaccharide-induced	O	ADJ	B
tyrosine	B-protein	NOUN	I
kinase	I-protein	NOUN	I
activation	O	NOUN	B
is	O	AUX	O
not	O	PART	O
required	O	VERB	O
for	O	ADP	O
NFkappaB	B-protein	NOUN	B
nuclear	O	ADJ	O
translocation	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
sought	O	VERB	O
to	O	PART	O
determine	O	VERB	O
whether	O	SCONJ	O
NFkappaB	B-protein	NOUN	B
translocated	O	VERB	B
in	O	ADP	O
the	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
tyrosine	B-protein	NOUN	B
kinase	I-protein	NOUN	I
activity	O	NOUN	I
was	O	AUX	O
active	O	ADJ	B
in	O	ADP	O
stimulating	O	VERB	B
transcription	O	NOUN	B
.	O	PUNCT	O


Nuclear	O	ADJ	B
translocation	O	NOUN	I
of	O	ADP	O
NF-kappaB	B-protein	NOUN	B
subunits	I-protein	NOUN	I
may	O	AUX	O
ultimately	O	ADV	O
increase	O	VERB	B
the	O	DET	O
intracellular	O	ADJ	B
pool	O	NOUN	B
of	O	ADP	O
NF-kappaB/IkappaBalpha	B-protein	NOUN	B
by	O	ADP	O
an	O	DET	O
autoregulatory	O	ADJ	B
mechanism	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
transcription	O	NOUN	B
and	O	CCONJ	O
transformation	O	NOUN	B
activity	O	NOUN	B
of	O	ADP	O
c-Jun	B-protein	NOUN	B
is	O	AUX	O
governed	O	VERB	O
by	O	ADP	O
a	O	DET	O
27-amino	B-protein	ADJ	B
acid	I-protein	NOUN	I
regulatory	I-protein	ADJ	I
motif	I-protein	NOUN	I
,	O	PUNCT	O
labeled	O	VERB	B
the	O	DET	O
delta-domain	B-protein	NOUN	B
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
deleted	O	VERB	O
in	O	ADP	O
v-Jun	B-protein	NOUN	B
.	O	PUNCT	O


Moreover	O	ADV	O
,	O	PUNCT	O
alteration	O	NOUN	B
of	O	ADP	O
any	O	DET	O
one	O	NUM	O
of	O	ADP	O
these	O	DET	O
features	O	NOUN	B
(	O	PUNCT	O
e.g.	O	X	O
,	O	PUNCT	O
cis-element	B-DNA	NOUN	B
,	O	PUNCT	O
trans-factor	B-DNA	NOUN	B
,	O	PUNCT	O
or	O	CCONJ	O
cell-specific	O	ADJ	B
background	O	NOUN	I
)	O	PUNCT	O
switched	O	VERB	O
c-Jun	B-protein	NOUN	B
to	O	PART	O
a	O	DET	O
transcriptional	B-protein	ADJ	B
activator	I-protein	NOUN	I
of	O	ADP	O
the	O	DET	O
rPRL	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
.	O	PUNCT	O


Because	O	SCONJ	O
interferon	B-protein	NOUN	B
(	I-protein	PUNCT	O
IFN	I-protein	NOUN	B
)	I-protein	PUNCT	O
regulatory	I-protein	ADJ	B
factors	I-protein	NOUN	I
(	O	PUNCT	O
IRF-1	B-protein	NOUN	B
and	O	CCONJ	O
IRF-2	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
other	O	ADJ	O
IFN-inducible	B-protein	ADJ	B
gene	I-protein	NOUN	O
products	I-protein	NOUN	O
regulate	O	VERB	B
cell	O	NOUN	B
growth	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
analyzed	O	VERB	B
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	O
ATRA	O	NOUN	B
on	O	ADP	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
these	O	DET	O
genes	O	NOUN	B
.	O	PUNCT	O


Transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
of	O	ADP	O
the	O	DET	O
NFAT	B-protein	NOUN	B
family	I-protein	NOUN	O
play	O	VERB	O
a	O	DET	O
key	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
transcription	O	NOUN	B
of	O	ADP	O
cytokine	B-DNA	NOUN	B
genes	I-DNA	NOUN	I
and	O	CCONJ	O
other	O	ADJ	O
genes	O	NOUN	B
during	O	ADP	O
the	O	DET	O
immune	O	ADJ	B
response	O	NOUN	I
.	O	PUNCT	O


Transactivation	O	NOUN	B
by	O	ADP	O
recombinant	O	ADJ	B
NFAT1	B-protein	NOUN	B
in	O	ADP	O
Jurkat	B-cell_line	NOUN	B
T	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
requires	O	VERB	O
dual	O	ADJ	O
stimulation	O	NOUN	O
with	O	ADP	O
ionomycin	O	NOUN	B
and	O	CCONJ	O
phorbol	O	NOUN	B
12-myristate	O	NOUN	I
13-acetate	O	NOUN	I
;	O	PUNCT	O
this	O	DET	O
activity	O	NOUN	B
is	O	AUX	O
potentiated	O	VERB	B
by	O	ADP	O
coexpression	O	NOUN	B
of	O	ADP	O
constitutively	O	ADV	B
active	O	ADJ	O
calcineurin	B-protein	NOUN	B
and	O	CCONJ	O
is	O	AUX	O
inhibited	O	VERB	B
by	O	ADP	O
CsA	O	NOUN	B
.	O	PUNCT	O


When	O	SCONJ	O
expressed	O	VERB	B
in	O	ADP	O
COS	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
NFAT1	B-protein	NOUN	B
is	O	AUX	O
capable	O	ADJ	O
of	O	ADP	O
transactivation	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
it	O	PRON	O
is	O	AUX	O
not	O	PART	O
regulated	O	VERB	O
correctly	O	ADV	O
:	O	PUNCT	O
its	O	PRON	O
subcellular	O	ADJ	B
localization	O	NOUN	O
and	O	CCONJ	O
transcriptional	O	ADJ	B
function	O	NOUN	I
are	O	AUX	O
not	O	PART	O
affected	O	VERB	O
by	O	ADP	O
stimulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
COS	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
with	O	ADP	O
ionomycin	O	NOUN	B
and	O	CCONJ	O
phorbol	O	NOUN	B
12-myristate	O	NOUN	I
13-acetate	O	NOUN	I
.	O	PUNCT	O


Human	B-protein	ADJ	B
TAFII	I-protein	NOUN	B
105	I-protein	NUM	O
is	O	AUX	O
a	O	DET	O
cell	B-protein	NOUN	B
type-specific	I-protein	ADJ	I
TFIID	I-protein	NOUN	I
subunit	I-protein	NOUN	I
related	O	ADJ	O
to	O	PART	O
hTAFII130	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
cDNA	B-DNA	NOUN	B
encoding	O	NOUN	O
hTAFII105	B-protein	NOUN	B
reveals	O	VERB	O
a	O	DET	O
highly	O	ADV	O
conserved	O	VERB	O
C-terminal	B-protein	ADJ	B
domain	I-protein	NOUN	I
shared	O	VERB	O
by	O	ADP	O
hTAFII130	B-protein	NOUN	B
and	O	CCONJ	O
oTAFII110	B-protein	NOUN	O
,	O	PUNCT	O
while	O	SCONJ	O
the	O	DET	O
N-terminal	B-protein	ADJ	B
coactivator	I-protein	NOUN	I
domain	I-protein	NOUN	I
has	O	AUX	O
diverged	O	VERB	O
significantly	O	ADV	B
.	O	PUNCT	O


These	O	DET	O
properties	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
TAFII105	B-protein	NOUN	B
is	O	AUX	O
a	O	DET	O
cell	O	NOUN	B
type-specific	O	ADJ	I
subunit	O	NOUN	I
of	O	ADP	O
TFIID	B-protein	NOUN	B
that	O	PRON	O
may	O	AUX	O
be	O	AUX	O
responsible	O	ADJ	O
for	O	ADP	O
mediating	O	VERB	O
transcription	O	NOUN	B
by	O	ADP	O
a	O	DET	O
subset	O	NOUN	O
of	O	ADP	O
activators	O	NOUN	B
in	O	ADP	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Interstitial	O	ADJ	B
deletion	O	NOUN	I
constitutes	O	VERB	O
the	O	DET	O
major	O	ADJ	O
mechanism	O	NOUN	B
for	O	ADP	O
loss	O	NOUN	B
of	O	ADP	O
heterozygosity	O	NOUN	B
on	O	ADP	O
chromosome	B-DNA	NOUN	B
20q	I-DNA	NOUN	I
in	O	ADP	O
polycythemia	O	NOUN	B
vera	O	NOUN	B
.	O	PUNCT	O


Abnormalities	O	NOUN	B
of	O	ADP	O
retinoblastoma	B-protein	NOUN	B
protein	I-protein	NOUN	I
(	O	PUNCT	O
pRB	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
mutations	O	NOUN	B
of	O	ADP	O
RB	O	NOUN	B
gene	O	NOUN	I
have	O	AUX	O
been	O	AUX	O
reported	O	VERB	O
in	O	ADP	O
up	O	ADV	O
to	O	PART	O
70	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
MM	O	NOUN	B
patients	O	NOUN	B
and	O	CCONJ	O
80	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
MM-derived	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
.	O	PUNCT	O


Activation	O	NOUN	B
of	O	ADP	O
TGF-beta	B-protein	NOUN	B
2	I-protein	NUM	I
transcription	O	NOUN	B
correlates	O	VERB	O
with	O	ADP	O
the	O	DET	O
loss	O	NOUN	B
of	O	ADP	O
binding	O	NOUN	B
activity	O	NOUN	I
for	O	ADP	O
an	O	DET	O
80	B-protein	NUM	O
kDA	I-protein	NOUN	O
glial	I-protein	ADJ	B
labile	I-protein	ADJ	O
repressor	I-protein	NOUN	O
protein	I-protein	NOUN	O
,	O	PUNCT	O
GLRP	B-protein	NOUN	B
,	O	PUNCT	O
to	O	PART	O
a	O	DET	O
responsive	O	ADJ	B
region	O	NOUN	I
within	O	ADP	O
the	O	DET	O
TFG-beta	B-DNA	NOUN	B
2	I-DNA	NUM	I
promoter	I-DNA	NOUN	B
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
along	O	ADP	O
with	O	ADP	O
previous	O	ADJ	O
observations	O	NOUN	B
demonstrating	O	VERB	O
the	O	DET	O
potent	O	ADJ	O
immunosuppressive	O	ADJ	B
activity	O	NOUN	I
of	O	ADP	O
TGF-beta	B-protein	NOUN	B
2	I-protein	NUM	O
,	O	PUNCT	O
support	O	VERB	O
a	O	DET	O
model	O	NOUN	B
for	O	ADP	O
a	O	DET	O
feedback	O	NOUN	O
mechanism	O	NOUN	B
between	O	ADP	O
the	O	DET	O
activated	O	VERB	B
T-lymphocytes	B-cell_type	NOUN	B
and	O	CCONJ	O
astrocytes	B-cell_type	NOUN	B
via	O	ADP	O
TGF-beta	B-protein	NOUN	B
2	I-protein	NUM	O
to	O	PART	O
regulate	O	VERB	B
the	O	DET	O
immune	O	ADJ	B
response	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
Id1	O	NOUN	B
protein	O	NOUN	I
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
repress	O	VERB	B
ALF1	B-protein	NOUN	B
activity	O	NOUN	B
in	O	X	B
vitro	O	X	I
and	O	CCONJ	O
in	O	X	B
vivo	O	X	I
.	O	PUNCT	O


Moreover	O	ADV	O
,	O	PUNCT	O
ectopic	B-protein	ADJ	B
Id1	I-protein	NOUN	B
repressed	O	VERB	B
E	B-DNA	NOUN	I
(	I-DNA	PUNCT	O
gre	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
-directed	O	ADJ	O
but	O	CCONJ	O
not	O	PART	O
EA/S	B-DNA	NOUN	B
-directed	O	ADJ	O
MLV	O	NOUN	B
transcription	O	NOUN	B
in	O	ADP	O
lymphoid	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
to	O	PART	O
peptide	O	NOUN	B
vaccination	O	NOUN	I
,	O	PUNCT	O
immunization	O	NOUN	B
with	O	ADP	O
adenovirus	O	NOUN	B
,	O	PUNCT	O
expressing	O	VERB	B
Ad5E1A	B-protein	NOUN	B
,	O	PUNCT	O
induced	O	VERB	B
Ad5E1A	B-protein	NOUN	B
-specific	O	ADJ	O
immunity	O	NOUN	B
and	O	CCONJ	O
prevented	O	VERB	B
the	O	DET	O
outgrowth	O	NOUN	B
of	O	ADP	O
Ad5E1A	B-protein	NOUN	B
-expressing	O	ADJ	O
tumors	O	NOUN	B
.	O	PUNCT	O


NGFI-B/nur77	B-protein	NOUN	B
is	O	AUX	O
a	O	DET	O
member	O	NOUN	B
of	O	ADP	O
the	O	DET	O
steroid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
superfamily	I-protein	NOUN	B
.	O	PUNCT	O


NGFI-B/nur77	B-protein	NOUN	B
binds	O	VERB	B
to	O	PART	O
the	O	DET	O
response	B-DNA	NOUN	B
element	I-DNA	NOUN	I
by	O	ADP	O
monomer	O	NOUN	B
or	O	CCONJ	O
heterodimer	O	NOUN	B
with	O	ADP	O
retinoid	B-protein	NOUN	B
X	I-protein	NOUN	I
receptor	I-protein	NOUN	I
(	O	PUNCT	O
RXR	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Assuming	O	VERB	O
that	O	SCONJ	O
9-cis-retinoic	O	ADJ	B
acid	O	NOUN	I
(	O	PUNCT	O
9-cis-RA	O	NOUN	B
)	O	PUNCT	O
inhibits	O	VERB	B
TCR-mediated	O	ADJ	B
apoptosis	O	NOUN	B
,	O	PUNCT	O
nur77	B-protein	NOUN	B
may	O	AUX	O
cause	O	VERB	O
apoptosis	O	NOUN	B
by	O	ADP	O
monomer	O	NOUN	B
in	O	ADP	O
the	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
9-cis-RA	O	NOUN	B
and	O	CCONJ	O
may	O	AUX	O
inhibit	O	VERB	B
apoptosis	O	NOUN	B
by	O	ADP	O
heterodimer	O	NOUN	B
with	O	ADP	O
RXR	B-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
9-cis-RA	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
study	O	NOUN	B
we	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
structurally	O	ADV	B
unrelated	O	ADJ	O
antioxidant	O	ADJ	B
agents	O	NOUN	I
pyrrolidine	O	NOUN	B
dithiocarbamate	O	NOUN	I
(	O	PUNCT	O
PDTC	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
butylated	O	VERB	B
hydroxyanisole	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
Nacetylcysteine	O	NOUN	B
activated	O	VERB	B
JNK	B-protein	NOUN	B
(	O	PUNCT	O
c-Jun	B-protein	NOUN	B
NH2-terminal	I-protein	ADJ	I
kinase	I-protein	NOUN	I
)	O	PUNCT	O
in	O	ADP	O
Jurkat	B-cell_line	NOUN	B
T	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Transfection	O	NOUN	B
of	O	ADP	O
trans-dominant	B-DNA	ADJ	B
negative	I-DNA	ADJ	B
expression	I-DNA	NOUN	B
vectors	I-DNA	NOUN	I
of	O	ADP	O
ras	B-DNA	NOUN	B
and	O	CCONJ	O
raf	B-DNA	NOUN	B
,	O	PUNCT	O
together	O	ADV	O
with	O	ADP	O
AP-1-dependent	B-DNA	ADJ	B
reporter	I-DNA	NOUN	I
constructs	I-DNA	NOUN	O
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
Western	O	NOUN	B
blot	O	NOUN	I
analysis	O	NOUN	I
using	O	VERB	O
anti-ERK	B-protein	ADJ	B
(	I-protein	PUNCT	O
extracellular	I-protein	ADJ	O
signal-regulated	I-protein	ADJ	O
kinase	I-protein	NOUN	O
)	I-protein	PUNCT	O
antibodies	I-protein	NOUN	O
,	O	PUNCT	O
indicated	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
Ras/Raf/ERK	O	NOUN	B
pathway	O	NOUN	B
did	O	AUX	O
not	O	PART	O
appear	O	VERB	O
to	O	PART	O
mediate	O	VERB	O
the	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
the	O	DET	O
antioxidant	O	NOUN	B
.	O	PUNCT	O


It	O	PRON	O
is	O	AUX	O
directly	O	ADV	O
implicated	O	VERB	O
in	O	ADP	O
the	O	DET	O
emergence	O	NOUN	B
of	O	ADP	O
the	O	DET	O
age-related	O	ADJ	B
immune	O	ADJ	B
deficiency	O	NOUN	I
.	O	PUNCT	O


Induction	O	NOUN	B
of	O	ADP	O
bcl-2	B-protein	NOUN	B
expression	O	NOUN	B
by	O	ADP	O
phosphorylated	O	VERB	B
CREB	O	NOUN	B
proteins	O	NOUN	I
during	O	ADP	O
B-cell	O	NOUN	B
activation	O	NOUN	I
and	O	CCONJ	O
rescue	O	NOUN	O
from	O	ADP	O
apoptosis	O	NOUN	B
.	O	PUNCT	O


Engagement	O	NOUN	B
of	O	ADP	O
surface	O	NOUN	B
immunoglobulin	O	NOUN	B
on	O	ADP	O
mature	O	ADJ	B
B	O	NOUN	B
cells	O	NOUN	I
leads	O	VERB	O
to	O	PART	O
rescue	O	VERB	O
from	O	ADP	O
apoptosis	O	NOUN	B
and	O	CCONJ	O
to	O	PART	O
proliferation	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
located	O	VERB	O
the	O	DET	O
major	O	ADJ	O
positive	O	ADJ	B
regulatory	O	ADJ	B
region	O	NOUN	I
for	O	ADP	O
control	O	NOUN	B
of	O	ADP	O
bcl-2	B-protein	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
in	O	ADP	O
the	O	DET	O
5'-flanking	B-DNA	ADJ	B
region	I-DNA	NOUN	I
.	O	PUNCT	O


bcl-2	B-protein	NOUN	B
expression	O	NOUN	B
is	O	AUX	O
increased	O	VERB	B
following	O	VERB	O
phorbol	O	NOUN	B
ester	O	NOUN	I
treatment	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
increased	O	VERB	B
expression	O	NOUN	B
is	O	AUX	O
dependent	O	ADJ	B
on	O	ADP	O
the	O	DET	O
CRE	B-DNA	NOUN	B
site	I-DNA	NOUN	O
.	O	PUNCT	O


It	O	PRON	O
is	O	AUX	O
possible	O	ADJ	O
that	O	SCONJ	O
the	O	DET	O
CRE	B-DNA	NOUN	B
site	I-DNA	NOUN	O
is	O	AUX	O
responsible	O	ADJ	O
for	O	ADP	O
induction	O	NOUN	B
of	O	ADP	O
bcl-2	B-protein	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
other	O	ADJ	O
cell	O	NOUN	B
types	O	NOUN	I
,	O	PUNCT	O
particularly	O	ADV	O
those	O	DET	O
in	O	ADP	O
which	O	DET	O
protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
C	I-protein	NOUN	I
is	O	AUX	O
involved	O	VERB	O
.	O	PUNCT	O


MNDA	B-protein	NOUN	B
(	O	PUNCT	O
myeloid	B-protein	ADJ	B
cell	I-protein	NOUN	I
nuclear	I-protein	ADJ	B
differentiation	I-protein	NOUN	I
antigen	I-protein	NOUN	I
)	O	PUNCT	O
is	O	AUX	O
an	O	DET	O
interferon	B-protein	NOUN	B
alpha	I-protein	NOUN	I
regulated	I-protein	ADJ	O
nuclear	I-protein	ADJ	O
protein	I-protein	NOUN	O
expressed	O	VERB	B
only	O	ADV	O
in	O	ADP	O
cells	O	NOUN	B
of	O	ADP	O
the	O	DET	O
human	B-cell_type	ADJ	B
myelomonocytic	I-cell_type	ADJ	O
lineage	I-cell_type	NOUN	O
.	O	PUNCT	O


Importantly	O	ADV	O
,	O	PUNCT	O
nucleoprotein	O	NOUN	B
extracts	O	NOUN	I
showing	O	VERB	O
decreased	O	VERB	B
DNA-binding	O	ADJ	B
activity	O	NOUN	O
had	O	AUX	O
normal	O	ADJ	O
amounts	O	NOUN	O
of	O	ADP	O
Oct-1	B-protein	NOUN	B
proteins	O	NOUN	I
as	O	ADP	O
determined	O	VERB	O
by	O	ADP	O
immunoprecipitation	O	NOUN	B
,	O	PUNCT	O
implying	O	VERB	O
a	O	DET	O
functional	O	ADJ	B
defect	O	NOUN	O
in	O	ADP	O
the	O	DET	O
Oct-1	B-protein	NOUN	B
protein	I-protein	NOUN	I
.	O	PUNCT	O


Although	O	SCONJ	O
NFAT	B-protein	NOUN	B
has	O	AUX	O
been	O	AUX	O
recently	O	ADV	O
shown	O	VERB	O
to	O	PART	O
be	O	AUX	O
inducible	O	ADJ	B
in	O	ADP	O
several	O	ADJ	O
non-T	B-cell_type	ADJ	O
immune	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
the	O	DET	O
NFAT	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
family	I-DNA	NOUN	B
members	I-DNA	NOUN	I
characterized	O	VERB	B
to	O	PART	O
date	O	NOUN	O
have	O	AUX	O
been	O	AUX	O
isolated	O	VERB	B
only	O	ADV	O
from	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


To	O	PART	O
further	O	ADV	O
characterize	O	VERB	O
NFAT	B-protein	NOUN	B
function	O	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
B	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
and	O	CCONJ	O
to	O	PART	O
demonstrate	O	VERB	O
cytokine	O	NOUN	B
gene	O	NOUN	O
specificity	O	NOUN	B
of	O	ADP	O
NFAT	B-protein	NOUN	B
proteins	I-protein	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
report	O	VERB	O
here	O	ADV	O
the	O	DET	O
isolation	O	NOUN	B
and	O	CCONJ	O
characterization	O	NOUN	B
of	O	ADP	O
a	O	DET	O
cDNA	B-DNA	NOUN	B
clone	I-DNA	NOUN	B
from	O	ADP	O
the	O	DET	O
Raji	B-cell_line	NOUN	B
B	I-cell_line	NOUN	I
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
.	O	PUNCT	O


alpha	O	NOUN	B
in	O	ADP	O
the	O	DET	O
first	O	ADJ	O
NH2-terminal	B-protein	ADJ	B
29	I-protein	NUM	O
residues	I-protein	NOUN	B
and	O	CCONJ	O
contains	O	VERB	O
an	O	DET	O
additional	O	ADJ	O
region	O	NOUN	O
of	O	ADP	O
142	B-protein	NUM	O
residues	I-protein	NOUN	B
at	O	ADP	O
the	O	DET	O
COOH	B-protein	NOUN	B
terminus	I-protein	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
NFATc.beta	B-protein	NOUN	B
neither	O	CCONJ	O
bound	O	VERB	O
to	O	PART	O
the	O	DET	O
kappa3	B-DNA	NOUN	B
element	I-DNA	NOUN	I
(	O	PUNCT	O
an	O	DET	O
NFAT-binding	B-DNA	ADJ	B
site	I-DNA	NOUN	I
)	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
tumor	B-DNA	NOUN	B
necrosis	I-DNA	NOUN	I
factor-alpha	I-DNA	NOUN	I
promoter	I-DNA	NOUN	I
nor	O	CCONJ	O
activated	O	VERB	B
the	O	DET	O
tumor	B-DNA	NOUN	B
necrosis	I-DNA	NOUN	I
factor-alpha	I-DNA	NOUN	I
promoter	I-DNA	NOUN	I
in	O	ADP	O
cotransfection	O	NOUN	B
assays	O	NOUN	I
.	O	PUNCT	O


Interferon-gamma	O	NOUN	B
(	O	PUNCT	O
IFN-gamma	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
also	O	ADV	O
known	O	VERB	O
as	O	ADP	O
type	B-protein	NOUN	B
II	I-protein	NUM	I
interferon	I-protein	NOUN	I
,	O	PUNCT	O
is	O	AUX	O
an	O	DET	O
important	O	ADJ	O
immunoregulatory	O	ADJ	B
gene	O	NOUN	I
that	O	PRON	O
has	O	AUX	O
multiple	O	ADJ	B
effects	O	NOUN	B
on	O	ADP	O
the	O	DET	O
development	O	NOUN	B
,	O	PUNCT	O
maturation	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
function	O	NOUN	B
of	O	ADP	O
the	O	DET	O
immune	O	ADJ	B
system	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
review	O	NOUN	B
,	O	PUNCT	O
I	O	PRON	B
describe	O	VERB	O
how	O	SCONJ	O
DNA	O	NOUN	B
methylation	O	NOUN	I
and	O	CCONJ	O
specific	O	ADJ	O
DNA	B-protein	NOUN	B
binding	I-protein	NOUN	I
proteins	I-protein	NOUN	I
may	O	AUX	O
regulate	O	VERB	B
transcription	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IFN-gamma	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
in	O	ADP	O
response	O	NOUN	O
to	O	PART	O
extracellular	O	ADJ	B
signals	O	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
study	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
examined	O	VERB	O
seven	O	NUM	O
EBV-positive	O	ADJ	B
gastric	O	ADJ	B
carcinoma	O	NOUN	I
tissues	O	NOUN	B
for	O	ADP	O
viral	O	ADJ	B
gene	O	NOUN	I
expression	O	NOUN	B
at	O	ADP	O
the	O	DET	O
mRNA	O	NOUN	B
level	O	NOUN	B
,	O	PUNCT	O
from	O	ADP	O
which	O	DET	O
studies	O	NOUN	B
on	O	ADP	O
the	O	DET	O
EBV	O	NOUN	B
oncogenicity	O	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
epithelial	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
will	O	AUX	O
benefit	O	VERB	B
.	O	PUNCT	O


BZLF1	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
and	O	CCONJ	O
the	O	DET	O
product	O	NOUN	B
,	O	PUNCT	O
an	O	DET	O
immediate-early	B-DNA	ADJ	B
gene	I-DNA	NOUN	I
for	O	ADP	O
EBV	O	NOUN	B
replication	O	NOUN	B
,	O	PUNCT	O
was	O	AUX	O
not	O	PART	O
expressed	O	VERB	B
in	O	ADP	O
any	O	DET	O
of	O	ADP	O
them	O	PRON	O
,	O	PUNCT	O
thereby	O	ADV	O
suggesting	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
tumour	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
carried	O	VERB	O
EBV	B-DNA	NOUN	B
genomes	I-DNA	NOUN	B
in	O	ADP	O
a	O	DET	O
tightly	O	ADV	O
latent	O	ADJ	B
form	O	NOUN	O
.	O	PUNCT	O


These	O	DET	O
findings	O	NOUN	B
further	O	ADV	O
extended	O	VERB	O
our	O	PRON	O
previous	O	ADJ	O
data	O	NOUN	B
regarding	O	VERB	O
EBV	O	NOUN	B
latency	O	NOUN	B
in	O	ADP	O
gastric	B-cell_type	ADJ	B
carcinoma	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	B
at	O	ADP	O
the	O	DET	O
protein	O	NOUN	B
level	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
have	O	AUX	O
affirmed	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
programme	O	NOUN	B
of	O	ADP	O
viral	O	ADJ	B
gene	O	NOUN	I
expression	O	NOUN	B
in	O	ADP	O
the	O	DET	O
tumour	O	NOUN	B
more	O	ADV	O
closely	O	ADV	O
resembles	O	VERB	O
'latency	O	NOUN	B
I	O	NOUN	I
'	O	PUNCT	O
represented	O	VERB	O
by	O	ADP	O
Burkitt	O	NOUN	B
's	O	PART	I
lymphoma	O	NOUN	I
than	O	ADP	O
'latency	O	NOUN	B
II	O	NUM	I
'	O	PUNCT	O
represented	O	VERB	O
by	O	ADP	O
the	O	DET	O
majority	O	NOUN	O
of	O	ADP	O
nasopharyngeal	O	ADJ	B
carcinomas	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
75-kD	B-protein	ADJ	O
protein	I-protein	NOUN	B
is	O	AUX	O
recognized	O	VERB	O
by	O	ADP	O
antibodies	O	NOUN	B
to	O	PART	O
SLP-76	B-protein	NOUN	B
,	O	PUNCT	O
which	O	DET	O
has	O	AUX	O
recently	O	ADV	O
been	O	AUX	O
isolated	O	VERB	B
from	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
sequenced	O	VERB	B
.	O	PUNCT	O


An	O	DET	O
unidentified	O	ADJ	O
Ets	B-protein	NOUN	B
family	I-protein	NOUN	I
protein	I-protein	NOUN	I
binds	O	VERB	B
to	O	PART	O
the	O	DET	O
EBS	B-DNA	NOUN	B
overlapping	O	VERB	O
the	O	DET	O
consensus	B-DNA	NOUN	B
GAS	I-DNA	NOUN	I
motif	I-DNA	NOUN	B
and	O	CCONJ	O
appears	O	VERB	O
to	O	PART	O
negatively	O	ADV	O
regulate	O	VERB	B
the	O	DET	O
human	B-DNA	ADJ	B
IL-2R	I-DNA	NOUN	O
alpha	I-DNA	NOUN	O
promoter	I-DNA	NOUN	O
.	O	PUNCT	O


Immunodepletion	O	NOUN	B
studies	O	NOUN	I
show	O	VERB	O
that	O	SCONJ	O
PTF	B-protein	NOUN	B
beta	I-protein	NOUN	B
is	O	AUX	O
required	O	VERB	O
for	O	ADP	O
transcription	O	NOUN	B
of	O	ADP	O
both	O	DET	O
classes	O	NOUN	B
of	O	ADP	O
snRNA	B-DNA	NOUN	B
genes	I-DNA	NOUN	I
in	O	X	B
vitro	O	X	I
.	O	PUNCT	O


The	O	DET	O
NF-kappaB/Rel	B-protein	NOUN	B
family	I-protein	NOUN	O
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
regulates	O	VERB	B
the	O	DET	O
inducible	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
many	O	ADJ	O
genes	O	NOUN	B
in	O	ADP	O
activated	B-cell_type	VERB	B
human	I-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
and	O	CCONJ	O
endothelial	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
study	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
examined	O	VERB	O
the	O	DET	O
molecular	O	ADJ	B
mechanism	O	NOUN	O
by	O	ADP	O
which	O	DET	O
agents	O	NOUN	B
that	O	PRON	O
elevate	O	VERB	O
intracellular	O	ADJ	B
cAMP	O	NOUN	B
inhibit	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor	I-protein	NOUN	I
alpha	I-protein	NOUN	I
(	O	PUNCT	O
TNFalpha	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
tissue	B-protein	NOUN	B
factor	I-protein	NOUN	I
,	O	PUNCT	O
endothelial	B-protein	ADJ	B
leukocyte	I-protein	NOUN	I
adhesion	I-protein	NOUN	I
molecule-1	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
vascular	B-DNA	ADJ	B
cell	I-DNA	NOUN	I
adhesion	I-DNA	NOUN	I
molecule-1	I-DNA	NOUN	I
genes	I-DNA	NOUN	I
.	O	PUNCT	O


Induction	O	NOUN	B
of	O	ADP	O
NF-kappaB	B-protein	NOUN	B
-dependent	O	ADJ	O
gene	O	NOUN	B
expression	O	NOUN	I
in	O	ADP	O
transiently	O	ADV	O
transfected	O	VERB	B
human	B-cell_line	ADJ	B
monocytic	I-cell_line	ADJ	O
THP-1	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
and	O	CCONJ	O
human	B-cell_type	ADJ	B
umbilical	I-cell_type	ADJ	I
vein	I-cell_type	NOUN	I
endothelial	I-cell_type	ADJ	O
cells	I-cell_type	NOUN	O
was	O	AUX	O
inhibited	O	VERB	B
by	O	ADP	O
elevated	O	ADJ	B
cAMP	O	NOUN	B
and	O	CCONJ	O
by	O	ADP	O
overexpression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
catalytic	B-protein	ADJ	B
subunit	I-protein	NOUN	I
of	O	ADP	O
protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
A	I-protein	NOUN	I
(	O	PUNCT	O
PKA	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Analysis	O	NOUN	B
of	O	ADP	O
10	O	NUM	O
matched	O	VERB	B
pairs	O	NOUN	B
of	O	ADP	O
high	O	ADJ	B
grade	O	NOUN	O
malignant	O	ADJ	B
astrocytomas	O	NOUN	I
and	O	CCONJ	O
their	O	PRON	O
subsequent	O	ADJ	O
recurrences	O	NOUN	B
identified	O	VERB	B
three	O	NUM	O
distinct	O	ADJ	O
groups	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
primary	O	ADJ	B
and	O	CCONJ	O
recurrent	O	ADJ	B
tumors	O	NOUN	I
in	O	ADP	O
Group	O	PROPN	B
A	O	PROPN	O
did	O	AUX	O
not	O	PART	O
show	O	VERB	O
structural	O	ADJ	B
alterations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
p16	B-DNA	NOUN	B
,	I-DNA	PUNCT	O
p15	I-DNA	NOUN	B
or	I-DNA	CCONJ	O
CDK4	I-DNA	NOUN	B
genes	I-DNA	NOUN	I
,	O	PUNCT	O
whereas	O	SCONJ	O
homozygous	O	ADJ	B
codeletion	O	NOUN	B
of	O	ADP	O
p16	B-DNA	NOUN	B
and	O	CCONJ	O
p15	B-DNA	NOUN	B
was	O	AUX	O
observed	O	VERB	O
in	O	ADP	O
both	O	CCONJ	O
primary	O	ADJ	B
and	O	CCONJ	O
recurrent	O	ADJ	B
tumors	O	NOUN	I
in	O	ADP	O
Group	O	NOUN	B
B	O	NOUN	I
.	O	PUNCT	O


BCL-6	B-protein	NOUN	B
,	O	PUNCT	O
a	O	DET	O
POZ/zinc-finger	B-protein	NOUN	B
protein	I-protein	NOUN	I
,	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
sequence-specific	B-protein	ADJ	B
transcriptional	I-protein	ADJ	I
repressor	I-protein	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
BCL-6	B-protein	NOUN	B
protein	I-protein	NOUN	I
can	O	AUX	O
function	O	VERB	B
as	O	ADP	O
a	O	DET	O
sequence-specific	B-protein	ADJ	B
transcriptional	I-protein	ADJ	I
repressor	I-protein	NOUN	I
and	O	CCONJ	O
have	O	AUX	O
implications	O	NOUN	O
for	O	ADP	O
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
BCL6	B-protein	NOUN	B
in	O	ADP	O
normal	O	ADJ	O
lymphoid	O	ADJ	B
development	O	NOUN	O
and	O	CCONJ	O
lymphomagenesis	O	NOUN	B
.	O	PUNCT	O


Signals	O	NOUN	B
leading	O	VERB	O
to	O	PART	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
are	O	AUX	O
stronger	O	ADJ	O
in	O	ADP	O
neonatal	B-cell_type	ADJ	B
than	I-cell_type	ADP	O
adult	I-cell_type	ADJ	B
T	I-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
.	O	PUNCT	O


Analysis	O	NOUN	B
of	O	ADP	O
the	O	DET	O
nuclear	O	ADJ	B
extracts	O	NOUN	I
with	O	ADP	O
antibodies	B-protein	NOUN	B
directed	O	VERB	O
against	O	ADP	O
the	O	DET	O
major	O	ADJ	O
components	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
the	O	DET	O
p50	B-protein	NOUN	B
and	I-protein	CCONJ	O
RelA	I-protein	NOUN	B
(	I-protein	PUNCT	O
p65	I-protein	NOUN	O
)	I-protein	PUNCT	O
proteins	I-protein	NOUN	O
,	O	PUNCT	O
indicated	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
composition	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
was	O	AUX	O
similar	O	ADJ	O
in	O	ADP	O
neonatal	B-cell_type	ADJ	B
and	I-cell_type	CCONJ	O
adult	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
preliminary	O	ADJ	B
studies	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
analyzed	O	VERB	B
the	O	DET	O
hematopoietic	B-protein	ADJ	B
growth	I-protein	NOUN	I
factor	I-protein	NOUN	I
(	O	PUNCT	O
HGF	B-protein	NOUN	B
)	O	PUNCT	O
requirement	O	NOUN	O
of	O	ADP	O
hematopoietic	B-cell_type	ADJ	B
progenitor	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
(	O	PUNCT	O
HPCs	B-cell_type	NOUN	B
)	O	PUNCT	O
purified	O	VERB	O
from	O	ADP	O
embryonic-fetal	O	ADJ	B
liver	O	NOUN	I
(	O	PUNCT	O
FL	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
grown	O	VERB	B
in	O	ADP	O
fetal	O	ADJ	B
calf	O	NOUN	I
serum-supplemented	O	ADJ	B
(	O	PUNCT	O
FCS+	O	ADJ	B
)	O	PUNCT	O
clonogenic	O	ADJ	B
culture	O	NOUN	I
.	O	PUNCT	O


Altogether	O	ADV	O
,	O	PUNCT	O
these	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
ATRA/9-cis	O	NOUN	O
RA	O	NOUN	B
may	O	AUX	O
play	O	VERB	O
a	O	DET	O
key	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
FL	O	NOUN	B
hematopoiesis	O	NOUN	B
via	O	ADP	O
a	O	DET	O
dual	O	ADJ	O
effect	O	NOUN	O
hypothetically	O	ADV	O
mediated	O	VERB	O
by	O	ADP	O
interaction	O	NOUN	B
with	O	ADP	O
the	O	DET	O
RAR/RXR	B-protein	NOUN	B
heterodimer	I-protein	NOUN	I
,	O	PUNCT	O
ie	O	X	O
,	O	PUNCT	O
inhibition	O	NOUN	B
of	O	ADP	O
HSC/	B-cell_line	NOUN	B
primitive	I-cell_line	ADJ	O
HPC	I-cell_line	NOUN	B
proliferation	O	NOUN	O
and	O	CCONJ	O
induction	O	NOUN	B
of	O	ADP	O
CFU-GEMM/	O	NOUN	B
BFU-E/CFU-M	O	ADJ	O
shift	O	NOUN	B
from	O	ADP	O
the	O	DET	O
multipotent/erythroid/monocytic	O	ADJ	B
to	O	ADP	O
the	O	DET	O
granulocytic-neutrophilic	O	ADJ	B
differentiation	O	NOUN	I
program	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
previously	O	ADV	O
suggested	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
measurement	O	NOUN	B
of	O	ADP	O
corticosteroid	B-protein	NOUN	B
receptors	I-protein	NOUN	I
in	O	ADP	O
lymphocytes	B-cell_type	NOUN	B
is	O	AUX	O
an	O	DET	O
index	O	NOUN	O
of	O	ADP	O
an	O	DET	O
analogous	O	ADJ	B
pattern	O	NOUN	B
in	O	ADP	O
brain	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
present	O	ADJ	O
study	O	NOUN	B
,	O	PUNCT	O
corticosteroid	B-protein	NOUN	B
Type	I-protein	NOUN	I
I	I-protein	NUM	I
and	I-protein	CCONJ	O
Type	I-protein	NOUN	B
II	I-protein	NUM	I
receptors	I-protein	NOUN	I
in	O	ADP	O
mononuclear	B-cell_type	ADJ	B
leukocytes	I-cell_type	NOUN	B
were	O	AUX	O
measured	O	VERB	B
in	O	ADP	O
10	O	NUM	O
elderly	O	ADJ	B
subjects	O	NOUN	I
and	O	CCONJ	O
in	O	ADP	O
9	O	NUM	O
young	O	ADJ	B
adults	O	NOUN	I
,	O	PUNCT	O
before	O	ADP	O
and	O	CCONJ	O
after	O	ADP	O
overnight	O	ADJ	B
DST	O	NOUN	B
(	O	PUNCT	O
1	O	NUM	O
mg	O	NOUN	O
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
number	O	NOUN	O
of	O	ADP	O
Type	B-protein	NOUN	B
I	I-protein	NUM	I
and	I-protein	CCONJ	O
Type	I-protein	NOUN	B
II	I-protein	NUM	I
receptors	I-protein	NOUN	I
before	O	ADP	O
the	O	DET	O
test	O	NOUN	B
was	O	AUX	O
lower	O	ADJ	O
in	O	ADP	O
elderly	O	ADJ	B
subjects	O	NOUN	I
than	O	ADP	O
in	O	ADP	O
adults	O	NOUN	B
.	O	PUNCT	O


Changes	O	NOUN	B
of	O	ADP	O
any	O	DET	O
cysteine	O	NOUN	B
residue	O	NOUN	B
of	O	ADP	O
the	O	DET	O
hRAR	B-protein	NOUN	B
alpha-LBD	I-protein	NOUN	I
had	O	AUX	O
no	O	DET	O
significant	O	ADJ	O
influence	O	NOUN	B
on	O	ADP	O
the	O	DET	O
binding	O	NOUN	B
of	O	ADP	O
all-trans	O	ADJ	B
RA	O	NOUN	I
or	O	CCONJ	O
9-cis	O	ADJ	B
RA	O	NOUN	I
.	O	PUNCT	O


With	O	ADP	O
respect	O	NOUN	O
to	O	PART	O
arginine	O	NOUN	B
residues	O	NOUN	O
,	O	PUNCT	O
only	O	ADV	O
the	O	DET	O
two	O	NUM	O
single	O	ADJ	O
mutations	O	NOUN	B
of	O	ADP	O
R-276	O	NOUN	B
and	O	CCONJ	O
R-394	O	NOUN	B
to	O	PART	O
alanine	O	NOUN	B
showed	O	VERB	O
a	O	DET	O
dramatic	O	ADJ	O
decrease	O	NOUN	B
of	O	ADP	O
agonist	O	NOUN	B
and	O	CCONJ	O
antagonist	O	NOUN	B
binding	O	NOUN	B
whereas	O	SCONJ	O
the	O	DET	O
R272A	O	NOUN	B
mutation	O	NOUN	I
showed	O	VERB	O
only	O	ADV	O
a	O	DET	O
slight	O	ADJ	O
effect	O	NOUN	B
.	O	PUNCT	O


Calcineurin	B-protein	NOUN	B
mutants	I-protein	NOUN	B
render	O	VERB	O
T	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
resistant	O	ADJ	B
to	O	PART	O
cyclosporin	O	NOUN	B
A	O	NOUN	I
.	O	PUNCT	O


It	O	PRON	O
is	O	AUX	O
known	O	VERB	O
that	O	SCONJ	O
expression	O	NOUN	B
of	O	ADP	O
a	O	DET	O
single	O	ADJ	O
viral	B-protein	ADJ	B
immediate-early	I-protein	ADJ	I
protein	I-protein	NOUN	I
,	O	PUNCT	O
BZLF1	B-protein	NOUN	B
,	O	PUNCT	O
is	O	AUX	O
sufficient	O	ADJ	O
to	O	PART	O
initiate	O	VERB	B
the	O	DET	O
switch	O	NOUN	B
from	O	ADP	O
latent	O	ADJ	B
to	O	PART	O
lytic	O	ADJ	B
infection	O	NOUN	I
in	O	ADP	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Similarly	O	ADV	O
,	O	PUNCT	O
CTL	B-cell_type	NOUN	B
raised	O	VERB	O
against	O	ADP	O
the	O	DET	O
parent	O	NOUN	B
peptide	O	NOUN	B
did	O	AUX	O
not	O	PART	O
recognize	O	VERB	O
the	O	DET	O
succinimide	O	NOUN	B
derivative	O	NOUN	I
of	O	ADP	O
this	O	DET	O
peptide	O	NOUN	B
.	O	PUNCT	O


Moreover	O	ADV	O
,	O	PUNCT	O
since	O	SCONJ	O
succinimide	O	NOUN	B
intermediates	O	NOUN	I
of	O	ADP	O
deamidated	O	VERB	B
peptides	O	NOUN	I
can	O	AUX	O
occasionally	O	ADV	O
be	O	AUX	O
very	O	ADV	O
stable	O	ADJ	B
,	O	PUNCT	O
these	O	DET	O
peptides	O	NOUN	B
have	O	AUX	O
the	O	DET	O
potential	O	NOUN	B
to	O	PART	O
act	O	VERB	O
as	O	ADP	O
altered	O	ADJ	O
self-Ags	O	NOUN	B
with	O	ADP	O
significant	O	ADJ	O
implications	O	NOUN	O
for	O	ADP	O
autoimmunity	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
unwanted	O	ADJ	B
and	O	CCONJ	O
potentially	O	ADV	O
hazardous	O	ADJ	B
specificities	O	NOUN	I
may	O	AUX	O
be	O	AUX	O
elicited	O	VERB	O
when	O	SCONJ	O
using	O	VERB	O
synthetic	O	ADJ	B
peptides	O	NOUN	I
in	O	ADP	O
subunit	O	NOUN	B
vaccines	O	NOUN	I
in	O	ADP	O
which	O	DET	O
succinimide	O	NOUN	B
residues	O	NOUN	I
may	O	AUX	O
form	O	VERB	O
spontaneously	O	ADV	B
during	O	ADP	O
storage	O	NOUN	B
or	O	CCONJ	O
chemical	O	NOUN	B
synthesis	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
Ets	O	NOUN	B
protein	O	NOUN	I
Spi-B	B-protein	NOUN	B
is	O	AUX	O
expressed	O	VERB	B
exclusively	O	ADV	O
in	O	ADP	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
during	O	ADP	O
development	O	NOUN	B
.	O	PUNCT	O


In	O	X	B
situ	O	X	I
hybridizations	O	NOUN	B
of	O	ADP	O
adult	O	ADJ	B
murine	O	ADJ	B
tissues	O	NOUN	B
demonstrate	O	VERB	O
Spi-B	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
in	O	ADP	O
the	O	DET	O
medulla	O	NOUN	B
of	O	ADP	O
the	O	DET	O
thymus	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
white	O	ADJ	B
pulp	O	NOUN	I
of	O	ADP	O
the	O	DET	O
spleen	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
germinal	O	ADJ	B
centers	O	NOUN	I
of	O	ADP	O
lymph	O	NOUN	B
nodes	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
point	O	NOUN	B
mutations	O	NOUN	I
resulted	O	VERB	O
in	O	ADP	O
a	O	DET	O
2.5-	O	NUM	O
to	O	PART	O
3-fold	O	ADJ	O
reduction	O	NOUN	B
of	O	ADP	O
CAT	B-protein	NOUN	B
activity	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
a	O	DET	O
combination	O	NOUN	B
of	O	ADP	O
the	O	DET	O
three	O	NUM	O
proximal	O	ADJ	B
cis-acting	B-DNA	ADJ	B
elements	I-DNA	NOUN	I
may	O	AUX	O
constitute	O	VERB	O
a	O	DET	O
minimal	O	ADJ	B
region	O	NOUN	I
responsible	O	ADJ	O
for	O	ADP	O
CTL-specific	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
perforin	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
primary	B-RNA	ADJ	O
RNA	I-RNA	NOUN	B
transcript	I-RNA	NOUN	I
of	O	ADP	O
the	O	DET	O
gene	O	NOUN	B
is	O	AUX	O
subject	O	ADJ	O
to	O	PART	O
alternative	O	ADJ	B
splicing	O	NOUN	B
to	O	PART	O
yield	O	VERB	O
different	O	ADJ	O
variants	O	NOUN	B
which	O	DET	O
can	O	AUX	O
either	O	CCONJ	O
activate	O	VERB	B
or	O	CCONJ	O
repress	O	VERB	B
gene	O	NOUN	B
expression	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
forms	O	NOUN	O
produced	O	VERB	O
in	O	ADP	O
B	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
have	O	AUX	O
a	O	DET	O
predominantly	O	ADV	O
activating	O	VERB	B
effect	O	NOUN	B
on	O	ADP	O
gene	O	NOUN	B
expression	O	NOUN	I
whereas	O	SCONJ	O
those	O	DET	O
produced	O	VERB	O
in	O	ADP	O
neuronal	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
have	O	AUX	O
a	O	DET	O
predominantly	O	ADV	O
inhibitory	O	ADJ	B
effect	O	NOUN	O
and	O	CCONJ	O
can	O	AUX	O
repress	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
both	O	CCONJ	O
the	O	DET	O
herpes	B-DNA	NOUN	B
simplex	I-DNA	NOUN	I
virus	I-DNA	NOUN	I
immediate-early	I-DNA	ADJ	B
genes	I-DNA	NOUN	I
and	O	CCONJ	O
the	O	DET	O
cellular	B-DNA	ADJ	B
tyrosine	I-DNA	NOUN	I
hydroxylase	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
.	O	PUNCT	O


Consistent	O	ADJ	B
with	O	ADP	I
these	O	DET	O
results	O	NOUN	B
,	O	PUNCT	O
quantitative	O	ADJ	B
DNase	B-protein	NOUN	I
footprinting	O	NOUN	I
of	O	ADP	O
the	O	DET	O
TNF-alpha	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
using	O	VERB	O
increasing	O	VERB	B
amounts	O	NOUN	O
of	O	ADP	O
recombinant	O	ADJ	B
NFATp	B-protein	NOUN	B
demonstrated	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
-76	B-DNA	NUM	O
site	I-DNA	NOUN	B
binds	O	VERB	B
to	O	PART	O
NFATp	B-protein	NOUN	B
with	O	ADP	O
a	O	DET	O
higher	O	ADJ	O
affinity	O	NOUN	B
than	O	ADP	O
the	O	DET	O
kappa	B-DNA	NOUN	B
3	I-DNA	NUM	I
site	I-DNA	NOUN	I
.	O	PUNCT	O


Anergic	B-cell_line	ADJ	B
CD4+	I-cell_line	ADJ	O
Th	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
do	O	AUX	O
not	O	PART	O
produce	O	VERB	O
IL-2	B-protein	NOUN	B
when	O	SCONJ	O
challenged	O	VERB	O
with	O	ADP	O
Ag-pulsed	B-cell_line	ADJ	B
accessory	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
because	O	SCONJ	O
of	O	ADP	O
a	O	DET	O
transcriptional	O	ADJ	B
defect	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
find	O	VERB	O
that	O	SCONJ	O
OCA-B	B-protein	NOUN	B
binds	O	VERB	O
DNA	O	NOUN	O
directly	O	ADV	O
in	O	ADP	O
the	O	DET	O
major	O	ADJ	O
groove	O	NOUN	B
between	O	ADP	O
the	O	DET	O
two	O	NUM	O
subdomains	O	NOUN	B
of	O	ADP	O
the	O	DET	O
POU	B-DNA	NOUN	B
domain	I-DNA	NOUN	I
,	O	PUNCT	O
requiring	O	VERB	O
both	O	CCONJ	O
an	O	DET	O
A	O	NOUN	O
at	O	ADP	O
the	O	DET	O
fifth	B-DNA	ADJ	O
position	I-DNA	NOUN	O
of	O	ADP	O
the	O	DET	O
octamer	B-DNA	NOUN	B
element	I-DNA	NOUN	O
and	O	CCONJ	O
contact	O	NOUN	B
with	O	ADP	I
the	O	DET	O
POU	B-DNA	NOUN	B
domain	I-DNA	NOUN	I
.	O	PUNCT	O


[	O	PUNCT	O
Cortisone-resistant	O	ADJ	B
bronchial	O	ADJ	I
asthma	O	NOUN	I
]	O	PUNCT	O


New	O	ADJ	O
knowledge	O	NOUN	B
on	O	ADP	O
the	O	DET	O
mechanism	O	NOUN	B
of	O	ADP	O
steroid	O	NOUN	B
resistance	O	NOUN	B
may	O	AUX	O
have	O	AUX	O
important	O	ADJ	O
implications	O	NOUN	O
for	O	ADP	O
the	O	DET	O
treatment	O	NOUN	B
of	O	ADP	O
chronic	O	ADJ	B
asthma	O	NOUN	I
and	O	CCONJ	O
other	O	ADJ	O
diseases	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
NH2-terminal	B-protein	ADJ	B
transactivation	I-protein	NOUN	I
domain	I-protein	NOUN	I
is	O	AUX	O
modulated	O	VERB	B
by	O	ADP	O
an	O	DET	O
adjacent	O	ADJ	B
regulatory	B-protein	ADJ	B
region	I-protein	NOUN	I
that	O	PRON	O
contains	O	VERB	O
several	O	ADJ	O
conserved	B-DNA	VERB	O
sequence	I-DNA	NOUN	O
motifs	I-DNA	NOUN	B
represented	O	VERB	O
only	O	ADV	O
in	O	ADP	O
the	O	DET	O
NFAT	B-protein	NOUN	B
family	I-protein	NOUN	B
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	B
emphasize	O	VERB	O
the	O	DET	O
multiple	O	ADJ	B
levels	O	NOUN	B
at	O	ADP	O
which	O	DET	O
NFAT-dependent	O	ADJ	B
transactivation	O	NOUN	I
is	O	AUX	O
regulated	O	VERB	O
,	O	PUNCT	O
and	O	CCONJ	O
predict	O	VERB	O
significant	O	ADJ	O
differences	O	NOUN	O
in	O	ADP	O
the	O	DET	O
architecture	O	NOUN	B
of	O	ADP	O
cooperative	O	ADJ	O
transcription	B-protein	NOUN	O
complexes	I-protein	NOUN	O
containing	O	VERB	O
different	O	ADJ	O
NFAT-family	B-protein	NOUN	B
proteins	I-protein	NOUN	I
.	O	PUNCT	O


A	O	DET	O
major	O	ADJ	O
obstacle	O	NOUN	O
in	O	ADP	O
understanding	O	VERB	O
the	O	DET	O
signaling	O	NOUN	B
events	O	NOUN	I
that	O	PRON	O
follow	O	VERB	O
CD28	B-protein	NOUN	B
receptor	O	NOUN	I
ligation	O	NOUN	O
arises	O	VERB	O
from	O	ADP	O
the	O	DET	O
fact	O	NOUN	O
that	O	SCONJ	O
CD28	B-protein	NOUN	B
acts	O	VERB	O
as	O	ADP	O
a	O	DET	O
costimulus	O	NOUN	B
to	O	PART	O
TCR	B-protein	NOUN	B
engagement	O	NOUN	B
,	O	PUNCT	O
making	O	VERB	O
it	O	PRON	O
difficult	O	ADJ	O
to	O	PART	O
assess	O	VERB	B
the	O	DET	O
relative	O	ADJ	O
contribution	O	NOUN	O
of	O	ADP	O
CD28	B-protein	NOUN	B
signals	O	NOUN	B
as	O	ADP	O
distinct	O	ADJ	O
from	O	ADP	O
those	O	DET	O
of	O	ADP	O
the	O	DET	O
TCR	B-protein	NOUN	B
.	O	PUNCT	O


This	O	DET	O
finding	O	NOUN	B
may	O	AUX	O
lead	O	VERB	O
to	O	PART	O
a	O	DET	O
better	O	ADJ	O
understanding	O	NOUN	O
of	O	ADP	O
the	O	DET	O
reasons	O	NOUN	B
for	O	ADP	O
the	O	DET	O
prevalence	O	NOUN	B
of	O	ADP	O
lupus	O	NOUN	B
in	O	ADP	O
females	O	NOUN	B
and	O	CCONJ	O
of	O	ADP	O
the	O	DET	O
estrogenic	O	ADJ	B
effects	O	NOUN	O
on	O	ADP	O
SLE	O	NOUN	B
disease	O	NOUN	B
activity	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
cytokines	B-protein	NOUN	B
IFN-beta	B-protein	NOUN	B
,	O	PUNCT	O
IFN-gamma	B-protein	NOUN	B
,	O	PUNCT	O
IL-4	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
LPS	O	NOUN	B
,	O	PUNCT	O
although	O	SCONJ	O
unable	O	ADJ	O
to	O	PART	O
induce	O	VERB	B
sialoadhesin	B-protein	NOUN	B
expression	O	NOUN	B
by	O	ADP	O
themselves	O	PRON	O
,	O	PUNCT	O
were	O	AUX	O
able	O	ADJ	O
to	O	PART	O
enhance	O	VERB	O
GC-mediated	O	ADJ	B
induction	O	NOUN	B
of	O	ADP	O
sialoadhesin	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
sialoadhesin	B-protein	NOUN	B
expression	O	NOUN	B
was	O	AUX	O
mediated	O	VERB	O
by	O	ADP	O
the	O	DET	O
GC	B-protein	NOUN	B
receptor	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
not	O	PART	O
by	O	ADP	O
mineralocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
,	O	PUNCT	O
as	O	ADP	O
shown	O	VERB	O
by	O	ADP	O
inhibition	O	NOUN	B
experiments	O	NOUN	O
with	O	ADP	O
specific	O	ADJ	B
antagonists	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
a	O	DET	O
high	O	ADJ	O
level	O	NOUN	B
of	O	ADP	O
bcl-2	B-protein	NOUN	B
protects	O	VERB	O
cells	O	NOUN	B
in	O	X	B
vitro	O	X	I
and	O	CCONJ	O
in	O	X	B
vivo	O	X	I
from	O	ADP	O
the	O	DET	O
viral	B-protein	ADJ	B
protease	I-protein	NOUN	I
and	O	CCONJ	O
prevents	O	VERB	B
cell	O	NOUN	B
death	O	NOUN	I
following	O	VERB	O
HIV	O	NOUN	B
infection	O	NOUN	I
of	O	ADP	O
human	B-cell_type	ADJ	B
lymphocytes	I-cell_type	NOUN	B
,	O	PUNCT	O
while	O	SCONJ	O
reducing	O	VERB	B
the	O	DET	O
yields	O	NOUN	O
of	O	ADP	O
viral	B-protein	ADJ	B
structural	I-protein	ADJ	I
proteins	I-protein	NOUN	I
,	O	PUNCT	O
infectivity	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor	I-protein	NOUN	I
alpha	I-protein	NOUN	I
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
dose	O	NOUN	B
of	O	ADP	O
OKT3	B-protein	NOUN	B
required	O	VERB	O
to	O	PART	O
achieve	O	VERB	O
half-maximal	O	ADJ	O
activation	O	NOUN	B
was	O	AUX	O
the	O	DET	O
same	O	ADJ	O
using	O	VERB	O
PMA	O	NOUN	B
or	O	CCONJ	O
different	O	ADJ	O
concentrations	O	NOUN	B
of	O	ADP	O
alpha	B-protein	NOUN	B
4	I-protein	NUM	I
beta	I-protein	NOUN	O
1	I-protein	NUM	O
ligands	O	NOUN	B
.	O	PUNCT	O


Indeed	O	ADV	O
,	O	PUNCT	O
erythroid	B-DNA	ADJ	B
gene	I-DNA	NOUN	B
expression	O	NOUN	I
was	O	AUX	O
demonstrated	O	VERB	O
to	O	PART	O
be	O	AUX	O
regulated	O	VERB	O
transcriptionally	O	ADV	B
by	O	ADP	O
ACLA	O	NOUN	B
and	O	CCONJ	O
mainly	O	ADV	O
posttranscriptionally	O	ADV	B
by	O	ADP	O
DOX	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
findings	O	NOUN	B
establish	O	VERB	O
that	O	SCONJ	O
STAT1	B-protein	NOUN	B
and	O	CCONJ	O
STAT5	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
possibly	O	ADV	O
STAT3	B-protein	NOUN	B
,	O	PUNCT	O
are	O	AUX	O
activated	O	VERB	B
upon	O	SCONJ	O
stimulation	O	NOUN	B
of	O	ADP	O
precursor	B-cell_type	NOUN	B
B	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
with	O	ADP	O
IL-7	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
data	O	NOUN	B
further	O	ADV	O
indicate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
IL-7R	B-protein	NOUN	B
alpha	I-protein	NOUN	B
chains	I-protein	NOUN	I
are	O	AUX	O
directly	O	ADV	O
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
JAKs	B-protein	NOUN	B
and	O	CCONJ	O
STATs	B-protein	NOUN	B
and	O	CCONJ	O
have	O	AUX	O
a	O	DET	O
major	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
proliferative	O	ADJ	B
signaling	O	NOUN	I
in	O	ADP	O
precursor	B-cell_type	NOUN	B
B	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Stimulation	O	NOUN	B
of	O	ADP	O
human	O	ADJ	B
lymphocyte	O	NOUN	B
proliferation	O	NOUN	I
and	O	CCONJ	O
CD40	B-protein	NOUN	B
antigen	O	NOUN	B
expression	O	NOUN	B
by	O	ADP	O
phosphorothioate	O	NOUN	B
oligonucleotides	O	NOUN	I
complementary	O	ADJ	O
to	O	PART	O
hepatitis	B-DNA	NOUN	B
B	I-DNA	NOUN	I
virus	I-DNA	NOUN	I
genome	I-DNA	NOUN	B
.	O	PUNCT	O


Activation	B-protein	NOUN	B
protein	I-protein	NOUN	I
1	I-protein	NUM	I
-dependent	O	ADJ	O
transcriptional	O	ADJ	B
activation	O	NOUN	I
of	O	ADP	O
interleukin	B-DNA	NOUN	B
2	I-DNA	NUM	I
gene	I-DNA	NOUN	I
by	O	ADP	O
Ca2+/calmodulin	B-protein	NOUN	B
kinase	I-protein	NOUN	I
type	I-protein	NOUN	I
IV/Gr	I-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
responses	O	NOUN	B
of	O	ADP	O
lymphocytes	B-cell_type	NOUN	B
to	O	PART	O
IL-2	B-protein	NOUN	B
and	O	CCONJ	O
IL-12	B-protein	NOUN	B
,	O	PUNCT	O
involving	O	VERB	O
proliferation	O	NOUN	B
,	O	PUNCT	O
differentiation	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
cytokine	B-protein	NOUN	B
production	O	NOUN	I
,	O	PUNCT	O
are	O	AUX	O
only	O	ADV	O
partially	O	ADV	O
overlapping	O	VERB	O
,	O	PUNCT	O
and	O	CCONJ	O
may	O	AUX	O
depend	O	VERB	O
on	O	ADP	O
induced	O	VERB	B
differential	O	ADJ	O
expression	O	NOUN	B
of	O	ADP	O
specific	O	ADJ	O
sets	O	NOUN	O
of	O	ADP	O
genes	B-protein	NOUN	B
.	O	PUNCT	O


Analysis	O	NOUN	B
of	O	ADP	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
genes	B-protein	NOUN	B
reported	O	VERB	O
to	O	PART	O
regulate	O	VERB	B
cytokine	B-protein	NOUN	B
-induced	O	ADJ	O
proliferation	O	NOUN	B
demonstrated	O	VERB	O
that	O	SCONJ	O
both	O	CCONJ	O
IL-2	B-protein	NOUN	B
and	O	CCONJ	O
IL-12	B-protein	NOUN	B
induce	O	VERB	O
c-myc	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
accumulation	O	NOUN	B
in	O	ADP	O
NK	B-cell_type	NOUN	B
and	I-cell_type	CCONJ	O
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
whereas	O	SCONJ	O
only	O	ADV	O
IL-2	B-protein	NOUN	B
induces	O	VERB	O
bcl-2	B-DNA	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
indicates	O	VERB	O
that	O	SCONJ	O
functional	O	ADJ	B
differences	O	NOUN	O
observed	O	VERB	O
in	O	ADP	O
IL-2-	B-cell_line	NOUN	B
and	I-cell_line	CCONJ	O
IL-12-stimulated	I-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
may	O	AUX	O
depend	O	VERB	O
,	O	PUNCT	O
at	O	ADP	O
least	O	ADJ	O
in	O	ADP	O
part	O	NOUN	O
,	O	PUNCT	O
on	O	ADP	O
differential	O	ADJ	O
gene	O	NOUN	B
regulation	O	NOUN	I
.	O	PUNCT	O


Transfection	O	NOUN	B
of	O	ADP	O
a	O	DET	O
cDNA	O	NOUN	B
containing	O	VERB	O
the	O	DET	O
human	B-DNA	ADJ	B
CIITA	I-DNA	NOUN	B
coding	I-DNA	NOUN	B
sequence	I-DNA	NOUN	I
under	O	ADP	O
the	O	DET	O
control	O	NOUN	B
of	O	ADP	O
an	O	DET	O
heterologous	B-DNA	ADJ	B
promoter	I-DNA	NOUN	B
restores	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
human	B-DNA	ADJ	B
MHC	I-DNA	NOUN	O
class	I-DNA	NOUN	O
II	I-DNA	NUM	O
genes	I-DNA	NOUN	O
in	O	ADP	O
the	O	DET	O
hybrids	O	NOUN	B
and	O	CCONJ	O
is	O	AUX	O
responsible	O	ADJ	O
for	O	ADP	O
de	O	X	O
novo	O	X	O
expression	O	NOUN	B
of	O	ADP	O
mouse	B-DNA	NOUN	B
MHC	I-DNA	NOUN	B
class	I-DNA	NOUN	I
II	I-DNA	NUM	I
genes	I-DNA	NOUN	O
in	O	ADP	O
both	O	CCONJ	O
the	O	DET	O
mouse	B-cell_line	NOUN	B
plasmacytoma	I-cell_line	NOUN	I
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
and	O	CCONJ	O
the	O	DET	O
hybrids	B-cell_line	NOUN	B
.	O	PUNCT	O


Increasing	O	VERB	B
the	O	DET	O
levels	O	NOUN	B
of	O	ADP	O
BCL-2	B-protein	NOUN	B
retarded	O	VERB	B
the	O	DET	O
G0	O	NOUN	B
--	O	PUNCT	O
>	O	X	O
S	O	NOUN	B
transition	O	NOUN	B
,	O	PUNCT	O
sustained	O	VERB	B
the	O	DET	O
levels	O	NOUN	B
of	O	ADP	O
cyclin-dependent	B-protein	ADJ	B
kinase	I-protein	NOUN	I
inhibitor	O	NOUN	I
p27Kip1	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
repressed	O	VERB	B
postactivation	O	NOUN	B
death	O	NOUN	B
.	O	PUNCT	O


InterleUkin	B-protein	NOUN	B
2	I-protein	NUM	I
expression	O	NOUN	B
requires	O	VERB	O
several	O	ADJ	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
of	O	ADP	O
which	O	DET	O
nuclear	O	ADJ	B
translocation	O	NOUN	I
of	O	ADP	O
NFAT	B-protein	NOUN	B
(	O	PUNCT	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
of	I-protein	ADP	O
activated	I-protein	VERB	B
T	I-protein	NOUN	O
cells	I-protein	NOUN	O
)	O	PUNCT	O
and	O	CCONJ	O
NFAT	B-protein	NOUN	B
-mediated	O	ADJ	O
transactivation	O	NOUN	B
were	O	AUX	O
impaired	O	VERB	B
by	O	ADP	O
BCL-2	B-protein	NOUN	B
.	O	PUNCT	O


On	O	ADP	O
the	O	DET	O
basis	O	NOUN	O
of	O	ADP	O
several	O	ADJ	O
independent	O	ADJ	O
assays	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
now	O	ADV	O
report	O	VERB	O
a	O	DET	O
physical	O	ADJ	B
and	O	CCONJ	O
functional	O	ADJ	B
interaction	O	NOUN	B
between	O	ADP	O
Tax	B-protein	NOUN	B
and	O	CCONJ	O
the	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
,	O	PUNCT	O
TFIIA	B-protein	NOUN	B
.	O	PUNCT	O


Second	O	ADV	O
,	O	PUNCT	O
a	O	DET	O
glutathione-S-transferase	O	NOUN	B
(	O	PUNCT	I
GST	B-protein	NOUN	I
)	O	PUNCT	I
affinity-binding	O	ADJ	B
assay	O	NOUN	I
showed	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
interaction	O	NOUN	B
of	O	ADP	O
holo-	O	NOUN	O
TFIIA	B-protein	NOUN	B
with	O	ADP	O
GST-Tax	B-protein	NOUN	B
was	O	AUX	O
20-fold	O	ADV	O
higher	O	ADJ	O
than	O	ADP	O
that	O	DET	O
observed	O	VERB	O
with	O	ADP	O
either	O	CCONJ	O
the	O	DET	O
GST-Tax	B-protein	NOUN	B
M32	I-protein	NOUN	O
activation	I-protein	NOUN	B
mutant	I-protein	NOUN	I
or	O	CCONJ	O
the	O	DET	O
GST	O	NOUN	B
control	O	NOUN	B
.	O	PUNCT	O


Finally	O	ADV	O
,	O	PUNCT	O
TFIIA	B-protein	NOUN	B
facilitates	O	VERB	O
Tax	B-protein	NOUN	B
transactivation	O	NOUN	B
in	O	X	B
vitro	O	X	I
and	O	CCONJ	O
in	O	X	B
vivo	O	X	I
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
transfection	O	NOUN	B
of	O	ADP	O
human	B-cell_type	ADJ	B
T	I-cell_type	NOUN	O
lymphocytes	I-cell_type	NOUN	O
with	O	ADP	O
TFIIA	B-DNA	NOUN	B
expression	I-DNA	NOUN	B
vectors	I-DNA	NOUN	I
enhanced	O	VERB	O
Tax	B-protein	NOUN	B
-activated	O	ADJ	O
transcription	O	NOUN	B
of	O	ADP	O
an	O	DET	O
HTLV-1	B-DNA	NOUN	B
long	I-DNA	ADJ	B
terminal	I-DNA	ADJ	I
repeat-chloramphenicol	I-DNA	NOUN	I
acetyltransferase	I-DNA	NOUN	I
reporter	I-DNA	NOUN	I
construct	I-DNA	NOUN	I
.	O	PUNCT	O


cAMP	O	NOUN	B
signaling	O	NOUN	I
inhibited	O	VERB	B
Stat1	B-protein	NOUN	B
at	O	ADP	O
several	O	ADJ	O
different	O	ADJ	O
levels	O	NOUN	B
,	O	PUNCT	O
including	O	VERB	O
suppression	O	NOUN	B
of	O	ADP	O
DNA	O	NOUN	B
binding	O	NOUN	I
and	O	CCONJ	O
down-regulation	O	NOUN	B
of	O	ADP	O
Stat1	O	NOUN	B
protein	O	NOUN	I
and	O	CCONJ	O
mRNA	O	NOUN	B
levels	O	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
selecting	O	VERB	O
the	O	DET	O
most	O	ADV	O
specific	O	ADJ	B
and	O	CCONJ	O
potent	O	ADJ	O
oligonucleotide	O	NOUN	B
sequence	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
performed	O	VERB	O
extensive	O	ADJ	O
analyses	O	NOUN	B
for	O	ADP	O
the	O	DET	O
binding	O	NOUN	B
specificity	O	NOUN	B
between	O	ADP	O
all	O	DET	O
candidates	O	NOUN	O
of	O	ADP	O
c-jun	B-DNA	NOUN	B
AS	O	ADJ	I
oligonucleotides	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
whole	O	ADJ	O
sequences	O	NOUN	O
in	O	ADP	O
GenBank	O	NOUN	B
database	O	NOUN	I
,	O	PUNCT	O
using	O	VERB	O
a	O	DET	O
computer	O	NOUN	B
program	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
a	O	DET	O
critical	O	ADJ	O
role	O	NOUN	O
of	O	ADP	O
c-jun	B-DNA	NOUN	B
in	O	ADP	O
both	O	DET	O
cell	O	NOUN	B
proliferation	O	NOUN	I
and	O	CCONJ	O
PMA-induced	O	ADJ	B
cell	O	NOUN	O
adhesion	O	NOUN	O
but	O	CCONJ	O
not	O	PART	O
in	O	ADP	O
PMA-induced	O	ADJ	B
respiratory	O	ADJ	B
burst	O	NOUN	I
in	O	ADP	O
U937	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Effects	O	NOUN	B
of	O	ADP	O
IL-10	B-protein	NOUN	B
and	O	CCONJ	O
IL-4	B-protein	NOUN	B
on	O	ADP	O
LPS-induced	O	ADJ	B
transcription	B-protein	NOUN	O
factors	I-protein	NOUN	O
(	O	PUNCT	O
AP-1	B-protein	NOUN	B
,	O	PUNCT	O
NF-IL6	B-protein	NOUN	B
and	O	CCONJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
)	O	PUNCT	O
which	O	DET	O
are	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
IL-6	B-protein	NOUN	B
regulation	O	NOUN	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
these	O	DET	O
core	O	NOUN	B
regions	O	NOUN	I
of	O	ADP	O
the	O	DET	O
enhancer	O	NOUN	B
and	O	CCONJ	O
promoter	O	NOUN	B
each	O	DET	O
encompass	O	VERB	O
closely	B-DNA	ADV	O
linked	I-DNA	VERB	O
binding	I-DNA	VERB	B
sites	I-DNA	NOUN	I
for	O	ADP	O
CBF	B-protein	NOUN	B
,	O	PUNCT	O
AP-1	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
NFATp	B-protein	NOUN	B
.	O	PUNCT	O


Stepwise	O	ADJ	B
deletions	O	NOUN	B
into	O	ADP	O
the	O	DET	O
proximal	B-DNA	ADJ	B
promoter	I-DNA	NOUN	B
also	O	ADV	O
revealed	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
CBF	B-protein	NOUN	B
site	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
the	O	DET	O
YY-1	B-DNA	NOUN	B
site	I-DNA	NOUN	I
,	O	PUNCT	O
was	O	AUX	O
required	O	VERB	O
for	O	ADP	O
efficient	O	ADJ	B
induction	O	NOUN	B
of	O	ADP	O
transcriptional	O	ADJ	B
activation	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
current	O	ADJ	O
study	O	NOUN	B
examined	O	VERB	O
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	I
oxidative	O	ADJ	B
stress	O	NOUN	I
on	O	ADP	O
transcriptional	O	ADJ	B
activities	O	NOUN	I
mediated	O	VERB	O
by	O	ADP	O
c-Fos/c-Jun	B-protein	NOUN	B
AP-1	B-protein	NOUN	I
and	O	CCONJ	O
the	O	DET	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
of	I-protein	ADP	O
activated	I-protein	VERB	B
T	I-protein	NOUN	O
cells	I-protein	NOUN	O
(	O	PUNCT	O
NF-AT	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
sublethal	O	ADJ	B
levels	O	NOUN	B
of	O	ADP	O
H2O2	O	NOUN	B
actively	O	ADV	O
suppressed	O	VERB	B
the	O	DET	O
transcriptional	O	ADJ	B
activation	O	NOUN	I
of	O	ADP	O
NF-AT	B-protein	NOUN	B
and	O	CCONJ	O
IL-2	B-DNA	NOUN	B
reporters	I-DNA	NOUN	B
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
IL-2	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
in	O	ADP	O
cells	O	NOUN	B
stimulated	O	VERB	B
with	O	ADP	O
PHA/PMA	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
underlying	O	ADJ	O
molecular	O	ADJ	B
mechanism	O	NOUN	I
for	O	ADP	O
Pb	O	NOUN	B
's	O	PART	I
complex	O	ADJ	B
effects	O	NOUN	B
on	O	ADP	O
the	O	DET	O
immune	O	ADJ	B
system	O	NOUN	I
remain	O	VERB	O
obscure	O	ADJ	B
.	O	PUNCT	O


Many	O	ADJ	O
of	O	ADP	O
Pb	O	NOUN	B
's	O	PART	O
effects	O	NOUN	B
on	O	ADP	O
the	O	DET	O
immune	O	ADJ	B
system	O	NOUN	I
could	O	AUX	O
be	O	AUX	O
explained	O	VERB	O
through	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
,	O	PUNCT	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
.	O	PUNCT	O


Functional	O	ADJ	B
activation	O	NOUN	O
of	O	ADP	O
gene	O	NOUN	B
expression	O	NOUN	I
by	O	ADP	O
Pb	O	NOUN	B
was	O	AUX	O
confirmed	O	VERB	O
using	O	VERB	O
primary	B-cell_line	ADJ	B
CD4+	I-cell_line	ADJ	B
T	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
transfected	O	VERB	B
with	O	ADP	O
an	O	DET	O
NF-kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
dependent	I-DNA	ADJ	O
reporter	I-DNA	NOUN	O
gene	I-DNA	NOUN	O
construct	I-DNA	NOUN	O
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
IFN	B-protein	NOUN	B
(	I-protein	PUNCT	O
alpha	I-protein	NOUN	B
)	I-protein	PUNCT	O
does	O	AUX	O
not	O	PART	O
have	O	AUX	O
any	O	DET	O
effects	O	NOUN	B
on	O	ADP	O
the	O	DET	O
retinoid-dependent	O	ADJ	B
regulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
myeloid	B-protein	ADJ	B
surface	I-protein	NOUN	O
markers	I-protein	NOUN	B
CD11b	B-protein	NOUN	B
and	O	CCONJ	O
CD33	B-protein	NOUN	B
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
stress	O	NOUN	B
may	O	AUX	O
cause	O	VERB	O
a	O	DET	O
selective	O	ADJ	O
suppression	O	NOUN	B
of	O	ADP	O
TH1	O	NOUN	B
functions	O	NOUN	B
and	O	CCONJ	O
a	O	DET	O
shift	O	NOUN	B
toward	O	ADP	O
a	O	DET	O
TH2	B-protein	NOUN	B
cytokine	I-protein	NOUN	B
pattern	O	NOUN	I
rather	O	ADV	O
than	O	ADP	O
generalized	O	VERB	O
TH	O	NOUN	B
suppression	O	NOUN	B
.	O	PUNCT	O


Activation	O	NOUN	B
of	O	ADP	O
human	B-cell_type	ADJ	B
monocytic	I-cell_type	ADJ	O
cells	I-cell_type	NOUN	O
by	O	ADP	O
Treponema	B-protein	X	B
pallidum	I-protein	X	I
and	I-protein	CCONJ	O
Borrelia	I-protein	X	B
burgdorferi	I-protein	X	I
lipoproteins	I-protein	NOUN	I
and	O	CCONJ	O
synthetic	O	ADJ	B
lipopeptides	O	NOUN	B
proceeds	O	VERB	O
via	O	ADP	O
a	O	DET	O
pathway	O	NOUN	B
distinct	O	ADJ	O
from	O	ADP	O
that	O	DET	O
of	O	ADP	O
lipopolysaccharide	O	NOUN	B
but	O	CCONJ	O
involves	O	VERB	O
the	O	DET	O
transcriptional	O	ADJ	B
activator	O	NOUN	I
NF-kappa	B-protein	NOUN	O
B	I-protein	NOUN	O
.	O	PUNCT	O


By	O	ADP	O
using	O	VERB	O
70Z/3-derived	B-cell_line	ADJ	O
pre-B-cell	I-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
either	O	CCONJ	O
lacking	O	VERB	B
or	O	CCONJ	O
expressing	O	VERB	B
human	B-protein	ADJ	B
CD14	I-protein	NOUN	B
(	O	PUNCT	O
the	O	DET	O
LPS	B-protein	NOUN	B
receptor	I-protein	NOUN	I
)	O	PUNCT	O
,	O	PUNCT	O
it	O	PRON	O
was	O	AUX	O
observed	O	VERB	O
that	O	SCONJ	O
expression	O	NOUN	B
of	O	ADP	O
human	B-protein	ADJ	B
CD14	I-protein	NOUN	B
imparted	O	VERB	O
responsiveness	O	NOUN	B
to	O	PART	O
LPS	O	NOUN	B
but	O	CCONJ	O
not	O	PART	O
to	O	PART	O
OspA	B-protein	NOUN	B
or	O	CCONJ	O
spirochetal	B-protein	ADJ	B
lipopeptides	I-protein	NOUN	I
(	O	PUNCT	O
assessed	O	VERB	B
by	O	ADP	O
induction	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
and	O	CCONJ	O
expression	O	NOUN	B
of	O	ADP	O
surface	B-protein	NOUN	B
immunoglobulin	I-protein	NOUN	O
M	I-protein	NOUN	O
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
PML	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
is	O	AUX	O
fused	O	VERB	B
to	O	PART	O
the	O	DET	O
retinoic	B-DNA	ADJ	B
acid	I-DNA	NOUN	I
receptor	I-DNA	NOUN	I
alpha	I-DNA	NOUN	I
(	I-DNA	PUNCT	O
RAR	I-DNA	NOUN	B
alpha	I-DNA	NOUN	I
)	I-DNA	PUNCT	O
gene	I-DNA	NOUN	O
in	O	ADP	O
t	O	NOUN	O
(	O	PUNCT	O
15	O	NUM	O
;	O	PUNCT	O
17	O	NUM	O
)	O	PUNCT	O
acute	O	ADJ	B
promyelocytic	O	ADJ	I
leukemia	O	NOUN	I
(	O	PUNCT	O
APL	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
creating	O	VERB	O
a	O	DET	O
PML-RAR	B-protein	NOUN	B
alpha	I-protein	NOUN	I
fusion	I-protein	NOUN	I
oncoprotein	I-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
PML	B-protein	NOUN	B
gene	I-protein	NOUN	I
product	I-protein	NOUN	O
has	O	AUX	O
been	O	AUX	O
localized	O	ADJ	B
to	O	PART	O
subnuclear	B-cell_line	ADJ	B
dot-like	I-cell_line	ADJ	B
structures	I-cell_line	NOUN	I
variously	O	ADV	O
termed	O	VERB	O
PODs	O	NOUN	B
,	O	PUNCT	O
ND10s	O	NOUN	B
,	O	PUNCT	O
Kr	O	NOUN	B
bodies	O	NOUN	I
,	O	PUNCT	O
or	O	CCONJ	O
PML	O	NOUN	B
nuclear	O	ADJ	O
bodies	O	NOUN	O
(	O	PUNCT	O
PML	O	NOUN	B
NBs	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


By	O	ADP	O
immunofluorescence	O	NOUN	B
,	O	PUNCT	O
LYSP100	B-DNA	NOUN	B
was	O	AUX	O
localized	O	ADJ	B
to	O	PART	O
nuclear	O	ADJ	B
dots	O	NOUN	I
that	O	PRON	O
were	O	AUX	O
surprisingly	O	ADV	O
largely	O	ADV	O
nonoverlapping	O	ADJ	O
with	O	ADP	O
PML	O	NOUN	B
NBs	O	NOUN	B
.	O	PUNCT	O


LANDs	O	NOUN	B
were	O	AUX	O
most	O	ADV	O
often	O	ADV	O
found	O	VERB	O
in	O	ADP	O
the	O	DET	O
nucleoplasm	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
were	O	AUX	O
also	O	ADV	O
found	O	VERB	O
at	O	ADP	O
the	O	DET	O
nuclear	O	ADJ	B
membrane	O	NOUN	I
and	O	CCONJ	O
in	O	ADP	O
the	O	DET	O
cytoplasm	O	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
these	O	DET	O
structures	O	NOUN	B
may	O	AUX	O
traffic	O	VERB	B
between	O	ADP	O
the	O	DET	O
cytoplasm	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
nucleus	O	NOUN	B
.	O	PUNCT	O


GR	B-protein	NOUN	B
expression	O	NOUN	B
levels	O	NOUN	O
were	O	AUX	O
shown	O	VERB	O
to	O	PART	O
be	O	AUX	O
rate-limiting	O	ADJ	O
for	O	ADP	O
initiating	O	VERB	O
the	O	DET	O
apoptotic	O	ADJ	B
pathway	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
positive	O	ADJ	B
correlation	O	NOUN	B
between	O	ADP	O
steroid	O	NOUN	B
sensitivity	O	NOUN	B
and	O	CCONJ	O
GR	B-protein	NOUN	B
-mediated	O	ADJ	O
induction	O	NOUN	B
of	O	ADP	O
an	O	DET	O
integrated	O	ADJ	B
mouse	B-DNA	NOUN	I
mammary	I-DNA	ADJ	O
tumor	I-DNA	NOUN	O
virus	I-DNA	NOUN	O
(	I-DNA	PUNCT	O
MMTV	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
LTR	I-DNA	NOUN	B
reporter	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
was	O	AUX	O
observed	O	VERB	O
.	O	PUNCT	O


The	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
AP-1	B-protein	NOUN	B
by	O	ADP	O
p21ras	B-protein	NOUN	B
also	O	ADV	O
requires	O	VERB	O
Rac-1	B-protein	NOUN	B
function	O	NOUN	B
.	O	PUNCT	O


Moreover	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
combination	O	NOUN	B
of	O	ADP	O
activated	O	VERB	B
MAPKK-1	B-protein	NOUN	B
and	O	CCONJ	O
Rac-1	B-protein	NOUN	B
could	O	AUX	O
not	O	PART	O
substitute	O	VERB	O
for	O	ADP	O
activated	O	VERB	B
p21ras	B-protein	NOUN	B
and	O	CCONJ	O
synergize	O	VERB	B
with	O	ADP	O
calcium	O	NOUN	B
signals	O	NOUN	I
to	O	PART	O
induce	O	VERB	B
NFAT	B-protein	NOUN	B
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
p21ras	B-protein	NOUN	B
regulation	O	NOUN	I
of	O	ADP	O
NFAT	B-protein	NOUN	B
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
requires	O	VERB	O
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
multiple	O	ADJ	B
effector	O	NOUN	I
pathways	O	NOUN	I
including	O	VERB	O
those	O	DET	O
regulated	O	VERB	O
by	O	ADP	O
MAPKK-1	B-protein	NOUN	B
/ERK-2	B-protein	PUNCT	O
and	O	CCONJ	O
Rac-1	B-protein	NOUN	B
.	O	PUNCT	O


Acute	O	ADJ	B
promyelocytic	O	ADJ	I
leukemia	O	NOUN	I
(	O	PUNCT	O
APL	O	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
specific	O	ADJ	O
type	O	NOUN	O
of	O	ADP	O
acute	O	ADJ	B
myeloid	O	ADJ	I
leukemia	O	NOUN	I
characterized	O	VERB	B
by	O	ADP	O
the	O	DET	O
morphology	O	NOUN	B
of	O	ADP	O
the	O	DET	O
blast	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
a	O	DET	O
specific	O	ADJ	O
t	O	NOUN	O
(	O	PUNCT	O
15	O	NUM	O
;	O	PUNCT	O
17	O	NUM	O
)	O	PUNCT	O
translocation	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
risks	O	NOUN	B
of	O	ADP	O
definite	O	ADJ	O
coagulopathy	O	NOUN	B
.	O	PUNCT	O


Although	O	SCONJ	O
IL-2	B-protein	NOUN	B
and	O	CCONJ	O
IFN-alpha	B-protein	NOUN	B
activated	O	VERB	B
STAT1	B-protein	NOUN	B
alpha	I-protein	NOUN	I
and	O	CCONJ	O
STAT5	B-protein	NOUN	B
,	O	PUNCT	O
IL-2	B-protein	NOUN	B
predominantly	O	ADV	O
activated	O	VERB	B
STAT5	B-protein	NOUN	B
,	O	PUNCT	O
while	O	SCONJ	O
IFN-alpha	B-protein	NOUN	B
predominantly	O	ADV	O
activated	O	VERB	B
STAT1	B-protein	NOUN	B
alpha	I-protein	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
supershift	O	NOUN	B
analyses	O	NOUN	I
using	O	VERB	O
the	O	DET	O
c-fos	B-DNA	NOUN	B
promoter	I-DNA	NOUN	O
sis-inducible	I-DNA	ADJ	B
element	I-DNA	NOUN	I
probe	I-DNA	NOUN	I
showed	O	VERB	O
that	O	SCONJ	O
IL-12	B-protein	NOUN	B
activated	O	VERB	B
STAT4	B-protein	NOUN	B
,	O	PUNCT	O
STAT1	B-protein	NOUN	B
alpha	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
STAT3	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
induced	O	VERB	B
complexes	O	NOUN	B
containing	O	VERB	O
STAT4	B-protein	NOUN	B
only	O	ADV	O
,	O	PUNCT	O
STAT4	B-protein	NOUN	B
with	O	ADP	O
STAT1	B-protein	NOUN	B
alpha	I-protein	NOUN	I
,	O	PUNCT	O
STAT3	B-protein	NOUN	B
with	O	ADP	O
STAT1	B-protein	NOUN	B
alpha	I-protein	NOUN	I
,	O	PUNCT	O
or	O	CCONJ	O
STAT1	B-protein	NOUN	B
alpha	I-protein	NOUN	I
only	O	ADV	O
in	O	ADP	O
preactivated	B-cell_line	ADJ	B
primary	I-cell_line	ADJ	B
NK	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Differential	O	ADJ	B
phosphorylation	O	NOUN	B
and	O	CCONJ	O
consequent	O	ADJ	O
differential	O	ADJ	O
activation	O	NOUN	O
of	O	ADP	O
both	O	CCONJ	O
separate	O	ADJ	B
and	O	CCONJ	O
overlapping	O	VERB	O
STAT	B-protein	NOUN	B
proteins	I-protein	NOUN	I
by	O	ADP	O
IL-2	B-protein	NOUN	B
,	O	PUNCT	O
IL-12	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
IFN-alpha	B-protein	NOUN	B
may	O	AUX	O
provide	O	VERB	O
a	O	DET	O
molecular	O	ADJ	B
basis	O	NOUN	I
for	O	ADP	O
the	O	DET	O
similarities	O	NOUN	B
and	O	CCONJ	O
differences	O	NOUN	B
in	O	ADP	O
the	O	DET	O
actions	O	NOUN	B
of	O	ADP	O
these	O	DET	O
cytokines	B-protein	NOUN	B
on	O	ADP	O
NK	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
NAC	O	NOUN	B
blocks	O	VERB	B
the	O	DET	O
suppression	O	NOUN	B
of	O	ADP	O
T	O	NOUN	B
cell	O	NOUN	I
mitogenesis	O	NOUN	O
and	O	CCONJ	O
cytokine	B-protein	NOUN	B
production	O	NOUN	I
by	O	ADP	O
protease	O	NOUN	B
inhibitors	O	NOUN	I
such	O	ADJ	O
as	O	ADP	O
N-tosylphenylalanine	O	NOUN	B
chloromethyl	O	NOUN	I
ketone	O	NOUN	I
(	O	PUNCT	O
TPCK	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
discovery	O	NOUN	B
of	O	ADP	O
these	O	DET	O
signaling	O	NOUN	B
pathways	O	NOUN	I
has	O	AUX	O
led	O	VERB	O
to	O	PART	O
important	O	ADJ	O
new	O	ADJ	O
insights	O	NOUN	O
into	O	ADP	O
their	O	PRON	O
role	O	NOUN	O
in	O	ADP	O
lymphocyte	O	NOUN	B
maturation	O	NOUN	B
,	O	PUNCT	O
as	O	ADP	O
it	O	PRON	O
has	O	AUX	O
emerged	O	VERB	O
that	O	SCONJ	O
mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
genes	O	NOUN	B
encoding	O	VERB	B
both	O	CCONJ	O
gamma	B-protein	NOUN	B
c	I-protein	NOUN	I
and	O	CCONJ	O
JAK3	B-protein	NOUN	B
result	O	VERB	B
in	O	ADP	O
similar	O	ADJ	O
forms	O	NOUN	O
of	O	ADP	O
severe	O	ADJ	B
combined	O	ADJ	B
immunodeficiency	O	NOUN	I
(	O	PUNCT	O
SCID	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
review	O	NOUN	B
we	O	PRON	O
examine	O	VERB	O
the	O	DET	O
structure	O	NOUN	B
and	O	CCONJ	O
function	O	NOUN	B
of	O	ADP	O
cytokine	B-protein	NOUN	B
receptors	I-protein	NOUN	I
and	O	CCONJ	O
the	O	DET	O
signaling	O	NOUN	B
pathways	O	NOUN	I
involved	O	VERB	O
in	O	ADP	O
their	O	PRON	O
regulation	O	NOUN	B
of	O	ADP	O
gene	O	NOUN	B
expression	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
demonstrated	O	VERB	O
that	O	SCONJ	O
CMV	O	NOUN	B
infection	O	NOUN	I
increased	O	VERB	B
both	O	CCONJ	O
IL-6	B-protein	NOUN	B
protein	I-protein	NOUN	I
and	O	CCONJ	O
mRNA	B-RNA	NOUN	B
in	O	ADP	O
peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
mononuclear	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
also	O	ADV	O
demonstrated	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
CMV	B-protein	NOUN	B
immediate	I-protein	ADJ	B
early	I-protein	ADJ	B
1	I-protein	NUM	O
gene	I-protein	NOUN	B
product	I-protein	NOUN	I
increased	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IL-6	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
.	O	PUNCT	O


This	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
the	O	DET	O
CMV	B-protein	NOUN	B
immediate	I-protein	ADJ	B
early	I-protein	ADJ	B
1	I-protein	NUM	O
gene	I-protein	NOUN	B
product	I-protein	NOUN	I
was	O	AUX	O
dependent	O	ADJ	B
upon	O	SCONJ	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
specific	O	ADJ	O
transcription	B-DNA	NOUN	B
factor	I-DNA	NOUN	I
binding	I-DNA	NOUN	I
sites	I-DNA	NOUN	I
in	O	ADP	O
the	O	DET	O
IL-6	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
.	O	PUNCT	O


Therefore	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
analyzed	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
,	O	PUNCT	O
DNA	O	NOUN	B
binding	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
transcriptional	O	ADJ	B
activity	O	NOUN	I
of	O	ADP	O
the	O	DET	O
endogenous	B-protein	ADJ	B
RA	I-protein	NOUN	B
and	I-protein	CCONJ	O
VitD3	I-protein	NOUN	B
receptors	I-protein	NOUN	I
[	O	PUNCT	O
retinoic	B-protein	ADJ	B
acid	I-protein	NOUN	I
receptors	I-protein	NOUN	I
(	O	PUNCT	O
RARs	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
retinoid	B-protein	NOUN	B
X	I-protein	NOUN	I
receptors	I-protein	NOUN	I
(	O	PUNCT	O
RXRs	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
VitD3	B-protein	NOUN	B
receptor	I-protein	NOUN	I
(	O	PUNCT	O
VDR	B-protein	NOUN	B
)	O	PUNCT	O
]	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
U-937	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
,	O	PUNCT	O
in	O	ADP	O
which	O	DET	O
RA	O	NOUN	B
and	O	CCONJ	O
VitD3	O	NOUN	B
induce	O	VERB	O
distinct	O	ADJ	O
monocytic	O	ADJ	B
differentiation	O	NOUN	I
pathways	O	NOUN	I
.	O	PUNCT	O


VitD3	O	NOUN	B
induction	O	NOUN	B
resulted	O	VERB	O
in	O	ADP	O
the	O	DET	O
formation	O	NOUN	B
of	O	ADP	O
VDR/RXR	B-protein	NOUN	B
DNA-binding	I-protein	ADJ	I
complexes	I-protein	NOUN	I
on	O	ADP	O
both	O	CCONJ	O
VitD3	B-DNA	NOUN	B
response	I-DNA	NOUN	B
elements	I-DNA	NOUN	I
and	O	CCONJ	O
RA	B-DNA	NOUN	B
response	I-DNA	NOUN	B
elements	I-DNA	NOUN	I
(	O	PUNCT	O
RAREs	B-DNA	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Concomitant	O	ADJ	B
stimulation	O	NOUN	O
by	O	ADP	O
VitD3	O	NOUN	B
inhibited	O	VERB	B
the	O	DET	O
RA-stimulated	O	ADJ	B
formation	O	NOUN	B
of	O	ADP	O
RAR	B-protein	NOUN	B
beta/RXR	I-protein	NOUN	B
heterodimers	I-protein	NOUN	B
,	O	PUNCT	O
favoring	O	VERB	O
VDR	B-protein	NOUN	B
/RXR	B-protein	NOUN	I
binding	O	NOUN	B
to	O	PART	O
the	O	DET	O
RARE	B-DNA	NOUN	B
.	O	PUNCT	O


Also	O	ADV	O
,	O	PUNCT	O
VitD3	O	NOUN	B
inhibited	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
CD23	B-protein	NOUN	B
and	O	CCONJ	O
CD49f	B-protein	NOUN	B
,	O	PUNCT	O
characteristic	O	ADJ	O
markers	O	NOUN	B
of	O	ADP	O
retinoid-induced	O	ADJ	B
U-937	B-cell_line	NOUN	I
cell	I-cell_line	NOUN	I
differentiation	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
findings	O	NOUN	B
are	O	AUX	O
consistent	O	ADJ	B
with	O	ADP	I
a	O	DET	O
model	O	NOUN	B
for	O	ADP	O
Rex	B-protein	NOUN	B
-mediated	O	ADJ	O
trans-activation	O	NOUN	B
in	O	ADP	O
which	O	DET	O
Rex-viral	B-protein	ADJ	B
mRNA	I-protein	NOUN	B
complexes	I-protein	NOUN	I
are	O	AUX	O
targeted	O	VERB	B
for	O	ADP	O
nuclear	O	ADJ	B
export	O	NOUN	I
by	O	ADP	O
the	O	DET	O
direct	O	ADJ	O
action	O	NOUN	O
of	O	ADP	O
the	O	DET	O
activation	B-protein	NOUN	B
domain	I-protein	NOUN	I
.	O	PUNCT	O


Whereas	O	SCONJ	O
94-kD	B-protein	ADJ	O
STAT5A	I-protein	NOUN	B
was	O	AUX	O
clearly	O	ADV	O
tyrosine	O	NOUN	B
phosphorylated	O	ADJ	B
and	O	CCONJ	O
bound	O	VERB	B
to	O	PART	O
the	O	DET	O
enhancer	B-DNA	NOUN	B
element	I-DNA	NOUN	I
,	O	PUNCT	O
the	O	DET	O
gamma	B-DNA	NOUN	B
response	I-DNA	NOUN	I
region	I-DNA	NOUN	I
(	O	PUNCT	O
GRR	B-DNA	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
of	O	ADP	O
the	O	DET	O
Fc	B-DNA	NOUN	B
gamma	I-DNA	NOUN	I
RI	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
,	O	PUNCT	O
substantially	O	ADV	O
less	O	ADJ	O
tyrosine	O	NOUN	B
phosphorylated	O	ADJ	I
STAT5B	B-protein	NOUN	I
bound	O	VERB	O
to	O	PART	O
the	O	DET	O
immobilized	O	ADJ	B
GRR	B-DNA	NOUN	B
element	I-DNA	NOUN	B
.	O	PUNCT	O


Transgenic	O	ADJ	B
expression	O	NOUN	I
of	O	ADP	O
PML/RARalpha	B-protein	NOUN	B
impairs	O	VERB	B
myelopoiesis	O	NOUN	B
.	O	PUNCT	O


Cell	O	NOUN	B
sorter	O	NOUN	I
analysis	O	NOUN	I
of	O	ADP	O
CD11b+	B-cell_type	ADJ	B
bone	I-cell_type	NOUN	I
marrow	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
revealed	O	VERB	O
similar	O	ADJ	O
CD11b+	B-cell_type	ADJ	B
populations	I-cell_type	NOUN	I
in	O	ADP	O
transgenic	O	ADJ	B
and	O	CCONJ	O
control	O	NOUN	B
mice	O	NOUN	I
.	O	PUNCT	O


Impaired	O	ADJ	B
myelopoiesis	O	NOUN	B
in	O	X	B
vivo	O	X	I
was	O	AUX	O
shown	O	VERB	O
by	O	ADP	O
stressing	O	VERB	O
these	O	DET	O
mice	O	NOUN	B
with	O	ADP	O
sublethal	O	ADJ	B
irradiation	O	NOUN	B
.	O	PUNCT	O


Retinoic	O	ADJ	B
acid	O	NOUN	I
treatment	O	NOUN	B
of	O	ADP	O
irradiated	O	ADJ	B
PML/RARalpha	B-protein	NOUN	B
mice	O	NOUN	I
enhanced	O	VERB	B
granulocyte	B-cell_type	NOUN	B
recovery	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
is	O	AUX	O
achieved	O	VERB	O
in	O	ADP	O
part	O	NOUN	O
through	O	ADP	O
the	O	DET	O
positive	O	ADJ	B
activities	O	NOUN	B
of	O	ADP	O
the	O	DET	O
AP-1	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
Elf-1	I-DNA	NOUN	B
sites	I-DNA	NOUN	I
in	O	ADP	O
the	O	DET	O
IL-3	B-DNA	NOUN	B
promoter	I-DNA	NOUN	I
.	O	PUNCT	O


The	O	DET	O
AC	B-DNA	PROPN	B
unit	I-DNA	NOUN	I
is	O	AUX	O
demonstrated	O	VERB	O
to	O	PART	O
enhance	O	VERB	O
basal	O	ADJ	B
activity	O	NOUN	I
of	O	ADP	O
promoters	O	NOUN	B
both	O	CCONJ	O
in	O	ADP	O
fibroblasts	B-cell_type	NOUN	B
and	O	CCONJ	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


T	B-cell_type	NOUN	B
cell	I-cell_type	NOUN	I
blasts	I-cell_type	NOUN	I
treated	O	VERB	B
with	O	ADP	I
PMA	O	NOUN	B
are	O	AUX	O
now	O	ADV	O
responsive	O	ADJ	O
to	O	PART	O
IFN-gamma	B-protein	NOUN	B
.	O	PUNCT	O


Age-related	O	ADJ	B
decreases	O	NOUN	B
in	O	ADP	O
IL-2	B-protein	NOUN	B
production	O	NOUN	B
by	O	ADP	O
human	B-cell_type	ADJ	B
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
are	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
impaired	O	ADJ	B
activation	O	NOUN	B
of	O	ADP	O
nuclear	B-protein	ADJ	B
transcriptional	I-protein	ADJ	I
factors	I-protein	NOUN	I
AP-1	B-protein	NOUN	B
and	O	CCONJ	O
NF-AT	B-protein	NOUN	B
.	O	PUNCT	O


IL-13	B-protein	NOUN	B
induces	O	VERB	O
phosphorylation	O	NOUN	B
and	O	CCONJ	O
activation	O	NOUN	B
of	O	ADP	O
JAK2	B-protein	NOUN	B
Janus	I-protein	NOUN	B
kinase	I-protein	NOUN	I
in	O	ADP	O
human	B-cell_line	ADJ	B
colon	I-cell_line	NOUN	I
carcinoma	I-cell_line	NOUN	I
cell	I-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
:	O	PUNCT	O
similarities	O	NOUN	B
between	O	ADP	O
IL-4	B-protein	NOUN	B
and	O	CCONJ	O
IL-13	B-protein	NOUN	B
signaling	O	NOUN	B
.	O	PUNCT	O


Both	O	CCONJ	O
IL-4	B-protein	NOUN	B
and	O	CCONJ	O
IL-10	B-protein	NOUN	B
were	O	AUX	O
seen	O	VERB	O
to	O	PART	O
inhibit	O	VERB	B
IL-6	B-protein	NOUN	B
production	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
IL-6	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
in	O	ADP	O
both	O	CCONJ	O
monocytic	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
studied	O	VERB	O
.	O	PUNCT	O


On	O	ADP	O
the	O	DET	O
other	O	ADJ	O
hand	O	NOUN	B
,	O	PUNCT	O
IL-10	B-protein	NOUN	B
enhanced	O	VERB	B
the	O	DET	O
degradation	O	NOUN	B
of	O	ADP	O
IL-6	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
in	O	ADP	O
a	O	DET	O
mRNA	O	NOUN	B
stability	O	NOUN	I
assay	O	NOUN	O
.	O	PUNCT	O


Peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
stimulated	O	VERB	B
with	O	ADP	O
PMA	O	NOUN	B
/alphaCD28	B-protein	NOUN	B
produced	O	VERB	O
IL-2	B-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
CsA	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
compared	O	VERB	B
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	I
the	O	DET	O
deactivating	B-protein	VERB	B
cytokine	I-protein	NOUN	I
interleukin	B-protein	NOUN	I
10	I-protein	NUM	I
(	O	PUNCT	O
IL-10	B-protein	NOUN	B
)	O	PUNCT	O
on	O	ADP	O
human	B-cell_type	ADJ	B
peripheral	I-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
mononuclear	I-cell_type	ADJ	I
cell	I-cell_type	NOUN	I
(	O	PUNCT	O
PBMC	B-cell_type	NOUN	B
)	O	PUNCT	O
responses	O	NOUN	B
to	O	PART	O
lipopolysaccharide	O	NOUN	B
(	O	PUNCT	O
LPS	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
Cryptococcus	O	NOUN	B
neoformans	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
Candida	O	NOUN	B
albicans	O	NOUN	I
.	O	PUNCT	O


Identification	O	NOUN	B
as	O	ADP	O
lymphocyte-specific	B-protein	ADJ	B
protein	I-protein	NOUN	I
1	I-protein	NUM	I
(	O	PUNCT	O
LSP1	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
several	O	ADJ	O
of	O	ADP	O
these	O	DET	O
agents	O	NOUN	B
can	O	AUX	O
significantly	O	ADV	O
increase	O	VERB	B
HIV	O	NOUN	B
replication	O	NOUN	B
and	O	CCONJ	O
accelerate	O	VERB	O
CD4	B-protein	NOUN	B
-positive	O	ADJ	O
lymphocyte	O	NOUN	B
cytotoxicity	O	NOUN	B
in	O	X	B
vitro	O	X	I
.	O	PUNCT	O


The	O	DET	O
cytoplasmic	B-protein	ADJ	B
domain	I-protein	NOUN	O
of	O	ADP	O
the	O	DET	O
receptor	O	NOUN	B
for	O	ADP	O
interleukin	B-protein	NOUN	B
10	I-protein	NUM	I
(	O	PUNCT	O
IL-10R	B-protein	NOUN	B
)	O	PUNCT	O
contains	O	VERB	O
two	O	NUM	O
box	B-protein	NOUN	B
3	I-protein	NUM	I
sequence	I-protein	NOUN	I
motifs	I-protein	NOUN	B
that	O	PRON	O
have	O	AUX	O
been	O	AUX	O
identified	O	VERB	B
in	O	ADP	O
the	O	DET	O
signal-transducing	B-protein	ADJ	B
receptor	I-protein	NOUN	I
subunits	I-protein	NOUN	I
for	O	ADP	O
IL-6-type	B-protein	ADJ	B
cytokines	I-protein	NOUN	B
and	O	CCONJ	O
noted	O	VERB	O
to	O	PART	O
be	O	AUX	O
required	O	VERB	O
for	O	ADP	O
activating	O	VERB	B
STAT3	B-protein	NOUN	B
and	O	CCONJ	O
inducing	O	VERB	B
transcription	O	NOUN	B
through	O	ADP	O
IL-6-responsive	B-DNA	ADJ	B
elements	I-DNA	NOUN	I
.	O	PUNCT	O


The	O	DET	O
cell	O	NOUN	B
response	O	NOUN	I
to	O	PART	O
IL-10	B-protein	NOUN	B
characteristically	O	ADV	O
differed	O	VERB	O
from	O	ADP	O
that	O	DET	O
to	O	PART	O
IL-2/IL-15	B-protein	NOUN	B
,	O	PUNCT	O
IL-4	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
interferon	B-protein	NOUN	B
gamma	I-protein	NOUN	I
.	O	PUNCT	O


This	O	DET	O
cellular	O	ADJ	B
system	O	NOUN	I
offers	O	VERB	O
the	O	DET	O
advantage	O	NOUN	O
that	O	SCONJ	O
MHC	B-protein	NOUN	B
class	I-protein	NOUN	B
II	I-protein	NUM	I
induction	O	NOUN	B
is	O	AUX	O
studied	O	VERB	O
in	O	ADP	O
a	O	DET	O
``	B-cell_type	PUNCT	O
physiologic	I-cell_type	ADJ	B
''	I-cell_type	PUNCT	O
cell	I-cell_type	NOUN	B
lineage	I-cell_type	NOUN	I
that	O	PRON	O
,	O	PUNCT	O
as	O	ADP	O
a	O	DET	O
result	O	NOUN	O
of	O	ADP	O
this	O	DET	O
expression	O	NOUN	B
within	O	ADP	O
the	O	DET	O
thymus	O	NOUN	B
,	O	PUNCT	O
is	O	AUX	O
thought	O	VERB	O
to	O	PART	O
participate	O	VERB	B
to	O	ADP	O
the	O	DET	O
selection	O	NOUN	B
and	O	CCONJ	O
maturation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Inhibitory	O	ADJ	B
effect	O	NOUN	O
of	O	ADP	O
E3330	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
novel	O	ADJ	O
quinone	O	NOUN	B
derivative	O	NOUN	B
able	O	ADJ	O
to	O	PART	O
suppress	O	VERB	B
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor-alpha	I-protein	NOUN	I
generation	O	NOUN	I
,	O	PUNCT	O
on	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
nuclear	B-protein	ADJ	B
factor-kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
report	O	VERB	O
the	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
E3330	O	NOUN	B
on	O	ADP	O
transcriptional	O	ADJ	B
activation	O	NOUN	I
of	O	ADP	O
tumor	B-DNA	NOUN	B
necrosis	I-DNA	NOUN	I
factor	I-DNA	NOUN	I
(	I-DNA	PUNCT	O
TNF	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
-alpha	I-DNA	NOUN	O
gene	I-DNA	NOUN	B
and	O	CCONJ	O
on	O	ADP	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
(	I-protein	PUNCT	O
NF	I-protein	NOUN	B
)	I-protein	PUNCT	O
-kappa	I-protein	NOUN	O
B	I-protein	NOUN	O
activation	O	NOUN	B
.	O	PUNCT	O


Western	O	NOUN	B
blotting	O	NOUN	I
analysis	O	NOUN	I
with	O	ADP	O
anti-I	B-protein	ADJ	B
kappa	I-protein	NOUN	I
B-alpha	I-protein	NOUN	I
antibody	I-protein	NOUN	I
indicated	O	VERB	O
that	O	SCONJ	O
E3330	O	NOUN	B
inhibited	O	VERB	B
degradation	O	NOUN	B
of	O	ADP	O
I	B-protein	NOUN	O
kappa	I-protein	NOUN	O
B-alpha	I-protein	NOUN	B
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
an	O	DET	O
inhibitory	B-protein	ADJ	B
protein	I-protein	NOUN	I
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
,	O	PUNCT	O
in	O	ADP	O
LPS-stimulated	B-cell_line	ADJ	B
monocytes	I-cell_line	NOUN	B
.	O	PUNCT	O


E3330	O	NOUN	B
may	O	AUX	O
suppress	O	VERB	B
the	O	DET	O
production	O	NOUN	B
of	O	ADP	O
active	O	ADJ	B
oxygen	O	NOUN	I
species	O	NOUN	I
serving	O	VERB	O
as	O	ADP	O
common	O	ADJ	O
messengers	O	NOUN	B
to	O	PART	O
activate	O	VERB	B
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
.	O	PUNCT	O


Second	O	ADJ	O
messenger	O	NOUN	B
up-regulation	O	NOUN	B
of	O	ADP	O
androgen	B-DNA	NOUN	B
receptor	I-DNA	NOUN	I
gene	I-DNA	NOUN	B
transcription	O	NOUN	I
is	O	AUX	O
absent	O	ADJ	B
in	O	ADP	O
androgen	B-cell_line	NOUN	B
insensitive	I-cell_line	ADJ	O
human	I-cell_line	ADJ	B
prostatic	I-cell_line	ADJ	B
carcinoma	I-cell_line	NOUN	I
cell	I-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
,	O	PUNCT	O
PC-3	B-cell_line	NOUN	B
and	O	CCONJ	O
DU-145	B-cell_line	NOUN	B
.	O	PUNCT	O


Its	O	PRON	O
expression	O	NOUN	B
is	O	AUX	O
restricted	O	ADJ	O
to	O	PART	O
a	O	DET	O
few	O	ADJ	O
cell	O	NOUN	B
types	O	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
monocyte/macrophages	B-cell_type	NOUN	B
.	O	PUNCT	O


Within	O	ADP	O
the	O	DET	O
above	O	ADJ	O
region	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
fragment	O	NOUN	B
spanning	O	NOUN	O
nucleotides	B-DNA	NOUN	B
-158	I-DNA	NUM	O
to	I-DNA	PART	O
-90	I-DNA	NUM	O
was	O	AUX	O
required	O	VERB	O
for	O	ADP	O
optimal	O	ADJ	B
transcription	O	NOUN	B
in	O	ADP	O
monocytic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
directly	O	ADV	O
tested	O	VERB	B
the	O	DET	O
amino	O	NOUN	B
acid	O	NOUN	I
polymorphism	O	NOUN	B
at	O	ADP	O
this	O	DET	O
site	O	NOUN	B
as	O	ADP	O
a	O	DET	O
determinant	O	NOUN	O
for	O	ADP	O
peptide	O	NOUN	B
binding	O	NOUN	I
and	O	CCONJ	O
for	O	ADP	O
antigen-specific	O	ADJ	B
T	O	NOUN	I
cell	O	NOUN	I
stimulation	O	NOUN	O
.	O	PUNCT	O


These	O	DET	O
binding	O	NOUN	B
studies	O	NOUN	I
were	O	AUX	O
paralleled	O	VERB	O
by	O	ADP	O
specific	O	ADJ	O
T	O	NOUN	B
cell	O	NOUN	I
recognition	O	NOUN	O
of	O	ADP	O
the	O	DET	O
class	B-protein	NOUN	B
II-peptide	I-protein	NOUN	I
complex	I-protein	NOUN	I
,	O	PUNCT	O
in	O	ADP	O
which	O	DET	O
the	O	DET	O
substituted	O	VERB	B
peptide	O	NOUN	I
abolished	O	VERB	O
T	O	NOUN	B
cell	O	NOUN	I
reactivity	O	NOUN	O
,	O	PUNCT	O
which	O	DET	O
was	O	AUX	O
directed	O	VERB	O
to	O	PART	O
the	O	DET	O
DQ3.2-peptide	B-protein	NOUN	B
complex	I-protein	NOUN	I
,	O	PUNCT	O
whereas	O	SCONJ	O
the	O	DET	O
same	O	ADJ	O
T	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
clone	I-cell_line	NOUN	I
recognized	O	VERB	O
the	O	DET	O
substituted	O	VERB	B
peptide	O	NOUN	I
presented	O	VERB	O
by	O	ADP	O
DQ3.3	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
class	O	NOUN	B
II	O	NUM	I
restriction	O	NOUN	I
element	O	NOUN	I
differing	O	VERB	O
from	O	ADP	O
DQ3.2	O	NOUN	B
only	O	ADV	O
at	O	ADP	O
residue	O	NOUN	B
57	O	NUM	O
.	O	PUNCT	O


The	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
requires	O	VERB	O
engagement	O	NOUN	B
of	O	ADP	O
the	O	DET	O
T	B-protein	NOUN	B
cell	I-protein	NOUN	I
receptor/CD3	I-protein	NOUN	O
complex	I-protein	NOUN	O
and	O	CCONJ	O
co-stimulatory	B-protein	ADJ	B
molecules	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
results	O	VERB	B
in	O	ADP	O
the	O	DET	O
triggering	O	NOUN	B
of	O	ADP	O
several	O	ADJ	O
signaling	O	NOUN	B
pathways	O	NOUN	I
which	O	DET	O
lead	O	VERB	O
rapidly	O	ADV	O
to	O	PART	O
the	O	DET	O
nuclear	O	ADJ	B
translocation	O	NOUN	I
of	O	ADP	O
several	O	ADJ	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
,	O	PUNCT	O
such	O	ADJ	O
as	O	ADP	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
(	I-protein	PUNCT	O
NF	I-protein	NOUN	B
)	I-protein	PUNCT	O
-kappa	I-protein	NOUN	O
B	I-protein	NOUN	B
and	O	CCONJ	O
NF-AT	B-protein	NOUN	B
.	O	PUNCT	O


Appearance	O	NOUN	B
of	O	ADP	O
the	O	DET	O
STAT1	B-protein	NOUN	B
factor	O	NOUN	I
is	O	AUX	O
significantly	O	ADV	O
reduced	O	VERB	B
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
cyclosporin	O	NOUN	B
A	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
blocked	O	VERB	B
by	O	ADP	O
cycloheximide	O	NOUN	B
,	O	PUNCT	O
indicating	O	VERB	O
that	O	SCONJ	O
its	O	PRON	O
activation	O	NOUN	B
is	O	AUX	O
dependent	O	ADJ	O
upon	O	SCONJ	O
a	O	DET	O
protein	O	NOUN	B
(	O	PUNCT	O
s	O	NOUN	O
)	O	PUNCT	O
synthesized	O	VERB	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
initial	O	ADJ	O
signaling	O	NOUN	B
events	O	NOUN	I
.	O	PUNCT	O


Neutralizing	O	VERB	B
antiserum	O	NOUN	I
against	O	ADP	O
IFN-gamma	B-protein	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
other	O	ADJ	O
cytokines	B-protein	NOUN	B
tested	O	VERB	B
,	O	PUNCT	O
blocked	O	VERB	B
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
factor	O	NOUN	B
almost	O	ADV	O
completely	O	ADV	B
,	O	PUNCT	O
and	O	CCONJ	O
IFN-gamma	B-protein	NOUN	B
was	O	AUX	O
found	O	VERB	O
in	O	ADP	O
the	O	DET	O
culture	O	NOUN	B
supernatants	O	NOUN	I
of	O	ADP	O
stimulated	B-cell_line	VERB	B
cells	I-cell_line	NOUN	I
at	O	ADP	O
levels	O	NOUN	B
at	O	ADP	O
which	O	DET	O
recombinant	O	ADJ	B
IFN-gamma	B-protein	NOUN	B
could	O	AUX	O
activate	O	VERB	B
the	O	DET	O
factor	O	NOUN	B
in	O	ADP	O
naive	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Therefore	O	ADV	O
,	O	PUNCT	O
a	O	DET	O
STAT1	B-protein	NOUN	B
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
is	O	AUX	O
activated	O	VERB	B
by	O	ADP	O
IFN-gamma	B-protein	NOUN	B
synthesized	O	VERB	B
and	O	CCONJ	O
released	O	VERB	B
upon	O	SCONJ	O
stimulation	O	NOUN	B
of	O	ADP	O
T	B-cell_type	NOUN	B
lymphocyte	I-cell_type	NOUN	I
populations	I-cell_type	NOUN	I
.	O	PUNCT	O


The	O	DET	O
information	O	NOUN	B
obtained	O	VERB	O
from	O	ADP	O
these	O	DET	O
cell	B-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
has	O	AUX	O
also	O	ADV	O
been	O	AUX	O
used	O	VERB	O
in	O	ADP	O
arguments	O	NOUN	B
for	O	ADP	O
a	O	DET	O
lymphoid	O	ADJ	B
origin	O	NOUN	B
of	O	ADP	O
H-RS	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
in	O	ADP	O
tissue	O	NOUN	B
despite	O	SCONJ	O
the	O	DET	O
frequent	O	ADJ	B
absence	O	NOUN	B
of	O	ADP	O
lymphoid	B-protein	ADJ	B
markers	I-protein	NOUN	B
and	O	CCONJ	O
Ig/TcR	B-DNA	NOUN	B
gene	I-DNA	NOUN	B
rearrangements	I-DNA	NOUN	I
in	O	ADP	O
these	O	DET	O
cells	O	NOUN	B
.	O	PUNCT	O


An	O	DET	O
AP-1	O	NOUN	B
site	O	NOUN	I
at	O	ADP	O
-146	O	NUM	O
to	O	PART	O
-140	O	NUM	O
was	O	AUX	O
shown	O	VERB	O
to	O	PART	O
be	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IL-9	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
.	O	PUNCT	O


Within	O	ADP	O
this	O	DET	O
region	O	NOUN	B
,	O	PUNCT	O
an	O	DET	O
NF-kappaB	B-DNA	NOUN	B
site	I-DNA	NOUN	I
at	O	ADP	O
-59	B-DNA	NUM	O
to	I-DNA	PART	O
-50	I-DNA	NUM	O
and	O	CCONJ	O
its	O	PRON	O
adjacent	O	ADJ	B
20-base	B-DNA	ADJ	O
pair	I-DNA	NOUN	O
upstream	I-DNA	ADJ	O
sequence	I-DNA	NOUN	O
were	O	AUX	O
demonstrated	O	VERB	O
to	O	PART	O
play	O	VERB	O
a	O	DET	O
critical	O	ADJ	O
role	O	NOUN	O
for	O	ADP	O
the	O	DET	O
IL-9	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
activity	O	NOUN	I
.	O	PUNCT	O


Granulocyte-macrophage	B-protein	ADJ	B
colony-stimulating	I-protein	ADJ	I
factor	I-protein	NOUN	I
(	O	PUNCT	O
GM-CSF	B-protein	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
hemopoietic	O	ADJ	B
growth	O	NOUN	I
factor	O	NOUN	I
that	O	PRON	O
is	O	AUX	O
expressed	O	VERB	B
in	O	ADP	O
activated	O	VERB	B
T	O	NOUN	O
cells	O	NOUN	O
,	O	PUNCT	O
fibroblasts	O	NOUN	B
,	O	PUNCT	O
macrophages	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
endothelial	O	ADJ	B
cells	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
shown	O	VERB	O
that	O	SCONJ	O
1-	O	NUM	O
(	O	PUNCT	O
5-chloronaphthalene-1-sulfonyl	O	ADJ	O
)	O	PUNCT	O
-1H-hexahydro-1	O	PUNCT	O
,	O	PUNCT	O
4-diazepine	O	NOUN	B
hydrochloride	O	NOUN	I
(	O	PUNCT	O
ML-9	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
an	O	DET	O
inhibitor	O	NOUN	B
of	O	ADP	O
myosin	B-protein	ADJ	B
light	I-protein	ADJ	I
chain	I-protein	NOUN	I
kinase	I-protein	NOUN	I
,	O	PUNCT	O
induces	O	VERB	B
differentiation	O	NOUN	B
of	O	ADP	O
monocytoid	B-cell_line	NOUN	B
leukemia	I-cell_line	NOUN	I
cell	I-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
U937	B-cell_line	NOUN	B
and	O	CCONJ	O
THP-1	B-cell_line	NOUN	B
but	O	CCONJ	O
not	O	PART	O
of	O	ADP	O
myeloblastic	B-cell_line	ADJ	B
leukemic	I-cell_line	ADJ	I
ML-1	I-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
or	O	CCONJ	O
erythroleukemia	B-cell_line	NOUN	B
K562	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


ML-9	O	NOUN	B
induced	O	VERB	B
nitroblue	O	ADJ	B
tetrazolium	O	NOUN	I
(	O	PUNCT	O
NBT	O	NOUN	B
)	O	PUNCT	O
-reducing	O	ADJ	O
activity	O	NOUN	B
of	O	ADP	O
U937	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
more	O	ADV	O
rapidly	O	ADV	O
than	O	ADP	O
VD3	O	NOUN	B
:	O	PUNCT	O
This	O	DET	O
differentiation	O	NOUN	B
marker	O	NOUN	B
was	O	AUX	O
induced	O	VERB	B
significantly	O	ADV	O
after	O	ADP	O
incubation	O	NOUN	B
with	O	ADP	O
ML-9	O	NOUN	B
and	O	CCONJ	O
VD3	O	NOUN	B
for	O	ADP	O
4	O	NUM	O
hours	O	NOUN	B
and	O	CCONJ	O
1	O	NUM	O
day	O	NOUN	B
,	O	PUNCT	O
respectively	O	ADV	O
.	O	PUNCT	O


Similar	O	ADJ	O
effects	O	NOUN	B
were	O	AUX	O
observed	O	VERB	O
in	O	ADP	O
another	O	DET	O
line	O	NOUN	O
of	O	ADP	O
human	B-cell_line	ADJ	B
monoblastic	I-cell_line	ADJ	O
cells	I-cell_line	NOUN	O
,	O	PUNCT	O
THP-1	B-cell_line	NOUN	B
.	O	PUNCT	O


Costimulation	O	NOUN	B
of	O	ADP	O
U1	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
with	O	ADP	O
LPS	O	NOUN	B
plus	O	CCONJ	O
GM-CSF	B-protein	NOUN	B
resulted	O	VERB	O
in	O	ADP	O
the	O	DET	O
accumulation	O	NOUN	B
of	O	ADP	O
steady-state	O	ADJ	B
levels	O	NOUN	O
of	O	ADP	O
HIV	B-RNA	NOUN	B
RNA	I-RNA	NOUN	I
;	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
only	O	ADV	O
a	O	DET	O
weak	O	ADJ	B
induction	O	NOUN	B
of	O	ADP	O
HIV	B-DNA	NOUN	B
long	I-DNA	ADJ	B
terminal	I-DNA	ADJ	I
repeat	I-DNA	NOUN	I
-driven	O	ADJ	I
transcription	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
was	O	AUX	O
not	O	PART	O
associated	O	VERB	B
with	O	ADP	I
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
cellular	B-protein	ADJ	B
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
nuclear	B-protein	ADJ	I
factor-kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
,	O	PUNCT	O
was	O	AUX	O
noted	O	VERB	O
.	O	PUNCT	O


To	O	ADP	O
date	O	NOUN	O
,	O	PUNCT	O
a	O	DET	O
large	O	ADJ	O
number	O	NOUN	O
of	O	ADP	O
receptors	O	NOUN	B
for	O	ADP	O
IL-12	B-protein	NOUN	B
have	O	AUX	O
been	O	AUX	O
found	O	VERB	O
only	O	ADV	O
on	O	ADP	O
PBMC	B-cell_type	NOUN	B
following	O	VERB	O
activation	O	NOUN	B
with	O	ADP	O
PHA	B-protein	NOUN	B
or	O	CCONJ	O
IL-2	B-protein	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
humans	O	NOUN	B
infected	O	VERB	B
with	O	ADP	O
the	O	DET	O
HIV-1	O	NOUN	B
virus	O	NOUN	I
there	O	PRON	O
may	O	AUX	O
be	O	AUX	O
a	O	DET	O
disproportionate	O	ADJ	B
severity	O	NOUN	B
of	O	ADP	O
signs	O	NOUN	B
and	O	CCONJ	I
symptoms	O	NOUN	B
of	O	ADP	O
illness	O	NOUN	B
compared	O	VERB	B
to	O	PART	O
the	O	DET	O
fraction	O	NOUN	B
of	O	ADP	O
CD4+	B-cell_line	ADJ	B
infected	I-cell_line	ADJ	B
T-lymphoid	I-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


At	O	ADP	O
the	O	DET	O
cellular	O	ADJ	B
level	O	NOUN	I
,	O	PUNCT	O
it	O	PRON	O
is	O	AUX	O
known	O	VERB	O
that	O	SCONJ	O
both	O	CCONJ	O
acute	O	ADJ	B
HIV	O	NOUN	O
infection	O	NOUN	O
and	O	CCONJ	O
glucocorticoids	O	NOUN	B
can	O	AUX	O
cause	O	VERB	O
apoptotic	O	ADJ	B
cell	O	NOUN	I
death	O	NOUN	O
in	O	ADP	O
thymic	B-cell_type	ADJ	B
lymphocytes	I-cell_type	NOUN	I
.	O	PUNCT	O


In	O	X	B
vitro	O	X	I
,	O	PUNCT	O
chronically	B-cell_line	ADV	B
HIV-infected	I-cell_line	ADJ	B
cells	I-cell_line	NOUN	B
of	O	ADP	O
the	O	DET	O
lymphoid	B-cell_line	ADJ	B
CEM	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
displayed	O	VERB	O
resistance	O	NOUN	B
to	O	PART	O
glucocorticoid-induced	O	ADJ	B
apoptosis	O	NOUN	I
.	O	PUNCT	O


HL-60	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
were	O	AUX	O
found	O	VERB	O
to	O	PART	O
express	O	VERB	O
mafK	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
,	O	PUNCT	O
indicating	O	VERB	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
genuine	O	ADJ	O
NF-E2	B-protein	NOUN	B
complex	I-protein	NOUN	I
in	O	ADP	O
the	O	DET	O
cells	O	NOUN	B
.	O	PUNCT	O


PU.1	B-protein	NOUN	B
(	O	PUNCT	O
spi-1	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
a	O	DET	O
member	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Ets	B-protein	NOUN	B
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
family	I-protein	NOUN	I
,	O	PUNCT	O
is	O	AUX	O
predominantly	O	ADV	O
expressed	O	VERB	B
in	O	ADP	O
myeloid	B-cell_type	ADJ	B
and	I-cell_type	CCONJ	O
B	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
activates	O	VERB	B
many	O	ADJ	O
B	B-DNA	NOUN	B
cell	I-DNA	NOUN	I
and	I-DNA	CCONJ	O
myeloid	I-DNA	ADJ	B
genes	I-DNA	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
is	O	AUX	O
critical	O	ADJ	O
for	O	ADP	O
development	O	NOUN	B
of	O	ADP	O
both	O	DET	O
of	O	ADP	O
these	O	DET	O
lineages	O	NOUN	B
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
murine	B-DNA	ADJ	B
PU.1	I-DNA	NOUN	B
promoter	I-DNA	NOUN	B
is	O	AUX	O
also	O	ADV	O
specifically	O	ADV	O
and	O	CCONJ	O
highly	O	ADV	O
functional	O	ADJ	B
in	O	ADP	O
B	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
as	O	ADV	O
well	O	ADV	O
.	O	PUNCT	O


This	O	DET	O
B	B-protein	NOUN	B
cell	I-protein	NOUN	I
restricted	I-protein	ADJ	O
coactivator	I-protein	NOUN	B
may	O	AUX	O
be	O	AUX	O
responsible	O	ADJ	O
for	O	ADP	O
the	O	DET	O
B	O	NOUN	B
cell	O	NOUN	I
specific	O	ADJ	O
expression	O	NOUN	B
of	O	ADP	O
PU.1	B-protein	NOUN	B
mediated	O	VERB	O
by	O	ADP	O
the	O	DET	O
octamer	B-DNA	NOUN	B
site	I-DNA	NOUN	I
.	O	PUNCT	O


Inhibition	O	NOUN	B
of	O	ADP	O
p105	B-protein	NOUN	B
processing	O	NOUN	I
by	O	ADP	O
NF-kappaB	B-protein	NOUN	B
proteins	I-protein	NOUN	I
in	O	ADP	O
transiently	B-cell_line	ADV	O
transfected	I-cell_line	VERB	B
cells	I-cell_line	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
present	O	ADJ	O
study	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
signal-mediated	O	ADJ	B
induction	O	NOUN	I
of	O	ADP	O
p105	B-protein	NOUN	B
processing	O	NOUN	I
in	O	ADP	O
human	B-cell_type	ADJ	B
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
is	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
de	O	X	B
novo	O	X	I
synthesis	O	NOUN	B
of	O	ADP	O
this	O	DET	O
precursor	B-protein	NOUN	B
protein	I-protein	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
further	O	ADV	O
demonstrate	O	VERB	O
that	O	SCONJ	O
p105	B-protein	NOUN	B
undergoes	O	VERB	O
degradation	O	NOUN	B
in	O	ADP	O
lipopolysaccharide-stimulated	B-cell_line	ADJ	B
human	I-cell_line	ADJ	I
monocytic	I-cell_line	ADJ	I
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


The	O	DET	O
appearance	O	NOUN	B
of	O	ADP	O
the	O	DET	O
CMAT	B-protein	NOUN	B
binding	I-protein	NOUN	B
complex	I-protein	NOUN	I
was	O	AUX	O
inhibited	O	VERB	B
by	O	ADP	O
both	O	CCONJ	O
cyclosporin	O	NOUN	B
A	O	NOUN	I
and	O	CCONJ	O
rapamycin	O	NOUN	B
.	O	PUNCT	O


Identification	O	NOUN	B
of	O	ADP	O
the	O	DET	O
molecular	O	ADJ	B
target	O	NOUN	I
through	O	ADP	O
which	O	DET	O
CNI-	O	NOUN	B
1493	O	NUM	O
inhibits	O	VERB	B
TNF	B-protein	NOUN	B
translation	O	NOUN	B
should	O	AUX	O
provide	O	VERB	O
insight	O	NOUN	O
into	O	ADP	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
macrophage	O	NOUN	B
activation	O	NOUN	B
and	O	CCONJ	O
mechanisms	O	NOUN	B
of	O	ADP	O
inflammation	O	NOUN	B
.	O	PUNCT	O


r-hTBP-1	B-protein	NOUN	B
and	O	CCONJ	O
rhu	B-protein	ADJ	B
TNFR	I-protein	NOUN	B
:	I-protein	PUNCT	O
Fc	I-protein	NOUN	B
also	O	ADV	O
decreased	O	VERB	B
p24	B-protein	NOUN	B
antigen	I-protein	NOUN	I
synthesized	O	VERB	B
by	O	ADP	O
U1	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
other	O	ADJ	O
stimuli	O	NOUN	B
,	O	PUNCT	O
including	O	VERB	O
phytohemagglutinin	B-protein	NOUN	B
(	I-protein	PUNCT	O
PHA	I-protein	NOUN	B
)	I-protein	PUNCT	O
-induced	I-protein	ADJ	O
supernatant	I-protein	NOUN	B
,	O	PUNCT	O
granulocyte-macrophage	B-protein	ADJ	B
colony-stimulating	I-protein	ADJ	I
factor	I-protein	NOUN	I
,	O	PUNCT	O
interleukin-6	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
TNF	B-protein	NOUN	B
.	O	PUNCT	O


r-hTBP-1	B-protein	NOUN	B
also	O	ADV	O
partially	O	ADV	O
reversed	O	VERB	O
inhibition	O	NOUN	B
of	O	ADP	O
U1	O	NOUN	B
cellular	O	ADJ	B
proliferation	O	NOUN	I
caused	O	VERB	O
by	O	ADP	O
PMA	O	NOUN	B
.	O	PUNCT	O


Both	O	CCONJ	O
r-hTBP-1	B-protein	NOUN	B
and	O	CCONJ	O
rhu	B-protein	ADJ	B
TNFR	I-protein	NOUN	B
:	I-protein	PUNCT	O
Fc	I-protein	NOUN	B
blocked	O	VERB	B
PMA	O	NOUN	B
induction	O	NOUN	B
of	O	ADP	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
(	I-protein	PUNCT	O
NK	I-protein	NOUN	B
)	I-protein	PUNCT	O
-	I-protein	PUNCT	O
kappa	I-protein	NOUN	B
B	I-protein	NOUN	I
DNA-binding	O	ADJ	B
activity	O	NOUN	O
in	O	ADP	O
U1	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
in	O	ADP	O
association	O	NOUN	B
with	O	ADP	O
decreases	O	NOUN	B
in	O	ADP	O
HIV-1	O	NOUN	B
replication	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
Tax	B-protein	NOUN	B
stimulates	O	VERB	B
RNA	B-DNA	NOUN	B
polymerase	I-DNA	NOUN	I
III-dependent	I-DNA	ADJ	I
gene	I-DNA	NOUN	I
expression	O	NOUN	B
by	O	ADP	O
accelerating	O	VERB	B
the	O	DET	O
rate	O	NOUN	B
and/or	O	CCONJ	O
extent	O	NOUN	O
of	O	ADP	O
transcription	B-protein	NOUN	B
initiation	I-protein	NOUN	I
complex	I-protein	NOUN	I
assembly	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
MTCP1	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
is	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
t	B-DNA	NOUN	O
(	I-DNA	PUNCT	O
X	I-DNA	NOUN	O
;	I-DNA	PUNCT	O
14	I-DNA	NUM	O
)	I-DNA	PUNCT	O
(	I-DNA	PUNCT	O
q28	I-DNA	NOUN	B
;	I-DNA	PUNCT	O
q11	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
translocation	I-DNA	NOUN	B
associated	O	VERB	B
with	O	ADP	I
these	O	DET	O
T-cell	O	NOUN	B
proliferations	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
p13MTCP1	B-protein	NOUN	B
protein	I-protein	NOUN	I
was	O	AUX	O
detected	O	VERB	B
in	O	ADP	O
the	O	DET	O
three	O	NUM	O
T-cell	O	NOUN	B
proliferations	O	NOUN	I
with	O	ADP	O
MTCP1	B-DNA	NOUN	B
rearrangements	I-DNA	NOUN	I
because	O	SCONJ	O
of	O	ADP	O
t	O	NOUN	O
(	O	PUNCT	O
X	O	NOUN	O
;	O	PUNCT	O
14	O	NUM	O
)	O	PUNCT	O
translocations	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
neither	O	DET	O
in	O	ADP	O
normal	O	ADJ	B
resting	O	VERB	I
and	O	CCONJ	O
activated	B-cell_type	VERB	B
lymphocytes	I-cell_type	NOUN	O
nor	O	CCONJ	O
in	O	ADP	O
the	O	DET	O
other	O	ADJ	O
T-cell	B-cell_type	NOUN	B
leukemias	O	NOUN	I
.	O	PUNCT	O


Preassociation	O	NOUN	B
of	O	ADP	O
STAT1	B-protein	NOUN	B
with	O	ADP	O
STAT2	B-protein	NOUN	B
and	O	CCONJ	O
STAT3	B-protein	NOUN	B
in	O	ADP	O
separate	O	ADJ	O
signalling	B-protein	NOUN	B
complexes	I-protein	NOUN	B
prior	O	ADJ	O
to	O	PART	O
cytokine	B-protein	NOUN	B
stimulation	O	NOUN	I
.	O	PUNCT	O


Similarly	O	ADV	O
,	O	PUNCT	O
STAT1	B-protein	NOUN	B
-STAT3	B-protein	NOUN	O
heterocomplexes	O	NOUN	B
are	O	AUX	O
coimmunoadsorbed	O	VERB	B
from	O	ADP	O
hypotonic	O	ADJ	B
cytosol	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
view	O	NOUN	O
of	O	ADP	O
these	O	DET	O
findings	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
analyzed	O	VERB	B
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	O
IFN-gamma	B-protein	NOUN	B
on	O	ADP	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
different	O	ADJ	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
in	O	ADP	O
activated	O	VERB	B
human	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


It	O	PRON	O
is	O	AUX	O
also	O	ADV	O
expressed	O	VERB	B
in	O	ADP	O
transformed	B-cell_line	VERB	B
B-cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Recently	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
reported	O	VERB	O
that	O	SCONJ	O
HIV-1	B-protein	NOUN	B
tat	I-protein	NOUN	O
downregulates	O	VERB	B
MIP-1	B-protein	NOUN	B
alpha	I-protein	NOUN	B
expression	O	NOUN	I
in	O	ADP	O
Jurkat	B-cell_line	NOUN	B
T-cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Expression	O	NOUN	B
of	O	ADP	O
neither	O	CCONJ	O
HTLV-1	B-protein	NOUN	B
tax	I-protein	NOUN	O
in	O	ADP	O
Jurkat	B-cell_line	NOUN	B
T-cells	I-cell_line	NOUN	I
nor	O	CCONJ	O
EBV	O	NOUN	B
in	O	ADP	O
B-cells	B-cell_type	NOUN	B
had	O	AUX	O
any	O	DET	O
effect	O	NOUN	B
on	O	ADP	O
MNP-1	B-protein	NOUN	B
or	O	CCONJ	O
MNP-2	B-protein	NOUN	B
expression	O	NOUN	B
,	O	PUNCT	O
showing	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
effect	O	NOUN	B
is	O	AUX	O
specific	O	ADJ	O
for	O	ADP	O
HIV-1	B-protein	NOUN	B
tat	I-protein	NOUN	O
.	O	PUNCT	O


Cytokine	B-protein	NOUN	B
stimulation	O	NOUN	I
leads	O	VERB	O
to	O	PART	O
the	O	DET	O
phosphorylation	O	NOUN	B
of	O	ADP	O
specific	O	ADJ	O
tyrosine	O	NOUN	B
residues	O	NOUN	I
within	O	ADP	O
the	O	DET	O
intracellular	B-protein	ADJ	B
domain	I-protein	NOUN	B
of	O	ADP	O
the	O	DET	O
corresponding	O	ADJ	O
cytokine	B-protein	NOUN	B
receptor	I-protein	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
Jurkat	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
this	O	DET	O
effect	O	NOUN	B
was	O	AUX	O
rapid	O	ADJ	B
and	O	CCONJ	O
transient	O	ADJ	B
,	O	PUNCT	O
but	O	CCONJ	O
in	O	ADP	O
Wurzburg	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
the	O	DET	O
response	O	NOUN	B
was	O	AUX	O
slow	O	ADJ	B
and	O	CCONJ	O
sustained	O	ADJ	B
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
suggest	O	VERB	O
a	O	DET	O
general	O	ADJ	O
role	O	NOUN	O
for	O	ADP	O
Tax	B-protein	NOUN	B
induction	O	NOUN	B
of	O	ADP	O
IL-1alpha	B-DNA	NOUN	B
gene	I-DNA	NOUN	B
transcription	O	NOUN	I
by	O	ADP	O
the	O	DET	O
NF-kappaB	B-protein	NOUN	B
pathway	O	NOUN	I
.	O	PUNCT	O


Transient-transfection	O	ADJ	B
experiments	O	NOUN	I
demonstrated	O	VERB	O
that	O	SCONJ	O
plasmids	B-DNA	NOUN	B
containing	O	VERB	O
446	O	NUM	O
bp	O	NOUN	O
of	O	ADP	O
c-fes	B-DNA	NOUN	B
5'-flanking	I-DNA	ADJ	I
sequences	I-DNA	NOUN	I
linked	O	VERB	O
to	O	PART	O
a	O	DET	O
luciferase	O	NOUN	B
reporter	O	NOUN	I
gene	O	NOUN	I
were	O	AUX	O
active	O	ADJ	B
exclusively	O	ADV	O
in	O	ADP	O
myeloid	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
first	O	ADJ	O
two	O	NUM	O
footprints	O	NOUN	B
resided	O	VERB	O
in	O	ADP	O
sequences	O	NOUN	B
that	O	PRON	O
were	O	AUX	O
largely	O	ADV	O
dispensable	O	ADJ	O
for	O	ADP	O
transient	O	ADJ	B
activity	O	NOUN	I
.	O	PUNCT	O


Electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
analyses	O	NOUN	I
demonstrated	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
151-bp	B-DNA	ADJ	B
region	I-DNA	NOUN	I
contains	O	VERB	O
nuclear	B-DNA	ADJ	B
protein	I-DNA	NOUN	I
binding	I-DNA	NOUN	I
sites	I-DNA	NOUN	I
for	O	ADP	O
Sp1	B-protein	NOUN	B
,	O	PUNCT	O
PU.1	B-protein	NOUN	B
,	O	PUNCT	O
and/or	O	CCONJ	O
Elf-1	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
novel	B-protein	ADJ	O
factor	I-protein	NOUN	B
.	O	PUNCT	O


IL-10	B-protein	NOUN	B
markedly	O	ADV	O
reduces	O	VERB	B
nuclear	O	ADJ	B
factor	O	NOUN	I
(	B-protein	PUNCT	O
NF	I-protein	NOUN	B
)	I-protein	PUNCT	O
-kappa	I-protein	NOUN	O
B/Rel	I-protein	NOUN	B
nuclear	O	ADJ	B
activity	O	NOUN	I
induced	O	VERB	B
in	O	ADP	O
PBMC	B-cell_type	NOUN	B
by	O	ADP	O
stimulation	O	NOUN	B
with	O	ADP	O
the	O	DET	O
anti-CD3	B-protein	ADJ	B
mAb	I-protein	NOUN	O
OKT3	B-protein	NOUN	B
.	O	PUNCT	O


Since	O	SCONJ	O
inappropriate	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
kappa	B-DNA	NOUN	O
B-driven	I-DNA	ADJ	O
genes	I-DNA	NOUN	O
has	O	AUX	O
a	O	DET	O
physiopathologic	O	ADJ	B
role	O	NOUN	O
in	O	ADP	O
a	O	DET	O
number	O	NOUN	O
of	O	ADP	O
diseases	O	NOUN	B
,	O	PUNCT	O
such	O	ADJ	O
as	O	ADP	O
HIV	O	NOUN	B
infection	O	NOUN	I
,	O	PUNCT	O
our	O	PRON	O
findings	O	NOUN	B
support	O	VERB	O
the	O	DET	O
possibility	O	NOUN	O
of	O	ADP	O
using	O	VERB	O
this	O	DET	O
cytokine	O	NOUN	B
to	O	PART	O
suppress	O	VERB	B
an	O	DET	O
undesirable	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
these	O	DET	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
functional	O	ADJ	B
Ets	B-DNA	NOUN	B
binding	I-DNA	NOUN	I
site	I-DNA	NOUN	I
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
bind	O	VERB	B
Ets	B-protein	NOUN	B
family	I-protein	NOUN	I
proteins	I-protein	NOUN	I
,	O	PUNCT	O
principally	O	ADV	O
GA-binding	B-protein	ADJ	B
protein	I-protein	NOUN	I
and	O	CCONJ	O
Elf-1	B-protein	NOUN	B
and	O	CCONJ	O
could	O	AUX	O
be	O	AUX	O
transactivated	O	VERB	B
by	O	ADP	O
GABPalpha	B-protein	NOUN	B
and	O	CCONJ	O
-beta	B-protein	NOUN	O
synergistically	O	ADV	B
.	O	PUNCT	O


Because	O	SCONJ	O
relatively	O	ADV	O
little	O	ADJ	O
is	O	AUX	O
known	O	VERB	O
about	O	ADP	O
these	O	DET	O
events	O	NOUN	B
in	O	ADP	O
nonhuman	O	ADJ	B
primates	O	NOUN	I
,	O	PUNCT	O
our	O	PRON	O
laboratory	O	NOUN	B
defined	O	VERB	O
optimal	O	ADJ	B
conditions	O	NOUN	B
,	O	PUNCT	O
reagents	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
assays	O	NOUN	B
for	O	ADP	O
the	O	DET	O
study	O	NOUN	B
of	O	ADP	O
signal	O	NOUN	B
transduction	O	NOUN	I
events	O	NOUN	O
in	O	ADP	O
cells	O	NOUN	B
from	O	ADP	O
nonhuman	O	ADJ	B
primates	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
protein	O	NOUN	B
phosphorylation	O	NOUN	B
patterns	O	NOUN	B
in	O	ADP	O
the	O	DET	O
two	O	NUM	O
monkeys	O	NOUN	B
exhibited	O	VERB	O
quantitative	O	ADJ	B
,	O	PUNCT	O
qualitative	O	ADJ	B
,	O	PUNCT	O
and	O	CCONJ	O
kinetic	O	ADJ	B
differences	O	NOUN	B
.	O	PUNCT	O


Detection	O	NOUN	B
of	O	ADP	O
various	O	ADJ	O
other	O	ADJ	O
intracellular	B-protein	ADJ	B
signaling	I-protein	NOUN	B
proteins	I-protein	NOUN	I
is	O	AUX	O
also	O	ADV	O
described	O	VERB	O
.	O	PUNCT	O


We	O	PRON	O
constructed	O	VERB	O
a	O	DET	O
yeast	O	NOUN	B
reporter	O	NOUN	O
strain	O	NOUN	O
containing	O	VERB	O
the	O	DET	O
lacZ	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
under	O	ADP	O
the	O	DET	O
control	O	NOUN	B
of	O	ADP	O
the	O	DET	O
CYC1	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
associated	O	VERB	B
with	O	ADP	I
three	O	NUM	O
copies	O	NOUN	B
of	O	ADP	O
TRE-1	B-DNA	NOUN	B
.	O	PUNCT	O


Expression	O	NOUN	B
of	O	ADP	O
either	O	CCONJ	O
the	O	DET	O
cyclic	B-protein	ADJ	B
AMP	I-protein	NOUN	O
response	I-protein	NOUN	O
element-binding	I-protein	ADJ	O
protein	I-protein	NOUN	O
(	O	PUNCT	O
CREB	B-protein	NOUN	B
)	O	PUNCT	O
or	O	CCONJ	O
CREB	B-protein	NOUN	B
fused	O	VERB	B
to	O	PART	O
the	O	DET	O
GAL4	B-protein	NOUN	B
activation	I-protein	NOUN	O
domain	I-protein	NOUN	O
(	O	PUNCT	O
GAD	B-protein	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
this	O	DET	O
strain	O	NOUN	B
did	O	AUX	O
not	O	PART	O
modify	O	VERB	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
reporter	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
.	O	PUNCT	O


Trapoxin	O	NOUN	B
is	O	AUX	O
a	O	DET	O
microbially	O	ADV	B
derived	O	VERB	O
cyclotetrapeptide	O	NOUN	B
that	O	PRON	O
inhibits	O	VERB	B
histone	B-protein	NOUN	B
deacetylation	O	NOUN	I
in	O	X	B
vivo	O	X	I
and	O	CCONJ	O
causes	O	VERB	O
mammalian	O	ADJ	B
cells	O	NOUN	I
to	O	PART	O
arrest	O	VERB	B
in	O	ADP	O
the	O	DET	O
cell	O	NOUN	B
cycle	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
human	B-DNA	ADJ	B
IL-13	I-DNA	NOUN	O
gene	I-DNA	NOUN	O
was	O	AUX	O
located	O	ADJ	O
12.5-kb	B-DNA	ADJ	B
upstream	I-DNA	ADV	B
of	O	ADP	O
the	O	DET	O
IL-4	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
and	O	CCONJ	O
2-kb	B-DNA	ADJ	O
downstream	I-DNA	ADV	B
of	O	ADP	O
a	O	DET	O
CpG	B-DNA	NOUN	B
island	I-DNA	NOUN	I
.	O	PUNCT	O


The	O	DET	O
IL-13	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
5	I-DNA	NUM	I
'	I-DNA	PART	O
flank	I-DNA	ADJ	B
region	I-DNA	NOUN	I
included	O	VERB	O
a	O	DET	O
segment	O	NOUN	B
with	O	ADP	O
sequence	O	NOUN	B
homology	O	NOUN	I
to	O	PART	O
P	B-DNA	NOUN	O
elements	I-DNA	NOUN	B
of	O	ADP	O
the	O	DET	O
IL-4	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
involved	O	VERB	O
in	O	ADP	O
transcriptional	O	ADJ	B
activation	O	NOUN	I
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Similar	O	ADJ	O
to	O	PART	O
IL-4	B-protein	NOUN	B
,	O	PUNCT	O
IL-13	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
expression	O	NOUN	B
was	O	AUX	O
highest	O	ADJ	O
in	O	ADP	O
T-cell	B-cell_line	NOUN	B
populations	I-cell_line	NOUN	I
enriched	O	VERB	O
for	O	ADP	O
cells	O	NOUN	B
that	O	PRON	O
had	O	AUX	O
previously	O	ADV	O
been	O	AUX	O
primed	O	VERB	B
in	O	X	B
vivo	O	X	I
or	O	CCONJ	O
in	O	X	B
vitro	O	X	I
,	O	PUNCT	O
indicating	O	VERB	O
that	O	SCONJ	O
priming	O	NOUN	B
increases	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IL-13	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
IL-4	I-DNA	NOUN	B
genes	I-DNA	NOUN	I
in	O	ADP	O
a	O	DET	O
coordinate	O	NOUN	B
manner	O	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
report	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
demonstrated	O	VERB	O
that	O	SCONJ	O
phorbol	O	NOUN	B
ester	O	NOUN	I
treatment	O	NOUN	B
of	O	ADP	O
human	O	ADJ	B
peripheral	O	ADJ	B
blood	O	NOUN	I
monocytes	O	NOUN	O
dramatically	O	ADV	O
inhibits	O	VERB	B
activation	O	NOUN	B
of	O	ADP	O
IFN-alpha/B-stimulated	O	ADJ	O
early	O	ADJ	O
response	O	NOUN	B
genes	O	NOUN	I
but	O	CCONJ	O
by	O	ADP	O
a	O	DET	O
mechanism	O	NOUN	B
which	O	DET	O
does	O	AUX	O
not	O	PART	O
involve	O	VERB	O
abrogation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
ISRE	O	NOUN	B
binding	O	NOUN	B
of	O	ADP	O
ISGF3gamma	O	NOUN	B
.	O	PUNCT	O


Moreover	O	ADV	O
,	O	PUNCT	O
PMA	O	NOUN	B
caused	O	VERB	O
the	O	DET	O
dephosphorylation	O	NOUN	B
of	O	ADP	O
Tyk2	B-protein	NOUN	B
but	O	CCONJ	O
not	O	PART	O
of	O	ADP	O
Jak1	B-protein	NOUN	B
,	O	PUNCT	O
which	O	DET	O
was	O	AUX	O
activated	O	VERB	B
by	O	ADP	O
IFN	B-protein	NOUN	B
.	O	PUNCT	O


These	O	DET	O
observations	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
PMA	O	NOUN	B
exerts	O	VERB	O
its	O	PRON	O
inhibitory	O	ADJ	B
effects	O	NOUN	B
by	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
a	O	DET	O
tyrosine	B-protein	NOUN	B
phosphatase	I-protein	NOUN	I
which	O	DET	O
selectively	O	ADV	O
regulates	O	VERB	B
Tyk2	B-protein	NOUN	B
but	O	CCONJ	O
not	O	PART	O
Jak1	B-protein	NOUN	B
activity	O	NOUN	B
.	O	PUNCT	O


Both	O	CCONJ	O
primary	O	ADJ	B
activation	O	NOUN	I
,	O	PUNCT	O
with	O	ADP	O
phytohemagglutinin	B-protein	NOUN	B
or	O	CCONJ	O
antibodies	B-protein	NOUN	B
to	I-protein	PART	O
CD3	I-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
costimulation	O	NOUN	B
,	O	PUNCT	O
provided	O	VERB	O
by	O	ADP	O
pairs	O	NOUN	B
of	O	ADP	O
CD2	B-protein	NOUN	B
antibodies	I-protein	NOUN	B
or	O	CCONJ	O
B7-positive	B-cell_type	ADJ	B
(	I-cell_type	PUNCT	O
B	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
)	I-cell_type	PUNCT	O
or	O	CCONJ	O
B7-negative	B-cell_type	ADJ	B
(	I-cell_type	PUNCT	I
endothelial	I-cell_type	ADJ	B
)	I-cell_type	PUNCT	O
accessory	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
,	I-cell_type	PUNCT	O
are	O	AUX	O
mediated	O	VERB	O
through	O	ADP	O
the	O	DET	O
same	O	ADJ	O
cis-elements	B-DNA	NOUN	B
.	O	PUNCT	O


Previous	O	ADJ	O
studies	O	NOUN	B
have	O	AUX	O
shown	O	VERB	O
that	O	SCONJ	O
retinoic	O	ADJ	B
acid	O	NOUN	I
(	O	PUNCT	O
RA	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
similar	O	ADJ	O
to	O	PART	O
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor-alpha	I-protein	NOUN	I
(	O	PUNCT	O
TNF-alpha	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
can	O	AUX	O
act	O	VERB	O
as	O	ADP	O
a	O	DET	O
bifunctional	O	ADJ	B
regulator	O	NOUN	I
of	O	ADP	O
the	O	DET	O
growth	O	NOUN	B
of	O	ADP	O
bone	B-cell_type	NOUN	B
marrow	I-cell_type	NOUN	I
progenitors	I-cell_type	NOUN	I
,	O	PUNCT	O
in	O	ADP	O
that	O	SCONJ	O
it	O	PRON	O
can	O	AUX	O
stimulate	O	VERB	B
granulocyte-macrophage	O	ADJ	B
colony-stimulating	O	ADJ	I
factor	O	NOUN	I
(	O	PUNCT	O
GM-CSF	O	NOUN	B
)	O	PUNCT	O
-	O	PUNCT	O
or	O	CCONJ	O
interleukin-3	O	NOUN	B
(	O	PUNCT	O
IL-3	O	NOUN	B
)	O	PUNCT	O
-induced	O	ADJ	O
GM	O	NOUN	B
colony	O	NOUN	B
formation	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
potently	O	ADV	O
inhibit	O	VERB	B
G-CSF	B-protein	NOUN	B
-induced	O	ADJ	O
growth	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
specific	O	ADJ	B
,	O	PUNCT	O
retarded	O	ADJ	B
band	O	NOUN	O
containing	O	VERB	O
VDR-RXR	B-protein	NOUN	B
was	O	AUX	O
identified	O	VERB	B
when	O	SCONJ	O
wild	O	ADJ	B
type	O	NOUN	I
cell	O	NOUN	I
but	O	CCONJ	O
not	O	PART	O
when	O	SCONJ	O
vitamin	O	NOUN	B
D-resistant	O	ADJ	I
cell	O	NOUN	I
nuclear	O	ADJ	O
extract	O	NOUN	O
was	O	AUX	O
used	O	VERB	O
in	O	ADP	O
the	O	DET	O
binding	O	NOUN	B
reaction	O	NOUN	I
with	O	ADP	O
either	O	DET	O
probe	O	NOUN	B
.	O	PUNCT	O


Stimulation	O	NOUN	B
of	O	ADP	O
mouse	B-cell_type	NOUN	B
B	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
with	O	ADP	O
anti-IgM	B-protein	NOUN	B
or	I-protein	CCONJ	O
IgD	I-protein	NOUN	B
antibodies	I-protein	NOUN	I
,	O	PUNCT	O
bacterial	O	ADJ	B
lipopolysaccharide	O	NOUN	B
,	O	PUNCT	O
phorbol	O	NOUN	B
12-myristate	O	NOUN	I
13-acetate	O	NOUN	I
plus	O	CCONJ	I
ionomycin	O	NOUN	B
,	O	PUNCT	O
or	O	CCONJ	O
CD40	B-protein	NOUN	B
ligand	I-protein	NOUN	B
led	O	VERB	O
to	O	PART	O
a	O	DET	O
five-fold	O	ADJ	O
to	O	PART	O
35-fold	O	ADJ	O
decrease	O	NOUN	B
in	O	ADP	O
BCL-6	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
levels	O	NOUN	O
.	O	PUNCT	O


Inactivation	O	NOUN	B
of	O	ADP	O
IkappaBbeta	B-protein	NOUN	B
by	O	ADP	O
the	O	DET	O
tax	B-protein	NOUN	O
protein	I-protein	NOUN	B
of	O	ADP	O
human	O	ADJ	B
T-cell	O	NOUN	O
leukemia	O	NOUN	O
virus	O	NOUN	O
type	O	NOUN	O
1	O	NUM	O
:	O	PUNCT	O
a	O	DET	O
potential	O	ADJ	B
mechanism	O	NOUN	B
for	O	ADP	O
constitutive	O	ADJ	B
induction	O	NOUN	B
of	O	ADP	O
NF-kappaB	B-protein	NOUN	B
.	O	PUNCT	O


During	O	ADP	O
normal	O	ADJ	O
T-cell	O	NOUN	O
activation	O	NOUN	O
,	O	PUNCT	O
IkappaBalpha	B-protein	NOUN	B
is	O	AUX	O
rapidly	O	ADV	O
phosphorylated	O	VERB	B
,	O	PUNCT	O
ubiquitinated	O	ADJ	B
,	O	PUNCT	O
and	O	CCONJ	O
degraded	O	VERB	B
by	O	ADP	O
the	O	DET	O
26S	B-protein	NOUN	B
proteasome	I-protein	NOUN	I
,	O	PUNCT	O
thus	O	ADV	O
permitting	O	VERB	O
the	O	DET	O
release	O	NOUN	B
of	O	ADP	O
functional	O	ADJ	B
NF-kappaB	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
mouse	O	NOUN	B
mammary	O	ADJ	O
tumor	O	NOUN	O
virus	O	NOUN	O
env	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
contains	O	VERB	O
a	O	DET	O
transcriptional	B-DNA	ADJ	B
activator	I-DNA	NOUN	I
(	O	PUNCT	O
META	B-DNA	NOUN	B
)	O	PUNCT	O
that	O	PRON	O
can	O	AUX	O
control	O	VERB	O
transcription	O	NOUN	B
of	O	ADP	O
the	O	DET	O
adjacent	O	ADJ	B
long	B-DNA	ADJ	B
terminal	I-DNA	ADJ	I
repeat	I-DNA	NOUN	I
region	I-DNA	NOUN	I
.	O	PUNCT	O


It	O	PRON	O
may	O	AUX	O
be	O	AUX	O
relevant	O	ADJ	B
to	O	PART	O
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
MMTV	O	NOUN	B
in	O	ADP	O
expression	O	NOUN	B
of	O	ADP	O
Mls	B-protein	NOUN	B
antigens	I-protein	NOUN	I
or	O	CCONJ	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
T	O	NOUN	B
cell	O	NOUN	I
lymphomas	O	NOUN	I
.	O	PUNCT	O


Binding	O	NOUN	B
parameters	O	NOUN	B
of	O	ADP	O
[	O	PUNCT	O
3H	O	NOUN	B
]	O	PUNCT	O
pyrilamine	O	NOUN	B
binding	O	NOUN	O
were	O	AUX	O
Kd	O	NOUN	O
=	O	ADJ	O
5.53	O	NUM	O
nM	O	NOUN	O
and	O	CCONJ	O
Bmax	O	NOUN	B
=	O	ADJ	O
2	O	NUM	O
,	O	PUNCT	O
647	O	NUM	O
sites/cell	O	NOUN	O
.	O	PUNCT	O


Pretreatment	O	NOUN	B
with	O	ADP	O
B.pertussis	O	NOUN	B
,	O	PUNCT	O
V.cholera.	O	NOUN	B
or	O	CCONJ	O
C.botulinum	O	NOUN	B
toxin	O	NOUN	I
did	O	AUX	O
not	O	PART	O
influence	O	VERB	B
histamine-induced	O	ADJ	B
[	O	PUNCT	O
Ca2+	O	NOUN	B
]	O	PUNCT	O
i	O	PRON	O
rise	O	VERB	O
.	O	PUNCT	O


Histamine	O	NOUN	B
induced	O	VERB	B
mRNA	B-RNA	NOUN	B
expression	O	NOUN	O
of	O	ADP	O
an	O	DET	O
immediate	B-DNA	ADJ	B
early	I-DNA	ADJ	B
gene	I-DNA	NOUN	B
c-fos	B-DNA	NOUN	I
.	O	PUNCT	O


A	O	DET	O
signal	O	NOUN	B
transduction	O	NOUN	I
pathway	O	NOUN	O
activated	O	VERB	B
by	O	ADP	O
many	O	ADJ	O
cytokines	B-protein	NOUN	B
has	O	AUX	O
recently	O	ADV	O
been	O	AUX	O
elaborated	O	VERB	O
.	O	PUNCT	O


The	O	DET	O
JAK	B-protein	NOUN	B
kinases	I-protein	NOUN	I
and	O	CCONJ	O
the	O	DET	O
signal	B-protein	NOUN	B
transducers	I-protein	NOUN	I
and	I-protein	CCONJ	O
activators	I-protein	NOUN	B
of	I-protein	ADP	O
transcription	I-protein	NOUN	O
(	I-protein	PUNCT	O
STAT	I-protein	NOUN	O
)	I-protein	PUNCT	O
factors	I-protein	NOUN	O
have	O	AUX	O
been	O	AUX	O
found	O	VERB	O
to	O	PART	O
be	O	AUX	O
essential	O	ADJ	B
components	O	NOUN	I
.	O	PUNCT	O


By	O	ADP	O
using	O	VERB	O
a	O	DET	O
SOX9	B-DNA	NOUN	B
coding	I-DNA	NOUN	B
sequence	I-DNA	NOUN	I
polymorphism	I-DNA	NOUN	B
,	O	PUNCT	O
expression	O	NOUN	B
of	O	ADP	O
both	O	CCONJ	O
SOX9	B-DNA	NOUN	B
alleles	O	NOUN	B
has	O	AUX	O
been	O	AUX	O
demonstrated	O	VERB	O
by	O	ADP	O
the	O	DET	O
reverse	B-protein	ADJ	B
transcriptase	I-protein	NOUN	I
polymerase	O	NOUN	I
chain	O	NOUN	I
reaction	O	NOUN	I
in	O	ADP	O
lymphoblastoid	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
from	O	ADP	O
one	O	NUM	O
of	O	ADP	O
the	O	DET	O
translocation	O	NOUN	B
cases	O	NOUN	B
.	O	PUNCT	O


Spi-B	B-protein	NOUN	B
is	O	AUX	O
an	O	DET	O
Ets	B-protein	NOUN	B
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
related	O	ADJ	O
to	O	PART	O
the	O	DET	O
oncoprotein	B-protein	NOUN	B
Spi-1/PU.1	B-protein	NOUN	I
and	O	CCONJ	O
highly	O	ADV	O
expressed	O	VERB	B
in	O	ADP	O
B	B-cell_type	NOUN	B
lymphoid	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Binding	O	NOUN	B
and	O	CCONJ	O
cooperative	O	ADJ	O
interactions	O	NOUN	B
between	O	ADP	O
two	O	NUM	O
B	B-protein	NOUN	O
cell-specific	I-protein	ADJ	O
transcriptional	I-protein	ADJ	O
coactivators	I-protein	NOUN	O
.	O	PUNCT	O


Stimulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
cAMP-dependent	O	ADJ	B
signaling	O	NOUN	I
pathway	O	NOUN	I
exerts	O	VERB	O
an	O	DET	O
inhibitory	O	ADJ	B
effect	O	NOUN	O
on	O	ADP	O
the	O	DET	O
proliferation	O	NOUN	B
and	O	CCONJ	O
effector	O	NOUN	B
functions	O	NOUN	I
of	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
ICER	B-protein	NOUN	B
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
may	O	AUX	O
play	O	VERB	O
an	O	DET	O
important	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
cAMP-induced	O	ADJ	B
quiescence	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
persistent	O	ADJ	B
latency	O	NOUN	B
of	O	ADP	O
HTLV-I	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
propose	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
hydrophobic	B-protein	ADJ	B
C-terminal	I-protein	ADJ	B
tail	I-protein	NOUN	I
of	O	ADP	O
CAML	B-protein	NOUN	B
forms	O	VERB	O
its	O	PRON	O
effector	O	NOUN	B
domain	O	NOUN	I
,	O	PUNCT	O
thus	O	ADV	O
implicating	O	VERB	O
the	O	DET	O
N-terminal	B-protein	ADJ	B
hydrophilic	I-protein	ADJ	I
domain	I-protein	NOUN	I
in	O	ADP	O
a	O	DET	O
regulatory	O	ADJ	B
role	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
describe	O	VERB	O
a	O	DET	O
patient	O	NOUN	B
with	O	ADP	O
APL	O	NOUN	B
in	O	ADP	O
whom	O	PRON	O
the	O	DET	O
leukaemic	O	ADJ	B
clone	O	NOUN	B
was	O	AUX	O
characterized	O	VERB	B
by	O	ADP	O
a	O	DET	O
true	O	ADJ	O
variant	O	NOUN	B
of	O	ADP	O
the	O	DET	O
classical	B-DNA	ADJ	O
t	I-DNA	NOUN	O
(	I-DNA	PUNCT	O
15	I-DNA	NUM	O
;	I-DNA	PUNCT	O
17	I-DNA	NUM	O
)	I-DNA	PUNCT	O
.	O	PUNCT	O


Forty	O	NUM	O
animals	O	NOUN	B
were	O	AUX	O
inoculated	O	VERB	B
intranasally	O	ADV	B
with	O	ADP	O
10	O	NUM	O
(	O	PUNCT	O
7.0	O	NUM	O
)	O	PUNCT	O
pfu	O	NOUN	B
of	O	ADP	O
Ad5/animal	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
15	O	NUM	O
animals	O	NOUN	B
inoculated	O	VERB	B
with	O	ADP	O
sterile	O	ADJ	B
culture	O	NOUN	I
media	O	NOUN	I
served	O	VERB	O
as	O	ADP	O
controls	O	NOUN	B
.	O	PUNCT	O


In	O	X	B
situ	O	X	I
hybridization	O	NOUN	I
to	O	PART	O
viral	B-DNA	ADJ	B
DNA	I-DNA	NOUN	I
and	O	CCONJ	O
immunocytochemistry	O	NOUN	B
for	O	ADP	O
Ad5	O	NOUN	B
E1A	B-protein	NOUN	I
protein	I-protein	NOUN	I
localized	O	VERB	B
the	O	DET	O
virus	O	NOUN	B
to	O	PART	O
airway	O	NOUN	B
and	O	CCONJ	O
alveolar	B-cell_type	ADJ	B
epithelial	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Ad5	B-DNA	NOUN	B
E1A	I-DNA	NOUN	I
DNA	I-DNA	NOUN	I
was	O	AUX	O
detected	O	VERB	B
by	O	ADP	O
polymerase	O	NOUN	B
chain	O	NOUN	I
reaction	O	NOUN	I
in	O	ADP	O
five	O	NUM	O
of	O	ADP	O
six	O	NUM	O
animals	O	NOUN	B
20	O	NUM	O
days	O	NOUN	B
after	O	ADP	O
infection	O	NOUN	B
and	O	CCONJ	O
in	O	ADP	O
five	O	NUM	O
of	O	ADP	O
five	O	NUM	O
animals	O	NOUN	B
47	O	NUM	O
days	O	NOUN	B
after	O	ADP	O
infection	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
recently	O	ADV	O
shown	O	VERB	O
that	O	SCONJ	O
infection	O	NOUN	B
of	O	ADP	O
Epstein-Barr	B-cell_line	ADJ	B
virus	I-cell_line	NOUN	I
(	I-cell_line	PUNCT	O
EBV	I-cell_line	NOUN	B
)	I-cell_line	PUNCT	O
genome-positive	I-cell_line	ADJ	B
B	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
by	O	ADP	O
human	O	ADJ	B
herpesvirus	O	NOUN	I
6	O	NUM	I
(	O	PUNCT	O
HHV-6	O	NOUN	B
)	O	PUNCT	O
results	O	VERB	B
in	O	ADP	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
immediate-early	B-DNA	ADJ	B
EBV	I-DNA	NOUN	B
Zebra	I-DNA	NOUN	B
gene	I-DNA	NOUN	I
,	O	PUNCT	O
followed	O	VERB	O
by	O	ADP	O
virus	O	NOUN	B
replication	O	NOUN	B
(	O	PUNCT	O
L.Flamand	O	PROPN	B
,	O	PUNCT	O
I.Stefanescu	O	PROPN	B
,	O	PUNCT	O
D.V.Ablashi	O	PROPN	B
,	O	PUNCT	O
and	O	CCONJ	O
J.Menezes	O	PROPN	B
,	O	PUNCT	O
J.Virol.67	O	PROPN	O
:	O	PUNCT	O
6768-6777	O	NUM	O
,	O	PUNCT	O
1993	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Using	O	VERB	O
human	B-cell_line	ADJ	B
B-	I-cell_line	NOUN	B
or	I-cell_line	CCONJ	O
T-cell	I-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
transfected	O	VERB	B
with	O	ADP	O
ZpCat	B-DNA	NOUN	B
reporter	I-DNA	NOUN	I
gene	I-DNA	NOUN	O
constructs	I-DNA	NOUN	O
,	O	PUNCT	O
we	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
a	O	DET	O
region	O	NOUN	B
designated	O	VERB	O
the	O	DET	O
ZII	B-DNA	NOUN	B
domain	I-DNA	NOUN	B
of	O	ADP	O
Zp	B-DNA	NOUN	B
is	O	AUX	O
the	O	DET	O
target	O	NOUN	B
of	O	ADP	O
HHV-6	O	NOUN	B
transactivation	O	NOUN	B
.	O	PUNCT	O


Regulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
of	I-protein	ADP	O
activated	I-protein	VERB	B
T	I-protein	NOUN	O
cells	I-protein	NOUN	O
in	O	ADP	O
stably	O	ADV	B
transfected	O	VERB	B
Jurkat	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
clones	I-cell_line	NOUN	O
.	O	PUNCT	O


Upon	O	SCONJ	O
stimulation	O	NOUN	B
,	O	PUNCT	O
they	O	PRON	O
express	O	VERB	O
high	O	ADJ	O
levels	O	NOUN	B
of	O	ADP	O
secreted	O	VERB	B
heat	O	NOUN	B
stable	O	ADJ	O
placental	B-protein	ADJ	B
alkaline	I-protein	NOUN	B
phosphatase	I-protein	NOUN	I
.	O	PUNCT	O


Selective	O	ADJ	B
phosphatase	O	NOUN	I
inhibitors	O	NOUN	I
for	O	ADP	O
protein	B-protein	NOUN	B
phosphatase	I-protein	NOUN	I
1	I-protein	NUM	I
(	O	PUNCT	O
PP1	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
2A	B-protein	NOUN	B
(	O	PUNCT	O
PP2A	B-protein	NOUN	B
)	O	PUNCT	O
that	O	PRON	O
do	O	AUX	O
not	O	PART	O
inhibit	O	VERB	B
calcineurin	B-protein	NOUN	B
,	O	PUNCT	O
such	O	ADJ	O
as	O	ADP	O
okadaic	O	ADJ	B
acid	O	NOUN	I
and	O	CCONJ	O
calyculin	O	NOUN	B
A	O	NOUN	I
,	O	PUNCT	O
also	O	ADV	O
inhibited	O	VERB	B
NFAT	B-protein	NOUN	B
activation	O	NOUN	B
with	O	ADP	O
IC50s	O	NOUN	B
of	O	ADP	O
87	O	NUM	O
nM	O	NOUN	O
and	O	CCONJ	O
4	O	NUM	O
nM	O	NOUN	O
,	O	PUNCT	O
respectively	O	ADV	O
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
okadaic	O	ADJ	B
acid	O	NOUN	I
and	O	CCONJ	O
related	O	ADJ	O
inhibitors	O	NOUN	B
may	O	AUX	O
block	O	VERB	B
NFAT	B-protein	NOUN	B
activation	O	NOUN	B
through	O	ADP	O
the	O	DET	O
inhibition	O	NOUN	B
of	O	ADP	O
PP1	B-protein	NOUN	B
,	O	PUNCT	O
instead	O	ADV	O
of	O	ADP	O
PP2A	B-protein	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
repression	O	NOUN	B
is	O	AUX	O
strongly	O	ADV	O
dependent	O	ADJ	O
on	O	ADP	O
the	O	DET	O
type	O	NOUN	B
of	O	ADP	I
enhancer	B-DNA	NOUN	I
present	O	ADJ	O
in	O	ADP	O
the	O	DET	O
reporter	B-DNA	NOUN	B
plasmid	I-DNA	NOUN	I
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
on	O	ADP	O
the	O	DET	O
cell	B-cell_line	NOUN	B
line	I-cell_line	NOUN	I
tested	O	VERB	B
.	O	PUNCT	O


The	O	DET	O
onset	O	NOUN	O
of	O	ADP	O
apoptosis	O	NOUN	B
in	O	ADP	O
both	O	DET	O
cell	O	NOUN	B
types	O	NOUN	I
can	O	AUX	O
be	O	AUX	O
delayed	O	VERB	B
by	O	ADP	O
hemopoietins	B-protein	NOUN	B
and	O	CCONJ	O
inflammatory	B-protein	ADJ	B
mediators	I-protein	NOUN	I
.	O	PUNCT	O


This	O	DET	O
work	O	NOUN	O
aimed	O	VERB	O
to	O	PART	O
ascertain	O	VERB	O
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
kappaB-responsive	B-DNA	ADJ	B
elements	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
immunodeficiency	I-DNA	NOUN	I
virus	I-DNA	NOUN	I
type	I-DNA	NOUN	I
1	I-DNA	NUM	I
(	I-DNA	PUNCT	O
HIV-1	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
enhancer	I-DNA	NOUN	B
not	O	PART	O
only	O	ADV	O
in	O	ADP	O
early	O	ADJ	B
initiation	O	NOUN	I
but	O	CCONJ	O
also	O	ADV	O
in	O	ADP	O
long-term	O	ADJ	B
maintenance	O	NOUN	B
of	O	ADP	O
proviral	O	ADJ	B
transcription	O	NOUN	I
in	O	ADP	O
cells	O	NOUN	B
of	O	ADP	O
the	O	DET	O
monocytic	B-cell_type	ADJ	B
lineage	I-cell_type	NOUN	I
.	O	PUNCT	O


The	O	DET	O
third	O	ADJ	O
approach	O	NOUN	O
was	O	AUX	O
to	O	PART	O
monitor	O	VERB	B
the	O	DET	O
replication	O	NOUN	B
competence	O	NOUN	B
in	O	ADP	O
U937	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
of	O	ADP	O
an	O	DET	O
infectious	O	ADJ	B
HIV-1	O	NOUN	B
provirus	O	NOUN	B
carrying	O	NOUN	O
point	O	NOUN	O
mutations	O	NOUN	O
in	O	ADP	O
the	O	DET	O
kappaB-responsive	B-DNA	ADJ	B
elements	I-DNA	NOUN	O
of	O	ADP	O
both	O	CCONJ	O
long	B-DNA	ADJ	B
terminal	I-DNA	ADJ	I
repeats	I-DNA	NOUN	I
.	O	PUNCT	O


The	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
cell	O	NOUN	B
surface	O	NOUN	I
markers	O	NOUN	B
including	O	VERB	O
the	O	DET	O
interleukin	B-protein	NOUN	B
2	I-protein	NUM	I
receptor	I-protein	NOUN	I
alpha	I-protein	NOUN	I
(	I-protein	PUNCT	O
IL-2R	I-protein	NOUN	B
alpha	I-protein	NOUN	I
)	I-protein	PUNCT	O
chain	I-protein	NOUN	O
(	O	PUNCT	O
CD25	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
CD69	B-protein	NOUN	B
and	O	CCONJ	O
L-selectin	B-protein	NOUN	B
(	O	PUNCT	O
CD62	B-protein	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
normal	O	ADJ	O
in	O	ADP	O
mitogen-activated	B-cell_line	ADJ	B
Rel-/-	I-cell_line	ADJ	O
T	I-cell_line	NOUN	O
cells	I-cell_line	NOUN	O
,	O	PUNCT	O
but	O	CCONJ	O
cytokine	B-protein	NOUN	B
production	O	NOUN	I
is	O	AUX	O
impaired	O	ADJ	B
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
anti-CD3	B-protein	ADJ	B
and	O	CCONJ	O
anti-CD28	B-protein	ADJ	B
stimulated	O	VERB	B
Rel-/-	B-cell_line	ADJ	B
T	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
which	O	DET	O
fail	O	VERB	O
to	O	PART	O
proliferate	O	VERB	B
,	O	PUNCT	O
make	O	VERB	O
little	O	ADJ	O
or	O	CCONJ	O
no	O	DET	O
detectable	O	ADJ	B
cytokines	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
IL-2	B-protein	NOUN	B
enhancer	O	NOUN	I
contains	O	VERB	O
a	O	DET	O
functional	O	ADJ	B
motif	O	NOUN	B
named	O	VERB	O
CD28	B-DNA	NOUN	B
response	I-DNA	NOUN	I
element	I-DNA	NOUN	I
(	O	PUNCT	O
CD28RE	B-DNA	NOUN	B
)	O	PUNCT	O
that	O	PRON	O
serves	O	VERB	O
a	O	DET	O
role	O	NOUN	O
as	O	ADP	O
a	O	DET	O
target	O	NOUN	B
for	O	ADP	O
mitogenic	O	ADJ	B
T	O	NOUN	I
cell	O	NOUN	I
activation	O	NOUN	B
signals	O	NOUN	O
.	O	PUNCT	O


Nonmitogenic	O	ADJ	B
T	O	NOUN	I
cell	O	NOUN	I
stimulation	O	NOUN	O
did	O	AUX	O
not	O	PART	O
result	O	VERB	O
in	O	ADP	O
appearance	O	NOUN	B
of	O	ADP	O
NF-MATp35	B-protein	NOUN	B
.	O	PUNCT	O


Similar	O	ADJ	O
to	O	PART	O
its	O	PRON	O
effect	O	NOUN	B
on	O	ADP	O
IL-2	B-protein	NOUN	B
production	O	NOUN	B
,	O	PUNCT	O
cyclosporin	O	NOUN	B
A	O	NOUN	O
inhibited	O	VERB	B
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
NF-MATp35	B-protein	NOUN	B
.	O	PUNCT	O


Two	O	NUM	O
explanations	O	NOUN	O
for	O	ADP	O
hyporesponsiveness	O	NOUN	B
of	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
iNOS	I-DNA	NOUN	B
promoter	I-DNA	NOUN	B
to	O	PART	O
LPS	O	NOUN	B
+/-	O	CCONJ	O
IFN-gamma	B-protein	NOUN	B
were	O	AUX	O
found	O	VERB	O
:	O	PUNCT	O
(	O	PUNCT	O
1	O	X	O
)	O	PUNCT	O
multiple	O	ADJ	O
inactivating	O	ADJ	B
nucleotide	O	NOUN	B
substitutions	O	NOUN	I
in	O	ADP	O
the	O	DET	O
human	O	ADJ	B
counterpart	O	NOUN	B
of	O	ADP	O
the	O	DET	O
enhancer	B-DNA	NOUN	B
element	I-DNA	NOUN	I
that	O	PRON	O
has	O	AUX	O
been	O	AUX	O
shown	O	VERB	O
to	O	PART	O
regulate	O	VERB	B
LPS/	O	NOUN	B
IFN-gamma	B-protein	NOUN	B
induced	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
mouse	B-DNA	NOUN	B
iNOS	I-DNA	NOUN	B
gene	I-DNA	NOUN	O
;	O	PUNCT	O
and	O	CCONJ	O
(	O	PUNCT	O
2	O	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
absence	O	NOUN	B
of	O	ADP	O
one	O	NUM	O
or	O	CCONJ	O
more	O	ADV	O
nuclear	B-protein	ADJ	B
factors	I-protein	NOUN	I
in	O	ADP	O
human	B-cell_type	ADJ	B
macrophages	I-cell_type	NOUN	O
(	O	PUNCT	O
e.g.	O	X	O
,	O	PUNCT	O
an	O	DET	O
LPS-inducible	B-protein	ADJ	B
nuclear	I-protein	ADJ	B
factor-kappa	I-protein	NOUN	I
B/Rel	I-protein	NOUN	O
complex	I-protein	NOUN	O
)	O	PUNCT	O
,	O	PUNCT	O
that	O	ADV	O
is	O	AUX	O
(	O	PUNCT	O
are	O	AUX	O
)	O	PUNCT	O
required	O	VERB	O
for	O	ADP	O
maximal	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
gene	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
function	O	NOUN	B
of	O	ADP	O
oriP	B-DNA	NOUN	B
depends	O	VERB	O
on	O	ADP	O
a	O	DET	O
trans-acting	B-protein	ADJ	B
factor	I-protein	NOUN	I
(	O	PUNCT	O
s	O	NOUN	O
)	O	PUNCT	O
encoded	O	VERB	B
by	O	ADP	O
the	O	DET	O
viral	B-DNA	ADJ	B
genome	I-DNA	NOUN	I
.	O	PUNCT	O


In	O	X	B
vivo	O	X	I
anergized	B-cell_line	VERB	B
CD4+	I-cell_line	ADJ	B
T	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
express	O	VERB	O
perturbed	O	VERB	O
AP-1	O	NOUN	B
and	O	CCONJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
transcription	B-protein	NOUN	I
factors	I-protein	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
study	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
used	O	VERB	O
the	O	DET	O
T-cell-activating	B-protein	ADJ	B
superantigen	I-protein	NOUN	O
staphylococcal	B-protein	ADJ	O
enterotoxin	I-protein	NOUN	O
A	I-protein	NOUN	O
(	O	PUNCT	O
SEA	B-protein	NOUN	B
)	O	PUNCT	O
to	O	PART	O
investigate	O	VERB	B
molecular	O	ADJ	B
mechanisms	O	NOUN	I
of	O	ADP	O
T-lymphocyte	O	NOUN	B
anergy	O	NOUN	I
in	O	X	B
vivo	O	X	I
.	O	PUNCT	O


Stimulation	O	NOUN	B
through	O	ADP	O
the	O	DET	O
Fas/APO-1	B-protein	ADJ	B
receptor	I-protein	NOUN	I
results	O	VERB	B
in	O	ADP	O
apoptosis	O	NOUN	B
through	O	ADP	O
an	O	DET	O
incompletely	O	ADV	O
characterized	O	VERB	B
signaling	O	NOUN	B
pathway	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
active	O	ADJ	B
vitamin	O	NOUN	B
D3	O	NOUN	I
metabolite	O	NOUN	O
1	O	NUM	O
,	O	PUNCT	O
25-dihydroxycholecalciferol	O	NOUN	B
(	O	PUNCT	O
1	O	NUM	O
,	O	PUNCT	O
25	O	NUM	O
(	O	PUNCT	O
OH	O	NOUN	B
)	O	PUNCT	O
2D3	O	NOUN	B
)	O	PUNCT	O
acts	O	VERB	O
as	O	ADP	O
an	O	DET	O
antiproliferative	O	ADJ	B
and	O	CCONJ	O
differentiating	O	VERB	O
agent	O	NOUN	B
for	O	ADP	O
the	O	DET	O
monoblastoid	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
U937	I-cell_line	NOUN	I
and	O	CCONJ	O
as	O	ADP	O
an	O	DET	O
important	O	ADJ	O
immunologic	O	ADJ	B
mediator	O	NOUN	O
implicated	O	VERB	O
particularly	O	ADV	O
in	O	ADP	O
the	O	DET	O
function	O	NOUN	B
of	O	ADP	O
cells	O	NOUN	B
belonging	O	VERB	O
to	O	PART	O
the	O	DET	O
monocyte/macrophage	B-cell_type	NOUN	B
lineage	I-cell_type	NOUN	B
.	O	PUNCT	O


The	O	DET	O
objective	O	NOUN	B
of	O	ADP	O
this	O	DET	O
study	O	NOUN	B
was	O	AUX	O
to	O	PART	O
develop	O	VERB	O
U937	B-cell_line	NOUN	B
transfectants	O	NOUN	I
expressing	O	VERB	B
antisense	O	ADJ	B
VDR	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
to	O	PART	O
use	O	VERB	O
these	O	DET	O
to	O	PART	O
examine	O	VERB	O
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
1	O	NUM	O
,	O	PUNCT	O
25	O	NUM	O
(	O	PUNCT	O
OH	O	NOUN	B
)	O	PUNCT	O
2D3	O	NOUN	B
-VDR	B-protein	NOUN	O
interaction	O	NOUN	B
in	O	ADP	O
this	O	DET	O
lineage	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
subpopulation	O	NOUN	B
of	O	ADP	O
smaller	O	ADJ	O
cells	O	NOUN	B
did	O	AUX	O
not	O	PART	O
express	O	VERB	O
the	O	DET	O
differentiation	O	NOUN	B
markers	O	NOUN	B
after	O	ADP	O
cadmium	O	NOUN	B
stimulation	O	NOUN	I
.	O	PUNCT	O


Galectin-3	O	NOUN	B
is	O	AUX	O
a	O	DET	O
beta-galactoside-binding	B-protein	ADJ	B
lectin	I-protein	NOUN	I
previously	O	ADV	O
designated	O	VERB	O
as	O	ADP	O
epsilon	B-protein	NOUN	B
BP	I-protein	NOUN	I
(	O	PUNCT	O
IgE-binding	B-protein	ADJ	B
protein	I-protein	NOUN	I
)	O	PUNCT	O
,	O	PUNCT	O
CBP35	B-protein	NOUN	B
,	O	PUNCT	O
Mac-2	B-protein	NOUN	B
,	O	PUNCT	O
L-29	B-protein	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
L-34	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
its	O	PRON	O
expression	O	NOUN	B
has	O	AUX	O
been	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
various	O	ADJ	O
physiological	O	ADJ	B
and	O	CCONJ	O
pathological	O	ADJ	B
processes	O	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
cell	O	NOUN	B
growth	O	NOUN	I
,	O	PUNCT	O
tumor	O	NOUN	B
transformation	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
metastasis	O	NOUN	B
.	O	PUNCT	O


LPS	O	NOUN	B
treatment	O	NOUN	B
of	O	ADP	O
RAW	B-cell_line	NOUN	B
264.7	I-cell_line	NUM	I
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
murine	B-cell_type	ADJ	B
bone	I-cell_type	NOUN	B
marrow-derived	I-cell_type	ADJ	B
macrophages	I-cell_type	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
human	B-cell_line	ADJ	B
monocyte	I-cell_line	NOUN	O
cell	I-cell_line	NOUN	O
line	I-cell_line	NOUN	O
THP-1	I-cell_line	NOUN	B
resulted	O	VERB	O
in	O	ADP	O
rapid	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
p46	B-protein	NOUN	B
and	I-protein	CCONJ	O
p54	I-protein	NOUN	B
isoforms	I-protein	NOUN	B
of	O	ADP	O
JNK	B-protein	NOUN	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
LPS	O	NOUN	B
activation	O	NOUN	B
of	O	ADP	O
JNK	B-protein	NOUN	B
in	O	ADP	O
monocyte/macrophage	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
is	O	AUX	O
a	O	DET	O
CD14-	O	ADJ	B
and	O	CCONJ	O
protein	O	NOUN	B
tyrosine	O	NOUN	I
phosphorylation-dependent	O	ADJ	O
event	O	NOUN	O
that	O	PRON	O
may	O	AUX	O
mediate	O	VERB	O
the	O	DET	O
early	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
AP-1	B-protein	NOUN	B
in	O	ADP	O
regulating	O	VERB	O
LPS-triggered	O	ADJ	B
gene	O	NOUN	B
induction	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
study	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
report	O	VERB	O
that	O	SCONJ	O
both	O	CCONJ	O
Exosurf	O	NOUN	B
and	O	CCONJ	O
Survanta	O	NOUN	B
suppress	O	VERB	B
TNF	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
and	O	CCONJ	O
secretion	O	NOUN	B
(	O	PUNCT	O
85	O	NUM	O
+/-	O	CCONJ	O
4	O	NUM	O
%	O	NOUN	O
mean	O	NOUN	O
percent	O	NOUN	O
inhibition	O	NOUN	B
+/-	O	CCONJ	O
SEM	O	NOUN	B
by	O	ADP	O
Exosurf	O	NOUN	B
;	O	PUNCT	O
71	O	NUM	O
+/-	O	CCONJ	O
6	O	NUM	O
%	O	NOUN	O
by	O	ADP	O
Survanta	O	NOUN	B
)	O	PUNCT	O
by	O	ADP	O
endotoxin-stimulated	B-cell_line	ADJ	B
THP-1	I-cell_line	NOUN	B
,	O	PUNCT	O
a	O	DET	O
human	B-cell_line	ADJ	B
monocytic	I-cell_line	ADJ	I
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
.	O	PUNCT	O


To	O	PART	O
identify	O	VERB	O
the	O	DET	O
molecular	O	ADJ	B
basis	O	NOUN	I
for	O	ADP	O
specificity	O	NOUN	B
and	O	CCONJ	O
inducibility	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
chromatin	B-DNA	NOUN	B
configuration	O	NOUN	O
of	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
B7.1	I-DNA	NOUN	B
gene	I-DNA	NOUN	I
was	O	AUX	O
examined	O	VERB	O
in	O	ADP	O
intact	O	ADJ	B
nuclei	O	NOUN	B
from	O	ADP	O
various	O	ADJ	O
cell	O	NOUN	B
types	O	NOUN	I
.	O	PUNCT	O


This	O	DET	O
is	O	AUX	O
the	O	DET	O
first	O	ADJ	O
description	O	NOUN	B
,	O	PUNCT	O
to	O	PART	O
our	O	PRON	O
knowledge	O	NOUN	B
,	O	PUNCT	O
of	O	ADP	O
regulatory	B-DNA	ADJ	B
elements	I-DNA	NOUN	I
that	O	PRON	O
control	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
a	O	DET	O
gene	O	NOUN	B
encoding	O	VERB	B
a	O	DET	O
B7	B-protein	NOUN	B
costimulatory	I-protein	ADJ	I
molecule	I-protein	NOUN	I
.	O	PUNCT	O


Ubiquitinylation	O	NOUN	B
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
c-Jun	B-protein	NOUN	B
and	O	CCONJ	O
c-Fos	B-protein	NOUN	B
using	O	VERB	O
reconstituted	B-protein	VERB	B
ubiquitinylating	I-protein	ADJ	I
enzymes	I-protein	NOUN	I
.	O	PUNCT	O


Recombinant	O	ADJ	B
c-Jun	B-protein	NOUN	B
and	O	CCONJ	O
c-Fos	B-protein	NOUN	B
were	O	AUX	O
ubiquitinylated	O	VERB	B
by	O	ADP	O
the	O	DET	O
ubiquitin	B-protein	NOUN	B
carrier	I-protein	NOUN	I
enzymes	I-protein	NOUN	I
E214K	B-protein	NOUN	B
,	O	PUNCT	O
E220K	B-protein	NOUN	B
,	O	PUNCT	O
or	O	CCONJ	O
E232K	B-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
the	O	DET	O
ubiquitin-activating	B-protein	ADJ	B
enzyme	I-protein	NOUN	I
,	O	PUNCT	O
E1	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
E3-dependent	O	ADJ	B
ubiquitinylation	O	NOUN	B
of	O	ADP	O
c-Jun	B-protein	NOUN	B
was	O	AUX	O
inhibited	O	VERB	B
upon	O	SCONJ	O
the	O	DET	O
heterodimerization	O	NOUN	B
of	O	ADP	O
c-Jun	B-protein	NOUN	B
with	O	ADP	O
c-Fos	B-protein	NOUN	B
.	O	PUNCT	O


Further	O	ADJ	O
addition	O	NOUN	O
of	O	ADP	O
E220K	B-protein	NOUN	B
significantly	O	ADV	O
enhanced	O	VERB	B
ubiquitinylation	O	NOUN	B
of	O	ADP	O
c-Jun	B-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
heterodimer	O	NOUN	B
suggesting	O	VERB	O
a	O	DET	O
regulatory	O	ADJ	O
role	O	NOUN	O
of	O	ADP	O
E220K	B-protein	NOUN	B
.	O	PUNCT	O


Cloning	O	NOUN	B
and	O	CCONJ	O
characterization	O	NOUN	B
of	O	ADP	O
the	O	DET	O
murine	B-protein	ADJ	B
B-cell	I-protein	NOUN	B
specific	I-protein	ADJ	O
transcriptional	I-protein	ADJ	O
coactivator	I-protein	NOUN	O
Bob1	B-protein	NOUN	B
.	O	PUNCT	O


mBob1	B-protein	NOUN	B
interacts	O	VERB	O
with	O	ADP	O
the	O	DET	O
octamer	B-protein	NOUN	B
transcription	I-protein	NOUN	O
factors	I-protein	NOUN	O
Oct-1	B-protein	NOUN	B
and	O	CCONJ	O
Oct-2	B-protein	NOUN	B
and	O	CCONJ	O
stimulates	O	VERB	B
transcription	O	NOUN	B
mediated	O	VERB	O
by	O	ADP	O
these	O	DET	O
factors	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
study	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
investigated	O	VERB	B
the	O	DET	O
ability	O	NOUN	O
of	O	ADP	O
the	O	DET	O
major	B-protein	ADJ	O
envelope	I-protein	NOUN	O
glycoprotein	I-protein	NOUN	O
of	O	ADP	O
HIV	O	NOUN	B
,	O	PUNCT	O
glycoprotein	B-protein	NOUN	B
120	I-protein	NUM	I
(	O	PUNCT	O
gp120	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
to	O	PART	O
regulate	O	VERB	B
intercellular	B-protein	ADJ	B
adhesion	I-protein	NOUN	I
molecule-1	I-protein	NOUN	I
(	O	PUNCT	O
ICAM-1	B-protein	NOUN	B
)	O	PUNCT	O
expression	O	NOUN	B
in	O	ADP	O
glial	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
because	O	SCONJ	O
ICAM-1	B-protein	NOUN	B
is	O	AUX	O
important	O	ADJ	O
in	O	ADP	O
mediating	O	VERB	O
immune	O	ADJ	B
responsiveness	O	NOUN	I
in	O	ADP	O
the	O	DET	O
CNS	O	NOUN	B
,	O	PUNCT	O
facilitating	O	VERB	O
entry	O	NOUN	B
of	O	ADP	O
HIV-infected	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	B
into	O	ADP	O
the	O	DET	O
CNS	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
promoting	O	VERB	O
syncytia	O	NOUN	B
formation	O	NOUN	B
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
gp120	B-protein	NOUN	B
enhances	O	VERB	B
ICAM-1	B-protein	NOUN	B
gene	O	NOUN	O
expression	O	NOUN	B
in	O	ADP	O
primary	B-cell_type	ADJ	O
rat	I-cell_type	NOUN	B
astrocytes	I-cell_type	NOUN	B
,	O	PUNCT	O
primary	B-cell_type	ADJ	O
human	I-cell_type	ADJ	B
astrocytes	I-cell_type	NOUN	B
,	O	PUNCT	O
a	O	DET	O
human	B-cell_line	ADJ	B
astroglioma	I-cell_line	NOUN	O
cell	I-cell_line	NOUN	B
line	I-cell_line	NOUN	I
CRT	I-cell_line	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
primary	B-cell_type	ADJ	O
rat	I-cell_type	NOUN	B
microglia	I-cell_type	NOUN	B
.	O	PUNCT	O


IL-10	B-protein	NOUN	B
is	O	AUX	O
elevated	O	ADJ	B
in	O	ADP	O
HIV-1-infected	O	ADJ	B
individuals	O	NOUN	B
and	O	CCONJ	O
has	O	AUX	O
been	O	AUX	O
implicated	O	VERB	O
in	O	ADP	O
disease	O	NOUN	B
progression	O	NOUN	I
.	O	PUNCT	O


Neutralizing	O	VERB	B
mAbs	B-protein	NOUN	I
to	O	PART	O
IL-10	B-protein	NOUN	B
and	O	CCONJ	O
TNF-alpha	B-protein	NOUN	B
indicated	O	VERB	O
that	O	SCONJ	O
both	O	DET	O
cytokines	B-protein	NOUN	B
were	O	AUX	O
essential	O	ADJ	B
for	O	ADP	O
the	O	DET	O
induction	O	NOUN	B
and	O	CCONJ	O
were	O	AUX	O
required	O	VERB	O
to	O	PART	O
generate	O	VERB	O
a	O	DET	O
synergistic	O	ADJ	B
increase	O	NOUN	B
in	O	ADP	O
virus	O	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
combination	O	NOUN	B
with	O	ADP	O
TNF-alpha	B-protein	NOUN	B
,	O	PUNCT	O
IL-10	B-protein	NOUN	B
stimulated	O	VERB	O
activating	B-protein	NOUN	O
protein-1	I-protein	NOUN	O
(	O	PUNCT	O
AP-1	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
(	I-protein	PUNCT	O
NF	I-protein	NOUN	B
)	I-protein	PUNCT	O
-kappa	I-protein	NOUN	O
B	I-protein	NOUN	B
binding	O	NOUN	I
activities	O	NOUN	I
and	O	CCONJ	O
cooperated	O	VERB	O
to	O	PART	O
increase	O	VERB	B
HIV-1	O	NOUN	B
steady-state	O	ADJ	B
mRNA	O	NOUN	B
levels	O	NOUN	O
and	O	CCONJ	O
enhance	O	VERB	B
long	B-DNA	ADJ	B
terminal	I-DNA	ADJ	I
repeat	I-DNA	NOUN	I
-directed	O	ADJ	O
transcription	O	NOUN	B
through	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
NF-kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
binding	I-DNA	NOUN	I
sites	I-DNA	NOUN	I
,	O	PUNCT	O
suggesting	O	VERB	O
the	O	DET	O
IL-10	B-protein	NOUN	B
effect	O	NOUN	B
occurs	O	VERB	O
at	O	ADP	O
least	O	ADJ	O
in	O	ADP	O
part	O	NOUN	O
at	O	ADP	O
the	O	DET	O
transcriptional	O	ADJ	B
level	O	NOUN	B
.	O	PUNCT	O


Similarly	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
p105	B-protein	NOUN	B
precursor	I-protein	NOUN	I
of	O	ADP	O
the	O	DET	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
p50	B-protein	NOUN	I
subunit	I-protein	NOUN	I
is	O	AUX	O
also	O	ADV	O
post-translationally	O	ADV	B
processed	O	VERB	B
in	O	ADP	O
the	O	DET	O
proteasome	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
mechanisms	O	NOUN	B
by	O	ADP	O
which	O	DET	O
Tax	B-protein	NOUN	B
activates	O	VERB	B
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
remain	O	VERB	O
unclear	O	ADJ	B
,	O	PUNCT	O
and	O	CCONJ	O
findings	O	NOUN	B
presented	O	VERB	O
in	O	ADP	O
the	O	DET	O
literature	O	NOUN	B
are	O	AUX	O
often	O	ADV	O
controversial	O	ADJ	O
.	O	PUNCT	O


All	O	DET	O
seven	O	NUM	O
IDCs	O	NOUN	B
associated	O	VERB	B
with	O	ADP	I
Paget	O	NOUN	B
's	O	PART	I
disease	O	NOUN	I
showed	O	VERB	O
positive	O	ADJ	B
reactions	O	NOUN	I
for	O	ADP	O
HER-2/neu	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
immunophenotype	O	NOUN	B
of	O	ADP	O
IDC	O	NOUN	B
is	O	AUX	O
helpful	O	ADJ	O
in	O	ADP	O
subclassifying	O	VERB	O
an	O	DET	O
IDC	O	NOUN	B
and	O	CCONJ	O
could	O	AUX	O
prove	O	VERB	O
useful	O	ADJ	O
as	O	ADP	O
a	O	DET	O
prognostic	O	ADJ	B
indicator	O	NOUN	O
for	O	ADP	O
local	O	ADJ	B
control	O	NOUN	I
in	O	ADP	O
patients	O	NOUN	B
treated	O	VERB	B
by	O	ADP	O
breast-conserving	O	ADJ	B
therapy	O	NOUN	I
.	O	PUNCT	O


Here	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
studied	O	VERB	O
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
serine/threonine	B-protein	NOUN	B
phosphatases	I-protein	NOUN	I
in	O	ADP	O
STAT3	B-protein	NOUN	B
signaling	O	NOUN	B
in	O	ADP	O
human	B-cell_line	ADJ	B
antigen-specific	I-cell_line	ADJ	O
CD4	I-cell_line	NOUN	O
(	I-cell_line	PUNCT	O
+	I-cell_line	CCONJ	O
)	I-cell_line	PUNCT	O
T	I-cell_line	NOUN	O
cell	I-cell_line	NOUN	O
lines	I-cell_line	NOUN	O
and	O	CCONJ	O
cutaneous	B-cell_line	ADJ	B
T	I-cell_line	NOUN	I
cell	I-cell_line	NOUN	I
lymphoma	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
,	O	PUNCT	O
expressing	O	VERB	B
a	O	DET	O
constitutively	O	ADV	B
activated	O	VERB	O
STAT3	B-protein	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
an	O	DET	O
inhibitor	O	NOUN	B
of	O	ADP	O
protein	B-protein	NOUN	B
phosphatases	I-protein	NOUN	I
(	O	PUNCT	O
PPs	B-protein	NOUN	B
)	O	PUNCT	O
PP1/PP2A	B-protein	NOUN	B
,	O	PUNCT	O
calyculin	B-protein	NOUN	B
A	I-protein	NOUN	I
,	O	PUNCT	O
induces	O	VERB	B
(	O	PUNCT	O
i	O	X	O
)	O	PUNCT	O
phosphorylation	O	NOUN	B
of	O	ADP	O
STAT3	B-protein	NOUN	B
on	O	ADP	O
serine	O	NOUN	B
and	O	CCONJ	O
threonine	O	NOUN	B
residues	O	NOUN	I
,	O	PUNCT	O
(	O	PUNCT	O
ii	O	X	O
)	O	PUNCT	O
inhibition	O	NOUN	B
of	O	ADP	O
STAT3	B-protein	NOUN	B
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	B
and	O	CCONJ	O
DNA	O	NOUN	B
binding	O	NOUN	I
activity	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
(	O	PUNCT	O
iii	O	X	O
)	O	PUNCT	O
relocation	O	NOUN	B
of	O	ADP	O
STAT3	B-protein	NOUN	B
from	O	ADP	O
the	O	DET	O
nucleus	O	NOUN	B
to	O	PART	O
the	O	DET	O
cytoplasm	O	NOUN	B
.	O	PUNCT	O


Polyamines	O	NOUN	B
have	O	AUX	O
been	O	AUX	O
determined	O	VERB	O
in	O	ADP	O
tissue	O	NOUN	B
and	O	CCONJ	O
erythrocyte	O	NOUN	B
samples	O	NOUN	O
from	O	ADP	O
100	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
primary	O	ADJ	B
invasive	O	ADJ	I
breast	O	NOUN	B
cancer	O	NOUN	I
and	O	CCONJ	O
30	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
fibroadenomas	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
malignant	O	ADJ	B
tissues	O	NOUN	I
,	O	PUNCT	O
polyamine	O	NOUN	B
levels	O	NOUN	I
were	O	AUX	O
significantly	O	ADV	O
higher	O	ADJ	O
than	O	ADP	O
in	O	ADP	O
benign	O	ADJ	B
tissues	O	NOUN	I
.	O	PUNCT	O


Erythrocyte	O	NOUN	B
polyamines	O	NOUN	B
levels	O	NOUN	B
were	O	AUX	O
identical	O	ADJ	B
between	O	ADP	O
cancer	O	NOUN	B
patients	O	NOUN	B
and	O	CCONJ	O
controls	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
knowledge	O	NOUN	B
of	O	ADP	O
the	O	DET	O
polyamine	O	NOUN	B
pattern	O	NOUN	O
in	O	ADP	O
breast	O	NOUN	B
cancer	O	NOUN	I
could	O	AUX	O
become	O	VERB	O
useful	O	ADJ	O
in	O	ADP	O
clinical	O	ADJ	B
practice	O	NOUN	I
particularly	O	ADV	O
if	O	SCONJ	O
polyamine	O	NOUN	B
metabolism	O	NOUN	I
is	O	AUX	O
targeted	O	VERB	O
as	O	ADP	O
a	O	DET	O
therapeutic	O	ADJ	B
approach	O	NOUN	I
.	O	PUNCT	O


Tyrosine	B-protein	NOUN	B
kinase	I-protein	NOUN	I
-dependent	O	ADJ	O
,	O	PUNCT	O
and	O	CCONJ	O
not	O	PART	O
protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
C	I-protein	NOUN	I
-dependent	O	ADJ	O
,	O	PUNCT	O
pathways	O	NOUN	B
mediate	O	VERB	O
CD23	B-protein	NOUN	B
-triggered	O	ADJ	O
NF-kappaB	B-protein	NOUN	B
activation	O	NOUN	B
but	O	CCONJ	O
do	O	AUX	O
not	O	PART	O
participate	O	VERB	O
in	O	ADP	O
the	O	DET	O
direct	O	ADJ	O
phosphorylation	O	NOUN	B
of	O	ADP	O
IkappaBalpha	B-protein	NOUN	B
.	O	PUNCT	O


Flavonoids	O	NOUN	B
are	O	AUX	O
a	O	DET	O
group	O	NOUN	B
of	O	ADP	O
naturally-occurring	O	ADJ	O
phenolic	O	ADJ	B
compounds	O	NOUN	I
in	O	ADP	O
the	O	DET	O
plant	O	NOUN	B
kingdom	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
many	O	ADJ	O
flavonoids	O	NOUN	B
are	O	AUX	O
found	O	VERB	O
with	O	ADP	O
vascular	O	ADJ	B
protective	O	ADJ	O
properties	O	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
view	O	NOUN	O
of	O	ADP	O
the	O	DET	O
nuclear	B-protein	ADJ	B
factor-kappaB	I-protein	NOUN	I
(	O	PUNCT	I
NFkappaB	B-protein	NOUN	B
)	O	PUNCT	O
may	O	AUX	O
play	O	VERB	O
a	O	DET	O
central	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
initiation	O	NOUN	B
of	O	ADP	O
atherosclerosis	O	NOUN	B
,	O	PUNCT	O
prevention	O	NOUN	B
of	O	ADP	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
NFkappaB	B-protein	NOUN	B
represents	O	VERB	O
an	O	DET	O
important	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
protecting	O	VERB	O
vascular	O	ADJ	B
injury	O	NOUN	I
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
myricetin	O	NOUN	B
was	O	AUX	O
also	O	ADV	O
found	O	VERB	O
to	O	PART	O
inhibit	O	VERB	B
NFkappaB	B-protein	NOUN	B
activity	O	NOUN	O
correlated	O	VERB	B
with	O	ADP	O
suppression	O	NOUN	B
of	O	ADP	O
monocyte	O	NOUN	B
adhesion	O	NOUN	I
to	O	PART	O
ECV304	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


The	O	DET	O
decrease	O	NOUN	B
using	O	VERB	O
weaker	O	ADJ	O
binding	O	NOUN	B
peptides	O	NOUN	I
was	O	AUX	O
gradual	O	ADJ	O
as	O	ADP	O
stimulation	O	NOUN	B
with	O	ADP	O
a	O	DET	O
peptide	O	NOUN	B
with	O	ADP	O
intermediate	O	ADJ	B
affinity	O	NOUN	B
yielded	O	VERB	O
intermediate	O	ADJ	B
T	B-cell_type	NOUN	B
cell	I-cell_type	NOUN	I
proliferation	O	NOUN	O
and	O	CCONJ	O
the	O	DET	O
poorest	O	ADJ	B
binding	O	NOUN	I
peptide	O	NOUN	I
induced	O	VERB	B
an	O	DET	O
even	O	ADV	O
weaker	O	ADJ	O
T	B-cell_type	NOUN	B
cell	I-cell_type	NOUN	I
response	O	NOUN	O
.	O	PUNCT	O


MHC	B-protein	NOUN	B
class	I-protein	NOUN	O
II	I-protein	NUM	O
density	O	NOUN	B
on	O	ADP	O
the	O	DET	O
APC	B-cell_type	NOUN	B
was	O	AUX	O
modified	O	VERB	B
using	O	VERB	O
DQ2	B-cell_line	NOUN	B
homo	I-cell_line	NOUN	I
-and	I-cell_line	NOUN	O
heterozygous	I-cell_line	ADJ	B
B-LCLs	I-cell_line	NOUN	B
as	O	ADP	O
APCs	B-cell_type	NOUN	B
,	O	PUNCT	O
however	O	ADV	O
this	O	DET	O
variation	O	NOUN	B
of	O	ADP	O
MHC	O	NOUN	B
concentration	O	NOUN	B
had	O	AUX	O
no	O	DET	B
effect	O	NOUN	I
on	O	ADP	O
T	B-cell_type	NOUN	B
cell	I-cell_type	NOUN	I
proliferation	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
interpret	O	VERB	O
this	O	DET	O
as	O	ADP	O
a	O	DET	O
reflection	O	NOUN	B
of	O	ADP	O
a	O	DET	O
low	O	ADJ	B
threshold	O	NOUN	B
for	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
T	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
clone	I-cell_line	NOUN	I
,	O	PUNCT	O
in	O	ADP	O
which	O	DET	O
peptide-	O	ADJ	O
MHC	B-protein	NOUN	B
avidity	O	NOUN	B
is	O	AUX	O
the	O	DET	O
over-riding	O	ADJ	B
determinant	O	NOUN	B
of	O	ADP	O
the	O	DET	O
strength	O	NOUN	B
of	O	ADP	O
ligand	O	NOUN	B
signal	O	NOUN	I
.	O	PUNCT	O


Exogenously	O	ADV	B
administered	O	VERB	B
IL-11	B-protein	NOUN	B
substantially	O	ADV	O
reduced	O	VERB	B
,	O	PUNCT	O
in	O	ADP	O
a	O	DET	O
dose-dependent	O	ADJ	B
manner	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
intrapulmonary	O	ADJ	B
accumulation	O	NOUN	B
of	O	ADP	O
neutrophils	B-cell_type	NOUN	B
and	O	CCONJ	O
the	O	DET	O
lung	O	NOUN	B
vascular	O	ADJ	I
leak	O	NOUN	I
of	O	ADP	I
albumin	B-protein	NOUN	I
.	O	PUNCT	O


These	O	DET	O
in	O	X	B
vivo	O	X	I
anti-inflammatory	O	ADJ	B
effects	O	NOUN	O
of	O	ADP	O
IL-11	B-protein	NOUN	B
were	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
reduced	O	VERB	B
NF-kappaB	B-protein	NOUN	B
activation	O	NOUN	O
in	O	ADP	O
lung	O	NOUN	B
,	O	PUNCT	O
reduced	O	VERB	B
levels	O	NOUN	B
of	O	ADP	O
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor	I-protein	NOUN	I
alpha	I-protein	NOUN	I
(	O	PUNCT	O
TNF-alpha	B-protein	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
bronchoalveolar	O	ADJ	B
lavage	O	NOUN	I
(	O	PUNCT	I
BAL	O	NOUN	B
)	O	PUNCT	O
fluids	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
diminished	O	VERB	B
up-regulation	O	NOUN	B
of	O	ADP	O
lung	B-protein	NOUN	B
vascular	I-protein	ADJ	I
ICAM-1	I-protein	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
BAL	O	NOUN	B
content	O	NOUN	B
of	O	ADP	O
C5a	O	NOUN	B
was	O	AUX	O
reduced	O	VERB	B
by	O	ADP	O
IL-11	B-protein	NOUN	B
.	O	PUNCT	O


Thrombopoietin	B-protein	NOUN	B
also	O	ADV	O
induced	O	VERB	B
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	I
of	O	ADP	O
Stat3	B-protein	NOUN	B
and	O	CCONJ	O
Stat5	B-protein	NOUN	B
in	O	ADP	O
FDCP-2	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
genetically	O	ADV	B
engineered	O	VERB	I
to	O	PART	O
constitutively	O	ADV	B
express	O	VERB	O
human	B-protein	ADJ	B
c-Mpl	I-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
latter	O	ADJ	O
mechanism	O	NOUN	B
is	O	AUX	O
especially	O	ADV	O
important	O	ADJ	O
because	O	SCONJ	O
evasion	O	NOUN	B
of	O	ADP	O
the	O	DET	O
impending	O	ADJ	B
immune	O	ADJ	B
response	O	NOUN	I
is	O	AUX	O
a	O	DET	O
prerequisite	O	NOUN	O
for	O	ADP	O
the	O	DET	O
progression	O	NOUN	B
of	O	ADP	O
lymphoproliferative	O	ADJ	B
diseases	O	NOUN	I
.	O	PUNCT	O


Dehydroepiandrosterone	O	NOUN	B
modulation	O	NOUN	B
of	O	ADP	O
lipopolysaccharide-stimulated	O	ADJ	B
monocyte	O	NOUN	I
cytotoxicity	O	NOUN	I
.	O	PUNCT	O


Dehydroepiandrosterone	O	NOUN	B
(	O	PUNCT	O
DHEA	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
the	O	DET	O
predominant	O	ADJ	B
androgen	O	NOUN	B
secreted	O	VERB	B
by	O	ADP	O
the	O	DET	O
adrenal	O	ADJ	B
cortex	O	NOUN	I
,	O	PUNCT	O
can	O	AUX	O
be	O	AUX	O
converted	O	VERB	O
to	O	PART	O
both	O	CCONJ	O
potent	O	ADJ	O
androgens	O	NOUN	B
and	O	CCONJ	O
estrogens	O	NOUN	B
.	O	PUNCT	O


Cytotoxicity	B-protein	NOUN	B
markers	I-protein	NOUN	B
assessed	O	VERB	B
include	O	VERB	O
tumor	O	NOUN	B
cell	O	NOUN	I
killing	O	NOUN	O
,	O	PUNCT	O
IL-1	B-protein	NOUN	B
secretion	O	NOUN	B
,	O	PUNCT	O
reactive	O	ADJ	B
oxygen	O	NOUN	I
intermediate	O	NOUN	I
release	O	NOUN	I
,	O	PUNCT	O
nitric	B-protein	ADJ	B
oxide	I-protein	NOUN	I
synthetase	I-protein	NOUN	I
activity	O	NOUN	O
as	O	ADP	O
measured	O	VERB	B
by	O	ADP	O
the	O	DET	O
release	O	NOUN	B
of	O	ADP	O
reactive	O	ADJ	B
nitrogen	O	NOUN	I
intermediates	O	NOUN	I
,	O	PUNCT	O
complement	B-protein	NOUN	B
receptor-1	I-protein	NOUN	I
cell	I-protein	NOUN	I
surface	I-protein	NOUN	I
protein	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
TNF-alpha	B-protein	NOUN	B
protein	I-protein	NOUN	I
presence	O	NOUN	B
.	O	PUNCT	O


Interferons	B-protein	NOUN	B
(	O	PUNCT	O
IFNs	B-protein	NOUN	B
)	O	PUNCT	O
inhibit	O	VERB	B
induction	O	NOUN	B
by	O	ADP	O
IL-4	B-protein	NOUN	B
of	O	ADP	O
multiple	O	ADJ	B
genes	O	NOUN	I
in	O	ADP	O
human	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
mechanism	O	NOUN	B
by	O	ADP	O
which	O	DET	O
IFNs	B-protein	NOUN	B
mediate	O	VERB	O
this	O	DET	O
inhibition	O	NOUN	B
has	O	AUX	O
not	O	PART	O
been	O	AUX	O
defined	O	VERB	O
.	O	PUNCT	O


IL-4	B-protein	NOUN	B
activates	O	VERB	B
gene	O	NOUN	B
expression	O	NOUN	I
by	O	ADP	O
inducing	O	VERB	O
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	B
,	O	PUNCT	O
homodimerization	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
nuclear	O	ADJ	B
translocation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
latent	B-protein	ADJ	B
transcription	I-protein	NOUN	O
factor	I-protein	NOUN	O
,	O	PUNCT	O
STAT6	B-protein	NOUN	B
(	O	PUNCT	O
signal	B-protein	NOUN	B
transducer	I-protein	NOUN	I
and	I-protein	CCONJ	I
activator	I-protein	NOUN	O
of	I-protein	ADP	O
transcription-6	I-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


In	O	ADP	O
humans	O	NOUN	B
,	O	PUNCT	O
there	O	PRON	O
are	O	AUX	O
two	O	NUM	O
highly	O	ADV	O
homologous	B-DNA	ADJ	B
genes	I-DNA	NOUN	I
encoding	O	VERB	O
SCM-1alpha	B-protein	NOUN	B
and	O	CCONJ	O
SCM-1beta	B-protein	NOUN	B
.	O	PUNCT	O


Collectively	O	ADV	O
,	O	PUNCT	O
a	O	DET	O
unique	O	ADJ	O
mechanism	O	NOUN	B
involving	O	VERB	O
NF-ATp	B-protein	NOUN	B
appears	O	VERB	O
to	O	PART	O
regulate	O	VERB	B
the	O	DET	O
cell	O	NOUN	B
type-specific	O	ADJ	I
and	O	CCONJ	O
activation-dependent	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
SCM-1	B-DNA	NOUN	B
genes	I-DNA	NOUN	I
.	O	PUNCT	O


The	O	DET	O
combination	O	NOUN	B
of	O	ADP	O
dopamine	O	NOUN	B
and	O	CCONJ	O
TNF-alpha	B-protein	NOUN	B
led	O	VERB	O
to	O	PART	O
a	O	DET	O
stimulation	O	NOUN	B
of	O	ADP	O
HIV-1	O	NOUN	B
transcription	O	NOUN	B
and	O	CCONJ	O
replication	O	NOUN	B
.	O	PUNCT	O


[	O	PUNCT	O
Hormonal	O	ADJ	B
metabolic	O	ADJ	B
status	O	NOUN	I
in	O	ADP	O
breast	O	NOUN	B
cancer	O	NOUN	I
patients	O	NOUN	B
after	O	ADP	O
conservative	O	ADJ	B
surgery	O	NOUN	I
:	O	PUNCT	O
comparison	O	NOUN	B
with	O	ADP	O
known	O	ADJ	O
prognostic	O	ADJ	B
criteria	O	NOUN	I
]	O	PUNCT	O


Said	O	PROPN	O
anthropometric	O	ADJ	B
,	O	PUNCT	O
metabolic	O	ADJ	B
and	O	CCONJ	O
hormonal	O	ADJ	B
parameters	O	NOUN	B
were	O	AUX	O
compared	O	VERB	B
with	O	ADP	O
the	O	DET	O
index	O	NOUN	B
of	O	ADP	O
lymphocytic	O	ADJ	B
infiltration	O	NOUN	I
of	O	ADP	O
tumor	O	NOUN	B
selected	O	VERB	O
as	O	ADP	O
a	O	DET	O
prognostic	O	ADJ	B
factor	O	NOUN	I
.	O	PUNCT	O


Also	O	ADV	O
,	O	PUNCT	O
smoking	O	NOUN	B
contributed	O	VERB	O
to	O	PART	O
loss	O	NOUN	B
of	O	ADP	O
body	O	NOUN	B
mass	O	NOUN	I
and	O	CCONJ	O
fat	O	NOUN	B
;	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
it	O	PRON	O
caused	O	VERB	O
lymphocytic	O	ADJ	B
infiltration	O	NOUN	B
to	O	PART	O
rise	O	VERB	O
.	O	PUNCT	O


It	O	PRON	O
has	O	AUX	O
been	O	AUX	O
demonstrated	O	VERB	O
that	O	SCONJ	O
interferon-gamma	B-protein	NOUN	B
(	O	PUNCT	O
IFN-gamma	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
interleukin-10	B-protein	NOUN	B
(	O	PUNCT	O
IL-10	B-protein	NOUN	B
)	O	PUNCT	O
have	O	AUX	O
various	O	ADJ	O
reverse	O	ADJ	B
effects	O	NOUN	I
on	O	ADP	O
macrophages	B-cell_type	NOUN	B
;	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
molecular	O	ADJ	B
mechanism	O	NOUN	O
of	O	ADP	O
this	O	DET	O
difference	O	NOUN	B
has	O	AUX	O
not	O	PART	O
been	O	AUX	O
fully	O	ADV	O
understood	O	VERB	O
.	O	PUNCT	O


IL-10-activated	B-protein	ADJ	B
STAT1	I-protein	NOUN	B
could	O	AUX	O
bind	O	VERB	B
to	O	PART	O
the	O	DET	O
GAS-motif	B-DNA	ADJ	B
sequence	I-DNA	NOUN	I
in	O	ADP	O
the	O	DET	O
promoter	O	NOUN	B
region	O	NOUN	I
of	O	ADP	O
the	O	DET	O
Fcgamma	B-protein	NOUN	B
receptor	I-protein	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
to	O	PART	O
that	O	DET	O
in	O	ADP	O
the	O	DET	O
promoter	B-DNA	NOUN	B
region	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
COX-2	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
,	O	PUNCT	O
whereas	O	SCONJ	O
IFN-gamma-activated	B-protein	ADJ	B
STAT1	I-protein	NOUN	B
and	O	CCONJ	O
STAT5	B-protein	NOUN	B
could	O	AUX	O
bind	O	VERB	B
to	O	PART	O
both	O	DET	O
sequences	O	NOUN	B
.	O	PUNCT	O


IL-10	B-protein	NOUN	B
inhibited	O	VERB	B
IFN-gamma	B-protein	NOUN	B
-induced	O	ADJ	O
STAT	B-protein	NOUN	B
activation	O	NOUN	I
without	O	ADP	O
newly	B-protein	ADV	O
synthesized	I-protein	VERB	O
protein	I-protein	NOUN	O
.	O	PUNCT	O


This	O	DET	O
may	O	AUX	O
explain	O	VERB	O
the	O	DET	O
difference	O	NOUN	O
between	O	ADP	O
IL-10	B-protein	NOUN	B
and	O	CCONJ	O
IFN-gamma	B-protein	NOUN	B
in	O	ADP	O
biological	O	ADJ	B
activity	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
inhibitory	O	ADJ	B
effect	O	NOUN	O
of	O	ADP	O
IL-10	B-protein	NOUN	B
on	O	ADP	O
IFN-gamma	B-protein	NOUN	B
activities	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
truncated	O	VERB	B
version	O	NOUN	O
of	O	ADP	O
430-444	O	NUM	B
,	O	PUNCT	O
i.e.	O	X	O
,	O	PUNCT	O
VP16	O	NOUN	B
433-442	O	NUM	O
,	O	PUNCT	O
binds	O	VERB	B
with	O	ADP	O
an	O	DET	O
affinity	O	NOUN	B
10-fold	O	ADV	O
lower	O	ADJ	O
compared	O	VERB	B
to	O	PART	O
430-444	O	NUM	O
at	O	ADP	O
acidic	O	ADJ	B
pH	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
binding	O	NOUN	B
at	O	ADP	O
neutral	O	ADJ	B
pH	O	NOUN	B
was	O	AUX	O
barely	O	ADV	O
detectable	O	ADJ	B
.	O	PUNCT	O


Both	O	CCONJ	O
the	O	DET	O
wild	O	ADJ	B
type	O	NOUN	I
430-444	O	NUM	I
and	O	CCONJ	O
433-442	O	NUM	O
peptides	O	NOUN	B
stimulated	O	VERB	B
a	O	DET	O
HSV-specific	O	ADJ	B
T	O	NOUN	I
cell	O	NOUN	I
clone	O	NOUN	O
after	O	ADP	O
a	O	DET	O
brief	O	ADJ	O
incubation	O	NOUN	B
with	O	ADP	O
antigen	B-cell_type	NOUN	B
presenting	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
(	O	PUNCT	O
APC	B-cell_type	NOUN	B
)	O	PUNCT	O
expressing	O	VERB	B
DQ0302	O	NOUN	B
at	O	ADP	O
acidic	O	ADJ	B
pH	O	NOUN	B
.	O	PUNCT	O


E2F-1	B-protein	NOUN	B
blocks	O	VERB	B
terminal	O	ADJ	B
differentiation	O	NOUN	O
and	O	CCONJ	O
causes	O	VERB	O
proliferation	O	NOUN	B
in	O	ADP	O
transgenic	B-cell_type	ADJ	B
megakaryocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


E2F-1	B-protein	NOUN	B
activity	O	NOUN	B
is	O	AUX	O
regulated	O	VERB	O
by	O	ADP	O
a	O	DET	O
number	O	NOUN	O
of	O	ADP	O
proteins	O	NOUN	B
,	O	PUNCT	O
including	O	VERB	O
the	O	DET	O
retinoblastoma	O	NOUN	B
susceptibility	B-DNA	NOUN	I
gene	I-DNA	NOUN	I
product	O	NOUN	I
,	O	PUNCT	O
cyclin-dependent	B-protein	ADJ	B
kinases	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
their	O	PRON	O
inhibitors	O	NOUN	B
,	O	PUNCT	O
proteins	O	NOUN	B
that	O	PRON	O
have	O	AUX	O
been	O	AUX	O
implicated	O	VERB	O
in	O	ADP	O
the	O	DET	O
control	O	NOUN	B
of	O	ADP	O
certain	O	ADJ	O
developmental	O	ADJ	B
processes	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
E2F-1	B-protein	NOUN	B
can	O	AUX	O
prevent	O	VERB	B
terminal	O	ADJ	B
differentiation	O	NOUN	B
,	O	PUNCT	O
probably	O	ADV	O
through	O	ADP	O
its	O	PRON	O
cell	O	NOUN	B
cycle-stimulatory	O	ADJ	I
activity	O	NOUN	B
.	O	PUNCT	O


Atopy	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
predisposes	O	VERB	O
individuals	O	NOUN	B
to	O	PART	O
develop	O	VERB	O
asthma	O	NOUN	B
,	O	PUNCT	O
severe	O	ADJ	B
systemic	O	ADJ	B
anaphylaxis	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
atopic	O	ADJ	B
dermatitis	O	NOUN	I
,	O	PUNCT	O
is	O	AUX	O
usually	O	ADV	O
associated	O	VERB	B
with	O	ADP	I
dramatically	O	ADV	O
elevated	O	ADJ	B
total	O	ADJ	O
serum	O	NOUN	O
IgE	B-protein	NOUN	O
levels	O	NOUN	B
and	O	CCONJ	O
is	O	AUX	O
thought	O	VERB	O
to	O	PART	O
be	O	AUX	O
controlled	O	VERB	B
by	O	ADP	O
a	O	DET	O
major	O	ADJ	O
susceptibility	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
and	O	CCONJ	O
multiple	O	ADJ	O
minor	O	ADJ	O
susceptibility	B-DNA	NOUN	O
genes	I-DNA	NOUN	O
.	O	PUNCT	O


A	O	DET	O
recent	O	ADJ	O
sib-pair	O	ADJ	B
analysis	O	NOUN	I
revealed	O	VERB	O
a	O	DET	O
tight	O	ADJ	O
linkage	O	NOUN	O
between	O	ADP	O
markers	O	NOUN	B
on	O	ADP	O
5q31.1	B-DNA	NOUN	B
and	O	CCONJ	O
a	O	DET	O
major	B-DNA	ADJ	O
susceptibility	I-DNA	NOUN	B
gene	I-DNA	NOUN	O
controlling	O	VERB	O
total	O	ADJ	O
serum	O	NOUN	O
IgE	B-protein	NOUN	O
levels	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
support	O	NOUN	O
of	O	ADP	O
this	O	DET	O
model	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
report	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
human	B-DNA	ADJ	B
IL-4	I-DNA	NOUN	B
promoter	I-DNA	NOUN	B
exists	O	VERB	O
in	O	ADP	O
multiple	O	ADJ	B
allelic	O	ADJ	B
forms	O	NOUN	O
that	O	PRON	O
exhibit	O	VERB	O
distinct	O	ADJ	O
transcriptional	O	ADJ	B
activities	O	NOUN	I
in	O	ADP	O
IL-4-positive	B-cell_type	ADJ	B
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
an	O	DET	O
age-associated	O	ADJ	B
decline	O	NOUN	I
in	O	ADP	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
NF	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
in	O	ADP	O
activated	O	VERB	B
T	B-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
from	O	ADP	O
elderly	O	ADJ	B
individuals	O	NOUN	B
may	O	AUX	O
be	O	AUX	O
attributable	O	ADJ	O
to	O	PART	O
altered	O	ADJ	O
regulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
inhibitor	O	NOUN	B
,	O	PUNCT	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
may	O	AUX	O
play	O	VERB	O
an	O	DET	O
important	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
immune	O	ADJ	B
dysregulation	O	NOUN	I
accompanying	O	VERB	O
aging	O	NOUN	B
.	O	PUNCT	O


Here	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
readdressed	O	VERB	O
the	O	DET	O
issue	O	NOUN	B
of	O	ADP	O
CD8	B-cell_type	NOUN	B
(	I-cell_type	PUNCT	O
+	I-cell_type	CCONJ	O
)	I-cell_type	PUNCT	O
T	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
specific	O	ADJ	O
for	O	ADP	O
the	O	DET	O
72-kDa	B-protein	ADJ	O
major	I-protein	ADJ	O
immediate-early	I-protein	ADJ	B
protein	I-protein	NOUN	I
(	O	PUNCT	O
IE-1	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
nonstructural	O	ADJ	B
but	O	CCONJ	O
is	O	AUX	O
found	O	VERB	O
very	O	ADV	O
early	O	ADV	B
and	O	CCONJ	O
throughout	O	ADP	O
the	O	DET	O
replicative	O	ADJ	B
cycle	O	NOUN	I
.	O	PUNCT	O


For	O	ADP	O
this	O	DET	O
purpose	O	NOUN	O
,	O	PUNCT	O
81	O	NUM	O
pentadecamer	O	NOUN	B
peptides	O	NOUN	I
covering	O	VERB	O
the	O	DET	O
complete	O	ADJ	O
491-amino-acid	B-protein	NOUN	O
sequence	I-protein	NOUN	O
of	O	ADP	O
IE-1	B-protein	NOUN	B
were	O	AUX	O
tested	O	VERB	B
on	O	ADP	O
peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
mononuclear	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
of	O	ADP	O
anti-HCMV	O	NOUN	B
immunoglobulin	O	NOUN	I
G-seropositive	O	ADJ	I
donors	O	NOUN	I
.	O	PUNCT	O


AIDS-related	O	ADJ	B
non-Hodgkin	O	ADJ	I
's	O	PART	I
lymphoma	O	NOUN	I
(	O	PUNCT	O
AIDS	O	NOUN	B
NHL	O	NOUN	B
)	O	PUNCT	O
comprises	O	VERB	O
a	O	DET	O
diverse	O	ADJ	B
and	O	CCONJ	O
heterogeneous	O	ADJ	B
group	O	NOUN	B
of	O	ADP	O
high-grade	O	ADJ	B
B	O	NOUN	I
cell	O	NOUN	I
tumors	O	NOUN	I
.	O	PUNCT	O


Certain	O	ADJ	O
classes	O	NOUN	B
of	O	ADP	O
AIDS	O	NOUN	B
NHL	O	NOUN	B
are	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
alterations	O	NOUN	B
in	O	ADP	O
oncogenes	B-DNA	NOUN	B
or	O	CCONJ	O
tumor-suppressor	B-DNA	ADJ	B
genes	I-DNA	NOUN	I
or	O	CCONJ	O
infections	O	NOUN	B
by	O	ADP	O
oncogenic	O	ADJ	B
herpesviruses	O	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
clinically	O	ADV	B
significant	O	ADJ	I
class	O	NOUN	O
of	O	ADP	O
AIDS	O	NOUN	B
NHL	O	NOUN	B
designated	O	VERB	O
immunoblastic	O	ADJ	B
lymphoma	O	NOUN	I
plasmacytoid	O	NOUN	I
(	O	PUNCT	O
AIDS	O	NOUN	B
IBLP	O	NOUN	I
)	O	PUNCT	O
lacks	O	VERB	B
any	O	DET	O
consistent	O	ADJ	O
genetic	O	ADJ	B
alterations	O	NOUN	O
.	O	PUNCT	O


Hyperplastic	O	ADJ	B
lymph	O	NOUN	I
node	O	NOUN	I
and	O	CCONJ	O
tonsil	O	NOUN	B
also	O	ADV	O
exhibit	O	VERB	O
strong	O	ADJ	O
TCL1	B-protein	NOUN	B
protein	O	NOUN	I
expression	O	NOUN	B
in	O	ADP	O
mantle	B-cell_type	NOUN	B
zone	I-cell_type	NOUN	I
B	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
in	O	ADP	O
rare	O	ADJ	B
interfollicular	B-cell_type	ADJ	B
zone	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
whereas	O	SCONJ	O
follicle-center	B-cell_type	ADJ	B
B	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
(	O	PUNCT	O
centroblasts	B-cell_type	NOUN	B
and	O	CCONJ	O
centrocytes	B-cell_type	NOUN	B
)	O	PUNCT	O
show	O	VERB	O
weaker	O	ADJ	O
expression	O	NOUN	B
.	O	PUNCT	O


IL-2	B-protein	NOUN	B
-independent	O	ADJ	O
activation	O	NOUN	B
and	O	CCONJ	O
proliferation	O	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
T	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
induced	O	VERB	B
by	O	ADP	O
CD28	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
data	O	NOUN	B
imply	O	VERB	O
that	O	SCONJ	O
JAK	B-protein	NOUN	B
/STAT	B-protein	NOUN	O
signaling	O	NOUN	O
has	O	AUX	O
a	O	DET	O
role	O	NOUN	O
in	O	ADP	O
EBV-associated	O	ADJ	B
malignancies	O	NOUN	I
.	O	PUNCT	O


Alveolar	B-cell_type	ADJ	B
macrophages	I-cell_type	NOUN	I
are	O	AUX	O
located	O	ADJ	O
directly	O	ADV	O
in	O	ADP	O
the	O	DET	O
surrounding	O	NOUN	B
of	O	ADP	O
these	O	DET	O
cells	O	NOUN	B
,	O	PUNCT	O
so	O	SCONJ	O
that	O	SCONJ	O
we	O	PRON	O
suppose	O	VERB	O
an	O	DET	O
interaction	O	NOUN	B
between	O	ADP	O
epithelial	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
macrophages	B-cell_type	NOUN	B
regarding	O	VERB	O
to	O	PART	O
the	O	DET	O
release	O	NOUN	B
of	O	ADP	O
inflammatory	B-protein	ADJ	B
mediators	I-protein	NOUN	I
.	O	PUNCT	O


After	O	ADP	O
up	O	ADV	O
to	O	PART	O
90	O	NUM	O
min	O	NOUN	O
exposure	O	NOUN	B
time	O	NOUN	I
ELISA	O	NOUN	B
,	O	PUNCT	O
EMSA	O	NOUN	B
(	O	PUNCT	O
electromobility	O	NOUN	B
shift	O	NOUN	I
assay	O	NOUN	I
)	O	PUNCT	O
and	O	CCONJ	O
RT-PCR	O	NOUN	B
were	O	AUX	O
used	O	VERB	O
to	O	PART	O
measure	O	VERB	B
protein	B-protein	NOUN	B
tyrosine	I-protein	NOUN	I
kinase	I-protein	NOUN	I
activity	O	NOUN	I
,	O	PUNCT	O
protein	O	NOUN	B
activity	O	NOUN	I
of	O	ADP	O
NF-kappaB	B-protein	NOUN	B
and	O	CCONJ	O
cytokine	B-protein	NOUN	B
(	O	PUNCT	O
IL-1beta	B-protein	NOUN	B
,	O	PUNCT	O
IL-6	B-protein	NOUN	B
,	O	PUNCT	O
TNF-alpha	B-protein	NOUN	B
)	O	PUNCT	O
specific	O	ADJ	O
mRNA	B-RNA	NOUN	B
levels	O	NOUN	O
in	O	ADP	O
BEAS-2B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
suggest	O	VERB	O
a	O	DET	O
ROI-dependent	O	ADJ	B
NF-kappaB	B-protein	NOUN	B
mediated	O	VERB	O
transcription	O	NOUN	B
of	O	ADP	O
inflammatory	B-protein	ADJ	B
cytokines	I-protein	NOUN	O
in	O	ADP	O
bronchial	B-cell_type	ADJ	B
epithelial	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


PMA	O	NOUN	B
and	O	CCONJ	O
TNF	B-protein	NOUN	B
alpha	I-protein	NOUN	I
induced	O	ADJ	B
activation	O	NOUN	B
of	O	ADP	O
(	B-protein	PUNCT	O
NF	I-protein	NOUN	B
)	I-protein	PUNCT	O
-kappa	I-protein	NOUN	O
B	I-protein	NOUN	O
in	O	ADP	O
human	O	ADJ	B
Jurkat	B-cell_line	NOUN	O
T-cells	I-cell_line	NOUN	O
was	O	AUX	O
partially	O	ADV	O
inhibited	O	VERB	B
by	O	ADP	O
ADT	O	NOUN	B
(	O	PUNCT	O
0.1	O	NUM	O
mM	O	NOUN	O
)	O	PUNCT	O
pretreatment	O	NOUN	B
.	O	PUNCT	O


ADT	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
pro-glutathione	O	NOUN	B
antioxidant	O	NOUN	B
,	O	PUNCT	O
was	O	AUX	O
observed	O	VERB	O
to	O	PART	O
be	O	AUX	O
capable	O	ADJ	O
of	O	ADP	O
modulating	O	VERB	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activation	O	NOUN	B
.	O	PUNCT	O


Induction	O	NOUN	B
of	O	ADP	O
endothelial	B-protein	ADJ	B
adhesion	I-protein	NOUN	I
molecules	I-protein	NOUN	I
by	O	ADP	O
the	O	DET	O
cytokine	B-protein	NOUN	B
tumor	B-protein	NOUN	O
necrosis	I-protein	NOUN	O
factor-alpha	I-protein	NOUN	O
(	O	PUNCT	O
TNF	B-protein	NOUN	B
)	O	PUNCT	O
can	O	AUX	O
occur	O	VERB	O
independently	O	ADV	O
of	O	ADP	O
protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
C	I-protein	NOUN	I
and	O	CCONJ	O
activation	O	NOUN	B
of	O	ADP	O
a	O	DET	O
protein	B-protein	NOUN	B
tyrosine	I-protein	NOUN	I
kinase	I-protein	NOUN	I
(	O	PUNCT	O
PTK	B-protein	NOUN	B
)	O	PUNCT	O
has	O	AUX	O
recently	O	ADV	O
been	O	AUX	O
implicated	O	VERB	O
in	O	ADP	O
the	O	DET	O
upregulation	O	NOUN	B
of	O	ADP	O
vascular	B-protein	ADJ	B
cell	I-protein	NOUN	I
adhesion	I-protein	NOUN	I
molecule	I-protein	NOUN	I
1	I-protein	NUM	I
(	O	PUNCT	O
VCAM-1	B-protein	NOUN	B
)	O	PUNCT	O
by	O	ADP	O
interleukin-4	B-protein	NOUN	B
(	O	PUNCT	O
IL-4	B-protein	NOUN	B
)	O	PUNCT	O
on	O	ADP	O
endothelial	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


PKC-zeta	B-protein	NOUN	B
belongs	O	VERB	O
to	O	PART	O
this	O	DET	O
family	O	NOUN	B
and	O	CCONJ	O
is	O	AUX	O
known	O	VERB	O
to	O	PART	O
be	O	AUX	O
an	O	DET	O
important	O	ADJ	O
step	O	NOUN	O
in	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activation	O	NOUN	B
in	O	ADP	O
other	O	ADJ	O
cell	O	NOUN	B
systems	O	NOUN	I
.	O	PUNCT	O


Induction	O	NOUN	B
of	O	ADP	O
Bcl-x	B-protein	NOUN	B
(	I-protein	PUNCT	O
L	I-protein	NOUN	B
)	I-protein	PUNCT	O
expression	O	NOUN	B
by	O	ADP	O
human	B-protein	ADJ	B
T-cell	I-protein	NOUN	O
leukemia	I-protein	NOUN	O
virus	I-protein	NOUN	O
type	I-protein	NOUN	O
1	I-protein	NUM	O
Tax	I-protein	NOUN	B
through	O	ADP	O
NF-kappaB	B-protein	NOUN	B
in	O	ADP	O
apoptosis-resistant	B-cell_line	ADJ	B
T-cell	I-cell_line	NOUN	I
transfectants	I-cell_line	NOUN	B
with	O	ADP	O
Tax	B-protein	NOUN	B
.	O	PUNCT	O


Transient-transfection	O	ADJ	B
assays	O	NOUN	I
showed	O	VERB	O
that	O	SCONJ	O
bcl-x	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
was	O	AUX	O
transactivated	O	VERB	B
by	O	ADP	O
wild-type	B-protein	ADJ	B
Tax	I-protein	NOUN	B
.	O	PUNCT	O


Our	O	PRON	O
findings	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
constitutive	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
Bcl-x	B-protein	NOUN	B
(	I-protein	PUNCT	O
L	I-protein	NOUN	B
)	I-protein	PUNCT	O
induced	O	VERB	B
by	O	ADP	O
Tax	B-protein	NOUN	B
through	O	ADP	O
the	O	DET	O
NF-kappaB	B-protein	NOUN	B
pathway	O	NOUN	I
contributes	O	VERB	O
to	O	PART	O
the	O	DET	O
inhibition	O	NOUN	B
of	O	ADP	O
apoptosis	O	NOUN	B
in	O	ADP	O
CTLL-2	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
after	O	ADP	O
IL-2	B-protein	NOUN	B
deprivation	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
report	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
use	O	VERB	O
the	O	DET	O
PIN*POINT	O	ADJ	B
assay	O	NOUN	B
to	O	PART	O
study	O	VERB	B
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
the	O	DET	O
promoter	O	NOUN	B
on	O	ADP	O
the	O	DET	O
recruitment	O	NOUN	B
of	O	ADP	O
EKLF	B-protein	NOUN	B
to	O	PART	O
5'HS2	B-DNA	NOUN	B
and	O	CCONJ	O
5'HS3	B-DNA	NOUN	B
of	O	ADP	O
the	O	DET	O
LCR	B-DNA	NOUN	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
recruitment	O	NOUN	B
of	O	ADP	O
EKLF	B-protein	NOUN	B
to	O	PART	O
5'HS3	B-DNA	NOUN	B
only	O	ADV	O
occurred	O	VERB	O
in	O	ADP	O
beta-globin-expressing	B-cell_type	ADJ	B
murine	I-cell_type	ADJ	I
erythroid	I-cell_type	ADJ	O
leukemia	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	B
,	O	PUNCT	O
whereas	O	SCONJ	O
recruitment	O	NOUN	B
of	O	ADP	O
EKLF	B-protein	NOUN	B
to	O	PART	O
5'HS2	B-DNA	NOUN	B
occurred	O	VERB	O
in	O	ADP	O
both	O	CCONJ	O
gamma-globin-expressing	B-cell_line	ADJ	B
K562	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
and	O	CCONJ	O
murine	B-cell_type	ADJ	B
erythroid	I-cell_type	ADJ	O
leukemia	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	B
.	O	PUNCT	O


Transient	O	ADJ	B
transfection	O	NOUN	O
studies	O	NOUN	O
in	O	ADP	O
HeLa	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
an	O	DET	O
E	O	NOUN	B
(	O	PUNCT	O
2	O	NUM	O
)	O	PUNCT	O
receptor-negative	O	ADJ	B
line	O	NOUN	I
,	O	PUNCT	O
suggest	O	VERB	O
that	O	SCONJ	O
E	O	NOUN	B
(	O	PUNCT	O
2	O	NUM	O
)	O	PUNCT	O
inhibits	O	VERB	B
TNF	B-protein	NOUN	B
gene	O	NOUN	B
expression	O	NOUN	I
through	O	ADP	O
an	O	DET	O
effect	O	NOUN	B
mediated	O	VERB	O
by	O	ADP	O
estrogen	B-protein	NOUN	B
receptor	I-protein	NOUN	I
beta	I-protein	NOUN	I
(	O	PUNCT	O
ERbeta	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Compared	O	VERB	B
with	O	ADP	O
IL-2	B-protein	NOUN	B
,	O	PUNCT	O
CD3	B-protein	NOUN	B
ligation	O	NOUN	I
induces	O	VERB	B
a	O	DET	O
delayed	O	VERB	B
Stat3	B-protein	NOUN	B
binding	O	NOUN	O
to	O	PART	O
oligonucleotide	O	NOUN	B
probes	O	NOUN	I
from	O	ADP	O
the	O	DET	O
ICAM-1	B-protein	NOUN	B
and	O	CCONJ	O
IL-2R	B-DNA	NOUN	B
alpha	I-DNA	NOUN	I
promoter	I-DNA	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
report	O	VERB	O
that	O	SCONJ	O
both	O	CCONJ	O
natural	O	ADJ	B
and	O	CCONJ	O
synthetic	O	ADJ	B
PPARgamma	O	NOUN	B
agonists	O	NOUN	O
induce	O	VERB	B
time-	O	NOUN	O
and	O	CCONJ	O
dose-dependent	O	ADJ	B
increases	O	NOUN	B
in	O	ADP	O
aP2	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
in	O	ADP	O
both	O	CCONJ	O
primary	B-cell_type	ADJ	O
human	I-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
and	O	CCONJ	O
the	O	DET	O
monocytic	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
,	O	PUNCT	O
THP-1	B-cell_line	NOUN	B
.	O	PUNCT	O


Identification	O	NOUN	B
of	O	ADP	O
a	O	DET	O
physical	O	ADJ	B
interaction	O	NOUN	I
between	O	ADP	O
calcineurin	B-protein	NOUN	B
and	O	CCONJ	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
of	I-protein	ADP	O
activated	I-protein	VERB	B
T	I-protein	NOUN	O
cells	I-protein	NOUN	O
(	O	PUNCT	O
NFATp	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Consistent	O	ADJ	B
with	O	ADP	I
these	O	DET	O
data	O	NOUN	B
,	O	PUNCT	O
CD40	B-protein	NOUN	B
signals	O	NOUN	B
up-regulate	O	VERB	B
c-jun	B-RNA	NOUN	B
but	I-RNA	CCONJ	O
not	I-RNA	PART	O
c-fos	I-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
and	O	CCONJ	O
alter	O	VERB	O
the	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
ATF2	B-protein	NOUN	B
but	O	CCONJ	O
not	O	PART	O
the	O	DET	O
Raf-1	B-protein	NOUN	B
protein	I-protein	NOUN	I
.	O	PUNCT	O


Side-chain	O	NOUN	B
modified	O	ADJ	I
vitamin	O	NOUN	B
D	O	NOUN	I
analogs	O	NOUN	B
including	O	VERB	O
20-Epi-22-oxa-24a	O	NUM	O
,	O	PUNCT	O
26a	O	NOUN	B
,	O	PUNCT	O
27a-trihomo-1alpha	O	NOUN	O
,	O	PUNCT	O
2	O	NUM	O
5-dihydroxyvitamin	O	NOUN	O
D3	O	NOUN	B
(	O	PUNCT	O
KH1060	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
1	O	NUM	O
,	O	PUNCT	O
24-dihydroxy-22-ene-24-cyclopropyl-vitamin	O	ADJ	O
D3	O	NOUN	B
(	O	PUNCT	O
MC903	O	NOUN	B
)	O	PUNCT	O
were	O	AUX	O
originally	O	ADV	O
designed	O	VERB	O
to	O	PART	O
aid	O	VERB	O
in	O	ADP	O
the	O	DET	O
treatment	O	NOUN	B
of	O	ADP	O
hyperproliferative	O	ADJ	B
disorders	O	NOUN	I
including	O	VERB	O
psoriasis	O	NOUN	B
and	O	CCONJ	O
cancer	O	NOUN	B
.	O	PUNCT	O


Human	B-DNA	ADJ	B
T-cell	I-DNA	NOUN	I
lymphotrophic	I-DNA	ADJ	I
virus	I-DNA	NOUN	I
type-I	I-DNA	ADJ	I
tax	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
induces	O	VERB	O
secretion	O	NOUN	B
of	O	ADP	O
human	B-protein	ADJ	B
macrophage	I-protein	NOUN	B
inflammatory	I-protein	ADJ	B
protein-1alpha	I-protein	NOUN	B
.	O	PUNCT	O


Induced	O	VERB	B
MIP-1alpha	B-protein	NOUN	B
expression	O	NOUN	B
and	O	CCONJ	O
secretion	O	NOUN	B
in	O	ADP	O
PMA/PHA	B-cell_line	NOUN	B
stimulated	I-cell_line	ADJ	B
tax	I-cell_line	NOUN	O
transfected	I-cell_line	VERB	B
cells	I-cell_line	NOUN	O
correlate	O	VERB	O
with	O	ADP	O
the	O	DET	O
noninduction	O	NOUN	B
of	O	ADP	O
MNP-1	B-protein	NOUN	B
transcription	B-protein	NOUN	I
factor	I-protein	NOUN	I
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
intimately	O	ADV	O
involved	O	VERB	O
in	O	ADP	O
downmodulating	O	VERB	B
the	O	DET	O
MIP-1alpha	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
.	O	PUNCT	O


DC	O	NOUN	B
at	O	ADP	O
many	O	ADJ	O
effector	O	NOUN	B
sites	O	NOUN	I
have	O	AUX	O
a	O	DET	O
characteristic	O	ADJ	O
pattern	O	NOUN	B
of	O	ADP	O
infiltration	O	NOUN	B
and	O	CCONJ	O
differentiation	O	NOUN	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
expression	O	NOUN	B
of	O	ADP	O
physiological	O	ADJ	B
levels	O	NOUN	O
of	O	ADP	O
Bcl-x	B-cell_type	NOUN	B
protected	I-cell_type	ADJ	O
B	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
from	O	ADP	O
Fas-mediated	O	ADJ	B
apoptosis	O	NOUN	I
in	O	ADP	O
the	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
NF-kappaB	B-protein	NOUN	B
signaling	O	NOUN	O
.	O	PUNCT	O


Stimulation	O	NOUN	B
of	O	ADP	O
neutrophil	B-cell_type	NOUN	B
interleukin-8	B-protein	NOUN	B
production	O	NOUN	B
by	O	ADP	O
eosinophil	B-protein	NOUN	B
granule	I-protein	NOUN	I
major	I-protein	ADJ	I
basic	I-protein	ADJ	I
protein	I-protein	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
evaluated	O	VERB	B
the	O	DET	O
ability	O	NOUN	O
of	O	ADP	O
eosinophil	B-protein	NOUN	B
granule	I-protein	NOUN	I
major	I-protein	ADJ	I
basic	I-protein	ADJ	I
protein	I-protein	NOUN	I
(	O	PUNCT	O
MBP	B-protein	NOUN	B
)	O	PUNCT	O
to	O	PART	O
stimulate	O	VERB	B
interleukin	B-protein	NOUN	B
(	I-protein	PUNCT	O
IL	I-protein	NOUN	B
)	I-protein	PUNCT	O
-8	I-protein	NUM	O
production	O	NOUN	B
by	O	ADP	O
neutrophils	B-cell_type	NOUN	B
.	O	PUNCT	O


MBP	B-protein	NOUN	B
over	O	ADP	O
the	O	DET	O
concentration	O	NOUN	B
range	O	NOUN	O
of	O	ADP	O
0.1	O	NUM	O
to	O	PART	O
10	O	NUM	O
microM	O	NOUN	O
stimulated	O	VERB	B
the	O	DET	O
release	O	NOUN	B
of	O	ADP	O
up	O	ADV	O
to	O	PART	O
approximately	O	ADV	B
8	O	NUM	O
ng/ml	O	NOUN	O
IL-8	B-protein	NOUN	B
.	O	PUNCT	O


No	O	DET	O
NF-IL-6	B-protein	NOUN	B
binding	O	NOUN	I
activity	O	NOUN	I
was	O	AUX	O
detected	O	VERB	B
in	O	ADP	O
the	O	DET	O
same	O	ADJ	O
nuclear	O	ADJ	B
extracts	O	NOUN	I
.	O	PUNCT	O


T-PLL	O	NOUN	B
is	O	AUX	O
also	O	ADV	O
seen	O	VERB	O
in	O	ADP	O
non-A-T	O	ADJ	B
individuals	O	NOUN	B
where	O	SCONJ	O
expression	O	NOUN	B
of	O	ADP	O
either	O	CCONJ	O
TCL1	B-protein	NOUN	B
(	O	PUNCT	O
at	O	ADP	O
14q32	B-DNA	NOUN	B
)	O	PUNCT	O
or	O	CCONJ	O
the	O	DET	O
c6.1B/MTCP1	B-protein	NOUN	B
A1	I-protein	NOUN	I
transcript	I-protein	NOUN	B
(	O	PUNCT	O
at-Xq28	B-DNA	NOUN	O
)	O	PUNCT	O
has	O	AUX	O
been	O	AUX	O
demonstrated	O	VERB	O
in	O	ADP	O
just	O	ADV	O
a	O	DET	O
few	O	ADJ	O
instances	O	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
also	O	ADV	O
show	O	VERB	O
that	O	SCONJ	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
B1	B-RNA	NOUN	B
transcript	I-RNA	NOUN	B
from	O	ADP	O
a	O	DET	O
second	O	ADJ	O
gene	O	NOUN	B
,	O	PUNCT	O
MTCP1	B-DNA	NOUN	B
,	O	PUNCT	O
occurred	O	VERB	O
at	O	ADP	O
a	O	DET	O
relatively	O	ADV	O
high	O	ADJ	O
level	O	NOUN	B
only	O	ADV	O
in	O	ADP	O
two	O	NUM	O
T-PLL	O	NOUN	B
tumours	O	NOUN	B
from	O	ADP	O
A-T	O	NOUN	B
patients	O	NOUN	B
with	O	ADP	O
t	O	NOUN	O
(	O	PUNCT	O
X	O	NOUN	O
;	O	PUNCT	O
14	O	NUM	O
)	O	PUNCT	O
translocations	O	NOUN	B
whereas	O	SCONJ	O
the	O	DET	O
MTCP1/A1	B-RNA	NOUN	B
transcript	I-RNA	NOUN	I
is	O	AUX	O
much	O	ADV	O
more	O	ADV	O
widely	O	ADV	O
expressed	O	VERB	B
in	O	ADP	O
both	O	CCONJ	O
tumour	B-cell_type	NOUN	B
and	I-cell_type	CCONJ	O
non	I-cell_type	ADJ	B
tumour	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
of	O	ADP	O
A-T	O	NOUN	B
and	O	CCONJ	O
non-A-T	O	ADJ	B
individuals	O	NOUN	B
.	O	PUNCT	O


Transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
,	O	PUNCT	O
such	O	ADJ	O
as	O	ADP	O
NF	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
and	O	CCONJ	O
AP-1	B-protein	NOUN	B
,	O	PUNCT	O
are	O	AUX	O
activated	O	VERB	B
upon	O	SCONJ	O
stimulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
cells	O	NOUN	B
with	O	ADP	O
several	O	ADJ	O
chemoattractants	O	NOUN	B
at	O	ADP	O
physiologically	O	ADV	B
relevant	O	ADJ	B
concentrations	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
peptide	O	NOUN	B
potently	O	ADV	O
inhibited	O	VERB	B
NFAT	B-protein	NOUN	B
activation	O	NOUN	B
and	O	CCONJ	O
NFAT	B-protein	NOUN	B
-dependent	O	ADJ	O
expression	O	NOUN	B
of	O	ADP	O
endogenous	B-DNA	ADJ	B
cytokine	I-DNA	NOUN	B
genes	I-DNA	NOUN	I
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
without	O	ADP	O
affecting	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
other	O	ADJ	O
cytokines	B-protein	NOUN	B
that	O	PRON	O
require	O	VERB	O
calcineurin	B-protein	NOUN	B
but	O	CCONJ	O
not	O	PART	O
NFAT	B-protein	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
BRL49653	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
PPARgamma	B-protein	NOUN	B
ligand	O	NOUN	B
,	O	PUNCT	O
failed	O	VERB	O
to	O	PART	O
induce	O	VERB	B
MCP-1	B-protein	NOUN	B
secretion	O	NOUN	B
either	O	CCONJ	O
alone	O	ADV	O
or	O	CCONJ	O
to	O	PART	O
modify	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
level	O	NOUN	B
induced	O	VERB	B
by	O	ADP	O
RA	O	NOUN	B
.	O	PUNCT	O


Other	O	ADJ	O
peroxisome	B-protein	NOUN	B
proliferator	I-protein	NOUN	I
activated	I-protein	ADJ	I
receptor	I-protein	NOUN	I
(	O	PUNCT	O
PPAR	B-protein	NOUN	B
)	O	PUNCT	O
ligands	O	NOUN	B
,	O	PUNCT	O
15d-PGJ	O	NOUN	B
(	O	PUNCT	O
2	O	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
troglitazone	O	NOUN	B
(	O	PUNCT	O
PPARgamma	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
Wy14	O	NOUN	B
,	O	PUNCT	O
643	O	NUM	O
(	O	PUNCT	O
PPARalpha	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
PD195599	O	NOUN	B
(	O	PUNCT	O
PPARbeta	B-protein	NOUN	B
)	O	PUNCT	O
inhibited	O	VERB	B
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
MCP-1	B-protein	NOUN	B
by	O	ADP	O
RA	O	NOUN	B
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
both	O	DET	O
copies	O	NOUN	B
of	O	ADP	O
BRCA1	B-DNA	NOUN	B
were	O	AUX	O
retained	O	VERB	O
in	O	ADP	O
tumor	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
DNA	O	NOUN	B
variation	O	NOUN	I
,	O	PUNCT	O
233G	O	NOUN	O
--	O	PUNCT	O
>	O	X	O
A	O	NOUN	O
,	O	PUNCT	O
does	O	AUX	O
not	O	PART	O
result	O	VERB	O
in	O	ADP	O
an	O	DET	O
amino	O	NOUN	B
acid	O	NOUN	I
change	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
is	O	AUX	O
considered	O	VERB	O
a	O	DET	O
benign	O	ADJ	B
polymorphism	O	NOUN	B
.	O	PUNCT	O


Myb-transformed	B-cell_type	ADJ	B
hematopoietic	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
as	O	ADP	O
a	O	DET	O
model	O	NOUN	B
for	O	ADP	O
monocyte	O	NOUN	B
differentiation	O	NOUN	I
into	O	ADP	O
dendritic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
macrophages	B-cell_type	NOUN	B
.	O	PUNCT	O


Immune	O	ADJ	B
induction	O	NOUN	I
is	O	AUX	O
effected	O	VERB	O
through	O	ADP	O
the	O	DET	O
interaction	O	NOUN	B
of	O	ADP	O
antigen-presenting	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
with	O	ADP	O
specific	O	ADJ	O
receptors	B-protein	NOUN	B
on	O	ADP	O
the	O	DET	O
surface	O	NOUN	B
of	O	ADP	O
thymus-derived	B-cell_type	ADJ	B
lymphocytes	I-cell_type	NOUN	I
.	O	PUNCT	O


MTHC	B-cell_line	NOUN	B
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
TNF-alpha	B-protein	NOUN	B
and	O	CCONJ	O
IL-4	B-protein	NOUN	B
will	O	AUX	O
differentiate	O	VERB	B
into	O	ADP	O
cells	O	NOUN	B
that	O	PRON	O
have	O	AUX	O
many	O	ADJ	O
of	O	ADP	O
the	O	DET	O
properties	O	NOUN	B
of	O	ADP	O
macrophages	B-cell_type	NOUN	B
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
L.	O	X	B
pneumophila	O	X	I
possesses	O	VERB	O
a	O	DET	O
growth	O	NOUN	B
phase-dependent	O	ADJ	O
resistance	O	NOUN	O
to	O	PART	O
stress	O	NOUN	B
that	O	PRON	O
is	O	AUX	O
independent	O	ADJ	O
of	O	ADP	O
RpoS	B-protein	NOUN	B
control	O	NOUN	B
and	O	CCONJ	O
that	O	SCONJ	O
RpoS	B-protein	NOUN	B
likely	O	ADV	O
regulates	O	VERB	B
genes	O	NOUN	B
that	O	PRON	O
enable	O	VERB	O
it	O	PRON	O
to	O	PART	O
survive	O	VERB	B
in	O	ADP	O
the	O	DET	O
environment	O	NOUN	B
within	O	ADP	O
protozoa	O	NOUN	B
.	O	PUNCT	O


Recently	O	ADV	O
we	O	PRON	O
have	O	AUX	O
reported	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
Pax5	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
is	O	AUX	O
subject	O	ADJ	O
to	O	PART	O
allele	B-DNA	NOUN	B
-specific	O	ADJ	O
regulation	O	NOUN	B
during	O	ADP	O
B	O	NOUN	B
cell	O	NOUN	I
development	O	NOUN	O
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
disruption	O	NOUN	B
of	O	ADP	O
a	O	DET	O
membrane-proximal	B-protein	ADJ	B
proline-rich	I-protein	ADJ	I
sequence	I-protein	NOUN	I
motif	I-protein	NOUN	I
(	O	PUNCT	O
'	O	PUNCT	O
box1	B-protein	NOUN	O
'	O	PUNCT	O
)	O	PUNCT	O
in	O	ADP	O
either	O	DET	O
subunit	O	NOUN	B
of	O	ADP	O
the	O	DET	O
bipartite	B-protein	ADJ	B
IL-4R	I-protein	NOUN	B
abolished	O	VERB	O
not	O	PART	O
only	O	ADV	O
ligand-induced	O	ADJ	B
tyrosine	O	NOUN	I
phosphorylation	O	NOUN	B
of	O	ADP	O
Janus	B-protein	NOUN	B
kinases	I-protein	NOUN	I
JAK1	B-protein	NOUN	I
and	O	CCONJ	O
JAK3	B-protein	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
also	O	ADV	O
IL-4	B-protein	NOUN	B
-triggered	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
STAT5	B-protein	NOUN	B
and	O	CCONJ	O
concomitant	O	ADJ	B
cell	O	NOUN	B
proliferation	O	NOUN	I
.	O	PUNCT	O


When	O	SCONJ	O
tested	O	VERB	B
for	O	ADP	O
its	O	PRON	O
ability	O	NOUN	O
to	O	PART	O
block	O	VERB	B
calcineurin	B-protein	NOUN	B
-dependent	O	ADJ	O
signaling	O	NOUN	B
in	O	ADP	O
Jurkat	O	NOUN	B
cells	O	NOUN	I
,	O	PUNCT	O
expression	O	NOUN	B
of	O	ADP	O
this	O	DET	O
``	B-DNA	PUNCT	O
B-subunit	I-DNA	NOUN	B
knock-out	I-DNA	NOUN	O
''	I-DNA	PUNCT	O
(	I-DNA	PUNCT	O
BKO	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
construct	I-DNA	NOUN	O
suppressed	O	VERB	B
reporter	B-DNA	NOUN	O
gene	I-DNA	NOUN	O
activity	O	NOUN	O
driven	O	VERB	O
by	O	ADP	O
NF-AT	B-protein	NOUN	B
,	O	PUNCT	O
the	O	DET	O
pivotal	O	ADJ	O
promoter	B-DNA	NOUN	B
element	I-DNA	NOUN	I
for	O	ADP	O
interleukin	B-DNA	NOUN	B
(	I-DNA	PUNCT	I
IL	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
-2	I-DNA	NUM	O
gene	I-DNA	NOUN	B
induction	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
suggest	O	VERB	O
the	O	DET	O
potential	O	ADJ	B
utility	O	NOUN	O
of	O	ADP	O
agents	O	NOUN	B
that	O	PRON	O
disrupt	O	VERB	B
calcineurin	B-protein	NOUN	B
-mediated	O	ADJ	O
signal	O	NOUN	B
transduction	O	NOUN	I
pathways	O	NOUN	I
by	O	ADP	O
blocking	O	VERB	B
formation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
catalytically	B-protein	ADV	B
active	I-protein	ADJ	O
dimer	I-protein	NOUN	O
of	O	ADP	O
calcineurin	B-protein	NOUN	B
A	I-protein	NOUN	I
and	I-protein	CCONJ	O
B	I-protein	NOUN	B
subunits	I-protein	NOUN	I
.	O	PUNCT	O


Monoclonal	B-protein	ADJ	B
anti-D	I-protein	ADJ	I
antibodies	I-protein	NOUN	I
submitted	O	VERB	O
to	O	ADP	O
the	O	DET	O
Third	O	PROPN	B
Monoclonal	O	PROPN	I
International	O	PROPN	I
Workshop	O	PROPN	I
were	O	AUX	O
evaluated	O	VERB	B
against	O	ADP	O
a	O	DET	O
number	O	NOUN	O
of	O	ADP	O
D	B-cell_line	NOUN	B
variant	I-cell_line	ADJ	I
cells	I-cell_line	NOUN	O
using	O	VERB	O
standard	O	ADJ	B
serological	O	ADJ	I
techniques	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
monoclonal	B-protein	ADJ	B
antibodies	I-protein	NOUN	I
were	O	AUX	O
able	O	ADJ	O
to	O	PART	O
discriminate	O	VERB	B
between	O	ADP	O
the	O	DET	O
cells	O	NOUN	B
of	O	ADP	O
Categories	B-cell_line	PROPN	B
Va	I-cell_line	PROPN	B
,	I-cell_line	PUNCT	O
VI	I-cell_line	PROPN	B
and	I-cell_line	CCONJ	O
DFR	I-cell_line	NOUN	B
but	I-cell_line	CCONJ	O
not	I-cell_line	PART	O
Category	I-cell_line	NOUN	B
III	I-cell_line	NUM	I
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
H-7	O	NOUN	B
(	O	PUNCT	O
10	O	NUM	O
microM	O	NOUN	O
)	O	PUNCT	O
,	O	PUNCT	O
a	O	DET	O
specific	O	ADJ	O
inhibitor	O	NOUN	B
of	O	ADP	O
serine/threonine	B-protein	NOUN	B
kinases	I-protein	NOUN	I
,	O	PUNCT	O
significantly	O	ADV	O
blocked	O	VERB	B
IL-10	B-protein	NOUN	B
mediated	O	ADJ	O
c-fos	B-DNA	NOUN	B
expression	O	NOUN	I
(	O	PUNCT	O
p	O	NOUN	O
<	O	X	O
0.05	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


A	O	DET	O
subset	O	NOUN	O
of	O	ADP	O
B	B-cell_type	NOUN	B
cell	I-cell_type	NOUN	I
neoplasms	I-cell_type	NOUN	I
expressing	O	VERB	B
MNDA	B-protein	NOUN	B
included	O	VERB	O
hairy	O	ADJ	B
cell	O	NOUN	I
leukemia	O	NOUN	I
,	O	PUNCT	O
parafollicular	O	ADJ	B
(	O	PUNCT	I
monocytoid	O	ADJ	O
)	O	PUNCT	O
B	O	NOUN	O
cell	O	NOUN	O
lymphoma	O	NOUN	O
,	O	PUNCT	O
mantle	O	NOUN	B
cell	O	NOUN	I
lymphoma	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
small	O	ADJ	B
lymphocytic	O	ADJ	I
lymphoma	O	NOUN	I
.	O	PUNCT	O


Intracellular	O	ADJ	B
adhesion	O	NOUN	O
molecule-1	O	NOUN	O
induction	O	NOUN	B
by	O	ADP	O
PMA	O	NOUN	B
was	O	AUX	O
unaffected	O	ADJ	O
by	O	ADP	O
any	O	DET	O
of	O	ADP	O
the	O	DET	O
molecules	O	NOUN	B
tested	O	VERB	B
.	O	PUNCT	O


Inactive	B-protein	ADJ	B
SHP1-D421A	I-protein	NOUN	B
and	O	CCONJ	O
wild-type	B-protein	ADJ	B
SHP2	I-protein	NOUN	B
were	O	AUX	O
without	O	ADP	O
effects	O	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
two	O	NUM	O
SH2	B-protein	NOUN	B
domains	I-protein	NOUN	I
of	O	ADP	O
SHP1	B-protein	NOUN	B
did	O	AUX	O
not	O	PART	O
facilitate	O	VERB	O
its	O	PRON	O
recognition	O	NOUN	B
of	O	ADP	O
ZAP-70	B-protein	NOUN	B
and	O	CCONJ	O
Syk	B-protein	NOUN	B
as	O	ADP	O
substrates	O	NOUN	B
in	O	ADP	O
intact	O	ADJ	B
cells	O	NOUN	I
.	O	PUNCT	O


Therefore	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
suggest	O	VERB	O
that	O	SCONJ	O
SHP1	B-protein	NOUN	B
is	O	AUX	O
not	O	PART	O
actively	O	ADV	O
recruited	O	VERB	O
to	O	PART	O
inhibit	O	VERB	B
TCR	B-protein	NOUN	B
signaling	O	NOUN	B
induced	O	VERB	B
by	O	ADP	O
ligation	O	NOUN	B
of	O	ADP	O
this	O	DET	O
receptor	O	NOUN	B
alone	O	ADV	O
.	O	PUNCT	O


Further	O	ADJ	O
analysis	O	NOUN	B
of	O	ADP	O
the	O	DET	O
MBP	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
region	I-DNA	NOUN	I
identified	O	VERB	O
a	O	DET	O
C/EBP	B-DNA	NOUN	B
(	I-DNA	PUNCT	O
CCAAT/enhancer-binding	I-DNA	ADJ	O
protein	I-DNA	NOUN	O
)	I-DNA	PUNCT	O
consensus	I-DNA	NOUN	B
binding	I-DNA	NOUN	I
site	I-DNA	NOUN	I
6	O	NUM	O
bp	O	NOUN	O
upstream	O	ADJ	O
of	O	ADP	O
the	O	DET	O
functional	O	ADJ	B
GATA-binding	B-DNA	ADJ	B
site	I-DNA	NOUN	I
in	O	ADP	O
the	O	DET	O
MBP	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
.	O	PUNCT	O


Tissue-specific	O	ADJ	B
regulation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
ecto-5'-nucleotidase	B-DNA	ADJ	B
promoter	I-DNA	NOUN	I
.	O	PUNCT	O


STAT3	B-protein	NOUN	B
(	O	PUNCT	O
signal	B-protein	NOUN	B
transducer	I-protein	NOUN	I
and	I-protein	CCONJ	I
activator	I-protein	NOUN	O
of	I-protein	ADP	O
transcription	I-protein	NOUN	O
3	I-protein	NUM	O
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
latent	O	ADJ	B
transcription	O	NOUN	B
factor	O	NOUN	I
that	O	PRON	O
is	O	AUX	O
activated	O	VERB	B
by	O	ADP	O
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	I
(	O	PUNCT	O
Tyr-705	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
cells	O	NOUN	B
stimulated	O	VERB	B
with	O	ADP	O
cytokines	B-protein	NOUN	B
or	O	CCONJ	O
growth	B-protein	NOUN	B
factors	I-protein	NOUN	I
.	O	PUNCT	O


(	O	PUNCT	O
2-Amino-3'-methoxyphenyl	O	NUM	B
)	O	PUNCT	O
oxanaphthalen-4-one	O	NOUN	B
(	O	PUNCT	O
PD	O	NOUN	B
98059	O	NUM	I
)	O	PUNCT	O
,	O	PUNCT	O
an	O	DET	O
inhibitor	O	NOUN	B
of	O	ADP	O
extracellular	O	ADJ	B
signal-regulated	B-protein	ADJ	I
protein	I-protein	NOUN	I
kinase	I-protein	NOUN	I
(	O	PUNCT	O
ERK	B-protein	NOUN	B
)	O	PUNCT	O
activation	O	NOUN	B
,	O	PUNCT	O
blocked	O	VERB	B
the	O	DET	O
serine	O	NOUN	B
phosphorylation	O	NOUN	B
of	O	ADP	O
STAT3	B-protein	NOUN	B
induced	O	VERB	B
by	O	ADP	O
chemotactic	B-protein	ADJ	B
factors	I-protein	NOUN	I
or	O	CCONJ	O
PMA	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
GATA-1	B-protein	NOUN	B
nuclear	O	ADJ	B
bodies	O	NOUN	I
differed	O	VERB	O
from	O	ADP	O
previously	O	ADV	O
described	O	VERB	O
nuclear	O	ADJ	B
structures	O	NOUN	I
and	O	CCONJ	O
there	O	PRON	O
was	O	AUX	O
no	O	DET	O
co-localization	O	NOUN	B
with	O	ADP	O
nuclear	B-protein	ADJ	B
antigens	I-protein	NOUN	I
involved	O	VERB	O
in	O	ADP	O
RNA	O	NOUN	B
processing	O	NOUN	I
or	O	CCONJ	O
other	O	ADJ	O
ubiquitous	B-protein	ADJ	O
(	I-protein	PUNCT	O
Spl	I-protein	NOUN	B
,	I-protein	PUNCT	O
c-Jun	I-protein	NOUN	B
and	I-protein	CCONJ	O
TBP	I-protein	NOUN	B
)	I-protein	PUNCT	O
or	I-protein	CCONJ	O
haemopoietic	I-protein	ADJ	B
(	I-protein	PUNCT	O
NF-E2	I-protein	NOUN	B
)	I-protein	PUNCT	O
transcription	I-protein	NOUN	B
factors	I-protein	NOUN	I
.	O	PUNCT	O


This	O	DET	O
pattern	O	NOUN	B
of	O	ADP	O
distribution	O	NOUN	B
is	O	AUX	O
,	O	PUNCT	O
thus	O	ADV	O
far	O	ADV	O
,	O	PUNCT	O
unique	O	ADJ	O
to	O	PART	O
the	O	DET	O
GATA	B-protein	NOUN	B
transcription	I-protein	NOUN	O
factors	I-protein	NOUN	O
and	O	CCONJ	O
suggests	O	VERB	O
a	O	DET	O
protein-protein	O	ADJ	B
interaction	O	NOUN	I
with	O	ADP	O
other	O	ADJ	O
components	O	NOUN	B
of	O	ADP	O
the	O	DET	O
nuclear	O	ADJ	B
bodies	O	NOUN	I
via	O	ADP	O
the	O	DET	O
GATA	B-protein	NOUN	B
zinc	I-protein	NOUN	B
finger	I-protein	NOUN	I
domain	I-protein	NOUN	I
.	O	PUNCT	O


Following	O	VERB	O
PCr	O	NOUN	B
administration	O	NOUN	B
we	O	PRON	O
observed	O	VERB	O
lower	O	ADJ	B
blood	O	NOUN	B
lactate	O	NOUN	I
concentrations	O	NOUN	O
and	O	CCONJ	O
different	O	ADJ	O
patterns	O	NOUN	B
of	O	ADP	O
some	O	DET	O
enzyme	O	NOUN	B
activities	O	NOUN	I
,	O	PUNCT	O
less	O	ADV	O
pronounced	O	ADJ	O
changes	O	NOUN	B
in	O	ADP	O
plasma	B-protein	NOUN	B
ACTH	I-protein	NOUN	B
and	O	CCONJ	O
cortisol	O	NOUN	B
concentrations	O	NOUN	B
and	O	CCONJ	O
in	O	ADP	O
glucocorticoid	O	NOUN	B
binding	O	NOUN	I
in	O	ADP	O
lymphocytes	B-cell_type	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
no	O	DET	O
changes	O	NOUN	O
in	O	ADP	O
plasma	O	NOUN	B
growth	O	NOUN	I
hormone	O	NOUN	B
concentrations	O	NOUN	B
compared	O	VERB	O
to	O	PART	O
the	O	DET	O
placebo	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
bacterially-produced	B-DNA	ADJ	B
MR	I-DNA	NOUN	B
constructs	I-DNA	NOUN	B
had	O	AUX	O
no	O	DET	O
steroid	O	NOUN	B
binding	O	NOUN	O
activity	O	NOUN	O
per	O	X	O
se	O	X	O
.	O	PUNCT	O


The	O	DET	O
Kd	O	NOUN	B
value	O	NOUN	I
for	O	ADP	O
aldosterone	O	NOUN	B
was	O	AUX	O
0.3	O	NUM	O
nM	O	NOUN	O
and	O	CCONJ	O
the	O	DET	O
Bmax	O	NOUN	B
=	O	ADJ	O
32	O	NUM	O
pmol/mg	O	NOUN	O
.	O	PUNCT	O


Hormone	O	NOUN	B
binding	O	NOUN	I
specificity	O	NOUN	B
was	O	AUX	O
assessed	O	VERB	B
by	O	ADP	O
competition	O	NOUN	B
studies	O	NOUN	I
with	O	ADP	O
various	O	ADJ	O
steroid	O	NOUN	B
ligands	O	NOUN	B
.	O	PUNCT	O


Overall	O	ADV	O
,	O	PUNCT	O
these	O	DET	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
integrity	O	NOUN	B
of	O	ADP	O
domain	B-protein	NOUN	B
E	I-protein	NOUN	I
is	O	AUX	O
necessary	O	ADJ	O
and	O	CCONJ	O
sufficient	O	ADJ	B
to	O	PART	O
bind	O	VERB	B
steroid	O	NOUN	B
ligands	O	NOUN	O
,	O	PUNCT	O
agonists	O	NOUN	B
or	O	CCONJ	O
antagonists	O	NOUN	B
,	O	PUNCT	O
with	O	ADP	O
characteristics	O	NOUN	B
similar	O	ADJ	O
to	O	PART	O
the	O	DET	O
entire	O	ADJ	O
native	O	ADJ	B
MR	B-protein	NOUN	B
.	O	PUNCT	O


Renal	O	ADJ	B
cell	O	NOUN	I
carcinoma-derived	O	ADJ	B
gangliosides	O	NOUN	B
suppress	O	VERB	B
nuclear	B-protein	ADJ	B
factor-kappaB	I-protein	NOUN	I
activation	O	NOUN	I
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
nuclear	I-protein	ADJ	I
factor-kappaB	I-protein	NOUN	I
(	O	PUNCT	O
NFkappaB	B-protein	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
impaired	O	ADJ	B
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
from	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
renal	O	ADJ	B
cell	O	NOUN	I
carcinomas	O	NOUN	I
(	O	PUNCT	O
RCCs	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


In	O	ADP	O
circulating	O	VERB	B
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
from	O	ADP	O
a	O	DET	O
subset	O	NOUN	O
of	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
RCCs	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
suppression	O	NOUN	B
of	O	ADP	O
NFkappaB	B-protein	NOUN	B
binding	O	NOUN	I
activity	O	NOUN	I
is	O	AUX	O
downstream	O	ADJ	B
from	O	ADP	O
the	O	DET	O
stimulus-induced	O	ADJ	B
degradation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
cytoplasmic	B-protein	ADJ	B
factor	I-protein	NOUN	I
IkappaBalpha	B-protein	NOUN	B
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
TNFalpha	B-protein	NOUN	B
induces	O	VERB	O
a	O	DET	O
delayed	O	VERB	O
ROS-dependent	O	ADJ	B
signalling	O	NOUN	O
pathway	O	NOUN	O
that	O	PRON	O
is	O	AUX	O
required	O	VERB	O
for	O	ADP	O
NF-kappaB	B-protein	NOUN	B
transcriptional	O	ADJ	O
activation	O	NOUN	O
and	O	CCONJ	O
is	O	AUX	O
separable	O	ADJ	O
from	O	ADP	O
that	O	DET	O
required	O	VERB	O
for	O	ADP	O
its	O	PRON	O
nuclear	O	ADJ	B
translocation	O	NOUN	I
.	O	PUNCT	O


Although	O	SCONJ	O
estrogens	O	NOUN	B
initiate	O	VERB	O
vascular	O	ADJ	B
responses	O	NOUN	I
,	O	PUNCT	O
genomic	O	ADJ	B
sex	O	NOUN	I
may	O	AUX	O
influence	O	VERB	B
and/or	O	CCONJ	O
limit	O	VERB	O
expression	O	NOUN	B
of	O	ADP	O
estrogen	O	NOUN	B
receptors	O	NOUN	I
and	O	CCONJ	O
therefore	O	ADV	O
actions	O	NOUN	B
of	O	ADP	O
sex	O	NOUN	B
steroid	O	NOUN	B
hormones	O	NOUN	I
throughout	O	ADP	O
the	O	DET	O
vasculature	O	NOUN	B
.	O	PUNCT	O


M0/M1	B-cell_line	NOUN	O
leukemic	I-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
are	O	AUX	O
not	O	PART	O
sensitive	O	ADJ	B
to	O	PART	O
differentiating	O	VERB	O
agents	O	NOUN	B
,	O	PUNCT	O
whereas	O	SCONJ	O
M3	B-cell_line	NOUN	B
leukemic	I-cell_line	ADJ	I
cells	I-cell_line	NOUN	I
are	O	AUX	O
induced	O	VERB	B
to	O	PART	O
undergo	O	VERB	O
granulocytic	O	ADJ	B
differentiation	O	NOUN	I
after	O	ADP	O
ATRA	O	NOUN	B
treatment	O	NOUN	B
but	O	CCONJ	O
are	O	AUX	O
not	O	PART	O
sensitive	O	ADJ	B
to	O	PART	O
VD	O	NOUN	B
.	O	PUNCT	O


M2	B-cell_line	NOUN	B
leukemic	I-cell_line	ADJ	I
blast	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
behave	O	VERB	O
differently	O	ADV	O
because	O	SCONJ	O
they	O	PRON	O
undergo	O	VERB	O
monocytic	O	ADJ	B
differentiation	O	NOUN	I
with	O	ADP	O
both	O	CCONJ	O
the	O	DET	O
differentiation	O	NOUN	B
inducers	O	NOUN	B
.	O	PUNCT	O


To	O	PART	O
gain	O	VERB	O
some	O	DET	O
insight	O	NOUN	O
into	O	ADP	O
the	O	DET	O
maturation	O	NOUN	B
of	O	ADP	O
M2-type	B-cell_type	ADJ	B
leukemic	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
studied	O	VERB	O
the	O	DET	O
molecular	O	ADJ	B
mechanisms	O	NOUN	I
underlying	O	VERB	O
monocytic	O	ADJ	B
differentiation	O	NOUN	I
induced	O	VERB	B
by	O	ADP	O
ATRA	O	NOUN	B
and	O	CCONJ	O
VD	O	NOUN	B
in	O	ADP	O
spontaneous	O	ADJ	B
M2	B-cell_line	NOUN	B
blast	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
in	O	ADP	O
Kasumi-1	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
(	O	PUNCT	O
an	O	DET	O
acute	B-cell_line	ADJ	B
myeloid	I-cell_line	ADJ	I
leukemia	I-cell_line	NOUN	I
M2-type	I-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
ATRA	O	NOUN	B
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
VD	O	NOUN	B
efficiently	O	ADV	B
increases	O	VERB	B
the	O	DET	O
nuclear	O	ADJ	B
abundance	O	NOUN	B
of	O	ADP	O
VD	B-protein	NOUN	B
receptor	I-protein	NOUN	I
(	O	PUNCT	O
VDR	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
promotes	O	VERB	B
monocytic	O	ADJ	B
differentiation	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
molecular	O	ADJ	B
mechanism	O	NOUN	I
by	O	ADP	O
which	O	DET	O
ATRA	O	NOUN	B
increases	O	VERB	B
the	O	DET	O
nuclear	O	ADJ	B
abundance	O	NOUN	B
of	O	ADP	O
a	O	DET	O
functional	O	ADJ	B
VDR	B-protein	NOUN	B
is	O	AUX	O
still	O	ADV	O
unknown	O	ADJ	O
,	O	PUNCT	O
but	O	CCONJ	O
our	O	PRON	O
data	O	NOUN	B
clearly	O	ADV	O
indicate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
M2	B-cell_line	NOUN	B
leukemic	I-cell_line	ADJ	I
cell	I-cell_line	NOUN	I
context	O	NOUN	O
is	O	AUX	O
only	O	ADV	O
permissive	O	ADJ	O
of	O	ADP	O
monocytic	O	ADJ	B
differentiation	O	NOUN	I
.	O	PUNCT	O


mRNA	B-RNA	NOUN	B
levels	O	NOUN	O
for	O	ADP	O
IL-13R	B-protein	NOUN	B
alpha1	I-protein	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
IL-4R	B-protein	NOUN	B
alpha	I-protein	NOUN	B
,	O	PUNCT	O
were	O	AUX	O
markedly	O	ADV	O
decreased	O	VERB	B
in	O	ADP	O
in	B-cell_line	X	B
vitro	I-cell_line	X	I
monocyte-derived	I-cell_line	ADJ	B
macrophages	I-cell_line	NOUN	I
(	O	PUNCT	O
MDMac	B-cell_line	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
with	O	ADP	O
increasing	O	VERB	B
time	O	NOUN	B
of	O	ADP	O
monocytes	B-cell_type	NOUN	B
in	O	ADP	O
culture	O	NOUN	B
correlated	O	VERB	B
with	O	ADP	O
the	O	DET	O
loss	O	NOUN	B
of	O	ADP	O
IL-13	B-protein	NOUN	B
regulation	O	NOUN	B
of	O	ADP	O
lipopolysaccharide-induced	O	ADJ	O
TNF-alpha	B-protein	NOUN	B
production	O	NOUN	B
.	O	PUNCT	O


Experiments	O	NOUN	B
with	O	ADP	O
a	O	DET	O
blocking	O	VERB	B
antibody	O	NOUN	B
to	O	PART	O
IL-4R	B-protein	NOUN	B
alpha	I-protein	NOUN	B
showed	O	VERB	O
that	O	SCONJ	O
this	O	DET	O
chain	O	NOUN	B
remains	O	VERB	O
an	O	DET	O
essential	O	ADJ	O
component	O	NOUN	O
of	O	ADP	O
the	O	DET	O
IL-13	B-protein	NOUN	B
receptor	I-protein	NOUN	I
complex	I-protein	NOUN	I
on	O	ADP	O
MDMac	B-cell_line	NOUN	B
.	O	PUNCT	O


Both	O	CCONJ	O
TNF-alpha	B-protein	NOUN	B
and	O	CCONJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
are	O	AUX	O
also	O	ADV	O
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
stimulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
pathway	O	NOUN	B
that	O	PRON	O
leads	O	VERB	O
to	O	PART	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
major	B-protein	ADJ	B
histocompatibility	I-protein	NOUN	I
complex	I-protein	NOUN	I
(	I-protein	PUNCT	O
MHC	I-protein	NOUN	B
)	I-protein	PUNCT	O
class	I-protein	NOUN	B
I	I-protein	NUM	I
molecules	I-protein	NOUN	I
and	O	CCONJ	O
,	O	PUNCT	O
hence	O	ADV	O
,	O	PUNCT	O
antigen	O	NOUN	B
presentation	O	NOUN	B
to	O	PART	O
the	O	DET	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


The	O	DET	O
human	O	ADJ	B
B29	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
lacks	O	VERB	O
either	O	CCONJ	O
a	O	DET	O
TATA	B-DNA	NOUN	B
or	I-DNA	CCONJ	O
a	I-DNA	DET	O
CAAT	I-DNA	NOUN	B
box	I-DNA	NOUN	I
and	O	CCONJ	O
transcription	O	NOUN	B
is	O	AUX	O
initiated	O	VERB	O
at	O	ADP	O
multiple	B-DNA	ADJ	B
sites	I-DNA	NOUN	I
.	O	PUNCT	O


The	O	DET	O
minimal	O	ADJ	B
promoter	O	NOUN	B
of	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
B29	I-DNA	NOUN	B
gene	I-DNA	NOUN	I
is	O	AUX	O
contained	O	VERB	O
within	O	ADP	O
a	O	DET	O
193-bp	B-DNA	ADJ	O
region	I-DNA	NOUN	O
5	O	NUM	O
'	O	PUNCT	O
of	O	ADP	O
these	O	DET	O
multiple	B-DNA	ADJ	B
start	I-DNA	NOUN	O
sites	I-DNA	NOUN	O
.	O	PUNCT	O


A	O	DET	O
factor	O	NOUN	O
in	O	ADP	O
bovine	O	ADJ	B
colostrum	O	NOUN	I
(	O	PUNCT	O
colostrum	B-protein	NOUN	B
inhibitory	I-protein	ADJ	I
factor	I-protein	NOUN	I
,	O	PUNCT	O
CIF	B-protein	NOUN	B
)	O	PUNCT	O
inhibits	O	VERB	B
interleukin	B-protein	NOUN	B
2	I-protein	NUM	I
(	O	PUNCT	O
IL2	B-protein	NOUN	B
)	O	PUNCT	O
production	O	NOUN	B
in	O	ADP	O
activated	O	VERB	B
T	B-cell_type	NOUN	B
helper	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
by	O	ADP	O
blocking	O	VERB	B
the	O	DET	O
accumulation	O	NOUN	B
of	O	ADP	O
IL2	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
.	O	PUNCT	O


Heat	O	NOUN	B
shock	O	NOUN	I
induces	O	VERB	O
HIV-1	O	NOUN	B
replication	O	NOUN	B
in	O	ADP	O
chronically	O	ADV	B
infected	O	ADJ	B
promyelocyte	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
OM10.1	I-cell_line	NOUN	B
.	O	PUNCT	O


Staurosporine	O	NOUN	B
(	O	PUNCT	O
PKC	O	NOUN	B
inhibitor	O	NOUN	I
)	O	PUNCT	O
,	O	PUNCT	O
pentoxifylline	O	NOUN	B
(	O	PUNCT	O
NF-kappa	O	NOUN	B
B	O	NOUN	I
inhibitor	O	NOUN	I
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
Ro5-3335	O	NOUN	B
(	O	PUNCT	O
HIV-1	O	NOUN	B
Tat	B-protein	NOUN	B
inhibitor	O	NOUN	B
)	O	PUNCT	O
also	O	ADV	O
inhibited	O	VERB	B
significantly	O	ADV	O
the	O	DET	O
heat	O	NOUN	B
shock	O	NOUN	I
induced	O	VERB	B
virus	O	NOUN	B
activation	O	NOUN	B
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
present	O	ADJ	O
observations	O	NOUN	B
will	O	AUX	O
provide	O	VERB	O
a	O	DET	O
further	O	ADJ	O
insight	O	NOUN	O
into	O	ADP	O
the	O	DET	O
pathogenesis	O	NOUN	B
of	O	ADP	O
HIV-1	O	NOUN	B
infections	O	NOUN	O
.	O	PUNCT	O


Activation	O	NOUN	B
of	O	ADP	O
N-WASP	B-protein	NOUN	B
by	O	ADP	O
IcsA	B-protein	NOUN	B
unmasks	O	VERB	O
two	O	NUM	O
domains	O	NOUN	B
acting	O	VERB	O
together	O	ADV	O
in	O	ADP	O
insertional	O	ADJ	B
actin	B-protein	NOUN	I
polymerization	O	NOUN	B
.	O	PUNCT	O


On	O	ADP	O
the	O	DET	O
other	O	ADJ	O
hand	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
NH	B-protein	PROPN	B
(	I-protein	PUNCT	O
2	I-protein	NUM	O
)	I-protein	PUNCT	O
-terminal	I-protein	ADJ	O
domain	I-protein	NOUN	B
of	O	ADP	O
N-WASP	B-protein	NOUN	B
interacts	O	VERB	O
with	O	ADP	O
F-actin	B-protein	NOUN	B
,	O	PUNCT	O
mediating	O	VERB	O
the	O	DET	O
attachment	O	NOUN	B
of	O	ADP	O
the	O	DET	O
actin	B-protein	NOUN	B
tail	I-protein	NOUN	I
to	O	PART	O
the	O	DET	O
bacterium	O	NOUN	B
surface	O	NOUN	B
.	O	PUNCT	O


c-Maf	B-protein	NOUN	B
induces	O	VERB	O
monocytic	O	ADJ	B
differentiation	O	NOUN	I
and	O	CCONJ	O
apoptosis	O	NOUN	B
in	O	ADP	O
bipotent	B-cell_type	ADJ	B
myeloid	I-cell_type	ADJ	I
progenitors	I-cell_type	NOUN	I
.	O	PUNCT	O


AML1	B-protein	NOUN	B
(	I-protein	PUNCT	O
CBFalpha2	I-protein	NOUN	B
)	I-protein	PUNCT	O
cooperates	O	VERB	B
with	O	ADP	O
B	B-protein	NOUN	B
cell-specific	I-protein	ADJ	I
activating	I-protein	NOUN	I
protein	I-protein	NOUN	I
(	I-protein	PUNCT	O
BSAP/PAX5	I-protein	NOUN	B
)	I-protein	PUNCT	O
in	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
B	B-DNA	NOUN	B
cell-specific	I-DNA	ADJ	O
BLK	I-DNA	NOUN	O
gene	I-DNA	NOUN	O
promoter	I-DNA	NOUN	O
.	O	PUNCT	O


Physical	O	ADJ	B
interaction	O	NOUN	I
of	O	ADP	O
AML1	B-protein	NOUN	B
with	O	ADP	O
BSAP	B-protein	NOUN	B
correlates	O	VERB	O
with	O	ADP	O
functional	O	ADJ	B
cooperativity	O	NOUN	B
in	O	ADP	O
transfection	O	NOUN	B
studies	O	NOUN	I
where	O	SCONJ	O
AML1	B-protein	NOUN	B
and	O	CCONJ	O
BSAP	B-protein	NOUN	B
synergistically	O	ADV	B
activate	O	VERB	B
blk	B-DNA	NOUN	B
promoter	O	NOUN	B
transcription	O	NOUN	I
by	O	ADP	O
more	O	ADJ	O
than	O	ADP	O
50-fold	O	ADV	O
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
demonstrate	O	VERB	O
physical	O	ADJ	B
and	O	CCONJ	O
functional	O	ADJ	B
interactions	O	NOUN	B
between	O	ADP	O
AML1	B-protein	NOUN	B
and	O	CCONJ	O
BSAP	B-protein	NOUN	B
and	O	CCONJ	O
suggest	O	VERB	O
that	O	SCONJ	O
AML1	B-protein	NOUN	B
is	O	AUX	O
an	O	DET	O
important	O	ADJ	O
factor	O	NOUN	B
for	O	ADP	O
regulating	O	VERB	B
a	O	DET	O
critical	O	ADJ	O
B	B-DNA	NOUN	O
cell-specific	I-DNA	ADJ	O
gene	I-DNA	NOUN	O
,	O	PUNCT	O
blk	B-DNA	NOUN	B
.	O	PUNCT	O


Analysis	O	NOUN	B
of	O	ADP	O
MSR	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
activity	O	NOUN	I
in	O	ADP	O
THP-1	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
transfected	O	VERB	B
with	O	ADP	O
an	O	DET	O
MSR	B-DNA	NOUN	B
promoter-reporter	I-DNA	NOUN	B
gene	I-DNA	NOUN	I
construct	I-DNA	NOUN	I
demonstrated	O	VERB	O
decreased	O	VERB	B
activity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
MSR	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
in	O	ADP	O
IL-6	B-protein	NOUN	B
-treated	O	ADJ	O
THP-1	B-cell_line	NOUN	B
macrophages	B-cell_type	NOUN	I
.	O	PUNCT	O


Electrophoretic	O	ADJ	B
mobility	O	NOUN	I
gel	O	NOUN	I
shift	O	NOUN	I
assay	O	NOUN	O
also	O	ADV	O
showed	O	VERB	O
a	O	DET	O
reduction	O	NOUN	B
in	O	ADP	O
the	O	DET	O
binding	O	NOUN	B
of	O	ADP	O
a	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
to	O	PART	O
the	O	DET	O
MSR	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
AP-1/ets	I-DNA	NOUN	B
elements	I-DNA	NOUN	I
in	O	ADP	O
IL-6	B-protein	NOUN	B
-treated	O	ADJ	O
cells	O	NOUN	B
.	O	PUNCT	O


Retinoblastoma	O	NOUN	B
protein	O	NOUN	I
expression	O	NOUN	B
leads	O	VERB	O
to	O	PART	O
reduced	O	VERB	B
Oct-1	B-protein	NOUN	B
DNA	O	NOUN	I
binding	O	NOUN	I
activity	O	NOUN	I
and	O	CCONJ	O
enhances	O	VERB	B
interleukin-8	B-protein	NOUN	B
expression	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
data	O	NOUN	B
obtained	O	VERB	O
show	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
three	O	NUM	O
GCH	O	NOUN	B
molecules	O	NOUN	B
exert	O	VERB	O
an	O	DET	O
immunosuppression	O	NOUN	B
on	O	ADP	O
cytokine	B-protein	NOUN	B
production	O	NOUN	I
by	O	ADP	O
T	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
and	O	CCONJ	O
a	O	DET	O
strong	O	ADJ	O
decrease	O	NOUN	B
in	O	ADP	O
the	O	DET	O
nuclear	O	ADJ	B
translocation	O	NOUN	I
of	O	ADP	O
NF-kB	B-protein	NOUN	B
in	O	ADP	O
Jurkat	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
;	O	PUNCT	O
moreover	O	ADV	O
,	O	PUNCT	O
(	O	PUNCT	O
a	O	X	O
)	O	PUNCT	O
not	O	PART	O
all	O	DET	O
the	O	DET	O
cytokines	B-protein	NOUN	B
investigated	O	VERB	B
were	O	AUX	O
affected	O	VERB	B
,	O	PUNCT	O
and	O	CCONJ	O
not	O	PART	O
with	O	ADP	O
the	O	DET	O
same	O	ADJ	O
intensity	O	NOUN	B
,	O	PUNCT	O
by	O	ADP	O
the	O	DET	O
three	O	NUM	O
GCH	O	NOUN	B
and	O	CCONJ	O
(	O	PUNCT	O
b	O	X	O
)	O	PUNCT	O
DXM	O	NOUN	B
inhibited	O	VERB	B
the	O	DET	O
binding	O	NOUN	B
activity	O	NOUN	I
of	O	ADP	O
NF-kB	B-protein	NOUN	B
less	O	ADJ	O
than	O	ADP	O
that	O	DET	O
of	O	ADP	O
DFC	O	NOUN	B
and	O	CCONJ	O
PDN	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
staining	O	NOUN	B
pattern	O	NOUN	O
clearly	O	ADV	O
differed	O	VERB	O
from	O	ADP	O
that	O	DET	O
of	O	ADP	O
classical	O	ADJ	O
HD	O	NOUN	B
,	O	PUNCT	O
whose	O	DET	O
cellular	O	ADJ	B
background	O	NOUN	I
was	O	AUX	O
made	O	VERB	O
up	O	ADP	O
of	O	ADP	O
CD3+/CD4+	B-cell_type	ADJ	B
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
showing	O	VERB	O
the	O	DET	O
BCL-6	B-protein	NOUN	B
-/	O	NOUN	O
CD40L	B-protein	NOUN	B
+	O	CCONJ	O
phenotype	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
eukaryotic	B-protein	ADJ	B
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
NF-kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
is	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
inducible	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
various	O	ADJ	O
inflammatory	B-DNA	ADJ	B
genes	I-DNA	NOUN	I
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
in	O	ADP	O
HIV-1	O	NOUN	B
replication	O	NOUN	B
.	O	PUNCT	O


Activation	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
is	O	AUX	O
induced	O	VERB	B
by	O	ADP	O
prooxidants	O	NOUN	B
and	O	CCONJ	O
several	O	ADJ	O
stimuli	O	NOUN	B
eliciting	O	VERB	O
oxidative	O	ADJ	B
stress	O	NOUN	I
,	O	PUNCT	O
such	O	ADJ	O
as	O	ADP	O
cytokines	B-protein	NOUN	B
,	O	PUNCT	O
lipopolysaccharide	O	NOUN	B
,	O	PUNCT	O
UV	O	NOUN	B
irradiation	O	NOUN	B
and	O	CCONJ	O
other	O	ADJ	O
mediators	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
effects	O	NOUN	B
of	O	ADP	O
selenium	O	NOUN	B
were	O	AUX	O
specific	O	ADJ	O
for	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
,	O	PUNCT	O
since	O	SCONJ	O
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
transcription	O	NOUN	B
factor	O	NOUN	I
AP-1	B-protein	NOUN	B
was	O	AUX	O
not	O	PART	O
suppressed	O	VERB	B
.	O	PUNCT	O


To	O	PART	O
better	O	ADV	O
understand	O	VERB	O
the	O	DET	O
assembly	O	NOUN	B
mechanism	O	NOUN	B
for	O	ADP	O
the	O	DET	O
progesterone	B-protein	NOUN	B
receptor	I-protein	NOUN	I
(	O	PUNCT	O
PR	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
developed	O	VERB	O
cell-free	O	ADJ	B
systems	O	NOUN	I
for	O	ADP	O
studying	O	VERB	O
interactions	O	NOUN	B
of	O	ADP	O
PR	B-protein	NOUN	B
,	O	PUNCT	O
hsp90	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
other	O	ADJ	O
associated	B-protein	VERB	O
proteins	I-protein	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
studied	O	VERB	O
two	O	NUM	O
pre-formed	B-protein	ADJ	O
hsp90	I-protein	NOUN	B
complexes	I-protein	NOUN	B
that	O	PRON	O
may	O	AUX	O
participate	O	VERB	B
in	O	ADP	O
the	O	DET	O
assembly	O	NOUN	B
of	O	ADP	O
PR	B-protein	NOUN	B
complexes	I-protein	NOUN	B
.	O	PUNCT	O


A	O	DET	O
second	O	ADJ	O
complex	O	NOUN	B
contains	O	VERB	O
hsp90	B-protein	NOUN	B
bound	O	VERB	O
to	O	PART	O
p23	B-protein	NOUN	B
plus	O	CCONJ	O
the	O	DET	O
three	O	NUM	O
immunophilins	B-protein	NOUN	B
and	O	CCONJ	O
some	O	DET	O
hsp70	B-protein	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
further	O	ADJ	O
studies	O	NOUN	B
we	O	PRON	O
have	O	AUX	O
shown	O	VERB	O
that	O	SCONJ	O
purified	O	VERB	B
hsp90	B-protein	NOUN	B
can	O	AUX	O
bind	O	VERB	B
to	O	PART	O
purified	O	VERB	B
p23	B-protein	NOUN	B
and	O	CCONJ	O
this	O	DET	O
interaction	O	NOUN	B
requires	O	VERB	O
both	O	CCONJ	O
ATP	O	NOUN	B
and	O	CCONJ	O
molybdate	O	NOUN	B
.	O	PUNCT	O


Nuclear	O	ADJ	B
extracts	O	NOUN	I
and	O	CCONJ	O
total	O	ADJ	B
cell	O	NOUN	I
lysates	O	NOUN	I
were	O	AUX	O
prepared	O	VERB	O
from	O	ADP	O
MNC	B-cell_type	NOUN	B
by	O	ADP	O
standard	O	ADJ	B
techniques	O	NOUN	I
.	O	PUNCT	O


It	O	PRON	O
was	O	AUX	O
inhibited	O	VERB	B
at	O	ADP	O
1	O	NUM	O
hr	O	NOUN	O
,	O	PUNCT	O
reached	O	VERB	O
a	O	DET	O
nadir	O	NOUN	B
at	O	ADP	O
2-4	O	NUM	O
hr	O	NOUN	O
,	O	PUNCT	O
started	O	VERB	O
to	O	PART	O
increase	O	VERB	B
at	O	ADP	O
8	O	NUM	O
hr	O	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
returned	O	VERB	O
to	O	PART	O
basal	O	ADJ	B
levels	O	NOUN	I
at	O	ADP	O
24	O	NUM	O
hr	O	NOUN	O
.	O	PUNCT	O


Peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
monocytes	I-cell_type	NOUN	I
were	O	AUX	O
isolated	O	VERB	B
by	O	ADP	O
density	O	NOUN	B
centrifugation	O	NOUN	I
methods	O	NOUN	I
with	O	ADP	O
a	O	DET	O
purity	O	NOUN	B
of	O	ADP	O
>	O	X	O
90	O	NUM	O
%	O	NOUN	O
and	O	CCONJ	O
were	O	AUX	O
cultured	O	VERB	B
in	O	ADP	O
RPMI	O	NOUN	B
1640	O	NUM	I
medium	O	NOUN	I
.	O	PUNCT	O


Continuous	O	ADJ	B
treatment	O	NOUN	I
of	O	ADP	O
monocytes	B-cell_type	NOUN	B
with	O	ADP	O
IL-1beta	B-protein	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
with	O	ADP	O
TNF-alpha	B-protein	NOUN	B
,	O	PUNCT	O
could	O	AUX	O
almost	O	ADV	O
completely	O	ADV	O
prevent	O	VERB	O
GC-induced	O	ADJ	B
cell	O	NOUN	I
death	O	NOUN	O
.	O	PUNCT	O


Second	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
studied	O	VERB	O
the	O	DET	O
modulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
sensitivity	O	NOUN	B
of	O	ADP	O
these	O	DET	O
cells	O	NOUN	B
to	O	PART	O
dexamethasone	O	NOUN	B
by	O	ADP	O
preincubation	O	NOUN	B
with	O	ADP	O
TNFalpha	B-protein	NOUN	B
or	O	CCONJ	O
IL-10	B-protein	NOUN	B
and	O	CCONJ	O
measurement	O	NOUN	B
of	O	ADP	O
LPS-stimulated	O	ADJ	B
IL-6	B-protein	NOUN	B
secretion	O	NOUN	B
.	O	PUNCT	O


TNFalpha	B-protein	NOUN	B
decreased	O	VERB	B
(	O	PUNCT	O
P	O	NOUN	O
<	O	X	O
0.001	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
while	O	SCONJ	O
IL-10	B-protein	NOUN	B
increased	O	VERB	B
(	O	PUNCT	O
P	O	NOUN	O
<	O	X	O
0.001	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
the	O	DET	O
concentration	O	NOUN	B
of	O	ADP	O
dexamethasone	O	NOUN	B
binding	O	NOUN	B
sites	O	NOUN	I
in	O	ADP	O
these	O	DET	O
cells	O	NOUN	B
,	O	PUNCT	O
with	O	ADP	O
no	O	DET	O
discernible	O	ADJ	O
effect	O	NOUN	B
on	O	ADP	O
their	O	PRON	O
binding	O	NOUN	B
affinity	O	NOUN	B
.	O	PUNCT	O


Block	O	NOUN	B
of	O	ADP	O
granulocytic	O	ADJ	B
differentiation	O	NOUN	I
of	O	ADP	O
32Dcl3	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
by	O	ADP	O
AML1/ETO	B-DNA	NOUN	B
(	I-DNA	PUNCT	O
MTG8	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
by	O	ADP	O
highly	O	ADV	O
expressed	O	VERB	B
Bcl-2	B-protein	NOUN	B
.	O	PUNCT	O


On	O	ADP	O
the	O	DET	O
contrary	O	NOUN	O
,	O	PUNCT	O
32Dcl3	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
stably	O	ADV	O
expressing	O	VERB	B
AML1/ETO	B-DNA	NOUN	B
were	O	AUX	O
completely	O	ADV	O
resistant	O	ADJ	B
to	O	PART	O
differentiation	O	NOUN	B
and	O	CCONJ	O
continued	O	VERB	O
to	O	PART	O
grow	O	VERB	B
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
G-CSF	B-protein	NOUN	B
.	O	PUNCT	O


When	O	SCONJ	O
compared	O	VERB	B
with	O	ADP	O
normal	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activity	O	NOUN	O
in	O	ADP	O
SLE	O	NOUN	B
patients	O	NOUN	B
was	O	AUX	O
significantly	O	ADV	O
decreased	O	VERB	B
in	O	ADP	O
SLE	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
in	O	ADP	O
RA	O	NOUN	B
,	O	PUNCT	O
patients	O	NOUN	B
.	O	PUNCT	O


Human	B-protein	ADJ	B
Toll-like	I-protein	ADJ	B
receptor	I-protein	NOUN	I
2	I-protein	NUM	I
(	I-protein	PUNCT	O
TLR2	I-protein	NOUN	B
)	I-protein	PUNCT	O
is	O	AUX	O
a	O	DET	O
signaling	B-protein	NOUN	B
receptor	I-protein	NOUN	I
that	O	PRON	O
responds	O	VERB	O
to	O	PART	O
LPS	O	NOUN	B
and	O	CCONJ	O
activates	O	VERB	B
NF-kappaB	B-protein	NOUN	B
.	O	PUNCT	O


PU.1	B-protein	NOUN	B
is	O	AUX	O
a	O	DET	O
hematopoietic-specific	B-protein	ADJ	B
Ets	I-protein	NOUN	I
family	I-protein	NOUN	I
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
that	O	PRON	O
is	O	AUX	O
required	O	VERB	O
for	O	ADP	O
development	O	NOUN	B
of	O	ADP	O
some	O	DET	O
lymphoid	B-cell_type	ADJ	B
and	I-cell_type	CCONJ	O
myeloid	I-cell_type	ADJ	B
lineages	I-cell_type	NOUN	I
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
investigate	O	VERB	B
the	O	DET	O
mechanism	O	NOUN	B
by	O	ADP	O
which	O	DET	O
PU.1	B-protein	NOUN	B
interferes	O	VERB	B
with	O	ADP	I
erythroid	O	ADJ	B
differentiation	O	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
also	O	ADV	O
show	O	VERB	O
that	O	SCONJ	O
ectopic	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
PU.1	B-protein	NOUN	B
in	O	ADP	O
Xenopus	O	NOUN	B
embryos	O	NOUN	B
is	O	AUX	O
sufficient	O	ADJ	O
to	O	PART	O
block	O	VERB	B
erythropoiesis	O	NOUN	B
during	O	ADP	O
normal	O	ADJ	B
development	O	NOUN	I
.	O	PUNCT	O


IL-12	B-protein	NOUN	B
induces	O	VERB	O
IFN	B-protein	NOUN	B
regulating	I-protein	NOUN	I
factor-1	I-protein	NOUN	I
(	I-protein	PUNCT	O
IRF-1	I-protein	NOUN	B
)	I-protein	PUNCT	O
gene	O	NOUN	B
expression	O	NOUN	I
in	O	ADP	O
human	O	ADJ	B
NK	B-cell_type	NOUN	B
and	O	CCONJ	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


First	O	ADV	O
,	O	PUNCT	O
STAT4	B-protein	NOUN	B
was	O	AUX	O
required	O	VERB	O
for	O	ADP	O
the	O	DET	O
IL-12	B-protein	NOUN	B
-dependent	O	ADJ	O
transactivation	O	NOUN	B
of	O	ADP	O
an	O	DET	O
IRF-1	B-DNA	NOUN	B
reporter	I-DNA	NOUN	I
construct	I-DNA	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
second	O	ADV	O
,	O	PUNCT	O
STAT4	B-protein	NOUN	B
binding	O	VERB	B
to	O	PART	O
the	O	DET	O
IRF-1	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
was	O	AUX	O
shown	O	VERB	O
using	O	VERB	O
EMSA	O	NOUN	B
.	O	PUNCT	O


To	O	PART	O
determine	O	VERB	O
whether	O	SCONJ	O
it	O	PRON	O
is	O	AUX	O
possible	O	ADJ	O
to	O	PART	O
artificially	O	ADV	B
enhance	O	VERB	B
the	O	DET	O
opening	O	NOUN	B
of	O	ADP	O
the	O	DET	O
chromatin	O	NOUN	B
structure	O	NOUN	I
of	O	ADP	O
a	O	DET	O
minimal	B-DNA	ADJ	B
beta-globin	I-DNA	NOUN	B
promoter	I-DNA	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
placed	O	VERB	O
a	O	DET	O
101bp	O	ADJ	O
,	O	PUNCT	O
erythroid-specific	B-DNA	ADJ	B
DNase	I-DNA	NOUN	I
1	I-DNA	NUM	I
hypersensitive	I-DNA	ADJ	O
site-forming	I-DNA	ADJ	O
element	I-DNA	NOUN	O
(	O	PUNCT	O
HSFE	B-DNA	NOUN	B
)	O	PUNCT	O
immediately	O	ADV	O
upstream	O	ADV	B
of	O	ADP	O
the	O	DET	O
beta-globin	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
and	I-DNA	CCONJ	O
gene	I-DNA	NOUN	B
.	O	PUNCT	O


The	O	DET	O
HSFE	B-DNA	NOUN	B
induced	O	VERB	B
an	O	DET	O
area	O	NOUN	B
of	O	ADP	O
enhanced	O	VERB	B
DNase	B-protein	NOUN	B
1	I-protein	NUM	I
hypersensitivity	O	NOUN	I
extending	O	VERB	O
from	O	ADP	O
the	O	DET	O
transcriptional	O	ADJ	B
start	O	NOUN	O
site	O	NOUN	O
to	O	PART	O
-300bp	O	NOUN	O
of	O	ADP	O
the	O	DET	O
artificial	B-DNA	ADJ	B
promoter	I-DNA	NOUN	O
and	O	CCONJ	O
significantly	O	ADV	O
increased	O	VERB	B
the	O	DET	O
proportion	O	NOUN	B
of	O	ADP	O
beta-globin	B-DNA	NOUN	B
promoters	I-DNA	NOUN	B
in	O	ADP	O
an	O	DET	O
open	O	ADJ	O
chromatin	O	NOUN	B
configuration	O	NOUN	O
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
a	O	DET	O
relatively	O	ADV	O
small	O	ADJ	O
cis-acting	B-DNA	ADJ	B
element	I-DNA	NOUN	I
is	O	AUX	O
able	O	ADJ	O
to	O	PART	O
enhance	O	VERB	O
remodeling	O	NOUN	B
of	O	ADP	O
promoter	O	NOUN	B
chromatin	O	NOUN	I
structure	O	NOUN	I
resulting	O	VERB	O
in	O	ADP	O
increased	O	VERB	B
beta-globin	B-DNA	NOUN	B
gene	I-DNA	NOUN	B
expression	O	NOUN	I
.	O	PUNCT	O


NF-kappaB	B-protein	NOUN	B
activation	O	NOUN	B
is	O	AUX	O
required	O	VERB	O
for	O	ADP	O
C5a-induced	B-DNA	ADJ	B
interleukin-8	I-DNA	NOUN	B
gene	I-DNA	NOUN	I
expression	O	NOUN	B
in	O	ADP	O
mononuclear	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Pertussis	O	NOUN	B
toxin	O	NOUN	I
,	O	PUNCT	O
which	O	DET	O
ADP-ribosylates	O	VERB	B
the	O	DET	O
Gi	B-protein	NOUN	B
proteins	I-protein	NOUN	I
known	O	VERB	O
to	O	PART	O
couple	O	VERB	O
to	O	PART	O
the	O	DET	O
C5a	B-protein	NOUN	B
receptor	I-protein	NOUN	I
,	O	PUNCT	O
produced	O	VERB	O
minimal	O	ADJ	B
inhibition	O	NOUN	B
of	O	ADP	O
C5a-induced	O	ADJ	B
IL-8	B-protein	NOUN	B
expression	O	NOUN	B
and	O	CCONJ	O
had	O	AUX	O
little	O	ADJ	O
effect	O	NOUN	B
on	O	ADP	O
C5a-induced	O	ADJ	B
calcium	O	NOUN	B
mobilization	O	NOUN	I
in	O	ADP	O
RAW264.7	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Increased	O	VERB	B
glucocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
beta	I-protein	NOUN	B
in	O	ADP	O
airway	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
of	O	ADP	O
glucocorticoid-insensitive	O	ADJ	B
asthma	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
also	O	ADV	O
examined	O	VERB	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
GCRbeta	B-protein	NOUN	B
in	O	ADP	O
specimens	O	NOUN	B
from	O	ADP	O
the	O	DET	O
airways	O	NOUN	B
of	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
chronic	O	ADJ	B
bronchitis	O	NOUN	I
.	O	PUNCT	O


Therefore	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
studied	O	VERB	O
the	O	DET	O
CD40	B-protein	NOUN	B
pathway	O	NOUN	B
in	O	ADP	O
highly	O	ADV	O
purified	O	VERB	B
human	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
and	O	CCONJ	O
resting	B-cell_type	VERB	B
B	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


After	O	ADP	O
CD40	B-protein	NOUN	B
triggering	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
similar	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
NF-kappaB	B-protein	NOUN	B
(	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
of	O	ADP	O
the	O	DET	O
AP-1	B-protein	NOUN	B
)	O	PUNCT	O
transcription	B-protein	NOUN	O
factor	I-protein	NOUN	O
complex	I-protein	NOUN	O
occurred	O	VERB	O
in	O	ADP	O
both	O	DET	O
cell	O	NOUN	B
preparations	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
activation	O	NOUN	B
signals	O	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
B	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
and	O	CCONJ	O
monocytes	B-cell_type	NOUN	B
differ	O	VERB	O
following	O	VERB	O
CD40	B-protein	NOUN	B
stimulation	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
observation	O	NOUN	B
is	O	AUX	O
consistent	O	ADJ	B
with	O	ADP	I
the	O	DET	O
detection	O	NOUN	B
of	O	ADP	O
normal	O	ADJ	O
CD40	B-protein	NOUN	B
-induced	O	ADJ	O
monocyte	O	NOUN	B
activation	O	NOUN	I
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
CD40	B-protein	NOUN	B
ligand+	O	ADJ	B
hyper	O	ADJ	B
IgM	B-protein	NOUN	I
syndrome	O	NOUN	I
in	O	ADP	O
whom	O	PRON	O
a	O	DET	O
defect	O	NOUN	B
in	O	ADP	O
CD40	B-protein	NOUN	B
-induced	O	ADJ	O
B	O	NOUN	B
cell	O	NOUN	I
activation	O	NOUN	O
has	O	AUX	O
been	O	AUX	O
reported	O	VERB	O
.	O	PUNCT	O


For	O	ADP	O
the	O	DET	O
moment	O	NOUN	B
,	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
field	O	NOUN	B
of	O	ADP	O
pharmacogenetics	O	NOUN	B
is	O	AUX	O
embryonic	O	ADJ	B
.	O	PUNCT	O


Regrettably	O	ADV	O
,	O	PUNCT	O
recent	O	ADJ	O
evidence	O	NOUN	B
suggests	O	VERB	O
that	O	SCONJ	O
loss-of-function	O	NOUN	B
alone	O	ADV	O
is	O	AUX	O
not	O	PART	O
always	O	ADV	O
sufficient	O	ADJ	O
to	O	PART	O
prevent	O	VERB	B
the	O	DET	O
emergence	O	NOUN	B
of	O	ADP	O
virulent	O	ADJ	B
mutants	O	NOUN	B
.	O	PUNCT	O


Here	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
propose	O	VERB	O
gain-of-function	O	NOUN	B
to	O	PART	O
be	O	AUX	O
used	O	VERB	O
simultaneously	O	ADV	B
with	O	ADP	O
loss-of-function	O	NOUN	B
as	O	ADP	O
a	O	DET	O
novel	O	ADJ	O
approach	O	NOUN	O
for	O	ADP	O
attenuating	O	VERB	B
HIV-1	O	NOUN	B
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
IkappaB-alphaS32/36A	B-protein	NOUN	B
offers	O	VERB	O
proof-of-principle	O	NOUN	O
that	O	SCONJ	O
artifactually	O	ADV	B
gained	O	VERB	O
functions	O	NOUN	O
,	O	PUNCT	O
when	O	SCONJ	O
used	O	VERB	O
to	O	PART	O
attenuate	O	VERB	B
the	O	DET	O
replication	O	NOUN	B
of	O	ADP	O
live	O	ADJ	B
HIV-1	O	NOUN	B
,	O	PUNCT	O
can	O	AUX	O
be	O	AUX	O
stable	O	ADJ	B
.	O	PUNCT	O


TCR	B-protein	NOUN	B
affinities	O	NOUN	B
were	O	AUX	O
then	O	ADV	O
indirectly	O	ADV	O
estimated	O	VERB	O
by	O	ADP	O
blocking	O	VERB	B
CD8	B-protein	NOUN	B
interaction	O	NOUN	B
with	O	ADP	O
an	O	DET	O
anti-CD8	B-protein	ADJ	B
mAb	I-protein	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
response	O	NOUN	B
to	O	PART	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Wnt	O	NOUN	B
signaling	O	NOUN	I
pathway	O	NOUN	I
,	O	PUNCT	O
beta-catenin	B-protein	NOUN	B
accumulates	O	VERB	B
in	O	ADP	O
the	O	DET	O
nucleus	O	NOUN	B
,	O	PUNCT	O
where	O	SCONJ	O
it	O	PRON	O
cooperates	O	VERB	B
with	O	ADP	O
LEF/TCF	B-protein	NOUN	B
(	O	PUNCT	O
for	O	ADP	O
lymphoid	B-protein	ADJ	B
enhancer	I-protein	NOUN	I
factor	I-protein	NOUN	I
and	I-protein	CCONJ	O
T-cell	I-protein	NOUN	B
factor	I-protein	NOUN	I
)	O	PUNCT	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
to	O	PART	O
activate	O	VERB	B
gene	O	NOUN	B
expression	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
introduced	O	VERB	O
a	O	DET	O
small	O	ADJ	O
deletion	O	NOUN	B
within	O	ADP	O
beta-catenin	B-protein	NOUN	B
(	O	PUNCT	O
Delta19	B-DNA	NOUN	B
)	O	PUNCT	O
that	O	PRON	O
disrupts	O	VERB	B
binding	O	NOUN	B
to	O	PART	O
LEF-1	B-protein	NOUN	B
,	O	PUNCT	O
E-cadherin	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
APC	B-protein	NOUN	B
but	O	CCONJ	O
not	O	PART	O
axin	B-protein	NOUN	B
.	O	PUNCT	O


Targeted	O	VERB	B
expression	O	NOUN	B
to	O	PART	O
specific	O	ADJ	O
tissues	O	NOUN	B
or	O	CCONJ	O
cell	O	NOUN	B
lineages	O	NOUN	I
is	O	AUX	O
a	O	DET	O
necessary	O	ADJ	O
feature	O	NOUN	O
of	O	ADP	O
a	O	DET	O
gene	O	NOUN	B
therapy	O	NOUN	I
vector	O	NOUN	I
for	O	ADP	O
many	O	ADJ	O
clinical	O	ADJ	B
applications	O	NOUN	I
,	O	PUNCT	O
such	O	ADJ	O
as	O	ADP	O
correction	O	NOUN	B
of	O	ADP	O
hemoglobinopathies	O	NOUN	B
or	O	CCONJ	O
thalassemias	O	NOUN	B
by	O	ADP	O
transplantation	O	NOUN	B
of	O	ADP	O
genetically	B-cell_type	ADV	B
modified	I-cell_type	VERB	O
hematopoietic	I-cell_type	ADJ	B
stem	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Programmed	O	ADJ	B
cell	O	NOUN	I
death	O	NOUN	I
is	O	AUX	O
a	O	DET	O
process	O	NOUN	B
required	O	VERB	O
for	O	ADP	O
the	O	DET	O
normal	O	ADJ	B
development	O	NOUN	I
of	O	ADP	O
an	O	DET	O
organism	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
ALG-4	B-protein	NOUN	B
is	O	AUX	O
necessary	O	ADJ	O
and	O	CCONJ	O
sufficient	O	ADJ	B
for	O	ADP	O
FasL	B-protein	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


Fas/	O	NOUN	B
FasL	B-protein	NOUN	B
interaction	O	NOUN	B
initiates	O	VERB	O
cell	O	NOUN	B
death	O	NOUN	I
in	O	ADP	O
many	O	ADJ	O
other	O	ADJ	O
systems	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
its	O	PRON	O
dysregulation	O	NOUN	B
is	O	AUX	O
a	O	DET	O
mechanism	O	NOUN	B
by	O	ADP	O
which	O	DET	O
several	O	ADJ	O
pathologic	O	ADJ	B
conditions	O	NOUN	I
arise	O	VERB	O
.	O	PUNCT	O


LMP1	B-protein	NOUN	B
needs	O	VERB	O
only	O	ADV	O
11	O	NUM	O
amino	O	NOUN	B
acids	O	NOUN	I
to	O	PART	O
activate	O	VERB	B
NF-kappaB	B-protein	NOUN	B
or	O	CCONJ	O
synergize	O	VERB	B
with	O	ADP	O
TRADD	B-protein	NOUN	B
in	O	ADP	O
NF-kappaB	B-protein	NOUN	B
activation	O	NOUN	B
,	O	PUNCT	O
while	O	SCONJ	O
TNFR1	B-protein	NOUN	B
requires	O	VERB	O
approximately	O	ADV	O
70	O	NUM	O
residues	O	NOUN	B
.	O	PUNCT	O


Unlike	O	ADP	O
TNFR1	B-protein	NOUN	B
,	O	PUNCT	O
LMP1	B-protein	NOUN	B
can	O	AUX	O
interact	O	VERB	B
directly	O	ADV	O
with	O	ADP	O
receptor-interacting	B-protein	ADJ	B
protein	I-protein	NOUN	I
(	O	PUNCT	O
RIP	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
stably	O	ADV	B
associates	O	VERB	B
with	O	ADP	I
RIP	B-protein	NOUN	B
in	O	ADP	O
EBV-transformed	B-cell_line	ADJ	B
lymphoblastoid	I-cell_line	ADJ	I
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
marked	O	ADJ	O
contrast	O	NOUN	O
to	O	PART	O
neutrophils	B-cell_type	NOUN	B
and	O	CCONJ	O
MO7e	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
GM-CSF	B-protein	NOUN	B
did	O	AUX	O
not	O	PART	O
induce	O	VERB	B
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	I
and	O	CCONJ	O
activation	O	NOUN	B
of	O	ADP	O
ERK	B-protein	NOUN	B
in	O	ADP	O
monocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


PD98059	O	NOUN	B
inhibited	O	VERB	B
GM-CSF	B-protein	NOUN	B
-dependent	O	ADJ	O
proliferation	O	NOUN	B
of	O	ADP	O
MO7e	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Possible	O	ADJ	O
roles	O	NOUN	O
of	O	ADP	O
ERK	B-protein	NOUN	B
in	O	ADP	O
proliferation	O	NOUN	B
of	O	ADP	O
transformed	B-cell_line	VERB	B
cells	I-cell_line	NOUN	I
were	O	AUX	O
also	O	ADV	O
suggested	O	VERB	O
.	O	PUNCT	O


Indirect	O	ADJ	B
immunofluorescence	O	NOUN	I
shows	O	VERB	O
that	O	SCONJ	O
IL-2	B-protein	NOUN	B
controls	O	VERB	I
the	O	DET	O
cellular	O	ADJ	B
distribution	O	NOUN	I
of	O	ADP	O
Aiolos	B-protein	NOUN	B
and	O	CCONJ	O
induces	O	VERB	B
its	O	PRON	O
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	B
,	O	PUNCT	O
required	O	VERB	O
for	O	ADP	O
dissociation	O	NOUN	B
from	O	ADP	O
Ras	B-protein	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
both	O	CCONJ	O
atopic	O	ADJ	B
and	O	CCONJ	O
nonatopic	O	ADJ	B
asthma	O	NOUN	I
,	O	PUNCT	O
elevated	O	ADJ	B
IL-5	B-protein	NOUN	B
has	O	AUX	O
been	O	AUX	O
detected	O	VERB	B
in	O	ADP	O
peripheral	O	ADJ	B
blood	O	NOUN	I
and	O	CCONJ	O
the	O	DET	O
airways	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
investigated	O	VERB	B
several	O	ADJ	O
molecular	O	ADJ	B
pathways	O	NOUN	I
that	O	PRON	O
are	O	AUX	O
known	O	VERB	O
to	O	PART	O
be	O	AUX	O
activated	O	VERB	B
by	O	ADP	O
IL-2	B-protein	NOUN	B
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


PNU156804	O	NOUN	B
action	O	NOUN	B
is	O	AUX	O
restricted	O	ADJ	O
to	O	PART	O
some	O	DET	O
signaling	O	NOUN	B
pathways	O	NOUN	I
;	O	PUNCT	O
it	O	PRON	O
does	O	AUX	O
not	O	PART	O
affect	O	VERB	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activation	O	NOUN	B
by	O	ADP	O
PMA	O	NOUN	B
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
but	O	CCONJ	O
blocks	O	VERB	B
that	O	PRON	O
induced	O	VERB	B
by	O	ADP	O
CD40	B-protein	NOUN	B
cross-linking	O	NOUN	B
in	O	ADP	O
B	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
.	O	PUNCT	O


Control	O	NOUN	B
of	O	ADP	O
IL-5	B-protein	NOUN	B
production	O	NOUN	B
may	O	AUX	O
be	O	AUX	O
effective	O	ADJ	B
for	O	ADP	O
the	O	DET	O
management	O	NOUN	B
of	O	ADP	O
allergic	O	ADJ	B
diseases	O	NOUN	I
.	O	PUNCT	O


pIL-5	B-DNA	NOUN	B
(	I-DNA	PUNCT	I
-511	I-DNA	NUM	I
)	I-DNA	PUNCT	I
Luc	I-DNA	NOUN	I
was	O	AUX	O
transcribed	O	VERB	B
by	O	ADP	O
T-cell	B-cell_line	NOUN	B
hybridomas	I-cell_line	NOUN	I
derived	O	VERB	O
from	O	ADP	O
fusion	O	NOUN	B
between	O	ADP	O
IL-5-producing	B-cell_line	ADJ	B
T-cell	I-cell_line	NOUN	I
clones	I-cell_line	NOUN	O
and	O	CCONJ	O
an	O	DET	O
IL-5	B-cell_line	NOUN	B
gene-nonexpressing	I-cell_line	ADJ	I
T-cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
by	O	ADP	O
hybridomas	B-cell_line	NOUN	B
derived	O	VERB	O
from	O	ADP	O
IL-5-nonproducing	B-cell_line	ADJ	B
T-cell	I-cell_line	NOUN	I
clones	I-cell_line	NOUN	O
.	O	PUNCT	O


IL-5	B-protein	NOUN	B
synthesis	O	NOUN	O
was	O	AUX	O
not	O	PART	O
only	O	ADV	O
induced	O	VERB	B
by	O	ADP	O
T-cell	O	NOUN	B
receptor	O	NOUN	I
stimulation	O	NOUN	I
but	O	CCONJ	O
also	O	ADV	O
by	O	ADP	O
IL-2	B-protein	NOUN	B
receptor	O	NOUN	I
stimulation	O	NOUN	B
.	O	PUNCT	O


CONCLUSION	O	NOUN	O
:	O	PUNCT	O
IL-5	B-protein	NOUN	B
synthesis	O	NOUN	I
by	O	ADP	O
human	B-cell_type	ADJ	B
helper	I-cell_type	NOUN	O
T	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
is	O	AUX	O
regulated	O	VERB	O
at	O	ADP	O
the	O	DET	O
transcriptional	O	ADJ	B
level	O	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
little	O	ADJ	O
is	O	AUX	O
known	O	VERB	O
regarding	O	VERB	O
whether	O	SCONJ	O
follicles	O	NOUN	B
in	O	ADP	O
the	O	DET	O
liver	O	NOUN	B
belong	O	VERB	O
to	O	PART	O
functional	O	ADJ	B
lymphoid	O	ADJ	B
tissues	O	NOUN	B
,	O	PUNCT	O
where	O	SCONJ	O
B	O	NOUN	B
cells	O	NOUN	I
are	O	AUX	O
activated	O	VERB	B
,	O	PUNCT	O
differentiated	O	VERB	B
,	O	PUNCT	O
and	O	CCONJ	O
proliferated	O	VERB	B
,	O	PUNCT	O
or	O	CCONJ	O
if	O	SCONJ	O
the	O	DET	O
lymphocytes	O	NOUN	B
are	O	AUX	O
merely	O	ADV	O
infiltrated	O	VERB	B
after	O	ADP	O
recruitment	O	NOUN	B
from	O	ADP	O
the	O	DET	O
secondary	O	ADJ	B
lymphoid	O	ADJ	B
organs	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
Wilms	B-DNA	NOUN	B
'	I-DNA	PART	I
tumor	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
(	O	PUNCT	O
WT1	B-DNA	NOUN	B
)	O	PUNCT	O
encodes	O	VERB	B
a	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
of	O	ADP	O
the	O	DET	O
zinc	B-protein	NOUN	B
finger	I-protein	NOUN	I
type	I-protein	NOUN	I
.	O	PUNCT	O


A	O	DET	O
high	O	ADJ	O
expression	O	NOUN	B
of	O	ADP	O
WT1	B-DNA	NOUN	B
has	O	AUX	O
been	O	AUX	O
detected	O	VERB	B
in	O	ADP	O
a	O	DET	O
range	O	NOUN	O
of	O	ADP	O
acute	O	ADJ	B
leukemias	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
WT1	B-DNA	NOUN	B
is	O	AUX	O
downregulated	O	VERB	B
during	O	ADP	O
induced	O	VERB	B
differentiation	O	NOUN	B
of	O	ADP	O
some	O	DET	O
leukemic	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
study	O	NOUN	B
,	O	PUNCT	O
each	O	DET	O
of	O	ADP	O
the	O	DET	O
four	O	NUM	O
different	O	ADJ	O
isoforms	O	NOUN	B
of	O	ADP	O
WT1	B-DNA	NOUN	B
was	O	AUX	O
constitutively	O	ADV	B
overexpressed	O	VERB	B
in	O	ADP	O
the	O	DET	O
leukemic	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
K562	I-cell_line	NOUN	I
.	O	PUNCT	O


IL-4	B-protein	NOUN	B
conducts	O	VERB	O
its	O	PRON	O
biological	O	ADJ	B
activities	O	NOUN	I
through	O	ADP	O
binding	O	VERB	B
to	O	PART	O
the	O	DET	O
IL-4	B-protein	NOUN	B
receptor	I-protein	NOUN	I
(	O	PUNCT	O
IL-4R	B-protein	NOUN	B
)	O	PUNCT	O
on	O	ADP	O
the	O	DET	O
surface	O	NOUN	B
of	O	ADP	O
target	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
report	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
two	O	NUM	O
tyrosines	O	NOUN	B
,	O	PUNCT	O
Tyr-113	O	NOUN	B
and	O	CCONJ	O
Tyr-128	O	NOUN	B
,	O	PUNCT	O
of	O	ADP	O
SLP-76	B-protein	NOUN	B
are	O	AUX	O
required	O	VERB	O
for	O	ADP	O
its	O	PRON	O
binding	O	NOUN	B
to	O	PART	O
Vav	B-protein	NOUN	B
,	O	PUNCT	O
both	O	CCONJ	O
in	O	X	B
vitro	O	X	I
and	O	CCONJ	O
in	O	ADP	O
intact	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
little	O	ADJ	O
is	O	AUX	O
known	O	VERB	O
about	O	ADP	O
the	O	DET	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
that	O	PRON	O
regulate	O	VERB	B
its	O	PRON	O
expression	O	NOUN	B
.	O	PUNCT	O


Consistent	O	ADJ	B
with	O	ADP	I
its	O	PRON	O
Rel/NF-kappaB	B-protein	NOUN	B
-dependent	O	ADJ	O
induction	O	NOUN	B
,	O	PUNCT	O
Jagged1	B-protein	NOUN	B
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
be	O	AUX	O
highly	O	ADV	O
expressed	O	VERB	B
in	O	ADP	O
splenic	B-cell_type	ADJ	B
B	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
where	O	SCONJ	O
c-Rel	B-protein	NOUN	B
is	O	AUX	O
expressed	O	VERB	B
constitutively	O	ADV	B
.	O	PUNCT	O


These	O	DET	O
findings	O	NOUN	B
also	O	ADV	O
highlight	O	VERB	O
the	O	DET	O
potential	O	NOUN	B
for	O	ADP	O
an	O	DET	O
interplay	O	NOUN	O
between	O	ADP	O
the	O	DET	O
Notch	O	NOUN	B
and	O	CCONJ	O
NF-kappaB	O	NOUN	B
signaling	O	NOUN	I
pathways	O	NOUN	I
in	O	ADP	O
the	O	DET	O
immune	O	ADJ	B
system	O	NOUN	I
.	O	PUNCT	O


Peptidoglycan	O	NOUN	B
(	O	PUNCT	O
PGN	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
the	O	DET	O
major	O	ADJ	O
cell	O	NOUN	B
wall	O	NOUN	I
component	O	NOUN	O
of	O	ADP	O
Gram-positive	O	ADJ	B
bacteria	O	NOUN	I
,	O	PUNCT	O
induces	O	VERB	O
secretion	O	NOUN	B
of	O	ADP	O
cytokines	B-protein	NOUN	B
in	O	ADP	O
macrophages	B-cell_type	NOUN	B
through	O	ADP	O
CD14	B-protein	NOUN	B
,	O	PUNCT	O
the	O	DET	O
pattern	O	NOUN	B
recognition	O	NOUN	I
receptor	O	NOUN	I
that	O	PRON	O
binds	O	VERB	B
lipopolysaccharide	O	NOUN	B
and	O	CCONJ	O
other	O	ADJ	O
microbial	O	ADJ	B
products	O	NOUN	I
.	O	PUNCT	O


Interleukin	O	NOUN	B
(	O	PUNCT	O
IL	O	NOUN	B
)	O	PUNCT	O
6	O	NUM	O
levels	O	NOUN	B
were	O	AUX	O
determined	O	VERB	O
by	O	ADP	O
enzyme-linked	O	ADJ	B
immunosorbent	O	ADJ	I
assay	O	NOUN	I
(	O	PUNCT	O
ELISA	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


ICSAT	B-protein	NOUN	B
overexpression	O	NOUN	B
is	O	AUX	O
not	O	PART	O
sufficient	O	ADJ	O
to	O	PART	O
cause	O	VERB	O
adult	O	ADJ	B
T-cell	O	NOUN	B
leukemia	O	NOUN	I
or	O	CCONJ	O
multiple	O	ADJ	B
myeloma	O	NOUN	I
.	O	PUNCT	O


Th2	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
could	O	AUX	O
be	O	AUX	O
induced	O	VERB	B
in	O	ADP	O
all	O	DET	O
healthy	O	ADJ	B
controls	O	NOUN	I
by	O	ADP	O
priming	O	VERB	B
with	O	ADP	O
anti-CD28	B-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
TCR	B-protein	NOUN	B
ligation	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
intracellular	O	ADJ	B
parasite	O	NOUN	B
Theileria	O	X	B
parva	O	X	I
secures	O	VERB	O
its	O	PRON	O
propagation	O	NOUN	B
and	O	CCONJ	O
spreads	O	VERB	B
through	O	ADP	O
the	O	DET	O
infected	O	ADJ	B
animal	O	NOUN	B
by	O	ADP	O
infecting	O	VERB	B
and	O	CCONJ	O
transforming	O	VERB	B
T	B-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
inducing	O	VERB	B
their	O	PRON	O
continuous	O	ADJ	B
proliferation	O	NOUN	B
and	O	CCONJ	O
rendering	O	VERB	O
them	O	PRON	O
metastatic	O	ADJ	B
.	O	PUNCT	O


Consequently	O	ADV	O
,	O	PUNCT	O
inhibition	O	NOUN	B
of	O	ADP	O
NF-kappaB	B-protein	NOUN	B
nuclear	O	ADJ	O
translocation	O	NOUN	O
and	O	CCONJ	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
dominant	B-protein	ADJ	B
negative	I-protein	ADJ	B
mutant	I-protein	ADJ	B
forms	O	NOUN	O
of	O	ADP	O
components	O	NOUN	B
of	O	ADP	O
the	O	DET	O
NF-kappaB	B-protein	NOUN	B
activation	O	NOUN	I
pathway	O	NOUN	I
,	O	PUNCT	O
such	O	ADJ	O
as	O	ADP	O
IkappaBalpha	B-protein	NOUN	B
or	O	CCONJ	O
p65	B-protein	NOUN	B
,	O	PUNCT	O
prompt	O	VERB	O
rapid	O	ADJ	O
apoptosis	O	NOUN	B
of	O	ADP	O
T.	B-cell_type	X	B
parva-transformed	I-cell_type	ADJ	I
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Our	O	PRON	O
findings	O	NOUN	B
offer	O	VERB	O
important	O	ADJ	O
insights	O	NOUN	O
into	O	ADP	O
parasite	O	ADJ	B
survival	O	NOUN	B
strategies	O	NOUN	O
and	O	CCONJ	O
demonstrate	O	VERB	O
that	O	SCONJ	O
parasite-induced	O	ADJ	B
constitutive	O	ADJ	O
NF-kappaB	B-protein	NOUN	B
activation	O	NOUN	O
is	O	AUX	O
an	O	DET	O
essential	O	ADJ	O
step	O	NOUN	O
in	O	ADP	O
maintaining	O	VERB	O
the	O	DET	O
transformed	O	VERB	O
phenotype	O	NOUN	B
of	O	ADP	O
the	O	DET	O
infected	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	B
.	O	PUNCT	O


Genetic	O	ADJ	B
variation	O	NOUN	I
in	O	ADP	O
cytokine	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
regions	I-DNA	NOUN	I
is	O	AUX	O
postulated	O	VERB	O
to	O	PART	O
influence	O	VERB	B
susceptibility	O	NOUN	B
to	O	PART	O
infection	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
the	O	DET	O
molecular	O	ADJ	B
mechanisms	O	NOUN	I
by	O	ADP	O
which	O	DET	O
such	O	ADJ	O
polymorphisms	O	NOUN	B
might	O	AUX	O
affect	O	VERB	O
gene	O	NOUN	B
regulation	O	NOUN	I
are	O	AUX	O
unknown	O	ADJ	O
.	O	PUNCT	O


A	O	DET	O
semiquantitative	O	ADJ	O
reverse	B-protein	ADJ	O
transcriptase	I-protein	NOUN	O
-linked	O	ADJ	O
polymerase	O	NOUN	B
chain	O	NOUN	I
reaction	O	NOUN	I
(	O	PUNCT	O
RT-PCR	O	NOUN	B
)	O	PUNCT	O
was	O	AUX	O
used	O	VERB	O
for	O	ADP	O
analysis	O	NOUN	B
of	O	ADP	O
gene	O	NOUN	B
expression	O	NOUN	I
in	O	ADP	O
the	O	DET	O
treated	B-cell_type	VERB	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Together	O	ADV	O
,	O	PUNCT	O
these	O	DET	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
UV-induced	O	ADJ	B
CYP1A1	B-protein	NOUN	B
gene	O	NOUN	B
expression	O	NOUN	I
in	O	ADP	O
mammalian	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
is	O	AUX	O
mediated	O	VERB	O
by	O	ADP	O
an	O	DET	O
Ah	B-protein	NOUN	B
receptor	I-protein	NOUN	I
ligand	O	NOUN	B
formed	O	VERB	O
from	O	ADP	O
tryptophan	O	NOUN	B
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
lymphoid	B-protein	ADJ	B
lineage-determining	I-protein	ADJ	B
factors	I-protein	NOUN	I
Ikaros	B-protein	NOUN	B
and	O	CCONJ	O
Aiolos	B-protein	NOUN	B
can	O	AUX	O
function	O	VERB	B
as	O	ADP	O
strong	B-protein	ADJ	O
transcriptional	I-protein	ADJ	B
repressors	I-protein	NOUN	I
.	O	PUNCT	O


PI3-kinase	B-protein	NOUN	B
activity	O	NOUN	B
was	O	AUX	O
an	O	DET	O
upstream	O	ADJ	B
activator	O	NOUN	I
of	O	ADP	O
PKB/Akt	B-protein	NOUN	B
because	O	SCONJ	O
the	O	DET	O
PI3-kinase	B-protein	NOUN	B
inhibitor	O	NOUN	I
LY294002	O	NOUN	B
blocked	O	VERB	B
both	O	CCONJ	O
constitutive	O	ADJ	B
PKB/Akt	B-protein	NOUN	B
and	O	CCONJ	O
factor-dependent	O	ADJ	O
PKB/Akt	B-protein	NOUN	B
activity	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
LY294002	O	NOUN	B
study	O	NOUN	B
showed	O	VERB	O
that	O	SCONJ	O
proliferation	O	NOUN	B
and	O	CCONJ	O
viability	O	NOUN	B
of	O	ADP	O
both	O	CCONJ	O
HCD57-SREI	B-cell_line	NOUN	B
and	O	CCONJ	O
HCD57	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
correlated	O	VERB	B
with	O	ADP	O
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
PKB/Akt	B-protein	NOUN	B
;	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
PKB/Akt	B-protein	NOUN	B
activity	O	NOUN	B
alone	O	ADV	O
did	O	AUX	O
not	O	PART	O
protect	O	VERB	O
these	O	DET	O
cells	O	NOUN	B
from	O	ADP	O
apoptosis	O	NOUN	B
.	O	PUNCT	O


Disruption	O	NOUN	B
of	O	ADP	O
alpha	O	NOUN	B
beta	O	NOUN	I
but	O	CCONJ	O
not	O	PART	O
of	O	ADP	O
gamma	O	NOUN	B
delta	O	NOUN	I
T	O	NOUN	I
cell	O	NOUN	I
development	O	NOUN	B
by	O	ADP	O
overexpression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
helix-loop-helix	B-protein	ADJ	B
protein	I-protein	NOUN	I
Id3	B-protein	NOUN	B
in	O	ADP	O
committed	B-cell_type	VERB	O
T	I-cell_type	NOUN	B
cell	I-cell_type	NOUN	I
progenitors	I-cell_type	NOUN	O
.	O	PUNCT	O


These	O	DET	O
cells	O	NOUN	B
had	O	AUX	O
properties	O	NOUN	B
of	O	ADP	O
both	O	CCONJ	O
natural	B-cell_type	ADJ	B
killer	I-cell_type	NOUN	I
(	O	PUNCT	O
NK	B-cell_type	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
pre-T	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


These	O	DET	O
findings	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
bHLH	B-protein	ADJ	B
factors	I-protein	NOUN	I
are	O	AUX	O
required	O	VERB	O
to	O	PART	O
control	O	VERB	B
T	O	NOUN	B
cell	O	NOUN	I
development	O	NOUN	O
after	O	ADP	O
the	O	DET	O
T/NK	O	NOUN	B
developmental	O	ADJ	O
checkpoint	O	NOUN	O
.	O	PUNCT	O


HIV-1	O	NOUN	B
reactivation	O	NOUN	B
in	O	ADP	O
resting	B-cell_type	VERB	B
peripheral	I-cell_type	ADJ	I
blood	I-cell_type	NOUN	I
mononuclear	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
of	O	ADP	O
infected	O	ADJ	B
adults	O	NOUN	B
upon	O	SCONJ	O
in	O	X	B
vitro	O	X	I
CD4	B-protein	NOUN	B
cross-linking	O	NOUN	B
by	O	ADP	O
ligands	O	NOUN	B
of	O	ADP	O
the	O	DET	O
CDR2-loop	B-protein	NOUN	B
in	O	ADP	O
extracellular	B-protein	ADJ	B
domain	I-protein	NOUN	I
1	I-protein	NUM	I
.	O	PUNCT	O


HIV-1	O	NOUN	B
infects	O	VERB	B
resting	B-cell_type	VERB	B
peripheral	I-cell_type	ADJ	I
blood	I-cell_type	NOUN	I
mononuclear	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
(	O	PUNCT	O
PBMCs	B-cell_type	NOUN	B
)	O	PUNCT	O
but	O	CCONJ	O
remains	O	VERB	O
inactive	O	ADJ	B
state	O	NOUN	O
until	O	ADP	O
subsequent	O	ADJ	O
cell	O	NOUN	B
activation	O	NOUN	I
.	O	PUNCT	O


This	O	DET	O
viral	O	ADJ	B
reactivation	O	NOUN	I
was	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
increased	O	VERB	B
NF-kappaB	B-protein	NOUN	B
nuclear	O	ADJ	O
translocation	O	NOUN	B
in	O	ADP	O
patients	O	NOUN	B
'	O	PART	O
PBMCs	B-cell_type	NOUN	B
.	O	PUNCT	O


The	O	DET	O
level	O	NOUN	B
of	O	ADP	O
ongoing	O	ADJ	O
HIV-1	O	NOUN	B
replication	O	NOUN	B
within	O	ADP	O
an	O	DET	O
individual	O	NOUN	B
is	O	AUX	O
critical	O	ADJ	O
to	O	PART	O
HIV-1	O	NOUN	B
pathogenesis	O	NOUN	B
.	O	PUNCT	O


Given	O	VERB	O
the	O	DET	O
critical	O	ADJ	O
role	O	NOUN	O
that	O	PRON	O
LT-alpha1beta2	B-protein	NOUN	B
plays	O	VERB	O
in	O	ADP	O
lymphoid	O	ADJ	B
architecture	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
speculate	O	VERB	O
that	O	SCONJ	O
LT-alpha1beta2	B-protein	NOUN	B
may	O	AUX	O
be	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
HIV-associated	O	ADJ	B
abnormalities	O	NOUN	B
of	O	ADP	O
the	O	DET	O
lymphoid	O	ADJ	B
organs	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
secretion	O	NOUN	B
levels	O	NOUN	B
of	O	ADP	O
interleukin-6	B-protein	NOUN	B
(	O	PUNCT	O
IL-6	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
von	O	NOUN	B
Willebrand	O	NOUN	I
factor	O	NOUN	I
(	O	PUNCT	O
vWF	O	NOUN	B
)	O	PUNCT	O
were	O	AUX	O
determined	O	VERB	O
,	O	PUNCT	O
to	O	PART	O
serve	O	VERB	O
as	O	ADP	O
markers	O	NOUN	B
for	O	ADP	O
EC	O	NOUN	B
activation	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
activated	B-cell_line	VERB	B
EC	I-cell_line	NOUN	B
were	O	AUX	O
examined	O	VERB	O
for	O	ADP	O
the	O	DET	O
adherence	O	NOUN	B
of	O	ADP	O
a	O	DET	O
monocytic	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
(	O	PUNCT	O
U937	B-cell_line	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
for	O	ADP	O
expression	O	NOUN	B
of	O	ADP	O
vascular	B-protein	ADJ	B
cell	I-protein	NOUN	I
adhesion	I-protein	NOUN	I
molecule	I-protein	NOUN	I
1	I-protein	NUM	I
,	O	PUNCT	O
intercellular	O	ADJ	B
adhesion	O	NOUN	I
molecule	O	NOUN	I
1	O	NUM	I
,	O	PUNCT	O
and	O	CCONJ	O
E-selectin	B-protein	NOUN	B
.	O	PUNCT	O


RESULTS	O	NOUN	B
:	O	PUNCT	O
Six	O	NUM	O
mAECA	B-protein	NOUN	B
were	O	AUX	O
selected	O	VERB	O
,	O	PUNCT	O
the	O	DET	O
mixture	O	NOUN	O
of	O	ADP	O
which	O	DET	O
produced	O	VERB	O
100	O	NUM	O
%	O	NOUN	O
inhibition	O	NOUN	B
of	O	ADP	O
binding	O	NOUN	B
of	O	ADP	O
the	O	DET	O
original	O	ADJ	B
IgG	B-protein	NOUN	B
(	O	PUNCT	O
from	O	ADP	O
the	O	DET	O
patient	O	NOUN	B
with	O	ADP	O
Takayasu	O	NOUN	B
arteritis	O	NOUN	I
)	O	PUNCT	O
to	O	PART	O
HUVEC	B-cell_line	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
these	O	DET	O
mAECA	B-protein	NOUN	B
stimulated	O	VERB	B
the	O	DET	O
nuclear	O	ADJ	B
translocation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
NF-kappaB	B-protein	NOUN	B
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
report	O	VERB	O
that	O	SCONJ	O
NF-AT1	B-protein	NOUN	B
and	O	CCONJ	O
NF-AT4	B-protein	NOUN	B
are	O	AUX	O
expressed	O	VERB	B
cytoplasmically	O	ADV	B
in	O	ADP	O
resting	B-cell_type	VERB	B
eosinophils	I-cell_type	NOUN	I
,	O	PUNCT	O
whereas	O	SCONJ	O
NF-AT2	B-protein	NOUN	B
and	O	CCONJ	O
NF-AT3	B-protein	NOUN	B
have	O	AUX	O
not	O	PART	O
been	O	AUX	O
seen	O	VERB	O
.	O	PUNCT	O


Likewise	O	ADV	O
,	O	PUNCT	O
NF-AT1	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
and	O	CCONJ	O
NF-AT4	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
have	O	AUX	O
been	O	AUX	O
detected	O	VERB	B
in	O	ADP	O
resting	B-cell_type	VERB	B
eosinophils	I-cell_type	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
their	O	PRON	O
levels	O	NOUN	B
can	O	AUX	O
be	O	AUX	O
significantly	O	ADV	O
up-regulated	O	VERB	B
by	O	ADP	O
the	O	DET	O
Th2-associated	B-protein	ADJ	B
cytokines	I-protein	NOUN	B
IL-4	B-protein	NOUN	B
and	O	CCONJ	O
IL-5	B-protein	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
NF-ATs	B-protein	NOUN	B
appear	O	VERB	O
in	O	ADP	O
the	O	DET	O
nuclei	O	NOUN	B
of	O	ADP	O
IL-4-	B-cell_line	NOUN	B
,	I-cell_line	PUNCT	O
IL-5-	I-cell_line	NOUN	B
,	I-cell_line	PUNCT	O
or	I-cell_line	CCONJ	O
ionomycin-stimulated	I-cell_line	ADJ	B
eosinophils	I-cell_line	NOUN	B
.	O	PUNCT	O


METHODS	O	NOUN	O
AND	O	CCONJ	O
RESULTS	O	NOUN	B
:	O	PUNCT	O
Immunohistochemistry	O	NOUN	B
revealed	O	VERB	O
that	O	SCONJ	O
human	B-cell_type	ADJ	B
carotid	I-cell_type	NOUN	B
artery	I-cell_type	NOUN	I
ECs	I-cell_type	NOUN	I
express	O	VERB	O
PPARalpha	B-protein	NOUN	B
.	O	PUNCT	O


Transient	O	ADJ	B
transfection	O	NOUN	B
of	O	ADP	O
deletional	O	ADJ	B
VCAM-1	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
constructs	I-DNA	NOUN	I
and	O	CCONJ	O
electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assays	O	NOUN	I
suggest	O	VERB	O
that	O	SCONJ	O
fenofibrate	O	NOUN	B
inhibits	O	VERB	B
VCAM-1	B-protein	NOUN	B
transcription	O	NOUN	I
in	O	ADP	O
part	O	NOUN	O
by	O	ADP	O
inhibiting	O	VERB	B
NF-kappaB	B-protein	NOUN	B
.	O	PUNCT	O


NF-ATc	B-protein	NOUN	B
,	O	PUNCT	O
an	O	DET	O
inducibly	O	ADV	B
expressed	O	VERB	B
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
,	O	PUNCT	O
controls	O	VERB	B
gene	O	NOUN	B
expression	O	NOUN	I
in	O	ADP	O
T	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
and	O	CCONJ	O
cardiomyocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


The	O	DET	O
interaction	O	NOUN	B
of	O	ADP	O
LMP1	B-protein	NOUN	B
and	O	CCONJ	O
JAK3	B-protein	NOUN	B
leads	O	VERB	O
to	O	PART	O
the	O	DET	O
enhanced	O	VERB	B
tyrosine	O	NOUN	B
auto/transphosphorylation	O	NOUN	I
of	O	ADP	O
JAK3	B-protein	NOUN	B
within	O	ADP	O
minutes	O	NOUN	O
after	O	ADP	O
crosslinking	O	NOUN	B
of	O	ADP	O
a	O	DET	O
conditional	O	ADJ	B
NGF-R	B-protein	NOUN	B
:	I-protein	PUNCT	O
LMP1	I-protein	NOUN	B
chimera	I-protein	NOUN	B
and	O	CCONJ	O
is	O	AUX	O
a	O	DET	O
prerequisite	O	NOUN	O
for	O	ADP	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
STAT	B-protein	NOUN	B
transcription	I-protein	NOUN	I
factors	I-protein	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
rolling	O	NOUN	B
of	O	ADP	O
monocytes	B-cell_type	NOUN	B
was	O	AUX	O
increased	O	VERB	B
by	O	ADP	O
IkappaB-alpha	B-protein	NOUN	B
transfer	O	NOUN	I
and	O	CCONJ	O
was	O	AUX	O
partly	O	ADV	O
mediated	O	VERB	O
by	O	ADP	O
P-selectin	B-protein	NOUN	B
;	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
it	O	PRON	O
appeared	O	VERB	O
to	O	PART	O
be	O	AUX	O
unaffected	O	ADJ	O
by	O	ADP	O
the	O	DET	O
inhibition	O	NOUN	B
of	O	ADP	O
E-selectin	B-protein	NOUN	B
induction	O	NOUN	B
.	O	PUNCT	O


Recognition	O	NOUN	B
of	O	ADP	O
NFATp/AP-1	B-DNA	NOUN	B
composite	I-DNA	ADJ	I
elements	I-DNA	NOUN	B
within	O	ADP	O
genes	O	NOUN	B
induced	O	VERB	B
upon	O	SCONJ	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
immune	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


A	O	DET	O
well-studied	O	ADJ	O
example	O	NOUN	O
is	O	AUX	O
nuclear	B-DNA	ADJ	B
factors	I-DNA	NOUN	I
of	I-DNA	ADP	O
activated	I-DNA	VERB	B
T-cell	I-DNA	NOUN	I
(	I-DNA	PUNCT	O
NFAT	I-DNA	NOUN	O
)	I-DNA	PUNCT	O
sites	I-DNA	NOUN	O
which	O	DET	O
are	O	AUX	O
composite	O	ADJ	B
elements	O	NOUN	B
of	O	ADP	O
a	O	DET	O
NFATp/c	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
an	I-DNA	DET	O
activating	I-DNA	VERB	B
protein	I-DNA	NOUN	O
1	I-DNA	NUM	O
(	I-DNA	PUNCT	O
AP-1	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
binding	I-DNA	NOUN	B
site	I-DNA	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
identified	O	VERB	B
an	O	DET	O
E	B-DNA	NOUN	B
box	I-DNA	NOUN	I
around	O	ADP	O
-260	B-DNA	NUM	O
and	O	CCONJ	O
a	O	DET	O
YY1	B-DNA	NOUN	B
binding	I-DNA	NOUN	B
site	I-DNA	NOUN	I
around	O	ADP	O
-300	B-DNA	NUM	O
relative	O	ADJ	O
to	O	PART	O
the	O	DET	O
transcription	B-DNA	NOUN	B
start	I-DNA	NOUN	O
site	I-DNA	NOUN	O
.	O	PUNCT	O


Suppression	O	NOUN	B
of	O	ADP	O
NF-kappaB	B-protein	NOUN	B
activation	O	NOUN	B
in	O	ADP	O
normal	B-cell_type	ADJ	O
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
by	O	ADP	O
supernatant	O	ADJ	B
fluid	O	NOUN	I
from	O	ADP	O
human	O	ADJ	B
renal	O	ADJ	I
cell	O	NOUN	I
carcinomas	O	NOUN	I
.	O	PUNCT	O


RCC-S	O	NOUN	B
did	O	AUX	O
not	O	PART	O
alter	O	VERB	O
the	O	DET	O
cytoplasmic	O	ADJ	B
levels	O	NOUN	B
of	O	ADP	O
RelA	B-protein	NOUN	B
and	O	CCONJ	O
NF-kappaB1	B-protein	NOUN	B
but	O	CCONJ	O
did	O	AUX	O
suppress	O	VERB	B
their	O	PRON	O
nuclear	O	ADJ	B
localization	O	NOUN	I
and	O	CCONJ	O
inhibited	O	VERB	B
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
RelA/NF-kappaB1	B-protein	NOUN	B
binding	I-protein	NOUN	I
complexes	I-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
mediator	O	NOUN	O
(	O	PUNCT	O
s	O	NOUN	O
)	O	PUNCT	O
of	O	ADP	O
this	O	DET	O
maturation	O	NOUN	B
process	O	NOUN	B
has	O	AUX	O
not	O	PART	O
been	O	AUX	O
yet	O	ADV	O
defined	O	VERB	O
.	O	PUNCT	O


STAT1	B-protein	NOUN	B
activity	O	NOUN	B
was	O	AUX	O
evident	O	ADJ	O
on	O	ADP	O
the	O	DET	O
STAT	B-DNA	NOUN	B
binding	I-DNA	NOUN	I
sequences	I-DNA	NOUN	I
(	O	PUNCT	O
SBE	B-DNA	NOUN	B
)	O	PUNCT	O
present	O	ADJ	O
in	O	ADP	O
the	O	DET	O
promoters	B-DNA	NOUN	B
of	O	ADP	O
genes	O	NOUN	B
which	O	DET	O
are	O	AUX	O
up-regulated	O	VERB	B
during	O	ADP	O
monocyte	O	NOUN	B
to	O	PART	O
macrophage	O	NOUN	B
maturation	O	NOUN	B
such	O	ADJ	O
as	O	ADP	O
FcgammaRI	B-DNA	NOUN	B
and	O	CCONJ	O
ICAM-1	B-DNA	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
in	O	ADP	O
the	O	DET	O
promoter	O	NOUN	B
of	O	ADP	O
the	O	DET	O
transcription	B-DNA	NOUN	B
factor	I-DNA	NOUN	I
IFN	I-DNA	NOUN	I
regulatory	I-DNA	ADJ	I
factor-1	I-DNA	NOUN	I
.	O	PUNCT	O


These	O	DET	O
findings	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
PML	B-protein	NOUN	B
is	O	AUX	O
required	O	VERB	O
for	O	ADP	O
early	O	ADJ	O
hematopoiesis	O	NOUN	B
and	O	CCONJ	O
erythroid	O	ADJ	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
granulocytic	O	ADJ	B
maturation	O	NOUN	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
PML	B-protein	NOUN	B
and	O	CCONJ	O
pRb	B-protein	NOUN	B
105	I-protein	NUM	O
were	O	AUX	O
co-immunoprecipitated	O	VERB	B
in	O	ADP	O
cellular	O	ADJ	B
lysates	O	NOUN	I
derived	O	VERB	O
from	O	ADP	O
erythroid	B-cell_type	ADJ	B
precursors	I-cell_type	NOUN	B
indicating	O	VERB	O
that	O	SCONJ	O
this	O	DET	O
functional	O	ADJ	B
interaction	O	NOUN	B
may	O	AUX	O
have	O	AUX	O
a	O	DET	O
biochemical	O	ADJ	B
basis	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
JNK1	B-protein	NOUN	B
was	O	AUX	O
also	O	ADV	O
significantly	O	ADV	O
induced	O	VERB	B
,	O	PUNCT	O
with	O	ADP	O
JNK1	B-protein	NOUN	B
protein	O	NOUN	I
levels	O	NOUN	O
increasing	O	VERB	B
moderately	O	ADV	B
during	O	ADP	O
exposure	O	NOUN	B
to	O	PART	I
TPA	O	NOUN	B
.	O	PUNCT	O


63	O	NUM	O
%	O	NOUN	O
nucleotide	O	NOUN	B
identity	O	NOUN	B
with	O	ADP	O
a	O	DET	O
more	O	ADV	O
conserved	O	VERB	O
core	O	NOUN	O
of	O	ADP	O
169	B-DNA	NUM	O
base	I-DNA	NOUN	B
pairs	I-DNA	NOUN	I
(	O	PUNCT	O
86	O	NUM	O
%	O	NOUN	O
identity	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


These	O	DET	O
findings	O	NOUN	B
demonstrate	O	VERB	O
differential	O	ADJ	O
lineage	O	NOUN	B
requirements	O	NOUN	B
for	O	ADP	O
expression	O	NOUN	B
within	O	ADP	O
the	O	DET	O
HS	B-DNA	NOUN	B
I	I-DNA	NUM	I
element	I-DNA	NOUN	B
.	O	PUNCT	O


Recent	O	ADJ	O
studies	O	NOUN	B
have	O	AUX	O
shown	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
non-steroidal	O	ADJ	B
anti-inflammatory	O	ADJ	I
drugs	O	NOUN	I
(	O	PUNCT	O
NSAIDs	O	NOUN	B
)	O	PUNCT	O
activate	O	VERB	B
heat	B-protein	NOUN	B
shock	I-protein	NOUN	I
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
(	O	PUNCT	O
HSF1	B-protein	NOUN	B
)	O	PUNCT	O
from	O	ADP	O
a	O	DET	O
latent	B-protein	ADJ	B
cytoplasmic	I-protein	ADJ	B
form	I-protein	NOUN	O
to	O	PART	O
a	O	DET	O
nuclear	B-protein	ADJ	B
,	I-protein	PUNCT	O
DNA	I-protein	NOUN	B
binding	I-protein	NOUN	I
state	I-protein	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
only	O	ADV	O
a	O	DET	O
subset	O	NOUN	O
of	O	ADP	O
the	O	DET	O
NSAIDs	O	NOUN	B
induced	O	VERB	B
HSP70	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
species	I-RNA	NOUN	I
.	O	PUNCT	O


Overall	O	ADV	O
therefore	O	ADV	O
,	O	PUNCT	O
exposure	O	NOUN	B
to	O	PART	I
NSAIDs	O	NOUN	B
leads	O	VERB	O
to	O	PART	O
a	O	DET	O
profound	O	ADJ	O
switch	O	NOUN	B
in	O	ADP	O
gene	O	NOUN	B
expression	O	NOUN	I
in	O	ADP	O
monocytic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
with	O	ADP	O
suppression	O	NOUN	B
of	O	ADP	O
genes	O	NOUN	B
involved	O	VERB	O
in	O	ADP	O
macrophage	O	NOUN	B
activation	O	NOUN	I
and	O	CCONJ	O
induction	O	NOUN	B
of	O	ADP	O
stress	B-DNA	NOUN	B
genes	I-DNA	NOUN	I
and	O	CCONJ	O
HSF1	B-protein	NOUN	B
appears	O	VERB	O
to	O	PART	O
play	O	VERB	O
a	O	DET	O
regulatory	O	ADJ	B
role	O	NOUN	O
in	O	ADP	O
these	O	DET	O
effects	O	NOUN	B
.	O	PUNCT	O


Copyright	O	NOUN	O
1999	O	NUM	O
Academic	O	PROPN	B
Press	O	PROPN	I
.	O	PUNCT	O


FGF-1	B-protein	NOUN	B
is	O	AUX	O
abundantly	O	ADV	O
expressed	O	VERB	B
in	O	ADP	O
the	O	DET	O
synovium	O	NOUN	B
in	O	ADP	O
rheumatoid	O	ADJ	B
arthritis	O	NOUN	I
and	O	CCONJ	O
in	O	ADP	O
rejecting	O	VERB	O
allografts	O	NOUN	B
,	O	PUNCT	O
sites	O	NOUN	B
of	O	ADP	O
chronic	O	ADJ	B
immune-mediated	O	ADJ	I
inflammation	O	NOUN	I
.	O	PUNCT	O


Analogous	O	ADJ	O
to	O	PART	O
costimulation	O	NOUN	B
via	O	ADP	O
CD28	B-protein	NOUN	B
,	O	PUNCT	O
this	O	DET	O
activity	O	NOUN	B
is	O	AUX	O
mediated	O	VERB	O
through	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
Rel/kappaB	B-protein	NOUN	B
,	O	PUNCT	O
a	O	DET	O
family	O	NOUN	B
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
known	O	VERB	O
to	O	PART	O
regulate	O	VERB	B
IL-2	B-protein	NOUN	B
and	O	CCONJ	O
other	O	ADJ	O
activation-inducible	B-protein	ADJ	B
proteins	I-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
signaling	O	NOUN	B
events	O	NOUN	I
that	O	PRON	O
link	O	VERB	O
FGF	B-protein	NOUN	B
receptor-1	I-protein	NOUN	I
engagement	O	NOUN	B
and	O	CCONJ	O
NF-kappaB	B-protein	NOUN	B
activation	O	NOUN	B
in	O	ADP	O
Jurkat	B-cell_line	NOUN	B
are	O	AUX	O
probably	O	ADV	O
distinct	O	ADJ	O
from	O	ADP	O
the	O	DET	O
CD28	B-protein	NOUN	B
costimulation	O	NOUN	I
pathway	O	NOUN	I
,	O	PUNCT	O
since	O	SCONJ	O
FGF-1	B-protein	NOUN	B
-induced	O	ADJ	O
Rel/kappaB	B-protein	NOUN	B
binding	I-protein	NOUN	B
proteins	I-protein	NOUN	I
do	O	AUX	O
not	O	PART	O
contain	O	VERB	O
significant	O	ADJ	B
levels	O	NOUN	B
of	O	ADP	O
c-Rel	B-protein	NOUN	B
and	O	CCONJ	O
are	O	AUX	O
not	O	PART	O
identical	O	ADJ	B
with	O	ADP	O
the	O	DET	O
CD28	B-protein	NOUN	B
response	I-protein	NOUN	I
complex	I-protein	NOUN	I
.	O	PUNCT	O


3-deazaadenosine	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
S-adenosylhomocysteine	B-protein	NOUN	B
hydrolase	I-protein	NOUN	I
inhibitor	O	NOUN	I
,	O	PUNCT	O
has	O	AUX	O
dual	O	ADJ	O
effects	O	NOUN	B
on	O	ADP	O
NF-kappaB	B-protein	NOUN	B
regulation	O	NOUN	I
.	O	PUNCT	O


Inhibition	O	NOUN	B
of	O	ADP	O
NF-kappaB	B-protein	NOUN	B
transcriptional	O	ADJ	O
activity	O	NOUN	O
and	O	CCONJ	O
promotion	O	NOUN	B
of	O	ADP	O
IkappaBalpha	B-protein	NOUN	B
degradation	O	NOUN	I
.	O	PUNCT	O


DZA	O	NOUN	B
inhibits	O	VERB	B
the	O	DET	O
transcriptional	O	ADJ	B
activity	O	NOUN	I
of	O	ADP	O
NF-kappaB	B-protein	NOUN	B
through	O	ADP	O
the	O	DET	O
hindrance	O	NOUN	O
of	O	ADP	O
p65	B-protein	NOUN	B
(	O	PUNCT	O
Rel-A	B-protein	NOUN	B
)	O	PUNCT	O
phosphorylation	O	NOUN	B
without	O	ADP	O
reduction	O	NOUN	B
of	O	ADP	O
its	O	PRON	O
nuclear	O	ADJ	B
translocation	O	NOUN	I
and	O	CCONJ	O
DNA	O	NOUN	B
binding	O	NOUN	I
activity	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
inhibitory	O	ADJ	B
effect	O	NOUN	O
of	O	ADP	O
DZA	O	NOUN	B
on	O	ADP	O
NF-kappaB	B-protein	NOUN	B
transcriptional	O	ADJ	B
activity	O	NOUN	I
is	O	AUX	O
potentiated	O	VERB	B
by	O	ADP	O
the	O	DET	O
addition	O	NOUN	O
of	O	ADP	O
homocysteine	O	NOUN	B
.	O	PUNCT	O


PROBLEM	O	NOUN	B
:	O	PUNCT	O
Due	O	ADP	O
to	O	PART	O
the	O	DET	O
lack	O	NOUN	B
of	O	ADP	O
classical	B-protein	ADJ	O
HLA	I-protein	NOUN	B
antigens	I-protein	NOUN	I
on	O	ADP	O
the	O	DET	O
trophoblast	O	NOUN	B
,	O	PUNCT	O
fetal	B-protein	ADJ	B
antigens	I-protein	NOUN	I
are	O	AUX	O
possibly	O	ADV	O
presented	O	VERB	O
in	O	ADP	O
a	O	DET	O
non	O	ADJ	B
major	B-protein	ADJ	I
histocompatibility	I-protein	NOUN	I
complex	I-protein	NOUN	I
(	O	PUNCT	O
MHC	B-protein	NOUN	B
)	O	PUNCT	O
restricted	O	ADJ	O
way	O	NOUN	O
.	O	PUNCT	O


Ninety-seven	O	NUM	O
percent	O	NOUN	O
of	O	ADP	O
gamma/delta	B-cell_type	NOUN	B
TCR+	I-cell_type	ADJ	I
pregnancy	I-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	O
expressed	O	VERB	O
progesterone	B-protein	NOUN	B
receptor	I-protein	NOUN	I
.	O	PUNCT	O


Monocyte	O	NOUN	B
adhesion	O	NOUN	I
and	O	CCONJ	O
spreading	O	NOUN	B
on	O	ADP	O
human	B-cell_type	ADJ	B
endothelial	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
is	O	AUX	O
dependent	O	ADJ	O
on	O	ADP	O
Rho	B-protein	NOUN	B
-regulated	O	ADJ	O
receptor	O	NOUN	B
clustering	O	NOUN	B
.	O	PUNCT	O


Although	O	SCONJ	O
recognized	O	VERB	O
as	O	ADP	O
fundamental	O	ADJ	O
aspects	O	NOUN	O
of	O	ADP	O
T	B-cell_type	NOUN	B
lymphocyte	I-cell_type	NOUN	I
development	O	NOUN	B
,	O	PUNCT	O
only	O	ADV	O
recently	O	ADV	O
have	O	AUX	O
the	O	DET	O
mechanisms	O	NOUN	B
governing	O	VERB	O
positive	O	ADJ	B
and	O	CCONJ	O
negative	O	ADJ	B
selection	O	NOUN	B
been	O	AUX	O
examined	O	VERB	O
at	O	ADP	O
a	O	DET	O
molecular	O	ADJ	B
level	O	NOUN	I
.	O	PUNCT	O


This	O	DET	O
review	O	NOUN	B
focuses	O	VERB	O
on	O	ADP	O
interactions	O	NOUN	B
during	O	ADP	O
thymocyte	B-cell_type	NOUN	B
maturation	O	NOUN	B
that	O	PRON	O
define	O	VERB	O
the	O	DET	O
T	O	NOUN	B
cell	O	NOUN	I
repertoire	O	NOUN	O
,	O	PUNCT	O
with	O	ADP	O
an	O	DET	O
emphasis	O	NOUN	O
placed	O	VERB	O
on	O	ADP	O
current	O	ADJ	O
literature	O	NOUN	B
within	O	ADP	O
this	O	DET	O
field	O	NOUN	B
.	O	PUNCT	O


LP	B-cell_type	NOUN	B
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
exhibit	O	VERB	O
enhanced	O	VERB	O
IL-2	B-protein	NOUN	B
secretion	O	NOUN	B
when	O	SCONJ	O
activated	O	VERB	B
through	O	ADP	O
the	O	DET	O
CD2	B-protein	NOUN	B
pathway	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
results	O	NOUN	B
reported	O	VERB	O
herein	O	ADV	O
indicate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
molecular	O	ADJ	B
mechanisms	O	NOUN	I
involved	O	VERB	O
in	O	ADP	O
CD28	B-protein	NOUN	B
cosignaling	O	NOUN	I
and	O	CCONJ	O
regulation	O	NOUN	B
of	O	ADP	O
IL-2	B-protein	NOUN	B
secretion	O	NOUN	B
in	O	ADP	O
LP	B-cell_type	NOUN	B
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
are	O	AUX	O
unique	O	ADJ	B
to	O	PART	O
that	O	DET	O
compartment	O	NOUN	B
and	O	CCONJ	O
differ	O	VERB	O
from	O	ADP	O
those	O	DET	O
seen	O	VERB	O
in	O	ADP	O
peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Upon	O	SCONJ	O
HBsAg	B-protein	NOUN	B
stimulation	O	NOUN	B
,	O	PUNCT	O
expression	O	NOUN	B
of	O	ADP	O
IFN-gamma	B-protein	NOUN	B
,	O	PUNCT	O
IL-2	B-protein	NOUN	B
,	O	PUNCT	O
IL-4	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
IL-10	B-protein	NOUN	B
was	O	AUX	O
detected	O	VERB	B
in	O	ADP	O
41	O	NUM	O
%	O	NOUN	O
,	O	PUNCT	O
8	O	NUM	O
%	O	NOUN	O
,	O	PUNCT	O
41	O	NUM	O
%	O	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
50	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
the	O	DET	O
patients	O	NOUN	B
,	O	PUNCT	O
respectively	O	ADV	O
.	O	PUNCT	O


Control	O	NOUN	B
of	O	ADP	I
cell	O	NOUN	I
cycle	O	NOUN	I
entry	O	NOUN	I
and	O	CCONJ	O
apoptosis	O	NOUN	B
in	O	ADP	O
B	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
infected	O	VERB	B
by	O	ADP	O
Epstein-Barr	O	ADJ	B
virus	O	NOUN	I
.	O	PUNCT	O


Our	O	PRON	O
data	O	NOUN	B
suggests	O	VERB	O
that	O	SCONJ	O
NF-kappaB	B-protein	NOUN	B
may	O	AUX	O
function	O	VERB	B
as	O	ADP	O
an	O	DET	O
antiapoptotic	O	ADJ	B
factor	O	NOUN	I
in	O	ADP	O
thymocytes	B-cell_type	NOUN	B
while	O	SCONJ	O
functioning	O	VERB	B
as	O	ADP	O
a	O	DET	O
proapoptotic	O	ADJ	B
factor	O	NOUN	I
in	O	ADP	O
mature	B-cell_type	ADJ	B
peripheral	I-cell_type	ADJ	B
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


To	O	PART	O
date	O	VERB	O
no	O	DET	O
SOCS	B-protein	NOUN	B
proteins	I-protein	NOUN	O
have	O	AUX	O
been	O	AUX	O
specifically	O	ADV	O
implicated	O	VERB	O
in	O	ADP	O
interleukin-2	B-protein	NOUN	B
(	O	PUNCT	O
IL-2	B-protein	NOUN	B
)	O	PUNCT	O
signaling	O	NOUN	B
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Studies	O	NOUN	B
over	O	ADP	O
the	O	DET	O
past	O	ADJ	O
few	O	ADJ	O
years	O	NOUN	B
have	O	AUX	O
identified	O	VERB	B
lymphotoxin	O	NOUN	B
as	O	ADP	O
a	O	DET	O
critical	O	ADJ	O
signaling	O	NOUN	B
molecule	O	NOUN	I
not	O	PART	O
only	O	ADV	O
for	O	ADP	O
the	O	DET	O
organogenesis	O	NOUN	B
of	O	ADP	O
secondary	O	ADJ	B
lymphoid	O	ADJ	B
tissues	O	NOUN	B
but	O	CCONJ	O
for	O	ADP	O
the	O	DET	O
maintenance	O	NOUN	B
of	O	ADP	O
aspects	O	NOUN	O
of	O	ADP	O
their	O	PRON	O
microarchitecture	O	NOUN	B
as	O	ADV	O
well	O	ADV	O
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
T	O	NOUN	B
cell	O	NOUN	I
activation	O	NOUN	B
induces	O	VERB	O
a	O	DET	O
parallel	O	ADJ	O
decline	O	NOUN	B
in	O	ADP	O
both	O	CCONJ	O
site	O	NOUN	B
alpha-	O	NOUN	O
and	O	CCONJ	O
beta-binding	O	ADJ	B
activities	O	NOUN	I
.	O	PUNCT	O


CD4+	O	ADJ	B
and	O	CCONJ	O
CD8+	B-cell_type	ADJ	B
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
differ	O	VERB	O
in	O	ADP	O
their	O	PRON	O
beta-binding	O	ADJ	B
profiles	O	NOUN	I
,	O	PUNCT	O
which	O	DET	O
may	O	AUX	O
explain	O	VERB	O
the	O	DET	O
more	O	ADV	O
pronounced	O	ADJ	O
down-regulation	O	NOUN	B
of	O	ADP	O
CD28	B-protein	NOUN	B
in	O	ADP	O
senescent	O	ADJ	B
CD8+	B-cell_type	ADJ	B
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
now	O	ADV	O
used	O	VERB	O
this	O	DET	O
assay	O	NOUN	B
to	O	PART	O
identify	O	VERB	O
another	O	DET	O
export	O	NOUN	B
factor	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
RanQ69L	B-protein	NOUN	B
preincubation	O	NOUN	B
leads	O	VERB	O
to	O	PART	O
accumulation	O	NOUN	B
of	O	ADP	O
CRM1	B-protein	NOUN	B
at	O	ADP	O
the	O	DET	O
cytoplasmic	O	ADJ	B
periphery	O	NOUN	I
of	O	ADP	O
the	O	DET	O
nuclear	B-protein	ADJ	B
pore	I-protein	NOUN	I
complex	I-protein	NOUN	I
(	O	PUNCT	O
NPC	B-protein	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
association	O	NOUN	B
with	O	ADP	I
the	O	DET	O
p62	B-protein	NOUN	B
complex	I-protein	NOUN	O
and	O	CCONJ	O
Can/Nup214	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
late	O	ADJ	B
stages	O	NOUN	I
of	O	ADP	O
erythroid	O	ADJ	B
maturation	O	NOUN	B
,	O	PUNCT	O
GPA	B-protein	NOUN	B
was	O	AUX	O
upregulated	O	VERB	B
,	O	PUNCT	O
whereas	O	SCONJ	O
CD34	B-protein	NOUN	B
,	O	PUNCT	O
c-kit	B-protein	NOUN	B
,	O	PUNCT	O
PU.1	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
GATA-2	B-protein	NOUN	B
were	O	AUX	O
barely	O	ADV	O
or	O	CCONJ	O
not	O	PART	O
detected	O	VERB	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
expression	O	NOUN	B
of	O	ADP	O
SHP-1	B-protein	NOUN	B
phosphatase	I-protein	NOUN	I
which	O	DET	O
is	O	AUX	O
a	O	DET	O
negative	O	ADJ	B
regulator	O	NOUN	B
of	O	ADP	O
cytokine	B-protein	NOUN	B
receptor	I-protein	NOUN	I
signaling	O	NOUN	I
,	O	PUNCT	O
was	O	AUX	O
lost	O	VERB	O
in	O	ADP	O
most	O	ADJ	O
IL-2	B-cell_line	NOUN	B
independent	I-cell_line	ADJ	O
cell	I-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
(	O	PUNCT	O
3/4	O	NUM	O
)	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
in	O	ADP	O
the	O	DET	O
leukemic	O	ADJ	B
ATLL	B-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
(	O	PUNCT	O
0/3	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


We	O	PRON	O
conclude	O	VERB	O
that	O	SCONJ	O
(	O	PUNCT	O
1	O	X	O
)	O	PUNCT	O
HTLV-I	O	NOUN	B
infection	O	NOUN	I
per	O	X	O
se	O	X	O
does	O	AUX	O
not	O	PART	O
result	O	VERB	O
in	O	ADP	O
a	O	DET	O
constitutive	O	ADJ	B
phosphorylation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Jak3	B-protein	NOUN	B
,	O	PUNCT	O
STAT3	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
STAT5	B-protein	NOUN	B
proteins	O	NOUN	I
;	O	PUNCT	O
(	O	PUNCT	O
2	O	X	O
)	O	PUNCT	O
malignant	O	ADJ	B
transformation	O	NOUN	I
in	O	ADP	O
at	O	ADP	O
least	O	ADJ	O
some	O	DET	O
cases	O	NOUN	B
of	O	ADP	O
ATLL	O	NOUN	B
does	O	AUX	O
not	O	PART	O
require	O	VERB	O
the	O	DET	O
constitutive	O	ADJ	B
,	O	PUNCT	O
but	O	CCONJ	O
may	O	AUX	O
require	O	VERB	O
IL-2	B-protein	NOUN	B
-induced	O	ADJ	O
,	O	PUNCT	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IL-2R	B-protein	NOUN	B
Jak/STAT	B-protein	NOUN	B
pathway	O	NOUN	I
;	O	PUNCT	O
and	O	CCONJ	O
(	O	PUNCT	O
3	O	X	O
)	O	PUNCT	O
there	O	PRON	O
are	O	AUX	O
major	O	ADJ	O
differences	O	NOUN	O
in	O	ADP	O
T-cell	O	NOUN	B
immortalization	O	NOUN	I
mechanism	O	NOUN	B
(	O	PUNCT	O
s	O	NOUN	O
)	O	PUNCT	O
which	O	DET	O
appear	O	VERB	O
to	O	PART	O
involve	O	VERB	O
SHP-1	B-protein	NOUN	B
and	O	CCONJ	O
target	O	NOUN	B
molecules	O	NOUN	O
for	O	ADP	O
rapamycin	O	NOUN	B
and	O	CCONJ	O
RAD	O	NOUN	B
.	O	PUNCT	O


Clonality	O	NOUN	B
analysis	O	NOUN	I
using	O	VERB	O
X-chromosome	B-DNA	NOUN	B
inactivation	O	NOUN	B
at	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
androgen	I-DNA	NOUN	B
receptor	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
(	O	PUNCT	O
Humara	B-DNA	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
report	O	VERB	O
that	O	SCONJ	O
in	O	ADP	O
erythroid	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
GATA-1	B-protein	NOUN	B
strongly	O	ADV	O
induces	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
anti-apoptotic	B-protein	ADJ	B
protein	I-protein	NOUN	I
bcl-xL	B-protein	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
the	O	DET	O
related	O	ADJ	O
proteins	O	NOUN	B
bcl-2	B-protein	NOUN	B
and	O	CCONJ	O
mcl-1	B-protein	NOUN	B
.	O	PUNCT	O


Consistent	O	ADJ	B
with	O	ADP	I
a	O	DET	O
role	O	NOUN	O
for	O	ADP	O
bcl-xL	B-protein	NOUN	B
in	O	ADP	O
mediating	O	VERB	O
GATA-1	B-protein	NOUN	B
-induced	O	ADJ	O
erythroid	O	ADJ	B
cell	O	NOUN	I
survival	O	NOUN	B
,	O	PUNCT	O
in	O	X	O
vitro-differentiated	B-cell_line	ADJ	B
bcl-xL-/-	I-cell_line	ADJ	B
embryonic	I-cell_line	ADJ	I
stem	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
fail	O	VERB	O
to	O	PART	O
generate	O	VERB	O
viable	O	ADJ	O
mature	O	ADJ	B
definitive	O	ADJ	O
erythroid	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
a	O	DET	O
phenotype	O	NOUN	B
resembling	O	VERB	O
that	O	DET	O
of	O	ADP	O
GATA-1	B-DNA	NOUN	B
gene	I-DNA	NOUN	O
disruption	O	NOUN	B
.	O	PUNCT	O


PI	B-protein	NOUN	B
3-kinase	I-protein	NOUN	I
also	O	ADV	O
regulates	O	VERB	B
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
p70	B-protein	NOUN	B
(	I-protein	PUNCT	O
s6k	I-protein	NOUN	B
)	I-protein	PUNCT	O
,	O	PUNCT	O
the	O	DET	O
40S	B-protein	ADJ	B
ribosomal	I-protein	ADJ	I
protein	I-protein	NOUN	I
S6	I-protein	NOUN	I
kinase	I-protein	NOUN	I
,	O	PUNCT	O
a	O	DET	O
response	O	NOUN	B
that	O	PRON	O
is	O	AUX	O
abrogated	O	VERB	O
by	O	ADP	O
the	O	DET	O
macrolide	O	NOUN	B
rapamycin	O	NOUN	B
.	O	PUNCT	O


Moreover	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	I
rapamycin	O	NOUN	B
on	O	ADP	O
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
p70	B-protein	NOUN	B
(	I-protein	PUNCT	O
s6k	I-protein	NOUN	B
)	I-protein	PUNCT	O
in	O	ADP	O
,	O	PUNCT	O
IL-2	B-protein	NOUN	B
and	O	CCONJ	O
PI	B-protein	NOUN	B
3-kinase	I-protein	NOUN	O
activation	O	NOUN	B
of	O	ADP	O
E2Fs	B-protein	NOUN	B
have	O	AUX	O
not	O	PART	O
been	O	AUX	O
characterized	O	VERB	B
.	O	PUNCT	O


Evidence	O	NOUN	B
is	O	AUX	O
also	O	ADV	O
presented	O	VERB	O
,	O	PUNCT	O
using	O	VERB	O
Fe2+/Cu2+	O	ADJ	B
ions	O	NOUN	B
,	O	PUNCT	O
that.OH	O	NOUN	O
generated	O	VERB	O
from	O	ADP	O
H2O2	O	NOUN	B
through	O	ADP	O
Fenton	O	NOUN	B
reactions	O	NOUN	I
could	O	AUX	O
be	O	AUX	O
a	O	DET	O
candidate	O	NOUN	O
oxygen	O	NOUN	O
reactive	O	ADJ	O
species	O	NOUN	O
to	O	PART	O
directly	O	ADV	O
activate	O	VERB	B
STAT3	B-protein	NOUN	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
demonstrate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
DNA	O	NOUN	B
binding	O	NOUN	I
activity	O	NOUN	I
of	O	ADP	O
STAT3	B-protein	NOUN	B
can	O	AUX	O
be	O	AUX	O
modulated	O	VERB	B
by	O	ADP	O
oxidizing	O	VERB	B
agents	O	NOUN	I
and	O	CCONJ	O
provide	O	VERB	O
a	O	DET	O
framework	O	NOUN	B
to	O	PART	O
understand	O	VERB	O
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	I
oxidative	O	ADJ	B
stress	O	NOUN	I
on	O	ADP	O
the	O	DET	O
JAK	B-protein	NOUN	B
-STAT	B-protein	ADJ	O
signaling	O	NOUN	B
pathway	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
include	O	VERB	O
the	O	DET	O
Ikaros	B-protein	NOUN	B
,	O	PUNCT	O
LKLF	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
GATA3	B-protein	NOUN	B
zinc-finger	I-protein	ADJ	B
proteins	I-protein	NOUN	I
;	O	PUNCT	O
the	O	DET	O
Ets	B-protein	NOUN	B
,	O	PUNCT	O
CREB/ATF	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
NF-kappa	B-protein	NOUN	B
B/Rel/NFAT	I-protein	NOUN	B
transcription	I-protein	NOUN	B
factors	I-protein	NOUN	I
;	O	PUNCT	O
the	O	DET	O
Stat	B-protein	NOUN	B
proteins	I-protein	NOUN	I
;	O	PUNCT	O
and	O	CCONJ	O
HMG	B-protein	NOUN	B
box	I-protein	NOUN	I
transcription	I-protein	NOUN	I
factors	I-protein	NOUN	I
such	O	ADJ	O
as	O	ADP	O
LEF1	B-protein	NOUN	B
,	O	PUNCT	O
TCF1	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
Sox4	B-protein	NOUN	B
.	O	PUNCT	O


TNF	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
expression	O	NOUN	B
induced	O	VERB	B
by	O	ADP	O
LPS	O	NOUN	B
was	O	AUX	O
decreased	O	VERB	B
when	O	SCONJ	O
the	O	DET	O
pre-treatment	O	NOUN	B
of	O	ADP	O
PBMC	B-cell_type	NOUN	B
with	O	ADP	O
IL-10	B-protein	NOUN	B
was	O	AUX	O
performed	O	VERB	O
on	O	ADP	O
plastic	O	NOUN	B
,	O	PUNCT	O
whereas	O	SCONJ	O
this	O	DET	O
was	O	AUX	O
not	O	PART	O
the	O	DET	O
case	O	NOUN	B
when	O	SCONJ	O
cells	O	NOUN	B
were	O	AUX	O
pre-cultured	O	ADJ	B
with	O	ADP	O
IL-10	B-protein	NOUN	B
on	O	ADP	O
Teflon	O	NOUN	B
.	O	PUNCT	O


Cell	O	NOUN	O
growth-regulated	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
mammalian	B-DNA	ADJ	B
MCM5	I-DNA	NOUN	B
and	I-DNA	CCONJ	O
MCM6	I-DNA	NOUN	B
genes	I-DNA	NOUN	I
mediated	O	VERB	O
by	O	ADP	O
the	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
E2F	B-protein	NOUN	I
.	O	PUNCT	O


Human	B-DNA	ADJ	B
MCM5	I-DNA	NOUN	B
and	I-DNA	CCONJ	O
MCM6	I-DNA	NOUN	B
promoters	I-DNA	NOUN	B
with	O	ADP	O
mutation	O	NOUN	B
in	O	ADP	O
the	O	DET	O
E2F	B-DNA	NOUN	B
sites	I-DNA	NOUN	I
failed	O	VERB	B
in	O	ADP	O
promoter	O	NOUN	B
regulation	O	NOUN	I
following	O	VERB	O
serum	O	NOUN	B
stimulation	O	NOUN	I
and	O	CCONJ	O
exogenous	O	ADJ	B
E2F	B-protein	NOUN	B
expression	O	NOUN	I
.	O	PUNCT	O


It	O	PRON	O
is	O	AUX	O
known	O	VERB	O
that	O	SCONJ	O
sulfated	O	VERB	B
polysaccharides	O	NOUN	I
can	O	AUX	O
mimic	O	VERB	O
the	O	DET	O
action	O	NOUN	B
of	O	ADP	O
common	B-protein	ADJ	O
T-cell	I-protein	NOUN	B
mitogens	I-protein	NOUN	I
.	O	PUNCT	O


To	O	PART	O
investigate	O	VERB	B
the	O	DET	O
molecular	O	ADJ	B
basis	O	NOUN	I
of	O	ADP	O
the	O	DET	O
mitogenic	O	ADJ	B
effect	O	NOUN	O
of	O	ADP	O
high	O	ADJ	O
molecular	O	ADJ	B
weight	O	NOUN	I
dextran	O	NOUN	I
sulfate	O	NOUN	I
(	O	PUNCT	O
HMDS	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
monocyte-derived	B-cell_type	ADJ	B
macrophages	I-cell_type	NOUN	I
were	O	AUX	O
transfected	O	VERB	B
with	O	ADP	O
recombinant	B-DNA	ADJ	B
plasmid	I-DNA	NOUN	I
containing	O	VERB	O
chloramphenicol	B-DNA	NOUN	B
acetyl	I-DNA	ADJ	I
transferase	I-DNA	NOUN	I
(	I-DNA	PUNCT	O
CAT	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
reporter	I-DNA	NOUN	O
gene	I-DNA	NOUN	O
under	O	ADP	O
the	O	DET	O
control	O	NOUN	B
of	O	ADP	O
the	O	DET	O
HIV-1	B-DNA	NOUN	B
long	I-DNA	ADJ	B
terminal	I-DNA	ADJ	I
repeat	I-DNA	NOUN	I
(	I-DNA	PUNCT	I
LTR	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
promoter	I-DNA	NOUN	B
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
regulated	O	VERB	O
by	O	ADP	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
NF-kappaB	B-protein	NOUN	I
.	O	PUNCT	O


Previous	O	ADJ	O
studies	O	NOUN	B
have	O	AUX	O
implicated	O	VERB	O
activation	O	NOUN	B
of	O	ADP	O
both	O	CCONJ	O
protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
C	I-protein	NOUN	I
(	O	PUNCT	O
PKC	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
protein	B-protein	NOUN	B
tyrosine	I-protein	NOUN	I
kinases	I-protein	NOUN	I
(	O	PUNCT	O
PTK	B-protein	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
LPS-induced	O	ADJ	B
NF-kappaB	B-protein	NOUN	B
activation	O	NOUN	B
and	O	CCONJ	O
TNF-alpha	B-protein	NOUN	B
production	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
hypothesized	O	VERB	O
that	O	SCONJ	O
inhibition	O	NOUN	B
of	O	ADP	O
either	O	CCONJ	O
PKC	B-protein	NOUN	B
or	O	CCONJ	O
PTK	B-protein	NOUN	B
would	O	AUX	O
decrease	O	VERB	B
LPS-induced	O	ADJ	B
NF-kappaB	B-protein	NOUN	O
DNA	O	NOUN	B
binding	O	NOUN	I
and	O	CCONJ	O
TNF-alpha	B-protein	NOUN	B
release	O	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


MATERIALS	O	NOUN	O
AND	O	CCONJ	O
METHODS	O	NOUN	O
:	O	PUNCT	O
Human	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
were	O	AUX	O
stimulated	O	VERB	B
with	O	ADP	O
PMA	O	NOUN	B
(	O	PUNCT	O
50	O	NUM	O
ng/ml	O	NOUN	O
)	O	PUNCT	O
alone	O	ADV	O
or	O	CCONJ	O
LPS	O	NOUN	B
(	O	PUNCT	O
100	O	NUM	O
ng/ml	O	NOUN	O
)	O	PUNCT	O
with	O	ADP	O
and	O	CCONJ	O
without	O	ADP	O
a	O	DET	O
nonspecific	O	ADJ	B
serine/threonine	B-protein	NOUN	B
protein	I-protein	NOUN	I
kinase	I-protein	NOUN	I
inhibitor	O	NOUN	I
staurosporine	O	NOUN	B
(	O	PUNCT	O
Stauro	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
a	O	DET	O
specific	O	ADJ	O
pan-	O	VERB	B
PKC	B-protein	NOUN	B
inhibitor	O	NOUN	I
bisindolylmaleimide	O	NOUN	B
(	O	PUNCT	O
Bis	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
or	O	CCONJ	O
an	O	DET	O
inhibitor	O	NOUN	B
of	O	ADP	O
PTK	B-protein	NOUN	B
genistein	O	NOUN	B
(	O	PUNCT	O
Gen	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
effects	O	NOUN	B
of	O	ADP	I
GDSP	O	NOUN	B
on	O	ADP	O
pancreatic	O	ADJ	B
weight	O	NOUN	I
,	O	PUNCT	O
serum	B-protein	NOUN	B
amylase	I-protein	NOUN	I
and	I-protein	CCONJ	O
lipase	I-protein	NOUN	B
,	O	PUNCT	O
morphologic	O	ADJ	B
changes	O	NOUN	I
in	O	ADP	O
the	O	DET	O
pancreas	O	NOUN	B
,	O	PUNCT	O
neutrophil	O	NOUN	B
infiltration	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
KB	I-protein	NOUN	I
(	O	PUNCT	O
NF-KB	B-protein	NOUN	B
)	O	PUNCT	O
activation	O	NOUN	B
were	O	AUX	O
measured	O	VERB	B
in	O	ADP	O
rats	O	NOUN	B
infused	O	VERB	B
with	O	ADP	O
supramaximal	O	ADJ	B
dose	O	NOUN	I
of	O	ADP	O
cerulein	O	NOUN	B
(	O	PUNCT	O
5	O	NUM	O
(	O	PUNCT	O
g/kg/h	O	NOUN	B
)	O	PUNCT	O
for	O	ADP	O
6	O	NUM	O
h	O	NOUN	O
.	O	PUNCT	O


GDSP	O	NOUN	B
also	O	ADV	O
completely	O	ADV	O
inhibited	O	VERB	B
superoxide	O	NOUN	B
formation	O	NOUN	I
in	O	ADP	O
the	O	DET	O
human	B-cell_type	ADJ	B
neutrophils	I-cell_type	NOUN	B
stimulated	O	VERB	B
by	O	ADP	O
N-formyl-methionine-leucine-phenyl-alanine	O	NOUN	B
(	O	PUNCT	O
fMLP	O	NOUN	B
)	O	PUNCT	O
or	O	CCONJ	O
12-O-tetradecanoylphorbol-13-acetate	O	NOUN	B
(	O	PUNCT	O
TPA	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
demonstrate	O	VERB	O
a	O	DET	O
beneficial	O	ADJ	O
effect	O	NOUN	B
of	O	ADP	O
GDSP	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
novel	O	ADJ	O
specific	O	ADJ	O
elastase	O	NOUN	B
inhibitor	O	NOUN	I
,	O	PUNCT	O
on	O	ADP	O
the	O	DET	O
development	O	NOUN	B
of	O	ADP	O
rat	O	NOUN	B
cerulein	O	NOUN	B
pancreatitis	O	NOUN	B
.	O	PUNCT	O


Given	O	VERB	O
the	O	DET	O
deleterious	O	ADJ	B
effects	O	NOUN	I
to	O	PART	O
the	O	DET	O
host	O	NOUN	B
of	O	ADP	O
TNF-alpha	B-protein	NOUN	B
,	O	PUNCT	O
it	O	PRON	O
has	O	AUX	O
been	O	AUX	O
postulated	O	VERB	O
that	O	SCONJ	O
TNF-alpha	B-protein	NOUN	B
gene	O	NOUN	O
expression	O	NOUN	B
must	O	AUX	O
be	O	AUX	O
tightly	O	ADV	O
regulated	O	VERB	O
.	O	PUNCT	O


Our	O	PRON	O
previous	O	ADJ	O
studies	O	NOUN	B
pertaining	O	VERB	O
to	O	PART	O
macrophage	O	NOUN	B
response	O	NOUN	O
to	O	PART	O
LPS	O	NOUN	B
identified	O	VERB	B
a	O	DET	O
novel	O	ADJ	O
DNA-binding	B-protein	ADJ	B
domain	I-protein	NOUN	I
located	O	ADJ	O
from	O	ADP	O
-550	O	NUM	O
to	O	PART	O
-487	O	NUM	O
in	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
TNF-alpha	I-DNA	NOUN	B
promoter	I-DNA	NOUN	B
that	O	PRON	O
contains	O	VERB	O
transcriptional	O	ADJ	B
activity	O	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
lacks	O	VERB	O
any	O	DET	O
known	O	ADJ	O
NF-kappaB	B-protein	NOUN	B
-binding	B-DNA	ADJ	O
sites	I-DNA	NOUN	B
.	O	PUNCT	O


A	O	DET	O
novel	O	ADJ	O
cDNA	B-DNA	NOUN	B
clone	I-DNA	NOUN	O
(	O	PUNCT	O
1.8	O	NUM	O
kb	O	NOUN	O
)	O	PUNCT	O
was	O	AUX	O
isolated	O	VERB	B
and	O	CCONJ	O
fully	O	ADV	O
sequenced	O	VERB	B
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
high	O	ADJ	O
level	O	NOUN	B
of	O	ADP	O
expression	O	NOUN	B
of	O	ADP	O
LITAF	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
was	O	AUX	O
observed	O	VERB	O
predominantly	O	ADV	O
in	O	ADP	O
the	O	DET	O
placenta	O	NOUN	B
,	O	PUNCT	O
peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
leukocytes	I-cell_type	NOUN	B
,	O	PUNCT	O
lymph	O	NOUN	B
nodes	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
spleen	O	NOUN	B
.	O	PUNCT	O


Together	O	ADV	O
,	O	PUNCT	O
these	O	DET	O
findings	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
LITAF	B-protein	NOUN	B
plays	O	VERB	O
an	O	DET	O
important	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
TNF-alpha	I-DNA	NOUN	B
gene	I-DNA	NOUN	I
and	O	CCONJ	O
proposes	O	VERB	O
a	O	DET	O
new	O	ADJ	O
mechanism	O	NOUN	B
to	O	PART	O
control	O	VERB	O
TNF-alpha	B-protein	NOUN	B
gene	O	NOUN	O
expression	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
immunogenetic	O	ADJ	B
basis	O	NOUN	O
of	O	ADP	O
severe	O	ADJ	B
infections	O	NOUN	B
caused	O	VERB	O
by	O	ADP	O
bacille	O	X	B
Calmette-Guerin	O	X	I
vaccine	O	NOUN	B
and	O	CCONJ	O
environmental	O	ADJ	B
mycobacteria	O	NOUN	I
in	O	ADP	O
humans	O	NOUN	B
remains	O	VERB	O
largely	O	ADV	O
unknown	O	ADJ	O
.	O	PUNCT	O


The	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
NF-kappaB	B-protein	NOUN	I
has	O	AUX	O
been	O	AUX	O
shown	O	VERB	O
to	O	PART	O
play	O	VERB	O
a	O	DET	O
role	O	NOUN	O
in	O	ADP	O
protecting	O	VERB	B
cells	O	NOUN	I
against	O	ADP	O
death	O	NOUN	B
mediated	O	VERB	O
by	O	ADP	O
TNF	B-protein	NOUN	B
We	O	PRON	O
show	O	VERB	O
here	O	ADV	O
that	O	SCONJ	O
NF-kappaB	B-protein	NOUN	B
also	O	ADV	O
has	O	AUX	O
a	O	DET	O
role	O	NOUN	O
in	O	ADP	O
regulating	O	VERB	B
Fas	B-protein	NOUN	B
/	O	PUNCT	O
APO-1	B-protein	PROPN	B
/	O	SYM	O
CD95	B-protein	NOUN	B
-mediated	O	ADJ	O
death	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
major	O	ADJ	O
pathway	O	NOUN	B
of	O	ADP	O
peripheral	B-cell_type	ADJ	B
T	I-cell_type	NOUN	I
cell	I-cell_type	NOUN	I
death	O	NOUN	O
.	O	PUNCT	O


Correspondingly	O	ADV	O
,	O	PUNCT	O
transfection	O	NOUN	B
of	O	ADP	O
p50	B-protein	NOUN	B
and	O	CCONJ	O
p65	B-protein	NOUN	B
provided	O	VERB	O
considerable	O	ADJ	O
protection	O	NOUN	B
from	O	ADP	O
TCR-mediated	O	ADJ	B
apoptosis	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
blocking	O	VERB	B
TNF	B-protein	NOUN	B
,	O	PUNCT	O
itself	O	PRON	O
a	O	DET	O
positive	O	ADJ	B
regulator	O	NOUN	B
of	O	ADP	O
NF-kappaB	B-protein	NOUN	B
,	O	PUNCT	O
with	O	ADP	O
neutralizing	B-protein	VERB	B
antibodies	I-protein	NOUN	I
renders	O	VERB	O
the	O	DET	O
cells	O	NOUN	B
more	O	ADV	O
susceptible	O	ADJ	B
to	O	PART	O
anti-Fas-mediated	O	ADJ	B
apoptosis	O	NOUN	B
.	O	PUNCT	O


Whereas	O	SCONJ	O
IL-4	B-protein	NOUN	B
appears	O	VERB	O
to	O	PART	O
repress	O	VERB	B
functional	O	ADJ	B
IL-12	B-protein	NOUN	B
signaling	O	NOUN	O
through	O	ADP	O
inhibition	O	NOUN	B
of	O	ADP	O
IL-12R	B-protein	NOUN	B
beta	I-protein	NOUN	I
2	I-protein	NUM	I
expression	O	NOUN	B
,	O	PUNCT	O
IFN-gamma	B-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
mouse	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
IFN-alpha	B-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
human	O	NOUN	B
appear	O	VERB	O
to	O	PART	O
induce	O	VERB	B
IL-12R	B-protein	NOUN	B
beta	I-protein	NOUN	I
2	I-protein	NUM	I
expression	O	NOUN	B
and	O	CCONJ	O
promote	O	VERB	B
IL-12	B-protein	NOUN	B
responsiveness	O	NOUN	B
.	O	PUNCT	O


Estrogen	O	NOUN	B
and	O	CCONJ	O
progesterone	O	NOUN	B
induction	O	NOUN	B
of	O	ADP	O
survival	O	NOUN	B
of	O	ADP	O
monoblastoid	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
undergoing	O	VERB	O
TNF-alpha	B-protein	NOUN	B
-induced	O	ADJ	O
apoptosis	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
female	O	ADJ	B
steroid	O	NOUN	B
hormones	O	NOUN	I
estrogen	O	NOUN	B
(	O	PUNCT	O
E2	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
progesterone	O	NOUN	B
(	O	PUNCT	O
Prog	O	NOUN	B
)	O	PUNCT	O
are	O	AUX	O
known	O	VERB	O
to	O	PART	O
modulate	O	VERB	B
the	O	DET	O
reactivity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
immune	O	ADJ	B
system	O	NOUN	I
;	O	PUNCT	O
recently	O	ADV	O
it	O	PRON	O
has	O	AUX	O
been	O	AUX	O
demonstrated	O	VERB	O
that	O	SCONJ	O
they	O	PRON	O
can	O	AUX	O
regulate	O	VERB	O
induction	O	NOUN	B
of	O	ADP	O
apoptosis	O	NOUN	B
of	O	ADP	O
endothelial	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
osteoblasts	B-cell_type	NOUN	B
.	O	PUNCT	O


Estrogen	O	NOUN	B
and	O	CCONJ	O
progesterone	O	NOUN	B
induction	O	NOUN	B
of	O	ADP	O
survival	O	NOUN	B
of	O	ADP	O
monoblastoid	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
undergoing	O	VERB	O
TNF-alpha	B-protein	NOUN	B
-inuced	O	ADJ	O
apoptosis	O	NOUN	B
.	O	PUNCT	O


Dicarba-closo-dodecaboranes	O	NOUN	B
as	O	ADP	O
a	O	DET	O
pharmacophore	O	NOUN	B
.	O	PUNCT	O


Efforts	O	NOUN	O
to	O	PART	O
pinpoint	O	VERB	O
the	O	DET	O
exact	O	ADJ	O
site	O	NOUN	O
of	O	ADP	O
action	O	NOUN	B
and	O	CCONJ	O
specificity	O	NOUN	B
of	O	ADP	O
HePTP	B-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
signaling	O	NOUN	B
cascade	O	NOUN	I
revealed	O	VERB	O
that	O	SCONJ	O
HePTP	B-protein	NOUN	B
acts	O	VERB	O
directly	O	ADV	O
on	O	ADP	O
the	O	DET	O
mitogen-activated	B-protein	ADJ	B
protein	I-protein	NOUN	I
(	I-protein	PUNCT	O
MAP	I-protein	NOUN	B
)	I-protein	PUNCT	O
kinases	I-protein	NOUN	O
Erk1	B-protein	NOUN	O
and	I-protein	CCONJ	O
2	I-protein	NUM	O
and	O	CCONJ	O
consequently	O	ADV	O
reduces	O	VERB	B
the	O	DET	O
magnitude	O	NOUN	B
and	O	CCONJ	O
duration	O	NOUN	B
of	O	ADP	O
their	O	PRON	O
catalytic	O	ADJ	B
activation	O	NOUN	I
in	O	ADP	O
intact	B-cell_type	ADJ	B
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
HePTP	B-protein	NOUN	B
had	O	AUX	O
no	O	DET	B
effects	O	NOUN	I
on	O	ADP	O
N-terminal	B-protein	ADJ	B
c-Jun	I-protein	NOUN	I
kinase	I-protein	NOUN	I
or	O	CCONJ	O
on	O	ADP	O
events	O	NOUN	B
upstream	O	ADJ	B
of	O	ADP	O
the	O	DET	O
MAP	O	NOUN	B
kinases	O	NOUN	I
.	O	PUNCT	O


Optimal	O	ADJ	B
T	O	NOUN	B
cell	O	NOUN	I
activation	O	NOUN	B
requires	O	VERB	O
two	O	NUM	O
signals	O	NOUN	B
,	O	PUNCT	O
one	O	NUM	O
generated	O	VERB	O
by	O	ADP	O
TCR	B-protein	NOUN	B
and	O	CCONJ	O
another	O	DET	O
by	O	ADP	O
the	O	DET	O
CD28	B-protein	NOUN	B
costimulatory	I-protein	ADJ	I
receptor	I-protein	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
PMA-induced	O	ADJ	B
JNK	B-protein	NOUN	B
activation	O	NOUN	B
is	O	AUX	O
inhibited	O	VERB	B
by	O	ADP	O
Ca2+	O	NOUN	B
ionophore	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
UT-7	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
exhibits	O	VERB	O
both	O	CCONJ	O
erythroid	O	ADJ	B
and	O	CCONJ	O
megakaryocytic	O	ADJ	B
characteristics	O	NOUN	B
and	O	CCONJ	O
can	O	AUX	O
be	O	AUX	O
induced	O	VERB	B
to	O	PART	O
differentiate	O	VERB	B
along	O	ADP	O
the	O	DET	O
erythroid	O	ADJ	B
pathway	O	NOUN	I
by	O	ADP	O
Epo	B-protein	NOUN	B
or	O	CCONJ	O
the	O	DET	O
megakaryocytic	O	ADJ	B
pathway	O	NOUN	I
by	O	ADP	O
phorbol	O	NOUN	B
myristic	O	ADJ	B
acetate	O	NOUN	I
.	O	PUNCT	O


Epo	B-protein	NOUN	B
caused	O	VERB	O
an	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
the	O	DET	O
proportion	O	NOUN	B
of	O	ADP	O
cells	O	NOUN	B
expressing	O	VERB	B
cell	O	NOUN	B
surface	O	NOUN	I
glycophorin	B-protein	NOUN	B
A	I-protein	NOUN	I
(	O	PUNCT	O
GPA	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
up-regulated	O	VERB	B
beta-	B-protein	NOUN	B
and	I-protein	CCONJ	O
gamma-globin	I-protein	NOUN	B
by	O	ADP	O
several	O	ADJ	O
fold	O	ADV	O
.	O	PUNCT	O


Both	O	CCONJ	O
haemin	O	NOUN	B
and	O	CCONJ	O
delta-ALA	O	NOUN	B
caused	O	VERB	O
a	O	DET	O
de	O	X	O
novo	O	X	O
increase	O	NOUN	B
in	O	ADP	O
alpha-globin	B-protein	NOUN	B
expression	O	NOUN	I
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
enhancing	O	VERB	O
Epo	B-protein	NOUN	B
-induced	O	ADJ	O
beta-globin	B-protein	NOUN	B
expression	O	NOUN	B
,	O	PUNCT	O
leading	O	VERB	O
to	O	PART	O
a	O	DET	O
marked	O	ADJ	O
increase	O	NOUN	B
in	O	ADP	O
haemoglobin	O	NOUN	B
production	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
,	O	PUNCT	O
in	O	ADP	O
this	O	DET	O
inflammatory	O	ADJ	B
model	O	NOUN	I
,	O	PUNCT	O
initial	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
NF-kappaB	B-protein	NOUN	B
occurs	O	VERB	O
in	O	ADP	O
alveolar	B-cell_type	ADJ	B
macrophages	I-cell_type	NOUN	I
and	O	CCONJ	O
the	O	DET	O
ensuing	O	VERB	O
production	O	NOUN	B
of	O	ADP	O
TNF-alpha	B-protein	NOUN	B
may	O	AUX	O
propagate	O	VERB	O
NF-kappaB	B-protein	NOUN	B
activation	O	NOUN	B
to	O	PART	O
other	O	ADJ	O
cell	O	NOUN	B
types	O	NOUN	I
in	O	ADP	O
the	O	DET	O
lung	O	NOUN	B
.	O	PUNCT	O


Interferon-beta	B-protein	NOUN	B
mediates	O	VERB	O
stromal	O	ADJ	B
cell	O	NOUN	I
rescue	O	NOUN	O
of	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
from	O	ADP	O
apoptosis	O	NOUN	B
.	O	PUNCT	O


Cytokines	B-protein	NOUN	B
that	O	PRON	O
bind	O	VERB	B
to	O	PART	O
the	O	DET	O
common	O	ADJ	O
gamma	B-protein	NOUN	B
chain	I-protein	NOUN	I
of	O	ADP	I
the	O	DET	O
IL-2	B-protein	NOUN	B
receptor	O	NOUN	I
promote	O	VERB	B
the	O	DET	O
survival	O	NOUN	B
of	O	ADP	O
T	B-cell_type	NOUN	B
cell	I-cell_type	NOUN	I
blasts	I-cell_type	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
also	O	ADV	O
induce	O	VERB	B
proliferation	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
also	O	ADV	O
show	O	VERB	O
that	O	SCONJ	O
this	O	DET	O
mechanism	O	NOUN	B
may	O	AUX	O
play	O	VERB	O
a	O	DET	O
fundamental	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
persistence	O	NOUN	B
of	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
at	O	ADP	O
sites	O	NOUN	B
of	O	ADP	O
chronic	O	ADJ	B
inflammation	O	NOUN	I
;	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
chronic	O	ADJ	B
inflammation	O	NOUN	I
is	O	AUX	O
an	O	DET	O
aberrant	O	ADJ	B
consequence	O	NOUN	O
of	O	ADP	O
immunological	O	ADJ	B
memory	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
authors	O	NOUN	B
have	O	AUX	O
previously	O	ADV	O
demonstrated	O	VERB	O
that	O	SCONJ	O
in	O	X	B
vitro	O	X	I
exposure	O	NOUN	B
of	O	ADP	I
mononuclear	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
to	O	PART	O
DFX	O	NOUN	B
decreases	O	VERB	B
the	O	DET	O
bioavailability	O	NOUN	B
of	O	ADP	O
tumour	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor	I-protein	NOUN	I
alpha	I-protein	NOUN	I
(	O	PUNCT	O
TNF-alpha	B-protein	NOUN	B
)	O	PUNCT	O
which	O	DET	O
has	O	AUX	O
a	O	DET	O
stimulatory	O	ADJ	B
effect	O	NOUN	I
on	O	ADP	O
HIV-1	O	NOUN	B
replication	O	NOUN	B
.	O	PUNCT	O


Smad6	B-protein	NOUN	B
and	O	CCONJ	O
Smad7	B-protein	NOUN	B
prevent	O	VERB	O
ligand-induced	O	ADJ	B
activation	O	NOUN	I
of	O	ADP	O
signal-transducing	B-protein	ADJ	B
Smad	I-protein	NOUN	I
proteins	I-protein	NOUN	I
in	O	ADP	O
the	O	DET	O
transforming	B-protein	VERB	B
growth	I-protein	NOUN	I
factor-beta	I-protein	NOUN	I
family	I-protein	NOUN	I
.	O	PUNCT	O


These	O	DET	O
conflicting	O	VERB	O
observations	O	NOUN	B
may	O	AUX	O
be	O	AUX	O
due	O	ADJ	O
to	O	PART	O
different	O	ADJ	O
effects	O	NOUN	B
of	O	ADP	O
anti-inflammatory	O	ADJ	B
agents	O	NOUN	I
on	O	ADP	O
adhesion	O	NOUN	B
molecule	O	NOUN	I
and	O	CCONJ	O
Hsp	O	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
EC	B-cell_type	NOUN	B
,	O	PUNCT	O
respectively	O	ADV	O
.	O	PUNCT	O


All	O	DET	O
agents	O	NOUN	B
tested	O	VERB	B
induced	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
Hsp60	B-protein	NOUN	B
6	O	NUM	O
hr	O	NOUN	O
after	O	ADP	O
application	O	NOUN	B
.	O	PUNCT	O


METHODS	O	NOUN	O
:	O	PUNCT	O
Ten	O	NUM	O
atopic	O	ADJ	B
asthmatic	O	ADJ	I
subjects	O	NOUN	B
were	O	AUX	O
treated	O	VERB	B
with	O	ADP	I
FP	O	NOUN	B
250	O	NUM	O
microg	O	NOUN	O
twice	O	ADV	O
daily	O	ADV	O
for	O	ADP	O
4	O	NUM	O
weeks	O	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
detected	O	VERB	B
a	O	DET	O
significant	O	ADJ	O
reduction	O	NOUN	B
of	O	ADP	O
the	O	DET	O
GR	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
levels	O	NOUN	O
in	O	ADP	O
the	O	DET	O
endobronchial	O	ADJ	B
biopsy	O	NOUN	I
specimens	O	NOUN	I
after	O	ADP	O
FP	O	NOUN	B
treatment	O	NOUN	B
(	O	PUNCT	O
36.6	O	NUM	O
+/-	O	CCONJ	O
23.1	O	NUM	O
and	O	CCONJ	O
25.0	O	NUM	O
+/-	O	CCONJ	O
10.9	O	NUM	O
amol	O	NOUN	O
GR	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
/microg	O	NOUN	O
RNA	O	NOUN	B
,	O	PUNCT	O
respectively	O	ADV	O
;	O	PUNCT	O
P	O	NOUN	O
<	O	X	O
.01	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


CONCLUSION	O	NOUN	O
:	O	PUNCT	O
The	O	DET	O
results	O	NOUN	B
in	O	ADP	O
this	O	DET	O
study	O	NOUN	B
confirm	O	VERB	O
the	O	DET	O
potency	O	NOUN	B
of	O	ADP	O
the	O	DET	O
inhaled	O	VERB	B
corticosteroid	O	NOUN	I
FP	O	NOUN	I
and	O	CCONJ	O
provide	O	VERB	O
evidence	O	NOUN	B
for	O	ADP	O
a	O	DET	O
considerable	O	ADJ	O
tissue-specific	O	ADJ	B
interindividual	O	ADJ	O
variation	O	NOUN	B
in	O	ADP	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
GR	B-protein	NOUN	B
.	O	PUNCT	O


When	O	SCONJ	O
activated	O	VERB	B
,	O	PUNCT	O
glucocorticoid	B-protein	NOUN	B
receptors	I-protein	NOUN	I
form	O	VERB	O
a	O	DET	O
dimer	B-protein	NOUN	B
and	O	CCONJ	O
bind	O	VERB	B
to	O	PART	O
DNA	O	NOUN	B
after	O	ADP	O
migration	O	NOUN	B
into	O	ADP	O
the	O	DET	O
nucleus	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
influence	O	NOUN	B
on	O	ADP	O
interleukin	B-protein	NOUN	B
(	I-protein	PUNCT	I
IL	I-protein	NOUN	B
)	I-protein	PUNCT	O
-2	I-protein	NUM	O
,	O	PUNCT	O
IL-4	B-protein	NOUN	B
and	O	CCONJ	O
interferon	B-protein	NOUN	B
(	I-protein	PUNCT	O
IFN	I-protein	NOUN	B
)	I-protein	PUNCT	O
-gamma	I-protein	NOUN	O
production	O	NOUN	B
;	O	PUNCT	O
IL-2	B-protein	NOUN	B
receptor	I-protein	NOUN	I
(	I-protein	PUNCT	O
IL-2R	I-protein	NOUN	B
)	I-protein	PUNCT	O
alpha	I-protein	NOUN	B
-	O	PUNCT	O
,	O	PUNCT	O
beta	B-protein	PROPN	B
-	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
gamma-chain	B-protein	NOUN	B
;	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
signaling	B-protein	NOUN	B
pathway	I-protein	NOUN	I
molecules	I-protein	NOUN	O
Janus	B-protein	NOUN	B
kinase	I-protein	NOUN	I
(	B-protein	PUNCT	O
Jak	I-protein	NOUN	B
)	I-protein	PUNCT	O
1	I-protein	NUM	O
,	O	PUNCT	O
Jak3	B-protein	NOUN	B
,	O	PUNCT	O
signal	O	NOUN	B
transducers	O	NOUN	I
and	O	CCONJ	O
activators	B-protein	NOUN	B
of	I-protein	ADP	O
transcription	I-protein	NOUN	O
(	B-protein	PUNCT	O
Stat	I-protein	NOUN	O
)	I-protein	PUNCT	O
1	I-protein	NUM	O
,	O	PUNCT	O
Stat3	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
Stat5	B-protein	NOUN	B
should	O	AUX	O
be	O	AUX	O
investigated	O	VERB	B
.	O	PUNCT	O


METHOD	O	NOUN	B
OF	O	ADP	O
STUDY	O	NOUN	O
:	O	PUNCT	O
For	O	ADP	O
assessment	O	NOUN	B
of	O	ADP	O
IL	O	NOUN	B
production	O	NOUN	B
,	O	PUNCT	O
whole	O	ADJ	O
peripheral	O	ADJ	B
venous	O	ADJ	B
blood	O	NOUN	I
from	O	ADP	O
healthy	O	ADJ	B
donors	O	NOUN	I
was	O	AUX	O
stimulated	O	VERB	B
with	O	ADP	O
phorbol-myristate-acetate	O	NOUN	B
and	O	CCONJ	O
ionomycine	O	NOUN	B
.	O	PUNCT	O


RESULTS	O	NOUN	B
:	O	PUNCT	O
Phorbol-myristate-acetate	O	NOUN	B
and	O	CCONJ	O
ionomycine	O	NOUN	B
strongly	O	ADV	O
increase	O	VERB	B
the	O	DET	O
percent-age	O	NOUN	B
of	O	ADP	O
IL-2+	B-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
;	O	PUNCT	O
an	O	DET	O
additional	O	ADJ	O
50	O	NUM	O
%	O	NOUN	O
HCSs	O	NOUN	B
significantly	O	ADV	O
suppresses	O	VERB	B
the	O	DET	O
percentage	O	NOUN	B
to	O	PART	O
,	O	PUNCT	O
or	O	CCONJ	O
below	O	ADP	O
the	O	DET	O
level	O	NOUN	B
of	O	ADP	O
unstimulated	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
we	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
inducible	O	ADJ	B
transcriptional	O	ADJ	B
activity	O	NOUN	I
of	O	ADP	O
the	O	DET	O
FasL	B-DNA	NOUN	B
reporter	I-DNA	NOUN	I
is	O	AUX	O
abolished	O	VERB	O
by	O	ADP	O
specific	O	ADJ	O
inhibitors	O	NOUN	B
of	O	ADP	O
NF-kappaB	B-protein	NOUN	B
activation	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
Th2-type	B-protein	ADJ	B
cytokines	I-protein	NOUN	B
,	O	PUNCT	O
interleukin-4	B-protein	NOUN	B
(	O	PUNCT	O
IL-4	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
interleukin-13	B-protein	NOUN	B
(	O	PUNCT	O
IL-13	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
induce	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
a	O	DET	O
distinct	O	ADJ	O
subset	O	NOUN	O
of	O	ADP	O
genes	O	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
,	O	PUNCT	O
including	O	VERB	O
FcepsilonRIIb	B-protein	NOUN	B
(	O	PUNCT	O
CD23	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
15-lipoxygenase	B-protein	NOUN	B
,	O	PUNCT	O
IL-1	B-protein	NOUN	B
receptor	I-protein	NOUN	I
antagonist	I-protein	NOUN	I
(	O	PUNCT	O
IL-1ra	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
type	B-protein	NOUN	B
I	I-protein	NUM	I
and	I-protein	CCONJ	O
type	I-protein	NOUN	B
II	I-protein	NUM	I
IL-1	I-protein	NOUN	I
receptors	I-protein	NOUN	I
(	O	PUNCT	O
IL-1R	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


We	O	PRON	O
also	O	ADV	O
discuss	O	VERB	O
our	O	PRON	O
recent	O	ADJ	O
findings	O	NOUN	B
that	O	SCONJ	O
type	B-protein	NOUN	B
I	I-protein	NUM	I
and	I-protein	CCONJ	O
type	I-protein	NOUN	B
II	I-protein	NUM	I
IFNs	I-protein	NOUN	I
suppress	O	VERB	B
IL-4	B-protein	NOUN	B
/	O	SYM	O
IL-13	B-protein	NOUN	B
-inducible	O	ADJ	O
gene	O	NOUN	B
expression	O	NOUN	I
by	O	ADP	O
inhibiting	O	VERB	B
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	I
and	O	CCONJ	O
nuclear	O	ADJ	B
translocation	O	NOUN	I
of	O	ADP	O
STAT6	B-protein	NOUN	B
.	O	PUNCT	O


HLA	B-protein	NOUN	B
class	I-protein	NOUN	I
I	I-protein	NUM	I
-mediated	O	ADJ	O
induction	O	NOUN	B
of	O	ADP	O
cell	O	NOUN	B
proliferation	O	NOUN	I
involves	O	VERB	O
cyclin	B-DNA	NOUN	B
E	I-DNA	NOUN	I
-mediated	O	ADJ	O
inactivation	O	NOUN	B
of	O	ADP	O
Rb	O	NOUN	B
function	O	NOUN	I
and	O	CCONJ	O
induction	O	NOUN	B
of	O	ADP	O
E2F	B-protein	NOUN	B
activity	O	NOUN	I
.	O	PUNCT	O


Chronic	O	ADJ	B
rejection	O	NOUN	I
of	O	ADP	O
transplanted	O	VERB	B
organs	O	NOUN	I
is	O	AUX	O
manifested	O	VERB	O
as	O	ADP	O
atherosclerosis	O	NOUN	B
of	O	ADP	O
the	O	DET	O
blood	O	NOUN	B
vessels	O	NOUN	I
of	O	ADP	O
the	O	DET	O
allograft	O	NOUN	B
.	O	PUNCT	O


Although	O	SCONJ	O
it	O	PRON	O
can	O	AUX	O
be	O	AUX	O
incorporated	O	VERB	O
into	O	ADP	O
the	O	DET	O
DNA	O	NOUN	B
of	O	ADP	O
dividing	O	VERB	B
cells	O	NOUN	I
,	O	PUNCT	O
fludarabine	O	NOUN	B
is	O	AUX	O
also	O	ADV	O
a	O	DET	O
potent	O	ADJ	O
inhibitor	O	NOUN	B
of	O	ADP	O
cells	O	NOUN	B
with	O	ADP	O
a	O	DET	O
low	O	ADJ	B
growth	O	NOUN	B
fraction	O	NOUN	I
,	O	PUNCT	O
thus	O	ADV	O
it	O	PRON	O
must	O	AUX	O
have	O	AUX	O
other	O	ADJ	O
mechanisms	O	NOUN	B
of	O	ADP	O
action	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
loss	O	NOUN	B
of	O	ADP	O
STAT1	B-protein	NOUN	B
was	O	AUX	O
also	O	ADV	O
seen	O	VERB	O
in	O	ADP	O
cells	O	NOUN	B
from	O	ADP	O
patients	O	NOUN	B
treated	O	VERB	B
with	O	ADP	I
fludarabine	O	NOUN	B
in	O	X	B
vivo	O	X	I
.	O	PUNCT	O


Finally	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
a	O	DET	O
failure	O	NOUN	B
to	O	PART	O
degrade	O	VERB	O
IkappaB-alpha	B-protein	NOUN	B
in	O	ADP	O
cytosols	O	NOUN	B
of	O	ADP	O
TNF-treated	B-cell_type	ADJ	B
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
pretreated	O	VERB	B
with	O	ADP	O
PAO	O	NOUN	B
is	O	AUX	O
due	O	ADJ	O
to	O	PART	O
its	O	PRON	O
interference	O	NOUN	B
with	O	ADP	O
the	O	DET	O
phosphorylation	O	NOUN	B
of	O	ADP	O
IkappaB-alpha	B-protein	NOUN	B
and	O	CCONJ	O
not	O	PART	O
due	O	ADJ	O
to	O	PART	O
its	O	PRON	O
inhibitory	O	ADJ	B
effect	O	NOUN	O
on	O	ADP	O
proteasomal	O	ADJ	B
degradation	O	NOUN	I
.	O	PUNCT	O


Spi-C	B-protein	NOUN	B
,	O	PUNCT	O
a	O	DET	O
novel	O	ADJ	O
Ets	B-protein	NOUN	B
protein	I-protein	NOUN	I
that	O	PRON	O
is	O	AUX	O
temporally	O	ADV	B
regulated	O	VERB	I
during	O	ADP	O
B	O	NOUN	B
lymphocyte	O	NOUN	I
development	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
to	O	PART	O
the	O	DET	O
negative	O	ADJ	B
autoregulation	O	NOUN	B
of	O	ADP	O
glucocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
(	O	PUNCT	O
GR	B-protein	NOUN	B
)	O	PUNCT	O
expression	O	NOUN	B
seen	O	VERB	O
in	O	ADP	O
most	O	ADJ	O
cells	O	NOUN	B
and	O	CCONJ	O
tissues	O	NOUN	B
,	O	PUNCT	O
GR	B-protein	NOUN	B
expression	O	NOUN	B
is	O	AUX	O
positively	O	ADV	O
autoregulated	O	VERB	B
in	O	ADP	O
human	B-cell_type	ADJ	B
leukemic	I-cell_type	ADJ	O
T	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
and	O	CCONJ	O
in	O	ADP	O
other	O	ADJ	O
cells	O	NOUN	B
sensitive	O	ADJ	B
to	O	PART	O
glucocorticoid-induced	O	ADJ	B
cell	O	NOUN	I
death	O	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
HTLV-I	B-DNA	NOUN	B
genes	I-DNA	NOUN	I
including	O	VERB	O
Tax	B-protein	NOUN	B
are	O	AUX	O
not	O	PART	O
expressed	O	VERB	B
significantly	O	ADV	O
in	O	ADP	O
primary	B-cell_type	ADJ	B
leukemic	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
from	O	ADP	O
ATL	O	NOUN	B
patients	O	NOUN	B
.	O	PUNCT	O


Interestingly	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
NF-kappaB	B-protein	NOUN	B
in	O	ADP	O
TL-Om1	O	NOUN	B
consists	O	VERB	O
of	O	ADP	O
p50/p50	B-protein	NOUN	B
and	O	CCONJ	O
p50/p65	B-protein	NOUN	B
like	O	ADP	O
that	O	DET	O
in	O	ADP	O
fresh	O	ADJ	B
primary	B-cell_type	ADJ	O
leukemic	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Data	O	NOUN	B
regarding	O	VERB	O
the	O	DET	O
processes	O	NOUN	B
by	O	ADP	O
which	O	DET	O
these	O	DET	O
cytokines	B-protein	NOUN	B
transduce	O	VERB	B
signals	O	NOUN	B
from	O	ADP	O
the	O	DET	O
cell	O	NOUN	B
membrane	O	NOUN	I
to	O	PART	O
the	O	DET	O
nucleus	O	NOUN	B
are	O	AUX	O
becoming	O	VERB	O
increasingly	O	ADV	O
complex	O	ADJ	B
.	O	PUNCT	O


Finally	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
results	O	NOUN	B
demonstrate	O	VERB	O
that	O	SCONJ	O
IFN-alpha	B-protein	NOUN	B
exerts	O	VERB	O
an	O	DET	O
antiproliferative	O	ADJ	B
effect	O	NOUN	I
in	O	ADP	O
all	O	DET	O
three	O	NUM	O
cell	O	NOUN	B
lines	O	NOUN	I
.	O	PUNCT	O


Activation	O	NOUN	B
of	O	ADP	O
leukocytes	B-cell_type	NOUN	B
by	O	ADP	O
proinflammatory	O	ADJ	B
stimuli	O	NOUN	I
selectively	O	ADV	O
initiates	O	VERB	O
intracellular	O	ADJ	B
signal	O	NOUN	O
transduction	O	NOUN	O
via	O	ADP	O
sequential	O	ADJ	B
phosphorylation	O	NOUN	B
of	O	ADP	O
kinases	B-protein	NOUN	B
.	O	PUNCT	O


Specific	O	ADJ	O
inhibitors	O	NOUN	B
of	O	ADP	O
p38alpha	B-protein	NOUN	B
MAPk	I-protein	NOUN	O
blocked	O	VERB	B
LPS-induced	O	ADJ	B
adhesion	O	NOUN	I
,	O	PUNCT	O
nuclear	O	ADJ	B
factor-kappa	O	NOUN	I
B	O	NOUN	I
(	O	PUNCT	I
NF-kappaB	B-protein	NOUN	B
)	O	PUNCT	O
activation	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
synthesis	O	NOUN	B
of	O	ADP	O
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor-alpha	I-protein	NOUN	I
(	O	PUNCT	O
TNF-alpha	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
I	B-protein	NOUN	B
gamma	I-protein	NOUN	I
3	I-protein	NUM	I
ECS	B-DNA	NOUN	B
lies	O	VERB	O
upstream	O	ADV	B
of	O	ADP	O
the	O	DET	O
major	B-DNA	ADJ	O
I	I-DNA	NOUN	O
gamma	I-DNA	NOUN	O
3	I-DNA	NUM	O
transcription	I-DNA	NOUN	O
initiation	I-DNA	NOUN	O
site	I-DNA	NOUN	O
and	O	CCONJ	O
displays	O	VERB	O
more	O	ADJ	O
than	O	ADP	O
90	O	NUM	O
%	O	NOUN	O
identity	O	NOUN	B
with	O	ADP	O
the	O	DET	O
corresponding	O	ADJ	O
human	B-DNA	ADJ	B
I	I-DNA	NOUN	I
gamma	I-DNA	NOUN	I
1	I-DNA	NUM	I
,	O	PUNCT	O
I	B-DNA	NOUN	B
gamma	I-DNA	NOUN	I
2	I-DNA	NUM	I
,	O	PUNCT	O
and	O	CCONJ	O
I	B-DNA	NOUN	B
gamma	I-DNA	NOUN	I
4	I-DNA	NUM	I
regions	O	NOUN	I
.	O	PUNCT	O


Targeted	O	VERB	B
mutational	O	ADJ	I
analysis	O	NOUN	I
demonstrated	O	VERB	O
that	O	SCONJ	O
a	O	DET	O
tandem	O	ADJ	B
NF-kappa	B-DNA	NOUN	I
B/Rel	I-DNA	NOUN	B
binding	I-DNA	NOUN	I
motif	I-DNA	NOUN	I
is	O	AUX	O
critical	O	ADJ	O
for	O	ADP	O
the	O	DET	O
gamma	B-DNA	NOUN	B
3	I-DNA	NUM	I
ECS	I-DNA	NOUN	B
responsiveness	O	NOUN	B
to	O	PART	O
both	O	CCONJ	O
CD40L	B-protein	NOUN	B
and	O	CCONJ	O
IL-4	B-protein	NOUN	B
,	O	PUNCT	O
while	O	SCONJ	O
a	O	DET	O
STAT-6-binding	B-DNA	ADJ	B
site	I-DNA	NOUN	I
is	O	AUX	O
additionally	O	ADV	O
required	O	VERB	O
for	O	ADP	O
IL-4	B-protein	NOUN	B
inducibility	O	NOUN	B
.	O	PUNCT	O


Precise	O	ADJ	O
regulation	O	NOUN	B
of	O	ADP	O
MHC	B-cell_type	NOUN	B
class	I-cell_type	NOUN	O
II	I-cell_type	NUM	O
expression	O	NOUN	B
plays	O	VERB	O
a	O	DET	O
crucial	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
control	O	NOUN	B
of	O	ADP	O
the	O	DET	O
immune	O	ADJ	B
response	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
show	O	VERB	O
,	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
that	O	SCONJ	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
CIITA	B-protein	NOUN	B
does	O	AUX	O
not	O	PART	O
affect	O	VERB	O
the	O	DET	O
stability	O	NOUN	B
of	O	ADP	O
the	O	DET	O
higher-order	O	ADJ	B
protein	O	NOUN	I
complex	O	NOUN	I
formed	O	VERB	O
on	O	ADP	O
DNA	O	NOUN	B
by	O	ADP	O
RFX	B-protein	NOUN	B
,	O	PUNCT	O
X2BP	B-protein	NOUN	B
and	O	CCONJ	O
NF-Y	B-protein	NOUN	B
.	O	PUNCT	O


Increased	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
IFNgamma	B-protein	NOUN	B
-induced	O	ADJ	O
IP-10	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
following	O	VERB	O
the	O	DET	O
differentiation	O	NOUN	B
of	O	ADP	O
U937	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
was	O	AUX	O
mediated	O	VERB	O
largely	O	ADV	O
by	O	ADP	O
augmented	O	ADJ	B
transcriptional	O	ADJ	B
activity	O	NOUN	I
of	O	ADP	O
the	O	DET	O
gene	O	NOUN	B
and	O	CCONJ	O
was	O	AUX	O
related	O	ADJ	O
to	O	PART	O
differentiation-dependent	O	ADJ	B
changes	O	NOUN	B
of	O	ADP	O
the	O	DET	O
proteins	O	NOUN	B
bound	O	VERB	O
to	O	PART	O
IFN	B-DNA	NOUN	B
stimulus	I-DNA	NOUN	B
response	I-DNA	NOUN	O
element	I-DNA	NOUN	O
(	I-DNA	PUNCT	O
ISRE	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
and	O	CCONJ	O
kB	B-DNA	NOUN	O
sites	I-DNA	NOUN	O
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
these	O	DET	O
nuclear	B-protein	ADJ	B
proteins	I-protein	NOUN	I
may	O	AUX	O
determine	O	VERB	O
the	O	DET	O
IP-10	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
inducibility	O	NOUN	B
by	O	ADP	O
IFNgamma	B-protein	NOUN	B
.	O	PUNCT	O


Cleavage	O	NOUN	B
of	O	ADP	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
SP1	B-protein	NOUN	B
by	O	ADP	O
caspases	B-protein	NOUN	B
during	O	ADP	O
anti-IgM-induced	O	ADJ	B
B-cell	B-cell_type	NOUN	I
apoptosis	O	NOUN	B
.	O	PUNCT	O


DNA	O	NOUN	B
band-shift	O	NOUN	I
assays	O	NOUN	I
revealed	O	VERB	O
a	O	DET	O
decrease	O	NOUN	B
in	O	ADP	O
the	O	DET	O
intensity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
full	O	ADJ	O
length	O	NOUN	O
SP1	B-protein	NOUN	B
/DNA	O	NOUN	O
complex	O	NOUN	O
and	O	CCONJ	O
an	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
the	O	DET	O
intensity	O	NOUN	B
of	O	ADP	O
a	O	DET	O
smaller	O	ADJ	O
complex	O	NOUN	B
due	O	ADP	O
to	O	PART	O
the	O	DET	O
binding	O	NOUN	B
of	O	ADP	O
one	O	NUM	O
SP1	B-protein	NOUN	B
cleavage	O	NOUN	O
product	O	NOUN	O
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	B
show	O	VERB	O
the	O	DET	O
cleavage	O	NOUN	B
of	O	ADP	O
the	O	DET	O
human	O	ADJ	B
transcription	B-protein	NOUN	O
factor	I-protein	NOUN	O
SP1	B-protein	NOUN	B
in	O	X	B
vivo	O	X	I
and	O	CCONJ	O
in	O	X	B
vitro	O	X	I
,	O	PUNCT	O
underlining	O	VERB	O
the	O	DET	O
central	O	ADJ	O
role	O	NOUN	O
of	O	ADP	O
caspase	B-protein	NOUN	B
3-like	I-protein	ADJ	I
proteases	I-protein	NOUN	I
during	O	ADP	O
the	O	DET	O
process	O	NOUN	B
of	O	ADP	O
anti-IgM-induced	O	ADJ	B
apoptosis	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
study	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
applied	O	VERB	O
these	O	DET	O
two	O	NUM	O
markers	O	NOUN	B
to	O	PART	O
the	O	DET	O
study	O	NOUN	B
of	O	ADP	O
HIV-HD	O	NOUN	B
histogenesis	O	NOUN	B
and	O	CCONJ	O
correlated	O	VERB	B
their	O	PRON	O
expression	O	NOUN	B
status	O	NOUN	I
to	O	PART	O
the	O	DET	O
virologic	O	ADJ	B
features	O	NOUN	B
of	O	ADP	O
this	O	DET	O
disease	O	NOUN	B
.	O	PUNCT	O


Although	O	SCONJ	O
BCL-6	B-protein	NOUN	B
(	O	PUNCT	O
-	O	PUNCT	O
)	O	PUNCT	O
/syn-1	O	NOUN	B
(	O	PUNCT	O
+	O	CCONJ	O
)	O	PUNCT	O
RS	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
of	O	ADP	O
HIV-HD	O	NOUN	B
express	O	VERB	O
CD40	B-protein	NOUN	B
,	O	PUNCT	O
they	O	PRON	O
are	O	AUX	O
not	O	PART	O
surrounded	O	VERB	O
by	O	ADP	O
CD40	B-cell_type	NOUN	B
ligand-positive	I-cell_type	ADJ	B
(	I-cell_type	PUNCT	O
CD40L+	I-cell_type	ADJ	B
)	I-cell_type	PUNCT	O
reactive	I-cell_type	ADJ	B
T	I-cell_type	NOUN	I
lymphocytes	I-cell_type	NOUN	I
,	O	PUNCT	O
which	O	DET	O
,	O	PUNCT	O
in	O	ADP	O
HD	O	NOUN	B
of	O	ADP	O
the	O	DET	O
general	O	ADJ	B
population	O	NOUN	I
,	O	PUNCT	O
are	O	AUX	O
thought	O	VERB	O
to	O	PART	O
regulate	O	VERB	B
the	O	DET	O
disease	O	NOUN	B
phenotype	O	NOUN	B
through	O	ADP	O
CD40	B-protein	NOUN	B
/CD40L	B-protein	NOUN	O
interactions	O	NOUN	B
.	O	PUNCT	O


MDS1/EVI1	B-DNA	NOUN	B
,	O	PUNCT	O
located	O	ADJ	O
on	O	ADP	O
chromosome	B-DNA	NOUN	B
3	I-DNA	NUM	I
band	I-DNA	NOUN	I
q26	I-DNA	NOUN	I
,	O	PUNCT	O
encodes	O	VERB	B
a	O	DET	O
zinc-finger	B-protein	ADJ	B
DNA-binding	I-protein	ADJ	O
transcription	I-protein	NOUN	O
activator	I-protein	NOUN	O
not	O	PART	O
detected	O	VERB	O
in	O	ADP	O
normal	B-cell_type	ADJ	O
hematopoietic	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
but	O	CCONJ	O
expressed	O	VERB	B
in	O	ADP	O
several	O	ADJ	O
normal	O	ADJ	B
tissues	O	NOUN	I
.	O	PUNCT	O


They	O	PRON	O
are	O	AUX	O
growth-inhibited	O	VERB	B
by	O	ADP	O
TGF-beta1	B-protein	NOUN	B
.	O	PUNCT	O


Abnormalities	O	NOUN	B
of	O	ADP	O
cyclic	O	ADJ	B
adenosine	O	NOUN	I
monophosphate	O	NOUN	I
signaling	O	NOUN	I
in	O	ADP	O
platelets	B-cell_type	NOUN	B
from	O	ADP	O
untreated	O	ADJ	B
patients	O	NOUN	B
with	O	ADP	O
bipolar	O	ADJ	B
disorder	O	NOUN	I
.	O	PUNCT	O


BACKGROUND	O	NOUN	B
:	O	PUNCT	O
Abnormalities	O	NOUN	B
in	O	ADP	O
the	O	DET	O
cyclic	O	ADJ	B
adenosine	O	NOUN	I
monophosphate	O	NOUN	I
(	O	PUNCT	O
cAMP	O	NOUN	B
)	O	PUNCT	O
-dependent	O	ADJ	O
phosphorylation	O	NOUN	B
system	O	NOUN	I
have	O	AUX	O
been	O	AUX	O
recently	O	ADV	O
reported	O	VERB	O
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
bipolar	O	ADJ	B
disorder	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
levels	O	NOUN	B
of	O	ADP	O
cAMP-dependent	B-protein	ADJ	B
protein	I-protein	NOUN	I
kinase	I-protein	NOUN	I
and	O	CCONJ	O
Rap1	B-protein	NOUN	B
were	O	AUX	O
assessed	O	VERB	B
by	O	ADP	O
Western	O	NOUN	B
blot	O	NOUN	I
analysis	O	NOUN	I
,	O	PUNCT	O
immunostaining	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
computer-assisted	O	ADJ	B
imaging	O	NOUN	I
.	O	PUNCT	O


CONCLUSIONS	O	NOUN	O
:	O	PUNCT	O
Levels	O	NOUN	B
of	O	ADP	O
Rap1	B-protein	NOUN	B
and	O	CCONJ	O
the	O	DET	O
catalytic	B-protein	ADJ	B
subunit	I-protein	NOUN	I
of	O	ADP	O
cAMP-dependent	B-protein	ADJ	O
protein	I-protein	NOUN	O
kinase	I-protein	NOUN	O
are	O	AUX	O
altered	O	VERB	O
in	O	ADP	O
the	O	DET	O
platelets	B-cell_type	NOUN	B
of	O	ADP	O
bipolar	O	ADJ	B
patients	O	NOUN	B
.	O	PUNCT	O


Cytokine	B-protein	NOUN	B
expression	O	NOUN	B
by	O	ADP	O
immune	O	ADJ	B
system	O	NOUN	I
cells	O	NOUN	I
plays	O	VERB	O
an	O	DET	O
important	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
immune	O	ADJ	B
response	O	NOUN	I
.	O	PUNCT	O


Two	O	NUM	O
types	O	NOUN	O
of	O	ADP	O
effector	O	NOUN	B
cells	O	NOUN	I
characterized	O	VERB	B
by	O	ADP	O
their	O	PRON	O
distinct	O	ADJ	O
expression	O	NOUN	B
of	O	ADP	O
cytokine	B-protein	NOUN	B
profiles	O	NOUN	I
have	O	AUX	O
been	O	AUX	O
described	O	VERB	O
.	O	PUNCT	O


Tcf-1	B-protein	NOUN	B
-mediated	O	ADJ	O
transcription	O	NOUN	B
in	O	ADP	O
T	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
:	O	PUNCT	O
differential	O	ADJ	O
role	O	NOUN	O
for	O	ADP	O
glycogen	B-protein	NOUN	B
synthase	I-protein	NOUN	I
kinase-3	I-protein	NOUN	I
in	O	ADP	O
fibroblasts	B-cell_type	NOUN	B
and	O	CCONJ	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
report	O	VERB	O
that	O	SCONJ	O
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
Tcf-1	B-protein	NOUN	B
also	O	ADV	O
becomes	O	VERB	O
transcriptionally	O	ADV	B
active	O	ADJ	O
through	O	ADP	O
interaction	O	NOUN	B
with	O	ADP	O
beta-catenin	B-protein	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
Wnt	O	NOUN	B
signal	O	NOUN	I
transduction	O	NOUN	I
pathway	O	NOUN	I
is	O	AUX	O
operational	O	ADJ	B
in	O	ADP	O
T	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
as	O	ADV	O
well	O	ADV	O
.	O	PUNCT	O


That	O	ADV	O
is	O	ADV	O
,	O	PUNCT	O
a	O	DET	O
dominant	B-protein	ADJ	B
negative	I-protein	ADJ	B
GSK-3beta	I-protein	NOUN	B
does	O	AUX	O
not	O	PART	O
specifically	O	ADV	O
activate	O	VERB	B
Tcf	O	NOUN	B
transcription	O	NOUN	I
and	O	CCONJ	O
stimuli	O	NOUN	B
(	O	PUNCT	O
lithium	O	NOUN	B
or	O	CCONJ	O
phytohemagglutinin	B-protein	NOUN	B
)	O	PUNCT	O
that	O	PRON	O
inhibit	O	VERB	B
GSK-3beta	B-protein	NOUN	B
activity	O	NOUN	B
also	O	ADV	O
do	O	AUX	O
not	O	PART	O
activate	O	VERB	O
Tcf	B-DNA	NOUN	B
reporter	I-DNA	NOUN	I
genes	I-DNA	NOUN	I
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
inhibition	O	NOUN	B
of	O	ADP	O
GSK-3beta	B-protein	NOUN	B
is	O	AUX	O
insufficient	O	ADJ	O
to	O	PART	O
activate	O	VERB	B
Tcf-dependent	O	ADJ	B
transcription	O	NOUN	B
in	O	ADP	O
T	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
present	O	ADJ	O
study	O	NOUN	B
we	O	PRON	O
investigated	O	VERB	B
the	O	DET	O
possible	O	ADJ	O
involvement	O	NOUN	B
of	O	ADP	O
the	O	DET	O
mitogen-activated	B-protein	ADJ	B
protein	I-protein	NOUN	I
kinase	I-protein	NOUN	I
family	I-protein	NOUN	I
members	O	NOUN	I
extracellular-regulated	B-protein	ADJ	B
kinase	I-protein	NOUN	I
1/2	I-protein	NUM	I
(	O	PUNCT	O
ERK1/2	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
c-	O	NOUN	B
Jun	B-protein	NOUN	I
N-terminal	I-protein	ADJ	I
kinase	I-protein	NOUN	I
(	O	PUNCT	O
JNK	B-protein	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
mediating	O	VERB	O
IL-6	B-protein	NOUN	B
gene	O	NOUN	B
expression	O	NOUN	I
in	O	ADP	O
human	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
,	O	PUNCT	O
in	O	ADP	O
particular	O	ADJ	O
their	O	PRON	O
role	O	NOUN	O
in	O	ADP	O
enhancing	O	VERB	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activity	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
ERK	O	NOUN	B
pathway-specific	O	ADJ	B
inhibitor	O	NOUN	I
PD98059	O	NOUN	B
inhibited	O	VERB	B
IL-6	B-protein	NOUN	B
secretion	O	NOUN	B
from	O	ADP	O
monocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


Epstein-Barr	B-protein	ADJ	B
virus	I-protein	NOUN	I
nuclear	I-protein	ADJ	I
antigen	I-protein	NOUN	I
2	I-protein	NUM	I
(	O	PUNCT	O
EBNA2	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
a	O	DET	O
protein	O	NOUN	B
involved	O	VERB	O
in	O	ADP	O
cell	O	NOUN	B
transformation	O	NOUN	I
,	O	PUNCT	O
interferes	O	VERB	B
with	O	ADP	I
the	O	DET	O
cellular	O	ADJ	B
response	O	NOUN	I
to	O	PART	O
type	B-protein	NOUN	B
I	I-protein	NUM	I
interferons	I-protein	NOUN	I
(	O	PUNCT	O
IFN-alpha/beta	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


We	O	PRON	O
investigated	O	VERB	B
the	O	DET	O
function	O	NOUN	B
of	O	ADP	O
conditionally	O	ADV	O
expressed	O	VERB	B
EBNA2	B-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
context	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IFN	B-protein	NOUN	B
response	O	NOUN	B
in	O	ADP	O
Burkitt	B-cell_line	NOUN	B
's	I-cell_line	PART	I
lymphoma	I-cell_line	NOUN	I
cell	I-cell_line	NOUN	O
lines	I-cell_line	NOUN	O
.	O	PUNCT	O


Similar	O	ADJ	O
glucocorticoid-mediated	O	ADJ	B
potentiation	O	NOUN	I
was	O	AUX	O
observed	O	VERB	O
with	O	ADP	O
5-day	O	ADJ	O
M	O	NOUN	B
phi	O	NOUN	I
uptake	O	NOUN	B
of	O	ADP	O
alternative	O	ADJ	B
apoptotic	O	ADJ	B
``	O	PUNCT	O
targets	O	NOUN	B
''	O	PUNCT	O
(	O	PUNCT	O
eosinophils	B-cell_type	NOUN	B
and	O	CCONJ	O
Jurkat	B-cell_line	NOUN	B
T	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
)	O	PUNCT	O
and	O	CCONJ	O
in	O	ADP	O
uptake	O	NOUN	O
of	O	ADP	O
apoptotic	B-cell_type	ADJ	B
neutrophils	I-cell_type	NOUN	B
by	O	ADP	O
alternative	O	ADJ	B
phagocytes	B-cell_type	NOUN	B
(	O	PUNCT	O
human	B-cell_type	ADJ	B
glomerular	I-cell_type	ADJ	I
mesangial	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
murine	B-cell_line	ADJ	B
M	I-cell_line	NOUN	I
phi	I-cell_line	NOUN	I
elicited	O	VERB	O
into	O	ADP	O
the	O	DET	O
peritoneum	O	NOUN	B
or	O	CCONJ	O
derived	O	VERB	O
from	O	ADP	O
bone	O	NOUN	B
marrow	O	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
mechanisms	O	NOUN	B
and	O	CCONJ	O
strategies	O	NOUN	B
to	O	PART	O
overcome	O	VERB	O
RA	O	NOUN	B
resistance	O	NOUN	B
by	O	ADP	O
APL	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
are	O	AUX	O
still	O	ADV	O
unclear	O	ADJ	B
.	O	PUNCT	O


RXRs	B-protein	NOUN	B
heterodimerize	O	VERB	B
with	O	ADP	O
1	B-protein	NUM	O
,	I-protein	PUNCT	O
25-dihydroxyvitamin	I-protein	NOUN	B
D3	I-protein	NOUN	I
[	I-protein	PUNCT	O
1	I-protein	NUM	O
,	I-protein	PUNCT	O
25	I-protein	NUM	O
(	I-protein	PUNCT	O
OH	I-protein	NOUN	B
)	I-protein	PUNCT	O
2D3	I-protein	NOUN	O
]	I-protein	PUNCT	O
receptor	I-protein	NOUN	O
(	O	PUNCT	O
VDR	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
enabling	O	VERB	O
their	O	PRON	O
efficient	O	ADJ	B
transcriptional	O	ADJ	B
activation	O	NOUN	I
.	O	PUNCT	O


Interestingly	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
combination	O	NOUN	B
of	O	ADP	O
1	O	NUM	O
,	O	PUNCT	O
25	O	NUM	O
(	O	PUNCT	O
OH	O	NOUN	B
)	O	PUNCT	O
2D3	O	NOUN	B
and	O	CCONJ	O
RA	O	NOUN	B
markedly	O	ADV	O
enhanced	O	VERB	B
the	O	DET	O
levels	O	NOUN	B
of	O	ADP	O
p27	B-protein	NOUN	B
(	I-protein	PUNCT	O
KIP1	I-protein	NOUN	B
)	I-protein	PUNCT	O
transcript	O	NOUN	B
and	O	CCONJ	O
protein	O	NOUN	B
as	O	ADP	O
compared	O	VERB	B
with	O	ADP	O
levels	O	NOUN	B
induced	O	VERB	B
by	O	ADP	O
1	O	NUM	O
,	O	PUNCT	O
25	O	NUM	O
(	O	PUNCT	O
OH	O	NOUN	B
)	O	PUNCT	O
2D3	O	NOUN	B
alone	O	ADV	O
.	O	PUNCT	O


Taken	O	VERB	O
together	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
conclude	O	VERB	O
that	O	SCONJ	O
1	O	NUM	O
,	O	PUNCT	O
25	O	NUM	O
(	O	PUNCT	O
OH	O	NOUN	B
)	O	PUNCT	O
2D3	O	NOUN	B
induces	O	VERB	B
increased	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
cdk	B-protein	NOUN	B
inhibitors	I-protein	NOUN	I
,	O	PUNCT	O
which	O	DET	O
mediates	O	VERB	O
a	O	DET	O
G1	O	NOUN	B
arrest	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
this	O	DET	O
may	O	AUX	O
be	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
differentiation	O	NOUN	B
of	O	ADP	O
RA-resistant	O	ADJ	B
UF-1	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
toward	O	ADP	O
mature	O	ADJ	B
granulocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


Molecular	O	ADJ	B
mechanisms	O	NOUN	I
of	O	ADP	O
neutrophil-endothelial	O	ADJ	B
cell	O	NOUN	I
adhesion	O	NOUN	I
induced	O	VERB	B
by	O	ADP	O
redox	O	NOUN	B
imbalance	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
study	O	NOUN	B
was	O	AUX	O
designed	O	VERB	O
to	O	PART	O
determine	O	VERB	O
whether	O	SCONJ	O
changes	O	NOUN	B
in	O	ADP	O
endothelial	O	ADJ	B
cell	O	NOUN	I
glutathione	O	NOUN	I
(	O	PUNCT	O
GSH	O	NOUN	B
)	O	PUNCT	O
or	O	CCONJ	O
oxidized	O	VERB	B
glutathione	O	NOUN	I
(	O	PUNCT	O
GSSG	O	NOUN	B
)	O	PUNCT	O
can	O	AUX	O
alter	O	VERB	O
neutrophil	O	NOUN	B
adhesivity	O	NOUN	B
and	O	CCONJ	O
to	O	PART	O
define	O	VERB	O
the	O	DET	O
molecular	O	ADJ	B
mechanism	O	NOUN	O
that	O	PRON	O
underlies	O	VERB	O
this	O	DET	O
GSSG/GSH-induced	O	ADJ	B
adhesion	O	NOUN	I
response	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
redox	O	NOUN	B
changes	O	NOUN	I
are	O	AUX	O
similar	O	ADJ	O
to	O	PART	O
those	O	DET	O
observed	O	VERB	O
with	O	ADP	O
anoxia/reoxygenation	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
percentage	O	NOUN	B
of	O	ADP	O
CD3+	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
among	O	ADP	O
all	O	DET	O
immunocompetent	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	B
in	O	ADP	O
the	O	DET	O
tubal	O	ADJ	B
epithelium	O	NOUN	I
was	O	AUX	O
46.6	O	NUM	O
%	O	NOUN	O
(	O	PUNCT	O
39.9	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
CD3+	B-cell_type	NOUN	B
were	O	AUX	O
also	O	ADV	O
CD8+	B-cell_type	ADJ	B
)	O	PUNCT	O
;	O	PUNCT	O
the	O	DET	O
other	O	ADJ	O
53.4	O	NUM	O
%	O	NOUN	O
were	O	AUX	O
CD68+	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Angiotensin	B-protein	NOUN	B
II	I-protein	NUM	I
activates	O	VERB	B
the	O	DET	O
proinflammatory	B-protein	ADJ	B
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
nuclear	B-protein	ADJ	I
factor-kappaB	I-protein	NOUN	I
in	O	ADP	O
human	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


A	O	DET	O
common	O	ADJ	O
feature	O	NOUN	O
of	O	ADP	O
all	O	DET	O
stages	O	NOUN	B
of	O	ADP	O
atherosclerosis	O	NOUN	B
is	O	AUX	O
inflammation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
vessel	O	NOUN	B
wall	O	NOUN	I
.	O	PUNCT	O


ANG	B-protein	NOUN	B
II	I-protein	NUM	O
,	O	PUNCT	O
like	O	ADP	O
TNFalpha	B-protein	NOUN	B
,	O	PUNCT	O
caused	O	VERB	O
rapid	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
NF-kappaB	B-protein	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
mononuclear	I-cell_type	ADJ	O
cells	I-cell_type	NOUN	O
isolated	O	VERB	B
from	O	ADP	O
peripheral	O	ADJ	B
blood	O	NOUN	I
by	O	ADP	O
Ficoll	O	NOUN	B
density	O	NOUN	I
gradient	O	NOUN	I
.	O	PUNCT	O


Specificity	O	NOUN	B
of	O	ADP	O
ANG	B-protein	NOUN	B
II	I-protein	NUM	I
-induced	O	ADJ	O
NF-kappaB	B-protein	NOUN	B
activation	O	NOUN	B
was	O	AUX	O
ascertained	O	VERB	O
by	O	ADP	O
supershift	O	NOUN	B
and	O	CCONJ	O
competition	O	NOUN	B
experiments	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
report	O	VERB	O
the	O	DET	O
case	O	NOUN	B
of	O	ADP	O
a	O	DET	O
54-year-old	O	ADJ	O
woman	O	NOUN	B
with	O	ADP	O
multifocal	O	ADJ	B
cancer	O	NOUN	I
of	O	ADP	O
the	O	DET	O
colon	O	NOUN	B
,	O	PUNCT	O
who	O	PRON	O
developed	O	VERB	O
PHA	O	NOUN	B
after	O	ADP	O
subtotal	O	ADJ	B
colectomy	O	NOUN	I
,	O	PUNCT	O
ileal	O	ADJ	B
resection	O	NOUN	B
and	O	CCONJ	O
jejunostomy	O	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
plasma	O	NOUN	B
cortisol	O	NOUN	B
was	O	AUX	O
high	O	ADJ	O
(	O	PUNCT	O
66	O	NUM	O
microg/100	O	NOUN	O
ml	O	NOUN	O
at	O	ADP	O
10	O	NUM	O
:	O	PUNCT	O
00	O	NUM	O
h	O	NOUN	O
;	O	PUNCT	O
N	O	NOUN	O
:	O	PUNCT	O
8-15	O	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
ACTH	O	NOUN	B
was	O	AUX	O
normal	O	ADJ	O
(	O	PUNCT	O
13	O	NUM	O
pg/ml	O	NOUN	O
,	O	PUNCT	O
N	O	NOUN	O
:	O	PUNCT	O
10-60	O	NUM	O
)	O	PUNCT	O
;	O	PUNCT	O
there	O	PRON	O
was	O	AUX	O
a	O	DET	O
marked	O	ADJ	O
increase	O	NOUN	B
in	O	ADP	O
plasma	O	NOUN	B
renin	O	NOUN	B
activity	O	NOUN	B
(	O	PUNCT	O
>	O	NOUN	O
37	O	NUM	O
ng/ml/h	O	NOUN	O
;	O	PUNCT	O
N	O	NOUN	B
supine	O	NOUN	I
<	O	X	O
3	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
active	O	ADJ	B
renin	O	NOUN	B
(	O	PUNCT	O
869	O	NUM	O
pg/ml	O	NOUN	O
;	O	PUNCT	O
N	O	NOUN	O
supine	O	NOUN	B
:	O	PUNCT	O
1.120	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
aldosterone	O	NOUN	B
(	O	PUNCT	O
>	O	NOUN	O
2000	O	NUM	O
pg/ml	O	NOUN	O
;	O	PUNCT	O
N	O	NOUN	B
supine	O	NOUN	I
<	O	X	O
150	O	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
plasma	O	NOUN	B
AVP	O	NOUN	B
(	O	PUNCT	O
20	O	NUM	O
pmol/l	O	NOUN	O
;	O	PUNCT	O
N	O	NOUN	O
:	O	PUNCT	O
0.5-2.5	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
number	O	NOUN	O
of	O	ADP	O
mineralocorticoid	B-protein	NOUN	B
receptors	I-protein	NOUN	I
in	O	ADP	O
mononuclear	B-cell_type	ADJ	B
leukocytes	I-cell_type	NOUN	B
was	O	AUX	O
in	O	ADP	O
the	O	DET	O
lower	O	ADJ	O
normal	O	ADJ	O
range	O	NOUN	O
for	O	ADP	O
age	O	NOUN	B
,	O	PUNCT	O
while	O	SCONJ	O
the	O	DET	O
number	O	NOUN	O
of	O	ADP	O
glucocorticoid	B-protein	NOUN	B
receptors	I-protein	NOUN	I
was	O	AUX	O
reduced	O	VERB	B
.	O	PUNCT	O


Induction	O	NOUN	B
of	O	ADP	O
HL-60	B-cell_line	NOUN	B
and	O	CCONJ	O
U-937	B-cell_line	NOUN	B
cell	O	NOUN	I
differentiation	O	NOUN	O
into	O	ADP	O
monocytes/macrophages	B-cell_type	NOUN	B
by	O	ADP	O
IFN-gamma	B-protein	NOUN	B
or	O	CCONJ	O
PMA	O	NOUN	B
results	O	VERB	B
in	O	ADP	O
a	O	DET	O
dephosphorylation	O	NOUN	B
and	O	CCONJ	O
consequent	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
4E-BP1	B-protein	NOUN	B
.	O	PUNCT	O


Most	O	ADJ	O
mutations	O	NOUN	B
were	O	AUX	O
outside	O	ADP	O
the	O	DET	O
motifs	O	NOUN	B
potentially	O	ADV	O
important	O	ADJ	O
for	O	ADP	O
transcription	O	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
they	O	PRON	O
were	O	AUX	O
not	O	PART	O
important	O	ADJ	O
in	O	ADP	O
lymphomagenesis	O	NOUN	B
but	O	CCONJ	O
may	O	AUX	O
,	O	PUNCT	O
like	O	ADP	O
Ig	O	NOUN	B
mutation	O	NOUN	I
,	O	PUNCT	O
represent	O	VERB	O
an	O	DET	O
inherent	O	ADJ	O
feature	O	NOUN	O
of	O	ADP	O
the	O	DET	O
lymphoma	B-cell_type	NOUN	B
precursor	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


The	O	DET	O
frequency	O	NOUN	B
,	O	PUNCT	O
distribution	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
nature	O	NOUN	B
of	O	ADP	O
these	O	DET	O
mutations	O	NOUN	B
were	O	AUX	O
similar	O	ADJ	O
to	O	PART	O
those	O	DET	O
resulting	O	VERB	O
from	O	ADP	O
the	O	DET	O
Ig	O	NOUN	B
hypermutation	O	NOUN	I
process	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
analyzed	O	VERB	B
the	O	DET	O
ability	O	NOUN	O
of	O	ADP	O
the	O	DET	O
trans-dimer	O	NOUN	B
encoded	O	VERB	B
by	O	ADP	O
HLA-DQA1*0501/DQB1*0302	B-protein	NOUN	B
to	O	PART	O
bind	O	VERB	B
a	O	DET	O
peptide	O	NOUN	B
antigen	O	NOUN	I
which	O	DET	O
interacts	O	VERB	O
with	O	ADP	O
DQ	B-protein	NOUN	B
molecules	I-protein	NOUN	I
encoded	O	VERB	B
by	O	ADP	O
both	O	DET	O
parental	O	ADJ	B
haplotypes	O	NOUN	B
.	O	PUNCT	O


Detection	O	NOUN	B
of	O	ADP	O
intracellular	B-protein	ADJ	B
phosphorylated	I-protein	VERB	B
STAT-1	I-protein	NOUN	B
by	O	ADP	O
flow	O	NOUN	B
cytometry	O	NOUN	I
.	O	PUNCT	O


Consequently	O	ADV	O
,	O	PUNCT	O
cytosolic	O	ADJ	B
activation	O	NOUN	I
,	O	PUNCT	O
nuclear	O	ADJ	B
translocation	O	NOUN	I
and	O	CCONJ	O
DNA-binding	O	NOUN	B
of	O	ADP	O
nuclear	B-protein	ADJ	B
factor-kappaB	I-protein	NOUN	I
were	O	AUX	O
decreased	O	VERB	B
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
this	O	DET	O
therapeutic	O	ADJ	B
potency	O	NOUN	I
may	O	AUX	O
reside	O	VERB	O
in	O	ADP	O
retention	O	NOUN	B
of	O	ADP	O
inactive	O	ADJ	B
nuclear	B-protein	ADJ	B
factor-kappaB	I-protein	NOUN	I
in	O	ADP	O
the	O	DET	O
cytosol	B-cell_type	NOUN	B
thereby	O	ADV	O
abrogating	O	VERB	B
interleukin-1beta	B-protein	NOUN	B
gene	O	NOUN	B
transcription	O	NOUN	I
.	O	PUNCT	O


1.	O	X	O
Bioactivation	O	NOUN	B
of	O	ADP	O
sulphamethoxazole	O	NOUN	B
(	O	PUNCT	O
SMX	O	NOUN	B
)	O	PUNCT	O
to	O	PART	O
chemically-reactive	O	ADJ	B
metabolites	O	NOUN	B
and	O	CCONJ	O
subsequent	O	ADJ	O
protein	O	NOUN	B
conjugation	O	NOUN	I
is	O	AUX	O
thought	O	VERB	O
to	O	PART	O
be	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
SMX	O	NOUN	B
hypersensitivity	O	NOUN	B
.	O	PUNCT	O


Bcl-6	B-protein	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
reactive	O	ADJ	B
follicular	O	ADJ	I
hyperplasia	O	NOUN	I
,	O	PUNCT	O
follicular	O	ADJ	B
lymphoma	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
angioimmunoblastic	O	ADJ	B
T-cell	O	NOUN	I
lymphoma	O	NOUN	I
with	O	ADP	O
hyperplastic	O	ADJ	B
germinal	O	ADJ	I
centers	O	NOUN	I
:	O	PUNCT	O
heterogeneity	O	NOUN	B
of	O	ADP	O
intrafollicular	B-cell_type	ADJ	B
T-cells	I-cell_type	NOUN	I
and	O	CCONJ	O
their	O	PRON	O
altered	O	ADJ	O
distribution	O	NOUN	B
in	O	ADP	O
the	O	DET	O
pathogenesis	O	NOUN	B
of	O	ADP	O
angioimmunoblastic	O	ADJ	B
T-cell	O	NOUN	I
lymphoma	O	NOUN	I
.	O	PUNCT	O


An	O	DET	O
occasional	O	ADJ	O
GC	O	NOUN	B
with	O	ADP	O
an	O	DET	O
ill-defined	O	ADJ	B
border	O	NOUN	I
was	O	AUX	O
invariably	O	ADV	O
surrounded	O	VERB	B
by	O	ADP	O
a	O	DET	O
broad	O	ADJ	B
mantle	O	NOUN	I
zone	O	NOUN	I
;	O	PUNCT	O
those	O	DET	O
with	O	ADP	O
indistinct	O	ADJ	B
mantle	O	NOUN	I
zones	O	NOUN	B
had	O	AUX	O
well-defined	O	ADJ	O
,	O	PUNCT	O
regular	O	ADJ	B
borders	O	NOUN	I
.	O	PUNCT	O


Intrafollicular	O	ADJ	B
CD57+	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
did	O	AUX	O
not	O	PART	O
stain	O	VERB	B
for	O	ADP	O
Bcl-6	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
were	O	AUX	O
also	O	ADV	O
depleted	O	VERB	B
in	O	ADP	O
AITL/GC	O	NOUN	B
.	O	PUNCT	O


First	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
showed	O	VERB	O
that	O	SCONJ	O
viral	O	ADJ	B
binding	O	NOUN	I
induced	O	VERB	B
a	O	DET	O
number	O	NOUN	O
of	O	ADP	O
immunoregulatory	B-cell_type	ADJ	B
genes	I-cell_type	NOUN	I
(	O	PUNCT	O
IL-1beta	B-protein	NOUN	B
,	O	PUNCT	O
A20	B-protein	NOUN	B
,	O	PUNCT	O
NF-kappaB-p105/p50	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
IkappaBalpha	B-protein	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
unactivated	O	ADJ	B
monocytes	B-cell_type	NOUN	I
and	O	CCONJ	O
that	O	SCONJ	O
neutralizing	B-protein	VERB	B
Abs	I-protein	NOUN	B
to	O	PART	O
the	O	DET	O
major	O	ADJ	O
HCMV	B-protein	NOUN	B
glycoproteins	I-protein	NOUN	I
,	O	PUNCT	O
gB	B-protein	NOUN	B
(	O	PUNCT	O
UL55	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
gH	B-protein	NOUN	B
(	O	PUNCT	I
UL75	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
inhibited	O	VERB	B
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
these	O	DET	O
genes	O	NOUN	B
.	O	PUNCT	O


Lastly	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
demonstrated	O	VERB	O
that	O	SCONJ	O
p38	B-protein	NOUN	B
kinase	O	NOUN	I
activity	O	NOUN	O
played	O	VERB	O
a	O	DET	O
central	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
IL-1beta	B-protein	NOUN	B
production	O	NOUN	B
and	O	CCONJ	O
that	O	SCONJ	O
it	O	PRON	O
was	O	AUX	O
rapidly	O	ADV	O
up-regulated	O	VERB	B
following	O	VERB	O
infection	O	NOUN	B
.	O	PUNCT	O


Previous	O	ADJ	O
characterization	O	NOUN	B
of	O	ADP	O
the	O	DET	O
GPIX	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
identified	O	VERB	B
a	O	DET	O
functional	O	ADJ	B
Ets	O	NOUN	B
site	O	NOUN	I
that	O	PRON	O
,	O	PUNCT	O
when	O	SCONJ	O
disrupted	O	VERB	B
,	O	PUNCT	O
reduced	O	VERB	B
promoter	O	NOUN	B
activity	O	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
Ets	B-protein	NOUN	B
protein	I-protein	NOUN	I
(	O	PUNCT	O
s	O	NOUN	O
)	O	PUNCT	O
that	O	PRON	O
regulated	O	VERB	O
GPIX	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
expression	O	NOUN	I
was	O	AUX	O
unknown	O	ADJ	O
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
Fli-1	B-protein	NOUN	B
binding	O	NOUN	I
of	O	ADP	O
the	O	DET	O
GPIX	B-DNA	NOUN	B
Ets	I-DNA	NOUN	I
site	I-DNA	NOUN	I
was	O	AUX	O
identified	O	VERB	B
in	O	ADP	O
antibody	O	NOUN	B
supershift	O	NOUN	O
experiments	O	NOUN	O
in	O	ADP	O
nuclear	O	ADJ	B
extracts	O	NOUN	I
derived	O	VERB	O
from	O	ADP	O
hematopoietic	B-cell_type	ADJ	B
human	I-cell_type	ADJ	I
erythroleukemia	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
demonstrate	O	VERB	O
the	O	DET	O
nuclear	O	ADJ	B
localization	O	NOUN	I
of	O	ADP	I
I	B-protein	NOUN	I
(	I-protein	PUNCT	O
kappa	I-protein	NOUN	O
)	I-protein	PUNCT	O
B	I-protein	NOUN	O
(	I-protein	PUNCT	O
alpha	I-protein	NOUN	B
)	I-protein	PUNCT	O
in	O	ADP	O
PBL	B-cell_type	NOUN	B
by	O	ADP	O
different	O	ADJ	O
techniques	O	NOUN	B
:	O	PUNCT	O
Western	O	NOUN	B
blot	O	NOUN	I
,	O	PUNCT	O
indirect	O	ADJ	B
immunofluorescence	O	NOUN	I
and	O	CCONJ	O
electron	O	NOUN	B
microscopy	O	NOUN	I
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	B
demonstrate	O	VERB	O
that	O	SCONJ	O
in	O	ADP	O
resting	O	VERB	B
and	O	CCONJ	O
PMA-activated	B-cell_type	ADJ	B
human	I-cell_type	ADJ	B
PBL	I-cell_type	NOUN	B
,	O	PUNCT	O
I	B-protein	NOUN	B
(	I-protein	PUNCT	O
kappa	I-protein	NOUN	O
)	I-protein	PUNCT	O
B	I-protein	NOUN	O
(	I-protein	PUNCT	O
alpha	I-protein	NOUN	B
)	I-protein	PUNCT	O
is	O	AUX	O
present	O	ADJ	O
in	O	ADP	O
the	O	DET	O
nucleus	O	NOUN	B
in	O	ADP	O
an	O	DET	O
apparently	O	ADV	O
inactive	O	ADJ	B
form	O	NOUN	O
unable	O	ADJ	O
to	O	PART	O
disrupt	O	VERB	B
NF-kappaB	B-protein	NOUN	B
binding	O	NOUN	I
from	O	ADP	O
DNA	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
introduce	O	VERB	O
a	O	DET	O
new	O	ADJ	O
experimental	O	ADJ	B
system	O	NOUN	I
combining	O	VERB	O
adenovirus-mediated	O	ADJ	B
gene	O	NOUN	I
transfer	O	NOUN	I
and	O	CCONJ	O
fetal	O	ADJ	B
thymic	O	ADJ	O
organ	O	NOUN	O
culture	O	NOUN	O
(	O	PUNCT	O
FTOC	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Proliferation	O	NOUN	B
,	O	PUNCT	O
as	O	ADP	O
measured	O	VERB	B
by	O	ADP	O
the	O	DET	O
percentage	O	NOUN	B
of	O	ADP	O
cells	O	NOUN	B
in	O	ADP	O
cycle	O	NOUN	B
appeared	O	VERB	O
normal	O	ADJ	B
,	O	PUNCT	O
as	O	ADP	O
did	O	AUX	O
rearrangement	O	NOUN	B
and	O	CCONJ	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
TCR	B-protein	NOUN	B
beta-chain	I-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
FECa2+	O	NOUN	B
was	O	AUX	O
measured	O	VERB	B
as	O	ADP	O
the	O	DET	O
ionomycin-evoked	O	ADJ	B
Ca2+	O	NOUN	B
release	O	NOUN	B
(	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
thapsigargin	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
Ca2+-free	O	ADJ	B
medium	O	NOUN	I
.	O	PUNCT	O


SERCA	B-protein	NOUN	B
activity	O	NOUN	B
was	O	AUX	O
measured	O	VERB	B
as	O	ADP	O
the	O	DET	O
thapsigargin	O	NOUN	B
sensitive	O	ADJ	B
,	O	PUNCT	O
Ca2+	O	NOUN	B
dependent	O	ADJ	B
and	O	CCONJ	O
ouabain	O	NOUN	B
resistant	O	ADJ	B
,	O	PUNCT	O
ATP	O	NOUN	B
hydrolyses	O	NOUN	B
in	O	ADP	O
platelet	O	NOUN	B
membranes	O	NOUN	I
.	O	PUNCT	O


Highly	O	ADV	B
significant	O	ADJ	I
correlations	O	NOUN	B
were	O	AUX	O
observed	O	VERB	O
for	O	ADP	O
FECa2+	O	NOUN	B
in	O	ADP	O
the	O	DET	O
dense	O	ADJ	B
tubules	O	NOUN	B
with	O	ADP	O
:	O	PUNCT	O
1	O	X	O
)	O	PUNCT	O
the	O	DET	O
maximal	O	ADJ	B
reaction	O	NOUN	O
velocity	O	NOUN	O
(	O	PUNCT	O
Vmax	O	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
the	O	DET	O
SERCA	B-protein	NOUN	B
(	O	PUNCT	O
r	O	NOUN	O
=	O	ADJ	O
0.592	O	NUM	O
,	O	PUNCT	O
P	O	NOUN	O
=	O	ADJ	O
.0014	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
2	O	X	O
)	O	PUNCT	O
Rapl	B-protein	NOUN	B
(	O	PUNCT	O
r	O	NOUN	O
=	O	ADJ	O
0.551	O	NUM	O
,	O	PUNCT	O
P	O	NOUN	O
=	O	ADJ	O
.0035	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


No	O	DET	O
correlations	O	NOUN	B
were	O	AUX	O
observed	O	VERB	O
for	O	ADP	O
these	O	DET	O
variables	O	NOUN	B
with	O	ADP	O
blood	O	NOUN	B
pressure	O	NOUN	I
or	O	CCONJ	O
serum	B-protein	NOUN	B
lipoproteins	I-protein	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
utilized	O	VERB	O
CoCl2	O	NOUN	B
as	O	ADP	O
a	O	DET	O
mimetic	O	ADJ	B
molecule	O	NOUN	I
for	O	ADP	O
hypoxia	O	NOUN	B
to	O	PART	O
study	O	VERB	B
cellular	O	ADJ	B
signaling	O	NOUN	I
pathways	O	NOUN	I
.	O	PUNCT	O


Inhibitors	O	NOUN	B
of	O	ADP	O
MAP	B-protein	NOUN	B
kinase	I-protein	NOUN	I
(	O	PUNCT	O
PD98059	O	NOUN	B
)	O	PUNCT	O
or	O	CCONJ	O
platelet-activating	O	ADJ	B
factor	O	NOUN	I
(	O	PUNCT	O
PAF	O	NOUN	B
)	O	PUNCT	O
-	O	PUNCT	O
receptor	O	NOUN	B
antagonist	O	NOUN	I
(	O	PUNCT	O
CV3988	O	NOUN	B
)	O	PUNCT	O
inhibited	O	VERB	B
the	O	DET	O
CoCl2-induced	O	ADJ	B
NF-kappaB	B-protein	NOUN	I
activation	O	NOUN	B
and	O	CCONJ	O
VCAM-1	B-protein	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


LPS-induced	O	ADJ	B
activation	O	NOUN	B
of	O	ADP	O
NF-kappaB-responsive	B-DNA	ADJ	B
reporter	I-DNA	NOUN	I
gene	I-DNA	NOUN	O
was	O	AUX	O
not	O	PART	O
inhibited	O	VERB	B
by	O	ADP	O
IL-1	B-protein	NOUN	B
receptor	O	NOUN	I
antagonist	O	NOUN	B
.	O	PUNCT	O


Signal	O	NOUN	B
transduction	O	NOUN	I
through	O	ADP	O
interferon-gamma	B-protein	NOUN	B
receptor	I-protein	NOUN	I
on	O	ADP	O
human	B-cell_type	ADJ	B
eosinophils	I-cell_type	NOUN	B
.	O	PUNCT	O


To	O	PART	O
investigate	O	VERB	B
its	O	PRON	O
biological	O	ADJ	B
role	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
generated	O	VERB	O
transgenic	O	ADJ	B
mice	O	NOUN	I
expressing	O	VERB	B
E2A-HLF	B-protein	NOUN	B
using	O	VERB	O
Ig	B-DNA	NOUN	B
enhancer	I-DNA	NOUN	I
and	I-DNA	CCONJ	O
promoter	I-DNA	NOUN	B
,	O	PUNCT	O
which	O	DET	O
direct	O	VERB	O
transgene	O	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
cells	O	NOUN	B
committed	O	VERB	O
to	O	PART	O
the	O	DET	O
lymphoid	O	ADJ	B
lineage	O	NOUN	B
.	O	PUNCT	O


Unexpectedly	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
observed	O	VERB	O
that	O	SCONJ	O
an	O	DET	O
RXR	B-protein	NOUN	B
-specific	O	ADJ	O
,	O	PUNCT	O
rather	O	ADV	O
than	O	ADP	O
an	O	DET	O
RAR	B-protein	NOUN	B
-specific	O	ADJ	O
,	O	PUNCT	O
agonist	O	NOUN	B
induces	O	VERB	B
terminal	O	ADJ	B
granulocytic	O	ADJ	B
differentiation	O	NOUN	I
of	O	ADP	O
MPRO	B-cell_type	NOUN	B
promyelocytes	I-cell_type	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
this	O	DET	O
differentiation	O	NOUN	B
is	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
activation	O	NOUN	B
of	O	ADP	O
DNA	B-DNA	NOUN	B
response	I-DNA	NOUN	I
elements	I-DNA	NOUN	I
corresponding	O	VERB	O
to	O	PART	O
RAR-RXR	B-protein	NOUN	B
heterodimers	I-protein	NOUN	B
rather	O	ADV	O
than	O	ADP	O
RXR-RXR	B-protein	NOUN	B
homodimers	I-protein	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
more	O	ADV	O
immature	O	ADJ	B
,	O	PUNCT	O
multipotent	O	ADJ	B
EML	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	B
we	O	PRON	O
observed	O	VERB	O
that	O	SCONJ	O
this	O	DET	O
RXR	B-protein	NOUN	B
-specific	O	ADJ	O
agonist	O	NOUN	B
is	O	AUX	O
inactive	O	ADJ	B
either	O	CCONJ	O
in	O	ADP	O
potentiating	O	VERB	O
IL-3	B-protein	NOUN	B
-mediated	O	ADJ	O
commitment	O	NOUN	B
of	O	ADP	O
EML	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	B
to	O	PART	O
the	O	DET	O
granulocyte	B-cell_type	NOUN	B
lineage	I-cell_type	NOUN	I
or	O	CCONJ	O
in	O	ADP	O
transactivating	O	VERB	B
RAR-RXR	B-DNA	NOUN	I
response	I-DNA	NOUN	I
elements	I-DNA	NOUN	I
.	O	PUNCT	O


A	O	DET	O
specific	O	ADJ	O
inhibitor	O	NOUN	B
of	O	ADP	O
p38	O	NOUN	B
MAP	O	NOUN	I
kinase	O	NOUN	I
completely	O	ADV	O
inhibits	O	VERB	B
the	O	DET	O
serine	O	NOUN	B
phosphorylation	O	NOUN	B
of	O	ADP	O
STAT1	B-protein	NOUN	B
and	O	CCONJ	O
STAT3	B-protein	NOUN	B
induced	O	VERB	B
by	O	ADP	O
IL-12	B-protein	NOUN	B
and	O	CCONJ	O
IL-2	B-protein	NOUN	B
and	O	CCONJ	O
abrogates	O	VERB	B
the	O	DET	O
functional	O	ADJ	B
synergy	O	NOUN	I
between	O	ADP	O
IL-12	B-protein	NOUN	B
and	O	CCONJ	O
IL-2	B-protein	NOUN	B
without	O	ADP	O
affecting	O	VERB	B
STAT	O	NOUN	B
tyrosine	O	NOUN	I
phosphorylation	O	NOUN	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
two	O	NUM	O
VDR	B-DNA	NOUN	B
3'-UTR	I-DNA	NOUN	I
haplotypes	O	NOUN	B
conferred	O	VERB	O
an	O	DET	O
identical	O	ADJ	B
half-life	O	NOUN	B
on	O	ADP	O
a	O	DET	O
heterologous	B-DNA	ADJ	B
beta-globin	I-DNA	NOUN	B
reporter	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
,	O	PUNCT	O
in	O	ADP	O
an	O	DET	O
in	O	X	B
vitro	O	X	I
assay	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
current	O	ADJ	O
study	O	NOUN	B
clearly	O	ADV	O
demonstrates	O	VERB	O
that	O	SCONJ	O
IL-2	B-protein	NOUN	B
does	O	AUX	O
not	O	PART	O
induce	O	VERB	B
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
alpha	O	NOUN	I
degradation	O	NOUN	I
or	O	CCONJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activation	O	NOUN	B
in	O	ADP	O
primary	B-cell_type	ADJ	O
human	I-cell_type	ADJ	B
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
that	O	PRON	O
respond	O	VERB	O
to	O	PART	O
IL-2	B-protein	NOUN	B
by	O	ADP	O
entering	O	VERB	O
the	O	DET	O
cell	O	NOUN	B
cycle	O	NOUN	I
and	O	CCONJ	O
avoiding	O	VERB	O
apoptosis	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
conclude	O	VERB	O
from	O	ADP	O
these	O	DET	O
studies	O	NOUN	B
that	O	SCONJ	O
the	O	DET	O
phosphorylation	O	NOUN	B
of	O	ADP	O
TRAF2	B-protein	NOUN	B
is	O	AUX	O
likely	O	ADJ	O
to	O	PART	O
play	O	VERB	O
an	O	DET	O
important	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
regulating	O	VERB	B
signaling	O	NOUN	I
by	O	ADP	O
virtue	O	NOUN	O
of	O	ADP	O
its	O	PRON	O
ability	O	NOUN	O
to	O	PART	O
influence	O	VERB	B
the	O	DET	O
CD40	B-protein	NOUN	B
-TRAF2	B-protein	ADJ	O
interaction	O	NOUN	B
.	O	PUNCT	O


One	O	NUM	O
of	O	ADP	O
the	O	DET	O
prominent	O	ADJ	B
substrates	O	NOUN	B
for	O	ADP	O
these	O	DET	O
kinases	B-protein	NOUN	B
is	O	AUX	O
the	O	DET	O
adaptor	B-protein	NOUN	B
protein	I-protein	NOUN	I
Cbl	O	NOUN	B
[	O	PUNCT	O
3	O	NUM	O
]	O	PUNCT	O
and	O	CCONJ	O
recent	O	ADJ	O
studies	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
Cbl	B-protein	NOUN	B
negatively	O	ADV	B
regulates	O	VERB	B
upstream	B-protein	ADJ	B
kinases	I-protein	NOUN	I
such	O	ADJ	O
as	O	ADP	O
Syk	B-protein	NOUN	B
and	O	CCONJ	O
Zap-70	B-protein	NOUN	B
[	O	PUNCT	O
4	O	NUM	O
]	O	PUNCT	O
[	O	PUNCT	O
5	O	NUM	O
]	O	PUNCT	O
.	O	PUNCT	O


Incidentally	O	ADV	O
,	O	PUNCT	O
Grf40	B-protein	NOUN	B
binds	O	VERB	B
to	O	PART	O
linker	B-protein	NOUN	B
for	I-protein	ADP	O
activation	I-protein	NOUN	B
of	I-protein	ADP	O
T	I-protein	NOUN	B
cells	I-protein	NOUN	I
(	O	PUNCT	O
LAT	B-protein	NOUN	B
)	O	PUNCT	O
possibly	O	ADV	O
via	O	ADP	O
its	O	PRON	O
SH2	B-protein	NOUN	B
domain	I-protein	NOUN	I
.	O	PUNCT	O


Overexpression	O	NOUN	B
of	O	ADP	O
wild-type	B-protein	ADJ	B
Grf40	I-protein	NOUN	B
in	O	ADP	O
Jurkat	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
induced	O	VERB	B
a	O	DET	O
significant	O	ADJ	O
increase	O	NOUN	B
of	O	ADP	O
SLP-76-dependent	B-DNA	ADJ	B
interleukin	I-DNA	NOUN	O
(	I-DNA	PUNCT	O
IL	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
-2	I-DNA	NUM	O
promoter	I-DNA	NOUN	B
and	O	CCONJ	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
of	I-protein	ADP	O
activated	I-protein	VERB	B
T	I-protein	NOUN	O
cell	I-protein	NOUN	O
(	O	PUNCT	O
NF-AT	B-protein	NOUN	B
)	O	PUNCT	O
activation	O	NOUN	B
upon	O	SCONJ	O
T	B-protein	NOUN	B
cell	I-protein	NOUN	I
receptor	I-protein	NOUN	I
(	O	PUNCT	O
TCR	B-protein	NOUN	B
)	O	PUNCT	O
stimulation	O	NOUN	B
,	O	PUNCT	O
whereas	O	SCONJ	O
the	O	DET	O
COOH-terminal	B-protein	ADJ	B
SH3-deleted	I-protein	ADJ	I
Grf40	I-protein	NOUN	B
mutant	I-protein	NOUN	I
lacked	O	VERB	O
any	O	DET	O
recognizable	O	ADJ	O
increase	O	NOUN	B
in	O	ADP	O
IL-2	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
activity	O	NOUN	I
.	O	PUNCT	O


Several	O	ADJ	O
new	O	ADJ	O
functions	O	NOUN	B
of	O	ADP	O
Ras	B-protein	NOUN	B
,	O	PUNCT	O
such	O	ADJ	O
as	O	ADP	O
downregulation	O	NOUN	B
of	O	ADP	O
major	B-protein	ADJ	B
histocompatibility	I-protein	NOUN	I
complex	I-protein	NOUN	I
molecules	I-protein	NOUN	I
,	O	PUNCT	O
upregulation	O	NOUN	B
of	O	ADP	O
certain	O	ADJ	O
cytokines	B-protein	NOUN	B
,	O	PUNCT	O
growth	B-protein	NOUN	B
factors	I-protein	NOUN	I
and	O	CCONJ	O
degradative	B-protein	ADJ	B
enzymes	I-protein	NOUN	I
have	O	AUX	O
been	O	AUX	O
uncovered	O	VERB	O
in	O	ADP	O
the	O	DET	O
last	O	ADJ	O
decade	O	NOUN	B
.	O	PUNCT	O


Modulation	O	NOUN	B
of	O	ADP	O
E2F	B-protein	NOUN	B
complexes	I-protein	NOUN	I
during	O	ADP	O
G0	O	NOUN	B
to	O	PART	O
S	O	NOUN	B
phase	O	NOUN	I
transition	O	NOUN	I
in	O	ADP	O
human	B-cell_type	ADJ	B
primary	I-cell_type	ADJ	O
B-lymphocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
also	O	ADV	O
observed	O	VERB	O
an	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
electrophoretic	O	ADJ	B
mobility	O	NOUN	I
of	O	ADP	O
the	O	DET	O
predominant	O	ADJ	O
E2F	B-protein	NOUN	B
components	I-protein	NOUN	I
,	O	PUNCT	O
DP1	B-protein	NOUN	B
and	O	CCONJ	O
E2F4	B-protein	NOUN	B
,	O	PUNCT	O
as	O	ADP	O
B-lymphocytes	B-cell_type	NOUN	B
progressed	O	VERB	O
from	O	ADP	O
G0	O	NOUN	B
into	O	ADP	O
early	O	ADJ	B
G1	O	NOUN	B
.	O	PUNCT	O


NK	O	NOUN	B
cell	O	NOUN	I
cytotoxicity	O	NOUN	B
is	O	AUX	O
a	O	DET	O
fast	O	ADJ	B
and	O	CCONJ	O
efficient	O	ADJ	B
mechanism	O	NOUN	B
of	O	ADP	O
target	O	NOUN	B
cell	O	NOUN	B
lysis	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
DNA-binding	O	ADJ	B
activities	O	NOUN	I
of	O	ADP	O
Jun-Fos	B-protein	NOUN	B
heterodimers	I-protein	NOUN	I
were	O	AUX	O
observed	O	VERB	O
by	O	ADP	O
electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assays	O	NOUN	I
during	O	ADP	O
the	O	DET	O
course	O	NOUN	B
of	O	ADP	O
natural	O	ADJ	B
cytotoxicity	O	NOUN	B
.	O	PUNCT	O


Evidence	O	NOUN	B
for	O	ADP	O
a	O	DET	O
polyclonal	O	ADJ	B
etiology	O	NOUN	I
of	O	ADP	O
palmar	O	ADJ	B
fibromatosis	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
tissue	O	NOUN	B
from	O	ADP	O
both	O	DET	O
patients	O	NOUN	B
generated	O	VERB	O
a	O	DET	O
polyclonal	O	ADJ	B
pattern	O	NOUN	I
of	O	ADP	O
X	B-DNA	NOUN	B
chromosome	I-DNA	NOUN	I
inactivation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
androgen	I-DNA	NOUN	O
receptor	I-DNA	NOUN	O
gene	I-DNA	NOUN	O
.	O	PUNCT	O


This	O	DET	O
finding	O	NOUN	O
supports	O	VERB	O
a	O	DET	O
polyclonal	O	ADJ	B
reactive	O	ADJ	O
process	O	NOUN	O
as	O	ADP	O
the	O	DET	O
underlying	O	ADJ	O
etiology	O	NOUN	B
for	O	ADP	O
palmar	O	ADJ	B
fibromatosis	O	NOUN	I
.	O	PUNCT	O


This	O	DET	O
observation	O	NOUN	B
was	O	AUX	O
further	O	ADV	O
confirmed	O	VERB	O
in	O	ADP	O
a	O	DET	O
rat	O	NOUN	B
air	O	NOUN	B
pouch	O	NOUN	I
model	O	NOUN	B
in	O	X	B
vivo	O	X	I
,	O	PUNCT	O
in	O	ADP	O
which	O	DET	O
both	O	CCONJ	O
aspirin	O	NOUN	B
and	O	CCONJ	O
triflusal	O	NOUN	B
inhibited	O	VERB	B
PGE2	O	NOUN	B
production	O	NOUN	B
(	O	PUNCT	O
ID50	O	NOUN	B
=	O	ADJ	O
18.9	O	NUM	O
and	O	CCONJ	O
11.4	O	NUM	O
mg/kg	O	NOUN	O
p.o.	O	NOUN	B
,	O	PUNCT	O
respectively	O	ADV	O
)	O	PUNCT	O
but	O	CCONJ	O
only	O	ADV	O
triflusal-treated	O	ADJ	B
animals	O	NOUN	B
showed	O	VERB	O
a	O	DET	O
decrease	O	NOUN	B
in	O	ADP	O
COX-2	B-protein	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
in	O	ADP	O
addition	O	NOUN	O
to	O	PART	O
inhibiting	O	VERB	B
the	O	DET	O
COX-2	O	NOUN	B
activity	O	NOUN	B
at	O	ADP	O
therapeutic	O	ADJ	B
concentrations	O	NOUN	I
,	O	PUNCT	O
triflusal	O	NOUN	B
is	O	AUX	O
able	O	ADJ	O
to	O	PART	O
block	O	VERB	B
through	O	ADP	O
its	O	PRON	O
metabolite	O	NOUN	B
HTB	O	NOUN	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
new	O	ADJ	O
enzyme	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
hence	O	ADV	O
the	O	DET	O
resumption	O	NOUN	B
of	O	ADP	O
PGE2	O	NOUN	B
synthesis	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
CD34+	B-cell_line	ADJ	B
myelomonocytic	I-cell_line	ADJ	I
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
KG1	B-cell_line	NOUN	B
differentiates	O	VERB	O
into	O	ADP	O
dendritic-like	O	ADJ	B
cells	O	NOUN	I
in	O	ADP	O
response	O	NOUN	O
to	O	PART	O
granulocyte-macrophage	B-protein	ADJ	B
CSF	I-protein	NOUN	B
plus	O	CCONJ	O
TNF-alpha	B-protein	NOUN	B
,	O	PUNCT	O
or	O	CCONJ	O
PMA	O	NOUN	B
(	O	PUNCT	O
with	O	ADP	O
or	O	CCONJ	O
without	O	ADP	O
the	O	DET	O
calcium	O	NOUN	B
ionophore	O	NOUN	I
ionomycin	O	NOUN	B
,	O	PUNCT	O
or	O	CCONJ	O
TNF-alpha	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
with	O	ADP	O
different	O	ADJ	O
stimuli	O	NOUN	B
mediating	O	VERB	O
different	O	ADJ	O
aspects	O	NOUN	O
of	O	ADP	O
the	O	DET	O
process	O	NOUN	B
.	O	PUNCT	O


Functional	O	ADJ	B
DC	B-cell_type	NOUN	B
characteristics	O	NOUN	B
include	O	VERB	O
fluid	O	ADJ	B
phase	O	NOUN	O
macromolecule	O	NOUN	O
uptake	O	NOUN	O
(	O	PUNCT	O
FITC-dextran	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
activation	O	NOUN	B
of	O	ADP	O
resting	B-cell_type	VERB	B
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Comparison	O	NOUN	B
of	O	ADP	O
KG1	B-cell_line	NOUN	B
to	O	PART	O
the	O	DET	O
PMA-unresponsive	B-cell_line	ADJ	B
subline	I-cell_line	NOUN	I
KG1a	I-cell_line	NOUN	B
reveals	O	VERB	O
differences	O	NOUN	O
in	O	ADP	O
expression	O	NOUN	B
of	O	ADP	O
TNF	B-protein	NOUN	B
receptors	I-protein	NOUN	I
1	I-protein	NUM	I
and	I-protein	CCONJ	O
2	I-protein	NUM	O
;	O	PUNCT	O
PKC	B-protein	NOUN	B
isoforms	I-protein	NOUN	B
alpha	I-protein	NOUN	B
,	I-protein	PUNCT	O
beta	I-protein	NOUN	B
I	I-protein	NUM	I
,	I-protein	PUNCT	O
beta	I-protein	NOUN	B
II	I-protein	NUM	I
,	I-protein	PUNCT	O
and	I-protein	CCONJ	O
mu	I-protein	NOUN	O
;	O	PUNCT	O
and	O	CCONJ	O
RelB	B-protein	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
these	O	DET	O
components/pathways	O	NOUN	B
are	O	AUX	O
important	O	ADJ	O
for	O	ADP	O
DC	B-cell_type	NOUN	B
differentiation	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
signal	O	NOUN	B
cascade	O	NOUN	I
transducing	O	VERB	I
this	O	DET	O
effect	O	NOUN	B
is	O	AUX	O
not	O	PART	O
yet	O	ADV	O
clear	O	ADJ	O
.	O	PUNCT	O


The	O	DET	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
PU.1	B-protein	NOUN	B
and	O	CCONJ	O
C/EBPalpha	B-protein	NOUN	B
are	O	AUX	O
responsible	O	ADJ	O
for	O	ADP	O
normal	O	ADJ	O
myeloid	O	ADJ	B
differentiation	O	NOUN	I
from	O	ADP	O
stem	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
to	O	PART	O
monocytes	B-cell_type	NOUN	B
or	O	CCONJ	O
granulocytes	O	NOUN	B
.	O	PUNCT	O


On	O	ADP	O
the	O	DET	O
other	O	ADJ	O
hand	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
PML/RARalpha	B-protein	NOUN	B
fusion	I-protein	NOUN	I
protein	I-protein	NOUN	I
causes	O	VERB	O
transcriptional	O	ADJ	B
repression	O	NOUN	I
by	O	ADP	O
recruiting	O	VERB	O
the	O	DET	O
nuclear	B-protein	ADJ	B
corepressor	I-protein	NOUN	I
(	I-protein	PUNCT	I
N-CoR	I-protein	NOUN	B
)	I-protein	PUNCT	O
histone	I-protein	NOUN	B
deacetylase	I-protein	NOUN	I
complex	I-protein	NOUN	I
to	O	PART	O
the	O	DET	O
DNA	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
results	O	VERB	B
in	O	ADP	O
decreased	O	VERB	B
histone	B-protein	NOUN	B
acetylation	O	NOUN	O
and	O	CCONJ	O
a	O	DET	O
repressive	O	ADJ	B
chromatin	B-DNA	NOUN	O
organization	O	NOUN	O
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
phenotypic	O	ADJ	B
analysis	O	NOUN	I
of	O	ADP	O
NF-AT	B-protein	NOUN	B
-deficient	O	ADJ	O
mice	O	NOUN	B
supports	O	VERB	O
the	O	DET	O
idea	O	NOUN	O
that	O	SCONJ	O
there	O	PRON	O
are	O	AUX	O
tissue-	O	NOUN	B
and	O	CCONJ	O
gene-	O	NOUN	O
specific	O	ADJ	B
functions	O	NOUN	B
as	O	ADV	O
well	O	ADV	O
.	O	PUNCT	O


Despite	O	SCONJ	O
minimal	O	ADJ	B
discrepancies	O	NOUN	B
in	O	ADP	O
the	O	DET	O
coding	B-DNA	VERB	B
region	I-DNA	NOUN	I
,	O	PUNCT	O
there	O	PRON	O
are	O	AUX	O
striking	O	ADJ	O
tissue-	O	NOUN	B
and	O	CCONJ	O
cell	O	NOUN	B
type-specific	O	ADJ	I
differences	O	NOUN	I
in	O	ADP	O
isoform	O	NOUN	B
expression	O	NOUN	B
patterns	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
demonstrate	O	VERB	O
another	O	DET	O
level	O	NOUN	B
of	O	ADP	O
regulation	O	NOUN	B
within	O	ADP	O
the	O	DET	O
NF-AT	B-protein	NOUN	B
family	I-protein	NOUN	B
that	O	PRON	O
can	O	AUX	O
contribute	O	VERB	O
to	O	PART	O
cell	O	NOUN	B
type-specific	O	ADJ	I
gene	O	NOUN	I
expression	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
CTL	B-cell_line	NOUN	B
clones	I-cell_line	NOUN	B
that	O	PRON	O
recognized	O	VERB	O
viral	O	ADJ	B
and	O	CCONJ	O
self	O	NOUN	B
peptides	O	NOUN	I
were	O	AUX	O
more	O	ADV	O
oligoclonal	O	ADJ	B
,	O	PUNCT	O
whereas	O	SCONJ	O
clones	O	NOUN	B
that	O	PRON	O
strictly	O	ADV	O
recognized	O	VERB	O
the	O	DET	O
viral	O	ADJ	B
peptide	O	NOUN	I
displayed	O	VERB	O
a	O	DET	O
diverse	O	ADJ	B
TCR	B-protein	NOUN	B
profile	O	NOUN	B
.	O	PUNCT	O


RFLAT-1	B-protein	NOUN	B
is	O	AUX	O
a	O	DET	O
novel	O	ADJ	B
,	O	PUNCT	O
phosphorylated	O	VERB	B
,	O	PUNCT	O
zinc	B-protein	NOUN	B
finger	I-protein	NOUN	I
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
that	O	PRON	O
is	O	AUX	O
expressed	O	VERB	B
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
3	O	NUM	I
days	O	NOUN	B
after	O	ADP	O
activation	O	NOUN	B
,	O	PUNCT	O
coincident	O	ADJ	B
with	O	ADP	O
RANTES	B-protein	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


Here	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
report	O	VERB	O
that	O	SCONJ	O
expression	O	NOUN	B
of	O	ADP	O
FasL	B-protein	NOUN	B
protein	I-protein	NOUN	I
and	O	CCONJ	O
mRNA	B-RNA	NOUN	B
in	O	ADP	O
activated	B-cell_type	VERB	B
NK	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
is	O	AUX	O
also	O	ADV	O
regulated	O	VERB	O
by	O	ADP	O
redox	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
CD16	B-protein	NOUN	B
stimulation	O	NOUN	I
requires	O	VERB	O
cellular	O	ADJ	B
reducing	O	NOUN	I
status	O	NOUN	I
for	O	ADP	O
FasL	B-protein	NOUN	B
induction	O	NOUN	B
in	O	ADP	O
NK	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Purified	B-cell_line	VERB	B
human	I-cell_line	ADJ	B
peripheral	I-cell_line	ADJ	O
T	I-cell_line	NOUN	O
cells	I-cell_line	NOUN	O
or	O	CCONJ	O
Jurkat	B-cell_line	NOUN	B
T	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
were	O	AUX	O
stimulated	O	VERB	B
with	O	ADP	O
Chinese	O	ADJ	B
hamster	O	NOUN	I
ovary	O	NOUN	I
(	O	PUNCT	O
CHO	O	NOUN	B
)	O	PUNCT	O
cells	O	NOUN	B
expressing	O	VERB	B
either	O	CCONJ	O
human	B-protein	ADJ	B
CD80	I-protein	NOUN	B
(	O	PUNCT	O
CHO-CD80	B-protein	NOUN	B
)	O	PUNCT	O
or	O	CCONJ	O
human	B-protein	ADJ	B
CD86	I-protein	NOUN	B
(	O	PUNCT	O
CHO-CD86	B-protein	NOUN	B
)	O	PUNCT	O
or	O	CCONJ	O
with	O	ADP	O
anti-CD28	B-protein	ADJ	B
monoclonal	I-protein	ADJ	I
antibody	I-protein	NOUN	I
(	O	PUNCT	O
mAb	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
phorbol	O	NOUN	B
12-myristate	O	NOUN	I
13-acetate	O	NOUN	I
,	O	PUNCT	O
both	O	CCONJ	O
CHO-CD80	B-protein	NOUN	B
and	O	CCONJ	O
CHO-CD86	B-protein	NOUN	B
,	O	PUNCT	O
like	O	ADP	O
anti-CD28	B-protein	ADJ	B
mAb	I-protein	NOUN	B
,	O	PUNCT	O
were	O	AUX	O
capable	O	ADJ	O
of	O	ADP	O
stimulating	O	VERB	B
cytokine	B-protein	NOUN	B
production	O	NOUN	I
from	O	ADP	O
both	O	CCONJ	O
human	B-cell_type	ADJ	B
peripheral	I-cell_type	ADJ	B
T	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
and	O	CCONJ	O
Jurkat	B-cell_line	NOUN	B
T	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
association	O	NOUN	B
of	O	ADP	O
phosphoinositide	B-protein	NOUN	B
3-kinase	I-protein	NOUN	I
with	O	ADP	O
CD28	B-protein	NOUN	B
and	O	CCONJ	O
enhanced	O	VERB	B
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	I
of	O	ADP	O
phospholipase	O	NOUN	B
Cgamma	O	NOUN	I
were	O	AUX	O
seen	O	VERB	O
after	O	ADP	O
anti-CD28	O	ADJ	B
mAb	O	NOUN	B
and	O	CCONJ	O
CHO-CD80	O	NOUN	B
stimulation	O	NOUN	I
but	O	CCONJ	O
to	O	ADP	O
a	O	DET	O
much	O	ADV	O
lesser	O	ADJ	B
extent	O	NOUN	O
after	O	ADP	O
CHO-CD86	B-protein	NOUN	B
stimulation	O	NOUN	I
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
ligation	O	NOUN	B
of	O	ADP	O
CD28	B-protein	NOUN	B
with	O	ADP	O
either	O	CCONJ	O
CD80	B-protein	NOUN	B
or	O	CCONJ	O
CD86	B-protein	NOUN	B
leads	O	VERB	O
to	O	PART	O
shared	O	VERB	O
early	O	ADJ	O
signal	O	NOUN	B
transduction	O	NOUN	I
events	O	NOUN	B
such	O	ADJ	O
as	O	ADP	O
the	O	DET	O
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	B
of	O	ADP	O
CBL	B-protein	NOUN	B
and	O	CCONJ	O
VAV	B-protein	NOUN	B
,	O	PUNCT	O
to	O	PART	O
NFAT	B-protein	NOUN	B
-mediated	O	ADJ	O
transcriptional	O	ADJ	B
activation	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
to	O	PART	O
the	O	DET	O
costimulation	O	NOUN	B
of	O	ADP	O
interleukin-2	B-protein	NOUN	B
and	O	CCONJ	O
granulocyte-macrophage	B-protein	ADJ	B
colony-stimulating	I-protein	ADJ	I
factor	I-protein	NOUN	I
production	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
previously	O	ADV	O
showed	O	VERB	O
that	O	SCONJ	O
repression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
beta-globin	O	NOUN	B
gene	O	NOUN	I
appears	O	VERB	O
to	O	PART	O
be	O	AUX	O
mediated	O	VERB	O
through	O	ADP	O
two	O	NUM	O
DNA	B-DNA	NOUN	B
sequences	I-DNA	NOUN	I
,	O	PUNCT	O
silencers	B-DNA	NOUN	B
I	I-DNA	NUM	I
and	I-DNA	CCONJ	I
II	I-DNA	NUM	B
,	O	PUNCT	O
and	O	CCONJ	O
identified	O	VERB	B
a	O	DET	O
protein	O	NOUN	B
termed	O	VERB	O
BP1	B-protein	NOUN	B
which	O	DET	O
binds	O	VERB	B
to	O	PART	O
both	O	CCONJ	O
silencer	O	NOUN	B
sequences	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
cDNAs	B-DNA	NOUN	B
correspond	O	VERB	O
to	O	PART	O
HMG-I	B-protein	NOUN	B
and	O	CCONJ	O
HMG-Y	B-protein	NOUN	B
,	O	PUNCT	O
isoforms	O	NOUN	B
regarded	O	VERB	O
as	O	ADP	O
architectural	B-protein	ADJ	B
proteins	I-protein	NOUN	I
.	O	PUNCT	O


HMG-I	B-protein	NOUN	B
(	I-protein	PUNCT	O
Y	I-protein	NOUN	B
)	I-protein	PUNCT	O
also	O	ADV	O
binds	O	VERB	B
to	O	PART	O
a	O	DET	O
second	O	ADJ	O
oligonucleotide	O	NOUN	B
containing	O	VERB	O
a	O	DET	O
BP1	B-DNA	NOUN	B
binding	I-DNA	NOUN	B
site	I-DNA	NOUN	I
located	O	ADJ	O
in	O	ADP	O
a	O	DET	O
negative	B-DNA	ADJ	B
control	I-DNA	NOUN	O
region	I-DNA	NOUN	O
upstream	O	ADJ	O
of	O	ADP	O
the	O	DET	O
delta-globin	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
,	O	PUNCT	O
suggesting	O	VERB	O
a	O	DET	O
role	O	NOUN	O
for	O	ADP	O
HMG-I	B-protein	NOUN	B
(	I-protein	PUNCT	O
Y	I-protein	NOUN	B
)	I-protein	PUNCT	O
in	O	ADP	O
repression	O	NOUN	B
of	O	ADP	O
adult	O	ADJ	B
globin	O	NOUN	B
genes	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
present	O	VERB	O
a	O	DET	O
model	O	NOUN	B
in	O	ADP	O
which	O	DET	O
HMG-I	B-protein	NOUN	B
(	I-protein	PUNCT	O
Y	I-protein	NOUN	B
)	I-protein	PUNCT	O
alters	O	VERB	O
DNA	O	NOUN	B
conformation	O	NOUN	I
to	O	PART	O
allow	O	VERB	O
binding	O	NOUN	B
of	O	ADP	O
repressor	B-protein	NOUN	B
proteins	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
in	O	ADP	O
which	O	DET	O
the	O	DET	O
relative	O	ADJ	O
amount	O	NOUN	O
of	O	ADP	O
HMG-I	O	NOUN	B
(	O	PUNCT	O
Y	O	NOUN	O
)	O	PUNCT	O
helps	O	VERB	O
to	O	PART	O
determine	O	VERB	O
the	O	DET	O
repressive	O	ADJ	B
state	O	NOUN	I
of	O	ADP	O
the	O	DET	O
beta-globin	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
hypothesized	O	VERB	O
that	O	SCONJ	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
A	I-protein	NOUN	I
signaling	O	NOUN	B
pathway	O	NOUN	I
may	O	AUX	O
inhibit	O	VERB	B
NF-kappaB	B-protein	NOUN	B
-mediated	O	ADJ	O
transcription	O	NOUN	B
by	O	ADP	O
phosphorylating	O	VERB	B
proteins	O	NOUN	I
,	O	PUNCT	O
such	O	ADJ	O
as	O	ADP	O
cAMP	B-protein	NOUN	B
response	I-protein	NOUN	I
element-binding	I-protein	ADJ	I
protein	I-protein	NOUN	I
(	O	PUNCT	O
CREB	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
which	O	DET	O
compete	O	VERB	O
for	O	ADP	O
limiting	O	VERB	O
amounts	O	NOUN	O
of	O	ADP	O
the	O	DET	O
coactivator	O	NOUN	B
CBP	B-protein	NOUN	I
.	O	PUNCT	O


Glucocorticoid	B-protein	NOUN	B
receptors	I-protein	NOUN	I
in	O	ADP	O
cord	B-cell_type	NOUN	B
blood	I-cell_type	NOUN	I
lymphocytes	I-cell_type	NOUN	I
of	O	ADP	O
healthy	O	ADJ	B
neonates	O	NOUN	B
and	O	CCONJ	O
of	O	ADP	O
preterms	O	NOUN	B
suffering	O	VERB	O
from	O	ADP	O
respiratory	O	ADJ	B
distress	O	NOUN	I
syndrome	O	NOUN	I
.	O	PUNCT	O


Seven	O	NUM	O
preterms	O	NOUN	B
developed	O	VERB	O
neonatal	O	ADJ	B
respiratory	O	ADJ	B
distress	O	NOUN	I
syndrome	O	NOUN	I
(	O	PUNCT	O
NRDS	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Sensitivity	O	NOUN	B
(	O	PUNCT	O
ID50	O	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
the	O	DET	O
lymphocytes	B-cell_type	NOUN	B
for	O	ADP	O
the	O	DET	O
inhibitory	O	ADJ	B
effect	O	NOUN	O
of	O	ADP	O
dexamethasone	O	NOUN	B
was	O	AUX	O
the	O	DET	O
same	O	ADJ	O
in	O	ADP	O
all	O	DET	O
groups	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
study	O	NOUN	B
on	O	ADP	O
the	O	DET	O
number	O	NOUN	B
and	O	CCONJ	O
function	O	NOUN	B
of	O	ADP	O
GR	B-protein	NOUN	B
in	O	ADP	O
lymphocytes	B-cell_type	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
were	O	AUX	O
unable	O	ADJ	O
to	O	PART	O
find	O	VERB	O
a	O	DET	O
relation	O	NOUN	O
between	O	ADP	O
the	O	DET	O
functionality	O	NOUN	B
of	O	ADP	O
the	O	DET	O
GR	B-protein	NOUN	B
and	O	CCONJ	O
the	O	DET	O
development	O	NOUN	B
of	O	ADP	O
NRDS	O	PROPN	B
.	O	PUNCT	O


Such	O	ADJ	O
NF-ATp	B-protein	NOUN	B
-/-	O	ADJ	O
mice	O	NOUN	B
are	O	AUX	O
born	O	VERB	B
and	O	CCONJ	O
appear	O	VERB	O
to	O	PART	O
develop	O	VERB	O
a	O	DET	O
normal	O	ADJ	O
immune	O	ADJ	B
system	O	NOUN	I
.	O	PUNCT	O


Apart	O	ADV	O
from	O	ADP	O
clear-cut	O	ADJ	O
defects	O	NOUN	B
in	O	ADP	O
the	O	DET	O
synthesis	O	NOUN	B
of	O	ADP	O
mRNAs	B-RNA	NOUN	B
for	O	ADP	O
Th2-type	B-protein	ADJ	B
lymphokines	I-protein	NOUN	B
,	O	PUNCT	O
such	O	ADJ	O
as	O	ADP	O
IL-4	B-protein	NOUN	B
,	O	PUNCT	O
IL-5	B-protein	NOUN	B
,	O	PUNCT	O
IL-10	B-protein	NOUN	B
and	O	CCONJ	O
IL-13	B-protein	NOUN	B
,	O	PUNCT	O
in	O	ADP	O
primary	O	ADJ	B
and	O	CCONJ	O
secondary	O	ADJ	B
stimulations	O	NOUN	B
of	O	ADP	O
spleen	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
in	O	X	B
vitro	O	X	I
,	O	PUNCT	O
of	O	ADP	O
a	O	DET	O
distinct	O	ADJ	O
impaired	O	ADJ	B
deletion	O	NOUN	B
of	O	ADP	O
V	B-cell_line	NOUN	O
beta	I-cell_line	NOUN	O
11+/CD4+	I-cell_line	ADJ	O
T	I-cell_line	NOUN	O
lymphocytes	I-cell_line	NOUN	O
from	O	ADP	O
these	O	DET	O
mice	O	NOUN	B
was	O	AUX	O
detected	O	VERB	B
after	O	ADP	O
superantigen	O	NOUN	B
injection	O	NOUN	B
.	O	PUNCT	O


Daidzein	O	NOUN	B
and	O	CCONJ	O
genistein	O	NOUN	B
glucuronides	O	NOUN	B
in	O	X	B
vitro	O	X	I
are	O	AUX	O
weakly	O	ADV	O
estrogenic	O	ADJ	B
and	O	CCONJ	O
activate	O	VERB	B
human	B-cell_type	ADJ	B
natural	I-cell_type	ADJ	O
killer	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
at	O	ADP	O
nutritionally	O	ADV	B
relevant	O	ADJ	I
concentrations	O	NOUN	B
.	O	PUNCT	O


DG	O	NOUN	B
and	O	CCONJ	O
GG	O	NOUN	B
were	O	AUX	O
further	O	ADV	O
purified	O	VERB	B
by	O	ADP	O
a	O	DET	O
Sephadex	O	NOUN	B
LH-20	O	NOUN	I
column	O	NOUN	I
.	O	PUNCT	O


Cross-linking	O	NOUN	B
of	O	ADP	O
CD44	B-protein	NOUN	B
on	O	ADP	O
rheumatoid	B-cell_type	ADJ	B
synovial	I-cell_type	ADJ	O
cells	I-cell_type	NOUN	O
up-regulates	O	VERB	B
VCAM-1	B-protein	NOUN	B
.	O	PUNCT	O


CD44	O	NOUN	B
is	O	AUX	O
a	O	DET	O
ubiquitous	O	ADJ	B
molecule	O	NOUN	I
also	O	ADV	O
known	O	VERB	O
as	O	ADP	O
hyaluronic	O	ADJ	B
acid	O	NOUN	I
or	O	CCONJ	O
homing	O	VERB	B
receptor	O	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
cellular	O	ADJ	B
functions	O	NOUN	I
and	O	CCONJ	O
its	O	PRON	O
role	O	NOUN	O
in	O	ADP	O
inflammation	O	NOUN	B
,	O	PUNCT	O
for	O	ADP	O
example	O	NOUN	O
,	O	PUNCT	O
rheumatoid	O	ADJ	B
synovitis	O	NOUN	I
,	O	PUNCT	O
are	O	AUX	O
currently	O	ADV	O
unknown	O	ADJ	B
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
study	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
propose	O	VERB	O
a	O	DET	O
novel	O	ADJ	O
function	O	NOUN	B
for	O	ADP	O
CD44	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
therefore	O	ADV	O
propose	O	VERB	O
that	O	SCONJ	O
such	O	ADJ	O
cross-talking	O	NOUN	B
among	O	ADP	O
distinct	O	ADJ	O
adhesion	O	NOUN	B
molecules	O	NOUN	O
may	O	AUX	O
be	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
pathogenesis	O	NOUN	B
of	O	ADP	O
inflammation	O	NOUN	B
,	O	PUNCT	O
including	O	VERB	O
RA	O	NOUN	B
synovitis	O	NOUN	B
.	O	PUNCT	O


NF-kappaB	B-protein	NOUN	B
activation	O	NOUN	B
is	O	AUX	O
a	O	DET	O
critical	O	ADJ	O
regulator	O	NOUN	B
of	O	ADP	O
human	O	ADJ	B
granulocyte	O	NOUN	O
apoptosis	O	NOUN	B
in	O	X	B
vitro	O	X	I
.	O	PUNCT	O


Although	O	SCONJ	O
overexpressed	O	VERB	B
Egr-1	B-protein	NOUN	B
was	O	AUX	O
ineffective	O	ADJ	B
,	O	PUNCT	O
overexpressed	O	VERB	B
Egr-2	B-protein	NOUN	B
was	O	AUX	O
as	O	ADV	O
potent	O	ADJ	O
as	O	ADP	O
Egr-3	B-protein	NOUN	B
in	O	ADP	O
inducing	O	VERB	O
fasL	B-DNA	NOUN	B
promoter-dependent	I-DNA	ADJ	B
reporter	I-DNA	NOUN	I
constructs	I-DNA	NOUN	I
in	O	ADP	O
T	O	NOUN	B
cell	O	NOUN	I
hybridomas	O	NOUN	B
and	O	CCONJ	O
HeLa	O	NOUN	B
cells	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
both	O	DET	O
up-regulated	O	VERB	B
endogenous	O	ADJ	B
fasL	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
in	O	ADP	O
HeLa	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
study	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
analyzed	O	VERB	B
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
NF-Y	B-protein	NOUN	B
expression	O	NOUN	I
during	O	ADP	O
human	O	ADJ	B
monocyte	O	NOUN	B
to	O	PART	O
macrophage	O	NOUN	B
maturation	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
protein	O	NOUN	B
tyrosine	O	NOUN	I
kinase	O	NOUN	I
ZAP-70	B-protein	NOUN	B
plays	O	VERB	O
an	O	DET	O
important	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
T-cell	O	NOUN	B
activation	O	NOUN	I
and	O	CCONJ	O
development	O	NOUN	B
.	O	PUNCT	O


Previously	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
demonstrated	O	VERB	O
that	O	SCONJ	O
Y292	O	NOUN	B
negatively	O	ADV	O
regulates	O	VERB	B
ZAP-70	B-protein	NOUN	B
function	O	NOUN	B
and	O	CCONJ	O
that	O	SCONJ	O
Y315	O	NOUN	B
positively	O	ADV	B
regulates	O	VERB	B
ZAP-70	B-protein	NOUN	B
function	O	NOUN	B
by	O	ADP	O
interacting	O	VERB	B
with	O	ADP	O
Vav	B-protein	NOUN	B
.	O	PUNCT	O


Recent	O	ADJ	O
studies	O	NOUN	B
have	O	AUX	O
suggested	O	VERB	O
that	O	SCONJ	O
Y319	O	NOUN	B
also	O	ADV	O
positively	O	ADV	O
regulate	O	VERB	B
ZAP-70	B-protein	NOUN	B
function	O	NOUN	B
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
Delta	B-protein	NOUN	B
still	O	ADV	O
utilizes	O	VERB	O
the	O	DET	O
same	O	ADJ	O
pathways	O	NOUN	B
as	O	ADP	O
wild-type	O	ADJ	B
ZAP-70	B-protein	NOUN	B
to	O	PART	O
mediate	O	VERB	O
NF-AT	B-protein	NOUN	B
induction	O	NOUN	B
.	O	PUNCT	O


Lysates	O	NOUN	B
from	O	ADP	O
CD19	B-protein	NOUN	B
cross-linked	O	ADJ	B
1E8	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
induced	O	VERB	B
robust	O	ADJ	B
phosphorylation	O	NOUN	B
of	O	ADP	O
an	O	DET	O
Elk-1	B-protein	NOUN	B
fusion	I-protein	NOUN	I
protein	I-protein	NOUN	I
in	O	X	B
vitro	O	X	I
,	O	PUNCT	O
whereas	O	SCONJ	O
no	O	DET	O
phosphorylation	O	NOUN	B
of	O	ADP	O
Elk-1	B-protein	NOUN	B
fusion	I-protein	NOUN	I
protein	I-protein	NOUN	I
occurred	O	VERB	O
using	O	VERB	O
lysates	O	NOUN	B
from	O	ADP	O
CD19	B-cell_line	NOUN	B
cross-linked	I-cell_line	ADJ	B
BLIN-1	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	O
.	O	PUNCT	O


Identification	O	NOUN	B
of	O	ADP	O
target	B-DNA	NOUN	B
genes	I-DNA	NOUN	O
of	O	ADP	O
the	O	DET	O
lymphoid-specific	B-protein	ADJ	B
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
Oct2	I-protein	NOUN	B
.	O	PUNCT	O


Whereas	O	SCONJ	O
CD36	B-protein	NOUN	B
and	O	CCONJ	O
mEI	B-protein	NOUN	B
were	O	AUX	O
expressed	O	VERB	B
in	O	ADP	O
all	O	DET	O
hematopoetic	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
containing	O	VERB	O
Oct2	B-protein	NOUN	B
,	O	PUNCT	O
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
purified	O	VERB	B
the	O	DET	O
RFX	B-protein	NOUN	B
complex	I-protein	NOUN	B
and	O	CCONJ	O
sequenced	O	VERB	B
its	O	PRON	O
three	O	NUM	O
subunits	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
sequence	O	NOUN	B
of	O	ADP	O
the	O	DET	O
smallest	O	ADJ	O
subunit	O	NOUN	B
describes	O	VERB	O
a	O	DET	O
novel	O	ADJ	O
gene	O	NOUN	B
,	O	PUNCT	O
termed	O	VERB	O
RFX-B	B-DNA	NOUN	B
.	O	PUNCT	O


A	O	DET	O
characteristic	O	NOUN	O
of	O	ADP	O
HTLV-I-transformed	B-cell_type	ADJ	B
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
is	O	AUX	O
the	O	DET	O
constitutive	O	ADJ	B
nuclear	O	ADJ	B
expression	O	NOUN	I
of	O	ADP	O
NF-kappaB/Rel	B-protein	NOUN	B
family	I-protein	NOUN	O
of	O	ADP	O
transcription	O	NOUN	B
factors	O	NOUN	I
,	O	PUNCT	O
which	O	DET	O
appears	O	VERB	O
to	O	PART	O
be	O	AUX	O
essential	O	ADJ	B
for	O	ADP	O
the	O	DET	O
growth	O	NOUN	B
of	O	ADP	O
these	O	DET	O
transformed	B-cell_type	VERB	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Using	O	VERB	O
sequential	B-DNA	ADJ	B
deletion	I-DNA	NOUN	B
mutants	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
fas	I-DNA	NOUN	O
promoter	I-DNA	NOUN	B
in	O	ADP	O
transient	O	ADJ	B
transfection	O	NOUN	B
assays	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
identified	O	VERB	B
a	O	DET	O
47-bp	B-DNA	ADJ	O
sequence	I-DNA	NOUN	B
(	O	PUNCT	O
positions	B-DNA	NOUN	B
-306	I-DNA	NUM	O
to	I-DNA	PART	O
-260	I-DNA	NUM	O
relative	O	ADJ	O
to	O	PART	O
the	O	DET	O
ATG	O	NOUN	B
)	O	PUNCT	O
required	O	VERB	O
for	O	ADP	O
activation-driven	O	ADJ	O
fas	O	NOUN	B
upregulation	O	NOUN	B
.	O	PUNCT	O


Sp1	B-protein	NOUN	B
and	O	CCONJ	O
NF-kappaB	B-protein	NOUN	B
transcription	O	NOUN	I
factor	O	NOUN	I
binding	O	NOUN	I
was	O	AUX	O
shown	O	VERB	O
to	O	PART	O
be	O	AUX	O
mutually	O	ADV	O
exclusive	O	ADJ	O
by	O	ADP	O
EMSA	O	NOUN	B
displacement	O	NOUN	O
studies	O	NOUN	O
with	O	ADP	O
purified	O	VERB	O
recombinant	O	ADJ	B
Sp1	B-protein	NOUN	B
and	O	CCONJ	O
recombinant	O	ADJ	B
p50	B-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
functional	O	ADJ	B
contribution	O	NOUN	B
of	O	ADP	O
the	O	DET	O
kappaB-Sp1	B-DNA	NOUN	B
composite	I-DNA	ADJ	I
site	I-DNA	NOUN	B
in	O	ADP	O
P/I-inducible	B-DNA	ADJ	B
fas	I-DNA	NOUN	I
promoter	I-DNA	NOUN	B
activation	O	NOUN	I
was	O	AUX	O
verified	O	VERB	O
by	O	ADP	O
using	O	VERB	O
kappaB-	O	NOUN	B
Sp1	B-protein	NOUN	I
concatamers	O	NOUN	I
(	O	PUNCT	O
-295	B-DNA	NUM	O
to	I-DNA	PART	O
-286	I-DNA	NUM	O
)	O	PUNCT	O
in	O	ADP	O
a	O	DET	O
thymidine	B-DNA	NOUN	B
kinase	I-DNA	NOUN	I
promoter-driven	I-DNA	ADJ	I
reporter	I-DNA	NOUN	I
construct	I-DNA	NOUN	I
and	O	CCONJ	O
native	B-DNA	ADJ	B
promoter	I-DNA	NOUN	B
constructs	I-DNA	NOUN	I
in	O	ADP	O
Jurkat	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
overexpressing	O	VERB	B
IkappaB-alpha	B-protein	NOUN	B
.	O	PUNCT	O


Fusion	O	NOUN	B
of	O	ADP	O
anergic	B-cell_type	ADJ	B
murine	I-cell_type	ADJ	I
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
to	O	PART	O
human	B-cell_type	ADJ	B
Jurkat	I-cell_type	NOUN	O
T	I-cell_type	NOUN	O
leukemia	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	B
and	O	CCONJ	O
formation	O	NOUN	B
of	O	ADP	O
heterokaryons	B-cell_line	NOUN	B
failed	O	VERB	B
to	O	PART	O
result	O	VERB	O
in	O	ADP	O
a	O	DET	O
complementation	O	NOUN	B
of	O	ADP	O
this	O	DET	O
signaling	O	NOUN	B
defect	O	NOUN	I
and	O	CCONJ	O
restoration	O	NOUN	B
of	O	ADP	O
murine	B-RNA	ADJ	B
IL-2	I-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
inducibility	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
amounts	O	NOUN	O
of	O	ADP	O
transcriptionally	O	ADV	B
active	O	ADJ	O
phosphorylated	B-protein	ADJ	B
CREB	I-protein	NOUN	O
protein	I-protein	NOUN	O
(	O	PUNCT	O
P-CREB	B-protein	NOUN	B
)	O	PUNCT	O
differ	O	VERB	O
between	O	ADP	O
activated	O	VERB	B
PBMC	B-cell_type	NOUN	B
and	O	CCONJ	O
Jurkat	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Using	O	VERB	O
electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assays	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
determined	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
pattern	O	NOUN	B
of	O	ADP	O
band	O	NOUN	B
migration	O	NOUN	I
differed	O	VERB	O
between	O	ADP	O
the	O	DET	O
two	O	NUM	O
cell	O	NOUN	B
types	O	NOUN	I
.	O	PUNCT	O


Inhibition	O	NOUN	B
of	O	ADP	O
NO	B-protein	NOUN	B
synthase	I-protein	NOUN	I
(	O	PUNCT	O
NOS	B-protein	NOUN	B
)	O	PUNCT	O
during	O	ADP	O
the	O	DET	O
second	O	ADJ	O
A/R	O	NOUN	B
challenge	O	NOUN	O
prevents	O	VERB	B
the	O	DET	O
development	O	NOUN	B
of	O	ADP	O
A/R	O	NOUN	B
tolerance	O	NOUN	B
with	O	ADP	O
respect	O	NOUN	O
to	O	PART	O
PMN	O	NOUN	B
adhesion	O	NOUN	B
.	O	PUNCT	O


Oxidized	O	VERB	B
low-density	B-protein	ADJ	I
lipoproteins	I-protein	NOUN	I
(	O	PUNCT	O
oxLDLs	B-protein	NOUN	B
)	O	PUNCT	O
are	O	AUX	O
considered	O	VERB	O
to	O	PART	O
be	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
pathogenesis	O	NOUN	B
of	O	ADP	O
the	O	DET	O
lesions	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
we	O	PRON	O
have	O	AUX	O
previously	O	ADV	O
demonstrated	O	VERB	O
that	O	SCONJ	O
oxLDLs	B-protein	NOUN	B
inhibit	O	VERB	B
not	O	PART	O
only	O	ADV	O
interleukin	B-protein	NOUN	B
(	I-protein	PUNCT	O
IL	I-protein	NOUN	B
)	I-protein	PUNCT	O
-2-receptor	I-protein	NOUN	O
expression	O	NOUN	B
on	O	ADP	O
the	O	DET	O
surface	O	NOUN	B
of	O	ADP	O
in	O	ADP	O
vitro-activated	O	ADJ	B
T-lymphocytes	O	NOUN	B
but	O	CCONJ	O
also	O	ADV	O
their	O	PRON	O
proliferation	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
now	O	ADV	O
investigated	O	VERB	B
the	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
oxLDLs	B-protein	NOUN	B
on	O	ADP	O
blast	O	NOUN	B
differentiation	O	NOUN	I
,	O	PUNCT	O
on	O	ADP	O
IL-2	B-protein	NOUN	B
synthesis	O	NOUN	B
and	O	CCONJ	O
on	O	ADP	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
kappaB	I-protein	NOUN	I
(	O	PUNCT	O
NF-kappaB	B-protein	NOUN	B
)	O	PUNCT	O
system	O	NOUN	O
in	O	ADP	O
activated	O	VERB	B
lymphocytes	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
B29	B-DNA	NOUN	B
(	I-DNA	PUNCT	O
immunoglobulin	I-DNA	NOUN	O
beta-chain	I-DNA	NOUN	O
)	I-DNA	PUNCT	O
gene	I-DNA	NOUN	O
is	O	AUX	O
a	O	DET	O
genetic	O	ADJ	B
target	O	NOUN	I
for	O	ADP	O
early	B-protein	ADJ	B
B-cell	I-protein	NOUN	B
factor	I-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
lack	O	NOUN	B
of	O	ADP	O
B29	B-RNA	NOUN	B
transcripts	I-RNA	NOUN	I
,	O	PUNCT	O
coding	O	VERB	B
for	O	ADP	O
the	O	DET	O
beta	B-protein	NOUN	B
subunit	I-protein	NOUN	I
of	O	ADP	I
the	O	DET	I
B-cell	O	NOUN	I
receptor	O	NOUN	I
complex	O	NOUN	I
,	O	PUNCT	O
in	O	ADP	O
pro-B	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
from	O	ADP	O
EBF	B-protein	NOUN	B
-deficient	O	ADJ	O
mice	O	NOUN	B
suggested	O	VERB	O
that	O	SCONJ	O
B29	O	NOUN	B
might	O	AUX	O
be	O	AUX	O
a	O	DET	O
genetic	O	ADJ	B
target	O	NOUN	I
for	O	ADP	O
EBF	B-protein	NOUN	B
.	O	PUNCT	O


DOR1	B-protein	NOUN	B
ligation	O	NOUN	B
by	O	ADP	O
a	O	DET	O
specific	O	ADJ	O
DOR1	B-protein	NOUN	B
agonist	O	NOUN	B
,	O	PUNCT	O
deltorphin	O	NOUN	B
,	O	PUNCT	O
augmented	O	VERB	B
IL-2	B-protein	NOUN	B
secretion	O	NOUN	O
by	O	ADP	O
synergizing	O	VERB	B
with	O	ADP	O
signals	O	NOUN	B
from	O	ADP	O
TCR-CD3	B-protein	NOUN	B
and	O	CCONJ	O
CD28	B-protein	NOUN	B
.	O	PUNCT	O


Although	O	SCONJ	O
DOR1	B-protein	NOUN	B
signaling	O	NOUN	B
increased	O	VERB	B
[	O	PUNCT	O
Ca2+	O	NOUN	B
]	O	PUNCT	O
i	O	NUM	O
,	O	PUNCT	O
deltorphin	O	NOUN	B
enhanced	O	VERB	O
transcriptional	O	ADJ	B
activity	O	NOUN	I
of	O	ADP	O
the	O	DET	O
NF-AT/AP-1-binding	B-DNA	VERB	B
site	I-DNA	NOUN	I
via	O	ADP	O
a	O	DET	O
mechanism	O	NOUN	B
independent	O	ADJ	B
of	O	ADP	O
calcineurin	B-protein	NOUN	B
and	O	CCONJ	O
distinct	O	ADJ	O
from	O	ADP	O
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	I
elevated	O	ADJ	B
[	O	PUNCT	O
Ca2+	O	NOUN	B
]	O	PUNCT	O
i	O	NUM	O
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
present	O	ADJ	O
study	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
characterized	O	VERB	B
the	O	DET	O
transcriptional	O	ADJ	B
induction	O	NOUN	O
of	O	ADP	O
p40	B-protein	NOUN	B
by	O	ADP	O
CD40	B-protein	NOUN	B
ligation	O	NOUN	B
in	O	ADP	O
a	O	DET	O
human	B-cell_line	ADJ	B
B	I-cell_line	NOUN	I
lymphoblastoid	I-cell_line	ADJ	I
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
,	O	PUNCT	O
Daudi	B-cell_line	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
human	B-cell_line	ADJ	B
acute	I-cell_line	ADJ	O
monocytic	I-cell_line	ADJ	O
leukemia	I-cell_line	NOUN	O
cell	I-cell_line	NOUN	B
line	I-cell_line	NOUN	I
,	O	PUNCT	O
THP-1	B-cell_line	NOUN	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
NF-kappaB	B-DNA	NOUN	B
binding	I-DNA	NOUN	I
site	I-DNA	NOUN	I
located	O	ADJ	O
around	O	ADP	O
120	O	NUM	O
bp	O	NOUN	O
upstream	O	ADJ	O
of	O	ADP	O
the	O	DET	O
transcription	B-DNA	NOUN	B
initiation	I-DNA	NOUN	I
site	I-DNA	NOUN	I
in	O	ADP	O
murine	B-DNA	ADJ	B
and	I-DNA	CCONJ	O
human	I-DNA	ADJ	B
p40	I-DNA	NOUN	I
promoter	I-DNA	NOUN	B
regions	I-DNA	NOUN	I
could	O	AUX	O
be	O	AUX	O
important	O	ADJ	O
for	O	ADP	O
the	O	DET	O
p40	B-protein	NOUN	B
induction	O	NOUN	B
by	O	ADP	O
CD40	B-protein	NOUN	B
ligation	O	NOUN	B
via	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
NF-kappaB	B-protein	NOUN	B
.	O	PUNCT	O


No	O	DET	O
mutation	O	NOUN	B
was	O	AUX	O
identified	O	VERB	B
in	O	ADP	O
either	O	DET	O
of	O	ADP	O
the	O	DET	O
genes	O	NOUN	B
in	O	ADP	O
the	O	DET	O
gynecomastias	O	NOUN	B
.	O	PUNCT	O


Reactive	O	ADJ	B
oxygen	O	NOUN	I
intermediate-dependent	O	ADJ	O
NF-kappaB	B-protein	NOUN	B
activation	O	NOUN	B
by	O	ADP	O
interleukin-1beta	B-protein	NOUN	B
requires	O	VERB	O
5-lipoxygenase	B-protein	NOUN	B
or	O	CCONJ	O
NADPH	O	NOUN	B
oxidase	O	NOUN	I
activity	O	NOUN	B
.	O	PUNCT	O


Stimulation	O	NOUN	B
of	O	ADP	O
lymphoid	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
with	O	ADP	O
interleukin-1beta	B-protein	NOUN	B
(	O	PUNCT	O
IL-1beta	B-protein	NOUN	B
)	O	PUNCT	O
led	O	VERB	O
to	O	PART	O
ROI	O	NOUN	B
production	O	NOUN	B
and	O	CCONJ	O
NF-kappaB	B-protein	NOUN	B
activation	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
could	O	AUX	O
both	O	DET	O
be	O	AUX	O
blocked	O	VERB	B
by	O	ADP	O
antioxidants	O	NOUN	B
or	O	CCONJ	O
FLAP	B-protein	NOUN	B
inhibitors	O	NOUN	B
,	O	PUNCT	O
confirming	O	VERB	O
that	O	SCONJ	O
5-LOX	B-protein	NOUN	B
was	O	AUX	O
the	O	DET	O
source	O	NOUN	B
of	O	ADP	O
ROIs	O	NOUN	B
and	O	CCONJ	O
was	O	AUX	O
required	O	VERB	O
for	O	ADP	O
NF-kappaB	B-protein	NOUN	B
activation	O	NOUN	B
in	O	ADP	O
these	O	DET	O
cells	O	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
reintroduction	O	NOUN	B
of	O	ADP	O
a	O	DET	O
functional	O	ADJ	B
5-LOX	B-protein	NOUN	B
system	O	NOUN	I
in	O	ADP	O
these	O	DET	O
cells	O	NOUN	B
allowed	O	VERB	O
ROI	O	NOUN	B
production	O	NOUN	B
and	O	CCONJ	O
5-LOX	B-protein	NOUN	B
-dependent	O	ADJ	O
NF-kappaB	B-protein	NOUN	B
activation	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
conclusion	O	NOUN	O
,	O	PUNCT	O
three	O	NUM	O
different	O	ADJ	O
cell-specific	O	ADJ	B
pathways	O	NOUN	I
lead	O	VERB	O
to	O	PART	O
NF-kappaB	B-protein	NOUN	B
activation	O	NOUN	B
by	O	ADP	O
IL-1beta	B-protein	NOUN	B
:	O	PUNCT	O
a	O	DET	O
pathway	O	NOUN	B
dependent	O	ADJ	B
on	O	ADP	O
ROI	O	NOUN	B
production	O	NOUN	B
by	O	ADP	O
5-LOX	B-protein	NOUN	B
in	O	ADP	O
lymphoid	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
an	O	DET	O
ROI-	O	NOUN	B
and	O	CCONJ	O
5-LOX	B-protein	NOUN	B
-independent	O	ADJ	O
pathway	O	NOUN	B
in	O	ADP	O
epithelial	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
pathway	O	NOUN	B
requiring	O	VERB	O
ROI	O	NOUN	B
production	O	NOUN	B
by	O	ADP	O
NADPH	B-protein	NOUN	B
oxidase	I-protein	NOUN	I
in	O	ADP	O
monocytic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Two	O	NUM	O
variants	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IL-4R	B-DNA	NOUN	B
alpha-chain	I-DNA	NOUN	O
(	I-DNA	PUNCT	O
IL-4Ralpha	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
gene	I-DNA	NOUN	O
have	O	AUX	O
been	O	AUX	O
recently	O	ADV	O
identified	O	VERB	B
in	O	ADP	O
association	O	NOUN	B
with	O	ADP	I
different	O	ADJ	O
atopic	O	ADJ	B
disorders	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
agar	O	NOUN	B
cultures	O	NOUN	I
,	O	PUNCT	O
47.10	B-cell_line	NUM	O
cells	I-cell_line	NOUN	B
form	O	VERB	O
7-	O	NUM	O
and	O	CCONJ	O
14-day	O	ADJ	O
colonies	O	NOUN	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
a	O	DET	O
cocktail	O	NOUN	B
of	O	ADP	O
granulocyte/macrophage	B-protein	NOUN	B
colony-stimulating	I-protein	ADJ	I
factor	I-protein	NOUN	I
(	O	PUNCT	O
2.5	O	NUM	O
ng/mL	O	NOUN	O
)	O	PUNCT	O
,	O	PUNCT	O
interleukin-3	B-protein	NOUN	B
(	O	PUNCT	O
1	O	NUM	O
ng/mL	O	NOUN	O
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
mouse	O	NOUN	B
CSF-1	B-protein	NOUN	B
(	O	PUNCT	O
10	O	NUM	O
ng/mL	O	NOUN	O
)	O	PUNCT	O
.	O	PUNCT	O


In	O	ADP	O
conclusion	O	NOUN	O
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
characterized	O	VERB	B
a	O	DET	O
novel	O	ADJ	O
continuous	B-cell_line	ADJ	B
myeloid	I-cell_line	ADJ	I
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
presenting	O	VERB	O
a	O	DET	O
hierarchical	O	ADJ	B
structure	O	NOUN	I
similar	O	ADJ	O
to	O	PART	O
that	O	DET	O
of	O	ADP	O
the	O	DET	O
bone	B-cell_line	NOUN	B
marrow	I-cell_line	NOUN	I
progenitor	I-cell_line	NOUN	I
cell	I-cell_line	NOUN	I
compartment	I-cell_line	NOUN	B
.	O	PUNCT	O


Previous	O	ADJ	O
studies	O	NOUN	B
found	O	VERB	O
that	O	SCONJ	O
P1	B-DNA	NOUN	B
,	O	PUNCT	O
an	O	DET	O
element	O	NOUN	B
of	O	ADP	O
the	O	DET	O
interleukin	B-DNA	NOUN	B
4	I-DNA	NUM	I
(	I-DNA	PUNCT	O
IL-4	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
promoter	I-DNA	NOUN	B
that	O	PRON	O
binds	O	VERB	B
AP-1	O	NOUN	B
,	O	PUNCT	O
is	O	AUX	O
important	O	ADJ	O
for	O	ADP	O
Th2-restricted	O	ADJ	B
IL-4	B-protein	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
JunB	B-protein	NOUN	B
binds	O	VERB	B
directly	O	ADV	O
to	O	PART	O
the	O	DET	O
P1	B-DNA	NOUN	B
site	I-DNA	NOUN	I
and	O	CCONJ	O
synergizes	O	VERB	B
with	O	ADP	O
c-Maf	B-protein	NOUN	B
to	O	PART	O
activate	O	VERB	B
an	O	DET	O
IL-4	B-DNA	NOUN	B
luciferase	I-DNA	NOUN	O
reporter	I-DNA	NOUN	O
gene	I-DNA	NOUN	O
.	O	PUNCT	O


Human	O	ADJ	B
T-cell	O	NOUN	I
leukemia	O	NOUN	I
virus	O	NOUN	O
type	O	NOUN	O
1	O	NUM	O
(	O	PUNCT	O
HTLV-1	O	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
the	O	DET	O
etiologic	O	ADJ	B
agent	O	NOUN	I
of	O	ADP	O
adult	O	ADJ	B
T-cell	O	NOUN	B
leukemia	O	NOUN	I
.	O	PUNCT	O


Tax	B-protein	NOUN	B
stimulated	O	VERB	B
transcription	O	NOUN	B
through	O	ADP	O
NF-kappaB	B-protein	NOUN	B
and	O	CCONJ	O
the	O	DET	O
cyclic	B-DNA	ADJ	B
AMP-responsive	I-DNA	ADJ	B
element-like	I-DNA	ADJ	I
sequence	I-DNA	NOUN	I
in	O	ADP	O
the	O	DET	O
HTLV-1	O	NOUN	B
promoter	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
finding	O	NOUN	B
of	O	ADP	O
Tax	B-protein	NOUN	B
mutants	O	NOUN	B
segregating	O	VERB	B
these	O	DET	O
two	O	NUM	O
pathways	O	NOUN	B
suggested	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
NF-kappaB	B-protein	NOUN	B
pathway	O	NOUN	I
was	O	AUX	O
essential	O	ADJ	O
for	O	ADP	O
IL-2	B-protein	NOUN	B
-independent	O	ADJ	O
growth	O	NOUN	B
of	O	ADP	O
CTLL-2	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
while	O	SCONJ	O
the	O	DET	O
CRE	B-DNA	NOUN	B
pathway	O	NOUN	I
was	O	AUX	O
unnecessary	O	ADJ	O
.	O	PUNCT	O


Regulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
interleukin-2	I-DNA	NOUN	O
gene	I-DNA	NOUN	O
by	O	ADP	O
the	O	DET	O
alpha	B-protein	NOUN	B
and	I-protein	CCONJ	O
beta	I-protein	NOUN	B
isoforms	I-protein	NOUN	I
of	O	ADP	O
the	O	DET	O
glucocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
humans	O	NOUN	B
,	O	PUNCT	O
alternative	O	ADJ	B
splicing	O	NOUN	I
of	O	ADP	O
the	O	DET	O
GR	B-RNA	NOUN	B
precursor	I-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
gives	O	VERB	O
rise	O	NOUN	O
to	O	PART	O
two	O	NUM	O
receptor	O	NOUN	B
isoforms	O	NOUN	I
,	O	PUNCT	O
termed	O	VERB	O
GRalpha	B-protein	NOUN	B
and	O	CCONJ	O
GRbeta	B-protein	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
molecular	O	ADJ	B
mechanism	O	NOUN	I
(	O	PUNCT	O
s	O	NOUN	O
)	O	PUNCT	O
underlying	O	VERB	O
Ig	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
extinction	O	NOUN	B
can	O	AUX	O
be	O	AUX	O
explained	O	VERB	O
,	O	PUNCT	O
at	O	ADP	O
least	O	ADJ	O
in	O	ADP	O
part	O	NOUN	O
,	O	PUNCT	O
by	O	ADP	O
a	O	DET	O
lack	O	NOUN	B
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
that	O	PRON	O
are	O	AUX	O
essential	O	ADJ	B
for	O	ADP	O
Ig	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
transcription	O	NOUN	I
.	O	PUNCT	O


By	O	ADP	O
isolating	O	VERB	O
Daudi	B-cell_line	NOUN	B
x	I-cell_line	NOUN	O
HeLa	I-cell_line	NOUN	B
heterokaryons	I-cell_line	NOUN	B
a	O	DET	O
few	O	ADJ	O
hours	O	NOUN	O
after	O	ADP	O
fusion	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
studied	O	VERB	O
the	O	DET	O
initial	O	ADJ	O
fate	O	NOUN	O
of	O	ADP	O
two	O	NUM	O
B	B-protein	NOUN	O
cell-specific	I-protein	ADJ	O
transcription	I-protein	NOUN	O
factors	I-protein	NOUN	O
involved	O	VERB	O
in	O	ADP	O
Ig	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
transcription	O	NOUN	I
,	O	PUNCT	O
Oct-2	B-DNA	NOUN	B
and	O	CCONJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
.	O	PUNCT	O


Evidence	O	NOUN	B
for	O	ADP	O
suppressed	O	VERB	B
activity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
NFAT1	B-protein	NOUN	B
at	O	ADP	O
its	O	PRON	O
proximal	B-DNA	ADJ	B
binding	I-DNA	NOUN	I
element	I-DNA	NOUN	I
P0	B-DNA	NOUN	O
in	O	ADP	O
the	O	DET	O
IL-4	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
associated	O	VERB	B
with	O	ADP	I
enhanced	O	VERB	B
IL-4	B-DNA	NOUN	B
gene	I-DNA	NOUN	B
transcription	O	NOUN	I
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
of	O	ADP	O
atopic	O	ADJ	B
patients	O	NOUN	B
.	O	PUNCT	O


IL-4	B-DNA	NOUN	B
gene	I-DNA	NOUN	O
regulation	O	NOUN	O
in	O	ADP	O
general	O	ADJ	O
involves	O	VERB	O
the	O	DET	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
of	I-protein	ADP	O
activated	I-protein	VERB	B
T	I-protein	NOUN	O
cells	I-protein	NOUN	O
(	I-protein	PUNCT	O
NFAT	I-protein	NOUN	B
)	I-protein	PUNCT	O
family	I-protein	NOUN	O
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
,	O	PUNCT	O
of	O	ADP	O
which	O	DET	O
NFAT1	B-protein	NOUN	B
and	O	CCONJ	O
NFAT2	B-protein	NOUN	B
are	O	AUX	O
most	O	ADV	O
prominent	O	ADJ	O
in	O	ADP	O
peripheral	B-cell_type	ADJ	B
T	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
.	O	PUNCT	O


At	O	ADP	O
the	O	DET	O
most	O	ADV	O
proximal	O	ADJ	B
P0	B-DNA	NOUN	B
site	O	NOUN	I
,	O	PUNCT	O
NFAT-containing	O	ADJ	B
complexes	O	NOUN	I
devoid	O	ADJ	O
of	O	ADP	O
NFAT2	B-protein	NOUN	B
were	O	AUX	O
readily	O	ADV	O
inducible	O	ADJ	B
in	O	ADP	O
the	O	DET	O
Th1	B-cell_line	NOUN	B
clones	I-cell_line	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
hardly	O	ADV	B
or	O	CCONJ	O
not	O	PART	O
in	O	ADP	O
the	O	DET	O
Th2	B-cell_line	NOUN	B
clones	I-cell_line	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
both	O	CCONJ	O
in	O	ADP	O
Th1	B-cell_line	NOUN	B
and	I-cell_line	CCONJ	O
Th2	I-cell_line	NOUN	B
clones	I-cell_line	NOUN	B
NFAT-containing	O	ADJ	B
complexes	O	NOUN	I
were	O	AUX	O
strongly	O	ADV	O
inducible	O	ADJ	B
at	O	ADP	O
the	O	DET	O
P1	B-DNA	NOUN	B
site	I-DNA	NOUN	I
,	O	PUNCT	O
consisting	O	VERB	O
of	O	ADP	O
NFAT2	B-protein	NOUN	B
and	O	CCONJ	O
a	O	DET	O
P0	B-DNA	NOUN	B
-compatible	O	ADJ	O
NFAT	B-protein	NOUN	B
activity	O	NOUN	B
,	O	PUNCT	O
without	O	ADP	O
apparent	O	ADJ	B
differences	O	NOUN	O
between	O	ADP	O
Th1	B-cell_line	NOUN	B
and	I-cell_line	CCONJ	O
Th2	I-cell_line	NOUN	B
clones	I-cell_line	NOUN	B
.	O	PUNCT	O


Glucocorticoid	O	NOUN	B
resistance	O	NOUN	I
in	O	ADP	O
the	O	DET	O
squirrel	O	NOUN	B
monkey	O	NOUN	I
is	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
overexpression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
immunophilin	B-protein	NOUN	B
FKBP51	I-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
immunophilin	B-protein	NOUN	B
FKBP51	I-protein	NOUN	I
was	O	AUX	O
13-fold	O	ADV	O
higher	O	ADJ	O
in	O	ADP	O
SML	B-cell_type	NOUN	B
than	O	ADP	O
in	O	ADP	O
HL	O	NOUN	B
cytosol	O	NOUN	B
;	O	PUNCT	O
FKBP52	B-protein	NOUN	B
in	O	ADP	O
SML	B-cell_type	NOUN	B
was	O	AUX	O
42	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
that	O	DET	O
in	O	ADP	O
HL	O	NOUN	B
cytosol	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
previously	O	ADV	O
demonstrated	O	VERB	O
that	O	SCONJ	O
interaction	O	NOUN	B
of	O	ADP	O
infected	O	ADJ	B
thymocytes	B-cell_type	NOUN	B
with	O	ADP	O
autologous	O	ADJ	B
thymic	B-cell_type	ADJ	I
epithelial	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
(	O	PUNCT	O
TEC	B-cell_type	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
prerequisite	O	NOUN	O
for	O	ADP	O
a	O	DET	O
high	O	ADJ	O
level	O	NOUN	B
of	O	ADP	O
human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
type	O	NOUN	I
1	O	NUM	I
(	O	PUNCT	O
HIV-1	O	NOUN	B
)	O	PUNCT	O
replication	O	NOUN	B
in	O	ADP	O
thymocytes	B-cell_type	NOUN	B
(	O	PUNCT	O
M.Rothe	O	PROPN	B
,	O	PUNCT	O
L.Chene	O	PROPN	B
,	O	PUNCT	O
M.Nugeyre	O	PROPN	B
,	O	PUNCT	O
F.Barre-Sinoussi	O	PROPN	B
,	O	PUNCT	O
and	O	CCONJ	O
N.Israel	O	PROPN	B
,	O	PUNCT	O
J.Virol.72	O	PROPN	B
:	O	PUNCT	O
5852-5861	O	NUM	O
,	O	PUNCT	O
1998	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
prevalent	O	ADJ	O
complex	O	NOUN	B
is	O	AUX	O
the	O	DET	O
heterodimer	B-protein	NOUN	B
p50-p65	I-protein	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
a	O	DET	O
variety	O	NOUN	O
of	O	ADP	O
other	O	ADJ	O
cell	O	NOUN	B
types	O	NOUN	I
,	O	PUNCT	O
which	O	DET	O
display	O	VERB	O
a	O	DET	O
constitutive	O	ADJ	O
Elk-1	B-protein	NOUN	B
expression	O	NOUN	B
,	O	PUNCT	O
HS	O	NOUN	B
2	O	NUM	O
did	O	AUX	O
not	O	PART	O
exist	O	VERB	O
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
inducibility	O	NOUN	B
of	O	ADP	O
elk-1	B-DNA	NOUN	B
expression	O	NOUN	B
is	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
HS	O	NOUN	B
2	O	NUM	I
.	O	PUNCT	O


Immunohistochemical	O	ADJ	B
study	O	NOUN	I
of	O	ADP	O
c-fos-positive	B-protein	ADJ	B
lymphocytes	I-protein	NOUN	B
infiltrated	O	VERB	B
into	O	ADP	O
human	O	ADJ	B
squamous	O	ADJ	B
cell	O	NOUN	I
carcinomas	O	NOUN	I
of	O	ADP	O
the	O	DET	O
head	O	NOUN	B
and	O	CCONJ	I
neck	O	NOUN	B
during	O	ADP	O
radiation	O	NOUN	B
therapy	O	NOUN	I
and	O	CCONJ	O
its	O	PRON	O
clinical	O	ADJ	B
significance	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
study	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
attempted	O	VERB	O
to	O	PART	O
determine	O	VERB	O
whether	O	SCONJ	O
c-fos	B-DNA	NOUN	B
expression	O	NOUN	B
is	O	AUX	O
induced	O	VERB	B
by	O	ADP	O
radiotherapy	O	NOUN	B
in	O	ADP	O
human	O	ADJ	B
squamous	O	ADJ	O
cell	O	NOUN	O
carcinomas	O	NOUN	O
of	O	ADP	O
the	O	DET	O
head	O	NOUN	B
and	O	CCONJ	I
neck	O	NOUN	B
and	O	CCONJ	O
to	O	PART	O
establish	O	VERB	O
a	O	DET	O
possible	O	ADJ	O
correlation	O	NOUN	B
between	O	ADP	O
c-fos	B-DNA	NOUN	B
expression	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
therapeutic	O	ADJ	B
effects	O	NOUN	O
of	O	ADP	O
radiation	O	NOUN	B
therapy	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
patients	O	NOUN	B
whose	O	DET	O
infiltration	O	NOUN	B
of	O	ADP	O
c-fos-positive	B-protein	ADJ	B
lymphocytes	I-protein	NOUN	B
into	O	ADP	O
tumor	O	NOUN	B
tissues	O	NOUN	I
were	O	AUX	O
moderate	O	ADJ	B
or	O	CCONJ	O
remarkable	O	ADJ	O
at	O	ADP	O
4	O	NUM	O
Gy	O	NOUN	O
of	O	ADP	O
radiotherapy	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
tumors	O	NOUN	B
responded	O	VERB	O
significantly	O	ADV	O
well	O	ADV	O
to	O	PART	O
radiation	O	NOUN	B
therapy	O	NOUN	I
(	O	PUNCT	O
P	O	NOUN	O
<	O	X	O
0.025	O	NUM	O
,	O	PUNCT	O
chi2	O	NOUN	B
test	O	NOUN	I
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
patients	O	NOUN	B
took	O	VERB	O
a	O	DET	O
significantly	O	ADV	O
favorable	O	ADJ	O
clinical	O	ADJ	B
course	O	NOUN	I
(	O	PUNCT	O
P	O	NOUN	O
<	O	X	O
0.05	O	NUM	O
,	O	PUNCT	O
chi2	O	NOUN	B
test	O	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


We	O	PRON	O
examined	O	VERB	O
the	O	DET	O
allele-specific	O	ADJ	B
expression	O	NOUN	I
of	O	ADP	O
WT1	B-protein	NOUN	B
in	O	ADP	O
cultured	O	VERB	B
human	B-cell_type	ADJ	B
fibroblasts	I-cell_type	NOUN	B
from	O	ADP	O
15	O	NUM	O
individuals	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
allele-specific	O	ADJ	B
expression	O	NOUN	I
profiles	O	NOUN	I
of	O	ADP	O
other	O	ADJ	O
imprinted	B-DNA	ADJ	B
genes	I-DNA	NOUN	I
,	O	PUNCT	O
IGF2	B-DNA	NOUN	B
and	O	CCONJ	O
H19	B-DNA	NOUN	B
,	O	PUNCT	O
on	O	ADP	O
human	B-DNA	ADJ	B
chromosome	I-DNA	NOUN	I
11	I-DNA	NUM	I
were	O	AUX	O
constant	O	ADJ	B
and	O	CCONJ	O
consistent	O	ADJ	B
with	O	ADP	I
those	O	DET	O
in	O	ADP	O
other	O	ADJ	O
tissues	O	NOUN	B
.	O	PUNCT	O


Many	O	ADJ	O
patients	O	NOUN	B
with	O	ADP	O
primary	O	ADJ	B
Sjogren	O	NOUN	I
's	O	PART	I
syndrome	O	NOUN	I
(	O	PUNCT	O
SS	O	NOUN	B
)	O	PUNCT	O
make	O	VERB	O
high	O	ADJ	O
titer	O	NOUN	O
IgG	B-protein	NOUN	O
autoantibodies	I-protein	NOUN	O
to	O	PART	O
the	O	DET	O
La	B-protein	NOUN	B
(	I-protein	PUNCT	O
SSB	I-protein	NOUN	O
)	I-protein	PUNCT	O
antigen	O	NOUN	O
,	O	PUNCT	O
suggesting	O	VERB	O
antigen	O	NOUN	B
specific	O	ADJ	O
T	O	NOUN	B
cell-B	O	NOUN	I
cell	O	NOUN	I
interactions	O	NOUN	B
.	O	PUNCT	O


RESULTS	O	NOUN	B
.	O	PUNCT	O


Anti-	O	ADJ	O
HLA-DR	B-protein	NOUN	B
abrogated	O	VERB	B
proliferation	O	NOUN	B
to	O	PART	O
SSB	B-protein	NOUN	B
and	O	CCONJ	O
tetanus	O	NOUN	B
toxoid	O	NOUN	B
.	O	PUNCT	O


Down-regulation	O	NOUN	B
of	O	ADP	O
NF-kappaB	B-protein	NOUN	B
activation	O	NOUN	B
is	O	AUX	O
known	O	VERB	O
to	O	PART	O
inhibit	O	VERB	B
HIV	O	NOUN	B
replication	O	NOUN	B
from	O	ADP	O
the	O	DET	O
latently	B-cell_type	ADV	B
infected	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Specific	O	ADJ	O
staining	O	NOUN	B
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
electron	O	NOUN	B
microscopic	O	ADJ	I
examinations	O	NOUN	B
revealed	O	VERB	O
the	O	DET	O
accumulation	O	NOUN	B
of	O	ADP	O
metal	O	NOUN	B
gold	O	NOUN	B
in	O	ADP	O
the	O	DET	O
cells	O	NOUN	B
,	O	PUNCT	O
supporting	O	VERB	O
our	O	PRON	O
previous	O	ADJ	O
hypothesis	O	NOUN	B
that	O	SCONJ	O
gold	O	NOUN	B
ions	O	NOUN	B
could	O	AUX	O
block	O	VERB	B
NF-kappaB	B-protein	NOUN	B
-DNA	O	NOUN	O
binding	O	NOUN	B
by	O	ADP	O
a	O	DET	O
redox	O	NOUN	B
mechanism	O	NOUN	B
.	O	PUNCT	O


After	O	ADP	O
corticosteroid	O	NOUN	B
suppression	O	NOUN	B
of	O	ADP	O
her	O	PRON	O
blood	O	NOUN	B
eosinophilia	O	NOUN	I
,	O	PUNCT	O
a	O	DET	O
clonal	O	ADJ	B
population	O	NOUN	I
of	O	ADP	O
eosinophils	B-cell_type	NOUN	B
could	O	AUX	O
no	O	ADV	O
longer	O	ADV	O
be	O	AUX	O
detected	O	VERB	B
in	O	ADP	O
purified	B-cell_type	VERB	B
eosinophils	I-cell_type	NOUN	I
.	O	PUNCT	O


The	O	DET	O
finding	O	NOUN	B
of	O	ADP	O
clonal	O	ADJ	B
eosinophilia	O	NOUN	I
in	O	ADP	O
a	O	DET	O
patient	O	NOUN	B
presenting	O	VERB	O
with	O	ADP	O
IHES	O	NOUN	B
indicates	O	VERB	O
that	O	SCONJ	O
such	O	ADJ	O
patients	O	NOUN	B
may	O	AUX	O
have	O	AUX	O
,	O	PUNCT	O
in	O	ADP	O
reality	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
low-grade	O	ADJ	B
clonal	O	ADJ	B
disorder	O	NOUN	I
that	O	PRON	O
can	O	AUX	O
be	O	AUX	O
distinguished	O	VERB	O
from	O	ADP	O
reactive	O	ADJ	B
eosinophilias	O	NOUN	I
by	O	ADP	O
HUMARA	B-DNA	NOUN	B
analysis	O	NOUN	I
.	O	PUNCT	O


Phospholipid	O	NOUN	B
analyses	O	NOUN	I
indicated	O	VERB	O
a	O	DET	O
selective	O	ADJ	O
increase	O	NOUN	B
in	O	ADP	O
the	O	DET	O
lysoPC	O	NOUN	B
content	O	NOUN	B
of	O	ADP	O
the	O	DET	O
monocytes	B-cell_type	NOUN	B
after	O	ADP	O
preincubation	O	NOUN	B
with	O	ADP	O
the	O	DET	O
lysophospholipid	O	NOUN	B
.	O	PUNCT	O


Preincubation	O	NOUN	B
with	O	ADP	O
lysoPC	O	NOUN	B
increased	O	VERB	B
monocytic	O	ADJ	B
cAMP	O	NOUN	O
levels	O	NOUN	O
.	O	PUNCT	O


Inhibition	O	NOUN	B
of	O	ADP	O
adenylyl	B-protein	ADJ	B
cyclase	I-protein	NOUN	I
by	O	ADP	O
pretreatment	O	NOUN	B
with	O	ADP	O
2'-deoxy-3'-adenosine	B-protein	ADJ	B
monophosphate	I-protein	NOUN	I
partially	O	ADV	I
reversed	O	VERB	O
the	O	DET	O
inhibition	O	NOUN	B
of	O	ADP	O
TF	O	NOUN	B
activity	O	NOUN	O
promoted	O	VERB	O
by	O	ADP	O
lysoPC	O	NOUN	B
.	O	PUNCT	O


LysoPC	O	NOUN	B
may	O	AUX	O
thus	O	ADV	O
attenuate	O	VERB	B
activation	O	NOUN	B
of	O	ADP	O
coagulation	O	NOUN	B
during	O	ADP	O
inflammation	O	NOUN	B
and	O	CCONJ	O
atherosclerosis	O	NOUN	B
.	O	PUNCT	O


T	O	NOUN	B
cell	O	NOUN	I
receptor	O	NOUN	I
engagement	O	NOUN	B
activates	O	VERB	B
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
important	O	ADJ	O
for	O	ADP	O
cytokine	B-DNA	NOUN	B
gene	I-DNA	NOUN	B
regulation	O	NOUN	I
.	O	PUNCT	O


Additionally	O	ADV	O
,	O	PUNCT	O
this	O	DET	O
signaling	O	NOUN	B
pathway	O	NOUN	I
also	O	ADV	O
leads	O	VERB	O
to	O	PART	O
activation-induced	O	ADJ	B
apoptosis	O	NOUN	B
in	O	ADP	O
T	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
that	O	PRON	O
is	O	AUX	O
dependent	O	ADJ	O
on	O	ADP	O
FasL	O	NOUN	B
transcription	O	NOUN	B
and	O	CCONJ	O
expression	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
AP-1	I-protein	NOUN	B
is	O	AUX	O
not	O	PART	O
required	O	VERB	O
for	O	ADP	O
activation-induced	O	ADJ	B
FasL	B-protein	NOUN	B
promoter	O	NOUN	B
activity	O	NOUN	I
.	O	PUNCT	O


Promoter	B-DNA	NOUN	B
sequence	I-DNA	NOUN	I
,	O	PUNCT	O
exon	O	NOUN	B
:	O	PUNCT	O
intron	O	NOUN	B
structure	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
synteny	O	NOUN	B
of	O	ADP	O
genetic	O	ADJ	B
location	O	NOUN	I
show	O	VERB	O
that	O	SCONJ	O
a	O	DET	O
chicken	B-protein	NOUN	B
cytokine	I-protein	NOUN	B
with	O	ADP	O
T-cell	O	NOUN	B
proliferative	O	ADJ	I
activity	O	NOUN	I
is	O	AUX	O
IL2	B-protein	NOUN	B
and	O	CCONJ	O
not	O	PART	O
IL15	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
results	O	NOUN	B
show	O	VERB	O
that	O	SCONJ	O
this	O	DET	O
cytokine	B-protein	NOUN	B
is	O	AUX	O
chicken	O	NOUN	B
IL2	B-protein	NOUN	B
and	O	CCONJ	O
not	O	PART	O
IL15	B-protein	NOUN	B
.	O	PUNCT	O


A	O	DET	O
number	O	NOUN	O
of	O	ADP	O
potential	B-DNA	ADJ	B
regulatory	I-DNA	ADJ	B
sequences	I-DNA	NOUN	I
similar	O	ADJ	O
to	O	PART	O
those	O	DET	O
found	O	VERB	O
in	O	ADP	O
mammals	O	NOUN	B
have	O	AUX	O
been	O	AUX	O
identified	O	VERB	B
in	O	ADP	O
the	O	DET	O
promoter	B-DNA	NOUN	B
.	O	PUNCT	O


Interestingly	O	ADV	O
,	O	PUNCT	O
Nmi	B-protein	NOUN	B
lacks	O	VERB	O
an	O	DET	O
intrinsic	O	ADJ	B
transcriptional	B-protein	ADJ	O
activation	I-protein	NOUN	O
domain	I-protein	NOUN	O
;	O	PUNCT	O
instead	O	ADV	O
,	O	PUNCT	O
Nmi	B-protein	NOUN	B
enhances	O	VERB	B
the	O	DET	O
association	O	NOUN	B
of	O	ADP	O
CBP/p300	B-protein	NOUN	B
coactivator	I-protein	NOUN	I
proteins	I-protein	NOUN	I
with	O	ADP	O
Stat1	B-protein	NOUN	B
and	O	CCONJ	O
Stat5	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
together	O	ADV	O
with	O	ADP	O
CBP/p300	B-protein	NOUN	B
can	O	AUX	O
augment	O	VERB	O
IL-2-	O	NOUN	B
and	O	CCONJ	O
IFNgamma-dependent	O	ADJ	B
transcription	O	NOUN	O
.	O	PUNCT	O


Electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assays	O	NOUN	I
demonstrated	O	VERB	O
no	O	DET	O
difference	O	NOUN	O
in	O	ADP	O
the	O	DET	O
pattern	O	NOUN	B
of	O	ADP	O
TNF	B-protein	NOUN	B
-stimulated	O	ADJ	O
nuclear	B-protein	ADJ	B
factor-kappaB	I-protein	NOUN	I
activation	O	NOUN	I
between	O	ADP	O
HUVECs	B-cell_type	NOUN	B
and	O	CCONJ	O
HUAECs	B-cell_type	NOUN	B
.	O	PUNCT	O


To	O	PART	O
assess	O	VERB	O
the	O	DET	O
phosphorylation	O	NOUN	B
of	O	ADP	O
serine	O	NOUN	B
residues	O	NOUN	I
of	O	ADP	O
STAT1	B-protein	NOUN	B
and	O	CCONJ	O
STAT3	B-protein	NOUN	B
in	O	ADP	O
CLL	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
raised	O	VERB	B
antibodies	O	NOUN	B
that	O	PRON	O
specifically	O	ADV	O
recognize	O	VERB	O
the	O	DET	O
form	O	NOUN	O
of	O	ADP	O
STAT1	B-protein	NOUN	B
phosphorylated	O	VERB	B
on	O	ADP	O
ser-727	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
form	O	NOUN	O
of	O	ADP	O
STAT3	B-protein	NOUN	B
phosphorylated	O	VERB	B
on	O	ADP	O
ser-727	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
STAT	O	NOUN	B
serine	O	NOUN	I
kinase	O	NOUN	I
in	O	ADP	O
CLL	O	NOUN	B
cells	O	NOUN	B
has	O	AUX	O
not	O	PART	O
been	O	AUX	O
identified	O	VERB	B
,	O	PUNCT	O
and	O	CCONJ	O
appears	O	VERB	O
to	O	PART	O
be	O	AUX	O
neither	O	CCONJ	O
mitogen-activated	B-protein	ADJ	B
protein	I-protein	NOUN	I
kinase	I-protein	NOUN	I
nor	O	CCONJ	O
pp70	B-protein	NOUN	B
(	I-protein	PUNCT	O
s6k	I-protein	NOUN	B
)	I-protein	PUNCT	O
.	O	PUNCT	O


Activation	O	NOUN	B
of	O	ADP	O
human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
type	O	NOUN	I
1	O	NUM	O
expression	O	NOUN	B
by	O	ADP	O
Gardnerella	O	X	B
vaginalis	O	X	I
.	O	PUNCT	O


Bacterial	O	ADJ	B
vaginosis	O	NOUN	I
(	O	PUNCT	O
BV	O	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
an	O	DET	O
increased	O	VERB	B
rate	O	NOUN	B
of	O	ADP	O
sexual	O	ADJ	B
transmission	O	NOUN	I
of	O	ADP	O
human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
(	O	PUNCT	O
HIV	O	NOUN	B
)	O	PUNCT	O
type	O	NOUN	O
1	O	NUM	O
,	O	PUNCT	O
and	O	CCONJ	O
Gardnerella	O	X	B
vaginalis	O	X	I
is	O	AUX	O
frequently	O	ADV	O
isolated	O	VERB	B
from	O	ADP	O
the	O	DET	O
genital	O	ADJ	B
tracts	O	NOUN	I
of	O	ADP	O
women	O	NOUN	B
with	O	ADP	O
BV	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
present	O	ADJ	O
study	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
clonal	O	ADJ	B
relationship	O	NOUN	B
was	O	AUX	O
investigated	O	VERB	B
between	O	ADP	O
peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
polymorphonuclear	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
(	O	PUNCT	O
PMNCs	B-cell_type	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
marrow	B-cell_type	NOUN	B
progenitor	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
the	O	DET	O
origin	O	NOUN	B
of	O	ADP	O
ringed	B-cell_type	ADJ	B
sideroblasts	I-cell_type	NOUN	I
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
refractory	O	ADJ	B
anemia	O	NOUN	I
with	O	ADP	O
ring	B-cell_type	NOUN	B
sideroblasts	I-cell_type	NOUN	I
(	O	PUNCT	O
RARS	B-cell_type	NOUN	B
)	O	PUNCT	O
by	O	ADP	O
polymerase	O	NOUN	B
chain	O	NOUN	I
reaction	O	NOUN	I
(	O	PUNCT	O
PCR	O	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
HUMARA	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
.	O	PUNCT	O


All	O	DET	O
erythroid	B-cell_line	ADJ	B
colonies	I-cell_line	NOUN	B
consisted	O	VERB	O
of	O	ADP	O
ringed	B-cell_type	ADJ	B
sideroblasts	I-cell_type	NOUN	B
exclusively	O	ADV	O
showed	O	VERB	O
one	O	NUM	O
pattern	O	NOUN	B
dominant	O	ADJ	O
in	O	ADP	O
those	O	DET	O
of	O	ADP	O
PMNCs	B-cell_type	NOUN	B
.	O	PUNCT	O


Our	O	PRON	O
findings	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
non-clonal	B-cell_type	ADJ	B
progenitor	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
persist	O	VERB	O
in	O	ADP	O
some	O	DET	O
RARS	B-cell_type	NOUN	B
cases	O	NOUN	B
,	O	PUNCT	O
that	O	SCONJ	O
erythroid	B-cell_type	ADJ	B
progenitors	I-cell_type	NOUN	B
show	O	VERB	O
mosaicism	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
that	O	SCONJ	O
ringed	B-cell_type	ADJ	B
sideroblasts	I-cell_type	NOUN	B
may	O	AUX	O
be	O	AUX	O
derived	O	VERB	O
from	O	ADP	O
an	O	DET	O
abnormal	O	ADJ	B
clone	O	NOUN	B
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
pathogenesis	O	NOUN	B
of	O	ADP	O
this	O	DET	O
disease	O	NOUN	B
.	O	PUNCT	O


BACKGROUND	O	NOUN	B
AND	O	CCONJ	O
METHODS	O	NOUN	O
:	O	PUNCT	O
Because	O	SCONJ	O
the	O	DET	O
use	O	NOUN	O
of	O	ADP	O
immunohistochemistry	O	NOUN	B
in	O	ADP	O
the	O	DET	O
diagnosis	O	NOUN	B
of	O	ADP	O
granulosa	O	NOUN	B
cell	O	NOUN	I
tumor	O	NOUN	I
(	O	PUNCT	O
GCT	O	NOUN	B
)	O	PUNCT	O
has	O	AUX	O
not	O	PART	O
been	O	AUX	O
fully	O	ADV	O
explored	O	VERB	O
,	O	PUNCT	O
routinely	O	ADV	O
processed	O	VERB	O
(	O	PUNCT	O
formalin-fixed	O	ADJ	B
,	O	PUNCT	O
paraffin-embedded	O	ADJ	B
)	O	PUNCT	O
tissue	O	NOUN	O
from	O	ADP	O
11	O	NUM	O
GCT	O	NOUN	B
,	O	PUNCT	O
adult	O	ADJ	B
type	O	NOUN	O
,	O	PUNCT	O
was	O	AUX	O
investigated	O	VERB	B
immunohistochemically	O	ADV	B
(	O	PUNCT	O
ABC	O	NOUN	B
method	O	NOUN	I
)	O	PUNCT	O
with	O	ADP	O
a	O	DET	O
broad	O	ADJ	O
spectrum	O	NOUN	O
of	O	ADP	O
antibodies	O	NOUN	B
against	O	ADP	O
various	O	ADJ	O
markers	O	NOUN	B
,	O	PUNCT	O
including	O	VERB	O
p53	B-protein	NOUN	B
and	O	CCONJ	O
Ki-67	B-protein	NOUN	B
.	O	PUNCT	O


RESULTS	O	NOUN	B
:	O	PUNCT	O
All	O	DET	O
the	O	DET	O
tumors	O	NOUN	B
exhibited	O	VERB	O
strong	O	ADJ	O
expression	O	NOUN	B
of	O	ADP	O
vimentin	B-protein	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
most	O	ADJ	O
other	O	ADJ	O
antigens	O	NOUN	B
(	O	PUNCT	O
including	O	VERB	O
smooth	B-protein	ADJ	B
muscle	I-protein	NOUN	I
actin	I-protein	NOUN	I
)	O	PUNCT	O
were	O	AUX	O
expressed	O	VERB	B
infrequently	O	ADV	O
by	O	ADP	O
a	O	DET	O
minority	O	NOUN	B
of	O	ADP	O
tumor	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
or	O	CCONJ	O
not	O	PART	O
at	O	ADV	O
all	O	ADV	O
.	O	PUNCT	O


Tumor	O	NOUN	B
cells	O	NOUN	I
in	O	ADP	O
9	O	NUM	O
GCT	O	NOUN	B
expressed	O	VERB	B
inhibin	O	NOUN	B
A	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
data	O	NOUN	B
presented	O	VERB	O
below	O	ADP	O
indicate	O	VERB	O
that	O	SCONJ	O
Notch-1	B-protein	NOUN	B
expression	O	NOUN	B
provides	O	VERB	O
significant	O	ADJ	O
protection	O	NOUN	B
to	O	PART	O
T	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
from	O	ADP	O
TCR	B-protein	NOUN	B
-mediated	O	ADJ	O
apoptosis	O	NOUN	B
.	O	PUNCT	O


Monocytes	B-cell_type	NOUN	B
were	O	AUX	O
effective	O	ADJ	B
APC	B-cell_type	NOUN	B
for	O	ADP	O
VZV	O	NOUN	B
peptides	O	NOUN	B
only	O	ADV	O
after	O	ADP	O
immunization	O	NOUN	B
.	O	PUNCT	O


Although	O	SCONJ	O
this	O	DET	O
reversal	O	NOUN	B
by	O	ADP	O
IL-2	B-protein	NOUN	B
was	O	AUX	O
pronounced	O	ADJ	O
,	O	PUNCT	O
it	O	PRON	O
was	O	AUX	O
not	O	PART	O
complete	O	ADJ	O
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
IL-10	B-protein	NOUN	B
may	O	AUX	O
have	O	AUX	O
some	O	DET	O
effects	O	NOUN	B
not	O	PART	I
directly	O	ADV	O
related	O	VERB	O
to	O	PART	O
the	O	DET	O
suppression	O	NOUN	B
of	O	ADP	O
IL-2	B-protein	NOUN	B
production	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
include	O	VERB	O
Fc	B-protein	NOUN	B
epsilonRII	I-protein	NOUN	I
(	O	PUNCT	O
CD23	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
15-lipoxygenase	B-protein	NOUN	B
,	O	PUNCT	O
IL-1	B-protein	NOUN	B
receptor	I-protein	NOUN	I
antagonist	I-protein	NOUN	I
(	O	PUNCT	O
IL-1ra	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
type	B-protein	NOUN	B
I	I-protein	NUM	I
and	I-protein	CCONJ	O
type	I-protein	NOUN	B
II	I-protein	NUM	I
IL-1	I-protein	NOUN	I
receptors	I-protein	NOUN	I
(	O	PUNCT	O
IL-1R	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Inhibition	O	NOUN	B
of	O	ADP	O
IL-1RI	B-protein	NOUN	B
and	O	CCONJ	O
IL-1RII	O	NOUN	B
mRNA	O	NOUN	B
levels	O	NOUN	O
by	O	ADP	O
IFN-gamma	B-protein	NOUN	B
was	O	AUX	O
transcriptionally	O	ADV	B
mediated	O	VERB	O
,	O	PUNCT	O
and	O	CCONJ	O
correlated	O	VERB	B
directly	O	ADV	O
with	O	ADP	O
decreased	O	VERB	B
production	O	NOUN	B
of	O	ADP	O
soluble	O	ADJ	B
IL-1RII	B-protein	NOUN	B
.	O	PUNCT	O


Inhibition	O	NOUN	B
of	O	ADP	O
IL-1R	B-DNA	NOUN	B
gene	I-DNA	NOUN	O
expression	O	NOUN	B
by	O	ADP	O
IFN-gamma	B-protein	NOUN	B
and	O	CCONJ	O
IL-10	B-protein	NOUN	B
was	O	AUX	O
not	O	PART	O
due	O	ADJ	O
to	O	PART	O
down-regulation	O	NOUN	B
of	O	ADP	O
surface	B-protein	NOUN	B
IL-4R	I-protein	NOUN	B
because	O	SCONJ	O
pretreatment	O	NOUN	B
with	O	ADP	O
these	O	DET	O
cytokines	O	NOUN	B
did	O	AUX	O
not	O	PART	O
decrease	O	VERB	B
the	O	DET	O
number	O	NOUN	O
of	O	ADP	O
IL-4	B-protein	NOUN	B
binding	O	NOUN	O
sites	O	NOUN	O
per	O	ADP	O
cell	O	NOUN	B
.	O	PUNCT	O


Cytokine	B-protein	NOUN	B
rescue	O	NOUN	I
from	O	ADP	O
glucocorticoid	O	NOUN	B
induced	O	ADJ	B
apoptosis	O	NOUN	B
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
is	O	AUX	O
mediated	O	VERB	O
through	O	ADP	O
inhibition	O	NOUN	B
of	O	ADP	O
IkappaBalpha	B-protein	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
both	O	DET	O
cell	O	NOUN	B
types	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
cytokine	B-protein	NOUN	B
that	O	PRON	O
inhibits	O	VERB	B
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
IkappaBalpha	B-protein	NOUN	B
by	O	ADP	O
DEX	O	NOUN	B
,	O	PUNCT	O
also	O	ADV	O
rescues	O	VERB	B
these	O	DET	O
cells	O	NOUN	B
from	O	ADP	O
DEX-induced	O	ADJ	B
apoptosis	O	NOUN	B
,	O	PUNCT	O
although	O	SCONJ	O
the	O	DET	O
rescue	O	NOUN	B
cytokine	O	NOUN	B
is	O	AUX	O
different	O	ADJ	O
in	O	ADP	O
Th1	B-cell_type	NOUN	B
and	I-cell_type	CCONJ	O
Th2	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
identified	O	VERB	B
a	O	DET	O
cell-type-specific	O	ADJ	B
differential	O	ADJ	O
response	O	NOUN	O
:	O	PUNCT	O
CREB	B-DNA	NOUN	B
,	I-DNA	PUNCT	O
CTF	I-DNA	NOUN	B
,	I-DNA	PUNCT	O
OTF-1	I-DNA	NOUN	B
,	I-DNA	PUNCT	O
OFT-2	I-DNA	NOUN	B
,	I-DNA	PUNCT	O
and	I-DNA	CCONJ	O
NF-kappa	I-DNA	NOUN	B
B	I-DNA	NOUN	I
genes	I-DNA	NOUN	I
were	O	AUX	O
strongly	O	ADV	O
induced	O	VERB	B
1	O	NUM	O
to	O	PART	O
4	O	NUM	O
hours	O	NOUN	B
after	O	ADP	O
influenza	O	NOUN	B
A	O	NOUN	I
virus	O	NOUN	I
infection	O	NOUN	O
in	O	ADP	O
the	O	DET	O
monocytic	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
Mono	B-cell_line	NOUN	I
Mac	I-cell_line	NOUN	I
6	I-cell_line	NUM	I
,	O	PUNCT	O
while	O	SCONJ	O
in	O	ADP	O
freshly	O	ADV	B
prepared	O	VERB	O
human	O	ADJ	B
monocytes	B-cell_type	NOUN	B
no	O	DET	B
significant	O	ADJ	I
changes	O	NOUN	B
were	O	AUX	O
detected	O	VERB	B
.	O	PUNCT	O


In	O	ADP	O
a	O	DET	O
3	O	NUM	O
day	O	NOUN	B
intervention	O	NOUN	B
study	O	NOUN	I
in	O	ADP	O
which	O	DET	O
600	O	NUM	O
mg	O	NOUN	O
of	O	ADP	O
the	O	DET	O
antioxidant	O	ADJ	B
thioctic	O	ADJ	I
acid	O	NOUN	I
(	O	PUNCT	O
alpha-lipoic	O	ADJ	B
acid	O	NOUN	I
)	O	PUNCT	O
per	O	ADP	O
day	O	NOUN	B
were	O	AUX	O
given	O	VERB	O
to	O	ADP	O
nine	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
diabetic	O	ADJ	B
nephropathy	O	NOUN	I
oxidative	O	ADJ	B
stress	O	NOUN	I
in	O	ADP	O
plasma	O	NOUN	B
samples	O	NOUN	O
was	O	AUX	O
decreased	O	VERB	B
by	O	ADP	O
48	O	NUM	O
%	O	NOUN	O
and	O	CCONJ	O
NF-kappaB	B-protein	NOUN	B
binding	O	NOUN	I
activity	O	NOUN	I
in	O	ADP	O
ex	O	X	B
vivo	O	X	I
isolated	B-cell_type	VERB	B
peripheral	I-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
mononuclear	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
by	O	ADP	O
38	O	NUM	O
%	O	NOUN	O
.	O	PUNCT	O


When	O	SCONJ	O
cultured	O	VERB	B
on	O	ADP	O
bone	O	NOUN	B
,	O	PUNCT	O
VR+	B-cell_line	ADJ	B
,	I-cell_line	PUNCT	O
TRAP+	I-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
of	O	ADP	O
low	O	ADJ	B
multinuclearity	O	NOUN	B
appear	O	VERB	O
and	O	CCONJ	O
cover	O	VERB	B
up	O	ADV	O
to	O	PART	O
50	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
the	O	DET	O
surface	O	NOUN	B
.	O	PUNCT	O


Because	O	SCONJ	O
oleic	O	ADJ	B
acid	O	NOUN	I
is	O	AUX	O
implicated	O	VERB	O
in	O	ADP	O
the	O	DET	O
antiatherogenic	O	ADJ	B
effects	O	NOUN	B
attributed	O	VERB	O
to	O	ADP	O
the	O	DET	O
Mediterranean	O	ADJ	B
diet	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
investigated	O	VERB	B
whether	O	SCONJ	O
this	O	DET	O
fatty	O	ADJ	B
acid	O	NOUN	I
can	O	AUX	O
modulate	O	VERB	O
endothelial	O	ADJ	B
activation	O	NOUN	I
,	O	PUNCT	O
ie	O	X	O
,	O	PUNCT	O
the	O	DET	O
concerted	O	ADJ	O
expression	O	NOUN	B
of	O	ADP	O
gene	B-protein	NOUN	B
products	I-protein	NOUN	I
involved	O	VERB	O
in	O	ADP	O
leukocyte	O	NOUN	B
recruitment	O	NOUN	B
and	O	CCONJ	O
early	O	ADJ	B
atherogenesis	O	NOUN	B
.	O	PUNCT	O


At	O	ADP	O
10	O	NUM	O
to	O	PART	O
100	O	NUM	O
micromol/L	O	NOUN	O
for	O	ADP	O
>	O	NOUN	O
24	O	NUM	O
hours	O	NOUN	B
,	O	PUNCT	O
oleate	O	NOUN	B
inhibited	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
all	O	DET	O
adhesion	B-protein	NOUN	B
molecules	I-protein	NOUN	B
tested	O	VERB	B
.	O	PUNCT	O


Although	O	SCONJ	O
less	O	ADV	O
potent	O	ADJ	O
than	O	ADP	O
polyunsaturated	O	ADJ	B
fatty	O	ADJ	I
acids	O	NOUN	I
in	O	ADP	O
inhibiting	O	VERB	B
endothelial	O	ADJ	B
activation	O	NOUN	I
,	O	PUNCT	O
oleic	O	ADJ	B
acid	O	NOUN	I
may	O	AUX	O
contribute	O	VERB	O
to	O	PART	O
the	O	DET	O
prevention	O	NOUN	B
of	O	ADP	O
atherogenesis	O	NOUN	B
through	O	ADP	O
selective	O	ADJ	O
displacement	O	NOUN	B
of	O	ADP	O
saturated	O	ADJ	B
fatty	O	ADJ	I
acids	O	NOUN	I
in	O	ADP	O
cell	O	NOUN	B
membrane	O	NOUN	I
phospholipids	O	NOUN	I
and	O	CCONJ	O
a	O	DET	O
consequent	O	ADJ	O
modulation	O	NOUN	B
of	O	ADP	O
gene	O	NOUN	B
expression	O	NOUN	I
for	O	ADP	O
molecules	O	NOUN	B
involved	O	VERB	O
in	O	ADP	O
monocyte	O	NOUN	B
recruitment	O	NOUN	B
.	O	PUNCT	O


Involvement	O	NOUN	B
of	O	ADP	O
mitogen-activated	B-protein	ADJ	B
protein	I-protein	NOUN	I
kinase	I-protein	NOUN	I
pathways	O	NOUN	I
in	O	ADP	O
interleukin-8	B-protein	NOUN	B
production	O	NOUN	B
by	O	ADP	O
human	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
and	O	CCONJ	O
polymorphonuclear	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
stimulated	O	VERB	B
with	O	ADP	O
lipopolysaccharide	O	NOUN	B
or	O	CCONJ	O
Mycoplasma	B-protein	NOUN	B
fermentans	I-protein	NOUN	I
membrane	I-protein	NOUN	I
lipoproteins	I-protein	NOUN	I
.	O	PUNCT	O


IL-8	B-protein	NOUN	B
is	O	AUX	O
secreted	O	VERB	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
inflammatory	O	ADJ	B
stimuli	O	NOUN	I
,	O	PUNCT	O
notably	O	ADV	O
bacterial	O	ADJ	B
products	O	NOUN	I
such	O	ADJ	O
as	O	ADP	O
lipopolysaccharide	O	NOUN	B
(	O	PUNCT	O
LPS	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
but	O	CCONJ	O
little	O	ADJ	O
is	O	AUX	O
known	O	VERB	O
about	O	ADP	O
the	O	DET	O
mechanisms	O	NOUN	B
by	O	ADP	O
which	O	DET	O
these	O	DET	O
agents	O	NOUN	B
mediate	O	VERB	O
IL-8	B-protein	NOUN	B
induction	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
demonstrate	O	VERB	O
the	O	DET	O
capacity	O	NOUN	B
of	O	ADP	O
intact	O	ADJ	B
C3a	B-protein	NOUN	B
and	O	CCONJ	O
its	O	PRON	O
circulating	O	VERB	B
des-Arg	B-protein	ADJ	B
form	I-protein	NOUN	O
to	O	PART	O
exert	O	VERB	O
immunmodulatory	O	ADJ	B
effects	O	NOUN	I
in	O	X	B
vitro	O	X	I
.	O	PUNCT	O


These	O	DET	O
observations	O	NOUN	B
can	O	AUX	O
be	O	AUX	O
linked	O	VERB	O
with	O	ADP	O
the	O	DET	O
inhibition	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activation	O	NOUN	B
when	O	SCONJ	O
uninfected	O	ADJ	B
monocytes	O	NOUN	B
are	O	AUX	O
induced	O	VERB	B
by	O	ADP	O
either	O	CCONJ	O
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor	I-protein	NOUN	I
alpha	I-protein	NOUN	I
(	O	PUNCT	O
TNF-alpha	B-protein	NOUN	B
)	O	PUNCT	O
phorbol	O	NOUN	B
12-myristate	O	NOUN	I
13-acetate	O	NOUN	I
(	O	PUNCT	O
PMA	O	NOUN	B
)	O	PUNCT	O
or	O	CCONJ	O
lipopolysaccharide	O	NOUN	B
(	O	PUNCT	O
LPS	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
tetracyclines	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
transfected	O	VERB	B
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
were	O	AUX	O
shown	O	VERB	O
to	O	PART	O
express	O	VERB	O
the	O	DET	O
chimeric	B-protein	ADJ	B
receptor	I-protein	NOUN	I
on	O	ADP	O
the	O	DET	O
cell	O	NOUN	B
surface	O	NOUN	I
and	O	CCONJ	O
could	O	AUX	O
be	O	AUX	O
activated	O	VERB	B
by	O	ADP	O
its	O	PRON	O
cognate	B-protein	ADJ	B
Ag	I-protein	NOUN	B
,	O	PUNCT	O
leading	O	VERB	O
to	O	PART	O
the	O	DET	O
secretion	O	NOUN	B
of	O	ADP	O
IL-2	B-protein	NOUN	B
.	O	PUNCT	O


Prolonged	O	ADJ	B
suppression	O	NOUN	B
of	O	ADP	O
trans-gene	O	ADJ	B
expression	O	NOUN	B
for	O	ADP	O
up	O	ADV	O
to	O	PART	O
7	O	NUM	O
days	O	NOUN	B
was	O	AUX	O
observed	O	VERB	O
after	O	ADP	O
doxycycline	O	NOUN	B
was	O	AUX	O
removed	O	VERB	O
from	O	ADP	O
the	O	DET	O
cultures	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
eventual	O	ADJ	B
recovery	O	NOUN	B
of	O	ADP	O
surface	O	NOUN	B
expression	O	NOUN	B
was	O	AUX	O
complete	O	ADJ	B
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
absolute	O	ADJ	B
time	O	NOUN	O
to	O	ADP	O
recovery	O	NOUN	B
was	O	AUX	O
directly	O	ADV	O
proportional	O	ADJ	O
to	O	PART	O
the	O	DET	O
initial	O	ADJ	O
concentration	O	NOUN	B
of	O	ADP	O
the	O	DET	O
drug	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
suggested	O	VERB	O
that	O	SCONJ	O
negative	O	ADJ	B
feedback	O	NOUN	B
of	O	ADP	O
cortisol	O	NOUN	B
could	O	AUX	O
be	O	AUX	O
deranged	O	VERB	B
.	O	PUNCT	O


The	O	DET	O
role	O	NOUN	O
of	O	ADP	O
the	O	DET	O
GR	B-protein	NOUN	B
and	O	CCONJ	O
mineralocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
(	O	PUNCT	O
MR	B-protein	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
CRH	O	NOUN	B
regulation	O	NOUN	B
in	O	ADP	O
the	O	DET	O
FMS	O	NOUN	B
patients	O	NOUN	B
remains	O	VERB	O
to	O	PART	O
be	O	AUX	O
solved	O	VERB	O
.	O	PUNCT	O


Temporal	O	ADJ	B
control	O	NOUN	I
of	O	ADP	O
IgH	B-DNA	NOUN	O
gene	I-DNA	NOUN	O
expression	O	NOUN	B
in	O	ADP	O
developing	B-cell_type	VERB	O
B	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
by	O	ADP	O
the	O	DET	O
3	B-DNA	NUM	O
'	I-DNA	PART	O
locus	I-DNA	NOUN	B
control	I-DNA	NOUN	I
region	I-DNA	NOUN	I
.	O	PUNCT	O


HLA	O	NOUN	B
binding	O	NOUN	I
characteristics	O	NOUN	B
and	O	CCONJ	O
generation	O	NOUN	B
of	O	ADP	O
cytotoxic	B-cell_type	ADJ	B
lymphocytes	I-cell_type	NOUN	O
against	O	ADP	O
peptides	O	NOUN	B
derived	O	VERB	O
from	O	ADP	O
oncogenic	B-protein	ADJ	B
proteins	I-protein	NOUN	I
.	O	PUNCT	O


RESULTS	O	NOUN	B
:	O	PUNCT	O
We	O	PRON	O
identified	O	VERB	B
peptides	O	NOUN	B
derived	O	VERB	O
from	O	ADP	O
EWS/FLI-1	B-protein	NOUN	B
fusion	I-protein	NOUN	I
protein	I-protein	NOUN	I
and	O	CCONJ	O
from	O	ADP	O
mutated	B-protein	VERB	B
K-RAS	I-protein	NOUN	O
protein	I-protein	NOUN	O
(	O	PUNCT	O
encompassing	O	VERB	O
respectively	O	ADV	O
the	O	DET	O
fusion	B-protein	NOUN	B
point	I-protein	NOUN	I
and	O	CCONJ	O
the	O	DET	O
mutation	O	NOUN	B
at	O	ADP	O
position	B-protein	NOUN	O
12	I-protein	NUM	O
)	O	PUNCT	O
that	O	PRON	O
showed	O	VERB	O
binding	B-protein	VERB	B
motif	I-protein	NOUN	I
for	O	ADP	O
HLA-Cw*0702	B-protein	NOUN	B
and	O	CCONJ	O
HLA-A3	B-protein	NOUN	B
respectively	O	ADV	O
.	O	PUNCT	O


OCA-B	B-protein	NOUN	B
is	O	AUX	O
a	O	DET	O
B-cell-specific	B-protein	ADJ	B
coregulator	I-protein	NOUN	I
of	O	ADP	O
the	O	DET	O
broadly	O	ADV	O
expressed	O	VERB	B
POU	B-protein	NOUN	B
domain	I-protein	NOUN	I
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
Oct-1	B-protein	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
nuclear	O	ADJ	B
targets	O	NOUN	I
for	O	ADP	O
PI3K	B-protein	NOUN	B
are	O	AUX	O
not	O	PART	O
known	O	VERB	O
.	O	PUNCT	O


A	O	DET	O
yeast	O	NOUN	B
two-hybrid	O	ADJ	B
screen	O	NOUN	I
identified	O	VERB	O
TES2	B-protein	NOUN	B
interacting	I-protein	NOUN	O
proteins	I-protein	NOUN	O
,	O	PUNCT	O
including	O	VERB	O
the	O	DET	O
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor	I-protein	NOUN	I
receptor-associated	I-protein	ADJ	I
death	I-protein	NOUN	I
domain	I-protein	NOUN	I
protein	I-protein	NOUN	I
(	O	PUNCT	O
TRADD	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


In	O	ADP	O
transfection	O	NOUN	B
assays	O	NOUN	I
,	O	PUNCT	O
TRADD	B-protein	NOUN	B
and	O	CCONJ	O
TES2	B-protein	NOUN	B
synergistically	O	ADV	B
mediated	O	VERB	O
high-level	O	ADJ	O
NF-kappaB	B-protein	NOUN	B
activation	O	NOUN	I
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
this	O	DET	O
C/EBP	B-RNA	NOUN	B
epsilon	I-RNA	NOUN	I
mRNA	I-RNA	NOUN	B
accumulation	O	NOUN	B
did	O	AUX	O
not	O	PART	O
require	O	VERB	O
synthesis	O	NOUN	B
of	O	ADP	O
new	O	ADJ	O
protein	B-protein	NOUN	B
factors	I-protein	NOUN	I
because	O	SCONJ	O
9-cis	O	ADJ	O
RA	O	NOUN	B
induced	O	VERB	B
C/EBP	B-RNA	NOUN	B
epsilon	I-RNA	NOUN	I
mRNA	I-RNA	NOUN	B
accumulation	O	NOUN	B
in	O	ADP	O
the	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
new	O	ADJ	O
protein	O	NOUN	B
synthesis	O	NOUN	I
.	O	PUNCT	O


This	O	DET	O
study	O	NOUN	B
tested	O	VERB	B
the	O	DET	O
hypothesis	O	NOUN	B
that	O	SCONJ	O
anti-LPS	B-protein	ADJ	B
Abs	I-protein	NOUN	B
neutralize	O	VERB	B
endotoxin	O	NOUN	B
by	O	ADP	O
blocking	O	VERB	B
cellular	O	ADJ	B
uptake	O	NOUN	I
through	O	ADP	O
mCD14	B-protein	NOUN	B
.	O	PUNCT	O


LPS-specific	B-protein	ADJ	B
Abs	I-protein	NOUN	B
thus	O	ADV	O
mediate	O	VERB	O
anti-inflammatory	O	ADJ	B
and	O	CCONJ	O
proinflammatory	O	ADJ	B
functions	O	NOUN	I
,	O	PUNCT	O
respectively	O	ADV	O
,	O	PUNCT	O
by	O	ADP	O
preventing	O	VERB	B
target	O	NOUN	B
cell	O	NOUN	O
uptake	O	NOUN	O
of	O	ADP	O
LPS	O	NOUN	B
through	O	ADP	O
mCD14	B-protein	NOUN	B
and	O	CCONJ	O
augmenting	O	VERB	B
uptake	O	NOUN	B
through	O	ADP	O
CR1	B-protein	NOUN	B
or	O	CCONJ	O
other	O	ADJ	O
cell	B-protein	NOUN	B
receptors	I-protein	NOUN	I
.	O	PUNCT	O


Four	O	NUM	O
P-like	B-DNA	ADJ	B
elements	I-DNA	NOUN	I
are	O	AUX	O
required	O	VERB	O
for	O	ADP	O
optimal	O	ADJ	B
transcription	O	NOUN	B
of	O	ADP	O
the	O	DET	O
mouse	B-DNA	NOUN	B
IL-4	I-DNA	NOUN	B
gene	I-DNA	NOUN	I
:	O	PUNCT	O
involvement	O	NOUN	B
of	O	ADP	O
a	O	DET	O
distinct	O	ADJ	O
set	O	NOUN	O
of	O	ADP	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
of	I-protein	ADP	O
activated	I-protein	VERB	B
T	I-protein	NOUN	O
cells	I-protein	NOUN	O
and	O	CCONJ	O
activator	B-protein	NOUN	B
protein-1	I-protein	NOUN	I
family	I-protein	NOUN	B
proteins	I-protein	NOUN	I
.	O	PUNCT	O


Cross-competition	O	NOUN	B
assays	O	NOUN	I
among	O	ADP	O
the	O	DET	O
P-like	B-DNA	ADJ	B
elements	I-DNA	NOUN	I
revealed	O	VERB	O
element-specific	B-protein	ADJ	B
and	I-protein	CCONJ	O
common	I-protein	ADJ	O
complexes	I-protein	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
hypothesized	O	VERB	O
that	O	SCONJ	O
such	O	ADJ	O
defects	O	NOUN	B
in	O	ADP	O
fetal/neonatal	O	ADJ	B
T-cell	O	NOUN	I
activation	O	NOUN	B
may	O	AUX	O
be	O	AUX	O
due	O	ADJ	O
to	O	PART	O
lack	O	NOUN	B
of	O	ADP	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
transcriptional	B-protein	ADJ	B
regulatory	I-protein	ADJ	O
elements	I-protein	NOUN	O
required	O	VERB	O
for	O	ADP	O
T-cell	O	NOUN	B
activation	O	NOUN	I
.	O	PUNCT	O


N-Acetylcysteine	O	NOUN	B
,	O	PUNCT	O
alpha	O	NOUN	B
,	O	PUNCT	O
alpha'-dipyridyl	O	ADJ	B
,	O	PUNCT	O
aminotriazole	O	NOUN	B
or	O	CCONJ	O
nitrofurantoin	O	NOUN	B
did	O	AUX	O
not	O	PART	O
show	O	VERB	O
any	O	DET	O
effect	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
inhibition	O	NOUN	B
by	O	ADP	O
PDTC	O	NOUN	B
was	O	AUX	O
reversible	O	ADJ	O
unless	O	SCONJ	O
glutathione	O	NOUN	B
synthesis	O	NOUN	O
was	O	AUX	O
blocked	O	VERB	B
by	O	ADP	O
buthionine	O	NOUN	B
sulfoximine	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
better	O	ADJ	O
understanding	O	NOUN	O
of	O	ADP	O
transcriptional	O	ADJ	B
regulation	O	NOUN	I
at	O	ADP	O
this	O	DET	O
important	O	ADJ	O
stage	O	NOUN	B
of	O	ADP	O
T-cell	O	NOUN	B
maturation	O	NOUN	I
may	O	AUX	O
yield	O	VERB	O
new	O	ADJ	O
insights	O	NOUN	O
into	O	ADP	O
T-cell	O	NOUN	B
development	O	NOUN	B
and	O	CCONJ	O
new	O	ADJ	O
immunotherapeutic	O	ADJ	B
targets	O	NOUN	O
.	O	PUNCT	O


All	O	DET	O
fusions	O	NOUN	B
splice	O	VERB	O
the	O	DET	O
5	B-DNA	NUM	O
'	I-DNA	PUNCT	O
ends	I-DNA	NOUN	B
of	O	ADP	O
the	O	DET	O
3q21	B-DNA	NOUN	B
genes	I-DNA	NOUN	I
into	O	ADP	O
exon	B-DNA	NOUN	B
2	I-DNA	NUM	I
of	O	ADP	O
the	O	DET	O
EVI1	B-DNA	NOUN	B
gene	O	NOUN	I
,	O	PUNCT	O
an	O	DET	O
event	O	NOUN	B
that	O	PRON	O
is	O	AUX	O
similar	O	ADJ	O
to	O	PART	O
the	O	DET	O
normal	O	ADJ	O
intergenic	O	ADJ	B
splicing	O	NOUN	I
of	O	ADP	O
MDS1-EVI1	B-DNA	NOUN	B
and	O	CCONJ	O
to	O	PART	O
those	O	DET	O
previously	O	ADV	O
documented	O	VERB	B
in	O	ADP	O
leukemias	O	NOUN	B
with	O	ADP	I
t	B-DNA	NOUN	O
(	I-DNA	PUNCT	O
3	I-DNA	NUM	O
;	I-DNA	PUNCT	O
21	I-DNA	NUM	O
)	I-DNA	PUNCT	O
and	O	CCONJ	O
t	B-DNA	NOUN	O
(	I-DNA	PUNCT	O
3	I-DNA	NUM	O
;	I-DNA	PUNCT	O
12	I-DNA	NUM	O
)	I-DNA	PUNCT	O
,	O	PUNCT	O
in	O	ADP	O
which	O	DET	O
acute	O	ADJ	B
myelogenous	B-DNA	ADJ	I
leukemia	I-DNA	NOUN	I
1-EVI1	I-DNA	NUM	O
fusions	I-DNA	NOUN	B
and	O	CCONJ	O
ETV6-EVI1	B-DNA	ADJ	B
fusions	I-DNA	NOUN	B
,	O	PUNCT	O
respectively	O	ADV	O
,	O	PUNCT	O
occur	O	VERB	O
.	O	PUNCT	O


Both	O	DET	O
have	O	AUX	O
been	O	AUX	O
shown	O	VERB	O
to	O	PART	O
be	O	AUX	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
.	O	PUNCT	O


It	O	PRON	O
was	O	AUX	O
recently	O	ADV	O
shown	O	VERB	O
by	O	ADP	O
us	O	PRON	O
that	O	SCONJ	O
the	O	DET	O
protein	O	NOUN	B
is	O	AUX	O
located	O	ADJ	O
in	O	ADP	O
germinal	B-cell_type	ADJ	B
center	I-cell_type	NOUN	I
B	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
their	O	PRON	O
neoplastic	B-cell_type	ADJ	B
counterparts	I-cell_type	NOUN	O
.	O	PUNCT	O


Squamous	O	ADJ	B
cell	O	NOUN	I
carcinomas	O	NOUN	I
showed	O	VERB	O
a	O	DET	O
variety	O	NOUN	O
of	O	ADP	O
expression	O	NOUN	B
levels	O	NOUN	O
,	O	PUNCT	O
while	O	SCONJ	O
two	O	NUM	O
undifferentiated	O	ADJ	B
spindle-shaped	O	ADJ	B
carcinomas	O	NOUN	I
and	O	CCONJ	O
one	O	NUM	O
undifferentiated	O	ADJ	B
SCC	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	O
line	I-cell_line	NOUN	O
remained	O	VERB	O
unstained	O	ADJ	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
bcl-6	B-protein	NOUN	B
protein	I-protein	NOUN	I
may	O	AUX	O
be	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
morphological	O	ADJ	B
differentiation	O	NOUN	B
in	O	ADP	O
normal	O	ADJ	B
and	O	CCONJ	O
neoplastic	B-cell_type	ADJ	B
epidermal	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


The	O	DET	O
leukocyte	B-DNA	NOUN	B
integrin	I-DNA	NOUN	B
genes	I-DNA	NOUN	I
CD11c	B-DNA	NOUN	B
and	O	CCONJ	O
CD11b	B-DNA	NOUN	B
are	O	AUX	O
expressed	O	VERB	B
predominately	O	ADV	O
in	O	ADP	O
myelomonocytic	O	ADJ	B
cells	O	NOUN	I
.	O	PUNCT	O


Cotransfection	O	NOUN	B
of	O	ADP	O
Sp3	B-protein	NOUN	B
along	O	ADP	O
with	O	ADP	O
CD11c	B-DNA	NOUN	B
promoter-luciferase	I-DNA	ADJ	B
constructs	I-DNA	NOUN	O
into	O	ADP	O
Sp-deficient	B-cell_line	ADJ	B
Drosophila	I-cell_line	X	B
Schneider	I-cell_line	NOUN	B
2	I-cell_line	NUM	I
cells	I-cell_line	NOUN	I
showed	O	VERB	O
that	O	SCONJ	O
Sp3	B-protein	NOUN	B
could	O	AUX	O
activate	O	VERB	B
the	O	DET	O
CD11c	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
now	O	ADV	O
studied	O	VERB	O
Trident	B-protein	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
cell	B-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
,	O	PUNCT	O
differentiating	B-cell_type	VERB	O
thymocytes	I-cell_type	NOUN	B
and	O	CCONJ	O
in	O	ADP	O
lymphocytes	O	NOUN	B
derived	O	VERB	O
from	O	ADP	O
peripheral	O	ADJ	B
blood	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
study	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
investigated	O	VERB	B
the	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
ER	B-protein	NOUN	B
alpha	I-protein	NOUN	I
(	O	PUNCT	O
referred	O	VERB	O
to	O	PART	O
throughout	O	ADV	O
as	O	ADP	O
ER	B-protein	NOUN	B
)	O	PUNCT	O
on	O	ADP	O
DNA-binding	O	ADJ	B
activities	O	NOUN	I
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
involved	O	VERB	O
in	O	ADP	O
regulating	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
erythroid-specific	B-DNA	ADJ	B
genes	I-DNA	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
,	O	PUNCT	O
in	O	ADP	O
particular	O	ADJ	O
,	O	PUNCT	O
the	O	DET	O
histone	B-DNA	NOUN	B
H5	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
.	O	PUNCT	O


Using	O	VERB	O
electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assays	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
found	O	VERB	O
that	O	SCONJ	O
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
rabbit	O	NOUN	B
reticulocyte	O	NOUN	B
lysate	O	NOUN	I
,	O	PUNCT	O
human	B-protein	ADJ	B
ER	I-protein	NOUN	B
reduced	O	VERB	B
the	O	DET	O
binding	O	NOUN	B
activities	O	NOUN	I
of	O	ADP	O
chicken	B-protein	NOUN	B
immature	I-protein	ADJ	B
erythrocyte	I-protein	NOUN	B
nuclear	I-protein	ADJ	O
extracted	I-protein	VERB	O
proteins	I-protein	NOUN	O
to	O	PART	O
GATA	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
CACCC	I-DNA	NOUN	B
sites	I-DNA	NOUN	O
in	O	ADP	O
the	O	DET	O
H5	B-DNA	NOUN	B
promoter	I-DNA	NOUN	I
and	I-DNA	CCONJ	O
enhancer	I-DNA	NOUN	B
.	O	PUNCT	O


Both	O	CCONJ	O
GATA-1	B-protein	NOUN	B
and	O	CCONJ	O
CACCC-binding	B-protein	ADJ	B
proteins	I-protein	NOUN	I
are	O	AUX	O
critical	O	ADJ	O
for	O	ADP	O
the	O	DET	O
developmentally	O	ADV	O
regulated	O	VERB	O
expression	O	NOUN	B
of	O	ADP	O
erythroid-specific	B-DNA	ADJ	B
genes	I-DNA	NOUN	I
.	O	PUNCT	O


Cdk2-dependent	O	ADJ	B
phosphorylation	O	NOUN	B
therefore	O	ADV	O
provides	O	VERB	O
a	O	DET	O
switch	O	NOUN	B
during	O	ADP	O
late	O	ADJ	O
G1-to-S	O	ADJ	B
phase	O	NOUN	I
that	O	PRON	O
both	O	CCONJ	O
nullifies	O	VERB	O
an	O	DET	O
early	O	ADJ	O
G1	O	NOUN	B
cell	O	NOUN	I
cycle	O	NOUN	O
regulatory	O	ADJ	O
function	O	NOUN	O
of	O	ADP	O
Id3	B-protein	NOUN	B
and	O	CCONJ	O
modulates	O	VERB	B
its	O	PRON	O
target	O	NOUN	B
bHLH	B-protein	ADJ	B
specificity	O	NOUN	B
.	O	PUNCT	O


Molecular	O	ADJ	B
cloning	O	NOUN	I
and	O	CCONJ	O
functional	O	ADJ	B
characterization	O	NOUN	B
of	O	ADP	O
murine	B-protein	ADJ	B
cDNA	I-protein	NOUN	B
encoding	I-protein	NOUN	B
transcription	I-protein	NOUN	B
factor	I-protein	NOUN	I
NFATc	B-protein	NOUN	I
.	O	PUNCT	O


Transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
of	O	ADP	O
the	O	DET	O
NFAT	B-protein	NOUN	B
(	I-protein	PUNCT	O
nuclear	I-protein	ADJ	B
factor	I-protein	NOUN	I
of	I-protein	ADP	O
activated	I-protein	VERB	B
T	I-protein	NOUN	O
cells	I-protein	NOUN	O
)	I-protein	PUNCT	O
family	I-protein	NOUN	B
play	O	VERB	O
important	O	ADJ	O
roles	O	NOUN	O
in	O	ADP	O
immune	O	ADJ	B
and	O	CCONJ	O
inflammatory	O	ADJ	B
responses	O	NOUN	I
by	O	ADP	O
regulating	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
genes	O	NOUN	B
encoding	O	VERB	B
cytokines	B-protein	NOUN	B
and	O	CCONJ	O
immunoregulatory	B-protein	ADJ	B
proteins	I-protein	NOUN	I
.	O	PUNCT	O


These	O	DET	O
downstream	B-DNA	ADJ	B
sequence	I-DNA	NOUN	I
elements	I-DNA	NOUN	I
,	O	PUNCT	O
termed	O	VERB	O
DSE	B-DNA	NOUN	B
,	O	PUNCT	O
can	O	AUX	O
bind	O	VERB	B
both	O	CCONJ	O
AP-1	B-protein	NOUN	B
and	O	CCONJ	O
CREB/ATF	B-protein	NOUN	B
transcription	B-protein	NOUN	I
factors	I-protein	NOUN	I
.	O	PUNCT	O


Recently	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
demonstrated	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
DSE	B-DNA	NOUN	B
are	O	AUX	O
also	O	ADV	O
cAMP-responsive	B-DNA	ADJ	B
elements	I-DNA	NOUN	I
(	O	PUNCT	O
CRE	B-DNA	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
since	O	SCONJ	O
they	O	PRON	O
mediated	O	VERB	O
activation	O	NOUN	B
signals	O	NOUN	B
elicited	O	VERB	O
by	O	ADP	O
cholera	B-protein	NOUN	B
toxin	I-protein	NOUN	I
(	O	PUNCT	O
Ctx	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
a	O	DET	O
potent	O	ADJ	O
activator	O	NOUN	B
of	O	ADP	O
the	O	DET	O
cAMP-dependent	O	ADJ	B
protein	B-protein	NOUN	I
kinase	I-protein	NOUN	I
A	I-protein	NOUN	I
(	O	PUNCT	O
PKA	B-protein	NOUN	B
)	O	PUNCT	O
signal	O	NOUN	B
transduction	O	NOUN	I
pathway	O	NOUN	O
.	O	PUNCT	O


Because	O	SCONJ	O
the	O	DET	O
DSE	B-DNA	NOUN	B
are	O	AUX	O
also	O	ADV	O
TRE	B-DNA	NOUN	B
sites	O	NOUN	O
,	O	PUNCT	O
we	O	PRON	O
assessed	O	VERB	B
the	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
the	O	DET	O
agonist	O	NOUN	B
combinations	O	NOUN	B
on	O	ADP	O
AP-1	B-protein	NOUN	B
-dependent	O	ADJ	O
transcription	O	NOUN	B
.	O	PUNCT	O


Copyright	O	NOUN	O
1997	O	NUM	O
Academic	O	PROPN	B
Press	O	PROPN	I
.	O	PUNCT	O


Association	O	NOUN	B
of	O	ADP	O
glucocorticoid	O	NOUN	B
insensitivity	O	NOUN	B
with	O	ADP	O
increased	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
glucocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
beta	I-protein	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
many	O	ADJ	O
chronic	O	ADJ	B
inflammatory	O	ADJ	I
disorders	O	NOUN	I
,	O	PUNCT	O
glucocorticoid	O	NOUN	B
(	O	PUNCT	O
GC	O	NOUN	B
)	O	PUNCT	O
insensitivity	O	NOUN	B
is	O	AUX	O
a	O	DET	O
challenging	O	ADJ	O
clinical	O	ADJ	B
problem	O	NOUN	I
associated	O	VERB	B
with	O	ADP	I
life-threatening	O	ADJ	B
disease	O	NOUN	B
progression	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
survey	O	NOUN	B
of	O	ADP	O
promoters	O	NOUN	B
has	O	AUX	O
revealed	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
wild-type	B-protein	ADJ	B
,	I-protein	PUNCT	O
unfused	I-protein	ADJ	B
EBNA3C	I-protein	NOUN	I
can	O	AUX	O
specifically	O	ADV	O
repress	O	VERB	B
expression	O	NOUN	B
from	O	ADP	O
reporter	B-DNA	NOUN	B
plasmids	I-DNA	NOUN	I
containing	O	VERB	O
the	O	DET	O
Epstein-Barr	O	ADJ	B
virus	O	NOUN	I
Cp	B-DNA	NOUN	B
latency-associated	I-DNA	ADJ	I
promoter	I-DNA	NOUN	I
.	O	PUNCT	O


Since	O	SCONJ	O
repression	O	NOUN	B
by	O	ADP	O
these	O	DET	O
fusions	O	NOUN	B
was	O	AUX	O
not	O	PART	O
observed	O	VERB	O
in	O	ADP	O
all	O	DET	O
cell	O	NOUN	B
types	O	NOUN	I
,	O	PUNCT	O
it	O	PRON	O
seems	O	VERB	O
likely	O	ADJ	O
that	O	SCONJ	O
EBNA3C	B-protein	NOUN	B
either	O	CCONJ	O
depends	O	VERB	O
on	O	ADP	O
a	O	DET	O
corepressor	B-protein	NOUN	B
which	O	DET	O
may	O	AUX	O
interact	O	VERB	B
with	O	ADP	O
amino	B-protein	NOUN	B
acids	I-protein	NOUN	I
346	I-protein	NUM	O
to	I-protein	PART	O
543	I-protein	NUM	O
or	O	CCONJ	O
is	O	AUX	O
modified	O	VERB	B
in	O	ADP	O
a	O	DET	O
cell-specific	O	ADJ	B
manner	O	NOUN	I
in	O	ADP	O
order	O	NOUN	O
to	O	PART	O
repress	O	VERB	B
.	O	PUNCT	O


Finally	O	ADV	O
,	O	PUNCT	O
although	O	SCONJ	O
it	O	PRON	O
has	O	AUX	O
been	O	AUX	O
reported	O	VERB	O
that	O	SCONJ	O
EBNA3C	B-protein	NOUN	B
can	O	AUX	O
upregulate	O	VERB	B
CD21	B-protein	NOUN	B
in	O	ADP	O
some	O	DET	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
were	O	AUX	O
unable	O	ADJ	O
to	O	PART	O
demonstrate	O	VERB	O
any	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
EBNA3C	B-protein	NOUN	B
on	O	ADP	O
reporter	B-DNA	NOUN	B
plasmids	I-DNA	NOUN	I
which	O	DET	O
contain	O	VERB	O
the	O	DET	O
CD21	B-DNA	NOUN	B
promoter	I-DNA	NOUN	I
.	O	PUNCT	O


The	O	DET	O
number	O	NOUN	O
and	O	CCONJ	O
apparent	O	ADJ	B
dissociation	O	NOUN	B
constant	O	NOUN	O
of	O	ADP	O
glucocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
were	O	AUX	O
measured	O	VERB	B
using	O	VERB	O
a	O	DET	O
whole-cell	O	ADJ	B
binding	O	NOUN	I
assay	O	NOUN	I
.	O	PUNCT	O


CONCLUSIONS	O	NOUN	O
:	O	PUNCT	O
The	O	DET	O
increased	O	VERB	B
number	O	NOUN	O
and	O	CCONJ	O
apparent	O	ADJ	B
dissociation	O	NOUN	B
constant	O	NOUN	O
of	O	ADP	O
glucocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
are	O	AUX	O
closely	O	ADV	O
associated	O	VERB	B
with	O	ADP	I
the	O	DET	O
effectiveness	O	NOUN	B
of	O	ADP	O
glucocorticoid	O	NOUN	B
therapy	O	NOUN	I
.	O	PUNCT	O


Ig	B-protein	NOUN	B
heavy	I-protein	ADJ	I
chain	I-protein	NOUN	I
class	O	NOUN	I
switching	O	NOUN	I
is	O	AUX	O
directed	O	VERB	O
by	O	ADP	O
cytokines	B-protein	NOUN	B
inducing	O	VERB	O
transcription	O	NOUN	B
from	O	ADP	O
unrearranged	O	ADJ	B
CH	B-DNA	NOUN	I
genes	I-DNA	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
case	O	NOUN	B
of	O	ADP	O
IgE	B-protein	NOUN	B
class	O	NOUN	B
switching	O	NOUN	I
,	O	PUNCT	O
IL-4	B-protein	NOUN	B
activates	O	VERB	B
the	O	DET	O
IgE	B-DNA	NOUN	B
germline	I-DNA	NOUN	O
promoter	I-DNA	NOUN	O
by	O	ADP	O
inducing	O	VERB	B
the	O	DET	O
interaction	O	NOUN	B
of	O	ADP	O
the	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
STAT6	B-protein	NOUN	I
(	O	PUNCT	O
IL-4STAT	B-protein	NOUN	B
)	O	PUNCT	O
with	O	ADP	O
a	O	DET	O
responsive	B-DNA	ADJ	B
DNA	I-DNA	NOUN	B
element	I-DNA	NOUN	I
in	O	ADP	O
the	O	DET	O
proximal	B-DNA	ADJ	B
region	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
promoter	B-DNA	NOUN	B
.	O	PUNCT	O


When	O	SCONJ	O
monocytes	B-cell_type	NOUN	B
are	O	AUX	O
stimulated	O	VERB	B
with	O	ADP	O
LPS	O	NOUN	B
(	O	PUNCT	O
lipopolysaccharide	O	NOUN	B
)	O	PUNCT	O
repeatedly	O	ADV	O
then	O	ADV	O
the	O	DET	O
initially	O	ADV	O
high	O	ADJ	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
TNF	B-DNA	NOUN	B
(	I-DNA	PUNCT	O
tumor	I-DNA	NOUN	B
necrosis	I-DNA	NOUN	I
factor	I-DNA	NOUN	I
)	I-DNA	PUNCT	O
gene	I-DNA	NOUN	O
is	O	AUX	O
only	O	ADV	O
very	O	ADV	O
low	O	ADJ	B
,	O	PUNCT	O
i.e.	O	X	O
the	O	DET	O
cells	O	NOUN	B
are	O	AUX	O
tolerant	O	ADJ	B
to	O	PART	O
LPS	O	NOUN	B
.	O	PUNCT	O


Tolerant	O	ADJ	B
cells	O	NOUN	I
still	O	ADV	O
express	O	VERB	O
the	O	DET	O
CD14	B-protein	NOUN	B
receptor	I-protein	NOUN	I
and	O	CCONJ	O
they	O	PRON	O
can	O	AUX	O
still	O	ADV	O
be	O	AUX	O
activated	O	VERB	B
to	O	PART	O
mobilize	O	VERB	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
into	O	ADP	O
nucleus	O	NOUN	B
.	O	PUNCT	O


Conversely	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
murine	B-DNA	NOUN	B
kappa	I-DNA	NOUN	I
light	I-DNA	ADJ	I
chain	I-DNA	NOUN	I
enhancer	I-DNA	NOUN	I
motif	I-DNA	NOUN	I
(	O	PUNCT	O
GGGGACTTTCCG	O	NOUN	B
)	O	PUNCT	O
does	O	AUX	O
not	O	PART	O
efficiently	O	ADV	O
bind	O	VERB	B
the	O	DET	O
nuclear	O	ADJ	B
p50p50	B-protein	NOUN	I
from	O	ADP	O
tolerant	B-cell_line	ADJ	B
murine	I-cell_line	ADJ	B
P388	I-cell_line	NOUN	B
macrophages	I-cell_line	NOUN	I
.	O	PUNCT	O


Using	O	VERB	O
a	O	DET	O
sensitive	O	ADJ	B
,	O	PUNCT	O
reverse	O	ADJ	B
transcription-polymerase	O	ADJ	I
chain	O	NOUN	I
reaction	O	NOUN	I
(	O	PUNCT	O
RT-PCR	O	NOUN	B
)	O	PUNCT	O
assay	O	NOUN	B
,	O	PUNCT	O
G0S2	B-DNA	NOUN	B
mRNA	O	NOUN	B
levels	O	NOUN	O
were	O	AUX	O
assayed	O	VERB	B
in	O	ADP	O
cultured	B-cell_line	VERB	B
blood	I-cell_line	NOUN	I
mononuclear	I-cell_line	ADJ	I
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Repression	O	NOUN	B
of	O	ADP	O
human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
type	O	NOUN	I
1	O	NUM	I
through	O	ADP	O
the	O	DET	O
novel	O	ADJ	B
cooperation	O	NOUN	B
of	O	ADP	O
human	B-protein	ADJ	B
factors	I-protein	NOUN	O
YY1	B-protein	NOUN	B
and	O	CCONJ	O
LSF	B-protein	NOUN	B
[	O	PUNCT	O
published	O	VERB	O
erratum	O	NOUN	O
appears	O	VERB	O
in	O	ADP	O
J	O	PROPN	O
Virol	O	PROPN	O
1998	O	NUM	O
Feb	O	PROPN	O
;	O	PUNCT	O
72	O	NUM	O
(	O	PUNCT	O
2	O	NUM	O
)	O	PUNCT	O
:	O	PUNCT	O
1709	O	NUM	O
]	O	PUNCT	O


We	O	PRON	O
report	O	VERB	O
that	O	SCONJ	O
both	O	CCONJ	O
YY1	B-protein	NOUN	B
and	O	CCONJ	O
LSF	B-protein	NOUN	B
participate	O	VERB	B
in	O	ADP	O
the	O	DET	O
formation	O	NOUN	B
of	O	ADP	O
a	O	DET	O
complex	O	NOUN	B
that	O	PRON	O
recognizes	O	VERB	O
the	O	DET	O
initiation	O	NOUN	B
region	O	NOUN	I
of	O	ADP	O
the	O	DET	O
HIV-1	B-DNA	NOUN	B
LTR	I-DNA	NOUN	B
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
report	O	VERB	O
a	O	DET	O
real-time	O	ADJ	B
study	O	NOUN	I
of	O	ADP	O
factor/DNA	O	NOUN	B
interactions	O	NOUN	O
using	O	VERB	O
a	O	DET	O
surface	O	NOUN	B
plasmon	O	NOUN	I
resonance	O	NOUN	I
approach	O	NOUN	I
and	O	CCONJ	O
further	O	ADJ	O
characterization	O	NOUN	B
of	O	ADP	O
recovered	B-protein	ADJ	B
proteins	I-protein	NOUN	I
involved	O	VERB	O
in	O	ADP	O
this	O	DET	O
interaction	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
particular	O	ADJ	O
,	O	PUNCT	O
the	O	DET	O
part	O	NOUN	O
played	O	VERB	O
by	O	ADP	O
the	O	DET	O
retinoid	B-protein	NOUN	B
X	I-protein	NOUN	I
receptors	I-protein	NOUN	I
(	O	PUNCT	O
RXRs	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
which	O	DET	O
are	O	AUX	O
members	O	NOUN	B
of	O	ADP	O
the	O	DET	O
steroid/thyroid	B-protein	NOUN	B
hormone	I-protein	NOUN	I
nuclear	I-protein	ADJ	I
receptor	I-protein	NOUN	I
family	I-protein	NOUN	I
,	O	PUNCT	O
has	O	AUX	O
not	O	PART	O
been	O	AUX	O
explored	O	VERB	O
.	O	PUNCT	O


The	O	DET	O
combination	O	NOUN	B
of	O	ADP	O
RA	O	NOUN	B
and	O	CCONJ	O
DHCC	O	NOUN	B
together	O	ADV	O
inhibited	O	VERB	B
growth	O	NOUN	B
of	O	ADP	O
both	O	DET	O
sense	O	NOUN	B
and	O	CCONJ	I
antisense	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
alpha	B-protein	NOUN	B
G2S	I-protein	NOUN	I
exhibited	O	VERB	O
increased	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
CD11b	B-protein	NOUN	B
and	O	CCONJ	O
CD54	B-protein	NOUN	B
,	O	PUNCT	O
while	O	SCONJ	O
alpha	B-cell_line	NOUN	B
B5A	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
showed	O	VERB	O
increased	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
CD102	B-protein	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
RXR-alpha	B-protein	NOUN	B
has	O	AUX	O
a	O	DET	O
role	O	NOUN	O
in	O	ADP	O
regulating	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
cell	B-protein	NOUN	B
adhesion	I-protein	NOUN	I
molecules	I-protein	NOUN	I
in	O	ADP	O
U937	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


The	O	DET	O
HIV-1	B-protein	NOUN	B
accessory	I-protein	NOUN	B
gene	I-protein	NOUN	I
product	I-protein	NOUN	I
Vpr	B-protein	NOUN	B
can	O	AUX	O
influence	O	VERB	B
viral	O	ADJ	B
pathogenesis	O	NOUN	B
by	O	ADP	O
affecting	O	VERB	B
viral	O	ADJ	B
replication	O	NOUN	I
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
host	O	NOUN	B
cell	O	NOUN	B
transcription	O	NOUN	I
and	O	CCONJ	O
proliferation	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
TCR	B-protein	NOUN	B
-mediated	O	ADJ	O
activation	O	NOUN	B
,	O	PUNCT	O
Vpr	B-protein	NOUN	B
induces	O	VERB	O
apoptosis	O	NOUN	B
whereas	O	SCONJ	O
in	O	ADP	O
its	O	PRON	O
presence	O	NOUN	B
,	O	PUNCT	O
Vpr	B-protein	NOUN	B
interrupts	O	VERB	O
the	O	DET	O
expected	O	VERB	O
induction	O	NOUN	B
of	O	ADP	O
apoptosis	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
retinoblastoma	B-protein	NOUN	B
gene	I-protein	NOUN	I
product	I-protein	NOUN	I
(	O	PUNCT	O
pRB	B-protein	NOUN	B
)	O	PUNCT	O
plays	O	VERB	O
an	O	DET	O
important	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
controlling	O	VERB	B
both	O	CCONJ	O
cell	O	NOUN	B
release	O	NOUN	I
from	O	ADP	O
the	O	DET	O
G1	O	NOUN	B
phase	O	NOUN	I
and	O	CCONJ	O
apoptosis	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
shift	O	NOUN	B
in	O	ADP	O
pRB	B-protein	NOUN	B
molecular	O	ADJ	B
weight	O	NOUN	I
was	O	AUX	O
reproduced	O	VERB	O
by	O	ADP	O
adding	O	VERB	O
exogenous	O	ADJ	B
purified	O	VERB	B
tTG	O	NOUN	B
to	O	PART	O
extracts	O	NOUN	B
obtained	O	VERB	O
from	O	ADP	O
viable	O	ADJ	O
U937	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
and	O	CCONJ	O
was	O	AUX	O
prevented	O	VERB	B
by	O	ADP	O
dansylcadaverine	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
potent	O	ADJ	O
enzyme	O	NOUN	B
inhibitor	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
the	O	DET	O
pRB	B-protein	NOUN	B
posttranslational	O	ADJ	B
modification	O	NOUN	I
during	O	ADP	O
apoptosis	O	NOUN	B
was	O	AUX	O
investigated	O	VERB	B
by	O	ADP	O
determining	O	VERB	O
the	O	DET	O
E2F-1	B-protein	NOUN	B
levels	O	NOUN	B
and	O	CCONJ	O
by	O	ADP	O
isolating	O	VERB	B
and	O	CCONJ	O
characterizing	O	VERB	O
pRB-null	B-cell_line	ADJ	B
clones	I-cell_line	NOUN	B
from	O	ADP	O
U937	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Taken	O	VERB	O
together	O	ADV	O
,	O	PUNCT	O
these	O	DET	O
data	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
tTG	B-protein	NOUN	B
,	O	PUNCT	O
acting	O	VERB	O
on	O	ADP	O
the	O	DET	O
pRB	B-protein	NOUN	B
protein	I-protein	NOUN	I
,	O	PUNCT	O
might	O	AUX	O
play	O	VERB	O
an	O	DET	O
important	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
cell	O	NOUN	B
progression	O	NOUN	I
through	O	ADP	O
the	O	DET	O
death	O	NOUN	B
program	O	NOUN	I
.	O	PUNCT	O


Interleukin	B-protein	NOUN	B
2	I-protein	NUM	I
(	O	PUNCT	O
IL-2	B-protein	NOUN	B
)	O	PUNCT	O
induces	O	VERB	O
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	B
of	O	ADP	O
STATs	B-protein	NOUN	B
3	I-protein	NUM	I
and	I-protein	CCONJ	O
5	I-protein	NUM	O
(	O	PUNCT	O
signal	O	NOUN	B
transducer	O	NOUN	I
and	O	CCONJ	I
activator	O	NOUN	O
of	O	ADP	O
transcription	O	NOUN	O
)	O	PUNCT	O
.	O	PUNCT	O


NF-kappa	B-protein	NOUN	B
B/Rel	I-protein	NOUN	B
family	I-protein	NOUN	B
members	I-protein	NOUN	I
regulating	O	VERB	B
the	O	DET	O
ICAM-1	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
in	O	ADP	O
monocytic	B-cell_line	ADJ	B
THP-1	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


The	O	DET	O
human	O	ADJ	B
autosomal	O	ADJ	O
recessive	O	ADJ	O
disease	O	NOUN	O
,	O	PUNCT	O
xeroderma	O	NOUN	B
pigmentosum	O	NOUN	I
(	O	PUNCT	O
XP	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
can	O	AUX	O
result	O	VERB	O
from	O	ADP	O
mutations	O	NOUN	B
in	O	ADP	O
any	O	DET	O
one	O	NUM	O
of	O	ADP	O
seven	O	NUM	O
genes	O	NOUN	B
,	O	PUNCT	O
designated	O	VERB	O
XPA	B-DNA	NOUN	B
through	O	ADP	O
XPG	B-DNA	NOUN	B
.	O	PUNCT	O


Of	O	ADP	O
these	O	DET	O
,	O	PUNCT	O
the	O	DET	O
XPB	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
XPD	I-DNA	NOUN	B
genes	I-DNA	NOUN	I
encode	O	VERB	B
proteins	O	NOUN	B
that	O	PRON	O
are	O	AUX	O
subunits	O	NOUN	B
of	O	ADP	O
a	O	DET	O
general	B-protein	ADJ	O
transcription	I-protein	NOUN	O
factor	I-protein	NOUN	O
,	O	PUNCT	O
TFIIH	B-protein	NOUN	B
,	O	PUNCT	O
involved	O	VERB	O
in	O	ADP	O
both	O	CCONJ	O
nucleotide	O	NOUN	B
excision	O	NOUN	I
repair	O	NOUN	I
(	O	PUNCT	O
NER	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
initiation	O	NOUN	B
of	O	ADP	O
mRNA	O	NOUN	B
transcription	O	NOUN	I
by	O	ADP	O
RNA	B-protein	NOUN	B
polymerase	I-protein	NOUN	I
II	I-protein	NUM	I
.	O	PUNCT	O


Binding	O	NOUN	B
capacity	O	NOUN	O
(	O	PUNCT	O
4978+/-391	O	ADJ	O
versus	O	CCONJ	O
4131+/-321	O	NUM	O
sites/cell	O	NOUN	O
)	O	PUNCT	O
,	O	PUNCT	O
Kd	O	NOUN	B
values	O	NOUN	I
for	O	ADP	O
dexamethasone	O	NOUN	B
(	O	PUNCT	O
6.7+/-0.5	O	NUM	O
versus	O	CCONJ	O
5.7+/-0.3	O	NUM	O
nmol/L	O	NOUN	O
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
IC50	O	NOUN	B
values	O	NOUN	B
for	O	ADP	O
dexamethasone	O	NOUN	B
(	O	PUNCT	O
3.4+/-0.3	O	NUM	O
versus	O	CCONJ	O
3.1+/-0.2	O	NUM	O
nmol/L	O	NOUN	O
)	O	PUNCT	O
and	O	CCONJ	O
cortisol	O	NOUN	B
(	O	PUNCT	O
12.2+/-1.6	O	NUM	O
versus	O	CCONJ	O
9.5+/-0.3	O	NUM	O
nmol/L	O	NOUN	O
)	O	PUNCT	O
were	O	AUX	O
not	O	PART	O
significantly	O	ADV	O
different	O	ADJ	O
.	O	PUNCT	O


Patients	O	NOUN	B
with	O	ADP	O
renin	B-protein	NOUN	B
values	O	NOUN	B
less	O	ADJ	O
than	O	ADP	O
0.13	O	NUM	O
ng	O	NOUN	O
angiotensin	O	NOUN	B
I/L	O	NOUN	I
per	O	ADP	O
second	O	NOUN	O
were	O	AUX	O
markedly	O	ADV	O
less	O	ADV	O
sensitive	O	ADJ	B
to	O	PART	O
cortisol	O	NOUN	B
than	O	ADP	O
those	O	DET	O
with	O	ADP	O
higher	O	ADJ	B
values	O	NOUN	B
.	O	PUNCT	O


Both	O	CCONJ	O
Kd	O	NOUN	B
(	O	PUNCT	O
30.3+/-2.5	O	NUM	O
versus	O	CCONJ	O
19.2+/-2.4	O	NUM	O
nmol/L	O	NOUN	O
)	O	PUNCT	O
and	O	CCONJ	O
IC50	O	NOUN	B
values	O	NOUN	B
(	O	PUNCT	O
15.5+/-1.8	O	NUM	O
versus	O	CCONJ	O
8.9+/-1.2	O	NUM	O
nmol/L	O	NOUN	O
)	O	PUNCT	O
for	O	ADP	O
cortisol	O	NOUN	B
were	O	AUX	O
significantly	O	ADV	O
higher	O	ADJ	O
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
lower	O	ADJ	O
renin	B-protein	NOUN	B
values	O	NOUN	B
(	O	PUNCT	O
P	O	NOUN	O
<	O	X	O
.03	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


PU.1/Pip	B-protein	NOUN	B
and	O	CCONJ	O
basic	B-protein	ADJ	O
helix	I-protein	NOUN	O
loop	I-protein	NOUN	O
helix	I-protein	NOUN	O
zipper	I-protein	NOUN	O
transcription	I-protein	NOUN	O
factors	I-protein	NOUN	O
interact	O	VERB	B
with	O	ADP	O
binding	B-DNA	VERB	B
sites	I-DNA	NOUN	I
in	O	ADP	O
the	O	DET	O
CD20	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
to	O	PART	O
help	O	VERB	O
confer	O	VERB	O
lineage-	O	NOUN	B
and	O	CCONJ	O
stage-specific	O	ADJ	B
expression	O	NOUN	O
of	O	ADP	O
CD20	B-protein	NOUN	B
in	O	ADP	O
B	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
.	O	PUNCT	O


These	O	DET	O
findings	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
cortisol	O	NOUN	B
and	O	CCONJ	O
its	O	PRON	O
receptors	O	NOUN	B
are	O	AUX	O
critically	O	ADV	O
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
immune	O	ADJ	B
function	O	NOUN	I
in	O	ADP	O
HIV	O	NOUN	B
infection	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
conclusion	O	NOUN	O
,	O	PUNCT	O
we	O	PRON	O
propose	O	VERB	O
that	O	SCONJ	O
Bcl-xL	B-protein	NOUN	B
expression	O	NOUN	B
is	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
differentiation	O	NOUN	B
and	O	CCONJ	O
survival	O	NOUN	B
of	O	ADP	O
hematopoietic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
along	O	ADP	O
the	O	DET	O
monocyte/macrophage	B-cell_type	NOUN	B
lineage	I-cell_type	NOUN	B
.	O	PUNCT	O


Evidence	O	NOUN	B
that	O	SCONJ	O
calcineurin	O	NOUN	B
is	O	AUX	O
rate-limiting	O	ADJ	O
for	O	ADP	O
primary	O	ADJ	B
human	O	ADJ	B
lymphocyte	O	NOUN	O
activation	O	NOUN	O
.	O	PUNCT	O


Cyclosporine	O	NOUN	B
(	O	PUNCT	O
CsA	O	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
both	O	CCONJ	O
a	O	DET	O
clinical	O	ADJ	B
immunosuppressive	O	ADJ	I
drug	O	NOUN	I
and	O	CCONJ	O
a	O	DET	O
probe	O	NOUN	B
to	O	PART	O
dissect	O	VERB	O
intracellular	O	ADJ	B
signaling	O	NOUN	B
pathways	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
selected	O	VERB	O
16	B-DNA	NUM	O
sequences	I-DNA	NOUN	B
and	O	CCONJ	O
confirmed	O	VERB	O
their	O	PRON	O
down-regulation	O	NOUN	B
along	O	ADP	O
the	O	DET	O
TPA-induced	O	ADJ	B
monocytic	O	ADJ	B
differentiation	O	NOUN	I
of	O	ADP	O
HL60	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


A	O	DET	O
single-chain	B-protein	ADJ	O
Fv	I-protein	NOUN	O
(	O	PUNCT	O
sFv	B-protein	NOUN	B
)	O	PUNCT	O
was	O	AUX	O
expressed	O	VERB	B
from	O	ADP	O
the	O	DET	O
variable	B-protein	ADJ	B
regions	I-protein	NOUN	I
of	O	ADP	O
the	O	DET	O
CD40-specific	O	ADJ	B
mAb	B-protein	NOUN	B
G28-5	I-protein	NOUN	B
.	O	PUNCT	O


Surprisingly	O	ADV	O
,	O	PUNCT	O
G28-5	B-protein	NOUN	B
sFv	I-protein	NOUN	B
was	O	AUX	O
a	O	DET	O
potent	O	ADJ	O
CD40	B-protein	NOUN	B
agonist	I-protein	NOUN	B
that	O	PRON	O
rapidly	O	ADV	O
crosslinked	O	VERB	B
CD40	B-protein	NOUN	B
on	O	ADP	O
the	O	DET	O
cell	O	NOUN	B
surface	O	NOUN	I
but	O	CCONJ	O
did	O	AUX	O
not	O	PART	O
crosslink	O	VERB	B
CD40-Ig	B-protein	NOUN	B
in	O	ADP	O
solution	O	NOUN	B
.	O	PUNCT	O


G28-5	B-protein	NOUN	B
IgG	I-protein	NOUN	B
partially	O	ADV	O
blocked	O	VERB	B
,	O	PUNCT	O
whereas	O	SCONJ	O
G28-5	B-protein	NOUN	O
sFv	I-protein	NOUN	B
augmented	O	VERB	B
CD40	B-protein	NOUN	B
responses	O	NOUN	B
during	O	ADP	O
stimulation	O	NOUN	B
with	O	ADP	O
natural	B-protein	ADJ	B
ligand	I-protein	NOUN	I
(	O	PUNCT	O
gp39-CD8	B-protein	NOUN	B
fusion	I-protein	NOUN	I
protein	I-protein	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
purpose	O	NOUN	O
of	O	ADP	O
these	O	DET	O
studies	O	NOUN	B
was	O	AUX	O
to	O	PART	O
identify	O	VERB	O
whether	O	SCONJ	O
transcription	O	NOUN	B
factors	O	NOUN	I
,	O	PUNCT	O
associated	O	VERB	B
with	O	ADP	I
cytokine	O	NOUN	B
signalling	O	NOUN	I
,	O	PUNCT	O
affected	O	VERB	O
promoter	O	NOUN	B
activity	O	NOUN	I
of	O	ADP	O
the	O	DET	O
corticotropin	B-DNA	NOUN	B
releasing	I-DNA	NOUN	I
hormone	I-DNA	NOUN	I
(	I-DNA	PUNCT	O
CRH	I-DNA	NOUN	O
)	I-DNA	PUNCT	O
gene	I-DNA	NOUN	O
.	O	PUNCT	O


Increased	O	VERB	B
CRH	B-protein	NOUN	B
promoter	O	NOUN	B
activity	O	NOUN	I
following	O	VERB	O
phorbol	O	NOUN	B
ester	O	NOUN	I
treatment	O	NOUN	B
was	O	AUX	O
inhibited	O	VERB	B
by	O	ADP	O
a	O	DET	O
dominant	O	ADJ	B
negative	O	ADJ	B
NF-IL6	B-protein	NOUN	B
mutant	I-protein	NOUN	I
,	O	PUNCT	O
showing	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	O
phorbol	O	NOUN	B
ester	O	NOUN	I
were	O	AUX	O
principally	O	ADV	O
mediated	O	VERB	O
by	O	ADP	O
C/EBP	B-protein	NOUN	B
.	O	PUNCT	O


While	O	SCONJ	O
we	O	PRON	O
can	O	AUX	O
not	O	PART	O
exclude	O	VERB	O
that	O	SCONJ	O
alterations	O	NOUN	B
in	O	ADP	O
TSG101	B-DNA	NOUN	B
and	O	CCONJ	O
FHIT	B-DNA	NOUN	B
occur	O	VERB	O
during	O	ADP	O
cancer	O	NOUN	B
development	O	NOUN	I
,	O	PUNCT	O
our	O	PRON	O
data	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
in	O	ADP	O
this	O	DET	O
context	O	NOUN	O
the	O	DET	O
commonly	O	ADV	O
observed	O	VERB	O
transcript	O	NOUN	B
abnormalities	O	NOUN	B
are	O	AUX	O
misleading	O	VERB	O
.	O	PUNCT	O


Inhibition	O	NOUN	B
of	O	ADP	O
proliferation	O	NOUN	B
and	O	CCONJ	O
apoptosis	O	NOUN	B
of	O	ADP	O
human	B-cell_type	ADJ	B
and	I-cell_type	CCONJ	O
rat	I-cell_type	NOUN	B
T	I-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
by	O	ADP	O
curcumin	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
curry	O	NOUN	B
pigment	O	NOUN	B
.	O	PUNCT	O


Complete	O	ADJ	B
suppression	O	NOUN	B
of	O	ADP	O
AP-1	B-protein	NOUN	B
activity	O	NOUN	I
was	O	AUX	O
observed	O	VERB	O
in	O	ADP	O
Con	B-cell_line	NOUN	B
A-treated	I-cell_line	ADJ	B
,	I-cell_line	PUNCT	O
proliferating	I-cell_line	VERB	B
thymocytes	I-cell_line	NOUN	B
.	O	PUNCT	O


Production	O	NOUN	B
of	O	ADP	O
IL-2	B-protein	NOUN	B
requires	O	VERB	O
the	O	DET	O
formation	O	NOUN	B
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
IL-2-gene	B-DNA	NOUN	B
regulation	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
spatial	O	ADJ	B
distribution	O	NOUN	B
of	O	ADP	O
human	B-DNA	ADJ	B
immunoglobulin	I-DNA	NOUN	B
genes	I-DNA	NOUN	I
within	O	ADP	O
the	O	DET	O
nucleus	O	NOUN	B
:	O	PUNCT	O
evidence	O	NOUN	B
for	O	ADP	O
gene	O	NOUN	B
topography	O	NOUN	I
independent	O	ADJ	B
of	O	ADP	O
cell	O	NOUN	B
type	O	NOUN	I
and	O	CCONJ	O
transcriptional	O	ADJ	B
activity	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
three-dimensional	O	ADJ	B
positioning	O	NOUN	B
of	O	ADP	O
immunoglobulin	B-DNA	NOUN	B
(	I-DNA	PUNCT	I
Ig	I-DNA	NOUN	I
)	I-DNA	PUNCT	I
genes	I-DNA	NOUN	I
within	O	ADP	O
the	O	DET	O
nucleus	O	NOUN	B
of	O	ADP	O
human	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
was	O	AUX	O
investigated	O	VERB	B
using	O	VERB	O
in	O	X	B
situ	O	X	I
hybridization	O	NOUN	I
and	O	CCONJ	O
confocal	O	ADJ	B
microscopy	O	NOUN	I
.	O	PUNCT	O


Although	O	SCONJ	O
subtle	O	ADJ	O
gene	O	NOUN	B
movements	O	NOUN	I
within	O	ADP	O
those	O	DET	O
defined	O	VERB	O
topographical	O	ADJ	B
regions	O	NOUN	I
can	O	AUX	O
not	O	PART	O
be	O	AUX	O
excluded	O	VERB	O
by	O	ADP	O
this	O	DET	O
study	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
tissue	O	NOUN	B
specificity	O	NOUN	B
of	O	ADP	O
gene	O	NOUN	B
expression	O	NOUN	I
is	O	AUX	O
not	O	PART	O
accompanied	O	VERB	O
by	O	ADP	O
drastic	O	ADJ	B
changes	O	NOUN	B
in	O	ADP	O
gene	O	NOUN	B
nuclear	O	ADJ	I
topography	O	NOUN	I
,	O	PUNCT	O
rather	O	ADV	O
suggesting	O	VERB	O
that	O	SCONJ	O
gene	O	NOUN	B
organization	O	NOUN	I
within	O	ADP	O
the	O	DET	O
nucleus	O	NOUN	B
may	O	AUX	O
be	O	AUX	O
primarily	O	ADV	O
dependent	O	ADJ	O
on	O	ADP	O
structural	O	ADJ	B
constraints	O	NOUN	O
imposed	O	VERB	O
on	O	ADP	O
the	O	DET	O
respective	O	ADJ	O
chromosomes	B-DNA	NOUN	B
.	O	PUNCT	O


Dominant	O	ADJ	B
cytotoxic	B-cell_type	ADJ	B
T	I-cell_type	NOUN	B
lymphocyte	I-cell_type	NOUN	I
response	O	NOUN	I
to	O	PART	O
the	O	DET	O
immediate-early	B-protein	ADJ	B
trans-activator	I-protein	NOUN	I
protein	I-protein	NOUN	I
,	O	PUNCT	O
BZLF1	B-protein	NOUN	B
,	O	PUNCT	O
in	O	ADP	O
persistent	O	ADJ	B
type	O	NOUN	B
A	O	NOUN	I
or	O	CCONJ	O
B	O	NOUN	B
Epstein-Barr	O	ADJ	I
virus	O	NOUN	I
infection	O	NOUN	I
.	O	PUNCT	O


Using	O	VERB	O
limiting-dilution	O	ADJ	B
analysis	O	NOUN	I
of	O	ADP	O
peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
mononuclear	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
a	O	DET	O
high	O	ADJ	O
RAKFKQLLQ-specific	O	ADJ	B
CTL	O	NOUN	B
precursor	O	NOUN	O
frequency	O	NOUN	O
was	O	AUX	O
demonstrated	O	VERB	O
after	O	ADP	O
specific	O	ADJ	O
peptide	O	NOUN	B
or	O	CCONJ	O
autologous	O	ADJ	B
lymphoblastoid	O	ADJ	I
cell	O	NOUN	I
line	O	NOUN	I
stimulation	O	NOUN	O
in	O	ADP	O
both	O	CCONJ	O
type	O	NOUN	B
A	O	NOUN	I
and	O	CCONJ	O
type	O	NOUN	B
B	O	NOUN	I
EBV	O	NOUN	I
carriers	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
findings	O	NOUN	B
show	O	VERB	O
that	O	SCONJ	O
healthy	O	ADJ	B
virus	O	NOUN	B
carriers	O	NOUN	B
maintain	O	VERB	O
a	O	DET	O
high	O	ADJ	O
frequency	O	NOUN	B
of	O	ADP	O
BZLF1-specific	B-cell_type	ADJ	B
memory	I-cell_type	NOUN	I
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
potentially	O	ADV	O
to	O	PART	O
control	O	VERB	B
virus	O	NOUN	B
spread	O	VERB	B
from	O	ADP	O
lytically	B-cell_type	ADV	B
infected	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
therefore	O	ADV	O
investigated	O	VERB	B
the	O	DET	O
transcriptional	O	ADJ	B
activity	O	NOUN	I
of	O	ADP	O
A-MYB	B-protein	NOUN	B
and	O	CCONJ	O
its	O	PRON	O
regulation	O	NOUN	B
in	O	ADP	O
several	O	ADJ	O
human	B-cell_line	ADJ	B
lymphoid	I-cell_line	ADJ	O
cell	I-cell_line	NOUN	O
lines	I-cell_line	NOUN	O
using	O	VERB	O
co-transfection	O	NOUN	B
assays	O	NOUN	I
and	O	CCONJ	O
show	O	VERB	O
that	O	SCONJ	O
A-MYB	B-protein	NOUN	B
is	O	AUX	O
transcriptionally	O	ADV	B
active	O	ADJ	O
in	O	ADP	O
all	O	DET	O
the	O	DET	O
B	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
studied	O	VERB	O
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
particular	O	ADJ	O
the	O	DET	O
best	O	ADJ	O
responder	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	O
line	I-cell_line	NOUN	O
was	O	AUX	O
the	O	DET	O
Burkitt	B-cell_line	NOUN	B
's	I-cell_line	PART	I
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
Namalwa	I-cell_line	NOUN	B
.	O	PUNCT	O


To	O	PART	O
identify	O	VERB	O
such	O	ADJ	O
target	B-DNA	NOUN	B
genes	I-DNA	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
established	O	VERB	O
Egr-1-overexpressing	B-cell_line	ADJ	O
transfectants	I-cell_line	NOUN	B
from	O	ADP	O
the	O	DET	O
murine	B-cell_line	NOUN	B
B	I-cell_line	NOUN	O
cell	I-cell_line	NOUN	O
line	I-cell_line	NOUN	O
K46	I-cell_line	NOUN	O
and	O	CCONJ	O
from	O	ADP	O
human	B-cell_line	ADJ	B
Ramos	I-cell_line	NOUN	B
B	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
Egr-1	B-protein	NOUN	B
seems	O	VERB	O
to	O	PART	O
control	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
downstream	B-DNA	ADJ	B
target	I-DNA	NOUN	O
genes	I-DNA	NOUN	O
not	O	PART	O
only	O	ADV	O
as	O	ADP	O
a	O	DET	O
transcriptional	O	ADJ	B
activator	O	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
also	O	ADV	O
as	O	ADP	O
a	O	DET	O
repressor	B-protein	NOUN	B
molecule	I-protein	NOUN	I
.	O	PUNCT	O


Increased	O	VERB	B
turnover	O	NOUN	B
has	O	AUX	O
been	O	AUX	O
implicated	O	VERB	O
in	O	ADP	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
constitutive	O	ADJ	B
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activity	O	NOUN	O
in	O	ADP	O
mature	B-cell_type	ADJ	B
B	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


There	O	PRON	O
is	O	AUX	O
no	O	DET	B
significant	O	ADJ	I
difference	O	NOUN	O
in	O	ADP	O
the	O	DET	O
turnover	O	NOUN	B
of	O	ADP	O
pre-	O	ADJ	B
and	O	CCONJ	I
post-inductive	O	ADJ	I
I	B-protein	NOUN	I
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
alpha	I-protein	NOUN	I
.	O	PUNCT	O


Repertoire	O	ADJ	B
selection	O	NOUN	B
was	O	AUX	O
monitored	O	VERB	O
by	O	ADP	O
determining	O	VERB	O
the	O	DET	O
TCR	B-protein	NOUN	B
beta	I-protein	NOUN	B
chain	I-protein	NOUN	I
sequences	I-protein	NOUN	I
of	O	ADP	O
RAKFKQLLQ-specific	B-cell_line	ADJ	B
CTL	I-cell_line	NOUN	I
established	O	VERB	O
from	O	ADP	O
primary	O	ADJ	O
infected	O	ADJ	B
and	O	CCONJ	O
healthy	O	ADJ	B
virus	O	NOUN	B
carriers	O	NOUN	B
.	O	PUNCT	O


Pretreatment	O	NOUN	B
with	O	ADP	O
actinomycin	O	NOUN	B
D	O	NOUN	I
and	O	CCONJ	O
cycloheximide	O	NOUN	B
or	O	CCONJ	O
with	O	ADP	O
competing	O	VERB	O
ds-oligonucleotides	O	NOUN	B
containing	O	VERB	O
the	O	DET	O
nuclear	B-protein	ADJ	B
factor-kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
or	O	CCONJ	O
activator	B-protein	NOUN	O
protein-1	I-protein	NOUN	O
cognate	B-DNA	NOUN	O
DNA	I-DNA	NOUN	B
sequences	I-DNA	NOUN	I
significantly	O	ADV	O
attenuated	O	VERB	B
phase-2	O	ADJ	B
response	O	NOUN	I
,	O	PUNCT	O
suggesting	O	VERB	O
a	O	DET	O
role	O	NOUN	O
for	O	ADP	O
de	O	X	O
novo	O	X	O
macromolecule	O	NOUN	B
synthesis	O	NOUN	O
.	O	PUNCT	O


Surface	O	NOUN	B
expression	O	NOUN	B
of	O	ADP	O
ICAM-1	B-protein	NOUN	B
,	O	PUNCT	O
P-selectin	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
E-selectin	B-protein	NOUN	B
on	O	ADP	O
HUVECs	B-cell_line	NOUN	B
correlated	O	VERB	B
with	O	ADP	O
the	O	DET	O
phase-1	O	NOUN	B
and	O	CCONJ	O
-2	O	NUM	O
neutrophil	O	NOUN	B
adhesion	O	NOUN	B
responses	O	NOUN	B
.	O	PUNCT	O


Collectively	O	ADV	O
,	O	PUNCT	O
these	O	DET	O
findings	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
A/R	O	NOUN	B
elicits	O	VERB	O
a	O	DET	O
two-phase	O	ADJ	O
neutrophil-endothelial	O	ADJ	O
cell	O	NOUN	O
adhesion	O	NOUN	O
response	O	NOUN	B
that	O	PRON	O
involves	O	VERB	O
transcription-independent	O	ADJ	B
and	O	CCONJ	O
transcription-dependent	O	ADJ	B
surface	O	NOUN	O
expression	O	NOUN	B
of	O	ADP	O
different	O	ADJ	O
endothelial	B-protein	ADJ	B
cell	I-protein	NOUN	I
adhesion	I-protein	NOUN	O
molecules	I-protein	NOUN	O
.	O	PUNCT	O


To	O	PART	O
define	O	VERB	O
the	O	DET	O
CD40	B-protein	NOUN	B
signaling	O	NOUN	B
components	O	NOUN	I
upstream	O	ADJ	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activation	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
functional	O	ADJ	B
consequences	O	NOUN	O
downstream	O	ADJ	O
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activation	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
examined	O	VERB	O
mouse	B-cell_line	NOUN	B
B	I-cell_line	NOUN	O
cell	I-cell_line	NOUN	O
transfectants	I-cell_line	NOUN	O
expressing	O	VERB	B
wild-type	B-protein	ADJ	B
or	I-protein	CCONJ	O
mutant	I-protein	ADJ	B
human	I-protein	ADJ	B
CD40	I-protein	NOUN	B
.	O	PUNCT	O


NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activation	O	NOUN	O
correlated	O	VERB	B
with	O	ADP	O
the	O	DET	O
ability	O	NOUN	O
of	O	ADP	O
CD40	B-protein	NOUN	B
to	O	PART	O
induce	O	VERB	B
Ab	O	NOUN	B
secretion	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
up-regulation	O	NOUN	B
of	O	ADP	O
ICAM-1	B-protein	NOUN	B
and	O	CCONJ	O
LFA-1	B-protein	NOUN	B
.	O	PUNCT	O


CD30	B-protein	NOUN	B
is	O	AUX	O
a	O	DET	O
cell-surface	B-protein	ADJ	B
receptor	I-protein	NOUN	I
that	O	PRON	O
can	O	AUX	O
augment	O	VERB	O
lymphocyte	O	NOUN	B
activation	O	NOUN	I
and	O	CCONJ	O
survival	O	NOUN	B
through	O	ADP	O
its	O	PRON	O
ability	O	NOUN	O
to	O	PART	O
induce	O	VERB	B
the	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
NF-kappaB	B-protein	NOUN	I
.	O	PUNCT	O


CD30	B-protein	NOUN	B
,	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
has	O	AUX	O
also	O	ADV	O
been	O	AUX	O
implicated	O	VERB	O
in	O	ADP	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
apoptotic	O	ADJ	B
cell	O	NOUN	I
death	O	NOUN	O
of	O	ADP	O
lymphocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


During	O	ADP	O
CD30	B-protein	NOUN	B
signal	O	NOUN	I
transduction	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
found	O	VERB	O
that	O	SCONJ	O
binding	O	NOUN	B
of	O	ADP	O
TRAF2	B-protein	NOUN	B
to	O	PART	O
the	O	DET	O
cytoplasmic	B-protein	ADJ	B
domain	I-protein	NOUN	I
of	O	ADP	O
CD30	B-protein	NOUN	B
results	O	VERB	B
in	O	ADP	O
the	O	DET	O
rapid	O	ADJ	O
depletion	O	NOUN	B
of	O	ADP	O
TRAF2	B-protein	NOUN	B
and	O	CCONJ	O
the	O	DET	O
associated	O	VERB	O
protein	O	NOUN	B
TRAF1	B-protein	NOUN	B
by	O	ADP	O
proteolysis	O	NOUN	B
.	O	PUNCT	O


Different	O	ADJ	O
cocktails	O	NOUN	B
of	O	ADP	O
the	O	DET	O
identified	O	VERB	B
ligands	O	NOUN	B
were	O	AUX	O
added	O	VERB	O
to	O	PART	O
sorted	B-cell_line	VERB	B
CD34+Thy-1+	I-cell_line	ADJ	B
single	I-cell_line	ADJ	I
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Mycobacterium	O	X	B
tuberculosis	O	X	I
and	O	CCONJ	O
its	O	PRON	O
components	O	NOUN	B
are	O	AUX	O
strong	O	ADJ	O
signals	O	NOUN	B
to	O	PART	O
activate	O	VERB	B
monocytes	B-cell_type	NOUN	B
to	O	PART	O
production	O	NOUN	B
of	O	ADP	O
cytokines	B-protein	NOUN	B
.	O	PUNCT	O


Further	O	ADV	O
,	O	PUNCT	O
M.	O	X	B
tuberculosis	O	X	I
and	O	CCONJ	O
its	O	PRON	O
tuberculin	B-protein	NOUN	B
,	O	PUNCT	O
purified	B-protein	VERB	B
protein	I-protein	NOUN	I
derivative	I-protein	NOUN	I
,	O	PUNCT	O
induced	O	VERB	B
the	O	DET	O
degradation	O	NOUN	B
of	O	ADP	O
I	B-protein	NOUN	O
kappa	I-protein	NOUN	O
B-alpha	I-protein	NOUN	B
and	O	CCONJ	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
I	B-RNA	NOUN	B
kappa	I-RNA	NOUN	I
B-alpha	I-RNA	NOUN	I
mRNA	I-RNA	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
purified	O	VERB	B
protein	O	NOUN	I
derivative	O	NOUN	I
induced	O	VERB	B
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
in	O	ADP	O
monocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


Although	O	SCONJ	O
devoid	O	ADJ	O
of	O	ADP	O
any	O	DET	O
effect	O	NOUN	B
by	O	ADP	O
itself	O	PRON	O
,	O	PUNCT	O
a	O	DET	O
mutant	B-protein	ADJ	B
p53	I-protein	NOUN	O
cooperated	O	VERB	O
with	O	ADP	O
Spi-1	B-protein	NOUN	B
and	O	CCONJ	O
EpoR	B-protein	NOUN	B
(	I-protein	PUNCT	O
R129C	I-protein	NOUN	B
)	I-protein	PUNCT	O
to	O	PART	O
reinforce	O	VERB	O
both	O	DET	O
phenotypes	O	NOUN	B
.	O	PUNCT	O


As	O	ADP	O
shown	O	VERB	O
by	O	ADP	O
reverse	O	ADJ	B
transcription-polymerase	O	ADJ	I
chain	O	NOUN	I
reaction	O	NOUN	I
and	O	CCONJ	O
electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assay	O	NOUN	I
,	O	PUNCT	O
respectively	O	ADV	O
,	O	PUNCT	O
treatment	O	NOUN	B
with	O	ADP	O
CsA	O	NOUN	B
leads	O	VERB	O
to	O	PART	O
decreased	O	VERB	B
TF	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
expression	O	NOUN	B
and	O	CCONJ	O
reduced	O	VERB	B
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
NF-kappaB	B-protein	NOUN	B
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
known	O	VERB	O
to	O	PART	O
contribute	O	VERB	O
to	O	PART	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
the	O	DET	O
TF	B-DNA	NOUN	B
promotor	I-DNA	NOUN	I
in	O	ADP	O
human	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


IL-2	B-protein	NOUN	B
and	O	CCONJ	O
IL-7	B-protein	NOUN	B
induce	O	VERB	O
heterodimerization	O	NOUN	B
of	O	ADP	O
STAT5	B-protein	NOUN	B
isoforms	I-protein	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
peripheral	I-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
T	I-cell_type	NOUN	I
lymphoblasts	I-cell_type	NOUN	I
.	O	PUNCT	O


Moreover	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
observed	O	VERB	O
constitutive	O	ADJ	B
association	O	NOUN	B
of	O	ADP	O
STAT3	B-protein	NOUN	B
with	O	ADP	O
each	O	DET	O
STAT5	B-protein	NOUN	B
isomer	I-protein	NOUN	B
.	O	PUNCT	O


Suppression	O	NOUN	B
of	O	ADP	O
MHC	B-protein	NOUN	B
class	I-protein	NOUN	O
II	I-protein	NUM	O
expression	O	NOUN	B
by	O	ADP	O
human	B-DNA	ADJ	B
class	I-DNA	NOUN	O
II	I-DNA	NUM	O
trans-activator	I-DNA	NOUN	O
constructs	I-DNA	NOUN	B
lacking	O	VERB	B
the	O	DET	O
N-terminal	B-protein	ADJ	B
domain	I-protein	NOUN	I
.	O	PUNCT	O


While	O	SCONJ	O
these	O	DET	O
compounds	O	NOUN	B
affect	O	VERB	O
various	O	ADJ	O
cellular	O	ADJ	B
processes	O	NOUN	I
,	O	PUNCT	O
current	O	ADJ	O
data	O	NOUN	B
do	O	AUX	O
not	O	PART	O
fully	O	ADV	O
explain	O	VERB	O
how	O	SCONJ	O
sesquiterpene	O	NOUN	B
lactones	O	NOUN	I
exert	O	VERB	O
their	O	PRON	O
anti-inflammatory	O	ADJ	B
effect	O	NOUN	I
.	O	PUNCT	O


This	O	DET	O
difference	O	NOUN	O
in	O	ADP	O
efficacy	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
correlates	O	VERB	O
with	O	ADP	O
the	O	DET	O
compounds	O	NOUN	B
'	O	PART	O
anti-inflammatory	O	ADJ	B
potency	O	NOUN	B
in	O	X	B
vivo	O	X	I
,	O	PUNCT	O
may	O	AUX	O
be	O	AUX	O
explained	O	VERB	O
by	O	ADP	O
differences	O	NOUN	B
in	O	ADP	O
structure	O	NOUN	B
and	O	CCONJ	O
conformation	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
tax	B-protein	NOUN	O
protein	I-protein	NOUN	B
of	O	ADP	O
human	O	ADJ	B
T-cell	O	NOUN	O
leukemia	O	NOUN	O
virus	O	NOUN	O
type	O	NOUN	O
1	O	NUM	O
mediates	O	VERB	O
the	O	DET	O
transactivation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
c-sis/platelet-derived	B-DNA	ADJ	B
growth	I-DNA	NOUN	I
factor-B	I-DNA	NOUN	B
promoter	I-DNA	NOUN	B
through	O	ADP	O
interactions	O	NOUN	B
with	O	ADP	O
the	O	DET	O
zinc	B-protein	NOUN	B
finger	I-protein	NOUN	I
transcription	I-protein	NOUN	B
factors	I-protein	NOUN	I
Sp1	B-protein	NOUN	B
and	O	CCONJ	O
NGFI-A/Egr-1	B-protein	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
previous	O	ADJ	O
work	O	NOUN	O
,	O	PUNCT	O
we	O	PRON	O
identified	O	VERB	B
an	O	DET	O
essential	O	ADJ	B
site	O	NOUN	I
in	O	ADP	O
the	O	DET	O
c-sis/PDGF-B	B-DNA	NOUN	B
promoter	I-DNA	NOUN	I
,	O	PUNCT	O
Tax-responsive	B-DNA	ADJ	B
element	I-DNA	NOUN	I
1	I-DNA	NUM	I
(	O	PUNCT	O
TRE1	B-DNA	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
necessary	O	ADJ	O
for	O	ADP	O
transactivation	O	NOUN	B
by	O	ADP	O
Tax	B-protein	NOUN	B
.	O	PUNCT	O


RelB	B-protein	NOUN	B
protein	O	NOUN	I
and	O	CCONJ	O
mRNA	B-RNA	NOUN	B
were	O	AUX	O
detected	O	VERB	B
constitutively	O	ADV	B
in	O	ADP	O
lymphocytes	B-cell_type	NOUN	B
and	O	CCONJ	O
in	O	ADP	O
activated	B-cell_type	VERB	B
monocytes	I-cell_type	NOUN	B
,	O	PUNCT	O
differentiated	B-cell_type	VERB	O
DC	I-cell_type	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
monocyte-derived	B-cell_line	ADJ	B
DC	I-cell_line	NOUN	B
.	O	PUNCT	O


A	O	DET	O
member	O	NOUN	O
of	O	ADP	O
the	O	DET	O
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor	I-protein	NOUN	I
receptor	I-protein	NOUN	I
superfamily	I-protein	NOUN	B
was	O	AUX	O
isolated	O	VERB	B
by	O	ADP	O
virtue	O	NOUN	O
of	O	ADP	O
its	O	PRON	O
affinity	O	NOUN	B
for	O	ADP	O
CAML	B-protein	NOUN	B
.	O	PUNCT	O


Recent	O	ADJ	O
work	O	NOUN	O
from	O	ADP	O
several	O	ADJ	O
laboratories	O	NOUN	B
has	O	AUX	O
demonstrated	O	VERB	O
that	O	SCONJ	O
Rel/NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
transcription	B-protein	NOUN	O
factors	I-protein	NOUN	O
regulate	O	VERB	B
apoptosis	O	NOUN	B
in	O	ADP	O
many	O	ADJ	O
cell	O	NOUN	B
types	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
most	O	ADJ	O
cells	O	NOUN	B
,	O	PUNCT	O
Rel/NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
transcription	B-protein	NOUN	I
factors	I-protein	NOUN	I
appear	O	VERB	O
to	O	PART	O
mediate	O	VERB	O
survival	O	NOUN	B
signals	O	NOUN	O
that	O	PRON	O
protect	O	VERB	O
cells	O	NOUN	B
from	O	ADP	O
apoptosis	O	NOUN	B
;	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
under	O	ADP	O
some	O	DET	O
circumstances	O	NOUN	O
,	O	PUNCT	O
activation	O	NOUN	B
of	O	ADP	O
these	O	DET	O
factors	O	NOUN	B
may	O	AUX	O
also	O	ADV	O
promote	O	VERB	B
apoptosis	O	NOUN	B
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
our	O	PRON	O
data	O	NOUN	B
establish	O	VERB	O
that	O	SCONJ	O
ATF/CREB	B-protein	NOUN	B
factors	I-protein	NOUN	B
functionally	O	ADV	O
modulate	O	VERB	O
histone	B-DNA	NOUN	B
H4	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
transcription	O	NOUN	O
at	O	ADP	O
distal	B-DNA	ADJ	B
and	I-DNA	CCONJ	O
proximal	I-DNA	ADJ	B
promoter	I-DNA	NOUN	B
elements	I-DNA	NOUN	I
.	O	PUNCT	O


Dimers	O	NOUN	B
encoded	O	VERB	B
by	O	ADP	O
HLA-DR	B-protein	NOUN	B
haplotypes	O	NOUN	B
may	O	AUX	O
be	O	AUX	O
the	O	DET	O
primary	B-DNA	ADJ	B
restriction	I-DNA	NOUN	I
elements	I-DNA	NOUN	I
for	O	ADP	O
lectin-like	O	ADJ	B
,	O	PUNCT	O
gliadin	O	NOUN	B
peptides	O	NOUN	I
while	O	SCONJ	O
the	O	DET	O
degree	O	NOUN	B
of	O	ADP	O
immune	O	ADJ	B
suppression	O	NOUN	I
(	O	PUNCT	O
or	O	CCONJ	O
lack	O	NOUN	B
thereof	O	ADV	B
)	O	PUNCT	O
to	O	PART	O
ingested	O	VERB	B
gliadins	O	NOUN	B
is	O	AUX	O
governed	O	VERB	O
by	O	ADP	O
inherited	O	VERB	B
HLA-DQ	B-DNA	NOUN	B
haplotypes	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
Epstein-Barr	O	ADJ	B
virus	O	NOUN	I
latent	B-protein	ADJ	B
membrane	I-protein	NOUN	I
protein-1	I-protein	NOUN	I
(	O	PUNCT	O
LMP-1	B-protein	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
an	O	DET	O
integral	B-protein	ADJ	B
membrane	I-protein	NOUN	I
protein	I-protein	NOUN	I
which	O	DET	O
transforms	O	VERB	O
fibroblasts	B-cell_type	NOUN	B
and	O	CCONJ	O
is	O	AUX	O
essential	O	ADJ	O
for	O	ADP	O
EBV-mediated	O	ADJ	B
B-cell	O	NOUN	O
immortalization	O	NOUN	B
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
LMP-1	B-protein	NOUN	B
induces	O	VERB	B
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
AP-1	B-protein	NOUN	B
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
,	O	PUNCT	O
a	O	DET	O
dimer	O	NOUN	B
of	O	ADP	O
Jun/Jun	B-protein	NOUN	B
or	I-protein	CCONJ	O
Jun/Fos	I-protein	NOUN	B
proteins	I-protein	NOUN	I
.	O	PUNCT	O


Consequently	O	ADV	O
,	O	PUNCT	O
LMP-1	B-protein	NOUN	B
triggers	O	VERB	B
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
c-Jun	B-protein	NOUN	B
N-terminal	I-protein	ADJ	I
transactivation	I-protein	NOUN	I
domain	I-protein	NOUN	I
which	O	DET	O
is	O	AUX	O
known	O	VERB	O
to	O	PART	O
be	O	AUX	O
activated	O	VERB	B
upon	O	SCONJ	O
JNK	B-protein	NOUN	B
-mediated	O	ADJ	O
phosphorylation	O	NOUN	B
.	O	PUNCT	O


Deletion	O	NOUN	B
analysis	O	NOUN	I
indicates	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
55	O	NUM	O
C-terminal	B-protein	ADJ	B
amino	I-protein	NOUN	I
acids	I-protein	NOUN	I
of	O	ADP	O
the	O	DET	O
LMP-1	B-protein	NOUN	B
molecule	I-protein	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
its	O	PRON	O
TRAF	B-protein	NOUN	B
interaction	I-protein	NOUN	O
domain	I-protein	NOUN	O
,	O	PUNCT	O
are	O	AUX	O
essential	O	ADJ	O
for	O	ADP	O
AP-1	B-protein	NOUN	B
activation	O	NOUN	I
.	O	PUNCT	O


1.	O	X	O
In	O	ADP	O
this	O	DET	O
study	O	NOUN	B
we	O	PRON	O
hypothesized	O	VERB	O
that	O	SCONJ	O
in	O	ADP	O
individuals	O	NOUN	B
with	O	ADP	O
certain	O	ADJ	O
genetic	O	ADJ	B
makeup	O	NOUN	O
,	O	PUNCT	O
MTBE	O	NOUN	B
,	O	PUNCT	O
benzene	O	NOUN	B
or	O	CCONJ	O
their	O	PRON	O
metabolites	O	NOUN	B
act	O	VERB	O
as	O	ADP	O
adducts	O	NOUN	B
and	O	CCONJ	O
may	O	AUX	O
induce	O	VERB	B
programmed	O	VERB	B
cell	O	NOUN	I
death	O	NOUN	I
.	O	PUNCT	O


3	O	X	O
.	O	PUNCT	O
Peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
lymphocytes	I-cell_type	NOUN	I
(	O	PUNCT	O
PBL	B-cell_type	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
both	O	DET	O
groups	O	NOUN	B
were	O	AUX	O
tested	O	VERB	B
for	O	ADP	O
the	O	DET	O
percentage	O	NOUN	B
of	O	ADP	O
apoptotic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
cell	O	NOUN	B
cycle	O	NOUN	I
progression	O	NOUN	I
using	O	VERB	O
flow	O	NOUN	B
cytometry	O	NOUN	I
.	O	PUNCT	O


5.	O	X	O
One	O	NUM	O
of	O	ADP	O
the	O	DET	O
signaling	B-protein	NOUN	B
molecules	I-protein	NOUN	I
which	O	DET	O
mediates	O	VERB	O
programmed	O	VERB	B
cell	O	NOUN	I
death	O	NOUN	I
is	O	AUX	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
Kappa-B	I-protein	NOUN	I
(	O	PUNCT	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


This	O	DET	O
reversal	O	NOUN	B
of	O	ADP	O
apoptosis	O	NOUN	B
almost	O	ADV	O
to	O	PART	O
the	O	DET	O
control	O	ADJ	B
level	O	NOUN	B
by	O	ADP	O
inhibitor	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activation	O	NOUN	B
may	O	AUX	O
indicate	O	VERB	O
involvement	O	NOUN	B
of	O	ADP	O
this	O	DET	O
signaling	B-protein	NOUN	B
molecule	I-protein	NOUN	I
in	O	ADP	O
MTBE	O	NOUN	B
and	O	CCONJ	O
benzene	O	NOUN	B
induction	O	NOUN	I
of	O	ADP	O
programmed	O	VERB	B
cell	O	NOUN	I
death	O	NOUN	I
.	O	PUNCT	O


When	O	SCONJ	O
studying	O	VERB	O
the	O	DET	O
binding	O	NOUN	B
of	O	ADP	O
SR	O	ADJ	B
31747A	O	NOUN	O
on	O	ADP	O
membranes	O	NOUN	B
from	O	ADP	O
yeast	O	NOUN	B
expressing	O	VERB	B
SR-BP	B-protein	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
found	O	VERB	O
a	O	DET	O
pharmacological	O	ADJ	B
profile	O	NOUN	I
of	O	ADP	O
sigma	B-protein	NOUN	B
1	I-protein	NUM	I
receptors	I-protein	NOUN	I
;	O	PUNCT	O
binding	O	NOUN	B
was	O	AUX	O
displaced	O	VERB	O
by	O	ADP	O
(	O	PUNCT	O
+	O	CCONJ	O
)	O	PUNCT	O
-pentazocine	O	NOUN	O
,	O	PUNCT	O
haloperidol	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
(	O	PUNCT	O
+	O	CCONJ	O
)	O	PUNCT	O
-SKF	O	PUNCT	O
10	O	NUM	O
,	O	PUNCT	O
047	O	NUM	O
,	O	PUNCT	O
with	O	ADP	O
(	O	PUNCT	O
+	O	CCONJ	O
)	O	PUNCT	O
-SKF	O	PUNCT	O
10	O	NUM	O
,	O	PUNCT	O
047	O	NUM	O
being	O	AUX	O
a	O	DET	O
more	O	ADV	O
potent	O	ADJ	O
competitor	O	NOUN	B
than	O	ADP	O
(	O	PUNCT	O
-	O	PUNCT	O
)	O	PUNCT	O
-SKF	O	SYM	O
10	O	NUM	O
,	O	PUNCT	O
047	O	NUM	O
.	O	PUNCT	O


Scatchard	O	NOUN	B
plot	O	NOUN	I
analysis	O	NOUN	I
revealed	O	VERB	O
Kd	O	NOUN	B
values	O	NOUN	I
of	O	ADP	O
7.1	O	NUM	O
nM	O	NOUN	O
and	O	CCONJ	O
0.15	O	NUM	O
nM	O	NOUN	O
for	O	ADP	O
(	O	PUNCT	O
+	O	CCONJ	O
)	O	PUNCT	O
-pentazocine	O	NOUN	O
and	O	CCONJ	O
SR	O	ADJ	B
31747A	O	PROPN	O
,	O	PUNCT	O
respectively	O	ADV	O
,	O	PUNCT	O
indicating	O	VERB	O
an	O	DET	O
affinity	O	NOUN	B
of	O	ADP	O
SR-BP	B-protein	NOUN	B
50-fold	O	ADV	O
higher	O	ADJ	O
for	O	ADP	O
SR	O	ADJ	B
31747A	O	NOUN	O
than	O	ADP	O
for	O	ADP	O
pentazocine	O	NOUN	B
.	O	PUNCT	O


Taken	O	VERB	O
together	O	ADV	O
,	O	PUNCT	O
these	O	DET	O
findings	O	NOUN	B
strongly	O	ADV	O
suggest	O	VERB	O
that	O	SCONJ	O
SR-BP	B-protein	NOUN	B
represents	O	VERB	O
the	O	DET	O
molecular	O	ADJ	B
target	O	NOUN	B
for	O	ADP	O
SR	O	ADJ	B
31747A	O	NOUN	O
in	O	ADP	O
mammalian	O	ADJ	B
tissues	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
could	O	AUX	O
be	O	AUX	O
critical	O	ADJ	O
for	O	ADP	O
T	O	NOUN	B
cell	O	NOUN	I
proliferation	O	NOUN	O
.	O	PUNCT	O


Phospholipase	B-protein	NOUN	B
C	I-protein	NOUN	I
gamma	I-protein	NOUN	I
1	I-protein	NUM	I
overexpression	O	NOUN	B
and	O	CCONJ	O
activation	O	NOUN	B
induced	O	VERB	B
by	O	ADP	O
interferon	B-protein	NOUN	B
beta	I-protein	NOUN	I
in	O	ADP	O
human	B-cell_type	ADJ	B
T	I-cell_type	NOUN	O
lymphocytes	I-cell_type	NOUN	O
:	O	PUNCT	O
an	O	DET	O
ISGF3	B-protein	NOUN	B
-independent	O	ADJ	O
response	O	NOUN	B
.	O	PUNCT	O


None	O	NOUN	O
of	O	ADP	O
these	O	DET	O
polymorphisms	B-DNA	NOUN	B
change	O	VERB	O
the	O	DET	O
translated	B-protein	VERB	B
protein	I-protein	NOUN	B
.	O	PUNCT	O


Anti-TNF-alpha	B-protein	NOUN	B
also	O	ADV	O
prevented	O	VERB	B
nuclear	B-protein	ADJ	B
factor-kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
(	O	PUNCT	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
)	O	PUNCT	O
activation	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
good	O	ADJ	O
correlation	O	NOUN	B
between	O	ADP	O
this	O	DET	O
inhibition	O	NOUN	B
and	O	CCONJ	O
inhibition	O	NOUN	B
of	O	ADP	O
HIV	O	NOUN	B
replication	O	NOUN	B
was	O	AUX	O
observed	O	VERB	O
.	O	PUNCT	O


The	O	DET	O
synergistic	O	ADJ	B
effect	O	NOUN	O
on	O	ADP	O
growth	O	NOUN	B
inhibition	O	NOUN	I
and	O	CCONJ	O
induction	O	NOUN	B
of	O	ADP	O
differentiation	O	NOUN	B
required	O	VERB	O
simultaneous	O	ADJ	B
treatment	O	NOUN	B
with	O	ADP	O
differanisole	O	NOUN	B
A	O	NOUN	I
and	O	CCONJ	O
9cisRA	O	NOUN	B
.	O	PUNCT	O


Nuclear	B-protein	ADJ	B
factor-kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
(	I-protein	PUNCT	O
NF-kappa	I-protein	NOUN	B
B	I-protein	NOUN	I
)	I-protein	PUNCT	O
/Rel	I-protein	NOUN	O
transcription	I-protein	NOUN	B
factors	I-protein	NOUN	I
may	O	AUX	O
be	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
atherosclerosis	O	NOUN	B
,	O	PUNCT	O
as	O	ADP	O
is	O	AUX	O
suggested	O	VERB	O
by	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
activated	O	VERB	B
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
in	O	ADP	O
human	O	ADJ	B
atherosclerotic	O	ADJ	B
lesions	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
intracellular	O	ADJ	B
localization	O	NOUN	B
of	O	ADP	O
NFkappaB	B-protein	NOUN	B
after	O	ADP	O
TNFalpha	B-protein	NOUN	B
simulation	O	NOUN	B
was	O	AUX	O
determined	O	VERB	O
by	O	ADP	O
confocal	O	ADJ	B
immunocytochemistry	O	NOUN	I
using	O	VERB	O
an	O	DET	O
anti-p65	B-protein	ADJ	B
antibody	I-protein	NOUN	I
.	O	PUNCT	O


This	O	DET	O
increased	O	VERB	B
adhesion	O	NOUN	B
was	O	AUX	O
suppressed	O	VERB	B
by	O	ADP	O
the	O	DET	O
addition	O	NOUN	O
of	O	ADP	O
anti-CD18	B-protein	ADJ	B
antibody	I-protein	NOUN	I
(	O	PUNCT	O
157.6+/-25.1	O	NUM	O
cells/mm2	O	NOUN	O
,	O	PUNCT	O
n	O	NOUN	O
=	O	ADJ	O
8	O	NUM	O
,	O	PUNCT	O
P	O	NOUN	O
<	O	X	O
0.01	O	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
by	O	ADP	O
pretreatment	O	NOUN	B
with	O	ADP	O
10	O	NUM	O
(	O	PUNCT	O
-7	O	NUM	O
)	O	PUNCT	O
M	O	NOUN	O
dexamethasone	O	NOUN	B
(	O	PUNCT	O
207.9+/-31.5	O	NUM	O
cells/mm2	O	NOUN	B
,	O	PUNCT	O
n	O	NOUN	O
=	O	ADJ	O
10	O	NUM	O
,	O	PUNCT	O
P	O	NOUN	O
<	O	X	O
0.01	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Immunocytochemistry	O	NOUN	B
60	O	NUM	O
minutes	O	NOUN	B
after	O	ADP	O
stimulation	O	NOUN	B
revealed	O	VERB	O
that	O	SCONJ	O
NFkappaB	B-protein	NOUN	B
was	O	AUX	O
located	O	ADJ	O
in	O	ADP	O
the	O	DET	O
cytoplasm	O	NOUN	B
in	O	ADP	O
unstimulated	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
;	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
addition	O	NOUN	O
of	O	ADP	O
TNFalpha	B-protein	NOUN	B
caused	O	VERB	O
NFkappaB	B-protein	NOUN	B
to	O	PART	O
translocate	O	VERB	B
into	O	ADP	O
the	O	DET	O
nucleus	O	NOUN	B
.	O	PUNCT	O


CONCLUSIONS	O	NOUN	O
:	O	PUNCT	O
Leukocyte	O	NOUN	B
adhesion	O	NOUN	I
to	O	PART	O
the	O	DET	O
corneal	O	NOUN	B
endothelium	O	NOUN	I
was	O	AUX	O
shown	O	VERB	O
to	O	PART	O
be	O	AUX	O
mediated	O	VERB	O
by	O	ADP	O
CD18	B-protein	NOUN	B
expressed	O	VERB	B
on	O	ADP	O
activated	B-cell_type	VERB	B
leukocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


Pretreatment	O	NOUN	B
of	O	ADP	O
the	O	DET	O
endothelium	O	NOUN	B
with	O	ADP	O
dexamethasone	O	NOUN	B
inhibited	O	VERB	B
leukocyte	O	NOUN	B
adhesion	O	NOUN	I
;	O	PUNCT	O
this	O	DET	O
may	O	AUX	O
be	O	AUX	O
due	O	ADJ	O
in	O	ADP	O
part	O	NOUN	O
to	O	PART	O
the	O	DET	O
suppression	O	NOUN	B
of	O	ADP	O
NFkappaB	B-protein	NOUN	B
entry	O	NOUN	O
into	O	ADP	O
the	O	DET	O
nucleus	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
protein	O	NOUN	B
is	O	AUX	O
believed	O	VERB	O
to	O	PART	O
bind	O	VERB	B
small	O	ADJ	O
lipophilic	O	ADJ	B
substances	O	NOUN	I
such	O	ADJ	O
as	O	ADP	O
bacterial	O	ADJ	B
derived	O	VERB	O
formylpeptides	O	NOUN	B
and	O	CCONJ	O
lipopolysaccharides	O	NOUN	B
(	O	PUNCT	O
LPS	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
might	O	AUX	O
function	O	VERB	B
as	O	ADP	O
a	O	DET	O
modulator	O	NOUN	B
of	O	ADP	O
inflammation	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
NGAL	B-protein	NOUN	B
gene	O	NOUN	I
is	O	AUX	O
highly	O	ADV	O
homologous	O	ADJ	B
to	O	PART	O
the	O	DET	O
mouse	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
24p3	I-DNA	NOUN	O
.	O	PUNCT	O


Moreover	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
mechanism	O	NOUN	B
of	O	ADP	O
action	O	NOUN	B
of	O	ADP	O
BHRF1	B-protein	NOUN	B
resembled	O	VERB	O
that	O	DET	O
of	O	ADP	O
Bcl-2	B-protein	NOUN	B
and	O	CCONJ	O
Bcl-xL	B-protein	NOUN	B
as	O	ADP	O
it	O	PRON	O
inhibited	O	VERB	B
TNF-	O	NOUN	B
and	O	CCONJ	O
anti-Fas-induced	O	ADJ	B
activation	O	NOUN	B
of	O	ADP	O
two	O	NUM	O
enzymes	O	NOUN	B
participating	O	VERB	B
in	O	ADP	O
the	O	DET	O
apoptosis	O	NOUN	B
pathway	O	NOUN	I
,	O	PUNCT	O
cytosolic	B-protein	ADJ	B
phospholipase	I-protein	NOUN	I
A2	I-protein	NOUN	I
and	O	CCONJ	O
caspase-3/CPP32	B-protein	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
did	O	AUX	O
not	O	PART	O
interfere	O	VERB	B
with	O	ADP	I
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
NF-kappaB-like	B-protein	ADJ	B
transcription	I-protein	NOUN	I
factors	I-protein	NOUN	I
.	O	PUNCT	O


Among	O	ADP	O
the	O	DET	O
regulatory	B-DNA	ADJ	B
promoter	I-DNA	NOUN	O
elements	I-DNA	NOUN	O
potentially	O	ADV	O
regulating	O	VERB	B
eotaxin	B-DNA	NOUN	B
gene	I-DNA	NOUN	O
expression	O	NOUN	B
and/or	O	CCONJ	O
mediating	O	VERB	O
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	O
anti-inflammatory	O	ADJ	B
drugs	O	NOUN	I
we	O	PRON	O
identified	O	VERB	O
consensus	B-DNA	NOUN	B
sequences	I-DNA	NOUN	I
known	O	VERB	O
to	O	PART	O
interact	O	VERB	B
with	O	ADP	O
nuclear	B-protein	ADJ	B
factors	I-protein	NOUN	I
like	O	ADP	O
NF-IL6	B-protein	NOUN	B
,	O	PUNCT	O
AP-1	B-protein	NOUN	B
,	O	PUNCT	O
a	O	DET	O
NF-kappa-B	B-DNA	NOUN	B
like	I-DNA	ADP	O
consensus	I-DNA	NOUN	B
sequence	I-DNA	NOUN	I
and	O	CCONJ	O
gamma-interferon-	B-DNA	NOUN	B
as	I-DNA	ADV	O
well	I-DNA	ADV	O
as	I-DNA	ADP	O
glucocorticoid	I-DNA	NOUN	B
response	I-DNA	NOUN	I
elements	I-DNA	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
previously	O	ADV	O
detected	O	VERB	B
a	O	DET	O
tissue-specific	B-DNA	ADJ	B
promoter	I-DNA	NOUN	O
preceding	O	VERB	O
the	O	DET	O
exon	O	NOUN	B
encoding	O	VERB	B
the	O	DET	O
N	B-protein	NOUN	B
terminus	I-protein	NOUN	I
of	O	ADP	O
the	O	DET	O
pp52	B-protein	NOUN	B
leukocyte	I-protein	NOUN	I
protein	I-protein	NOUN	I
.	O	PUNCT	O


Mutations	O	NOUN	B
that	O	PRON	O
abolish	O	VERB	B
the	O	DET	O
binding	O	NOUN	B
of	O	ADP	O
each	O	DET	O
factor	O	NOUN	B
to	O	PART	O
its	O	PRON	O
cognate	O	ADJ	B
site	O	NOUN	I
are	O	AUX	O
introduced	O	VERB	O
in	O	ADP	O
an	O	DET	O
infectious	O	ADJ	B
HIV-1	O	NOUN	B
molecular	O	ADJ	B
clone	O	NOUN	I
to	O	PART	O
study	O	VERB	B
their	O	PRON	O
effect	O	NOUN	B
on	O	ADP	O
HIV-1	O	NOUN	B
transcription	O	NOUN	B
and	O	CCONJ	O
replication	O	NOUN	B
.	O	PUNCT	O


METHODS	O	NOUN	O
AND	O	CCONJ	O
RESULTS	O	NOUN	B
:	O	PUNCT	O
Incubation	O	NOUN	B
of	O	ADP	O
human	O	ADJ	B
whole	O	ADJ	O
blood	O	NOUN	O
with	O	ADP	O
platelet-activating	B-protein	ADJ	B
factor	I-protein	NOUN	I
(	O	PUNCT	O
PAF	B-protein	NOUN	B
,	O	PUNCT	O
1	O	NUM	O
mumol/L	O	NOUN	O
)	O	PUNCT	O
evoked	O	VERB	O
downregulation	O	NOUN	B
of	O	ADP	O
L-selectin	B-protein	NOUN	B
and	O	CCONJ	O
upregulation	O	NOUN	B
of	O	ADP	O
CD11/CD18	B-protein	NOUN	B
adhesion	B-protein	NOUN	I
receptors	I-protein	NOUN	I
on	O	ADP	O
neutrophils	O	NOUN	B
as	O	ADP	O
measured	O	VERB	B
by	O	ADP	O
flow	O	NOUN	B
cytometry	O	NOUN	I
.	O	PUNCT	O


While	O	SCONJ	O
dexamethasone	O	NOUN	B
(	O	PUNCT	O
0.1	O	NUM	O
nmol/L	O	NOUN	O
to	O	PART	O
100	O	NUM	O
mumol/L	O	NOUN	O
)	O	PUNCT	O
did	O	AUX	O
not	O	PART	O
affect	O	VERB	O
expression	O	NOUN	B
of	O	ADP	O
adhesion	B-protein	NOUN	B
molecules	I-protein	NOUN	O
on	O	ADP	O
resting	B-cell_type	VERB	B
neutrophils	I-cell_type	NOUN	I
,	O	PUNCT	O
it	O	PRON	O
attenuated	O	VERB	B
the	O	DET	O
PAF	B-protein	NOUN	B
-induced	O	ADJ	O
changes	O	NOUN	B
in	O	ADP	O
L-selectin	B-protein	NOUN	B
and	O	CCONJ	O
CD18	B-protein	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
a	O	DET	O
time-	O	NOUN	O
and	O	CCONJ	O
concentration-dependent	O	ADJ	B
fashion	O	NOUN	O
with	O	ADP	O
IC50	O	NOUN	B
values	O	NOUN	B
of	O	ADP	O
31	O	NUM	O
and	O	CCONJ	O
13	O	NUM	O
nmol/L	O	NOUN	O
,	O	PUNCT	O
respectively	O	ADV	O
.	O	PUNCT	O


Acquisition	O	NOUN	B
of	O	ADP	O
heat	O	NOUN	B
shock	O	NOUN	I
factor	O	NOUN	I
2	O	NUM	I
(	O	PUNCT	O
HSF2	O	NOUN	B
)	O	PUNCT	O
DNA	O	NOUN	B
binding	O	NOUN	I
activity	O	NOUN	I
is	O	AUX	O
accompanied	O	VERB	O
by	O	ADP	O
induced	O	VERB	B
transcription	O	NOUN	B
of	O	ADP	O
heat	B-DNA	NOUN	B
shock	I-DNA	NOUN	I
genes	I-DNA	NOUN	I
in	O	ADP	O
hemin-treated	O	ADJ	B
K562	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
undergoing	O	VERB	O
erythroid	O	ADJ	B
differentiation	O	NOUN	I
.	O	PUNCT	O


Previous	O	ADJ	O
studies	O	NOUN	B
revealed	O	VERB	O
that	O	SCONJ	O
HSF2	B-protein	NOUN	B
consists	O	VERB	O
of	O	ADP	O
two	O	NUM	O
alternatively	O	ADV	O
spliced	O	VERB	B
isoforms	O	NOUN	B
,	O	PUNCT	O
HSF2-alpha	B-protein	NOUN	B
and	O	CCONJ	O
HSF2-beta	B-protein	NOUN	B
,	O	PUNCT	O
whose	O	DET	O
relative	O	ADJ	O
abundance	O	NOUN	B
is	O	AUX	O
developmentally	O	ADV	O
regulated	O	VERB	B
and	O	CCONJ	O
varies	O	VERB	O
between	O	ADP	O
different	O	ADJ	O
tissues	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
initial	O	ADJ	O
changes	O	NOUN	B
are	O	AUX	O
followed	O	VERB	O
by	O	ADP	O
the	O	DET	O
eventual	O	ADJ	B
loss	O	NOUN	B
of	O	ADP	O
TCR	B-protein	NOUN	B
zeta	I-protein	NOUN	B
chain	I-protein	NOUN	I
and	O	CCONJ	O
p56	B-protein	NOUN	B
(	I-protein	PUNCT	O
lck	I-protein	NOUN	B
)	I-protein	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
marked	O	ADJ	O
decrease	O	NOUN	B
in	O	ADP	O
cytotoxic	O	ADJ	B
function	O	NOUN	I
.	O	PUNCT	O


Deletion	O	NOUN	B
analysis	O	NOUN	I
showed	O	VERB	O
that	O	SCONJ	O
expression	O	NOUN	B
from	O	ADP	O
the	O	DET	O
DM	B-DNA	NOUN	B
promoters	I-DNA	NOUN	I
is	O	AUX	O
dependent	O	ADJ	O
on	O	ADP	O
the	O	DET	O
conserved	O	VERB	O
S-X-Y	B-DNA	NOUN	B
region	I-DNA	NOUN	O
.	O	PUNCT	O


None	O	NOUN	O
of	O	ADP	O
the	O	DET	O
other	O	ADJ	O
putative	O	ADJ	O
regulatory	O	ADJ	O
sites	O	NOUN	O
was	O	AUX	O
occupied	O	VERB	B
in	O	X	B
vivo	O	X	I
,	O	PUNCT	O
indicating	O	VERB	O
that	O	SCONJ	O
they	O	PRON	O
may	O	AUX	O
not	O	PART	O
be	O	AUX	O
functional	O	ADJ	B
.	O	PUNCT	O


Finally	O	ADV	O
,	O	PUNCT	O
gel	O	NOUN	B
shift	O	NOUN	I
analysis	O	NOUN	I
showed	O	VERB	O
synergistic	O	ADJ	B
complex	O	ADJ	B
formation	O	NOUN	B
between	O	ADP	O
proteins	O	NOUN	B
that	O	PRON	O
bind	O	VERB	B
to	O	PART	O
the	O	DET	O
putative	O	ADJ	B
X	B-DNA	NOUN	I
boxes	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
DM	O	NOUN	B
genes	O	NOUN	I
,	O	PUNCT	O
as	O	ADP	O
is	O	AUX	O
found	O	VERB	O
for	O	ADP	O
the	O	DET	O
DRA	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
.	O	PUNCT	O


No	O	DET	O
virus	O	NOUN	B
replication	O	NOUN	B
and	O	CCONJ	O
no	O	DET	O
transcription	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Ad2	B-DNA	NOUN	B
early	I-DNA	ADJ	O
genes	I-DNA	NOUN	O
was	O	AUX	O
observed	O	VERB	O
in	O	ADP	O
either	O	DET	O
of	O	ADP	O
the	O	DET	O
cells	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
macrophages	B-cell_type	NOUN	B
,	O	PUNCT	O
a	O	DET	O
slight	O	ADJ	O
enhancement	O	NOUN	B
of	O	ADP	O
TNF-alpha	B-protein	NOUN	B
production	O	NOUN	B
was	O	AUX	O
seen	O	VERB	O
,	O	PUNCT	O
whereas	O	SCONJ	O
IL-1	B-protein	NOUN	B
beta	I-protein	NOUN	B
was	O	AUX	O
not	O	PART	O
detected	O	VERB	B
.	O	PUNCT	O


This	O	DET	O
sequence	O	NOUN	B
contains	O	VERB	O
consensus	B-DNA	NOUN	B
elements	I-DNA	NOUN	I
consistent	O	ADJ	B
with	O	ADP	I
myeloid-specific	O	ADJ	B
gene	O	NOUN	I
expression	O	NOUN	O
,	O	PUNCT	O
including	O	VERB	O
a	O	DET	O
PU.1	B-DNA	NOUN	B
consensus	I-DNA	NOUN	B
site	I-DNA	NOUN	I
near	O	ADP	O
the	O	DET	O
major	O	ADJ	O
transcription	B-DNA	NOUN	B
start	I-DNA	NOUN	O
site	I-DNA	NOUN	O
and	O	CCONJ	O
a	O	DET	O
cluster	O	NOUN	B
of	O	ADP	O
c-Myb	B-DNA	NOUN	B
sites	I-DNA	NOUN	B
located	O	ADJ	O
several	O	ADJ	O
hundred	O	NUM	O
bases	O	NOUN	B
upstream	O	ADV	B
of	O	ADP	O
this	O	DET	O
region	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
4-bp	O	ADJ	O
mutation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
core	B-DNA	NOUN	B
Sp1	I-DNA	NOUN	B
consensus	I-DNA	NOUN	B
element	I-DNA	NOUN	I
(	O	PUNCT	O
GC	B-DNA	NOUN	B
box	I-DNA	NOUN	I
)	O	PUNCT	I
(	O	PUNCT	O
-20	O	NUM	O
)	O	PUNCT	O
reduced	O	VERB	B
overall	O	ADJ	O
promoter	O	NOUN	B
activity	O	NOUN	I
of	O	ADP	O
the	O	DET	O
1-kb	B-DNA	ADJ	O
fragment	I-DNA	NOUN	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
cooperation	O	NOUN	B
or	O	CCONJ	O
cross-talk	O	NOUN	B
of	O	ADP	O
signaling	O	VERB	B
molecules	O	NOUN	I
associated	O	VERB	B
with	O	ADP	I
different	O	ADJ	O
domains	O	NOUN	B
of	O	ADP	O
IL-9Ralpha	B-protein	NOUN	B
other	O	ADJ	O
than	O	ADP	O
STAT3	B-protein	NOUN	B
is	O	AUX	O
essential	O	ADJ	O
for	O	ADP	O
IL-9	B-protein	NOUN	B
-mediated	O	ADJ	O
cell	O	NOUN	B
growth	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
a	O	DET	O
previous	O	ADJ	O
study	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
demonstrated	O	VERB	O
that	O	SCONJ	O
bufalin	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
an	O	DET	O
active	O	ADJ	B
principle	O	NOUN	O
of	O	ADP	O
Chinese	O	ADJ	B
medicine	O	NOUN	I
,	O	PUNCT	O
chan'su	O	NOUN	B
,	O	PUNCT	O
caused	O	VERB	O
apoptosis	O	NOUN	B
in	O	ADP	O
human	B-cell_line	ADJ	B
leukemia	I-cell_line	NOUN	I
U937	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
by	O	ADP	O
anomalous	O	ADJ	B
activation	O	NOUN	B
of	O	ADP	O
mitogen-activated	B-protein	ADJ	B
protein	I-protein	NOUN	I
kinase	I-protein	NOUN	I
(	O	PUNCT	O
MAPK	B-protein	NOUN	B
)	O	PUNCT	O
via	O	ADP	O
the	O	DET	O
signaling	O	NOUN	B
pathway	O	NOUN	I
of	O	ADP	O
Ras	B-protein	NOUN	B
,	O	PUNCT	O
Raf-1	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
MAPK	B-protein	NOUN	B
kinase-1	I-protein	NOUN	I
.	O	PUNCT	O


Bufalin	O	NOUN	B
treatment	O	NOUN	B
activated	B-protein	VERB	O
activator	I-protein	NOUN	O
protein-1	I-protein	NOUN	O
transcriptional	O	ADJ	O
activity	O	NOUN	O
;	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
this	O	DET	O
activation	O	NOUN	B
was	O	AUX	O
decreased	O	VERB	B
to	O	PART	O
40	O	NUM	O
%	O	NOUN	O
in	O	ADP	O
bcl-2	B-protein	NOUN	B
-overexpressed	O	ADJ	O
U937	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


The	O	DET	O
transcriptional	O	ADJ	B
hierarchy	O	NOUN	I
of	O	ADP	O
HNFs	O	NOUN	B
suggests	O	VERB	O
that	O	SCONJ	O
other	O	ADJ	O
proteins	O	NOUN	B
of	O	ADP	O
the	O	DET	O
regulatory	O	ADJ	B
cascade	O	NOUN	I
might	O	AUX	O
be	O	AUX	O
responsible	O	ADJ	O
for	O	ADP	O
other	O	ADJ	O
forms	O	NOUN	O
of	O	ADP	O
MODY	O	NOUN	B
and/or	O	CCONJ	O
late-onset	O	ADJ	B
type	O	NOUN	B
2	O	NUM	I
diabetes	O	NOUN	I
.	O	PUNCT	O


Human	B-cell_line	ADJ	B
monocytic	I-cell_line	ADJ	I
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
THP-1	I-cell_line	NOUN	B
was	O	AUX	O
treated	O	VERB	B
with	O	ADP	I
E.	O	X	B
chaffeensis	O	X	I
which	O	DET	O
had	O	AUX	O
been	O	AUX	O
preincubated	O	VERB	B
with	O	ADP	O
human	O	ADJ	B
anti-E.	O	X	O
chaffeensis	O	NOUN	O
serum	O	NOUN	B
for	O	ADP	O
2	O	NUM	O
h	O	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
levels	O	NOUN	B
of	O	ADP	O
cytokine	B-RNA	NOUN	B
mRNAs	I-RNA	NOUN	B
were	O	AUX	O
evaluated	O	VERB	B
by	O	ADP	O
competitive	O	ADJ	B
reverse	O	ADJ	B
transcription-PCR	O	NOUN	I
.	O	PUNCT	O


Fab	O	NOUN	B
fragment	O	NOUN	I
of	O	ADP	O
anti-E.	B-protein	X	B
chaffeensis	I-protein	NOUN	I
immunoglobulin	I-protein	NOUN	B
G	I-protein	NOUN	I
complexed	O	VERB	O
with	O	ADP	O
E.	O	X	B
chaffeensis	O	NOUN	I
did	O	AUX	O
not	O	PART	O
induce	O	VERB	B
any	O	DET	O
of	O	ADP	O
these	O	DET	O
three	O	NUM	O
cytokines	O	NOUN	B
,	O	PUNCT	O
indicating	O	VERB	O
that	O	SCONJ	O
ehrlichial	O	ADJ	B
binding	O	NOUN	I
is	O	AUX	O
required	O	VERB	O
for	O	ADP	O
IL-1beta	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
expression	O	NOUN	B
and	O	CCONJ	O
that	O	SCONJ	O
binding	O	NOUN	B
of	O	ADP	O
the	O	DET	O
immune	B-protein	ADJ	B
complex	I-protein	NOUN	I
to	O	PART	O
the	O	DET	O
Fc	B-protein	NOUN	B
gamma	I-protein	NOUN	I
receptor	I-protein	NOUN	I
is	O	AUX	O
required	O	VERB	O
for	O	ADP	O
TNF-alpha	B-protein	NOUN	B
and	O	CCONJ	O
IL-6	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
expression	O	NOUN	B
and	O	CCONJ	O
enhanced	O	VERB	B
IL-1beta	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
prolonged	O	ADJ	B
degradation	O	NOUN	B
of	O	ADP	O
IkappaB-alpha	B-protein	NOUN	B
and	O	CCONJ	O
activation	O	NOUN	B
of	O	ADP	O
NF-kappaB	B-protein	NOUN	B
were	O	AUX	O
demonstrated	O	VERB	O
in	O	ADP	O
THP-1	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
exposed	O	VERB	B
to	O	PART	I
anti-E.	O	X	B
chaffeensis	O	NOUN	I
serum	O	NOUN	B
and	O	CCONJ	O
E.	O	X	B
chaffeensis	O	X	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
cellular	O	ADJ	B
or	O	CCONJ	O
molecular	B-protein	ADJ	B
factors	I-protein	NOUN	I
responsible	O	ADJ	O
for	O	ADP	O
a	O	DET	O
delay	O	NOUN	B
in	O	ADP	O
B-CLL	O	NOUN	B
cell	O	NOUN	O
death	O	NOUN	O
are	O	AUX	O
unknown	O	ADJ	O
.	O	PUNCT	O


The	O	DET	O
interleukin-10	B-protein	NOUN	B
(	I-protein	PUNCT	O
IL-10	I-protein	NOUN	B
)	I-protein	PUNCT	O
receptor	I-protein	NOUN	O
is	O	AUX	O
another	O	DET	O
member	O	NOUN	O
of	O	ADP	O
the	O	DET	O
IFN	B-protein	NOUN	B
receptor	I-protein	NOUN	I
family	I-protein	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
its	O	PRON	O
ligand	O	NOUN	B
,	O	PUNCT	O
IL-10	B-protein	NOUN	B
,	O	PUNCT	O
has	O	AUX	O
been	O	AUX	O
reported	O	VERB	O
to	O	PART	O
induce	O	VERB	B
apoptosis	O	NOUN	B
in	O	ADP	O
B-CLL	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	B
.	O	PUNCT	O


Further	O	ADV	O
,	O	PUNCT	O
in	O	ADP	O
consecutive	O	ADJ	B
samples	O	NOUN	B
of	O	ADP	O
fresh	O	ADJ	B
blood	O	NOUN	B
obtained	O	VERB	O
from	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
B-CLL	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	O
,	O	PUNCT	O
the	O	DET	O
addition	O	NOUN	O
of	O	ADP	O
IL-10	B-protein	NOUN	B
inhibited	O	VERB	B
B-CLL	B-cell_line	NOUN	B
proliferation	O	NOUN	B
,	O	PUNCT	O
enhanced	O	VERB	O
B-CLL	B-cell_line	NOUN	B
differentiation	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
did	O	AUX	O
not	O	PART	O
induce	O	VERB	B
apoptosis	O	NOUN	B
.	O	PUNCT	O


To	O	PART	O
gain	O	VERB	O
a	O	DET	O
better	O	ADJ	O
understanding	O	NOUN	O
of	O	ADP	O
the	O	DET	O
mechanism	O	NOUN	B
of	O	ADP	O
binding	O	VERB	B
to	O	PART	O
the	O	DET	O
human	B-protein	ADJ	B
mineralocorticoid	I-protein	NOUN	O
receptor	I-protein	NOUN	O
(	O	PUNCT	O
hMR	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
we	O	PRON	O
developed	O	VERB	O
a	O	DET	O
new	O	ADJ	O
monoclonal	B-protein	ADJ	B
antibody	I-protein	NOUN	I
(	O	PUNCT	O
mAb	B-protein	NOUN	B
)	O	PUNCT	O
raised	O	VERB	O
against	O	ADP	O
the	O	DET	O
hormone-binding	B-protein	ADJ	B
domain	I-protein	NOUN	I
(	O	PUNCT	O
HBD	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
prolactin	B-protein	NOUN	B
receptor	I-protein	NOUN	I
,	O	PUNCT	O
a	O	DET	O
member	O	NOUN	B
of	O	ADP	O
the	O	DET	O
hematopoietin/cytokine	B-protein	NOUN	B
receptor	I-protein	NOUN	I
superfamily	I-protein	NOUN	B
,	O	PUNCT	O
is	O	AUX	O
ubiquitously	O	ADV	O
expressed	O	VERB	B
by	O	ADP	O
cells	O	NOUN	B
in	O	ADP	O
the	O	DET	O
immune	O	ADJ	B
system	O	NOUN	I
.	O	PUNCT	O


From	O	ADP	O
analyses	O	NOUN	B
of	O	ADP	O
mice	O	NOUN	B
deficient	O	ADJ	B
in	O	ADP	O
transcription	B-DNA	NOUN	B
factor	I-DNA	NOUN	I
genes	I-DNA	NOUN	I
and	O	CCONJ	O
from	O	ADP	O
the	O	DET	O
characterizations	O	NOUN	B
of	O	ADP	O
chromosome	B-DNA	NOUN	B
breakpoints	I-DNA	NOUN	I
in	O	ADP	O
human	O	ADJ	B
leukemias	O	NOUN	I
,	O	PUNCT	O
it	O	PRON	O
has	O	AUX	O
become	O	VERB	O
evident	O	ADJ	O
that	O	SCONJ	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
are	O	AUX	O
important	O	ADJ	O
regulators	O	NOUN	B
of	O	ADP	O
hematopoiesis	O	NOUN	B
.	O	PUNCT	O


Induction	O	NOUN	B
of	O	ADP	O
HIV	O	NOUN	B
by	O	ADP	O
C.	O	X	B
neoformans	O	X	I
was	O	AUX	O
enhanced	O	VERB	O
by	O	ADP	O
anti-capsular	B-protein	ADJ	B
antibody	I-protein	NOUN	I
,	O	PUNCT	O
while	O	SCONJ	O
induction	O	NOUN	B
by	O	ADP	O
both	O	DET	O
organisms	O	NOUN	B
was	O	AUX	O
inhibited	O	VERB	B
by	O	ADP	O
anti-TNF-alpha	B-protein	ADJ	B
antibody	I-protein	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
THP-1	O	NOUN	B
cells	O	NOUN	I
transfected	O	VERB	B
with	O	ADP	O
HIV	B-DNA	NOUN	B
plasmid	I-DNA	NOUN	I
constructs	I-DNA	NOUN	B
,	O	PUNCT	O
both	O	DET	O
organisms	O	NOUN	B
induced	O	VERB	B
transcription	O	NOUN	B
from	O	ADP	O
the	O	DET	O
HIV	B-DNA	NOUN	B
long	I-DNA	ADJ	B
terminal	I-DNA	ADJ	I
repeat	I-DNA	NOUN	I
that	O	PRON	O
was	O	AUX	O
dependent	O	ADJ	B
on	O	ADP	O
intact	O	ADJ	B
NF-kappaB	B-DNA	NOUN	B
binding	I-DNA	NOUN	I
sequences	I-DNA	NOUN	I
.	O	PUNCT	O


Nuclear	O	ADJ	B
levels	O	NOUN	I
of	O	ADP	O
NF-kappaB	B-protein	NOUN	B
correlate	O	VERB	O
with	O	ADP	O
syncytium-forming	O	ADJ	B
capacity	O	NOUN	I
of	O	ADP	O
8e51	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
expressing	O	VERB	B
a	O	DET	O
defective	O	ADJ	B
HIV	O	NOUN	B
virus	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
double	B-DNA	ADJ	O
NF-kappaB	I-DNA	NOUN	B
site	I-DNA	NOUN	I
identified	O	VERB	B
in	O	ADP	O
the	O	DET	O
LTR	B-DNA	NOUN	B
of	O	ADP	O
the	O	DET	O
human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus-1	O	NOUN	I
(	O	PUNCT	O
HIV-1	O	NOUN	B
)	O	PUNCT	O
has	O	AUX	O
been	O	AUX	O
demonstrated	O	VERB	O
to	O	PART	O
be	O	AUX	O
necessary	O	ADJ	O
for	O	ADP	O
efficient	O	ADJ	B
viral	O	ADJ	B
transcription	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
factors	O	NOUN	B
act	O	VERB	O
synergistically	O	ADV	B
to	O	PART	O
activate	O	VERB	B
transcription	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
this	O	DET	O
synergy	O	NOUN	B
is	O	AUX	O
required	O	VERB	O
for	O	ADP	O
transcription	O	NOUN	B
of	O	ADP	O
at	O	ADP	O
least	O	ADV	O
several	O	ADJ	O
important	O	ADJ	O
hematopoietic	B-DNA	ADJ	B
genes	I-DNA	NOUN	I
.	O	PUNCT	O


Such	O	ADJ	O
repression	O	NOUN	B
imposes	O	VERB	O
a	O	DET	O
requirement	O	NOUN	B
for	O	ADP	O
both	O	CCONJ	O
c-Myb	B-protein	NOUN	B
and	O	CCONJ	O
Ets	B-protein	NOUN	B
for	O	ADP	O
transcriptional	O	ADJ	B
activity	O	NOUN	I
,	O	PUNCT	O
providing	O	VERB	O
one	O	NUM	O
explanation	O	NOUN	B
for	O	ADP	O
why	O	SCONJ	O
synergy	O	NOUN	B
between	O	ADP	O
these	O	DET	O
factors	O	NOUN	B
is	O	AUX	O
important	O	ADJ	O
.	O	PUNCT	O


We	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
one	O	NUM	O
target	O	NOUN	B
of	O	ADP	O
this	O	DET	O
positive/negative	O	ADJ	O
regulation	O	NOUN	O
in	O	X	B
vivo	O	X	I
is	O	AUX	O
the	O	DET	O
alpha4	B-protein	NOUN	B
integrin	I-protein	NOUN	I
,	O	PUNCT	O
which	O	DET	O
play	O	VERB	O
a	O	DET	O
key	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
normal	O	ADJ	O
hematopoiesis	O	NOUN	B
and	O	CCONJ	O
function	O	NOUN	B
of	O	ADP	O
mature	B-cell_type	ADJ	B
leukocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


They	O	PRON	O
are	O	AUX	O
rapidly	O	ADV	O
activated	O	VERB	B
by	O	ADP	O
various	O	ADJ	O
cytokines	B-protein	NOUN	B
,	O	PUNCT	O
hormones	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
growth	O	NOUN	B
factors	O	NOUN	I
.	O	PUNCT	O


Both	O	DET	O
cytokines	B-protein	NOUN	B
are	O	AUX	O
able	O	ADJ	O
to	O	PART	O
stimulate	O	VERB	B
cell	O	NOUN	B
proliferation	O	NOUN	I
,	O	PUNCT	O
differentiation	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
survival	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
glucocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
was	O	AUX	O
able	O	ADJ	O
to	O	PART	O
further	O	ADV	O
enhance	O	VERB	O
IL-4	B-protein	NOUN	B
-induced	O	ADJ	O
gene	O	NOUN	B
transcription	O	NOUN	I
through	O	ADP	O
the	O	DET	O
action	O	NOUN	B
of	O	ADP	O
Stat6	B-protein	NOUN	B
.	O	PUNCT	O


Deletion	O	NOUN	B
analysis	O	NOUN	I
of	O	ADP	O
the	O	DET	O
carboxyl-terminal	B-protein	ADJ	B
region	I-protein	NOUN	I
of	O	ADP	O
Stat6	B-protein	NOUN	B
and	O	CCONJ	O
recombination	O	NOUN	B
of	O	ADP	O
this	O	DET	O
region	O	NOUN	B
with	O	ADP	O
a	O	DET	O
heterologous	B-protein	ADJ	B
DNA	I-protein	NOUN	B
binding	I-protein	NOUN	I
domain	I-protein	NOUN	I
allowed	O	VERB	O
the	O	DET	O
delimitation	O	NOUN	B
and	O	CCONJ	O
characterization	O	NOUN	B
of	O	ADP	O
the	O	DET	O
transactivation	O	NOUN	B
domain	O	NOUN	I
of	O	ADP	O
Stat6	B-protein	NOUN	B
.	O	PUNCT	O


ETS1	B-protein	NOUN	B
,	O	PUNCT	O
NFkappaB	B-protein	NOUN	B
and	O	CCONJ	O
AP1	B-protein	NOUN	B
synergistically	O	ADV	B
transactivate	O	VERB	B
the	O	DET	O
human	B-DNA	ADJ	B
GM-CSF	I-DNA	NOUN	B
promoter	I-DNA	NOUN	B
.	O	PUNCT	O


Data	O	NOUN	B
reported	O	VERB	O
herein	O	ADV	O
support	O	VERB	O
the	O	DET	O
hypothesis	O	NOUN	B
that	O	SCONJ	O
cognate	O	ADJ	B
interactions	O	NOUN	I
between	O	ADP	O
tissue	B-cell_type	NOUN	B
fibroblasts	I-cell_type	NOUN	B
and	O	CCONJ	O
infiltrating	O	VERB	B
T	O	NOUN	B
lymphocytes	O	NOUN	I
,	O	PUNCT	O
via	O	ADP	O
the	O	DET	O
CD40	B-protein	NOUN	B
/CD40L	B-protein	NOUN	O
pathway	O	NOUN	B
,	O	PUNCT	O
augment	O	VERB	O
inflammation	O	NOUN	B
and	O	CCONJ	O
may	O	AUX	O
promote	O	VERB	O
fibrogenesis	O	NOUN	B
by	O	ADP	O
activating	O	VERB	B
both	O	CCONJ	O
cell	O	NOUN	B
types	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
fact	O	NOUN	O
,	O	PUNCT	O
mAb	B-protein	NOUN	B
L243	I-protein	NOUN	I
but	O	CCONJ	O
not	O	PART	O
the	O	DET	O
staphylococcal	B-protein	ADJ	B
superantigens	I-protein	NOUN	B
,	O	PUNCT	O
staphylococcal	B-protein	ADJ	B
exotoxin	I-protein	NOUN	B
toxic	I-protein	ADJ	O
shock	I-protein	NOUN	O
syndrome	I-protein	NOUN	O
toxin-I	I-protein	NOUN	B
or	O	CCONJ	O
staphylococcal	B-protein	ADJ	B
enterotoxin	I-protein	NOUN	I
B	I-protein	NOUN	I
,	O	PUNCT	O
regulate	O	VERB	B
the	O	DET	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
binding	O	NOUN	I
activity	O	NOUN	I
.	O	PUNCT	O


Additional	O	ADJ	O
major	O	ADJ	O
protein-DNA	O	ADJ	B
interactions	O	NOUN	B
do	O	AUX	O
not	O	PART	O
occur	O	VERB	O
within	O	ADP	O
the	O	DET	O
promoter	O	NOUN	B
region	O	NOUN	I
after	O	ADP	O
T	O	NOUN	B
lymphocyte	O	NOUN	I
activation	O	NOUN	I
,	O	PUNCT	O
indicating	O	VERB	O
a	O	DET	O
requirement	O	NOUN	B
for	O	ADP	O
additional	O	ADJ	O
protein-protein	O	ADJ	B
interactions	O	NOUN	I
and/or	O	CCONJ	O
post-translational	O	ADJ	B
modifications	O	NOUN	I
of	O	ADP	O
pre-bound	B-protein	ADJ	B
transcription	I-protein	NOUN	I
factors	I-protein	NOUN	I
to	O	PART	O
account	O	VERB	O
for	O	ADP	O
the	O	DET	O
observed	O	VERB	O
increase	O	NOUN	B
in	O	ADP	O
IMPDH	O	NOUN	B
type	O	NOUN	I
II	O	NUM	I
gene	O	NOUN	I
expression	O	NOUN	O
.	O	PUNCT	O


Monocytic	O	ADJ	B
cell	O	NOUN	I
adhesion	O	NOUN	O
to	O	PART	O
EC	B-cell_type	NOUN	B
in	O	ADP	O
response	O	NOUN	O
to	O	PART	O
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor-alpha	I-protein	NOUN	I
(	O	PUNCT	O
TNF-alpha	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
lipopolysaccharide	O	NOUN	B
(	O	PUNCT	O
LPS	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
alpha-thrombin	B-protein	NOUN	B
,	O	PUNCT	O
or	O	CCONJ	O
phorbol	O	NOUN	B
12-myristate	O	NOUN	I
13-acetate	O	NOUN	I
(	O	PUNCT	O
PMA	O	NOUN	B
)	O	PUNCT	O
was	O	AUX	O
similarly	O	ADV	O
inhibited	O	VERB	B
by	O	ADP	O
NAC	O	NOUN	B
.	O	PUNCT	O


NAC	O	NOUN	B
had	O	AUX	O
no	O	DET	B
effect	O	NOUN	I
on	O	ADP	O
the	O	DET	O
half-life	O	NOUN	B
of	O	ADP	O
E-selectin	B-RNA	NOUN	B
or	I-RNA	CCONJ	O
VCAM-1	I-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
.	O	PUNCT	O


Fusion	O	NOUN	B
proteins	O	NOUN	I
involving	O	VERB	O
the	O	DET	O
retinoic	O	ADJ	B
acid	O	NOUN	I
receptor	B-protein	NOUN	I
alpha	I-protein	NOUN	I
(	O	PUNCT	O
RAR	B-protein	NOUN	B
alpha	I-protein	NOUN	I
)	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
PML	B-protein	NOUN	B
or	O	CCONJ	O
PLZF	B-protein	NOUN	B
nuclear	I-protein	ADJ	I
protein	I-protein	NOUN	I
are	O	AUX	O
the	O	DET	O
genetic	O	ADJ	B
markers	O	NOUN	I
of	O	ADP	O
acute	O	ADJ	B
promyelocytic	O	ADJ	I
leukemias	O	NOUN	I
(	O	PUNCT	O
APLs	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Deletion	O	NOUN	B
of	O	ADP	O
the	O	DET	O
PLZF	B-protein	NOUN	B
POZ	I-protein	NOUN	B
domain	I-protein	NOUN	O
partially	O	ADV	O
abrogated	O	VERB	O
the	O	DET	O
inhibitory	O	ADJ	B
effect	O	NOUN	O
of	O	ADP	O
PLZF-RAR	B-protein	NOUN	B
alpha	I-protein	NOUN	I
on	O	ADP	O
RA-induced	O	ADJ	B
differentiation	O	NOUN	B
and	O	CCONJ	O
on	O	ADP	O
RA-mediated	O	ADJ	B
type	B-protein	NOUN	I
II	I-protein	NUM	I
TGase	I-protein	NOUN	I
up-regulation	O	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
POZ-mediated	O	ADJ	B
protein	O	NOUN	I
interactions	O	NOUN	B
might	O	AUX	O
be	O	AUX	O
responsible	O	ADJ	O
for	O	ADP	O
the	O	DET	O
inhibitory	O	ADJ	B
transcriptional	O	ADJ	B
activities	O	NOUN	I
of	O	ADP	O
PLZF-RAR	B-protein	NOUN	B
alpha	I-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
mechanisms	O	NOUN	B
that	O	PRON	O
control	O	VERB	B
the	O	DET	O
initial	O	ADJ	O
induction	O	NOUN	B
of	O	ADP	O
these	O	DET	O
signals	O	NOUN	B
upon	O	SCONJ	O
infection	O	NOUN	B
are	O	AUX	O
poorly	O	ADV	O
understood	O	VERB	O
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
show	O	VERB	O
,	O	PUNCT	O
by	O	ADP	O
electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assays	O	NOUN	I
,	O	PUNCT	O
that	O	SCONJ	O
ascorbate	O	NOUN	B
increases	O	VERB	B
the	O	DET	O
binding	O	NOUN	B
of	O	ADP	O
NF-kappaB	B-protein	NOUN	B
to	O	PART	O
DNA	O	NOUN	B
in	O	ADP	O
TNF-alpha-stimulated	B-cell_line	ADJ	B
Jurkat	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Human	O	ADJ	B
cytomegalovirus	O	NOUN	I
induces	O	VERB	O
interleukin-8	B-protein	NOUN	B
production	O	NOUN	I
by	O	ADP	O
a	O	DET	O
human	B-cell_line	ADJ	B
monocytic	I-cell_line	ADJ	I
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
,	O	PUNCT	O
THP-1	B-cell_line	NOUN	B
,	O	PUNCT	O
through	O	ADP	O
acting	O	VERB	O
concurrently	O	ADV	O
on	O	ADP	O
AP-1-	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
NF-kappaB-binding	I-DNA	ADJ	B
sites	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
interleukin-8	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
.	O	PUNCT	O


The	O	DET	O
combination	O	NOUN	B
of	O	ADP	O
the	O	DET	O
immune	B-protein	ADJ	B
costimulatory	I-protein	ADJ	I
molecule	I-protein	NOUN	I
B7.1	B-protein	NOUN	I
and	O	CCONJ	O
IL-12	B-protein	NOUN	B
has	O	AUX	O
been	O	AUX	O
shown	O	VERB	O
to	O	PART	O
be	O	AUX	O
synergistic	O	ADJ	B
for	O	ADP	O
T	O	NOUN	B
cell	O	NOUN	I
activation	O	NOUN	B
.	O	PUNCT	O


By	O	ADP	O
transfecting	O	VERB	B
tumor	O	NOUN	B
cells	O	NOUN	I
with	O	ADP	O
both	O	CCONJ	O
IL-12	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
B7.1	I-DNA	NOUN	B
cDNAs	I-DNA	NOUN	I
,	O	PUNCT	O
it	O	PRON	O
may	O	AUX	O
be	O	AUX	O
possible	O	ADJ	O
to	O	PART	O
use	O	VERB	O
these	O	DET	O
modified	O	VERB	B
targets	O	NOUN	B
as	O	ADP	O
vaccines	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
major	O	ADJ	O
obstacle	O	NOUN	O
in	O	ADP	O
designing	O	VERB	B
a	O	DET	O
vector	O	NOUN	B
to	O	PART	O
deliver	O	VERB	O
these	O	DET	O
genes	O	NOUN	B
results	O	VERB	B
from	O	ADP	O
the	O	DET	O
structure	O	NOUN	B
of	O	ADP	O
IL-12	B-protein	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
also	O	ADV	O
shown	O	VERB	O
that	O	SCONJ	O
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
STAT	B-protein	NOUN	B
4	I-protein	NUM	I
transcription	I-protein	NOUN	B
factor	I-protein	NOUN	I
,	O	PUNCT	O
which	O	DET	O
has	O	AUX	O
been	O	AUX	O
shown	O	VERB	O
to	O	PART	O
be	O	AUX	O
unique	O	ADJ	B
to	O	PART	O
the	O	DET	O
IL-12	B-protein	NOUN	B
signaling	O	NOUN	O
pathway	O	NOUN	O
,	O	PUNCT	O
occurs	O	VERB	O
with	O	ADP	O
Flexi-12	B-protein	NOUN	B
at	O	ADP	O
levels	O	NOUN	B
similar	O	ADJ	O
to	O	PART	O
those	O	DET	O
seen	O	VERB	O
with	O	ADP	O
rIL-12	B-protein	NOUN	B
.	O	PUNCT	O


While	O	SCONJ	O
there	O	PRON	O
was	O	AUX	O
a	O	DET	O
significant	O	ADJ	O
increase	O	NOUN	B
in	O	ADP	O
plasma	O	NOUN	B
cortisol	O	NOUN	O
levels	O	NOUN	O
in	O	ADP	O
the	O	DET	O
depressed	O	ADJ	B
group	O	NOUN	I
,	O	PUNCT	O
there	O	PRON	O
were	O	AUX	O
no	O	DET	O
changes	O	NOUN	O
in	O	ADP	O
the	O	DET	O
lymphocyte	O	NOUN	B
GR	B-protein	NOUN	B
binding	O	NOUN	O
parameters	O	NOUN	O
(	O	PUNCT	O
K	O	NOUN	B
(	O	PUNCT	O
m	O	NOUN	O
)	O	PUNCT	O
and	O	CCONJ	O
Bmax	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Together	O	ADV	O
,	O	PUNCT	O
these	O	DET	O
studies	O	NOUN	B
begin	O	VERB	O
a	O	DET	O
dissection	O	NOUN	B
of	O	ADP	O
the	O	DET	O
biochemical	O	ADJ	B
events	O	NOUN	O
that	O	PRON	O
lead	O	VERB	O
to	O	PART	O
expression	O	NOUN	B
of	O	ADP	O
CD95	B-protein	NOUN	B
ligand	I-protein	NOUN	B
,	O	PUNCT	O
a	O	DET	O
required	O	ADJ	O
step	O	NOUN	O
for	O	ADP	O
TCR	B-protein	NOUN	B
-induced	O	ADJ	O
apoptosis	O	NOUN	B
.	O	PUNCT	O


There	O	PRON	O
is	O	AUX	O
a	O	DET	O
clearly	O	ADV	O
defined	O	VERB	O
and	O	CCONJ	O
substantial	O	ADJ	O
role	O	NOUN	O
for	O	ADP	O
free	O	ADJ	B
radicals	O	NOUN	I
or	O	CCONJ	O
reactive	O	ADJ	B
oxygen	O	NOUN	I
species	O	NOUN	I
(	O	PUNCT	O
ROS	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
periodontitis	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
little	O	ADJ	O
research	O	NOUN	B
has	O	AUX	O
been	O	AUX	O
performed	O	VERB	O
in	O	ADP	O
this	O	DET	O
area	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
recent	O	ADJ	O
discovery	O	NOUN	B
of	O	ADP	O
the	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
nuclear	I-protein	ADJ	I
factor	I-protein	NOUN	I
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
(	O	PUNCT	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
)	O	PUNCT	O
is	O	AUX	O
reviewed	O	VERB	B
and	O	CCONJ	O
several	O	ADJ	O
potential	O	ADJ	B
pathways	O	NOUN	B
for	O	ADP	O
cytokine	B-protein	NOUN	B
-induced	O	ADJ	O
periodontal	O	ADJ	B
tissue	O	NOUN	I
damage	O	NOUN	O
,	O	PUNCT	O
mediated	O	VERB	O
by	O	ADP	O
NF-kappa	B-protein	NOUN	B
B1	I-protein	NOUN	I
are	O	AUX	O
discussed	O	VERB	O
.	O	PUNCT	O


The	O	DET	O
link	O	NOUN	O
between	O	ADP	O
cellular	O	ADJ	B
production	O	NOUN	I
of	O	ADP	O
such	O	ADJ	O
important	O	ADJ	O
mediators	O	NOUN	B
of	O	ADP	O
inflammation	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
antioxidant	O	ADJ	B
(	O	PUNCT	O
AO	O	ADJ	B
)	O	PUNCT	O
thiols	O	NOUN	O
,	O	PUNCT	O
cysteine	O	NOUN	B
and	O	CCONJ	O
reduced	O	VERB	B
glutathione	O	NOUN	O
(	O	PUNCT	O
GSH	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
is	O	AUX	O
discussed	O	VERB	O
and	O	CCONJ	O
it	O	PRON	O
is	O	AUX	O
hypothesised	O	VERB	O
that	O	SCONJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
antagonists	O	NOUN	B
may	O	AUX	O
offer	O	VERB	O
important	O	ADJ	O
therapeutic	O	ADJ	B
benefits	O	NOUN	I
.	O	PUNCT	O


Three	O	NUM	O
cases	O	NOUN	B
were	O	AUX	O
predicted	O	VERB	B
to	O	PART	O
be	O	AUX	O
TSC2	B-DNA	NOUN	B
mutations	I-DNA	NOUN	B
on	O	ADP	O
the	O	DET	O
basis	O	NOUN	O
of	O	ADP	O
linkage	O	NOUN	B
analysis	O	NOUN	I
or	O	CCONJ	O
because	O	SCONJ	O
a	O	DET	O
hamartoma	O	NOUN	B
from	O	ADP	O
the	O	DET	O
patient	O	NOUN	B
showed	O	VERB	O
loss	O	NOUN	B
of	O	ADP	O
heterozygosity	O	NOUN	B
for	O	ADP	O
16p13.3	B-DNA	NOUN	B
markers	I-DNA	NOUN	B
.	O	PUNCT	O


Five	O	NUM	O
of	O	ADP	O
these	O	DET	O
were	O	AUX	O
caused	O	VERB	O
by	O	ADP	O
mutations	O	NOUN	B
predicted	O	VERB	B
to	O	PART	O
produce	O	VERB	O
a	O	DET	O
truncated	B-protein	VERB	B
protein	I-protein	NOUN	I
:	O	PUNCT	O
(	O	PUNCT	O
i	O	X	O
)	O	PUNCT	O
a	O	DET	O
sporadic	O	ADJ	B
case	O	NOUN	I
showed	O	VERB	O
a	O	DET	O
32	B-DNA	NUM	O
bp	I-DNA	NOUN	O
deletion	I-DNA	NOUN	B
in	O	ADP	O
exon	B-RNA	NOUN	B
11	I-RNA	NUM	I
,	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
mutant	B-RNA	ADJ	B
mRNA	I-RNA	NOUN	B
without	O	ADP	O
exon	B-RNA	NOUN	B
11	I-RNA	NUM	O
was	O	AUX	O
produced	O	VERB	O
;	O	PUNCT	O
the	O	DET	O
normal	O	ADJ	O
exon	O	NOUN	O
10	O	NUM	O
was	O	AUX	O
also	O	ADV	O
spliced	O	VERB	B
out	O	ADP	O
;	O	PUNCT	O
(	O	PUNCT	O
ii	O	X	O
)	O	PUNCT	O
a	O	DET	O
sporadic	O	ADJ	B
case	O	NOUN	I
had	O	AUX	O
a	O	DET	O
1	B-DNA	NUM	O
bp	I-DNA	NOUN	O
deletion	I-DNA	NOUN	B
in	O	ADP	O
exon	B-RNA	NOUN	B
12	I-RNA	NUM	I
(	O	PUNCT	O
1634delT	B-RNA	X	O
)	O	PUNCT	O
;	O	PUNCT	O
(	O	PUNCT	O
iii	O	X	O
)	O	PUNCT	O
a	O	DET	O
TSC2-linked	B-RNA	ADJ	B
mother	I-RNA	NOUN	B
and	I-RNA	CCONJ	O
daughter	I-RNA	NOUN	B
pair	I-RNA	NOUN	I
had	O	AUX	O
a	O	DET	O
G	O	NOUN	B
--	O	PUNCT	O
>	O	X	O
T	O	NOUN	B
transversion	O	NOUN	I
in	O	ADP	O
exon	B-RNA	NOUN	O
23	I-RNA	NUM	O
(	O	PUNCT	O
G2715T	B-RNA	NOUN	B
)	O	PUNCT	O
introducing	O	VERB	O
a	O	DET	O
cryptic	O	ADJ	B
splice	O	NOUN	I
site	O	NOUN	I
causing	O	VERB	O
a	O	DET	O
29	O	NUM	O
bp	O	NOUN	O
truncation	O	NOUN	B
of	O	ADP	O
mRNA	O	NOUN	B
from	O	ADP	O
exon	B-RNA	NOUN	B
23	I-RNA	NUM	O
;	O	PUNCT	O
(	O	PUNCT	O
iv	O	X	O
)	O	PUNCT	O
a	O	DET	O
sporadic	O	ADJ	B
case	O	NOUN	I
showed	O	VERB	O
a	O	DET	O
2	B-DNA	NUM	O
bp	I-DNA	NOUN	O
deletion	I-DNA	NOUN	B
in	O	ADP	O
exon	B-RNA	NOUN	B
36	I-RNA	NUM	I
;	O	PUNCT	O
(	O	PUNCT	O
v	O	X	O
)	O	PUNCT	O
a	O	DET	O
sporadic	O	ADJ	B
case	O	NOUN	I
showed	O	VERB	O
a	O	DET	O
1	B-DNA	NUM	O
bp	I-DNA	NOUN	O
insertion	I-DNA	NOUN	B
disrupting	O	VERB	B
the	O	DET	O
donor	O	NOUN	B
splice	O	NOUN	I
site	O	NOUN	I
of	O	ADP	O
exon	B-RNA	NOUN	O
37	I-RNA	NUM	O
(	O	PUNCT	O
5007+2insA	B-RNA	NOUN	O
)	O	PUNCT	O
,	O	PUNCT	O
resulting	O	VERB	O
in	O	ADP	O
the	O	DET	O
use	O	NOUN	O
of	O	ADP	O
an	O	DET	O
upstream	B-RNA	ADJ	B
exonic	I-RNA	ADJ	O
cryptic	I-RNA	ADJ	O
splice	I-RNA	NOUN	O
site	I-RNA	NOUN	O
to	O	PART	O
cause	O	VERB	O
a	O	DET	O
29	B-RNA	NUM	O
bp	I-RNA	NOUN	O
truncation	I-RNA	NOUN	B
of	O	ADP	O
mRNA	B-RNA	NOUN	B
from	O	ADP	O
exon	B-RNA	NOUN	B
37	I-RNA	NUM	O
.	O	PUNCT	O


Electrophoretic	O	ADJ	B
mobility-shift	O	ADJ	I
assays	O	NOUN	I
of	O	ADP	O
HUVEC	B-cell_line	NOUN	B
nuclear	B-protein	ADJ	B
proteins	I-protein	NOUN	I
revealed	O	VERB	O
a	O	DET	O
decrease	O	NOUN	B
in	O	ADP	O
TNF-alpha-stimulated	B-protein	ADJ	B
nuclear	I-protein	ADJ	O
factor-kappa	I-protein	NOUN	O
B	I-protein	NOUN	O
(	O	PUNCT	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
)	O	PUNCT	O
activation	O	NOUN	O
after	O	ADP	O
pretreatment	O	NOUN	B
of	O	ADP	O
HUVEC	B-cell_line	NOUN	B
with	O	ADP	O
TCP	O	NOUN	B
succinate	O	NOUN	B
but	O	CCONJ	O
not	O	PART	O
with	O	ADP	O
TCP	O	NOUN	B
,	O	PUNCT	O
TCP	O	NOUN	B
acetate	O	NOUN	B
,	O	PUNCT	O
or	O	CCONJ	O
succinate	O	NOUN	B
alone	O	ADV	O
.	O	PUNCT	O


The	O	DET	O
Eed	B-protein	NOUN	B
-mediated	O	ADJ	O
transcriptional	O	ADJ	B
effects	O	NOUN	I
are	O	AUX	O
likely	O	ADJ	O
to	O	PART	O
reflect	O	VERB	O
the	O	DET	O
interaction	O	NOUN	B
of	O	ADP	O
Eed	B-protein	NOUN	B
with	O	ADP	O
multiple	O	ADJ	O
molecular	O	ADJ	B
partners	O	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
K	B-protein	NOUN	B
protein	I-protein	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
characterized	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
STAT	B-protein	NOUN	B
and	I-protein	CCONJ	O
IFN	I-protein	NOUN	B
regulatory	I-protein	ADJ	I
factor	I-protein	NOUN	I
(	I-protein	PUNCT	O
IRF	I-protein	NOUN	B
)	I-protein	PUNCT	O
family	I-protein	NOUN	B
transcription	I-protein	NOUN	I
factors	I-protein	NOUN	I
in	O	ADP	O
primary	B-cell_type	ADJ	O
human	I-cell_type	ADJ	B
blood	I-cell_type	NOUN	O
mononuclear	I-cell_type	ADJ	O
cells	I-cell_type	NOUN	O
and	O	CCONJ	O
macrophages	B-cell_type	NOUN	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
IFN-alpha	O	NOUN	B
and	O	CCONJ	O
IFN-gamma	O	NOUN	B
stimulation	O	NOUN	B
.	O	PUNCT	O


When	O	SCONJ	O
macrophages	B-cell_type	NOUN	B
were	O	AUX	O
pretreated	O	VERB	B
with	O	ADP	O
low	O	ADJ	B
doses	O	NOUN	I
of	O	ADP	O
IFN-gamma	B-protein	NOUN	B
and	O	CCONJ	O
then	O	ADV	O
stimulated	O	VERB	B
with	O	ADP	O
IFN-alpha	B-protein	NOUN	B
,	O	PUNCT	O
clearly	O	ADV	O
enhanced	O	VERB	O
formation	O	NOUN	B
of	O	ADP	O
specific	O	ADJ	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
complexes	O	NOUN	I
was	O	AUX	O
detected	O	VERB	B
.	O	PUNCT	O


Liberated	O	ADJ	B
NF-kappa	B-protein	NOUN	I
B	I-protein	NOUN	I
migrates	O	VERB	B
to	O	PART	O
the	O	DET	O
nucleus	O	NOUN	B
,	O	PUNCT	O
where	O	SCONJ	O
it	O	PRON	O
binds	O	VERB	B
to	O	PART	O
specific	B-DNA	ADJ	O
promoter	I-DNA	NOUN	B
sites	I-DNA	NOUN	I
and	O	CCONJ	O
activates	O	VERB	B
gene	O	NOUN	B
transcription	O	NOUN	I
.	O	PUNCT	O


Recently	O	ADV	O
,	O	PUNCT	O
activation	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
has	O	AUX	O
been	O	AUX	O
linked	O	VERB	O
to	O	PART	O
ARDS	O	NOUN	B
and	O	CCONJ	O
has	O	AUX	O
been	O	AUX	O
shown	O	VERB	O
to	O	PART	O
be	O	AUX	O
a	O	DET	O
critical	O	ADJ	O
proximal	O	ADJ	B
step	O	NOUN	O
in	O	ADP	O
the	O	DET	O
initiation	O	NOUN	B
of	O	ADP	O
neutrophilic	O	ADJ	B
inflammation	O	NOUN	B
in	O	ADP	O
animal	O	NOUN	B
models	O	NOUN	I
.	O	PUNCT	O


Chimeric	B-protein	ADJ	B
oncoprotein	I-protein	NOUN	I
E2a-Pbx1	B-protein	NOUN	B
induces	O	VERB	O
apoptosis	O	NOUN	B
of	O	ADP	O
hematopoietic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
by	O	ADP	O
a	O	DET	O
p53	B-protein	NOUN	B
-independent	O	ADJ	O
mechanism	O	NOUN	B
that	O	PRON	O
is	O	AUX	O
suppressed	O	VERB	B
by	O	ADP	O
Bcl-2	B-protein	NOUN	B
.	O	PUNCT	O


C/EBPepsilon	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
was	O	AUX	O
greatly	O	ADV	O
induced	O	VERB	B
during	O	ADP	O
in	O	X	B
vitro	O	X	I
granulocytic	O	ADJ	B
differentiation	O	NOUN	I
of	O	ADP	O
human	B-cell_type	ADJ	B
primary	I-cell_type	ADJ	O
CD34	I-cell_type	NOUN	O
(	I-cell_type	PUNCT	O
+	I-cell_type	CCONJ	O
)	I-cell_type	PUNCT	O
cells	I-cell_type	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
now	O	ADV	O
report	O	VERB	O
that	O	SCONJ	O
PO-B	B-protein	NOUN	B
DNA-binding	O	NOUN	B
in	O	ADP	O
HL-60	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
is	O	AUX	O
similarly	O	ADV	O
induced	O	VERB	B
during	O	ADP	O
differentiation	O	NOUN	B
to	O	PART	O
the	O	DET	O
granulocytic	B-cell_type	ADJ	B
lineage	I-cell_type	NOUN	I
(	O	PUNCT	O
with	O	ADP	O
either	O	CCONJ	O
retinoic	O	ADJ	B
acid	O	NOUN	I
or	O	CCONJ	O
dimethylsulfoxide	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


These	O	DET	O
studies	O	NOUN	B
have	O	AUX	O
prompted	O	VERB	O
our	O	PRON	O
interest	O	NOUN	O
in	O	ADP	O
the	O	DET	O
dynamics	O	NOUN	B
of	O	ADP	O
other	O	ADJ	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
changes	O	NOUN	I
during	O	ADP	O
HL-60	O	NOUN	B
differentiation	O	NOUN	I
.	O	PUNCT	O


Of	O	ADP	O
these	O	DET	O
,	O	PUNCT	O
we	O	PRON	O
observed	O	VERB	O
that	O	SCONJ	O
another	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
(	O	PUNCT	O
AP-1	B-protein	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
also	O	ADV	O
robustly	O	ADV	O
induced	O	VERB	B
at	O	ADP	O
the	O	DET	O
DNA-binding	O	ADJ	B
level	O	NOUN	B
during	O	ADP	O
macrophage-like	O	ADJ	B
HL-60	O	NOUN	B
differentiation	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
during	O	ADP	O
granulocytic	O	ADJ	B
differentiation	O	NOUN	I
.	O	PUNCT	O


One	O	NUM	O
of	O	ADP	O
them	O	PRON	O
,	O	PUNCT	O
hT86	O	NOUN	B
,	O	PUNCT	O
encoding	O	VERB	B
a	O	DET	O
putative	B-protein	ADJ	O
zinc	I-protein	NOUN	B
finger	I-protein	NOUN	I
protein	I-protein	NOUN	I
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
derepress	O	VERB	B
beta-galactosidase	B-protein	NOUN	B
activity	O	NOUN	B
in	O	ADP	O
the	O	DET	O
Oct-2	B-protein	NOUN	B
-harboring	O	NOUN	O
tester	O	NOUN	B
strain	O	NOUN	B
at	O	ADP	O
the	O	DET	O
transcriptional	O	ADJ	B
level	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
strategy	O	NOUN	O
described	O	VERB	O
here	O	ADV	O
provides	O	VERB	O
a	O	DET	O
new	O	ADJ	O
approach	O	NOUN	O
for	O	ADP	O
studying	O	VERB	O
protein-protein	O	ADJ	B
interactions	O	NOUN	I
that	O	PRON	O
govern	O	VERB	O
the	O	DET	O
complex	O	ADJ	B
regulation	O	NOUN	B
of	O	ADP	O
gene	O	NOUN	B
expression	O	NOUN	I
.	O	PUNCT	O


By	O	ADP	O
electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assays	O	NOUN	I
,	O	PUNCT	O
this	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
mRNA	B-RNA	NOUN	B
was	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
a	O	DET	O
5-	O	NUM	O
to	O	PART	O
10-fold	O	ADJ	O
increase	O	NOUN	B
in	O	ADP	O
the	O	DET	O
STAT1-containing	B-protein	ADJ	B
DNA-binding	I-protein	ADJ	I
complex	I-protein	NOUN	I
that	O	PRON	O
binds	O	VERB	B
to	O	PART	O
Fc	B-DNA	NOUN	B
gammaRI	I-DNA	NOUN	I
promoter	I-DNA	NOUN	B
elements	I-DNA	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
a	O	DET	O
novel	O	ADJ	O
mechanism	O	NOUN	B
by	O	ADP	O
which	O	DET	O
integrin	B-protein	NOUN	B
-mediated	O	ADJ	O
cell	O	NOUN	B
adhesion	O	NOUN	I
can	O	AUX	O
modulate	O	VERB	B
the	O	DET	O
magnitude	O	NOUN	B
of	O	ADP	O
cytokine	B-protein	NOUN	B
-induced	O	ADJ	O
signal	O	NOUN	B
transduction	O	NOUN	I
pathways	O	NOUN	I
,	O	PUNCT	O
thereby	O	ADV	O
amplifying	O	VERB	O
cellular	O	ADJ	B
events	O	NOUN	I
leading	O	VERB	O
to	O	PART	O
monocyte	O	NOUN	B
activation	O	NOUN	I
and	O	CCONJ	O
inflammation	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
many	O	ADJ	O
genes	O	NOUN	B
for	O	ADP	O
which	O	DET	O
products	O	NOUN	B
are	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
inflammation	O	NOUN	B
is	O	AUX	O
controlled	O	VERB	B
by	O	ADP	O
the	O	DET	O
transcriptional	B-protein	ADJ	B
regulator	I-protein	NOUN	I
nuclear	I-protein	ADJ	O
factor	I-protein	NOUN	O
(	I-protein	PUNCT	O
NF	I-protein	NOUN	B
)	I-protein	PUNCT	O
-kappa	I-protein	NOUN	O
B	I-protein	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
used	O	VERB	O
gel	O	NOUN	B
shift	O	NOUN	I
assays	O	NOUN	I
to	O	PART	O
determine	O	VERB	O
whether	O	SCONJ	O
SP-A	B-protein	NOUN	B
activated	O	VERB	B
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
in	O	ADP	O
the	O	DET	O
THP-1	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
,	O	PUNCT	O
a	O	DET	O
human	B-cell_line	ADJ	B
monocytic	I-cell_line	ADJ	I
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
.	O	PUNCT	O


Triggering	O	NOUN	B
of	O	ADP	O
the	O	DET	O
T-cell	B-protein	NOUN	B
receptor-CD3	I-protein	ADJ	I
complex	I-protein	NOUN	I
activates	O	VERB	B
two	O	NUM	O
major	O	ADJ	O
signal	O	NOUN	B
cascades	O	NOUN	I
in	O	ADP	O
T	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
,	O	PUNCT	O
(	O	PUNCT	O
i	O	X	O
)	O	PUNCT	O
Ca2+-dependent	O	ADJ	B
signal	O	NOUN	O
cascades	O	NOUN	O
and	O	CCONJ	O
(	O	PUNCT	O
ii	O	X	O
)	O	PUNCT	O
protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
cascades	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
show	O	VERB	O
here	O	ADV	O
that	O	SCONJ	O
c-Raf	B-protein	NOUN	B
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
at	O	ADP	O
the	O	DET	O
helm	O	NOUN	O
of	O	ADP	O
the	O	DET	O
classic	O	ADJ	B
MAP-	O	ADJ	B
Erk	B-protein	NOUN	B
cascade	O	NOUN	O
,	O	PUNCT	O
contributes	O	VERB	O
to	O	PART	O
IL-2	B-protein	NOUN	B
induction	O	NOUN	B
through	O	ADP	O
a	O	DET	O
distal	B-DNA	ADJ	B
enhancer	I-DNA	NOUN	I
element	I-DNA	NOUN	I
spanning	O	VERB	O
the	O	DET	O
nucleotides	O	NOUN	B
from	O	ADP	O
positions	O	NOUN	B
-502	O	NUM	O
to	O	PART	O
-413	O	NUM	O
in	O	ADP	O
front	O	NOUN	O
of	O	ADP	O
the	O	DET	O
transcriptional	O	ADJ	B
start	O	NOUN	O
site	O	NOUN	O
of	O	ADP	O
the	O	DET	O
IL-2	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
.	O	PUNCT	O


These	O	DET	O
studies	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
maximal	O	ADJ	B
LPS	O	NOUN	B
induction	O	NOUN	B
of	O	ADP	O
the	O	DET	O
TNF-alpha	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
is	O	AUX	O
mediated	O	VERB	O
by	O	ADP	O
concerted	O	ADJ	O
participation	O	NOUN	B
of	O	ADP	O
at	O	ADP	O
least	O	ADJ	O
two	O	NUM	O
separate	O	ADJ	O
cis-acting	B-DNA	ADJ	B
regulatory	I-DNA	ADJ	O
elements	I-DNA	NOUN	O
.	O	PUNCT	O


The	O	DET	O
control	O	NOUN	B
of	O	ADP	O
cell	O	NOUN	B
survival	O	NOUN	I
and	O	CCONJ	O
cell	O	NOUN	B
death	O	NOUN	I
is	O	AUX	O
of	O	ADP	O
central	O	ADJ	O
importance	O	NOUN	O
in	O	ADP	O
tissues	O	NOUN	B
with	O	ADP	O
high	O	ADJ	B
cell	O	NOUN	B
turnover	O	NOUN	B
such	O	ADJ	O
as	O	ADP	O
the	O	DET	O
lymphoid	O	ADJ	B
system	O	NOUN	I
.	O	PUNCT	O


IFN-alpha/beta	B-protein	NOUN	B
specifically	O	ADV	O
induced	O	VERB	B
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	I
and	O	CCONJ	O
translocation	O	NOUN	B
into	O	ADP	O
nucleus	O	NOUN	B
of	O	ADP	O
signal	B-protein	NOUN	B
transducers	I-protein	NOUN	I
and	I-protein	CCONJ	O
activators	I-protein	NOUN	B
of	I-protein	ADP	O
transcription	I-protein	NOUN	O
(	I-protein	PUNCT	O
STAT	I-protein	NOUN	O
)	I-protein	PUNCT	O
2	I-protein	NUM	O
protein	I-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
T	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
clones	I-cell_line	NOUN	I
.	O	PUNCT	O


Interleukin-10	B-protein	NOUN	B
(	O	PUNCT	O
IL-10	B-protein	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
potent	O	ADJ	O
monocyte	B-protein	NOUN	B
regulatory	I-protein	ADJ	O
cytokine	I-protein	NOUN	O
that	O	PRON	O
inhibits	O	VERB	B
gene	O	NOUN	B
expression	O	NOUN	I
of	O	ADP	O
proinflammatory	B-protein	ADJ	B
mediators	I-protein	NOUN	I
.	O	PUNCT	O


Nuclear	O	ADJ	B
run-on	O	ADJ	I
transcription	O	NOUN	I
assays	O	NOUN	I
showed	O	VERB	O
that	O	SCONJ	O
IL-10	B-protein	NOUN	B
inhibited	O	VERB	B
the	O	DET	O
rate	O	NOUN	B
of	O	ADP	O
IFN-gamma	B-protein	NOUN	B
-induced	O	ADJ	O
transcription	O	NOUN	B
of	O	ADP	O
the	O	DET	O
ICAM-1	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
mRNA	O	NOUN	B
stability	O	NOUN	I
studies	O	NOUN	I
showed	O	VERB	O
that	O	SCONJ	O
IL-10	B-protein	NOUN	B
did	O	AUX	O
not	O	PART	O
alter	O	VERB	O
the	O	DET	O
half-life	O	NOUN	B
of	O	ADP	O
IFN-gamma-induced	B-RNA	ADJ	B
ICAM-1	I-RNA	NOUN	B
message	I-RNA	NOUN	B
.	O	PUNCT	O


Instead	O	ADV	O
,	O	PUNCT	O
IL-10	B-protein	NOUN	B
prevented	O	VERB	O
IFN-gamma	B-protein	NOUN	B
-induced	O	ADJ	O
binding	O	NOUN	B
activity	O	NOUN	I
at	O	ADP	O
the	O	DET	O
NF-kappaB	B-protein	NOUN	B
site	O	NOUN	I
of	O	ADP	O
the	O	DET	O
tumor	B-DNA	NOUN	B
necrosis	I-DNA	NOUN	I
factor	I-DNA	NOUN	I
alpha	I-DNA	NOUN	I
(	I-DNA	PUNCT	O
TNF-alpha	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
-responsive	I-DNA	ADJ	O
NF-kappaB/C-EBP	I-DNA	NOUN	B
composite	I-DNA	ADJ	B
element	I-DNA	NOUN	B
in	O	ADP	O
the	O	DET	O
ICAM-1	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
.	O	PUNCT	O


Finally	O	ADV	O
,	O	PUNCT	O
a	O	DET	O
direct	O	ADJ	O
interaction	O	NOUN	B
between	O	ADP	O
RFX5	B-protein	NOUN	B
and	O	CCONJ	O
CIITA	B-protein	NOUN	B
was	O	AUX	O
detected	O	VERB	B
with	O	ADP	O
the	O	DET	O
yeast	O	NOUN	B
two-hybrid	O	ADJ	O
and	O	CCONJ	O
far-Western	O	ADJ	B
blot	O	NOUN	I
assays	O	NOUN	I
.	O	PUNCT	O


To	O	PART	O
further	O	ADV	O
explore	O	VERB	O
the	O	DET	O
involvement	O	NOUN	B
of	O	ADP	O
PI3-K	B-protein	NOUN	B
in	O	ADP	O
T	O	NOUN	B
cell	O	NOUN	I
activation	O	NOUN	O
,	O	PUNCT	O
we	O	PRON	O
created	O	VERB	O
a	O	DET	O
set	O	NOUN	O
of	O	ADP	O
potentially	O	ADV	O
dominant	B-DNA	ADJ	O
negative	I-DNA	ADJ	B
PI3-K	I-DNA	NOUN	B
constructs	I-DNA	NOUN	B
comprising	O	VERB	O
individual	O	ADJ	B
or	O	CCONJ	O
tandem	B-DNA	ADJ	B
domains	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
regulatory	B-protein	ADJ	B
p85	I-protein	NOUN	I
subunit	I-protein	NOUN	I
and	O	CCONJ	O
tested	O	VERB	B
their	O	PRON	O
effect	O	NOUN	B
on	O	ADP	O
downstream	O	ADJ	B
signaling	O	NOUN	I
events	O	NOUN	O
like	O	ADP	O
Erk2	B-protein	NOUN	B
activation	O	NOUN	B
and	O	CCONJ	O
transcription	O	NOUN	B
from	O	ADP	O
an	O	DET	O
NFAT	B-DNA	NOUN	B
(	I-DNA	PUNCT	O
nuclear	I-DNA	ADJ	B
factor	I-DNA	NOUN	I
of	I-DNA	ADP	O
activated	I-DNA	VERB	B
T	I-DNA	NOUN	O
cells	I-DNA	NOUN	O
)	I-DNA	PUNCT	O
element	I-DNA	NOUN	O
taken	O	VERB	O
from	O	ADP	O
the	O	DET	O
interleukin-2	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
.	O	PUNCT	O


Wortmannin	O	NOUN	B
did	O	AUX	O
not	O	PART	O
interfere	O	VERB	B
with	O	ADP	I
NFAT	B-protein	NOUN	B
activation	O	NOUN	B
,	O	PUNCT	O
although	O	SCONJ	O
it	O	PRON	O
inhibited	O	VERB	B
PI3-K	B-protein	NOUN	B
and	O	CCONJ	O
Erk2	B-protein	NOUN	B
activation	O	NOUN	B
in	O	ADP	O
the	O	DET	O
same	O	ADJ	O
experiment	O	NOUN	B
.	O	PUNCT	O


Constitutive	O	ADJ	B
and	O	CCONJ	O
inducible	O	ADJ	B
protein/DNA	O	NOUN	B
interactions	O	NOUN	I
of	O	ADP	O
the	O	DET	O
interferon-gamma	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
in	O	X	B
vivo	O	X	I
in	O	ADP	O
[	O	PUNCT	O
corrected	O	VERB	O
]	O	PUNCT	O
CD45RA	B-cell_type	NOUN	B
and	I-cell_type	CCONJ	O
CD45R0	I-cell_type	NOUN	B
T	I-cell_type	NOUN	I
helper	I-cell_type	NOUN	I
subsets	I-cell_type	NOUN	I
[	O	PUNCT	O
published	O	VERB	B
erratum	O	NOUN	O
appears	O	VERB	O
in	O	ADP	O
Eur	O	PROPN	O
J	O	PROPN	O
Immunol	O	PROPN	O
1997	O	NUM	O
Jul	O	PROPN	O
;	O	PUNCT	O
27	O	NUM	O
(	O	PUNCT	O
7	O	NUM	O
)	O	PUNCT	O
:	O	PUNCT	O
1830	O	NUM	O
]	O	PUNCT	O


ZEBRA	B-protein	NOUN	B
is	O	AUX	O
also	O	ADV	O
indispensable	O	ADJ	O
for	O	ADP	O
viral	O	ADJ	B
replication	O	NOUN	I
and	O	CCONJ	O
binds	O	VERB	B
directly	O	ADV	O
to	O	PART	O
the	O	DET	O
EBV	O	NOUN	B
lytic	O	ADJ	B
origin	O	NOUN	I
of	O	ADP	O
replication	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
aim	O	NOUN	O
of	O	ADP	O
this	O	DET	O
study	O	NOUN	B
was	O	AUX	O
to	O	PART	O
analyze	O	VERB	B
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
cholecystokinin	B-protein	NOUN	B
(	I-protein	PUNCT	O
CCK	I-protein	NOUN	B
(	I-protein	PUNCT	O
B	I-protein	NOUN	B
)	I-protein	PUNCT	O
)	I-protein	PUNCT	O
receptor	I-protein	NOUN	O
in	O	ADP	O
human	B-cell_line	ADJ	B
lymphoblastic	I-cell_line	ADJ	I
Jurkat	I-cell_line	NOUN	I
T	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


The	O	DET	O
involvement	O	NOUN	B
of	O	ADP	O
the	O	DET	O
CCK	B-protein	NOUN	B
(	I-protein	PUNCT	O
B	I-protein	NOUN	O
)	I-protein	PUNCT	O
receptor	I-protein	NOUN	O
in	O	ADP	O
such	O	DET	O
a	O	DET	O
stimulation	O	NOUN	B
was	O	AUX	O
demonstrated	O	VERB	O
by	O	ADP	O
the	O	DET	O
inhibiting	O	ADJ	B
effect	O	NOUN	B
of	O	ADP	O
the	O	DET	O
selective	O	ADJ	O
CCK	B-protein	NOUN	B
(	I-protein	PUNCT	O
B	I-protein	NOUN	O
)	I-protein	PUNCT	O
receptor	I-protein	NOUN	O
antagonist	O	NOUN	O
PD-135	O	NOUN	B
,	O	PUNCT	O
158	O	NUM	O
.	O	PUNCT	O


Our	O	PRON	O
investigation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
TCR	I-DNA	NOUN	B
beta	I-DNA	NOUN	B
gene	I-DNA	NOUN	I
uncovers	O	VERB	O
a	O	DET	O
surprisingly	O	ADV	O
complex	O	ADJ	B
and	O	CCONJ	O
tissue-specific	O	ADJ	B
structure	O	NOUN	I
at	O	ADP	O
the	O	DET	O
TCR	B-DNA	NOUN	B
Vbeta	I-DNA	NOUN	O
8.1	I-DNA	NUM	O
promoter	I-DNA	NOUN	B
.	O	PUNCT	O


While	O	SCONJ	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
JAK2	B-protein	NOUN	B
,	O	PUNCT	O
Shc	B-protein	NOUN	B
,	O	PUNCT	O
Erk	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
STAT5	B-protein	NOUN	B
proteins	I-protein	NOUN	I
correlated	O	VERB	B
with	O	ADP	O
hGM-CSF	B-protein	NOUN	B
-mediated	O	ADJ	O
cell	O	NOUN	B
growth	O	NOUN	I
,	O	PUNCT	O
cellular	O	ADJ	B
differentiation	O	NOUN	I
occurred	O	VERB	O
in	O	ADP	O
the	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
these	O	DET	O
signal	O	NOUN	B
transduction	O	NOUN	I
pathways	O	NOUN	O
.	O	PUNCT	O


Northern	O	NOUN	B
blot	O	NOUN	I
analysis	O	NOUN	I
in	O	ADP	O
mouse	O	NOUN	B
cell	O	NOUN	I
lines	O	NOUN	I
suggests	O	VERB	O
that	O	SCONJ	O
its	O	PRON	O
expression	O	NOUN	B
is	O	AUX	O
found	O	VERB	O
in	O	ADP	O
a	O	DET	O
variety	O	NOUN	O
of	O	ADP	O
cells	O	NOUN	B
,	O	PUNCT	O
including	O	VERB	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
macrophages	B-cell_type	NOUN	B
.	O	PUNCT	O


A	O	DET	O
TBP	O	NOUN	B
mutant	O	NOUN	O
defective	O	ADJ	B
in	O	ADP	O
interaction	O	NOUN	B
with	O	ADP	O
TBP-associated	B-protein	ADJ	B
factor	I-protein	NOUN	I
TAFII250	B-protein	NOUN	I
also	O	ADV	O
failed	O	VERB	O
to	O	PART	O
mediate	O	VERB	O
transactivation	O	NOUN	B
through	O	ADP	O
the	O	DET	O
CIITA	B-protein	NOUN	B
activation	I-protein	NOUN	B
domain	I-protein	NOUN	I
.	O	PUNCT	O


Stimulation	O	NOUN	B
of	O	ADP	O
purified	O	VERB	B
T	O	NOUN	B
lymphocytes	O	NOUN	I
by	O	ADP	O
a	O	DET	O
combination	O	NOUN	B
of	O	ADP	O
monoclonal	B-protein	ADJ	B
antibodies	I-protein	NOUN	I
directed	O	VERB	O
at	O	ADP	O
CD2	B-protein	NOUN	B
and	O	CCONJ	O
CD28	B-protein	NOUN	B
adhesion	B-protein	NOUN	I
molecules	I-protein	NOUN	B
gives	O	VERB	O
rise	O	NOUN	O
to	O	ADP	O
a	O	DET	O
long	O	ADJ	O
lasting	O	NOUN	O
proliferation	O	NOUN	B
in	O	ADP	O
the	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
accessory	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
recently	O	ADV	O
reported	O	VERB	O
a	O	DET	O
series	O	NOUN	B
(	O	PUNCT	O
A	O	NOUN	O
)	O	PUNCT	O
of	O	ADP	O
1	O	NUM	O
,	O	PUNCT	O
25D3-resistant	O	NUM	O
variants	O	NOUN	B
of	O	ADP	O
HL60	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
which	O	DET	O
proliferate	O	VERB	B
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
1	O	NUM	O
,	O	PUNCT	O
25D3	O	NOUN	B
and	O	CCONJ	O
do	O	AUX	O
not	O	PART	O
express	O	VERB	O
differentiation	O	NOUN	B
markers	O	NOUN	B
(	O	PUNCT	O
Exp.	O	PROPN	O
Cell	O	PROPN	O
Res.	O	PROPN	O
224	O	NUM	O
,	O	PUNCT	O
312	O	NUM	O
,	O	PUNCT	O
1996	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
availability	O	NOUN	O
of	O	ADP	O
these	O	DET	O
variant	O	ADJ	B
cells	O	NOUN	I
should	O	AUX	O
provide	O	VERB	O
a	O	DET	O
system	O	NOUN	B
for	O	ADP	O
studying	O	VERB	O
the	O	DET	O
link	O	NOUN	O
between	O	ADP	O
differentiation	O	NOUN	B
and	O	CCONJ	O
cell	O	NOUN	B
cycle	O	NOUN	I
arrest	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
combined	O	ADJ	O
use	O	NOUN	O
of	O	ADP	O
anti-Tat	B-protein	ADJ	B
sFv	I-protein	NOUN	B
intrabodies	I-protein	NOUN	B
and	O	CCONJ	O
the	O	DET	O
two	O	NUM	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
inhibitors	O	NOUN	I
retained	O	VERB	O
the	O	DET	O
virus	O	NOUN	B
in	O	ADP	O
the	O	DET	O
latent	O	ADJ	B
state	O	NOUN	I
for	O	ADP	O
as	O	ADV	O
long	O	ADV	O
as	O	ADP	O
45	O	NUM	O
days	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
characterization	O	NOUN	B
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
selectively	O	ADV	O
regulating	O	VERB	B
cytokine	O	NOUN	B
production	O	NOUN	O
by	O	ADP	O
CD4+	B-cell_type	ADJ	B
T	I-cell_type	NOUN	I
cell	I-cell_type	NOUN	I
subsets	I-cell_type	NOUN	I
is	O	AUX	O
at	O	ADP	O
a	O	DET	O
very	O	ADV	O
early	O	ADJ	B
stage	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
functional	O	ADJ	B
complexes	O	NOUN	O
encompassing	O	VERB	O
both	O	CCONJ	O
the	O	DET	O
CD28RE	B-DNA	NOUN	B
and	O	CCONJ	O
the	O	DET	O
AP-1-binding	B-DNA	ADJ	B
sites	I-DNA	NOUN	I
influence	O	VERB	B
IL-2	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
activity	O	NOUN	I
in	O	ADP	O
CD28	B-protein	NOUN	B
-costimulated	O	ADJ	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


BOB.1/OBF.1	B-protein	NOUN	B
is	O	AUX	O
a	O	DET	O
transcriptional	B-protein	ADJ	B
coactivator	I-protein	NOUN	I
that	O	PRON	O
is	O	AUX	O
constitutively	O	ADV	B
expressed	O	VERB	B
in	O	ADP	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
interacts	O	VERB	O
with	O	ADP	O
the	O	DET	O
Oct1	O	NOUN	B
and	O	CCONJ	O
Oct2	O	NOUN	B
transcription	B-protein	NOUN	O
factors	I-protein	NOUN	O
.	O	PUNCT	O


Thrombin	B-protein	NOUN	B
generation	O	NOUN	O
by	O	ADP	O
apoptotic	B-cell_type	ADJ	B
vascular	I-cell_type	ADJ	O
smooth	I-cell_type	ADJ	O
muscle	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
previously	O	ADV	O
shown	O	VERB	O
that	O	SCONJ	O
anionic	O	ADJ	B
phosphatidylserine	O	NOUN	I
is	O	AUX	O
exposed	O	VERB	O
by	O	ADP	O
rat	B-cell_type	NOUN	B
vascular	I-cell_type	ADJ	B
smooth	I-cell_type	ADJ	I
muscle	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
(	O	PUNCT	O
VSMCs	B-cell_type	NOUN	B
)	O	PUNCT	O
undergoing	O	VERB	O
apoptosis	O	NOUN	B
after	O	ADP	O
serum	O	NOUN	B
withdrawal	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
study	O	NOUN	B
,	O	PUNCT	O
using	O	VERB	O
a	O	DET	O
chromogenic	O	ADJ	B
assay	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
shown	O	VERB	O
thrombin	B-protein	NOUN	B
generation	O	NOUN	O
by	O	ADP	O
apoptotic	B-cell_type	ADJ	B
VSMCs	I-cell_type	NOUN	B
expressing	O	VERB	O
c-myc	B-protein	NOUN	O
(	O	PUNCT	O
VSMC-myc	B-cell_line	NOUN	B
)	O	PUNCT	O
with	O	ADP	O
an	O	DET	O
area	O	NOUN	B
under	O	ADP	O
the	O	DET	O
thrombin	B-protein	NOUN	B
-generation	O	NOUN	O
curve	O	NOUN	O
(	O	PUNCT	O
AUC	O	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
305	O	NUM	O
+/-	O	CCONJ	O
17	O	NUM	O
nmol	O	NOUN	O
x	O	NOUN	O
min/L	O	NOUN	O
and	O	CCONJ	O
a	O	DET	O
peak	O	NOUN	B
thrombin	B-protein	NOUN	I
(	O	PUNCT	O
PT	O	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
154	O	NUM	O
+/-	O	CCONJ	O
9	O	NUM	O
nmol/L	O	NOUN	O
.	O	PUNCT	O


VSMCs	B-cell_type	NOUN	B
derived	O	VERB	O
from	O	ADP	O
human	O	ADJ	B
coronary	O	ADJ	B
atherosclerotic	O	ADJ	I
plaques	O	NOUN	I
that	O	PRON	O
apoptose	O	VERB	B
even	O	ADV	O
in	O	ADP	O
serum	O	NOUN	B
also	O	ADV	O
generated	O	VERB	O
thrombin	B-protein	NOUN	B
(	O	PUNCT	O
AUC	O	NOUN	B
of	O	ADP	O
260	O	NUM	O
+/-	O	CCONJ	O
2	O	NUM	O
nmol	O	NOUN	O
x	O	NOUN	O
min/L	O	NOUN	O
;	O	PUNCT	O
PT	O	NOUN	B
of	O	ADP	O
128	O	NUM	O
+/-	O	CCONJ	O
4	O	NUM	O
nmol/L	O	NOUN	O
)	O	PUNCT	O
.	O	PUNCT	O


Patients	O	NOUN	B
with	O	ADP	O
one	O	NUM	O
type	O	NOUN	O
of	O	ADP	O
major	B-protein	ADJ	O
histocompatibility	I-protein	NOUN	O
complex	I-protein	NOUN	O
class	I-protein	NOUN	O
II	I-protein	NUM	O
combined	O	ADJ	O
immunodeficiency	O	NOUN	O
have	O	AUX	O
mutations	O	NOUN	B
in	O	ADP	O
a	O	DET	O
gene	O	NOUN	B
termed	O	VERB	O
class	B-protein	NOUN	B
II	I-protein	NUM	I
transactivator	I-protein	NOUN	I
(	O	PUNCT	O
CIITA	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
which	O	DET	O
coordinately	O	ADV	O
controls	O	VERB	O
the	O	DET	O
transcription	O	NOUN	B
of	O	ADP	O
the	O	DET	O
three	O	NUM	O
major	O	ADJ	O
human	B-DNA	ADJ	B
class	I-DNA	NOUN	B
II	I-DNA	NUM	I
genes	I-DNA	NOUN	I
,	O	PUNCT	O
HLA-DR	B-DNA	NOUN	B
,	I-DNA	PUNCT	O
-DQ	I-DNA	NOUN	B
,	I-DNA	PUNCT	O
and	I-DNA	CCONJ	O
-DP	I-DNA	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
somatic	O	ADJ	B
cell	O	NOUN	O
fusion	O	NOUN	O
between	O	ADP	O
clone	B-cell_line	NOUN	B
13	I-cell_line	NUM	O
and	O	CCONJ	O
RJ2.2.5	B-cell_line	NOUN	B
restored	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
HLA-DQ	B-DNA	NOUN	B
haplotype	O	NOUN	B
encoded	O	VERB	B
by	O	ADP	O
the	O	DET	O
RJ2.2.5	B-DNA	NOUN	B
DQB	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
.	O	PUNCT	O


The	O	DET	O
IL-4	B-protein	NOUN	B
receptor	I-protein	NOUN	I
(	O	PUNCT	O
IL-4R	B-protein	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
is	O	AUX	O
composed	O	VERB	O
of	O	ADP	O
two	O	NUM	O
chains	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
IL-4-binding	B-protein	ADJ	B
IL-4Ralpha	I-protein	NOUN	B
chain	I-protein	NOUN	I
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
shared	O	VERB	O
with	O	ADP	O
the	O	DET	O
IL-13R	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
IL-2Rgamma	B-protein	NOUN	B
(	I-protein	PUNCT	O
gammac	I-protein	NOUN	O
)	I-protein	PUNCT	O
chain	I-protein	NOUN	O
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
shared	O	VERB	O
with	O	ADP	O
IL-7R	B-protein	NOUN	B
,	O	PUNCT	O
IL-9R	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
IL-15R	B-protein	NOUN	B
.	O	PUNCT	O


Alternatively	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
IL-4Ralpha	B-protein	NOUN	B
chain	I-protein	NOUN	I
may	O	AUX	O
transduce	O	VERB	O
intracellular	O	ADJ	B
signals	O	NOUN	B
that	O	PRON	O
lead	O	VERB	O
to	O	PART	O
Cepsilon	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
transcription	O	NOUN	O
independently	O	ADV	O
of	O	ADP	O
its	O	PRON	O
association	O	NOUN	B
with	O	ADP	O
other	O	ADJ	O
chains	O	NOUN	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
transfected	O	VERB	B
with	O	ADP	O
a	O	DET	O
chimeric	B-protein	ADJ	B
CD8alpha/IL-4Ralpha	I-protein	NOUN	B
receptor	I-protein	NOUN	I
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
expressed	O	VERB	B
on	O	ADP	O
the	O	DET	O
cell	O	NOUN	B
surface	O	NOUN	I
as	O	ADP	O
a	O	DET	O
homodimer	B-protein	NOUN	B
,	O	PUNCT	O
constitutively	O	ADV	B
expressed	O	VERB	B
Cepsilon	B-RNA	NOUN	B
germline	I-RNA	NOUN	B
transcripts	I-RNA	NOUN	I
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
Elf-1	B-protein	NOUN	B
is	O	AUX	O
able	O	ADJ	O
to	O	PART	O
stimulate	O	VERB	B
gene	O	NOUN	B
transcription	O	NOUN	I
which	O	DET	O
may	O	AUX	O
be	O	AUX	O
required	O	VERB	O
for	O	ADP	O
the	O	DET	O
development	O	NOUN	B
and	O	CCONJ	O
activity	O	NOUN	B
of	O	ADP	O
lymphocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
for	O	ADP	O
the	O	DET	O
clonal	O	ADJ	B
expansion	O	NOUN	B
of	O	ADP	O
CD4+	B-cell_type	ADJ	B
T-cells	I-cell_type	NOUN	I
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
a	O	DET	O
characteristic	O	ADJ	O
result	O	NOUN	O
of	O	ADP	O
HTLV-I	O	NOUN	B
infection	O	NOUN	I
,	O	PUNCT	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
CREB/ATF	O	NOUN	B
and	O	CCONJ	O
SRF	O	NOUN	B
pathways	O	NOUN	O
is	O	AUX	O
also	O	ADV	O
required	O	VERB	O
.	O	PUNCT	O


Importantly	O	ADV	O
,	O	PUNCT	O
despite	O	SCONJ	O
high	O	ADJ	O
ligand	O	NOUN	B
binding	O	NOUN	O
affinity	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
prototypic	O	ADJ	B
dissociated	O	ADJ	I
compound	O	NOUN	I
,	O	PUNCT	O
RU24858	O	NOUN	B
,	O	PUNCT	O
acted	O	VERB	O
as	O	ADP	O
a	O	DET	O
weak	O	ADJ	B
agonist	O	NOUN	B
and	O	CCONJ	O
did	O	AUX	O
not	O	PART	O
efficiently	O	ADV	O
antagonize	O	VERB	B
dexamethasone-induced	O	ADJ	B
transcription	O	NOUN	I
in	O	ADP	O
transfected	B-cell_type	VERB	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


In	O	X	B
vivo	O	X	I
footprinting	O	NOUN	B
and	O	CCONJ	O
mutational	O	ADJ	B
analysis	O	NOUN	I
of	O	ADP	O
the	O	DET	O
proximal	B-DNA	ADJ	B
CD19	I-DNA	NOUN	O
promoter	I-DNA	NOUN	O
reveal	O	VERB	O
important	O	ADJ	O
roles	O	NOUN	O
for	O	ADP	O
an	O	DET	O
SP1/Egr-1	B-DNA	NOUN	B
binding	I-DNA	NOUN	I
site	I-DNA	NOUN	I
and	O	CCONJ	O
a	O	DET	O
novel	O	ADJ	O
site	O	NOUN	B
termed	O	VERB	O
the	O	DET	O
PyG	B-DNA	NOUN	B
box	I-DNA	NOUN	I
.	O	PUNCT	O


Reporter	O	NOUN	B
constructs	O	NOUN	I
spanning	O	VERB	O
portions	O	NOUN	B
of	O	ADP	O
the	O	DET	O
promoter	O	NOUN	B
identified	O	VERB	B
a	O	DET	O
region	B-DNA	NOUN	B
between	I-DNA	ADP	O
-85	I-DNA	NUM	O
and	I-DNA	CCONJ	O
-200	I-DNA	NUM	O
that	O	PRON	O
produced	O	VERB	O
high	O	ADJ	O
levels	O	NOUN	B
of	O	ADP	O
reporter	O	NOUN	B
gene	O	NOUN	I
activity	O	NOUN	I
in	O	ADP	O
lymphoid	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Gel	O	NOUN	B
shift	O	NOUN	I
assays	O	NOUN	I
demonstrated	O	VERB	O
SP1	O	NOUN	B
and	O	CCONJ	O
Egr-1	B-protein	NOUN	B
binding	O	NOUN	O
to	O	PART	O
the	O	DET	O
CD19	B-DNA	NOUN	B
GC	I-DNA	NOUN	I
box	I-DNA	NOUN	B
,	O	PUNCT	O
while	O	SCONJ	O
unknown	O	ADJ	O
nuclear	O	ADJ	B
proteins	O	NOUN	I
bound	O	VERB	O
the	O	DET	O
PyG	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
AT	I-DNA	ADP	B
boxes	I-DNA	NOUN	I
.	O	PUNCT	O


Early	B-protein	ADJ	B
B	I-protein	NOUN	O
cell	I-protein	NOUN	O
factor	I-protein	NOUN	O
(	O	PUNCT	O
EBF	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
E47	B-protein	NOUN	B
participate	O	VERB	B
in	O	ADP	O
the	O	DET	O
transcriptional	O	ADJ	B
control	O	NOUN	I
of	O	ADP	O
early	O	ADJ	B
B	O	NOUN	O
lymphocyte	O	NOUN	O
differentiation	O	NOUN	O
.	O	PUNCT	O


Taken	O	VERB	O
together	O	ADV	O
,	O	PUNCT	O
these	O	DET	O
data	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
EBF	B-protein	NOUN	B
and	O	CCONJ	O
E47	B-protein	NOUN	B
synergize	O	VERB	B
to	O	PART	O
activate	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
a	O	DET	O
subset	O	NOUN	O
of	O	ADP	O
genes	O	NOUN	B
that	O	PRON	O
define	O	VERB	O
an	O	DET	O
early	O	ADJ	B
stage	O	NOUN	I
of	O	ADP	O
the	O	DET	O
B	B-cell_type	NOUN	B
cell	I-cell_type	NOUN	I
lineage	I-cell_type	NOUN	O
.	O	PUNCT	O


This	O	DET	O
has	O	AUX	O
led	O	VERB	O
to	O	PART	O
the	O	DET	O
suggestion	O	NOUN	O
that	O	SCONJ	O
a	O	DET	O
surrogate	B-protein	ADJ	B
gamma'-chain	I-protein	NOUN	B
,	O	PUNCT	O
which	O	DET	O
can	O	AUX	O
interact	O	VERB	B
with	O	ADP	O
the	O	DET	O
IL-4R	B-protein	NOUN	B
alpha	I-protein	NOUN	B
chain	I-protein	NOUN	I
to	O	PART	O
mediate	O	VERB	O
signaling	O	NOUN	B
,	O	PUNCT	O
is	O	AUX	O
expressed	O	VERB	B
on	O	ADP	O
cells	O	NOUN	B
lacking	O	VERB	B
gamma	B-protein	NOUN	I
(	I-protein	PUNCT	I
c	I-protein	NOUN	O
)	I-protein	PUNCT	O
.	O	PUNCT	O


An	O	DET	O
alternative	O	ADJ	B
possibility	O	NOUN	O
is	O	AUX	O
that	O	SCONJ	O
in	O	ADP	O
the	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
gamma	B-protein	NOUN	B
(	I-protein	PUNCT	I
c	I-protein	NOUN	I
)	I-protein	PUNCT	O
,	O	PUNCT	O
the	O	DET	O
IL-4R	B-protein	NOUN	B
alpha	I-protein	NOUN	B
chain	I-protein	NOUN	I
is	O	AUX	O
able	O	ADJ	O
to	O	PART	O
transduce	O	VERB	B
signals	O	NOUN	B
by	O	ADP	O
homodimerization	O	NOUN	B
.	O	PUNCT	O


Dose-dependence	O	ADJ	B
studies	O	NOUN	B
using	O	VERB	O
histamine	O	NOUN	B
and	O	CCONJ	O
dimaprit	O	NOUN	B
showed	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
EC50	O	NOUN	B
values	O	NOUN	B
for	O	ADP	O
cAMP	O	NOUN	B
production	O	NOUN	O
and	O	CCONJ	O
c-fos	B-DNA	NOUN	B
increase	O	NOUN	B
were	O	AUX	O
similar	O	ADJ	O
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
cAMP	O	NOUN	B
might	O	AUX	O
be	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
c-fos	B-DNA	NOUN	B
induction	O	NOUN	I
via	O	ADP	O
H2	B-protein	NOUN	B
receptors	I-protein	NOUN	I
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
studies	O	NOUN	B
carried	O	VERB	O
out	O	ADP	O
using	O	VERB	O
H7	B-protein	NOUN	B
,	O	PUNCT	O
a	O	DET	O
protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
A/protein	I-protein	NOUN	I
kinase	I-protein	NOUN	I
C	I-protein	NOUN	I
inhibitor	I-protein	NOUN	I
,	O	PUNCT	O
blocked	O	VERB	B
c-fos	B-DNA	NOUN	B
induction	O	NOUN	B
,	O	PUNCT	O
whereas	O	SCONJ	O
no	O	DET	B
effect	O	NOUN	I
was	O	AUX	O
observed	O	VERB	O
with	O	ADP	O
bisindolylmaleimide	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
specific	O	ADJ	O
protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
C	I-protein	NOUN	I
inhibitor	O	NOUN	I
.	O	PUNCT	O


Nevertheless	O	ADV	O
,	O	PUNCT	O
dibutyryl	O	NOUN	B
cAMP	O	NOUN	B
induced	O	VERB	B
a	O	DET	O
down-regulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
levels	O	NOUN	B
of	O	ADP	O
this	O	DET	O
proto-oncogene	B-DNA	NOUN	B
.	O	PUNCT	O


METHODS	O	NOUN	O
AND	O	CCONJ	O
RESULTS	O	NOUN	B
:	O	PUNCT	O
We	O	PRON	O
obtained	O	VERB	O
peripheral	O	ADJ	B
venous	O	ADJ	B
blood	O	NOUN	I
samples	O	NOUN	I
in	O	ADP	O
20	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
AMI	O	NOUN	B
before	O	ADP	O
and	O	CCONJ	O
daily	O	ADV	B
for	O	ADP	O
5	O	NUM	O
days	O	NOUN	B
after	O	ADP	O
direct	O	ADJ	O
percutaneous	O	ADJ	B
transluminal	O	ADJ	I
coronary	O	ADJ	I
angioplasty	O	NOUN	I
(	O	PUNCT	O
PTCA	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
in	O	ADP	O
20	O	NUM	O
patients	O	NOUN	B
undergoing	O	VERB	O
elective	O	ADJ	B
PTCA	O	PROPN	B
.	O	PUNCT	O


The	O	DET	O
present	O	ADJ	O
work	O	NOUN	O
shows	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
primary	O	ADJ	O
CD8+	O	ADJ	B
CTL	O	NOUN	B
response	O	NOUN	O
to	O	PART	O
EBV	O	NOUN	B
in	O	ADP	O
infectious	O	ADJ	B
mononucleosis	O	NOUN	B
patients	O	NOUN	B
contains	O	VERB	O
multiple	O	ADJ	O
lytic	O	ADJ	B
antigen-specific	O	ADJ	B
reactivities	O	NOUN	I
at	O	ADP	O
levels	O	NOUN	B
at	O	ADP	O
least	O	ADJ	O
as	O	ADV	O
high	O	ADJ	O
as	O	ADP	O
those	O	DET	O
seen	O	VERB	O
against	O	ADP	O
latent	B-protein	ADJ	B
antigens	I-protein	NOUN	I
;	O	PUNCT	O
similar	O	ADJ	O
reactivities	O	NOUN	B
are	O	AUX	O
also	O	ADV	O
detectable	O	ADJ	B
in	O	ADP	O
CTL	O	NOUN	B
memory	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
contrasts	O	VERB	O
with	O	ADP	O
findings	O	NOUN	B
in	O	ADP	O
alpha-	O	NOUN	B
and	O	CCONJ	O
beta-	O	NOUN	B
herpesvirus	O	NOUN	I
systems	O	NOUN	I
(	O	PUNCT	O
herpes	O	NOUN	B
simplex	O	NOUN	I
,	O	PUNCT	O
cytomegalovirus	O	NOUN	B
)	O	PUNCT	O
where	O	SCONJ	O
viral	O	ADJ	B
interference	O	NOUN	I
with	O	ADP	O
the	O	DET	O
antigen-processing	O	ADJ	B
pathway	O	NOUN	I
during	O	ADP	O
lytic	O	ADJ	B
infection	O	NOUN	I
renders	O	VERB	O
immediate	B-protein	ADJ	O
early	I-protein	ADV	B
and	I-protein	CCONJ	O
early	I-protein	ADJ	B
proteins	I-protein	NOUN	B
much	O	ADV	O
less	O	ADV	O
immunogenic	O	ADJ	B
.	O	PUNCT	O


Triggering	O	NOUN	B
of	O	ADP	O
HLA-DR	B-protein	NOUN	B
antigens	I-protein	NOUN	B
differentially	O	ADV	B
modulates	O	VERB	B
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor	I-protein	NOUN	I
alpha	I-protein	NOUN	I
release	O	NOUN	O
by	O	ADP	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
at	O	ADP	O
distinct	O	ADJ	O
stage	O	NOUN	B
of	O	ADP	O
maturation	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
previously	O	ADV	O
established	O	VERB	O
a	O	DET	O
critical	O	ADJ	O
role	O	NOUN	O
for	O	ADP	O
the	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
GATA-3	B-protein	NOUN	B
in	O	ADP	O
IL-5	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
activation	O	NOUN	I
in	O	ADP	O
EL-4	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
which	O	DET	O
express	O	VERB	O
both	O	CCONJ	O
Th1-	B-protein	NOUN	B
and	I-protein	CCONJ	O
Th2-type	I-protein	ADJ	B
cytokines	I-protein	NOUN	B
.	O	PUNCT	O


Whereas	O	SCONJ	O
mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
GATA-3	B-protein	NOUN	B
site	O	NOUN	O
abolished	O	VERB	B
antigen-	O	NOUN	O
or	O	CCONJ	O
cAMP-	O	NOUN	B
stimulated	O	VERB	B
IL-5	O	NOUN	B
promoter	O	NOUN	B
activation	O	NOUN	I
in	O	ADP	O
Th2	O	NOUN	B
cells	O	NOUN	I
,	O	PUNCT	O
ectopic	O	ADJ	B
expression	O	NOUN	I
of	O	ADP	O
GATA-3	B-protein	NOUN	B
in	O	ADP	O
Th1	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
or	O	CCONJ	O
in	O	ADP	O
a	O	DET	O
non-lymphoid	B-cell_line	ADJ	B
,	I-cell_line	PUNCT	O
non-IL-5-producing	I-cell_line	ADJ	O
cell	I-cell_line	NOUN	B
line	I-cell_line	NOUN	I
activated	O	VERB	B
the	O	DET	O
IL-5	B-DNA	NOUN	B
promoter	I-DNA	NOUN	I
.	O	PUNCT	O


Inhibition	O	NOUN	B
of	O	ADP	O
GATA-3	B-protein	NOUN	B
activity	O	NOUN	O
has	O	AUX	O
therapeutic	O	ADJ	B
potential	O	NOUN	B
in	O	ADP	O
the	O	DET	O
treatment	O	NOUN	B
of	O	ADP	O
asthma	O	NOUN	B
and	O	CCONJ	O
other	O	ADJ	O
hypereosinophilic	O	ADJ	B
diseases	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
ratio	O	NOUN	B
of	O	ADP	O
adult	B-RNA	ADJ	B
beta-globin/alpha-globin	I-RNA	NOUN	O
mRNA	I-RNA	NOUN	B
in	O	ADP	O
the	O	DET	O
mutant	B-cell_line	ADJ	B
ES	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
was	O	AUX	O
1/15	O	NUM	O
of	O	ADP	O
that	O	DET	O
in	O	ADP	O
wild-type	B-cell_type	ADJ	B
ES	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


RP1	B-DNA	NOUN	B
,	O	PUNCT	O
a	O	DET	O
new	O	ADJ	O
member	O	NOUN	O
of	O	ADP	O
the	O	DET	O
adenomatous	B-DNA	ADJ	B
polyposis	I-DNA	NOUN	I
coli-binding	I-DNA	ADJ	B
EB1-like	I-DNA	ADJ	I
gene	I-DNA	NOUN	I
family	I-DNA	NOUN	O
,	O	PUNCT	O
is	O	AUX	O
differentially	O	ADV	O
expressed	O	VERB	B
in	O	ADP	O
activated	B-cell_type	VERB	B
T	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
.	O	PUNCT	O


The	O	DET	O
predictive	B-DNA	ADJ	B
protein-coding	I-DNA	ADJ	B
region	I-DNA	NOUN	I
of	O	ADP	O
RP1	B-DNA	NOUN	B
had	O	AUX	O
a	O	DET	O
significant	O	ADJ	O
homology	O	NOUN	B
to	O	PART	O
members	O	NOUN	B
of	O	ADP	O
the	O	DET	O
recently	O	ADV	O
found	O	VERB	O
adenomatous	B-DNA	ADJ	B
polyposis	I-DNA	NOUN	I
coli	I-DNA	NOUN	I
(	I-DNA	PUNCT	O
APC	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
protein-binding	I-DNA	ADJ	B
EB1	I-DNA	NOUN	B
gene	I-DNA	NOUN	O
family	I-DNA	NOUN	O
,	O	PUNCT	O
which	O	DET	O
codes	O	VERB	B
for	O	ADP	O
yet	O	ADV	O
unknown	O	ADJ	O
protein	O	NOUN	B
(	O	PUNCT	O
s	O	NOUN	O
)	O	PUNCT	O
.	O	PUNCT	O


Cyclosporin	O	NOUN	B
A	O	NOUN	O
interferes	O	VERB	B
with	O	ADP	I
the	O	DET	O
inducible	O	ADJ	B
degradation	O	NOUN	I
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
inhibitors	O	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
with	O	ADP	O
the	O	DET	O
processing	O	NOUN	B
of	O	ADP	O
p105/	O	NOUN	B
NF-kappa	B-protein	NOUN	B
B1	I-protein	NOUN	I
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Glucocorticoid	O	NOUN	B
therapy	O	NOUN	I
resolves	O	VERB	O
clinical	O	ADJ	B
symptoms	O	NOUN	I
within	O	ADP	O
hours	O	NOUN	O
to	O	PART	O
days	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
therapy	O	NOUN	B
has	O	AUX	O
to	O	PART	O
be	O	AUX	O
continued	O	VERB	O
over	O	ADP	O
several	O	ADJ	O
years	O	NOUN	B
to	O	PART	O
prevent	O	VERB	B
disease	O	NOUN	B
relapses	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
synthesis	O	NOUN	B
of	O	ADP	O
IFN-gamma	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
was	O	AUX	O
only	O	ADV	O
slightly	O	ADV	O
decreased	O	VERB	B
,	O	PUNCT	O
and	O	CCONJ	O
expression	O	NOUN	B
of	O	ADP	O
TGF-beta1	B-protein	NOUN	B
was	O	AUX	O
unaffected	O	ADJ	B
.	O	PUNCT	O


Following	O	VERB	O
an	O	DET	O
initial	O	ADJ	O
genotype	O	NOUN	B
screening	O	NOUN	B
of	O	ADP	O
85	O	NUM	O
normal	O	ADJ	B
volunteers	O	NOUN	I
by	O	ADP	O
polymerase	O	NOUN	B
chain	O	NOUN	I
reaction	O	NOUN	I
or	O	CCONJ	O
restriction	B-DNA	NOUN	B
fragment	I-DNA	NOUN	I
length	I-DNA	NOUN	I
polymorphism	I-DNA	NOUN	I
analysis	O	NOUN	I
,	O	PUNCT	O
14	O	NUM	O
individuals	O	NOUN	B
with	O	ADP	O
the	O	DET	O
Bb	O	NOUN	B
genotype	O	NOUN	B
,	O	PUNCT	O
12	O	NUM	O
with	O	ADP	O
the	O	DET	O
bb	O	NOUN	B
genotype	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
12	O	NUM	O
with	O	ADP	O
the	O	DET	O
BB	O	NOUN	B
genotype	O	NOUN	B
were	O	AUX	O
selected	O	VERB	O
.	O	PUNCT	O


We	O	PRON	O
conclude	O	VERB	O
that	O	SCONJ	O
VDR	B-protein	NOUN	B
polymorphism	O	NOUN	B
does	O	AUX	O
not	O	PART	O
affect	O	VERB	O
the	O	DET	O
abundance	O	NOUN	B
of	O	ADP	O
the	O	DET	O
VDR	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
.	O	PUNCT	O


EMS	O	NOUN	B
analyses	O	NOUN	B
utilizing	O	VERB	O
a	O	DET	O
series	O	NOUN	O
of	O	ADP	O
mutated	B-DNA	VERB	B
pp	I-DNA	NOUN	O
repeat	I-DNA	NOUN	O
elements	I-DNA	NOUN	O
demonstrate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
nucleotide	O	NOUN	B
sequence	O	NOUN	I
requirements	O	NOUN	O
for	O	ADP	O
U1	B-DNA	NOUN	B
(	O	PUNCT	O
U1A/U1B	B-DNA	NOUN	O
)	O	PUNCT	O
and	O	CCONJ	O
U2	B-DNA	NOUN	B
formation	O	NOUN	B
are	O	AUX	O
separable	O	ADJ	O
from	O	ADP	O
those	O	DET	O
required	O	VERB	O
for	O	ADP	O
C1-C3	B-DNA	NOUN	B
formation	O	NOUN	B
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
STAT3	B-protein	NOUN	B
may	O	AUX	O
play	O	VERB	O
a	O	DET	O
role	O	NOUN	O
in	O	ADP	O
B	O	NOUN	B
cell	O	NOUN	I
antigen-specific	O	ADJ	B
signaling	O	NOUN	I
responses	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
its	O	PRON	O
constitutive	O	ADJ	B
activation	O	NOUN	B
is	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
a	O	DET	O
normal	O	ADJ	B
cell	O	NOUN	I
population	O	NOUN	O
exhibiting	O	VERB	O
intrinsic	O	ADJ	B
proliferative	O	ADJ	O
behavior	O	NOUN	O
.	O	PUNCT	O


Recently	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
developed	O	VERB	O
a	O	DET	O
quantitative	O	ADJ	B
assay	O	NOUN	B
using	O	VERB	O
competitive	O	ADJ	B
reverse	B-protein	ADJ	O
transcriptase	I-protein	NOUN	O
polymerase	I-protein	NOUN	O
chain	O	NOUN	O
reaction	O	NOUN	O
that	O	PRON	O
estimates	O	VERB	B
the	O	DET	O
number	O	NOUN	O
of	O	ADP	O
AML1/ETO	B-RNA	NOUN	B
transcripts	I-RNA	NOUN	I
in	O	ADP	O
t	O	NOUN	O
(	O	PUNCT	O
8	O	NUM	O
;	O	PUNCT	O
21	O	NUM	O
)	O	PUNCT	O
acute	O	ADJ	B
myelogenous	O	ADJ	I
leukemia	O	NOUN	I
(	O	PUNCT	O
AML	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
in	O	ADP	O
order	O	NOUN	O
to	O	PART	O
determine	O	VERB	O
the	O	DET	O
degree	O	NOUN	B
of	O	ADP	O
leukemic	O	ADJ	B
cell	O	NOUN	I
contamination	O	NOUN	B
in	O	ADP	O
PBSC	B-cell_type	NOUN	B
harvests	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
to	O	PART	O
monitor	O	VERB	O
minimal	O	ADJ	O
residual	O	ADJ	O
disease	O	NOUN	O
(	O	PUNCT	O
MRD	O	NOUN	B
)	O	PUNCT	O
quantitatively	O	ADV	B
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
t	O	NOUN	O
(	O	PUNCT	O
8	O	NUM	O
;	O	PUNCT	O
21	O	NUM	O
)	O	PUNCT	O
AML	O	NOUN	B
.	O	PUNCT	O


Synergistic	O	ADJ	B
transactivation	O	NOUN	O
of	O	ADP	O
the	O	DET	O
LPS	B-DNA	NOUN	B
response	I-DNA	NOUN	B
element	I-DNA	NOUN	I
in	O	ADP	O
Drosophila	B-cell_line	X	B
Schneider	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
by	O	ADP	O
coexpression	O	NOUN	B
of	O	ADP	O
c-Fos	B-protein	NOUN	B
,	O	PUNCT	O
c-Jun	B-protein	NOUN	B
,	O	PUNCT	O
c-Rel	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
p65	B-protein	NOUN	B
or	O	CCONJ	O
c-Jun	B-protein	NOUN	B
and	O	CCONJ	O
p65	B-protein	NOUN	B
required	O	VERB	O
the	O	DET	O
transactivation	B-protein	NOUN	B
domains	I-protein	NOUN	O
of	O	ADP	O
c-Jun	B-protein	NOUN	B
and	O	CCONJ	O
p65	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
GH	O	NOUN	B
appears	O	VERB	O
to	O	PART	O
occur	O	VERB	O
in	O	ADP	O
an	O	DET	O
autocrine	O	ADJ	B
fashion	O	NOUN	I
,	O	PUNCT	O
since	O	SCONJ	O
the	O	DET	O
inhibitory	O	ADJ	B
effect	O	NOUN	O
on	O	ADP	O
TNF-alpha	B-protein	NOUN	B
secretion	O	NOUN	B
by	O	ADP	O
constitutive	O	ADJ	B
GH	O	NOUN	B
production	O	NOUN	I
could	O	AUX	O
be	O	AUX	O
abolished	O	VERB	B
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
anti-hGH	B-protein	NOUN	B
mAb	I-protein	NOUN	I
.	O	PUNCT	O


On	O	ADP	O
the	O	DET	O
other	O	ADJ	O
hand	O	NOUN	B
,	O	PUNCT	O
FCM	O	NOUN	B
produced	O	VERB	O
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
indomethacin	O	NOUN	B
does	O	AUX	O
not	O	PART	O
inhibit	O	VERB	B
NF-kappaB	B-protein	NOUN	B
activation	O	NOUN	B
by	O	ADP	O
LPS	O	NOUN	B
.	O	PUNCT	O


By	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
phosphatidic	O	ADJ	B
acid	O	NOUN	I
accumulation	O	NOUN	B
,	O	PUNCT	O
pleckstrin	O	NOUN	B
phosphorylation	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
calcium	O	NOUN	B
mobilization	O	NOUN	I
produced	O	VERB	O
by	O	ADP	O
the	O	DET	O
combination	O	NOUN	B
of	O	ADP	O
NE	B-protein	NOUN	B
and	O	CCONJ	O
threshold	O	NOUN	B
of	O	ADP	O
cathepsin	B-protein	NOUN	B
G	I-protein	NOUN	I
were	O	AUX	O
not	O	PART	O
significantly	O	ADV	O
different	O	ADJ	O
from	O	ADP	O
those	O	DET	O
measured	O	VERB	B
with	O	ADP	O
threshold	O	NOUN	B
of	O	ADP	O
cathepsin	B-protein	NOUN	B
G	I-protein	NOUN	I
alone	O	ADV	O
(	O	PUNCT	O
p	O	NOUN	O
>	O	X	O
0.05	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
indicating	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
phospholipase	B-protein	NOUN	B
C	I-protein	NOUN	I
/protein	B-protein	NOUN	I
kinase	I-protein	NOUN	I
C	I-protein	NOUN	I
pathway	O	NOUN	I
is	O	AUX	O
not	O	PART	O
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
potentiation	O	NOUN	B
of	O	ADP	O
aggregation	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
suppression	O	NOUN	B
of	O	ADP	O
productive	O	ADJ	B
LAI	O	NOUN	B
replication	O	NOUN	B
in	O	ADP	O
naive	B-cell_type	ADJ	B
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
is	O	AUX	O
not	O	PART	O
due	O	ADJ	O
to	O	PART	O
differential	O	ADJ	O
expression	O	NOUN	B
of	O	ADP	O
viral	B-protein	ADJ	B
coreceptors	I-protein	NOUN	I
,	O	PUNCT	O
nor	O	CCONJ	O
is	O	AUX	O
it	O	PRON	O
due	O	ADJ	O
to	O	PART	O
inhibition	O	NOUN	B
of	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
important	O	ADJ	O
HIV	O	NOUN	B
transcription	B-protein	NOUN	O
factors	I-protein	NOUN	O
,	O	PUNCT	O
nuclear	B-protein	ADJ	B
factor-kappaB	I-protein	NOUN	I
and	O	CCONJ	I
activator	B-protein	NOUN	I
protein-1	I-protein	NOUN	I
.	O	PUNCT	O


To	O	PART	O
test	O	VERB	O
the	O	DET	O
hypothesis	O	NOUN	B
that	O	SCONJ	O
the	O	DET	O
chimera	B-protein	NOUN	B
PMLRAR	I-protein	NOUN	B
alpha	I-protein	NOUN	I
plays	O	VERB	O
a	O	DET	O
role	O	NOUN	O
in	O	ADP	O
leukemogenesis	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
expressed	O	VERB	B
a	O	DET	O
PMLRAR	B-DNA	NOUN	B
alpha	I-DNA	NOUN	I
cDNA	I-DNA	NOUN	B
in	O	ADP	O
myeloid	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
of	O	ADP	O
transgenic	O	ADJ	B
mice	O	NOUN	I
.	O	PUNCT	O


PMLRAR	O	NOUN	B
alpha	O	NOUN	I
transgenic	O	ADJ	B
mice	O	NOUN	I
exhibited	O	VERB	O
impaired	O	ADJ	B
neutrophil	O	NOUN	B
maturation	O	NOUN	B
early	O	ADV	B
in	O	ADP	O
life	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
progressed	O	VERB	O
at	O	ADP	O
a	O	DET	O
low	O	ADJ	B
frequency	O	NOUN	I
over	O	ADP	O
the	O	DET	O
course	O	NOUN	B
of	O	ADP	O
several	O	ADJ	O
months	O	NOUN	B
to	O	PART	O
overt	O	ADJ	B
APL	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
model	O	NOUN	B
should	O	AUX	O
be	O	AUX	O
useful	O	ADJ	O
for	O	ADP	O
exploring	O	VERB	O
the	O	DET	O
molecular	O	ADJ	B
pathogenesis	O	NOUN	B
of	O	ADP	O
APL	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
mechanisms	O	NOUN	B
of	O	ADP	O
the	O	DET	O
therapeutic	O	ADJ	B
response	O	NOUN	I
to	O	PART	O
retinoic	O	ADJ	B
acid	O	NOUN	I
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
for	O	ADP	O
preclinical	O	ADJ	B
studies	O	NOUN	I
of	O	ADP	O
therapeutic	O	ADJ	B
regimens	O	NOUN	I
.	O	PUNCT	O


Such	O	ADJ	O
hypermethylation-associated	O	ADJ	B
silencing	O	NOUN	B
of	O	ADP	O
gene	O	NOUN	B
expression	O	NOUN	I
has	O	AUX	O
been	O	AUX	O
shown	O	VERB	O
for	O	ADP	O
several	O	ADJ	O
genes	O	NOUN	B
regulating	O	VERB	B
the	O	DET	O
growth	O	NOUN	B
and	O	CCONJ	O
differentiation	O	NOUN	B
of	O	ADP	O
hematopoietic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
the	O	DET	O
estrogen	B-DNA	NOUN	B
receptor	I-DNA	NOUN	I
(	I-DNA	PUNCT	O
ER	I-DNA	NOUN	O
)	I-DNA	PUNCT	O
gene	I-DNA	NOUN	O
,	O	PUNCT	O
P15	O	NOUN	B
,	O	PUNCT	O
P16	O	NOUN	B
and	O	CCONJ	O
others	O	NOUN	O
.	O	PUNCT	O


To	O	PART	O
extend	O	VERB	O
these	O	DET	O
initial	O	ADJ	O
observations	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
examined	O	VERB	O
the	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
antioxidant	O	ADJ	B
treatment	O	NOUN	O
on	O	ADP	O
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
mitogen-activated	B-protein	ADJ	B
protein	I-protein	NOUN	I
kinases	I-protein	NOUN	I
erk1	B-protein	NOUN	I
and	O	CCONJ	O
erk2	B-protein	NOUN	B
,	O	PUNCT	O
as	O	ADP	O
members	O	NOUN	B
of	O	ADP	O
a	O	DET	O
signal	O	NOUN	B
transduction	O	NOUN	I
pathway	O	NOUN	O
known	O	VERB	O
to	O	PART	O
directly	O	ADV	O
regulate	O	VERB	B
transcription	O	NOUN	B
factor	O	NOUN	I
function	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
observations	O	NOUN	B
provide	O	VERB	O
further	O	ADJ	O
evidence	O	NOUN	B
to	O	PART	O
suggest	O	VERB	O
a	O	DET	O
role	O	NOUN	O
for	O	ADP	O
intracellular	O	ADJ	B
oxidant	O	ADJ	B
generation	O	NOUN	O
as	O	ADP	O
a	O	DET	O
regulatory	O	ADJ	B
mechanism	O	NOUN	B
during	O	ADP	O
cell	O	NOUN	B
cycle	O	NOUN	I
entry	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
establish	O	VERB	O
a	O	DET	O
link	O	NOUN	O
between	O	ADP	O
oxidative	O	ADJ	B
signalling	O	NOUN	I
and	O	CCONJ	O
other	O	ADJ	O
aspects	O	NOUN	O
of	O	ADP	O
the	O	DET	O
intracellular	O	ADJ	B
signalling	O	NOUN	B
network	O	NOUN	B
that	O	PRON	O
is	O	AUX	O
activated	O	VERB	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
mitogenic	O	ADJ	B
stimulation	O	NOUN	I
.	O	PUNCT	O


Using	O	VERB	O
the	O	DET	O
yeast	O	NOUN	B
two-hybrid	O	ADJ	B
system	O	NOUN	I
to	O	PART	O
screen	O	VERB	B
for	O	ADP	O
proteins	O	NOUN	B
which	O	DET	O
interact	O	VERB	B
with	O	ADP	O
Tax1	B-protein	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
isolated	O	VERB	B
the	O	DET	O
B	B-protein	NOUN	B
subunit	I-protein	NOUN	I
of	O	ADP	O
the	O	DET	O
CCAAT	B-protein	NOUN	B
binding	I-protein	NOUN	I
protein	I-protein	NOUN	I
NF-Y	B-protein	NOUN	B
from	O	ADP	O
a	O	DET	O
HeLa	B-DNA	NOUN	B
cDNA	I-DNA	NOUN	B
library	I-DNA	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
mutation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Y-box	B-DNA	NOUN	B
element	I-DNA	NOUN	O
alone	O	ADV	O
abrogated	O	VERB	B
Tax1	B-protein	NOUN	B
-mediated	O	ADJ	O
activation	O	NOUN	B
.	O	PUNCT	O


High	O	ADJ	O
levels	O	NOUN	B
of	O	ADP	O
the	O	DET	O
DNA-binding	O	ADJ	B
activity	O	NOUN	O
of	O	ADP	O
E2F	B-protein	NOUN	B
in	O	ADP	O
adult	O	ADJ	B
T-cell	O	NOUN	B
leukemia	O	NOUN	I
and	O	CCONJ	O
human	B-cell_type	ADJ	B
T-cell	I-cell_type	NOUN	I
leukemia	I-cell_type	NOUN	I
virus	I-cell_type	NOUN	O
type	I-cell_type	NOUN	O
I-infected	I-cell_type	ADJ	O
cells	I-cell_type	NOUN	O
:	O	PUNCT	O
possible	O	ADJ	O
enhancement	O	NOUN	B
of	O	ADP	O
DNA-binding	O	NOUN	B
of	O	ADP	O
E2F	B-protein	NOUN	B
by	O	ADP	O
the	O	DET	O
human	B-protein	ADJ	B
T-cell	I-protein	NOUN	I
leukemia	I-protein	NOUN	I
virus	I-protein	NOUN	O
I	I-protein	NOUN	O
transactivating	I-protein	NOUN	O
protein	I-protein	NOUN	O
,	O	PUNCT	O
Tax	B-protein	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
study	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
examined	O	VERB	O
early	O	ADJ	B
signaling	O	NOUN	O
events	O	NOUN	O
in	O	ADP	O
proliferating	B-cell_type	NOUN	B
and	O	CCONJ	O
terminally	B-cell_type	ADV	B
differentiated	I-cell_type	VERB	I
cells	I-cell_type	NOUN	I
following	O	VERB	O
G-CSF	B-protein	NOUN	B
stimulation	O	NOUN	B
to	O	PART	O
determine	O	VERB	O
whether	O	SCONJ	O
identical	O	ADJ	B
signaling	O	NOUN	B
cascades	O	NOUN	I
are	O	AUX	O
activated	O	VERB	B
.	O	PUNCT	O


BACKGROUND	O	NOUN	B
:	O	PUNCT	O
Retinoic	O	ADJ	B
acid	O	NOUN	I
(	O	PUNCT	O
RA	O	NOUN	B
)	O	PUNCT	O
has	O	AUX	O
important	O	ADJ	O
immune-modulating	O	ADJ	B
effects	O	NOUN	I
on	O	ADP	O
both	O	CCONJ	O
T	O	NOUN	B
and	O	CCONJ	O
B	O	NOUN	B
cell	O	NOUN	I
function	O	NOUN	O
.	O	PUNCT	O


Our	O	PRON	O
laboratory	O	NOUN	B
has	O	AUX	O
shown	O	VERB	O
that	O	SCONJ	O
RA	O	NOUN	B
can	O	AUX	O
enhance	O	VERB	O
in	O	X	B
vitro	O	X	I
polyclonal	O	ADJ	B
B	O	NOUN	I
cell	O	NOUN	I
immunoglobulin	B-protein	NOUN	I
(	O	PUNCT	I
Ig	O	NOUN	I
)	O	PUNCT	I
response	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
changes	O	NOUN	B
appear	O	VERB	O
to	O	PART	O
be	O	AUX	O
mediated	O	VERB	O
by	O	ADP	O
RAR-alpha	B-protein	NOUN	B
.	O	PUNCT	O


Characterization	O	NOUN	B
of	O	ADP	O
the	O	DET	O
DNA-binding	B-protein	ADJ	B
protein	I-protein	NOUN	I
by	O	ADP	O
UV	O	NOUN	B
cross-linking	O	NOUN	B
,	O	PUNCT	O
Southwestern	O	NOUN	B
blot	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
antibody	O	NOUN	B
ablation/supershift	O	NOUN	O
assays	O	NOUN	O
revealed	O	VERB	B
that	O	SCONJ	O
it	O	PRON	O
is	O	AUX	O
similar	O	ADJ	O
to	O	PART	O
a	O	DET	O
recently	O	ADV	O
reported	O	VERB	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
designated	O	VERB	O
SAF	B-protein	NOUN	B
.	O	PUNCT	O


Interleukin-6	B-protein	NOUN	B
(	O	PUNCT	O
IL-6	B-protein	NOUN	B
)	O	PUNCT	O
plays	O	VERB	O
a	O	DET	O
central	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
numerous	O	ADJ	O
inflammatory	O	ADJ	B
and	O	CCONJ	O
immune	O	ADJ	B
processes	O	NOUN	I
.	O	PUNCT	O


Interleukin-6	B-protein	NOUN	B
levels	O	NOUN	B
are	O	AUX	O
increased	O	VERB	B
in	O	ADP	O
lung	O	NOUN	B
transplant	O	NOUN	I
patients	O	NOUN	B
clinically	O	ADV	B
diagnosed	O	VERB	I
with	O	ADP	O
CMV	O	NOUN	B
pneumonitis	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
studies	O	NOUN	B
examined	O	VERB	O
the	O	DET	O
ability	O	NOUN	O
of	O	ADP	O
CMV	O	NOUN	B
IE	O	NOUN	I
gene	O	NOUN	B
products	O	NOUN	I
to	O	PART	O
modulate	O	VERB	O
IL-6	B-protein	NOUN	B
production	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
ALY	B-protein	NOUN	B
can	O	AUX	O
increase	O	VERB	B
DNA	O	NOUN	B
binding	O	NOUN	I
by	O	ADP	O
both	O	CCONJ	O
LEF-1	B-protein	NOUN	B
and	O	CCONJ	O
AML	B-protein	NOUN	B
proteins	I-protein	NOUN	I
.	O	PUNCT	O


On	O	ADP	O
the	O	DET	O
other	O	ADJ	O
hand	O	NOUN	B
,	O	PUNCT	O
AML1b	B-protein	NOUN	B
conferred	O	VERB	O
a	O	DET	O
similar	O	ADJ	O
differentiation-inducing	O	ADJ	B
capacity	O	NOUN	I
upon	O	SCONJ	O
K562	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
transfected	O	VERB	B
with	O	ADP	O
vector	O	NOUN	B
alone	O	ADV	O
.	O	PUNCT	O


AML1a	B-protein	NOUN	B
expression	O	NOUN	B
was	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
enhanced	O	VERB	B
sensitivity	O	NOUN	B
to	O	PART	O
megakaryocytic	O	ADJ	B
differentiation	O	NOUN	I
induced	O	VERB	B
by	O	ADP	O
phorbol	O	NOUN	B
ester	O	NOUN	I
.	O	PUNCT	O


Two	O	NUM	O
sets	O	NOUN	O
of	O	ADP	O
independent	O	ADJ	O
evidences	O	NOUN	B
are	O	AUX	O
presented	O	VERB	O
here	O	ADV	O
that	O	PRON	O
demonstrate	O	VERB	O
a	O	DET	O
biological	O	ADJ	B
relevance	O	NOUN	B
for	O	ADP	O
this	O	DET	O
model	O	NOUN	B
.	O	PUNCT	O


Secondly	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
investigated	O	VERB	B
whether	O	SCONJ	O
polyomavirus	O	NOUN	B
reactivation	O	NOUN	I
occurs	O	VERB	O
in	O	ADP	O
SLE	O	NOUN	B
patients	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
whether	O	SCONJ	O
antibodies	B-protein	NOUN	B
to	O	PART	O
T-antigen	B-protein	NOUN	B
,	O	PUNCT	O
DNA	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
to	O	PART	O
TBP	B-protein	NOUN	B
and	O	CCONJ	O
CREB	B-protein	NOUN	B
are	O	AUX	O
linked	O	VERB	O
to	O	ADP	O
such	O	ADJ	O
events	O	NOUN	B
.	O	PUNCT	O


Both	O	CCONJ	O
within	O	ADP	O
and	O	CCONJ	O
among	O	ADP	O
these	O	DET	O
SLE	O	NOUN	B
patients	O	NOUN	B
,	O	PUNCT	O
frequent	O	ADJ	B
polyomavirus	O	NOUN	B
reactivations	O	NOUN	B
were	O	AUX	O
observed	O	VERB	O
that	O	PRON	O
could	O	AUX	O
not	O	PART	O
be	O	AUX	O
explained	O	VERB	O
by	O	ADP	O
certain	O	ADJ	O
rearrangements	O	NOUN	B
of	O	ADP	O
the	O	DET	O
noncoding	O	ADJ	B
control	O	NOUN	I
regions	O	NOUN	I
,	O	PUNCT	O
nor	O	CCONJ	O
by	O	ADP	O
corticosteroid	O	NOUN	B
treatment	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
results	O	NOUN	B
described	O	VERB	O
here	O	ADV	O
indicate	O	VERB	O
that	O	SCONJ	O
cognate	O	ADJ	B
interaction	O	NOUN	B
of	O	ADP	O
B	O	NOUN	B
cells	O	NOUN	I
recognizing	O	VERB	O
DNA	O	NOUN	B
or	O	CCONJ	O
DNA-associated	B-protein	ADJ	B
proteins	I-protein	NOUN	I
and	O	CCONJ	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
recognizing	O	VERB	O
T	B-protein	NOUN	B
antigen	I-protein	NOUN	I
had	O	AUX	O
taken	O	VERB	O
place	O	NOUN	O
as	O	ADP	O
a	O	DET	O
consequence	O	NOUN	B
of	O	ADP	I
complex	O	ADJ	B
formation	O	NOUN	B
between	O	ADP	O
T	B-protein	NOUN	B
ag	I-protein	NOUN	I
and	O	CCONJ	O
DNA	O	NOUN	B
in	O	X	B
vivo	O	X	I
in	O	ADP	O
the	O	DET	O
context	O	NOUN	B
of	O	ADP	O
polyomavirus	O	NOUN	B
reactivations	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
engagement	O	NOUN	B
of	O	ADP	O
CD40	B-protein	NOUN	B
induces	O	VERB	B
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	B
and	O	CCONJ	O
activation	O	NOUN	B
of	O	ADP	O
Jak3	B-protein	NOUN	B
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
of	O	ADP	O
STAT3	B-protein	NOUN	B
.	O	PUNCT	O


Jak3	B-protein	NOUN	B
is	O	AUX	O
constitutively	O	ADV	B
associated	O	VERB	B
with	O	ADP	I
CD40	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
this	O	DET	O
interaction	O	NOUN	B
requires	O	VERB	O
a	O	DET	O
proline-rich	B-protein	ADJ	B
sequence	I-protein	NOUN	I
in	O	ADP	O
the	O	DET	O
membrane-proximal	B-protein	ADJ	B
region	I-protein	NOUN	I
of	O	ADP	O
CD40	B-protein	NOUN	B
.	O	PUNCT	O


Transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
required	O	VERB	O
for	O	ADP	O
lymphoid	O	ADJ	B
lineage	O	NOUN	B
commitment	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
two	O	NUM	O
distinct	O	ADJ	O
IL-4	B-protein	NOUN	B
signaling	O	NOUN	O
pathways	O	NOUN	O
exist	O	VERB	O
.	O	PUNCT	O


HIV-1	B-DNA	NOUN	B
LTR	I-DNA	NOUN	B
transcription	O	NOUN	I
is	O	AUX	O
controlled	O	VERB	B
by	O	ADP	O
a	O	DET	O
complex	O	ADJ	B
array	O	NOUN	O
of	O	ADP	O
virus-encoded	B-protein	ADJ	B
and	I-protein	CCONJ	O
cellular	I-protein	ADJ	B
proteins	I-protein	NOUN	I
.	O	PUNCT	O


Cell-to-cell	O	ADJ	B
contact	O	NOUN	B
activates	O	VERB	B
in	O	X	B
vitro	O	X	I
binding	O	NOUN	B
of	O	ADP	O
the	O	DET	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
kappaB	I-protein	NOUN	I
(	I-protein	PUNCT	O
NF-kappaB	I-protein	NOUN	B
)	I-protein	PUNCT	O
p50/p65	I-protein	NOUN	B
heterodimer	I-protein	NOUN	I
to	O	PART	O
an	O	DET	O
HIV-1	O	NOUN	B
kappaB	O	NOUN	I
oligonucleotide	O	NOUN	I
.	O	PUNCT	O


Both	O	CCONJ	O
IL-4	B-protein	NOUN	B
and	O	CCONJ	O
anti-	O	NOUN	O
CD40	B-protein	NOUN	B
mAb	I-protein	NOUN	B
induced	O	VERB	B
activation	O	NOUN	B
of	O	ADP	O
phosphatidylinositol	B-protein	NOUN	B
3-kinase	I-protein	NOUN	I
(	O	PUNCT	O
PI3-kinase	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
translocation	O	NOUN	B
of	O	ADP	O
a	O	DET	O
zeta	O	NOUN	B
isoform	O	NOUN	I
of	O	ADP	O
protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
C	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
nuclear	O	ADJ	B
expression	O	NOUN	I
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
.	O	PUNCT	O


Activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
NF-kappaB	B-protein	NOUN	B
pathway	O	NOUN	I
by	O	ADP	O
inflammatory	O	ADJ	B
stimuli	O	NOUN	I
in	O	ADP	O
human	B-cell_type	ADJ	B
neutrophils	I-cell_type	NOUN	B
.	O	PUNCT	O


Activated	B-cell_type	VERB	B
neutrophils	I-cell_type	NOUN	B
have	O	AUX	O
the	O	DET	O
ability	O	NOUN	O
to	O	PART	O
upregulate	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
many	O	ADJ	O
genes	O	NOUN	B
,	O	PUNCT	O
in	O	ADP	O
particular	O	ADJ	O
those	O	DET	O
encoding	O	VERB	B
cytokines	B-protein	NOUN	B
and	O	CCONJ	O
chemokines	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
to	O	PART	O
subsequently	O	ADV	O
release	O	VERB	B
the	O	DET	O
corresponding	O	ADJ	O
proteins	O	NOUN	B
.	O	PUNCT	O


To	O	PART	O
delineate	O	VERB	O
the	O	DET	O
regulatory	O	ADJ	B
mechanisms	O	NOUN	B
of	O	ADP	O
human	O	ADJ	B
IL-5	B-protein	NOUN	B
synthesis	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
established	O	VERB	O
allergen-specific	B-cell_line	ADJ	B
CD4+	I-cell_line	ADJ	I
T-cell	I-cell_line	NOUN	I
clones	I-cell_line	NOUN	I
from	O	ADP	O
asthmatic	O	ADJ	B
patients	O	NOUN	B
.	O	PUNCT	O


Human	O	ADJ	B
IL-5	B-protein	NOUN	B
promoter/enhancer-luciferase	O	NOUN	I
gene	O	NOUN	I
construct	O	NOUN	O
transfected	O	VERB	B
to	O	PART	O
T-cell	B-cell_line	NOUN	B
clones	I-cell_line	NOUN	I
was	O	AUX	O
transcribed	O	VERB	B
on	O	ADP	O
either	O	CCONJ	O
TCR	B-protein	NOUN	B
or	O	CCONJ	O
IL-2R	B-protein	NOUN	B
stimulation	O	NOUN	B
and	O	CCONJ	O
was	O	AUX	O
clearly	O	ADV	O
downregulated	O	VERB	B
by	O	ADP	O
dexamethasone	O	NOUN	B
,	O	PUNCT	O
indicating	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
approximately	O	ADV	O
500-bp	B-DNA	ADJ	O
human	I-DNA	ADJ	B
IL-5	I-DNA	NOUN	B
gene	I-DNA	NOUN	I
segment	I-DNA	NOUN	O
located	O	ADJ	O
5	B-DNA	NUM	O
'	I-DNA	PUNCT	O
upstream	I-DNA	ADJ	B
of	O	ADP	O
the	O	DET	O
coding	O	VERB	B
region	O	NOUN	I
contains	O	VERB	O
activation-inducible	B-DNA	ADJ	B
enhancer	I-DNA	NOUN	I
elements	I-DNA	NOUN	I
responsible	O	ADJ	O
for	O	ADP	O
the	O	DET	O
regulation	O	NOUN	B
by	O	ADP	O
GC	O	NOUN	B
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	B
showing	O	VERB	O
that	O	SCONJ	O
GC	O	NOUN	B
suppressed	O	VERB	B
IL-5	B-protein	NOUN	B
production	O	NOUN	O
by	O	ADP	O
human	B-cell_type	ADJ	B
CD4+	I-cell_type	ADJ	B
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
activated	O	VERB	B
by	O	ADP	O
two	O	NUM	O
distinct	O	ADJ	O
stimuli	O	NOUN	B
,	O	PUNCT	O
TCR	B-protein	NOUN	B
and	O	CCONJ	O
IL-2R	B-protein	NOUN	B
stimulation	O	NOUN	B
,	O	PUNCT	O
underscore	O	VERB	O
the	O	DET	O
efficacy	O	NOUN	B
of	O	ADP	O
GC	O	NOUN	B
in	O	ADP	O
the	O	DET	O
treatment	O	NOUN	B
of	O	ADP	O
allergic	O	ADJ	B
diseases	O	NOUN	I
via	O	ADP	O
suppression	O	NOUN	B
of	O	ADP	O
T-cell	O	NOUN	B
IL-5	B-protein	NOUN	B
synthesis	O	NOUN	I
.	O	PUNCT	O


Itk	B-protein	NOUN	B
,	O	PUNCT	O
a	O	DET	O
T	B-protein	NOUN	B
cell-specific	I-protein	ADJ	O
tyrosine	I-protein	NOUN	O
kinase	I-protein	NOUN	O
,	O	PUNCT	O
is	O	AUX	O
required	O	VERB	O
for	O	ADP	O
CD2-mediated	B-DNA	ADJ	B
interleukin-2	I-DNA	NOUN	I
promoter	I-DNA	NOUN	B
activation	O	NOUN	I
in	O	ADP	O
the	O	DET	O
human	B-cell_line	ADJ	B
T	I-cell_line	NOUN	O
cell	I-cell_line	NOUN	O
line	I-cell_line	NOUN	O
Jurkat	I-cell_line	NOUN	O
.	O	PUNCT	O


Stimulation	O	NOUN	B
of	O	ADP	O
CD2	B-protein	NOUN	B
or	O	CCONJ	O
TCR/CD3	B-protein	NOUN	B
induced	O	VERB	B
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
of	I-protein	ADP	O
activated	I-protein	VERB	B
T	I-protein	NOUN	O
cells	I-protein	NOUN	O
(	O	PUNCT	O
NFAT	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
the	O	DET	O
binding	B-DNA	VERB	B
site	I-DNA	NOUN	I
of	O	ADP	O
which	O	DET	O
is	O	AUX	O
included	O	VERB	O
in	O	ADP	O
the	O	DET	O
IL-2	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
promoter	I-DNA	NOUN	B
.	O	PUNCT	O


Therefore	O	ADV	O
we	O	PRON	O
studied	O	VERB	O
the	O	DET	O
expression	O	NOUN	B
pattern	O	NOUN	O
of	O	ADP	O
LAZ3/BCL6	B-protein	NOUN	B
by	O	ADP	O
in	O	X	B
situ	O	X	I
hybridization	O	NOUN	I
with	O	ADP	O
synthetic	O	ADJ	B
oligonucleotide	O	NOUN	I
probes	O	NOUN	I
in	O	ADP	O
frozen	O	ADJ	B
tissue	O	NOUN	I
sections	O	NOUN	I
from	O	ADP	O
five	O	NUM	O
reactive	O	ADJ	B
lymph	O	NOUN	I
nodes	O	NOUN	I
and	O	CCONJ	O
38	O	NUM	O
B	O	NOUN	B
cell	O	NOUN	I
and	O	CCONJ	O
non-B	O	ADJ	B
NHL	O	NOUN	I
.	O	PUNCT	O


Oxidants	O	NOUN	B
such	O	ADJ	O
as	O	ADP	O
hydrogen	O	NOUN	B
peroxide	O	NOUN	I
are	O	AUX	O
known	O	VERB	O
to	O	PART	O
activate	O	VERB	B
certain	O	ADJ	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
such	O	ADJ	O
as	O	ADP	O
nuclear	B-protein	ADJ	B
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
kappa	I-protein	NOUN	I
beta	I-protein	NOUN	I
.	O	PUNCT	O


Based	O	VERB	O
upon	O	SCONJ	O
work	O	NOUN	O
from	O	ADP	O
our	O	PRON	O
laboratory	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
propose	O	VERB	O
that	O	SCONJ	O
inhibition	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activation	O	NOUN	B
produces	O	VERB	O
significant	O	ADJ	O
anti	O	ADJ	B
inflammatory	O	ADJ	I
activity	O	NOUN	I
which	O	DET	O
may	O	AUX	O
be	O	AUX	O
mediated	O	VERB	O
by	O	ADP	O
the	O	DET	O
inhibition	O	NOUN	B
of	O	ADP	O
transcription	O	NOUN	B
of	O	ADP	O
certain	O	ADJ	O
pro-inflammatory	B-protein	ADJ	B
mediators	I-protein	NOUN	O
and	O	CCONJ	O
adhesion	B-protein	NOUN	B
molecules	I-protein	NOUN	I
.	O	PUNCT	O


or	O	CCONJ	O
intranasally	O	ADV	B
with	O	ADP	O
wild-type	O	ADJ	B
Ad	O	NOUN	B
or	O	CCONJ	O
an	O	DET	O
Ad	O	NOUN	B
vector	O	NOUN	I
lacking	O	VERB	B
most	O	ADJ	O
of	O	ADP	O
the	O	DET	O
E1	B-DNA	NOUN	B
region	I-DNA	NOUN	I
,	O	PUNCT	O
subdominant	O	ADJ	B
epitopes	O	NOUN	I
outside	O	ADP	O
this	O	DET	O
region	O	NOUN	B
were	O	AUX	O
recognized	O	VERB	O
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
C3H	O	NOUN	B
mice	O	NOUN	I
inoculated	O	VERB	B
with	O	ADP	O
wild-type	O	ADJ	B
Ad	O	NOUN	B
recognized	O	VERB	O
an	O	DET	O
epitope	O	NOUN	B
mapping	O	NOUN	I
within	O	ADP	O
E1B	B-DNA	NOUN	B
.	O	PUNCT	O
When	O	SCONJ	O
inoculated	O	VERB	B
twice	O	ADV	O
with	O	ADP	O
Ad	O	NOUN	B
vectors	O	NOUN	I
lacking	O	VERB	B
both	O	CCONJ	O
E1A	B-DNA	NOUN	B
and	O	CCONJ	O
E1B	B-DNA	NOUN	B
,	O	PUNCT	O
no	O	DET	O
immunorecessive	B-protein	ADJ	B
epitopes	I-protein	NOUN	I
were	O	AUX	O
recognized	O	VERB	O
.	O	PUNCT	O


CTLs	B-cell_type	NOUN	B
from	O	ADP	O
BALB/c	O	NOUN	B
mice	O	NOUN	I
inoculated	O	VERB	B
i.p.	O	ADV	B
with	O	ADP	O
wild-type	O	ADJ	B
Ad	O	NOUN	B
recognized	O	VERB	O
E1B	B-DNA	NOUN	B
in	O	ADP	O
the	O	DET	O
context	O	NOUN	B
of	O	ADP	O
the	O	DET	O
major	B-DNA	ADJ	B
histocompatibility	I-DNA	NOUN	I
complex	I-DNA	NOUN	I
(	I-DNA	PUNCT	O
MHC	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
class	I-DNA	NOUN	B
I	I-DNA	NUM	I
Dd	I-DNA	NOUN	B
allele	I-DNA	NOUN	I
and	O	CCONJ	O
a	O	DET	O
region	O	NOUN	B
outside	O	ADP	O
E1	B-DNA	NOUN	B
associated	O	VERB	B
with	O	ADP	I
the	O	DET	O
Kd	B-DNA	NOUN	B
allele	I-DNA	NOUN	I
.	O	PUNCT	O


When	O	SCONJ	O
BALB/c	O	NOUN	B
mice	O	NOUN	I
were	O	AUX	O
inoculated	O	VERB	B
with	O	ADP	O
E1	B-DNA	NOUN	B
-deleted	O	ADJ	O
Ad	O	NOUN	B
vectors	O	NOUN	I
,	O	PUNCT	O
only	O	ADV	O
the	O	DET	O
immunodominant	B-protein	ADJ	B
Kd-restricted	I-protein	ADJ	B
epitope	I-protein	NOUN	I
was	O	AUX	O
recognized	O	VERB	O
,	O	PUNCT	O
and	O	CCONJ	O
Dd-restricted	O	ADJ	B
CTLs	B-cell_type	NOUN	I
did	O	AUX	O
not	O	PART	O
develop	O	VERB	O
.	O	PUNCT	O


Putative	O	ADJ	B
cis-acting	B-DNA	ADJ	I
control	I-DNA	NOUN	I
elements	I-DNA	NOUN	I
present	O	ADJ	O
within	O	ADP	O
a	O	DET	O
300-bp	B-DNA	ADJ	B
core	I-DNA	NOUN	I
promoter	I-DNA	NOUN	I
included	O	VERB	O
two	O	NUM	O
ets	B-DNA	NOUN	B
sites	I-DNA	NOUN	I
,	O	PUNCT	O
an	O	DET	O
Sp1	B-DNA	NOUN	B
site	I-DNA	NOUN	B
,	O	PUNCT	O
tandem	O	ADJ	B
E-box	B-DNA	NOUN	I
domains	I-DNA	NOUN	I
,	O	PUNCT	O
two	O	NUM	O
GATA-associated	B-DNA	ADJ	B
sites	I-DNA	NOUN	I
(	O	PUNCT	O
CACCC	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
an	O	DET	O
AP-2	B-DNA	NOUN	B
binding	I-DNA	NOUN	I
site	I-DNA	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
GATA	B-DNA	NOUN	B
element	I-DNA	NOUN	O
at	O	ADP	O
-24	B-DNA	NUM	O
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
identified	O	VERB	O
a	O	DET	O
negative	B-DNA	ADJ	B
regulatory	I-DNA	ADJ	B
element	I-DNA	NOUN	I
located	O	ADJ	O
in	O	ADP	O
the	O	DET	O
region	O	NOUN	B
between	O	ADP	O
-685	B-DNA	NUM	O
and	I-DNA	CCONJ	O
-395	I-DNA	NUM	O
.	O	PUNCT	O


This	O	DET	O
is	O	AUX	O
the	O	DET	O
first	O	ADJ	O
description	O	NOUN	B
of	O	ADP	O
a	O	DET	O
negative	B-DNA	ADJ	B
regulatory	I-DNA	ADJ	B
region	I-DNA	NOUN	I
responsive	O	ADJ	O
to	O	PART	O
glucocorticoids	O	NOUN	B
in	O	ADP	O
a	O	DET	O
cytokine	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
.	O	PUNCT	O


One	O	NUM	O
of	O	ADP	O
these	O	DET	O
subregions	O	NOUN	B
,	O	PUNCT	O
NRE	B-DNA	NOUN	B
gamma	I-DNA	NOUN	O
,	O	PUNCT	O
is	O	AUX	O
active	O	ADJ	B
in	O	ADP	O
both	O	CCONJ	O
HeLa	B-cell_line	NOUN	B
cervical	I-cell_line	ADJ	B
carcinoma	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	O
and	O	CCONJ	O
Huh7	B-cell_line	NOUN	B
hepatoma	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
and	O	CCONJ	O
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
be	O	AUX	O
bound	O	VERB	B
by	O	ADP	O
a	O	DET	O
protein	O	NOUN	B
factor	O	NOUN	I
present	O	ADJ	O
in	O	ADP	O
both	O	DET	O
cell	O	NOUN	B
types	O	NOUN	I
.	O	PUNCT	O


Clinical	O	ADJ	B
CR	O	NOUN	O
was	O	AUX	O
achieved	O	VERB	O
in	O	ADP	O
nine	O	NUM	O
of	O	ADP	O
10	O	NUM	O
(	O	PUNCT	O
90	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
patients	O	NOUN	B
treated	O	VERB	B
with	O	ADP	I
As2O3	O	NOUN	B
alone	O	ADV	O
and	O	CCONJ	O
in	O	ADP	O
the	O	DET	O
remaining	O	VERB	O
five	O	NUM	O
patients	O	NOUN	B
treated	O	VERB	B
by	O	ADP	O
the	O	DET	O
combination	O	NOUN	B
of	O	ADP	O
As2O3	O	NOUN	B
and	O	CCONJ	O
low-dose	O	ADJ	B
chemotherapeutic	O	ADJ	B
drugs	O	NOUN	I
or	O	CCONJ	O
ATRA	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
increased	O	VERB	B
amounts	O	NOUN	O
of	O	ADP	O
arsenic	O	NOUN	B
appeared	O	VERB	O
in	O	ADP	O
the	O	DET	O
urine	O	NOUN	B
,	O	PUNCT	O
with	O	ADP	O
a	O	DET	O
daily	O	ADJ	B
excretion	O	NOUN	B
accounting	O	VERB	O
for	O	ADP	O
approximately	O	ADV	B
1	O	NUM	O
%	O	NOUN	O
to	O	PART	O
8	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
the	O	DET	O
total	O	ADJ	O
daily	O	ADJ	O
dose	O	NOUN	O
administered	O	VERB	B
.	O	PUNCT	O


This	O	DET	O
identification	O	NOUN	B
,	O	PUNCT	O
initially	O	ADV	B
made	O	VERB	O
by	O	ADP	O
microsequence	O	NOUN	B
analysis	O	NOUN	I
,	O	PUNCT	O
was	O	AUX	O
verified	O	VERB	O
by	O	ADP	O
showing	O	VERB	O
that	O	SCONJ	O
(	O	PUNCT	O
i	O	X	O
)	O	PUNCT	O
LR1	B-protein	NOUN	B
-DNA	O	NOUN	O
binding	O	NOUN	B
activity	O	NOUN	I
increased	O	VERB	B
in	O	ADP	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
transfected	O	VERB	B
with	O	ADP	O
a	O	DET	O
nucleolin	B-DNA	NOUN	B
cDNA	I-DNA	NOUN	B
expression	I-DNA	NOUN	B
construct	I-DNA	NOUN	I
;	O	PUNCT	O
(	O	PUNCT	O
ii	O	X	O
)	O	PUNCT	O
LR1	B-protein	NOUN	B
-DNA	O	NOUN	O
binding	O	NOUN	B
activity	O	NOUN	I
was	O	AUX	O
recognized	O	VERB	O
by	O	ADP	O
antibodies	O	NOUN	B
raised	O	VERB	O
against	O	ADP	O
recombinant	B-protein	ADJ	B
human	I-protein	ADJ	B
nucleolin	I-protein	NOUN	B
;	O	PUNCT	O
and	O	CCONJ	O
(	O	PUNCT	O
iii	O	X	O
)	O	PUNCT	O
in	O	ADP	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
transfected	O	VERB	B
with	O	ADP	O
epitope-tagged	B-DNA	ADJ	B
nucleolin	I-DNA	NOUN	B
expression	I-DNA	NOUN	O
constructs	I-DNA	NOUN	O
,	O	PUNCT	O
the	O	DET	O
LR1-DNA	B-protein	NOUN	B
complex	I-protein	NOUN	I
was	O	AUX	O
recognized	O	VERB	O
by	O	ADP	O
the	O	DET	O
anti-tag	B-protein	ADJ	B
antibody	I-protein	NOUN	I
.	O	PUNCT	O


Glucocorticoid-resistance	O	NOUN	B
in	O	ADP	O
peripheral-blood	B-cell_type	ADJ	B
lymphocytes	I-cell_type	NOUN	I
does	O	AUX	O
not	O	PART	O
correlate	O	VERB	O
with	O	ADP	O
number	O	NOUN	O
of	O	ADP	O
affinity	O	NOUN	B
of	O	ADP	O
glucocorticoid-receptors	B-protein	NOUN	B
in	O	ADP	O
chronic	O	ADJ	B
renal	O	ADJ	I
failure	O	NOUN	I
patients	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
healthy	O	ADJ	B
subjects	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
mean	O	ADJ	O
GC-R	B-protein	NOUN	B
Bmax	O	NOUN	I
and	O	CCONJ	O
Kd	O	NOUN	B
in	O	ADP	O
quiescent	O	ADJ	B
PBMC	B-cell_type	NOUN	B
of	O	ADP	O
the	O	DET	O
GC-sensitive	O	ADJ	B
group	O	NOUN	B
were	O	AUX	O
2.89	O	NUM	O
+/-	O	CCONJ	O
1.23	O	NUM	O
fmol/10	O	NOUN	O
(	O	PUNCT	O
6	O	NUM	O
)	O	PUNCT	O
cells	O	NOUN	B
and	O	CCONJ	O
4.00	O	NUM	O
+/-	O	CCONJ	O
2.24	O	NUM	O
nM	O	NOUN	O
,	O	PUNCT	O
respectively	O	ADV	O
.	O	PUNCT	O


We	O	PRON	O
demonstrated	O	VERB	O
that	O	SCONJ	O
constitutive	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
NF-kappaB	B-protein	NOUN	B
in	O	ADP	O
primary	B-cell_type	ADJ	O
human	I-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
changed	O	VERB	O
significantly	O	ADV	B
with	O	ADP	I
differentiation	O	NOUN	B
in	O	X	B
vitro	O	X	I
to	O	PART	O
monocyte-derived	B-cell_type	ADJ	B
macrophages	I-cell_type	NOUN	I
(	O	PUNCT	O
MDMs	B-cell_type	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
differentiation	O	NOUN	B
in	O	X	B
vivo	O	X	I
to	O	PART	O
alveolar	B-cell_type	ADJ	B
macrophages	I-cell_type	NOUN	I
(	O	PUNCT	O
AMs	B-cell_type	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


As	O	ADP	O
in	O	ADP	O
MDMs	B-cell_type	NOUN	B
,	O	PUNCT	O
AMs	B-cell_type	NOUN	B
constitutively	O	ADV	B
expressed	O	VERB	B
p50/p65	B-protein	NOUN	B
and	O	CCONJ	O
p50/RelB	B-protein	NOUN	B
although	O	SCONJ	O
at	O	ADP	O
lower	O	ADJ	O
levels	O	NOUN	B
.	O	PUNCT	O


Ascorbic	O	NOUN	B
acid	O	NOUN	I
(	O	PUNCT	O
ascorbate	O	NOUN	B
or	O	CCONJ	O
vitamin	O	NOUN	B
C	O	NOUN	I
)	O	PUNCT	O
has	O	AUX	O
been	O	AUX	O
shown	O	VERB	O
to	O	PART	O
suppress	O	VERB	B
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
HIV	O	NOUN	B
in	O	ADP	O
latently	B-cell_type	ADV	B
infected	I-cell_type	ADJ	I
T	I-cell_type	NOUN	B
lymphocytic	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
following	O	VERB	O
stimulation	O	NOUN	B
with	O	ADP	O
a	O	DET	O
tumor	O	NOUN	B
promoter	O	NOUN	I
(	O	PUNCT	O
PMA	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
inflammatory	B-protein	ADJ	B
cytokine	I-protein	NOUN	I
(	O	PUNCT	O
TNF-alpha	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Pretreatment	O	NOUN	B
of	O	ADP	O
ACH-2	B-cell_line	NOUN	B
T	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
by	O	ADP	O
NAC	O	NOUN	B
followed	O	VERB	O
by	O	ADP	O
stimulation	O	NOUN	B
with	O	ADP	O
PMA	O	NOUN	B
,	O	PUNCT	O
TNF-alpha	B-protein	NOUN	B
,	O	PUNCT	O
or	O	CCONJ	O
hydrogen	O	NOUN	B
peroxide	O	NOUN	I
(	O	PUNCT	O
H2O2	O	NOUN	B
)	O	PUNCT	O
resulted	O	VERB	O
in	O	ADP	O
strong	O	ADJ	O
suppression	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activation	O	NOUN	B
.	O	PUNCT	O


One	O	NUM	O
of	O	ADP	O
these	O	DET	O
NFAT-like	B-DNA	ADJ	B
elements	I-DNA	NOUN	I
encompassed	O	VERB	O
overlapping	O	VERB	O
Oct-	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
NFATp/c-binding	I-DNA	NOUN	B
sites	I-DNA	NOUN	I
,	O	PUNCT	O
which	O	DET	O
functioned	O	VERB	O
in	O	ADP	O
a	O	DET	O
highly	O	ADV	O
synergistic	O	ADJ	B
manner	O	NOUN	O
.	O	PUNCT	O


Early	O	ADJ	B
viral	O	ADJ	B
RNA	O	NOUN	I
splicing	O	NOUN	O
patterns	O	NOUN	O
also	O	ADV	O
differ	O	VERB	O
between	O	ADP	O
wild-type	B-cell_line	ADJ	B
and	I-cell_line	CCONJ	O
dl337-infected	I-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


TCC	B-protein	NOUN	B
also	O	ADV	O
stimulate	O	VERB	B
a	O	DET	O
variety	O	NOUN	O
of	O	ADP	O
cellular	O	ADJ	B
activities	O	NOUN	I
,	O	PUNCT	O
which	O	DET	O
include	O	VERB	O
cytokine	B-protein	NOUN	B
synthesis	O	NOUN	I
,	O	PUNCT	O
proto-oncogene	B-DNA	NOUN	B
activation	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
mitotic	O	ADJ	B
signaling	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
observations	O	NOUN	B
imply	O	VERB	O
that	O	SCONJ	O
during	O	ADP	O
persistent	O	ADJ	B
infection	O	NOUN	O
Ad5	O	NOUN	B
underwent	O	VERB	O
spontaneous	O	ADJ	B
mutations	O	NOUN	B
by	O	ADP	O
sequence-specific	O	ADJ	B
breakage	O	NOUN	I
and	O	CCONJ	O
nonhomologous	O	ADJ	O
end-end	O	ADJ	O
joining	O	NOUN	O
recombination	O	NOUN	O
events	O	NOUN	O
.	O	PUNCT	O


These	O	DET	O
E1a	O	NOUN	B
reiteration	O	NOUN	I
mutants	O	NOUN	B
could	O	AUX	O
be	O	AUX	O
propagated	O	VERB	O
in	O	ADP	O
HeLa	B-cell_line	NOUN	B
,	O	PUNCT	O
A549	B-cell_line	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
KB	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
;	O	PUNCT	O
they	O	PRON	O
were	O	AUX	O
genetically	O	ADV	B
stable	O	ADJ	I
;	O	PUNCT	O
and	O	CCONJ	O
they	O	PRON	O
killed	O	VERB	B
CREF	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
at	O	ADP	O
a	O	DET	O
strikingly	O	ADV	O
high	O	ADJ	O
frequency	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
observed	O	VERB	O
E1a	B-DNA	NOUN	B
reiterations	I-DNA	NOUN	O
provide	O	VERB	O
a	O	DET	O
model	O	NOUN	B
to	O	PART	O
gain	O	VERB	O
insight	O	NOUN	O
into	O	ADP	O
understanding	O	VERB	O
the	O	DET	O
evolutionary	O	ADJ	B
events	O	NOUN	I
of	O	ADP	O
some	O	DET	O
,	O	PUNCT	O
if	O	SCONJ	O
not	O	PART	O
all	O	DET	O
,	O	PUNCT	O
adenovirus	O	NOUN	B
types	O	NOUN	O
during	O	ADP	O
many	O	ADJ	O
years	O	NOUN	B
of	O	ADP	O
symbiotic	O	ADJ	B
,	O	PUNCT	O
persistent	O	ADJ	B
relationship	O	NOUN	B
in	O	ADP	O
human	O	ADJ	B
tonsils	O	NOUN	B
and	O	CCONJ	O
adenoids	O	NOUN	B
and	O	CCONJ	O
possibly	O	ADV	O
other	O	ADJ	O
lymphoid	O	ADJ	B
organs	O	NOUN	I
.	O	PUNCT	O


Binding	O	NOUN	B
of	O	ADP	O
viral	O	ADJ	B
peptide	O	NOUN	I
to	O	PART	O
cell	O	NOUN	B
lines	O	NOUN	I
bearing	O	VERB	O
DQA1*0201	B-protein	NOUN	B
,	O	PUNCT	O
in	O	ADP	O
comparison	O	NOUN	B
to	O	PART	O
DQA1*0501	B-protein	NOUN	B
,	O	PUNCT	O
was	O	AUX	O
only	O	ADV	O
moderately	O	ADV	O
reduced	O	VERB	B
and	O	CCONJ	O
may	O	AUX	O
not	O	PART	O
explain	O	VERB	O
this	O	DET	O
effect	O	NOUN	B
.	O	PUNCT	O


Here	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
demonstrate	O	VERB	O
a	O	DET	O
novel	O	ADJ	O
role	O	NOUN	O
for	O	ADP	O
IK	B-protein	NOUN	B
in	O	ADP	O
MHC	B-protein	NOUN	B
class	I-protein	NOUN	I
II	I-protein	NUM	I
expression	O	NOUN	B
since	O	SCONJ	O
over-expression	O	NOUN	B
of	O	ADP	O
this	O	DET	O
protein	O	NOUN	B
by	O	ADP	O
stable	O	ADJ	O
transfection	O	NOUN	B
into	O	ADP	O
human	O	ADJ	B
B	O	NOUN	O
cells	O	NOUN	O
led	O	VERB	O
to	O	PART	O
a	O	DET	O
total	O	ADJ	O
disappearance	O	NOUN	B
of	O	ADP	O
constitutive	O	ADJ	B
MHC	B-RNA	NOUN	B
class	I-RNA	NOUN	I
II	I-RNA	NUM	I
mRNA	I-RNA	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
hypothesis	O	NOUN	B
that	O	SCONJ	O
the	O	DET	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
of	I-protein	ADP	O
activated	I-protein	VERB	B
T	I-protein	NOUN	O
cells	I-protein	NOUN	O
(	O	PUNCT	O
NF-AT	B-protein	NOUN	B
)	O	PUNCT	O
may	O	AUX	O
influence	O	VERB	B
HIV-1	O	NOUN	B
replication	O	NOUN	B
is	O	AUX	O
therefore	O	ADV	O
compelling	O	ADJ	O
given	O	VERB	O
the	O	DET	O
tight	O	ADJ	B
correlation	O	NOUN	I
of	O	ADP	O
HIV-1	O	NOUN	B
transcriptional	O	ADJ	B
induction	O	NOUN	B
to	O	PART	O
T	O	NOUN	B
cell	O	NOUN	I
activation	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
link	O	VERB	O
regulatory	B-protein	ADJ	B
factors	I-protein	NOUN	I
critical	O	ADJ	O
to	O	PART	O
T	O	NOUN	B
cell	O	NOUN	I
commitment	O	NOUN	O
directly	O	ADV	O
to	O	PART	O
HIV-1	O	NOUN	B
replication	O	NOUN	B
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
have	O	AUX	O
used	O	VERB	O
reporter	O	NOUN	B
transgenic	O	ADJ	I
mice	O	NOUN	I
to	O	PART	O
show	O	VERB	O
that	O	SCONJ	O
DNA	O	NOUN	B
binding	O	NOUN	I
and	O	CCONJ	O
transcriptional	O	ADJ	B
activities	O	NOUN	I
of	O	ADP	O
NFAT	B-protein	NOUN	B
are	O	AUX	O
transiently	O	ADV	O
induced	O	VERB	B
during	O	ADP	O
the	O	DET	O
differentiation	O	NOUN	B
of	O	ADP	O
pTh	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
into	O	ADP	O
either	O	CCONJ	O
eTh1	B-cell_type	NOUN	B
or	O	CCONJ	O
eTh2	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
to	O	PART	O
mediate	O	VERB	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
IL-2	B-protein	NOUN	B
as	O	ADP	O
a	O	DET	O
common	O	ADJ	O
growth	O	NOUN	B
factor	O	NOUN	I
in	O	ADP	O
both	O	DET	O
pathways	O	NOUN	B
.	O	PUNCT	O


During	O	ADP	O
the	O	DET	O
course	O	NOUN	B
of	O	ADP	O
serious	O	ADJ	O
bacterial	O	ADJ	B
infections	O	NOUN	I
,	O	PUNCT	O
lipopolysaccharide	O	NOUN	B
(	O	PUNCT	O
LPS	O	NOUN	B
)	O	PUNCT	O
interacts	O	VERB	O
with	O	ADP	O
monocyte/macrophage	B-protein	NOUN	B
receptors	I-protein	NOUN	I
,	O	PUNCT	O
resulting	O	VERB	O
in	O	ADP	O
the	O	DET	O
generation	O	NOUN	B
of	O	ADP	O
inflammatory	B-protein	ADJ	B
cytokines	I-protein	NOUN	O
.	O	PUNCT	O


No	O	DET	O
degradation	O	NOUN	B
of	O	ADP	O
p105	B-protein	NOUN	B
and	I-protein	CCONJ	O
p100	I-protein	NOUN	B
inhibitors	I-protein	NOUN	B
was	O	AUX	O
observed	O	VERB	O
under	O	ADP	O
these	O	DET	O
conditions	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
transduction	O	NOUN	B
pathway	O	NOUN	B
leading	O	VERB	O
to	O	PART	O
NF-kappaB	B-protein	NOUN	B
activation	O	NOUN	B
in	O	ADP	O
U937	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
involved	O	VERB	O
the	O	DET	O
intracellular	O	ADJ	B
generation	O	NOUN	B
of	O	ADP	O
reactive	O	ADJ	B
oxygen	O	NOUN	I
species	O	NOUN	I
(	O	PUNCT	O
ROS	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
as	O	ADP	O
demonstrated	O	VERB	O
by	O	ADP	O
the	O	DET	O
concomitant	O	ADJ	B
inhibitory	O	ADJ	B
effects	O	NOUN	O
of	O	ADP	O
antioxidants	O	NOUN	B
on	O	ADP	O
NF-kappaB	B-protein	NOUN	B
activation	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
emission	O	NOUN	B
of	O	ADP	O
a	O	DET	O
fluorescent	O	ADJ	B
probe	O	NOUN	I
reacting	O	VERB	O
intracellularly	O	ADV	B
with	O	ADP	O
hydrogen	O	NOUN	B
peroxide	O	NOUN	I
.	O	PUNCT	O


c-Rel	B-protein	NOUN	B
is	O	AUX	O
a	O	DET	O
target	O	NOUN	B
of	O	ADP	O
pentoxifylline-mediated	O	ADJ	B
inhibition	O	NOUN	I
of	O	ADP	O
T	O	NOUN	B
lymphocyte	O	NOUN	I
activation	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
found	O	VERB	O
that	O	SCONJ	O
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
anti-CD3-induced	O	ADJ	B
c-Rel	B-protein	NOUN	B
expression	O	NOUN	B
was	O	AUX	O
blocked	O	VERB	B
by	O	ADP	O
PF	O	NOUN	B
,	O	PUNCT	O
whereas	O	SCONJ	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
other	O	ADJ	O
NF-kappaB	B-protein	NOUN	B
family	I-protein	NOUN	O
members	I-protein	NOUN	O
was	O	AUX	O
not	O	PART	O
significantly	O	ADV	O
affected	O	VERB	B
.	O	PUNCT	O


A	O	DET	O
negative	O	ADJ	B
role	O	NOUN	O
for	O	ADP	O
phosphoinositide	B-protein	NOUN	B
3-kinase	I-protein	NOUN	I
in	O	ADP	O
T-cell	B-protein	NOUN	B
antigen	I-protein	NOUN	I
receptor	I-protein	NOUN	I
function	O	NOUN	I
.	O	PUNCT	O


Phosphoinositide	B-protein	NOUN	B
3-kinase	I-protein	NOUN	I
(	O	PUNCT	O
PI	B-protein	NOUN	B
3-kinase	I-protein	NOUN	I
)	O	PUNCT	O
is	O	AUX	O
activated	O	VERB	B
by	O	ADP	O
a	O	DET	O
diverse	O	ADJ	B
set	O	NOUN	O
of	O	ADP	O
receptors	O	NOUN	B
that	O	PRON	O
determine	O	VERB	O
T-cell	O	NOUN	B
function	O	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
the	O	DET	O
T-cell	B-protein	NOUN	B
antigen	I-protein	NOUN	I
receptor	I-protein	NOUN	I
(	O	PUNCT	O
TCR	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
the	O	DET	O
costimulatory	B-protein	ADJ	B
receptor	I-protein	NOUN	I
CD28	I-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
negative	B-protein	ADJ	B
regulators	I-protein	NOUN	B
of	O	ADP	O
T-cell	O	NOUN	B
activation	O	NOUN	I
such	O	ADJ	O
as	O	ADP	O
CTLA-4	B-protein	NOUN	B
.	O	PUNCT	O


CONCLUSIONS	O	NOUN	O
:	O	PUNCT	O
Our	O	PRON	O
results	O	NOUN	B
establish	O	VERB	O
that	O	SCONJ	O
PI	B-protein	NOUN	B
3-kinase	I-protein	NOUN	I
can	O	AUX	O
both	O	CCONJ	O
positively	O	ADV	B
and	O	CCONJ	O
negatively	O	ADV	O
regulate	O	VERB	O
T-cell	O	NOUN	B
function	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
uncover	O	VERB	O
a	O	DET	O
previously	O	ADV	O
unrecognized	O	ADJ	B
function	O	NOUN	B
for	O	ADP	O
PI	B-protein	NOUN	B
3-kinase	I-protein	NOUN	I
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
as	O	ADP	O
a	O	DET	O
selective	O	ADJ	O
negative	O	ADJ	O
regulator	O	NOUN	O
of	O	ADP	O
TCR	B-protein	NOUN	B
-signalling	O	ADJ	O
events	O	NOUN	B
and	O	CCONJ	O
therefore	O	ADV	O
as	O	ADP	O
a	O	DET	O
determinant	O	NOUN	O
of	O	ADP	O
T-cell	O	NOUN	B
homeostasis	O	NOUN	B
.	O	PUNCT	O


Isoforms	O	NOUN	B
Pax-5d	O	NOUN	B
and	O	CCONJ	O
Pax-5e	B-protein	NOUN	B
have	O	AUX	O
deleted	O	VERB	O
the	O	DET	O
3'-region	B-protein	NOUN	B
,	O	PUNCT	O
which	O	DET	O
encodes	O	VERB	B
the	O	DET	O
transactivating	O	VERB	B
domain	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
replaced	O	VERB	O
it	O	PRON	O
with	O	ADP	O
a	O	DET	O
novel	O	ADJ	O
sequence	O	NOUN	B
.	O	PUNCT	O


Using	O	VERB	O
this	O	DET	O
assay	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
also	O	ADV	O
showed	O	VERB	O
that	O	SCONJ	O
Pax-5d	B-protein	NOUN	B
was	O	AUX	O
present	O	ADJ	O
in	O	ADP	O
nuclear	O	ADJ	B
extracts	O	NOUN	I
of	O	ADP	O
some	O	DET	O
(	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
all	O	DET	O
)	O	PUNCT	O
B-lymphoid	B-cell_line	ADJ	B
lines	I-cell_line	NOUN	I
and	O	CCONJ	O
interacts	O	VERB	O
with	O	ADP	O
the	O	DET	O
B-cell-specific	B-DNA	ADJ	B
activator	I-DNA	NOUN	I
protein-binding	I-DNA	ADJ	O
site	I-DNA	NOUN	O
.	O	PUNCT	O


Reconstitution	O	NOUN	B
of	O	ADP	O
T	O	NOUN	B
cell	O	NOUN	I
antigen	O	NOUN	I
receptor-induced	O	ADJ	B
Erk2	B-protein	NOUN	I
kinase	I-protein	NOUN	I
activation	O	NOUN	I
in	O	ADP	O
Lck-negative	B-cell_line	ADJ	B
JCaM1	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
by	O	ADP	O
Syk	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
two	O	NUM	O
related	O	ADJ	O
protein-tyrosine	B-protein	ADJ	B
kinases	I-protein	NOUN	I
Syk	B-protein	NOUN	B
and	O	CCONJ	O
Zap	B-protein	NOUN	B
are	O	AUX	O
rapidly	O	ADV	O
phosphorylated	O	VERB	B
on	O	ADP	O
tyrosine	O	NOUN	B
residues	O	NOUN	I
and	O	CCONJ	O
enzymatically	O	ADV	B
activated	O	VERB	I
upon	O	SCONJ	O
crosslinking	O	NOUN	B
of	O	ADP	O
the	O	DET	O
T	B-protein	NOUN	B
cell	I-protein	NOUN	I
antigen	I-protein	NOUN	I
receptor	I-protein	NOUN	I
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
report	O	VERB	O
that	O	SCONJ	O
overexpression	O	NOUN	B
of	O	ADP	O
Syk	B-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
Lck-negative	B-cell_line	ADJ	B
JCaM1	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
enabled	O	VERB	O
the	O	DET	O
T	B-protein	NOUN	B
cell	I-protein	NOUN	I
antigen	I-protein	NOUN	I
receptor/CD3	I-protein	NOUN	O
complex	I-protein	NOUN	O
to	O	PART	O
induce	O	VERB	B
a	O	DET	O
normal	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
mitogen-activated	B-protein	ADJ	B
protein	I-protein	NOUN	I
kinase	I-protein	NOUN	I
(	O	PUNCT	O
MAPK	B-protein	NOUN	O
)	O	PUNCT	O
pathway	O	NOUN	O
and	O	CCONJ	O
expression	O	NOUN	B
of	O	ADP	O
a	O	DET	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
of	I-protein	ADP	O
activated	I-protein	VERB	B
T	I-protein	NOUN	O
cells	I-protein	NOUN	O
reporter	O	NOUN	O
construct	O	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
parallel	O	NOUN	O
,	O	PUNCT	O
Syk	B-protein	NOUN	B
was	O	AUX	O
phosphorylated	O	VERB	B
on	O	ADP	O
tyrosine	O	NOUN	B
,	O	PUNCT	O
while	O	SCONJ	O
Zap	B-protein	NOUN	B
was	O	AUX	O
not	O	PART	O
.	O	PUNCT	O


The	O	DET	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
stimulation	O	NOUN	B
of	O	ADP	O
NK	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
either	O	CCONJ	O
freshly	O	ADV	B
isolated	O	VERB	B
from	O	ADP	O
peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
lymphocytes	I-cell_type	NOUN	I
(	O	PUNCT	O
PBL	B-cell_type	NOUN	B
)	O	PUNCT	O
or	O	CCONJ	O
long-term	B-cell_line	ADJ	B
cultured	I-cell_line	VERB	O
NK	I-cell_line	NOUN	O
clones	I-cell_line	NOUN	O
,	O	PUNCT	O
with	O	ADP	O
specific	O	ADJ	O
cell	O	NOUN	B
targets	O	NOUN	O
results	O	VERB	B
in	O	ADP	O
an	O	DET	O
increased	O	VERB	B
binding	O	NOUN	B
activity	O	NOUN	I
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
and	O	CCONJ	O
AP-1	B-protein	NOUN	B
transcription	B-protein	NOUN	I
factors	I-protein	NOUN	I
measured	O	VERB	B
by	O	ADP	O
gel	O	NOUN	B
retardation	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
predominant	O	ADJ	O
E2F	B-protein	NOUN	B
complex	I-protein	NOUN	I
in	O	ADP	O
human	B-cell_type	ADJ	B
primary	I-cell_type	ADJ	B
haemopoietic	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
in	O	ADP	O
AML	B-cell_type	NOUN	B
blasts	I-cell_type	NOUN	B
contains	O	VERB	O
E2F-4	B-protein	NOUN	B
,	O	PUNCT	O
DP-1	B-protein	NOUN	B
and	O	CCONJ	O
p130	B-protein	NOUN	B
.	O	PUNCT	O


Therefore	O	ADV	O
we	O	PRON	O
analysed	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
E2F	B-protein	NOUN	B
-DNA	O	NOUN	O
binding	O	NOUN	B
activity	O	NOUN	I
and	O	CCONJ	O
the	O	DET	O
constituent	O	NOUN	B
proteins	O	NOUN	I
found	O	VERB	O
in	O	ADP	O
the	O	DET	O
complexes	O	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
primary	I-cell_type	ADJ	B
haemopoietic	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
of	O	ADP	O
various	O	ADJ	O
lineages	O	NOUN	B
.	O	PUNCT	O


Characterization	O	NOUN	B
of	O	ADP	O
a	O	DET	O
mutant	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
that	O	PRON	O
does	O	AUX	O
not	O	PART	O
activate	O	VERB	B
NF-kappaB	B-protein	NOUN	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
multiple	O	ADJ	B
stimuli	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
transduction	O	NOUN	B
pathways	O	NOUN	I
that	O	PRON	O
lead	O	VERB	O
to	O	PART	O
I	B-protein	NOUN	O
kappaB	I-protein	NOUN	O
inactivation	O	NOUN	B
remain	O	VERB	O
poorly	O	ADV	O
understood	O	VERB	O
.	O	PUNCT	O


Previously	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
and	O	CCONJ	O
others	O	NOUN	O
have	O	AUX	O
demonstrated	O	VERB	O
that	O	SCONJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
regulates	O	VERB	B
the	O	DET	O
NF-kappa	B-DNA	NOUN	B
B1	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
.	O	PUNCT	O


Characterization	O	NOUN	B
of	O	ADP	O
the	O	DET	O
NF-kappa	B-DNA	NOUN	B
B1	I-DNA	NOUN	I
promoter	I-DNA	NOUN	B
identified	O	VERB	O
an	O	DET	O
Egr-1	B-DNA	NOUN	B
site	I-DNA	NOUN	O
which	O	DET	O
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
be	O	AUX	O
essential	O	ADJ	B
for	O	ADP	O
both	O	CCONJ	O
the	O	DET	O
PMA/	O	NOUN	B
PHA	B-protein	NOUN	B
-mediated	O	ADJ	O
induction	O	NOUN	B
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
the	O	DET	O
synergistic	O	ADJ	B
activation	O	NOUN	B
observed	O	VERB	B
after	O	ADP	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
RelA	O	NOUN	B
subunit	O	NOUN	I
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
and	O	CCONJ	O
Egr-1	B-protein	NOUN	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
Egr-1	B-protein	NOUN	B
induction	O	NOUN	B
was	O	AUX	O
required	O	VERB	O
for	O	ADP	O
endogenous	O	ADJ	B
NF-kappa	B-DNA	NOUN	B
B1	I-DNA	NOUN	I
gene	O	NOUN	B
expression	O	NOUN	I
,	O	PUNCT	O
since	O	SCONJ	O
PMA/	O	NOUN	B
PHA-stimulated	B-cell_line	ADJ	B
T	I-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
expressing	O	VERB	B
antisense	O	ADJ	B
Egr-1	B-RNA	NOUN	I
RNA	I-RNA	NOUN	I
were	O	AUX	O
inhibited	O	VERB	B
in	O	ADP	O
their	O	PRON	O
ability	O	NOUN	O
to	O	PART	O
upregulate	O	VERB	B
NF-kappa	O	NOUN	B
B1	O	NOUN	I
transcription	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
synthesis	O	NOUN	B
and	O	CCONJ	O
immunogenicity	O	NOUN	B
of	O	ADP	O
varicella-zoster	B-protein	NOUN	B
virus	I-protein	NOUN	I
glycoprotein	I-protein	NOUN	I
E	I-protein	NOUN	I
and	O	CCONJ	O
immediate-early	B-protein	ADJ	O
protein	I-protein	NOUN	O
(	O	PUNCT	O
IE62	B-protein	NOUN	B
)	O	PUNCT	O
expressed	O	VERB	B
in	O	ADP	O
recombinant	O	ADJ	B
herpes	O	NOUN	I
simplex	O	NOUN	I
virus-1	O	NOUN	I
.	O	PUNCT	O


When	O	SCONJ	O
tested	O	VERB	B
in	O	ADP	O
cytotoxicity	O	NOUN	B
assays	O	NOUN	I
using	O	VERB	O
T-lymphocytes	B-cell_type	NOUN	B
from	O	ADP	O
VZV	O	NOUN	B
immune	O	ADJ	B
human	O	ADJ	B
donors	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
range	O	NOUN	O
of	O	ADP	O
precursor	O	NOUN	B
frequencies	O	NOUN	B
for	O	ADP	O
T-lymphocytes	B-cell_type	NOUN	B
that	O	PRON	O
recognized	O	VERB	O
VZV	B-protein	NOUN	B
gE	I-protein	NOUN	B
or	O	CCONJ	O
VZV	B-protein	NOUN	B
IE62	I-protein	NOUN	B
was	O	AUX	O
similar	O	ADJ	O
whether	O	SCONJ	O
these	O	DET	O
proteins	O	NOUN	B
were	O	AUX	O
expressed	O	VERB	B
by	O	ADP	O
HSV-1	O	NOUN	B
or	O	CCONJ	O
a	O	DET	O
vaccinia	O	NOUN	B
vector	O	NOUN	I
.	O	PUNCT	O


Using	O	VERB	O
a	O	DET	O
panel	O	NOUN	O
of	O	ADP	O
specific	O	ADJ	O
antisera	O	NOUN	B
in	O	ADP	O
immunoprecipitation	O	NOUN	B
assays	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
found	O	VERB	O
that	O	SCONJ	O
NFATp	B-protein	NOUN	B
(	O	PUNCT	O
135	B-protein	NUM	O
kDa	I-protein	NOUN	O
)	O	PUNCT	O
is	O	AUX	O
constitutively	O	ADV	B
expressed	O	VERB	B
in	O	ADP	O
normal	B-cell_type	ADJ	O
human	I-cell_type	ADJ	B
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
while	O	SCONJ	O
synthesis	O	NOUN	B
of	O	ADP	O
NFATc	B-protein	NOUN	B
(	O	PUNCT	O
predominant	O	ADJ	O
form	O	NOUN	O
of	O	ADP	O
86	B-protein	NUM	O
kDa	I-protein	NOUN	O
)	O	PUNCT	O
is	O	AUX	O
induced	O	VERB	B
by	O	ADP	O
ionomycin	O	NOUN	B
treatment	O	NOUN	B
.	O	PUNCT	O


Higher-molecular-weight	B-protein	ADJ	B
species	I-protein	NOUN	B
of	O	ADP	O
NFATc	B-protein	NOUN	B
(	O	PUNCT	O
of	O	ADP	O
110	O	NUM	O
and	O	CCONJ	O
140	O	NUM	O
kDa	O	NOUN	O
)	O	PUNCT	O
were	O	AUX	O
also	O	ADV	O
detected	O	VERB	B
.	O	PUNCT	O


Of	O	ADP	O
the	O	DET	O
GATA-binding	B-protein	ADJ	B
proteins	I-protein	NOUN	I
,	O	PUNCT	O
only	O	ADV	O
GATA-4	B-protein	NOUN	B
selectively	O	ADV	O
regulates	O	VERB	B
the	O	DET	O
human	B-DNA	ADJ	B
IL-5	I-DNA	NOUN	B
gene	I-DNA	NOUN	I
promoter	I-DNA	NOUN	B
in	O	ADP	O
IL-5	B-cell_type	NOUN	B
producing	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	B
which	O	DET	O
express	O	VERB	O
multiple	B-protein	ADJ	O
GATA-binding	I-protein	ADJ	B
proteins	I-protein	NOUN	I
.	O	PUNCT	O


By	O	ADP	O
promoter	O	NOUN	B
deletion	O	NOUN	I
and	O	CCONJ	O
mutation	O	NOUN	B
analyses	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
established	O	VERB	O
this	O	DET	O
region	O	NOUN	O
as	O	ADP	O
a	O	DET	O
positive	B-DNA	ADJ	B
regulatory	I-DNA	ADJ	B
element	I-DNA	NOUN	I
.	O	PUNCT	O


Neuronal	B-protein	ADJ	B
(	I-protein	PUNCT	O
type	I-protein	NOUN	O
I	I-protein	NUM	O
)	I-protein	PUNCT	O
nitric	I-protein	ADJ	O
oxide	I-protein	NOUN	O
synthase	I-protein	NOUN	O
regulates	O	VERB	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
kappaB	I-protein	NOUN	I
activity	O	NOUN	I
and	O	CCONJ	O
immunologic	B-protein	ADJ	B
(	I-protein	PUNCT	O
type	I-protein	NOUN	B
II	I-protein	NUM	I
)	I-protein	PUNCT	I
nitric	I-protein	ADJ	I
oxide	I-protein	NOUN	I
synthase	I-protein	NOUN	I
expression	O	NOUN	B
.	O	PUNCT	O


NO	O	NOUN	B
is	O	AUX	O
produced	O	VERB	O
from	O	ADP	O
at	O	ADP	O
least	O	ADJ	O
three	O	NUM	O
different	O	ADJ	O
NO	B-protein	NOUN	B
synthase	I-protein	NOUN	I
(	I-protein	PUNCT	O
NOS	I-protein	NOUN	B
)	I-protein	PUNCT	O
isoforms	I-protein	NOUN	B
:	O	PUNCT	O
neuronal	B-protein	ADJ	B
NOS	I-protein	NOUN	I
(	O	PUNCT	O
nNOS	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
endothelial	B-protein	ADJ	B
NOS	I-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
immunologic	B-protein	ADJ	B
NOS	I-protein	NOUN	O
(	O	PUNCT	O
iNOS	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


NF	B-protein	NOUN	B
kappaB	I-protein	NOUN	I
activation	O	NOUN	I
in	O	ADP	O
glia	B-cell_type	NOUN	B
from	O	ADP	O
mice	O	NOUN	B
lacking	O	VERB	O
nNOS	B-protein	NOUN	B
responds	O	VERB	O
more	O	ADV	O
rapidly	O	ADV	O
to	O	PART	O
PDTC	O	NOUN	B
compared	O	VERB	B
with	O	ADP	O
astrocytes	B-cell_type	NOUN	B
from	O	ADP	O
wild-type	O	ADJ	B
mice	O	NOUN	I
.	O	PUNCT	O


Interleukin-6	B-protein	NOUN	B
(	O	PUNCT	O
IL-6	B-protein	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
an	O	DET	O
important	O	ADJ	O
B-cell	B-protein	NOUN	B
growth	I-protein	NOUN	I
and	I-protein	CCONJ	O
differentiation	I-protein	NOUN	B
factor	I-protein	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
in	O	ADP	O
differentiating	B-cell_type	VERB	O
erythroid	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
which	O	DET	O
must	O	AUX	O
incorporate	O	VERB	O
high	O	ADJ	O
levels	O	NOUN	B
of	O	ADP	O
iron	O	NOUN	B
to	O	PART	O
sustain	O	VERB	O
hemoglobin	B-protein	NOUN	B
synthesis	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
in	O	ADP	O
macrophages	B-cell_type	NOUN	B
,	O	PUNCT	O
which	O	DET	O
are	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
iron	O	NOUN	B
storage	O	NOUN	I
,	O	PUNCT	O
transcriptional	O	ADJ	B
regulation	O	NOUN	I
seemed	O	VERB	O
to	O	PART	O
be	O	AUX	O
a	O	DET	O
relevant	O	ADJ	B
mechanism	O	NOUN	B
.	O	PUNCT	O


Rap1	B-protein	NOUN	B
is	O	AUX	O
a	O	DET	O
small	O	ADJ	B
,	O	PUNCT	O
Ras-like	B-protein	ADJ	B
GTPase	I-protein	NOUN	I
whose	O	DET	O
function	O	NOUN	B
and	O	CCONJ	O
regulation	O	NOUN	B
are	O	AUX	O
still	O	ADV	O
largely	O	ADV	O
unknown	O	ADJ	O
.	O	PUNCT	O


Despite	O	SCONJ	O
these	O	DET	O
findings	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
molecular	O	ADJ	B
mechanisms	O	NOUN	I
by	O	ADP	O
which	O	DET	O
Ets	B-protein	NOUN	B
and	I-protein	CCONJ	O
NF-kappaB/NFAT	I-protein	NOUN	B
proteins	I-protein	NOUN	I
cooperatively	O	ADV	O
regulate	O	VERB	O
inducible	O	ADJ	B
T-cell	O	NOUN	O
gene	O	NOUN	O
expression	O	NOUN	O
remained	O	VERB	O
unknown	O	ADJ	O
.	O	PUNCT	O


An	O	DET	O
acute	B-DNA	ADJ	B
myeloid	I-DNA	ADJ	I
leukemia	I-DNA	NOUN	I
gene	I-DNA	NOUN	B
,	O	PUNCT	O
AML1	B-DNA	NOUN	B
,	O	PUNCT	O
regulates	O	VERB	B
transcriptional	O	ADJ	B
activation	O	NOUN	I
and	O	CCONJ	O
hemopoietic	O	ADJ	B
myeloid	O	ADJ	I
cell	O	NOUN	I
differentiation	O	NOUN	O
antagonistically	O	ADV	B
by	O	ADP	O
two	O	NUM	O
alternative	O	ADJ	B
spliced	O	ADJ	B
forms	O	NOUN	O
.	O	PUNCT	O


Both	O	DET	O
forms	O	NOUN	O
have	O	AUX	O
DNA-binding	B-protein	ADJ	B
domain	I-protein	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
AML1a	B-protein	NOUN	B
lacks	O	VERB	O
a	O	DET	O
putative	O	ADJ	O
transcriptional	O	ADJ	O
activation	O	NOUN	O
domain	O	NOUN	O
which	O	DET	O
AML1b	B-protein	NOUN	B
has	O	AUX	O
.	O	PUNCT	O


Furthermore	O	ADV	O
a	O	DET	O
dominant	B-protein	ADJ	B
negative	I-protein	ADJ	B
form	I-protein	NOUN	O
of	O	ADP	O
AML1	B-protein	NOUN	B
,	O	PUNCT	O
AML1a	B-protein	NOUN	B
,	O	PUNCT	O
totally	O	ADV	O
suppressed	O	VERB	B
granulocytic	O	ADJ	B
differentiation	O	NOUN	I
otherwise	O	ADV	O
induced	O	VERB	B
by	O	ADP	O
granulocyte	B-protein	NOUN	B
colony-stimulating	I-protein	ADJ	I
factor	I-protein	NOUN	I
when	O	SCONJ	O
AML1a	B-protein	NOUN	B
was	O	AUX	O
overexpressed	O	VERB	B
in	O	ADP	O
32Dc13	B-cell_type	NOUN	O
murine	I-cell_type	ADJ	B
myeloid	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
strongly	O	ADV	O
suggest	O	VERB	O
that	O	SCONJ	O
a	O	DET	O
transcriptionally	O	ADV	B
active	O	ADJ	O
form	O	NOUN	O
of	O	ADP	O
AML1	B-protein	NOUN	B
is	O	AUX	O
essential	O	ADJ	O
for	O	ADP	O
the	O	DET	O
myeloid	O	ADJ	B
cell	O	NOUN	I
differentiation	O	NOUN	O
.	O	PUNCT	O


RANTES	B-protein	NOUN	B
(	O	PUNCT	O
regulated	B-protein	VERB	O
upon	I-protein	SCONJ	O
activation	I-protein	NOUN	B
,	I-protein	PUNCT	O
normal	I-protein	ADJ	O
T	I-protein	NOUN	B
cell	I-protein	NOUN	I
expressed	I-protein	VERB	B
and	I-protein	CCONJ	O
secreted	I-protein	VERB	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
cytokine	B-protein	NOUN	B
that	O	PRON	O
belongs	O	VERB	O
to	O	PART	O
the	O	DET	O
beta-chemokine	B-protein	NOUN	B
family	I-protein	NOUN	I
;	O	PUNCT	O
it	O	PRON	O
is	O	AUX	O
chemoattractant	O	NOUN	B
for	O	ADP	O
CD4+/CD45RO	B-cell_type	ADJ	B
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
it	O	PRON	O
is	O	AUX	O
produced	O	VERB	O
by	O	ADP	O
various	O	ADJ	O
cell	O	NOUN	B
types	O	NOUN	I
including	O	VERB	O
CD8+	B-cell_type	ADJ	B
and	I-cell_type	CCONJ	O
CD4+	I-cell_type	ADJ	B
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
monocytes/macrophages	B-cell_type	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
has	O	AUX	O
recently	O	ADV	O
been	O	AUX	O
shown	O	VERB	O
to	O	PART	O
suppress	O	VERB	B
replication	O	NOUN	B
of	O	ADP	O
macrophage-tropic	O	ADJ	B
strains	O	NOUN	I
of	O	ADP	O
HIV	O	NOUN	B
in	O	ADP	O
CD4+	B-cell_type	ADJ	B
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
:	O	PUNCT	O
1	O	X	O
)	O	PUNCT	O
RANTES	B-protein	NOUN	B
promoter	O	NOUN	B
activity	O	NOUN	I
is	O	AUX	O
up-regulated	O	VERB	B
by	O	ADP	O
PMA	O	NOUN	B
plus	O	CCONJ	O
ionomycin	O	NOUN	B
,	O	PUNCT	O
coexpression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
p65	B-protein	NOUN	B
subunit	I-protein	NOUN	I
of	O	ADP	O
nuclear	B-protein	ADJ	O
factor	I-protein	NOUN	O
(	I-protein	PUNCT	O
NF	I-protein	NOUN	B
)	I-protein	PUNCT	O
-kappa	I-protein	NOUN	O
B	I-protein	NOUN	O
,	O	PUNCT	O
the	O	DET	O
proinflammatory	B-protein	ADJ	B
cytokines	I-protein	NOUN	I
TNF-alpha	B-protein	NOUN	B
and	O	CCONJ	O
IL-1	B-protein	NOUN	B
beta	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
CD28	B-protein	NOUN	B
costimulatory	O	ADJ	I
pathway	O	NOUN	I
;	O	PUNCT	O
2	O	X	O
)	O	PUNCT	O
the	O	DET	O
RANTES	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
region	I-DNA	NOUN	I
contains	O	VERB	O
four	O	NUM	O
NF-kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
binding	I-DNA	NOUN	I
sites	I-DNA	NOUN	I
at	O	ADP	O
positions	B-DNA	NOUN	B
-30	I-DNA	NUM	O
,	I-DNA	PUNCT	O
-44	I-DNA	NUM	O
,	I-DNA	PUNCT	O
-213	I-DNA	NUM	O
,	I-DNA	PUNCT	O
and	I-DNA	CCONJ	O
-579	I-DNA	NUM	O
relative	O	ADJ	O
to	O	PART	O
the	O	DET	O
transcription	B-DNA	NOUN	B
start	I-DNA	NOUN	O
site	I-DNA	NOUN	O
;	O	PUNCT	O
3	O	X	O
)	O	PUNCT	O
one	O	NUM	O
site	O	NOUN	B
(	O	PUNCT	O
-213	O	NUM	O
)	O	PUNCT	O
is	O	AUX	O
an	O	DET	O
NF-AT	B-DNA	NOUN	B
(	I-DNA	PUNCT	O
nuclear	I-DNA	ADJ	B
factor	I-DNA	NOUN	I
of	I-DNA	ADP	O
activated	I-DNA	VERB	B
T	I-DNA	NOUN	O
cells	I-DNA	NOUN	O
)	I-DNA	PUNCT	O
binding	I-DNA	NOUN	B
site	I-DNA	NOUN	I
that	O	PRON	O
also	O	ADV	O
has	O	AUX	O
weak	O	ADJ	B
affinity	O	NOUN	B
to	O	PART	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
most	O	ADV	O
distal	O	ADJ	B
site	O	NOUN	I
(	O	PUNCT	O
-579	O	NUM	O
)	O	PUNCT	O
also	O	ADV	O
serves	O	VERB	O
as	O	ADP	O
a	O	DET	O
CD28-responsive	B-DNA	ADJ	B
element	I-DNA	NOUN	I
;	O	PUNCT	O
and	O	CCONJ	O
4	O	NUM	O
)	O	PUNCT	O
mutation	O	NOUN	B
on	O	ADP	O
any	O	DET	O
of	O	ADP	O
those	O	DET	O
NF-kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
sites	I-DNA	NOUN	I
or	O	CCONJ	O
coexpression	O	NOUN	B
of	O	ADP	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
alpha	I-protein	NOUN	I
(	O	PUNCT	O
cytoplasmic	B-protein	ADJ	B
inhibitor	I-protein	NOUN	I
of	I-protein	ADP	O
NF-kappa	I-protein	NOUN	B
B	I-protein	NOUN	I
)	O	PUNCT	O
markedly	O	ADV	O
reduced	O	VERB	B
the	O	DET	O
promoter	O	NOUN	B
activity	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
specific	O	ADJ	O
p38	B-protein	NOUN	B
MAPk	I-protein	NOUN	B
inhibitor	O	NOUN	I
(	O	PUNCT	O
SK	O	PROPN	B
&	O	CCONJ	O
F	O	PROPN	O
86002	O	NUM	O
)	O	PUNCT	O
blocked	O	VERB	B
superoxide	O	NOUN	B
anion	O	NOUN	I
production	O	NOUN	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
FMLP	B-protein	NOUN	B
and	O	CCONJ	O
reduced	O	VERB	B
adhesion	O	NOUN	B
and	O	CCONJ	O
chemotaxis	O	NOUN	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
PAF	B-protein	NOUN	B
or	O	CCONJ	O
FMLP	B-protein	NOUN	B
.	O	PUNCT	O


Chicken	B-protein	NOUN	B
NF-M	I-protein	NOUN	B
transcription	I-protein	NOUN	B
factor	I-protein	NOUN	I
,	O	PUNCT	O
in	O	ADP	O
cooperation	O	NOUN	B
with	O	ADP	O
either	O	CCONJ	O
c-Myb	B-protein	NOUN	B
or	O	CCONJ	O
v-Myb	B-protein	NOUN	B
,	O	PUNCT	O
is	O	AUX	O
active	O	ADJ	B
in	O	ADP	O
the	O	DET	O
combinatorial	O	ADJ	B
activation	O	NOUN	I
of	O	ADP	O
myeloid-cell-specific	B-DNA	ADJ	B
genes	I-DNA	NOUN	I
in	O	ADP	O
heterologous	B-cell_type	ADJ	B
cell	I-cell_type	NOUN	B
types	I-cell_type	NOUN	I
,	O	PUNCT	O
such	O	ADJ	O
as	O	ADP	O
embryonic	B-cell_type	ADJ	B
fibroblasts	I-cell_type	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
humans	O	NOUN	B
,	O	PUNCT	O
similar	O	ADJ	O
effects	O	NOUN	B
were	O	AUX	O
observed	O	VERB	O
with	O	ADP	O
homologous	O	ADJ	B
members	O	NOUN	I
of	O	ADP	O
the	O	DET	O
CCAAT/enhancer-binding	B-protein	ADJ	B
protein	I-protein	NOUN	I
(	I-protein	PUNCT	O
C/EBP	I-protein	NOUN	B
)	I-protein	PUNCT	O
family	I-protein	NOUN	B
of	O	ADP	O
transcriptional	B-protein	ADJ	B
regulators	I-protein	NOUN	I
,	O	PUNCT	O
especially	O	ADV	O
the	O	DET	O
human	O	ADJ	B
homolog	O	NOUN	B
of	O	ADP	O
chicken	B-protein	NOUN	B
NF-M	I-protein	NOUN	B
,	O	PUNCT	O
C/EBP-beta	B-protein	NOUN	B
(	O	PUNCT	O
NF-IL6	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
NF-IL6	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
is	O	AUX	O
expressed	O	VERB	B
in	O	ADP	O
a	O	DET	O
variety	O	NOUN	O
of	O	ADP	O
nonmyeloid	O	ADJ	B
cell	O	NOUN	I
types	O	NOUN	O
and	O	CCONJ	O
is	O	AUX	O
strongly	O	ADV	O
inducible	O	ADJ	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
inflammatory	O	ADJ	B
stimuli	O	NOUN	I
,	O	PUNCT	O
making	O	VERB	O
it	O	PRON	O
an	O	DET	O
unlikely	O	ADJ	O
candidate	O	NOUN	O
to	O	PART	O
have	O	AUX	O
an	O	DET	O
exclusive	O	ADJ	O
role	O	NOUN	O
as	O	ADP	O
a	O	DET	O
combinatorial	O	ADJ	B
differentiation	O	NOUN	I
switch	O	NOUN	B
during	O	ADP	O
myelopoiesis	O	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Primer	O	NOUN	B
extension	O	NOUN	I
analysis	O	NOUN	I
of	O	ADP	O
C/EBP-epsilon	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
detected	O	VERB	B
a	O	DET	O
single	O	ADJ	O
major	O	ADJ	O
transcription	B-DNA	NOUN	B
start	I-DNA	NOUN	O
site	I-DNA	NOUN	O
approximately	O	ADV	B
200	O	NUM	O
bp	O	NOUN	O
upstream	O	ADJ	B
of	O	ADP	O
the	O	DET	O
start	B-DNA	NOUN	O
codon	I-DNA	NOUN	B
.	O	PUNCT	O


The	O	DET	O
putative	O	ADJ	O
promoter	O	NOUN	B
area	O	NOUN	I
is	O	AUX	O
similar	O	ADJ	O
to	O	PART	O
those	O	DET	O
of	O	ADP	O
several	O	ADJ	O
other	O	ADJ	O
myeloid-cell-specific	O	ADJ	B
genes	O	NOUN	I
in	O	ADP	O
that	O	SCONJ	O
it	O	PRON	O
contains	O	VERB	O
no	O	DET	O
TATAAA	B-DNA	NOUN	B
box	I-DNA	NOUN	I
but	O	CCONJ	O
has	O	AUX	O
a	O	DET	O
number	O	NOUN	O
of	O	ADP	O
purine-rich	B-DNA	ADJ	B
stretches	I-DNA	NOUN	B
with	O	ADP	O
multiple	O	ADJ	B
sites	O	NOUN	I
for	O	ADP	O
the	O	DET	O
factors	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Ets	B-protein	NOUN	B
family	I-protein	NOUN	I
of	O	ADP	O
transcriptional	B-protein	ADJ	B
regulators	I-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
human	O	ADJ	B
C/EBP-epsilon	B-protein	NOUN	O
protein	O	NOUN	O
exhibited	O	VERB	O
strong	O	ADJ	B
and	O	CCONJ	O
specific	O	ADJ	O
binding	O	NOUN	B
to	O	PART	O
double-stranded	B-DNA	ADJ	B
DNA	I-DNA	NOUN	I
containing	I-DNA	NOUN	O
consensus	I-DNA	NOUN	B
C/EBP	I-DNA	NOUN	B
sites	I-DNA	NOUN	I
.	O	PUNCT	O


Cotransfection	O	NOUN	B
of	O	ADP	O
the	O	DET	O
C/EBP-epsilon	B-protein	NOUN	B
sense	O	NOUN	O
and	O	CCONJ	O
antisense	O	ADJ	B
expression	O	NOUN	I
constructs	O	NOUN	O
together	O	ADV	O
with	O	ADP	O
chloramphenicol	B-DNA	NOUN	B
acetyltransferase	I-DNA	NOUN	I
reporter	I-DNA	NOUN	I
vectors	I-DNA	NOUN	I
containing	O	VERB	O
myeloid-cell-specific	B-DNA	ADJ	B
c-mim	I-DNA	NOUN	I
and	I-DNA	CCONJ	O
human	I-DNA	ADJ	B
myeloperoxidase	I-DNA	NOUN	B
promoters	I-DNA	NOUN	I
suggested	O	VERB	O
a	O	DET	O
role	O	NOUN	O
for	O	ADP	O
C/EBP-epsilon	B-protein	NOUN	B
transcription	B-protein	NOUN	I
factor	I-protein	NOUN	I
in	O	ADP	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
a	O	DET	O
subset	O	NOUN	O
of	O	ADP	O
myeloid-cell-specific	B-DNA	ADJ	B
genes	I-DNA	NOUN	I
.	O	PUNCT	O


The	O	DET	O
A6H	B-protein	NOUN	B
monoclonal	I-protein	ADJ	B
antibody	I-protein	NOUN	I
(	O	PUNCT	O
mAb	O	NOUN	B
)	O	PUNCT	O
recognizes	O	VERB	O
a	O	DET	O
120	B-protein	NUM	O
,	I-protein	PUNCT	O
000-140	I-protein	NUM	O
,	I-protein	PUNCT	O
000	I-protein	NUM	O
MW	I-protein	NOUN	B
antigen	I-protein	NOUN	I
that	O	PRON	O
is	O	AUX	O
expressed	O	VERB	B
at	O	ADP	O
similar	O	ADJ	O
densities	O	NOUN	B
on	O	ADP	O
85-90	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
human	O	ADJ	B
CD4+	B-cell_type	ADJ	B
and	I-cell_type	CCONJ	O
CD8+	I-cell_type	ADJ	B
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
on	O	ADP	O
renal	O	ADJ	B
cell	O	NOUN	I
carcinomas	O	NOUN	I
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
no	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
AP-1	B-protein	NOUN	B
was	O	AUX	O
seen	O	VERB	O
in	O	ADP	O
A6H	B-protein	NOUN	B
costimulated	O	VERB	B
CD8+	B-cell_type	ADJ	B
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Twenty-two	O	NUM	O
differences	O	NOUN	O
from	O	ADP	O
the	O	DET	O
human	O	ADJ	B
sequence	O	NOUN	B
were	O	AUX	O
found	O	VERB	O
in	O	ADP	O
the	O	DET	O
N-terminal	B-protein	ADJ	B
region	I-protein	NOUN	I
(	O	PUNCT	O
amino	B-protein	NOUN	B
acids	I-protein	NOUN	I
1-421	I-protein	NUM	I
)	O	PUNCT	O
of	O	ADP	O
the	O	DET	O
squirrel	O	NOUN	B
monkey	O	NOUN	I
receptor	O	NOUN	I
.	O	PUNCT	O


Nonetheless	O	ADV	O
,	O	PUNCT	O
only	O	ADV	O
a	O	DET	O
limited	O	ADJ	O
portion	O	NOUN	B
of	O	ADP	O
the	O	DET	O
cytoplasmic	B-protein	ADJ	B
domain	I-protein	NOUN	I
of	O	ADP	O
gamma	B-protein	NOUN	O
(	I-protein	PUNCT	O
c	I-protein	NOUN	O
)	I-protein	PUNCT	O
is	O	AUX	O
necessary	O	ADJ	O
for	O	ADP	O
IL-7R	B-protein	NOUN	B
signal	O	NOUN	B
transduction	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
recently	O	ADV	O
reported	O	VERB	O
that	O	SCONJ	O
a	O	DET	O
garlic	O	ADJ	B
compound	O	NOUN	I
,	O	PUNCT	O
S-allyl	O	ADJ	B
cysteine	O	NOUN	I
(	O	PUNCT	O
SAC	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
protects	O	VERB	O
bovine	B-cell_type	ADJ	B
pulmonary	I-cell_type	ADJ	B
artery	I-cell_type	NOUN	I
endothelial	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
from	O	ADP	O
oxidant	O	ADJ	B
injury	O	NOUN	I
induced	O	VERB	B
by	O	ADP	O
hydrogen	O	NOUN	B
peroxide	O	NOUN	I
(	O	PUNCT	O
H2O2	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
study	O	NOUN	B
we	O	PRON	O
determined	O	VERB	O
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	O
SAC	O	NOUN	B
on	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activation	O	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
T	I-cell_type	NOUN	O
lymphocytes	I-cell_type	NOUN	O
(	O	PUNCT	O
Jurkat	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
)	O	PUNCT	O
induced	O	VERB	B
by	O	ADP	O
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor	I-protein	NOUN	I
alpha	I-protein	NOUN	I
(	O	PUNCT	O
TNF-	B-protein	NOUN	B
alpha	I-protein	NOUN	I
)	O	PUNCT	O
and	O	CCONJ	O
H2O2	O	NOUN	B
.	O	PUNCT	O


Supershift	O	NOUN	B
with	O	ADP	O
specific	O	ADJ	O
antibodies	O	NOUN	B
to	O	PART	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
subunits	I-protein	NOUN	I
confirmed	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
inducible	O	ADJ	B
retarded	O	ADJ	O
bands	O	NOUN	O
observed	O	VERB	B
in	O	ADP	O
the	O	DET	O
EMSA	O	NOUN	B
and	O	CCONJ	O
p65-p50	B-protein	ADJ	B
heterodimer	I-protein	NOUN	I
of	O	ADP	O
the	O	DET	O
NF-kappa	B-protein	NOUN	B
B/Rel	I-protein	NOUN	I
protein	I-protein	NOUN	I
.	O	PUNCT	O


This	O	DET	O
protein	O	NOUN	B
was	O	AUX	O
named	O	VERB	O
elf-2	B-protein	PROPN	B
because	O	SCONJ	O
its	O	PRON	O
DNA-binding	B-protein	ADJ	B
domain	I-protein	NOUN	I
is	O	AUX	O
virtually	O	ADV	O
identical	O	ADJ	B
to	O	PART	O
that	O	DET	O
of	O	ADP	O
ets	B-protein	NOUN	B
family	I-protein	NOUN	I
member	I-protein	NOUN	I
elf-1	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
expression	O	NOUN	B
patterns	O	NOUN	I
suggest	O	VERB	O
that	O	SCONJ	O
RBTN-2	B-protein	NOUN	B
normally	O	ADV	O
interacts	O	VERB	O
equally	O	ADV	O
with	O	ADP	O
elf-2a	B-protein	NOUN	O
and	O	CCONJ	O
elf-2b	B-protein	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
when	O	SCONJ	O
RBTN-2	B-protein	NOUN	B
is	O	AUX	O
inappropriately	O	ADV	O
expressed	O	VERB	B
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
RBTN-2	B-protein	NOUN	B
would	O	AUX	O
interact	O	VERB	B
predominantly	O	ADV	O
with	O	ADP	O
elf-2b	B-protein	NOUN	O
;	O	PUNCT	O
this	O	DET	O
interaction	O	NOUN	B
may	O	AUX	O
lead	O	VERB	O
to	O	PART	O
T	O	NOUN	B
cell	O	NOUN	I
proliferation	O	NOUN	I
.	O	PUNCT	O


Although	O	SCONJ	O
no	O	DET	O
single	O	ADJ	B
chromosome	O	NOUN	I
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
correlate	O	VERB	B
with	O	ADP	O
Ig	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
silencing	O	NOUN	O
,	O	PUNCT	O
we	O	PRON	O
discovered	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
two	O	NUM	O
types	O	NOUN	O
of	O	ADP	O
hybrids	O	NOUN	B
had	O	AUX	O
undergone	O	VERB	O
distinct	O	ADJ	O
patterns	O	NOUN	B
of	O	ADP	O
chromosome	O	NOUN	B
loss	O	NOUN	I
.	O	PUNCT	O


Moreover	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
found	O	VERB	O
that	O	SCONJ	O
ectopic	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
a	O	DET	O
B-cell-specific	B-protein	ADJ	B
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
(	O	PUNCT	O
Oct-2	B-protein	NOUN	B
)	O	PUNCT	O
dramatically	O	ADV	O
altered	O	VERB	O
both	O	CCONJ	O
the	O	DET	O
phenotype	O	NOUN	B
and	O	CCONJ	O
chromosome	O	NOUN	B
constitution	O	NOUN	B
of	O	ADP	O
hybrids	O	NOUN	B
arising	O	VERB	O
in	O	ADP	O
these	O	DET	O
cell	O	NOUN	B
fusions	O	NOUN	I
.	O	PUNCT	O


Reactivation	O	NOUN	B
of	O	ADP	O
Kaposi	O	NOUN	B
's	O	PART	I
sarcoma-associated	O	ADJ	I
herpesvirus	O	NOUN	I
infection	O	NOUN	I
from	O	ADP	O
latency	O	NOUN	B
by	O	ADP	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
ORF	B-protein	NOUN	B
50	I-protein	NUM	O
transactivator	I-protein	NOUN	B
,	O	PUNCT	O
a	O	DET	O
homolog	O	NOUN	B
of	O	ADP	O
the	O	DET	O
EBV	B-protein	NOUN	B
R	I-protein	NOUN	I
protein	I-protein	NOUN	I
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
deregulated	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
a	O	DET	O
single	O	ADJ	O
viral	B-DNA	ADJ	B
gene	I-DNA	NOUN	I
,	O	PUNCT	O
ORF	B-DNA	NOUN	B
50	I-DNA	NUM	O
,	O	PUNCT	O
which	O	DET	O
encodes	O	VERB	B
a	O	DET	O
transactivator	O	NOUN	B
able	O	ADJ	O
to	O	PART	O
selectively	O	ADV	O
upregulate	O	VERB	B
delayed-early	B-DNA	ADJ	B
viral	I-DNA	ADJ	B
genes	I-DNA	NOUN	I
,	O	PUNCT	O
suffices	O	VERB	O
to	O	PART	O
disrupt	O	VERB	B
latency	O	NOUN	B
and	O	CCONJ	O
induce	O	VERB	B
the	O	DET	O
lytic	O	ADJ	B
gene	O	NOUN	I
cascade	O	NOUN	I
in	O	ADP	O
latently	B-cell_type	ADV	B
infected	I-cell_type	ADJ	B
B	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Copyright	O	NOUN	O
1998	O	NUM	O
Academic	O	PROPN	B
Press	O	PROPN	I
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
requirement	O	NOUN	B
for	O	ADP	O
CD28	B-protein	NOUN	B
in	O	ADP	O
IL-2	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
activation	O	NOUN	I
appears	O	VERB	O
to	O	PART	O
be	O	AUX	O
due	O	ADJ	O
to	O	PART	O
RE/AP	B-protein	NOUN	B
and	O	CCONJ	O
not	O	PART	O
the	O	DET	O
NFAT	B-DNA	NOUN	B
or	I-DNA	CCONJ	O
AP-1	I-DNA	NOUN	B
sites	I-DNA	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
these	O	DET	O
data	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
transcriptional	O	ADJ	B
activation	O	NOUN	I
of	O	ADP	O
RE/AP	B-protein	NOUN	B
is	O	AUX	O
not	O	PART	O
mediated	O	VERB	O
by	O	ADP	O
NFAT	B-protein	NOUN	B
,	O	PUNCT	O
because	O	SCONJ	O
activation	O	NOUN	B
of	O	ADP	O
a	O	DET	O
NFAT	B-protein	NOUN	B
reporter	O	NOUN	I
is	O	AUX	O
not	O	PART	O
affected	O	VERB	O
by	O	ADP	O
the	O	DET	O
addition	O	NOUN	O
of	O	ADP	O
CTLA4Ig	O	NOUN	B
.	O	PUNCT	O


Uncontrolled	O	ADJ	B
replication	O	NOUN	B
of	O	ADP	O
a	O	DET	O
virus	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
harmful	O	ADJ	O
to	O	PART	O
the	O	DET	O
host	O	NOUN	B
is	O	AUX	O
also	O	ADV	O
disadvantageous	O	ADJ	O
to	O	PART	O
the	O	DET	O
virus	O	NOUN	B
.	O	PUNCT	O


Therefore	O	ADV	O
,	O	PUNCT	O
only	O	ADV	O
the	O	DET	O
time	O	NOUN	B
between	O	ADP	O
infection	O	NOUN	B
and	O	CCONJ	O
eradication	O	NOUN	B
remains	O	VERB	O
for	O	ADP	O
these	O	DET	O
viruses	O	NOUN	B
to	O	PART	O
proliferate	O	VERB	B
.	O	PUNCT	O


This	O	DET	O
strategy	O	NOUN	O
depends	O	VERB	O
on	O	ADP	O
a	O	DET	O
separation	O	NOUN	B
of	O	ADP	O
latency	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
lytic	O	ADJ	B
replication	O	NOUN	B
,	O	PUNCT	O
either	O	CCONJ	O
by	O	ADP	O
time	O	NOUN	O
due	O	ADJ	O
to	O	PART	O
differentiation-dependent	O	ADJ	B
mechanisms	O	NOUN	B
or	O	CCONJ	O
by	O	ADP	O
spatial	O	ADJ	B
separation	O	NOUN	I
as	O	ADP	O
the	O	DET	O
result	O	NOUN	O
of	O	ADP	O
different	O	ADJ	O
host	O	NOUN	B
cell	O	NOUN	B
types	O	NOUN	I
.	O	PUNCT	O


B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
epithelial	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
have	O	AUX	O
a	O	DET	O
pivotal	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
life	O	NOUN	B
cycle	O	NOUN	I
of	O	ADP	O
the	O	DET	O
virus	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
factors	O	NOUN	B
control	O	VERB	B
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
regulatory	B-DNA	ADJ	B
immediate-early	I-DNA	ADJ	I
genes	I-DNA	NOUN	I
and	O	CCONJ	O
,	O	PUNCT	O
in	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
lytic	O	ADJ	B
and	O	CCONJ	O
latent	O	ADJ	B
cycle	O	NOUN	O
regulatory	O	ADJ	O
genes	O	NOUN	O
negatively	O	ADV	O
interfere	O	VERB	B
with	O	ADP	I
each	O	DET	O
other	O	ADJ	O
and	O	CCONJ	O
thus	O	ADV	O
link	O	VERB	O
cellular	O	ADJ	B
and	O	CCONJ	O
viral	B-DNA	ADJ	B
gene	I-DNA	NOUN	I
regulatory	O	ADJ	B
mechanisms	O	NOUN	I
.	O	PUNCT	O


Using	O	VERB	O
a	O	DET	O
yeast	O	NOUN	B
two-hybrid	O	ADJ	B
screen	O	NOUN	I
to	O	PART	O
identify	O	VERB	O
Syk	B-protein	NOUN	B
kinases-interacting	I-protein	ADJ	I
proteins	I-protein	NOUN	I
(	O	PUNCT	O
SKIPs	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
we	O	PRON	O
isolated	O	VERB	B
3BP2	B-protein	NOUN	B
,	O	PUNCT	O
an	O	DET	O
Abl	B-protein	NOUN	B
SH3-interacting	I-protein	ADJ	I
protein	I-protein	NOUN	I
of	O	ADP	O
unknown	O	ADJ	O
function	O	NOUN	O
.	O	PUNCT	O


In	O	X	B
vitro	O	X	I
suppression	O	NOUN	B
of	O	ADP	O
programmed	O	VERB	B
cell	O	NOUN	I
death	O	NOUN	I
of	O	ADP	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
by	O	ADP	O
tissue	O	NOUN	B
inhibitor	O	NOUN	I
of	O	ADP	O
metalloproteinases-1	B-protein	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
study	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
series	O	NOUN	O
of	O	ADP	O
Burkitt	B-cell_line	NOUN	B
's	I-cell_line	PART	I
lymphoma	I-cell_line	NOUN	I
(	I-cell_line	PUNCT	O
BL	I-cell_line	NOUN	B
)	I-cell_line	PUNCT	O
cell	I-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
were	O	AUX	O
assayed	O	VERB	B
for	O	ADP	O
their	O	PRON	O
expression	O	NOUN	B
of	O	ADP	O
tissue	B-protein	NOUN	B
inhibitor	I-protein	NOUN	I
of	I-protein	ADP	O
metalloproteinases	I-protein	NOUN	O
(	I-protein	PUNCT	O
TIMP	I-protein	NOUN	B
)	I-protein	PUNCT	O
-1	I-protein	NUM	O
.	O	PUNCT	O


To	O	PART	O
investigate	O	VERB	B
in	O	X	B
vivo	O	X	I
regulatory	O	ADJ	B
mechanisms	O	NOUN	I
that	O	PRON	O
control	O	VERB	B
the	O	DET	O
population	O	NOUN	B
of	O	ADP	O
type	B-cell_type	NOUN	B
2	I-cell_type	NUM	I
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
disease	O	NOUN	B
susceptibility	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
created	O	VERB	O
lines	O	NOUN	O
of	O	ADP	O
transgenic	O	ADJ	B
mice	O	NOUN	I
in	O	ADP	O
which	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
a	O	DET	O
chimeric	B-protein	ADJ	B
cytokine	I-protein	NOUN	O
receptor	I-protein	NOUN	O
(	O	PUNCT	O
the	O	DET	O
mouse	B-protein	NOUN	B
interleukin	I-protein	NOUN	I
2	I-protein	NUM	I
receptor	I-protein	NOUN	I
beta	I-protein	NOUN	I
chain	I-protein	NOUN	I
[	I-protein	PUNCT	I
IL-2Rbeta	I-protein	NOUN	O
]	I-protein	PUNCT	O
extracellular	I-protein	ADJ	B
domain	I-protein	NOUN	I
fused	O	VERB	O
to	O	PART	O
the	O	DET	O
cytoplasmic	B-protein	ADJ	B
tail	I-protein	NOUN	O
of	O	ADP	O
IL-4Ralpha	B-protein	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
targeted	O	VERB	B
to	O	PART	O
the	O	DET	O
T	B-cell_type	NOUN	B
lymphoid	I-cell_type	ADJ	I
lineage	I-cell_type	NOUN	I
using	O	VERB	O
the	O	DET	O
proximal	B-DNA	ADJ	B
lck	I-DNA	NOUN	O
promoter	I-DNA	NOUN	O
.	O	PUNCT	O


This	O	DET	O
chimera	O	NOUN	B
transduced	O	VERB	B
IL-4	B-protein	NOUN	B
-specific	O	ADJ	O
signals	O	NOUN	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
IL-2	B-protein	NOUN	B
binding	O	NOUN	I
and	O	CCONJ	O
dramatically	O	ADV	O
enhanced	O	VERB	B
type	O	NOUN	O
2	O	NUM	O
responses	O	NOUN	B
(	O	PUNCT	O
IL-4	B-protein	NOUN	B
,	O	PUNCT	O
IL-5	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
immunoglobulin	B-protein	NOUN	B
E	I-protein	NOUN	I
production	O	NOUN	I
)	O	PUNCT	O
upon	O	SCONJ	O
in	O	X	B
vitro	O	X	I
TCR	B-protein	NOUN	B
stimulation	O	NOUN	B
or	O	CCONJ	O
in	O	X	B
vivo	O	X	I
antigen	O	NOUN	B
challenge	O	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
PMA-treated	B-cell_line	ADJ	B
THP-1	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
we	O	PRON	O
could	O	AUX	O
detect	O	VERB	B
three	O	NUM	O
major	O	ADJ	O
transcription	B-DNA	NOUN	B
initiation	I-DNA	NOUN	I
sites	I-DNA	NOUN	I
as	O	ADP	O
revealed	O	VERB	O
by	O	ADP	O
Nuclease	O	PROPN	B
Protection	O	PROPN	I
Assay	O	NOUN	I
carried	O	VERB	O
out	O	ADP	O
with	O	ADP	O
two	O	NUM	O
overlapping	B-RNA	VERB	O
antisense	I-RNA	ADJ	B
RNA	I-RNA	NOUN	I
probes	I-RNA	NOUN	O
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
Ikaros-null	B-cell_type	ADJ	B
thymocytes	I-cell_type	NOUN	B
hyperproliferate	O	VERB	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
T	B-protein	NOUN	B
cell	I-protein	NOUN	I
receptor	I-protein	NOUN	I
(	O	PUNCT	O
TCR	B-protein	NOUN	B
)	O	PUNCT	O
signaling	O	NOUN	B
;	O	PUNCT	O
within	O	ADP	O
days	O	NOUN	B
after	O	ADP	O
their	O	PRON	O
appearance	O	NOUN	B
in	O	ADP	O
the	O	DET	O
thymus	O	NOUN	B
,	O	PUNCT	O
clonally	O	ADV	O
expanding	O	VERB	O
populations	O	NOUN	B
are	O	AUX	O
detected	O	VERB	B
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
putative	O	ADJ	O
GAS	B-DNA	NOUN	B
element	I-DNA	NOUN	O
in	O	ADP	O
the	O	DET	O
CAEV	B-DNA	NOUN	B
LTR	I-DNA	NOUN	B
binds	O	VERB	B
specifically	O	ADV	O
to	O	PART	O
a	O	DET	O
cellular	B-protein	ADJ	B
factor	I-protein	NOUN	I
induced	O	VERB	B
by	O	ADP	O
IFN-gamma	B-protein	NOUN	B
in	O	ADP	O
promonocytic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


The	O	DET	O
mechanism	O	NOUN	B
underlying	O	VERB	O
this	O	DET	O
association	O	NOUN	B
is	O	AUX	O
so	O	ADV	O
far	O	ADV	O
not	O	PART	O
explored	O	VERB	O
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
present	O	ADJ	O
study	O	NOUN	B
we	O	PRON	O
have	O	AUX	O
performed	O	VERB	O
electrophoretic	O	ADJ	B
mobility-shift	O	ADJ	I
assays	O	NOUN	I
to	O	PART	O
investigate	O	VERB	B
the	O	DET	O
pattern	O	NOUN	B
of	O	ADP	O
protein	O	NOUN	B
binding	O	NOUN	I
to	O	PART	O
a	O	DET	O
150	B-DNA	NUM	O
bp	I-DNA	NOUN	O
fragment	I-DNA	NOUN	O
of	O	ADP	O
the	O	DET	O
proximal	B-DNA	ADJ	B
5'-flanking	I-DNA	ADJ	B
region	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
monoamine	I-DNA	NOUN	B
oxidase	I-DNA	NOUN	I
B	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
.	O	PUNCT	O


Receptor	B-protein	NOUN	B
activator	I-protein	NOUN	I
of	I-protein	ADP	O
NF-kappaB	I-protein	NOUN	B
(	O	PUNCT	O
RANK	B-protein	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
recently	O	ADV	O
identified	O	VERB	O
member	O	NOUN	O
of	O	ADP	O
the	O	DET	O
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor	I-protein	NOUN	I
receptor	I-protein	NOUN	I
superfamily	I-protein	NOUN	B
and	O	CCONJ	O
is	O	AUX	O
expressed	O	VERB	B
on	O	ADP	O
activated	B-cell_type	VERB	B
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
dendritic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


When	O	SCONJ	O
this	O	DET	O
membrane-proximal	B-protein	ADJ	B
TRAF6	I-protein	NOUN	B
interaction	I-protein	NOUN	B
domain	I-protein	NOUN	O
was	O	AUX	O
deleted	O	VERB	B
,	O	PUNCT	O
RANK	B-protein	NOUN	B
-mediated	O	ADJ	O
NF-kappaB	B-protein	NOUN	B
signaling	O	NOUN	O
was	O	AUX	O
completely	O	ADV	O
inhibited	O	VERB	B
while	O	SCONJ	O
c-Jun	B-protein	NOUN	B
NH2-terminal	I-protein	ADJ	I
kinase	I-protein	NOUN	I
activation	O	NOUN	B
was	O	AUX	O
partially	O	ADV	O
inhibited	O	VERB	B
.	O	PUNCT	O


Stat6	B-protein	NOUN	B
inhibits	O	VERB	B
human	O	ADJ	B
interleukin-4	B-DNA	NOUN	O
promoter	I-DNA	NOUN	B
activity	O	NOUN	I
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


The	O	DET	O
molecular	O	ADJ	B
mechanisms	O	NOUN	I
by	O	ADP	O
which	O	DET	O
IL-4	B-protein	NOUN	B
induces	O	VERB	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IL-4	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
are	O	AUX	O
not	O	PART	O
known	O	VERB	O
,	O	PUNCT	O
although	O	SCONJ	O
the	O	DET	O
IL-4-activated	B-protein	ADJ	B
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
signal	I-protein	NOUN	I
transducer	I-protein	NOUN	I
and	I-protein	CCONJ	O
activator	I-protein	NOUN	O
of	I-protein	ADP	O
transcription	I-protein	NOUN	O
6	I-protein	NUM	O
(	O	PUNCT	O
Stat6	B-protein	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
required	O	VERB	O
for	O	ADP	O
this	O	DET	O
effect	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
conclude	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
function	O	NOUN	B
of	O	ADP	O
Stat6	B-protein	NOUN	B
is	O	AUX	O
highly	O	ADV	O
dependent	O	ADJ	B
on	O	ADP	O
promoter	O	NOUN	B
context	O	NOUN	I
and	O	CCONJ	O
that	O	SCONJ	O
this	O	DET	O
factor	O	NOUN	B
promotes	O	VERB	B
IL-4	B-protein	NOUN	B
gene	O	NOUN	B
expression	O	NOUN	I
in	O	ADP	O
an	O	DET	O
indirect	O	ADJ	B
manner	O	NOUN	O
.	O	PUNCT	O


BACKGROUND	O	NOUN	O
&	O	CCONJ	O
AIMS	O	NOUN	B
:	O	PUNCT	O
Entamoeba	O	X	B
histolytica	O	NOUN	I
infection	O	NOUN	I
of	O	ADP	O
the	O	DET	O
intestine	O	NOUN	B
can	O	AUX	O
induce	O	VERB	B
severe	O	ADJ	B
gut	O	NOUN	B
inflammation	O	NOUN	I
.	O	PUNCT	O


Human	O	ADJ	B
intestinal	B-cell_type	ADJ	B
epithelial	I-cell_type	ADJ	B
cell	I-cell_type	NOUN	I
inflammatory	O	ADJ	B
responses	O	NOUN	I
to	O	PART	O
amebic	O	ADJ	B
infection	O	NOUN	I
were	O	AUX	O
inhibited	O	VERB	B
by	O	ADP	O
the	O	DET	O
intraluminal	O	ADJ	B
administration	O	NOUN	B
of	O	ADP	O
an	O	DET	O
antisense	O	ADJ	B
oligonucleotide	O	NOUN	I
to	O	PART	O
the	O	DET	O
human	B-protein	ADJ	B
p65	I-protein	NOUN	I
subunit	I-protein	NOUN	I
of	O	ADP	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
kappaB	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
neutrophils	O	NOUN	B
in	O	ADP	O
tissue	O	NOUN	B
damage	O	NOUN	I
observed	O	VERB	O
with	O	ADP	O
amebiasis	O	NOUN	B
was	O	AUX	O
studied	O	VERB	O
by	O	ADP	O
depleting	O	VERB	B
neutrophils	B-cell_type	NOUN	B
from	O	ADP	O
SCID-HU-INT	O	ADJ	B
mice	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
attempting	O	VERB	O
to	O	PART	O
investigate	O	VERB	B
its	O	PRON	O
effect	O	NOUN	B
on	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
T	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
found	O	VERB	O
triptolide	O	NOUN	B
induces	O	VERB	O
apoptotic	O	ADJ	B
death	O	NOUN	I
of	O	ADP	O
T	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
hybridomas	I-cell_line	NOUN	B
and	O	CCONJ	O
peripheral	B-cell_type	ADJ	B
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
but	O	CCONJ	O
not	O	PART	O
that	O	DET	O
of	O	ADP	O
thymocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	B
seem	O	VERB	O
to	O	PART	O
confirm	O	VERB	O
a	O	DET	O
possible	O	ADJ	O
role	O	NOUN	O
of	O	ADP	O
the	O	DET	O
transcriptional	B-protein	ADJ	B
complex	I-protein	NOUN	I
AP-1	B-protein	NOUN	B
in	O	ADP	O
activating	O	VERB	B
GST-pi	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
plasma	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Recently	O	ADV	O
,	O	PUNCT	O
there	O	PRON	O
has	O	AUX	O
been	O	AUX	O
some	O	DET	O
progress	O	NOUN	B
in	O	ADP	O
the	O	DET	O
understanding	O	NOUN	O
of	O	ADP	O
the	O	DET	O
signal	O	NOUN	B
transduction	O	NOUN	I
pathways	O	NOUN	I
activated	O	VERB	B
by	O	ADP	O
these	O	DET	O
cytokines	B-protein	NOUN	B
in	O	ADP	O
eosinophils	B-cell_type	NOUN	B
.	O	PUNCT	O


Moreover	O	ADV	O
,	O	PUNCT	O
antisense	O	ADJ	B
oligodeoxynucleotides	O	NOUN	I
targeting	O	VERB	B
either	O	CCONJ	O
GATA-1	B-protein	NOUN	B
or	O	CCONJ	O
p45	B-protein	NOUN	B
NF-E2	I-protein	NOUN	I
proteins	O	NOUN	I
inhibited	O	VERB	B
both	O	CCONJ	O
protein	O	NOUN	B
expression	O	NOUN	I
and	O	CCONJ	O
BA-induced	O	ADJ	B
differentiation	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
BA-induced	O	ADJ	B
cell	O	NOUN	O
growth	O	NOUN	O
inhibition	O	NOUN	B
was	O	AUX	O
not	O	PART	O
affected	O	VERB	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
provide	O	VERB	O
the	O	DET	O
first	O	ADJ	O
direct	O	ADJ	O
evidence	O	NOUN	B
for	O	ADP	O
the	O	DET	O
requirement	O	NOUN	B
of	O	ADP	O
GATA-1	B-protein	NOUN	B
and	O	CCONJ	O
NF-E2	B-protein	NOUN	B
in	O	ADP	O
BA-induced	O	ADJ	B
differentiation	O	NOUN	O
process	O	NOUN	O
.	O	PUNCT	O


Characterisation	O	NOUN	B
of	O	ADP	O
regulatory	O	ADJ	B
sequences	O	NOUN	I
at	O	ADP	O
the	O	DET	O
Epstein-Barr	B-DNA	ADJ	B
virus	I-DNA	NOUN	I
BamHI	I-DNA	NOUN	I
W	I-DNA	NOUN	I
promoter	I-DNA	NOUN	B
.	O	PUNCT	O


The	O	DET	O
initiation	O	NOUN	B
of	O	ADP	O
this	O	DET	O
growth	O	NOUN	B
transforming	O	NOUN	I
infection	O	NOUN	I
depends	O	VERB	O
on	O	ADP	O
a	O	DET	O
viral	B-DNA	ADJ	B
promoter	I-DNA	NOUN	I
in	O	ADP	O
BamHI	O	NOUN	B
W	O	NOUN	I
(	O	PUNCT	O
Wp	O	NOUN	B
)	O	PUNCT	O
whose	O	DET	O
regulation	O	NOUN	B
is	O	AUX	O
poorly	O	ADV	O
understood	O	VERB	O
.	O	PUNCT	O


By	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
UAS1	B-DNA	NOUN	B
(	O	PUNCT	O
-140	B-DNA	NUM	O
to	I-DNA	PART	O
-87	I-DNA	NUM	O
)	O	PUNCT	O
was	O	AUX	O
B	O	NOUN	B
cell	O	NOUN	I
specific	O	ADJ	B
and	O	CCONJ	O
was	O	AUX	O
the	O	DET	O
key	O	ADJ	O
determinant	O	NOUN	O
of	O	ADP	O
the	O	DET	O
promoter	O	NOUN	B
's	O	PART	I
increased	O	VERB	B
activity	O	NOUN	B
in	O	ADP	O
B	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
.	O	PUNCT	O


Following	O	VERB	O
EBV	O	NOUN	B
infection	O	NOUN	O
,	O	PUNCT	O
Epstein-Barr	O	ADJ	B
nuclear	O	ADJ	I
antigen	O	NOUN	I
(	O	PUNCT	O
EBNA	B-protein	NOUN	B
)	O	PUNCT	O
expression	O	NOUN	B
could	O	AUX	O
be	O	AUX	O
detected	O	VERB	B
in	O	ADP	O
T	B-cell_type	NOUN	B
rosetting	I-cell_type	NOUN	I
CD4+	I-cell_type	ADJ	I
and	I-cell_type	CCONJ	O
CD8+	I-cell_type	ADJ	B
T	I-cell_type	NOUN	I
lymphocytes	I-cell_type	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
to	O	PART	O
myeloid-related	B-cell_type	ADJ	B
DC	I-cell_type	NOUN	B
,	O	PUNCT	O
granulocyte-macrophage	B-protein	ADJ	B
colony-stimulating	I-protein	ADJ	I
factor	I-protein	NOUN	I
is	O	AUX	O
not	O	PART	O
required	O	VERB	O
for	O	ADP	O
the	O	DET	O
development	O	NOUN	B
of	O	ADP	O
these	O	DET	O
lymphoid-related	B-cell_type	ADJ	O
DC	I-cell_type	NOUN	B
in	O	X	B
vivo	O	X	I
or	O	CCONJ	O
in	O	X	B
vitro	O	X	I
.	O	PUNCT	O


Post	O	VERB	B
HIV-1	O	NOUN	B
entry	O	NOUN	B
,	O	PUNCT	O
productive	O	ADJ	O
HIV-1	O	NOUN	B
infection	O	NOUN	B
of	O	ADP	O
primary	B-cell_type	ADJ	B
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
requires	O	VERB	O
overcoming	O	VERB	O
several	O	ADJ	O
cellular	O	ADJ	B
blocks	O	NOUN	I
to	O	PART	O
provirus	O	NOUN	B
establishment	O	NOUN	B
and	O	CCONJ	O
replication	O	NOUN	B
.	O	PUNCT	O


Regulation	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
,	O	PUNCT	O
AP-1	B-protein	NOUN	B
,	O	PUNCT	O
NFAT	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
STAT1	B-protein	NOUN	B
nuclear	O	ADJ	B
import	O	NOUN	I
in	O	ADP	O
T	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
by	O	ADP	O
noninvasive	O	ADJ	B
delivery	O	NOUN	I
of	O	ADP	O
peptide	O	NOUN	B
carrying	O	VERB	O
the	O	DET	O
nuclear	B-protein	ADJ	B
localization	I-protein	NOUN	I
sequence	I-protein	NOUN	I
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
p50	I-protein	NOUN	B
.	O	PUNCT	O


NLS	B-protein	NOUN	B
peptide-mediated	O	ADJ	B
disruption	O	NOUN	B
of	O	ADP	O
the	O	DET	O
nuclear	O	ADJ	B
import	O	NOUN	I
of	O	ADP	O
these	O	DET	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
results	O	VERB	B
in	O	ADP	O
inhibition	O	NOUN	B
of	O	ADP	O
I	O	NOUN	O
kappa	O	NOUN	O
B	O	NOUN	O
alpha	O	NOUN	O
and	O	CCONJ	O
IL-2	O	NOUN	B
gene	O	NOUN	I
expression	O	NOUN	B
,	O	PUNCT	O
processes	O	NOUN	B
dependent	O	ADJ	O
on	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
or	O	CCONJ	O
the	O	DET	O
combination	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
,	O	PUNCT	O
AP-1	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
NFAT	B-protein	NOUN	B
.	O	PUNCT	O


Taken	O	VERB	O
together	O	ADV	O
,	O	PUNCT	O
these	O	DET	O
data	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
inducible	O	ADJ	B
nuclear	O	ADJ	B
import	O	NOUN	I
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
,	O	PUNCT	O
AP-1	B-protein	NOUN	B
,	O	PUNCT	O
NFAT	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
STAT1	B-protein	NOUN	B
in	O	ADP	O
Jurkat	B-cell_line	NOUN	B
T	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
can	O	AUX	O
be	O	AUX	O
regulated	O	VERB	O
by	O	ADP	O
NLS	B-protein	NOUN	B
peptide	O	NOUN	I
delivered	O	VERB	O
noninvasively	O	ADV	B
to	O	PART	O
the	O	DET	O
cytoplasm	O	NOUN	B
of	O	ADP	O
Jurkat	B-cell_line	NOUN	B
T	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
to	O	PART	O
target	O	VERB	B
members	O	NOUN	O
of	O	ADP	O
the	O	DET	O
importin	B-protein	NOUN	B
(	I-protein	PUNCT	O
karyopherin	I-protein	NOUN	B
)	I-protein	PUNCT	O
-alpha	I-protein	NOUN	O
beta	I-protein	NOUN	B
NLS	B-protein	NOUN	I
receptor	I-protein	NOUN	I
complex	I-protein	NOUN	I
.	O	PUNCT	O


Forty-eight	O	NUM	O
hours	O	NOUN	O
after	O	ADP	O
transfection	O	NOUN	B
,	O	PUNCT	O
EC	B-cell_type	NOUN	B
were	O	AUX	O
stimulated	O	VERB	B
with	O	ADP	O
NK	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
or	O	CCONJ	O
NK	B-cell_type	NOUN	B
cell	I-cell_type	NOUN	I
membrane	I-cell_type	NOUN	I
extracts	I-cell_type	NOUN	O
for	O	ADP	O
7	O	NUM	O
hr	O	NOUN	O
and	O	CCONJ	O
activation	O	NOUN	B
was	O	AUX	O
measured	O	VERB	B
by	O	ADP	O
a	O	DET	O
luciferase	B-protein	NOUN	B
assay	O	NOUN	I
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
LTalpha	B-protein	NOUN	B
was	O	AUX	O
secreted	O	VERB	B
in	O	ADP	O
NK	B-cell_line	NOUN	B
:	I-cell_line	PUNCT	O
EC	I-cell_line	NOUN	B
co-cultures	I-cell_line	NOUN	B
.	O	PUNCT	O


Coexpression	O	NOUN	B
of	O	ADP	O
dominant	B-protein	ADJ	B
negative	I-protein	ADJ	B
Ras	I-protein	NOUN	B
abrogated	O	VERB	B
the	O	DET	O
basal	O	ADJ	B
or	O	CCONJ	O
ionomycin-stimulated	O	ADJ	B
,	O	PUNCT	O
70Z/3	B-protein	NOUN	B
-mediated	O	ADJ	O
NFAT	B-protein	NOUN	B
activation	O	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
a	O	DET	O
functional	B-protein	ADJ	B
Ras	I-protein	NOUN	B
is	O	AUX	O
required	O	VERB	O
for	O	ADP	O
this	O	DET	O
activation	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
previously	O	ADV	O
reported	O	VERB	O
that	O	SCONJ	O
monocyte	O	NOUN	B
adhesion	O	NOUN	I
to	O	PART	O
tumor	B-cell_line	NOUN	B
necrosis	I-cell_line	NOUN	I
factor-alpha	I-cell_line	NOUN	I
(	I-cell_line	PUNCT	O
TNF-alpha	I-cell_line	NOUN	B
)	I-cell_line	PUNCT	O
-treated	I-cell_line	ADJ	O
endothelial	I-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
increased	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
tissue	O	NOUN	B
factor	O	NOUN	I
and	O	CCONJ	O
CD36	B-protein	NOUN	B
on	O	ADP	O
monocytes	O	NOUN	B
.	O	PUNCT	O


To	O	PART	O
examine	O	VERB	O
transcriptional	O	ADJ	B
regulation	O	NOUN	I
of	O	ADP	O
cytokine	B-DNA	NOUN	B
genes	I-DNA	NOUN	I
by	O	ADP	O
CD15	O	NOUN	B
engagement	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
CAT	O	NOUN	B
plasmid	O	NOUN	I
reporter	O	NOUN	B
construct	O	NOUN	I
containing	O	VERB	O
IL-1	B-DNA	NOUN	B
beta	I-DNA	NOUN	O
promoter/enhancer	I-DNA	NOUN	O
sequences	I-DNA	NOUN	O
was	O	AUX	O
introduced	O	VERB	O
into	O	ADP	O
MM6	B-cell_line	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
to	O	PART	O
its	O	PRON	O
well-recognized	O	ADJ	O
adhesive	O	ADJ	B
role	O	NOUN	O
,	O	PUNCT	O
CD15	O	NOUN	B
may	O	AUX	O
function	O	VERB	B
as	O	ADP	O
an	O	DET	O
important	O	ADJ	O
signaling	O	NOUN	B
molecule	O	NOUN	I
capable	O	ADJ	O
of	O	ADP	O
initiating	O	VERB	O
proinflammatory	O	ADJ	B
events	O	NOUN	I
in	O	ADP	O
monocytes	B-cell_type	NOUN	B
that	O	PRON	O
come	O	VERB	O
into	O	ADP	O
contact	O	NOUN	B
with	O	ADP	I
activated	O	VERB	B
endothelium	O	NOUN	I
.	O	PUNCT	O


CD2	B-protein	NOUN	B
cross-linking	O	NOUN	B
concurrently	O	ADV	O
increased	O	VERB	B
phosphorylation	O	NOUN	B
of	O	ADP	O
CREB	B-protein	NOUN	B
detected	O	VERB	B
by	O	ADP	O
immunoblot	O	NOUN	B
assay	O	NOUN	I
eightfold	O	ADV	B
.	O	PUNCT	O


The	O	DET	O
importance	O	NOUN	O
of	O	ADP	O
these	O	DET	O
observations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
pathophysiology	O	NOUN	B
of	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
AIDS-related	O	ADJ	B
cancers	O	NOUN	I
treated	O	VERB	B
by	O	ADP	I
radiotherapy	O	NOUN	B
remains	O	VERB	O
to	O	PART	O
be	O	AUX	O
established	O	VERB	O
.	O	PUNCT	O


Activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
delta-globin	I-DNA	NOUN	O
gene	I-DNA	NOUN	O
promoter	I-DNA	NOUN	B
in	O	ADP	O
primary	B-cell_type	ADJ	B
adult	I-cell_type	ADJ	I
erythroid	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Restoration	O	NOUN	B
of	O	ADP	O
the	O	DET	O
CCAAT	B-DNA	NOUN	B
box	I-DNA	NOUN	I
or	O	CCONJ	O
insertion	O	NOUN	B
of	O	ADP	O
an	O	DET	O
erythroid	B-DNA	ADJ	B
Kruppel-like	I-DNA	ADJ	O
factor	I-DNA	NOUN	O
(	I-DNA	PUNCT	O
EKLF	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
binding	I-DNA	NOUN	B
site	I-DNA	NOUN	I
in	O	ADP	O
the	O	DET	O
delta	B-DNA	NOUN	B
promoter	I-DNA	NOUN	I
activates	O	VERB	B
its	O	PRON	O
expression	O	NOUN	B
in	O	ADP	O
several	O	ADJ	O
erythroid	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	O
lines	I-cell_line	NOUN	O
.	O	PUNCT	O


The	O	DET	O
lung	B-cell_type	NOUN	B
macrophage	I-cell_type	NOUN	I
was	O	AUX	O
identified	O	VERB	O
as	O	ADP	O
the	O	DET	O
main	O	ADJ	O
cellular	O	ADJ	B
source	O	NOUN	I
for	O	ADP	O
critical	O	ADJ	O
inflammatory	B-protein	ADJ	B
mediators	I-protein	NOUN	I
such	O	ADJ	O
as	O	ADP	O
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor-alpha	I-protein	NOUN	I
,	O	PUNCT	O
the	O	DET	O
chemokines	B-protein	NOUN	B
interleukin	B-protein	NOUN	I
(	I-protein	PUNCT	O
IL	I-protein	NOUN	B
)	I-protein	PUNCT	O
-8	I-protein	NUM	O
and	I-protein	CCONJ	O
-6	I-protein	NUM	B
,	O	PUNCT	O
and	O	CCONJ	O
matrix	B-protein	NOUN	B
metalloproteinase-9	I-protein	NOUN	I
in	O	ADP	O
this	O	DET	O
model	O	NOUN	B
system	O	NOUN	I
of	O	ADP	O
mechanical	O	ADJ	B
ventilation	O	NOUN	I
.	O	PUNCT	O


Other	O	ADJ	O
lung	O	NOUN	B
cell	O	NOUN	I
types	O	NOUN	O
such	O	ADJ	O
as	O	ADP	O
endothelial	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
bronchial	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
fibroblasts	B-cell_type	NOUN	B
failed	O	VERB	B
to	O	PART	O
produce	O	VERB	O
IL-8	B-protein	NOUN	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
a	O	DET	O
prolonged	O	ADJ	B
cyclic	O	ADJ	B
pressure-stretching	O	ADJ	I
load	O	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
system	O	NOUN	B
,	O	PUNCT	O
simultaneous	O	ADJ	B
exposure	O	NOUN	B
to	O	PART	O
CD40L	B-protein	NOUN	B
together	O	ADV	O
with	O	ADP	O
either	O	CCONJ	O
IL-4	B-protein	NOUN	B
or	O	CCONJ	O
IFN-gamma	B-protein	NOUN	B
does	O	AUX	O
not	O	PART	O
lead	O	VERB	O
to	O	PART	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
novel	O	ADJ	O
Rel/STAT	B-protein	NOUN	B
complexes	I-protein	NOUN	I
.	O	PUNCT	O


Human	B-cell_type	ADJ	B
monocytic	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
express	O	VERB	O
interleukin-1beta	B-protein	NOUN	B
(	O	PUNCT	O
IL-1beta	B-protein	NOUN	B
)	O	PUNCT	O
when	O	SCONJ	O
stimulated	O	VERB	B
with	O	ADP	O
the	O	DET	O
extracellular	B-protein	ADJ	B
matrix	I-protein	NOUN	I
glycoprotein	I-protein	NOUN	I
,	O	PUNCT	O
fibronectin	B-protein	NOUN	B
(	O	PUNCT	O
FN	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
C	I-protein	NOUN	I
(	O	PUNCT	O
PKC	B-protein	NOUN	B
)	O	PUNCT	O
activation	O	NOUN	B
is	O	AUX	O
considered	O	VERB	O
important	O	ADJ	O
for	O	ADP	O
this	O	DET	O
process	O	NOUN	B
;	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
metabolic	O	ADJ	B
steps	O	NOUN	B
at	O	ADP	O
which	O	DET	O
PKC	B-protein	NOUN	B
acts	O	VERB	O
upon	O	SCONJ	O
to	O	PART	O
mediate	O	VERB	O
the	O	DET	O
FN	B-protein	NOUN	B
-induced	O	ADJ	O
IL-1beta	B-protein	NOUN	B
response	O	NOUN	B
remain	O	VERB	O
unclear	O	ADJ	B
.	O	PUNCT	O


U937	O	NOUN	B
cells	O	NOUN	I
transfected	O	VERB	B
with	O	ADP	O
the	O	DET	O
human	O	ADJ	B
full-length	B-DNA	ADJ	B
IL-1beta	I-DNA	NOUN	B
promoter	I-DNA	NOUN	B
connected	O	VERB	O
to	O	PART	O
a	O	DET	O
luciferase	B-DNA	NOUN	B
reporter	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
were	O	AUX	O
submitted	O	VERB	O
to	O	PART	O
transcription	O	NOUN	B
assays	O	NOUN	I
,	O	PUNCT	O
Northern	O	NOUN	B
blotting	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
DNA	O	NOUN	B
electrophoresis	O	NOUN	I
mobility	O	NOUN	B
gel	O	NOUN	I
shift	O	NOUN	O
assays	O	NOUN	O
.	O	PUNCT	O


To	O	PART	O
approach	O	VERB	O
this	O	DET	O
issue	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
used	O	VERB	O
CD36	B-protein	NOUN	B
transfected	O	ADJ	B
Chinese	B-cell_type	ADJ	B
hampster	I-cell_type	NOUN	I
ovary	I-cell_type	NOUN	I
(	I-cell_type	PUNCT	O
CHO	I-cell_type	NOUN	O
)	I-cell_type	PUNCT	O
cells	I-cell_type	NOUN	O
,	O	PUNCT	O
exposed	O	VERB	B
them	O	PRON	O
to	O	PART	O
Ox	O	NOUN	B
LDL	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
determined	O	VERB	O
changes	O	NOUN	B
in	O	ADP	O
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
NF-kappaB	B-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
structural	O	ADJ	B
organization	O	NOUN	I
of	O	ADP	O
the	O	DET	O
393	B-protein	NUM	O
amino	I-protein	NOUN	B
acid	I-protein	NOUN	I
long	I-protein	ADJ	O
human	I-protein	ADJ	B
TRAMP	I-protein	NOUN	B
is	O	AUX	O
most	O	ADV	O
homologous	O	ADJ	B
to	O	PART	O
TNF	B-protein	NOUN	B
receptor	I-protein	NOUN	I
1	I-protein	NUM	I
.	O	PUNCT	O


The	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
both	O	DET	O
cytokines	B-protein	NOUN	B
on	O	ADP	O
the	O	DET	O
monocyte	O	NOUN	B
maturation/differentiation	O	NOUN	I
(	O	PUNCT	O
CD11b	B-protein	NOUN	B
,	O	PUNCT	O
CD13	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
CD26	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
other	O	ADJ	O
macrophage	B-protein	NOUN	B
markers	I-protein	NOUN	B
(	O	PUNCT	O
CD14	B-protein	NOUN	B
and	O	CCONJ	O
CD68	B-protein	NOUN	B
)	O	PUNCT	O
was	O	AUX	O
examined	O	VERB	B
.	O	PUNCT	O


Mice	O	NOUN	B
lacking	O	VERB	B
the	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
CIITA	B-protein	NOUN	B
--	O	PUNCT	O
a	O	DET	O
second	O	ADJ	O
look	O	NOUN	O
.	O	PUNCT	O


Our	O	PRON	O
and	O	CCONJ	O
the	O	DET	O
previously	O	ADV	O
published	O	VERB	B
lines	O	NOUN	I
differ	O	VERB	O
in	O	ADP	O
the	O	DET	O
deletion	O	NOUN	B
that	O	PRON	O
was	O	AUX	O
engineered	O	VERB	B
and	O	CCONJ	O
by	O	ADP	O
the	O	DET	O
fact	O	NOUN	O
that	O	SCONJ	O
we	O	PRON	O
removed	O	VERB	O
the	O	DET	O
neomycin-resistance	B-DNA	ADJ	B
promoter	I-DNA	NOUN	I
and	O	CCONJ	O
structural	B-DNA	ADJ	B
gene	I-DNA	NOUN	I
via	O	ADP	O
the	O	DET	O
cre-loxP	O	ADJ	B
recombination	O	NOUN	I
system	O	NOUN	I
.	O	PUNCT	O


Second	O	ADV	O
,	O	PUNCT	O
in	O	ADP	O
contrast	O	NOUN	O
to	O	PART	O
recent	O	ADJ	O
results	O	NOUN	B
on	O	ADP	O
human	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	O
lines	I-cell_line	NOUN	O
,	O	PUNCT	O
CIITA	B-protein	NOUN	B
is	O	AUX	O
not	O	PART	O
critically	O	ADV	O
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
IFN-gamma	B-protein	NOUN	B
-induced	O	ADJ	O
up-regulation	O	NOUN	B
of	O	ADP	O
MHC	B-DNA	NOUN	B
class	I-DNA	NOUN	B
I	I-DNA	NUM	I
genes	I-DNA	NOUN	I
.	O	PUNCT	O


NF-kappaB	B-protein	NOUN	B
activation	O	NOUN	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
inflammatory	O	ADJ	B
signals	O	NOUN	O
is	O	AUX	O
dependent	O	ADJ	O
upon	O	SCONJ	O
degradation	O	NOUN	B
of	O	ADP	O
its	O	PRON	O
associated	O	VERB	O
inhibitory	O	ADJ	B
peptide	O	NOUN	O
,	O	PUNCT	O
inhibitory	B-protein	ADJ	B
kappaB-alpha	I-protein	NOUN	B
(	O	PUNCT	O
IkappaB-alpha	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Following	O	VERB	O
stimulation	O	NOUN	B
,	O	PUNCT	O
TNF-alpha	B-protein	NOUN	B
was	O	AUX	O
measured	O	VERB	B
in	O	ADP	O
cell	O	NOUN	B
supernatants	O	NOUN	I
by	O	ADP	O
ELISA	O	NOUN	B
,	O	PUNCT	O
NF-kappaB	B-protein	NOUN	B
activity	O	NOUN	B
by	O	ADP	O
electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assay	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
IkappaB-alpha	B-protein	NOUN	B
levels	O	NOUN	B
by	O	ADP	O
Western	O	NOUN	B
blot	O	NOUN	I
.	O	PUNCT	O


After	O	ADP	O
LPS	O	NOUN	B
stimulation	O	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
,	O	PUNCT	O
IkappaB-alpha	B-protein	NOUN	B
protein	O	NOUN	I
levels	O	NOUN	O
decreased	O	VERB	B
,	O	PUNCT	O
and	O	CCONJ	O
NF-kappaB	B-protein	NOUN	B
DNA	O	NOUN	B
binding	O	NOUN	I
increased	O	VERB	B
.	O	PUNCT	O


Dexamethasone	O	NOUN	B
inhibits	O	VERB	B
binding	O	VERB	B
to	O	PART	O
the	O	DET	O
Ikaros	B-protein	NOUN	B
and	O	CCONJ	O
AP-1	B-DNA	NOUN	B
regulatory	I-DNA	ADJ	I
elements	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
granzyme	B-DNA	NOUN	B
B	I-DNA	NOUN	I
promoter	I-DNA	NOUN	B
.	O	PUNCT	O


Dexamethasone	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
glucocorticoid	O	NOUN	B
that	O	PRON	O
is	O	AUX	O
widely	O	ADV	O
used	O	VERB	O
as	O	ADP	O
an	O	DET	O
immunomodulatory	O	ADJ	B
and	O	CCONJ	O
anti-inflammatory	O	ADJ	B
agent	O	NOUN	I
,	O	PUNCT	O
inhibits	O	VERB	B
granzyme	B-RNA	NOUN	B
B	I-RNA	NOUN	I
mRNA	I-RNA	NOUN	B
transcript	I-RNA	NOUN	I
in	O	ADP	O
phytohemagglutinin-activated	B-cell_type	ADJ	B
peripheral	I-cell_type	ADJ	I
blood	I-cell_type	NOUN	I
mononuclear	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Glucocorticoid	B-protein	NOUN	B
receptors	I-protein	NOUN	I
on	O	ADP	O
mononuclear	B-cell_type	ADJ	B
leukocytes	I-cell_type	NOUN	B
in	O	ADP	O
polycystic	O	ADJ	B
ovary	O	ADJ	I
syndrome	O	NOUN	I
.	O	PUNCT	O


METHOD	O	NOUN	B
:	O	PUNCT	O
For	O	ADP	O
this	O	DET	O
purpose	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
number	O	NOUN	B
and	O	CCONJ	O
affinity	O	NOUN	B
of	O	ADP	O
GR	B-protein	NOUN	B
in	O	ADP	O
peripheral	O	ADJ	B
mononuclear	B-cell_type	ADJ	I
leukocytes	I-cell_type	NOUN	B
(	O	PUNCT	O
MNL	O	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
10	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
PCOS	O	NOUN	B
and	O	CCONJ	O
10	O	NUM	O
healthy	O	ADJ	B
women	O	NOUN	B
(	O	PUNCT	O
controls	O	NOUN	B
)	O	PUNCT	O
were	O	AUX	O
determined	O	VERB	O
.	O	PUNCT	O


NGAL	B-protein	NOUN	B
levels	O	NOUN	B
varied	O	VERB	O
in	O	ADP	O
these	O	DET	O
tumors	O	NOUN	B
from	O	ADP	O
undetectable	O	ADJ	B
to	O	PART	O
exceeding	O	VERB	O
those	O	DET	O
in	O	ADP	O
normal	O	ADJ	O
breast	O	NOUN	B
parenchyma	O	NOUN	I
.	O	PUNCT	O


BASH	B-protein	NOUN	B
shows	O	VERB	O
a	O	DET	O
substantial	O	ADJ	O
sequence	O	NOUN	O
similarity	O	NOUN	O
to	O	PART	O
SLP-76	B-protein	NOUN	B
,	O	PUNCT	O
an	O	DET	O
adaptor	O	NOUN	B
protein	O	NOUN	I
functioning	O	VERB	B
in	O	ADP	O
TCR	B-protein	NOUN	B
-signal	O	ADJ	O
transduction	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
investigation	O	NOUN	B
was	O	AUX	O
undertaken	O	VERB	O
to	O	PART	O
determine	O	VERB	O
the	O	DET	O
composition	O	NOUN	B
of	O	ADP	O
StatG	B-protein	NOUN	B
in	O	ADP	O
mature	B-cell_type	ADJ	B
normal	I-cell_type	ADJ	O
human	I-cell_type	ADJ	B
myeloid	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
i.e	O	ADV	O
.	O	PUNCT	O
polymorphonuclear	B-cell_type	ADJ	B
neutrophilic	I-cell_type	ADJ	O
granulocytes	I-cell_type	NOUN	O
(	O	PUNCT	O
PMN	B-cell_type	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Stat3gamma	B-protein	NOUN	B
is	O	AUX	O
derived	O	VERB	O
from	O	ADP	O
Stat3alpha	B-protein	NOUN	B
by	O	ADP	O
limited	O	ADJ	B
proteolysis	O	NOUN	B
and	O	CCONJ	O
lacks	O	VERB	B
the	O	DET	O
carboxyl-terminal	B-protein	ADJ	B
portion	I-protein	NOUN	I
of	O	ADP	O
Stat3alpha	B-protein	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
order	O	NOUN	O
to	O	PART	O
investigate	O	VERB	B
the	O	DET	O
factors	O	NOUN	B
that	O	PRON	O
influence	O	VERB	B
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
ICAM-1	B-protein	NOUN	B
molecules	O	NOUN	I
,	O	PUNCT	O
Northern	O	NOUN	B
blot	O	NOUN	I
analysis	O	NOUN	I
to	O	PART	O
measure	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
level	O	NOUN	B
of	O	ADP	O
ICAM-1	B-RNA	NOUN	B
mRNAs	I-RNA	NOUN	B
and	O	CCONJ	O
Southern	O	NOUN	B
blot	O	NOUN	I
hybridization	O	NOUN	I
to	O	PART	O
analyze	O	VERB	B
the	O	DET	O
integration	O	NOUN	B
of	O	ADP	O
human	O	ADJ	B
T-cell-leukemia	O	NOUN	I
virus	O	NOUN	I
type	O	NOUN	I
1	O	NUM	I
(	O	PUNCT	O
HTLV-1	O	NOUN	B
)	O	PUNCT	O
provirus	O	NOUN	B
were	O	AUX	O
done	O	VERB	O
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
monoclonal	O	ADJ	B
integration	O	NOUN	B
of	O	ADP	O
HTLV-1	O	NOUN	B
provirus	O	NOUN	B
to	O	PART	O
the	O	DET	O
genome	O	NOUN	B
of	O	ADP	O
T	B-cell_type	NOUN	B
cell	I-cell_type	NOUN	I
,	O	PUNCT	O
especially	O	ADV	O
the	O	DET	O
number	O	NOUN	O
of	O	ADP	O
integration	O	NOUN	B
sites	O	NOUN	I
,	O	PUNCT	O
is	O	AUX	O
one	O	NUM	O
of	O	ADP	O
the	O	DET	O
factors	O	NOUN	B
for	O	ADP	O
induction	O	NOUN	B
of	O	ADP	O
ICAM-1	B-protein	NOUN	B
molecules	I-protein	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
both	O	DET	O
heat	O	NOUN	B
and	O	CCONJ	O
cadmium	O	NOUN	B
produced	O	VERB	O
an	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
the	O	DET	O
amount	O	NOUN	B
of	O	ADP	O
the	O	DET	O
intermediate	B-protein	NOUN	B
filament	I-protein	NOUN	I
protein	I-protein	NOUN	I
vimentin	B-protein	NOUN	O
,	O	PUNCT	O
as	O	ADP	O
determined	O	VERB	O
by	O	ADP	O
immunoblot	O	NOUN	B
and	O	CCONJ	O
immunofluorescence	O	NOUN	B
assays	O	NOUN	I
.	O	PUNCT	O


By	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
amounts	O	NOUN	O
of	O	ADP	O
actin	B-protein	NOUN	B
and	O	CCONJ	O
beta-tubulin	B-protein	NOUN	B
were	O	AUX	O
not	O	PART	O
significantly	O	ADV	O
altered	O	VERB	O
.	O	PUNCT	O


Ovarian	O	ADJ	B
and	O	CCONJ	O
breast	O	NOUN	B
cytotoxic	B-cell_type	ADJ	I
T	I-cell_type	NOUN	I
lymphocytes	I-cell_type	NOUN	I
can	O	AUX	O
recognize	O	VERB	O
peptides	O	NOUN	B
from	O	ADP	O
the	O	DET	O
amino	O	NOUN	B
enhancer	O	NOUN	I
of	O	ADP	O
split	O	ADJ	B
protein	O	NOUN	I
of	O	ADP	O
the	O	DET	O
Notch	B-protein	NOUN	B
complex	I-protein	NOUN	I
.	O	PUNCT	O


Three	O	NUM	O
of	O	ADP	O
these	O	DET	O
peptides	O	NOUN	B
designated	O	VERB	O
as	O	ADP	O
G75	O	NOUN	B
:	O	PUNCT	O
AES1/2	O	NOUN	B
(	O	PUNCT	O
128-135	B-protein	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
G60	O	NOUN	B
:	O	PUNCT	O
AES1/2	O	NOUN	B
(	O	PUNCT	O
127-137	B-protein	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
G61	O	NOUN	B
:	O	PUNCT	O
AES1/2	O	NOUN	B
(	O	PUNCT	O
125-133	B-protein	NUM	B
)	O	PUNCT	O
correspond	O	VERB	O
to	O	PART	O
the	O	DET	O
wildtype	B-DNA	ADJ	B
AES	I-DNA	NOUN	B
sequence	I-DNA	NOUN	B
,	O	PUNCT	O
while	O	SCONJ	O
the	O	DET	O
fourth	O	ADJ	O
G76	O	NOUN	B
:	O	PUNCT	O
GPLTPLPV	O	PROPN	B
,	O	PUNCT	O
AES1/2	B-protein	NOUN	B
(	I-protein	PUNCT	O
128-135	I-protein	NUM	O
)	I-protein	PUNCT	O
corresponds	O	VERB	O
to	O	PART	O
a	O	DET	O
variant	O	ADJ	B
sequence	O	NOUN	B
of	O	ADP	O
the	O	DET	O
peptide	O	NOUN	B
G75	O	NOUN	I
with	O	ADP	O
the	O	DET	O
N-terminal	O	ADJ	B
Leu	O	NOUN	I
substituted	O	VERB	O
to	O	PART	O
glycine	O	NOUN	B
.	O	PUNCT	O


Our	O	PRON	O
data	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
stimulation	O	NOUN	B
of	O	ADP	O
PML	B-DNA	NOUN	B
expression	O	NOUN	B
by	O	ADP	O
interferons	B-protein	NOUN	B
and	O	CCONJ	O
IL-1	B-protein	NOUN	B
may	O	AUX	O
account	O	VERB	O
for	O	ADP	O
upregulation	O	NOUN	B
of	O	ADP	O
PML	B-protein	NOUN	B
proteins	I-protein	NOUN	I
observed	O	VERB	O
in	O	ADP	O
inflammatory	O	ADJ	B
tissues	O	NOUN	I
and	O	CCONJ	O
in	O	ADP	O
proliferative	O	ADJ	B
states	O	NOUN	O
.	O	PUNCT	O


EBV	O	NOUN	B
encodes	O	VERB	B
a	O	DET	O
unique	O	ADJ	O
transcriptional	O	ADJ	B
activator	O	NOUN	I
,	O	PUNCT	O
known	O	VERB	O
as	O	ADP	O
ZEBRA	B-protein	NOUN	B
,	O	PUNCT	O
which	O	DET	O
can	O	AUX	O
disrupt	O	VERB	B
viral	O	ADJ	B
latency	O	NOUN	I
in	O	ADP	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
induce	O	VERB	B
lytic	O	ADJ	B
viral	O	ADJ	B
replication	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
mutants	O	NOUN	B
were	O	AUX	O
used	O	VERB	O
to	O	PART	O
demonstrate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
ability	O	NOUN	O
of	O	ADP	O
ZEBRA	B-protein	NOUN	B
's	I-protein	PART	I
wild	I-protein	ADJ	B
type	I-protein	NOUN	I
domain	I-protein	NOUN	I
to	O	PART	O
function	O	VERB	B
in	O	ADP	O
the	O	DET	O
complex	O	ADJ	B
biological	O	ADJ	B
process	O	NOUN	O
of	O	ADP	O
virus	O	NOUN	B
activation	O	NOUN	B
is	O	AUX	O
not	O	PART	O
compromised	O	VERB	O
by	O	ADP	O
altering	O	VERB	B
its	O	PRON	O
position	O	NOUN	B
within	O	ADP	O
the	O	DET	O
protein	O	NOUN	B
.	O	PUNCT	O


Interleukin-10	B-protein	NOUN	B
(	O	PUNCT	O
IL-10	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
transforming	B-protein	VERB	B
growth	I-protein	NOUN	I
factor	I-protein	NOUN	I
beta	I-protein	NOUN	I
(	O	PUNCT	O
TGF-beta	B-protein	NOUN	B
)	O	PUNCT	O
are	O	AUX	O
inhibitory	O	ADJ	B
for	O	ADP	O
B	B-cell_type	NOUN	B
and	I-cell_type	CCONJ	O
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
IgE	B-protein	NOUN	B
production	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
mast	O	NOUN	B
cell	O	NOUN	I
proliferation	O	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
they	O	PRON	O
induce	O	VERB	B
apoptosis	O	NOUN	B
in	O	ADP	O
eosinophils	B-cell_type	NOUN	B
.	O	PUNCT	O


The	O	DET	O
IL-10	B-protein	NOUN	B
gene	O	NOUN	B
polymorphism	O	NOUN	B
was	O	AUX	O
a	O	DET	O
C-to-A	O	ADJ	B
exchange	O	NOUN	I
571	B-DNA	NUM	I
base	I-DNA	NOUN	O
pairs	I-DNA	NOUN	O
upstream	I-DNA	ADJ	O
from	O	ADP	O
the	O	DET	O
translation	B-DNA	NOUN	B
start	I-DNA	NOUN	O
site	I-DNA	NOUN	B
and	O	CCONJ	O
was	O	AUX	O
present	O	ADJ	O
between	O	ADP	O
consensus	B-DNA	NOUN	B
binding	I-DNA	NOUN	I
sequences	I-DNA	NOUN	I
for	O	ADP	O
Sp1	B-protein	NOUN	B
and	O	CCONJ	O
elevated	O	ADJ	B
total	O	ADJ	O
serum	O	NOUN	B
.	O	PUNCT	O


Since	O	SCONJ	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
NFAT	B-protein	NOUN	B
is	O	AUX	O
MAPK	B-protein	NOUN	B
-dependent	O	ADJ	O
these	O	DET	O
findings	O	NOUN	B
suggested	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
MAPK	B-protein	NOUN	B
by	O	ADP	O
Tpl-2	B-protein	NOUN	B
is	O	AUX	O
either	O	CCONJ	O
independent	O	ADJ	B
or	O	CCONJ	O
only	O	ADV	O
partially	O	ADV	B
dependent	O	ADJ	I
on	O	ADP	O
MEK1	B-protein	NOUN	B
and	O	CCONJ	O
MEK2	B-protein	NOUN	B
.	O	PUNCT	O


Experiments	O	NOUN	B
in	O	ADP	O
COS-1	B-cell_line	NOUN	B
and	O	CCONJ	O
EL-4	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
confirmed	O	VERB	O
both	O	DET	O
hypotheses	O	NOUN	B
and	O	CCONJ	O
revealed	O	VERB	B
that	O	SCONJ	O
the	O	DET	O
second	O	ADJ	O
factor	O	NOUN	B
activated	O	VERB	B
by	O	ADP	O
Tpl-2	B-protein	NOUN	B
is	O	AUX	O
NF-kappaB	B-protein	NOUN	B
.	O	PUNCT	O


While	O	SCONJ	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IL-2	B-DNA	NOUN	B
promoter	I-DNA	NOUN	I
and	O	CCONJ	O
an	O	DET	O
NFAT-driven	B-DNA	ADJ	B
minimal	I-DNA	ADJ	B
promoter	I-DNA	NOUN	B
by	O	ADP	O
Tpl-2	B-protein	NOUN	B
was	O	AUX	O
fully	O	ADV	O
blocked	O	VERB	B
by	O	ADP	O
the	O	DET	O
dominant	B-protein	ADJ	B
negative	I-protein	ADJ	B
mutant	I-protein	ADJ	B
NFAT	B-protein	NOUN	O
delta418	I-protein	NOUN	O
,	O	PUNCT	O
it	O	PRON	O
was	O	AUX	O
only	O	ADV	O
partially	O	ADV	O
blocked	O	VERB	B
by	O	ADP	O
the	O	DET	O
calcineurin	B-protein	NOUN	B
inhibitor	O	NOUN	O
cyclosporin	O	NOUN	B
A	O	NOUN	O
suggesting	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
Tpl-2	B-protein	NOUN	B
-mediated	O	ADJ	O
NFAT	B-protein	NOUN	B
activation	O	NOUN	B
is	O	AUX	O
under	O	ADP	O
the	O	DET	O
control	O	NOUN	B
of	O	ADP	O
a	O	DET	O
combination	O	NOUN	B
of	O	ADP	O
calcineurin-dependent	O	ADJ	B
and	O	CCONJ	O
independent	O	ADJ	O
pathways	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
finding	O	NOUN	B
that	O	SCONJ	O
functionally	O	ADV	O
distinct	O	ADJ	O
isoforms	O	NOUN	B
of	O	ADP	O
STAT5	B-protein	NOUN	B
are	O	AUX	O
activated	O	VERB	B
during	O	ADP	O
the	O	DET	O
early	O	ADJ	B
and	O	CCONJ	O
late	O	ADJ	B
differentiation	O	NOUN	I
stages	O	NOUN	I
of	O	ADP	O
granulocytes	O	NOUN	B
suggests	O	VERB	O
that	O	SCONJ	O
they	O	PRON	O
might	O	AUX	O
be	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
regulating	O	VERB	B
different	O	ADJ	O
biological	O	ADJ	B
functions	O	NOUN	I
in	O	ADP	O
these	O	DET	O
cells	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
sharp	O	ADJ	O
contrast	O	NOUN	O
,	O	PUNCT	O
in	O	ADP	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
treated	O	VERB	B
with	O	ADP	I
the	O	DET	O
phorbol	O	NOUN	B
ester	O	NOUN	I
12-O-tetradecanoylphorbol-13-acetate	O	NOUN	I
(	O	PUNCT	O
TPA	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
strong	O	ADJ	O
interactions	O	NOUN	B
between	O	ADP	O
the	O	DET	O
X2	B-DNA	NOUN	B
box	I-DNA	NOUN	I
and	O	CCONJ	I
NF-X2	B-DNA	NOUN	I
containing	O	VERB	O
c-Fos	B-protein	NOUN	B
were	O	AUX	O
observed	O	VERB	B
.	O	PUNCT	O


We	O	PRON	O
analyzed	O	VERB	B
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
enhancer	B-DNA	NOUN	B
,	O	PUNCT	O
the	O	DET	O
promoter	B-DNA	NOUN	B
and	O	CCONJ	O
the	O	DET	O
silencer	B-DNA	NOUN	B
of	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
CD4	I-DNA	NOUN	B
gene	I-DNA	NOUN	I
during	O	ADP	O
T	O	NOUN	B
cell	O	NOUN	I
development	O	NOUN	B
using	O	VERB	O
transgenic	O	ADJ	B
mice	O	NOUN	I
.	O	PUNCT	O


Immunofluorescence	O	NOUN	B
studies	O	NOUN	I
on	O	ADP	O
thymic	B-cell_type	ADJ	B
populations	I-cell_type	NOUN	I
of	O	ADP	O
mice	O	NOUN	B
carrying	O	VERB	O
transgenes	O	NOUN	B
in	O	ADP	O
various	O	ADJ	O
combinations	O	NOUN	B
of	O	ADP	O
these	O	DET	O
regulatory	B-DNA	ADJ	B
DNA	I-DNA	NOUN	I
elements	I-DNA	NOUN	I
revealed	O	VERB	O
that	O	SCONJ	O
thymocytes	B-cell_type	NOUN	B
control	O	VERB	B
the	O	DET	O
CD4	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
in	O	ADP	O
a	O	DET	O
different	O	ADJ	O
manner	O	NOUN	O
than	O	ADP	O
mature	O	ADJ	B
peripheral	B-cell_type	ADJ	B
T	I-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
.	O	PUNCT	O


Glucocorticoids	O	NOUN	B
can	O	AUX	O
induce	O	VERB	B
apoptosis	O	NOUN	B
on	O	ADP	O
normal	B-cell_type	ADJ	O
lymphoid	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
play	O	VERB	O
a	O	DET	O
key	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
physiology	O	NOUN	B
of	O	ADP	O
thymic	O	ADJ	B
selection	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
clinics	O	NOUN	B
these	O	DET	O
molecules	O	NOUN	B
are	O	AUX	O
also	O	ADV	O
used	O	VERB	O
for	O	ADP	O
their	O	PRON	O
potencies	O	NOUN	B
in	O	ADP	O
inducing	O	VERB	B
apoptosis	O	NOUN	B
of	O	ADP	O
malignant	B-cell_type	ADJ	B
lymphoid	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Similar	O	ADJ	O
to	O	PART	O
the	O	DET	O
E2	O	NOUN	B
response	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
slope	O	NOUN	B
factors	O	NOUN	I
for	O	ADP	O
alpha-zearalenol	O	NOUN	B
,	O	PUNCT	O
zearalenone	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
genistein	O	NOUN	B
were	O	AUX	O
close	O	ADJ	O
to	O	PART	O
3.0	O	NUM	O
,	O	PUNCT	O
suggesting	O	VERB	O
positive	O	ADJ	B
cooperativity	O	NOUN	B
in	O	ADP	O
the	O	DET	O
estrogenic	O	ADJ	B
response	O	NOUN	I
.	O	PUNCT	O


Unlike	O	ADP	O
the	O	DET	O
mycoestrogens	O	NOUN	B
,	O	PUNCT	O
none	O	NOUN	O
of	O	ADP	O
the	O	DET	O
compounds	O	NOUN	B
,	O	PUNCT	O
with	O	ADP	O
the	O	DET	O
exception	O	NOUN	O
of	O	ADP	O
genistein	O	NOUN	B
,	O	PUNCT	O
synergized	O	VERB	B
with	O	ADP	O
LPS	O	NOUN	B
to	O	PART	O
enhance	O	VERB	O
IL-1beta	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
activity	O	NOUN	I
.	O	PUNCT	O


Dendritic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
autologous	B-cell_type	ADJ	B
CD4+	I-cell_type	ADJ	B
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
were	O	AUX	O
isolated	O	VERB	B
from	O	ADP	O
peripheral	O	ADJ	B
blood	O	NOUN	I
by	O	ADP	O
a	O	DET	O
series	O	NOUN	O
of	O	ADP	O
density-gradient	O	ADJ	B
centrifugations	O	NOUN	I
or	O	CCONJ	O
magnetic	O	ADJ	B
bead	O	NOUN	I
separations	O	NOUN	I
(	O	PUNCT	O
or	O	CCONJ	O
both	O	DET	O
)	O	PUNCT	O
.	O	PUNCT	O


Peptides	O	NOUN	B
corresponding	O	VERB	O
to	O	PART	O
residues	O	NOUN	B
of	O	ADP	O
the	O	DET	O
immediate	B-protein	ADJ	O
early	I-protein	ADJ	O
protein	I-protein	NOUN	B
,	O	PUNCT	O
IE62	B-protein	NOUN	B
,	O	PUNCT	O
of	O	ADP	O
varicella-zoster	O	NOUN	B
virus	O	NOUN	I
(	O	PUNCT	O
VZV	O	NOUN	B
)	O	PUNCT	O
were	O	AUX	O
used	O	VERB	O
as	O	ADP	O
stimulating	B-protein	VERB	B
antigens	I-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
persons	O	NOUN	B
with	O	ADP	O
no	O	DET	O
history	O	NOUN	O
of	O	ADP	O
varicella	O	NOUN	B
and	O	CCONJ	O
no	O	DET	O
humoral	O	ADJ	B
or	O	CCONJ	O
cellular	O	ADJ	B
immunity	O	NOUN	I
to	O	PART	O
VZV	O	NOUN	B
served	O	VERB	O
as	O	ADP	O
naive	O	ADJ	B
donors	O	NOUN	I
for	O	ADP	O
the	O	DET	O
assays	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
assay	O	NOUN	B
has	O	AUX	O
potential	O	ADJ	B
as	O	ADP	O
a	O	DET	O
screen	O	NOUN	B
to	O	PART	O
establish	O	VERB	O
the	O	DET	O
immunogenicity	O	NOUN	B
of	O	ADP	O
viral	O	ADJ	B
antigens	O	NOUN	I
in	O	X	B
vitro	O	X	I
using	O	VERB	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
from	O	ADP	O
naive	O	ADJ	B
donors	O	NOUN	I
.	O	PUNCT	O


Anaphylatoxins	B-protein	NOUN	B
C5a	B-protein	NOUN	I
and	O	CCONJ	O
C3a	B-protein	NOUN	B
induce	O	VERB	B
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
kappaB	I-protein	NOUN	I
activation	O	NOUN	I
in	O	ADP	O
human	B-cell_type	ADJ	B
peripheral	I-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
monocytes	I-cell_type	NOUN	O
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
imply	O	VERB	O
a	O	DET	O
potential	O	ADJ	O
role	O	NOUN	O
of	O	ADP	O
the	O	DET	O
anaphylatoxins	B-protein	NOUN	B
C5a	B-protein	NOUN	I
and	O	CCONJ	O
C3a	B-protein	NOUN	B
in	O	ADP	O
regulating	O	VERB	B
leukocytes	O	NOUN	B
gene	O	NOUN	B
expression	O	NOUN	I
through	O	ADP	O
G	O	NOUN	B
protein-coupled	O	ADJ	I
transcription	O	NOUN	I
factor	O	NOUN	I
activation	O	NOUN	I
.	O	PUNCT	O


Thrombopoietin	B-protein	NOUN	B
and	O	CCONJ	O
its	O	PRON	O
receptor	O	NOUN	B
.	O	PUNCT	O


TPO	B-protein	NOUN	B
is	O	AUX	O
a	O	DET	O
hormone	O	NOUN	B
constitutively	O	ADV	B
produced	O	VERB	O
mainly	O	ADV	O
by	O	ADP	O
the	O	DET	O
liver	O	NOUN	B
and	O	CCONJ	O
kidney	O	NOUN	B
.	O	PUNCT	O


TAL1	B-protein	NOUN	B
and	O	CCONJ	O
LIM-only	B-protein	ADJ	B
proteins	I-protein	NOUN	B
synergistically	O	ADV	B
induce	O	VERB	B
retinaldehyde	B-protein	NOUN	B
dehydrogenase	I-protein	NOUN	I
2	I-protein	NUM	I
expression	O	NOUN	B
in	O	ADP	O
T-cell	O	NOUN	B
acute	O	ADJ	I
lymphoblastic	O	ADJ	I
leukemia	O	NOUN	I
by	O	ADP	O
acting	O	VERB	O
as	O	ADP	O
cofactors	O	NOUN	B
for	O	ADP	O
GATA3	B-protein	NOUN	B
.	O	PUNCT	O


As	O	ADP	O
a	O	DET	O
step	O	NOUN	O
toward	O	ADP	O
elucidating	O	VERB	O
the	O	DET	O
pathophysiological	O	ADJ	B
background	O	NOUN	B
of	O	ADP	O
the	O	DET	O
so-called	O	ADJ	O
glucose	O	NOUN	B
toxicity	O	NOUN	B
to	O	PART	O
pancreatic	B-cell_type	ADJ	B
beta	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
induced	O	VERB	B
glycation	O	NOUN	B
in	O	ADP	O
HIT-T15	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
using	O	VERB	O
a	O	DET	O
sugar	O	NOUN	B
with	O	ADP	O
strong	O	ADJ	O
deoxidizing	O	NOUN	B
activity	O	NOUN	I
,	O	PUNCT	O
D-ribose	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
examined	O	VERB	B
the	O	DET	O
effects	O	NOUN	B
on	O	ADP	O
insulin	O	NOUN	B
gene	O	NOUN	I
transcription	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
results	O	NOUN	B
of	O	ADP	O
reporter	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
analyses	O	NOUN	I
revealed	O	VERB	B
that	O	SCONJ	O
the	O	DET	O
insulin	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
promoter	I-DNA	NOUN	B
is	O	AUX	O
more	O	ADV	O
sensitive	O	ADJ	B
to	O	PART	O
glycation	O	NOUN	B
than	O	ADP	O
the	O	DET	O
control	O	ADJ	B
beta-actin	B-DNA	NOUN	B
gene	I-DNA	NOUN	O
promoter	I-DNA	NOUN	O
;	O	PUNCT	O
approximately	O	ADV	O
50	O	NUM	O
and	O	CCONJ	O
80	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
the	O	DET	O
insulin	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
promoter	I-DNA	NOUN	B
activity	O	NOUN	I
was	O	AUX	O
lost	O	VERB	B
when	O	SCONJ	O
the	O	DET	O
cells	O	NOUN	B
were	O	AUX	O
kept	O	VERB	O
for	O	ADP	O
3	O	NUM	O
d	O	NOUN	O
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
40	O	NUM	O
and	O	CCONJ	O
60	O	NUM	O
mM	O	NOUN	O
D-ribose	O	NOUN	B
,	O	PUNCT	O
respectively	O	ADV	O
.	O	PUNCT	O


Nuclear	B-protein	ADJ	B
factor-kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
activity	O	NOUN	I
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
from	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
rheumatic	O	ADJ	B
diseases	O	NOUN	I
:	O	PUNCT	O
a	O	DET	O
preliminary	O	ADJ	B
report	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
this	O	DET	O
nuclear	O	ADJ	B
factor	O	NOUN	I
is	O	AUX	O
qualitatively	O	ADV	B
different	O	ADJ	O
in	O	ADP	O
rheumatoid	B-cell_type	ADJ	B
synovial	I-cell_type	ADJ	O
T	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
to	O	PART	O
that	O	DET	O
in	O	ADP	O
other	O	ADJ	O
forms	O	NOUN	O
of	O	ADP	O
non-rheumatoid	O	ADJ	B
arthritis	O	NOUN	I
(	O	PUNCT	O
for	O	ADP	O
example	O	NOUN	O
,	O	PUNCT	O
osteoarthritis	O	NOUN	B
,	O	PUNCT	O
spondyloarthropathies	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


In-vitro	O	X	B
transcription/translation	O	NOUN	B
of	O	ADP	O
this	O	DET	O
cDNA	B-DNA	NOUN	B
expressed	O	VERB	B
a	O	DET	O
protein	O	NOUN	B
of	O	ADP	O
approximately	O	ADV	O
20	O	NUM	O
kDa	O	NOUN	O
.	O	PUNCT	O


Conserved	B-DNA	VERB	B
elements	I-DNA	NOUN	I
containing	O	VERB	O
NF-E2	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
tandem	I-DNA	ADJ	B
GATA	I-DNA	NOUN	B
binding	I-DNA	NOUN	I
sites	I-DNA	NOUN	I
are	O	AUX	O
required	O	VERB	O
for	O	ADP	O
erythroid-specific	O	ADJ	B
chromatin	O	NOUN	I
structure	O	NOUN	I
reorganization	O	NOUN	O
within	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
beta-globin	I-DNA	NOUN	O
locus	I-DNA	NOUN	O
control	I-DNA	NOUN	O
region	I-DNA	NOUN	O
.	O	PUNCT	O


These	O	DET	O
domains	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
have	O	AUX	O
been	O	AUX	O
characterized	O	VERB	B
as	O	ADP	O
DNase	B-DNA	NOUN	B
I	I-DNA	NUM	I
hypersensitive	I-DNA	ADJ	O
sites	I-DNA	NOUN	O
(	O	PUNCT	O
HSs	B-DNA	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
comprise	O	VERB	O
the	O	DET	O
active	O	ADJ	B
elements	O	NOUN	I
of	O	ADP	O
the	O	DET	O
LCR	B-DNA	NOUN	B
.	O	PUNCT	O


Our	O	PRON	O
previous	O	ADJ	O
investigations	O	NOUN	B
on	O	ADP	O
the	O	DET	O
formation	O	NOUN	B
of	O	ADP	O
LCR	B-DNA	NOUN	B
HS4	I-DNA	NOUN	B
demonstrated	O	VERB	O
that	O	SCONJ	O
NF-E2	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
tandem	I-DNA	ADJ	B
,	I-DNA	PUNCT	O
inverted	I-DNA	ADJ	O
GATA	I-DNA	NOUN	O
binding	I-DNA	NOUN	O
sites	I-DNA	NOUN	O
are	O	AUX	O
required	O	VERB	O
for	O	ADP	O
the	O	DET	O
formation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
native	B-DNA	ADJ	B
HS	I-DNA	NOUN	B
.	O	PUNCT	O


Similarly	O	ADV	O
arranged	O	VERB	O
NF-E2	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
tandem	I-DNA	ADJ	B
GATA	I-DNA	NOUN	B
sites	I-DNA	NOUN	I
are	O	AUX	O
present	O	ADJ	O
within	O	ADP	O
the	O	DET	O
core	B-DNA	NOUN	B
regions	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
other	O	ADJ	O
human	B-DNA	ADJ	B
LCR	I-DNA	NOUN	B
HSs	I-DNA	NOUN	B
and	O	CCONJ	O
are	O	AUX	O
evolutionarily	O	ADV	O
conserved	O	VERB	O
.	O	PUNCT	O


AU-DD	B-DNA	NOUN	B
is	O	AUX	O
an	O	DET	O
AU-motif-directed	B-DNA	ADJ	B
differential	I-DNA	ADJ	I
display	I-DNA	NOUN	I
that	O	PRON	O
permits	O	VERB	O
the	O	DET	O
identification	O	NOUN	B
of	O	ADP	O
ARE-containing	B-DNA	ADJ	B
genes	I-DNA	NOUN	I
differentially	O	ADV	B
expressed	O	VERB	B
after	O	ADP	O
cell	O	NOUN	B
activation	O	NOUN	I
.	O	PUNCT	O


When	O	SCONJ	O
introduced	O	VERB	O
in	O	ADP	O
front	O	NOUN	O
of	O	ADP	O
a	O	DET	O
luciferase	B-DNA	NOUN	B
reporter	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
,	O	PUNCT	O
this	O	DET	O
promoter	O	NOUN	B
is	O	AUX	O
able	O	ADJ	O
to	O	PART	O
direct	O	VERB	O
a	O	DET	O
high	O	ADJ	O
luciferase	B-protein	NOUN	B
activity	O	NOUN	I
in	O	ADP	O
a	O	DET	O
human	B-cell_line	ADJ	B
B-LCL	I-cell_line	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
with	O	ADP	O
endometriosis	O	NOUN	B
,	O	PUNCT	O
adenomyotic	O	ADJ	B
lesions	O	NOUN	I
showed	O	VERB	O
identical	O	ADJ	O
steroid	B-protein	NOUN	B
hormone	I-protein	NOUN	I
receptor	I-protein	NOUN	I
expression	O	NOUN	B
,	O	PUNCT	O
proliferative	O	ADJ	B
activity	O	NOUN	I
,	O	PUNCT	O
bcl-2	B-protein	NOUN	B
expression	O	NOUN	B
and	O	CCONJ	O
leukocyte	O	NOUN	B
subpopulations	O	NOUN	I
to	O	PART	O
eutopic	O	ADJ	B
endometrium	O	NOUN	I
,	O	PUNCT	O
indicating	O	VERB	O
different	O	ADJ	O
aetiologies	O	NOUN	B
for	O	ADP	O
these	O	DET	O
disorders	O	NOUN	B
.	O	PUNCT	O


CD27	B-protein	NOUN	B
/CD70	O	NOUN	O
interaction	O	NOUN	B
augments	O	VERB	O
IgE	B-protein	NOUN	B
secretion	O	NOUN	B
by	O	ADP	O
promoting	O	VERB	B
the	O	DET	O
differentiation	O	NOUN	B
of	O	ADP	O
memory	B-cell_type	NOUN	B
B	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
into	O	ADP	O
plasma	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


The	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
IgE	B-protein	NOUN	B
switching	O	NOUN	B
in	O	ADP	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
requires	O	VERB	O
several	O	ADJ	O
signals	O	NOUN	B
given	O	VERB	O
by	O	ADP	O
cytokines	B-protein	NOUN	B
and	O	CCONJ	O
cell	O	NOUN	B
contact-delivered	O	ADJ	I
signals	O	NOUN	I
.	O	PUNCT	O


Recent	O	ADJ	O
studies	O	NOUN	B
,	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
demonstrate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
transcribed	O	VERB	B
5'-untranslated	B-DNA	ADJ	B
leader	I-DNA	NOUN	I
region	I-DNA	NOUN	I
(	O	PUNCT	O
5'-UTR	B-DNA	NOUN	B
)	O	PUNCT	O
also	O	ADV	O
contains	O	VERB	O
important	O	ADJ	O
transcriptional	B-DNA	ADJ	B
elements	I-DNA	NOUN	I
.	O	PUNCT	O


These	O	DET	O
regulatory	B-DNA	ADJ	B
elements	I-DNA	NOUN	I
situated	O	VERB	O
downstream	O	ADV	B
of	O	ADP	O
transcription	O	NOUN	B
interact	O	VERB	B
with	O	ADP	O
constitutive	O	ADJ	B
and	O	CCONJ	O
inducible	O	ADJ	B
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
,	O	PUNCT	O
mediate	O	VERB	O
transmission	O	NOUN	B
of	O	ADP	O
cellular	O	ADJ	B
activation	O	NOUN	I
signals	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
are	O	AUX	O
important	O	ADJ	O
for	O	ADP	O
efficient	O	ADJ	B
HIV-1	O	NOUN	B
transcription	O	NOUN	B
and	O	CCONJ	O
replication	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
5'-UTR	B-DNA	NOUN	B
also	O	ADV	O
interacts	O	VERB	O
with	O	ADP	O
a	O	DET	O
specific	O	ADJ	O
nucleosome	B-protein	NOUN	B
that	O	PRON	O
is	O	AUX	O
rapidly	O	ADV	O
displaced	O	VERB	O
during	O	ADP	O
transcriptional	O	ADJ	B
activation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
latent	O	ADJ	B
provirus	O	NOUN	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
transfection	O	NOUN	B
with	O	ADP	O
LMP1	B-DNA	NOUN	B
expression	I-DNA	NOUN	B
vector	I-DNA	NOUN	I
into	O	ADP	O
a	O	DET	O
human	B-cell_line	ADJ	B
B	I-cell_line	NOUN	I
lymphoma	I-cell_line	NOUN	I
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
,	O	PUNCT	O
Daudi	B-cell_line	NOUN	B
,	O	PUNCT	O
led	O	VERB	O
to	O	PART	O
p40	B-protein	NOUN	B
production	O	NOUN	B
with	O	ADP	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
(	I-protein	PUNCT	O
NF	I-protein	NOUN	B
)	I-protein	PUNCT	O
-kappaB	I-protein	NOUN	B
activation	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
transformation	O	NOUN	B
of	O	ADP	O
primary	B-cell_type	ADJ	B
B	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
with	O	ADP	O
EBV	O	NOUN	B
induces	O	VERB	O
IL-12	B-protein	NOUN	B
expression	O	NOUN	B
potentially	O	ADV	O
through	O	ADP	O
LMP1	B-protein	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
human	B-DNA	ADJ	B
gene	I-DNA	NOUN	O
encoding	O	VERB	B
the	O	DET	O
lectin-type	B-protein	ADJ	B
oxidized	I-protein	VERB	B
LDL	I-protein	NOUN	I
receptor	I-protein	NOUN	I
(	O	PUNCT	O
OLR1	B-protein	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
novel	O	ADJ	O
member	O	NOUN	B
of	O	ADP	O
the	O	DET	O
natural	B-protein	ADJ	B
killer	I-protein	NOUN	I
gene	I-protein	NOUN	I
complex	I-protein	NOUN	I
with	O	ADP	O
a	O	DET	O
unique	O	ADJ	O
expression	O	NOUN	B
profile	O	NOUN	I
.	O	PUNCT	O


LOX-1	B-protein	NOUN	B
has	O	AUX	O
the	O	DET	O
highest	O	ADJ	O
homology	O	NOUN	B
with	O	ADP	O
C-type	B-protein	ADJ	B
lectin	I-protein	NOUN	I
receptors	I-protein	NOUN	I
expressed	O	VERB	B
on	O	ADP	O
natural	B-cell_type	ADJ	B
killer	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
demonstrate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
human	B-DNA	ADJ	B
LOX-1	I-DNA	NOUN	B
gene	I-DNA	NOUN	I
is	O	AUX	O
a	O	DET	O
new	O	ADJ	O
member	O	NOUN	O
of	O	ADP	O
the	O	DET	O
natural	B-protein	ADJ	B
killer	I-protein	NOUN	I
gene	I-protein	NOUN	I
complex	I-protein	NOUN	I
with	O	ADP	O
a	O	DET	O
unique	O	ADJ	O
expression	O	NOUN	B
profile	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
apparent	O	ADJ	B
contradiction	O	NOUN	O
,	O	PUNCT	O
expression	O	NOUN	B
of	O	ADP	O
a	O	DET	O
dominant	O	ADJ	B
negative	O	ADJ	B
form	O	NOUN	O
of	O	ADP	O
Ras	B-protein	NOUN	B
,	O	PUNCT	O
RasN17	B-protein	NOUN	B
,	O	PUNCT	O
also	O	ADV	O
inhibited	O	VERB	B
IL-2	B-protein	NOUN	B
-induced	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
promoter	O	NOUN	B
containing	O	VERB	O
the	O	DET	O
minimal	O	ADJ	B
beta-casein	B-DNA	NOUN	B
STAT5	I-DNA	NOUN	B
element	I-DNA	NOUN	B
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
the	O	DET	O
promoters	O	NOUN	B
of	O	ADP	O
CIS	B-protein	NOUN	B
and	O	CCONJ	O
OSM	B-protein	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
Ras	B-protein	NOUN	B
(	I-protein	PUNCT	O
G12V	I-protein	NOUN	B
)	I-protein	PUNCT	O
complemented	O	VERB	B
signaling	O	NOUN	B
by	O	ADP	O
an	O	DET	O
erythropoietin	B-protein	NOUN	B
receptor	I-protein	NOUN	I
mutant	I-protein	NOUN	I
defective	O	ADJ	B
in	O	ADP	O
Ras	B-protein	NOUN	B
activation	O	NOUN	B
and	O	CCONJ	O
augmented	O	VERB	B
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
beta-casein	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
by	O	ADP	O
the	O	DET	O
mutant	B-protein	ADJ	B
erythropoietin	I-protein	NOUN	I
receptor	I-protein	NOUN	I
signaling	O	NOUN	I
,	O	PUNCT	O
suggesting	O	VERB	O
a	O	DET	O
possible	O	ADJ	O
role	O	NOUN	O
of	O	ADP	O
Ras	B-protein	NOUN	B
in	O	ADP	O
Stat5	B-protein	NOUN	B
-mediated	O	ADJ	O
gene	O	NOUN	B
expression	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
collectively	O	ADV	O
reveal	O	VERB	O
a	O	DET	O
complex	O	ADJ	B
interaction	O	NOUN	B
of	O	ADP	O
STAT5	B-protein	NOUN	B
with	O	ADP	O
other	O	ADJ	O
signaling	O	NOUN	B
pathways	O	NOUN	I
and	O	CCONJ	O
illustrate	O	VERB	O
that	O	SCONJ	O
regulation	O	NOUN	B
of	O	ADP	O
gene	O	NOUN	B
expression	O	NOUN	I
requires	O	VERB	O
integration	O	NOUN	B
of	O	ADP	O
opposing	O	ADJ	O
signals	O	NOUN	B


We	O	PRON	O
have	O	AUX	O
investigated	O	VERB	B
the	O	DET	O
signal	O	NOUN	B
transduction	O	NOUN	I
pathway	O	NOUN	I
from	O	ADP	O
Fc	B-protein	NOUN	B
receptors	I-protein	NOUN	I
that	O	PRON	O
leads	O	VERB	O
to	O	PART	O
gene	O	NOUN	B
activation	O	NOUN	I
and	O	CCONJ	O
production	O	NOUN	B
of	O	ADP	O
cytokines	B-protein	NOUN	B
in	O	ADP	O
monocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
further	O	ADV	O
demonstrated	O	VERB	O
that	O	SCONJ	O
IL-2	B-protein	NOUN	B
,	I-protein	PUNCT	O
-7	I-protein	NUM	B
,	I-protein	PUNCT	O
and	I-protein	CCONJ	O
-15	I-protein	NUM	O
induce	O	VERB	B
multiple	B-protein	ADJ	O
STAT	I-protein	NOUN	B
proteins	I-protein	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
STAT5a	B-protein	NOUN	B
,	O	PUNCT	O
STAT5b	B-protein	NOUN	B
,	O	PUNCT	O
STAT1	B-protein	NOUN	B
alpha	I-protein	NOUN	I
,	O	PUNCT	O
STAT3	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
another	O	DET	O
unidentified	O	ADJ	O
Fc	B-protein	NOUN	B
gamma	I-protein	NOUN	I
RI	I-protein	NOUN	I
GAS	I-protein	NOUN	B
DNA-binding	I-protein	ADJ	B
protein	I-protein	NOUN	I
.	O	PUNCT	O


Finally	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
observed	O	VERB	O
that	O	SCONJ	O
activated	O	VERB	B
STAT5a	B-protein	NOUN	B
and	O	CCONJ	O
STAT5b	B-protein	NOUN	B
proteins	O	NOUN	I
form	O	VERB	O
distinct	O	ADJ	O
Fc	O	NOUN	B
gamma	O	NOUN	I
RI	O	NOUN	I
GAS	O	NOUN	B
binding	O	NOUN	I
patterns	O	NOUN	O
in	O	ADP	O
T	B-cell_type	NOUN	B
and	I-cell_type	CCONJ	O
NK	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
they	O	PRON	O
might	O	AUX	O
have	O	AUX	O
different	O	ADJ	O
roles	O	NOUN	O
in	O	ADP	O
gene	O	NOUN	B
regulation	O	NOUN	I
.	O	PUNCT	O


Our	O	PRON	O
data	O	NOUN	B
provide	O	VERB	O
evidence	O	NOUN	B
that	O	SCONJ	O
the	O	DET	O
differential	O	ADJ	B
responses	O	NOUN	I
in	O	ADP	O
gene	O	NOUN	B
expression	O	NOUN	I
and	O	CCONJ	O
cell	O	NOUN	B
activation	O	NOUN	I
seen	O	VERB	O
in	O	ADP	O
primary	O	ADJ	B
NK	B-cell_type	NOUN	B
and	I-cell_type	CCONJ	O
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
on	O	ADP	O
direct	O	ADJ	O
stimulation	O	NOUN	B
with	O	ADP	O
different	O	ADJ	O
cytokines	B-protein	NOUN	B
may	O	AUX	O
be	O	AUX	O
a	O	DET	O
direct	O	ADJ	O
result	O	NOUN	O
of	O	ADP	O
distinct	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
STAT	B-protein	NOUN	B
transcription	I-protein	NOUN	I
factors	I-protein	NOUN	I
.	O	PUNCT	O


To	O	PART	O
study	O	VERB	B
the	O	DET	O
molecular	O	ADJ	B
mechanisms	O	NOUN	I
of	O	ADP	O
transcriptional	O	ADJ	B
control	O	NOUN	I
of	O	ADP	O
CD95L	B-protein	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
investigated	O	VERB	B
the	O	DET	O
human	B-DNA	ADJ	B
CD95L	I-DNA	NOUN	B
promoter	I-DNA	NOUN	B
in	O	ADP	O
Jurkat	B-cell_line	NOUN	B
T	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


A	O	DET	O
mouse	O	NOUN	B
carrying	O	VERB	O
genetic	O	ADJ	B
defect	O	NOUN	I
in	O	ADP	O
the	O	DET	O
choice	O	NOUN	O
between	O	ADP	O
T	B-cell_type	NOUN	B
and	I-cell_type	CCONJ	O
B	I-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
.	O	PUNCT	O


Downstream	O	ADJ	B
activation	O	NOUN	B
of	O	ADP	O
a	O	DET	O
TATA-less	B-DNA	ADJ	B
promoter	I-DNA	NOUN	B
by	O	ADP	O
Oct-2	B-protein	NOUN	B
,	O	PUNCT	O
Bob1	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
NF-kappaB	B-protein	NOUN	B
directs	O	VERB	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
homing	B-protein	ADJ	B
receptor	I-protein	NOUN	I
BLR1	I-protein	NOUN	B
to	O	PART	O
mature	B-cell_type	ADJ	B
B	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


The	O	DET	O
long-term	O	ADJ	B
exposure	O	NOUN	B
of	O	ADP	I
Jurkat	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
to	O	PART	O
hormone	O	NOUN	B
eventually	O	ADV	O
results	O	VERB	O
in	O	ADP	O
a	O	DET	O
selection	O	NOUN	B
of	O	ADP	O
cell	B-cell_line	NOUN	B
clones	I-cell_line	NOUN	I
that	O	PRON	O
have	O	AUX	O
lost	O	VERB	O
Tax	B-protein	NOUN	B
activity	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
study	O	NOUN	B
suggests	O	VERB	O
a	O	DET	O
therapeutic	O	ADJ	B
approach	O	NOUN	I
against	O	ADP	O
AIDS	O	NOUN	B
by	O	ADP	O
application	O	NOUN	B
of	O	ADP	O
two	O	NUM	O
drugs	O	NOUN	B
,	O	PUNCT	O
one	O	NUM	O
against	O	ADP	O
a	O	DET	O
cellular	O	ADJ	B
and	O	CCONJ	O
the	O	DET	O
other	O	ADJ	O
a	O	DET	O
viral	O	ADJ	B
target	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
may	O	AUX	O
provide	O	VERB	O
an	O	DET	O
approach	O	NOUN	O
to	O	ADP	O
the	O	DET	O
problem	O	NOUN	B
of	O	ADP	O
frequent	O	ADJ	B
emergence	O	NOUN	B
of	O	ADP	O
resistant	O	ADJ	B
variants	O	NOUN	B
to	O	PART	O
combinations	O	NOUN	B
of	O	ADP	O
drugs	O	NOUN	B
that	O	PRON	O
target	O	VERB	B
only	O	ADV	O
HIV	B-DNA	NOUN	B
genes	I-DNA	NOUN	I
.	O	PUNCT	O


Intestinal	B-cell_type	ADJ	B
epithelial	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
can	O	AUX	O
express	O	VERB	O
HLA	B-protein	NOUN	B
class	I-protein	NOUN	I
II	I-protein	NUM	I
antigens	I-protein	NOUN	B
and	O	CCONJ	O
may	O	AUX	O
function	O	VERB	B
as	O	ADP	O
antigen-presenting	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
to	I-cell_type	PART	O
CD4	I-cell_type	NOUN	B
(	I-cell_type	PUNCT	O
+	I-cell_type	CCONJ	O
)	I-cell_type	PUNCT	O
T	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
within	O	ADP	O
the	O	DET	O
intestinal	O	ADJ	B
mucosa	O	NOUN	I
.	O	PUNCT	O


Tobacco	O	NOUN	B
smoke	O	NOUN	I
(	O	PUNCT	O
TS	O	NOUN	B
)	O	PUNCT	O
exposure	O	NOUN	B
is	O	AUX	O
a	O	DET	O
major	O	ADJ	O
risk	O	NOUN	B
factor	O	NOUN	I
for	O	ADP	O
human	O	ADJ	B
disease	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
macrophages	B-cell_type	NOUN	B
of	O	ADP	O
healthy	O	ADJ	B
smokers	O	NOUN	I
have	O	AUX	O
a	O	DET	O
depressed	O	ADJ	B
capacity	O	NOUN	I
to	O	PART	O
release	O	VERB	B
cytokines	B-protein	NOUN	B
,	O	PUNCT	O
including	O	VERB	O
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor	I-protein	NOUN	I
(	I-protein	PUNCT	O
TNF	I-protein	NOUN	B
)	I-protein	PUNCT	O
alpha	I-protein	NOUN	O
.	O	PUNCT	O


HSF	B-protein	NOUN	B
activation	O	NOUN	B
has	O	AUX	O
been	O	AUX	O
shown	O	VERB	O
to	O	PART	O
inhibit	O	VERB	B
NFkappaB	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
altered	O	ADJ	O
cytokine	B-protein	NOUN	B
profile	I-protein	NOUN	I
observed	O	VERB	O
in	O	ADP	O
smokers	O	NOUN	B
may	O	AUX	O
relate	O	VERB	O
to	O	PART	O
an	O	DET	O
HSF	B-protein	NOUN	B
/	O	PUNCT	O
Hsp70	B-protein	NOUN	B
-mediated	O	ADJ	O
inhibition	O	NOUN	B
of	O	ADP	O
NFkappaB	B-protein	NOUN	B
activity	O	NOUN	O
.	O	PUNCT	O


Activation	O	NOUN	B
of	O	ADP	O
helper	B-cell_type	NOUN	B
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
mediated	O	VERB	O
by	O	ADP	O
the	O	DET	O
T	O	NOUN	B
cell	O	NOUN	I
receptor	O	NOUN	I
induces	O	VERB	B
a	O	DET	O
series	O	NOUN	O
of	O	ADP	O
biochemical	O	ADJ	B
events	O	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
propose	O	VERB	O
that	O	SCONJ	O
one	O	NUM	O
of	O	ADP	O
the	O	DET	O
targets	O	NOUN	B
of	O	ADP	O
PGE2	O	NOUN	B
,	O	PUNCT	O
whose	O	DET	O
effect	O	NOUN	B
distinguishes	O	VERB	O
Th1	B-cell_line	NOUN	B
from	O	ADP	O
Th2	O	NOUN	B
,	O	PUNCT	O
resides	O	VERB	B
in	O	ADP	O
the	O	DET	O
downstream	O	ADJ	B
PKC/Ras	B-protein	ADJ	B
-mediated	O	ADJ	O
pathway	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
translocation	O	NOUN	B
process	O	NOUN	B
coupled	O	VERB	B
to	O	PART	O
the	O	DET	O
subsequent	O	ADJ	O
active	O	ADJ	B
maintenance	O	NOUN	B
of	O	ADP	O
NFAT	B-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
nucleus	O	NOUN	B
compartment	O	NOUN	B
is	O	AUX	O
critical	O	ADJ	O
for	O	ADP	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
expression	O	NOUN	B
of	O	ADP	O
several	O	ADJ	O
genes	O	NOUN	B
encoding	O	VERB	B
cytokines	B-protein	NOUN	B
and	O	CCONJ	O
membrane	B-protein	NOUN	B
proteins	I-protein	NOUN	I
that	O	PRON	O
modulate	O	VERB	B
immune	O	ADJ	B
responses	O	NOUN	I
.	O	PUNCT	O


Differential	O	ADJ	B
RNA	O	NOUN	O
display	O	NOUN	O
identifies	O	VERB	O
novel	B-DNA	ADJ	O
genes	I-DNA	NOUN	B
associated	O	VERB	B
with	O	ADP	I
decreased	O	VERB	B
vitamin	B-protein	NOUN	B
D	I-protein	NOUN	I
receptor	I-protein	NOUN	I
expression	O	NOUN	B
.	O	PUNCT	O


Experiments	O	NOUN	B
conducted	O	VERB	O
with	O	ADP	O
different	O	ADJ	O
HIV-1	B-DNA	NOUN	B
LTR-based	I-DNA	ADJ	B
vectors	I-DNA	NOUN	I
suggested	O	VERB	O
that	O	SCONJ	O
PGE2-mediated	O	ADJ	B
activation	O	NOUN	B
effect	O	NOUN	O
on	O	ADP	O
HIV-1	O	NOUN	B
transcription	O	NOUN	B
was	O	AUX	O
transduced	O	VERB	B
via	O	ADP	O
both	O	CCONJ	O
NF-kappaB-dependent	O	ADJ	B
and	O	CCONJ	O
-independent	O	ADJ	O
signaling	O	NOUN	B
pathways	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
study	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
investigated	O	VERB	B
whether	O	SCONJ	O
these	O	DET	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
become	O	VERB	O
activated	O	VERB	B
under	O	ADP	O
stimulatory	O	ADJ	B
conditions	O	NOUN	I
which	O	DET	O
are	O	AUX	O
known	O	VERB	O
to	O	PART	O
induce	O	VERB	B
gene	O	NOUN	B
transcription	O	NOUN	I
in	O	ADP	O
neutrophils	B-cell_type	NOUN	B
.	O	PUNCT	O


Collectively	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
current	O	ADJ	O
findings	O	NOUN	B
open	O	VERB	O
new	O	ADJ	O
perspectives	O	NOUN	B
about	O	ADP	O
mechanisms	O	NOUN	B
that	O	PRON	O
are	O	AUX	O
likely	O	ADJ	O
to	O	PART	O
regulate	O	VERB	B
gene	O	NOUN	B
transcription	O	NOUN	I
in	O	ADP	O
neutrophils	B-cell_type	NOUN	B
.	O	PUNCT	O


Low	O	ADJ	B
CD3+CD28-induced	O	ADJ	B
interleukin-2	B-protein	NOUN	I
production	O	NOUN	B
correlates	O	VERB	B
with	O	ADP	O
decreased	O	VERB	B
reactive	O	ADJ	B
oxygen	O	NOUN	I
intermediate	O	NOUN	I
formation	O	NOUN	I
in	O	ADP	O
neonatal	B-cell_type	ADJ	B
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
analysed	O	VERB	B
IL-2	B-protein	NOUN	B
production	O	NOUN	B
in	O	ADP	O
purified	O	VERB	B
neonatal	B-cell_type	ADJ	B
and	I-cell_type	CCONJ	O
adult	I-cell_type	ADJ	B
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
using	O	VERB	O
polyclonal	O	ADJ	B
activator	O	NOUN	I
phorbol	O	NOUN	B
ester	O	NOUN	I
+	O	CCONJ	O
calcium	O	NOUN	B
ionophore	O	NOUN	I
(	O	PUNCT	O
PDBu	O	NOUN	B
+	O	CCONJ	O
iono	O	NOUN	B
)	O	PUNCT	O
or	O	CCONJ	O
receptor-mediated	O	ADJ	B
anti-CD3	B-protein	ADJ	I
/anti-CD3+	O	PUNCT	O
anti-CD28	B-protein	ADJ	B
stimulation	O	NOUN	O
.	O	PUNCT	O


Expression	O	NOUN	B
of	O	ADP	O
CD30	B-protein	NOUN	B
by	O	ADP	O
these	O	DET	O
cells	O	NOUN	B
is	O	AUX	O
induced	O	VERB	B
by	O	ADP	O
CD40L	B-protein	NOUN	B
but	O	CCONJ	O
is	O	AUX	O
inhibited	O	VERB	B
by	O	ADP	O
B	O	NOUN	B
cell	O	NOUN	I
receptor	O	NOUN	I
coengagement	O	NOUN	B
and/or	O	CCONJ	O
exposure	O	NOUN	B
to	O	PART	I
IL-6	B-protein	NOUN	B
and	O	CCONJ	O
IL-12	B-protein	NOUN	B
.	O	PUNCT	O


Finally	O	ADV	O
,	O	PUNCT	O
it	O	PRON	O
would	O	AUX	O
be	O	AUX	O
useful	O	ADJ	O
to	O	PART	O
know	O	VERB	O
what	O	PRON	O
the	O	DET	O
inhibitory	O	ADJ	B
effects	O	NOUN	B
of	O	ADP	O
CyA	O	NOUN	B
are	O	AUX	O
on	O	ADP	O
tolerance	O	NOUN	B
and	O	CCONJ	O
negative	O	ADJ	B
regulatory	O	ADJ	O
events	O	NOUN	O
.	O	PUNCT	O


During	O	ADP	O
B	O	NOUN	B
and	O	CCONJ	O
T	O	NOUN	B
cell	O	NOUN	I
differentiation	O	NOUN	O
and	O	CCONJ	O
proliferation	O	NOUN	B
many	O	ADJ	O
genes	O	NOUN	B
are	O	AUX	O
induced	O	VERB	B
or	O	CCONJ	O
repressed	O	VERB	B
while	O	SCONJ	O
certain	O	ADJ	O
genes	O	NOUN	B
are	O	AUX	O
constitutively	O	ADV	B
expressed	O	VERB	B
.	O	PUNCT	O


Also	O	ADV	O
genes	O	NOUN	B
encoding	O	VERB	B
proteins	O	NOUN	B
involved	O	VERB	O
in	O	ADP	O
DNA	O	NOUN	B
replication	O	NOUN	I
,	O	PUNCT	O
binding	O	NOUN	B
,	O	PUNCT	O
transcription	O	NOUN	B
and	O	CCONJ	O
translation	O	NOUN	B
were	O	AUX	O
induced	O	VERB	B
.	O	PUNCT	O


Large	O	ADJ	O
part	O	NOUN	O
of	O	ADP	O
the	O	DET	O
activated	B-DNA	VERB	B
genes	I-DNA	NOUN	I
were	O	AUX	O
under	O	ADP	O
very	O	ADV	O
stringent	O	ADJ	O
regulation	O	NOUN	B
being	O	AUX	O
expressed	O	VERB	B
only	O	ADV	O
after	O	ADP	O
stimulation	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
mechanism	O	NOUN	B
and	O	CCONJ	O
function	O	NOUN	B
of	O	ADP	O
the	O	DET	O
expressed	B-DNA	VERB	B
genes	I-DNA	NOUN	I
during	O	ADP	O
lymphocyte	O	NOUN	B
differentiation	O	NOUN	I
and	O	CCONJ	O
in	O	ADP	O
disorders	O	NOUN	B
is	O	AUX	O
discussed	O	VERB	O
.	O	PUNCT	O


Interleukin	B-protein	NOUN	B
2	I-protein	NUM	I
and	I-protein	CCONJ	O
15	I-protein	NUM	O
activate	O	VERB	B
Stat3alpha	B-protein	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
T	I-cell_type	NOUN	O
lymphocytes	I-cell_type	NOUN	O
.	O	PUNCT	O


It	O	PRON	O
is	O	AUX	O
unknown	O	ADJ	O
which	O	DET	O
Stat3	B-protein	NOUN	B
isoform	I-protein	NOUN	B
(	O	PUNCT	O
s	O	NOUN	O
)	O	PUNCT	O
is	O	AUX	O
activated	O	VERB	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	I
interleukin	B-protein	NOUN	O
(	I-protein	PUNCT	O
IL	I-protein	NOUN	B
)	I-protein	PUNCT	O
-2	I-protein	NUM	O
and	O	CCONJ	O
IL-15	B-protein	NOUN	B
.	O	PUNCT	O


Here	O	ADV	O
,	O	PUNCT	O
cytokine	B-protein	NOUN	B
-induced	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
Stat3	B-protein	NOUN	B
in	O	ADP	O
previously	O	ADV	O
activated	O	VERB	B
CD4	B-cell_type	NOUN	B
(	I-cell_type	PUNCT	O
+	I-cell_type	CCONJ	O
)	I-cell_type	PUNCT	O
human	I-cell_type	ADJ	B
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
was	O	AUX	O
examined	O	VERB	O
using	O	VERB	O
Stat3	B-protein	NOUN	B
antibodies	O	NOUN	I
directed	O	VERB	O
against	O	ADP	O
different	O	ADJ	O
regions	O	NOUN	B
of	O	ADP	O
Stat3	B-protein	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
minimal	O	ADJ	B
or	O	CCONJ	O
no	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
Stat3beta	B-protein	NOUN	B
was	O	AUX	O
observed	O	VERB	B
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
IL-2	B-protein	NOUN	B
and	O	CCONJ	O
IL-15	B-protein	NOUN	B
predominantly	O	ADV	O
activate	O	VERB	B
Stat3alpha	B-protein	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
CD4	I-cell_type	NOUN	B
(	I-cell_type	PUNCT	O
+	I-cell_type	CCONJ	O
)	I-cell_type	PUNCT	O
T	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
.	O	PUNCT	O


The	O	DET	O
cell	O	NOUN	B
type-specific	O	ADJ	I
increase	O	NOUN	B
in	O	ADP	O
LAL	B-protein	NOUN	B
expression	O	NOUN	B
is	O	AUX	O
further	O	ADV	O
investigated	O	VERB	B
in	O	ADP	O
the	O	DET	O
THP-1	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
with	O	ADP	O
respect	O	NOUN	O
to	O	PART	O
transcriptional	O	ADJ	B
regulation	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
order	O	NOUN	O
to	O	PART	O
determine	O	VERB	O
the	O	DET	O
cis-acting	B-DNA	ADJ	B
elements	I-DNA	NOUN	I
necessary	O	ADJ	O
for	O	ADP	O
both	O	CCONJ	O
basal	O	ADJ	B
and	O	CCONJ	O
phorbol	O	NOUN	B
12-myristate-13	O	ADJ	I
acetate	O	NOUN	I
(	O	PUNCT	O
PMA	O	NOUN	B
)	O	PUNCT	O
-enhanced	O	ADJ	O
promoter	O	NOUN	B
activity	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
performed	O	VERB	O
deletion	O	NOUN	B
analysis	O	NOUN	I
and	O	CCONJ	O
reporter	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
assays	O	NOUN	I
.	O	PUNCT	O


Relationship	O	NOUN	B
between	O	ADP	O
IkappaBalpha	B-protein	NOUN	B
constitutive	O	ADJ	O
expression	O	NOUN	B
,	O	PUNCT	O
TNFalpha	B-protein	NOUN	B
synthesis	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
apoptosis	O	NOUN	B
in	O	ADP	O
EBV-infected	B-cell_type	ADJ	B
lymphoblastoid	I-cell_type	ADJ	O
cells	I-cell_type	NOUN	O
.	O	PUNCT	O


Potent	O	ADJ	B
inhibition	O	NOUN	B
of	O	ADP	O
HIV	O	NOUN	B
type	O	NOUN	O
1	O	NUM	O
replication	O	NOUN	B
by	O	ADP	O
an	O	DET	O
antiinflammatory	O	ADJ	B
alkaloid	O	NOUN	I
,	O	PUNCT	O
cepharanthine	O	NOUN	B
,	O	PUNCT	O
in	O	ADP	O
chronically	B-cell_type	ADV	B
infected	I-cell_type	ADJ	B
monocytic	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Cepharanthine	O	NOUN	B
is	O	AUX	O
a	O	DET	O
biscoclaurine	O	NOUN	B
alkaloid	O	NOUN	I
isolated	O	VERB	B
from	O	ADP	O
Stephania	O	X	B
cepharantha	O	X	I
Hayata	O	X	I
and	O	CCONJ	O
has	O	AUX	O
been	O	AUX	O
shown	O	VERB	O
to	O	PART	O
have	O	AUX	O
antiinflammatory	O	ADJ	B
,	O	PUNCT	O
antiallergic	O	ADJ	B
,	O	PUNCT	O
and	O	CCONJ	O
immunomodulatory	O	ADJ	B
activities	O	NOUN	I
in	O	X	B
vivo	O	X	I
.	O	PUNCT	O


Two	O	NUM	O
chronically	B-cell_line	ADV	B
HIV-1-infected	I-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
,	O	PUNCT	O
U1	B-cell_line	NOUN	B
(	O	PUNCT	O
monocytic	O	ADJ	B
)	O	PUNCT	O
and	O	CCONJ	O
ACH-2	B-cell_line	NOUN	B
(	O	PUNCT	O
T	O	NOUN	B
lymphocytic	O	ADJ	I
)	O	PUNCT	O
,	O	PUNCT	O
were	O	AUX	O
stimulated	O	VERB	B
with	O	ADP	O
TNF-alpha	B-protein	NOUN	B
or	O	CCONJ	O
PMA	O	NOUN	B
and	O	CCONJ	O
cultured	O	VERB	B
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
various	O	ADJ	O
concentrations	O	NOUN	B
of	O	ADP	O
the	O	DET	O
compound	O	NOUN	B
.	O	PUNCT	O


NF-kappaB	B-protein	NOUN	B
only	O	ADV	O
partially	O	ADV	O
mediates	O	VERB	O
Epstein-Barr	B-protein	ADJ	B
virus	I-protein	NOUN	I
latent	I-protein	ADJ	B
membrane	I-protein	NOUN	I
protein	I-protein	NOUN	I
1	I-protein	NUM	I
activation	O	NOUN	B
of	O	ADP	O
B	O	NOUN	B
cells	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
purpose	O	NOUN	O
of	O	ADP	O
the	O	DET	O
present	O	ADJ	O
study	O	NOUN	B
was	O	AUX	O
to	O	PART	O
investigate	O	VERB	B
the	O	DET	O
importance	O	NOUN	O
of	O	ADP	O
NF-kappaB	B-protein	NOUN	B
induction	O	NOUN	B
in	O	ADP	O
the	O	DET	O
up-regulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
B	O	NOUN	B
cell	O	NOUN	I
activation	O	NOUN	O
markers	O	NOUN	B
ICAM-1	B-protein	NOUN	B
and	O	CCONJ	O
CD71	B-protein	NOUN	B
by	O	ADP	O
LMP1	B-protein	NOUN	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
LMP1	B-protein	NOUN	B
-induced	O	ADJ	O
cell	O	NOUN	B
size	O	NOUN	I
increase	O	NOUN	B
of	O	ADP	O
primary	B-cell_type	ADJ	B
B	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
was	O	AUX	O
unaffected	O	ADJ	O
by	O	ADP	O
IkappaB	B-protein	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


It	O	PRON	O
was	O	AUX	O
concluded	O	VERB	O
that	O	SCONJ	O
even	O	ADV	O
when	O	SCONJ	O
LMP1	B-protein	NOUN	B
is	O	AUX	O
unable	O	ADJ	O
to	O	PART	O
activate	O	VERB	B
NF-kappaB	B-protein	NOUN	B
,	O	PUNCT	O
it	O	PRON	O
is	O	AUX	O
still	O	ADV	O
capable	O	ADJ	O
of	O	ADP	O
inducing	O	VERB	B
certain	O	ADJ	O
characteristics	O	NOUN	B
of	O	ADP	O
activated	B-cell_type	VERB	B
B	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
strongly	O	ADV	O
suggesting	O	VERB	O
that	O	SCONJ	O
LMP1	B-protein	NOUN	B
can	O	AUX	O
also	O	ADV	O
activate	O	VERB	B
cells	O	NOUN	I
independently	O	ADV	O
of	O	ADP	O
NF-kappaB	B-protein	NOUN	B
.	O	PUNCT	O


A	O	DET	O
new	O	ADJ	O
human	B-cell_line	ADJ	B
leukemia	I-cell_line	NOUN	O
cell	I-cell_line	NOUN	B
line	I-cell_line	NOUN	I
with	O	ADP	O
an	O	DET	O
eosinophilic	O	ADJ	B
phenotype	O	NOUN	B
,	O	PUNCT	O
designated	O	VERB	O
YJ	B-cell_line	NOUN	B
,	O	PUNCT	O
was	O	AUX	O
established	O	VERB	O
from	O	ADP	O
the	O	DET	O
peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
of	O	ADP	O
a	O	DET	O
patient	O	NOUN	B
with	O	ADP	O
chronic	O	ADJ	B
myelomonocytic	O	ADJ	I
leukemia	O	NOUN	I
(	O	PUNCT	O
CMMoL	O	NOUN	B
)	O	PUNCT	O
with	O	ADP	O
eosinophilia	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
eosinophilic	O	ADJ	B
characteristics	O	NOUN	B
of	O	ADP	O
YJ	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
were	O	AUX	O
confirmed	O	VERB	O
by	O	ADP	O
histochemical	O	ADJ	B
staining	O	NOUN	I
with	O	ADP	O
Fast-Green/Neutral-Red	O	NOUN	B
and	O	CCONJ	O
by	O	ADP	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
mRNAs	B-RNA	NOUN	B
for	O	ADP	O
eosinophil-associated	B-protein	ADJ	B
granule	I-protein	NOUN	I
proteins	I-protein	NOUN	I
,	O	PUNCT	O
eosinophil	B-protein	NOUN	B
cationic	I-protein	ADJ	I
protein	I-protein	NOUN	I
(	O	PUNCT	O
ECP	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
eosinophil-derived	B-protein	ADJ	B
neurotoxin	I-protein	NOUN	I
(	O	PUNCT	I
EDN	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
eosinophil	B-protein	NOUN	B
peroxidase	I-protein	NOUN	I
(	O	PUNCT	O
EPO	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
major	B-protein	ADJ	O
basic	I-protein	ADJ	O
protein	I-protein	NOUN	O
(	O	PUNCT	O
MBP	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
for	O	ADP	O
the	O	DET	O
Charcot-Leyden	B-protein	NOUN	B
crystal	I-protein	NOUN	I
(	I-protein	PUNCT	O
CLC	I-protein	NOUN	O
)	I-protein	PUNCT	O
protein	I-protein	NOUN	O
.	O	PUNCT	O


Hemorrhagic	O	ADJ	B
shock	O	NOUN	I
(	O	PUNCT	O
HS	O	NOUN	B
)	O	PUNCT	O
initiates	O	VERB	B
an	O	DET	O
inflammatory	O	ADJ	B
cascade	O	NOUN	I
that	O	PRON	O
includes	O	VERB	O
the	O	DET	O
production	O	NOUN	B
of	O	ADP	O
cytokines	B-protein	NOUN	B
and	O	CCONJ	O
recruitment	O	NOUN	B
of	O	ADP	O
neutrophils	B-cell_type	NOUN	B
(	O	PUNCT	O
PMN	B-cell_type	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
may	O	AUX	O
progress	O	VERB	B
to	O	PART	O
organ	O	VERB	B
failure	O	NOUN	I
,	O	PUNCT	O
inducing	O	VERB	O
acute	O	ADJ	B
respiratory	O	ADJ	I
distress	O	NOUN	I
syndrome	O	NOUN	I
(	O	PUNCT	O
ARDS	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Increased	O	VERB	B
IL-6	B-protein	NOUN	B
protein	O	NOUN	O
expression	O	NOUN	B
was	O	AUX	O
localized	O	ADJ	B
to	O	PART	O
bronchial	B-cell_type	ADJ	B
and	I-cell_type	CCONJ	O
alveolar	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
showed	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
interaction	O	NOUN	B
of	O	ADP	O
SS	B-cell_type	NOUN	B
RBC	I-cell_type	NOUN	B
at	O	ADP	O
2	O	NUM	O
%	O	NOUN	O
concentration	O	NOUN	B
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
multimers	O	NOUN	B
of	O	ADP	O
von	B-protein	NOUN	B
Willebrand	I-protein	NOUN	I
factor	I-protein	NOUN	I
(	O	PUNCT	O
vWf	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
derived	O	VERB	O
from	O	ADP	O
endothelial	O	ADJ	B
cell-derived	O	ADJ	O
conditioned	O	ADJ	O
medium	O	NOUN	O
(	O	PUNCT	O
E-CM	O	NOUN	B
)	O	PUNCT	O
with	O	ADP	O
cultured	B-cell_line	VERB	B
human	I-cell_line	ADJ	I
umbilical	I-cell_line	ADJ	I
vein	I-cell_line	NOUN	I
endothelial	I-cell_line	ADJ	I
cells	I-cell_line	NOUN	I
(	O	PUNCT	O
HUVEC	B-cell_line	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
resulted	O	VERB	O
in	O	ADP	O
a	O	DET	O
fivefold	O	ADV	O
increased	O	VERB	B
formation	O	NOUN	B
of	O	ADP	O
thiobarbituric	O	ADJ	B
acid-reactive	O	ADJ	O
substances	O	NOUN	O
(	O	PUNCT	O
TBARS	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
NF-kB	B-protein	NOUN	I
,	O	PUNCT	O
both	O	DET	O
indicators	O	NOUN	B
of	O	ADP	O
cellular	O	ADJ	B
oxidant	O	ADJ	O
stress	O	NOUN	O
.	O	PUNCT	O


Additionally	O	ADV	O
,	O	PUNCT	O
preincubation	O	NOUN	B
of	O	ADP	O
HUVEC	B-cell_line	NOUN	B
with	O	ADP	O
a	O	DET	O
synthetic	O	ADJ	B
peptide	O	NOUN	I
Arg-Gly-Asp	O	NOUN	I
(	O	PUNCT	O
RGD	O	NOUN	B
)	O	PUNCT	O
that	O	PRON	O
prevents	O	VERB	B
vWf	B-protein	NOUN	B
-mediated	O	ADJ	O
adhesion	O	NOUN	B
of	O	ADP	O
SS	B-cell_type	NOUN	B
RBC	I-cell_type	NOUN	B
reduced	O	VERB	B
the	O	DET	O
surface	O	NOUN	B
expression	O	NOUN	B
of	O	ADP	O
VCAM-1	B-protein	NOUN	B
and	O	CCONJ	O
NF-kB	B-protein	NOUN	B
activation	O	NOUN	B
.	O	PUNCT	O


Correlations	O	NOUN	B
of	O	ADP	O
TCRzeta	B-protein	NOUN	B
or	O	CCONJ	O
p56	B-protein	NOUN	B
(	I-protein	PUNCT	O
lck	I-protein	NOUN	B
)	I-protein	PUNCT	O
levels	O	NOUN	B
with	O	ADP	O
response	O	NOUN	B
or	O	CCONJ	O
disease	O	NOUN	B
variables	O	NOUN	B
,	O	PUNCT	O
except	O	SCONJ	O
for	O	ADP	O
lower	O	ADJ	O
TCRzeta	B-protein	NOUN	B
levels	O	NOUN	B
(	O	PUNCT	O
P	O	NOUN	O
<	O	X	O
0.001	O	NUM	O
)	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
bone	O	NOUN	B
metastases	O	NOUN	I
,	O	PUNCT	O
were	O	AUX	O
not	O	PART	O
found	O	VERB	O
.	O	PUNCT	O


The	O	DET	O
clinical	O	ADJ	B
significance	O	NOUN	I
of	O	ADP	O
these	O	DET	O
findings	O	NOUN	B
remains	O	VERB	O
unclear	O	ADJ	B
.	O	PUNCT	O


In	O	ADP	O
order	O	NOUN	O
to	O	PART	O
understand	O	VERB	O
this	O	DET	O
block	O	NOUN	B
the	O	DET	O
cascade	O	NOUN	O
of	O	ADP	O
molecular	O	ADJ	B
events	O	NOUN	I
needs	O	VERB	O
to	O	PART	O
be	O	AUX	O
characterized	O	VERB	B
.	O	PUNCT	O


CD38+	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
committed	O	VERB	O
towards	O	ADP	O
this	O	DET	O
lineage	O	NOUN	B
were	O	AUX	O
enriched	O	VERB	O
and	O	CCONJ	O
a	O	DET	O
population	O	NOUN	B
of	O	ADP	O
these	O	DET	O
cells	O	NOUN	B
treated	O	VERB	B
with	O	ADP	I
dihydroxyvitamin	O	NOUN	B
D3	O	NOUN	I
to	O	PART	O
induce	O	VERB	B
neutrophil	O	NOUN	B
maturation	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
pattern	O	NOUN	B
of	O	ADP	O
gene	O	NOUN	B
expression	O	NOUN	I
was	O	AUX	O
suggested	O	VERB	O
from	O	ADP	O
the	O	DET	O
number	O	NOUN	O
of	O	ADP	O
clones	O	NOUN	B
in	O	ADP	O
each	O	DET	O
group	O	NOUN	B
at	O	ADP	O
neutrophil	O	NOUN	B
commitment	O	NOUN	O
and	O	CCONJ	O
maturation	O	NOUN	B
.	O	PUNCT	O


Interleukin-4	B-protein	NOUN	B
and	I-protein	CCONJ	O
-13	I-protein	NUM	B
induce	O	VERB	B
upregulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
murine	O	ADJ	B
macrophage	O	NOUN	B
12/15-lipoxygenase	B-protein	NOUN	B
activity	I-protein	NOUN	I
:	O	PUNCT	O
evidence	O	NOUN	B
for	O	ADP	O
the	O	DET	O
involvement	O	NOUN	B
of	O	ADP	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
STAT6	B-protein	NOUN	I
.	O	PUNCT	O


To	O	PART	O
investigate	O	VERB	B
whether	O	SCONJ	O
both	O	CCONJ	O
lipoxygenase	B-protein	NOUN	B
isoforms	I-protein	NOUN	B
exhibit	O	VERB	O
a	O	DET	O
similar	O	ADJ	O
regulatory	O	ADJ	B
response	O	NOUN	I
toward	O	ADP	O
cytokine	B-protein	NOUN	B
stimulation	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
studied	O	VERB	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
leukocyte-type	B-protein	NOUN	B
12-lipoxygenase	I-protein	NOUN	I
of	O	ADP	O
murine	B-cell_type	ADJ	B
peritoneal	I-cell_type	ADJ	B
macrophages	I-cell_type	NOUN	O
by	O	ADP	O
interleukins	B-protein	NOUN	B
and	O	CCONJ	O
found	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
this	O	DET	O
enzyme	B-protein	NOUN	B
is	O	AUX	O
upregulated	O	VERB	B
in	O	ADP	O
a	O	DET	O
dose-dependent	O	ADJ	B
manner	O	NOUN	O
when	O	SCONJ	O
the	O	DET	O
cells	O	NOUN	B
were	O	AUX	O
cultured	O	VERB	B
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IL-4	B-protein	NOUN	B
or	O	CCONJ	O
IL-13	B-protein	NOUN	B
but	O	CCONJ	O
not	O	PART	O
by	O	ADP	O
IL-10	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
intermediate	O	ADJ	B
complex	O	NOUN	I
appeared	O	VERB	O
to	O	PART	O
react	O	VERB	O
with	O	ADP	O
both	O	CCONJ	O
anti-STAT	B-protein	NOUN	B
6	I-protein	NUM	O
and	O	CCONJ	O
anti-STAT	B-protein	NOUN	B
1	I-protein	NUM	I
.	O	PUNCT	O


Although	O	SCONJ	O
IFN-gamma	B-protein	NOUN	B
alone	O	ADV	O
did	O	AUX	O
not	O	PART	O
induce	O	VERB	O
CD23	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
transcription	O	NOUN	I
,	O	PUNCT	O
Northern	O	NOUN	B
blot	O	NOUN	I
analysis	O	NOUN	I
revealed	O	VERB	O
a	O	DET	O
transient	O	ADJ	B
up-regulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IL-4-induced	B-RNA	ADJ	B
CD23	I-RNA	NOUN	I
mRNA	I-RNA	NOUN	B
by	O	ADP	O
IFN-gamma	B-protein	NOUN	B
within	O	ADP	O
2	O	NUM	O
h	O	NOUN	O
of	O	ADP	O
IFN-gamma	B-protein	NOUN	B
treatment	O	NOUN	B
in	O	ADP	O
these	O	DET	O
tonsillar	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


CD2	B-protein	NOUN	B
-mediated	O	ADJ	O
interleukin-2	B-protein	NOUN	B
production	O	NOUN	B
occurs	O	VERB	O
via	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
Jun	B-protein	NOUN	B
kinase	I-protein	NOUN	I
in	O	ADP	O
cell	O	NOUN	B
lines	O	NOUN	I
lacking	O	VERB	O
p56	B-protein	NOUN	B
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
elucidate	O	VERB	O
differences	O	NOUN	O
between	O	ADP	O
TCR	B-protein	NOUN	B
and	O	CCONJ	O
CD2	B-protein	NOUN	B
signaling	O	NOUN	O
pathways	O	NOUN	O
in	O	ADP	O
the	O	DET	O
same	O	ADJ	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Inhibition	O	NOUN	B
of	O	ADP	O
iNO	B-protein	NOUN	B
synthase	I-protein	NOUN	I
(	O	PUNCT	O
iNOS	B-protein	NOUN	B
)	O	PUNCT	O
activity	O	NOUN	B
with	O	ADP	O
N	O	NOUN	B
omega-monomethyl-L-arginine	O	NOUN	I
in	O	ADP	O
endothelial-RAW264.7	B-cell_line	NOUN	B
cocultures	I-cell_line	NOUN	B
,	O	PUNCT	O
stimulated	O	VERB	B
with	O	ADP	O
murine-specific	B-protein	ADJ	B
IFN-gamma	I-protein	NOUN	B
and	O	CCONJ	O
LPS	O	NOUN	B
,	O	PUNCT	O
decreased	O	VERB	B
iNO	O	NOUN	B
production	O	NOUN	B
by	O	ADP	O
86	O	NUM	O
%	O	NOUN	O
,	O	PUNCT	O
augmented	O	VERB	B
VCAM-1	B-protein	NOUN	B
and	O	CCONJ	O
iNOS	B-protein	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
endothelial	O	ADJ	B
and	O	CCONJ	O
RAW264.7	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
respectively	O	ADV	O
,	O	PUNCT	O
and	O	CCONJ	O
increased	O	VERB	B
monocyte	O	NOUN	B
adhesion	O	NOUN	I
to	O	PART	O
the	O	DET	O
endothelial	O	ADJ	B
cell	O	NOUN	I
surface	O	NOUN	B
.	O	PUNCT	O


Transient	O	ADJ	B
transfection	O	NOUN	O
studies	O	NOUN	O
using	O	VERB	O
various	O	ADJ	O
VCAM-1	B-DNA	NOUN	B
promoter	I-DNA	NOUN	O
constructs	O	NOUN	O
demonstrated	O	VERB	O
that	O	SCONJ	O
inhibitory	O	ADJ	B
effects	O	NOUN	B
of	O	ADP	O
iNO	O	NOUN	B
on	O	ADP	O
VCAM-1	B-protein	NOUN	B
gene	O	NOUN	I
transcription	O	NOUN	O
were	O	AUX	O
mediated	O	VERB	O
,	O	PUNCT	O
in	O	ADP	O
part	O	NOUN	O
,	O	PUNCT	O
by	O	ADP	O
inhibitory	O	ADJ	B
effects	O	NOUN	B
of	O	ADP	O
iNO	O	NOUN	B
on	O	ADP	O
kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
cis-acting	I-DNA	ADJ	I
elements	I-DNA	NOUN	I
.	O	PUNCT	O


The	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
aberrant	O	ADJ	B
ER	B-protein	NOUN	B
forms	O	NOUN	O
in	O	ADP	O
Oestrogen-dependent	O	ADJ	B
tumours	O	NOUN	I
has	O	AUX	O
been	O	AUX	O
discussed	O	VERB	O
in	O	ADP	O
correlation	O	NOUN	B
with	O	ADP	O
tumour	O	NOUN	B
progression	O	NOUN	I
.	O	PUNCT	O


p21ras	B-protein	NOUN	B
initiates	O	VERB	B
Rac-1	B-protein	NOUN	B
but	O	CCONJ	O
not	O	PART	O
phosphatidyl	B-protein	ADJ	B
inositol	I-protein	NOUN	I
3	I-protein	NUM	I
kinase/PKB	I-protein	NOUN	B
,	O	PUNCT	O
mediated	O	ADJ	O
signaling	O	NOUN	B
pathways	O	NOUN	I
in	O	ADP	O
T	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
fibroblasts	B-cell_type	NOUN	B
,	O	PUNCT	O
an	O	DET	O
important	O	ADJ	O
effector	O	NOUN	B
for	O	ADP	O
the	O	DET	O
Ras	B-DNA	NOUN	B
oncogene	I-DNA	NOUN	I
is	O	AUX	O
Phosphatidylinositol	B-protein	NOUN	B
3-kinase	I-protein	NOUN	I
(	O	PUNCT	O
PtdIns	B-protein	NOUN	B
3-kinase	I-protein	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


Activation	O	NOUN	B
of	O	ADP	O
this	O	DET	O
lipid	B-protein	NOUN	B
kinase	I-protein	NOUN	I
is	O	AUX	O
able	O	ADJ	O
to	O	PART	O
induce	O	VERB	B
critical	O	ADJ	O
Rac-1	B-protein	NOUN	B
signaling	O	NOUN	B
pathways	O	NOUN	I
and	O	CCONJ	O
can	O	AUX	O
couple	O	VERB	O
p21ras	B-protein	NOUN	B
to	O	PART	O
cell	O	NOUN	B
survival	O	NOUN	I
mechanisms	O	NOUN	B
via	O	ADP	O
the	O	DET	O
serine/threonine	B-protein	NOUN	B
kinase	I-protein	NOUN	I
Akt/PKB	I-protein	NOUN	B
.	O	PUNCT	O


Ras	B-protein	NOUN	B
can	O	AUX	O
initiate	O	VERB	O
Rac-1	B-protein	NOUN	B
regulated	O	ADJ	O
signaling	O	NOUN	O
pathways	O	NOUN	O
in	O	ADP	O
the	O	DET	O
context	O	NOUN	B
of	O	ADP	O
T	B-protein	NOUN	B
cell	I-protein	NOUN	I
antigen	I-protein	NOUN	I
receptor	I-protein	NOUN	I
function	O	NOUN	I
independently	O	ADV	O
of	O	ADP	O
PtdIns	B-protein	NOUN	B
3-kinase	I-protein	NOUN	I
activity	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
present	O	ADJ	O
study	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
evaluated	O	VERB	B
whether	O	SCONJ	O
peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
monocytes	I-cell_type	NOUN	I
that	O	PRON	O
exhibit	O	VERB	O
anti-tumour	O	ADJ	B
activity	O	NOUN	I
in	O	ADP	O
haematopoietic	O	ADJ	B
and	O	CCONJ	O
solid	O	ADJ	B
tumours	O	NOUN	I
influence	O	VERB	B
growth	O	NOUN	B
and	O	CCONJ	O
secretion	O	NOUN	B
in	O	ADP	O
the	O	DET	O
LNCaP	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
a	O	DET	O
different	O	ADJ	O
study	O	NOUN	B
,	O	PUNCT	O
GATA-3	B-protein	NOUN	B
was	O	AUX	O
shown	O	VERB	O
to	O	PART	O
be	O	AUX	O
sufficient	O	ADJ	B
for	O	ADP	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
IL-4	B-protein	NOUN	B
and	O	CCONJ	O
other	O	ADJ	O
Th2	B-DNA	NOUN	B
cytokine	I-DNA	NOUN	B
genes	I-DNA	NOUN	I
.	O	PUNCT	O


The	O	DET	O
two	O	NUM	O
Duffy	B-protein	NOUN	B
polymorphic	I-protein	ADJ	B
antigens	I-protein	NOUN	I
,	O	PUNCT	O
Fya	B-protein	NOUN	B
and	O	CCONJ	O
Fyb	B-protein	NOUN	B
(	O	PUNCT	O
coded	O	VERB	O
by	O	ADP	O
the	O	DET	O
FY*A	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
FY*B	I-DNA	NOUN	B
alleles	I-DNA	NOUN	I
)	O	PUNCT	O
,	O	PUNCT	O
are	O	AUX	O
present	O	ADJ	O
on	O	ADP	O
erythrocyte	B-protein	NOUN	B
membranes	I-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
271C	O	NOUN	B
--	O	PUNCT	O
>	O	X	O
T	O	NOUN	B
and	O	CCONJ	O
304G	O	NOUN	B
--	O	PUNCT	O
>	O	X	O
A	O	NOUN	O
can	O	AUX	O
be	O	AUX	O
identified	O	VERB	B
by	O	ADP	O
restriction	B-DNA	NOUN	B
enzyme-generated	I-DNA	ADJ	O
restriction	I-DNA	NOUN	O
fragment	I-DNA	NOUN	O
length	I-DNA	NOUN	O
polymorphisms	I-DNA	NOUN	B
.	O	PUNCT	O


The	O	DET	O
mutation	O	NOUN	B
may	O	AUX	O
have	O	AUX	O
implications	O	NOUN	O
for	O	ADP	O
some	O	DET	O
physiological	O	ADJ	B
roles	O	NOUN	O
of	O	ADP	O
DARC	B-protein	NOUN	B
and	O	CCONJ	O
be	O	AUX	O
of	O	ADP	O
interest	O	NOUN	O
in	O	ADP	O
malaria	O	NOUN	B
research	O	NOUN	B
and	O	CCONJ	O
in	O	ADP	O
studies	O	NOUN	B
of	O	ADP	O
population	O	NOUN	B
genetics	O	NOUN	B
.	O	PUNCT	O


Although	O	SCONJ	O
treatment	O	NOUN	B
with	O	ADP	O
TNF-alpha	B-protein	NOUN	B
induced	O	VERB	B
nuclear	O	ADJ	B
localization	O	NOUN	I
of	O	ADP	O
NFkappaB	B-protein	NOUN	B
in	O	ADP	O
both	O	CCONJ	O
memory	B-cell_type	NOUN	B
and	I-cell_type	CCONJ	O
naive	I-cell_type	ADJ	B
T	I-cell_type	NOUN	I
cell	I-cell_type	NOUN	I
subsets	I-cell_type	NOUN	I
,	O	PUNCT	O
irrespective	O	ADV	O
of	O	ADP	O
the	O	DET	O
age	O	NOUN	B
of	O	ADP	O
the	O	DET	O
donor	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
levels	O	NOUN	B
of	O	ADP	O
induced	O	VERB	B
NFkappaB	B-protein	NOUN	B
were	O	AUX	O
significantly	O	ADV	O
lower	O	ADJ	O
in	O	ADP	O
both	O	DET	O
subsets	O	NOUN	B
of	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
obtained	O	VERB	O
from	O	ADP	O
the	O	DET	O
elderly	O	ADJ	B
,	O	PUNCT	O
when	O	SCONJ	O
compared	O	VERB	B
to	O	PART	O
those	O	DET	O
in	O	ADP	O
young	O	ADJ	B
.	O	PUNCT	O


Examination	O	NOUN	B
of	O	ADP	O
IkappaB	B-protein	NOUN	B
alpha	I-protein	NOUN	I
regulation	O	NOUN	I
revealed	O	VERB	O
that	O	SCONJ	O
TNF-alpha	B-protein	NOUN	B
-mediated	O	ADJ	O
degradation	O	NOUN	B
of	O	ADP	O
IkappaB	B-protein	NOUN	B
alpha	I-protein	NOUN	I
in	O	ADP	O
both	O	CCONJ	O
memory	B-cell_type	NOUN	B
and	I-cell_type	CCONJ	O
naive	I-cell_type	ADJ	B
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
from	O	ADP	O
the	O	DET	O
elderly	O	ADJ	B
was	O	AUX	O
severely	O	ADV	O
impaired	O	ADJ	B
,	O	PUNCT	O
thus	O	ADV	O
contributing	O	VERB	O
to	O	PART	O
the	O	DET	O
lowered	O	ADJ	B
induction	O	NOUN	B
of	O	ADP	O
the	O	DET	O
observed	O	VERB	O
NFkappaB	B-protein	NOUN	B
.	O	PUNCT	O


Taken	O	VERB	O
together	O	ADV	O
,	O	PUNCT	O
our	O	PRON	O
results	O	NOUN	O
suggest	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
age-related	O	ADJ	B
hyporesponsiveness	O	NOUN	I
can	O	AUX	O
not	O	PART	O
be	O	AUX	O
attributed	O	VERB	O
to	O	PART	O
a	O	DET	O
skewing	O	NOUN	B
of	O	ADP	O
the	O	DET	O
T	O	NOUN	B
cell	O	NOUN	I
population	O	NOUN	O
towards	O	ADP	O
a	O	DET	O
memory	O	NOUN	B
phenotype	O	NOUN	B
in	O	ADP	O
the	O	DET	O
elderly	O	ADJ	B
.	O	PUNCT	O


The	O	DET	O
purpose	O	NOUN	O
of	O	ADP	O
this	O	DET	O
study	O	NOUN	B
was	O	AUX	O
to	O	PART	O
examine	O	VERB	O
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	I
bis	O	NOUN	B
[	O	PUNCT	O
4-	O	NUM	O
[	O	PUNCT	O
2	O	NUM	O
,	O	PUNCT	O
4-dioxo-5-thiazolidinyl	O	ADJ	O
)	O	PUNCT	O
methyl	O	NOUN	O
]	O	PUNCT	O
phenyl	O	NOUN	O
]	O	PUNCT	O
methane	O	NOUN	O
(	O	PUNCT	O
YM-268	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
a	O	DET	O
thiazolidinedione	O	ADJ	B
derivative	O	NOUN	B
,	O	PUNCT	O
on	O	ADP	O
glucose	O	NOUN	B
uptake	O	NOUN	I
,	O	PUNCT	O
adipocyte	B-cell_type	NOUN	B
differentiation	O	NOUN	B
through	O	ADP	O
peroxisome	B-protein	NOUN	B
proliferator-activated	I-protein	ADJ	I
receptor	I-protein	NOUN	I
gamma	I-protein	NOUN	I
(	O	PUNCT	O
PPARgamma	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
phosphatidylinositol	B-protein	NOUN	B
3-kinase	I-protein	NOUN	I
(	O	PUNCT	O
PI	B-protein	NOUN	B
3-kinase	I-protein	NOUN	I
)	O	PUNCT	O
activity	O	NOUN	B
in	O	ADP	O
cultured	B-cell_line	VERB	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


To	O	PART	O
examine	O	VERB	O
the	O	DET	O
possible	O	ADJ	O
involvement	O	NOUN	B
of	O	ADP	O
the	O	DET	O
increased	O	VERB	B
activity	O	NOUN	B
of	O	ADP	O
PI	B-protein	NOUN	B
3-kinase	I-protein	NOUN	I
in	O	ADP	O
YM268-stimulated	O	ADJ	B
glucose	O	NOUN	I
uptake	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
enzyme	O	NOUN	B
activity	O	NOUN	I
was	O	AUX	O
estimated	O	VERB	O
by	O	ADP	O
measuring	O	VERB	B
the	O	DET	O
phosphatidylinositol-3	O	NOUN	B
,	O	PUNCT	O
4	O	NUM	O
,	O	PUNCT	O
5-trisphosphate	O	ADJ	B
(	O	PUNCT	O
PI-3	O	NOUN	B
,	O	PUNCT	O
4	O	NUM	O
,	O	PUNCT	O
5-P3	O	NOUN	B
)	O	PUNCT	O
concentration	O	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
monocytic	I-cell_type	ADJ	O
cells	I-cell_type	NOUN	O
.	O	PUNCT	O


Work	O	NOUN	B
reported	O	VERB	O
over	O	ADP	O
the	O	DET	O
past	O	ADJ	O
year	O	NOUN	B
has	O	AUX	O
provided	O	VERB	O
insights	O	NOUN	O
into	O	ADP	O
the	O	DET	O
mechanisms	O	NOUN	B
whereby	O	SCONJ	O
ligand	O	NOUN	B
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
nuclear	B-protein	ADJ	B
receptor	I-protein	NOUN	I
peroxisome	I-protein	NOUN	I
proliferator-activated	I-protein	ADJ	I
receptor	I-protein	NOUN	I
gamma	I-protein	NOUN	I
(	O	PUNCT	O
PPARgamma	B-protein	NOUN	B
)	O	PUNCT	O
regulates	O	VERB	B
systemic	O	ADJ	B
glucose	O	NOUN	I
and	O	CCONJ	O
lipid	O	NOUN	B
homeostasis	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
role	O	NOUN	O
of	O	ADP	O
caspases	O	NOUN	B
in	O	ADP	O
T	O	NOUN	B
cell	O	NOUN	I
development	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
control	O	NOUN	B
of	O	ADP	O
immune	O	ADJ	B
responses	O	NOUN	I
.	O	PUNCT	O


Cross-priming	O	NOUN	B
of	O	ADP	O
CTL	O	NOUN	B
responses	O	NOUN	B
in	O	X	B
vivo	O	X	I
does	O	AUX	O
not	O	PART	O
require	O	VERB	O
antigenic	O	ADJ	B
peptides	O	NOUN	I
in	O	ADP	O
the	O	DET	O
endoplasmic	O	ADJ	B
reticulum	O	NOUN	I
of	O	ADP	O
immunizing	B-cell_type	VERB	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Recently	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
reported	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
histogenesis	O	NOUN	B
of	O	ADP	O
B-cell	B-cell_type	NOUN	B
lymphomas	I-cell_type	NOUN	I
may	O	AUX	O
be	O	AUX	O
assessed	O	VERB	B
by	O	ADP	O
monitoring	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
pattern	O	NOUN	O
of	O	ADP	O
BCL-6	B-protein	NOUN	B
,	O	PUNCT	O
a	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
expressed	O	VERB	B
in	O	ADP	O
germinal	B-cell_type	ADJ	B
center	I-cell_type	NOUN	I
(	I-cell_type	PUNCT	O
GC	I-cell_type	NOUN	B
)	I-cell_type	PUNCT	O
B	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
CD138/syndecan-1	B-protein	NOUN	B
(	O	PUNCT	O
syn-1	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
a	O	DET	O
proteoglycan	O	NOUN	B
associated	O	VERB	B
with	O	ADP	I
post-GC	O	ADJ	B
,	O	PUNCT	O
terminal	O	ADJ	B
B-cell	O	NOUN	B
differentiation	O	NOUN	I
.	O	PUNCT	O


p130	B-protein	NOUN	B
,	O	PUNCT	O
p107	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
pRb	B-protein	NOUN	B
are	O	AUX	O
differentially	O	ADV	O
regulated	O	VERB	O
in	O	ADP	O
proliferating	B-cell_type	VERB	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
during	O	ADP	O
cell	O	NOUN	B
cycle	O	NOUN	I
arrest	O	NOUN	I
by	O	ADP	O
alpha-interferon	B-protein	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
p107	B-protein	NOUN	B
is	O	AUX	O
dephosphorylated	O	VERB	B
and	O	CCONJ	O
is	O	AUX	O
then	O	ADV	O
depleted	O	VERB	B
from	O	ADP	O
cells	O	NOUN	B
as	O	ADP	O
they	O	PRON	O
exit	O	VERB	B
the	O	DET	O
cell	O	NOUN	B
cycle	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
phosphorylated	O	ADJ	B
forms	O	NOUN	O
of	O	ADP	O
E2F-4	B-protein	NOUN	B
that	O	PRON	O
bind	O	VERB	B
to	O	PART	O
the	O	DET	O
E2F	B-DNA	NOUN	B
DNA	I-DNA	NOUN	I
site	I-DNA	NOUN	I
are	O	AUX	O
different	O	ADJ	O
from	O	ADP	O
hyperphosphorylated	O	VERB	B
E2F-4	B-protein	NOUN	B
,	O	PUNCT	O
which	O	DET	O
predominates	O	VERB	O
in	O	ADP	O
primary	B-cell_type	ADJ	B
hemopoietic	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
in	O	ADP	O
G0	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
entry	O	NOUN	B
of	O	ADP	O
microorganisms	O	NOUN	B
into	O	ADP	O
the	O	DET	O
body	O	NOUN	B
induces	O	VERB	O
inflammatory	O	ADJ	B
processes	O	NOUN	I
.	O	PUNCT	O


MRP14	B-DNA	NOUN	B
(	O	PUNCT	O
Macrophage	B-protein	NOUN	B
migration	I-protein	NOUN	I
inhibitory	I-protein	ADJ	B
related	I-protein	ADJ	O
protein	I-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
MRP8	B-protein	NOUN	B
,	O	PUNCT	O
two	O	NUM	O
S-100	B-protein	NOUN	B
proteins	I-protein	NOUN	I
contained	O	VERB	O
in	O	ADP	O
high	O	ADJ	O
concentrations	O	NOUN	B
in	O	ADP	O
these	O	DET	O
cells	O	NOUN	B
are	O	AUX	O
obviously	O	ADV	O
essential	O	ADJ	B
for	O	ADP	O
adhesion	O	NOUN	B
and	O	CCONJ	O
migration	O	NOUN	B
of	O	ADP	O
monocytes	B-cell_type	NOUN	B
and	O	CCONJ	O
granulocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


Decreased	O	VERB	B
IL-12	B-protein	NOUN	B
production	O	NOUN	B
and	O	CCONJ	O
Th1	O	NOUN	B
cell	O	NOUN	O
development	O	NOUN	O
by	O	ADP	O
acetyl	O	ADJ	B
salicylic	O	ADJ	I
acid-mediated	O	ADJ	O
inhibition	O	NOUN	B
of	O	ADP	O
NF-kappaB	B-protein	NOUN	B
.	O	PUNCT	O


ASA	O	NOUN	B
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
inhibit	O	VERB	B
secretion	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IL-12	B-protein	NOUN	B
heterodimer	I-protein	NOUN	B
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
p40	B-protein	NOUN	B
monomer	I-protein	NOUN	B
by	O	ADP	O
human	B-cell_type	ADJ	B
monocytic	I-cell_type	ADJ	O
cells	I-cell_type	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
CAT	B-DNA	NOUN	B
reporter	I-DNA	NOUN	I
constructions	I-DNA	NOUN	O
no	O	DET	O
appreciable	O	ADJ	O
level	O	NOUN	B
of	O	ADP	O
CAT	B-protein	NOUN	B
activity	O	NOUN	I
was	O	AUX	O
supported	O	VERB	O
by	O	ADP	O
the	O	DET	O
beta	B-DNA	NOUN	B
globin	I-DNA	NOUN	I
promoter	I-DNA	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
only	O	ADV	O
low	O	ADJ	B
level	O	NOUN	O
activity	O	NOUN	B
by	O	ADP	O
the	O	DET	O
delta	B-DNA	NOUN	B
promoter	I-DNA	NOUN	I
.	O	PUNCT	O


Analysis	O	NOUN	B
of	O	ADP	O
cytokine	B-protein	NOUN	B
signaling	O	NOUN	I
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
extrinsic	O	ADJ	B
asthma	O	NOUN	I
and	O	CCONJ	O
hyperimmunoglobulin	O	NOUN	B
E	O	NOUN	I
.	O	PUNCT	O


BACKGROUND	O	NOUN	B
:	O	PUNCT	O
Recent	O	ADJ	O
data	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
class	O	NOUN	B
switching	O	NOUN	I
to	O	PART	O
IgE	B-protein	NOUN	B
by	O	ADP	O
cytokines	B-protein	NOUN	B
is	O	AUX	O
mediated	O	VERB	O
by	O	ADP	O
STAT	B-protein	NOUN	B
transcription	I-protein	NOUN	I
factors	I-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
IgE	B-protein	NOUN	B
by	O	ADP	O
IL-4	B-protein	NOUN	B
and	O	CCONJ	O
IL-13	B-protein	NOUN	B
occurs	O	VERB	O
through	O	ADP	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
intracellular	B-protein	ADJ	B
signal-transducing	I-protein	ADJ	O
protein	I-protein	NOUN	O
Stat6	I-protein	NOUN	B
,	O	PUNCT	O
whereas	O	SCONJ	O
the	O	DET	O
inhibition	O	NOUN	B
of	O	ADP	O
IgE	B-protein	NOUN	B
class	O	NOUN	B
switching	O	NOUN	I
by	O	ADP	O
interferon-y	B-protein	NOUN	B
(	O	PUNCT	O
IFN-gamma	B-protein	NOUN	B
)	O	PUNCT	O
occurs	O	VERB	O
through	O	ADP	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
Statl	B-protein	NOUN	B
.	O	PUNCT	O


METHODS	O	NOUN	O
:	O	PUNCT	O
PBMCs	B-cell_type	NOUN	B
and	O	CCONJ	O
sera	O	NOUN	B
from	O	ADP	O
8	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
extrinsic	O	ADJ	B
asthma	O	NOUN	I
(	O	PUNCT	O
mean	O	ADJ	B
IgE	B-protein	NOUN	I
,	O	PUNCT	O
285+/-100	O	NUM	O
IU/mL	O	NOUN	O
)	O	PUNCT	O
,	O	PUNCT	O
3	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
HIE	O	NOUN	B
(	O	PUNCT	O
mean	O	ADJ	B
IgE	B-protein	NOUN	I
,	O	PUNCT	O
7050+/-1122	O	NUM	O
IU/mL	O	NOUN	O
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
14	O	NUM	O
nonatopic	O	ADJ	B
control	O	ADJ	O
subjects	O	NOUN	O
(	O	PUNCT	O
mean	O	ADJ	B
IgE	B-protein	NOUN	I
,	O	PUNCT	O
112+/-28	O	NUM	O
IU/mL	O	NOUN	O
)	O	PUNCT	O
were	O	AUX	O
analyzed	O	VERB	B
.	O	PUNCT	O


RESULTS	O	NOUN	B
:	O	PUNCT	O
The	O	DET	O
mean	O	ADJ	O
IL-4	B-protein	NOUN	B
level	O	NOUN	B
detected	O	VERB	B
by	O	ADP	O
ELISA	O	NOUN	B
was	O	AUX	O
much	O	ADV	O
greater	O	ADJ	O
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
HIE	O	NOUN	B
than	O	ADP	O
control	O	ADJ	B
subjects	O	NOUN	I
(	O	PUNCT	O
88.6+/-11.5	O	NUM	O
pg/mL	O	NOUN	O
vs	O	CCONJ	O
11.5+/-7.1	O	NUM	O
pg/mL	O	NOUN	O
,	O	PUNCT	O
P	O	NOUN	O
=	O	ADJ	O
.005	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
increased	O	VERB	B
IL-4	B-protein	NOUN	B
levels	O	NOUN	B
among	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
both	O	CCONJ	O
asthma	O	NOUN	B
and	O	CCONJ	O
HIE	O	NOUN	B
correlated	O	VERB	B
with	O	ADP	O
the	O	DET	O
increased	O	VERB	B
IgE	B-protein	NOUN	B
levels	O	NOUN	B
.	O	PUNCT	O


Interestingly	O	ADV	O
,	O	PUNCT	O
this	O	DET	O
15-amino	B-protein	ADJ	B
acid	I-protein	NOUN	I
transactivation	I-protein	NOUN	I
sequence	I-protein	NOUN	I
is	O	AUX	O
well	O	ADV	O
conserved	O	VERB	O
in	O	ADP	O
NFAT	B-protein	NOUN	B
family	I-protein	NOUN	I
proteins	I-protein	NOUN	I
,	O	PUNCT	O
although	O	SCONJ	O
the	O	DET	O
sequences	O	NOUN	B
contiguous	O	ADJ	O
to	O	PART	O
the	O	DET	O
carboxyl-terminal	B-protein	ADJ	B
regions	I-protein	NOUN	I
of	O	ADP	O
the	O	DET	O
NFAT	B-protein	NOUN	B
family	I-protein	NOUN	B
are	O	AUX	O
much	O	ADV	O
less	O	ADV	O
conserved	O	VERB	O
.	O	PUNCT	O


We	O	PRON	O
also	O	ADV	O
report	O	VERB	O
three	O	NUM	O
additional	O	ADJ	O
isoforms	O	NOUN	B
of	O	ADP	O
NFATx	B-protein	NOUN	B
,	O	PUNCT	O
designated	O	VERB	O
NFATx2	B-protein	NOUN	B
,	O	PUNCT	O
NFATx3	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
NFATx4	B-protein	NOUN	B
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
expression	O	NOUN	B
of	O	ADP	O
Rta	B-protein	NOUN	B
is	O	AUX	O
also	O	ADV	O
sufficient	O	ADJ	O
for	O	ADP	O
disruption	O	NOUN	B
of	O	ADP	O
latency	O	NOUN	B
in	O	ADP	O
a	O	DET	O
permissive	B-cell_line	ADJ	O
B-cell	I-cell_line	NOUN	O
line	I-cell_line	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
increased	O	VERB	B
transcription	O	NOUN	B
of	O	ADP	O
the	O	DET	O
NF-IL6	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
is	O	AUX	O
responsible	O	ADJ	O
,	O	PUNCT	O
at	O	ADP	O
least	O	ADJ	O
in	O	ADP	O
part	O	NOUN	O
,	O	PUNCT	O
for	O	ADP	O
induction	O	NOUN	B
of	O	ADP	O
NF-IL6	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
following	O	VERB	O
activation	O	NOUN	B
of	O	ADP	O
U937	B-cell_line	NOUN	B
promonocytic	I-cell_line	ADJ	I
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Using	O	VERB	O
interspecies	O	NOUN	B
hybrids	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
segregation	O	NOUN	B
of	O	ADP	O
human	B-DNA	ADJ	B
chromosomes	I-DNA	NOUN	B
allowed	O	VERB	O
us	O	PRON	O
to	O	PART	O
establish	O	VERB	O
that	O	SCONJ	O
MHC	B-protein	NOUN	B
class	I-protein	NOUN	B
II	I-protein	NUM	I
extinction	O	NOUN	B
is	O	AUX	O
linked	O	VERB	O
to	O	PART	O
the	O	DET	O
presence	O	NOUN	B
in	O	ADP	O
the	O	DET	O
hybrids	O	NOUN	B
of	O	ADP	O
the	O	DET	O
chromosomes	B-DNA	NOUN	B
from	O	ADP	O
the	O	DET	O
epithelial	B-cell_type	ADJ	B
fusion	I-cell_type	NOUN	I
partner	I-cell_type	NOUN	I
.	O	PUNCT	O


Class	O	NOUN	B
II	O	NUM	I
transactivator-independent	O	ADJ	O
endothelial	O	ADJ	O
cell	O	NOUN	O
MHC	B-protein	NOUN	O
class	I-protein	NOUN	O
II	I-protein	NUM	O
gene	O	NOUN	B
activation	O	NOUN	I
induced	O	VERB	B
by	O	ADP	O
lymphocyte	O	NOUN	B
adhesion	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
Janus	B-cell_line	NOUN	B
kinase-1-deficient	I-cell_line	ADJ	I
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
U4A	I-cell_line	NOUN	O
expresses	O	VERB	O
HLA-DR	B-RNA	NOUN	B
alpha	I-RNA	NOUN	O
mRNA	I-RNA	NOUN	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
NK	O	NOUN	B
cell	O	NOUN	I
activation	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
HLA-DR	B-DNA	NOUN	B
alpha	I-DNA	NOUN	I
promoter	I-DNA	NOUN	B
constructs	I-DNA	NOUN	I
transfected	O	VERB	B
into	O	ADP	O
these	O	DET	O
cells	O	NOUN	B
are	O	AUX	O
induced	O	VERB	B
by	O	ADP	O
NK	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
but	O	CCONJ	O
not	O	PART	O
IFN-gamma	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
association	O	NOUN	B
and	O	CCONJ	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IL-1	B-protein	NOUN	B
receptor-associated	I-protein	ADJ	I
protein	I-protein	NOUN	I
kinase	I-protein	NOUN	I
(	O	PUNCT	O
IRAK	B-protein	NOUN	B
)	O	PUNCT	O
to	O	PART	O
the	O	DET	O
IL-1	B-protein	NOUN	B
receptor	I-protein	NOUN	I
complex	I-protein	NOUN	I
is	O	AUX	O
one	O	NUM	O
of	O	ADP	O
the	O	DET	O
earliest	O	ADJ	O
events	O	NOUN	B
detectable	O	ADJ	B
in	O	ADP	O
IL-1	B-protein	NOUN	B
signal	O	NOUN	O
transduction	O	NOUN	O
.	O	PUNCT	O


Inhibition	O	NOUN	B
of	O	ADP	O
RNA	B-protein	NOUN	B
polymerase	I-protein	NOUN	I
II	I-protein	NUM	I
transcription	O	NOUN	I
in	O	ADP	O
human	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
by	O	ADP	O
synthetic	O	ADJ	B
DNA-binding	O	ADJ	B
ligands	O	NOUN	I
[	O	PUNCT	O
see	O	VERB	O
comments	O	NOUN	B
]	O	PUNCT	O


The	O	DET	O
MBP	B-protein	NOUN	B
-selected	O	ADJ	O
line	O	NOUN	O
could	O	AUX	O
likewise	O	ADV	O
be	O	AUX	O
rendered	O	VERB	O
unresponsive	O	ADJ	O
by	O	ADP	O
incubation	O	NOUN	B
with	O	ADP	O
supraoptimal	O	ADJ	B
concentrations	O	NOUN	B
of	O	ADP	O
immunodominant	O	ADJ	B
peptide	O	NOUN	I
and	O	CCONJ	O
anergy	O	NOUN	B
induction	O	NOUN	B
was	O	AUX	O
accompanied	O	VERB	O
by	O	ADP	O
IL-10	B-protein	NOUN	B
release	O	NOUN	B
.	O	PUNCT	O


Copyright	O	NOUN	O
1998	O	NUM	O
Academic	O	PROPN	B
Press	O	PROPN	I
.	O	PUNCT	O


Previously	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
demonstrated	O	VERB	O
that	O	SCONJ	O
granulocyte	B-RNA	NOUN	B
colony-stimulating	I-RNA	ADJ	I
factor	I-RNA	NOUN	I
(	I-RNA	PUNCT	O
G-CSF	I-RNA	NOUN	B
)	I-RNA	PUNCT	O
receptor	I-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
was	O	AUX	O
undetectable	O	ADJ	B
and	O	CCONJ	O
granulocyte	O	NOUN	B
maturation	O	NOUN	O
blocked	O	VERB	B
in	O	ADP	O
CCAAT	B-protein	NOUN	B
enhancer	I-protein	NOUN	I
binding	I-protein	NOUN	I
protein	I-protein	NOUN	I
alpha	I-protein	NOUN	I
(	O	PUNCT	O
C/EBPalpha	B-protein	NOUN	B
)	O	PUNCT	O
-deficient	O	ADJ	O
mice	O	NOUN	B
.	O	PUNCT	O


Protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
C	I-protein	NOUN	I
regulates	O	VERB	B
Fas	B-protein	NOUN	B
(	O	PUNCT	O
CD95/APO-1	B-protein	NOUN	B
)	O	PUNCT	O
expression	O	NOUN	B
.	O	PUNCT	O


Fas	B-protein	NOUN	B
(	O	PUNCT	O
CD95/APO-1	B-protein	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
transmembrane	B-protein	ADJ	B
protein	I-protein	NOUN	I
of	O	ADP	O
the	O	DET	O
TNF/neuron	B-protein	NOUN	B
growth	I-protein	NOUN	I
factor	I-protein	NOUN	I
receptor	I-protein	NOUN	I
family	I-protein	NOUN	B
.	O	PUNCT	O


Since	O	SCONJ	O
the	O	DET	O
inhibition	O	NOUN	B
of	O	ADP	O
Ca2+	O	NOUN	B
redistribution	O	NOUN	B
by	O	ADP	O
an	O	DET	O
inhibitor	O	NOUN	B
of	O	ADP	O
intracellular	O	ADJ	B
Ca2+	O	NOUN	B
mobilization	O	NOUN	B
,	O	PUNCT	O
8-	O	NUM	O
(	O	PUNCT	O
diethylamino	O	NOUN	B
)	O	PUNCT	O
-octyl-3	O	NOUN	O
,	O	PUNCT	O
4	O	NUM	O
,	O	PUNCT	O
5-trimethoxybenzoate	O	NOUN	B
hydrochloride	O	NOUN	I
,	O	PUNCT	O
inhibited	O	VERB	B
TCR-induced	B-protein	ADJ	B
FasL	I-protein	NOUN	B
but	O	CCONJ	O
not	O	PART	O
Fas	B-protein	NOUN	B
,	O	PUNCT	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
Fas	B-protein	NOUN	B
appears	O	VERB	O
to	O	PART	O
be	O	AUX	O
independent	O	ADJ	B
of	O	ADP	O
Ca2+	O	NOUN	B
mobilization	O	NOUN	B
.	O	PUNCT	O


To	O	PART	O
elucidate	O	VERB	O
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
retinoic	O	ADJ	B
acid	O	NOUN	I
(	O	PUNCT	O
RA	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
anti-CD40	B-protein	NOUN	B
+	O	CCONJ	I
interleukin-4	B-protein	NOUN	B
(	O	PUNCT	O
IL-4	B-protein	NOUN	B
)	O	PUNCT	O
-mediated	O	ADJ	O
B-cell	O	NOUN	B
activation	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
10	O	NUM	O
(	O	PUNCT	O
-12	O	NUM	B
)	O	PUNCT	O
to	O	PART	O
10	O	NUM	O
(	O	PUNCT	O
-6	O	NUM	O
)	O	PUNCT	O
mol/L	O	NOUN	O
RA	O	NOUN	B
was	O	AUX	O
studied	O	VERB	O
in	O	ADP	O
anti-CD40	B-protein	NOUN	B
(	O	PUNCT	O
1	O	NUM	O
microgram/mL	O	NOUN	O
)	O	PUNCT	O
+	O	CCONJ	O
IL-4	B-protein	NOUN	B
(	O	PUNCT	O
5	O	NUM	O
ng/mL	O	NOUN	O
)	O	PUNCT	O
-mediated	O	ADJ	O
proliferation	O	NOUN	B
and	O	CCONJ	O
Ig	O	NOUN	B
synthesis	O	NOUN	I
by	O	ADP	O
human	B-cell_type	ADJ	B
peripheral	I-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
mononuclear	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
(	O	PUNCT	O
PBMC	B-cell_type	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
in	O	ADP	O
healthy	O	ADJ	B
donors	O	NOUN	I
.	O	PUNCT	O


Anti-CD40	B-protein	NOUN	B
+	O	CCONJ	O
IL-4	B-protein	NOUN	B
-mediated	O	ADJ	O
proliferation	O	NOUN	B
of	O	ADP	O
PBMC	B-cell_type	NOUN	B
and	O	CCONJ	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
was	O	AUX	O
inhibited	O	VERB	B
by	O	ADP	O
RA	O	NOUN	B
in	O	ADP	O
a	O	DET	O
dose-dependent	O	ADJ	B
manner	O	NOUN	O
,	O	PUNCT	O
with	O	ADP	O
maximal	O	ADJ	B
inhibition	O	NOUN	B
of	O	ADP	O
62	O	NUM	O
%	O	NOUN	O
+/-	O	CCONJ	O
5	O	NUM	O
%	O	NOUN	O
in	O	ADP	O
PBMC	B-cell_type	NOUN	B
and	O	CCONJ	O
55	O	NUM	O
%	O	NOUN	O
+/-	O	CCONJ	O
4.4	O	NUM	O
%	O	NOUN	O
in	O	ADP	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
by	O	ADP	O
all-trans	O	ADJ	B
RA	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
58	O	NUM	O
%	O	NOUN	O
+/-	O	CCONJ	O
6.7	O	NUM	O
%	O	NOUN	O
and	O	CCONJ	O
51	O	NUM	O
%	O	NOUN	O
+/-	O	CCONJ	O
4.7	O	NUM	O
%	O	NOUN	O
,	O	PUNCT	O
respectively	O	ADV	O
by	O	ADP	O
13-cis	O	ADJ	O
RA	O	NOUN	B
.	O	PUNCT	O


Elucidation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
mechanism	O	NOUN	B
involved	O	VERB	O
in	O	ADP	O
this	O	DET	O
inhibition	O	NOUN	B
of	O	ADP	O
IgE	B-protein	NOUN	B
production	O	NOUN	B
shows	O	VERB	O
that	O	SCONJ	O
epsilon	O	NOUN	O
germline	B-DNA	NOUN	B
transcription	O	NOUN	I
is	O	AUX	O
decreased	O	VERB	B
by	O	ADP	O
RA	O	NOUN	B
,	O	PUNCT	O
whereas	O	SCONJ	O
production	O	NOUN	B
of	O	ADP	O
interferon-gamma	B-protein	NOUN	B
(	O	PUNCT	O
IFN-gamma	B-protein	NOUN	B
)	O	PUNCT	O
was	O	AUX	O
not	O	PART	O
enhanced	O	VERB	B
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
RA	O	NOUN	B
.	O	PUNCT	O


Human	O	ADJ	B
T-cell	O	NOUN	I
leukemia	O	NOUN	I
virus	O	NOUN	O
type	O	NOUN	O
1	O	NUM	O
Tax	B-protein	NOUN	B
induction	O	NOUN	B
of	O	ADP	O
NF-kappaB	B-protein	NOUN	B
involves	O	VERB	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IkappaB	B-protein	NOUN	B
kinase	I-protein	NOUN	I
alpha	I-protein	NOUN	I
(	O	PUNCT	O
IKKalpha	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
IKKbeta	B-protein	NOUN	B
cellular	B-protein	ADJ	B
kinases	I-protein	NOUN	I
.	O	PUNCT	O


Tax	B-protein	NOUN	B
expression	O	NOUN	B
promotes	O	VERB	B
N-terminal	O	ADJ	B
phosphorylation	O	NOUN	B
and	O	CCONJ	O
degradation	O	NOUN	B
of	O	ADP	O
IkappaB	B-protein	NOUN	B
alpha	I-protein	NOUN	I
,	O	PUNCT	O
a	O	DET	O
principal	O	ADJ	B
cytoplasmic	O	ADJ	I
inhibitor	O	NOUN	I
of	O	ADP	O
NF-kappaB	B-protein	NOUN	B
.	O	PUNCT	O


At	O	ADP	O
present	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
the	O	DET	O
IKKs	O	NOUN	B
in	O	ADP	O
LPS	O	NOUN	B
signaling	O	NOUN	B
has	O	AUX	O
not	O	PART	O
been	O	AUX	O
investigated	O	VERB	B
.	O	PUNCT	O


Here	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
report	O	VERB	O
that	O	SCONJ	O
LPS	O	NOUN	B
induces	O	VERB	O
IKK	B-protein	NOUN	B
activity	O	NOUN	O
in	O	ADP	O
human	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
and	O	CCONJ	O
THP-1	B-cell_line	NOUN	B
monocytic	I-cell_line	ADJ	I
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
LPS	O	NOUN	B
induction	O	NOUN	B
of	O	ADP	O
kappaB-dependent	O	ADJ	B
gene	O	NOUN	O
expression	O	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
monocytic	I-cell_type	ADJ	O
cells	I-cell_type	NOUN	O
requires	O	VERB	O
activation	O	NOUN	B
of	O	ADP	O
IKK2	B-protein	NOUN	B
.	O	PUNCT	O


Whereas	O	SCONJ	O
IL-4	B-protein	NOUN	B
had	O	AUX	O
little	O	ADJ	O
or	O	CCONJ	O
no	O	DET	B
effect	O	NOUN	I
,	O	PUNCT	O
IL-7	B-protein	NOUN	B
delayed	O	VERB	B
both	O	CCONJ	O
the	O	DET	O
apoptosis	O	NOUN	B
and	O	CCONJ	O
cell	O	NOUN	B
cycle	O	NOUN	I
arrest	O	NOUN	I
that	O	PRON	O
occur	O	VERB	O
upon	O	SCONJ	O
v-Abl	B-protein	NOUN	B
kinase	O	NOUN	O
inactivation	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
provide	O	VERB	O
evidence	O	NOUN	B
for	O	ADP	O
differential	O	ADJ	B
regulation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
promoter	O	NOUN	B
function	O	NOUN	I
of	O	ADP	O
CPO	B-protein	NOUN	B
gene	O	NOUN	I
between	O	ADP	O
erythroid	B-cell_type	ADJ	B
and	I-cell_type	CCONJ	O
nonerythroid	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Tumor	B-protein	NOUN	B
suppressor	I-protein	NOUN	I
proteins	I-protein	NOUN	I
as	O	ADP	O
regulators	O	NOUN	B
of	O	ADP	O
cell	O	NOUN	B
differentiation	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
products	O	NOUN	B
of	O	ADP	O
the	O	DET	O
tumor	B-DNA	NOUN	B
suppressor	I-DNA	NOUN	I
genes	I-DNA	NOUN	I
are	O	AUX	O
considered	O	VERB	O
to	O	PART	O
function	O	VERB	B
as	O	ADP	O
specific	O	ADJ	O
inhibitors	O	NOUN	B
of	O	ADP	O
tumor	O	NOUN	B
cell	O	NOUN	I
growth	O	NOUN	O
.	O	PUNCT	O


It	O	PRON	O
was	O	AUX	O
found	O	VERB	O
that	O	SCONJ	O
expression	O	NOUN	B
of	O	ADP	O
wild-type	B-protein	ADJ	B
RXR	I-protein	NOUN	O
and	O	CCONJ	O
of	O	ADP	O
the	O	DET	O
RXR	B-protein	NOUN	B
mutants	I-protein	NOUN	B
devoid	O	ADJ	B
of	O	ADP	O
AF-1	B-protein	NOUN	B
and/or	O	CCONJ	O
AF-2	B-protein	NOUN	B
supported	O	VERB	O
a	O	DET	O
transient	O	ADJ	B
outgrowth	O	NOUN	B
of	O	ADP	O
erythroid	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


T	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
from	O	ADP	O
6	O	NUM	O
of	O	ADP	O
the	O	DET	O
14	O	NUM	O
patients	O	NOUN	B
also	O	ADV	O
exhibited	O	VERB	O
an	O	DET	O
increased	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
dual	O	ADJ	B
specificity	B-protein	NOUN	I
phosphatase	I-protein	NOUN	I
,	O	PUNCT	O
map	B-protein	NOUN	B
kinase	I-protein	NOUN	I
phosphatase-1	I-protein	NOUN	I
(	O	PUNCT	O
MKP-1	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


We	O	PRON	O
studied	O	VERB	O
the	O	DET	O
number	O	NOUN	O
of	O	ADP	O
glucocorticoid	B-protein	NOUN	B
receptors	I-protein	NOUN	I
and	O	CCONJ	O
dissociation	O	NOUN	B
constant	O	NOUN	O
in	O	ADP	O
isolated	B-cell_type	VERB	B
human	I-cell_type	ADJ	B
lymphocytes	I-cell_type	NOUN	B
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
blood	O	NOUN	B
concentrations	O	NOUN	I
of	O	ADP	O
hormones	O	NOUN	B
produced	O	VERB	O
by	O	ADP	O
the	O	DET	O
hypothalamic-hypophyseal-adrenocortical	O	ADJ	B
system	O	NOUN	I
in	O	ADP	O
three	O	NUM	O
experimental	O	ADJ	B
series	O	NOUN	I
:	O	PUNCT	O
at	O	ADP	O
normal	O	ADJ	B
(	O	PUNCT	O
17	O	NUM	O
subjects	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
decreased	O	VERB	B
(	O	PUNCT	O
10	O	NUM	O
subjects	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
360-d	O	ADJ	O
head-down	O	ADJ	B
bed	O	NOUN	I
rest	O	NOUN	I
)	O	PUNCT	O
and	O	CCONJ	O
increased	O	VERB	B
(	O	PUNCT	O
8	O	NUM	O
subjects	O	NOUN	B
,	O	PUNCT	O
physical	O	ADJ	B
exercise	O	NOUN	I
on	O	ADP	O
bicycle	O	NOUN	B
ergometer	O	NOUN	I
)	O	PUNCT	O
levels	O	NOUN	B
of	O	ADP	O
motor	O	NOUN	B
activity	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
small	B-protein	ADJ	O
GTP-binding	I-protein	ADJ	B
protein	I-protein	NOUN	I
Rho	I-protein	NOUN	B
potentiates	O	VERB	O
AP-1	B-protein	NOUN	B
transcription	O	NOUN	I
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


The	O	DET	O
Rho	B-protein	NOUN	B
family	O	NOUN	B
of	O	ADP	O
small	B-protein	ADJ	O
GTP-binding	I-protein	ADJ	B
proteins	I-protein	NOUN	I
is	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
cytoskeletal	O	ADJ	B
structure	O	NOUN	I
,	O	PUNCT	O
gene	O	NOUN	B
transcription	O	NOUN	I
,	O	PUNCT	O
specific	O	ADJ	O
cell	O	NOUN	B
fate	O	NOUN	I
development	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
transformation	O	NOUN	B
.	O	PUNCT	O


To	O	PART	O
evaluate	O	VERB	B
a	O	DET	O
potential	O	ADJ	B
mechanism	O	NOUN	B
for	O	ADP	O
these	O	DET	O
differences	O	NOUN	B
in	O	ADP	O
function	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
evaluated	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
C	I-protein	NOUN	I
(	I-protein	PUNCT	O
PKC	I-protein	NOUN	B
)	I-protein	PUNCT	O
isoforms	I-protein	NOUN	B
.	O	PUNCT	O


One	O	NUM	O
consequence	O	NOUN	B
of	O	ADP	I
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
PKC	B-protein	NOUN	B
can	O	AUX	O
be	O	AUX	O
increased	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
mitogen-activated	B-protein	ADJ	B
protein	I-protein	NOUN	I
(	I-protein	PUNCT	O
MAP	I-protein	NOUN	B
)	I-protein	PUNCT	O
kinase	I-protein	NOUN	O
pathways	O	NOUN	O
.	O	PUNCT	O


Similarly	O	ADV	O
,	O	PUNCT	O
substantial	O	ADJ	O
evidence	O	NOUN	O
indicates	O	VERB	O
that	O	SCONJ	O
full	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
NF-kappaB	B-protein	NOUN	B
requires	O	VERB	O
dual	O	ADJ	O
signals	O	NOUN	B
.	O	PUNCT	O


To	O	PART	O
investigate	O	VERB	B
further	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
then	O	ADV	O
purified	O	VERB	B
a	O	DET	O
number	O	NOUN	O
of	O	ADP	O
different	O	ADJ	O
kinases	O	NOUN	B
,	O	PUNCT	O
including	O	VERB	O
PKC	B-protein	NOUN	B
,	O	PUNCT	O
PhK	B-protein	NOUN	B
,	O	PUNCT	O
ZAP-70	B-protein	NOUN	B
,	O	PUNCT	O
ERK	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
MEK	B-protein	NOUN	B
1	I-protein	NUM	I
(	O	PUNCT	O
a	O	DET	O
MKK	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
showed	O	VERB	O
that	O	SCONJ	O
Ro	O	NOUN	B
09-2210	O	NUM	B
was	O	AUX	O
a	O	DET	O
selective	O	ADJ	O
inhibitor	O	NOUN	B
of	O	ADP	O
MEK1	B-protein	NOUN	B
in	O	X	B
vitro	O	X	I
(	O	PUNCT	O
IC50	O	NOUN	B
=	O	ADJ	O
59	O	NUM	O
nM	O	NOUN	O
)	O	PUNCT	O
.	O	PUNCT	O


Molecular	O	ADJ	B
dissection	O	NOUN	I
of	O	ADP	O
the	O	DET	O
B-cell-specific	O	ADJ	B
transcription	O	NOUN	I
coactivator	O	NOUN	I
OCA-B	B-protein	NOUN	I
has	O	AUX	O
revealed	O	VERB	O
distinct	O	ADJ	O
regions	O	NOUN	B
important	O	ADJ	O
,	O	PUNCT	O
respectively	O	ADV	O
,	O	PUNCT	O
for	O	ADP	O
recruitment	O	NOUN	B
to	O	PART	O
immunoglobulin	B-DNA	NOUN	B
promoters	I-DNA	NOUN	I
through	O	ADP	O
interaction	O	NOUN	B
with	O	ADP	O
octamer-bound	B-protein	ADJ	B
Oct-1	I-protein	NOUN	I
and	O	CCONJ	O
for	O	ADP	O
subsequent	O	ADJ	O
coactivator	O	NOUN	B
function	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
Stat-3	B-protein	NOUN	B
was	O	AUX	O
tyrosine	O	NOUN	B
phosphorylated	O	VERB	B
in	O	ADP	O
the	O	DET	O
cytoplasm	O	NOUN	B
and	O	CCONJ	O
subsequently	O	ADV	O
translocated	O	VERB	B
to	O	PART	O
the	O	DET	O
cell	O	NOUN	B
nucleus	O	NOUN	I
.	O	PUNCT	O


To	O	PART	O
investigate	O	VERB	B
the	O	DET	O
function	O	NOUN	B
of	O	ADP	O
the	O	DET	O
activated	O	VERB	B
Stat-3	B-protein	NOUN	B
,	O	PUNCT	O
Jurkat	B-cell_line	NOUN	B
T	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
were	O	AUX	O
transiently	O	ADV	O
transfected	O	VERB	B
with	O	ADP	O
a	O	DET	O
Stat-3	B-protein	NOUN	B
isoform	I-protein	NOUN	B
lacking	O	VERB	O
the	O	DET	O
transactivating	B-protein	VERB	B
domain	I-protein	NOUN	I
.	O	PUNCT	O


This	O	DET	O
dominant-negative	B-protein	ADJ	B
acting	I-protein	VERB	O
Stat-3	I-protein	NOUN	B
isoform	I-protein	NOUN	B
significantly	O	ADV	O
inhibited	O	VERB	B
apoptosis	O	NOUN	B
induced	O	VERB	B
by	O	ADP	O
ligation	O	NOUN	B
of	O	ADP	O
MHC-I	B-protein	NOUN	B
.	O	PUNCT	O


Flow	O	NOUN	B
cytometry	O	NOUN	I
revealed	O	VERB	O
that	O	SCONJ	O
primary	B-cell_type	ADJ	B
leukemia	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	B
from	O	ADP	O
a	O	DET	O
patient	O	NOUN	B
with	O	ADP	O
CD8+	O	ADJ	B
T-PLL	O	NOUN	I
expressed	O	VERB	B
IL-2Ralpha	B-protein	NOUN	B
and	I-protein	CCONJ	O
beta	I-protein	NOUN	B
chains	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
cells	O	NOUN	B
showed	O	VERB	O
a	O	DET	O
proliferative	O	ADJ	B
response	O	NOUN	I
and	O	CCONJ	O
an	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
IL-2Ralpha	B-protein	NOUN	B
expression	O	NOUN	B
on	O	ADP	O
culture	O	NOUN	B
with	O	ADP	O
exogeneous	O	ADJ	B
IL-2	B-protein	NOUN	B
.	O	PUNCT	O


Electrophoretic	O	ADJ	B
mobility-shift	O	ADJ	I
assays	O	NOUN	I
revealed	O	VERB	O
that	O	SCONJ	O
recombinant	O	ADJ	B
IL-2	B-protein	NOUN	B
increased	O	VERB	B
NF-kappaB	B-protein	NOUN	B
binding	O	NOUN	I
activity	O	NOUN	I
in	O	ADP	O
nuclear	O	ADJ	B
extracts	O	NOUN	I
of	O	ADP	O
the	O	DET	O
leukemia	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
Northern	O	NOUN	B
blot	O	NOUN	I
analysis	O	NOUN	I
showed	O	VERB	O
that	O	SCONJ	O
IL-2	B-protein	NOUN	B
increased	O	VERB	B
the	O	DET	O
abundance	O	NOUN	B
of	O	ADP	O
mRNAs	O	NOUN	B
encoding	O	VERB	B
the	O	DET	O
NF-kappaB	B-protein	NOUN	B
components	O	NOUN	O
c-Rel	B-protein	NOUN	B
and	O	CCONJ	O
KBF1	B-protein	NOUN	B
in	O	ADP	O
these	O	DET	O
cells	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
apparent	O	ADJ	B
inconsistencies	O	NOUN	B
reflect	O	VERB	O
the	O	DET	O
complexity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
DTCs	O	NOUN	B
biological	O	ADJ	B
activities	O	NOUN	I
and	O	CCONJ	O
are	O	AUX	O
probably	O	ADV	O
due	O	ADJ	O
in	O	ADP	O
part	O	NOUN	O
to	O	PART	O
differences	O	NOUN	B
in	O	ADP	O
dose	O	NOUN	B
,	O	PUNCT	O
route	O	NOUN	B
of	O	ADP	I
exposure	O	NOUN	I
,	O	PUNCT	O
animal	O	ADJ	B
species	O	NOUN	I
used	O	VERB	O
and/or	O	CCONJ	O
specific	O	ADJ	O
compound	O	NOUN	B
tested	O	VERB	B
.	O	PUNCT	O


The	O	DET	O
studies	O	NOUN	B
described	O	VERB	O
herein	O	ADV	O
were	O	AUX	O
undertaken	O	VERB	O
to	O	PART	O
investigate	O	VERB	B
the	O	DET	O
immunotoxicity	O	NOUN	B
of	O	ADP	O
one	O	NUM	O
member	O	NOUN	B
of	O	ADP	O
this	O	DET	O
family	O	NOUN	B
,	O	PUNCT	O
dimethyldithiocarbamate	O	NOUN	B
(	O	PUNCT	O
DMDTC	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
demonstrate	O	VERB	O
that	O	SCONJ	O
DMDTC	O	NOUN	B
is	O	AUX	O
a	O	DET	O
potent	O	ADJ	O
immunosuppressive	O	ADJ	B
compound	O	NOUN	I
in	O	X	B
vitro	O	X	I
.	O	PUNCT	O


After	O	ADP	O
5-day	O	ADJ	O
anti-CD3	B-protein	ADJ	B
/IL-2	B-protein	NOUN	O
activation	O	NOUN	B
,	O	PUNCT	O
levels	O	NOUN	B
of	O	ADP	O
p56lck	B-protein	NOUN	B
and	O	CCONJ	O
p59fyn	B-protein	NOUN	B
and	O	CCONJ	O
protein	O	NOUN	B
tyrosine	O	NOUN	I
kinase	O	NOUN	I
activity	O	NOUN	I
increased	O	VERB	B
.	O	PUNCT	O


These	O	DET	O
findings	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
recovery	O	NOUN	B
of	O	ADP	O
proteins	O	NOUN	B
mediating	O	VERB	O
signal	O	NOUN	B
transduction	O	NOUN	I
through	O	ADP	O
the	O	DET	O
T	B-protein	NOUN	B
cell	I-protein	NOUN	I
receptor/CD3	I-protein	NOUN	O
complex	I-protein	NOUN	O
in	O	ADP	O
LN	B-cell_type	NOUN	B
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
activated	O	VERB	B
ex	O	X	B
vivo	O	X	I
was	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
the	O	DET	O
acquisition	O	NOUN	B
of	O	ADP	O
antitumor	O	ADJ	B
function	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
previously	O	ADV	O
demonstrated	O	VERB	O
that	O	SCONJ	O
a	O	DET	O
mutated	O	VERB	B
form	O	NOUN	O
of	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
CIITA	I-DNA	NOUN	O
gene	I-DNA	NOUN	O
,	O	PUNCT	O
coding	O	VERB	B
for	O	ADP	O
a	O	DET	O
protein	O	NOUN	B
lacking	O	VERB	O
the	O	DET	O
amino	B-protein	NOUN	B
terminal	I-protein	ADJ	I
151	I-protein	NUM	I
amino	I-protein	NOUN	B
acids	I-protein	NOUN	I
,	O	PUNCT	O
acts	O	VERB	O
as	O	ADP	O
a	O	DET	O
potent	O	ADJ	O
dominant-negative	O	ADJ	B
suppressor	O	NOUN	I
of	O	ADP	O
HLA	B-protein	NOUN	B
class	I-protein	NOUN	I
II	I-protein	NUM	I
expression	O	NOUN	B
.	O	PUNCT	O


PIEC	B-cell_line	NOUN	B
clones	I-cell_line	NOUN	B
stably	O	ADV	B
transfected	O	VERB	B
with	O	ADP	O
one	O	NUM	O
of	O	ADP	O
these	O	DET	O
constructs	O	NOUN	B
showed	O	VERB	O
up	O	ADV	O
to	O	PART	O
99	O	NUM	O
%	O	NOUN	O
suppression	O	NOUN	B
of	O	ADP	O
SLA-DR	B-protein	NOUN	B
and	O	CCONJ	O
SLA-DQ	B-protein	NOUN	B
antigen	O	NOUN	O
induction	O	NOUN	B
and	O	CCONJ	O
marked	O	ADJ	O
suppression	O	NOUN	B
of	O	ADP	O
SLA-DRA	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
induction	O	NOUN	B
.	O	PUNCT	O


Peroxisomal	B-protein	ADJ	B
proliferator-activated	I-protein	ADJ	I
receptor	I-protein	NOUN	I
gamma	I-protein	NOUN	I
(	O	PUNCT	O
PPARgamma	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
a	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
in	O	ADP	O
the	O	DET	O
nuclear	O	ADJ	B
receptor	O	NOUN	I
superfamily	O	NOUN	I
,	O	PUNCT	O
regulates	O	VERB	B
gene	O	NOUN	B
expression	O	NOUN	I
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
various	O	ADJ	O
activators	O	NOUN	B
,	O	PUNCT	O
including	O	VERB	O
15-deoxy-delta12	O	PROPN	B
,	O	PUNCT	O
14-prostaglandin	O	NOUN	B
J2	O	NOUN	I
and	O	CCONJ	O
the	O	DET	O
antidiabetic	O	ADJ	B
agent	O	NOUN	I
troglitazone	O	NOUN	B
.	O	PUNCT	O


Human	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
and	O	CCONJ	O
monocyte-derived	B-cell_type	ADJ	B
macrophages	I-cell_type	NOUN	I
cultured	O	VERB	B
for	O	ADP	O
6	O	NUM	O
days	O	NOUN	B
in	O	ADP	O
5	O	NUM	O
%	O	NOUN	O
human	O	ADJ	B
serum	O	NOUN	B
expressed	O	VERB	B
PPARgamma	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
and	O	CCONJ	O
protein	O	NOUN	B
by	O	ADP	O
reverse	O	ADJ	B
transcription-polymerase	O	ADJ	I
chain	O	NOUN	I
reaction	O	NOUN	I
and	O	CCONJ	O
Western	O	NOUN	B
blotting	O	NOUN	I
,	O	PUNCT	O
respectively	O	ADV	O
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
PPARgamma	B-protein	NOUN	B
is	O	AUX	O
present	O	ADJ	O
in	O	ADP	O
macrophages	B-cell_type	NOUN	B
in	O	ADP	O
human	O	ADJ	B
atherosclerotic	O	ADJ	B
lesions	O	NOUN	I
and	O	CCONJ	O
may	O	AUX	O
regulate	O	VERB	B
expression	O	NOUN	B
and	O	CCONJ	O
activity	O	NOUN	B
of	O	ADP	O
MMP-9	B-protein	NOUN	B
,	O	PUNCT	O
an	O	DET	O
enzyme	O	NOUN	B
implicated	O	VERB	O
in	O	ADP	O
plaque	O	NOUN	B
rupture	O	NOUN	B
.	O	PUNCT	O


PPARgamma	B-protein	NOUN	B
is	O	AUX	O
likely	O	ADJ	O
to	O	PART	O
be	O	AUX	O
an	O	DET	O
important	O	ADJ	O
regulator	O	NOUN	B
of	O	ADP	O
monocyte/macrophage	O	NOUN	B
function	O	NOUN	I
with	O	ADP	O
relevance	O	NOUN	B
for	O	ADP	O
human	O	ADJ	B
atherosclerotic	O	ADJ	B
disease	O	NOUN	I
.	O	PUNCT	O


Erythropoietin	B-protein	NOUN	B
induces	O	VERB	O
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	B
of	O	ADP	O
Jak2	B-protein	NOUN	B
,	O	PUNCT	O
STAT5A	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
STAT5B	B-protein	NOUN	B
in	O	ADP	O
primary	B-cell_type	ADJ	B
cultured	I-cell_type	VERB	I
human	I-cell_type	ADJ	B
erythroid	I-cell_type	ADJ	O
precursors	I-cell_type	NOUN	O
.	O	PUNCT	O


Crkl	B-protein	NOUN	B
,	O	PUNCT	O
an	O	DET	O
SH2/SH3	B-protein	NOUN	B
adapter	I-protein	NOUN	I
protein	I-protein	NOUN	I
,	O	PUNCT	O
becomes	O	VERB	O
coimmunoprecipitated	O	VERB	B
specifically	O	ADV	O
with	O	ADP	O
STAT5	B-protein	NOUN	B
from	O	ADP	O
erythropoietin-stimulated	B-cell_type	ADJ	B
erythroid	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
;	O	PUNCT	O
although	O	SCONJ	O
it	O	PRON	O
was	O	AUX	O
shown	O	VERB	O
to	O	PART	O
become	O	VERB	O
associated	O	VERB	B
with	O	ADP	I
c-Cbl	B-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
studies	O	NOUN	B
using	O	VERB	O
cell	B-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
.	O	PUNCT	O


DNA-binding	O	ADJ	B
activities	O	NOUN	O
(	O	PUNCT	O
determined	O	VERB	O
by	O	ADP	O
the	O	DET	O
electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assay	O	NOUN	I
)	O	PUNCT	O
of	O	ADP	O
three	O	NUM	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
:	O	PUNCT	O
NFkappaB	B-protein	NOUN	B
,	O	PUNCT	O
AP-1	B-protein	NOUN	B
and	O	CCONJ	O
NFAT	B-protein	NOUN	B
,	O	PUNCT	O
were	O	AUX	O
abolished	O	VERB	O
in	O	ADP	O
the	O	DET	O
lymphocytes	B-cell_type	NOUN	B
by	O	ADP	O
all	O	DET	O
three	O	NUM	O
modes	O	NOUN	B
of	O	ADP	O
oxidative	O	ADJ	B
stress	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
lymphocytes	B-cell_type	NOUN	B
exhibited	O	VERB	O
lipid	O	NOUN	B
peroxidation	O	NOUN	I
only	O	ADV	O
upon	O	SCONJ	O
exposure	O	NOUN	B
to	O	PART	I
the	O	DET	O
lowest	O	ADJ	B
level	O	NOUN	B
of	O	ADP	O
hydrogen	O	NOUN	B
peroxide	O	NOUN	I
used	O	VERB	O
(	O	PUNCT	O
20	O	NUM	O
microM	O	NOUN	O
)	O	PUNCT	O
.	O	PUNCT	O


Cells	O	NOUN	B
were	O	AUX	O
analyzed	O	VERB	B
by	O	ADP	O
in	O	X	B
situ	O	X	I
hybridization	O	NOUN	I
and	O	CCONJ	O
immunohistochemistry	O	NOUN	B
.	O	PUNCT	O


Consistent	O	ADJ	B
with	O	ADP	I
the	O	DET	O
ability	O	NOUN	O
of	O	ADP	O
IL-4	B-protein	NOUN	B
to	O	PART	O
regulate	O	VERB	B
eosinophil	O	NOUN	B
responses	O	NOUN	O
,	O	PUNCT	O
IL-4	B-protein	NOUN	B
signaling	I-protein	NOUN	I
molecules	I-protein	NOUN	I
are	O	AUX	O
present	O	ADJ	O
in	O	ADP	O
human	B-cell_type	ADJ	B
eosinophils	I-cell_type	NOUN	B
.	O	PUNCT	O


A	O	DET	O
recent	O	ADJ	O
study	O	NOUN	O
showed	O	VERB	O
a	O	DET	O
MLL/AF10	B-DNA	NOUN	B
fusion	I-DNA	NOUN	B
in	O	ADP	O
all	O	DET	O
cases	O	NOUN	B
of	O	ADP	O
AML	O	NOUN	B
with	O	ADP	O
t	B-DNA	NOUN	O
(	I-DNA	PUNCT	O
10	I-DNA	NUM	O
;	I-DNA	PUNCT	O
11	I-DNA	NUM	O
)	I-DNA	PUNCT	O
and	O	CCONJ	O
various	O	ADJ	O
breakpoints	O	NOUN	B
on	O	ADP	O
chromosome	B-DNA	NOUN	B
11	I-DNA	NUM	O
ranging	O	VERB	B
from	O	ADP	O
q13	B-DNA	NOUN	B
to	O	PART	I
q23	B-DNA	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
recently	O	ADV	O
cloned	O	VERB	B
CALM	B-DNA	NOUN	B
(	O	PUNCT	O
Clathrin	B-DNA	NOUN	B
Assembly	I-DNA	PROPN	O
Lymphoid	I-DNA	ADJ	B
Myeloid	I-DNA	ADJ	I
leukemia	I-DNA	NOUN	I
gene	I-DNA	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
the	O	DET	O
fusion	O	NOUN	B
partner	O	NOUN	O
of	O	ADP	O
AF10	B-DNA	NOUN	B
at	O	ADP	O
11q14	B-DNA	NOUN	B
in	O	ADP	O
the	O	DET	O
monocytic	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
U937	I-cell_line	NOUN	I
.	O	PUNCT	O


For	O	ADP	O
the	O	DET	O
7	O	NUM	O
AML	O	NOUN	B
cases	O	NOUN	B
that	O	PRON	O
were	O	AUX	O
uniformly	O	ADV	O
treated	O	VERB	B
according	O	VERB	O
to	O	PART	O
the	O	DET	O
AMLCG86/92	O	NOUN	B
protocols	O	NOUN	I
,	O	PUNCT	O
disease-free	O	ADJ	B
and	O	CCONJ	O
overall	O	ADJ	B
survival	O	NOUN	B
was	O	AUX	O
significantly	O	ADV	O
worse	O	ADJ	O
than	O	ADP	O
for	O	ADP	O
the	O	DET	O
overall	O	ADJ	O
study	O	NOUN	B
group	O	NOUN	I
(	O	PUNCT	O
P	O	NOUN	O
=	O	ADJ	O
.03	O	NUM	O
and	O	CCONJ	O
P	O	NOUN	O
=	O	ADJ	O
.01	O	NUM	O
,	O	PUNCT	O
respectively	O	ADV	O
)	O	PUNCT	O
.	O	PUNCT	O


IkappaB	B-protein	NOUN	B
alpha	I-protein	NOUN	I
phosphorylation	O	NOUN	B
on	O	ADP	O
Ser-32	O	NOUN	B
and	O	CCONJ	O
Ser-36	O	NOUN	B
is	O	AUX	O
followed	O	VERB	O
by	O	ADP	O
its	O	PRON	O
degradation	O	NOUN	B
and	O	CCONJ	O
NF-kappaB	B-protein	NOUN	B
activation	O	NOUN	B
.	O	PUNCT	O


Taken	O	VERB	O
together	O	ADV	O
,	O	PUNCT	O
these	O	DET	O
results	O	NOUN	B
demonstrate	O	VERB	O
that	O	SCONJ	O
MyD88	B-protein	NOUN	B
is	O	AUX	O
a	O	DET	O
critical	O	ADJ	O
component	O	NOUN	O
in	O	ADP	O
the	O	DET	O
signaling	O	NOUN	B
cascade	O	NOUN	I
that	O	PRON	O
is	O	AUX	O
mediated	O	VERB	O
by	O	ADP	O
IL-1	B-protein	NOUN	B
receptor	I-protein	NOUN	I
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
IL-18	B-protein	NOUN	B
receptor	I-protein	NOUN	I
.	O	PUNCT	O


Using	O	VERB	O
this	O	DET	O
RAR-selective	O	ADJ	B
antagonist	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
RXR	B-protein	NOUN	B
and	O	CCONJ	O
RAR	B-protein	NOUN	B
agonist	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
demonstrate	O	VERB	O
the	O	DET	O
RAR	B-protein	NOUN	B
-mediated	O	ADJ	O
signaling	O	NOUN	B
pathway	O	NOUN	I
is	O	AUX	O
important	O	ADJ	O
for	O	ADP	O
differentiation	O	NOUN	B
and	O	CCONJ	O
apoptosis	O	NOUN	B
of	O	ADP	O
myeloid	B-cell_type	ADJ	B
leukemic	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Additional	O	ADJ	O
experiments	O	NOUN	B
showed	O	VERB	O
that	O	SCONJ	O
levels	O	NOUN	B
of	O	ADP	O
BCL-2	B-protein	NOUN	B
protein	I-protein	NOUN	I
decreased	O	VERB	B
during	O	ADP	O
differentiation	O	NOUN	B
of	O	ADP	O
myeloid	B-cell_type	ADJ	B
leukemic	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
isolated	O	VERB	B
a	O	DET	O
novel	O	ADJ	O
subline	O	NOUN	B
,	O	PUNCT	O
UT-7/GMT	B-cell_line	PROPN	B
,	O	PUNCT	O
from	O	ADP	O
the	O	DET	O
human	B-cell_line	ADJ	B
leukemia	I-cell_line	NOUN	I
cell	I-cell_line	NOUN	B
line	I-cell_line	NOUN	I
UT-7/GM	I-cell_line	NOUN	I
(	O	PUNCT	O
N.	O	PROPN	O
Komatsu	O	PROPN	O
,	O	PUNCT	O
et	O	X	O
al.	O	X	O
,	O	PUNCT	O
Blood	O	PROPN	B
,	O	PUNCT	O
89	O	NUM	O
:	O	PUNCT	O
4021-4033	O	NUM	O
,	O	PUNCT	O
1997	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
our	O	PRON	O
data	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
TPO	B-protein	NOUN	B
has	O	AUX	O
a	O	DET	O
distinct	O	ADJ	O
action	O	NOUN	B
on	O	ADP	O
erythropoiesis	O	NOUN	B
.	O	PUNCT	O


To	O	PART	O
elucidate	O	VERB	O
the	O	DET	O
contributions	O	NOUN	B
of	O	ADP	O
GATA-1	B-protein	NOUN	B
to	O	PART	O
definitive	O	ADJ	O
hematopoiesis	O	NOUN	B
in	O	X	B
vivo	O	X	I
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
examined	O	VERB	O
adult	O	ADJ	B
mice	O	NOUN	B
that	O	PRON	O
were	O	AUX	O
rendered	O	VERB	O
genetically	O	ADV	B
defective	O	ADJ	B
in	O	ADP	O
GATA-1	B-protein	NOUN	B
synthesis	O	NOUN	B
(	O	PUNCT	O
Takahashi	O	PROPN	O
et	O	X	O
al	O	X	O
,	O	PUNCT	O
J	O	PROPN	O
Biol	O	PROPN	O
Chem	O	PROPN	O
272	O	NUM	O
:	O	PUNCT	O
12611	O	NUM	O
,	O	PUNCT	O
1997	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Proerythroblasts	B-cell_type	NOUN	B
and	O	CCONJ	O
megakaryocytes	B-cell_type	NOUN	B
massively	O	ADV	O
accumulated	O	VERB	O
in	O	ADP	O
the	O	DET	O
spleens	O	NOUN	B
of	O	ADP	O
the	O	DET	O
heterozygotes	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
we	O	PRON	O
showed	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
neomycin	B-DNA	NOUN	B
resistance	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
(	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
the	O	DET	O
positive	O	ADJ	B
selection	O	NOUN	B
marker	O	NOUN	I
in	O	ADP	O
ES	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
)	O	PUNCT	O
was	O	AUX	O
expressed	O	VERB	B
profusely	O	ADV	O
in	O	ADP	O
the	O	DET	O
abnormally	O	ADV	B
abundant	O	ADJ	O
cells	O	NOUN	B
generated	O	VERB	O
in	O	ADP	O
the	O	DET	O
GATA-1.05	B-protein	NOUN	B
mutant	O	ADJ	B
females	O	NOUN	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
IL-13	B-protein	NOUN	B
,	O	PUNCT	O
like	O	ADP	O
IL-4	B-protein	NOUN	B
,	O	PUNCT	O
induces	O	VERB	B
distinct	O	ADJ	O
STAT6-DNA	B-protein	NOUN	B
binding	I-protein	NOUN	I
complexes	I-protein	NOUN	I
and	O	CCONJ	O
tyrosine	O	NOUN	B
phosphorylation	O	NOUN	I
of	O	ADP	O
STAT6	B-protein	NOUN	B
and	O	CCONJ	O
Janus	B-protein	NOUN	B
kinase	I-protein	NOUN	I
3	I-protein	NUM	I
(	O	PUNCT	O
JAK3	B-protein	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
NK	O	NOUN	B
and	O	CCONJ	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


These	O	DET	O
findings	O	NOUN	B
show	O	VERB	O
that	O	SCONJ	O
IL-13	B-protein	NOUN	B
and	O	CCONJ	O
IL-4	B-protein	NOUN	B
have	O	AUX	O
the	O	DET	O
ability	O	NOUN	O
to	O	PART	O
regulate	O	VERB	B
NK	O	NOUN	B
and	O	CCONJ	O
T	O	NOUN	B
cell	O	NOUN	I
activation	O	NOUN	B
and	O	CCONJ	O
that	O	SCONJ	O
IL-13	B-protein	NOUN	B
is	O	AUX	O
a	O	DET	O
potent	O	ADJ	O
regulator	O	NOUN	B
of	O	ADP	O
STAT6	B-protein	NOUN	B
and	O	CCONJ	O
JAK3	B-protein	NOUN	B
in	O	ADP	O
these	O	DET	O
cell	O	NOUN	B
types	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
human	O	ADJ	B
homologue	O	NOUN	B
of	O	ADP	O
Drosophila	B-protein	X	B
Toll	I-protein	NOUN	B
(	O	PUNCT	O
hToll	B-protein	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
recently	O	ADV	O
cloned	O	VERB	B
receptor	O	NOUN	I
of	O	ADP	O
the	O	DET	O
interleukin	B-protein	NOUN	B
1	I-protein	NUM	I
receptor	I-protein	NOUN	I
(	I-protein	PUNCT	O
IL-1R	I-protein	NOUN	B
)	I-protein	PUNCT	O
superfamily	I-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
has	O	AUX	O
been	O	AUX	O
implicated	O	VERB	O
in	O	ADP	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
adaptive	O	ADJ	B
immunity	O	NOUN	I
.	O	PUNCT	O


Conversely	O	ADV	O
,	O	PUNCT	O
a	O	DET	O
dominant	O	ADJ	B
negative	O	ADJ	B
version	O	NOUN	B
of	O	ADP	O
TRAF6	B-protein	NOUN	B
failed	O	VERB	B
to	O	PART	O
block	O	VERB	B
hToll	B-protein	ADJ	B
-induced	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
stress-activated	B-protein	ADJ	B
protein	I-protein	NOUN	I
kinase/c-Jun	I-protein	NOUN	B
NH2-terminal	I-protein	ADJ	I
kinases	I-protein	NOUN	I
,	O	PUNCT	O
thus	O	ADV	O
suggesting	O	VERB	O
an	O	DET	O
early	O	ADJ	B
divergence	O	NOUN	B
of	O	ADP	O
the	O	DET	O
two	O	NUM	O
pathways	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
local	O	ADJ	B
cellular	O	ADJ	B
immune	O	ADJ	O
response	O	NOUN	O
to	O	PART	O
herpes	O	NOUN	B
simplex	O	NOUN	I
virus	O	NOUN	I
(	O	PUNCT	O
HSV	O	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
important	O	ADJ	O
in	O	ADP	O
the	O	DET	O
control	O	NOUN	B
of	O	ADP	O
recurrent	O	ADJ	O
HSV	O	NOUN	B
infection	O	NOUN	I
.	O	PUNCT	O


Reactivity	O	NOUN	B
with	O	ADP	O
the	O	DET	O
tegument	B-protein	ADJ	B
protein	I-protein	NOUN	I
encoded	O	VERB	B
by	O	ADP	O
UL21	B-DNA	NOUN	B
was	O	AUX	O
identified	O	VERB	B
for	O	ADP	O
an	O	DET	O
additional	O	ADJ	O
patient	O	NOUN	B
.	O	PUNCT	O


Peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
monocytes	B-cell_type	NOUN	B
and	O	CCONJ	O
B	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
derived	O	VERB	O
from	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
lupus	O	NOUN	B
express	O	VERB	O
estrogen	O	NOUN	B
receptor	O	NOUN	I
transcripts	O	NOUN	B
similar	O	ADJ	O
to	O	PART	O
those	O	DET	O
of	O	ADP	O
normal	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


The	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
variants	O	NOUN	B
did	O	AUX	O
not	O	PART	O
correlate	O	VERB	O
with	O	ADP	O
disease	O	NOUN	B
activity	O	NOUN	I
or	O	CCONJ	O
medication	O	NOUN	B
.	O	PUNCT	O


Mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
relevant	O	ADJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
and	O	CCONJ	O
AP-1	B-DNA	NOUN	B
binding	I-DNA	NOUN	I
sites	I-DNA	NOUN	I
eliminated	O	VERB	O
these	O	DET	O
responses	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
percentages	O	NOUN	B
of	O	ADP	O
the	O	DET	O
T/NK-cell	B-cell_type	NOUN	B
subsets	I-cell_type	NOUN	I
in	O	ADP	O
the	O	DET	O
PB	O	NOUN	B
were	O	AUX	O
not	O	PART	O
significantly	O	ADV	O
different	O	ADJ	O
among	O	ADP	O
these	O	DET	O
groups	O	NOUN	B
.	O	PUNCT	O


Tuberculosis	O	NOUN	B
has	O	AUX	O
emerged	O	VERB	O
as	O	ADP	O
an	O	DET	O
epidemic	O	NOUN	B
,	O	PUNCT	O
extended	O	VERB	O
by	O	ADP	O
the	O	DET	O
large	O	ADJ	O
number	O	NOUN	O
of	O	ADP	O
individuals	O	NOUN	B
infected	O	VERB	B
with	O	ADP	O
human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
type	O	NOUN	I
1	O	NUM	I
(	O	PUNCT	O
HIV-1	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
major	O	ADJ	O
goal	O	NOUN	B
of	O	ADP	O
this	O	DET	O
study	O	NOUN	B
was	O	AUX	O
to	O	PART	O
determine	O	VERB	O
whether	O	SCONJ	O
the	O	DET	O
mycobacterial	B-cell_type	ADJ	B
cell	I-cell_type	NOUN	B
wall	O	NOUN	I
component	O	NOUN	O
mannose-capped	O	ADJ	O
lipoarabinomannan	O	NOUN	O
(	O	PUNCT	O
ManLAM	O	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
Mycobacterium	O	X	B
tuberculosis	O	X	I
(	O	PUNCT	O
M.	O	X	B
tuberculosis	O	X	I
)	O	PUNCT	O
could	O	AUX	O
activate	O	VERB	B
transcription	O	NOUN	B
of	O	ADP	O
HIV-1	O	NOUN	B
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
with	O	ADP	O
the	O	DET	O
use	O	NOUN	O
of	O	ADP	O
an	O	DET	O
in	O	X	B
vitro	O	X	I
cell	O	NOUN	B
culture	O	NOUN	I
system	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
experiments	O	NOUN	B
are	O	AUX	O
of	O	ADP	O
prime	O	ADJ	B
importance	O	NOUN	O
considering	O	VERB	O
that	O	SCONJ	O
CD4-expressing	B-cell_type	ADJ	B
T	I-cell_type	NOUN	I
lymphocytes	I-cell_type	NOUN	I
represent	O	VERB	O
the	O	DET	O
major	O	ADJ	O
virus	O	NOUN	B
reservoir	O	NOUN	B
in	O	ADP	O
the	O	DET	O
peripheral	O	ADJ	B
blood	O	NOUN	I
of	O	ADP	O
infected	O	ADJ	B
individuals	O	NOUN	B
.	O	PUNCT	O


Human	B-DNA	ADJ	B
immunodeficiency	I-DNA	NOUN	I
virus	I-DNA	NOUN	I
type	I-DNA	NOUN	I
1	I-DNA	NUM	I
long	I-DNA	ADJ	I
terminal	I-DNA	ADJ	I
repeat	I-DNA	NOUN	I
quasispecies	I-DNA	NOUN	B
differ	O	VERB	O
in	O	ADP	O
basal	O	ADJ	B
transcription	O	NOUN	I
and	O	CCONJ	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
recruitment	O	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
glial	I-cell_type	ADJ	O
cells	I-cell_type	NOUN	O
and	I-cell_type	CCONJ	O
lymphocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


TCF/LEF	B-protein	NOUN	B
proteins	I-protein	NOUN	I
have	O	AUX	O
recently	O	ADV	O
been	O	AUX	O
found	O	VERB	O
to	O	PART	O
constitute	O	VERB	O
a	O	DET	O
downstream	O	ADJ	B
component	O	NOUN	O
of	O	ADP	O
the	O	DET	O
Wingless/Wnt	O	NOUN	B
signal	O	NOUN	I
transduction	O	NOUN	I
pathway	O	NOUN	I
.	O	PUNCT	O


Deregulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
pathway	O	NOUN	B
occurs	O	VERB	O
in	O	ADP	O
several	O	ADJ	O
human	O	ADJ	B
tumors	O	NOUN	I
.	O	PUNCT	O


Molecular	O	ADJ	B
genetic	O	ADJ	I
characterization	O	NOUN	I
of	O	ADP	O
the	O	DET	O
variant	B-DNA	ADJ	B
allele	I-DNA	NOUN	B
can	O	AUX	O
serve	O	VERB	O
as	O	ADP	O
a	O	DET	O
primary	O	ADJ	O
tool	O	NOUN	O
for	O	ADP	O
diagnosis	O	NOUN	B
and	O	CCONJ	O
subsequent	O	ADJ	O
therapy	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
can	O	AUX	O
provide	O	VERB	O
a	O	DET	O
basis	O	NOUN	O
for	O	ADP	O
distinguishing	O	VERB	O
heterozygous	O	ADJ	B
carriers	O	NOUN	B
in	O	ADP	O
familial	O	ADJ	B
androgen	O	NOUN	O
resistance	O	NOUN	O
.	O	PUNCT	O


METHODS	O	NOUN	O
.	O	PUNCT	O


RESULTS	O	NOUN	B
.	O	PUNCT	O


Tumors	O	NOUN	B
with	O	ADP	O
high	O	ADJ	O
Ki-67	B-protein	NOUN	B
proliferation	O	NOUN	I
indices	O	NOUN	I
(	O	PUNCT	O
>	O	NOUN	O
20	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
were	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
a	O	DET	O
higher	O	ADJ	O
4-year	O	ADJ	O
probability	O	NOUN	B
of	O	ADP	O
relapse	O	NOUN	B
of	O	ADP	O
disease	O	NOUN	O
(	O	PUNCT	O
55.3	O	NUM	O
%	O	NOUN	O
versus	O	CCONJ	O
79.1	O	NUM	O
%	O	NOUN	O
;	O	PUNCT	O
P	O	NOUN	O
=	O	ADJ	O
0.003	O	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
death	O	NOUN	B
(	O	PUNCT	O
71	O	NUM	O
%	O	NOUN	O
versus	O	CCONJ	O
95.6	O	NUM	O
%	O	NOUN	O
;	O	PUNCT	O
P	O	NOUN	O
=	O	ADJ	O
0.00005	O	NUM	O
)	O	PUNCT	O
when	O	SCONJ	O
compared	O	VERB	B
with	O	ADP	O
tumors	O	NOUN	B
with	O	ADP	O
low	O	ADJ	O
Ki-67	B-protein	NOUN	B
values	O	NOUN	I
.	O	PUNCT	O


Tumor	O	NOUN	B
proliferative	O	ADJ	I
activity	O	NOUN	I
as	O	ADP	O
evaluated	O	VERB	B
by	O	ADP	O
the	O	DET	O
monoclonal	B-protein	ADJ	B
antibody	I-protein	NOUN	I
Ki-67	I-protein	NOUN	B
seems	O	VERB	O
to	O	PART	O
be	O	AUX	O
an	O	DET	O
effective	O	ADJ	B
indicator	O	NOUN	B
of	O	ADP	O
prognosis	O	NOUN	B
in	O	ADP	O
breast	O	NOUN	B
cancer	O	NOUN	I
for	O	ADP	O
DFS	O	NOUN	B
and	O	CCONJ	O
OS	O	NOUN	B
.	O	PUNCT	O


Sequence	O	NOUN	B
analysis	O	NOUN	I
of	O	ADP	O
nine	O	NUM	O
different	O	ADJ	O
2.3-kb	O	ADJ	O
cDNA	O	NOUN	B
clones	O	NOUN	I
obtained	O	VERB	O
from	O	ADP	O
NK-derived	O	ADJ	B
polyA+	O	ADJ	I
RNA	O	NOUN	I
confirmed	O	VERB	O
that	O	SCONJ	O
they	O	PRON	O
corresponded	O	VERB	O
to	O	PART	O
an	O	DET	O
unrearranged	O	ADJ	B
TcR	B-DNA	NOUN	I
delta	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
.	O	PUNCT	O


All	O	DET	O
NK	B-cell_line	NOUN	B
clones	I-cell_line	NOUN	I
and	O	CCONJ	O
cell	O	NOUN	B
lines	O	NOUN	I
studied	O	VERB	O
were	O	AUX	O
found	O	VERB	O
to	O	PART	O
express	O	VERB	O
hGATA-3-specific	B-RNA	ADJ	O
mRNA	I-RNA	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
hGATA-3	B-protein	NOUN	B
may	O	AUX	O
be	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
unrearranged	O	ADJ	B
TcR	B-DNA	NOUN	I
delta	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
expression	O	NOUN	O
in	O	ADP	O
NK	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Finally	O	ADV	O
,	O	PUNCT	O
no	O	DET	O
transcription	O	NOUN	B
of	O	ADP	O
the	O	DET	O
RAG-1	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
could	O	AUX	O
be	O	AUX	O
detected	O	VERB	B
in	O	ADP	O
all	O	DET	O
NK	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
or	O	CCONJ	O
clones	O	NOUN	B
analyzed	O	VERB	B
.	O	PUNCT	O


Nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
,	O	PUNCT	O
a	O	DET	O
mediator	O	NOUN	O
of	O	ADP	O
lipopolysaccharide	O	NOUN	B
effects	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
event	O	NOUN	B
is	O	AUX	O
also	O	ADV	O
triggered	O	VERB	O
under	O	ADP	O
various	O	ADJ	O
other	O	ADJ	O
conditions	O	NOUN	B
of	O	ADP	O
biomedical	O	ADJ	B
importance	O	NOUN	O
.	O	PUNCT	O


This	O	DET	O
common	O	ADJ	O
pathway	O	NOUN	B
may	O	AUX	O
involve	O	VERB	O
reactive	O	ADJ	B
oxygen	O	NOUN	I
intermediates	O	NOUN	I
(	O	PUNCT	O
ROI	O	NOUN	B
)	O	PUNCT	O
as	O	ADP	O
messenger	O	NOUN	B
molecules	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
lymphoid-specific	B-protein	ADJ	B
transcription	I-protein	NOUN	I
complex	I-protein	NOUN	I
,	O	PUNCT	O
NF-AT	B-protein	NOUN	B
,	O	PUNCT	O
is	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
early	O	ADJ	O
gene	O	NOUN	B
activation	O	NOUN	I
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
is	O	AUX	O
assembled	O	VERB	O
from	O	ADP	O
a	O	DET	O
pre-existing	O	ADJ	B
,	O	PUNCT	O
T	B-protein	NOUN	B
cell	I-protein	NOUN	I
restricted	I-protein	ADJ	O
cytoplasmic	I-protein	ADJ	B
factor	I-protein	NOUN	I
and	O	CCONJ	O
an	O	DET	O
inducible	O	ADJ	B
ubiquitous	B-protein	ADJ	O
nuclear	B-protein	ADJ	O
component	I-protein	NOUN	O
within	O	ADP	O
30	O	NUM	O
min	O	NOUN	O
after	O	ADP	O
activation	O	NOUN	B
through	O	ADP	O
the	O	DET	O
antigen	B-protein	NOUN	B
receptor	I-protein	NOUN	I
.	O	PUNCT	O


Finally	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
partially	O	ADV	O
purified	O	VERB	B
the	O	DET	O
cytoplasmic	O	ADJ	B
component	O	NOUN	O
of	O	ADP	O
NF-AT	O	NOUN	B
and	O	CCONJ	O
show	O	VERB	O
by	O	ADP	O
elution	O	NOUN	B
and	O	CCONJ	O
renaturation	O	NOUN	B
from	O	ADP	O
SDS-polyacrylamide	O	NOUN	B
gel	O	NOUN	I
electrophoresis	O	NOUN	I
gels	O	NOUN	B
that	O	PRON	O
it	O	PRON	O
has	O	AUX	O
a	O	DET	O
molecular	O	ADJ	B
mass	O	NOUN	I
between	O	ADP	O
94	O	NUM	O
and	O	CCONJ	O
116	O	NUM	O
kDa	O	NOUN	O
and	O	CCONJ	O
may	O	AUX	O
have	O	AUX	O
multiple	O	ADJ	O
differentially	O	ADV	O
modified	O	ADJ	O
forms	O	NOUN	O
.	O	PUNCT	O


4	O	NUM	O
patients	O	NOUN	B
were	O	AUX	O
receiving	O	VERB	O
dopamine	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
did	O	AUX	O
not	O	PART	O
affect	O	VERB	O
the	O	DET	O
GR	B-protein	NOUN	B
count	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
study	O	NOUN	B
of	O	ADP	O
human	O	ADJ	B
disorders	O	NOUN	I
known	O	VERB	O
as	O	ADP	O
premature	O	ADJ	B
aging	O	NOUN	I
syndromes	O	NOUN	I
may	O	AUX	O
provide	O	VERB	O
insight	O	NOUN	O
into	O	ADP	O
the	O	DET	O
mechanisms	O	NOUN	B
of	O	ADP	O
cellular	O	ADJ	B
senescence	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
transient-transfection	O	ADJ	B
assay	O	NOUN	I
,	O	PUNCT	O
ICP0	B-protein	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
ICP4	B-protein	NOUN	B
,	O	PUNCT	O
activated	O	VERB	B
the	O	DET	O
HIV-1	B-DNA	NOUN	B
long	I-DNA	ADJ	B
terminal	I-DNA	ADJ	I
repeat	I-DNA	NOUN	I
promoter	I-DNA	NOUN	B
region	I-DNA	NOUN	I
and	O	CCONJ	O
the	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
ICP0	B-protein	NOUN	B
was	O	AUX	O
greatly	O	ADV	O
enhanced	O	VERB	B
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
the	O	DET	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
binding	I-protein	NOUN	I
proteins	I-protein	NOUN	I
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
induction	O	NOUN	B
of	O	ADP	O
the	O	DET	O
HIV-1	O	NOUN	B
provirus	O	NOUN	B
involves	O	VERB	O
cooperation	O	NOUN	B
between	O	ADP	O
the	O	DET	O
HSV-1-activated	B-protein	ADJ	B
cellular	I-protein	ADJ	I
factor	I-protein	NOUN	I
,	O	PUNCT	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
virus-encoded	B-protein	ADJ	B
transactivator	I-protein	NOUN	I
,	O	PUNCT	O
ICP0	B-protein	NOUN	B
.	O	PUNCT	O


Human	B-cell_type	ADJ	B
peripheral	I-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
monocytes	I-cell_type	NOUN	I
(	O	PUNCT	O
Mo	B-cell_type	NOUN	B
)	O	PUNCT	O
constitutively	O	ADV	B
display	O	VERB	I
the	O	DET	O
beta-chain	O	NOUN	B
of	O	ADP	O
the	O	DET	O
receptor	O	NOUN	B
for	O	ADP	O
IL-2	B-protein	NOUN	B
,	O	PUNCT	O
whereas	O	SCONJ	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IL-2R	B-protein	NOUN	B
alpha-chain	I-protein	NOUN	I
is	O	AUX	O
not	O	PART	O
constitutive	O	ADJ	B
but	O	CCONJ	O
inducible	O	ADJ	B
with	O	ADP	O
IL-2	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
cytokines	O	NOUN	B
interleukin-1	O	NOUN	B
beta	O	NOUN	I
(	O	PUNCT	I
IL-1	B-protein	NOUN	B
beta	I-protein	NOUN	I
)	O	PUNCT	O
and	O	CCONJ	O
tumor	O	NOUN	B
necrosis	O	NOUN	I
factor	O	NOUN	I
alpha	O	NOUN	I
(	O	PUNCT	O
TNF-alpha	B-protein	NOUN	B
)	O	PUNCT	O
are	O	AUX	O
released	O	VERB	O
by	O	ADP	O
mononuclear	B-cell_type	ADJ	B
phagocytes	I-cell_type	NOUN	B
in	O	X	B
vitro	O	X	I
after	O	ADP	O
stimulation	O	NOUN	B
with	O	ADP	O
mycobacteria	O	NOUN	B
and	O	CCONJ	O
are	O	AUX	O
considered	O	VERB	O
to	O	PART	O
mediate	O	VERB	O
pathophysiologic	O	ADJ	B
events	O	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
granuloma	O	NOUN	B
formation	O	NOUN	I
and	O	CCONJ	O
systemic	O	ADJ	B
symptoms	O	NOUN	I
.	O	PUNCT	O


Site-directed	O	ADJ	B
mutagenesis	O	NOUN	I
demonstrated	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
two	O	NUM	O
NF-IL-6	B-DNA	NOUN	B
motifs	I-DNA	NOUN	B
could	O	AUX	O
be	O	AUX	O
independently	O	ADV	O
activated	O	VERB	B
by	O	ADP	O
LAM	O	NOUN	B
,	O	PUNCT	O
LPS	O	NOUN	B
,	O	PUNCT	O
or	O	CCONJ	O
TNF-alpha	B-protein	NOUN	B
and	O	CCONJ	O
that	O	SCONJ	O
they	O	PRON	O
acted	O	VERB	B
in	O	ADP	O
an	O	DET	O
orientation-independent	O	ADJ	B
manner	O	NOUN	O
.	O	PUNCT	O


An	O	DET	O
enhancement	O	NOUN	B
of	O	ADP	O
NK	O	NOUN	B
activity	O	NOUN	B
by	O	ADP	O
E2	O	NOUN	B
was	O	AUX	O
also	O	ADV	O
seen	O	VERB	O
in	O	ADP	O
large	B-cell_type	ADJ	O
granular	I-cell_type	ADJ	B
lymphocytes	I-cell_type	NOUN	B
obtained	O	VERB	O
from	O	ADP	O
normal	O	ADJ	B
subjects	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
it	O	PRON	O
was	O	AUX	O
again	O	ADV	O
suppressed	O	VERB	B
by	O	ADP	O
Tx	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
E2	O	NOUN	B
is	O	AUX	O
one	O	NUM	O
of	O	ADP	O
the	O	DET	O
activating	O	VERB	B
factors	O	NOUN	B
for	O	ADP	O
NK/LGL	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	B
.	O	PUNCT	O


The	O	DET	O
proximal	B-DNA	ADJ	B
element	I-DNA	NOUN	B
contains	O	VERB	O
the	O	DET	O
sequence	O	NOUN	B
5'-GGCCAATGGG-3	O	NOUN	B
'	O	PUNCT	I
,	O	PUNCT	O
which	O	DET	O
closely	O	ADV	O
resembles	O	VERB	O
the	O	DET	O
consensus	O	NOUN	B
binding	O	NOUN	I
motif	O	NOUN	O
for	O	ADP	O
the	O	DET	O
CCAAT-binding	B-DNA	ADJ	B
factor	I-DNA	NOUN	I
NF-Y	B-protein	NOUN	I
(	O	PUNCT	O
CBF	B-protein	NOUN	B
,	O	PUNCT	O
CP1	B-protein	NOUN	B
,	O	PUNCT	O
alpha	B-protein	NOUN	B
CP1	I-protein	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


We	O	PRON	O
conclude	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
serum	O	NOUN	B
response	O	NOUN	I
of	O	ADP	O
the	O	DET	O
human	O	ADJ	B
TSP	B-DNA	NOUN	B
1	I-DNA	NUM	O
gene	I-DNA	NOUN	B
requires	O	VERB	O
the	O	DET	O
coordinated	O	VERB	B
function	O	NOUN	B
of	O	ADP	O
an	O	DET	O
SRE-	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
NF-Y-binding	I-DNA	ADJ	B
site	I-DNA	NOUN	I
.	O	PUNCT	O


There	O	PRON	O
were	O	AUX	O
two	O	NUM	O
main	O	ADJ	O
goals	O	NOUN	B
:	O	PUNCT	O
(	O	PUNCT	O
1	O	X	O
)	O	PUNCT	O
to	O	PART	O
evaluate	O	VERB	B
whether	O	SCONJ	O
workers	O	NOUN	B
with	O	ADP	O
a	O	DET	O
moderately	O	ADV	O
increased	O	VERB	B
PCDD/PCDF-body	O	NOUN	B
burden	O	NOUN	I
[	O	PUNCT	O
25-140	O	NUM	O
ppt	O	NOUN	O
TCDD	O	NOUN	B
or	O	CCONJ	O
104-522	O	NUM	O
ppt	O	NOUN	O
I-TE	O	NOUN	B
in	O	ADP	O
blood	O	NOUN	B
fat	O	NOUN	I
]	O	PUNCT	O
exhibit	O	VERB	O
changes	O	NOUN	B
in	O	ADP	O
the	O	DET	O
surface	B-protein	NOUN	B
receptors	I-protein	NOUN	I
of	O	ADP	O
white	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
as	O	ADP	O
observed	O	VERB	O
in	O	ADP	O
previous	O	ADJ	O
studies	O	NOUN	B
in	O	ADP	O
non-human	O	ADJ	B
primates	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
(	O	PUNCT	O
2	O	X	O
)	O	PUNCT	O
to	O	PART	O
clarify	O	VERB	O
whether	O	SCONJ	O
persons	O	NOUN	B
at	O	ADP	O
the	O	DET	O
upper	O	ADJ	B
range	O	NOUN	I
[	O	PUNCT	O
10-23	O	NUM	O
ppt	O	NOUN	O
TCDD	O	NOUN	B
or	O	CCONJ	O
30-90	O	NUM	O
ppt	O	NOUN	O
I-TE	O	NOUN	B
in	O	ADP	O
blood	O	NOUN	B
fat	O	NOUN	I
]	O	PUNCT	O
of	O	ADP	O
the	O	DET	O
body	O	NOUN	B
burden	O	NOUN	I
reference	O	NOUN	O
values	O	NOUN	O
of	O	ADP	O
a	O	DET	O
not	O	PART	O
particularly	O	ADV	O
exposed	O	VERB	B
population	O	NOUN	I
show	O	VERB	O
detectable	O	ADJ	B
deviations	O	NOUN	B
in	O	ADP	O
these	O	DET	O
immunological	O	ADJ	B
variables	O	NOUN	B
,	O	PUNCT	O
when	O	SCONJ	O
compared	O	VERB	B
with	O	ADP	O
persons	O	NOUN	B
at	O	ADP	O
the	O	DET	O
lower	O	ADJ	B
and	O	CCONJ	O
medium	O	NOUN	B
range	O	NOUN	O
[	O	PUNCT	O
1-3	O	NUM	O
ppt	O	NOUN	O
TCDD	O	NOUN	B
or	O	CCONJ	O
9-29	O	NUM	O
ppt	O	NOUN	O
I-TE	O	NOUN	O
]	O	PUNCT	O
of	O	ADP	O
these	O	DET	O
body	O	NOUN	B
burden	O	NOUN	I
reference	O	NOUN	O
values	O	NOUN	O
.	O	PUNCT	O


None	O	NOUN	O
of	O	ADP	O
the	O	DET	O
alterations	O	NOUN	B
observed	O	VERB	B
are	O	AUX	O
of	O	ADP	O
medical	O	ADJ	B
relevance	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
slight	O	ADJ	O
increase	O	NOUN	B
in	O	ADP	O
the	O	DET	O
percentage	O	NOUN	B
of	O	ADP	O
CD4+CD45R0+	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
remained	O	VERB	O
significant	O	ADJ	B
even	O	ADV	O
after	O	ADP	O
covariant	O	ADJ	B
analysis	O	NOUN	I
taking	O	VERB	O
age-related	O	ADJ	B
changes	O	NOUN	O
into	O	ADP	O
account	O	NOUN	O
.	O	PUNCT	O


Inhibition	O	NOUN	B
of	O	ADP	O
HIV-1	O	NOUN	B
latency	O	NOUN	B
reactivation	O	NOUN	I
by	O	ADP	O
dehydroepiandrosterone	O	NOUN	B
(	O	PUNCT	O
DHEA	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
an	O	DET	O
analog	O	NOUN	B
of	O	ADP	O
DHEA	O	NOUN	B
.	O	PUNCT	O


So	O	ADV	O
far	O	ADV	O
,	O	PUNCT	O
there	O	PRON	O
are	O	AUX	O
no	O	DET	O
drugs	O	NOUN	B
or	O	CCONJ	O
therapy	O	NOUN	B
available	O	ADJ	O
that	O	PRON	O
can	O	AUX	O
provide	O	VERB	O
protection	O	NOUN	B
against	O	ADP	O
HIV-1	O	NOUN	B
latency	O	NOUN	B
reactivation	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
immune	O	ADJ	B
system	O	NOUN	I
the	O	DET	O
first	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
a	O	DET	O
naive	B-cell_type	ADJ	B
T	I-cell_type	NOUN	O
cell	I-cell_type	NOUN	O
by	O	ADP	O
antigen	O	NOUN	B
is	O	AUX	O
a	O	DET	O
key	O	ADJ	O
step	O	NOUN	O
in	O	ADP	O
the	O	DET	O
shaping	O	NOUN	O
of	O	ADP	O
the	O	DET	O
peripheral	O	ADJ	B
T	O	NOUN	B
cell	O	NOUN	I
specificity	O	NOUN	B
repertoire	O	NOUN	O
and	O	CCONJ	O
maintenance	O	NOUN	B
of	O	ADP	O
self-tolerance	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
present	O	ADJ	O
study	O	NOUN	B
,	O	PUNCT	O
analysis	O	NOUN	B
of	O	ADP	O
the	O	DET	O
interleukin-2	B-DNA	NOUN	B
(	I-DNA	PUNCT	O
IL-2	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
gene	I-DNA	NOUN	B
activation	O	NOUN	I
shows	O	VERB	O
that	O	SCONJ	O
naive	B-cell_type	ADJ	B
human	I-cell_type	ADJ	B
helper	I-cell_type	NOUN	O
T	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
(	O	PUNCT	O
cord	B-cell_type	NOUN	B
blood	I-cell_type	NOUN	I
CD4+	I-cell_type	ADJ	B
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
adult	B-cell_type	ADJ	B
CD4+CD45RO-	I-cell_type	ADJ	B
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
)	O	PUNCT	O
regulate	O	VERB	B
IL-2	B-protein	NOUN	B
transcription	O	NOUN	O
by	O	ADP	O
a	O	DET	O
mechanism	O	NOUN	B
involving	O	VERB	O
both	O	CCONJ	O
a	O	DET	O
silencer	B-DNA	NOUN	B
and	O	CCONJ	O
an	O	DET	O
activator	B-DNA	NOUN	B
acting	O	VERB	O
on	O	ADP	O
the	O	DET	O
purine-rich	B-DNA	ADJ	B
IL-2	I-DNA	NOUN	I
promoter	I-DNA	NOUN	I
elements	I-DNA	NOUN	I
(	O	PUNCT	O
NF-AT	B-DNA	NOUN	B
binding	I-DNA	NOUN	I
sites	I-DNA	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


Their	O	PRON	O
IL-2	B-protein	NOUN	B
transcription	O	NOUN	B
seems	O	VERB	O
to	O	PART	O
be	O	AUX	O
controlled	O	VERB	B
solely	O	ADV	O
by	O	ADP	O
the	O	DET	O
transition	O	NOUN	B
from	O	ADP	O
inactive	O	ADJ	B
to	O	PART	O
active	O	ADJ	O
functional	O	ADJ	O
state	O	NOUN	O
of	O	ADP	O
a	O	DET	O
positive	B-protein	ADJ	B
transcription	I-protein	NOUN	O
factor	I-protein	NOUN	O
binding	O	VERB	O
to	O	PART	O
these	O	DET	O
promoter	O	NOUN	B
elements	O	NOUN	I
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
its	O	PRON	O
cytoplasmic	O	ADJ	B
or	O	CCONJ	O
nuclear	O	ADJ	B
location	O	NOUN	I
:	O	PUNCT	O
in	O	ADP	O
resting	B-cell_type	VERB	B
memory	I-cell_type	NOUN	I
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
the	O	DET	O
activator	B-DNA	NOUN	B
is	O	AUX	O
located	O	ADJ	O
in	O	ADP	O
the	O	DET	O
cytoplasm	O	NOUN	B
and	O	CCONJ	O
is	O	AUX	O
inactive	O	ADJ	B
,	O	PUNCT	O
whereas	O	SCONJ	O
in	O	ADP	O
stimulated	B-cell_line	VERB	B
cells	I-cell_line	NOUN	I
it	O	PRON	O
is	O	AUX	O
functional	O	ADJ	B
in	O	ADP	O
promoting	O	VERB	B
transcription	O	NOUN	B
and	O	CCONJ	O
now	O	ADV	O
resides	O	VERB	B
in	O	ADP	O
the	O	DET	O
nucleus	O	NOUN	B
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
gene	O	NOUN	B
coding	O	VERB	I
for	O	ADP	O
the	O	DET	O
main	O	ADJ	O
T	B-protein	NOUN	B
cell	I-protein	NOUN	I
growth	I-protein	NOUN	O
factor	I-protein	NOUN	O
changes	O	VERB	O
irreversibly	O	ADV	O
after	O	ADP	O
the	O	DET	O
first	O	ADJ	O
encounter	O	NOUN	O
of	O	ADP	O
T	O	NOUN	B
cells	O	NOUN	I
with	O	ADP	O
antigen	O	NOUN	B
.	O	PUNCT	O


To	O	PART	O
examine	O	VERB	O
the	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
Trx	B-protein	NOUN	B
in	O	ADP	O
intact	O	ADJ	B
cells	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
performed	O	VERB	O
transient	O	ADJ	B
assay	O	NOUN	O
with	O	ADP	O
a	O	DET	O
chloramphenicol	B-DNA	NOUN	B
acetyltransferase-expressing	I-DNA	ADJ	B
plasmid	I-DNA	NOUN	I
under	O	ADP	O
the	O	DET	O
control	O	NOUN	B
of	O	ADP	O
human	B-DNA	ADJ	B
immunodeficiency	I-DNA	NOUN	I
virus	I-DNA	NOUN	I
(	I-DNA	PUNCT	O
HIV	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
long	I-DNA	ADJ	B
terminal	I-DNA	ADJ	I
repeat	I-DNA	NOUN	I
and	O	CCONJ	O
an	O	DET	O
effector	B-DNA	NOUN	B
plasmid	I-DNA	NOUN	I
expressing	O	VERB	B
human	B-protein	ADJ	B
Trx	I-protein	NOUN	B
.	O	PUNCT	O


Exploration	O	NOUN	B
at	O	ADP	O
the	O	DET	O
level	O	NOUN	B
of	O	ADP	O
induction	O	NOUN	B
of	O	ADP	O
DNA-binding	B-protein	ADJ	B
proteins	I-protein	NOUN	I
and	O	CCONJ	O
characterization	O	NOUN	B
of	O	ADP	O
the	O	DET	O
inhibitory	O	ADJ	B
activity	O	NOUN	O
of	O	ADP	O
cyclosporine	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
demonstrated	O	VERB	O
earlier	O	ADV	O
that	O	SCONJ	O
the	O	DET	O
crosslinkage	O	NOUN	B
of	O	ADP	O
the	O	DET	O
CD3/TCR	B-protein	NOUN	B
complex	I-protein	NOUN	O
with	O	ADP	O
the	O	DET	O
CD2	B-protein	NOUN	B
antigen	I-protein	NOUN	I
results	O	VERB	B
in	O	ADP	O
the	O	DET	O
proliferation	O	NOUN	B
of	O	ADP	O
normal	B-cell_type	ADJ	O
human	I-cell_type	ADJ	B
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


The	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
this	O	DET	O
synergism	O	NOUN	B
was	O	AUX	O
perceptible	O	ADJ	O
at	O	ADP	O
the	O	DET	O
level	O	NOUN	B
of	O	ADP	O
induction	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IL-2	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
,	O	PUNCT	O
a	O	DET	O
process	O	NOUN	B
critical	O	ADJ	O
for	O	ADP	O
T	O	NOUN	B
cell	O	NOUN	I
growth	O	NOUN	O
.	O	PUNCT	O


Antigen	O	NOUN	B
receptor	O	NOUN	I
signals	O	NOUN	B
could	O	AUX	O
be	O	AUX	O
mimicked	O	VERB	O
by	O	ADP	O
suboptimal	O	ADJ	B
activation	O	NOUN	B
of	O	ADP	O
protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
C	I-protein	NOUN	I
(	O	PUNCT	O
PKC	B-protein	NOUN	B
)	O	PUNCT	O
with	O	ADP	O
phorbol	O	NOUN	B
esters	O	NOUN	I
in	O	ADP	O
combination	O	NOUN	B
with	O	ADP	O
calcium	O	NOUN	B
mobilization	O	NOUN	I
by	O	ADP	O
an	O	DET	O
ionophore	O	NOUN	B
.	O	PUNCT	O


Activated	O	VERB	B
ras	B-protein	NOUN	B
expression	O	NOUN	I
also	O	ADV	O
replaced	O	VERB	O
the	O	DET	O
requirement	O	NOUN	B
for	O	ADP	O
PKC	B-protein	NOUN	B
stimulation	O	NOUN	B
in	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
T-cell	B-protein	NOUN	B
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
NF-AT	B-protein	NOUN	I
.	O	PUNCT	O


A	O	DET	O
dominant	B-protein	ADJ	B
inhibitory	I-protein	ADJ	B
ras	I-protein	NOUN	B
mutant	I-protein	NOUN	I
specifically	O	ADV	O
blocked	O	VERB	B
antigen	O	NOUN	B
receptor	O	NOUN	I
agonism	O	NOUN	B
,	O	PUNCT	O
indicating	O	VERB	O
that	O	SCONJ	O
ras	B-protein	NOUN	B
activity	O	NOUN	I
is	O	AUX	O
required	O	VERB	O
for	O	ADP	O
antigen	B-protein	NOUN	B
receptor	I-protein	NOUN	I
signaling	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Tat	B-protein	NOUN	B
protein	I-protein	NOUN	I
constitutively	O	ADV	B
expressed	O	VERB	B
by	O	ADP	O
these	O	DET	O
cells	O	NOUN	B
upon	O	SCONJ	O
their	O	PRON	O
differentiation	O	NOUN	B
was	O	AUX	O
then	O	ADV	O
evaluated	O	VERB	B
by	O	ADP	O
looking	O	VERB	O
for	O	ADP	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
c-fos	B-DNA	NOUN	B
and	O	CCONJ	O
of	O	ADP	O
the	O	DET	O
c-fms	B-DNA	NOUN	B
proto-oncogenes	I-DNA	NOUN	I
which	O	DET	O
are	O	AUX	O
linked	O	VERB	O
to	O	PART	O
the	O	DET	O
differentiation	O	NOUN	B
of	O	ADP	O
myelomonoblastic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
ability	O	NOUN	O
to	O	PART	O
detect	O	VERB	B
NF-ATp	B-protein	NOUN	B
in	O	ADP	O
a	O	DET	O
gel	O	NOUN	B
shift	O	NOUN	I
assay	O	NOUN	I
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
essential	O	ADJ	O
for	O	ADP	O
purification	O	NOUN	B
and	O	CCONJ	O
biochemical	O	ADJ	B
studies	O	NOUN	I
of	O	ADP	O
this	O	DET	O
protein	O	NOUN	B
,	O	PUNCT	O
is	O	AUX	O
strikingly	O	ADV	O
dependent	O	ADJ	O
on	O	ADP	O
the	O	DET	O
precise	O	ADJ	O
sequence	O	NOUN	B
of	O	ADP	O
the	O	DET	O
NF-AT	B-protein	NOUN	B
oligonucleotide	O	NOUN	B
used	O	VERB	O
as	O	ADP	O
the	O	DET	O
labeled	O	VERB	B
probe	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
results	O	NOUN	B
are	O	AUX	O
discussed	O	VERB	O
in	O	ADP	O
the	O	DET	O
context	O	NOUN	B
of	O	ADP	O
a	O	DET	O
model	O	NOUN	B
relating	O	VERB	O
the	O	DET	O
two	O	NUM	O
nuclear	O	ADJ	B
NF-AT	B-protein	NOUN	I
complexes	I-protein	NOUN	I
to	O	PART	O
NF-ATp	B-protein	NOUN	B
.	O	PUNCT	O


Cell	O	NOUN	B
cycle	O	NOUN	I
analysis	O	NOUN	I
of	O	ADP	O
E2F	B-protein	NOUN	B
in	O	ADP	O
primary	B-cell_type	ADJ	B
human	I-cell_type	ADJ	B
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
reveals	O	VERB	O
novel	B-protein	ADJ	O
E2F	I-protein	NOUN	B
complexes	I-protein	NOUN	I
and	O	CCONJ	O
biochemically	O	ADV	B
distinct	O	ADJ	O
forms	O	NOUN	O
of	O	ADP	O
free	O	ADJ	B
E2F	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
results	O	NOUN	B
demonstrate	O	VERB	O
that	O	SCONJ	O
multidrug-resistant	B-cell_line	ADJ	B
HL-60	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
designated	O	VERB	O
HL-60/vinc	O	NOUN	B
,	O	PUNCT	O
fail	O	VERB	O
to	O	PART	O
respond	O	VERB	O
to	O	ADP	O
TPA	O	NOUN	B
with	O	ADP	O
an	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
c-jun	B-RNA	NOUN	B
transcripts	I-RNA	NOUN	I
or	O	CCONJ	O
other	O	ADJ	O
phenotypic	O	ADJ	B
characteristics	O	NOUN	B
of	O	ADP	O
monocytic	O	ADJ	B
differentiation	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
finding	O	NOUN	B
that	O	SCONJ	O
HL-60/vinc/R	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
respond	O	VERB	O
to	O	PART	O
TPA	O	NOUN	B
with	O	ADP	O
induction	O	NOUN	B
of	O	ADP	O
a	O	DET	O
monocytic	O	ADJ	B
phenotype	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
c-jun	B-DNA	NOUN	B
expression	O	NOUN	I
,	O	PUNCT	O
suggests	O	VERB	O
that	O	SCONJ	O
c-jun	B-DNA	NOUN	B
induction	O	NOUN	I
is	O	AUX	O
not	O	PART	O
obligatory	O	ADJ	O
for	O	ADP	O
monocytic	O	ADJ	B
differentiation	O	NOUN	I
.	O	PUNCT	O


Since	O	SCONJ	O
TPA	O	NOUN	B
activates	O	VERB	O
protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
C	I-protein	NOUN	I
(	O	PUNCT	O
PKC	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
we	O	PRON	O
examined	O	VERB	O
translocation	O	NOUN	B
of	O	ADP	O
PKC	B-protein	NOUN	B
from	O	ADP	O
the	O	DET	O
cytosol	O	NOUN	B
to	O	PART	O
the	O	DET	O
membrane	O	NOUN	B
fraction	O	NOUN	I
.	O	PUNCT	O


Taken	O	VERB	O
together	O	ADV	O
,	O	PUNCT	O
these	O	DET	O
findings	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
vincristine	O	NOUN	B
resistance	O	NOUN	B
confers	O	VERB	O
insensitivity	O	NOUN	B
to	O	PART	O
TPA-induced	O	ADJ	B
differentiation	O	NOUN	B
and	O	CCONJ	O
can	O	AUX	O
include	O	VERB	O
defects	O	NOUN	B
in	O	ADP	O
PKC	B-protein	NOUN	B
-mediated	O	ADJ	O
signaling	O	NOUN	B
events	O	NOUN	I
and	O	CCONJ	O
induction	O	NOUN	B
of	O	ADP	O
jun/fos	B-DNA	NOUN	B
early	I-DNA	ADJ	O
response	I-DNA	NOUN	O
gene	I-DNA	NOUN	B
expression	O	NOUN	I
.	O	PUNCT	O


Both	O	CCONJ	O
p105	B-protein	NOUN	B
and	O	CCONJ	O
p98	B-protein	NOUN	B
were	O	AUX	O
found	O	VERB	O
to	O	PART	O
form	O	VERB	O
stable	O	ADJ	B
complexes	O	NOUN	B
with	O	ADP	O
other	O	ADJ	O
Rel/NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
family	I-protein	NOUN	I
members	I-protein	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
p65	B-protein	NOUN	B
and	O	CCONJ	O
c-Rel	B-protein	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
these	O	DET	O
studies	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
identified	O	VERB	B
DNA	B-DNA	NOUN	B
sequences	I-DNA	NOUN	I
and	O	CCONJ	O
specific	O	ADJ	O
protein	O	NOUN	B
interactions	O	NOUN	B
necessary	O	ADJ	O
for	O	ADP	O
transcriptional	O	ADJ	B
regulation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
prointerleukin	I-DNA	NOUN	O
1	I-DNA	NUM	O
beta	I-DNA	NOUN	O
(	I-DNA	PUNCT	O
proIL-1	I-DNA	NOUN	B
beta	I-DNA	NOUN	O
)	I-DNA	PUNCT	O
gene	I-DNA	NOUN	O
.	O	PUNCT	O


A	O	DET	O
cell-type-independent	B-DNA	ADJ	B
lipopolysaccharide	I-DNA	NOUN	B
(	I-DNA	PUNCT	O
LPS	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
-responsive	I-DNA	ADJ	O
enhancer	I-DNA	NOUN	B
element	I-DNA	NOUN	I
located	O	ADJ	O
between	O	ADP	O
-3757	B-DNA	NUM	O
and	I-DNA	CCONJ	O
-2729	I-DNA	NUM	O
bp	I-DNA	NOUN	O
upstream	I-DNA	ADJ	O
from	O	ADP	O
the	O	DET	O
transcription	B-DNA	NOUN	B
start	I-DNA	NOUN	O
site	I-DNA	NOUN	O
(	O	PUNCT	O
cap	B-DNA	NOUN	B
site	I-DNA	NOUN	I
)	O	PUNCT	O
consisted	O	VERB	O
of	O	ADP	O
at	O	ADP	O
least	O	ADJ	O
six	O	NUM	O
discrete	O	ADJ	O
subregions	O	NOUN	B
which	O	DET	O
were	O	AUX	O
essential	O	ADJ	O
to	O	PART	O
the	O	DET	O
maximal	O	ADJ	B
induction	O	NOUN	B
by	O	ADP	O
LPS	O	NOUN	B
in	O	ADP	O
transfected	B-cell_line	VERB	B
monocytes	I-cell_line	NOUN	B
.	O	PUNCT	O


Antisense	O	ADJ	B
phosphorothioate	O	NOUN	I
oligonucleotides	O	NOUN	I
to	O	PART	O
the	O	DET	O
p50	B-protein	NOUN	B
and	O	CCONJ	O
p65	B-protein	NOUN	B
subunits	I-protein	NOUN	I
of	O	ADP	O
the	O	DET	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
complex	I-protein	NOUN	I
were	O	AUX	O
used	O	VERB	O
to	O	PART	O
define	O	VERB	O
the	O	DET	O
physiologic	O	ADJ	B
role	O	NOUN	O
of	O	ADP	O
this	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
in	O	ADP	O
resting	B-cell_line	VERB	B
and	I-cell_line	CCONJ	O
stimulated	I-cell_line	VERB	B
granulocytes	I-cell_line	NOUN	B
.	O	PUNCT	O


These	O	DET	O
effects	O	NOUN	B
were	O	AUX	O
characterized	O	VERB	B
by	O	ADP	O
a	O	DET	O
marked	O	ADJ	O
reduction	O	NOUN	B
in	O	ADP	O
CD11b	B-protein	NOUN	B
integrin	B-protein	NOUN	B
expression	O	NOUN	B
on	O	ADP	O
the	O	DET	O
surface	O	NOUN	B
of	O	ADP	O
treated	B-cell_line	VERB	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
p65	B-protein	NOUN	B
antisense	O	ADJ	I
oligomer	O	NOUN	I
effectively	O	ADV	O
abolished	O	VERB	O
an	O	DET	O
upregulation	O	NOUN	B
of	O	ADP	O
CD11b	B-protein	NOUN	B
that	O	PRON	O
was	O	AUX	O
produced	O	VERB	O
by	O	ADP	O
formyl-met-leu-phe	O	NOUN	B
and	O	CCONJ	O
TPA	O	NOUN	B
.	O	PUNCT	O


Nuclear	O	ADJ	B
localization	O	NOUN	I
of	O	ADP	O
these	O	DET	O
proteins	O	NOUN	B
occurred	O	VERB	O
concomitantly	O	ADV	O
with	O	ADP	O
a	O	DET	O
rapid	O	ADJ	O
decrease	O	NOUN	B
in	O	ADP	O
their	O	PRON	O
cytosolic	O	ADJ	B
levels	O	NOUN	O
and	O	CCONJ	O
was	O	AUX	O
independent	O	ADJ	O
of	O	ADP	O
phorbol	B-protein	NOUN	B
ester-sensitive	I-protein	ADJ	I
protein	I-protein	NOUN	I
kinase	I-protein	NOUN	I
C	I-protein	NOUN	I
.	O	PUNCT	O


Within	O	ADP	O
24	O	NUM	O
h	O	NOUN	O
following	O	VERB	O
LPS	O	NOUN	B
stimulation	O	NOUN	B
there	O	PRON	O
was	O	AUX	O
a	O	DET	O
striking	O	ADJ	O
increase	O	NOUN	B
in	O	ADP	O
the	O	DET	O
levels	O	NOUN	B
of	O	ADP	O
c-Rel	B-protein	NOUN	B
,	O	PUNCT	O
p105	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
p50	B-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
cytosol	O	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
a	O	DET	O
hybrid	O	NOUN	B
receptor	O	NOUN	I
composed	O	VERB	O
of	O	ADP	O
the	O	DET	O
extracellular	B-protein	ADJ	B
and	I-protein	CCONJ	O
transmembrane	I-protein	ADJ	B
regions	I-protein	NOUN	I
of	O	ADP	O
the	O	DET	O
human	B-protein	ADJ	B
type	I-protein	NOUN	O
II	I-protein	NUM	O
interleukin-1	I-protein	NOUN	O
fused	O	VERB	O
to	O	PART	O
the	O	DET	O
cytoplasmic	B-protein	ADJ	B
domain	I-protein	NOUN	I
of	O	ADP	O
the	O	DET	O
human	B-protein	ADJ	B
type	I-protein	NOUN	O
I	I-protein	NUM	O
IL-1R	I-protein	NOUN	B
was	O	AUX	O
capable	O	ADJ	O
of	O	ADP	O
transducing	O	VERB	B
a	O	DET	O
signal	O	NOUN	B
across	O	ADP	O
the	O	DET	O
membrane	O	NOUN	B
resulting	O	VERB	O
in	O	ADP	O
a	O	DET	O
pattern	O	NOUN	B
of	O	ADP	O
gene	O	NOUN	B
activation	O	NOUN	I
identical	O	ADJ	B
to	O	PART	O
that	O	DET	O
mediated	O	VERB	O
by	O	ADP	O
the	O	DET	O
type	B-protein	NOUN	B
I	I-protein	NUM	I
IL-1R	I-protein	NOUN	I
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	B
indicated	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
extracellular	B-protein	ADJ	B
domain	I-protein	NOUN	I
of	O	ADP	O
the	O	DET	O
type	B-protein	NOUN	B
II	I-protein	NUM	I
IL-1R	I-protein	NOUN	I
was	O	AUX	O
capable	O	ADJ	O
of	O	ADP	O
functionally	O	ADV	O
interacting	O	VERB	B
with	O	ADP	O
interleukin-1	B-protein	NOUN	B
and	O	CCONJ	O
transmitting	O	VERB	B
the	O	DET	O
resulting	O	VERB	O
signal	O	NOUN	B
to	O	PART	O
a	O	DET	O
heterologous	B-protein	ADJ	B
cytoplasmic	I-protein	ADJ	B
domain	I-protein	NOUN	I
.	O	PUNCT	O


Total	O	ADJ	O
RNA	O	NOUN	O
isolated	O	VERB	B
from	O	ADP	O
the	O	DET	O
index	O	NOUN	B
subject	O	NOUN	I
's	O	PART	I
mononuclear	B-cell_type	ADJ	B
leukocytes	I-cell_type	NOUN	B
was	O	AUX	O
used	O	VERB	O
to	O	PART	O
produce	O	VERB	O
first	O	ADJ	O
strand	O	NOUN	B
hGR	B-DNA	NOUN	B
cDNAs	I-DNA	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
entire	O	ADJ	O
hGR	B-DNA	NOUN	B
cDNA	I-DNA	NOUN	B
was	O	AUX	O
amplified	O	VERB	B
in	O	ADP	O
segments	O	NOUN	B
and	O	CCONJ	O
sequenced	O	VERB	B
.	O	PUNCT	O


When	O	SCONJ	O
the	O	DET	O
wild-type	B-protein	ADJ	B
hGR	I-protein	NOUN	B
and	O	CCONJ	O
hGR-Ile	B-protein	NOUN	O
729	I-protein	NUM	O
were	O	AUX	O
expressed	O	VERB	B
in	O	ADP	O
COS-1	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
and	O	CCONJ	O
assayed	O	VERB	B
for	O	ADP	O
[	O	PUNCT	O
3H	O	NOUN	B
]	O	PUNCT	O
-Dexamethasone	O	NOUN	O
binding	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
dissociation	O	NOUN	B
constants	O	NOUN	O
were	O	AUX	O
0.799	O	NUM	O
+/-	O	CCONJ	O
0.068	O	NUM	O
and	O	CCONJ	O
1.54	O	NUM	O
+/-	O	CCONJ	O
0.06	O	NUM	O
nM	O	NOUN	O
(	O	PUNCT	O
mean	O	NOUN	O
+/-	O	CCONJ	O
SEM	O	NOUN	B
)	O	PUNCT	O
(	O	PUNCT	O
P	O	NOUN	O
<	O	X	O
0.01	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
respectively	O	ADV	O
.	O	PUNCT	O


Overexpression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
p50	B-protein	NOUN	B
,	O	PUNCT	O
p65	B-protein	NOUN	B
and	O	CCONJ	O
Rel	B-protein	NOUN	B
proteins	I-protein	NOUN	I
in	O	ADP	O
these	O	DET	O
cells	O	NOUN	B
showed	O	VERB	O
that	O	SCONJ	O
significant	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IL-2R	B-protein	NOUN	B
alpha	I-protein	NOUN	I
kappa	B-DNA	NOUN	I
B	I-DNA	NOUN	I
site	I-DNA	NOUN	I
was	O	AUX	O
observed	O	VERB	O
only	O	ADV	O
with	O	ADP	O
Rel	B-protein	NOUN	B
and	O	CCONJ	O
Rel	B-protein	NOUN	B
plus	O	CCONJ	I
p65	B-protein	NOUN	I
.	O	PUNCT	O


Transcriptional	O	ADJ	B
regulation	O	NOUN	I
of	O	ADP	O
interleukin	B-protein	NOUN	B
3	I-protein	NUM	I
(	O	PUNCT	O
IL3	B-protein	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
primary	B-cell_type	ADJ	B
human	I-cell_type	ADJ	B
T	I-cell_type	NOUN	O
lymphocytes	I-cell_type	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
investigated	O	VERB	B
the	O	DET	O
molecular	O	ADJ	B
and	O	CCONJ	O
biochemical	O	ADJ	B
basis	O	NOUN	O
for	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
interleukin	B-protein	NOUN	B
3	I-protein	NUM	I
(	O	PUNCT	O
IL3	B-protein	NOUN	B
)	O	PUNCT	O
gene	O	NOUN	B
expression	O	NOUN	I
in	O	ADP	O
primary	B-cell_type	ADJ	O
human	I-cell_type	ADJ	B
T	I-cell_type	NOUN	O
lymphocytes	I-cell_type	NOUN	O
following	O	VERB	O
CD3	O	NOUN	B
and	O	CCONJ	O
CD2	O	NOUN	B
receptor	O	NOUN	I
stimulation	O	NOUN	B
or	O	CCONJ	O
activation	O	NOUN	B
by	O	ADP	O
phytohemagglutinin	B-protein	NOUN	B
plus	O	CCONJ	O
phorbol	O	NOUN	B
12-myristate	O	NOUN	I
13-acetate	O	NOUN	I
.	O	PUNCT	O


Inducible	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
(	O	PUNCT	O
HIV	O	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
regulated	O	VERB	O
by	O	ADP	O
a	O	DET	O
cellular	O	ADJ	B
transcription	B-protein	NOUN	I
factor	I-protein	NOUN	I
,	O	PUNCT	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
(	O	PUNCT	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
previously	O	ADV	O
found	O	VERB	O
that	O	SCONJ	O
NFKB2	B-protein	NOUN	B
(	I-protein	PUNCT	O
p49/p52	I-protein	NOUN	B
)	I-protein	PUNCT	O
acts	O	VERB	O
in	O	ADP	O
concert	O	NOUN	O
with	O	ADP	O
RelA	B-protein	NOUN	B
(	I-protein	PUNCT	O
p65	I-protein	NOUN	B
)	I-protein	PUNCT	O
to	O	PART	O
stimulate	O	VERB	B
the	O	DET	O
HIV	B-DNA	NOUN	B
enhancer	I-DNA	NOUN	I
in	O	ADP	O
Jurkat	O	NOUN	B
T-leukemia	B-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


(	O	PUNCT	O
ABSTRACT	O	NOUN	B
TRUNCATED	O	VERB	I
AT	O	ADP	I
250	O	NUM	I
WORDS	O	NOUN	I
)	O	PUNCT	O


These	O	DET	O
inhibitory	O	ADJ	B
effects	O	NOUN	B
of	O	ADP	O
c-Rel	B-protein	NOUN	B
correlate	O	VERB	O
with	O	ADP	O
its	O	PRON	O
DNA-binding	O	ADJ	B
activity	O	NOUN	O
but	O	CCONJ	O
not	O	PART	O
with	O	ADP	O
its	O	PRON	O
ability	O	NOUN	O
to	O	PART	O
heterodimerize	O	VERB	B
with	O	ADP	O
p50	B-protein	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
c-Rel	B-protein	NOUN	B
inhibition	O	NOUN	B
involves	O	VERB	O
competition	O	NOUN	B
with	O	ADP	O
p50/p65	B-protein	NOUN	B
for	O	ADP	O
occupancy	O	NOUN	B
of	O	ADP	O
the	O	DET	O
kappa	O	NOUN	B
B	O	NOUN	I
enhancer	O	NOUN	I
element	O	NOUN	I
.	O	PUNCT	O


Together	O	ADV	O
,	O	PUNCT	O
these	O	DET	O
findings	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
one	O	NUM	O
function	O	NOUN	B
of	O	ADP	O
c-Rel	B-protein	NOUN	B
is	O	AUX	O
as	O	ADP	O
a	O	DET	O
physiologic	O	ADJ	B
repressor	O	NOUN	B
of	O	ADP	O
the	O	DET	O
HIV-1	B-DNA	NOUN	B
LTR	I-DNA	NOUN	B
and	O	CCONJ	O
IL-2R	B-protein	NOUN	B
alpha	I-protein	NOUN	O
promoters	O	NOUN	O
,	O	PUNCT	O
serving	O	VERB	O
to	O	PART	O
efficiently	O	ADV	B
counter	O	VERB	O
the	O	DET	O
strong	O	ADJ	O
transcriptional	O	ADJ	B
activating	O	NOUN	I
effects	O	NOUN	B
of	O	ADP	I
p65	B-protein	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
present	O	ADJ	O
study	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
examined	O	VERB	O
the	O	DET	O
relationship	O	NOUN	B
between	O	ADP	O
ras	O	NOUN	B
transformation	O	NOUN	I
and	O	CCONJ	O
differentiation	O	NOUN	B
of	O	ADP	O
human	B-cell_type	ADJ	B
B	I-cell_type	NOUN	O
lymphocytes	I-cell_type	NOUN	O
.	O	PUNCT	O


The	O	DET	O
B	B-protein	NOUN	B
cell	I-protein	NOUN	I
NFAT	I-protein	NOUN	I
complex	I-protein	NOUN	I
,	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
was	O	AUX	O
not	O	PART	O
functional	O	ADJ	B
,	O	PUNCT	O
since	O	SCONJ	O
it	O	PRON	O
failed	O	VERB	O
to	O	PART	O
activate	O	VERB	B
transcription	O	NOUN	B
from	O	ADP	O
an	O	DET	O
NFAT-driven	B-DNA	ADJ	B
chloramphenicol	I-DNA	NOUN	I
acetyltransferase	I-DNA	NOUN	I
(	I-DNA	PUNCT	O
CAT	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
construct	I-DNA	NOUN	O
.	O	PUNCT	O


Induction	O	NOUN	B
of	O	ADP	O
CD8	B-protein	NOUN	B
antigen	I-protein	NOUN	I
and	O	CCONJ	O
suppressor	O	NOUN	B
activity	O	NOUN	I
by	O	ADP	O
glucocorticoids	O	NOUN	B
in	O	ADP	O
a	O	DET	O
CEM	B-cell_line	NOUN	B
human	I-cell_line	ADJ	B
leukemic	I-cell_line	ADJ	O
cell	I-cell_line	NOUN	O
clone	I-cell_line	NOUN	O
.	O	PUNCT	O


The	O	DET	O
relationship	O	NOUN	B
between	O	ADP	O
glucocorticoid	O	NOUN	B
effect	O	NOUN	I
and	O	CCONJ	O
regulation	O	NOUN	B
of	O	ADP	O
cell	B-protein	NOUN	B
surface	I-protein	NOUN	I
antigens	I-protein	NOUN	O
was	O	AUX	O
investigated	O	VERB	B
in	O	ADP	O
two	O	NUM	O
models	O	NOUN	B
of	O	ADP	O
leukemic	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
,	O	PUNCT	O
CEM	B-cell_line	NOUN	B
C7	I-cell_line	NOUN	I
denoted	O	VERB	I
(	O	PUNCT	O
r+	O	ADJ	O
,	O	PUNCT	O
ly+	O	ADJ	B
)	O	PUNCT	O
and	O	CCONJ	O
CEM	B-cell_line	NOUN	B
C1	I-cell_line	NOUN	I
(	O	PUNCT	O
r+	O	ADJ	B
,	O	PUNCT	O
ly-	O	ADJ	O
)	O	PUNCT	O
.	O	PUNCT	O


Dexamethasone	O	NOUN	B
treatment	O	NOUN	B
of	O	ADP	O
a	O	DET	O
human	B-cell_line	ADJ	B
leukemic	I-cell_line	ADJ	O
cell	I-cell_line	NOUN	O
clone	I-cell_line	NOUN	O
CEM	I-cell_line	NOUN	O
C7	I-cell_line	NOUN	B
caused	O	VERB	O
an	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
a	O	DET	O
subset	O	NOUN	O
of	O	ADP	O
cells	O	NOUN	B
expressing	O	VERB	B
the	O	DET	O
surface	B-protein	NOUN	B
antigen	I-protein	NOUN	I
CD8	I-protein	NOUN	B
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
present	O	ADJ	O
on	O	ADP	O
suppressor	O	NOUN	B
and	O	CCONJ	O
cytotoxic	B-cell_type	ADJ	B
T-lymphocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
human	O	ADJ	B
leukemic	O	ADJ	O
cells	O	NOUN	O
studied	O	VERB	O
here	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
ability	O	NOUN	O
to	O	PART	O
induce	O	VERB	B
CD8	B-protein	NOUN	B
antigen	I-protein	NOUN	I
expression	O	NOUN	B
in	O	ADP	O
a	O	DET	O
CD4+	B-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
correlates	O	VERB	B
with	O	ADP	O
the	O	DET	O
ability	O	NOUN	O
to	O	PART	O
induce	O	VERB	B
cell	O	NOUN	B
lysis	O	NOUN	I
in	O	ADP	O
a	O	DET	O
glucocorticoid	B-cell_line	NOUN	B
receptor	I-cell_line	NOUN	I
positive	I-cell_line	ADJ	B
cell	I-cell_line	NOUN	B
population	I-cell_line	NOUN	I
.	O	PUNCT	O


DNA	O	NOUN	B
sequence	O	NOUN	I
homology	O	NOUN	B
of	O	ADP	O
E1A	B-DNA	NOUN	B
genes	O	NOUN	I
between	O	ADP	O
different	O	ADJ	O
Ad	O	NOUN	B
groups	O	NOUN	B
(	O	PUNCT	O
group	O	NOUN	B
A	O	NOUN	I
,	O	PUNCT	O
Ad12	O	NOUN	B
;	O	PUNCT	O
group	O	NOUN	B
C	O	NOUN	I
,	O	PUNCT	O
Ad5	O	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
limited	O	VERB	O
almost	O	ADV	O
entirely	O	ADV	O
to	O	PART	O
three	O	NUM	O
conserved	O	VERB	B
regions	O	NOUN	I
located	O	ADJ	O
within	O	ADP	O
the	O	DET	O
first	O	ADJ	O
exon	O	NOUN	B
of	O	ADP	O
E1A	B-DNA	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
summary	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
E1A	B-protein	NOUN	B
gene	I-protein	NOUN	I
products	I-protein	NOUN	I
inhibited	O	VERB	B
IFN	B-protein	NOUN	B
-MCP	O	NOUN	O
independently	O	ADV	O
of	O	ADP	O
virus	O	NOUN	B
infection	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
,	O	PUNCT	O
in	O	ADP	O
normal	O	ADJ	O
human	O	ADJ	B
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
an	O	DET	O
AP-1	B-protein	NOUN	B
protein	I-protein	NOUN	I
is	O	AUX	O
a	O	DET	O
component	O	NOUN	B
of	O	ADP	O
the	O	DET	O
NF-AT	B-protein	NOUN	B
protein	I-protein	NOUN	I
complex	I-protein	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
find	O	VERB	O
that	O	SCONJ	O
a	O	DET	O
short	O	ADJ	B
enhancer	O	NOUN	I
element	O	NOUN	I
containing	O	VERB	O
the	O	DET	O
NF-kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
binding	I-DNA	NOUN	I
site	I-DNA	NOUN	I
from	O	ADP	O
the	O	DET	O
interleukin-2	B-DNA	NOUN	B
receptor	I-DNA	NOUN	I
alpha-chain	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
(	O	PUNCT	O
IL-2R	B-protein	NOUN	B
alpha	I-protein	NOUN	I
)	O	PUNCT	O
is	O	AUX	O
preferentially	O	ADV	O
activated	O	VERB	B
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
propose	O	VERB	O
a	O	DET	O
model	O	NOUN	B
in	O	ADP	O
which	O	DET	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
and	O	CCONJ	O
I	B-protein	NOUN	O
kappa	I-protein	NOUN	O
B-alpha	I-protein	NOUN	B
mutually	O	ADV	O
regulate	O	VERB	B
each	O	DET	O
other	O	ADJ	O
in	O	ADP	O
a	O	DET	O
cycle	O	NOUN	B
:	O	PUNCT	O
saturating	O	ADJ	B
amounts	O	NOUN	O
of	O	ADP	O
the	O	DET	O
inhibitory	O	ADJ	B
I	B-protein	NOUN	I
kappa	I-protein	NOUN	I
B-alpha	I-protein	NOUN	I
protein	O	NOUN	I
are	O	AUX	O
destroyed	O	VERB	O
upon	O	SCONJ	O
stimulation	O	NOUN	B
,	O	PUNCT	O
allowing	O	VERB	O
rapid	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
.	O	PUNCT	O


Three	O	NUM	O
mutants	O	NOUN	B
(	O	PUNCT	O
-201/-184	O	NUM	O
NXS	O	NOUN	B
,	O	PUNCT	O
-165/-148	O	NUM	O
NXS	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
-147/-130	O	NUM	O
NXS	O	NOUN	B
)	O	PUNCT	O
had	O	AUX	O
effects	O	NOUN	B
on	O	ADP	O
viral	O	ADJ	B
replication	O	NOUN	I
that	O	PRON	O
were	O	AUX	O
much	O	ADV	O
more	O	ADV	O
severe	O	ADJ	B
than	O	ADP	O
the	O	DET	O
effects	O	NOUN	B
predicted	O	VERB	O
from	O	ADP	O
their	O	PRON	O
performance	O	NOUN	B
in	O	ADP	O
transfection	O	NOUN	B
analyses	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	O
two	O	NUM	O
LS	O	NOUN	B
mutations	O	NOUN	B
(	O	PUNCT	O
-201/-184	O	NUM	O
NXS	O	NOUN	B
and	O	CCONJ	O
-183/-166	O	NUM	O
NXS	O	NOUN	B
)	O	PUNCT	O
were	O	AUX	O
not	O	PART	O
predicted	O	VERB	O
by	O	ADP	O
their	O	PRON	O
effects	O	NOUN	B
in	O	ADP	O
transfection	O	NOUN	B
.	O	PUNCT	O


Although	O	SCONJ	O
the	O	DET	O
assay	O	NOUN	B
involves	O	VERB	O
the	O	DET	O
dramatic	O	ADJ	O
loss	O	NOUN	B
of	O	ADP	O
red	O	ADJ	B
cell	O	NOUN	I
production	O	NOUN	O
,	O	PUNCT	O
it	O	PRON	O
should	O	AUX	O
be	O	AUX	O
possible	O	ADJ	O
to	O	PART	O
define	O	VERB	O
important	O	ADJ	O
regulatory	O	ADJ	B
domains	O	NOUN	I
that	O	PRON	O
can	O	AUX	O
then	O	ADV	O
be	O	AUX	O
assayed	O	VERB	B
using	O	VERB	O
less	O	ADV	O
stringent	O	ADJ	O
systems	O	NOUN	O
,	O	PUNCT	O
such	O	ADJ	O
as	O	ADP	O
cell-free	O	ADJ	B
extracts	O	NOUN	I
for	O	ADP	O
in	O	X	B
vitro	O	X	I
transcription	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
ideal	O	ADJ	B
situation	O	NOUN	B
would	O	AUX	O
be	O	AUX	O
analyses	O	NOUN	B
conducted	O	VERB	O
in	O	ADP	O
GATA-1	B-cell_line	NOUN	B
-erythroid	I-cell_line	ADJ	O
cells	I-cell_line	NOUN	B
.	O	PUNCT	O


A	O	DET	O
human	B-DNA	ADJ	B
putative	I-DNA	ADJ	B
lymphocyte	I-DNA	NOUN	I
G0/G1	I-DNA	NOUN	O
switch	I-DNA	NOUN	O
gene	I-DNA	NOUN	B
homologous	O	ADJ	I
to	O	PART	O
a	O	DET	O
rodent	B-DNA	ADJ	B
gene	I-DNA	NOUN	O
encoding	O	VERB	B
a	O	DET	O
zinc-binding	B-protein	ADJ	B
potential	I-protein	ADJ	O
transcription	I-protein	NOUN	B
factor	I-protein	NOUN	I
.	O	PUNCT	O


Group	O	NOUN	B
1	O	NUM	O
contains	O	VERB	O
G0S24	B-DNA	NOUN	B
and	O	CCONJ	O
the	O	DET	O
rat	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
mouse	I-DNA	NOUN	B
TIS11	I-DNA	NOUN	B
genes	I-DNA	NOUN	B
(	O	PUNCT	O
also	O	ADV	O
known	O	VERB	O
as	O	ADP	O
TTP	B-DNA	NOUN	B
,	O	PUNCT	O
Nup475	B-DNA	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
Zfp36	B-DNA	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Groups	O	NOUN	B
1	O	NUM	O
and	O	CCONJ	O
2	O	NUM	O
have	O	AUX	O
a	O	DET	O
serine-rich	B-protein	ADJ	B
region	I-protein	NOUN	I
and	O	CCONJ	O
an	O	DET	O
``	O	PUNCT	O
arginine	B-protein	NOUN	B
element	I-protein	NOUN	O
``	O	PUNCT	O
(	O	PUNCT	O
RRLPIF	B-protein	NOUN	B
)	O	PUNCT	O
at	O	ADP	O
the	O	DET	O
carboxyl	B-protein	NOUN	B
terminus	I-protein	NOUN	I
.	O	PUNCT	O


A	O	DET	O
CpG	O	NOUN	B
island	O	NOUN	O
suggests	O	VERB	O
expression	O	NOUN	B
in	O	ADP	O
the	O	DET	O
germ	O	NOUN	B
line	O	NOUN	I
.	O	PUNCT	O


Protein	O	NOUN	B
and	O	CCONJ	O
genomic	O	ADJ	B
sequences	O	NOUN	I
show	O	VERB	O
similarities	O	NOUN	B
with	O	ADP	O
those	O	DET	O
of	O	ADP	O
a	O	DET	O
variety	O	NOUN	O
of	O	ADP	O
proteins	O	NOUN	B
involved	O	VERB	O
in	O	ADP	O
transcription	O	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
G0S24	B-protein	NOUN	B
product	I-protein	NOUN	B
has	O	AUX	O
a	O	DET	O
similar	O	ADJ	O
role	O	NOUN	O
.	O	PUNCT	O


Co-expression	O	NOUN	B
of	O	ADP	O
both	O	CCONJ	O
PU.1	B-protein	NOUN	B
and	O	CCONJ	O
Ets-1	B-protein	NOUN	B
in	O	ADP	O
nonlymphoid	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
trans-activated	B-DNA	ADJ	B
reporter	I-DNA	NOUN	I
plasmids	I-DNA	NOUN	I
that	O	PRON	O
contained	O	VERB	O
the	O	DET	O
minimal	O	ADJ	B
mu	B-DNA	NOUN	O
enhancer	I-DNA	NOUN	O
.	O	PUNCT	O


1	O	NUM	O
,	O	PUNCT	O
25-dihydroxy	O	ADJ	O
vitamin	O	NOUN	B
D3	O	NOUN	I
and	O	CCONJ	O
12-O-tetradecanoyl	O	NOUN	B
phorbol-13-acetate	O	NOUN	I
(	O	PUNCT	O
TPA	O	NOUN	B
)	O	PUNCT	O
interact	O	VERB	B
synergistically	O	ADV	B
to	O	PART	O
induce	O	VERB	B
monocytic	O	ADJ	B
differentiation	O	NOUN	I
of	O	ADP	O
U937	B-cell_line	NOUN	B
histiocytic	I-cell_line	ADJ	I
lymphoma	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


The	O	DET	O
kinetics	O	NOUN	B
of	O	ADP	O
induced	O	VERB	B
differentiation	O	NOUN	B
are	O	AUX	O
consistent	O	ADJ	B
with	O	ADP	I
a	O	DET	O
G1	O	NOUN	B
specific	O	ADJ	O
cellular	O	ADJ	B
response	O	NOUN	I
to	O	PART	O
initiate	O	VERB	B
the	O	DET	O
metabolic	O	ADJ	B
cascade	O	NOUN	I
culminating	O	VERB	O
in	O	ADP	O
cell	O	NOUN	B
differentiation	O	NOUN	I
.	O	PUNCT	O


When	O	SCONJ	O
stably	O	ADV	B
introduced	O	VERB	O
into	O	ADP	O
primary	B-cell_type	ADJ	B
erythroblasts	I-cell_type	NOUN	B
or	O	CCONJ	O
conditionally	B-cell_line	ADV	B
transformed	I-cell_line	VERB	O
erythroid	I-cell_line	ADJ	O
progenitors	I-cell_line	NOUN	O
cells	I-cell_line	NOUN	B
,	O	PUNCT	O
exogenous	O	ADJ	B
GATA-2/ER	B-protein	NOUN	B
promoted	O	VERB	B
proliferation	O	NOUN	B
and	O	CCONJ	O
inhibited	O	VERB	B
terminal	O	ADJ	B
differentiation	O	NOUN	B
in	O	ADP	O
an	O	DET	O
estrogen-dependent	O	ADJ	B
manner	O	NOUN	O
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
GATA-2	B-protein	NOUN	B
transcription	I-protein	NOUN	B
factor	I-protein	NOUN	I
appears	O	VERB	O
to	O	PART	O
play	O	VERB	O
a	O	DET	O
role	O	NOUN	O
in	O	ADP	O
regulating	O	VERB	B
the	O	DET	O
self-renewal	O	ADJ	B
capacity	O	NOUN	B
of	O	ADP	O
early	B-cell_type	ADJ	O
erythroid	I-cell_type	ADJ	B
progenitor	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
TNF	B-protein	NOUN	B
signaling	O	NOUN	B
is	O	AUX	O
largely	O	ADV	O
abolished	O	VERB	B
,	O	PUNCT	O
as	O	ADP	O
judged	O	VERB	O
by	O	ADP	O
the	O	DET	O
failure	O	NOUN	B
of	O	ADP	O
TNF	B-protein	NOUN	B
to	O	PART	O
induce	O	VERB	B
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
in	O	ADP	O
T	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
from	O	ADP	O
TNFRp55	B-protein	NOUN	B
-deficient	O	ADJ	O
mice	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
studied	O	VERB	O
the	O	DET	O
functional	O	ADJ	B
interaction	O	NOUN	B
between	O	ADP	O
human	B-DNA	ADJ	B
embryonic	I-DNA	ADJ	O
zeta	I-DNA	NOUN	O
2	I-DNA	NUM	O
globin	I-DNA	NOUN	B
promoter	I-DNA	NOUN	I
and	O	CCONJ	O
the	O	DET	O
alpha	B-DNA	NOUN	B
globin	I-DNA	NOUN	I
regulatory	I-DNA	ADJ	B
element	I-DNA	NOUN	I
(	O	PUNCT	O
HS-40	B-DNA	NOUN	B
)	O	PUNCT	O
located	O	ADJ	O
40	B-DNA	NUM	O
kb	I-DNA	NOUN	O
upstream	I-DNA	ADV	O
of	O	ADP	O
the	O	DET	O
zeta	B-DNA	NOUN	B
2	I-DNA	NUM	I
globin	I-DNA	NOUN	B
gene	I-DNA	NOUN	I
.	O	PUNCT	O


Bal	O	NOUN	B
31	O	NUM	I
deletion	O	NOUN	B
mapping	O	NOUN	I
data	O	NOUN	B
suggested	O	VERB	O
that	O	SCONJ	O
one	O	NUM	O
GATA-1	O	NOUN	B
motif	O	NOUN	B
,	O	PUNCT	O
one	O	NUM	O
GT	O	NOUN	B
motif	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
two	O	NUM	O
NF-E2/AP1	O	NOUN	B
motifs	O	NOUN	B
together	O	ADV	O
formed	O	VERB	O
the	O	DET	O
functional	O	ADJ	B
core	O	NOUN	O
of	O	ADP	O
HS-40	B-DNA	NOUN	B
in	O	ADP	O
the	O	DET	O
erythroid-specific	O	ADJ	B
activation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
zeta	B-DNA	NOUN	B
2	I-DNA	NUM	I
globin	I-DNA	NOUN	B
promoter	I-DNA	NOUN	I
.	O	PUNCT	O


On	O	ADP	O
the	O	DET	O
other	O	ADJ	O
hand	O	NOUN	B
,	O	PUNCT	O
only	O	ADV	O
one	O	NUM	O
of	O	ADP	O
the	O	DET	O
apparently	O	ADV	O
nonfunctional	B-DNA	ADJ	O
sequence	I-DNA	NOUN	O
motifs	I-DNA	NOUN	B
was	O	AUX	O
bound	O	VERB	O
with	O	ADP	O
factors	O	NOUN	B
in	O	X	B
vivo	O	X	I
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
to	O	PART	O
the	O	DET	O
wild-type	B-cell_line	ADJ	B
B	I-cell_line	NOUN	I
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
Raji	I-cell_line	NOUN	I
,	O	PUNCT	O
two	B-cell_line	NUM	O
class	I-cell_line	NOUN	B
II	I-cell_line	NUM	I
transcriptional	I-cell_line	ADJ	B
mutant	I-cell_line	ADJ	I
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
,	O	PUNCT	O
SJO	B-cell_line	NOUN	B
and	O	CCONJ	O
RJ2.2.5	B-cell_line	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
Jurkat	B-cell_line	NOUN	B
,	O	PUNCT	O
a	O	DET	O
class	B-cell_line	NOUN	B
II	I-cell_line	NUM	I
negative	I-cell_line	ADJ	I
T	I-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
,	O	PUNCT	O
were	O	AUX	O
examined	O	VERB	O
.	O	PUNCT	O


The	O	DET	O
human	B-DNA	ADJ	B
immunodeficiency	I-DNA	NOUN	I
virus	I-DNA	NOUN	I
(	I-DNA	PUNCT	O
HIV	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
type	I-DNA	NOUN	O
1	I-DNA	NUM	O
long	I-DNA	ADJ	B
terminal	I-DNA	ADJ	I
repeat	I-DNA	NOUN	I
(	O	PUNCT	I
LTR	B-DNA	NOUN	B
)	O	PUNCT	O
contains	O	VERB	O
binding	O	VERB	B
sites	O	NOUN	I
for	O	ADP	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
(	O	PUNCT	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
)	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
constitutively	O	ADV	B
expressed	O	VERB	B
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
Sp1	I-protein	NOUN	B
,	O	PUNCT	O
both	O	DET	O
of	O	ADP	O
which	O	DET	O
are	O	AUX	O
highly	O	ADV	O
conserved	O	VERB	O
in	O	ADP	O
HIV	O	NOUN	B
and	O	CCONJ	O
simian	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
isolates	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
comparison	O	NOUN	B
,	O	PUNCT	O
PBMC	B-cell_type	NOUN	B
from	O	ADP	O
two	O	NUM	O
children	O	NOUN	B
with	O	ADP	O
fatal	O	ADJ	B
adenoviral	O	ADJ	B
infection	O	NOUN	I
were	O	AUX	O
both	O	CCONJ	O
strongly	O	ADV	O
positive	O	ADJ	B
for	O	ADP	O
adenovirus	B-DNA	NOUN	B
DNA	I-DNA	NOUN	B
.	O	PUNCT	O


DESIGN	O	NOUN	O
:	O	PUNCT	O
Infected	O	ADJ	B
promyelocytic	B-cell_type	ADJ	I
and	O	CCONJ	O
promonocytic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
were	O	AUX	O
examined	O	VERB	B
because	O	SCONJ	O
they	O	PRON	O
normally	O	ADV	O
express	O	VERB	O
both	O	DET	O
types	O	NOUN	O
of	O	ADP	O
TNF	B-protein	NOUN	B
receptors	I-protein	NOUN	I
.	O	PUNCT	O


A	O	DET	O
series	O	NOUN	B
of	O	ADP	O
uninfected	B-cell_line	ADJ	B
parental	I-cell_line	ADJ	B
HL-60	I-cell_line	NOUN	B
subclones	I-cell_line	NOUN	I
all	O	DET	O
reduced	O	VERB	B
TR75	B-protein	NOUN	B
surface	O	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
TNF-alpha	B-protein	NOUN	B
treatment	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
used	O	VERB	O
in	O	X	B
situ	O	X	I
hybridization	O	NOUN	I
to	O	PART	O
define	O	VERB	O
these	O	DET	O
rearrangements	O	NOUN	B
at	O	ADP	O
the	O	DET	O
molecular	O	ADJ	B
level	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
,	O	PUNCT	O
combined	O	VERB	O
with	O	ADP	O
previous	O	ADJ	O
studies	O	NOUN	B
,	O	PUNCT	O
suggest	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
Y	O	NOUN	B
chromosome	O	NOUN	I
in	O	ADP	O
great	O	ADJ	O
apes	O	NOUN	B
has	O	AUX	O
a	O	DET	O
conserved	O	VERB	B
region	O	NOUN	I
including	O	VERB	O
the	O	DET	O
pseudoautosomal	B-DNA	ADJ	B
region	I-DNA	NOUN	I
and	O	CCONJ	O
the	O	DET	O
testis-determining	O	ADJ	B
region	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
reporter	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
under	O	ADP	O
the	O	DET	O
control	O	NOUN	B
of	O	ADP	O
a	O	DET	O
T-cell	B-DNA	NOUN	B
antigen	I-DNA	NOUN	I
receptor	I-DNA	NOUN	I
element	I-DNA	NOUN	I
was	O	AUX	O
activated	O	VERB	B
in	O	ADP	O
Jurkat	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
by	O	ADP	O
antigen	O	NOUN	B
receptor	O	NOUN	I
triggering	O	NOUN	B
or	O	CCONJ	O
by	O	ADP	O
a	O	DET	O
combination	O	NOUN	B
of	O	ADP	O
phorbol	O	NOUN	B
myristate	O	NOUN	I
acetate	O	NOUN	I
,	O	PUNCT	O
which	O	DET	O
activates	O	VERB	O
protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
C	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
calcium	O	NOUN	B
ionophore	O	NOUN	I
.	O	PUNCT	O


Thus	O	ADV	O
p59fyn	B-protein	NOUN	B
could	O	AUX	O
replace	O	VERB	O
the	O	DET	O
calcium	O	NOUN	B
ionophore	O	NOUN	I
but	O	CCONJ	O
not	O	PART	O
activation	O	NOUN	B
of	O	ADP	O
protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
C	I-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
levels	O	NOUN	B
of	O	ADP	O
GATA-1	B-protein	NOUN	B
,	O	PUNCT	O
Epo-R	B-protein	NOUN	B
and	O	CCONJ	O
globin	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
expressed	O	VERB	B
were	O	AUX	O
not	O	PART	O
affected	O	VERB	O
by	O	ADP	O
a	O	DET	O
24-hour	O	ADJ	B
incubation	O	NOUN	I
of	O	ADP	O
either	O	DET	O
cell	O	NOUN	B
line	O	NOUN	I
with	O	ADP	O
Epo	B-protein	NOUN	B
,	O	PUNCT	O
GM-CSF	B-protein	NOUN	B
or	O	CCONJ	O
interleukin-3	B-protein	NOUN	B
(	O	PUNCT	O
IL-3	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Protein	B-protein	NOUN	B
phosphatases	I-protein	NOUN	I
1	I-protein	NUM	I
and	I-protein	CCONJ	O
2A	I-protein	NOUN	B
are	O	AUX	O
important	O	ADJ	O
in	O	ADP	O
regulating	O	VERB	B
cellular	O	ADJ	B
functions	O	NOUN	I
by	O	ADP	O
controlling	O	VERB	B
the	O	DET	O
phosphorylation	O	NOUN	B
state	O	NOUN	O
of	O	ADP	O
their	O	PRON	O
substrates	O	NOUN	B
.	O	PUNCT	O


Okadaic	O	ADJ	B
acid	O	NOUN	I
increased	O	VERB	B
the	O	DET	O
synthesis	O	NOUN	B
of	O	ADP	O
the	O	DET	O
interleukin-1	B-protein	NOUN	B
beta	I-protein	NOUN	I
precursor	O	NOUN	I
and	O	CCONJ	O
mature	O	ADJ	B
forms	O	NOUN	O
and	O	CCONJ	O
their	O	PRON	O
secretion	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
increased	O	VERB	B
processing	O	NOUN	B
and	O	CCONJ	O
secretion	O	NOUN	B
correlated	O	VERB	B
with	O	ADP	O
the	O	DET	O
stimulation	O	NOUN	B
of	O	ADP	O
IL-1	B-RNA	NOUN	B
beta	I-RNA	NOUN	B
convertase	I-RNA	NOUN	I
mRNA	I-RNA	NOUN	B
accumulation	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
stimulation	O	NOUN	B
of	O	ADP	O
interleukin-1	B-protein	NOUN	B
alpha	I-protein	NOUN	I
production	O	NOUN	B
by	O	ADP	O
okadaic	O	ADJ	B
acid	O	NOUN	I
was	O	AUX	O
more	O	ADV	O
modest	O	ADJ	O
than	O	ADP	O
that	O	DET	O
of	O	ADP	O
interleukin-1	B-protein	NOUN	B
beta	I-protein	NOUN	I
.	O	PUNCT	O


It	O	PRON	O
is	O	AUX	O
also	O	ADV	O
shown	O	VERB	O
in	O	ADP	O
this	O	DET	O
report	O	NOUN	B
that	O	SCONJ	O
,	O	PUNCT	O
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
PMA/anti-CD28	B-protein	ADJ	B
mAb	I-protein	NOUN	I
or	O	CCONJ	O
anti-CD3/anti-CD28	B-protein	ADJ	B
mAb	I-protein	NOUN	B
,	O	PUNCT	O
c-Rel	B-protein	NOUN	B
,	O	PUNCT	O
p50	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
p65	B-protein	NOUN	B
are	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
CD28-responsive	B-DNA	ADJ	B
element	I-DNA	NOUN	I
present	O	ADJ	O
in	O	ADP	O
the	O	DET	O
promoter	B-DNA	NOUN	B
of	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
interleukin	I-DNA	NOUN	O
2	I-DNA	NUM	O
gene	I-DNA	NOUN	O
.	O	PUNCT	O


Tal-1	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
encodes	O	VERB	B
a	O	DET	O
putative	O	ADJ	B
transcription	B-protein	NOUN	I
factor	I-protein	NOUN	I
with	O	ADP	O
a	O	DET	O
basic	B-protein	ADJ	O
helix-loop-helix	I-protein	ADJ	B
domain	I-protein	NOUN	I
and	O	CCONJ	O
is	O	AUX	O
known	O	VERB	O
to	O	PART	O
be	O	AUX	O
predominantly	O	ADV	O
expressed	O	VERB	B
in	O	ADP	O
hematopoietic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Altogether	O	ADV	O
our	O	PRON	O
results	O	NOUN	B
strongly	O	ADV	O
suggest	O	VERB	O
that	O	SCONJ	O
GATA-1	B-protein	NOUN	B
modulates	O	VERB	B
the	O	DET	O
transcription	O	NOUN	B
of	O	ADP	O
tal-1	B-protein	NOUN	B
during	O	ADP	O
the	O	DET	O
differentiation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
erythroid	B-cell_type	ADJ	B
,	I-cell_type	PUNCT	O
megakaryocytic	I-cell_type	ADJ	B
,	I-cell_type	PUNCT	O
and	I-cell_type	CCONJ	O
basosophilic	I-cell_type	ADJ	B
lineages	I-cell_type	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
developed	O	VERB	O
eukaryotic	O	ADJ	B
vectors	O	NOUN	I
suitable	O	ADJ	O
to	O	PART	O
imitate	O	VERB	B
the	O	DET	O
processes	O	NOUN	B
involved	O	VERB	O
in	O	ADP	O
lytic	O	ADJ	B
transition	O	NOUN	B
in	O	ADP	O
cell	O	NOUN	B
culture	O	NOUN	I
systems	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
detected	O	VERB	B
an	O	DET	O
association	O	NOUN	B
between	O	ADP	O
the	O	DET	O
reduced	O	VERB	B
mitogenic	O	ADJ	B
response	O	NOUN	I
and	O	CCONJ	O
low	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
both	O	CCONJ	O
interleukin-2	B-protein	NOUN	B
(	O	PUNCT	O
IL-2	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
alpha	B-protein	NOUN	B
chain	I-protein	NOUN	I
(	O	PUNCT	O
CD25	B-protein	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
the	O	DET	O
IL-2	B-protein	NOUN	B
receptor	I-protein	NOUN	I
(	O	PUNCT	O
IL-2R	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Altogether	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
data	O	NOUN	B
provide	O	VERB	O
the	O	DET	O
evidence	O	NOUN	B
that	O	SCONJ	O
both	O	DET	O
pathways	O	NOUN	B
complement	O	VERB	O
each	O	DET	O
other	O	ADJ	O
in	O	ADP	O
regulating	O	VERB	B
gene	O	NOUN	B
expression	O	NOUN	I
and	O	CCONJ	O
,	O	PUNCT	O
conversely	O	ADV	O
,	O	PUNCT	O
downregulate	O	VERB	B
the	O	DET	O
TcR	B-protein	NOUN	B
transduction	O	NOUN	B
mechanisms	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
lymphotoxin	B-DNA	NOUN	B
promoter	I-DNA	NOUN	I
is	O	AUX	O
stimulated	O	VERB	B
by	O	ADP	O
HTLV-I	B-protein	NOUN	B
tax	I-protein	NOUN	O
activation	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
in	O	ADP	O
human	B-cell_line	ADJ	B
T-cell	I-cell_line	NOUN	O
lines	I-cell_line	NOUN	O
.	O	PUNCT	O


Tax	B-protein	NOUN	B
co-transfected	O	VERB	B
with	O	ADP	O
reporter	B-DNA	NOUN	B
constructs	I-DNA	NOUN	I
into	O	ADP	O
Jurkat	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
maximally	O	ADV	O
activated	O	VERB	B
HTLV-I-LTR-CAT	B-protein	NOUN	B
and	O	CCONJ	O
kappa	B-protein	NOUN	B
B-fos-CAT	I-protein	NOUN	B
and	O	CCONJ	O
also	O	ADV	O
activated	O	VERB	B
LT-293	B-DNA	NOUN	B
to	O	PART	O
a	O	DET	O
lesser	O	ADJ	B
extent	O	NOUN	B
.	O	PUNCT	O


Restriction	O	NOUN	B
enzyme	O	NOUN	B
analysis	O	NOUN	I
followed	O	VERB	O
by	O	ADP	O
Southern	O	NOUN	B
blot	O	NOUN	I
hybridization	O	NOUN	I
identified	O	VERB	B
a	O	DET	O
significant	O	ADJ	O
increase	O	NOUN	B
in	O	ADP	O
the	O	DET	O
fused	O	VERB	B
fragment	O	NOUN	O
encompassing	O	VERB	O
both	O	DET	O
ends	O	NOUN	B
of	O	ADP	O
EBV	B-DNA	NOUN	B
DNA	I-DNA	NOUN	B
.	O	PUNCT	O


Southern	O	NOUN	B
blot	O	NOUN	I
analysis	O	NOUN	I
of	O	ADP	O
in	O	X	B
situ	O	X	I
lysing	O	NOUN	I
gels	O	NOUN	B
revealed	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
cellular	O	ADJ	B
content	O	NOUN	I
of	O	ADP	O
linear	B-DNA	ADJ	B
EBV	I-DNA	NOUN	I
DNA	I-DNA	NOUN	B
was	O	AUX	O
also	O	ADV	O
increased	O	VERB	B
significantly	O	ADV	O
after	O	ADP	O
the	O	DET	O
initiation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
viral	O	ADJ	B
lytic	O	ADJ	I
cycle	O	NOUN	I
,	O	PUNCT	O
while	O	SCONJ	O
the	O	DET	O
amount	O	NOUN	B
of	O	ADP	O
circular	O	ADJ	B
DNA	O	NOUN	I
remained	O	VERB	O
approximately	O	ADV	O
constant	O	ADJ	B
.	O	PUNCT	O


gamma-Interferon	B-protein	NOUN	B
expression	O	NOUN	B
was	O	AUX	O
only	O	ADV	O
detectable	O	ADJ	B
in	O	ADP	O
1	O	NUM	O
Hashimoto	O	NOUN	B
's	O	PART	I
goiter	O	NOUN	I
.	O	PUNCT	O


1	O	NUM	O
,	O	PUNCT	O
25	O	NUM	O
alpha-Dihydroxicholecalciferol	O	NOUN	B
(	O	PUNCT	O
VitD3	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
retinoic	O	ADJ	B
acid	O	NOUN	I
(	O	PUNCT	O
RA	O	NOUN	B
)	O	PUNCT	O
are	O	AUX	O
important	O	ADJ	O
regulators	O	NOUN	B
of	O	ADP	O
the	O	DET	O
proliferation	O	NOUN	B
and	O	CCONJ	O
differentiation	O	NOUN	B
of	O	ADP	O
several	O	ADJ	O
cell	O	NOUN	B
types	O	NOUN	I
.	O	PUNCT	O


While	O	SCONJ	O
inducing	O	VERB	O
CD14	B-protein	NOUN	B
expression	O	NOUN	B
,	O	PUNCT	O
VitD3	O	NOUN	B
concomitantly	O	ADV	O
suppressed	O	VERB	B
the	O	DET	O
basal	O	ADJ	B
,	O	PUNCT	O
PMA-	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
RA-inducible	O	ADJ	B
CD23	B-protein	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
a	O	DET	O
dose-dependent	O	ADJ	B
manner	O	NOUN	O
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
VitD3	O	NOUN	B
-and	O	PUNCT	O
the	O	DET	O
PMA-induced	O	ADJ	B
CD14	B-protein	NOUN	B
expression	O	NOUN	B
was	O	AUX	O
inhibited	O	VERB	B
as	O	ADP	O
a	O	DET	O
temporal	O	ADJ	B
consequence	O	NOUN	O
of	O	ADP	O
the	O	DET	O
RA-induced	O	ADJ	B
differentiation	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
effect	O	NOUN	B
was	O	AUX	O
abrogated	O	VERB	O
by	O	ADP	O
the	O	DET	O
PKC	B-protein	NOUN	B
inhibitor	O	NOUN	B
staurosporine	O	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
a	O	DET	O
role	O	NOUN	O
for	O	ADP	O
PKC	B-protein	NOUN	B
.	O	PUNCT	O


Increased	O	VERB	B
c-jun	B-protein	NOUN	B
,	O	PUNCT	O
jun-B	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
jun-D	B-protein	NOUN	B
expression	O	NOUN	B
above	O	ADP	O
basal	O	ADJ	B
levels	O	NOUN	I
and	O	CCONJ	O
increased	O	VERB	B
transcriptional	O	ADJ	B
activity	O	NOUN	I
of	O	ADP	O
AP-1/TPA	B-DNA	NOUN	O
responsive	I-DNA	ADJ	B
elements	I-DNA	NOUN	I
fused	O	VERB	O
to	O	PART	O
chloramphenicol	B-DNA	NOUN	B
acetyl-transferase	I-DNA	NOUN	O
vectors	I-DNA	NOUN	O
were	O	AUX	O
observed	O	VERB	O
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
treated	O	VERB	B
with	O	ADP	I
TPA	O	NOUN	B
alone	O	ADV	O
or	O	CCONJ	O
in	O	ADP	O
combination	O	NOUN	B
with	O	ADP	O
dexamethasone	O	NOUN	B
.	O	PUNCT	O


Conversely	O	ADV	O
,	O	PUNCT	O
c-jun	B-protein	NOUN	B
and	O	CCONJ	O
jun-B	B-protein	NOUN	B
transfection	O	NOUN	I
blunted	O	VERB	B
GR	B-protein	NOUN	B
-dependent	O	ADJ	O
transcription	O	NOUN	B
in	O	ADP	O
HeLa	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Furthermore	O	ADV	O
overexpression	O	NOUN	B
of	O	ADP	O
exogenous	B-protein	ADJ	B
c-fos	I-protein	NOUN	O
has	O	AUX	O
an	O	DET	O
inhibitory	O	ADJ	B
effect	O	NOUN	O
on	O	ADP	O
GR	B-protein	NOUN	B
-dependent	O	ADJ	O
transcription	O	NOUN	B
from	O	ADP	O
GRE	B-DNA	NOUN	B
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


This	O	DET	O
sequence	B-DNA	NOUN	B
element	I-DNA	NOUN	I
was	O	AUX	O
referred	O	VERB	O
to	O	PART	O
as	O	ADP	O
the	O	DET	O
BAT	B-DNA	NOUN	B
box	I-DNA	NOUN	B
and	O	CCONJ	O
its	O	PRON	O
deletion	O	NOUN	B
significantly	O	ADV	O
reduced	O	VERB	O
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
a	O	DET	O
CD20	O	NOUN	B
promoter-CAT	O	ADJ	B
construct	O	NOUN	I
in	O	ADP	O
B	O	NOUN	B
cells	O	NOUN	I
.	O	PUNCT	O


Southwestern	O	NOUN	B
blotting	O	NOUN	I
and	O	CCONJ	O
UV	O	NOUN	B
cross-linking	O	NOUN	I
studies	O	NOUN	I
confirmed	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
BAT	B-protein	NOUN	B
box	I-protein	NOUN	B
binding	I-protein	NOUN	I
proteins	I-protein	NOUN	I
were	O	AUX	O
Oct-1	B-protein	NOUN	B
and	O	CCONJ	O
Oct-2	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
autologous	B-cell_line	ADJ	B
DE	I-cell_line	NOUN	B
LCL	I-cell_line	NOUN	I
containing	O	VERB	O
a	O	DET	O
transduced	O	VERB	B
pml/RAR	B-DNA	NOUN	B
alpha	I-DNA	NOUN	I
fusion	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
and	O	CCONJ	O
expressing	O	VERB	B
a	O	DET	O
bcr1	O	NOUN	B
type	O	NOUN	O
of	O	ADP	O
the	O	DET	O
pml/RAR	B-protein	NOUN	B
alpha	I-protein	NOUN	I
hybrid	O	NOUN	I
protein	O	NOUN	I
induced	O	VERB	B
the	O	DET	O
proliferation	O	NOUN	B
of	O	ADP	O
DE	B-cell_line	NOUN	B
anti-BCR1/25	I-cell_line	NUM	O
T	I-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
clones	I-cell_line	NOUN	O
.	O	PUNCT	O


It	O	PRON	O
is	O	AUX	O
concluded	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
bcr1	B-protein	NOUN	B
type-pml/RAR	I-protein	NOUN	B
alpha	I-protein	NOUN	B
fusion	I-protein	NOUN	I
protein	I-protein	NOUN	I
of	O	ADP	O
APL	B-cell_line	NOUN	B
contains	O	VERB	O
an	O	DET	O
antigenic	O	ADJ	B
site	O	NOUN	I
,	O	PUNCT	O
absent	O	ADJ	B
from	O	ADP	O
the	O	DET	O
normal	O	ADJ	B
parent	O	NOUN	O
molecules	O	NOUN	O
and	O	CCONJ	O
recognized	O	VERB	O
by	O	ADP	O
human	B-cell_line	ADJ	B
CD4+	I-cell_line	ADJ	B
lymphocytes	I-cell_line	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
present	O	ADJ	O
studies	O	NOUN	B
we	O	PRON	O
have	O	AUX	O
examined	O	VERB	O
the	O	DET	O
signaling	O	NOUN	B
pathways	O	NOUN	I
by	O	ADP	O
which	O	DET	O
this	O	DET	O
monocyte-specific	O	ADJ	B
response	O	NOUN	I
is	O	AUX	O
induced	O	VERB	B
.	O	PUNCT	O


Infection	O	NOUN	B
with	O	ADP	O
the	O	DET	O
human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
(	O	PUNCT	O
HIV	O	NOUN	B
)	O	PUNCT	O
has	O	AUX	O
been	O	AUX	O
shown	O	VERB	O
to	O	PART	O
induce	O	VERB	B
production	O	NOUN	B
of	O	ADP	O
several	O	ADJ	O
cytokines	B-protein	NOUN	B
both	O	CCONJ	O
in	O	X	B
vitro	O	X	I
and	O	CCONJ	O
in	O	X	B
vivo	O	X	I
.	O	PUNCT	O


Problems	O	NOUN	B
of	O	ADP	O
antihypertensive	O	ADJ	B
therapy	O	NOUN	I
are	O	AUX	O
discussed	O	VERB	O
and	O	CCONJ	O
the	O	DET	O
first	O	ADJ	O
results	O	NOUN	B
of	O	ADP	O
a	O	DET	O
pilot	O	NOUN	B
study	O	NOUN	I
with	O	ADP	O
Urapidil	O	NOUN	B
are	O	AUX	O
presented	O	VERB	O
.	O	PUNCT	O


Further	O	ADJ	O
studies	O	NOUN	B
will	O	AUX	O
have	O	AUX	O
to	O	PART	O
prove	O	VERB	O
if	O	SCONJ	O
Urapidil	O	NOUN	B
is	O	AUX	O
suited	O	VERB	O
for	O	ADP	O
prepartal	O	ADJ	B
treatment	O	NOUN	O
of	O	ADP	O
PIH	O	NOUN	B
as	O	ADV	O
well	O	ADV	O
.	O	PUNCT	O


Interleukin-4	B-protein	NOUN	B
inhibits	O	VERB	B
the	O	DET	O
lipopolysaccharide-induced	O	ADJ	B
expression	O	NOUN	I
of	O	ADP	O
c-jun	B-RNA	NOUN	B
and	I-RNA	CCONJ	O
c-fos	I-RNA	NOUN	B
messenger	I-RNA	NOUN	I
RNA	I-RNA	NOUN	I
and	O	CCONJ	O
activator	B-protein	NOUN	B
protein-1	I-protein	NOUN	I
binding	O	NOUN	I
activity	O	NOUN	O
in	O	ADP	O
human	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
one	O	NUM	O
patient	O	NOUN	B
,	O	PUNCT	O
transient	O	ADJ	B
reduction	O	NOUN	B
of	O	ADP	O
aldosterone	B-protein	NOUN	B
receptors	I-protein	NOUN	I
could	O	AUX	O
be	O	AUX	O
documented	O	VERB	B
,	O	PUNCT	O
while	O	SCONJ	O
in	O	ADP	O
the	O	DET	O
second	O	ADJ	O
patient	O	NOUN	B
the	O	DET	O
clinical	O	ADJ	B
and	O	CCONJ	O
biochemical	O	ADJ	B
parameters	O	NOUN	B
were	O	AUX	O
consistent	O	ADJ	B
with	O	ADP	I
transient	O	ADJ	B
pseudohypoaldosteronism	O	NOUN	I
.	O	PUNCT	O


Such	O	ADJ	O
changes	O	NOUN	B
clearly	O	ADV	O
can	O	AUX	O
not	O	PART	O
be	O	AUX	O
explained	O	VERB	O
by	O	ADP	O
genomic	O	ADJ	B
mechanisms	O	NOUN	I
,	O	PUNCT	O
which	O	DET	O
are	O	AUX	O
responsible	O	ADJ	O
for	O	ADP	O
later	O	ADJ	O
effects	O	NOUN	B
than	O	ADP	O
the	O	DET	O
membrane	O	NOUN	B
related	O	ADJ	O
rapid	O	ADJ	O
responses	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
unique	O	ADJ	B
characteristics	O	NOUN	B
of	O	ADP	O
this	O	DET	O
new	O	ADJ	O
pathway	O	NOUN	B
for	O	ADP	O
steroid	O	NOUN	B
action	O	NOUN	O
include	O	VERB	O
its	O	PRON	O
rapid	O	ADJ	O
time	O	NOUN	O
course	O	NOUN	O
,	O	PUNCT	O
10	O	NUM	O
,	O	PUNCT	O
000-fold	O	ADJ	O
selectivity	O	NOUN	B
for	O	ADP	O
aldosterone	O	NOUN	B
over	O	ADP	O
cortisol	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
ineffectiveness	O	NOUN	B
of	O	ADP	O
spironolactones	O	NOUN	B
,	O	PUNCT	O
classical	O	ADJ	O
mineralocorticoid	O	NOUN	B
antagonists	O	NOUN	B
,	O	PUNCT	O
as	O	ADP	O
antagonists	O	NOUN	B
of	O	ADP	O
the	O	DET	O
response	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
activation	O	NOUN	B
is	O	AUX	O
mediated	O	VERB	O
by	O	ADP	O
the	O	DET	O
host	B-protein	NOUN	B
transcription	I-protein	NOUN	B
factor	I-protein	NOUN	I
NF-kappa	B-protein	NOUN	I
B	I-protein	NOUN	I
[	O	PUNCT	O
G.Nabel	O	PROPN	B
and	O	CCONJ	O
D.Baltimore	O	PROPN	B
,	O	PUNCT	O
Nature	O	PROPN	B
(	O	PUNCT	O
London	O	PROPN	B
)	O	PUNCT	O
326	O	NUM	O
:	O	PUNCT	O
711-717	O	NUM	B
,	O	PUNCT	O
1987	O	NUM	O
]	O	PUNCT	O
.	O	PUNCT	O


Our	O	PRON	O
analyses	O	NOUN	B
show	O	VERB	O
that	O	SCONJ	O
several	O	ADJ	O
Oct2	B-protein	NOUN	B
isoforms	I-protein	NOUN	B
can	O	AUX	O
stimulate	O	VERB	B
from	O	ADP	O
a	O	DET	O
remote	O	ADJ	B
position	O	NOUN	O
but	O	CCONJ	O
that	O	SCONJ	O
this	O	DET	O
stimulation	O	NOUN	B
is	O	AUX	O
restricted	O	ADJ	O
to	O	PART	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


This	O	DET	O
high-affinity	B-DNA	ADJ	B
site	I-DNA	NOUN	I
has	O	AUX	O
been	O	AUX	O
conserved	O	VERB	O
in	O	ADP	O
the	O	DET	O
promoters	B-DNA	NOUN	B
of	O	ADP	O
both	O	CCONJ	O
human	B-DNA	ADJ	B
and	I-DNA	CCONJ	O
mouse	I-DNA	NOUN	B
CD19	I-DNA	NOUN	B
genes	I-DNA	NOUN	I
and	O	CCONJ	O
was	O	AUX	O
furthermore	O	ADV	O
shown	O	VERB	O
to	O	PART	O
confer	O	VERB	O
B-cell	O	NOUN	B
specificity	O	NOUN	B
to	O	PART	O
a	O	DET	O
beta-globin	O	NOUN	B
reporter	O	NOUN	I
gene	O	NOUN	I
in	O	ADP	O
transient	O	ADJ	B
transfection	O	NOUN	O
experiments	O	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
BSAP	B-protein	NOUN	B
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
be	O	AUX	O
the	O	DET	O
only	O	ADV	O
abundant	O	ADJ	B
DNA-binding	O	ADJ	B
activity	O	NOUN	O
of	O	ADP	O
B-cell	O	NOUN	B
nuclear	O	ADJ	I
extracts	O	NOUN	I
that	O	PRON	O
interacts	O	VERB	O
with	O	ADP	O
the	O	DET	O
CD19	B-DNA	NOUN	B
promoter	I-DNA	NOUN	I
.	O	PUNCT	O


Eicosanoids	O	NOUN	B
in	O	ADP	O
breast	O	NOUN	B
cancer	O	NOUN	I
patients	O	NOUN	B
before	O	ADP	O
and	O	CCONJ	O
after	O	ADP	O
mastectomy	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
19	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
a	O	DET	O
malignant	O	ADJ	B
breast	O	NOUN	I
tumor	O	NOUN	I
,	O	PUNCT	O
tumor	O	NOUN	B
tissue	O	NOUN	I
and	O	CCONJ	O
blood	O	NOUN	B
were	O	AUX	O
taken	O	VERB	O
to	O	PART	O
determine	O	VERB	O
the	O	DET	O
eicosanoid	O	NOUN	B
profile	O	NOUN	O
and	O	CCONJ	O
platelet	B-cell_type	NOUN	B
aggregation	O	NOUN	I
.	O	PUNCT	O


Postoperatively	O	ADV	B
,	O	PUNCT	O
blood	O	NOUN	B
was	O	AUX	O
taken	O	VERB	O
as	O	ADV	O
well	O	ADV	O
in	O	ADP	O
order	O	NOUN	O
to	O	PART	O
compare	O	VERB	B
pre-	O	ADJ	B
and	O	CCONJ	O
postoperative	O	ADJ	B
values	O	NOUN	O
.	O	PUNCT	O


MR	B-protein	NOUN	B
count	O	NOUN	B
was	O	AUX	O
significantly	O	ADV	O
(	O	PUNCT	O
P	O	NOUN	O
less	O	ADJ	O
than	O	ADP	O
0.0005	O	NUM	O
)	O	PUNCT	O
decreased	O	VERB	B
in	O	ADP	O
the	O	DET	O
PIH	O	NOUN	B
group	O	NOUN	B
(	O	PUNCT	O
148	O	NUM	O
+/-	O	CCONJ	O
9	O	NUM	O
binding	O	VERB	B
sites/cell	O	NOUN	I
)	O	PUNCT	O
compared	O	VERB	B
with	O	ADP	O
the	O	DET	O
control	O	NOUN	B
group	O	NOUN	I
(	O	PUNCT	O
300	O	NUM	O
+/-	O	CCONJ	O
17	O	NUM	O
binding	O	VERB	B
sites/cell	O	NOUN	I
;	O	PUNCT	O
mean	O	NOUN	O
+/-	O	CCONJ	O
SEM	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Plasma	O	NOUN	B
aldosterone	O	NOUN	B
in	O	ADP	O
women	O	NOUN	B
with	O	ADP	O
PIH	O	NOUN	B
was	O	AUX	O
281	O	NUM	O
+/-	O	CCONJ	O
61	O	NUM	O
pmol/L	O	NOUN	O
;	O	PUNCT	O
in	O	ADP	O
normal	O	ADJ	O
pregnant	O	ADJ	B
women	O	NOUN	I
it	O	PRON	O
was	O	AUX	O
697	O	NUM	O
+/-	O	CCONJ	O
172	O	NUM	O
pmol/L	O	NOUN	O
(	O	PUNCT	O
P	O	NOUN	O
less	O	ADJ	O
than	O	ADP	O
0.025	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
differentiating	O	VERB	O
effects	O	NOUN	B
of	O	ADP	O
the	O	DET	O
other	O	ADJ	O
C-11	O	NOUN	B
analogs	O	NOUN	I
on	O	ADP	O
human	B-cell_line	ADJ	B
promyeloid	I-cell_line	ADJ	O
leukemia	I-cell_line	NOUN	O
cells	I-cell_line	NOUN	O
(	O	PUNCT	O
HL-60	B-cell_line	NOUN	B
)	O	PUNCT	O
agreed	O	VERB	O
well	O	ADV	O
with	O	ADP	O
their	O	PRON	O
bone-resorbing	O	ADJ	B
activity	O	NOUN	I
and	O	CCONJ	O
receptor	O	NOUN	B
affinity	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
they	O	PRON	O
demonstrated	O	VERB	O
lower	O	ADJ	O
calcemic	O	ADJ	B
effects	O	NOUN	O
in	O	X	B
vivo	O	X	I
.	O	PUNCT	O


Initial	O	ADJ	B
and	O	CCONJ	O
post-dexamethasone	O	ADJ	B
in	O	X	B
vitro	O	X	I
fibroblast	O	NOUN	B
binding	O	NOUN	I
to	O	PART	O
glucocorticoid	O	NOUN	B
was	O	AUX	O
not	O	PART	O
different	O	ADJ	O
between	O	ADP	O
major	O	ADJ	O
depressive	O	ADJ	B
disorder	O	NOUN	I
and	O	CCONJ	O
non-depressed	O	ADJ	B
control	O	ADJ	I
subjects	O	NOUN	I
.	O	PUNCT	O


High	O	ADJ	O
affinity	O	NOUN	O
aldosterone	O	NOUN	O
binding	O	VERB	O
to	O	PART	O
plasma	O	NOUN	B
membrane	O	NOUN	I
rich	O	ADJ	O
fractions	O	NOUN	B
from	O	ADP	O
mononuclear	B-cell_type	ADJ	B
leukocytes	I-cell_type	NOUN	B
:	O	PUNCT	O
is	O	AUX	O
there	O	PRON	O
a	O	DET	O
membrane	B-protein	NOUN	B
receptor	I-protein	NOUN	I
for	O	ADP	O
mineralocorticoids	O	NOUN	B
?	O	PUNCT	O


High	O	ADJ	O
affinity	O	NOUN	B
binding	O	NOUN	I
of	O	ADP	O
the	O	DET	O
radioligand	O	NOUN	B
with	O	ADP	O
an	O	DET	O
apparent	O	ADJ	B
Kd	O	NOUN	O
of	O	ADP	O
approximately	O	ADV	B
0.1	O	NUM	O
nM	O	NOUN	O
was	O	AUX	O
found	O	VERB	O
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
are	O	AUX	O
perfectly	O	ADV	O
compatible	O	ADJ	O
with	O	ADP	O
major	O	ADJ	O
properties	O	NOUN	B
of	O	ADP	O
steroidal	O	ADJ	B
effects	O	NOUN	O
on	O	ADP	O
the	O	DET	O
sodium-proton-antiport	B-protein	NOUN	B
in	O	ADP	O
HML	B-cell_type	NOUN	B
and	O	CCONJ	O
thus	O	ADV	O
very	O	ADV	O
likely	O	ADV	O
represent	O	VERB	O
membrane	B-protein	NOUN	B
receptors	I-protein	NOUN	I
for	O	ADP	O
aldosterone	O	NOUN	B
.	O	PUNCT	O


Natural	O	ADJ	B
variants	O	NOUN	I
of	O	ADP	O
the	O	DET	O
HIV-1	B-DNA	NOUN	B
long	I-DNA	ADJ	B
terminal	I-DNA	ADJ	I
repeat	I-DNA	NOUN	I
:	O	PUNCT	O
analysis	O	NOUN	B
of	O	ADP	O
promoters	B-DNA	NOUN	B
with	O	ADP	O
duplicated	O	ADJ	B
DNA	B-DNA	NOUN	B
regulatory	I-DNA	ADJ	I
motifs	I-DNA	NOUN	O
.	O	PUNCT	O


Cell	O	NOUN	B
culture	O	NOUN	I
experiments	O	NOUN	I
demonstrated	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
natural	O	ADJ	B
variant	O	NOUN	O
with	O	ADP	O
four	O	NUM	O
Sp1	B-DNA	NOUN	B
sites	I-DNA	NOUN	B
had	O	AUX	O
a	O	DET	O
slightly	O	ADV	O
higher	O	ADJ	O
promoter	O	NOUN	B
activity	O	NOUN	I
and	O	CCONJ	O
viral	O	ADJ	B
replication	O	NOUN	I
rate	O	NOUN	B
than	O	ADP	O
the	O	DET	O
isogenic	B-DNA	ADJ	B
control	I-DNA	NOUN	I
LTR	I-DNA	NOUN	B
with	O	ADP	O
three	O	NUM	O
Sp1	B-DNA	NOUN	B
sites	I-DNA	NOUN	B
.	O	PUNCT	O


The	O	DET	O
helix-loop-helix	B-protein	ADJ	B
(	I-protein	PUNCT	O
HLH	I-protein	ADJ	O
)	I-protein	PUNCT	O
proteins	I-protein	NOUN	O
are	O	AUX	O
a	O	DET	O
family	O	NOUN	B
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
that	O	PRON	O
include	O	VERB	O
proteins	O	NOUN	B
critical	O	ADJ	O
to	O	PART	O
differentiation	O	NOUN	B
and	O	CCONJ	O
development	O	NOUN	B
in	O	ADP	O
species	O	NOUN	B
ranging	O	VERB	O
from	O	ADP	O
plants	O	NOUN	B
to	O	ADP	O
mammals	O	NOUN	B
.	O	PUNCT	O


To	O	PART	O
address	O	VERB	O
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
Oct-2	B-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
T-cell	B-cell_type	NOUN	B
lineage	I-cell_type	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
studied	O	VERB	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
Oct-2	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
and	O	CCONJ	O
protein	O	NOUN	B
in	O	ADP	O
nontransformed	B-cell_line	ADJ	B
human	I-cell_line	ADJ	B
and	I-cell_line	CCONJ	O
mouse	I-cell_line	NOUN	B
T	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


The	O	DET	O
GR	B-protein	NOUN	B
in	O	ADP	O
peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
leukocytes	I-cell_type	NOUN	B
in	O	ADP	O
aged	O	ADJ	B
runner	O	NOUN	B
was	O	AUX	O
65	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
the	O	DET	O
control	O	NOUN	B
.	O	PUNCT	O


MR	B-protein	NOUN	B
were	O	AUX	O
reduced	O	VERB	B
before	O	ADP	O
delivery	O	NOUN	B
(	O	PUNCT	O
96	O	NUM	O
+/-	O	CCONJ	O
27	O	NUM	O
receptors/cell	O	NOUN	O
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
SPD	O	NOUN	B
increased	O	VERB	B
(	O	PUNCT	O
64	O	NUM	O
+/-	O	CCONJ	O
8	O	NUM	O
mV	O	NOUN	O
)	O	PUNCT	O
,	O	PUNCT	O
with	O	ADP	O
both	O	DET	O
parameters	O	NOUN	B
normalizing	O	VERB	B
after	O	ADP	O
delivery	O	NOUN	B
(	O	PUNCT	O
MR	B-protein	PROPN	B
,	O	PUNCT	O
242	O	NUM	O
+/-	O	CCONJ	O
79	O	NUM	O
;	O	PUNCT	O
SPD	O	NOUN	B
,	O	PUNCT	O
14.0	O	NUM	O
+/-	O	CCONJ	O
4	O	NUM	O
mV	O	NOUN	O
)	O	PUNCT	O
.	O	PUNCT	O


Kinetics	O	NOUN	B
of	O	ADP	O
nuclear	O	ADJ	B
translocation	O	NOUN	I
and	O	CCONJ	O
turnover	O	NOUN	B
of	O	ADP	O
the	O	DET	O
vitamin	B-protein	NOUN	B
D	I-protein	NOUN	I
receptor	I-protein	NOUN	I
in	O	ADP	O
human	B-cell_line	ADJ	B
HL60	I-cell_line	NOUN	B
leukemia	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	B
and	O	CCONJ	O
peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
lymphocytes	I-cell_type	NOUN	I
--	O	PUNCT	O
coincident	O	ADJ	B
rise	O	NOUN	O
of	O	ADP	O
DNA-relaxing	O	ADJ	B
activity	O	NOUN	B
in	O	ADP	O
nuclear	O	ADJ	B
extracts	O	NOUN	I
.	O	PUNCT	O


Specific	O	ADJ	O
nuclear	O	ADJ	B
translocation	O	NOUN	B
of	O	ADP	O
[	B-protein	PUNCT	O
3H	I-protein	NOUN	B
]	I-protein	PUNCT	O
calcitriol/VDR	I-protein	NOUN	O
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
be	O	AUX	O
time	O	NOUN	B
dependent	O	ADJ	I
reaching	O	VERB	O
a	O	DET	O
maximum	O	NOUN	B
of	O	ADP	O
approximately	O	ADV	B
2100	O	NUM	O
binding	O	VERB	O
sites/nucleus	O	NOUN	O
after	O	ADP	O
3	O	NUM	O
h	O	NOUN	O
of	O	ADP	O
incubation	O	NOUN	B
in	O	ADP	O
HL60	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
whereas	O	SCONJ	O
a	O	DET	O
maximum	O	NOUN	B
of	O	ADP	O
approximately	O	ADV	O
310	O	NUM	O
binding	O	VERB	B
sites/nucleus	O	NOUN	I
was	O	AUX	O
found	O	VERB	O
after	O	ADP	O
3	O	NUM	O
h	O	NOUN	O
in	O	ADP	O
PBL	B-cell_type	NOUN	B
.	O	PUNCT	O


The	O	DET	O
enhanced	O	VERB	B
activity	O	NOUN	B
disappeared	O	VERB	O
after	O	ADP	O
2	O	NUM	O
h	O	NOUN	O
in	O	ADP	O
PBL	B-cell_type	NOUN	B
,	O	PUNCT	O
whereas	O	SCONJ	O
it	O	PRON	O
was	O	AUX	O
still	O	ADV	O
enhanced	O	VERB	B
by	O	ADP	O
4	O	NUM	O
h	O	NOUN	O
in	O	ADP	O
HL60	B-cell_line	NOUN	B
.	O	PUNCT	O


Enhanced	O	VERB	B
activity	O	NOUN	B
of	O	ADP	O
topoisomerases	B-protein	NOUN	B
in	O	ADP	O
nuclear	O	ADJ	B
extracts	O	NOUN	I
upon	O	SCONJ	O
translocation	O	NOUN	B
of	O	ADP	O
VDR	B-protein	NOUN	B
might	O	AUX	O
reflect	O	VERB	O
interaction	O	NOUN	B
of	O	ADP	O
both	O	DET	O
within	O	ADP	O
the	O	DET	O
nuclear	O	ADJ	B
compartment	O	NOUN	I
,	O	PUNCT	O
thus	O	ADV	O
initiating	O	VERB	O
DNA-unwinding	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
prerequisite	O	NOUN	O
of	O	ADP	O
transcription	O	NOUN	B
initiation	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
design	O	NOUN	B
of	O	ADP	O
combination	O	NOUN	B
hormonal	O	ADJ	B
and	O	CCONJ	O
immunotherapeutic	O	ADJ	B
protocols	O	NOUN	I
for	O	ADP	O
breast	O	NOUN	B
cancer	O	NOUN	I
patients	O	NOUN	B
may	O	AUX	O
be	O	AUX	O
facilitated	O	VERB	O
by	O	ADP	O
analysis	O	NOUN	B
of	O	ADP	O
preclinical	O	ADJ	B
in	O	X	B
vitro	O	X	I
model	O	NOUN	B
systems	O	NOUN	I
.	O	PUNCT	O


Estrogen	B-cell_line	NOUN	B
receptor	I-cell_line	NOUN	I
positive	I-cell_line	ADJ	I
(	I-cell_line	PUNCT	O
ER+	I-cell_line	ADJ	B
:	I-cell_line	PUNCT	O
MCF-7	I-cell_line	NOUN	B
)	I-cell_line	PUNCT	O
and	I-cell_line	CCONJ	O
negative	I-cell_line	ADJ	B
(	I-cell_line	PUNCT	O
ER-	I-cell_line	ADJ	B
:	I-cell_line	PUNCT	O
MDA-MB-231	I-cell_line	NOUN	B
)	I-cell_line	PUNCT	O
human	I-cell_line	ADJ	B
breast	I-cell_line	NOUN	O
cancer	I-cell_line	NOUN	O
cell	I-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
were	O	AUX	O
utilized	O	VERB	O
to	O	PART	O
evaluate	O	VERB	B
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	I
tamoxifen	O	NOUN	B
(	O	PUNCT	O
TAM	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
estradiol	O	NOUN	B
(	O	PUNCT	O
E2	O	NOUN	B
)	O	PUNCT	O
on	O	ADP	O
modulation	O	NOUN	B
of	O	ADP	O
breast	O	NOUN	B
cancer	O	NOUN	I
target	O	NOUN	B
susceptibility	O	NOUN	B
to	O	PART	O
lysis	O	NOUN	B
by	O	ADP	O
lymphokine-activated	B-cell_type	ADJ	B
killer	I-cell_type	NOUN	I
(	I-cell_type	PUNCT	O
LAK	I-cell_type	NOUN	B
)	I-cell_type	PUNCT	O
cells	I-cell_type	NOUN	O
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
c-myb	B-protein	NOUN	B
proto-oncogene	I-protein	NOUN	I
product	I-protein	NOUN	O
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
itself	O	PRON	O
a	O	DET	O
DNA-binding	B-protein	ADJ	B
protein	I-protein	NOUN	I
and	O	CCONJ	O
transcriptional	B-protein	ADJ	B
transactivator	I-protein	NOUN	I
,	O	PUNCT	O
can	O	AUX	O
interact	O	VERB	B
synergistically	O	ADV	B
with	O	ADP	I
Z	B-protein	NOUN	B
in	O	ADP	O
activating	O	VERB	B
the	O	DET	O
BMRF1	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
in	O	ADP	O
Jurkat	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
(	O	PUNCT	O
a	O	DET	O
T-cell	B-cell_line	NOUN	B
line	I-cell_line	NOUN	I
)	O	PUNCT	O
or	O	CCONJ	O
Raji	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
(	O	PUNCT	O
an	O	DET	O
EBV-positive	B-cell_line	ADJ	B
B-cell	I-cell_line	NOUN	I
)	O	PUNCT	O
,	O	PUNCT	O
whereas	O	SCONJ	O
the	O	DET	O
c-myb	B-protein	NOUN	B
gene	I-protein	NOUN	I
product	I-protein	NOUN	O
by	O	ADP	O
itself	O	PRON	O
has	O	AUX	O
little	O	ADJ	O
effect	O	NOUN	B
.	O	PUNCT	O


Reticuloendotheliosis	B-DNA	NOUN	B
virus	I-DNA	NOUN	I
long	I-DNA	ADJ	B
terminal	I-DNA	ADJ	I
repeat	I-DNA	NOUN	I
elements	I-DNA	NOUN	I
are	O	AUX	O
efficient	O	ADJ	B
promoters	B-DNA	NOUN	B
in	O	ADP	O
cells	O	NOUN	B
of	O	ADP	O
various	O	ADJ	O
species	O	NOUN	B
and	O	CCONJ	O
tissue	O	NOUN	B
origin	O	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
human	B-cell_type	ADJ	B
lymphoid	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


The	O	DET	O
latent	O	ADJ	B
phases	O	NOUN	O
of	O	ADP	O
both	O	CCONJ	O
HIV-1	O	NOUN	B
and	O	CCONJ	O
HIV-2	O	NOUN	B
infection	O	NOUN	I
have	O	AUX	O
been	O	AUX	O
shown	O	VERB	O
to	O	PART	O
be	O	AUX	O
disrupted	O	VERB	B
by	O	ADP	O
T-cell	O	NOUN	B
activation	O	NOUN	I
,	O	PUNCT	O
a	O	DET	O
process	O	NOUN	B
that	O	PRON	O
requires	O	VERB	O
host	O	NOUN	B
cell	O	NOUN	B
transcription	O	NOUN	I
factors	O	NOUN	I
.	O	PUNCT	O


Mutagenesis	O	NOUN	B
experiments	O	NOUN	B
demonstrated	O	VERB	O
that	O	SCONJ	O
these	O	DET	O
Elf-1	B-DNA	NOUN	B
binding	I-DNA	NOUN	I
sites	I-DNA	NOUN	I
are	O	AUX	O
required	O	VERB	O
for	O	ADP	O
induction	O	NOUN	B
of	O	ADP	O
HIV-2	O	NOUN	B
transcription	O	NOUN	B
following	O	VERB	O
T-cell-receptor-mediated	O	ADJ	B
T-cell	O	NOUN	I
activation	O	NOUN	O
.	O	PUNCT	O


Moreover	O	ADV	O
,	O	PUNCT	O
Elf-1	B-protein	NOUN	B
is	O	AUX	O
the	O	DET	O
only	O	ADJ	O
factor	O	NOUN	B
present	O	ADJ	O
in	O	ADP	O
activated	O	VERB	B
T-cell	O	NOUN	O
nuclear	O	ADJ	O
extracts	O	NOUN	O
that	O	PRON	O
binds	O	VERB	B
to	O	PART	O
these	O	DET	O
sites	O	NOUN	B
in	O	ADP	O
electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assays	O	NOUN	I
.	O	PUNCT	O


Okadaic	O	ADJ	B
acid	O	NOUN	I
is	O	AUX	O
a	O	DET	O
potent	O	ADJ	O
inducer	O	NOUN	B
of	O	ADP	O
AP-1	B-protein	NOUN	B
,	O	PUNCT	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor-alpha	I-protein	NOUN	I
in	O	ADP	O
human	B-cell_type	ADJ	B
B	I-cell_type	NOUN	O
lymphocytes	I-cell_type	NOUN	O
.	O	PUNCT	O


c-myc	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
minor	O	ADJ	O
salivary	O	ADJ	B
glands	O	NOUN	I
of	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
Sjogren	O	NOUN	B
's	O	PART	I
syndrome	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
study	O	NOUN	B
,	O	PUNCT	O
c-myc	B-RNA	NOUN	B
protooncogene	I-RNA	NOUN	I
mRNA	I-RNA	NOUN	B
expression	O	NOUN	O
in	O	ADP	O
29	O	NUM	O
labial	O	ADJ	B
minor	O	ADJ	O
salivary	O	ADJ	O
gland	O	NOUN	O
biopsies	O	NOUN	B
from	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
primary	O	ADJ	O
SS	O	NOUN	B
and	O	CCONJ	O
15	O	NUM	O
controls	O	NOUN	B
was	O	AUX	O
examined	O	VERB	O
using	O	VERB	O
in	O	X	B
situ	O	X	I
hybridization	O	NOUN	I
histochemistry	O	NOUN	I
.	O	PUNCT	O


All	O	DET	O
of	O	ADP	O
the	O	DET	O
parameters	O	NOUN	B
were	O	AUX	O
also	O	ADV	O
tested	O	VERB	B
for	O	ADP	O
correlation	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
significant	O	ADJ	O
inverse	O	ADJ	B
correlation	O	NOUN	B
was	O	AUX	O
found	O	VERB	O
between	O	ADP	O
age	O	NOUN	B
and	O	CCONJ	O
type	B-protein	NOUN	B
I	I-protein	NUM	I
and	O	CCONJ	O
type	B-protein	NOUN	B
II	I-protein	NUM	I
receptors	I-protein	NOUN	I
when	O	SCONJ	O
all	O	DET	O
subjects	O	NOUN	B
were	O	AUX	O
plotted	O	VERB	B
and	O	CCONJ	O
between	O	ADP	O
aged	O	ADJ	B
and	O	CCONJ	O
CD4	B-cell_type	NOUN	B
and	O	CCONJ	O
age	O	NOUN	B
and	O	CCONJ	O
CD4/CD8	B-cell_type	NOUN	B
in	O	ADP	O
the	O	DET	O
aged	O	ADJ	B
group	O	NOUN	I
.	O	PUNCT	O


Transcriptional	O	ADJ	B
regulation	O	NOUN	I
during	O	ADP	O
T-cell	B-cell_type	NOUN	B
development	O	NOUN	I
:	O	PUNCT	O
the	O	DET	O
alpha	B-DNA	NOUN	B
TCR	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
as	O	ADP	O
a	O	DET	O
molecular	O	ADJ	B
model	O	NOUN	I
.	O	PUNCT	O


Sodium	O	NOUN	B
dodecyl	O	NOUN	I
sulfate-polyacrylamide	O	ADJ	I
gel	O	NOUN	I
electrophoresis	O	NOUN	I
showed	O	VERB	O
significant	O	ADJ	O
aldosterone	O	NOUN	B
binding	O	NOUN	I
at	O	ADP	O
a	O	DET	O
molecular	O	ADJ	B
weight	O	NOUN	I
of	O	ADP	O
approximately	O	ADV	O
50000	O	NUM	O
Dalton	O	NOUN	B
which	O	DET	O
was	O	AUX	O
absent	O	ADJ	B
with	O	ADP	O
1	O	NUM	O
microM	O	NOUN	O
cold	O	ADJ	B
aldosterone	O	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
cortisol	O	NOUN	B
in	O	ADP	O
the	O	DET	O
binding	O	VERB	B
media	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
product	O	NOUN	B
of	O	ADP	O
the	O	DET	O
proto-oncogene	B-DNA	NOUN	B
c-rel	I-DNA	NOUN	I
can	O	AUX	O
bind	O	VERB	B
to	O	PART	O
similar	O	ADJ	O
DNA	O	NOUN	B
motifs	O	NOUN	I
by	O	ADP	O
itself	O	PRON	O
or	O	CCONJ	O
as	O	ADP	O
a	O	DET	O
heterodimer	O	NOUN	B
with	O	ADP	O
p50	B-protein	NOUN	B
or	O	CCONJ	O
p65	B-protein	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
these	O	DET	O
studies	O	NOUN	B
have	O	AUX	O
used	O	VERB	O
a	O	DET	O
limited	O	ADJ	O
number	O	NOUN	O
of	O	ADP	O
known	O	VERB	O
kappa	O	NOUN	O
B	O	NOUN	O
DNA	O	NOUN	O
motifs	O	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
question	O	NOUN	O
of	O	ADP	O
the	O	DET	O
optimal	O	ADJ	B
DNA	O	NOUN	B
sequences	O	NOUN	I
preferred	O	VERB	O
by	O	ADP	O
each	O	DET	O
homodimer	O	NOUN	B
has	O	AUX	O
not	O	PART	O
been	O	AUX	O
addressed	O	VERB	O
.	O	PUNCT	O


NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
-dependent	O	ADJ	O
induction	O	NOUN	B
of	O	ADP	O
the	O	DET	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
p50	B-DNA	NOUN	I
subunit	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
promoter	I-DNA	NOUN	O
underlies	O	VERB	O
self-perpetuation	O	NOUN	B
of	O	ADP	O
human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
transcription	O	NOUN	B
in	O	ADP	O
monocytic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Analysis	O	NOUN	B
of	O	ADP	O
cytosolic	O	ADJ	B
extracts	O	NOUN	I
indicated	O	VERB	O
that	O	SCONJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
levels	O	NOUN	B
were	O	AUX	O
increased	O	VERB	B
in	O	ADP	O
HIV-infected	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
to	O	PART	O
the	O	DET	O
transient	O	ADJ	B
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activation	O	NOUN	B
induced	O	VERB	B
by	O	ADP	O
phorbol	O	NOUN	B
ester	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
permanent	O	ADJ	B
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
translocation	O	NOUN	B
induced	O	VERB	B
by	O	ADP	O
HIV	O	NOUN	B
infection	O	NOUN	I
was	O	AUX	O
not	O	PART	O
dependent	O	ADJ	O
on	O	ADP	O
PKC	B-protein	NOUN	B
isoenzymes	I-protein	NOUN	B
alpha	I-protein	NOUN	B
and	I-protein	CCONJ	O
beta	I-protein	NOUN	B
as	O	ADP	O
shown	O	VERB	O
by	O	ADP	O
the	O	DET	O
use	O	NOUN	O
of	O	ADP	O
a	O	DET	O
specific	O	ADJ	O
inhibitor	O	NOUN	B
(	O	PUNCT	O
GF	O	NOUN	B
109203X	O	NOUN	O
)	O	PUNCT	O
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
IL-2	B-protein	NOUN	B
is	O	AUX	O
capable	O	ADJ	O
of	O	ADP	O
increasing	O	VERB	B
transcript	O	NOUN	B
levels	O	NOUN	B
of	O	ADP	O
the	O	DET	O
p50	B-protein	NOUN	B
gene	O	NOUN	I
coding	O	VERB	O
for	O	ADP	O
the	O	DET	O
p50	B-protein	NOUN	B
subunit	I-protein	NOUN	I
of	O	ADP	O
the	O	DET	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
transcription	O	NOUN	I
factor	O	NOUN	I
,	O	PUNCT	O
whereas	O	SCONJ	O
mRNA	O	NOUN	B
levels	O	NOUN	B
of	O	ADP	O
the	O	DET	O
p65	B-protein	NOUN	B
NF-kappa	B-DNA	NOUN	I
B	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
remained	O	VERB	O
unchanged	O	ADJ	B
.	O	PUNCT	O


Thyroid	O	NOUN	B
hormones	O	NOUN	I
inhibit	O	VERB	B
[	O	PUNCT	O
3H	O	NOUN	B
]	O	PUNCT	O
glycosaminoglycan	O	NOUN	B
synthesis	O	NOUN	I
by	O	ADP	O
cultured	B-cell_line	VERB	B
human	I-cell_line	ADJ	B
dermal	I-cell_line	ADJ	B
fibroblasts	I-cell_line	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
T3SO4	O	NOUN	B
displayed	O	VERB	O
about	O	ADV	O
0.5	O	NUM	O
%	O	NOUN	O
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
T3	O	NOUN	B
at	O	ADP	O
72	O	NUM	O
h	O	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
studied	O	VERB	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
AP-1	B-protein	NOUN	B
activity	O	NOUN	I
in	O	ADP	O
human	B-cell_type	ADJ	B
peripheral	I-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
T	I-cell_type	NOUN	I
lymphocytes	I-cell_type	NOUN	I
stimulated	O	VERB	B
through	O	ADP	O
the	O	DET	O
activation	O	NOUN	B
inducer	O	NOUN	O
molecule	O	NOUN	O
(	O	PUNCT	O
AIM	O	NOUN	B
)	O	PUNCT	O
/	O	SYM	O
CD69	B-protein	NOUN	B
activation	O	NOUN	B
pathway	O	NOUN	I
.	O	PUNCT	O


Gangliosides	O	NOUN	B
suppress	O	VERB	B
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor	I-protein	NOUN	I
production	O	NOUN	I
in	O	ADP	O
human	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


On	O	ADP	O
the	O	DET	O
other	O	ADJ	O
hand	O	NOUN	B
,	O	PUNCT	O
phorbol	O	NOUN	B
ester-induced	O	ADJ	B
production	O	NOUN	B
of	O	ADP	O
O2-	O	NOUN	B
was	O	AUX	O
similar	O	ADJ	O
in	O	ADP	O
cells	O	NOUN	B
treated	O	VERB	B
with	O	ADP	I
and	O	CCONJ	O
without	O	ADP	O
gangliosides	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
vitro-translated	B-protein	ADJ	B
proteins	I-protein	NOUN	I
,	O	PUNCT	O
truncated	O	VERB	B
downstream	O	ADV	I
of	O	ADP	O
the	O	DET	O
Rel	B-DNA	NOUN	B
domain	I-DNA	NOUN	I
and	O	CCONJ	O
excluding	O	VERB	O
the	O	DET	O
repeats	O	NOUN	B
,	O	PUNCT	O
bind	O	VERB	B
kappa	B-DNA	NOUN	I
B	I-DNA	NOUN	I
sites	I-DNA	NOUN	O
.	O	PUNCT	O


Transient-transfection	O	ADJ	B
experiments	O	NOUN	O
in	O	ADP	O
embryonal	B-cell_line	ADJ	B
carcinoma	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	B
demonstrate	O	VERB	O
a	O	DET	O
functional	O	ADJ	B
cooperation	O	NOUN	B
between	O	ADP	O
p50B	B-protein	NOUN	B
and	O	CCONJ	O
RelB	B-protein	NOUN	B
or	O	CCONJ	O
p65	B-protein	NOUN	B
in	O	ADP	O
transactivation	O	NOUN	B
of	O	ADP	O
a	O	DET	O
reporter	B-DNA	NOUN	B
plasmid	I-DNA	NOUN	I
dependent	O	ADJ	B
on	O	ADP	O
a	O	DET	O
kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
site	I-DNA	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
investigated	O	VERB	B
whether	O	SCONJ	O
a	O	DET	O
palmitate	B-protein	NOUN	B
conjugate	I-protein	NOUN	I
of	O	ADP	O
a	O	DET	O
human	B-protein	ADJ	B
monoclonal	I-protein	ADJ	B
antibody	I-protein	NOUN	I
specific	O	ADJ	O
for	O	ADP	O
thyroglobulin	B-protein	NOUN	B
(	O	PUNCT	O
TG	B-protein	NOUN	B
)	O	PUNCT	O
could	O	AUX	O
function	O	VERB	B
as	O	ADP	O
a	O	DET	O
surrogate	B-protein	ADJ	B
TG	I-protein	NOUN	B
receptor	I-protein	NOUN	I
on	O	ADP	O
blood	B-cell_type	NOUN	B
mononuclear	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
separated	O	VERB	O
into	O	ADP	O
fractions	O	NOUN	B
enriched	O	VERB	O
for	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
or	O	CCONJ	O
depleted	O	VERB	B
of	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
(	O	PUNCT	O
non-T	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


v-Fos	B-protein	NOUN	B
protein	I-protein	NOUN	I
,	O	PUNCT	O
the	O	DET	O
retroviral	O	ADJ	B
counterpart	O	NOUN	I
of	O	ADP	O
c-Fos	B-protein	NOUN	B
,	O	PUNCT	O
was	O	AUX	O
not	O	PART	O
susceptible	O	ADJ	B
to	O	PART	O
degradation	O	NOUN	B
targeted	O	VERB	B
by	O	ADP	O
c-Jun	B-protein	NOUN	B
.	O	PUNCT	O


These	O	DET	O
AP-2	B-DNA	NOUN	B
and	O	CCONJ	O
AP-1	B-DNA	NOUN	B
sites	I-DNA	NOUN	I
were	O	AUX	O
each	O	DET	O
modified	O	VERB	B
with	O	ADP	O
a	O	DET	O
double	O	ADJ	B
point	O	NOUN	I
mutation	O	NOUN	I
.	O	PUNCT	O


While	O	SCONJ	O
all	O	DET	O
the	O	DET	O
M10-expressing	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
remained	O	VERB	O
infectable	O	ADJ	B
by	O	ADP	O
HIV-1	O	NOUN	B
,	O	PUNCT	O
these	O	DET	O
same	O	ADJ	O
cells	O	NOUN	B
failed	O	VERB	B
to	O	PART	O
support	O	VERB	O
a	O	DET	O
productive	O	ADJ	O
replication	O	NOUN	B
cycle	O	NOUN	I
when	O	SCONJ	O
infected	O	VERB	B
with	O	ADP	O
a	O	DET	O
cloned	O	VERB	B
isolate	O	NOUN	B
of	O	ADP	O
HIV-1	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
two	O	NUM	O
out	O	ADP	O
of	O	ADP	O
three	O	NUM	O
M10-expressing	B-cell_line	ADJ	B
CEM	I-cell_line	NOUN	I
clones	I-cell_line	NOUN	B
were	O	AUX	O
also	O	ADV	O
resistant	O	ADJ	B
to	O	PART	O
highly	O	ADV	O
productive	O	ADJ	O
infection	O	NOUN	O
by	O	ADP	O
a	O	DET	O
heterogeneous	O	ADJ	B
HIV-1	O	NOUN	B
pool	O	NOUN	B
.	O	PUNCT	O


Expression	O	NOUN	B
of	O	ADP	O
M10	B-protein	NOUN	B
did	O	AUX	O
not	O	PART	O
affect	O	VERB	O
induction	O	NOUN	B
of	O	ADP	O
HIV	O	NOUN	B
transcription	O	NOUN	B
mediated	O	VERB	O
by	O	ADP	O
the	O	DET	O
kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
regulatory	I-DNA	ADJ	I
element	I-DNA	NOUN	I
or	O	CCONJ	O
Tat	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
present	O	ADJ	O
work	O	NOUN	O
has	O	AUX	O
examined	O	VERB	O
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	O
okadaic	O	ADJ	B
acid	O	NOUN	I
,	O	PUNCT	O
an	O	DET	O
inhibitor	O	NOUN	B
of	O	ADP	O
type	B-protein	NOUN	O
1	I-protein	NUM	O
and	I-protein	CCONJ	O
2A	I-protein	NOUN	B
protein	I-protein	NOUN	I
phosphatases	I-protein	NOUN	I
,	O	PUNCT	O
on	O	ADP	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
c-jun	B-DNA	NOUN	B
expression	O	NOUN	I
during	O	ADP	O
monocytic	O	ADJ	B
differentiation	O	NOUN	I
of	O	ADP	O
U-937	B-cell_line	NOUN	B
leukemia	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	B
.	O	PUNCT	O


Since	O	SCONJ	O
previous	O	ADJ	O
studies	O	NOUN	B
have	O	AUX	O
demonstrated	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
c-jun	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
is	O	AUX	O
autoinduced	O	VERB	O
by	O	ADP	O
Jun/AP-1	B-protein	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
also	O	ADV	O
studied	O	VERB	O
transcription	O	NOUN	B
of	O	ADP	O
c-jun	B-DNA	NOUN	B
promoter	I-DNA	NOUN	I
(	I-DNA	PUNCT	O
positions	I-DNA	NOUN	B
-132/+170	I-DNA	NUM	O
)	I-DNA	PUNCT	O
-reporter	I-DNA	NOUN	O
gene	I-DNA	NOUN	B
constructs	I-DNA	NOUN	I
with	O	ADP	O
and	O	CCONJ	O
without	O	ADP	O
a	O	DET	O
mutated	O	VERB	B
AP-1	B-DNA	NOUN	B
element	I-DNA	NOUN	I
.	O	PUNCT	O


The	O	DET	O
mitogen-induced	O	ADJ	B
increase	O	NOUN	B
of	O	ADP	O
c-Fos	B-protein	NOUN	B
and	O	CCONJ	O
c-Jun	B-protein	NOUN	B
immunoreactivity	O	NOUN	B
was	O	AUX	O
inhibited	O	VERB	B
by	O	ADP	O
H-7	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
kinase	O	NOUN	B
inhibitor	O	NOUN	I
with	O	ADP	O
relatively	O	ADV	O
high	O	ADJ	O
specificity	O	NOUN	B
for	O	ADP	O
PKC	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
less	O	ADV	O
efficiently	O	ADV	B
by	O	ADP	O
H-8	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
structurally	O	ADV	B
related	O	ADJ	O
kinase	O	NOUN	B
inhibitor	O	NOUN	I
less	O	ADV	O
active	O	ADJ	B
on	O	ADP	O
PKC	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
more	O	ADV	O
active	O	ADJ	B
on	O	ADP	O
cyclic	O	ADJ	B
nucleotide-dependent	O	ADJ	B
kinases	O	NOUN	I
.	O	PUNCT	O


An	O	DET	O
11-base-pair	O	ADJ	O
DNA	O	NOUN	B
sequence	O	NOUN	I
motif	O	NOUN	B
apparently	O	ADV	O
unique	O	ADJ	B
to	O	PART	O
the	O	DET	O
human	B-DNA	ADJ	B
interleukin	I-DNA	NOUN	O
4	I-DNA	NUM	O
gene	I-DNA	NOUN	O
confers	O	VERB	O
responsiveness	O	NOUN	B
to	O	PART	O
T-cell	O	NOUN	B
activation	O	NOUN	I
signals	O	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
identified	O	VERB	O
a	O	DET	O
DNA	B-DNA	NOUN	B
segment	I-DNA	NOUN	I
that	O	PRON	O
confers	O	VERB	O
responsiveness	O	NOUN	B
to	O	PART	O
antigen	O	NOUN	B
stimulation	O	NOUN	I
signals	O	NOUN	B
on	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
interleukin	I-DNA	NOUN	I
(	I-DNA	PUNCT	O
IL	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
4	I-DNA	NUM	O
gene	I-DNA	NOUN	B
in	O	ADP	O
Jurkat	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
we	O	PRON	O
looked	O	VERB	O
at	O	ADP	O
the	O	DET	O
modulation	O	NOUN	B
of	O	ADP	O
nuclear	B-protein	ADJ	B
factors	I-protein	NOUN	I
binding	O	VERB	B
specifically	O	ADV	O
to	O	PART	O
the	O	DET	O
AP-1	B-DNA	NOUN	B
element	I-DNA	NOUN	I
after	O	ADP	O
LTB4	O	NOUN	B
stimulation	O	NOUN	B
.	O	PUNCT	O


Nuclear	O	ADJ	B
transcription	O	NOUN	I
studies	O	NOUN	I
in	O	X	B
vitro	O	X	I
showed	O	VERB	O
that	O	SCONJ	O
LTB4	O	NOUN	B
increased	O	VERB	B
the	O	DET	O
transcription	O	NOUN	B
of	O	ADP	O
the	O	DET	O
c-fos	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
7-fold	O	ADV	O
and	O	CCONJ	O
the	O	DET	O
c-jun	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
1.4-fold	O	ADV	O
.	O	PUNCT	O


Resting	B-cell_type	VERB	B
monocytes	I-cell_type	NOUN	B
contained	O	VERB	O
nuclear	B-protein	ADJ	B
factors	I-protein	NOUN	I
binding	O	VERB	B
to	O	PART	O
the	O	DET	O
AP-1	B-DNA	NOUN	B
element	I-DNA	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
stimulation	O	NOUN	B
of	O	ADP	O
monocytes	B-cell_type	NOUN	B
with	O	ADP	O
LTB4	O	NOUN	B
induced	O	VERB	B
greater	O	ADJ	O
AP-1	B-protein	NOUN	B
-binding	O	ADJ	O
activity	O	NOUN	B
of	O	ADP	O
nuclear	B-protein	ADJ	B
proteins	I-protein	NOUN	I
.	O	PUNCT	O


Retinoic	O	ADJ	B
acid	O	NOUN	I
(	O	PUNCT	O
RA	O	NOUN	B
)	O	PUNCT	O
distinctly	O	ADV	O
modulated	O	VERB	B
the	O	DET	O
erythroid	O	ADJ	B
differentiation	O	NOUN	I
program	O	NOUN	I
of	O	ADP	O
normal	B-cell_type	ADJ	O
erythroid	I-cell_type	ADJ	B
progenitors	I-cell_type	NOUN	B
and	O	CCONJ	O
erythroblasts	O	NOUN	B
reversibly	O	ADV	O
transformed	O	VERB	O
by	O	ADP	O
a	O	DET	O
conditional	O	ADJ	B
tyrosine	B-DNA	NOUN	B
kinase	I-DNA	NOUN	I
oncogene	I-DNA	NOUN	I
.	O	PUNCT	O


Expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
human	B-protein	ADJ	B
RAR-alpha	I-protein	NOUN	B
in	O	ADP	O
receptor-negative	B-cell_line	ADJ	B
erythroblasts	I-cell_line	NOUN	I
conferred	O	VERB	O
RA-induced	O	ADJ	B
regulation	O	NOUN	O
of	O	ADP	O
differentiation	O	NOUN	B
to	O	ADP	O
the	O	DET	O
otherwise	O	ADV	O
unresponsive	B-cell_type	ADJ	O
cells	I-cell_type	NOUN	B
,	O	PUNCT	O
thus	O	ADV	O
showing	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
RAR-alpha	B-protein	NOUN	B
is	O	AUX	O
essential	O	ADJ	O
for	O	ADP	O
the	O	DET	O
RA	O	NOUN	B
effect	O	NOUN	B
.	O	PUNCT	O


GM2	B-DNA	NOUN	B
defines	O	VERB	O
a	O	DET	O
binding	B-DNA	VERB	B
site	I-DNA	NOUN	I
for	O	ADP	O
protein	O	NOUN	B
(	O	PUNCT	O
s	O	NOUN	O
)	O	PUNCT	O
whose	O	DET	O
binding	O	NOUN	B
is	O	AUX	O
inducible	O	ADJ	B
by	O	ADP	O
PMA	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
viral	B-protein	ADJ	B
trans-activators	I-protein	NOUN	I
appear	O	VERB	O
to	O	PART	O
target	O	VERB	B
specific	O	ADJ	O
DNA	B-protein	NOUN	B
binding	I-protein	NOUN	I
protein	I-protein	NOUN	I
such	O	ADJ	O
as	O	ADP	O
NF-kB	B-protein	NOUN	B
and	O	CCONJ	O
Sp1	B-protein	NOUN	B
to	O	PART	O
cis-acting	B-DNA	ADJ	B
DNA	I-DNA	NOUN	I
site	I-DNA	NOUN	I
and	O	CCONJ	O
promote	O	VERB	B
lymphokine	B-DNA	NOUN	B
gene	I-DNA	NOUN	O
expression	O	NOUN	B
without	O	ADP	O
TCR	B-protein	NOUN	B
-mediated	O	ADJ	O
stimulation	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
earlier	O	ADV	O
found	O	VERB	O
that	O	SCONJ	O
in	O	ADP	O
Jurkat	O	NOUN	B
cells	O	NOUN	I
activation	O	NOUN	B
of	O	ADP	O
protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
C	I-protein	NOUN	I
(	O	PUNCT	O
PKC	B-protein	NOUN	B
)	O	PUNCT	O
enhances	O	VERB	B
the	O	DET	O
cyclic	O	ADJ	B
adenosine	O	NOUN	I
monophosphate	O	NOUN	I
(	O	PUNCT	O
cAMP	O	NOUN	B
)	O	PUNCT	O
accumulation	O	NOUN	B
induced	O	VERB	B
by	O	ADP	O
adenosine	O	NOUN	B
receptor	O	NOUN	I
stimulation	O	NOUN	B
or	O	CCONJ	O
activation	O	NOUN	B
of	O	ADP	O
Gs	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
purpose	O	NOUN	O
of	O	ADP	O
these	O	DET	O
studies	O	NOUN	B
was	O	AUX	O
to	O	PART	O
investigate	O	VERB	B
the	O	DET	O
modulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
proliferation	O	NOUN	B
of	O	ADP	O
human	B-cell_type	ADJ	B
T	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
obtained	O	VERB	O
from	O	ADP	O
peripheral	O	ADJ	B
blood	O	NOUN	I
by	O	ADP	O
dexamethasone	O	NOUN	B
(	O	PUNCT	O
DEX	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
isoproterenol	O	NOUN	B
(	O	PUNCT	O
ISO	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
prostaglandin	O	NOUN	B
E2	O	NOUN	I
(	O	PUNCT	O
PGE2	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Although	O	SCONJ	O
DEX	O	NOUN	B
and	O	CCONJ	O
PGE2	O	NOUN	B
were	O	AUX	O
equipotent	O	ADJ	B
in	O	ADP	O
suppressing	O	VERB	B
T-cell	O	NOUN	B
proliferation	O	NOUN	I
,	O	PUNCT	O
ISO	O	NOUN	B
was	O	AUX	O
much	O	ADV	O
less	O	ADV	O
effective	O	ADJ	B
.	O	PUNCT	O


Class	B-cell_line	NOUN	B
II	I-cell_line	NUM	I
antigen	I-cell_line	NOUN	I
expressing	I-cell_line	NOUN	O
T-cell	I-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
maintained	O	VERB	O
contacts	O	NOUN	B
identical	O	ADJ	B
to	O	PART	O
B-cell	B-cell_line	NOUN	B
lines	I-cell_line	NOUN	I
,	O	PUNCT	O
while	O	SCONJ	O
class	B-cell_line	NOUN	B
II-negative	I-cell_line	ADJ	I
T-cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
exhibited	O	VERB	O
no	O	DET	O
interactions	O	NOUN	B
.	O	PUNCT	O


Interferon	B-protein	NOUN	B
gamma	I-protein	NOUN	I
induces	O	VERB	O
class	O	NOUN	B
II	O	NUM	I
expression	O	NOUN	B
in	O	ADP	O
this	O	DET	O
glioblastoma	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
and	O	CCONJ	O
,	O	PUNCT	O
in	O	ADP	O
parallel	O	NOUN	O
,	O	PUNCT	O
up-regulates	O	VERB	B
X1	O	NOUN	B
and	O	CCONJ	O
X2	O	NOUN	O
box	O	NOUN	O
protein-DNA	O	ADJ	O
interactions	O	NOUN	B
,	O	PUNCT	O
while	O	SCONJ	O
all	O	DET	O
other	O	ADJ	O
interactions	O	NOUN	B
remain	O	VERB	O
unchanged	O	ADJ	B
.	O	PUNCT	O


3	O	X	O
.	O	PUNCT	O


This	O	DET	O
modification	O	NOUN	B
of	O	ADP	O
a	O	DET	O
previously	O	ADV	O
described	O	VERB	O
protocol	O	NOUN	B
simplifies	O	VERB	O
and	O	CCONJ	O
reduces	O	VERB	B
laboratory	O	ADJ	B
work	O	NOUN	I
and	O	CCONJ	O
allows	O	VERB	O
assay	O	NOUN	B
reproducibility	O	NOUN	B
to	O	PART	O
be	O	AUX	O
controlled	O	VERB	B
more	O	ADV	O
reliably	O	ADV	O
.	O	PUNCT	O


The	O	DET	O
potential	O	ADJ	B
clinical	O	ADJ	B
usefulness	O	NOUN	I
of	O	ADP	O
these	O	DET	O
CL	O	NOUN	B
assays	O	NOUN	B
was	O	AUX	O
suggested	O	VERB	O
by	O	ADP	O
the	O	DET	O
ability	O	NOUN	O
of	O	ADP	O
both	O	CCONJ	O
monocytes	B-cell_type	NOUN	B
and	O	CCONJ	O
IFN-U937	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
to	O	PART	O
respond	O	VERB	O
to	O	PART	O
red	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
platelets	B-cell_type	NOUN	B
or	O	CCONJ	O
granulocytes	B-cell_type	NOUN	B
sensitized	O	VERB	O
with	O	ADP	O
sera	O	NOUN	B
from	O	ADP	O
pregnant	O	ADJ	B
women	O	NOUN	I
whose	O	DET	O
babies	O	NOUN	B
had	O	AUX	O
either	O	CCONJ	O
haemolytic	O	ADJ	B
disease	O	NOUN	I
of	O	ADP	O
the	O	DET	O
newborn	O	ADJ	B
(	O	PUNCT	O
HDN	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
alloimmune	O	ADJ	B
thrombocytopenia	O	NOUN	I
or	O	CCONJ	O
alloimmune	O	ADJ	B
neutropenia	O	NOUN	I
respectively	O	ADV	O
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
monocytes	B-cell_type	NOUN	B
and	O	CCONJ	O
IFN-U937	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
both	O	DET	O
responded	O	VERB	O
to	O	PART	O
red	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
sensitized	O	VERB	B
with	O	ADP	O
antibodies	B-protein	NOUN	B
against	O	ADP	O
a	O	DET	O
variety	O	NOUN	O
of	O	ADP	O
specificities	O	NOUN	B
of	O	ADP	O
assumed	O	VERB	O
(	O	PUNCT	O
although	O	SCONJ	O
not	O	PART	O
documented	O	VERB	B
)	O	PUNCT	O
clinical	O	ADJ	B
significance	O	NOUN	I
for	O	ADP	O
blood	O	NOUN	B
transfusion	O	NOUN	I
recipients	O	NOUN	B
.	O	PUNCT	O


In	O	X	B
vitro	O	X	I
inhibition	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
expression	O	NOUN	B
by	O	ADP	O
antisense	O	ADJ	B
oligodeoxynucleotides	O	NOUN	I
(	O	PUNCT	O
ODNs	O	NOUN	B
)	O	PUNCT	O
inhibited	O	VERB	B
growth	O	NOUN	B
of	O	ADP	O
these	O	DET	O
culture-adapted	B-cell_line	ADJ	B
Tax-transformed	I-cell_line	ADJ	B
fibroblasts	I-cell_line	NOUN	B
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
an	O	DET	O
HTLV-I-transformed	B-cell_line	ADJ	B
human	I-cell_line	ADJ	B
lymphocyte	I-cell_line	NOUN	O
line	I-cell_line	NOUN	O
.	O	PUNCT	O


This	O	DET	O
includes	O	VERB	O
a	O	DET	O
very	O	ADV	O
low	O	ADJ	O
apparent	O	ADJ	O
dissociation	O	NOUN	O
constant	O	NOUN	O
(	O	PUNCT	O
Kd	O	NOUN	O
)	O	PUNCT	O
of	O	ADP	O
0.1	O	NUM	O
nM	O	NOUN	O
for	O	ADP	O
both	O	CCONJ	O
aldosterone	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
effect	O	NOUN	B
on	O	ADP	O
the	O	DET	O
Na	B-protein	PROPN	B
(	I-protein	PUNCT	O
+	I-protein	CCONJ	O
)	I-protein	PUNCT	O
-H	I-protein	NOUN	O
(	I-protein	PUNCT	O
+	I-protein	CCONJ	O
)	I-protein	PUNCT	O
-antiport	I-protein	NOUN	O
,	O	PUNCT	O
a	O	DET	O
high	O	ADJ	O
turnover	O	NOUN	B
rate	O	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
almost	O	ADV	O
exclusive	O	ADJ	O
binding	O	NOUN	B
selectivity	O	NOUN	B
for	O	ADP	O
aldosterone	O	NOUN	B
.	O	PUNCT	O


Deoxycorticosterone	O	NOUN	B
acetate	O	NOUN	B
had	O	AUX	O
an	O	DET	O
intermediate	O	ADJ	B
activity	O	NOUN	I
with	O	ADP	O
an	O	DET	O
apparent	O	ADJ	B
Kd	O	NOUN	O
of	O	ADP	O
100	O	NUM	O
nM	O	NOUN	O
.	O	PUNCT	O


PLB-985	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	O
represent	O	VERB	O
a	O	DET	O
bipotential	B-cell_line	ADJ	B
myelomonoblastic	I-cell_line	ADJ	O
cell	I-cell_line	NOUN	O
population	I-cell_line	NOUN	O
capable	O	ADJ	O
of	O	ADP	O
either	O	CCONJ	O
granulocytic	O	ADJ	B
or	O	CCONJ	O
monocytic	O	ADJ	B
differentiation	O	NOUN	I
after	O	ADP	O
induction	O	NOUN	B
with	O	ADP	O
appropriate	O	ADJ	O
inducers	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
diurnal	O	ADJ	B
rhythm	O	NOUN	I
of	O	ADP	O
ACTH	O	NOUN	B
and	O	CCONJ	O
cortisol	O	NOUN	B
was	O	AUX	O
intact	O	ADJ	B
,	O	PUNCT	O
albeit	O	SCONJ	O
at	O	ADP	O
an	O	DET	O
elevated	O	ADJ	B
level	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
lowered	O	ADJ	B
affinity	O	NOUN	B
to	O	PART	O
dexamethasone	O	NOUN	B
was	O	AUX	O
found	O	VERB	O
in	O	ADP	O
one	O	NUM	O
female	O	ADJ	B
patient	O	NOUN	B
,	O	PUNCT	O
while	O	SCONJ	O
a	O	DET	O
lowered	O	ADJ	B
number	O	NOUN	O
of	O	ADP	O
receptors	O	NOUN	B
was	O	AUX	O
found	O	VERB	O
in	O	ADP	O
three	O	NUM	O
patients	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
six	O	NUM	O
patients	O	NOUN	B
presented	O	VERB	O
,	O	PUNCT	O
at	O	ADP	O
least	O	ADJ	O
three	O	NUM	O
different	O	ADJ	O
forms	O	NOUN	O
can	O	AUX	O
be	O	AUX	O
recognized	O	VERB	O
.	O	PUNCT	O


The	O	DET	O
work	O	NOUN	O
reviewed	O	VERB	B
in	O	ADP	O
this	O	DET	O
article	O	NOUN	B
separates	O	VERB	O
T	O	NOUN	B
cell	O	NOUN	I
development	O	NOUN	B
into	O	ADP	O
four	O	NUM	O
phases	O	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
profound	O	ADJ	O
T	O	NOUN	B
cell	O	NOUN	I
deficit	O	NOUN	O
of	O	ADP	O
nude	O	ADJ	B
mice	O	NOUN	I
indicates	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
thymus	O	NOUN	B
is	O	AUX	O
by	O	ADP	O
far	O	ADV	O
the	O	DET	O
most	O	ADV	O
potent	O	ADJ	O
site	O	NOUN	B
for	O	ADP	O
inducing	O	VERB	B
the	O	DET	O
expansion	O	NOUN	B
per	O	X	O
se	O	X	O
,	O	PUNCT	O
even	O	ADV	O
if	O	SCONJ	O
other	O	ADJ	O
sites	O	NOUN	B
can	O	AUX	O
induce	O	VERB	B
some	O	DET	O
response	O	NOUN	B
acquisition	O	NOUN	I
.	O	PUNCT	O


Whereas	O	SCONJ	O
peripheral	B-cell_type	ADJ	B
T	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
can	O	AUX	O
undergo	O	VERB	O
forms	O	NOUN	O
of	O	ADP	O
positive	O	ADJ	B
selection	O	NOUN	B
(	O	PUNCT	O
by	O	ADP	O
antigen-driven	O	ADJ	B
clonal	O	ADJ	I
expansion	O	NOUN	I
)	O	PUNCT	O
and	O	CCONJ	O
negative	O	ADJ	B
selection	O	NOUN	B
(	O	PUNCT	O
by	O	ADP	O
abortive	O	ADJ	B
stimulation	O	NOUN	I
leading	O	VERB	O
to	O	PART	O
anergy	O	NOUN	B
or	O	CCONJ	O
death	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
neither	O	CCONJ	O
is	O	AUX	O
exactly	O	ADV	O
the	O	DET	O
same	O	ADJ	O
phenomenon	O	NOUN	B
that	O	PRON	O
occurs	O	VERB	O
in	O	ADP	O
the	O	DET	O
thymic	O	ADJ	B
cortex	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
p65	I-protein	NOUN	I
subunit	I-protein	NOUN	I
provides	O	VERB	O
the	O	DET	O
transactivation	O	NOUN	B
activity	O	NOUN	O
in	O	ADP	O
this	O	DET	O
complex	O	NOUN	B
and	O	CCONJ	O
serves	O	VERB	O
as	O	ADP	O
an	O	DET	O
intracellular	O	ADJ	B
receptor	O	NOUN	I
for	O	ADP	O
a	O	DET	O
cytoplasmic	O	ADJ	B
inhibitor	O	NOUN	I
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
,	O	PUNCT	O
termed	O	VERB	O
I	O	NOUN	B
kappa	O	NOUN	I
B	O	NOUN	I
.	O	PUNCT	O


[	O	PUNCT	O
Mechanism	O	NOUN	B
of	O	ADP	O
action	O	NOUN	B
of	O	ADP	O
steroid	O	NOUN	B
hormones.	O	NOUN	I
I.	O	PROPN	I
Estrogens	O	NOUN	B
]	O	PUNCT	O


Their	O	PRON	O
action	O	NOUN	B
mechanism	O	NOUN	I
is	O	AUX	O
not	O	PART	O
completely	O	ADV	O
cleared	O	VERB	B
.	O	PUNCT	O


Currently	O	ADV	O
it	O	PRON	O
is	O	AUX	O
accepted	O	VERB	O
the	O	DET	O
existence	O	NOUN	O
of	O	ADP	O
a	O	DET	O
cytoplasmic	B-protein	ADJ	B
and/or	I-protein	CCONJ	O
nuclear	I-protein	ADJ	B
receptor	I-protein	NOUN	I
,	O	PUNCT	O
without	O	ADP	O
explaining	O	VERB	O
satisfactorily	O	ADV	O
how	O	SCONJ	O
the	O	DET	O
hormones	O	NOUN	B
come	O	VERB	O
to	O	PART	O
the	O	DET	O
nucleus	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
endocrine	O	ADJ	B
events	O	NOUN	O
that	O	PRON	O
are	O	AUX	O
rapidly	O	ADV	O
expressed	O	VERB	B
(	O	PUNCT	O
seconds	O	NOUN	B
)	O	PUNCT	O
are	O	AUX	O
due	O	ADJ	O
to	O	PART	O
a	O	DET	O
possible	O	ADJ	O
interaction	O	NOUN	B
with	O	ADP	O
cellular	O	ADJ	B
membrane	O	NOUN	I
.	O	PUNCT	O


Since	O	SCONJ	O
HIV-1	B-DNA	NOUN	B
long	I-DNA	ADJ	B
terminal	I-DNA	ADJ	I
repeat	I-DNA	NOUN	I
contains	O	VERB	O
two	O	NUM	O
functional	O	ADJ	B
nuclear	B-DNA	ADJ	O
factor	I-DNA	NOUN	O
kB	I-DNA	NOUN	O
(	I-DNA	PUNCT	O
NF-kB	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
regulatory	I-DNA	ADJ	B
elements	I-DNA	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
studied	O	VERB	O
the	O	DET	O
ability	O	NOUN	O
of	O	ADP	O
PMA	O	NOUN	B
to	O	PART	O
induce	O	VERB	B
NF-kB	B-protein	NOUN	B
binding	O	NOUN	O
activity	O	NOUN	O
by	O	ADP	O
different	O	ADJ	O
assays	O	NOUN	B
.	O	PUNCT	O


Deoxycholate	O	ADJ	B
treatment	O	NOUN	B
of	O	ADP	O
cytoplasmic	O	ADJ	B
extracts	O	NOUN	I
from	O	ADP	O
these	O	DET	O
subclones	O	NOUN	B
released	O	VERB	O
much	O	ADV	O
reduced	O	VERB	B
NF-kB	B-protein	NOUN	B
binding	I-protein	NOUN	I
proteins	I-protein	NOUN	I
from	O	ADP	O
their	O	PRON	O
cytoplasmic	O	ADJ	B
pools	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
NF-AT	I-protein	NOUN	I
(	O	PUNCT	O
ref.	O	NOUN	O
1	O	NUM	O
)	O	PUNCT	O
is	O	AUX	O
induced	O	VERB	B
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
stimulated	O	VERB	B
through	O	ADP	O
the	O	DET	O
T-cell	B-protein	NOUN	B
receptor/CD3	I-protein	NOUN	I
complex	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
is	O	AUX	O
required	O	VERB	O
for	O	ADP	O
interleukin-2	B-DNA	NOUN	B
(	I-DNA	PUNCT	O
IL-2	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
gene	I-DNA	NOUN	B
induction	O	NOUN	I
.	O	PUNCT	O


NF-AT	B-protein	NOUN	B
induction	O	NOUN	B
may	O	AUX	O
require	O	VERB	O
two	O	NUM	O
activation-dependent	O	ADJ	B
events	O	NOUN	I
:	O	PUNCT	O
the	O	DET	O
CsA-sensitive	O	ADJ	B
translocation	O	NOUN	B
of	O	ADP	O
a	O	DET	O
pre-existing	O	ADJ	B
component	O	NOUN	O
and	O	CCONJ	O
the	O	DET	O
CsA-resistant	O	ADJ	B
synthesis	O	NOUN	O
of	O	ADP	O
a	O	DET	O
nuclear	B-protein	ADJ	B
component	I-protein	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
particular	O	ADJ	O
,	O	PUNCT	O
the	O	DET	O
c-Rel	B-protein	NOUN	B
homodimer	I-protein	NOUN	B
has	O	AUX	O
a	O	DET	O
high	O	ADJ	O
affinity	O	NOUN	B
for	O	ADP	O
interleukin-6	B-protein	NOUN	B
(	O	PUNCT	O
IL-6	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
beta	B-DNA	NOUN	B
interferon	I-DNA	NOUN	I
kappa	I-DNA	NOUN	I
B	I-DNA	NOUN	I
sites	I-DNA	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
,	O	PUNCT	O
therefore	O	ADV	O
,	O	PUNCT	O
examined	O	VERB	O
glucocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
characteristics	O	NOUN	B
on	O	ADP	O
mononuclear	B-cell_type	ADJ	B
leukocytes	I-cell_type	NOUN	B
by	O	ADP	O
measuring	O	VERB	B
[	O	PUNCT	O
3H	O	NOUN	B
]	O	PUNCT	O
dexamethasone	O	NOUN	B
binding	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
dexamethasone	O	NOUN	B
on	O	ADP	O
[	O	PUNCT	O
3H	O	NOUN	B
]	O	PUNCT	O
thymidine	O	NOUN	B
incorporation	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
one	O	NUM	O
of	O	ADP	O
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	O
glucocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
activation	O	NOUN	B
.	O	PUNCT	O


Glucocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
density	O	NOUN	B
was	O	AUX	O
increased	O	VERB	B
in	O	ADP	O
AIDS	O	NOUN	B
patients	O	NOUN	B
with	O	ADP	O
an	O	DET	O
Addisonian	O	ADJ	B
picture	O	NOUN	B
(	O	PUNCT	O
group	O	NOUN	B
1	O	NUM	O
;	O	PUNCT	O
16.2	O	NUM	O
+/-	O	CCONJ	O
9.4	O	NUM	O
fmol/million	O	NOUN	O
cells	O	NOUN	O
)	O	PUNCT	O
compared	O	VERB	O
to	O	PART	O
values	O	NOUN	B
in	O	ADP	O
12	O	NUM	O
AIDS	O	NOUN	B
patients	O	NOUN	B
without	O	ADP	O
an	O	DET	O
Addisonian	O	ADJ	B
picture	O	NOUN	B
(	O	PUNCT	O
group	O	NOUN	B
2	O	NUM	O
;	O	PUNCT	O
6.05	O	NUM	O
+/-	O	CCONJ	O
2.6	O	NUM	O
fmol/million	O	NOUN	O
cells	O	NOUN	O
;	O	PUNCT	O
P	O	NOUN	O
less	O	ADJ	O
than	O	ADP	O
0.01	O	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
sex-	O	NOUN	B
and	O	CCONJ	O
age-matched	O	ADJ	O
controls	O	NOUN	B
(	O	PUNCT	O
3.15	O	NUM	O
+/-	O	CCONJ	O
2.3	O	NUM	O
fmol/million	O	NOUN	O
cells	O	NOUN	O
;	O	PUNCT	O
P	O	NOUN	O
less	O	ADJ	O
than	O	ADP	O
0.01	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


In	O	ADP	O
conclusion	O	NOUN	O
,	O	PUNCT	O
AIDS	O	NOUN	B
patients	O	NOUN	B
with	O	ADP	O
hypercortisolism	O	NOUN	B
and	O	CCONJ	O
clinical	O	ADJ	B
features	O	NOUN	I
of	O	ADP	O
peripheral	O	ADJ	B
resistance	O	NOUN	I
to	O	PART	O
glucocorticoids	O	NOUN	B
are	O	AUX	O
characterized	O	VERB	B
by	O	ADP	O
abnormal	B-protein	ADJ	B
glucocorticoid	I-protein	NOUN	B
receptors	I-protein	NOUN	I
on	O	ADP	O
lymphocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


The	O	DET	O
constitutive	B-protein	ADJ	B
transcription	I-protein	NOUN	O
factor	I-protein	NOUN	O
SP1	B-protein	NOUN	B
was	O	AUX	O
unaffected	O	ADJ	O
by	O	ADP	O
addition	O	NOUN	O
of	O	ADP	O
TPA	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
THP-1	O	NOUN	B
cells	O	NOUN	I
,	O	PUNCT	O
TPA	O	NOUN	B
also	O	ADV	O
induced	O	VERB	B
a	O	DET	O
new	O	ADJ	O
,	O	PUNCT	O
faster-migrating	B-protein	ADJ	O
NF	I-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
species	I-protein	NOUN	B
not	O	PART	O
induced	O	VERB	B
in	O	ADP	O
monocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


The	O	DET	O
endothelium	O	NOUN	B
plays	O	VERB	O
a	O	DET	O
critical	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
inflammation	O	NOUN	B
by	O	ADP	O
directing	O	VERB	O
circulating	B-cell_type	VERB	B
leukocytes	I-cell_type	NOUN	B
into	O	ADP	O
extravascular	O	ADJ	B
tissues	O	NOUN	I
by	O	ADP	O
expressing	O	VERB	B
adhesive	B-protein	ADJ	B
molecules	I-protein	NOUN	I
for	O	ADP	O
leukocytes	B-cell_type	NOUN	B
[	O	PUNCT	O
e.g.	O	X	O
,	O	PUNCT	O
endothelial-leukocyte	B-protein	ADJ	B
adhesion	I-protein	NOUN	I
molecule	I-protein	NOUN	I
1	I-protein	NUM	I
(	O	PUNCT	O
ELAM-1	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
intercellular	B-protein	ADJ	B
adhesion	I-protein	NOUN	I
molecule	I-protein	NOUN	I
1	I-protein	NUM	I
(	O	PUNCT	O
ICAM-1	B-protein	NOUN	B
)	O	PUNCT	O
]	O	PUNCT	O
.	O	PUNCT	O


Treatment	O	NOUN	B
of	O	ADP	O
endothelial	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
with	O	ADP	O
LPS	O	NOUN	B
(	O	PUNCT	O
1	O	NUM	O
microgram/ml	O	NOUN	O
)	O	PUNCT	O
stimulated	O	VERB	B
transcription	O	NOUN	B
of	O	ADP	O
ELAM-1	B-protein	NOUN	B
,	O	PUNCT	O
as	O	ADP	O
shown	O	VERB	O
by	O	ADP	O
Northern	O	NOUN	B
blot	O	NOUN	I
analysis	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
expression	O	NOUN	B
of	O	ADP	O
membrane-associated	B-protein	ADJ	O
ELAM-1	I-protein	NOUN	B
and	O	CCONJ	O
ICAM-1	B-protein	NOUN	B
,	O	PUNCT	O
as	O	ADP	O
shown	O	VERB	O
by	O	ADP	O
quantitative	O	ADJ	B
immunofluorescence	O	NOUN	I
(	O	PUNCT	O
both	O	DET	O
P	O	NOUN	O
<	O	X	O
0.001	O	NUM	O
,	O	PUNCT	O
n	O	NOUN	O
=	O	ADJ	O
9	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


As	O	ADP	O
in	O	ADP	O
the	O	DET	O
adhesion	O	NOUN	B
studies	O	NOUN	B
,	O	PUNCT	O
cortisol	O	NOUN	B
but	O	CCONJ	O
not	O	PART	O
tetrahydrocortisol	O	NOUN	B
inhibited	O	VERB	B
expression	O	NOUN	B
of	O	ADP	O
ELAM-1	B-protein	NOUN	B
and	O	CCONJ	O
ICAM-1	B-protein	NOUN	B
(	O	PUNCT	O
both	O	DET	O
P	O	NOUN	O
<	O	X	O
0.005	O	NUM	O
,	O	PUNCT	O
n	O	NOUN	O
=	O	ADJ	O
3	O	NUM	O
or	O	CCONJ	O
4	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


BSAP	B-protein	NOUN	B
expression	O	NOUN	B
persists	O	VERB	B
in	O	ADP	O
B	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
and	O	CCONJ	O
is	O	AUX	O
also	O	ADV	O
seen	O	VERB	O
in	O	ADP	O
the	O	DET	O
testis	O	NOUN	B
of	O	ADP	O
the	O	DET	O
adult	O	ADJ	B
mouse	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
programmed	O	VERB	B
activation/repression	O	NOUN	B
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
in	O	ADP	O
early	O	ADJ	O
hematopoietic	O	ADJ	B
differentiation	O	NOUN	I
has	O	AUX	O
not	O	PART	O
yet	O	ADV	O
been	O	AUX	O
explored	O	VERB	O
.	O	PUNCT	O


Little	O	ADJ	O
effect	O	NOUN	B
was	O	AUX	O
observed	O	VERB	O
with	O	ADP	O
50-kDa	B-protein	ADJ	O
forms	I-protein	NOUN	O
of	O	ADP	O
p105	B-protein	NOUN	B
NF-kappa	B-protein	NOUN	I
B	I-protein	NOUN	I
or	O	CCONJ	O
rel	B-protein	NOUN	B
,	O	PUNCT	O
in	O	ADP	O
combination	O	NOUN	B
with	O	ADP	O
p65	B-protein	NOUN	B
or	O	CCONJ	O
full-length	B-protein	ADJ	O
c-rel	I-protein	NOUN	B
,	O	PUNCT	O
which	O	DET	O
do	O	AUX	O
not	O	PART	O
stimulate	O	VERB	O
the	O	DET	O
HIV	B-DNA	NOUN	B
enhancer	I-DNA	NOUN	O
in	O	ADP	O
these	O	DET	O
cells	O	NOUN	B
.	O	PUNCT	O


Stable	O	ADJ	B
transfectants	O	NOUN	B
of	O	ADP	O
HB24	B-DNA	NOUN	B
were	O	AUX	O
established	O	VERB	O
that	O	PRON	O
expressed	O	VERB	B
high	O	ADJ	O
levels	O	NOUN	B
of	O	ADP	O
HB24	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
and	O	CCONJ	O
possessed	O	VERB	B
an	O	DET	O
altered	O	ADJ	O
phenotype	O	NOUN	B
suggestive	O	ADJ	O
of	O	ADP	O
activated	B-cell_type	VERB	B
T	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
stable	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
HB24	B-DNA	NOUN	B
confers	O	VERB	O
an	O	DET	O
activation	O	NOUN	B
phenotype	O	NOUN	B
on	O	ADP	O
a	O	DET	O
human	B-cell_line	ADJ	B
T	I-cell_line	NOUN	O
cell	I-cell_line	NOUN	O
line	I-cell_line	NOUN	O
,	O	PUNCT	O
implicating	O	VERB	O
this	O	DET	O
gene	O	NOUN	B
as	O	ADP	O
an	O	DET	O
important	O	ADJ	O
transcriptional	B-protein	ADJ	B
factor	I-protein	NOUN	I
during	O	ADP	O
T	O	NOUN	B
cell	O	NOUN	I
activation	O	NOUN	B
and	O	CCONJ	O
growth	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
recent	O	ADJ	O
definition	O	NOUN	B
of	O	ADP	O
a	O	DET	O
consensus	O	NOUN	B
DNA	B-DNA	NOUN	I
binding	I-DNA	NOUN	I
sequence	I-DNA	NOUN	I
for	O	ADP	O
the	O	DET	O
Ets	B-protein	NOUN	B
family	I-protein	NOUN	I
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
has	O	AUX	O
allowed	O	VERB	O
the	O	DET	O
identification	O	NOUN	B
of	O	ADP	O
potential	O	ADJ	B
Ets	B-DNA	NOUN	B
binding	I-DNA	NOUN	I
sites	I-DNA	NOUN	I
in	O	ADP	O
the	O	DET	O
promoters	B-DNA	NOUN	B
and	O	CCONJ	O
enhancers	B-DNA	NOUN	B
of	O	ADP	O
many	O	ADJ	O
inducible	B-DNA	ADJ	B
T-cell	I-DNA	NOUN	B
genes	I-DNA	NOUN	I
.	O	PUNCT	O


Transcription	O	NOUN	B
of	O	ADP	O
the	O	DET	O
hypersensitive	B-DNA	ADJ	B
site	I-DNA	NOUN	I
HS2	I-DNA	NOUN	B
enhancer	I-DNA	NOUN	I
in	O	ADP	O
erythroid	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


The	O	DET	O
mechanism	O	NOUN	B
of	O	ADP	O
HS2	B-DNA	NOUN	B
enhancer	I-DNA	NOUN	I
function	O	NOUN	I
is	O	AUX	O
not	O	PART	O
known	O	VERB	O
.	O	PUNCT	O


In	O	ADP	O
directing	O	VERB	O
the	O	DET	O
synthesis	O	NOUN	B
of	O	ADP	O
RNA	B-RNA	NOUN	B
through	O	ADP	O
the	O	DET	O
intervening	O	VERB	O
DNA	B-DNA	NOUN	B
and	O	CCONJ	O
the	O	DET	O
gene	O	NOUN	B
by	O	ADP	O
a	O	DET	O
tracking	O	NOUN	B
and	O	CCONJ	O
transcription	O	NOUN	B
mechanism	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
HS2	B-DNA	NOUN	B
enhancer	I-DNA	NOUN	I
may	O	AUX	O
(	O	PUNCT	O
i	O	X	O
)	O	PUNCT	O
open	O	VERB	O
up	O	ADP	O
the	O	DET	O
chromatin	B-DNA	NOUN	B
structure	I-DNA	NOUN	I
of	O	ADP	O
a	O	DET	O
gene	B-DNA	NOUN	B
domain	I-DNA	NOUN	I
and	O	CCONJ	O
(	O	PUNCT	O
ii	O	X	O
)	O	PUNCT	O
deliver	O	VERB	B
enhancer	B-protein	NOUN	B
binding	I-protein	NOUN	I
proteins	I-protein	NOUN	I
to	O	PART	O
the	O	DET	O
promoter	O	NOUN	B
sequence	O	NOUN	I
where	O	SCONJ	O
they	O	PRON	O
may	O	AUX	O
stimulate	O	VERB	B
the	O	DET	O
transcription	O	NOUN	B
of	O	ADP	O
the	O	DET	O
gene	O	NOUN	B
at	O	ADP	O
the	O	DET	O
cap	B-DNA	NOUN	B
site	I-DNA	NOUN	I
.	O	PUNCT	O


The	O	DET	O
palindromic	B-DNA	ADJ	B
site	I-DNA	NOUN	I
(	O	PUNCT	O
site	B-DNA	NOUN	B
B	I-DNA	NOUN	I
)	O	PUNCT	O
recognized	O	VERB	O
by	O	ADP	O
this	O	DET	O
protein	O	NOUN	B
is	O	AUX	O
related	O	ADJ	O
to	O	PART	O
the	O	DET	O
palindromic	B-DNA	ADJ	B
binding	I-DNA	VERB	I
sites	I-DNA	NOUN	I
of	O	ADP	O
members	O	NOUN	B
of	O	ADP	O
the	O	DET	O
steroid/thyroid	B-protein	NOUN	B
hormone	I-protein	NOUN	I
receptor	I-protein	NOUN	I
family	I-protein	NOUN	O
.	O	PUNCT	O


Further	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
observe	O	VERB	O
that	O	SCONJ	O
TAR-deleted	B-DNA	ADJ	B
mutants	I-DNA	NOUN	B
of	O	ADP	O
HIV-1	O	NOUN	B
demonstrate	O	VERB	O
normal	O	ADJ	O
late	O	ADJ	O
gene	O	NOUN	B
expression	O	NOUN	I
in	O	ADP	O
glial	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
as	O	ADP	O
evidenced	O	VERB	O
by	O	ADP	O
syncytia	O	NOUN	B
formation	O	NOUN	B
and	O	CCONJ	O
production	O	NOUN	B
of	O	ADP	O
viral	B-protein	ADJ	B
p24	I-protein	NOUN	I
antigen	I-protein	NOUN	I
.	O	PUNCT	O


Mutagenesis	O	NOUN	B
indicates	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
21	B-DNA	NUM	O
bp	I-DNA	NOUN	O
repeats	I-DNA	NOUN	B
can	O	AUX	O
be	O	AUX	O
subdivided	O	VERB	O
into	O	ADP	O
three	O	NUM	O
motifs	O	NOUN	B
,	O	PUNCT	O
A	O	NOUN	B
,	O	PUNCT	O
B	O	NOUN	B
and	O	CCONJ	O
C	O	NOUN	O
,	O	PUNCT	O
each	O	DET	O
of	O	ADP	O
which	O	DET	O
influences	O	VERB	B
the	O	DET	O
level	O	NOUN	B
of	O	ADP	O
tax	B-protein	NOUN	O
activation	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
demonstrated	O	VERB	O
that	O	SCONJ	O
AP-2	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
was	O	AUX	O
present	O	ADJ	O
in	O	ADP	O
T-lymphocytes	B-cell_type	NOUN	B
and	O	CCONJ	O
that	O	SCONJ	O
cellular	O	ADJ	B
factors	O	NOUN	I
from	O	ADP	O
both	O	CCONJ	O
non-transformed	O	ADJ	B
and	O	CCONJ	O
transformed	O	VERB	B
T-lymphocytes	B-cell_type	NOUN	B
specifically	O	ADV	O
bound	O	VERB	O
to	O	PART	O
the	O	DET	O
consensus	B-DNA	NOUN	B
motif	I-DNA	NOUN	I
for	O	ADP	O
AP-2	B-protein	NOUN	B
in	O	ADP	O
each	O	DET	O
21	O	NUM	O
bp	O	NOUN	B
.	O	PUNCT	O


Transfection	O	NOUN	B
of	O	ADP	O
an	O	DET	O
AP-2	B-DNA	NOUN	B
expression	I-DNA	NOUN	O
construct	I-DNA	NOUN	O
into	O	ADP	O
T-lymphocytes	B-cell_type	NOUN	B
activated	O	VERB	B
gene	O	NOUN	B
expression	O	NOUN	I
from	O	ADP	O
the	O	DET	O
HTLV-I	B-DNA	NOUN	B
LTR	I-DNA	NOUN	B
.	O	PUNCT	O


Several	O	ADJ	O
DNA-binding	B-protein	ADJ	B
proteins	I-protein	NOUN	I
are	O	AUX	O
known	O	VERB	O
to	O	PART	O
bind	O	VERB	B
this	O	DET	O
sequence	O	NOUN	B
.	O	PUNCT	O


Together	O	ADV	O
these	O	DET	O
results	O	NOUN	B
constitute	O	VERB	O
the	O	DET	O
first	O	ADJ	O
direct	O	ADJ	O
evidence	O	NOUN	B
of	O	ADP	O
a	O	DET	O
positive	O	ADJ	B
role	O	NOUN	O
for	O	ADP	O
the	O	DET	O
lymphoid-specific	B-protein	ADJ	B
octamer-binding	I-protein	ADJ	I
factor	I-protein	NOUN	I
in	O	ADP	O
DRA	O	NOUN	B
gene	O	NOUN	B
transcription	O	NOUN	I
.	O	PUNCT	O


Interferon	B-protein	NOUN	B
gamma	I-protein	NOUN	I
activated	O	VERB	I
strongly	O	ADV	O
c-fos	B-DNA	NOUN	B
and	O	CCONJ	O
weakly	O	ADV	O
c-jun	B-DNA	NOUN	B
and	O	CCONJ	O
AP1	B-protein	NOUN	B
.	O	PUNCT	O


Glucocorticoids	O	NOUN	B
are	O	AUX	O
known	O	VERB	O
to	O	PART	O
downregulate	O	VERB	B
interleukin-1	B-protein	NOUN	B
beta	I-protein	NOUN	I
production	O	NOUN	I
in	O	ADP	O
monocytic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
by	O	ADP	O
two	O	NUM	O
different	O	ADJ	O
mechanims	O	NOUN	B
:	O	PUNCT	O
direct	O	ADJ	O
inhibition	O	NOUN	B
of	O	ADP	O
the	O	DET	O
gene	O	NOUN	B
transcription	O	NOUN	I
and	O	CCONJ	O
destabilization	O	NOUN	B
of	O	ADP	O
the	O	DET	O
preformed	O	ADJ	B
interleukin-1	B-RNA	NOUN	B
beta	I-RNA	NOUN	I
mRNA	I-RNA	NOUN	B
.	O	PUNCT	O


When	O	SCONJ	O
dexamethasone	O	NOUN	B
was	O	AUX	O
added	O	VERB	O
to	O	PART	O
the	O	DET	O
cultures	O	NOUN	B
3	O	NUM	O
hours	O	NOUN	B
after	O	ADP	O
the	O	DET	O
stimulators	O	NOUN	B
,	O	PUNCT	O
it	O	PRON	O
clearly	O	ADV	O
decreased	O	VERB	B
the	O	DET	O
interleukin-1	B-RNA	NOUN	B
beta	I-RNA	NOUN	I
mRNA	I-RNA	NOUN	B
levels	O	NOUN	O
regardless	O	ADV	O
of	O	ADP	O
the	O	DET	O
stimulator	O	NOUN	B
used	O	VERB	O
(	O	PUNCT	O
although	O	SCONJ	O
the	O	DET	O
effect	O	NOUN	B
was	O	AUX	O
clearly	O	ADV	O
weaker	O	ADJ	O
on	O	ADP	O
the	O	DET	O
PMA-induced	B-RNA	ADJ	B
mRNA	I-RNA	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Only	O	ADV	O
the	O	DET	O
activities	O	NOUN	B
for	O	ADP	O
NF-AT	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
AP-1	I-DNA	NOUN	B
sites	I-DNA	NOUN	I
require	O	VERB	O
two	O	NUM	O
signals	O	NOUN	B
for	O	ADP	O
optimal	O	ADJ	B
induction	O	NOUN	B
,	O	PUNCT	O
i.e.	O	X	O
,	O	PUNCT	O
PMA	O	NOUN	B
plus	O	CCONJ	O
either	O	CCONJ	O
lectin	B-protein	NOUN	B
or	O	CCONJ	O
antibody	B-protein	NOUN	B
to	O	PART	O
the	O	DET	O
CD3	B-protein	NOUN	B
or	O	CCONJ	O
CD28	B-protein	NOUN	B
surface	I-protein	NOUN	O
molecules	I-protein	NOUN	O
.	O	PUNCT	O


This	O	DET	O
region	O	NOUN	B
contains	O	VERB	O
two	O	NUM	O
DNA-binding	B-DNA	ADJ	B
motifs	I-DNA	NOUN	B
,	O	PUNCT	O
GM2	B-DNA	NOUN	B
and	O	CCONJ	O
GC-box	B-DNA	NOUN	B
.	O	PUNCT	O


The	O	DET	O
MAD-3	B-DNA	NOUN	B
cDNA	I-DNA	NOUN	B
encodes	O	VERB	B
an	O	DET	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B-like	I-protein	ADJ	I
protein	I-protein	NOUN	I
that	O	PRON	O
is	O	AUX	O
likely	O	ADJ	O
to	O	PART	O
be	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
regulation	O	NOUN	B
of	O	ADP	O
transcriptional	O	ADJ	B
responses	O	NOUN	I
to	O	PART	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
adhesion-dependent	O	ADJ	B
pathways	O	NOUN	I
of	O	ADP	O
monocyte	O	NOUN	B
activation	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
fixed	O	VERB	B
tissue	O	NOUN	I
macrophages	B-cell_type	NOUN	I
express	O	VERB	O
detectable	O	ADJ	B
HIV	B-protein	NOUN	B
proteins	I-protein	NOUN	I
,	O	PUNCT	O
indicating	O	VERB	O
permanent	O	ADJ	B
virus	O	NOUN	O
transcription	O	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
show	O	VERB	O
here	O	ADV	O
that	O	SCONJ	O
chronic	O	ADJ	B
HIV	O	NOUN	O
infection	O	NOUN	O
results	O	VERB	B
in	O	ADP	O
both	O	CCONJ	O
induction	O	NOUN	B
of	O	ADP	O
a	O	DET	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
with	O	ADP	O
antigenic	O	ADJ	B
properties	O	NOUN	O
indistinguishable	O	ADJ	B
from	O	ADP	O
those	O	DET	O
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
and	O	CCONJ	O
permanently	O	ADV	B
increased	O	VERB	B
HIV	B-DNA	NOUN	B
enhancer	I-DNA	NOUN	O
activity	O	NOUN	O
.	O	PUNCT	O


In	O	X	B
vitro	O	X	I
transcription	O	NOUN	B
and	O	CCONJ	O
translation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
complementary	B-DNA	ADJ	B
DNA	I-DNA	NOUN	B
resulted	O	VERB	O
in	O	ADP	O
the	O	DET	O
synthesis	O	NOUN	B
of	O	ADP	O
a	O	DET	O
protein	O	NOUN	B
with	O	ADP	O
an	O	DET	O
apparent	O	ADJ	B
molecular	O	ADJ	B
size	O	NOUN	I
of	O	ADP	O
65	B-protein	NUM	O
kilodaltons	I-protein	NOUN	B
(	O	PUNCT	O
kD	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
65-kD	B-protein	ADJ	O
protein	I-protein	NOUN	B
associated	O	VERB	B
with	O	ADP	I
the	O	DET	O
p50	B-protein	NOUN	B
subunit	I-protein	NOUN	I
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
and	O	CCONJ	O
the	O	DET	O
kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
probe	I-DNA	NOUN	I
to	O	PART	O
form	O	VERB	O
a	O	DET	O
complex	O	NOUN	B
with	O	ADP	O
the	O	DET	O
same	O	ADJ	O
electrophoretic	O	ADJ	B
mobility	O	NOUN	I
as	O	ADP	O
the	O	DET	O
NF-kappa	B-protein	NOUN	B
B-DNA	I-protein	NOUN	B
complex	I-protein	NOUN	I
.	O	PUNCT	O


All	O	DET	O
three	O	NUM	O
cell	O	NOUN	B
lines	O	NOUN	I
expressed	O	VERB	B
vitamin	O	NOUN	B
D	O	NOUN	I
receptor	O	NOUN	I
and	O	CCONJ	O
had	O	AUX	O
increased	O	VERB	B
levels	O	NOUN	B
of	O	ADP	O
IL-1	B-RNA	NOUN	B
beta	I-RNA	NOUN	O
mRNA	I-RNA	NOUN	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
LPS	O	NOUN	B
.	O	PUNCT	O


Preincubation	O	NOUN	B
of	O	ADP	O
cells	O	NOUN	B
with	O	ADP	O
1	O	NUM	O
,	O	PUNCT	O
25-	O	NUM	O
(	O	PUNCT	O
OH	O	NOUN	B
)	O	PUNCT	O
2D3	O	NOUN	B
had	O	AUX	O
no	O	DET	B
effect	O	NOUN	I
on	O	ADP	O
the	O	DET	O
time	O	NOUN	B
course	O	NOUN	I
of	O	ADP	O
IL-1	B-RNA	NOUN	B
beta	I-RNA	NOUN	O
mRNA	I-RNA	NOUN	B
appearance	O	NOUN	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
LPS	O	NOUN	B
.	O	PUNCT	O


Comparing	O	VERB	B
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
these	O	DET	O
related	O	ADJ	O
zinc-finger-encoding	B-DNA	ADJ	B
genes	I-DNA	NOUN	I
showed	O	VERB	O
coordinate	O	ADJ	O
induction	O	NOUN	B
upon	O	SCONJ	O
mitogenic	O	ADJ	B
stimulation	O	NOUN	I
of	O	ADP	O
resting	B-cell_type	VERB	B
T	I-cell_type	NOUN	I
lymphocytes	I-cell_type	NOUN	I
and	O	CCONJ	O
of	O	ADP	O
resting	B-cell_type	VERB	B
fibroblasts	I-cell_type	NOUN	I
.	O	PUNCT	O


v-erbA	B-protein	NOUN	B
overexpression	O	NOUN	B
is	O	AUX	O
required	O	VERB	O
to	O	PART	O
extinguish	O	VERB	O
c-erbA	B-protein	NOUN	B
function	O	NOUN	O
in	O	ADP	O
erythroid	B-cell_type	ADJ	B
cell	I-cell_type	NOUN	O
differentiation	O	NOUN	O
and	O	CCONJ	O
regulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
erbA	B-DNA	NOUN	B
target	I-DNA	NOUN	B
gene	I-DNA	NOUN	B
CAII	B-DNA	NOUN	I
.	O	PUNCT	O


The	O	DET	O
c-erbA	B-protein	NOUN	B
-dependent	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
this	O	DET	O
CAII	B-DNA	NOUN	B
reporter	I-DNA	NOUN	I
construct	I-DNA	NOUN	O
could	O	AUX	O
only	O	ADV	O
be	O	AUX	O
suppressed	O	VERB	B
by	O	ADP	O
very	O	ADV	O
high	O	ADJ	O
amounts	O	NOUN	O
of	O	ADP	O
v-erbA	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
CD2	B-protein	NOUN	B
T	I-protein	NOUN	B
lymphocyte	I-protein	NOUN	I
glycoprotein	I-protein	NOUN	I
surface	I-protein	NOUN	O
molecule	I-protein	NOUN	O
mediates	O	VERB	O
both	O	CCONJ	O
cell	O	NOUN	B
to	O	PART	O
cell	O	NOUN	B
adhesion	O	NOUN	I
and	O	CCONJ	O
T	O	NOUN	B
cell	O	NOUN	I
activation	O	NOUN	O
,	O	PUNCT	O
two	O	NUM	O
processes	O	NOUN	B
that	O	PRON	O
are	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
spread	O	NOUN	B
of	O	ADP	O
HIV	O	NOUN	B
infection	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
study	O	NOUN	B
we	O	PRON	O
investigated	O	VERB	B
the	O	DET	O
mechanisms	O	NOUN	B
whereby	O	SCONJ	O
anti-CD2	B-protein	ADJ	B
antibodies	I-protein	NOUN	I
stimulate	O	VERB	O
viral	O	ADJ	B
production	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
KBF1/p50	B-protein	NOUN	B
factor	I-protein	NOUN	I
binds	O	VERB	B
as	O	ADP	O
a	O	DET	O
homodimer	B-protein	NOUN	B
but	O	CCONJ	O
can	O	AUX	O
also	O	ADV	O
form	O	VERB	O
heterodimers	B-protein	NOUN	B
with	O	ADP	O
the	O	DET	O
products	O	NOUN	B
of	O	ADP	O
other	O	ADJ	O
members	O	NOUN	B
of	O	ADP	O
the	O	DET	O
same	O	ADJ	O
family	O	NOUN	B
,	O	PUNCT	O
like	O	ADP	O
the	O	DET	O
c-rel	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
v-rel	I-DNA	NOUN	B
(	I-DNA	PUNCT	O
proto	I-DNA	NOUN	O
)	I-DNA	PUNCT	O
oncogenes	I-DNA	NOUN	B
.	O	PUNCT	O


A	O	DET	O
mutant	O	NOUN	B
of	O	ADP	O
KBF1/p50	B-protein	NOUN	B
(	O	PUNCT	O
delta	B-protein	NOUN	O
SP	I-protein	NOUN	O
)	O	PUNCT	O
,	O	PUNCT	O
unable	O	ADJ	O
to	O	PART	O
bind	O	VERB	B
to	O	PART	O
DNA	O	NOUN	B
but	O	CCONJ	O
able	O	ADJ	O
to	O	PART	O
form	O	VERB	O
homo-	O	ADJ	B
or	O	CCONJ	O
heterodimers	B-protein	NOUN	B
,	O	PUNCT	O
has	O	AUX	O
been	O	AUX	O
constructed	O	VERB	O
.	O	PUNCT	O


Tissue-specific	O	ADJ	B
expression	O	NOUN	I
of	O	ADP	O
the	O	DET	O
platelet	B-DNA	NOUN	B
GPIIb	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
.	O	PUNCT	O


One	O	NUM	O
region	O	NOUN	O
,	O	PUNCT	O
centered	O	VERB	O
at	O	ADP	O
-54	O	NUM	O
,	O	PUNCT	O
is	O	AUX	O
similar	O	ADJ	O
to	O	PART	O
a	O	DET	O
nuclear	B-DNA	ADJ	B
factor	I-DNA	NOUN	I
E1-binding	I-DNA	ADJ	I
site	I-DNA	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
region	O	NOUN	B
located	O	ADJ	O
at	O	ADP	O
position	O	NOUN	B
-233	O	NUM	O
contains	O	VERB	O
a	O	DET	O
CCAAT	B-DNA	NOUN	B
motif	I-DNA	NOUN	B
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
support	O	VERB	O
the	O	DET	O
view	O	NOUN	O
of	O	ADP	O
an	O	DET	O
impaired	O	ADJ	B
ligand-induced	O	ADJ	B
plasticity	O	NOUN	I
of	O	ADP	O
glucocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
regulation	O	NOUN	I
rather	O	ADV	O
than	O	ADP	O
the	O	DET	O
hypothesis	O	NOUN	B
of	O	ADP	O
decreased	O	VERB	B
glucocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
numbers	O	NOUN	O
during	O	ADP	O
depression	O	NOUN	B
.	O	PUNCT	O


Every	O	DET	O
enhancer	O	NOUN	B
works	O	VERB	O
with	O	ADP	O
every	O	DET	O
promoter	B-DNA	NOUN	B
for	O	ADP	O
all	O	DET	O
the	O	DET	O
combinations	O	NOUN	B
tested	O	VERB	B
:	O	PUNCT	O
could	O	AUX	O
new	O	ADJ	O
regulatory	O	ADJ	B
pathways	O	NOUN	I
evolve	O	VERB	O
by	O	ADP	O
enhancer	O	NOUN	B
shuffling	O	NOUN	I
?	O	PUNCT	O


Towards	O	ADP	O
a	O	DET	O
molecular	O	ADJ	B
understanding	O	NOUN	O
of	O	ADP	O
T-cell	O	NOUN	B
differentiation	O	NOUN	I
.	O	PUNCT	O


Deletion	O	NOUN	B
of	O	ADP	O
all	O	DET	O
the	O	DET	O
Sp	B-DNA	NOUN	B
1-binding	I-DNA	ADJ	I
sites	I-DNA	NOUN	B
from	O	ADP	O
the	O	DET	O
enhancer	B-DNA	NOUN	B
reduces	O	VERB	B
transcription	O	NOUN	B
by	O	ADP	O
80-90	O	NUM	O
%	O	NOUN	O
in	O	ADP	O
HeLa	O	NOUN	B
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
in	O	ADP	O
BJA-B	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
whereas	O	SCONJ	O
the	O	DET	O
removal	O	NOUN	B
of	O	ADP	O
the	O	DET	O
octamer-binding	B-DNA	ADJ	B
site	I-DNA	NOUN	I
reduces	O	VERB	B
transcription	O	NOUN	B
to	O	PART	O
levels	O	NOUN	B
below	O	ADP	O
detection	O	NOUN	B
in	O	ADP	O
both	O	DET	O
cell	O	NOUN	B
types	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
results	O	NOUN	B
also	O	ADV	O
revealed	O	VERB	O
a	O	DET	O
similar	O	ADJ	O
functional	O	ADJ	B
cooperation	O	NOUN	B
between	O	ADP	O
the	O	DET	O
transcription	O	NOUN	B
factors	O	NOUN	I
which	O	DET	O
bind	O	VERB	B
to	O	PART	O
the	O	DET	O
Oct	B-DNA	NOUN	O
and	O	CCONJ	O
the	O	DET	O
adjacent	O	ADJ	B
Sp	B-DNA	NOUN	B
1-binding	I-DNA	ADJ	I
site	I-DNA	NOUN	O
in	O	ADP	O
BJA-B	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
as	O	ADP	O
has	O	AUX	O
been	O	AUX	O
observed	O	VERB	O
in	O	ADP	O
HeLa	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
since	O	SCONJ	O
a	O	DET	O
template	O	NOUN	B
which	O	DET	O
contains	O	VERB	O
a	O	DET	O
weak	O	ADJ	B
binding	O	VERB	B
site	O	NOUN	I
for	O	ADP	O
OTFs	B-DNA	NOUN	B
expresses	O	VERB	O
wild-type	O	ADJ	B
levels	O	NOUN	O
of	O	ADP	O
U2	B-RNA	NOUN	B
snRNA	I-RNA	NOUN	I
in	O	ADP	O
both	O	DET	O
cell	O	NOUN	B
types	O	NOUN	I
when	O	SCONJ	O
the	O	DET	O
weak	O	ADJ	B
octamer-binding	B-DNA	ADJ	B
site	I-DNA	NOUN	I
is	O	AUX	O
combined	O	VERB	O
with	O	ADP	O
a	O	DET	O
Sp	B-DNA	NOUN	B
1-binding	I-DNA	ADJ	I
site	I-DNA	NOUN	B
.	O	PUNCT	O


TCF-1	B-protein	NOUN	B
consists	O	VERB	O
of	O	ADP	O
two	O	NUM	O
polypeptides	O	NOUN	B
of	O	ADP	O
about	O	ADV	O
50	O	NUM	O
kD	O	NOUN	B
and	O	CCONJ	O
105	O	NUM	O
kD	O	NOUN	B
;	O	PUNCT	O
the	O	DET	O
former	O	ADJ	O
seems	O	VERB	O
to	O	PART	O
be	O	AUX	O
related	O	ADJ	O
to	O	PART	O
the	O	DET	O
50	B-protein	NUM	O
kD	I-protein	NOUN	O
polypeptide	I-protein	NOUN	B
of	O	ADP	O
NF-kB	B-protein	NOUN	B
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
substitution	O	NOUN	B
of	O	ADP	O
the	O	DET	O
underlined	O	VERB	B
A	O	NOUN	I
residue	O	NOUN	B
to	O	PART	O
a	O	DET	O
C	O	NOUN	B
within	O	ADP	O
the	O	DET	O
GGGATTTCACC	B-DNA	NOUN	B
motif	I-DNA	NOUN	B
abolishes	O	VERB	O
its	O	PRON	O
T	O	NOUN	B
cell-restricted	O	ADJ	I
activity	O	NOUN	I
and	O	CCONJ	O
leads	O	VERB	O
to	O	ADP	O
its	O	PRON	O
functioning	O	NOUN	B
in	O	ADP	O
both	O	DET	O
El4	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	O
and	O	CCONJ	O
HeLa	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


The	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
GATA-1	B-protein	NOUN	B
is	O	AUX	O
expressed	O	VERB	B
in	O	ADP	O
a	O	DET	O
subset	O	NOUN	O
of	O	ADP	O
hemopoietic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
where	O	SCONJ	O
it	O	PRON	O
mediates	O	VERB	O
the	O	DET	O
cell-type	O	ADJ	B
specific	O	ADJ	O
expression	O	NOUN	B
of	O	ADP	O
several	O	ADJ	O
genes	O	NOUN	B
.	O	PUNCT	O


Using	O	VERB	O
Western	O	NOUN	B
blot	O	NOUN	I
analysis	O	NOUN	I
with	O	ADP	O
a	O	DET	O
monoclonal	B-protein	ADJ	B
antibody	I-protein	NOUN	I
recognizing	O	VERB	O
a	O	DET	O
17-amino	B-protein	NOUN	B
acid	I-protein	NOUN	I
epitope	I-protein	NOUN	I
of	O	ADP	O
the	O	DET	O
1	B-protein	NUM	O
,	I-protein	PUNCT	O
25-dihydroxyvitamin	I-protein	NOUN	B
D3	I-protein	NOUN	I
[	I-protein	PUNCT	O
1	I-protein	NUM	O
,	I-protein	PUNCT	O
25	I-protein	NUM	O
(	I-protein	PUNCT	O
OH	I-protein	NOUN	B
)	I-protein	PUNCT	O
2D3	I-protein	NOUN	O
]	I-protein	PUNCT	O
receptor	I-protein	NOUN	O
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
detected	O	VERB	B
two	O	NUM	O
crossreacting	B-protein	VERB	B
proteins	I-protein	NOUN	I
in	O	ADP	O
activated	B-cell_type	VERB	B
normal	I-cell_type	ADJ	O
human	I-cell_type	ADJ	B
lymphocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


Regulation	O	NOUN	B
of	O	ADP	O
glucocorticoid	B-protein	NOUN	B
receptors	I-protein	NOUN	I
in	O	ADP	O
human	B-cell_type	ADJ	B
mononuclear	I-cell_type	ADJ	O
cells	I-cell_type	NOUN	O
:	O	PUNCT	O
effects	O	NOUN	B
of	O	ADP	I
glucocorticoid	O	NOUN	B
treatment	O	NOUN	O
,	O	PUNCT	O
Cushing	O	NOUN	B
's	O	PART	I
disease	O	NOUN	I
and	O	CCONJ	O
ketoconazole	O	NOUN	B
.	O	PUNCT	O


Glucocorticoid	B-protein	NOUN	B
receptors	I-protein	NOUN	I
(	O	PUNCT	O
GcR	B-protein	NOUN	B
)	O	PUNCT	O
were	O	AUX	O
determined	O	VERB	O
by	O	ADP	O
a	O	DET	O
whole	O	ADJ	B
cell	O	NOUN	I
assay	O	NOUN	O
in	O	ADP	O
human	B-cell_type	ADJ	B
mononulear	I-cell_type	ADJ	O
leukocytes	I-cell_type	NOUN	B
(	O	PUNCT	O
hMNL	B-cell_type	NOUN	B
)	O	PUNCT	O
from	O	ADP	O
control	O	ADJ	B
subjects	O	NOUN	I
,	O	PUNCT	O
patients	O	NOUN	B
receiving	O	VERB	O
glucocorticoid	O	NOUN	B
therapy	O	NOUN	I
for	O	ADP	O
systemic	O	ADJ	B
diseases	O	NOUN	I
and	O	CCONJ	O
Cushing	O	NOUN	B
's	O	PART	I
disease	O	NOUN	I
patients	O	NOUN	B
with	O	ADP	O
or	O	CCONJ	O
without	O	ADP	O
ketoconazole	O	NOUN	B
therapy	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
group	O	NOUN	B
,	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
receptor	O	NOUN	B
levels	O	NOUN	I
and	O	CCONJ	O
morning	O	NOUN	B
plasma	O	NOUN	B
cortisol	O	NOUN	B
values	O	NOUN	I
showed	O	VERB	O
a	O	DET	O
negative	O	ADJ	B
correlation	O	NOUN	B
,	O	PUNCT	O
indicating	O	VERB	O
a	O	DET	O
subtle	O	ADJ	O
down-regulatory	O	ADJ	B
effect	O	NOUN	I
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
GcR	B-protein	NOUN	B
were	O	AUX	O
unaltered	O	ADJ	B
after	O	ADP	O
these	O	DET	O
patients	O	NOUN	B
received	O	VERB	O
ketoconazole	O	NOUN	B
,	O	PUNCT	O
in	O	ADP	O
spite	O	NOUN	O
of	O	ADP	O
a	O	DET	O
marked	O	ADJ	O
reduction	O	NOUN	B
in	O	ADP	O
morning	O	NOUN	B
plasma	O	NOUN	B
cortisol	O	NOUN	O
and	O	CCONJ	O
urinary	O	ADJ	B
free	O	ADJ	I
cortisol	O	NOUN	I
.	O	PUNCT	O


Human	O	ADJ	B
T-cell	O	NOUN	I
leukemia	O	NOUN	I
virus	O	NOUN	O
type	O	NOUN	O
1	O	NUM	O
(	O	PUNCT	O
HTLV-1	O	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
an	O	DET	O
etiological	O	ADJ	B
agent	O	NOUN	I
of	O	ADP	O
adult	O	ADJ	B
T-cell	O	NOUN	O
leukemia	O	NOUN	O
(	O	PUNCT	O
ATL	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
signals	O	NOUN	B
controlling	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
receptor	B-protein	NOUN	B
protein	I-protein	NOUN	I
for	O	ADP	O
1	O	NUM	O
alpha	O	NOUN	B
,	O	PUNCT	O
25-dihydroxyvitamin	O	NOUN	B
D3	O	NOUN	I
in	O	ADP	O
normal	O	ADJ	O
human	B-cell_type	ADJ	B
lymphocytes	I-cell_type	NOUN	B
and	O	CCONJ	O
the	O	DET	O
relationship	O	NOUN	B
of	O	ADP	O
this	O	DET	O
protein	O	NOUN	B
to	O	PART	O
the	O	DET	O
classical	B-protein	ADJ	O
vitamin	I-protein	NOUN	B
D	I-protein	NOUN	I
receptor	I-protein	NOUN	I
were	O	AUX	O
examined	O	VERB	O
.	O	PUNCT	O


The	O	DET	O
receptor	O	NOUN	B
from	O	ADP	O
OKT3	B-protein	NOUN	B
and	O	CCONJ	O
OKT3	B-protein	NOUN	B
+	O	CCONJ	O
phorbol	O	NOUN	B
myristate	O	NOUN	B
acetate	O	NOUN	I
-activated	B-cell_type	ADJ	O
lymphocytes	I-cell_type	NOUN	B
exhibited	O	VERB	O
decreased	O	VERB	B
binding	O	NOUN	B
to	O	PART	O
DNA-cellulose	O	NOUN	B
compared	O	VERB	O
to	O	PART	O
PHA-activated	B-cell_type	ADJ	B
lymphocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
these	O	DET	O
genes	O	NOUN	B
are	O	AUX	O
not	O	PART	O
constitutively	O	ADV	B
active	O	ADJ	O
in	O	ADP	O
B	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
other	O	ADJ	O
regulatory	O	ADJ	B
mechanisms	O	NOUN	I
must	O	AUX	O
play	O	VERB	O
a	O	DET	O
role	O	NOUN	O
in	O	ADP	O
determining	O	VERB	O
the	O	DET	O
patterns	O	NOUN	B
of	O	ADP	O
expression	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
investigated	O	VERB	B
the	O	DET	O
constitutive	O	ADJ	B
and	O	CCONJ	O
inducible	O	ADJ	B
transcriptional	O	ADJ	O
activity	O	NOUN	O
mediated	O	VERB	O
by	O	ADP	O
five	O	NUM	O
kappa	B-DNA	NOUN	O
B-related	I-DNA	ADJ	B
sequence	I-DNA	NOUN	I
elements	I-DNA	NOUN	I
in	O	ADP	O
two	O	NUM	O
different	O	ADJ	O
cell	O	NOUN	B
types	O	NOUN	I
.	O	PUNCT	O


Interferons	B-protein	NOUN	B
(	O	PUNCT	O
IFNs	B-protein	NOUN	B
)	O	PUNCT	O
are	O	AUX	O
well	O	ADV	O
known	O	VERB	O
both	O	CCONJ	O
as	O	ADP	O
antiviral	B-protein	ADJ	B
proteins	I-protein	NOUN	I
and	O	CCONJ	O
as	O	ADP	O
potent	O	ADJ	O
regulators	O	NOUN	B
of	O	ADP	O
cell	O	NOUN	B
growth	O	NOUN	I
and	O	CCONJ	O
differentiation	O	NOUN	B
.	O	PUNCT	O


Previously	O	ADV	O
,	O	PUNCT	O
a	O	DET	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
,	O	PUNCT	O
IRF-1	B-protein	NOUN	B
(	O	PUNCT	O
interferon	B-protein	NOUN	B
regulatory	I-protein	ADJ	I
factor	I-protein	NOUN	I
1	I-protein	NUM	I
)	O	PUNCT	O
,	O	PUNCT	O
which	O	DET	O
binds	O	VERB	B
to	O	PART	O
type	B-DNA	NOUN	B
I	I-DNA	NUM	I
IFN	I-DNA	NOUN	I
and	O	CCONJ	O
some	O	DET	O
IFN-inducible	B-DNA	ADJ	B
gene	I-DNA	NOUN	B
promoters	I-DNA	NOUN	I
,	O	PUNCT	O
was	O	AUX	O
identified	O	VERB	B
and	O	CCONJ	O
cloned	O	VERB	B
.	O	PUNCT	O


Preparation	O	NOUN	B
and	O	CCONJ	O
analysis	O	NOUN	B
of	O	ADP	O
bone	B-cell_type	NOUN	B
marrow	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
from	O	ADP	O
the	O	DET	O
chimeric	O	ADJ	B
mice	O	NOUN	I
indicated	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
bone	O	NOUN	B
marrow	O	NOUN	I
is	O	AUX	O
the	O	DET	O
effective	O	ADJ	B
site	O	NOUN	B
for	O	ADP	O
specific	O	ADJ	O
depletion	O	NOUN	B
of	O	ADP	O
the	O	DET	O
B-cell	B-cell_type	NOUN	B
population	I-cell_type	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
DCoH	B-protein	NOUN	B
did	O	AUX	O
not	O	PART	O
confer	O	VERB	O
transcriptional	O	ADJ	B
activation	O	NOUN	I
to	O	PART	O
the	O	DET	O
GAL4	B-protein	NOUN	B
DNA	I-protein	NOUN	B
binding	I-protein	NOUN	I
domain	I-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
finding	O	NOUN	B
that	O	SCONJ	O
dexamethasone	O	NOUN	B
has	O	AUX	O
no	O	DET	O
effect	O	NOUN	O
on	O	ADP	O
TPA-induced	O	ADJ	B
activation	O	NOUN	B
of	O	ADP	O
PKC	B-protein	NOUN	B
suggests	O	VERB	O
that	O	SCONJ	O
this	O	DET	O
glucocorticoid	O	NOUN	B
inhibits	O	VERB	B
signals	O	NOUN	B
downstream	O	ADV	I
or	O	CCONJ	O
parallel	O	ADJ	O
to	O	PART	O
this	O	DET	O
enzyme	B-protein	NOUN	B
.	O	PUNCT	O


Human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
(	O	PUNCT	O
HIV	O	NOUN	B
)	O	PUNCT	O
expression	O	NOUN	B
and	O	CCONJ	O
replication	O	NOUN	B
are	O	AUX	O
under	O	ADP	O
tight	O	ADJ	B
regulatory	O	ADJ	I
control	O	NOUN	I
.	O	PUNCT	O


1	O	NUM	O
,	O	PUNCT	O
25	O	NUM	O
(	O	PUNCT	O
OH	O	NOUN	B
)	O	PUNCT	O
2D3	O	NOUN	B
is	O	AUX	O
therefore	O	ADV	O
one	O	NUM	O
of	O	ADP	O
the	O	DET	O
most	O	ADV	O
potent	O	ADJ	O
regulators	O	NOUN	B
of	O	ADP	O
HIV-1	O	NOUN	B
replication	O	NOUN	B
described	O	VERB	O
to	O	ADP	O
date	O	NOUN	O
.	O	PUNCT	O


These	O	DET	O
studies	O	NOUN	B
may	O	AUX	O
have	O	AUX	O
important	O	ADJ	O
implications	O	NOUN	O
for	O	ADP	O
the	O	DET	O
design	O	NOUN	B
of	O	ADP	O
effective	O	ADJ	B
therapy	O	NOUN	B
of	O	ADP	O
HIV-1	O	NOUN	B
infection	O	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
TGF-beta	B-protein	NOUN	B
had	O	AUX	O
only	O	ADV	O
minimal	O	ADJ	B
effects	O	NOUN	B
on	O	ADP	O
two	O	NUM	O
other	O	ADJ	O
B	B-protein	NOUN	B
cell	I-protein	NOUN	I
membrane	I-protein	NOUN	I
proteins	I-protein	NOUN	I
,	O	PUNCT	O
HLA-DR	B-protein	NOUN	B
and	O	CCONJ	O
CD20	B-protein	NOUN	B
.	O	PUNCT	O


Internal	O	ADJ	B
labeling	O	NOUN	I
with	O	ADP	I
[	O	PUNCT	O
35S	O	NOUN	O
]	O	PUNCT	O
methionine	O	NOUN	B
and	O	CCONJ	O
immunoprecipitation	O	NOUN	B
with	O	ADP	O
anti-IgM	B-protein	NOUN	B
,	O	PUNCT	O
anti-kappa	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
anti-lambda	B-protein	ADJ	B
antibodies	I-protein	NOUN	I
revealed	O	VERB	O
a	O	DET	O
striking	O	ADJ	O
reduction	O	NOUN	B
in	O	ADP	O
kappa	B-protein	NOUN	B
L	I-protein	NOUN	I
chain	I-protein	NOUN	I
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
TGF-beta	B-protein	NOUN	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
a	O	DET	O
significant	O	ADJ	O
decrease	O	NOUN	B
in	O	ADP	O
the	O	DET	O
switch	O	NOUN	B
from	O	ADP	O
the	O	DET	O
membrane	B-RNA	NOUN	B
forms	I-RNA	NOUN	O
of	O	ADP	O
mu	B-RNA	NOUN	B
and	O	CCONJ	O
gamma	B-RNA	NOUN	O
to	O	PART	O
their	O	PRON	O
respective	O	ADJ	O
secreted	B-RNA	VERB	B
forms	I-RNA	NOUN	O
was	O	AUX	O
noted	O	VERB	O
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
TGF-beta	B-protein	NOUN	B
.	O	PUNCT	O


These	O	DET	O
findings	O	NOUN	B
demonstrate	O	VERB	O
that	O	SCONJ	O
TGF-beta	B-protein	NOUN	B
decreases	O	VERB	B
B	O	NOUN	B
lymphocyte	O	NOUN	I
Ig	B-protein	NOUN	I
secretion	O	NOUN	I
by	O	ADP	O
inhibiting	O	VERB	B
the	O	DET	O
synthesis	O	NOUN	B
of	O	ADP	O
Ig	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	I
and	O	CCONJ	O
inhibiting	O	VERB	B
the	O	DET	O
switch	O	NOUN	B
from	O	ADP	O
the	O	DET	O
membrane	B-RNA	NOUN	B
form	I-RNA	NOUN	O
to	O	PART	O
the	O	DET	O
secreted	B-RNA	VERB	B
forms	I-RNA	NOUN	O
of	O	ADP	O
mu	B-RNA	NOUN	B
and	I-RNA	CCONJ	O
gamma	I-RNA	NOUN	B
mRNA	I-RNA	NOUN	I
.	O	PUNCT	O


One	O	NUM	O
of	O	ADP	O
the	O	DET	O
members	O	NOUN	B
of	O	ADP	O
this	O	DET	O
multigene	O	NOUN	B
family	O	NOUN	I
,	O	PUNCT	O
cGATA-3	B-protein	NOUN	B
,	O	PUNCT	O
is	O	AUX	O
most	O	ADV	O
abundantly	O	ADV	O
expressed	O	VERB	B
in	O	ADP	O
the	O	DET	O
T-lymphocyte	B-cell_type	NOUN	B
cell	I-cell_type	NOUN	I
lineage	I-cell_type	NOUN	O
.	O	PUNCT	O


Processing	O	NOUN	B
of	O	ADP	O
the	O	DET	O
precursor	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
by	O	ADP	O
the	O	DET	O
HIV-1	B-protein	NOUN	B
protease	I-protein	NOUN	I
during	O	ADP	O
acute	O	ADJ	B
infection	O	NOUN	I
.	O	PUNCT	O


T-cell	O	NOUN	B
activation	O	NOUN	O
also	O	ADV	O
correlates	O	VERB	O
with	O	ADP	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
the	O	DET	O
factor	O	NOUN	B
NF-kappa	B-protein	NOUN	I
B	I-protein	NOUN	I
which	O	DET	O
binds	O	VERB	B
to	O	PART	O
two	O	NUM	O
adjacent	O	ADJ	B
sites	O	NOUN	O
in	O	ADP	O
the	O	DET	O
HIV-1	B-DNA	NOUN	B
long	I-DNA	ADJ	B
terminal	I-DNA	ADJ	I
repeat	I-DNA	NOUN	I
.	O	PUNCT	O


1	O	NUM	O
,	O	PUNCT	O
25-Dihydroxyvitamin	O	NOUN	B
D3	O	NOUN	I
[	O	PUNCT	O
1	O	NUM	O
,	O	PUNCT	O
25	O	NUM	O
(	O	PUNCT	O
OH	O	NOUN	B
)	O	PUNCT	O
2D3	O	NOUN	O
]	O	PUNCT	O
induces	O	VERB	B
differentiation	O	NOUN	B
and	O	CCONJ	O
inhibits	O	VERB	B
proliferation	O	NOUN	B
of	O	ADP	O
myeloid	B-cell_type	ADJ	B
leukemic	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
from	O	ADP	O
various	O	ADJ	O
lines	O	NOUN	B
and	O	CCONJ	O
patients	O	NOUN	B
;	O	PUNCT	O
these	O	DET	O
effects	O	NOUN	B
are	O	AUX	O
probably	O	ADV	O
mediated	O	VERB	O
through	O	ADP	O
the	O	DET	O
1	B-protein	NUM	O
,	I-protein	PUNCT	O
25	I-protein	NUM	O
(	I-protein	PUNCT	O
OH	I-protein	NOUN	B
)	I-protein	PUNCT	O
2D3	I-protein	NOUN	B
receptor	I-protein	NOUN	I
.	O	PUNCT	O


Levels	O	NOUN	B
of	O	ADP	O
occupied	O	VERB	B
1	B-protein	NUM	O
,	I-protein	PUNCT	O
25	I-protein	NUM	O
(	I-protein	PUNCT	O
OH	I-protein	NOUN	B
)	I-protein	PUNCT	O
2D3	I-protein	NOUN	B
receptor	I-protein	NOUN	I
protein	I-protein	NOUN	I
increased	O	VERB	B
in	O	ADP	O
these	O	DET	O
HL-60	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
;	O	PUNCT	O
but	O	CCONJ	O
the	O	DET	O
total	O	ADJ	O
number	O	NOUN	O
of	O	ADP	O
1	B-protein	NUM	O
,	I-protein	PUNCT	O
25	I-protein	NUM	O
(	I-protein	PUNCT	O
OH	I-protein	NOUN	B
)	I-protein	PUNCT	O
2D3	I-protein	NOUN	B
receptors	I-protein	NOUN	I
decreased	O	VERB	B
about	O	ADV	O
50	O	NUM	O
%	O	NOUN	O
at	O	ADP	O
24	O	NUM	O
hours	O	NOUN	B
and	O	CCONJ	O
returned	O	VERB	O
toward	O	ADP	O
normal	O	ADJ	B
at	O	ADP	O
72	O	NUM	O
hours	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
suggest	O	VERB	O
a	O	DET	O
role	O	NOUN	O
for	O	ADP	O
HSP27	B-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
signal	O	NOUN	B
transduction	O	NOUN	I
events	O	NOUN	B
of	O	ADP	O
platelet	B-cell_type	NOUN	B
activation	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
isolated	O	VERB	B
a	O	DET	O
human	B-DNA	ADJ	B
cDNA	I-DNA	NOUN	B
clone	I-DNA	NOUN	O
encoding	O	VERB	B
a	O	DET	O
zinc	B-protein	NOUN	B
finger	I-protein	NOUN	I
protein	I-protein	NOUN	I
(	O	PUNCT	O
NF-E1	B-protein	NOUN	B
)	O	PUNCT	O
that	O	PRON	O
binds	O	VERB	B
to	O	PART	O
the	O	DET	O
negative-acting	B-DNA	ADJ	B
segment	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
kappa	B-DNA	NOUN	O
E3	I-DNA	NOUN	O
'	I-DNA	PART	O
enhancer	I-DNA	NOUN	O
.	O	PUNCT	O


A	O	DET	O
human	B-DNA	ADJ	B
putative	I-DNA	ADJ	B
lymphocyte	I-DNA	NOUN	I
G0/G1	I-DNA	NOUN	O
switch	I-DNA	NOUN	O
gene	I-DNA	NOUN	O
containing	O	VERB	O
a	O	DET	O
CpG-rich	B-DNA	ADJ	B
island	I-DNA	NOUN	I
encodes	O	VERB	B
a	O	DET	O
small	B-protein	ADJ	O
basic	I-protein	ADJ	O
protein	I-protein	NOUN	O
with	O	ADP	O
the	O	DET	O
potential	O	NOUN	B
to	O	PART	O
be	O	AUX	O
phosphorylated	O	VERB	B
.	O	PUNCT	O


This	O	DET	O
paper	O	NOUN	O
presents	O	VERB	O
studies	O	NOUN	B
of	O	ADP	O
G0S2	B-DNA	NOUN	B
,	O	PUNCT	O
a	O	DET	O
member	O	NOUN	O
of	O	ADP	O
a	O	DET	O
set	O	NOUN	O
of	O	ADP	O
putative	O	ADJ	O
G0S	B-RNA	NOUN	B
genes	I-RNA	NOUN	I
,	O	PUNCT	O
for	O	ADP	O
which	O	DET	O
cDNAs	B-DNA	NOUN	B
were	O	AUX	O
cloned	O	VERB	B
and	O	CCONJ	O
selected	O	VERB	O
on	O	ADP	O
the	O	DET	O
basis	O	NOUN	O
of	O	ADP	O
differential	O	ADJ	O
cDNA	O	NOUN	B
hybridization	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
derived	O	VERB	O
103-amino-acid	B-protein	ADJ	O
basic	I-protein	ADJ	O
protein	I-protein	NOUN	B
has	O	AUX	O
two	O	NUM	O
potential	O	ADJ	O
alpha-helical	B-protein	ADJ	B
domains	I-protein	NOUN	I
separated	O	VERB	O
by	O	ADP	O
a	O	DET	O
hydrophobic	B-protein	ADJ	B
region	I-protein	NOUN	I
with	O	ADP	O
the	O	DET	O
potential	O	NOUN	B
to	O	PART	O
generate	O	VERB	O
turns	O	NOUN	B
and	O	CCONJ	O
assume	O	VERB	O
a	O	DET	O
beta-sheet	O	ADJ	B
conformation	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
gene	O	NOUN	B
contains	O	VERB	O
a	O	DET	O
CpG-rich	B-protein	ADJ	B
island	I-protein	NOUN	B
suggesting	O	VERB	O
expression	O	NOUN	B
in	O	ADP	O
the	O	DET	O
germ	O	NOUN	B
line	O	NOUN	I
.	O	PUNCT	O


An	O	DET	O
upstream	B-DNA	ADJ	B
segment	I-DNA	NOUN	I
contains	O	VERB	O
tandem	B-DNA	ADJ	B
dinucleotide	I-DNA	NOUN	I
repeats	I-DNA	NOUN	I
(	B-DNA	PUNCT	O
CT	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
19/	I-DNA	NUM	O
(	I-DNA	PUNCT	O
CA	I-DNA	PROPN	B
)	I-DNA	PUNCT	O
16	I-DNA	NUM	O
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
HIV-TF1	B-protein	NOUN	B
is	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
transcriptional	O	ADJ	B
regulation	O	NOUN	I
of	O	ADP	O
HIV-1	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
study	O	NOUN	B
population	O	NOUN	I
included	O	VERB	O
the	O	DET	O
affected	O	VERB	B
patient	O	NOUN	B
(	O	PUNCT	O
proband	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
nine	O	NUM	O
of	O	ADP	O
her	O	PRON	O
blood	O	NOUN	B
relatives	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
seven	O	NUM	O
healthy	O	ADJ	B
volunteers	O	NOUN	I
.	O	PUNCT	O


Three	O	NUM	O
DNA	O	NOUN	B
clones	O	NOUN	I
containing	O	VERB	O
HHV-6	B-DNA	NOUN	B
(	I-DNA	PUNCT	O
GS	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
genomic	I-DNA	ADJ	B
fragments	I-DNA	NOUN	I
transactivated	O	VERB	B
the	O	DET	O
HIV	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
in	O	ADP	O
cotransfected	B-cell_line	VERB	B
T	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Using	O	VERB	O
amino	O	NOUN	B
acid	O	NOUN	I
sequence	O	NOUN	I
information	O	NOUN	B
derived	O	VERB	O
from	O	ADP	O
the	O	DET	O
DNA	B-protein	NOUN	B
affinity-purified	I-protein	ADJ	I
protein	I-protein	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
now	O	ADV	O
isolated	O	VERB	B
cDNA	B-DNA	NOUN	B
clones	I-DNA	NOUN	I
encoding	O	VERB	B
TCF-1	B-protein	NOUN	B
alpha	I-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
phenotypic	O	ADJ	B
differences	O	NOUN	O
observed	O	VERB	O
were	O	AUX	O
attributable	O	ADJ	O
,	O	PUNCT	O
in	O	ADP	O
large	O	ADJ	O
part	O	NOUN	O
,	O	PUNCT	O
to	O	PART	O
changes	O	NOUN	B
affecting	O	VERB	B
the	O	DET	O
viral	B-DNA	ADJ	B
LTR	I-DNA	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
cotransfection	O	NOUN	B
experiments	O	NOUN	O
we	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
all	O	DET	O
the	O	DET	O
isoforms	B-protein	NOUN	B
are	O	AUX	O
able	O	ADJ	O
to	O	PART	O
activate	O	VERB	B
an	O	DET	O
octamer	B-DNA	NOUN	B
containing	O	VERB	O
promoter	B-DNA	NOUN	B
element	I-DNA	NOUN	I
in	O	ADP	O
fibroblasts	O	NOUN	B
revealing	O	VERB	O
an	O	DET	O
unexpected	O	ADJ	O
functional	O	ADJ	B
redundancy	O	NOUN	B
.	O	PUNCT	O


[	O	PUNCT	O
Regulation	O	NOUN	B
of	O	ADP	O
intracellular	O	ADJ	B
cholesterol	O	NOUN	B
synthesis	O	NOUN	I
in	O	ADP	O
hypercholesterolemia	O	NOUN	B
by	O	ADP	O
glucocorticoids	O	NOUN	B
]	O	PUNCT	O


This	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
binding	O	NOUN	B
was	O	AUX	O
localized	O	ADJ	B
to	O	PART	O
the	O	DET	O
NF-kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
region	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
HIV-1	B-DNA	NOUN	B
enhancer	I-DNA	NOUN	B
;	O	PUNCT	O
the	O	DET	O
65-kDa	B-protein	ADJ	O
plus	I-protein	CCONJ	O
50-kDa	I-protein	ADJ	O
NF-kappa	I-protein	NOUN	B
B	I-protein	NOUN	I
heterodimer	I-protein	NOUN	B
was	O	AUX	O
preferentially	O	ADV	O
lost	O	VERB	B
.	O	PUNCT	O


Glucocorticoid	B-protein	NOUN	B
receptors	I-protein	NOUN	I
in	O	ADP	O
normal	B-cell_type	ADJ	O
leukocytes	I-cell_type	NOUN	B
:	O	PUNCT	O
effects	O	NOUN	B
of	O	ADP	I
age	O	NOUN	B
,	O	PUNCT	O
gender	O	NOUN	B
,	O	PUNCT	O
season	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
plasma	O	NOUN	B
cortisol	O	NOUN	B
concentrations	O	NOUN	B
.	O	PUNCT	O


Eight	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
dermatomyositis/polymyositis	O	NOUN	B
were	O	AUX	O
examined	O	VERB	O
to	O	PART	O
determine	O	VERB	O
whether	O	SCONJ	O
the	O	DET	O
number	O	NOUN	O
of	O	ADP	O
GR	B-protein	NOUN	B
in	O	ADP	O
MNL	B-cell_type	NOUN	B
could	O	AUX	O
be	O	AUX	O
down-regulated	O	VERB	B
by	O	ADP	O
their	O	PRON	O
cognate	O	ADJ	B
ligands	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
C26	B-DNA	NOUN	B
element	I-DNA	NOUN	B
conferred	O	VERB	O
partial	O	ADJ	B
responsiveness	O	NOUN	B
to	O	PART	O
p40tax	B-protein	NOUN	B
when	O	SCONJ	O
linked	O	VERB	O
to	O	PART	O
one	O	NUM	O
copy	O	NOUN	B
of	O	ADP	I
the	O	DET	I
21-bp	B-DNA	ADJ	I
element	I-DNA	NOUN	I
that	O	PRON	O
,	O	PUNCT	O
by	O	ADP	O
itself	O	PRON	O
,	O	PUNCT	O
showed	O	VERB	O
little	O	ADJ	O
activation	O	NOUN	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
p40tax	B-protein	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
C26	B-DNA	NOUN	B
element	I-DNA	NOUN	B
itself	O	PRON	O
was	O	AUX	O
profoundly	O	ADV	O
activated	O	VERB	B
upon	O	SCONJ	O
stimulation	O	NOUN	B
with	O	ADP	O
12-O-tetradecanoylphorbol-13-acetate	O	NOUN	B
.	O	PUNCT	O


Human	O	ADJ	B
tumor	B-protein	NOUN	O
necrosis	I-protein	NOUN	O
factor	I-protein	NOUN	O
alpha	I-protein	NOUN	O
gene	O	NOUN	O
regulation	O	NOUN	O
in	O	ADP	O
phorbol	O	NOUN	B
ester	O	NOUN	I
stimulated	B-cell_line	VERB	B
T	I-cell_line	NOUN	B
and	I-cell_line	CCONJ	O
B	I-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
generated	O	VERB	O
a	O	DET	O
monoclonal	B-protein	ADJ	B
antibody	I-protein	NOUN	I
,	O	PUNCT	O
BZ1	B-protein	NOUN	B
,	O	PUNCT	O
to	O	PART	O
BZLF1	B-protein	NOUN	B
which	O	DET	O
reacts	O	VERB	O
in	O	ADP	O
immunohistology	O	NOUN	B
,	O	PUNCT	O
immunoblotting	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
immunoprecipitation	O	NOUN	B
and	O	CCONJ	O
which	O	DET	O
recognizes	O	VERB	O
both	O	CCONJ	O
the	O	DET	O
active	B-protein	ADJ	B
,	I-protein	PUNCT	O
dimeric	I-protein	ADJ	B
form	I-protein	NOUN	I
and	O	CCONJ	O
the	O	DET	O
inactive	B-protein	ADJ	B
,	I-protein	PUNCT	O
monomeric	I-protein	ADJ	B
form	I-protein	NOUN	I
of	O	ADP	O
the	O	DET	O
protein	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
differentiation-associated	O	ADJ	O
pattern	O	NOUN	O
of	O	ADP	O
BZLF1	B-protein	NOUN	B
expression	O	NOUN	B
was	O	AUX	O
observed	O	VERB	O
,	O	PUNCT	O
BZ1	B-protein	NOUN	B
reacting	O	VERB	O
with	O	ADP	O
nuclei	O	NOUN	B
of	O	ADP	O
the	O	DET	O
upper	O	ADJ	B
spinous	O	ADJ	I
layer	O	NOUN	I
of	O	ADP	O
the	O	DET	O
lesion	O	NOUN	B
.	O	PUNCT	O


[	O	PUNCT	O
Changes	O	NOUN	B
in	O	ADP	O
levels	O	NOUN	B
of	O	ADP	O
leucocytic	B-protein	ADJ	B
estrogen	I-protein	NOUN	I
receptor	I-protein	NOUN	I
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
menopausal	O	ADJ	B
type	O	NOUN	I
II	O	NUM	I
diabetes	O	NOUN	I
and	O	CCONJ	O
its	O	PRON	O
significance	O	NOUN	B
]	O	PUNCT	O


OBJECTIVE	O	NOUN	B
:	O	PUNCT	O
The	O	DET	O
authors	O	NOUN	B
'	O	PART	O
objective	O	NOUN	B
was	O	AUX	O
to	O	PART	O
investigate	O	VERB	B
the	O	DET	O
possibility	O	NOUN	O
that	O	SCONJ	O
glucocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
changes	O	NOUN	B
may	O	AUX	O
be	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
dysregulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
hypothalamic-pituitary-adrenal	O	ADJ	B
(	O	PUNCT	I
HPA	O	ADJ	I
)	O	PUNCT	I
axis	O	NOUN	I
in	O	ADP	O
posttraumatic	O	ADJ	B
stress	O	NOUN	I
disorder	O	NOUN	I
(	O	PUNCT	O
PTSD	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Also	O	ADV	O
,	O	PUNCT	O
in	O	ADP	O
a	O	DET	O
promonocyte	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
chronically	O	ADV	B
infected	O	VERB	B
with	O	ADP	O
HIV	O	NOUN	B
,	O	PUNCT	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
expression	O	NOUN	B
and	O	CCONJ	O
HIV	O	NOUN	B
transcription	O	NOUN	B
were	O	AUX	O
enhanced	O	VERB	B
on	O	ADP	O
stimulation	O	NOUN	B
with	O	ADP	O
phorbol	O	NOUN	B
ester	O	NOUN	I
or	O	CCONJ	O
TNF	B-protein	NOUN	B
alpha	I-protein	NOUN	I
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
stimulation	O	NOUN	B
of	O	ADP	O
monocyte	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
by	O	ADP	O
phorbol	O	NOUN	B
esters	O	NOUN	I
or	O	CCONJ	O
TNF	B-protein	NOUN	B
alpha	I-protein	NOUN	I
induces	O	VERB	O
cell	O	NOUN	B
differentiation	O	NOUN	I
and	O	CCONJ	O
activates	O	VERB	B
HIV	O	NOUN	B
transcription	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
describe	O	VERB	O
a	O	DET	O
slide	O	NOUN	B
assay	O	NOUN	I
that	O	PRON	O
allows	O	VERB	O
the	O	DET	O
demonstration	O	NOUN	B
of	O	ADP	O
antigens	B-protein	NOUN	B
localized	O	VERB	B
in	O	ADP	O
the	O	DET	O
nucleus	O	NOUN	B
from	O	ADP	O
isolated	B-cell_type	VERB	B
white	I-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
from	O	ADP	O
single	B-cell_type	ADJ	O
tumor	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
derived	O	VERB	O
from	O	ADP	O
malignant	O	ADJ	B
effusions	O	NOUN	I
.	O	PUNCT	O


Pleural	O	ADJ	B
effusions	O	NOUN	I
from	O	ADP	O
20	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
breast	O	NOUN	B
cancer	O	NOUN	I
were	O	AUX	O
tested	O	VERB	B
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
examined	O	VERB	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
NF-kB	B-protein	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
T	I-cell_type	NOUN	B
cell	I-cell_type	NOUN	I
thymic	I-cell_type	ADJ	O
progenitors	I-cell_type	NOUN	O
.	O	PUNCT	O


These	O	DET	O
observations	O	NOUN	B
imply	O	VERB	O
that	O	SCONJ	O
TCF-1	B-protein	NOUN	B
is	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
control	O	NOUN	B
of	O	ADP	O
several	O	ADJ	O
T	B-DNA	NOUN	B
cell-specific	I-DNA	ADJ	I
genes	I-DNA	NOUN	I
and	O	CCONJ	O
might	O	AUX	O
thus	O	ADV	O
play	O	VERB	O
an	O	DET	O
important	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
establishment	O	NOUN	B
and	O	CCONJ	O
maintenance	O	NOUN	B
of	O	ADP	O
the	O	DET	O
mature	B-cell_type	ADJ	B
T	I-cell_type	NOUN	B
cell	I-cell_type	NOUN	I
phenotype	I-cell_type	NOUN	B
.	O	PUNCT	O


The	O	DET	O
mature	O	ADJ	B
mitochondrial	O	ADJ	B
forms	O	NOUN	I
of	O	ADP	O
the	O	DET	O
erythroid	O	ADJ	B
and	O	CCONJ	O
housekeeping	B-protein	ADJ	B
ALAS	I-protein	NOUN	I
isozymes	I-protein	NOUN	I
are	O	AUX	O
predicted	O	VERB	O
to	O	PART	O
have	O	AUX	O
molecular	O	ADJ	B
weights	O	NOUN	I
of	O	ADP	O
59.5	O	NUM	O
kd	O	NOUN	O
and	O	CCONJ	O
64.6	O	NUM	O
kd	O	NOUN	O
,	O	PUNCT	O
respectively	O	ADV	O
.	O	PUNCT	O


The	O	DET	O
present	O	ADJ	O
studies	O	NOUN	B
have	O	AUX	O
examined	O	VERB	O
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	O
M-CSF	B-protein	NOUN	B
on	O	ADP	O
potential	O	ADJ	B
signaling	O	NOUN	B
pathways	O	NOUN	I
involving	O	VERB	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
jun	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
fos	I-DNA	NOUN	B
early	I-DNA	ADJ	O
response	I-DNA	NOUN	O
genes	I-DNA	NOUN	O
.	O	PUNCT	O


Moreover	O	ADV	O
,	O	PUNCT	O
M-CSF	B-protein	NOUN	B
-induced	O	ADJ	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
fos-related	B-DNA	ADJ	B
gene	I-DNA	NOUN	I
,	O	PUNCT	O
fra-1	B-DNA	NOUN	B
,	O	PUNCT	O
was	O	AUX	O
delayed	O	VERB	B
compared	O	VERB	B
to	O	PART	O
that	O	DET	O
for	O	ADP	O
both	O	CCONJ	O
c-fos	B-DNA	NOUN	B
and	O	CCONJ	O
fos-B	B-DNA	NOUN	B
.	O	PUNCT	O


Over	O	ADP	O
the	O	DET	O
past	O	ADJ	O
decade	O	NOUN	O
it	O	PRON	O
has	O	AUX	O
become	O	VERB	O
clear	O	ADJ	O
that	O	SCONJ	O
glucocorticosteroid	B-protein	NOUN	B
receptors	I-protein	NOUN	I
play	O	VERB	O
a	O	DET	O
significant	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
mechanism	O	NOUN	B
of	O	ADP	O
glucocorticosteroid	O	NOUN	B
action	O	NOUN	O
.	O	PUNCT	O


Kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
binding	I-protein	NOUN	I
proteins	I-protein	NOUN	I
are	O	AUX	O
constitutively	O	ADV	B
expressed	O	VERB	B
in	O	ADP	O
an	O	DET	O
IL-2	B-cell_line	NOUN	B
autocrine	I-cell_line	ADJ	B
human	I-cell_line	ADJ	B
T	I-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
agreement	O	NOUN	O
with	O	ADP	O
this	O	DET	O
finding	O	NOUN	B
,	O	PUNCT	O
both	O	CCONJ	O
the	O	DET	O
IL-2	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
IL-2-R	I-DNA	NOUN	B
alpha	I-DNA	NOUN	I
promoters	I-DNA	NOUN	I
are	O	AUX	O
active	O	ADJ	B
in	O	ADP	O
transient	O	ADJ	B
transfection	O	NOUN	O
assays	O	NOUN	O
in	O	ADP	O
IARC	B-cell_line	NOUN	B
301	I-cell_line	NUM	O
cells	I-cell_line	NOUN	B
.	O	PUNCT	O


Protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
C	I-protein	NOUN	I
activation	O	NOUN	B
and	O	CCONJ	O
protooncogene	B-DNA	NOUN	B
expression	O	NOUN	I
in	O	ADP	O
differentiation/retrodifferentiation	O	NOUN	B
of	O	ADP	O
human	B-cell_line	ADJ	B
U-937	I-cell_line	NOUN	O
leukemia	I-cell_line	NOUN	O
cells	I-cell_line	NOUN	B
.	O	PUNCT	O


Treatment	O	NOUN	B
of	O	ADP	O
U-937	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
with	O	ADP	O
TPA	O	NOUN	B
resulted	O	VERB	O
in	O	ADP	O
a	O	DET	O
rapid	O	ADJ	O
translocation	O	NOUN	B
of	O	ADP	O
protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
C	I-protein	NOUN	I
(	O	PUNCT	O
PKC	B-protein	NOUN	B
)	O	PUNCT	O
from	O	ADP	O
the	O	DET	O
cytosol	O	NOUN	B
to	O	PART	O
cell	O	NOUN	B
membrane	O	NOUN	I
fractions	O	NOUN	B
within	O	ADP	O
2-8	O	NUM	O
min	O	NOUN	O
.	O	PUNCT	O


(	O	PUNCT	O
ABSTRACT	O	NOUN	B
TRUNCATED	O	VERB	I
AT	O	ADP	I
250	O	NUM	I
WORDS	O	NOUN	I
)	O	PUNCT	O


Kappa	B-protein	NOUN	B
B-specific	I-protein	ADJ	I
DNA	I-protein	NOUN	I
binding	I-protein	NOUN	I
proteins	I-protein	NOUN	I
are	O	AUX	O
differentially	O	ADV	O
inhibited	O	VERB	B
by	O	ADP	O
enhancer	O	NOUN	B
mutations	O	NOUN	I
and	O	CCONJ	O
biological	O	ADJ	B
oxidation	O	NOUN	B
.	O	PUNCT	O


Kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
(	I-protein	PUNCT	O
kappa	I-protein	NOUN	O
B	I-protein	NOUN	O
)	I-protein	PUNCT	O
enhancer	I-protein	NOUN	O
binding	I-protein	NOUN	O
proteins	I-protein	NOUN	O
isolated	O	VERB	B
from	O	ADP	O
the	O	DET	O
nuclei	O	NOUN	B
of	O	ADP	O
activated	O	VERB	B
human	B-cell_type	ADJ	B
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
produce	O	VERB	O
two	O	NUM	O
distinct	O	ADJ	O
nucleoprotein	B-protein	NOUN	B
complexes	I-protein	NOUN	I
when	O	SCONJ	O
incubated	O	VERB	B
with	O	ADP	O
the	O	DET	O
kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
element	I-DNA	NOUN	I
from	O	ADP	O
the	O	DET	O
interleukin-2	B-DNA	NOUN	B
receptor-alpha	I-DNA	NOUN	I
(	I-DNA	PUNCT	O
IL-2R	I-DNA	NOUN	B
alpha	I-DNA	NOUN	I
)	I-DNA	PUNCT	O
gene	I-DNA	NOUN	O
.	O	PUNCT	O


[	O	PUNCT	O
Changes	O	NOUN	B
in	O	ADP	O
leucocytic	O	ADJ	B
estrogen	B-protein	NOUN	I
receptor	I-protein	NOUN	I
levels	O	NOUN	B
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
climacteric	O	ADJ	B
syndrome	O	NOUN	I
and	O	CCONJ	O
therapeutic	O	ADJ	B
effect	O	NOUN	I
of	O	ADP	O
liuwei	O	X	B
dihuang	O	X	I
pills	O	NOUN	I
]	O	PUNCT	O


Evaluation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
ligand	O	NOUN	B
and	O	CCONJ	O
thermal	O	ADJ	B
activation	O	NOUN	B
of	O	ADP	O
specific	O	ADJ	O
DNA	O	NOUN	B
binding	O	NOUN	I
by	O	ADP	O
in	B-protein	X	B
vitro	I-protein	X	I
synthesized	I-protein	VERB	B
human	I-protein	ADJ	B
glucocorticoid	I-protein	NOUN	B
receptor	I-protein	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
used	O	VERB	O
a	O	DET	O
DNA-binding/immunoprecipitation	O	ADJ	O
assay	O	NOUN	B
to	O	PART	O
analyze	O	VERB	B
the	O	DET	O
capacity	O	NOUN	B
of	O	ADP	O
human	B-protein	ADJ	B
glucocorticoid	I-protein	NOUN	B
receptor	I-protein	NOUN	I
(	O	PUNCT	O
hGR	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
generated	O	VERB	O
in	O	ADP	O
rabbit	O	NOUN	B
reticulocyte	O	NOUN	B
lysates	O	NOUN	I
,	O	PUNCT	O
to	O	PART	O
bind	O	VERB	B
DNA	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
order	O	NOUN	O
to	O	PART	O
characterize	O	VERB	O
the	O	DET	O
cell	O	NOUN	B
types	O	NOUN	I
that	O	PRON	O
are	O	AUX	O
targets	O	NOUN	B
for	O	ADP	O
this	O	DET	O
immunoregulatory	O	ADJ	B
hormone	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
evaluated	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
1	B-protein	NUM	O
,	I-protein	PUNCT	O
25	I-protein	NUM	O
(	I-protein	PUNCT	O
OH	I-protein	NOUN	B
)	I-protein	PUNCT	O
2D3	I-protein	NOUN	B
receptors	I-protein	NOUN	I
on	O	ADP	O
peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
T-lymphocytes	I-cell_type	NOUN	B
and	O	CCONJ	O
those	O	DET	O
recovered	O	VERB	O
from	O	ADP	O
the	O	DET	O
lung	O	NOUN	B
by	O	ADP	O
bronchoalveolar	O	ADJ	B
lavage	O	NOUN	I
from	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
pulmonary	O	ADJ	B
granulomatous	O	ADJ	I
diseases	O	NOUN	I
(	O	PUNCT	O
tuberculosis	O	NOUN	B
and	O	CCONJ	O
sarcoidosis	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
from	O	ADP	O
normal	O	ADJ	B
control	O	ADJ	I
subjects	O	NOUN	I
using	O	VERB	O
combined	O	ADJ	O
autoradiographic	O	ADJ	B
and	O	CCONJ	O
immunohistochemical	O	ADJ	B
techniques	O	NOUN	I
.	O	PUNCT	O


Lavage	O	NOUN	B
T-lymphocytes	O	NOUN	I
from	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
tuberculosis	O	NOUN	B
or	O	CCONJ	O
with	O	ADP	O
sarcoidosis	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
those	O	DET	O
from	O	ADP	O
normal	O	ADJ	B
control	O	ADJ	I
subjects	O	NOUN	I
,	O	PUNCT	O
expressed	O	VERB	B
1	B-protein	NUM	O
,	I-protein	PUNCT	O
25	I-protein	NUM	O
(	I-protein	PUNCT	O
OH	I-protein	NOUN	B
)	I-protein	PUNCT	O
2D3	I-protein	NOUN	B
receptors	I-protein	NOUN	I
as	O	ADP	O
demonstrated	O	VERB	O
by	O	ADP	O
binding	O	NOUN	B
of	O	ADP	O
[	O	PUNCT	O
3H	O	NOUN	B
]	O	PUNCT	O
1	O	NUM	O
,	O	PUNCT	O
25	O	NUM	O
(	O	PUNCT	O
OH	O	NOUN	B
)	O	PUNCT	O
2D3	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
was	O	AUX	O
inhibited	O	VERB	B
by	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
excess	O	ADJ	B
unlabeled	O	ADJ	O
1	O	NUM	O
,	O	PUNCT	O
25	O	NUM	O
(	O	PUNCT	O
OH	O	NOUN	B
)	O	PUNCT	O
2D3	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
by	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
unlabeled	O	ADJ	B
25	O	NUM	O
(	O	PUNCT	O
OH	O	NOUN	O
)	O	PUNCT	O
D3	O	NOUN	O
(	O	PUNCT	O
receptor-positive	B-cell_type	ADJ	B
lymphocytes	I-cell_type	NOUN	I
:	O	PUNCT	O
sarcoidosis	O	NOUN	B
,	O	PUNCT	O
20	O	NUM	O
+/-	O	CCONJ	O
12	O	NUM	O
%	O	NOUN	O
;	O	PUNCT	O
tuberculosis	O	NOUN	B
,	O	PUNCT	O
31	O	NUM	O
+/-	O	CCONJ	O
17	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
.	O	PUNCT	O


1	B-protein	NUM	O
,	I-protein	PUNCT	O
25	I-protein	NUM	O
(	I-protein	PUNCT	O
OH	I-protein	NOUN	B
)	I-protein	PUNCT	O
2D3	I-protein	NOUN	B
receptors	I-protein	NOUN	I
were	O	AUX	O
expressed	O	VERB	B
to	O	PART	O
a	O	DET	O
greater	O	ADJ	O
extent	O	NOUN	O
on	O	ADP	O
CD8+	B-cell_type	ADJ	B
T-lymphocytes	I-cell_type	NOUN	B
than	O	ADP	O
on	O	ADP	O
CD4+	B-cell_type	ADJ	B
T-lymphocytes	I-cell_type	NOUN	B
in	O	ADP	O
sarcoidosis	O	NOUN	B
,	O	PUNCT	O
whereas	O	SCONJ	O
a	O	DET	O
greater	O	ADJ	O
proportion	O	NOUN	B
of	O	ADP	O
CD4+	B-cell_type	ADJ	B
than	O	ADP	O
of	O	ADP	O
CD8+	B-cell_type	ADJ	B
T-lymphocytes	I-cell_type	NOUN	I
from	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
tuberculosis	O	NOUN	B
were	O	AUX	O
receptor-positive	O	ADJ	B
.	O	PUNCT	O


During	O	ADP	O
latent	O	ADJ	B
Epstein-Barr	O	ADJ	B
virus	O	NOUN	I
(	O	PUNCT	O
EBV	O	NOUN	B
)	O	PUNCT	O
infection	O	NOUN	B
of	O	ADP	O
human	B-cell_type	ADJ	B
B	I-cell_type	NOUN	O
lymphocytes	I-cell_type	NOUN	O
,	O	PUNCT	O
six	B-protein	NUM	O
viral	I-protein	ADJ	B
nuclear	I-protein	ADJ	I
antigen	I-protein	NOUN	I
(	O	PUNCT	O
EBNAs	B-protein	NOUN	B
)	O	PUNCT	O
are	O	AUX	O
expressed	O	VERB	B
from	O	ADP	O
long	B-RNA	ADJ	O
primary	I-RNA	ADJ	O
transcripts	I-RNA	NOUN	B
by	O	ADP	O
means	O	NOUN	O
of	O	ADP	O
alternative	B-RNA	ADJ	B
splicing	I-RNA	NOUN	O
and	O	CCONJ	O
alternative	B-RNA	ADJ	B
polyadenylylation	I-RNA	NOUN	B
sites	I-RNA	NOUN	I
.	O	PUNCT	O


These	O	DET	O
studies	O	NOUN	B
have	O	AUX	O
been	O	AUX	O
extended	O	VERB	O
to	O	PART	O
show	O	VERB	O
that	O	SCONJ	O
(	O	PUNCT	O
i	O	X	O
)	O	PUNCT	O
a	O	DET	O
mutant	O	ADJ	B
EBV	O	NOUN	B
strain	O	NOUN	B
lacking	O	VERB	O
the	O	DET	O
gene	O	NOUN	B
encoding	O	NOUN	O
EBNA	B-protein	NOUN	B
2	I-protein	NUM	I
fails	O	VERB	O
to	O	PART	O
switch	O	VERB	B
from	O	ADP	O
Wp	O	NOUN	B
to	O	PART	O
Cp	B-DNA	NOUN	B
usage	O	NOUN	B
in	O	ADP	O
primary	B-cell_type	ADJ	B
B	I-cell_type	NOUN	I
lymphocytes	I-cell_type	NOUN	I
,	O	PUNCT	O
although	O	SCONJ	O
the	O	DET	O
virus	O	NOUN	B
contains	O	VERB	O
a	O	DET	O
functional	O	ADJ	B
Cp	B-DNA	NOUN	B
;	O	PUNCT	O
(	O	PUNCT	O
ii	O	X	O
)	O	PUNCT	O
a	O	DET	O
region	O	NOUN	B
from	O	ADP	O
-429	B-DNA	NUM	O
to	I-DNA	PART	O
-245	I-DNA	NUM	O
base	I-DNA	NOUN	B
pairs	I-DNA	NOUN	I
upstream	O	ADJ	I
of	O	ADP	O
Cp	B-DNA	NOUN	B
is	O	AUX	O
essential	O	ADJ	O
for	O	ADP	O
Cp	B-DNA	NOUN	B
activity	O	NOUN	B
in	O	ADP	O
B	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
only	O	ADV	O
in	O	ADP	O
the	O	DET	O
context	O	NOUN	B
of	O	ADP	O
upstream	B-DNA	ADJ	B
and	I-DNA	CCONJ	O
downstream	I-DNA	ADJ	B
sequences	I-DNA	NOUN	I
;	O	PUNCT	O
(	O	PUNCT	O
iii	O	X	O
)	O	PUNCT	O
this	O	DET	O
region	O	NOUN	B
contains	O	VERB	O
an	O	DET	O
EBNA	B-DNA	NOUN	B
2-dependent	I-DNA	ADJ	I
enhancer	I-DNA	NOUN	I
;	O	PUNCT	O
and	O	CCONJ	O
(	O	PUNCT	O
iv	O	X	O
)	O	PUNCT	O
DNase	B-protein	NOUN	B
I	I-protein	NUM	I
protection	O	NOUN	B
employing	O	VERB	O
nuclear	O	ADJ	B
extracts	O	NOUN	I
from	O	ADP	O
B	B-cell_type	NOUN	B
and	I-cell_type	CCONJ	O
T	I-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
revealed	O	VERB	O
a	O	DET	O
B-cell-specific	B-DNA	ADJ	B
footprint	I-DNA	NOUN	I
in	O	ADP	O
the	O	DET	O
region	O	NOUN	B
of	O	ADP	O
the	O	DET	O
EBNA	B-DNA	NOUN	B
2-dependent	I-DNA	ADJ	I
enhancer	I-DNA	NOUN	I
.	O	PUNCT	O


Using	O	VERB	O
recombinant	B-protein	ADJ	B
HBxAg	I-protein	NOUN	I
protein	I-protein	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
found	O	VERB	O
HBxAg	B-protein	NOUN	B
-specific	O	ADJ	O
stimulation	O	NOUN	B
of	O	ADP	O
peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
mononuclear	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
acute	O	ADJ	B
hepatitis	O	NOUN	I
B	O	NOUN	I
virus	O	NOUN	I
infection	O	NOUN	I
(	O	PUNCT	O
6	O	NUM	O
of	O	ADP	O
6	O	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
chronic	O	ADJ	B
hepatitis	O	NOUN	I
B	O	NOUN	I
virus	O	NOUN	I
infection	O	NOUN	I
(	O	PUNCT	O
6	O	NUM	O
of	O	ADP	O
17	O	NUM	O
)	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
in	O	ADP	O
healthy	O	ADJ	B
individuals	O	NOUN	B
.	O	PUNCT	O


Five	O	NUM	O
T-cell	B-cell_line	NOUN	B
clones	I-cell_line	NOUN	I
specific	O	ADJ	B
for	O	ADP	O
a	O	DET	O
T-cell	B-protein	NOUN	B
epitope	I-protein	NOUN	I
located	O	ADJ	O
at	O	ADP	O
the	O	DET	O
carboxyterminal	B-protein	ADJ	B
region	I-protein	NOUN	I
of	O	ADP	O
HBxAg	B-protein	NOUN	B
were	O	AUX	O
established	O	VERB	O
and	O	CCONJ	O
found	O	VERB	O
to	O	PART	O
belong	O	VERB	O
to	O	PART	O
the	O	DET	O
CD2/CD4-positive	B-cell_line	ADJ	B
,	I-cell_line	PUNCT	O
CD8-negative	I-cell_line	ADJ	B
subtype	I-cell_line	NOUN	B
.	O	PUNCT	O


It	O	PRON	O
suggested	O	VERB	O
that	O	SCONJ	O
increase	O	NOUN	B
of	O	ADP	O
ER	O	NOUN	B
levels	O	NOUN	B
play	O	VERB	O
an	O	DET	O
important	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
pathogenesis	O	NOUN	B
of	O	ADP	O
gynecomastia	O	NOUN	B
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
response	O	NOUN	B
of	O	ADP	O
the	O	DET	O
HIV-1	B-DNA	NOUN	B
LTR	I-DNA	NOUN	B
may	O	AUX	O
be	O	AUX	O
governed	O	VERB	O
by	O	ADP	O
two	O	NUM	O
independent	O	ADJ	O
sequences	O	NOUN	B
located	O	ADJ	O
5	O	NUM	O
'	O	PUNCT	O
to	O	ADP	O
the	O	DET	O
site	O	NOUN	B
of	O	ADP	O
transcription	O	NOUN	B
initiation	O	NOUN	I
sequences	O	NOUN	I
that	O	PRON	O
bind	O	VERB	B
either	O	CCONJ	O
NFAT-1	B-protein	NOUN	B
or	O	CCONJ	O
NF	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
.	O	PUNCT	O


The	O	DET	O
rate	O	NOUN	B
of	O	ADP	O
LTR	B-DNA	NOUN	B
-directed	O	ADJ	O
gene	O	NOUN	B
expression	O	NOUN	I
increased	O	VERB	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	I
treatment	O	NOUN	B
with	O	ADP	O
either	O	CCONJ	O
a	O	DET	O
phorbol	O	NOUN	B
ester	O	NOUN	I
or	O	CCONJ	O
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor	I-protein	NOUN	I
alpha	I-protein	NOUN	I
if	O	SCONJ	O
either	O	CCONJ	O
the	O	DET	O
NFAT-1	B-protein	NOUN	B
or	O	CCONJ	O
NF	B-DNA	NOUN	B
kappa	I-DNA	NOUN	I
B	I-DNA	NOUN	I
binding	I-DNA	NOUN	I
sites	I-DNA	NOUN	I
were	O	AUX	O
deleted	O	VERB	B
,	O	PUNCT	O
but	O	CCONJ	O
failed	O	VERB	B
to	O	PART	O
respond	O	VERB	O
to	O	PART	O
these	O	DET	O
mitogenic	O	ADJ	B
stimuli	O	NOUN	I
if	O	SCONJ	O
both	O	DET	O
sequences	O	NOUN	B
were	O	AUX	O
absent	O	ADJ	B
.	O	PUNCT	O


Activation	O	NOUN	B
of	O	ADP	O
proenkephalin	O	NOUN	B
transcription	O	NOUN	I
by	O	ADP	O
JunD	B-protein	NOUN	B
is	O	AUX	O
dependent	O	ADJ	O
upon	O	SCONJ	O
a	O	DET	O
previously	O	ADV	O
characterized	O	VERB	B
cAMP-	B-DNA	ADJ	B
,	I-DNA	PUNCT	O
phorbol	I-DNA	NOUN	B
ester-	I-DNA	NOUN	I
,	I-DNA	PUNCT	O
and	I-DNA	CCONJ	O
Ca	I-DNA	VERB	B
(	I-DNA	PUNCT	O
2+	I-DNA	NUM	O
)	I-DNA	PUNCT	O
-inducible	I-DNA	ADJ	O
enhancer	I-DNA	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
JunD	B-protein	NOUN	B
is	O	AUX	O
shown	O	VERB	O
to	O	PART	O
bind	O	VERB	B
the	O	DET	O
enhancer	B-DNA	NOUN	B
as	O	ADP	O
a	O	DET	O
homodimer	B-protein	NOUN	B
.	O	PUNCT	O


Another	O	DET	O
component	O	NOUN	O
of	O	ADP	O
the	O	DET	O
AP-1	B-protein	NOUN	B
transcription	I-protein	NOUN	I
complex	I-protein	NOUN	I
,	O	PUNCT	O
JunB	B-protein	NOUN	B
,	O	PUNCT	O
is	O	AUX	O
shown	O	VERB	O
to	O	PART	O
inhibit	O	VERB	B
activation	O	NOUN	B
mediated	O	VERB	O
by	O	ADP	O
JunD	B-protein	NOUN	B
.	O	PUNCT	O


[	O	PUNCT	O
Plasma	O	NOUN	B
cortisol	O	NOUN	B
concentration	O	NOUN	B
and	O	CCONJ	O
blood	O	NOUN	B
leukocyte	O	NOUN	I
content	O	NOUN	B
of	O	ADP	O
glucocorticoid	B-protein	NOUN	B
receptors	I-protein	NOUN	I
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
deficiency-cold	O	ADJ	B
vs	O	CCONJ	O
deficiency-heat	O	ADJ	B
syndromes	O	NOUN	I
]	O	PUNCT	O


Differentiation	O	NOUN	B
assays	O	NOUN	I
using	O	VERB	O
water	O	NOUN	B
soluble	O	ADJ	B
phorbol	O	NOUN	B
esters	O	NOUN	I
reveal	O	VERB	O
that	O	SCONJ	O
differentiation	O	NOUN	B
becomes	O	VERB	O
irreversible	O	ADJ	B
soon	O	ADV	O
after	O	ADP	O
AP-1	B-protein	NOUN	B
appears	O	VERB	O
.	O	PUNCT	O


This	O	DET	O
tight	O	ADJ	O
correlation	O	NOUN	B
between	O	ADP	O
c-jun	B-DNA	NOUN	B
expression	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
generation	O	NOUN	B
of	O	ADP	O
AP-1	B-protein	NOUN	B
activity	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
differentiation	O	NOUN	B
suggests	O	VERB	O
a	O	DET	O
critical	O	ADJ	O
role	O	NOUN	O
for	O	ADP	O
this	O	DET	O
gene	O	NOUN	B
and	O	CCONJ	O
transcriptional	B-protein	ADJ	B
complex	I-protein	NOUN	I
during	O	ADP	O
this	O	DET	O
process	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
putative	B-protein	ADJ	O
intracellular	I-protein	ADJ	O
receptors	I-protein	NOUN	O
for	O	ADP	O
FK506	O	NOUN	B
and	O	CCONJ	O
cyclosporin	O	NOUN	B
are	O	AUX	O
cis-trans	O	ADJ	B
prolyl	O	ADJ	I
isomerases	O	NOUN	I
.	O	PUNCT	O


FK506	O	NOUN	B
and	O	CCONJ	O
cyclosporin	O	NOUN	B
A	O	NOUN	O
block	O	NOUN	B
translocation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
cytoplasmic	B-protein	ADJ	B
component	I-protein	NOUN	O
without	O	ADP	O
affecting	O	VERB	B
synthesis	O	NOUN	B
of	O	ADP	O
the	O	DET	O
nuclear	B-protein	ADJ	B
subunit	I-protein	NOUN	I
.	O	PUNCT	O


Glucocorticoid	B-protein	NOUN	B
receptors	I-protein	NOUN	I
in	O	ADP	O
lymphocytes	B-cell_type	NOUN	B
in	O	ADP	O
anorexia	O	NOUN	B
nervosa	O	NOUN	I
.	O	PUNCT	O


Cloning	O	NOUN	B
of	O	ADP	O
murine	B-protein	ADJ	B
TCF-1	I-protein	NOUN	B
,	O	PUNCT	O
a	O	DET	O
T	O	NOUN	B
cell-specific	O	ADJ	I
transcription	B-protein	NOUN	I
factor	I-protein	NOUN	I
interacting	O	VERB	I
with	O	ADP	O
functional	B-DNA	ADJ	B
motifs	I-DNA	NOUN	B
in	O	ADP	O
the	O	DET	O
CD3-epsilon	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
T	I-DNA	NOUN	B
cell	I-DNA	NOUN	I
receptor	I-DNA	NOUN	I
alpha	I-DNA	NOUN	I
enhancers	I-DNA	NOUN	B
.	O	PUNCT	O


The	O	DET	O
T	O	NOUN	B
lineage-specific	O	ADJ	O
expression	O	NOUN	O
and	O	CCONJ	O
the	O	DET	O
affinity	O	NOUN	B
for	O	ADP	O
functional	O	ADJ	B
motifs	O	NOUN	B
in	O	ADP	O
the	O	DET	O
TCR-alpha	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
CD3-epsilon	I-DNA	NOUN	B
enhancers	I-DNA	NOUN	B
imply	O	VERB	O
an	O	DET	O
important	O	ADJ	O
role	O	NOUN	O
for	O	ADP	O
TCF-1	B-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
establishment	O	NOUN	O
of	O	ADP	O
the	O	DET	O
mature	B-cell_type	ADJ	B
T	I-cell_type	NOUN	B
cell	I-cell_type	NOUN	I
phenotype	I-cell_type	NOUN	B
.	O	PUNCT	O


Cloning	O	NOUN	B
of	O	ADP	O
a	O	DET	O
human	B-DNA	ADJ	B
homeobox	I-DNA	NOUN	O
gene	I-DNA	NOUN	O
that	O	PRON	O
resembles	O	VERB	O
a	O	DET	O
diverged	B-DNA	ADJ	O
Drosophila	I-DNA	NOUN	B
homeobox	I-DNA	NOUN	B
gene	I-DNA	NOUN	I
and	O	CCONJ	O
is	O	AUX	O
expressed	O	VERB	B
in	O	ADP	O
activated	O	VERB	B
lymphocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
report	O	NOUN	O
we	O	PRON	O
begin	O	VERB	O
to	O	PART	O
uncover	O	VERB	O
the	O	DET	O
influence	O	NOUN	B
of	O	ADP	O
platelet-activating	B-protein	ADJ	B
factor	I-protein	NOUN	I
on	O	ADP	O
B	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
further	O	ADV	O
demonstrate	O	VERB	O
the	O	DET	O
impact	O	NOUN	B
of	O	ADP	O
platelet-activating	B-protein	ADJ	B
factor	I-protein	NOUN	I
binding	O	VERB	I
to	O	PART	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
by	O	ADP	O
measuring	O	VERB	B
platelet-activating	B-protein	ADJ	B
factor	I-protein	NOUN	I
induced	O	ADJ	B
arachidonic	O	ADJ	B
acid	O	NOUN	I
release	O	NOUN	O
and	O	CCONJ	O
5-hydroxyeicosatetraenoic	O	ADJ	B
acid	O	NOUN	I
production	O	NOUN	O
.	O	PUNCT	O


Positive	O	ADJ	B
and	O	CCONJ	O
negative	O	ADJ	B
regulation	O	NOUN	O
of	O	ADP	O
immunoglobulin	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
expression	O	NOUN	B
by	O	ADP	O
a	O	DET	O
novel	O	ADJ	O
B-cell-specific	B-DNA	ADJ	B
enhancer	I-DNA	NOUN	I
element	I-DNA	NOUN	I
.	O	PUNCT	O


A	O	DET	O
new	O	ADJ	O
B-cell-specific	B-DNA	ADJ	B
enhancer	I-DNA	NOUN	I
element	I-DNA	NOUN	I
has	O	AUX	O
been	O	AUX	O
identified	O	VERB	O
3	O	NUM	O
'	O	PUNCT	O
of	O	ADP	O
E4	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
the	I-DNA	DET	O
octamerlike	I-DNA	ADJ	B
motifs	I-DNA	NOUN	B
in	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
immunoglobulin	I-DNA	NOUN	O
heavy-chain	I-DNA	ADJ	O
gene	I-DNA	NOUN	O
enhancer	I-DNA	NOUN	O
.	O	PUNCT	O


Tandem	O	ADJ	B
copies	O	NOUN	B
of	O	ADP	O
this	O	DET	O
67-bp	B-DNA	ADJ	O
MnlI-AluI	I-DNA	NOUN	B
fragment	I-DNA	NOUN	I
,	O	PUNCT	O
when	O	SCONJ	O
fused	O	VERB	B
to	O	PART	O
the	O	DET	O
chloramphenicol	B-DNA	NOUN	B
acetyltransferase	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
driven	O	VERB	O
by	O	ADP	O
the	O	DET	O
conalbumin	B-DNA	ADJ	B
promoter	I-DNA	NOUN	B
,	O	PUNCT	O
stimulated	O	VERB	B
transcription	O	NOUN	B
in	O	ADP	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
but	O	CCONJ	O
not	O	PART	O
in	O	ADP	O
Jurkat	B-cell_line	NOUN	B
T	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
or	O	CCONJ	O
HeLa	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Inasmuch	O	ADV	B
as	O	ADP	O
the	O	DET	O
change	O	NOUN	B
in	O	ADP	O
membrane	O	NOUN	B
potential	O	NOUN	B
is	O	AUX	O
dependent	O	ADJ	B
on	O	ADP	O
elevation	O	NOUN	B
of	O	ADP	O
free	O	ADJ	B
cytosolic	O	ADJ	O
calcium	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
hyperpolarization	O	NOUN	B
is	O	AUX	O
presumably	O	ADV	O
through	O	ADP	O
opening	O	NOUN	B
of	O	ADP	O
Ca	O	NOUN	B
(	O	PUNCT	O
2+	O	NUM	O
)	O	PUNCT	O
-stimulated	O	ADJ	O
K+	O	NOUN	B
channels	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
imply	O	VERB	O
that	O	SCONJ	O
membrane	O	NOUN	B
potential	O	ADJ	B
changes	O	NOUN	B
secondary	O	ADJ	B
to	O	PART	O
the	O	DET	O
ligand-dependent	O	ADJ	B
opening	O	NOUN	O
of	O	ADP	O
Ca	B-protein	NOUN	B
(	I-protein	PUNCT	O
2+	I-protein	NUM	O
)	I-protein	PUNCT	O
-activated	I-protein	ADJ	O
K+	I-protein	NOUN	B
channels	I-protein	NOUN	I
are	O	AUX	O
not	O	PART	O
involved	O	VERB	O
in	O	ADP	O
B	B-cell_type	NOUN	B
and	I-cell_type	CCONJ	O
T	I-cell_type	NOUN	B
lymphocyte	I-cell_type	NOUN	I
activation	O	NOUN	O
and	O	CCONJ	O
mitogenesis	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
enhancer	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
gene	O	NOUN	B
encoding	O	VERB	B
the	O	DET	O
interleukin-2	B-protein	NOUN	B
(	I-protein	PUNCT	O
IL-2	I-protein	NOUN	B
)	I-protein	PUNCT	O
receptor	I-protein	NOUN	B
alpha	I-protein	NOUN	I
chain	I-protein	NOUN	I
(	O	PUNCT	O
IL-2R	B-protein	NOUN	O
alpha	I-protein	NOUN	O
)	O	PUNCT	O
is	O	AUX	O
functional	O	ADJ	B
only	O	ADV	O
in	O	ADP	O
the	O	DET	O
hybrids	B-cell_line	NOUN	B
expressing	O	VERB	B
nuclear	B-protein	ADJ	B
NF-kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
.	O	PUNCT	O


These	O	DET	O
are	O	AUX	O
prominent	O	ADJ	O
enzymes	B-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
endocytic	O	ADJ	B
pathway	O	NOUN	I
through	O	ADP	O
which	O	DET	O
soluble	B-protein	ADJ	B
protein	I-protein	NOUN	B
Ag	I-protein	NOUN	I
enter	O	VERB	O
APC	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
resistant	B-protein	ADJ	B
segments	I-protein	NOUN	B
in	O	ADP	O
Ag	B-protein	NOUN	B
may	O	AUX	O
,	O	PUNCT	O
therefore	O	ADV	O
,	O	PUNCT	O
be	O	AUX	O
expected	O	VERB	O
to	O	PART	O
contain	O	VERB	O
more	O	ADJ	O
T-cell	B-protein	NOUN	B
determinants	I-protein	NOUN	B
than	O	ADP	O
susceptible	B-protein	ADJ	B
segments	I-protein	NOUN	B
.	O	PUNCT	O


By	O	ADP	O
searching	O	VERB	O
protein	O	NOUN	B
Ag	B-protein	NOUN	I
for	O	ADP	O
clusters	O	NOUN	B
of	O	ADP	O
amino	O	NOUN	B
acids	O	NOUN	I
containing	O	VERB	O
cysteine	O	NOUN	B
and	O	CCONJ	O
two	O	NUM	O
of	O	ADP	O
the	O	DET	O
other	O	ADJ	O
amino	O	NOUN	B
acids	O	NOUN	I
we	O	PRON	O
were	O	AUX	O
able	O	ADJ	O
to	O	PART	O
predict	O	VERB	O
17	O	NUM	O
out	O	ADP	O
of	O	ADP	O
23	O	NUM	O
empirically	O	ADV	O
known	O	VERB	O
T-cell	B-protein	NOUN	B
determinants	I-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
Ag	B-protein	NOUN	B
with	O	ADP	O
a	O	DET	O
relatively	O	ADV	O
low	O	ADJ	O
number	O	NOUN	O
of	O	ADP	O
false	O	ADJ	O
(	O	PUNCT	O
positive	O	ADJ	B
)	O	PUNCT	O
predictions	O	NOUN	B
.	O	PUNCT	O


Such	O	ADJ	O
segments	O	NOUN	B
accord	O	VERB	O
well	O	ADV	O
with	O	ADP	O
empirically	O	ADV	O
known	O	VERB	O
T-cell	B-protein	NOUN	B
determinants	I-protein	NOUN	B
and	O	CCONJ	O
our	O	PRON	O
algorithm	O	NOUN	B
produces	O	VERB	O
a	O	DET	O
lower	O	ADJ	O
number	O	NOUN	O
of	O	ADP	O
false	O	ADJ	O
positive	O	ADJ	O
predictions	O	NOUN	B
than	O	ADP	O
the	O	DET	O
principle	O	NOUN	O
based	O	VERB	O
on	O	ADP	O
discrete	O	ADJ	O
Fourier	O	NOUN	B
transformations	O	NOUN	I
previously	O	ADV	O
described	O	VERB	O
.	O	PUNCT	O


Starting	O	VERB	O
with	O	ADP	O
a	O	DET	O
replication-incompetent	O	ADJ	B
molecular	O	ADJ	I
clone	O	NOUN	I
of	O	ADP	O
human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
type	O	NOUN	I
1	O	NUM	I
,	O	PUNCT	O
lacking	O	VERB	B
all	O	DET	O
the	O	DET	O
NF-kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
and	I-DNA	CCONJ	O
Sp1	I-DNA	NOUN	B
binding	I-DNA	NOUN	B
sites	I-DNA	NOUN	I
present	O	ADJ	O
in	O	ADP	O
the	O	DET	O
native	B-DNA	ADJ	B
long	I-DNA	ADJ	B
terminal	I-DNA	ADJ	I
repeat	I-DNA	NOUN	I
(	O	PUNCT	I
LTR	B-DNA	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
proviruses	O	NOUN	B
containing	O	VERB	O
reconstructed	B-DNA	VERB	B
LTRs	I-DNA	NOUN	B
with	O	ADP	O
individual	O	NOUN	B
or	O	CCONJ	O
combinations	O	NOUN	B
of	O	ADP	O
NF-kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
and	I-DNA	CCONJ	O
Sp1	I-DNA	NOUN	B
elements	I-DNA	NOUN	O
were	O	AUX	O
generated	O	VERB	O
and	O	CCONJ	O
evaluated	O	VERB	B
for	O	ADP	O
their	O	PRON	O
capacity	O	NOUN	B
to	O	PART	O
produce	O	VERB	O
virus	O	NOUN	B
progeny	O	NOUN	B
following	O	VERB	O
transfection-cocultivation	O	NOUN	B
.	O	PUNCT	O


For	O	ADP	O
example	O	NOUN	O
,	O	PUNCT	O
in	O	ADP	O
experiments	O	NOUN	B
involving	O	VERB	O
proviral	O	ADJ	B
clones	O	NOUN	I
with	O	ADP	O
LTRs	B-DNA	NOUN	B
containing	O	VERB	O
one	O	NUM	O
or	O	CCONJ	O
two	O	NUM	O
NF-kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
elements	I-DNA	NOUN	I
(	O	PUNCT	O
and	O	CCONJ	O
no	O	DET	O
Sp1	B-DNA	NOUN	B
binding	I-DNA	NOUN	B
sites	I-DNA	NOUN	I
)	O	PUNCT	O
,	O	PUNCT	O
a	O	DET	O
hierarchy	O	NOUN	O
of	O	ADP	O
cellular	O	ADJ	B
permissivity	O	NOUN	I
to	O	PART	O
virus	O	NOUN	B
replication	O	NOUN	B
(	O	PUNCT	O
peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
lymphocytes	I-cell_type	NOUN	I
=	O	ADJ	O
MT4	B-cell_line	NOUN	B
greater	O	ADJ	O
than	O	ADP	O
H9	B-cell_line	NOUN	B
greater	O	ADJ	O
than	O	ADP	O
CEM	B-cell_line	NOUN	B
greater	O	ADJ	O
than	O	ADP	O
Jurkat	B-cell_line	NOUN	B
)	O	PUNCT	O
was	O	AUX	O
observed	O	VERB	B
.	O	PUNCT	O


Of	O	ADP	O
note	O	NOUN	O
was	O	AUX	O
the	O	DET	O
associated	O	VERB	O
emergence	O	NOUN	B
of	O	ADP	O
second-site	B-DNA	ADJ	B
LTR	I-DNA	NOUN	B
revertants	O	NOUN	B
which	O	DET	O
involved	O	VERB	O
an	O	DET	O
alteration	O	NOUN	B
of	O	ADP	O
the	O	DET	O
TATA	B-DNA	NOUN	B
box	I-DNA	NOUN	O
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
human	B-DNA	ADJ	B
immunodeficiency	I-DNA	NOUN	I
virus	I-DNA	NOUN	I
type	I-DNA	NOUN	I
1	I-DNA	NUM	I
LTR	I-DNA	NOUN	I
possesses	O	VERB	O
functional	O	ADJ	B
redundancy	O	NOUN	B
which	O	DET	O
ensures	O	VERB	O
virus	O	NOUN	B
replication	O	NOUN	B
in	O	ADP	O
different	O	ADJ	O
T-cell	B-cell_type	NOUN	B
types	I-cell_type	NOUN	I
and	O	CCONJ	O
is	O	AUX	O
capable	O	ADJ	O
of	O	ADP	O
changing	O	VERB	B
depending	O	VERB	O
on	O	ADP	O
the	O	DET	O
particular	O	ADJ	O
combination	O	NOUN	B
of	O	ADP	O
transcriptional	B-protein	ADJ	B
factors	I-protein	NOUN	I
present	O	ADJ	O
.	O	PUNCT	O


From	O	ADP	O
HeLa	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
two	O	NUM	O
major	O	ADJ	O
proteins	O	NOUN	B
of	O	ADP	O
52	B-protein	NUM	O
and	I-protein	CCONJ	O
45	I-protein	NUM	O
kilodaltons	I-protein	NOUN	B
(	I-protein	PUNCT	O
kD	I-protein	NOUN	O
)	I-protein	PUNCT	O
copurified	O	VERB	B
with	O	ADP	O
DNA	O	NOUN	B
binding	O	NOUN	I
activity	O	NOUN	I
,	O	PUNCT	O
whereas	O	SCONJ	O
from	O	ADP	O
T-cells	B-cell_type	NOUN	B
,	O	PUNCT	O
four	O	NUM	O
proteins	O	NOUN	B
--	O	PUNCT	O
a	O	DET	O
major	B-protein	ADJ	O
protein	I-protein	NOUN	B
of	O	ADP	O
52	B-protein	NUM	O
kD	I-protein	NOUN	B
and	O	CCONJ	O
three	O	NUM	O
minor	B-protein	ADJ	B
proteins	I-protein	NOUN	I
of	O	ADP	O
82	B-protein	NUM	O
,	O	PUNCT	O
67	B-protein	NUM	O
,	O	PUNCT	O
and	O	CCONJ	O
43-47	B-protein	NUM	O
kD	I-protein	NOUN	B
--	O	PUNCT	O
were	O	AUX	O
purified	O	VERB	B
.	O	PUNCT	O


Also	O	ADV	O
,	O	PUNCT	O
an	O	DET	O
induction	O	NOUN	B
specific	B-protein	ADJ	O
DNA	I-protein	NOUN	B
binding	I-protein	NOUN	I
protein	I-protein	NOUN	I
was	O	AUX	O
purified	O	VERB	O
from	O	ADP	O
HeLa	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
that	O	PRON	O
interacted	O	VERB	B
with	O	ADP	O
the	O	DET	O
(	O	PUNCT	O
AAGTGA	O	NOUN	B
)	O	PUNCT	O
4	O	NUM	O
tetrahexamer	B-DNA	NOUN	B
sequence	I-DNA	NOUN	I
and	O	CCONJ	O
the	O	DET	O
PRDI	B-DNA	NOUN	B
domain	I-DNA	NOUN	B
.	O	PUNCT	O


Uninduced	O	ADJ	B
or	O	CCONJ	O
Sendai	O	NOUN	B
virus	O	NOUN	I
induced	O	ADJ	B
HeLa	O	NOUN	B
extracts	O	NOUN	B
were	O	AUX	O
used	O	VERB	O
to	O	PART	O
examine	O	VERB	O
transcription	O	NOUN	B
in	O	X	B
vitro	O	X	I
using	O	VERB	O
a	O	DET	O
series	O	NOUN	O
of	O	ADP	O
IFN	B-DNA	NOUN	B
beta	I-DNA	NOUN	I
promoter	I-DNA	NOUN	I
deletions	I-DNA	NOUN	O
.	O	PUNCT	O


Deletions	O	NOUN	B
upstream	O	ADJ	B
of	O	ADP	O
the	O	DET	O
PRDII	B-DNA	NOUN	B
element	I-DNA	NOUN	O
increased	O	VERB	B
transcription	O	NOUN	B
in	O	ADP	O
the	O	DET	O
uninduced	O	ADJ	B
extract	O	NOUN	I
,	O	PUNCT	O
indicating	O	VERB	O
predominantly	O	ADV	O
negative	O	ADJ	B
regulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
promoter	B-DNA	NOUN	B
.	O	PUNCT	O


The	O	DET	O
rhombotin	B-DNA	NOUN	B
family	I-DNA	NOUN	B
of	O	ADP	O
cysteine-rich	B-DNA	ADJ	B
LIM-domain	I-DNA	ADJ	I
oncogenes	I-DNA	NOUN	I
:	O	PUNCT	O
distinct	O	ADJ	O
members	O	NOUN	B
are	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
T-cell	B-DNA	NOUN	B
translocations	I-DNA	NOUN	I
to	O	PART	O
human	B-DNA	ADJ	B
chromosomes	I-DNA	NOUN	O
11p15	I-DNA	NOUN	O
and	I-DNA	CCONJ	O
11p13	I-DNA	NOUN	B
.	O	PUNCT	O


NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activation	O	NOUN	B
by	O	ADP	O
tumor	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor	I-protein	NOUN	I
alpha	I-protein	NOUN	I
in	O	ADP	O
the	O	DET	O
Jurkat	B-cell_line	NOUN	B
T	I-cell_line	NOUN	I
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
is	O	AUX	O
independent	O	ADJ	O
of	O	ADP	O
protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
A	I-protein	NOUN	I
,	O	PUNCT	O
protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
C	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
Ca	B-protein	VERB	B
(	I-protein	PUNCT	O
2+	I-protein	NUM	O
)	I-protein	PUNCT	O
-regulated	I-protein	ADJ	O
kinases	I-protein	NOUN	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
found	O	VERB	O
that	O	SCONJ	O
cytoplasmic	O	ADJ	B
acidification	O	NOUN	I
facilitated	O	VERB	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activation	O	NOUN	B
by	O	ADP	O
both	O	CCONJ	O
TNF	B-protein	NOUN	B
alpha	I-protein	NOUN	I
and	O	CCONJ	O
PKC	B-protein	NOUN	B
,	O	PUNCT	O
by	O	ADP	O
a	O	DET	O
mechanism	O	NOUN	B
that	O	PRON	O
increases	O	VERB	B
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
/I	B-protein	NOUN	I
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
dissociation	O	NOUN	O
without	O	ADP	O
affecting	O	VERB	B
the	O	DET	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
translocation	O	NOUN	B
step	O	NOUN	O
.	O	PUNCT	O


It	O	PRON	O
can	O	AUX	O
only	O	ADV	O
be	O	AUX	O
activated	O	VERB	B
in	O	ADP	O
a	O	DET	O
tissue-specific	O	ADJ	B
manner	O	NOUN	O
by	O	ADP	O
elements	O	NOUN	B
that	O	PRON	O
lie	O	VERB	O
downstream	O	ADJ	B
of	O	ADP	O
the	O	DET	O
initiation	B-DNA	NOUN	B
site	I-DNA	NOUN	I
.	O	PUNCT	O


DNase	O	NOUN	B
I	O	NUM	I
and	O	CCONJ	O
gel	O	NOUN	B
mobility	O	NOUN	O
shift	O	NOUN	O
assays	O	NOUN	O
show	O	VERB	O
the	O	DET	O
binding	O	NOUN	B
of	O	ADP	O
a	O	DET	O
number	O	NOUN	O
of	O	ADP	O
nuclear	B-protein	ADJ	B
factors	I-protein	NOUN	I
to	O	PART	O
these	O	DET	O
elements	B-DNA	NOUN	B
,	O	PUNCT	O
including	O	VERB	O
Sp1	B-protein	NOUN	B
and	O	CCONJ	O
CP1	B-protein	NOUN	B
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	B
show	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
structure	O	NOUN	B
of	O	ADP	O
this	O	DET	O
promoter	B-DNA	NOUN	B
only	O	ADV	O
permits	O	VERB	O
productive	O	ADJ	O
interactions	O	NOUN	B
of	O	ADP	O
the	O	DET	O
two	O	NUM	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
Sp1	B-protein	NOUN	B
and	O	CCONJ	O
CP1	B-protein	NOUN	B
with	O	ADP	O
the	O	DET	O
basal	O	ADJ	B
transcription	O	NOUN	I
machinery	O	NOUN	I
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
enhancer	B-DNA	NOUN	B
sequences	I-DNA	NOUN	I
.	O	PUNCT	O


Upon	O	SCONJ	O
activation	O	NOUN	B
,	O	PUNCT	O
T	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
accumulate	O	VERB	O
high	O	ADJ	O
levels	O	NOUN	B
of	O	ADP	O
the	O	DET	O
neuropeptide	O	NOUN	B
enkephalin	O	NOUN	I
which	O	DET	O
correlate	O	VERB	B
with	O	ADP	O
high	O	ADJ	O
levels	O	NOUN	B
of	O	ADP	O
proenkephalin	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
in	O	ADP	O
the	O	DET	O
cells	O	NOUN	B
.	O	PUNCT	O


Activation	O	NOUN	B
of	O	ADP	O
T	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
induces	O	VERB	O
an	O	DET	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
-like	O	ADJ	O
binding	O	NOUN	B
activity	O	NOUN	I
to	O	PART	O
the	O	DET	O
B2	B-DNA	NOUN	B
site	O	NOUN	I
,	O	PUNCT	O
concomitant	O	ADJ	B
with	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
proenkephalin	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
.	O	PUNCT	O


The	O	DET	O
purified	O	VERB	O
homodimer	B-protein	NOUN	B
(	O	PUNCT	O
two	O	NUM	O
p50s	B-protein	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
the	O	DET	O
DNA-binding	B-protein	ADJ	B
subunit	I-protein	NOUN	I
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
binds	O	VERB	B
the	O	DET	O
B2	B-DNA	NOUN	B
site	O	NOUN	I
of	O	ADP	O
proenkephalin	O	NOUN	B
relatively	O	ADV	O
better	O	ADJ	O
than	O	ADP	O
does	O	AUX	O
the	O	DET	O
heterotetramer	B-protein	NOUN	B
(	O	PUNCT	O
two	O	NUM	O
p65s	B-protein	NOUN	O
plus	O	CCONJ	O
two	O	NUM	O
p50s	B-protein	NOUN	B
)	O	PUNCT	O
form	O	NOUN	O
of	O	ADP	O
the	O	DET	O
factor	O	NOUN	B
.	O	PUNCT	O


Induction	O	NOUN	B
of	O	ADP	O
NF-KB	B-protein	NOUN	B
during	O	ADP	O
monocyte	B-cell_type	NOUN	B
differentiation	O	NOUN	I
by	O	ADP	O
HIV	O	NOUN	B
type	O	NOUN	I
1	O	NUM	I
infection	O	NOUN	I
.	O	PUNCT	O


Electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assays	O	NOUN	I
and	O	CCONJ	O
Southwestern	O	NOUN	B
blotting	O	NOUN	I
experiments	O	NOUN	I
were	O	AUX	O
used	O	VERB	O
to	O	PART	O
detect	O	VERB	B
the	O	DET	O
binding	O	NOUN	B
of	O	ADP	O
cellular	B-protein	ADJ	B
transactivation	I-protein	NOUN	I
factor	I-protein	NOUN	I
NF-KB	B-protein	NOUN	I
to	O	PART	O
the	O	DET	O
double	B-DNA	ADJ	B
repeat-KB	I-DNA	ADJ	I
enhancer	I-DNA	NOUN	I
sequence	I-DNA	NOUN	I
located	O	ADJ	O
in	O	ADP	O
the	O	DET	O
long	B-DNA	ADJ	B
terminal	I-DNA	ADJ	I
repeat	I-DNA	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
nuclear	O	ADJ	B
extracts	O	NOUN	I
from	O	ADP	O
monocytes	B-cell_type	NOUN	B
or	O	CCONJ	O
macrophages	B-cell_type	NOUN	B
,	O	PUNCT	O
induction	O	NOUN	B
of	O	ADP	O
NF-KB	B-protein	NOUN	B
occurred	O	VERB	O
only	O	ADV	O
if	O	SCONJ	O
the	O	DET	O
cells	O	NOUN	B
were	O	AUX	O
previously	O	ADV	O
infected	O	VERB	B
with	O	ADP	O
HIV-1	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
fusion	B-DNA	NOUN	B
complementary	I-DNA	ADJ	I
DNA	I-DNA	NOUN	I
in	O	ADP	O
the	O	DET	O
T	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
HSB-2	I-cell_line	NOUN	B
elucidates	O	VERB	O
a	O	DET	O
provocative	O	ADJ	B
mechanism	O	NOUN	B
for	O	ADP	O
the	O	DET	O
disruption	O	NOUN	B
of	O	ADP	O
the	O	DET	O
putative	O	ADJ	O
hematopoietic	B-protein	ADJ	O
transcription	I-protein	NOUN	O
factor	I-protein	NOUN	O
SCL	B-protein	NOUN	B
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
in	O	ADP	O
lymphocytes	B-cell_type	NOUN	B
,	O	PUNCT	O
growth-affecting	B-DNA	ADJ	B
genes	I-DNA	NOUN	I
other	O	ADJ	O
than	O	ADP	O
immune	B-protein	ADJ	B
receptors	I-protein	NOUN	I
risk	O	VERB	B
rearrangements	O	NOUN	I
.	O	PUNCT	O


(	O	PUNCT	O
ABSTRACT	O	NOUN	B
TRUNCATED	O	VERB	I
AT	O	ADP	I
250	O	NUM	I
WORDS	O	NOUN	I
)	O	PUNCT	O


Paramyxovirus	O	NOUN	B
infection	O	NOUN	I
induced	O	VERB	B
a	O	DET	O
5-	O	NUM	O
to	O	PART	O
10-fold	O	ADJ	O
increase	O	NOUN	B
in	O	ADP	O
the	O	DET	O
steady-state	O	ADJ	B
level	O	NOUN	B
of	O	ADP	O
TNF-alpha	B-RNA	NOUN	B
RNA	I-RNA	NOUN	I
in	O	ADP	O
U9-IIIB	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
compared	O	VERB	B
with	O	ADP	O
U937	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
HIV-infected	B-cell_line	ADJ	B
monocytic	I-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
produced	O	VERB	O
higher	O	ADJ	O
levels	O	NOUN	B
of	O	ADP	O
TNF-alpha	B-protein	NOUN	B
than	O	ADP	O
did	O	AUX	O
normal	O	ADJ	B
cells	O	NOUN	I
after	O	ADP	O
a	O	DET	O
secondary	O	ADJ	B
virus	O	NOUN	B
infection	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
order	O	NOUN	O
to	O	PART	O
characterize	O	VERB	B
the	O	DET	O
function	O	NOUN	B
of	O	ADP	O
cis-acting	B-DNA	ADJ	B
elements	I-DNA	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
developed	O	VERB	O
an	O	DET	O
in	O	X	B
vitro	O	X	I
system	O	NOUN	I
in	O	ADP	O
which	O	DET	O
a	O	DET	O
DRA	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
construct	I-DNA	NOUN	I
is	O	AUX	O
transcribed	O	VERB	B
more	O	ADV	O
efficiently	O	ADV	B
in	O	ADP	O
extracts	O	NOUN	B
from	O	ADP	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
than	O	ADP	O
in	O	ADP	O
extracts	O	NOUN	B
from	O	ADP	O
class	B-cell_line	NOUN	B
II-negative	I-cell_line	ADJ	I
HeLa	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


1	O	NUM	O
,	O	PUNCT	O
25	O	NUM	O
(	O	PUNCT	O
OH	O	NOUN	B
)	O	PUNCT	O
2D3	O	NOUN	B
was	O	AUX	O
produced	O	VERB	O
both	O	CCONJ	O
by	O	ADP	O
lavage	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
(	O	PUNCT	O
12/12	O	NUM	O
tuberculosis	O	NOUN	B
patients	O	NOUN	B
,	O	PUNCT	O
2/6	O	NUM	O
sarcoidosis	O	NOUN	B
patients	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
blood	B-cell_type	NOUN	B
mononuclear	I-cell_type	ADJ	I
cells	I-cell_type	NOUN	I
(	O	PUNCT	O
3/5	O	NUM	O
tuberculosis	O	NOUN	B
patients	O	NOUN	B
,	O	PUNCT	O
0/3	O	NUM	O
sarcoidosis	O	NOUN	B
patients	O	NOUN	B
)	O	PUNCT	O
from	O	ADP	O
patients	O	NOUN	B
but	O	CCONJ	O
not	O	PART	O
controls	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
significantly	O	ADV	O
greater	O	ADJ	O
amounts	O	NOUN	O
were	O	AUX	O
produced	O	VERB	O
by	O	ADP	O
lavage	O	NOUN	B
cells	O	NOUN	I
from	O	ADP	O
tuberculosis	O	NOUN	B
patients	O	NOUN	B
than	O	ADP	O
those	O	DET	O
of	O	ADP	O
sarcoidosis	O	NOUN	B
patients	O	NOUN	B
(	O	PUNCT	O
P	O	NOUN	O
less	O	ADJ	O
than	O	ADP	O
0.001	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Megakaryocytic	B-cell_line	ADJ	B
and	I-cell_line	CCONJ	O
erythrocytic	I-cell_line	ADJ	B
lineages	I-cell_line	NOUN	I
share	O	VERB	O
specific	O	ADJ	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
.	O	PUNCT	O


Our	O	PRON	O
data	O	NOUN	B
strengthen	O	VERB	O
the	O	DET	O
idea	O	NOUN	O
of	O	ADP	O
a	O	DET	O
close	O	ADJ	O
association	O	NOUN	B
between	O	ADP	O
the	O	DET	O
erythrocytic	B-cell_line	ADJ	B
and	I-cell_line	CCONJ	O
the	I-cell_line	DET	O
megakaryocytic	I-cell_line	ADJ	B
lineages	I-cell_line	NOUN	B
and	O	CCONJ	O
could	O	AUX	O
also	O	ADV	O
explain	O	VERB	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
markers	O	NOUN	B
specific	O	ADJ	B
to	O	PART	O
the	O	DET	O
erythrocytic	B-cell_type	ADJ	B
and	I-cell_type	CCONJ	O
megakaryocytic	I-cell_type	ADJ	B
lineages	I-cell_type	NOUN	O
in	O	ADP	O
most	O	ADJ	O
erythroblastic	B-cell_line	ADJ	B
and	I-cell_line	CCONJ	O
megakaryoblastic	I-cell_line	ADJ	B
permanent	I-cell_line	ADJ	O
cell	I-cell_line	NOUN	O
lines	I-cell_line	NOUN	O
.	O	PUNCT	O


Cultured	B-cell_line	VERB	B
MCF-7	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
derived	O	VERB	O
from	O	ADP	O
a	O	DET	O
pleural	O	ADJ	B
effusion	O	NOUN	I
of	O	ADP	O
a	O	DET	O
breast	O	NOUN	B
cancer	O	NOUN	I
patient	O	NOUN	B
,	O	PUNCT	O
known	O	VERB	O
to	O	PART	O
contain	O	VERB	O
high	O	ADJ	O
levels	O	NOUN	B
of	O	ADP	O
ER	B-protein	NOUN	B
were	O	AUX	O
used	O	VERB	O
as	O	ADP	O
a	O	DET	O
positive	O	ADJ	B
control	O	NOUN	I
(	O	PUNCT	O
40-48	O	NUM	O
%	O	NOUN	O
ER	B-cell_type	NOUN	B
positive	I-cell_type	ADJ	O
cells	I-cell_type	NOUN	O
by	O	ADP	O
immunocytochemistry	O	NOUN	B
;	O	PUNCT	O
200	O	NUM	O
fmol/mg	O	ADJ	O
protein	O	NOUN	B
by	O	ADP	O
EIA	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
relative	O	ADJ	O
binding	O	NOUN	B
affinity	O	NOUN	B
of	O	ADP	O
quercetin	O	NOUN	B
,	O	PUNCT	O
rutin	O	NOUN	B
,	O	PUNCT	O
DES	O	PROPN	B
and	O	CCONJ	O
TAM	O	PROPN	B
for	O	ADP	O
type-II	B-protein	ADJ	B
EBS	I-protein	NOUN	B
correlated	O	VERB	B
well	O	ADV	O
with	O	ADP	O
their	O	PRON	O
potency	O	NOUN	B
as	O	ADP	O
cell	O	NOUN	B
growth	O	NOUN	I
inhibitors	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
report	O	NOUN	O
we	O	PRON	O
describe	O	VERB	O
the	O	DET	O
use	O	NOUN	O
of	O	ADP	O
recombinant	O	ADJ	B
retroviruses	O	NOUN	I
to	O	PART	O
characterize	O	VERB	O
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
an	O	DET	O
exogenous	B-DNA	ADJ	B
promoter	I-DNA	NOUN	B
in	O	ADP	O
primary	O	ADJ	B
cells	O	NOUN	I
obtained	O	VERB	O
from	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
lymphoproliferative	O	ADJ	B
disorders	O	NOUN	I
.	O	PUNCT	O


Active	O	ADJ	B
metabolite	O	NOUN	I
of	O	ADP	O
vitamin	O	NOUN	B
D3	O	NOUN	I
,	O	PUNCT	O
24R	O	NOUN	B
,	O	PUNCT	O
25	O	NUM	O
(	O	PUNCT	O
OH	O	NOUN	B
)	O	PUNCT	O
2D3	O	NOUN	O
(	O	PUNCT	O
dioxyvit	O	NOUN	B
)	O	PUNCT	O
was	O	AUX	O
used	O	VERB	O
at	O	ADP	O
a	O	DET	O
daily	O	ADJ	B
dose	O	NOUN	I
of	O	ADP	O
100	O	NUM	O
micrograms	O	NOUN	B
in	O	ADP	O
treatment	O	NOUN	B
of	O	ADP	O
children	O	NOUN	B
affected	O	VERB	B
with	O	ADP	O
tubulointerstitial	O	ADJ	B
disease	O	NOUN	I
of	O	ADP	O
kidney	O	NOUN	B
and	O	CCONJ	O
with	O	ADP	O
chronic	O	ADJ	B
glomerulonephritis	O	NOUN	I
under	O	ADP	O
conditions	O	NOUN	O
of	O	ADP	O
kidney	O	NOUN	B
insufficiency	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
levels	O	NOUN	B
of	O	ADP	O
glucocorticoid	B-protein	NOUN	B
receptors	I-protein	NOUN	I
in	O	ADP	O
lymphocytes	B-cell_type	NOUN	B
of	O	ADP	O
the	O	DET	O
patients	O	NOUN	B
are	O	AUX	O
lower	O	ADJ	O
than	O	ADP	O
in	O	ADP	O
normal	O	ADJ	B
subjects	O	NOUN	I
both	O	CCONJ	O
in	O	ADP	O
the	O	DET	O
active	O	ADJ	B
stage	O	NOUN	I
of	O	ADP	O
the	O	DET	O
disease	O	NOUN	B
and	O	CCONJ	O
following	O	VERB	O
bilateral	O	ADJ	B
total	O	ADJ	O
adrenalectomy	O	NOUN	O
.	O	PUNCT	O


Because	O	SCONJ	O
of	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
a	O	DET	O
functional	O	ADJ	B
receptor-effector	O	ADJ	O
system	O	NOUN	O
for	O	ADP	O
VD3	O	NOUN	B
and	O	CCONJ	O
multiple	O	ADJ	B
biological	O	ADJ	B
responses	O	NOUN	O
to	O	PART	O
the	O	DET	O
hormone	O	NOUN	B
,	O	PUNCT	O
these	O	DET	O
cells	O	NOUN	B
provide	O	VERB	O
a	O	DET	O
unique	O	ADJ	B
model	O	NOUN	B
system	O	NOUN	O
with	O	ADP	O
which	O	DET	O
to	O	PART	O
probe	O	VERB	B
the	O	DET	O
specific	O	ADJ	O
effects	O	NOUN	B
of	O	ADP	O
VD3	O	NOUN	B
on	O	ADP	O
cell	O	NOUN	B
growth	O	NOUN	I
and	O	CCONJ	O
differentiation	O	NOUN	B
in	O	ADP	O
chronic	O	ADJ	B
myelogenous	O	ADJ	I
leukemia	O	NOUN	I
.	O	PUNCT	O


Pseudohypoaldosteronism	O	NOUN	B
in	O	ADP	O
eight	O	NUM	O
families	O	NOUN	B
:	O	PUNCT	O
different	O	ADJ	O
forms	O	NOUN	O
of	O	ADP	O
inheritance	O	NOUN	B
are	O	AUX	O
evidence	O	NOUN	B
for	O	ADP	O
various	O	ADJ	O
genetic	O	ADJ	B
defects	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
patients	O	NOUN	B
are	O	AUX	O
insensitive	O	ADJ	O
to	O	PART	O
mineralocorticoids	O	NOUN	B
;	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
sodium	O	NOUN	B
supplementation	O	NOUN	I
is	O	AUX	O
able	O	ADJ	O
to	O	PART	O
correct	O	VERB	O
electrolyte	O	NOUN	B
abnormalities	O	NOUN	I
.	O	PUNCT	O


There	O	PRON	O
was	O	AUX	O
evidence	O	NOUN	B
for	O	ADP	O
an	O	DET	O
autosomal	O	ADJ	B
recessive	O	ADJ	I
form	O	NOUN	I
of	O	ADP	O
inheritance	O	NOUN	B
in	O	ADP	O
four	O	NUM	O
families	O	NOUN	B
,	O	PUNCT	O
while	O	SCONJ	O
the	O	DET	O
other	O	ADJ	O
four	O	NUM	O
families	O	NOUN	B
appeared	O	VERB	O
to	O	PART	O
have	O	AUX	O
an	O	DET	O
autosomal	O	ADJ	B
dominant	O	ADJ	O
mode	O	NOUN	O
of	O	ADP	O
transmission	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
erythroid-specific	B-protein	ADJ	B
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
NF-E1	B-protein	NOUN	I
was	O	AUX	O
shown	O	VERB	O
to	O	PART	O
be	O	AUX	O
expressed	O	VERB	B
coordinately	O	ADV	B
with	O	ADP	O
that	O	DET	O
of	O	ADP	O
globin	B-protein	NOUN	B
in	O	ADP	O
embryoid	B-cell_type	ADJ	B
bodies	I-cell_type	NOUN	I
.	O	PUNCT	O


A	O	DET	O
truncated	O	ADJ	B
form	O	NOUN	O
of	O	ADP	O
the	O	DET	O
product	O	NOUN	B
of	O	ADP	O
this	O	DET	O
gene	O	NOUN	B
translated	O	VERB	B
in	O	X	B
vitro	O	X	I
is	O	AUX	O
a	O	DET	O
DNA-binding	B-protein	ADJ	B
protein	I-protein	NOUN	I
which	O	DET	O
interacts	O	VERB	O
specifically	O	ADV	O
with	O	ADP	O
the	O	DET	O
kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
binding	I-DNA	NOUN	I
site	I-DNA	NOUN	I
found	O	VERB	O
in	O	ADP	O
many	O	ADJ	O
inducible	B-DNA	ADJ	B
genes	I-DNA	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
the	O	DET	O
enhancer	O	NOUN	B
in	O	ADP	O
human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
sodium/proton	B-protein	ADJ	B
exchanger	I-protein	NOUN	I
of	O	ADP	I
the	O	DET	I
cell	O	NOUN	I
membrane	O	NOUN	I
could	O	AUX	O
be	O	AUX	O
identified	O	VERB	B
as	O	ADP	O
the	O	DET	O
primary	O	ADJ	B
target	O	NOUN	B
of	O	ADP	O
the	O	DET	O
aldosterone	O	NOUN	B
action	O	NOUN	B
,	O	PUNCT	O
possibly	O	ADV	O
non-genomically	O	ADV	B
mediated	O	VERB	O
through	O	ADP	O
membrane	B-protein	NOUN	B
receptors	I-protein	NOUN	I
.	O	PUNCT	O


Additionally	O	ADV	O
,	O	PUNCT	O
an	O	DET	O
abnormal	O	ADJ	B
effector	O	NOUN	B
mechanism	O	NOUN	B
could	O	AUX	O
be	O	AUX	O
demonstrated	O	VERB	O
in	O	ADP	O
human	B-cell_type	ADJ	B
mononuclear	I-cell_type	ADJ	B
leukocytes	I-cell_type	NOUN	B
from	O	ADP	O
essential	O	ADJ	B
hypertensives	O	NOUN	I
.	O	PUNCT	O


Seventeen	O	NUM	O
cases	O	NOUN	B
revealed	O	VERB	O
distinct	O	ADJ	O
immunostaining	O	NOUN	B
against	O	ADP	O
at	O	ADP	O
least	O	ADJ	O
1	O	NUM	O
of	O	ADP	O
the	O	DET	O
5	O	NUM	O
steroid	O	NOUN	B
hormones	O	NOUN	O
.	O	PUNCT	O


Immunostained	B-cell_type	ADJ	B
tumor	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
were	O	AUX	O
more	O	ADV	O
frequently	O	ADV	O
distributed	O	VERB	B
in	O	ADP	O
the	O	DET	O
area	O	NOUN	B
where	O	SCONJ	O
tumor	O	NOUN	B
cell	O	NOUN	I
infiltration	O	NOUN	B
was	O	AUX	O
more	O	ADV	O
invasive	O	ADJ	B
.	O	PUNCT	O


We	O	PRON	O
concluded	O	VERB	O
that	O	SCONJ	O
steroid	O	NOUN	B
hormones	O	NOUN	O
might	O	AUX	O
be	O	AUX	O
closely	O	ADV	O
related	O	ADJ	O
to	O	PART	O
tumor	O	NOUN	B
cell	O	NOUN	I
infiltration	O	NOUN	B
of	O	ADP	O
some	O	DET	O
malignant	B-cell_type	ADJ	B
soft	I-cell_type	ADJ	B
tissue	I-cell_type	NOUN	I
tumors	I-cell_type	NOUN	I
.	O	PUNCT	O


Expression	O	NOUN	B
of	O	ADP	O
a	O	DET	O
highly	O	ADV	O
specific	O	ADJ	O
protein	O	NOUN	B
inhibitor	O	NOUN	I
for	O	ADP	O
cyclic	B-protein	ADJ	B
AMP-dependent	I-protein	ADJ	I
protein	I-protein	NOUN	I
kinases	I-protein	NOUN	I
in	O	ADP	O
interleukin-1	B-cell_line	NOUN	B
(	I-cell_line	PUNCT	O
IL-1	I-cell_line	NOUN	B
)	I-cell_line	PUNCT	O
-responsive	I-cell_line	ADJ	O
cells	I-cell_line	NOUN	B
blocked	O	VERB	B
IL-1-induced	B-DNA	ADJ	B
gene	I-DNA	NOUN	B
transcription	O	NOUN	I
that	O	PRON	O
was	O	AUX	O
driven	O	VERB	O
by	O	ADP	O
the	O	DET	O
kappa	B-DNA	NOUN	B
immunoglobulin	I-DNA	NOUN	I
enhancer	I-DNA	NOUN	I
or	O	CCONJ	O
the	O	DET	O
human	B-DNA	ADJ	B
immunodeficiency	I-DNA	NOUN	I
virus	I-DNA	NOUN	I
long	I-DNA	ADJ	B
terminal	I-DNA	ADJ	I
repeat	I-DNA	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
there	O	PRON	O
is	O	AUX	O
an	O	DET	O
EB1-binding	B-DNA	ADJ	B
site	I-DNA	NOUN	O
(	O	PUNCT	O
ZRE-B	B-DNA	NOUN	B
)	O	PUNCT	O
located	O	ADJ	O
within	O	ADP	O
the	O	DET	O
R-responsive	B-DNA	ADJ	B
enhancer	I-DNA	NOUN	I
region	I-DNA	NOUN	I
.	O	PUNCT	O


Binding	O	NOUN	B
of	O	ADP	O
[	O	PUNCT	O
3H	O	NOUN	B
]	O	PUNCT	O
1	O	NUM	O
alpha	O	NOUN	B
,	O	PUNCT	O
25-dihydroxyvitamin	O	NOUN	B
D3	O	NOUN	I
(	O	PUNCT	O
1	O	NUM	O
,	O	PUNCT	O
25	O	NUM	O
(	O	PUNCT	O
OH	O	NOUN	B
)	O	PUNCT	O
2D3	O	NOUN	B
)	O	PUNCT	O
to	O	PART	O
its	O	PRON	O
receptor	O	NOUN	B
in	O	ADP	O
these	O	DET	O
cell	O	NOUN	B
lines	O	NOUN	I
was	O	AUX	O
compared	O	VERB	O
to	O	PART	O
binding	O	NOUN	B
studies	O	NOUN	I
using	O	VERB	O
a	O	DET	O
T-lymphocyte	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
(	O	PUNCT	O
S-LB1	B-cell_line	NOUN	B
)	O	PUNCT	O
from	O	ADP	O
a	O	DET	O
normal	O	ADJ	O
individual	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
a	O	DET	O
fourth	O	ADJ	O
cell	B-cell_line	NOUN	B
line	I-cell_line	NOUN	I
,	O	PUNCT	O
A1-VDR	B-cell_line	NOUN	O
,	O	PUNCT	O
the	O	DET	O
receptor	O	NOUN	B
for	O	ADP	O
1	O	NUM	O
,	O	PUNCT	O
25	O	NUM	O
(	O	PUNCT	O
OH	O	NOUN	B
)	O	PUNCT	O
2D3	O	NOUN	B
had	O	AUX	O
a	O	DET	O
low	O	ADJ	B
binding	O	NOUN	B
capacity	O	NOUN	I
and	O	CCONJ	O
25	B-protein	NUM	O
(	I-protein	PUNCT	O
OH	I-protein	NOUN	B
)	I-protein	PUNCT	O
D3-24-hydroxylase	I-protein	NOUN	B
activity	O	NOUN	B
was	O	AUX	O
not	O	PART	O
detectable	O	ADJ	B
.	O	PUNCT	O


Induction	O	NOUN	B
of	O	ADP	O
24	O	NUM	O
,	O	PUNCT	O
25-	O	NUM	O
(	O	PUNCT	O
OH	O	NOUN	B
)	O	PUNCT	O
2D3	O	NOUN	B
synthesis	O	NOUN	I
by	O	ADP	O
1	O	NUM	O
,	O	PUNCT	O
25	O	NUM	O
(	O	PUNCT	O
OH	O	NOUN	B
)	O	PUNCT	O
2D3	O	NOUN	B
was	O	AUX	O
observed	O	VERB	O
in	O	ADP	O
the	O	DET	O
fifth	O	ADJ	B
cell	B-cell_line	NOUN	I
line	I-cell_line	NOUN	I
,	O	PUNCT	O
designated	O	VERB	O
Ro-VDR	B-cell_line	NOUN	B
,	O	PUNCT	O
although	O	SCONJ	O
the	O	DET	O
sensitivity	O	NOUN	B
to	O	PART	O
hormone	O	NOUN	B
treatment	O	NOUN	B
was	O	AUX	O
lower	O	ADJ	O
than	O	ADP	O
in	O	ADP	O
the	O	DET	O
control	B-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
from	O	ADP	O
a	O	DET	O
normal	O	ADJ	B
donor	O	NOUN	I
.	O	PUNCT	O


Binding	O	NOUN	B
and	O	CCONJ	O
elution	O	NOUN	B
properties	O	NOUN	B
to	O	PART	O
DNA-cellulose	O	NOUN	B
,	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
differed	O	VERB	O
from	O	ADP	O
normal	O	ADJ	B
in	O	ADP	O
both	O	CCONJ	O
Ro-VDR	B-cell_line	NOUN	B
and	O	CCONJ	O
A1-VDR	B-cell_line	NOUN	O
cells	I-cell_line	NOUN	B
where	O	SCONJ	O
elution	O	NOUN	B
from	O	ADP	O
DNA-cellulose	O	NOUN	B
occurred	O	VERB	O
at	O	ADP	O
a	O	DET	O
lower	O	ADJ	B
salt	O	NOUN	B
concentration	O	NOUN	B
than	O	ADP	O
is	O	AUX	O
typical	O	ADJ	O
of	O	ADP	O
the	O	DET	O
1	B-protein	NUM	O
,	I-protein	PUNCT	O
25	I-protein	NUM	O
(	I-protein	PUNCT	O
OH	I-protein	NOUN	B
)	I-protein	PUNCT	O
2D3	I-protein	NOUN	B
receptor	I-protein	NOUN	I
.	O	PUNCT	O


Similar	O	ADJ	O
findings	O	NOUN	B
were	O	AUX	O
obtained	O	VERB	O
with	O	ADP	O
bryostatin	O	NOUN	B
1	O	NUM	I
(	O	PUNCT	O
10	O	NUM	O
nM	O	NOUN	O
)	O	PUNCT	O
,	O	PUNCT	O
another	O	DET	O
activator	O	NOUN	B
of	O	ADP	O
protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
C	I-protein	NOUN	I
and	O	CCONJ	O
inducer	O	NOUN	B
of	O	ADP	O
monocytic	O	ADJ	B
differentiation	O	NOUN	I
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
1	O	NUM	O
,	O	PUNCT	O
25-dihydroxyvitamin	O	NOUN	B
D3	O	NOUN	I
(	O	PUNCT	O
0.5	O	NUM	O
microM	O	NOUN	O
)	O	PUNCT	O
,	O	PUNCT	O
a	O	DET	O
structurally	O	ADV	B
distinct	O	ADJ	O
agent	O	NOUN	B
which	O	DET	O
also	O	ADV	O
induces	O	VERB	O
HL-60	O	NOUN	B
monocytic	O	ADJ	I
differentiation	O	NOUN	I
,	O	PUNCT	O
increased	O	VERB	B
c-jun	B-DNA	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


It	O	PRON	O
is	O	AUX	O
shown	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
low	O	ADJ	B
level	O	NOUN	B
of	O	ADP	O
steroid	B-protein	NOUN	B
receptors	I-protein	NOUN	I
,	O	PUNCT	O
thyroid	O	NOUN	B
hormones	O	NOUN	I
that	O	PRON	O
the	O	DET	O
low	O	ADJ	B
level	O	NOUN	B
of	O	ADP	O
steroid	B-protein	NOUN	B
receptors	I-protein	NOUN	I
,	O	PUNCT	O
thyroid	O	NOUN	B
hormones	O	NOUN	I
(	O	PUNCT	O
T3	O	NOUN	B
and	O	CCONJ	O
T4	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
cortisol	O	NOUN	B
is	O	AUX	O
typical	O	ADJ	O
of	O	ADP	O
children	O	NOUN	B
with	O	ADP	O
the	O	DET	O
signs	O	NOUN	O
of	O	ADP	O
renal	O	ADJ	B
dysplasia	O	NOUN	I
.	O	PUNCT	O


To	O	PART	O
determine	O	VERB	O
whether	O	SCONJ	O
different	O	ADJ	O
cellular	B-protein	ADJ	B
factors	I-protein	NOUN	I
were	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
E3	O	NOUN	B
regulation	O	NOUN	I
in	O	ADP	O
lymphocytes	B-cell_type	NOUN	B
as	O	ADP	O
compared	O	VERB	O
with	O	ADP	O
HeLa	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
both	O	CCONJ	O
DNA	O	NOUN	B
binding	O	NOUN	I
and	O	CCONJ	O
transfection	O	NOUN	B
analysis	O	NOUN	I
with	O	ADP	O
the	O	DET	O
E3	B-DNA	NOUN	B
promoter	I-DNA	NOUN	I
in	O	ADP	O
both	O	DET	O
cell	O	NOUN	B
types	O	NOUN	I
were	O	AUX	O
performed	O	VERB	O
.	O	PUNCT	O


The	O	DET	O
predicted	O	VERB	O
periplasmic	B-protein	ADJ	B
domain	I-protein	NOUN	I
of	O	ADP	O
the	O	DET	O
PhoQ	B-protein	NOUN	B
protein	I-protein	NOUN	I
contained	O	VERB	O
a	O	DET	O
markedly	O	ADV	O
anionic	O	ADJ	B
domain	O	NOUN	I
that	O	PRON	O
could	O	AUX	O
interact	O	VERB	B
with	O	ADP	O
cationic	B-protein	ADJ	B
proteins	I-protein	NOUN	I
and	O	CCONJ	O
that	O	DET	O
could	O	AUX	O
be	O	AUX	O
responsible	O	ADJ	O
for	O	ADP	O
resistance	O	NOUN	B
to	O	PART	O
defensin	B-protein	NOUN	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
our	O	PRON	O
results	O	NOUN	O
suggest	O	VERB	O
that	O	SCONJ	O
events	O	NOUN	B
linked	O	VERB	O
to	O	PART	O
T-cell	O	NOUN	B
activation	O	NOUN	I
,	O	PUNCT	O
in	O	ADP	O
addition	O	NOUN	O
to	O	PART	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
translocation	O	NOUN	B
per	O	X	O
se	O	X	O
,	O	PUNCT	O
induce	O	VERB	B
functional	O	ADJ	B
interactions	O	NOUN	B
of	O	ADP	O
the	O	DET	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
complex	I-protein	NOUN	I
with	O	ADP	O
the	O	DET	O
HIV	B-DNA	NOUN	B
enhancer	I-DNA	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
two	O	NUM	O
patients	O	NOUN	B
,	O	PUNCT	O
VDR	B-protein	NOUN	B
was	O	AUX	O
increased	O	VERB	B
after	O	ADP	O
daily	O	ADJ	B
phosphate	O	NOUN	B
supplementation	O	NOUN	B
was	O	AUX	O
started	O	VERB	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
a	O	DET	O
decreased	O	VERB	B
concentration	O	NOUN	B
of	O	ADP	O
VDR	B-protein	NOUN	B
secondary	O	ADJ	B
to	O	PART	I
persistent	O	ADJ	B
hypophosphatemia	O	NOUN	B
is	O	AUX	O
one	O	NUM	O
of	O	ADP	O
the	O	DET	O
causes	O	NOUN	O
of	O	ADP	O
vitamin	O	NOUN	B
D	O	NOUN	I
resistance	O	NOUN	B
in	O	ADP	O
XLH	O	NOUN	B
.	O	PUNCT	O


Its	O	PRON	O
expression	O	NOUN	B
appears	O	VERB	O
to	O	PART	O
be	O	AUX	O
activated	O	VERB	B
during	O	ADP	O
pro-B-cell	O	ADJ	B
development	O	NOUN	I
,	O	PUNCT	O
is	O	AUX	O
abundant	O	ADJ	B
at	O	ADP	O
the	O	DET	O
pre-B-	O	ADJ	B
and	O	CCONJ	O
mature	O	ADJ	B
B-cell	O	NOUN	B
stages	O	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
is	O	AUX	O
absent	O	ADJ	B
in	O	ADP	O
terminally	B-cell_type	ADV	O
differentiated	I-cell_type	VERB	O
plasma	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


TAR	B-DNA	NOUN	B
independent	O	ADJ	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
in	O	ADP	O
phorbol	O	NOUN	B
ester	O	NOUN	I
stimulated	O	VERB	B
T	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
.	O	PUNCT	O


Multiple	B-DNA	ADJ	B
regulatory	I-DNA	ADJ	B
elements	I-DNA	NOUN	I
in	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
immunodeficiency	I-DNA	NOUN	I
virus	I-DNA	NOUN	I
long	I-DNA	ADJ	B
terminal	I-DNA	ADJ	I
repeat	I-DNA	NOUN	I
(	O	PUNCT	O
HIV	B-DNA	NOUN	B
LTR	I-DNA	NOUN	O
)	O	PUNCT	O
are	O	AUX	O
required	O	VERB	O
for	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
HIV	O	NOUN	B
gene	O	NOUN	O
expression	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
constructs	O	NOUN	B
were	O	AUX	O
transfected	O	VERB	B
into	O	ADP	O
either	O	CCONJ	O
HeLa	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
Jurkat	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
or	O	CCONJ	O
U937	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
in	O	ADP	O
both	O	CCONJ	O
the	O	DET	O
presence	O	NOUN	B
and	O	CCONJ	O
absence	O	NOUN	B
of	O	ADP	O
phorbol	O	NOUN	B
esters	O	NOUN	I
which	O	DET	O
have	O	AUX	O
previously	O	ADV	O
been	O	AUX	O
demonstrated	O	VERB	O
to	O	PART	O
activate	O	VERB	B
HIV	O	NOUN	B
gene	O	NOUN	B
expression	O	NOUN	I
.	O	PUNCT	O


At	O	ADP	O
the	O	DET	O
end	O	NOUN	O
of	O	ADP	O
this	O	DET	O
incubation	O	NOUN	B
the	O	DET	O
resting	B-cell_type	VERB	B
cells	I-cell_type	NOUN	I
were	O	AUX	O
stimulated	O	VERB	B
with	O	ADP	O
M-CSF	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
RNA	O	NOUN	B
was	O	AUX	O
isolated	O	VERB	B
for	O	ADP	O
analysis	O	NOUN	B
by	O	ADP	O
Northern	O	NOUN	B
blotting	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
also	O	ADV	O
observed	O	VERB	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
the	O	DET	O
myelomonocytic	B-DNA	ADJ	B
specific	I-DNA	ADJ	O
tyrosine	I-DNA	NOUN	B
kinase	I-DNA	NOUN	I
hck	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
simultaneously	O	ADV	B
with	O	ADP	O
the	O	DET	O
other	O	ADJ	O
immediate	B-DNA	ADJ	O
early	I-DNA	ADJ	O
response	I-DNA	NOUN	B
genes	I-DNA	NOUN	I
.	O	PUNCT	O


Inducible	O	ADJ	B
nuclear	B-protein	ADJ	O
factor	I-protein	NOUN	O
binding	O	VERB	O
to	O	PART	O
the	O	DET	O
kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
elements	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
immunodeficiency	I-DNA	NOUN	I
virus	I-DNA	NOUN	I
enhancer	I-DNA	NOUN	I
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
can	O	AUX	O
be	O	AUX	O
blocked	O	VERB	B
by	O	ADP	O
cyclosporin	O	NOUN	B
A	O	NOUN	O
in	O	ADP	O
a	O	DET	O
signal-dependent	O	ADJ	B
manner	O	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
(	O	PUNCT	O
HIV	O	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
partially	O	ADV	O
suppressed	O	VERB	B
.	O	PUNCT	O


This	O	DET	O
suggests	O	VERB	O
a	O	DET	O
model	O	NOUN	B
in	O	ADP	O
which	O	DET	O
functionally	O	ADV	O
indistinguishable	O	ADJ	O
kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
complexes	I-protein	NOUN	I
can	O	AUX	O
be	O	AUX	O
activated	O	VERB	B
via	O	ADP	O
two	O	NUM	O
separate	O	ADJ	O
pathways	O	NOUN	B
of	O	ADP	O
signal	O	NOUN	B
transduction	O	NOUN	I
distinguishable	O	ADJ	O
by	O	ADP	O
CsA	O	NOUN	B
.	O	PUNCT	O


Curiously	O	ADV	B
,	O	PUNCT	O
the	O	DET	O
TCF-1	B-protein	NOUN	B
alpha	I-protein	NOUN	B
binding	O	NOUN	I
element	O	NOUN	I
was	O	AUX	O
inactive	O	ADJ	B
in	O	X	B
vivo	O	X	I
when	O	SCONJ	O
removed	O	VERB	B
from	O	ADP	O
its	O	PRON	O
neighboring	O	NOUN	B
elements	O	NOUN	I
on	O	ADP	O
the	O	DET	O
TCR	B-DNA	NOUN	B
alpha	I-DNA	NOUN	I
enhancer	I-DNA	NOUN	I
and	O	CCONJ	O
positioned	O	ADJ	O
in	O	ADP	O
one	O	NUM	O
or	O	CCONJ	O
more	O	ADJ	O
copies	O	NOUN	B
upstream	O	ADV	B
of	O	ADP	O
a	O	DET	O
heterologous	B-DNA	ADJ	B
promoter	I-DNA	NOUN	B
.	O	PUNCT	O


Purified	O	VERB	B
OTF1	B-protein	NOUN	I
from	O	ADP	O
HeLa	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
and	O	CCONJ	O
OTF1	B-protein	NOUN	B
and	O	CCONJ	O
OTF2	B-protein	NOUN	B
from	O	ADP	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
bound	O	VERB	O
to	O	PART	O
identical	O	ADJ	B
sequences	O	NOUN	B
within	O	ADP	O
the	O	DET	O
heavy-chain	B-DNA	ADJ	B
promoter	I-DNA	NOUN	I
.	O	PUNCT	O


The	O	DET	O
OTF	O	NOUN	B
interactions	O	NOUN	B
we	O	PRON	O
observed	O	VERB	O
extended	O	VERB	B
over	O	ADP	O
the	O	DET	O
heptamer	B-DNA	NOUN	B
element	I-DNA	NOUN	O
5'-CTCAGGA-3	O	NOUN	O
'	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
it	O	PRON	O
seems	O	VERB	O
likely	O	ADJ	O
that	O	SCONJ	O
the	O	DET	O
binding	O	NOUN	B
of	O	ADP	O
the	O	DET	O
purified	B-protein	VERB	B
factors	I-protein	NOUN	I
involves	O	VERB	O
cooperation	O	NOUN	B
between	O	ADP	O
octamer	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
heptamer	I-DNA	NOUN	B
sites	I-DNA	NOUN	I
in	O	ADP	O
this	O	DET	O
promoter	B-DNA	NOUN	B
.	O	PUNCT	O


The	O	DET	O
same	O	ADJ	O
agents	O	NOUN	B
induce	O	VERB	B
transcription	O	NOUN	B
from	O	ADP	O
the	O	DET	O
interleukin-2	B-DNA	NOUN	B
receptor	I-DNA	NOUN	I
alpha-chain	I-DNA	NOUN	I
and	I-DNA	CCONJ	O
interleukin-2	I-DNA	NOUN	B
genes	I-DNA	NOUN	I
,	O	PUNCT	O
depending	O	VERB	O
on	O	ADP	O
promoter	B-DNA	NOUN	B
elements	I-DNA	NOUN	I
that	O	PRON	O
bind	O	VERB	B
the	O	DET	O
inducible	B-protein	ADJ	B
transcription	I-protein	NOUN	O
factor	I-protein	NOUN	O
NF-kappa	B-protein	NOUN	O
B	I-protein	NOUN	O
(	O	PUNCT	O
or	O	CCONJ	O
an	O	DET	O
NF-kappa	B-protein	NOUN	B
B-like	I-protein	ADJ	I
factor	I-protein	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


Two	O	NUM	O
kappa	B-DNA	NOUN	O
B-like	I-DNA	ADJ	B
motifs	I-DNA	NOUN	I
at	O	ADP	O
positions	B-DNA	NOUN	B
-98	I-DNA	NUM	O
to	I-DNA	PART	O
-108	I-DNA	NUM	O
of	O	ADP	O
the	O	DET	O
GM-CSF	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
were	O	AUX	O
also	O	ADV	O
recognized	O	VERB	O
but	O	CCONJ	O
with	O	ADP	O
much	O	ADV	O
lower	O	ADJ	O
affinities	O	NOUN	B
.	O	PUNCT	O


PMA	O	NOUN	B
enhanced	O	VERB	B
slightly	O	ADV	O
the	O	DET	O
stimulatory	O	ADJ	B
effect	O	NOUN	I
of	O	ADP	O
PHA	B-protein	NOUN	B
.	O	PUNCT	O


To	O	PART	O
be	O	AUX	O
or	O	CCONJ	O
not	O	PART	O
to	O	PART	O
be	O	AUX	O
a	O	DET	O
responder	O	NOUN	B
in	O	ADP	O
T-cell	O	NOUN	B
responses	O	NOUN	I
:	O	PUNCT	O
ubiquitous	O	ADJ	O
oligopeptides	O	NOUN	B
in	O	ADP	O
all	O	DET	O
proteins	O	NOUN	B
.	O	PUNCT	O


Proliferation	O	NOUN	B
and	O	CCONJ	O
immunologic	O	ADJ	B
function	O	NOUN	I
of	O	ADP	O
T	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
are	O	AUX	O
initiated	O	VERB	O
by	O	ADP	O
signals	O	NOUN	B
from	O	ADP	O
the	O	DET	O
antigen	B-protein	NOUN	B
receptor	I-protein	NOUN	I
that	O	PRON	O
are	O	AUX	O
inhibited	O	VERB	B
by	O	ADP	O
the	O	DET	O
immunosuppressant	O	ADJ	B
FK506	O	NOUN	B
but	O	CCONJ	O
not	O	PART	O
by	O	ADP	O
its	O	PRON	O
structural	O	ADJ	B
analog	O	NOUN	I
,	O	PUNCT	O
rapamycin	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
hypothesized	O	VERB	O
that	O	SCONJ	O
adherence	O	NOUN	B
itself	O	PRON	O
might	O	AUX	O
be	O	AUX	O
an	O	DET	O
important	O	ADJ	O
trigger	O	NOUN	O
for	O	ADP	O
a	O	DET	O
sequence	O	NOUN	B
of	O	ADP	O
gene	O	NOUN	B
activation	O	NOUN	I
culminating	O	VERB	O
in	O	ADP	O
cells	O	NOUN	B
with	O	ADP	O
increased	O	VERB	B
mRNA	B-RNA	NOUN	B
encoding	O	VERB	B
profibrotic	O	ADJ	B
growth	B-protein	NOUN	I
factors	I-protein	NOUN	I
such	O	ADJ	O
as	O	ADP	O
platelet-derived	B-protein	ADJ	B
growth	I-protein	NOUN	I
factor	I-protein	NOUN	I
B	I-protein	NOUN	I
subunit	I-protein	NOUN	I
(	O	PUNCT	O
PDGF	B-protein	NOUN	B
[	I-protein	PUNCT	O
B	I-protein	NOUN	B
]	I-protein	PUNCT	O
)	O	PUNCT	O
and	O	CCONJ	O
transforming	B-protein	VERB	B
growth	I-protein	NOUN	I
factor-beta	I-protein	NOUN	I
(	O	PUNCT	O
TGF-beta	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


After	O	ADP	O
in	O	X	B
vitro	O	X	I
adherence	O	NOUN	B
,	O	PUNCT	O
human	O	ADJ	B
monocytes	O	NOUN	B
had	O	AUX	O
a	O	DET	O
biphasic	O	ADJ	B
increase	O	NOUN	B
in	O	ADP	O
PDGF	B-RNA	NOUN	B
(	I-RNA	PUNCT	O
B	I-RNA	NOUN	B
)	I-RNA	PUNCT	O
mRNA	I-RNA	NOUN	B
with	O	ADP	O
peaks	O	NOUN	B
at	O	ADP	O
6	O	NUM	O
h	O	NOUN	O
and	O	CCONJ	O
13	O	NUM	O
d	O	NOUN	O
.	O	PUNCT	O


No	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
TGF-beta	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
was	O	AUX	O
observed	O	VERB	O
.	O	PUNCT	O


Adherence	O	NOUN	B
to	O	PART	O
either	O	CCONJ	O
fibronectin	O	NOUN	B
or	O	CCONJ	O
collagen-coated	O	ADJ	B
plastic	O	NOUN	I
had	O	AUX	O
little	O	ADJ	O
consistent	O	ADJ	O
effect	O	NOUN	O
on	O	ADP	O
PDGF	B-RNA	NOUN	B
(	I-RNA	PUNCT	O
B	I-RNA	NOUN	B
)	I-RNA	PUNCT	O
mRNA	I-RNA	NOUN	B
accumulation	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
increased	O	VERB	B
PDGF	B-RNA	NOUN	B
(	I-RNA	PUNCT	O
B	I-RNA	NOUN	B
)	I-RNA	PUNCT	O
mRNA	I-RNA	NOUN	B
observed	O	VERB	B
in	O	ADP	O
adherent	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
was	O	AUX	O
accompanied	O	VERB	O
by	O	ADP	O
increases	O	NOUN	B
in	O	ADP	O
mRNAs	B-RNA	NOUN	B
of	O	ADP	O
the	O	DET	O
early	B-DNA	ADJ	B
growth	I-DNA	NOUN	B
response	I-DNA	NOUN	I
genes	I-DNA	NOUN	I
c-fos	B-DNA	NOUN	O
(	O	PUNCT	O
maximal	O	ADJ	B
at	O	ADP	O
20	O	NUM	O
min	O	NOUN	O
)	O	PUNCT	O
,	O	PUNCT	O
c-jun	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
EGR2	O	NOUN	B
(	O	PUNCT	O
maximal	O	ADJ	B
at	O	ADP	O
6-24	O	NUM	O
h	O	NOUN	O
)	O	PUNCT	O
.	O	PUNCT	O


These	O	DET	O
observations	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
adherence	O	NOUN	B
results	O	NOUN	B
in	O	ADP	O
increases	O	NOUN	B
of	O	ADP	O
c-fos	B-RNA	NOUN	B
,	I-RNA	PUNCT	O
c-jun	I-RNA	NOUN	B
,	I-RNA	PUNCT	O
EGR2	I-RNA	NOUN	B
,	I-RNA	PUNCT	O
and	I-RNA	CCONJ	O
PDGF	I-RNA	NOUN	B
(	I-RNA	PUNCT	O
B	I-RNA	NOUN	B
)	I-RNA	PUNCT	O
mRNA	I-RNA	NOUN	B
.	O	PUNCT	O


Modulation	O	NOUN	B
of	O	ADP	O
these	O	DET	O
events	O	NOUN	B
at	O	ADP	O
the	O	DET	O
time	O	NOUN	B
of	O	ADP	O
adherence	O	NOUN	B
offers	O	VERB	O
a	O	DET	O
mechanism	O	NOUN	B
by	O	ADP	O
which	O	DET	O
differential	O	ADJ	O
priming	O	NOUN	B
of	O	ADP	O
the	O	DET	O
cells	O	NOUN	B
may	O	AUX	O
be	O	AUX	O
accomplished	O	VERB	O
.	O	PUNCT	O


Unexpectedly	O	ADV	O
,	O	PUNCT	O
stimulation	O	NOUN	B
of	O	ADP	O
cloned	B-cell_line	VERB	B
stably	I-cell_line	ADV	B
transfected	I-cell_line	VERB	B
Jurkat	I-cell_line	NOUN	B
T	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
leads	O	VERB	O
to	O	PART	O
a	O	DET	O
bimodal	O	ADJ	B
pattern	O	NOUN	I
of	O	ADP	O
beta-gal	O	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
which	O	DET	O
some	O	DET	O
cells	O	NOUN	B
express	O	VERB	O
no	O	DET	O
beta-gal	B-protein	NOUN	B
and	O	CCONJ	O
others	O	NOUN	O
express	O	VERB	O
high	O	ADJ	O
levels	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
investigated	O	VERB	B
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
promoter	B-DNA	NOUN	B
(	O	PUNCT	O
BMRF1	B-DNA	NOUN	B
)	O	PUNCT	O
for	O	ADP	O
this	O	DET	O
early	O	ADJ	O
gene	O	NOUN	B
by	O	ADP	O
studying	O	VERB	O
its	O	PRON	O
responsiveness	O	NOUN	B
in	O	X	B
vitro	O	X	I
to	O	PART	O
two	O	NUM	O
immediate-early	B-protein	ADJ	B
viral	I-protein	ADJ	B
transactivators	I-protein	NOUN	I
,	O	PUNCT	O
BZLF1	B-protein	NOUN	B
(	O	PUNCT	O
Z	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
BRLF1	B-protein	NOUN	B
(	O	PUNCT	O
R	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
focusing	O	VERB	O
on	O	ADP	O
the	O	DET	O
differences	O	NOUN	B
in	O	ADP	O
response	O	NOUN	B
in	O	ADP	O
lymphoid	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
epithelial	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
EA-D	B-DNA	NOUN	B
(	I-DNA	PUNCT	O
BMRF1	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
promoter	I-DNA	NOUN	B
regulation	O	NOUN	I
by	O	ADP	O
Z	B-protein	NOUN	B
and	O	CCONJ	O
R	B-protein	NOUN	B
is	O	AUX	O
cell	O	NOUN	B
type	O	NOUN	I
specific	O	ADJ	B
and	O	CCONJ	O
appears	O	VERB	O
to	O	PART	O
involve	O	VERB	O
different	O	ADJ	O
mechanisms	O	NOUN	B
in	O	ADP	O
each	O	DET	O
cell	O	NOUN	B
type	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
DNA	O	NOUN	B
isolated	O	VERB	B
contained	O	VERB	O
an	O	DET	O
open	O	ADJ	B
reading	O	NOUN	I
frame	O	NOUN	I
encoding	O	VERB	B
108	O	NUM	O
amino	O	NOUN	B
acid	O	NOUN	I
residues	O	NOUN	I
.	O	PUNCT	O


DNase	O	NOUN	B
footprinting	O	NOUN	I
analysis	O	NOUN	I
corroborated	O	VERB	O
the	O	DET	O
functional	O	ADJ	B
data	O	NOUN	B
showing	O	VERB	O
that	O	SCONJ	O
a	O	DET	O
lymphoid-specific	B-protein	ADJ	B
protein	I-protein	NOUN	I
binds	O	VERB	B
to	O	PART	O
the	O	DET	O
microB	B-DNA	NOUN	B
DNA	I-DNA	NOUN	I
motif	I-DNA	NOUN	O
.	O	PUNCT	O


Depletion	O	NOUN	B
of	O	ADP	O
CD8+	B-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
was	O	AUX	O
accompanied	O	VERB	O
by	O	ADP	O
62	O	NUM	O
+/-	O	CCONJ	O
18	O	NUM	O
%	O	NOUN	O
loss	O	NOUN	B
of	O	ADP	O
progesterone	B-cell_line	NOUN	B
receptor-bearing	I-cell_line	ADJ	O
cells	I-cell_line	NOUN	O
,	O	PUNCT	O
while	O	SCONJ	O
depletion	O	NOUN	B
of	O	ADP	O
CD4+	B-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
resulted	O	VERB	O
in	O	ADP	O
a	O	DET	O
twofold	O	ADJ	O
increase	O	NOUN	B
in	O	ADP	O
the	O	DET	O
number	O	NOUN	O
of	O	ADP	O
positively	O	ADV	B
staining	O	VERB	I
lymphocytes	B-cell_line	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
nonpregnancy	B-cell_line	NOUN	B
lymphocytes	I-cell_line	NOUN	B
a	O	DET	O
3-day	O	ADJ	O
PHA	B-protein	NOUN	B
treatment	O	NOUN	B
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
allogeneic	O	ADJ	B
stimulation	O	NOUN	O
,	O	PUNCT	O
resulted	O	VERB	O
in	O	ADP	O
a	O	DET	O
significant	O	ADJ	O
increase	O	NOUN	B
in	O	ADP	O
the	O	DET	O
number	O	NOUN	O
of	O	ADP	O
receptor-containing	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Activation	O	NOUN	B
of	O	ADP	O
human	B-cell_line	ADJ	B
CD4	I-cell_line	NOUN	O
T	I-cell_line	NOUN	O
lymphocytes	I-cell_line	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
an	O	DET	O
analysis	O	NOUN	B
of	O	ADP	O
the	O	DET	O
molecular	O	ADJ	B
mechanism	O	NOUN	I
by	O	ADP	O
which	O	DET	O
IL-2	B-protein	NOUN	B
message	O	NOUN	B
was	O	AUX	O
generated	O	VERB	O
,	O	PUNCT	O
we	O	PRON	O
showed	O	VERB	O
that	O	SCONJ	O
a	O	DET	O
fibronectin	B-protein	NOUN	B
-VLA-5	O	NOUN	O
fibronectin	B-protein	NOUN	B
receptor	I-protein	NOUN	I
interaction	O	NOUN	B
may	O	AUX	O
contribute	O	VERB	O
an	O	DET	O
independent	O	ADJ	B
signal	O	NOUN	B
distinct	O	ADJ	O
from	O	ADP	O
the	O	DET	O
CD3	B-protein	NOUN	B
pathway	O	NOUN	I
of	O	ADP	O
activation	O	NOUN	B
by	O	ADP	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
an	O	DET	O
AP-1	B-protein	NOUN	B
transcriptional	I-protein	ADJ	I
factor	I-protein	NOUN	I
.	O	PUNCT	O


Several	O	ADJ	O
lines	O	NOUN	O
of	O	ADP	O
evidence	O	NOUN	B
suggest	O	VERB	O
disturbances	O	NOUN	B
of	O	ADP	O
the	O	DET	O
hypothalamic-pituitary-adrenal	O	ADJ	B
(	O	PUNCT	I
HPA	O	ADJ	I
)	O	PUNCT	I
system	O	NOUN	I
in	O	ADP	O
Alzheimer	O	NOUN	B
's	O	PART	I
disease	O	NOUN	I
(	O	PUNCT	O
AD	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Suppression	O	NOUN	B
of	O	ADP	O
signals	O	NOUN	B
required	O	VERB	O
for	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
NF-kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
in	O	ADP	O
cells	O	NOUN	B
constitutively	O	ADV	B
expressing	O	VERB	B
the	O	DET	O
HTLV-I	B-protein	NOUN	B
Tax	I-protein	NOUN	I
protein	I-protein	NOUN	I
.	O	PUNCT	O


Transient	O	ADJ	B
short-term	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Tax	B-protein	NOUN	B
protein	I-protein	NOUN	I
of	O	ADP	O
human	O	ADJ	B
T-cell	O	NOUN	O
leukemia	O	NOUN	O
virus	O	NOUN	O
type-I	O	NOUN	O
(	O	PUNCT	O
HTLV-I	O	NOUN	B
)	O	PUNCT	O
leads	O	VERB	O
to	O	PART	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
pleiotropic	O	ADJ	B
transcription	B-protein	NOUN	I
factor	I-protein	NOUN	I
NF-kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
.	O	PUNCT	O


Consistent	O	ADJ	B
with	O	ADP	I
findings	O	NOUN	B
obtained	O	VERB	O
with	O	ADP	O
transient	O	ADJ	B
expression	O	NOUN	O
assays	O	NOUN	O
,	O	PUNCT	O
we	O	PRON	O
observed	O	VERB	O
marked	O	ADJ	O
accumulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
NF-kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
in	O	ADP	O
the	O	DET	O
nucleus	O	NOUN	B
of	O	ADP	O
Namalwa	B-cell_line	NOUN	B
B	I-cell_line	NOUN	I
lymphoid	I-cell_line	ADJ	I
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
which	O	DET	O
constitutively	O	ADV	B
express	O	VERB	O
Tax	B-protein	NOUN	B
.	O	PUNCT	O


Sex	O	NOUN	B
steroid	O	NOUN	B
regulation	O	NOUN	O
of	O	ADP	O
the	O	DET	O
production	O	NOUN	B
of	O	ADP	O
this	O	DET	O
molecule	O	NOUN	B
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
other	O	ADJ	O
cytokines	B-protein	NOUN	B
,	O	PUNCT	O
may	O	AUX	O
help	O	VERB	O
explain	O	VERB	O
the	O	DET	O
gender-specific	O	ADJ	O
differences	O	NOUN	O
in	O	ADP	O
the	O	DET	O
immune	O	ADJ	B
system	O	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
autoimmunity	O	NOUN	B
.	O	PUNCT	O


Cloning	O	NOUN	B
of	O	ADP	O
a	O	DET	O
transcriptionally	B-protein	ADV	B
active	I-protein	ADJ	O
human	I-protein	ADJ	B
TATA	I-protein	NOUN	O
binding	I-protein	NOUN	O
factor	I-protein	NOUN	O
.	O	PUNCT	O


Using	O	VERB	O
a	O	DET	O
combination	O	NOUN	B
of	O	ADP	O
transfection	O	NOUN	B
,	O	PUNCT	O
protein-DNA	O	ADJ	B
binding	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
in	O	X	B
vitro	O	X	I
transcription	O	NOUN	B
methods	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
discovered	O	VERB	O
the	O	DET	O
novel	B-protein	ADJ	O
T-cell-specific	I-protein	ADJ	B
transcriptional	I-protein	ADJ	I
activator	I-protein	NOUN	I
TCF-1	B-protein	NOUN	B
(	O	PUNCT	O
for	O	ADP	O
T-Cell	B-protein	NOUN	B
Factor-1	I-protein	NOUN	I
)	O	PUNCT	O
,	O	PUNCT	O
which	O	DET	O
recognizes	O	VERB	O
a	O	DET	O
T-cell-specific	B-DNA	ADJ	B
response	I-DNA	NOUN	I
element	I-DNA	NOUN	I
(	O	PUNCT	O
TCE	B-DNA	NOUN	B
)	O	PUNCT	O
located	O	ADJ	O
within	O	ADP	O
the	O	DET	O
IL-2	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
.	O	PUNCT	O


Second	O	ADV	O
,	O	PUNCT	O
TRE-DNA	B-protein	ADJ	B
binding	I-protein	NOUN	I
proteins	I-protein	NOUN	I
sedimented	O	VERB	B
through	O	ADP	O
a	O	DET	O
glycerol	O	NOUN	B
density	O	NOUN	B
gradient	O	NOUN	B
at	O	ADP	O
rates	O	NOUN	B
corresponding	O	VERB	O
to	O	PART	O
proteins	O	NOUN	B
of	O	ADP	O
native	O	ADJ	B
molecular	O	ADJ	B
weights	O	NOUN	I
of	O	ADP	O
35	O	NUM	O
to	O	PART	O
50	O	NUM	O
kD	O	NOUN	B
and	O	CCONJ	O
110	O	NUM	O
kD	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
cAMP-response	B-DNA	ADJ	B
element	I-DNA	NOUN	I
CRE	B-DNA	NOUN	B
,	O	PUNCT	O
TGACGTCA	O	NOUN	B
,	O	PUNCT	O
present	O	ADJ	O
in	O	ADP	O
the	O	DET	O
21	B-DNA	NUM	O
base-pair	I-DNA	NOUN	B
sequence	I-DNA	NOUN	I
,	O	PUNCT	O
appears	O	VERB	O
to	O	PART	O
be	O	AUX	O
essential	O	ADJ	B
for	O	ADP	O
specific	O	ADJ	B
protein-	O	NOUN	O
TRE	B-DNA	NOUN	B
-DNA	O	NOUN	O
interactions	O	NOUN	B
because	O	SCONJ	O
mutation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
two	O	NUM	O
G	O	NOUN	B
's	O	PART	I
destroys	O	VERB	B
this	O	DET	O
complex	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
complementary	B-DNA	ADJ	B
DNAs	I-DNA	NOUN	B
are	O	AUX	O
the	O	DET	O
products	O	NOUN	B
of	O	ADP	O
distinct	O	ADJ	O
genes	O	NOUN	B
,	O	PUNCT	O
yet	O	CCONJ	O
both	O	CCONJ	O
ITF-1	B-protein	NOUN	B
and	O	CCONJ	O
ITF-2	B-protein	NOUN	B
are	O	AUX	O
structurally	O	ADV	B
and	O	CCONJ	O
functionally	O	ADV	O
similar	O	ADJ	O
.	O	PUNCT	O


The	O	DET	O
dissociation	O	NOUN	B
constant	O	NOUN	B
was	O	AUX	O
not	O	PART	O
affected	O	VERB	O
by	O	ADP	O
methylprednisolone	O	ADJ	B
treatment	O	NOUN	B
in	O	ADP	O
either	O	DET	O
group	O	NOUN	B
.	O	PUNCT	O


Using	O	VERB	O
constructs	O	NOUN	B
in	O	ADP	O
which	O	DET	O
mRNA	B-RNA	NOUN	B
production	O	NOUN	I
controlled	O	VERB	O
by	O	ADP	O
a	O	DET	O
specific	O	ADJ	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
could	O	AUX	O
be	O	AUX	O
readily	O	ADV	O
measured	O	VERB	B
we	O	PRON	O
found	O	VERB	O
that	O	SCONJ	O
both	O	CCONJ	O
cyclosporin	O	NOUN	B
A	O	NOUN	I
and	O	CCONJ	O
FK506	O	NOUN	B
completely	O	ADV	O
inhibited	O	VERB	B
transcription	O	NOUN	B
activated	O	VERB	B
by	O	ADP	O
NF-AT	B-protein	NOUN	B
,	O	PUNCT	O
NFIL2	B-protein	NOUN	B
A	I-protein	NOUN	O
,	O	PUNCT	O
NFIL2	B-protein	NOUN	B
B	I-protein	NOUN	I
and	O	CCONJ	O
partially	O	ADV	O
inhibited	O	VERB	B
transcription	O	NOUN	B
activated	O	VERB	B
by	O	ADP	O
NF	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
.	O	PUNCT	O


Cyclosporin	O	NOUN	B
A	O	NOUN	I
and	O	CCONJ	O
FK506	O	NOUN	B
inhibited	O	VERB	B
only	O	ADV	O
transcriptional	O	ADJ	B
activation	O	NOUN	I
that	O	PRON	O
was	O	AUX	O
dependent	O	ADJ	O
on	O	ADP	O
Ca2+	O	NOUN	B
mobilization	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
proteins	O	NOUN	B
are	O	AUX	O
differentially	O	ADV	O
expressed	O	VERB	B
in	O	ADP	O
human	B-cell_line	ADJ	B
glioblastoma	I-cell_line	NOUN	B
and	I-cell_line	CCONJ	O
neuroblastoma	I-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
.	O	PUNCT	O


The	O	DET	O
relationship	O	NOUN	B
of	O	ADP	O
the	O	DET	O
N-Oct	B-protein	NOUN	B
proteins	I-protein	NOUN	I
to	O	PART	O
Oct-1	B-protein	NOUN	B
and	O	CCONJ	O
Oct-2A	B-protein	NOUN	B
was	O	AUX	O
analyzed	O	VERB	B
by	O	ADP	O
proteolytic	O	ADJ	B
clipping	O	VERB	I
bandshift	O	NOUN	B
assays	O	NOUN	I
and	O	CCONJ	O
by	O	ADP	O
their	O	PRON	O
reactivity	O	NOUN	B
towards	O	ADP	O
antisera	O	NOUN	B
raised	O	VERB	O
against	O	ADP	O
recombinant	O	ADJ	B
Oct-1	B-protein	NOUN	I
and	O	CCONJ	O
Oct-2A	B-protein	NOUN	B
proteins	O	NOUN	I
.	O	PUNCT	O


with	O	ADP	O
culture	O	NOUN	B
doubling	O	NOUN	I
times	O	NOUN	O
of	O	ADP	O
about	O	ADV	O
25	O	NUM	O
h	O	NOUN	O
for	O	ADP	O
both	O	CCONJ	O
serum-supplemented	B-cell_line	ADJ	B
and	I-cell_line	CCONJ	O
serum-free	I-cell_line	ADJ	B
cultures	I-cell_line	NOUN	I
(	O	PUNCT	O
viability	O	NOUN	B
greater	O	ADJ	O
than	O	ADP	O
or	O	CCONJ	O
equal	O	ADJ	O
to	O	PART	O
90	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
increased	O	VERB	B
sensitivity	O	NOUN	B
of	O	ADP	O
CEM-C7	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
and	O	CCONJ	O
its	O	PRON	O
subclones	O	NOUN	B
to	O	PART	O
dexamethasone	O	NOUN	B
in	O	ADP	O
serum-free	O	ADJ	B
medium	O	NOUN	I
returned	O	VERB	O
to	O	PART	O
previous	O	ADJ	O
levels	O	NOUN	B
when	O	SCONJ	O
these	O	DET	O
cells	O	NOUN	B
were	O	AUX	O
recultured	O	VERB	B
in	O	ADP	O
serum-containing	O	ADJ	B
medium	O	NOUN	I
.	O	PUNCT	O


[	O	PUNCT	O
Glucocorticoid	B-protein	NOUN	B
receptors	I-protein	NOUN	I
on	O	ADP	O
human	B-cell_type	ADJ	B
peripheral	I-cell_type	ADJ	O
mononuclear	I-cell_type	ADJ	O
and	I-cell_type	CCONJ	O
polymorphonuclear	I-cell_type	ADJ	B
leucocytes	I-cell_type	NOUN	B
:	O	PUNCT	O
changes	O	NOUN	B
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
yang-deficiency	O	NOUN	B
]	O	PUNCT	O


The	O	DET	O
ubiquitous	B-protein	ADJ	O
octamer-binding	I-protein	ADJ	O
protein	I-protein	NOUN	O
(	O	PUNCT	O
s	O	NOUN	O
)	O	PUNCT	O
is	O	AUX	O
sufficient	O	ADJ	O
for	O	ADP	O
transcription	O	NOUN	B
of	O	ADP	O
immunoglobulin	B-DNA	NOUN	B
genes	I-DNA	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
present	O	ADJ	O
paper	O	NOUN	O
this	O	DET	O
easily	O	ADV	O
accessible	O	ADJ	O
human	O	ADJ	B
cell	O	NOUN	O
model	O	NOUN	O
was	O	AUX	O
investigated	O	VERB	B
in	O	ADP	O
13	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
essential	O	ADJ	B
hypertension	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
independence	O	NOUN	B
of	O	ADP	O
intracellular	O	ADJ	B
electrolytes	O	NOUN	B
from	O	ADP	O
aldosterone	O	NOUN	B
despite	O	SCONJ	O
a	O	DET	O
normal	O	ADJ	O
number	O	NOUN	O
of	O	ADP	O
mineralocorticoid	B-protein	NOUN	B
receptors	I-protein	NOUN	I
may	O	AUX	O
reflect	O	VERB	O
an	O	DET	O
impairment	O	NOUN	B
of	O	ADP	O
the	O	DET	O
mineralocorticoid	O	NOUN	B
effector	O	NOUN	I
mechanism	O	NOUN	B
in	O	ADP	O
the	O	DET	O
HML	B-cell_type	NOUN	B
of	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
essential	O	ADJ	B
hypertension	O	NOUN	I
.	O	PUNCT	O


Inhibition	O	NOUN	B
of	O	ADP	O
sequence-specific	B-protein	ADJ	B
DNA-binding	I-protein	ADJ	I
proteins	I-protein	NOUN	I
was	O	AUX	O
achieved	O	VERB	O
with	O	ADP	O
double-stranded	O	ADJ	B
(	O	PUNCT	I
ds	O	ADJ	O
)	O	PUNCT	O
phosphorothioate	O	NOUN	B
oligonucleotides	O	NOUN	I
that	O	PRON	O
contained	O	VERB	O
octamer	B-DNA	NOUN	B
or	I-DNA	CCONJ	O
kappa	I-DNA	NOUN	B
B	I-DNA	NOUN	I
consensus	I-DNA	NOUN	I
sequences	I-DNA	NOUN	I
.	O	PUNCT	O


Addition	O	NOUN	B
of	O	ADP	O
phosphorothioate	O	NOUN	B
oligonucleotides	O	NOUN	I
that	O	PRON	O
contained	O	VERB	O
the	O	DET	O
octamer	B-DNA	NOUN	B
consensus	I-DNA	NOUN	B
to	O	PART	O
Jurkat	B-cell_line	NOUN	B
T	I-cell_line	NOUN	I
leukemia	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	O
inhibited	O	VERB	B
interleukin-2	B-protein	NOUN	B
(	O	PUNCT	O
IL-2	B-protein	NOUN	B
)	O	PUNCT	O
secretion	O	NOUN	B
to	O	PART	O
a	O	DET	O
degree	O	NOUN	B
similar	O	ADJ	O
to	O	PART	O
that	O	DET	O
observed	O	VERB	O
with	O	ADP	O
a	O	DET	O
mutated	B-DNA	VERB	B
octamer	I-DNA	NOUN	O
site	I-DNA	NOUN	O
in	O	ADP	O
the	O	DET	O
IL-2	B-DNA	NOUN	B
enhancer	I-DNA	NOUN	I
.	O	PUNCT	O


The	O	DET	O
plasma	O	NOUN	B
cortisol	O	NOUN	B
concentration	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
sites	O	NOUN	B
of	O	ADP	O
glucocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
(	O	PUNCT	O
GCR	B-protein	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
peripheral	B-cell_type	ADJ	B
lymphocytes	I-cell_type	NOUN	I
were	O	AUX	O
measured	O	VERB	B
in	O	ADP	O
32	O	NUM	O
healthy	O	ADJ	B
aged	O	ADJ	B
persons	O	NOUN	B
and	O	CCONJ	O
13	O	NUM	O
young	O	ADJ	B
adults	O	NOUN	I
.	O	PUNCT	O


Exposure	O	NOUN	B
of	O	ADP	O
CML	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	O
to	O	PART	O
IFN-alpha	B-protein	NOUN	B
diminished	O	VERB	B
the	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
the	O	DET	O
CML	B-protein	NOUN	B
cytoplasmic	I-protein	ADJ	B
proteins	I-protein	NOUN	I
on	O	ADP	O
these	O	DET	O
nuclear	B-protein	ADJ	B
protein-DNA	I-protein	ADJ	I
complexes	I-protein	NOUN	I
.	O	PUNCT	O


Epstein-Barr	B-protein	ADJ	B
virus	I-protein	NOUN	I
nuclear	I-protein	ADJ	I
antigen	I-protein	NOUN	I
2	I-protein	NUM	I
transactivates	O	VERB	B
latent	B-protein	ADJ	B
membrane	I-protein	NOUN	I
protein	I-protein	NOUN	I
LMP1	B-protein	NOUN	B
.	O	PUNCT	O


LMP1	B-protein	NOUN	B
is	O	AUX	O
a	O	DET	O
potent	O	ADJ	O
effector	O	NOUN	B
of	O	ADP	O
B-lymphocyte	O	NOUN	B
activation	O	NOUN	B
and	O	CCONJ	O
can	O	AUX	O
act	O	VERB	O
synergistically	O	ADV	B
with	O	ADP	O
EBNA-2	B-protein	NOUN	B
to	O	PART	O
induce	O	VERB	B
cellular	O	ADJ	B
CD23	O	NOUN	I
gene	O	NOUN	I
expression	O	NOUN	B
.	O	PUNCT	O


Such	O	ADJ	O
tests	O	NOUN	B
may	O	AUX	O
become	O	VERB	O
useful	O	ADJ	O
diagnostic	O	ADJ	B
tools	O	NOUN	I
.	O	PUNCT	O


[	O	PUNCT	O
The	O	DET	O
inhibitory	O	ADJ	B
effect	O	NOUN	O
of	O	ADP	O
hydrocortisone	O	NOUN	B
on	O	ADP	O
the	O	DET	O
chemotactic	O	ADJ	B
migration	O	NOUN	I
of	O	ADP	O
human	B-cell_type	ADJ	B
leukocytes	I-cell_type	NOUN	B
]	O	PUNCT	O


Random	O	ADJ	B
migration	O	NOUN	I
(	O	PUNCT	O
RM	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
chemotactic	O	ADJ	B
migration	O	NOUN	I
(	O	PUNCT	O
ChtM	O	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
human	B-cell_type	ADJ	B
leukocytes	I-cell_type	NOUN	B
to	O	PART	O
yeast	O	NOUN	B
activated	O	VERB	B
serum	O	NOUN	B
were	O	AUX	O
studied	O	VERB	O
with	O	ADP	O
the	O	DET	O
modified	O	VERB	B
Boyden	O	PROPN	B
chamber	O	NOUN	I
method	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
difference	O	NOUN	O
between	O	ADP	O
the	O	DET	O
peak	O	NOUN	B
(	O	PUNCT	O
0	O	NUM	O
:	O	PUNCT	O
00	O	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
trough	O	NOUN	B
values	O	NOUN	I
(	O	PUNCT	O
8	O	NUM	O
:	O	PUNCT	O
00	O	NUM	O
)	O	PUNCT	O
of	O	ADP	O
RM	O	NOUN	B
and	O	CCONJ	O
ChtM	O	NOUN	B
was	O	AUX	O
significant	O	ADJ	O
statistically	O	ADV	B
(	O	PUNCT	O
P	O	NOUN	O
less	O	ADJ	O
than	O	ADP	O
0.01	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Using	O	VERB	O
a	O	DET	O
monoclonal	B-protein	ADJ	B
antibody	I-protein	NOUN	I
,	O	PUNCT	O
Lt-4	B-protein	NOUN	B
,	O	PUNCT	O
directed	O	VERB	O
against	O	ADP	O
human	B-protein	ADJ	B
T	I-protein	NOUN	B
cell	I-protein	NOUN	I
leukemia	I-protein	NOUN	I
virus	I-protein	NOUN	O
type	I-protein	NOUN	O
I	I-protein	NUM	O
(	I-protein	PUNCT	O
HTLV-I	I-protein	NOUN	O
)	I-protein	PUNCT	O
trans-activator	I-protein	NOUN	O
(	I-protein	PUNCT	O
tax1	I-protein	NOUN	O
)	I-protein	PUNCT	O
antigen	I-protein	NOUN	O
,	O	PUNCT	O
we	O	PRON	O
examined	O	VERB	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
tax1	B-protein	NOUN	B
and	O	CCONJ	O
related	O	ADJ	O
antigens	B-protein	NOUN	B
in	O	ADP	O
a	O	DET	O
variety	O	NOUN	O
of	O	ADP	O
T	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
bearing	O	VERB	O
HTLV-I	O	NOUN	B
and	O	CCONJ	O
related	O	ADJ	O
retroviruses	O	NOUN	B
,	O	PUNCT	O
simian	O	ADJ	B
T	O	NOUN	I
cell	O	NOUN	I
leukemia	O	NOUN	I
virus	O	NOUN	O
type	O	NOUN	O
I	O	NUM	O
(	O	PUNCT	O
STLV-I	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
HTLV-II	O	NOUN	B
,	O	PUNCT	O
by	O	ADP	O
immunofluorescence	O	NOUN	B
and	O	CCONJ	O
immunoblot	O	NOUN	B
assays	O	NOUN	I
.	O	PUNCT	O


Characterization	O	NOUN	B
of	O	ADP	O
the	O	DET	O
human	B-protein	ADJ	B
immunodeficiency	I-protein	NOUN	I
virus	I-protein	NOUN	I
type	I-protein	NOUN	I
1	I-protein	NUM	I
enhancer-binding	I-protein	ADJ	I
proteins	I-protein	NOUN	I
from	O	ADP	O
the	O	DET	O
human	B-cell_line	ADJ	B
T-cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
Jurkat	B-cell_line	NOUN	I
.	O	PUNCT	O


The	O	DET	O
two	O	NUM	O
proteins	O	NOUN	B
differ	O	VERB	O
in	O	ADP	O
their	O	PRON	O
surface	O	NOUN	B
charge	O	NOUN	I
,	O	PUNCT	O
since	O	SCONJ	O
they	O	PRON	O
are	O	AUX	O
separable	O	ADJ	O
by	O	ADP	O
anion-exchange	O	ADJ	B
chromatography	O	NOUN	I
.	O	PUNCT	O


Bivalent	O	ADJ	B
cations	O	NOUN	I
such	O	ADJ	O
as	O	ADP	O
Mg2+	O	NOUN	B
and	O	CCONJ	O
Zn2+	O	NOUN	B
differentially	O	ADV	B
affect	O	VERB	O
their	O	PRON	O
binding	O	NOUN	B
to	O	PART	O
oligonucleotides	O	NOUN	B
which	O	DET	O
contain	O	VERB	O
the	O	DET	O
HIV-enhancer	B-DNA	NOUN	B
domain	I-DNA	NOUN	O
.	O	PUNCT	O


Both	O	CCONJ	O
C1	B-protein	NOUN	B
and	O	CCONJ	O
C2	B-protein	NOUN	B
proteins	I-protein	NOUN	I
also	O	ADV	O
bind	O	VERB	B
to	O	PART	O
a	O	DET	O
similar	O	ADJ	O
sequence	O	NOUN	B
found	O	VERB	O
in	O	ADP	O
the	O	DET	O
interleukin-2-receptor	B-DNA	NOUN	B
alpha-subunit	I-DNA	NOUN	I
enhancer	I-DNA	NOUN	I
.	O	PUNCT	O


Differences	O	NOUN	B
in	O	ADP	O
transcriptional	B-DNA	ADJ	B
enhancers	I-DNA	NOUN	I
of	O	ADP	O
HIV-1	O	NOUN	B
and	O	CCONJ	O
HIV-2	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
HIV-1	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
sequences	O	NOUN	B
that	O	PRON	O
respond	O	VERB	O
to	O	PART	O
these	O	DET	O
signaling	O	NOUN	B
events	O	NOUN	I
are	O	AUX	O
found	O	VERB	O
in	O	ADP	O
the	O	DET	O
long	B-DNA	ADJ	B
terminal	I-DNA	ADJ	I
repeat	I-DNA	NOUN	I
(	O	PUNCT	I
LTR	B-DNA	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
comprise	O	VERB	O
the	O	DET	O
transcriptional	B-DNA	ADJ	B
enhancer	I-DNA	NOUN	I
,	O	PUNCT	O
which	O	DET	O
contains	O	VERB	O
two	O	NUM	O
conserved	B-DNA	VERB	O
binding	I-DNA	VERB	B
sites	I-DNA	NOUN	I
for	O	ADP	O
the	O	DET	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
(	O	PUNCT	O
NF	B-protein	NOUN	O
kappa	I-protein	NOUN	O
B	I-protein	NOUN	O
)	O	PUNCT	O
.	O	PUNCT	O


In	O	ADP	O
electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assays	O	NOUN	I
,	O	PUNCT	O
NF	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
binds	O	VERB	B
to	O	PART	O
both	O	CCONJ	O
conserved	O	VERB	B
sites	O	NOUN	I
in	O	ADP	O
the	O	DET	O
HIV-1	B-DNA	NOUN	B
transcriptional	I-DNA	ADJ	B
enhancer	I-DNA	NOUN	I
and	O	CCONJ	O
only	O	ADV	O
to	O	PART	O
the	O	DET	O
single	O	ADJ	O
conserved	O	VERB	O
site	O	NOUN	O
in	O	ADP	O
the	O	DET	O
HIV-2	B-DNA	NOUN	B
transcriptional	I-DNA	ADJ	B
enhancer	I-DNA	NOUN	I
.	O	PUNCT	O


When	O	SCONJ	O
tested	O	VERB	B
in	O	ADP	O
a	O	DET	O
radioreceptor	O	NOUN	B
assay	O	NOUN	I
in	O	ADP	O
human	B-cell_type	ADJ	B
mononuclear	I-cell_type	ADJ	B
leukocytes	I-cell_type	NOUN	B
the	O	DET	O
synthesized	O	VERB	B
compounds	O	NOUN	O
showed	O	VERB	O
only	O	ADV	O
low	O	ADJ	O
relative	O	ADJ	O
binding	O	NOUN	O
affinities	O	NOUN	O
(	O	PUNCT	O
RBA	O	NOUN	B
)	O	PUNCT	O
to	O	PART	O
type	B-protein	NOUN	B
1	I-protein	NUM	I
receptor	I-protein	NOUN	I
,	O	PUNCT	O
the	O	DET	O
highest	O	ADJ	B
being	O	AUX	O
0.72	O	NUM	O
%	O	NOUN	O
for	O	ADP	O
13	O	NUM	O
(	O	PUNCT	O
aldosterone	O	NOUN	B
=	O	ADJ	O
100	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
.	O	PUNCT	O


For	O	ADP	O
comparison	O	NOUN	B
,	O	PUNCT	O
other	O	ADJ	O
RBA	O	NOUN	B
in	O	ADP	O
this	O	DET	O
system	O	NOUN	B
were	O	AUX	O
:	O	PUNCT	O
19-noraldosterone	O	NOUN	B
,	O	PUNCT	O
20	O	NUM	O
%	O	NOUN	O
;	O	PUNCT	O
18-deoxyaldosterone	O	NOUN	O
,	O	PUNCT	O
5.8	O	NUM	O
%	O	NOUN	O
;	O	PUNCT	O
18-deoxy-19-noraldosterone	O	NOUN	B
,	O	PUNCT	O
4.7	O	NUM	O
%	O	NOUN	O
;	O	PUNCT	O
18	O	NUM	O
,	O	PUNCT	O
21-anhydroaldosterone	O	NOUN	B
,	O	PUNCT	O
0.37	O	NUM	O
%	O	NOUN	O
;	O	PUNCT	O
17-isoaldosterone	O	NOUN	B
,	O	PUNCT	O
7.6	O	NUM	O
%	O	NOUN	O
and	O	CCONJ	O
apoaldosterone	O	NOUN	B
,	O	PUNCT	O
4.3	O	NUM	O
%	O	NOUN	O


Cell	O	NOUN	B
type	O	NOUN	I
specificity	O	NOUN	B
and	O	CCONJ	O
activation	O	NOUN	B
requirements	O	NOUN	O
for	O	ADP	O
NFAT-1	B-protein	NOUN	B
(	O	PUNCT	O
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
of	O	ADP	O
activated	B-cell_type	VERB	B
T-cells	I-cell_type	NOUN	I
)	O	PUNCT	O
transcriptional	O	ADJ	B
activity	O	NOUN	I
determined	O	VERB	O
by	O	ADP	O
a	O	DET	O
new	O	ADJ	O
method	O	NOUN	B
using	O	VERB	O
transgenic	O	ADJ	B
mice	O	NOUN	I
to	O	PART	O
assay	O	VERB	B
transcriptional	O	ADJ	B
activity	O	NOUN	I
of	O	ADP	O
an	O	DET	O
individual	O	ADJ	B
nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
.	O	PUNCT	O


By	O	ADP	O
targeting	O	VERB	B
NFAT-1	B-protein	NOUN	B
-dependent	O	ADJ	O
gene	O	NOUN	B
expression	O	NOUN	I
in	O	ADP	O
transgenic	O	ADJ	B
mice	O	NOUN	I
we	O	PRON	O
discovered	O	VERB	O
new	O	ADJ	O
sites	O	NOUN	B
of	O	ADP	O
NFAT-1	B-protein	NOUN	B
activity	O	NOUN	B
.	O	PUNCT	O


Progesterone	O	NOUN	B
suppression	O	NOUN	B
of	O	ADP	O
pregnancy	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
is	O	AUX	O
not	O	PART	O
mediated	O	VERB	O
by	O	ADP	O
glucocorticoid	O	NOUN	B
effect	O	NOUN	I
.	O	PUNCT	O


RU	O	NOUN	B
486	O	NUM	O
tested	O	VERB	B
at	O	ADP	O
an	O	DET	O
equal	O	ADJ	O
concentration	O	NOUN	B
as	O	ADP	O
progesterone	O	NOUN	B
significantly	O	ADV	O
inhibited	O	VERB	B
the	O	DET	O
production	O	NOUN	B
of	O	ADP	O
the	O	DET	O
blocking	B-protein	NOUN	B
factor	I-protein	NOUN	O
,	O	PUNCT	O
while	O	SCONJ	O
RU	O	NOUN	B
43044	O	NUM	O
was	O	AUX	O
without	O	ADP	O
effect	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
in	O	ADP	O
pregnancy	O	NOUN	B
,	O	PUNCT	O
lymphocyte	O	NOUN	B
progesterone	O	NOUN	B
acts	O	VERB	O
on	O	ADP	O
specific	O	ADJ	O
progesterone	B-protein	NOUN	B
receptors	I-protein	NOUN	I
and	O	CCONJ	O
glucocorticoid	B-protein	NOUN	B
binding	I-protein	NOUN	I
sites	I-protein	NOUN	I
are	O	AUX	O
not	O	PART	O
involved	O	VERB	O
.	O	PUNCT	O


The	O	DET	O
human	O	ADJ	B
protein	O	NOUN	I
recognized	O	VERB	O
by	O	ADP	O
the	O	DET	O
EC1	B-protein	NOUN	B
antibody	I-protein	NOUN	I
is	O	AUX	O
a	O	DET	O
56-kDa	B-protein	ADJ	B
protein	I-protein	NOUN	I
(	O	PUNCT	O
p56	B-protein	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
moderate	O	ADJ	B
abundance	O	NOUN	B
located	O	ADJ	O
predominantly	O	ADV	O
in	O	ADP	O
the	O	DET	O
cytoplasm	O	NOUN	B
by	O	ADP	O
indirect	O	ADJ	B
immunofluorescence	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
ORF	B-DNA	NOUN	B
was	O	AUX	O
expressed	O	VERB	B
in	O	ADP	O
bacteria	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
30-kD	B-protein	ADJ	O
protein	I-protein	NOUN	B
product	I-protein	NOUN	I
was	O	AUX	O
shown	O	VERB	O
to	O	PART	O
bind	O	VERB	B
DNA	O	NOUN	B
in	O	ADP	O
a	O	DET	O
sequence-specific	O	ADJ	B
manner	O	NOUN	O
by	O	ADP	O
mobility-shift	O	ADJ	B
assays	O	NOUN	I
,	O	PUNCT	O
Southwestern	O	NOUN	B
blot	O	NOUN	I
analysis	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
methylation	O	NOUN	B
interference	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
postmenopausal	O	ADJ	B
women	O	NOUN	B
the	O	DET	O
mean	O	ADJ	B
type	B-protein	NOUN	I
II	I-protein	NUM	I
EBS	I-protein	NOUN	I
levels	O	NOUN	B
were	O	AUX	O
similar	O	ADJ	O
to	O	PART	O
those	O	DET	O
observed	O	VERB	B
in	O	ADP	O
the	O	DET	O
follicular	O	ADJ	B
phase	O	NOUN	B
of	O	ADP	O
the	O	DET	O
cycle	O	NOUN	B
.	O	PUNCT	O


Some	O	DET	O
patients	O	NOUN	B
with	O	ADP	O
major	O	ADJ	O
depressive	O	ADJ	B
disorder	O	NOUN	I
(	O	PUNCT	O
MDD	O	NOUN	B
)	O	PUNCT	O
have	O	AUX	O
elevated	O	VERB	B
plasma	O	NOUN	B
cortisol	O	NOUN	B
concentrations	O	NOUN	B
and	O	CCONJ	O
show	O	VERB	O
failure	O	NOUN	B
to	O	PART	O
suppress	O	VERB	B
cortisol	O	NOUN	B
secretion	O	NOUN	I
upon	O	SCONJ	O
administration	O	NOUN	B
of	O	ADP	O
dexamethasone	O	NOUN	B
(	O	PUNCT	O
DEX	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
yet	O	CCONJ	O
they	O	PRON	O
do	O	AUX	O
not	O	PART	O
have	O	AUX	O
Cushingoid	O	ADJ	B
features	O	NOUN	B
.	O	PUNCT	O


Compared	O	VERB	B
to	O	ADP	O
the	O	DET	O
control	O	NOUN	B
group	O	NOUN	I
,	O	PUNCT	O
fewer	O	ADV	O
depressed	O	ADJ	B
subjects	O	NOUN	I
down-regulated	O	VERB	B
Bmax	O	NOUN	B
after	O	ADP	O
DEX	O	NOUN	B
.	O	PUNCT	O


Ras-related	B-protein	ADJ	B
GTP-binding	I-protein	ADJ	B
proteins	I-protein	NOUN	I
and	O	CCONJ	O
leukocyte	B-cell_type	NOUN	B
signal	O	NOUN	I
transduction	O	NOUN	I
.	O	PUNCT	O


Recent	O	ADJ	O
progress	O	NOUN	B
in	O	ADP	O
understanding	O	VERB	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
phagocyte	B-protein	NOUN	B
NADPH	I-protein	NOUN	B
oxidase	I-protein	NOUN	I
by	O	ADP	O
the	O	DET	O
Rac	B-protein	NOUN	B
GTP-binding	I-protein	ADJ	B
proteins	I-protein	NOUN	I
provides	O	VERB	O
a	O	DET	O
basis	O	NOUN	O
for	O	ADP	O
defining	O	VERB	O
the	O	DET	O
operational	O	ADJ	B
characteristics	O	NOUN	B
of	O	ADP	O
one	O	NUM	O
such	O	ADJ	O
phagocyte	O	NOUN	B
system	O	NOUN	I
.	O	PUNCT	O


Besides	O	SCONJ	O
p50	B-protein	NOUN	B
,	O	PUNCT	O
1	O	NUM	O
,	O	PUNCT	O
25	O	NUM	O
(	O	PUNCT	O
OH	O	NOUN	B
)	O	PUNCT	O
2D3	O	NOUN	B
decreased	O	VERB	B
the	O	DET	O
levels	O	NOUN	B
of	O	ADP	O
another	O	DET	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
protein	I-protein	NOUN	I
,	O	PUNCT	O
namely	O	ADV	O
c-rel	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
myeloid	B-DNA	ADJ	B
zinc	I-DNA	NOUN	B
finger	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
,	O	PUNCT	O
MZF-1	B-DNA	NOUN	B
,	O	PUNCT	O
regulates	O	VERB	B
the	O	DET	O
CD34	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
in	O	X	B
vitro	O	X	I
.	O	PUNCT	O


MZF-1	B-DNA	NOUN	B
expression	O	NOUN	B
vectors	O	NOUN	I
were	O	AUX	O
cotransfected	O	VERB	B
with	O	ADP	O
the	O	DET	O
luciferase	B-DNA	NOUN	B
reporter	I-DNA	NOUN	I
plasmids	I-DNA	NOUN	O
regulated	O	VERB	O
by	O	ADP	O
the	O	DET	O
CD34	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
into	O	ADP	O
both	O	CCONJ	O
nonhematopoietic	B-cell_line	ADJ	B
and	I-cell_line	CCONJ	O
hematopoietic	I-cell_line	ADJ	B
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
.	O	PUNCT	O


The	O	DET	O
cell	O	NOUN	B
type-specific	O	ADJ	I
regulation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
CD34	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
by	O	ADP	O
MZF-1	B-DNA	NOUN	B
suggests	O	VERB	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
tissue-specific	O	ADJ	B
regulators/adapters	O	NOUN	I
or	O	CCONJ	O
differential	O	ADJ	O
MZF-1	B-DNA	NOUN	B
modifications	O	NOUN	B
that	O	PRON	O
determine	O	VERB	O
MZF-1	B-DNA	NOUN	B
transcriptional	O	ADJ	B
regulatory	O	ADJ	B
function	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
BCL6	B-protein	NOUN	B
plays	O	VERB	O
a	O	DET	O
role	O	NOUN	O
in	O	ADP	O
activated	B-cell_type	VERB	B
lymphocytes	I-cell_type	NOUN	B
as	O	ADP	O
an	O	DET	O
immediate	O	ADJ	O
early	O	ADJ	B
gene	O	NOUN	B
.	O	PUNCT	O


Avian	O	ADJ	B
cells	O	NOUN	I
express	O	VERB	O
three	O	NUM	O
heat	B-DNA	NOUN	B
shock	I-DNA	NOUN	I
transcription	I-DNA	NOUN	I
factor	I-DNA	NOUN	I
(	I-DNA	PUNCT	O
HSF	I-DNA	NOUN	O
)	I-DNA	PUNCT	O
genes	I-DNA	NOUN	O
corresponding	O	VERB	O
to	O	PART	O
a	O	DET	O
novel	B-protein	ADJ	O
factor	I-protein	NOUN	B
,	O	PUNCT	O
HSF3	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
homologs	O	NOUN	B
of	O	ADP	O
mouse	O	NOUN	B
and	O	CCONJ	O
human	O	ADJ	B
HSF1	B-protein	NOUN	B
and	O	CCONJ	O
HSF2	B-protein	NOUN	B
.	O	PUNCT	O


Analysis	O	NOUN	B
of	O	ADP	O
the	O	DET	O
biochemical	O	ADJ	B
and	O	CCONJ	O
cell	O	NOUN	B
biological	O	ADJ	B
properties	O	NOUN	B
of	O	ADP	O
these	O	DET	O
HSFs	B-protein	NOUN	B
reveals	O	VERB	O
that	O	SCONJ	O
HSF3	B-protein	NOUN	B
has	O	AUX	O
properties	O	NOUN	B
in	O	ADP	O
common	O	ADJ	O
with	O	ADP	O
both	O	CCONJ	O
HSF1	B-protein	NOUN	B
and	O	CCONJ	O
HSF2	B-protein	NOUN	B
and	O	CCONJ	O
yet	O	ADV	O
has	O	AUX	O
features	O	NOUN	B
which	O	DET	O
are	O	AUX	O
distinct	O	ADJ	O
from	O	ADP	O
both	O	DET	O
.	O	PUNCT	O


HSF3	B-protein	NOUN	B
is	O	AUX	O
constitutively	O	ADV	B
expressed	O	VERB	B
in	O	ADP	O
the	O	DET	O
erythroblast	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
HD6	I-cell_line	NOUN	B
,	O	PUNCT	O
the	O	DET	O
lymphoblast	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
MSB	I-cell_line	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
embryo	B-cell_line	NOUN	B
fibroblasts	I-cell_line	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
yet	O	ADV	O
its	O	PRON	O
DNA-binding	O	ADJ	B
activity	O	NOUN	O
is	O	AUX	O
induced	O	VERB	B
only	O	ADV	O
upon	O	SCONJ	O
exposure	O	NOUN	B
of	O	ADP	I
HD6	O	NOUN	B
cells	O	NOUN	I
to	O	PART	O
heat	O	NOUN	B
shock	O	NOUN	I
.	O	PUNCT	O


Acquisition	O	NOUN	B
of	O	ADP	O
HSF3	B-protein	NOUN	B
DNA-binding	O	ADJ	B
activity	O	NOUN	O
in	O	ADP	O
HD6	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
is	O	AUX	O
accompanied	O	VERB	O
by	O	ADP	O
oligomerization	O	NOUN	B
from	O	ADP	O
a	O	DET	O
non-DNA-binding	B-protein	ADJ	B
dimer	I-protein	NOUN	I
to	O	PART	O
a	O	DET	O
DNA-binding	B-protein	ADJ	B
trimer	I-protein	NOUN	B
,	O	PUNCT	O
whereas	O	SCONJ	O
the	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
heat	O	NOUN	B
shock	O	NOUN	I
on	O	ADP	O
HSF1	B-protein	NOUN	B
is	O	AUX	O
oligomerization	O	NOUN	B
of	O	ADP	O
an	O	DET	O
inert	B-protein	ADJ	B
monomer	I-protein	NOUN	I
to	O	PART	O
a	O	DET	O
DNA-binding	B-protein	ADJ	B
trimer	I-protein	NOUN	B
.	O	PUNCT	O


Induction	O	NOUN	B
of	O	ADP	O
HSF3	B-protein	NOUN	B
DNA-binding	O	ADJ	B
activity	O	NOUN	O
is	O	AUX	O
delayed	O	VERB	B
compared	O	VERB	B
with	O	ADP	O
that	O	DET	O
of	O	ADP	O
HSF1	B-protein	NOUN	B
.	O	PUNCT	O


As	O	ADP	O
occurs	O	VERB	O
for	O	ADP	O
HSF1	B-protein	NOUN	B
,	O	PUNCT	O
heat	O	NOUN	B
shock	O	NOUN	I
leads	O	VERB	O
to	O	PART	O
the	O	DET	O
translocation	O	NOUN	B
of	O	ADP	O
HSF3	B-protein	NOUN	B
to	O	PART	O
the	O	DET	O
nucleus	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
putative	O	ADJ	B
factors	O	NOUN	I
that	O	PRON	O
couple	O	VERB	O
the	O	DET	O
signal	O	NOUN	B
transduction	O	NOUN	I
from	O	ADP	O
surface	O	NOUN	B
receptors	O	NOUN	I
to	O	PART	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
cytokine	B-protein	NOUN	B
synthesis	O	NOUN	I
in	O	ADP	O
natural	B-cell_type	ADJ	B
killer	I-cell_type	NOUN	I
(	I-cell_type	PUNCT	O
NK	I-cell_type	NOUN	O
)	I-cell_type	PUNCT	O
cells	I-cell_type	NOUN	O
have	O	AUX	O
not	O	PART	O
been	O	AUX	O
elucidated	O	VERB	O
.	O	PUNCT	O


The	O	DET	O
results	O	NOUN	B
of	O	ADP	O
supershift	O	NOUN	B
assays	O	NOUN	I
using	O	VERB	O
NFATp-	B-protein	PROPN	B
and	I-protein	CCONJ	O
NFATc-	I-protein	NOUN	B
specific	I-protein	ADJ	O
antibodies	I-protein	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
NK	O	NOUN	B
cell	O	NOUN	I
activation	O	NOUN	B
early	O	ADV	O
after	O	ADP	O
CD16	B-protein	NOUN	B
ligand	O	NOUN	O
binding	O	NOUN	B
involves	O	VERB	O
primarily	O	ADV	O
,	O	PUNCT	O
if	O	SCONJ	O
not	O	PART	O
exclusively	O	ADV	O
,	O	PUNCT	O
NFATp	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
Western	O	NOUN	B
blot	O	NOUN	I
analysis	O	NOUN	I
shows	O	VERB	O
that	O	SCONJ	O
this	O	DET	O
has	O	AUX	O
the	O	DET	O
same	O	ADJ	O
electrophoretic	O	ADJ	B
mobility	O	NOUN	I
(	O	PUNCT	O
approximately	O	ADV	O
120	O	NUM	O
kD	O	NOUN	O
)	O	PUNCT	O
as	O	ADP	O
that	O	DET	O
of	O	ADP	O
T	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
.	O	PUNCT	O


The	O	DET	O
mechanisms	O	NOUN	B
by	O	ADP	O
which	O	DET	O
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	I
IL-2	B-protein	NOUN	B
are	O	AUX	O
propagated	O	VERB	O
within	O	ADP	O
cells	O	NOUN	B
are	O	AUX	O
not	O	PART	O
understood	O	VERB	O
.	O	PUNCT	O


p94	B-protein	NOUN	B
and	O	CCONJ	O
p95	B-protein	NOUN	B
share	O	VERB	O
homology	O	NOUN	B
with	O	ADP	O
Stat1	B-protein	NOUN	B
at	O	ADP	O
the	O	DET	O
phosphorylation	B-protein	NOUN	B
site	I-protein	NOUN	O
and	O	CCONJ	O
in	O	ADP	O
the	O	DET	O
Src	B-protein	NOUN	B
homology	I-protein	NOUN	I
2	I-protein	NUM	I
(	I-protein	PUNCT	O
SH2	I-protein	NOUN	B
)	I-protein	PUNCT	O
domain	I-protein	NOUN	O
,	O	PUNCT	O
but	O	CCONJ	O
otherwise	O	ADV	O
are	O	AUX	O
immunologically	O	ADV	B
distinct	O	ADJ	O
from	O	ADP	O
Stat1	B-protein	NOUN	B
.	O	PUNCT	O


Expression	O	NOUN	B
of	O	ADP	O
c-fos	B-DNA	NOUN	B
correlates	O	VERB	O
with	O	ADP	O
IFN-alpha	B-protein	NOUN	B
responsiveness	O	NOUN	B
in	O	ADP	O
Philadelphia	O	NOUN	B
chromosome	O	NOUN	I
positive	O	ADJ	I
chronic	O	ADJ	B
myelogenous	O	ADJ	I
leukemia	O	NOUN	I
.	O	PUNCT	O


Menopause	O	NOUN	B
is	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
a	O	DET	O
significant	O	ADJ	O
increase	O	NOUN	B
in	O	ADP	O
blood	O	NOUN	B
monocyte	O	NOUN	I
number	O	NOUN	I
and	O	CCONJ	O
a	O	DET	O
relative	O	ADJ	O
decrease	O	NOUN	B
in	O	ADP	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
estrogen	B-protein	NOUN	B
receptors	I-protein	NOUN	I
in	O	ADP	O
human	B-cell_type	ADJ	B
peripheral	I-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
monocyte	O	NOUN	B
and	O	CCONJ	O
lymphocyte	O	NOUN	B
counts	O	NOUN	I
and	O	CCONJ	O
the	O	DET	O
blood	O	NOUN	B
estrogen	O	NOUN	I
levels	O	NOUN	I
of	O	ADP	O
each	O	DET	O
patient	O	NOUN	B
were	O	AUX	O
determine	O	VERB	O
.	O	PUNCT	O


Transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
belonging	O	VERB	O
to	O	PART	O
the	O	DET	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
family	I-protein	NOUN	O
are	O	AUX	O
controlled	O	VERB	B
by	O	ADP	O
inhibitory	B-protein	ADJ	B
I	I-protein	NOUN	I
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
proteins	I-protein	NOUN	I
,	O	PUNCT	O
mainly	O	ADV	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
alpha	I-protein	NOUN	I
and	O	CCONJ	O
I	B-protein	NOUN	O
kappa	I-protein	NOUN	O
B	I-protein	NOUN	O
beta	I-protein	NOUN	O
.	O	PUNCT	O


The	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
Janus	B-protein	NOUN	B
protein	I-protein	NOUN	I
tyrosine	I-protein	NOUN	I
kinases	I-protein	NOUN	I
(	O	PUNCT	O
Jak	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
STAT	B-protein	NOUN	B
(	I-protein	PUNCT	O
signal	I-protein	NOUN	B
transducer	I-protein	NOUN	I
and	I-protein	CCONJ	O
activator	I-protein	NOUN	O
of	I-protein	ADP	O
transcription	I-protein	NOUN	O
)	I-protein	PUNCT	O
proteins	I-protein	NOUN	O
has	O	AUX	O
recently	O	ADV	O
been	O	AUX	O
linked	O	VERB	O
to	O	PART	O
the	O	DET	O
signal	O	NOUN	B
transduction	O	NOUN	B
mechanism	O	NOUN	B
of	O	ADP	O
several	O	ADJ	O
cytokines	B-protein	NOUN	B
.	O	PUNCT	O


Analysis	O	NOUN	B
of	O	ADP	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
human	B-protein	ADJ	B
I	I-protein	NOUN	I
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
alpha	I-protein	NOUN	I
protein	I-protein	NOUN	I
in	O	ADP	O
stable	O	ADJ	O
transfectants	O	NOUN	B
of	O	ADP	O
mouse	B-cell_line	NOUN	B
70Z/3	I-cell_line	NOUN	O
cells	I-cell_line	NOUN	O
shows	O	VERB	O
that	O	SCONJ	O
,	O	PUNCT	O
as	O	ADP	O
for	O	ADP	O
the	O	DET	O
endogenous	O	ADJ	B
murine	O	ADJ	B
protein	O	NOUN	I
,	O	PUNCT	O
exogenous	O	ADJ	B
I	B-protein	NOUN	I
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
alpha	I-protein	NOUN	I
is	O	AUX	O
degraded	O	VERB	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
inducers	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activity	O	NOUN	O
,	O	PUNCT	O
such	O	ADJ	O
as	O	ADP	O
phorbol	O	NOUN	B
myristate	O	NOUN	B
acetate	O	NOUN	I
or	O	CCONJ	O
lipopolysaccharide	O	NOUN	B
.	O	PUNCT	O


By	O	ADP	O
expressing	O	VERB	B
mutant	O	ADJ	B
forms	O	NOUN	O
of	O	ADP	O
the	O	DET	O
human	O	ADJ	B
protein	O	NOUN	I
in	O	ADP	O
this	O	DET	O
cell	B-cell_line	NOUN	B
line	I-cell_line	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
been	O	AUX	O
able	O	ADJ	O
to	O	PART	O
delineate	O	VERB	O
the	O	DET	O
sequences	O	NOUN	B
responsible	O	ADJ	O
for	O	ADP	O
both	O	CCONJ	O
the	O	DET	O
ligand-induced	O	ADJ	B
phosphorylation	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
degradation	O	NOUN	B
of	O	ADP	O
I	B-protein	NOUN	O
kappa	I-protein	NOUN	O
B	I-protein	NOUN	O
alpha	I-protein	NOUN	O
.	O	PUNCT	O


Although	O	SCONJ	O
the	O	DET	O
interrelationship	O	NOUN	B
between	O	ADP	O
the	O	DET	O
two	O	NUM	O
messengers	O	NOUN	B
Ca2+	O	NOUN	B
and	O	CCONJ	O
cyclic	O	ADJ	B
AMP	O	NOUN	I
in	O	ADP	O
platelet	O	NOUN	B
function	O	NOUN	I
is	O	AUX	O
well	O	ADV	O
documented	O	VERB	B
,	O	PUNCT	O
its	O	PRON	O
mechanism	O	NOUN	B
of	O	ADP	O
action	O	NOUN	B
still	O	ADV	O
remains	O	VERB	O
to	O	PART	O
be	O	AUX	O
established	O	VERB	O
.	O	PUNCT	O


3	O	X	O
)	O	PUNCT	O
In	O	ADP	O
Cushing	O	NOUN	B
's	O	PART	I
syndrome	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
CR	O	NOUN	B
of	O	ADP	O
GR	B-protein	NOUN	B
was	O	AUX	O
normal	O	ADJ	O
in	O	ADP	O
spite	O	NOUN	O
of	O	ADP	O
the	O	DET	O
fact	O	NOUN	O
that	O	SCONJ	O
the	O	DET	O
CR	O	NOUN	B
of	O	ADP	O
plasma	O	NOUN	B
cortisol	O	NOUN	B
was	O	AUX	O
disturbed	O	VERB	O
.	O	PUNCT	O


Whether	O	SCONJ	O
the	O	DET	O
putative	O	ADJ	O
new	O	ADJ	O
retrovirus	O	NOUN	O
(	O	PUNCT	O
es	O	NOUN	O
)	O	PUNCT	O
and	O	CCONJ	O
EBV	O	NOUN	B
have	O	AUX	O
any	O	DET	O
causal	O	ADJ	O
relationship	O	NOUN	B
to	O	PART	O
MS	O	NOUN	B
is	O	AUX	O
still	O	ADV	O
not	O	PART	O
known	O	VERB	O
,	O	PUNCT	O
but	O	CCONJ	O
the	O	DET	O
findings	O	NOUN	B
support	O	VERB	O
this	O	DET	O
possibility	O	NOUN	O
.	O	PUNCT	O


Activation	O	NOUN	B
through	O	ADP	O
the	O	DET	O
Ca2+/	O	NOUN	B
calcineurin	B-protein	NOUN	I
pathway	O	NOUN	I
is	O	AUX	O
essential	O	ADJ	O
to	O	PART	O
the	O	DET	O
transcription	O	NOUN	B
of	O	ADP	O
many	O	ADJ	O
cytokine	B-DNA	NOUN	B
genes	I-DNA	NOUN	I
.	O	PUNCT	O


The	O	DET	O
conserved	B-DNA	VERB	O
cis-acting	I-DNA	ADJ	B
sequence	I-DNA	NOUN	I
,	O	PUNCT	O
GGAAAA	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
binding	O	VERB	B
to	O	PART	O
this	O	DET	O
sequence	O	NOUN	B
are	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
response	O	NOUN	B
to	O	PART	O
increased	O	VERB	B
intracellular	O	ADJ	B
Ca2+	O	NOUN	B
concentrations	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
requirement	O	NOUN	B
has	O	AUX	O
been	O	AUX	O
attributed	O	VERB	O
to	O	PART	O
the	O	DET	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
NF-kappa	B-protein	NOUN	I
B	I-protein	NOUN	I
,	O	PUNCT	O
which	O	DET	O
synergizes	O	VERB	B
with	O	ADP	I
the	O	DET	O
constitutive	B-protein	ADJ	B
transcription	I-protein	NOUN	O
factor	I-protein	NOUN	O
Sp1	B-protein	NOUN	B
to	O	PART	O
drive	O	VERB	O
the	O	DET	O
HIV-1	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
.	O	PUNCT	O


The	O	DET	O
B4-2	B-DNA	NOUN	B
clone	O	NOUN	B
coded	O	VERB	B
for	O	ADP	O
an	O	DET	O
mRNA	B-RNA	NOUN	B
of	O	ADP	O
2061	O	NUM	O
bp	O	NOUN	O
in	O	ADP	O
length	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
polyclonal	O	ADJ	B
antiserum	O	NOUN	I
raised	O	VERB	O
against	O	ADP	O
recombinant	B-protein	ADJ	B
B4-2	I-protein	NOUN	B
recognizes	O	VERB	O
a	O	DET	O
32-34	B-protein	NUM	O
kDa	I-protein	NOUN	O
protein	I-protein	NOUN	O
in	O	ADP	O
lymphocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


Bound	O	VERB	B
[	O	PUNCT	O
3H	O	NOUN	B
]	O	PUNCT	O
DHEA	O	NOUN	B
was	O	AUX	O
displaced	O	VERB	O
sensitively	O	ADV	O
by	O	ADP	O
DHEA	O	NOUN	B
and	O	CCONJ	O
secondarily	O	ADV	O
by	O	ADP	O
dihydrotestosterone	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
effectively	O	ADV	O
by	O	ADP	O
other	O	ADJ	O
steroids	O	NOUN	B
,	O	PUNCT	O
including	O	VERB	O
DHEA	O	NOUN	B
sulfate	O	NOUN	B
.	O	PUNCT	O


They	O	PRON	O
have	O	AUX	O
also	O	ADV	O
shown	O	VERB	O
that	O	SCONJ	O
proteasome	B-protein	NOUN	B
inhibitors	O	NOUN	O
block	O	VERB	B
the	O	DET	O
processing	O	NOUN	B
both	O	CCONJ	O
in	O	X	B
vitro	O	X	I
and	O	CCONJ	O
in	O	X	B
vivo	O	X	I
.	O	PUNCT	O


OBJECTIVE	O	NOUN	B
:	O	PUNCT	O
To	O	PART	O
investigate	O	VERB	B
the	O	DET	O
long-term	O	ADJ	B
effects	O	NOUN	B
of	O	ADP	O
treatment	O	NOUN	B
with	O	ADP	O
low	O	ADJ	B
doses	O	NOUN	I
of	O	ADP	O
flutamide	O	NOUN	B
on	O	ADP	O
clinical	O	ADJ	B
and	O	CCONJ	O
hormonal	O	ADJ	B
parameters	O	NOUN	B
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
on	O	ADP	O
the	O	DET	O
androgen	B-protein	NOUN	B
receptor	I-protein	NOUN	I
status	O	NOUN	I
,	O	PUNCT	O
in	O	ADP	O
hirsute	O	ADJ	B
women	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
reduction	O	NOUN	B
of	O	ADP	O
serum	O	NOUN	B
androgens	O	NOUN	B
was	O	AUX	O
found	O	VERB	O
,	O	PUNCT	O
whereas	O	SCONJ	O
no	O	DET	O
change	O	NOUN	O
was	O	AUX	O
observed	O	VERB	O
in	O	ADP	O
either	O	CCONJ	O
basal	O	ADJ	B
or	O	CCONJ	O
GnRH-stimulated	O	ADJ	B
gonadotropins	O	NOUN	I
or	O	CCONJ	O
in	O	ADP	O
the	O	DET	O
cortisol	O	NOUN	B
and	O	CCONJ	O
17	O	NUM	O
alpha-hydroxyprogesterone	O	NOUN	B
response	O	NOUN	O
to	O	PART	O
ACTH	O	NOUN	B
.	O	PUNCT	O


Androgen	O	NOUN	B
receptor	O	NOUN	I
blockade	O	NOUN	B
might	O	AUX	O
be	O	AUX	O
potentiated	O	VERB	B
by	O	ADP	O
a	O	DET	O
reduction	O	NOUN	B
of	O	ADP	O
serum	O	NOUN	B
androgens	O	NOUN	B
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
show	O	VERB	O
,	O	PUNCT	O
using	O	VERB	O
nuclear	O	ADJ	B
extracts	O	NOUN	I
,	O	PUNCT	O
recombinant	B-protein	ADJ	B
protein	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
specific	O	ADJ	O
antiserum	O	NOUN	B
against	O	ADP	O
AML-1	B-protein	NOUN	B
proteins	I-protein	NOUN	I
in	O	ADP	O
DNA-binding	O	ADJ	B
assays	O	NOUN	I
,	O	PUNCT	O
that	O	SCONJ	O
one	O	NUM	O
member	O	NOUN	O
of	O	ADP	O
this	O	DET	O
family	O	NOUN	B
,	O	PUNCT	O
AML-1B	B-protein	NOUN	B
,	O	PUNCT	O
binds	O	VERB	B
specifically	O	ADV	O
to	O	PART	O
OSE2	O	NOUN	B
and	O	CCONJ	O
is	O	AUX	O
immunologically	O	ADV	B
related	O	ADJ	O
to	O	PART	O
OSF2	B-protein	NOUN	B
,	O	PUNCT	O
the	O	DET	O
factor	O	NOUN	B
present	O	ADJ	O
in	O	ADP	O
osteoblast	O	NOUN	B
nuclear	O	ADJ	I
extracts	O	NOUN	I
that	O	PRON	O
binds	O	VERB	B
to	O	PART	O
OSE2	O	NOUN	B
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
this	O	DET	O
study	O	NOUN	B
demonstrates	O	VERB	O
that	O	SCONJ	O
AML-1B	B-protein	NOUN	B
can	O	AUX	O
increase	O	VERB	B
gene	O	NOUN	B
expression	O	NOUN	I
of	O	ADP	O
an	O	DET	O
osteoblast-specific	B-DNA	ADJ	B
gene	I-DNA	NOUN	I
through	O	ADP	O
its	O	PRON	O
binding	O	NOUN	B
to	O	PART	O
an	O	DET	O
osteoblast-specific	B-DNA	ADJ	B
cis-acting	I-DNA	ADJ	O
element	I-DNA	NOUN	O
and	O	CCONJ	O
presents	O	VERB	O
evidence	O	NOUN	B
that	O	SCONJ	O
OSF2	B-protein	NOUN	B
is	O	AUX	O
a	O	DET	O
member	O	NOUN	B
of	O	ADP	O
the	O	DET	O
PEBP2	B-protein	NOUN	B
alpha/AML-1	I-protein	NOUN	B
family	I-protein	NOUN	B
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
.	O	PUNCT	O


Initiation	B-protein	NOUN	B
binding	I-protein	NOUN	I
repressor	I-protein	NOUN	I
,	O	PUNCT	O
a	O	DET	O
factor	O	NOUN	B
that	O	PRON	O
binds	O	VERB	B
to	O	PART	O
the	O	DET	O
transcription	B-DNA	NOUN	B
initiation	I-DNA	NOUN	I
site	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
histone	B-DNA	NOUN	B
h5	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
,	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
glycosylated	B-protein	VERB	B
member	I-protein	NOUN	I
of	O	ADP	O
a	O	DET	O
family	O	NOUN	B
of	O	ADP	O
cell	B-protein	NOUN	B
growth	I-protein	NOUN	I
regulators	I-protein	NOUN	I
[	O	PUNCT	O
corrected	O	VERB	O
]	O	PUNCT	O
[	O	PUNCT	O
published	O	VERB	B
erratum	O	NOUN	O
appears	O	VERB	O
in	O	ADP	O
Mol	O	PROPN	B
Cell	O	PROPN	I
Biol	O	PROPN	O
1996	O	NUM	O
Feb	O	PROPN	O
;	O	PUNCT	O
16	O	NUM	O
(	O	PUNCT	O
2	O	NUM	O
)	O	PUNCT	O
:	O	PUNCT	O
735	O	NUM	O
]	O	PUNCT	O


We	O	PRON	O
present	O	VERB	O
evidence	O	NOUN	B
that	O	SCONJ	O
IBR	B-protein	NOUN	B
and	O	CCONJ	O
IBF	B-protein	NOUN	B
are	O	AUX	O
most	O	ADV	O
likely	O	ADV	O
identical	O	ADJ	B
proteins	O	NOUN	B
,	O	PUNCT	O
differing	O	VERB	O
in	O	ADP	O
their	O	PRON	O
degree	O	NOUN	B
of	O	ADP	O
glycosylation	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
removal	O	NOUN	B
occurred	O	VERB	O
by	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
constitutive	B-protein	ADJ	B
Sp1	I-protein	NOUN	B
factor	I-protein	NOUN	O
,	O	PUNCT	O
whose	O	DET	O
increased	O	VERB	B
binding	O	NOUN	B
activity	O	NOUN	I
and	O	CCONJ	O
phosphorylation	O	NOUN	B
were	O	AUX	O
mediated	O	VERB	O
by	O	ADP	O
IFN-gamma	B-protein	NOUN	B
.	O	PUNCT	O


Males	O	NOUN	B
with	O	ADP	O
X-linked	O	ADJ	B
severe	O	ADJ	I
combined	O	ADJ	I
immunodeficiency	O	NOUN	I
(	O	PUNCT	O
XSCID	O	NOUN	B
)	O	PUNCT	O
have	O	AUX	O
defects	O	NOUN	B
in	O	ADP	O
the	O	DET	O
common	O	ADJ	O
cytokine	B-DNA	NOUN	B
receptor	I-DNA	NOUN	I
gamma	I-DNA	NOUN	I
chain	I-DNA	NOUN	I
(	I-DNA	PUNCT	O
gamma	I-DNA	NOUN	O
c	I-DNA	NOUN	O
)	I-DNA	PUNCT	O
gene	I-DNA	NOUN	O
that	O	PRON	O
encodes	O	VERB	B
a	O	DET	O
shared	O	ADJ	B
,	O	PUNCT	O
essential	O	ADJ	B
component	O	NOUN	O
of	O	ADP	O
the	O	DET	O
receptors	O	NOUN	B
of	O	ADP	O
interleukin-2	B-protein	NOUN	B
(	O	PUNCT	O
IL-2	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
IL-4	B-protein	NOUN	B
,	O	PUNCT	O
IL-7	B-protein	NOUN	B
,	O	PUNCT	O
IL-9	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
IL-15	B-protein	NOUN	B
.	O	PUNCT	O


An	O	DET	O
Epstein-Barr	B-cell_line	ADJ	B
virus	I-cell_line	NOUN	I
(	I-cell_line	PUNCT	O
EBV	I-cell_line	NOUN	B
)	I-cell_line	PUNCT	O
-transformed	I-cell_line	ADJ	O
cell	I-cell_line	NOUN	B
line	I-cell_line	NOUN	I
derived	O	VERB	O
from	O	ADP	O
her	O	PRON	O
lymphocytes	B-cell_type	NOUN	B
had	O	AUX	O
normal	O	ADJ	B
gamma	B-protein	NOUN	I
c	I-protein	NOUN	I
expression	O	NOUN	B
but	O	CCONJ	O
lacked	O	VERB	O
Jak3	B-protein	NOUN	B
protein	I-protein	NOUN	I
and	O	CCONJ	O
had	O	AUX	O
greatly	O	ADV	O
diminished	O	VERB	O
Jak3	B-RNA	NOUN	B
messenger	I-RNA	NOUN	O
RNA	I-RNA	NOUN	O
.	O	PUNCT	O


Intravenous	O	ADJ	B
injection	O	NOUN	I
of	O	ADP	O
a	O	DET	O
rat	B-cell_line	NOUN	B
T-cell	I-cell_line	NOUN	B
line	I-cell_line	NOUN	I
that	O	PRON	O
overexpresses	O	VERB	B
L-selectin	B-protein	NOUN	B
showed	O	VERB	O
increased	O	VERB	B
organ	O	NOUN	B
infiltration	O	NOUN	I
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
have	O	AUX	O
confirmed	O	VERB	O
and	O	CCONJ	O
extended	O	VERB	B
such	O	ADJ	O
observations	O	NOUN	B
,	O	PUNCT	O
showing	O	VERB	O
that	O	SCONJ	O
(	O	PUNCT	O
1	O	X	O
)	O	PUNCT	O
this	O	DET	O
phenomenon	O	NOUN	B
is	O	AUX	O
restricted	O	ADJ	O
to	O	PART	O
the	O	DET	O
variant	O	ADJ	B
A	O	NOUN	I
of	O	ADP	O
HHV-6	O	NOUN	B
:	O	PUNCT	O
in	O	ADP	O
fact	O	NOUN	O
two	O	NUM	O
isolates	O	NOUN	B
belonging	O	VERB	O
to	O	PART	O
the	O	DET	O
HHV-6	O	NOUN	B
variant	O	ADJ	O
B	O	NOUN	O
(	O	PUNCT	O
BA92	O	NOUN	B
and	O	CCONJ	O
Z29	O	NOUN	B
)	O	PUNCT	O
were	O	AUX	O
neither	O	CCONJ	O
able	O	ADJ	O
to	O	PART	O
infect	O	VERB	B
any	O	DET	O
B	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
,	O	PUNCT	O
independently	O	ADV	O
of	O	ADP	O
the	O	DET	O
EBV	O	NOUN	B
status	O	NOUN	B
,	O	PUNCT	O
nor	O	CCONJ	O
to	O	PART	O
induce	O	VERB	B
the	O	DET	O
EBV	O	NOUN	B
genome	O	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


Absorptive	O	ADJ	B
hypercalciuria	O	NOUN	I
(	O	PUNCT	O
a	O	DET	O
stone-forming	O	ADJ	B
condition	O	NOUN	I
)	O	PUNCT	O
is	O	AUX	O
characterized	O	VERB	B
by	O	ADP	O
gut	O	NOUN	B
hyperabsorption	O	NOUN	I
of	O	ADP	O
calcium	O	NOUN	B
,	O	PUNCT	O
hypercalciuria	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
reduced	O	VERB	B
bone	O	NOUN	B
density	O	NOUN	I
.	O	PUNCT	O


Inasmuch	O	ADV	B
as	O	ADP	O
these	O	DET	O
features	O	NOUN	B
implicate	O	VERB	O
enhanced	O	VERB	B
calcitriol	O	NOUN	B
action	O	NOUN	O
in	O	ADP	O
gut	O	NOUN	B
and	O	CCONJ	O
bone	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
analyzed	O	VERB	B
the	O	DET	O
vitamin	B-DNA	NOUN	B
D	I-DNA	NOUN	I
receptor	I-DNA	NOUN	I
(	I-DNA	PUNCT	O
VDR	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
gene	I-DNA	NOUN	O
to	O	PART	O
ascertain	O	VERB	O
whether	O	SCONJ	O
an	O	DET	O
abnormality	O	NOUN	B
of	O	ADP	O
this	O	DET	O
gene	O	NOUN	B
marks	O	VERB	I
patients	O	NOUN	B
with	O	ADP	O
intestinal	O	ADJ	B
hyperabsorption	O	NOUN	B
of	O	ADP	O
calcium	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
coding	O	VERB	B
region	O	NOUN	I
of	O	ADP	O
VDR	B-RNA	NOUN	B
messenger	I-RNA	NOUN	I
RNA	I-RNA	NOUN	I
was	O	AUX	O
also	O	ADV	O
normal	O	ADJ	B
,	O	PUNCT	O
as	O	ADP	O
determined	O	VERB	O
by	O	ADP	O
both	O	CCONJ	O
DNA	B-DNA	NOUN	B
sequence	I-DNA	NOUN	I
analysis	O	NOUN	I
and	O	CCONJ	O
chemical	O	ADJ	B
mismatch	O	NOUN	O
cleavage	O	NOUN	O
analysis	O	NOUN	O
of	O	ADP	O
copy	O	NOUN	B
DNA	O	NOUN	I
from	O	ADP	O
11	O	NUM	O
index	O	NOUN	O
absorptive	O	ADJ	B
hypercalciuric	O	NOUN	B
patients	O	NOUN	B
.	O	PUNCT	O


Platelet	B-protein	NOUN	B
thromboxane	I-protein	NOUN	I
receptors	I-protein	NOUN	I
are	O	AUX	O
acutely	O	ADV	B
and	O	CCONJ	O
reversibly	O	ADV	O
upregulated	O	VERB	B
after	O	ADP	O
acute	O	ADJ	B
myocardial	O	ADJ	I
infarction	O	NOUN	I
.	O	PUNCT	O


Promoter	O	NOUN	B
function	O	NOUN	I
of	O	ADP	O
the	O	DET	O
5	B-DNA	NUM	O
'	I-DNA	PART	O
flanking	I-DNA	ADJ	B
region	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
thromboxane	B-DNA	NOUN	B
receptor	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
was	O	AUX	O
evaluated	O	VERB	B
by	O	ADP	O
transfection	O	NOUN	B
of	O	ADP	O
thromboxane	B-DNA	NOUN	B
receptor	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
promoter/chloramphenicol	I-DNA	NOUN	O
acetyltransferase	I-DNA	NOUN	O
(	I-DNA	PUNCT	O
CAT	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
chimera	I-DNA	NOUN	B
plasmids	I-DNA	NOUN	I
into	O	ADP	O
platelet-like	O	ADJ	B
K562	B-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Functional	O	ADJ	B
analysis	O	NOUN	I
of	O	ADP	O
5	B-DNA	NUM	O
'	I-DNA	PART	O
deletion	I-DNA	NOUN	B
constructs	I-DNA	NOUN	I
in	O	ADP	O
transfected	O	VERB	B
K562	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
and	O	CCONJ	O
gel	O	NOUN	B
mobility	O	NOUN	I
shift	O	NOUN	I
localized	O	VERB	B
the	O	DET	O
major	O	ADJ	O
phorbol	O	NOUN	B
ester-responsive	O	ADJ	O
motifs	O	NOUN	B
in	O	ADP	O
the	O	DET	O
thromboxane	B-DNA	NOUN	B
receptor	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
promoter	O	NOUN	O
to	O	PART	O
a	O	DET	O
cluster	O	NOUN	B
of	O	ADP	O
activator	B-DNA	NOUN	O
protein-2	I-DNA	NOUN	O
(	I-DNA	PUNCT	O
AP-2	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
binding	I-DNA	NOUN	O
consensus	I-DNA	NOUN	B
sites	I-DNA	NOUN	I
located	O	ADJ	O
approximately	O	ADV	O
1.8	O	NUM	O
kb	O	NOUN	O
5	O	NUM	O
'	O	PUNCT	O
from	O	ADP	O
the	O	DET	O
transcription	B-DNA	NOUN	B
initiation	I-DNA	NOUN	I
site	I-DNA	NOUN	I
.	O	PUNCT	O


These	O	DET	O
findings	O	NOUN	B
strongly	O	ADV	O
suggest	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
mechanism	O	NOUN	B
for	O	ADP	O
previously	O	ADV	O
described	O	VERB	O
upregulation	O	NOUN	B
of	O	ADP	O
platelet	B-protein	NOUN	B
thromboxane	I-protein	NOUN	I
receptors	I-protein	NOUN	I
after	O	ADP	O
acute	O	ADJ	B
myocardial	O	ADJ	I
infarction	O	NOUN	I
is	O	AUX	O
increased	O	VERB	B
thromboxane	B-DNA	NOUN	B
receptor	I-DNA	NOUN	I
gene	I-DNA	NOUN	B
transcription	O	NOUN	I
in	O	ADP	O
platelet-progenitor	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Confirmation	O	NOUN	B
of	O	ADP	O
a	O	DET	O
model	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
seeking	O	VERB	O
social	O	ADJ	B
support	O	NOUN	I
as	O	ADP	O
a	O	DET	O
coping	O	NOUN	B
strategy	O	NOUN	O
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
the	O	DET	O
perceived	O	VERB	B
quality	O	NOUN	B
of	O	ADP	O
support	O	NOUN	O
,	O	PUNCT	O
also	O	ADV	O
entered	O	VERB	O
the	O	DET	O
model	O	NOUN	B
to	O	PART	O
account	O	VERB	O
for	O	ADP	O
a	O	DET	O
significant	O	ADJ	O
amount	O	NOUN	O
of	O	ADP	O
NK	O	NOUN	B
activity	O	NOUN	I
variance	O	NOUN	I
(	O	PUNCT	O
multivariate	O	ADJ	B
F	O	NOUN	I
=	O	ADJ	O
5.25	O	NUM	O
,	O	PUNCT	O
p	O	NOUN	O
less	O	ADJ	O
than	O	ADP	O
0.001	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Helices	B-protein	NOUN	B
I	I-protein	NUM	I
and	I-protein	CCONJ	O
II	I-protein	NUM	B
are	O	AUX	O
positioned	O	ADJ	O
in	O	ADP	O
an	O	DET	O
antiparallel	B-protein	ADJ	B
mode	I-protein	NOUN	O
and	O	CCONJ	O
form	O	VERB	O
one	O	NUM	O
arm	O	NOUN	O
of	O	ADP	O
the	O	DET	O
HMG	B-protein	NOUN	B
box	I-protein	NOUN	I
.	O	PUNCT	O


PRE-I	B-DNA	NOUN	B
forms	O	VERB	O
multiple	B-protein	ADJ	O
DNA-protein	I-protein	ADJ	B
complexes	I-protein	NOUN	I
with	O	ADP	O
nuclear	O	ADJ	B
extracts	O	NOUN	I
from	O	ADP	O
Jurkat	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


Some	O	DET	O
of	O	ADP	O
these	O	DET	O
complexes	O	NOUN	B
were	O	AUX	O
demonstrated	O	VERB	O
to	O	PART	O
contain	O	VERB	O
NF-IL6	B-protein	NOUN	B
by	O	ADP	O
using	O	VERB	O
anti-C/EBP	B-protein	ADJ	B
beta	I-protein	NOUN	I
Abs	I-protein	NOUN	I
.	O	PUNCT	O


Promoter	O	NOUN	B
deletion	O	NOUN	I
studies	O	NOUN	I
revealed	O	VERB	O
two	O	NUM	O
additional	O	ADJ	O
NF-IL6	B-DNA	NOUN	B
binding	I-DNA	NOUN	I
sites	I-DNA	NOUN	I
located	O	ADJ	O
at	O	ADP	O
positions	O	NOUN	B
-44	O	NUM	O
to	O	PART	O
-36	O	NUM	O
(	O	PUNCT	O
C/EBP	B-protein	NOUN	B
proximal	I-protein	ADJ	I
)	O	PUNCT	O
and	O	CCONJ	O
-87	O	NUM	O
to	O	PART	O
-79	O	NUM	O
(	O	PUNCT	O
C/EBP	B-protein	NOUN	B
medial	I-protein	ADJ	I
)	O	PUNCT	O
,	O	PUNCT	O
respectively	O	ADV	O
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	B
demonstrate	O	VERB	O
that	O	SCONJ	O
NF-IL6	B-protein	NOUN	B
is	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
transcriptional	O	ADJ	B
activation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
IL-4	I-DNA	NOUN	B
promoter	I-DNA	NOUN	B
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


Nuclear	B-protein	ADJ	B
factor	I-protein	NOUN	I
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
(	O	PUNCT	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
)	O	PUNCT	O
is	O	AUX	O
stored	O	VERB	B
in	O	ADP	O
the	O	DET	O
cytoplasm	O	NOUN	B
as	O	ADP	O
an	O	DET	O
inactive	O	ADJ	B
form	O	NOUN	O
through	O	ADP	O
interaction	O	NOUN	B
with	O	ADP	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
.	O	PUNCT	O


Mutational	O	ADJ	B
analyses	O	NOUN	I
of	O	ADP	O
I	B-protein	NOUN	B
kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
alpha	O	NOUN	I
and	O	CCONJ	O
competition	O	NOUN	B
experiments	O	NOUN	B
with	O	ADP	O
the	O	DET	O
synthetic	O	ADJ	B
peptides	O	NOUN	I
identified	O	VERB	O
major	O	ADJ	O
phosphorylation	B-protein	NOUN	B
sites	I-protein	NOUN	O
by	O	ADP	O
the	O	DET	O
bound	O	VERB	B
kinase	B-protein	NOUN	I
as	O	ADP	O
Ser	O	NOUN	B
and	O	CCONJ	O
Thr	O	NOUN	B
residues	O	NOUN	I
in	O	ADP	O
the	O	DET	O
C-terminal	B-protein	ADJ	B
acidic	I-protein	ADJ	I
domain	I-protein	NOUN	I
of	O	ADP	O
I	B-protein	NOUN	O
kappa	I-protein	NOUN	O
B	I-protein	NOUN	O
alpha	I-protein	NOUN	O
.	O	PUNCT	O


The	O	DET	O
survival-promoting	O	ADJ	B
activity	O	NOUN	I
of	O	ADP	O
the	O	DET	O
Bcl-2	B-protein	NOUN	B
family	I-protein	NOUN	O
of	O	ADP	O
proteins	O	NOUN	B
appears	O	VERB	O
to	O	PART	O
be	O	AUX	O
modulated	O	VERB	B
by	O	ADP	O
interactions	O	NOUN	B
between	O	ADP	O
various	O	ADJ	O
cellular	B-protein	ADJ	B
proteins	I-protein	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
expression	O	NOUN	B
reportedly	O	ADV	O
occurs	O	VERB	O
in	O	ADP	O
multiple	O	ADJ	B
nonlymphoid	O	ADJ	B
tissues	O	NOUN	B
during	O	ADP	O
murine	O	ADJ	B
embryogenesis	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
these	O	DET	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
nuclear	O	ADJ	B
TCF-1	B-protein	NOUN	B
expression	O	NOUN	B
can	O	AUX	O
serve	O	VERB	O
as	O	ADP	O
a	O	DET	O
pan-T-lineage	O	ADJ	B
marker	O	NOUN	I
in	O	ADP	O
the	O	DET	O
diagnosis	O	NOUN	B
of	O	ADP	O
lymphoid	O	ADJ	B
malignancies	O	NOUN	I
.	O	PUNCT	O


TCL1	O	NOUN	B
oncogene	O	NOUN	I
activation	O	NOUN	B
in	O	ADP	O
preleukemic	B-cell_type	ADJ	B
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
from	O	ADP	O
a	O	DET	O
case	O	NOUN	B
of	O	ADP	O
ataxia-telangiectasia	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
determined	O	VERB	O
the	O	DET	O
functional	O	ADJ	B
role	O	NOUN	O
of	O	ADP	O
C/EBP	B-protein	NOUN	B
proteins	I-protein	NOUN	I
and	O	CCONJ	O
C/EBP	B-DNA	NOUN	B
sites	I-DNA	NOUN	I
in	O	ADP	O
regulating	O	VERB	B
transcription	O	NOUN	I
from	O	ADP	O
the	O	DET	O
HIV-	B-DNA	ADJ	B
1	I-DNA	NUM	O
LTR	I-DNA	NOUN	B
in	O	ADP	O
monocytes/macrophages	B-cell_type	NOUN	B
.	O	PUNCT	O


Mutational	O	ADJ	B
analyses	O	NOUN	I
of	O	ADP	O
the	O	DET	O
HIV-1	B-DNA	NOUN	B
LTR	I-DNA	NOUN	B
showed	O	VERB	O
that	O	SCONJ	O
one	O	NUM	O
C/EBP	B-DNA	NOUN	B
site	I-DNA	NOUN	I
is	O	AUX	O
required	O	VERB	O
for	O	ADP	O
normal	O	ADJ	O
LTR	B-DNA	NOUN	B
transcription	O	NOUN	O
both	O	CCONJ	O
before	O	ADP	O
and	O	CCONJ	O
after	O	ADP	O
cellular	O	ADJ	B
activation	O	NOUN	I
and	O	CCONJ	O
that	O	SCONJ	O
the	O	DET	O
two	O	NUM	O
3	O	NUM	O
'	O	PART	O
C/EBP	B-DNA	NOUN	B
sites	I-DNA	NOUN	I
are	O	AUX	O
functionally	O	ADV	O
equivalent	O	ADJ	B
.	O	PUNCT	O


Several	O	ADJ	O
models	O	NOUN	B
are	O	AUX	O
suggested	O	VERB	O
for	O	ADP	O
how	O	SCONJ	O
elevated	O	ADJ	B
NF-IL6	B-protein	NOUN	B
may	O	AUX	O
participate	O	VERB	B
in	O	ADP	O
an	O	DET	O
autostimulatory	O	ADJ	B
loop	O	NOUN	O
involving	O	VERB	O
HIV	O	NOUN	B
infection	O	NOUN	I
,	O	PUNCT	O
macrophage	O	NOUN	B
activation	O	NOUN	I
,	O	PUNCT	O
cytokine	B-protein	NOUN	B
expression	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
HIV	O	NOUN	B
replication	O	NOUN	B
.	O	PUNCT	O


Since	O	SCONJ	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
viruses	O	NOUN	B
is	O	AUX	O
in	O	ADP	O
large	O	ADJ	O
part	O	NOUN	O
regulated	O	VERB	O
by	O	ADP	O
the	O	DET	O
sequence	B-DNA	NOUN	B
elements	I-DNA	NOUN	I
in	O	ADP	O
their	O	PRON	O
long	B-DNA	ADJ	B
terminal	I-DNA	ADJ	I
repeats	I-DNA	NOUN	I
(	O	PUNCT	O
LTRs	B-DNA	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
this	O	DET	O
study	O	NOUN	B
was	O	AUX	O
directed	O	VERB	O
to	O	PART	O
an	O	DET	O
analysis	O	NOUN	B
of	O	ADP	O
the	O	DET	O
regulatory	B-DNA	ADJ	B
elements	I-DNA	NOUN	I
in	O	ADP	O
the	O	DET	O
HIV-2	B-DNA	NOUN	B
LTR	I-DNA	NOUN	B
.	O	PUNCT	O


The	O	DET	O
HIV-2	B-DNA	NOUN	B
LTR	I-DNA	NOUN	B
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
contain	O	VERB	O
two	O	NUM	O
enhancers	B-DNA	NOUN	B
.	O	PUNCT	O


One	O	NUM	O
of	O	ADP	O
these	O	DET	O
enhancers	B-DNA	NOUN	B
is	O	AUX	O
,	O	PUNCT	O
in	O	ADP	O
part	O	NOUN	O
,	O	PUNCT	O
identical	O	ADJ	B
to	O	PART	O
the	O	DET	O
HIV-1	B-DNA	NOUN	B
enhancer	I-DNA	NOUN	B
.	O	PUNCT	O


The	O	DET	O
GM-CSF	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
,	O	PUNCT	O
modified	O	VERB	B
in	O	ADP	O
this	O	DET	O
way	O	NOUN	O
to	O	PART	O
be	O	AUX	O
ETS1	B-protein	NOUN	B
specific	O	ADJ	B
,	O	PUNCT	O
is	O	AUX	O
fully	O	ADV	O
responsive	O	ADJ	O
to	O	PART	O
PMA/ionomycin	O	NOUN	B
induction	O	NOUN	B
,	O	PUNCT	O
in	O	ADP	O
addition	O	NOUN	O
to	O	PART	O
ETS1	B-protein	NOUN	B
transactivation	O	NOUN	B
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
PMA	O	NOUN	B
and	O	CCONJ	O
ionomycin	O	NOUN	B
.	O	PUNCT	O


Together	O	ADV	O
these	O	DET	O
data	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
ETS1	B-protein	NOUN	B
may	O	AUX	O
be	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
mediating	O	VERB	O
the	O	DET	O
increased	O	VERB	B
GM-CSF	B-protein	NOUN	B
production	O	NOUN	B
associated	O	VERB	B
with	O	ADP	I
T	B-cell_type	NOUN	B
cell	I-cell_type	NOUN	I
activation	O	NOUN	B
.	O	PUNCT	O


Thyroid	O	NOUN	B
hormones	O	NOUN	I
act	O	VERB	O
by	O	ADP	O
binding	O	VERB	B
to	O	PART	O
nuclear	B-protein	ADJ	B
receptor	I-protein	NOUN	I
proteins	I-protein	NOUN	I
,	O	PUNCT	O
the	O	DET	O
thyroid	B-protein	NOUN	B
hormone	I-protein	NOUN	I
receptors	I-protein	NOUN	I
(	I-protein	PUNCT	O
TR	I-protein	NOUN	O
)	I-protein	PUNCT	O
alpha	I-protein	NOUN	O
and	I-protein	CCONJ	O
beta	I-protein	NOUN	B
.	O	PUNCT	O


Similar	O	ADJ	O
levels	O	NOUN	B
of	O	ADP	O
hTR	B-RNA	NOUN	B
beta	I-RNA	NOUN	O
1	I-RNA	NUM	O
mRNA	I-RNA	NOUN	B
levels	O	NOUN	O
were	O	AUX	O
detected	O	VERB	B
in	O	ADP	O
thyroid	O	NOUN	B
gland	O	NOUN	I
from	O	ADP	O
euthyroid	O	NOUN	B
patients	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
effects	O	NOUN	B
of	O	ADP	I
CsA	O	NOUN	B
on	O	ADP	O
endothelial	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
were	O	AUX	O
also	O	ADV	O
detected	O	VERB	B
at	O	ADP	O
the	O	DET	O
chromatin	B-DNA	NOUN	B
structure	O	NOUN	I
level	O	NOUN	I
,	O	PUNCT	O
as	O	ADP	O
DNasel	B-DNA	NOUN	B
hypersensitive	I-DNA	ADJ	O
sites	I-DNA	NOUN	O
within	O	ADP	O
both	O	CCONJ	O
the	O	DET	O
GM-CSF	B-protein	NOUN	B
enhancer	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
E-selectin	B-DNA	NOUN	B
promoter	I-DNA	NOUN	I
were	O	AUX	O
suppressed	O	VERB	B
by	O	ADP	O
CsA	O	NOUN	B
.	O	PUNCT	O


Regulation	O	NOUN	B
of	O	ADP	O
human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
type	O	NOUN	I
1	O	NUM	I
and	O	CCONJ	O
cytokine	O	NOUN	B
gene	O	NOUN	B
expression	O	NOUN	I
in	O	ADP	O
myeloid	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
by	O	ADP	O
NF-kappa	B-protein	NOUN	B
B/Rel	I-protein	NOUN	B
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
.	O	PUNCT	O


CD4+	B-cell_line	ADJ	B
macrophages	I-cell_line	NOUN	I
in	O	ADP	O
tissues	O	NOUN	B
such	O	ADJ	O
as	O	ADP	O
lung	O	NOUN	B
,	O	PUNCT	O
skin	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
lymph	O	NOUN	B
nodes	O	NOUN	I
,	O	PUNCT	O
promyelocytic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
in	O	ADP	O
bone	O	NOUN	B
marrow	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
monocytes	I-cell_type	NOUN	I
serve	O	VERB	O
as	O	ADP	O
important	O	ADJ	O
targets	O	NOUN	B
and	O	CCONJ	O
reservoirs	O	NOUN	B
for	O	ADP	O
human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
type	O	NOUN	I
1	O	NUM	I
(	O	PUNCT	O
HIV-1	O	NOUN	B
)	O	PUNCT	O
replication	O	NOUN	B
.	O	PUNCT	O


B	O	NOUN	O
cell-specific	O	ADJ	B
transcriptional	O	ADJ	I
promoter	O	NOUN	O
activity	O	NOUN	O
mediated	O	VERB	O
by	O	ADP	O
the	O	DET	O
octamer	B-DNA	NOUN	B
motif	I-DNA	NOUN	B
requires	O	VERB	O
the	O	DET	O
Oct1	B-protein	NOUN	B
or	O	CCONJ	O
Oct2	B-protein	NOUN	B
protein	I-protein	NOUN	I
and	O	CCONJ	O
additional	O	ADJ	O
B	B-protein	NOUN	O
cell-restricted	I-protein	ADJ	O
cofactors	I-protein	NOUN	O
.	O	PUNCT	O


One	O	NUM	O
such	O	ADJ	O
cofactor	B-protein	NOUN	B
,	O	PUNCT	O
BOB.1/OBF.1	B-protein	NOUN	B
,	O	PUNCT	O
was	O	AUX	O
recently	O	ADV	O
isolated	O	VERB	B
from	O	ADP	O
human	B-cell_type	ADJ	B
B	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
.	O	PUNCT	O


Consistent	O	ADJ	B
with	O	ADP	I
the	O	DET	O
failure	O	NOUN	B
of	O	ADP	O
full-length	B-protein	ADJ	O
BOB.1/OBF.1	I-protein	NOUN	B
to	O	PART	O
stimulate	O	VERB	B
octamer-dependent	B-DNA	ADJ	B
enhancer	I-DNA	NOUN	O
elements	I-DNA	NOUN	O
in	O	ADP	O
non	B-cell_type	ADJ	B
B	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
the	O	DET	O
GAL4	B-protein	NOUN	B
fusions	I-protein	NOUN	B
likewise	O	ADV	O
only	O	ADV	O
stimulate	O	VERB	B
from	O	ADP	O
a	O	DET	O
promoter-proximal	O	ADJ	B
position	O	NOUN	I
.	O	PUNCT	O


Kinase	O	NOUN	B
activity	O	NOUN	I
was	O	AUX	O
reduced	O	VERB	B
in	O	ADP	O
lysates	O	NOUN	B
preadsorbed	O	VERB	B
using	O	VERB	O
an	O	DET	O
antibody	B-protein	NOUN	B
specific	O	ADJ	B
for	O	ADP	O
CaM	B-protein	NOUN	B
kinase	I-protein	NOUN	I
II	I-protein	NUM	I
.	O	PUNCT	O


In	O	ADP	O
lymphoid	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
higher	O	ADJ	O
activation	O	NOUN	B
levels	O	NOUN	O
were	O	AUX	O
observed	O	VERB	B
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
distinct	O	ADJ	O
B-cell-specific	B-protein	ADJ	B
cofactors	I-protein	NOUN	I
in	O	ADP	O
concert	O	NOUN	O
with	O	ADP	O
the	O	DET	O
effector	B-protein	NOUN	B
domains	I-protein	NOUN	I
of	O	ADP	O
Oct-2a	B-protein	NOUN	B
might	O	AUX	O
be	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
mediating	O	VERB	O
transcription	O	NOUN	B
from	O	ADP	O
proximal	O	ADJ	B
and	O	CCONJ	O
remote	O	ADJ	B
positions	O	NOUN	B
.	O	PUNCT	O


Whereas	O	SCONJ	O
the	O	DET	O
mechanism	O	NOUN	B
of	O	ADP	O
nonopsonic	O	ADJ	B
phagocytosis	O	NOUN	I
of	O	ADP	O
Pseudomonas	O	X	B
aeruginosa	O	X	I
has	O	AUX	O
been	O	AUX	O
described	O	VERB	O
,	O	PUNCT	O
the	O	DET	O
bacterial	O	ADJ	B
ligands	O	NOUN	O
required	O	VERB	O
are	O	AUX	O
poorly	O	ADV	O
understood	O	VERB	O
.	O	PUNCT	O


The	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
a	O	DET	O
flagellum	O	NOUN	B
was	O	AUX	O
not	O	PART	O
required	O	VERB	O
for	O	ADP	O
binding	O	NOUN	B
of	O	ADP	O
P.	O	X	B
aeruginosa	O	X	I
to	O	PART	O
macrophages	B-cell_type	NOUN	B
but	O	CCONJ	O
was	O	AUX	O
critical	O	ADJ	O
for	O	ADP	O
the	O	DET	O
subsequent	O	ADJ	O
internalization	O	NOUN	B
of	O	ADP	O
the	O	DET	O
bacterium	O	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
this	O	DET	O
factor	O	NOUN	B
or	O	CCONJ	O
a	O	DET	O
surface	O	NOUN	B
ligand	O	NOUN	B
associated	O	VERB	B
with	O	ADP	I
its	O	PRON	O
assembly	O	NOUN	B
was	O	AUX	O
responsible	O	ADJ	O
for	O	ADP	O
stimulation	O	NOUN	B
of	O	ADP	O
nonopsonic	O	ADJ	B
phagocytosis	O	NOUN	I
.	O	PUNCT	O


Gel	O	NOUN	B
shift	O	NOUN	I
assays	O	NOUN	I
and	O	CCONJ	O
site-directed	O	ADJ	B
mutagenesis	O	NOUN	I
studies	O	NOUN	I
defined	O	VERB	O
essential	O	ADJ	O
GATA	B-DNA	NOUN	B
and	O	CCONJ	O
Ets	B-DNA	NOUN	B
binding	I-DNA	NOUN	I
motifs	I-DNA	NOUN	O
93	B-DNA	NUM	O
and	I-DNA	CCONJ	O
150	I-DNA	NUM	O
nucleotides	I-DNA	NOUN	B
upstream	I-DNA	ADJ	B
of	O	ADP	O
the	O	DET	O
transcription	B-DNA	NOUN	B
start	I-DNA	NOUN	O
site	I-DNA	NOUN	O
,	O	PUNCT	O
a	O	DET	O
finding	O	NOUN	B
which	O	DET	O
further	O	ADV	O
substantiates	O	VERB	O
these	O	DET	O
elements	O	NOUN	B
as	O	ADP	O
important	O	ADJ	O
determinants	O	NOUN	B
of	O	ADP	O
megakaryocytic	O	ADJ	B
gene	O	NOUN	B
expression	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
all	O	DET	O
cell	O	NOUN	B
lines	O	NOUN	I
investigated	O	VERB	B
,	O	PUNCT	O
the	O	DET	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
complexes	I-protein	NOUN	I
induced	O	VERB	B
following	O	VERB	O
CD30	B-protein	NOUN	B
engagement	O	NOUN	I
were	O	AUX	O
shown	O	VERB	O
to	O	PART	O
contain	O	VERB	O
p50	B-protein	NOUN	B
NF-kappa	I-protein	NOUN	I
B1	I-protein	NOUN	I
,	O	PUNCT	O
p65	B-protein	NOUN	B
RelA	I-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
possibly	O	ADV	O
other	O	ADJ	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
.	O	PUNCT	O


It	O	PRON	O
has	O	AUX	O
long	O	ADV	O
been	O	AUX	O
a	O	DET	O
puzzle	O	NOUN	O
that	O	SCONJ	O
MHC	B-protein	NOUN	B
class	I-protein	NOUN	B
II	I-protein	NUM	I
molecules	I-protein	NOUN	I
are	O	AUX	O
expressed	O	VERB	B
in	O	ADP	O
human	B-cell_type	ADJ	B
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
after	O	ADP	O
activation	O	NOUN	B
but	O	CCONJ	O
not	O	PART	O
in	O	ADP	O
mouse	B-cell_type	NOUN	B
T	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
;	O	PUNCT	O
this	O	DET	O
expression	O	NOUN	B
is	O	AUX	O
believed	O	VERB	O
to	O	PART	O
play	O	VERB	O
a	O	DET	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
cell	O	NOUN	B
mediated	O	ADJ	O
immune	O	ADJ	B
response	O	NOUN	I
.	O	PUNCT	O


SF	O	NOUN	B
suppression	O	NOUN	B
was	O	AUX	O
mediated	O	VERB	O
by	O	ADP	O
IL-4	B-protein	NOUN	B
and	O	CCONJ	O
IL-10	B-protein	NOUN	B
and	O	CCONJ	O
inhibition	O	NOUN	B
of	O	ADP	O
IL-12	B-protein	NOUN	B
expression	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
it	O	PRON	O
was	O	AUX	O
reversed	O	VERB	O
in	O	ADP	O
a	O	DET	O
dominant	O	ADJ	B
fashion	O	NOUN	I
by	O	ADP	O
exogenous	O	ADJ	B
IL-12	O	NOUN	B
.	O	PUNCT	O


Triggering	O	NOUN	B
of	O	ADP	O
complement	B-protein	NOUN	B
receptors	I-protein	NOUN	I
CR1	B-protein	NOUN	I
(	O	PUNCT	O
CD35	B-protein	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
CR3	B-protein	NOUN	B
(	O	PUNCT	O
CD11b/CD18	B-protein	NOUN	B
)	O	PUNCT	O
induces	O	VERB	O
nuclear	O	ADJ	B
translocation	O	NOUN	I
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
(	O	PUNCT	O
p50/p65	B-protein	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
human	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
and	O	CCONJ	O
enhances	O	VERB	B
viral	O	ADJ	B
replication	O	NOUN	I
in	O	ADP	O
HIV-infected	B-cell_type	ADJ	B
monocytic	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


The	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
LPS	O	NOUN	B
and	O	CCONJ	O
TNF-alpha	B-protein	NOUN	B
is	O	AUX	O
mediated	O	VERB	O
by	O	ADP	O
their	O	PRON	O
ability	O	NOUN	O
to	O	PART	O
induce	O	VERB	B
nuclear	O	ADJ	B
translocation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
DNA-binding	B-protein	ADJ	B
heterodimer	I-protein	NOUN	I
NF-kappa	B-protein	NOUN	I
B	I-protein	NOUN	I
(	O	PUNCT	O
p50/p65	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
which	O	DET	O
binds	O	VERB	B
to	O	PART	O
a	O	DET	O
specific	O	ADJ	O
sequence	O	NOUN	B
in	O	ADP	O
the	O	DET	O
HIV-long	B-DNA	ADJ	B
terminal	I-DNA	ADJ	O
repeat	I-DNA	NOUN	O
.	O	PUNCT	O


Stimulation	O	NOUN	B
of	O	ADP	O
CR1	B-protein	NOUN	B
or	O	CCONJ	O
CR3	B-protein	NOUN	B
induces	O	VERB	B
a	O	DET	O
two-	O	NUM	O
to	O	PART	O
fourfold	O	ADJ	O
increase	O	NOUN	B
in	O	ADP	O
the	O	DET	O
amount	O	NOUN	B
of	O	ADP	O
cell-associated	O	ADJ	B
and	O	CCONJ	O
released	O	VERB	O
p24	B-protein	NOUN	B
Ag	I-protein	NOUN	B
in	O	ADP	O
cell	B-cell_line	NOUN	B
cultures	I-cell_line	NOUN	I
that	O	PRON	O
was	O	AUX	O
equivalent	O	ADJ	O
to	O	PART	O
that	O	DET	O
observed	O	VERB	B
in	O	ADP	O
control	B-cell_line	ADJ	B
cultures	I-cell_line	NOUN	I
triggered	O	VERB	B
with	O	ADP	I
LPS	O	NOUN	B
.	O	PUNCT	O


Taken	O	VERB	O
together	O	ADV	O
,	O	PUNCT	O
these	O	DET	O
observations	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
HIV	O	NOUN	B
gene	O	NOUN	B
expression	O	NOUN	I
may	O	AUX	O
be	O	AUX	O
activated	O	VERB	B
in	O	ADP	O
infected	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
through	O	ADP	O
interaction	O	NOUN	B
of	O	ADP	O
the	O	DET	O
cells	O	NOUN	B
with	O	ADP	O
complement-opsonized	B-protein	ADJ	B
particles	I-protein	NOUN	I
and	O	CCONJ	O
that	O	SCONJ	O
enhanced	O	VERB	B
viral	O	ADJ	B
replication	O	NOUN	I
is	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
C3	B-protein	NOUN	B
receptor	I-protein	NOUN	I
-mediated	O	ADJ	O
nuclear	O	ADJ	B
translocation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
complex	I-protein	NOUN	I
.	O	PUNCT	O


Tyrosine	O	NOUN	B
phosphorylation	O	NOUN	I
of	O	ADP	O
Jak1	B-protein	NOUN	B
,	O	PUNCT	O
Jak2	B-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
Stat1	B-protein	NOUN	B
increased	O	VERB	B
markedly	O	ADV	B
,	O	PUNCT	O
in	O	ADP	O
a	O	DET	O
dose-dependent	O	ADJ	B
manner	O	NOUN	O
,	O	PUNCT	O
in	O	ADP	O
U-937	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
incubated	O	VERB	B
with	O	ADP	O
gamma	B-protein	NOUN	B
interferon	I-protein	NOUN	I
.	O	PUNCT	O


Results	O	NOUN	B
similar	O	ADJ	O
to	O	PART	O
those	O	DET	O
observed	O	VERB	O
with	O	ADP	O
U-937	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
were	O	AUX	O
also	O	ADV	O
obtained	O	VERB	O
with	O	ADP	O
human	B-cell_type	ADJ	B
peripheral	I-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
monocytes	I-cell_type	NOUN	O
.	O	PUNCT	O


Growth	B-protein	NOUN	B
factor	I-protein	NOUN	I
receptors	I-protein	NOUN	I
play	O	VERB	O
an	O	DET	O
important	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
hematopoiesis	O	NOUN	B
.	O	PUNCT	O


Here	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
human	B-DNA	ADJ	B
GM-CSF	I-DNA	NOUN	O
receptor	I-DNA	NOUN	O
alpha	I-DNA	NOUN	O
promoter	I-DNA	NOUN	B
directs	O	VERB	O
reporter	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
activity	O	NOUN	O
in	O	ADP	O
a	O	DET	O
tissue-specific	O	ADJ	B
fashion	O	NOUN	I
in	O	ADP	O
myelomonocytic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
which	O	DET	O
correlates	O	VERB	O
with	O	ADP	O
its	O	PRON	O
expression	O	NOUN	B
pattern	O	NOUN	I
as	O	ADP	O
analyzed	O	VERB	B
by	O	ADP	O
reverse	O	ADJ	B
transcription	O	NOUN	I
PCR	O	NOUN	I
.	O	PUNCT	O


Point	O	NOUN	B
mutations	O	NOUN	I
of	O	ADP	O
either	O	CCONJ	O
the	O	DET	O
PU.1	B-DNA	NOUN	B
site	I-DNA	NOUN	I
or	O	CCONJ	O
the	O	DET	O
C/EBP	B-DNA	NOUN	B
site	I-DNA	NOUN	I
that	O	PRON	O
abolish	O	VERB	B
the	O	DET	O
binding	O	NOUN	B
of	O	ADP	O
the	O	DET	O
respective	O	ADJ	O
factors	O	NOUN	B
result	O	VERB	B
in	O	ADP	O
a	O	DET	O
significant	O	ADJ	O
decrease	O	NOUN	B
of	O	ADP	O
GM-CSF	B-DNA	NOUN	B
receptor	I-DNA	NOUN	I
alpha	I-DNA	NOUN	I
promoter	I-DNA	NOUN	B
activity	O	NOUN	I
in	O	ADP	O
myelomonocytic	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
only	O	ADV	O
.	O	PUNCT	O


This	O	DET	O
is	O	AUX	O
the	O	DET	O
first	O	ADJ	O
demonstration	O	NOUN	B
of	O	ADP	O
a	O	DET	O
specific	O	ADJ	O
interaction	O	NOUN	B
with	O	ADP	O
PU.1	B-protein	NOUN	B
on	O	ADP	O
a	O	DET	O
myeloid	B-DNA	ADJ	B
PU.1	I-DNA	NOUN	B
binding	I-DNA	NOUN	I
site	I-DNA	NOUN	I
.	O	PUNCT	O


Expression	O	NOUN	B
of	O	ADP	O
PU.1	B-protein	NOUN	B
in	O	ADP	O
nonmyeloid	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
can	O	AUX	O
activate	O	VERB	B
the	O	DET	O
GM-CSF	B-DNA	NOUN	B
receptor	I-DNA	NOUN	I
alpha	I-DNA	NOUN	I
promoter	I-DNA	NOUN	O
.	O	PUNCT	O


(	O	PUNCT	O
ABSTRACT	O	NOUN	B
TRUNCATED	O	VERB	I
AT	O	ADP	I
400	O	NUM	I
WORDS	O	NOUN	I
)	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
examined	O	VERB	O
binding	O	NOUN	B
of	O	ADP	O
the	O	DET	O
nuclear	B-protein	ADJ	B
protein	I-protein	NOUN	I
HMG-I	B-protein	NOUN	I
to	O	PART	O
the	O	DET	O
human	B-DNA	ADJ	B
gamma-globin	I-DNA	NOUN	O
promoter	I-DNA	NOUN	O
.	O	PUNCT	O


Interrelations	O	NOUN	B
between	O	ADP	O
the	O	DET	O
hypothalamic-pituitary-adrenal	O	ADJ	B
system	O	NOUN	I
(	O	PUNCT	O
HPA	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
immune	O	ADJ	B
system	O	NOUN	I
represent	O	VERB	O
a	O	DET	O
well-documented	O	ADJ	O
biological	O	ADJ	B
phenomenon	O	NOUN	B
.	O	PUNCT	O


Glucocorticoid	O	NOUN	B
effects	O	NOUN	I
were	O	AUX	O
assessed	O	VERB	B
in	O	X	B
vivo	O	X	I
by	O	ADP	O
depletion	O	NOUN	B
of	O	ADP	O
endogenous	O	ADJ	B
glucocorticoids	O	NOUN	B
after	O	ADP	O
oral	O	ADJ	B
administration	O	NOUN	I
of	O	ADP	O
1.5	O	NUM	O
g	O	NOUN	O
metyrapone	O	NOUN	B
(	O	PUNCT	O
MET	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
subsequent	O	ADJ	O
glucocorticoid	O	NOUN	B
replacement	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
in	O	X	B
vitro	O	X	I
by	O	ADP	O
incubation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
cells	O	NOUN	B
with	O	ADP	O
different	O	ADJ	O
doses	O	NOUN	B
of	O	ADP	O
dexamethasone	O	NOUN	B
(	O	PUNCT	O
DEX	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


In	O	X	B
vitro	O	X	I
treatment	O	NOUN	B
of	O	ADP	O
a	O	DET	O
monocyte/macrophage	O	NOUN	B
cell	O	NOUN	I
line	O	NOUN	I
with	O	ADP	O
CCl4	O	NOUN	B
led	O	VERB	O
to	O	PART	O
enhanced	O	VERB	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
binding	O	NOUN	O
and	O	CCONJ	O
an	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
tumor	B-RNA	NOUN	B
necrosis	I-RNA	NOUN	I
factor-alpha	I-RNA	NOUN	I
(	I-RNA	PUNCT	O
TNF-alpha	I-RNA	NOUN	B
)	I-RNA	PUNCT	O
messenger	I-RNA	NOUN	O
RNA	I-RNA	NOUN	O
levels	O	NOUN	O
.	O	PUNCT	O


T-lymphocyte	O	NOUN	B
proliferation	O	NOUN	I
is	O	AUX	O
suppressed	O	VERB	B
by	O	ADP	O
1	O	NUM	O
,	O	PUNCT	O
25-dihydroxyvitamin	O	NOUN	B
D3	O	NOUN	I
[	O	PUNCT	O
1	O	NUM	O
,	O	PUNCT	O
25	O	NUM	O
(	O	PUNCT	O
OH	O	NOUN	B
)	O	PUNCT	O
2D3	O	NOUN	O
]	O	PUNCT	O
,	O	PUNCT	O
the	O	DET	O
active	O	ADJ	B
metabolite	O	NOUN	I
of	O	ADP	O
vitamin	O	NOUN	B
D3	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
is	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
a	O	DET	O
decrease	O	NOUN	B
in	O	ADP	O
interleukin	O	NOUN	B
2	O	NUM	I
(	O	PUNCT	O
IL-2	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
gamma	O	NOUN	B
interferon	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
granulocyte-macrophage	O	ADJ	B
colony-stimulating	O	ADJ	I
factor	O	NOUN	I
mRNA	O	NOUN	I
levels	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
report	O	VERB	O
here	O	ADV	O
that	O	SCONJ	O
1	O	NUM	O
,	O	PUNCT	O
25	O	NUM	O
(	O	PUNCT	O
OH	O	NOUN	B
)	O	PUNCT	O
2D3-mediated	O	ADJ	O
repression	O	NOUN	B
in	O	ADP	O
Jurkat	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
is	O	AUX	O
cycloheximide	O	NOUN	B
resistant	O	ADJ	B
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
it	O	PRON	O
is	O	AUX	O
a	O	DET	O
direct	O	ADJ	O
transcriptional	O	ADJ	B
repressive	O	ADJ	O
effect	O	NOUN	O
on	O	ADP	O
IL-2	B-protein	NOUN	B
expression	O	NOUN	B
by	O	ADP	O
the	O	DET	O
vitamin	B-protein	NOUN	B
D3	I-protein	NOUN	I
receptor	I-protein	NOUN	I
(	O	PUNCT	O
VDR	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


VDR	B-protein	NOUN	B
DNA-binding	I-protein	ADJ	B
mutants	I-protein	NOUN	B
were	O	AUX	O
unable	O	ADJ	O
to	O	PART	O
either	O	CCONJ	O
bind	O	VERB	B
to	O	PART	O
this	O	DET	O
element	O	NOUN	B
in	O	X	B
vitro	O	X	I
or	O	CCONJ	O
repress	O	VERB	B
in	O	X	B
vivo	O	X	I
;	O	PUNCT	O
the	O	DET	O
VDR	B-protein	NOUN	B
DNA-binding	I-protein	ADJ	B
domain	I-protein	NOUN	I
alone	O	ADV	O
,	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
bound	O	VERB	B
the	O	DET	O
element	O	NOUN	B
but	O	CCONJ	O
also	O	ADV	O
could	O	AUX	O
not	O	PART	O
repress	O	VERB	B
IL-2	B-protein	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
direct	O	ADJ	O
inhibition	O	NOUN	B
by	O	ADP	O
a	O	DET	O
nuclear	O	ADJ	B
hormone	O	NOUN	I
receptor	O	NOUN	I
of	O	ADP	O
transcriptional	B-protein	ADJ	B
activators	I-protein	NOUN	I
of	O	ADP	O
the	O	DET	O
IL-2	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
may	O	AUX	O
provide	O	VERB	O
a	O	DET	O
mechanistic	O	ADJ	O
explanation	O	NOUN	B
of	O	ADP	O
how	O	SCONJ	O
vitamin	O	NOUN	B
derivatives	O	NOUN	I
can	O	AUX	O
act	O	VERB	O
as	O	ADP	O
potent	O	ADJ	O
immunosuppressive	O	ADJ	B
agents	O	NOUN	I
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
report	O	VERB	O
that	O	SCONJ	O
CsA	O	NOUN	B
treatment	O	NOUN	B
of	O	ADP	O
Raji	B-cell_line	NOUN	B
B	I-cell_line	NOUN	I
and	O	CCONJ	O
Jurkat	B-cell_line	NOUN	B
T	I-cell_line	NOUN	I
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
yields	O	VERB	O
a	O	DET	O
phosphorylated	O	ADJ	B
form	O	NOUN	O
of	O	ADP	O
NFATp	B-protein	NOUN	B
that	O	PRON	O
is	O	AUX	O
inhibited	O	VERB	B
in	O	ADP	O
DNA-binding	O	ADJ	B
and	O	CCONJ	O
in	O	ADP	O
its	O	PRON	O
ability	O	NOUN	O
to	O	PART	O
form	O	VERB	O
an	O	DET	O
NFAT	B-protein	NOUN	B
complex	I-protein	NOUN	I
with	O	ADP	O
Fos	B-protein	NOUN	B
and	O	CCONJ	O
Jun	B-protein	NOUN	B
.	O	PUNCT	O


Dephosphorylation	O	NOUN	B
by	O	ADP	O
in	O	X	B
vitro	O	X	I
treatment	O	NOUN	B
with	O	ADP	O
calcineurin	B-protein	NOUN	B
or	O	CCONJ	O
alkaline	B-protein	NOUN	B
phosphatase	I-protein	NOUN	I
restores	O	VERB	B
NFATp	B-protein	NOUN	B
DNA	O	NOUN	B
binding	O	NOUN	I
activity	O	NOUN	I
and	O	CCONJ	O
its	O	PRON	O
ability	O	NOUN	O
to	O	PART	O
reconstitute	O	VERB	B
an	O	DET	O
NFAT	B-protein	NOUN	B
complex	I-protein	NOUN	I
with	O	ADP	O
Fos	B-protein	NOUN	B
and	O	CCONJ	O
Jun	B-protein	NOUN	B
proteins	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
previously	O	ADV	O
have	O	AUX	O
demonstrated	O	VERB	O
a	O	DET	O
requirement	O	NOUN	B
for	O	ADP	O
oxidative	O	ADJ	B
events	O	NOUN	I
during	O	ADP	O
cell	O	NOUN	B
cycle	O	NOUN	I
entry	O	NOUN	I
in	O	ADP	O
T	B-cell_type	NOUN	B
lymphocytes	I-cell_type	NOUN	I
and	O	CCONJ	O
have	O	AUX	O
hypothesised	O	VERB	O
that	O	SCONJ	O
reactive	O	ADJ	B
oxygen	O	NOUN	I
species	O	NOUN	I
may	O	AUX	O
act	O	VERB	O
as	O	ADP	O
intracellular	O	ADJ	B
signalling	O	NOUN	O
agents	O	NOUN	O
during	O	ADP	O
lymphocyte	O	NOUN	B
activation	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
resting	B-cell_type	VERB	O
PBL	I-cell_type	NOUN	B
constitutively	O	ADV	B
expressed	O	VERB	B
prominent	O	ADJ	O
levels	O	NOUN	B
of	O	ADP	O
Id2	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
Id3	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
.	O	PUNCT	O


Upon	O	SCONJ	O
PHA	B-protein	NOUN	B
-stimulation	O	NOUN	O
,	O	PUNCT	O
Id2	B-protein	NOUN	B
expression	O	NOUN	B
decreased	O	VERB	B
and	O	CCONJ	O
Id3	B-protein	NOUN	B
levels	O	NOUN	B
increased	O	VERB	B
with	O	ADP	O
biphasic	O	ADJ	B
kinetics	O	NOUN	B
.	O	PUNCT	O


TF	O	NOUN	B
expression	O	NOUN	B
by	O	ADP	O
circulating	B-cell_type	VERB	B
monocytes	I-cell_type	NOUN	B
is	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
thrombotic	O	ADJ	B
and	O	CCONJ	O
inflammatory	O	ADJ	B
complications	O	NOUN	B
in	O	ADP	O
a	O	DET	O
variety	O	NOUN	O
of	O	ADP	O
diseases	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
two	O	NUM	O
other	O	ADJ	O
nonsteroidal	O	ADJ	B
anti-inflammatory	O	ADJ	I
drugs	O	NOUN	I
,	O	PUNCT	O
ibuprofen	O	NOUN	B
and	O	CCONJ	O
indomethacin	O	NOUN	B
,	O	PUNCT	O
did	O	AUX	O
not	O	PART	O
inhibit	O	VERB	B
LPS	O	NOUN	B
induction	O	NOUN	B
of	O	ADP	O
the	O	DET	O
TF	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
.	O	PUNCT	O


The	O	DET	O
T	O	NOUN	B
cell	O	NOUN	I
activation	O	NOUN	B
is	O	AUX	O
initiated	O	VERB	O
by	O	ADP	O
interaction	O	NOUN	B
of	O	ADP	O
specific	O	ADJ	O
Ags	B-protein	NOUN	B
with	O	ADP	O
TCR	B-protein	NOUN	B
,	O	PUNCT	O
followed	O	VERB	O
by	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
intracellular	O	ADJ	B
biochemical	O	ADJ	B
events	O	NOUN	O
leading	O	VERB	O
to	O	PART	O
activation	O	NOUN	B
of	O	ADP	O
several	O	ADJ	O
genes	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
purified	B-cell_type	VERB	B
human	I-cell_type	ADJ	B
peripheral	I-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
T	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
nuclear	B-protein	ADJ	B
STAT	I-protein	NOUN	I
proteins	I-protein	NOUN	I
were	O	AUX	O
activated	O	VERB	B
approximately	O	ADV	O
3	O	NUM	O
h	O	NOUN	O
after	O	ADP	O
activation	O	NOUN	B
by	O	ADP	O
cross-linked	O	ADJ	B
anti-CD3	B-protein	ADJ	B
Abs	I-protein	NOUN	B
.	O	PUNCT	O


Expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
chemokine	B-protein	NOUN	B
receptor	I-protein	NOUN	I
BLR2/EBI1	B-protein	NOUN	B
is	O	AUX	O
specifically	O	ADV	O
transactivated	O	VERB	B
by	O	ADP	O
Epstein-Barr	B-protein	ADJ	B
virus	I-protein	NOUN	I
nuclear	I-protein	ADJ	I
antigen	I-protein	NOUN	I
2	I-protein	NUM	I
.	O	PUNCT	O


BLR2-specific	B-RNA	ADJ	B
mRNA	I-RNA	NOUN	B
could	O	AUX	O
be	O	AUX	O
detected	O	VERB	B
in	O	ADP	O
all	O	DET	O
Epstein-Barr	B-cell_line	ADJ	B
virus	I-cell_line	NOUN	I
positive	I-cell_line	ADJ	B
B	I-cell_line	NOUN	I
cell	I-cell_line	NOUN	I
lines	I-cell_line	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
now	O	ADV	O
show	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
core	O	NOUN	B
contains	O	VERB	O
a	O	DET	O
single	O	ADJ	O
critical	O	ADJ	O
c-Myb	B-DNA	NOUN	B
binding	I-DNA	NOUN	B
site	I-DNA	NOUN	I
.	O	PUNCT	O


c-Myb	B-protein	NOUN	B
protein	I-protein	NOUN	I
was	O	AUX	O
strongly	O	ADV	O
evident	O	ADJ	O
in	O	ADP	O
T	B-cell_type	NOUN	B
lymphoblasts	I-cell_type	NOUN	I
in	O	ADP	O
which	O	DET	O
the	O	DET	O
enhancer	B-DNA	NOUN	B
was	O	AUX	O
active	O	ADJ	B
and	O	CCONJ	O
was	O	AUX	O
localized	O	ADJ	B
within	O	ADP	O
discrete	O	ADJ	O
nuclear	O	ADJ	B
structures	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
paper	O	NOUN	O
we	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
distal	O	ADJ	B
region	O	NOUN	I
of	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
immunodeficiency	I-DNA	NOUN	I
virus-1	I-DNA	NOUN	I
(	I-DNA	PUNCT	O
HIV-1	I-DNA	NOUN	B
)	I-DNA	PUNCT	O
enhancer	I-DNA	NOUN	B
,	O	PUNCT	O
which	O	DET	O
contains	O	VERB	O
DNA-binding	B-DNA	ADJ	B
sites	I-DNA	NOUN	I
for	O	ADP	O
LEF-1	B-protein	NOUN	B
and	O	CCONJ	O
Ets-1	O	NOUN	B
,	O	PUNCT	O
also	O	ADV	O
provides	O	VERB	O
a	O	DET	O
functional	O	ADJ	B
context	O	NOUN	O
for	O	ADP	O
activation	O	NOUN	B
by	O	ADP	O
LEF-1	B-protein	NOUN	B
.	O	PUNCT	O


Addition	O	NOUN	B
of	O	ADP	O
TFE-3	B-protein	NOUN	B
,	O	PUNCT	O
which	O	DET	O
binds	O	VERB	B
to	O	PART	O
an	O	DET	O
E-box	B-DNA	NOUN	B
motif	I-DNA	NOUN	B
upstream	O	ADJ	I
of	O	ADP	O
the	O	DET	O
LEF-1	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
Ets-1	I-DNA	NOUN	B
sites	I-DNA	NOUN	O
,	O	PUNCT	O
further	O	ADV	O
augments	O	VERB	O
transcription	O	NOUN	B
in	O	ADP	O
this	O	DET	O
system	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
truncation	B-protein	NOUN	B
mutant	I-protein	NOUN	I
of	O	ADP	O
LEF-1	B-protein	NOUN	B
(	O	PUNCT	O
HMG-88	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
which	O	DET	O
contains	O	VERB	O
the	O	DET	O
HMG	B-protein	NOUN	B
box	I-protein	NOUN	I
but	O	CCONJ	O
lacks	O	VERB	O
the	O	DET	O
trans-activation	B-protein	NOUN	B
domain	I-protein	NOUN	I
,	O	PUNCT	O
did	O	AUX	O
not	O	PART	O
activate	O	VERB	B
transcription	O	NOUN	B
from	O	ADP	O
nucleosomal	B-DNA	ADJ	B
DNA	I-DNA	NOUN	I
,	O	PUNCT	O
indicating	O	VERB	O
that	O	SCONJ	O
bending	O	NOUN	B
of	O	ADP	O
DNA	O	NOUN	B
by	O	ADP	O
the	O	DET	O
HMG	B-protein	NOUN	B
domain	I-protein	NOUN	I
is	O	AUX	O
not	O	PART	O
sufficient	O	ADJ	O
to	O	PART	O
activate	O	VERB	B
transcription	O	NOUN	B
in	O	X	B
vitro	O	X	I
.	O	PUNCT	O


Immunoprecipitation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
gp	B-protein	NOUN	B
160	I-protein	NUM	O
-induced	O	ADJ	O
nuclear	O	ADJ	B
extracts	O	NOUN	I
with	O	ADP	O
polyclonal	B-protein	ADJ	B
antibodies	I-protein	NOUN	I
to	O	PART	O
Fos	B-protein	NOUN	B
and	O	CCONJ	O
Jun	B-protein	NOUN	B
proteins	I-protein	NOUN	I
indicates	O	VERB	O
that	O	SCONJ	O
AP-1	B-protein	NOUN	B
complex	I-protein	NOUN	I
is	O	AUX	O
comprised	O	VERB	O
of	O	ADP	O
members	O	NOUN	B
of	O	ADP	O
these	O	DET	O
family	O	NOUN	B
of	O	ADP	I
proteins	O	NOUN	I
.	O	PUNCT	O


